<SEC-DOCUMENT>0000874716-22-000007.txt : 20220216
<SEC-HEADER>0000874716-22-000007.hdr.sgml : 20220216
<ACCEPTANCE-DATETIME>20220216145707
ACCESSION NUMBER:		0000874716-22-000007
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		230
CONFORMED PERIOD OF REPORT:	20211231
FILED AS OF DATE:		20220216
DATE AS OF CHANGE:		20220216

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			IDEXX LABORATORIES INC /DE
		CENTRAL INDEX KEY:			0000874716
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				010393723
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-19271
		FILM NUMBER:		22643214

	BUSINESS ADDRESS:	
		STREET 1:		ONE IDEXX DRIVE
		CITY:			WESTBROOK
		STATE:			ME
		ZIP:			04092-2041
		BUSINESS PHONE:		2075560300

	MAIL ADDRESS:	
		STREET 1:		ONE IDEXX DRIVE
		CITY:			WESTBROOK
		STATE:			ME
		ZIP:			04092-2041

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	IDEXX CORP / DE
		DATE OF NAME CHANGE:	19600201
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>idxx-20211231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:f52bcaef-ba11-42ce-aefc-0c16e0e0e054,g:8ec733b7-1a7e-4401-9212-15a98e503c1c,d:5d795a6851d746ca914a2ddae761c329--><html xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns="http://www.w3.org/1999/xhtml" xmlns:idxx="http://www.idexx.com/20211231" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xbrli="http://www.xbrl.org/2003/instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>idxx-20211231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV80L2ZyYWc6ZWM4ZDU0ZTJmOGVjNGQ1NjgyZTQ1YmJkOTRkYWMzMzUvdGFibGU6OTdhNDg3ZjA2MzBlNDQ1Mzg4ZjRkNzU5ZjBiMTcxZGQvdGFibGVyYW5nZTo5N2E0ODdmMDYzMGU0NDUzODhmNGQ3NTlmMGIxNzFkZF8zLTEtMS0xLTA_e6301fcf-81b1-407c-bca3-37def8e7b962">false</ix:nonNumeric><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV80L2ZyYWc6ZWM4ZDU0ZTJmOGVjNGQ1NjgyZTQ1YmJkOTRkYWMzMzUvdGFibGU6OTdhNDg3ZjA2MzBlNDQ1Mzg4ZjRkNzU5ZjBiMTcxZGQvdGFibGVyYW5nZTo5N2E0ODdmMDYzMGU0NDUzODhmNGQ3NTlmMGIxNzFkZF80LTEtMS0xLTA_ca45dcb0-f67c-4c5e-81c6-c622471f7fbe">2021</ix:nonNumeric><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV80L2ZyYWc6ZWM4ZDU0ZTJmOGVjNGQ1NjgyZTQ1YmJkOTRkYWMzMzUvdGFibGU6OTdhNDg3ZjA2MzBlNDQ1Mzg4ZjRkNzU5ZjBiMTcxZGQvdGFibGVyYW5nZTo5N2E0ODdmMDYzMGU0NDUzODhmNGQ3NTlmMGIxNzFkZF81LTEtMS0xLTA_edacf6ee-f0c7-4530-996c-8cc8e691a766">FY</ix:nonNumeric><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV80L2ZyYWc6ZWM4ZDU0ZTJmOGVjNGQ1NjgyZTQ1YmJkOTRkYWMzMzUvdGFibGU6OTdhNDg3ZjA2MzBlNDQ1Mzg4ZjRkNzU5ZjBiMTcxZGQvdGFibGVyYW5nZTo5N2E0ODdmMDYzMGU0NDUzODhmNGQ3NTlmMGIxNzFkZF82LTEtMS0xLTA_d344e9dd-ce2a-4298-a344-18128164bde8">IDEXX LABORATORIES INC /DE</ix:nonNumeric><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV80L2ZyYWc6ZWM4ZDU0ZTJmOGVjNGQ1NjgyZTQ1YmJkOTRkYWMzMzUvdGFibGU6OTdhNDg3ZjA2MzBlNDQ1Mzg4ZjRkNzU5ZjBiMTcxZGQvdGFibGVyYW5nZTo5N2E0ODdmMDYzMGU0NDUzODhmNGQ3NTlmMGIxNzFkZF83LTEtMS0xLTA_0f8276a4-e799-4a56-a84b-fe7d930802f7">0000874716</ix:nonNumeric><ix:nonNumeric contextRef="i35fada0f29454b9e9fbe5fa23ce2f2e7_D20210101-20211231" name="idxx:ExtendedProductWarrantyTerm" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzQ4MjE_1e3581e2-aa87-4799-8610-c43eba500df3">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="id896191bdc6d41d1afbef82d66327428_D20210101-20211231" name="idxx:ExtendedProductWarrantyTerm" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzIzNTc2_f9986b18-206a-41dd-850a-8be4c0938fc3">P5Y</ix:nonNumeric><ix:nonNumeric contextRef="ia8d9c432d3bf4b74adffb2d189372886_I20211231" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODEvZnJhZzoyMTM0ZDg3OGJjZTE0MWQ2YTk5MDRiZTI3YTljMTM0Ny90YWJsZTpjNWJhYWYwMTY5YWI0ODAwYmI5ODIyZTU1MDljOWIwNS90YWJsZXJhbmdlOmM1YmFhZjAxNjlhYjQ4MDBiYjk4MjJlNTUwOWM5YjA1XzItMS0xLTEtMA_b2b1751e-51e6-4a7e-bbd6-0c8faf837743">1</ix:nonNumeric><ix:nonNumeric contextRef="id18052a9bc8947e885971777f75a622b_I20211231" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODEvZnJhZzoyMTM0ZDg3OGJjZTE0MWQ2YTk5MDRiZTI3YTljMTM0Ny90YWJsZTpjNWJhYWYwMTY5YWI0ODAwYmI5ODIyZTU1MDljOWIwNS90YWJsZXJhbmdlOmM1YmFhZjAxNjlhYjQ4MDBiYjk4MjJlNTUwOWM5YjA1XzItMi0xLTEtMA_2412c471-c7b4-4763-bc4f-67f2a39a69ff">1</ix:nonNumeric><ix:nonNumeric contextRef="i489a306049d8454da4686e43ac9f9be5_I20211231" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODEvZnJhZzoyMTM0ZDg3OGJjZTE0MWQ2YTk5MDRiZTI3YTljMTM0Ny90YWJsZTpjNWJhYWYwMTY5YWI0ODAwYmI5ODIyZTU1MDljOWIwNS90YWJsZXJhbmdlOmM1YmFhZjAxNjlhYjQ4MDBiYjk4MjJlNTUwOWM5YjA1XzItMy0xLTEtMA_798c85ef-3b4f-46f2-bcaf-fc1d12210417">1</ix:nonNumeric><ix:nonNumeric contextRef="iee7069d3c7944d9d8e2527acff1fbc06_I20211231" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODEvZnJhZzoyMTM0ZDg3OGJjZTE0MWQ2YTk5MDRiZTI3YTljMTM0Ny90YWJsZTpjNWJhYWYwMTY5YWI0ODAwYmI5ODIyZTU1MDljOWIwNS90YWJsZXJhbmdlOmM1YmFhZjAxNjlhYjQ4MDBiYjk4MjJlNTUwOWM5YjA1XzItNC0xLTEtMA_8b88f6b1-79b2-4bd3-8c56-421d4a6821c9">1</ix:nonNumeric><ix:nonNumeric contextRef="i047ec28985a54ca496f585918ccf62f6_I20211231" xsi:nil="true" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODEvZnJhZzoyMTM0ZDg3OGJjZTE0MWQ2YTk5MDRiZTI3YTljMTM0Ny90YWJsZTpjNWJhYWYwMTY5YWI0ODAwYmI5ODIyZTU1MDljOWIwNS90YWJsZXJhbmdlOmM1YmFhZjAxNjlhYjQ4MDBiYjk4MjJlNTUwOWM5YjA1XzItNS0xLTEtMA_6ecee727-b857-43ac-a346-4c5d1a816848"></ix:nonNumeric><ix:nonNumeric contextRef="i3f8679f022804acba3547f27b82749ee_I20211231" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODEvZnJhZzoyMTM0ZDg3OGJjZTE0MWQ2YTk5MDRiZTI3YTljMTM0Ny90YWJsZTpjNWJhYWYwMTY5YWI0ODAwYmI5ODIyZTU1MDljOWIwNS90YWJsZXJhbmdlOmM1YmFhZjAxNjlhYjQ4MDBiYjk4MjJlNTUwOWM5YjA1XzMtMS0xLTEtMA_fed92f74-3318-40f5-95cc-a96959949376">1</ix:nonNumeric><ix:nonNumeric contextRef="ia1b14ac41fb14c2d8d6ba017fa4e925e_I20211231" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODEvZnJhZzoyMTM0ZDg3OGJjZTE0MWQ2YTk5MDRiZTI3YTljMTM0Ny90YWJsZTpjNWJhYWYwMTY5YWI0ODAwYmI5ODIyZTU1MDljOWIwNS90YWJsZXJhbmdlOmM1YmFhZjAxNjlhYjQ4MDBiYjk4MjJlNTUwOWM5YjA1XzMtMi0xLTEtMA_b1365d85-eb03-4768-b6f0-adc21a7aaae7">1</ix:nonNumeric><ix:nonNumeric contextRef="icb7e410e248e43c994cb93d2f03fbf8f_I20211231" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODEvZnJhZzoyMTM0ZDg3OGJjZTE0MWQ2YTk5MDRiZTI3YTljMTM0Ny90YWJsZTpjNWJhYWYwMTY5YWI0ODAwYmI5ODIyZTU1MDljOWIwNS90YWJsZXJhbmdlOmM1YmFhZjAxNjlhYjQ4MDBiYjk4MjJlNTUwOWM5YjA1XzMtMy0xLTEtMA_e1ea477e-b77e-4d35-9da2-cc12436f7449">1</ix:nonNumeric><ix:nonNumeric contextRef="ie2230e0e134c41099416ecb0514e3a3c_I20211231" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODEvZnJhZzoyMTM0ZDg3OGJjZTE0MWQ2YTk5MDRiZTI3YTljMTM0Ny90YWJsZTpjNWJhYWYwMTY5YWI0ODAwYmI5ODIyZTU1MDljOWIwNS90YWJsZXJhbmdlOmM1YmFhZjAxNjlhYjQ4MDBiYjk4MjJlNTUwOWM5YjA1XzMtNC0xLTEtMA_929d1ebb-af21-4771-a85e-e4fb3d0d7a44">1</ix:nonNumeric><ix:nonNumeric contextRef="i3e0eda093e4c442d97a50489871ee0c6_I20211231" xsi:nil="true" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODEvZnJhZzoyMTM0ZDg3OGJjZTE0MWQ2YTk5MDRiZTI3YTljMTM0Ny90YWJsZTpjNWJhYWYwMTY5YWI0ODAwYmI5ODIyZTU1MDljOWIwNS90YWJsZXJhbmdlOmM1YmFhZjAxNjlhYjQ4MDBiYjk4MjJlNTUwOWM5YjA1XzMtNS0xLTEtMA_a3c5585d-4222-400a-ad6e-243f1cbe82cb"></ix:nonNumeric><ix:nonNumeric contextRef="i76e3709ae6e04372b5824637c99c55ce_I20211231" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODEvZnJhZzoyMTM0ZDg3OGJjZTE0MWQ2YTk5MDRiZTI3YTljMTM0Ny90YWJsZTpjNWJhYWYwMTY5YWI0ODAwYmI5ODIyZTU1MDljOWIwNS90YWJsZXJhbmdlOmM1YmFhZjAxNjlhYjQ4MDBiYjk4MjJlNTUwOWM5YjA1XzQtMS0xLTEtMA_c38eb3af-98fe-4502-ae06-d6ce05ccb86b">1</ix:nonNumeric><ix:nonNumeric contextRef="ide72157b20624cbba3e378503b944506_I20211231" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODEvZnJhZzoyMTM0ZDg3OGJjZTE0MWQ2YTk5MDRiZTI3YTljMTM0Ny90YWJsZTpjNWJhYWYwMTY5YWI0ODAwYmI5ODIyZTU1MDljOWIwNS90YWJsZXJhbmdlOmM1YmFhZjAxNjlhYjQ4MDBiYjk4MjJlNTUwOWM5YjA1XzQtMi0xLTEtMA_e2d490b2-6094-4aad-8bb6-8ff9d8d8d446">1</ix:nonNumeric><ix:nonNumeric contextRef="i8af8821a5a8e4e06898dabdea6965ee3_I20211231" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODEvZnJhZzoyMTM0ZDg3OGJjZTE0MWQ2YTk5MDRiZTI3YTljMTM0Ny90YWJsZTpjNWJhYWYwMTY5YWI0ODAwYmI5ODIyZTU1MDljOWIwNS90YWJsZXJhbmdlOmM1YmFhZjAxNjlhYjQ4MDBiYjk4MjJlNTUwOWM5YjA1XzQtMy0xLTEtMA_b898e5c2-3782-4948-b237-8bd7214838a6">1</ix:nonNumeric><ix:nonNumeric contextRef="i865e2c5df39b4cecb1d900db1ae6ca7d_I20211231" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODEvZnJhZzoyMTM0ZDg3OGJjZTE0MWQ2YTk5MDRiZTI3YTljMTM0Ny90YWJsZTpjNWJhYWYwMTY5YWI0ODAwYmI5ODIyZTU1MDljOWIwNS90YWJsZXJhbmdlOmM1YmFhZjAxNjlhYjQ4MDBiYjk4MjJlNTUwOWM5YjA1XzQtNC0xLTEtMA_6b055acb-acb9-4690-b65a-bf14993d3754">1</ix:nonNumeric><ix:nonNumeric contextRef="if8efddd0307c4f6c9b1fab4c82f7cd7b_I20211231" xsi:nil="true" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODEvZnJhZzoyMTM0ZDg3OGJjZTE0MWQ2YTk5MDRiZTI3YTljMTM0Ny90YWJsZTpjNWJhYWYwMTY5YWI0ODAwYmI5ODIyZTU1MDljOWIwNS90YWJsZXJhbmdlOmM1YmFhZjAxNjlhYjQ4MDBiYjk4MjJlNTUwOWM5YjA1XzQtNS0xLTEtMA_b37ba342-8004-476e-b83a-b2d11cd9a29d"></ix:nonNumeric><ix:nonNumeric contextRef="i0e53a7345431421d90c84f0714010ab8_I20211231" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODEvZnJhZzoyMTM0ZDg3OGJjZTE0MWQ2YTk5MDRiZTI3YTljMTM0Ny90YWJsZTpjNWJhYWYwMTY5YWI0ODAwYmI5ODIyZTU1MDljOWIwNS90YWJsZXJhbmdlOmM1YmFhZjAxNjlhYjQ4MDBiYjk4MjJlNTUwOWM5YjA1XzUtMS0xLTEtMA_59822875-22e5-4793-87b2-fd135bfb8f38">1</ix:nonNumeric><ix:nonNumeric contextRef="i26a9c61e7add4db7b09dd7228e5adf11_I20211231" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODEvZnJhZzoyMTM0ZDg3OGJjZTE0MWQ2YTk5MDRiZTI3YTljMTM0Ny90YWJsZTpjNWJhYWYwMTY5YWI0ODAwYmI5ODIyZTU1MDljOWIwNS90YWJsZXJhbmdlOmM1YmFhZjAxNjlhYjQ4MDBiYjk4MjJlNTUwOWM5YjA1XzUtMi0xLTEtMA_9fef5566-be30-4e03-b95a-43711818522d">1</ix:nonNumeric><ix:nonNumeric contextRef="i552f56ee344349d0a8fe803f1d4ac028_I20211231" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODEvZnJhZzoyMTM0ZDg3OGJjZTE0MWQ2YTk5MDRiZTI3YTljMTM0Ny90YWJsZTpjNWJhYWYwMTY5YWI0ODAwYmI5ODIyZTU1MDljOWIwNS90YWJsZXJhbmdlOmM1YmFhZjAxNjlhYjQ4MDBiYjk4MjJlNTUwOWM5YjA1XzUtMy0xLTEtMA_2c7339aa-6b7c-473d-9d44-1b1fbc99f9ae">1</ix:nonNumeric><ix:nonNumeric contextRef="ia21b4eae913c4602899f11b240ecd020_I20211231" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODEvZnJhZzoyMTM0ZDg3OGJjZTE0MWQ2YTk5MDRiZTI3YTljMTM0Ny90YWJsZTpjNWJhYWYwMTY5YWI0ODAwYmI5ODIyZTU1MDljOWIwNS90YWJsZXJhbmdlOmM1YmFhZjAxNjlhYjQ4MDBiYjk4MjJlNTUwOWM5YjA1XzUtNC0xLTEtMA_479dd2aa-dcd6-4790-a76f-b26a13baf80d">1</ix:nonNumeric><ix:nonNumeric contextRef="i8e6515d33c104d37893035bf37f096ad_I20211231" xsi:nil="true" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODEvZnJhZzoyMTM0ZDg3OGJjZTE0MWQ2YTk5MDRiZTI3YTljMTM0Ny90YWJsZTpjNWJhYWYwMTY5YWI0ODAwYmI5ODIyZTU1MDljOWIwNS90YWJsZXJhbmdlOmM1YmFhZjAxNjlhYjQ4MDBiYjk4MjJlNTUwOWM5YjA1XzUtNS0xLTEtMA_578439bd-f5fd-4b3e-b058-463b7d111e21"></ix:nonNumeric><ix:nonNumeric contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDgvZnJhZzo2YjI1NjU3MGQ2Y2M0ZTllYWY5MDBhYzk2ZTU2Yjg3My90YWJsZTpkMzgwNTNlNWU4ZTg0N2FhYWQ5MDI3M2UxMDAzMzM5MS90YWJsZXJhbmdlOmQzODA1M2U1ZThlODQ3YWFhZDkwMjczZTEwMDMzMzkxXzctMC0xLTEtMA_5d2faed1-a462-48ce-9b44-a109b44ef227">http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDgvZnJhZzo2YjI1NjU3MGQ2Y2M0ZTllYWY5MDBhYzk2ZTU2Yjg3My90YWJsZTpkMzgwNTNlNWU4ZTg0N2FhYWQ5MDI3M2UxMDAzMzM5MS90YWJsZXJhbmdlOmQzODA1M2U1ZThlODQ3YWFhZDkwMjczZTEwMDMzMzkxXzctMC0xLTEtMA_e4f554de-7131-4a19-8325-4f920319c89c">http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="idxx-20211231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i309abd36f89849cfae9056eea2c66b2e_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i36ae306a96da42d1a0ef962db0aad1ea_I20220202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-02-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i257dea584c2540acb77224b3a70b171d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bc10811c8b443b6ae93662c965b99e4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ic726475fb9e14ee5a91a94f1384e1a43_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3e97410fa904f6b9da8bf1da4160760_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icaff31c4dfc74beebd9e4f2367f76db7_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e1d4a27d5524619b8f8d3d7ab6dc3e9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5e9c5621d1e4b70b61639e6582ff3c2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida0b80c182f342c3996f1a84b8b8fb9c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c634b937c58472e84857eacf99e17df_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28d0821cac8841b29cf960002d3bc993_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc55888d777a4d23bc9cfb38c781c1b0_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5198e31e82c4830868ddd894d8bea8e_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47457672ea94468ab1c5cd3068086847_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:DeferredStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia510c04f9d61478ea746fbff0dd20e7a_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0030920649fc4bfeaec05aad85e23ea9_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ca52acda88f4806b415035b2e87a637_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4eba3ab172724f5cb99036c1a25946f4_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3eebac5bf6864fc4a7c5f697b102c9f9_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie44c061415214719bc569b35577d8629_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52c9d97bec804143a591d49a316a5d59_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ddfcdc960064849802514d1f2a8bbfb_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i459299d77adf46b2baa2eefe5c566758_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1564d43c43d4ed28f279068c2cec341_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3ee522263ee4c1ab1a5860feaa32d9b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:DeferredStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb04d957babc4708830136f812aa04c6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia754ac48509b4751bfa3915a39627bc6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i979a783478524796bf27df092c164acb_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:DeferredStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0d07a5bb51144978faf2ec5745936dc_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf017de1fe8245b490bf3ba36d73909c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8fa2c23303164297bbef06a53a57f47d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i070ac0c233c64a6b8c2c8c44a84a6b9c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40d60db7ecae431bbb3cc52673c3f08c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9dcdb5ab830946f987d2c255bb59ed41_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i843cb27f38cc4792b41236eefc1a5b9a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c49c956c8bd476fbc5a218bb26fc1e7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifefe9c40d7f444cfaa6687822f8d9fe2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6390dc8d6016472b99f4f5e8bcd76bd7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1405c98ed2d04737be98553084c09616_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7353d8a3c0814b3387f39a6d5c074615_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb488124070d493c8bc4c944a20bf01a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:DeferredStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib43cc74de7f9447797f368526c52d81a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iacf2e4f12bb748b29e58438c9e86121d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie21fa7b167864efaa91ab594caaa329f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:DeferredStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e204f1ef8454b7688e083aa906679b1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57792c148d4b4ba5b2eb677b657b7a2b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iffadbee2ebda4dbd995c7ad9756f26ae_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i592d601cd0814365b50dc596de883440_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5494ccc733ab4588a07cf0c681f7fc5b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i429f0a9281954c8991dd7a289fa848cf_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62a7d75347e640f1a8e7e3577bb0a247_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17c7e782291f468da00d43bcb50b822f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80d844cab93d4373b5a710038b7a3f8a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4e99dbc526e4e2185b83986a19641e6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifdf9b694355c4799a0d984c56a7af188_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:DeferredStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8486d76f7282415c96b78263d0e53fed_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65e8850835e644b0a942d37199d2fac2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9152bd3467a54594bc1a3df15df505af_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:DeferredStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22db15f5a3f64f13a2a4241901d35b3e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4ce9f46b7a347608b97422112175f6f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8be03ed376d64697b29c2563ea25de6d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i727ded70819a4775adf0f51b27e35673_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21b5e95e95564226a627f64e7713aea8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201613Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb0fcabcbe0847e89f685ded467776c8_D20200101-20200101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201613Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic23d3f2012b145a986354fd6baa91f83_I20200101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201613Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i464c41d2cb9948979da5af09e9a6709b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2547ad5bc951453f98e34b5d0f26b8bb_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35fada0f29454b9e9fbe5fa23ce2f2e7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:ExtendedWarrantiesAndPostContractSupportMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id896191bdc6d41d1afbef82d66327428_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:ExtendedWarrantiesAndPostContractSupportMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if381570659954770b2820ee07047c157_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:ExtendedWarrantiesAndPostContractSupportMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i242e9b6f55554b858443459f0e68afb7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:ExtendedWarrantiesAndPostContractSupportMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i685e23f0c6e840b7aecebc2994601eb2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:ExtendedWarrantiesAndPostContractSupportMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8d9c432d3bf4b74adffb2d189372886_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:ExtendedWarrantiesAndPostContractSupportMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="id18052a9bc8947e885971777f75a622b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:ExtendedWarrantiesAndPostContractSupportMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i489a306049d8454da4686e43ac9f9be5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2024-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:ExtendedWarrantiesAndPostContractSupportMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee7069d3c7944d9d8e2527acff1fbc06_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2025-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:ExtendedWarrantiesAndPostContractSupportMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i047ec28985a54ca496f585918ccf62f6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2026-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:ExtendedWarrantiesAndPostContractSupportMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96beb1b4304e4f20a74ee69716a60a3e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:UpFrontCustomerLoyaltyProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i437a7bd65c7c46ae8cd7c9e49b4ee334_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:UpFrontCustomerLoyaltyProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7205413c9894bd7a9838d72705913eb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:UpFrontCustomerLoyaltyProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f2f5cdb189f4934b1e3cebeb924b507_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:VolumeCommitmentProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79ce71bddf09448f9ea714ce6102c47b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:VolumeCommitmentProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09befd933773486bbae96a48cee3829b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:VolumeCommitmentProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51f68fc78b89418293d672d19db8aff1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:UpFrontCustomerLoyaltyProgramsAndVolumeCommitmentProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f8679f022804acba3547f27b82749ee_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:UpFrontCustomerLoyaltyProgramsAndVolumeCommitmentProgramsMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1b14ac41fb14c2d8d6ba017fa4e925e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:UpFrontCustomerLoyaltyProgramsAndVolumeCommitmentProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb7e410e248e43c994cb93d2f03fbf8f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:UpFrontCustomerLoyaltyProgramsAndVolumeCommitmentProgramsMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2024-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2230e0e134c41099416ecb0514e3a3c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:UpFrontCustomerLoyaltyProgramsAndVolumeCommitmentProgramsMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2025-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e0eda093e4c442d97a50489871ee0c6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2026-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:UpFrontCustomerLoyaltyProgramsAndVolumeCommitmentProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c2e03def5d746e991b38bd94dccfbdb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:InstrumentRebateProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf88e478362d4b679f69d782be7a8360_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:InstrumentRebateProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id886e662c2af48208ad13c5d0017a93e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:InstrumentRebateProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76e3709ae6e04372b5824637c99c55ce_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:InstrumentRebateProgramsMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide72157b20624cbba3e378503b944506_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:InstrumentRebateProgramsMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8af8821a5a8e4e06898dabdea6965ee3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:InstrumentRebateProgramsMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2024-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i865e2c5df39b4cecb1d900db1ae6ca7d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:InstrumentRebateProgramsMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2025-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8efddd0307c4f6c9b1fab4c82f7cd7b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2026-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:InstrumentRebateProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i269b18a6e9c74892a68183dfb6d26182_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:ReagentRentalProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e53a7345431421d90c84f0714010ab8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:ReagentRentalProgramsMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26a9c61e7add4db7b09dd7228e5adf11_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:ReagentRentalProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i552f56ee344349d0a8fe803f1d4ac028_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:ReagentRentalProgramsMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2024-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia21b4eae913c4602899f11b240ecd020_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:ReagentRentalProgramsMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2025-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e6515d33c104d37893035bf37f096ad_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2026-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:ReagentRentalProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i723287d015984ccaa532d58c82848761_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:CompanionAnimalGroupSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:CAGDiagnosticsRecurringRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if77b95f4c71f4d27a4b24d6a7f47cb19_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:CompanionAnimalGroupSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:CAGDiagnosticsRecurringRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3495e15513b94d078ea449cf5f428620_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:CompanionAnimalGroupSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:CAGDiagnosticsRecurringRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf886748aba34b2dae8f6c7817ad2a16_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:VetLabConsumablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:CompanionAnimalGroupSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45c842be487a4adeaf405fb278d02adb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:VetLabConsumablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:CompanionAnimalGroupSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iecf199144d3940e08f79eb67130f5a22_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:VetLabConsumablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:CompanionAnimalGroupSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a1a0bb358d847259b4ee304e5a46a33_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:RapidAssayProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:CompanionAnimalGroupSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i793b95b40c3a4a9490a98b288a146ee0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:RapidAssayProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:CompanionAnimalGroupSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56aa1f828bc845f58439fe0a42646b60_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:RapidAssayProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:CompanionAnimalGroupSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82504fe08ede4c6f89672ec5a625601e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:ReferenceLaboratoryDiagnosticAndConsultingServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:CompanionAnimalGroupSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32b9c9eff8ca4148be177ce0cbdddd6b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:ReferenceLaboratoryDiagnosticAndConsultingServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:CompanionAnimalGroupSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1430c1be15d34b1abe49cb43d2d401ba_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:ReferenceLaboratoryDiagnosticAndConsultingServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:CompanionAnimalGroupSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a2f9d2f1d5a4674af66963a5565e7f1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:CompanionAnimalGroupSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:CAGDiagnosticsServiceAndAccessoriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib81ecabbb8614cf1b2acb2b54f2c36f9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:CompanionAnimalGroupSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:CAGDiagnosticsServiceAndAccessoriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91c8a095edc841769c85865c8e5036f2_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:CompanionAnimalGroupSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:CAGDiagnosticsServiceAndAccessoriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4caa366375c4cb9a3594b681a103170_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:CAGDiagnosticCapitalVetlabInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:CompanionAnimalGroupSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i726e9c456ab44126a671318ab9275f7f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:CAGDiagnosticCapitalVetlabInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:CompanionAnimalGroupSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e5c3cd621d24cb28572507163aed2f7_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:CAGDiagnosticCapitalVetlabInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:CompanionAnimalGroupSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7fd4d20f53cd47b499e032d174f468fc_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:VeterinarySoftwareServicesAndDiagnosticImagingSystemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:CompanionAnimalGroupSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69584183a25e434eb0dbc26d4f7a118d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:VeterinarySoftwareServicesAndDiagnosticImagingSystemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:CompanionAnimalGroupSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8301f630e8b443fe8e590fcd68eab16f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:VeterinarySoftwareServicesAndDiagnosticImagingSystemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:CompanionAnimalGroupSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c823cc0aa3945d9874ea09ab5940878_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:CompanionAnimalGroupSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40313073e9c743ad89084e7fbcbd7e5e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:CompanionAnimalGroupSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief827aa39f934947a553685160a5543c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:CompanionAnimalGroupSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81c0a80f385a4f18ab5cb5919ed28318_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:WaterSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0b173f4625a4e1e807adc8eeb4e0592_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:WaterSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab0b6ebdef1a4be9b052a1b82c635759_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:WaterSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4174c33ea3f8443fbc6587f7ac9a43ab_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:LivestockAndPoultryDiagnosticsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4525be5d1c1b4d458fe78f047e981dc1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:LivestockAndPoultryDiagnosticsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34e8ebea941e457cbadc1ce152e6a396_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:LivestockAndPoultryDiagnosticsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94cd933d7b7b431caa324dc2936f5c55_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:OtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i100119c49d8f4098bf6afdc675782162_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:OtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6f9b6007f00420291efefe0008f3d10_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:OtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i074301c2df824186bd2aba7d250d51cf_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01f16b1d8f40480ea91113c41cce5e7a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4020a52f56894866abcca95a1a1497f1_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i766a0f5291584f90863a5968d8de067c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c8215241a5640df9c12270ca8891308_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i098a241b58744ea38131468a239f7847_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d89e0f871864b189335e7739d42fe07_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">idxx:LatinAmericaAndCaribbeanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7743a6f4bd764d2a9da6c4de5e290df5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">idxx:LatinAmericaAndCaribbeanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i875c0d290dfb4cbf8a2b59d7e2c6d1fe_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">idxx:LatinAmericaAndCaribbeanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76f3ab4debf64563bc6a167ac410e9c3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe22eae831934369a9a0015d3c260ab2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4ec176e93ab43bb98dd7714f2512730_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie659b0df466445ae9609de3ee174d80c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0c4109668754b8693ca7161318090f9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa67f291b9eb45a780298d9ae25ddaf3_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7dbddd91eb54624978a0b4ed56ec859_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaded4b965f664c0d806bbe1ac965cd5d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d87cb22b86c44f4b570eed70a1378eb_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75c498c811384ef09dcd9c2fe08380c8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66eb4e58d2ee4aaca353fee7f134054f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0dc62339001e4ad4a1835c85eedc299e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f1ed5c7ebf34e30a0fdb012cddf7440_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IT</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9c07a32fa054809a3705b5c0d25c972_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IT</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i024ff5694a8c4073a3e5ce8f499229f6_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IT</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a12365e7904425790e4a07eca696916_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:ES</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib98678b4e8cf4f749ac3e5c05952d91b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:ES</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2f16826ba294aa484551884f87d09e8_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:ES</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7896731fe12243f1875fd4ce04068904_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie109583690ce4e2eae0a0a5c373a2ee4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie037b3568c7d47d8914ff5010a0aedcd_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8207a8f256ab4cc6a3250a19887134bd_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:NL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ec2b03ad795418a8009824d2524452f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:NL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33cd1326584149ccbfa7ddc29ff1f6c8_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:NL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b82ba0179564e93a090862f65ad1917_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">idxx:EuropetheMiddleEastandAfricaOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id596dfd4731c4532a3f61ad928fd2c5c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">idxx:EuropetheMiddleEastandAfricaOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07e74761556442abb8ddcffbbc211fcf_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">idxx:EuropetheMiddleEastandAfricaOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if20538cc41914789b22efe5b91f2f3a7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5db3ce1c3924c83b379d8a61e0f7372_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b9195b1ced7483697bc7828d38b1dc3_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf1299bd5850495db5bab930c750f59c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icaa60874497e43898b35ee415a2bc80f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i220bf3ab1a154b9a8693e8e99867b9ac_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f4a460cb3fc481b87a66c1143b1c6ae_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idfb45a09b6c94d2f9c4fa39784fc4f4c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27d98417a7ed441dbaefaf4e3c7d8e3e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice113159eb944073881b74017325c32e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25c97c45426b49229b105df880a272e6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i725b5e5dc5f042a7ae398d70fbeee8a5_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c7784e6972a40e794a9b073a04021a7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">idxx:AsiaPacificRegionOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id95808181fe340cf9c9a3e0c0794af01_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">idxx:AsiaPacificRegionOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8756d035ba8e462584f1d7c8d7dddac4_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">idxx:AsiaPacificRegionOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic225702a7bba4086a0eb7207e3dcb702_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b04ff1af6a74efbb011731141a869fb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i471d983af3ad4dbda5429f440f2683ff_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec94ca1756b3473faecedf9258139d41_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9aa403826a744b88a310a196d527c4da_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i842723fe206441498f4f17f31a9787fc_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FI</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:ReferenceLaboratoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8c73a699ac1449a83257aa402845ff6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FI</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:ReferenceLaboratoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0b97d19fd5e4d9da47732f2832e48e0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FI</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:ReferenceLaboratoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea6bbd7bf4aa409f81e8b4939eaeebb7_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FI</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:ReferenceLaboratoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5aeff8abf9cf474cb8eef1fda56b68fb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FI</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:ReferenceLaboratoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i809c93aee53e4f94943260050b20b48b_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FI</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:ReferenceLaboratoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd3e48c2fc1c450db3e7a70a7d818589_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:TeleradiologyBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifce9ad75783047eca6a078e591b5a29e_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:TeleradiologyBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1280d77ec9a4626b628ba48e7a82fee_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:TeleradiologyBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida01d0b9ae19406cba72ddf3076630da_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:TeleradiologyBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4cad12a2c61c492fa2913b23e32f05f6_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:EzyVetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2728c192ba740b3bccbeb6af69b3ba8_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:EzyVetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfd9997d2b384ba184794f3511297632_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:EzyVetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i385bd1940c0e4f08b7a962517de3c1b1_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:EzyVetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i305a1c1723984399939954021ea102bb_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:EzyVetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6b9086908654520873d5861115fad00_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:EzyVetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d303cab977e469191f8b6b1552d036c_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:EzyVetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i331a2e7b2a724d3d95f8d3fa0aa4fb7f_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:EzyVetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55647d483f84421fa97e4bd81c6d5d69_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:EzyVetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21fecd38873f4b64b92a766a37bdf70b_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:EzyVetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37946dde29a24a35b13eae3f304d5a27_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:VetLabConsumablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:EzyVetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9efbaf1e37c410ea20352d5d9dfc9b2_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:ReferenceLaboratoryDiagnosticAndConsultingServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:EzyVetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51b0af3a479b46bfa75da33ccbef5a0d_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:RapidAssayProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:EzyVetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee0529f10fe24e86ad8b423b1dcfdfcd_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:EzyVetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:VeterinarySoftwareServicesAndDiagnosticImagingSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb7924f502ed418b8a52fa0f86e77e1b_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:EzyVetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19e2681a08f94930a55705e928524d31_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:EzyVetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8e658249a1b4ada9bf653d6f869d521_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:ReferenceLaboratoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19c6a768e2a14d0bb7d30636dbb2c293_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:ReferenceLaboratoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98a1c47a6a4347cd86ea3a19f76e6f2c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:ReferenceLaboratoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf189d70c3364256b7c496f71fbb573e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:ReferenceLaboratoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa9a585d1027406aaf397c11d9f703e3_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:ReferenceLaboratoryinMidWestUnitedStatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d6f007fbb65407089a89432eb6964c5_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:ReferenceLaboratoryinMidWestUnitedStatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21fe577fc12d43d6aa8593e56fbbd4ba_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:ReferenceLaboratoryinMidWestUnitedStatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80310c05b475409f9d808f6d23317bc9_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:ReferenceLaboratoryinMidWestUnitedStatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd0bd4a0a64d4c9fa9955ab39bcd5b33_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3338ed00513241bc832c9f2114b7b270_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">idxx:TwoThousandEighteenStockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97018d52b0af4870b3849b272b1355ec_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">idxx:StockOptionsAndStockAppreciationRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c8ce4fcf0ad47d1a61060c9d791ef17_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">idxx:AwardsOtherThanStockOptionsAndStockAppreciationRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a16b614e5514b46a709cdefac9167c9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">idxx:TwoThousandEighteenStockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida1ffc64f6764bb4be6d2faec82e9f3f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b83a53333fa4f00b4d62d186eefc036_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie726a1d133bf4ad5a692bd283baf4341_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i154151cc952a42e2b9337039f8030f64_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">idxx:OperatingExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0b2c60d6a4244439cacf26a55fa991c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">idxx:OperatingExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3a4a8e504c24b93880965b1c3991089_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">idxx:OperatingExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77a5beb76e6b48498eed44e9a602baed_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3cf8555002d4b4cbd01dce8c9e1e1d3_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">idxx:StockOptionsGrantedToEmployeesWithRatableVestingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45554c00d32c4d45a16d94dd9b602937_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">idxx:StockOptionsGrantedToEmployeesWithRatableVestingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idae58301e68b412eb28334afea378d2b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c3e894425d54b5a84d42ae55eb839ae_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i982c1764182b47d1b743c71bb7b33923_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0491e8e2530147698782b2a10a30d90b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3299da84372d432f98da6898831dd963_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1594d5a312e047069a064e029de5cf8b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">idxx:RestrictedStockUnitsGrantedToEmployeesWithRatableVestingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84fa425282ab417da8ba5a3609c0031e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">idxx:RestrictedStockUnitsGrantedToEmployeesWithRatableVestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief941e5acd344fed862240efdd3a7288_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibcdf728b3b3f46f08f1609441281d24e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0cad033f6b01464bbca11ea746ae0dd3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i694b32aa47f046748a1598cc0d558051_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf6a2e2744a44ea98ebe5ee2a3b57059_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">idxx:RestrictedStockUnitsExpectedToVestReducedForEstimatedForfeituresMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib209d359b518453c8297929f6c24722a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9958c792661247119c39c9e01d982deb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">idxx:DeferredStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7663c8e364ea4807a7ad1cbb6bafde89_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">idxx:DeferredStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i230d8313826f436cae6610d654452ab4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">idxx:DeferredStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e7ee8e291c54e02a81d0c39ffc5ad6b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">idxx:NineteenNinetySevenEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id26ee05f76cc40ac87ab6c4856efecfa_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">idxx:NineteenNinetySevenEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a5d4fe659be4cccaf4e997156b223a2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">idxx:NineteenNinetySevenEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07cab270359146efa8ad17bde260ed6c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">idxx:NineteenNinetySevenEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4706d2219354fd4aca929cb8a8e0ce0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">idxx:NineteenNinetySevenEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2d8a957b59b41bd9d689b2d4b69d6a4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancingReceivablesPeriodPastDueAxis">idxx:FinancialAssetGreaterThan60DaysPastDueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4fa881c75f4742dfb92d9cee4bd32188_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancingReceivablesPeriodPastDueAxis">idxx:FinancialAssetGreaterThan60DaysPastDueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if03c9c1348554db4936cf06e9bd802c2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:ReagentRentalProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f415ad968794c3b9bf10b5e7c9d08e8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:ReagentRentalProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69d7e5c1eec24001a74325f821a31cba_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:ReagentRentalProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i358c864968b04228b7d1de65d4356012_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaae1104f80a84293b957aad0e5ba9d49_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6f5e29e1d644e1380b56d80b5c8ab21_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec5713b70bef4889b876769c7518056a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3d9107992e245d2808adc5e2bef7264_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a4a3d9081da4e4890098ab4828eff02_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifcd90bb4b001420db3089207a9817b90_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iefcc27d08de64329bcdafc6e24f95d6f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e07bfbfbbdc4286ac526097dcc2014a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">idxx:ComputerHardwareAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i283cc22fdf494c59a8affd0dcad7b35a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">idxx:ComputerHardwareAndSoftwareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c5014947c2d49ac8200d45c4f5828a0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndLandImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6e52598ae7b4d548bd924fa1808d713_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndLandImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84c5988a324d4a31a0b062f598b122e2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27518b77901a4762b6f2872c61ab1b01_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5325a16dfc33486bb52b0c132af02290_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ced4bf3c1a540939075a145fafad2f1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id90597dbb49948fabb735806b012f616_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7dad70e6dd004c2695b06a59bd68945a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a2074f7bc9b4a2cbf6ed3b610f98409_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69684bf965814a318039fff0559aee1f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4c3038a1c6e434f960b3b42480ee814_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">idxx:ComputerHardwareAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24004ed53abe4277a8577a3ab12dd906_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">idxx:ComputerHardwareAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9bc87de78fd14b56ba2c24532ac28a94_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46df05df390f4fb8b267041b3f7c430b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17db583051954f429123c0a1d6ba693f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">idxx:SoftwareDevelopedForInternalUseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc48fab68f194aaa84d1e8ed6fa2892f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">idxx:SoftwareDevelopedForInternalUseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6de38908909247f4abb7093d04baaf61_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">idxx:SoftwareDevelopedForInternalUseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a0c9bdb38c5437ba4c6b8c7c0183c5d_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:CompanionAnimalGroupSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf8bbc6500694651b48a90bd7484b109_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:WaterSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf7bd16dde3b49debd9c67b5be3e1fb9_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:LivestockAndPoultryDiagnosticsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i553fbb83ebff498cbd25aefa9eee9276_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:OtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f05fb527b154dee8865a625a6eff114_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:CompanionAnimalGroupSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if93e0292c6f54be59c39937e7fd58164_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:WaterSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e064fdd1f8949e0a40782734de7a004_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:LivestockAndPoultryDiagnosticsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7599f68f6de408b80c30adab94958b2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:OtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief4601e8865549a09377d9dfd17d74d4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:CompanionAnimalGroupSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i463e678af3d24f9d8074cd935b869239_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:WaterSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i929ca297bc5248beabe8f044d7430225_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:LivestockAndPoultryDiagnosticsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8867f1bde2348b596b2427e15fb4d2e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:OtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91597ef710044b0aaf747bf9fd3b6882_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:CompanionAnimalGroupSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b559b62389c4dffbc62f92796f64370_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:WaterSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib956b0023d37451a873e726de05dc04d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:LivestockAndPoultryDiagnosticsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81db4aa26c9a45f9b2ac5198a22acfe8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:OtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib25dbfb85b114a83a3384494c07c9a83_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iccd74787592547aabe3fc45e8160f1f6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d6af357c77b4c45a43103bb36b9db75_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">idxx:ProductRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6625320757264c3d977d4eb7923c35ee_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">idxx:ProductRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i570237e99c1d4a9b8c6dca9eae26bea8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i637fcf9a068c4d6798c09d00dea42126_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic59101fdcfff4269aef991be04a88a6f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24ed2ad1bc274728bf194148636a8d78_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia89659b032284471b33d455d42efc26b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">idxx:ProductRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87c2ea63490848ab92d756e41e990b46_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">idxx:ProductRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f20409febb84c2483223228e9e1771a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8bec47a954cb4a1d86389d1590f9c5e0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d67cbfaa5224fec8d1c48c0eb22dc85_D20211209-20211209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-09</xbrli:startDate><xbrli:endDate>2021-12-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie379750e8a014b58b9ca70bcde9817d8_I20211209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88842c37e6494006b237d52fce7c5c33_I20200414"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7027aef0a2c5405c8952b0b711093dd4_D20200414-20200414"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-14</xbrli:startDate><xbrli:endDate>2020-04-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c25f29396c647aa8d6098ef0911bfef_I20200414"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5cc431806cd042369dfc78d28f3b1659_D20200414-20200414"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-14</xbrli:startDate><xbrli:endDate>2020-04-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if38e3d02f10c4f32b074213b34fef777_D20200414-20200414"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-14</xbrli:startDate><xbrli:endDate>2020-04-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1da5c94143f545488db1a5e8851e0d7b_I20200414"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2743639b7f854d2faacd705017e8a980_D20200414-20200414"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-14</xbrli:startDate><xbrli:endDate>2020-04-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc1466922ecb4c6d968b86b7b8b94009_D20200414-20200414"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-14</xbrli:startDate><xbrli:endDate>2020-04-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb88319a299b42b499f9dd03bbc3c710_D20200414-20200414"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-14</xbrli:startDate><xbrli:endDate>2020-04-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id297fa8846f44eef8316d35feb8ee7fc_D20200414-20200414"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-14</xbrli:startDate><xbrli:endDate>2020-04-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77d25639b7e24f3b863f76aff1a3baf2_I20211209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c3da4e4c9c14ee59aa58eb74d6eaf8c_D20211209-20211209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-09</xbrli:startDate><xbrli:endDate>2021-12-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90bd3d6a0a4241c0aea364074afe7a3d_D20211209-20211209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-09</xbrli:startDate><xbrli:endDate>2021-12-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9320b95542d34067bb078b7df10a68d7_I20211209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc7eca7b08f24e31ad1cdc3bac81938f_D20211209-20211209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-09</xbrli:startDate><xbrli:endDate>2021-12-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9a066585bb047ed81604bdfa2257801_D20211209-20211209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-09</xbrli:startDate><xbrli:endDate>2021-12-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1a6a37dfa0846f0a5ce8ea8202bfac9_D20211209-20211209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-09</xbrli:startDate><xbrli:endDate>2021-12-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icfa56c2f5e4b4609b398b0b8b4950963_D20211209-20211209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-09</xbrli:startDate><xbrli:endDate>2021-12-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82a6155f7ccc4f55b9a6fe7e36a127df_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae060c362bae4cb5b9a839012e39422e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c8cf4c740be48fd83d344c66d438cd7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">idxx:RevolvingCreditFacilityIndividualBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0707fa55e90849738007f16cfef51f10_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">idxx:RevolvingCreditFacilityIndividualBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99c7fc5496044f18a226eb36d6d3f865_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i291ef135622f4a9baf284e7cfaad88c9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:A2023SeriesANotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i870fa3036a764a809f0d8c67c310cf72_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:A2025SeriesBNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3dd02565f2614274847ab1493dffefe3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:A2026SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0978c28bf335475c882b17687ef6c41d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:A2024SeriesBNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b730ee02fe84774a4802313f2dbde61_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:A2025SeriesCNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:context id="iea3b4083103c42cb8b20a1a66e2e0b7e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:A2022SeriesANotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7ee5545c45b452ba5b532018c57c675_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:A2027SeriesBNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71fe397c3c014eb0902555a2b916dc0b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:A2029SeriesCNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19e6230043be4bc494d45facd3995c64_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:MetLife2030SeriesDNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5dc25052aa62435dbe48e2738f88c2ff_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:Prudential2030SeriesDNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d9352de44824a5bb1085c5d21e9f1f4_I20131231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:A2023SeriesANotesAnd2025SeriesBNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2013-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0a1cfdb16bd4fe5831d9ba3c46d91ef_I20131231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:A2023SeriesANotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2013-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1acbae80f997433a88234dd2778c498b_I20131231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:A2025SeriesBNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2013-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9268fbd98f1642a29877996cd39b28a8_I20140930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:A2026SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85b9b901dae14f1f8f19b213cedc6d10_I20140731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:A2021SeriesANotesAnd2024SeriesBNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i728c0393124f4d3aa9ce9f98a65c1909_I20140731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:A2021SeriesANotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b9efa5452f740aca86e464a7d20a380_I20140731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:A2024SeriesBNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9096849c1ac4387b32b1369124e6e10_D20210721-20210721"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:A2021SeriesANotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-21</xbrli:startDate><xbrli:endDate>2021-07-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6fd942875b8149d6801ca7948aa50eb9_I20150630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:A2025SeriesCNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c27f682ff974979b7a9c14a0852f4b1_I20200410"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:Prudential2030SeriesDNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4f21d4f936e451bb937db30e6e6c516_I20200414"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:Prudential2030SeriesDNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7f558575c4f45f3b51e71f291325f3a_I20141219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:A2022SeriesANotesand2027SeriesBNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-12-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1b615997c6845d992165c221d916601_I20141219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:A2022SeriesANotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-12-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c06758cf49c487989c8d74d5a4fe45a_D20141219-20141219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:A2022SeriesANotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2014-12-19</xbrli:startDate><xbrli:endDate>2014-12-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i693b06087db042f486f6b01601900261_I20141219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:A2027SeriesBNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-12-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea5f10448a374b6f90d116e53e14ac51_D20141219-20141219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:A2027SeriesBNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2014-12-19</xbrli:startDate><xbrli:endDate>2014-12-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78dd1a8fbcfa4a6d8b5587990a0d4b8b_I20211209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:A2022SeriesANotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69f00534ab5c47f6bb7e698a1e5b33f2_I20190314"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:A2029SeriesCNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e2ecd2fe69f46929ab4f66300904bb0_I20200322"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:MetLife2030SeriesDNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94bcd6d66d644d71ba9e5e425c3343f9_I20200323"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:MetLife2030SeriesDNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82a0a4b3853c4d43b57df66540d93b3a_I20200402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:MetLife2030SeriesDNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9b830d7b3a74e4f9431f662334d4e77_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie58c704216a6458da306b8341192f2b4_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94032e21bcdb4fd5a7a56338b7e76c84_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">idxx:EmployeeHealthCareInsurancePolicyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a8414f50ab04a91a3892300c9d0d3d7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">idxx:EmployeeHealthCareInsurancePolicyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c3f540bc4ee4adeaf82639617d91385_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">idxx:EmployeeHealthCareInsurancePolicyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib865674d7bab445389b9c3bbec146020_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">idxx:EmployeeHealthCareInsurancePolicyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie45306aad98e47fdbad67873c8c7d7cd_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">idxx:EmployeeHealthCareInsurancePolicyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44fa2e5abf144441938e326da9122112_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">idxx:EmployeeHealthCareInsurancePolicyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i773e63ef7fdd42e489afb58247b219a0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">idxx:EmployeeHealthCareInsurancePolicyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5c4c6cccd414bef949b6f0b3b152901_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">idxx:EmployeeHealthCareInsurancePolicyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f64c178a0b14875b7618692b20160b1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="idxx:PaymentRequiredUponTerminationOfEmploymentAxis">idxx:PaymentRequiredToCeoUponTerminationOfEmploymentWithoutCauseOtherThanFollowingChangeInControlMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4f5b7c174554a70b226143cb3f524f5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="idxx:PaymentRequiredUponTerminationOfEmploymentAxis">idxx:PaymentRequiredToOfficersUponTerminationOfEmploymentFollowingChangeOfControlMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>idxx:segment</xbrli:measure></xbrli:unit><xbrli:context id="ia2df645a45b34a2399502ce17943dcf7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b80e825cd834af08c3a61075a948afe_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3c0173254014c148d3b60dec589c0b2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:BR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19eca0b32b324c3498847ac936ef58f4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:BR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f5c837a15cc413bb88e37606fc78b84_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d6b1606b16f45a0ac3be2c84a8d6205_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a98d26251bb48daa1b953041bbb17e4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2b60381ab6f424a9ae0d17bcd461dc7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d067073a4ae4d32b902fa480a4007da_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if14611aca76842bd9bd4db89f308d803_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i374199d035fc499c91845154d21c433e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8c119688026495c80d9335fe78c12c9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a516ef8f02d4ad4b2f748492aab4933_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:NL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c16c76e13144f0ba4ee1ef3535feacb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:NL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id29d95bc12294baa874f679042b1e77e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4c58acfb1f047b382030e4bc62b5020_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iccfd38ad58364c78a9294def05c76d02_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6da1a2f76bee4a21ac439aeda4137fa7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e3d1826c3d34af3978413aa009dbae7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">idxx:EuropetheMiddleEastandAfricaOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e3cdf5fc1964d82bdc2516cce09684d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">idxx:EuropetheMiddleEastandAfricaOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2106bb13edcc49e8b8fce61d61723790_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64399f2ed4a0466e9bdbbf1a7f6103c6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3de7482682304e00b18c68ebffb19f78_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iceb0cdafe9d44f85a2de864face16fef_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if41bc213fa8343d59b436514629c5506_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76762f7f0d2c450d89d3f32990898187_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26ff5d65efbd4393a5a6f50b163b1890_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">idxx:OtherAsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia347a126d78942fbbf80ff326e0aa2a5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">idxx:OtherAsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ffc4cfd2c574feda0ea3ae4daaa562c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a25163d8a7f45b78b59192fe48c8632_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1bc42ef3733b4728851d7a59ec0cfb20_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86eb4694a98b40318766c041f67be8c5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieeaf8edb07e74b67a220042fa77426c6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i206dbd1506c344a7b46d2edcee18de52_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2258666cd26e4775980e24a9d689b0c1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">idxx:EquityMutualFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i787da85c3dea4d1b8cbac83c56d8a8c7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">idxx:EquityMutualFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib92b086f14c04b4cafa21f8ec54f598a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">idxx:EquityMutualFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0bf1cce14634a27bdb520f17b857f93_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">idxx:EquityMutualFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i224b783ac8494c7db115e134494538a7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idaf6c4c313dd4b59950dfdc2cebfd879_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i991a2d9a94c94f4ea20968ce0eeb2d8a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5defc11409fd41638fd2fde139f135f5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02adea61db9c4d30a6aebbf9a1e7dbef_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief2e06ac5412417d8e6cdbbfb30aaabe_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9bbbcba12a794c06878aa6883f1b3785_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89ead21a0e784572a2136d6d2a0a1694_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77cb9a89ff4949bb8bc7f0848c680d19_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">idxx:DeferredCompensationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f5042c99e1f40d89108212d50d27e54_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">idxx:DeferredCompensationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6298f7d8f2c4ee7926bc69c8be65de3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">idxx:DeferredCompensationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i335b527a64fd4bee959d70654d76f369_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">idxx:DeferredCompensationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2631d5bf8f7b4edf839dd6d1ffca5a4d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">idxx:ContingentPaymentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83f6672993344e548b6db84a0a80f0da_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">idxx:ContingentPaymentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c872711fc4b45339979cdb106678fe3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">idxx:ContingentPaymentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58118ac9fa5b41048fd3e947040036e9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">idxx:ContingentPaymentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i608997adc8b645bcbaaf1f91a45b978b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d3f919fc9944acb95a3e26a8e3a840b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3de38ceae5e40a3a39f1ed4d9f73eb2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iccdf369f478f4fb8b529dbbf7bf67b64_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idca6b93b00b44f62bbc514784faff67d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">idxx:EquityMutualFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife95a3279b8f411aa329c1a3be662fd3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">idxx:EquityMutualFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id52d5e57570042d09f53a0980b212d20_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">idxx:EquityMutualFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic08687ee74ce470e94fd105bae7ecbdc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">idxx:EquityMutualFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a44d7e6553d48599a9003be65d3c761_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0dbc7dd68361493785eff3dfc58a1b14_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i315d962b616d493fb4d154dd8f021e44_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae303435a98a42f1bc19b02e47518558_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ded36872dbb4598a2981b577f9f6307_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i00732657e2a24ab78c424730ef55e468_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3c0063a469d414bb87cadabfe0a1f2b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd016343073542aaa9022d71864f8954_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ideb425f832b5493cadaae1d434f30a46_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">idxx:DeferredCompensationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i966b54bea1fd484184ebf43c56e298a7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">idxx:DeferredCompensationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i671303cff5aa4ae2b8d910b00202004d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">idxx:DeferredCompensationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82b77254c5584204b9d7b6c3d673b43b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">idxx:DeferredCompensationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1902b241fd2f47aaaa617a00218e386f_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1ef4a96731942908ce11fe9891aa0bf_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9c53b6812ef44e0a021ef872c3e03e2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12d3943c8fa0485b86f83616b4c036c1_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie463159bdbe0401fa1699ea9bbc087e7_I20150630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">idxx:SeriesCSeniorNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78c0899cc8ce4403916f4aed0daa467b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i500dd303994d474bb3c6133348ce968f_D20230630-20230630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-30</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied1674e5cf1c49dab027aef8b772a006_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">idxx:CrossCurrencyInterestRateContract1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29716f7451ce47209ffc3a126855c5bc_D20250618-20250618"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">idxx:CrossCurrencyInterestRateContract1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-06-18</xbrli:startDate><xbrli:endDate>2025-06-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d594a7833ec49b39f9b6d981b10a581_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2a5f0696ab0404987ffb0a495402d7d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c94572bec9745c49286936d60cee01c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i545077a6c3224507841852d11c8c9273_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfce4063123c459eb84ed75e6fc79108_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iacbb16db3cb7452eb84960f47dc683ab_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i050978c75e2a45678abaff399b9bc5f6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4698c4affbf4e699d54f34e5350d605_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06a7e9fd40ce477ebb37684aa46d2543_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie64c1bfe251d4ea8a0ed2f0eea68ad6d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22e9c32bb1ff4a549672a6a6a514fca9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e5cf4395f024a8996343fcdfd9b3ca3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i286b8b14cd394335903921c6ba48d7f5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91aaaf38003044fe91000cefb4286f16_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie944714e2148495fabc8b885bf09a852_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i051a71adeb9449eea0629393ed4795bc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">idxx:ForeignCurrencyBorrowingsDesignatedAsNetInvestmentHedgeOnBalanceSheetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53807fb41e524bf69fec4117ad94a99b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">idxx:ForeignCurrencyBorrowingsDesignatedAsNetInvestmentHedgeOnBalanceSheetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib94d76d2a4f64ef8baf558bb1ad20c66_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i00c84acd109f46f4b2185c4801aa483a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:AccumulatedNetGainLossFromCashFlowHedgesForeignCurrencyExchangeContractsIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i516b4d9fd6fd4bb08abfd83a2b8ece20_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:AccumulatedNetGainLossFromNetInvestmentHedgesEuroDenominatedNotesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b7ca21c16c34b8ebd18b0be7aa71fb1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:AccumulatedNetGainLossFromNetInvestmentHedgesCrossCurrencySwapsIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6aa0f83e00f94d788fc79a84dd2ef035_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72ee32005bc94787a60e211d2b2aaa25_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i142bd154aa264e73939304fcd4c000c4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72130b38c837460c9d490b3337d85e4d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:AccumulatedNetGainLossFromCashFlowHedgesForeignCurrencyExchangeContractsIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6870132d22054c5ebea0784212917113_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:AccumulatedNetGainLossFromNetInvestmentHedgesEuroDenominatedNotesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3230b72e1154329a7f1a763ed0a1187_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:AccumulatedNetGainLossFromNetInvestmentHedgesCrossCurrencySwapsIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03c7f98144624caeae57bd38fd0dd2a5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea843d40d1ac442bba04f284af6399c9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a978f3211e44df89ba9cd591258b169_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:AccumulatedNetGainLossFromCashFlowHedgesForeignCurrencyExchangeContractsIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2758281c7e1d44f1bc14207e44f8c0d7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:AccumulatedNetGainLossFromNetInvestmentHedgesEuroDenominatedNotesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee2ff9304f8843b881a4c91cf1c6c997_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:AccumulatedNetGainLossFromNetInvestmentHedgesCrossCurrencySwapsIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66e22c6b00494e2c8ccec8824592cb57_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3d475356743442ba6915b1578a8771f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d04bcb41a5b4086b6a2d38ce5f3b1a9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd5c0e3eaafc4cd3b022efb186592847_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:AccumulatedNetGainLossFromCashFlowHedgesForeignCurrencyExchangeContractsIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic61a4aba587c4549ba286bb3f06809be_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:AccumulatedNetGainLossFromNetInvestmentHedgesEuroDenominatedNotesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a726385a3934ca297a4094723c83a69_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:AccumulatedNetGainLossFromNetInvestmentHedgesCrossCurrencySwapsIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if975ef26add547cc8029bf3cfcc205a4_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1cfcd32b9eb44fc909c66daaa2fdc89_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1e09d47b7c249178ff89343c0d5d024_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:AccumulatedNetGainLossFromCashFlowHedgesForeignCurrencyExchangeContractsIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2708e84b292c4f1bafc45174e5905b07_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:AccumulatedNetGainLossFromNetInvestmentHedgesEuroDenominatedNotesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78635773a43a47999ed10eb8f309ed8a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:AccumulatedNetGainLossFromNetInvestmentHedgesCrossCurrencySwapsIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa324d754a4d4cb0ab3eb052f773e75e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2aefce1f274544f1b2e978eb3e0fa0dc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie311c88fa22749e2b4cf06d52ec95566_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:AccumulatedNetGainLossFromCashFlowHedgesForeignCurrencyExchangeContractsIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6de86e101cec44aa84d8d1454d201a7f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:AccumulatedNetGainLossFromCashFlowHedgesForeignCurrencyExchangeContractsIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8ae9e76f2d44f91afd70c49049644e1_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:AccumulatedNetGainLossFromCashFlowHedgesForeignCurrencyExchangeContractsIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7c4b2e2ed354c54b264719bdf6db254_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="idxx:RetirementAndIncentiveSavingsPlanAxis">idxx:FourZeroOneKPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c65cec1a82840efbc15a4b904412850_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="idxx:RetirementAndIncentiveSavingsPlanAxis">idxx:FourZeroOneKPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibbe59bdb4621433ca1dedcd48056713a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="idxx:RetirementAndIncentiveSavingsPlanAxis">idxx:FourZeroOneKPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i5d795a6851d746ca914a2ddae761c329_1"></div><div style="min-height:9pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Form <ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGV4dHJlZ2lvbjo0ZTZiNWVlMjc2OWM0ZDgxOWNkZjVkN2FlZDlkMGQzN18zMzM3_aef457c6-3957-465f-afb2-446b9de6d1d2">10-K</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:12.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:67.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Mark One)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="dei:DocumentAnnualReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGFibGU6ZDA3OWI0MmRmMDMzNDI4Zjk3M2I4MTUyNGQ5ZDMxODMvdGFibGVyYW5nZTpkMDc5YjQyZGYwMzM0MjhmOTczYjgxNTI0ZDlkMzE4M18xLTAtMS0xLTA_1e9255eb-ae58-4009-af5e-85da8be253a4">&#9746;</ix:nonNumeric></span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For the fiscal year ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGV4dHJlZ2lvbjo0ZTZiNWVlMjc2OWM0ZDgxOWNkZjVkN2FlZDlkMGQzN18xMTY_531cec0c-c8bd-421c-8c13-214c1bea0ea1"><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGV4dHJlZ2lvbjo0ZTZiNWVlMjc2OWM0ZDgxOWNkZjVkN2FlZDlkMGQzN18xMTY_f09f3280-0a62-42f6-8083-8388d08479ca">December 31</ix:nonNumeric>, 2021</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:12.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:67.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGFibGU6ZDlkNDc0NzZkZjA0NGNkYjhmZGU3MDIxMmM2ZDBiOTAvdGFibGVyYW5nZTpkOWQ0NzQ3NmRmMDQ0Y2RiOGZkZTcwMjEyYzZkMGI5MF8wLTAtMS0xLTA_59c797f4-5829-4b17-814c-cd85b2193c0b">&#9744;</ix:nonNumeric></span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For the transition period from _______________ to _______________.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">COMMISSION FILE NUMBER: <ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGV4dHJlZ2lvbjo0ZTZiNWVlMjc2OWM0ZDgxOWNkZjVkN2FlZDlkMGQzN18zMzQw_c1a9986d-965f-4c38-9416-e65f0769e1f1">0-19271</ix:nonNumeric> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><img src="idxx-20211231_g1.jpg" alt="idxx-20211231_g1.jpg" style="height:24px;margin-bottom:5pt;vertical-align:text-bottom;width:111px"/></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">IDEXX LABORATORIES, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.594%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.430%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGFibGU6ZjNjNzRmNGNkMjkwNGViMWJkNmU0NzlmMjFhZDhjN2MvdGFibGVyYW5nZTpmM2M3NGY0Y2QyOTA0ZWIxYmQ2ZTQ3OWYyMWFkOGM3Y18wLTAtMS0xLTA_ae206a52-606f-4aa4-85f6-d096d4508cd8">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGFibGU6ZjNjNzRmNGNkMjkwNGViMWJkNmU0NzlmMjFhZDhjN2MvdGFibGVyYW5nZTpmM2M3NGY0Y2QyOTA0ZWIxYmQ2ZTQ3OWYyMWFkOGM3Y18wLTMtMS0xLTA_c31f28ba-a2db-4d29-b489-8f8cd7915491">01-0393723</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation&#160;<br/>or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(IRS Employer Identification No.)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGFibGU6ZjNjNzRmNGNkMjkwNGViMWJkNmU0NzlmMjFhZDhjN2MvdGFibGVyYW5nZTpmM2M3NGY0Y2QyOTA0ZWIxYmQ2ZTQ3OWYyMWFkOGM3Y18zLTAtMS0xLTA_a4835bec-6f16-458a-9bdb-8e0ded30b118">One IDEXX Drive</ix:nonNumeric> </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGFibGU6ZjNjNzRmNGNkMjkwNGViMWJkNmU0NzlmMjFhZDhjN2MvdGFibGVyYW5nZTpmM2M3NGY0Y2QyOTA0ZWIxYmQ2ZTQ3OWYyMWFkOGM3Y18zLTEtMS0xLTA_5577cbbe-014f-4775-9c89-2aed50e24580">Westbrook,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGFibGU6ZjNjNzRmNGNkMjkwNGViMWJkNmU0NzlmMjFhZDhjN2MvdGFibGVyYW5nZTpmM2M3NGY0Y2QyOTA0ZWIxYmQ2ZTQ3OWYyMWFkOGM3Y18zLTItMS0xLTA_a341fa25-07f2-4119-b50d-d7b3c4ce3402">Maine</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGFibGU6ZjNjNzRmNGNkMjkwNGViMWJkNmU0NzlmMjFhZDhjN2MvdGFibGVyYW5nZTpmM2M3NGY0Y2QyOTA0ZWIxYmQ2ZTQ3OWYyMWFkOGM3Y18zLTMtMS0xLTA_2b6a0c95-922d-4413-b920-e8c109adc477">04092</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(ZIP Code)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGV4dHJlZ2lvbjo0ZTZiNWVlMjc2OWM0ZDgxOWNkZjVkN2FlZDlkMGQzN18zMzQx_3ab02d48-c509-4819-b04d-1fe7b5726780">207</ix:nonNumeric>-<ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGV4dHJlZ2lvbjo0ZTZiNWVlMjc2OWM0ZDgxOWNkZjVkN2FlZDlkMGQzN18zMzMy_0264ef35-8b19-4fdb-b513-44bd5e97d2b4">556-0300</ix:nonNumeric> </span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGFibGU6ZTVmYmZjNDgwYzRiNGYxYWJkY2IxMjQwMWIzMTIyMzkvdGFibGVyYW5nZTplNWZiZmM0ODBjNGI0ZjFhYmRjYjEyNDAxYjMxMjIzOV8xLTAtMS0xLTA_4ac5026c-4796-4ae8-96a1-cec1b334cd76">Common Stock, $0.10 par value per share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGFibGU6ZTVmYmZjNDgwYzRiNGYxYWJkY2IxMjQwMWIzMTIyMzkvdGFibGVyYW5nZTplNWZiZmM0ODBjNGI0ZjFhYmRjYjEyNDAxYjMxMjIzOV8xLTEtMS0xLTA_24c5a157-67cf-42ed-88b2-f346a4d774b8">IDXX</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGFibGU6ZTVmYmZjNDgwYzRiNGYxYWJkY2IxMjQwMWIzMTIyMzkvdGFibGVyYW5nZTplNWZiZmM0ODBjNGI0ZjFhYmRjYjEyNDAxYjMxMjIzOV8xLTItMS0xLTA_6e8e41a6-a14d-4709-9612-aa5ef5248f55">NASDAQ Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(g) of the Act: None</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.&#160;&#160;<ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGV4dHJlZ2lvbjo0ZTZiNWVlMjc2OWM0ZDgxOWNkZjVkN2FlZDlkMGQzN18zMzMz_397a4b24-a718-44cf-84d9-562fc21c23c0">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGV4dHJlZ2lvbjo0ZTZiNWVlMjc2OWM0ZDgxOWNkZjVkN2FlZDlkMGQzN18zMzM0_934beb28-b076-4756-af41-eef0611d65f0">No</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#9746;</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGV4dHJlZ2lvbjo0ZTZiNWVlMjc2OWM0ZDgxOWNkZjVkN2FlZDlkMGQzN18zMzM5_cdeeb6f3-82a7-446c-b53f-ff517d04508b">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGV4dHJlZ2lvbjo0ZTZiNWVlMjc2OWM0ZDgxOWNkZjVkN2FlZDlkMGQzN18zMzM1_1c0793df-c9b0-416d-84d9-5abf646447cc">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> &#160;No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and "emerging growth company" in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.861%"><tr><td style="width:1.0%"></td><td style="width:22.472%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.957%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGFibGU6NzFhOTk1Nzc2NGFmNGQ4N2I4Yjg4MWJkNTcxZTdkZGEvdGFibGVyYW5nZTo3MWE5OTU3NzY0YWY0ZDg3YjhiODgxYmQ1NzFlN2RkYV8wLTAtMS0xLTA_c9ee7fca-b86d-4fb3-ad3a-c357639dd153">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGFibGU6NzFhOTk1Nzc2NGFmNGQ4N2I4Yjg4MWJkNTcxZTdkZGEvdGFibGVyYW5nZTo3MWE5OTU3NzY0YWY0ZDg3YjhiODgxYmQ1NzFlN2RkYV8xLTMtMS0xLTA_28e5f661-bf3e-459e-80f1-e123e1a45931">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGFibGU6NzFhOTk1Nzc2NGFmNGQ4N2I4Yjg4MWJkNTcxZTdkZGEvdGFibGVyYW5nZTo3MWE5OTU3NzY0YWY0ZDg3YjhiODgxYmQ1NzFlN2RkYV8yLTMtMS0xLTA_b67048cf-1e12-463f-8c37-7dfb5beb46d8">&#9744;</ix:nonNumeric></span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ndicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">                      </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="dei:IcfrAuditorAttestationFlag" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGV4dHJlZ2lvbjo0ZTZiNWVlMjc2OWM0ZDgxOWNkZjVkN2FlZDlkMGQzN18zMzQy_5e0b5be0-174b-4b1f-8b62-d30eb6c3e6cf">&#9746;</ix:nonNumeric></span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGV4dHJlZ2lvbjo0ZTZiNWVlMjc2OWM0ZDgxOWNkZjVkN2FlZDlkMGQzN18zMzQz_25a69deb-98cd-47ed-8334-0a8374827ca4">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Based on the closing sale price on June 30</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> 2021 of the registrant&#8217;s Common Stock, the last business day of the registrant&#8217;s most recently completed second fiscal quarter, as reported by the NASDAQ Global Select Market, the aggregate market value of the voting stock held by non-affiliates of the registrant was $<ix:nonFraction unitRef="usd" contextRef="i309abd36f89849cfae9056eea2c66b2e_I20210630" decimals="0" name="dei:EntityPublicFloat" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGV4dHJlZ2lvbjo0ZTZiNWVlMjc2OWM0ZDgxOWNkZjVkN2FlZDlkMGQzN18yODM3_110e2fd1-aa27-4082-ae3e-9dd08cc5f3e0">53,417,914,936</ix:nonFraction>. For these purposes, the registrant considers its directors and executive officers to be its only affiliates.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The number of shares outstanding of the registrant&#8217;s Common Stock was <ix:nonFraction unitRef="shares" contextRef="i36ae306a96da42d1a0ef962db0aad1ea_I20220202" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGV4dHJlZ2lvbjo0ZTZiNWVlMjc2OWM0ZDgxOWNkZjVkN2FlZDlkMGQzN18zMDIw_ff0ded5b-ef04-4386-bc34-a820464a7cbd">84,249,085</ix:nonFraction> on February 11, 2022.</span></div><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGV4dHJlZ2lvbjo0ZTZiNWVlMjc2OWM0ZDgxOWNkZjVkN2FlZDlkMGQzN18zMzM2_5af5e692-9d7b-4493-a63a-64a87eb06205" escape="true"><div style="margin-top:5pt;text-align:center;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Part III&#8212;Specifically identified portions of the Company&#8217;s definitive Proxy Statement to be filed in connection with the Company&#8217;s 2022 annual meeting of stockholders (the &#8220;2022 Annual Meeting&#8221;), to be held on May 11, 2022, are incorporated herein by referenc</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">e.</span></div></ix:nonNumeric><div style="height:9pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i5d795a6851d746ca914a2ddae761c329_7"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GLOSSARY OF TERMS AND SELECTED ABBREVIATIONS</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.872%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:72.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Term/Abbreviation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Definition</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">AOCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive income or loss</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounting Standards Codification</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CAG</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Companion Animal Group, a reporting segment&#160;that provides&#160;veterinarians&#160;diagnostic products and services and information management solutions that enhance the health and well-being of&#160;pets.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">cGMP</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The FDA&#8217;s current Good Manufacturing Practice regulations.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Clinical visits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The reason for the visit involves an interaction between a clinician and a pet.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Credit Facility</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Our $1 billion five-year unsecured revolving credit facility under an amended and restated credit agreement that was executed in December 2021, also referred to as line of credit.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">EPA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. Environmental Protection Agency</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">EPS</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Earnings per share, if not specifically stated, EPS refers to earnings per share on a diluted basis.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">EU</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">European Union</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">EURIBOR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate used in lending between banks on the European Union interbank market and also used as a reference for setting the interest rate on other loans.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">FASB</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. Financial Accounting Standards Board</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">FDA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. Food and Drug Administration</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Instrument rebate programs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Our customer instrument rebate programs, previously referred to as IDEXX Instrument Marketing Programs, which require an instrument purchase and provide customers the opportunity to earn future rebates based on the volume of products and services they purchase over the term of the program.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">IVLS</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">IDEXX VetLab Station, connects and integrates the diagnostic information from all the IDEXX VetLab analyzers and thus provides reference laboratory information management system&#160;capability.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Kits and consumables</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rapid assay kits and IDEXX VetLab consumables</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIBOR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">London Interbank Offered Rate, a benchmark interest rate used between banks and used to set interest rates on loans.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LPD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Livestock, Poultry and Dairy, a reporting segment that provides diagnostic products&#160;and services&#160;for livestock and poultry health and ensures the quality and safety of milk and improves producer efficiency.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">OCI</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income or loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">OPTI Medical</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">OPTI Medical Systems, Inc., a wholly-owned subsidiary of IDEXX Laboratories Inc., located in Roswell, Georgia. This business provides point-of-care and laboratory diagnostics (including electrolyte and blood gas analyzers and related consumable products) for the human medical diagnostics sector, as well as COVID-19 testing products and services. The Roswell facility also manufactures electrolytes slides (instrument consumables) to run Catalyst One</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">, Catalyst Dx</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">, and blood gas analyzers and consumables for the veterinary market; also referred to as OPTI.</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Organic revenue growth</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">A non-GAAP financial measure that represents the percentage change in revenue, as compared to the same period for the prior year, net of the effect of changes in foreign currency exchange rates, certain business acquisitions and divestitures. Organic revenue growth should be considered in addition to, and not as a replacement for or as a superior measure to, revenues reported in accordance with U.S. GAAP, and may not be comparable to similarly titled measures reported by other companies.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ortho</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ortho Clinical Diagnostics, Inc., a supplier of dry slide consumables used in our Catalyst One and Catalyst Dx Chemistry Analyzers and VetTest Chemistry Analyzer.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Prime rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The prime rate is an interest rate determined by individual banks. It is often used as a reference rate for many types of loans.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Up-Front customer loyalty programs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Our up-front loyalty programs provide customers with incentives in the form of cash payments or IDEXX Points upon entering into multi-year agreements to purchase annual minimum amounts of future products or services.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PACS</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Picture archiving and communication software, our software solution for accessing, storing, and sharing diagnostic images.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PCR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Polymerase chain reaction, a technique used to amplify small segments of DNA.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">R&amp;D</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and Development</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Reagent rentals</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Instruments being placed at customer sites at little or no cost in exchange for a long-term customer commitment to purchase instrument consumables.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Reported revenue growth</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The percentage change in revenue reported in accordance with U.S. GAAP, as compared to the same period in the prior year.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">S&amp;P</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Standard &amp; Poor&#8217;s</span></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.872%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:72.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">S&amp;P 500 Health Care Index</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The index for the S&amp;P 500 Health Care (U.S. companies) measures the performance of companies that are classified as members in the Global Industry Classification Standard of health care services sub-industry.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">S&amp;P 500 Index</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The S&amp;P 500 Index is a U.S. stock market index based on the market capitalization of 500 large companies having common stock listed on the New York Stock Exchange or NASDAQ, including IDEXX.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SaaS</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Software-as-a-service</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SDMA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Symmetrical dimethyl arginine, a biomarker that detects kidney disease.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SEC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. Securities and Exchange Commission</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Senior Note Agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Note purchase agreements for the private placement of senior notes, referred to as senior notes&#160;or long-term debt.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">T4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thyroxine, a hormone produced by the thyroid gland, tested to indicate thyroid health.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S. GAAP</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounting principles generally accepted in the United States of America</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">USDA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. Department of Agriculture</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Volume commitment programs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Programs that provide customers with a free or discounted instrument or system upon entering into multi-year agreements to purchase annual minimum amounts of products and services, such as our IDEXX 360 program.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Water</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Water, a reporting segment that provides water microbiology testing products.</span></td></tr></table></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i5d795a6851d746ca914a2ddae761c329_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IDEXX LABORATORIES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Annual Report on Form 10-K</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Table of Contents</span></div><div style="text-align:center"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:10.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:71.960%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.981%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Item No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Page No.</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PART I</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_19">Item 1</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_19">Business</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_19">6</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_22">Item 1A</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_22">Risk Factors</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_22">17</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_25">Item 1B</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_25">Unresolved Staff Comments</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_25">30</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_28">Item 2</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_28">Properties</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_28">31</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_31">Item 3</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_31">Legal Proceedings</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_31">31</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_34">Item 4</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_34">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_34">31</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PART II</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_40">Item 5</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_40">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_40">32</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_43">Item 6</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_43">[Reserved]</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_43">33</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_46">Item 7</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_46">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_46">34</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_106">Item 7A</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_106">Quantitative and Qualitative Disclosures about Market Risk</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_106">58</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_109">Item 8</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_109">Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_109">60</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_112">Item 9</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_112">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_112">60</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_115">Item 9A</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_115">Controls and Procedures</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_115">60</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_118">Item 9B</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_118">Other Information</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_118">61</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_10445360466006">Item 9C</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_10445360466006">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_10445360466006">61</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PART III</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_124">Item 10</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_124">Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_124">62</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_127">Item 11</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_127">Executive Compensation</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_127">62</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_130">Item 12</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_130">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_130">62</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_133">Item 13</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_133">Certain Relationships and Related Transactions, and Director Independence</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_133">62</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_136">Item 14</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_136">Principal Accountant Fees and Services</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_136">62</a></span></div></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PART IV</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_142">Item 15</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_142">Exhibits, Financial Statement Schedules</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_142">63</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_145">Item 16</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_145">Form 10-K Summary</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_145">63</a></span></div></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_148">Financial Statements and Supplementary Data &#8211; Index to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_148">F</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_148">-1</a></span></div></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_250">Exhibit Index</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_253">Signatures</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="text-indent:72pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i5d795a6851d746ca914a2ddae761c329_13"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The terms &#8220;IDEXX,&#8221; &#8220;Company,&#8221; &#8220;registrant,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221; included in this Annual Report on Form 10-K mean IDEXX Laboratories, Inc. and all subsidiaries that are consolidated under U.S. GAAP.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have included certain terms and abbreviations used throughout this Annual Report on Form 10-K in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Glossary of Terms and Selected Abbreviations.&#8221;&#160;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our name, logo and the following terms used in this Annual Report on Form 10-K are either registered trademarks or trademarks of IDEXX Laboratories, Inc. in the United States and/or other countries: 4Dx</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Alertys</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Animana</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Veterinary Software, Catalyst Dx</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Catalyst One</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Coag Dx</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Colilert</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Colisure</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Cornerstone</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, DVMAX</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Enterolert</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, ezyVet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Feline&#160;Triple</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Filta-Max</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,  Filta-Max</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">xpress</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, IDEXX I-Vision CR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, IDEXX I-Vision DR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, IDEXX I-Vision Mobile</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, IDEXX ImageBank</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%"> &#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, IDEXX Neo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, IDEXX-PACS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, IDEXX SDMA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, IDEXX VetLab</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LaserCyte</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, LaserCyte</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Dx, OPTI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Pet Health Network</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Petly</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Plans, Practice Profile</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, ProCyte Dx</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pseudalert</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Quanti-Tray</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, rVetLink</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, SediVue Dx</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, SNAP</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, SNAPduo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, SNAP Pro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, SNAP</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">cPL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, SNAP</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">fPL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, SNAPshot Dx</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, IDEXX VetAutoread</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VetConnect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, IDEXX</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VetLab</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%"> &#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, VetLINK</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, VetLyte</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Vet Radar</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, VetStat</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and VetTest</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. VetAutoread is a trademark of QBC Diagnostics.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION</span></div><div style="text-indent:72pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Annual Report on Form 10-K for the year ended December 31, 2021, contains statements which, to the extent they are not statements of historical fact, constitute &#8220;forward-looking statements.&#8221; Such forward-looking statements about our business and expectations within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), include statements relating to the impact of the COVID-19 pandemic; our expectations regarding supply chain and logistics disruptions; our expectations regarding the labor supply; future revenue growth rates;&#160;future tax benefits; the impact of tax legislation and regulatory action; revenue recognition timing and amounts; business trends,&#160;earnings and other measures of financial performance;&#160;the effect of economic downturns on our business performance; the projected effect of patent and license expirations; the projected impact of foreign currency exchange rates and hedging activities; demand for our products;&#160;realizability of assets; future cash flow and uses of cash; future repurchases of common stock; future levels of indebtedness and capital spending; interest expense; warranty expense; share-based compensation expense;&#160;the adoption and projected impact of new accounting standards; critical accounting estimates; future commercial and operational efforts;&#160;future product launches; projected cost and completion of capital investments; and competition. Forward-looking statements can be identified by the use of words such as &#8220;expects,&#8221; &#8220;may,&#8221; &#8220;anticipates,&#8221; &#8220;intends,&#8221; &#8220;would,&#8221; &#8220;will,&#8221; &#8220;plans,&#8221; &#8220;believes,&#8221; &#8220;estimates,&#8221; &#8220;should,&#8221;&#160;&#8220;project,&#8221;&#160;and similar words and expressions. These forward-looking statements are intended to provide our current expectations or forecasts of future events, are based on current estimates, projections, beliefs, and assumptions, and are not guarantees of future performance. Actual events or results may differ materially from those described in the forward-looking statements. These forward-looking statements involve a number of risks and uncertainties, including, among other things, the matters described under the headings "Business," "Risk Factors," "Legal Proceedings," "Management's Discussion and Analysis of Financial Condition and Results of Operations," and "Quantitative and Qualitative Disclosures About Market Risk" in this Annual Report on Form 10-K. Any forward-looking statements represent our estimates only as of the day this Annual Report on Form 10-K was first filed with the Securities and Exchange Commission (&#8220;SEC&#8221;) and should not be relied upon as representing our estimates as of any subsequent date. From time to time, oral or written forward-looking statements may also be included in other materials released to the public and they are subject to the risks and uncertainties described or cross-referenced in this section. While we may elect to update forward-looking statements at some point in the future, we specifically disclaim any obligation to do so, even if our estimates or expectations change.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i5d795a6851d746ca914a2ddae761c329_16"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div><div id="i5d795a6851d746ca914a2ddae761c329_19"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1.&#160;&#160;&#160;&#160;BUSINESS</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COMPANY OVERVIEW</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IDEXX was incorporated in Delaware in 1983. We develop, manufacture, and distribute products and provide services primarily for the companion animal veterinary, livestock and poultry, dairy and water testing industries. We also provide human medical point-of-care and laboratory diagnostics. Our primary products and services are:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Point-of-care veterinary diagnostic products, comprised of&#160;instruments, consumables, and rapid assay test&#160;kits;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Veterinary reference laboratory&#160;diagnostic&#160;and consulting services;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Practice&#160;management&#160;and diagnostic imaging&#160;systems and&#160;services used by veterinarians;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Health monitoring, biological materials testing, laboratory diagnostic instruments, and services used by the biomedical research community;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Diagnostic,&#160;health-monitoring&#160;products for&#160;livestock, poultry, and dairy;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Products that test water for certain microbiological contaminants; and</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Point-of-care electrolytes and blood gas analyzers and SARS-CoV-2 RT-PCR (COVID-19 test) used in the human diagnostics sector.</span></div><div style="padding-left:54pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Purpose is to be a great company that creates exceptional long-term value for our customers, employees, and stockholders by enhancing the health and well-being of pets, people, and livestock.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DESCRIPTION OF BUSINESS BY SEGMENT</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate primarily through three business segments: Companion Animal Group, Water quality products, and Livestock, Poultry and Dairy. Our Other operating segment combines and presents our human medical diagnostic products and services business with our out-licensing arrangements because they do not meet the quantitative or qualitative thresholds for reportable segments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Companion Animal Group (&#8220;CAG&#8221;) - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services.</span></div><div style="padding-left:31.5pt;text-indent:-31.5pt"><span><br/></span></div><div style="padding-left:31.5pt;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CAG Diagnostics</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide diagnostic capabilities that meet veterinarians&#8217; diverse needs through a variety of modalities, including in-clinic diagnostic solutions and outside reference laboratory services. Regardless of modality utilized, veterinarians are provided with clinically relevant data which is integrated within our information management technologies. The result is a comprehensive view of patient diagnostic information that is easily accessible by both the veterinarian and pet owner.</span></div><div style="padding-left:31.5pt;text-indent:-31.5pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Integrated Diagnostic Information Management</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VetConnect PLUS is a cloud-based technology that enables veterinarians to access and analyze patients&#8217; data from all of IDEXX&#8217;s diagnostic modalities. These integrated diagnostic results provide the veterinarian with a visualization of patient-specific testing results, allowing the veterinarian to easily see and trend diagnostic results, enabling greater medical insight and enhanced decision-making. In addition, VetConnect PLUS provides instant mobile or browser-based access to results, which can be printed or emailed to pet owners and other veterinarians.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">In-Clinic Diagnostic Solutions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our in-clinic diagnostic solutions are comprised of our IDEXX VetLab suite of in-clinic chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers, as well as associated consumable products that provide real-time reference lab quality diagnostic results. Our in-clinic diagnostic solutions also include a broad range of single-use, IDEXX SNAP</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rapid assay test kits that provide quick, accurate, and convenient point-of-care diagnostic test results for a variety of companion animal disease causing pathogens and health conditions. Additionally, we offer extended maintenance agreements in connection with the sale of our instruments.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Blood and Urine Chemistry</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We have three blood and urine chemistry analyzers that are used by veterinarians to measure levels of certain enzymes and other substances in blood or urine for monitoring health status and assisting in diagnosing physiologic conditions. We actively sell the Catalyst One Chemistry analyzer. We continue to support our Catalyst Dx and VetTest Chemistry analyzers.&#160;We also support the VetStat Electrolyte and Blood Gas analyzer. Sales of consumables to customers who use our chemistry analyzers provide the majority of our instrument consumables revenues from our installed base of IDEXX VetLab instruments. </span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Hematology</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We sell three hematology analyzers that assess the cellular components of blood, including red blood cells, white blood cells, and platelets (also called a complete blood count). These analyzers include the ProCyte One and ProCyte&#160;Dx</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">hematology&#160;analyzers. We introduced the ProCyte One analyzer in 2020 and began delivery of these analyzers in 2021. We also sell the Coag Dx analyzer, which permits the detection and diagnosis of blood clotting disorders. While we currently do not sell the LaserCyte Dx hematology&#160;analyzer and the IDEXX VetAutoread hematology&#160;analyzer, we continue to support these analyzers.</span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Rapid Assay</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The SNAP rapid assays are single-use, handheld test kits that can work without the use of instrumentation, although many kits may also be activated with results automatically captured and interpreted by the SNAP Pro Analyzer. This device improves medical care by allowing veterinarians to share the test results with the pet owner on the SNAP Pro Analyzer screen, or via VetConnect PLUS. Our SNAPshot Dx analyzer can run multiple patient samples at once. The principal canine SNAP rapid assay tests include SNAP 4Dx Plus, which tests for the six vector-borne diseases causing pathogens, including Lyme disease as well as canine heartworm, and SNAP Heartworm RT, which tests for heartworm. Sales of our canine vector-borne disease tests are greater in the first half of our fiscal year due to seasonality of disease testing in the veterinary practices in the Northern&#160;Hemisphere. The principal feline SNAP rapid assay tests include SNAP Feline Triple, which tests for feline immunodeficiency virus (&#8220;FIV&#8221;) (which is similar to the virus that leads to AIDS in humans), and SNAP FIV/FeLV Combo Test, which tests for FIV and Feline leukemia virus&#160;("FeLV").</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Urinalysis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The SediVue Dx analyzer is designed to provide automated real-time results in a fraction of the time of manual microscope analysis, which allows veterinary staff to perform a urine sediment analysis in approximately 3 minutes. The IDEXX VetLab UA analyzer provides rapid, automated capture of semi-quantitative chemical urinalysis from IDEXX UA strips and is validated specifically for veterinary use.</span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">IDEXX VetLab Station</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The IDEXX VetLab Station (&#8220;IVLS&#8221;) connects and integrates the diagnostic information from all the IDEXX VetLab analyzers, and thus, provides reference laboratory information management system capability. IVLS also sends all results created on connected instruments instantly to VetConnect PLUS. We sell IVLS as an integral component for our in-clinic analyzer suite. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Outside Reference Laboratory Diagnostic and Consulting Services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We offer commercial reference laboratory diagnostic and consulting services to veterinarians in many developed geographies worldwide, including customers in the U.S., Europe, Canada, Australia, Japan, New Zealand, South Africa, South Korea, and Brazil, through a network of approximately 80 laboratories. Customers use our services by submitting samples by courier or overnight delivery to one of our facilities. Most test results have same-day or next-day turnaround times. Our diagnostic laboratory business also provides health monitoring and diagnostic testing services to biomedical research customers in North America, Europe, and Asia.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reference laboratories offer a large selection of tests and diagnostic panels to detect a number of disease states and other conditions in animals, including all tests that can be run in-clinic at the veterinary practice with our instruments or rapid assays. This menu of tests also includes a number of specialized tests that we have developed that allow practitioners to diagnose increasingly relevant diseases and conditions in dogs and cats, including parasites, heart disease, allergies, pancreatitis, diabetes, renal disease, and infectious diseases.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we provide specialized veterinary consultation, telemedicine, and advisory services, including radiology, cardiology, internal medicine, and ultrasound consulting. These services enable veterinarians to obtain readings and interpretations of test results transmitted by telephone and over the Internet.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Veterinary Software and Services &amp; Diagnostic Imaging Systems</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Veterinary Software and Services.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We develop, market, and sell a portfolio of software and services for independent veterinary clinics and corporate groups. This portfolio includes:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Practice management systems</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;Software, hardware, and integrated services that run key functions of veterinary clinics, including managing patient electronic health records, scheduling, client communication, billing, and inventory management. Our practice information management systems offerings include cloud-based ezyVet, Animana, IDEXX Neo, and Cornerstone Cloud, and on-premise Cornerstone and DVMAX. To support the software system needs of practices, IDEXX provides integrated services including: Payment Solutions, Data Backup &amp; Recovery, and Practice Supplies.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Software applications that extend workflow capabilities for practices and groups</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We are able to improve overall patient management and workflow optimization through coordination and tracking of every step of a patient during a hospital stay. Our SmartFlow cloud offering works in conjunction with major veterinary practice management systems, including Cornerstone, Animana, IDEXX Neo, DVMAX, and certain third-party practice management systems, and VetRadar provides workflow capability for ezyVet.&#160;</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Client marketing and wellness plan management</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;In addition, we offer cloud-based client communication (Pet Health Network Pro and Pet Health Network 3D) and preventive care plan management software (Petly Plans) designed to strengthen the relationship between the veterinarian and the pet owner. To support the communication needs between general practices and specialty referral practices, IDEXX offers rVetLink software. Lastly, IDEXX Enterprise provides centralized management and reporting capabilities for groups of veterinary practices. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Diagnostic Imaging Systems</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;Our diagnostic imaging systems capture radiographic images in digital form, replacing traditional x-ray film and the film development process, which generally requires the use of hazardous chemicals and darkrooms. We market and sell two diagnostic imaging systems primarily used in small animal veterinary applications:&#160;the IDEXX ImageVue DR50 and the IDEXX ImageVue DR30.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our diagnostic imaging systems employ picture archiving and communication system (&#8220;PACS&#8221;) software called IDEXX-PACS, which facilitates radiographic image capture and review. IDEXX Web PACS is our cloud-based software-as-a-service (&#8220;SaaS&#8221;) offering for viewing, accessing, storing, and sharing multi-modality diagnostic images. IDEXX Web PACS is integrated with Cornerstone, ezyVet, IDEXX Neo, DVMAX, and IDEXX&#160;VetConnect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PLUS to provide centralized access to diagnostic imaging results&#160;alongside patient diagnostic results from any internet connected device. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IDEXX I-Vision Mobile is a software application that allows veterinarians with IDEXX digital radiography systems the ability to request, view and send images using an iPad</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> mobile tablet. This application integrates with our IDEXX-PACS software.&#160;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the breadth of our full diagnostic solution, including novel products and services developed and made available only by IDEXX, as well as the seamless software integration of our offering, provide a differentiated competitive advantage by giving veterinarians the tools and services to offer advanced veterinary medical care. We believe that with the use of our products and services, veterinary practices significantly improve the quality of veterinary care provided to their patients, increase staff efficiencies, and better communicate the value of this medical care to the pet owner. We believe that these capabilities, enabled by the use of IDEXX products and services, improve the effectiveness and financial health of the veterinary practice.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Water quality products (&#8220;Water&#8221;) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Water provides innovative testing solutions for easy, rapid, and accurate detection and quantification of various microbiological parameters in water.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Water testing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our principal products are the Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">E. coli</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in water. These organisms are broadly used as microbial indicators for potential fecal contamination in water. Our products utilize nutrient-indicators that produce a change in color or fluorescence when metabolized by target microbes in the sample. Our water tests are used by government laboratories, water utilities, and private certified laboratories to test drinking water in compliance with regulatory standards, including U.S. Environmental Protection Agency (&#8220;EPA&#8221;) standards. The tests also are used in evaluating water used in production processes (for example, in beverage and pharmaceutical applications) and in evaluating bottled water, recreational water, wastewater, and water from private wells. We also sell consumables, parts, and accessories to be used with many of our water testing products.</span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Enterolert</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our Enterolert products detect the presence of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">enterococci</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in drinking, waste, and recreational waters. Enterococci, bacteria normally found in human and animal waste, are organisms broadly used as microbial indicators for potential fecal contamination in water. </span></div><div style="padding-left:36pt;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Pseudalert</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our Pseudalert products detect the presence of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pseudomonas aeruginosa</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in pool, spa, and bottled water. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pseudomonas aeruginosa</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a pathogen that can cause &#8220;hot-tub rash,&#8221; &#8220;swimmer&#8217;s ear,&#8221; and potentially fatal infections in individuals with weakened immune systems. </span></div><div style="padding-left:36pt;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Filta-Max and Filta-Max</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">xpress</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Filta-Max and Filta-Max</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">xpress</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> products are used in the detection of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cryptosporidium</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Giardia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in water. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cryptosporidium</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Giardia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> are parasites that can cause potentially fatal gastrointestinal illness if ingested. We also distribute certain water testing kits manufactured by Thermo Fisher Scientific, Inc. that complement our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cryptosporidium</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Giardia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> testing products.</span></div><div style="padding-left:36pt;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Legiolert</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our Legiolert product is a simple culture method test for the detection of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legionella pneumophila, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the most common </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legionella</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> species in water and the primary cause of Legionnaires&#8217; disease. The Legiolert test is designed to be used on potable or non-potable water sources with results in seven days.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Quanti-Tray products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our Quanti-Tray products, when used in conjunction with our Colilert, Colilert-18, Colisure, Enterolert, Pseudalert, Heterotrophic Plate Count ("HPC") or Legiolert products, provide users quantitative measurements of microbial contamination rather than a presence/absence indication. Our Quanti-Tray Sealer PLUS, and Quanti-Tray Sealer 2X are used with the Quanti-Tray products for the determination of bacterial density in water samples. Our SimPlate for HPC product detects the total number of the most common bacteria in a water sample.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Livestock, Poultry and Dairy (&#8220;LPD&#8221;)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - LPD provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, to improve producer efficiency, and to ensure the quality and safety of milk and food.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Livestock, Poultry, Heard Health Screening and Production Management</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We sell diagnostic tests, services and related instrumentation that are used to manage the health status of livestock and poultry, to improve producer efficiency, and to ensure the quality and safety of milk. Our livestock and poultry diagnostic products are purchased by government and private laboratories that provide testing services to livestock veterinarians, producers, and processors. Our herd health screening services are offered to livestock veterinarians and producers. Our principal livestock and poultry diagnostic products include tests for Bovine Viral Diarrhea Virus (&#8220;BVDV&#8221;), Porcine Reproductive and Respiratory Syndrome (&#8220;PRRS&#8221;), and African Swine Fever ("ASFV"). BVDV is a common and contagious viral infection that suppresses the immune system, making the animal susceptible to a host of other infections, impacting beef and dairy production yields as a result. PRRS is a contagious virus causing reproductive problems and respiratory diseases in swine, leading to increased piglet mortality, reduced growth, and vulnerability to secondary infections. Our RealPCR ASFV Test is a real-time polymerase chain reaction ("PCR") assay that provides early and accurate detection of ASFV supporting prevention, control, and eradication programs by veterinarians and producers. We also sell our Rapid Visual Pregnancy Test and Alertys On-Farm Pregnancy Test for cattle, which can detect pregnancy 28 days after breeding using whole blood samples.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Dairy products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our principal dairy products use our SNAP test platform and are used by dairy producers and processors worldwide to detect antibiotic drug residue in milk. Our primary product lines are SNAP Beta-Lactam ST and SNAPduo Beta-Tetra ST, which detect certain beta lactam and tetracycline antibiotic residues. We also sell SNAP</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">tests for the detection of certain other contaminants in milk, such as Aflatoxin M1.&#160;</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Other operating segment combines and presents our human medical diagnostic products and services business (&#8220;OPTI Medical&#8221;) with our out-licensing arrangements because they do not meet the quantitative or qualitative thresholds for reportable segments.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">OPTI Medical.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through OPTI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical, we sell point-of-care analyzers and related consumables for use in human medical hospitals and clinics to measure electrolytes, blood gases, acid-base balance, glucose, lactate, blood urea nitrogen and ionized calcium, and to calculate other parameters such as base excess and anion gap. These OPTI analyzers are used primarily in emergency rooms, operating rooms, cardiac monitoring areas, and other locations where time-critical diagnostic testing is performed within the hospital setting. Our OPTI CCA-TS2 Blood Gas and Electrolyte analyzer contains many new features relative to previous generation blood gas analyzers including customized workflows, faster time to result, improved communication, and a multi-level electronic control. Similar to our earlier generation OPTI CCA and OPTI Touch Electrolyte analyzers, the OPTI CCA-TS2 analyzer runs whole blood, plasma, and serum samples on single-use disposable cassettes that contain various configurations of analytes.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through OPTI Medical we also provide human COVID-19 testing products and laboratory services. On May 7, 2020, we announced that OPTI Medical was granted by the United States Food and Drug Administration ("FDA") an Emergency Use Authorization ("EUA") for the OPTI SARS-CoV-2 RT-PCR laboratory test kit for the detection of SARS-CoV-2, the virus that causes COVID-19. On June 5, 2020 OPTI Medical announced that it had received the CE mark certification in the European Union for its OPTI SARS-CoV-2 RT-PCR laboratory test kit. Additionally, the FDA has granted EUA for the OPTI DNA/RNA Magnetic Bead Kit for nucleic acid extraction from respiratory samples to be used with the OPTI SARS-CoV-2 RT-PCR test kit, which enables OPTI Medical Systems to provide laboratories with a complete OPTI Medical Systems-manufactured workflow solution for COVID-19 testing. We also provide human COVID-19 testing laboratories services to the Maine Center for Disease Control and Prevention in support of their COVID-19 testing program.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other Activities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We own certain drug delivery technology intellectual property, that we continue to seek to commercialize through agreements with third parties, such as pharmaceutical companies, which are included in the Other&#160;segment.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional information about our products and services can be found on our website. Information contained on or connected to our website is not incorporated by reference into this Annual Report on Form 10-K and should not be considered part of this annual report or any other filing we make with the SEC.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MARKETING AND DISTRIBUTION</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We market, sell, and service our products worldwide through our marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. We maintain sales offices outside the U.S. in all major regions including Africa, Asia Pacific, Canada, Europe,&#160;Middle East, and Latin America.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, we select the appropriate distribution channel for our products based on the type of product, technical service requirements, number and concentration of customers, regulatory requirements, and other factors. We market our companion animal diagnostic products to veterinarians directly in the U.S. Outside the U.S., we sell our companion animal diagnostic products through our direct sales force and, in certain countries, through distributors and other resellers. We sell our veterinary reference laboratory diagnostic and consulting services worldwide, generally through our direct sales force. We market our diagnostic imaging products primarily through our direct sales force in the U.S. and Canada. We market our software products primarily through our direct sales force in the U.S., Canada, Europe, and Australia. We market our Water and LPD products primarily through our direct sales force in the U.S. and Canada. Outside the U.S. and Canada, we market these products through our direct sales force and, in certain countries, through selected independent distributors. We sell our OPTI products and services both directly and through independent human medical product distributors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESEARCH AND DEVELOPMENT</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business includes the development and introduction of new products and services and may involve entry into new business areas. We maintain active research and development programs in each of our business segments. Our research and development expenses, which consist of salaries, employee benefits, materials and external consulting and development costs, were $161.0 million for the year ended December 31, 2021, or 5.0% of our consolidated revenue, $141.2 million for the year ended December 31, 2020, or 5.2% of our consolidated revenue and $133.2 million for the year ended December 31, 2019, or 5.5% of our consolidated revenue.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PATENTS AND LICENSES</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We actively seek to obtain patent protection in the U.S. and other countries for inventions covering our products and technologies. We also license patents and technologies from third parties. Patents and licenses of patents and technologies from third parties are considered important to us based on a variety of factors, including providing protection for our inventions and other intellectual property; affording protection from competitors in certain sectors; enabling the use of more effective and efficient technologies in the development and production of our products and offerings; strengthening our reputation and standing among customers, employees, and key suppliers; and acting as a deterrent against counterfeiters, imitators, and other copiers of technologies.&#160;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Important patents and licenses include those related to:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Methods for detecting BVDV that started to expire in 2017 and will continue into 2022;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Reagents and methods for the detection of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Anaplasma phagocytophilum</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that started to expire in 2017 and will continue into 2022;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Reagents and methods for the detection of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ehrlichia canis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that began to expire in 2019 and will continue into 2022;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Catalyst</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consumables that began to expire in 2020 and will continue into 2035;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Catalyst instruments that expire beginning in 2026 and will continue into 2032;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Reagents and methods for the detection of canine pancreatic lipase that expire in 2026; and</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Patents relating to reagents and methods for the detection of SDMA that expire beginning in 2029 and will continue into 2037.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we consider these technology rights to be important to us, a range of factors help to mitigate the future effects of patent and license expiration on our results of operations and financial position. These factors include publications, including peer-reviewed third-party studies, that demonstrate the accuracy of our products; our brand strength and reputation in the marketplace; the breadth, quality and integration of our product offerings; our existing customer relationships and our customer support; our sales force; our online ordering platform that enables direct ordering of (including establishing automatic reorder schedules for) our consumables, tests and other products by our customers; the applicable regulatory approval status for certain products; our continued investments in innovative product improvements that often result in new technologies and/or additional patents; our investment in diagnostic innovations that results in new product offerings that often are patentable and that expand the test menu for our in-clinic instruments and/or reference laboratory business;&#160;and our significant know-how, scale and investments related to manufacturing processes of associated product offerings and certain supply arrangements for consumables that are compatible with our instruments. Although we have certain patents and licenses of patents and technologies from third parties that are expected to expire in 2022 and beyond, the expiration of these patents and licenses, individually or in the aggregate, is not expected to have a material effect on our financial position or future operations. In addition, we already face robust competition as other companies have been successful in bringing competitive products to market, despite the protections afforded by these technology rights.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent some of our products may now, or in the future, embody technologies protected by patents, copyrights, or trade secrets of others, we may be required to obtain licenses to such technologies in order to continue to sell our products. These licenses may not be available on commercially reasonable terms or at all. Our failure to obtain any such licenses may delay or prevent the sale of certain new or existing products. Refer to &#8220;Part I, Item 1A. Risk Factors.&#8221;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PRODUCTION AND SUPPLY</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of the instruments that we sell are manufactured by third parties.&#160;We rely on third parties in our supply chain to supply us, and our direct suppliers, with certain important components, raw materials, and consumables used in or with our products. In some cases, these third parties are sole or single-source suppliers. From time to time, we seek to qualify alternative suppliers.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Instruments and consumables</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Significant products supplied by sole and single-source providers include certain Catalyst Dx and Catalyst One&#160;consumables (other than electrolyte consumables and the fructosamine, T4, CRP, progesterone, and SDMA slides), VetTest slides, VetLyte consumables, LaserCyte Dx consumables, VetAutoread and ProCyte Dx analyzers and consumables, SediVue Dx urinalysis instruments and consumables, and certain components of our internally manufactured analyzers.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VetTest and certain Catalyst chemistry slides are supplied by Ortho under supply agreements that are currently set to expire in December of 2031. We are required to purchase all of our requirements for our current menu of Catalyst and VetTest chemistry slides from Ortho to the extent Ortho is able to supply those requirements. The agreements provide for pricing based on purchase volumes and a fixed annual inflationary adjustment. The agreements also prohibit Ortho from promoting and selling these chemistry slides in the veterinary sector, excluding the EU, other than to IDEXX.&#160;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We purchase other analyzers and consumables under supply agreements with terms extending through 2034, which in some cases may be extended at our option. We have minimum purchase obligations under some of these agreements, and our failure to satisfy these obligations may result in loss of some or all of our rights under these agreements. Refer to &#8220;Part I, Item 1A. Risk Factors.&#8221;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other components</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We purchase certain other products, raw materials, and components from sole and single-source suppliers. These products include certain diagnostic&#160;imaging systems and certain components used in our SNAP rapid assay and dairy devices, livestock and poultry testing kits and water testing products.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have been successful in ensuring an uninterrupted supply of products purchased from sole and single-source suppliers. However, there can be no assurance that uninterrupted supply can be maintained if these agreements terminate for any reason or our suppliers otherwise are unable to satisfy our requirements for products. Refer to &#8220;Part I, Item 1A. Risk Factors.&#8221;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BACKLOG</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not generally maintain a significant backlog of orders and believe that our backlog at any particular date historically has not been indicative of future sales.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COMPETITION</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compete with many companies ranging from large human and animal health pharmaceutical and medical diagnostics companies to small businesses focused on animal health. Our companion animal veterinary diagnostic products and services compete with both reference laboratory service and in-clinic product providers. Our competitors vary in our different sectors. In some sectors, academic institutions, governmental agencies, and other public and private research organizations conduct research activities and may commercialize products or services which could compete with our products, on their own or through joint ventures. Several of our direct and potential competitors have substantially greater financial and managerial resources than us, as well as greater experience in manufacturing, marketing, research and development, and obtaining regulatory approvals than we do. For more information on risks related to our competition, refer to &#8220;Part I, Item 1A. Risk Factors."</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Competitive factors in our different business areas are detailed below:</span></div><div><span><br/></span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Companion animal diagnostic offerings.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We compete primarily on the basis of ease of use and speed of our products, diagnostic accuracy, product quality, breadth of our product line and services, differentiated product innovations, fully integrated technology, information management capability, enhancement of veterinary practice efficiency, availability of medical consultation, effectiveness of our sales and distribution channels, quality of our technical and customer service, and our pricing relative to the value of our products and services in comparison with competitive products and services. Our major competitors in most geographic locations in North America are Antech Diagnostics, a unit of VCA Inc., a division of Mars, Incorporated; Zoetis Inc. (including its wholly-owned subsidiary Abaxis, Inc.); Heska Corporation, and Samsung Electronics Co., Ltd. We also compete in certain international geographies with Zoetis, Fujifilm Holdings Corporation, Samsung Electronics, Arkray, Inc., Heska, Mindray and BioNote, Inc.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Water, livestock,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">poultry,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">and dairy testing products.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We compete primarily on the basis of the ease of use, speed, accuracy, product quality, and other performance characteristics of our products and services (including differentiated tests), the breadth of our product line and services, the effectiveness of our sales and distribution channels, the quality of our technical and customer service, our ability to receive regulatory approvals from governing agencies and our pricing relative to the value of our products in comparison with competitive products and services. Our competitors include highly focused smaller companies and multibillion-dollar companies with small livestock and poultry diagnostics and water testing solution franchises.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Veterinary Software, Services and Diagnostic Imaging Systems</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We compete primarily on the basis of functionality, connectivity to equipment and other systems, performance characteristics, effectiveness of our implementation, training process and customer service, information handling capabilities, advances in technologies, enhancement of veterinary practice efficiency, and our pricing relative to the value of our products and services. We sell these products primarily in North America and Europe. Our largest competitor in North America and the U.K. is Covetrus, Inc., which offers several systems and leverages its animal health distribution business in sales and service. We also compete with numerous focused smaller companies throughout the geographies in which we offer veterinary software, including those offering cloud-based solutions. Our competitors in the diagnostic imaging systems sector include Sound-Eklin, Antech Diagnostics, FUJIFILM, and Heska.</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Human point-of-care medical diagnostic products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We compete primarily on the basis of the ease of use, menu, convenience, international distribution and service, instrument reliability, and our pricing relative to the value of our products. We compete primarily with large human medical diagnostics companies such as Radiometer A/S, Siemens Medical Solutions Diagnostics, Instrumentation Laboratory Company, Abbott Diagnostics, a division of Abbott Laboratories and Roche Diagnostics Corporation. We also compete with a number of companies around the world that produce human COVID-19 testing.</span></div><div style="padding-left:45pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GOVERNMENT REGULATION</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of our products are subject to comprehensive regulation by U.S. and foreign regulatory agencies that relate to, among other things, product approvals, product registrations, manufacturing, import, export, distribution, marketing and promotion, labeling, recordkeeping, testing, quality, storage, product disposal, environmental compliance, and workplace safety. The following is a description of the principal regulations affecting our businesses.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Veterinary diagnostic products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. These products include our diagnostic test kits for companion and food animal infectious diseases, including most of our livestock and poultry products and many of our rapid assay products. These products are licensed and regulated in the U.S. by the Center for Veterinary Biologics within the United States Department of Agriculture (&#8220;USDA&#8221;) Animal and Plant Health Inspection Service (&#8220;APHIS&#8221;). These products must be approved by APHIS before they may be sold in and from the U.S. The APHIS regulatory approval process involves the submission of product validation data, including manufacturing process and facility documentation. Following regulatory licensure to market a product, APHIS requires that each lot of product be submitted for test review before release to customers. In addition, APHIS requires special approval to market products where test results are used in part for government-mandated disease management programs. A number of foreign governments accept APHIS&#160;approval to support product registration for sale, distribution, and use within their countries. However, compliance with extensive country-specific regulatory processes is required in connection with importing and marketing diagnostic products in Japan, Germany, Canada, Brazil, the Netherlands, China, and many other countries. We are also required to have a facility license from APHIS to manufacture USDA-licensed products. We have a facility license for our manufacturing facility in Westbrook, Maine which also covers our distribution center in Memphis, Tennessee. Our LPD manufacturing facility in Montpellier, France has been approved by APHIS and we have a permit to import one LPD product manufactured in Montpellier, France to the U.S. for distribution.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our veterinary diagnostic slide and instrument systems, including T4, fructosamine, progesterone, CRP, and SDMA, are veterinary medical devices regulated by the FDA&#160;under the Food, Drug and Cosmetics Act (the &#8220;FDC Act&#8221;). Other FDA regulated products include our non-licensed rapid assay products such as SNAP Pancreatic Lipase, Cortisol, Bile Acid, Foal IgG, and ProBNP. While the sale of these products does not require premarket approval by the FDA and does not subject us to FDA inspections or the FDA&#8217;s current Good Manufacturing Practices regulations (&#8220;cGMP&#8221;), the FDC Act specifies that these products must not be adulterated, mislabeled, or misbranded.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Water testing products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our water tests are not subject to formal premarket regulatory approval. However, before a test can be used as part of a water quality monitoring program in the U.S. that is regulated by the EPA, the test method must first be approved by the EPA. The EPA approval process involves submission of extensive product performance data in accordance with an EPA-approved protocol, evaluation of the data by the EPA, and publication for public comment of any proposed approval in the Federal Register before final approval. Our Colilert, Colilert-18, Colisure, Quanti-Tray, Filta-Max </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">xpress</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Enterolert, and SimPlate for heterotrophic plate counts products have been approved by the EPA for use under various regulatory programs. Water testing products are subject to similarly extensive regulatory processes in other countries around the world.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Dairy testing products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Dairy products used in National Conference on Interstate Milk Shipments (&#8220;NCIMS&#8221;) milk-monitoring programs in the U.S. are regulated by the FDA as veterinary medical devices. However,&#160;before products requiring FDA approval can be sold in the U.S., performance data must be submitted in accordance with an FDA-approved protocol administered by an independent body, such as the Association of Analytical Chemists Research Institute (&#8220;AOAC RI&#8221;). Following approval of a product by the FDA, the product must also be accepted by NCIMS, an oversight body that includes state, federal, and industry representatives. Our SNAP Beta-Lactam antibiotic residue test product has been accepted by the FDA, NCIMS, and AOAC RI for sale in the U.S. While some foreign countries accept AOAC RI certification as part of their regulatory approval process, many countries have separate regulatory processes.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Human point-of-care electrolyte and blood gas analyzers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our OPTI instrument systems are classified as Class I and/or Class II medical devices, and their design, manufacture, and marketing are regulated by the FDA. Accordingly, we must comply with cGMP in the manufacture of our OPTI products. The FDA&#8217;s Quality System regulations further set forth standards for product design and manufacturing processes, require the maintenance of certain records, and provide for inspections of our facilities by the FDA. New OPTI products fall into FDA classifications that require notification of and review by the FDA before marketing, and which are submitted as a 510(k) application. These OPTI products are also subject to the regulations governing the manufacture and marketing of medical devices in other countries in which they are sold, including the EU Regulations on Medical Devices and In Vitro Diagnostic Devices.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Human COVID-19 test products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. OPTI manufactures, sells and distributes PCR and antibody ELISA test kits for the detection of the virus that causes COVID-19. These test kits are subject to regulation by the FDA pursuant to the FDC Act, and more specifically, are sold and distributed pursuant to FDA Emergency Use Authorization. These products are also subject to the regulations governing the manufacturing and marketing of medical devices in other countries in which they are sold, including the EU Regulations on Medical Devices and In Vitro Diagnostic Devices.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other Chemical, Environmental, and Human Health Safety Regulations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. All IDEXX products must comply with applicable global product regulations, including those governing consumer product safety and materials requirements such as the Europeans Union's Electromagnetic Compatibility ("EMC") Directive, the European Regulation for Registration, Evaluation, Authorization and Restriction of Chemical Substances ("REACH"), the Restriction of Hazardous Substances ("RoHS") Directive, and the Waste Electrical and Electronic Equipment ("WEEE") Directive. These complex regulatory requirements create risk to IDEXX&#8217;s ability to market and sell our products, our business, and our financial performance. For more information about the risks associated with various U.S. and foreign government regulation, refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"Various U.S. and foreign government regulations could limit or delay our ability to market and sell our products or otherwise negatively impact our business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" under "Part I, Item 1A. Risk Factors." </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the European Union, our analyzers and certain associated equipment are subject to the requirements of the RoHS Directive, which regulates and restricts certain hazardous substances in electrical and electronic equipment. Other countries, including China, Russia, the United Arab Emirates, and Turkey have implemented or anticipate implementing regulatory regimes similar to the RoHS Directive. Our veterinary diagnostic instrument systems are not subject to regulation under the European Medical Device Directive or the In Vitro Diagnostic Directive, which are both strictly applicable to human use products. However, these systems are required to meet CE certification, which require compliance with the RoHS Directive, the EMC Directive, and other safety requirements. Most countries in which we sell our products impose similar registrations and/or certification requirements.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The European Union was among the first to regulate and restrict the use of certain substances that we currently use in our products. These requirements include the Biocidal Products Regulation, which requires the use of only approved biocides in our products imported to or used in the European Union, and REACH, which regulates and restricts the use of certain chemicals in the European Union. Compliance with these regulations (and similar regulations that have been or may be adopted elsewhere, such as Australia, China, Russia, Turkey, Korea, and other countries) may require registration, notification, or certification regarding regulated substances, imposition of import restrictions, or in certain cases the redesign or reformulation of our products. Some of our products, including some of our Companion Animal products, may be subject to pending restriction of microplastics pursuant to REACH.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the U.S., the EPA regulates chemical use similarly to the EU. In addition, certain states have their own chemical regulations, such as California's Proposition 65, which requires businesses to provide&#160;warnings&#160;to California residents about significant risk of exposures to chemicals in products that are known to cause cancer, birth defects, or other reproductive harm; and Maine's pending 2023 restrictions on PFAS (per- and polyfluoroalkyl substances) used in all products.&#160;</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the foregoing, our business is generally subject to various U.S. and foreign regulatory authorities, including the U.S. Federal Trade Commission (the &#8220;FTC&#8221;) and other anti-competition authorities, and we are also subject to anti-bribery and anti-corruption laws, such as the Foreign Corrupt Practices Act, import and export laws and regulations, including U.S. import and export control and sanctions laws, and laws and regulations governing the collection, use, retention, sharing and security of data. Development or acquisition of new products and technologies may subject us to additional areas of government regulation. These may involve medical device, water-quality and other regulations of the FDA, the EPA, the USDA, the FTC, and other federal agencies, as well as state, local and foreign governments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HUMAN CAPITAL</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As innovation and customer focus are important parts of our strategy to create long-term value, we aim to attract, motivate, develop, and retain talented employees at all levels who are aligned with and passionate about our Purpose by:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Building and sustaining an inclusive, ethical culture that values diversity, equity and inclusion ("DEI"); </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Offering competitive and locally relevant compensation and benefits; and </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Providing growth and development opportunities. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because our strategy includes developing strong, deep relationships with our veterinary customers, we have focused on growing our global companion animal diagnostics field-based organization.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Diversity, Equity, and Inclusion.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We believe that DEI among our employees helps drive both innovation and a better understanding of our increasingly global customer base. We employ inclusive recruitment practices to source diverse candidates and mitigate potential bias. Our global recruiting team connects our sourcing strategies with diversified talent channels and adopts core competencies that focus on valuing differences, to attract candidates with different backgrounds, ideas, and experiences who will help enrich our culture. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, we had approximately 10,350 regular full-time and part-time employees, with underrepresented minorities representing an estimated 22.5% of our U.S. employees, as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:80.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.825%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Self-Identified Racial or Ethnic Background </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percentage of our U.S. Employees</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Black/African American</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asian</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Hispanic/Latinx</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">White</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">(1) Data regarding racial and ethnic background are based on self-identification by our U.S. employees; underrepresented minorities is defined as Black/African American, Asian, Hispanic/Latinx and Other. The percentages provided do not add up to 100% because some U.S. employees declined to specify race and/or ethnicity.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">(2) Other is defined as American Indian, Alaska Native, Native Hawaiian/Other Pacific Islander, and two or more races.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, as of December 31, 2021, women represented 58% of our global employees and were represented in leadership as follows: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:80.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.825%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percentage who self- identify as women</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Global Senior Leadership Team</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Global Senior Executive Team</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">(1) Global Senior Leaders are employees in compensation grades considered Director or above.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">(2) Global Senior Executives are employees in compensation grades considered Senior Vice President or above.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Compensation, Benefits and Well-being</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We offer fair, competitive compensation and a wide array of competitive and locally relevant benefits (which vary by country and region) that support our employees&#8217; overall well-being, including comprehensive health and welfare insurance, generous time-off and leave, and retirement and financial support. We provide emotional well-being services through our Employee Assistance Program and a variety of interactive resources as well as lifestyle coaching, a global well-being speaker series, and ergonomic programs that help support employees&#8217; physical well-being. In addition, a majority of our employees have access to financial education and our U.S. employees can engage with a financial wellness coach for further tools and resources to reach their personal financial goals. </span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the COVID-19 pandemic spread globally in early 2020, we implemented significant changes that we determined were in the best interest of our employees as well as the communities in which we operate. These included having the majority of our employees work from home, while implementing additional safety measures for employees continuing critical on-site work. We also provided a work-from-home fund to assist employees and added paid time off and caregiving support to enhance employee health and well-being. While many of our employees have continued to work from home since March 2020, we have re-opened some of our offices, consistent with public health guidance and protocols, and support flexible work options. We continue to monitor the state of the pandemic to ensure the continued safety and health of our employees.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Growth and Development</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We are steadfast in our focus on cultivating the diverse leaders of tomorrow and making career development opportunities more accessible across the global organization. Our training is 100% virtual and available in multiple languages. Our career development programs are designed to build capabilities and enable career progression. We also encourage our employees to enhance their career development through job-related courses and degree programs.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Employee Turnover and Engagement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We monitor employee turnover and engagement to identify opportunities to strengthen our approach to human capital management. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, our voluntary employee turnover rate was approximately 12%. Our voluntary turnover among managerial and professional staff was approximately 6%. With the contraction of the labor force as a result of the global pandemic, we have recently experienced the effects of the labor shortage in our staffing. We expect the labor shortage to continue in 2022 and will continue to monitor and analyze retention closely to identify any areas of concern.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We regularly conduct company-wide employee surveys conducted by a third party to collect employee input</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on our culture, their experiences, and workplace conditions. These survey results provide insights that help us to improve employee engagement. Our most recent global employee survey received a high level of response and indicated an 82% engagement level. Given the pandemic-related impacts on our front-line workers' engagement, we are actively working to better understand what matters the most to them and what drives their engagement and retention. Some of the actions taken in 2021 as a result of this increased focus include increasing the frequency of bonus payments to twice per year for our U.S. operations workers and advancing market competitive pay increases, as appropriate. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, we plan to further leverage the insights gained to develop a roadmap for improving front-line worker engagement and retention. We are also monitoring the current landscape of wage inflation and labor shortages in connection with our employees' overall compensation. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">AVAILABLE INFORMATION</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal executive offices are located at One IDEXX Drive, Westbrook, Maine 04092, our telephone number is 207-556-0300, and our internet address is www.idexx.com. References to our website in this Annual Report on Form 10-K are inactive textual references only and the content of our website should not be deemed incorporated by reference for any purpose.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We make available free of charge at www.idexx.com our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act as soon as reasonably practicable after we file such information with, or furnish it to, the SEC. In addition, copies of our reports filed electronically with the SEC may be accessed at www.sec.gov. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Corporate Governance Guidelines and our Code of Ethics are also available on our website at&#160;www.idexx.com.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><div id="i5d795a6851d746ca914a2ddae761c329_22"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A.&#160;&#160;&#160;&#160;RISK FACTORS</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You should consider carefully the risks and uncertainties described below in addition to the other&#160;information included or incorporated by reference in this Annual Report on Form 10-K in evaluating our company and our business. Our future operating results involve a number of risks and uncertainties and actual events or results may differ materially from those discussed in this Annual Report on Form 10-K. Factors that could cause or contribute to such differences include, but are not limited to, the factors discussed below, as well as those factors discussed elsewhere herein. Any of these factors, in whole or in part, could materially and adversely affect our business, financial condition, operating results and stock price.&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISK RELATED TO THE COVID-19 PANDEMIC</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The effects of the ongoing&#160;COVID-19 pandemic could have a material adverse impact on our business, results of operations, liquidity, financial condition, and stock price.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The duration, extent, and impacts of the ongoing COVID-19 pandemic remain uncertain and could have a material adverse impact on our business, results of operations, liquidity, financial condition, and stock price. The spread of COVID-19 has caused us to modify aspects of our business practices (including the management of and access to our faciliti</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">es, employee remote work locations, and employee travel), an</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d we may take further actions, as may be required by federal, state, and local governments or as we determine to be in the best interests of our employees and customers. Such actions may disrupt our supply chain, logistics network, operations, facilities, and employee workforce, which could negatively affect our employees' efficiency and productivity; our development and introduction of innovative new products and services; our ability to manufacture, market, sell, and distribute our products and services; and our financial performance. In addition, public health-related guidance and directives, including stay-at-home orders that may be further deployed to combat the spread of COVID-19, including variants (such as Delta and Omicron), and possible higher infection rates could result in a decrease in companion animal clinical visits, labor shortages, the delay of elective procedures and wellness visits, and disruption of veterinary clinic operations, all of which would have a negative effect on veterinary service providers and result in declines in demand for our CAG products and services, which represented 90% of our 2021 consolidated revenues. If stay-at-home orders or other similar public health-related directives are re-implemented periodically to combat the spread of COVID-19, particularly in the United States, the negative impact on veterinary service providers and their businesses, and correspondingly on demand for our CAG products and services, may be material. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Business lockdowns, pool and beach closures and weakened economic conditions related to the COVID-19 pandemic reduced demand for our water testing products in 2020. While our water testing volumes have been recovering during 2021, public health-related guidance and directives that may be further deployed to combat the spread of COVID-19, including variants, may significantly reduce demand. In addition, the ongoing pandemic has increased economic uncertainty and caused economic slowdowns that may continue or recur. Economic weakness in our key geographies related to the COVID-19 pandemic may also reduce demand for our companion animal, water, livestock, poultry and dairy products and services, which could have an adverse impact on our results of operations.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While demand for our CAG products and services remained strong in 2021, the degree to which the COVID-19 pandemic ultimately impacts us depends on future developments that are unpredictable and most of which are outside of our control, including the duration, scope, and severity of the COVID-19 pandemic, the emergence of new variants, changes in infection rates, the vaccine participation rate, the effectiveness of vaccines, the availability of testing kits, as well as regulations and requirements impacting the ability of veterinarians to treat patients, the return to our offices, and/or our ability to visit customer sites. There can be no assurance that we will be able to prevent or mitigate any or all of the COVID-19 near or long-term adverse impacts. Any of the foregoing factors, or other cascading effects of the COVID-19 pandemic that are not currently foreseeable, could have a material adverse effect on our business, results of operations, liquidity, financial conditions, and stock price.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKS RELATED TO OUR BUSINESS AND INDUSTRY</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Because our business lines are highly attractive, they are also highly competitive. Our failure to successfully execute certain strategies within this competitive environment could have a material negative impact on our future growth and profitability</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The companion animal healthcare industry is highly competitive, and we anticipate increasing levels of competition from both existing competitors and new sector entrants given our performance and the industry&#8217;s strong growth and returns. Our ability to maintain or enhance our growth rates and our profitability depends on our successful execution of many elements of our strategy, including:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Developing, manufacturing, and marketing innovative new or improved and cost competitive in-clinic laboratory analyzers that drive sales of IDEXX VetLab instruments, grow our installed base of instruments, and increase demand for related recurring sales of consumable products, services, and accessories;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Developing and introducing new innovative diagnostic tests and services for both our reference laboratories and in-clinic applications that provide valuable medical information to our customers and effectively differentiate our products and services from those of our competitors;</span></div><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Developing and introducing innovative, data-insightful software solutions that increase the value to our customers of our companion animal products and services by enhancing the integration of the information and transactions of these products and the management of diagnostic information derived from our products;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Maintaining premium pricing, including by effectively implementing price increases, for our differentiated products and services through, among other things, effective communication and promotion of the value of our products and services in an environment where many of our competitors promote, market, and sell lesser offerings at prices lower than ours;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Providing our veterinary customers with the medical and business tools, information, and resources that enable them to grow their practices&#160;and the utilization of our diagnostic products and services, through increased pet visits, use of preventive care protocols, enhanced practice of real-time care, and improved practice efficiency;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Achieving cost improvements in our worldwide network of reference laboratories by implementing global best practices, including lean processing techniques, incorporating technological enhancements, including laboratory automation and a global laboratory information management system, employing purchasing strategies to maximize leverage of our global scale, increasing the leverage of existing infrastructure and consolidating testing in high volume laboratory hubs;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Achieving cost improvements in the manufacture and service of our in-clinic laboratory analyzers by employing the benefits of economies of scale in both negotiating supply contracts and leveraging manufacturing overhead, and by improving reliability of our instruments;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Continuing to expand, develop, and advance the productivity of our companion animal diagnostic sales, marketing, customer support, and logistics organizations in the U.S. and international regions in support of, among other things, our all-direct sales strategies;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Attracting, developing, and retaining key leadership and talent necessary to support all elements of our strategy, which is challenging due to the increasingly competitive and tight labor markets in which we operate, as well as COVID-19-related impacts on the workforce; </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Strengthening our sales and marketing activities to continue to grow our profitability both in the U.S. and in geographies outside of the U.S.; </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Identifying, completing, and integrating acquisitions that enhance our existing businesses or create new business or geographic areas for us;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Developing and implementing new technology and licensing strategies; and</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Continuing to effectively manage our growth and expansion on a global scale through, among other things, designing and implementing cost-effective improvements to our processes, procedures, and infrastructure.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are unsuccessful in implementing and executing on some or all of these strategies, our rate of growth or profitability may be negatively impacted.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our dependence on third-party suppliers could limit our ability to sell certain products or negatively affect our operating results</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on third-party suppliers to provide components and raw materials (including biological materials) for our manufactured products, manufacture some of the products that we sell, and perform certain services, including package-delivery services. Actions taken by third-party suppliers in operating their business, as well as any disruptions to their business operations (or their supplier's business operations), could disrupt our supply chain or operations and materially negatively impact our ability to supply the market, substantially decrease sales, lead to higher costs, and damage our reputation with our customers. Longer-term disruptions could potentially result in the permanent loss of our customers, which could reduce our recurring revenues and long-term profitability.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our supply chain and our cost of goods also may be adversely impacted by unanticipated price increases due to factors such as inflation, including wage inflation, or to supply restrictions beyond our control or the control of our suppliers. If current suppliers fail to supply sufficient goods or materials to us on a timely basis, or at all, we could experience inventory shortages and disruptions in our supply of goods or materials.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For examples of some of the events that could result in disruption to our supply chain or operations, and negatively impact our operating results, refer to &#8220;We are increasingly dependent on the continuous and reliable operation of our information technology systems, and a disruption of these systems or significant security breaches could adversely affect our business&#8221; and "Factors and events beyond our control could disrupt our operations, supply chain, and logistics network and adversely affect our business" below.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we currently purchase many products, components, and materials from sole or single sources. Some of these products are proprietary and, therefore, cannot be readily or easily replaced by alternative sources. These products, components, and materials are used in a majority of our instruments, including our Catalyst Dx, Catalyst One, ProCyte Dx, and ProCyte One analyzers; consumables and accessories used in our instruments; livestock and poultry diagnostic tests, dairy testing products, and water testing products. Even if products, components, and materials were to become available to us from alternative suppliers, we likely would incur additional costs and delays in identifying or qualifying replacement materials, and there can be no assurance that replacements would be available to us on acceptable terms, or at all. In certain cases, we may be required to obtain regulatory approval to use alternative suppliers, and this process of approval could delay production of our products or development of product candidates indefinitely.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We seek to mitigate sole and single-source suppliers risks on a risk-prioritized basis and in a variety of ways, including, when possible, by identifying and qualifying alternative suppliers, developing applicable in-house manufacturing capabilities and expertise, and entering into escrow arrangements for manufacturing information for certain single or sole-sourced products. We also seek to enter into long-term contracts that provide for an uninterrupted supply of products at predictable or fixed prices. However, there can be no assurance that we will successfully implement any of these mitigating activities or that, if implemented, any of them will be effective in preventing any delay or other disruption in our ability to supply our customers. In addition, suppliers may decline to enter into long-term contracts for any number of reasons, which would require us to purchase products, components, or raw materials via short-term contracts or on a purchase order basis. There can be no assurance that suppliers with which we do not have long-term contracts will continue to supply our requirements, will always fulfill their obligations under those contracts, or will not experience disruptions in their ability to supply our requirements. In cases where we purchase sole and single-source products, components, or raw materials under purchase orders, we are more susceptible to unanticipated cost increases or changes in other terms of supply. In addition, under some contracts with suppliers we have minimum purchase obligations, and our failure to satisfy those obligations may result in loss of some or all of our rights under these contracts or require us to compensate the supplier. If we are unable to obtain adequate quantities of products, components, or raw materials in the future from sole and single-source suppliers, or if such sole and single-source suppliers are unable to obtain the components or other materials required to manufacture the products, we may be unable to supply our customers, which could have a material adverse effect on our results of operations, and any longer-term disruptions could potentially result in the permanent loss of customers, which could reduce our recurring revenues and long-term profitability.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our biologic products are complex and difficult to manufacture, which could</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">negatively</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">affect our ability to supply our customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of our rapid assay, livestock and poultry diagnostic, water, and dairy products are biologic products that include biological materials, such as antibodies, cells, and sera. Manufacturing biologic products is highly complex due to the inherent variability of biological materials and the difficulty of controlling the interactions of these materials with other components of the products, samples, and the environment. There can be no assurance that we will be able to maintain adequate sources of biological materials or that we will be able to consistently manufacture biologic products that satisfy applicable product release criteria and regulatory requirements. Further, products that meet release criteria at the time of manufacture may fall out of specification while in customer inventory, which could require us to incur expenses associated with recalling products and providing customers with new products, either of which could damage customer relations. Our inability to produce or obtain necessary biological materials or to successfully manufacture biologic products that incorporate such materials could result in our inability to supply our customers with these products, which would have an adverse effect on our results of operations. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Various U.S. and foreign government regulations could limit or delay our ability to market and sell our products&#160;or otherwise negatively impact our business</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a global business, we sell products and services in more than 175 countries and operate in an increasingly complex legal and regulatory environment. In the U.S., the manufacture and sale of certain of our products are regulated by agencies such as the USDA, the FDA, and the EPA. Our diagnostic tests for animal health applications that involve the detection of infectious diseases, including most rapid assay canine and feline SNAP tests and livestock and poultry diagnostic tests, must be approved by the USDA prior to sale in the U.S. Our dairy testing products as well as the manufacture and sale of our OPTI line of human point-of-care electrolytes and blood gas analyzers require approval by the FDA before they may be sold commercially in the U.S., and our OPTI PCR test kits for the detection of the virus that causes COVID-19, are subject to regulation by the FDA and sold and distributed pursuant to Emergency Use Authorizations issued by the FDA. The methods used by our water testing products must be approved by the EPA, as a part of its water quality monitoring program, before they can be used by customers in the U.S. Delays in obtaining regulatory approvals for new products or product upgrades, or any termination, revision, or revocation of an Emergency Use Authorization for our OPTI test kits, could have a negative impact on our growth and profitability.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The manufacture, import, and sale of our products, as well as our research and development processes, are subject to similar and sometimes more stringent laws in many foreign countries. For example, the European Union regulates the use of certain substances that we currently use in our products or processes. These regulations include, but are not limited to, the Biocidal Products Regulation, which requires the use of approved biocides in our products prior to being manufactured, used, or sold in the European Union; the European Regulation for Registration, Evaluation, Authorization and Restriction of Chemical Substances, or REACH, which regulates and restricts the use of chemicals in the European Union; the Restriction of Hazardous Substances ("RoHS") Directive, which regulates and restricts certain hazardous substances in electrical and electronic equipment; the Electromagnetic Compatibility Directive; and the Waste Electrical and Electronic Equipment Directive. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compliance with these and similar regulations in the U.S. and abroad may require registration of the applicable substances or the redesign or reformulation of our products and may reduce or eliminate the availability of certain parts and components used in our products and services in the event our suppliers are unable to comply with the applicable regulations in a timely and cost-effective manner. Any redesign or reformulation or restricted supply of parts and components may negatively affect the availability or performance of our products and services, add testing lead-times for products and reformulated products, reduce our margins, result in additional costs, or have other similar effects. In addition, the costs to comply with these regulations may be significant. Any of these could adversely affect our business, financial condition, or results of operations. These legal and regulatory requirements are complex and subject to change, and we continue to evaluate their impact.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, some foreign governments require us to register or certify our products before they can be distributed or sold, and these product registration requirements, which vary among the applicable jurisdictions and change from time to time, are often complex and require us to engage in lengthy and costly processes and provide confidential, proprietary information about those products to foreign regulatory agencies. For example, compliance with extensive country-specific regulatory processes is required in connection with importing, marketing, and selling our diagnostic products in Japan, Germany, Canada, Brazil, the Netherlands, China, and many other countries. There can be no assurance that we will be able to obtain or maintain any product registration required by one or more foreign governments. Any inability to obtain or maintain a required product registration in a jurisdiction could adversely affect our ability to market and sell the applicable product in that jurisdiction, which could have a negative effect on our business, financial condition, and results of operations. There can also be no assurance that confidential, proprietary information provided to foreign regulatory agencies may not be accessed by </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">unauthorized persons or otherwise stolen, which could negatively impact our ability to protect our proprietary rights in our innovative products and our future success. For more information about the risks related to the protection of our proprietary rights in our products and services, refer to "Our success is heavily dependent on our continued differentiated product and service innovation" below.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also subject to a variety of federal, state, local, and international laws and regulations governing, as well as legal and political environments that vary broadly regarding, among other things, the importation and exportation of products; our global business practices, such as anti-corruption, anti-money laundering, and anti-competition laws; and immigration and travel restrictions. These legal, regulatory, and political requirements and environments differ among jurisdictions around the world and are rapidly changing and increasingly complex. The costs associated with compliance with these legal and regulatory requirements and adjusting to changing legal and political environments are significant and likely to increase in the future.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any failure by us to comply with applicable legal and regulatory requirements, or to adjust to changing legal and political environments, could result in fines, penalties, and sanctions; product recalls; suspensions or discontinuations of, or limitations or restrictions on, our ability to design, manufacture, market, import, export or sell our products; and damage to our reputation. Any of these could negatively impact our business.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our success is heavily dependent on our continued differentiated product and service innovation </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our future success significantly depends on our ability to continue, on a cost-effective and timely basis, to enhance our existing differentiated product and service offerings and to develop and introduce new and innovative differentiated products and services. As a result, we invest substantial funds and efforts into R&amp;D, investigating new products and technologies being developed by third parties and obtaining certain such new products and technologies through licenses or acquisitions. There can be no assurance that our R&amp;D, licensing, or acquisition efforts will achieve expected results, when or whether any of our products or services now under development will be launched, or whether we may be able to develop, license or otherwise acquire new products or technologies. We also cannot predict whether any product or service offering, once launched, will achieve market acceptance or achieve sales and revenue consistent with our expectations. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on a combination of patent, trade secret, trademark, and copyright laws to protect our proprietary rights. We also license patents and technologies from third parties to enable the use of third-party technologies in the development and production of our products and offerings. If we do not have adequate protection of our proprietary rights or are unable to license third-party patents and technologies on reasonable terms, our business may be adversely affected by competitors who utilize substantially equivalent technologies to compete with us.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot ensure that we will obtain issued patents, that any patents issued or licensed to us will remain valid, or that any patents owned or licensed by us will provide protection against competitors with similar technologies. Even if our patents cover products sold by our competitors, the time and expense of litigating to enforce our patent rights could be substantial and could have an adverse effect on our results of operations. In addition, expiration of patent rights could result in substantial new competition for products previously covered by those patent rights.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the past, we have received notices claiming that our products infringe third-party patents, and we may receive such notices in the future. Patent litigation is complex and expensive, and the outcome of patent litigation can be difficult to predict. We cannot ensure that we will win a patent litigation case or negotiate an acceptable resolution of such a case. If we lose, we may be prohibited from selling certain products and/or we may be required to pay damages and/or ongoing royalties as a result of the lawsuit. Any such result could have an adverse effect on our results of operations. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Increased competition from and technological advances by our competitors could negatively affect our operating results</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We face intense competition, and we expect that future competition will become even more intense as new products, services and technologies become available and new competitors enter the space. Our competitors in the veterinary diagnostic sector in the United States and abroad include companies that develop, manufacture, and sell veterinary diagnostic tests and commercial veterinary reference laboratories, certain large and well-funded animal health pharmaceutical companies, as well as corporate hospital chains that operate reference laboratories that serve both their hospitals and unaffiliated hospitals, such as VCA Inc., which is wholly owned by Mars, Incorporated, another operator of corporate hospital chains. Consolidation among our competitors and our customers may intensify the competition we face. While we believe that our offerings are competitively differentiated due to our innovative products and services (such as the IDEXX SDMA test and VetConnect Plus) that offer an integrated, comprehensive diagnostic solution and the quality of our technical and customer service, there can be no assurance </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">that increased consolidation among our competitors or customers (as well as any resulting reference laboratory vertical integration among our customers) would not have a negative impact on our ability to compete successfully. For more information regarding the risks presented by consolidation and reference laboratory vertical integration among our customers, refer to &#8220;Consolidation in our customer base, including through increased corporate hospital ownership, and prevalence of buying consortiums could negatively affect our business&#8221; below.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Competition could negatively affect our sales and profitability in a number of ways. New competitors may emerge through the development of innovative new technology, the acquisition of rights to use existing technologies or the use of existing technologies when patents protecting such existing technologies expire. New or existing competitors may introduce new, innovative, and competitive products and services, which could be superior, or be perceived by our customers to be superior, to our products and services or lead to the obsolescence of one or more of our products or services. Business combinations and mergers among our competitors may result in competitors that are better positioned to create, market, and sell more compelling product and service offerings. While an important aspect of our strategy is to continue, on a cost-effective and timely basis, to enhance our existing products and services and to develop and introduce new and innovative products and services, there can be no assurance that we will be able to successfully develop such products and services or that those products or services will be superior to our competitors&#8217; products or services or otherwise achieve customer acceptance. Some of our competitors and potential competitors may choose to differentiate themselves by offering products and services perceived in the eyes of customers as similar, at substantially lower sales prices, which could have an adverse effect on our results of operations through loss of sales and/or revenues or a decision to lower our own sales prices to remain competitive. In addition, our ability to attract and retain customers depends on the effectiveness of our customer marketing and incentive programs and multiple competitors could bundle product and service offerings through co-marketing or other arrangements, which could enhance their ability to compete with our broad product and service offering. Certain of our competitors and potential competitors, including large diagnostic and pharmaceutical companies, also have substantially greater financial and managerial resources than us, as well as greater experience in manufacturing, marketing, research and development, and obtaining regulatory approvals than we do.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidation in our customer base, including through increased corporate hospital ownership, and prevalence of buying consortiums could negatively affect our business </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Veterinarians are our primary customers for our CAG products and services, and the veterinary services industry in the U.S. and abroad has been consolidating at an accelerating rate in recent years. In the United States, the number of owners of veterinary hospitals has been declining, and an increasing percentage of veterinary hospitals are owned by corporations that are in the business of acquiring veterinary hospitals and/or opening new veterinary hospitals nationally or regionally. Major corporate hospital owners in the U.S. include Mars, Incorporated (owner of Banfield Pet Hospitals, Blue Pearl Veterinary Partners, Pet Partners and VCA Inc.), and National Veterinary Associates, and are joined by dozens of other consolidators. A similar trend exists in other regions such as Canada, Europe, Australia, New Zealand, China, and Brazil. Furthermore, an increasing percentage of individually-owned veterinary hospitals in the U.S. are participating in buying consortiums. Corporate owners of veterinary hospitals and buying consortiums often seek to improve profitability by leveraging the buying power they derive from their scale to obtain favorable pricing from suppliers, which could have a negative impact on our profitability and results of operations. While we have strong supplier relationships with several corporate hospital groups and buying consortiums, decisions by larger corporate owners and buying consortiums to shift their purchasing of products and services away from us and to a competitor would have a negative impact on our results of operations. In addition, certain corporate owners also operate reference laboratories that serve both their hospitals and unaffiliated hospitals. Any hospitals acquired by these companies generally attempt to shift all or a large portion of their testing to the reference laboratories operated by these companies, and there can be no assurance that hospitals that otherwise become affiliated with these companies would not shift all or a portion of their testing to such reference laboratories. Furthermore, because these companies compete with us in the reference laboratory services marketplace, hospitals acquired by these companies or those that establish other affiliations with these companies may cease to be customers or potential customers of our other companion animal products and services, which would cause our sales of these products and services to decline.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in testing patterns could negatively affect our operating results</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Demand for our companion animal, livestock and poultry diagnostic tests and our dairy and water testing products could be negatively impacted by a number of factors impacting testing practices. The introduction or broad market acceptance of vaccines or preventatives for the diseases and conditions for which we sell diagnostic tests and services could result in a decline in testing. Changes in accepted medical protocols regarding the diagnosis of certain diseases and conditions could have a similar effect. Eradication or substantial declines in the prevalence of certain diseases also could lead to a decline in diagnostic testing for such diseases. Our livestock and poultry products business in particular is subject to fluctuations resulting </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">from changes in disease prevalence. The outbreak of certain diseases (such as African swine fever) among livestock or poultry, or the adverse impact of climate change-related events (such as hurricanes, earthquakes, fires, and floods), could lead to the widespread death or precautionary destruction of such animals in the affected regions, reducing herd or flock sizes, which could reduce the demand for our testing products for such animals. Changes in government regulations or in the availability of government funds available for monitoring programs could negatively affect sales of our products that are driven by compliance testing, such as our livestock and poultry, dairy and water products. In addition, changes and trends in local dairy, poultry, or other food sectors around the world could negatively affect the related production markets resulting in a decline in demand for our testing products. Economic weakness (whether or not related to the COVID-19 pandemic) may also reduce demand for our companion animal, water, livestock, poultry, and dairy products and services, and public health-related guidance and directives, including stay-at-home orders that may be further deployed to combat the spread of COVID-19, and possible higher infection rates could result in a decrease in companion animal clinical visits, the delay of elective procedures and wellness visits and disruption of veterinary clinic operations, all of which would have a negative effect on veterinary service providers and result in declines in demand for our CAG products and services. Declines in testing for any reason, including the reasons described above, along with lost opportunities associated with a reduction in veterinary visits, could have an adverse effect on our results of operations.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">We sell many products through distributors, which presents risks that could negatively affect our operating&#160;results</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of our international product sales occur through third-party distributors. As a result, we are dependent on these distributors to promote and create demand for our products. Our distributors often offer products from several different companies, including our competitors, and may promote our competitors&#8217; products over our own products. We have limited ability, if any, to cause our distributors to devote adequate resources to promoting, marketing, selling, and supporting our products or to maintain certain inventory levels, and changes in our distributors&#8217; inventory levels, as compared to comparable prior periods, could negatively impact our revenue growth rates. We cannot assure you that we will be successful in maintaining and strengthening our relationships with our distributors or establishing relationships with new distributors who have the ability to market, sell, and support our products effectively. We may rely on one or more key distributors for a product or a region, and the loss of these distributors could reduce our revenue. Distributors may face financial difficulties, including bankruptcy, which could harm our collection of accounts receivable and financial results. While we maintain a rigorous distribution compliance program, violations of anti-corruption or similar laws by our distributors could have a material impact on our business and reputation, and any termination of a distributor relationship may result in increased competition in the applicable jurisdiction. Failure to manage the risks associated with our use of distributors outside of the U.S. may reduce sales, increase expenses, and weaken our competitive position, any of which could have a negative effect on our operating results.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our limited experience and small scale in the human point-of-care and related human laboratory diagnostics sector could inhibit our success in this sector&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have limited experience in the human point-of-care and related human laboratory medical diagnostics sector, and we operate at a small scale in this area. This sector differs in many respects from the veterinary diagnostic sector. Significant differences include the impact of third-party reimbursement on diagnostic testing, more extensive regulation, greater product liability risks, larger competitors, a more segmented customer base, and more rapid technological innovation. Our limited experience and small scale in the human point-of-care and laboratory medical diagnostics sector could negatively affect our ability to successfully manage the risks and features of this sector that differ from the veterinary diagnostic sector. There can be no assurance that we will be successful in achieving growth and profitability in the human point-of-care and laboratory medical diagnostics sector comparable to the results we have achieved in the veterinary diagnostic sector.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GENERAL RISKS</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We depend on key leadership and talent to succeed and compete effectively</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our continued success is substantially dependent on our ability to attract, develop, and retain highly capable, skilled and diverse employees and leaders. As we continue to grow our business, expand our geographic scope, and develop and offer innovative, new products and services, we require an engaged, qualified workforce and the organizational&#160;talent&#160;necessary to ensure effective succession for our senior leadership and other key personnel. Competition for experienced leaders and employees, particularly for persons with specialized skills, can be intense. Our ability to recruit and retain such&#160;talent&#160;will depend on a number of factors, including compensation and benefits, work location, work environment and development opportunities. Furthermore, the recent pandemic-related labor force shortages have made it more difficult and costly to attract qualified labor, and prolonged shortages could adversely affect our ability to achieve our business objectives. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The loss of the services of, or our failure to recruit or develop and implement effective succession plans for, our senior leadership or other key personnel may significantly delay or prevent the achievement of our strategic objectives, disrupt our operations, and adversely affect our business and our future success. In addition, even if we effectively develop and implement succession plans and make key leadership transitions, we cannot provide assurances as to whether we may experience management or other challenges in connection with any of those leadership transitions that could adversely affect our future success.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We are increasingly dependent on the continuous and reliable operation of our information technology systems, and a disruption of these systems or significant security breaches could adversely affect our business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on our information systems, as well as our third-party business partners&#8217; and suppliers&#8217; information systems, to provide access to our web-based products and services, keep financial records, analyze results of operations, process customer orders, manage inventory, process shipments to customers, store confidential or proprietary information and operate other critical functions. Although we maintain security policies, employ system backup measures and engage in redundancy planning and processes, such policies, measures, planning and processes, as well as our current disaster recovery plans, may be ineffective or inadequate to address all eventualities. Further, our information systems and our business partners' and suppliers' information systems may be vulnerable to attacks by hackers and other security breaches, including, among other things, computer viruses and malware, ransomware, denial of service actions, misappropriation of data and similar events through the internet (including via devices and applications connected to the internet), and through email attachments and persons with access to these information systems, such as our employees or third parties with whom we do business. Due to governmental mandates and recommended safety measures to control the spread of COVID-19, we modified aspects of our business practices. This has resulted in a greater number of our employees working remotely for extended periods of time, which may result in some increased risk of vulnerability or attacks associated with additional individuals accessing our data and systems remotely. In addition, security industry experts and government officials have warned about the risks of hackers and cybersecurity attacks targeting U.S. organizations conducting COVID-19-related research, such as IDEXX.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As information systems and the use of software and related applications by us, our business partners, suppliers, and customers become more cloud-based and connected to the &#8220;Internet of Things,&#8221; which is inherently susceptible to cyberattacks, there has been an increase in global cybersecurity vulnerabilities and threats, including more sophisticated and targeted cyber-related attacks that pose a risk to the security of our information systems and networks and the confidentiality, availability and integrity of data and information. We process credit card payments electronically over secure networks and also offer products and services that connect to and are part of the &#8220;Internet of Things,&#8221; such as our connected devices (e.g., IDEXX VetLab instruments). Any such attack or breach could compromise our networks and the information stored thereon could be accessed, publicly disclosed, lost, or stolen. While we have implemented network security and internal control measures, especially for the purpose of protecting our connected products and services from cyberattacks, and invested in our data and information technology infrastructure, there can be no assurance that these efforts will prevent a system disruption, attack, or security breach and, as such, the risk of system disruptions and security breaches from a cyberattack remains.</span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We, and some of our third-party vendors, have experienced cybersecurity attacks in the past and may experience further attacks in the future, potentially with more frequency. To our knowledge, most of these attacks have been unsuccessful, and none have resulted in any material adverse impact to our business or operations. We have adopted measures to mitigate potential risks associated with information technology disruptions and cybersecurity threats; however, given the unpredictability of the timing, nature and scope of such disruptions and the evolving nature of cybersecurity threats, which vary in technique and sources, if we or our business partners or suppliers were to experience a system disruption, attack or security breach that impacts any of our critical functions, or our customers were to experience a system disruption, attack or security breach via any of our connected products and services, we could potentially be subject to production downtimes, operational delays, other detrimental impacts on our operations or ability to provide products and services to our customers, the compromising of confidential or otherwise protected information, destruction or corruption of data, security breaches, other manipulation or improper use of our systems or networks, financial losses and additional costs from remedial actions, repairs to infrastructure, physical systems or data processing systems, increased cybersecurity and information technology protection costs, loss of business or potential liability, and/or damage to our reputation, any of which could have a material adverse effect on our competitive position, results of operations, cash flows or financial condition. Our customers could also face negative consequences such as the compromises of sensitive or critical information or systems. Furthermore, any access to, public disclosure of, or other loss of data or information (including any of our confidential or proprietary information or personal data or information) as a result of an attack or security breach could result in governmental actions or private claims or proceedings, which could damage our reputation, cause a loss of confidence in our products and services, damage our ability to develop (and protect our rights to) our differentiated technologies and have a material adverse effect on our business, financial condition, </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">results of operations or prospects. For more information regarding data and information privacy and protection risks, refer to &#8220;Our operations and reputation may be impaired if we, our products, or our services do not comply with our global privacy policy or evolving laws and regulations regarding data privacy and protection&#8221; below.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Factors and events beyond our control could disrupt our operations, supply chain, and logistics network and adversely affect our business</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business and results of operations could be negatively affected by certain factors and events beyond our control, such as natural disasters, severe weather conditions and/or climate change-related events (such as hurricanes, earthquakes, fires, and floods); public health issues (such as outbreaks, epidemics, or pandemics, including the ongoing COVID-19 pandemic); civil unrest; geopolitical conditions and developments; war, terrorism, or other man-made disasters; increases in wages that drive up prices; workforce disruptions; labor shortages or stoppages; the imposition of regulations, trade protection measures, tariffs, duties, import/export restrictions, quotas or embargoes on key components; transportation failures affecting the supply and shipment of materials and finished goods; and the unavailability of raw materials. Any of these events could result in, among other things, damage to or the temporary closure of one or more of our manufacturing or distribution facilities or reference laboratories (damage to one of our facilities or the manufacturing equipment we use could be costly and may require substantial lead-time to repair or replace); damage to or closure of one or more facilities of our third-party business partners or suppliers on which we rely; a temporary lack of an adequate work force in one or more markets; an interruption in power supply; a temporary or long-term disruption in our supply chain or logistics network (including a disruption to our ability to obtain critical components for the manufacture of our products); a temporary disruption in our ability to deliver (or delays in the delivery of) our products or services; and short- or long-term damage to our customers&#8217; businesses (which would adversely impact customer demand for our products and services). For more information regarding the risks presented by disruption to our suppliers&#8217; operations and supply chain, refer to &#8220;Our dependence on third-party suppliers could limit our ability to sell certain products or negatively affect our operating results&#8221; above.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We manufacture many of our significant companion animal products, including our rapid assay devices and certain instruments, many of our water testing products and certain of our livestock, poultry, and dairy testing products, at a single facility in Westbrook, Maine. Certain of our companion animal products, as well as our human point-of-care products, are manufactured in Roswell, Georgia. We also manufacture certain of our livestock and poultry testing products in Bern, Switzerland and Montpellier, France. In addition, we maintain major distribution facilities in North America and in the Netherlands and major reference laboratories in Memphis, Tennessee; Kornwestheim, Germany; Sacramento, California; Elmhurst, Illinois; North Grafton, Massachusetts; East Brisbane, Australia; Markham, Ontario; Wetherby, U.K.; and Tokyo, Japan. Interruption of operations at any of these facilities due to the occurrence of one or more of the events described above could have an adverse effect on our results of operations.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">While we maintain plans to continue business under such circumstances, there can be no assurance that such plans will be successful in fully or partially mitigating the effects of such events. We also maintain property and business interruption insurance to insure against the financial impact of certain events of this nature. However, this insurance may be insufficient to compensate us for the full amount of any losses that we may incur. In addition, such insurance will not compensate us for potential long-term competitive effects of being out of the market for the period of any interruption in operations.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks associated with doing business internationally could negatively affect our operating results</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2021, approximately 38% of our overall revenue and approximately 35%, 89% and 52% of our CAG, LPD, and Water revenues, respectively, were attributable to sales of products and services to customers outside the U.S. Although we intend to continue to expand our international operations and business, we may not be able to successfully promote, market, import, export, sell, or distribute our products and services outside the U.S. Various risks associated with foreign operations may impact our international sales, including, but not limited to, disruptions in transportation of our products or our supply chain; fluctuations in oil prices; increased border protection and restriction on travel; the differing product and service needs of foreign customers; difficulties in building, staffing, and managing foreign operations (including a geographically dispersed workforce); differing protection of intellectual property; trade protection measures, quotas, embargoes, import/export restrictions, tariffs, duties, and regulatory and licensing requirements; natural and other disasters; public health issues (such as outbreaks, epidemics, the ongoing COVID-19 pandemic, or the prospect of a&#160;pandemic); ongoing instability or changes in a country&#8217;s or region&#8217;s regulatory, economic, or political conditions; other unfavorable geopolitical conditions; security concerns; and local business and cultural factors that differ from our normal standards and practices, including business practices prohibited by the Foreign Corrupt Practices Act and other anti-corruption laws and regulations. </span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, to market and sell many of our products outside the U.S., we are subject to product approval and registration requirements that often require us to provide confidential, proprietary information about those products to foreign regulatory agencies. There can be no assurance that the confidential, proprietary information provided to foreign regulatory agencies to comply with product approval and registration requirements may not be accessed by unauthorized persons or otherwise stolen, which could negatively affect our ability to protect our proprietary rights in our innovative products and our future success. We also may forgo marketing and selling some of our products in certain foreign jurisdictions due to the risk of intellectual property theft, which could negatively affect our ability to expand our international operations and business. For more information about the risks related to the protection of our proprietary rights in our products and services, refer to "Our success is heavily dependent on our continued differentiated product and service innovation" above. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, prices that we charge to foreign customers may be different than the prices we charge for the same products in the U.S. due to competitive, market or other factors, or changes in foreign currency exchange rates. Our results of operations are also susceptible to changes in foreign currency exchange rates. As a result, the mix of domestic and international sales in a particular period could have an adverse impact on our results of operations for that period.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our operations and reputation may be impaired if we, our products, or our services do not comply with our global privacy policy or evolving laws and regulations regarding data privacy and protection</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The nature of our business involves the receipt, storage and use of information, including personal data, about our customers, pet owners, suppliers, and employees. We collect and use personal data in a variety of ways. We offer products and services that collect and use personal data, including veterinary practice management systems, online customer communication tools and services, VetConnect PLUS, and two-way integration technology. Some of these products and services rely on third-party providers for cloud storage. We also engage in e-commerce through various websites and collect contact and other personal data from our customers and website visitors. In addition, we transfer information, including personal data, among IDEXX, our subsidiaries and third parties with which we have commercial relations for business purposes. Our collection, protection, security, retention, storage, disclosure, sharing and use of personal data described above are subject to expanding and increasingly complex laws and regulations in the U.S. and abroad. In addition, these laws and regulations continue to develop and are subject to frequent revisions (and generally have become more stringent over time), are subject to differing interpretations, may be applied inconsistently from jurisdiction to jurisdiction and may be inconsistent with our current global privacy policy and data protection practices. Compliance with these evolving requirements can be costly, require us to change our business practices in a manner adverse to our business or delay or impede the development and offering of innovative products and services. Additionally, public perception and standards related to the privacy of personal data can shift rapidly, in ways that may affect our reputation or influence regulators in the U.S. and abroad to expand or adopt more stringent regulations and laws. Examples of laws and regulations that have impacted or could impact our business include: </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The California Consumer Privacy Act (&#8220;CCPA&#8221;), which became effective in January 2020, gives California residents, among other things, expanded rights to access and delete their personal information, opt out of certain personal information sharing, and receive detailed information about how their personal information is used. The CCPA provides for civil penalties for violations, as well as a private right of action for data breaches. Moreover, a new privacy law, the California Privacy Rights Act ("CPRA"), which is scheduled to take effect on January 1, 2023 (with a lookback to January 1, 2022), will significantly modify the CCPA, and will impose additional data protection obligations on companies such as ours doing business in California. Similarly, other states such as Virginia and Colorado, have instituted privacy and data security laws, rules, and regulations, and many similar laws have been proposed at the federal and state level, all of which may have potentially conflicting requirements that would make compliance challenging. The effects of the CCPA, CRPA, and other similar laws may require us to modify our data processing practices and policies and to incur substantial costs and expenses to comply. </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The European Union's General Data Protection Regulation ("GDPR"), which became effective in May 2018, imposes stringent operational requirements for controllers and processors of personal data of individuals in the European Economic Area ("EEA"), and noncompliance can trigger fines of up to the greater of &#8364;20 million or 4% of global annual revenues. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Following the United Kingdom&#8217;s ("UK") withdrawal from the EEA and the EU on December 31, 2020, we became subject to the GDPR as incorporated into the United Kingdom law "UK GDPR"), and noncompliance can trigger fines of up to the greater of &#163;17.5 million or 4% of global turnover. The European Commission adopted a UK adequacy decision in June 2021 which organizations can rely on for EEA to UK personal data transfers. This decision will automatically expire four years after its entry into force, but it might be renewed provided the UK maintains an adequate level of data protection. The relationship between the UK and the EU in relation to certain aspects of data </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">protection law remains unclear, however, and it is unclear how UK data protection laws and regulations will develop in the medium to longer term, and how data transfers to and from the UK will be regulated in the long term. Any changes to these laws may require us to modify our data processing practices and policies and to incur substantial costs and expenses to comply.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In July 2020, the Court of Justice of the European Union invalidated the EU-U.S. and Swiss-U.S. Privacy Shields calling into question data transfers carried out under the European Commission's Standard Contractual Clauses (&#8220;SCCs&#8221;), which has created compliance challenges for our transfer of personal data from the EEA and/or Switzerland to the U.S. and other third countries. The European Commission updated the SCCs on June 4, 2021, and additional regulatory guidance has been released that seeks to impose additional obligations on companies seeking to rely on the SCCs for such transfers. Parties transferring personal data from the EEA to third countries with &#8220;inadequate data protection&#8221; such as the U.S. will have until December 27, 2022 to update any existing agreements, or any new agreements executed before September 27, 2021, that rely on SCCs. The new SCCs apply only to the transfer of data outside of the EEA and not the UK, though on January 31, 2022, the UK&#8217;s Information Commissioner&#8217;s Officer announced that proposals for the U.K.'s own form of agreement and addendum to the E.U. SCCs (the "U.K. SCCs") which could be used for transfers for data from the U.K., have been laid before Parliament. If no objections are raised in Parliament and the proposals are approved, the U.K. SCCs will come into force on March 21, 2022 (subject to a grace period for implementation). Any transfers by us or our vendors of personal data from the EEA/UK may not comply with EEA/UK data protection laws, may increase our exposure to the GDPR&#8217;s/UK GDPR&#8217;s heightened sanctions for violations of its cross-border data transfer restrictions and may reduce demand for our products from companies subject to European/United Kingdom data protection laws. Similar laws have been proposed or passed in other countries, which may create additional compliance challenges for cross-border transfers of personal data.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In August 2021, China passed the new China Personal Information Protection Law ("PIPL"), which became effective November 2021. The PIPL provides a comprehensive set of data privacy and protection requirements that apply to the processing of personal information and expands data protection compliance obligations to cover the processing of personal information of persons by organizations and individuals in China, and the processing of personal information of persons in China outside of China if such processing is for purposes of providing products and services to, or analyzing and evaluating the behavior of, persons in China. Several PIPL requirements (such as data localization requirements and international cross border transfer restrictions) remain unclear as the processing amount thresholds for these requirements have not been implemented by the Chinese authorities yet. These thresholds could result in data localization practices that may complicate our operations and create additional compliance challenges for cross-border transfers of personal information. This may require us to modify our data processing practices and policies and to incur substantial costs and expenses to comply. The PIPL provides a comprehensive set of data privacy and protection requirements that apply to the processing of personal information and expands data protection compliance obligations to cover the processing of personal information of persons by organizations and individuals in China, and the processing of personal information of persons in China outside of China if such processing is for purposes of providing products and services to, or analyzing and evaluating the behavior of, persons in China.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Brazilian General Data Protection Law (&#8220;LGPD&#8221;), which became effective in September 2020, and the South African Protection of Personal Information Act ("POPIA"), which became effective in July 2020 (with a one-year grace period until June 30, 2021), and the Amendments to the Japanese Act on the Protection of Personal Information ("APPI") which will enter into full effect in April 2022, are examples of other non-U.S. data privacy-related laws to which we are subject. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any failure or perceived failure by us, the third parties with whom we work or our products and services to comply with all applicable privacy-related laws and regulations, as well as our contractual obligations, could result in damage to our reputation or legal proceedings or actions against us by governmental entities or others, any of which could have an adverse effect on our business. In addition, concerns about our practices with regard to the collection, use, retention, disclosure, or security of personal data or other privacy-related matters, even if unfounded and even if we are in compliance with applicable laws and regulations, could damage our reputation and harm our business. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Future operating results could be negatively affected by changes in tax rates, the adoption of new U.S. or international tax legislation or exposure to additional tax liabilities</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The nature of our global operations subjects us to local, state, regional and federal tax laws in jurisdictions around the world. Our future tax expense could be affected by changes in the mix of earnings in countries with differing statutory tax rates, changes in the valuation of deferred tax assets and liabilities or changes in tax laws or their interpretation. Additionally, tax </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rules governing cross-border activities are continually subject to modification as a result of coordinated actions by governments and organizations such as the Organization for Economic Cooperation and Development ("OECD") and unilateral measures designed by individual countries, both intended to tackle concerns over base erosion and profit shifting ("BEPS") and perceived international tax avoidance techniques.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021, the current U.S. administration proposed comprehensive corporate tax reforms, including (among other things) an increased tax rate and the promotion of a global minimum tax rate. In addition, in June 2021, finance leaders of the Group of Seven countries agreed to back a new global minimum tax rate that would apply regardless of the location of headquarters or physical presence, and in October 2021, 136 countries (including all Group of Twenty countries) agreed to the OECD&#8217;s global corporate tax reform plan, which would aim to modify the determination of taxable presence for digital activities and provide for a global minimum tax rate. Furthermore, in December 2021, the Dutch Government modified its tax laws and regulations, eliminating the benefits under our Dutch tax ruling for fiscal years beginning after December 31, 2021. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we have taken, and may take further, actions intended to align our corporate structure and intercompany relationships with supporting our growth in international markets and maintaining operational and tax efficiency and continue to consider all of these developments within our overall tax strategy, changes in tax law in the U.S. and other countries in which we operate or have a presence may materially and adversely impact our income tax liability, provision for income taxes, effective tax rate and results of operation, and there can be no assurance that any actions we take to maintain operational and tax efficiency will effectively mitigate these impacts. Moreover, these actions may increase our operating costs, and if ineffectual, could increase our income tax liabilities and our global effective tax rate. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our income tax filings are regularly under audit by various tax authorities, and the final determination of tax audits could be materially different from that which is reflected in historical income tax provisions and accruals. Significant judgment is required in determining our worldwide provision for income taxes. We regularly assess our exposures related to our worldwide provision for income taxes to determine the adequacy of our provision for taxes. Any reduction in these contingent liabilities or additional assessments would increase or decrease income, respectively, in the period such determination is made.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A weak worldwide economy could result in reduced demand for our products and services or increased customer credit risk</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A substantial percentage of our sales are made worldwide to the companion animal veterinary industry. Demand for our companion animal diagnostic products and services is driven in part by the number of patient visits to veterinary hospitals and the practices of veterinarians with respect to the recommendations for diagnostic testing, as well as pet owner compliance with these recommendations. Pet owners generally pay cash out of pocket for health care services for their pets from veterinary practices. The ongoing COVID-19 global pandemic has increased economic uncertainty and caused economic slowdowns that may continue or recur. Economic weakness in our significant geographies could cause pet owners to forgo or defer visits to veterinary hospitals or affect their willingness to approve certain diagnostic tests, comply with a treatment plan or, even more fundamentally, continue to own a pet. In addition, concerns about the financial resources of pet owners could cause veterinarians to be less likely to recommend certain diagnostic tests, and concerns about the economy may cause veterinarians to defer purchasing capital items such as our instruments and systems. These conditions, if they continue, could result in a decrease in sales or decrease in sales growth, of diagnostic products and services, which could have an adverse effect on our results of operations.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Demand for our water products is driven in part by the availability of funds at government laboratories, water utilities, and private certified laboratories that utilize our products. Availability of funds also affects demand by government laboratories and cattle, swine and poultry producers that utilize our livestock and poultry diagnostic products, and by users of our human diagnostic products and services. Economic weakness related to the ongoing COVID-19 global pandemic has caused and could continue to cause our customers to reduce their investment in such testing, which could have an adverse effect on our results of operations.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A weak economy may also cause deterioration in the financial condition of our distributors and customers, which could inhibit their ability to pay us amounts owed for products delivered or services provided in a timely fashion or at all.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Strengthening of the rate of exchange for the U.S. dollar has a negative effect on our business</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a global business, with 38% of our revenue during the year ended December 31, 2021, attributable to sales of products and services to customers outside of the U.S. Any strengthening of the rate of exchange for the U.S. dollar against foreign currencies, and in particular the euro, British pound, Canadian dollar, Chinese renminbi, Japanese yen, Australian dollar and Brazilian real, adversely affects our results, as it reduces the dollar value of sales and profits that are made in those currencies. The strengthening of the U.S. dollar has a greater adverse effect on the profits from products manufactured or sourced in U.S. dollars that are exported to international markets and a lesser effect on profits from foreign sourced products and services due to a natural hedge from international expenses denominated in the corresponding foreign currencies. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2021, approximately 23% of our consolidated revenue was derived from products manufactured or sourced in U.S. dollars and sold internationally in local currencies, as compared to 21% for the year ended December 31, 2020, and 22% for the year ended December 31, 2019. A strengthening U.S. dollar could also negatively impact the ability of customers outside the U.S. to pay for purchases denominated in U.S. dollars as well as affect our overall competitiveness in international markets. The accumulated impacts from any continued, longer-term growth in the value of the U.S. dollar against foreign currencies may have a material adverse effect on our operating results. Refer to &#8220;Part II, Item 7A. Quantitative and Qualitative Disclosures About Market Risk&#8221; included in this Annual Report on Form 10-K for additional information regarding currency impact.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our foreign currency hedging activities (refer to "Part II, Item 8. Financial Statements and Supplementary Data, Note 19. Hedging Instruments" in the accompanying Notes to consolidated financial statements), which are designed to minimize and delay, but not to eliminate, the effects of foreign currency fluctuations, may not sufficiently offset the adverse financial effect of unfavorable movements in foreign exchange rates on our financial results over the limited time the hedges are in place. In addition, our hedging activities involve costs and risks, such as transactions costs and the risk that our hedging counterparties will default on their obligations.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We primarily hedge intercompany product purchases and sales denominated in the euro, British pound, Canadian dollar, Japanese yen, and Australian dollar. Other foreign currency exposures related to foreign sourced services and emerging markets may not be practical to hedge. In certain cases, these exposures are not offset by foreign currency denominated costs. As we primarily use foreign currency exchange contracts with durations of less than 24 months and enter into contracts to hedge incremental portions of anticipated foreign currency transactions on a quarterly basis for the current and following year, the effectiveness of our foreign currency hedging activities to offset longer-term appreciation in the value of the U.S. dollar against non-U.S. currencies may be limited. Factors that could affect the effectiveness of our hedging activities include accuracy of sales and other forecasts, volatility of currency markets, and the cost and availability of hedging instruments. Since our hedging activities are designed to minimize volatility, they not only temporarily reduce the negative impact of a stronger U.S. dollar, but they also temporarily reduce the positive impact of a weaker U.S. dollar. Our future financial results could be significantly affected by a strengthening value of the U.S. dollar in relation to the foreign currencies in which we conduct business. The degree to which our financial results are affected for any given time period will depend in part upon our hedging activities.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restrictions in our</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">debt agreements</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">or our inability to obtain financing on favorable terms may increase our cost of borrowing and limit our activities</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to make scheduled payments and satisfy our other obligations under our Credit Facility and senior notes depends on our future operating performance and on economic, financial, competitive, and other factors beyond our control. Our business may not generate sufficient cash flows to meet these obligations or generate sufficient levels of earnings to satisfy the applicable affirmative, negative, and financial covenants. Our failure to comply with these covenants and the other terms of the Credit Facility and senior notes could result in an event of default and acceleration of our obligations under these agreements, which may require us to seek additional financing or restructure existing debt on unfavorable terms. In addition, adverse changes in credit markets could increase our cost of borrowing and make it more difficult for us to obtain financing, which could limit our ability to execute certain strategies and have an adverse effect on our revenue growth and profitability.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our senior notes include provisions which stipulate a prepayment penalty for which we will be obligated in the event that we elect to repay the notes prior to their stated maturity dates. Should we elect to repay some or all of the outstanding principal balance on our senior notes, the prepayment penalty we incur could adversely affect our results of operations and cash flows.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We fund our operations, capital purchase requirements and strategic growth needs through cash on hand, funds generated from operations, amounts available under our Credit Facility and senior note financings. If we are unable to obtain financing on favorable terms, we could face restrictions that would limit our ability to execute certain strategies, which could have an adverse effect on our revenue growth and profitability.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrowings under our Credit Facility bear interest at variable rates, including rates based on the London Interbank Offered Rate (LIBOR), exposing us to interest rate risk. If interest rates were to increase, our debt service obligations under our variable-rate Credit Facility would increase even if the principal amount borrowed remained the same. Our Credit Facility includes a provision for the determination of one or more benchmark replacement rates (including based on the secured overnight financing rate ("SOFR")) as a successor to the LIBOR rate.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKS RELATED TO AN INVESTMENT IN OUR SECURITIES</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fluctuations in our quarterly or annual results may cause our stock price to decline</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our prior operating results have fluctuated due to a number of factors, many of which are beyond our control, including seasonality of certain product lines; changes in our accounting estimates; the impact of acquisitions; timing of distributor purchases product launches, operating expenditures, and customer marketing and incentive programs; changes in the number and type of competitors and their product offerings; changes in our sales and distribution model; changes in the economy affecting consumer spending; and other matters. Similarly, our future operating results may vary significantly from quarter to quarter or year to year due to these and other factors. If our operating results or projections of future operating results do not meet the expectations of securities analysts or investors in future periods, our stock price may fall.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The market price of our common stock may be highly volatile, and you may not be able to resell your shares at or above the price you paid</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The trading price of our common stock may be volatile. Securities markets worldwide experience significant price and volume fluctuations. This market volatility, as well as other general economic, market or political conditions, could reduce the market price of our common stock rapidly and unexpectedly, in spite of our operating performance. Factors that may impact the market price of our common stock include the factors described in this &#8220;Risk Factors&#8221; section and elsewhere in this Form 10-K, as well as:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our stock repurchase program and changes in our capital structure, including the issuance of additional debt;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Public announcements (including the timing of these announcements) regarding our business, financial performance and prospects or new products or services, product enhancements or technological advances by our competitors or us;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Trading activity in our stock, including portfolio transactions in our stock by us, our executive officers and directors, and significant stockholders; trading activity that results from the ordinary course rebalancing of stock indices in which we may be included, such as the S&amp;P 500 Index; trading activity related to our inclusion in, or removal from, any stock indices; and short interest in our common stock, which could be significant from time to time;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Investor perception of us and the industry and sectors in which we operate, including changes in earnings estimates or buy/sell recommendations by securities analysts; and whether or not we meet earnings estimates of securities analysts who follow us; and</span></div><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">General financial, domestic, international, economic, and market conditions, including overall fluctuations in the U.S. equity markets, which may experience extreme volatility that, in some cases, is unrelated or disproportionate to the operating performance of particular companies.</span></div><div><span><br/></span></div><div><span><br/></span></div><div id="i5d795a6851d746ca914a2ddae761c329_25"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1B.&#160;&#160;&#160;&#160;UNRESOLVED STAFF COMMENTS</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div id="i5d795a6851d746ca914a2ddae761c329_28"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.&#160;&#160;&#160;&#160;PROPERTIES</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our worldwide headquarters and principal executive offices are located in Westbrook, Maine where we engage in manufacturing, research and development, marketing, sales, and general and administrative support functions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Primary Facility Locations</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Functions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Own/Lease</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Westbrook, Maine</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Worldwide Headquarters, principal executive offices</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Own</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hoofddorp, Netherlands</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution center, warehousing, International administrative offices</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Memphis, Tennessee</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution Center and Reference Lab</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kornwestheim, Germany</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reference Lab</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Own</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wetherby, United Kingdom</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reference Lab</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Newmarket, United Kingdom</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Water manufacturing</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bern, Switzerland</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LPD manufacturing</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Montpellier, France</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LPD manufacturing </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Roswell, Georgia</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OPTI Medical manufacturing</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Including the locations above, we have over 50 reference laboratories throughout the United States and over 25 reference laboratories internationally, including locations in Europe, Canada, Australia, New Zealand, Brazil, Asia, and South Africa. The majority of our reference laboratories are leased, with the remainder being owned. We also lease space in various locations worldwide for administrative support, manufacturing, sales, distribution, and storage. We believe that our leased and owned properties are generally in good condition, are well-maintained, and are generally suitable and adequate to carry on our business. A detailed listing of all our locations can be found on our website.</span></div><div><span><br/></span></div><div id="i5d795a6851d746ca914a2ddae761c329_31"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3.&#160;&#160;&#160;&#160;LEGAL PROCEEDINGS</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the nature of our activities, we are&#160;at times subject to pending and threatened legal actions that arise out of the ordinary course of business. In the opinion of management, based in part upon advice of legal counsel, the disposition of any such currently pending or threatened matters is not expected to have a material effect on our results of operations, financial condition, or cash flows. However, the results of legal actions cannot be predicted with certainty. Therefore, it is possible that our results of operations, financial condition or cash flows could be materially adversely affected in any particular period by the unfavorable resolution of one or more legal actions.</span></div><div id="i5d795a6851d746ca914a2ddae761c329_34"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4.&#160;&#160;&#160;&#160;MINE SAFETY DISCLOSURES</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><div id="i5d795a6851d746ca914a2ddae761c329_37"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div id="i5d795a6851d746ca914a2ddae761c329_40"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 5.&#160;&#160;&#160;&#160;MARKET FOR THE REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Market Information</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock is quoted on the NASDAQ Global Select Market under the symbol IDXX.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Holders of Common Stock</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of February 11, 2022, there were 390 holders of record of our common stock. Because the majority of our common stock is held by brokers and other institutions on behalf of stockholders, we are unable to estimate the total number of stockholders represented by these record holders.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Purchases of Equity Securities by the Issuer</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended December 31, 2021, we repurchased shares of common stock as described&#160;below:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:30.076%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.300%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.932%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Number of Shares Purchased<br/>(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Average Price Paid per Share<br/>(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(c)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(d)</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 1, 2021 to October 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101,855&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">632.26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101,855&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,280,968&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 1, 2021 to November 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129,176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">629.38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129,174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,151,794&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 1, 2021 to December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">159,662&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">619.88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">159,563&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,992,231&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">390,693&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">390,592&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,992,231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">As of December 31, 2021, our Board of Directors had approved the repurchase of up to 73 million shares of our common stock in the open market or in negotiated transactions pursuant to the Company&#8217;s share repurchase program. The program was approved and announced on August 13, 1999, and the maximum number of shares that may be purchased under the program has been increased by the Board of Directors on numerous occasions. There is no specified expiration date for this repurchase program. There were no other repurchase programs outstanding during the three months ended December 31, 2021, and no repurchase programs expired during the period.</span></div><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the three months ended December 31, 2021, we received 101 shares of our common stock that were surrendered by employees in payment for the required withholding taxes due on the vesting of restricted stock units and settlement of deferred stock units. In the above table, these shares are included in columns (a) and (b) but excluded from columns (c) and (d). These shares do not reduce the number of shares that may yet be purchased under the repurchase program.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2021, we repurchased approximately 1.3 million shares of our common stock in transactions made pursuant to our repurchase program and received approximately 0.03 million shares of our common stock that were surrendered by employees in payment for the minimum required withholding taxes due on the vesting of restricted stock units and settlement of deferred stock units. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> "Part II, Item 8. Financial Statements and Supplementary Data, Note 20. Repurchases of Common Stock" to the consolidated financial statements for the year ended December 31, 2021, included in this Annual Report on Form 10-K for further information.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividends</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have never declared or paid any cash dividends on our common stock. From time to time our Board of Directors may consider the declaration of a dividend. However, we have no intention to declare or pay a dividend at this time.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Performance</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This graph compares our total stockholder returns, the Total Return for the Standard &amp; Poor&#8217;s (&#8220;S&amp;P&#8221;) 500 Index, the Total Return for the S&amp;P 500 Health Care Index, and the Total Return for the NASDAQ Stock Market Index (U.S. Companies) (the &#8220;NASDAQ Index&#8221;) prepared by the Center for Research in Security Prices. This graph assumes the investment of $100 on December 31, 2016, in IDEXX&#8217;s common stock, the S&amp;P 500 Index, the S&amp;P 500 Health Care Index, and the NASDAQ Index and assumes dividends, if any, are reinvested. Measurement points are the last trading days of the years ended December 2016 to 2021.</span></div><div style="text-align:center"><img src="idxx-20211231_g2.jpg" alt="idxx-20211231_g2.jpg" style="height:406px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:35.649%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.714%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12/31/2016</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12/31/2017</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12/31/2018</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12/31/2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12/31/2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12/31/2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">IDEXX Laboratories, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$100.00</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$133.35</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$158.63</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$222.67</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$426.26</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$561.49</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">NASDAQ Index</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$100.00</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$129.64</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$125.96</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$172.18</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$249.51</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$304.85</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">S&amp;P 500 Index</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$100.00</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$121.83</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$116.49</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$153.17</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$181.35</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$233.41</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">S&amp;P 500 Health Care Index</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$100.00</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$122.08</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$129.97</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$157.04</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$178.15</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$224.71</span></td></tr></table></div><div id="i5d795a6851d746ca914a2ddae761c329_43"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 6.&#160;&#160;&#160;&#160;[RESERVED]</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="padding-left:27pt;text-indent:-18pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><div id="i5d795a6851d746ca914a2ddae761c329_46"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 7.&#160;&#160;&#160;&#160;MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the consolidated financial statements and related notes appearing elsewhere in this Annual Report on Form&#160;10&#8209;K</span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The discussion of our financial condition and results of operations and liquidity and capital resources for the year ended&#160;December 31, 2019, and year-over-year comparisons between 2020 and 2019,&#160;is included in our&#160;Annual Report on Form 10-K for the year ended December 31, 2020, within Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations,&#160;and is&#160;incorporated by reference&#160;herein.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have included certain terms and abbreviations used throughout this Annual Report on Form 10-K in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Glossary of Terms and Selected Abbreviations.&#8221;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Description of Business Segments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We operate primarily through three business segments: diagnostic and information management-based products and services for the companion animal veterinary industry, which we refer to as the Companion Animal Group (&#8220;CAG&#8221;); water quality products (&#8220;Water&#8221;); and diagnostic products and services for livestock and poultry health and to ensure the quality and safety of milk and improve producer efficiency, which we refer to as Livestock, Poultry and Dairy (&#8220;LPD&#8221;). Our Other operating segment combines and presents our human medical diagnostic products and services business (&#8220;OPTI Medical&#8221;) with our out-licensing arrangements because they do not meet the quantitative or qualitative thresholds for reportable segments.&#160;Refer to "Part II, Item 8. Financial Statements and Supplementary Data, Note 3. Revenue Recognition and Note 17. Segment Reporting" to the consolidated financial statements for the year ended December 31, 2021, included in this Annual Report on Form 10-K for financial information about our segments, including our product and service categories, and our geographic&#160;areas.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a discussion of the strategic and operating factors that we believe have the most significant effect on the performance of our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Companion Animal Group</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our strategy is to provide veterinarians with the highest quality diagnostic information, software products and services, and medical evidence to support more advanced medical care and information management solutions that help demonstrate the value of diagnostics to pet owners and enable efficient and effective practice management. By doing so, we are able to build a mutually successful relationship with our veterinarian customers based on healthy pets, loyal customers, staff efficiency, and expanding practice revenues.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">CAG Diagnostics.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;We provide diagnostic capabilities that meet veterinarians&#8217; diverse needs through a variety of modalities including in-clinic diagnostic solutions and outside reference laboratory services. Veterinarians that utilize our full line of diagnostic modalities obtain a single view of a patient&#8217;s diagnostic results, which allows them to track and evaluate trends and achieve greater medical insight.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our diagnostic capabilities generate both recurring and non-recurring revenues. Revenues related to capital placements of our in-clinic IDEXX VetLab suite of instruments and our SNAP Pro Analyzer are non-recurring in nature in that they are sold to a particular customer only once. Revenues from the associated IDEXX VetLab consumables, SNAP rapid assay test kits, reference laboratory and consulting services, and extended maintenance agreements and accessories related to our IDEXX VetLab instruments and our SNAP Pro Analyzer are recurring in nature, in that they are regularly purchased by our customers, typically as they perform diagnostic testing as part of ongoing veterinary care services.&#160;Our recurring revenues, most prominently IDEXX VetLab consumables and rapid assay test kits, have significantly higher gross margins than those provided by our instrument sales. Therefore, the mix of recurring and non-recurring revenues in a particular period will impact our gross&#160;margins.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Diagnostic Capital Revenue.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Revenues related to the placement of the IDEXX VetLab suite of instruments are non-recurring in nature, in that the customer will buy an instrument once over its respective product life cycle, but will purchase consumables for that instrument on a recurring basis as they use that instrument for testing purposes. During the early stage of an instrument&#8217;s life cycle, we derive relatively greater revenues from instrument placements, while consumable sales become relatively more significant in later stages as the installed base of instruments increases and instrument placement revenues begin to decline. In the early stage of an instrument&#8217;s life cycle, placements are made primarily through sales transactions.&#160;As the demand for the product matures, an increasing percentage of placements are made in transactions, sometimes referred to as </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">volume commitments, such as our IDEXX 360 program, or reagent rentals, in which instruments are placed at customer sites at little or no cost in exchange for a multi-year customer commitment to purchase recurring products and services.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a table showing active installed base units of our diagnostic instruments as of the years ended December 31, 2021, 2020, and 2019:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"></td><td style="width:54.703%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.590%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.590%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.594%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(units in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Installed Base</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Instrument</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Catalyst</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Premium Hematology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SediVue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We place our Catalyst chemistry analyzers through sales, leases, rental, and other programs. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A majority of our Catalyst chemistry analyzer placements were to customers that are new to IDEXX, including customers who had been using instruments from one of our competitors, sometimes referred to as competitive accounts. Generally, placement of an instrument with a new or competitive account has the highest economic value as the entire consumable stream associated with that placement represents incremental recurring revenue. We also place additional chemistry analyzers at existing large customers where utilization supports multiple analyzers.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We place our premium hematology analyzers through multiple sales programs as well. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A majority of our ProCyte analyzer placements were made to new or competitive accounts. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second half of 2020, we began selling our new ProCyte One analyzer. As we continue to experience growth in placements of ProCyte analyzers and in sales of related consumables, we expect this growth to be partly offset by a decline in placements of LaserCyte Dx and VetAutoread analyzers and a decrease in&#160;the associated&#160;recurring revenue stream. With our ProCyte One analyzer, we provide customers with consumables that are charged upon utilization, which we refer to as pay-per-run, as compared to the ProCyte Dx analyzer, where we charge upon shipment of consumables.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our premium SediVue Dx analyzer and single-use consumable system provides a highly accurate way to automate the process of examining urine under a microscope. We provide customers with SediVue Dx consumables that are charged upon utilization, similar to the ProCyte One analyzer. Other than our ProCyte One and SediVue analyzers, we charge upon shipment of consumables for all our other analyzers.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We seek to enhance the attractiveness and customer loyalty of our SNAP rapid assay tests, including by providing the SNAP Pro Analyzer, which activates SNAP tests, properly times the run, captures, and saves images of the results and,&#160;in conjunction with IVLS, records invoice charges in the patient record. Our ProRead software interprets results of the SNAP Pro Analyzer. These features promote practice efficiency by eliminating manual entry of test results in patient records and also helps ensure that the services are recorded and accurately invoiced. In addition, SNAP Pro Analyzer results can be shared with pet owners on the SNAP Pro screen or, in conjunction with IVLS, via VetConnect PLUS. We also sell the&#160;SNAPshot Dx, which automatically reads certain SNAP test results and, in conjunction with IVLS, records those results in the electronic medical record. We continue to work on enhancing the functionality of our analyzers to read the results of additional tests from our canine and feline family of rapid assay products.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our long-term success in the continuing growth of our CAG recurring diagnostic product and services is dependent upon: growing volumes at existing customers by increasing their utilization of existing and new test offerings, acquiring new customers, maintaining high customer loyalty and retention, and realizing modest annual price increases based on our differentiated products and the growing value of our diagnostic offering. We continuously seek opportunities to enhance the care that veterinary professionals give to their patients and clients through supporting the implementation of real-time care testing workflows, which is performing tests and sharing test results with the client at the time of the patient visit. Our latest generation of chemistry, hematology, and urinalysis instruments demonstrates this commitment by offering enhanced ease of use, faster time to results, broader test menu and connectivity to various information technology platforms that enhance the value of the diagnostic information generated by the instruments. In addition, we provide marketing tools and customer support that help drive efficiencies in veterinary practice processes and allow practices to increase the number of clients they see on a daily basis.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With all of our instrument product lines, we seek to differentiate our products from our competitors&#8217; products based on time-to-result, ease-of-use, throughput, breadth of diagnostic menu, flexibility of menu selection, accuracy, reliability, ability to </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">handle compromised samples, analytical capability of diagnostics software, integration with the IVLS and VetConnect PLUS, client communications capabilities, education and training, and superior sales and customer service. Our success depends, in part, on our ability to differentiate our products in a way that justifies a premium price.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Recurring Diagnostic Revenue.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Revenues from our IDEXX VetLab consumable products, our SNAP rapid assay test kits, outside reference laboratory and consulting services, and extended maintenance agreements and accessories related to our CAG Diagnostics instruments are considered recurring in nature. For the year ended December 31, 2021, recurri</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ng diagnostic revenue, which is both highly durable and profitable, accounted for approximately 79% of our consolidated&#160;revenue.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our in-clinic diagnostic solutions, consisting of our IDEXX VetLab consumable products and SNAP rapid assay test kits, provide real-time reference lab quality diagnostic results for a variety of companion animal diseases and health conditions. Our outside reference laboratories provide veterinarians with the benefits of a more comprehensive list of diagnostic tests and access to consultations with board-certified veterinary specialists and pathologists, combined with the benefit of same-day or next-day turnaround times.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We derive substantial revenues and margins from the sale of consumables that are used in IDEXX VetLab instruments, and the multi-year consumable revenue stream is significantly more valuable than the placement of the instrument. Our strategy is to increase diagnostic testing within veterinary practices by placing IDEXX VetLab instruments and increasing instrument utilization of consumables. Utilization can increase due to a greater number of patient samples being run or to an increase in the number of tests being run per patient sample. Our strategy is to increase both drivers. To increase utilization, we seek to educate veterinarians about best medical practices that emphasize the importance of chemistry, hematology, and urinalysis testing for a variety of diagnostic purposes, as well as by introducing new testing capabilities that were previously not available to veterinarians. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our in-clinic diagnostic solutions also include SNAP rapid assay tests that address important medical needs for particular diseases prevalent in the companion animal population. We seek to differentiate these tests from those of other in-clinic test providers and reference laboratory diagnostic service providers based on critically important sensitivity and specificity, as demonstrated by peer-reviewed third-party research, as well as overall superior performance and ease of use by providing our customers with combination tests that test a single sample for up to six diseases at once, including the ability to utilize our SNAP Pro Analyzer.&#160;We further augment our product development and customer service efforts with sales and marketing programs that enhance medical awareness and understanding regarding certain diseases and the importance of diagnosti</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c testing.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The prevalence of in-clinic testing, as opposed to outside reference laboratories such as IDEXX Reference Laboratories, may vary by region. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We attempt to differentiate our reference laboratory testing services from those of competitive reference laboratories and competitive in-clinic offerings primarily on the basis of a differentiated test menu, technology employed, quality, turnaround time, customer service and tools such as VetConnect PLUS that demonstrate the complementary manner in which our laboratory services work with our in-clinic offerings.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Profitability in our lab business is supported, in part, by our expanding business scale globally. Profit improvements also reflect benefits from price increases and our ability to achieve operational efficiencies. When possible, we utilize core reference laboratories to service samples from other states or countries, expanding our customer reach without an associated expansion in our reference laboratory footprint.&#160;New laboratories may operate at a loss until testing volumes achieve sufficient scale. Acquired laboratories frequently operate less profitably than our existing laboratories and acquired laboratories may not achieve the profitability of our existing laboratory network for several years until we complete the implementation of operating improvements and efficiencies. Therefore, in the short term, new and acquired reference laboratories generally may have a negative effect on our operating margin. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recurring reference lab revenue growth is achieved both through increased testing volumes with existing customers and through the acquisition of new customers, net of customer losses. We believe the increased number of customer visits by our sales professionals as a result of the growth in our field sales organization has led to increased reference laboratory opportunities with customers who already use one of our in-clinic diagnostic modalities. In recent years, recurring reference laboratory diagnostic and consulting revenues have also been increased through reference laboratory acquisitions, customer list acquisitions, the opening of new reference laboratories, including laboratories that are co-located with large practice customers, and as a result of our up-front customer loyalty programs and our volume commitment programs. Our up-front customer loyalty programs are associated with customer acquisitions and retention and provide incentives to customers in the form of cash payments or IDEXX Points upon entering multi-year contractual agreements to purchase annual minimum amounts of products or services, including reference laboratory services.&#160;Our volume commitment programs, such as IDEXX 360, provide </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">customers with a free or discounted instrument or system upon entering into multi-year agreements to purchase annual minimum amounts of products and services.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Veterinary Software, Services and Diagnostic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Imaging Systems</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our portfolio of practice management offerings is designed to serve the full range of customers primarily within the North American, Australian, and European regions. Cornerstone, ezyVet, Animana, IDEXX Neo, and DVMAX practice management systems provide superior integrated information solutions, backed by exceptional customer support and education. These practice management systems allow the veterinarian to practice better medicine and achieve the practice&#8217;s business objectives, including a quality client experience, staff efficiency and practice effectiveness and profitability. We market Cornerstone, ezyVet, IDEXX Neo, and DVMAX practice management systems to customers primarily in North America and Australia. We market our Animana offering to customers primarily throughout Europe.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Animana, ezyVet, and IDEXX Neo practice management systems are subscription-based SaaS offerings designed to provide flexible pricing and a durable, recurring revenue stream, while utilizing cloud technology instead of a client server platform. While we continue to develop, sell, and support our licensed-based Cornerstone and DVMAX software, we are growing our installed base of subscription-based practice management offerings for new customers of IDEXX practice management systems. We believe that once established, this subscription-based model will provide higher profitability as compared to the historical license-based placements. Our Cornerstone and DVMAX customer base continues to be an important driver of growth through enhanced diagnostic integrations and high value add-on subscription services, such as Pet Health Network Pro, Petly Plans, and credit card processing, and we continue to make investments to enhance the customer experience of all of our license-based software offerings. We also offer rVetLink, a comprehensive referral management solution for specialty care hospitals that streamlines the referral process between primary care and specialty care veterinarians. rVetLink&#8217;s cloud technology integrates with major specialty hospital management systems, including Cornerstone Software and DVMAX&#160;Software.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We differentiate our practice management systems through enhanced functionality, ease of use, and embedded integration with in-clinic IDEXX VetLab instruments and outside reference laboratory test results. Our client communication services create more meaningful pet owner experiences through personalized communication. With our SmartFlow and Vet Radar cloud technology, we are able to improve overall patient management through coordination and tracking of every step in a patient workflow. Pet Health Network Pro online client communication and education service complements the entire IDEXX product offering by educating pet owners and building loyalty through engaging the pet owner before, during and after the visit, thereby building client loyalty and driving more patient visits.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our diagnostic imaging systems offer a convenient radiographic solution that provides superior image quality and the ability to share images with clients virtually anywhere. IDEXX imaging software enables enhanced diagnostic features and streamlined integration with our other products and services. Our digital radiography systems, enables low-dose radiation image capture without sacrificing clear, high-quality diagnostic images,&#160;reducing the risk posed by excess radiation exposure for veterinary professionals. Placements of imaging systems are important to the growth of revenue streams that are recurring in nature, including extended maintenance agreements and IDEXX Web PACS, which is our cloud-based SaaS offering for viewing, accessing, storing, and sharing multi-modality diagnostic images. We derive relatively higher margins from our subscription-based products. IDEXX Web PACS is integrated with Cornerstone, ezyVet, IDEXX Neo, DVMAX, and IDEXX VetConnect&#160;PLUS to provide centralized access to diagnostic imaging results alongside patient diagnostic results from any internet connected&#160;device.&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Water</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our strategy in the water testing business is to develop, manufacture, market and sell products that test primarily for the presence of microbial contamination in water matrices, including drinking water supplies, with superior performance, supported by exceptional customer service. Our customers primarily consist of water utilities, government laboratories and private certified laboratories that highly value strong relationships and customer support. We expect that future growth in this business will be partially dependent on our ability to increase international sales. Growth also will be dependent on our ability to enhance and broaden our product line. Most water microbiological testing is driven by regulation, and, in many countries, a test may not be used for compliance testing unless it has been approved by the applicable regulatory body and integrated into customers&#8217; testing protocols. As a result, we maintain an active regulatory program that involves applying for a growing number of regulatory approvals in a number of countries, primarily in Europe. Further, we seek to receive regulatory approvals from governing agencies as a means to differentiate our products from the competition.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Livestock, Poultry and Dairy</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We develop, manufacture, market, and sell a broad range of tests and perform services for various livestock diseases and conditions, and have active research and development and in-licensing programs in this area. Our strategy is to offer differentiated tests with superior performance characteristics for use in government programs to control or eradicate disease and disease outbreaks and in livestock and poultry producers&#8217; disease, reproductive, and herd health and production management programs. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Rapid Visual Pregnancy Test and Alertys On-Farm Pregnancy Test for cattle can detect pregnancy 28 days after breeding. These tests provide a quick and accurate identifier using whole blood samples.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Disease outbreaks are episodic and unpredictable, and certain diseases that are prevalent at one time may be substantially contained or eradicated at a later time. In response to outbreaks, testing initiatives may lead to exceptional demand for certain products in certain periods. Conversely, successful eradication programs may result in significantly decreased demand for certain products. In addition, increases in government funding may lead to increased demand for certain products and budgetary constraints may lead to decreased demand for certain products. As result, the performance in certain sectors of this business can fluctuate.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our strategy in the dairy testing business is to develop, manufacture and sell antibiotic residue and contaminant testing products that satisfy applicable regulatory requirements or dairy processor standards for testing of milk and provide reliable field performance. The manufacture of these testing products leverages&#160;the SNAP platform and production assets that also support our rapid assay business, which also leverages the SNAP platform. The dairy SNAP products incorporate customized reagents for antibiotic and contaminant detection. To suc</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">cessfully increase sales of dairy testing products, we believe that we need to increase penetration in dairy processors.&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">OPTI Medical</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our strategy in the OPTI Medical business for the human market is to develop, manufacture, and sell electrolyte and blood gas analyzers, and related consumable products for the medical point-of-care diagnostics sector worldwide, with a focus on small to mid-sized hospitals. We seek to differentiate our products based on ease of use, convenience, international distribution and service and instrument reliability. Similar to our veterinary instruments and consumables strategy, a substantial portion of the revenues from this product line is derived from the sale of consumables for use on the installed base of electrolyte and blood gas analyzers. During the early stage of an instrument&#8217;s life cycle, relatively greater revenues are derived from instrument placements, while consumable sales become relatively more significant in later stages as the installed base of instruments increases and instrument placement revenues begin to decline. Our long-term success in this area of our business is dependent upon new customer acquisition, customer retention and increased customer utilization of existing and new assays introduced on these instruments. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, we introduced the OPTI SARS-CoV-2 RT-PCR test kit for human COVID-19 testing. A significant portion of the growth in our OPTI Medical business was from revenue generated from the test kits and related laboratory services. The future demand for this product is difficult to project given the uncertain nature of the COVID-19 pandemic, including short-term project commitments, available PCR testing capacity, alternative suppliers, and the potential impact of vaccinations and other treatments.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our facility in Roswell, Georgia develops and manufactures the OPTI product lines using the same or similar technology to support the electrolyte requirements of certain CAG products. We leverage this facility&#8217;s know-how, intellectual property, and manufacturing capability to continue to expand the menu and instrument capability of the VetStat and Catalyst platforms for veterinary applications, while reducing our cost of consumables by leveraging experience and economies of scale.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><div id="i5d795a6851d746ca914a2ddae761c329_49"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CRITICAL ACCOUNTING ESTIMATES AND ASSUMPTIONS</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The discussion and analysis of our financial condition and results of operations is based upon the consolidated financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. We evaluate our estimates on an ongoing basis. We base our estimates on historical experience and on various assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates. Refer to "Part II, Item 8. Financial Statements and Supplementary Data, Note 2. Summary of Significant Accounting Policies" to the consolidated financial statements included in this Annual Report on Form 10-K for a description of the significant accounting policies used in preparation of these consolidated financial statements.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe the following critical accounting estimates and assumptions may have a material impact on reported financial condition and operating performance and involve significant levels of judgment to account for highly uncertain matters or are susceptible to significant change. </span></div><div><span><br/></span></div><div id="i5d795a6851d746ca914a2ddae761c329_52"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to "Part II, Item 8. Financial Statements and Supplementary Data, Note 3. Revenue Recognition" to the consolidated financial statements for the year ended December 31, 2021, included in this Annual Report on Form 10-K for additional information about our revenue recognition policy and criteria for recognizing revenue.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into contracts with multiple performance obligations where customers purchase a combination of IDEXX products and services. Determining whether products and services are considered distinct performance obligations that should be accounted for separately requires judgment. We determine the transaction price for a contract based on the total consideration we expect to receive in exchange for the transferred goods or services. To the extent the transaction price includes variable consideration, such as volume rebates or expected price adjustments, we apply judgment in constraining the estimated variable consideration due to factors that may cause reversal of revenue recognized. We evaluate constraints based on our historical and projected experience with similar customer contracts.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We allocate revenue to each performance obligation in proportion to the relative standalone selling prices and recognize revenue when control of the related goods or services is transferred for each obligation. We utilize the observable standalone selling price when available, which represents the price charged for the performance obligation when sold separately. When standalone selling prices for our products or services are not directly observable, we determine the standalone selling prices using relevant information available and apply suitable estimation methods including, but not limited to, the cost plus a margin approach. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our up-front loyalty programs provide customers with incentives in the form of cash payments or IDEXX Points upon entering into multi-year agreements to purchase annual minimum amounts of future products or services. If a customer breaches its agreement, they are required to refund all or a portion of the up-front cash or IDEXX Points, or make other repayments, remedial actions, or both. Up-front incentives to customers in the form of cash or IDEXX Points are not made in exchange for distinct goods or services and are capitalized as customer acquisition costs within other current and long-term assets, which are subsequently recognized as a reduction to revenue over the term of the customer agreement. If these up-front incentives are subsequently utilized to purchase instruments, we allocate total consideration, including future committed purchases less up-front incentives and estimates of expected price adjustments, based on relative standalone selling prices to identified performance obligations and recognize instrument revenue and cost at the time of installation and customer acceptance. We estimate, based on historical experience, and apply judgment to predict the amounts of future customer purchases and expected price adjustments related to these multi-year agreements. Differences between estimated and actual customer purchases may impact the timing and amount of revenue recognition during the term of the customer contract, and a 10% change in these estimates would have increased or reduced deferred revenue and cumulative revenue related to these programs by approximately $1.3 million at December 31, 2021.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our volume commitment programs, such as our IDEXX 360 program, provide customers with free or discounted instruments or systems upon entering into multi-year agreements to purchase annual minimum amounts of products and services. We allocate total consideration, including future committed purchases and expected price adjustments, based on relative standalone selling prices to identified performance obligations and recognize instrument revenue and cost at the time of installation and customer acceptance in advance of billing the customer, which is also when the customer obtains control of the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">instrument based on legal title transfer. Our right to future consideration related to instrument revenue is recorded as a contract asset within other current and long-term assets. The contract asset is transferred to accounts receivable when customers are billed for future products and services over the term of the contract. We estimate, based on historical experience, and apply judgment to predict the amounts of future customer purchases and expected price adjustments related to these multi-year agreements. Differences between estimated and actual customer purchases may impact the timing and amount of revenue recognition during the term of the customer contract, and a 10% change in these estimates would have increased or reduced contract assets and cumulative revenue related to these programs by approximately $4.0 million at December 31, 2021.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our instrument rebate programs require an instrument purchase and provide customers the opportunity to earn future rebates based on the volume of products and services they purchase over the term of the program. We account for the customer&#8217;s right to earn rebates on future purchases as a separate performance obligation and determine the standalone selling price based on an estimate of rebates the customer will earn over the term of the program. Total consideration allocated to identified performance obligations is limited to goods and services that the customer is presently obligated to purchase and does not include estimates of future purchases that are optional. We allocate total consideration to identified performance obligations, including a customer&#8217;s right to earn rebates on future purchases, which is deferred and recognized upon the purchase of future products and services, partly offsetting future rebates as they are earned. We estimate, based on historical experience, and apply judgment to predict the amounts of future customer rebates related to these multi-year agreements. Differences between estimated and actual customer rebates may impact the timing and amount of revenue recognition during the term of the customer contract, and a 10% change in these estimates would have increased or reduced deferred revenue and cumulative revenue related to these programs by approximately $2.0 million at December 31, 2021.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future market conditions and changes in product offerings may cause us to change marketing strategies to increase or decrease customer incentive offerings, possibly resulting in incremental reductions of revenue in future periods as compared to reductions in the current or prior periods. Additionally, certain customer programs require us to estimate, based on historical experience, and apply judgment to predict the amounts of future customer purchases, customer rebates and other incentive payments, and price adjustments related to multi-year agreements. Differences between estimated and actual customer purchases may impact the timing and amount of revenue recognition as described above.</span></div><div><span><br/></span></div><div id="i5d795a6851d746ca914a2ddae761c329_55"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Valuation of Goodwill and Other Intangible Assets</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A significant portion of the purchase price for acquired businesses is generally assigned to intangible assets. Intangible assets other than goodwill are initially valued at fair value. If a quoted price in an active market for the identical asset is not readily available at the measurement date, the fair value of the intangible asset is estimated based on discounted cash flows using market participant assumptions, which are assumptions that are not specific to IDEXX. The selection of appropriate valuation methodologies and the estimation of discounted cash flows require significant assumptions about the timing and amounts of future cash flows, risks, appropriate discount rates, and the useful lives of intangible assets. When significant, we typically utilize independent valuation experts to advise and assist us in determining the fair values of the identified intangible assets acquired in connection with a business acquisition and in determining appropriate amortization methods and periods for those intangible assets. Goodwill is initially valued based on the excess of the purchase price of a business combination over the fair value of acquired net assets recognized and represents the future economic benefits arising from other assets acquired that could not be separately identified and recognized.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We assess goodwill for impairment annually, at the reporting unit level, in the fourth quarter and whenever events or circumstances indicate impairment may exist. An impairment charge is recorded for the amount, if any, by which the carrying amount of goodwill exceeds its implied fair value. Our reporting units are the individual product and service categories that comprise our CAG operating segment, our Water and LPD operating segments and goodwill remaining from the restructuring of our pharmaceutical business in the fourth quarter of 2008. A substantial portion of the goodwill remaining from the pharmaceutical business, included in our &#8220;Other Segment&#8221;, is associated with intellectual property that has been, or may be, licensed to third parties. Realization of this goodwill is dependent upon the success of those third parties in developing and commercializing products, which will result in our receipt of royalties and other payments.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our goodwill testing process, we evaluate factors specific to a reporting unit as well as industry and macroeconomic factors that are reasonably likely to have a material impact on the fair value of a reporting unit. Examples of the factors considered in assessing the fair value of a reporting unit include: the results of the most recent impairment test; the competitive environment; the regulatory environment; the effects of the ongoing COVID-19 pandemic; anticipated changes in product, supply chain, or labor costs; revenue growth trends; the consistency of operating margins and cash flows; and current and long-range financial forecasts. The long-range financial forecasts of the reporting units, which are based upon </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">management&#8217;s long-term view of our markets, are used by senior management and the Board of Directors to evaluate operating&#160;performance.&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarters of 2021 and 2020, we elected to bypass the qualitative approach that allows the assessment of qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount and instead proceeded directly to assessing the fair value of all of our reporting units and comparing the fair value of each reporting unit to the carrying value to determine if any impairment exists.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate the fair values of applicable reporting units using an income approach based on discounted forecasted cash flows. We make significant assumptions about the extent and timing of future cash flows, growth rates and discount rates. Model assumptions are based on our projections and best estimates, using appropriate and customary market participant assumptions. In addition, we make certain assumptions in allocating shared assets and liabilities to individual reporting units in determining the carrying value of each reporting unit. To validate the reasonableness of the estimated fair values of our reporting units, we reconcile the&#160;aggregate&#160;fair&#160;values&#160;of our&#160;reporting units to our total market capitalization. Valuation assumptions reflect our projections and best estimates, based on significant assumptions about the extent and timing of future cash flows, growth rates and discount rates.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of our most recent goodwill impairment test in the fourth quarter of 2021 indicated an excess of estimated fair value over the carrying amount for each of our reporting units with a minimum of approximately 65% and a weighted average of approximately 1,375% in total. The majority of our goodwill is related to our CAG Diagnostics reporting units with a weighted average of approximately 1,550% excess of estimated fair value over the carrying amount, including our Reference Laboratory Diagnostic and Consulting Services, Rapid Assay Products, and IDEXX VetLab Consumables, Instruments, Services and Accessories.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also maintain approximately $94 million of goodwill associated with our Veterinary Software and Services reporting unit, which is primarily comprised of recent acquisitions of early-stage software companies that expand our suite of technology applications for the veterinary profession, including SaaS-based practice management systems, applications that extend workflow capabilities, client marketing, wellness plan management and other connectivity and communication needs. These software applications are in various stages of commercial development, and therefore our Veterinary Software and Services reporting unit has a relatively lower excess of estimated fair value over the carrying amount, as indicated by the results of our most recent goodwill impairment test, which indicated approximately $385 million and 210% of the reporting unit&#8217;s carrying value. Realization of this goodwill is dependent on our successful commercialization of these software applications.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we maintain&#160;approximately $6.5 million of goodwill associated with our remaining pharmaceutical intellectual property, out-licensing arrangements, and certain retained drug delivery technologies (collectively &#8220;Pharmaceutical Activities&#8221;) that we seek to commercialize through arrangements with third parties. Currently, our primary support for the carrying value of this goodwill is royalty revenue associated with the commercialization of certain intellectual property. There is no guarantee that we will be able to maintain or increase revenues from our remaining Pharmaceutical Activities. The results of our goodwill impairment test for these Pharmaceutical Activities indicate an excess of estimated fair value over the carrying amount of this reporting unit by approximately $4.2 million and approximately 65% of the reporting unit&#8217;s carrying value. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we believe that the assumptions used to determine the estimated fair values of each of our reporting units are reasonable, a change in assumptions underlying these estimates could result in a material negative effect on the estimated fair value of the reporting units. Our fair value estimate assumes the achievement of future financial results contemplated in our forecasted cash flows, and there can be no assurance that we will realize that value. We use forecasts to estimate future cash flows and include an estimate of long-term future growth rates based on our most recent views of the long-term outlooks for our reporting units. Actual results may differ from those assumed in our forecasts. The discount rate is based on a weighted average cost of capital derived from industry peers. Changes in market conditions, interest rates, growth rates, tax rates, costs, pricing, or the discount rate would affect the estimated fair values of our reporting units and could result in a goodwill impairment charge in a future period. No goodwill impairments were identified during the years ended December 31, 2021, 2020, and 2019.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A prolonged economic downturn in the U.S. or internationally resulting in lower long-term growth rates and reduced long-term profitability may reduce the fair value of our reporting units. Industry specific events or circumstances could have a negative impact on our reporting units and may also reduce the fair value of our reporting units. Should such events occur, and it becomes more likely than not that a reporting unit&#8217;s fair value has fallen below its carrying value, we will perform an interim goodwill impairment test, in addition to the annual impairment test. Future impairment tests may result in an impairment of goodwill, depending on the outcome of future impairment tests. An impairment of goodwill would be reported as a non-cash charge to earnings.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We assess the realizability of intangible assets whenever events or changes in circumstances indicate that the carrying value may not be recoverable. If an impairment review is triggered, we evaluate the carrying value of intangible assets, other than goodwill, based on estimated undiscounted future cash flows over the remaining useful life of the primary asset of the asset group and compare that value to the carrying value of the asset group. The asset group is the lowest level for which identifiable cash flows associated with the intangible asset are largely independent. The cash flows that are used contain our best estimates, using appropriate and customary assumptions and projections at the time. If the net carrying value of the asset group exceeds the related estimated undiscounted future cash flows, an impairment to adjust the intangible asset to its fair value would be reported as a non-cash charge to earnings. If necessary, we would calculate the fair value of an intangible asset using the present value of the estimated future cash flows to be generated by the intangible asset and applying a risk-adjusted discount rate. We had no impairments of our intangible assets during the years ended December 31, 2021, and December 31, 2019. The amount of impairment for the year ended December 31, 2020, was immaterial.</span></div><div><span><br/></span></div><div id="i5d795a6851d746ca914a2ddae761c329_58"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes is determined using the asset and liability approach of accounting for income taxes. Under this approach, deferred taxes represent the estimated future tax effects of temporary differences between book and tax treatment of assets and liabilities and carryforwards to the extent they are realizable.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On a quarterly basis, we assess our current and projected earnings by jurisdiction to determine whether or not our earnings during the periods when the temporary differences become deductible will be sufficient to realize the related future tax benefits. Should we determine that we would not be able to realize all or part of our net deferred tax asset in a particular jurisdiction in the future, an adjustment to the deferred tax asset would be charged to income in the period such determination was made.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For those jurisdictions where tax carryforwards are likely to expire unused or the projected operating results indicate that realization is not more likely than not, a valuation allowance is recorded to offset the deferred tax asset within that jurisdiction. In assessing the need for a valuation allowance, we consider future taxable income and ongoing prudent and feasible tax planning strategies. In the event that we determine that we would be able to realize our deferred tax assets in the future in excess of the net recorded amount, a reduction of the valuation allowance would increase income in the period such determination was made. Likewise, should we determine that we would not be able to realize all or part of our net deferred tax asset in the future, a reduction to the deferred tax asset would be charged against income in the period such determination was made.&#160;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our net taxable temporary differences and tax carryforwards are recorded using the enacted tax rates expected to apply to taxable income in the periods in which the deferred tax liability or asset is expected to be settled or realized. Should the expected applicable tax rates change in the future, an adjustment to our deferred taxes would be credited or charged, as appropriate, to income in the period such determination was made.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We periodically assess our exposures related to our worldwide provision for income taxes and believe that we have appropriately accrued taxes for contingencies. Any reduction of these contingent liabilities or additional assessment would increase or decrease income, respectively, in the period such determination was made.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record a liability for uncertain tax positions that do not meet the more likely than not standard as prescribed by the authoritative guidance for income tax accounting. We record tax benefits for only those positions that we believe will more likely than not be sustained.&#160;For positions that we believe that it is more likely than not that we will prevail, we record a benefit considering the amounts and probabilities that could be realized upon ultimate settlement.&#160;If our judgment as to the likely resolution of the uncertainty changes, if the uncertainty is ultimately settled or if the statute of limitation related to the uncertainty expires, the effects of the change would be recognized in the period in which the change, resolution or expiration occurs. Our net liability for uncertain tax positions was $25.5 million as of December 31, 2021, and $26.0 million as of December 31, 2020, which includes estimated interest expense and penalties. Refer to "Part II, Item 8. Financial Statements and Supplementary Data, Note 14. Income Taxes" in the accompanying Notes to consolidated financial statements&#160;for more information.</span></div><div id="i5d795a6851d746ca914a2ddae761c329_61"></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RECENT ACCOUNTING PRONOUNCEMENTS</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to "Part II, Item 8. Financial Statements and Supplementary Data, Note 2. Summary of Significant Accounting Policies (v) and (w)" to the consolidated financial statements for the year ended December 31, 2021, included in this Annual Report on Form 10-K for a complete discussion of recent accounting pronouncements adopted and not adopted.</span></div><div><span><br/></span></div><div id="i5d795a6851d746ca914a2ddae761c329_64"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESULTS OF OPERATIONS AND TRENDS</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Effects of Certain Factors on Results of Operations</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Sector Trends and COVID-19 Pandemic Impact</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The primary impacts of the COVID-19 pandemic have been seen in our CAG business. While veterinary care is widely recognized as an &#8220;essential&#8221; service, stay-at-home policies deployed to combat the spread of COVID-19 constrained visits to veterinary practices significantly in late March 2020 through early April 2020, pressuring diagnostic testing volumes. Restrictions on sales professionals&#8217; access to veterinary clinics also contributed to deferrals on new CAG instrument placements.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As stay-at-home policies were relaxed, there was a sharp rebound in clinical visit activity which accelerated through the second quarter of 2020 and continued through the second half of 2020. Weekly U.S. companion animal practice data showed improvement in same-store clinical visits trends since mid-April 2020 and solid CAG market momentum continued in early 2021.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Companion animal sector improvement trends globally have supported a strong recovery in demand for CAG diagnostic products and services. Global CAG Diagnostics recurring revenues declined approximately 16% in April 2020, followed by increases of approximately 8% in May 2020, 30% in June 2020, 24% in July 2020, and approximately 20% for the remainder of the third and fourth quarters of 2020.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, positive trends in companion animal healthcare continued to support strong growth for CAG diagnostic products and services across regions. U.S. same-store clinical visit growth at veterinary practices was 12% in the first quarter of 2021, 13% in the second quarter, and 2% in both the third and fourth quarters of 2021. These clinical visit gains in the second half of 2021 are compared to strong prior year period clinical visit growth, which included benefits from pent-up demand from delayed veterinary visits during the COVID-19 pandemic as policies and restrictions were relaxed. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While these trends are encouraging, potential effects related to ongoing COVID-19 case management efforts are challenging to predict and may pressure future revenues should enhanced social distancing policies and higher infection rates impact veterinary clinic operations in certain regions. At the beginning of 2022, we are monitoring the increase in Omicron cases globally, including impacts on factors like veterinary practice staffing levels, which may impact clinic level growth.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have also seen impacts from the COVID-19 pandemic on Water testing volumes. There was some disruption to compliance Water testing early in the second quarter of 2020 related to business lockdown effects, as well as beach and pool closures, which has since had a solid recovery. Approximately 20% of our Water revenues are related to non-compliance testing, which declined due to reduced overall business activity and prioritization of laboratory spending. During 2021, our Water testing volumes continued to recover for both compliance and non-compliance testing. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LPD revenues, which expanded 10% in 2020 and contracted by 7% in 2021, were impacted by reduced demand for African Swine fever testing in China, reflecting the relaxation of local African Swine Fever disease management programs, as well as additional impacts in China from lower pork prices and changing government requirements related to live animal imports and livestock infectious disease programs, beginning in the second quarter of 2021. We anticipate continued pressure on LPD revenues in the first half of 2022 related to these factors.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Human COVID-19 Testing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. On May 7, 2020, we announced that OPTI Medical was granted by the United States Food and Drug Administration ("FDA") an Emergency Use Authorization ("EUA") for the OPTI SARS-CoV-2 RT-PCR laboratory test kit for the detection of SARS-CoV-2, the virus that causes COVID-19. On June 5, 2020 OPTI Medical announced that it has received the CE mark certification in the European Union for its OPTI SARS-CoV-2 RT-PCR laboratory test kit. Additionally, the FDA has granted EUA for the new OPTI DNA/RNA Magnetic Bead Kit for nucleic acid extraction from respiratory samples to be used with the OPTI SARS-CoV-2 RT-PCR test kit, which enables OPTI Medical Systems to provide laboratories with a complete OPTI Medical Systems-manufactured workflow solution for COVID-19 testing. We also provide human COVID-19 testing laboratories services to the Maine Center for Disease Control and Prevention in support of their COVID-19 testing program. These products and services are included within our OPTI Medical business in our Other segment </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">and are the primary driver of growth in that segment. We anticipate that revenues from these products will decline in 2022, as we focus our growth efforts on IDEXX core businesses.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In managing our businesses, we continue to provide high levels of service delivery and product support for customers during this time and maintain high health and safety standards to protect the health and safety of our employees and their families and our communities and ensure business continuity. Many of our employees continue to work remotely. For our laboratory and warehouse employees that are required to work on-site, we have enhanced safety procedures and protocols to help protect the health of our employees.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Supply Chain and Logistics Challenges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We believe that building and maintaining a well-managed and disciplined infrastructure have helped minimize impacts of the COVID-19 pandemic-related supply chain constraints, including product and component availability issues, logistics challenges, including extended shipping periods and delays, and inflationary pressures that are currently occurring worldwide. Our proactive approach to managing our operational processes, including forward planning with a focus on working closely with our suppliers and logistics partners, has enabled us to maintain continued high levels of product and service availability, and customer service. Although we expect the current supply chain and logistics challenges to continue in 2022, we believe we are well positioned to enable sustained high growth in our businesses going forward, and to effectively manage the impacts of potentially relatively higher costs in certain areas to support these growth plans. However, there can be no assurance as to the duration or severity of the supply chain and logistics challenges or the effectiveness of our mitigating activities.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Distributor Purchasing and Inventories</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. When selling our products through distributors, changes in distributors&#8217; inventory levels can impact our reported sales, and these changes may be affected by many factors, which may not be directly related to underlying demand for our products by veterinary practices, which are the end users.&#160;If during the current year, distributors&#8217; inventories grew by less than those inventories grew in the comparable period of the prior year, then changes in distributors&#8217; inventories would have an unfavorable impact on our reported sales growth in the current period. Conversely, if during the current year, distributors&#8217; inventories grew by more than those inventories grew in the comparable period of the prior year, then changes in distributors&#8217; inventories would have a favorable impact on our reported sales growth in the current period.&#160;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In certain countries, we sell our products through third-party distributors and may be unable to obtain data for sales to end users. We do not believe the impact of changes in these distributors&#8217; inventories had or would have a material impact on our growth rates. Refer to &#8220;Part I, Item 1. Business, Marketing and Distribution&#8221; included in this Annual Report on Form 10-K for additional information regarding distribution channels.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Currency Impact</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. For the year ended December 31, 2021, approximately 23% of our consolidated revenue was derived from products manufactured or sourced in U.S. dollars and sold internationally in local currencies, as compared to 21% for the year ended December 31, 2020 and 22% for the year ended December 31, 2019. Strengthening of the rate of exchange for the U.S. dollar relative to other currencies has a negative impact on our revenues derived in currencies other than the U.S. dollar and on profits of products manufactured or purchased in U.S. dollars and sold internationally, and a weakening of the U.S. dollar has the opposite effect. Similarly, to the extent that the U.S. dollar is stronger in current or future periods relative to the exchange rates in effect in the corresponding prior periods, our growth rate will be negatively affected. The impact of foreign currency denominated operating expenses and foreign currency denominated supply contracts partly offsets this exposure. Additionally, our designated hedges of intercompany inventory purchases and sales help delay the impact of certain exchange rate fluctuations on non-U.S. denominated revenues. Refer to &#8220;Part II, Item 7A. Quantitative and Qualitative Disclosures About Market Risk&#8221; included in this Annual Report on Form 10-K for additional information regarding currency impact. Our future income tax expense could also be affected by changes in the mix of earnings, including as a result of changes in the rate of exchange for the U.S. dollar relative to currencies in countries with differing statutory tax rates. Refer to &#8220;Part I, Item 1A. Risk Factors&#8221; included in this Annual Report on Form 10-K for additional information regarding tax impacts.&#160;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Effects of Economic Conditions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Demand for our products and services is vulnerable to changes in the economic environment, including slow economic growth, high unemployment, and credit availability. Negative or cautious consumer sentiment can lead to reduced or delayed consumer spending, resulting in a decreased number of patient visits to veterinary clinics. Unfavorable economic conditions can impact sales of instruments, diagnostic imaging and practice management systems, which are larger capital purchases for veterinarians. Additionally, economic turmoil and inflationary pressure can cause our customers to remain sensitive to the pricing of our products and services. In the U.S., we monitor patient visits and clinic revenue data provided by a subset of our CAG customers. Although this data is a limited sample and susceptible to short-term impacts such as weather, which may affect the number of patient visits in a given period, we believe that this data provides </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a fair and meaningful long-term representation of the trend in patient visit activity in the U.S., providing us insight regarding demand for our products and services.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Economic conditions can also affect the purchasing decisions of our Water and LPD business customers. Water testing volumes may be susceptible to declines in discretionary testing for existing home and commercial sales and in mandated testing as a result of decreases in home and commercial construction. Testing volumes may also be impacted by severe weather conditions such as drought. In addition, fiscal difficulties can also reduce government funding for water and herd health screening services.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the diversity of our products and services and the geographic diversity of our customers partially mitigate the potential effects of the economic environment and negative consumer sentiment on our revenue growth rates.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Effects of Patent Expiration</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Although we have several patents and licenses of patents and technologies from third parties that expired during 2021, and several that are expected to expire in 2022 and beyond, the expiration of these patents or licenses, individually or in the aggregate, is not expected to have a material effect on our financial position or future operations due to a range of factors as described in "Part I, Item 1. Business, Patents and Licenses&#8221;.&#160;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Non-GAAP Financial Measures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The following revenue analysis and discussion focuses on organic revenue growth, and references in this analysis and discussion to &#8220;revenue,&#8221; &#8220;revenues&#8221; or &#8220;revenue growth&#8221; are references to &#8220;organic revenue growth.&#8221; Organic revenue growth is a non-GAAP financial measure and represents the percentage change in revenue during the current year, as compared to the same period&#160;for the prior year, net of the effect of changes in foreign currency exchange rates, certain business acquisitions,&#160;and divestitures. Organic revenue growth should be considered in addition to, and not as a replacement for,&#160;or as a superior measure to, revenues reported in accordance with U.S. GAAP, and may not be comparable to similarly titled measures reported by other companies. Management believes that reporting organic revenue growth provides useful information to investors by facilitating easier comparisons of our revenue performance with prior and future periods and to the performance of our peers.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We exclude from organic revenue growth the effect of changes in foreign currency exchange rates because changes in foreign currency exchange rates are not under&#160;management&#8217;s control, are subject to volatility and can obscure underlying business trends. We calculate the impact on revenue resulting from changes in foreign currency exchange&#160;rates by applying the difference between the weighted average exchange rates during the current year period and the&#160;comparable prior year period to foreign currency denominated revenues for the prior year period.&#160;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also exclude from organic revenue growth the effect of certain business acquisitions and divestitures because the nature, size and number of these transactions can vary dramatically from period to period, and because they either require or generate cash as an inherent consequence of the transaction, and therefore can also obscure underlying business and operating&#160;trends. We consider acquisitions to be a business when all three elements of inputs, processes and outputs are present, consistent with ASU 2017-01, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations: (Topic 805) Clarifying the Definition of a Business.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; In a business combination, if substantially all the fair value of the assets acquired is concentrated in a single identifiable asset or group of similar identifiable assets, we do not consider these assets to be a business. A typical acquisition that we do not consider a business is a customer list asset acquisition, which does not have all elements necessary to operate a business, such as employees or infrastructure. We believe the efforts required to convert and retain these acquired customers are similar in nature to our existing customer base and therefore are included in organic revenue growth. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also use Adjusted EBITDA, gross debt, net debt, gross debt to Adjusted EBITDA ratio and net debt to Adjusted EBITDA ratio, all of which&#160;are non-GAAP financial measures that&#160;should&#160;be&#160;considered&#160;in&#160;addition&#160;to, and&#160;not&#160;as&#160;a replacement&#160;for, financial measures presented according to U.S. GAAP. Management believes that reporting these non-GAAP financial measures provides supplemental analysis to help investors further evaluate our business performance and available borrowing capacity under our Credit Facility.&#160;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Comparisons to Prior Periods</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our fiscal years end on December 31. Unless otherwise stated, the analysis and&#160;discussion of our financial condition, results of operations and liquidity, including references to growth and organic growth and increases and decreases, are being compared to the equivalent prior year period.&#160;</span></div><div><span><br/></span></div><div id="i5d795a6851d746ca914a2ddae761c329_67"></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Twelve Months Ended December 31, 2021,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compared to Twelve Months Ended December 31, 2020</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total Company</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents revenue by operating segment by U.S. and non-U.S., or international geographies:&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:19.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.492%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Revenue </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(dollars in thousands)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Dollar Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Reported Revenue Growth </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percentage Change from Currency</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percentage Change from Acquisitions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Organic Revenue Growth </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CAG</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,889,960</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,385,765</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">504,195</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">21.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">18.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">1,881,887&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">1,593,855&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">288,032&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">18.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">1,008,073&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">791,910&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">216,163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">27.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">22.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Water</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">146,505</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">128,625</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">17,880</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">13.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">11.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">70,654&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">62,083&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">8,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">75,851&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">66,542&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">9,309&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 12.25pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LPD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">135,887</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">145,845</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(9,958)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(6.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(9.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">15,626&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">14,533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">1,093&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">120,261&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">131,312&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(11,051)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(8.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(11.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%)</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 12.25pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">43,008</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">46,420</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(3,412)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(7.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(8.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%)</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Company</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,215,360</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,706,655</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">508,705</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">18.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">16.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">1,995,683&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">1,691,224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">304,459&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">18.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">1,219,677&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">1,015,431&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">204,246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">20.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">15.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Reported revenue growth and organic revenue growth may not recalculate due to rounding.</span></div><div style="padding-left:27pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Total Company Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in both U.S. and international organic revenues was driven by strong volume gains in CAG Diagnostics recurring revenue, reflecting continued high demand for companion animal diagnostics globally, supported by an </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">increase in clinical visits</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and diagnostic utilization per clinical visit, as compared to 2020. Our CAG Diagnostics instru</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ment revenue reflects high placement volumes compared to the prior year, which was impacted by the global pandemic. The higher revenue in our Water business was primarily a result of the continued improvement in non-compliance testing that has been constrained since the beginning of the pandemic and disruptions in certain compliance testing during the prior year. The decline in our LPD business was primarily due to the lower demand for African Swine Fever testing in China. The impact of currency movements on revenue was immaterial.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our total Company results of operations:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:37.044%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.472%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.472%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.472%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.472%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.472%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.480%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Company - Results of Operations</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(dollars in thousands)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percent of Revenue</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percent of Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percentage</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,215,360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,706,655&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">508,705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,325,928&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,135,615&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">190,313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,889,432&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,571,040&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">318,392&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">486,735&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">434,435&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">309,660&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">300,832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,828&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">161,009&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">141,249&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,760&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">957,404&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">876,516&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80,888&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">932,028&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">694,524&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">237,504&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Gross Profit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Gross&#160;profit increased due to higher sales volumes&#160;and an&#160;80&#160;basis&#160;point increase in the gross profit margin. The increase in the gross profit margin was primarily due to volume leverage in our CAG Diagnostics recurring revenue portfolio following the initial pandemic impacts in the first half of the prior year, price increases, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and strong growth in veterinary soft</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ware, services, and diagnostic imaging recurring revenues. These increases were partially offset by product mix, with higher CAG Diagnostics instrument revenue, and higher freight and distribution costs. The impact from foreign currency movements did not have a material impact on gross profit.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Operating Expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Overall operating expenses were higher compared to 2020, during which cost containment efforts were implemented in response to the COVID-19 pandemic, including temporary reductions to compensation and benefits and travel costs. Sales and marketing expense increased primarily due to higher personnel-related costs, including investments in our global commercial capability. General and administrative expense increased primarily due to higher personnel-related costs and costs associated with acquisitions. These increases were partially offset by an accrual related to an ongoing litigation matter and higher charitable donations in the prior year. Research and development expense increased primarily due to increased project and personnel-related costs. The overall change in currency exchange rates resulted in an increase in operating expenses by approximately 1%.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><div id="i5d795a6851d746ca914a2ddae761c329_70"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Companion Animal Group</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents revenue by product and service category for CAG:&#160;</span><span style="font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%"></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:19.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.492%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Revenue</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(dollars in thousands)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Dollar Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Reported Revenue Growth </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percentage Change from Currency</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percentage Change from Acquisitions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Organic Revenue Growth </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CAG Diagnostics recurring revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,534,562&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,113,839&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">420,723&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">IDEXX VetLab consumables</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">1,006,781&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">824,376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">182,405&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">22.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Rapid assay products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">296,852&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">253,018&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">43,834&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">17.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Reference laboratory diagnostic and consulting services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">1,123,656&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">946,268&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">177,388&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">18.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">16.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">CAG Diagnostics services and accessories</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">107,273&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">90,177&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">17,096&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">17.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CAG Diagnostics capital - instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">149,140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108,950&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,190&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">36.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Veterinary software, services and diagnostic imaging systems</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">206,258&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">162,976&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,282&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net CAG revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,889,960&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,385,765&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">504,195&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Reported revenue growth and organic revenue growth may not recalculate due to rounding.</span></div><div style="padding-left:27pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">CAG Diagnostics Recurring Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. S</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">trong demand for companion animal diagnostics globally across modalities, including higher levels of growth in testing volumes following the initial pandemic impacts, which constrained volumes beginning in mid-March 2020 through May 2020 resulted in higher volume growth. This volume growth includes an </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">increase in clinical visits and</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> diagnostic utilization per clinical visi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">t. The increase in C</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AG Diagnostics recurring revenue was p</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rimarily due to volume growth in IDEXX VetLab consumables, reference laboratory diagnostic services, and rapid assay products and, to a lesser extent, higher realized prices.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in IDEXX VetLab&#160;consumables revenue was primarily due to higher sales volumes for our Catalyst consumables and, to a lesser extent, ProCyte consumables. These increases were supported by an increase in testing utilization across regions, high customer retention levels, and expansion of our global premium instrument installed base. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in rapid assay revenue resulted primarily from higher clinic testing levels, primarily from SNAP</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 4Dx Plus, as well as higher realized prices. Results reflected strong growth in all major regions. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in reference laboratory diagnostic and consulting services revenue was primarily due to higher testing volumes globally, particularly in the U.S., as well as higher average unit sales prices. Acquisitions increased revenue by 0.5%. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CAG Diagnostic services and accessories revenue growth was primarily a result of the increase in our active installed base of instruments. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">CAG Diagnostics Capital &#8211; Instruments Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;The increase in instrument revenue was primarily due to strong premium instrument placements globally, including our new ProCyte One analyzer, as compared to constrained placements in 2020, as a result of the global pandemic, due to restrictions on our sales professionals&#8217; access to clinics and certain customers&#8217; deferral of new instrument purchases.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Veterinary Software, Services, and Diagnostic Imaging Systems Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Acquisitions increased revenue 10.5%. Excluding the impact of acquisitions, the increase in veterinary software and services revenue was primarily due to increases in our active installed base, higher veterinary software system placements, and higher realized prices on these service offerings. The increase in our diagnostic imaging systems revenues was primarily due to higher imaging systems placements, specifically our ImageVue DR 30 platform, as compared to 2020 when diagnostic imaging placements were lower due to restrictions on our </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sales professionals&#8217; access to clinics and certain customers deferring purchase decisions as a result of the COVID-19 pandemic, partially offset by a decrease in diagnostic imaging instrument revenue impacted by a reduction in earlier generation instrument platform sales.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the CAG segment results of operations:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:36.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Results of Operations<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(dollars in thousands)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percent of Revenue</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percent of Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percentage</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,889,960&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,385,765&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">504,195&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,206,156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,022,579&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">183,577&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,683,804&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,363,186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">320,618&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">444,694&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">396,792&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,902&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">274,470&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">269,464&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,006&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">140,618&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">122,043&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,575&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">859,782&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">788,299&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71,483&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">824,022&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">574,887&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">249,135&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:1pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Gross Profit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;Gross profit&#160;increased primarily due to higher sales volumes, as well as a 120 basis point increase in the gross profit margin. The increase in the gross profit margin was primarily due to the benefit of volume leverage and price increases in our CAG Diagnostics recurring revenue portfolio and higher veterinary software, services, and diagnostic imaging systems revenues. These favorable factors were partially offset by product mix, with higher CAG Diagnostics instrument revenue, and higher product, freight and distribution costs. The impact from foreign currency movements had an immaterial impact on our gross profit.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Operating Expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Overall operating expenses were higher compared to 2020, during which cost containment efforts were implemented in response to the COVID-19 pandemic, including temporary reductions to compensation and benefits and travel costs. Sales and marketing expense increased primarily due to higher personnel-related costs, including investments in our global commercial capability, partially offset by lower travel costs. General and administrative expense increased primarily due to higher personnel-related costs and costs associated with acquisitions. These increases were partially offset by an accrual related to an ongoing litigation matter and a charitable donation in the prior year. Research and development expense increased primarily due to increased project and personnel-related costs. The overall change in currency exchange rates resulted in an increase in operating expenses by approximately 1%.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><div id="i5d795a6851d746ca914a2ddae761c329_73"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Water</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Water segment results of operations:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:36.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Results of Operations<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(dollars in thousands)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percent of Revenue</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percent of Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percentage</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">146,505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">128,625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,880&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,561&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,245&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100,944&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90,380&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,564&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,814&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,768&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,442&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,595&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">847&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,872&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">372&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,513&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,987&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65,444&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,867&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,577&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;The&#160;increase in our Water business was primarily a result of the recovery in overall testing volumes, including continued improvement in non-compliance testing volume that has been constrained since the beginning of the COVID-19 pandemic and disruptions in certain compliance testing areas due to social distancing policies. The increase in revenue, to a lesser extent, was also due to the benefit of price increases in our Colilert test products and related accessories used in coliform and E. coli testing. The impact of currency movements increased revenue by approximately 2.2%.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Gross Profit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;Gross profit for Water increased due to higher sales volumes despite a 140 basis point decrease in the gross profit margin, which reflected a 50 basis point reduction due to foreign currency movements, incl</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">uding the impact of hedge losses in the current year compared to hedge gains in the prior year. The gross profit margin was further reduced by higher product, distribution, and freight costs, partially offset by the net benefit of price increases.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Operating Expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Overall operating expenses were higher compared to 2020, during which cost containment efforts were implemented in response to the COVID-19 pandemic, including temporary reductions to compensation and benefits and travel costs. Sales and marketing increased primarily due to higher personnel-related costs, including sales incentive compensation. General and administration and research and development expenses increased primarily due to higher personnel-related costs. The overall change in currency exchange rates resulted in an increase in operating expenses of approximately 1%.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><div id="i5d795a6851d746ca914a2ddae761c329_76"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Livestock, Poultry and Dairy</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the LPD segment results of operations:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:36.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Results of Operations<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(dollars in thousands)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percent of Revenue</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percent of Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percentage</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">135,887&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">145,845&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,958)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54,323&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56,643&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,320)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81,564&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89,202&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,638)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%)</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,681&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,026&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,606&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,061&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">545&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,928&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,194&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,734&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,636&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,008&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,372)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(28.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%)</span></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The favorable impact of foreign currency movements increased revenue by 2.3%. Excluding the impact of currency, overall revenues decreased primarily due to lower demand for diagnostic testing in China, partially offset by higher testing volumes and realized prices in Europe and the Americas, as compared to pandemic impacts in the prior year. Beginning in the second quarter of 2021, and continuing through the fourth quarter, we experienced lower livestock test</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> volumes in China, as changes in disease management approaches, lower pork prices, and changes in government requirements related to live animal imports and livestock infectious disease programs unfavorably impacted test volumes, in comparison to high prior-year demand for African Swine Fever testing.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Gross Profit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;The decrease in LPD gross profit was primarily due to lower sales volumes and a 120 basis point decrease in the gross profit margin. The decrease in the gross profit margin is primarily due to higher distribution and freight costs, and lower realized prices, partially offset by lower product costs. The impact from foreign currency movements was immaterial for the year.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Operating Expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Overall operating expenses were higher compared to 2020, during which cost containment efforts were implemented in response to the COVID-19 pandemic, including temporary reductions to compensation and benefits, and travel costs.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Sales and marketing expense increased primarily due to higher personnel-related costs, as well as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">higher marketing and promotional materials costs</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, partially offset by lower sales incentive compensation. General and administrative expenses increased primarily due to higher personnel-related costs, partially offset by an impairment of an intangible asset associated with our food safety and dairy business in the fourth quarter of 2020 and an increase in the bad debt reserve during the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">first half of 2020. Research and development expense increased primarily due to h</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">igher personnel-related costs as we leveraged LPD personnel to support our human COVID-19 testing initiatives in the prior year,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and software development costs. The overall change in currency exchange rates resulted in an increase in operating expenses of approximately 1.5%.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><div id="i5d795a6851d746ca914a2ddae761c329_79"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Other results of operations:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:36.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Results of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(dollars in thousands)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percent of Revenue</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percent of Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percentage</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,412)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,888&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,120&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,272&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,152)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%)</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,546&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,942&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">604&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,142&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,712&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,430&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">141.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,506&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,856&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,350)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,194&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,510&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,684&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,926&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,762&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,836)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%)</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-indent:72pt"><span style="font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%"></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;The decrease in Other revenue was primarily due to lower OPTI COVID-19 PCR testing products and services, primarily due to lower international volume, as well as lower royalty revenue associated with intellectual property related to our former pharmaceutical product line. These decreases were partially offset by higher OPTI Medical consumables sales. We currently estimate that future demand for our OPTI COVID-19 PCR testing products and services will continue to be lower than prior periods, although it is difficult to project given the uncertain nature of the COVID-19 pandemic. The impact of currency movements increased revenues by 0.9%.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Gross Profit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The decrease in gross profit was primarily due to lower sales volumes and a gross profit margin decrease of 780 basis points. The decrease in the gross profit margin was primarily due to higher product costs associated with write-downs of excess COVID-19 testing inventory in the current year and lower mix benefits, primarily from lower royalty revenue associated with our former pharmaceutical product line. The overall change in currency exchange rates had an immaterial impact on gross profit.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Operating Expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales and marketing expense increased primarily due to higher personnel-related costs associated with our OPTI COVID-19 PCR product and services. General and administrative expense increased primarily due to higher foreign exchange losses on settlements of foreign currency denominated transactions, as compared to the prior year, for all operating segments, which are reported within our Other segment. Research and development expense decreased primarily due to lower project costs associated with the development of the OPTI COVID-19 PCR test in the prior year.</span></div><div id="i5d795a6851d746ca914a2ddae761c329_82"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-Operating Items</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Interest Expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Interest expense&#160;was $29.8 million for the year ended December 31, 2021, as compared to $33.1 million for the prior year. The decrease in interest expense was primarily the result of lower average debt levels.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective income tax rate was 17.5% for the year ended December 31, 2021, and 12.1% for the year ended December 31, 2020. The increase in our effective tax rate during 2021 was primarily due to the prior year one-time positive impact related to the enactment of tax reform in Switzerland related to the transitional benefits, as well as higher tax benefits in the prior year related to share-based compensation. Our projected effective tax rate for 2022 is approximately 22%. This projected increase in the effective tax rate is primarily due to lower estimated tax benefits from share-based compensation as well as the estimated impacts of international tax changes.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><div id="i5d795a6851d746ca914a2ddae761c329_103"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIQUIDITY AND CAPITAL RESOURCES</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We fund the capital needs of our business through cash on hand, funds generated from operations, proceeds from long-term senior note financings, and amounts available under our Credit Facility. We generate cash primarily through the payments made by customers for our companion animal veterinary, livestock, poultry, dairy, and water products and services, consulting services, and other various systems and services. Our cash disbursements are primarily related to compensation and benefits for our employees, inventory and supplies, taxes, research and development, capital expenditures, rents, occupancy-related charges, interest expense, and business acquisitions.&#160;At December 31, 2021, we had $144.5 million of cash and cash equivalents, as compared to $383.9 million on December 31, 2020. Working capital, including our Credit Facility, totaled $192.1 million at December 31, 2021, as compared to $480.0 million at December 31, 2020. Additionally, at December 31, 2021, we had a remaining borrowing availability of $925.1 million under our $1 billion Credit Facility, which in December 2021 was amended and extended to December 2026. We believe that, if necessary, we could obtain additional borrowings to fund our growth objectives. We further believe that current cash and cash equivalents, funds generated from operations, and committed borrowing availability will be sufficient to fund our operations, capital purchase requirements, and anticipated growth needs for the next twelve months. We believe that these resources, coupled with our ability, as needed, to obtain additional financing, will also be sufficient to fund our business as currently conducted for the foreseeable future. We may enter into new financing arrangements or refinance or retire existing debt in the future depending on market conditions. Should we require more capital in the U.S. than is generated by our operations, for example to fund significant discretionary activities, we could elect to raise capital in the U.S. through the incurrence of debt or equity issuances, which we may not be able to complete on favorable terms or at all. In addition, these alternatives could result in increased interest expense or other dilution of our earnings. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We manage our worldwide cash requirements considering available funds among all of our subsidiaries. Our foreign cash and cash equivalents are generally available without restrictions&#160;to fund ordinary business operations outside the U.S.&#160;&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents cash, cash equivalents and marketable securities held domestically, and by our foreign subsidiaries:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:67.860%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.687%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.689%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,632&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">248,374&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">141,822&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">135,554&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">144,454&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">383,928&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total cash, cash equivalents and marketable securities held in U.S. dollars by our foreign subsidiaries</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,245&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,042&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021 and 2020, more than 99% of the cash and cash equivalents held was as bank deposits.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents additional key information concerning working capital:</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:36.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.794%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.794%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.794%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.798%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Days sales outstanding </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventory turns </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;Days sales outstanding represents the average of the accounts receivable balances at the beginning and end of each quarter divided by revenue for that quarter, the result of which is then multiplied by 91.25 days.</span></div><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2) &#160;&#160;&#160;&#160;Inventory turns represent inventory-related cost of product revenue for the 12 months preceding each quarter-end divided by the average inventory balances at the beginning and end of each quarter.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sources and Uses of Cash</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents cash provided (used):&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.954%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.200%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Dollar Change</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">755,546&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">648,063&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107,483&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used by investing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(292,967)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(109,376)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(183,591)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used by financing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(697,414)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(248,416)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(448,998)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net effect of changes in exchange rates on cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,639)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,331&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,970)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net change in cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(239,474)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">293,602&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(533,076)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Operating Activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The increase in cash provided by operating activities of $107.5 million during 2021 as compared to 2020, was primarily due to the increase in net income partially offset by changes in other assets and liabilities. The increase in adjustments to reconcile net income to net cash provided by operating activities was primarily due to lower deferred tax benefits in the current year, as related to the enactment of tax reform in Switzerland in the prior year, as well as higher depreciation and amortization expense in the current year, primarily related to the completion of our major facilities projects early in 2020 and amortization of intangible assets from current year acquisitions, as well as higher share-based compensation expense.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents cash flows (used) provided from changes in operating assets and liabilities:&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.807%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.201%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Dollar Change</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33,141)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(60,722)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,581&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(52,919)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,885)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34,034)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,233&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">981&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,252&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,551)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13,373)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,822&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets and liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(55,145)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,238&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(115,383)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total change in cash due to changes in operating assets and liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(137,523)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31,761)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(105,762)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash used due to changes in operating assets and liabilities during the year ended December 31, 2021, as compared to the same period in the prior year, decreased approximately $105.8 million. The change in other assets and liabilities was due to higher payroll and income tax payments, as compared to the prior year when the timing of these payments was deferred under COVID-19 stimulus guidance, as well as higher incentive payments, and higher investments in customer commitment programs to support instrument placements. Additionally, the prior year included a non-cash operating expense related to an ongoing litigation matter. The increase in cash used for inventory, as compared to the prior year, was primarily due to higher inventory levels to support increasing demand and to mitigate potential supply-chain disruptions. The change in accounts receivable was primarily due to an acceleration of sales in the later part of 2020 related to pent-up demand resulting from the COVID-19 pandemic, resulting in high levels of growth in our accounts receivable during the prior year. The change in accounts payable was primarily due to timing of payments at the end of the year, as well as increases in activity to support infrastructure and capacity growth. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have historically experienced proportionally lower net cash flows from operating activities during the first quarter and proportionally higher cash flows from operating activities for the remainder of the year and for the annual period driven primarily by payments related to annual employee incentive programs in the first quarter following the year for which the bonuses were earned. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Investing Activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash used by investing activities was $293.0 million during 2021 as compared to $109.4 million used during 2020. The increase in cash used by investing activities during 2021 as compared to 2020 was primarily due to business acquisitions completed during 2021, including a cloud-based veterinary software business.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total capital expenditure plan for 2022 is estimated to be approximately $180 million, which includes capital investments in a new warehouse and manufacturing site expansion to support growth.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Financing Activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Cash used by financing activities was $697.4 million during 2021, as compared to $248.4 million used during 2020. The increase in cash used by financing activities was primarily due to the increase in repurchases of our common stock, as compared to the prior year during which we suspended repurchases due to the COVID-19 pandemic. Cash was also used to pay off our $50 million 2021 Series A Notes when due and payable on July 21, 2021. We also generated cash from outstanding borrowings on our revolving credit facility of $73.5 million on December 31, 2021. During 2020, we repaid borrowings under our Credit Facility in the amount of $289.6 million, and borrowed $200.0 million through the issuance and sale of 10-year, 2.50% fixed-rate senior notes. As of December 31, 2020, we had no outstanding borrowings on our Credit Facility. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash used to repurchase shares of our common s</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">tock increased by $564.0 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> during 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as compared to 2020. Due to the uncertainty of the duration and magnitude of the COVID-19 pandemic and its impacts during 2020, we suspended our open market share repurchase activity beginning in the first quarter of 2020. We resumed share repurchases during the first quarter of 2021. From the inception of our share repurchase program in August 1999 to December 31, 2021, we have repurchased 68.0 million shares for $5.0 billion. During 2021, we purchased 1.3 million shares for an aggregate cost of $755.5 million, as compared to purchases of 0.7 million shares for an aggregate cost of $179.6 million during 2020. We believe that the repurchase of our common stock is a favorable means of returning value to our stockholders and we also repurchase our stock to offset the dilutive effect of our share-based compensation programs. Repurchases of our common stock may vary depending upon the level of other investing activities and the share price. We primarily fund our share repurchases with cash generated from operations, as well as from various capital market activities, including the committed available financing through our Credit Facility. Refer to "Part II, Item 8. Financial Statements and Supplementary Data, Note 20. Repurchases of Common Stock" to the consolidated financial statements included in this Annual Report on Form 10-K for additional information about our share&#160;repurchases.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $1.0 billion unsecured revolving Credit Facility matures on December 9, 2026 and requires no scheduled prepayments before that date. Amounts borrowed under the terms of the Credit Facility are reflected in the current liabilities section in the accompanying consolidated balance sheets. Currently, the applicable interest rates on borrowings under the Credit Facility are based on the prevailing LIBOR, plus a credit spread of 0.875%, depending upon our gross leverage ratio. Refer to "Part II, Item 8. Financial Statements and Supplementary Data, Note 13, Debt" for additional information about our applicable interest rates on our Credit Facility. Under the Credit Facility, we also pay quarterly commitment fees ranging from 0.075% to 0.25%, based on our leverage ratio, on any unused commitment. Our Credit Facility includes a provision for the determination of a benchmark replacement rate as a successor to the LIBOR rate. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Credit Facility, the net repayment and borrowing activity resulted in increased cash used of $363.1 million during 2021, as compared to 2020. At December 31, 2021, we had $73.5 million outstanding under the Credit Facility. At December 31, 2020, we had no borrowings outstanding under the Credit Facility. The general availability of funds under the Credit Facility was further reduced by $1.4 million for letters of credit that were issued in connection with our workers' compensation policy at December 31, 2021 and 2020, respectively. The Credit Facility contains affirmative, negative, and financial covenants customary for financings of this type. The negative covenants include restrictions on liens, indebtedness of subsidiaries of the Company, fundamental changes, investments, transactions with affiliates, and certain restrictive agreements and violations of laws and regulations. The financial covenant is a consolidated leverage ratio test that requires our ratio of debt to earnings before interest, taxes, depreciation, amortization, and share-based compensation not to exceed 3.5-to-1. At December 31, 2021, we were in compliance with the covenants of the Credit Facility.&#160;The obligations under the Credit Facility may be accelerated upon the occurrence of an event of default under the Credit Facility, which includes customary events of default including payment defaults, defaults in the performance of the affirmative, negative and financial covenants, the inaccuracy of representations or warranties, bankruptcy and insolvency related defaults, defaults relating to judgments, certain events related to employee pension benefit plans under the Employee Retirement Income Security Act of 1974, ("ERISA"), the failure to pay specified indebtedness, cross-acceleration to specified indebtedness and a change of control default.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 21, 2021, we repaid our $50.0 million 2021 Series A Notes in full with cash provided by operations. The aggregate principal amounts of our 2022 Series A Notes for $75.0 million will become due and payable on February 14, 2022. We anticipate paying off our 2022 Series A Notes when due with cash provided by borrowings under our Credit Facility and cash provided by operations. Should we elect to prepay any of our senior notes, such aggregate prepayment will include the applicable make-whole amount(s), as defined within the applicable Senior Note Agreements. Additionally, in the event of a change in control of the Company or upon the disposition of certain assets of the Company, the proceeds of which are not reinvested (as defined in the Senior Note Agreements), we may be required to prepay all or a portion of the senior notes. The obligations under the senior notes may be accelerated upon the occurrence of an event of default under the applicable Senior Note Agreements, each of which includes customary events of default including payment defaults, defaults in the performance of the affirmative, negative and financial covenants, the inaccuracy of representations or warranties, bankruptcy and </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">insolvency-related defaults, defaults relating to judgments, certain events related to employee pension benefit plans under ERISA, the failure to pay specified indebtedness, and cross-acceleration to specified indebtedness.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to "Part II, Item 8. Financial Statements and Supplementary Data, Note 13, Debt" for additional information about our Credit Facility, Senior Notes, and Senior Note Agreements.  &#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Effect of currency translation on cash</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;The net effect of changes in foreign currency exchange rates are related to changes in exchange rates between the U.S. dollar and the functional currencies of our foreign subsidiaries. These changes will fluctuate each year as the value of the U.S. dollar relative to the value of the foreign currencies change. The value of a currency depends on many factors, including interest rates, and the issuing governments' debt levels and strength of economy.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Off-Balance Sheet Arrangements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We have no off-balance sheet arrangements or variable interest entities except for letters of credit and third-party guarantees, as reflected in "Part II, Item 8. Financial Statements and Supplementary Data, Note 13 Debt" and "Part II, Item 8. Financial Statements and Supplementary Data. Note 16. Commitments, Contingencies and Guarantees" to the consolidated financial statements for the year ended December 31, 2021, included in this Annual Report on Form 10-K, respectively.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Financial Covenant</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The financial covenant is a consolidated leverage ratio test that requires our ratio of debt to earnings before interest, taxes, depreciation, amortization, and share-based compensation, as defined in the Senior Note Agreements and Credit Facility, not to exceed 3.5-to-1. At December 31, 2021, we were in compliance with the covenants of the Senior Note Agreements. The following details our consolidated leverage ratio calculation:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:80.891%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.909%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Twelve months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Trailing 12 Months Adjusted EBITDA:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 7.75pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to stockholders</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">744,845&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,808&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">157,810&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104,596&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition-related expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,755&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Extraordinary and other non-recurring non-cash charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,084,089&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Twelve months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Debt to Adjusted EBITDA Ratio:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Line of credit</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current and long-term portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">850,201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">923,701&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition-related consideration payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,708&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">510&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross debt</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">934,933&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross debt to Adjusted EBITDA ratio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(144,454)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net debt</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">790,479&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net debt to Adjusted EBITDA ratio</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.73&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commitments, Contingencies and Guarantees</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more information regarding our commitments, contingencies and guarantees, refer to "Part II, Item 8. Financial Statements and Supplementary Data, Note 16. Commitments, Contingencies and Guarantees". </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more information on our future lease payments, refer to "Part II, Item 8. Financial Statements and Supplementary Data, Note 8. Leases" for our minimum lease payment schedule. The expected timing of payments of our leases may be different in future years, depending on decisions to extend lease terms and/or enter into additional leases in the preceding years. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more information on our repayment of our Senior Notes, refer to "Part II, Item 8. Financial Statements and Supplementary Data, Note 13. Debt". </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have purchase obligations that including agreements and purchase orders to purchase goods or services that are contractually enforceable and that specify all significant terms, including fixed or minimum quantities, pricing and approximate timing of purchases. As of December 31, 2021, we have approximately $377.1 million in purchase obligations due in 2022. Our purchase obligations beyond 2022 are approximately $44.3 million. Expected timing of payments of our purchase obligations is estimated based on current information. Timing of payments and actual amounts paid may be different, depending on the time of receipt of goods or services, or changes to agreed-upon amounts for some obligations. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we have agreements with third parties that we have entered into in the ordinary course of business under which we are obligated to indemnify such third parties for and against various risks and losses. The precise terms of such indemnities vary with the nature of the agreement. In many cases, we limit the maximum amount of our indemnification obligations, but in some cases those obligations may be theoretically unlimited. We have not incurred material expenses in discharging any of these indemnification obligations and, based on our analysis of the nature of the risks involved, we believe that the fair value of these agreements is minimal. Accordingly, we did not record any liabilities for these obligations at December 31, 2021 and 2020, and do not anticipate any future payments for these guarantees.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, our remaining obligation associated with the deemed&#160;repatriation&#160;tax resulting from the Tax Cut and Jobs Act of 2017 is&#160;$27.0 million. Our prior overpayments continue to satisfy our installment obligations through 2022. In 2023, our installment obligation will exceed our remaining overpayment and we will be required to remit the balance due on the installment. Our final installment will be paid in 2025. For information on our unrecognized tax benefits, refer to "Part II, Item 8. Financial Statements and Supplementary Data, Note 14. Income Taxes".</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><div id="i5d795a6851d746ca914a2ddae761c329_106"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 7A.&#160;&#160;&#160;&#160;QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our market risk consists primarily of foreign currency exchange risk, interest rate risk, and effects of inflation. Our functional currency is the U.S. dollar and our primary manufacturing operations and inventory supply contracts are in the U.S. or in U.S. dollars, but we distribute our products worldwide both through direct export and through our foreign subsidiaries. Our primary foreign currency transaction risk consists of intercompany purchases and sales of products and we attempt to mitigate this risk through our hedging program described below. For the year ended December 31, 2021, approximatel</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">y 23% o</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f our consolidated revenue was derived from products manufactured or sourced in U.S. dollars and sold internationally in local currencies, as compared to 21% and 22% for the years ended December 31, 2020, and 2019, respectively. The functional currency of most of our subsidiaries is their local currency, except four of our foreign subsidiaries where the functional currency is the U.S. dollar.&#160;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our foreign currency exchange impacts are comprised of three components: 1) local currency revenues and expenses; 2) the impact of hedge contracts; and 3) intercompany and monetary balances for our subsidiaries that are denominated in a currency that is different from the functional currency used by each subsidiary.&#160;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table presents the estimated foreign currency&#160;exchange impact&#160;on our revenues,&#160;operating&#160;profit, and diluted earnings per share for the current period and as compared to the respective prior-year period:</span></div><div style="text-indent:42.75pt"><span style="font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:120%"></span></div><div style="margin-top:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.332%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Year Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands, except per share amounts)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenue increase (decrease)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">46,001</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,301</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(38,624)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating profit increase (decrease), excluding hedge activity and exchange impacts on settlement of foreign currency denominated transactions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,557&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">887&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,989)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Hedge gains (losses) - current period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,121)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">829&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,628&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exchange gains (losses) on settlements of foreign currency denominated transactions - current period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,111)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">699&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,116)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating profit increase (decrease) - current period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">19,325</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,415</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(9,477)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Hedge (gains) losses - prior period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(829)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10,628)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">976&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exchange (gains) losses on settlement of foreign currency denominated transactions - prior period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(699)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating profit increase (decrease) - as compared to prior period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">17,797</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(7,097)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(5,343)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Diluted earnings per share increase (decrease) - as compared to prior period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.16</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(0.06)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(0.05)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on projected revenues and expenses for 2022, excluding the impact of intercompany and trade balances denominated in currencies other than the functional subsidiary currencies, a 1% strengthening of the U.S. dollar would reduce revenue by approximately $12 million and operating income by approximately $7 million. Additionally, we project our foreign currency hedge contracts in place as of December 31, 2021, would provide incremental offsetting gains of approximately $3 million.&#160;The impact of the intercompany and monetary balances referred to in the third component above have been excluded, as they are transacted at multiple times during the year and we are not able to reliably forecast the impact that changes in exchange rates would have.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At our current foreign exchange rate assumptions, we anticipate the effect of a stronger U.S. dollar will have a unfavorable effect on our operating results by decreasing our revenues, operating profit, and diluted earnings per share in the year ended December 31, 2022, by approximately $55 million, $9 million, and $0.08 per share, respectively. This unfavorable impact includes foreign currency hedging activity, which is expected to increase total company operating profit by approximately $18 million and diluted earnings per share by $0.16 during the year ending December 31, 2022. The actual impact of changes in the value of the U.S. dollar against foreign currencies in which we transact may materially differ from our expectations described above. The above estimate assumes that the value of the U.S. dollar relative to other currencies will reflect the euro at $1.12, the British pound at $1.34, the Canadian dollar at $0.78, and the Australian dollar at $0.71; and the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Japanese yen at &#165;117, the Chinese renminbi at RMB 6.47, and the Brazilian real at R$5.74 to the U.S. dollar for the full year of 2022.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary purpose of our foreign currency hedging activities is to protect against the volatility associated with foreign currency transactions. We also utilize natural hedges to mitigate our transaction and commitment exposures. Our corporate policy prescribes the range of allowable hedging activity. We enter into foreign currency exchange contracts with large multinational financial institutions and we do not hold or engage in transactions involving derivative instruments for purposes other than risk management. Our accounting policies for these contracts are based on our designation of such instruments as hedging transactions. If a hedging instrument qualifies for hedge accounting, changes in the fair value of the derivative instrument from the effective portion of the hedge are deferred in accumulated other comprehensive income, net of tax, and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. We immediately record in earnings the extent to which a hedge instrument is not effective in achieving offsetting changes in fair value. We primarily utilize foreign currency exchange contracts with durations of less than 24 months.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our subsidiaries enter into foreign currency exchange contracts to manage the exchange risk associated with their forecasted intercompany inventory purchases and sales for the next year. From time to time, we may also enter into other foreign currency exchange contracts or foreign-denominated debt issuances to minimize the impact of foreign currency fluctuations associated with specific balance sheet exposures, including net investments in certain foreign subsidiaries. Refer to "Part II, Item 8. Financial Statements and Supplementary Data, Note 19. Hedging Instruments" to the consolidated financial statements of this Annual Report on Form 10-K for details regarding euro-denominated notes that we designated as a hedge of our euro net investment in certain foreign subsidiaries.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our foreign currency hedging strategy is consistent with prior periods and there were no material changes in our market risk exposure during the year ended December 31, 2021. We enter into foreign currency exchange contracts designated as cash flow hedges for amounts that are less than the full value of forecasted intercompany purchases and sales and for amounts that are equivalent to, or less than, other significant transactions. As a result, no significant ineffectiveness has resulted or been recorded through the statements of income for the years ended December 31, 2021, 2020, and 2019. Our hedging strategy related to intercompany inventory purchases and sales is to employ the full amount of our hedges for the succeeding year at the conclusion of our budgeting process for that year. Quarterly, we enter into contracts to hedge incremental portions of anticipated foreign currency transactions for the current and following year. Accordingly, our risk with respect to foreign currency exchange rate fluctuations may vary throughout each annual cycle.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into hedge agreements where we believe we have meaningful exposure to foreign currency exchange risk, with the exception of certain emerging markets where it is not practical to hedge our exposure. We target to hedge approximately 75% to 85% of the estimated exposure from intercompany product purchases and sales denominated in the euro, British pound, Canadian dollar, Japanese yen, and Australian dollar. We have additional unhedged foreign currency exposures related to foreign services and emerging markets where it is not practical to hedge. The notional amount of foreign currency exchange contracts to hedge forecasted intercompany purchases and sales totaled $286.7 million at December 31, 2021, and $202.7 million at December 31, 2020. At December 31, 2021, we had $8.2 million of net unrealized gains on foreign currency exchange contracts recorded in accumulated other comprehensive loss, net of related tax. For more information on our hedge agreements refer to "Part II, Item 8. Financial Statements and Supplementary Data, Note 19. Hedging Instruments."</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information, refer to "Part I, Item 1A. Risk Factors; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risks associated with doing business internationally could negatively affect our operating results </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Strengthening of the rate of exchange for the U.S. dollar has a negative effect on our business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">," and "Part II, Item 8. Financial Statements and Supplementary Data, Note 2. Summary of Significant Accounting Policies."</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Rate Risk and Effects of Inflation</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a Credit Facility with a syndicate of multinational banks, which matures on December 9, 2026, and requires no scheduled prepayments before that date. Although the Credit Facility does not mature until December 9, 2026, all individual borrowings under the terms of the Credit Facility predominantly have a stated term between 1 and 180 days. At December 31, 2021, we had $73.5 million of borrowings outstanding under the Credit Facility. As of December 31, 2021, based on our gross leverage ratio, our borrowing costs under the Credit Facility were approximately 1.1%. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inflation generally impacts us by increasing our costs of labor, material, transportation and general overhead costs. The rates of inflation experienced in recent years have not had a material impact on our financial statements as inflationary cost increases have been more than offset by net realized annual price increases and productivity gains. We cannot reasonably estimate our ability to successfully recover any impact of inflation cost increases into the future.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div id="i5d795a6851d746ca914a2ddae761c329_109"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 8.&#160;&#160;&#160;&#160;FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The response to this item is submitted as a separate section of this report commencing on page F-1.</span></div><div><span><br/></span></div><div id="i5d795a6851d746ca914a2ddae761c329_112"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9.&#160;&#160;&#160;&#160;CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div><span><br/></span></div><div id="i5d795a6851d746ca914a2ddae761c329_115"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9A.&#160;&#160;&#160;&#160;CONTROLS AND PROCEDURES</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disclosure Controls and Procedures</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management is responsible for establishing and maintaining disclosure controls and procedures, as defined by the SEC in its Rules 13a-15(e) and 15d-15(e) under the Exchange Act. The term &#8220;disclosure controls and procedures,&#8221; as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of an issuer that are designed to ensure that information required to be disclosed by the issuer in the reports that it files or submits under the Exchange Act is recorded, processed, summarized, and reported, within the time periods specified in the SEC's rules and forms. Disclosure controls and procedures include controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company&#8217;s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on the evaluation of our disclosure controls and procedures at December 31, 2021, our chief executive officer and chief financial officer have concluded that, as of such date, the Company&#8217;s disclosure controls and procedures were effective at the reasonable assurance level.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Management on Internal Control Over Financial Reporting</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act. The Company&#8217;s internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. GAAP and includes those policies and procedures that:</span></div><div><span><br/></span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the Company;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company&#8217;s assets that could have a material adverse effect on the financial statements.</span></div><div style="padding-left:45pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. In addition, projections of any evaluation of effectiveness to future periods are subject to risk that controls may become inadequate because of changes in conditions and that the degree of compliance with the policies and procedures may deteriorate.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted an evaluation of the effectiveness of internal control over financial reporting based on the framework in Internal Control &#8211; Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on this evaluation, we concluded that, at December 31, 2021, our internal control over financial reporting was effective.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effectiveness of the Company's internal control over financial reporting at December 31, 2021, has been audited by PricewaterhouseCoopers LLP, an independent registered public accounting firm, as stated in their report which appears herein.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control Over Financial Reporting</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the three months ended December 31, 2021, that materially affected, or are reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certifications</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The certifications with respect to disclosure controls and procedures and internal control over financial reporting of the Company&#8217;s chief executive officer and chief financial officer are attached as Exhibits 31.1 and 31.2 to this Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div id="i5d795a6851d746ca914a2ddae761c329_118"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9B.&#160;&#160;&#160;&#160;OTHER INFORMATION</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div><span><br/></span></div><div id="i5d795a6851d746ca914a2ddae761c329_10445360466006"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9C.&#160;&#160;&#160;&#160;DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><div id="i5d795a6851d746ca914a2ddae761c329_121"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III</span></div><div id="i5d795a6851d746ca914a2ddae761c329_124"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 10.&#160;&#160;&#160;&#160;DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item with respect to Directors, executive officers, compliance with Section 16(a)&#160;of the Exchange Act, our code of ethics and corporate governance is omitted from this Annual Report on Form 10-K and, pursuant to Regulation 14A of the Exchange Act, is incorporated herein by reference from the sections entitled &#8220;Corporate Governance - Proposal One - Election of Directors,&#8221; &#8220;Executive Officers,&#8221; &#8220;Stock Ownership Information - Delinquent Section 16(a) Reports,&#8221; &#8220;Corporate Governance &#8211; Corporate Governance Guidelines and Code of Ethics,&#8221; and &#8220;Corporate Governance &#8211;Board Committees&#8221; in the Company&#8217;s definitive Proxy Statement with respect to its 2022 Annual Meeting, which Proxy Statement will be filed with the SEC within 120 days after the end of the fiscal year covered by this Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div id="i5d795a6851d746ca914a2ddae761c329_127"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 11.&#160;&#160;&#160;&#160;EXECUTIVE COMPENSATION</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item is omitted from this Annual Report on Form 10-K and, pursuant to Regulation 14A of the Exchange Act, is incorporated herein by reference from the sections entitled &#8220;Executive Compensation &#8211; Compensation Discussion and Analysis,&#8221; &#8220;Executive Compensation &#8211; Executive Compensation Tables,&#8221; &#8220;Executive Compensation &#8211; Potential Payments Upon Termination or Change-in-Control,&#8221; &#8220;Corporate Governance &#8211; Board Committees &#8211; Compensation and Talent Committee &#8211; Compensation and Talent Committee Interlocks and Insider Participation,&#8221; and &#8220;Compensation and Talent Committee Report&#8221; in the Company&#8217;s definitive Proxy Statement with respect to its 2022 Annual Meeting, which Proxy Statement will be filed with the SEC within 120 days after the end of the fiscal year covered by this Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div id="i5d795a6851d746ca914a2ddae761c329_130"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 12.&#160;&#160;&#160;&#160;SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AND RELATED STOCKHOLDER MATTERS</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item with respect to Item 201(d) of Regulation S-K is omitted from this Annual Report on Form 10-K and, pursuant to Regulation 14A of the Exchange Act, is incorporated herein by reference from the section entitled &#8220;Equity Compensation Plan Information&#8221; in the Company&#8217;s definitive Proxy Statement with respect to its 2022 Annual Meeting, which Proxy Statement will be filed with the SEC within 120 days after the end of the fiscal year covered by this Annual Report on Form 10-K. The information required by this Item with respect to Item 403 of Regulation S-K is omitted from this Annual Report on Form 10-K and, pursuant to Regulation 14A of the Exchange Act, is incorporated herein by reference from the sections entitled &#8220;Stock Ownership Information&#8221; in the Company&#8217;s definitive Proxy Statement with respect to its 2022 Annual Meeting, which Proxy Statement will be filed with the SEC within 120 days after the end of the fiscal year covered by this Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div id="i5d795a6851d746ca914a2ddae761c329_133"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 13.&#160;&#160;&#160;&#160;CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item is omitted from this Annual Report on Form 10-K and, pursuant to Regulation 14A of the Exchange Act, is incorporated herein by reference from the sections entitled &#8220;Corporate Governance &#8211; Related Person Transactions&#8221; and &#8220;Corporate Governance &#8211; Director Independence&#8221; in the Company&#8217;s definitive Proxy Statement with respect to its 2022 Annual Meeting, which Proxy Statement will be filed with the SEC within 120 days after the end of the fiscal year covered by this Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div id="i5d795a6851d746ca914a2ddae761c329_136"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 14.&#160;&#160;&#160;&#160;PRINCIPAL ACCOUNTANT FEES AND SERVICES</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item is omitted from this Annual Report on Form 10-K and, pursuant to Regulation 14A of the Exchange Act, is incorporated herein by reference from the section entitled &#8220;Audit Committee Matters - Independent Auditors&#8217; Fees&#8221; in the Company&#8217;s definitive Proxy Statement with respect to its 2022 Annual Meeting, which Proxy Statement will be filed with the SEC within 120 days after the end of the fiscal year covered by this report.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><div id="i5d795a6851d746ca914a2ddae761c329_139"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV</span></div><div id="i5d795a6851d746ca914a2ddae761c329_142"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 15.&#160;&#160;&#160;&#160;EXHIBITS, FINANCIAL STATEMENT SCHEDULES</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:501.75pt"><tr><td style="width:1.0pt"></td><td style="width:34.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:52.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:408.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following documents are filed as part of this Form 10-K:</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:33pt"><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)(1) and (a)(2)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The financial statements set forth in the Index to Consolidated Financial Statements and the Consolidated Financial Statement Schedule are filed as a part of this Annual Report on Form 10-K commencing on page F-1.</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:24pt"><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)(3) and (b)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The exhibits listed in the accompanying Exhibit Index are filed as part of this Annual Report on Form 10-K and either filed herewith or incorporated by reference herein, as applicable.</span></td></tr></table></div><div><span><br/></span></div><div id="i5d795a6851d746ca914a2ddae761c329_145"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 16. FORM 10-K SUMMARY</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#c8d9f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><div id="i5d795a6851d746ca914a2ddae761c329_148"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL STATEMENTS AND SUPPLEMENTAL DATA</span></div><div style="text-align:center;text-indent:72pt"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AND</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED FINANCIAL STATEMENT SCHEDULE</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:89.090%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.710%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page No.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_151">Report of Independent Registered Public Accounting Firm </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_151">- PCAOB ID</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_151"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_151"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_151">No.</a></span><span style="color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_151"> </a><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="dei:AuditorFirmId" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNDgvZnJhZzo5Mjk5NDZhZTdlN2Y0OWU2YWYzMWE5Nzk0ZDZmZmRiZi90YWJsZTpkMzQ0ZThhNmI3MTY0YTA5YTFjZTk4OTg5ODNmNGYzZi90YWJsZXJhbmdlOmQzNDRlOGE2YjcxNjRhMDlhMWNlOTg5ODk4M2Y0ZjNmXzMtMC0xLTEtNDk2OTcvdGV4dHJlZ2lvbjo5MmJkNDRiNTRhY2Q0MzVlYmI3YWI0Yzk1NzFlNTA1ZV80OTQ3ODAyMzI1MTg4_55748079-f0e7-46fb-8eec-1592a1d929d9">238</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_151">F-</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_151">2</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_154">Consolidated Balance Sheets as of December 31, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_154">1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_154"> and 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_154">20</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_154">F-</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_154">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_157">Consolidated Statements of Income for the Years Ended December 31, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_157">1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_157">, 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_157">20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_157"> and 201</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_157">9</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_157">F-</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_157">5</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_160">Consolidated Statements of Comprehensive Income for the Years Ended December 31, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_160">1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_160">, 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_160">20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_160"> and 201</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_160">9</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_160">F-</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_160">6</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_163">Consolidated Statements of Stockholders&#8217; Equity (Deficit) for the Years Ended December 31, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_163">1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_163">, 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_163">20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_163"> and 201</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_163">9</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_163">F-</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_163">7</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_166">Consolidated Statements of Cash Flows for the Years Ended December 31, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_166">1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_166">, 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_166">20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_166"> and 201</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_166">9</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_166">F-</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_166">8</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_169">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_169">F-</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d795a6851d746ca914a2ddae761c329_169">9</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-1</span></div></div></div><div id="i5d795a6851d746ca914a2ddae761c329_151"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To the Board of Directors and Stockholders of IDEXX Laboratories, Inc.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Opinions on the Financial Statements and Internal Control over Financial Reporting</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have audited the accompanying consolidated balance sheets of IDEXX Laboratories, Inc. and its subsidiaries (the &#8220;Company&#8221;) as of December 31, 2021 and 2020, and the related consolidated statements of income, of comprehensive income, of stockholders' equity (deficit) and of cash flows for each of the three years in the period ended December 31, 2021, including the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;). We also have audited the Company's internal control over financial reporting as of December 31, 2021, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Internal Control - Integrated Framework</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2021 and 2020, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2021 in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2021, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Internal Control - Integrated Framework</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (2013) issued by the COSO.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Basis for Opinions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in Report of Management on Internal Control Over Financial Reporting appearing under Item 9A. Our responsibility is to express opinions on the Company&#8217;s consolidated financial statements and on the Company's internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Definition and Limitations of Internal Control over Financial Reporting</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Critical Audit Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that (i) relates to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Revenue Recognition Relating to Customer Commitment Programs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As described in Note 3 to the consolidated financial statements, the Company recognized revenue associated with instruments totaling $149.1 million for the year ended December 31, 2021, the majority of which were sales under customer commitment programs. The Company enters into contracts with multiple performance obligations where customers purchase a combination of the Company&#8217;s products and services. The Company offers customer incentives through its various customer commitment programs. These customer commitment programs provide customers with a free or discounted instrument or system, upon entering into multi-year agreements to purchase annual minimum amounts of future products or services.  Management determines the transaction price for a contract based on the total consideration expected to be received in exchange for the transferred goods or services. To the extent the transaction price includes variable consideration, such as volume rebates or expected price adjustments, management applies judgment in estimating variable consideration based on the Company&#8217;s historical and projected experience with similar customer contracts. Management monitors customer purchases over the term of the agreement and reviews estimates of variable consideration.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The principal considerations for our determination that performing procedures relating to revenue recognition relating to the customer commitment program is a critical audit matter are the significant judgment by management in estimating the amount of variable consideration included in the transaction price, which in turn led to significant auditor judgment, subjectivity, effort and complexity in assessing audit evidence in performing procedures to evaluate the amount of variable consideration included in the transaction price and significant assumptions related to forecasted product purchases.   </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to the revenue recognition process and customer commitment programs, including controls over the estimation of the amount of variable consideration included in the transaction price. These procedures also included, among others, (i) examining contracts on a test basis, (ii) testing management&#8217;s process for estimating the amount of variable consideration included in the transaction price, (iii) testing the completeness and accuracy of historical sales data and (iv) evaluating the significant assumptions used by management related to the forecasted purchase of products.  Evaluating management&#8217;s assumptions related to forecasted product purchases involved evaluating whether the assumptions used by management were reasonable by comparing the forecasted product purchases to historical sales data.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">/s/ <ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="dei:AuditorName" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTEvZnJhZzo1NzYxNjUxMTUwNTA0ZThiYTUwN2EwYjBkNzVjZDdjZi90ZXh0cmVnaW9uOjU3NjE2NTExNTA1MDRlOGJhNTA3YTBiMGQ3NWNkN2NmXzY1OTcwNjk3ODU3NTY_7064828b-e8d0-4a15-9d85-7edd63a71a74">PricewaterhouseCoopers LLP</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="dei:AuditorLocation" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTEvZnJhZzo1NzYxNjUxMTUwNTA0ZThiYTUwN2EwYjBkNzVjZDdjZi90ZXh0cmVnaW9uOjU3NjE2NTExNTA1MDRlOGJhNTA3YTBiMGQ3NWNkN2NmXzY1OTcwNjk3ODU3NTg_b73ecc07-cc04-4687-bc8e-0f5ecaa93a88">Boston, Massachusetts</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">February 16, 2022</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have served as the Company&#8217;s auditor since 2002. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-3</span></div></div></div><div id="i5d795a6851d746ca914a2ddae761c329_154"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IDEXX LABORATORIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in thousands, except per share amounts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:63.321%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.323%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.324%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzQtMS0xLTEtMA_0ab8889f-0746-4157-a6f5-b98c715f8f3f">144,454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzQtMy0xLTEtMA_59b8c571-c83d-4e12-9390-85e094799548">383,928</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable, net of allowance of $<ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzUtMC0xLTEtMC90ZXh0cmVnaW9uOjMyMjNhMmY0OWJjMjQwNzNhMzVjMTlhYzgwZTIwNjA1XzQ0_17b9dc9c-acd5-4f2d-a4c3-cfc0d7560a32">5,668</ix:nonFraction> in 2021 and $<ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzUtMC0xLTEtMC90ZXh0cmVnaW9uOjMyMjNhMmY0OWJjMjQwNzNhMzVjMTlhYzgwZTIwNjA1XzU5_431b0eb6-dab0-469f-8b3a-9d6860ff7044">6,784</ix:nonFraction> in 2020</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzUtMS0xLTEtMA_6b71d3d7-9978-4a2c-ab7d-7b0932214ae4">368,348</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzUtMy0xLTEtMA_aab449e9-f60a-4d72-9f22-537ab619eb34">331,429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzYtMS0xLTEtMA_bb414073-fe5d-4bc0-b89b-f57ce1965a5a">269,030</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzYtMy0xLTEtMA_ac6db532-5d9d-46fb-a49b-39690a5a8780">209,873</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzctMS0xLTEtMA_d27a2d32-1d99-49a6-a000-c2a9d491feea">173,823</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzctMy0xLTEtMA_9a1f3b39-595f-40d6-8f61-5a290bfba772">137,508</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzgtMS0xLTEtMA_91eaf403-cc3f-4024-83a0-900f530a28cb">955,655</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzgtMy0xLTEtMA_83a0779a-3150-4c2e-bd6b-fc040845273c">1,062,738</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-Term Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzEwLTEtMS0xLTA_5490efd4-f9ca-4458-874b-64ac1271572d">587,667</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzEwLTMtMS0xLTA_380a2b3b-ede0-4ff6-9282-6448f7898243">555,167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzExLTEtMS0xLTA_6947c108-4f70-4be0-b3ab-00866fff8089">105,101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzExLTMtMS0xLTA_6efa60a7-b0b3-4ce6-8bc7-848e9e7eab8b">91,171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzEyLTEtMS0xLTA_ec3c7f8d-d4f4-421d-b063-737569ab6481">359,345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzEyLTMtMS0xLTA_d143c37b-7281-4fea-bcb5-c0ea2e3dd859">243,347</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzEzLTEtMS0xLTA_e3330425-5b1c-4855-bccd-ec71fb1c2af7">99,035</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzEzLTMtMS0xLTA_34cb3589-7e6e-47dc-96bb-9547b535aa30">52,543</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzE0LTEtMS0xLTA_d19924ae-e02c-4ae0-a8c0-1366262aacbc">330,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzE0LTMtMS0xLTA_c4ee1e92-3207-460a-b3ea-c6ec9e69c70b">289,595</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:AssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzE1LTEtMS0xLTA_61e7a4e3-5d92-4c26-8601-4bceb2309622">1,481,548</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:AssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzE1LTMtMS0xLTA_feac8879-26ce-4d7a-8ca5-0a0d079922fa">1,231,823</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">TOTAL ASSETS</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzE2LTEtMS0xLTA_a21d390f-55ed-4b33-b1ba-84d39a8732fd">2,437,203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzE2LTMtMS0xLTA_71467f79-586b-4f14-a158-d16db6a4e763">2,294,561</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzIwLTEtMS0xLTA_6ca45926-1cad-45fd-8198-941e48bfadef">116,140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzIwLTMtMS0xLTA_643f7208-baa5-40cf-a67e-5519cb913f3f">74,558</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzIxLTEtMS0xLTA_1392a55d-02e9-484f-b19a-eba75f24a614">458,909</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzIxLTMtMS0xLTA_a7dff9ef-d398-4f09-8888-59cf6dcc1df2">415,648</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Line of credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:LinesOfCreditCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzIyLTEtMS0xLTA_946d5f47-e365-4d56-8109-61b8c048db9f">73,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:LinesOfCreditCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzIyLTMtMS0xLTA_e4c4c85d-dc86-4d8f-bb1f-0c6f74417d31">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzIzLTEtMS0xLTA_90f3fc4a-f74a-4eeb-8db1-49db3c16126b">74,996</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzIzLTMtMS0xLTA_94c84fb7-96fc-46f4-afba-b66832854d22">49,988</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzI0LTEtMS0xLTA_5cc61e43-f2fe-46a9-997b-11e0a350d50f">40,034</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzI0LTMtMS0xLTA_7b715940-e1d6-4b44-b458-5aec9ee96e54">42,567</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzI1LTEtMS0xLTA_4196313d-0d9d-426b-8704-d67117947b1b">763,579</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzI1LTMtMS0xLTA_97a2bfa4-7dd6-4e07-867e-91fb2a2ce08e">582,761</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-Term Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzI3LTEtMS0xLTA_ab898cd7-8580-434c-b5e3-1c14b6ee8ca3">8,935</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzI3LTMtMS0xLTA_d1844b8e-44ee-4b01-9751-42cc7d22fec3">11,707</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzI4LTEtMS0xLTA_1a23176a-038e-4619-9dd7-a007f8de6e90">775,205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzI4LTMtMS0xLTA_537fba2c-0f6e-474d-b9c4-744bc15fdf72">858,492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term deferred revenue, net of current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzI5LTEtMS0xLTA_aaf1dd6c-fd0b-434d-9b21-fad112c09c58">41,174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzI5LTMtMS0xLTA_290f2700-242e-44c0-baec-9c5a4cbdb3f8">46,163</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzMwLTEtMS0xLTA_eb82ea0d-a786-44ff-83dc-77b6fade8792">87,377</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzMwLTMtMS0xLTA_4f99a029-2f2d-4e0a-83af-beebe5109ee7">77,039</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzMxLTEtMS0xLTA_5238b733-9e15-442d-b4b7-f50021855573">70,941</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzMxLTMtMS0xLTA_62216a61-9ffc-4a56-9012-5bb37dc94d19">85,604</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:LiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzMyLTEtMS0xLTA_7d14d78b-45e0-4024-8584-4b7b65df5e2d">983,632</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:LiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzMyLTMtMS0xLTA_965f4b2a-d071-4b9e-84f8-51643fb23c79">1,079,005</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzMzLTEtMS0xLTA_86933f8a-a046-4636-981b-552851c44964">1,747,211</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzMzLTMtMS0xLTA_f70e270f-d8e2-48e3-b25a-6aec6cf5ea3d">1,661,766</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commitments and Contingencies (Note 16)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzM1LTEtMS0xLTA_0797c32c-a822-431d-a453-c55addc21c9c"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzM1LTMtMS0xLTA_132eac87-2b4b-491f-96f0-a884e14a9575"></ix:nonFraction></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stockholders&#8217; Equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzM4LTAtMS0xLTAvdGV4dHJlZ2lvbjpjMGE2YTI4NmMwOGU0MWFiOTE5MjQyYzRiOTIwZjhmYV8xOA_9f0430ce-186f-44ed-9952-741a20f9f16c"><ix:nonFraction unitRef="usdPerShare" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzM4LTAtMS0xLTAvdGV4dHJlZ2lvbjpjMGE2YTI4NmMwOGU0MWFiOTE5MjQyYzRiOTIwZjhmYV8xOA_f30eafc3-4904-43e9-b0f9-47845a19abfa">0.10</ix:nonFraction></ix:nonFraction> par value: Authorized: <ix:nonFraction unitRef="shares" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzM4LTAtMS0xLTAvdGV4dHJlZ2lvbjpjMGE2YTI4NmMwOGU0MWFiOTE5MjQyYzRiOTIwZjhmYV80NA_0a0fd88a-0cac-4dd0-9089-21ae48ebfc44"><ix:nonFraction unitRef="shares" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzM4LTAtMS0xLTAvdGV4dHJlZ2lvbjpjMGE2YTI4NmMwOGU0MWFiOTE5MjQyYzRiOTIwZjhmYV80NA_b4a15684-fed9-45b8-a802-558439d14dcc">120,000</ix:nonFraction></ix:nonFraction> shares; Issued: <ix:nonFraction unitRef="shares" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzM4LTAtMS0xLTAvdGV4dHJlZ2lvbjpjMGE2YTI4NmMwOGU0MWFiOTE5MjQyYzRiOTIwZjhmYV82Mw_0dc82297-af16-49fd-952a-0ed5cf9deea2">106,878</ix:nonFraction> shares in 2021 and <ix:nonFraction unitRef="shares" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzM4LTAtMS0xLTAvdGV4dHJlZ2lvbjpjMGE2YTI4NmMwOGU0MWFiOTE5MjQyYzRiOTIwZjhmYV84NQ_bd4bc1d4-5d33-4060-867e-91fec41a8428">106,457</ix:nonFraction> shares in 2020; Outstanding: <ix:nonFraction unitRef="shares" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzM4LTAtMS0xLTAvdGV4dHJlZ2lvbjpjMGE2YTI4NmMwOGU0MWFiOTE5MjQyYzRiOTIwZjhmYV8xMTc_dd3d1a0c-5a07-495f-9c6e-ed84663a7f8d">84,562</ix:nonFraction> shares in 2021 and <ix:nonFraction unitRef="shares" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzM4LTAtMS0xLTAvdGV4dHJlZ2lvbjpjMGE2YTI4NmMwOGU0MWFiOTE5MjQyYzRiOTIwZjhmYV8xMzk_f39f6259-dada-4ee8-9fa7-d8c50b195b79">85,449</ix:nonFraction> shares in 2020</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzM4LTEtMS0xLTA_8ef33d2c-394e-456c-b4bc-91d4c287ddd5">10,688</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzM4LTMtMS0xLTA_ec8cffc1-ca10-41e4-adae-caf4f6cbf3c3">10,646</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzM5LTEtMS0xLTA_46ff2846-0555-4552-8bf6-d4bc411c20f7">1,377,320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzM5LTMtMS0xLTA_c34462e1-9340-4806-9fcf-381020b0b184">1,294,849</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred stock units: Outstanding: <ix:nonFraction unitRef="shares" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:CommonStockOtherSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzQwLTAtMS0xLTAvdGV4dHJlZ2lvbjo5ZDRlMmVlNjliODA0ODRlODI5YjQxMjgzNDI4ODUxZF8zOQ_1c1b9930-5053-4226-915a-7ad6d7bae8ea">90</ix:nonFraction> units in 2021 and <ix:nonFraction unitRef="shares" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:CommonStockOtherSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzQwLTAtMS0xLTAvdGV4dHJlZ2lvbjo5ZDRlMmVlNjliODA0ODRlODI5YjQxMjgzNDI4ODUxZF82MA_d2f04924-b8a1-41a7-b735-be1f6b5e5c46">87</ix:nonFraction> units in 2020</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:CommonStockOtherValueOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzQwLTEtMS0xLTA_62fb1057-5157-4f29-913f-ed40f1dc2168">5,719</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:CommonStockOtherValueOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzQwLTMtMS0xLTA_a60fc317-62cf-4d4a-b409-5a2de8509d7b">4,503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzQxLTEtMS0xLTA_2a93bc7f-e300-4947-9fc9-e1c374daf487">2,920,440</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzQxLTMtMS0xLTA_0a1696bf-1054-41bd-8f42-db37e90f6334">2,175,595</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzQyLTEtMS0xLTA_12d73362-d7e8-4d24-b3e8-6cbafb2756b3">53,484</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzQyLTMtMS0xLTA_8b3ba948-2d93-4d30-ab56-3f995941ab34">53,615</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Treasury stock, at cost: <ix:nonFraction unitRef="shares" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzQzLTAtMS0xLTAvdGV4dHJlZ2lvbjpkMTE5NGY3OTE0YmY0NTVmYTc0NGM0ZjYyZTgwMzczMF8yOQ_22567f3f-3889-49e2-99a5-619e1a914241">22,317</ix:nonFraction> shares in 2021 and <ix:nonFraction unitRef="shares" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzQzLTAtMS0xLTAvdGV4dHJlZ2lvbjpkMTE5NGY3OTE0YmY0NTVmYTc0NGM0ZjYyZTgwMzczMF81MQ_2b327e5e-012b-4817-8cda-ccefd64f5333">21,008</ix:nonFraction> shares in 2020</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzQzLTEtMS0xLTA_072159cf-58af-4976-b488-b6ea2099568e">3,570,691</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzQzLTMtMS0xLTA_9561cdfe-c82e-4f51-b244-2cf4a04305a2">2,799,890</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total IDEXX Laboratories, Inc. stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzQ0LTEtMS0xLTA_0e797a78-8358-47c1-9d43-7c0ffca26bf1">689,992</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzQ0LTMtMS0xLTA_5a4e09d0-126d-4f50-873c-28719a49a1eb">632,088</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:MinorityInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzQ1LTEtMS0xLTA_34e9f8f8-ff92-4acb-beb7-f8e3b30d3573">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:MinorityInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzQ1LTMtMS0xLTA_cf2bcf49-fb30-4611-8b32-d7f502e4697e">707</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzQ2LTEtMS0xLTA_aa5ba6f9-4def-4ed9-ae99-c09e4b2cdc0e">689,992</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzQ2LTMtMS0xLTA_e8fe0f51-17fc-4ee8-bda8-fbece1ea7b6e">632,795</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">TOTAL LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzQ3LTEtMS0xLTA_56e91076-5eb6-4cca-9678-539dec0fb9ed">2,437,203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzQ3LTMtMS0xLTA_4dfbd97b-4cd9-440f-91f6-1fde2bb8f75c">2,294,561</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">The accompanying notes are an integral part of these consolidated financial statements.</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-4</span></div></div></div><div id="i5d795a6851d746ca914a2ddae761c329_157"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IDEXX LABORATORIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in thousands, except per share amounts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:58.490%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic726475fb9e14ee5a91a94f1384e1a43_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzQtMi0xLTEtMA_51a269ad-8708-4ae1-bc5a-2f864a7bece1">1,875,308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3e97410fa904f6b9da8bf1da4160760_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzQtNC0xLTEtMA_690a0296-4789-47f5-8f1c-17707870575f">1,586,809</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaff31c4dfc74beebd9e4f2367f76db7_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzQtNi0xLTEtMA_a676fd82-3ad0-4124-ab77-1a7b7fa7f93f">1,423,144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e1d4a27d5524619b8f8d3d7ab6dc3e9_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzUtMi0xLTEtMA_54e198ae-c2a0-4d1a-87ee-7ebcb437bb11">1,340,052</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e9c5621d1e4b70b61639e6582ff3c2_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzUtNC0xLTEtMA_f16264a0-823e-4705-b971-3159f8f5072c">1,119,846</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida0b80c182f342c3996f1a84b8b8fb9c_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzUtNi0xLTEtMA_361bbe5c-bacb-4540-86eb-6ebbfde8af1c">983,764</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzYtMi0xLTEtMA_830c9b53-920a-456e-b479-86179f91216c">3,215,360</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzYtNC0xLTEtMA_61f38393-e584-4908-8691-826f3ec02d7f">2,706,655</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzYtNi0xLTEtMA_f0f0c014-cefb-4ae0-8199-dbc34f7271eb">2,406,908</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of Revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of product revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic726475fb9e14ee5a91a94f1384e1a43_D20210101-20211231" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzgtMi0xLTEtMA_e37016f6-3cac-4c7a-aab1-1c69877a9eb6">656,823</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3e97410fa904f6b9da8bf1da4160760_D20200101-20201231" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzgtNC0xLTEtMA_87273e52-bcf4-47a3-a712-8766c59c10d0">557,795</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaff31c4dfc74beebd9e4f2367f76db7_D20190101-20191231" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzgtNi0xLTEtMA_4eeb5b70-5607-426e-9a14-12603974ae5f">506,202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of service revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e1d4a27d5524619b8f8d3d7ab6dc3e9_D20210101-20211231" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzktMi0xLTEtMA_675e953a-ab67-4276-8043-fdadd0cdc026">669,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e9c5621d1e4b70b61639e6582ff3c2_D20200101-20201231" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzktNC0xLTEtMA_1a464bca-922a-4537-b406-10560b75cbee">577,820</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida0b80c182f342c3996f1a84b8b8fb9c_D20190101-20191231" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzktNi0xLTEtMA_3fa427b6-45d7-465c-ba58-4d0eaa32f12c">535,157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total cost of revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzEwLTItMS0xLTA_dd82f00e-d630-4f2a-9a5c-26ccd6c32236">1,325,928</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzEwLTQtMS0xLTA_b1e330f6-89fc-4a56-850e-b17265ea9b23">1,135,615</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzEwLTYtMS0xLTA_221a0350-5ba1-49dc-b424-2eb99208802f">1,041,359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzExLTItMS0xLTA_d1cc86d3-b04a-4e3e-bcc1-a808ca73e509">1,889,432</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzExLTQtMS0xLTA_3dacfd0d-9e2e-4b13-a483-901c4b955d77">1,571,040</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzExLTYtMS0xLTA_1a8dd90c-89f5-4a4d-b601-735459c658f3">1,365,549</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzEzLTItMS0xLTA_20a2249b-4e0c-4510-ba52-d286be45d671">486,735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzEzLTQtMS0xLTA_0c7cc69d-56fd-407e-9e4e-8e65f70af159">434,435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzEzLTYtMS0xLTA_21f65ea2-aed9-4600-a465-3b07e2ea0883">418,193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzE0LTItMS0xLTA_150aad81-be01-4937-b5a6-9b462d66b9aa">309,660</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzE0LTQtMS0xLTA_57e6b859-bf09-489b-a2bf-460fc01a6551">300,832</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzE0LTYtMS0xLTA_f9d3f698-2075-42e6-a638-5cc5ceccda80">261,317</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzE1LTItMS0xLTA_fab49f0a-d79c-4ebd-ad05-c86405e4a2fe">161,009</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzE1LTQtMS0xLTA_9956d6dc-2872-480c-a24d-ff7c59cbcd3c">141,249</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzE1LTYtMS0xLTA_aa455517-b492-41fc-bc18-9891399ee454">133,193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzE2LTItMS0xLTA_0b0f853a-2ed1-4a23-8170-0c65b0bfdd7a">932,028</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzE2LTQtMS0xLTA_3e33db7e-ba13-490b-b0b9-cbd613d9af8b">694,524</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzE2LTYtMS0xLTA_6bcdc547-d9cf-44a4-977d-5dabaf47cc82">552,846</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzE3LTItMS0xLTA_891ba522-fc16-430b-8e6e-115336a8b389">29,808</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzE3LTQtMS0xLTA_8832ac1e-ece0-4ac7-beeb-1a540e1c5882">33,125</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzE3LTYtMS0xLTA_12679f55-0979-4d49-8f28-3f0dc532a5d3">31,055</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:InterestAndOtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzE4LTItMS0xLTA_bed8f5d2-0126-4cb4-9f0a-dac0dd82f962">434</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:InterestAndOtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzE4LTQtMS0xLTA_df0f8702-5b27-4424-aaed-0c549b94b4a5">586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:InterestAndOtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzE4LTYtMS0xLTA_887d9996-eb9a-4d6d-aa47-45e55e0cfe0a">427</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income before provision for income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzE5LTItMS0xLTA_db1f4b71-4ceb-452f-9b52-6086e07de634">902,654</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzE5LTQtMS0xLTA_74d9086b-e373-4f7a-878a-3f7bb1eebf15">661,985</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzE5LTYtMS0xLTA_43c13105-1381-493e-b484-3f3ce9f427c9">522,218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzIwLTItMS0xLTA_4b024c58-dd52-499d-86c2-3d044873bf6c">157,810</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzIwLTQtMS0xLTA_c4ce0d38-4abb-4fb7-ae42-75a7ec1e9084">79,854</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzIwLTYtMS0xLTA_3da8ffb3-16e1-45cc-a01e-24e26e29429c">94,426</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzIxLTItMS0xLTA_9b82a0f6-e35b-4f0c-aed2-744268feaeba">744,844</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzIxLTQtMS0xLTA_2d51578d-92c0-422d-b3e2-e238a80c2423">582,131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzIxLTYtMS0xLTA_43ac8608-e191-49bc-b647-affe6f7dfd33">427,792</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Net (loss) income attributable to noncontrolling interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzIyLTItMS0xLTA_659c30b3-a477-4bc4-a982-11e5dd1188e7">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzIyLTQtMS0xLTA_e1cc6bd0-be46-4ddd-878c-144dc770c1cc">355</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzIyLTYtMS0xLTA_7cbe7e35-9daa-4c25-9154-baf0adc82fb4">72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to IDEXX Laboratories, Inc. stockholders</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzIzLTItMS0xLTA_a25ad020-062b-4d76-bb88-085b587eb3aa">744,845</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzIzLTQtMS0xLTA_77022c00-dbd9-402d-b475-7938770eab02">581,776</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzIzLTYtMS0xLTA_93816e3c-0831-432c-bbdf-e9f509e5be30">427,720</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Earnings per Share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzI2LTItMS0xLTA_b8a65a7a-acb0-469f-a982-746fa723fd39">8.74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzI2LTQtMS0xLTA_145e807b-a4bf-4177-8520-7d111fb704be">6.82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzI2LTYtMS0xLTA_6599b26d-78de-4ea5-b609-d74bf2262d28">4.97</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzI3LTItMS0xLTA_97359304-d4cd-424d-b98f-3bf60387aa28">8.60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzI3LTQtMS0xLTA_60cb88cc-602f-421c-848d-f373faeeddd7">6.71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzI3LTYtMS0xLTA_d9cd5f85-b98f-467a-8704-135cdab5a036">4.89</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted Average Shares Outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzI5LTItMS0xLTA_dec4462e-e9c7-4c2d-b86a-c4d82fd902a7">85,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzI5LTQtMS0xLTA_b4307fb8-1593-4c8c-a59b-ff6b024aa491">85,342</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzI5LTYtMS0xLTA_6c2bb234-bd1e-4204-a9e6-10f730ea2eaf">86,115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzMwLTItMS0xLTA_7d32e950-2e03-4c99-8724-7b9d2d28ee79">86,572</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzMwLTQtMS0xLTA_78342e3c-3e59-44ad-95af-3251c4656f5d">86,722</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzMwLTYtMS0xLTA_c7b30374-fb8d-4ebe-8902-bc14be43b33e">87,542</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">The accompanying notes are an integral part of these consolidated financial statements.</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-5</span></div></div></div><div id="i5d795a6851d746ca914a2ddae761c329_160"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IDEXX LABORATORIES, INC. AND SUBSIDIARIES</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COMPREHENSIVE INCOME</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:51.246%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.149%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.004%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzMtMi0xLTEtMA_ecaecda6-0f59-4a04-978c-de52bfd438e1">744,844</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzMtNC0xLTEtMA_f22bbd8a-519a-411f-9f99-a8121eb3e508">582,131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzMtNi0xLTEtMA_da79eddc-6525-4111-bc5b-ca460903dc14">427,792</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzUtMi0xLTEtMA_798bfb26-cfb3-430d-bcf2-1d97929af7d7">26,731</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzUtNC0xLTEtMA_0851cf7a-60cd-45f1-8e19-bb44ed6dedda">15,151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzUtNi0xLTEtMA_fd80ae1b-255c-45a6-9676-502b4b1672c2">1,590</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized gain (loss) on Euro-denominated notes, net of tax expense (benefit) of $<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="idxx:OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzYtMC0xLTEtMC90ZXh0cmVnaW9uOjFhY2ExNTYzZmExZTRmY2Q5NGRhZGI3MjA5MDBkZjg2Xzg2_cc1c3633-fea4-4eaf-b7f4-b7e1d8ce80a7">2,011</ix:nonFraction> in 2021, $(<ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" sign="-" name="idxx:OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzYtMC0xLTEtMC90ZXh0cmVnaW9uOjFhY2ExNTYzZmExZTRmY2Q5NGRhZGI3MjA5MDBkZjg2Xzk2_912bddd8-8f70-4225-9c44-38eb1b990877">2,325</ix:nonFraction>) in 2020 and $<ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="idxx:OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzYtMC0xLTEtMC90ZXh0cmVnaW9uOjFhY2ExNTYzZmExZTRmY2Q5NGRhZGI3MjA5MDBkZjg2XzEwOQ_a2e351a7-aac7-4038-9d35-d60c9ef5e70f">564</ix:nonFraction> in 2019</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="idxx:OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzYtMi0xLTEtMA_f3e7aa16-4031-405d-9942-ca28585252f3">6,404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" sign="-" name="idxx:OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzYtNC0xLTEtMA_d80cdb2e-1541-47f3-a5c9-09c448454903">7,378</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="idxx:OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzYtNi0xLTEtMA_40f95300-e7c8-422b-a3d8-528b518700c4">1,790</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized gain (loss) on investments, net of tax expense (benefit) of $<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzctMC0xLTEtMC90ZXh0cmVnaW9uOjlhMmY3MThjZjJmYzRjMDViM2NlZGMzYTZjMTA4ZGE4Xzc1_4211f045-051a-411d-9928-b5a88e9af2b7">46</ix:nonFraction> in 2021, $(<ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzctMC0xLTEtMC90ZXh0cmVnaW9uOjlhMmY3MThjZjJmYzRjMDViM2NlZGMzYTZjMTA4ZGE4Xzg1_ce1f7031-875e-42a6-b3e9-c97733a4cd7b">120</ix:nonFraction>) in 2020 and $<ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzctMC0xLTEtMC90ZXh0cmVnaW9uOjlhMmY3MThjZjJmYzRjMDViM2NlZGMzYTZjMTA4ZGE4Xzk4_a4251b36-0a8a-4377-89a1-a1d835ea2b3f">84</ix:nonFraction> in 2019</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzctMi0xLTEtMA_b0444eca-0e2b-46b6-a88b-3b4a6ac922c9">146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzctNC0xLTEtMA_2a7f0920-7e15-43df-bbe7-91e891fd8d7c">382</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzctNi0xLTEtMA_a236d5cf-649a-49f5-968a-a8f37682036e">267</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized gain (loss) on derivative instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized gain (loss) on foreign currency exchange contracts, net of tax expense (benefit) of $<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzktMC0xLTEtMC90ZXh0cmVnaW9uOmY0MGM2OTM5ODliZDQ4M2E4ZGYxNjBiN2I2ODZlZDQ4Xzk5_3fc43863-4b7d-4d51-ac39-90da9dbcc537">2,133</ix:nonFraction> in 2021, $(<ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzktMC0xLTEtMC90ZXh0cmVnaW9uOmY0MGM2OTM5ODliZDQ4M2E4ZGYxNjBiN2I2ODZlZDQ4XzEwOQ_bff33f10-a3b9-42ab-9fb5-79b691a178c6">2,013</ix:nonFraction>) in 2020 and $<ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzktMC0xLTEtMC90ZXh0cmVnaW9uOmY0MGM2OTM5ODliZDQ4M2E4ZGYxNjBiN2I2ODZlZDQ4XzEyMg_6d1d77d2-4538-49b1-8aa7-56ad4b194572">362</ix:nonFraction> in 2019</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzktMi0xLTEtMA_fdf20d6a-d371-46cd-b1f1-00d5dd8f3427">9,139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzktNC0xLTEtMA_b22c9d9d-7712-44a1-9e94-5dc58c5da168">8,527</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzktNi0xLTEtMA_bb07c84a-d14b-4c26-ab04-4e8cc198f774">1,196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized gain (loss) on cross currency swaps, net of tax expense of $<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="idxx:OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzEwLTAtMS0xLTAvdGV4dHJlZ2lvbjo4OGQ4NTQxN2FjNzY0ODhjODdhODA3ZjJhMDBlYTE5NF83NA_92e90e31-8d07-4043-95d7-70f040f264e8">1,699</ix:nonFraction> in 2021, $(<ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" sign="-" name="idxx:OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzEwLTAtMS0xLTAvdGV4dHJlZ2lvbjo4OGQ4NTQxN2FjNzY0ODhjODdhODA3ZjJhMDBlYTE5NF84NA_32a804fb-2694-41d9-a2a1-7d6e1e0b994d">1,774</ix:nonFraction>) in 2020 and $<ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="idxx:OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzEwLTAtMS0xLTAvdGV4dHJlZ2lvbjo4OGQ4NTQxN2FjNzY0ODhjODdhODA3ZjJhMDBlYTE5NF85Nw_1dba11a0-deca-4539-a8ad-73b894812636">664</ix:nonFraction> in 2019</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="idxx:OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzEwLTItMS0xLTA_0aa49bc8-f768-4a15-9c0d-f065d1c02ce6">5,399</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" sign="-" name="idxx:OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzEwLTQtMS0xLTA_4d4134d7-1330-41e3-91cc-18f44ae7aace">5,626</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="idxx:OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzEwLTYtMS0xLTA_0b3af18e-dbf8-482f-aef0-ab698b532ee8">2,107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reclassification adjustment for (gain) loss included in net income, net of tax (expense) benefit of $<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzExLTAtMS0xLTAvdGV4dHJlZ2lvbjo0MmVhZDQ3NGRkZjA0Zjg5YjgxZWZjMTc3ZmI5M2QxNl8xMTM_57792ab0-3227-4769-a0b6-2377903ca3dd">1,347</ix:nonFraction> in 2021, $(<ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzExLTAtMS0xLTAvdGV4dHJlZ2lvbjo0MmVhZDQ3NGRkZjA0Zjg5YjgxZWZjMTc3ZmI5M2QxNl8xMjM_94cbc67a-e998-4557-bc13-df263f4169d5">158</ix:nonFraction>) in 2020 and $(<ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzExLTAtMS0xLTAvdGV4dHJlZ2lvbjo0MmVhZDQ3NGRkZjA0Zjg5YjgxZWZjMTc3ZmI5M2QxNl8xMzY_2df48049-06df-43a8-84f8-e3d466351378">2,467</ix:nonFraction>) in 2019</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzExLTItMS0xLTA_6c2dec65-db44-481a-b4a4-db430cd4db6d">5,774</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzExLTQtMS0xLTA_a2141a38-5a99-4045-96e9-f44b4c68e353">671</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzExLTYtMS0xLTA_e68336fc-fec6-4fd5-8fb6-144fc035c8cf">8,161</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized gain (loss) on derivative instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="idxx:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossAfterReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzEyLTItMS0xLTA_c801422f-5c1e-483d-a6e0-c36091d38cc9">20,312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" sign="-" name="idxx:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossAfterReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzEyLTQtMS0xLTA_770a1d3d-543c-426f-a78f-6fd3e6662aa5">14,824</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" sign="-" name="idxx:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossAfterReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzEyLTYtMS0xLTA_40508bd5-1157-4d69-bdb1-28845387d864">4,858</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive gain (loss), net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzEzLTItMS0xLTA_567aec53-fc03-4de9-91f0-c6e5e7456b49">131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzEzLTQtMS0xLTA_2bbc11d1-9132-410c-9279-197a575525e1">7,433</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzEzLTYtMS0xLTA_f7569ad7-04b3-4cd9-aa46-89df51c7e0ba">4,391</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzE0LTItMS0xLTA_d5501668-69a5-4e61-91ac-ef23fad52b95">744,975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzE0LTQtMS0xLTA_8345c9d4-7ed2-459a-a7bf-4453ff3b649c">574,698</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzE0LTYtMS0xLTA_f570eee6-c9d2-43db-82c5-d382df144317">423,401</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: comprehensive income attributable to noncontrolling interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzE1LTItMS0xLTA_5b0bc255-5011-41a8-81fd-c2cd1c406d7f">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzE1LTQtMS0xLTA_14141bea-302a-4d96-aac4-8bfeedf5017e">355</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzE1LTYtMS0xLTA_2cadb6d4-df7a-4fec-b3e1-fc05065c14c0">72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive income attributable to IDEXX Laboratories, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzE2LTItMS0xLTA_8a1f2eb3-599b-4d38-8618-e3f6bac9d7ee">744,976</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzE2LTQtMS0xLTA_722d4784-2378-42cd-87a0-71c715970c03">574,343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzE2LTYtMS0xLTA_ba18acd6-dbce-49ae-b23f-69f330e9236f">423,329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">The accompanying notes are an integral part of these consolidated financial statements.</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-6</span></div></div></div><div id="i5d795a6851d746ca914a2ddae761c329_163"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IDEXX LABORATORIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(DEFICIT)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands, except per share amounts)</span></div><div style="text-indent:36pt"><span style="font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%"></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:18.510%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.436%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.436%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.993%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.331%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.244%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.165%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.227%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Number of Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i0c634b937c58472e84857eacf99e17df_I20191231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzEtMy0xLTEtMC90ZXh0cmVnaW9uOmE1YzgwNmEzODhkYTQxMDM5OWQxMzMwNjk0NWVmOGY2XzQ_27fa8067-4248-4613-8c86-d7a95995b465"><ix:nonFraction unitRef="usdPerShare" contextRef="i28d0821cac8841b29cf960002d3bc993_I20181231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzEtMy0xLTEtMC90ZXh0cmVnaW9uOmE1YzgwNmEzODhkYTQxMDM5OWQxMzMwNjk0NWVmOGY2XzQ_2e9f3f3b-51bd-4bf0-b4fd-e521d3b0bc3c"><ix:nonFraction unitRef="usdPerShare" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzEtMy0xLTEtMC90ZXh0cmVnaW9uOmE1YzgwNmEzODhkYTQxMDM5OWQxMzMwNjk0NWVmOGY2XzQ_4af2980a-5972-4335-9289-593eb41ac66a"><ix:nonFraction unitRef="usdPerShare" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzEtMy0xLTEtMC90ZXh0cmVnaW9uOmE1YzgwNmEzODhkYTQxMDM5OWQxMzMwNjk0NWVmOGY2XzQ_62fcfd21-2da4-4f5a-8a07-5045993adb13">0.10</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> Par Value</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Deferred Stock Units</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Noncontrolling Interest</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total Stockholders&#8217; Equity (Deficit)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Balance December 31, 2018</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifc55888d777a4d23bc9cfb38c781c1b0_I20181231" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzItMS0xLTEtMA_4b9ef2aa-0b1a-4d57-a516-2539507099f1">105,087</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc55888d777a4d23bc9cfb38c781c1b0_I20181231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzItMy0xLTEtMA_ecfe4a9c-732e-4df6-9d52-9e2021075aa2">10,509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5198e31e82c4830868ddd894d8bea8e_I20181231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzItNS0xLTEtMA_19521d79-fe09-4eb7-8384-3acd68ed5b5d">1,138,216</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47457672ea94468ab1c5cd3068086847_I20181231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzItNy0xLTEtMA_f84779da-fa48-4e6c-8a51-a54887ec2ae1">4,524</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia510c04f9d61478ea746fbff0dd20e7a_I20181231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzItOS0xLTEtMA_abf4fa53-381e-4fc4-bab9-ff1e7333d7bd">1,167,928</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0030920649fc4bfeaec05aad85e23ea9_I20181231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzItMTEtMS0xLTA_b4d00d0a-523b-4f27-a7db-62fd323ca7a6">41,791</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca52acda88f4806b415035b2e87a637_I20181231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzItMTMtMS0xLTA_e2ab3fca-21df-48b9-90e0-0fc7e47cd114">2,288,899</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4eba3ab172724f5cb99036c1a25946f4_I20181231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzItMTUtMS0xLTA_c0627aa8-7bf3-4ece-a635-e0262d21b68f">280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i28d0821cac8841b29cf960002d3bc993_I20181231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzItMTctMS0xLTA_056136ca-416a-4612-b8d8-9b06afa593b9">9,233</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3eebac5bf6864fc4a7c5f697b102c9f9_D20190101-20191231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzQtOS0xLTEtMA_b4dba41b-a123-43c9-97c7-fc5c320aa875">427,720</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie44c061415214719bc569b35577d8629_D20190101-20191231" decimals="-3" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzQtMTUtMS0xLTA_9d228ae9-3ea7-40bb-9380-49a3f0cb58d6">72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzQtMTctMS0xLTA_55fa0ad8-cbc4-452b-9090-de9f0c645b08">427,792</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other comprehensive loss, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52c9d97bec804143a591d49a316a5d59_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzUtMTEtMS0xLTA_2ba28d54-b8c8-4afd-ac31-22b2f3d7228e">4,391</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzUtMTctMS0xLTA_d2e2d144-f17c-46a7-8586-4be255b78ec4">4,391</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Repurchases of common stock, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ddfcdc960064849802514d1f2a8bbfb_D20190101-20191231" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzYtMTMtMS0xLTA_4386aeea-8bfe-4406-8fa9-e8ddb60b0de5">311,644</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzYtMTctMS0xLTA_a0eda618-33e1-426f-9cf8-3cce5b395f0e">311,644</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Common stock issued under stock plans, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i459299d77adf46b2baa2eefe5c566758_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzctMS0xLTEtMA_45ed194e-cfd5-4a7a-8d79-c3f1ac233f5b">624</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i459299d77adf46b2baa2eefe5c566758_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzctMy0xLTEtMA_14036ae2-36fb-47c0-a77f-a31d5f12013b">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1564d43c43d4ed28f279068c2cec341_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzctNS0xLTEtMA_22e734b9-31a1-454b-b3dc-30ea8516d5e2">36,551</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3ee522263ee4c1ab1a5860feaa32d9b_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzctNy0xLTEtMA_d97781c4-990d-46b3-8176-10e731dd4846">590</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzctMTctMS0xLTA_6b095257-0e61-480d-bd3c-d74df96b6b63">36,023</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Deferred stock units activity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1564d43c43d4ed28f279068c2cec341_D20190101-20191231" decimals="-3" sign="-" name="idxx:IssuanceVestingAndSettlementOfDeferredStockUnits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzgtNS0xLTEtMA_19432e37-f4b3-4e58-9b97-cc9751eb5134">324</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3ee522263ee4c1ab1a5860feaa32d9b_D20190101-20191231" decimals="-3" name="idxx:IssuanceVestingAndSettlementOfDeferredStockUnits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzgtNy0xLTEtMA_faf1e2ef-c0d3-4b13-adbf-f7dce407b68d">324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="idxx:IssuanceVestingAndSettlementOfDeferredStockUnits" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzgtMTctMS0xLTA_b11baa09-b082-40d9-83a6-772fb5e54b54">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Share-based compensation cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1564d43c43d4ed28f279068c2cec341_D20190101-20191231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzktNS0xLTEtMA_ccde1724-73e5-445e-a1f0-3942afd2e0e0">39,074</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3ee522263ee4c1ab1a5860feaa32d9b_D20190101-20191231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzktNy0xLTEtMA_c9135eef-907f-4344-8285-d9f3be60da74">204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzktMTctMS0xLTA_acd8a7cc-a10d-4e8a-8524-127f0d76613b">39,278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Balance December 31, 2019</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifb04d957babc4708830136f812aa04c6_I20191231" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzEwLTEtMS0xLTA_c9ba0775-f67d-42ef-a1b2-a328e16ed566">105,711</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb04d957babc4708830136f812aa04c6_I20191231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzEwLTMtMS0xLTA_d7a32438-b482-4471-b459-ede647ac4fb9">10,571</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia754ac48509b4751bfa3915a39627bc6_I20191231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzEwLTUtMS0xLTA_8900e67c-94c7-4bd6-8869-52a989349a5f">1,213,517</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i979a783478524796bf27df092c164acb_I20191231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzEwLTctMS0xLTA_09822db4-24a4-45fc-8bc6-bd961e7217cf">4,462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0d07a5bb51144978faf2ec5745936dc_I20191231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzEwLTktMS0xLTA_9ed9afe8-c169-46de-ad64-d909b2428c20">1,595,648</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf017de1fe8245b490bf3ba36d73909c_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzEwLTExLTEtMS0w_24fd2fef-9dcc-4888-aaaf-2b2499c7e463">46,182</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8fa2c23303164297bbef06a53a57f47d_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzEwLTEzLTEtMS0w_ad0f8ef3-7802-4490-a2a0-dc20faf241fe">2,600,543</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i070ac0c233c64a6b8c2c8c44a84a6b9c_I20191231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzEwLTE1LTEtMS0w_ae833369-9ddc-4b00-b3d3-adf5fd517f0e">352</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c634b937c58472e84857eacf99e17df_I20191231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzEwLTE3LTEtMS0w_b14d33da-2cf1-4a19-9e08-6a2227d20899">177,825</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Cumulative effect of accounting changes (Note 2)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40d60db7ecae431bbb3cc52673c3f08c_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzExLTktMS0xLTI4ODY5_80053aed-f3ef-4cc7-8102-641923a39179">1,829</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9dcdb5ab830946f987d2c255bb59ed41_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzExLTE3LTEtMS0yODg1OA_ccaeb2e3-fb84-421e-a83e-b1de962526e6">1,829</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843cb27f38cc4792b41236eefc1a5b9a_D20200101-20201231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzExLTktMS0xLTA_b7677535-433f-4e8f-82ee-34eacc5d20cf">581,776</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c49c956c8bd476fbc5a218bb26fc1e7_D20200101-20201231" decimals="-3" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzExLTE1LTEtMS0w_3437b91d-4efc-4cd2-995d-4dfeec5209bd">355</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzExLTE3LTEtMS0w_6593bc2d-aca5-4c50-b911-08a0226ef64f">582,131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other comprehensive loss, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifefe9c40d7f444cfaa6687822f8d9fe2_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzEyLTExLTEtMS0w_7b78cf0c-ce99-4060-a1b6-16fc71f56618">7,433</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzEyLTE3LTEtMS0w_a74711b1-8fa5-42b5-b97f-a286f22ea75a">7,433</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Repurchases of common stock, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6390dc8d6016472b99f4f5e8bcd76bd7_D20200101-20201231" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzEzLTEzLTEtMS0w_601fa4ff-c4ca-4a46-aabe-9aa2e63231a6">199,347</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzEzLTE3LTEtMS0w_17125669-4830-469f-9751-e8dc3f0d2da5">199,347</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Common stock issued under stock plans, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1405c98ed2d04737be98553084c09616_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzE0LTEtMS0xLTA_7a3ca31f-cc34-4411-84ad-68f12f7cfd0b">746</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1405c98ed2d04737be98553084c09616_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzE0LTMtMS0xLTA_7567c8e5-cb55-4be1-a020-74c93a30cd25">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7353d8a3c0814b3387f39a6d5c074615_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzE0LTUtMS0xLTA_3636a6ab-0041-434e-b62f-4516ab8e86e4">51,368</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb488124070d493c8bc4c944a20bf01a_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzE0LTctMS0xLTA_bad92b73-327c-4197-9542-32275d3f097b">946</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzE0LTE3LTEtMS0w_45430939-8b6e-41d1-a800-d39ea634c8cb">50,497</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Deferred stock units activity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7353d8a3c0814b3387f39a6d5c074615_D20200101-20201231" decimals="-3" sign="-" name="idxx:IssuanceVestingAndSettlementOfDeferredStockUnits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzE1LTUtMS0xLTA_551686d6-0e82-4560-a4bf-ba91270f62ec">894</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb488124070d493c8bc4c944a20bf01a_D20200101-20201231" decimals="-3" name="idxx:IssuanceVestingAndSettlementOfDeferredStockUnits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzE1LTctMS0xLTA_6e55b56b-1808-41eb-aa26-b70978ca8c37">894</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="idxx:IssuanceVestingAndSettlementOfDeferredStockUnits" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzE1LTE3LTEtMS0w_d4219928-c36b-45ff-b097-ee5e0a6260ae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Share-based compensation cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7353d8a3c0814b3387f39a6d5c074615_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzE2LTUtMS0xLTA_e59daf5c-9e38-4092-ab35-aaa3b7b807c1">30,858</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb488124070d493c8bc4c944a20bf01a_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzE2LTctMS0xLTA_b5ad080d-1501-4a89-b2bd-8af6500d4597">93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzE2LTE3LTEtMS0w_9afa0454-87c7-457a-a4fa-f6b6506b6b7d">30,951</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Balance December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib43cc74de7f9447797f368526c52d81a_I20201231" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzE3LTEtMS0xLTA_42ab4769-c701-4af2-9035-87ce1296e1bc">106,457</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib43cc74de7f9447797f368526c52d81a_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzE3LTMtMS0xLTA_a0735728-8a26-4154-af3c-147c6f3c82b3">10,646</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacf2e4f12bb748b29e58438c9e86121d_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzE3LTUtMS0xLTA_a9c4ab08-ba1b-4b4b-b48d-80040f5bebf5">1,294,849</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie21fa7b167864efaa91ab594caaa329f_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzE3LTctMS0xLTA_f4af18fc-4477-41b5-af1b-c9910b7fa43b">4,503</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e204f1ef8454b7688e083aa906679b1_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzE3LTktMS0xLTA_57b19dd5-b7ea-4e89-aabe-a5897cf5b01a">2,175,595</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i57792c148d4b4ba5b2eb677b657b7a2b_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzE3LTExLTEtMS0w_963d4442-309f-4019-b73a-6c35bcbf4dc9">53,615</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iffadbee2ebda4dbd995c7ad9756f26ae_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzE3LTEzLTEtMS0w_02fb8be7-02a3-464f-b80e-d8677a3ae28b">2,799,890</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i592d601cd0814365b50dc596de883440_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzE3LTE1LTEtMS0w_9e31d667-6377-429f-b4d7-82617a2a0947">707</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzE3LTE3LTEtMS0w_1212ce8f-c6ff-4217-8292-a967c2176550">632,795</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5494ccc733ab4588a07cf0c681f7fc5b_D20210101-20211231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzE5LTktMS0xLTA_23e43693-a5cc-4df3-9059-88f99648038c">744,845</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i429f0a9281954c8991dd7a289fa848cf_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzE5LTE1LTEtMS0w_f5f7a651-bfc3-4b55-8cdd-5e1965b17578">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzE5LTE3LTEtMS0w_74840288-293b-4e05-9482-1f3635942d84">744,844</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other comprehensive gain, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62a7d75347e640f1a8e7e3577bb0a247_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzIwLTExLTEtMS0w_59f40b9f-2d27-472e-9bcf-2c15470528a2">131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzIwLTE3LTEtMS0w_8da826e7-080e-4ee0-95e2-800de322f01f">131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Acquisition of noncontrolling interest (Note 4)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17c7e782291f468da00d43bcb50b822f_D20210101-20211231" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzIwLTUtMS0xLTMxNTYz_d275cc01-4223-4bd0-945a-c7d65a44790a">284</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i429f0a9281954c8991dd7a289fa848cf_D20210101-20211231" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzIwLTE1LTEtMS0zMTU2Mw_a71eabe4-3139-4f23-9355-69469b02d1ee">706</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzIwLTE3LTEtMS0zMTU2Mw_ad4c1ddb-424d-4c40-a1ac-ed86de804594">990</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Repurchases of common stock, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80d844cab93d4373b5a710038b7a3f8a_D20210101-20211231" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzIxLTEzLTEtMS0w_d670f73b-ce39-4f61-ab08-2ee029d7f425">770,801</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzIxLTE3LTEtMS0w_f3149966-01aa-4f36-b579-d8782f49c41e">770,801</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Common stock issued under stock plans, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if4e99dbc526e4e2185b83986a19641e6_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzIyLTEtMS0xLTA_89e2c711-1c7f-4c72-be97-d0696ae63b50">421</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4e99dbc526e4e2185b83986a19641e6_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzIyLTMtMS0xLTA_7598a588-d343-43ec-aaa8-85f63d3e1791">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17c7e782291f468da00d43bcb50b822f_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzIyLTUtMS0xLTA_3baac1cd-e2e0-4391-bae6-a10f2921521a">46,228</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifdf9b694355c4799a0d984c56a7af188_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzIyLTctMS0xLTA_15aa6c5b-a9dc-4c11-9f0e-de86ec1b4d1e">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80d844cab93d4373b5a710038b7a3f8a_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzIyLTEzLTEtMS0w_0e99af05-d86f-4c19-b5fd-fe6ab28ac8b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzIyLTE3LTEtMS0w_2b018eaf-1f11-43f9-ba6a-a882f224cdd2">46,258</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Deferred stock units activity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17c7e782291f468da00d43bcb50b822f_D20210101-20211231" decimals="-3" sign="-" name="idxx:IssuanceVestingAndSettlementOfDeferredStockUnits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzIzLTUtMS0xLTA_de4ee581-ab02-44fb-b9da-896285ee38d6">1,035</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdf9b694355c4799a0d984c56a7af188_D20210101-20211231" decimals="-3" name="idxx:IssuanceVestingAndSettlementOfDeferredStockUnits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzIzLTctMS0xLTA_ffcc72ac-c8f4-4229-80c8-e703ea750bb1">1,035</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="idxx:IssuanceVestingAndSettlementOfDeferredStockUnits" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzIzLTE3LTEtMS0w_a5f37628-e3a0-4da5-b83e-24251a93de35">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Share-based compensation cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17c7e782291f468da00d43bcb50b822f_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzI0LTUtMS0xLTA_cc25cc18-f460-4c03-b236-90345c41c701">37,562</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdf9b694355c4799a0d984c56a7af188_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzI0LTctMS0xLTA_70615075-9122-43a7-9174-df7da04cbf73">193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzI0LTE3LTEtMS0w_92296602-fc32-42d6-904c-db9822269653">37,755</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Balance December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8486d76f7282415c96b78263d0e53fed_I20211231" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzI1LTEtMS0xLTA_37cbb891-d853-4a85-97a2-69d598036f3c">106,878</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8486d76f7282415c96b78263d0e53fed_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzI1LTMtMS0xLTA_404ffebe-c402-4d38-a3c3-6e90a54ab8e8">10,688</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e8850835e644b0a942d37199d2fac2_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzI1LTUtMS0xLTA_5730f417-37b3-4eba-84f3-1c59471e041a">1,377,320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9152bd3467a54594bc1a3df15df505af_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzI1LTctMS0xLTA_36d9b52e-b44d-42f5-9a2c-66d03a18719a">5,719</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22db15f5a3f64f13a2a4241901d35b3e_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzI1LTktMS0xLTA_f99741c5-def1-4035-8b88-07e94329e3e7">2,920,440</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia4ce9f46b7a347608b97422112175f6f_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzI1LTExLTEtMS0w_f3c99153-6598-47d1-9965-738bee66bc8a">53,484</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8be03ed376d64697b29c2563ea25de6d_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzI1LTEzLTEtMS0w_e57eacf4-4f9c-473b-a732-51fc56d4c172">3,570,691</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i727ded70819a4775adf0f51b27e35673_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzI1LTE1LTEtMS0w_a9115ab3-2a1e-4be4-bb9d-a7bf6bfb3c3c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzI1LTE3LTEtMS0w_a363c6ff-d340-42a0-9ec3-f8a6788d14f8">689,992</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="54" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:100%">The accompanying notes are an integral part of these consolidated financial statements.</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-7</span></div></div></div><div id="i5d795a6851d746ca914a2ddae761c329_166"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IDEXX LABORATORIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span></div><div style="text-indent:72pt"><span style="font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%"></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:58.490%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash Flows from Operating Activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzQtMi0xLTEtMA_0efccce3-5c43-4891-a3a0-2b1944c10dcc">744,844</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzQtNC0xLTEtMA_ffc2f92f-6fa2-4c3f-a20f-3919947f43fc">582,131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzQtNi0xLTEtMA_3b000992-dd1b-42a3-a99c-c67a188cc7a9">427,792</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzYtMi0xLTEtMA_f1464019-0f4c-4fa6-b6e9-3e4052d8927d">104,596</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzYtNC0xLTEtMA_e3abde26-ce3e-470d-bb5c-b5da65456761">95,998</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzYtNi0xLTEtMA_44fca121-a341-45bb-aa85-9be5cc9edaa5">88,011</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment charge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzctMi0xLTEtMA_da1e7504-c44e-461a-b965-787ae80d96fe">5,148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzctNC0xLTEtMA_0ccbcf1c-6710-4ef2-a414-57aff504f5c2">2,501</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:AssetImpairmentCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzctNi0xLTEtMA_aa83c43b-e800-48e7-aca1-416947831549">968</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for uncollectible accounts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:ProvisionForLoanLeaseAndOtherLosses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzgtMi0xLTEtMA_92a346c5-f42c-477d-bdaf-455290c87006">1,484</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:ProvisionForLoanLeaseAndOtherLosses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzgtNC0xLTEtMA_79c19930-d967-4002-853f-745cdb899758">4,946</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:ProvisionForLoanLeaseAndOtherLosses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzgtNi0xLTEtMA_52028e1b-16ff-46db-9388-23920108395e">662</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzktMi0xLTEtMA_ac90128f-ef53-4e80-918d-223804944e75">3,377</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzktNC0xLTEtMA_3ad2bc36-6b92-44f0-90a7-1f6d892f88b7">38,082</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzktNi0xLTEtMA_304cc79a-3d77-4400-bab7-00073b9bc4e4">6,162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzEwLTItMS0xLTA_ee20a3f6-e359-4956-88d1-062c8419f2bd">37,755</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzEwLTQtMS0xLTA_a39d18d0-d53a-45f3-9da2-487b366e4f72">30,951</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzEwLTYtMS0xLTA_574d90c1-bd2c-4251-baaf-03d4684dcae6">39,278</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzExLTItMS0xLTA_de82355c-6ac1-4b92-b4cf-5001c1232f3e">2,619</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzExLTQtMS0xLTA_7fddb226-0fb9-4507-985e-c5a84fd60a26">1,379</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzExLTYtMS0xLTA_e9800855-6942-4e7a-a31e-36db237c2632">1,254</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzEzLTItMS0xLTA_15ae1033-5486-4244-ac62-121cf826dca3">33,141</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzEzLTQtMS0xLTA_944b5e96-0f55-46ed-a83f-54bf0ead6fe0">60,722</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzEzLTYtMS0xLTA_c302eb70-698f-4dbe-8cda-d549ac490fc5">22,472</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzE0LTItMS0xLTA_2de93bca-430c-4a1f-b5ca-d8c494727d9f">52,919</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzE0LTQtMS0xLTA_c25ead62-6c96-49fe-87f9-a902ce14de13">18,885</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzE0LTYtMS0xLTA_5bb594f5-5134-484d-b693-98cf9983e092">37,306</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzE1LTItMS0xLTA_2c607698-e94d-4eb7-882c-75f8756a0fe2">11,233</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzE1LTQtMS0xLTA_b06d9d8d-f8b1-42e2-ad50-70e4516fa83e">981</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzE1LTYtMS0xLTA_be864fcc-614f-4293-9c0b-ea8d5bb2c286">1,957</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzE2LTItMS0xLTA_323a4d2f-45ad-4d1c-b7b9-d26896d4e08f">7,551</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzE2LTQtMS0xLTA_df1c5f60-7f74-4fe2-bc72-232ad41363b9">13,373</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzE2LTYtMS0xLTA_e139ead5-57f9-4a6c-b63a-bf1b6660c156">12,360</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets and liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzE3LTItMS0xLTA_01c6fb52-baeb-4e9e-b532-575d40866756">55,145</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzE3LTQtMS0xLTA_5897be2e-5ff4-4944-8e2b-1bd29ecd8e53">60,238</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzE3LTYtMS0xLTA_461f4ee8-c738-4a90-9ad9-0ff36ac12556">34,788</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzE4LTItMS0xLTA_c13fe369-ef48-4601-8054-ab533fa5b3ad">755,546</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzE4LTQtMS0xLTA_6f9e8f2f-5a1e-4283-823a-a8e389d93df5">648,063</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzE4LTYtMS0xLTA_d9cee97c-1696-4a17-9c50-e0546a384b76">459,158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash Flows from Investing Activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzIwLTItMS0xLTA_9db66aaf-1450-4234-9534-98b71cc487c2">119,549</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzIwLTQtMS0xLTA_4dbe35c9-43d3-40a8-ae2f-394c1945c48e">106,958</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzIwLTYtMS0xLTA_0ef4011a-bce6-4640-a7e6-8d6481c0c6bc">154,969</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions of intangible assets and equity investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="idxx:PaymentsToAcquireIntangibleAssetsAndEquityMethodInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzIzLTItMS0xLTA_63a1ff8c-b2a9-4d66-8c93-2cab654851bb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="idxx:PaymentsToAcquireIntangibleAssetsAndEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzIzLTQtMS0xLTA_318eb179-e2f2-4152-85b4-757d75f04391">918</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="idxx:PaymentsToAcquireIntangibleAssetsAndEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzIzLTYtMS0xLTA_0e7bf4c0-29d1-4c5b-b82a-3812a58f454b">255</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions of businesses, net of cash acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzI0LTItMS0xLTA_76efc731-aa90-4f73-9f29-03fcf0c61a53">173,418</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzI0LTQtMS0xLTA_610ffdc7-2382-4cc3-b8d4-c2d56878e7c5">1,500</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzI0LTYtMS0xLTA_2c416ee3-acb9-4327-bb34-352e4db50570">50,304</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used by investing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzI1LTItMS0xLTA_fc0368fd-7e9e-4418-9f6f-97fbc61fc66b">292,967</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzI1LTQtMS0xLTA_4b3e8135-429e-4501-9a86-d98299505e9c">109,376</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzI1LTYtMS0xLTA_08c17e43-b744-4059-9862-48fc347aaa3f">205,528</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash Flows from Financing Activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Borrowings (repayments) on revolving credit facilities, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromRepaymentsOfLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzI3LTItMS0xLTA_99981711-cbc7-4663-bbff-e2fefce888a9">73,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:ProceedsFromRepaymentsOfLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzI3LTQtMS0xLTA_dbb270e3-2399-4f9b-b296-d42233c6be13">289,625</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:ProceedsFromRepaymentsOfLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzI3LTYtMS0xLTA_43cc4fb9-3702-4092-8400-903bfa73d848">110,275</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of senior notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzI4LTItMS0xLTA_0e29e375-1b63-4f72-890a-64cb0f16a31f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzI4LTQtMS0xLTA_946aabd6-5b55-48fc-88b4-5b3237facac6">200,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzI4LTYtMS0xLTA_c15cb58e-539d-4480-96f5-69fbffefa5c7">100,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments of senior notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:RepaymentsOfSeniorDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzI5LTItMS0xLTQwNTUw_457dcd2e-89bb-4115-a785-bf08187164e6">50,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:RepaymentsOfSeniorDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzI5LTQtMS0xLTQwNTUw_d06e2c1d-5ee6-43e2-9d08-0defada41e34">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:RepaymentsOfSeniorDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzI5LTYtMS0xLTQwNTUw_590f288a-54c0-44e9-a8cc-90c40f9ded4f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzI5LTItMS0xLTA_4b2f03fa-d1b9-417e-a0d6-9fb185360248">2,650</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzI5LTQtMS0xLTA_d4ce1321-280a-4ffc-ba88-1556c1dadba6">5,025</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzI5LTYtMS0xLTA_f9b71842-8752-47c3-a9ab-c785c8d1415d">154</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of minority interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToMinorityShareholders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzMwLTItMS0xLTQwNTI3_c3cf4484-77f6-4157-b01f-d8cd447bb698">990</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToMinorityShareholders" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzMwLTQtMS0xLTQwNTI3_18084601-c407-405d-98d4-d15d28bf3dba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsToMinorityShareholders" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzMwLTYtMS0xLTQwNTI3_81564388-ff1a-4acf-b679-3657cc7fc69d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchases of common stock, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzMwLTItMS0xLTA_ab11deb9-bcb4-45d3-99d1-e1cfdc010f01">746,777</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzMwLTQtMS0xLTA_372febf5-dc77-4640-962e-1accb8ab0f0f">182,815</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzMwLTYtMS0xLTA_edd0d123-d57b-4bdb-a108-94f1b2311f20">301,658</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from exercises of stock options and employee stock purchase plans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzMxLTItMS0xLTA_f8cbbdac-2745-47b8-b7c5-2c5c48662a8c">46,565</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzMxLTQtMS0xLTA_8b145c7d-9dd3-415c-b951-c089ed50763b">51,328</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzMxLTYtMS0xLTA_2d60c797-12d9-4f75-9791-e3062abda59a">36,106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payment of acquisition-related contingent consideration and holdbacks</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzMyLTItMS0xLTA_f1440f49-204c-48d6-8389-c25a441adfae">1,500</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzMyLTQtMS0xLTA_b347eb25-d722-40d5-ba36-d9dcd209a109">1,676</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzMyLTYtMS0xLTA_8b1fc936-c744-4a77-9e0b-d235c7b2a280">2,375</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares withheld for statutory tax withholding payments on restricted stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzMzLTItMS0xLTA_6ebd56f7-c1fb-4249-a837-cd86aea19e2f">15,562</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzMzLTQtMS0xLTA_ffb0d83f-b872-42d5-999b-90c946e40ce2">20,603</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzMzLTYtMS0xLTA_1b0f3657-1d57-4ee0-a776-3080dae3d4f3">8,053</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used by financing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzM0LTItMS0xLTA_f3b6a67a-c891-47f9-846e-fdad60afe123">697,414</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzM0LTQtMS0xLTA_15f3046f-4313-4cf5-b08e-72ca47cdefc1">248,416</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzM0LTYtMS0xLTA_5ca9a259-c95f-4ab2-b8e1-a138100cf8d1">286,409</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net effect of changes in exchange rates on cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzM1LTItMS0xLTA_8538c46c-765e-4148-a051-b0b7b8d1eec8">4,639</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzM1LTQtMS0xLTA_038ffe51-e0dd-4449-b1d2-66f6bcec94b8">3,331</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzM1LTYtMS0xLTA_36deb11b-5013-4836-a538-76f7cc59696d">689</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (decrease) increase in cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzM2LTItMS0xLTA_15e9b253-4105-404b-bf33-0028b39a4cfe">239,474</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzM2LTQtMS0xLTA_4a4b6e63-23c2-4b89-a4bc-85d0e6ba0507">293,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzM2LTYtMS0xLTA_3266e7ad-6169-4d4a-9440-b5dd14fa8b4e">33,468</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents at beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzM3LTItMS0xLTA_7105a6ec-cab2-4a98-b6ff-711ea789e49b">383,928</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c634b937c58472e84857eacf99e17df_I20191231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzM3LTQtMS0xLTA_414e8f0f-24c0-4633-9caf-07b5ba14612d">90,326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28d0821cac8841b29cf960002d3bc993_I20181231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzM3LTYtMS0xLTA_a2a74a5a-1fc5-4ee9-a740-9cf2cfda87ac">123,794</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents at end of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzM4LTItMS0xLTA_874ae737-458f-431b-8700-85910e01b8e5">144,454</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzM4LTQtMS0xLTA_48598edc-6a1d-4826-a090-518288717d2a">383,928</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c634b937c58472e84857eacf99e17df_I20191231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzM4LTYtMS0xLTA_8ff2001c-4a93-4603-9223-902d3785f2aa">90,326</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">The accompanying notes are an integral part of these consolidated financial statements.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-8</span></div></div></div><div id="i5d795a6851d746ca914a2ddae761c329_169"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IDEXX LABORATORIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div><span><br/></span></div><div id="i5d795a6851d746ca914a2ddae761c329_172"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 1.&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzIvZnJhZzoxNWNmZjJlMWNjMmY0MzA1OTAwOWMxOGIyZjQ5MDg4YS90ZXh0cmVnaW9uOjE1Y2ZmMmUxY2MyZjQzMDU5MDA5YzE4YjJmNDkwODhhXzI5Mzg_e409fe1c-95a1-4747-a060-7f30711b41cf" continuedAt="i4c00b7f5b4e0458e93d02f430a7ba63b" escape="true">NATURE OF BUSINESS, BASIS OF PRESENTATION AND PRINCIPLES OF CONSOLIDATION</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i4c00b7f5b4e0458e93d02f430a7ba63b"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements of IDEXX Laboratories, Inc. and its subsidiaries have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") and with the requirements of Regulation S-X.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These statements include the accounts of IDEXX Laboratories, Inc., and our wholly-owned and majority-owned subsidiaries (&#8220;IDEXX,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; or &#8220;our&#8221;). We do not have any variable interest entities for which we are the primary beneficiary. All intercompany transactions and balances have been eliminated in&#160;consolidation.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have included certain terms and abbreviations used throughout this Annual Report on Form 10-K in the &#8220;Glossary of Terms and Selected Abbreviations.&#8221;&#160;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We develop, manufacture, and distribute products and provide services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing industries. We also sell human medical point-of-care products and laboratory diagnostics. Our principal line of business, which we refer to as our Companion Animal Group (&#8220;CAG&#8221;) operating segment, provides diagnostic capabilities and information management solutions for the companion animal veterinary industry, as well as the biomedical research community. Our principal regions for these products and services are the United States (&#8220;U.S.&#8221;), Europe, Japan, China, and Australia, but we also sell to customers and distributors in many other countries around the world. Our Water operating segment provides innovative testing solutions for the quality and safety of water principally in the U.S. and Europe, but we also sell to customers in many other countries around the world. Our Livestock, Poultry and Dairy (&#8220;LPD&#8221;) operating segment provides diagnostic tests and related instrumentation and performs services that are used to manage the health status of livestock and poultry, to improve producer efficiency, and to ensure the quality and safety of milk. Our principal regions for these products and services are Europe, China, and Australia, but we also sell to customers in many other countries around the world. We also operate a smaller operating segment that is comprised of our human medical diagnostic products and services business (&#8220;OPTI Medical&#8221;). Financial information about our OPTI Medical operating segment is combined and presented with our out-licensing arrangements remaining from our pharmaceutical business in an &#8220;Other&#8221; category because they do not meet the quantitative or qualitative thresholds for reportable segments. Refer to "Note 3. Revenue Recognition" for additional information regarding disaggregated revenue by segment, major product and service categories, and geographical areas. Refer to "Note 17. Segment Reporting" for additional information regarding our reportable operating segments.</span></div></ix:continuation><div><span><br/></span></div><div id="i5d795a6851d746ca914a2ddae761c329_175"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 2.&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzUvZnJhZzoyMGZkYjA1ZDllZjM0ODQyYmVjNzIwYzAxMzcxMTc1Yy90ZXh0cmVnaW9uOjIwZmRiMDVkOWVmMzQ4NDJiZWM3MjBjMDEzNzExNzVjXzEzNTM0_168b9816-8b10-4a97-ab8f-7b9f733a1851" continuedAt="i4f4da7d8ca0b44af8cc7bb8d47e6162e" escape="true">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i4f4da7d8ca0b44af8cc7bb8d47e6162e" continuedAt="i0c6d1643cf1b4bda99365acd3ec2081f"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzUvZnJhZzoyMGZkYjA1ZDllZjM0ODQyYmVjNzIwYzAxMzcxMTc1Yy90ZXh0cmVnaW9uOjIwZmRiMDVkOWVmMzQ4NDJiZWM3MjBjMDEzNzExNzVjXzEzNTUw_a184097d-9e43-4b38-9b83-2e27e7f552b3" continuedAt="ifd5a11177cae469c81fe7e072b1cc6ee" escape="true">Estimates</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ifd5a11177cae469c81fe7e072b1cc6ee">The preparation of these consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures. On an ongoing basis, we evaluate these estimates, including those related to reserves for accounts receivable; goodwill and other intangible assets; income taxes; inventory valuation; revenue recognition, product returns, customer programs, and multiple element arrangements; share-based compensation; warranty reserves; self-insurance reserves; fair value measurements and loss contingencies. We accrue contingent liabilities when it is probable that future expenditures will be made and such expenditures can be reasonably estimated. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ materially from these estimates.</ix:continuation></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">b</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzUvZnJhZzoyMGZkYjA1ZDllZjM0ODQyYmVjNzIwYzAxMzcxMTc1Yy90ZXh0cmVnaW9uOjIwZmRiMDVkOWVmMzQ4NDJiZWM3MjBjMDEzNzExNzVjXzEzNTI2_9540dee4-7e51-41b8-83a8-623e55e03f69" continuedAt="if072af0fec6743dda4d959aad59a5d83" escape="true">Cash and Cash Equivalents</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if072af0fec6743dda4d959aad59a5d83">We consider all highly liquid investments with original maturities of ninety days or less to be cash equivalents. Cash and cash equivalents consist primarily of demand deposits, money market funds, and short-duration agency bonds and commercial paper as described above.</ix:continuation> There is <ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="INF" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzUvZnJhZzoyMGZkYjA1ZDllZjM0ODQyYmVjNzIwYzAxMzcxMTc1Yy90ZXh0cmVnaW9uOjIwZmRiMDVkOWVmMzQ4NDJiZWM3MjBjMDEzNzExNzVjXzE3Nzg_3a43f338-0acb-423b-8069-a8fd0a7a8058"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="INF" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzUvZnJhZzoyMGZkYjA1ZDllZjM0ODQyYmVjNzIwYzAxMzcxMTc1Yy90ZXh0cmVnaW9uOjIwZmRiMDVkOWVmMzQ4NDJiZWM3MjBjMDEzNzExNzVjXzE3Nzg_a858cc59-c5d2-4214-99e6-23baf53a2de5">no</ix:nonFraction></ix:nonFraction> restricted cash on our consolidated balance sheets for the years ended December 31, 2021 and 2020.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span><br/></span></div><ix:continuation id="i0c6d1643cf1b4bda99365acd3ec2081f" continuedAt="iaa618484a27c46e78b7d789aac29e4dc"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(c)&#160;&#160;&#160;&#160;Inventories &#8211; Refer to Note 7 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(d)&#160;&#160;&#160;&#160;Property and Equipment &#8211; Refer to Note 9 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(e)&#160;&#160;&#160;&#160;Goodwill and Other Intangible Assets &#8211; Refer to Note 11 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(f)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:StandardProductWarrantyPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzUvZnJhZzoyMGZkYjA1ZDllZjM0ODQyYmVjNzIwYzAxMzcxMTc1Yy90ZXh0cmVnaW9uOjIwZmRiMDVkOWVmMzQ4NDJiZWM3MjBjMDEzNzExNzVjXzEzNTI3_b264ca6b-11ed-49da-ab9a-36372b4ce884" continuedAt="i0b82ce607811466397dc86dece352af2" escape="true">Warranty Reserves</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i0b82ce607811466397dc86dece352af2">We provide a standard twelve-month warranty on all instruments sold. We recognize the cost of instrument warranties in cost of product revenue at the time revenue is recognized based on the estimated cost to repair the instrument over its warranty period. Cost of product revenue reflects not only estimated warranty expense for instruments sold in the current period, but also any changes in estimated warranty expense for the portion of the aggregate installed base that is under warranty. Estimated warranty expense is based on a variety of inputs, including historical instrument performance in the customers&#8217; environments, historical and estimated costs incurred in servicing instruments and projected instrument reliability. Should actual service rates or costs differ from our estimates, revisions to the estimated warranty liability would be required. The liability for warranties is included in accrued liabilities in the accompanying consolidated balance sheets.</ix:continuation> The amount of warranty reserve during the years ended December 31, 2021 and 2020, was not material.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(g)&#160;&#160;&#160;&#160;Income Taxes &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Refer to Note 14 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(h)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="idxx:TaxesRemittedToGovernmentalAuthoritiesOnBehalfOfCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzUvZnJhZzoyMGZkYjA1ZDllZjM0ODQyYmVjNzIwYzAxMzcxMTc1Yy90ZXh0cmVnaW9uOjIwZmRiMDVkOWVmMzQ4NDJiZWM3MjBjMDEzNzExNzVjXzEzNTQ2_c1594c82-b593-4556-8005-e076003f73f5" continuedAt="i0adc3d3f57a7415094f012d3b93b3a8c" escape="true">Taxes Remitted to Governmental Authorities by IDEXX on Behalf of Customer</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i0adc3d3f57a7415094f012d3b93b3a8c">We calculate, collect from our customers, and remit to governmental authorities, sales, value-added, and excise taxes assessed by governmental authorities in connection with revenue-producing transactions with our customers. We report these taxes on a net basis and do not include these tax amounts in revenue or cost of product or service revenue.</ix:continuation></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(i)&#160;&#160;&#160;&#160;Revenue Recognition &#8211; Refer to Note 3 </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(j)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzUvZnJhZzoyMGZkYjA1ZDllZjM0ODQyYmVjNzIwYzAxMzcxMTc1Yy90ZXh0cmVnaW9uOjIwZmRiMDVkOWVmMzQ4NDJiZWM3MjBjMDEzNzExNzVjXzEzNTQz_15cd0857-5173-4cde-b0ec-a83de8e45dd0" continuedAt="icdbc4e3479af4a0e8f1cd2091d32947b" escape="true">Research and Development Costs</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="icdbc4e3479af4a0e8f1cd2091d32947b">Research and development costs, which consist of employee compensation and benefits, materials and external consulting, and product development costs, are expensed as incurred. We evaluate our research and development costs for capitalization after the technological feasibility has been established for software and products containing software to be sold; however, <ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="INF" name="idxx:ResearchAndDevelopmentCostsCapitalized" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzUvZnJhZzoyMGZkYjA1ZDllZjM0ODQyYmVjNzIwYzAxMzcxMTc1Yy90ZXh0cmVnaW9uOjIwZmRiMDVkOWVmMzQ4NDJiZWM3MjBjMDEzNzExNzVjXzM5NzQ_4935365b-3c20-4117-974f-614a5af6b62b"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="INF" name="idxx:ResearchAndDevelopmentCostsCapitalized" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzUvZnJhZzoyMGZkYjA1ZDllZjM0ODQyYmVjNzIwYzAxMzcxMTc1Yy90ZXh0cmVnaW9uOjIwZmRiMDVkOWVmMzQ4NDJiZWM3MjBjMDEzNzExNzVjXzM5NzQ_4aa5f4f8-62a6-46c3-9584-b991cf07a699"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="INF" name="idxx:ResearchAndDevelopmentCostsCapitalized" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzUvZnJhZzoyMGZkYjA1ZDllZjM0ODQyYmVjNzIwYzAxMzcxMTc1Yy90ZXh0cmVnaW9uOjIwZmRiMDVkOWVmMzQ4NDJiZWM3MjBjMDEzNzExNzVjXzM5NzQ_928a15c7-b83a-4438-83a7-94079bf6d112">no</ix:nonFraction></ix:nonFraction></ix:nonFraction> costs were capitalized during the years ended December 31, 2021, 2020, and 2019. Software developed to deliver hosted services to our customers has been designated as internal use, and we capitalize certain costs incurred in connection with developing or obtaining software designated for internal use based on three distinct stages of development. Refer to "Note 9. Property and Equipment, Net" for further information on internal use software.</ix:continuation> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(k)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:AdvertisingCostsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzUvZnJhZzoyMGZkYjA1ZDllZjM0ODQyYmVjNzIwYzAxMzcxMTc1Yy90ZXh0cmVnaW9uOjIwZmRiMDVkOWVmMzQ4NDJiZWM3MjBjMDEzNzExNzVjXzEzNTEy_7d4afc3d-3de9-46b1-852d-6d6211e0bdcc" continuedAt="ifdc907645aab420ea7d66540d748c94c" escape="true">Advertising Costs</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ifdc907645aab420ea7d66540d748c94c">Advertising costs, which are recognized as sales and marketing expense in the period in which they are incurred, were $<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-5" name="us-gaap:AdvertisingExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzUvZnJhZzoyMGZkYjA1ZDllZjM0ODQyYmVjNzIwYzAxMzcxMTc1Yy90ZXh0cmVnaW9uOjIwZmRiMDVkOWVmMzQ4NDJiZWM3MjBjMDEzNzExNzVjXzQ1MTc_9961c4b4-70ca-460b-a276-8421b6bb55d1">3.3</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-5" name="us-gaap:AdvertisingExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzUvZnJhZzoyMGZkYjA1ZDllZjM0ODQyYmVjNzIwYzAxMzcxMTc1Yy90ZXh0cmVnaW9uOjIwZmRiMDVkOWVmMzQ4NDJiZWM3MjBjMDEzNzExNzVjXzQ1MjE_e73e3f5a-6d01-47fc-8c32-e2263237176b">1.4</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-5" name="us-gaap:AdvertisingExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzUvZnJhZzoyMGZkYjA1ZDllZjM0ODQyYmVjNzIwYzAxMzcxMTc1Yy90ZXh0cmVnaW9uOjIwZmRiMDVkOWVmMzQ4NDJiZWM3MjBjMDEzNzExNzVjXzQ1Mjk_4c1b473a-d977-45ed-b2ea-d7e16a4518bf">1.5</ix:nonFraction> million for the years ended December 31, 2021, 2020, and 2019, respectively.</ix:continuation></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(l)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:LegalCostsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzUvZnJhZzoyMGZkYjA1ZDllZjM0ODQyYmVjNzIwYzAxMzcxMTc1Yy90ZXh0cmVnaW9uOjIwZmRiMDVkOWVmMzQ4NDJiZWM3MjBjMDEzNzExNzVjXzEzNTIz_0f320136-e787-4f15-ac7f-f9d008613d4f" continuedAt="i21c2af4cd6274d658c593672a043d365" escape="true">Legal Costs</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i21c2af4cd6274d658c593672a043d365">Legal costs are considered period costs and, accordingly, are expensed in the year services are provided.</ix:continuation></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(m)&#160;&#160;&#160;&#160;Share-Based Compensation &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Refer to Note 5 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(n)&#160;&#160;&#160;&#160;Self-Insurance Accruals &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Refer to Note 16 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(o)&#160;&#160;&#160;&#160;Leases &#8211; Refer to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 8 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(p)&#160;&#160;&#160;&#160;Earnings per Share &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Refer to Note 15 </span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="iaa618484a27c46e78b7d789aac29e4dc" continuedAt="iab1eecce402146e2a9ea183a228c884b"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(q)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzUvZnJhZzoyMGZkYjA1ZDllZjM0ODQyYmVjNzIwYzAxMzcxMTc1Yy90ZXh0cmVnaW9uOjIwZmRiMDVkOWVmMzQ4NDJiZWM3MjBjMDEzNzExNzVjXzEzNTU3_333ca656-9185-4fe3-ae4f-64b1bb32bc20" continuedAt="if761252014ff456b9c9358bd80a724d4" escape="true">Foreign Currency</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if761252014ff456b9c9358bd80a724d4" continuedAt="id2fb6a16cb6a48b0863caf795f3f213f">The functional currency of all except eight of our subsidiaries is their local currency, however, the assets and liabilities of the majority of our foreign subsidiaries are translated to the U.S. dollar using the exchange rate in effect at the balance sheet date. Revenue and expense accounts are translated to the U.S. dollar using the exchange rate at the date which those elements are recognized, and where it is impractical to do so, an average exchange rate in effect during the period is used to translate those elements. Cumulative translation gains and losses are shown in the accompanying consolidated balance sheets as a separate component of accumulated other comprehensive income (&#8220;AOCI&#8221;). &#160;</ix:continuation></span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id2fb6a16cb6a48b0863caf795f3f213f">Revenues and expenses denominated in a currency other than the respective subsidiary&#8217;s functional currency are recorded at the current exchange rate when the transaction is recognized. Monetary assets and liabilities denominated in a currency other than the respective subsidiary&#8217;s functional currency are remeasured at each balance sheet date using the exchange rate in effect at each balance sheet date. These foreign currency gains and losses are included in general and administrative expenses within our Other segment.</ix:continuation> We recognized aggregate foreign currency losses of $<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzUvZnJhZzoyMGZkYjA1ZDllZjM0ODQyYmVjNzIwYzAxMzcxMTc1Yy90ZXh0cmVnaW9uOjIwZmRiMDVkOWVmMzQ4NDJiZWM3MjBjMDEzNzExNzVjXzYxMzU_641335c5-b72e-4254-8c00-239398742650">2.1</ix:nonFraction> million, gains of $<ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-5" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzUvZnJhZzoyMGZkYjA1ZDllZjM0ODQyYmVjNzIwYzAxMzcxMTc1Yy90ZXh0cmVnaW9uOjIwZmRiMDVkOWVmMzQ4NDJiZWM3MjBjMDEzNzExNzVjXzYxNTM_8687bbbf-50c7-464c-b93c-b982e5da2779">0.6</ix:nonFraction> million, and losses of $<ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzUvZnJhZzoyMGZkYjA1ZDllZjM0ODQyYmVjNzIwYzAxMzcxMTc1Yy90ZXh0cmVnaW9uOjIwZmRiMDVkOWVmMzQ4NDJiZWM3MjBjMDEzNzExNzVjXzYxNjA_c8b42c23-510a-49eb-83c9-eb75c8534a0f">1.1</ix:nonFraction> million for the years ended December 31, 2021, 2020, and 2019, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(r)&#160;&#160;&#160;&#160;Hedging Instruments &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Refer to Note 19 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(s)&#160;&#160;&#160;&#160;Fair Value Measurements &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Refer to Note 18 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(t)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzUvZnJhZzoyMGZkYjA1ZDllZjM0ODQyYmVjNzIwYzAxMzcxMTc1Yy90ZXh0cmVnaW9uOjIwZmRiMDVkOWVmMzQ4NDJiZWM3MjBjMDEzNzExNzVjXzEzNTUz_82fa2710-070b-4fb8-bf99-6f1913e8ad0e" continuedAt="i630e43401bc147498347cecd94a18ee0" escape="true">Comprehensive Income</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i630e43401bc147498347cecd94a18ee0">&#160;&#160;&#160;&#160;We report all changes in equity, including net income and transactions or other events and circumstances from non-owner sources during the period in which they are recognized. We have chosen to present comprehensive income, which encompasses net income, foreign currency translation adjustments, gains and losses on our net investment hedges and the difference between the cost and the fair market value of investments in debt and equity securities, and forward currency exchange contracts, in the consolidated statements of comprehensive income. Refer to</ix:continuation> "Note 21. Accumulated Other Comprehensive Income" for information about the effects on net income of significant amounts reclassified out of each component of AOCI for the years ended December 31, 2021, 2020, and 2019.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(u)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="idxx:ConcentrationRiskPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzUvZnJhZzoyMGZkYjA1ZDllZjM0ODQyYmVjNzIwYzAxMzcxMTc1Yy90ZXh0cmVnaW9uOjIwZmRiMDVkOWVmMzQ4NDJiZWM3MjBjMDEzNzExNzVjXzEzNTMw_cbe1cb29-3d10-4288-9c07-043665a0b665" continuedAt="i3cb0e70f94e54f649dd2d4e4467162f6" escape="true">Concentrations of Risk</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i3cb0e70f94e54f649dd2d4e4467162f6"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Financial instruments that potentially subject us to concentrations of credit risk are principally cash, cash equivalents, accounts receivable, and derivatives. To mitigate such risk with respect to cash and cash equivalents, we place our cash with highly-rated financial institutions, in non-interest bearing accounts that are insured by the U.S. government and money market funds invested in government securities. Concentration of credit risk with respect to accounts receivable is limited to certain customers to whom we make substantial sales. To reduce risk, we routinely assess the financial strength of our most significant customers and monitor the amounts owed to us, taking appropriate action when necessary. As a result, we believe that accounts receivable credit risk exposure is limited. We maintain an allowance for doubtful accounts, but historically have not experienced any material losses related to an individual customer or group of customers in any particular industry or geographic area.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To mitigate concentration of credit risk with respect to derivatives we enter into transactions with highly-rated financial institutions, enter into master netting arrangements with counterparties to our derivative transactions and frequently monitor the creditworthiness of our counterparties. Our master netting arrangements reduce our exposure in that they permit outstanding receivables and payables with the counterparties to our derivative transactions to be offset in the event of default. We have not incurred such losses and consider the risk of counterparty default to be minimal.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Inventory</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If we are unable to obtain adequate quantities of the inventory we need to sell our products, we could face cost increases or delays or discontinuations in product shipments, which could have a material adverse effect on our results of operations. Many of the third parties that provide us with the instruments we sell, as well as certain components, raw materials and consumables used in or with our products, are sole or single-source suppliers. Some of the products that we purchase from these sources are proprietary or complex in nature, and, therefore, cannot be readily or easily replaced by alternative sources.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="iab1eecce402146e2a9ea183a228c884b"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(v)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzUvZnJhZzoyMGZkYjA1ZDllZjM0ODQyYmVjNzIwYzAxMzcxMTc1Yy90ZXh0cmVnaW9uOjIwZmRiMDVkOWVmMzQ4NDJiZWM3MjBjMDEzNzExNzVjXzEzNTI1_5d2d9431-1e96-4f8f-a40d-edb7cb158794" continuedAt="i0ebe8523f71e4f0194b245ea0d9871af" escape="true">New Accounting Pronouncements Adopted</ix:nonNumeric></span></div><div style="text-indent:36pt"><span><br/></span></div><ix:continuation id="i0ebe8523f71e4f0194b245ea0d9871af" continuedAt="i161f4589889d40a6bd1090e8b5474208"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We adopted ASU 2016-02, "Leases (Topic 842)," as of January 1, 2019, using the optional transition method that allows for a cumulative-effect adjustment in the period of adoption and did not restate prior periods.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We adopted ASU 2018-13, "Fair Value Measurement (Topic 820)," as of January 1, 2020, which modifies the disclosure requirements on fair value measurements under ASC Topic No. 820, Fair Value Measurement, as amended (&#8220;ASC 820&#8221;). ASU 2018-13 removes (a) the prior requirement to disclose the amount and reason for transfers between Level 1 and Level 2 of the fair value hierarchy contained in ASC 820, (b) the policy for timing of transfers between levels, and (c) the valuation processes used for Level 3 fair value measurements. ASU 2018-13 also adds, among other things, a requirement to disclose the range and weighted average of significant unobservable inputs used in Level 3 fair value measurements. The adoption did not have a material impact on our consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;We adopted ASU 2016-13, &#8220;Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,&#8221; effective January 1, 2020, using the modified retrospective transition method. This ASU amends the impairment model to utilize an expected loss methodology in place of the incurred loss methodology for financial instruments, including trade receivables and leased equipment. The amendment requires entities to consider a broader range of information to estimate expected credit losses, which may result in earlier recognition of losses. We recorded a non-cash cumulative effect adjustment to retained earnings of $<ix:nonFraction unitRef="usd" contextRef="i21b5e95e95564226a627f64e7713aea8_I20191231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzUvZnJhZzoyMGZkYjA1ZDllZjM0ODQyYmVjNzIwYzAxMzcxMTc1Yy90ZXh0cmVnaW9uOjIwZmRiMDVkOWVmMzQ4NDJiZWM3MjBjMDEzNzExNzVjXzExMjUx_b4658067-17e5-4607-a14f-9523fb0cee2d">1.8</ix:nonFraction>&#160;million, net of $<ix:nonFraction unitRef="usd" contextRef="idb0fcabcbe0847e89f685ded467776c8_D20200101-20200101" decimals="-5" sign="-" name="us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquityCumulativeEffectOfChangeInAccountingPrinciple" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzUvZnJhZzoyMGZkYjA1ZDllZjM0ODQyYmVjNzIwYzAxMzcxMTc1Yy90ZXh0cmVnaW9uOjIwZmRiMDVkOWVmMzQ4NDJiZWM3MjBjMDEzNzExNzVjXzExMjYy_a33f5d2c-1a34-4187-8e1e-b9e557a958c5">0.6</ix:nonFraction>&#160;million of income taxes, on our opening consolidated balance sheet as of January 1, 2020. This adjustment, before the impact of income taxes, was comprised of $<ix:nonFraction unitRef="usd" contextRef="ic23d3f2012b145a986354fd6baa91f83_I20200101" decimals="-5" name="idxx:ContractwithCustomerAssetAndSalesTypeLeaseNetInvestmentInLeaseAllowanceforCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzUvZnJhZzoyMGZkYjA1ZDllZjM0ODQyYmVjNzIwYzAxMzcxMTc1Yy90ZXh0cmVnaW9uOjIwZmRiMDVkOWVmMzQ4NDJiZWM3MjBjMDEzNzExNzVjXzExNDE2_9cb1620b-c278-4c3a-9fb1-8104037c435c">2.3</ix:nonFraction>&#160;million related to our contract assets and sales-type leases, and $<ix:nonFraction unitRef="usd" contextRef="ic23d3f2012b145a986354fd6baa91f83_I20200101" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzUvZnJhZzoyMGZkYjA1ZDllZjM0ODQyYmVjNzIwYzAxMzcxMTc1Yy90ZXh0cmVnaW9uOjIwZmRiMDVkOWVmMzQ4NDJiZWM3MjBjMDEzNzExNzVjXzExNDc3_d01307e9-d41b-4772-8e67-69aa96de424b">0.2</ix:nonFraction>&#160;million related to accounts receivable. Refer to "Note 6. Credit Losses" for more information on our presentation of credit losses.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective January 1, 2021, we adopted ASU 2019-12, &#8220;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes.&#8221; The new guidance is intended to simplify the accounting for income taxes by removing certain exceptions and by updating accounting requirements around goodwill recognized for tax purposes and the allocation of current and deferred tax expense among legal entities, among other minor changes. The adoption of ASU 2019-12 did not have a material impact on our consolidated financial statements.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In July 2021, the FASB issued ASU 2021-05, &#8220;Leases (Topic 842); Lessors - Certain Leases with Variable Lease Payments.&#8221; ASU 2021-05 requires a lessor to classify a lease with variable payments that do not depend on an index or rate as an operating lease if another lease classification (i.e., sales-type or direct financing) would result in recognition of a day-one loss. We have elected to adopt this standard as of the third quarter of 2021, on a prospective basis. The adoption of ASU 2021-05 did not have a material impact on our consolidated financial statements.</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(w)&#160;&#160;&#160;&#160;<ix:continuation id="i161f4589889d40a6bd1090e8b5474208" continuedAt="i66113dc3729249169b438458e1bf3122">New Accounting Pronouncements Not Yet Adopted</ix:continuation></span></div><div><span><br/></span></div><ix:continuation id="i66113dc3729249169b438458e1bf3122"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued ASU 2021-08, &#8220;Business Combinations (Topic 805): Accounting for Acquired Contract Assets and Contract Liabilities.&#8221; ASU 2021-08 is intended to improve comparability for both the recognition and measurement of acquired revenue contracts with customers at the date of and after a business combination by providing consistent recognition guidance. This standard is effective for fiscal years beginning after December 15, 2022. Adoption of the ASU 2021-08 should be applied prospectively. Early adoption is permitted, including in an interim period, for any period for which financial statements have not yet been issued. We are currently evaluating the impact, if any, of ASU 2021-08 on our consolidated financial statements.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU 2020-04, "Facilitation of the Effects of Reference Rate Reform on Financial Reporting.&#8221; ASU 2020-04 is intended to provide optional expedients and exceptions to the U.S. GAAP guidance on contract modifications and hedge accounting to ease the financial reporting burdens related to the discontinuation of the London Interbank Offered Rate (&#8220;LIBOR&#8221;) or by another reference rate expected to be discontinued. The FASB also issued ASU 2021-01, "Reference Rate Reform (Topic 848): Scope," in January 2021. It clarifies that certain optional expedients and exceptions apply to derivatives that are affected by the discounting transition. The amendments in this ASU affect the guidance in ASU No. 2020-04 and are effective in the same timeframe as ASU 2020-04. The relief offered by this guidance, if adopted, is available to companies for the period March 12, 2020 through December 31, 2022. Our Credit Facility includes a provision for the determination of a benchmark replacement rate as a successor to the LIBOR rate, therefore; we do not expect the discontinuation of LIBOR to have an impact on our consolidated financial statements.</span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span><br/></span></div><div><span><br/></span></div><div id="i5d795a6851d746ca914a2ddae761c329_178"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 3.&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzIzNTc0_085b6220-4db2-4c0a-bcbf-8a56720282a2" continuedAt="i045b424ca06f403b83f1f40cd3bf663b" escape="true">REVENUE RECOGNITION </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i045b424ca06f403b83f1f40cd3bf663b" continuedAt="i8ac1fd7d0ad44564a187993056550a4f"><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzIzNTc1_beef8fe9-ff47-4ae1-af48-cd7a1eceb6ac" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue is recognized when, or as, performance obligations under the terms of a contract are satisfied, which occurs when control of the promised products or services is transferred to a customer. We exclude sales, use, value-added, and other taxes we collect on behalf of third parties from revenue. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring products or services to a customer. To accurately present the consideration received in exchange for promised products or services, we apply the five-step model outlined below:</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Identification of a contract or agreement with a customer</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Identification of our performance obligations in the contract or agreement</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Determination of the transaction price</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Allocation of the transaction price to the performance obligations</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Recognition of revenue when, or as, we satisfy a performance obligation</span></div></ix:nonNumeric><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into contracts that can include various combinations of products and services, which are generally capable of being distinct and accounted for as separate performance obligations. The timing of revenue recognition, billings, and cash collections results in accounts receivable, lease receivables, and contract assets as a result of revenue recognized in advance of billings (included within other assets), and contract liabilities or deferred revenue as a result of receiving consideration in advance of revenue recognition within our consolidated balance sheet. Our general payment terms range from&#160;<ix:nonNumeric contextRef="i464c41d2cb9948979da5af09e9a6709b_D20210101-20211231" name="idxx:RevenuePerformanceObligationPaymentTerm" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzE1MzI_e1c55c46-1e87-4142-8010-325ec3912d57">30</ix:nonNumeric>&#160;to&#160;<ix:nonNumeric contextRef="i2547ad5bc951453f98e34b5d0f26b8bb_D20210101-20211231" name="idxx:RevenuePerformanceObligationPaymentTerm" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzE1Mzg_1718c9b6-02ee-4782-a728-f2cdf982131c">60</ix:nonNumeric>&#160;days, with exceptions in certain geographies. Below is a listing of our major categories of revenue for our products and services.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Diagnostic Products and Accessories</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Diagnostic products and accessories revenues, including IDEXX VetLab</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> consumables and accessories, rapid assay, LPD, Water, and OPTI testing products, are predominantly recognized and invoiced at the time of shipment, which is when the customer obtains control of the product based on legal title transfer and we have the right to payment. We also provide customers with certain consumables that are recognized upon utilization by the customer, which is when we have the right to payment and the risks and rewards of ownership transfer. Shipping costs reimbursed by the customer are included in revenue and cost of sales. As a practical expedient, we do not account for shipping activities as a separate performance obligation.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Laboratory Diagnostic and Consulting Services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Laboratory diagnostic and consulting services revenues are recognized and invoiced when the laboratory diagnostic service is performed.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Instruments, Software and Systems</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;CAG Diagnostics capital instruments, veterinary software, and diagnostic imaging systems revenues are recognized and invoiced when the customer obtains control of the products based on legal title transfer and we have the right to payment, which generally occurs at the time of installation and customer acceptance. Our instruments, software, and systems are often included in one of our significant customer programs, as further described below. For veterinary software systems that include multiple performance obligations, such as perpetual software licenses and computer hardware, we allocate revenue to each performance obligation based on estimates of the price that we would charge the customer for each promised product or service if it were sold on a standalone basis.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Lease Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Revenues from instrument rental agreements and reagent rental programs are recognized either as operating leases on a ratable basis over the term of the agreement or as sales-type leases at the time of installation and customer acceptance. Customers typically pay for the right to use instruments under rental agreements in equal monthly amounts over the term of the rental agreement. Our reagent rental programs provide our customers the right to use our instruments upon entering into agreements to purchase specified amounts of consumables, which are considered embedded leases. For some agreements, the customers are provided with the right to purchase the instrument at the end of the lease term. Lease revenues from these agreements are presented in product revenue on our consolidated income statement. Lease revenue was approximately $<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-5" name="us-gaap:LeaseIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzQyOTc_914ec932-9e26-4cfd-bae9-2bedece2ad38">20.8</ix:nonFraction> million for the&#160;year ended December 31, 2021, as compared to $<ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-5" name="us-gaap:LeaseIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzQzMzg_829701db-eb94-432c-bf77-cc10d713fa38">17.5</ix:nonFraction> million for the year ended December 31, 2020, including both operating leases and sales-type leases under ASC 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for leases entered into after January 1, 2019, and ASC 840, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for leases entered into prior to 2019. Refer to below for revenue recognition under our reagent rental programs. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Extended Warranties and Post-Contract Support</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. CAG Diagnostics capital instruments and diagnostic imaging systems&#160;extended warranties typically provide customers with continued coverage for a period of&#160;<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzQ4MjE_1e3581e2-aa87-4799-8610-c43eba500df3">one</span>&#160;to&#160;<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzIzNTc2_f9986b18-206a-41dd-850a-8be4c0938fc3">five&#160;years</span> beyond the first-year standard warranty. Customers can either pay in full for the extended warranty at the time of instrument or system purchase, or can be billed on a quarterly basis over the term of the contract. We recognize revenue associated with extended </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i8ac1fd7d0ad44564a187993056550a4f" continuedAt="i80964e7451514044ac892c1694b9c6be"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">warranties over time on a ratable basis using a time-elapsed measure of performance over the contract term, which approximates the expected timing in which applicable services are performed.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Veterinary software post-contract support provides customers with access to technical support when and as needed through access to call centers and online customer assistance. Post-contract support contracts typically have a term of&#160;<ix:nonNumeric contextRef="if381570659954770b2820ee07047c157_D20210101-20211231" name="idxx:PostContractSupportContractTerm" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzIzNTc3_4a4a79ca-a423-40a2-a1a0-ab31b6e7ac3b">12</ix:nonNumeric> months and customers are billed for post-contract support in equal quarterly amounts over the term. We recognize revenue for post-contract support services over time on a ratable basis using a time elapsed measure of performance over the contract term, which approximates the expected timing in which applicable services are performed.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 31, 2020, our deferred revenue related to extended warranties and post-contract support was&#160;$<ix:nonFraction unitRef="usd" contextRef="i242e9b6f55554b858443459f0e68afb7_I20201231" decimals="-5" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzU5NTI_3304372b-4c4b-4d7f-b9bd-a2daf5b64309">35.1</ix:nonFraction> million, of which approximately&#160;$<ix:nonFraction unitRef="usd" contextRef="if381570659954770b2820ee07047c157_D20210101-20211231" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzU5Nzk_e5a1d643-b27b-40e7-baeb-85aea3d9c74a">23.1</ix:nonFraction> million&#160;was recognized during the year ended&#160;December 31, 2021. Furthermore, as a result of new agreements, our deferred revenue related to extended warranties and post-contract support was $<ix:nonFraction unitRef="usd" contextRef="i685e23f0c6e840b7aecebc2994601eb2_I20211231" decimals="-5" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzYxNDk_9c5ca92d-0b58-4848-9cb1-4faf2688c933">30.0</ix:nonFraction> million at&#160;December 31, 2021. We do not disclose information about remaining performance obligations that are part of contracts with an original expected duration of one year or less, and do not adjust for the effect of the financing components when the period between customer payment and revenue recognition is one year or less. Deferred revenue related to extended warranties and post-contract support with an original duration of more than&#160;one year&#160;was&#160;$<ix:nonFraction unitRef="usd" contextRef="i685e23f0c6e840b7aecebc2994601eb2_I20211231" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzY1Nzk_802d08f3-fbd3-49be-81b8-554a5c279a62">16.0</ix:nonFraction> million&#160;at&#160;December 31, 2021, of which approximately <ix:nonFraction unitRef="number" contextRef="ia8d9c432d3bf4b74adffb2d189372886_I20211231" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzY2MTI_5106b11e-aa25-4dfd-870d-dee83223fe11">49</ix:nonFraction>%,&#160;<ix:nonFraction unitRef="number" contextRef="id18052a9bc8947e885971777f75a622b_I20211231" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzY2MTY_0c25985f-375d-4aa9-9925-58b4e200e972">29</ix:nonFraction>%,&#160;<ix:nonFraction unitRef="number" contextRef="i489a306049d8454da4686e43ac9f9be5_I20211231" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzY2MjA_8a8a28c8-a455-4ae1-8807-aab64080e170">14</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="iee7069d3c7944d9d8e2527acff1fbc06_I20211231" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzY2MjQ_5a14fea0-f40f-44fe-9e57-753aa9c2d1b5">5</ix:nonFraction>%,&#160;and&#160;<ix:nonFraction unitRef="number" contextRef="i047ec28985a54ca496f585918ccf62f6_I20211231" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzY2MzI_17bf9768-c097-4aa9-b0db-4588548a7433">3</ix:nonFraction>%&#160;are expected to be recognized during 2022, 2023, 2024, 2025, and thereafter, respectively. Additionally, we have determined these agreements do not include a significant financing component.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">SaaS Subscriptions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;We offer a variety of veterinary software and diagnostic imaging SaaS subscriptions including ezyVet, Animana, Neo, Cornerstone Cloud, Pet Health Network Pro, Petly Plans, Web PACS, rVetLink, and SmartFlow. We recognize revenue for our SaaS subscriptions over time on a ratable basis over the contract term, beginning on the date our service is made available to the customer. Our subscription contracts vary in term from monthly to&#160;<ix:nonNumeric contextRef="i2547ad5bc951453f98e34b5d0f26b8bb_D20210101-20211231" name="idxx:SaasSubscriptionTermOfContract" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzcyNTI_9fa7dbee-1933-45b0-8376-1e621cc76216">two years</ix:nonNumeric>. Customers typically pay for our subscription contracts in equal monthly amounts over the term of the agreement. Deferred revenue related to our SaaS subscriptions is not material.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Contracts with Multiple Performance Obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We enter into contracts with multiple performance obligations where customers purchase a combination of IDEXX products and services. Determining whether products and services are considered distinct performance obligations that should be accounted for separately requires significant judgment. We determine the transaction price for a contract based on the total consideration we expect to receive in exchange for the transferred goods or services. To the extent the transaction price includes variable consideration, such as volume rebates or expected price adjustments, we apply judgment in constraining the estimated variable consideration due to factors that may cause reversal of revenue recognized. We evaluate constraints based on our historical and projected experience with similar customer contracts.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We allocate revenue to each performance obligation in proportion to the relative standalone selling prices, and recognize revenue when transfer of the related goods or services has occurred for each obligation. We utilize the observable standalone selling price when available, which represents the price charged for the performance obligation when sold separately. When standalone selling prices for our products or services are not directly observable, we determine the standalone selling prices using relevant information available and apply suitable estimation methods including, but not limited to, the cost plus a margin approach. We recognize revenue as each performance obligation is satisfied, either at a point in time or over time, as described in the revenue categories above. We do not disclose information about remaining performance obligations that are part of contracts with an original expected duration of one year or less.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following customer programs represent our most significant customer contracts which contain multiple performance obligations:</span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Customer Commitment Programs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We offer customer incentives upon entering into multi-year agreements to   purchase annual minimum amounts of products and services.</span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Up-Front Customer Loyalty Programs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our up-front loyalty programs provide customers with incentives in the form of cash payments or IDEXX Points upon entering into multi-year agreements to purchase annual minimum amounts of future products or services. If a customer breaches their agreement, they are required to refund all or a portion of the up-front cash or IDEXX Points, or make other repayments, remedial actions, or both. Up-front incentives to customers in the form of cash or IDEXX Points are not made in exchange for distinct goods or services and are capitalized as customer acquisition costs within other current and long-term assets, which are subsequently recognized as a reduction to revenue over the term of the customer agreement. If these up-front incentives are subsequently utilized to purchase instruments, we </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i80964e7451514044ac892c1694b9c6be" continuedAt="i4d845ae121d145e9a53560c92691c194"><div style="padding-left:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">allocate total consideration, including future committed purchases less up-front incentives and estimates of expected price adjustments, based on relative standalone selling prices to identified performance obligations, and recognize instrument revenue and cost at the time of installation and customer acceptance. To the extent invoiced instrument revenue exceeds recognized instrument revenue, we record deferred revenue as a contract liability, which is subsequently recognized upon the purchase of products and services over the term of the contract. We have determined these agreements do not include a significant financing component. Differences between estimated and actual customer purchases may impact the timing and amount of revenue recognition.</span></div><div style="padding-left:72pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 31, 2020, our capitalized customer acquisition costs were&#160;$<ix:nonFraction unitRef="usd" contextRef="i96beb1b4304e4f20a74ee69716a60a3e_I20201231" decimals="-5" name="us-gaap:CapitalizedContractCostGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzExMTgx_62aa3602-b111-4d50-a4d9-9f20953c4b9f">148.1</ix:nonFraction> million, of which approximately&#160;$<ix:nonFraction unitRef="usd" contextRef="i437a7bd65c7c46ae8cd7c9e49b4ee334_D20210101-20211231" decimals="-5" name="us-gaap:CapitalizedContractCostAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzExMjA4_7918085c-1e0f-470c-b8a4-570301a85241">43.6</ix:nonFraction> million&#160;was recognized as a reduction of revenue during the&#160;year ended&#160;December 31, 2021. Furthermore, as a result of new up-front customer loyalty payments, net of subsequent recognition, our capitalized customer acquisition costs were&#160;$<ix:nonFraction unitRef="usd" contextRef="ib7205413c9894bd7a9838d72705913eb_I20211231" decimals="-5" name="us-gaap:CapitalizedContractCostGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzExNDI2_1af4cea4-25f6-49a1-8b70-040fe410e9d7">158.3</ix:nonFraction> million&#160;at&#160;December 31, 2021. We monitor customer purchases over the term of their agreement to assess the realizability of our capitalized customer acquisition costs and review estimates of variable consideration. Impairments, revenue adjustments that relate to performance obligations satisfied in prior periods, and contract modifications during the&#160;years ended&#160;December 31, 2021 and 2020, were not material.</span></div><div style="padding-left:72pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Volume Commitment Programs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our volume commitment programs, such as our IDEXX 360 program, provide customers with a free or discounted instrument or system upon entering into multi-year agreements to purchase annual minimum amounts of products and services. We allocate total consideration, including future committed purchases and expected price adjustments, based on relative standalone selling prices to identified performance obligations and recognize instrument revenue and cost at the time of installation and customer acceptance in advance of billing the customer, which is also when the customer obtains control of the instrument based on legal title transfer. Our right to future consideration related to instrument revenue is recorded as a contract asset within other current and long-term assets. The contract asset is transferred to accounts receivable when customers are billed for products and services over the term of the contract. We have determined these agreements do not include a significant financing component. Differences between estimated and actual customer purchases may impact the timing and amount of revenue recognition. </span></div><div style="padding-left:72pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 31, 2020, our volume commitment contract assets were&#160;$<ix:nonFraction unitRef="usd" contextRef="i2f2f5cdb189f4934b1e3cebeb924b507_I20201231" decimals="-5" name="us-gaap:ContractWithCustomerAssetNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzEzMDA1_aeee6fe5-2c98-4883-a3cb-ffd5d7c433a4">115.5</ix:nonFraction> million, of which approximately $<ix:nonFraction unitRef="usd" contextRef="i79ce71bddf09448f9ea714ce6102c47b_D20210101-20211231" decimals="-5" name="us-gaap:ContractWithCustomerAssetReclassifiedToReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzEzMDMy_8ce65d17-3dcb-410f-970c-64404635fb8d">26.3</ix:nonFraction> million&#160;was reclassified to accounts receivable when customers were billed for related products and services during the&#160;year ended&#160;December 31, 2021. Furthermore, as a result of new placements under volume commitment programs, net of subsequent amounts reclassified to accounts receivable, and allowances established for credit losses, our contract assets were&#160;$<ix:nonFraction unitRef="usd" contextRef="i09befd933773486bbae96a48cee3829b_I20211231" decimals="-5" name="us-gaap:ContractWithCustomerAssetNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzEzMzc0_68c0cc5d-2874-4902-b7f7-df145ecc01ab">159.9</ix:nonFraction> million&#160;at&#160;December 31, 2021. We monitor customer purchases over the term of their agreement to assess the realizability of our contract assets and review estimates of variable consideration. Impairments, revenue adjustments that relate to performance obligations satisfied in prior periods, and contract modifications during the&#160;years ended&#160;December 31, 2021 and 2020, were not material.</span></div><div style="padding-left:72pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For our up-front customer loyalty and volume commitment programs, we estimate future revenues related to multi-year agreements to be approximately&#160;$<ix:nonFraction unitRef="usd" contextRef="i51f68fc78b89418293d672d19db8aff1_I20211231" decimals="-8" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzEzODc0_8c76a91a-eab9-4a44-9678-d68e2edfb446">2.9</ix:nonFraction> billion, of which approximately&#160;<ix:nonFraction unitRef="number" contextRef="i3f8679f022804acba3547f27b82749ee_I20211231" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzEzOTAx_3de8bb83-dc1a-4cb2-a310-eb3f01bc61ea">25</ix:nonFraction>%,&#160;<ix:nonFraction unitRef="number" contextRef="ia1b14ac41fb14c2d8d6ba017fa4e925e_I20211231" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzEzOTA1_96e5beab-ffa7-4472-a645-949dd60e723d">24</ix:nonFraction>%,&#160;<ix:nonFraction unitRef="number" contextRef="icb7e410e248e43c994cb93d2f03fbf8f_I20211231" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzEzOTA5_ae4913a1-9724-4771-ab75-c7e89ec20197">20</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="ie2230e0e134c41099416ecb0514e3a3c_I20211231" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzEzOTEz_a35f27cb-4767-4e90-9972-6f7bb0cf6e31">15</ix:nonFraction>%, and&#160;<ix:nonFraction unitRef="number" contextRef="i3e0eda093e4c442d97a50489871ee0c6_I20211231" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzEzOTIx_09d536b9-7ca0-4066-8642-0b601b48fa20">16</ix:nonFraction>%&#160;are expected to be recognized during 2022, 2023, 2024, 2025, and thereafter, respectively. These future revenues relate to performance obligations not yet satisfied, for which customers have committed to purchase goods and services, net of the expected revenue reductions from customer acquisition costs and expected price adjustments, and as a result, are lower than stated contractual commitments by our customers.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Instrument Rebate Programs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our instrument rebate programs require an instrument purchase and provide customers the opportunity to earn future rebates based on the volume of products and services they purchase over the term of the program. We account for the customer&#8217;s right to earn rebates on future purchases as a separate performance obligation and determine the standalone selling price based on an estimate of rebates the customer will earn over the term of the program. Total consideration allocated to identified performance obligations is limited to goods and services that the customer is presently obligated to purchase and does not include estimates of future purchases that are optional. We allocate total consideration to identified performance obligations, including the customer&#8217;s right to earn rebates on future purchases, which is deferred and recognized upon the purchase of future products and services, partly offsetting future rebates as they are earned.</span></div></ix:continuation><div style="padding-left:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i4d845ae121d145e9a53560c92691c194" continuedAt="i8b30c20263064a458afa722ee978889c"><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 31, 2020, our deferred revenue related to instrument rebate programs was&#160;$<ix:nonFraction unitRef="usd" contextRef="i4c2e03def5d746e991b38bd94dccfbdb_I20201231" decimals="-5" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzE1Mzgz_8251292b-8875-45ab-9c40-fb13d61a2cc9">39.3</ix:nonFraction> million, of which approximately $<ix:nonFraction unitRef="usd" contextRef="icf88e478362d4b679f69d782be7a8360_D20210101-20211231" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzE1NDEw_8798b6ff-3588-442e-ae4d-c392f0160538">14.3</ix:nonFraction> million was recognized when customers purchased eligible products and services and earned rebates during the&#160;year ended&#160;December 31, 2021. Furthermore, as a result of new instrument purchases under rebate programs, net of subsequent recognition, our deferred revenue was&#160;$<ix:nonFraction unitRef="usd" contextRef="id886e662c2af48208ad13c5d0017a93e_I20211231" decimals="-5" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzE1NjYy_e997b525-808d-4015-9347-0725d0782f6e">33.0</ix:nonFraction> million&#160;at&#160;December 31, 2021, of which approximately&#160;<ix:nonFraction unitRef="number" contextRef="i76e3709ae6e04372b5824637c99c55ce_I20211231" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzE1Njk1_c6ae1e71-77c5-456d-8ffa-7ef4b507336e">36</ix:nonFraction>%,&#160;<ix:nonFraction unitRef="number" contextRef="ide72157b20624cbba3e378503b944506_I20211231" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzE1Njk5_9952d751-c734-4ed0-917f-81d35b41cb41">26</ix:nonFraction>%,&#160;<ix:nonFraction unitRef="number" contextRef="i8af8821a5a8e4e06898dabdea6965ee3_I20211231" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzE1NzAz_b0ddc4d9-b0dd-4b00-a447-1f0600330a4a">17</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="i865e2c5df39b4cecb1d900db1ae6ca7d_I20211231" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzE1NzA3_6e65844e-efc5-4132-abe8-5a7e2f4d35ae">11</ix:nonFraction>%, and&#160;<ix:nonFraction unitRef="number" contextRef="if8efddd0307c4f6c9b1fab4c82f7cd7b_I20211231" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzE1NzE1_f6f69a34-ac1d-413b-9b61-8cb734b30231">10</ix:nonFraction>%&#160;are expected to be recognized during 2022, 2023, 2024, 2025, and thereafter, respectively.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Reagent Rental Programs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our reagent rental programs provide our customers the right to use our instruments upon entering into multi-year agreements to purchase annual minimum amounts of consumables. These types of agreements include an embedded lease for the right to use our instrument and we determine the amount of lease revenue allocated to the instrument based on relative standalone selling prices. We evaluate the terms of these embedded leases to determine classification as either a sales-type lease or an operating lease.</span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Sales-type Reagent Rental Programs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our reagent rental programs that effectively transfer control of instruments to our customers are classified as sales-type leases and we recognize instrument revenue and cost in advance of billing the customer, at the time of installation and customer acceptance. Our right to future consideration related to instrument revenue is recorded as a lease receivable within other current and long-term assets, and is transferred to accounts receivable when customers are billed for products and services over the term of the contract. On December 31, 2020, our lease receivable assets were $<ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-5" name="us-gaap:SalesTypeLeaseLeaseReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzE2OTU3_c226a4cd-e7fa-4e96-803e-c15963b31bd0">11.1</ix:nonFraction>&#160;million, of which approximately $<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-5" name="idxx:SalesTypeLeaseLeaseReceivableReclassifiedToReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzE2OTg0_678f82f6-bd89-4120-87df-a6e70bc833d7">2.2</ix:nonFraction>&#160;million was reclassified to accounts receivable when customers were billed for related products and services during the year ended December 31, 2021. Furthermore, as a result of new placements under sales-type reagent rental programs, net of subsequent amounts reclassified to accounts receivable, and allowances established for credit losses, our lease receivable assets were $<ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-5" name="us-gaap:SalesTypeLeaseLeaseReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzE3MzU2_9af734fc-5f5b-4b53-b78f-e54f02a0b913">15.3</ix:nonFraction> million at December 31, 2021. The impacts of discounting and unearned income at December 31, 2021, were not material. Profit and loss recognized at the commencement date and interest income during the year ended December 31, 2021, were not material. We monitor customer purchases over the term of their agreement to assess the realizability of our lease receivable assets. Impairments during the year ended December 31, 2021, were not material.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Operating-type Reagent Rental Programs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our reagent rental programs that do not effectively transfer control of instruments to our customers are classified as operating leases and we recognize instrument revenue and costs ratably over the term of the agreement. The cost of the instrument is capitalized within property and equipment.</span></div><div style="padding-left:72pt;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate future revenue to be recognized related to our reagent rental programs of approximately&#160;$<ix:nonFraction unitRef="usd" contextRef="i269b18a6e9c74892a68183dfb6d26182_I20211231" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzE4MTcz_b41f6098-c152-4cad-a300-2448f56103d3">38.3</ix:nonFraction> million, of which approximately&#160;<ix:nonFraction unitRef="number" contextRef="i0e53a7345431421d90c84f0714010ab8_I20211231" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzE4MjAw_4a96aedf-dffb-4e07-8637-57d3cdeab51f">32</ix:nonFraction>%,&#160;<ix:nonFraction unitRef="number" contextRef="i26a9c61e7add4db7b09dd7228e5adf11_I20211231" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzE4MjA0_1ee506ea-203c-4861-a02a-99a00ced3023">26</ix:nonFraction>%,&#160;<ix:nonFraction unitRef="number" contextRef="i552f56ee344349d0a8fe803f1d4ac028_I20211231" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzE4MjA4_c5ac9b71-99a7-4f27-90be-3a4bb766f30d">20</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="ia21b4eae913c4602899f11b240ecd020_I20211231" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzE4MjEy_a67bab8b-3402-42c4-ba68-512f11378121">14</ix:nonFraction>%, and <ix:nonFraction unitRef="number" contextRef="i8e6515d33c104d37893035bf37f096ad_I20211231" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzE4MjIw_6770813d-c79f-41f8-af04-dadad6b9f43c">8</ix:nonFraction>%&#160;are expected to be recognized during 2022, 2023, 2024, 2025, and thereafter, respectively. These future revenues relate to performance obligations not yet satisfied for which customers have committed to future purchases, net of any expected price adjustments, and as a result, may be lower than stated contractual commitments by our customers.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other Customer Incentive Programs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Certain agreements with customers include discounts or rebates on the sale of products and services applied retrospectively, such as volume rebates achieved by purchasing a specified purchase threshold of goods and services. We account for these discounts as variable consideration and estimate the likelihood of a customer meeting the threshold in order to determine the transaction price using the most predictive approach. We typically use the most-likely-amount method for incentives that are offered to individual customers, and the expected-value method for programs that are offered to a broad group of customers. Revenue adjustments that relate to performance obligations satisfied in prior periods during the&#160;years ended&#160;December 31, 2021 and 2020, were not material. Refund obligations related to customer incentive programs are recorded in accrued liabilities for the actual issuance of incentives, incentives earned but not yet issued, and estimates of incentives to be earned in the future.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Program Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. At times, we combine elements of our significant customer programs within a single customer contract. We separate each significant program element and include the contract assets, customer acquisition costs, deferred revenues, and estimated future revenues within the most relevant program disclosures above. Each customer contract is presented as a net contract asset or net contract liability on our consolidated balance sheet.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">IDEXX Points</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. IDEXX Points may be applied to trade receivables due to us, converted to cash, or applied against the purchase price of IDEXX products and services. We consider IDEXX Points equivalent to cash. IDEXX Points that have not </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i8b30c20263064a458afa722ee978889c" continuedAt="i42f713176b8c4d099c0b1dd145e91378"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">yet been used by customers are included in accrued liabilities until utilized or expired. Breakage is not material because customers can apply IDEXX Points to trade receivables at any time.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Accounts Receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We recognize revenue when it is probable that we will collect substantially all of the consideration to which we will be entitled, based on the customer&#8217;s intent and ability to pay the promised consideration. We apply judgment in determining the customer&#8217;s ability and intention to pay, which is based on a variety of factors including the customer&#8217;s historical payment experience or, in the case of a new customer, published credit and financial information pertaining to the customer. We have&#160;no&#160;significant customers that accounted for greater than 10% of our consolidated revenues and we have&#160;no&#160;concentration of credit risk as of&#160;December 31, 2021.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Disaggregated Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We present disaggregated revenue for our CAG segment based on major product and service categories. Our Water segment is comprised of a single major product category. Although our LPD segment does not meet the quantitative requirements to be reported as a separate segment, we believe it is important to disaggregate these revenues as a major product and service category separately from our Other reportable segment given its distinct markets, and therefore we have elected to report LPD as a reportable segment.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzIzNTcz_f1134e75-3536-41b6-b52f-ed9606aaca08" continuedAt="i4259ce3da0c34cd1871b5f01a0357660" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table&#160;presents disaggregated revenue by major product and service categories:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:58.311%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.696%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CAG segment revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CAG Diagnostics recurring revenue:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i723287d015984ccaa532d58c82848761_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzMtMi0xLTEtMA_d69b8f79-8abb-43da-84b6-1c89a42c44e4">2,534,562</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if77b95f4c71f4d27a4b24d6a7f47cb19_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzMtNC0xLTEtMA_5a0ec126-1832-496c-81ae-b983de0b3cfc">2,113,839</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3495e15513b94d078ea449cf5f428620_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzMtNi0xLTEtMA_a4fd2997-6afe-4de6-8da7-de39b3c1a28d">1,828,329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">IDEXX VetLab consumables</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf886748aba34b2dae8f6c7817ad2a16_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzQtMi0xLTEtMA_4fdde402-6c59-486a-8072-61b26aa2386d">1,006,781</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45c842be487a4adeaf405fb278d02adb_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzQtNC0xLTEtMA_362c52f5-ed85-4bec-8502-e79ac8a2fe2a">824,376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecf199144d3940e08f79eb67130f5a22_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzQtNi0xLTEtMA_98321059-7bed-4ee5-8720-033c74f509b1">693,360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Rapid assay products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a1a0bb358d847259b4ee304e5a46a33_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzUtMi0xLTEtMA_eb2aa210-feac-4b16-a342-357072b936b3">296,852</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i793b95b40c3a4a9490a98b288a146ee0_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzUtNC0xLTEtMA_c804f623-cb61-4e13-b84d-f4d00a925809">253,018</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56aa1f828bc845f58439fe0a42646b60_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzUtNi0xLTEtMA_41e41d19-61c5-465a-baf7-7efec90e8a18">232,149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Reference laboratory diagnostic and consulting services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82504fe08ede4c6f89672ec5a625601e_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzYtMi0xLTEtMA_378387a7-4c53-4318-aa44-863652e5964a">1,123,656</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32b9c9eff8ca4148be177ce0cbdddd6b_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzYtNC0xLTEtMA_312e42f8-39ba-4a85-ab79-4c503da7781a">946,268</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1430c1be15d34b1abe49cb43d2d401ba_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzYtNi0xLTEtMA_aeff330b-4e32-432e-8c77-6a45eee5b945">822,497</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">CAG Diagnostics services and accessories</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a2f9d2f1d5a4674af66963a5565e7f1_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzctMi0xLTEtMA_ef043ca3-8c62-486f-b3d0-4ec621c8a182">107,273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib81ecabbb8614cf1b2acb2b54f2c36f9_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzctNC0xLTEtMA_0abda156-3605-46ec-9fd5-e0bfbac97fda">90,177</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c8a095edc841769c85865c8e5036f2_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzctNi0xLTEtMA_558ac567-a4aa-4aa1-8b2f-828e65b64948">80,323</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CAG Diagnostics capital - instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4caa366375c4cb9a3594b681a103170_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzgtMi0xLTEtMA_da4aaf74-f3c8-41b7-bd59-83bff6230a90">149,140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i726e9c456ab44126a671318ab9275f7f_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzgtNC0xLTEtMA_1a831201-94b8-4f81-8eb6-72fb6226caf1">108,950</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e5c3cd621d24cb28572507163aed2f7_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzgtNi0xLTEtMA_01181bfd-a147-49cb-a2be-62ebb72e9ec8">132,685</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Veterinary software, services and diagnostic imaging systems</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fd4d20f53cd47b499e032d174f468fc_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzktMi0xLTEtMA_a0de7785-f4de-45a8-ba8b-3888a6056118">206,258</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69584183a25e434eb0dbc26d4f7a118d_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzktNC0xLTEtMA_e99d5d2f-f511-43e6-ac73-17a24ecce476">162,976</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8301f630e8b443fe8e590fcd68eab16f_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzktNi0xLTEtMA_7315fb63-ade3-4f23-ac47-92c9f3792132">158,169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CAG segment revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c823cc0aa3945d9874ea09ab5940878_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzEwLTItMS0xLTA_0d5e780a-01df-4f69-bf59-290b706bcfe0">2,889,960</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40313073e9c743ad89084e7fbcbd7e5e_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzEwLTQtMS0xLTA_5cd3dee0-6fb2-4dac-9050-7c7291eec553">2,385,765</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief827aa39f934947a553685160a5543c_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzEwLTYtMS0xLTA_06b9ba11-2976-463c-b6e9-a550a8570864">2,119,183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Water segment revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81c0a80f385a4f18ab5cb5919ed28318_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzEyLTItMS0xLTA_374c905f-d485-45f3-903c-31322db10ccb">146,505</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0b173f4625a4e1e807adc8eeb4e0592_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzEyLTQtMS0xLTA_5b6ded7e-98ba-4b1a-8677-12b5d5ebee12">128,625</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab0b6ebdef1a4be9b052a1b82c635759_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzEyLTYtMS0xLTA_8d7422ab-12c0-447e-88b7-ce29b3a3bd7f">132,850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LPD segment revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4174c33ea3f8443fbc6587f7ac9a43ab_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzEzLTItMS0xLTA_afcea5fc-2d51-407a-8daf-ff5b06b99f5b">135,887</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4525be5d1c1b4d458fe78f047e981dc1_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzEzLTQtMS0xLTA_c80331f0-45d0-4333-8883-1f1a0061a08a">145,845</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34e8ebea941e457cbadc1ce152e6a396_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzEzLTYtMS0xLTA_41df3fab-00e3-42fd-aede-e5a4e64f420f">132,635</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other segment revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94cd933d7b7b431caa324dc2936f5c55_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzE0LTItMS0xLTA_c1b545ae-dc5f-42c4-ab73-0a6a43e0e34a">43,008</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100119c49d8f4098bf6afdc675782162_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzE0LTQtMS0xLTA_fad925b1-69cf-412b-aa35-e07ddbe858b0">46,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6f9b6007f00420291efefe0008f3d10_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzE0LTYtMS0xLTA_2d8b879a-ac10-4297-a2be-df9a5a13dd7d">22,240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzE2LTItMS0xLTA_403475ed-0cd7-493b-9483-10adc47f07ea">3,215,360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzE2LTQtMS0xLTA_fbf1a4c4-0d6f-488e-be08-e6b22b1acc51">2,706,655</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzE2LTYtMS0xLTA_948f0e8e-8e7a-4ac5-bb9b-96a4d5bcfa29">2,406,908</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i42f713176b8c4d099c0b1dd145e91378"><ix:continuation id="i4259ce3da0c34cd1871b5f01a0357660"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue by principal geographic area, based on customers&#8217; domiciles, was as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:58.311%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.696%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Americas</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i074301c2df824186bd2aba7d250d51cf_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzMtMi0xLTEtMA_0a7f1689-b310-460e-83c5-dafe2e33e91d">1,995,683</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01f16b1d8f40480ea91113c41cce5e7a_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzMtNC0xLTEtMA_7d36203e-fd72-4051-8b79-463e5674e298">1,691,224</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4020a52f56894866abcca95a1a1497f1_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzMtNi0xLTEtMA_57178030-b766-4e22-ae78-cc23d18448c1">1,495,516</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766a0f5291584f90863a5968d8de067c_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzQtMi0xLTEtMA_fd789936-bc8e-49fc-8b3c-9a3d7ded5df8">139,727</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8215241a5640df9c12270ca8891308_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzQtNC0xLTEtMA_fb9cec10-0281-49da-9737-0a523101850d">107,398</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098a241b58744ea38131468a239f7847_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzQtNi0xLTEtMA_3a8ff9cc-bda5-4c23-baad-7e3eefdede60">99,550</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Latin America &amp; Caribbean</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d89e0f871864b189335e7739d42fe07_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzUtMi0xLTEtMA_e8aff146-147a-40d6-8a6d-a0be43335cc0">66,623</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7743a6f4bd764d2a9da6c4de5e290df5_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzUtNC0xLTEtMA_46e98154-3447-48f6-803e-207a3e177231">51,863</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i875c0d290dfb4cbf8a2b59d7e2c6d1fe_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzUtNi0xLTEtMA_1a32a823-4736-438d-b43d-34e13e0f812b">56,515</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76f3ab4debf64563bc6a167ac410e9c3_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzYtMi0xLTEtMA_9d73f19a-3043-45ef-9252-6eb68c2aa273">2,202,033</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe22eae831934369a9a0015d3c260ab2_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzYtNC0xLTEtMA_3d7c9e85-73e1-49e6-9fd2-4f47fb9b4ed9">1,850,485</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4ec176e93ab43bb98dd7714f2512730_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzYtNi0xLTEtMA_0fdee1c7-476c-4879-a0e1-cfeb0c0cc085">1,651,581</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Europe, the Middle East and Africa</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie659b0df466445ae9609de3ee174d80c_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzktMi0xLTEtMA_6992afe9-ceb1-4fe5-a8cf-59ad8d191bf2">146,762</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0c4109668754b8693ca7161318090f9_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzktNC0xLTEtMA_5d5f5f5c-6b01-4976-98cf-598cb2ab5ae7">119,353</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa67f291b9eb45a780298d9ae25ddaf3_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzktNi0xLTEtMA_18fba1ee-f7ac-4dc7-b672-606565f91377">104,081</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7dbddd91eb54624978a0b4ed56ec859_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzEwLTItMS0xLTA_2fee71fb-b074-4693-9138-73020abd47b8">114,955</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaded4b965f664c0d806bbe1ac965cd5d_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzEwLTQtMS0xLTA_fe076dbc-9d1b-4590-86bc-e4101bbf846b">90,156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d87cb22b86c44f4b570eed70a1378eb_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzEwLTYtMS0xLTA_000bd2c5-56e8-41eb-a60e-c8f854a1f987">90,969</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">France</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75c498c811384ef09dcd9c2fe08380c8_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzExLTItMS0xLTA_3604e7e9-f9c8-4383-8525-52218f65b224">90,836</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66eb4e58d2ee4aaca353fee7f134054f_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzExLTQtMS0xLTA_67732d51-91d0-4f4f-91d3-e13b202890ca">74,814</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dc62339001e4ad4a1835c85eedc299e_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzExLTYtMS0xLTA_339fd872-5d8b-4d51-b41d-40041adf4648">64,767</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Italy</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f1ed5c7ebf34e30a0fdb012cddf7440_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzEyLTItMS0xLTA_cb30c38b-63da-4bd0-8fce-fa3e9d74b01a">52,062</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9c07a32fa054809a3705b5c0d25c972_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzEyLTQtMS0xLTA_fc0ecc47-a83f-4d59-84da-276abe8ade53">42,817</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i024ff5694a8c4073a3e5ce8f499229f6_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzEyLTYtMS0xLTA_0d2d40e4-1f26-47d3-b948-4677e5f025c9">39,725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Spain</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a12365e7904425790e4a07eca696916_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzEzLTItMS0xLTA_93143bae-bda5-4183-8dd3-b918ef47463c">48,169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib98678b4e8cf4f749ac3e5c05952d91b_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzEzLTQtMS0xLTA_db51dbad-88f0-4534-b14c-e841384f0fa6">39,265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2f16826ba294aa484551884f87d09e8_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzEzLTYtMS0xLTA_5f2db307-74ac-4fc2-b2da-1c5ae8a9d2a6">36,439</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Switzerland</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7896731fe12243f1875fd4ce04068904_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzE0LTItMS0xLTA_fdbcca44-4bcb-447f-b09f-d5c9ef2be156">31,984</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie109583690ce4e2eae0a0a5c373a2ee4_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzE0LTQtMS0xLTA_5f0999c8-9151-499d-bee7-53924e5621dc">24,850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie037b3568c7d47d8914ff5010a0aedcd_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzE0LTYtMS0xLTA_2f160ade-2355-4ff6-8ed6-9678a52b5ba2">20,855</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Netherlands</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8207a8f256ab4cc6a3250a19887134bd_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzE1LTItMS0xLTA_d2f275f6-ddae-46d2-9ccd-dfe80ee5aea3">29,656</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ec2b03ad795418a8009824d2524452f_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzE1LTQtMS0xLTA_e073d6bc-5367-4cc6-b090-9f669087c6b4">23,461</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33cd1326584149ccbfa7ddc29ff1f6c8_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzE1LTYtMS0xLTA_1332e15a-342a-4a9d-9108-0944131ed327">19,397</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b82ba0179564e93a090862f65ad1917_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzE2LTItMS0xLTA_33fa03a2-d8b3-435a-8555-b253db89be57">167,525</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id596dfd4731c4532a3f61ad928fd2c5c_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzE2LTQtMS0xLTA_6c51b680-ce22-486f-9ca8-29a1b4113f67">148,049</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07e74761556442abb8ddcffbbc211fcf_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzE2LTYtMS0xLTA_ab0ebada-6086-4174-9768-f21ad2380aa2">122,206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if20538cc41914789b22efe5b91f2f3a7_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzE3LTItMS0xLTA_363a8935-2209-4e33-a81b-6c45331a33fb">681,949</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5db3ce1c3924c83b379d8a61e0f7372_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzE3LTQtMS0xLTA_8544ebc3-e824-47f9-96c7-9f39329e9129">562,765</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9195b1ced7483697bc7828d38b1dc3_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzE3LTYtMS0xLTA_d0fe0450-4a74-4db7-98c6-0cc570ed9c1d">498,439</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asia Pacific Region</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Australia</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf1299bd5850495db5bab930c750f59c_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzE5LTItMS0xLTA_e47a8cc9-9bc1-49df-8870-8b02a6a657d8">94,414</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaa60874497e43898b35ee415a2bc80f_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzE5LTQtMS0xLTA_94413a82-6c86-4465-844c-b1871b373f74">79,629</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220bf3ab1a154b9a8693e8e99867b9ac_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzE5LTYtMS0xLTA_3e7f780b-ccd7-48c4-9a60-0c8e2131d57a">71,069</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f4a460cb3fc481b87a66c1143b1c6ae_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzIwLTItMS0xLTA_b9462a58-01ca-4644-a724-f27671f0a339">84,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfb45a09b6c94d2f9c4fa39784fc4f4c_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzIwLTQtMS0xLTA_6e2712bb-3252-4db1-94d6-c6d691bfb65d">74,725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27d98417a7ed441dbaefaf4e3c7d8e3e_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzIwLTYtMS0xLTA_422022a3-a0b8-4811-9ff8-107eb9279e08">67,246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">China</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice113159eb944073881b74017325c32e_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzIxLTItMS0xLTA_22f2d0e9-9cc5-4b2d-b1cb-9df51374bf53">63,166</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25c97c45426b49229b105df880a272e6_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzIxLTQtMS0xLTA_65e89083-eada-4d2d-8ec2-8c9809b81c56">70,845</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i725b5e5dc5f042a7ae398d70fbeee8a5_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzIxLTYtMS0xLTA_280f2379-09d5-4e36-858e-7880f687a64d">57,518</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c7784e6972a40e794a9b073a04021a7_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzIyLTItMS0xLTA_45bf8219-1180-4047-aa71-444713ca0350">89,523</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id95808181fe340cf9c9a3e0c0794af01_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzIyLTQtMS0xLTA_2a559437-ead2-49de-ab58-d897a7e39735">68,206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8756d035ba8e462584f1d7c8d7dddac4_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzIyLTYtMS0xLTA_01d851b6-cd0e-48e8-878f-f9cb4f11b8d4">61,055</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic225702a7bba4086a0eb7207e3dcb702_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzIzLTItMS0xLTA_6b779038-d124-4b6f-844a-d103d1c3c5e7">331,378</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b04ff1af6a74efbb011731141a869fb_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzIzLTQtMS0xLTA_d66a7af7-edc8-4011-927c-11a798c38150">293,405</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471d983af3ad4dbda5429f440f2683ff_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzIzLTYtMS0xLTA_4e833e79-84e1-4b1d-b7f7-f638b1292007">256,888</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzI0LTItMS0xLTA_839a9841-a7c0-440f-9ca5-87efc43394b9">3,215,360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzI0LTQtMS0xLTA_b4420b77-80cb-45c0-8d6a-7601ec168ef2">2,706,655</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzI0LTYtMS0xLTA_58d1c9bf-65af-4e1f-9dbb-5e5234b15006">2,406,908</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Costs to Obtain a Contract</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We capitalize sales commissions and the related fringe benefits earned by our sales force when considered incremental and recoverable costs of obtaining a contract. Our contracts include performance obligations related to various goods and services, some of which are satisfied at a point in time and others over time. Commission costs related to performance obligations satisfied at a point in time are expensed at the time of sale, which is when revenue is recognized. Commission costs related to long-term service contracts and performance obligations satisfied over time, including extended warranties and SaaS subscriptions, are deferred and recognized on a systematic basis that is consistent with the transfer of the goods or services to which the asset relates. We apply judgment in estimating the amortization period, which ranges from&#160;<ix:nonNumeric contextRef="iec94ca1756b3473faecedf9258139d41_I20211231" name="us-gaap:CapitalizedContractCostAmortizationPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzIyNzM5_a0c4fc7d-aeb6-4afa-af61-7b2e74003d4f">3</ix:nonNumeric>&#160;to&#160;<ix:nonNumeric contextRef="i9aa403826a744b88a310a196d527c4da_I20211231" name="us-gaap:CapitalizedContractCostAmortizationPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzIyNzQ1_14874113-3a17-4360-9b06-25abd3f9ff61">7</ix:nonNumeric> years, by taking into consideration our customer contract terms, history of renewals, and expected length of customer relationship, as well as the useful life of the underlying technology and products. Amortization expense is included in sales and marketing expenses in the accompanying consolidated statements of income. Deferred commission costs are periodically reviewed for impairment.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 31, 2020, our deferred commission costs, included within other assets, were&#160;$<ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-5" name="us-gaap:CapitalizedContractCostNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzIzMjA5_afa7fd7f-9311-4732-9aa9-cd1814b81f44">17.5</ix:nonFraction> million, of which approximately&#160;$<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-5" name="us-gaap:SalesCommissionsAndFees" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzIzMjM2_db0f47cc-140b-4ff1-aed7-4f0f7b6dc49a">5.7</ix:nonFraction> million&#160;of commission expense was recognized during the&#160;year ended&#160;December 31, 2021. Furthermore, as a result of commissions related to new extended warranties and SaaS subscriptions, net of subsequent recognition, our deferred commission costs were&#160;$<ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-5" name="us-gaap:CapitalizedContractCostNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzIzNDY4_847b3f72-ea40-4167-97f8-0719ecf623f9">19.5</ix:nonFraction> million&#160;at&#160;December 31, 2021. Impairments of deferred commission costs during the&#160;years ended&#160;December 31, 2021 and 2020, were not material.</span></div></ix:continuation><div><span><br/></span></div><div id="i5d795a6851d746ca914a2ddae761c329_184"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 4.&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzIxNjU_38f061a6-09e1-4183-93be-b42569794d09" continuedAt="i1574cd45c2b440e8a00f243b7829c298" escape="true">ACQUISITIONS AND INVESTMENTS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i1574cd45c2b440e8a00f243b7829c298" continuedAt="i4002e1d50b734362b80bb32a4e8204de"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our acquisitions of businesses and other assets enhance our existing businesses by either expanding our geographic range, customer base, or existing product and service lines. From time to time, we may acquire small reference laboratories or radiology practices that we account for as either asset purchases or business combinations.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2021, we acquired the shares of a reference laboratory located in Finland for approximately $<ix:nonFraction unitRef="usd" contextRef="i842723fe206441498f4f17f31a9787fc_D20211001-20211231" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzQ5NDc4MDIzNDY2NzA_38bc3e78-d6f5-480c-b4fe-a5d8a1ce5a9a">13.4</ix:nonFraction>&#160;million in cash, including a holdback of approximately $<ix:nonFraction unitRef="usd" contextRef="ie8c73a699ac1449a83257aa402845ff6_I20211231" decimals="-5" name="idxx:BusinessCombinationContingentConsiderationHoldback" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzQ5NDc4MDIzNDY2ODU_90a7db38-79de-4cf6-a139-84f19594c6d3">1.4</ix:nonFraction>&#160;million. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This acquisition expands our international reference laboratory presence and was accounted for as a business combination. The fair values of the assets acquired consist of&#160;customer relationship intangibles of approximately $<ix:nonFraction unitRef="usd" contextRef="ic0b97d19fd5e4d9da47732f2832e48e0_I20211231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzQ5NDc4MDIzNDY2OTk_f0404de9-c156-4d7f-aaaa-79102d6b4d23">7.4</ix:nonFraction>&#160;million, with a life of <ix:nonNumeric contextRef="iea6bbd7bf4aa409f81e8b4939eaeebb7_D20211001-20211231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzQ5NDc4MDIzNDY3MTU_5ea37576-4ad7-493c-8dbc-b1342b8fde9d">10</ix:nonNumeric> years; a non-compete agreement of approximately $<ix:nonFraction unitRef="usd" contextRef="i5aeff8abf9cf474cb8eef1fda56b68fb_I20211231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzQ5NDc4MDIzNDY3Mjg_0fffefe0-5637-421b-9388-5864b38edfff">0.8</ix:nonFraction>&#160;million, with a life of <ix:nonNumeric contextRef="i809c93aee53e4f94943260050b20b48b_D20211001-20211231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzQ5NDc4MDIzNDY3NDQ_a2d5a95f-99d2-4515-98fe-dc5ad88d7421">3</ix:nonNumeric> years; approximately $<ix:nonFraction unitRef="usd" contextRef="ie8c73a699ac1449a83257aa402845ff6_I20211231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzQ5NDc4MDIzNDY3NTY_6bd6a3f3-fd14-4535-9449-d9b063823f3b">5.3</ix:nonFraction>&#160;million of goodwill, representing synergies within our broader CAG portfolio; and approximately $<ix:nonFraction unitRef="usd" contextRef="ie8c73a699ac1449a83257aa402845ff6_I20211231" decimals="-5" name="idxx:BusinessCombinationsTangibleLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzI3NDg3NzkwOTEzMzY_ad505da9-84e8-48e0-b00b-b9081f5ccca6">0.1</ix:nonFraction>&#160;million in net tangible liabilities. The purchase price allocation is </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i4002e1d50b734362b80bb32a4e8204de" continuedAt="i0797612ed1ea487e9070ccd8dfee188f"><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">subject to revision as additional information becomes available regarding review of taxes and the settlement of the working capital adjustment. Goodwill related to this acquisition is not expected to be deductible for tax purposes. Pro forma information has not been presented for this acquisition because such information is not material to the financial statements. The results of operations have been included in our CAG segment since the acquisition date. The acquisition expenses were not material.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2021, we acquired the assets of a teleradiology business for approximately $<ix:nonFraction unitRef="usd" contextRef="ifd3e48c2fc1c450db3e7a70a7d818589_D20210701-20210930" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzEwOTk1MTE2NDIzMTc_361160d6-36e7-487f-a00a-00e6f6ad3797">5.4</ix:nonFraction>&#160;million, including a contingent payment of $<ix:nonFraction unitRef="usd" contextRef="ifce9ad75783047eca6a078e591b5a29e_I20210930" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzEwOTk1MTE2NDIzNTY_94d7e966-e7a4-4666-aa76-caab586e69ce">0.3</ix:nonFraction>&#160;million. This acquisition expands our current teleradiology capability. The acquired assets primarily consist of a customer relationship intangible of approximately $<ix:nonFraction unitRef="usd" contextRef="id1280d77ec9a4626b628ba48e7a82fee_I20210930" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzEwOTk1MTE2NDI1MTc_f9bb5c06-7a38-4f87-8704-62b7bbb374b0">1.7</ix:nonFraction>&#160;million, with a weighted average life of</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="ida01d0b9ae19406cba72ddf3076630da_D20210701-20210930" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzEwOTk1MTE2NDI1NTQ_4e079b01-81f1-4c64-9acb-f4e2c7471a75">10</ix:nonNumeric> years</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and approximately $<ix:nonFraction unitRef="usd" contextRef="ifce9ad75783047eca6a078e591b5a29e_I20210930" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzEwOTk1MTE2NDI1Nzc_ee7ea99f-0f7d-489c-b683-38914afa7a72">3.7</ix:nonFraction>&#160;million in goodwill. Goodwill related to this acquisition is expected to be deductible for tax purposes. Pro forma information has not been presented for this acquisition because such information is not material to the financial statements. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of operations have been included in our CAG segment since the acquisition date. The acquisition expenses were not material.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2021, we acquired the assets of the ezyVet cloud-based veterinary software businesses and the shares of ezyVet US, Inc., as well as the Vet Radar business assets, for approximately $<ix:nonFraction unitRef="usd" contextRef="i4cad12a2c61c492fa2913b23e32f05f6_D20210401-20210630" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzEwOTk1MTE2NDMzMDc_5470db9e-d49a-44da-a73a-9f541e908854">157.2</ix:nonFraction>&#160;million, including an estimated contingent payment of $<ix:nonFraction unitRef="usd" contextRef="ia2728c192ba740b3bccbeb6af69b3ba8_I20210630" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzEwOTk1MTE2NDMzNTc_1df1f96d-c03d-484f-8451-289cef63931f">5.0</ix:nonFraction>&#160;million. The acquired assets include the ezyVet cloud-native practice management system software and the Vet Radar cloud-based workflow management software. The acquisition expands our cloud-based software offerings to support our customers with technology solutions that raise the standards of care for patients and improve practice efficiency. The fair values of assets acquired were as follow: approximately </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="ibfd9997d2b384ba184794f3511297632_I20210630" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzEwOTk1MTE2NDM4MTc_9e1a8422-0585-4d27-a5bd-119a255f95e3">32.0</ix:nonFraction>&#160;million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in customer-related intangible with a weighted average life of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i385bd1940c0e4f08b7a962517de3c1b1_D20210401-20210630" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzEwOTk1MTE2NDM4ODQ_5a01c875-0683-4d26-9b23-57cded50bc7a">10</ix:nonNumeric> years;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> approximately </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i305a1c1723984399939954021ea102bb_I20210630" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzEwOTk1MTE2NDM5MDM_33c602e8-f585-441e-bb81-eed6ff9ffd98">8.4</ix:nonFraction>&#160;million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in technology-related intangibles with a weighted average life </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if6b9086908654520873d5861115fad00_D20210401-20210630" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzEwOTk1MTE2NDM5NzM_c095bcb3-1cff-45a6-aa17-4e9d37bb8dac">6</ix:nonNumeric> years;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> approximately </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i2d303cab977e469191f8b6b1552d036c_I20210630" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzEwOTk1MTE2NDM5OTI_ec064426-8c18-4295-bf80-a27fd34e0692">2.4</ix:nonFraction>&#160;million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in trademarks with a weighted average life of</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="i331a2e7b2a724d3d95f8d3fa0aa4fb7f_D20210401-20210630" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzEwOTk1MTE2NDQwNDI_8538fd21-30d1-4c94-bb9f-8f89ca3ef74a">14</ix:nonNumeric> years;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> approximately </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i55647d483f84421fa97e4bd81c6d5d69_I20210630" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzEwOTk1MTE2NDQwNjE_92a41a4b-7a74-44cf-a34f-d636f30a2868">1.8</ix:nonFraction>&#160;million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in non-compete agreements with a weighted average life of</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="i21fecd38873f4b64b92a766a37bdf70b_D20210401-20210630" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzEwOTk1MTE2NDQxMjM_a611f7a9-b64e-487c-b043-362f3194ea9d">5</ix:nonNumeric> years;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> approximately </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="ia2728c192ba740b3bccbeb6af69b3ba8_I20210630" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzEwOTk1MTE2NDQxNDI_2523057b-23ba-40c0-9996-8b449766ff53">109.4</ix:nonFraction>&#160;million </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in goodwill, r</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">epresenting synergies within our broader CAG portfolio; and approximately $<ix:nonFraction unitRef="usd" contextRef="ia2728c192ba740b3bccbeb6af69b3ba8_I20210630" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzEwOTk1MTE2NDQyMzQ_9e0760b6-50dc-4c28-afef-43be274acf48">3.2</ix:nonFraction>&#160;million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in net tangible assets. Goodwill has been allocated to multiple reporting units based upon the fair value of projected earnings as of the date of the acquisition. The goodwill was allocated as follows: approximately $<ix:nonFraction unitRef="usd" contextRef="i37946dde29a24a35b13eae3f304d5a27_I20210630" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzEwOTk1MTE2NDQ0MjY_151e21b4-9b1a-4706-993b-872c51d6f146">23.4</ix:nonFraction>&#160;million to IDEXX VetLab&#174;, approximately $<ix:nonFraction unitRef="usd" contextRef="ie9efbaf1e37c410ea20352d5d9dfc9b2_I20210630" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzEwOTk1MTE2NDQ0NjI_25a85a6d-c473-45db-b58f-cfe0099dde9e">27.0</ix:nonFraction> million to Reference Laboratories, approximately $<ix:nonFraction unitRef="usd" contextRef="i51b0af3a479b46bfa75da33ccbef5a0d_I20210630" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzEwOTk1MTE2NDQ1MDU_963b11c7-3d52-4755-a937-4d3d7ba9b54b">11.1</ix:nonFraction>&#160;million to Rapid Assay, and approximately $<ix:nonFraction unitRef="usd" contextRef="iee0529f10fe24e86ad8b423b1dcfdfcd_I20210630" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzEwOTk1MTE2NDQ1NDM_f401ca23-c5b0-48c2-a8b9-9377f6c06e8f">47.9</ix:nonFraction>&#160;million to Veterinary Software Services. Goodwill related to this acquisition is expected to be deductible for tax purposes. Pro forma information has not been presented for this acquisition because such information is not material to the financial statements. The results of operations have been included in our CAG segment since the acquisition date. During the fourth quarter, we increased the contingent payable by $<ix:nonFraction unitRef="usd" contextRef="ifb7924f502ed418b8a52fa0f86e77e1b_D20211001-20211231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzQzOTgwNDY1MzM0NDE_b9385caa-da15-4d19-842b-691e4ddefdcd">2.0</ix:nonFraction>&#160;million, for a total expected payment of $<ix:nonFraction unitRef="usd" contextRef="i19e2681a08f94930a55705e928524d31_I20211231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzQzOTgwNDY1MzM0Mjk_b376ce64-f92d-424f-a774-64d0a3f8ee65">7.0</ix:nonFraction>&#160;million. This increase to the contingent payment is expensed as the adjustment was made after the measurement period. The acquisition expenses were approximately $<ix:nonFraction unitRef="usd" contextRef="ifb7924f502ed418b8a52fa0f86e77e1b_D20211001-20211231" decimals="-5" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzI3NDg3NzkwOTE0MDA_1de41898-277f-48ce-ac16-eeab98c6b798">2.2</ix:nonFraction>&#160;million. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2021, we acquired the shares of a reference laboratory located in Switzerland for approximately $<ix:nonFraction unitRef="usd" contextRef="id8e658249a1b4ada9bf653d6f869d521_D20210101-20210331" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzEwOTk1MTE2NDUwNjc_58c0a9b9-5a96-4ca8-a957-f0c2c225fb3b">5.5</ix:nonFraction>&#160;million in cash, including holdback and contingent payments of approximately $<ix:nonFraction unitRef="usd" contextRef="i19c6a768e2a14d0bb7d30636dbb2c293_I20210331" decimals="-5" name="idxx:BusinessCombinationContingentConsiderationLiabilityAndHoldback" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzEwOTk1MTE2NDUxNDA_9cb3187d-c147-4eac-8dc3-9c00a68706ed">1.1</ix:nonFraction>&#160;million. This acquisition expands our international reference laboratory presence and was accounted for as a business combination. The fair values of the assets acquired consist of&#160;approximately $<ix:nonFraction unitRef="usd" contextRef="i98a1c47a6a4347cd86ea3a19f76e6f2c_I20210331" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzEwOTk1MTE2NDUzMzE_ea5fe9b3-acfc-4971-81c9-07fae65c4009">4.3</ix:nonFraction>&#160;million&#160;in intangible assets, primarily for customer relationships, which will be amortized over <ix:nonNumeric contextRef="ibf189d70c3364256b7c496f71fbb573e_D20210101-20210331" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzEwOTk1MTE2NDU0MjQ_684d2ec1-3e3a-4cbc-8b5f-c38fe1909dfc">9</ix:nonNumeric> years, approximately $<ix:nonFraction unitRef="usd" contextRef="i19c6a768e2a14d0bb7d30636dbb2c293_I20210331" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzEwOTk1MTE2NDU0NDM_c919c6aa-243f-4794-9766-a827032f4d45">1.8</ix:nonFraction>&#160;million for goodwill, representing synergies within our broader CAG portfolio, and approximately $<ix:nonFraction unitRef="usd" contextRef="i19c6a768e2a14d0bb7d30636dbb2c293_I20210331" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzEwOTk1MTE2NDU1MzY_9a694b35-98b3-4dd0-95cc-af01730991b1">0.6</ix:nonFraction>&#160;million&#160;of liabilities, including deferred taxes associated with the acquired intangible assets. Goodwill related to this acquisition is not deductible for tax purposes. Pro forma information has not been presented for this acquisition because such information is not material to the financial statements. The results of operations have been included in our CAG segment since the acquisition date. The acquisition expenses were not material.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2019 we acquired the assets of a multi-site reference laboratory business in the mid-west of the U.S. for $<ix:nonFraction unitRef="usd" contextRef="iaa9a585d1027406aaf397c11d9f703e3_D20191001-20191231" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzM1OA_7d794169-8046-4de6-88e9-e279d9d92ff9">50.0</ix:nonFraction> million in cash. This acquisition expands our national reference laboratory presence in the U.S., and was accounted for as a business combination. We finalized the valuation of the fair value of the assets acquired during the first quarter of 2020. The fair value of the assets acquired consists of $<ix:nonFraction unitRef="usd" contextRef="i1d6f007fbb65407089a89432eb6964c5_I20200331" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzY1Mg_f153a26f-54e7-44bb-bcd3-f3532fea67cd">26.9</ix:nonFraction> million in intangible assets, primarily for customer relationships, with a weighted average life of <ix:nonNumeric contextRef="i21fe577fc12d43d6aa8593e56fbbd4ba_D20200101-20200331" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1Xzc0Nw_ba86227d-06b7-418c-acb1-101a1cb0e8d7">13.8</ix:nonNumeric> years, $<ix:nonFraction unitRef="usd" contextRef="i80310c05b475409f9d808f6d23317bc9_I20200331" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1Xzc1MQ_8fe6acc3-7c7e-4762-9b0a-2f3f5ba4fe1d">0.2</ix:nonFraction> million of tangible assets, and $<ix:nonFraction unitRef="usd" contextRef="i80310c05b475409f9d808f6d23317bc9_I20200331" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1Xzc3OA_208a46d4-0158-4998-9a08-9c6ae355efae">22.9</ix:nonFraction> million of goodwill, representing synergies within our reference laboratory portfolio.&#160;The goodwill is expected to be deductible for income tax purposes. Pro forma information has not been presented for this acquisition because such information is not material to the financial statements. The results of operations have been included in our CAG segment since the acquisition date. The acquisition expenses incurred were not material. </span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:continuation id="i0797612ed1ea487e9070ccd8dfee188f" continuedAt="i4f27affc088d4be7a32c404ecd7e6fce">Acquisition of noncontrolling interest</ix:continuation></span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i4f27affc088d4be7a32c404ecd7e6fce">During the fourth quarter of 2021, we acquired the remaining <ix:nonFraction unitRef="number" contextRef="ifd0bd4a0a64d4c9fa9955ab39bcd5b33_D20211001-20211231" decimals="INF" name="idxx:NoncontrollingInterestOwnershipPercentageAcquiredFromNoncontrollingOwners" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzQ5NDc4MDIzNDY3NzA_b8695fbc-1db9-4fb3-8d21-7fbeb97d5f45">5</ix:nonFraction>% interest of our sole foreign joint venture operation for approximately $<ix:nonFraction unitRef="usd" contextRef="ifd0bd4a0a64d4c9fa9955ab39bcd5b33_D20211001-20211231" decimals="-5" name="us-gaap:MinorityInterestDecreaseFromRedemptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzQ5NDc4MDIzNDY3NzQ_3318ab33-b352-4d2d-bbcc-339d07cdc0ed">1.0</ix:nonFraction>&#160;million. As a result, we no longer record any minority interest in the equity section of our consolidated balance sheet. This transaction is recorded as an equity transaction, with no gain or loss reflected in the consolidated statements of income.</ix:continuation> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div id="i5d795a6851d746ca914a2ddae761c329_187"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 5.&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzExMjM0_cfbfa2e9-4e2e-4a2e-af98-eefc53a857f8" continuedAt="i78862280f69d4961b0c12564e431a106" escape="true">SHARE-BASED COMPENSATION </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i78862280f69d4961b0c12564e431a106" continuedAt="ie19bac89a7cf45efbc93199661e13aeb"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzExMjQz_8fefd82e-6376-4704-a6f7-73046461e0c0" escape="true">We provide for various forms of share-based compensation awards to our employees and non-employee directors. Our share-based compensation plans allow for the issuance of a mix of stock options, restricted stock, stock appreciation rights, employee stock purchase rights, and other stock unit awards.&#160;With the exception of stock options, the fair value of our awards is equal to the closing stock price of IDEXX common stock on the date of grant. We calculate the fair value of our stock option awards using the Black-Scholes-Merton option-pricing model. For stock options, restricted stock units (&#8220;RSUs&#8221;), and deferred stock units (&#8220;DSUs&#8221;), share-based compensation expense is recognized net of estimated forfeitures, on a straight-line basis over the requisite service period of the award for stock options.&#160;For performance-based restricted stock units (&#8220;PBRSUs&#8221;), share-based compensation expense is recognized net of estimated forfeitures, on a grade-vesting methodology over the requisite service period.</ix:nonNumeric>&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options permit a holder to buy IDEXX stock upon vesting at the stock option exercise price set on the day of grant. An RSU is an agreement to issue shares of IDEXX stock at the time of vesting. A PBRSU is an agreement to issue shares of IDEXX stock at the time of vesting upon successful completion of certain performance goals. DSUs are granted under our Executive Deferred Compensation Plan (the &#8220;Executive Plan&#8221;) and non-employee Director Deferred Compensation Plan (the &#8220;Director Plan&#8221;). DSUs may or may not have vesting conditions depending on the plan under which they are issued. We did not issue any restricted stock or stock appreciation rights during the years ended December 31, 2021, 2020, and 2019, nor were any restricted stock or stock appreciation rights outstanding as of those years ended.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We primarily issue shares of common stock to satisfy stock option exercises and employee stock purchase rights and to settle RSUs, PBRSUs, and DSUs. We issue shares of treasury stock to settle certain RSUs and upon the exercise of certain stock options, which were not material for the years ended December 31, 2021, 2020, and 2019. The number of shares of common stock and treasury stock issued are equivalent to the number of awards exercised or&#160;settled.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With the exception of employee stock purchase rights, equity awards are issued to employees and non-employee di</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rectors under the 2018 Stock Incentive Plan (the "2018 Stock Plan"). Our Board of Directors has authorized the issuance of <ix:nonFraction unitRef="shares" contextRef="i3338ed00513241bc832c9f2114b7b270_I20181231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzI1MDc_c5ef602a-5162-4dea-8df9-a394484c92f1">7.5</ix:nonFraction> million shar</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">es of our common stock under the 2018 Stock Plan. Any shares that are subject to awards of stock options or stock appreciation rights will be counted against the share limit as <ix:nonFraction unitRef="number" contextRef="i97018d52b0af4870b3849b272b1355ec_D20180101-20181231" decimals="INF" name="idxx:RatioSharesIssuedUnderShareBasedAwardsToSharesAuthorizedUnderStockPlans" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzI2OTE_d28b9186-29a1-48b5-81da-55a6bcddbdb1">one</ix:nonFraction> share for every share granted. Any shares that are issued other than stock options and stock appreciation rights will be counted against the share limit as <ix:nonFraction unitRef="number" contextRef="i8c8ce4fcf0ad47d1a61060c9d791ef17_D20180101-20181231" decimals="INF" name="idxx:RatioSharesIssuedUnderShareBasedAwardsToSharesAuthorizedUnderStockPlans" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzI4NTA_7ba1dfe1-b9ba-4598-8699-98ef34e0d74c">2.4</ix:nonFraction> shares for every share granted. If any shares issued under our prior plans are forfeited, settled for cash, or expire, these shares, to the extent of such forfeiture, cash settlement, or expiration, will again be available for issuance under the 2018 Stock Plan. As of December 31, 2021, there were approximately <ix:nonFraction unitRef="shares" contextRef="i4a16b614e5514b46a709cdefac9167c9_I20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzMxNTA_08508169-11be-4733-9f7b-23a9847e5951">6.5</ix:nonFraction> million remaining shares available for issuance under the 2018 Stock Plan.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ie19bac89a7cf45efbc93199661e13aeb" continuedAt="ic34ec86fe70e49238e835aa8e2181315"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation costs are classified in the consolidated financial statements consistent with the classification of cash compensation paid to the employees receiving such share-based compensation. <ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzExMjQ1_9a539c7e-3280-4409-9b0f-9f9bf6ec1223" continuedAt="ie5c7f603307b434c8d6de06103430ad9" escape="true">The following is a summary of share-based compensation costs and related tax benefits recorded in our consolidated statements of income:</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="ie5c7f603307b434c8d6de06103430ad9"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:58.490%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense included in cost of revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida1ffc64f6764bb4be6d2faec82e9f3f_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo0YTZjNWMzNDg2Zjk0ZGRjOGIwMjA1ZDIxMjQxYTA3OC90YWJsZXJhbmdlOjRhNmM1YzM0ODZmOTRkZGM4YjAyMDVkMjEyNDFhMDc4XzMtMi0xLTEtMA_246f2a06-1161-41b8-903a-56428d58a26d">4,044</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b83a53333fa4f00b4d62d186eefc036_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo0YTZjNWMzNDg2Zjk0ZGRjOGIwMjA1ZDIxMjQxYTA3OC90YWJsZXJhbmdlOjRhNmM1YzM0ODZmOTRkZGM4YjAyMDVkMjEyNDFhMDc4XzMtNC0xLTEtMA_45b2c289-7979-4a6e-a20f-e89998900d8e">3,415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie726a1d133bf4ad5a692bd283baf4341_D20190101-20191231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo0YTZjNWMzNDg2Zjk0ZGRjOGIwMjA1ZDIxMjQxYTA3OC90YWJsZXJhbmdlOjRhNmM1YzM0ODZmOTRkZGM4YjAyMDVkMjEyNDFhMDc4XzMtNi0xLTEtMA_f06f1eaa-1cc3-4c8c-a8cf-3aecf0b67b25">2,681</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense included in operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i154151cc952a42e2b9337039f8030f64_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo0YTZjNWMzNDg2Zjk0ZGRjOGIwMjA1ZDIxMjQxYTA3OC90YWJsZXJhbmdlOjRhNmM1YzM0ODZmOTRkZGM4YjAyMDVkMjEyNDFhMDc4XzQtMi0xLTEtMA_4082491c-1a2b-49c1-95ff-5fafb14bb2cb">33,711</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0b2c60d6a4244439cacf26a55fa991c_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo0YTZjNWMzNDg2Zjk0ZGRjOGIwMjA1ZDIxMjQxYTA3OC90YWJsZXJhbmdlOjRhNmM1YzM0ODZmOTRkZGM4YjAyMDVkMjEyNDFhMDc4XzQtNC0xLTEtMA_c1c1f284-d8e9-44a8-bd3b-9699cc6f86e5">27,536</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3a4a8e504c24b93880965b1c3991089_D20190101-20191231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo0YTZjNWMzNDg2Zjk0ZGRjOGIwMjA1ZDIxMjQxYTA3OC90YWJsZXJhbmdlOjRhNmM1YzM0ODZmOTRkZGM4YjAyMDVkMjEyNDFhMDc4XzQtNi0xLTEtMA_0b5353c7-aed9-41f0-9685-42eeaa8dabe9">36,597</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total share-based compensation expense included in consolidated statements of income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo0YTZjNWMzNDg2Zjk0ZGRjOGIwMjA1ZDIxMjQxYTA3OC90YWJsZXJhbmdlOjRhNmM1YzM0ODZmOTRkZGM4YjAyMDVkMjEyNDFhMDc4XzUtMi0xLTEtMA_e5ca5b71-088c-412c-aeb6-75efdcf1e4c3">37,755</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo0YTZjNWMzNDg2Zjk0ZGRjOGIwMjA1ZDIxMjQxYTA3OC90YWJsZXJhbmdlOjRhNmM1YzM0ODZmOTRkZGM4YjAyMDVkMjEyNDFhMDc4XzUtNC0xLTEtMA_d16589c9-9700-4241-a0f8-590cf3079e04">30,951</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo0YTZjNWMzNDg2Zjk0ZGRjOGIwMjA1ZDIxMjQxYTA3OC90YWJsZXJhbmdlOjRhNmM1YzM0ODZmOTRkZGM4YjAyMDVkMjEyNDFhMDc4XzUtNi0xLTEtMA_d07038a8-ac48-416c-a787-75bf06cd778d">39,278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax benefit resulting from share-based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo0YTZjNWMzNDg2Zjk0ZGRjOGIwMjA1ZDIxMjQxYTA3OC90YWJsZXJhbmdlOjRhNmM1YzM0ODZmOTRkZGM4YjAyMDVkMjEyNDFhMDc4XzYtMi0xLTEtMA_b874558e-beaf-422d-a5b1-aadb89117951">4,734</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo0YTZjNWMzNDg2Zjk0ZGRjOGIwMjA1ZDIxMjQxYTA3OC90YWJsZXJhbmdlOjRhNmM1YzM0ODZmOTRkZGM4YjAyMDVkMjEyNDFhMDc4XzYtNC0xLTEtMA_3284a2e4-15a3-42b7-baf4-87d2c4df05d5">3,965</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo0YTZjNWMzNDg2Zjk0ZGRjOGIwMjA1ZDIxMjQxYTA3OC90YWJsZXJhbmdlOjRhNmM1YzM0ODZmOTRkZGM4YjAyMDVkMjEyNDFhMDc4XzYtNi0xLTEtMA_673f3f8a-e625-4ffb-9f93-dea61e7dbe1b">4,861</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net share-based compensation expense included in consolidated statements of income, excluding tax benefit from settlement of share-based awards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="idxx:AllocatedShareBasedCompensationExpenseNetOfTaxExcludingTaxBenefitFromSettlementOfShareBasedAwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo0YTZjNWMzNDg2Zjk0ZGRjOGIwMjA1ZDIxMjQxYTA3OC90YWJsZXJhbmdlOjRhNmM1YzM0ODZmOTRkZGM4YjAyMDVkMjEyNDFhMDc4XzctMi0xLTEtMA_046835b3-d44a-4870-960f-e2d361eac0a9">33,021</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="idxx:AllocatedShareBasedCompensationExpenseNetOfTaxExcludingTaxBenefitFromSettlementOfShareBasedAwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo0YTZjNWMzNDg2Zjk0ZGRjOGIwMjA1ZDIxMjQxYTA3OC90YWJsZXJhbmdlOjRhNmM1YzM0ODZmOTRkZGM4YjAyMDVkMjEyNDFhMDc4XzctNC0xLTEtMA_bd6b8677-ab63-4b2d-8839-990469da1063">26,986</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="idxx:AllocatedShareBasedCompensationExpenseNetOfTaxExcludingTaxBenefitFromSettlementOfShareBasedAwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo0YTZjNWMzNDg2Zjk0ZGRjOGIwMjA1ZDIxMjQxYTA3OC90YWJsZXJhbmdlOjRhNmM1YzM0ODZmOTRkZGM4YjAyMDVkMjEyNDFhMDc4XzctNi0xLTEtMA_2838f635-744d-4683-b221-7436ff5b9d58">34,417</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax benefit resulting from settlement of share-based awards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo0YTZjNWMzNDg2Zjk0ZGRjOGIwMjA1ZDIxMjQxYTA3OC90YWJsZXJhbmdlOjRhNmM1YzM0ODZmOTRkZGM4YjAyMDVkMjEyNDFhMDc4XzgtMi0xLTEtMA_bdf57399-504d-4ca8-a6b0-3ad570389b20">32,474</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo0YTZjNWMzNDg2Zjk0ZGRjOGIwMjA1ZDIxMjQxYTA3OC90YWJsZXJhbmdlOjRhNmM1YzM0ODZmOTRkZGM4YjAyMDVkMjEyNDFhMDc4XzgtNC0xLTEtMA_d57cac91-efad-4b20-a879-cffdb38059b5">38,981</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo0YTZjNWMzNDg2Zjk0ZGRjOGIwMjA1ZDIxMjQxYTA3OC90YWJsZXJhbmdlOjRhNmM1YzM0ODZmOTRkZGM4YjAyMDVkMjEyNDFhMDc4XzgtNi0xLTEtMA_e29a4859-cef6-444d-b2da-9b72d474888d">19,140</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net expense (benefit) related to share-based compensation arrangements included in consolidated statements of income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo0YTZjNWMzNDg2Zjk0ZGRjOGIwMjA1ZDIxMjQxYTA3OC90YWJsZXJhbmdlOjRhNmM1YzM0ODZmOTRkZGM4YjAyMDVkMjEyNDFhMDc4XzktMi0xLTEtMA_881b8767-afeb-49ed-9f22-d24510dcdfce">547</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo0YTZjNWMzNDg2Zjk0ZGRjOGIwMjA1ZDIxMjQxYTA3OC90YWJsZXJhbmdlOjRhNmM1YzM0ODZmOTRkZGM4YjAyMDVkMjEyNDFhMDc4XzktNC0xLTEtMA_acf9bdb6-97e3-4402-9d1b-59b6e38097f5">11,995</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo0YTZjNWMzNDg2Zjk0ZGRjOGIwMjA1ZDIxMjQxYTA3OC90YWJsZXJhbmdlOjRhNmM1YzM0ODZmOTRkZGM4YjAyMDVkMjEyNDFhMDc4XzktNi0xLTEtMA_cad656f6-ac7a-4282-9a14-67d2839383df">15,277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2019, we entered into a mutual separation agreement with our former CEO, pursuant to which Mr. Ayers&#8217;s outstanding stock options were modified, resulting in a share-based compensation expense of approximately $<ix:nonFraction unitRef="usd" contextRef="i77a5beb76e6b48498eed44e9a602baed_D20191001-20191231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzM4MzE_82538d87-0db5-49f6-8df7-afe9f46b6b2b">10.9</ix:nonFraction> million, primarily representing an acceleration of the cost of the equity awards. This expense was partially offset by a reduction to our provision for income taxes of approximately $<ix:nonFraction unitRef="usd" contextRef="i77a5beb76e6b48498eed44e9a602baed_D20191001-20191231" decimals="-5" sign="-" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzQwMDg_b6e2131a-c46b-4a66-b4c2-c0af91c192e1">0.8</ix:nonFraction> million. Other than the modification to Mr. Ayers's stock options, as described above, there were no other material modifications to the terms of outstanding options, RSUs,&#160;PBRSUs, or DSUs during the years ended December 31, 2021, 2020, or 2019.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense is reduced for an estimate of the number of awards that are expected to be forfeited. We use historical data and other factors to estimate expected employee terminations and to evaluate whether particular groups of employees have significantly different forfeiture expectations.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total unrecognized compensation expense, net of estimated forfeitures, for unvested share-based compensation awards at December 31, 2021, was $<ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzQ2Nzc_b1653f82-53ea-4394-9cd7-930d60087fc8">64.1</ix:nonFraction> million, which will be recognized over a weighted average period of approximately <ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzQ3NTQ_0f0c65ca-5a5a-4585-808c-e7020df69a91">1.3</ix:nonNumeric> years.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Options</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to December 4, 2019, all options granted to employees primarily vest ratably over <ix:nonNumeric contextRef="ie3cf8555002d4b4cbd01dce8c9e1e1d3_D20190101-20191231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzQ4NjM_caec9f54-1dc9-4947-98d8-cc8ec7b8b49e">five years</ix:nonNumeric> on each anniversary of the date of grant. Options granted to non-employee directors vest fully on the first anniversary of the date of grant. Employee grants after December 4, 2019 vest ratably over <ix:nonNumeric contextRef="i45554c00d32c4d45a16d94dd9b602937_D20190101-20191231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzUwNzE_1e1ad7ff-9b5f-4e74-a7e6-ab95704dbd48">four years</ix:nonNumeric>. Vesting of option awards issued is conditional based on continuous service. Options granted after May 8, 2013 have a contractual term of <ix:nonNumeric contextRef="idae58301e68b412eb28334afea378d2b_D20190101-20191231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzUyMTI_507a95c4-80a8-458c-a32d-ec6e48fe9c7c">ten years</ix:nonNumeric> and options granted between January 1, 2006 and May 8, 2013 had contractual terms of <ix:nonNumeric contextRef="i9c3e894425d54b5a84d42ae55eb839ae_D20190101-20191231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzUzMDA_cbef7407-2093-46a6-8247-6bba21f7acda">seven years</ix:nonNumeric>. Upon any change in control of the company, <ix:nonFraction unitRef="number" contextRef="i982c1764182b47d1b743c71bb7b33923_D20190101-20191231" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzUzNDc_c42e7db7-186f-492a-a61b-0a52ef3fc788">25</ix:nonFraction>% of the unvested stock options then outstanding will vest and become exercisable. However, if the acquiring entity does not assume outstanding options, then all options will vest immediately prior to the change in control.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the Black-Scholes-Merton option-pricing model to determine the fair value of options granted. Option-pricing models require the input of highly subjective assumptions, particularly for the expected stock price volatility and the expected term of options. Changes in the subjective input assumptions can affect the fair value estimate. Our expected stock price volatility assumptions are based on the historical volatility of our stock over periods that are similar to the expected terms of grants and other relevant factors. We derive the expected term based on historical experience and other relevant factors concerning expected employee behavior with regard to option exercise. The risk-free interest rate is based on U.S. Treasury yields for a maturity approximating the expected term calculated at the date of grant. We have never paid any cash dividends on our common stock and we have no intention to pay a dividend at this time; therefore, we assume that no dividends will be paid over the expected terms of option awards.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ic34ec86fe70e49238e835aa8e2181315" continuedAt="icb32079a87d54ea18f99489df1b6434c"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine the assumptions used in the valuation of option awards as of the date of grant. Differences in the expected stock price volatility, expected term or risk-free interest rate may necessitate distinct valuation assumptions at those grant dates. As such, we may use different assumptions for options granted throughout the year. <ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzExMjM2_d92b136e-6c4d-4764-adbf-7dcadb1a0fd9" continuedAt="ic37c84576b2d4f9a8eebea7011f26e86" escape="true">The weighted averages of the valuation assumptions used to determine the fair value of each option award on the date of grant and the weighted average estimated fair values were as follows:</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="ic37c84576b2d4f9a8eebea7011f26e86"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:58.490%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share price at grant</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="INF" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTBhNWZjNzgzMmQ0NjIxYWExOGUxMDdmYzdkMTUzZi90YWJsZXJhbmdlOmU1MGE1ZmM3ODMyZDQ2MjFhYTE4ZTEwN2ZjN2QxNTNmXzMtMi0xLTEtMA_87ad5995-f4e4-4cff-b297-66aff1f9e297">546.36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="INF" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTBhNWZjNzgzMmQ0NjIxYWExOGUxMDdmYzdkMTUzZi90YWJsZXJhbmdlOmU1MGE1ZmM3ODMyZDQ2MjFhYTE4ZTEwN2ZjN2QxNTNmXzMtNC0xLTEtMA_c170dc96-83bd-4ed2-b5c7-f7e5d377a327">291.14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0c634b937c58472e84857eacf99e17df_I20191231" decimals="INF" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTBhNWZjNzgzMmQ0NjIxYWExOGUxMDdmYzdkMTUzZi90YWJsZXJhbmdlOmU1MGE1ZmM3ODMyZDQ2MjFhYTE4ZTEwN2ZjN2QxNTNmXzMtNi0xLTEtMA_a9d64541-ce3b-4a8e-a391-8cfb58128381">218.66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share exercise price</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTBhNWZjNzgzMmQ0NjIxYWExOGUxMDdmYzdkMTUzZi90YWJsZXJhbmdlOmU1MGE1ZmM3ODMyZDQ2MjFhYTE4ZTEwN2ZjN2QxNTNmXzQtMi0xLTEtMA_92e47f8c-ba12-4f26-a37f-147b1b891e0f">550.10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTBhNWZjNzgzMmQ0NjIxYWExOGUxMDdmYzdkMTUzZi90YWJsZXJhbmdlOmU1MGE1ZmM3ODMyZDQ2MjFhYTE4ZTEwN2ZjN2QxNTNmXzQtNC0xLTEtMA_71c99001-e44d-4bee-a256-e3920bd99abc">291.14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0c634b937c58472e84857eacf99e17df_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTBhNWZjNzgzMmQ0NjIxYWExOGUxMDdmYzdkMTUzZi90YWJsZXJhbmdlOmU1MGE1ZmM3ODMyZDQ2MjFhYTE4ZTEwN2ZjN2QxNTNmXzQtNi0xLTEtMA_b334b07a-cc19-4229-81f3-22c2c969ec0c">220.88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected stock price volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTBhNWZjNzgzMmQ0NjIxYWExOGUxMDdmYzdkMTUzZi90YWJsZXJhbmdlOmU1MGE1ZmM3ODMyZDQ2MjFhYTE4ZTEwN2ZjN2QxNTNmXzUtMi0xLTEtMA_80b8e04b-eb99-4489-bf70-4b3149699cb3">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTBhNWZjNzgzMmQ0NjIxYWExOGUxMDdmYzdkMTUzZi90YWJsZXJhbmdlOmU1MGE1ZmM3ODMyZDQ2MjFhYTE4ZTEwN2ZjN2QxNTNmXzUtNC0xLTEtMA_49ea2a81-08e8-459f-bd2e-bb4dcd1ca63f">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTBhNWZjNzgzMmQ0NjIxYWExOGUxMDdmYzdkMTUzZi90YWJsZXJhbmdlOmU1MGE1ZmM3ODMyZDQ2MjFhYTE4ZTEwN2ZjN2QxNTNmXzUtNi0xLTEtMA_ede791bb-8c9c-4d9e-a4b3-d42f1885a8a4">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected term, in years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTBhNWZjNzgzMmQ0NjIxYWExOGUxMDdmYzdkMTUzZi90YWJsZXJhbmdlOmU1MGE1ZmM3ODMyZDQ2MjFhYTE4ZTEwN2ZjN2QxNTNmXzYtMi0xLTEtMA_f482111f-0425-4586-ac36-1ecce8a50829">6.2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTBhNWZjNzgzMmQ0NjIxYWExOGUxMDdmYzdkMTUzZi90YWJsZXJhbmdlOmU1MGE1ZmM3ODMyZDQ2MjFhYTE4ZTEwN2ZjN2QxNTNmXzYtNC0xLTEtMA_ad124f19-9fff-4203-971c-e2c8d17cd3aa">6.0</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTBhNWZjNzgzMmQ0NjIxYWExOGUxMDdmYzdkMTUzZi90YWJsZXJhbmdlOmU1MGE1ZmM3ODMyZDQ2MjFhYTE4ZTEwN2ZjN2QxNTNmXzYtNi0xLTEtMA_cf9e1ac6-5684-47d8-91e9-76f6f0917508">6.0</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTBhNWZjNzgzMmQ0NjIxYWExOGUxMDdmYzdkMTUzZi90YWJsZXJhbmdlOmU1MGE1ZmM3ODMyZDQ2MjFhYTE4ZTEwN2ZjN2QxNTNmXzctMi0xLTEtMA_95016b85-f1b1-47cd-a277-8bedae7bd5bf">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTBhNWZjNzgzMmQ0NjIxYWExOGUxMDdmYzdkMTUzZi90YWJsZXJhbmdlOmU1MGE1ZmM3ODMyZDQ2MjFhYTE4ZTEwN2ZjN2QxNTNmXzctNC0xLTEtMA_ba3a7604-ac64-480f-85a8-3270abd8d232">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTBhNWZjNzgzMmQ0NjIxYWExOGUxMDdmYzdkMTUzZi90YWJsZXJhbmdlOmU1MGE1ZmM3ODMyZDQ2MjFhYTE4ZTEwN2ZjN2QxNTNmXzctNi0xLTEtMA_16323669-6051-4be4-8d0b-6a3a72c87a3d">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average fair value of options granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTBhNWZjNzgzMmQ0NjIxYWExOGUxMDdmYzdkMTUzZi90YWJsZXJhbmdlOmU1MGE1ZmM3ODMyZDQ2MjFhYTE4ZTEwN2ZjN2QxNTNmXzgtMi0xLTEtMA_22d07a98-3150-4a2c-be09-48571217159c">169.15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTBhNWZjNzgzMmQ0NjIxYWExOGUxMDdmYzdkMTUzZi90YWJsZXJhbmdlOmU1MGE1ZmM3ODMyZDQ2MjFhYTE4ZTEwN2ZjN2QxNTNmXzgtNC0xLTEtMA_24044ce8-77f2-42f6-844c-d0abb196bd56">84.92</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTBhNWZjNzgzMmQ0NjIxYWExOGUxMDdmYzdkMTUzZi90YWJsZXJhbmdlOmU1MGE1ZmM3ODMyZDQ2MjFhYTE4ZTEwN2ZjN2QxNTNmXzgtNi0xLTEtMA_5188b2ad-e5fc-422d-81ea-598b5a3c6b34">65.53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzExMjM5_c331eae3-875b-4e69-af19-69a41ed77786" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the status of options granted under our share-based compensation plans at December 31, 2021, and changes during the year then ended, are presented in the table below:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:39.575%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.996%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.996%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.996%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Options (000)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Remaining Contractual Term</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value ($000)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding as of December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTU1NDRhM2FkM2E0YzY1YjA5MWMyZWI2NTc3NDBjYi90YWJsZXJhbmdlOmU1NTU0NGEzYWQzYTRjNjViMDkxYzJlYjY1Nzc0MGNiXzItMi0xLTEtMA_27b479d5-0c04-4f42-814c-8e8e843a9b98">1,953</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTU1NDRhM2FkM2E0YzY1YjA5MWMyZWI2NTc3NDBjYi90YWJsZXJhbmdlOmU1NTU0NGEzYWQzYTRjNjViMDkxYzJlYjY1Nzc0MGNiXzItNC0xLTEtMA_872a9f74-a442-4278-9fde-08b818370a40">149.32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTU1NDRhM2FkM2E0YzY1YjA5MWMyZWI2NTc3NDBjYi90YWJsZXJhbmdlOmU1NTU0NGEzYWQzYTRjNjViMDkxYzJlYjY1Nzc0MGNiXzMtMi0xLTEtMA_4af2ba0b-41ab-41f1-9f42-003304171d90">144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTU1NDRhM2FkM2E0YzY1YjA5MWMyZWI2NTc3NDBjYi90YWJsZXJhbmdlOmU1NTU0NGEzYWQzYTRjNjViMDkxYzJlYjY1Nzc0MGNiXzMtNC0xLTEtMA_2ca61173-8832-419f-bab7-311453c78b29">550.10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTU1NDRhM2FkM2E0YzY1YjA5MWMyZWI2NTc3NDBjYi90YWJsZXJhbmdlOmU1NTU0NGEzYWQzYTRjNjViMDkxYzJlYjY1Nzc0MGNiXzQtMi0xLTEtMA_f9de1bda-6b49-41de-92b1-2102b3ade15d">310</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTU1NDRhM2FkM2E0YzY1YjA5MWMyZWI2NTc3NDBjYi90YWJsZXJhbmdlOmU1NTU0NGEzYWQzYTRjNjViMDkxYzJlYjY1Nzc0MGNiXzQtNC0xLTEtMA_57e0a063-a60e-45bc-8884-26a059257868">102.78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTU1NDRhM2FkM2E0YzY1YjA5MWMyZWI2NTc3NDBjYi90YWJsZXJhbmdlOmU1NTU0NGEzYWQzYTRjNjViMDkxYzJlYjY1Nzc0MGNiXzUtMi0xLTEtMA_fc9fb370-bc69-45f6-9081-27f38d0bc4a7">30</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTU1NDRhM2FkM2E0YzY1YjA5MWMyZWI2NTc3NDBjYi90YWJsZXJhbmdlOmU1NTU0NGEzYWQzYTRjNjViMDkxYzJlYjY1Nzc0MGNiXzUtNC0xLTEtMA_f5a5a1ef-96cc-4597-8198-16ab0976a252">261.95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding as of December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTU1NDRhM2FkM2E0YzY1YjA5MWMyZWI2NTc3NDBjYi90YWJsZXJhbmdlOmU1NTU0NGEzYWQzYTRjNjViMDkxYzJlYjY1Nzc0MGNiXzYtMi0xLTEtMA_2990f27b-b1dc-41a7-b7fc-71610c902aad">1,757</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTU1NDRhM2FkM2E0YzY1YjA5MWMyZWI2NTc3NDBjYi90YWJsZXJhbmdlOmU1NTU0NGEzYWQzYTRjNjViMDkxYzJlYjY1Nzc0MGNiXzYtNC0xLTEtMA_d742fc98-4d50-488f-a6de-8b87f67586cc">188.47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTU1NDRhM2FkM2E0YzY1YjA5MWMyZWI2NTc3NDBjYi90YWJsZXJhbmdlOmU1NTU0NGEzYWQzYTRjNjViMDkxYzJlYjY1Nzc0MGNiXzYtNi0xLTEtMA_4276888c-f5f2-4a49-b2eb-a7ada86d7b56">5.8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTU1NDRhM2FkM2E0YzY1YjA5MWMyZWI2NTc3NDBjYi90YWJsZXJhbmdlOmU1NTU0NGEzYWQzYTRjNjViMDkxYzJlYjY1Nzc0MGNiXzYtOC0xLTEtMA_779d10c5-1180-4931-9033-6df1dd896822">825,745</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fully vested as of December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTU1NDRhM2FkM2E0YzY1YjA5MWMyZWI2NTc3NDBjYi90YWJsZXJhbmdlOmU1NTU0NGEzYWQzYTRjNjViMDkxYzJlYjY1Nzc0MGNiXzgtMi0xLTEtMA_0a8da189-0fb6-4cfd-b6c8-ad6ee617f151">1,109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTU1NDRhM2FkM2E0YzY1YjA5MWMyZWI2NTc3NDBjYi90YWJsZXJhbmdlOmU1NTU0NGEzYWQzYTRjNjViMDkxYzJlYjY1Nzc0MGNiXzgtNC0xLTEtMA_ee2d1bdc-18df-4620-aaa1-106059d83353">127.30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTU1NDRhM2FkM2E0YzY1YjA5MWMyZWI2NTc3NDBjYi90YWJsZXJhbmdlOmU1NTU0NGEzYWQzYTRjNjViMDkxYzJlYjY1Nzc0MGNiXzgtNi0xLTEtMA_efe93f92-1074-46bd-8510-5d1b164a2541">4.8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTU1NDRhM2FkM2E0YzY1YjA5MWMyZWI2NTc3NDBjYi90YWJsZXJhbmdlOmU1NTU0NGEzYWQzYTRjNjViMDkxYzJlYjY1Nzc0MGNiXzgtOC0xLTEtMA_27c827be-0725-4821-9ef4-6a95d8b1fbae">588,831</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fully vested and expected to vest as of December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTU1NDRhM2FkM2E0YzY1YjA5MWMyZWI2NTc3NDBjYi90YWJsZXJhbmdlOmU1NTU0NGEzYWQzYTRjNjViMDkxYzJlYjY1Nzc0MGNiXzEwLTItMS0xLTA_7f1e33ff-d49b-4842-b27a-06b3e032a4c9">1,738</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTU1NDRhM2FkM2E0YzY1YjA5MWMyZWI2NTc3NDBjYi90YWJsZXJhbmdlOmU1NTU0NGEzYWQzYTRjNjViMDkxYzJlYjY1Nzc0MGNiXzEwLTQtMS0xLTA_082779d2-4ae5-4c22-8087-d13c62193492">186.72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTU1NDRhM2FkM2E0YzY1YjA5MWMyZWI2NTc3NDBjYi90YWJsZXJhbmdlOmU1NTU0NGEzYWQzYTRjNjViMDkxYzJlYjY1Nzc0MGNiXzEwLTYtMS0xLTA_563a93b8-6483-463e-8fef-62d7d60c8c45">5.7</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTU1NDRhM2FkM2E0YzY1YjA5MWMyZWI2NTc3NDBjYi90YWJsZXJhbmdlOmU1NTU0NGEzYWQzYTRjNjViMDkxYzJlYjY1Nzc0MGNiXzEwLTgtMS0xLTA_39156b82-1169-4908-a1b1-e7ad3f11603e">819,777</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total fair value of options vested were $<ix:nonFraction unitRef="usd" contextRef="i0491e8e2530147698782b2a10a30d90b_D20210101-20211231" decimals="-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzczNjE_ded332d0-5914-4b00-96d6-87271b01a8e7">17.3</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i3299da84372d432f98da6898831dd963_D20200101-20201231" decimals="-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzczNjU_2da5711f-fa9b-48b6-aa77-78d63366f355">14.6</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i982c1764182b47d1b743c71bb7b33923_D20190101-20191231" decimals="-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzczNzM_82da06e1-2128-4460-991f-7739331abddd">12.2</ix:nonFraction> million during the years ended December 31, 2021, 2020, and 2019, respectively</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intrinsic value of stock options exercised represents the amount by which the market price of the common stock exceeded the exercise price, before applicable income taxes. The total intrinsic values of stock options exercised were $<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzc2NTk_beb42eec-e23d-4c33-91b2-e51596161f23">147.9</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzc2NjM_296ac358-7da8-427a-a54d-c82cbe13eaf4">163.0</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzc2NzE_8f478a3e-a478-4b7a-9c6c-9c4453c99612">83.7</ix:nonFraction> million during the years ended December 31, 2021, 2020, and 2019, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Stock Units&#160;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to December 4, 2019, the majority of RSUs, including our PBRSUs, granted to employees vest ratably over <ix:nonNumeric contextRef="i1594d5a312e047069a064e029de5cf8b_D20190101-20191231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzc4NjM_3f5ae400-6726-4910-9522-5ed7d546c58b">five years</ix:nonNumeric> on each anniversary of the date of grant. Employee grants after December 4, 2019, will vest ratably over <ix:nonNumeric contextRef="i84fa425282ab417da8ba5a3609c0031e_D20190101-20191231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzc5NzE_8f6a556a-5eb0-4289-935e-048b654e684d">4</ix:nonNumeric> years. PBRSUs granted to employees vest based on meeting performance goals set on the day of grant. RSUs granted to non-employee directors vest fully on the first anniversary of the date of grant. Vesting as it relates to RSUs and PBRSUs issued is conditional based on continuous service. Upon any change in control of the company, <ix:nonFraction unitRef="number" contextRef="ief941e5acd344fed862240efdd3a7288_D20190101-20191231" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzgzMDA_6d5d7f51-fb63-4120-bf4b-b3c0faea9dbe">25</ix:nonFraction>% of the unvested RSUs and PBRSUs then outstanding will vest, provided, however, that if the acquiring entity does not assume the RSUs and PBRSUs, then all such units will vest immediately prior to the change in control. At time of grant, we assume all PBRSUs will meet performance goals to vest.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="icb32079a87d54ea18f99489df1b6434c"><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzExMjQx_2ef7d456-48c5-4a38-b643-72f496281dba" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the status of RSUs and PBRSUs granted under our share-based compensation plans at December 31, 2021, and changes during the period then ended, are presented in the table below:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:69.281%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.977%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Units (000)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Grant-Date Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nonvested as of December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibcdf728b3b3f46f08f1609441281d24e_I20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo3MWY2NGQ2MjUxZjQ0M2E5OGQzZmQ1OTBiOWIyNDhiZi90YWJsZXJhbmdlOjcxZjY0ZDYyNTFmNDQzYTk4ZDNmZDU5MGI5YjI0OGJmXzItMi0xLTEtMA_34ae9642-0e0c-4981-90e8-4d39be568149">218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibcdf728b3b3f46f08f1609441281d24e_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo3MWY2NGQ2MjUxZjQ0M2E5OGQzZmQ1OTBiOWIyNDhiZi90YWJsZXJhbmdlOjcxZjY0ZDYyNTFmNDQzYTk4ZDNmZDU5MGI5YjI0OGJmXzItNC0xLTEtMA_aa2b48d6-8a1e-4635-ad1a-869abdae5e5d">202.47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0cad033f6b01464bbca11ea746ae0dd3_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo3MWY2NGQ2MjUxZjQ0M2E5OGQzZmQ1OTBiOWIyNDhiZi90YWJsZXJhbmdlOjcxZjY0ZDYyNTFmNDQzYTk4ZDNmZDU5MGI5YjI0OGJmXzMtMi0xLTEtMA_2bc0120a-cb10-4be4-a577-b24e1cb10ee5">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usdPerShare" contextRef="i0cad033f6b01464bbca11ea746ae0dd3_D20210101-20211231" xsi:nil="true" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo3MWY2NGQ2MjUxZjQ0M2E5OGQzZmQ1OTBiOWIyNDhiZi90YWJsZXJhbmdlOjcxZjY0ZDYyNTFmNDQzYTk4ZDNmZDU5MGI5YjI0OGJmXzMtNC0xLTEtMA_f74847d2-1894-4d4b-84c3-3bc4f0567535"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i0cad033f6b01464bbca11ea746ae0dd3_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo3MWY2NGQ2MjUxZjQ0M2E5OGQzZmQ1OTBiOWIyNDhiZi90YWJsZXJhbmdlOjcxZjY0ZDYyNTFmNDQzYTk4ZDNmZDU5MGI5YjI0OGJmXzQtMi0xLTEtMA_a45f5551-5337-4d1a-ba1d-26d48e47d95d">85</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usdPerShare" contextRef="i0cad033f6b01464bbca11ea746ae0dd3_D20210101-20211231" xsi:nil="true" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo3MWY2NGQ2MjUxZjQ0M2E5OGQzZmQ1OTBiOWIyNDhiZi90YWJsZXJhbmdlOjcxZjY0ZDYyNTFmNDQzYTk4ZDNmZDU5MGI5YjI0OGJmXzQtNC0xLTEtMA_54a8b2fa-ea77-41fb-aff2-cef9fa1a2414"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i0cad033f6b01464bbca11ea746ae0dd3_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo3MWY2NGQ2MjUxZjQ0M2E5OGQzZmQ1OTBiOWIyNDhiZi90YWJsZXJhbmdlOjcxZjY0ZDYyNTFmNDQzYTk4ZDNmZDU5MGI5YjI0OGJmXzUtMi0xLTEtMA_e0a7396b-ec25-4a58-bb00-8a83c56fdc3e">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usdPerShare" contextRef="i0cad033f6b01464bbca11ea746ae0dd3_D20210101-20211231" xsi:nil="true" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo3MWY2NGQ2MjUxZjQ0M2E5OGQzZmQ1OTBiOWIyNDhiZi90YWJsZXJhbmdlOjcxZjY0ZDYyNTFmNDQzYTk4ZDNmZDU5MGI5YjI0OGJmXzUtNC0xLTEtMA_a626de08-cd72-4eee-b26f-13e3772a9c1d"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nonvested as of December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i694b32aa47f046748a1598cc0d558051_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo3MWY2NGQ2MjUxZjQ0M2E5OGQzZmQ1OTBiOWIyNDhiZi90YWJsZXJhbmdlOjcxZjY0ZDYyNTFmNDQzYTk4ZDNmZDU5MGI5YjI0OGJmXzYtMi0xLTEtMA_7fd9d354-b7d9-49ad-884f-9842cc0c0293">165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i694b32aa47f046748a1598cc0d558051_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo3MWY2NGQ2MjUxZjQ0M2E5OGQzZmQ1OTBiOWIyNDhiZi90YWJsZXJhbmdlOjcxZjY0ZDYyNTFmNDQzYTk4ZDNmZDU5MGI5YjI0OGJmXzYtNC0xLTEtMA_aaec2cd5-8d12-4650-b1eb-1aba39eb4a68">306.18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected to vest as of December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibf6a2e2744a44ea98ebe5ee2a3b57059_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo3MWY2NGQ2MjUxZjQ0M2E5OGQzZmQ1OTBiOWIyNDhiZi90YWJsZXJhbmdlOjcxZjY0ZDYyNTFmNDQzYTk4ZDNmZDU5MGI5YjI0OGJmXzgtMi0xLTEtMA_ccae6ac8-2fd5-4c46-87f1-b81654719c44">156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibf6a2e2744a44ea98ebe5ee2a3b57059_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo3MWY2NGQ2MjUxZjQ0M2E5OGQzZmQ1OTBiOWIyNDhiZi90YWJsZXJhbmdlOjcxZjY0ZDYyNTFmNDQzYTk4ZDNmZDU5MGI5YjI0OGJmXzgtNC0xLTEtMA_4933ac3a-5c69-4273-a5df-280e3801f1a1">303.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total fair values of RSUs and PBRSUs vested were $<ix:nonFraction unitRef="usd" contextRef="i0cad033f6b01464bbca11ea746ae0dd3_D20210101-20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzg4MzI_4158357b-a5f2-49e5-a0db-7651d899d425">46.1</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ib209d359b518453c8297929f6c24722a_D20200101-20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzg4MzY_fd3ae318-d13e-4917-8577-12d79a83d0c3">27.9</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="ief941e5acd344fed862240efdd3a7288_D20190101-20191231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzg4NDQ_ecc6861a-6335-497e-9941-e8e1216b815a">23.8</ix:nonFraction> million during the years ended December 31, 2021, 2020, and 2019, respectively. The aggregate intrinsic value of nonvested RSUs and PBRSUs as of December 31, 2021, which is equal to the fair value of IDEXX&#8217;s common stock as of December 31, 2021, multiplied by the number of nonvested units as of December 31, 2021, was $<ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzkwOTM_108a1b0a-0282-4f90-b070-c39de84ba402">108.8</ix:nonFraction> million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Deferred Stock Units</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our Director Plan, non-employee directors may defer a portion of their cash fees in the form of vested DSUs. Prior to 2014, certain members of our management could elect to defer a portion of their cash compensation in the form of vested deferred stock units under our Executive Plan. Each DSU represents the right to receive <ix:nonFraction unitRef="number" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="INF" name="idxx:RatioOfDeferredStockUnitsToSharesOfCommonStock" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzk0NTM_6e708f7b-8667-4b72-8208-61786cf9fc9c">one</ix:nonFraction> unissued share of our common stock. These recipients receive a number of DSUs equal to the amount of cash fees or compensation deferred divided by the closing sale price of the common stock on the date of deferral. Also, under the Director Plan, non-employee directors are awarded annual grants of either RSUs or DSUs that vest fully on the first anniversary of the date of grant. Vesting for these annual RSU and DSU grants is conditional based on continuous service. Vested DSUs are distributed as shares of common stock on the distribution date elected by the participant and pursuant to the terms of the Director or Executive Plan, as applicable.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were approximately <ix:nonFraction unitRef="shares" contextRef="i9958c792661247119c39c9e01d982deb_I20211231" decimals="-3" name="us-gaap:CommonStockOtherSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzEwMTEx_1aebfeef-ceff-41d7-af28-f72dcb031e04">90,000</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i7663c8e364ea4807a7ad1cbb6bafde89_I20201231" decimals="-3" name="us-gaap:CommonStockOtherSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzEwMTE4_9fa6461a-1f04-49d2-b6ec-4a13e8221a55">87,000</ix:nonFraction> vested DSUs outstanding under our share-based compensation plans as of December 31, 2021 and 2020, respectively. During 2020, approximately <ix:nonFraction unitRef="shares" contextRef="i230d8313826f436cae6610d654452ab4_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzEwMjQ0_8486a44e-1dc7-46db-834e-b7990ddf77b5">59,000</ix:nonFraction> DSUs were distributed as shares of common stock to our former CEO in accordance with the terms of the Executive Plan and the deferral elections he previously made. Unvested DSUs as of December 31, 2021 and 2020, were not material.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee Stock Purchase Rights</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employee stock purchase rights are issued under the 1997 Employee Stock Purchase Plan, under which we reserved and may issue up to an aggregate of <ix:nonFraction unitRef="shares" contextRef="i6e7ee8e291c54e02a81d0c39ffc5ad6b_I20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzEwNjQz_5b17ea97-05d5-4af2-9454-1ca83297ddb1">4.7</ix:nonFraction> million shares of common stock in periodic offerings. Under this plan, stock is sold to employees at a <ix:nonFraction unitRef="number" contextRef="id26ee05f76cc40ac87ab6c4856efecfa_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzEwNzQx_c7d27e35-1354-4c37-80ec-a16d2e385a61">15</ix:nonFraction>% discount off the closing price of the stock on the last day of each quarter. The dollar value of this discount is equal to the fair value of purchase rights recognized as share-based compensation. We issued approximately <ix:nonFraction unitRef="shares" contextRef="i0a5d4fe659be4cccaf4e997156b223a2_D20210101-20211231" decimals="-2" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzEwOTY2_4b79be3a-3f27-4459-84ac-d3007e4de95b">29,500</ix:nonFraction>,&#160;<ix:nonFraction unitRef="shares" contextRef="id26ee05f76cc40ac87ab6c4856efecfa_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzEwOTcw_e9d09de4-21e6-420a-9cf3-9aacb9108585">39,000</ix:nonFraction>, and <ix:nonFraction unitRef="shares" contextRef="i07cab270359146efa8ad17bde260ed6c_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzEwOTc4_b169ade2-9b3b-4927-aab5-0fe65795839c">47,000</ix:nonFraction> shares of common stock in connection with the Employee Stock Purchase Plan during the years ended December 31, 2021, 2020, and 2019, respectively. As of December 31, 2021, there were approximately <ix:nonFraction unitRef="shares" contextRef="id4706d2219354fd4aca929cb8a8e0ce0_I20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzExMTQz_d877016e-e281-4e5b-acab-f8892174b308">1.1</ix:nonFraction> million remaining shares available for issuance under the 1997 Employee Stock Purchase Plan.</span></div></ix:continuation><div id="i5d795a6851d746ca914a2ddae761c329_190"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">      </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:CreditLossFinancialInstrumentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTAvZnJhZzoxNDIxNDRiOTBlNmQ0YzcyODE3MDg1Y2FhZjkxNWUwYi90ZXh0cmVnaW9uOjE0MjE0NGI5MGU2ZDRjNzI4MTcwODVjYWFmOTE1ZTBiXzMwOTY_cd4f712c-2fe6-42fc-9598-4c490ab67412" continuedAt="i8e561c36943844b59ec367c221eb7719" escape="true">CREDIT LOSSES</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i8e561c36943844b59ec367c221eb7719" continuedAt="i40743010ae2b4becb1be65bdea4f3db7"><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:CreditLossFinancialInstrumentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTAvZnJhZzoxNDIxNDRiOTBlNmQ0YzcyODE3MDg1Y2FhZjkxNWUwYi90ZXh0cmVnaW9uOjE0MjE0NGI5MGU2ZDRjNzI4MTcwODVjYWFmOTE1ZTBiXzMwOTc_6c5acba4-9b75-46a4-a8ee-b8cb0fd777b0" continuedAt="i4bfbb50239254310bf6fac2296146e7a" escape="true">We are exposed to credit losses primarily through our sales of products and services to our customers. We maintain allowances for credit losses for potentially uncollectible receivables. We base our estimates on a detailed analysis of specific customer situations and a percentage of our accounts receivable by aging category. Historical credit loss experience provides the basis for the estimation of expected credit losses. Adjustments to historical loss information are made for differences in current economic conditions. Refer to "Note 2. Accounting Policies" for more information on our adoption of ASU 2016-13 on January 1, 2020, using the modified retrospective transition method.</ix:nonNumeric></ix:continuation></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i40743010ae2b4becb1be65bdea4f3db7"><ix:continuation id="i4bfbb50239254310bf6fac2296146e7a"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional allowances may be required if either the financial condition of our customers was to deteriorate, or a strengthening U.S. dollar impacts the ability of foreign customers to make payments to us on their U.S. dollar-denominated purchases. We monitor our ongoing credit exposure through active review of counterparty balances against contract terms and due dates. Our activities include timely account reconciliations, dispute resolution, and payment confirmations. We may employ collection agencies and legal counsel to pursue recovery of defaulted receivables.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Account balances are charged off against the allowance when we believe it is probable the receivable will not be recovered. We may require collateralized asset support or a prepayment to mitigate credit risk. We do not have any off-balance sheet credit exposure related to our customers.</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts Receivable</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The allowance for credit losses associated with accounts receivable was $<ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTAvZnJhZzoxNDIxNDRiOTBlNmQ0YzcyODE3MDg1Y2FhZjkxNWUwYi90ZXh0cmVnaW9uOjE0MjE0NGI5MGU2ZDRjNzI4MTcwODVjYWFmOTE1ZTBiXzU0OTc1NTgxNDI0OTI_db3428db-6aa3-416f-959c-1354889dde6b">5.7</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTAvZnJhZzoxNDIxNDRiOTBlNmQ0YzcyODE3MDg1Y2FhZjkxNWUwYi90ZXh0cmVnaW9uOjE0MjE0NGI5MGU2ZDRjNzI4MTcwODVjYWFmOTE1ZTBiXzU0OTc1NTgxNDI0NzU_6ed40290-c107-4245-8d9a-cfe17cd1010f">6.8</ix:nonFraction>&#160;million at December 31, 2021, and December 31, 2020, respectively. Accounts receivable reflected on the balance sheet is net of this reserve. Based on an aging analysis, at December 31, 2021, approximately <ix:nonFraction unitRef="number" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="2" name="idxx:AccountsReceivablePercentNotPastDue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTAvZnJhZzoxNDIxNDRiOTBlNmQ0YzcyODE3MDg1Y2FhZjkxNWUwYi90ZXh0cmVnaW9uOjE0MjE0NGI5MGU2ZDRjNzI4MTcwODVjYWFmOTE1ZTBiXzE4NzY_ed44e7c0-3590-4465-99cf-22360696a0c2">90</ix:nonFraction>% of our accounts receivable had not yet reached the invoice due date and approximately <ix:nonFraction unitRef="number" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="2" name="idxx:AccountsReceivablePercentPastDue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTAvZnJhZzoxNDIxNDRiOTBlNmQ0YzcyODE3MDg1Y2FhZjkxNWUwYi90ZXh0cmVnaW9uOjE0MjE0NGI5MGU2ZDRjNzI4MTcwODVjYWFmOTE1ZTBiXzE5NjU_0252b9a6-4769-4ce0-8e2a-d68d6f2393a8">10</ix:nonFraction>% was considered past due, of which approximately <ix:nonFraction unitRef="number" contextRef="if2d8a957b59b41bd9d689b2d4b69d6a4_I20211231" decimals="3" name="idxx:AccountsReceivablePercentPastDue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTAvZnJhZzoxNDIxNDRiOTBlNmQ0YzcyODE3MDg1Y2FhZjkxNWUwYi90ZXh0cmVnaW9uOjE0MjE0NGI5MGU2ZDRjNzI4MTcwODVjYWFmOTE1ZTBiXzIwMTY_2eac47b0-6cbc-41c1-bf68-b33f78616da2">1.8</ix:nonFraction>% was greater than <ix:nonNumeric contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" name="us-gaap:AccountsReceivableNoncurrentThresholdPeriodPastDue" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTAvZnJhZzoxNDIxNDRiOTBlNmQ0YzcyODE3MDg1Y2FhZjkxNWUwYi90ZXh0cmVnaW9uOjE0MjE0NGI5MGU2ZDRjNzI4MTcwODVjYWFmOTE1ZTBiXzIwMzY_3eabe38b-46a0-4942-b00e-580db70c14d5">60</ix:nonNumeric> days past due. At December 31, 2020, approximately <ix:nonFraction unitRef="number" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="2" name="idxx:AccountsReceivablePercentNotPastDue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTAvZnJhZzoxNDIxNDRiOTBlNmQ0YzcyODE3MDg1Y2FhZjkxNWUwYi90ZXh0cmVnaW9uOjE0MjE0NGI5MGU2ZDRjNzI4MTcwODVjYWFmOTE1ZTBiXzU0OTc1NTgxNDI1MjE_c69b8c08-dd20-46e6-9c81-71f2d6a7677a">88</ix:nonFraction>% of our accounts receivable had not yet reached the invoice due date and approximately <ix:nonFraction unitRef="number" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="2" name="idxx:AccountsReceivablePercentPastDue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTAvZnJhZzoxNDIxNDRiOTBlNmQ0YzcyODE3MDg1Y2FhZjkxNWUwYi90ZXh0cmVnaW9uOjE0MjE0NGI5MGU2ZDRjNzI4MTcwODVjYWFmOTE1ZTBiXzU0OTc1NTgxNDI1MzA_20c1bf69-e54d-4685-a900-e418136e06c4">12</ix:nonFraction>% was considered past due, of which approximately <ix:nonFraction unitRef="number" contextRef="i4fa881c75f4742dfb92d9cee4bd32188_I20201231" decimals="3" name="idxx:AccountsReceivablePercentPastDue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTAvZnJhZzoxNDIxNDRiOTBlNmQ0YzcyODE3MDg1Y2FhZjkxNWUwYi90ZXh0cmVnaW9uOjE0MjE0NGI5MGU2ZDRjNzI4MTcwODVjYWFmOTE1ZTBiXzU0OTc1NTgxNDI1MTE_1d044b17-dd0e-4976-8619-b994830eca66">1.5</ix:nonFraction>% was greater than <ix:nonNumeric contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" name="us-gaap:AccountsReceivableNoncurrentThresholdPeriodPastDue" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTAvZnJhZzoxNDIxNDRiOTBlNmQ0YzcyODE3MDg1Y2FhZjkxNWUwYi90ZXh0cmVnaW9uOjE0MjE0NGI5MGU2ZDRjNzI4MTcwODVjYWFmOTE1ZTBiXzIyNDU_cb1fdae6-cccb-4772-bcda-b0fd7624da46">60</ix:nonNumeric> days past due. Write-offs and recoveries related to credit losses during the years ended December 31, 2021, 2020, and 2019 were not material.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract assets and lease receivables</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The allowance for credit losses associated with the contract assets and lease receivables was $<ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-5" name="idxx:ContractwithCustomerAssetAndSalesTypeLeaseNetInvestmentInLeaseAllowanceforCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTAvZnJhZzoxNDIxNDRiOTBlNmQ0YzcyODE3MDg1Y2FhZjkxNWUwYi90ZXh0cmVnaW9uOjE0MjE0NGI5MGU2ZDRjNzI4MTcwODVjYWFmOTE1ZTBiXzQzOTgwNDY1MTQ5MTU_fb4e12f0-04c3-4a76-a001-d203216440aa">4.4</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-5" name="idxx:ContractwithCustomerAssetAndSalesTypeLeaseNetInvestmentInLeaseAllowanceforCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTAvZnJhZzoxNDIxNDRiOTBlNmQ0YzcyODE3MDg1Y2FhZjkxNWUwYi90ZXh0cmVnaW9uOjE0MjE0NGI5MGU2ZDRjNzI4MTcwODVjYWFmOTE1ZTBiXzI1MDI_28ee1a6d-eb83-4dd7-bce5-b3541c86c7aa">3.7</ix:nonFraction>&#160;million at December 31, 2021 and 2020, respectively. The assets reflected on the balance sheet are net of these reserves. Historically, we have experienced low credit loss rates on our customer commitment programs and lease receivables. We apply judgment in determining the customer&#8217;s ability and intention to pay, which is based on a variety of factors including the customer&#8217;s historical payment experience or, in the case of a new customer, published credit and financial information pertaining to the customer. Write-offs and recoveries related to credit losses during the years ended December 31, 2021, 2020, and 2019 were not material.</span></div></ix:continuation><div><span><br/></span></div><div id="i5d795a6851d746ca914a2ddae761c329_193"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 7.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTMvZnJhZzoyNTY0Yjc1NDkzMDg0NTBhYTIxY2I0MzNlMTMzZmUyZS90ZXh0cmVnaW9uOjI1NjRiNzU0OTMwODQ1MGFhMjFjYjQzM2UxMzNmZTJlXzk4Ng_ab217dc1-62e1-46b8-bfd2-95894bcb7903" continuedAt="i8acf5b131e624cc28b97cc228a906da1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INVENTORIES</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></ix:nonNumeric></div><div><span><br/></span></div><ix:continuation id="i8acf5b131e624cc28b97cc228a906da1"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTMvZnJhZzoyNTY0Yjc1NDkzMDg0NTBhYTIxY2I0MzNlMTMzZmUyZS90ZXh0cmVnaW9uOjI1NjRiNzU0OTMwODQ1MGFhMjFjYjQzM2UxMzNmZTJlXzk4Nw_e4b03bac-2f49-4f86-87da-ab6ab6000f3c" escape="true">Inventories are stated at the lower of cost (first-in, first-out) or net realizable value. Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. We write down the carrying value of inventory for estimated obsolescence by an amount equal to the difference between the cost of inventory and the estimated market value when warranted based on assumptions of future demand, market conditions, remaining shelf life, or product functionality. If actual market conditions or results of estimated functionality are less favorable than those we estimated, additional inventory write-downs may be required, which would have a negative effect on results of operations.</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unpaid inventory reflected within accounts payable in our consolidated balance sheets was $<ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-5" name="us-gaap:AccountsPayableTradeCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTMvZnJhZzoyNTY0Yjc1NDkzMDg0NTBhYTIxY2I0MzNlMTMzZmUyZS90ZXh0cmVnaW9uOjI1NjRiNzU0OTMwODQ1MGFhMjFjYjQzM2UxMzNmZTJlXzg4OA_df35dafa-13ca-4f1c-a642-c99bcc84240b">64.4</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-5" name="us-gaap:AccountsPayableTradeCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTMvZnJhZzoyNTY0Yjc1NDkzMDg0NTBhYTIxY2I0MzNlMTMzZmUyZS90ZXh0cmVnaW9uOjI1NjRiNzU0OTMwODQ1MGFhMjFjYjQzM2UxMzNmZTJlXzg5Mg_e33a1207-c3fa-4bad-ac49-23069e783061">45.6</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i0c634b937c58472e84857eacf99e17df_I20191231" decimals="-5" name="us-gaap:AccountsPayableTradeCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTMvZnJhZzoyNTY0Yjc1NDkzMDg0NTBhYTIxY2I0MzNlMTMzZmUyZS90ZXh0cmVnaW9uOjI1NjRiNzU0OTMwODQ1MGFhMjFjYjQzM2UxMzNmZTJlXzkwMA_02f34747-41dd-487d-ba55-487c4bed2ba1">39.5</ix:nonFraction> million at December 31, 2021, 2020, and 2019, respectively. Instrument inventory transferred to property and equipment related to rental and operating-type reagent rental programs was $<ix:nonFraction unitRef="usd" contextRef="if03c9c1348554db4936cf06e9bd802c2_D20210101-20211231" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTMvZnJhZzoyNTY0Yjc1NDkzMDg0NTBhYTIxY2I0MzNlMTMzZmUyZS90ZXh0cmVnaW9uOjI1NjRiNzU0OTMwODQ1MGFhMjFjYjQzM2UxMzNmZTJlXzQzOTgwNDY1MTI5MTY_644b5637-20d6-4b4b-92b5-3c80dd81429e">11.6</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="i6f415ad968794c3b9bf10b5e7c9d08e8_D20200101-20201231" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTMvZnJhZzoyNTY0Yjc1NDkzMDg0NTBhYTIxY2I0MzNlMTMzZmUyZS90ZXh0cmVnaW9uOjI1NjRiNzU0OTMwODQ1MGFhMjFjYjQzM2UxMzNmZTJlXzQzOTgwNDY1MTI5MjA_d782d0e2-bd2c-4f0c-b1e7-f2daeecacca4">9.6</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="i69d7e5c1eec24001a74325f821a31cba_D20190101-20191231" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTMvZnJhZzoyNTY0Yjc1NDkzMDg0NTBhYTIxY2I0MzNlMTMzZmUyZS90ZXh0cmVnaW9uOjI1NjRiNzU0OTMwODQ1MGFhMjFjYjQzM2UxMzNmZTJlXzQzOTgwNDY1MTI5MjQ_393a903e-c51c-454f-829e-665a730e3d87">14.5</ix:nonFraction>&#160;million during the years ended December 31, 2021, 2020, and 2019, respectively.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTMvZnJhZzoyNTY0Yjc1NDkzMDg0NTBhYTIxY2I0MzNlMTMzZmUyZS90ZXh0cmVnaW9uOjI1NjRiNzU0OTMwODQ1MGFhMjFjYjQzM2UxMzNmZTJlXzk5MQ_0b546b4c-f77a-4df4-b599-abc6e4404109" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of inventories are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"><tr><td style="width:1.0%"></td><td style="width:68.015%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.292%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.895%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:InventoryRawMaterialsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTMvZnJhZzoyNTY0Yjc1NDkzMDg0NTBhYTIxY2I0MzNlMTMzZmUyZS90YWJsZTo1ZWZkYzA5NWU3YmE0MjVjODE5OTUwNWU5ZDY3ODZjMC90YWJsZXJhbmdlOjVlZmRjMDk1ZTdiYTQyNWM4MTk5NTA1ZTlkNjc4NmMwXzItMi0xLTEtMA_552d329c-ab59-466d-b009-b62fa74abb60">60,427</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:InventoryRawMaterialsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTMvZnJhZzoyNTY0Yjc1NDkzMDg0NTBhYTIxY2I0MzNlMTMzZmUyZS90YWJsZTo1ZWZkYzA5NWU3YmE0MjVjODE5OTUwNWU5ZDY3ODZjMC90YWJsZXJhbmdlOjVlZmRjMDk1ZTdiYTQyNWM4MTk5NTA1ZTlkNjc4NmMwXzItNC0xLTEtMA_104efb77-7fa2-4e6d-ae23-96bed8df7d72">45,986</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:InventoryWorkInProcessNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTMvZnJhZzoyNTY0Yjc1NDkzMDg0NTBhYTIxY2I0MzNlMTMzZmUyZS90YWJsZTo1ZWZkYzA5NWU3YmE0MjVjODE5OTUwNWU5ZDY3ODZjMC90YWJsZXJhbmdlOjVlZmRjMDk1ZTdiYTQyNWM4MTk5NTA1ZTlkNjc4NmMwXzMtMi0xLTEtMA_3455bcce-449a-4352-b6fe-954ca3a5b0d8">26,397</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:InventoryWorkInProcessNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTMvZnJhZzoyNTY0Yjc1NDkzMDg0NTBhYTIxY2I0MzNlMTMzZmUyZS90YWJsZTo1ZWZkYzA5NWU3YmE0MjVjODE5OTUwNWU5ZDY3ODZjMC90YWJsZXJhbmdlOjVlZmRjMDk1ZTdiYTQyNWM4MTk5NTA1ZTlkNjc4NmMwXzMtNC0xLTEtMA_2197b9b7-7c46-4a3d-98e8-63752cd8d49e">20,374</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTMvZnJhZzoyNTY0Yjc1NDkzMDg0NTBhYTIxY2I0MzNlMTMzZmUyZS90YWJsZTo1ZWZkYzA5NWU3YmE0MjVjODE5OTUwNWU5ZDY3ODZjMC90YWJsZXJhbmdlOjVlZmRjMDk1ZTdiYTQyNWM4MTk5NTA1ZTlkNjc4NmMwXzQtMi0xLTEtMA_cc09e511-fc3c-4ba0-aeae-52d2c651b5e5">182,206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTMvZnJhZzoyNTY0Yjc1NDkzMDg0NTBhYTIxY2I0MzNlMTMzZmUyZS90YWJsZTo1ZWZkYzA5NWU3YmE0MjVjODE5OTUwNWU5ZDY3ODZjMC90YWJsZXJhbmdlOjVlZmRjMDk1ZTdiYTQyNWM4MTk5NTA1ZTlkNjc4NmMwXzQtNC0xLTEtMA_1a2ee7d8-1810-4217-95ce-f52ffa8e5283">143,513</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTMvZnJhZzoyNTY0Yjc1NDkzMDg0NTBhYTIxY2I0MzNlMTMzZmUyZS90YWJsZTo1ZWZkYzA5NWU3YmE0MjVjODE5OTUwNWU5ZDY3ODZjMC90YWJsZXJhbmdlOjVlZmRjMDk1ZTdiYTQyNWM4MTk5NTA1ZTlkNjc4NmMwXzUtMi0xLTEtMA_12097070-d4fd-456f-b3dc-513103353e85">269,030</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTMvZnJhZzoyNTY0Yjc1NDkzMDg0NTBhYTIxY2I0MzNlMTMzZmUyZS90YWJsZTo1ZWZkYzA5NWU3YmE0MjVjODE5OTUwNWU5ZDY3ODZjMC90YWJsZXJhbmdlOjVlZmRjMDk1ZTdiYTQyNWM4MTk5NTA1ZTlkNjc4NmMwXzUtNC0xLTEtMA_10e3672e-f86b-42d5-ad9d-9bf2984661d2">209,873</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:5pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt"><span><br/></span></div><div id="i5d795a6851d746ca914a2ddae761c329_196"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 8.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90ZXh0cmVnaW9uOmQ4MDc4ODc3YTVmODQ0YWE4YjFmM2FhNTFkMzEyMTMxXzM2MTc_85f24314-14e5-40ef-bd4e-fc2a0432f0f4" continuedAt="if8abb465414b43f1a0f84dc9167f520e" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LEASES</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></ix:nonNumeric></div><div><span><br/></span></div><ix:continuation id="if8abb465414b43f1a0f84dc9167f520e" continuedAt="i18ce8e9444ee45a8ad6b464e85cd4f73"><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:LessorLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90ZXh0cmVnaW9uOmQ4MDc4ODc3YTVmODQ0YWE4YjFmM2FhNTFkMzEyMTMxXzM2MTk_4b71a4af-146f-489a-a128-0212c94a4b3f" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of our facilities are occupied under operating lease arrangements with various expiration dates through 2067, some of which include options to extend the life of the lease, and some of which include options to terminate the lease within <ix:nonNumeric contextRef="i2547ad5bc951453f98e34b5d0f26b8bb_D20210101-20211231" name="idxx:LesseeOperatingLeaseTerminationPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90ZXh0cmVnaW9uOmQ4MDc4ODc3YTVmODQ0YWE4YjFmM2FhNTFkMzEyMTMxXzYwNDczMTM5NTc2OTE_6988ae0b-d8f0-4846-aa07-ec42235693c5">1</ix:nonNumeric> year. In certain instances, we are responsible for the real estate taxes and operating expenses related to these facilities.&#160;Additionally, we enter into operating leases for certain vehicles and office equipment in the normal course of business. We determine the expected term of any executed agreements using the non-cancelable lease term plus any renewal options by which the failure to renew imposes a penalty in such amount that renewal is reasonably assured. The derived expected term is then used in the determination of a financing or operating lease and in the calculation of straight-line rent expense. Rent escalations are considered in the calculation of minimum lease payments in our capital lease tests and in determining straight-line rent expense for operating leases. Minimum&#160;lease&#160;payments include the fixed&#160;lease&#160;component of the agreement, as well as fixed rate increases that are initially measured at the&#160;lease&#160;commencement date. Variable lease payments based on an index and payments associated with&#160;non-lease&#160;components and short-term rentals (leases with terms less than 12 months) are expensed as incurred. Consideration is&#160;allocated&#160;to the&#160;lease&#160;and non-lease components based on the estimated standalone prices.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine if an arrangement is a lease at its inception. Operating leases are included in operating lease right-of-use assets, accrued liabilities, and long-term operating lease liabilities in our consolidated balance sheets. Our financing leases are not material to the financial statements.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease liabilities and right-of-use assets are recognized at commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an explicit rate, we use our incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. Our lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Rent expense for lease payments is recognized on a straight-line basis over the lease term. The operating lease right-of-use assets also includes any rent prepayments, lease incentives upon receipt, and straight-line rent expense impacts, which represent the differences between our operating lease liabilities and right-of-use assets.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90ZXh0cmVnaW9uOmQ4MDc4ODc3YTVmODQ0YWE4YjFmM2FhNTFkMzEyMTMxXzM2MTM_9ec6a663-6334-47bc-a91f-89df04a0ccb0" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of operating lease liabilities are as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:85.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.283%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90YWJsZTo2YjBkNDJlYjhiODY0MTM1ODFmNzlmODJkNTM5YzliMi90YWJsZXJhbmdlOjZiMGQ0MmViOGI4NjQxMzU4MWY3OWY4MmQ1MzljOWIyXzItMS0xLTEtMA_25c7b207-d950-4e2d-a21f-0c23d5748687">22,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90YWJsZTo2YjBkNDJlYjhiODY0MTM1ODFmNzlmODJkNTM5YzliMi90YWJsZXJhbmdlOjZiMGQ0MmViOGI4NjQxMzU4MWY3OWY4MmQ1MzljOWIyXzMtMS0xLTEtMA_b1a34c08-8343-4986-a699-cfe3d413c350">21,122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90YWJsZTo2YjBkNDJlYjhiODY0MTM1ODFmNzlmODJkNTM5YzliMi90YWJsZXJhbmdlOjZiMGQ0MmViOGI4NjQxMzU4MWY3OWY4MmQ1MzljOWIyXzQtMS0xLTEtMA_1bd11d33-34e6-4514-b5c7-13ca160eb58e">16,523</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90YWJsZTo2YjBkNDJlYjhiODY0MTM1ODFmNzlmODJkNTM5YzliMi90YWJsZXJhbmdlOjZiMGQ0MmViOGI4NjQxMzU4MWY3OWY4MmQ1MzljOWIyXzUtMS0xLTEtMA_78e9d52a-09bc-497f-b0e3-e3f234c1524d">12,675</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90YWJsZTo2YjBkNDJlYjhiODY0MTM1ODFmNzlmODJkNTM5YzliMi90YWJsZXJhbmdlOjZiMGQ0MmViOGI4NjQxMzU4MWY3OWY4MmQ1MzljOWIyXzYtMS0xLTEtMA_18e6bd6a-3c05-4935-a15c-1b6a11997a62">10,437</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90YWJsZTo2YjBkNDJlYjhiODY0MTM1ODFmNzlmODJkNTM5YzliMi90YWJsZXJhbmdlOjZiMGQ0MmViOGI4NjQxMzU4MWY3OWY4MmQ1MzljOWIyXzctMS0xLTEtMA_e0a4a841-f7c0-4575-aaac-5994659b2d4c">39,047</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90YWJsZTo2YjBkNDJlYjhiODY0MTM1ODFmNzlmODJkNTM5YzliMi90YWJsZXJhbmdlOjZiMGQ0MmViOGI4NjQxMzU4MWY3OWY4MmQ1MzljOWIyXzgtMS0xLTEtMA_e43d4af1-8437-42c5-baf8-159180107a9d">122,206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90YWJsZTo2YjBkNDJlYjhiODY0MTM1ODFmNzlmODJkNTM5YzliMi90YWJsZXJhbmdlOjZiMGQ0MmViOGI4NjQxMzU4MWY3OWY4MmQ1MzljOWIyXzktMS0xLTEtMA_1d53385b-c532-437e-92b8-c88f3cbcac3c">14,898</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease liability (current and long-term)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90YWJsZTo2YjBkNDJlYjhiODY0MTM1ODFmNzlmODJkNTM5YzliMi90YWJsZXJhbmdlOjZiMGQ0MmViOGI4NjQxMzU4MWY3OWY4MmQ1MzljOWIyXzEwLTEtMS0xLTA_000bd66a-f040-4770-987e-08f24a3c7ce2">107,308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total minimum future lease payments of approximately $<ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-5" name="idxx:OperatingLeaseLeaseNotyetCommencedExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90ZXh0cmVnaW9uOmQ4MDc4ODc3YTVmODQ0YWE4YjFmM2FhNTFkMzEyMTMxXzI5NDM_690c5df6-6842-4caa-8c62-761b071269a1">1.6</ix:nonFraction> million for leases that have not commenced as of December 31, 2021, are not included in the consolidated financial statements, as we do not yet control the underlying assets. These leases are expected to commence during 2022 through 2024 with lease terms of approximately <ix:nonNumeric contextRef="iec94ca1756b3473faecedf9258139d41_I20211231" name="us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90ZXh0cmVnaW9uOmQ4MDc4ODc3YTVmODQ0YWE4YjFmM2FhNTFkMzEyMTMxXzMxODE_18530353-0774-4ea5-9b4f-8ee50d07909e">3</ix:nonNumeric> to <ix:nonNumeric contextRef="i9aa403826a744b88a310a196d527c4da_I20211231" name="us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90ZXh0cmVnaW9uOmQ4MDc4ODc3YTVmODQ0YWE4YjFmM2FhNTFkMzEyMTMxXzMxODc_9d58680b-3eb1-477c-b1a5-21cb4504ecf7">5.25</ix:nonNumeric> years.</span></div><div><span><br/></span></div><div><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90ZXh0cmVnaW9uOmQ4MDc4ODc3YTVmODQ0YWE4YjFmM2FhNTFkMzEyMTMxXzM2MjA_54e0ecfd-a868-4cd5-862c-825a4bf38a84" continuedAt="i7b901e06aee54f1c825640e14de17d77" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.205%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average remaining lease term - operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90YWJsZTo2YzY5NTJiNjg5YmQ0MDAwOTFiNDk3NTVmZTViNWEyNS90YWJsZXJhbmdlOjZjNjk1MmI2ODliZDQwMDA5MWI0OTc1NWZlNWI1YTI1XzItMS0xLTEtMA_ba81b78c-f03e-4f6a-8384-32581d58d10b">9.4</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90YWJsZTo2YzY5NTJiNjg5YmQ0MDAwOTFiNDk3NTVmZTViNWEyNS90YWJsZXJhbmdlOjZjNjk1MmI2ODliZDQwMDA5MWI0OTc1NWZlNWI1YTI1XzItMy0xLTEtMA_a7d98133-bfc7-4866-a4da-af51f204c110">10.3</ix:nonNumeric> years</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average discount rate - operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90YWJsZTo2YzY5NTJiNjg5YmQ0MDAwOTFiNDk3NTVmZTViNWEyNS90YWJsZXJhbmdlOjZjNjk1MmI2ODliZDQwMDA5MWI0OTc1NWZlNWI1YTI1XzQtMS0xLTEtMA_d54a9f64-c10c-448a-aad2-140799579ecf">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90YWJsZTo2YzY5NTJiNjg5YmQ0MDAwOTFiNDk3NTVmZTViNWEyNS90YWJsZXJhbmdlOjZjNjk1MmI2ODliZDQwMDA5MWI0OTc1NWZlNWI1YTI1XzQtMy0xLTEtMA_469d5e27-1b13-44fb-b463-e2ea33976eb2">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expenses incurred related to operating leases, excluding variable and short-term leases, were approximately $<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-5" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90ZXh0cmVnaW9uOmQ4MDc4ODc3YTVmODQ0YWE4YjFmM2FhNTFkMzEyMTMxXzMzMDY_b21d0694-9c26-496f-8e6c-979d20911e20">23.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-5" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90ZXh0cmVnaW9uOmQ4MDc4ODc3YTVmODQ0YWE4YjFmM2FhNTFkMzEyMTMxXzMzMTM_3157e538-d78b-40b7-a609-035b2eaf4c3f">21.7</ix:nonFraction>&#160;million during the year ended December 31, 2021 and 2020, respectively. Total expenses incurred related to </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i18ce8e9444ee45a8ad6b464e85cd4f73"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">operating leases, including variable rent and short-term leases, were approximately $<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-5" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90ZXh0cmVnaW9uOmQ4MDc4ODc3YTVmODQ0YWE4YjFmM2FhNTFkMzEyMTMxXzI3NDg3NzkwNzQzMzU_4d9c80ee-2f99-478c-adf4-69acd783180b">25.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-5" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90ZXh0cmVnaW9uOmQ4MDc4ODc3YTVmODQ0YWE4YjFmM2FhNTFkMzEyMTMxXzM0ODY_bcaa6d59-1763-42f0-a77c-4db77913173d">24.5</ix:nonFraction> million for the years ended December 31, 2021 and 2020, respectively.</span></div><div><span><br/></span></div><ix:continuation id="i7b901e06aee54f1c825640e14de17d77"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information for leases is as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.205%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended <br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of operating lease liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90YWJsZToxODhhN2NkZTYwMmQ0NzBmYTA5MTZhNjRhZGM4YWU5NS90YWJsZXJhbmdlOjE4OGE3Y2RlNjAyZDQ3MGZhMDkxNmE2NGFkYzhhZTk1XzMtMS0xLTEtMA_d579c071-43e7-4f23-87c1-b013214b1cc8">24,214</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90YWJsZToxODhhN2NkZTYwMmQ0NzBmYTA5MTZhNjRhZGM4YWU5NS90YWJsZXJhbmdlOjE4OGE3Y2RlNjAyZDQ3MGZhMDkxNmE2NGFkYzhhZTk1XzMtMy0xLTEtMA_96217bed-29a8-47df-a200-9a07d3a9ea17">19,619</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for operating lease obligations, net of early lease&#160;terminations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90YWJsZToxODhhN2NkZTYwMmQ0NzBmYTA5MTZhNjRhZGM4YWU5NS90YWJsZXJhbmdlOjE4OGE3Y2RlNjAyZDQ3MGZhMDkxNmE2NGFkYzhhZTk1XzQtMS0xLTEtMA_c5305ad6-03e8-46ef-be52-3c1cad7a5a6b">37,572</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90YWJsZToxODhhN2NkZTYwMmQ0NzBmYTA5MTZhNjRhZGM4YWU5NS90YWJsZXJhbmdlOjE4OGE3Y2RlNjAyZDQ3MGZhMDkxNmE2NGFkYzhhZTk1XzQtMy0xLTEtMA_872ee0e3-f6d7-46fd-a635-44b641b65520">26,807</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div id="i5d795a6851d746ca914a2ddae761c329_199"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 9.&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90ZXh0cmVnaW9uOjMxYTU2MmNlNGEzOTRlMDBhYmIyMGQwNGIxZTk0ZDY3XzI2MjA_f50acbcf-1b5d-46c1-a6dd-eca798d28d8c" continuedAt="ie2fd7b2ba6d6465ead12fe881cab8c1e" escape="true">PROPERTY AND EQUIPMENT, NET </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ie2fd7b2ba6d6465ead12fe881cab8c1e" continuedAt="i163c51f516ad4142b7b3aef092e24435"><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90ZXh0cmVnaW9uOjMxYTU2MmNlNGEzOTRlMDBhYmIyMGQwNGIxZTk0ZDY3XzI2MTA_0e156fe4-41b4-4c78-9bdd-7b45ba1bbbfd" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost, net of accumulated depreciation and amortization. The costs of additions and improvements are capitalized, while maintenance and repairs are charged to expense as incurred. When an item is sold or retired, the cost and related accumulated depreciation are relieved, and the resulting gain or loss, if any, is recognized in the consolidated statements of income. We evaluate our property and equipment for impairment periodically or as changes in circumstances or the occurrence of events suggest the remaining value is not recoverable from future cash flows. If the carrying value of our&#160;property and equipment is impaired, an impairment charge is recorded for the amount by which the carrying value of the property and equipment exceeds its fair value.&#160;<ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="idxx:ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90ZXh0cmVnaW9uOjMxYTU2MmNlNGEzOTRlMDBhYmIyMGQwNGIxZTk0ZDY3XzI2MjI_58797505-bb23-4e19-b18e-15e01fd3fa60" continuedAt="i563061c1eb48422db1172330f293d822" escape="true">We provide for depreciation and amortization primarily using the straight-line method by charges to the consolidated statements of income in amounts that allocate the cost of property and equipment over their estimated useful lives as follows:</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="i563061c1eb48422db1172330f293d822"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:60.246%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.731%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.723%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Asset Classification</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Land improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i358c864968b04228b7d1de65d4356012_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo4NzFmNDBiZmYxYzc0ZDA4OWQ2MmU1ODljNjc5ZDhlZS90YWJsZXJhbmdlOjg3MWY0MGJmZjFjNzRkMDg5ZDYyZTU4OWM2NzlkOGVlXzItMi0xLTEtMC90ZXh0cmVnaW9uOjdlZWViMDFjZTQwNDRkYTM4NDU5NDdhNjIzM2Y1OGNmXzQ_cfcb217b-f828-4796-a36f-7c7be74d7983">15</ix:nonNumeric> to <ix:nonNumeric contextRef="iaae1104f80a84293b957aad0e5ba9d49_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo4NzFmNDBiZmYxYzc0ZDA4OWQ2MmU1ODljNjc5ZDhlZS90YWJsZXJhbmdlOjg3MWY0MGJmZjFjNzRkMDg5ZDYyZTU4OWM2NzlkOGVlXzItMi0xLTEtMC90ZXh0cmVnaW9uOjdlZWViMDFjZTQwNDRkYTM4NDU5NDdhNjIzM2Y1OGNmXzEw_44f271e7-1b85-4dff-9604-7bb1705a8e34">20</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie6f5e29e1d644e1380b56d80b5c8ab21_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo4NzFmNDBiZmYxYzc0ZDA4OWQ2MmU1ODljNjc5ZDhlZS90YWJsZXJhbmdlOjg3MWY0MGJmZjFjNzRkMDg5ZDYyZTU4OWM2NzlkOGVlXzMtMi0xLTEtMC90ZXh0cmVnaW9uOmI2OTM1YmIxMmMxNzQ4OTU5ZDhiMmU5YjczM2Q1MWFkXzQ_44bbac0d-181c-4b1f-a09d-555ece335e92">10</ix:nonNumeric> to <ix:nonNumeric contextRef="iec5713b70bef4889b876769c7518056a_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo4NzFmNDBiZmYxYzc0ZDA4OWQ2MmU1ODljNjc5ZDhlZS90YWJsZXJhbmdlOjg3MWY0MGJmZjFjNzRkMDg5ZDYyZTU4OWM2NzlkOGVlXzMtMi0xLTEtMC90ZXh0cmVnaW9uOmI2OTM1YmIxMmMxNzQ4OTU5ZDhiMmU5YjczM2Q1MWFkXzEw_9a225f21-3d35-4b47-b0c2-acf296b8e4f1">40</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shorter of remaining lease term or useful life of improvements</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia3d9107992e245d2808adc5e2bef7264_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo4NzFmNDBiZmYxYzc0ZDA4OWQ2MmU1ODljNjc5ZDhlZS90YWJsZXJhbmdlOjg3MWY0MGJmZjFjNzRkMDg5ZDYyZTU4OWM2NzlkOGVlXzUtMi0xLTEtMC90ZXh0cmVnaW9uOjhkYmNlZDAxZDAxZjQ3MGFhOGFiNGU3YmU4ODMwYjVhXzQ_57dd9166-1a01-4ede-97d4-0d4cb0119386">3</ix:nonNumeric> to <ix:nonNumeric contextRef="i9a4a3d9081da4e4890098ab4828eff02_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo4NzFmNDBiZmYxYzc0ZDA4OWQ2MmU1ODljNjc5ZDhlZS90YWJsZXJhbmdlOjg3MWY0MGJmZjFjNzRkMDg5ZDYyZTU4OWM2NzlkOGVlXzUtMi0xLTEtMC90ZXh0cmVnaW9uOjhkYmNlZDAxZDAxZjQ3MGFhOGFiNGU3YmU4ODMwYjVhXzEw_f91f8e86-ea95-485b-9bc2-c1c75c1902ea">8</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Office furniture and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ifcd90bb4b001420db3089207a9817b90_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo4NzFmNDBiZmYxYzc0ZDA4OWQ2MmU1ODljNjc5ZDhlZS90YWJsZXJhbmdlOjg3MWY0MGJmZjFjNzRkMDg5ZDYyZTU4OWM2NzlkOGVlXzYtMi0xLTEtMC90ZXh0cmVnaW9uOjU4MGZmYjYyYmNhNjRhMGNiN2IyZWI2MzdiZmY3M2QwXzQ_933751f3-7012-4cf3-9f82-7c2b8352fd6d">3</ix:nonNumeric> to <ix:nonNumeric contextRef="iefcc27d08de64329bcdafc6e24f95d6f_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo4NzFmNDBiZmYxYzc0ZDA4OWQ2MmU1ODljNjc5ZDhlZS90YWJsZXJhbmdlOjg3MWY0MGJmZjFjNzRkMDg5ZDYyZTU4OWM2NzlkOGVlXzYtMi0xLTEtMC90ZXh0cmVnaW9uOjU4MGZmYjYyYmNhNjRhMGNiN2IyZWI2MzdiZmY3M2QwXzEw_2490b725-173f-4769-b838-8b622f6d3197">7</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Computer hardware and software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1e07bfbfbbdc4286ac526097dcc2014a_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo4NzFmNDBiZmYxYzc0ZDA4OWQ2MmU1ODljNjc5ZDhlZS90YWJsZXJhbmdlOjg3MWY0MGJmZjFjNzRkMDg5ZDYyZTU4OWM2NzlkOGVlXzctMi0xLTEtMC90ZXh0cmVnaW9uOmM0YTAzNGUyMTdlMDQ5Yjg5ZDk5YmEyYzEzM2FmNTEwXzQ_7cf2a121-5f04-4e9c-a758-9555fbffa43c">3</ix:nonNumeric> to <ix:nonNumeric contextRef="i283cc22fdf494c59a8affd0dcad7b35a_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo4NzFmNDBiZmYxYzc0ZDA4OWQ2MmU1ODljNjc5ZDhlZS90YWJsZXJhbmdlOjg3MWY0MGJmZjFjNzRkMDg5ZDYyZTU4OWM2NzlkOGVlXzctMi0xLTEtMC90ZXh0cmVnaW9uOmM0YTAzNGUyMTdlMDQ5Yjg5ZDk5YmEyYzEzM2FmNTEwXzEw_9d84e4d7-84b3-4551-b983-1a037fb2d55f">7</ix:nonNumeric> years</span></div></td></tr></table></ix:continuation></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We capitalize interest on the acquisition and construction of significant assets that require a substantial period of time to be made ready for use. The capitalized interest is included in the cost of the completed asset and depreciated over the asset&#8217;s estimated useful life. The amount of interest capitalized during the years ended December 31, 2021 and 2020, was not material.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We capitalize certain costs incurred in connection with developing or obtaining software designated for internal use based on three distinct stages of development. Qualifying costs incurred during the application development stage, which consist primarily of internal payroll and direct fringe benefits and external direct project costs, including labor and travel, are capitalized and amortized on a straight-line basis over the estimated useful life of the asset. Costs incurred during the preliminary project and post-implementation and operation phases are expensed as incurred. These costs relate primarily to the determination of performance requirements, data conversion, and training. Software developed to deliver hosted services to our customers has been designated as internal use.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i163c51f516ad4142b7b3aef092e24435"><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90ZXh0cmVnaW9uOjMxYTU2MmNlNGEzOTRlMDBhYmIyMGQwNGIxZTk0ZDY3XzI2MjM_70cdf313-b59a-411e-98fb-e97e84c88857" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net, consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.490%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.377%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 7.75pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Land and improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c5014947c2d49ac8200d45c4f5828a0_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo5NDJiMTM5ZDRkYTM0NWQ1ODQ3ZjdkZjZjZWY3ZjAyYi90YWJsZXJhbmdlOjk0MmIxMzlkNGRhMzQ1ZDU4NDdmN2RmNmNlZjdmMDJiXzItMi0xLTEtMA_0d73f3b2-b1c1-4f66-8243-2614c8cd3b1f">22,642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6e52598ae7b4d548bd924fa1808d713_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo5NDJiMTM5ZDRkYTM0NWQ1ODQ3ZjdkZjZjZWY3ZjAyYi90YWJsZXJhbmdlOjk0MmIxMzlkNGRhMzQ1ZDU4NDdmN2RmNmNlZjdmMDJiXzItNC0xLTEtMA_8aee411a-2c88-4db0-87b9-539f015a6e5d">13,982</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84c5988a324d4a31a0b062f598b122e2_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo5NDJiMTM5ZDRkYTM0NWQ1ODQ3ZjdkZjZjZWY3ZjAyYi90YWJsZXJhbmdlOjk0MmIxMzlkNGRhMzQ1ZDU4NDdmN2RmNmNlZjdmMDJiXzMtMi0xLTEtMA_35139ff4-eeb5-4a09-8753-15b7d171248b">329,091</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27518b77901a4762b6f2872c61ab1b01_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo5NDJiMTM5ZDRkYTM0NWQ1ODQ3ZjdkZjZjZWY3ZjAyYi90YWJsZXJhbmdlOjk0MmIxMzlkNGRhMzQ1ZDU4NDdmN2RmNmNlZjdmMDJiXzMtNC0xLTEtMA_80103309-a6a9-4d9e-84be-2ae37ac0fa4f">319,384</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5325a16dfc33486bb52b0c132af02290_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo5NDJiMTM5ZDRkYTM0NWQ1ODQ3ZjdkZjZjZWY3ZjAyYi90YWJsZXJhbmdlOjk0MmIxMzlkNGRhMzQ1ZDU4NDdmN2RmNmNlZjdmMDJiXzQtMi0xLTEtMA_a5a9774d-ebef-455a-a010-2f1d93bdb7ec">93,248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ced4bf3c1a540939075a145fafad2f1_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo5NDJiMTM5ZDRkYTM0NWQ1ODQ3ZjdkZjZjZWY3ZjAyYi90YWJsZXJhbmdlOjk0MmIxMzlkNGRhMzQ1ZDU4NDdmN2RmNmNlZjdmMDJiXzQtNC0xLTEtMA_08c976e0-708f-414e-b958-46e3c88e15a9">82,459</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id90597dbb49948fabb735806b012f616_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo5NDJiMTM5ZDRkYTM0NWQ1ODQ3ZjdkZjZjZWY3ZjAyYi90YWJsZXJhbmdlOjk0MmIxMzlkNGRhMzQ1ZDU4NDdmN2RmNmNlZjdmMDJiXzUtMi0xLTEtMA_f7a37199-110e-42c7-b153-19b316fdee26">382,753</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dad70e6dd004c2695b06a59bd68945a_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo5NDJiMTM5ZDRkYTM0NWQ1ODQ3ZjdkZjZjZWY3ZjAyYi90YWJsZXJhbmdlOjk0MmIxMzlkNGRhMzQ1ZDU4NDdmN2RmNmNlZjdmMDJiXzUtNC0xLTEtMA_e716150a-df98-4bc7-9e95-6d13f3db0296">353,301</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Office furniture and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a2074f7bc9b4a2cbf6ed3b610f98409_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo5NDJiMTM5ZDRkYTM0NWQ1ODQ3ZjdkZjZjZWY3ZjAyYi90YWJsZXJhbmdlOjk0MmIxMzlkNGRhMzQ1ZDU4NDdmN2RmNmNlZjdmMDJiXzYtMi0xLTEtMA_bdf1e153-a0e7-4cfe-a02b-048205fd86bd">69,090</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69684bf965814a318039fff0559aee1f_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo5NDJiMTM5ZDRkYTM0NWQ1ODQ3ZjdkZjZjZWY3ZjAyYi90YWJsZXJhbmdlOjk0MmIxMzlkNGRhMzQ1ZDU4NDdmN2RmNmNlZjdmMDJiXzYtNC0xLTEtMA_66d337c7-e083-426d-a985-b1eb5db7fad9">67,527</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Computer hardware and software</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4c3038a1c6e434f960b3b42480ee814_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo5NDJiMTM5ZDRkYTM0NWQ1ODQ3ZjdkZjZjZWY3ZjAyYi90YWJsZXJhbmdlOjk0MmIxMzlkNGRhMzQ1ZDU4NDdmN2RmNmNlZjdmMDJiXzctMi0xLTEtMA_677dec54-1fcc-4c9d-9726-0d442a69a142">276,895</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24004ed53abe4277a8577a3ab12dd906_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo5NDJiMTM5ZDRkYTM0NWQ1ODQ3ZjdkZjZjZWY3ZjAyYi90YWJsZXJhbmdlOjk0MmIxMzlkNGRhMzQ1ZDU4NDdmN2RmNmNlZjdmMDJiXzctNC0xLTEtMA_d6851aa5-3893-446c-9276-1665f0ed5d15">265,664</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc87de78fd14b56ba2c24532ac28a94_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo5NDJiMTM5ZDRkYTM0NWQ1ODQ3ZjdkZjZjZWY3ZjAyYi90YWJsZXJhbmdlOjk0MmIxMzlkNGRhMzQ1ZDU4NDdmN2RmNmNlZjdmMDJiXzgtMi0xLTEtMA_e555d2ab-a124-4824-af04-f46e3ad7f7c4">62,339</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46df05df390f4fb8b267041b3f7c430b_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo5NDJiMTM5ZDRkYTM0NWQ1ODQ3ZjdkZjZjZWY3ZjAyYi90YWJsZXJhbmdlOjk0MmIxMzlkNGRhMzQ1ZDU4NDdmN2RmNmNlZjdmMDJiXzgtNC0xLTEtMA_509524d0-30f9-476c-9d8c-e0e6d1a9f70d">39,764</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo5NDJiMTM5ZDRkYTM0NWQ1ODQ3ZjdkZjZjZWY3ZjAyYi90YWJsZXJhbmdlOjk0MmIxMzlkNGRhMzQ1ZDU4NDdmN2RmNmNlZjdmMDJiXzktMi0xLTEtMA_e4909243-edd0-4e7f-ab10-5fccab4d5a6d">1,236,058</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo5NDJiMTM5ZDRkYTM0NWQ1ODQ3ZjdkZjZjZWY3ZjAyYi90YWJsZXJhbmdlOjk0MmIxMzlkNGRhMzQ1ZDU4NDdmN2RmNmNlZjdmMDJiXzktNC0xLTEtMA_b35a8c3b-e190-4709-958c-37ddf99cc36a">1,142,081</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo5NDJiMTM5ZDRkYTM0NWQ1ODQ3ZjdkZjZjZWY3ZjAyYi90YWJsZXJhbmdlOjk0MmIxMzlkNGRhMzQ1ZDU4NDdmN2RmNmNlZjdmMDJiXzEwLTItMS0xLTA_9374e6ea-81ab-4b0d-bd15-f4a7cf75c614">648,391</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo5NDJiMTM5ZDRkYTM0NWQ1ODQ3ZjdkZjZjZWY3ZjAyYi90YWJsZXJhbmdlOjk0MmIxMzlkNGRhMzQ1ZDU4NDdmN2RmNmNlZjdmMDJiXzEwLTQtMS0xLTA_bfbabdc4-eb6e-41d6-9697-2aedac3a7840">586,914</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo5NDJiMTM5ZDRkYTM0NWQ1ODQ3ZjdkZjZjZWY3ZjAyYi90YWJsZXJhbmdlOjk0MmIxMzlkNGRhMzQ1ZDU4NDdmN2RmNmNlZjdmMDJiXzExLTItMS0xLTA_cbb20e83-7e93-46b1-a106-6b781f567d30">587,667</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo5NDJiMTM5ZDRkYTM0NWQ1ODQ3ZjdkZjZjZWY3ZjAyYi90YWJsZXJhbmdlOjk0MmIxMzlkNGRhMzQ1ZDU4NDdmN2RmNmNlZjdmMDJiXzExLTQtMS0xLTA_1a1f8e85-e248-4484-b024-176f885fe6a6">555,167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="idxx:SummaryOfDepreciationAndAmortizationCapitalizedComputerSoftwareForInternalUseAndUnpaidPropertyEquipmentReflectedInAccountPayableAndAccruedExpensesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90ZXh0cmVnaW9uOjMxYTU2MmNlNGEzOTRlMDBhYmIyMGQwNGIxZTk0ZDY3XzI2MTg_a5548e97-6a8f-440c-a81c-3af1053ff42d" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below are the amounts of depreciation and amortization of property and equipment, capitalized computer software for internal use, unpaid property and equipment reflected in accounts payable and accrued expenses, and rental and reagent rental program instruments transferred from inventory to property and equipment:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:58.490%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 7.75pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:OtherDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTpjZTA3M2I4MWY0OWI0NmVmODcyYTc0ZjQ4YjJmOTk5OS90YWJsZXJhbmdlOmNlMDczYjgxZjQ5YjQ2ZWY4NzJhNzRmNDhiMmY5OTk5XzMtMi0xLTEtMA_a5bc9b21-44bc-4929-993a-380eeeb52d30">92,376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:OtherDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTpjZTA3M2I4MWY0OWI0NmVmODcyYTc0ZjQ4YjJmOTk5OS90YWJsZXJhbmdlOmNlMDczYjgxZjQ5YjQ2ZWY4NzJhNzRmNDhiMmY5OTk5XzMtNC0xLTEtMA_347c890e-1ea5-4728-b6de-a7940ba85387">86,095</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:OtherDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTpjZTA3M2I4MWY0OWI0NmVmODcyYTc0ZjQ4YjJmOTk5OS90YWJsZXJhbmdlOmNlMDczYjgxZjQ5YjQ2ZWY4NzJhNzRmNDhiMmY5OTk5XzMtNi0xLTEtMA_8ac2b7d2-ab91-4917-8e24-ba0836eb1103">78,495</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capitalized computer software developed for internal use</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17db583051954f429123c0a1d6ba693f_D20210101-20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAdditions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTpjZTA3M2I4MWY0OWI0NmVmODcyYTc0ZjQ4YjJmOTk5OS90YWJsZXJhbmdlOmNlMDczYjgxZjQ5YjQ2ZWY4NzJhNzRmNDhiMmY5OTk5XzQtMi0xLTEtMA_32a07f6d-2466-44e0-a7ff-6c4d5dbd89a3">14,753</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc48fab68f194aaa84d1e8ed6fa2892f_D20200101-20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAdditions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTpjZTA3M2I4MWY0OWI0NmVmODcyYTc0ZjQ4YjJmOTk5OS90YWJsZXJhbmdlOmNlMDczYjgxZjQ5YjQ2ZWY4NzJhNzRmNDhiMmY5OTk5XzQtNC0xLTEtMA_414cd894-e42d-47de-b8df-bed8ff571306">18,472</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de38908909247f4abb7093d04baaf61_D20190101-20191231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAdditions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTpjZTA3M2I4MWY0OWI0NmVmODcyYTc0ZjQ4YjJmOTk5OS90YWJsZXJhbmdlOmNlMDczYjgxZjQ5YjQ2ZWY4NzJhNzRmNDhiMmY5OTk5XzQtNi0xLTEtMA_1babf52a-21a2-498d-9419-f4e054c9dd2e">20,130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unpaid property and equipment, reflected in accounts payable and accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTpjZTA3M2I4MWY0OWI0NmVmODcyYTc0ZjQ4YjJmOTk5OS90YWJsZXJhbmdlOmNlMDczYjgxZjQ5YjQ2ZWY4NzJhNzRmNDhiMmY5OTk5XzUtMi0xLTEtMA_a9f2046c-5a48-4054-9adb-79f66340d07d">19,326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTpjZTA3M2I4MWY0OWI0NmVmODcyYTc0ZjQ4YjJmOTk5OS90YWJsZXJhbmdlOmNlMDczYjgxZjQ5YjQ2ZWY4NzJhNzRmNDhiMmY5OTk5XzUtNC0xLTEtMA_6c1ec6c4-9ec2-4778-a183-2c786edb13df">13,343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTpjZTA3M2I4MWY0OWI0NmVmODcyYTc0ZjQ4YjJmOTk5OS90YWJsZXJhbmdlOmNlMDczYjgxZjQ5YjQ2ZWY4NzJhNzRmNDhiMmY5OTk5XzUtNi0xLTEtMA_6f65f129-9aa7-4d60-8825-cf665f576202">24,688</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rental and operating-type reagent rental program instruments transferred from inventory to property and equipment (Note 3)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if03c9c1348554db4936cf06e9bd802c2_D20210101-20211231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTpjZTA3M2I4MWY0OWI0NmVmODcyYTc0ZjQ4YjJmOTk5OS90YWJsZXJhbmdlOmNlMDczYjgxZjQ5YjQ2ZWY4NzJhNzRmNDhiMmY5OTk5XzYtMi0xLTEtMA_02ab951a-e15d-4ab7-a17b-d0d66afa990f">11,628</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f415ad968794c3b9bf10b5e7c9d08e8_D20200101-20201231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTpjZTA3M2I4MWY0OWI0NmVmODcyYTc0ZjQ4YjJmOTk5OS90YWJsZXJhbmdlOmNlMDczYjgxZjQ5YjQ2ZWY4NzJhNzRmNDhiMmY5OTk5XzYtNC0xLTEtMA_851b06e0-6c8b-43a6-a63b-0af3fd2fa530">9,645</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69d7e5c1eec24001a74325f821a31cba_D20190101-20191231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTpjZTA3M2I4MWY0OWI0NmVmODcyYTc0ZjQ4YjJmOTk5OS90YWJsZXJhbmdlOmNlMDczYjgxZjQ5YjQ2ZWY4NzJhNzRmNDhiMmY5OTk5XzYtNi0xLTEtMA_2e72faf5-212a-4ac0-ab29-d5c549b87106">14,498</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="padding-left:72pt;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had impairments of $<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-5" name="us-gaap:TangibleAssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90ZXh0cmVnaW9uOjMxYTU2MmNlNGEzOTRlMDBhYmIyMGQwNGIxZTk0ZDY3XzQzOTgwNDY1MTM4OTA_041a3bae-3bf6-4a11-a4cc-a5ce3ebb1248">5.1</ix:nonFraction>&#160;million for the year ended December 31, 2021, associated with a write-down of rental assets in certain regions.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div id="i5d795a6851d746ca914a2ddae761c329_202"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:OtherAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90ZXh0cmVnaW9uOjg2YzFiOWYxOTI3MjQxMmY4N2Y4ODQ3ZTBkYjEyZDk4XzEzNg_cc3a327d-bf26-41bb-980a-afe80dcb7209" continuedAt="i51ef2f3a9bb64e4cb065560a8ec8e850" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OTHER CURRENT AND LONG-TERM ASSETS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></ix:nonNumeric></div><div><span><br/></span></div><ix:continuation id="i51ef2f3a9bb64e4cb065560a8ec8e850" continuedAt="ic4153e99b957433b9a26fb5834c3a873"><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90ZXh0cmVnaW9uOjg2YzFiOWYxOTI3MjQxMmY4N2Y4ODQ3ZTBkYjEyZDk4XzEzNw_593d5212-175c-4ec6-bd4b-6a6ebe24d5f4" continuedAt="i558a211d870740168dc56f6f086216cb" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current assets consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.391%"><tr><td style="width:1.0%"></td><td style="width:67.399%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.542%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.542%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.613%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 7.75pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer acquisition costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:DeferredCostsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTpiZTczZDVlNGZhYjk0ZjdjYTAxYWNhOTUwNzM2OWJkYy90YWJsZXJhbmdlOmJlNzNkNWU0ZmFiOTRmN2NhMDFhY2E5NTA3MzY5YmRjXzItMi0xLTEtMA_019ba8f0-2f22-4e51-8334-ec79c4fc35d1">48,942</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:DeferredCostsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTpiZTczZDVlNGZhYjk0ZjdjYTAxYWNhOTUwNzM2OWJkYy90YWJsZXJhbmdlOmJlNzNkNWU0ZmFiOTRmN2NhMDFhY2E5NTA3MzY5YmRjXzItNC0xLTEtMA_536ffc45-d166-4a98-a1e8-14ce28979271">43,751</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:PrepaidExpenseCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTpiZTczZDVlNGZhYjk0ZjdjYTAxYWNhOTUwNzM2OWJkYy90YWJsZXJhbmdlOmJlNzNkNWU0ZmFiOTRmN2NhMDFhY2E5NTA3MzY5YmRjXzMtMi0xLTEtMA_4b3c333d-ddbc-4c22-807f-1aacaec2b1e2">41,997</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:PrepaidExpenseCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTpiZTczZDVlNGZhYjk0ZjdjYTAxYWNhOTUwNzM2OWJkYy90YWJsZXJhbmdlOmJlNzNkNWU0ZmFiOTRmN2NhMDFhY2E5NTA3MzY5YmRjXzMtNC0xLTEtMA_f7d67c31-a687-48d1-b2c8-669ef2068632">34,556</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract assets, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerAssetNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTpiZTczZDVlNGZhYjk0ZjdjYTAxYWNhOTUwNzM2OWJkYy90YWJsZXJhbmdlOmJlNzNkNWU0ZmFiOTRmN2NhMDFhY2E5NTA3MzY5YmRjXzQtMi0xLTEtMA_7b2b88f9-64c9-4706-b0d3-bc746a109665">37,772</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:ContractWithCustomerAssetNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTpiZTczZDVlNGZhYjk0ZjdjYTAxYWNhOTUwNzM2OWJkYy90YWJsZXJhbmdlOmJlNzNkNWU0ZmFiOTRmN2NhMDFhY2E5NTA3MzY5YmRjXzQtNC0xLTEtMA_5769b9e6-d9f7-44fa-9ea6-1c2712552af8">23,837</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taxes receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:IncomeTaxesReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTpiZTczZDVlNGZhYjk0ZjdjYTAxYWNhOTUwNzM2OWJkYy90YWJsZXJhbmdlOmJlNzNkNWU0ZmFiOTRmN2NhMDFhY2E5NTA3MzY5YmRjXzUtMi0xLTEtMA_4f02b86a-cd90-4d76-ab11-ee70fcd91635">19,464</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:IncomeTaxesReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTpiZTczZDVlNGZhYjk0ZjdjYTAxYWNhOTUwNzM2OWJkYy90YWJsZXJhbmdlOmJlNzNkNWU0ZmFiOTRmN2NhMDFhY2E5NTA3MzY5YmRjXzUtNC0xLTEtMA_46e696cb-6507-4f4b-bbb4-243c0f36de08">19,476</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred sales commissions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:CapitalizedContractCostNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTpiZTczZDVlNGZhYjk0ZjdjYTAxYWNhOTUwNzM2OWJkYy90YWJsZXJhbmdlOmJlNzNkNWU0ZmFiOTRmN2NhMDFhY2E5NTA3MzY5YmRjXzYtMi0xLTEtMA_b6298812-3dc7-432d-a34d-1c0e08095623">6,475</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:CapitalizedContractCostNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTpiZTczZDVlNGZhYjk0ZjdjYTAxYWNhOTUwNzM2OWJkYy90YWJsZXJhbmdlOmJlNzNkNWU0ZmFiOTRmN2NhMDFhY2E5NTA3MzY5YmRjXzYtNC0xLTEtMA_6a27e3c8-d69c-4940-a7b9-5c0c4dd5bc21">5,738</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:OtherAssetsMiscellaneousCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTpiZTczZDVlNGZhYjk0ZjdjYTAxYWNhOTUwNzM2OWJkYy90YWJsZXJhbmdlOmJlNzNkNWU0ZmFiOTRmN2NhMDFhY2E5NTA3MzY5YmRjXzctMi0xLTEtMA_30d1f688-e810-478d-8cb5-91a649671038">19,173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:OtherAssetsMiscellaneousCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTpiZTczZDVlNGZhYjk0ZjdjYTAxYWNhOTUwNzM2OWJkYy90YWJsZXJhbmdlOmJlNzNkNWU0ZmFiOTRmN2NhMDFhY2E5NTA3MzY5YmRjXzctNC0xLTEtMA_d2ed089c-a7bc-433e-94e6-27d94214340b">10,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTpiZTczZDVlNGZhYjk0ZjdjYTAxYWNhOTUwNzM2OWJkYy90YWJsZXJhbmdlOmJlNzNkNWU0ZmFiOTRmN2NhMDFhY2E5NTA3MzY5YmRjXzgtMi0xLTEtMA_e4336139-4afc-44ce-b331-832b6aad0098">173,823</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTpiZTczZDVlNGZhYjk0ZjdjYTAxYWNhOTUwNzM2OWJkYy90YWJsZXJhbmdlOmJlNzNkNWU0ZmFiOTRmN2NhMDFhY2E5NTA3MzY5YmRjXzgtNC0xLTEtMA_aa55874a-4d66-4a84-b45f-6ed02f81845e">137,508</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Contract assets, net, are net of allowances for credit loss. Refer to "Note 6. Credit Losses."</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ic4153e99b957433b9a26fb5834c3a873" continuedAt="i9a68fed1131b4e70bfd08b8a929d2c43"><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90ZXh0cmVnaW9uOjg2YzFiOWYxOTI3MjQxMmY4N2Y4ODQ3ZTBkYjEyZDk4XzEzNQ_2b3f22b4-f466-450a-ac77-fe08de06ed27" continuedAt="ief5b51fa91ad4597afa8b7a37cfe120b" escape="true"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term assets consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"></td><td style="width:67.196%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.862%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.162%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 7.75pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract assets, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerAssetNetNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTo1ZmQyYTkxYzE2MDA0MjhjODhkZjczZTVhMWJjMzYzOS90YWJsZXJhbmdlOjVmZDJhOTFjMTYwMDQyOGM4OGRmNzNlNWExYmMzNjM5XzItMi0xLTEtMA_af54e3ff-1622-4040-b959-5550a5bff692">122,160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:DeferredCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTo1ZmQyYTkxYzE2MDA0MjhjODhkZjczZTVhMWJjMzYzOS90YWJsZXJhbmdlOjVmZDJhOTFjMTYwMDQyOGM4OGRmNzNlNWExYmMzNjM5XzItNC0xLTEtMA_a6af2fef-9514-4779-9aba-b879364ab0ea">91,681</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer acquisition costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:DeferredCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTo1ZmQyYTkxYzE2MDA0MjhjODhkZjczZTVhMWJjMzYzOS90YWJsZXJhbmdlOjVmZDJhOTFjMTYwMDQyOGM4OGRmNzNlNWExYmMzNjM5XzMtMi0xLTEtMA_f3cd7ae9-53b2-472c-aa2b-9658437fa0ec">109,392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:ContractWithCustomerAssetNetNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTo1ZmQyYTkxYzE2MDA0MjhjODhkZjczZTVhMWJjMzYzOS90YWJsZXJhbmdlOjVmZDJhOTFjMTYwMDQyOGM4OGRmNzNlNWExYmMzNjM5XzMtNC0xLTEtMA_1db2d8e8-78e0-45e3-be80-d8a27c28e324">104,369</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTo1ZmQyYTkxYzE2MDA0MjhjODhkZjczZTVhMWJjMzYzOS90YWJsZXJhbmdlOjVmZDJhOTFjMTYwMDQyOGM4OGRmNzNlNWExYmMzNjM5XzQtMi0xLTEtMA_8b95cad5-b190-4f64-a8b4-ca50f7dd2b3f">24,784</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTo1ZmQyYTkxYzE2MDA0MjhjODhkZjczZTVhMWJjMzYzOS90YWJsZXJhbmdlOjVmZDJhOTFjMTYwMDQyOGM4OGRmNzNlNWExYmMzNjM5XzQtNC0xLTEtMA_0bb617e1-e291-4df7-8782-3346beb2c5d3">31,549</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investment in long-term product supply arrangements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:PrepaidExpenseOtherNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTo1ZmQyYTkxYzE2MDA0MjhjODhkZjczZTVhMWJjMzYzOS90YWJsZXJhbmdlOjVmZDJhOTFjMTYwMDQyOGM4OGRmNzNlNWExYmMzNjM5XzUtMi0xLTEtMA_11cdfde4-4f5c-4e93-a7ba-ce0bb44ef58e">13,348</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:PrepaidExpenseOtherNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTo1ZmQyYTkxYzE2MDA0MjhjODhkZjczZTVhMWJjMzYzOS90YWJsZXJhbmdlOjVmZDJhOTFjMTYwMDQyOGM4OGRmNzNlNWExYmMzNjM5XzUtNC0xLTEtMA_96d0637b-61f3-4514-8f7c-1e7642562df6">12,065</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred sales commissions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:CapitalizedContractCostNetNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTo1ZmQyYTkxYzE2MDA0MjhjODhkZjczZTVhMWJjMzYzOS90YWJsZXJhbmdlOjVmZDJhOTFjMTYwMDQyOGM4OGRmNzNlNWExYmMzNjM5XzYtMi0xLTEtMA_769c9cfc-beb0-4b3d-b39e-97b99f534d7b">13,019</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:CapitalizedContractCostNetNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTo1ZmQyYTkxYzE2MDA0MjhjODhkZjczZTVhMWJjMzYzOS90YWJsZXJhbmdlOjVmZDJhOTFjMTYwMDQyOGM4OGRmNzNlNWExYmMzNjM5XzYtNC0xLTEtMA_b9e7efc1-e7a8-4b55-8df7-7b85ef5ea740">11,719</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taxes receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:IncomeTaxesReceivableNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTo1ZmQyYTkxYzE2MDA0MjhjODhkZjczZTVhMWJjMzYzOS90YWJsZXJhbmdlOjVmZDJhOTFjMTYwMDQyOGM4OGRmNzNlNWExYmMzNjM5XzctMi0xLTEtMA_d84ce9f3-dd87-48bc-9534-822628368075">1,806</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:IncomeTaxesReceivableNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTo1ZmQyYTkxYzE2MDA0MjhjODhkZjczZTVhMWJjMzYzOS90YWJsZXJhbmdlOjVmZDJhOTFjMTYwMDQyOGM4OGRmNzNlNWExYmMzNjM5XzctNC0xLTEtMA_04b6ded9-2283-4616-8318-cbba355514c0">6,329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:OtherAssetsMiscellaneousNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTo1ZmQyYTkxYzE2MDA0MjhjODhkZjczZTVhMWJjMzYzOS90YWJsZXJhbmdlOjVmZDJhOTFjMTYwMDQyOGM4OGRmNzNlNWExYmMzNjM5XzgtMi0xLTEtMA_0afb2c38-4998-47ef-8b10-af4717de1596">45,891</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:OtherAssetsMiscellaneousNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTo1ZmQyYTkxYzE2MDA0MjhjODhkZjczZTVhMWJjMzYzOS90YWJsZXJhbmdlOjVmZDJhOTFjMTYwMDQyOGM4OGRmNzNlNWExYmMzNjM5XzgtNC0xLTEtMA_1ba1460e-c80a-4e20-a8a1-edb4b47f249d">31,883</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTo1ZmQyYTkxYzE2MDA0MjhjODhkZjczZTVhMWJjMzYzOS90YWJsZXJhbmdlOjVmZDJhOTFjMTYwMDQyOGM4OGRmNzNlNWExYmMzNjM5XzktMi0xLTEtMA_44139037-3ad4-4652-9809-c5673e599326">330,400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTo1ZmQyYTkxYzE2MDA0MjhjODhkZjczZTVhMWJjMzYzOS90YWJsZXJhbmdlOjVmZDJhOTFjMTYwMDQyOGM4OGRmNzNlNWExYmMzNjM5XzktNC0xLTEtMA_3e82effc-5c49-42d8-9611-0386a7a690a3">289,595</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="i9a68fed1131b4e70bfd08b8a929d2c43"><ix:continuation id="i558a211d870740168dc56f6f086216cb"><ix:continuation id="ief5b51fa91ad4597afa8b7a37cfe120b">(1) Contract assets, net, are net of allowances for credit loss. Refer to "Note 6. Credit Losses</ix:continuation></ix:continuation></ix:continuation>."</span></div><div id="i5d795a6851d746ca914a2ddae761c329_205"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90ZXh0cmVnaW9uOjFiMzBlOTFiNDExNTRmNGRhYzlmYTU1ZGIwNTIxMzBkXzc2NzQ_9cea3ba8-27fb-4d49-b9db-cb17052ec907" continuedAt="i9d2baf5b90db48a2948475a0a0b74ff0" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GOODWILL AND INTANGIBLE ASSETS, NET</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></ix:nonNumeric></div><div><span><br/></span></div><ix:continuation id="i9d2baf5b90db48a2948475a0a0b74ff0" continuedAt="i1b94414730ed441db8bce1d470e8d3e7"><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90ZXh0cmVnaW9uOjFiMzBlOTFiNDExNTRmNGRhYzlmYTU1ZGIwNTIxMzBkXzc2ODQ_29b0e79b-e8cb-4e16-adc4-08cf18e053d2" continuedAt="i6dd553e21b2a45c580fba279caa4d615" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A significant portion of the purchase price for acquired businesses is generally assigned to intangible assets. Intangible assets other than goodwill are initially valued at fair value. If a quoted price in an active market for the identical asset is not readily available at the measurement date, the fair value of the intangible asset is estimated based on discounted cash flows using market participant assumptions, which are assumptions that are not specific to IDEXX. The selection of appropriate valuation methodologies and the estimation of discounted cash flows require significant assumptions about the timing and amounts of future cash flows, risks, appropriate discount rates, and the useful lives of intangible assets. When significant, we utilize independent valuation experts to advise and assist us in determining the fair values of the identified intangible assets acquired in connection with a business acquisition and in determining appropriate amortization methods and periods for those intangible assets. Goodwill is initially valued based on the excess of the purchase price of a business combination over the fair value of acquired net assets recognized and represents the future economic benefits arising from other assets acquired that could not be separately identified and recognized.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business combinations regularly include contingent consideration arrangements that require additional consideration to be paid based on the achievement of established objectives, most commonly related to customer retention or revenue growth of the customer base during the post-combination period. We assess contingent consideration to determine if it should be recognized at its fair value on the acquisition date. A liability resulting from contingent consideration is remeasured to fair value at each reporting date until the contingency is resolved, with changes in fair value recognized in earnings if changes in estimates are made after the measurement period. During the fourth quarter of 2021, we increased the fair value of the contingent payment to ezyVet by $<ix:nonFraction unitRef="usd" contextRef="ifb7924f502ed418b8a52fa0f86e77e1b_D20211001-20211231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90ZXh0cmVnaW9uOjFiMzBlOTFiNDExNTRmNGRhYzlmYTU1ZGIwNTIxMzBkXzQzOTgwNDY1MjAyMjI_d83a8d36-fda6-49d4-b1ca-ea0bbda85a83">2.0</ix:nonFraction>&#160;million. Changes in the fair value of contingent consideration and differences arising upon settlement were not material during the years ended December 31, 2020, and 2019.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We assess goodwill for impairment annually, at the reporting unit level, in the fourth quarter and whenever events or circumstances indicate impairment may exist. In evaluating goodwill for impairment, we have the option to first assess the qualitative factors to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the goodwill impairment test. The more likely than not threshold is defined as having a likelihood of more than 50%. If, after assessing the totality of events or circumstances, we determine that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, we would assess the fair value of all of our reporting units and compare the fair value of the reporting unit to its carrying value to determine if the carrying value exceeds its fair value, and if a goodwill impairment loss should be recognized. In contrast, we can opt to bypass the qualitative assessment for any reporting unit in any period and proceed directly to assessing the fair value of all of our reporting units and compare the fair value of the reporting unit to carrying value to determine if any impairment exists. Doing so does not preclude us from performing the qualitative assessment in any subsequent&#160;period.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2021, we elected to bypass the qualitative approach that allows the assessment of qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount and instead proceeded directly to assessing the fair value of all of our reporting units and comparing the fair values of each reporting unit to the carrying values to determine if any impairment exists. We estimate the fair values of applicable reporting units using an income approach based on discounted forecasted cash flows. We make significant assumptions about the extent and timing of future cash flows, growth rates and discount rates. Model assumptions are based on our projections and best estimates, using appropriate and customary market participant assumptions. In addition, we make certain assumptions in allocating shared assets and liabilities to individual reporting units in determining the carrying value of each reporting unit. </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i1b94414730ed441db8bce1d470e8d3e7" continuedAt="id273f10213704220be3b814c50a4c9d7"><ix:continuation id="i6dd553e21b2a45c580fba279caa4d615" continuedAt="i3e09385792324f4fad174e218a4c655b"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in forecasted cash flows or the discount rate would affect the estimated fair values of our reporting units and could result in a goodwill impairment loss in a future period.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="INF" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90ZXh0cmVnaW9uOjFiMzBlOTFiNDExNTRmNGRhYzlmYTU1ZGIwNTIxMzBkXzQ3OTY_313132f7-3603-4cbe-8ac0-ae46b5ec9605"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="INF" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90ZXh0cmVnaW9uOjFiMzBlOTFiNDExNTRmNGRhYzlmYTU1ZGIwNTIxMzBkXzQ3OTY_d325378b-81ca-44c5-abee-bb6a4c93c6f1"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="INF" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90ZXh0cmVnaW9uOjFiMzBlOTFiNDExNTRmNGRhYzlmYTU1ZGIwNTIxMzBkXzQ3OTY_d3a604d9-d95e-4c66-bdba-98933b3e12d7">No</ix:nonFraction></ix:nonFraction></ix:nonFraction> goodwill impairments were identified during the years ended December 31, 2021, 2020, or 2019, and no accumulated impairment losses are recorded.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We assess the realizability of intangible assets other than goodwill whenever events or changes in circumstances indicate that the carrying value may not be recoverable. If an impairment review is triggered, we evaluate the carrying value of intangible assets based on estimated undiscounted future cash flows over the remaining useful life of the primary asset of the asset group and compare that value to the carrying value of the asset group. The asset group is the lowest level for which identifiable cash flows associated with the intangible asset are largely independent. The cash flows that are used contain our best estimates, using appropriate and customary assumptions and projections at the time. If the net carrying value of an intangible asset exceeds the related estimated undiscounted future cash flows, an impairment loss to adjust the intangible asset to its fair value would be reported as a non-cash charge to earnings. If necessary, we would calculate the fair value of an intangible asset using the present value of the estimated future cash flows to be generated by the intangible asset, and applying a risk-adjusted discount rate. We had <ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="INF" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90ZXh0cmVnaW9uOjFiMzBlOTFiNDExNTRmNGRhYzlmYTU1ZGIwNTIxMzBkXzYxNTA_d6b97470-ce81-44cb-bf44-b9716374c789"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="INF" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90ZXh0cmVnaW9uOjFiMzBlOTFiNDExNTRmNGRhYzlmYTU1ZGIwNTIxMzBkXzYxNTA_dcdf7ca5-df1c-4fd8-ac1d-972e3d398d8c">no</ix:nonFraction></ix:nonFraction> impairments of our intangible assets during the years ended December 31, 2021 and 2019.&#160;The amount of impairment for the year ended December 31, 2020 was immaterial.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90ZXh0cmVnaW9uOjFiMzBlOTFiNDExNTRmNGRhYzlmYTU1ZGIwNTIxMzBkXzc2NzA_182ce805-570b-4993-b1ef-9af3f92bbbd0" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill for the years ended December 31, 2021, 2020, and 2019, were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:31.550%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.642%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CAG</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Water</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LPD</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a0c9bdb38c5437ba4c6b8c7c0183c5d_I20181231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzEtMi0xLTEtMA_2259adba-0738-478d-9351-d9207c149722">182,386</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf8bbc6500694651b48a90bd7484b109_I20181231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzEtNC0xLTEtMA_fe916338-a1b2-4d7a-8c2c-09e763eed3c7">11,221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf7bd16dde3b49debd9c67b5be3e1fb9_I20181231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzEtNi0xLTEtMA_f2bedd7f-ec57-40f2-bf8e-c1eef62961f3">14,351</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i553fbb83ebff498cbd25aefa9eee9276_I20181231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzEtOC0xLTEtMA_e7405303-3842-44e2-afce-aaf91c84ba55">6,531</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28d0821cac8841b29cf960002d3bc993_I20181231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzEtMTAtMS0xLTA_68c38ee2-e7d9-4f55-a178-0c226cf25a44">214,489</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Business combinations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief827aa39f934947a553685160a5543c_D20190101-20191231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzItMi0xLTEtMA_94a6eb78-5daf-4a84-bf42-912cd2ee3ae7">24,826</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab0b6ebdef1a4be9b052a1b82c635759_D20190101-20191231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzItNC0xLTEtMA_6c269d81-f981-4b0e-8e69-d2982f0f3e23">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34e8ebea941e457cbadc1ce152e6a396_D20190101-20191231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzItNi0xLTEtMA_cd958492-a52f-4145-acb1-c81fe0009666">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6f9b6007f00420291efefe0008f3d10_D20190101-20191231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzItOC0xLTEtMA_7a488d99-2946-4ec8-95a4-4d4b0302b1bc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzItMTAtMS0xLTA_3f9d09c3-93ff-4233-a85a-b042354f4e7a">24,826</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impact of changes in foreign currency exchange rates</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief827aa39f934947a553685160a5543c_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzMtMi0xLTEtMA_04f86268-d98f-4403-b739-31c34ba00300">138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab0b6ebdef1a4be9b052a1b82c635759_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzMtNC0xLTEtMA_85bb2380-a310-45d4-a5c0-420ef24939c3">390</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i34e8ebea941e457cbadc1ce152e6a396_D20190101-20191231" decimals="-3" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzMtNi0xLTEtMA_f504ba8d-6ee5-4133-8613-376646c97628">119</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6f9b6007f00420291efefe0008f3d10_D20190101-20191231" decimals="-3" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzMtOC0xLTEtMA_c41bc164-4ddb-4e3e-8a93-a333b8e74284">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzMtMTAtMS0xLTA_a79196e1-a389-461a-ac4e-2117fa3fcd90">409</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f05fb527b154dee8865a625a6eff114_I20191231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzQtMi0xLTEtMA_6ac0a0c4-3cec-404a-832b-aa0a26c3e7c7">207,350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if93e0292c6f54be59c39937e7fd58164_I20191231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzQtNC0xLTEtMA_ef01b307-c070-42b2-a38b-1a30df0019a6">11,611</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e064fdd1f8949e0a40782734de7a004_I20191231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzQtNi0xLTEtMA_b4388e07-558c-4bbd-abc8-7b65ae69cb9f">14,232</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7599f68f6de408b80c30adab94958b2_I20191231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzQtOC0xLTEtMA_1d5ed016-c96c-4e26-a93c-877285039a8b">6,531</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c634b937c58472e84857eacf99e17df_I20191231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzQtMTAtMS0xLTA_6e120d19-130b-46ae-8337-3b1da9ab32b2">239,724</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Business combinations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40313073e9c743ad89084e7fbcbd7e5e_D20200101-20201231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzUtMi0xLTEtMA_20346f77-72a0-4c0a-89a1-f824e3725dca">220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0b173f4625a4e1e807adc8eeb4e0592_D20200101-20201231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzUtNC0xLTEtMA_12eabf14-e167-4df5-87f5-687eff8ac897">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4525be5d1c1b4d458fe78f047e981dc1_D20200101-20201231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzUtNi0xLTEtMA_fb197374-ad41-461e-b0d2-2aafe1f6367c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100119c49d8f4098bf6afdc675782162_D20200101-20201231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzUtOC0xLTEtMA_dd811bcf-d654-4b82-a978-a52fe7abc222">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzUtMTAtMS0xLTA_6ae02961-bd5e-46b1-b8d6-4282d435f232">220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition adjustment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40313073e9c743ad89084e7fbcbd7e5e_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzYtMi0xLTEtMA_c4231755-3573-4d85-894b-c01faf8205d3">1,900</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0b173f4625a4e1e807adc8eeb4e0592_D20200101-20201231" decimals="-3" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzYtNC0xLTEtMA_f3eb753b-9610-403a-be0e-e41fda2c3432">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4525be5d1c1b4d458fe78f047e981dc1_D20200101-20201231" decimals="-3" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzYtNi0xLTEtMA_8e188804-75c7-4608-8873-25ca5bcd9316">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100119c49d8f4098bf6afdc675782162_D20200101-20201231" decimals="-3" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzYtOC0xLTEtMA_8481792a-6c68-432e-9f7d-981d1688825b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzYtMTAtMS0xLTA_17db7785-c5ae-404e-8537-a12791f66034">1,900</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impact of changes in foreign currency exchange rates</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40313073e9c743ad89084e7fbcbd7e5e_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzctMi0xLTEtMA_fd522346-3ded-43b4-be9c-3e5ccdd5c78f">4,724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0b173f4625a4e1e807adc8eeb4e0592_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzctNC0xLTEtMA_0a6f4385-f57b-4839-b04d-d31cfbad3079">412</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4525be5d1c1b4d458fe78f047e981dc1_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzctNi0xLTEtMA_afdffa45-d8ca-45aa-9141-f3f0f9e938e7">167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100119c49d8f4098bf6afdc675782162_D20200101-20201231" decimals="-3" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzctOC0xLTEtMA_09733ec5-db8e-466e-93d0-af38103b9185">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzctMTAtMS0xLTA_d28cb60d-b2fe-4170-9163-5f5836ecbe48">5,303</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4601e8865549a09377d9dfd17d74d4_I20201231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzgtMi0xLTEtMA_09c10078-d9bd-48ed-9867-3b281a01efab">210,394</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i463e678af3d24f9d8074cd935b869239_I20201231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzgtNC0xLTEtMA_fa541906-3163-40ad-a4ce-9976522956a2">12,023</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i929ca297bc5248beabe8f044d7430225_I20201231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzgtNi0xLTEtMA_30bf45f5-dd8b-4de2-876a-906f61b1d76f">14,399</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8867f1bde2348b596b2427e15fb4d2e_I20201231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzgtOC0xLTEtMA_52e3a3df-bee9-4692-817d-05934a2ca023">6,531</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzgtMTAtMS0xLTA_76585e2e-6073-4a16-8e7f-180ac7f6ae57">243,347</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Business combinations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c823cc0aa3945d9874ea09ab5940878_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzktMi0xLTEtNDExMTU_a2489cd8-bb6b-4406-ba09-b0285c72dd97">120,346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81c0a80f385a4f18ab5cb5919ed28318_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzktNC0xLTEtNDExMTU_e0366cbb-80bb-40b3-aacb-770450ab644d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4174c33ea3f8443fbc6587f7ac9a43ab_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzktNi0xLTEtNDExMTU_0fa9ae23-bed2-4763-aee3-b9d7a814778b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94cd933d7b7b431caa324dc2936f5c55_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzktOC0xLTEtNDExMTU_8ba27478-580d-41e5-ab92-e15c08047189">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzktMTAtMS0xLTQxMTE1_5226de27-b65f-4c4d-bcd5-95cc68ee8632">120,346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impact of changes in foreign currency exchange rates</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c823cc0aa3945d9874ea09ab5940878_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzEwLTItMS0xLTA_dd27579f-6075-4be9-b648-36975d6c015a">3,569</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i81c0a80f385a4f18ab5cb5919ed28318_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzEwLTQtMS0xLTA_9a624329-0a94-43a5-9407-ef19a5a0675a">84</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4174c33ea3f8443fbc6587f7ac9a43ab_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzEwLTYtMS0xLTA_ffb92cc7-8312-4418-8f58-d9503ba368d2">695</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94cd933d7b7b431caa324dc2936f5c55_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzEwLTgtMS0xLTA_5bde7576-8fe2-4180-bcc9-bfdb0ee4c73a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzEwLTEwLTEtMS0w_a0054c1c-e4a6-43aa-a8f3-b0b1f258e20a">4,348</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91597ef710044b0aaf747bf9fd3b6882_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzExLTItMS0xLTA_0e5c6615-22d0-4148-8b4a-151685948d21">327,171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b559b62389c4dffbc62f92796f64370_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzExLTQtMS0xLTA_a4739948-f92b-4d7c-9aa8-fdabee87a2ae">11,939</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib956b0023d37451a873e726de05dc04d_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzExLTYtMS0xLTA_ff35a402-f330-45be-97a1-8b252fcde5fb">13,704</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81db4aa26c9a45f9b2ac5198a22acfe8_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzExLTgtMS0xLTA_69e9bef0-1913-45c9-837b-cf0f19518293">6,531</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzExLTEwLTEtMS0w_d392c9ac-80e4-4515-a9c1-8072e823af17">359,345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to "Note 4. Acquisitions and Investments" for information regarding goodwill and other intangible assets recognized in connection with the acquisition of businesses and other assets during the years ended December 31, 2021, 2020, and 2019.</span></div></ix:continuation><div><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="id273f10213704220be3b814c50a4c9d7"><ix:continuation id="i3e09385792324f4fad174e218a4c655b"><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="idxx:ScheduleOfEstimatedUsefulLivesForIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90ZXh0cmVnaW9uOjFiMzBlOTFiNDExNTRmNGRhYzlmYTU1ZGIwNTIxMzBkXzc2NzE_da0fe9e5-28ed-434f-a76c-aacd1ccd582e" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide for amortization primarily using the straight-line method by charges to income in amounts that allocate the intangible assets over their estimated useful lives as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:60.246%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.731%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.723%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Asset Classification</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer-related intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib25dbfb85b114a83a3384494c07c9a83_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTpkNzdmNWM4OTEwYzQ0NGI1YTUzMzU4ZjIwN2I0Njg1Ny90YWJsZXJhbmdlOmQ3N2Y1Yzg5MTBjNDQ0YjVhNTMzNThmMjA3YjQ2ODU3XzItMi0xLTEtMC90ZXh0cmVnaW9uOmJlMTUwZDc4YzJhYzRjOTE5OTc0MzcyNmZlNzc5ODMzXzQ_444537be-3fb5-49a2-bdae-549bdc908ac9">3</ix:nonNumeric> to <ix:nonNumeric contextRef="iccd74787592547aabe3fc45e8160f1f6_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTpkNzdmNWM4OTEwYzQ0NGI1YTUzMzU4ZjIwN2I0Njg1Ny90YWJsZXJhbmdlOmQ3N2Y1Yzg5MTBjNDQ0YjVhNTMzNThmMjA3YjQ2ODU3XzItMi0xLTEtMC90ZXh0cmVnaW9uOmJlMTUwZDc4YzJhYzRjOTE5OTc0MzcyNmZlNzc5ODMzXzEw_92d7833f-21da-404f-8bf9-dd0585d86ed9">17</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product rights </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6d6af357c77b4c45a43103bb36b9db75_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTpkNzdmNWM4OTEwYzQ0NGI1YTUzMzU4ZjIwN2I0Njg1Ny90YWJsZXJhbmdlOmQ3N2Y1Yzg5MTBjNDQ0YjVhNTMzNThmMjA3YjQ2ODU3XzMtMi0xLTEtMC90ZXh0cmVnaW9uOjc0MzIzMTc5ZmVmNTQ5ZTQ5NDRjNjRlZDI2MjYyZDU0XzQ_9de915bf-911c-4797-b3af-dd00fbfbd180">5</ix:nonNumeric> to <ix:nonNumeric contextRef="i6625320757264c3d977d4eb7923c35ee_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTpkNzdmNWM4OTEwYzQ0NGI1YTUzMzU4ZjIwN2I0Njg1Ny90YWJsZXJhbmdlOmQ3N2Y1Yzg5MTBjNDQ0YjVhNTMzNThmMjA3YjQ2ODU3XzMtMi0xLTEtMC90ZXh0cmVnaW9uOjc0MzIzMTc5ZmVmNTQ5ZTQ5NDRjNjRlZDI2MjYyZDU0XzEw_990f9b9d-bc82-459d-9836-27c2fb37a28a">15</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncompete agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i570237e99c1d4a9b8c6dca9eae26bea8_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTpkNzdmNWM4OTEwYzQ0NGI1YTUzMzU4ZjIwN2I0Njg1Ny90YWJsZXJhbmdlOmQ3N2Y1Yzg5MTBjNDQ0YjVhNTMzNThmMjA3YjQ2ODU3XzQtMi0xLTEtMC90ZXh0cmVnaW9uOmUyNzcxNTY0ZTFkZjQxMzJhOThmYWZlMzQxNDgxOGQxXzQ_ad2c0112-f294-4e8d-9329-7f1193e18a4f">3</ix:nonNumeric> to <ix:nonNumeric contextRef="i637fcf9a068c4d6798c09d00dea42126_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTpkNzdmNWM4OTEwYzQ0NGI1YTUzMzU4ZjIwN2I0Njg1Ny90YWJsZXJhbmdlOmQ3N2Y1Yzg5MTBjNDQ0YjVhNTMzNThmMjA3YjQ2ODU3XzQtMi0xLTEtMC90ZXh0cmVnaW9uOmUyNzcxNTY0ZTFkZjQxMzJhOThmYWZlMzQxNDgxOGQxXzEw_1684e271-2ec8-4b32-9926-9be0d921b37c">5</ix:nonNumeric> years</span></div></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90ZXh0cmVnaW9uOjFiMzBlOTFiNDExNTRmNGRhYzlmYTU1ZGIwNTIxMzBkXzc2NzI_002747d3-467c-4cec-86ee-5c9bf8fe84ba" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets other than goodwill consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:33.307%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.124%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.124%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.124%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.125%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer-related intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic59101fdcfff4269aef991be04a88a6f_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTowODVlOTk3NmE3OWQ0ODAyYjgyODdiNzFhMTY0YjI2Zi90YWJsZXJhbmdlOjA4NWU5OTc2YTc5ZDQ4MDJiODI4N2I3MWExNjRiMjZmXzMtMi0xLTEtMA_9212b2ed-d608-4a7d-a1cb-9d1bda4166b6">121,936</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic59101fdcfff4269aef991be04a88a6f_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTowODVlOTk3NmE3OWQ0ODAyYjgyODdiNzFhMTY0YjI2Zi90YWJsZXJhbmdlOjA4NWU5OTc2YTc5ZDQ4MDJiODI4N2I3MWExNjRiMjZmXzMtNC0xLTEtMA_becfeefe-7ce5-4205-a52e-8ff2e2d0c20b">38,349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic59101fdcfff4269aef991be04a88a6f_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTowODVlOTk3NmE3OWQ0ODAyYjgyODdiNzFhMTY0YjI2Zi90YWJsZXJhbmdlOjA4NWU5OTc2YTc5ZDQ4MDJiODI4N2I3MWExNjRiMjZmXzMtNi0xLTEtMA_796bd5c3-dafb-472d-93a2-7209c1c122c4">83,587</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ed2ad1bc274728bf194148636a8d78_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTowODVlOTk3NmE3OWQ0ODAyYjgyODdiNzFhMTY0YjI2Zi90YWJsZXJhbmdlOjA4NWU5OTc2YTc5ZDQ4MDJiODI4N2I3MWExNjRiMjZmXzMtOC0xLTEtMA_c65a6e0a-2632-4c57-8849-67ddb88bd9bc">80,810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ed2ad1bc274728bf194148636a8d78_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTowODVlOTk3NmE3OWQ0ODAyYjgyODdiNzFhMTY0YjI2Zi90YWJsZXJhbmdlOjA4NWU5OTc2YTc5ZDQ4MDJiODI4N2I3MWExNjRiMjZmXzMtMTAtMS0xLTA_24d93e6b-0be2-43f0-a11f-2ab88096a127">32,838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ed2ad1bc274728bf194148636a8d78_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTowODVlOTk3NmE3OWQ0ODAyYjgyODdiNzFhMTY0YjI2Zi90YWJsZXJhbmdlOjA4NWU5OTc2YTc5ZDQ4MDJiODI4N2I3MWExNjRiMjZmXzMtMTItMS0xLTA_db9c98a4-4e57-4c6b-8ab8-8128166f7d41">47,972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product rights </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia89659b032284471b33d455d42efc26b_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTowODVlOTk3NmE3OWQ0ODAyYjgyODdiNzFhMTY0YjI2Zi90YWJsZXJhbmdlOjA4NWU5OTc2YTc5ZDQ4MDJiODI4N2I3MWExNjRiMjZmXzQtMi0xLTEtMA_6b701ed2-f3f9-4ca2-b5e9-01ed86526ecd">17,350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia89659b032284471b33d455d42efc26b_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTowODVlOTk3NmE3OWQ0ODAyYjgyODdiNzFhMTY0YjI2Zi90YWJsZXJhbmdlOjA4NWU5OTc2YTc5ZDQ4MDJiODI4N2I3MWExNjRiMjZmXzQtNC0xLTEtMA_033d671e-1555-4d22-936b-62ef6f83e2c4">5,332</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia89659b032284471b33d455d42efc26b_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTowODVlOTk3NmE3OWQ0ODAyYjgyODdiNzFhMTY0YjI2Zi90YWJsZXJhbmdlOjA4NWU5OTc2YTc5ZDQ4MDJiODI4N2I3MWExNjRiMjZmXzQtNi0xLTEtMA_4642de26-affd-40f0-9edf-49c71c39fad0">12,018</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87c2ea63490848ab92d756e41e990b46_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTowODVlOTk3NmE3OWQ0ODAyYjgyODdiNzFhMTY0YjI2Zi90YWJsZXJhbmdlOjA4NWU5OTc2YTc5ZDQ4MDJiODI4N2I3MWExNjRiMjZmXzQtOC0xLTEtMA_64882342-7b58-484b-ba8f-5e983ec14a0a">15,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87c2ea63490848ab92d756e41e990b46_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTowODVlOTk3NmE3OWQ0ODAyYjgyODdiNzFhMTY0YjI2Zi90YWJsZXJhbmdlOjA4NWU5OTc2YTc5ZDQ4MDJiODI4N2I3MWExNjRiMjZmXzQtMTAtMS0xLTA_ec14f4d5-16ec-4db1-ab3b-72ede1c1d789">11,609</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87c2ea63490848ab92d756e41e990b46_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTowODVlOTk3NmE3OWQ0ODAyYjgyODdiNzFhMTY0YjI2Zi90YWJsZXJhbmdlOjA4NWU5OTc2YTc5ZDQ4MDJiODI4N2I3MWExNjRiMjZmXzQtMTItMS0xLTA_5796b8f4-03f9-4130-a6ce-8c202e3de94c">3,541</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncompete agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f20409febb84c2483223228e9e1771a_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTowODVlOTk3NmE3OWQ0ODAyYjgyODdiNzFhMTY0YjI2Zi90YWJsZXJhbmdlOjA4NWU5OTc2YTc5ZDQ4MDJiODI4N2I3MWExNjRiMjZmXzUtMi0xLTEtMA_2da1c856-090d-42cc-b51d-58310ea78b97">4,257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f20409febb84c2483223228e9e1771a_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTowODVlOTk3NmE3OWQ0ODAyYjgyODdiNzFhMTY0YjI2Zi90YWJsZXJhbmdlOjA4NWU5OTc2YTc5ZDQ4MDJiODI4N2I3MWExNjRiMjZmXzUtNC0xLTEtMA_bd256324-8514-495d-9244-9c56aadeec09">827</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f20409febb84c2483223228e9e1771a_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTowODVlOTk3NmE3OWQ0ODAyYjgyODdiNzFhMTY0YjI2Zi90YWJsZXJhbmdlOjA4NWU5OTc2YTc5ZDQ4MDJiODI4N2I3MWExNjRiMjZmXzUtNi0xLTEtMA_81a95ec4-422b-4f88-aebe-fcbd62e72fee">3,430</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bec47a954cb4a1d86389d1590f9c5e0_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTowODVlOTk3NmE3OWQ0ODAyYjgyODdiNzFhMTY0YjI2Zi90YWJsZXJhbmdlOjA4NWU5OTc2YTc5ZDQ4MDJiODI4N2I3MWExNjRiMjZmXzUtOC0xLTEtMA_ab3d0ed7-eea3-4e8d-9857-c61ef434340c">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bec47a954cb4a1d86389d1590f9c5e0_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTowODVlOTk3NmE3OWQ0ODAyYjgyODdiNzFhMTY0YjI2Zi90YWJsZXJhbmdlOjA4NWU5OTc2YTc5ZDQ4MDJiODI4N2I3MWExNjRiMjZmXzUtMTAtMS0xLTA_2480176a-c354-4c65-8b27-d548dff39571">220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bec47a954cb4a1d86389d1590f9c5e0_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTowODVlOTk3NmE3OWQ0ODAyYjgyODdiNzFhMTY0YjI2Zi90YWJsZXJhbmdlOjA4NWU5OTc2YTc5ZDQ4MDJiODI4N2I3MWExNjRiMjZmXzUtMTItMS0xLTA_7277b2de-9d38-4f5e-b606-fc9d9c476248">1,030</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTowODVlOTk3NmE3OWQ0ODAyYjgyODdiNzFhMTY0YjI2Zi90YWJsZXJhbmdlOjA4NWU5OTc2YTc5ZDQ4MDJiODI4N2I3MWExNjRiMjZmXzYtMi0xLTEtMA_45f4092b-c25c-4ccd-a636-6da796ca0b3e">143,543</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTowODVlOTk3NmE3OWQ0ODAyYjgyODdiNzFhMTY0YjI2Zi90YWJsZXJhbmdlOjA4NWU5OTc2YTc5ZDQ4MDJiODI4N2I3MWExNjRiMjZmXzYtNC0xLTEtMA_d9c8ccfa-5340-44e7-a8bb-b69b20f49c66">44,508</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTowODVlOTk3NmE3OWQ0ODAyYjgyODdiNzFhMTY0YjI2Zi90YWJsZXJhbmdlOjA4NWU5OTc2YTc5ZDQ4MDJiODI4N2I3MWExNjRiMjZmXzYtNi0xLTEtMA_63ec3ae6-8d1a-4615-b785-557fe108349e">99,035</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTowODVlOTk3NmE3OWQ0ODAyYjgyODdiNzFhMTY0YjI2Zi90YWJsZXJhbmdlOjA4NWU5OTc2YTc5ZDQ4MDJiODI4N2I3MWExNjRiMjZmXzYtOC0xLTEtMA_766428be-f30a-443c-a679-6920d2f1af96">97,210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTowODVlOTk3NmE3OWQ0ODAyYjgyODdiNzFhMTY0YjI2Zi90YWJsZXJhbmdlOjA4NWU5OTc2YTc5ZDQ4MDJiODI4N2I3MWExNjRiMjZmXzYtMTAtMS0xLTA_17c5c49e-bfed-408f-b06f-c88d2a294981">44,667</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTowODVlOTk3NmE3OWQ0ODAyYjgyODdiNzFhMTY0YjI2Zi90YWJsZXJhbmdlOjA4NWU5OTc2YTc5ZDQ4MDJiODI4N2I3MWExNjRiMjZmXzYtMTItMS0xLTA_9085c0ee-9e1c-4ecf-a1ce-aefdc572294d">52,543</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">     The above table excludes fully amortized intangible assets for the periods presented.</span></div><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Customer-related intangible assets are comprised of customer lists and customer relationships acquired from third parties.</span></div><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Product rights comprise certain technologies, intellectual property, licenses, and trade names acquired from third parties.</span></div></ix:nonNumeric><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense of intangible assets other than goodwill was $<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90ZXh0cmVnaW9uOjFiMzBlOTFiNDExNTRmNGRhYzlmYTU1ZGIwNTIxMzBkXzc0NDM_62d158a9-712a-44f5-8b74-5d7c46657ee1">12.1</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90ZXh0cmVnaW9uOjFiMzBlOTFiNDExNTRmNGRhYzlmYTU1ZGIwNTIxMzBkXzc0NDc_1d569401-74c3-486c-81d8-e9291538b713">9.8</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90ZXh0cmVnaW9uOjFiMzBlOTFiNDExNTRmNGRhYzlmYTU1ZGIwNTIxMzBkXzc0NTU_6faaf4de-135a-44e9-a1a7-62b8308164fa">9.4</ix:nonFraction> million for the years ended December 31, 2021, 2020, and 2019, respectively.</span></div><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90ZXh0cmVnaW9uOjFiMzBlOTFiNDExNTRmNGRhYzlmYTU1ZGIwNTIxMzBkXzc2Nzg_ea9a9f19-d9bf-40a0-9386-9fa068b831cc" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2021, the aggregate amortization expense associated with intangible assets is estimated to be as follows for each of the next five years and thereafter:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:81.330%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.470%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortization Expense</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo1MmJiMTNhNzRhNjQ0ZDhiYTgzNjllNWI0NTRlYjU4OC90YWJsZXJhbmdlOjUyYmIxM2E3NGE2NDRkOGJhODM2OWU1YjQ1NGViNTg4XzItMS0xLTEtMA_14841a19-41b3-4b6d-b94a-18d9a04464fc">14,188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo1MmJiMTNhNzRhNjQ0ZDhiYTgzNjllNWI0NTRlYjU4OC90YWJsZXJhbmdlOjUyYmIxM2E3NGE2NDRkOGJhODM2OWU1YjQ1NGViNTg4XzMtMS0xLTEtMA_945eba3a-441c-4d95-ba22-9202120d914b">12,430</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo1MmJiMTNhNzRhNjQ0ZDhiYTgzNjllNWI0NTRlYjU4OC90YWJsZXJhbmdlOjUyYmIxM2E3NGE2NDRkOGJhODM2OWU1YjQ1NGViNTg4XzQtMS0xLTEtMA_994efa0c-adb2-49c6-b9f5-7fcd388be541">11,381</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo1MmJiMTNhNzRhNjQ0ZDhiYTgzNjllNWI0NTRlYjU4OC90YWJsZXJhbmdlOjUyYmIxM2E3NGE2NDRkOGJhODM2OWU1YjQ1NGViNTg4XzUtMS0xLTEtMA_a674bbd5-439b-42f8-82c0-9de4f91f75a2">10,633</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo1MmJiMTNhNzRhNjQ0ZDhiYTgzNjllNWI0NTRlYjU4OC90YWJsZXJhbmdlOjUyYmIxM2E3NGE2NDRkOGJhODM2OWU1YjQ1NGViNTg4XzYtMS0xLTEtMA_76e6b99f-f51b-41fd-8e6c-69fc0aa2c691">10,370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo1MmJiMTNhNzRhNjQ0ZDhiYTgzNjllNWI0NTRlYjU4OC90YWJsZXJhbmdlOjUyYmIxM2E3NGE2NDRkOGJhODM2OWU1YjQ1NGViNTg4XzctMS0xLTEtMA_ef9d7109-d612-4c9e-8475-87eccf4af44f">40,033</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo1MmJiMTNhNzRhNjQ0ZDhiYTgzNjllNWI0NTRlYjU4OC90YWJsZXJhbmdlOjUyYmIxM2E3NGE2NDRkOGJhODM2OWU1YjQ1NGViNTg4XzgtMS0xLTEtMA_51f56b8e-4a74-4465-9fbd-807b4d0fbd6e">99,035</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="i5d795a6851d746ca914a2ddae761c329_208"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:OtherLiabilitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDgvZnJhZzo2YjI1NjU3MGQ2Y2M0ZTllYWY5MDBhYzk2ZTU2Yjg3My90ZXh0cmVnaW9uOjZiMjU2NTcwZDZjYzRlOWVhZjkwMGFjOTZlNTZiODczXzE0MA_0f17602e-47a4-4aec-b854-72effc8d0c5d" continuedAt="iede146245d4745edaf487169ba7607cc" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ACCRUED LIABILITIES AND OTHER LONG-TERM LIABILITIES</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></ix:nonNumeric></div><div><span><br/></span></div><ix:continuation id="iede146245d4745edaf487169ba7607cc" continuedAt="i5d16b2857cbe4f49920c08108bebf48d"><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDgvZnJhZzo2YjI1NjU3MGQ2Y2M0ZTllYWY5MDBhYzk2ZTU2Yjg3My90ZXh0cmVnaW9uOjZiMjU2NTcwZDZjYzRlOWVhZjkwMGFjOTZlNTZiODczXzE0Mg_d67a8dc4-5727-47a2-bacd-714fa6055f21" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"><tr><td style="width:1.0%"></td><td style="width:67.705%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.676%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.827%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued employee compensation and related expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDgvZnJhZzo2YjI1NjU3MGQ2Y2M0ZTllYWY5MDBhYzk2ZTU2Yjg3My90YWJsZTpkMzgwNTNlNWU4ZTg0N2FhYWQ5MDI3M2UxMDAzMzM5MS90YWJsZXJhbmdlOmQzODA1M2U1ZThlODQ3YWFhZDkwMjczZTEwMDMzMzkxXzItMi0xLTEtMA_50fa8b91-c277-4f9a-9306-916097ace4a3">182,926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDgvZnJhZzo2YjI1NjU3MGQ2Y2M0ZTllYWY5MDBhYzk2ZTU2Yjg3My90YWJsZTpkMzgwNTNlNWU4ZTg0N2FhYWQ5MDI3M2UxMDAzMzM5MS90YWJsZXJhbmdlOmQzODA1M2U1ZThlODQ3YWFhZDkwMjczZTEwMDMzMzkxXzItNC0xLTEtMA_6d2cd230-3a75-4bf3-879d-f39a36262b25">167,649</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDgvZnJhZzo2YjI1NjU3MGQ2Y2M0ZTllYWY5MDBhYzk2ZTU2Yjg3My90YWJsZTpkMzgwNTNlNWU4ZTg0N2FhYWQ5MDI3M2UxMDAzMzM5MS90YWJsZXJhbmdlOmQzODA1M2U1ZThlODQ3YWFhZDkwMjczZTEwMDMzMzkxXzMtMi0xLTEtMA_e5ce586c-fdf9-48e5-b1e6-458e057948e3">133,978</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDgvZnJhZzo2YjI1NjU3MGQ2Y2M0ZTllYWY5MDBhYzk2ZTU2Yjg3My90YWJsZTpkMzgwNTNlNWU4ZTg0N2FhYWQ5MDI3M2UxMDAzMzM5MS90YWJsZXJhbmdlOmQzODA1M2U1ZThlODQ3YWFhZDkwMjczZTEwMDMzMzkxXzMtNC0xLTEtMA_01909c46-24a6-498f-a8b1-955a8842fdf2">112,526</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued customer incentives and refund obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:AccruedMarketingCostsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDgvZnJhZzo2YjI1NjU3MGQ2Y2M0ZTllYWY5MDBhYzk2ZTU2Yjg3My90YWJsZTpkMzgwNTNlNWU4ZTg0N2FhYWQ5MDI3M2UxMDAzMzM5MS90YWJsZXJhbmdlOmQzODA1M2U1ZThlODQ3YWFhZDkwMjczZTEwMDMzMzkxXzQtMi0xLTEtMA_fa223819-e51c-4835-aa0b-75b389965a7f">79,469</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:AccruedMarketingCostsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDgvZnJhZzo2YjI1NjU3MGQ2Y2M0ZTllYWY5MDBhYzk2ZTU2Yjg3My90YWJsZTpkMzgwNTNlNWU4ZTg0N2FhYWQ5MDI3M2UxMDAzMzM5MS90YWJsZXJhbmdlOmQzODA1M2U1ZThlODQ3YWFhZDkwMjczZTEwMDMzMzkxXzQtNC0xLTEtMA_99f8a856-5d95-43c1-aab0-1a38c7689a8d">75,064</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:AccruedIncomeTaxesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDgvZnJhZzo2YjI1NjU3MGQ2Y2M0ZTllYWY5MDBhYzk2ZTU2Yjg3My90YWJsZTpkMzgwNTNlNWU4ZTg0N2FhYWQ5MDI3M2UxMDAzMzM5MS90YWJsZXJhbmdlOmQzODA1M2U1ZThlODQ3YWFhZDkwMjczZTEwMDMzMzkxXzUtMi0xLTEtMA_172676ba-8b13-4f05-903c-5a0494afda77">42,605</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:AccruedIncomeTaxesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDgvZnJhZzo2YjI1NjU3MGQ2Y2M0ZTllYWY5MDBhYzk2ZTU2Yjg3My90YWJsZTpkMzgwNTNlNWU4ZTg0N2FhYWQ5MDI3M2UxMDAzMzM5MS90YWJsZXJhbmdlOmQzODA1M2U1ZThlODQ3YWFhZDkwMjczZTEwMDMzMzkxXzUtNC0xLTEtMA_d6d818f9-dbdb-4df6-a670-f24a89c358d0">42,676</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDgvZnJhZzo2YjI1NjU3MGQ2Y2M0ZTllYWY5MDBhYzk2ZTU2Yjg3My90YWJsZTpkMzgwNTNlNWU4ZTg0N2FhYWQ5MDI3M2UxMDAzMzM5MS90YWJsZXJhbmdlOmQzODA1M2U1ZThlODQ3YWFhZDkwMjczZTEwMDMzMzkxXzYtMi0xLTEtMA_f0c16dab-25c4-47db-911f-98abfc9a286c">19,931</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDgvZnJhZzo2YjI1NjU3MGQ2Y2M0ZTllYWY5MDBhYzk2ZTU2Yjg3My90YWJsZTpkMzgwNTNlNWU4ZTg0N2FhYWQ5MDI3M2UxMDAzMzM5MS90YWJsZXJhbmdlOmQzODA1M2U1ZThlODQ3YWFhZDkwMjczZTEwMDMzMzkxXzYtNC0xLTEtMA_b54293a3-6ff3-43ec-a1a7-30d0777474fe">17,733</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDgvZnJhZzo2YjI1NjU3MGQ2Y2M0ZTllYWY5MDBhYzk2ZTU2Yjg3My90YWJsZTpkMzgwNTNlNWU4ZTg0N2FhYWQ5MDI3M2UxMDAzMzM5MS90YWJsZXJhbmdlOmQzODA1M2U1ZThlODQ3YWFhZDkwMjczZTEwMDMzMzkxXzctMC0xLTEtMA_5d2faed1-a462-48ce-9b44-a109b44ef227"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDgvZnJhZzo2YjI1NjU3MGQ2Y2M0ZTllYWY5MDBhYzk2ZTU2Yjg3My90YWJsZTpkMzgwNTNlNWU4ZTg0N2FhYWQ5MDI3M2UxMDAzMzM5MS90YWJsZXJhbmdlOmQzODA1M2U1ZThlODQ3YWFhZDkwMjczZTEwMDMzMzkxXzctMC0xLTEtMA_e4f554de-7131-4a19-8325-4f920319c89c">Accrued liabilities</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDgvZnJhZzo2YjI1NjU3MGQ2Y2M0ZTllYWY5MDBhYzk2ZTU2Yjg3My90YWJsZTpkMzgwNTNlNWU4ZTg0N2FhYWQ5MDI3M2UxMDAzMzM5MS90YWJsZXJhbmdlOmQzODA1M2U1ZThlODQ3YWFhZDkwMjczZTEwMDMzMzkxXzctMi0xLTEtMA_c6e50415-59e7-4f9a-88a3-21777f9194a8">458,909</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDgvZnJhZzo2YjI1NjU3MGQ2Y2M0ZTllYWY5MDBhYzk2ZTU2Yjg3My90YWJsZTpkMzgwNTNlNWU4ZTg0N2FhYWQ5MDI3M2UxMDAzMzM5MS90YWJsZXJhbmdlOmQzODA1M2U1ZThlODQ3YWFhZDkwMjczZTEwMDMzMzkxXzctNC0xLTEtMA_52693fa7-05d3-47b2-a624-117a52063c8e">415,648</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i5d16b2857cbe4f49920c08108bebf48d"><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:OtherNoncurrentLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDgvZnJhZzo2YjI1NjU3MGQ2Y2M0ZTllYWY5MDBhYzk2ZTU2Yjg3My90ZXh0cmVnaW9uOjZiMjU2NTcwZDZjYzRlOWVhZjkwMGFjOTZlNTZiODczXzE0NA_171a78b4-e6f1-4665-a089-19c6041b3c2c" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term liabilities consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"></td><td style="width:67.501%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.780%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.931%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:AccruedIncomeTaxesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDgvZnJhZzo2YjI1NjU3MGQ2Y2M0ZTllYWY5MDBhYzk2ZTU2Yjg3My90YWJsZTo3Zjk5NTQzZGE4N2U0NjE4ODRlYWM3YzM5ZmI5NGZjOC90YWJsZXJhbmdlOjdmOTk1NDNkYTg3ZTQ2MTg4NGVhYzdjMzlmYjk0ZmM4XzItMi0xLTEtMA_e8c1c8e1-131f-4919-9682-475eb55da76e">56,466</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:AccruedIncomeTaxesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDgvZnJhZzo2YjI1NjU3MGQ2Y2M0ZTllYWY5MDBhYzk2ZTU2Yjg3My90YWJsZTo3Zjk5NTQzZGE4N2U0NjE4ODRlYWM3YzM5ZmI5NGZjOC90YWJsZXJhbmdlOjdmOTk1NDNkYTg3ZTQ2MTg4NGVhYzdjMzlmYjk0ZmM4XzItNC0xLTEtMA_59b1b931-2358-4f0e-a8fd-ab0762e1f03f">60,313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued long-term expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDgvZnJhZzo2YjI1NjU3MGQ2Y2M0ZTllYWY5MDBhYzk2ZTU2Yjg3My90YWJsZTo3Zjk5NTQzZGE4N2U0NjE4ODRlYWM3YzM5ZmI5NGZjOC90YWJsZXJhbmdlOjdmOTk1NDNkYTg3ZTQ2MTg4NGVhYzdjMzlmYjk0ZmM4XzMtMi0xLTEtMA_51e0796e-b8a6-4599-8b24-299b419adc92">14,475</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDgvZnJhZzo2YjI1NjU3MGQ2Y2M0ZTllYWY5MDBhYzk2ZTU2Yjg3My90YWJsZTo3Zjk5NTQzZGE4N2U0NjE4ODRlYWM3YzM5ZmI5NGZjOC90YWJsZXJhbmdlOjdmOTk1NDNkYTg3ZTQ2MTg4NGVhYzdjMzlmYjk0ZmM4XzMtNC0xLTEtMA_8bb35a11-8322-4653-9d23-89850182f0a5">25,291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDgvZnJhZzo2YjI1NjU3MGQ2Y2M0ZTllYWY5MDBhYzk2ZTU2Yjg3My90YWJsZTo3Zjk5NTQzZGE4N2U0NjE4ODRlYWM3YzM5ZmI5NGZjOC90YWJsZXJhbmdlOjdmOTk1NDNkYTg3ZTQ2MTg4NGVhYzdjMzlmYjk0ZmM4XzQtMi0xLTEtMA_255d5dfc-b224-43a2-ba52-3d70ab9de0f0">70,941</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDgvZnJhZzo2YjI1NjU3MGQ2Y2M0ZTllYWY5MDBhYzk2ZTU2Yjg3My90YWJsZTo3Zjk5NTQzZGE4N2U0NjE4ODRlYWM3YzM5ZmI5NGZjOC90YWJsZXJhbmdlOjdmOTk1NDNkYTg3ZTQ2MTg4NGVhYzdjMzlmYjk0ZmM4XzQtNC0xLTEtMA_22d77e30-20ff-4998-a1dd-5e3f162c894c">85,604</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="i5d795a6851d746ca914a2ddae761c329_214"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 13.&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzEzNjcz_9c67180f-e36c-4440-b99d-c36e394485f8" continuedAt="i2ec99c148e5a4f39843d40fee84c4746" escape="true">DEBT </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i2ec99c148e5a4f39843d40fee84c4746" continuedAt="i7aa9ee0020e14906807dc2a2283f91fc"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Credit Facility</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December&#160;9, 2021, we, along with IDEXX Distribution, Inc., IDEXX Operations, Inc., OPTI Medical Systems, Inc., IDEXX Laboratories Canada Corporation, IDEXX B.V., IDEXX Laboratories B.V., and IDEXX Laboratories GmbH, our wholly-owned subsidiaries (whether directly or indirectly held) (collectively, the &#8220;Borrowers&#8221;), entered into a fourth amended and restated credit agreement (the &#8220;Credit Agreement&#8221;) relating to a <ix:nonNumeric contextRef="i3d67cbfaa5224fec8d1c48c0eb22dc85_D20211209-20211209" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzQzOTgwNDY1NTI3MjM_eeeb100a-ff79-46bc-812f-4dc56fff9da6">five year</ix:nonNumeric> unsecured revolving credit facility in the principal amount of $<ix:nonFraction unitRef="usd" contextRef="ie379750e8a014b58b9ca70bcde9817d8_I20211209" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzI3NDg3NzkxMTA5ODE_4c68eefe-3789-4325-8515-29e9117ccdb9">1</ix:nonFraction> billion, among the Borrowers, the lenders party thereto, JPMorgan Chase Bank, N.A., as administrative agent, JPMorgan Chase Bank, N.A., Toronto Branch, as Toronto agent, and the other parties thereto.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement amends and restates that certain third amended and restated credit agreement, dated as of April 14, 2020, (which provided for a $<ix:nonFraction unitRef="usd" contextRef="i88842c37e6494006b237d52fce7c5c33_I20200414" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzg1Ng_b077570f-14bb-4b6f-acbc-48246c22a46d">1</ix:nonFraction>&#160;billion <ix:nonNumeric contextRef="i7027aef0a2c5405c8952b0b711093dd4_D20200414-20200414" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzQzOTgwNDY1MjcxOTI_0a92cfbf-02de-44a7-b9e4-a0b18971f08c">three-year</ix:nonNumeric> unsecured revolving credit facility) to extend the maturity to December 9, 2026 with aggregate commitments available for borrowing by the Borrowers of $<ix:nonFraction unitRef="usd" contextRef="i88842c37e6494006b237d52fce7c5c33_I20200414" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzEwMzE_8a5eb8b4-3e69-41b9-a695-a77f72cb2e63">1</ix:nonFraction>&#160;billion with the option to increase the aggregate commitments by $<ix:nonFraction unitRef="usd" contextRef="i88842c37e6494006b237d52fce7c5c33_I20200414" decimals="INF" name="idxx:LineofCreditFacilityAccordionFeatureIncreaseLimit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzEwOTE_e15aef0d-79be-4b4c-bc32-763c477a6cf3">250</ix:nonFraction>&#160;million, for an aggregate maximum of up to $<ix:nonFraction unitRef="usd" contextRef="i88842c37e6494006b237d52fce7c5c33_I20200414" decimals="INF" name="idxx:LineofCreditFacilityAccordionFeatureHigherBorrowingCapacityOption" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzExMjk_7597d925-ac33-4cb8-8da3-b7efbddde604">1.25</ix:nonFraction>&#160;billion, subject to the Borrowers obtaining commitments from existing or new lenders and satisfying other conditions specified in the Credit Agreement.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our Credit Facility prior to the December&#160;9, 2021 amendment, the applicable interest rates on borrowings are based on the prevailing LIBOR, Canadian Dollar Rate, or EURIBOR, but not less than <ix:nonFraction unitRef="number" contextRef="i4c25f29396c647aa8d6098ef0911bfef_I20200414" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzY1OTcwNjk4MDcxMjY_9f43d5c1-19d9-4b01-a01a-8b0949028409">1.0</ix:nonFraction>%, plus a credit spread ranging from <ix:nonFraction unitRef="number" contextRef="i5cc431806cd042369dfc78d28f3b1659_D20200414-20200414" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzY1OTcwNjk4MDcxMzI_15720a9b-56f2-46c0-b3b7-97a791ff7e3a">1.375</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="if38e3d02f10c4f32b074213b34fef777_D20200414-20200414" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzY1OTcwNjk4MDcxNDA_e6f59e93-eb5a-48dc-bf05-7b574341b225">2.00</ix:nonFraction>%, based on our gross leverage ratio. The Credit Facility also allowed for borrowings based on the prevailing Prime rate, but not less than <ix:nonFraction unitRef="number" contextRef="i1da5c94143f545488db1a5e8851e0d7b_I20200414" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzY1OTcwNjk4MDcxNDc_72e325e7-7ee3-49af-bfb1-b10b03eb89ab">2.00</ix:nonFraction>%, plus a credit spread from <ix:nonFraction unitRef="number" contextRef="i2743639b7f854d2faacd705017e8a980_D20200414-20200414" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzY1OTcwNjk4MDcxNTQ_43b56fce-011b-4406-b3d6-963133523728">0.375</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="idc1466922ecb4c6d968b86b7b8b94009_D20200414-20200414" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzY1OTcwNjk4MDcxNjM_c4dd1a78-1043-4ca0-81bf-aeb75d408c49">1.00</ix:nonFraction>%. Under the Credit Facility, we also pay quarterly commitment fees ranging from <ix:nonFraction unitRef="number" contextRef="icb88319a299b42b499f9dd03bbc3c710_D20200414-20200414" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzY1OTcwNjk4MDcxNzA_22811e59-82c0-44da-8152-f527c4f297ce">0.2</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="id297fa8846f44eef8316d35feb8ee7fc_D20200414-20200414" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzY1OTcwNjk4MDcxNzY_8a5c9429-1c69-4a20-9f8f-0caf6ff84866">0.375</ix:nonFraction>%, based on our leverage ratio, on any unused commitment. Under our current amended Credit Facility, the applicable interest rates on borrowings are based on the prevailing LIBOR, Canadian Dollar Rate, or EURIBOR, but not less than <ix:nonFraction unitRef="number" contextRef="i77d25639b7e24f3b863f76aff1a3baf2_I20211209" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzY1OTcwNjk4MDcxODQ_4ff3e872-f5e5-4daa-893a-acded9492168">0.0</ix:nonFraction>%, plus a credit spread ranging from <ix:nonFraction unitRef="number" contextRef="i7c3da4e4c9c14ee59aa58eb74d6eaf8c_D20211209-20211209" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzY1OTcwNjk4MDcxOTE_b375866b-95bc-4152-a216-f2dd3370275f">0.875</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i90bd3d6a0a4241c0aea364074afe7a3d_D20211209-20211209" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzY1OTcwNjk4MDcxOTk_29756013-221c-48f8-954e-52619b25f89c">1.375</ix:nonFraction>%, depending on our gross leverage ratio. The Credit Facility also allowed for borrowings based on the prevailing Prime rate, but not less than <ix:nonFraction unitRef="number" contextRef="i9320b95542d34067bb078b7df10a68d7_I20211209" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzY1OTcwNjk4MDcyMDc_38f21725-a891-487e-9808-e19b002fb45e">1.00</ix:nonFraction>%, plus a credit spread from <ix:nonFraction unitRef="number" contextRef="ibc7eca7b08f24e31ad1cdc3bac81938f_D20211209-20211209" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzY1OTcwNjk4MDcyMTQ_abe2396d-3428-46ab-8534-257954f67ac9">0.0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="ib9a066585bb047ed81604bdfa2257801_D20211209-20211209" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzY1OTcwNjk4MDcyMjE_d5dbf1f5-b177-4965-a875-f95ac8fb7e58">0.375</ix:nonFraction>%. Under the current Credit Facility, we also pay quarterly commitment fees ranging from <ix:nonFraction unitRef="number" contextRef="ib1a6a37dfa0846f0a5ce8ea8202bfac9_D20211209-20211209" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzY1OTcwNjk4MDcyMjk_0ff8da99-1a6e-4bce-bd30-c379e26a91eb">0.075</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="icfa56c2f5e4b4609b398b0b8b4950963_D20211209-20211209" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzY1OTcwNjk4MDcyMzc_eb47b5f4-0d2e-42f7-b67e-a8d1f572f88c">0.25</ix:nonFraction>%, based on our leverage ratio, on any unused commitment. Our Credit Facility includes a provision for the determination of one or more benchmark replacement rates (including SOFR) as a successor to the LIBOR rate. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2021, we had $<ix:nonFraction unitRef="usd" contextRef="i82a6155f7ccc4f55b9a6fe7e36a127df_I20211231" decimals="-5" name="us-gaap:LinesOfCreditCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzI3NDg3NzkxMDQzOTI_897687f1-0bb4-4293-8826-183493dbf312">73.5</ix:nonFraction> million outstanding borrowings under our Credit Facility with a weighted average effective interest rate of <ix:nonFraction unitRef="number" contextRef="i82a6155f7ccc4f55b9a6fe7e36a127df_I20211231" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzI3NDg3NzkxMDQ0OTY_ec2f1ce9-4d1b-4c4c-accb-bc030411ffcc">1.1</ix:nonFraction>%. Our weighted average borrowing rate for the year ended December 31, 2021, was <ix:nonFraction unitRef="number" contextRef="i82a6155f7ccc4f55b9a6fe7e36a127df_I20211231" decimals="3" name="us-gaap:DebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzY1OTcwNjk4MDcyNDU_f3cceb5a-3b5c-4d9d-9573-0dccc51679c2">2.7</ix:nonFraction>%, which reflected borrowings under our prior Credit Facility. At December 31, 2020, we had&#160;<ix:nonFraction unitRef="usd" contextRef="iae060c362bae4cb5b9a839012e39422e_I20201231" decimals="INF" name="us-gaap:LinesOfCreditCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzI3NDg3NzkxMDQ2NjA_a497e487-6ccd-458e-ac86-d86f051d674b">no</ix:nonFraction>&#160;outstanding borrowings under our Credit Facility. The funds available under the Credit Facility reflect a further reduction due to the issuance of letters of credit, which were issued in connection with our workers&#8217; compensation&#160;policy, for $<ix:nonFraction unitRef="usd" contextRef="i82a6155f7ccc4f55b9a6fe7e36a127df_I20211231" decimals="-5" name="us-gaap:LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzI3NDg3NzkxMDQ5MDU_6bb4e359-6705-4bf4-ae56-061d862baede"><ix:nonFraction unitRef="usd" contextRef="iae060c362bae4cb5b9a839012e39422e_I20201231" decimals="-5" name="us-gaap:LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzI3NDg3NzkxMDQ5MDU_88a8323f-9ed6-48bd-9f18-c3bcaf36b2e2">1.4</ix:nonFraction></ix:nonFraction> million in the year ended December 31, 2021 and 2020.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Credit Facility does not mature until December 9, 2026, all individual borrowings under the terms of the Credit Facility with an interest rate based on the prevailing LIBOR, Canadian Dollar Rate, or EURIBOR (as selected by the Borrower) have a stated term between <ix:nonNumeric contextRef="i9c8cf4c740be48fd83d344c66d438cd7_D20210101-20211231" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzE1NDE_43ef5d0a-79d3-40d6-b63c-805fdbc5e0fd">1</ix:nonNumeric> and <ix:nonNumeric contextRef="i0707fa55e90849738007f16cfef51f10_D20210101-20211231" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzE1NDg_2a7492eb-a3fa-4d23-96cc-c7052243d277">180</ix:nonNumeric> days. At the end of each term, the obligation is either repaid or rolled over into a new borrowing, or replaced by a borrowing based on a specific benchmark rate (where interest is then paid monthly). The Credit Facility contains a subjective material adverse event notification clause, which allows the debt holders to call the loans under the Credit Facility if we fail to provide prompt written notice to the syndicate of such an event. Based on the stated term and the existence of the subjective material adverse event clause, this Credit Facility is reflected in the current liabilities section of our consolidated balance sheets. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The obligations under the Credit Facility may be accelerated upon the occurrence of an event of default under the Credit Facility, which includes customary events of default including payment defaults, defaults in the performance of the affirmative, negative and financial covenants, the inaccuracy of representations or warranties, bankruptcy and insolvency </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i7aa9ee0020e14906807dc2a2283f91fc" continuedAt="i6751ff19d1e74bec9de000c14ac0ebb1"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">related defaults, defaults relating to judgments, certain events related to employee pension benefit plans under the Employee Retirement Income Security Act of 1974, the failure to pay specified indebtedness, cross-acceleration to specified indebtedness, and a change of control default. The Credit Facility contains affirmative, negative, and financial covenants customary for financings of this type. The negative covenants include restrictions on liens, indebtedness of subsidiaries of the Company, fundamental changes, investments, transactions with affiliates, and certain restrictive agreements. The sole financial covenant is a consolidated leverage ratio test that requires our ratio of debt to earnings before interest, taxes, depreciation, amortization, and share-based compensation defined as the consolidated leverage ratio under the terms of the Credit Facility, not to exceed <ix:nonFraction unitRef="number" contextRef="i99c7fc5496044f18a226eb36d6d3f865_D20210101-20211231" decimals="INF" name="idxx:ConsolidatedLeverageRatioUnderCreditFacilityNotePayable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzQ0Mzg_f032b6a0-5306-40e5-a997-76f1b2d4a925">3.5</ix:nonFraction>-to-1. At December 31, 2021, we were in compliance with the covenants of the Credit Facility.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Senior Notes</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzEzNjc0_24d33cef-4f21-47e5-a530-ae89f2ad7b99" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following describes all of our currently outstanding unsecured senior notes issued and sold in private placements (collectively, the "Senior Notes") as of December 31, 2021:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:8.796%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.833%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.387%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.833%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.272%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.981%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.205%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.833%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.580%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.833%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.847%"></td><td style="width:0.1%"></td></tr><tr><td colspan="33" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Principal Amount in thousands)</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Issue Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Due Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Series</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Principal Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Coupon Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Senior Note Agreement</span></td></tr><tr style="height:8pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12/11/2013</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12/11/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023 Series A Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i291ef135622f4a9baf284e7cfaad88c9_I20211231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90YWJsZTplMDI3OTM0NTBhNDY0ZjYyOWVjMmY2YzYyZjgyMTAxMS90YWJsZXJhbmdlOmUwMjc5MzQ1MGE0NjRmNjI5ZWMyZjZjNjJmODIxMDExXzQtNi0xLTEtMA_4e3b74d0-b3d7-46b4-9e50-9648ce32b07f">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i291ef135622f4a9baf284e7cfaad88c9_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90YWJsZTplMDI3OTM0NTBhNDY0ZjYyOWVjMmY2YzYyZjgyMTAxMS90YWJsZXJhbmdlOmUwMjc5MzQ1MGE0NjRmNjI5ZWMyZjZjNjJmODIxMDExXzQtOC0xLTEtMA_2055c4dd-e03c-4dd6-96b6-5fd398ba0c73">3.94</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">NY Life 2013 Note Agreement</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12/11/2013</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12/11/2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025 Series B Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i870fa3036a764a809f0d8c67c310cf72_I20211231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90YWJsZTplMDI3OTM0NTBhNDY0ZjYyOWVjMmY2YzYyZjgyMTAxMS90YWJsZXJhbmdlOmUwMjc5MzQ1MGE0NjRmNjI5ZWMyZjZjNjJmODIxMDExXzUtNi0xLTEtMA_f634cfe4-a36d-4898-952f-a822d3dd5efb">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i870fa3036a764a809f0d8c67c310cf72_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90YWJsZTplMDI3OTM0NTBhNDY0ZjYyOWVjMmY2YzYyZjgyMTAxMS90YWJsZXJhbmdlOmUwMjc5MzQ1MGE0NjRmNjI5ZWMyZjZjNjJmODIxMDExXzUtOC0xLTEtMA_a9c715df-0b9c-40e3-8237-40da30935f33">4.04</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">NY Life 2013 Note Agreement</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9/4/2014</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9/4/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026 Senior Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dd02565f2614274847ab1493dffefe3_I20211231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90YWJsZTplMDI3OTM0NTBhNDY0ZjYyOWVjMmY2YzYyZjgyMTAxMS90YWJsZXJhbmdlOmUwMjc5MzQ1MGE0NjRmNjI5ZWMyZjZjNjJmODIxMDExXzYtNi0xLTEtMA_442f2248-a94b-4dc4-8b0e-37693549dcd3">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3dd02565f2614274847ab1493dffefe3_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90YWJsZTplMDI3OTM0NTBhNDY0ZjYyOWVjMmY2YzYyZjgyMTAxMS90YWJsZXJhbmdlOmUwMjc5MzQ1MGE0NjRmNjI5ZWMyZjZjNjJmODIxMDExXzYtOC0xLTEtMA_de2d09b3-4c07-4811-b9f9-b6b938d34a99">3.72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">NY Life 2014 Note Agreement</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7/21/2014</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7/21/2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024 Series B Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0978c28bf335475c882b17687ef6c41d_I20211231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90YWJsZTplMDI3OTM0NTBhNDY0ZjYyOWVjMmY2YzYyZjgyMTAxMS90YWJsZXJhbmdlOmUwMjc5MzQ1MGE0NjRmNjI5ZWMyZjZjNjJmODIxMDExXzgtNi0xLTEtMA_5cf31689-ff09-44b7-94dd-65b3e49b2b64">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0978c28bf335475c882b17687ef6c41d_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90YWJsZTplMDI3OTM0NTBhNDY0ZjYyOWVjMmY2YzYyZjgyMTAxMS90YWJsZXJhbmdlOmUwMjc5MzQ1MGE0NjRmNjI5ZWMyZjZjNjJmODIxMDExXzgtOC0xLTEtMA_c426f887-e22a-46d6-9077-58bcef027b9f">3.76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prudential 2015 Amended Agreement</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6/18/2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6/18/2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025 Series C Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8364;</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9b730ee02fe84774a4802313f2dbde61_I20211231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90YWJsZTplMDI3OTM0NTBhNDY0ZjYyOWVjMmY2YzYyZjgyMTAxMS90YWJsZXJhbmdlOmUwMjc5MzQ1MGE0NjRmNjI5ZWMyZjZjNjJmODIxMDExXzktNi0xLTEtMA_48e3abbf-f25a-4cdf-8fad-e1bd0d56a58b">88,857</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9b730ee02fe84774a4802313f2dbde61_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90YWJsZTplMDI3OTM0NTBhNDY0ZjYyOWVjMmY2YzYyZjgyMTAxMS90YWJsZXJhbmdlOmUwMjc5MzQ1MGE0NjRmNjI5ZWMyZjZjNjJmODIxMDExXzktOC0xLTEtMA_93e6ef6b-262e-4922-a69b-4b2aa05245a1">1.785</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prudential 2015 Amended Agreement</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/12/2015</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/12/2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022 Series A Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea3b4083103c42cb8b20a1a66e2e0b7e_I20211231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90YWJsZTplMDI3OTM0NTBhNDY0ZjYyOWVjMmY2YzYyZjgyMTAxMS90YWJsZXJhbmdlOmUwMjc5MzQ1MGE0NjRmNjI5ZWMyZjZjNjJmODIxMDExXzEwLTYtMS0xLTA_bfdd5f2d-b5ad-4d6c-9f4e-b20077ee9285">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iea3b4083103c42cb8b20a1a66e2e0b7e_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90YWJsZTplMDI3OTM0NTBhNDY0ZjYyOWVjMmY2YzYyZjgyMTAxMS90YWJsZXJhbmdlOmUwMjc5MzQ1MGE0NjRmNjI5ZWMyZjZjNjJmODIxMDExXzEwLTgtMS0xLTA_7dabc754-f1db-4e89-b371-9ca3c3c70d16">3.25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MetLife 2014 Note Agreement</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/12/2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/12/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027 Series B Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7ee5545c45b452ba5b532018c57c675_I20211231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90YWJsZTplMDI3OTM0NTBhNDY0ZjYyOWVjMmY2YzYyZjgyMTAxMS90YWJsZXJhbmdlOmUwMjc5MzQ1MGE0NjRmNjI5ZWMyZjZjNjJmODIxMDExXzExLTYtMS0xLTA_7da5434f-7247-41df-b8b2-1bb016ca3c22">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id7ee5545c45b452ba5b532018c57c675_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90YWJsZTplMDI3OTM0NTBhNDY0ZjYyOWVjMmY2YzYyZjgyMTAxMS90YWJsZXJhbmdlOmUwMjc5MzQ1MGE0NjRmNjI5ZWMyZjZjNjJmODIxMDExXzExLTgtMS0xLTA_759e420d-3741-4776-9809-aeeae0310148">3.72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MetLife 2014 Note Agreement</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3/14/2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3/14/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2029 Series C Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71fe397c3c014eb0902555a2b916dc0b_I20211231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90YWJsZTplMDI3OTM0NTBhNDY0ZjYyOWVjMmY2YzYyZjgyMTAxMS90YWJsZXJhbmdlOmUwMjc5MzQ1MGE0NjRmNjI5ZWMyZjZjNjJmODIxMDExXzEyLTYtMS0xLTA_3e954e36-933b-44c7-89e5-99cb675ecc5b">100,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i71fe397c3c014eb0902555a2b916dc0b_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90YWJsZTplMDI3OTM0NTBhNDY0ZjYyOWVjMmY2YzYyZjgyMTAxMS90YWJsZXJhbmdlOmUwMjc5MzQ1MGE0NjRmNjI5ZWMyZjZjNjJmODIxMDExXzEyLTgtMS0xLTA_15b44fe6-dadc-4845-89cd-4d091f284b2a">4.19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MetLife 2014 Note Agreement</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4/2/2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4/2/2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MetLife 2030 Series D Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19e6230043be4bc494d45facd3995c64_I20211231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90YWJsZTplMDI3OTM0NTBhNDY0ZjYyOWVjMmY2YzYyZjgyMTAxMS90YWJsZXJhbmdlOmUwMjc5MzQ1MGE0NjRmNjI5ZWMyZjZjNjJmODIxMDExXzEzLTYtMS0xLTA_5b2ca874-619e-4756-ab50-bd35c516addc">125,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i19e6230043be4bc494d45facd3995c64_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90YWJsZTplMDI3OTM0NTBhNDY0ZjYyOWVjMmY2YzYyZjgyMTAxMS90YWJsZXJhbmdlOmUwMjc5MzQ1MGE0NjRmNjI5ZWMyZjZjNjJmODIxMDExXzEzLTgtMS0xLTA_469d0da4-c318-454d-96a2-584588005bf5">2.50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MetLife 2014 Note Agreement</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4/14/2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4/14/2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prudential 2030 Series D Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc25052aa62435dbe48e2738f88c2ff_I20211231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90YWJsZTplMDI3OTM0NTBhNDY0ZjYyOWVjMmY2YzYyZjgyMTAxMS90YWJsZXJhbmdlOmUwMjc5MzQ1MGE0NjRmNjI5ZWMyZjZjNjJmODIxMDExXzE0LTYtMS0xLTA_f2c4e402-9dd9-453f-831e-cfbb92e1536a">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5dc25052aa62435dbe48e2738f88c2ff_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90YWJsZTplMDI3OTM0NTBhNDY0ZjYyOWVjMmY2YzYyZjgyMTAxMS90YWJsZXJhbmdlOmUwMjc5MzQ1MGE0NjRmNjI5ZWMyZjZjNjJmODIxMDExXzE0LTgtMS0xLTA_83eacedd-c8ff-4b39-91cd-9ff5f69d28ce">2.50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prudential 2015 Amended Agreement</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following narrative represents our Senior Note activity:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">NY Life 2013 and 2014 Note Agreements, Including Amendments</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2013, we issued and sold through a private placement an aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="i2d9352de44824a5bb1085c5d21e9f1f4_I20131231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzQ5MTc_54714351-5290-4043-97ec-432155497723">150</ix:nonFraction> million of unsecured senior notes consisting of $<ix:nonFraction unitRef="usd" contextRef="ib0a1cfdb16bd4fe5831d9ba3c46d91ef_I20131231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzQ5NjA_f0c3e5eb-6991-4929-a988-4d98d6e74d04">75</ix:nonFraction> million of <ix:nonFraction unitRef="number" contextRef="ib0a1cfdb16bd4fe5831d9ba3c46d91ef_I20131231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzQ5NjY_f60f8954-171b-47fd-b8f8-a6348c052718">3.94</ix:nonFraction>% Series A Senior Notes due December&#160;11, 2023 (the &#8220;2023 Series A Notes&#8221;) and $<ix:nonFraction unitRef="usd" contextRef="i1acbae80f997433a88234dd2778c498b_I20131231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzUwNDU_39dbe970-33eb-4cc9-9fbf-f9836f5010df">75</ix:nonFraction> million of <ix:nonFraction unitRef="number" contextRef="i1acbae80f997433a88234dd2778c498b_I20131231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzUwNTE_653c3c0c-adcb-46f9-9694-c0e9d6db3ef1">4.04</ix:nonFraction>% Series B Senior Notes due December&#160;11, 2025 (the &#8220;2025 Series B Notes&#8221;) under a Note Purchase Agreement among the Company, New York Life Insurance Company and the accredited institutional purchasers named therein (as amended on April 10, 2020, the &#8220;NY Life 2013 Note Agreement&#8221;).</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2014, we issued and sold through a private placement an aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="i9268fbd98f1642a29877996cd39b28a8_I20140930" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzU0MzU_b2920275-7578-4d03-b420-06f81f319532">75</ix:nonFraction> million of unsecured <ix:nonFraction unitRef="number" contextRef="i9268fbd98f1642a29877996cd39b28a8_I20140930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzU0NTE_d4de045c-ecee-498d-a850-3d7fd5192dc3">3.72</ix:nonFraction>% senior notes due September 4, 2026 (the &#8220;2026 Senior Notes&#8221;) under a Note Purchase Agreement dated as of July 22, 2014, among the Company, New York Life Insurance Company and the accredited institutional purchasers named therein (as amended April 10, 2020, the &#8220;NY Life 2014 Note Agreement&#8221;).</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 10, 2020, we amended the NY Life 2013 Note Agreement and the NY Life 2014 Note Agreement by entering into two Amendments to Note Purchase Agreement with New York Life Insurance Company and the other parties thereto, which modified several defined terms, schedules and covenant baskets in the NY Life 2013 Agreement and the NY Life 2014 Note Agreement to create additional operating flexibility, and in particular to align such provisions with similar modifications we made substantially concurrently in our other debt facilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Prudential 2015 Amended Agreement, Including Amendments</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2014, we issued and sold through a private placement an aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="i85b9b901dae14f1f8f19b213cedc6d10_I20140731" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzY0NDI_835e465a-b50b-456e-b36b-a5554b43425a">125</ix:nonFraction> million of unsecured senior notes consisting of $<ix:nonFraction unitRef="usd" contextRef="i728c0393124f4d3aa9ce9f98a65c1909_I20140731" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzY0ODU_6cbf77dc-803b-4bb8-86e1-29e246e5377a">50</ix:nonFraction> million of <ix:nonFraction unitRef="number" contextRef="i728c0393124f4d3aa9ce9f98a65c1909_I20140731" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzY0OTE_28c1eea4-a1ce-43e0-94bd-7e5c40ce2204">3.32</ix:nonFraction>% Series A Senior Notes due July&#160;21, 2021 (the &#8220;2021 Series A Notes&#8221;) and $<ix:nonFraction unitRef="usd" contextRef="i6b9efa5452f740aca86e464a7d20a380_I20140731" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzY1NjY_613bcbaf-11df-48c6-b6a0-f43c7a00dc0d">75</ix:nonFraction> million of <ix:nonFraction unitRef="number" contextRef="i6b9efa5452f740aca86e464a7d20a380_I20140731" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzY1NzI_a535c88f-a905-4546-9959-1767fd501854">3.76</ix:nonFraction>% Series B Senior Notes due July&#160;21, 2024 (the &#8220;2024 Series B Notes&#8221;) under a Note Purchase and Private Shelf Agreement among the Company, Prudential Investment Management, Inc. (&#8220;Prudential&#8221;) and the accredited </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i6751ff19d1e74bec9de000c14ac0ebb1" continuedAt="i8537d5f7aa6c4e2ab33daba39fabb3c6"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">institutional purchasers named therein (the &#8220;Prudential 2014 Note Agreement&#8221;). The $<ix:nonFraction unitRef="usd" contextRef="ie9096849c1ac4387b32b1369124e6e10_D20210721-20210721" decimals="-6" name="us-gaap:RepaymentsOfSeniorDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzY1OTcwNjk4MDcyNTE_95744b78-6e70-4735-8ef3-997c70067e05">50</ix:nonFraction>&#160;million <ix:nonFraction unitRef="number" contextRef="i728c0393124f4d3aa9ce9f98a65c1909_I20140731" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzY1OTcwNjk4MDcyNjQ_62070bf6-88de-4f1f-9d7e-c47d10d6d4f8">3.32</ix:nonFraction>% Series A Senior Note was repaid in full on the July 21, 2021 due date.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2015, we entered into an Amended and Restated Multi-Currency Note Purchase and Private Shelf Agreement (the &#8220;Original Prudential 2015 Amended Agreement"), among the Company, Prudential, and the accredited institutional purchasers named therein, which amends and restates the Prudential 2014 Note Agreement. Pursuant to the Original Prudential 2015 Amended Agreement, we issued and sold through an aggregated private placement an aggregate principal amount of &#8364;<ix:nonFraction unitRef="eur" contextRef="i6fd942875b8149d6801ca7948aa50eb9_I20150630" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzczMzM_ee328302-5d15-4b36-96a8-32c1558d557b">88.9</ix:nonFraction> million of unsecured <ix:nonFraction unitRef="number" contextRef="i6fd942875b8149d6801ca7948aa50eb9_I20150630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzczNDk_eea7333d-c3fa-4adb-ba7e-7d9abbeb9964">1.785</ix:nonFraction>%&#160;Series&#160;C Senior Notes due June&#160;18, 2025 (the &#8220;2025 Series C Notes&#8221;).</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 9, 2019, we entered into the Amendment to Note Purchase and Private Shelf Agreement (the "Prudential First Amendment") with Prudential and the other parties thereto, which amended certain reporting provisions in the Original Prudential 2015 Amended Agreement. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 10, 2020, we entered into the Second Amendment to the Prudential 2015 Amended Agreement (the &#8220;Prudential Second Amendment&#8221;), in order to (i) increase the facility size to $<ix:nonFraction unitRef="usd" contextRef="i2c27f682ff974979b7a9c14a0852f4b1_I20200410" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzc4NzQ_eb80b803-ccc5-46e6-88a3-f13513dbfff8">425</ix:nonFraction>&#160;million, (ii) extend the facility issuance period to April 10, 2023, (iii) make various implementing and administrative changes in order to facilitate a $<ix:nonFraction unitRef="usd" contextRef="ia4f21d4f936e451bb937db30e6e6c516_I20200414" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzgwMjI_8f5e6bd2-ae89-4728-bc7c-4bf3c3002f72">75</ix:nonFraction>&#160;million notes issuance on April 14, 2020, (iv) allow the amount available to be issued under the facility to equal $<ix:nonFraction unitRef="usd" contextRef="i2c27f682ff974979b7a9c14a0852f4b1_I20200410" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzgxMzI_0f1767c2-60e3-47e1-95a8-d398ea8a18e5">425</ix:nonFraction>&#160;million less the amount of notes outstanding from time to time during the issuance period and (v)&#160;modify several defined terms, schedules and covenant baskets in the Original Prudential 2015 Amended Agreement, as amended by the Prudential First Amendment, to create additional operating flexibility, and in particular to align such provisions with similar modifications we made substantially concurrently in our other debt facilities. We refer to the Original Prudential 2015 Agreement, as amended by the Prudential First Amendment and the Prudential Second Amendment, as the "Prudential 2015 Amended Agreement."</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 14, 2020, we issued and sold to Prudential and other purchasers $<ix:nonFraction unitRef="usd" contextRef="ia4f21d4f936e451bb937db30e6e6c516_I20200414" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzg4MTY_28650b2b-0d2e-4f47-8f1f-3c1b5609c61e">75</ix:nonFraction>&#160;million of our unsecured senior notes (the &#8220;Prudential 2030 Series D Notes&#8221;) pursuant to the Prudential Second Amendment. The entire outstanding balance of the Prudential 2030 Series D Notes is due and payable on April 14, 2030, and the Prudential 2030 Series D Notes bear interest at the rate of <ix:nonFraction unitRef="number" contextRef="ia4f21d4f936e451bb937db30e6e6c516_I20200414" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzkxMDg_7bfeeca8-3c72-41de-bfdc-4d0f08b28d45">2.50</ix:nonFraction>% per annum. We used the proceeds received from the Prudential 2030 Series D Notes for general corporate purposes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">MetLife 2014 Note Agreement, Including Amendments</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We entered into a Multicurrency Note Purchase and Private Shelf Agreement, dated as of December 19, 2014 (the "Original MetLife 2014 Note Agreement"), among the Company, Metropolitan Life Insurance Company (&#8220;MetLife&#8221;) and the accredited institutional purchasers named therein pursuant to which we agreed to issue and sell an aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="ia7f558575c4f45f3b51e71f291325f3a_I20141219" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzk2MzM_9a7e1b43-2542-4387-88aa-baa1d8dc07d9">150</ix:nonFraction> million of unsecured senior notes consisting of $<ix:nonFraction unitRef="usd" contextRef="ia1b615997c6845d992165c221d916601_I20141219" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzk2NzY_d488b7f0-47c3-41fa-8892-a870abd77169">75</ix:nonFraction> million of our <ix:nonFraction unitRef="number" contextRef="ia1b615997c6845d992165c221d916601_I20141219" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzk2ODY_b7682b89-9bab-4788-a6cc-a4700899cb22">3.25</ix:nonFraction>% Series A Senior Notes having a <ix:nonNumeric contextRef="i5c06758cf49c487989c8d74d5a4fe45a_D20141219-20141219" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzQzOTgwNDY1MjcxOTM_449e97ad-ab00-4107-94b2-73cec69f71e6">seven-year</ix:nonNumeric> term (the "2022 Series A Notes"), and $<ix:nonFraction unitRef="usd" contextRef="i693b06087db042f486f6b01601900261_I20141219" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzk3NjY_bb6331c3-163b-475a-a79d-7351a2f41beb">75</ix:nonFraction> million of our <ix:nonFraction unitRef="number" contextRef="i693b06087db042f486f6b01601900261_I20141219" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzk3NzY_c2c56abc-add2-45c9-a0db-7f99db4ce2bd">3.72</ix:nonFraction>% Series B Senior Notes having a <ix:nonNumeric contextRef="iea5f10448a374b6f90d116e53e14ac51_D20141219-20141219" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzQzOTgwNDY1MjcxOTQ_d0124635-8836-4edb-9327-a9b9d8d34eea">twelve-year</ix:nonNumeric> term ("2027 Series B Notes"). The issuance, sale and purchase of these&#160;notes occurred in February 2015. The aggregate principal amount of our 2022 Series A Notes for $<ix:nonFraction unitRef="usd" contextRef="i78dd1a8fbcfa4a6d8b5587990a0d4b8b_I20211209" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzI3NDg3NzkwOTQ0NDc_3c8cf305-efb6-417d-be10-bb5a240445e7">75.0</ix:nonFraction>&#160;million will become due and payable on February 12, 2022.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 14, 2019, we amended the Original MetLife 2014 Note Agreement. Pursuant to the Original MetLife 2014 Note Agreement, as so amended, we issued and sold through a private placement an aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="i69f00534ab5c47f6bb7e698a1e5b33f2_I20190314" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzEwMTQ1_5f1508d6-985f-4500-940a-570e994d79ae">100</ix:nonFraction> million of unsecured senior notes at a <ix:nonFraction unitRef="number" contextRef="i69f00534ab5c47f6bb7e698a1e5b33f2_I20190314" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzEwMTc5_db808952-01bc-4f18-8bad-748f05621232">4.19</ix:nonFraction>% per annum rate, due March 14, 2029 (the "2029 Series C Notes").</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 23, 2020, we entered into the Second Amendment to the Original MetLife 2014 Note Agreement (the &#8220;MetLife Second Amendment&#8221;), in order to (i) increase the facility size from $<ix:nonFraction unitRef="usd" contextRef="i8e2ecd2fe69f46929ab4f66300904bb0_I20200322" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzEwNDMx_b3ca29ff-582c-4722-9eed-cb2bcdac13f2">150</ix:nonFraction>&#160;million to $<ix:nonFraction unitRef="usd" contextRef="i94bcd6d66d644d71ba9e5e425c3343f9_I20200323" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzEwNDM3_bea32b16-1502-46ed-997b-0448553c498f">300</ix:nonFraction>&#160;million, (ii) extend the facility issuance period to December 20, 2022, (iii) make various implementing and administrative changes in order to facilitate a $<ix:nonFraction unitRef="usd" contextRef="i82a0a4b3853c4d43b57df66540d93b3a_I20200402" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzEwNTg4_d92876e5-0ad5-4ecf-8927-2c6f202338be">125</ix:nonFraction>&#160;million notes issuance on April 2, 2020 and (iv) allow the amount available to be issued under the facility to equal $<ix:nonFraction unitRef="usd" contextRef="i94bcd6d66d644d71ba9e5e425c3343f9_I20200323" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzEwNzAw_841fe419-e147-43bf-a638-6582c7d52da8">300</ix:nonFraction>&#160;million, less the amounts outstanding on 2029 Series C Notes and MetLife 2030 Series D Notes.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 2, 2020, we issued and sold to MetLife and other purchasers $<ix:nonFraction unitRef="usd" contextRef="i82a0a4b3853c4d43b57df66540d93b3a_I20200402" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzEwODYx_259c9a82-bfce-4256-adc9-3a498c449f69">125</ix:nonFraction>&#160;million of our unsecured senior notes (the &#8220;MetLife 2030 Series D Notes&#8221;) pursuant to the MetLife Second Amendment. The entire outstanding principal balance of the MetLife 2030 Series D Notes is due and payable on April 2, 2030, and the MetLife 2030 Series D Notes bear interest at the rate of <ix:nonFraction unitRef="number" contextRef="i82a0a4b3853c4d43b57df66540d93b3a_I20200402" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzExMTUw_f880a169-8555-4737-9edf-aa55ce6e9415">2.50</ix:nonFraction>% per annum. We used the proceeds received from the MetLife 2030 Series D Notes for general corporate purposes. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We refer to the Original MetLife 2014 Agreement, as so amended, as the "MetLife 2014 Agreement," and together with the NY Life 2013 Note Agreement, NY Life 2014 Note Agreement, and Prudential 2015 Amended Note Agreement, collectively, as the "Senior Note Agreements."</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i8537d5f7aa6c4e2ab33daba39fabb3c6"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Senior Note Agreements</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Senior Note Agreements contain affirmative, negative, and financial covenants customary for agreements of this type. The negative covenants include restrictions on liens, indebtedness of our subsidiaries, priority indebtedness, fundamental changes, investments, transactions with affiliates, certain restrictive agreements, and violations of laws and regulations. The sole financial covenant is a consolidated leverage ratio test that requires our ratio of debt to earnings before interest, taxes, depreciation, amortization, and share-based compensation, as defined in the Senior Note Agreements, not to exceed <ix:nonFraction unitRef="number" contextRef="ie9b830d7b3a74e4f9431f662334d4e77_D20210101-20211231" decimals="3" name="idxx:ConsolidatedLeverageRatioUnderCreditFacilityNotePayable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzEyMTc2_dfdb22d5-6100-4217-ae65-eca09101bfe0">3.5</ix:nonFraction>-to-1. At December 31, 2021, we were in compliance with the covenants of the Senior Note Agreements.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Should we elect to prepay the Senior Notes, such aggregate prepayment will include the applicable make-whole amount(s), as defined within the applicable Senior Note Agreements. Additionally, in the event of a change in control of the Company or upon the disposition of certain assets of the Company the proceeds of which are not reinvested (as defined in the Senior Note Agreements), we may be required to prepay all or a portion of the Senior Notes. The obligations under the Senior Notes may be accelerated upon the occurrence of an event of default under the applicable Senior Note Agreement, each of which includes customary events of default including payment defaults, defaults in the performance of the affirmative, negative and financial covenants, the inaccuracy of representations or warranties, bankruptcy and insolvency related defaults, defaults relating to judgments, certain events related to employee pension benefit plans under the Employee Retirement Income Security Act of 1974, the failure to pay specified indebtedness and cross-acceleration to specified indebtedness. We used the net proceeds from the issuances and sale of the Senior Notes for general corporate purposes. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzEzNjY5_e967ae23-128a-442f-b9df-2c244be03e78" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Annual principal payments on long-term debt at December 31, 2021, are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:71.773%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ending December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90YWJsZTo2ODliY2QwYzk3Nzc0MGY2OTE3NWJkNDYyNmMwNzA0MC90YWJsZXJhbmdlOjY4OWJjZDBjOTc3NzQwZjY5MTc1YmQ0NjI2YzA3MDQwXzMtMi0xLTEtMA_ba4aaf28-e0ab-4076-bf0e-0b1aab66e81b">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90YWJsZTo2ODliY2QwYzk3Nzc0MGY2OTE3NWJkNDYyNmMwNzA0MC90YWJsZXJhbmdlOjY4OWJjZDBjOTc3NzQwZjY5MTc1YmQ0NjI2YzA3MDQwXzQtMi0xLTEtMA_750f8663-a4f9-4215-90d2-0d46f5c168b5">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90YWJsZTo2ODliY2QwYzk3Nzc0MGY2OTE3NWJkNDYyNmMwNzA0MC90YWJsZXJhbmdlOjY4OWJjZDBjOTc3NzQwZjY5MTc1YmQ0NjI2YzA3MDQwXzUtMi0xLTEtMA_3c167701-3072-47d7-b103-a838163d113e">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90YWJsZTo2ODliY2QwYzk3Nzc0MGY2OTE3NWJkNDYyNmMwNzA0MC90YWJsZXJhbmdlOjY4OWJjZDBjOTc3NzQwZjY5MTc1YmQ0NjI2YzA3MDQwXzYtMi0xLTEtMA_df7af7c8-ac50-4493-8537-0d2e01abbd43">175,711</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90YWJsZTo2ODliY2QwYzk3Nzc0MGY2OTE3NWJkNDYyNmMwNzA0MC90YWJsZXJhbmdlOjY4OWJjZDBjOTc3NzQwZjY5MTc1YmQ0NjI2YzA3MDQwXzctMi0xLTEtMA_b3f7d765-f115-4be9-b87a-33e8cd6119b8">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90YWJsZTo2ODliY2QwYzk3Nzc0MGY2OTE3NWJkNDYyNmMwNzA0MC90YWJsZXJhbmdlOjY4OWJjZDBjOTc3NzQwZjY5MTc1YmQ0NjI2YzA3MDQwXzgtMi0xLTEtMA_f4e4150d-e10f-4afe-b06b-7b087ff13ff4">375,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90YWJsZTo2ODliY2QwYzk3Nzc0MGY2OTE3NWJkNDYyNmMwNzA0MC90YWJsZXJhbmdlOjY4OWJjZDBjOTc3NzQwZjY5MTc1YmQ0NjI2YzA3MDQwXzktMi0xLTEtMA_01ebb413-5871-46cf-aad7-a1ccc411ff36">850,711</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div></ix:nonNumeric><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total interest paid on all debt (including our Credit Facility) for the years ended December 31, 2021, 2020, and 2019, was $<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-5" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzEzNjQw_3906c4ad-dcdf-4a75-afef-8a878c96db42">30.5</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-5" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzEzNjQ0_48457be5-319a-4915-8b29-44ae61d3000e">32.4</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-5" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzEzNjUy_b19829d9-9ab3-4caa-92ef-15e4bfd8b916">29.7</ix:nonFraction> million, respectively.</span></div></ix:continuation><div><span><br/></span></div><div id="i5d795a6851d746ca914a2ddae761c329_217"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 14.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90ZXh0cmVnaW9uOjk2Y2VlMWJjZmEwNDRkMTc5MDEwMDVkMTk1MTExYmFjXzY1OTU_8e28ab85-41a1-4153-ab71-d0e6ac649536" continuedAt="i3788d48cdf024f108d5fefda0d43e2c9" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INCOME TAXES</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></ix:nonNumeric></div><div><span><br/></span></div><ix:continuation id="i3788d48cdf024f108d5fefda0d43e2c9" continuedAt="ie291d0d7866948aa992115ffaa76d486"><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90ZXh0cmVnaW9uOjk2Y2VlMWJjZmEwNDRkMTc5MDEwMDVkMTk1MTExYmFjXzY1OTA_ffb4f78b-2e1f-4bb4-a508-1a32a043ba48" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes is determined using the asset and liability approach of accounting for income taxes. Under this approach, deferred taxes represent the estimated future tax effects of temporary differences between book and tax treatment of assets and liabilities and carryforwards to the extent they are realizable. We record a valuation allowance to reduce our deferred tax assets to the amount that is more likely than not to be realized. In assessing the need for a valuation allowance, we consider future taxable income and ongoing prudent and feasible tax planning strategies. In the event that we determine that we would be able to realize our deferred tax assets in the future in excess of the net recorded amount, a reduction of the valuation allowance would increase income in the period such determination was made. Likewise, should we determine that we would not be able to realize all or part of our net deferred tax asset in the future, a reduction to the deferred tax asset would be charged to income in the period such determination was made.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record a liability for uncertain tax positions that do not meet the more likely than not standard as prescribed by the authoritative guidance for income tax accounting. We record tax benefits for only those positions that we believe will more likely than not be sustained.&#160;Unrecognized tax benefits are the differences between tax positions taken, or expected to be taken, in tax returns, and the benefits recognized for accounting purposes. We classify uncertain tax positions as long-term liabilities.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant judgment is required in determining our worldwide provision for income taxes and our income tax filings are regularly under audit by tax authorities. Any audit result differing from amounts recorded would increase or decrease income in the period that we determine such adjustment is likely. Interest expense and penalties associated with the underpayment of income taxes are included in income tax expense.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ie291d0d7866948aa992115ffaa76d486" continuedAt="i7a26419dbfed437699fcdc1c3cc0fb46"><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90ZXh0cmVnaW9uOjk2Y2VlMWJjZmEwNDRkMTc5MDEwMDVkMTk1MTExYmFjXzY1Nzk_042658e7-23a1-4c57-ac72-7ce01dcdf69f" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings before income taxes were as follows:</span><span style="font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%"></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:58.490%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Domestic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo2NmY3YTlmNjkxY2Q0Yzc5YmQ4YTUzZThhOGZmOWQ2MS90YWJsZXJhbmdlOjY2ZjdhOWY2OTFjZDRjNzliZDhhNTNlOGE4ZmY5ZDYxXzMtMi0xLTEtMA_d7589c9d-58b0-4ef6-85b6-ef8233bb838a">689,994</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo2NmY3YTlmNjkxY2Q0Yzc5YmQ4YTUzZThhOGZmOWQ2MS90YWJsZXJhbmdlOjY2ZjdhOWY2OTFjZDRjNzliZDhhNTNlOGE4ZmY5ZDYxXzMtNC0xLTEtMA_c857d390-2462-4f28-97dd-4cadcd10e2de">483,694</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo2NmY3YTlmNjkxY2Q0Yzc5YmQ4YTUzZThhOGZmOWQ2MS90YWJsZXJhbmdlOjY2ZjdhOWY2OTFjZDRjNzliZDhhNTNlOGE4ZmY5ZDYxXzMtNi0xLTEtMA_fcfd19d5-c689-40a0-a691-977578c41e4d">377,964</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo2NmY3YTlmNjkxY2Q0Yzc5YmQ4YTUzZThhOGZmOWQ2MS90YWJsZXJhbmdlOjY2ZjdhOWY2OTFjZDRjNzliZDhhNTNlOGE4ZmY5ZDYxXzQtMi0xLTEtMA_27c4ffa1-c17c-43d5-be1d-3bda236b2d68">212,660</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo2NmY3YTlmNjkxY2Q0Yzc5YmQ4YTUzZThhOGZmOWQ2MS90YWJsZXJhbmdlOjY2ZjdhOWY2OTFjZDRjNzliZDhhNTNlOGE4ZmY5ZDYxXzQtNC0xLTEtMA_797c6956-9007-4278-aa4e-f36726b6b7fc">178,291</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo2NmY3YTlmNjkxY2Q0Yzc5YmQ4YTUzZThhOGZmOWQ2MS90YWJsZXJhbmdlOjY2ZjdhOWY2OTFjZDRjNzliZDhhNTNlOGE4ZmY5ZDYxXzQtNi0xLTEtMA_74f8677c-e4a6-4b61-b2f2-8acebcf2fd2a">144,254</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 30.25pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo2NmY3YTlmNjkxY2Q0Yzc5YmQ4YTUzZThhOGZmOWQ2MS90YWJsZXJhbmdlOjY2ZjdhOWY2OTFjZDRjNzliZDhhNTNlOGE4ZmY5ZDYxXzUtMi0xLTEtMA_a32bd2d5-8585-46d3-8560-8405c6fe7fb2">902,654</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo2NmY3YTlmNjkxY2Q0Yzc5YmQ4YTUzZThhOGZmOWQ2MS90YWJsZXJhbmdlOjY2ZjdhOWY2OTFjZDRjNzliZDhhNTNlOGE4ZmY5ZDYxXzUtNC0xLTEtMA_b260549d-27c5-40cb-93a2-f99b1ec40c68">661,985</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo2NmY3YTlmNjkxY2Q0Yzc5YmQ4YTUzZThhOGZmOWQ2MS90YWJsZXJhbmdlOjY2ZjdhOWY2OTFjZDRjNzliZDhhNTNlOGE4ZmY5ZDYxXzUtNi0xLTEtMA_963ea20a-d8a9-4dad-b301-b99432eb0f1f">522,218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90ZXh0cmVnaW9uOjk2Y2VlMWJjZmEwNDRkMTc5MDEwMDVkMTk1MTExYmFjXzY1OTI_3a5b94b9-4c9f-4873-86f4-ec9bfbdf0f77" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision (benefit) for income taxes comprised the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:58.490%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo5NmEzYzU2NjI0YzA0Y2JiOTBhZGMyYWNkYTBhNTkzZi90YWJsZXJhbmdlOjk2YTNjNTY2MjRjMDRjYmI5MGFkYzJhY2RhMGE1OTNmXzMtMi0xLTEtMA_c160d3ee-3cf5-42fb-8dc6-97a64a38628f">112,811</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo5NmEzYzU2NjI0YzA0Y2JiOTBhZGMyYWNkYTBhNTkzZi90YWJsZXJhbmdlOjk2YTNjNTY2MjRjMDRjYmI5MGFkYzJhY2RhMGE1OTNmXzMtNC0xLTEtMA_082e900b-fb86-4821-a8ce-7ea4a255ce1f">72,921</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo5NmEzYzU2NjI0YzA0Y2JiOTBhZGMyYWNkYTBhNTkzZi90YWJsZXJhbmdlOjk2YTNjNTY2MjRjMDRjYmI5MGFkYzJhY2RhMGE1OTNmXzMtNi0xLTEtMA_3c9c2c24-afea-4735-9533-d4cffa8a7cd2">52,194</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo5NmEzYzU2NjI0YzA0Y2JiOTBhZGMyYWNkYTBhNTkzZi90YWJsZXJhbmdlOjk2YTNjNTY2MjRjMDRjYmI5MGFkYzJhY2RhMGE1OTNmXzQtMi0xLTEtMA_83951d9c-d7c1-413e-ae6e-632f20ce64fc">19,147</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo5NmEzYzU2NjI0YzA0Y2JiOTBhZGMyYWNkYTBhNTkzZi90YWJsZXJhbmdlOjk2YTNjNTY2MjRjMDRjYmI5MGFkYzJhY2RhMGE1OTNmXzQtNC0xLTEtMA_76c00914-ec5d-427e-9e27-40737f4f2d4d">17,346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo5NmEzYzU2NjI0YzA0Y2JiOTBhZGMyYWNkYTBhNTkzZi90YWJsZXJhbmdlOjk2YTNjNTY2MjRjMDRjYmI5MGFkYzJhY2RhMGE1OTNmXzQtNi0xLTEtMA_0377e197-8556-48f3-9eef-9fc304653a6e">11,967</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:CurrentForeignTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo5NmEzYzU2NjI0YzA0Y2JiOTBhZGMyYWNkYTBhNTkzZi90YWJsZXJhbmdlOjk2YTNjNTY2MjRjMDRjYmI5MGFkYzJhY2RhMGE1OTNmXzUtMi0xLTEtMA_8d6d1c57-4f0c-4e38-a1a6-7c2a7c43831b">29,288</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:CurrentForeignTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo5NmEzYzU2NjI0YzA0Y2JiOTBhZGMyYWNkYTBhNTkzZi90YWJsZXJhbmdlOjk2YTNjNTY2MjRjMDRjYmI5MGFkYzJhY2RhMGE1OTNmXzUtNC0xLTEtMA_a34301a4-4214-4ba8-bd31-ec7822907884">26,301</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:CurrentForeignTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo5NmEzYzU2NjI0YzA0Y2JiOTBhZGMyYWNkYTBhNTkzZi90YWJsZXJhbmdlOjk2YTNjNTY2MjRjMDRjYmI5MGFkYzJhY2RhMGE1OTNmXzUtNi0xLTEtMA_eb04068c-2a2f-4aca-9471-1c2204c62d04">24,239</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo5NmEzYzU2NjI0YzA0Y2JiOTBhZGMyYWNkYTBhNTkzZi90YWJsZXJhbmdlOjk2YTNjNTY2MjRjMDRjYmI5MGFkYzJhY2RhMGE1OTNmXzYtMi0xLTEtMA_ac800317-b67a-438f-a31b-7cccbcb4517d">161,246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo5NmEzYzU2NjI0YzA0Y2JiOTBhZGMyYWNkYTBhNTkzZi90YWJsZXJhbmdlOjk2YTNjNTY2MjRjMDRjYmI5MGFkYzJhY2RhMGE1OTNmXzYtNC0xLTEtMA_c6b36a07-0e3b-46d0-b001-a450fc0f0483">116,568</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo5NmEzYzU2NjI0YzA0Y2JiOTBhZGMyYWNkYTBhNTkzZi90YWJsZXJhbmdlOjk2YTNjNTY2MjRjMDRjYmI5MGFkYzJhY2RhMGE1OTNmXzYtNi0xLTEtMA_581092b6-f0e6-4ea2-a420-dbc76e57ef25">88,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo5NmEzYzU2NjI0YzA0Y2JiOTBhZGMyYWNkYTBhNTkzZi90YWJsZXJhbmdlOjk2YTNjNTY2MjRjMDRjYmI5MGFkYzJhY2RhMGE1OTNmXzgtMi0xLTEtMA_bfc1e11d-7ddf-4221-a8bc-30495c085adb">7,019</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo5NmEzYzU2NjI0YzA0Y2JiOTBhZGMyYWNkYTBhNTkzZi90YWJsZXJhbmdlOjk2YTNjNTY2MjRjMDRjYmI5MGFkYzJhY2RhMGE1OTNmXzgtNC0xLTEtMA_b31e76c3-dde0-401b-8a91-a7750bd3bd7e">14,126</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo5NmEzYzU2NjI0YzA0Y2JiOTBhZGMyYWNkYTBhNTkzZi90YWJsZXJhbmdlOjk2YTNjNTY2MjRjMDRjYmI5MGFkYzJhY2RhMGE1OTNmXzgtNi0xLTEtMA_2e658a17-e52f-4d22-9636-d16fd46a569b">4,826</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo5NmEzYzU2NjI0YzA0Y2JiOTBhZGMyYWNkYTBhNTkzZi90YWJsZXJhbmdlOjk2YTNjNTY2MjRjMDRjYmI5MGFkYzJhY2RhMGE1OTNmXzktMi0xLTEtMA_ae606d0e-77fe-404a-9d85-866ffc1631f8">503</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo5NmEzYzU2NjI0YzA0Y2JiOTBhZGMyYWNkYTBhNTkzZi90YWJsZXJhbmdlOjk2YTNjNTY2MjRjMDRjYmI5MGFkYzJhY2RhMGE1OTNmXzktNC0xLTEtMA_f330f4e5-a91d-4fcc-a1a8-6bf9573b6ce0">2,863</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo5NmEzYzU2NjI0YzA0Y2JiOTBhZGMyYWNkYTBhNTkzZi90YWJsZXJhbmdlOjk2YTNjNTY2MjRjMDRjYmI5MGFkYzJhY2RhMGE1OTNmXzktNi0xLTEtMA_487e080c-c1c9-4090-bd8f-270ebc728fb8">269</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo5NmEzYzU2NjI0YzA0Y2JiOTBhZGMyYWNkYTBhNTkzZi90YWJsZXJhbmdlOjk2YTNjNTY2MjRjMDRjYmI5MGFkYzJhY2RhMGE1OTNmXzEwLTItMS0xLTA_ef8598fb-78dd-43f2-b6dc-d704c056eb33">4,086</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo5NmEzYzU2NjI0YzA0Y2JiOTBhZGMyYWNkYTBhNTkzZi90YWJsZXJhbmdlOjk2YTNjNTY2MjRjMDRjYmI5MGFkYzJhY2RhMGE1OTNmXzEwLTQtMS0xLTA_7cfb136f-8652-4db4-8f61-23a50f90dca5">19,725</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo5NmEzYzU2NjI0YzA0Y2JiOTBhZGMyYWNkYTBhNTkzZi90YWJsZXJhbmdlOjk2YTNjNTY2MjRjMDRjYmI5MGFkYzJhY2RhMGE1OTNmXzEwLTYtMS0xLTA_24ca264a-c54d-4840-80f8-46f9521cff9f">931</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo5NmEzYzU2NjI0YzA0Y2JiOTBhZGMyYWNkYTBhNTkzZi90YWJsZXJhbmdlOjk2YTNjNTY2MjRjMDRjYmI5MGFkYzJhY2RhMGE1OTNmXzExLTItMS0xLTA_5e261b0d-3fd2-4151-a44c-32f20cdce95e">3,436</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo5NmEzYzU2NjI0YzA0Y2JiOTBhZGMyYWNkYTBhNTkzZi90YWJsZXJhbmdlOjk2YTNjNTY2MjRjMDRjYmI5MGFkYzJhY2RhMGE1OTNmXzExLTQtMS0xLTA_0165fdc9-fa98-40b3-97f6-0da43f70af1c">36,714</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo5NmEzYzU2NjI0YzA0Y2JiOTBhZGMyYWNkYTBhNTkzZi90YWJsZXJhbmdlOjk2YTNjNTY2MjRjMDRjYmI5MGFkYzJhY2RhMGE1OTNmXzExLTYtMS0xLTA_57dd3967-b0bf-439e-b701-2501f079abec">6,026</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo5NmEzYzU2NjI0YzA0Y2JiOTBhZGMyYWNkYTBhNTkzZi90YWJsZXJhbmdlOjk2YTNjNTY2MjRjMDRjYmI5MGFkYzJhY2RhMGE1OTNmXzEyLTItMS0xLTA_b918dc7a-b8e9-49cc-ab33-44c855f57d12">157,810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo5NmEzYzU2NjI0YzA0Y2JiOTBhZGMyYWNkYTBhNTkzZi90YWJsZXJhbmdlOjk2YTNjNTY2MjRjMDRjYmI5MGFkYzJhY2RhMGE1OTNmXzEyLTQtMS0xLTA_904d1ff7-db89-4487-a5e9-e04ec4d36926">79,854</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo5NmEzYzU2NjI0YzA0Y2JiOTBhZGMyYWNkYTBhNTkzZi90YWJsZXJhbmdlOjk2YTNjNTY2MjRjMDRjYmI5MGFkYzJhY2RhMGE1OTNmXzEyLTYtMS0xLTA_68b3b25e-ee2c-456f-a2f1-e5c8cc45c422">94,426</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90ZXh0cmVnaW9uOjk2Y2VlMWJjZmEwNDRkMTc5MDEwMDVkMTk1MTExYmFjXzY1OTM_b556150a-33d4-418f-980c-8300767c4304" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes differs from the amounts computed by applying the statutory federal income tax rate as follows:</span><span style="font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%"></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:58.490%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. federal statutory rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxMDQwMGE1N2VmMmY0YjU2OGMzNDk4NTAwOTIyN2YwNS90YWJsZXJhbmdlOjEwNDAwYTU3ZWYyZjRiNTY4YzM0OTg1MDA5MjI3ZjA1XzMtMi0xLTEtMA_aec978db-87bf-4e9d-8afe-90765209e510">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxMDQwMGE1N2VmMmY0YjU2OGMzNDk4NTAwOTIyN2YwNS90YWJsZXJhbmdlOjEwNDAwYTU3ZWYyZjRiNTY4YzM0OTg1MDA5MjI3ZjA1XzMtNC0xLTEtMA_54748e5c-e2ad-43bd-b5e5-75d25815ab02">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxMDQwMGE1N2VmMmY0YjU2OGMzNDk4NTAwOTIyN2YwNS90YWJsZXJhbmdlOjEwNDAwYTU3ZWYyZjRiNTY4YzM0OTg1MDA5MjI3ZjA1XzMtNi0xLTEtMA_3be39fbf-c64b-4aa1-9089-cf209a2da3f8">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State income tax, net of federal tax benefit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxMDQwMGE1N2VmMmY0YjU2OGMzNDk4NTAwOTIyN2YwNS90YWJsZXJhbmdlOjEwNDAwYTU3ZWYyZjRiNTY4YzM0OTg1MDA5MjI3ZjA1XzQtMi0xLTEtMA_38204ef9-263c-4053-9c67-7c69a5ad4ecb">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxMDQwMGE1N2VmMmY0YjU2OGMzNDk4NTAwOTIyN2YwNS90YWJsZXJhbmdlOjEwNDAwYTU3ZWYyZjRiNTY4YzM0OTg1MDA5MjI3ZjA1XzQtNC0xLTEtMA_a7d241a6-dc77-41cc-b904-dd8deb79bd65">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxMDQwMGE1N2VmMmY0YjU2OGMzNDk4NTAwOTIyN2YwNS90YWJsZXJhbmdlOjEwNDAwYTU3ZWYyZjRiNTY4YzM0OTg1MDA5MjI3ZjA1XzQtNi0xLTEtMA_892dddea-65e7-4aae-bcd7-893afe5fe88a">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taxation on international earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxMDQwMGE1N2VmMmY0YjU2OGMzNDk4NTAwOTIyN2YwNS90YWJsZXJhbmdlOjEwNDAwYTU3ZWYyZjRiNTY4YzM0OTg1MDA5MjI3ZjA1XzUtMi0xLTEtMA_a00837db-a6c9-43cb-9c71-bf796feaaa99">0.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxMDQwMGE1N2VmMmY0YjU2OGMzNDk4NTAwOTIyN2YwNS90YWJsZXJhbmdlOjEwNDAwYTU3ZWYyZjRiNTY4YzM0OTg1MDA5MjI3ZjA1XzUtNC0xLTEtMA_2a5f84d8-2cc4-4332-a349-93cdd496be35">1.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxMDQwMGE1N2VmMmY0YjU2OGMzNDk4NTAwOTIyN2YwNS90YWJsZXJhbmdlOjEwNDAwYTU3ZWYyZjRiNTY4YzM0OTg1MDA5MjI3ZjA1XzUtNi0xLTEtMA_25782b06-e7ba-4322-b59d-fcee499cd413">1.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign derived intangible income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="3" name="idxx:EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxMDQwMGE1N2VmMmY0YjU2OGMzNDk4NTAwOTIyN2YwNS90YWJsZXJhbmdlOjEwNDAwYTU3ZWYyZjRiNTY4YzM0OTg1MDA5MjI3ZjA1XzYtMi0xLTEtMA_366c7c44-306f-41a1-977c-a8cd81552dba">1.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="3" name="idxx:EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxMDQwMGE1N2VmMmY0YjU2OGMzNDk4NTAwOTIyN2YwNS90YWJsZXJhbmdlOjEwNDAwYTU3ZWYyZjRiNTY4YzM0OTg1MDA5MjI3ZjA1XzYtNC0xLTEtMA_9d97ba4a-c5b1-484d-a58a-69daf1268c07">1.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="3" name="idxx:EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxMDQwMGE1N2VmMmY0YjU2OGMzNDk4NTAwOTIyN2YwNS90YWJsZXJhbmdlOjEwNDAwYTU3ZWYyZjRiNTY4YzM0OTg1MDA5MjI3ZjA1XzYtNi0xLTEtMA_731ae5ff-572d-469e-966c-8f8c03c25ecc">1.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation from settlements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxMDQwMGE1N2VmMmY0YjU2OGMzNDk4NTAwOTIyN2YwNS90YWJsZXJhbmdlOjEwNDAwYTU3ZWYyZjRiNTY4YzM0OTg1MDA5MjI3ZjA1XzctMi0xLTEtMA_cdb0b33a-9286-4568-a2e1-0fea98e89084">3.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxMDQwMGE1N2VmMmY0YjU2OGMzNDk4NTAwOTIyN2YwNS90YWJsZXJhbmdlOjEwNDAwYTU3ZWYyZjRiNTY4YzM0OTg1MDA5MjI3ZjA1XzctNC0xLTEtMA_cbea06b7-eccd-46a4-87a5-534145e09f6e">5.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxMDQwMGE1N2VmMmY0YjU2OGMzNDk4NTAwOTIyN2YwNS90YWJsZXJhbmdlOjEwNDAwYTU3ZWYyZjRiNTY4YzM0OTg1MDA5MjI3ZjA1XzctNi0xLTEtMA_fdc35f73-785a-4042-b7f0-2db2b77b8acd">3.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development credit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxMDQwMGE1N2VmMmY0YjU2OGMzNDk4NTAwOTIyN2YwNS90YWJsZXJhbmdlOjEwNDAwYTU3ZWYyZjRiNTY4YzM0OTg1MDA5MjI3ZjA1XzgtMi0xLTEtMA_49b4f9a1-7e11-4eac-b748-37a13f5cd171">0.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxMDQwMGE1N2VmMmY0YjU2OGMzNDk4NTAwOTIyN2YwNS90YWJsZXJhbmdlOjEwNDAwYTU3ZWYyZjRiNTY4YzM0OTg1MDA5MjI3ZjA1XzgtNC0xLTEtMA_f226998f-f4fb-47e1-8355-6ebf5c76a537">0.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxMDQwMGE1N2VmMmY0YjU2OGMzNDk4NTAwOTIyN2YwNS90YWJsZXJhbmdlOjEwNDAwYTU3ZWYyZjRiNTY4YzM0OTg1MDA5MjI3ZjA1XzgtNi0xLTEtMA_41026c3f-4240-4de6-9789-b61660dfea75">0.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impact of Switzerland tax reform</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="3" name="idxx:EffectiveIncomeTaxRateReconciliationSwitzerlandTaxReformEffectPercent" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxMDQwMGE1N2VmMmY0YjU2OGMzNDk4NTAwOTIyN2YwNS90YWJsZXJhbmdlOjEwNDAwYTU3ZWYyZjRiNTY4YzM0OTg1MDA5MjI3ZjA1XzktMi0xLTEtMA_3469ba26-90a0-4fd0-9e5a-be7ce62ed515">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="3" sign="-" name="idxx:EffectiveIncomeTaxRateReconciliationSwitzerlandTaxReformEffectPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxMDQwMGE1N2VmMmY0YjU2OGMzNDk4NTAwOTIyN2YwNS90YWJsZXJhbmdlOjEwNDAwYTU3ZWYyZjRiNTY4YzM0OTg1MDA5MjI3ZjA1XzktNC0xLTEtMA_7633077f-677a-4f0b-947f-b9f143ae34bd">3.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="3" name="idxx:EffectiveIncomeTaxRateReconciliationSwitzerlandTaxReformEffectPercent" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxMDQwMGE1N2VmMmY0YjU2OGMzNDk4NTAwOTIyN2YwNS90YWJsZXJhbmdlOjEwNDAwYTU3ZWYyZjRiNTY4YzM0OTg1MDA5MjI3ZjA1XzktNi0xLTEtMA_e457b743-f47b-43fa-bbb7-5015ccb2aacd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxMDQwMGE1N2VmMmY0YjU2OGMzNDk4NTAwOTIyN2YwNS90YWJsZXJhbmdlOjEwNDAwYTU3ZWYyZjRiNTY4YzM0OTg1MDA5MjI3ZjA1XzExLTItMS0xLTA_deffb944-f5e4-4a45-b7d9-df1111efafc9">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxMDQwMGE1N2VmMmY0YjU2OGMzNDk4NTAwOTIyN2YwNS90YWJsZXJhbmdlOjEwNDAwYTU3ZWYyZjRiNTY4YzM0OTg1MDA5MjI3ZjA1XzExLTQtMS0xLTA_8a205aba-4ab4-4e2d-9b43-85ce41193377">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxMDQwMGE1N2VmMmY0YjU2OGMzNDk4NTAwOTIyN2YwNS90YWJsZXJhbmdlOjEwNDAwYTU3ZWYyZjRiNTY4YzM0OTg1MDA5MjI3ZjA1XzExLTYtMS0xLTA_d6c98923-ebab-4a89-9be0-e18693401fcb">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxMDQwMGE1N2VmMmY0YjU2OGMzNDk4NTAwOTIyN2YwNS90YWJsZXJhbmdlOjEwNDAwYTU3ZWYyZjRiNTY4YzM0OTg1MDA5MjI3ZjA1XzEyLTItMS0xLTA_4a63e4e3-5806-498c-a17d-40a8ea0d449d">17.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxMDQwMGE1N2VmMmY0YjU2OGMzNDk4NTAwOTIyN2YwNS90YWJsZXJhbmdlOjEwNDAwYTU3ZWYyZjRiNTY4YzM0OTg1MDA5MjI3ZjA1XzEyLTQtMS0xLTA_4711924c-8612-4df1-8e50-2eb1c48e2e9e">12.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxMDQwMGE1N2VmMmY0YjU2OGMzNDk4NTAwOTIyN2YwNS90YWJsZXJhbmdlOjEwNDAwYTU3ZWYyZjRiNTY4YzM0OTg1MDA5MjI3ZjA1XzEyLTYtMS0xLTA_9c836bcf-8391-49f1-81f8-4d7e2d98b9e5">18.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div style="padding-left:27pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our effective income tax rate was <ix:nonFraction unitRef="number" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90ZXh0cmVnaW9uOjk2Y2VlMWJjZmEwNDRkMTc5MDEwMDVkMTk1MTExYmFjXzIzMjI_27cf2dc9-6fd4-40b6-8097-89e9139d04bb">17.5</ix:nonFraction>% for the year ended December 31, 2021, and <ix:nonFraction unitRef="number" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90ZXh0cmVnaW9uOjk2Y2VlMWJjZmEwNDRkMTc5MDEwMDVkMTk1MTExYmFjXzIzNTI_8f9edcc7-e163-4cff-b777-7181a02d8fc8">12.1</ix:nonFraction>% for the year ended December 31, 2020. Our effective income tax rate for the year ended December 31, 2021, was higher primarily due to the prior year one-time positive impact related to the enactment of tax reform in Switzerland due to recording a deferred tax asset related to the transitional benefits, as well as higher tax benefits in the prior year related to share-based compensation.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective income tax rate was <ix:nonFraction unitRef="number" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90ZXh0cmVnaW9uOjk2Y2VlMWJjZmEwNDRkMTc5MDEwMDVkMTk1MTExYmFjXzI3MzU_8f9edcc7-e163-4cff-b777-7181a02d8fc8">12.1</ix:nonFraction>% for the year ended December 31, 2020, and <ix:nonFraction unitRef="number" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90ZXh0cmVnaW9uOjk2Y2VlMWJjZmEwNDRkMTc5MDEwMDVkMTk1MTExYmFjXzI3NjU_94495aaf-78b0-465c-a594-7c7e32cf3492">18.1</ix:nonFraction>% for the year ended December 31, 2019. Our effective income tax rate for the year ended December 31, 2020, was lower primarily due to the one-time positive impact related to the enactment of tax reform in Switzerland due to recording a deferred tax asset related to the transitional benefits, as well as higher tax benefits related to share-based compensation. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes paid, net of refunds received, for the periods ended December 31, 2021, 2020, and 2019, were $<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-5" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90ZXh0cmVnaW9uOjk2Y2VlMWJjZmEwNDRkMTc5MDEwMDVkMTk1MTExYmFjXzMxNDQ_25fb71fa-7198-4be0-85bc-6174b3f67a17">161.7</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-5" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90ZXh0cmVnaW9uOjk2Y2VlMWJjZmEwNDRkMTc5MDEwMDVkMTk1MTExYmFjXzMxNDg_f45b4ef8-5afb-4118-b45c-b90ac792e232">110.7</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-5" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90ZXh0cmVnaW9uOjk2Y2VlMWJjZmEwNDRkMTc5MDEwMDVkMTk1MTExYmFjXzMxNTY_dd7d93ed-d0c2-4866-8597-71ccad058621">88.0</ix:nonFraction> million, respectively.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have received a tax ruling from the Netherlands that documents our mutual understanding of how existing tax laws apply to our circumstances. Primarily as a result of this tax ruling, our net income was higher by $<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-5" name="us-gaap:IncomeTaxHolidayAggregateDollarAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90ZXh0cmVnaW9uOjk2Y2VlMWJjZmEwNDRkMTc5MDEwMDVkMTk1MTExYmFjXzQwMjk_cd72edd8-938e-476b-9f28-fd610c4b3123">21.4</ix:nonFraction> million,&#160;$<ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-5" name="us-gaap:IncomeTaxHolidayAggregateDollarAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90ZXh0cmVnaW9uOjk2Y2VlMWJjZmEwNDRkMTc5MDEwMDVkMTk1MTExYmFjXzQwMzM_64031fb2-9101-412a-acd4-0e9512e1e70b">14.2</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-5" name="us-gaap:IncomeTaxHolidayAggregateDollarAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90ZXh0cmVnaW9uOjk2Y2VlMWJjZmEwNDRkMTc5MDEwMDVkMTk1MTExYmFjXzQwNDE_5db6af6a-ba19-4c07-b075-3b3a1748577c">13.7</ix:nonFraction> million for the years ended December 31, 2021, 2020,&#160;and&#160;2019, respectively. The benefits from our tax rulings are reflected within the overall benefits received from taxation on international earnings in the table above. On December 21, 2021, </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i7a26419dbfed437699fcdc1c3cc0fb46" continuedAt="i5dbb9b44bb4945c9825047d7ab8ce1ab"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">the Netherlands adopted legislation eliminating the tax benefits related to this tax ruling for tax years beginning after December 31, 2021. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90ZXh0cmVnaW9uOjk2Y2VlMWJjZmEwNDRkMTc5MDEwMDVkMTk1MTExYmFjXzY1OTg_157b94e3-bad6-4c4a-9e89-9a234217356b" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the net deferred tax assets (liabilities) included in the accompanying consolidated balance sheets are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:66.594%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.318%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.320%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzMtMi0xLTEtMA_a91e0df4-380f-4bac-b52f-5d6ca566b743">48,433</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzMtNC0xLTEtMA_f9410c94-7af9-4345-8455-9665d1f1af89">46,830</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable reserves</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzQtMi0xLTEtMA_e9afac53-704f-46a3-b2e3-c8c1adbd7926">2,131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzQtNC0xLTEtMA_192279b1-80a8-4165-b69c-54daed39b8ad">2,505</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsDeferredIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzUtMi0xLTEtMA_39431c7c-3b23-49d1-a61b-3ccf7e42480f">6,269</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsDeferredIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzUtNC0xLTEtMA_d2114fbe-4615-4491-97c8-4d759807f26c">7,629</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventory basis differences</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsInventory" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzYtMi0xLTEtMA_86f19db6-7ae4-4f90-a53d-683d842667dd">6,553</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsInventory" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzYtNC0xLTEtMA_e73be908-a144-4267-a149-ae6715bf2774">4,272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property-based differences</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzctMi0xLTEtMA_0829ff08-112c-499c-9d5b-f8aa517749f2">16,132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzctNC0xLTEtMA_a7f6f99a-3f46-41ef-b286-f26a1ba1f2d0">14,865</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible asset basis differences</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="idxx:DeferredTaxAssetsIntangibleAssetsBasisDifference" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzgtMi0xLTEtMA_c4e0b31e-62a4-4710-94c1-6631c5c370f3">46,606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="idxx:DeferredTaxAssetsIntangibleAssetsBasisDifference" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzgtNC0xLTEtMA_222d0cf5-e34a-4f97-82f0-1aad01d6abe5">51,319</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzktMi0xLTEtMA_a666453e-eb7d-4706-b272-3ae43a5295a4">10,740</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzktNC0xLTEtMA_fbe58b06-74c9-4adf-9665-a7c716a4cfbb">10,011</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzEwLTItMS0xLTA_ee9495aa-7ef0-4659-9af1-fbb48c30e338">1,163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzEwLTQtMS0xLTA_989b5e49-ece3-4930-a25c-e834317429fa">1,484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzExLTItMS0xLTA_63736df1-323f-49ae-af9c-076667ecf700">8,570</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzExLTQtMS0xLTA_0e50c294-fb49-4730-9ed1-049da1abf537">5,427</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax credit carryforwards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzEyLTItMS0xLTA_300127bd-8f5e-4a40-b93a-1f71f438a10f">13,483</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzEyLTQtMS0xLTA_14f37836-89eb-4051-bf1e-d2aa1177ca8a">13,385</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized losses on foreign currency exchange contracts and investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsOtherComprehensiveLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzEzLTItMS0xLTA_7be52536-5574-49e8-a9be-df5f101e5576">1,755</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsOtherComprehensiveLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzEzLTQtMS0xLTA_89adb518-faa9-4bcf-bdbb-fd0577e38256">5,060</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzE0LTItMS0xLTA_60534b96-3a2b-49b1-b84e-685d237c6943">161,835</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzE0LTQtMS0xLTA_5a0a4320-071e-4ea1-a8e9-8b83b5d655fc">162,787</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzE1LTItMS0xLTA_14de3c47-30b3-4ca9-b4eb-c420ee96ee93">39,280</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzE1LTQtMS0xLTA_fe97b850-a5e2-423a-95cc-a1aecfcddf73">40,262</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets, net of valuation allowance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzE2LTItMS0xLTA_13633e92-365d-4c0a-82d6-dc935fc45f38">122,555</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzE2LTQtMS0xLTA_b8b22ddb-b204-4a6d-9401-a8f83ae9b141">122,525</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7.75pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer acquisition costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzE5LTItMS0xLTA_e2119af7-a3f9-467a-a9b0-df6fe68ada4e">37,265</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzE5LTQtMS0xLTA_74a70c97-afa5-4676-bf2c-597856aed84c">34,449</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property-based differences</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzIwLTItMS0xLTA_78cd4382-a003-47c9-9223-41f49d7c1061">42,363</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzIwLTQtMS0xLTA_ceecfcb2-8127-464b-9eba-6bd4c4ddc4cf">49,547</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible asset basis differences</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzIxLTItMS0xLTA_74cd986a-89ec-4e14-9d2a-f48ee598f4c8">17,345</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzIxLTQtMS0xLTA_b899ecde-ba53-4aca-ad1f-0013b8555705">16,134</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzIyLTItMS0xLTA_9eca6a45-1949-4703-9510-d27082183da9">5,662</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzIyLTQtMS0xLTA_25be063a-9d9c-49ae-8d91-e77547644b59">2,241</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized gains on foreign currency exchange contracts and investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzIzLTItMS0xLTA_9189fd69-0c6a-4e96-93d3-fe8020959b93">4,071</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzIzLTQtMS0xLTA_15ef3e35-ee79-4fd7-93f9-1931a5980d62">312</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzI0LTItMS0xLTA_a4570cd5-ec52-42db-b779-cc957beacf03">106,706</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzI0LTQtMS0xLTA_c9177bbd-15b7-4228-bca2-653f997f83ac">102,683</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net deferred tax assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzI1LTItMS0xLTA_5f73a5f7-d827-4aca-8b97-8ef655ccf006">15,849</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzI1LTQtMS0xLTA_fd58df0a-c86e-442e-83b3-706864ed255d">19,842</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, we record valuation allowances against certain deferred tax assets related to temporary differences, including intangible asset basis differences and net operating loss (&#8220;NOL&#8221;) and tax credit carryforwards, as it is more likely than not that they will not be realized or utilized within the carryforward period.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:SummaryOfValuationAllowanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90ZXh0cmVnaW9uOjk2Y2VlMWJjZmEwNDRkMTc5MDEwMDVkMTk1MTExYmFjXzY1ODE_cee0886a-abee-4d8b-b851-8aa1a82ed929" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in valuation allowance for deferred tax assets:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:58.490%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1YTI4ODAxZmJjNjk0NTEyOTU0YzYwM2YzNTYwODhlYi90YWJsZXJhbmdlOjVhMjg4MDFmYmM2OTQ1MTI5NTRjNjAzZjM1NjA4OGViXzMtMi0xLTEtMA_e2a29535-765b-4c2d-be6c-4250b4338510">40,262</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c634b937c58472e84857eacf99e17df_I20191231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1YTI4ODAxZmJjNjk0NTEyOTU0YzYwM2YzNTYwODhlYi90YWJsZXJhbmdlOjVhMjg4MDFmYmM2OTQ1MTI5NTRjNjAzZjM1NjA4OGViXzMtNC0xLTEtMA_6e023e8c-6db2-40ce-8066-b6ff04bec888">9,454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28d0821cac8841b29cf960002d3bc993_I20181231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1YTI4ODAxZmJjNjk0NTEyOTU0YzYwM2YzNTYwODhlYi90YWJsZXJhbmdlOjVhMjg4MDFmYmM2OTQ1MTI5NTRjNjAzZjM1NjA4OGViXzMtNi0xLTEtMA_9c712a6b-9143-4ec2-90cd-fa8ff52c59c2">6,212</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Charges to costs and expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="idxx:DeferredTaxAssetsValuationAllowanceChargesToCostsAndExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1YTI4ODAxZmJjNjk0NTEyOTU0YzYwM2YzNTYwODhlYi90YWJsZXJhbmdlOjVhMjg4MDFmYmM2OTQ1MTI5NTRjNjAzZjM1NjA4OGViXzQtMi0xLTEtMA_bd62b46d-dd4b-4af6-9da5-8a258765e99a">1,464</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="idxx:DeferredTaxAssetsValuationAllowanceChargesToCostsAndExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1YTI4ODAxZmJjNjk0NTEyOTU0YzYwM2YzNTYwODhlYi90YWJsZXJhbmdlOjVhMjg4MDFmYmM2OTQ1MTI5NTRjNjAzZjM1NjA4OGViXzQtNC0xLTEtMA_3c62e9b1-9113-443a-b912-404addc10814">31,076</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="idxx:DeferredTaxAssetsValuationAllowanceChargesToCostsAndExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1YTI4ODAxZmJjNjk0NTEyOTU0YzYwM2YzNTYwODhlYi90YWJsZXJhbmdlOjVhMjg4MDFmYmM2OTQ1MTI5NTRjNjAzZjM1NjA4OGViXzQtNi0xLTEtMA_ae3f1a15-5d7e-4450-8baf-8f9837a4fd53">3,489</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Write-off/cash payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="idxx:DeferredTaxAssetsValuationAllowanceWriteOffCashPayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1YTI4ODAxZmJjNjk0NTEyOTU0YzYwM2YzNTYwODhlYi90YWJsZXJhbmdlOjVhMjg4MDFmYmM2OTQ1MTI5NTRjNjAzZjM1NjA4OGViXzUtMi0xLTEtMA_eece8492-cfef-411a-ba62-aa020b1ef34f">1,182</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="idxx:DeferredTaxAssetsValuationAllowanceWriteOffCashPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1YTI4ODAxZmJjNjk0NTEyOTU0YzYwM2YzNTYwODhlYi90YWJsZXJhbmdlOjVhMjg4MDFmYmM2OTQ1MTI5NTRjNjAzZjM1NjA4OGViXzUtNC0xLTEtMA_6553c0fd-7845-4284-a8f0-9b1c3089d51e">34</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="idxx:DeferredTaxAssetsValuationAllowanceWriteOffCashPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1YTI4ODAxZmJjNjk0NTEyOTU0YzYwM2YzNTYwODhlYi90YWJsZXJhbmdlOjVhMjg4MDFmYmM2OTQ1MTI5NTRjNjAzZjM1NjA4OGViXzUtNi0xLTEtMA_d9569f93-ace5-4986-9068-1b6d0aaf143d">226</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" sign="-" name="idxx:DeferredTaxAssetsValuationAllowanceForeignCurrencyTranslation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1YTI4ODAxZmJjNjk0NTEyOTU0YzYwM2YzNTYwODhlYi90YWJsZXJhbmdlOjVhMjg4MDFmYmM2OTQ1MTI5NTRjNjAzZjM1NjA4OGViXzYtMi0xLTEtMA_240f53df-1899-4483-9eb4-a2f1eb601902">1,264</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" sign="-" name="idxx:DeferredTaxAssetsValuationAllowanceForeignCurrencyTranslation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1YTI4ODAxZmJjNjk0NTEyOTU0YzYwM2YzNTYwODhlYi90YWJsZXJhbmdlOjVhMjg4MDFmYmM2OTQ1MTI5NTRjNjAzZjM1NjA4OGViXzYtNC0xLTEtMA_c5e72708-d201-46a2-bf32-eb0e1527306c">234</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" sign="-" name="idxx:DeferredTaxAssetsValuationAllowanceForeignCurrencyTranslation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1YTI4ODAxZmJjNjk0NTEyOTU0YzYwM2YzNTYwODhlYi90YWJsZXJhbmdlOjVhMjg4MDFmYmM2OTQ1MTI5NTRjNjAzZjM1NjA4OGViXzYtNi0xLTEtMA_0445d857-d838-425f-ab0e-6fd6cf691281">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at the end of the year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1YTI4ODAxZmJjNjk0NTEyOTU0YzYwM2YzNTYwODhlYi90YWJsZXJhbmdlOjVhMjg4MDFmYmM2OTQ1MTI5NTRjNjAzZjM1NjA4OGViXzctMi0xLTEtMA_4e78cf33-48a4-4c77-903d-03d50c096138">39,280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1YTI4ODAxZmJjNjk0NTEyOTU0YzYwM2YzNTYwODhlYi90YWJsZXJhbmdlOjVhMjg4MDFmYmM2OTQ1MTI5NTRjNjAzZjM1NjA4OGViXzctNC0xLTEtMA_25c5e502-3bf2-41fd-8130-cd09b76e193c">40,262</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c634b937c58472e84857eacf99e17df_I20191231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1YTI4ODAxZmJjNjk0NTEyOTU0YzYwM2YzNTYwODhlYi90YWJsZXJhbmdlOjVhMjg4MDFmYmM2OTQ1MTI5NTRjNjAzZjM1NjA4OGViXzctNi0xLTEtMA_4912c357-3456-4673-896c-45808edda1a3">9,454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, we have NOLs in certain state and international jurisdictions of approximately $<ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90ZXh0cmVnaW9uOjk2Y2VlMWJjZmEwNDRkMTc5MDEwMDVkMTk1MTExYmFjXzQ4OTI_e24d4876-0df7-4826-9182-77a687488309">32.9</ix:nonFraction> million available to offset future taxable income. Most of these NOLs will expire at various dates between 2022 and 2028 and the remainder have indefinite lives.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i5dbb9b44bb4945c9825047d7ab8ce1ab"><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:SummaryOfIncomeTaxContingenciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90ZXh0cmVnaW9uOjk2Y2VlMWJjZmEwNDRkMTc5MDEwMDVkMTk1MTExYmFjXzY1ODQ_059fba6f-5407-42b0-8a85-e7bd0c06b426" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in unrecognized tax positions:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:58.490%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total amounts of unrecognized tax benefits, beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxYWZjOWIwYWZkNDg0N2I4YTRhNjY3NDQxNTU0OWUyZS90YWJsZXJhbmdlOjFhZmM5YjBhZmQ0ODQ3YjhhNGE2Njc0NDE1NTQ5ZTJlXzMtMi0xLTEtMA_37888f2e-1c44-4775-ba53-42ec9143c9bd">22,484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c634b937c58472e84857eacf99e17df_I20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxYWZjOWIwYWZkNDg0N2I4YTRhNjY3NDQxNTU0OWUyZS90YWJsZXJhbmdlOjFhZmM5YjBhZmQ0ODQ3YjhhNGE2Njc0NDE1NTQ5ZTJlXzMtNC0xLTEtMA_d51f6848-1fbd-4d95-8143-550386e06103">26,841</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28d0821cac8841b29cf960002d3bc993_I20181231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxYWZjOWIwYWZkNDg0N2I4YTRhNjY3NDQxNTU0OWUyZS90YWJsZXJhbmdlOjFhZmM5YjBhZmQ0ODQ3YjhhNGE2Njc0NDE1NTQ5ZTJlXzMtNi0xLTEtMA_47408862-956c-40c1-abb7-a590705b59c2">24,247</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross increases (decreases) in unrecognized tax positions as a result of tax positions taken during a prior period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxYWZjOWIwYWZkNDg0N2I4YTRhNjY3NDQxNTU0OWUyZS90YWJsZXJhbmdlOjFhZmM5YjBhZmQ0ODQ3YjhhNGE2Njc0NDE1NTQ5ZTJlXzQtMi0xLTEtMA_cc5d6d2f-81ff-4f68-a02c-39287347b1cf">443</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxYWZjOWIwYWZkNDg0N2I4YTRhNjY3NDQxNTU0OWUyZS90YWJsZXJhbmdlOjFhZmM5YjBhZmQ0ODQ3YjhhNGE2Njc0NDE1NTQ5ZTJlXzQtNC0xLTEtMA_d3fe1adb-8ed1-47b8-bc4e-509f5f697718">1,755</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxYWZjOWIwYWZkNDg0N2I4YTRhNjY3NDQxNTU0OWUyZS90YWJsZXJhbmdlOjFhZmM5YjBhZmQ0ODQ3YjhhNGE2Njc0NDE1NTQ5ZTJlXzQtNi0xLTEtMA_b973e2ed-c37c-4015-bc7c-a42f57a4d155">276</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross increases in unrecognized tax positions as a result of tax positions taken in the current period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxYWZjOWIwYWZkNDg0N2I4YTRhNjY3NDQxNTU0OWUyZS90YWJsZXJhbmdlOjFhZmM5YjBhZmQ0ODQ3YjhhNGE2Njc0NDE1NTQ5ZTJlXzUtMi0xLTEtMA_6c61af83-c09a-4c26-976f-dda291d4e2b0">2,414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxYWZjOWIwYWZkNDg0N2I4YTRhNjY3NDQxNTU0OWUyZS90YWJsZXJhbmdlOjFhZmM5YjBhZmQ0ODQ3YjhhNGE2Njc0NDE1NTQ5ZTJlXzUtNC0xLTEtMA_c07d58c2-f621-4c2e-979d-2b5fef2ad16c">4,199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxYWZjOWIwYWZkNDg0N2I4YTRhNjY3NDQxNTU0OWUyZS90YWJsZXJhbmdlOjFhZmM5YjBhZmQ0ODQ3YjhhNGE2Njc0NDE1NTQ5ZTJlXzUtNi0xLTEtMA_823eb087-cd6c-42da-b420-394cb13f35db">4,083</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Decreases in unrecognized tax positions related to settlements with taxing authorities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxYWZjOWIwYWZkNDg0N2I4YTRhNjY3NDQxNTU0OWUyZS90YWJsZXJhbmdlOjFhZmM5YjBhZmQ0ODQ3YjhhNGE2Njc0NDE1NTQ5ZTJlXzYtMi0xLTEtMA_c3abec27-fd25-46b7-9352-ef2fe71fa03b">537</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxYWZjOWIwYWZkNDg0N2I4YTRhNjY3NDQxNTU0OWUyZS90YWJsZXJhbmdlOjFhZmM5YjBhZmQ0ODQ3YjhhNGE2Njc0NDE1NTQ5ZTJlXzYtNC0xLTEtMA_81235a65-6541-4c76-af85-b6d3e36da23b">6,446</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxYWZjOWIwYWZkNDg0N2I4YTRhNjY3NDQxNTU0OWUyZS90YWJsZXJhbmdlOjFhZmM5YjBhZmQ0ODQ3YjhhNGE2Njc0NDE1NTQ5ZTJlXzYtNi0xLTEtMA_df01e35e-fcad-44df-96f5-04a39b950fe6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Decreases in unrecognized tax positions as a result of a lapse of the applicable statutes of limitations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxYWZjOWIwYWZkNDg0N2I4YTRhNjY3NDQxNTU0OWUyZS90YWJsZXJhbmdlOjFhZmM5YjBhZmQ0ODQ3YjhhNGE2Njc0NDE1NTQ5ZTJlXzctMi0xLTEtMA_61f1b895-6898-489d-b6ad-ce92f813365f">3,015</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxYWZjOWIwYWZkNDg0N2I4YTRhNjY3NDQxNTU0OWUyZS90YWJsZXJhbmdlOjFhZmM5YjBhZmQ0ODQ3YjhhNGE2Njc0NDE1NTQ5ZTJlXzctNC0xLTEtMA_f2f79a2a-ccaa-4aea-8dbf-740e434d5337">355</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxYWZjOWIwYWZkNDg0N2I4YTRhNjY3NDQxNTU0OWUyZS90YWJsZXJhbmdlOjFhZmM5YjBhZmQ0ODQ3YjhhNGE2Njc0NDE1NTQ5ZTJlXzctNi0xLTEtMA_3c29033d-54b6-4071-bbac-7b3a977e9dd2">1,213</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total amounts of unrecognized tax benefits, end of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxYWZjOWIwYWZkNDg0N2I4YTRhNjY3NDQxNTU0OWUyZS90YWJsZXJhbmdlOjFhZmM5YjBhZmQ0ODQ3YjhhNGE2Njc0NDE1NTQ5ZTJlXzgtMi0xLTEtMA_f5676b33-d807-4cfa-b4b2-b86d9d48e39c">21,789</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxYWZjOWIwYWZkNDg0N2I4YTRhNjY3NDQxNTU0OWUyZS90YWJsZXJhbmdlOjFhZmM5YjBhZmQ0ODQ3YjhhNGE2Njc0NDE1NTQ5ZTJlXzgtNC0xLTEtMA_52a2ea28-57b8-470b-8dcd-9df94edf02a7">22,484</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c634b937c58472e84857eacf99e17df_I20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxYWZjOWIwYWZkNDg0N2I4YTRhNjY3NDQxNTU0OWUyZS90YWJsZXJhbmdlOjFhZmM5YjBhZmQ0ODQ3YjhhNGE2Njc0NDE1NTQ5ZTJlXzgtNi0xLTEtMA_b5deb5b1-ce00-4b85-98bc-2f1d1b08863d">26,841</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Of the total unrecognized tax benefits at December 31, 2021 and 2020, $<ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90ZXh0cmVnaW9uOjk2Y2VlMWJjZmEwNDRkMTc5MDEwMDVkMTk1MTExYmFjXzUyNzM_95b5f719-2837-44d2-a8e1-e9d1258769aa">22.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90ZXh0cmVnaW9uOjk2Y2VlMWJjZmEwNDRkMTc5MDEwMDVkMTk1MTExYmFjXzUyODA_64ca76a9-9ebb-4890-9436-ab6362abd4d4">21.8</ix:nonFraction> million, respectively, comprise unrecognized tax positions that would, if recognized, affect our effective tax rate.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December 31, 2021, 2020, and 2019, we recorded interest expense and penalties of $<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90ZXh0cmVnaW9uOjk2Y2VlMWJjZmEwNDRkMTc5MDEwMDVkMTk1MTExYmFjXzU0Nzg_daad9da0-6a47-4d36-b3dd-c87f86dd6ec2">1.1</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90ZXh0cmVnaW9uOjk2Y2VlMWJjZmEwNDRkMTc5MDEwMDVkMTk1MTExYmFjXzU0ODI_0e748207-9489-4d32-b383-09e6e2899554">1.3</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90ZXh0cmVnaW9uOjk2Y2VlMWJjZmEwNDRkMTc5MDEwMDVkMTk1MTExYmFjXzU0OTA_999d1675-f496-4102-afbb-e1fa138db1f5">1.8</ix:nonFraction> million, respectively, as income tax expense in our consolidated statement of income. At December 31, 2021, 2020, and 2019, we had $<ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90ZXh0cmVnaW9uOjk2Y2VlMWJjZmEwNDRkMTc5MDEwMDVkMTk1MTExYmFjXzU1OTY_5a972493-2f05-4af9-9c2e-e33c61d6f023">3.8</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90ZXh0cmVnaW9uOjk2Y2VlMWJjZmEwNDRkMTc5MDEwMDVkMTk1MTExYmFjXzU2MDA_05c06b2a-dce9-4263-ad89-af389a253189">3.6</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i0c634b937c58472e84857eacf99e17df_I20191231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90ZXh0cmVnaW9uOjk2Y2VlMWJjZmEwNDRkMTc5MDEwMDVkMTk1MTExYmFjXzU2MDg_ac886fbb-af46-4b1f-ba6f-654970d6d7bc">3.6</ix:nonFraction> million, respectively, of estimated interest expense and penalties accrued in our consolidated balance sheets.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of our business, our income tax filings are regularly under audit by tax authorities. While we believe we have appropriately provided for all uncertain tax positions, amounts asserted by taxing authorities could be greater or less than our accrued position. Accordingly, additional provisions on income tax matters, or reductions of previously accrued provisions, could be recorded in the future as we revise our estimates due to changing facts and circumstances or the underlying matters are settled or otherwise resolved. We are currently under tax examinations in various jurisdictions. We anticipate that these examinations will be concluded within the next two years. With few exceptions, we are no longer subject to income tax examinations in any jurisdiction in which we conduct significant taxable activities for years before 2016.</span></div></ix:continuation><div><span><br/></span></div><div id="i5d795a6851d746ca914a2ddae761c329_220"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 15.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjAvZnJhZzoxMmE3M2IwMjg3ODU0M2YxYTM2ZjAzYzJlMjhkYmQyMi90ZXh0cmVnaW9uOjEyYTczYjAyODc4NTQzZjFhMzZmMDNjMmUyOGRiZDIyXzE2Mzk_c34559b5-f0d0-432d-98e4-685d53155442" continuedAt="i7d23791add9e4a1da43a02fc4f86feb9" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EARNINGS PER SHARE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></ix:nonNumeric></div><div><span><br/></span></div><ix:continuation id="i7d23791add9e4a1da43a02fc4f86feb9" continuedAt="i965a6d7ac2964df4a7699f450d166edd"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjAvZnJhZzoxMmE3M2IwMjg3ODU0M2YxYTM2ZjAzYzJlMjhkYmQyMi90ZXh0cmVnaW9uOjEyYTczYjAyODc4NTQzZjFhMzZmMDNjMmUyOGRiZDIyXzE2MzI_c2a99c2e-2285-483d-a21b-9db233a20910" escape="true">Basic earnings per share is computed by dividing net income attributable to our stockholders by the weighted average number of shares of common stock and vested deferred stock units outstanding during the year. The computation of diluted earnings per share is similar to the computation of basic earnings per share, except that the denominator is increased for the assumed exercise of dilutive options and assumed issuance of unvested restricted stock units and unvested deferred stock units using the treasury stock method unless the effect is anti-dilutive. The treasury stock method assumes that proceeds, including cash received from the exercise of employee stock options and the&#160;total unrecognized compensation expense for unvested share-based compensation awards, would be used to purchase our common stock at the average market price during the period.&#160;Vested deferred stock units outstanding are included in shares outstanding for basic and diluted earnings per share because the associated shares of our common stock are issuable for no cash consideration, the number of shares of our common stock to be issued is fixed and issuance is not contingent. Refer to "Note 5. Share-Based Compensation" for additional information regarding deferred stock units.</ix:nonNumeric></span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjAvZnJhZzoxMmE3M2IwMjg3ODU0M2YxYTM2ZjAzYzJlMjhkYmQyMi90ZXh0cmVnaW9uOjEyYTczYjAyODc4NTQzZjFhMzZmMDNjMmUyOGRiZDIyXzE2MzM_b3d8afea-9947-42c1-9ff6-2b4331423a17" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of weighted average shares outstanding for basic and diluted earnings per share:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:58.490%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares outstanding for basic earnings per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjAvZnJhZzoxMmE3M2IwMjg3ODU0M2YxYTM2ZjAzYzJlMjhkYmQyMi90YWJsZTo4OTBkZmNlYjQ4NTU0YmFkOGYyN2U1NjI0NGIxODM0OC90YWJsZXJhbmdlOjg5MGRmY2ViNDg1NTRiYWQ4ZjI3ZTU2MjQ0YjE4MzQ4XzMtMi0xLTEtMA_c5b28276-0ad8-4cb5-a318-161feb5e3fc1">85,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjAvZnJhZzoxMmE3M2IwMjg3ODU0M2YxYTM2ZjAzYzJlMjhkYmQyMi90YWJsZTo4OTBkZmNlYjQ4NTU0YmFkOGYyN2U1NjI0NGIxODM0OC90YWJsZXJhbmdlOjg5MGRmY2ViNDg1NTRiYWQ4ZjI3ZTU2MjQ0YjE4MzQ4XzMtNC0xLTEtMA_3ec3dbea-d398-4276-8a44-6263cc2e4e05">85,342</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjAvZnJhZzoxMmE3M2IwMjg3ODU0M2YxYTM2ZjAzYzJlMjhkYmQyMi90YWJsZTo4OTBkZmNlYjQ4NTU0YmFkOGYyN2U1NjI0NGIxODM0OC90YWJsZXJhbmdlOjg5MGRmY2ViNDg1NTRiYWQ4ZjI3ZTU2MjQ0YjE4MzQ4XzMtNi0xLTEtMA_584528d1-f3b0-40dc-8751-e81c49b94f8a">86,115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares outstanding for diluted earnings per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares outstanding for basic earnings per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjAvZnJhZzoxMmE3M2IwMjg3ODU0M2YxYTM2ZjAzYzJlMjhkYmQyMi90YWJsZTo4OTBkZmNlYjQ4NTU0YmFkOGYyN2U1NjI0NGIxODM0OC90YWJsZXJhbmdlOjg5MGRmY2ViNDg1NTRiYWQ4ZjI3ZTU2MjQ0YjE4MzQ4XzYtMi0xLTEtMA_246e983e-e867-4452-b298-f0206c2c1fd1">85,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjAvZnJhZzoxMmE3M2IwMjg3ODU0M2YxYTM2ZjAzYzJlMjhkYmQyMi90YWJsZTo4OTBkZmNlYjQ4NTU0YmFkOGYyN2U1NjI0NGIxODM0OC90YWJsZXJhbmdlOjg5MGRmY2ViNDg1NTRiYWQ4ZjI3ZTU2MjQ0YjE4MzQ4XzYtNC0xLTEtMA_e883def2-519c-46c2-947d-689d57e9a3a7">85,342</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjAvZnJhZzoxMmE3M2IwMjg3ODU0M2YxYTM2ZjAzYzJlMjhkYmQyMi90YWJsZTo4OTBkZmNlYjQ4NTU0YmFkOGYyN2U1NjI0NGIxODM0OC90YWJsZXJhbmdlOjg5MGRmY2ViNDg1NTRiYWQ4ZjI3ZTU2MjQ0YjE4MzQ4XzYtNi0xLTEtMA_1f55cedb-2f50-41f9-ac82-386e9c5cb04c">86,115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive effect of share-based payment awards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjAvZnJhZzoxMmE3M2IwMjg3ODU0M2YxYTM2ZjAzYzJlMjhkYmQyMi90YWJsZTo4OTBkZmNlYjQ4NTU0YmFkOGYyN2U1NjI0NGIxODM0OC90YWJsZXJhbmdlOjg5MGRmY2ViNDg1NTRiYWQ4ZjI3ZTU2MjQ0YjE4MzQ4XzctMi0xLTEtMA_fa70cc86-1a89-45ed-980b-6077885bb617">1,372</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjAvZnJhZzoxMmE3M2IwMjg3ODU0M2YxYTM2ZjAzYzJlMjhkYmQyMi90YWJsZTo4OTBkZmNlYjQ4NTU0YmFkOGYyN2U1NjI0NGIxODM0OC90YWJsZXJhbmdlOjg5MGRmY2ViNDg1NTRiYWQ4ZjI3ZTU2MjQ0YjE4MzQ4XzctNC0xLTEtMA_d7ef67a6-51a0-4cc7-b718-059ba9e93cc9">1,380</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjAvZnJhZzoxMmE3M2IwMjg3ODU0M2YxYTM2ZjAzYzJlMjhkYmQyMi90YWJsZTo4OTBkZmNlYjQ4NTU0YmFkOGYyN2U1NjI0NGIxODM0OC90YWJsZXJhbmdlOjg5MGRmY2ViNDg1NTRiYWQ4ZjI3ZTU2MjQ0YjE4MzQ4XzctNi0xLTEtMA_0bb4fc21-617c-43f9-93dd-5411c9628187">1,427</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjAvZnJhZzoxMmE3M2IwMjg3ODU0M2YxYTM2ZjAzYzJlMjhkYmQyMi90YWJsZTo4OTBkZmNlYjQ4NTU0YmFkOGYyN2U1NjI0NGIxODM0OC90YWJsZXJhbmdlOjg5MGRmY2ViNDg1NTRiYWQ4ZjI3ZTU2MjQ0YjE4MzQ4XzgtMi0xLTEtMA_867f52b5-6081-4ebe-b466-22bf69d48429">86,572</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjAvZnJhZzoxMmE3M2IwMjg3ODU0M2YxYTM2ZjAzYzJlMjhkYmQyMi90YWJsZTo4OTBkZmNlYjQ4NTU0YmFkOGYyN2U1NjI0NGIxODM0OC90YWJsZXJhbmdlOjg5MGRmY2ViNDg1NTRiYWQ4ZjI3ZTU2MjQ0YjE4MzQ4XzgtNC0xLTEtMA_32ee942b-7464-473f-8762-332d943ea067">86,722</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjAvZnJhZzoxMmE3M2IwMjg3ODU0M2YxYTM2ZjAzYzJlMjhkYmQyMi90YWJsZTo4OTBkZmNlYjQ4NTU0YmFkOGYyN2U1NjI0NGIxODM0OC90YWJsZXJhbmdlOjg5MGRmY2ViNDg1NTRiYWQ4ZjI3ZTU2MjQ0YjE4MzQ4XzgtNi0xLTEtMA_939e26cf-cd5c-49be-a53f-f72738a543aa">87,542</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="i965a6d7ac2964df4a7699f450d166edd"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain options to acquire shares have been excluded from the calculation of shares outstanding for diluted earnings per share because they were anti-dilutive. <ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjAvZnJhZzoxMmE3M2IwMjg3ODU0M2YxYTM2ZjAzYzJlMjhkYmQyMi90ZXh0cmVnaW9uOjEyYTczYjAyODc4NTQzZjFhMzZmMDNjMmUyOGRiZDIyXzE2Mjk_53628577-87ee-4d71-883e-487c0fe79e22" continuedAt="i710e65c15b754faf88c05c617e6077c3" escape="true">The following table presents information concerning those anti-dilutive options:</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="i710e65c15b754faf88c05c617e6077c3"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:58.490%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average number of shares underlying anti-dilutive options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjAvZnJhZzoxMmE3M2IwMjg3ODU0M2YxYTM2ZjAzYzJlMjhkYmQyMi90YWJsZTphOTNmMTk3NTBlYTA0Y2Q5YTRlOWY3ZDQwYjZjNDIyNC90YWJsZXJhbmdlOmE5M2YxOTc1MGVhMDRjZDlhNGU5ZjdkNDBiNmM0MjI0XzMtMi0xLTEtMA_f7767806-5022-4639-a1bb-5be7195cacc5">121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjAvZnJhZzoxMmE3M2IwMjg3ODU0M2YxYTM2ZjAzYzJlMjhkYmQyMi90YWJsZTphOTNmMTk3NTBlYTA0Y2Q5YTRlOWY3ZDQwYjZjNDIyNC90YWJsZXJhbmdlOmE5M2YxOTc1MGVhMDRjZDlhNGU5ZjdkNDBiNmM0MjI0XzMtNC0xLTEtMA_336e5472-3e5b-4dd2-baa4-da5a9162e458">206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjAvZnJhZzoxMmE3M2IwMjg3ODU0M2YxYTM2ZjAzYzJlMjhkYmQyMi90YWJsZTphOTNmMTk3NTBlYTA0Y2Q5YTRlOWY3ZDQwYjZjNDIyNC90YWJsZXJhbmdlOmE5M2YxOTc1MGVhMDRjZDlhNGU5ZjdkNDBiNmM0MjI0XzMtNi0xLTEtMA_facf34af-7a3c-4e2a-9c0c-ebeaf77ada28">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div><span><br/></span></div><div id="i5d795a6851d746ca914a2ddae761c329_223"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 16.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:CommitmentsContingenciesAndGuaranteesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjMvZnJhZzpmNzg3MGU2OWQ2ZDc0ZTVhYWEyMzVlYmI1Y2IwNGZjYy90ZXh0cmVnaW9uOmY3ODcwZTY5ZDZkNzRlNWFhYTIzNWViYjVjYjA0ZmNjXzc1MTY_47be6efd-ba99-4db9-8b9a-2d5a20731bca" continuedAt="i537ccee06f9c4ea38b62c22ad607afd8" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COMMITMENTS, CONTINGENCIES AND GUARANTEES</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></ix:nonNumeric></div><div><span><br/></span></div><ix:continuation id="i537ccee06f9c4ea38b62c22ad607afd8" continuedAt="i6779a1ff3ff04c5b9c9b036c95d04768"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commitments</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to "Note 8. Leases" for more information regarding our lease commitments.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are required to annually purchase a minimum amount of inventory from certain suppliers. Through 2026, we have a total of $<ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-5" name="us-gaap:PurchaseObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjMvZnJhZzpmNzg3MGU2OWQ2ZDc0ZTVhYWEyMzVlYmI1Y2IwNGZjYy90ZXh0cmVnaW9uOmY3ODcwZTY5ZDZkNzRlNWFhYTIzNWViYjVjYjA0ZmNjXzIzNw_fa1fb302-06d7-4e50-81ce-295f09561d94">2.9</ix:nonFraction> million in minimum purchase commitments under these arrangements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingencies</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjMvZnJhZzpmNzg3MGU2OWQ2ZDc0ZTVhYWEyMzVlYmI1Y2IwNGZjYy90ZXh0cmVnaW9uOmY3ODcwZTY5ZDZkNzRlNWFhYTIzNWViYjVjYjA0ZmNjXzc1MTg_11d74a90-0baf-4a62-9be7-b3858f2f9c9d" escape="true">We are subject to claims that&#160;may&#160;arise in the ordinary course of business, including with respect to actual and threatened litigation and other matters. We accrue for loss contingencies when it is probable that future expenditures will be made, and such expenditures can be reasonably estimated. However, the results of legal actions cannot be predicted with certainty, and therefore our actual losses with respect to these contingencies could exceed our accruals.</ix:nonNumeric> Except for the litigation matter described below, at December 31, 2021, our accruals with respect to actual and threatened litigation were not material. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;We are a defendant in an ongoing litigation matter involving an alleged breach of contract for underpayment of royalty payments made from 2004 through 2017 under an expired patent license agreement. The plaintiff has asserted a claim of approximately $<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-6" name="us-gaap:LossContingencyDamagesSoughtValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjMvZnJhZzpmNzg3MGU2OWQ2ZDc0ZTVhYWEyMzVlYmI1Y2IwNGZjYy90ZXh0cmVnaW9uOmY3ODcwZTY5ZDZkNzRlNWFhYTIzNWViYjVjYjA0ZmNjXzExNzQ_ac1f9db2-57ba-4162-befa-b95a2328b5c7">50</ix:nonFraction>&#160;million, inclusive of interest through June 30, 2020, alleging that the incorrect royalty provision was applied to certain licensed products and services throughout the agreement term and that royalties were also due on non-licensed diagnostic services that were provided concurrently with licensed services. The trial court previously ruled in favor of the plaintiff in this matter and we are appealing the judgment and continue to vigorously defend ourselves against the plaintiff&#8217;s allegations. While we believe the claim is without merit, litigation is inherently unpredictable and there can be no assurance that we will prevail in this matter. During the third quarter of 2020, we established an accrual of $<ix:nonFraction unitRef="usd" contextRef="ie58c704216a6458da306b8341192f2b4_I20200930" decimals="-5" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjMvZnJhZzpmNzg3MGU2OWQ2ZDc0ZTVhYWEyMzVlYmI1Y2IwNGZjYy90ZXh0cmVnaW9uOmY3ODcwZTY5ZDZkNzRlNWFhYTIzNWViYjVjYjA0ZmNjXzE4MjM_ac548613-7bb4-4e87-bb5e-5afff886c698">27.5</ix:nonFraction>&#160;million related to this ongoing matter, which represents the amount of a contingent loss that we have determined to be probable and estimable. We have not made any adjustments to this accrual since it was established. The actual cost of resolving this matter may be higher or lower than the amount we have accrued.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We self-insure costs associated with health, workers&#8217; compensation, auto, and general welfare claims incurred by our U.S. and Canadian employees up to certain limits. Insurance companies provide insurance for claims above these limits. Claim liabilities are recorded for estimates of the loss that we will ultimately incur on reported claims, as well as estimates of claims that have been incurred but not yet reported. Such liabilities are based on individual coverage, the average time from when a claim is incurred to the time it is paid and judgments about the present, and expected levels of claim frequency and severity. Estimated claim liabilities could be significantly affected if future occurrences and claims differ from these assumptions and historical trends. Estimated claim liabilities are included in accrued liabilities in the accompanying consolidated balance sheets.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our current employee healthcare insurance policy for U.S. employees, we retain claims liability risk per incident up to $<ix:nonFraction unitRef="usd" contextRef="i94032e21bcdb4fd5a7a56338b7e76c84_I20201231" decimals="-5" name="idxx:RetainedClaimLiabilityPerIncident" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjMvZnJhZzpmNzg3MGU2OWQ2ZDc0ZTVhYWEyMzVlYmI1Y2IwNGZjYy90ZXh0cmVnaW9uOmY3ODcwZTY5ZDZkNzRlNWFhYTIzNWViYjVjYjA0ZmNjXzMwNzE_4d88381d-2e02-4022-bdc9-c039b4597b38"><ix:nonFraction unitRef="usd" contextRef="i9a8414f50ab04a91a3892300c9d0d3d7_I20191231" decimals="-5" name="idxx:RetainedClaimLiabilityPerIncident" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjMvZnJhZzpmNzg3MGU2OWQ2ZDc0ZTVhYWEyMzVlYmI1Y2IwNGZjYy90ZXh0cmVnaW9uOmY3ODcwZTY5ZDZkNzRlNWFhYTIzNWViYjVjYjA0ZmNjXzMwNzE_7100854d-2d58-49e0-adca-c7b8a5d38576"><ix:nonFraction unitRef="usd" contextRef="i1c3f540bc4ee4adeaf82639617d91385_I20211231" decimals="-5" name="idxx:RetainedClaimLiabilityPerIncident" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjMvZnJhZzpmNzg3MGU2OWQ2ZDc0ZTVhYWEyMzVlYmI1Y2IwNGZjYy90ZXh0cmVnaW9uOmY3ODcwZTY5ZDZkNzRlNWFhYTIzNWViYjVjYjA0ZmNjXzMwNzE_905be856-31ed-4c29-98c5-311bbb29ecc6">1</ix:nonFraction></ix:nonFraction></ix:nonFraction> million per year in 2021, 2020, and 2019. We recognized U.S. employee healthcare claim expense of $<ix:nonFraction unitRef="usd" contextRef="ib865674d7bab445389b9c3bbec146020_D20210101-20211231" decimals="-5" name="us-gaap:GeneralInsuranceExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjMvZnJhZzpmNzg3MGU2OWQ2ZDc0ZTVhYWEyMzVlYmI1Y2IwNGZjYy90ZXh0cmVnaW9uOmY3ODcwZTY5ZDZkNzRlNWFhYTIzNWViYjVjYjA0ZmNjXzMxNTg_7136930c-eb2c-4113-9c15-af89456aa10d">78.5</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ie45306aad98e47fdbad67873c8c7d7cd_D20200101-20201231" decimals="-5" name="us-gaap:GeneralInsuranceExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjMvZnJhZzpmNzg3MGU2OWQ2ZDc0ZTVhYWEyMzVlYmI1Y2IwNGZjYy90ZXh0cmVnaW9uOmY3ODcwZTY5ZDZkNzRlNWFhYTIzNWViYjVjYjA0ZmNjXzMxNjI_d901164f-f09a-4693-a565-1686bdc0c62b">59.5</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i44fa2e5abf144441938e326da9122112_D20190101-20191231" decimals="-5" name="us-gaap:GeneralInsuranceExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjMvZnJhZzpmNzg3MGU2OWQ2ZDc0ZTVhYWEyMzVlYmI1Y2IwNGZjYy90ZXh0cmVnaW9uOmY3ODcwZTY5ZDZkNzRlNWFhYTIzNWViYjVjYjA0ZmNjXzMxNzA_45084c3b-707d-430f-9c44-573aab4e1de0">59.3</ix:nonFraction> million for the years ended December 31, 2021, 2020, and 2019, respectively, which represents actual claims paid and an estimate of our liability for the uninsured portion of employee healthcare obligations that have been incurred but not paid. Should employee health insurance claims exceed our estimated liability, we would have further obligations. Our estimated liability for healthcare claims that have been incurred but not paid as of December 31, 2021 and 2020, was approximately $<ix:nonFraction unitRef="usd" contextRef="i773e63ef7fdd42e489afb58247b219a0_I20211231" decimals="-5" name="us-gaap:SelfInsuranceReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjMvZnJhZzpmNzg3MGU2OWQ2ZDc0ZTVhYWEyMzVlYmI1Y2IwNGZjYy90ZXh0cmVnaW9uOmY3ODcwZTY5ZDZkNzRlNWFhYTIzNWViYjVjYjA0ZmNjXzM2MTY_7dbfc972-cdc9-4b5c-9fa9-286b3492ad5e">7.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if5c4c6cccd414bef949b6f0b3b152901_I20201231" decimals="-5" name="us-gaap:SelfInsuranceReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjMvZnJhZzpmNzg3MGU2OWQ2ZDc0ZTVhYWEyMzVlYmI1Y2IwNGZjYy90ZXh0cmVnaW9uOmY3ODcwZTY5ZDZkNzRlNWFhYTIzNWViYjVjYjA0ZmNjXzM2MjM_5bc869e0-0b1e-417f-b224-9588c5fa3464">5.5</ix:nonFraction> million, respectively.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Workers&#8217; compensation and automobile claim expenses recognized during the years ended December 31, 2021, 2020, and 2019 and our respective liability for such claims as of December 31, 2021, 2020, and 2019 were not material. For the years ended on or prior to December&#160;31, 2018, based on our retained claim liability per incident and our aggregate claim liability per year, our maximum liability in excess of the amounts deemed probable and previously recognized is not material as of </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i6779a1ff3ff04c5b9c9b036c95d04768"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 31, 2021. As of December 31, 2021, we had outstanding letters of credit totaling $<ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-5" name="us-gaap:LettersOfCreditOutstandingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjMvZnJhZzpmNzg3MGU2OWQ2ZDc0ZTVhYWEyMzVlYmI1Y2IwNGZjYy90ZXh0cmVnaW9uOmY3ODcwZTY5ZDZkNzRlNWFhYTIzNWViYjVjYjA0ZmNjXzQxNDc_6fb47255-d946-4fcf-9095-ae46558cea9e">1.4</ix:nonFraction> million to the insurance companies as security for the claims in connection with these policies.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into an employment agreement with our chief executive officer whereby payment may be required if we terminate his employment without cause other than following a change in control. The amount payable is based upon the executive&#8217;s salary at the time of termination and the cost to us of continuing to provide certain benefits. Had this officer been terminated without cause at December 31, 2021, other than following a change in control, we would have had an obligation for salaries and benefits of approximately $<ix:nonFraction unitRef="usd" contextRef="i8f64c178a0b14875b7618692b20160b1_I20211231" decimals="-5" name="us-gaap:SupplementalUnemploymentBenefitsSeveranceBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjMvZnJhZzpmNzg3MGU2OWQ2ZDc0ZTVhYWEyMzVlYmI1Y2IwNGZjYy90ZXh0cmVnaW9uOmY3ODcwZTY5ZDZkNzRlNWFhYTIzNWViYjVjYjA0ZmNjXzQ3NTQ_286e0a21-964d-4278-9a5f-26578562c06a">2.0</ix:nonFraction> million under such agreement. In addition, the agreement provides for continued vesting of his outstanding equity awards for a period of <ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjMvZnJhZzpmNzg3MGU2OWQ2ZDc0ZTVhYWEyMzVlYmI1Y2IwNGZjYy90ZXh0cmVnaW9uOmY3ODcwZTY5ZDZkNzRlNWFhYTIzNWViYjVjYjA0ZmNjXzQ4ODY_0acb7610-3d0d-499c-9855-7bef31278c5b">two years</ix:nonNumeric>, which would accelerate approximately $<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjMvZnJhZzpmNzg3MGU2OWQ2ZDc0ZTVhYWEyMzVlYmI1Y2IwNGZjYy90ZXh0cmVnaW9uOmY3ODcwZTY5ZDZkNzRlNWFhYTIzNWViYjVjYjA0ZmNjXzQ5Mjc_bd57ca49-cd8a-4594-9060-ed49e727e83e">8.0</ix:nonFraction> million of share-based compensation expense as of December 31, 2021.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into employment agreements with each of our officers that require us to make certain payments in the event the officer&#8217;s employment is terminated under certain circumstances within a certain period following a change in control. The amount payable by us under each of these agreements is based on the officer&#8217;s salary and bonus history at the time of termination and the cost to us of continuing to provide certain benefits. Had all of our officers been terminated in qualifying terminations following a change in control at December 31, 2021, we would have had aggregate obligations of approximately $<ix:nonFraction unitRef="usd" contextRef="id4f5b7c174554a70b226143cb3f524f5_I20211231" decimals="-5" name="us-gaap:SupplementalUnemploymentBenefitsSeveranceBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjMvZnJhZzpmNzg3MGU2OWQ2ZDc0ZTVhYWEyMzVlYmI1Y2IwNGZjYy90ZXh0cmVnaW9uOmY3ODcwZTY5ZDZkNzRlNWFhYTIzNWViYjVjYjA0ZmNjXzU1ODA_7c9415db-6a65-49ce-a99b-e1f5c17ddbf1">42.2</ix:nonFraction> million under these agreements. These agreements also provide for the acceleration of the vesting of all stock options and restricted stock units upon any qualifying termination following a change in control. At this time, we believe the likelihood of terminations as a result of the scenarios described is remote, and therefore, we have not accrued for such loss contingencies.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we have received notices alleging that our products infringe third-party proprietary rights, although we are not aware of any pending litigation with respect to such claims. Patent litigation frequently is complex and expensive, and the outcome of patent litigation can be difficult to predict. There can be no assurance that we will prevail in any infringement proceedings that may be commenced against us. If we lose any such litigation, we may be stopped from selling certain products and/or we may be required to pay damages as a result of the litigation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Guarantees</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into agreements with third parties in the ordinary course of business under which we are obligated to indemnify such third parties for and against various risks and losses. The precise terms of such indemnities vary with the nature of the agreement. In many cases, we limit the maximum amount of our indemnification obligations, but in some cases, those obligations may be theoretically unlimited. We have not incurred material expenses in discharging any of these indemnification obligations and, based on our analysis of the nature of the risks involved, we believe that the fair value of potential indemnification under these agreements is minimal. Accordingly, we have recorded <ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="INF" name="us-gaap:GuaranteeObligationsCurrentCarryingValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjMvZnJhZzpmNzg3MGU2OWQ2ZDc0ZTVhYWEyMzVlYmI1Y2IwNGZjYy90ZXh0cmVnaW9uOmY3ODcwZTY5ZDZkNzRlNWFhYTIzNWViYjVjYjA0ZmNjXzcyMzk_7a69e850-5a5a-433b-be57-673f870b80e2"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="INF" name="us-gaap:GuaranteeObligationsCurrentCarryingValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjMvZnJhZzpmNzg3MGU2OWQ2ZDc0ZTVhYWEyMzVlYmI1Y2IwNGZjYy90ZXh0cmVnaW9uOmY3ODcwZTY5ZDZkNzRlNWFhYTIzNWViYjVjYjA0ZmNjXzcyMzk_c5f4972a-4ce2-4ba9-906f-d4d53cccabfe">no</ix:nonFraction></ix:nonFraction> liabilities for these obligations at December 31, 2021 and 2020.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When acquiring a business, we sometimes assume liability for certain events or occurrences that took place prior to the date of acquisition. As of December 31, 2021 and 2020, we do not have any material pre-acquisition liabilities recorded.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-39</span></div></div></div><div id="i5d795a6851d746ca914a2ddae761c329_226"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> NOTE 17.&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90ZXh0cmVnaW9uOmZlY2Q2OGE2MTBkNzQ0MzhiMzFhNDRiODBiZmZjZjliXzQ0MDI_2e2f7d0f-da25-42a2-b7a2-4be6cd1bd651" continuedAt="i841e8facf1de46e69eb55ff531db5865" escape="true">SEGMENT REPORTING </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i841e8facf1de46e69eb55ff531db5865" continuedAt="ia3adc32fd16b4d44bc4ff8e559296629"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate primarily through <ix:nonFraction unitRef="segment" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90ZXh0cmVnaW9uOmZlY2Q2OGE2MTBkNzQ0MzhiMzFhNDRiODBiZmZjZjliXzU0_a85012c6-d016-4ff9-85f0-e541e422706f">three</ix:nonFraction> business segments: diagnostic and information management-based products and services for the companion animal veterinary industry, which we refer to as CAG; water quality products (&#8220;Water&#8221;); and diagnostic products and services for livestock and poultry health, improve producer efficiency, and to ensure the quality and safety of milk, which we refer to as LPD. Our Other operating segment combines and presents our human medical diagnostic products and services business with our out-licensing arrangements because they do not meet the quantitative or qualitative thresholds for reportable segments.&#160;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision-maker (the "CODM"), or decision-making group, in deciding how to allocate resources and in assessing performance. Our CODM is our Chief Executive Officer. Our reportable segments include: CAG, Water, LPD, and Other. Assets are not allocated to segments for internal reporting purposes.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CAG provides products and provide services for veterinarians and the biomedical research community, primarily related to diagnostics and information management. Water provides a range of innovative products used in the detection and quantification of various microbiological parameters in water. LPD provides diagnostic tests and related instrumentation and provides services that are used to manage the health status of livestock and poultry, to improve producer efficiency, and to ensure the quality and safety of milk. OPTI Medical develops, manufactures, and distributes human medical diagnostic products and provides human medical diagnostic services.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intersegment revenues, which are not included in the table below, were not material for the years ended December 31, 2021, 2020, and 2019.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></ix:continuation><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90ZXh0cmVnaW9uOmZlY2Q2OGE2MTBkNzQ0MzhiMzFhNDRiODBiZmZjZjliXzQ0MDM_47edebee-ce88-4aa4-bc6d-c55eeb90507f" continuedAt="ia3cda9b9ab274968920177bd76c4f9af" escape="true"></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ia3adc32fd16b4d44bc4ff8e559296629" continuedAt="i92a176bac0a349f38407bab9e652d8e3"><ix:continuation id="ia3cda9b9ab274968920177bd76c4f9af"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of segment performance:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.797%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CAG</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Water</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LPD</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c823cc0aa3945d9874ea09ab5940878_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzMtMi0xLTEtMA_341cb13a-087b-4e03-a6db-8203e7df4e5b">2,889,960</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81c0a80f385a4f18ab5cb5919ed28318_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzMtNC0xLTEtMA_83e84e7e-e3d0-4979-a2d5-0b3ba51a817a">146,505</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4174c33ea3f8443fbc6587f7ac9a43ab_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzMtNi0xLTEtMA_60d86135-511a-45bd-9be0-8b8b22d93a5f">135,887</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94cd933d7b7b431caa324dc2936f5c55_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzMtOC0xLTEtMA_f20e37db-8421-4e78-9d46-981a2077c7ad">43,008</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzMtMTAtMS0xLTA_55c17136-2d70-40dd-8ffb-f9dc2e66d6b9">3,215,360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c823cc0aa3945d9874ea09ab5940878_D20210101-20211231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzUtMi0xLTEtMA_f1e55e99-607e-4009-8df8-33525b8871c2">824,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81c0a80f385a4f18ab5cb5919ed28318_D20210101-20211231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzUtNC0xLTEtMA_1f0222bf-44a8-4f72-9cdc-4b8f6c9c9e70">65,444</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4174c33ea3f8443fbc6587f7ac9a43ab_D20210101-20211231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzUtNi0xLTEtMA_8b19d128-7e57-4df7-8aca-8ecc1e41c2ba">28,636</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94cd933d7b7b431caa324dc2936f5c55_D20210101-20211231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzUtOC0xLTEtMA_bea61297-ef75-43ee-8e1f-50ba4feaa1a2">13,926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzUtMTAtMS0xLTA_246dfdb2-0389-4d61-82c7-69efefebd74b">932,028</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzYtMTAtMS0xLTA_14b9f4ab-b2a2-4845-98ac-4ccbd9221215">29,374</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income before provision for income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzctMTAtMS0xLTA_5a7d5869-45ee-4270-ad2d-599a6b80ac58">902,654</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzgtMTAtMS0xLTA_e8a19d4f-eb71-4a76-836a-5abea12930c0">157,810</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzktMTAtMS0xLTA_ea1f8dce-f200-4279-b5f3-d654b31e25c0">744,844</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Net income attributable to noncontrolling interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzEwLTEwLTEtMS0w_2460e4b3-65c6-4152-a0ce-1c033b068d39">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to IDEXX Laboratories, Inc. stockholders</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzExLTEwLTEtMS0w_5cee70c9-69f6-415e-a493-4df675cd2bbd">744,845</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c823cc0aa3945d9874ea09ab5940878_D20210101-20211231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzEzLTItMS0xLTA_f7e57ebc-cd88-401b-87fa-ac6dcb67452e">94,202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81c0a80f385a4f18ab5cb5919ed28318_D20210101-20211231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzEzLTQtMS0xLTA_3718c504-e8f2-4f13-a1da-6d95bd58f74f">2,709</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4174c33ea3f8443fbc6587f7ac9a43ab_D20210101-20211231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzEzLTYtMS0xLTA_df4af3c4-c18d-4f38-a71a-4cd146db3c08">3,908</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94cd933d7b7b431caa324dc2936f5c55_D20210101-20211231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzEzLTgtMS0xLTA_4f4ee1f6-4d6d-4558-86d7-acd56599bfcb">3,777</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzEzLTEwLTEtMS0w_c434f823-4f5f-48ec-b51a-a0f9c61cdec8">104,596</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40313073e9c743ad89084e7fbcbd7e5e_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzE2LTItMS0xLTA_24ebe4e4-f90f-4eb0-84aa-ea8ee4888e32">2,385,765</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0b173f4625a4e1e807adc8eeb4e0592_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzE2LTQtMS0xLTA_953220ce-74e8-4804-a105-ebb063c554ae">128,625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4525be5d1c1b4d458fe78f047e981dc1_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzE2LTYtMS0xLTA_419659a6-bc25-48e3-99b9-a533c7e24a64">145,845</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100119c49d8f4098bf6afdc675782162_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzE2LTgtMS0xLTA_e0fb1be7-1d65-4cb7-a6e5-aad0889c7613">46,420</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzE2LTEwLTEtMS0w_f5198a34-4f18-4da8-a09c-7550da50891c">2,706,655</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40313073e9c743ad89084e7fbcbd7e5e_D20200101-20201231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzE4LTItMS0xLTA_103b716b-e3bf-48b2-b328-c308e62ade82">574,887</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0b173f4625a4e1e807adc8eeb4e0592_D20200101-20201231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzE4LTQtMS0xLTA_84550578-807c-463d-bfd3-fd1b8615664a">58,867</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4525be5d1c1b4d458fe78f047e981dc1_D20200101-20201231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzE4LTYtMS0xLTA_3b5f6cdb-433d-4fcd-92c1-85454d5e7551">40,008</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100119c49d8f4098bf6afdc675782162_D20200101-20201231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzE4LTgtMS0xLTA_6f163f0d-f471-4149-8596-dccd5d3a4778">20,762</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzE4LTEwLTEtMS0w_3e96711b-fcdd-4d87-aa38-73d7a70ff845">694,524</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzE5LTEwLTEtMS0w_0656b1d0-fdbf-4431-a28c-eed64b06ec96">32,539</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income before provision for income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzIwLTEwLTEtMS0w_5f9be17a-190b-4c9e-ab63-119c42ef4759">661,985</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzIxLTEwLTEtMS0w_c44887fa-179d-4241-ae86-00d259489d5c">79,854</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzIyLTEwLTEtMS0w_94d3a76a-cded-4566-ba8e-b936e6eeef6e">582,131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Net income attributable to noncontrolling interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzIzLTEwLTEtMS0w_f23e0342-27d9-43a6-b2b2-e06212f20a80">355</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to IDEXX Laboratories, Inc. stockholders</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzI0LTEwLTEtMS0w_1d5ff033-f450-41af-8a82-caa3ccf94e99">581,776</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40313073e9c743ad89084e7fbcbd7e5e_D20200101-20201231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzI2LTItMS0xLTA_24b4edb9-5ec2-4715-96ea-678154576833">84,697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0b173f4625a4e1e807adc8eeb4e0592_D20200101-20201231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzI2LTQtMS0xLTA_8ca9196d-9f74-476c-97de-93bfd2ad68f9">2,630</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4525be5d1c1b4d458fe78f047e981dc1_D20200101-20201231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzI2LTYtMS0xLTA_aaf57688-692f-42e3-924d-64066f9b0081">4,070</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100119c49d8f4098bf6afdc675782162_D20200101-20201231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzI2LTgtMS0xLTA_66cd1ec0-2901-431a-9dc7-2078e27b8ed3">4,601</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzI2LTEwLTEtMS0w_508121ce-b828-4a42-bbe6-b0cbba4c86ab">95,998</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief827aa39f934947a553685160a5543c_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzI5LTItMS0xLTA_bb6d7ec8-7177-405c-9dcb-c8a93fd9e3f8">2,119,183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab0b6ebdef1a4be9b052a1b82c635759_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzI5LTQtMS0xLTA_d0fc02b7-cc1b-4eb3-8ea7-b4761f8948a2">132,850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34e8ebea941e457cbadc1ce152e6a396_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzI5LTYtMS0xLTA_b19c5753-926b-4fa1-b94b-9598a5856b1c">132,635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6f9b6007f00420291efefe0008f3d10_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzI5LTgtMS0xLTA_ee51dae1-9d46-4733-a9de-8916f941e74a">22,240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzI5LTEwLTEtMS0w_2e3eace4-3114-437f-933e-6697ee7a40da">2,406,908</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief827aa39f934947a553685160a5543c_D20190101-20191231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzMxLTItMS0xLTA_935fe98c-9f1f-4546-9bb1-032f514beec9">462,605</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab0b6ebdef1a4be9b052a1b82c635759_D20190101-20191231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzMxLTQtMS0xLTA_43724634-931d-4c6b-a8c0-96cd79f7d29d">61,923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34e8ebea941e457cbadc1ce152e6a396_D20190101-20191231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzMxLTYtMS0xLTA_2cf32d8e-e6f9-432b-ac60-5a3ae44aada4">24,735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6f9b6007f00420291efefe0008f3d10_D20190101-20191231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzMxLTgtMS0xLTA_e6cd222f-5c16-40db-8b7a-bee2e54a1a1a">3,583</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzMxLTEwLTEtMS0w_18fe7859-f6cf-45df-87ea-f820b63ebc0b">552,846</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzMyLTEwLTEtMS0w_92cb1668-960f-419b-b149-ddb97993a334">30,628</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income before provision for income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzMzLTEwLTEtMS0w_46e4e99d-c3a5-4259-b9d4-ae2b176f2e80">522,218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzM0LTEwLTEtMS0w_2b0c6f7a-3357-47b6-b78e-18c3c308c6bc">94,426</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzM1LTEwLTEtMS0w_d190080a-1f8c-4291-b2cb-a072c32b16e2">427,792</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Net income attributable to noncontrolling interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzM2LTEwLTEtMS0w_45d7d111-ef1f-4ac0-9e18-0463b1d04a76">72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to IDEXX Laboratories, Inc. stockholders</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzM3LTEwLTEtMS0w_f9d3f2a5-ec17-40dd-b668-f9c47a0a7a36">427,720</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief827aa39f934947a553685160a5543c_D20190101-20191231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzM5LTItMS0xLTA_9b9063cc-1be0-4e7a-b5cf-f0b7afb17921">77,620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab0b6ebdef1a4be9b052a1b82c635759_D20190101-20191231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzM5LTQtMS0xLTA_857bfac1-97c2-462d-8dfd-9a123878980b">2,794</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34e8ebea941e457cbadc1ce152e6a396_D20190101-20191231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzM5LTYtMS0xLTA_ff080e97-f92f-443e-9040-ea860beba78c">4,007</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6f9b6007f00420291efefe0008f3d10_D20190101-20191231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzM5LTgtMS0xLTA_5146231f-c424-458b-ac2a-bb0d6524a573">3,590</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzM5LTEwLTEtMS0w_af311426-8f66-4824-812e-c694de1a1239">88,011</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to "Note 3. Revenue Recognition" for a summary of disaggregated revenue by reportable segment and by major product and service category for the years ended December 31, 2021, 2020, and 2019.&#160;&#160;&#160;&#160;</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i92a176bac0a349f38407bab9e652d8e3"><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90ZXh0cmVnaW9uOmZlY2Q2OGE2MTBkNzQ0MzhiMzFhNDRiODBiZmZjZjliXzQ0MDU_13e80e16-e477-471e-bc15-34e7e31aedfc" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net long-lived assets, consisting of net property and equipment, are subject to geographic risks because they are generally difficult to move and to effectively utilize in another geographic area in a reasonable time period and because they are relatively illiquid. Net long-lived assets by principal geographic areas were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:66.594%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.318%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.320%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Americas</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2df645a45b34a2399502ce17943dcf7_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzMtMi0xLTEtMA_0234e19f-9128-432a-9541-4e82d2790243">436,003</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b80e825cd834af08c3a61075a948afe_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzMtNC0xLTEtMA_f67d9c11-107f-4961-a2f7-102b99feb92f">412,700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Brazil</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3c0173254014c148d3b60dec589c0b2_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzQtMi0xLTEtMA_9ba34bf2-d375-4be5-bd3b-3d465ed132e2">17,043</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19eca0b32b324c3498847ac936ef58f4_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzQtNC0xLTEtMA_12013b65-a6f7-41ba-992b-cf9afe9a2c9e">20,797</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f5c837a15cc413bb88e37606fc78b84_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzUtMi0xLTEtMA_b42a9c4d-7cea-4465-a743-f0eb21fd300c">7,003</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d6b1606b16f45a0ac3be2c84a8d6205_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzUtNC0xLTEtMA_60bf7a70-4a9b-45aa-a1cf-e3fdeea7c519">4,993</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 12.25pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a98d26251bb48daa1b953041bbb17e4_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzYtMi0xLTEtMA_aebbecbb-883e-4f44-bf96-1cdf73251107">460,049</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2b60381ab6f424a9ae0d17bcd461dc7_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzYtNC0xLTEtMA_b320825f-65f3-480c-a7fe-42c0d855702b">438,490</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Europe, the Middle East and Africa</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d067073a4ae4d32b902fa480a4007da_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzgtMi0xLTEtMA_fb5954e5-2957-4539-b685-bb8f9dc65749">60,451</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if14611aca76842bd9bd4db89f308d803_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzgtNC0xLTEtMA_7257d80b-1b58-4712-819f-74baf6813803">67,354</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i374199d035fc499c91845154d21c433e_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzktMi0xLTEtMA_bdb6d38b-d1cf-4aaf-81c7-60da053f6b12">9,828</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8c119688026495c80d9335fe78c12c9_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzktNC0xLTEtMA_bd39909b-e891-4da9-b444-ff2e1faa2291">10,191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Netherlands</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a516ef8f02d4ad4b2f748492aab4933_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzEwLTItMS0xLTA_c3d1a9bf-9903-464a-998d-f80ec1cb4db0">19,405</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c16c76e13144f0ba4ee1ef3535feacb_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzEwLTQtMS0xLTA_0db102f5-b973-4262-bb7f-da9d641bd053">15,267</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">France</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id29d95bc12294baa874f679042b1e77e_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzExLTItMS0xLTA_4a04a70a-01e4-4ab6-bcce-3742c7797e3f">1,884</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4c58acfb1f047b382030e4bc62b5020_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzExLTQtMS0xLTA_7503c189-2da7-4d38-8337-43ed252434d9">2,062</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Switzerland</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iccfd38ad58364c78a9294def05c76d02_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzEyLTItMS0xLTA_bc881ad8-435f-4691-af78-2fc5342e484d">3,545</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6da1a2f76bee4a21ac439aeda4137fa7_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzEyLTQtMS0xLTA_539802d1-69a1-479f-a711-67b475e0a825">3,743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e3d1826c3d34af3978413aa009dbae7_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzEzLTItMS0xLTA_13be48d3-8c33-4247-ad96-9e2184731e9c">3,821</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e3cdf5fc1964d82bdc2516cce09684d_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzEzLTQtMS0xLTA_f2ae0d83-b3e4-4dbb-8cf3-5674e6a23cad">3,668</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2106bb13edcc49e8b8fce61d61723790_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzE0LTItMS0xLTA_ebe83fb2-cf7b-40b7-8059-ea912d2a71e8">98,934</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64399f2ed4a0466e9bdbbf1a7f6103c6_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzE0LTQtMS0xLTA_f3585062-67d7-40eb-845e-04d5e9ce99e4">102,285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asia Pacific Region</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3de7482682304e00b18c68ebffb19f78_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzE2LTItMS0xLTA_3a9ea9e4-897f-4d4b-8011-20baa8c0843a">5,845</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iceb0cdafe9d44f85a2de864face16fef_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzE2LTQtMS0xLTA_fe979967-3fbc-4bbb-8e91-8fb99493b158">4,503</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Australia</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if41bc213fa8343d59b436514629c5506_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzE3LTItMS0xLTA_0bafe0f9-3758-42f4-b522-edd14cdba1a1">14,584</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76762f7f0d2c450d89d3f32990898187_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzE3LTQtMS0xLTA_53dcad28-c67f-44d6-b6a3-3adecd142824">3,304</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26ff5d65efbd4393a5a6f50b163b1890_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzE4LTItMS0xLTA_1bac0985-2c3f-4483-b446-279b486d328c">8,255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia347a126d78942fbbf80ff326e0aa2a5_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzE4LTQtMS0xLTA_96261911-e756-4507-ac64-94eb946906f6">6,585</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ffc4cfd2c574feda0ea3ae4daaa562c_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzE5LTItMS0xLTA_755f7ea0-fe11-47e1-bf23-2ec92f073c9c">28,684</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a25163d8a7f45b78b59192fe48c8632_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzE5LTQtMS0xLTA_522fbe71-f5fb-44c4-8460-9ac272afb916">14,392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzIwLTItMS0xLTA_aa42ca29-d330-4021-bb39-ba26a9c9ce72">587,667</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzIwLTQtMS0xLTA_45640a15-fc66-4588-bfa5-e93685856ab8">555,167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="i5d795a6851d746ca914a2ddae761c329_229"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 18.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90ZXh0cmVnaW9uOmVlODVkZTI1NGU5NzRiMmE4YjkxNGU1NTgwZTIxNjlmXzQ1NjM_424453ed-c11f-4f56-9835-c87b3d024e49" continuedAt="i229476ba4a674f2b9c5946e3c3885af0" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FAIR VALUE MEASUREMENTS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></ix:nonNumeric></div><div><span><br/></span></div><ix:continuation id="i229476ba4a674f2b9c5946e3c3885af0" continuedAt="if2c7561bd4174186ba2afef3e0afe52e"><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90ZXh0cmVnaW9uOmVlODVkZTI1NGU5NzRiMmE4YjkxNGU1NTgwZTIxNjlmXzQ1NTk_494a22f5-7c01-4e61-b2af-af071e4f98a3" continuedAt="i77f7666be1ec49d1839963d766415714" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. GAAP defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. U.S. GAAP requires an entity to maximize the use of observable inputs, where available, and minimize the use of unobservable inputs when measuring fair value.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have certain financial assets and liabilities that are measured at fair value on a recurring basis, certain nonfinancial assets and liabilities that may be measured at fair value on a non-recurring basis, and certain financial assets and liabilities that are not measured at fair value in our consolidated balance sheets but for which we disclose the fair value. The fair value disclosures of these assets and liabilities are based on a three-level hierarchy, which is defined as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:498.00pt"><tr><td style="width:1.0pt"></td><td style="width:85.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:409.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quoted prices in active markets for identical assets or liabilities that the entity can access at the measurement date.</span></td></tr><tr style="height:33pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities measured at fair value are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability. We did not have any transfers between Level 1 and Level 2, or transfers in or out of Level 3, of the fair value hierarchy during the years ended December 31, 2021 and 2020.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cross currency swap contracts are measured at fair value on a recurring basis in our accompanying consolidated balance sheets. We measure the fair value of our cross currency swap contracts classified as derivative instruments using prevailing market conditions as of the close of business on each balance sheet date. The product of this calculation is then adjusted for counterparty risk.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our foreign currency exchange contracts are measured at fair value on a recurring basis in our accompanying consolidated balance sheets. We measure the fair value of our foreign currency exchange contracts classified as derivative </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="if2c7561bd4174186ba2afef3e0afe52e" continuedAt="i53fc6eaac598449c9b88bf72c8ed785f"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i77f7666be1ec49d1839963d766415714" continuedAt="i8470164ea9eb45a7b017312fe620e881">instruments using an income approach, based on prevailing market forward rates less the contract rate multiplied by the notional amount. The product of this calculation is then adjusted for counterparty risk.&#160;</ix:continuation></span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i8470164ea9eb45a7b017312fe620e881">The amounts outstanding under our unsecured revolving credit facility ("Credit Facility" or &#8220;line of credit&#8221;) and senior notes (&#8220;long-term debt&#8221;) are measured at carrying value in our accompanying consolidated balance sheets though we disclose the fair value of these financial instruments. We determine the fair value of the amount outstanding under our Credit Facility and long-term debt using an income approach, utilizing a discounted cash flow analysis based on current market interest rates for debt issues with similar remaining years to maturity, adjusted for applicable credit risk. Our Credit Facility and long-term debt are valued using Level 2 inputs. The estimated fair value of our Credit Facility approximates its carrying value.</ix:continuation> At December 31, 2021, the estimated fair value and carrying value of our long-term debt were $<ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-5" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90ZXh0cmVnaW9uOmVlODVkZTI1NGU5NzRiMmE4YjkxNGU1NTgwZTIxNjlmXzMwMzg_f5e555e8-5e8f-4a47-91f0-d93d7b1f6e1f">916.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90ZXh0cmVnaW9uOmVlODVkZTI1NGU5NzRiMmE4YjkxNGU1NTgwZTIxNjlmXzMwNDU_caf95622-112b-49ef-95ce-8be7668f40a1">850.7</ix:nonFraction> million, respectively. At December 31, 2020, the estimated fair value and carrying value of our long-term debt were $<ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-8" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90ZXh0cmVnaW9uOmVlODVkZTI1NGU5NzRiMmE4YjkxNGU1NTgwZTIxNjlmXzMxNDE_d3fe7dae-f677-4927-8026-93e607836087">1.0</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90ZXh0cmVnaW9uOmVlODVkZTI1NGU5NzRiMmE4YjkxNGU1NTgwZTIxNjlmXzMxNDg_468d62f6-cd6e-4e5b-b08c-4ea93c3ce05a">909.1</ix:nonFraction> million, respectively.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90ZXh0cmVnaW9uOmVlODVkZTI1NGU5NzRiMmE4YjkxNGU1NTgwZTIxNjlmXzQ1NjQ_44cc6beb-2d9b-4d18-9a13-dc5606b10bca" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth our assets and liabilities that were measured at fair value on a recurring basis by level within the fair value hierarchy:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:45.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.402%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Quoted Prices in Active Markets for Identical Assets <br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant Other Observable Inputs <br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant Unobservable Inputs <br/>(Level 3)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Money market funds </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc42ef3733b4728851d7a59ec0cfb20_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpmMDE1MzE2YmUyOTY0Y2VlOGRiMjdhYzE1Y2MyZmI3Yy90YWJsZXJhbmdlOmYwMTUzMTZiZTI5NjRjZWU4ZGIyN2FjMTVjYzJmYjdjXzQtMi0xLTEtMA_cee75b01-063e-4748-a73b-002a5f64933e">76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86eb4694a98b40318766c041f67be8c5_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpmMDE1MzE2YmUyOTY0Y2VlOGRiMjdhYzE1Y2MyZmI3Yy90YWJsZXJhbmdlOmYwMTUzMTZiZTI5NjRjZWU4ZGIyN2FjMTVjYzJmYjdjXzQtNC0xLTEtMA_3d0fd62e-80e0-43ef-a498-b2165930b0a3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieeaf8edb07e74b67a220042fa77426c6_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpmMDE1MzE2YmUyOTY0Y2VlOGRiMjdhYzE1Y2MyZmI3Yy90YWJsZXJhbmdlOmYwMTUzMTZiZTI5NjRjZWU4ZGIyN2FjMTVjYzJmYjdjXzQtNi0xLTEtMA_cfdba241-4441-4333-aff9-255c223e67f1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i206dbd1506c344a7b46d2edcee18de52_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpmMDE1MzE2YmUyOTY0Y2VlOGRiMjdhYzE1Y2MyZmI3Yy90YWJsZXJhbmdlOmYwMTUzMTZiZTI5NjRjZWU4ZGIyN2FjMTVjYzJmYjdjXzQtOC0xLTEtMA_f76c78a8-2b3a-4b40-9d5d-f3a41e0ed1a3">76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity mutual funds </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2258666cd26e4775980e24a9d689b0c1_I20211231" decimals="-3" name="us-gaap:OtherAssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpmMDE1MzE2YmUyOTY0Y2VlOGRiMjdhYzE1Y2MyZmI3Yy90YWJsZXJhbmdlOmYwMTUzMTZiZTI5NjRjZWU4ZGIyN2FjMTVjYzJmYjdjXzUtMi0xLTEtMA_0e129190-bfda-4532-ac99-72d82c92b613">826</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i787da85c3dea4d1b8cbac83c56d8a8c7_I20211231" decimals="-3" name="us-gaap:OtherAssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpmMDE1MzE2YmUyOTY0Y2VlOGRiMjdhYzE1Y2MyZmI3Yy90YWJsZXJhbmdlOmYwMTUzMTZiZTI5NjRjZWU4ZGIyN2FjMTVjYzJmYjdjXzUtNC0xLTEtMA_ab438e3e-a62e-4366-b34a-5f0b2e719066">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib92b086f14c04b4cafa21f8ec54f598a_I20211231" decimals="-3" name="us-gaap:OtherAssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpmMDE1MzE2YmUyOTY0Y2VlOGRiMjdhYzE1Y2MyZmI3Yy90YWJsZXJhbmdlOmYwMTUzMTZiZTI5NjRjZWU4ZGIyN2FjMTVjYzJmYjdjXzUtNi0xLTEtMA_e3926022-9951-47c5-9ff3-1219e4142f07">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0bf1cce14634a27bdb520f17b857f93_I20211231" decimals="-3" name="us-gaap:OtherAssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpmMDE1MzE2YmUyOTY0Y2VlOGRiMjdhYzE1Y2MyZmI3Yy90YWJsZXJhbmdlOmYwMTUzMTZiZTI5NjRjZWU4ZGIyN2FjMTVjYzJmYjdjXzUtOC0xLTEtMA_1c9d97d0-4008-4e86-9bc2-c84b2caf4845">826</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross currency swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i224b783ac8494c7db115e134494538a7_I20211231" decimals="-3" name="us-gaap:OtherAssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpmMDE1MzE2YmUyOTY0Y2VlOGRiMjdhYzE1Y2MyZmI3Yy90YWJsZXJhbmdlOmYwMTUzMTZiZTI5NjRjZWU4ZGIyN2FjMTVjYzJmYjdjXzYtMi0xLTEtMzc2MzM_dbfc85cd-1736-4fc8-bb3a-179204d76e70">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaf6c4c313dd4b59950dfdc2cebfd879_I20211231" decimals="-3" name="us-gaap:OtherAssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpmMDE1MzE2YmUyOTY0Y2VlOGRiMjdhYzE1Y2MyZmI3Yy90YWJsZXJhbmdlOmYwMTUzMTZiZTI5NjRjZWU4ZGIyN2FjMTVjYzJmYjdjXzYtNC0xLTEtMzc2MzM_1d9fbf08-8622-4ecb-a6fe-cf01054b9af5">4,256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i991a2d9a94c94f4ea20968ce0eeb2d8a_I20211231" decimals="-3" name="us-gaap:OtherAssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpmMDE1MzE2YmUyOTY0Y2VlOGRiMjdhYzE1Y2MyZmI3Yy90YWJsZXJhbmdlOmYwMTUzMTZiZTI5NjRjZWU4ZGIyN2FjMTVjYzJmYjdjXzYtNi0xLTEtMzc2MzM_2522b74f-b960-4b56-aaca-e3da30dd462b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5defc11409fd41638fd2fde139f135f5_I20211231" decimals="-3" name="us-gaap:OtherAssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpmMDE1MzE2YmUyOTY0Y2VlOGRiMjdhYzE1Y2MyZmI3Yy90YWJsZXJhbmdlOmYwMTUzMTZiZTI5NjRjZWU4ZGIyN2FjMTVjYzJmYjdjXzYtOC0xLTEtMzc2MzM_32de49ee-7dda-49c5-bc81-1e11faaeffa3">4,256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange contracts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02adea61db9c4d30a6aebbf9a1e7dbef_I20211231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpmMDE1MzE2YmUyOTY0Y2VlOGRiMjdhYzE1Y2MyZmI3Yy90YWJsZXJhbmdlOmYwMTUzMTZiZTI5NjRjZWU4ZGIyN2FjMTVjYzJmYjdjXzYtMi0xLTEtMA_f847ecd2-5577-434f-a0a1-a823e627a927">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief2e06ac5412417d8e6cdbbfb30aaabe_I20211231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpmMDE1MzE2YmUyOTY0Y2VlOGRiMjdhYzE1Y2MyZmI3Yy90YWJsZXJhbmdlOmYwMTUzMTZiZTI5NjRjZWU4ZGIyN2FjMTVjYzJmYjdjXzYtNC0xLTEtMA_517430dc-eaba-437b-81f9-9cecf7f8f3ca">6,512</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bbbcba12a794c06878aa6883f1b3785_I20211231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpmMDE1MzE2YmUyOTY0Y2VlOGRiMjdhYzE1Y2MyZmI3Yy90YWJsZXJhbmdlOmYwMTUzMTZiZTI5NjRjZWU4ZGIyN2FjMTVjYzJmYjdjXzYtNi0xLTEtMA_2b13ec29-83b5-4a3c-8a3f-9c6198b4d1bf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89ead21a0e784572a2136d6d2a0a1694_I20211231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpmMDE1MzE2YmUyOTY0Y2VlOGRiMjdhYzE1Y2MyZmI3Yy90YWJsZXJhbmdlOmYwMTUzMTZiZTI5NjRjZWU4ZGIyN2FjMTVjYzJmYjdjXzYtOC0xLTEtMA_f967414e-8ced-44b4-b639-f8211d9344a5">6,512</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange contracts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02adea61db9c4d30a6aebbf9a1e7dbef_I20211231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpmMDE1MzE2YmUyOTY0Y2VlOGRiMjdhYzE1Y2MyZmI3Yy90YWJsZXJhbmdlOmYwMTUzMTZiZTI5NjRjZWU4ZGIyN2FjMTVjYzJmYjdjXzktMi0xLTEtMA_2c01ccba-b0b4-4a22-b980-b8840d3498ae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief2e06ac5412417d8e6cdbbfb30aaabe_I20211231" decimals="-3" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpmMDE1MzE2YmUyOTY0Y2VlOGRiMjdhYzE1Y2MyZmI3Yy90YWJsZXJhbmdlOmYwMTUzMTZiZTI5NjRjZWU4ZGIyN2FjMTVjYzJmYjdjXzktNC0xLTEtMA_9d47f895-37ed-4f1a-90e2-07711201bb8a">601</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bbbcba12a794c06878aa6883f1b3785_I20211231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpmMDE1MzE2YmUyOTY0Y2VlOGRiMjdhYzE1Y2MyZmI3Yy90YWJsZXJhbmdlOmYwMTUzMTZiZTI5NjRjZWU4ZGIyN2FjMTVjYzJmYjdjXzktNi0xLTEtMA_0ea85be3-b0bc-427c-8b25-b2b20a924091">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89ead21a0e784572a2136d6d2a0a1694_I20211231" decimals="-3" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpmMDE1MzE2YmUyOTY0Y2VlOGRiMjdhYzE1Y2MyZmI3Yy90YWJsZXJhbmdlOmYwMTUzMTZiZTI5NjRjZWU4ZGIyN2FjMTVjYzJmYjdjXzktOC0xLTEtMA_b9e8d4b7-83a9-4062-be02-0f8e0b544961">601</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred compensation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77cb9a89ff4949bb8bc7f0848c680d19_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpmMDE1MzE2YmUyOTY0Y2VlOGRiMjdhYzE1Y2MyZmI3Yy90YWJsZXJhbmdlOmYwMTUzMTZiZTI5NjRjZWU4ZGIyN2FjMTVjYzJmYjdjXzEwLTItMS0xLTA_a97b75b6-e5a5-4167-827f-42b7720a9a18">826</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f5042c99e1f40d89108212d50d27e54_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpmMDE1MzE2YmUyOTY0Y2VlOGRiMjdhYzE1Y2MyZmI3Yy90YWJsZXJhbmdlOmYwMTUzMTZiZTI5NjRjZWU4ZGIyN2FjMTVjYzJmYjdjXzEwLTQtMS0xLTA_d9e7684a-caec-4b4c-b592-4efd6663ea92">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6298f7d8f2c4ee7926bc69c8be65de3_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpmMDE1MzE2YmUyOTY0Y2VlOGRiMjdhYzE1Y2MyZmI3Yy90YWJsZXJhbmdlOmYwMTUzMTZiZTI5NjRjZWU4ZGIyN2FjMTVjYzJmYjdjXzEwLTYtMS0xLTA_bd375bac-8a44-425c-b1f1-909dc6870669">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i335b527a64fd4bee959d70654d76f369_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpmMDE1MzE2YmUyOTY0Y2VlOGRiMjdhYzE1Y2MyZmI3Yy90YWJsZXJhbmdlOmYwMTUzMTZiZTI5NjRjZWU4ZGIyN2FjMTVjYzJmYjdjXzEwLTgtMS0xLTA_e7690c50-7f84-488f-b7bf-134f9debfdf2">826</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent payments - acquisitions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2631d5bf8f7b4edf839dd6d1ffca5a4d_I20211231" decimals="-3" name="idxx:BusinessCombinationContingencyFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpmMDE1MzE2YmUyOTY0Y2VlOGRiMjdhYzE1Y2MyZmI3Yy90YWJsZXJhbmdlOmYwMTUzMTZiZTI5NjRjZWU4ZGIyN2FjMTVjYzJmYjdjXzExLTItMS0xLTI5MDk2_7206acf6-e461-4922-be4f-51ea7f962af3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83f6672993344e548b6db84a0a80f0da_I20211231" decimals="-3" name="idxx:BusinessCombinationContingencyFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpmMDE1MzE2YmUyOTY0Y2VlOGRiMjdhYzE1Y2MyZmI3Yy90YWJsZXJhbmdlOmYwMTUzMTZiZTI5NjRjZWU4ZGIyN2FjMTVjYzJmYjdjXzExLTQtMS0xLTI5MDk2_4e4d1200-5f89-433a-a647-6d7045514433">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c872711fc4b45339979cdb106678fe3_I20211231" decimals="-3" name="idxx:BusinessCombinationContingencyFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpmMDE1MzE2YmUyOTY0Y2VlOGRiMjdhYzE1Y2MyZmI3Yy90YWJsZXJhbmdlOmYwMTUzMTZiZTI5NjRjZWU4ZGIyN2FjMTVjYzJmYjdjXzExLTYtMS0xLTI5MDk2_f3f38f0c-fc8f-4c69-8896-8b1c0d4ee58e">7,230</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58118ac9fa5b41048fd3e947040036e9_I20211231" decimals="-3" name="idxx:BusinessCombinationContingencyFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpmMDE1MzE2YmUyOTY0Y2VlOGRiMjdhYzE1Y2MyZmI3Yy90YWJsZXJhbmdlOmYwMTUzMTZiZTI5NjRjZWU4ZGIyN2FjMTVjYzJmYjdjXzExLTgtMS0xLTI5MDk2_ab359078-42e8-40bc-9102-a5d722a10ab3">7,230</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:45.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.402%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Quoted Prices in Active Markets for Identical Assets <br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant Other Observable Inputs <br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant Unobservable Inputs <br/>(Level 3)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at December 31, 2020</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Money market funds </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i608997adc8b645bcbaaf1f91a45b978b_I20201231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpjYmJiZTNhYjBiYmM0ZTVkYjNmNDFlZjA0NjBhOTZhYy90YWJsZXJhbmdlOmNiYmJlM2FiMGJiYzRlNWRiM2Y0MWVmMDQ2MGE5NmFjXzQtMi0xLTEtMA_8a9c6800-3eb4-4933-a489-6500de24ffcb">76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d3f919fc9944acb95a3e26a8e3a840b_I20201231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpjYmJiZTNhYjBiYmM0ZTVkYjNmNDFlZjA0NjBhOTZhYy90YWJsZXJhbmdlOmNiYmJlM2FiMGJiYzRlNWRiM2Y0MWVmMDQ2MGE5NmFjXzQtNC0xLTEtMA_94b33d70-2f20-42f1-81e4-86b5b751fdfd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3de38ceae5e40a3a39f1ed4d9f73eb2_I20201231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpjYmJiZTNhYjBiYmM0ZTVkYjNmNDFlZjA0NjBhOTZhYy90YWJsZXJhbmdlOmNiYmJlM2FiMGJiYzRlNWRiM2Y0MWVmMDQ2MGE5NmFjXzQtNi0xLTEtMA_12af8bba-76c6-467a-838d-6beef253188e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iccdf369f478f4fb8b529dbbf7bf67b64_I20201231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpjYmJiZTNhYjBiYmM0ZTVkYjNmNDFlZjA0NjBhOTZhYy90YWJsZXJhbmdlOmNiYmJlM2FiMGJiYzRlNWRiM2Y0MWVmMDQ2MGE5NmFjXzQtOC0xLTEtMA_5c7aa461-7705-4bca-bbe7-dc1a61f8d178">76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity mutual funds </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idca6b93b00b44f62bbc514784faff67d_I20201231" decimals="-3" name="us-gaap:OtherAssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpjYmJiZTNhYjBiYmM0ZTVkYjNmNDFlZjA0NjBhOTZhYy90YWJsZXJhbmdlOmNiYmJlM2FiMGJiYzRlNWRiM2Y0MWVmMDQ2MGE5NmFjXzUtMi0xLTEtMA_e3f4cbf7-6881-4639-b248-72891a7c1d06">1,145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife95a3279b8f411aa329c1a3be662fd3_I20201231" decimals="-3" name="us-gaap:OtherAssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpjYmJiZTNhYjBiYmM0ZTVkYjNmNDFlZjA0NjBhOTZhYy90YWJsZXJhbmdlOmNiYmJlM2FiMGJiYzRlNWRiM2Y0MWVmMDQ2MGE5NmFjXzUtNC0xLTEtMA_cdad74c9-dd69-4d86-a1d7-c190e86a21ec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id52d5e57570042d09f53a0980b212d20_I20201231" decimals="-3" name="us-gaap:OtherAssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpjYmJiZTNhYjBiYmM0ZTVkYjNmNDFlZjA0NjBhOTZhYy90YWJsZXJhbmdlOmNiYmJlM2FiMGJiYzRlNWRiM2Y0MWVmMDQ2MGE5NmFjXzUtNi0xLTEtMA_ce22a51c-039e-4921-9c7d-055bed408499">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic08687ee74ce470e94fd105bae7ecbdc_I20201231" decimals="-3" name="us-gaap:OtherAssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpjYmJiZTNhYjBiYmM0ZTVkYjNmNDFlZjA0NjBhOTZhYy90YWJsZXJhbmdlOmNiYmJlM2FiMGJiYzRlNWRiM2Y0MWVmMDQ2MGE5NmFjXzUtOC0xLTEtMA_2cf5ce1e-19ac-437a-8bac-d7fbdcae63c6">1,145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange contracts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a44d7e6553d48599a9003be65d3c761_I20201231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpjYmJiZTNhYjBiYmM0ZTVkYjNmNDFlZjA0NjBhOTZhYy90YWJsZXJhbmdlOmNiYmJlM2FiMGJiYzRlNWRiM2Y0MWVmMDQ2MGE5NmFjXzctMi0xLTEtMA_53648e0b-7953-4b09-a361-2518906ba189">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbc7dd68361493785eff3dfc58a1b14_I20201231" decimals="-3" name="us-gaap:DerivativeAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpjYmJiZTNhYjBiYmM0ZTVkYjNmNDFlZjA0NjBhOTZhYy90YWJsZXJhbmdlOmNiYmJlM2FiMGJiYzRlNWRiM2Y0MWVmMDQ2MGE5NmFjXzctNC0xLTEtMA_c0ee2966-6515-4710-9851-c834e2bc870b">125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i315d962b616d493fb4d154dd8f021e44_I20201231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpjYmJiZTNhYjBiYmM0ZTVkYjNmNDFlZjA0NjBhOTZhYy90YWJsZXJhbmdlOmNiYmJlM2FiMGJiYzRlNWRiM2Y0MWVmMDQ2MGE5NmFjXzctNi0xLTEtMA_9a61ad4b-96ce-4390-b985-916f4da0198d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae303435a98a42f1bc19b02e47518558_I20201231" decimals="-3" name="us-gaap:DerivativeAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpjYmJiZTNhYjBiYmM0ZTVkYjNmNDFlZjA0NjBhOTZhYy90YWJsZXJhbmdlOmNiYmJlM2FiMGJiYzRlNWRiM2Y0MWVmMDQ2MGE5NmFjXzctOC0xLTEtMA_c17f26bc-7029-4f98-b5b3-1b8dcd78051f">125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross currency swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ded36872dbb4598a2981b577f9f6307_I20201231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpjYmJiZTNhYjBiYmM0ZTVkYjNmNDFlZjA0NjBhOTZhYy90YWJsZXJhbmdlOmNiYmJlM2FiMGJiYzRlNWRiM2Y0MWVmMDQ2MGE5NmFjXzktMi0xLTEtMjUz_b0acf1b0-6c64-4e4b-9637-73f1383ec26b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00732657e2a24ab78c424730ef55e468_I20201231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpjYmJiZTNhYjBiYmM0ZTVkYjNmNDFlZjA0NjBhOTZhYy90YWJsZXJhbmdlOmNiYmJlM2FiMGJiYzRlNWRiM2Y0MWVmMDQ2MGE5NmFjXzktNC0xLTEtMjUz_0d7620c4-4f0a-4484-9ab2-3342f75ee66a">2,841</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3c0063a469d414bb87cadabfe0a1f2b_I20201231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpjYmJiZTNhYjBiYmM0ZTVkYjNmNDFlZjA0NjBhOTZhYy90YWJsZXJhbmdlOmNiYmJlM2FiMGJiYzRlNWRiM2Y0MWVmMDQ2MGE5NmFjXzktNi0xLTEtMjUz_70c183e9-acf6-4a77-8fa9-bcdbe0eefba2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd016343073542aaa9022d71864f8954_I20201231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpjYmJiZTNhYjBiYmM0ZTVkYjNmNDFlZjA0NjBhOTZhYy90YWJsZXJhbmdlOmNiYmJlM2FiMGJiYzRlNWRiM2Y0MWVmMDQ2MGE5NmFjXzktOC0xLTEtMjUz_66466b67-ed9b-4f60-84b4-a5b8542319d1">2,841</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange contracts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a44d7e6553d48599a9003be65d3c761_I20201231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpjYmJiZTNhYjBiYmM0ZTVkYjNmNDFlZjA0NjBhOTZhYy90YWJsZXJhbmdlOmNiYmJlM2FiMGJiYzRlNWRiM2Y0MWVmMDQ2MGE5NmFjXzktMi0xLTEtMA_fc9319f8-156e-45bd-9a53-6700794e0470">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbc7dd68361493785eff3dfc58a1b14_I20201231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpjYmJiZTNhYjBiYmM0ZTVkYjNmNDFlZjA0NjBhOTZhYy90YWJsZXJhbmdlOmNiYmJlM2FiMGJiYzRlNWRiM2Y0MWVmMDQ2MGE5NmFjXzktNC0xLTEtMA_c7e006e0-a45b-4c3d-ba20-c485a74eb61d">12,373</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i315d962b616d493fb4d154dd8f021e44_I20201231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpjYmJiZTNhYjBiYmM0ZTVkYjNmNDFlZjA0NjBhOTZhYy90YWJsZXJhbmdlOmNiYmJlM2FiMGJiYzRlNWRiM2Y0MWVmMDQ2MGE5NmFjXzktNi0xLTEtMA_1fe57a8e-d1ab-4ee9-ac06-5a8088b67421">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae303435a98a42f1bc19b02e47518558_I20201231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpjYmJiZTNhYjBiYmM0ZTVkYjNmNDFlZjA0NjBhOTZhYy90YWJsZXJhbmdlOmNiYmJlM2FiMGJiYzRlNWRiM2Y0MWVmMDQ2MGE5NmFjXzktOC0xLTEtMA_3aee6bc9-e01f-4b70-a551-fee8d5c4ed51">12,373</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred compensation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideb425f832b5493cadaae1d434f30a46_I20201231" decimals="-3" name="us-gaap:OtherLiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpjYmJiZTNhYjBiYmM0ZTVkYjNmNDFlZjA0NjBhOTZhYy90YWJsZXJhbmdlOmNiYmJlM2FiMGJiYzRlNWRiM2Y0MWVmMDQ2MGE5NmFjXzEwLTItMS0xLTA_adf4f4a4-9516-4052-8129-ca410d6b0c13">1,145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i966b54bea1fd484184ebf43c56e298a7_I20201231" decimals="-3" name="us-gaap:OtherLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpjYmJiZTNhYjBiYmM0ZTVkYjNmNDFlZjA0NjBhOTZhYy90YWJsZXJhbmdlOmNiYmJlM2FiMGJiYzRlNWRiM2Y0MWVmMDQ2MGE5NmFjXzEwLTQtMS0xLTA_f07a8749-abec-4c80-bef8-0ae1b4e11156">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671303cff5aa4ae2b8d910b00202004d_I20201231" decimals="-3" name="us-gaap:OtherLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpjYmJiZTNhYjBiYmM0ZTVkYjNmNDFlZjA0NjBhOTZhYy90YWJsZXJhbmdlOmNiYmJlM2FiMGJiYzRlNWRiM2Y0MWVmMDQ2MGE5NmFjXzEwLTYtMS0xLTA_b139fc43-85e6-4df0-9027-48b37e1b4649">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82b77254c5584204b9d7b6c3d673b43b_I20201231" decimals="-3" name="us-gaap:OtherLiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpjYmJiZTNhYjBiYmM0ZTVkYjNmNDFlZjA0NjBhOTZhYy90YWJsZXJhbmdlOmNiYmJlM2FiMGJiYzRlNWRiM2Y0MWVmMDQ2MGE5NmFjXzEwLTgtMS0xLTA_3a3dd76d-d075-4acc-8a6b-bba3fc4af738">1,145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Money market funds with an original maturity of less than ninety days are included within cash and cash equivalents. The remaining balance of cash and cash equivalents as of December 31, 2021, and December 31, 2020, consisted of demand deposits.</span></div><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Equity mutual funds relate to a deferred compensation plan that was assumed as part of a previous business combination. This amount is included within other long-term assets. Refer to footnote (4) below for a discussion of the related deferred compensation liability.</span></div><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Cross currency swaps and foreign currency exchange contracts are included within other current assets; other long-term assets; accrued liabilities; or other long-term liabilities depending on the gain (loss) position and anticipated settlement date.</span></div><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">A deferred compensation plan assumed as part of a previous business combination is included within accrued liabilities and other long-term liabilities. The fair value of our deferred compensation plan is indexed to the performance of the underlying equity mutual funds discussed in footnote (2) above.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="i53fc6eaac598449c9b88bf72c8ed785f"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair values of certain financial instruments, including cash and cash equivalents, accounts receivable, and accounts payable, approximate carrying value due to their short maturity.&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingent Consideration</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have classified our liabilities for contingent consideration related to acquisitions within Level 3 of the fair value hierarchy because the fair value is determined using significant unobservable inputs, which includes the achievements of future revenues. The contingent consideration is included within other short-term liabilities.</span></div><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90ZXh0cmVnaW9uOmVlODVkZTI1NGU5NzRiMmE4YjkxNGU1NTgwZTIxNjlmXzQzOTgwNDY1MTYzNzc_fd61f205-b9dc-4320-b55c-1047a6cd64a2" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record changes in the estimated fair value of contingent consideration in the consolidated statements of income. Changes in contingent consideration liabilities are measured at fair value on a recurring basis using unobservable inputs (Level 3) and during the year ended December 31, 2021, are as follows:</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.794%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.276%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Contingent consideration as of December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTo4MmMzZGExZjJkMGY0N2MzYThmYWQ4MTY3ZDcxMGU5Mi90YWJsZXJhbmdlOjgyYzNkYTFmMmQwZjQ3YzNhOGZhZDgxNjdkNzEwZTkyXzItMi0xLTEtMjg3Mzk_ab83e4b4-43dc-4376-89ac-f3ae6d902d0d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent consideration recorded from acquisitions (Note 4)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTo4MmMzZGExZjJkMGY0N2MzYThmYWQ4MTY3ZDcxMGU5Mi90YWJsZXJhbmdlOjgyYzNkYTFmMmQwZjQ3YzNhOGZhZDgxNjdkNzEwZTkyXzMtMi0xLTEtMjg3Mzk_a9b6cf68-f517-4564-b674-d29350c2ed51">5,230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in estimated fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTo4MmMzZGExZjJkMGY0N2MzYThmYWQ4MTY3ZDcxMGU5Mi90YWJsZXJhbmdlOjgyYzNkYTFmMmQwZjQ3YzNhOGZhZDgxNjdkNzEwZTkyXzQtMi0xLTEtMjg3Mzk_1349f35f-44ca-40d4-a490-eecbaa56b8e3">2,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Contingent consideration as of December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTo4MmMzZGExZjJkMGY0N2MzYThmYWQ4MTY3ZDcxMGU5Mi90YWJsZXJhbmdlOjgyYzNkYTFmMmQwZjQ3YzNhOGZhZDgxNjdkNzEwZTkyXzUtMi0xLTEtMjg3Mzk_7c777a4b-8092-4106-9d98-48801b10f6ed">7,230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We originally recorded a $<ix:nonFraction unitRef="usd" contextRef="i1902b241fd2f47aaaa617a00218e386f_D20210401-20210630" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90ZXh0cmVnaW9uOmVlODVkZTI1NGU5NzRiMmE4YjkxNGU1NTgwZTIxNjlmXzQ5NDc4MDIzMzEyODk_e4894180-cca2-43a3-97a8-9008bd09de8c">5.0</ix:nonFraction>&#160;million contingent consideration associated with our acquisition of ezyVet during the second quarter of 2021. During the fourth quarter of 2021, we increased the contingent consideration by $<ix:nonFraction unitRef="usd" contextRef="ifd0bd4a0a64d4c9fa9955ab39bcd5b33_D20211001-20211231" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90ZXh0cmVnaW9uOmVlODVkZTI1NGU5NzRiMmE4YjkxNGU1NTgwZTIxNjlmXzQ5NDc4MDIzMzEzMDE_a563fe74-0cfc-4535-9f39-77d56361e354">2.0</ix:nonFraction>&#160;million to reflect the most recent estimate associated with achievements of future revenue.</span></div></ix:continuation><div><span><br/></span></div><div id="i5d795a6851d746ca914a2ddae761c329_232"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 19. &#160;&#160;&#160;&#160; <ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90ZXh0cmVnaW9uOjQ3YTdmNzg2NDkyZjQwZmRiNDY3NDE3ODk2OWU4NTc0Xzk2Nzk_d61167ae-6eed-4925-a81a-d79648996d4d" continuedAt="ied664c875c324cb291fc2308f922ac39" escape="true">HEDGING INSTRUMENTS </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ied664c875c324cb291fc2308f922ac39" continuedAt="iec4ed76299974febac87ae1459a334f6"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Disclosure within this note is presented to provide transparency about how and why we use derivative and non-derivative instruments (collectively &#8220;hedging instruments&#8221;), how the instruments and related hedged items are accounted for, and how the instruments and related hedged items affect our financial position, results of operations, and cash flows.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to certain risks related to our ongoing business operations. The primary risk that we currently manage by using hedging instruments is foreign currency exchange risk. We may also enter into interest rate swaps to minimize the impact of interest rate fluctuations associated with borrowings under our variable-rate Credit Facility.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our subsidiaries enter into foreign currency exchange contracts to manage the exchange risk associated with their forecasted intercompany inventory purchases and sales for the next year. From time to time, we may also enter into other foreign currency exchange contracts, cross currency swaps, or foreign-denominated debt issuances to minimize the impact of foreign currency fluctuations associated with specific balance sheet exposures, including net investments in certain foreign subsidiaries. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary purpose of our foreign currency hedging activities is to protect against the volatility associated with foreign currency transactions, including transactions denominated in euro, British pound, Japanese yen, Canadian dollar, and Australian dollar. We also utilize natural hedges to mitigate our transaction and commitment exposures. Our corporate policy prescribes the range of allowable hedging activity. We enter into foreign currency exchange contracts with well-capitalized multinational financial institutions, and we do not hold or engage in transactions involving hedging instruments for purposes other than risk management. Our accounting policies for these contracts are based on our designation of such instruments as hedging transactions.&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90ZXh0cmVnaW9uOjQ3YTdmNzg2NDkyZjQwZmRiNDY3NDE3ODk2OWU4NTc0Xzk2ODA_e1fa8bfc-e0fb-4c51-bd38-71f290a0728e" continuedAt="ib0e3f20da2db467ba747f4a783c291dc" escape="true">We recognize all hedging instruments on the balance sheet at fair value at the balance sheet date. Instruments that do not qualify for hedge accounting treatment must be recorded at fair value through earnings. To qualify for hedge accounting treatment, cash flow and net investment hedges must be highly effective in offsetting changes to expected future cash flows or fair value on hedged transactions. If the instrument qualifies for hedge accounting, changes in the fair value of the hedging instrument from the effective portion of the hedge are deferred in AOCI, net of tax, and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. We immediately record in earnings the extent to which a hedging instrument is not effective in achieving offsetting changes in fair value. We de-designate hedging instruments from hedge accounting when the likelihood of the hedged transaction occurring becomes less than probable. For de-designated </ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="iec4ed76299974febac87ae1459a334f6" continuedAt="ieb6214616ee04c6bb929859d32261519"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib0e3f20da2db467ba747f4a783c291dc" continuedAt="ic6fda4546efd4b69a4d18fa4d2412699">instruments, the gain or loss from the time of de-designation through maturity of the instrument is recognized in earnings. Any gain or loss in AOCI at the time of de-designation is reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. Refer to &#8220;Note 21. Accumulated Other Comprehensive Income&#8221; for further information regarding the effect of hedging instruments on the consolidated statements of income for the years ended December 31, 2021, 2020, and 2019.</ix:continuation></span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic6fda4546efd4b69a4d18fa4d2412699">We enter into master netting arrangements with the counterparties to our derivative transactions which permit certain outstanding receivables and payables to be offset in the event of default. Our derivative contracts do not require either party to post cash collateral. We elect to present our derivative assets and liabilities in the accompanying consolidated balance sheets on a gross basis. All cash flows related to our foreign currency exchange contracts are classified as operating cash flows, which is consistent with the cash flow treatment of the underlying items being hedged.</ix:continuation>&#160;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to "Note 18. Fair Value Measurements" for additional information regarding the fair value of our derivative instruments and "Note 21. Accumulated Other Comprehensive Income" for additional information regarding the effect of derivative instruments designated as cash flow hedges on the consolidated statements of income.&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Flow Hedges</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have designated our foreign currency exchange contracts as cash flow hedges as these derivative instruments mitigate the exposure to variability in the cash flows of forecasted transactions attributable to foreign currency exchange. Unless noted otherwise, we have also designated our derivative instruments as qualifying for hedge accounting treatment.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not de-designate any instruments from hedge accounting treatment during the years ended December 31, 2021, 2020, and 2019. Gains and losses related to hedge ineffectiveness recognized in earnings during the years ended December 31, 2021, 2020, and 2019 were not material.&#160;At December 31, 2021, the estimated amount of net gains, net of tax, which are expected to be reclassified out of AOCI and into earnings within the next twelve months is $<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-5" name="us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90ZXh0cmVnaW9uOjQ3YTdmNzg2NDkyZjQwZmRiNDY3NDE3ODk2OWU4NTc0XzUwNzQ_71e2d97f-1037-4486-9dec-afd768c82d9b">5.0</ix:nonFraction> million if exchange rates do not fluctuate from the levels at December 31, 2021.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We target to hedge approximately <ix:nonFraction unitRef="number" contextRef="i464c41d2cb9948979da5af09e9a6709b_D20210101-20211231" decimals="2" name="idxx:CashFlowHedgeHedgePercentageOfEstimatedExposureFromIntercompanyProductsPurchasesAndSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90ZXh0cmVnaW9uOjQ3YTdmNzg2NDkyZjQwZmRiNDY3NDE3ODk2OWU4NTc0XzI3NDg3NzkwNzk0OTg_9afae603-32c6-49f1-94e5-fe57181c860e">75</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i2547ad5bc951453f98e34b5d0f26b8bb_D20210101-20211231" decimals="2" name="idxx:CashFlowHedgeHedgePercentageOfEstimatedExposureFromIntercompanyProductsPurchasesAndSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90ZXh0cmVnaW9uOjQ3YTdmNzg2NDkyZjQwZmRiNDY3NDE3ODk2OWU4NTc0XzUxNzA_16e160e6-c9c6-4925-881a-798df3928f07">85</ix:nonFraction>% of the estimated exposure from intercompany product purchases and sales denominated in the euro, British pound, Canadian dollar, Japanese yen, and Australian dollar. We have additional unhedged foreign currency exposures related to foreign services and emerging markets where it is not practical to hedge.&#160;We primarily utilize foreign currency exchange contracts with durations of less than <ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:MaximumLengthOfTimeForeignCurrencyCashFlowHedge" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90ZXh0cmVnaW9uOjQ3YTdmNzg2NDkyZjQwZmRiNDY3NDE3ODk2OWU4NTc0XzU1NjQ_36b21f9a-9092-4946-86f8-95af4719f268">24</ix:nonNumeric> months. Quarterly, we enter into contracts to hedge incremental portions of anticipated foreign currency transactions for the current and following year. As a result, our risk with respect to foreign currency exchange rate fluctuations and the notional value of foreign currency exchange contracts may vary throughout the year.&#160;The U.S. dollar is the currency purchased or sold in all of our foreign currency exchange contracts. The notional amount of foreign currency exchange contracts to hedge forecasted intercompany inventory purchases and sales totaled $<ix:nonFraction unitRef="usd" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90ZXh0cmVnaW9uOjQ3YTdmNzg2NDkyZjQwZmRiNDY3NDE3ODk2OWU4NTc0XzYxMTk_86eaaa49-452b-4e29-ad3f-79538dfb33d6">286.7</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90ZXh0cmVnaW9uOjQ3YTdmNzg2NDkyZjQwZmRiNDY3NDE3ODk2OWU4NTc0XzYxMjc_b66cb1f5-20ff-4e70-bc53-236d3f2ea076">202.7</ix:nonFraction> million at December 31, 2021 and 2020, respectively.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90ZXh0cmVnaW9uOjQ3YTdmNzg2NDkyZjQwZmRiNDY3NDE3ODk2OWU4NTc0Xzk2ODE_3e336ef9-de29-40a6-a6d6-05a350a3fae6" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the effect of cash flow hedge accounting on our consolidated statements of income and comprehensive income, and provides information regarding the location and amounts of pretax gains or losses of derivatives:&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:43.017%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.164%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.579%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Financial statement line items in which effects of cash flow hedges are recorded</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTo2OWI5YWRjNWU4YTg0YWU4ODMxOTQ5Y2QzMWZmYTE0OS90YWJsZXJhbmdlOjY5YjlhZGM1ZThhODRhZTg4MzE5NDljZDMxZmZhMTQ5XzMtNC0xLTEtMA_5e6e1013-88e6-4f58-b8e9-1d99859cb168">1,325,928</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTo2OWI5YWRjNWU4YTg0YWU4ODMxOTQ5Y2QzMWZmYTE0OS90YWJsZXJhbmdlOjY5YjlhZGM1ZThhODRhZTg4MzE5NDljZDMxZmZhMTQ5XzMtNi0xLTEtMA_a393cad8-0900-4aa9-82a0-16f2d924bf7e">1,135,615</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTo2OWI5YWRjNWU4YTg0YWU4ODMxOTQ5Y2QzMWZmYTE0OS90YWJsZXJhbmdlOjY5YjlhZGM1ZThhODRhZTg4MzE5NDljZDMxZmZhMTQ5XzMtOC0xLTEtMA_2e7ee554-bb18-42b5-ae63-21ba55260d1b">1,041,359</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount of (loss) gain reclassified from accumulated other comprehensive income into income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1ef4a96731942908ce11fe9891aa0bf_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTo2OWI5YWRjNWU4YTg0YWU4ODMxOTQ5Y2QzMWZmYTE0OS90YWJsZXJhbmdlOjY5YjlhZGM1ZThhODRhZTg4MzE5NDljZDMxZmZhMTQ5XzUtNC0xLTEtMA_9e2e73f5-5240-45d5-9107-951cff0362c5">7,121</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c53b6812ef44e0a021ef872c3e03e2_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTo2OWI5YWRjNWU4YTg0YWU4ODMxOTQ5Y2QzMWZmYTE0OS90YWJsZXJhbmdlOjY5YjlhZGM1ZThhODRhZTg4MzE5NDljZDMxZmZhMTQ5XzUtNi0xLTEtMA_c366acea-b1ec-464b-bc5b-5fe9362ae34f">829</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12d3943c8fa0485b86f83616b4c036c1_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTo2OWI5YWRjNWU4YTg0YWU4ODMxOTQ5Y2QzMWZmYTE0OS90YWJsZXJhbmdlOjY5YjlhZGM1ZThhODRhZTg4MzE5NDljZDMxZmZhMTQ5XzUtOC0xLTEtMA_96fe87c8-b44d-4a1c-9c86-281bf3ffc281">10,628</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Investment Hedges, Euro-Denominated Notes</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2015, we issued and sold through a private placement an aggregate principal amount of &#8364;<ix:nonFraction unitRef="eur" contextRef="ie463159bdbe0401fa1699ea9bbc087e7_I20150630" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90ZXh0cmVnaW9uOjQ3YTdmNzg2NDkyZjQwZmRiNDY3NDE3ODk2OWU4NTc0XzY1NDY_4f3937b8-7c27-438e-afb3-7772d4dd7c52">88.9</ix:nonFraction> million in euro-denominated <ix:nonFraction unitRef="number" contextRef="ie463159bdbe0401fa1699ea9bbc087e7_I20150630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90ZXh0cmVnaW9uOjQ3YTdmNzg2NDkyZjQwZmRiNDY3NDE3ODk2OWU4NTc0XzY1Njk_2a157f92-e783-449b-a4c5-ac95e95fd536">1.785</ix:nonFraction>% Series C Senior Notes due June 18, 2025. We have designated these euro-denominated notes as a hedge of our euro net investment in certain foreign subsidiaries to reduce the volatility in stockholders&#8217; equity caused by changes in foreign currency exchange rates in the euro relative to the U.S. dollar. As a result of this designation, gains and losses from the change in translated U.S. dollar value of these euro-denominated notes are recorded in AOCI rather than to earnings. We recorded a gain of $<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-5" name="idxx:OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90ZXh0cmVnaW9uOjQ3YTdmNzg2NDkyZjQwZmRiNDY3NDE3ODk2OWU4NTc0XzcwNzI_ea8c6c5d-434a-4064-b72b-e5fcfa7a2d43">6.4</ix:nonFraction> million, a loss of $<ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-5" sign="-" name="idxx:OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90ZXh0cmVnaW9uOjQ3YTdmNzg2NDkyZjQwZmRiNDY3NDE3ODk2OWU4NTc0XzcwODg_3b6efe8a-f33b-4503-b0ff-184dd6ce8021">7.4</ix:nonFraction> million, and a gain of $<ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-5" name="idxx:OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90ZXh0cmVnaW9uOjQ3YTdmNzg2NDkyZjQwZmRiNDY3NDE3ODk2OWU4NTc0XzcwOTU_7063a241-3163-401e-87f9-342e33568887">1.8</ix:nonFraction> million, net of tax, within AOCI as a result of this net </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ieb6214616ee04c6bb929859d32261519" continuedAt="i507103c8679048468d47d2234e52bad0"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">investment hedge for the years ended December 31, 2021, 2020, and 2019, respectively. The related cumulative unrealized gain recorded at December 31, 2021, will not be reclassified in earnings until the complete or substantially complete liquidation of the net investment in the hedged foreign operations or all or a portion of the hedge no longer qualifies for hedge accounting treatment. Refer to "Note 13. Debt" to the consolidated financial statements included in this Annual Report on Form 10-K for further information regarding the issuance of these euro-denominated notes.&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Investment Hedges, Cross Currency Swaps</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into several cross currency swap contracts as a hedge of our net investment in foreign operations to offset foreign currency translation gains and losses on the net investment. These cross currency swaps have maturity dates beginning on June 30, 2023, through June 18, 2025. At maturity of the cross currency swap contracts, we will deliver the notional amounts of&#160;&#8364;<ix:nonFraction unitRef="eur" contextRef="i78c0899cc8ce4403916f4aed0daa467b_I20211231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90ZXh0cmVnaW9uOjQ3YTdmNzg2NDkyZjQwZmRiNDY3NDE3ODk2OWU4NTc0XzgxMTY_e74fc6c6-53bf-4d15-b28d-270c53796cdb">90.0</ix:nonFraction> million and will receive approximately&#160;$<ix:nonFraction unitRef="usd" contextRef="i500dd303994d474bb3c6133348ce968f_D20230630-20230630" decimals="-5" name="us-gaap:ProceedsFromHedgeInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90ZXh0cmVnaW9uOjQ3YTdmNzg2NDkyZjQwZmRiNDY3NDE3ODk2OWU4NTc0XzgxNTA_5bc1dcdc-04b0-4751-967b-e310ef050b07">104.5</ix:nonFraction> million&#160;from the counterparties on June 30, 2023, and we will deliver the notional amount of &#8364;<ix:nonFraction unitRef="eur" contextRef="ied1674e5cf1c49dab027aef8b772a006_I20211231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90ZXh0cmVnaW9uOjQ3YTdmNzg2NDkyZjQwZmRiNDY3NDE3ODk2OWU4NTc0XzgyMzg_9eb844c2-c487-454b-aaab-756db61559de">15.0</ix:nonFraction> million and will receive approximately $<ix:nonFraction unitRef="usd" contextRef="i29716f7451ce47209ffc3a126855c5bc_D20250618-20250618" decimals="-5" name="us-gaap:ProceedsFromHedgeInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90ZXh0cmVnaW9uOjQ3YTdmNzg2NDkyZjQwZmRiNDY3NDE3ODk2OWU4NTc0XzgyNzI_8ed2eb99-9cbe-431c-b203-d6f091e6253f">17.5</ix:nonFraction> million from the counterparties on June 18, 2025. The change in fair value of the cross currency swap contracts are recorded in AOCI and will be reclassified to earnings when the foreign subsidiaries are sold or substantially liquidated. We recorded a gain of $<ix:nonFraction unitRef="usd" contextRef="i2d594a7833ec49b39f9b6d981b10a581_D20210101-20211231" decimals="-5" name="idxx:OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90ZXh0cmVnaW9uOjQ3YTdmNzg2NDkyZjQwZmRiNDY3NDE3ODk2OWU4NTc0Xzg1Mjc_86ed7eaa-32e9-4d85-8901-52b3cbba12b1">5.4</ix:nonFraction> million, a loss of $<ix:nonFraction unitRef="usd" contextRef="id2a5f0696ab0404987ffb0a495402d7d_D20200101-20201231" decimals="-5" sign="-" name="idxx:OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90ZXh0cmVnaW9uOjQ3YTdmNzg2NDkyZjQwZmRiNDY3NDE3ODk2OWU4NTc0Xzg1NDE_aeb1af32-1a28-4330-966b-a833659ed971">5.6</ix:nonFraction> million, and a gain of $<ix:nonFraction unitRef="usd" contextRef="i2c94572bec9745c49286936d60cee01c_D20190101-20191231" decimals="-5" name="idxx:OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90ZXh0cmVnaW9uOjQ3YTdmNzg2NDkyZjQwZmRiNDY3NDE3ODk2OWU4NTc0XzEwOTk1MTE2Mzc1ODY_08ca0047-be9a-404e-a6fd-94a89f7e5d4d">2.1</ix:nonFraction> million, net of tax, within AOCI as a result of these net investment hedges, during the&#160;years ended&#160;December 31, 2021, 2020, and 2019, respectively. We will receive quarterly interest payments from the counterparties based on a fixed interest rate until maturity of the cross currency swaps. This interest rate component is excluded from the assessment of hedge effectiveness and, thus, is recognized as a reduction to interest expense over the life of the hedge instrument. We recognized approximately&#160;$<ix:nonFraction unitRef="usd" contextRef="i2d594a7833ec49b39f9b6d981b10a581_D20210101-20211231" decimals="-5" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90ZXh0cmVnaW9uOjQ3YTdmNzg2NDkyZjQwZmRiNDY3NDE3ODk2OWU4NTc0XzkwMzk_1bc30d5b-587d-4d6c-835e-5002b0bfbf70">2.8</ix:nonFraction> million&#160;and $<ix:nonFraction unitRef="usd" contextRef="id2a5f0696ab0404987ffb0a495402d7d_D20200101-20201231" decimals="-5" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90ZXh0cmVnaW9uOjQ3YTdmNzg2NDkyZjQwZmRiNDY3NDE3ODk2OWU4NTc0XzkwNDY_839b50e8-08b2-4259-8737-23a763e9941d">2.7</ix:nonFraction> million related to the excluded component as a reduction of interest expense for the&#160;years ended&#160;December 31, 2021 and 2020, respectively.&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Values of Hedging Instruments Designated as Hedges in Consolidated Balance Sheets</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90ZXh0cmVnaW9uOjQ3YTdmNzg2NDkyZjQwZmRiNDY3NDE3ODk2OWU4NTc0Xzk2ODQ_111f5e4c-66fc-4499-9448-94371cd4e969" continuedAt="i3506da15eec14484b60f8b5ccf8d0e39" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of hedging instruments, their respective classification on the consolidated balance sheets, and amounts subject to offset under master netting arrangements consisted of the following derivative instruments, unless otherwise noted:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:47.798%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.786%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.905%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.909%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Hedging Assets</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives and non-derivatives designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i545077a6c3224507841852d11c8c9273_I20211231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTpjOTUxZDgwMjNhMGY0YmQ0YmNhNDZjOWUzYWQ2NjZmNC90YWJsZXJhbmdlOmM5NTFkODAyM2EwZjRiZDRiY2E0NmM5ZTNhZDY2NmY0XzQtNC0xLTEtMA_5faeb018-3c8d-4cf2-b46f-6fce5e64b11d">6,512</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfce4063123c459eb84ed75e6fc79108_I20201231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTpjOTUxZDgwMjNhMGY0YmQ0YmNhNDZjOWUzYWQ2NjZmNC90YWJsZXJhbmdlOmM5NTFkODAyM2EwZjRiZDRiY2E0NmM5ZTNhZDY2NmY0XzQtNi0xLTEtMA_40c4a849-8d00-4aa9-939b-0b876caf477e">125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross currency swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacbb16db3cb7452eb84960f47dc683ab_I20211231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTpjOTUxZDgwMjNhMGY0YmQ0YmNhNDZjOWUzYWQ2NjZmNC90YWJsZXJhbmdlOmM5NTFkODAyM2EwZjRiZDRiY2E0NmM5ZTNhZDY2NmY0XzUtNC0xLTEtMA_945511e4-8d83-479e-b045-e5bee7ea9447">4,256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i050978c75e2a45678abaff399b9bc5f6_I20201231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTpjOTUxZDgwMjNhMGY0YmQ0YmNhNDZjOWUzYWQ2NjZmNC90YWJsZXJhbmdlOmM5NTFkODAyM2EwZjRiZDRiY2E0NmM5ZTNhZDY2NmY0XzUtNi0xLTEtMA_6f090a6a-7527-4299-9042-d52744413b6e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total derivative instruments presented as hedge instruments on the balance sheet</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4698c4affbf4e699d54f34e5350d605_I20211231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTpjOTUxZDgwMjNhMGY0YmQ0YmNhNDZjOWUzYWQ2NjZmNC90YWJsZXJhbmdlOmM5NTFkODAyM2EwZjRiZDRiY2E0NmM5ZTNhZDY2NmY0XzctNC0xLTEtMA_99a68cbf-16af-430a-85f7-4ad30ac64b12">10,768</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06a7e9fd40ce477ebb37684aa46d2543_I20201231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTpjOTUxZDgwMjNhMGY0YmQ0YmNhNDZjOWUzYWQ2NjZmNC90YWJsZXJhbmdlOmM5NTFkODAyM2EwZjRiZDRiY2E0NmM5ZTNhZDY2NmY0XzctNi0xLTEtMA_32ec2fd2-5695-4927-bb71-fc397cad1b03">125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross amounts subject to master netting arrangements not offset on the balance sheet</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4698c4affbf4e699d54f34e5350d605_I20211231" decimals="-3" name="us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTpjOTUxZDgwMjNhMGY0YmQ0YmNhNDZjOWUzYWQ2NjZmNC90YWJsZXJhbmdlOmM5NTFkODAyM2EwZjRiZDRiY2E0NmM5ZTNhZDY2NmY0XzgtNC0xLTEtMA_7ed81def-e3ba-4ca1-89ed-557f774fa7e3">601</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i06a7e9fd40ce477ebb37684aa46d2543_I20201231" decimals="-3" name="us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTpjOTUxZDgwMjNhMGY0YmQ0YmNhNDZjOWUzYWQ2NjZmNC90YWJsZXJhbmdlOmM5NTFkODAyM2EwZjRiZDRiY2E0NmM5ZTNhZDY2NmY0XzgtNi0xLTEtMA_a08dfdec-7edd-4e7f-ba61-cb3d080dd740">125</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net amount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4698c4affbf4e699d54f34e5350d605_I20211231" decimals="-3" name="us-gaap:DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTpjOTUxZDgwMjNhMGY0YmQ0YmNhNDZjOWUzYWQ2NjZmNC90YWJsZXJhbmdlOmM5NTFkODAyM2EwZjRiZDRiY2E0NmM5ZTNhZDY2NmY0XzktNC0xLTEtMA_9a620fcd-f79b-46e1-beda-3d9a895d83e9">10,167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06a7e9fd40ce477ebb37684aa46d2543_I20201231" decimals="-3" name="us-gaap:DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTpjOTUxZDgwMjNhMGY0YmQ0YmNhNDZjOWUzYWQ2NjZmNC90YWJsZXJhbmdlOmM5NTFkODAyM2EwZjRiZDRiY2E0NmM5ZTNhZDY2NmY0XzktNi0xLTEtMA_80a8f4a4-4762-4210-bf42-9c7cdca26a46">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:1pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:1pt"><span style="font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%"></span></div><ix:continuation id="i507103c8679048468d47d2234e52bad0"><ix:continuation id="i3506da15eec14484b60f8b5ccf8d0e39"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:47.798%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.786%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.905%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.909%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Hedging Liabilities</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives and non-derivatives designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie64c1bfe251d4ea8a0ed2f0eea68ad6d_I20211231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTpjZDhkNzc4YzI1YjA0YjU1OTk4YWFjNTNmOWM3MjRkMC90YWJsZXJhbmdlOmNkOGQ3NzhjMjViMDRiNTU5OThhYWM1M2Y5YzcyNGQwXzQtNC0xLTEtMA_0fb65aeb-0fdb-4bb5-a49c-5549944ae41e">601</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22e9c32bb1ff4a549672a6a6a514fca9_I20201231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTpjZDhkNzc4YzI1YjA0YjU1OTk4YWFjNTNmOWM3MjRkMC90YWJsZXJhbmdlOmNkOGQ3NzhjMjViMDRiNTU5OThhYWM1M2Y5YzcyNGQwXzQtNi0xLTEtMA_2b8e1d67-1d99-4833-85fe-80ef63287b85">12,373</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross currency swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e5cf4395f024a8996343fcdfd9b3ca3_I20211231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTpjZDhkNzc4YzI1YjA0YjU1OTk4YWFjNTNmOWM3MjRkMC90YWJsZXJhbmdlOmNkOGQ3NzhjMjViMDRiNTU5OThhYWM1M2Y5YzcyNGQwXzYtNC0xLTEtMA_6ea8f02e-0acc-4ae0-8869-79e6a860a657">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i286b8b14cd394335903921c6ba48d7f5_I20201231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTpjZDhkNzc4YzI1YjA0YjU1OTk4YWFjNTNmOWM3MjRkMC90YWJsZXJhbmdlOmNkOGQ3NzhjMjViMDRiNTU5OThhYWM1M2Y5YzcyNGQwXzYtNi0xLTEtMA_3e87daea-8155-4a9a-94f8-b6c25c0de55f">2,841</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total derivative instruments presented as cash flow hedges on the balance sheet</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91aaaf38003044fe91000cefb4286f16_I20211231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTpjZDhkNzc4YzI1YjA0YjU1OTk4YWFjNTNmOWM3MjRkMC90YWJsZXJhbmdlOmNkOGQ3NzhjMjViMDRiNTU5OThhYWM1M2Y5YzcyNGQwXzctNC0xLTEtMA_ee2db50f-ecfd-4e5c-9705-0d0f47fbbf74">601</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie944714e2148495fabc8b885bf09a852_I20201231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTpjZDhkNzc4YzI1YjA0YjU1OTk4YWFjNTNmOWM3MjRkMC90YWJsZXJhbmdlOmNkOGQ3NzhjMjViMDRiNTU5OThhYWM1M2Y5YzcyNGQwXzctNi0xLTEtMA_fd764ab6-6914-4719-92f8-c2e92e7dca77">15,214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-derivative foreign currency denominated debt designated as net investment hedge on the balance sheet </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i051a71adeb9449eea0629393ed4795bc_I20211231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTpjZDhkNzc4YzI1YjA0YjU1OTk4YWFjNTNmOWM3MjRkMC90YWJsZXJhbmdlOmNkOGQ3NzhjMjViMDRiNTU5OThhYWM1M2Y5YzcyNGQwXzgtNC0xLTEtMA_4199c02c-5a57-4e5a-93d6-dda6603f7595">100,711</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53807fb41e524bf69fec4117ad94a99b_I20201231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTpjZDhkNzc4YzI1YjA0YjU1OTk4YWFjNTNmOWM3MjRkMC90YWJsZXJhbmdlOmNkOGQ3NzhjMjViMDRiNTU5OThhYWM1M2Y5YzcyNGQwXzgtNi0xLTEtMA_499452f6-c182-4f82-8603-ce9dc0c87805">109,125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total hedging instruments presented on the balance sheet</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4698c4affbf4e699d54f34e5350d605_I20211231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTpjZDhkNzc4YzI1YjA0YjU1OTk4YWFjNTNmOWM3MjRkMC90YWJsZXJhbmdlOmNkOGQ3NzhjMjViMDRiNTU5OThhYWM1M2Y5YzcyNGQwXzktNC0xLTEtMA_692b6834-50c7-4832-9e5f-d358b7a7499e">101,312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06a7e9fd40ce477ebb37684aa46d2543_I20201231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTpjZDhkNzc4YzI1YjA0YjU1OTk4YWFjNTNmOWM3MjRkMC90YWJsZXJhbmdlOmNkOGQ3NzhjMjViMDRiNTU5OThhYWM1M2Y5YzcyNGQwXzktNi0xLTEtMA_c320d88f-3dd0-4631-b290-de9cddcc1d4f">124,339</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross amounts subject to master netting arrangements not offset on the balance sheet</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4698c4affbf4e699d54f34e5350d605_I20211231" decimals="-3" name="us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTpjZDhkNzc4YzI1YjA0YjU1OTk4YWFjNTNmOWM3MjRkMC90YWJsZXJhbmdlOmNkOGQ3NzhjMjViMDRiNTU5OThhYWM1M2Y5YzcyNGQwXzEwLTQtMS0xLTA_e52e0bec-5a12-4e16-a4ee-167fb6e7050d">601</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i06a7e9fd40ce477ebb37684aa46d2543_I20201231" decimals="-3" name="us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTpjZDhkNzc4YzI1YjA0YjU1OTk4YWFjNTNmOWM3MjRkMC90YWJsZXJhbmdlOmNkOGQ3NzhjMjViMDRiNTU5OThhYWM1M2Y5YzcyNGQwXzEwLTYtMS0xLTA_0e39b81c-c911-4c8b-a424-7a8f26b029c5">125</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net amount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4698c4affbf4e699d54f34e5350d605_I20211231" decimals="-3" name="us-gaap:DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTpjZDhkNzc4YzI1YjA0YjU1OTk4YWFjNTNmOWM3MjRkMC90YWJsZXJhbmdlOmNkOGQ3NzhjMjViMDRiNTU5OThhYWM1M2Y5YzcyNGQwXzExLTQtMS0xLTA_67a3b278-0b23-49ad-82b6-00debbefc458">100,711</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06a7e9fd40ce477ebb37684aa46d2543_I20201231" decimals="-3" name="us-gaap:DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTpjZDhkNzc4YzI1YjA0YjU1OTk4YWFjNTNmOWM3MjRkMC90YWJsZXJhbmdlOmNkOGQ3NzhjMjViMDRiNTU5OThhYWM1M2Y5YzcyNGQwXzExLTYtMS0xLTA_d8991ad3-cd4e-4779-9d14-4c1bc2e6fb22">124,214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts represent reported carrying amounts of our foreign currency denominated debt. Refer to "Note 18. Fair Value Measurements" for information regarding the fair value of our long-term debt.</span></div></ix:continuation></ix:continuation><div style="padding-left:27pt"><span><br/></span></div><div id="i5d795a6851d746ca914a2ddae761c329_235"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 20.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:TreasuryStockTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90ZXh0cmVnaW9uOmE5MDExODRjYTg3YTQ3ZjhiMmRmZTcwMzhhOTg5NGJmXzE0MDM_eac71fd5-f79e-4166-8c00-07bcb701bbb6" continuedAt="ief0c38ef01654cd2bc6d0d2dd36777a1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REPURCHASES OF COMMON STOCK</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></ix:nonNumeric></div><div><span><br/></span></div><ix:continuation id="ief0c38ef01654cd2bc6d0d2dd36777a1"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, our Board of Directors has authorized the repurchase of u</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">p to <ix:nonFraction unitRef="shares" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="INF" name="us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90ZXh0cmVnaW9uOmE5MDExODRjYTg3YTQ3ZjhiMmRmZTcwMzhhOTg5NGJmXzExMg_50271533-ff34-4576-85a3-0c99b4263f9d">73.0</ix:nonFraction> million sh</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ares of our common stock in the open market or in negotiated transactions pursuant to the Company&#8217;s share repurchase program. We believe that the repurchase of our common stock is a favorable means of returning value to our stockholders, and we also repurchase to offset the dilutive effect of our share-based compensation programs. Repurchases of our common stock may vary depending upon the level of other investing activities and the share price. As of December 31, 2021, there are approximate</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ly <ix:nonFraction unitRef="shares" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="-5" name="us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90ZXh0cmVnaW9uOmE5MDExODRjYTg3YTQ3ZjhiMmRmZTcwMzhhOTg5NGJmXzYwMQ_5cfae2fa-447e-42ac-aa0b-24f0d2b1f088">5.0</ix:nonFraction> million rem</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">aining shares available for repurchase under this authorization.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We primarily acquire shares by repurchases in the open market. However, we also acquire shares that are surrendered by employees in payment for the minimum required statutory withholding taxes due on the vesting of restricted stock units and the settlement of deferred stock units, otherwise referred to herein as employee surrenders. We issue shares of treasury stock upon the vesting of certain restricted stock units and upon the exercise of certain stock options. The number of shares of treasury stock issued during the years ended December 31, 2021, 2020, and 2019, was not material.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:ScheduleOfTreasuryStockByClassTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90ZXh0cmVnaW9uOmE5MDExODRjYTg3YTQ3ZjhiMmRmZTcwMzhhOTg5NGJmXzE0MDQ_265d4c45-a315-409f-a56f-db11e47b2960" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our open market common stock repurchases, reported on a trade date basis, and shares acquired through employee surrenders:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:58.490%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands, except per share amounts)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares repurchased in the open market</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="idxx:TreasuryStockSharesAcquiredNetOfTaxWithholdings" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90YWJsZTo3MWNiNTA4OGFiNGE0ZWNjYjc5MDRjMDIzNTA3ZjNjOC90YWJsZXJhbmdlOjcxY2I1MDg4YWI0YTRlY2NiNzkwNGMwMjM1MDdmM2M4XzMtMi0xLTEtMA_1ccf71e7-1408-4e66-944a-32034a2165a5">1,283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="idxx:TreasuryStockSharesAcquiredNetOfTaxWithholdings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90YWJsZTo3MWNiNTA4OGFiNGE0ZWNjYjc5MDRjMDIzNTA3ZjNjOC90YWJsZXJhbmdlOjcxY2I1MDg4YWI0YTRlY2NiNzkwNGMwMjM1MDdmM2M4XzMtNC0xLTEtMA_e71c9a59-957b-4112-b1a3-6b28ee37cd62">721</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="idxx:TreasuryStockSharesAcquiredNetOfTaxWithholdings" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90YWJsZTo3MWNiNTA4OGFiNGE0ZWNjYjc5MDRjMDIzNTA3ZjNjOC90YWJsZXJhbmdlOjcxY2I1MDg4YWI0YTRlY2NiNzkwNGMwMjM1MDdmM2M4XzMtNi0xLTEtMA_5ebb0529-b87d-4ec6-9fec-9b25e699795d">1,215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares acquired through employee surrenders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">for statutory tax withholding</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90YWJsZTo3MWNiNTA4OGFiNGE0ZWNjYjc5MDRjMDIzNTA3ZjNjOC90YWJsZXJhbmdlOjcxY2I1MDg4YWI0YTRlY2NiNzkwNGMwMjM1MDdmM2M4XzQtMi0xLTEtMA_86c51f0d-7ee6-4db4-b10d-8569eddc04a3">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90YWJsZTo3MWNiNTA4OGFiNGE0ZWNjYjc5MDRjMDIzNTA3ZjNjOC90YWJsZXJhbmdlOjcxY2I1MDg4YWI0YTRlY2NiNzkwNGMwMjM1MDdmM2M4XzQtNC0xLTEtMA_74c348a9-1406-42c0-9e3b-2161c4e3bde6">58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90YWJsZTo3MWNiNTA4OGFiNGE0ZWNjYjc5MDRjMDIzNTA3ZjNjOC90YWJsZXJhbmdlOjcxY2I1MDg4YWI0YTRlY2NiNzkwNGMwMjM1MDdmM2M4XzQtNi0xLTEtMA_6756142d-db7a-462a-9860-7600224b326c">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total shares repurchased</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90YWJsZTo3MWNiNTA4OGFiNGE0ZWNjYjc5MDRjMDIzNTA3ZjNjOC90YWJsZXJhbmdlOjcxY2I1MDg4YWI0YTRlY2NiNzkwNGMwMjM1MDdmM2M4XzUtMi0xLTEtMA_1dc6a3da-de1a-4ad6-ba05-343f69597a18">1,312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90YWJsZTo3MWNiNTA4OGFiNGE0ZWNjYjc5MDRjMDIzNTA3ZjNjOC90YWJsZXJhbmdlOjcxY2I1MDg4YWI0YTRlY2NiNzkwNGMwMjM1MDdmM2M4XzUtNC0xLTEtMA_2508de74-c954-4e3d-bcc9-dc8908af35a6">779</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90YWJsZTo3MWNiNTA4OGFiNGE0ZWNjYjc5MDRjMDIzNTA3ZjNjOC90YWJsZXJhbmdlOjcxY2I1MDg4YWI0YTRlY2NiNzkwNGMwMjM1MDdmM2M4XzUtNi0xLTEtMA_1ff21611-120f-468d-8278-7adbb65c0941">1,254</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of shares repurchased in the open market</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="idxx:TreasuryStockValueAcquiredCostMethodNetOfTaxWithholdings" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90YWJsZTo3MWNiNTA4OGFiNGE0ZWNjYjc5MDRjMDIzNTA3ZjNjOC90YWJsZXJhbmdlOjcxY2I1MDg4YWI0YTRlY2NiNzkwNGMwMjM1MDdmM2M4XzctMi0xLTEtMA_4657cdba-4deb-4e9b-a946-6195ba0b624e">755,545</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="idxx:TreasuryStockValueAcquiredCostMethodNetOfTaxWithholdings" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90YWJsZTo3MWNiNTA4OGFiNGE0ZWNjYjc5MDRjMDIzNTA3ZjNjOC90YWJsZXJhbmdlOjcxY2I1MDg4YWI0YTRlY2NiNzkwNGMwMjM1MDdmM2M4XzctNC0xLTEtMA_e0e51326-7153-4b9f-886a-e6da43a380cc">179,623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="idxx:TreasuryStockValueAcquiredCostMethodNetOfTaxWithholdings" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90YWJsZTo3MWNiNTA4OGFiNGE0ZWNjYjc5MDRjMDIzNTA3ZjNjOC90YWJsZXJhbmdlOjcxY2I1MDg4YWI0YTRlY2NiNzkwNGMwMjM1MDdmM2M4XzctNi0xLTEtMA_535e762e-08a0-4b52-bb39-c516eb2be303">303,838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of shares for employee surrenders</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90YWJsZTo3MWNiNTA4OGFiNGE0ZWNjYjc5MDRjMDIzNTA3ZjNjOC90YWJsZXJhbmdlOjcxY2I1MDg4YWI0YTRlY2NiNzkwNGMwMjM1MDdmM2M4XzgtMi0xLTEtMA_105ee9a1-37b5-4cda-b520-ae1565edb668">15,562</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90YWJsZTo3MWNiNTA4OGFiNGE0ZWNjYjc5MDRjMDIzNTA3ZjNjOC90YWJsZXJhbmdlOjcxY2I1MDg4YWI0YTRlY2NiNzkwNGMwMjM1MDdmM2M4XzgtNC0xLTEtMA_00b84eae-5af4-4df6-a9b8-dfa01b58f1fc">20,603</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90YWJsZTo3MWNiNTA4OGFiNGE0ZWNjYjc5MDRjMDIzNTA3ZjNjOC90YWJsZXJhbmdlOjcxY2I1MDg4YWI0YTRlY2NiNzkwNGMwMjM1MDdmM2M4XzgtNi0xLTEtMA_d2f68903-d7b2-4880-8622-37d94b67e271">8,054</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total cost of shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90YWJsZTo3MWNiNTA4OGFiNGE0ZWNjYjc5MDRjMDIzNTA3ZjNjOC90YWJsZXJhbmdlOjcxY2I1MDg4YWI0YTRlY2NiNzkwNGMwMjM1MDdmM2M4XzktMi0xLTEtMA_fc8be775-42a0-43ed-a134-4d9e5c5ffdfc">771,107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90YWJsZTo3MWNiNTA4OGFiNGE0ZWNjYjc5MDRjMDIzNTA3ZjNjOC90YWJsZXJhbmdlOjcxY2I1MDg4YWI0YTRlY2NiNzkwNGMwMjM1MDdmM2M4XzktNC0xLTEtMA_9cb34eef-a052-4cdc-89e5-5c24487ab0ab">200,226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90YWJsZTo3MWNiNTA4OGFiNGE0ZWNjYjc5MDRjMDIzNTA3ZjNjOC90YWJsZXJhbmdlOjcxY2I1MDg4YWI0YTRlY2NiNzkwNGMwMjM1MDdmM2M4XzktNi0xLTEtMA_a3cfe86c-2ef9-46f9-bdf2-8105de875d76">311,892</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average cost per share - open market repurchases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="2" name="idxx:TreasuryStockAcquiredAverageCostPerShareOpenMarketRepurchase" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90YWJsZTo3MWNiNTA4OGFiNGE0ZWNjYjc5MDRjMDIzNTA3ZjNjOC90YWJsZXJhbmdlOjcxY2I1MDg4YWI0YTRlY2NiNzkwNGMwMjM1MDdmM2M4XzExLTItMS0xLTA_f1833ebb-7ea5-4917-9566-b9e02be28d2d">588.58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="2" name="idxx:TreasuryStockAcquiredAverageCostPerShareOpenMarketRepurchase" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90YWJsZTo3MWNiNTA4OGFiNGE0ZWNjYjc5MDRjMDIzNTA3ZjNjOC90YWJsZXJhbmdlOjcxY2I1MDg4YWI0YTRlY2NiNzkwNGMwMjM1MDdmM2M4XzExLTQtMS0xLTA_6103534d-fe9b-4ef2-bade-bb7a386e45bb">249.20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="2" name="idxx:TreasuryStockAcquiredAverageCostPerShareOpenMarketRepurchase" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90YWJsZTo3MWNiNTA4OGFiNGE0ZWNjYjc5MDRjMDIzNTA3ZjNjOC90YWJsZXJhbmdlOjcxY2I1MDg4YWI0YTRlY2NiNzkwNGMwMjM1MDdmM2M4XzExLTYtMS0xLTA_1463264d-1e90-486a-a9b2-0c7ef8817a19">249.84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average cost per share - employee surrenders</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="2" name="idxx:TreasuryStockAcquiredAverageCostPerShareEmployeeSurrenders" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90YWJsZTo3MWNiNTA4OGFiNGE0ZWNjYjc5MDRjMDIzNTA3ZjNjOC90YWJsZXJhbmdlOjcxY2I1MDg4YWI0YTRlY2NiNzkwNGMwMjM1MDdmM2M4XzEyLTItMS0xLTA_7719d257-204f-4314-8f74-0aa6c81c446f">548.08</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="2" name="idxx:TreasuryStockAcquiredAverageCostPerShareEmployeeSurrenders" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90YWJsZTo3MWNiNTA4OGFiNGE0ZWNjYjc5MDRjMDIzNTA3ZjNjOC90YWJsZXJhbmdlOjcxY2I1MDg4YWI0YTRlY2NiNzkwNGMwMjM1MDdmM2M4XzEyLTQtMS0xLTA_e5b531e4-7b89-4621-8db2-7c34ef97e703">354.98</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="2" name="idxx:TreasuryStockAcquiredAverageCostPerShareEmployeeSurrenders" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90YWJsZTo3MWNiNTA4OGFiNGE0ZWNjYjc5MDRjMDIzNTA3ZjNjOC90YWJsZXJhbmdlOjcxY2I1MDg4YWI0YTRlY2NiNzkwNGMwMjM1MDdmM2M4XzEyLTYtMS0xLTA_f85092fe-4840-4438-8d6a-a9dbeffd0630">210.10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average cost per share - total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90YWJsZTo3MWNiNTA4OGFiNGE0ZWNjYjc5MDRjMDIzNTA3ZjNjOC90YWJsZXJhbmdlOjcxY2I1MDg4YWI0YTRlY2NiNzkwNGMwMjM1MDdmM2M4XzEzLTItMS0xLTA_c87a211e-235a-429b-bd0d-1d765fdcdde0">587.70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90YWJsZTo3MWNiNTA4OGFiNGE0ZWNjYjc5MDRjMDIzNTA3ZjNjOC90YWJsZXJhbmdlOjcxY2I1MDg4YWI0YTRlY2NiNzkwNGMwMjM1MDdmM2M4XzEzLTQtMS0xLTA_d7a2fd49-63fe-4ddd-baaf-f013aeec42d8">257.08</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90YWJsZTo3MWNiNTA4OGFiNGE0ZWNjYjc5MDRjMDIzNTA3ZjNjOC90YWJsZXJhbmdlOjcxY2I1MDg4YWI0YTRlY2NiNzkwNGMwMjM1MDdmM2M4XzEzLTYtMS0xLTA_c71fdab6-5a26-42f1-ac32-489de5753ab2">248.62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="padding-left:27pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-47</span></div></div></div><div id="i5d795a6851d746ca914a2ddae761c329_238"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 21.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90ZXh0cmVnaW9uOjQ4ZTIzYjYxMmE1YzQwZWVhYmRhYzNmYzE5ZjVjYjA3XzE5Mw_05dc0d18-e30c-4d18-bd81-3deec9dfa695" continuedAt="iac82224dc63b4892bb357c02a631c849" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ACCUMULATED OTHER COMPREHENSIVE INCOME</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></ix:nonNumeric></div><div><span><br/></span></div><ix:continuation id="iac82224dc63b4892bb357c02a631c849"><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90ZXh0cmVnaW9uOjQ4ZTIzYjYxMmE1YzQwZWVhYmRhYzNmYzE5ZjVjYjA3XzE4OQ_61b81bab-4722-497b-bdbf-262786251152" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in AOCI, net of tax, consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:27.785%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.897%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.190%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.284%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.897%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.287%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31, 2021 and 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized (Loss) Gain on Cash Flow Hedges, Net of Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized (Loss) Gain on Net Investment Hedges, Net of Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized (Loss) Gain on Investments, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign Currency Exchange Contracts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Euro-Denominated Notes</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cross Currency Swaps</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cumulative Translation Adjustment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94d76d2a4f64ef8baf558bb1ad20c66_I20191231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzQtMi0xLTEtMA_a525912c-5896-4859-8e28-eaf6a5df33a6">110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00c84acd109f46f4b2185c4801aa483a_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzQtNC0xLTEtMA_b480b5f7-a2f8-4a7b-8dc2-bb9d826e159f">736</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i516b4d9fd6fd4bb08abfd83a2b8ece20_I20191231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzQtNi0xLTEtMA_5e7017d4-3b33-4625-ae17-009ebeedaae5">1,396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b7ca21c16c34b8ebd18b0be7aa71fb1_I20191231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzQtOC0xLTEtMA_3305d7c6-6840-42f1-a881-fc5e55f87478">3,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6aa0f83e00f94d788fc79a84dd2ef035_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzQtMTAtMS0xLTA_209630b4-4987-4f15-9a4e-0e83c9628c78">50,419</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i72ee32005bc94787a60e211d2b2aaa25_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzQtMTItMS0xLTA_191444ca-f18b-4cc0-b5e7-81f0ccf61224">46,182</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i142bd154aa264e73939304fcd4c000c4_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzUtMi0xLTEtMA_75f294b6-bf87-470b-8bcd-8d548585c920">382</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i72130b38c837460c9d490b3337d85e4d_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzUtNC0xLTEtMA_82fc8fb4-4e5f-49df-9ea7-5d25862b67bc">8,527</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6870132d22054c5ebea0784212917113_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzUtNi0xLTEtMA_4605d2f2-5502-4105-8eb4-98055add5675">7,378</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib3230b72e1154329a7f1a763ed0a1187_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzUtOC0xLTEtMA_27cb8ecd-00c5-4a11-a0b7-ea8eccf3eec8">5,626</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03c7f98144624caeae57bd38fd0dd2a5_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzUtMTAtMS0xLTA_bcb19a7a-ae61-4c40-a281-44fd72f14ffd">15,151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzUtMTItMS0xLTA_b734ea10-3e01-4307-ae6e-0cb2923c303b">6,762</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i142bd154aa264e73939304fcd4c000c4_D20200101-20201231" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzYtMi0xLTEtMA_6950000d-ddee-4c47-b26d-5578b955cf47">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i72130b38c837460c9d490b3337d85e4d_D20200101-20201231" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzYtNC0xLTEtMA_4d2f9f88-fab4-47d8-a4d1-b61e92285cc6">671</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6870132d22054c5ebea0784212917113_D20200101-20201231" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzYtNi0xLTEtMA_6bf0fba5-d9c5-46bc-a038-fe9a531c9550">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3230b72e1154329a7f1a763ed0a1187_D20200101-20201231" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzYtOC0xLTEtMA_b7dda998-3980-421f-8a09-6608857a8a34">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03c7f98144624caeae57bd38fd0dd2a5_D20200101-20201231" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzYtMTAtMS0xLTA_363c8215-958a-4229-81d7-2d0fdb8cca84">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzYtMTItMS0xLTA_b31ee764-a008-4f0c-9501-e9b480ac5997">671</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iea843d40d1ac442bba04f284af6399c9_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzctMi0xLTEtMA_e04d9cde-722e-4fe4-b618-e78cffc32a06">272</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a978f3211e44df89ba9cd591258b169_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzctNC0xLTEtMA_53991151-f210-425b-ad1d-8619e941d557">9,934</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2758281c7e1d44f1bc14207e44f8c0d7_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzctNi0xLTEtMA_62da6c3b-292a-499a-967c-49067bfa1bb8">5,982</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee2ff9304f8843b881a4c91cf1c6c997_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzctOC0xLTEtMA_e5d51a7b-a4fe-4c33-a814-11c4bedbd8b5">2,159</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i66e22c6b00494e2c8ccec8824592cb57_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzctMTAtMS0xLTA_c0febb6e-fa0e-4083-ba40-ea6627920f21">35,268</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3d475356743442ba6915b1578a8771f_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzctMTItMS0xLTA_e769cede-98e8-44e3-8aa6-6689f284549a">53,615</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d04bcb41a5b4086b6a2d38ce5f3b1a9_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzgtMi0xLTEtMA_4e360617-f4a1-4ae3-b5b3-15a23e7f1d83">146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd5c0e3eaafc4cd3b022efb186592847_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzgtNC0xLTEtMA_17c59af5-048a-44df-bc6f-bcf6339d59ab">9,139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic61a4aba587c4549ba286bb3f06809be_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzgtNi0xLTEtMA_cb8bff12-eade-497b-ad22-bdff0c9d5ae5">6,404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a726385a3934ca297a4094723c83a69_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzgtOC0xLTEtMA_4fe4f29f-f431-4721-948c-559fd3e3e6d0">5,399</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if975ef26add547cc8029bf3cfcc205a4_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzgtMTAtMS0xLTA_f01d5002-b560-44a8-8ea5-31a85b3ff56e">26,731</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzgtMTItMS0xLTA_df21352e-6d05-4883-9fc6-a80d7d295db5">5,643</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d04bcb41a5b4086b6a2d38ce5f3b1a9_D20210101-20211231" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzktMi0xLTEtMA_89ef95fc-8f42-4553-bb74-13f3b61cf6c0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd5c0e3eaafc4cd3b022efb186592847_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzktNC0xLTEtMA_883602a7-3524-4f2f-aa87-4fa451ed2b45">5,774</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic61a4aba587c4549ba286bb3f06809be_D20210101-20211231" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzktNi0xLTEtMA_96989505-0ef7-4e94-af6b-a8385d79412b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a726385a3934ca297a4094723c83a69_D20210101-20211231" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzktOC0xLTEtMA_9fe6cc43-1340-46d5-b855-6a2b866d2173">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if975ef26add547cc8029bf3cfcc205a4_D20210101-20211231" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzktMTAtMS0xLTA_7024916d-670c-465d-8e8f-dc5fa0c3c3be">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzktMTItMS0xLTA_da23849d-7480-457b-a7e5-4851ffa5a0c1">5,774</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic1cfcd32b9eb44fc909c66daaa2fdc89_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzEwLTItMS0xLTA_5c5b2946-4701-4890-b90f-92b7d3a25acc">126</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e09d47b7c249178ff89343c0d5d024_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzEwLTQtMS0xLTA_5e88ac99-14ec-428d-b062-792be53478fd">4,979</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2708e84b292c4f1bafc45174e5905b07_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzEwLTYtMS0xLTA_c80e8677-f8b5-466c-ae4e-d81fe3c7f8ec">422</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78635773a43a47999ed10eb8f309ed8a_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzEwLTgtMS0xLTA_2029448a-70ed-493f-842f-4d4a032bc1f4">3,240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifa324d754a4d4cb0ab3eb052f773e75e_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzEwLTEwLTEtMS0w_9bfc91a3-c4fa-41f4-83fc-f2af093eb493">61,999</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2aefce1f274544f1b2e978eb3e0fa0dc_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzEwLTEyLTEtMS0w_6bc5788d-c4db-428e-9615-c89dcb50e787">53,484</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90ZXh0cmVnaW9uOjQ4ZTIzYjYxMmE1YzQwZWVhYmRhYzNmYzE5ZjVjYjA3XzE4NQ_186861fe-9b3d-4603-8ca3-b748b860a990" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents components and amounts reclassified out of AOCI to net income:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"></td><td style="width:34.455%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.492%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.492%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Affected Line Item in the Statements of Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amounts Reclassified from AOCI for the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gains (losses) on derivative instruments included in net income:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie311c88fa22749e2b4cf06d52ec95566_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZTo1YjYyYTk5ODVlMTU0ZDgwOGNlMjdmMTllMTYwN2Y0MC90YWJsZXJhbmdlOjViNjJhOTk4NWUxNTRkODA4Y2UyN2YxOWUxNjA3ZjQwXzQtNC0xLTEtMA_2666b5a6-f21a-4b46-a81e-f42ee4832838">7,121</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de86e101cec44aa84d8d1454d201a7f_D20200101-20201231" decimals="-3" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZTo1YjYyYTk5ODVlMTU0ZDgwOGNlMjdmMTllMTYwN2Y0MC90YWJsZXJhbmdlOjViNjJhOTk4NWUxNTRkODA4Y2UyN2YxOWUxNjA3ZjQwXzQtNi0xLTEtMA_28741445-da35-4f25-bd69-0ead801aa446">829</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8ae9e76f2d44f91afd70c49049644e1_D20190101-20191231" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZTo1YjYyYTk5ODVlMTU0ZDgwOGNlMjdmMTllMTYwN2Y0MC90YWJsZXJhbmdlOjViNjJhOTk4NWUxNTRkODA4Y2UyN2YxOWUxNjA3ZjQwXzQtOC0xLTEtMA_394da584-0389-43db-87bb-ce0166684e5a">10,628</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax (benefit) expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie311c88fa22749e2b4cf06d52ec95566_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZTo1YjYyYTk5ODVlMTU0ZDgwOGNlMjdmMTllMTYwN2Y0MC90YWJsZXJhbmdlOjViNjJhOTk4NWUxNTRkODA4Y2UyN2YxOWUxNjA3ZjQwXzUtNC0xLTEtMA_90a1f90b-1a6c-4c2d-ad7c-264f84582ad8">1,347</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de86e101cec44aa84d8d1454d201a7f_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZTo1YjYyYTk5ODVlMTU0ZDgwOGNlMjdmMTllMTYwN2Y0MC90YWJsZXJhbmdlOjViNjJhOTk4NWUxNTRkODA4Y2UyN2YxOWUxNjA3ZjQwXzUtNi0xLTEtMA_5cb9cf94-b90f-402c-8279-973c24c6ab1e">158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8ae9e76f2d44f91afd70c49049644e1_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZTo1YjYyYTk5ODVlMTU0ZDgwOGNlMjdmMTllMTYwN2Y0MC90YWJsZXJhbmdlOjViNjJhOTk4NWUxNTRkODA4Y2UyN2YxOWUxNjA3ZjQwXzUtOC0xLTEtMA_869dd994-11ac-4aa5-93bd-268f5abfe9d2">2,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Losses) gains, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie311c88fa22749e2b4cf06d52ec95566_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZTo1YjYyYTk5ODVlMTU0ZDgwOGNlMjdmMTllMTYwN2Y0MC90YWJsZXJhbmdlOjViNjJhOTk4NWUxNTRkODA4Y2UyN2YxOWUxNjA3ZjQwXzYtNC0xLTEtMA_fd803e02-26ea-4596-9baf-09b7d8dbc8cf">5,774</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de86e101cec44aa84d8d1454d201a7f_D20200101-20201231" decimals="-3" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZTo1YjYyYTk5ODVlMTU0ZDgwOGNlMjdmMTllMTYwN2Y0MC90YWJsZXJhbmdlOjViNjJhOTk4NWUxNTRkODA4Y2UyN2YxOWUxNjA3ZjQwXzYtNi0xLTEtMA_843bb1c4-5ab7-4d50-a83c-d3f01ae289c5">671</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8ae9e76f2d44f91afd70c49049644e1_D20190101-20191231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZTo1YjYyYTk5ODVlMTU0ZDgwOGNlMjdmMTllMTYwN2Y0MC90YWJsZXJhbmdlOjViNjJhOTk4NWUxNTRkODA4Y2UyN2YxOWUxNjA3ZjQwXzYtOC0xLTEtMA_468c03a3-96bc-4745-9a52-d0dd70f3188a">8,161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="i5d795a6851d746ca914a2ddae761c329_241"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 22.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:PreferredStockTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yNDEvZnJhZzpkNDE2MjFiZjRiOWU0MGNlODY3OTZhYzZkZWNlYmQ5YS90ZXh0cmVnaW9uOmQ0MTYyMWJmNGI5ZTQwY2U4Njc5NmFjNmRlY2ViZDlhXzczOA_d07a2ed5-6fac-4d9d-b49b-eb96100e3351" continuedAt="i10ed1a126d98444d9aae00f1fc30aa7f" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PREFERRED STOCK</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></ix:nonNumeric></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i10ed1a126d98444d9aae00f1fc30aa7f">Our Board of Directors is authorized, subject to any limitations prescribed by law, without further stockholder approval, to issue from time to time up to <ix:nonFraction unitRef="shares" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yNDEvZnJhZzpkNDE2MjFiZjRiOWU0MGNlODY3OTZhYzZkZWNlYmQ5YS90ZXh0cmVnaW9uOmQ0MTYyMWJmNGI5ZTQwY2U4Njc5NmFjNmRlY2ViZDlhXzE4MA_68292f61-893e-4ae2-bbbc-030944d99300">500,000</ix:nonFraction> shares of Preferred Stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yNDEvZnJhZzpkNDE2MjFiZjRiOWU0MGNlODY3OTZhYzZkZWNlYmQ5YS90ZXh0cmVnaW9uOmQ0MTYyMWJmNGI5ZTQwY2U4Njc5NmFjNmRlY2ViZDlhXzIxMA_4bcb2674-db4c-4e71-b5b8-4cd6a5f6ce29">1.00</ix:nonFraction> par value per share (&#8220;Preferred Stock&#8221;), in one or more series. Each such series of Preferred Stock shall have such number of shares, designations, preferences, voting powers, qualifications, and special or relative rights or privileges as shall be determined by the Board of Directors, which may include, among others, dividend rights, voting rights, redemption and sinking fund provisions, liquidation preferences, conversion rights, and preemptive rights. There are <ix:nonFraction unitRef="shares" contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yNDEvZnJhZzpkNDE2MjFiZjRiOWU0MGNlODY3OTZhYzZkZWNlYmQ5YS90ZXh0cmVnaW9uOmQ0MTYyMWJmNGI5ZTQwY2U4Njc5NmFjNmRlY2ViZDlhXzY4MA_c10932dd-fdc4-49b5-9815-76779e7a242c"><ix:nonFraction unitRef="shares" contextRef="i257dea584c2540acb77224b3a70b171d_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yNDEvZnJhZzpkNDE2MjFiZjRiOWU0MGNlODY3OTZhYzZkZWNlYmQ5YS90ZXh0cmVnaW9uOmQ0MTYyMWJmNGI5ZTQwY2U4Njc5NmFjNmRlY2ViZDlhXzY4MA_c3514494-1f51-421f-ba53-17cbdb654194">no</ix:nonFraction></ix:nonFraction> shares of Preferred Stock outstanding as of December 31, 2021 and 2020.</ix:continuation></span></div><div><span><br/></span></div><div id="i5d795a6851d746ca914a2ddae761c329_244"></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 23.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><ix:nonNumeric contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yNDQvZnJhZzphNGE1ZGNlN2VjODc0NjY1YjczNGFlM2MwZTIzMDJkNi90ZXh0cmVnaW9uOmE0YTVkY2U3ZWM4NzQ2NjViNzM0YWUzYzBlMjMwMmQ2Xzc2NQ_562a8f79-9b7f-4470-ad6c-7c7dc9f4d5f1" continuedAt="ibc57d0f1f7644164878871ee013ae606" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IDEXX RETIREMENT AND INCENTIVE SAVINGS PLAN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></ix:nonNumeric></div><div><span><br/></span></div><ix:continuation id="ibc57d0f1f7644164878871ee013ae606"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have established the IDEXX Retirement and Incentive Savings Plan (the &#8220;401(k) Plan&#8221;). U.S. employees eligible to participate in the 401(k) Plan may contribute specified percentages of their salaries. We match a portion of these contributions, not to exceed <ix:nonFraction unitRef="number" contextRef="id7c4b2e2ed354c54b264719bdf6db254_D20210101-20211231" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yNDQvZnJhZzphNGE1ZGNlN2VjODc0NjY1YjczNGFlM2MwZTIzMDJkNi90ZXh0cmVnaW9uOmE0YTVkY2U3ZWM4NzQ2NjViNzM0YWUzYzBlMjMwMmQ2XzI4Ng_30e5f8df-d2ee-43a3-a246-135b06444e45"><ix:nonFraction unitRef="number" contextRef="i1c65cec1a82840efbc15a4b904412850_D20190101-20191231" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yNDQvZnJhZzphNGE1ZGNlN2VjODc0NjY1YjczNGFlM2MwZTIzMDJkNi90ZXh0cmVnaW9uOmE0YTVkY2U3ZWM4NzQ2NjViNzM0YWUzYzBlMjMwMmQ2XzI4Ng_6205be4c-0132-427f-99fc-0139ab1f5d5a"><ix:nonFraction unitRef="number" contextRef="ibbe59bdb4621433ca1dedcd48056713a_D20200101-20201231" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yNDQvZnJhZzphNGE1ZGNlN2VjODc0NjY1YjczNGFlM2MwZTIzMDJkNi90ZXh0cmVnaW9uOmE0YTVkY2U3ZWM4NzQ2NjViNzM0YWUzYzBlMjMwMmQ2XzI4Ng_a4e2834d-d797-45c7-8ed7-09ab26d84a63">5</ix:nonFraction></ix:nonFraction></ix:nonFraction>% of participants&#8217; eligible compensation. We matched $<ix:nonFraction unitRef="usd" contextRef="id7c4b2e2ed354c54b264719bdf6db254_D20210101-20211231" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yNDQvZnJhZzphNGE1ZGNlN2VjODc0NjY1YjczNGFlM2MwZTIzMDJkNi90ZXh0cmVnaW9uOmE0YTVkY2U3ZWM4NzQ2NjViNzM0YWUzYzBlMjMwMmQ2XzM0MA_f8759b76-8fc9-452e-82a0-063ca5e39d54">25.8</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ibbe59bdb4621433ca1dedcd48056713a_D20200101-20201231" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yNDQvZnJhZzphNGE1ZGNlN2VjODc0NjY1YjczNGFlM2MwZTIzMDJkNi90ZXh0cmVnaW9uOmE0YTVkY2U3ZWM4NzQ2NjViNzM0YWUzYzBlMjMwMmQ2XzM0NA_8dc984ee-d3c9-4704-956e-0a51c158739b">23.4</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i1c65cec1a82840efbc15a4b904412850_D20190101-20191231" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yNDQvZnJhZzphNGE1ZGNlN2VjODc0NjY1YjczNGFlM2MwZTIzMDJkNi90ZXh0cmVnaW9uOmE0YTVkY2U3ZWM4NzQ2NjViNzM0YWUzYzBlMjMwMmQ2XzM1Mg_fa939012-f40f-46e9-ad4e-72ec10589844">21.1</ix:nonFraction> million for the years ended December 31, 2021, 2020, and 2019, respectively. In addition, we may make contributions to the 401(k) Plan at the discretion of the Board of Directors. There were <ix:nonFraction unitRef="usd" contextRef="ibbe59bdb4621433ca1dedcd48056713a_D20200101-20201231" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yNDQvZnJhZzphNGE1ZGNlN2VjODc0NjY1YjczNGFlM2MwZTIzMDJkNi90ZXh0cmVnaW9uOmE0YTVkY2U3ZWM4NzQ2NjViNzM0YWUzYzBlMjMwMmQ2XzUxOA_7ad81184-23f6-462a-bb6f-e043bae58fab"><ix:nonFraction unitRef="usd" contextRef="i1c65cec1a82840efbc15a4b904412850_D20190101-20191231" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yNDQvZnJhZzphNGE1ZGNlN2VjODc0NjY1YjczNGFlM2MwZTIzMDJkNi90ZXh0cmVnaW9uOmE0YTVkY2U3ZWM4NzQ2NjViNzM0YWUzYzBlMjMwMmQ2XzUxOA_8254bb86-82db-4f17-9adf-d7f3c8779698"><ix:nonFraction unitRef="usd" contextRef="id7c4b2e2ed354c54b264719bdf6db254_D20210101-20211231" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yNDQvZnJhZzphNGE1ZGNlN2VjODc0NjY1YjczNGFlM2MwZTIzMDJkNi90ZXh0cmVnaW9uOmE0YTVkY2U3ZWM4NzQ2NjViNzM0YWUzYzBlMjMwMmQ2XzUxOA_d4f6212c-aac0-4db1-b73b-53098ef488c5">no</ix:nonFraction></ix:nonFraction></ix:nonFraction> discretionary contributions in 2021, 2020 or 2019.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have established defined contribution plans for regional employees in Europe and in Canada. With respect to these plans, our contributions over the past three years have not been material.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-49</span></div></div></div><div id="i5d795a6851d746ca914a2ddae761c329_250"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT INDEX</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.577%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Description</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000087471606000072/exh3i_restcertincorpamended.htm">3.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000087471606000072/exh3i_restcertincorpamended.htm">Restated Certificate of Incorporation of the Company, as amended (filed as Exhibit No. 3(i) to Quarterly Report on Form 10-Q for the quarter ended June 30, 2006, File No. 0-19271, and incorporated herein by reference).</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000114420417063358/tv481050_ex3-1.htm">3.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000114420417063358/tv481050_ex3-1.htm">Amended and Restated By-Laws of the Company (filed as Exhibit No. 3.1 to Current Report on Form 8-K filed December 12, 2017, File No. 0-19271, and incorporated herein by reference).</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000087471620000006/exhibit41.htm">4.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000087471620000006/exhibit41.htm">Description of the Registrant's Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (filed as Exhibit 4.1 to Annual Report on Form 10-K for the year ended December 31, 2019, File No. 0-19271 ("2019 Form 10-K"), and incorporated herein by reference).</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000119312513470776/d644436dex991.htm">4.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000119312513470776/d644436dex991.htm">Note Purchase Agreement, dated as of December 11, 2013, among the Company, as issuer, New York Life Insurance Company, New York Life Insurance and Annuity Corporation and New York Life Insurance and Annuity Corporation Institutionally Owned Life Insurance Separate Account (BOLI 30C), as purchasers (filed as Exhibit No. 99.1 to Current Report on Form 8-K filed December 12, 2013, File No. 0-19271, and incorporated herein by reference). </a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000119312514280513/d762829dex991.htm">4.3</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000119312514280513/d762829dex991.htm">Note Purchase and Private Shelf Agreement, dated as of July 21, 2014, among the Company, as issuer, Prudential Investment Management, Inc., Pruco Life Insurance Company, The Prudential Insurance Company of America, The Gibraltar Life Insurance Co., Ltd., PAR U Hartford Life Insurance Comfort Trust, The Independent Order of Foresters, Zurich American Insurance Company, Globe Life and Accident Insurance Company, Family Heritage Life Insurance Company of America, MTL Insurance Company, The Lincoln National Life Insurance Company, William Penn Life Insurance Company of New York, Farmers Insurance Exchange and Mid Century Insurance Company, as purchasers (filed as Exhibit No. 99.1 to Current Report on Form 8-K filed July 25, 2014, File No. 0-19271, and incorporated herein by reference).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000119312514280513/d762829dex992.htm">4.4</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000119312514280513/d762829dex992.htm">Note Purchase Agreement, dated as of July 22, 2014, among the Company, as issuer, New York Life Insurance Company, New York Life Insurance and Annuity Corporation and New York Life Insurance and Annuity Corporation Institutionally Owned Life Insurance Separate Account (BOLI 30C), as purchasers (filed as Exhibit No. 99.2 to Current Report on Form 8-K filed July 25, 2014, File No. 0-19271, and incorporated herein by reference).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000156459020017098/idxx-ex104_8.htm">4.5</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000156459020017098/idxx-ex104_8.htm">Amendment to Note Purchase Agreement, dated as of April 10, 2020, among the Company, as issuer, New York Life Insurance Company, New York Life Insurance and Annuity Corporation and New York Life Insurance and Annuity Corporation Institutionally Owned Life Insurance Separate Account (BOLI 30C), as purchasers (filed as Exhibit 10.4 to Current Report on Form 8-K filed April 16, 2020, File No. 0-19271, and incorporated herein by reference).</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000156459020017098/idxx-ex105_9.htm">4.6</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000156459020017098/idxx-ex105_9.htm">Amendment to Note Purchase Agreement, dated as of April 10, 2020, among the Company, as issuer, New York Life Insurance Company, New York Life Insurance and Annuity Corporation and New York Life Insurance and Annuity Corporation Institutionally Owned Life Insurance Separate Account (BOLI 30C), as purchasers (filed as Exhibit 10.5 to Current Report on Form 8-K filed April 16, 2020, File No. 0-19271, and incorporated herein by reference).</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000119312515233400/d946246dex991.htm">4.7</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000119312515233400/d946246dex991.htm">Amended and Restated Multi-Currency Note Purchase and Private Shelf Agreement, dated as of June 18, 2015, among the Company, Prudential Investment Management, Inc., Pruco Life Insurance Company, The Prudential Insurance Company of America, The Gibraltar Life Insurance Co., Ltd., PAR U Hartford Life Insurance Comfort Trust, The Independent Order of Foresters, Zurich American Insurance Company, Globe Life and Accident Insurance Company, Family Heritage Life Insurance Company of America, MTL Insurance Company, The Lincoln National Life Insurance Company, William Penn Life Insurance Company of New York, Farmers Insurance Exchange, Mid Century Insurance Company and Farmers New World Life Insurance Company, as purchasers (filed as Exhibit No. 99.1 to Current Report on Form 8-K filed June 24, 2015, File No. 0-19271, and incorporated herein by reference). </a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000156459020017098/idxx-ex102_6.htm">4.8</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000156459020017098/idxx-ex102_6.htm">Amendment to Amended and Restated Multi-Currency Note Purchase and Private Shelf Agreement, dated as of May 9, 2019, among the Company, as issuer, each of the Subsidiary Guarantors (as defined therein), Prudential and each of the holders of the Notes (as defined therein) (filed as Exhibit 10.2 to Current Report on Form 8-K filed April 16, 2020, File No. 0-19271, and incorporated herein by reference).</a></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.577%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000156459020017098/idxx-ex103_7.htm">4.9</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000156459020017098/idxx-ex103_7.htm">Second Amendment to Amended and Restated Multi-Currency Note Purchase and Private Shelf Agreement, dated as of April 10, 2020, among the Company, as issuer, each of the Subsidiary Guarantors (as defined therein), Prudential and each of the holders of the Notes (as defined therein) (filed as Exhibit 10.3 to Current Report on Form 8-K filed April 16, 2020, File No. 0-19271, and incorporated herein by reference).</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000087471619000007/ex101-idexxxmetlifeshelfag.htm">4.10</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000087471619000007/ex101-idexxxmetlifeshelfag.htm">Multicurrency Note Purchase and Private Shelf Agreement, dated as of December 19, 2014, among the Company, as issuer, and Metropolitan Life Insurance Company, MetLife Insurance Company USA, Symetra Life Insurance Company, MetLife Insurance K.K., AXIS Reinsurance Company, and Union Fidelity Life Insurance Company, as purchasers (filed as Exhibit 10.1 to Current Report on Form 8-K filed March 15, 2019, File No. 0-19271, and incorporated herein by reference).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.577%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000087471619000007/ex102-firstamendmenttoshel.htm">4.11</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000087471619000007/ex102-firstamendmenttoshel.htm">First Amendment to Multicurrency Note Purchase and Private Shelf Agreement, dated March 14, 2019, among the Company, as issuer, and IDEXX Distribution, Inc., IDEXX Operations, Inc., and OPTI Medical Systems, Inc., each as a subsidiary guarantor, and Metropolitan Life Insurance Company, MetLife Reinsurance Company of Bermuda, Ltd., Brighthouse Life Insurance Company, Symetra Life Insurance Company, and AXIS Reinsurance Company (filed as Exhibit 10.2 to Current Report on Form 8-K filed March 15, 2019, File No. 0-19271, and incorporated herein by reference).</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000156459020013641/idxx-ex101_6.htm">4.12</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000156459020013641/idxx-ex101_6.htm">Second Amendment to Multicurrency Note Purchase and Private Shelf Agreement, dated March 23, 2020, among the Company, as issuer, each of the Subsidiary Guarantors (as defined therein), Metropolitan Life Insurance Company and each of the holders of the Notes (as defined therein) (filed as Exhibit 10.1 to Current Report on Form 8-K filed March 27, 2020, File No. 0-19271, and incorporated herein by reference).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit101-orthoagreement.htm">10.1*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit101-orthoagreement.htm">U.S. Supply Agreement, effective as of October 16, 2003, among IDEXX Operations, Inc., the Company and Ortho-Clinical Diagnostics, Inc. (&#8220;Ortho&#8221;) (fi</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit101-orthoagreement.htm">led he</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit101-orthoagreement.htm">rew</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit101-orthoagreement.htm">ith</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit101-orthoagreement.htm">).</a></span></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.577%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit102-orthousagreemen.htm">10.2*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit102-orthousagreemen.htm">Amendment No. 1 to U.S. Supply Agreement effective as of January 1, 2005, among IDEXX Operations, Inc., the Company and Ortho (filed </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit102-orthousagreemen.htm">herewith</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit102-orthousagreemen.htm">).</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000136231008001141/c72515exv10w4.htm">10.3</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000136231008001141/c72515exv10w4.htm">Amendment No. 2 to U.S. Supply Agreement effective as of October 15, 2006, among IDEXX Operations, Inc., the Company and Ortho (filed as Exhibit No. 10.4 to Annual Report on Form 10-K for the year ended December 31, 2007, File No. 0-19271 (&#8220;2007 Form 10-K&#8221;), and incorporated herein by reference).</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000136231008001141/c72515exv10w5.htm">10.4*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000136231008001141/c72515exv10w5.htm">Amendment No. 3 to U.S. Supply Agreement effective as of January 18, 2008, among IDEXX Operations, Inc., the Company and Ortho (filed as Exhibit No. 10.5 to 2007 Form 10-K, and incorporated herein by reference).</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit105-orthousagreemen.htm">10.5*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit105-orthousagreemen.htm">Amendment No. 4 to U.S. Supply Agreement effective as of December 28, 2011, among IDEXX Operations, Inc., the Company and Ortho (filed as Exhibit No. 10.5 to Annual Report on Form 10-K for the year ended December 31, 2011, File No. 0-19271 (&#8220;2011 Form 10-K&#8221;) (filed herewith).</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit106-orthousagreemen.htm">10.6*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit106-orthousagreemen.htm">Amendment No. 5 to U.S. Supply Agreement effective as of December 9, 2013, among IDEXX Operations, Inc., the Company and Ortho </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit106-orthousagreemen.htm">(filed herewith)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit106-orthousagreemen.htm">.</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000087471618000005/idxx-20171231xex10_27.htm">10.7*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000087471618000005/idxx-20171231xex10_27.htm">Amendment No. 6 to U.S. Supply Agreement effective as of January 1, 2017, among IDEXX Operations, Inc., the Company and Ortho (filed as Exhibit No. 10.27 to Annual Report on Form 10-K for the year ended December 31, 2017, File No. 0-19271, and incorporated herein by reference).</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000874716/000087471621000055/ex101-orthoxidexxxamendmen.htm">10.8*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000874716/000087471621000055/ex101-orthoxidexxxamendmen.htm">Amendment No. 7 to U.S. Supply Agreement effective as of July 9, 2019, among IDEXX Operations, Inc., the Company and Ortho (filed as Exhibit 10.1 to Quarterly Report on Form 10-Q for the quarter ended September 230, 2021, File No. 0-19271 and incorporated herein by reference).</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit109-orthousagreemen.htm">10.9*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit109-orthousagreemen.htm">Amendment No. 8 to U.S. Supply Agreement effective as of September 1, 2021, among IDEXX Operations, Inc., the Company and Ortho (filed herewith).</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit1010-orthorowagreem.htm">10.10*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit1010-orthorowagreem.htm">European Supply Agreement, effective as of October 17, 2003, among IDEXX Europe B.V., the Company and Ortho (filed herewith).</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit1011-orthorowagreem.htm">10.11*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit1011-orthorowagreem.htm">Amendment No. 1 to European Supply Agreement effective as of January 1, 2005, among IDEXX Europe B.V., the Company and Ortho (filed herewith).</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.577%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000136231008001141/c72515exv10w8.htm">10.12*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000136231008001141/c72515exv10w8.htm">Amendment No. 2 to European Supply Agreement effective as of January 18, 2008, among IDEXX Europe B.V., the Company and Ortho (filed as Exhibit No. 10.8 to 2007 Form 10-K, and incorporated herein by reference).</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit1013-orthorowagreem.htm">10.13*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit1013-orthorowagreem.htm">Amendment No. 3 to European Supply Agreement effective as of December 28, 2011, among IDEXX Europe B.V., the Company and Ortho (filed herewith).</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit1014-orthorowagreem.htm">10.14*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit1014-orthorowagreem.htm">Amendment No. 4 to European Supply Agreement effective as of December 9, 2013, among IDEXX Europe B.V., the Company and Ortho (filed herewith).</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000874716/000087471621000055/ex102-orthoxiebvxamendment5.htm">10.15</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:12.05pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000874716/000087471621000055/ex102-orthoxiebvxamendment5.htm">Amendment No. 5 to European Supply Agreement effective as of July 9, 2019, among IDEXX Europe B.V., the Company and Ortho (filed as Exhibit 10.2 to Quarterly Report on Form 10-Q for the quarter ended September 30, 2021, File No. 0-19271 and incorporated herein by reference).</a></span></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:12.126%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.091%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit1016-orthorowagreem.htm">10.16*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="exhibit1016-orthorowagreem.htm">Amendment No. 6 to European Supply Agreement effective as of September 1, 2021, among IDEXX Europe B.V., the Company and Ortho (filed herewith).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000087471602000008/ocdidexxagree.htm">10.17*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000087471602000008/ocdidexxagree.htm">Amendment, Release and Settlement Agreement dated as of September 12, 2002, among the Company, IDEXX Europe B.V., and Ortho (filed as Exhibit No. 10.1 to Quarterly Report on Form 10-Q for the quarter ended September 30, 2002, File No. 0-19271, and incorporated herein by reference).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000087471620000018/ortholetterwaiver-conf.htm">10.18*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000087471620000018/ortholetterwaiver-conf.htm">Waiver to U.S. Supply Agreement, effective as of October 16, 2003, as amended, among IDEXX Operations, Inc., the Company and Ortho-Clinical Diagnostics, Inc. dated as of April 7, 2020 (filed as Exhibit 10.1 Quarterly Report on Form 10-Q for the quarter ended March 31, 2020, File No. 0-19271, and incorporated herein by reference).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a1019idexxortholetterdated.htm">10.19*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a1019idexxortholetterdated.htm">Letter Agreement between Ortho-Clinical Diagnostics, Inc. and IDEXX Operations, Inc. dated November 2, 2021 (filed herewith).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000874716/000087471620000041/exhibit101.htm">10.20*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000874716/000087471620000041/exhibit101.htm">Letter Agreement between Ortho-Clinical Diagnostics, Inc. and IDEXX Operations, Inc. and IDEXX Europe B.V. dated as of July 10, 2020 (filed as Exhibit 10.1 to Quarterly Report on Form 10-Q for the quarter ended September 30, 2020, File No. 0-19271, and incorporated herein by reference).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000087471613000014/c716-20130630ex103809f15.htm">10.21**</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000087471613000014/c716-20130630ex103809f15.htm">Form of Executive Employment Agreement dated May 26, 2013, between the Company and each of the Company&#8217;s Executive Officers, other than the Chief Executive Officer (filed as Exhibit No. 10.3 to Quarterly Report on Form 10-Q for the quarter ended June 30, 2013 File No. 0-19271,  and incorporated herein by reference).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="idexx-10_22amendeddirector.htm">10.22**</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="idexx-10_22amendeddirector.htm">Restated Director Deferred Compensation Plan, as amended (filed herewith).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000114420410039150/v191080_ex10-3.htm">10.23 **</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000114420410039150/v191080_ex10-3.htm">Restated Executive Deferred Compensation Plan, as amended (filed as Exhibit No. 10.3 to Quarterly Report on Form 10-Q for the quarter ended June 30, 2010, File No. 0-19271, and incorporated herein by reference).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000874716/000087471621000008/a1019esppplandocumentadopt.htm">10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000874716/000087471621000008/a1019esppplandocumentadopt.htm">2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000874716/000087471621000008/a1019esppplandocumentadopt.htm">4</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000874716/000087471621000008/a1019esppplandocumentadopt.htm">**</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000874716/000087471621000008/a1019esppplandocumentadopt.htm">IDEXX Laboratories, Inc. 1997 Employee Stock Purchase Plan, as amended filed as Exhibit 10.19 to Annual Report on Form 10-K for the year ended December 31, 2020, File No. 0-19271, and incorporated herein by reference.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000119312513487980/d651063dex991.htm">10.2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000119312513487980/d651063dex991.htm">5</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000119312513487980/d651063dex991.htm">**</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000119312513487980/d651063dex991.htm">2009 Stock Incentive Plan, as amended (filed as Exhibit No. 99.1 to Registration Statement on Form S-8 filed December 30, 2013, File No. 333-193136, and incorporated herein by reference).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000120677418001021/idexx3324671-def14a.htm#appendix_B">10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000120677418001021/idexx3324671-def14a.htm#appendix_B">2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000120677418001021/idexx3324671-def14a.htm#appendix_B">6</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000120677418001021/idexx3324671-def14a.htm#appendix_B">**</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000120677418001021/idexx3324671-def14a.htm#appendix_B">2018 Stock Incentive Plan (filed as Appendix B to the Definitive Proxy Statement on Schedule 14A for the 2018 Annual Meeting of Stockholders filed on March 28, 2018, and incorporated herein by reference). </a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000087471621000008/a1022summaryeip.htm">10.27**</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000087471621000008/a1022summaryeip.htm">Summary of Executive Incentive Plan (filed as Exhibit No. 10.22 to Annual Report on Form 10-K for the year December 31, 2020, File No. 0-19271, and incorporated herein by reference).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex1028idexx-directoroption.htm">10.28**</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex1028idexx-directoroption.htm">Form of Director Stock Option Agreement (filed herewith).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex1029idexx-directorrsuagr.htm">10.29**</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex1029idexx-directorrsuagr.htm">Form of Director Restricted Stock Unit (filed herewith).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:12.126%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.091%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000095012310014507/c96448exv10w21.htm">10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000095012310014507/c96448exv10w21.htm">30</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000095012310014507/c96448exv10w21.htm">**</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000095012310014507/c96448exv10w21.htm">Form of Employee Stock Option Agreement for grants in 2010 to 2015 (filed as Exhibit 10.21 to Annual Report on Form 10-K for the year ended December 31, 2009, File No. 0-19271, and incorporated herein by reference).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000087471616000020/c716-20151231ex1020599ba.htm">10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000087471616000020/c716-20151231ex1020599ba.htm">31</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000087471616000020/c716-20151231ex1020599ba.htm">**</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000087471616000020/c716-20151231ex1020599ba.htm">Form of Employee Stock Option Agreement for grants in 2016 and 2017 (filed as Exhibit 10.20 to Annual Report on Form 10-K for the year ended December 31, 2015, File No. 0-19271, and incorporated by reference herein).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000087471619000004/exhibit1025.htm">10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000087471619000004/exhibit1025.htm">32</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000087471619000004/exhibit1025.htm">**</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000087471619000004/exhibit1025.htm">Form of Employee Stock Option Agreement for grants in 2018 and 2019 (filed as Exhibit 10.25 to Annual Report on Form 10-K for the year ended December 31, 2018, File No. 0-19271 ("2018 Form 10-K"), and incorporated by reference herein).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000087471620000006/exhibit1028.htm">10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000087471620000006/exhibit1028.htm">33</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000087471620000006/exhibit1028.htm">**</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000087471620000006/exhibit1028.htm">Form of Employee Stock Option Agreement for grants</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000087471620000006/exhibit1028.htm"> in 2020</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000087471620000006/exhibit1028.htm"> and 2021</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000087471620000006/exhibit1028.htm"> (filed as Exhibit 10.28 to 2019 Form 10-K, and incorporated herein by reference).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a1034employeestockoptionaw.htm">10.34**</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a1034employeestockoptionaw.htm">Form of Employee Stock Option Agreement for grants beginning in 2022 (filed herewith).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000095012310014507/c96448exv10w24.htm">10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000095012310014507/c96448exv10w24.htm">35</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000095012310014507/c96448exv10w24.htm">**</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000095012310014507/c96448exv10w24.htm">Form of Employee Restricted Stock Unit Agreement for grants in 2015 (filed as Exhibit 10.24 to Annual Report on Form 10-K for the year ended December 31, 2009, File No. 0-19271, and incorporated herein by reference).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000087471616000020/c716-20151231ex1022bfa67.htm">10.3</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000087471616000020/c716-20151231ex1022bfa67.htm">6</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000087471616000020/c716-20151231ex1022bfa67.htm">**</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000087471616000020/c716-20151231ex1022bfa67.htm">Form of Employee Restricted Stock Unit Agreement for grants in 2016 and 2017 (filed as Exhibit 10.22 to Annual Report on Form 10-K for the year ended December 31, 2015, File No. 0-19271, and incorporated herein by reference).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000087471619000004/exhibit1026.htm">10.37**</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000087471619000004/exhibit1026.htm">Form of Employee Restricted Stock Unit Agreement for grants in 2018 and 2019 (filed as Exhibit 10.26 to 2018 Form 10-K, and incorporated herein by reference).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000087471620000006/exhibit1032.htm">10.3</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000087471620000006/exhibit1032.htm">8</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000087471620000006/exhibit1032.htm">**</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000087471620000006/exhibit1032.htm">Form of Employee Restricted Stock Unit for grants </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000087471620000006/exhibit1032.htm"> in 2020 </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000087471620000006/exhibit1032.htm">and 2021 </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000087471620000006/exhibit1032.htm">(filed as Exhibit 10.32 to 2019 Form 10-K, and incorporated herein by reference).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000087471621000031/exhibit101jmazelskystockop.htm">10.39**</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000087471621000031/exhibit101jmazelskystockop.htm">Form of CEO Stock Option Agreement for grant in 2021 (files as Exhibit 10.1 to Quarterly Report of Form 10-Q for the quarter ended March 31, 2021, File No. 0-19271, and incorporated herein by reference).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000087471621000031/exhibit102jmazelskyrsuawar.htm">10.40**</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000087471621000031/exhibit102jmazelskyrsuawar.htm">Form of CEO Restricted Stock Agreement for grant in 2021 (file as Exhibit 10.2 to Quarterly Report of Form 10-Q for the quarter ended March 31, 2021, File No. 0-19271, and incorporated herein by reference).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a1041employeersuawardagree.htm">10.41**</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a1041employeersuawardagree.htm">Form of Employee Restricted Stock Unit for grants beginning in 2022 (filed herewith).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a1042high-performerrsuagre.htm">10.42**</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a1042high-performerrsuagre.htm">Form of Employee High-Performer Restricted Stock Unit beginning in 2022 (filed herewith).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a1043jmazelskyrsuawardagre.htm">10.43**</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a1043jmazelskyrsuawardagre.htm">Form of Restricted Stock Unit for grants made to Jonathan J. Mazelsky in 2022 (filed herewith)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a1043jmazelskyrsuawardagre.htm">.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a1044jmazelskystockoptiona.htm">10.44**</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a1044jmazelskystockoptiona.htm">Form of Stock Option Agreement for grants made to Jonathan J. Mazelsky in 2022 (filed herewith).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000087471619000004/exhibit1027.htm">10.45**</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000087471619000004/exhibit1027.htm">Form of Employee Performance-Based Restricted Stock Unit Agreement (filed as Exhibit 10.27 to 2018 Form 10-K, and incorporated herein by reference).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000156459020017098/idxx-ex106_10.htm">10.46</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000156459020017098/idxx-ex106_10.htm">Third Amended and Restated Credit Agreement, dated as of April 14, 2020, among the Company, IDEXX Distribution, Inc., IDEXX Operations, Inc., OPTI Medical Systems, Inc., IDEXX Laboratories Canada Corporation, IDEXX Europe B.V., and IDEXX Holding B.V., as borrowers, the lenders party thereto, JPMorgan Chase Bank, N.A., as administrative agent, JPMorgan Chase Bank, N.A., Toronto Branch, as Toronto agent, and the other parties thereto (filed as Exhibit 10.6 to Current Report on Form 8-K filed April 16, 2020, File No. 0-19271, and incorporated herein by reference).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000874716/000119312521352679/d264618dex101.htm">10.47</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000874716/000119312521352679/d264618dex101.htm">Fourth Amended and Restated Credit Agreement, dated as of December 9, 2021, among the Company, IDEXX Distribution, Inc., IDEXX Operations, Inc., OPTI Medical Systems, Inc., IDEXX Laboratories Canada Corporation, IDEXX B.V., IDEXX Laboratories B.V., and IDEXX Laboratories GmbH, as borrowers, the lenders party thereto, JPMorgan Chase Bank, N.A., as administrative agent, JPMorgan Chase Bank, N.A., Toronto Branch, as Toronto agent, and the other parties thereto (filed as Exhibit 10.1 to Current Report on Form 8-K filed December 9, 2021, File No. 0-19271, and incorporated herein by reference).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000110465919055983/tm19207851_ex10-3.htm">10.48</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/874716/000110465919055983/tm19207851_ex10-3.htm">Second Amended and Restated Employment Agreement, dated October 23, 2019, by and between the Company and Jonathan (Jay) Mazelsky (filed as Exhibit 10.3 to Current Report on Form 8-K filed October 24, 2019, File No. 0-19271, and incorporated herein by reference).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:12.126%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.091%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit21-subsidiariesofth.htm">21</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit21-subsidiariesofth.htm">Subsidiaries of the Company (filed herewith).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="idexxfy21consent.htm">23</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="idexxfy21consent.htm">Consent of PricewaterhouseCoopers LLP, an independent registered public accounting firm (filed herewith).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit31111.htm">31.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit31111.htm">Certification of Principal Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit31211.htm">31.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit31211.htm">Certification of Principal Financial Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit32111.htm">32.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit32111.htm">Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.577%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit32211.htm">32.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit32211.htm">Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith).</a></span></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.577%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following financial and related information from IDEXX Laboratories, Inc.&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2021, formatted in Inline eXtensible Business Reportable Language (iXBRL) includes: (i) the Consolidated Balance Sheet; (ii) the Consolidated Statement of Income; (iii) the Consolidated Statements of Comprehensive Income; (iv) the Consolidated Statement of Changes in Stockholders' Equity (Deficit); (v) the Consolidated Statement of Cash Flows; and, (vi) Notes to Consolidated Financial Statements.</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The cover page from the Company's Annual Report of Form 10-K for the fiscal year ended December 31, 2021, formatted in Inline XBRL and contained in Exhibit 101.</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Confidential treatment requested as to certain portions.</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management contract or compensatory arrangement required to be filed as an exhibit pursuant to Item 15(a)(3) of Form 10-K.</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-54</span></div></div></div><div id="i5d795a6851d746ca914a2ddae761c329_253"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="margin-bottom:6pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:512.25pt"><tr><td style="width:1.0pt"></td><td style="width:280.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:228.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">IDEXX LABORATORIES, INC.</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:&#160;/s/ Jonathan J. Mazelsky</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: February 16, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jonathan J. Mazelsky</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated:</span></div><div style="margin-bottom:6pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:512.25pt"><tr><td style="width:1.0pt"></td><td style="width:90.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:24.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:79.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:21.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:18.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:82.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:79.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:16.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:81.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">SIGNATURE</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">TITLE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">DATE</span></td></tr><tr style="height:12pt"><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:17pt"><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Jonathan J. Mazelsky</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President, Chief Executive Officer and Director (Principal Executive Officer)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 16, 2022</span></td></tr><tr style="height:17pt"><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jonathan J. Mazelsky</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:17pt"><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Brian P. McKeon</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Chief Financial Officer and Treasurer (Principal Financial and Accounting Officer)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 16, 2022</span></td></tr><tr style="height:17pt"><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brian P. McKeon</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Lawrence D. Kingsley</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-Executive Board Chair</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 16, 2022</span></td></tr><tr style="height:15pt"><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lawrence D. Kingsley</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Jonathan W. Ayers</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 16, 2022</span></td></tr><tr style="height:15pt"><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jonathan W. Ayers</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Asha S. Collins, PhD</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 16, 2022</span></td></tr><tr style="height:15pt"><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asha S. Collins, PhD</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Bruce L. Claflin</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 16, 2022</span></td></tr><tr style="height:15pt"><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bruce L. Claflin</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:12pt"><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:15pt"><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Stuart M. Essig, PhD </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 16, 2022</span></td></tr><tr style="height:15pt"><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stuart M. Essig, PhD</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:12pt"><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:15pt"><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Daniel M. Junius</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 16, 2022</span></td></tr><tr style="height:15pt"><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Daniel M. Junius</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:12pt"><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:15pt"><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Sam A. Samad</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 16, 2022</span></td></tr><tr style="height:15pt"><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sam A. Samad</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:12pt"><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ M. Anne Szostak</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 16, 2022</span></td></tr><tr style="height:15pt"><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">M. Anne Szostak</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:12pt"><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:15pt"><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Sophie V. Vandebroek, PhD</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 16, 2022</span></td></tr><tr style="height:15pt"><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sophie V. Vandebroek, PhD</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-55</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>exhibit101-orthoagreement.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i74a11129358e4eec82e28538b5a23669_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit 10.1</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY ASTERISKS, HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED.</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AGREEMENT</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">THIS AGREEMENT is made effective as of the 16th day of October, 2003, between IDEXX Operations, Inc., a Delaware corporation whose principal place of business is at 6100 East Shelby Drive, Memphis, Tennessee 38141, U.S.A. (&#8220;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">IDEXX</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) and Ortho-Clinical Diagnostics, Inc., a New York corporation with offices at 100 Indigo Creek Drive, Rochester, New York, U.S.A. (&#8220;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">OCD</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">WHEREAS, OCD has been a supplier of analyzers for human applications and dry slides, and IDEXX has been a supplier of analyzers for animal applications&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">WHEREAS, OCD and IDEXX Laboratories, Inc. (&#8220;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">IDEXX Parent</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), the parent company of IDEXX, entered into a supply agreement effective as of January&#160;1, 1999 (the &#8220;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Prior US Agreement</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) with respect to the supply of VITROS slides in the United States and Asia for use on the VETTEST Analyzer (as defined below)&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">WHEREAS, OCD and IDEXX Europe B.V. (&#8220;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">IDEXX BV</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) entered into a supply agreement effective as of January&#160;1, 1999 with respect to the supply of VITROS slides in Europe for use on the VETTEST Analyzer (the &#8220;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Prior Europe Agreement</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), and intend to amend and restate the Prior Europe Agreement shortly after the date hereof to make certain modifications thereto&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">WHEREAS, OCD, IDEXX Parent and IDEXX BV entered into that certain Operations Agreement effective as of January&#160;1, 1999 (the &#8220;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Operations Agreement</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;)&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">WHEREAS, OCD, IDEXX Parent and IDEXX BV entered into that certain Amendment, Release and Settlement Agreement dated as of September&#160;12, 2002 (the &#8220;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Settlement Agreement</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) for purposes of, among other things, amending the Prior US Agreement, the Prior Europe Agreement and the Operations Agreement and resolving certain disputes between the parties&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">WHEREAS, OCD and IDEXX desire to expand their relationship in order to create a New Analyzer (as defined below) for animal applications, which will expand the sales of OCD&#8217;s dry slides and IDEXX&#8217;s analyzers, and to make IDEXX products more competitive&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">WHEREAS, OCD and IDEXX through this Agreement desire to combine certain of their respective skills and intellectual property and to invest significant capital to create the New Analyzer and related panel holder design, which is expected to provide a better product offering to customers&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><img alt="image_391.jpg" src="image_391.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">WHEREAS, this Agreement will ensure IDEXX of a continuing supply of Dry Slides necessary for its continued sale of analyzers, including the New Analyzer</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">WHEREAS, OCD and IDEXX now desire to enter into new arrangements for the supply and development of diagnostic slides and analyzers, the terms and conditions of which are documented herein&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NOW THEREFORE, the parties hereby agree as follows&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:1.944%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.132%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">DEFINITIONS</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In this Agreement the following expressions shall have the meaning set opposite them.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:70.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;Agreements&#8221;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This Agreement and the Europe Agreement.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;Analyzers&#8221;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The VETTEST Analyzer and the New Analzyer.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;Commencement Date&#8221;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October&#160;16, 2003.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;Dry Slide&#8221;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A chemical composition, comprising a layered, coated dry film, specifically formulated to analyze for a body constituent, which composition is immediately hydrated by any undiluted bodily fluid, including without limitation a VITROS slide. For avoidance of doubt, the term &#8220;Dry Slide&#8221; shall not include any assay based on immunomagnetic particle technology or any assay for which the analyte is DNA or RNA.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;Effective Rebate Rate&#8221;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For any year, the weighted average percentage reduction in the purchase price of any slides purchased in such year that IDEXX is entitled to receive pursuant to Section 7.03 hereunder. The calculation of the Effective Rebate Rate is illustrated in&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;Europe Agreement&#8221;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Prior Europe Agreement, until such time as it is amended and restated as contemplated by the preamble&#59; from and after such time, the &#8220;Europe Agreement&#8221; shall mean the Prior Europe Agreement as so amended and restated.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;Exclusivity Territory&#8221;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The United States of America and its possessions (including Puerto Rico), Canada, Australia, New Zealand, Japan, India, South Korea and Taiwan.</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</font></div><div><img alt="image_391.jpg" src="image_391.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:70.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;Existing Special &#91;**&#93; Slides&#8221;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VETTEST slides that have been &#91;**&#93;, as of the date of this Agreement, pursuant to Section&#160;4 of the Operations Agreement.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;IDEXX BV&#8221;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IDEXX Europe B.V., a Netherlands corporation.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;New Analyzer&#8221;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A new chemistry analyzer that uses OCD Dry Slides for veterinary applications, as contemplated by Article&#160;3 of this Agreement, and any updates or modifications to such analyzer.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;New Chemistry Slides&#8221;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As defined in Section&#160;5.06.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;New Slide&#47;Panel Design&#8221;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A new slide format for VETTEST slides to be used in conjunction with the New Analyzer, as well as a panel holder for such slides, as contemplated by Article&#160;3, and any updates or modifications to such design.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;New Slides&#8221;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VETTEST slides that are formatted and packaged in accordance with the New Slide&#47;Panel Design, as contemplated by Article&#160;3.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;New Special &#91;**&#93; Slides&#8221;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VETTEST slides that have been &#91;**&#93; pursuant to Section&#160;7.04 of this Agreement.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;PANELS&#47;PROFILES&#8221;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Packages of VETTEST slides for VETTEST Analyzers consisting of two or more sets of slides of specified chemistries. The initial PANEL and the initial PROFILES shall consist of the slides set forth on&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;attached hereto, with any changes or additional PANELS&#47;PROFILES to be mutually agreed upon by the parties as specified in&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;Prime Rate&#8221;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For any day in any calendar month, the prime rate of interest as published in the&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Wall Street Journal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;on the last business day of the immediately preceding month.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;Proportionate Share&#8221;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The percentage obtained by dividing (i)&#160;the number of VETTEST slides purchased by IDEXX in a given period,&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;(ii)&#160;the total number of VETTEST slides</font></div></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</font></div><div><img alt="image_391.jpg" src="image_391.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:70.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">purchased by IDEXX and its affiliates during such period.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;Special &#91;**&#93; Slides&#8221;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Existing Special &#91;**&#93; Slides and New Special &#91;**&#93; Slides.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;Term&#8221;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As defined in Section&#160;18.01.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;Territory&#8221;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Worldwide, except the European Union, Africa, and the countries listed on&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;attached hereto.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;VETTEST Analyzer&#8221;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The analyzer currently marketed as the VETTEST VT 8008 analyzer and any updates or modifications to such analyzer.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;VETTEST slides&#8221;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dry Slides currently manufactured by OCD, specially designed, bar coded, labeled, and&#47;or packaged for one or more of the Analyzers in accordance with the terms of this Agreement and supplied by OCD in accordance with the terms and conditions of this Agreement.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;VETTEST tips&#8221;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Metering tips sourced by OCD for use with the VETTEST Analyzer, specially packaged and supplied to IDEXX in accordance with the terms of this Agreement.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;VITROS slides&#8221;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Dry Slides currently manufactured by OCD for use in any current VITROS analyzer, including without limitation the DT60.</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All references to currency in this Agreement shall mean U.S. Dollars unless otherwise specifically indicated.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.684%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.292%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">EFFECTIVE DATE OF AGREEMENT</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.01 This Agreement shall become effective upon the Commencement Date. This Agreement shall apply solely within the Territory&#59; except that Sections&#160;3.04, 3.05 and 3.06 shall apply worldwide.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">DEVELOPMENT OF NEW ANALYZER AND NEW SLIDE&#47;PANEL DESIGN</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.105%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.150%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.043%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.202%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IDEXX and its affiliates shall, at their expense, and with cooperation from OCD as set forth below, devote chemistry instrument development resources to the development and launch of the New Analyzer. IDEXX and its affiliates shall use</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</font></div><div><img alt="image_391.jpg" src="image_391.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.408%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">commercially reasonable efforts to achieve commercial launch of such analyzer within the United States within &#91;**&#93; years of the Commencement Date. IDEXX shall have control and management of New Analyzer development, and sole approval of New Analyzer specifications.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.02</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IDEXX and its affiliates shall, at their expense, design, develop and validate the New Slide&#47;Panel Design, together with the injection molding tooling for the panel holder and associated label content and art work. IDEXX shall have control and management of New Slide&#47;Panel Design development, and sole approval of New Slide&#47;Panel Design specifications.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.03</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The parties recognize that the design, development and validation of the New Analyzer and the New Slide&#47;Panel Design (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Development Program</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) will benefit from the cooperation of both parties as set forth in this Article&#160;3. Accordingly, OCD agrees, until the third anniversary of the Commencement Date (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Development Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), to make technical personnel reasonably available from time to time upon the reasonable request of IDEXX and upon reasonable notice, (i)&#160;up to a maximum of 250 hours per calendar quarter, to provide consulting services with respect to development of the New Analyzer, including rendering advice, reviewing proposed instrument designs and making recommendations and (ii)&#160;up to a maximum of 250 hours per calendar quarter, to provide consulting services with respect to development of the New Slide&#47;Panel Design, including rendering advice, reviewing proposed slide format and panel holder designs and making recommendations. In connection with such consulting services, OCD may, but shall not be obligated to, disclose materials or other information to IDEXX that OCD considers to be proprietary or confidential. IDEXX agrees that, except as otherwise expressly agreed by OCD in writing, (a) IDEXX shall not acquire any rights to such materials or information, other than as set forth in paragraphs 3.04 through 3.07 below and (b)&#160;such materials and information shall be subject to the non-disclosure provisions of Schedule&#160;2 and shall not be used by IDEXX for any purpose for as long as they remain subject to those provisions.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.04</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ownership of any inventions resulting from the activities of the parties during the Development Period and directly in connection with the Development Program shall vest in the party or parties which, by virtue of the United States patent law, is&#47;are entitled to apply for and obtain patents for said invention. Such inventions the ownership of which (determined as aforesaid) vests (a)&#160;solely in IDEXX are hereinafter referred to as &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">IDEXX Inventions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;, (b)&#160;solely in OCD are hereinafter referred to as &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">OCD Inventions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; and (c) jointly in IDEXX and OCD are hereinafter referred to as &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Joint Inventions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IDEXX shall be responsible for filing, prosecuting and maintaining patent applications and patents relating to Joint Inventions&#59; provided that IDEXX will reasonably consult with OCD regarding any such applications&#59; and provided</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</font></div><div><img alt="image_391.jpg" src="image_391.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.105%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.043%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.126%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">further that if IDEXX elects not to file, prosecute or maintain any such patent application or patent in any country, OCD will have the right, but not the obligation, at its expense, to file, prosecute and maintain such patent or patent application. All patent applications relating to Joint Inventions shall be drafted and prosecuted by an outside law firm mutually agreed upon by IDEXX and OCD.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Except as otherwise set forth in the immediately preceding paragraph, the parties agree to execute and do all things necessary to vest the title and interest in such property rights in the relevant party as set out above, at the expense of said relevant party, which shall pay the costs of the prosecution of all applications for intellectual property rights to which it becomes entitled under this Agreement. A party agreed to be not responsible for the preparation and filing of patent applications on Joint Inventions shall have the right to review such applications a reasonable time prior to filing.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.05</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As used herein, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Background Technology</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; shall mean all technical information, know-how, processes, techniques, discoveries and inventions (patented, patentable or otherwise) owned by OCD that are not OCD Inventions or Joint Inventions, which OCD in its discretion provides IDEXX to facilitate IDEXX&#8217;s development of the New Analyzer or New Slide&#47;Panel Design. To the extent the New Analyzer or New Slide&#47;Panel Design include any Background Technology provided by OCD, OCD hereby grants IDEXX and its affiliates a non-exclusive, worldwide, perpetual, royalty-free, fully paid license, with the right to assign in connection with any assignment of this Agreement, but without the right to sublicense, to make, have made, use, sell, offer to sell and import New Analyzers and the New Slide&#47;Panel Design using Background Technology in the field of Dry Slide diagnostic testing of non-human animals. The licenses granted by this Section&#160;3.05 are subject to any rights of third parties in or to such intellectual property, and are limited to intellectual property that relates to equipment, instrumentation or packaging, rather than slides or reagents. Subject only to the licenses granted by this Section&#160;3.05, OCD shall, retain all right, title and interest in and to the Background Technology, notwithstanding that any such technology is provided to IDEXX or included in the New Analyzer or New Slide&#47;Panel Design. For avoidance of doubt, IDEXX and its affiliates shall have no right to use Background Technology other than in connection with the New Analyzer or the New Slide&#47;Panel Design.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.06</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IDEXX hereby grants OCD and its affiliates a non-exclusive, worldwide, perpetual, royalty-free, fully paid license, with the right to assign in connection with any assignment of this Agreement, but without the right to sublicense, to make, have made, use, sell, offer to sell and import products and services using IDEXX Inventions, in the field of human Dry Slide diagnostic testing. The licenses granted to OCD in this paragraph are subject to any rights of third parties in or to such intellectual property, and are limited to intellectual property that relates to equipment, instrumentation or packaging, rather than slides or reagents.</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</font></div><div><img alt="image_391.jpg" src="image_391.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.358%"><tr><td style="width:1.0%"></td><td style="width:2.125%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.254%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.058%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.063%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the avoidance of doubt, the licenses granted to OCD in this paragraph shall include the right for OCD to use IDEXX Inventions on any non-human animal species for the development of a product for marketing into the field of human Dry Slide diagnostic testing.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCD hereby grants IDEXX and its affiliates a non-exclusive, worldwide, perpetual, royalty-free, fully paid license, with the right to assign in connection with any assignment of this Agreement, but without the right to sublicense, to make, have made, use, sell, offer to sell and import New Analyzers and the New Slide&#47;Panel Design using OCD Inventions, in the field of Dry Slide diagnostic testing of non-human animals. The licenses granted to IDEXX in this paragraph are subject to any rights of third parties in or to such intellectual property, and are limited to intellectual property that relates to equipment, instrumentation or packaging, rather than slides or reagents.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.07</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCD hereby agrees that neither it nor its affiliates shall, prior to December&#160;31, 2018, grant any third party the license to make, have made, use, sell, offer to sell and import products and services using Joint Inventions in the field of diagnostic testing of non-human animals&#59; provided, the foregoing restrictions shall not prohibit the assignment by OCD of its interest in such Joint Inventions in connection with any assignment of this Agreement, nor, to the extent that any of the following actions may be deemed to be a license, shall they prohibit OCD from collaborating with any third party in the development of products using Joint Inventions in such field, from having any products using Joint Inventions made by any third party for sale in such field, or from selling any products using Joint Inventions into such field through any third party distributor or sales agent.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IDEXX hereby agrees that neither it nor its affiliates shall, prior to December&#160;31, 2018, grant any third party the license to make, have made, use, sell, offer to sell and import products and services using Joint Inventions in field of human diagnostic testing&#59; provided, the foregoing restrictions shall not prohibit the assignment by IDEXX of its interest in such Joint Inventions in connection with any assignment of this Agreement, nor, to the extent that any of the following actions may be deemed to be a license, shall they prohibit IDEXX from collaborating with any third party in the development of products using Joint Inventions in such field, from having any products using Joint Inventions made by any third party for sale in such field, or from selling any products using Joint Inventions into such field through any third party distributor or sales agent.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The provisions of this Section&#160;3.07 do not diminish any of the parties&#8217; respective obligations under Article&#160;9 of this Agreement.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.08</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)&#160;IDEXX shall develop detailed specifications for the New Slide&#47;Panel Design, and the parties shall meet promptly thereafter to review such specifications (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Design Review</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;). In connection with the Design Review,</font></div></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</font></div><div><img alt="image_391.jpg" src="image_391.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.740%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IDEXX shall also provide OCD with a good faith forecast of the number of New Slides that IDEXX and IDEXX BV anticipate ordering during each of the first five years following the date of the first commercial sale of the New Analyzer (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Design Forecast</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;). In addition, IDEXX shall provide OCD with its good faith estimate of its and IDEXX BV&#8217;s annual requirements for New Slides during the subsequent three years. Within 60&#160;days after the Design Review, or such other period as the parties may agree, OCD shall provide IDEXX a detailed summary showing OCD&#8217;s good faith estimate of (1)&#160;the cost to install a production line (including without limitation design costs, engineering costs, equipment costs and validation costs) for the New Slide&#47;Panel Design (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Automation Costs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) and (2) the ongoing expenses per New Slide associated with the formatting and packaging of New Slides that are in excess of OCD&#8217;s current expenses for manufacturing and packaging the current VITROS-formatted slides in 50-count cartridges (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Incremental Manufacturing Costs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;).</font></div></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.740%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)&#160;Automation Costs shall exclude the cost of any injection molding tooling associated with the New Slide&#47;Panel Design, for which IDEXX shall be solely responsible. The parties shall mutually agree on the selection of a third party vendor for such tooling. IDEXX shall own such tooling. After installation, OCD shall be solely responsible for the maintenance and repair of any such tooling.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)&#160;Incremental Manufacturing Costs shall be based on the average annual volumes of New Slides set forth in the Design Forecast during the first five years following the date of the first commercial sale of the New Analyzer, and will include the cost of direct labor and materials (including without limitation plastic components and all packaging materials), facility allocation and reasonable overhead, and will exclude depreciation of any Automation Costs.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)&#160;If OCD&#8217;s estimated Automation Costs are $&#91;**&#93; or less, and OCD&#8217;s estimated Incremental Manufacturing Costs are $&#91;**&#93; or less per New Slide, then OCD shall manufacture and package New Slides in accordance with IDEXX&#8217;s specifications for the New Slide&#47;Panel Design and supply them to IDEXX for the Term as provided in this Agreement. In this case, OCD shall be solely responsible for all Automation Costs and all costs of manufacturing such slides, including Incremental Manufacturing Costs, regardless of whether OCD&#8217;s actual costs are different than the estimates provided to IDEXX.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(e)&#160;If OCD&#8217;s estimated Automation Costs are greater than $&#91;**&#93;, or OCD&#8217;s estimated Incremental Manufacturing Costs are greater than $&#91;**&#93; per New Slide, then OCD may elect to be solely responsible for all such costs, in which case OCD shall manufacture and package New Slides in accordance with IDEXX&#8217;s specifications for the New Slide&#47;Panel Design and supply them to IDEXX for the Term as provided in this Agreement. In this case, OCD shall be solely responsible for all Automation Costs and all costs of manufacturing such slides,</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</font></div><div><img alt="image_391.jpg" src="image_391.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.740%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">including Incremental Manufacturing Costs, regardless of whether OCD&#8217;s actual costs are different than the estimates provided to IDEXX.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(f)&#160;If OCD does not elect to be solely responsible for all costs as provided in paragraph (e)&#160;of this Section&#160;3.08, then IDEXX shall have the option of either (1)&#160;changing the New Slide&#47;Panel Design to reduce OCD&#8217;s costs, such that paragraph (d)&#160;of this Section&#160;3.08 applies, or (2)&#160;assuming the entire amount (or such lesser portion as the parties mutually agree) of OCD&#8217;s estimated Automation Costs that exceeds $&#91;**&#93; and assuming the entire amount (or such lesser portion as the parties mutually agree) of OCD&#8217;s estimated Incremental Manufacturing Costs that exceeds $&#91;**&#93; per New Slide, or (3)&#160;performing the formatting and packaging of New Slides independently, as more particularly described below.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(g)&#160;If IDEXX elects to assume a portion of OCD&#8217;s Automation Costs or Incremental Manufacturing Costs as set forth in clause (2)&#160;of paragraph (f)&#160;of this Section&#160;3.08, then (1)&#160;in the event actual Automation Costs exceed the amount contemplated by the parties under clause (2)&#160;of paragraph (f)&#160;of this Section&#160;3.08, IDEXX and OCD shall &#91;**&#93; of such excess Automation Costs and (2)&#160;OCD shall be solely responsible for all costs of manufacturing and packaging New Slides, including Incremental Manufacturing Costs, that are not assumed by IDEXX, regardless of whether OCD&#8217;s actual costs are different than it had estimated when the parties agreed to the portion to be assumed by IDEXX, and OCD shall supply such slides to IDEXX for the Term as provided in this Agreement.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(h)&#160;If IDEXX elects to perform the formatting and packaging of the New Slides independently of OCD, then (1)&#160;in lieu of New Slides, OCD shall supply IDEXX with VITROS slides in the format currently manufactured for the VITROS mainframe analyzers and&#47;or the VETTEST Analyzer (i.e., VITROS slides packaged in 50-count cartridges, before further formatting and packaging for VETTEST Analyzer requirements), as applicable for New Slides, for the Term as provided in this Agreement, and all references in this Agreement to New Slides or to VETTEST slides, to the extent referring to OCD&#8217;s obligation to supply New Slides, shall mean such VITROS slides packaged in 50-count cartridges and (2)&#160;solely with respect to New Slides, the prices for Tiers 2 and 3 in the table set forth in Section&#160;7.02 shall be reduced by $&#91;**&#93; per New Slide.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)&#160;The parties acknowledge that the specifications for the New Slide&#47;Panel Design may change after the initial Design Review in accordance with IDEXX&#8217;s requirements. If OCD has elected to perform the formatting and packaging of the New Slides, then all incremental costs resulting from such change in specifications, to the extent that they cause Automation Costs to exceed $&#91;**&#93; or Incremental Manufacturing Costs to exceed $&#91;**&#93; per New Slide, shall be borne by the parties as they may agree. If the parties cannot so agree, then IDEXX may make the election provided for in paragraph (h)&#160;of this Section&#160;3.08, in which case IDEXX shall reimburse OCD for OCD&#8217;s Automation Costs incurred and take</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</font></div><div><img alt="image_391.jpg" src="image_391.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.740%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ownership of any capital equipment and related design materials funded as Automation Costs and developed in connection with OCD&#8217;s new production line for the New Slide&#47;Panel Design to the date of IDEXX&#8217;s election, and OCD shall cooperate with IDEXX in the transfer of such equipment and materials to IDEXX. If IDEXX has elected to perform the formatting and packaging of the New Slides independently of OCD, and if such change in specifications could reasonably result in a significant reduction in Automation Costs or Incremental Manufacturing Costs, then IDEXX shall notify OCD of such fact and OCD shall have the option to request that the parties conduct a further Design Review in accordance with paragraph (a)&#160;of this Section&#160;3.08, and OCD shall be permitted to re-estimate its Automation Costs and Incremental Manufacturing Costs, to require that the parties conduct the cost review, as otherwise provided in this Section&#160;3.08, and to make the election in paragraph 3.08(e).</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(j)&#160;If IDEXX and IDEXX BV shall not have attained &#91;**&#93;% of the Design Forecast during the first five years following the date of the first commercial sale of the New Analyzer, then IDEXX shall reimburse OCD for an amount equal to the product of (a)&#160;the Automation Costs borne by OCD, times (b)&#160;a fraction, the numerator of which is the number of slides by which IDEXX&#8217;s and IDEXX BV&#8217;s actual purchases of New Slides falls short of the Design Forecast and the denominator of which is the Design Forecast&#59; provided that, for avoidance of doubt, there shall be no change in the price of New Slides as a result of the failure to attain such percentage of the Design Forecast.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(k)&#160;If OCD elects to format and package New Slides, and if in the future the through-put capacity of such packaging line is insufficient to meet IDEXX&#8217;s and IDEXX BV&#8217;s forecasted demand, any additional capital investment or other costs required to meet such demand (other than for injection molding tooling), whether by increasing the through-put capacity of the packaging line or adding a new packaging line, shall be borne by the parties in the same relative proportions as all previous Automation Costs&#59; and IDEXX shall bear the costs for required injection molding tooling.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(l)&#160;Notwithstanding anything in this Section&#160;3.08 to the contrary, if the Design Forecast indicates that IDEXX and IDEXX BV expect to purchase fewer than &#91;**&#93; New Slides hereunder during the first five years following the date of first commercial sale of the New Analyzer, then OCD may in its sole discretion elect to be released from any obligation to format and package the New Slides, in which event IDEXX&#8217;s sole options hereunder shall be either (1)&#160;to reduce OCD&#8217;s costs to a level that is acceptable to OCD in light of the Design Forecast, or (2)&#160;to perform the formatting and packaging of New Slides independently, as more particularly described in paragraph 3.08(h) above.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.105%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.043%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.126%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.09</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IDEXX acknowledges that it has not relied upon any guarantee or assurance from OCD, express or implied, regarding the technical feasibility of the New Analyzer</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</font></div><div><img alt="image_391.jpg" src="image_391.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.740%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">or the New Slide&#47;Panel Design in deciding to engage in the development of the New Analyzer and New Slide&#47;Panel Design, and that OCD shall have no liability with respect to IDEXX&#8217;s termination of any of its other product development activities.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.203%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.773%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">AGREEMENT TO SUPPLY</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.105%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.043%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.126%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subject to the terms and conditions of this Agreement, OCD undertakes to manufacture for IDEXX and to supply to IDEXX VETTEST slides, VETTEST tips and Vetrol controls. OCD shall supply VETTEST slides in compliance with the VETTEST Slide Quality Assurance Procedures set out in&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. All slides supplied to IDEXX hereunder are supplied solely for sale within the Territory&#59; provided that IDEXX may make limited sales to IDEXX BV solely for purposes of adjusting inventory levels according to unanticipated changes in regional demand. For the avoidance of doubt, nothing in this Agreement shall obligate OCD, with respect to any particular chemistry, to furnish IDEXX with slides for such chemistry in any slit format that OCD does not currently manufacture for such chemistry, or that would otherwise be uneconomical for OCD to supply to IDEXX (other than the slit formats for such chemistry that OCD then sells or has agreed in writing to sell to IDEXX).</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.02</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)&#160;Notwithstanding any other provision of this Agreement, if after &#91;**&#93; the annual volume of VETTEST slides purchased by IDEXX and IDEXX BV is less than &#91;**&#93; slides, then OCD may in its sole discretion elect to be released from any obligation to format and package the New Slides and&#47;or package other VETTEST slides, in which event IDEXX&#8217;s sole options hereunder shall be either (x)&#160;to accept an increase in slide prices for New Slides and&#47;or other VETTEST slides that is adequate to compensate OCD for any increase in its costs due to such reduction in volume, or (y)&#160;with respect to slides for which IDEXX does not accept a price increase under the preceding clause (x), to perform the formatting and packaging of New Slides and&#47;or the packaging of other VETTEST slides, as applicable, independently of OCD.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.740%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)&#160;If IDEXX elects to perform the formatting and packaging of New Slides, then (1)&#160;in lieu of New Slides OCD shall supply IDEXX with VITROS slides in the format currently manufactured for the VITROS mainframe analyzers and&#47;or the VETTEST Analyzer (i.e., VITROS slides packaged in 50-count cartridges, before further formatting and packaging for VETTEST Analyzer requirements), as applicable for New Slides, for the Term as provided in this Agreement, and all references in this Agreement to New Slides or to VETTEST slides, to the extent referring to OCD&#8217;s obligation to supply New Slides, shall mean such VITROS slides packaged in 50-count cartridges, (2) the prices for Tiers 2 and 3 in the table set forth in Section&#160;7.02 shall be reduced by $&#91;**&#93; per New Slide, (3)&#160;IDEXX shall take ownership of any capital equipment and related design materials funded as Automation Costs and developed in connection with OCD&#8217;s new production</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</font></div><div><img alt="image_391.jpg" src="image_391.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.740%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">line for the New Slide&#47;Panel Design, and OCD shall cooperate with IDEXX in the transfer of such equipment and materials to IDEXX and (4)&#160;IDEXX shall reimburse OCD for the book value of such equipment.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)&#160;If IDEXX elects to perform the packaging of VETTEST slides other than New Slides, then (1)&#160;in lieu of such other VETTEST slides OCD shall supply IDEXX with VITROS slides in the format currently manufactured for the VETTEST Analyzer (i.e., VITROS slides packaged in 50-count cartridges, before further formatting and packaging for VETTEST Analyzer requirements) for the Term as provided in this Agreement, and all references in this Agreement to VETTEST slides, to the extent referring to OCD&#8217;s obligation to supply such slides (other than New Slides), shall mean such VITROS slides packaged in 50-count cartridges, (2)&#160;the prices for Tiers 1, 2 and 3 in the table set forth in Section&#160;7.02 shall be reduced by $&#91;**&#93; per slide for VETTEST slides (other than New Slides), (3) IDEXX shall take ownership of OCD&#8217;s packaging lines for VETTEST slides (other than New Slides), except equipment which OCD requires for the packaging of slides for the VITROS DT60 (or next generation OCD analyzer), but in any event including the VETTEST &#8220;panel assembly machine&#8221; (PAM)&#160;line which is used currently to package PANELS&#47;PROFILES, and OCD shall cooperate with IDEXX in the transfer of such packaging line(s) to IDEXX and (4)&#160;IDEXX shall reimburse OCD for the book value of such transferred equipment.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)&#160;In either case if IDEXX elects to perform the formatting and packaging of New Slides and&#47;or the packaging of other VETTEST slides independently, the parties shall cooperate to determine an appropriate timetable for the transfer of responsibilities to IDEXX, such that the supply of slides to IDEXX shall continue without interruption.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(e)&#160;For the avoidance of doubt, nothing in this Agreement shall obligate OCD to transfer to IDEXX any capital equipment used by OCD in the manufacture of VITROS slides.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.203%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.773%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">FORECASTS, COMMITMENTS AND ORDERS</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.105%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.043%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.126%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Attached hereto as&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;are aggregate Purchase Commitments by IDEXX and IDEXX BV for VETTEST slides for the VETTEST Analyzer for calendar years 2003 through and including 2010. The Purchase Commitments constitute the aggregate anticipated minimum aggregate purchase quantities by IDEXX and IDEXX BV for single chemistry VETTEST slides and PANELS&#47;PROFILES slides in the indicated calendar years.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Existing Special &#91;**&#93; Slides, New Special &#91;**&#93; Slides and New Chemistry Slides shall be excluded from the determination of IDEXX&#8217;s and IDEXX BV&#8217;s slide purchases for purposes of achieving their aggregate Purchase Commitments under Section&#160;5.01 of this Agreement or the Europe Agreement, as the case may be.</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</font></div><div><img alt="image_391.jpg" src="image_391.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.105%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.043%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.126%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Failure by IDEXX and IDEXX BV to purchase, in the aggregate, at least the indicated Purchase Commitment quantities of each type of slides in any year may subject IDEXX to the requirement to make a payment to OCD as set forth in Section&#160;5.02 below, but such failure shall in no event otherwise be deemed to be a breach of this Agreement.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.02</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If IDEXX and IDEXX BV fail to purchase in the aggregate the quantities of slides for the VETTEST Analyzer set forth as Purchase Commitments on&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;in a particular calendar year, unless there has been a Material Adverse Change (as defined in the following paragraph), IDEXX shall pay, or shall cause IDEXX BV to pay, to OCD within 30&#160;days after the end of such calendar year &#91;**&#93;% of the product of (i)&#160;the number of each type of slides (single or PANELS&#47;PROFILES) by which IDEXX and IDEXX BV have in the aggregate fallen short of the Purchase Commitment and (ii)&#160;the lowest per-slide price for the applicable type of slides under either of the Agreements.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the purposes of this Section&#160;5.02, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Material Adverse Changes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; shall mean material changes in the veterinary clinical chemistry markets which result from (a)&#160;the commercial introduction into the veterinary market, other than by IDEXX or its affiliates, of a technology not previously available in the veterinary clinical chemistry market, (b)&#160;the eradication of one or more diseases, or the development of new disease therapies, treatments or diagnostics, which significantly reduces demand for veterinary clinical chemistry testing or (c)&#160;the inability or unwillingness of OCD to supply VETTEST or VITROS slides in accordance with IDEXX&#8217;s Annual Purchase Forecasts pursuant to Section&#160;5.04 below. Whether a Material Adverse Change has occurred will be determined by reference to the effect of a change in the veterinary clinical chemistry market on IDEXX and IDEXX BV taken as a whole, and not on either individually.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The parties shall discuss in good faith any assertion by IDEXX or IDEXX BV that a Material Adverse Change has occurred or is continuing. If the parties agree that a Material Adverse Change has occurred or is continuing, they shall negotiate in good faith with respect to appropriate reductions in Purchase Commitments, VETTEST slide prices (including single and PANELS&#47;PROFILES slides) and&#47;or amounts which would otherwise be payable pursuant to the first sentence of this Section&#160;5.02 to appropriately allocate the effects of such Material Adverse Change on the parties.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.03</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Order and delivery of VETTEST slides (including PANELS&#47;PROFILES) shall be made in multiples of 100 boxes. Unless otherwise agreed between the parties in any particular case, IDEXX shall place orders for slides four times per calendar year, for delivery in each calendar quarter of the year. Each order shall specify a business day delivery date for each delivery, which shall be not less than three months after the order date. Unless otherwise agreed between the parties in any</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</font></div><div><img alt="image_391.jpg" src="image_391.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.105%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.043%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.126%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">particular case the number of deliveries shall be limited to four per year. IDEXX shall order quantities for delivery in any quarter in accordance with its good faith estimates of actual demand, with allowance for reasonable inventory management requirements and consistent with IDEXX&#8217;s stated desire to minimize its inventory levels.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Order and delivery of the VETTEST tips shall be made in multiples of 10,000 tips (20 cartons each containing 500 tips). Unless otherwise agreed between the parties in any particular case, the number of orders and deliveries of the VETTEST tips and Vetrols shall be limited to two in each year. OCD shall deliver the VETTEST tips and Vetrols in the ordered quantities in each year.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.04</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Not later than October 1 of each year, commencing October&#160;1, 2003, IDEXX shall notify OCD of the aggregate forecasted requirements of IDEXX for the subsequent calendar year for each of the VETTEST slides (single slides and PANELS&#47;PROFILES slides for the VETTEST Analyzer and New Slides) (each such notification, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Annual Purchase Forecast</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;). The aggregate order quantities in the subsequent year for each of the VETTEST slides shall be within &#177;25% of such aggregate Annual Purchase Forecast unless the parties otherwise agree. As long as slide orders do not exceed the applicable Annual Purchase Forecast by more than 25%, OCD shall deliver the slides in accordance with the orders. The Annual Purchase Forecasts constitute non-binding forecasts for OCD&#8217;s planning purposes and shall also be the basis for determining estimated slide pricing pursuant to Section&#160;7.02 below and the cash rebate pursuant to Section&#160;7.03 below.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In addition to the Annual Purchase Forecast, IDEXX shall furnish to OCD updated quarterly forecasts of the aggregate requirements of IDEXX for VETTEST slides in the four succeeding calendar quarters. The parties understand that such forecasts are merely estimates to assist OCD in production planning and are not to be considered orders or binding in any way.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The parties shall further coordinate with one another to keep OCD apprised of IDEXX&#8217;s current and anticipated inventories of stock keeping units and relevant conditions in the veterinary market. The provisions of this paragraph shall terminate immediately upon delivery by OCD of a notice of termination of Section&#160;9.04.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.05</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In the event that IDEXX in any year notifies OCD that it wishes to order quantities which exceed the quantities mentioned in Section&#160;5.04 above by more than 25%, OCD will endeavor to supply the excess quantities and notify IDEXX of the extent of its ability to so supply.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.06</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">It is understood and agreed that orders for the VETTEST slides shall include only those chemistries set forth in&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;hereto, as amended from time to time by</font></div></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</font></div><div><img alt="image_391.jpg" src="image_391.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.740%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">agreement of the parties. IDEXX may at any time request that the additional chemistries listed on&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;hereof, in the form they are available at the Commencement Date to the human market on VITROS slides, be added as VETTEST slides to&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;(any VETTEST slides so added, containing such additional chemistries, are referred to herein as &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">New Chemistry Slides</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;). Prior to adding a New Chemistry Slide on&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, the parties will negotiate in good faith to determine the initial price for such slides in accordance with the immediately following paragraph and shall set forth such price on&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. IDEXX shall have the right, from time to time, to elect to remove any New Chemistry Slides from&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, and&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;and&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;shall be updated to reflect such removal. IDEXX acknowledges that neither this nor any other provision of this Agreement shall obligate OCD to supply IDEXX with any slide or other product based on any technology that is not incorporated in the VITROS slides or VETTEST slides that OCD sells as of the date hereof.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Until &#91;**&#93;, the price per slide for any New Chemistry Slides shall be the greater of $&#91;**&#93; and &#91;**&#93; (as determined by OCD in good faith and taking into account IDEXX&#8217;s and IDEXX BV&#8217;s good faith forecast for the quantity of the chemistry in question). For orders placed for delivery during each calendar year beginning with &#91;**&#93;, if &#91;**&#93; of any New Chemistry Slide is determined to be greater than $&#91;**&#93; (as determined by OCD in good faith and taking into account IDEXX&#8217;s and IDEXX BV&#8217;s good faith forecast for the quantity of the chemistry in question), then the minimum price per slide for such New Chemistry Slides shall be &#91;**&#93;&#59; provided, that so long as IDEXX and IDEXX BV order &#91;**&#93; or more of such slides in the aggregate in any calendar year, the minimum price per slide for such New Chemistry Slides shall not exceed $&#91;**&#93;. OCD shall have the right, from time to time and in good faith, to revise its determination of &#91;**&#93; of any New Chemistry Slide that is priced on&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;if IDEXX&#8217;s and IDEXX BV&#8217;s aggregate actual annual orders of such slide fall below &#91;**&#93;, and&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;shall be updated to reflect such revised &#91;**&#93;.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In the event that a chemistry listed in&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;should become known by OCD to be unavailable at any future date during the Term, OCD will so notify IDEXX at the earliest practicable date, and the parties shall cooperate to determine an appropriate course of action.</font></div></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.203%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.773%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">DELIVERY</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.105%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.043%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.126%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Following acknowledgement by OCD of each order placed by IDEXX and on or before the delivery due date, OCD shall complete delivery of the appropriate quantity of slides and tips within &#177; 10%. Deviations of delivery quantities from order quantities within the &#177; 10% range may be compensated by IDEXX in the first subsequent order placed, subject to Section&#160;5. In the event of a price increase for one or more of the VETTEST slides, such compensating quantity of such slides shall be processed at the previous lower price.</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</font></div><div><img alt="image_391.jpg" src="image_391.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.105%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.043%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.126%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.02</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Order and delivery for all purchases hereunder shall be F.O.B. OCD&#8217;s facility in the U.S.A.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.03</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unless otherwise advised in writing by OCD to IDEXX, OCD shall pack the VETTEST slides in accordance with OCD&#8217;s standard shipping configuration which is known to IDEXX and which at the Commencement Date contains approximately 60 cases per pallet, each case containing 100 boxes of slides.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.04</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The parties shall reasonably cooperate to identify and implement potential savings for both parties, consistent with the principles of lean manufacturing across the value chain, in all processes in their relationship, including without limitation improvements relating to slide manufacturing, packaging, ordering, build schedules, component purchasing, delivery schedules, quality testing and calibration processes, and product distribution processes (including direct shipment to IDEXX distributors and end-users), and including without limitation, identifying and implementing processes to reduce the number of slide lots supplied to IDEXX and to reduce IDEXX calibration time&#59; provided, that neither party shall be obligated to implement a process change for which its net costs exceed its net benefits.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.203%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.773%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">PRICES</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.358%"><tr><td style="width:1.0%"></td><td style="width:2.125%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.254%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.058%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.063%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subject to the provisions of Sections&#160;3.08 and 4.02 that contemplate OCD&#8217;s delivery of slides in 50-count cartridges if IDEXX elects to format and&#47;or package slides independently, all references to pricing for VETTEST slides in this agreement refer to the completed and packaged product in form ready for delivery to an end-user. The initial prices for each of the VETTEST slides (including the PANELS&#47; PROFILES) shall be as set forth in&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;hereto. Such prices are broken out to provide prices for each individual product code for the following geographic regions (additional regions may be added, and changes within regions may be agreed to, from time to time in writing by the parties)&#58;</font></div></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.224%"><tr><td style="width:1.0%"></td><td style="width:13.997%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.803%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US&#8212;United States, Canada and all other countries not identified in this Section&#160;7.01&#59;</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.224%"><tr><td style="width:1.0%"></td><td style="width:13.997%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.803%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asian&#8212;Brunei, China, Hong Kong, Indonesia, Japan, Korea, Malaysia, Philippines, Singapore, Taiwan, Thailand, Viet Nam.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.224%"><tr><td style="width:1.0%"></td><td style="width:13.997%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.803%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Australia&#47;New Zealand</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.740%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IDEXX agrees that OCD may audit IDEXX&#8217;s books and records to verify sales of VETTEST slides in any region.</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16</font></div><div><img alt="image_391.jpg" src="image_391.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.105%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.043%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.126%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.02</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)&#160;The prices set forth in&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;shall remain in effect for orders placed through December&#160;31, &#91;**&#93;.</font></div></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.740%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)&#160;For orders placed for delivery during each calendar year beginning with &#91;**&#93;, the price for each VETTEST slide listed on&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;(whether New Slides, single chemistry VETTEST slides for the VETTEST Analyzer, or per slide in PANELS&#47;PROFILES, and, for avoidance of doubt, including New Chemistry Slides, subject to Section&#160;5.06), within the respective volume tiers set forth below (aggregating for this purpose purchases by IDEXX and IDEXX BV) shall be as set forth for such volume tier&#59;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, that Existing Special &#91;**&#93; Slides and New Special &#91;**&#93; Slides shall not be priced by reference to the volume tiers but will be priced as otherwise set forth below. For purposes of determining purchase volumes, up to &#91;**&#93; Existing Special &#91;**&#93; Slides shall be included in the determination, and all other Existing Special &#91;**&#93; Slides and New Special &#91;**&#93; Slides shall be excluded from the determination. The stated price shall apply only to slides purchased within the corresponding volume tier, and only with respect to the quantities within such tier.</font></div></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="padding-left:105.35pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:55.128%"><tr><td style="width:1.0%"></td><td style="width:67.795%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.962%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.202%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.586%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.855%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Annual Volume Tier</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Price per Slide</font></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><img alt="image_162.jpg" src="image_162.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_172.jpg" src="image_172.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tier 1&#58; Up to &#91;**&#93;</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tier 2&#58; In excess of &#91;**&#93;, but not exceeding &#91;**&#93;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tier 3&#58; In excess of &#91;**&#93;</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.740%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For all orders for Existing Special &#91;**&#93; Slides, the price per slide shall be as agreed between the parties pursuant to Section&#160;4 of the Operations Agreement.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For all orders for New Special &#91;**&#93; Slides, the price per slide shall be as agreed between the parties pursuant to Section&#160;7.04 of this Agreement.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, the price per slide for any New Chemistry Slide that is priced on&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;shall never be lower than the greater of (a)&#160;the minimum price as determined in accordance with Section&#160;5.06 and identified on Schedule&#160;6 as amended from time to time and (b)&#160;the price that would otherwise apply pursuant to the pricing tiers set forth above.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Promptly after IDEXX and IDEXX BV provide their aggregate Annual Purchase Forecast for a calendar year pursuant to Section&#160;5.04 and Section&#160;5.04 of the Europe Agreement, the parties shall calculate the weighted average price of slides included in such forecast (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">First Estimated Blended Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;).</font></div></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</font></div><div><img alt="image_391.jpg" src="image_391.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.740%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upon determination of the First Estimated Blended Price applicable to a calendar year, for each order placed by IDEXX for delivery during the first three calendar quarters of such year, the amount invoiced and paid per slide listed on&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;shall be the First Estimated Blended Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Before IDEXX places its order for the fourth calendar quarter of the year, the parties shall review IDEXX&#8217;s and IDEXX BV&#8217;s respective fourth-quarter orders and re-calculate the weighted average price of slides based on IDEXX&#8217;s and IDEXX BV&#8217;s aggregate actual orders for the first three quarters and their orders for the fourth quarter (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Second Estimated Blended Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;). If the Second Estimated Blended Price is different than the First Estimated Blended Price, the amount invoiced and paid per slide listed on&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;shall be the Second Estimated Blended Price. In addition, either party may calculate the resulting adjustment (up or down) for each slide delivered for the first three quarters to reflect the difference between the First Estimated Blended Price and the Second Estimated Blended Price, such that the amount paid by IDEXX for all slides delivered during the first three calendar quarters shall equal the Second Estimated Blended Price. If the adjustment is an upwards adjustment, then IDEXX shall pay OCD the aggregate amount of such adjustment, together with interest on such amount (calculated as set forth below), within 30&#160;days of OCD&#8217;s request for such payment. If the adjustment is a downwards adjustment, then OCD shall pay IDEXX the aggregate amount of such adjustment, together with interest on such amount (calculated as set forth below), within 30&#160;days of IDEXX&#8217;s request for such payment (or, at IDEXX&#8217;s option, apply such amount as a credit against IDEXX&#8217;s third or fourth quarter invoice).</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Within 30&#160;days after the end of the year (or 30&#160;days after IDEXX and IDEXX BV complete payment in full for all slides purchased during the year, if later), the parties shall perform a final calculation of the weighted average price based on all slides ordered by IDEXX and IDEXX BV and delivered during the year (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Final Blended Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;). If the Final Blended Price is different than the Second Estimated Blended Price, then IDEXX or OCD, as the case may be, shall make a final payment to the other, so that the final amount paid by IDEXX per slide for all slides ordered and delivered during the year shall equal the Final Blended Price. The party obligated to make such final payment shall do so within 30 days after the determination of the Final Blended Price.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Any adjustment payments made pursuant to either of the immediately preceding paragraphs, and any overdue payments by OCD or IDEXX of any amounts owed to the other pursuant to this Section&#160;7.02, shall bear interest at a rate per annum equal to the Prime Rate. Such interest shall be calculated based on a 365-day year and the actual number of days elapsed since the due date for the applicable payment to which it relates.</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18</font></div><div><img alt="image_391.jpg" src="image_391.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.740%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For avoidance of doubt, the blended price calculations of this Section&#160;7.02 shall apply only to chemistries listed on&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, and only after calendar year &#91;**&#93;.</font></div></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.740%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)&#160;OCD may, at its option, increase all prices for slides ordered for delivery (i)&#160;on or after January&#160;1, &#91;**&#93; by an amount not to exceed &#91;**&#93;% of the &#8220;PPI Increase&#8221; (as defined below), provided that OCD may not increase prices under this clause (i)&#160;unless the PPI Increase is greater than &#91;**&#93;%&#59; and (ii)&#160;on or after January&#160;1, &#91;**&#93;by an amount (x)&#160;as provided in the preceding clause (i)&#160;or (y) by an amount not to exceed &#91;**&#93;% of the PPI Increase, provided that OCD may not increase prices under this subclause (y)&#160;unless the PPI Increase is greater than &#91;**&#93;%. OCD may calculate the PPI Increase each year beginning in &#91;**&#93;, and any resulting price increase shall be effective for orders placed for delivery during the following calendar year and thereafter, unless and until increased again in accordance with the procedures set forth in this paragraph. For purposes of this Agreement, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">PPI Increase</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; shall be calculated by dividing (x)&#160;the average monthly &#8220;PPI&#8221; level for the most recent 12-month period ending with and including June of the year in which the PPI Increase is being calculated (each such period, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Measurement Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), by (y)&#160;the average monthly PPI level for the 12-month period immediately preceding that described in clause (x) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Baseline Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; with respect to such Measurement Period), then subtracting 1 and converting the remaining fraction into a percentage. All calculations shall be based on the latest version of the PPI level published as of the date the calculation is made. For purposes of this Agreement, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">PPI</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means the United States Producer Price Index &#8211; &#91;**&#93; (not seasonally adjusted), current series identification &#91;**&#93;, as published by the Bureau of Labor Statistics on its Web site (www.bls.gov&#47;ppi), or if not available from such Web site, then as published by the Bureau of Labor Statistics in its monthly periodical &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Producer Price Indexes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.&#8221; OCD shall give IDEXX written notice of any price increase pursuant to this paragraph 7.02(c) at least 120&#160;days before the beginning of the calendar year for which a price increase is to take effect&#59; otherwise, the prices shall remain unaffected by such increase for such year.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)&#160;With respect to slides ordered for delivery on or after January 1, &#91;**&#93;, if OCD&#8217;s aggregate cost of &#91;**&#93; (as defined below) for the most recent Measurement Period has increased on a per VETTEST slide basis as compared with the applicable Baseline Period by an amount that exceeds the PPI Increase for such Measurement Period as applied to the &#91;**&#93; for such Baseline Period, on a per VETTEST slide basis, then OCD shall be permitted to increase the price of each slide sold to IDEXX by the amount of such excess. &#8220;&#91;**&#93;&#8221; means &#91;**&#93; that are &#91;**&#93;.&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;attached hereto contains an example, for illustration purposes only, of the calculations described in this paragraph 7.02(d) and in paragraph 7.02(e).</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(e)&#160;With respect to slides ordered for delivery on or after January 1, &#91;**&#93;, if IDEXX&#8217;s share of Special Event Costs (as defined below) for the most recent</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19</font></div><div><img alt="image_391.jpg" src="image_391.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.740%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Measurement Period has increased on a per VETTEST slide basis as compared with the applicable Baseline Period by an amount that exceeds &#91;**&#93; above the PPI Increase for such Measurement Period as applied to IDEXX&#8217;s share of Special Event Costs for such Baseline Period, on a per VETTEST slide basis, then OCD shall be permitted to increase the price of each slide sold to IDEXX by the amount of such excess. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Special Event Costs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means the aggregate net amount of (i) &#91;**&#93; with respect to &#91;**&#93; on which &#91;**&#93;, (ii) &#91;**&#93; in the &#91;**&#93;, and (iii) &#91;**&#93; as a result of &#91;**&#93;. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">IDEXX&#8217;s share</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; of any of the foregoing shall mean the &#91;**&#93; that is attributable to the &#91;**&#93;.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(f)&#160;OCD shall give IDEXX written notice of any price increase pursuant to paragraph 7.02(d) or 7.02(e) at least 120&#160;days before the beginning of the calendar year for which a price increase is to take effect&#59; otherwise, the prices shall remain unaffected by such increase for such year. Any price increase pursuant to paragraph 7.02(d) or 7.02(e) shall be effective for orders placed for delivery during the following calendar year and thereafter, unless and until (i)&#160;increased again in accordance with the procedures set forth in such paragraphs or (ii)&#160;there occurs a decrease in any of the costs upon which the price increase was based (or any such cost that was relevant in one measuring period is not relevant in subsequent periods, for example, certain validation or other one-time costs incurred for compliance purposes), in which event IDEXX&#8217;s price per slide shall be reduced to the extent of such decrease (or one-time cost). In addition, OCD agrees to consider in good faith any request by IDEXX to reimburse OCD pursuant to paragraph 7.02(e) by a process other than an increase in slide prices, such as a lump sum payment or series of payments. Furthermore, with respect to any one-time cost or other temporary cost lasting no more than one year, IDEXX shall have the right to make such reimbursement in equal periodic payments (no less frequently than quarterly) over a period that is no longer than one year.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(g)&#160;OCD shall give IDEXX reasonable detail as to its incremental &#91;**&#93; costs and incremental Special Event Costs on which it seeks to base a price increase pursuant to paragraph 7.02(d) or 7.02(e) or otherwise pass on to IDEXX pursuant to paragraph 7.02(f)&#59; provided, however, that IDEXX shall not have any right to obtain any details concerning OCD&#8217;s actual costs (other than such incremental cost differences used in such calculation).</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(h)&#160;At any time after OCD&#8217;s aggregate annual sales volume of VITROS slides and VETTEST slides shall have declined more than &#91;**&#93;% from &#91;**&#93;, the parties shall, at OCD&#8217;s request, discuss appropriate pricing of slides under this Agreement. Neither party shall be obligated to agree to any price change under this Section&#160;7.02(h).</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)&#160;OCD agrees that IDEXX shall have the right, no more than once per calendar year, to cause a nationally recognized independent accounting firm to conduct an audit, on reasonable advance notice and during normal business hours,</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20</font></div><div><img alt="image_391.jpg" src="image_391.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.740%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">of OCD&#8217;s books and records to the extent reasonably necessary to confirm OCD&#8217;s price increase calculations under this Section&#160;7.02. Any report prepared by such independent accounting firm shall contain such firm&#8217;s conclusion concerning the validity of OCD&#8217;s price increase&#59; provided, however, that such report shall not contain, and IDEXX shall not have any right to obtain, any details concerning OCD&#8217;s actual costs (other than incremental cost differences used in the calculation of OCD price increases).</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(j)&#160;IDEXX agrees that OCD may audit IDEXX&#8217;s books and records relating to orders of VETTEST slides to confirm the pricing calculations under this Section&#160;7.02.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.105%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.043%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.126%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.03</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The provisions of this Section&#160;7.03 shall apply only to purchases of VETTEST slides for the VETTEST Analyzer during calendar years &#91;**&#93;. IDEXX shall be entitled to receive its Proportionate Share (based on sales during a calendar year) of a cash rebate in the amount set forth below if the total aggregate slide purchases by IDEXX and IDEXX BV, in calendar year &#91;**&#93;, exceed the aggregate quantities set forth below&#58;</font></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="padding-left:105.37pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:55.448%"><tr><td style="width:0.1%"></td><td style="width:2.112%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.391%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.245%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.061%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.954%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Incremental Cash Rebate &#8211;</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Annual Slide Purchases</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">% Off Purchase Price</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="9" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#91;**&#93; and above</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.740%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The rebate amounts set forth above constitute a percentage reduction in the purchase price of any slides (including both single slides and PANELS&#47;PROFILES slides) purchased above the corresponding quantity. The percentage amounts are incremental (as opposed to cumulative) and relate only to the quantities set forth opposite it. For example, if IDEXX and IDEXX BV were to purchase, in the aggregate, &#91;**&#93; slides in calendar year &#91;**&#93;, they would not be entitled to a &#91;**&#93;% price reduction on all slides that they purchased in such year, rather, they would be entitled to receive (i) &#91;**&#93; purchase price reduction on the first &#91;**&#93; slides purchased, (ii)&#160;a &#91;**&#93;% purchase price reduction on all slides purchased over &#91;**&#93;, up to and including &#91;**&#93;, (iii)&#160;an &#91;**&#93;% purchase price reduction on all slides purchased over &#91;**&#93; up to and including &#91;**&#93;, and (iv)&#160;a &#91;**&#93;% purchase price reduction on all slides purchased over &#91;**&#93; up to and including the &#91;**&#93; slides that they purchased. The foregoing notwithstanding, it is understood and agreed that if IDEXX and IDEXX BV do not, in the aggregate, achieve the aggregate Purchase Commitments set forth in Section&#160;5 in any calendar year, then they shall not be entitled to receive a rebate for such year.</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21</font></div><div><img alt="image_391.jpg" src="image_391.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.740%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In the beginning of calendar year &#91;**&#93;, OCD shall calculate an estimated Effective Rebate Rate (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Estimated Rebate Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) based on the lesser of (i)&#160;IDEXX&#8217;s and IDEXX BV&#8217;s aggregate Annual Purchase Forecast for such year and (ii) &#91;**&#93;% of the total aggregate number of slides that IDEXX and IDEXX BV together purchased in &#91;**&#93;. The Estimated Rebate Rate for calendar year &#91;**&#93; shall be such that the average VETTEST slide price for &#91;**&#93;, after giving effect to the rebate, shall be $&#91;**&#93;. Not later than thirty (30)&#160;days after the end of each of the first three calendar quarters of &#91;**&#93; (or thirty days after IDEXX and IDEXX BV complete payment in full for slides purchased during such quarter, if later), OCD shall pay to IDEXX its Proportionate Share (based on purchases during the preceding quarter) of an amount equal to the aggregate estimated rebate payment that IDEXX and IDEXX BV would together be entitled to receive in such quarter (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Estimated Rebate Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;). The Estimated Rebate Payment for any such quarter shall be calculated by (i)&#160;multiplying the Estimated Rebate Rate in effect during such quarter by the total aggregate purchase price for the VETTEST slides purchased by IDEXX and IDEXX BV during such quarter and (ii)&#160;subtracting from such amount an amount equal to &#91;**&#93;% of the total calculated in clause (i)&#160;above. The foregoing notwithstanding, if, in calendar year &#91;**&#93;, (i)&#160;IDEXX&#8217;s and IDEXX BV&#8217;s total aggregate slide orders for the immediately preceding calendar year were less than &#91;**&#93;% of their aggregate Annual Purchase Forecast for such preceding calendar year or (ii) OCD determines, in its reasonable discretion, at any time after the end of the second calendar quarter of such calendar year, or IDEXX indicates at any time, that IDEXX and IDEXX BV are reasonably unlikely to meet their aggregate Annual Purchase Forecast for such year, then OCD shall have the right to recalculate the Estimated Rebate Rate based on IDEXX&#8217;s and IDEXX BV&#8217;s aggregate Purchase Commitment for such year (such recalculated rate being hereinafter referred to as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">New Estimated Rebate Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;). If OCD elects to recalculate the Estimated Rebate Rate pursuant to the immediately preceding sentence, (i)&#160;OCD shall notify IDEXX in writing which notice shall set forth the New Estimated Rebate Rate, (ii)&#160;OCD shall calculate all remaining quarterly Estimated Rebate Payments (which may include the Estimated Rebate Payment for the second calendar quarter) using the New Estimated Rebate Rate and (iii)&#160;all such Estimated Rebate Payments shall be made in accordance with this sub-clause 7.03, except that such Estimated Rebate Payments shall be less the amount by which the aggregate Estimated Rebate Payments received by IDEXX and IDEXX BV during the then current calendar year exceed the aggregate Estimated Rebate Payments they would have received during such calendar year if the New Estimated Rebate Rate were in effect from the first day of such calendar year.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notwithstanding any provision in this Agreement to the contrary, OCD shall not be required to pay to IDEXX its Proportionate Share of any Estimated Rebate Payments in any calendar year if (A)&#160;any amounts payable to OCD from IDEXX pursuant to this Agreement are overdue, unless such amounts are being disputed</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22</font></div><div><img alt="image_391.jpg" src="image_391.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.740%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">in good faith by IDEXX, or (B)&#160;OCD determines in its reasonable judgment that IDEXX and IDEXX BV are reasonably unlikely to meet their aggregate Purchase Commitments for such year. In the case of clause (B)&#160;above, OCD shall have the right to make such determination at any time after the end of the second calendar quarter of calendar year &#91;**&#93;, as the case may be (or such earlier time as IDEXX or IDEXX BV indicates (through an Annual Purchase Forecast or otherwise) that their aggregate slide purchases are reasonably likely to be less than their aggregate Purchase Commitment for such year), provided that OCD has consulted with IDEXX and given IDEXX an opportunity (which opportunity shall be available for a period of not less than 5 business days nor more than 10 business days) to demonstrate its and IDEXX BV&#8217;s intent and ability to meet their aggregate Purchase Commitments for such year. For the avoidance of doubt, OCD&#8217;s obligation to make any Estimated Rebate Payments shall be suspended during the period referred to in the immediately preceding sentence and the days in such period shall not be counted when determining the date by which the next scheduled Estimated Rebate Payment is due and payable. If, after fulfilling the requirements set forth in this paragraph, OCD makes the determination described in clause (B)&#160;above, OCD (i)&#160;shall promptly notify IDEXX in writing of its determination and (ii) shall thereafter have the right to cease making Estimated Rebate Payments for the remainder of such calendar year.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Not later than thirty (30)&#160;business days after the end of the last calendar quarter of calendar year &#91;**&#93;, as the case may be (or thirty days after IDEXX and IDEXX BV complete payment in full for slides purchased during such quarter, if later), OCD shall pay to IDEXX its Proportionate Share (based on purchases during such calendar year) of the amount by which (i)&#160;the Effective Rebate Rate multiplied by the total aggregate purchase price for VETTEST slides purchased by IDEXX and IDEXX BV during such calendar year exceeds (ii)&#160;the total aggregate amount of the Estimated Rebate Payments made by OCD to IDEXX and IDEXX BV during such calendar year. If the amount in clause (ii)&#160;above exceeds the amount in clause (i) above, OCD shall deliver to IDEXX a written notice of such fact (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Reimbursement Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) and IDEXX shall pay to OCD, within thirty (30)&#160;days of receipt of such notice an amount in cash equal to its Proportionate Share of the amount of such excess.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, if IDEXX and IDEXX BV do not achieve their aggregate Purchase Commitment in calendar year &#91;**&#93;, as the case may be, then IDEXX shall return all Estimated Rebate Payments received from OCD for such year no later than thirty (30)&#160;days after the end of such calendar year.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">An illustrative representation of the foregoing rebate calculation methodology is attached hereto as&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notwithstanding any other provision of this Section&#160;7.03, if any amounts payable to OCD from IDEXX pursuant to this Agreement are overdue, other than amounts</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23</font></div><div><img alt="image_391.jpg" src="image_391.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.105%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.043%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.126%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">that are being disputed in good faith by IDEXX, then OCD shall be entitled to withhold such overdue amount (plus any accrued interest) from any rebate payments to which IDEXX may be entitled. Any overdue payments by OCD or IDEXX of any amounts owed to the other pursuant to this Section&#160;7.03 shall bear interest at a rate per annum equal to the Prime Rate. Such interest shall be payable at the same time as the payment to which it relates and shall be calculated daily on the basis of a year of 365&#160;days and the actual number of days elapsed.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCD shall prepare a remittance advice to accompany each rebate payment (or Reimbursement Notice), which shall set forth the reporting period for which the payment is made (or demanded) and a summary sheet which shall detail OCD&#8217;s calculation of the rebate (or reimbursement). If IDEXX disagrees with the rebate or reimbursement calculation, IDEXX shall promptly notify OCD, and the parties, together with IDEXX BV if appropriate, shall review the calculations together in good faith to agree on any appropriate corrections or adjustments.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Any Special &#91;**&#93; Slides and any New Chemistry Slides shall be excluded from the determination of any rebate entitlement under Section&#160;7.03 of this Agreement or the Europe Agreement, as the case may be, and the rebates described in Section&#160;7.03 shall not apply to such slides.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.04</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If IDEXX provides OCD with specific documentation regarding &#91;**&#93; that would require IDEXX and IDEXX BV, collectively, to purchase, in any calendar year, a number of slides over and above their most recent aggregate Annual Purchase Forecast for such year, &#91;**&#93; for slides, &#91;**&#93; for slides &#91;**&#93; by this Agreement, OCD agrees, within two weeks of its receipt of all additional information that OCD may reasonably request regarding such &#91;**&#93;, to inform IDEXX as to whether or not OCD &#91;**&#93; in respect of &#91;**&#93;, the number of slides &#91;**&#93; for such slides, and any other related terms and conditions that OCD deems applicable. OCD shall consider such requests in good faith. OCD agrees that &#91;**&#93; IDEXX or IDEXX BV pursuant to &#91;**&#93;, remain in effect with respect to &#91;**&#93; until such time as &#91;**&#93;, as the case may be.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.203%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.773%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">INVOICES AND PAYMENT</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.105%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.043%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.126%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCD shall invoice IDEXX in respect of each order for the VETTEST slides upon completion by OCD of the delivery of such order. Each order shall be billed by OCD under one invoice in US dollars and payment shall be made by IDEXX in US dollars not later than thirty (30)&#160;days following the date of invoice.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.203%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.773%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">EXCLUSIVITY</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.105%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.043%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.126%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCD undertakes not to sell or otherwise supply, and to cause its affiliates not to sell or otherwise supply, any Dry Slides (whether or not such slides are finished or complete) bar-coded for use in any Analyzers to any person, firm or company</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24</font></div><div><img alt="image_391.jpg" src="image_391.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.105%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.043%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.126%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">other than IDEXX or its affiliates. The provisions of this Section 9.01 shall survive the termination of this Agreement&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">unless</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;all of the following shall be true&#58; (i)&#160;prior to such termination IDEXX (or its permitted assignees) and its affiliates shall have ceased to market the VETTEST slides, (ii)&#160;such cessation shall not have been a consequence of action by OCD, and (iii)&#160;OCD shall have complied with its obligations under this Agreement prior to such termination.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.02</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IDEXX undertakes not to market, and to cause its affiliates not to market, any Dry Slide for any chemistry identified on&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, as amended from time to time, other than Dry Slides obtained by such person directly from OCD, to the extent that the desired chemistries are available from OCD&#59; provided that, for purposes of adjusting inventory levels according to unanticipated changes in regional demand, IDEXX may purchase from IDEXX BV VETTEST slides that IDEXX BV obtained directly from OCD</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.03</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)&#160;In consideration of the mutual obligations and commitments of the parties, IDEXX shall not actively promote, and shall cause IDEXX Parent and the other persons listed on&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;not to actively promote, the sale within the Exclusivity Territory of any Dry Slide for any chemistry identified on&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, as amended from time to time, or any instruments for use with any such Dry Slides, to any person (other than OCD and its affiliates) other than for use in the field of diagnostic testing of non-human animals. IDEXX may in its discretion terminate this provision at any time on &#91;**&#93; years&#8217; prior written notice to OCD&#59; provided that such notice may not be delivered until after June&#160;30, &#91;**&#93;.</font></div></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.740%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)&#160;Should OCD sell or cause to be sold for use in the field of diagnostic testing of non-human animals any product whose scope includes four or more of the chemistries identified on&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, then IDEXX may, in its sole discretion, terminate the provisions of Section&#160;9.03(a) immediately upon written notice to OCD. If IDEXX delivers such notice of termination of Section&#160;9.03(a) under this Section&#160;9.03(b), then OCD may in its discretion terminate the provisions of Section&#160;9.04(a) of this Agreement immediately upon written notice to IDEXX.</font></div></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.105%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.043%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.126%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.04</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)&#160;In consideration of the mutual obligations and commitments of the parties, OCD shall not actively promote, and shall cause the other persons (which for purposes of this clause may be divisions of OCD&#8217;s affiliates) listed on&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;not to actively promote, the sale within the Exclusivity Territory of any Dry Slide for any chemistry identified on&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, as amended from time to time, or any instruments for use with any such Dry Slides, to any person (other than IDEXX and its affiliates) for use in the field of diagnostic testing of non-human animals&#59; provided that this provision shall not apply to (i)&#160;any instruments weighing more than 200 pounds, or to any slides sold for use on such instruments, unless and until the parties have executed the distribution agreement contemplated by Section&#160;10.04 hereof and (ii) Ortho-Clinical Diagnostics K.K. until January&#160;1, 2004. OCD may in its discretion terminate this provision at any time on &#91;**&#93;</font></div></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25</font></div><div><img alt="image_391.jpg" src="image_391.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.740%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">years&#8217; prior written notice to IDEXX&#59; provided that such notice may not be delivered until after June&#160;30, &#91;**&#93;. The minimum purchase obligations of IDEXX shall terminate upon delivery of such a notice of termination.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.740%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)&#160;Should IDEXX fail to sell at least &#91;**&#93; units of the New Analyzer before December&#160;31, &#91;**&#93;, then OCD may in its discretion terminate the provisions of Section&#160;9.04(a) immediately upon written notice to IDEXX delivered after December&#160;31, &#91;**&#93;&#59; provided, that if OCD does not deliver such notice before IDEXX sells &#91;**&#93; units of the New Analyzer, then the provisions of this Section&#160;9.04(b) shall be of no further effect. If IDEXX can demonstrate that it has expended in excess of $&#91;**&#93; on the development of the New Analyzer from the Effective Date through December&#160;31, &#91;**&#93;, then IDEXX shall be given an additional &#91;**&#93; to sell the requisite &#91;**&#93; units of the New Analyzer. If OCD delivers such notice of termination of Section&#160;9.04(a) under this Section 9.04(b), then IDEXX may in its discretion terminate the provisions of Section&#160;9.03 of this Agreement immediately upon written notice to OCD.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)&#160;Should IDEXX sell or cause to be sold for use in the field of diagnostic testing of non-human animals any product, other than the New Analyzer, whose scope includes four or more of the chemistries identified on&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, then OCD may, in its sole discretion, terminate the provisions of Section&#160;9.04(a) immediately upon written notice to IDEXX. If OCD delivers such notice of termination of Section&#160;9.04(a) under this Section&#160;9.04(c), then IDEXX may in its discretion terminate the provisions of Section 9.03(a) of this Agreement immediately upon written notice to OCD.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)&#160;Notwithstanding any other provision of this Section&#160;9.04, OCD and its affiliates shall continue to have the right to sell, directly or through distributors, VITROS analyzers and VITROS slides to all persons that are current VITROS end-user customers as of the Commencement Date, and to renew or extend the term of any contracts with such end-user customers or, solely for the purpose of sales to such end-user customers, with such distributors.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.089%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.727%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.032%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.652%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.05</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCD shall use commercially reasonable efforts to (i)&#160;ensure that no OCD Dry Slides (including without limitation VITROS slides to which bar coding for use in any Analyzer has been added) are supplied, marketed, distributed or sold, by anyone other than IDEXX or its affiliates and their respective authorized distributors, for use in the Analyzers and (ii)&#160;promptly enjoin or otherwise terminate any such supplying, marketing, distribution or sale. Notwithstanding the foregoing, OCD&#8217;s obligation to use commercially reasonable efforts for the purposes of this Section&#160;9.05 shall not include any obligation to reduce non-VETTEST VITROS slide prices.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCD shall, where permitted by applicable law, use commercially reasonable efforts to include a provision in future supply and distributor contracts, that if a</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26</font></div><div><img alt="image_391.jpg" src="image_391.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.089%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.727%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.032%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.652%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">customer opens a mainframe slide cartridge and otherwise repackages or modifies OCD slides for a use other than for which the slides are sold by OCD, such activity, if not ceased upon notice, shall give OCD the right to terminate such contract. OCD will use commercially reasonable efforts to exercise such right where the customer does not cease such activity after due notice and a reasonable opportunity to cure. OCD and IDEXX shall also reasonably cooperate in efforts to stop any such unauthorized slide repackaging or modification, where the modified or repackaged slides are supplied, marketed or sold for use in Analyzers.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In the event of a breach by OCD of this Section&#160;9.05, OCD shall pay IDEXX, as IDEXX&#8217;s exclusive remedy for such breach, an amount equal to $&#91;**&#93; per slide sold for use in the Analyzers in breach of this Section&#160;9.05.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.06</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Within ninety (90)&#160;days of the date that either party (for purposes of this Section&#160;9.06, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Introducing Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) (i)&#160;builds or acquires a prototype of any veterinary clinical chemistry diagnostic instrument that is designed to analyze &#91;**&#93; or more of the chemistries identified on&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;(a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Veterinary Diagnostic Product</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) or (ii)&#160;has expended $&#91;**&#93; on a formal development project, or the acquisition of technology, for a Veterinary Diagnostic Product, such Introducing Party shall provide to the other party written notice of such decision. In addition, IDEXX agrees to provide such a notice if IDEXX Parent or IDEXX BV takes any of the actions described in clauses (i)&#160;or (ii)&#160;of this paragraph.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.07</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">During the Term of this Agreement, neither party shall directly recruit or otherwise directly solicit for employment (or instruct any third party so to do) any U.S. sales representative or first line sales manager of the other party &#59; provided that the foregoing shall not prohibit any advertisement or general solicitation or recruitment activity (or any hiring pursuant thereto) that is not specifically targeted at such persons.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.520%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.940%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">MARKETING ARRANGEMENTS</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.700%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IDEXX will be responsible for all marketing arrangements for the Analyzers and the VETTEST slides. IDEXX may appoint any of OCD&#8217;s medical&#47;surgical dealers as distributors of or agents for the Analyzers and the VETTEST slides but will not be obliged to do so.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.02</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IDEXX will be responsible for the establishment of dealer performance criteria for all dealers including OCD&#8217;s medical&#47;surgical dealers (if any are appointed by IDEXX as distributors of the Analyzers and the VETTEST slides).</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.03</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IDEXX will keep OCD informed of and consult with OCD as to marketing arrangements for the Analyzers and the VETTEST slides but will not be obligated to OCD beyond the terms of this Agreement in connection with such marketing arrangements.</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27</font></div><div><img alt="image_391.jpg" src="image_391.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.700%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.04</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCD hereby grants to IDEXX the exclusive right to distribute, solely in the veterinary market, under the terms set forth in this Section&#160;10.4, VITROS slides and VITROS analyzers that run solely VITROS slides. The parties also agree to use good faith, commercially reasonable efforts to negotiate a definitive distribution agreement not later than December&#160;31, 2003. OCD agrees to refer any inquiries for VITROS analyzers in the veterinary market to IDEXX, and shall not accept any orders for such analyzers in the veterinary market. IDEXX agrees to refer any inquiries for VITROS analyzers outside the veterinary market to OCD, and shall not accept any orders for such analyzers outside the veterinary market. Notwithstanding any other provision of this Section&#160;10.04, OCD and its affiliates shall continue to have the right to sell, directly or through distributors, VITROS analyzers and VITROS slides to all persons that are current VITROS end-user customers as of the Commencement Date, and to renew or extend the term of any contracts with such customers or, solely for the purpose of sales to such customers, with such distributors.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The parties shall discuss terms for any sales opportunity in the veterinary market in good faith, on a case-by-case basis. OCD shall be responsible, at its sole expense, for providing warranty and out-of-warranty service and support to any customers to whom IDEXX sells a VITROS analyzer&#59; provided that such analyzer is then covered by a maintenance agreement between OCD and that customer. IDEXX shall not modify or customize any VITROS product supplied hereunder, or remove or alter any product labels or re-label any products, packaging or related materials for VITROS product supplied hereunder. OCD shall provide IDEXX, without charge, with such training in the marketing and sale of VITROS products and with such marketing and technical assistance and product information as OCD may, in its discretion, consider necessary to assist with the promotion and sale of the products&#59; provided that OCD&#8217;s training obligation shall be limited to training employees of IDEXX to train other IDEXX employees and sales agents.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IDEXX shall defend and indemnify OCD from and against all damages, liabilities, costs and expenses (including reasonable attorneys&#8217; fees and costs) arising out of any claim resulting from (a)&#160;any negligent act or omission or any willful misconduct by IDEXX in connection with the VITROS products supplied by OCD under this Section&#160;10.04 or (b)&#160;any statement, representation or warranty made by IDEXX or any of its agents with respect to a VITROS product that is not contained in the labeling or package insert and is not otherwise approved by OCD in writing or (c)&#160;any breach of IDEXX&#8217;s covenants in the preceding paragraph. OCD shall defend and indemnify IDEXX from and against all damages, liabilities, costs and expenses (including reasonable attorneys&#8217; fees and costs) arising out of any claim (i)&#160;for injuries or death to persons or animals or damage to or destruction of tangible property arising out of the use of VITROS products sold under this Section&#160;10.04 (whether claimed by reason of breach of warranty, negligence,</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28</font></div><div><img alt="image_391.jpg" src="image_391.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.740%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">product defect or other similar cause of action, regardless of the form in which any such claim is made) or (ii)&#160;that any VITROS product sold under this Section&#160;10.04 infringes a patent, copyright, trademark or trade secret of a third party&#59; provided that this clause (ii)&#160;shall not apply to any claim arising out of the use of any product in conjunction with products not supplied by OCD. The indemnity procedures set forth in Section&#160;16.06 shall apply to this Section&#160;10.04.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The provisions of this Section&#160;10.04 shall apply only within the Exclusivity Territory. Furthermore, the provisions of this Section 10.04 granting IDEXX exclusivity or restricting sales or marketing by or on behalf of OCD shall, (a)&#160;automatically terminate immediately upon the termination of Section&#160;9.04(a) and (b)&#160;not apply to (i)&#160;any instruments weighing more than 200 pounds, or to any slides sold for use on such instruments, unless and until the parties have executed the distribution agreement contemplated by this Section&#160;10.04 and (ii)&#160;Ortho-Clinical Diagnostics K.K. until January&#160;1, 2004.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.520%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.940%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">SALES SUPPORT</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.700%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IDEXX will be responsible for all necessary sales support for the Analyzers and the VETTEST slides.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.02</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCD&#8217;s sole obligation in respect of sale support shall be at its own expense to assist IDEXX in resolving specific problems resulting from the failure of VETTEST slides to conform to specifications.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.520%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.940%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">TESTING</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.700%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">01 OCD shall disclose to IDEXX its quality assurance procedures used in final evaluation of the VETTEST slides and full particulars thereof as set out in the VETTEST Slide Quality Assurance Procedures forming&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;to this Agreement. OCD shall operate such quality assurance procedures in accordance with&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.02</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upon prior written notice from IDEXX, OCD shall grant authorized representatives of IDEXX access to that part of OCD production facilities which conducts final evaluation of the VETTEST slides for the purpose of enabling such representatives to monitor the application by OCD of the VETTEST Slide Quality Assurance Procedures set out in&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Such access shall be granted by OCD to IDEXX and IDEXX BV no more than twice in any twelve-month period. With respect to VETTEST slides for use in the New Analyzer, IDEXX shall be permitted to monitor those stages of the production process that are unique to VETTEST slides for the New Analyzer, but with respect to VETTEST slides for the VETTEST Analyzer, such access shall be limited to OCD&#8217;s final evaluation facilities. All information obtained as a result of the audits contemplated by this Section&#160;12.02 shall be subject to the provisions of&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29</font></div><div><img alt="image_391.jpg" src="image_391.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.520%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.940%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">BAR CODING AND PACKAGING</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.700%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The VETTEST slides shall be printed by OCD with special bar coding for use in Analyzers.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.02</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCD shall package the VETTEST slides and tips for the VETTEST Analyzer in the physical manner as used for the VITROS slides and tips at the time of packaging of such VETTEST slides and tips. In the event of a change in VITROS slide or tip packaging which has an impact on such VETTEST slide or tip packaging, OCD shall notify IDEXX as early as practicable of the relevant particulars of such change.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.03</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Except as authorized by Section&#160;14.01 below, the label content and art work associated with VETTEST slides and package materials (including without limitation package materials for the New Slides) shall not include any trademarks, trade names, or trade dress of OCD. IDEXX shall furnish such label content and art work to OCD on a timely basis, and such label content and art work shall not be changed at any time during the Term without the prior agreement of the parties.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.520%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.940%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">TRADE MARKS AND TRADE NAMES</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.700%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">01 OCD expressly authorizes IDEXX to use the phrase &#8220;manufactured by Ortho-Clinical Diagnostics, Inc. for IDEXX (IDEXX ADDRESS)&#8221; on package materials for VETTEST slides (including without limitation package materials for the New Slides). No other uses of OCD&#8217;s trademarks, trade names or trade dress are authorized by this Agreement.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.02</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IDEXX shall neither acquire, nor claim any right, title or interest in or to any of OCD&#8217;s trade marks or trade names by virtue of this Agreement or through advertising and sale of the Analyzers or the VETTEST slides or otherwise.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.520%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.940%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">PATENT INDEMNITIES</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.700%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCD shall indemnify and hold IDEXX harmless for all loss, damage, cost and expense whatsoever, including legal fees, patent attorney&#8217;s fees and court costs that IDEXX may incur or become liable for as a result of any action, suit or claim alleging infringement of any patent held by a third party arising from the use and&#47;or sale of the VETTEST slides or tips to the extent that such action, suit, or claim relates in a material way to the specification for the VITROS slides or tips. If as a result of any judgment or settlement it is determined that a claim or claims of a third party patent is infringed by the use and&#47;or sale of the VETTEST slides or tips as aforesaid and IDEXX is required to make any payments to any third party as a result thereof, IDEXX may off-set all such payments against any present and&#47;or future payments to be made to OCD hereunder.</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30</font></div><div><img alt="image_391.jpg" src="image_391.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.700%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.02</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IDEXX shall indemnify and hold OCD harmless for all loss, damage, cost and expense whatsoever, including legal fees, patent attorney&#8217;s fees and court costs that OCD may incur or become liable for as a result of any action, suit or claim alleging infringement of any patent held by a third party arising from (a)&#160;the manufacture, use or sale of the VETTEST slides or tips to the extent that the VETTEST slides or tips differ from the VITROS slides or tips, (b)&#160;the manufacture, use or sale of the New Slide&#47;Panel Design, or (c)&#160;the manufacture, use or sale of any Analyzer.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.03</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All claims for indemnity under this Article&#160;15 shall be subject to the rights, obligations and procedures set forth in Section&#160;16.06 below.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.520%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.940%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">WARRANTY, LIABILITY AND INDEMNIFICATION</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.700%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCD hereby warrants that&#58;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.360%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.360%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.260%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the VETTEST slides delivered to IDEXX shall be in compliance with&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, and</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCD shall pack and ship products under this Agreement in a manner consistent with OCD&#8217;s usual practices, which shall be sufficient to protect the products from damage during normal shipping and handling.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.700%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.02</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In the event of a breach on the part of OCD of Section&#160;16.01 above, OCD&#8217;s liability shall be limited to the replacement of the VETTEST slides or tips found to be defective, including shipping costs for return of defective slides or tips and delivery of replacement slides or tips.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.03</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCD&#8217;s liability as stated in Section&#160;16.02 shall be subject to the following conditions&#58;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.360%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.360%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.260%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IDEXX shall notify OCD promptly of any noncompliance contrary to Section&#160;16.01(a) or damage contrary to Section&#160;16.01(b).</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IDEXX and its transferees shall not alter or modify the VETTEST slides or packaging of the VETTEST slides or tips without prior approval of OCD.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.700%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.04</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Except as provided in this Section&#160;16 there are no other warranties, express or implied, including warranties for fitness for any particular use or of merchantability.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.05</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subject to Section&#160;15, IDEXX shall indemnify and hold harmless OCD from and against any claim, loss, damage, or expense (including attorney&#8217;s fees) with</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31</font></div><div><img alt="image_391.jpg" src="image_391.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.700%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">respect to any physical injury to persons, animals or property arising out of or in connection with IDEXX&#8217;s use or sale of any Analyzer or the VETTEST slides, and any claim of infringement of any trademark (except OCD&#8217;s own trademark), trade dress, trade secret, or copyright. IDEXX shall notify OCD (a)&#160;at the commencement of any action or suit based on any such claim and (b) in the event of any injunction or other order prohibiting the sale or use of any Analyzer or VETTEST slide.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.06</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Any party claiming indemnification under this Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Indemnitee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) shall notify the party from which indemnification is claimed (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Indemnifying Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) in writing promptly upon becoming aware of any claim to which such indemnification may apply. Failure to provide such notice shall constitute a waiver of the Indemnifying Party&#8217;s indemnity obligations hereunder if, and only to the extent that, the Indemnifying Party is materially damaged thereby. The Indemnifying Party shall have the right to assume and control the defense of the claim at its own expense. If the right to assume and have sole control of the defense is exercised, the Indemnitee shall have the right to participate in, but not to control, such defense at its own expense. If the Indemnifying Party does not assume the defense of the claim, the Indemnitee may defend the claim at the Indemnifying Party&#8217;s expense. The Indemnitee will not settle or compromise the claim without the prior written consent of the Indemnifying Party. The Indemnifying Party will not, without the consent of the Indemnitee (which consent will not be unreasonably withheld), settle or compromise the claim in any manner which would have an adverse effect on the Indemnitee, unless (x)&#160;prior to such settlement or compromise the Indemnifying Party acknowledges in writing its obligation to pay in full the amount of the settlement or compromise and the Indemnitee is furnished with security reasonably satisfactory to it that the Indemnifying Party can in fact pay such amount, (y)&#160;such settlement or compromise includes a full release of such claim against the Indemnitee and (z)&#160;such settlement or compromise provides for no relief or remedy other than money damages. The Indemnitee shall reasonably cooperate with the Indemnifying Party and will make available to the Indemnifying Party all pertinent information under the control of the Indemnitee.</font></div></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.&#160;&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">SECRECY</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.700%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Each of IDEXX, IDEXX Parent and OCD agrees to protect confidential information disclosed to it upon terms set out in&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;attached hereto.</font></div></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.520%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.940%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">PERIOD OF AGREEMENT</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.700%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subject to the terms and conditions set forth herein, the term (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Term</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) of the Agreement shall be the period from the Commencement Date until December&#160;31, 2018</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">.</font></div></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32</font></div><div><img alt="image_391.jpg" src="image_391.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.520%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.940%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">TERMINATION</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.700%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This Agreement may be terminated by either party in any of the following events&#58;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.360%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.360%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.260%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If the other party is guilty of gross or persistent breaches of the terms of this Agreement, which breaches are not remedied to the satisfaction of the other party after ninety (90)&#160;days notice in writing to do so. Any such breach shall entitle the innocent party to terminate this Agreement by notice in writing which notice shall be effective at the end of ninety (90)&#160;days following the date of such notice.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If the other party becomes insolvent or compounds with its creditors or goes into liquidation (other than for the purposes of corporate reorganization) then the innocent party may terminate this Agreement by notice in writing which shall have immediate effect.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If such party elects to cease marketing Dry Slide diagnostic products, then it shall have the right, by notice given at any time after January&#160;1, &#91;**&#93;, to terminate this Agreement upon&#91;**&#93; years&#8217; prior written notice.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.700%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.02</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in the equity ownership or corporate reorganizations of either party shall not be grounds for termination of this Agreement, except that if more than &#91;**&#93;% of the outstanding capital stock of IDEXX or IDEXX Parent is owned or controlled by a competitor of OCD, OCD may in its discretion terminate the provisions of Sections&#160;9.04 and 10.04 of this Agreement immediately upon written notice to IDEXX. If OCD delivers such notice of termination under this Section&#160;19.02, then IDEXX may in its discretion terminate the provisions of Section&#160;9.03 of this Agreement immediately upon written notice to OCD.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.03</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This Agreement shall terminate automatically upon any termination of the Europe Agreement.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.04</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The provisions of this Agreement dealing with rights and obligations after termination of this Agreement, including without limitation Sections&#160;3.04, 3.05, 3.06, 3.07, 15, 16, 17, 21, 22, 23, 24, 25, 26, 29 and 30, shall survive the expiration or termination of this Agreement and continue to be enforceable to the extent necessary to achieve the logical and intended purposes of such provisions.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.520%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.940%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">FORCE MAJEURE</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.700%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neither party shall be liable for any failure or delay in performing any of its respective obligations under this Agreement to the extent that such failure or delay is due to any cause beyond its reasonable control (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Force Majeure Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;). The non-performing party shall give the other party prompt written notice of such inability to perform and shall use commercially reasonable efforts to resume</font></div></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33</font></div><div><img alt="image_391.jpg" src="image_391.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.740%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">performance as soon as reasonably practicable. If as a result of a Force Majeure Event OCD is unable, using commercially reasonable efforts, to meet its supply obligations to IDEXX hereunder for a period exceeding twenty-four months, or if IDEXX reasonably determines that it will not be feasible for OCD through the use of commercially reasonable efforts to resume the supply of VETTEST slides within twenty-four months, then either party may terminate this Agreement immediately upon written notice to the other party.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.520%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.940%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">GOVERNING LAW&#59; JURISDICTION</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.700%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The construction, validity and performance of this Agreement shall be governed in all respects by the laws of the State of New York, USA. Any legal actions relating to this Agreement must be brought in the court of appropriate jurisdiction in the State of New York, which shall have exclusive jurisdiction, and the parties hereby waive any claim of lack of jurisdiction or inconvenient forum. The prevailing party in any litigation under this Agreement shall be entitled to an award of its costs, including reasonable attorneys&#8217; fees and expenses. Each party hereto waives its right to trial of any issue by jury. Each party hereto waives any claim to punitive, exemplary or multiplied damages from the other. Each party hereto waives any claim of consequential damages from the other.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.520%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.940%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">SEVERABILITY</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.700%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Any term or provision of this Agreement that is invalid or unenforceable in any situation in any jurisdiction shall not affect the validity or enforceability of the remaining terms and provisions hereof or the validity or enforceability of the offending term or provision in any other situation or in any other jurisdiction. If the final judgment of a court of competent jurisdiction declares that any term or provision hereof is invalid or unenforceable, then the parties agree that the court making the determination of invalidity or unenforceability shall have the power to reduce the scope, duration, or area of the term or provision, to delete specific words or phrases, or to replace any invalid or unenforceable term or provision with a term or provision that is valid and enforceable and that comes closest to expressing the intention of the invalid or unenforceable term or provision, and this Agreement shall be enforceable as so modified after the expiration of the time within which the judgment may be appealed.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.520%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.940%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">WAIVERS</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.700%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Failure of either party to this Agreement to insist upon strict observance or compliance with all its terms and conditions in one or more instances shall not be deemed to be a waiver of its right to insist upon such observance or compliance with such term or condition or with any other terms or conditions hereof in the future.</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34</font></div><div><img alt="image_391.jpg" src="image_391.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.520%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.940%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">PRIOR AGREEMENTS&#59; INTERPRETATION</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.700%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of the Commencement Date, this Agreement shall take effect in substitution for the Prior US Agreement, the Operations Agreement (except as otherwise provided in Section&#160;7.04 of this Agreement), Section&#160;B (Amendments) of the Settlement Agreement, and all or any other previous agreements relating to the subject matter hereof whether the same are formal agreements or agreements that would be inferred from the parties&#8217; correspondence or conduct, and all such substituted agreements shall be deemed to have been terminated by mutual consent on the Commencement Date&#59; provided, however, that nothing contained herein shall be deemed to modify or terminate the Europe Agreement, except that the Purchase Commitments and Annual Purchase Forecasts referred to in Section&#160;5 and in&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;of this Agreement and the Europe Agreement represent the aggregate commitments and forecasts of IDEXX and IDEXX BV and not the individual commitments and forecasts of IDEXX BV under the Europe Agreement or IDEXX under this Agreement.</font></div></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.520%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.940%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">ENTIRE AGREEMENT</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.700%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This Agreement, together with the Europe Agreement, the Settlement Agreement (other than Section&#160;B thereof), and that certain memorandum agreement dated September&#160;12, 2003 regarding slide packaging (as amended to date), constitutes the complete agreement of the parties concerning the subject matter hereof and thereof during the Term, and, with respect to all periods from and after the Commencement Date, supersedes all prior agreements between the parties regarding its subject matter.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.520%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.940%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">ALTERATION OR MODIFICATION</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.700%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No alteration, amendment or modification to this Agreement or the attached Schedules shall be of any force or effect unless in writing and signed by both parties. No modification shall be effected by the acknowledgement or acceptance of purchase order forms or order confirmations or invoices or other documents containing different conditions.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.520%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.940%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">ASSIGNMENT</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.700%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This Agreement shall not be capable of assignment by either party to a company of which it owns less than a majority or which owns less than a majority of the party save in the case of (i)&#160;an assignment at OCD&#8217;s sole discretion to an acquiror of OCD&#8217;s dry slide business or (ii)&#160;an assignment at IDEXX&#8217;s sole discretion to an acquiror of IDEXX&#8217;s VETTEST and New Analyzer business&#59; provided that no assignment shall release the assigning party from any obligations hereunder. In the case of an assignment under the preceding clause (ii)&#160;to an entity which is a competitor of OCD&#8217;s diagnostics business, OCD may in its discretion terminate</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35</font></div><div><img alt="image_391.jpg" src="image_391.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.740%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the provisions of Section&#160;9.04 of this Agreement immediately upon written notice to IDEXX. If OCD delivers such notice of termination of Section&#160;9.04 under this Section&#160;27.01, then IDEXX&#8217;s assignee may in its discretion terminate the provisions of Section 9.03 of this Agreement immediately upon written notice to OCD.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This Agreement shall be binding on and inure to the benefit of the parties hereto and their permitted successors and assigns.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.520%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.940%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">GOVERNING LANGUAGE</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.700%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;Reserved&#93;</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.520%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.940%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">NOTICES</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.700%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Any notice, statement or other communication to be given by one party to the other hereunder may be given by registered mail, airmail, nationally recognized courier, facsimile or telex to the party concerned at the addresses set out below&#58;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ortho-Clinical Diagnostics, Inc.<br>1001 US Highway 202<br>Raritan, New Jersey 08869, USA<br>For the attention of&#58; Vice President and General Manager, Americas</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With a copy to&#58;<br>Johnson &#38; Johnson<br>One Johnson &#38; Johnson Plaza<br>New Brunswick, New Jersey 08933, USA<br>For the attention of&#58; Office of General Counsel</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IDEXX Operations, Inc.<br>6100 East Shelby Drive<br>Memphis, Tennessee 38141, USA<br>For the attention of&#58; President</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With a copy to&#58;<br>IDEXX Laboratories, Inc.<br>One IDEXX Drive<br>Westbrook, Maine 04092, USA<br>For the attention of&#58; Office of General Counsel</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.02</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Any notice, payment or communication so given or made shall be deemed to have been received at the time when in the ordinary course of transmission the same should have reached its destination. Either party may change its address for the</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36</font></div><div><img alt="image_391.jpg" src="image_391.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.740%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">purpose of this Agreement by giving notice of such change to the other party pursuant to the provisions of this Section. For purposes of this Section&#160;29, notice given by OCD to IDEXX BV under the Europe Agreement shall be deemed given to IDEXX.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.520%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.940%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">GUARANTY</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.700%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IDEXX Parent hereby guarantees to OCD the due performance and observance by IDEXX of all of the provisions of the Agreement to be performed and observed by it under this Agreement, for which IDEXX Parent shall be jointly and severally liable, without requiring any notice of non-payment, non-performance or non-observance, or proof of notice or demand, all of which IDEXX Parent hereby waives. OCD may proceed against IDEXX Parent separately or jointly, before, after or simultaneously with proceeding against IDEXX for default. This guaranty shall not be terminated, affected or impaired in any way by reason of (i)&#160;the assertion by OCD against IDEXX of any of the rights or remedies reserved to OCD under this Agreement, (ii)&#160;the commencement by OCD of any proceedings against IDEXX, (iii)&#160;the granting by OCD of any extensions of time or indulgence to IDEXX, (iv)&#160;any change in or amendment to this Agreement, or (v)&#160;any payment or performance being invalid in connection with any bankruptcy, insolvency, reorganization or similar proceedings in respect to IDEXX. This guaranty is absolute and unconditional and shall continue in full force and effect as to any renewal, extension, amendment, addition, assignment or transfer or other modification of this Agreement, whether or not IDEXX Parent shall have been notified of or consented to any such action, and regardless of bankruptcy or insolvency of IDEXX or the actual or purported rejection by a trustee in such bankruptcy of this Agreement or any limitation on any claim in such bankruptcy for damages resulting from the actual or purported termination of this Agreement or the enforceability in such bankruptcy of this Agreement. IDEXX Parent hereby agrees that this guaranty shall continue to be effective or shall be reinstated, as the case may be, if at any time payment of any sum hereby guaranteed is rescinded or must be otherwise restored or returned by OCD upon the insolvency, bankruptcy or reorganization of IDEXX, or otherwise, all as though such payment had not been made.</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37</font></div><div><img alt="image_391.jpg" src="image_391.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">IN WITNESS WHEREOF</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;and intending to be legally bound, the parties hereto have caused this Agreement to be duly executed in duplicate by their respective authorized representatives the day and year first written above.</font></div><div style="padding-left:0.04pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.705%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.707%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ORTHO-CLINICAL</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IDEXX OPERATIONS, INC.</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIAGNOSTICS, INC.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Tony Zezzo</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Conan R. Deady</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tony Zezzo,</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conan R. Deady,</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President and General Manager,</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solely as to Sections&#160;17 and 30</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IDEXX LABORATORIES, INC.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Jonathan W. Ayers</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jonathan W. Ayers,</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38</font></div><div><img alt="image_391.jpg" src="image_391.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Schedule&#160;1 &#8211; VetTest&#174; Slide Quality Assurance Procedures</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">VETTEST Slides for the VETTEST Analyzer</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Introduction</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following procedure constitutes a generic overview of the quality assurance provisions for finishing of VITROS slides and applies in like manner to product release for the VETTEST slides.</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">VETTEST Slide Quality Assurance</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VETTEST slides will be produced to the same quality standards as VITROS and DT 60 slides for OCD&#8217;s human market unless otherwise agreed to by IDEXX.</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Bar Coding</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bar code printing on the VETTEST slides will render the VETTEST slides incompatible with use in VITROS analyzers. OCD will reserve certain number sequences for generation of the bar code patterns on the VETTEST slides.</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">New Slides</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specifications to be determined by IDEXX as part of the Development Program and, together with quality assurance procedures, reasonably agreed in writing by the parties for purposes of this&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;1</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39</font></div><div><img alt="image_391.jpg" src="image_391.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Schedule&#160;2</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Section&#160;1.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Obligation to Keep Information Confidential</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Each party agrees to hold, and to cause its respective officers, directors, employees, accountants, counsel, consultants, advisors and agents to hold, in confidence the terms of the Agreements, and all documents and information concerning the other party, whether oral or written, furnished or made known to such party in connection with either of the Agreements or any project or discussion under, or related to, either of the Agreements&#59;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">provided&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">that no party shall be required to keep any information confidential (i)&#160;if such party is compelled to disclose such information by judicial or administrative process or by other requirements of law (including without limitation the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended) and such party has provided prior written notice to the other party and given such other party reasonable opportunity to contest disclosure or (ii)&#160;to the extent such information can be shown to have been (A)&#160;previously known to such party on a nonconfidential basis, (B)&#160;in the public domain through no fault of such party, (C)&#160;later lawfully acquired from a third party source or (D)&#160;independently developed by such party without reference to confidential information. The foregoing notwithstanding, any party may disclose information concerning the other party or the Agreements to its and its affiliates&#8217; officers, directors, employees, accountants, counsel, consultants, advisors and agents in connection with its performance of this Agreement so long as such persons are informed by such party of the confidential nature of such information and are directed by such party to treat such information confidentially, it being understood and agreed that such party shall be responsible for any failure to treat such information confidentially by such persons. The obligation of each party to hold any information in confidence shall be satisfied if it exercises the same care with respect to such information as it would to preserve the confidentiality of its own similar information. The confidentiality provisions of this&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;2</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;shall remain in effect for so long as this Agreement is in effect and for a period of three (3)&#160;years thereafter.</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Section&#160;2.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Public Announcements</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. No party to this Agreement shall originate any news release or other public announcement, written or oral, relating to this Agreement or the Europe Agreement, without the prior written consent of the other party, except to the extent such news release or other public announcement is required by law&#59; provided that in the event an announcement is required by law, the party issuing same shall still be required to use its commercially reasonable efforts to consult with the other party or parties named or referred to in such announcement prior to its release as the circumstances reasonably permit, in order to allow such other party or parties to comment on the use of their names or the references to them and, after its release, shall provide such other party or parties with a copy thereof. If a party has previously reviewed and approved a public announcement, its further approval shall not be required with respect to those provisions of subsequent announcements that are substantially similar in scope and substance to provisions that have been previously approved. In no event shall IDEXX or IDEXX Parent use the name &#8220;Johnson &#38; Johnson&#8221; or &#8220;J&#38;J&#8221; in any publicity relating to this Agreement or the Europe Agreement, whether written or oral, other than to state that OCD is &#8220;a Johnson &#38; Johnson company&#8221; or a (wholly-owned) subsidiary of Johnson &#38; Johnson.</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40</font></div><div><img alt="image_391.jpg" src="image_391.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Section&#160;3.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Governing Law</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. The construction, validity and performance of this&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;2</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;shall be governed in all respects by the laws of the State of New York, USA.</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Section&#160;4.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Notices</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Any notices required to be given under this&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;2</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;shall be given in the manner specified by Section&#160;29 of the Agreement.</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41</font></div><div><img alt="image_391.jpg" src="image_391.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Schedule&#160;3 - Panels&#47;Profiles</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br>(Applicable only to VETTEST Analyzer)</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The initial PANEL shall be the &#8220;Pre-Anesthetic Panel&#8221; consisting of four sets of the following six VETTEST slides&#58;</font></div><div style="padding-left:0.07pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:13.915%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.774%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BUN</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urea Nitrogen</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ALT</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alanine aminotransferase</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GLU</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Glucose</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TP</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total protein</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CREA</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Creatinine</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ALKP</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alkaline phosphatase</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The initial PROFILES shall be the &#8220;General Health Profile&#8221; and the &#8220;Large Animal Profile&#8221;, each consisting of two sets of 12 VETTEST slides as follows&#58;</font></div><div style="padding-left:0.07pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:13.413%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.380%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.482%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.450%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">General Health Profile</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Large Animal Profile</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ALB</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Albumin</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ALB</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Albumin</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ALKP</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alkaline phosphatase</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ALKP</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alkaline phosphatase</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ALT(SGPT)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alanine aminotransferase</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AST</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AST</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AMYL</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amylase</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ca</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2+</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Calcium</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ca</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2+</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Calcium</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CK</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CK</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHOL</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cholesterol</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GGT</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gamma GT</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CREA</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Creatinine</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GLU</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Glucose</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GLU</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Glucose</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PHOS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inorganic phosphate</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PHOS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inorganic phosphate</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LDH</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LDH</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TBIL</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total bilirubin</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MG</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Magnesium</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TP</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total protein</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TP</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Protein</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BUN</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urea Nitrogen</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BUN</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urea Nitrogen</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Packaging for the Pre-Anesthetic Panels, the General Health Profiles and the Large Animal Profiles for the VETTEST Analyzer has been previously agreed upon by the parties, and any changes to the slide composition or packaging of the initial PANEL or the initial PROFILES shall be negotiated in good faith and mutually agreed upon by OCD and IDEXX. The slide composition, packaging and initial pricing of any additional PANELS&#47;PROFILES shall be mutually agreed upon by OCD and IDEXX. Unless otherwise agreed by the parties in writing with respect to one or more specific PANELS or PROFILES, all purchases by IDEXX or IDEXX BV of VETTEST slides packaged as PANELS&#47;PROFILES shall be credited against the Annual Purchase Forecasts and Purchase Commitments for such slides under this Agreement and the Europe Agreement.</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Slide&#47;Panel Design for the New Analyzer shall be as developed by IDEXX under Article&#160;3.</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42</font></div><div><img alt="image_391.jpg" src="image_391.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Schedule&#160;4 - Purchase Commitments</font></div><div style="padding-left:105.35pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:55.288%"><tr><td style="width:1.0%"></td><td style="width:47.305%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.668%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.479%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.482%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Minimum Slide Purchase</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commitment (&#91;**&#93;)</font></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><img alt="image_441.jpg" src="image_441.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_451.jpg" src="image_451.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2003</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2004</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2005</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2006</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2007</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2008</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2009</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2010</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43</font></div><div><img alt="image_391.jpg" src="image_391.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Schedule&#160;5 - Products and Prices<br>(as of the Commencement Date)</font></div><div style="padding-left:0.17pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.887%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.224%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.861%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.224%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.436%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.861%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.657%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.963%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Sales Region</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">US Sales</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asian Sales</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><img alt="image_471.jpg" src="image_471.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_481.jpg" src="image_481.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_491.jpg" src="image_491.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer Number</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164 9706</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318 3258</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:0.07pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.470%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.669%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.265%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.791%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.796%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">US Pricing</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="21" style="padding:0 1pt"><div><img alt="image_501.jpg" src="image_501.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#62;1500</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Single Slides (Bx 25)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Catalog Number</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">bxs*</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#60;1500 bxs*</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asian Pricing</font></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><img alt="image_512.jpg" src="image_512.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_521.jpg" src="image_521.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_55.jpg" src="image_55.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_55.jpg" src="image_55.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_55.jpg" src="image_55.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Albumin</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">822 7134</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alk Phos</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">831 5459</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ALT</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">808 3750</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ammonia</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181 6842</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amylase</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">820 8191</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AST</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">811 3979</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Calcium</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">804 8191</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cholesterol</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">835 4888</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CK</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">835 8582</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Creatinine</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">818 3477</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ECO2</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853 8670</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gamma GT</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">826 1315</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Glucose</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">813 0536</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LDH</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">835 1082</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lipase</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196 6191</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Magnesium</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108 0266</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phosphorus</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">807 0856</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Bilirubin</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838 0396</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Protein</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193 7093</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Triglycerides</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192 2285</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urea Nitrogen</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150 7326</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uric Acid</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 0793</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:0.05pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.963%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.471%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.312%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.868%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.836%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.773%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.868%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.840%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Profile Slides (Bx 24)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Catalog Number</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">US Pricing</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asian Pricing</font></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><img alt="image_56.jpg" src="image_56.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_57.jpg" src="image_57.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_58.jpg" src="image_58.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_59.jpg" src="image_59.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General Health Profile</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160 7175</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-Anesthetic Panel</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">801 5109</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Large Animal Profile</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680 0071</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="padding-left:0.07pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.456%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.874%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.512%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.515%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Catalog Number</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">WW Pricing</font></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><img alt="image_60.jpg" src="image_60.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_611.jpg" src="image_611.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_711.jpg" src="image_711.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vetrols</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">869 9852</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tips</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175 7384</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.740%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per chemistry per order</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Schedule&#160;5 - Products and Prices (continued)</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Sales Region&#58; Australia&#47;New Zealand</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer No.&#58; 314 8251</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:0.04pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.615%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.025%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.054%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.849%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.008%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.025%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.167%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.601%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Single Slides (Box of 25)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Catalog Number</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Australia&#47;NZ Pricing</font></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><img alt="image_631.jpg" src="image_631.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_64.jpg" src="image_64.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_65.jpg" src="image_65.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Albumin</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">822 7134</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alk Phos</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">831 5459</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ALT</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">808 3750</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ammonia</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181 6842</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amylase</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">820 8191</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AST</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">811 3979</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Calcium</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">804 8191</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cholesterol</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">835 4888</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CK</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">835 8582</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Creatinine</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">818 3477</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ECO2</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853 8670</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gamma GT</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">826 1315</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Glucose</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">813 0536</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LDH</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">835 1082</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lipase</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196 6191</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Magnesium</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108 0266</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phosphorus</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">807 0856</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Bilirubin</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838 0396</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Protein</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193 7093</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Triglycerides</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192 2285</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urea Nitrogen</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150 7326</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uric Acid</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 0793</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:0.07pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.088%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.887%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.088%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.685%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.574%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.691%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Profile Slides (Box of 24)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Catalog Number</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Australia&#47;NZ Pricing</font></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><img alt="image_66.jpg" src="image_66.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_67.jpg" src="image_67.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_68.jpg" src="image_68.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General Health Profile</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160 7175</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-Anesthetic Panel</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">801 5109</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Large Animal Profile</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680 0071</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="padding-left:0.07pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.456%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.874%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.512%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.515%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Catalog Number</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">WW Pricing</font></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><img alt="image_60.jpg" src="image_60.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_611.jpg" src="image_611.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_711.jpg" src="image_711.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vetrols</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">869 9852</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tips</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175 7384</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45</font></div><div><img alt="image_391.jpg" src="image_391.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Schedule&#160;6 &#8211; Minimum Prices for New Chemistries</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46</font></div><div><img alt="image_391.jpg" src="image_391.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Schedule&#160;7 - Illustrative Rebate Calculations</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Estimated Rebate Payments will be calculated for each of the first three calendar quarters using the Effective Rebate Rate, as described more fully in sub-clause 7.03 of the Agreement. Any required adjustments will be made at the end of the fourth calendar quarter, in accordance with sub-clause 7.03 of the Agreement.</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Example</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#58; The aggregate Annual Purchase Forecast for IDEXX and IDEXX BV in a given year is &#91;**&#93; slides&#59; pricing is $&#91;**&#93;&#47;slide&#59; blended rebate percentage rate is &#91;**&#93;%, as follows&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.740%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93; slides * &#91;**&#93;% &#61; &#91;**&#93; slides</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93; slides * &#91;**&#93;% &#61; &#91;**&#93; slides</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93; slides * &#91;**&#93;% &#61; &#91;**&#93; slides</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93; slides * &#91;**&#93;% &#61; &#91;**&#93; slides</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">slides *</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#91;**&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">% &#61;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#91;**&#93; slides</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Slides Eligible for Rebate &#61; &#91;**&#93; slides</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Effective Rebate &#61; Total slides eligible for rebate &#47; total purchases &#61; &#91;**&#93; &#61; &#91;**&#93;%</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Actual aggregate volume purchased by IDEXX and IDEXX BV equals volume projected at the beginning of the year</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">.</font></div><div style="padding-left:0.19pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.472%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.201%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.560%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.088%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.201%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.503%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.201%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.503%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.428%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.893%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.428%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.245%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.201%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.428%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.893%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.447%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Actual Qtrly.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Calculated</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#91;**&#93;%</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Vol.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Purchases</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Effective Rebate</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Rebate Each</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Holdback</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Rebate Paid</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(&#91;**&#93;)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">($&#91;**&#93;)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">% (&#91;**&#93; Vol.)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Qtr. (&#91;**&#93;)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(&#91;**&#93;)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(&#91;**&#93;)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_821.jpg" src="image_821.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_921.jpg" src="image_921.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_931.jpg" src="image_931.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_79.jpg" src="image_79.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_921.jpg" src="image_921.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_79.jpg" src="image_79.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1st Qtr</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2nd Qtr</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3rd Qtr</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4th Qtr</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">True-up&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total&#58;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"><div><img alt="image_97.jpg" src="image_97.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"><div><img alt="image_97.jpg" src="image_97.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Actual aggregate volume purchased by IDEXX and IDEXX BV is greater than volume projected at the beginning of the year</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">.</font></div><div style="padding-left:0.19pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.472%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.201%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.560%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.088%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.201%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.503%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.201%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.503%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.428%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.893%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.428%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.245%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.201%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.428%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.893%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.447%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Actual Qtrly.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Calculated</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#91;**&#93;%</font></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Vol.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Purchases</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Effective Rebate</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Rebate Each</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Holdback</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Rebate Paid</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(&#91;**&#93;)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">($&#91;**&#93;)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">% (&#91;**&#93; Vol.)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Qtr.(&#91;**&#93;)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(&#91;**&#93;)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(&#91;**&#93;)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_821.jpg" src="image_821.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_921.jpg" src="image_921.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_931.jpg" src="image_931.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_79.jpg" src="image_79.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_921.jpg" src="image_921.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_79.jpg" src="image_79.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1st Qtr</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2nd Qtr</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3rd Qtr</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4th Qtr</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">True-up&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total&#58;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"><div><img alt="image_97.jpg" src="image_97.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"><div><img alt="image_97.jpg" src="image_97.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47</font></div><div><img alt="image_391.jpg" src="image_391.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Actual aggregate volume purchased by IDEXX and IDEXX BV is lower than volume projected at the beginning of the year</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">.</font></div><div style="padding-left:0.19pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.472%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.201%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.560%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.088%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.201%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.503%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.201%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.503%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.428%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.893%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.428%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.245%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.201%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.428%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.893%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.447%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Actual Qtrly.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Calculated</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#91;**&#93;%</font></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Vol.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Purchases</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Effective Rebate</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Rebate Each</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Holdback</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Rebate Paid</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(&#91;**&#93;)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">($&#91;**&#93;)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">% (&#91;**&#93; Vol.)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Qtr. (&#91;**&#93;)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(&#91;**&#93;)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(&#91;**&#93;)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_821.jpg" src="image_821.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_921.jpg" src="image_921.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_931.jpg" src="image_931.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_79.jpg" src="image_79.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_921.jpg" src="image_921.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_79.jpg" src="image_79.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1st Qtr</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2nd Qtr</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3rd Qtr</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4th Qtr</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">True-up&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total&#58;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"><div><img alt="image_97.jpg" src="image_97.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"><div><img alt="image_97.jpg" src="image_97.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Calculation of IDEXX&#8217;s Proportionate Share of rebate (assuming Actual aggregate volume purchased by IDEXX and IDEXX BV equals volume projected at the beginning of the year)</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Assumptions</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.740%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of slides purchased by IDEXX and its wholly-owned subsidiaries other than IDEXX BV&#58; &#91;**&#93; slides</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total number of slides purchase by IDEXX and its wholly-owned subsidiaries&#58; &#91;**&#93; slides</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total rebate earned&#58; $&#91;**&#93;</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Calculation</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IDEXX&#8217;s rebate equals&#58; &#91;**&#93; slides &#47; &#91;**&#93; slides * $&#91;**&#93;, or $&#91;**&#93;.</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48</font></div><div><img alt="image_391.jpg" src="image_391.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Schedule&#160;8 &#8211; Eligible New Chemistry Slides</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49</font></div><div><img alt="image_391.jpg" src="image_391.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Schedule&#160;9 - Example of Cost Adjustment Calculations</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Assumes PPI &#61; &#91;**&#93;%)</font></div><div style="padding-left:0.62pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.423%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.414%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.201%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.104%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.661%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.414%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.104%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.414%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.104%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.414%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.104%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.414%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.433%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.104%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.661%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.414%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.104%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.414%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.104%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.414%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.104%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.060%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Scenario 1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Scenario 2</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="33" style="padding:0 1pt"><div><img alt="image_1011.jpg" src="image_1011.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="33" style="padding:0 1pt"><div><img alt="image_1021.jpg" src="image_1021.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">% of OCD &#8217;s</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Year 1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">% Change</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Year 2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$ Change</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">% Change</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Year 2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$ Change</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Costs</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Usage</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Cost</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">In Cost</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Cost</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">in Cost</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">in Cost</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Cost</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">in Cost</font></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><img alt="image_103.jpg" src="image_103.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_1041.jpg" src="image_1041.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_1111.jpg" src="image_1111.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_1111.jpg" src="image_1111.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_1111.jpg" src="image_1111.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_108.jpg" src="image_108.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_1111.jpg" src="image_1111.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_1111.jpg" src="image_1111.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_1111.jpg" src="image_1111.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total (x&#91;**&#93;)</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Scenario 1 Conclusion&#58; &#91;**&#93;Cost Adjustment Required (Other Costs Increased by &#60; &#91;**&#93;% over PPI)</font></div><div style="padding-left:105.3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:55.608%"><tr><td style="width:1.0%"></td><td style="width:2.934%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:76.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.934%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.934%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.528%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.937%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="6" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Adjustment Calculation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#91;**&#93;&#58;</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual &#91;**&#93;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="6" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less&#58; PPI Change (&#91;**&#93;% of $&#91;**&#93;)</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Adjustment</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Scenario 2 Conclusion&#58; &#91;**&#93; Costs Adjustments Required</font></div><div style="padding-left:105.32pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:55.288%"><tr><td style="width:0.1%"></td><td style="width:1.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:64.986%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.959%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.828%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.726%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.962%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="6" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Adjustment Calculation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#91;**&#93;&#58;</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Same as above</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="6" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Adjustment for</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#91;**&#93;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Costs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58;</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual Cost Change</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="6" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less&#58; &#8220;PPI Plus &#91;**&#93;%&#8221; Change (&#91;**&#93;% *$&#91;**&#93;)</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustment</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Adjustment</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"><div><img alt="image_1121.jpg" src="image_1121.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">* - &#91;**&#93; Costs - &#91;**&#93; $&#91;**&#93;, or $&#91;**&#93;&#47;slide &#64; &#91;**&#93; slides</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</font></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Schedule&#160;10 &#8211; Excluded Countries</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:0.02pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.775%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Albania</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liechtenstein</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Andorra</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lithuania</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Armenia</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Macedonia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Azerbaijan</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Malta</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bahrain</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Monaco</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Belarus</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Norway</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bosnia and Herzegovina</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oman</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bulgaria</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pakistan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Croatia</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Poland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cyprus</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Qatar</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Czech Republic</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Romania</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estonia</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Russia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Faroes Islands</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">San Marino</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Georgia</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Saudi Arabia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hungary</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Slovakia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Iceland</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Slovenia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Iran</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Switzerland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Iraq</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Syria</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tajikistan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jordan</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Turkey</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kazakhstan</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Turkmenistan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kuwait</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ukraine</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kyrgyzstan</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Arab Emirates</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latvia</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uzbekestan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lebanon</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yemen</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51</font></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Schedule&#160;11 &#8211; IDEXX Entities</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IDEXX Laboratories Canada Corporation (Canada)<br>IDEXX Laboratories Pty. Ltd. (Australia)<br>IDEXX Laboratories (NZ)&#160;Ltd. (New Zealand)<br>IDEXX Laboratories, KK (Japan)<br>IDEXX Laboratories (Taiwan) Inc. (Taiwan)</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52</font></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Schedule&#160;12 &#8211; OCD Entities</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ortho-Clinical Diagnostics, a division of Janssen-Ortho Inc. (Canada)<br>Ortho-Clinical Diagnostics, a division of Johnson &#38; Johnson Medical Pty. Limited (Australia)<br>Ortho-Clinical Diagnostics K.K. (Japan)<br>Ortho-Clinical Diagnostics, a division of Johnson &#38; Johnson Limited (India)<br>Ortho-Clinical Diagnostics, a division of Johnson &#38; Johnson Pte. Ltd. (Singapore)</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;*&#93; and &#91;**&#93; text omitted throughout this exhibit for confidential treatment. The redacted information has been excluded because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>exhibit102-orthousagreemen.htm
<DESCRIPTION>EX-10.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ic84b0ffc2beb43b2ae87ecbd83a55870_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY ASTERISKS, HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED.</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 10.2</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AMENDMENT NO. 1 TO<br>AGREEMENT</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">THIS AMENDMENT NO. 1 TO AGREEMENT (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) is made effective as of the 1st&#160;day of January, 2005, between IDEXX Operations, Inc., a Delaware corporation whose principal place of business is at 6100 East Shelby Drive, Memphis, Tennessee 38141, U.S.A. (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">IDEXX</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) and Ortho-Clinical Diagnostics, Inc., a New York corporation with offices at 100 Indigo Creek Drive, Rochester, New York, U.S.A. (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">OCD</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">WHEREAS, OCD and IDEXX entered into a certain Agreement dated as of October&#160;16, 2003 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) regarding supply by OCD of dry slides for IDEXX veterinary chemistry analyzers&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">WHEREAS, OCD and IDEXX desire to amend the Agreement as set forth in this Amendment.</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NOW THEREFORE, the parties hereby agree as follows&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160; Capitalized terms used in this Amendment, which are not otherwise defined, have the respective meanings ascribed to them in the Agreement.</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160; Section 3.08(b) is amended by deleting the same in its entirety and substituting therefor the following provision&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.980%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.820%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Automation Costs shall exclude the cost of any injection molding tooling associated with the New Slide&#47;Panel Design, for which IDEXX shall be solely responsible. The parties shall mutually agree on the selection of a third party vendor for such tooling. IDEXX shall own such tooling. After installation, IDEXX shall be solely responsible for the costs of maintaining, repairing and replacing any such tooling, and costs of spare tooling, in each case to the extent OCD deems necessary to maintain OCD&#8217;s piece part cost of the injection molded components at or below the levels realized with tooling that has suffered no degradation.</font></td></tr></table><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.&#160;&#160;&#160;&#160; Section 18.01 is amended by deleting the same in its entirety and substituting therefor the following provision&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.980%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.820%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subject to the terms and conditions set forth herein, the term (the &#8220;Term&#8221;) of the Agreement shall be the period from the Commencement Date until December 31, 2020</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">.</font></div></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">,&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">,&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;and&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;to the Agreement are amended by deleting the same in their entirety and substituting therefor the respective&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">,&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">,&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;and&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;attached to this Amendment.</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.&#160;&#160;&#160;&#160; The price for Vetrol controls (Catalog No. 8699852) supplied hereunder shall be $&#91;**&#93; and the price for tips (Catalog No. 6801762) supplied hereunder shall be $&#91;**&#93;.</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.&#160;&#160;&#160;&#160; The per slide prices for single VETTEST slides that are packaged 12 per box shall be the same as the per slide prices of the corresponding single VETTEST slides that are packaged 25 per box.</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.&#160;&#160;&#160;&#160; Except as modified by this Amendment, all provisions of the Agreement shall continue in full force and effect.</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF and intending to be legally bound, the parties hereto have caused this Amendment to be duly executed in duplicate by their respective authorized representatives as of the day and year first written above.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"></td><td style="width:38.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ORTHO-CLINICAL<br>DIAGNOSTICS, INC.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">IDEXX OPERATIONS, INC.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58; &#47;s&#47;Tony Zezzo</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58; &#47;s&#47;Laurel LaBauve</font></td></tr><tr style="height:10pt"><td colspan="3" style="padding:0 1pt"><div style="text-align:right"><img alt="image_1.jpg" src="image_1.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div style="text-align:right"><img alt="image_8.jpg" src="image_8.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58; Tony Zezzo</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58; Laurel LaBauve</font></td></tr><tr style="height:10pt"><td colspan="3" style="padding:0 1pt"><div style="text-align:right"><img alt="image_1.jpg" src="image_1.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div style="text-align:right"><img alt="image_8.jpg" src="image_8.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58; VP Americas</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58; President, IDEXX Operations</font></td></tr><tr style="height:10pt"><td colspan="3" style="padding:0 1pt"><div style="text-align:right"><img alt="image_1.jpg" src="image_1.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div style="text-align:right"><img alt="image_8.jpg" src="image_8.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acknowledged and consented to,</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">solely as guarantor pursuant to</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 30 of the Agreement</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">IDEXX LABORATORIES, INC.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58; &#47;s&#47;Conan R. Deady</font></td></tr><tr style="height:10pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div style="text-align:right"><img alt="image_8.jpg" src="image_8.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58; Conan R. Deady</font></td></tr><tr style="height:10pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div style="text-align:right"><img alt="image_8.jpg" src="image_8.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58; Vice President</font></td></tr><tr style="height:10pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div style="text-align:right"><img alt="image_8.jpg" src="image_8.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td></tr></table></div><div><font style="color:#000000;font-family:'Times',sans-serif;font-size:13.5pt;font-weight:400;line-height:100%"><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Schedule 3 &#8212; Panels&#47;Profiles</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br>(Applicable only to VETTEST Analyzer)</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The initial PANEL shall be the &#8220;Pre-Anesthetic Panel&#8221; consisting of four sets of the following six VETTEST slides&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"></td><td style="width:28.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:68.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BUN</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urea Nitrogen</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ALT</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alanine aminotransferase</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GLU</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Glucose</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TP</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total protein</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CREA</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Creatinine</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ALKP</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alkaline phosphatase</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The initial PROFILES shall be the &#8220;General Health Profile&#8221; and the &#8220;Large Animal Profile&#8221;, each consisting of two sets of 12 VETTEST slides as follows&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">General Health Profile</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Large Animal Profile</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ALB</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Albumin</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ALB</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Albumin</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ALKP</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alkaline phosphatase</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ALKP</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alkaline phosphatase</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ALT(SGPT)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alanine aminotransferase</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AST</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AST</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AMYL</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amylase</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ca</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2+</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Calcium</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ca</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2+</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Calcium</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CK</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CK</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHOL</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cholesterol</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GGT</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gamma GT</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CREA</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Creatinine</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GLU</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Glucose</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GLU</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Glucose</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PHOS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inorganic phosphate</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PHOS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inorganic phosphate</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LDH</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LDH</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TBIL</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total bilirubin</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MG</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Magnesium</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TP</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total protein</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TP</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Protein</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BUN</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urea Nitrogen</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BUN</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urea Nitrogen</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times',sans-serif;font-size:13.5pt;font-weight:400;line-height:100%"><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective as of March 4, 2004, &#8220;PROFILES&#8221; shall also include the &#8220;Equine Health Profile,&#8221; consisting of two sets of 12 VETTEST slides as follows&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"></td><td style="width:28.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:68.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ALB</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Albumin</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ALKP</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alkaline phosphatase</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AST</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AST</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ca</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2+</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Calcium</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CK</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CK</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GGT</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gamma GT</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GLU</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Glucose</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LDH</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LDH</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TP</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total protein</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BUN</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urea Nitrogen</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CREA</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Creatinine</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TBIL</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Bilirubin</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times',sans-serif;font-size:13.5pt;font-weight:400;line-height:100%"><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective as of May 25, 2004, &#8220;PROFILES&#8221; shall also include the &#8220;Urine P&#58;C Ratio&#8221; (OCD cat #6802061), consisting of six pairs of Urine Protein and Creatinine VETTEST slides.</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective as of June 1, 2005, &#8220;PANELS&#8221; shall also include the &#8220;&#91;**&#93;&#8221; (IDEXX part #98-13952-00, OCD cat #6802213), consisting of four sets of the following &#91;**&#93; VETTEST slides&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"></td><td style="width:28.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:68.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Packaging for the Pre-Anesthetic Panels, the General Health Profiles, the Large Animal Profiles, the Equine Health Profiles, the Urine P&#58;C Ratios and the &#91;**&#93; for the VETTEST Analyzer has been previously agreed upon by the parties, and any changes to the slide composition or packaging of the foregoing PANELS or PROFILES shall be negotiated in good faith and mutually agreed upon by OCD and IDEXX. The slide composition, packaging and initial pricing of any additional PANELS&#47;PROFILES shall be mutually agreed upon by OCD and IDEXX. Unless otherwise agreed by the parties in writing with respect to one or more specific PANELS or PROFILES, all purchases by IDEXX or IDEXX BV of VETTEST slides packaged as PANELS&#47;PROFILES shall be credited against the Annual Purchase Forecasts and Purchase Commitments for such slides under this Agreement and the Europe Agreement.</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Slide&#47;Panel Design for the New Analyzer shall be as developed by IDEXX under Article 3.</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Schedule 5 - Products<br>(as of January 1, 2005)</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"></td><td style="width:24.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Single Slides<br>(Box of 25)</font></div><div><img alt="image_10.jpg" src="image_10.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:592px"></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Catalog Number</font></div><div><img alt="image_11.jpg" src="image_11.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:592px"></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Single Slides<br>(Box of 12)<br>(added Dec 11, 2003)</font></div><div><img alt="image_10.jpg" src="image_10.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:592px"></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Catalog Number</font></div><div><img alt="image_11.jpg" src="image_11.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:592px"></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Albumin</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">822 7134</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Albumin</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6801907</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alk Phos</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">831 5459</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alk Phos</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6801919</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ALT</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">808 3750</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ALT</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6801916</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ammonia</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181 6842</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ammonia</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6801908</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amylase</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">820 8191</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amylase</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6801913</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AST</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">811 3979</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AST</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6801914</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Calcium</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">804 8191</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Calcium</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6801902</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cholesterol</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">835 4888</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cholesterol</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6801906</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CK</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">835 8582</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CK</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6801918</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Creatinine</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">818 3477</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Creatinine</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6801911</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ECO2 (HCO3)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853 8670</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ECO2 (HCO3)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6802306</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gamma GT</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">826 1315</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gamma GT</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6801920</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Glucose</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">813 0536</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Glucose</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6801900</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LDH</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">835 1082</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LDH</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6801917</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lipase</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196 6191</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lipase</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6801915</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Magnesium</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108 0266</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Magnesium</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6801912</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phosphorus</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">807 0856</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phosphorus</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6801909</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Bilirubin</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838 0396</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Bilirubin</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6801910</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Protein</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193 7093</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Protein</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6801904</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Triglycerides</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192 2285</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Triglycerides</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6801905</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urea Nitrogen</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150 7326</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urea Nitrogen</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6801901</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uric Acid</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 0793</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uric Acid</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6801903</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93; (added as of July 1, 2005)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6802307</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"></td><td style="width:24.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Profile Slides<br>(Box of 24)</font></div><div><img alt="image_10.jpg" src="image_10.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:592px"></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Profile Slides<br>(Box of 12)</font></div><div><img alt="image_10.jpg" src="image_10.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:592px"></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General Health Profile</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160 7175</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urine P&#59;C Ratio (added May 25, 2004)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6802061</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-Anesthetic Panel</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">801 5109</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Large Animal Profile</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680 0071</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equine Health Panel (added Mar 4, 2004)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680 1956</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93; (added as of June 1, 2005)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680 2213</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"></td><td style="width:24.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Other</font></div><div><img alt="image_10.jpg" src="image_10.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:592px"></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vetrols</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">869 9852</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tips</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6801762</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Schedule 6 &#8211; Minimum Prices for New Chemistries</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urine Protein (added May 25, 2004 as part of the Urine P&#58;C Ratio)&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.963%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.726%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prices for 2005 and thereafter shall be determined based on volume tiers pursuant to Section 7.02(b), subject to a minimum price for this New Chemistry of $&#91;**&#93; per slide.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times',sans-serif;font-size:13.5pt;font-weight:400;line-height:100%"><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;&#160;&#160;&#160;&#160; (added as of July 1, 2005)&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.963%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.726%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prices for 2005 and thereafter shall be determined based on volume tiers pursuant to Section 7.02(b), subject to a minimum price for this New Chemistry of $&#91;**&#93; per slide.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times',sans-serif;font-size:13.5pt;font-weight:400;line-height:100%"><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Schedule 8 &#8211; Eligible New Chemistry Slides</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"></td><td style="width:28.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:68.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;*&#93; and &#91;**&#93; text omitted throughout this exhibit for confidential treatment. The redacted information has been excluded because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>4
<FILENAME>exhibit105-orthousagreemen.htm
<DESCRIPTION>EX-10.5
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ie8be6b658e824ea4ade4652473fc1f59_1"></div><div style="min-height:23.76pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.2pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY ASTERISKS, HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED.</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 10.5</font></div><div style="margin-top:4.9pt;padding-left:231.1pt;padding-right:231.1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:113%">AMENDMENT NO. 4 TO AGREEMENT</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:13pt;padding-right:13.9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:113%">AMENDMENT, effective as of December 28, 2011 (this &#8220;Amendment&#8221;) to the Agreement, dated as of October 16, 2003, between IDEXX Operations, Inc. (&#8220;IDEXX&#8221;) and Ortho-Clinical Diagnostics, Inc. (&#8220;OCD&#8221;).</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:13pt;padding-right:13.9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">WHEREAS, OCD and IDEXX have entered into that certain Agreement dated as of October 16, 2003, as amended by Amendment No. 1 thereto effective January 1, 2005, by Amendment No. 2 thereto effective October 15, 2006, and by Amendment No. 3 thereto effective January 18, 2008 (as so amended, the &#8220;Ag</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">reement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), regarding supply by OCD of dry slides for IDEXX veterinary chemistry analyzers&#59;</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:13pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">WHEREAS, the parties wish to resolve a dispute under the Agreement as more fully described herein&#59; and</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:13pt;padding-right:38.9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:113%">WHEREAS, IDEXX and OCD wish to amend certain terms of the Agreement and the Europe Agreement to reflect the foregoing resolution&#59;</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:13pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NOW, THEREFORE, the parties agree as follows&#58;</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:31pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:10.5pt;text-decoration:underline"> DEFINITIONS</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:31pt;padding-right:29.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:113%">In this Amendment, terms capitalized but not defined herein shall have the meanings set forth in the Agreement. The following expressions shall have the meanings set forth opposite them&#58;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:188.05pt;padding-right:38.35pt;text-indent:-166.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:113%">     &#8220;Dispute&#8221;&#160;&#160;&#160;&#160;The dispute between IDEXX and OCD regarding the number of Existing Special &#91;**&#93; Slides that are counted toward Dry Slide volume.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:18.4pt;text-indent:13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;Difference&#8221;&#160;&#160;&#160;&#160;The dollar amount arrived at by &#91;**&#93;.</font></div><div><font><br></font></div><div style="margin-top:4.6pt;padding-left:31pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:10.5pt;text-decoration:underline"> SETTLEMENT</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:31pt;padding-right:21.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:152%">The parties acknowledge and agree that the covenants and agreements set forth herein represent a compromise and resolution of the Dispute. In consideration of entering into this Amendment and the corresponding amendment of the Europe Agreement, each party hereby waives and releases any claims such party has, had or may in the future have against any other party regarding the Dispute.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:31pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:10.5pt;text-decoration:underline"> PAYMENTS</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:85.05pt;padding-right:36.85pt;text-indent:-54.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:152%">3.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:152%;padding-left:41.55pt">IDEXX and IDEXX BV collectively shall pay to OCD, as a one-time payment, $&#91;**&#93; upon the execution of this Amendment and the corresponding amendment of the Europe Agreement.</font></div><div style="margin-top:0.05pt;padding-left:85.05pt;padding-right:53.1pt;text-indent:-54.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:152%">3.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:152%;padding-left:41.55pt">(a) For calendar years 2011 and 2012, OCD will price the Dry Slides in accordance with Section 7.02 of the Agreement, interpreting such Section 7.02 such that &#91;**&#93;.</font></div><div style="margin-top:0.05pt;padding-left:85.05pt;padding-right:16.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:152%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:152%;padding-left:11.29pt">No later than January 31, 2012, representatives from the respective finance departments of IDEXX and OCD will meet to discuss and come to agreement on the Difference.</font></div><div style="margin-top:0.05pt;padding-left:85.05pt;padding-right:15.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:152%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:152%;padding-left:11.86pt">No later than the &#91;**&#93;, IDEXX and IDEXX BV collectively will pay to OCD &#91;**&#93; of the Difference. The Difference payment shall be appropriately taken into account when calculating the Final Blended Price in accordance with Section 7.02(b) of the Agreement.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="height:23.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.367%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:23.76pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:31pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:10.5pt;text-decoration:underline"> AMENDMENTS</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:31pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The parties hereto agree that the Agreement shall be amended as follows&#58;</font></div><div style="margin-top:3.5pt;padding-left:67.05pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.55pt">A new Section 3.10 is hereby added to read in its entirety as follows&#58;</font></div><div style="margin-top:3.5pt;padding-left:67.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;3.10&#160;&#160;&#160;&#160;IDEXX will devote chemistry instrument development resources to the development and launch of &#91;**&#93;.</font></div><div style="margin-top:3.5pt;padding-left:121.1pt;padding-right:18.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:152%">IDEXX will use commercially reasonable efforts to achieve commercial launch of such analyzer within the United States by &#91;**&#93;.&#8221;</font></div><div style="margin-top:4.6pt;padding-left:67.05pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.55pt">Effective January 1, 2013 Section 7.02(a) is hereby replaced in its entirety with the following&#58;</font></div><div style="margin-top:3.5pt;padding-left:67.05pt;padding-right:11.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:152%">7.02(a) The prices for Dry Slides shall be in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:152%;text-decoration:underline">Schedule 5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:152%">. At a given volume of aggregate slide purchases by IDEXX and IDEXX BV in a given calendar year, the corresponding pricing in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:152%;text-decoration:underline">Schedule 5 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:152%">applies to the total aggregate volume of slides purchased in such calendar year by IDEXX and IDEXX BV. Effective January 1, 2013, no &#91;**&#93; will apply. In the event of an automatic extension of the Term pursuant to Section 18.02, pricing for calendar years after 2028 shall be increased yearly by &#91;**&#93;% over the prior year.&#8221;</font></div><div style="margin-top:0.05pt;padding-left:67.05pt;padding-right:84.25pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:152%">4.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:152%;padding-left:23.55pt">Effective January 1, 2013, all text in Section 7.02(b) preceding the paragraph that begins with the phrase &#8220;Notwithstanding the foregoing&#8221; is hereby deleted.</font></div><div style="margin-top:0.05pt;padding-left:67.05pt;padding-right:14.75pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:152%">4.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:152%;padding-left:23.55pt">Effective January 1, 2013, the paragraph beginning with the phrase &#8220;Notwithstanding the foregoing&#8221; in Section 7.02(b) of the Agreement is hereby amended to read in its entirety as follows&#58;</font></div><div style="margin-top:0.05pt;padding-left:67.05pt;padding-right:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:152%">&#8220;The price per slide for any New Chemistry Slide that is priced on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:152%;text-decoration:underline">Schedule 6 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:152%">shall never be lower than the greater of (a) the minimum price as determined in accordance with Section 5.06 and identified on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:152%;text-decoration:underline">Schedule 6 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:152%">as amended from time to time and (b) the price that would otherwise apply pursuant to Schedule 5.&#8221;</font></div><div style="margin-top:0.05pt;padding-left:67.05pt;padding-right:17.35pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:152%">4.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:152%;padding-left:23.55pt">Effective January 1, 2013, in Section 7.02(b), each instance of the words &#8220;weighted average price&#8221; are hereby changed to &#8220;price&#8221;.</font></div><div style="margin-top:0.05pt;padding-left:67.05pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.55pt">Effective January 1, 2013, the definition &#8220;First Estimated Blended Price&#8221; is hereby changed to &#8220;First Estimated Price&#8221;.</font></div><div style="margin-top:3.5pt;padding-left:67.05pt;padding-right:35.35pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:152%">4.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:152%;padding-left:23.55pt">Effective January 1, 2013, the definition &#8220;Second Estimated Blended Price&#8221; is hereby changed to &#8220;Second Estimated Price&#8221;.</font></div><div style="margin-top:0.05pt;padding-left:67.05pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.55pt">Effective January 1, 2013, the definition &#8220;Final Blended Price&#8221; is hereby changed to &#8220;Final Price&#8221;.</font></div><div style="margin-top:3.45pt;padding-left:67.05pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.55pt">Effective January 1, 2013, Section 7.02(c) is hereby deleted.</font></div><div style="margin-top:3.45pt;padding-left:67.05pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:18.55pt">Effective January 1, 2013, Section 7.02(d) of the Agreement is hereby amended to read in its entirety as follows&#58;</font></div><div style="padding-left:31.05pt;text-indent:-18.05pt"><font><br></font></div><div style="margin-top:3pt;padding-left:63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;(d) With respect to slides ordered for delivery on or after January 1, 2013, if OCD&#8217;s aggregate cost of all &#91;**&#93; (as defined below) for the most recently completed calendar year has increased on a per VETTEST slide basis as compared with aggregate cost of all &#91;**&#93; for the calendar year preceding the most recently completed calendar year, by an amount that exceeds the &#91;**&#93;% annual increase incorporated into </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, then OCD shall be permitted to increase the price of each slide sold to IDEXX by the amount of such excess. &#8220;&#91;**&#93;&#8221; means &#91;**&#93; that are &#91;**&#93;. No later than January 31 of each calendar year during the Term (beginning in 2013), OCD shall provide to IDEXX a summary of all charges for &#91;**&#93; for the previous calendar year and recurring charges that carry forward. IDEXX shall have the option to pay such charges in quarterly installments during the then-current calendar year or as a lump-sum payment no later than March 31 of each then-current calendar year.&#8221;</font></div><div style="margin-top:3pt;padding-left:0.67pt;text-indent:-0.36pt"><font><br></font></div><div style="margin-top:3pt;padding-left:67.05pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:18.55pt">Effective January 1, 2013, Section 7.02(e) of the Agreement is hereby amended to read in its entirety as follows&#58;</font></div><div style="margin-top:3pt;padding-left:27pt"><font><br></font></div><div style="margin-top:3pt;padding-left:63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;(e) With respect to slides ordered for delivery on or after January 1, 2013, if IDEXX&#8217;s share of Special Event Costs (as defined below) for the most recently completed calendar year has increased on a per VETTEST slide basis as compared with IDEXX&#8217;s share of Special Event Costs for the calendar year preceding the most recently completed calendar year, by an amount that exceeds &#91;**&#93; above the &#91;**&#93;% annual increase incorporated into </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, then OCD shall be permitted to increase the price of each slide sold to IDEXX by the amount of such excess. &#8220;Special Event Costs&#8221; means the aggregate net amount of (i) &#91;**&#93; with respect to &#91;**&#93; on which &#91;**&#93;, (ii) &#91;**&#93; in the &#91;**&#93;, and (iii) &#91;**&#93; as a result of &#91;**&#93;. &#8220;IDEXX&#8217;s share&#8221; of any of the foregoing shall mean the &#91;**&#93; that is attributable to the &#91;**&#93;. No later than January 31 of each calendar year during the Term (beginning in 2013), OCD shall provide to IDEXX a summary of all Special Events Costs for the previous calendar year. IDEXX shall have the option to pay such Special Events Costs in quarterly installments during the then-current calendar year or as a lump-sum payment no later than March 31 of each then-current calendar year.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;</font></div><div style="margin-top:3.5pt;padding-left:67.05pt;padding-right:12.7pt"><font><br></font></div><div style="height:23.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.367%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:23.76pt;width:100%"><div><font><br></font></div></div><div style="padding-left:67.05pt;padding-right:12.7pt"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:63pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14pt">Section 9.04(c) of the Agreement is hereby amended to read in its entirety as follows&#58;</font></div><div style="margin-top:3.5pt;padding-left:67.05pt;padding-right:24.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:152%">&#8220;(c) Should IDEXX sell or cause to be sold for use in the field of diagnostic testing of non-human animals any product, other than the New Analyzer (which includes without limitation &#91;**&#93;), whose scope includes four or more of the chemistries identified on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:152%;text-decoration:underline">Schedule 5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:152%">, then OCD may, in its sole discretion, terminate the provisions of Section 9.04(a) immediately upon written notice to IDEXX. If OCD delivers such notice of termination of Section 9.04(a) under this Section 9.04(c), then IDEXX may in its discretion terminate the provisions of Section 9.03(a) of this Agreement immediately upon written notice to OCD.&#8221;</font></div><div style="margin-top:0.05pt;padding-left:67.05pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:18.55pt">Section 18.01 of the Agreement is hereby amended by changing the year &#8220;2018&#8221; to the year &#8220;2028&#8221;.</font></div><div style="margin-top:3.5pt;padding-left:67.05pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:18.55pt">A new Section 18.02 is hereby added to read in its entirety as follows&#58;</font></div><div style="margin-top:3.5pt;padding-left:121.1pt;padding-right:20.7pt;text-indent:-54.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:152%">&#8220;18.02&#160;&#160;&#160;&#160;This Agreement may be terminated by either party upon &#91;**&#93; written notice to the other party&#59; provided, however, that no such termination shall be effective prior to December 31, 2028. If neither party provides such written notice, the then-current term of this Agreement shall automatically be extended for an additional three (3) years, and no termination under this Section 18.02 shall be effective prior to the end of such additional term. Within 60 days of either party providing such notice, the senior leaders of each of the parties shall meet to discuss the relationship of the parties.&#8221;</font></div><div style="margin-top:0.05pt;padding-left:67.05pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:18.55pt">Effective January 1, 2013, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 5 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">is hereby replaced in its entirety by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 5 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">attached hereto.</font></div><div style="margin-top:3.5pt;padding-left:67.05pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:18.55pt">Effective January 1, 2013, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 9 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">is hereby deleted.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:31pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:10.5pt">All remaining terms and conditions of the Agreement remain in full force and effect.</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:8.2pt;padding-left:184.9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">The remainder of this page intentionally left blank</font></div><div style="margin-top:8.2pt;padding-left:184.9pt"><font><br></font></div><div style="height:23.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.367%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:23.76pt;width:100%"><div><font><br></font></div></div><div style="padding-left:184.9pt"><font><br></font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:13pt;padding-right:30pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:152%;text-decoration:underline"> IN WITNESS WHEREOF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:152%">, and intending to be legally bound, the parties hereto have caused this Agreement to be duly executed in duplicate by their respective authorized representatives the day and year first written above.</font></div><div style="margin-top:0.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:516.00pt"><tr><td style="width:1.0pt"></td><td style="width:232.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:57.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:220.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:13pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ORTHO-CLINICAL DIAGNOSTICS, INC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IDEXX OPERATIONS, INC.</font></td></tr><tr style="height:13pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">___________________________________</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">______________________________</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:13pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;&#47;s&#47; Eric Compton</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;&#47;s&#47; Michael Williams</font></td></tr><tr style="height:13pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eric Compton</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael Williams</font></td></tr><tr style="height:13pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General Manager, WW Sales &#38; Service</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:13pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;  January 24, 2012</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;  January 24, 2012</font></td></tr><tr style="height:13pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">___________________________________</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">______________________________</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:286.25pt;padding-right:65.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing Amendment is hereby consented to and acknowledged by&#58;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:286.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IDEXX LABORATORIES, INC.,</font></div><div style="margin-top:0.5pt;padding-left:286.25pt;padding-right:156.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">solely as guarantor pursuant to Section 30 of the Agreement</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:286.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IDEXX LABORATORIES, INC.</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:313.25pt;padding-right:156.05pt;text-indent:-27.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">By&#58;&#160;&#160;&#160;&#160;&#47;s&#47; Michael Williams </font></div><div style="padding-left:324pt;padding-right:156.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael Williams Corporate Vice President</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:0.85pt;padding-left:286.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;  January 24, 2012</font></div><div style="padding-left:312.9pt"><img alt="image_13.jpg" src="image_13.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:327px"></div><div style="padding-left:312.9pt"><font><br></font></div><div style="height:23.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.367%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:23.76pt;width:100%"><div><font><br></font></div></div><div style="padding-left:312.9pt"><font><br></font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:231.05pt;padding-right:231.05pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Schedule 5</font></div><div style="margin-top:6pt;padding-left:13pt;padding-right:13.9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:113%">Note&#58; Price is for </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:113%;text-decoration:underline">all </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:113%">slides up to the levels indicated below. New levels are triggered as the volume reaches the noted level. For clarity see example below.</font></div><div style="margin-top:6.35pt;padding-left:134.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Example Example Example</font></div><div style="margin-top:0.45pt;padding-left:146.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">#1&#160;&#160;&#160;&#160;#2&#160;&#160;&#160;&#160;#3</font></div><div style="margin-top:0.45pt;padding-left:64.4pt;padding-right:326.15pt;text-indent:-1.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Year of Purchase&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;</font></div><div style="padding-left:63pt;padding-right:326.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Slide volume (a)&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;</font></div><div style="padding-left:48.45pt;padding-right:326.15pt;text-indent:47.9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Price (b)&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;</font></div><div style="padding-left:36pt;padding-right:326.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Purchase (a*b)&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;</font></div><div style="margin-top:6pt;padding-left:19.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Slides (in MM)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%;text-decoration:underline">2013&#160;&#160;&#160;&#160;2014&#160;&#160;&#160;&#160;2015&#160;&#160;&#160;&#160;2016&#160;&#160;&#160;&#160;2017&#160;&#160;&#160;&#160;2018&#160;&#160;&#160;&#160;2019&#160;&#160;&#160;&#160;2020&#160;&#160;&#160;&#160;2021&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;2023&#160;&#160;&#160;&#160;2024&#160;&#160;&#160;&#160;2025&#160;&#160;&#160;&#160;2026&#160;&#160;&#160;&#160;2027&#160;&#160;&#160;&#160;2028</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:113%">   &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;  &#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:113%">   &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;  &#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;</font></div><div><font><br></font></div><div style="margin-top:8.1pt;padding-left:13pt;padding-right:16.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. A total of 15 pages were omitted pursuant to a request for confidential treatment.</font></div><div style="margin-top:8.1pt;padding-left:13pt;padding-right:16.65pt"><font><br></font></div><div style="margin-top:8.1pt;padding-left:13pt;padding-right:16.65pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;*&#93; and &#91;**&#93; text omitted throughout this exhibit for confidential treatment. The redacted information has been excluded because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.</font></div><div style="margin-top:8.1pt;padding-left:13pt;padding-right:16.65pt"><font><br></font></div><div style="height:23.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.367%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.6
<SEQUENCE>5
<FILENAME>exhibit106-orthousagreemen.htm
<DESCRIPTION>EX-10.6
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i1f827fa84b8c4c6a82c7d58d16ca2ae9_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EXECUTION COPY</font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:133%">CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY ASTERISKS, HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED.</font></div><div style="margin-bottom:10pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">EXHIBIT 10.6</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">AMENDMENT NO.5 TO </font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">AGREEMENT</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">THIS AMENDMENT NO.5 TO AGREEMENT (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8221;) is made effective as of December 9, 2013, between IDEXX Operations, Inc., a Delaware corporation whose principal place of business is at 6100 east Shelby Drive, Memphis Tennessee 38141, U.S.A. (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">IDEXX</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8221;) and Ortho-Clinical Diagnostics, Inc., a New York corporation with offices at 100 Indigo Creek Drive, Rochester, New York, U.S.A. (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">OCD</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8221;).</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">WHEREAS, OCD and IDEXX have entered into that certain Agreement dated as of October 16, 2003, as amended by Amendment No. 1 thereto effective January 1, 2005, Amendment No. 2 thereto effective October 15, 2006, Amendment No. 3 thereto effective January 18, 2008 and Amendment No. 4 thereto effective December 28, 2011 (as so amended, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8221;), regarding supply by OCD of dry slides for IDEXX veterinary chemistry analyzers&#59; and  </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">WHEREAS, OCD and IDEXX now desire to amend the Agreement to reflect the foregoing&#59;</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">NOW THEREFORE, the parties hereby agree as follows&#58;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:9.75pt;text-decoration:underline">Schedule 3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> to the Agreement is deleted in its entirety and replaced with the attached </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Schedule 3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">.  All future adjustments to Schedule 3 will require the mutual agreement of both parties.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:9.75pt;text-decoration:underline">Schedule 5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> to the Agreement (as amended in Amendment No. 4 to the Agreement) is supplemented with the attached </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Schedule 5-A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">, and references in the Agreement to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Schedule 5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> shall be deemed to include </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Schedule 5-A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">.  For the avoidance of doubt, subject to the terms and conditions of the Agreement, OCD undertakes to manufacture for IDEXX and supply to IDEXX, the consumables listed on the attached  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Schedule 5-A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">.   All future adjustments to Schedule 5-A will require the mutual agreement of both parties.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:9.75pt;text-decoration:underline">Schedule 6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> to the Agreement is deleted in its entirety and replaced with the attached </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Schedule 6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">.  All future adjustments to Schedule 6 will require the mutual agreement of both parties.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:9.75pt">The specifications attached as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> to this Amendment are the mutually agreed specifications for the relevant products listed therein.  Exhibit A will be comprised of the &#8220;Purchase Material Specifications&#8221; documents for each test and panel listed in Schedule 5-A and may be changed or added to periodically by the mutual agreement of both parties and these routine changes will not require an amendment to the contract.  The change process will be managed by a change control document and the inclusion of signatures by both IDEXX and OCD on each current individual &#8220;Purchase Material Specification&#8221;.  Proposed changes should be submitted in writing by either IDEXX or OCD and confirmed in writing by the other party, such </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EXECUTION COPY</font></div></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">changes will be finalized by signature on the &#8220;Purchase Material Specification&#8221;.  Communications to IDEXX should be provided to the General Manager, IDEXX Vetlab and communication to OCD should be provided to the National Account Director, IDEXX.    The parties acknowledge and agree that the items listed in the &#8220;Quality Requirements&#8221; section of such specifications shall be provided by OCD to IDEXX at no charge to IDEXX.  The items provided at no charge will be capped at the quantities called for in Exhibit A as attached to this amendment, all additional quantities or items required for new products may be charged for by OCD.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:9.75pt">Except as modified by this Amendment, the Agreement remains in effect.  This Amendment is to be construed as part of the Agreement.  Each reference to &#8220;hereof&#8221;, &#8220;hereunder&#8221;, &#8220;herein&#8221; and &#8220;hereby&#8221; and each other similar reference and each reference to &#8220;this Agreement&#8221; and each other similar reference contained in the Agreement shall from and after the date set forth above, refer to the Agreement as amended hereby.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.75pt">This Amendment may be executed in counterparts, each of which shall be deemed to be an original and all of which together shall be deemed to be one and the same </font><img alt="image_02.jpg" src="image_02.jpg" style="height:12px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">instrument.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">*****<br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EXECUTION COPY</font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IN WITNESS WHEREOF and intending to be legally bound, the parties hereto have caused this Amendment to be duly executed in duplicate by their respective authorized representatives as of the day and year first written above&#58;</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">ORTHO-CLINICAL DIAGNOSTICS, INC.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;IDEXX OPERATIONS, INC.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">By&#58; _</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">&#47;s&#47; Thomas O&#8217;Neil</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">________________&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;By&#58; __</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">&#47;s&#47; Johnny Powers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">______________</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Name&#58; __</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline"> Thomas O&#8217;Neil</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> ______________&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Name&#58; __</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline"> Johnny Powers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> _______________</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Title&#58; __</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">VP Americas &#38; EMEA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">_________&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Title&#58; ____</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Executive Vice President</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">_______</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Date&#58; ____</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">12&#47;11&#47;13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">__________________&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Date&#58; ___</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">12&#47;9&#47;13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">__________________</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Acknowledged and consented to, solely as guarantor pursuant to Section 30 of the Agreement&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:10pt;padding-left:264.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IDEXX LABORATORIES, INC.</font></div><div style="margin-bottom:10pt;padding-left:264.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">By&#58; ___</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">&#47;s&#47; Jonathan Ayers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">______________</font></div><div style="margin-bottom:10pt;padding-left:264.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Name&#58; __</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline"> Jonathan Ayers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> _____________</font></div><div style="margin-bottom:10pt;padding-left:264.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Title&#58; ___</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Chairman, President and CEO</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">___</font></div><div style="margin-bottom:10pt;padding-left:264.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Date&#58; ____</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">12&#47;9&#47;13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">_____________________</font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EXECUTION COPY</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Schedule 3</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Panels&#47;Profiles&#47;CLIPs</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">VetTest &#8220;Pre-Anesthetic Panel&#8221; (IDEXX part #98-21718-US, OCD cat #8015109), consists of four sets of the following six VETTEST slides&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">BUN&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Urea Nitrogen</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALT (SGPT)&#160;&#160;&#160;&#160;Alanine aminotransferase</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">GLU&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Glucose</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">TP&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total protein</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CREA&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Creatinine</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALKP&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Alkaline phosphatase</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">VetTest &#8220;General Health Profile&#8221;, (IDEXX part #98-20590-00, OCD cat #1607175), the &#8220;Large Animal Profile&#8221;(OCD cat # 6800071)  and the &#8220;Equine Health Profile&#8221; (IDEXX part #98-24021-US, OCD cat #6801956), each consist of two sets of 12 VETTEST slides as follows&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">General Health Profile&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Large Animal Profile </font></div><div style="margin-bottom:0.1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.756%"><tr><td style="width:1.0%"></td><td style="width:14.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.719%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.129%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.115%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALB</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Albumin</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALB</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Albumin</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALKP</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Alkaline phosphatase</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALKP</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Alkaline phosphatase</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALT (SGPT)</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Alanine aminotransferase</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">AST (SGOT)</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Aspartate aminotransferase</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">AMYL</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Amylase</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Ca</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">2+</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Calcium</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Ca</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">2+</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Calcium</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CK</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CK</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CHOL</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Cholesterol</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">GGT</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Gamma GT</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CREA</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Creatinine</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">GLU</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Glucose</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">GLU</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Glucose</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">PHOS</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Inorganic phosphate</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">PHOS</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Inorganic phosphate</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">LDH</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">LDH</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">TBIL</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total bilirubin</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">MG</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Magnesium</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">TP</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total protein</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">TP</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total Protein</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">BUN</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Urea Nitrogen</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">BUN</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Urea Nitrogen</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Equine Health Profile</font></div><div><font><br></font></div><div style="margin-bottom:0.1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.711%"><tr><td style="width:1.0%"></td><td style="width:34.025%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.775%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALB</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Albumin</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALKP</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Alkaline phosphatase</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">AST (SGOT)</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Aspartate aminotransferase</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Ca</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">2+</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Calcium</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CK</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CK</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">GGT</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Gamma GT</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">GLU</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Glucose</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">LDH</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">LDH</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">TP</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total protein</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">BUN</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Urea Nitrogen</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CREA</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Creatinine</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">TBIL</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total Bilirubin</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;PROFILES&#8221; shall also include the &#8220;Urine P&#58;C Ratio&#8221; (OCD cat #6802061), consisting of six pairs of Urine Protein and Creatinine VetTest slides. </font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EXECUTION COPY</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;PANELS&#8221; shall also include the &#8220;QC Panel&#8221; (IDEXX part #98-13952-00, OCD cat #6802213), consisting of four sets of the following six VetTest slides&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALB&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Albumin</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALKP&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Alkaline phosphatase</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALT (SGPT)&#160;&#160;&#160;&#160;Alanine aminotransferase</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Ca</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">2+</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Calcium</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">GLU&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Glucose</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">NH3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Ammonia</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;PANELS&#8221; shall also include the &#8220;Diagnostic Health Profile&#8221; (IDEXX part #98-13835-00, OCD cat #6802590), consisting of two sets of the following twelve VetTest slides&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALB&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Albumin</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALKP&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Alkaline phosphatase</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALT (SGPT)&#160;&#160;&#160;&#160;Alanine aminotransferase</font></div><div style="margin-bottom:0.1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.435%"><tr><td style="width:1.0%"></td><td style="width:33.932%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.868%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">AMYL               Amylase</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Ca2+                  Calcium</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CREA                Creatinine</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">GGT                  Gamma GT</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">GLU&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Glucose</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">LIPA                  Lipase</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">TBIL                  Total Bilirubin</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">TP                      Total protein</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">BUN&#47;UREA      Urea nitrogen</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;PANELS&#8221; shall also include the &#8220;NSAID Monitoring Panel&#8221; (IDEXX part #98-13834-00, OCD cat #6802589), consisting of four sets of the following five VetTest slides&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALKP&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Alkaline phosphatase</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALT (SGPT)&#160;&#160;&#160;&#160;Alanine aminotransferase</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">AST (SGOT)     Aspartate aminotransferase</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CREA                Creatinine</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">BUN&#47;UREA      Urea nitrogen</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;PANELS&#8221; shall also include the &#8220;Avian Health Profile&#8221; (IDEXX part #98-12880-US, OCD cat #6802781), consisting of four sets of the following 6 VetTest slides&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALB&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Albumin</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">AST (SGOT)     Aspartate aminotransferase</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Ca</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">2+</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Calcium</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">GLU&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Glucose</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">TP                      Total protein</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">URIC                  Uric acid</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;PANELS&#8221; shall also include the &#8220;Catalyst Chem. 17 Clip&#8221; (IDEXX part #98-11003-02, OCD cat #6802678), consisting of the following fourteen (14) Catalyst slides assembled per the specifications detailed in the Purchase Material Specifications.  </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">LIPA                  Lipase</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Ca</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">2+</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Calcium</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">PHOS                Phosphorus</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALB&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Albumin</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">BUN&#47;UREA      Urea nitrogen</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">TBIL                  Total Bilirubin</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">GLU&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Glucose</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CREA                Creatinine</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EXECUTION COPY</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">AMYL               Amylase</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CHOL                Cholesterol</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALT (SGPT)&#160;&#160;&#160;&#160;Alanine aminotransferase</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALKP&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Alkaline phosphatase</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">TP                      Total protein</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">GGT                  Gamma GT</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;PANELS&#8221; shall also include the &#8220;Catalyst Chem. 15 Clip&#8221; (IDEXX part #98-11004-01, OCD cat #6802673), consisting of the following twelve (12) Catalyst slides assembled per the specifications detailed in the Purchase Material Specifications. </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Ca</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">2+</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Calcium</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">PHOS                Phosphorus</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALB&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Albumin</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">BUN&#47;UREA      Urea nitrogen</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">TBIL                  Total Bilirubin</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">GLU&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Glucose</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CREA                Creatinine</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CHOL                Cholesterol</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALT (SGPT)&#160;&#160;&#160;&#160;Alanine aminotransferase</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALKP&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Alkaline phosphatase</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">TP                      Total protein</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">GGT                  Gamma GT</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;PANELS&#8221; shall also include the &#8220;Catalyst Chem. 10 Clip&#8221; (IDEXX part #98-11005-01, OCD cat #6802675), consisting of the following seven (7) Catalyst slides assembled per the specifications detailed in the Purchase Material Specifications. </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">BUN&#47;UREA      Urea nitrogen</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALB&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Albumin </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">GLU&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Glucose</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CREA                Creatinine</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALT (SGPT)&#160;&#160;&#160;&#160;Alanine aminotransferase</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALKP&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Alkaline phosphatase</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">TP                      Total protein</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;PANELS&#8221; shall also include the &#8220;Catalyst NSAID 6 Clip&#8221; (IDEXX part #98-11007-01, OCD cat #6802676), consisting of the following five (5) Catalyst slides assembled per the specifications detailed in the Purchase Material Specifications.  &#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALKP&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Alkaline phosphatase</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALT (SGPT)&#160;&#160;&#160;&#160;Alanine aminotransferase</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">BUN&#47;UREA      Urea nitrogen</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CREA                Creatinine</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">AST (SGOT)     Aspartate aminotransferase</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;PANELS&#8221; shall also include the &#8220;Catalyst Equine 15 Clip&#8221; (IDEXX part #98-11006-01, OCD cat #6802674), consisting of the following twelve (12) Catalyst slides assembled per the specifications detailed in the Purchase Material Specifications.  </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Ca</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">2+</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Calcium</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">LDH                  Lactate dehydrogenase</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">GGT                  Gamma GT</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALB&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Albumin </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">BUN&#47;UREA      Urea nitrogen</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">TBIL                  Total Bilirubin</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">GLU&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Glucose</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">AST (SGOT)     Aspartate aminotransferase</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CK                     Creatine Kinase</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CREA                Creatinine</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALKP&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Alkaline phosphatase</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">TP                      Total protein</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EXECUTION COPY</font></div></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;PANELS&#8221; shall also include the &#8220;Catalyst QC  Clip&#8221; (IDEXX part #98-13700-00, OCD cat #6802804), consisting of the following six (6) Catalyst slides assembled per the specifications detailed in the Purchase Material Specifications. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Ca</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">2+</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Calcium</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALB&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Albumin</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">NH3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Ammonia</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALT (SGPT)&#160;&#160;&#160;&#160;Alanine aminotransferase </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALKP&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Alkaline phosphatase</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">GLU&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Glucose</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Packaging for the PANELS&#47;PROFILES listed above have been previously agreed upon by the parties, and any changes to the slide composition or packaging of the foregoing shall be negotiated in good faith and mutually agreed upon by OCD and IDEXX.  The slide composition and packaging of any additional PANELS&#47;PROFILES shall be mutually agreed upon by OCD and IDEXX.  All purchases by IDEXX or IDEXX BV of IDEXX slides packaged as PANELS&#47;PROFILES shall be included in quantities for price calculations for such slides under this Agreement and the Europe Agreement.</font></div><div style="margin-bottom:10pt"><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EXECUTION COPY</font></div></div><div style="margin-bottom:10pt;padding-left:144pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Schedule 5-A </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Products</font></div><div style="margin-bottom:0.1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.758%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.585%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.684%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.906%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.361%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.767%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">VETTEST SLIDES</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Single Slides</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">(Box of 25)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Catalog Number</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Single Slides</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">(Box of 12)</font></div></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Catalog Number</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Albumin</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8227134</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Albumin</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6801907</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Alk Phos</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8315459</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Alk Phos</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6801919</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALT (SGPT)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8083750</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALT (SGPT)</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6801916</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Ammonia</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1816842</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Ammonia</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6801908</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Amylase</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8208191</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Amylase</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6801913</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">AST (SGOT)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8113979</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">AST (SGOT)</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6801914</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Calcium</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8048191</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Calcium</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6801902</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Cholesterol</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8354888</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Cholesterol</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6801906</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CK</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8358582</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CK</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6801918</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Creatinine</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8183477</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Creatinine</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6801911</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ECO2</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8538670</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ECO2</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802306</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Gamma GT</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8261315</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Gamma GT</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6801920</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Glucose</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8130536</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Glucose</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6801900</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">LDH</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8351082</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">LDH</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6801917</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Lipase</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1966191</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Lipase</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6801915</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Magnesium</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1080266</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Magnesium</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6801912</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Phosphorus</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8070856</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Phosphorus</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6801909</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total Bilirubin</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8380396</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total Bilirubin</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6801910</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total Protein</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1937093</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total Protein</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6801904</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Triglycerides</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1922285</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Triglycerides</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6801905</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Urea Nitrogen</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1507326</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Urea Nitrogen</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6801901</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Uric Acid</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1000793</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Uric Acid</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Lactate </font></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6801903</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802307</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Profile Slides</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">(Bx 24)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Catalog Number</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Profile Slides</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">(Bx 12)</font></div></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Catalog Number</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">General Health Profile</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1607175</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Urine P&#58;C Ratio (added May&#160;25, 2004)</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802061</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Pre-Anesthetic Panel</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8015109</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Phenobarb (added July&#160;1, 2011)</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802644</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Large Animal Profile</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6800071</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Equine Health Panel (added March 4, 2004)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6801956</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">QC Panel (added as of June 1, 2005)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802213</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Diagnostic Health Profile</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802590</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">NSAID Monitoring Profile</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802589</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Avian Health Panel</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802781</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EXECUTION COPY</font></div></div><div style="margin-bottom:0.1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.758%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.585%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.684%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.906%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.361%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.767%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Other</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Catalog Number</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Vetrol</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802212</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">UPRO Control</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802141</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Black DTSC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6800865</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">White Ref</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6800866</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">White DTSC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6800867</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">CATALYST SLIDES</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">(added as of October 1, 2008)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Catalog</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Number</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX CHEM 15</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802673</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX EQUINE 15</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802674</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX CHEM 10</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802675</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX NSAID</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802676</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX QCP</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802804</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX CHEM 17</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802678</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX UPC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802679</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX ALKP</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802628</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX ALT</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802629</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX AMYL</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802630</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX AST</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802631</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX BUN</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802632</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX CA</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802633</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX CHOL</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802634</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX CK</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802635</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX CREA</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802636</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX GGT</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802637</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX GLU</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802638</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX LAC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802639</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX LDH</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802640</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX LIPA</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802641</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX MG</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802642</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX NH3</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802643</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX PHOS</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802645</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX TBIL</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802646</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX TP</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802647</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX TRIG</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802648</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX URIC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802649</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX ALB</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802627</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX PHBR</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(added as of August&#160;1, 2011)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802644</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX ECO2(12 slide) (added as of August&#160;1, 2011)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6842954</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EXECUTION COPY</font></div></div><div style="margin-bottom:0.1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.758%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.585%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.684%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.906%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.361%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.767%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX ECO2 (6 slide)</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(added as of August&#160;1, 2011)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6482955</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Other</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Catalog Number</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Vetrol</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802212</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Drop Volume Fluid</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802784</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Catalyst Slide Wash</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802813</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Drop Volume Slides</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802789</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Catalyst Pipette Tips</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802779</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Catalyst Sample Cups</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802780</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Catalyst PHBR Control</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802773</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Catalyst White Optical Slide (Box - 6)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6903001</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">250 mL Both PHBR Bulk Wash Bottles Part 1 and 2</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6842914</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">250 mL PHBR Bulk Wash Part 1</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6842923</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">250 mL PHBR Bulk Wash Part 2</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6842924</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">500 mL Both PHBR Bulk Wash Bottles Part 1 and 2</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6842913</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">500 mL PHBR Bulk Wash Part 1</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6842925</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">500 mL PHBR Bulk Wash Part 2</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6842926</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.0 L Both PHBR Bulk Wash Bottles Part 1 and 2</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6842915</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.0 L PHBR Bulk Wash Part 1</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6842928</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.0 L PHBR Bulk Wash Part 2</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6842927</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.0 L Both PHBR Bulk Wash Bottles Part 1 and 2</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6842912</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.0 L PHBR Bulk Wash Part 1</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6842922</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.0 L PHBR Bulk Wash Part 2</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6842929</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="27" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">CONSUMABLES (PRODUCTS NOT INCLUDED UNDER TIERED SLIDE PRICING)</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">OCD P&#47;N</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">IDEXX P&#47;N</font></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Description</font></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2013 Price*</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802784</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">44-14602-00</font></td><td colspan="12" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">DROP VOLUME FLUID</font></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802789</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">44-14739-00</font></td><td colspan="12" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Drop Volume Slides</font></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6842923</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">23-27337-00</font></td><td colspan="12" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX PHBR Part 1 Bulk Wash Fluid  250mL</font></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6842924</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">23-27338-00</font></td><td colspan="12" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX PHBR Part 2 Bulk Wash Fluid  250mL</font></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6842925</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">23-27339-00</font></td><td colspan="12" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX PHBR Part 1 Bulk Wash Fluid  500mL</font></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6842926</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">23-27340-00</font></td><td colspan="12" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX PHBR Part 2 Bulk Wash Fluid  500mL</font></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6842928</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">23-27341-00</font></td><td colspan="12" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX PHBR Part 1 Bulk Wash Fluid  1L</font></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6842927</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">23-27342-00</font></td><td colspan="12" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX PHBR Part 2 Bulk Wash Fluid  1L</font></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6842922</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">23-27343-00</font></td><td colspan="12" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CATALYST BULK SLIDE WASH PART 1 2.0 L</font></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6842929</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">23-27344-00</font></td><td colspan="12" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CATALYST BULK SLIDE WASH PART 2 2.0 L</font></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EXECUTION COPY</font></div></div><div style="margin-bottom:0.1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.758%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.585%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.684%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.906%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.361%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.767%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802212</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">98-11379-00</font></td><td colspan="12" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">VETTROL CONTROL 4-SET</font></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802779</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">98-12125-01</font></td><td colspan="12" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CATALYST DX TM PIPETTE TIP</font></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802780</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">98-12128-00</font></td><td colspan="12" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CATALYST DX SAMPLE CUP</font></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802773</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">98-12304-00</font></td><td colspan="12" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CATALYST PHBR CTRL (6)</font></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802141</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">98-12937-00</font></td><td colspan="12" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX UPRO CONTROL</font></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6903001</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">98-14931-00</font></td><td colspan="12" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CATALYST DX WHITE OPTICAL SLIDE, 6-PACK</font></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6800865</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">98-20520-00</font></td><td colspan="12" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SLIDE, CALIBRATION, BGS (BX25)</font></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6800866</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">98-20521-00</font></td><td colspan="12" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SLIDE, CALIBRATION, WHT (BX25)</font></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6800867</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">98-20522-00</font></td><td colspan="12" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SLIDE, CALIBRATION, WRSC (BX25)</font></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">* </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">OCD may, at its option, increase all prices for such consumables ordered for delivery&#160;on or after January 1, 2014 by an amount not to exceed &#91;**&#93;% each year.  </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%"><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EXECUTION COPY</font></div></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Schedule 6 &#8211; Minimum Prices for New Chemistries</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:36pt"><font><br></font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Urine Protein (added May 25, 2004 as part of the Urine P&#58;C Ratio)&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:14.15pt">Prices for 2005 and thereafter shall be determined based on volume tiers pursuant to Section 7.02(b), subject to a minimum price for this New Chemistry of $&#91;**&#93; per slide</font></div><div style="margin-bottom:10pt;padding-left:72pt"><font><br></font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Lactate (added as of July 1, 2005)&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:14.15pt">Prices for 2005 and thereafter shall be determined based on volume tiers pursuant to Section 7.02(b), subject to a minimum price for this New Chemistry of $&#91;**&#93; per slide</font></div><div style="margin-bottom:10pt;padding-left:72pt"><font><br></font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">ECO2 (added as of August 1, 2011)&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:14.15pt">Prices for 2005 and thereafter shall be determined based on volume tiers pursuant to Section 7.02(b), subject to a minimum price for this New Chemistry of $&#91;**&#93; per slide</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font><br></font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Phenobarb (added as of August 1, 2011)&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:14.15pt">Prices for 2005 and thereafter shall be determined based on volume tiers pursuant to Section 7.02(b), subject to a minimum price for this New Chemistry of $&#91;**&#93; per slide</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EXECUTION COPY</font></div></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%;text-decoration:underline">Exhibit A &#8211; Specifications</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#91;see attached&#93;</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Confidential Materials omitted and filed separately with the Securities and Exchange Commission. A total of 117 pages were omitted. &#91;**&#93;</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#91;*&#93; and &#91;**&#93; text omitted throughout this exhibit for confidential treatment. The redacted information has been excluded because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">13</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.9
<SEQUENCE>6
<FILENAME>exhibit109-orthousagreemen.htm
<DESCRIPTION>EX-10.9
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i7a2831b4ab4543a9999afe6d37bd5a80_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY ASTERISKS, HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED.</font></div><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%;text-decoration:underline">Exhibit 10.9</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">AMENDMENT NO. 8 TO</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">AGREEMENT</font></div><div style="margin-bottom:8pt;text-align:justify"><font><br></font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">THIS AMENDMENT NO.8 TO AGREEMENT (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8221;) is made effective as of September 1, 2021, between IDEXX Operations, Inc., a Delaware corporation whose principal place of business is at 6100 east Shelby Drive, Memphis Tennessee 38141, U.S.A. (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">IDEXX</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8221;)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">and Ortho-Clinical Diagnostics, Inc., a New York corporation with offices at 100 Indigo Creek Drive, Rochester, New York, U.S.A. (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">OCD</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Ortho</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8221;&#59; each of IDEXX and Ortho also a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8221; and together also the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8221;). </font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">WHEREAS, Ortho and IDEXX have entered into that certain agreement dated as of October 16, 2003 (such agreement, as amended by Amendment No. 1 thereto effective January 1, 2005, Amendment No. 2 thereto effective October 15, 2006, Amendment No. 3 thereto effective January 18, 2008, Amendment No. 4 thereto effective December 28, 2011, Amendment No. 5 thereto effective December 9, 2013, Amendment No. 6 thereto effective January 1, 2017, Amendment No. 7 thereto effective July 9, 2019 (as so amended, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8221;), regarding supply by Ortho of dry slides for IDEXX veterinary chemistry analyzers&#59; and </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">WHEREAS, the Parties now desire to update the annual Product forecast and price true-up processes, and agree to amend the Agreements accordingly&#59;</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">NOW THEREFORE, in consideration of the mutual promises, covenants and agreements hereinafter set forth, the Parties hereby agree as follows&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:9.75pt">The first and second paragraph of Section 5.04 shall be deleted in their entirety and replaced as follows&#58;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:54pt;padding-right:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8220;No later than &#91;**&#93; of each year, IDEXX shall provide Ortho with its notice of aggregate forecasted purchase volume and mix of Products (on a Product SKU level) for &#91;**&#93; of the subsequent &#91;**&#93; for each of the VETTEST slides (single slides and PANELS&#47;PROFILES slides for the VETTEST Analyzer and New Slides) (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">&#8220;Initial Forecast&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">).  Ortho shall review the Initial Forecast. In the event that Ortho considers, in good faith, that the Initial Forecast is outside of its manufacturing capability for the &#91;**&#93; allocations specified for each of the VETTEST slides (due to Ortho&#8217;s total manufacturing capacity, Product mix (including on a Product SKU level) or otherwise), Ortho will provide documented acknowledgement of the limitation and the Parties will agree to discuss solutions for provision of slide volume to meet IDEXX&#8217;s forecasted requirements (including any changes to the quarterly allocation of the Product volume or mix of Products, or the overall Product volume).  Any resulting mutually agreed updates shall be incorporated in writing into the Initial Forecast, which shall be deemed the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Annual Purchase Forecast</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8221;. If Ortho does not provide such acknowledgement by the &#91;**&#93; following the Initial Forecast, the Initial Forecast shall be deemed within Ortho&#8217;s capability for </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="padding-left:54pt;padding-right:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">production, and shall be deemed the Annual Purchase Forecast.  As long as the &#91;**&#93; slide order volumes for the &#91;**&#93; do not exceed &#91;**&#93; Ortho shall deliver the slides in accordance with IDEXX&#8217;s orders.  In the event an IDEXX order is outside of Ortho&#8217;s capacity limitation due to the mix of Products, Ortho shall notify IDEXX and the Parties shall discuss in good faith an amicable solution that reflects both Ortho&#8217;s capacity limitations and IDEXX&#8217;s order.</font></div><div style="padding-left:54pt;padding-right:18pt;text-align:justify"><font><br></font></div><div style="padding-left:54pt;padding-right:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">The &#91;**&#93; constitute non-binding forecasts for Ortho&#8217;s planning purposes and shall also be the basis for determining estimated slide pricing pursuant to Section 7.03 below.&#8221;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:9.75pt">Section 5.05 shall be deleted in its entirety and replaced as follows&#58;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:90pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8220;In the event IDEXX intends to place a purchase order for Products that exceeds &#91;**&#93; of the &#91;**&#93; (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Excess Order</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8221;), IDEXX will notify Ortho thereof at least two (2) weeks in advance of the Excess Order.  Within one (1) week following receipt of such request, Ortho will review and notify IDEXX of the extent of its ability to so supply the Excess Order.   Ortho shall use best efforts to deliver the Excess Order, provided that, if such Excess Order exceeds its manufacturing capability (due to either Ortho&#8217;s total manufacturing capacity, Product mix or otherwise, in each case within the quarterly and annual term specified), the Parties will enter into good faith discussions to find solutions for provision of slide volume to meet the Excess Order, but a failure by Ortho to manufacture the Excess Order shall not constitute a breach of contract by Ortho. </font></div><div style="padding-left:90pt;text-align:justify;text-indent:-27pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:9.75pt">Section 7.02(b) shall be modified as follows&#58;  The fifth paragraph (i.e., the paragraph that starts with &#8220;Within &#91;**&#93;&#8230;&#8221;) of Section 7.02(b) shall be deleted in its entirety and replaced as follows&#58;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:90pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8220;(i) &#160;&#160;&#160;&#160;&#91;**&#93;  </font></div><div style="padding-left:90pt;text-align:justify;text-indent:-27pt"><font><br></font></div><div style="padding-left:90pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">(ii) &#160;&#160;&#160;&#160;&#91;**&#93;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">.&#8221;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:9.75pt">Except as modified by this Amendment, the Agreement remains in effect.  This Amendment is to be construed as part of the Agreement.  Each reference to &#8220;hereof&#8221;, &#8220;hereunder&#8221;, &#8220;herein&#8221; and &#8220;hereby&#8221; and each other similar reference and each reference to &#8220;this Agreement&#8221; and each other similar reference contained in the Agreement shall from and after the date set forth above, refer to the Agreement as amended hereby.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.75pt">This Amendment may be executed in counterparts, each of which shall be deemed to be an original and all of which together shall be deemed to be one and the same instrument.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">*****<br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">IN WITNESS WHEREOF and intending to be legally bound, the parties hereto have caused this Amendment to be duly executed in duplicate by their respective authorized representatives as of the day and year first written above&#58;</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">ORTHO-CLINICAL DIAGNOSTICS, INC.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;IDEXX OPERATIONS, INC.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">By&#58; _&#47;s&#47; Michael S. Iskara&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;By&#58; &#47;s&#47; John Hart</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Name&#58; Michael S. Iskara&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Name&#58; John Hart</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Title&#58; EVP  Commercial Excellence and Strategy&#160;&#160;&#160;&#160;Title&#58; Vice President</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Date&#58; Nov 17, 2021&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Date&#58; Nov 2, 2021</font></div><div style="margin-bottom:8pt"><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Acknowledged and consented to, solely as guarantor pursuant to Section 30 of the Agreement&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:8pt;padding-left:264.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">IDEXX LABORATORIES, INC.</font></div><div style="margin-bottom:8pt;padding-left:264.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">By&#58; &#47;s&#47; John Hart</font></div><div style="margin-bottom:8pt;padding-left:264.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Name&#58; John Hart</font></div><div style="margin-bottom:8pt;padding-left:264.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Title&#58; Senior Vice President</font></div><div style="margin-bottom:8pt;padding-left:264.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Date&#58; Nov 5, 2012</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> &#91;**&#93; Text omitted throughout this exhibit for confidential treatment. The redacted information has been excluded because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.10
<SEQUENCE>7
<FILENAME>exhibit1010-orthorowagreem.htm
<DESCRIPTION>EX-10.10
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="id0f07492dcdf42eab8561d2ddb27e6d3_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:right"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit&#160;10.10</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY ASTERISKS, HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED.</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AGREEMENT</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">THIS AGREEMENT is made effective as of the 17</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;day of October, 2003, between IDEXX Europe B.V., a corporation organized under the law of The Netherlands whose principal place of business is at Koolhovenlaan 20, 1119 NE - Schiphol-Rijk, The Netherlands (&#8220;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">IDEXX</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) and Ortho-Clinical Diagnostics, Inc., a New York corporation with offices at 100 Indigo Creek Drive, Rochester, New York, U.S.A. (&#8220;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">OCD</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), and amends and restates the supply agreement effective as of January&#160;1, 1999 between IDEXX and OCD (the &#8220;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Prior Europe Agreement</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">WHEREAS, OCD has been a supplier of analyzers for human applications and dry slides, and IDEXX has been a supplier of analyzers for animal applications&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">WHEREAS, OCD and IDEXX Operations, Inc. (&#8220;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">IDEXX US</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) have entered into an agreement in the United States (the &#8220;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">US Agreement</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) to (a)&#160;combine certain of their respective skills and intellectual property and to invest significant capital to create a New Analyzer (as defined below) and related panel holder design for animal applications, which is expected to provide a superior analyzer offering to customers, expand the sales of OCD dry slides and IDEXX analyzers, and make IDEXX products more competitive and (b)&#160;ensure IDEXX US a continuing supply of Dry Slides necessary for its continued sale of analyzers, including the New Analyzer&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">WHEREAS, in the United States and in the Territory (as defined herein) different market conditions as well as regulatory differences prevail, for which reasons OCD and IDEXX desire to enter into a separate agreement for the supply of Dry Slides in the European market and the other regions in the Territory&#59; and as is the case with the US Agreement, OCD and IDEXX desire to reflect herein their mutual investments and exchange of know-how in connection with the supply of Dry Slides as well as their desire to enter into new arrangements for the supply of diagnostic slides and analyzers for Europe and the other regions in the Territory, the terms and conditions of which are documented herein&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NOW THEREFORE, the parties hereby agree as follows&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"><tr><td style="width:0.1%"></td><td style="width:2.215%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.748%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">DEFINITIONS</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In this Agreement the following expressions shall have the meaning set opposite them.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.020%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:56.820%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;Agreements&#8221;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This Agreement and the US Agreement.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;Analyzers&#8221;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The VETTEST Analyzer and the New Analzyer.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;Commencement Date&#8221;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October&#160;17, 2003.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;Dry Slide&#8221;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A chemical composition, comprising a layered, coated dry film, specifically formulated to analyze for a body constituent, which composition is immediately hydrated by any undiluted bodily fluid, including without limitation a VITROS slide. For avoidance of doubt, the term &#8220;Dry Slide&#8221; shall not include any assay based on immunomagnetic particle technology or any assay for which the analyte is DNA or RNA.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;Effective Rebate Rate&#8221;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For any year, the weighted average percentage reduction in the purchase price of any slides purchased in such year that IDEXX is entitled to receive pursuant to Section&#160;7.03 hereunder. The calculation of the Effective Rebate Rate is illustrated in&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;Exclusivity Territory&#8221;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Austria, Belgium, France, Germany, Italy, Netherlands, Portugal, Spain, Switzerland and the United Kingdom.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;Existing Special &#91;**&#93; Slides&#8221;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VETTEST slides that have been &#91;**&#93;, as of the date of this Agreement, pursuant to Section&#160;4 of the Operations Agreement.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;IDEXX Parent&#8221;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IDEXX Laboratories, Inc., a Delaware, USA corporation, the parent company of IDEXX.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;IDEXX US&#8221;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IDEXX Operations, Inc., a Delaware, USA corporation.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;New Analyzer&#8221;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A new chemistry analyzer that uses OCD Dry Slides for veterinary applications, as contemplated by</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="padding-left:0.04pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.020%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:56.820%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Article&#160;3 of the US Agreement, and any updates or modifications to such analyzer.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;New Chemistry Slides&#8221;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As defined in Section&#160;5.06.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;New Slide&#47;Panel Design&#8221;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A new slide format for VETTEST slides to be used in conjunction with the New Analyzer, as well as a panel holder for such slides, as contemplated by Article&#160;3 of the US Agreement, and any updates or modifications to such design.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;New Slides&#8221;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VETTEST slides that are formatted and packaged in accordance with the New Slide&#47;Panel Design, as contemplated by Article&#160;3 of the US Agreement.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;New Special &#91;**&#93; Slides&#8221;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VETTEST slides that have been &#91;**&#93; pursuant to Section&#160;7.04 of this Agreement.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;Operations Agreement&#8221;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Operations Agreement effective as of January 1, 1999 among OCD, IDEXX Parent and IDEXX.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;PANELS&#47;PROFILES&#8221;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Packages of VETTEST slides for VETTEST Analyzers consisting of two or more sets of slides of specified chemistries. The initial PANEL and the initial PROFILES shall consist of the slides set forth on&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;attached hereto, with any changes or additional PANELS&#47;PROFILES to be mutually agreed upon by the parties as specified in&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;Prime Rate&#8221;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For any day in any calendar month, the prime rate of interest as published in the&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Wall Street Journal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;on the last business day of the immediately preceding month.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;Proportionate Share&#8221;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The percentage obtained by dividing (i)&#160;the number of VETTEST slides purchased by IDEXX in a given period,&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;(ii)&#160;the total number of VETTEST slides purchased by IDEXX and its affiliates during such period.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;Settlement Agreement&#8221;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Amendment, Release and Settlement Agreement dated as of September&#160;12, 2002 among OCD, IDEXX Parent and IDEXX.</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</font></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="padding-left:0.04pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.020%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:56.820%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;Special &#91;**&#93; Slides&#8221;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Existing Special &#91;**&#93; Slides and New Special &#91;**&#93; Slides.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;Term&#8221;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As defined in Section&#160;18.01.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;Territory&#8221;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The European Union, Africa, and the countries listed on&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;attached hereto.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;VETTEST Analyzer&#8221;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The analyzer currently marketed as the VETTEST VT 8008 analyzer and any updates or modifications to such analyzer.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;VETTEST slides&#8221;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dry Slides currently manufactured by OCD, specially designed, bar coded, labeled, and&#47;or packaged for one or more of the Analyzers in accordance with the terms of this Agreement or the US Agreement and supplied by OCD in accordance with the terms and conditions of this Agreement.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;VETTEST tips&#8221;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Metering tips sourced by OCD for use with the VETTEST Analyzer, specially packaged and supplied to IDEXX in accordance with the terms of this Agreement.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;VITROS slides&#8221;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Dry Slides currently manufactured by OCD for use in any current VITROS analyzer, including without limitation the DT60.</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All references to currency in this Agreement shall mean U.S. Dollars unless otherwise specifically indicated.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.580%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">EFFECTIVE DATE OF AGREEMENT</font></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="padding-left:11.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.358%"><tr><td style="width:1.0%"></td><td style="width:4.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.738%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.417%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This Agreement shall become effective upon the Commencement Date. This Agreement shall apply solely within the Territory.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.580%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">NEW SLIDES AND THE NEW SLIDE&#47;PANEL DESIGN</font></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="padding-left:11.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.485%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notwithstanding any other provision of this Agreement, OCD&#8217;s obligations hereunder to supply, format or package New Slides hereunder shall be conditioned upon the successful development of the New Slides, the New Analyzer and the New Slide&#47;Panel Design in accordance with Article&#160;3 of the US Agreement.</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</font></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.126%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.02</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If IDEXX US elects under Section&#160;3.08 of the US Agreement to perform the formatting and packaging of the New Slides independently of OCD, then (1)&#160;in lieu of New Slides, OCD shall supply IDEXX with VITROS slides in the format currently manufactured for the VITROS mainframe analyzers and&#47;or the VETTEST Analyzer (i.e., VITROS slides packaged in 50-count cartridges, before further formatting and packaging for VETTEST Analyzer requirements), as applicable for New Slides, for the Term as provided in this Agreement, and all references in this Agreement to New Slides or to VETTEST slides, to the extent referring to OCD&#8217;s obligation to supply New Slides, shall mean such VITROS slides packaged in 50-count cartridges and (2) solely with respect to New Slides, the prices for Tiers 2 and 3 in the table set forth in Section&#160;7.02 shall be reduced by $&#91;**&#93; per New Slide.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.105%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.971%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">AGREEMENT TO SUPPLY</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.669%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.965%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subject to the terms and conditions of this Agreement, OCD undertakes to manufacture for IDEXX and to supply to IDEXX VETTEST slides, VETTEST tips and Vetrol controls. OCD shall supply VETTEST slides in compliance with the VETTEST Slide Quality Assurance Procedures set out in&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. All slides supplied to IDEXX hereunder are supplied solely for sale within the Territory&#59; provided that IDEXX may make limited sales to IDEXX US solely for purposes of adjusting inventory levels according to unanticipated changes in regional demand. For the avoidance of doubt, nothing in this Agreement shall obligate OCD, with respect to any particular chemistry, to furnish IDEXX with slides for such chemistry in any slit format that OCD does not currently manufacture for such chemistry, or that would otherwise be uneconomical for OCD to supply to IDEXX (other than the slit formats for such chemistry that OCD then sells or has agreed in writing to sell to IDEXX).</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.02</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)&#160;Notwithstanding any other provision of this Agreement, if after &#91;**&#93; the annual volume of VETTEST slides purchased by IDEXX and IDEXX US is less than &#91;**&#93; slides, then OCD may in its sole discretion elect to be released from any obligation to format and package the New Slides and&#47;or package other VETTEST slides, in which event IDEXX&#8217;s sole options hereunder shall be either (x)&#160;to accept an increase in slide prices for New Slides and&#47;or other VETTEST slides that is adequate to compensate OCD for any increase in its costs due to such reduction in volume, or (y)&#160;with respect to slides for which IDEXX does not accept a price increase under the preceding clause (x), but which IDEXX US has elected to format and&#47;or package independently of OCD as provided in Section&#160;4.02 of the US Agreement, to obtain such slides from IDEXX US.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:1.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.712%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)&#160;If IDEXX US elects under Section&#160;4.02 of the US Agreement to perform the formatting and packaging of New Slides, then (1)&#160;in lieu of New Slides OCD shall supply IDEXX with VITROS slides in the format currently manufactured for the VITROS mainframe analyzers and&#47;or the VETTEST Analyzer (i.e., VITROS</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</font></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:1.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.712%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">slides packaged in 50-count cartridges, before further formatting and packaging for VETTEST Analyzer requirements), as applicable for New Slides, for the Term as provided in this Agreement, and all references in this Agreement to New Slides or to VETTEST slides, to the extent referring to OCD&#8217;s obligation to supply New Slides, shall mean such VITROS slides packaged in 50-count cartridges, and (2)&#160;the prices for Tiers 2 and 3 in the table set forth in Section 7.02 shall be reduced by $&#91;**&#93; per New Slide.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)&#160;If IDEXX US elects under Section&#160;4.02 of the US Agreement to perform the packaging of VETTEST slides other than New Slides, then (1)&#160;in lieu of such other VETTEST slides OCD shall supply IDEXX with VITROS slides in the format currently manufactured for the VETTEST Analyzer (i.e., VITROS slides packaged in 50-count cartridges, before further formatting and packaging for VETTEST Analyzer requirements) for the Term as provided in this Agreement, and all references in this Agreement to VETTEST slides, to the extent referring to OCD&#8217;s obligation to supply such slides (other than New Slides), shall mean such VITROS slides packaged in 50-count cartridges, and (2)&#160;the prices for Tiers 1, 2 and 3 in the table set forth in Section&#160;7.02 shall be reduced by $&#91;**&#93;per slide for VETTEST slides (other than New Slides).</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.105%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.971%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">FORECASTS, COMMITMENTS AND ORDERS</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.126%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Attached hereto as&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;are aggregate Purchase Commitments by IDEXX and IDEXX US for VETTEST slides for the VETTEST Analyzer for calendar years 2003 through and including 2010. The Purchase Commitments constitute the aggregate anticipated minimum aggregate purchase quantities by IDEXX and IDEXX US for single chemistry VETTEST slides and PANELS&#47;PROFILES slides in the indicated calendar years.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Existing Special &#91;**&#93; Slides, New Special &#91;**&#93; Slides and New Chemistry Slides shall be excluded from the determination of IDEXX&#8217;s and IDEXX US&#8217;s slide purchases for purposes of achieving their aggregate Purchase Commitments under Section&#160;5.01 of this Agreement or the US Agreement, as the case may be.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Failure by IDEXX and IDEXX US to purchase, in the aggregate, at least the indicated Purchase Commitment quantities of each type of slides in any year may subject IDEXX to the requirement to make a payment to OCD as set forth in Section&#160;5.02 below, but such failure shall in no event otherwise be deemed to be a breach of this Agreement.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.02</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If IDEXX and IDEXX US fail to purchase in the aggregate the quantities of slides for the VETTEST Analyzer set forth as Purchase Commitments on&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;in a particular calendar year, unless there has been a Material Adverse Change (as defined in the following paragraph), IDEXX shall pay, or shall cause IDEXX US to pay, to OCD within 30&#160;days after the end of such calendar year &#91;**&#93;% of the</font></div></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</font></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.126%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">product of (i)&#160;the number of each type of slides (single or PANELS&#47;PROFILES) by which IDEXX and IDEXX US have in the aggregate fallen short of the Purchase Commitment and (ii)&#160;the lowest per-slide price for the applicable type of slides under either of the Agreements.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the purposes of this Section&#160;5.02, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Material Adverse Changes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; shall mean material changes in the veterinary clinical chemistry markets which result from (a)&#160;the commercial introduction into the veterinary market, other than by IDEXX or its affiliates, of a technology not previously available in the veterinary clinical chemistry market, (b)&#160;the eradication of one or more diseases, or the development of new disease therapies, treatments or diagnostics, which significantly reduces demand for veterinary clinical chemistry testing or (c)&#160;the inability or unwillingness of OCD to supply VETTEST or VITROS slides in accordance with IDEXX&#8217;s Annual Purchase Forecasts pursuant to Section&#160;5.04 below. Whether a Material Adverse Change has occurred will be determined by reference to the effect of a change in the veterinary clinical chemistry market on IDEXX and IDEXX US taken as a whole, and not on either individually.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The parties shall discuss in good faith any assertion by IDEXX or IDEXX US that a Material Adverse Change has occurred or is continuing. If the parties agree that a Material Adverse Change has occurred or is continuing, they shall negotiate in good faith with respect to appropriate reductions in Purchase Commitments, VETTEST slide prices (including single and PANELS&#47;PROFILES slides) and&#47;or amounts which would otherwise be payable pursuant to the first sentence of this Section&#160;5.02 to appropriately allocate the effects of such Material Adverse Change on the parties.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.03</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Order and delivery of VETTEST slides (including PANELS&#47;PROFILES) shall be made in multiples of 100 boxes. Unless otherwise agreed between the parties in any particular case, IDEXX shall place orders for slides four times per calendar year, for delivery in each calendar quarter of the year. Each order shall specify a business day delivery date for each delivery, which shall be not less than three months after the order date. Unless otherwise agreed between the parties in any particular case the number of deliveries shall be limited to four per year. IDEXX shall order quantities for delivery in any quarter in accordance with its good faith estimates of actual demand, with allowance for reasonable inventory management requirements and consistent with IDEXX&#8217;s stated desire to minimize its inventory levels.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Order and delivery of the VETTEST tips shall be made in multiples of 10,000 tips (20 cartons each containing 500 tips). Unless otherwise agreed between the parties in any particular case, the number of orders and deliveries of the VETTEST tips and Vetrols shall be limited to two in each year. OCD shall deliver the VETTEST tips and Vetrols in the ordered quantities in each year.</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.126%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.04</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Not later than October 1 of each year, commencing October&#160;1, 2003, IDEXX shall notify OCD of the aggregate forecasted requirements of IDEXX for the subsequent calendar year for each of the VETTEST slides (single slides and PANELS&#47;PROFILES slides for the VETTEST Analyzer and New Slides) (each such notification, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Annual Purchase Forecast</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;). The aggregate order quantities in the subsequent year for each of the VETTEST slides shall be within &#177;25% of such aggregate Annual Purchase Forecast unless the parties otherwise agree. As long as slide orders do not exceed the applicable Annual Purchase Forecast by more than 25%, OCD shall deliver the slides in accordance with the orders. The Annual Purchase Forecasts constitute non-binding forecasts for OCD&#8217;s planning purposes and shall also be the basis for determining estimated slide pricing pursuant to Section&#160;7.02 below and the cash rebate pursuant to Section&#160;7.03 below.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In addition to the Annual Purchase Forecast, IDEXX shall furnish to OCD updated quarterly forecasts of the aggregate requirements of IDEXX for VETTEST slides in the four succeeding calendar quarters. The parties understand that such forecasts are merely estimates to assist OCD in production planning and are not to be considered orders or binding in any way.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For production planning purposes, the parties shall further coordinate with one another to keep OCD apprised of IDEXX&#8217;s current and anticipated inventories of stock keeping units and relevant conditions in the veterinary market. The provisions of this paragraph shall terminate immediately upon any termination of the corresponding provisions of Section&#160;5.04 of the US Agreement.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.05</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In the event that IDEXX in any year notifies OCD that it wishes to order quantities which exceed the quantities mentioned in Section&#160;5.04 above by more than 25%, OCD will endeavor to supply the excess quantities and notify IDEXX of the extent of its ability to so supply.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.06</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">It is understood and agreed that orders for the VETTEST slides shall include only those chemistries set forth in&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;hereto, as amended from time to time by agreement of the parties. IDEXX may at any time request that the additional chemistries listed on&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;hereof, in the form they are available at the Commencement Date to the human market on VITROS slides, be added as VETTEST slides to&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;(any VETTEST slides so added, containing such additional chemistries, are referred to herein as &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">New Chemistry Slides</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;). Prior to adding a New Chemistry Slide on&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, the parties will negotiate in good faith to determine the initial price for such slides in accordance with the immediately following paragraph and shall set forth such price on&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. IDEXX shall have the right, from time to time, to elect to remove any New Chemistry Slides from&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, and&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;and&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;shall be updated to reflect such removal. IDEXX acknowledges that neither this nor any other provision of this Agreement shall obligate OCD to supply IDEXX with any</font></div></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</font></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:1.944%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.921%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.928%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">slide or other product based on any technology that is not incorporated in the VITROS slides or VETTEST slides that OCD sells as of the date hereof.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Until &#91;**&#93;, the price per slide for any New Chemistry Slides shall be the greater of $&#91;**&#93; and &#91;**&#93; (as determined by OCD in good faith and taking into account IDEXX&#8217;s and IDEXX US&#8217;s good faith forecast for the quantity of the chemistry in question). For orders placed for delivery during each calendar year beginning with &#91;**&#93;, if &#91;**&#93; of any New Chemistry Slide is determined to be greater than $&#91;**&#93; (as determined by OCD in good faith and taking into account IDEXX&#8217;s and IDEXX US&#8217;s good faith forecast for the quantity of the chemistry in question), then the minimum price per slide for such New Chemistry Slides shall be &#91;**&#93;&#59; provided, that so long as IDEXX and IDEXX US order &#91;**&#93; or more of such slides in the aggregate in any calendar year, the minimum price per slide for such New Chemistry Slides shall not exceed $&#91;**&#93;. OCD shall have the right, from time to time and in good faith, to revise its determination of &#91;**&#93; of any New Chemistry Slide that is priced on&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;if IDEXX&#8217;s and IDEXX US&#8217;s aggregate actual annual orders of such slide fall below &#91;**&#93;, and&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;shall be updated to reflect such revised &#91;**&#93;.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In the event that a chemistry listed in&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;should become known by OCD to be unavailable at any future date during the Term, OCD will so notify IDEXX at the earliest practicable date, and the parties shall cooperate to determine an appropriate course of action.</font></div></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:1.944%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.132%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">DELIVERY</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.126%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Following acknowledgement by OCD of each order placed by IDEXX and on or before the delivery due date, OCD shall complete delivery of the appropriate quantity of slides and tips within &#177; 10%. Deviations of delivery quantities from order quantities within the &#177; 10% range may be compensated by IDEXX in the first subsequent order placed, subject to Section&#160;5. In the event of a price increase for one or more of the VETTEST slides, such compensating quantity of such slides shall be processed at the previous lower price.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.02</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Order and delivery for all purchases hereunder shall be F.O.B. OCD&#8217;s facility in the U.S.A.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.03</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unless otherwise advised in writing by OCD to IDEXX, OCD shall pack the VETTEST slides in accordance with OCD&#8217;s standard shipping configuration which is known to IDEXX and which at the Commencement Date contains approximately 60 cases per pallet, each case containing 100 boxes of slides.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.04</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The parties shall reasonably cooperate to identify and implement potential savings for both parties, consistent with the principles of lean manufacturing across the value chain, in all processes in their relationship, including without limitation</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</font></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:1.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.712%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">improvements relating to slide manufacturing, packaging, ordering, build schedules, component purchasing, delivery schedules, quality testing and calibration processes, and product distribution processes (including direct shipment to IDEXX distributors and end-users), and including without limitation, identifying and implementing processes to reduce the number of slide lots supplied to IDEXX and to reduce IDEXX calibration time&#59; provided, that neither party shall be obligated to implement a process change for which its net costs exceed its net benefits.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.203%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.773%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">PRICES</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.126%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subject to the provisions of Sections&#160;3.02 and 4.02 that contemplate OCD&#8217;s delivery of slides in 50-count cartridges if IDEXX US elects to format and&#47;or package slides independently, all references to pricing for VETTEST slides in this agreement refer to the completed and packaged product in form ready for delivery to an end-user. The initial prices for each of the VETTEST slides (including the PANELS&#47; PROFILES) shall be as set forth in&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;hereto.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.02</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)&#160;The prices set forth in&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;shall remain in effect for orders placed through December&#160;31, &#91;**&#93;.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)&#160;For orders placed for delivery during each calendar year beginning with &#91;**&#93;, the price for each VETTEST slide listed on&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;(whether New Slides, single chemistry VETTEST slides for the VETTEST Analyzer, or per slide in PANELS&#47;PROFILES, and, for avoidance of doubt, including New Chemistry Slides, subject to Section&#160;5.06), within the respective volume tiers set forth below (aggregating for this purpose purchases by IDEXX and IDEXX US) shall be as set forth for such volume tier&#59;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, that Existing Special &#91;**&#93; Slides and New Special &#91;**&#93; Slides shall not be priced by reference to the volume tiers but will be priced as otherwise set forth below. For purposes of determining purchase volumes, up to &#91;**&#93; Existing Special &#91;**&#93; Slides shall be included in the determination, and all other Existing Special &#91;**&#93; Slides and New Special &#91;**&#93; Slides shall be excluded from the determination. The stated price shall apply only to slides purchased within the corresponding volume tier, and only with respect to the quantities within such tier.</font></div></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="padding-left:81.97pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.205%"><tr><td style="width:1.0%"></td><td style="width:75.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.842%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.301%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.894%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Annual Volume Tier</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Price per Slide</font></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><img alt="image_01.jpg" src="image_01.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_18.jpg" src="image_18.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tier 1&#58;&#160;Up to &#91;**&#93;</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tier 2&#58;&#160;In excess of &#91;**&#93; but not exceeding &#91;**&#93;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tier 3&#58;&#160;In excess of &#91;**&#93;</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</font></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:1.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.712%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For all orders for Existing Special &#91;**&#93; Slides, the price per slide shall be as agreed between the parties pursuant to Section&#160;4 of the Operations Agreement.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For all orders for New Special &#91;**&#93; Slides, the price per slide shall be as agreed between the parties pursuant to Section&#160;7.04 of this Agreement.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, the price per slide for any New Chemistry Slide that is priced on&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;shall never be lower than the greater of (a)&#160;the minimum price as determined in accordance with Section&#160;5.06 and identified on Schedule&#160;6 as amended from time to time and (b)&#160;the price that would otherwise apply pursuant to the pricing tiers set forth above.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Promptly after IDEXX and IDEXX US provide their aggregate Annual Purchase Forecast for a calendar year pursuant to Section&#160;5.04 and Section&#160;5.04 of the US Agreement, the parties shall calculate the weighted average price of slides included in such forecast (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">First Estimated Blended Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;).</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upon determination of the First Estimated Blended Price applicable to a calendar year, for each order placed by IDEXX for delivery during the first three calendar quarters of such year, the amount invoiced and paid per slide listed on&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;shall be the First Estimated Blended Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Before IDEXX places its order for the fourth calendar quarter of the year, the parties shall review IDEXX&#8217;s and IDEXX US&#8217;s respective fourth-quarter orders and re-calculate the weighted average price of slides based on IDEXX&#8217;s and IDEXX US&#8217;s aggregate actual orders for the first three quarters and their orders for the fourth quarter (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Second Estimated Blended Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;). If the Second Estimated Blended Price is different than the First Estimated Blended Price, the amount invoiced and paid per slide listed on&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;shall be the Second Estimated Blended Price. In addition, either party may calculate the resulting adjustment (up or down) for each slide delivered for the first three quarters to reflect the difference between the First Estimated Blended Price and the Second Estimated Blended Price, such that the amount paid by IDEXX for all slides delivered during the first three calendar quarters shall equal the Second Estimated Blended Price. If the adjustment is an upwards adjustment, then IDEXX shall pay OCD the aggregate amount of such adjustment, together with interest on such amount (calculated as set forth below), within 30&#160;days of OCD&#8217;s request for such payment. If the adjustment is a downwards adjustment, then OCD shall pay IDEXX the aggregate amount of such adjustment, together with interest on such amount (calculated as set forth below), within 30&#160;days of IDEXX&#8217;s request for such payment (or, at IDEXX&#8217;s option, apply such amount as a credit against IDEXX&#8217;s third or fourth quarter invoice).</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Within 30&#160;days after the end of the year (or 30&#160;days after IDEXX and IDEXX US complete payment in full for all slides purchased during the year, if later), the</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</font></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:1.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.712%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">parties shall perform a final calculation of the weighted average price based on all slides ordered by IDEXX and IDEXX US and delivered during the year (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Final Blended Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;). If the Final Blended Price is different than the Second Estimated Blended Price, then IDEXX or OCD, as the case may be, shall make a final payment to the other, so that the final amount paid by IDEXX per slide for all slides ordered and delivered during the year shall equal the Final Blended Price. The party obligated to make such final payment shall do so within 30&#160;days after the determination of the Final Blended Price.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Any adjustment payments made pursuant to either of the immediately preceding paragraphs, and any overdue payments by OCD or IDEXX of any amounts owed to the other pursuant to this Section&#160;7.02, shall bear interest at a rate per annum equal to the Prime Rate. Such interest shall be calculated based on a 365-day year and the actual number of days elapsed since the due date for the applicable payment to which it relates.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For avoidance of doubt, the blended price calculations of this Section&#160;7.02 shall apply only to chemistries listed on&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, and only after calendar year &#91;**&#93;.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)&#160;OCD may, at its option, increase all prices for slides ordered for delivery (i)&#160;on or after January&#160;1, &#91;**&#93; by an amount not to exceed &#91;**&#93;% of the &#8220;PPI Increase&#8221; (as defined below), provided that OCD may not increase prices under this clause (i)&#160;unless the PPI Increase is greater than &#91;**&#93;%&#59; and (ii)&#160;on or after January&#160;1, &#91;**&#93; by an amount (x)&#160;as provided in the preceding clause (i)&#160;or (y)&#160;by an amount not to exceed &#91;**&#93;% of the PPI Increase, provided that OCD may not increase prices under this subclause (y)&#160;unless the PPI Increase is greater than &#91;**&#93;%. OCD may calculate the PPI Increase each year beginning in &#91;**&#93;, and any resulting price increase shall be effective for orders placed for delivery during the following calendar year and thereafter, unless and until increased again in accordance with the procedures set forth in this paragraph. For purposes of this Agreement, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">PPI Increase</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; shall be calculated by dividing (x)&#160;the average monthly &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">PPI</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; level for the most recent 12-month period ending with and including June of the year in which the PPI Increase is being calculated (each such period, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Measurement Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), by (y)&#160;the average monthly PPI level for the 12-month period immediately preceding that described in clause (x) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Baseline Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; with respect to such Measurement Period), then subtracting 1 and converting the remaining fraction into a percentage. All calculations shall be based on the latest version of the PPI level published as of the date the calculation is made. For purposes of this Agreement, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">PPI</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means the United States Producer Price Index &#8211; &#91;**&#93; (not seasonally adjusted), current series identification &#91;**&#93;, as published by the Bureau of Labor Statistics on its Web site (www.bls.gov&#47;ppi), or if not available from such Web site, then as published by the Bureau of Labor Statistics in its monthly periodical &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Producer Price Indexes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.&#8221; OCD shall give IDEXX written notice of any price increase pursuant to this paragraph 7.02(c) at least 120&#160;days before the beginning of the calendar year for which a price increase</font></div></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</font></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:1.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.712%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">is to take effect&#59; otherwise, the prices shall remain unaffected by such increase for such year.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)&#160;With respect to slides ordered for delivery on or after January&#160;1, &#91;**&#93;, if OCD&#8217;s aggregate cost of &#91;**&#93; (as defined below) for the most recent Measurement Period has increased on a per VETTEST slide basis as compared with the applicable Baseline Period by an amount that exceeds the PPI Increase for such Measurement Period as applied to the &#91;**&#93; for such Baseline Period, on a per VETTEST slide basis, then OCD shall be permitted to increase the price of each slide sold to IDEXX by the amount of such excess. &#8220;&#91;**&#93;&#8221; means &#91;**&#93; that are &#91;**&#93;.&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;attached hereto contains an example, for illustration purposes only, of the calculations described in this paragraph 7.02(d) and in paragraph 7.02(e).</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(e)&#160;With respect to slides ordered for delivery on or after January 1, &#91;**&#93;, if IDEXX&#8217;s share of Special Event Costs (as defined below) for the most recent Measurement Period has increased on a per VETTEST slide basis as compared with the applicable Baseline Period by an amount that exceeds &#91;**&#93; above the PPI Increase for such Measurement Period as applied to IDEXX&#8217;s share of Special Event Costs for such Baseline Period, on a per VETTEST slide basis, then OCD shall be permitted to increase the price of each slide sold to IDEXX by the amount of such excess. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Special Event Costs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means the aggregate net amount of (i) &#91;**&#93; with respect to &#91;**&#93; on which &#91;**&#93;, (ii) &#91;**&#93; in the &#91;**&#93;, and (iii) &#91;**&#93; as a result of &#91;**&#93;. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">IDEXX&#8217;s share</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; of any of the foregoing shall mean the &#91;**&#93; that is attributable to the &#91;**&#93;.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(f)&#160;OCD shall give IDEXX written notice of any price increase pursuant to paragraph 7.02(d) or 7.02(e) at least 120&#160;days before the beginning of the calendar year for which a price increase is to take effect&#59; otherwise, the prices shall remain unaffected by such increase for such year. Any price increase pursuant to paragraph 7.02(d) or 7.02(e) shall be effective for orders placed for delivery during the following calendar year and thereafter, unless and until (i)&#160;increased again in accordance with the procedures set forth in such paragraphs or (ii)&#160;there occurs a decrease in any of the costs upon which the price increase was based (or any such cost that was relevant in one measuring period is not relevant in subsequent periods, for example, certain validation or other one-time costs incurred for compliance purposes), in which event IDEXX&#8217;s price per slide shall be reduced to the extent of such decrease (or one-time cost). In addition, OCD agrees to consider in good faith any request by IDEXX to reimburse OCD pursuant to paragraph 7.02(e) by a process other than an increase in slide prices, such as a lump sum payment or series of payments. Furthermore, with respect to any one-time cost or other temporary cost lasting no more than one year, IDEXX shall have the right to make such reimbursement in equal periodic payments (no less frequently than quarterly) over a period that is no longer than one year.</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</font></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:1.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.712%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(g)&#160;OCD shall give IDEXX reasonable detail as to its incremental &#91;**&#93; costs and incremental Special Event Costs on which it seeks to base a price increase pursuant to paragraph 7.02(d) or 7.02(e) or otherwise pass on to IDEXX pursuant to paragraph 7.02(f)&#59; provided, however, that IDEXX shall not have any right to obtain any details concerning OCD&#8217;s actual costs (other than such incremental cost differences used in such calculation).</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(h)&#160;At any time after OCD&#8217;s aggregate annual sales volume of VITROS slides and VETTEST slides shall have declined more than &#91;**&#93;% from &#91;**&#93;, the parties shall, at OCD&#8217;s request, discuss appropriate pricing of slides under this Agreement. Neither party shall be obligated to agree to any price change under this Section&#160;7.02(h).</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)&#160;OCD agrees that IDEXX shall have the right, no more than once per calendar year, to cause an internationally recognized independent accounting firm to conduct an audit, on reasonable advance notice and during normal business hours, of OCD&#8217;s books and records to the extent reasonably necessary to confirm OCD&#8217;s price increase calculations under this Section&#160;7.02. Any report prepared by such independent accounting firm shall contain such firm&#8217;s conclusion concerning the validity of OCD&#8217;s price increase&#59; provided, however, that such report shall not contain, and IDEXX shall not have any right to obtain, any details concerning OCD&#8217;s actual costs (other than incremental cost differences used in the calculation of OCD price increases).</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(j)&#160;IDEXX agrees that OCD may audit IDEXX&#8217;s books and records relating to orders of VETTEST slides to confirm the pricing calculations under this Section&#160;7.02.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.03</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The provisions of this Section&#160;7.03 shall apply only to purchases of VETTEST slides for the VETTEST Analyzer during calendar years &#91;**&#93;. IDEXX shall be entitled to receive its Proportionate Share (based on sales during a calendar year) of a cash rebate in the amount set forth below if the total aggregate slide purchases by IDEXX and IDEXX US, in calendar year &#91;**&#93;, exceed the aggregate quantities set forth below&#58;</font></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="padding-left:105.35pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:55.288%"><tr><td style="width:1.0%"></td><td style="width:51.653%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.117%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.930%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Incremental Cash Rebate &#8211;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Annual Slide Purchases</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">% Off Purchase Price</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0 &#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;%</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;%</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;%</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93; and above</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;%</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</font></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:1.944%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.921%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.569%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The rebate amounts set forth above constitute a percentage reduction in the purchase price of any slides (including both single slides and PANELS&#47;PROFILES slides) purchased above the corresponding quantity. The percentage amounts are incremental (as opposed to cumulative) and relate only to the quantities set forth opposite it. For example, if IDEXX and IDEXX US were to purchase, in the aggregate, &#91;**&#93; slides in calendar year &#91;**&#93;, they would not be entitled to a &#91;**&#93;% price reduction on all slides that they purchased in such year, rather, they would be entitled to receive (i) &#91;**&#93; purchase price reduction on the first &#91;**&#93; slides purchased, (ii)&#160;a &#91;**&#93;% purchase price reduction on all slides purchased over &#91;**&#93;, up to and including &#91;**&#93;, (iii)&#160;an &#91;**&#93;% purchase price reduction on all slides purchased over &#91;**&#93; up to and including &#91;**&#93;, and (iv)&#160;a &#91;**&#93;% purchase price reduction on all slides purchased over &#91;**&#93; up to and including the &#91;**&#93; slides that they purchased. The foregoing notwithstanding, it is understood and agreed that if IDEXX and IDEXX US do not, in the aggregate, achieve the aggregate Purchase Commitments set forth in Section&#160;5 in any calendar year, then they shall not be entitled to receive a rebate for such year.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In the beginning of calendar year &#91;**&#93;, OCD shall calculate an estimated Effective Rebate Rate (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Estimated Rebate Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) based on the lesser of (i)&#160;IDEXX&#8217;s and IDEXX US&#8217;s aggregate Annual Purchase Forecast for such year and (ii) &#91;**&#93;% of the total aggregate number of slides that IDEXX and IDEXX US together purchased in &#91;**&#93;. The Estimated Rebate Rate for calendar year &#91;**&#93;shall be such that the average VETTEST slide price for &#91;**&#93;, after giving effect to the rebate, shall be $&#91;**&#93;. Not later than thirty (30)&#160;days after the end of each of the first three calendar quarters of &#91;**&#93; (or thirty days after IDEXX and IDEXX US complete payment in full for slides purchased during such quarter, if later), OCD shall pay to IDEXX its Proportionate Share (based on purchases during the preceding quarter) of an amount equal to the aggregate estimated rebate payment that IDEXX and IDEXX US would together be entitled to receive in such quarter (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Estimated Rebate Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;). The Estimated Rebate Payment for any such quarter shall be calculated by (i)&#160;multiplying the Estimated Rebate Rate in effect during such quarter by the total aggregate purchase price for the VETTEST slides purchased by IDEXX and IDEXX US during such quarter and (ii)&#160;subtracting from such amount an amount equal to &#91;**&#93;% of the total calculated in clause (i)&#160;above. The foregoing notwithstanding, if, in calendar year &#91;**&#93;, (i)&#160;IDEXX&#8217;s and IDEXX US&#8217;s total aggregate slide orders for the immediately preceding calendar year were less than &#91;**&#93;% of their aggregate Annual Purchase Forecast for such preceding calendar year or (ii) OCD determines, in its reasonable discretion, at any time after the end of the second calendar quarter of such calendar year, or IDEXX indicates at any time, that IDEXX and IDEXX US are reasonably unlikely to meet their aggregate Annual Purchase Forecast for such year, then OCD shall have the right to recalculate the Estimated Rebate Rate based on IDEXX&#8217;s and IDEXX US&#8217;s aggregate Purchase Commitment for such year (such recalculated rate being hereinafter referred to as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">New Estimated Rebate Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;). If OCD elects to recalculate the Estimated Rebate Rate pursuant to the immediately</font></div></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</font></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:1.944%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.921%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.867%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.768%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">preceding sentence, (i)&#160;OCD shall notify IDEXX in writing which notice shall set forth the New Estimated Rebate Rate, (ii)&#160;OCD shall calculate all remaining quarterly Estimated Rebate Payments (which may include the Estimated Rebate Payment for the second calendar quarter) using the New Estimated Rebate Rate and (iii)&#160;all such Estimated Rebate Payments shall be made in accordance with this sub-clause 7.03, except that such Estimated Rebate Payments shall be less the amount by which the aggregate Estimated Rebate Payments received by IDEXX and IDEXX US during the then current calendar year exceed the aggregate Estimated Rebate Payments they would have received during such calendar year if the New Estimated Rebate Rate were in effect from the first day of such calendar year.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notwithstanding any provision in this Agreement to the contrary, OCD shall not be required to pay to IDEXX its Proportionate Share of any Estimated Rebate Payments in any calendar year if (A)&#160;any amounts payable to OCD from IDEXX pursuant to this Agreement are overdue, unless such amounts are being disputed in good faith by IDEXX, or (B)&#160;OCD determines in its reasonable judgment that IDEXX and IDEXX US are reasonably unlikely to meet their aggregate Purchase Commitments for such year. In the case of clause (B) above, OCD shall have the right to make such determination at any time after the end of the second calendar quarter of calendar year &#91;**&#93;, as the case may be (or such earlier time as IDEXX or IDEXX US indicates (through an Annual Purchase Forecast or otherwise) that their aggregate slide purchases are reasonably likely to be less than their aggregate Purchase Commitment for such year), provided that OCD has consulted with IDEXX and given IDEXX an opportunity (which opportunity shall be available for a period of not less than 5 business days nor more than 10 business days) to demonstrate its and IDEXX US&#8217;s intent and ability to meet their aggregate Purchase Commitments for such year. For the avoidance of doubt, OCD&#8217;s obligation to make any Estimated Rebate Payments shall be suspended during the period referred to in the immediately preceding sentence and the days in such period shall not be counted when determining the date by which the next scheduled Estimated Rebate Payment is due and payable. If, after fulfilling the requirements set forth in this paragraph, OCD makes the determination described in clause (B)&#160;above, OCD (i)&#160;shall promptly notify IDEXX in writing of its determination and (ii)&#160;shall thereafter have the right to cease making Estimated Rebate Payments for the remainder of such calendar year.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Not later than thirty (30)&#160;business days after the end of the last calendar quarter of calendar year &#91;**&#93;, as the case may be (or thirty days after IDEXX and IDEXX US complete payment in full for slides purchased during such quarter, if later), OCD shall pay to IDEXX its Proportionate Share (based on purchases during such calendar year) of the amount by which (i)&#160;the Effective Rebate Rate multiplied by the total aggregate purchase price for VETTEST slides purchased by IDEXX and IDEXX US during such calendar year exceeds (ii)&#160;the total aggregate amount of the Estimated Rebate Payments made by OCD to IDEXX and IDEXX US during</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16</font></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.348%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.286%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">such calendar year. If the amount in clause (ii)&#160;above exceeds the amount in clause (i)&#160;above, OCD shall deliver to IDEXX a written notice of such fact (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Reimbursement Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) and IDEXX shall pay to OCD, within thirty (30)&#160;days of receipt of such notice an amount in cash equal to its Proportionate Share of the amount of such excess.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, if IDEXX and IDEXX US do not achieve their aggregate Purchase Commitment in calendar year &#91;**&#93;, as the case may be, then IDEXX shall return all Estimated Rebate Payments received from OCD for such year no later than thirty (30)&#160;days after the end of such calendar year.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">An illustrative representation of the foregoing rebate calculation methodology is attached hereto as&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notwithstanding any other provision of this Section&#160;7.03, if any amounts payable to OCD from IDEXX pursuant to this Agreement are overdue, other than amounts that are being disputed in good faith by IDEXX, then OCD shall be entitled to withhold such overdue amount (plus any accrued interest) from any rebate payments to which IDEXX may be entitled. Any overdue payments by OCD or IDEXX of any amounts owed to the other pursuant to this Section&#160;7.03 shall bear interest at a rate per annum equal to the Prime Rate. Such interest shall be payable at the same time as the payment to which it relates and shall be calculated daily on the basis of a year of 365&#160;days and the actual number of days elapsed.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCD shall prepare a remittance advice to accompany each rebate payment (or Reimbursement Notice), which shall set forth the reporting period for which the payment is made (or demanded) and a summary sheet which shall detail OCD&#8217;s calculation of the rebate (or reimbursement). If IDEXX disagrees with the rebate or reimbursement calculation, IDEXX shall promptly notify OCD, and the parties, together with IDEXX US if appropriate, shall review the calculations together in good faith to agree on any appropriate corrections or adjustments.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Any Special &#91;**&#93; Slides and any New Chemistry Slides shall be excluded from the determination of any rebate entitlement under Section&#160;7.03 of this Agreement or the US Agreement, as the case may be, and the rebates described in Section&#160;7.03 shall not apply to such slides.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.04</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If IDEXX provides OCD with specific documentation regarding &#91;**&#93; that would require IDEXX and IDEXX US, collectively, to purchase, in any calendar year, a number of slides over and above their most recent aggregate Annual Purchase Forecast for such year, &#91;**&#93; for slides, &#91;**&#93; for slides &#91;**&#93; by this Agreement, OCD agrees, within two weeks of its receipt of all additional information that OCD may reasonably request regarding such &#91;**&#93;, to inform IDEXX as to whether or not OCD &#91;**&#93; in respect of &#91;**&#93;, the number of slides &#91;**&#93; for such slides, and any other related terms and conditions that OCD deems applicable. OCD shall</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</font></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:1.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.712%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">consider such requests in good faith. OCD agrees that &#91;**&#93; IDEXX or IDEXX US pursuant to &#91;**&#93; remain in effect with respect to &#91;**&#93; until such time as &#91;**&#93; as the case may be.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.364%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.612%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">INVOICES AND PAYMENT</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.348%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.286%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCD shall invoice IDEXX in respect of each order for the VETTEST slides upon completion by OCD of the delivery of such order. Each order shall be billed by OCD under one invoice in US dollars and payment shall be made by IDEXX in US dollars not later than thirty (30)&#160;days following the date of invoice.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.684%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.292%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">EXCLUSIVITY</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.867%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.767%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCD undertakes not to sell or otherwise supply, and to cause its affiliates not to sell or otherwise supply, any Dry Slides (whether or not such slides are finished or complete) bar-coded for use in any Analyzers to any person, firm or company other than IDEXX or its affiliates. The provisions of this Section&#160;9.01 shall survive the termination of this Agreement&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">unless</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;all of the following shall be true&#58; (i)&#160;prior to such termination IDEXX (or its permitted assignees) and its affiliates shall have ceased to market the VETTEST slides, (ii)&#160;such cessation shall not have been a consequence of action by OCD, and (iii)&#160;OCD shall have complied with its obligations under this Agreement prior to such termination.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.02</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IDEXX undertakes not to market, and to cause its affiliates not to market, any Dry Slide for any chemistry identified on&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, as amended from time to time, other than Dry Slides obtained by such person directly from OCD, to the extent that the desired chemistries are available from OCD&#59; provided that, for purposes of adjusting inventory levels according to unanticipated changes in regional demand, IDEXX may purchase from IDEXX US VETTEST slides that IDEXX US obtained directly from OCD. The provisions of this Section&#160;9.02 shall terminate &#91;**&#93; years after the Commencement Date with respect to VETTEST slides for the VETTEST Analyzer, and &#91;**&#93; years after the first commercial sale of the New Analyzer in the Territory, with respect to New Slides. At the time of termination (with respect to VETTEST slides for the VETTEST Analyzer, or New Slides, as the case may be), the parties shall negotiate whether they wish to renew the arrangements set out in this Section&#160;9.02 with respect to VETTEST slides for the VETTEST Analyzer, or New Slides, as the case may be. Any renewal of these arrangements shall be set forth in a written agreement entered into by the parties.</font></div></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.425%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.043%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.132%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">MARKETING ARRANGEMENTS</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.150%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.126%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IDEXX will be responsible for all marketing arrangements for the Analyzers and the VETTEST slides. IDEXX may appoint any of OCD&#8217;s medical&#47;surgical dealers as distributors of or agents for the Analyzers and the VETTEST slides but will not be obliged to do so.</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18</font></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.768%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.02</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IDEXX will be responsible for the establishment of dealer performance criteria for all dealers including OCD&#8217;s medical&#47;surgical dealers (if any are appointed by IDEXX as distributors of the Analyzers and the VETTEST slides).</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.03</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IDEXX will keep OCD informed of and consult with OCD as to marketing arrangements for the Analyzers and the VETTEST slides but will not be obligated to OCD beyond the terms of this Agreement in connection with such marketing arrangements.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.04</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCD hereby grants to IDEXX the exclusive right to distribute, to customers in the veterinary market, under the terms set forth in this Section&#160;10.04, VITROS slides and VITROS analyzers that run solely VITROS slides. The parties also agree to use good faith, commercially reasonable efforts to negotiate a definitive distribution agreement not later than December&#160;31, 2003. Notwithstanding any other provision of this Section&#160;10.04, OCD and its affiliates shall continue to have the right to sell, directly or through distributors, VITROS analyzers and VITROS slides to all persons that are current VITROS end-user customers as of the Commencement Date, and to renew or extend the term of any contracts with such customers or, solely for the purpose of sales to such customers, with such distributors.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The parties shall discuss terms for any sales opportunity in the veterinary market in good faith, on a case-by-case basis. OCD shall be responsible, at its sole expense, for providing warranty and out-of-warranty service and support to any customers to whom IDEXX sells a VITROS analyzer&#59; provided that such analyzer is then covered by a maintenance agreement between OCD and that customer. IDEXX shall not modify or customize any VITROS product supplied hereunder, or remove or alter any product labels or re-label any products, packaging or related materials for VITROS product supplied hereunder. OCD shall provide IDEXX, without charge, with such training in the marketing and sale of VITROS products and with such marketing and technical assistance and product information as OCD may, in its discretion, consider necessary to assist with the promotion and sale of the products&#59; provided that OCD&#8217;s training obligation shall be limited to training employees of IDEXX to train other IDEXX employees and sales agents.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IDEXX shall defend and indemnify OCD from and against all damages, liabilities, costs and expenses (including reasonable attorneys&#8217; fees and costs) arising out of any claim resulting from (a)&#160;any negligent act or omission or any willful misconduct by IDEXX in connection with the VITROS products supplied by OCD under this Section&#160;10.04 or (b)&#160;any statement, representation or warranty made by IDEXX or any of its agents with respect to a VITROS product that is not contained in the labeling or package insert and is not otherwise approved by OCD in writing or (c)&#160;any breach of IDEXX&#8217;s covenants in the preceding paragraph. OCD</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19</font></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:1.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.712%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">shall defend and indemnify IDEXX from and against all damages, liabilities, costs and expenses (including reasonable attorneys&#8217; fees and costs) arising out of any claim (i)&#160;for injuries or death to persons or animals or damage to or destruction of tangible property arising out of the use of VITROS products sold under this Section&#160;10.04 (whether claimed by reason of breach of warranty, negligence, product defect or other similar cause of action, regardless of the form in which any such claim is made) or (ii) that any VITROS product sold under this Section&#160;10.04 infringes a patent, copyright, trademark or trade secret of a third party&#59; provided that this clause (ii)&#160;shall not apply to any claim arising out of the use of any product in conjunction with products not supplied by OCD. The indemnity procedures set forth in Section 16.06 shall apply to this Section&#160;10.04.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The provisions of this Section&#160;10.04 shall apply only within the Exclusivity Territory. Furthermore, the provisions of this Section 10.04 granting IDEXX exclusivity shall (a)&#160;automatically terminate immediately upon the termination of Section&#160;9.02 and (b)&#160;not apply to any instruments weighing more than 200 pounds, or to any slides sold for use on such instruments, unless and until the parties have executed the distribution agreement contemplated by this Section 10.04.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.906%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.043%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.651%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">SALES SUPPORT</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.150%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.126%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IDEXX will be responsible for all necessary sales support for the Analyzers and the VETTEST slides.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.02</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCD&#8217;s sole obligation in respect of sale support shall be at its own expense to assist IDEXX in resolving specific problems resulting from the failure of VETTEST slides to conform to specifications.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.746%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.043%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.811%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">TESTING</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.768%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCD shall disclose to IDEXX its quality assurance procedures used in final evaluation of the VETTEST slides and full particulars thereof as set out in the VETTEST Slide Quality Assurance Procedures forming&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;to this Agreement. OCD shall operate such quality assurance procedures in accordance with&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.02</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upon prior written notice from IDEXX, OCD shall grant authorized representatives of IDEXX access to that part of OCD production facilities which conducts final evaluation of the VETTEST slides for the purpose of enabling such representatives to monitor the application by OCD of the VETTEST Slide Quality Assurance Procedures set out in&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Such access shall be granted by OCD to IDEXX and IDEXX US no more than twice in any twelve-month period. With respect to VETTEST slides for use in the New Analyzer, IDEXX shall be permitted to monitor those stages of the production process that are unique to</font></div></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20</font></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:1.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.712%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VETTEST slides for the New Analyzer, but with respect to VETTEST slides for the VETTEST Analyzer, such access shall be limited to OCD&#8217;s final evaluation facilities. All information obtained as a result of the audits contemplated by this Section&#160;12.02 shall be subject to the provisions of&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.906%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.043%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.651%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">BAR CODING AND PACKAGING</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.768%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The VETTEST slides shall be printed by OCD with special bar coding for use in Analyzers.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.02</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCD shall package the VETTEST slides and tips for the VETTEST Analyzer in the physical manner as used for the VITROS slides and tips at the time of packaging of such VETTEST slides and tips. In the event of a change in VITROS slide or tip packaging which has an impact on such VETTEST slide or tip packaging, OCD shall notify IDEXX as early as practicable of the relevant particulars of such change.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.03</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Except as authorized by Section&#160;14.01 below, the label content and art work associated with VETTEST slides and package materials (including without limitation package materials for the New Slides) shall not include any trademarks, trade names, or trade dress of OCD. IDEXX shall furnish such label content and art work to OCD on a timely basis, and such label content and art work shall not be changed at any time during the Term without the prior agreement of the parties.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.547%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.043%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.010%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">TRADE MARKS AND TRADE NAMES</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.005%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCD expressly authorizes IDEXX to use the phrase &#8220;manufactured by Ortho-Clinical Diagnostics, Inc. for IDEXX (IDEXX ADDRESS)&#8221; on package materials for VETTEST slides (including without limitation package materials for the New Slides). No other uses of OCD&#8217;s trademarks, trade names or trade dress are authorized by this Agreement.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.02</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IDEXX shall neither acquire, nor claim any right, title or interest in or to any of OCD&#8217;s trade marks or trade names by virtue of this Agreement or through advertising and sale of the Analyzers or the VETTEST slides or otherwise.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.867%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.043%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.690%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">PATENT INDEMNITIES</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCD shall indemnify and hold IDEXX harmless for all loss, damage, cost and expense whatsoever, including legal fees, patent attorney&#8217;s fees and court costs that IDEXX may incur or become liable for as a result of any action, suit or claim alleging infringement of any patent held by a third party arising from the use and&#47;or sale of the VETTEST slides or tips to the extent that such action, suit, or claim relates in a material way to the specification for the VITROS slides or tips. If as a result of any judgment or settlement it is determined that a claim or claims</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21</font></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.005%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">of a third party patent is infringed by the use and&#47;or sale of the VETTEST slides or tips as aforesaid and IDEXX is required to make any payments to any third party as a result thereof, IDEXX may off-set all such payments against any present and&#47;or future payments to be made to OCD hereunder.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.02</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IDEXX shall indemnify and hold OCD harmless for all loss, damage, cost and expense whatsoever, including legal fees, patent attorney&#8217;s fees and court costs that OCD may incur or become liable for as a result of any action, suit or claim alleging infringement of any patent held by a third party arising from (a)&#160;the manufacture, use or sale of the VETTEST slides or tips to the extent that the VETTEST slides or tips differ from the VITROS slides or tips, (b)&#160;the manufacture, use or sale of the New Slide&#47;Panel Design, or (c)&#160;the manufacture, use or sale of any Analyzer.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.03</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All claims for indemnity under this Article&#160;15 shall be subject to the rights, obligations and procedures set forth in Section&#160;16.06 below.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.043%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.331%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">WARRANTY, LIABILITY AND INDEMNIFICATION</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.470%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.806%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCD hereby warrants that&#58;</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.906%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.364%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.722%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the VETTEST slides delivered to IDEXX shall be in compliance with&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, and</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCD shall pack and ship products under this Agreement in a manner consistent with OCD&#8217;s usual practices, which shall be sufficient to protect the products from damage during normal shipping and handling.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"><tr><td style="width:0.1%"></td><td style="width:1.571%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.697%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.571%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.561%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.02</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In the event of a breach on the part of OCD of Section&#160;16.01 above, OCD&#8217;s liability shall be limited to the replacement of the VETTEST slides or tips found to be defective, including shipping costs for return of defective slides or tips and delivery of replacement slides or tips.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.03</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCD&#8217;s liability as stated in Section&#160;16.02 shall be subject to the following conditions&#58;</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"><tr><td style="width:1.0%"></td><td style="width:4.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.376%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IDEXX shall notify OCD promptly of any noncompliance contrary to Section&#160;16.01(a) or damage contrary to Section&#160;16.01(b).</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IDEXX and its transferees shall not alter or modify the VETTEST slides or packaging of the VETTEST slides or tips without prior approval of OCD.</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22</font></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.470%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.806%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.04</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Except as provided in this Section&#160;16 there are no other warranties, express or implied, including warranties for fitness for any particular use or of merchantability.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.05</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subject to Section&#160;15, IDEXX shall indemnify and hold harmless OCD from and against any claim, loss, damage, or expense (including attorney&#8217;s fees) with respect to any physical injury to persons, animals or property arising out of or in connection with IDEXX&#8217;s use or sale of any Analyzer or the VETTEST slides, and any claim of infringement of any trademark (except OCD&#8217;s own trademark), trade dress, trade secret, or copyright. IDEXX shall notify OCD (a) at the commencement of any action or suit based on any such claim and (b)&#160;in the event of any injunction or other order prohibiting the sale or use of any Analyzer or VETTEST slide.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.06</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Any party claiming indemnification under this Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Indemnitee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) shall notify the party from which indemnification is claimed (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Indemnifying Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) in writing promptly upon becoming aware of any claim to which such indemnification may apply. Failure to provide such notice shall constitute a waiver of the Indemnifying Party&#8217;s indemnity obligations hereunder if, and only to the extent that, the Indemnifying Party is materially damaged thereby. The Indemnifying Party shall have the right to assume and control the defense of the claim at its own expense. If the right to assume and have sole control of the defense is exercised, the Indemnitee shall have the right to participate in, but not to control, such defense at its own expense. If the Indemnifying Party does not assume the defense of the claim, the Indemnitee may defend the claim at the Indemnifying Party&#8217;s expense. The Indemnitee will not settle or compromise the claim without the prior written consent of the Indemnifying Party. The Indemnifying Party will not, without the consent of the Indemnitee (which consent will not be unreasonably withheld), settle or compromise the claim in any manner which would have an adverse effect on the Indemnitee, unless (x)&#160;prior to such settlement or compromise the Indemnifying Party acknowledges in writing its obligation to pay in full the amount of the settlement or compromise and the Indemnitee is furnished with security reasonably satisfactory to it that the Indemnifying Party can in fact pay such amount, (y)&#160;such settlement or compromise includes a full release of such claim against the Indemnitee and (z)&#160;such settlement or compromise provides for no relief or remedy other than money damages. The Indemnitee shall reasonably cooperate with the Indemnifying Party and will make available to the Indemnifying Party all pertinent information under the control of the Indemnitee.</font></div></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.906%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.043%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.651%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">SECRECY</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.646%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Each of IDEXX, IDEXX Parent and OCD agrees to protect confidential information disclosed to it upon terms set out in Schedule&#160;2 attached hereto.</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23</font></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.043%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.331%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">PERIOD OF AGREEMENT</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.150%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.126%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subject to the terms and conditions set forth herein, the term (the &#8220;Term&#8221;) of the Agreement shall be the period from the Commencement Date until December&#160;31, 2018.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.043%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.331%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">TERMINATION</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.989%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.287%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This Agreement may be terminated by either party in any of the following events&#58;</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.557%"><tr><td style="width:1.0%"></td><td style="width:4.591%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.152%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.356%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If the other party is guilty of gross or persistent breaches of the terms of this Agreement, which breaches are not remedied to the satisfaction of the other party after ninety (90)&#160;days notice in writing to do so. Any such breach shall entitle the innocent party to terminate this Agreement by notice in writing which notice shall be effective at the end of ninety (90)&#160;days following the date of such notice.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If the other party becomes insolvent or compounds with its creditors or goes into liquidation (other than for the purposes of corporate reorganization) then the innocent party may terminate this Agreement by notice in writing which shall have immediate effect.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If such party elects to cease marketing Dry Slide diagnostic products, then it shall have the right, by notice given at any time after January&#160;1, &#91;**&#93;, to terminate this Agreement upon &#91;**&#93; years&#8217; prior written notice.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.791%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.485%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.02</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in the equity ownership or corporate reorganizations of either party shall not be grounds for termination of this Agreement, except that if more than &#91;**&#93;% of the outstanding capital stock of IDEXX or IDEXX Parent is owned or controlled by a competitor of OCD, OCD may in its discretion terminate the provisions of Section&#160;10.04 of this Agreement immediately upon written notice to IDEXX.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.03</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This Agreement shall terminate automatically upon any termination of the US Agreement.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.04</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The provisions of this Agreement dealing with rights and obligations after termination of this Agreement, including without limitation Sections&#160;15, 16, 17, 21, 22, 23, 24, 25, 26, 28, 29 and 30, shall survive the expiration or termination of this Agreement and continue to be enforceable to the extent necessary to achieve the logical and intended purposes of such provisions.</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24</font></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.&#160;&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">FORCE MAJEURE</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.717%"><tr><td style="width:0.1%"></td><td style="width:1.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.581%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.649%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neither party shall be liable for any failure or delay in performing any of its respective obligations under this Agreement to the extent that such failure or delay is due to any cause beyond its reasonable control (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Force Majeure Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;). The non-performing party shall give the other party prompt written notice of such inability to perform and shall use commercially reasonable efforts to resume performance as soon as reasonably practicable. If as a result of a Force Majeure Event OCD is unable, using commercially reasonable efforts, to meet its supply obligations to IDEXX hereunder for a period exceeding twenty-four months, or if IDEXX reasonably determines that it will not be feasible for OCD through the use of commercially reasonable efforts to resume the supply of VETTEST slides within twenty-four months, then either party may terminate this Agreement immediately upon written notice to the other party.</font></div></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.&#160;&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">GOVERNING LAW&#59; JURISDICTION</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.791%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.485%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The construction, validity and performance of this Agreement shall be governed in all respects by the laws of the State of New York, USA. Any legal actions relating to this Agreement must be brought in the court of appropriate jurisdiction in the State of New York, which shall have exclusive jurisdiction, and the parties hereby waive any claim of lack of jurisdiction or inconvenient forum. The prevailing party in any litigation under this Agreement shall be entitled to an award of its costs, including reasonable attorneys&#8217; fees and expenses. Each party hereto waives its right to trial of any issue by jury. Each party hereto waives any claim to punitive, exemplary or multiplied damages from the other. Each party hereto waives any claim of consequential damages from the other.</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22. &#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">SEVERABILITY</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.470%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.806%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Any term or provision of this Agreement that is invalid or unenforceable in any situation in any jurisdiction shall not affect the validity or enforceability of the remaining terms and provisions hereof or the validity or enforceability of the offending term or provision in any other situation or in any other jurisdiction. If the final judgment of a court of competent jurisdiction declares that any term or provision hereof is invalid or unenforceable, then the parties agree that the court making the determination of invalidity or unenforceability shall have the power to reduce the scope, duration, or area of the term or provision, to delete specific words or phrases, or to replace any invalid or unenforceable term or provision with a term or provision that is valid and enforceable and that comes closest to expressing the intention of the invalid or unenforceable term or provision, and this Agreement shall be enforceable as so modified after the expiration of the time within which the judgment may be appealed.</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25</font></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.043%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.331%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">WAIVERS</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.768%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Failure of either party to this Agreement to insist upon strict observance or compliance with all its terms and conditions in one or more instances shall not be deemed to be a waiver of its right to insist upon such observance or compliance with such term or condition or with any other terms or conditions hereof in the future.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.265%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.043%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.292%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">PRIOR AGREEMENTS&#59; INTERPRETATION</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.768%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of the Commencement Date, this Agreement shall take effect in substitution for the Prior Europe Agreement, the Operations Agreement (except as otherwise provided in Section&#160;7.04 of this Agreement), Section&#160;B (Amendments) of the Settlement Agreement, and all or any other previous agreements relating to the subject matter hereof whether the same are formal agreements or agreements that would be inferred from the parties&#8217; correspondence or conduct, and all such substituted agreements shall be deemed to have been terminated by mutual consent on the Commencement Date&#59; provided, however, that nothing contained herein shall be deemed to modify or terminate the US Agreement, except that the Purchase Commitments and Annual Purchase Forecasts referred to in Section&#160;5 and in&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;of this Agreement and the US Agreement represent the aggregate commitments and forecasts of IDEXX and IDEXX US and not the individual commitments and forecasts of IDEXX US under the US Agreement or IDEXX under this Agreement. For avoidance of doubt, this Agreement (as it may be amended or restated from time to time) is the &#8220;Europe Agreement&#8221; referred to in the US Agreement.</font></div></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.265%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.043%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.292%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">ENTIRE AGREEMENT</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.768%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This Agreement, together with the US Agreement, the Settlement Agreement (other than Section&#160;B thereof), and that certain memorandum agreement dated September&#160;12, 2003 regarding slide packaging (as amended to date), constitutes the complete agreement of the parties concerning the subject matter hereof and thereof during the Term, and, with respect to all periods from and after the Commencement Date, supersedes all prior agreements between the parties regarding its subject matter.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.265%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.043%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.292%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">ALTERATION OR MODIFICATION</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.768%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No alteration, amendment or modification to this Agreement or the attached Schedules shall be of any force or effect unless in writing and signed by both parties. No modification shall be effected by the acknowledgement or acceptance of purchase order forms or order confirmations or invoices or other documents containing different conditions.</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26</font></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.265%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.043%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.292%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">ASSIGNMENT</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.768%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This Agreement shall not be capable of assignment by either party to a company of which it owns less than a majority or which owns less than a majority of the party save in the case of (i)&#160;an assignment at OCD&#8217;s sole discretion to an acquiror of OCD&#8217;s dry slide business or (ii)&#160;an assignment at IDEXX&#8217;s sole discretion to an acquiror of IDEXX&#8217;s VETTEST and New Analyzer business&#59; provided that no assignment shall release the assigning party from any obligations hereunder. In the case of an assignment under the preceding clause (ii)&#160;to an entity which is a competitor of OCD&#8217;s diagnostics business, OCD may in its discretion terminate the provisions of Section&#160;10.04 granting IDEXX exclusivity or restricting sales or marketing by or on behalf of OCD immediately upon written notice to IDEXX.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This Agreement shall be binding on and inure to the benefit of the parties hereto and their permitted successors and assigns.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.265%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.043%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.292%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">GOVERNING LANGUAGE</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.768%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This Agreement is drafted in English. If this Agreement is translated into a language other than English, then the original English version of this Agreement shall control all questions of interpretation with respect thereto. Any other documents delivered or given pursuant to this Agreement, including notices, shall be in English.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.061%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.247%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">NOTICES</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.768%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Any notice, statement or other communication to be given by one party to the other hereunder may be given by registered mail, airmail, internationally recognized courier, facsimile or telex to the party concerned at the addresses set out below&#58;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ortho-Clinical Diagnostics, Inc.<br>1001 US Highway 202<br>Raritan, New Jersey 08869, USA<br>For the attention of&#58; Vice President and General Manager, Americas</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With a copy to&#58;<br>Johnson &#38; Johnson<br>One Johnson &#38; Johnson Plaza<br>New Brunswick, New Jersey 08933, USA<br>For the attention of&#58; Office of General Counsel</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27</font></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.768%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IDEXX Europe B.V.<br>Koolhovenlaan 20<br>1119 NE &#8212; Schiphol-Rijk<br>The Netherlands<br>For the attention of&#58; Director of European Finance and Administration</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With a copy to&#58;<br>IDEXX Laboratories, Inc.<br>One IDEXX Drive<br>Westbrook, Maine 04092, USA<br>For the attention of&#58; Office of General Counsel</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.02</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Any notice, payment or communication so given or made shall be deemed to have been received at the time when in the ordinary course of transmission the same should have reached its destination. Either party may change its address for the purpose of this Agreement by giving notice of such change to the other party pursuant to the provisions of this Section. For purposes of this Section&#160;29, notice given by OCD to IDEXX US under the US Agreement shall be deemed given to IDEXX.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:2.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.283%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">GUARANTY</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.768%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IDEXX Parent hereby guarantees to OCD the due performance and observance by IDEXX of all of the provisions of the Agreement to be performed and observed by it under this Agreement, for which IDEXX Parent shall be jointly and severally liable, without requiring any notice of non-payment, non-performance or non-observance, or proof of notice or demand, all of which IDEXX Parent hereby waives. OCD may proceed against IDEXX Parent separately or jointly, before, after or simultaneously with proceeding against IDEXX for default. This guaranty shall not be terminated, affected or impaired in any way by reason of (i)&#160;the assertion by OCD against IDEXX of any of the rights or remedies reserved to OCD under this Agreement, (ii)&#160;the commencement by OCD of any proceedings against IDEXX, (iii)&#160;the granting by OCD of any extensions of time or indulgence to IDEXX, (iv)&#160;any change in or amendment to this Agreement, or (v)&#160;any payment or performance being invalid in connection with any bankruptcy, insolvency, reorganization or similar proceedings in respect to IDEXX. This guaranty is absolute and unconditional and shall continue in full force and effect as to any renewal, extension, amendment, addition, assignment or transfer or other modification of this Agreement, whether or not IDEXX Parent shall have been notified of or consented to any such action, and regardless of bankruptcy or insolvency of IDEXX or the actual or purported rejection by a trustee in such bankruptcy of this Agreement or any limitation on any claim in such bankruptcy for damages resulting from the actual or purported termination of this Agreement</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28</font></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:1.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.712%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">or the enforceability in such bankruptcy of this Agreement. IDEXX Parent hereby agrees that this guaranty shall continue to be effective or shall be reinstated, as the case may be, if at any time payment of any sum hereby guaranteed is rescinded or must be otherwise restored or returned by OCD upon the insolvency, bankruptcy or reorganization of IDEXX, or otherwise, all as though such payment had not been made.</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">IN WITNESS WHEREOF</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;and intending to be legally bound, the parties hereto have caused this Agreement to be duly executed in duplicate by their respective authorized representatives the day and year first written above.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.944%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.284%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.105%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.105%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.692%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ORTHO-CLINICAL<br>DIAGNOSTICS, INC.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IDEXX EUROPE B.V.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;Tony Zezzo</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;Conan R. Deady</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"><div><img alt="image_22.jpg" src="image_22.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"><div><img alt="image_35.jpg" src="image_35.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tony Zezzo,</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conan R. Deady,</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President and General Manager,</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solely as to Sections&#160;17 and 30<br>IDEXX LABORATORIES, INC.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;Jonathan W. Ayers</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"><div><img alt="image_35.jpg" src="image_35.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jonathan W. Ayers,</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29</font></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Schedule&#160;1 &#8211; VetTest&#174; Slide Quality Assurance Procedures</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">VETTEST Slides for the VETTEST Analyzer</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Introduction</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following procedure constitutes a generic overview of the quality assurance provisions for finishing of VITROS slides and applies in like manner to product release for the VETTEST slides.</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">VETTEST Slide Quality Assurance</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VETTEST slides will be produced to the same quality standards as VITROS and DT 60 slides for OCD&#8217;s human market unless otherwise agreed to by IDEXX.</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Bar Coding</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bar code printing on the VETTEST slides will render the VETTEST slides incompatible with use in VITROS analyzers. OCD will reserve certain number sequences for generation of the bar code patterns on the VETTEST slides.</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">New Slides</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specifications to be determined by IDEXX US as part of the Development Program contemplated in the US Agreement and, together with quality assurance procedures, reasonably agreed in writing by OCD and IDEXX US for purposes of this&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;1</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30</font></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Schedule&#160;2</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Section&#160;1.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Obligation to Keep Information Confidential</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Each party agrees to hold, and to cause its respective officers, directors, employees, accountants, counsel, consultants, advisors and agents to hold, in confidence the terms of the Agreements, and all documents and information concerning the other party, whether oral or written, furnished or made known to such party in connection with either of the Agreements or any project or discussion under, or related to, either of the Agreements&#59;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">provided&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">that no party shall be required to keep any information confidential (i)&#160;if such party is compelled to disclose such information by judicial or administrative process or by other requirements of law (including without limitation the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended) and such party has provided prior written notice to the other party and given such other party reasonable opportunity to contest disclosure or (ii)&#160;to the extent such information can be shown to have been (A)&#160;previously known to such party on a nonconfidential basis, (B)&#160;in the public domain through no fault of such party, (C)&#160;later lawfully acquired from a third party source or (D)&#160;independently developed by such party without reference to confidential information. The foregoing notwithstanding, any party may disclose information concerning the other party or the Agreements to its and its affiliates&#8217; officers, directors, employees, accountants, counsel, consultants, advisors and agents in connection with its performance of this Agreement so long as such persons are informed by such party of the confidential nature of such information and are directed by such party to treat such information confidentially, it being understood and agreed that such party shall be responsible for any failure to treat such information confidentially by such persons. The obligation of each party to hold any information in confidence shall be satisfied if it exercises the same care with respect to such information as it would to preserve the confidentiality of its own similar information. The confidentiality provisions of this&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;2</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;shall remain in effect for so long as this Agreement is in effect and for a period of three (3)&#160;years thereafter.</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Section&#160;2.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Public Announcements</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. No party to this Agreement shall originate any news release or other public announcement, written or oral, relating to this Agreement or the US Agreement, without the prior written consent of the other party, except to the extent such news release or other public announcement is required by law&#59; provided that in the event an announcement is required by law, the party issuing same shall still be required to use its commercially reasonable efforts to consult with the other party or parties named or referred to in such announcement prior to its release as the circumstances reasonably permit, in order to allow such other party or parties to comment on the use of their names or the references to them and, after its release, shall provide such other party or parties with a copy thereof. If a party has previously reviewed and approved a public announcement, its further approval shall not be required with respect to those provisions of subsequent announcements that are substantially similar in scope and substance to provisions that have been previously approved. In no event shall IDEXX or IDEXX Parent use the name &#8220;Johnson &#38; Johnson&#8221; or &#8220;J&#38;J&#8221; in any publicity relating to this Agreement or the US Agreement, whether written or oral, other than to state that OCD is &#8220;a Johnson &#38; Johnson company&#8221; or a (wholly-owned) subsidiary of Johnson &#38; Johnson.</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31</font></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Section&#160;3.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Governing Law</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. The construction, validity and performance of this&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;2</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;shall be governed in all respects by the laws of the State of New York, USA.</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Section&#160;4.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Notices</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Any notices required to be given under this Schedule 2 shall be given in the manner specified by&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;29</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;of the Agreement.</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32</font></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Schedule&#160;3 - Panels&#47;Profiles</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br>(Applicable only to VETTEST Analyzer)</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The initial PANEL shall be the &#8220;Pre-Anesthetic Panel&#8221; consisting of four sets of the following six VETTEST slides&#58;</font></div><div style="padding-left:0.07pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:13.915%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.774%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BUN</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urea Nitrogen</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ALT</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alanine aminotransferase</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GLU</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Glucose</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TP</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total protein</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CREA</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Creatinine</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ALKP</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alkaline phosphatase</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;The initial PROFILES shall be the &#8220;General Health Profile&#8221; and the &#8220;Large Animal Profile&#8221;, each consisting of two sets of 12 VETTEST slides as follows&#58;</font></div><div style="padding-left:0.04pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.505%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.498%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.046%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.808%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">General Health Profile</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Large Animal Profile</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ALB</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Albumin</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ALB</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Albumin</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ALKP</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alkaline phosphatase</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ALKP</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alkaline phosphatase</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ALT(SGPT)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alanine aminotransferase</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AST</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AST</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AMYL</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amylase</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ca</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2+</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Calcium</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ca</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2+</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Calcium</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CK</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CK</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHOL</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cholesterol</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GGT</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gamma GT</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CREA</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Creatinine</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GLU</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Glucose</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GLU</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Glucose</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PHOS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inorganic phosphate</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PHOS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inorganic phosphate</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LDH</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LDH</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TBIL</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total bilirubin</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MG</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Magnesium</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TP</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total protein</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TP</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Protein</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BUN</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urea Nitrogen</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BUN</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urea Nitrogen</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Packaging for the Pre-Anesthetic Panels, the General Health Profiles and the Large Animal Profiles for the VETTEST Analyzer has been previously agreed upon by the parties, and any changes to the slide composition or packaging of the initial PANEL or the initial PROFILES shall be negotiated in good faith and mutually agreed upon by OCD and IDEXX. The slide composition, packaging and initial pricing of any additional PANELS&#47;PROFILES shall be mutually agreed upon by OCD and IDEXX. Unless otherwise agreed by the parties in writing with respect to one or more specific PANELS or PROFILES, all purchases by IDEXX or IDEXX US of VETTEST slides packaged as PANELS&#47;PROFILES shall be credited against the Annual Purchase Forecasts and Purchase Commitments for such slides under this Agreement and the US Agreement.</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Slide&#47;Panel Design for the New Analyzer shall be as developed by IDEXX US under Article&#160;3 of the US Agreement.</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font><br></font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33</font></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Schedule&#160;4 - Purchase Commitments</font></div><div style="padding-left:105.32pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:55.288%"><tr><td style="width:1.0%"></td><td style="width:35.421%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.349%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.930%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Minimum Slide Purchase</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commitment ( &#91;**&#93; )</font></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><img alt="image_52.jpg" src="image_52.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><img alt="image_62.jpg" src="image_62.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2003</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2004</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2005</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2006</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2007</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2008</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2009</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2010</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Schedule&#160;5 - Products and Prices<br>(as of the Commencement Date)</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer No.&#58; 314 8251</font></div><div style="padding-left:0.05pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.237%"><tr><td style="width:1.0%"></td><td style="width:48.655%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.978%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.035%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.035%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.978%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.914%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.446%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.060%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Single Slides (Box of 25)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Catalog Number</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Territory Pricing</font></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><img alt="image_102.jpg" src="image_102.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_112.jpg" src="image_112.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_92.jpg" src="image_92.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Albumin</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">822 7134</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alk Phos</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">831 5459</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ALT</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">808 3750</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ammonia</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181 6842</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amylase</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">820 8191</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AST</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">811 3979</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Calcium</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">804 8191</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cholesterol</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">835 4888</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CK</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">835 8582</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Creatinine</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">818 3477</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ECO2</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853 8670</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gamma GT</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">826 1315</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Glucose</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">813 0536</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LDH</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">835 1082</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lipase</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196 6191</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Magnesium</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108 0266</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phosphorus</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">807 0856</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Bilirubin</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838 0396</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Protein</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193 7093</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Triglycerides</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192 2285</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urea Nitrogen</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150 7326</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uric Acid</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 0793</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="padding-left:0.05pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.182%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.906%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.944%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.874%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.874%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.906%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.916%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Profile Slides (Box of 24)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Catalog Number</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Territory Pricing</font></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><img alt="image_102.jpg" src="image_102.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_112.jpg" src="image_112.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_92.jpg" src="image_92.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General Health Profile</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160 7175</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-Anesthetic Panel</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">801 5109</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Large Animal Profile</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680 0071</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="padding-left:0.04pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.906%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.944%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.597%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Catalog Number</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">WW Pricing</font></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><img alt="image_133.jpg" src="image_133.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_142.jpg" src="image_142.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_152.jpg" src="image_152.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vetrols</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">869 9852</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tips</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175 7384</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35</font></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Schedule&#160;6 &#8211; Minimum Prices for New Chemistries</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36</font></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Schedule&#160;7 - Illustrative Rebate Calculations</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Estimated Rebate Payments will be calculated for each of the first three calendar quarters using the Effective Rebate Rate, as described more fully in sub-clause 7.03 of the Agreement. Any required adjustments will be made at the end of the fourth calendar quarter, in accordance with sub-clause 7.03 of the Agreement.</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Example</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#58; The aggregate Annual Purchase Forecast for IDEXX and IDEXX US in a given year is &#91;**&#93; slides&#59; pricing is $&#91;**&#93;&#47;slide&#59; blended rebate percentage rate is &#91;**&#93;%, as follows&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:1.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.712%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93; slides * &#91;**&#93;% &#61; &#91;**&#93; slides<br>&#91;**&#93; slides * &#91;**&#93;% &#61; &#91;**&#93; slides<br>&#91;**&#93; slides * &#91;**&#93;% &#61; &#91;**&#93; slides<br>&#91;**&#93; slides * &#91;**&#93;% &#61; &#91;**&#93; slides<br>&#91;**&#93; slides * &#91;**&#93;% &#61; &#91;**&#93; slides<br>Total Slides Eligible for Rebate &#61; &#91;**&#93; slides</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Effective Rebate &#61; Total slides eligible for rebate &#47; total purchases &#61; &#91;**&#93; &#61; &#91;**&#93;%<br><br></font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Actual aggregate volume purchased by IDEXX and IDEXX US equals volume projected at the beginning of the year</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">.</font></div><div style="padding-left:0.19pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.073%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.265%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.906%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.867%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.867%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.105%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.348%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.553%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.921%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.239%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.348%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.867%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.921%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.560%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.451%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Actual Qtrly.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Calculated</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#91;**&#93;%</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Vol.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Purchases</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Effective Rebate</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Rebate Each Qtr.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Holdback</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Rebate Paid</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(&#91;**&#93;)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">($&#91;**&#93;)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">% &#91;**&#93; Vol.)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(&#91;**&#93;)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(&#91;**&#93;)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(&#91;**&#93;)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_32.jpg" src="image_32.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_25.jpg" src="image_25.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_34.jpg" src="image_34.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_211.jpg" src="image_211.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_25.jpg" src="image_25.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_211.jpg" src="image_211.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1st Qtr</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2nd Qtr</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3rd Qtr</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4th Qtr</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">True-up&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total&#58;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"><div><img alt="image_38.jpg" src="image_38.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"><div><img alt="image_38.jpg" src="image_38.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Actual aggregate volume purchased by IDEXX and IDEXX US is greater than volume projected at the beginning of the year</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">.</font></div><div style="padding-left:0.19pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.714%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.746%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.547%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.874%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.921%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.201%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.387%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.921%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.278%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.449%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10.37pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10.37pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Actual Qtrly.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Calculated</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#91;**&#93;%</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10.37pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Vol.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Purchases</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Effective Rebate</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Rebate Each Qtr.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Holdback</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Rebate Paid</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10.37pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(&#91;**&#93;)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">($&#91;**&#93;)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">% 9&#91;**&#93; Vol.)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(&#91;**&#93;)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(&#91;**&#93;)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(&#91;**&#93;)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10.37pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_32.jpg" src="image_32.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_25.jpg" src="image_25.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_34.jpg" src="image_34.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_211.jpg" src="image_211.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_25.jpg" src="image_25.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_211.jpg" src="image_211.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1st Qtr</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2nd Qtr</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3rd Qtr</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4th Qtr</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">True-up&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total&#58;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"><div><img alt="image_38.jpg" src="image_38.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"><div><img alt="image_38.jpg" src="image_38.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Actual aggregate volume purchased by IDEXX and IDEXX US is lower than volume projected at the beginning of the year</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">.</font></div><div style="padding-left:0.19pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.996%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.944%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.867%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.585%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.944%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.387%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.921%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.348%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.951%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.921%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.996%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.452%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Actual Qtrly.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Calculated</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#91;**&#93;%</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Vol.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Purchases</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Effective Rebate</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Rebate Each Qtr.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Holdback</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Rebate Paid</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(&#91;**&#93;)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">($&#91;**&#93;)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">% &#91;**&#93; Vol.)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(&#91;**&#93;)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(&#91;**&#93;)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(&#91;**&#93;)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_32.jpg" src="image_32.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_25.jpg" src="image_25.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_34.jpg" src="image_34.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_211.jpg" src="image_211.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_25.jpg" src="image_25.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_211.jpg" src="image_211.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1st Qtr</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2nd Qtr</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3rd Qtr</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4th Qtr</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">True-up&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total&#58;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"><div><img alt="image_38.jpg" src="image_38.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"><div><img alt="image_38.jpg" src="image_38.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Calculation of IDEXX&#8217;s Proportionate Share of rebate (assuming Actual aggregate volume purchased by IDEXX and IDEXX US equals volume projected at the beginning of the year)</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Assumptions</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.740%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of slides purchased by IDEXX&#58; &#91;**&#93; slides</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total number of slides purchase by IDEXX and its affiliates&#58; &#91;**&#93; slides</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total rebate earned&#58; $&#91;**&#93;</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Calculation</font><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IDEXX&#8217;s rebate equals&#58; &#91;**&#93; slides &#47; &#91;**&#93; slides * $&#91;**&#93;, or $&#91;**&#93;.</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Schedule&#160;8 &#8211; Eligible New Chemistry Slides</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Schedule&#160;9 &#8211; Example of Cost Adjustment Calculations</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Assumes PPI &#61; &#91;**&#93;%)</font></div><div style="padding-left:0.44pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.203%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.242%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.547%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.242%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.203%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.203%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.265%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.867%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.105%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.746%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.203%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.105%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.105%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.364%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.746%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.707%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.364%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.547%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.377%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Scenario 1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Scenario 2</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="33" style="padding:0 1pt"><div><img alt="image_40.jpg" src="image_40.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="33" style="padding:0 1pt"><div><img alt="image_411.jpg" src="image_411.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">% of OCD&#8217;s</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Year 1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">% Change</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Year 2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$ Change</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">% Change</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Year 2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$ Change</font></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Costs</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Usage</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Cost</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">In Cost</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Cost</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">in Cost</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">in Cost</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Cost</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">in Cost</font></td></tr><tr><td colspan="15" style="padding:0 1pt"><div><img alt="image_42.jpg" src="image_42.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_43.jpg" src="image_43.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_45.jpg" src="image_45.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_45.jpg" src="image_45.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_45.jpg" src="image_45.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_47.jpg" src="image_47.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_45.jpg" src="image_45.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_45.jpg" src="image_45.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"><div><img alt="image_45.jpg" src="image_45.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total (x&#91;**&#93;)</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Scenario 1 Conclusion&#58; &#91;**&#93;Cost Adjustment Required (Other Costs Increased by &#60; &#91;**&#93;% over PPI)</font></div><div style="padding-left:105.32pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:55.448%"><tr><td style="width:1.0%"></td><td style="width:81.847%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.657%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.836%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.659%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Adjustment Calculation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#91;**&#93;&#58;</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual &#91;**&#93;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less&#58; PPI Change (&#91;**&#93;% of $&#91;**&#93;)</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Adjustment</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Scenario 2 Conclusion&#58; &#91;**&#93; Costs Adjustments Required</font></div><div style="padding-left:81.92pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:65.064%"><tr><td style="width:0.1%"></td><td style="width:0.785%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:70.574%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.785%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.545%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.787%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 10.37pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Adjustment Calculation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#91;**&#93;</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10.37pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Same as above</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 10.37pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Adjustment for</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#91;**&#93;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Costs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58;</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10.37pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual Cost Change</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 10.37pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less&#58; &#8220;PPI Plus &#91;**&#93;%&#8221; Change (&#91;**&#93;% *$&#91;**&#93;)</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10.37pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustment</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 10.37pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Adjustment</font></div></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9.37pt;text-indent:-7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"><div><img alt="image_511.jpg" src="image_511.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">* - &#91;**&#93; Costs - &#91;**&#93; $&#91;**&#93;, or $&#91;**&#93;&#47;slide &#64; &#91;**&#93; slides</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40</font></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Schedule&#160;10 &#8211; Additional Countries in the Territory</font></div><div style="padding-left:105.35pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:55.288%"><tr><td style="width:1.0%"></td><td style="width:51.653%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.117%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.930%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Albania</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liechtenstein</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Andorra</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lithuania</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Armenia</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Macedonia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Azerbaijan</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Malta</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bahrain</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Monaco</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Belarus</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Norway</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bosnia and Herzegovina</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oman</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bulgaria</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pakistan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Croatia</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Poland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cyprus</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Qatar</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Czech Republic</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Romania</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estonia</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Russia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Faroes Islands</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">San Marino</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Georgia</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Saudi Arabia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hungary</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Slovakia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Iceland</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Slovenia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Iran</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Switzerland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Iraq</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Syria</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tajikistan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jordan</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Turkey</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kazakhstan</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Turkmenistan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kuwait</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ukraine</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kyrgyzstan</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Arab Emirates</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latvia</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uzbekistan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lebanon</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yemen</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;*&#93; and &#91;**&#93; text omitted throughout this exhibit for confidential treatment. The redacted information has been excluded because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.11
<SEQUENCE>8
<FILENAME>exhibit1011-orthorowagreem.htm
<DESCRIPTION>EX-10.11
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i832ca41c2ac84f9fb94399357c949dd2_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY ASTERISKS, HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED.</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 10.11</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AMENDMENT NO. 1 TO<br>AGREEMENT</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">THIS AMENDMENT NO. 1 TO AGREEMENT (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) is made effective as of the 1st&#160;day of January, 2005, between IDEXX Europe B.V., a corporation organized under the laws of The Netherlands whose principal place of business is at Koolhovenlaan 20, 1119 NE &#8212; Schiphol-Rijk, The Netherlands (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">IDEXX</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), and Ortho-Clinical Diagnostics, Inc., a New York corporation with offices at 100 Indigo Creek Drive, Rochester, New York, U.S.A.&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(&#8220;OCD</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">WHEREAS, OCD and IDEXX entered into a certain Agreement dated as of October&#160;17, 2003 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) regarding supply by OCD of dry slides for IDEXX veterinary chemistry analyzers&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">WHEREAS, OCD and IDEXX desire to amend the Agreement as set forth in this Amendment.</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NOW THEREFORE, the parties hereby agree as follows&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160; Capitalized terms used in this Amendment, which are not otherwise defined, have the respective meanings ascribed to them in the Agreement.</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160; Section 18.01 is amended by deleting the same in its entirety and substituting therefor the following provision&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.980%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.820%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subject to the terms and conditions set forth herein, the term (the &#8220;Term&#8221;) of the Agreement shall be the period from the Commencement Date until December 31, 2020</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">.</font></div></td></tr></table></div><div><font style="color:#000000;font-family:'Times',sans-serif;font-size:13.5pt;font-weight:400;line-height:100%"><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">,&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">,&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;and&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;to the Agreement are amended by deleting the same in their entirety and substituting therefor the respective&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">,&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">,&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;and&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;8&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">attached to this Amendment.</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.&#160;&#160;&#160;&#160; The price for Vetrol controls (Catalog No. 8699852) supplied hereunder shall be $&#91;**&#93; and the price for tips (Catalog No. 6801762) supplied hereunder shall be $&#91;**&#93;.</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.&#160;&#160;&#160;&#160; The per slide prices for single VETTEST slides that are packaged 12 per box shall be the same as the per slide prices of the corresponding single VETTEST slides that are packaged 25 per box.</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.&#160;&#160;&#160;&#160; Except as modified by this Amendment, all provisions of the Agreement shall continue in full force and effect.</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF and intending to be legally bound, the parties hereto have caused this Amendment to be duly executed in duplicate by their respective authorized representatives as of the day and year first written above.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"></td><td style="width:38.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ORTHO-CLINICAL<br>DIAGNOSTICS, INC.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">IDEXX EUROPE B.V.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58; &#47;s&#47;Tony Zezzo</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58; &#47;s&#47;Conan R. Deady</font></td></tr><tr style="height:10pt"><td colspan="3" style="padding:0 1pt"><div style="text-align:right"><img alt="image_21.jpg" src="image_21.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div style="text-align:right"><img alt="image_81.jpg" src="image_81.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58; Tony Zezzo</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58; Conan R. Deady</font></td></tr><tr style="height:10pt"><td colspan="3" style="padding:0 1pt"><div style="text-align:right"><img alt="image_21.jpg" src="image_21.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div style="text-align:right"><img alt="image_81.jpg" src="image_81.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58; VP Americas</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58; Director</font></td></tr><tr style="height:10pt"><td colspan="3" style="padding:0 1pt"><div style="text-align:right"><img alt="image_21.jpg" src="image_21.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div style="text-align:right"><img alt="image_81.jpg" src="image_81.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acknowledged and consented to,</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">solely as guarantor pursuant to</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 30 of the Agreement</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">IDEXX LABORATORIES, INC.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58; &#47;s&#47;Conan R. Deady</font></td></tr><tr style="height:10pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div style="text-align:right"><img alt="image_81.jpg" src="image_81.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58; Conan R. Deady</font></td></tr><tr style="height:10pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div style="text-align:right"><img alt="image_81.jpg" src="image_81.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58; Vice President</font></td></tr><tr style="height:10pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div style="text-align:right"><img alt="image_81.jpg" src="image_81.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Schedule 3 &#8212; Panels&#47;Profiles</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br>(Applicable only to VETTEST Analyzer)</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The initial PANEL shall be the &#8220;Pre-Anesthetic Panel&#8221; consisting of four sets of the following six VETTEST slides&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"></td><td style="width:28.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:68.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BUN</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urea Nitrogen</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ALT</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alanine aminotransferase</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GLU</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Glucose</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TP</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total protein</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CREA</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Creatinine</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ALKP</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alkaline phosphatase</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font style="color:#000000;font-family:'Times',sans-serif;font-size:13.5pt;font-weight:400;line-height:100%"><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The initial PROFILES shall be the &#8220;General Health Profile&#8221; and the &#8220;Large Animal Profile&#8221;, each consisting of two sets of 12 VETTEST slides as follows&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">General Health Profile</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Large Animal Profile</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ALB</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Albumin</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ALB</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Albumin</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ALKP</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alkaline phosphatase</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ALKP</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alkaline phosphatase</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ALT(SGPT)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alanine aminotransferase</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AST</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AST</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AMYL</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amylase</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ca</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2+</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Calcium</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ca</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2+</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Calcium</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CK</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CK</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHOL</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cholesterol</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GGT</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gamma GT</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CREA</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Creatinine</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GLU</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Glucose</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GLU</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Glucose</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PHOS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inorganic phosphate</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PHOS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inorganic phosphate</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LDH</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LDH</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TBIL</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total bilirubin</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MG</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Magnesium</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TP</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total protein</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TP</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Protein</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BUN</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urea Nitrogen</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BUN</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urea Nitrogen</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective as of March 4, 2004, &#8220;PROFILES&#8221; shall also include the &#8220;Equine Health Profile,&#8221; consisting of two sets of 12 VETTEST slides as follows&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"></td><td style="width:28.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:68.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ALB</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Albumin</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ALKP</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alkaline phosphatase</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AST</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AST</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ca</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2+</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Calcium</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CK</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CK</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GGT</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gamma GT</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GLU</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Glucose</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LDH</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LDH</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TP</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total protein</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BUN</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urea Nitrogen</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CREA</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Creatinine</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TBIL</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Bilirubin</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times',sans-serif;font-size:13.5pt;font-weight:400;line-height:100%"><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective as of May 25, 2004, &#8220;PROFILES&#8221; shall also include the &#8220;Urine P&#58;C Ratio&#8221; (OCD cat #6802061), consisting of six pairs of Urine Protein and Creatinine VETTEST slides.</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective as of June 1, 2005, &#8220;PANELS&#8221; shall also include the &#8220;&#91;**&#93;&#8221; (IDEXX part #98-13952-00, OCD cat #6802213), consisting of four sets of the following &#91;**&#93; VETTEST slides&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"></td><td style="width:28.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:68.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times',sans-serif;font-size:13.5pt;font-weight:400;line-height:100%"><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Packaging for the Pre-Anesthetic Panels, the General Health Profiles, the Large Animal Profiles, the Equine Health Profiles, the Urine P&#58;C Ratios and the &#91;**&#93; for the VETTEST Analyzer has been previously agreed upon by the parties, and any changes to the slide composition or packaging of the foregoing PANELS or PROFILES shall be negotiated in good faith and mutually agreed upon by OCD and IDEXX. The slide composition, packaging and initial pricing of any additional PANELS&#47;PROFILES shall be mutually agreed upon by OCD and IDEXX. Unless otherwise agreed by the parties in writing with respect to one or more specific PANELS or PROFILES, all purchases by IDEXX or IDEXX US of VETTEST slides packaged as PANELS&#47;PROFILES shall be credited against the Annual Purchase Forecasts and Purchase Commitments for such slides under this Agreement and the US Agreement.</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Slide&#47;Panel Design for the New Analyzer shall be as developed by IDEXX US under Article 3 of the US Agreement.</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Schedule 5 - Products</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(as of January 1, 2005)</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"></td><td style="width:24.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Single Slides<br>(Box of 25)</font></div><div><img alt="image_141.jpg" src="image_141.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:592px"></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Catalog Number</font></div><div><img alt="image_121.jpg" src="image_121.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:592px"></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Single Slides<br>(Box of 12)<br>(added Dec 11, 2003)</font></div><div><img alt="image_141.jpg" src="image_141.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:592px"></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Catalog Number</font></div><div><img alt="image_121.jpg" src="image_121.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:592px"></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Albumin</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">822 7134</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Albumin</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6801907</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alk Phos</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">831 5459</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alk Phos</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6801919</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ALT</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">808 3750</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ALT</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6801916</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ammonia</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181 6842</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ammonia</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6801908</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amylase</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">820 8191</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amylase</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6801913</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AST</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">811 3979</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AST</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6801914</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Calcium</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">804 8191</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Calcium</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6801902</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cholesterol</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">835 4888</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cholesterol</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6801906</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CK</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">835 8582</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CK</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6801918</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Creatinine</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">818 3477</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Creatinine</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6801911</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ECO2 (HCO3)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853 8670</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ECO2 (HCO3)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6802306</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gamma GT</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">826 1315</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gamma GT</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6801920</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Glucose</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">813 0536</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Glucose</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6801900</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LDH</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">835 1082</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LDH</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6801917</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lipase</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196 6191</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lipase</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6801915</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Magnesium</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108 0266</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Magnesium</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6801912</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phosphorus</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">807 0856</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phosphorus</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6801909</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Bilirubin</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838 0396</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Bilirubin</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6801910</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Protein</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193 7093</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Protein</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6801904</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Triglycerides</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192 2285</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Triglycerides</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6801905</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urea Nitrogen</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150 7326</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urea Nitrogen</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6801901</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uric Acid</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 0793</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uric Acid</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6801903</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93; (added as of July 1, 2005)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6802307</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"></td><td style="width:24.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Profile Slides<br>(Box of 24)</font></div><div><img alt="image_141.jpg" src="image_141.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:592px"></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Profile Slides<br>(Box of 12)</font></div><div><img alt="image_141.jpg" src="image_141.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:592px"></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General Health Profile</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160 7175</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urine P&#59;C Ratio (added May 25, 2004)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6802061</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-Anesthetic Panel</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">801 5109</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Large Animal Profile</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680 0071</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equine Health Panel (added Mar 4, 2004)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680 1956</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93; (added as of June 1, 2005)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680 2213</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"></td><td style="width:24.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</font></div><div><img alt="image_141.jpg" src="image_141.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:592px"></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vetrols</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">869 9852</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tips</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6801762</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times',sans-serif;font-size:13.5pt;font-weight:400;line-height:100%"><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Schedule 6 &#8211; Minimum Prices for New Chemistries</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urine Protein (added May 25, 2004 as part of the Urine P&#58;C Ratio)&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.963%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.726%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prices for 2005 and thereafter shall be determined based on volume tiers pursuant to Section 7.02(b), subject to a minimum price for this New Chemistry of $&#91;**&#93; per slide.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times',sans-serif;font-size:13.5pt;font-weight:400;line-height:100%"><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;&#160;&#160;&#160;&#160; (added as of July 1, 2005)&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.963%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.726%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prices for 2005 and thereafter shall be determined based on volume tiers pursuant to Section 7.02(b), subject to a minimum price for this New Chemistry of $&#91;**&#93; per slide.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times',sans-serif;font-size:13.5pt;font-weight:400;line-height:100%"><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Schedule 8 &#8211; Eligible New Chemistry Slides</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"></td><td style="width:28.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:68.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;*&#93; and &#91;**&#93; text omitted throughout this exhibit for confidential treatment. The redacted information has been excluded because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.13
<SEQUENCE>9
<FILENAME>exhibit1013-orthorowagreem.htm
<DESCRIPTION>EX-10.13
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ibd4fee9eb99445a8ad2b2655df001984_1"></div><div style="min-height:23.76pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.45pt"><font><br></font></div><div><font><br></font></div><div style="margin-top:0.4pt"><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY ASTERISKS, HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED.</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 10.13</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:231.1pt;padding-right:231.1pt;text-align:center"><font><br></font></div><div style="padding-left:231.1pt;padding-right:231.1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AMENDMENT NO. 3 TO AGREEMENT</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:13pt;padding-right:13.9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AMENDMENT, effective as of December 28, 2011 (this &#8220;Amendment&#8221;) to the Agreement, dated as of October 17, 2003, between IDEXX Europe B.V. (&#8220;IDEXX&#8221;) and Ortho-Clinical Diagnostics, Inc. (&#8220;OCD&#8221;).</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:13pt;padding-right:13.9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WHEREAS, OCD and IDEXX have entered into that certain Agreement dated as of October 17, 2003, as amended by Amendment No. 1 thereto effective January 1, 2005 and by Amendment No. 2 thereto effective January 18, 2008 (as so amended, the &#8220;Ag</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">reement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), regarding supply by OCD of dry slides for IDEXX veterinary chemistry analyzers&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:13pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">WHEREAS, the parties wish to resolve a dispute under the Agreement as more fully described herein&#59; and</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:13pt;padding-right:29.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WHEREAS, IDEXX and OCD wish to amend certain terms of the Agreement and the US Agreement to reflect the foregoing resolution&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:13pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NOW, THEREFORE, the parties agree as follows&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:31pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:10.5pt;text-decoration:underline"> DEFINITIONS</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:31pt;padding-right:29.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In this Amendment, terms capitalized but not defined herein shall have the meanings set forth in the Agreement. The following expressions shall have the meanings set forth opposite them&#58;</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:166.1pt;padding-right:15.8pt;text-indent:-135.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:113%">&#8220;Dispute&#8221;&#160;&#160;&#160;&#160;The dispute between IDEXX and OCD regarding the number of Existing Special &#91;**&#93; Slides that are counted toward Dry Slide volume.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:30.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;Difference&#8221;&#160;&#160;&#160;&#160;The dollar amount arrived at by &#91;**&#93;.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:31pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:10.5pt;text-decoration:underline"> SETTLEMENT</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:31pt;padding-right:14.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The parties acknowledge and agree that the covenants and agreements set forth herein represent a compromise and resolution of the Dispute. In consideration of entering into this Amendment and the corresponding amendment of the US Agreement, each party hereby waives and releases any claims such party has, had or may in the future have against any other party regarding the Dispute.</font></div><div><font><br></font></div><div style="padding-left:31pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:10.5pt;text-decoration:underline"> PAYMENTS</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:85.05pt;padding-right:52.4pt;text-indent:-54.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:41.55pt">IDEXX and IDEXX US collectively shall make the payment described in Section 3.01 of the corresponding amendment of the US Agreement.</font></div><div style="margin-top:0.05pt;padding-left:85.05pt;padding-right:53.1pt;text-indent:-54.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:41.55pt">(a) For calendar years 2011 and 2012, OCD will price the Dry Slides in accordance with Section 7.02 of the Agreement, interpreting such Section 7.02 such that &#91;**&#93;.</font></div><div style="margin-top:0.05pt;padding-left:85.05pt;padding-right:16.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.29pt">No later than January 31, 2012, representatives from the respective finance departments of IDEXX and OCD will meet to discuss and come to agreement on the Difference.</font></div><div style="margin-top:0.05pt;padding-left:85.05pt;padding-right:23.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.86pt">IDEXX and IDEXX US collectively shall make the payments described in Section 3.02(c) of the corresponding amendment of the US Agreement.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:31pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:10.5pt;text-decoration:underline"> AMENDMENTS</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:31pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The parties hereto agree that the Agreement shall be amended as follows&#58;</font></div><div style="margin-top:0.5pt;padding-left:67.05pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.55pt">Effective January 1, 2013 Section 7.02(a) is hereby replaced in its entirety with the following&#58;</font></div><div style="margin-top:0.5pt;padding-left:67.05pt;padding-right:12.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.02(a) The prices for Dry Slides shall be in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Schedule 5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. At a given volume of aggregate slide purchases by IDEXX and IDEXX US in a given calendar year, the corresponding pricing in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Schedule 5 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">applies to the total aggregate volume of slides purchased in such calendar year by IDEXX and IDEXX US. Effective January 1, 2013, no &#91;**&#93; will apply. In the event of an automatic extension of the Term pursuant to Section 18.02, pricing for calendar years after 2028 shall be increased yearly by &#91;**&#93;% over the prior year.&#8221;</font></div><div style="margin-top:0.05pt;padding-left:67.05pt;padding-right:84.25pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.55pt">Effective January 1, 2013, all text in Section 7.02(b) preceding the paragraph that begins with the phrase &#8220;Notwithstanding the foregoing&#8221; is hereby deleted.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="height:23.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:23.76pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:67.05pt;padding-right:14.75pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.55pt">Effective January 1, 2013, the paragraph beginning with the phrase &#8220;Notwithstanding the foregoing&#8221; in Section 7.02(b) of the Agreement is hereby amended to read in its entirety as follows&#58;</font></div><div style="margin-top:0.05pt;padding-left:67.05pt;padding-right:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;The price per slide for any New Chemistry Slide that is priced on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Schedule 6 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shall never be lower than the greater of (a) the minimum price as determined in accordance with Section 5.06 and identified on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Schedule 6 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as amended from time to time and (b) the price that would otherwise apply pursuant to Schedule 5.&#8221;</font></div><div style="margin-top:0.05pt;padding-left:67.05pt;padding-right:17.35pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.55pt">Effective January 1, 2013, in Section 7.02(b), each instance of the words &#8220;weighted average price&#8221; are hereby changed to &#8220;price&#8221;.</font></div><div style="margin-top:0.05pt;padding-left:67.05pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.55pt">Effective January 1, 2013, the definition &#8220;First Estimated Blended Price&#8221; is hereby changed to &#8220;First Estimated Price&#8221;.</font></div><div style="margin-top:0.5pt;padding-left:67.05pt;padding-right:35.35pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.55pt">Effective January 1, 2013, the definition &#8220;Second Estimated Blended Price&#8221; is hereby changed to &#8220;Second Estimated Price&#8221;.</font></div><div style="margin-top:0.05pt;padding-left:67.05pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.55pt">Effective January 1, 2013, the definition &#8220;Final Blended Price&#8221; is hereby changed to &#8220;Final Price&#8221;.</font></div><div style="margin-top:0.5pt;padding-left:67.05pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.55pt">Effective January 1, 2013, Section 7.02(c) is hereby deleted.</font></div><div style="padding-left:67.05pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.55pt">Effective January 1, 2013, Section 7.02(d) of the Agreement is hereby amended to read in its entirety as follows&#58;</font></div><div style="margin-top:0.5pt;padding-left:67.05pt;padding-right:11.95pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;(d) With respect to slides ordered for delivery on or after January 1, 2013, if OCD&#8217;s aggregate cost of all &#91;**&#93; (as defined below) for the most recently completed calendar year has increased on a per VETTEST slide basis as compared with aggregate cost of all &#91;**&#93; for the calendar year preceding the most recently completed calendar year, by an amount that exceeds the &#91;**&#93;% annual increase incorporated into </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Schedule 5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, then OCD shall be permitted to increase the price of each slide sold to IDEXX by the amount of such excess. &#8220;&#91;**&#93;&#8221; means &#91;**&#93; that are &#91;**&#93;. No later than January 31 of each calendar year during the Term (beginning in 2013), OCD shall provide to IDEXX a summary of all charges for &#91;**&#93; for  the previous calendar year and recurring charges that carry forward. IDEXX shall have the option to pay such charges in quarterly installments during the then-current calendar year or as a lump-sum payment no later than March 31 of each then-current calendar year.&#8221;</font></div><div style="padding-left:67.05pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:18.55pt">Effective January 1, 2013, Section 7.02(e) of the Agreement is hereby amended to read in its entirety as follows&#58;</font></div><div style="margin-top:0.5pt;padding-left:67.05pt;padding-right:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;(e) With respect to slides ordered for delivery on or after January 1, 2013, if IDEXX&#8217;s share of Special Event Costs (as defined below) for the most recently completed calendar year has increased on a per VETTEST slide basis as compared with IDEXX&#8217;s share of Special Event Costs for the calendar year preceding the most recently completed calendar year, by an amount that exceeds &#91;**&#93; above the &#91;**&#93;% annual increase incorporated into </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Schedule 5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, then OCD shall be permitted to increase the price of each slide sold to IDEXX by the amount of such excess. &#8220;Special Event Costs&#8221; means the aggregate net amount of (i) &#91;**&#93; with respect to &#91;**&#93; on which &#91;**&#93;, (ii) &#91;**&#93; in the &#91;**&#93;, and (iii) &#91;**&#93; as a result of &#91;**&#93;. &#8220;IDEXX&#8217;s share&#8221; of any of the foregoing shall mean the &#91;**&#93; that is attributable to the &#91;**&#93;. No later than January 31 of each calendar year during the Term (beginning in 2013), OCD shall provide to IDEXX a summary of all Special Events Costs for the previous calendar year. IDEXX shall have the option to pay such Special Events Costs in quarterly installments during the then-current calendar year or as a lump-sum payment no later than March 31 of each then-current calendar year.&#8221;</font></div><div style="padding-left:67.05pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:18.55pt">Section 18.01 of the Agreement is hereby amended by changing the year &#8220;2018&#8221; to the year &#8220;2028&#8221;.</font></div><div style="margin-top:0.5pt;padding-left:67.05pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:18.55pt">A new Section 18.02 is hereby added to read in its entirety as follows&#58;</font></div><div style="margin-top:0.5pt;padding-left:103.05pt;padding-right:12.85pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;18.02    This Agreement may be terminated by either party upon &#91;**&#93; written notice to the other party&#59; provided, however, that no such termination shall be effective prior to December 31, 2028. If neither party provides such written notice, the then-current term of this Agreement shall automatically be extended for an additional three (3) years, and no termination under this Section 18.02 shall be effective prior to the end of such additional term.</font></div><div style="margin-top:0.05pt;padding-left:103.05pt;padding-right:41.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within 60 days of either party providing such notice, the senior leaders of each of the parties shall meet to discuss the relationship of the parties.&#8221;</font></div><div style="margin-top:0.05pt;padding-left:67.05pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:18.55pt">Effective January 1, 2013, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 5 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">is hereby replaced in its entirety by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 5 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">attached hereto.</font></div><div style="padding-left:67.05pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:18.55pt">Effective January 1, 2013, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 9 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">is hereby deleted.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:31pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:10.5pt">All remaining terms and conditions of the Agreement remain in full force and effect.</font></div><div><font><br></font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:184.9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">The remainder of this page intentionally left blank</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="height:23.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:23.76pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:13pt;padding-right:30pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"> IN WITNESS WHEREOF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and intending to be legally bound, the parties hereto have caused this Agreement to be duly executed in duplicate by their respective authorized representatives the day and year first written above.</font></div><div><font><br></font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:13pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ORTHO-CLINICAL DIAGNOSTICS, INC.&#160;&#160;&#160;&#160;IDEXX EUROPE B.V.</font></div><div><font><br></font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:10.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.406%"><tr><td style="width:1.0%"></td><td style="width:4.493%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.593%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.690%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.5pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Eric Compton</font></td><td colspan="3" style="padding:2px 1pt 2px 109.05pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Conan Deady</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:17.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Eric Compton</font></div><div style="margin-top:0.5pt;padding-left:17.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General Manager, WW Sales &#38; Service</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:17.25pt;padding-right:88.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Name&#58; Conan Deady Director</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:2.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></div></td><td colspan="3" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:17.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 25, 2012</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:108.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></div></td><td colspan="3" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:17.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 25, 2012</font></div></td></tr></table></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:340.25pt;padding-right:11.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing Amendment is hereby consented to and acknowledged by&#58;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:340.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IDEXX LABORATORIES, INC.,</font></div><div style="margin-top:0.5pt;padding-left:340.25pt;padding-right:84.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">solely as guarantor pursuant to Section 30 of the Agreement</font></div><div><font><br></font></div><div style="padding-left:340.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IDEXX LABORATORIES, INC.</font></div><div><font><br></font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:384.6pt;padding-right:84.7pt;text-indent:-44.35pt"><img alt="image_710.jpg" src="image_710.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:254px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">By&#58;&#47;s&#47; Michael Williams Michael Williams Corporate Vice President</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:0.85pt;margin-top:0.05pt;padding-left:340.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;&#160;&#160;&#160;&#160;January 25, 2012</font></div><div style="padding-left:366.9pt"><img alt="image_810.jpg" src="image_810.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:255px"></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="height:23.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:23.76pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:231.05pt;padding-right:231.05pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Schedule 5</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:13pt;padding-right:13.9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:113%">Note&#58; Price is for </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:113%;text-decoration:underline">all </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:113%">slides up to the levels indicated below. New levels are triggered as the volume reaches the noted level. For clarity see example below.</font></div><div style="padding-right:13.9pt"><font><br></font></div><div style="margin-top:6.35pt;padding-left:134.05pt"><font><br></font></div><div style="margin-top:6.35pt;padding-left:134.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Example Example Example</font></div><div style="margin-top:0.45pt;padding-left:146.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">#1&#160;&#160;&#160;&#160;#2&#160;&#160;&#160;&#160;#3</font></div><div style="margin-top:0.45pt;padding-left:64.4pt;padding-right:326.15pt;text-indent:-1.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Year of Purchase&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;</font></div><div style="padding-left:63pt;padding-right:326.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Slide volume (a)&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;</font></div><div style="padding-left:48.45pt;padding-right:326.15pt;text-indent:47.9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Price (b)&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;</font></div><div style="padding-left:36pt;padding-right:326.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Purchase (a*b)&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;</font></div><div style="margin-top:6pt;padding-left:19.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Slides (in MM)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%;text-decoration:underline">2013&#160;&#160;&#160;&#160;2014&#160;&#160;&#160;&#160;2015&#160;&#160;&#160;&#160;2016&#160;&#160;&#160;&#160;2017&#160;&#160;&#160;&#160;2018&#160;&#160;&#160;&#160;2019&#160;&#160;&#160;&#160;2020&#160;&#160;&#160;&#160;2021&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;2023&#160;&#160;&#160;&#160;2024&#160;&#160;&#160;&#160;2025&#160;&#160;&#160;&#160;2026&#160;&#160;&#160;&#160;2027&#160;&#160;&#160;&#160;2028</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">   &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:113%">&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">   &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:113%">&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;&#160;&#160;&#160;&#160;&#91;**&#93;</font></div><div><font><br></font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:13pt;padding-right:16.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. A total of 15 were omitted.</font></div><div style="padding-left:13pt;padding-right:16.65pt"><font><br></font></div><div style="padding-left:13pt;padding-right:16.65pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;*&#93; and &#91;**&#93; text omitted throughout this exhibit for confidential treatment. The redacted information has been excluded because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.</font></div><div style="padding-left:13pt;padding-right:16.65pt"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="height:23.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.14
<SEQUENCE>10
<FILENAME>exhibit1014-orthorowagreem.htm
<DESCRIPTION>EX-10.14
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ied96defbc46e482784812d3ac45440d0_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EXECUTION COPY</font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:133%">CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY ASTERISKS, HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED.</font></div><div style="margin-bottom:10pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Exhibit 10.14</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">AMENDMENT NO.4 TO </font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">AGREEMENT</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">THIS AMENDMENT NO.4 TO AGREEMENT (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8221;) is made effective as of December 9, 2013, between IDEXX Europe B.V., a corporation organized under the law of The Netherlands (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">IDEXX</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8221;) and Ortho-Clinical Diagnostics, Inc., a New York corporation with offices at 100 Indigo Creek Drive, Rochester, New York, U.S.A. (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">OCD</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8221;).</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">WHEREAS, OCD and IDEXX have entered into that certain Agreement dated as of October 17, 2003, as amended by Amendment No. 1 thereto effective January 1, 2005, Amendment No. 2 thereto  effective January 18, 2008 and Amendment No. 3 thereto effective December 28, 2011 (as so amended, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8221;), regarding supply by OCD of dry slides for IDEXX veterinary chemistry analyzers&#59; and  </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">WHEREAS, OCD and IDEXX now desire to amend the Agreement to reflect the foregoing&#59;</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">NOW THEREFORE, the parties hereby agree as follows&#58;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:9.75pt;text-decoration:underline">Schedule 3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> to the Agreement is deleted in its entirety and replaced with the attached </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Schedule 3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">.  All future adjustments to Schedule 3 will require the mutual agreement of both parties.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:9.75pt;text-decoration:underline">Schedule 5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> to the Agreement (as amended in Amendment No. 3 to the Agreement) is supplemented with the attached </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Schedule 5-A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">, and references in the Agreement to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Schedule 5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> shall be deemed to include </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Schedule 5-A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">.  For the avoidance of doubt, subject to the terms and conditions of the Agreement, OCD undertakes to manufacture for IDEXX and supply to IDEXX, the consumables listed on the attached  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Schedule 5-A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">.   All future adjustments to Schedule 5-A will require the mutual agreement of both parties.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:9.75pt;text-decoration:underline">Schedule 6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> to the Agreement is deleted in its entirety and replaced with the attached </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Schedule 6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">.  All future adjustments to Schedule 6 will require the mutual agreement of both parties.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:9.75pt">The specifications attached as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> to this Amendment are the mutually agreed specifications for the relevant products listed therein.  Exhibit A will be comprised of the &#8220;Purchase Material Specifications&#8221; documents for each test and panel listed in Schedule 5-A and may be changed or added to periodically by the mutual agreement of both parties and these routine changes will not require an amendment to the contract.  The change process will be managed by a change control document and the inclusion of signatures by both IDEXX and OCD on each current individual &#8220;Purchase Material Specification&#8221;.  Proposed changes should be submitted in writing by either IDEXX or OCD and confirmed in writing by the other party, such changes will be finalized by signature on the &#8220;Purchase Material Specification&#8221;.  Communications to IDEXX should be provided to the General Manager, IDEXX Vetlab and </font></div><div style="height:74.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EXECUTION COPY</font></div></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">communication to OCD should be provided to the National Account Director, IDEXX.    The parties acknowledge and agree that the items listed in the &#8220;Quality Requirements&#8221; section of such specifications shall be provided by OCD to IDEXX at no charge to IDEXX.  The items provided at no charge will be capped at the quantities called for in Exhibit A as attached to this amendment, all additional quantities or items required for new products may be charged for by OCD.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:9.75pt">Except as modified by this Amendment, the Agreement remains in effect.  This Amendment is to be construed as part of the Agreement.  Each reference to &#8220;hereof&#8221;, &#8220;hereunder&#8221;, &#8220;herein&#8221; and &#8220;hereby&#8221; and each other similar reference and each reference to &#8220;this Agreement&#8221; and each other similar reference contained in the Agreement shall from and after the date set forth above, refer to the Agreement as amended hereby.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.75pt">This Amendment may be executed in counterparts, each of which shall be deemed to be an original and all of which together shall be deemed to be one and the same instrument.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">*****<br></font></div><div><font><br></font></div><div style="height:74.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EXECUTION COPY</font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IN WITNESS WHEREOF and intending to be legally bound, the parties hereto have caused this Amendment to be duly executed in duplicate by their respective authorized representatives as of the day and year first written above&#58;</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">ORTHO-CLINICAL DIAGNOSTICS, INC.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;IDEXX EUROPE B.V.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">By&#58; _</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">&#47;s&#47; Thomas O&#8217;Neil</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">________________&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;By&#58; ____</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">&#47;s&#47; Michael Williams</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">_____________</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Name&#58; __</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline"> Thomas O&#8217;Neil</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> ______________&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Name&#58; ____</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline"> Michael Williams</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> ____________</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Title&#58; __</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">VP Americas &#38; EMEA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">_________&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Title&#58; ____</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Executive Vice President</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">________</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Date&#58; ____</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">12&#47;11&#47;13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">__________________&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Date&#58; _____</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">12&#47;9&#47;13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">____________________</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Acknowledged and consented to, solely as guarantor pursuant to Section 30 of the Agreement&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:10pt;padding-left:264.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IDEXX LABORATORIES, INC.</font></div><div style="margin-bottom:10pt;padding-left:264.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">By&#58; ___</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">&#47;s&#47; Jonathan Ayers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">______________</font></div><div style="margin-bottom:10pt;padding-left:264.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Name&#58; __</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline"> Jonathan Ayers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> _____________</font></div><div style="margin-bottom:10pt;padding-left:264.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Title&#58; ___</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Chairman, President and CEO</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">___</font></div><div style="margin-bottom:10pt;padding-left:264.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Date&#58; ____</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">12&#47;9&#47;13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">_____________________</font></div><div style="text-align:center"><font><br></font></div><div style="height:74.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EXECUTION COPY</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Schedule 3</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Panels&#47;Profiles&#47;CLIPs</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">VetTest &#8220;Pre-Anesthetic Panel&#8221; (IDEXX part #98-21718-US, OCD cat #8015109), consists of four sets of the following six VETTEST slides&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">BUN&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Urea Nitrogen</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALT (SGPT)&#160;&#160;&#160;&#160;Alanine aminotransferase</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">GLU&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Glucose</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">TP&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total protein</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CREA&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Creatinine</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALKP&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Alkaline phosphatase</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">VetTest &#8220;General Health Profile&#8221;, (IDEXX part #98-20590-00, OCD cat #1607175), the &#8220;Large Animal Profile&#8221;(OCD cat # 6800071)  and the &#8220;Equine Health Profile&#8221; (IDEXX part #98-24021-US, OCD cat #6801956), each consist of two sets of 12 VETTEST slides as follows&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">General Health Profile&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Large Animal Profile </font></div><div style="margin-bottom:0.1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.756%"><tr><td style="width:1.0%"></td><td style="width:14.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.719%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.129%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.115%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALB</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Albumin</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALB</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Albumin</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALKP</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Alkaline phosphatase</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALKP</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Alkaline phosphatase</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALT (SGPT)</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Alanine aminotransferase</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">AST (SGOT)</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Aspartate aminotransferase</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">AMYL</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Amylase</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Ca</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">2+</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Calcium</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Ca</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">2+</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Calcium</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CK</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CK</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CHOL</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Cholesterol</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">GGT</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Gamma GT</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CREA</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Creatinine</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">GLU</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Glucose</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">GLU</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Glucose</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">PHOS</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Inorganic phosphate</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">PHOS</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Inorganic phosphate</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">LDH</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">LDH</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">TBIL</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total bilirubin</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">MG</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Magnesium</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">TP</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total protein</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">TP</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total Protein</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">BUN</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Urea Nitrogen</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">BUN</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Urea Nitrogen</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Equine Health Profile</font></div><div><font><br></font></div><div style="margin-bottom:0.1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.711%"><tr><td style="width:1.0%"></td><td style="width:34.025%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.775%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALB</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Albumin</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALKP</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Alkaline phosphatase</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">AST (SGOT)</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Aspartate aminotransferase</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Ca</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">2+</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Calcium</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CK</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CK</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">GGT</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Gamma GT</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">GLU</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Glucose</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">LDH</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">LDH</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">TP</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total protein</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">BUN</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Urea Nitrogen</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CREA</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Creatinine</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">TBIL</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total Bilirubin</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;PROFILES&#8221; shall also include the &#8220;Urine P&#58;C Ratio&#8221; (OCD cat #6802061), consisting of six pairs of Urine Protein and Creatinine VetTest slides. </font></div><div style="text-align:center"><font><br></font></div><div style="height:74.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EXECUTION COPY</font></div></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;PANELS&#8221; shall also include the &#8220;QC Panel&#8221; (IDEXX part #98-13952-00, OCD cat #6802213), consisting of four sets of the following six VetTest slides&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALB&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Albumin</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALKP&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Alkaline phosphatase</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALT (SGPT)&#160;&#160;&#160;&#160;Alanine aminotransferase</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Ca</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">2+</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Calcium</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">GLU&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Glucose</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">NH3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Ammonia</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;PANELS&#8221; shall also include the &#8220;Diagnostic Health Profile&#8221; (IDEXX part #98-13835-00, OCD cat #6802590), consisting of two sets of the following twelve VetTest slides&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALB&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Albumin</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALKP&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Alkaline phosphatase</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALT (SGPT)&#160;&#160;&#160;&#160;Alanine aminotransferase</font></div><div style="margin-bottom:0.1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.435%"><tr><td style="width:1.0%"></td><td style="width:33.932%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.868%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">AMYL               Amylase</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Ca2+                  Calcium</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CREA                Creatinine</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">GGT                  Gamma GT</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">GLU&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Glucose</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">LIPA                  Lipase</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">TBIL                  Total Bilirubin</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">TP                      Total protein</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">BUN&#47;UREA      Urea nitrogen</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;PANELS&#8221; shall also include the &#8220;NSAID Monitoring Panel&#8221; (IDEXX part #98-13834-00, OCD cat #6802589), consisting of four sets of the following five VetTest slides&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALKP&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Alkaline phosphatase</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALT (SGPT)&#160;&#160;&#160;&#160;Alanine aminotransferase</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">AST (SGOT)     Aspartate aminotransferase</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CREA                Creatinine</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">BUN&#47;UREA      Urea nitrogen</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;PANELS&#8221; shall also include the &#8220;Avian Health Profile&#8221; (IDEXX part #98-12880-US, OCD cat #6802781), consisting of four sets of the following 6 VetTest slides&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALB&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Albumin</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">AST (SGOT)     Aspartate aminotransferase</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Ca</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">2+</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Calcium</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">GLU&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Glucose</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">TP                      Total protein</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">URIC                  Uric acid</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;PANELS&#8221; shall also include the &#8220;Catalyst Chem. 17 Clip&#8221; (IDEXX part #98-11003-02, OCD cat #6802678), consisting of the following fourteen (14) Catalyst slides assembled per the specifications detailed in the Purchase Material Specifications.  </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">LIPA                  Lipase</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Ca</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">2+</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Calcium</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">PHOS                Phosphorus</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALB&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Albumin</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">BUN&#47;UREA      Urea nitrogen</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">TBIL                  Total Bilirubin</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">GLU&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Glucose</font></div><div style="height:74.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EXECUTION COPY</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CREA                Creatinine</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">AMYL               Amylase</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CHOL                Cholesterol</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALT (SGPT)&#160;&#160;&#160;&#160;Alanine aminotransferase</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALKP&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Alkaline phosphatase</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">TP                      Total protein</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">GGT                  Gamma GT</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;PANELS&#8221; shall also include the &#8220;Catalyst Chem. 15 Clip&#8221; (IDEXX part #98-11004-01, OCD cat #6802673), consisting of the following twelve (12) Catalyst slides assembled per the specifications detailed in the Purchase Material Specifications. </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Ca</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">2+</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Calcium</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">PHOS                Phosphorus</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALB&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Albumin</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">BUN&#47;UREA      Urea nitrogen</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">TBIL                  Total Bilirubin</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">GLU&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Glucose</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CREA                Creatinine</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CHOL                Cholesterol</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALT (SGPT)&#160;&#160;&#160;&#160;Alanine aminotransferase</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALKP&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Alkaline phosphatase</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">TP                      Total protein</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">GGT                  Gamma GT</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;PANELS&#8221; shall also include the &#8220;Catalyst Chem. 10 Clip&#8221; (IDEXX part #98-11005-01, OCD cat #6802675), consisting of the following seven (7) Catalyst slides assembled per the specifications detailed in the Purchase Material Specifications. </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">BUN&#47;UREA      Urea nitrogen</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALB&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Albumin </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">GLU&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Glucose</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CREA                Creatinine</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALT (SGPT)&#160;&#160;&#160;&#160;Alanine aminotransferase</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALKP&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Alkaline phosphatase</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">TP                      Total protein</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;PANELS&#8221; shall also include the &#8220;Catalyst NSAID 6 Clip&#8221; (IDEXX part #98-11007-01, OCD cat #6802676), consisting of the following five (5) Catalyst slides assembled per the specifications detailed in the Purchase Material Specifications.  &#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALKP&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Alkaline phosphatase</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALT (SGPT)&#160;&#160;&#160;&#160;Alanine aminotransferase</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">BUN&#47;UREA      Urea nitrogen</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CREA                Creatinine</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">AST (SGOT)     Aspartate aminotransferase</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;PANELS&#8221; shall also include the &#8220;Catalyst Equine 15 Clip&#8221; (IDEXX part #98-11006-01, OCD cat #6802674), consisting of the following twelve (12) Catalyst slides assembled per the specifications detailed in the Purchase Material Specifications.  </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Ca</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">2+</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Calcium</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">LDH                  Lactate dehydrogenase</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">GGT                  Gamma GT</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALB&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Albumin </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">BUN&#47;UREA      Urea nitrogen</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">TBIL                  Total Bilirubin</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">GLU&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Glucose</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">AST (SGOT)     Aspartate aminotransferase</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CK                     Creatine Kinase</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CREA                Creatinine</font></div><div style="height:74.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EXECUTION COPY</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALKP&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Alkaline phosphatase</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">TP                      Total protein</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;PANELS&#8221; shall also include the &#8220;Catalyst QC  Clip&#8221; (IDEXX part #98-13700-00, OCD cat #6802804), consisting of the following six (6) Catalyst slides assembled per the specifications detailed in the Purchase Material Specifications. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Ca</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">2+</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Calcium</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALB&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Albumin</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">NH3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Ammonia</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALT (SGPT)&#160;&#160;&#160;&#160;Alanine aminotransferase </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALKP&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Alkaline phosphatase</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">GLU&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Glucose</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Packaging for the PANELS&#47;PROFILES listed above have been previously agreed upon by the parties, and any changes to the slide composition or packaging of the foregoing shall be negotiated in good faith and mutually agreed upon by OCD and IDEXX.  The slide composition and packaging of any additional PANELS&#47;PROFILES shall be mutually agreed upon by OCD and IDEXX.  All purchases by IDEXX or IDEXX BV of IDEXX slides packaged as PANELS&#47;PROFILES shall be included in quantities for price calculations for such slides under this Agreement and the Europe Agreement.</font></div><div style="margin-bottom:10pt"><font><br></font></div><div><font><br></font></div><div style="height:74.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EXECUTION COPY</font></div></div><div style="margin-bottom:10pt;padding-left:144pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Schedule 5-A </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Products</font></div><div style="margin-bottom:0.1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"><tr><td style="width:0.1%"></td><td style="width:1.571%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.816%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.299%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.774%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.689%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.756%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.770%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">VETTEST SLIDES</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Single Slides</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">(Box of 25)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Catalog Number</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Single Slides</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">(Box of 12)</font></div></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Catalog Number</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Albumin</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8227134</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Albumin</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6801907</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Alk Phos</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8315459</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Alk Phos</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6801919</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALT (SGPT)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8083750</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ALT (SGPT)</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6801916</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Ammonia</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1816842</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Ammonia</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6801908</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Amylase</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8208191</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Amylase</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6801913</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">AST (SGOT)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8113979</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">AST (SGOT)</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6801914</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Calcium</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8048191</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Calcium</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6801902</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Cholesterol</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8354888</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Cholesterol</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6801906</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CK</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8358582</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CK</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6801918</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Creatinine</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8183477</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Creatinine</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6801911</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ECO2</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8538670</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ECO2</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802306</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Gamma GT</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8261315</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Gamma GT</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6801920</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Glucose</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8130536</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Glucose</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6801900</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">LDH</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8351082</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">LDH</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6801917</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Lipase</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1966191</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Lipase</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6801915</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Magnesium</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1080266</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Magnesium</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6801912</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Phosphorus</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8070856</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Phosphorus</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6801909</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total Bilirubin</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8380396</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total Bilirubin</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6801910</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total Protein</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1937093</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total Protein</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6801904</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Triglycerides</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1922285</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Triglycerides</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6801905</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Urea Nitrogen</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1507326</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Urea Nitrogen</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6801901</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Uric Acid</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1000793</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Uric Acid</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Lactate </font></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6801903</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802307</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Profile Slides</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">(Bx 24)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Catalog Number</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Profile Slides</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">(Bx 12)</font></div></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Catalog Number</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">General Health Profile</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1607175</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Urine P&#58;C Ratio (added May&#160;25, 2004)</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802061</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Pre-Anesthetic Panel</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8015109</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Phenobarb (added July&#160;1, 2011)</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802644</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Large Animal Profile</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6800071</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Equine Health Panel (added March 4, 2004)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6801956</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">QC Panel (added as of June 1, 2005)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802213</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Diagnostic Health Profile</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802590</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">NSAID Monitoring Profile</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802589</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Avian Health Panel</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802781</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:74.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EXECUTION COPY</font></div></div><div style="margin-bottom:0.1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"><tr><td style="width:0.1%"></td><td style="width:1.571%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.816%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.299%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.774%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.689%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.756%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.770%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Other</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Catalog Number</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Vetrol</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802212</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">UPRO Control</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802141</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Black DTSC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6800865</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">White Ref</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6800866</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">White DTSC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6800867</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">CATALYST SLIDES</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">(added as of October 1, 2008)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Catalog</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Number</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX CHEM 15</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802673</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX EQUINE 15</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802674</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX CHEM 10</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802675</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX NSAID</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802676</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX QCP</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802804</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX CHEM 17</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802678</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX UPC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802679</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX ALKP</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802628</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX ALT</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802629</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX AMYL</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802630</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX AST</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802631</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX BUN</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802632</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX CA</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802633</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX CHOL</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802634</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX CK</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802635</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX CREA</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802636</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX GGT</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802637</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX GLU</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802638</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX LAC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802639</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX LDH</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802640</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX LIPA</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802641</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX MG</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802642</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX NH3</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802643</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX PHOS</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802645</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX TBIL</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802646</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX TP</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802647</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX TRIG</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802648</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX URIC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802649</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX ALB</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802627</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX PHBR</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(added as of August&#160;1, 2011)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802644</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX ECO2(12 slide) (added as of August&#160;1, 2011)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6842954</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Catalyst DX ECO2 (6 slide)</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(added as of August&#160;1, 2011)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6482955</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:74.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EXECUTION COPY</font></div></div><div style="margin-bottom:0.1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"><tr><td style="width:0.1%"></td><td style="width:1.571%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.816%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.299%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.774%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.689%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.756%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.770%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Other</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Catalog Number</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Vetrol</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802212</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Drop Volume Fluid</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802784</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Catalyst Slide Wash</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802813</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Drop Volume Slides</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802789</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Catalyst Pipette Tips</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802779</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Catalyst Sample Cups</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802780</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Catalyst PHBR Control</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802773</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Catalyst White Optical Slide (Box - 6)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6903001</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">250 mL Both PHBR Bulk Wash Bottles Part 1 and 2</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6842914</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">250 mL PHBR Bulk Wash Part 1</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6842923</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">250 mL PHBR Bulk Wash Part 2</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6842924</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">500 mL Both PHBR Bulk Wash Bottles Part 1 and 2</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6842913</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">500 mL PHBR Bulk Wash Part 1</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6842925</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">500 mL PHBR Bulk Wash Part 2</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6842926</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.0 L Both PHBR Bulk Wash Bottles Part 1 and 2</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6842915</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.0 L PHBR Bulk Wash Part 1</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6842928</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.0 L PHBR Bulk Wash Part 2</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6842927</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.0 L Both PHBR Bulk Wash Bottles Part 1 and 2</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6842912</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.0 L PHBR Bulk Wash Part 1</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6842922</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.0 L PHBR Bulk Wash Part 2</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6842929</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="27" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">CONSUMABLES (PRODUCTS NOT INCLUDED UNDER TIERED SLIDE PRICING)</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">OCD P&#47;N</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">IDEXX P&#47;N</font></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Description</font></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2013 Price*</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802784</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">44-14602-00</font></td><td colspan="12" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">DROP VOLUME FLUID</font></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802789</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">44-14739-00</font></td><td colspan="12" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Drop Volume Slides</font></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6842923</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">23-27337-00</font></td><td colspan="12" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX PHBR Part 1 Bulk Wash Fluid  250mL</font></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6842924</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">23-27338-00</font></td><td colspan="12" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX PHBR Part 2 Bulk Wash Fluid  250mL</font></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6842925</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">23-27339-00</font></td><td colspan="12" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX PHBR Part 1 Bulk Wash Fluid  500mL</font></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6842926</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">23-27340-00</font></td><td colspan="12" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX PHBR Part 2 Bulk Wash Fluid  500mL</font></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6842928</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">23-27341-00</font></td><td colspan="12" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX PHBR Part 1 Bulk Wash Fluid  1L</font></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6842927</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">23-27342-00</font></td><td colspan="12" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX PHBR Part 2 Bulk Wash Fluid  1L</font></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6842922</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">23-27343-00</font></td><td colspan="12" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CATALYST BULK SLIDE WASH PART 1 2.0 L</font></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6842929</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">23-27344-00</font></td><td colspan="12" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CATALYST BULK SLIDE WASH PART 2 2.0 L</font></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802212</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">98-11379-00</font></td><td colspan="12" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">VETTROL CONTROL 4-SET</font></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802779</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">98-12125-01</font></td><td colspan="12" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CATALYST DX TM PIPETTE TIP</font></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802780</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">98-12128-00</font></td><td colspan="12" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CATALYST DX SAMPLE CUP</font></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:74.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EXECUTION COPY</font></div></div><div style="margin-bottom:0.1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"><tr><td style="width:0.1%"></td><td style="width:1.571%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.816%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.299%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.774%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.689%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.756%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.770%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802773</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">98-12304-00</font></td><td colspan="12" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CATALYST PHBR CTRL (6)</font></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6802141</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">98-12937-00</font></td><td colspan="12" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX UPRO CONTROL</font></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6903001</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">98-14931-00</font></td><td colspan="12" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CATALYST DX WHITE OPTICAL SLIDE, 6-PACK</font></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6800865</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">98-20520-00</font></td><td colspan="12" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SLIDE, CALIBRATION, BGS (BX25)</font></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6800866</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">98-20521-00</font></td><td colspan="12" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SLIDE, CALIBRATION, WHT (BX25)</font></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6800867</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">98-20522-00</font></td><td colspan="12" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SLIDE, CALIBRATION, WRSC (BX25)</font></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;**&#93;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">* </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">OCD may, at its option, increase all prices for such consumables ordered for delivery&#160;on or after January 1, 2014 by an amount not to exceed &#91;**&#93;% each year.  </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%"><br></font></div><div><font><br></font></div><div style="height:74.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EXECUTION COPY</font></div></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Schedule 6 &#8211; Minimum Prices for New Chemistries</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:36pt"><font><br></font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Urine Protein (added May 25, 2004 as part of the Urine P&#58;C Ratio)&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:14.15pt">Prices for 2005 and thereafter shall be determined based on volume tiers pursuant to Section 7.02(b), subject to a minimum price for this New Chemistry of $&#91;**&#93; per slide</font></div><div style="margin-bottom:10pt;padding-left:72pt"><font><br></font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Lactate (added as of July 1, 2005)&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:14.15pt">Prices for 2005 and thereafter shall be determined based on volume tiers pursuant to Section 7.02(b), subject to a minimum price for this New Chemistry of $&#91;**&#93; per slide</font></div><div style="margin-bottom:10pt;padding-left:72pt"><font><br></font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">ECO2 (added as of August 1, 2011)&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:14.15pt">Prices for 2005 and thereafter shall be determined based on volume tiers pursuant to Section 7.02(b), subject to a minimum price for this New Chemistry of $&#91;**&#93; per slide</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font><br></font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Phenobarb (added as of August 1, 2011)&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:14.15pt">Prices for 2005 and thereafter shall be determined based on volume tiers pursuant to Section 7.02(b), subject to a minimum price for this New Chemistry of $&#91;**&#93; per slide</font></div><div><font><br></font></div><div style="height:74.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">12</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EXECUTION COPY</font></div></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%;text-decoration:underline">Exhibit A &#8211; Specifications</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#91;see attached&#93;</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Confidential Materials omitted and filed separately with the Securities and Exchange Commission. A total of 117 pages were omitted. &#91;**&#93;</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#91;*&#93; and &#91;**&#93; text omitted throughout this exhibit for confidential treatment. The redacted information has been excluded because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.</font></div><div style="text-align:center"><font><br></font></div><div style="height:74.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">13</font></div><div><font><br></font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.16
<SEQUENCE>11
<FILENAME>exhibit1016-orthorowagreem.htm
<DESCRIPTION>EX-10.16
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="iaf17393e4e6e42f5bd36dc516335b343_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY ASTERISKS, HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED.</font></div><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%;text-decoration:underline">Exhibit 10.16</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">AMENDMENT NO. 6 TO</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">AGREEMENT</font></div><div style="margin-bottom:8pt;text-align:justify"><font><br></font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">THIS AMENDMENT NO.6 TO AGREEMENT (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8221;) is made effective as of September 1, 2021, between IDEXX Europe B.V., a corporation organized under the law of the Netherlands (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">IDEXX</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8221;)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">and Ortho-Clinical Diagnostics, Inc., a New York corporation with offices at 100 Indigo Creek Drive, Rochester, New York, U.S.A. (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">OCD</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Ortho</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8221;&#59; each of IDEXX and Ortho also a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8221; and together also the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8221;). </font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">WHEREAS, Ortho and IDEXX have entered into that certain agreement dated as of October 17, 2003 (such agreement, as amended by Amendment No. 1 thereto effective January 1, 2005, Amendment No. 2 thereto effective January 18, 2008, Amendment No. 3 thereto effective December 28, 2011, Amendment No. 4 thereto effective December 9, 2013, Amendment No. 5 thereto effective July 9, 2019 (as so amended, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8221;), regarding supply by Ortho of dry slides for IDEXX veterinary chemistry analyzers&#59; and </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">WHEREAS, the Parties now desire to update the annual Product forecast and price true-up processes, and agree to amend the Agreements accordingly&#59;</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">NOW THEREFORE, in consideration of the mutual promises, covenants and agreements hereinafter set forth, the Parties hereby agree as follows&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:9.75pt">The first and second paragraph of Section 5.04 shall be deleted in their entirety and replaced as follows&#58;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:54pt;padding-right:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8220;No later than &#91;**&#93; of each year, IDEXX shall provide Ortho with its notice of aggregate forecasted purchase volume and mix of Products (on a Product SKU level) for &#91;**&#93; of the subsequent &#91;**&#93; for each of the VETTEST slides (single slides and PANELS&#47;PROFILES slides for the VETTEST Analyzer and New Slides) (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">&#8220;Initial Forecast&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">).  Ortho shall review the Initial Forecast. In the event that Ortho considers, in good faith, that the Initial Forecast is outside of its manufacturing capability for the &#91;**&#93; allocations specified for each of the VETTEST slides (due to Ortho&#8217;s total manufacturing capacity, Product mix (including on a Product SKU level) or otherwise), Ortho will provide documented acknowledgement of the limitation and the Parties will agree to discuss solutions for provision of slide volume to meet IDEXX&#8217;s forecasted requirements (including any changes to the quarterly allocation of the Product volume or mix of Products, or the overall Product volume).  Any resulting mutually agreed updates shall be incorporated in writing into the Initial Forecast, which shall be deemed the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Annual Purchase Forecast</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8221;. If Ortho does not provide such acknowledgement by the &#91;**&#93; following the Initial Forecast, the Initial Forecast shall be deemed within Ortho&#8217;s capability for production, and shall be deemed the Annual Purchase Forecast.  As long as the &#91;**&#93; slide </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="padding-left:54pt;padding-right:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">order volumes for the &#91;**&#93; do not exceed &#91;**&#93; Ortho shall deliver the slides in accordance with IDEXX&#8217;s orders.  In the event an IDEXX order is outside of Ortho&#8217;s capacity limitation due to the mix of Products, Ortho shall notify IDEXX and the Parties shall discuss in good faith an amicable solution that reflects both Ortho&#8217;s capacity limitations and IDEXX&#8217;s order.</font></div><div style="padding-left:54pt;padding-right:18pt;text-align:justify"><font><br></font></div><div style="padding-left:54pt;padding-right:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">The &#91;**&#93; constitute non-binding forecasts for Ortho&#8217;s planning purposes and shall also be the basis for determining estimated slide pricing pursuant to Section 7.03 below.&#8221;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:9.75pt">Section 5.05 shall be deleted in its entirety and replaced as follows&#58;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:54pt;padding-right:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8220;In the event IDEXX intends to place a purchase order for Products that exceeds &#91;**&#93; of the &#91;**&#93; (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Excess Order</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8221;), IDEXX will notify Ortho thereof at least two (2) weeks in advance of the Excess Order.  Within one (1) week following receipt of such request, Ortho will review and notify IDEXX of the extent of its ability to so supply the Excess Order.   Ortho shall use best efforts to deliver the Excess Order, provided that, if such Excess Order exceeds its manufacturing capability (due to either Ortho&#8217;s total manufacturing capacity, Product mix or otherwise, in each case within the quarterly and annual term specified), the Parties will enter into good faith discussions to find solutions for provision of slide volume to meet the Excess Order, but a failure by Ortho to manufacture the Excess Order shall not constitute a breach of contract by Ortho.&#8221;</font></div><div style="padding-left:54pt;padding-right:18pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:9.75pt">Section 7.02(b) shall be modified as follows&#58;  The fifth paragraph (i.e., the paragraph that starts with &#8220;Within &#91;**&#93;&#8230;&#8221;) of Section 7.02(b) shall be deleted in its entirety and replaced as follows&#58;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:90pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8220;(i) &#160;&#160;&#160;&#160;&#91;**&#93;  </font></div><div style="padding-left:90pt;text-align:justify;text-indent:-27pt"><font><br></font></div><div style="padding-left:90pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">(ii) &#160;&#160;&#160;&#160;&#91;**&#93;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">.&#8221;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:9.75pt">Except as modified by this Amendment, the Agreement remains in effect.  This Amendment is to be construed as part of the Agreement.  Each reference to &#8220;hereof&#8221;, &#8220;hereunder&#8221;, &#8220;herein&#8221; and &#8220;hereby&#8221; and each other similar reference and each reference to &#8220;this Agreement&#8221; and each other similar reference contained in the Agreement shall from and after the date set forth above, refer to the Agreement as amended hereby.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.75pt">This Amendment may be executed in counterparts, each of which shall be deemed to be an original and all of which together shall be deemed to be one and the same instrument.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">*****<br></font></div><div><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">IN WITNESS WHEREOF and intending to be legally bound, the parties hereto have caused this Amendment to be duly executed in duplicate by their respective authorized representatives as of the day and year first written above&#58;</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">ORTHO-CLINICAL DIAGNOSTICS, INC.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;IDEXX EUROPE B.V. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">By&#58; _&#47;s&#47; Michael S. Iskara&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;By&#58; &#47;s&#47; Lily J. Lu</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Name&#58; Michael S. Iskara&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Name&#58; Lily J. Lu</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Title&#58; EVP  Commercial Excellence and Strategy&#160;&#160;&#160;&#160;Title&#58; Managing Director</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Date&#58; Nov 17, 2021&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Date&#58; Nov 2, 2021</font></div><div style="margin-bottom:8pt"><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Acknowledged and consented to, solely as guarantor pursuant to Section 30 of the Agreement&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:8pt;padding-left:264.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">IDEXX LABORATORIES, INC.</font></div><div style="margin-bottom:8pt;padding-left:264.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">By&#58; &#47;s&#47; John Hart</font></div><div style="margin-bottom:8pt;padding-left:264.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Name&#58; John Hart</font></div><div style="margin-bottom:8pt;padding-left:264.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Title&#58; Senior Vice President</font></div><div style="margin-bottom:8pt;padding-left:264.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Date&#58; Nov 5, 2012</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> &#91;**&#93; Text omitted throughout this exhibit for confidential treatment. The redacted information has been excluded because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.19
<SEQUENCE>12
<FILENAME>a1019idexxortholetterdated.htm
<DESCRIPTION>EX-10.19
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i522082701bb348fd930e1daf10c50cc5_1"></div><div style="min-height:239.04pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 10.19</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASTERISKS, HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><img alt="image_04.jpg" src="image_04.jpg" style="height:4px;margin-bottom:5pt;vertical-align:text-bottom;width:648px"></div><div><img alt="image_114.jpg" src="image_114.jpg" style="height:22px;margin-bottom:5pt;vertical-align:text-bottom;width:240px"></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">November 2, 2021</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Laboratories, Inc. </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">One IDEXX Drive </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Westbrook, ME 04091 </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ATTN&#58; John Hart</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Corporate VP Worldwide Operations</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX Laboratories, Inc.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Subject&#58; Catalyst Capacity &#8211; Work Center 5 Project Approval </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Dear John&#58; </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Reference is made to the agreement between Ortho-Clinical Diagnostics, Inc. (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Ortho</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) and IDEXX Operations, Inc. (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">IDEXX</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) dated October 16, 2003 (such agreement as later amended from time to time (including subsequent amendments) the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). Capitalized terms not otherwise defined herein shall have the meanings ascribed to them in the Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In the past, Ortho retained a third-party company called &#91;**&#93; for the manufacture and sale to Ortho of manufacture lines used for the production of certain veterinary diagnostics slides at Ortho&#8217;s facility in Rochester, State of New York.  As Ortho manufactures and sells such slides to IDEXX, IDEXX reimbursed Ortho &#91;**&#93; of Ortho&#8217;s spend for such production lines with &#91;**&#93;. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Ortho and IDEXX agreed that IDEXX&#8217; increased demand for veterinary diagnostics slides is best addressed by constructing a new manufacturing line (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Catalyst Work Center 5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) instead of improving key assemblies of one of the existing manufacturing lines.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Following a competitive bid process (which solicited bids from &#91;**&#93; and &#91;**&#93;), Ortho and IDEXX agreed on June 9, 2021 to retain &#91;**&#93; for the manufacture and sale of Catalyst Work Center 5 by &#91;**&#93; to Ortho.</font></div><div style="padding-right:4.5pt;text-align:justify"><font><br></font></div><div style="padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">NOW, THEREFORE, in consideration of the mutual promises, covenants and agreements hereinafter set forth, the parties hereto agree as follows (this letter agreement the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Letter Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#58;</font></div><div style="padding-right:4.5pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;padding-right:4.5pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:9.75pt;text-decoration:underline">Agreement Between Ortho and &#91;**&#93;&#59; Catalyst Work Center 5 Costs</font></div><div style="padding-left:18pt;padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;**&#93;.  The Catalyst Work Center 5 project plan, as agreed by &#91;**&#93;, is set forth in Exhibit A to this Letter Agreement.</font></div><div style="padding-left:18pt;padding-right:4.5pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Ortho and IDEXX agree to equally share the costs for the Catalyst Work Center 5 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Catalyst Work Center 5 Costs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).  The Catalyst Work Center 5 Costs consist of (i) &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#91;**&#93; Specific Costs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;, which are actually incurred by Ortho under the Catalyst Work Center 5 Agreement, and (ii) &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#91;**&#93; Costs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;, which are actually incurred by Ortho in relation to the Catalyst Work Center 5 from &#91;**&#93;.</font></div><div style="height:90pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Ortho Clinical Diagnostics  &#124;  100 Indigo Creek Drive Rochester, NY 14650</font></div></div></div><hr style="page-break-after:always"><div style="min-height:239.04pt;width:100%"><div><font><br></font></div></div><div style="padding-left:18pt;padding-right:4.5pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Catalyst Work Center 5 Cost estimates are set forth in Exhibit A.  Any savings below the anticipated      $&#91;**&#93; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#91;**&#93; Specific Costs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> specified in the Exhibit A and the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Catalyst Work Center&#160;5 Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> will be shared &#91;**&#93; between the parties.  The parties agree to work together in good faith to minimize any costs in excess of the anticipated $&#91;**&#93; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#91;**&#93; Specific Costs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> as well as estimated </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#91;**&#93; Costs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="padding-left:18pt;padding-right:4.5pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;padding-right:4.5pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:9.75pt;text-decoration:underline">Invoices and Payments </font></div><div style="padding-left:18pt;padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Ortho shall invoice IDEXX in respect to &#91;**&#93; Specific Costs and &#91;**&#93; Costs following Ortho&#8217;s receipt of invoice for payment from the relevant vendor. Ortho shall provide IDEXX adequate documentation (including all relevant invoices and itemized expenses sufficient to identify the costs) to support all invoiced costs.   </font></div><div style="padding-right:4.5pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IDEXX shall pay all undisputed invoices within thirty (30) days following receipt of invoice conforming to the above requirements from Ortho.  </font></div><div style="padding-left:18pt;padding-right:4.5pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;padding-right:4.5pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:9.75pt;text-decoration:underline">Relationship to Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font></div><div style="padding-left:18pt;padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Except as explicitly set forth otherwise herein, the terms of the Agreement shall continue to apply to this Letter Agreement. In case of any conflict between this Letter Agreement and the Agreement, this Letter Agreement shall prevail with regard to the Catalyst Work Center 5 Costs.</font></div><div style="padding-left:18pt;padding-right:4.5pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;padding-right:4.5pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:9.75pt;text-decoration:underline">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">  </font></div><div style="padding-left:18pt;padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Letter Agreement and the Agreement constitute the entire understanding between the parties hereto with respect to the subject matter herein and no amendment or modification of its terms shall be valid or binding upon any party unless reduced to writing and signed by authorized representatives of the parties hereto.  </font></div><div style="padding-left:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Upon IDEXX&#8217;s countersignature below, this Letter Agreement shall become effective and binding upon the Parties in accordance with its terms.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Kind regards,</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">_&#47;s&#47; Marwan Fathallah</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">_____________________________</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Marwan </font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Fathallah</font></div><div><font style="color:#666666;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Head Of Quality, Regulatory, Compliance, Clinical &#38; Medical Affairs &#8226; Quality Assurance &#38; Quality Compliance</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Ortho Clinical Diagnostics</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">100 Indigo Creek Drive</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Rochester, NY 14626</font></div><div style="height:90pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:239.04pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Accepted and Agreed&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">IDEXX Operations, Inc.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;___</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; John Hart</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">_____________________________________________</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">___Senior Vice President</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">____________________________________</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><br>Date&#58;___</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">December 17, 2021</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">______________________________________</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:90pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.22
<SEQUENCE>13
<FILENAME>idexx-10_22amendeddirector.htm
<DESCRIPTION>EX-10.22
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i53d72bbf00794d98abfdb6039f1e1705_1"></div><div style="min-height:93.6pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Exhibit 10.22</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">IDEXX Laboratories, Inc. </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">DIRECTOR DEFERRED COMPENSATION PLAN </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Restated Effective as of October 13, 2021</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Director Deferred Compensation Plan of IDEXX Laboratories, Inc. (the &#8220;Plan&#8221;) was initially established effective July 1, 2003 to provide an additional mechanism for satisfying stock ownership guidelines, as well as to provide a vehicle for non-employee Directors to defer the receipt of taxable income. The Plan is intended to be an &#8220;unfunded&#8221; plan maintained for the purpose of providing deferred compensation to non-employee members of the Board of Directors for purposes of Title I of the Employee Retirement Income Security Act of 1974.  The Plan was amended and restated in its entirety, effective January 1, 2005, primarily for the purpose of complying with the applicable requirements of Section 409A of the Internal Revenue Code of 1986 (the &#8220;Code&#8221;), and Proposed Regulations &#167;&#167; 1.409A-1 et seq., and the Company operated the Plan in good faith compliance with Code Section 409A and the restated Plan document since that time.  The Plan was also amended and restated in its entirety, effective January 1, 2008, for the purpose of continuing compliance with Section 409A of the Code and Final Regulations &#167;&#167;1.409A-1 et seq., and effective May 6, 2009, for the purpose of replacing a reference to the 2003 Stock Incentive Plan with the 2009 Stock Incentive Plan, which superseded the 2003 Stock Incentive Plan on May 6, 2009, and effective as of July 14, 2010 for the purpose of modifying certain provisions relating to the payment of benefits.</font><font style="color:#00c000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Plan is now amended and restated for the purpose of replacing a reference to the 2009 Stock Incentive Plan with the 2018 Stock Incentive Plan, which superseded the 2009 Stock Incentive Plan on May 9, 2018, and revising the deferral features relating to Director&#8217;s annual equity grants.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ARTICLE I </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DEFINITIONS </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unless the context otherwise requires, the following words and phrases as used herein shall have the following meanings&#58;  </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 1.1 &#8220;ACCOUNT&#8221; means the bookkeeping Account maintained for a Participant to which Deferrals (including all Deferrals denominated as Deferred Stock Units) and Annual Grants, plus any earnings thereon, are credited.  </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 1.2 &#8220;ANNUAL EQUITY GRANT&#8221; means the equity award of a number of restricted stock units having a specified dollar value granted by the Company to Directors on an annual basis as part of their annual compensation for serving as a Director, such number of restricted stock units being determined by dividing the closing price of IDEXX Stock on the grant date by the specified dollar value.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 1.3 &#8220;ANNUAL RETAINER&#8221; means the annual cash retainer paid by the Company to Directors. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 1.4 &#8220;BENEFICIARY&#8221; means the person that the Participant designates to receive any unpaid portion of the Participant's Account balance should the Participant's death occur before the Participant receives the entire Account balance. If the Participant does not designate a beneficiary, his Beneficiary shall be his spouse if he is married at the time of his death, or his estate if he is unmarried at the time of his death.  </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 1.5 &#8220;BOARD OF DIRECTORS&#8221; means the Board of Directors of IDEXX Laboratories, Inc.  </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 1.6 &#8220;CHANGE IN CONTROL&#8221; means, solely for purposes of this Plan, the occurrence of one or more of the following events with respect to the Company&#58; </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) Any one person, or more than one person acting as a group, acquires (or has acquired during the 12-month period ending on the date of the most recent acquisition by such person or persons) beneficial ownership, directly or indirectly, of stock of the Company possessing 35% or more of the total voting power of the stock of the Company&#59; or </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b) Individuals constituting a majority of the members of the Company&#8217;s Board of Directors are replaced during any 12-month period by new directors whose appointment or election is not approved by a majority of the members of the Company&#8217;s Board of Directors serving immediately before the appointment or election of any such new directors&#59; or </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c) A change in the ownership of a substantial portion of the Company&#8217;s assets occurs on the date that any one person, or more than one person acting as a group, acquires (or has acquired during the 12-month period ending on the date of the most recent acquisition by such person or persons) assets from the Company that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of the Company immediately prior to such acquisition or acquisitions.  For this purpose, gross fair market value means the value of the assets of the Company, or the value of the assets being disposed of, determined without regard to any liabilities associated with such assets. </font></div><div style="text-align:justify"><font><br></font></div><div style="height:68.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For purposes of determining whether a Change in Control has occurred, the term &#34;person&#34; shall have the meaning given in Section 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;) and the term &#34;beneficial owner&#34; shall have the meaning given in Rule 13d-3 under the Exchange Act. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 1.7 &#8220;CODE&#8221; means the Internal Revenue Code of 1986, as amended.  </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 1.8 &#8220;COMPANY&#8221; means IDEXX Laboratories, Inc. and any subsidiary designated as a participating entity by the Plan Administrator. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 1.9 &#8220;DEFERRALS&#8221; means amounts deferred under the Plan pursuant to Article III and allocated to a Participant's Account. No money or other assets will actually be contributed to such Accounts.  </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 1.10 &#8220;DEFERRED STOCK UNIT&#8221; means a notional interest in one share of IDEXX Stock.  Each Deferred Stock Unit shall be equivalent in value to one share of IDEXX Stock and shall be subject to the terms of the 2018 Stock Incentive Plan. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 1.11 &#8220;DIRECTOR&#8221; means a non-employee member of the Board of Directors.   </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 1.12 &#8220;DISABLED&#8221; means that a Participant&#58;  (a) is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which can be expected to result in death or can be expected to last for a continuous period of not less than twelve months, or (b) is, by reason of any medically determinable physical or mental impairment which can be expected to result in death or can be expected to last for a continuous period of not less than twelve months.  </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 1.13 &#8220;EFFECTIVE DATE&#8221; means the effective date of this restated plan document, generally January 1, 2005.  </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 1.14 &#8220;EQUITY GRANT DEFERRAL ELECTION&#8221; means an election to receive a grant of a number of Deferred Stock Units in lieu of an Annual Equity Grant for a particular calendar year, which number of Deferred Stock Units shall be equal to the number of restricted stock units that would have been granted to the Participant as the Annual Equity Grant absent such election.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 1.15 &#8220;IDEXX STOCK&#8221; means Common Stock of IDEXX Laboratories, Inc.  </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 1.16 &#8220;OTHER COMPENSATION&#8221; means cash compensation paid to a Director, other than the Annual Retainer, including (without limitation) meeting fees, and annual fees for committee memberships and committee chairs. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 1.17 &#8220;PARTICIPANT&#8221; means a Director who participates in the Plan.  </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 1.18 &#8220;PLAN&#8221; means this Director Deferred Compensation Plan, as it may be amended from time to time.  </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 1.19 &#8220;PLAN ADMINISTRATOR&#8221; means the Chief Human Resources Officer of IDEXX Laboratories, Inc. or any person or entity designated by the Chief Human Resources Officer.  </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 1.20 &#8220;PLAN YEAR&#8221; means the 12-month period beginning January 1 and ending December 31.  </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 1.21 &#8220;RETAINER DEFERRAL ELECTION&#8221; means a deferral election of all or any portion of the Participant&#8217;s Annual Retainer and&#47;or Other Compensation.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 1.22 &#8220;UNFORESEEABLE EMERGENCY&#8221; means a severe financial hardship to the Participant, the Participant&#8217;s spouse or a dependent (as defined in Code Section 152(a)) of the Participant, loss of the Participant&#8217;s property due to casualty, or other similar extraordinary and unforeseeable circumstances arising as a result of events beyond the control of the Participant. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ARTICLE II</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ELIGIBILITY AND PARTICIPATION </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 2.1 ELIGIBILITY. Each Director shall be eligible to become a Participant in the Plan immediately upon the commencement of his or her membership on the Board. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 2.2 PARTICIPATION. A Director may become a Participant in the Plan by making the applicable election described in Section 3.1 and&#47;or Section 3.2(b) below (as applicable).  A Director&#8217;s participation will commence with the first quarterly payment of the Annual Retainer paid, or the first Annual Equity Grant, after the completion of the Participant&#8217;s deferral election (as applicable). Each Director shall remain a Participant under the Plan until all amounts credited to the Participant's Account Balance have been distributed to the Participant or the Participant's Beneficiary.  </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="height:68.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ARTICLE III</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DEFERRALS&#59; ANNUAL GRANTS&#59; VESTING </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 3.1 DEFERRALS OF ANNUAL RETAINER AND OTHER COMPENSATION</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  A Participant who elects to defer a portion of the Participant&#8217;s Annual Retainer and&#47;or Other Compensation shall make, subject, to Sections 3.1(b) - (d) below, a Retainer Deferral Election by completing and returning to the Plan Administrator (or his or her designee) a written election on the form prescribed by the Plan Administrator.  In general, a Participant&#8217;s Retainer Deferral Election shall be made between December 1 and December 31 of the year immediately preceding the year in which the Annual Retainer and&#47;or Other Compensation (as applicable) will be earned, and shall become irrevocable with respect to a Plan Year as of December 31 of such preceding year.  However, a Director who shall first become eligible to participate in the Plan or any similar non-qualified deferred compensation plan of the Company after the time specified for making a Retainer Deferral Election under the Plan for the Plan Year as provided in the preceding sentence may make his or her initial Retainer Deferral Election within 30 days after first becoming eligible, such election to apply only to the Annual Retainer and&#47;or Other Compensation (as applicable) to be earned for services provided during the remainder of such Plan Year.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A Participant&#8217;s Retainer Deferral Election shall remain in effect until the date on which such Participant ceases to be a Director, or until he or she modifies such election on a prospective basis with respect to a subsequent Plan Year (in accordance with the requirements of subsection (a) above and any applicable procedures prescribed by the Plan Administrator, which may include, without limitation, the Plan Administrator periodically confirming the status of prior Retainer Deferral Elections with the Participant).  Notwithstanding the foregoing, the Retainer Deferral Election of a Participant who shall receive a distribution from the Plan on account of an Unforeseeable Emergency shall be canceled for the remainder of the Plan Year, as soon as administratively practicable following the approval of such distribution, and may not resume unless and until the Participant shall make a new Retainer Deferral Election for a future Plan Year. </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Plan Years Ending On or Before December 31, 2005</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. For Plan Years ending on or before December 31, 2005, a Participant shall be required to defer 50% of his or her Annual Retainer, which shall be credited to his or her Account in the form of Deferred Stock Units.  For such Plan Years, a Participant may elect to defer any or all of the remaining portion of such Annual Retainer and any or all of his or her Other Compensation for a Plan Year. </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Plan Years Beginning On or After January 1, 2006</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  For Plan Years beginning on and after January 1, 2006, a Participant may elect to defer receipt of all, but not less than all, of his or her Annual Retainer payable for any Plan Year, and a Participant shall not be permitted to defer the receipt of any Other Compensation under the Plan. </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Plan Years Beginning On and After January 1, 2007</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  For Plan Years beginning on and after January 1, 2007, a Participant may elect to defer receipt of all or any portion of his or her Annual Retainer and&#47;or Other Compensation payable for any Plan Year, in accordance with subsection (a) of this Section. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 3.2 ANNUAL GRANTS.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)  For Plan Years Beginning on January 1, 2006 and Ending with the Plan Year Beginning January 1, 2021. For Plan Years beginning on January 1, 2006 and ending with the Plan Year beginning January 1, 2021, the Board may make an annual grant to Directors of a number of Deferred Stock Units having a specified dollar value.  The number of Deferred Stock Units granted to a Director shall be determined by dividing the closing price of IDEXX Stock on the grant date by such specified dollar value. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)   For Plan Years Beginning on or After January 1, 2022. For Plan Years Beginning on or after January 1, 2022, a Participant who elects to defer the Participant&#8217;s Annual Equity Grant, shall make an Equity Grant Deferral Election by completing and returning to the Plan Administrator (or his or her designee) a written election on the form prescribed by the Plan Administrator. In general, a Participant&#8217;s Equity Grant Deferral Election shall be made between December 1 and December 31 of the year immediately preceding the year in which the Annual Equity Grant is granted to Directors, and shall become irrevocable with respect to a Plan Year as of December 31 of such preceding year.  A Participant&#8217;s Equity Grant Deferral Election shall be made each year for each subsequent Plan Year (in accordance with the requirements of this subsection (b) and any applicable procedures prescribed by the Plan Administrator). Notwithstanding the foregoing, the Equity Grant Deferral Election of a Participant who shall receive a distribution from the Plan prior to the grant date of the Annual Equity Grant in that Plan Year on account of an Unforeseeable Emergency shall be canceled for that Plan Year,</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 3.3 VESTING.   </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Retainer and Other Compensation Deferrals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  A Participant&#8217;s interest in Deferrals made under Section 3.1 of the Plan shall be fully vested and non-forfeitable at all times. </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Annual Grants Deferrals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  Each grant of Deferred Stock Units, including pursuant to an Equity Grant Deferral Election made on or after December 1, 2021, shall vest on the first anniversary of the grant date of the Deferred Stock Units, if </font></div><div style="height:68.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the Participant subject to the grant shall then be a member of the Board of Directors&#59; provided, however, that a Participant&#8217;s interest in his or her unvested Deferred Stock Units shall vest upon the earliest to occur of a Change in Control, the Participant&#8217;s death, or the Participant&#8217;s Disability.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ARTICLE IV </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">INVESTMENT OF DEFERRALS&#59; DISTRIBUTIONS </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 4.1 INVESTMENT OF DEFERRALS.  All amounts deferred under the Plan shall be credited to the Participant&#8217;s Account and shall be deemed to be invested in notional shares of IDEXX Stock, denominated as Deferred Stock Units.  The number of Deferred Stock Units credited to a Participant&#8217;s Account with respect to any elective or mandatory deferral shall be determined by dividing the amount of the deferral by the closing price of one share of IDEXX Stock on the conversion date established by the Plan Administrator with respect to any deferral period, which conversion date shall not be later than 30 days after the end of the deferral period.   </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 4.2 DISTRIBUTIONS.  </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.91pt">(a)&#160;&#160;&#160;&#160;Subject to the limitations set forth in this Section, a Participant shall be permitted to elect the form or timing of the distribution of his or her benefits under the Plan.  A Participant shall make a distribution election with respect to deferrals pursuant to a Retainer Deferral Election and&#47;or an Equity Grant Deferral Election for any Plan Year by completing and returning to the Plan Administrator (or his or her designee) a written election on the form prescribed by the Plan Administrator.  A Participant&#8217;s election shall be made at the same time as he or she makes a Retainer Deferral Election and&#47;or an Equity Grant Deferral Election under Sections 3.1(a) and 3.2(b), respectively, above.  </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;A Participant may choose to receive his or her benefits under the Plan at the time and in the form selected from the following alternatives&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)&#160;&#160;&#160;&#160;with respect to deferrals before January 1, 2022, (x) a single lump sum as soon as practicable on or after the first business day following the first anniversary of his or her last day of service on the Board of Directors&#59; or (y) with respect to deferrals on and after January 1, 2011, on a nondiscretionary and objectively determinable date (a &#8220;Fixed Date&#8221;) in a single lump sum payable as soon as practicable on or after the Fixed Date or in equal annual installments over a period of four (4) years commencing as soon as practicable on or after the Fixed Date&#59; and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(ii)&#160;&#160;&#160;&#160;with respect to deferrals on or after January 1, 2022, (x) a single lump sum as soon as practicable on or after the first business day following his or her last day of service on the Board of Directors&#59; or (y) on a Fixed Date in a single lump sum payable as soon as practicable on or after the Fixed Date or in equal annual installments over a period of four (4) years commencing as soon as practicable on or after the Fixed Date</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If no timely election is returned to the Plan Administrator, a Participant&#8217;s benefits shall be distributed in a single lump sum as soon as practicable on or after (i) in respect of Deferred Stock Units credited to the Participant&#8217;s Account prior to January 1, 2022, the first business day following the first anniversary of his or her last day of service on the Board of Directors&#59; and (ii) in respect of Deferred Stock Units credited to the Participant&#8217;s Account on or after January 1, 2022, the first business day following his or her last day of service on the Board of Directors.    Notwithstanding the foregoing&#58;  (x) the Participant&#8217;s benefit shall be distributed in a single lump sum as soon as practicable on or after a Change in Control of the Company&#59; and (y) a Participant&#8217;s benefit shall be distributed to his or her personal representative if the Participant should die prior to the otherwise elected or scheduled distribution date as set forth herein.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;A Participant&#8217;s election as to the distribution of benefits previously deferred under the Plan may be modified only subject to the following requirements&#58; </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)&#160;&#160;&#160;&#160;such change in a distribution election shall be made in writing using such forms and in accordance with such procedures as the Plan Administrator shall prescribe&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(ii)&#160;&#160;&#160;&#160;no change in a distribution election may take effect until 12 months after the date on which the change in election is made&#59;  </font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(iii)&#160;&#160;&#160;&#160;a Participant may not modify an election to receive a fixed schedule of payments within 12 months of the first scheduled payment date, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">and</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(iv)&#160;&#160;&#160;&#160;a change in a Participant&#8217;s distribution election must defer the date of the distribution by at least 5 years from the date the distribution would otherwise have been made. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">An installment form of distribution shall be treated as an entitlement to receive a single payment, as described in Treasury Regulations &#167; 1.409A-2(b)(2)(iii), for purposes of applying the requirements relating to the timing and effect of subsequent change in a distribution election.</font></div><div style="height:68.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;Upon application by the Participant, if the Plan Administrator determines that a Participant has experienced an Unforeseeable Emergency, the Plan Administrator may authorize the distribution of all or a portion of the Participant&#8217;s benefits under the Plan.  The amount distributed with respect to the Unforeseeable Emergency must not exceed the amounts necessary to satisfy such emergency plus amounts necessary to pay taxes reasonably anticipated as a result of the distribution, after taking into account the extent to which such hardship is or may be relieved through reimbursement or compensation by insurance or otherwise or by liquidation of the Participant&#8217;s assets (to the extent the liquidation of such assets would not itself cause severe financial hardship).</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(e)&#160;&#160;&#160;&#160;All benefit distributions shall be made in the form of shares of IDEXX Stock equal to the number of Deferred Stock Units credited to the Account of the Participant (in the case of a lump sum distribution), or equal to the number of Deferred Stock Units subject to distribution as of the applicable distribution date (in the case of distributions to be made in installments). </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ARTICLE V </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ADMINISTRATIVE PROCEDURES </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 5.1 GENERAL. The Plan shall be administered by the Plan Administrator. The Plan Administrator shall establish such procedures and rules as he or she, in his or her sole discretion, shall deem appropriate regarding the making of deferral elections and distributions, and all other administrative items for this Plan, in all events consistent with the written terms of the Plan and Section 409A of the Code.  </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 5.2 PLAN INTERPRETATION. The Plan Administrator shall have the authority and responsibility to interpret and construe the Plan and to decide all questions arising thereunder, including without limitation, questions of eligibility for participation, eligibility for deferrals, Account status, and the timing of the distribution thereof, and shall have the authority to deviate from the literal terms of the Plan only to the extent the Plan Administrator shall determine, in his or her sole discretion, to be necessary or appropriate to operate the Plan in compliance with the provisions of applicable law, including, without limitation, Code Section 409A.  In no event shall the Plan Administrator use its authority or discretion to accelerate the timing of benefit distributions under the Plan. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 5.3 RESPONSIBILITIES AND REPORTS. The Plan Administrator may, pursuant to a written instruction, name other persons to carry out specific responsibilities. The Plan Administrator shall be entitled to rely conclusively upon all tables, valuations, certificates, opinions and reports that are furnished by any accountant, controller, counsel, or other person who is employed or engaged for such purposes.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ARTICLE VI</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CLAIMS PROCEDURE </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 6.1 DENIAL OF CLAIM FOR BENEFITS. Any denial by the Plan Administrator of any claim for benefits under the Plan by a Participant or Beneficiary shall be stated in writing by the Plan Administrator and delivered or mailed to the Participant or Beneficiary. The Plan Administrator shall furnish the claimant with notice of the decision not later than 90 days after receipt of the claim, unless special circumstances require an extension of time for processing the claim. If such an extension of time for processing is required, written notice of the extension shall be furnished to the claimant prior to the termination of the initial 90-day period. In no event shall such extension exceed a period of 90 days from the end of such initial period. The extension notice shall indicate the special circumstances requiring an extension of time and the date by which the Plan Administrator expects to render the final decision. The notice of the Plan Administrator's decision shall be written in a manner calculated to be understood by the claimant and shall include (i) the specific reasons for the denial, including, where appropriate, references to the Plan, (ii) any additional information necessary to perfect the claim with an explanation of why the information is necessary, and (iii) an explanation of the procedure for perfecting the claim.  </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 6.2 APPEAL OF DENIAL. The claimant shall have 60 days after receipt of written notification of denial of his or her claim in which to file a written appeal with the Plan Administrator. As a part of any such appeal, the claimant may submit issues and comments in writing and shall, on request, be afforded an opportunity to review any documents pertinent to the perfection of his or her claim. The Plan Administrator shall render a written decision on the claimant's appeal ordinarily within 60 days of receipt of notice thereof but, in no case, later than 120 days.  </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ARTICLE VII </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FUNDING </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 7.1 FUNDING. The Company shall not segregate or hold separately from its general assets any amounts credited to Participant Accounts, and shall be under no obligation whatsoever to fund in advance any amounts under the Plan, including Deferrals and earnings thereon.  </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 7.2 INSOLVENCY. In the event that the Company becomes insolvent, all Participants and Beneficiaries shall be treated as general, unsecured creditors of the Company with respect to any amounts credited to Participant Accounts.  </font></div><div style="height:68.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ARTICLE VIII </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">AMENDMENT AND TERMINATION </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Company reserves the right to amend or terminate the Plan at any time by action of the Board or the Compensation Committee thereof&#59; provided, however, that the Chief Human Resources Officer may approve amendments to the Plan that are primarily technical or administrative in nature (such as amendments that are necessary to bring the Plan into formal compliance with applicable law and do not materially alter the design or benefit structure of the Plan).  Notwithstanding the foregoing, no such amendment or termination shall reduce any Participant's Account Balance as of the date of such amendment or termination, or accelerate the distribution of benefits to any Participant.  Any distributions made in connection with the termination of the Plan shall be made&#58;  (a) not sooner than the last day of the 12th month after the termination date, (b) not later than the 24th month after the termination date, and (c) in all other ways in accordance with all applicable requirements of Section 409A of the Code.   </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ARTICLE IX </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MISCELLANEOUS </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 9.1 NO EMPLOYMENT CONTRACT. The establishment or existence of the Plan shall not confer upon any individual the right to be continued as a Director.  </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 9.2 NON-ALIENATION. No amounts payable under the Plan shall be subject in any manner to anticipation, assignment, or voluntary or involuntary alienation.  </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 9.3 GOVERNING LAW. The Plan shall be governed by and construed in accordance with the laws of the State of Maine to the extent not preempted by federal law.  </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 9.4 INCAPACITY. If the Plan Administrator, in his or her sole discretion, deems a Participant or Beneficiary who is eligible to receive any payment hereunder to be incompetent to receive the same by reason of illness or any infirmity or incapacity of any kind, the Plan Administrator may direct the Company to apply such payment directly for the benefit of such person, or to make payment to any person selected by the Plan Administrator to disburse the same for the benefit of the Participant or Beneficiary. Payments made pursuant to this Section shall operate as a discharge, to the extent thereof, of all liabilities of the Company, the Plan Administrator and the Plan to the person for whose benefit the payments are made.  </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 9.5 CONSTRUCTION OF TERMS. For purposes of the Plan, the singular shall include the plural, and vice versa and the masculine shall include the feminine.  </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 9.6 BINDING UPON SUCCESSORS. The liabilities under the Plan shall be binding upon any successor, assign or purchaser of the Company or any purchaser of substantially all of the assets of the Company.  </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 9.7 NO TRUST ARRANGEMENT. All benefits under the Plan represent an unsecured promise to pay by the Company. The Plan shall be unfunded and the benefits hereunder shall be paid only from the general assets of the Company resulting in the Participants having no greater rights than the Company's other general creditors. Nothing herein shall prevent or prohibit the Company from establishing a trust or other arrangement for the purpose of providing for the payment of the benefits payable under the Plan.  </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Approved May 21, 2003 </font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restated on February 22, 2006 </font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restated on January 1, 2008 </font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restated on May 6, 2009</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restated on July 14, 2010 </font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restated on October 13, 2021</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:68.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</font></div><div><font><br></font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.28
<SEQUENCE>14
<FILENAME>ex1028idexx-directoroption.htm
<DESCRIPTION>EX-10.28
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ib0e8aec34fd94f7abe0c6425b827a741_1"></div><div style="min-height:67.68pt;width:100%"><div style="text-align:right;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exhibit 10.28</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Director Stock Option Agreement&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted Under IDEXX Laboratories, Inc. 2018 Stock Incentive Plan</font></div><div><font><br></font></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.321%"><div style="padding-right:-9.55pt;text-indent:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">1.  Grant of Option.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </font></div><div style="padding-right:-9.55pt;text-indent:9pt"><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">IDEXX Laboratories, Inc., a Delaware corporation (the</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Company&#8221;), hereby grants to the member of the Board named on the opposite side of this Agreement (the &#8220;Optionee&#8221;), an option, pursuant to the Company&#8217;s 2018 Stock Incentive Plan (the &#8220;Plan&#8221;), to purchase, in whole or in part, the number of shares of common stock, par value $0.10 per share, of the Company (&#8220;Shares&#8221;) at a price per Share as noted on the opposite side of this Agreement, subject to the terms and conditions of this Agreement, the Plan and the description of the Plan set forth in the Plan Prospectus.  The Plan and the Plan Prospectus are provided to the Optionee with this Agreement.  Capitalized terms not otherwise defined in this Agreement shall have the meanings set forth in the Plan or the Plan Prospectus.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">2.  Type of Stock Option.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">  </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">This Option is a &#8220;Non-Qualified Stock Option&#8221; and shall not be considered an incentive stock option within the meaning of Section 422 of the Internal Revenue Code of 1986, as amended from time to time (the &#8220;Code&#8221;).</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">3.  Exercise of Option and Provisions for Termination.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;(a) Vesting Schedule and Expiration</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Except as otherwise provided in this Agreement, this Option shall expire at 4&#58;00 p.m., Eastern time, on the Expiration Date indicated on the opposite side of this Agreement.  This Option will become exercisable (&#8220;vest&#8221;) in installments as to the number of Shares and during the respective installment periods set forth on the opposite side of this Agreement.  The right of exercise shall be cumulative so that if the Option is not exercised to the maximum extent permissible during an exercise period, it shall continue to be exercisable, in whole or in part, with respect to all Shares not so purchased at any time prior to the Expiration Date or the earlier termination of this Option.  This Option may not be exercised at any time after the Expiration Date.  </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;(b) Exercise Procedure</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Subject to the conditions set forth in this Agreement, this Option shall be exercised by the Optionee&#8217;s delivery of written notice of exercise through the online service designated by the Company (currently E*TRADE OptionsLink), specifying the number of Shares to be purchased and the purchase price to be paid therefor and accompanied by payment in full in accordance with Section 4.  Such exercise shall be effective upon receipt by such online service of such written notice together with the required payment.  The Optionee may purchase less than the number of Shares covered hereby, provided that no partial exercise of this Option may be for any fractional share.  </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;(c) Continuous Relationship with the Company Required.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Except as otherwise provided in this Section 3, this Option may not be exercised unless the Optionee, at the time he or she exercises this option, is, and has been at all times since the Grant Date indicated on the opposite side of this Agreement, a Director (an &#8220;Eligible Optionee&#8221;).  </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;(d) Exercise Period Upon Termination of Relationship with the Company.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">If the Optionee ceases to be an Eligible Optionee for any reason, then, except as provided in paragraphs (e), (f) and (g) below, the right to exercise this Option shall terminate 3 months after such cessation (but in no event after the Expiration Date), provided that this Option shall be exercisable only to the extent that the Optionee was entitled to exercise this option on the date of such cessation.   Notwithstanding the foregoing, if the Optionee, prior to the Expiration Date, violates any legal duty to the Company or violates any agreement between the Optionee and the Company, the right to exercise this Option shall terminate immediately upon such violation. Notwithstanding any provision in this Agreement that may be to the contrary, if, following the Optionee&#8217;s cessation of being an Eligible Optionee for any reason, except as provided in paragraphs (e), (f) and (g) below, all or a portion of the three-month exercise period applicable to the Option as described above occurs during a time when the Optionee is prohibited from trading in securities of the Company without violating applicable federal or state securities laws or the rules related to a blackout period or quiet period declared by the Company pursuant to its insider trading or similar policy, the three-month exercise period applicable to the Option will be tolled for the number of days that such prohibitions or restrictions apply, such that the three-month exercise period will be extended by the same number of days as were subject to the prohibitions or restrictions&#59;&#160;provided,&#160;however, that such three-month exercise period may not be extended due to such tolling past the Expiration Date of the Option.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;(e) Exercise Period Upon Death or Disability&#59; Immediate Vesting Upon Death or Disability.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">If the Optionee dies or becomes disabled (within the meaning of Section 22(e)(3) of the Code) prior to the Expiration Date while he or she is an Eligible Optionee, or if the Optionee dies within 3 months after the Optionee ceases to be an Eligible Optionee, and the Company has not terminated such relationship for &#8220;cause&#8221; as specified in paragraph (g) below, this Option shall be exercisable until the 1 year anniversary date following the date of death or disability of the Optionee, by the Optionee or by the person to whom this Option is transferred by will or the laws of descent and distribution, provided that this Option shall be exercisable only to the extent that this </font></div></div><div style="display:inline-block;max-width:7.356%;min-width:6.356%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:46.323%"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Option was exercisable by the Optionee on the date he or she ceased to be an Eligible Optionee.  Notwithstanding anything in this Agreement that may be to the contrary, in the event the Optionee dies or becomes disabled (as defined above) at a time when the Optionee is an Eligible Optionee, then this Option shall immediately vest and become exercisable with respect to all Shares underlying this Option as of the date of the Optionee&#8217;s death or disability.  </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;(f) Exercise Period Upon Retirement.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">If the Optionee retires (as defined below) prior to the Expiration Date while he or she is an Eligible Optionee, and the Company or its Affiliate has not terminated such relationship for &#8220;cause&#8221; as specified in paragraph (g) below, this Option shall, to the extent vested, remain exercisable until the 3 year anniversary date following the date of retirement of the Optionee (but in no event after the Expiration Date). &#8220;Retire&#8221; and &#8220;retirement&#8221; shall mean retirement from the Board, provided that the Optionee has been a Director for at least 5 years, not including any years during which the Optionee was a director of a company that was acquired by or merged with the Company.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;(g)  Discharge for Cause.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">If the Optionee, prior to the Expiration Date, ceases his or her relationship with the Company because he or she is discharged for &#8220;cause&#8221; (as defined below), the right to exercise this Option shall terminate immediately upon such cessation of employment.  &#8220;Cause&#8221; shall mean willful misconduct in connection with the Optionee&#8217;s director responsibilities or willful failure to perform his or her director responsibilities in the best interests of the Company (including, without limitation, breach by the Optionee of any legal duty to the Company or breach of any r agreement between the Optionee and the Company), as determined by the Company, which determination shall be conclusive.  The Optionee shall be considered to have been discharged for &#8220;cause&#8221; if the Company determines, within 30 days of the Optionee&#8217;s resignation, that discharge for cause was warranted.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">4.  Payment of Purchase Price.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;(a) Method of Payment.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payment of the purchase price for Shares purchased upon exercise of this Option shall be made (i) by delivery to the Company, or to the online service designated by the Company, of an amount equal to the purchase price of such Shares, (ii) by delivery to the Company of Shares (either actually or by attestation) then owned by the Optionee for at least 6 months (or any shorter period sufficient to avoid a charge to the Company&#8217;s earnings for financial reporting purposes) or delivery of other consideration having a fair market value equal in amount to the purchase price of such shares, (iii) to the extent permitted by the Board, in its sole discretion, by delivery of an irrevocable and unconditional undertaking by a creditworthy broker to deliver promptly to the Company sufficient funds to pay the purchase price and any required Tax-Related Items (as defined below) or delivery by the Optionee to the Company of a copy of irrevocable and unconditional instructions to a creditworthy broker to deliver promptly to the Company cash or a check sufficient to pay the purchase price and any required Tax-Related Items&#59; or (iv) by any combination of cash, Shares, and other consideration as the Board may specify. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;(b) Valuation of Shares or Other Non-Cash Consideration Tendered in Payment of Purchase Price.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">For the purposes hereof, the fair market value of any Shares or other non-cash consideration which may be delivered to the Company in exercise of this Option shall be determined as provided in the Plan.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;(c) Delivery of Shares Tendered in Payment of Purchase Price.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">If the Optionee exercises Options by delivery Shares, any certificate or certificates representing the Shares to be delivered shall be duly executed in blank by the Optionee or shall be accompanied by a stock power duly executed in blank suitable for purposes of transferring such Shares, and any electronic delivery of Shares shall be in a manner sufficient for purposes of transferring such Shares.  Fractional Shares of Common Stock of the Company will not be accepted in payment of the purchase price of Shares acquired upon exercise of this Option.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">5.  Delivery of Shares&#59; Compliance with Securities Laws, Etc.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">   </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"> </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(a) General.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Company shall, upon payment of the Option price for the number of Shares purchased and paid for, make prompt delivery of such Shares to the Optionee, provided that if any law or regulation requires the Company to take any action with respect to such Shares before the issuance thereof, then the date of delivery of such Shares shall be extended for the period necessary to complete such action.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;(b) Listing, Qualification, Etc.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">This Option shall be subject to the requirement that if, at any time, counsel to the Company shall determine that the listing, registration or qualification of Shares subject hereto upon any securities exchange or under any state, federal or foreign law, or the consent or approval of any governmental or regulatory body, or that the disclosure of non-public information or the satisfaction of any other condition is necessary as a condition of, or in connection with, the issuance or purchase of Shares hereunder, this Option may not be exercised, in whole or part, unless such listing, registration, qualification, consent or approval, disclosure or </font></div></div></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.321%"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">satisfaction of such other condition shall have been effected or obtained on terms acceptable to the Board.  Nothing herein shall be deemed to require the Company to apply for, effect disclosure, or to satisfy such other condition.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">6.  Nontransferability of Option.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Except as provided in paragraph (e) of Section 3, this Option is personal and no rights granted hereunder may be sold, assigned, transferred, pledged or otherwise encumbered by the Optionee (whether by operation of law or otherwise).   During the lifetime of the Optionee, this Option shall be exercised only by the Optionee.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">7.  No Special Service Rights.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nothing contained in the Plan, the Plan Prospectus or this Agreement shall be construed or deemed to constitute a service contract or confer or be deemed to confer on the Optionee any right to continue in the service of, or to continue any other relationship with, the Company or limit in any way any right of the Company to terminate the Optionee&#8217;s service or other relationship at any time, with or without cause.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">8.  Rights as a Shareholder.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Optionee shall have no rights as a shareholder with respect to any Shares which may be purchased by exercise of this Option (including, without limitation, any rights to receive dividends or non-cash distributions with respect to such Shares) unless and until a certificate representing such Shares, or electronic equivalent, is duly issued and delivered to the Optionee.  No adjustment shall be made for dividends or other rights for which the record date is prior to the date such stock certificate or electronic equivalent is issued.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">9.  Taxes.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(a) Responsibility for Taxes.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> The Optionee acknowledges that, regardless of any action taken by the Company, the ultimate liability for all income tax (whether foreign, federal, state or local), social insurance, payroll tax, fringe benefits tax, payment on account and other tax-related items related to the Optionee&#8217;s participation in the Plan and legally applicable to the Optionee (the &#8220;Tax-Related Items&#8221;) is and remains the Optionee&#8217;s responsibility as it may come due and may exceed the amount actually withheld by the Company.  The Optionee further acknowledges that the Company (i) makes no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Option, and (ii) does not commit to and is under no obligation to structure the terms of the grant or any aspect of the Option to reduce or eliminate the Optionee&#8217;s liability for Tax-Related Items or achieve any particular tax result.  Further, if the Optionee is subject to Tax-Related Items in more than one jurisdiction, the Optionee acknowledges that the Company may be required to withhold or account for Tax-Related Items in more than one jurisdiction. In addition, the Optionee further acknowledges that Tax-Related Items may be incurred at different times.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(b) Withholding.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> The Optionee acknowledges and agrees to make arrangements satisfactory to the Company with respect to any withholding obligation the Company may have for Tax-Related Items.  Without limitation to the foregoing, the Optionee acknowledges and agrees that to satisfy any such withholding obligation for Tax-Related Items, the Company may (i) withhold from the Optionee's wages or other cash compensation paid to the Optionee by the Company, (ii) withhold from proceeds of the sale of Shares acquired upon exercise of the Option, either through a voluntary sale or through a mandatory sale arranged by the Company (on the Optionee&#8217;s behalf pursuant to this authorization), or (iii) withhold by any other method permitted under the Plan and applicable law.  Depending on the withholding method, the Company may withhold or account for Tax-Related Items by considering applicable minimum statutory withholding amounts or other applicable withholding rates, including up to the maximum applicable rate in the Optionee's jurisdiction (in which case, the Optionee may receive a refund of any over-withheld amount in cash and will have no entitlement to the equivalent amount in Shares). The Company may refuse to deliver the Shares or the proceeds of the sale of Shares, if the Optionee fails to comply with his or her obligations in connection with the Tax-Related Items.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(c)  Tax Consequences.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  The Optionee has reviewed with his or her own tax advisors the applicable tax consequences of this investment and the transactions contemplated by this Agreement.  With respect to such matters, the Optionee relies solely on such advisors and not on any statements or representations of the Company or any of its agents, written or oral.&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">10.  Data Privacy</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Optionee hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of the Optionee&#8217;s personal data as described in this Agreement and any other Option grant materials by and among, as applicable, the Company and its Subsidiaries and </font></div></div><div style="display:inline-block;max-width:7.356%;min-width:6.356%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:46.323%"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Affiliates for the exclusive purpose of implementing, administering and managing the Optionee&#8217;s participation in the Plan.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;The Optionee understands that the Company may hold certain personal information about the Optionee, including, but not limited to, the Optionee&#8217;s name, home address, email address and telephone number, date of birth, social insurance number, passport or other identification number, salary, nationality, job title, any shares of stock or directorships held in the Company, details of all Options or any other entitlement to shares of stock awarded, canceled, exercised, vested, unvested or outstanding in the Optionee&#8217;s favor (&#8220;Data&#8221;), for the exclusive purpose of implementing, administering and managing the Plan. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;The Optionee understands that Data will be transferred to E*TRADE, or such other stock plan service provider as may be selected by the Company in the future, which is assisting the Company with the implementation, administration and management of the Plan.  The Optionee understands that the recipients of the Data may be located in the United States or elsewhere, and that the recipient&#8217;s country may have different data privacy laws and protections than the Optionee&#8217;s country.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;The Optionee authorizes the Company, E*TRADE and any other possible recipients which may assist the Company (presently or in the future) with implementing, administering and managing the Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the sole purposes of implementing, administering and managing the Optionee&#8217;s participation in the Plan.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">11.  Miscellaneous.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(a)    This Agreement and the Plan constitute the entire agreement between the parties, and supersedes all prior agreements and understandings, relating to the subject matter of this Agreement.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(b)   Except as provided herein, this Agreement may not be amended or otherwise modified unless evidenced in writing and signed by the Company and the Optionee. Any provision for the benefit of the Company contained in this Agreement may be waived, either generally or in any particular instance, by the Board.  The Board may amend, alter, suspend, discontinue or terminate the Plan, or any portion thereof, at any time, subject to the requirements for certain amendments or alterations set forth in the Plan.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(c)    This Agreement shall be binding upon and inure to the benefit of the Company and the Optionee and their respective heirs, executors, administrators, representatives, successors and assigns, subject to the restrictions on transfer set forth in Section 6 hereof.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(d)    The Option and the provisions of this Agreement shall be governed by and construed in accordance with the laws of the State of Delaware and applicable federal law, without regard to applicable conflict of laws principles.  </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(e)    The invalidity or unenforceability of any provision of this Agreement shall not affect the validity or enforceability of any other provision of this Agreement, and each other provision of this Agreement shall be severable and enforceable to the extent permitted by law.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(f)    The Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding the Optionee&#8217;s participation in the Plan, or the Optionee&#8217;s acquisition or sale of the underlying Shares. </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(g)   All notices under this Agreement shall be mailed or delivered by hand to the parties at their respective addresses set forth in this Agreement or at such other address as may be designated in writing by either of the parties to one another.</font></div><div style="text-indent:18pt"><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(h)  The Company may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plan by electronic means.  The Optionee hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Company or a third party designated by the Company. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(j)   The Company reserves the right to impose other requirements on the Optionee&#8217;s participation in the Plan, on the Option and on any Shares acquired under the Plan, to the extent the Company determines it is necessary or advisable for legal or administrative reasons, and to require the Optionee to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.</font></div><div style="text-indent:-4.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </font></div></div></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.29
<SEQUENCE>15
<FILENAME>ex1029idexx-directorrsuagr.htm
<DESCRIPTION>EX-10.29
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i7c2cecd2913b411a8848a77db0e3ab08_1"></div><div style="min-height:79.92pt;width:100%"><div style="text-align:right;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit 10.29</font></div><div style="padding-left:82.13pt;padding-right:82.13pt;text-align:center;text-indent:0.18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Director Restricted Stock Unit Agreement</font></div><div style="padding-left:167.6pt;padding-right:167.6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted Under IDEXX Laboratories, Inc. 2018 Stock Incentive Plan</font></div><div><font><br></font></div></div><div style="margin-top:0.05pt"><font><br></font></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.677%"><div style="margin-top:4.25pt;padding-left:17.25pt;padding-right:2.6pt;text-indent:-11.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:4.59pt;text-decoration:underline">Grant of Restricted Stock.</font></div><div style="margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font><br></font></div><div style="margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">IDEXX Laboratories, Inc., a Delaware corporation (the &#8220;Company&#8221;), hereby grants to the Participant a Restricted Stock Unit Award consisting of the number of Restricted Stock Units (&#8220;RSUs&#8221;) stated in this Agreement, including any exhibit, appendix or addendum hereto (the &#8220;Agreement&#8221;). Each RSU represents the right to receive one share of common stock, $.010 par value, of the Company (individually a &#8220;Share&#8221; and collectively the &#8220;Shares&#8221;). The Company will record on its books the grant of the RSUs to the Participant and will issue Shares upon vesting of the RSUs as provided below. This award of RSUs is subject to the terms and conditions set forth in this Agreement, the Company&#8217;s 2018 Stock Incentive Plan (the &#8220;Plan&#8221;) and the description of the Plan set forth in the Plan Prospectus. The Plan and the Plan Prospectus are provided to the Participant with this Agreement. Capitalized terms not otherwise defined in this Agreement shall have the meanings set forth in the Plan or the Plan Prospectus.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:17.25pt;padding-right:2.6pt;text-indent:-11.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:4.59pt;text-decoration:underline">Vesting and Forfeiture.</font></div><div style="padding-left:17.25pt;padding-right:2.6pt"><font><br></font></div><div style="margin-top:0.4pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:117%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:117%;padding-left:2.24pt">Vesting. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:117%">Subject to Section 2(b) and (c), the RSUs shall vest and become nonforfeitable in accordance with the vesting schedule set forth in this Agreement.</font></div><div style="margin-top:0.4pt;padding-left:24pt;padding-right:2.6pt"><font><br></font></div><div style="margin-top:0.2pt;padding-left:6pt;padding-right:1.15pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:117%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:117%;padding-left:1.8pt">Forfeiture</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:117%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:117%">Except as otherwise provided in this Section 2, in the event that the Participant ceases to be a member of the Board (an &#8220;Eligible Grantee&#8221;) for any reason or no reason, the balance of RSUs that have not vested as of the date of such cessation will be forfeited and the Participant will have no future rights with respect to any such unvested RSUs. </font></div><div style="margin-top:0.2pt;padding-left:24pt;padding-right:1.15pt"><font><br></font></div><div style="margin-top:0.2pt;padding-left:6pt;padding-right:1.15pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:117%">(c)</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:117%;padding-left:2.24pt">Disability or Death</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:117%">.&#160; In the event that the Participant&#8217;s service to the Company is terminated as a result of the Participant&#8217;s Disability (as defined in Section 22(e)(3) of the Code) or as a result of the Participant&#8217;s death, all RSUs that have not vested as of the date of such cessation of service shall immediately vest and become nonforfeitable as of the date of the Participant&#8217;s Disability or death&#59; provided, however, if such Disability or death occurs within one year of the grant date of this award, then this award shall continue to vest after the date of such Disability or death in accordance with the schedule described in Section 2(a) above, except that all RSUs that have not vested as of the date of such cessation of service will immediately vest and become nonforfeitable as of the date that is the one-year anniversary of the grant date of this award.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:15pt;padding-right:2.6pt;text-indent:-9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:2.34pt;text-decoration:underline">Restrictions on Transfer.</font></div><div style="padding-left:15pt;padding-right:2.6pt"><font><br></font></div><div style="margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Participant may not sell, assign, transfer, pledge, hypothecate or otherwise dispose of by operation of law or otherwise, any RSUs, or any interest therein, except by will or the laws of descent and distribution.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:17.25pt;padding-right:2.6pt;text-indent:-11.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:4.59pt;text-decoration:underline">Rights as Stockholder.</font></div><div style="padding-left:17.25pt;padding-right:2.6pt"><font><br></font></div><div style="margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Neither the Participant, nor any person claiming through the Participant, will have any of the rights or privileges of a stockholder of the Company with respect to the RSUs unless and until Shares have been issued, recorded on the records of the Company or its transfer agent, and delivered to the Participant upon vesting of the RSUs. No adjustment shall be made for dividends or distributions or other rights for which the record date is prior to the date such Shares are issued. After such issuance, recordation and delivery, the Participant will have all the rights of a stockholder of the Company with respect to the Shares.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:17.25pt;padding-right:2.6pt;text-indent:-11.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:4.59pt;text-decoration:underline">Delivery of Shares&#59; Compliance with Securities Laws, Etc.</font></div><div style="padding-left:17.25pt;padding-right:2.6pt"><font><br></font></div><div style="margin-top:0.4pt;padding-left:6pt;padding-right:1pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:117%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:117%;padding-left:2.24pt">General. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:117%">The Company shall, upon vesting of RSUs hereunder, make prompt delivery of vested Shares to the Participant, or if the Participant has died or become Disabled (as defined in Section 2(c) above), to the person to whom this award is transferred by will or the laws of descent and distribution, provided that if any law or regulation requires the Company to take any action with respect to such Shares before the issuance thereof, then the date of delivery of such Shares shall be extended for the period necessary to complete such action.</font></div><div style="margin-top:0.4pt;padding-left:24pt;padding-right:1pt"><font><br></font></div><div style="margin-top:0.4pt;padding-left:6pt;padding-right:1pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:117%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:117%;padding-left:1.8pt">Listing, Qualification, Etc</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:117%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:117%">The RSUs shall be subject to the requirement that if, at any time, counsel to the Company shall determine that the listing, registration or qualification of Shares subject hereto upon any </font></div></div><div style="display:inline-block;max-width:2.644%;min-width:1.644%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.679%"><div style="margin-top:0.4pt;padding-left:6pt;padding-right:1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:117%">securities exchange or under any state or federal law, or the consent or approval of any governmental or regulatory body, or that the disclosure of non-public information or the satisfaction of any other condition is necessary as a condition of, or in connection with,  the  issuance of Shares hereunder, then such issuance shall be deferred until such listing, registration, qualification, consent or approval, disclosure or satisfaction of such other condition shall have been effected or obtained on terms acceptable to the Board. Nothing herein shall be deemed to require the Company to apply for, effect disclosure, or to satisfy such other condition.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:17.25pt;padding-right:7.25pt;text-indent:-11.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">6.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:4.59pt;text-decoration:underline">No Special Service Rights.</font></div><div style="padding-left:17.25pt;padding-right:7.25pt"><font><br></font></div><div style="margin-top:0.15pt;padding-left:6pt;padding-right:7.25pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nothing contained in the Plan, the Plan Prospectus or this Agreement shall be construed or deemed to constitute a service contract or confer or be deemed to confer on the Participant any right to continue in the service of, or to continue any other relationship with, the Company or an Affiliate or limit in any way any right of the Company or an Affiliate, as applicable, to terminate the Participant&#8217;s service or other relationship at any time, with or without cause.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:17.25pt;padding-right:7.25pt;text-indent:-11.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">7.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:4.59pt;text-decoration:underline">Taxes.</font></div><div style="padding-left:17.25pt;padding-right:7.25pt"><font><br></font></div><div style="margin-top:0.2pt;padding-left:6pt;padding-right:14.45pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:118%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:118%;padding-left:2.24pt">Responsibility for Taxes. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:118%">The Participant acknowledges that, regardless of any action taken by the Company, the ultimate liability for all income tax (whether foreign, federal, state or local), social insurance, payroll tax, fringe benefits tax, payment on account and other tax-related items related to the Participant&#8217;s participation in the Plan and legally applicable to the Participant (the &#8220;Tax-Related Items&#8221;) is and remains the Participant&#8217;s responsibility as it may come due and may exceed the amount actually withheld by the Company.  The Participant further acknowledges that the Company (i) makes no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the RSUs, and (ii) does not commit to and is under no obligation to structure the terms of the grant or any aspect of the RSUs to reduce or eliminate the Participant&#8217;s liability for Tax-Related Items or achieve any particular tax result.  Further, if the Participant is subject to Tax-Related Items in more than one jurisdiction, the Participant acknowledges that the Company may be required to withhold or account for Tax-Related Items in more than one jurisdiction.  In addition, the Participant further acknowledges that Tax-Related Items may be incurred at different times. The Participant acknowledges that no election under Section 83(b) of the Internal Revenue Code of 1986 may be filed with respect to this award.</font></div><div style="margin-top:0.2pt;padding-left:24pt;padding-right:14.45pt"><font><br></font></div><div style="margin-top:0.2pt;padding-left:6pt;padding-right:14.45pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:118%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:118%;padding-left:1.8pt">Withholding.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:118%"> The Participant acknowledges and agrees to make arrangements satisfactory to the Company with respect to any withholding obligation the Company may have for Tax-Related Items. Without limitation to the foregoing, the Participant acknowledges and agrees that to satisfy any such withholding obligation for Tax-Related Items, the Company may (i) deduct and retain from the Shares to be distributed upon vesting of RSUs such number of Shares as is equal in value to the Tax-Related Items, (ii) withhold from the Participant's wages or other cash compensation paid to the Participant by the Company, (iii) withhold from proceeds of the sale of Shares acquired upon vesting and settlement of the RSUs, either through a voluntary sale or through a mandatory sale arranged by the Company (on the Participant&#8217;s behalf pursuant to this authorization), or (iv) withhold by any other method permitted under the Plan and applicable law.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%">  </font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:7.25pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depending on the withholding method, the Company may withhold or account for Tax-Related Items by considering applicable minimum statutory withholding amounts or other applicable withholding rates, including up to the maximum applicable rate in the Participant's jurisdiction (in which case, the Participant may receive a refund of any over-withheld amount in cash and will have no entitlement to the equivalent amount in Shares).  If the obligation for Tax-Related Items is satisfied by withholding in Shares, as described in (i) above, for tax purposes, the Participant will be deemed to have been issued the full number of Shares subject to the vested portion of the RSUs.  The Company may refuse to issue or deliver the Shares or the proceeds of the sale of Shares, if the Participant fails to comply with his or her obligations in connection with the Tax-Related Items.</font></div></div></div><div style="height:56.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:79.92pt;width:100%"><div><font><br></font></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.677%"><div style="margin-top:0.2pt;padding-left:6pt;padding-right:14.45pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:118%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:118%;padding-left:2.24pt">Tax Consequences</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:118%">.  The Participant has reviewed with his or her own tax advisors the applicable tax consequences of this investment and the transactions contemplated by this Agreement.  With respect to such matters, the Participant relies solely on such advisors and not on any statements or representations of the Company or any of its agents, written or oral.  </font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:17.25pt;padding-right:7.25pt;text-indent:-11.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">8.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:4.59pt;text-decoration:underline">Data Privacy.</font></div><div style="padding-left:17.25pt;padding-right:7.25pt"><font><br></font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Participant hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of the Participant&#8217;s personal data as described in this Agreement and any other RSU grant materials by and among, as applicable, the Company and its Subsidiaries and Affiliates for the exclusive purpose of implementing, administering and managing the Participant&#8217;s participation in the Plan.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:7.25pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Participant understands that the Company may hold certain personal information about the Participant, including, but not limited to, the Participant&#8217;s name, home address, email address and telephone number, date of birth, social insurance number, passport or other identification number, salary, nationality, job title, any shares of stock or directorships held in the Company, details of all RSUs or any other entitlement to shares of stock awarded, canceled, exercised, vested, unvested or outstanding in the Participant&#8217;s favor (&#8220;Data&#8221;), for the exclusive purpose of implementing, administering and managing the Plan. </font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Participant understands that Data will be transferred to E*TRADE or such other stock plan service provider as may be selected by the Company in the future, which is assisting the Company with the implementation, administration and management of the Plan. The Participant understands that the recipients of the Data may be located in the United States or elsewhere, and that the recipient&#8217;s country may have different data privacy laws and protections than the Participant&#8217;s country.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Participant authorizes the Company, E*TRADE and any other possible recipients which may assist the Company (presently or in the future) with implementing, administering and managing the Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the sole purposes of implementing, administering and managing the Participant&#8217;s participation in the Plan.  </font></div><div style="padding-left:17.25pt;padding-right:7.25pt;text-indent:-11.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">9.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:4.59pt;text-decoration:underline">Miscellaneous.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:7.8pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;padding-left:6.09pt">This Agreement and the Plan constitute the entire agreement between the parties, and supersedes all prior agreements and understandings, relating to the subject matter of this Agreement. </font></div><div style="margin-top:0.4pt;padding-left:6pt;padding-right:7.25pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:117%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:117%;padding-left:1.8pt">Except as provided herein, this Agreement may not be amended or otherwise modified unless evidenced in writing and signed by the Company and the Participant. Any provision for the benefit of the Company contained in this Agreement may be waived, either generally or in any particular instance, by the Board. The Board may amend, alter, suspend, discontinue or terminate the Plan, or any portion thereof, at any time, subject to the requirements for certain amendments or alterations set forth in the Plan.</font></div><div style="margin-top:0.4pt;padding-left:24pt;padding-right:7.25pt"><font><br></font></div><div style="margin-top:0.2pt;padding-left:6pt;padding-right:18.2pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:117%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:117%;padding-left:2.24pt">This Agreement shall be binding upon and inure to the benefit of the Company and the Participant and their respective heirs, executors, administrators, representatives, successors and assigns, subject to the restrictions on transfer set forth in Section 3 hereof.</font></div><div style="margin-top:0.2pt;padding-right:18.2pt"><font><br></font></div><div style="margin-top:0.2pt;padding-left:6pt;padding-right:12.05pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:117%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:117%;padding-left:1.8pt">The right of the Participant to receive Shares pursuant to this award is an unfunded and unsecured obligation of the Company. The Participant shall have no rights under this award other than those of an unsecured general creditor of the Company.</font></div><div style="margin-top:0.2pt;padding-right:12.05pt"><font><br></font></div><div style="margin-top:0.2pt;padding-left:6pt;padding-right:11.8pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:117%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:117%;padding-left:2.24pt">The RSUs and the provisions of this Agreement shall be governed by and construed in accordance with the laws of the State of Delaware and applicable federal law, without regard to applicable conflict of laws principles.</font></div><div><font><br></font></div><div style="margin-top:0.2pt;padding-left:6pt;padding-right:11.8pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:117%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:117%;padding-left:4.02pt">The invalidity or unenforceability of any provision of this Agreement shall not affect the validity or enforceability of any other </font></div></div><div style="display:inline-block;max-width:2.644%;min-width:1.644%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.679%"><div style="margin-top:0.2pt;padding-left:6pt;padding-right:11.8pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:117%">provision of this Agreement, and each other provision of this Agreement shall be severable and enforceable to the extent permitted by law.</font></div><div><font><br></font></div><div style="margin-top:0.2pt;padding-left:6pt;padding-right:11.8pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:117%">(g)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:117%;padding-left:1.8pt">The Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding the Participant&#8217;s participation in the Plan, or the Participant&#8217;s acquisition or sale of the underlying Shares.  </font></div><div><font><br></font></div><div style="margin-top:0.2pt;padding-left:6pt;padding-right:11.8pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:117%">(h)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:117%;padding-left:1.8pt">All notices under this Agreement shall be mailed or delivered by hand to the parties at their respective addresses set forth in this Agreement or at such other address as may be designated in writing by either of the parties to one another.</font></div><div><font><br></font></div><div style="margin-top:0.2pt;padding-left:6pt;padding-right:11.8pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:117%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:117%;padding-left:4.46pt">The Company may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plan by electronic means.  The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Company or a third party designated by the Company. </font></div><div><font><br></font></div><div style="margin-top:0.2pt;padding-left:6pt;padding-right:11.8pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:117%">(j)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:117%;padding-left:4.46pt">The Company reserves the right to impose other requirements on the Participant&#8217;s participation in the Plan, on the RSUs and on any Shares acquired under the Plan, to the extent the Company determines it is necessary or advisable for legal or administrative reasons, and to require the Participant to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.</font></div></div></div><div style="height:56.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.34
<SEQUENCE>16
<FILENAME>a1034employeestockoptionaw.htm
<DESCRIPTION>EX-10.34
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i921951bb9a144a0abf7620c57dbcaf74_1"></div><div style="min-height:72.72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exhibit 10.34</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee Stock Option Agreement</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted Under IDEXX Laboratories, Inc. 2018 Stock Incentive Plan</font></div><div><font><br></font></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:47.825%"><div style="margin-bottom:12pt;padding-right:-9.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">1.  Grant of Option.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:6.09pt">Grant.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  IDEXX Laboratories, Inc., a Delaware corporation (the &#8220;Company&#8221;), pursuant to the Company&#8217;s 2018 Stock Incentive Plan (the &#8220;Plan&#8221;) and this Employee Stock Option Agreement, including any exhibit, appendix or addendum hereto (the &#8220;Agreement&#8221;), hereby grants to the employee named on the opposite side of this Agreement (the &#8220;Optionee&#8221;) an option to purchase, in whole or in part, the number of shares of common stock, par value $0.10 per share, of the Company (&#8220;Shares&#8221;) at a price per Share as noted on the opposite side of this Agreement, subject to the terms and conditions of this Agreement, the Plan and the description of the Plan set forth in the Plan Prospectus.  The Plan and the Plan Prospectus are provided to the Optionee with this Agreement.  Capitalized terms not otherwise defined in this Agreement shall have the meanings set forth in the Plan or the Plan Prospectus.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:5.65pt">Restrictive Covenant Agreements.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  Optionee acknowledges and affirms that&#58; (i) Optionee is subject to non-competition, non-solicitation and&#47;or confidentiality provisions set forth in one or more agreements with the Company or any of its Affiliates (including, as applicable, employment, consulting or advisory contracts&#59; confidentiality and nondisclosure agreements&#59; or other agreements&#59; in each case as may be amended, supplemented or replaced from time to time) (collectively, the &#8220;Restrictive Covenant Agreements&#8221;)&#59; (ii) this Option is granted in consideration of Optionee&#8217;s agreement to be bound by the Optionee&#8217;s Restrictive Covenant Agreements&#59; (iii) if the Company requests that Optionee execute updated Restrictive Covenant Agreements, the vesting of this Option is conditioned on Optionee&#8217;s execution and delivery of such updated Restrictive Covenant Agreements in a manner and by a date satisfactory to the Company in its sole discretion, and the failure of Optionee to so execute and deliver any such requested updated Restrictive Covenant Agreement by such date will result in the immediate cancellation of, and automatic forfeiture of any rights Optionee may have with respect to, this Option&#59;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">and (iv) Optionee agrees to comply with the restrictions and obligations set forth in Optionee&#8217;s Restrictive Covenant Agreements.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">2.  Type of Stock Option.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">If the opposite side of this Agreement indicates that this Option is an &#8220;Incentive Stock Option&#8221;, this Option is intended to qualify as an incentive stock option within the meaning of Section 422 of the Internal Revenue Code of 1986, as amended from time to time (the &#8220;Code&#8221;).  If the opposite side of this Agreement indicates that this Option is a &#8220;Non-Qualified Stock Option&#8221;, this Option shall not be considered an incentive stock option as defined by Section 422 of the Code.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">3.  Exercise of Option and Provisions for Termination.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:6.93pt">Vesting Schedule and Expiration.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  Except as otherwise provided in this Agreement, this Option shall expire at 4&#58;00 p.m., Eastern time, on the Expiration Date indicated on the opposite side of this Agreement.  This Option will become exercisable (&#8220;vest&#8221;) in installments as to the number of Shares and during the respective installment periods set forth on the opposite side of this Agreement.  The right of exercise shall be cumulative so that if the Option is not exercised to the maximum extent permissible during an exercise period, it shall continue to be exercisable, in whole or in part, with respect to all Shares not so purchased at any time prior to the Expiration Date or the earlier termination of this Option.  This Option may not be exercised at any time after the Expiration Date.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:6.58pt">Exercise Procedure.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  Subject to the conditions set forth in this Agreement, this Option shall be exercised by the Optionee&#8217;s delivery of written notice of exercise through the online service designated by the Company (currently E*TRADE OptionsLink), specifying the number of Shares to be purchased and the purchase price to be paid therefor and accompanied by payment in full in accordance with Section 4.  Such exercise shall be effective upon receipt by such online service of such written notice together with the required payment.  The Optionee may purchase less than the number of Shares covered hereby, provided that no partial exercise of this Option may be for any fractional share.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:7.53pt">Continuous Relationship with the Company Required.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  Except as otherwise provided in this Section 3, this Option may not be exercised unless the Optionee, at the time he or she exercises this Option, is, and has been at all times since the Grant Date indicated on the opposite side of this Agreement, an employee of the Company or an Affiliate or a member of the Board (an &#8220;Eligible Optionee&#8221;). </font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Company shall determine in good faith (including in accordance with Section 409A of the Code) and in the exercise of its discretion whether the Optionee has ceased to be an employee and </font></div></div><div style="display:inline-block;max-width:4.348%;min-width:3.348%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:47.827%"><div style="margin-bottom:12pt;padding-left:5.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">the effective date of the Optionee&#8217;s termination of such status, and such determinations shall be final, binding and conclusive.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:6.58pt">Exercise Period Upon Termination of Relationship with the Company.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  If the Optionee ceases to be an Eligible Optionee for any reason, then, except as provided in paragraphs (e), (f) and (g) below, the right to exercise this Option shall terminate 3 months after such cessation (but in no event after the Expiration Date), provided that this Option shall be exercisable only to the extent that the Optionee was entitled to exercise this Option on the date of such cessation. Notwithstanding any provision in this Agreement that may be to the contrary, if, following the Optionee&#8217;s cessation of being an Eligible Optionee for any reason, except as provided in paragraphs (e), (f) and (g) below, all or a portion of the three-month exercise period applicable to the Option as described above occurs during a time when the Optionee is prohibited from trading in securities of the Company without violating applicable federal or state securities laws or the rules related to a blackout period or quiet period declared by the Company pursuant to its insider trading or similar policy, the three-month exercise period applicable to the Option will be tolled for the number of days that such prohibitions or restrictions apply, such that the three-month exercise period will be extended by the same number of days as were subject to the prohibitions or restrictions&#59;&#160;provided,&#160;however, that such three-month exercise period may not be extended due to such tolling past the Expiration Date of the Option.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:6.85pt">Exercise Period Upon Death or Disability&#59; Immediate Vesting upon Death or Disability.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  If the Optionee dies or becomes disabled (within the meaning of Section 22(e)(3) of the Code) prior to the Expiration Date while he or she is an Eligible Optionee, or if the Optionee dies within 3 months after the Optionee ceases to be an Eligible Optionee, and the Company or its Affiliate has not terminated such relationship for &#8220;cause&#8221; as specified in paragraph (g) below, this Option shall be exercisable until the 1 year anniversary date following the date of death or disability of the Optionee by the Optionee or by the person to whom this Option is transferred by will or the laws of descent and distribution, provided that this Option shall be exercisable only to the extent that this Option was exercisable by the Optionee on the date he or she ceased to be an Eligible Optionee.  Notwithstanding anything in this Agreement that may be to the contrary, in the event the Optionee dies or becomes disabled (as defined above) at a time when the Optionee is an Eligible Optionee, then this Option shall immediately vest and become exercisable with respect to all Shares underlying this Option as of the date of the Optionee&#8217;s death or disability&#59; provided, however, if such death or disability occurs within one year of the Grant Date, then this Option shall continue to vest after the date of such death or disability in accordance with the schedule described in Section 3(a) above, except that it will immediately vest and become exercisable with respect to all Shares underlying this Option as of the date that is the one-year anniversary of the Grant Date of this Option.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:8.34pt">Exercise Period Upon Retirement.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">If the Optionee retires (as defined below) prior to the Expiration Date while he or she is an Eligible Optionee, and the Company or its Affiliate has not terminated such relationship for &#8220;cause&#8221; as specified in paragraph (g) below, this Option shall (i) to the extent the date of such retirement occurs on or after the first vesting date set forth on the opposite side of this Agreement, continue to vest after the date of such retirement in accordance with the schedule described in Section 3(a) above for a period that encompass (and until) the occurrence of the second vesting date following the date of such retirement (the &#8220;Extended Vesting Date&#8221;) and (ii) to the extent vested, remain exercisable until the 3 year anniversary date following the date of retirement of the Optionee (but in no event after the Expiration Date). Notwithstanding anything in this Agreement that may be to the contrary, in the event the Optionee dies or becomes disabled (as defined above) at a time after the Optionee&#8217;s retirement but before the Extended Vesting Date, then this Option shall immediately vest and become exercisable with respect to all Shares underlying this Option as of the date of the Optionee&#8217;s death or disability. &#8220;Retire&#8221; and &#8220;retirement&#8221; shall mean retirement at or after the attainment of age 60, provided that the Optionee has been an employee of the Company or its Affiliate for at least 10 years as of the date of the Optionee&#8217;s termination date, not including any years during which the Optionee was employed by a company that was acquired by or merged with the Company, and provided further that the Optionee shall be eligible to retire under the terms of this Agreement if the Optionee has provided the Company written notice of such retirement in the form required by the Company at least six months prior to the Optionee&#8217;s anticipated termination date due to retirement. Notwithstanding anything herein to the contrary, any of the Chief Executive Officer, the Chief Human Resources Officer or the General Counsel of the Company may waive at any time the requirement that the Optionee provide at least six-months&#8217; prior written notice of retirement in a form required by the Company to be eligible to retire under the terms of this Agreement, unless the Optionee is an officer (within the meaning of Rule 16b-7 under the Exchange Act) of the Company, or otherwise reports directly to the Chief Executive Officer of the Company&#59; </font></div></div></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72.72pt;width:100%"><div><font><br></font></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:47.825%"><div style="margin-bottom:12pt;padding-left:5.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">only the Board or the Compensation Committee of the Board may grant such a waiver to the Optionee if the Optionee is an officer of the Company or a direct report of the Chief Executive Officer at the time of such waiver. </font></div><div style="margin-bottom:12pt;padding-left:5.75pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(g)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:7.08pt">Discharge for Cause.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  If the Optionee, prior to the Expiration Date, ceases his or her employment with the Company or its Affiliate because he or she is discharged for &#8220;cause&#8221; (as defined below), the right to exercise this Option shall terminate immediately upon such cessation of employment.  &#8220;Cause&#8221; shall mean willful misconduct in connection with the Optionee&#8217;s employment or willful failure to perform his or her employment responsibilities in the best interests of the Company (including, without limitation, breach by the Optionee of any provision of the Restrictive Covenant Agreements), as determined by the Company, which determination shall be final, binding and conclusive. The Optionee shall be considered to have been discharged for &#8220;cause&#8221; if the Company determines, within 30 days of the Optionee&#8217;s resignation, that discharge for cause was warranted.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(h)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:5.65pt">Restrictive Covenant Agreements</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">. Notwithstanding anything in the Agreement that may be to the contrary, if the Company determines that Optionee has violated any provisions set forth in the Restrictive Covenant Agreements, in addition to any and all rights and remedies set forth therein or otherwise available under law or equity, Optionee covenants and agrees that&#58; (i) the unvested portion of this Option will immediately be cancelled, and Optionee shall automatically forfeit any rights Optionee may have with respect to such unvested Option Shares as of the date of such determination&#59; (ii)&#160;the right to exercise this Option shall automatically terminate as of the date of such determination&#59; and (iii) the Company or its Affiliate may also take action at equity or in law to enforce the provisions of the Restrictive Covenant Agreements.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Following application of this provision of the Agreement, Optionee will continue to be bound by the obligations, promises and other agreements contained in the Restrictive Covenant Agreements and this Agreement.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">4.  Payment of Purchase Price.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:6.93pt">Method of Payment.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> Payment of the purchase price for Shares purchased upon exercise of this Option shall be made (i) by delivery to the Company, or to the online service designated by the Company, of an amount equal to the purchase price of such Shares, (ii)&#160;by delivery to the Company of Shares (either actually or by attestation) then owned by the Optionee for at least 6 months (or any shorter period sufficient to avoid a charge to the Company&#8217;s earnings for financial reporting purposes) or delivery of other consideration having a fair market value equal in amount to the purchase price of such Shares, (iii) to the extent permitted by the Board, in its sole discretion, by delivery of an irrevocable and unconditional undertaking by a creditworthy broker to deliver promptly to the Company sufficient funds to pay the purchase price and any required Tax-Related Items (as defined below), or delivery by the Optionee to the Company of a copy of irrevocable and unconditional instructions to a creditworthy broker to deliver promptly to the Company cash or a check sufficient to pay the purchase price and any required Tax-Related Items&#59; or (iv) by any combination of cash, Shares, and other consideration as the Board may specify.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:6.58pt">Valuation of Shares or Other Non-Cash Consideration Tendered in Payment of Purchase Price.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  For the purposes hereof, the fair market value of any Shares or other non-cash consideration which may be delivered to the Company in exercise of this Option shall be determined as provided in the Plan.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:7.53pt">Delivery of Shares Tendered in Payment of Purchase Price.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  If the Optionee exercises Options by delivery of Shares, any certificate or certificates representing the Shares to be delivered shall be duly executed in blank by the Optionee or shall be accompanied by a stock power duly executed in blank suitable for purposes of transferring such Shares, and any electronic delivery of Shares shall be in a manner sufficient for purposes of transferring such Shares to the Company.  Fractional Shares will not be accepted in payment of the purchase price of Shares acquired upon exercise of this Option.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">5.  Delivery of Shares&#59; Compliance with Securities Laws, Etc.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:6.09pt">General.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  The Company shall, upon payment of the Option price for the number of Shares purchased and paid for, make prompt delivery of such Shares to the Optionee, provided that if any law or regulation requires the Company to take any action with respect to such Shares before the issuance thereof, then the date of delivery of such Shares shall be extended for the period necessary to complete such action.</font></div></div><div style="display:inline-block;max-width:4.348%;min-width:3.348%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:47.827%"><div style="margin-bottom:12pt;padding-left:5.75pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:5.65pt">Listing, Qualification, Etc.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  This Option shall be subject to the requirement that if, at any time, counsel to the Company shall determine that the listing, registration or qualification of Shares subject hereto upon any securities exchange or under any state, federal or foreign law, or the consent or approval of any governmental or regulatory body, or that the disclosure of non-public information or the satisfaction of any other condition is necessary as a condition of, or in connection with, the issuance or purchase of Shares hereunder, this Option may not be exercised, in whole or part, unless such listing, registration, qualification, consent or approval, disclosure or satisfaction of such other condition shall have been effected or obtained on terms acceptable to the Board.  Nothing herein shall be deemed to require the Company to apply for, effect disclosure, or to satisfy such other condition.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">6.  Nontransferability of Option.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Except as provided in paragraph (e) of Section 3, this Option is personal and no rights granted hereunder may be sold, assigned, transferred, pledged or otherwise encumbered by the Optionee (whether by operation of law or otherwise).  During the lifetime of the Optionee, this Option shall be exercised only by the Optionee.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">7.  No Special Employment Rights.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nothing contained in the Plan, the Plan Prospectus or this Agreement shall be construed or deemed to constitute an employment or service contract or confer or be deemed to confer on the Optionee any right to continue in the employ or service of, or to continue any other relationship with, the Company or an Affiliate or limit in any way any right of the Company or an Affiliate, as applicable, to terminate the Optionee's employment or service or other relationship at any time, with or without cause.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">8.  Rights as a Shareholder.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Optionee shall have no rights as a shareholder with respect to any Shares which may be purchased by exercise of this Option (including, without limitation, any rights to receive dividends or non-cash distributions with respect to such Shares) unless and until a certificate representing such Shares, or electronic equivalent, is duly issued and delivered to the Optionee.  No adjustment shall be made for dividends or other rights for which the record date is prior to the date such stock certificate or electronic equivalent is issued.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">9.  Taxes.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:6.09pt">Responsibility for Taxes. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Optionee acknowledges that, regardless of any action taken by the Company or, if different, the Optionee's employer (the &#34;Employer&#8221;), the ultimate liability for all income tax (whether foreign, federal, state or local), social insurance, payroll tax, fringe benefits tax, payment on account and other tax-related items related to the Optionee&#8217;s participation in the Plan and legally applicable to the Optionee (the &#8220;Tax-Related Items&#8221;) is and remains the Optionee&#8217;s responsibility as it may come due and may exceed the amount actually withheld by the Company or the Employer.  The Optionee further acknowledges that the Company and&#47;or the Employer (i) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Option, and (ii) do not commit to and are under no obligation to structure the terms of the grant or any aspect of the Option to reduce or eliminate the Optionee&#8217;s liability for Tax-Related Items or achieve any particular tax result.  Further, if the Optionee is subject to Tax-Related Items in more than one jurisdiction, the Optionee acknowledges that the Company and&#47;or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction. In addition, the Optionee further acknowledges that Tax-Related Items may be incurred at different times.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:5.65pt">Withholding.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> The Optionee acknowledges and agrees to make arrangements satisfactory to the Company with respect to any withholding obligation the Company or the Employer (or former employer) may have for Tax-Related Items.   Without limitation to the foregoing, the Optionee acknowledges and agrees that to satisfy any such withholding obligation for Tax-Related Items, the Company may (i) withhold from the Optionee's wages or other cash compensation paid to the Optionee by the Company and&#47;or the Employer, (ii) withhold from proceeds of the sale of Shares acquired upon exercise of the Option, either through a voluntary sale or through a mandatory sale arranged by the Company (on the Optionee&#8217;s behalf pursuant to this authorization), or (iii) withhold by any other method permitted under the Plan and applicable law.  Depending on the withholding method, the Company may withhold or account for Tax-Related Items by </font></div></div></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72.72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exhibit 10.34</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee Stock Option Agreement</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted Under IDEXX Laboratories, Inc. 2018 Stock Incentive Plan</font></div><div><font><br></font></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:47.825%"><div style="margin-bottom:12pt;padding-left:5.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">considering applicable minimum statutory withholding amounts or other applicable withholding rates, including up to the maximum applicable rate in the Optionee's jurisdiction (in which case, the Optionee may receive a refund of any over-withheld amount in cash and will have no entitlement to the equivalent amount in Shares). The Company may refuse to deliver the Shares or the proceeds of the sale of Shares, if the Optionee fails to comply with his or her obligations in connection with the Tax-Related Items.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:6.09pt">Tax Consequences</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.  The Optionee has reviewed with his or her own tax advisors the applicable tax consequences of this investment and the transactions contemplated by this Agreement.  With respect to such matters, the Optionee relies solely on such advisors and not on any statements or representations of the Company or any of its agents, written or oral.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">10.  Limitations on Disposition of Incentive Stock Option Shares.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:9pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">If, as indicated on the opposite side of this Agreement, this Option is an &#8220;incentive stock option&#8221;, the Optionee understands that in order to obtain the benefits of an incentive stock option under Section 422 of the Code, no sale or other disposition may be made of any Shares acquired upon exercise of the Option within 1 year after such Shares were acquired pursuant to such exercise, nor within 2 years after the Grant Date.  If the Optionee intends to dispose, or does dispose (whether by sale, exchange, gift, transfer or otherwise), of any such Shares within said periods, he or she will notify the Company in writing within 10 days after such disposition, and provide any other information regarding such disposition that the Company may require.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">11.  Data Privacy.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Optionee hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of the Optionee&#8217;s personal data as described in this Agreement and any other Option grant materials by and among, as applicable, the Employer, the Company and its Subsidiaries and Affiliates for the exclusive purpose of implementing, administering and managing the Optionee&#8217;s participation in the Plan.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Optionee understands that the Company and the Employer may hold certain personal information about the Optionee, including, but not limited to, the Optionee&#8217;s name, home address, email address and telephone number, date of birth, social insurance number, passport or other identification number, salary, nationality, job title, any shares of stock or directorships held in the Company, details of all Options or any other entitlement to shares of stock awarded, canceled, exercised, vested, unvested or outstanding in the Optionee&#8217;s favor (&#8220;Data&#8221;), for the exclusive purpose of implementing, administering and managing the Plan. </font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Optionee understands that Data will be transferred to E*TRADE, or such other stock plan service provider as may be selected by the Company in the future, which is assisting the Company with the implementation, administration and management of the Plan.  The Optionee understands that the recipients of the Data may be located in the United States or elsewhere, and that the recipient&#8217;s country may have different data privacy laws and protections than the Optionee&#8217;s country.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Optionee authorizes the Company, E*TRADE and any other possible recipients which may assist the Company (presently or in the future) with implementing, administering and managing the Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the sole purposes of implementing, administering and managing the Optionee&#8217;s participation in the Plan.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">12.  Miscellaneous.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:7.25pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;padding-left:6.09pt">This Agreement and the Plan constitute the entire agreement between the parties, and supersedes all prior agreements and understandings, relating to the subject matter of this Agreement.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:7.25pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;padding-left:6.58pt">Except as provided herein, this Agreement may not be amended or otherwise modified unless evidenced in writing and signed by the Company and the Optionee. Any provision for the benefit of the Company contained in this Agreement may be waived, either generally or in any particular instance, by the Board.  The Board may amend, alter, suspend, discontinue or terminate the Plan, or any portion thereof, at any time, subject to the requirements for certain amendments or alterations set forth in the Plan.</font></div></div><div style="display:inline-block;max-width:4.348%;min-width:3.348%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:47.827%"><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:18.2pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;padding-left:6.09pt">This Agreement shall be binding upon and inure to the benefit of the Company and the Optionee and their respective heirs, executors, administrators, representatives, successors and assigns, subject to the restrictions on transfer set forth in Section 6 hereof.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:12.05pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;padding-left:5.65pt">The Option and the provisions of this Agreement shall be governed by and construed in accordance with the laws of the State of Delaware and applicable federal law, without regard to applicable conflict of laws principles.  </font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:7.8pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;padding-left:6.09pt">The invalidity or unenforceability of any provision of this Agreement shall not affect the validity or enforceability of any other provision of this Agreement, and each other provision of this Agreement shall be severable and enforceable to the extent permitted by law.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:12.05pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;padding-left:7.87pt">The Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding the Optionee&#8217;s participation in the Plan, or the Optionee&#8217;s acquisition or sale of the underlying Shares.  </font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:8.65pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(g)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;padding-left:7.08pt">All notices under this Agreement shall be mailed or delivered by hand to the parties at their respective addresses set forth in this Agreement or at such other address as may be designated in writing by either of the parties to one another.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:8.65pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(h)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;padding-left:5.65pt">The Company may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plan by electronic means.  The Optionee hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Company or a third party designated by the Company. </font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:12.05pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;padding-left:8.31pt">If the Optionee works and&#47;or resides outside the United States, the Option and any Shares subject to the Option shall be subject to any special terms and conditions set forth in Exhibit A.  Moreover, if the Optionee relocates outside of the United States and to one of the countries included in Exhibit A, the special terms and conditions for such country will apply to the Optionee to the extent the Company determines that the application of such terms and conditions is necessary or advisable for legal or administrative reasons.  Exhibit A constitutes part of this Agreement.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:8.65pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(j)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;padding-left:8.31pt">The Company reserves the right to impose other requirements on the Optionee&#8217;s participation in the Plan, on the Option and on any Shares acquired under the Plan, to the extent the Company determines it is necessary or advisable for legal or administrative reasons, and to require the Optionee to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.</font></div><div style="padding-left:5.75pt;padding-right:2.9pt"><font><br></font></div></div></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72.72pt;width:100%"><div><font><br></font></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:47.825%"><div style="padding-left:5.75pt;padding-right:2.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit A to</font></div><div style="padding-left:5.75pt;padding-right:2.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee Stock Option Agreement</font></div><div style="padding-left:5.75pt;padding-right:2.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">IDEXX Laboratories, Inc. 2018 Stock Incentive Plan  </font></div><div style="padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">This Exhibit A includes special terms and conditions and notifications applicable to the Optionee resides and&#47;or works outside the United States and, as applicable, in one of the countries listed below.  These terms and conditions and notifications supplement or replace (as indicated) the terms and conditions set forth in the Agreement to which it is attached.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">If the Optionee is a citizen or resident of a country other than the one in which he or she is currently residing and&#47;or working, or if the Optionee transfers employment or residency to another country after the Option is granted, the Company, in its discretion, will determine the extent to which the terms and conditions set forth in this Exhibit A will apply to the Optionee. </font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Capitalized terms used but not defined in this Exhibit A shall have the same meanings as in the Agreement and&#47;or the Plan, as applicable.</font></div><div style="margin-bottom:12pt;padding-left:1.45pt;padding-right:1.45pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ALL NON-U.S. LOCATIONS</font></div><div style="margin-bottom:12pt;padding-right:2.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">In accepting the Option, the Optionee acknowledges, understands and agrees that&#58;</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(a) the Plan is established voluntarily by the Company it is discretionary in nature&#59;</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(b) the grant of the Option is exceptional, voluntary and occasional and does not create any contractual or other right to receive future grants of options, or benefits in lieu of options, even if options have been granted in the past&#59; </font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(c) all decisions with respect to future option or other grants, if any, will be at the sole discretion of the Company&#59;</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(d) the Optionee is voluntarily participating in the Plan&#59;</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(e) the Option and any Shares acquired under the Plan, and the income and value of same, are not intended to replace any pension rights or compensation&#59;</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(f) the Option and any Shares acquired under the Plan, and the income and value of same, are not part of normal or expected compensation for any purpose, including, without limitation, calculating any severance, resignation, termination, redundancy, dismissal, end-of-service payments, holiday pay, bonuses, long-service awards, pension or retirement or welfare benefits or similar payments&#59;</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(g) unless otherwise agreed with the Company, the Option and any Shares acquired under the Plan, and the income and value of same, are not granted as consideration for, or in connection with, services the Optionee may provide as a director of a Subsidiary or Affiliate&#59;</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(h) the future value of the Shares underlying the Option is unknown, indeterminable, and cannot be predicted with certainty&#59; if the underlying Shares do not increase in value, the Option will have no value&#59; if the Optionee exercises the Option and acquires Shares, the value of such Shares may increase or decrease in value, even below the purchase price&#59; </font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:30.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(i) for purposes of the Option, the Optionee will be considered to have ceased employment as of the date the Optionee is no longer actively providing services to the Company or an Affiliate&#59; the Company shall have the exclusive discretion to determine when the Optionee is no longer actively providing services for purposes of the vesting of the Option and the exercise of the Option following termination of employment. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Further, no claim or entitlement to compensation or damages shall arise from forfeiture of the Option resulting from the Optionee ceasing to be employed by or provide services to the Company or an Affiliate for any reason whatsoever&#59; and</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:5.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(j) neither the Company, the Employer nor any Subsidiary or Affiliate shall be liable for any foreign exchange rate fluctuation between the Optionee&#8217;s local currency and the United States Dollar that may affect the value of the </font></div></div><div style="display:inline-block;max-width:4.348%;min-width:3.348%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:47.827%"><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Option or of any amounts due to the Optionee pursuant to the exercise of the Option or the subsequent sale of any Shares acquired upon exercise.</font></div><div style="margin-bottom:12pt;padding-right:2.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Choice of Venue</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:5.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">For purposes of litigating any dispute that arises under this grant or the Agreement, the parties hereby submit to and consent to the exclusive jurisdiction of the State of Maine, agree that such litigation shall be conducted in the courts of Cumberland County, Maine, or the federal courts for the United States for the District of Maine, where this grant is made and&#47;or to be performed.</font></div><div style="margin-bottom:12pt;padding-right:2.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Language</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Optionee acknowledges that he or she is sufficiently proficient in English to understand the terms and conditions of the Agreement.  Furthermore, if the Optionee has received this Agreement or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.</font></div><div style="margin-bottom:12pt;padding-right:2.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Insider Trading Restrictions&#47;Market Abuse Laws</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Optionee acknowledges that he or she may be subject to insider trading restrictions and&#47;or market abuse laws in applicable jurisdictions including, but not limited to, the United States and the Optionee&#8217;s country of residence, which may affect the Optionee&#8217;s ability to acquire or sell Shares or rights to Shares (e.g., Options) during such time as the Optionee is considered to have &#8220;inside information&#8221; regarding the Company (as defined by the laws in the applicable jurisdictions).  Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable insider trading policy of the Company.  The Optionee is responsible for ensuring compliance with any applicable restrictions and should consult with his or her personal legal advisor on this matter. </font></div><div style="margin-bottom:12pt;padding-right:2.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Foreign Asset&#47;Account and Exchange Control Requirements</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depending on the Optionee&#8217;s country, the Optionee may be subject to foreign asset&#47;account and&#47;or exchange control reporting or other requirements as a result of the exercise of the Option, the acquisition, holding and&#47;or transfer of Shares or cash resulting from participation in the Plan and&#47;or the opening and maintaining of a brokerage or bank account in connection with the Plan.  The Optionee may be required to report such assets, accounts, account balances and values, and&#47;or related transactions to the applicable authorities in his or her country.  The Optionee may also be required to repatriate sale proceeds or other funds received as a result of his or her participation in the Plan to his or her country through a designated bank or broker and&#47;or within a certain time after receipt.  The Optionee acknowledges that he or she is responsible for ensuring compliance with any such requirements and that he or she should consult with the Optionee&#8217;s own personal tax and legal advisors, as applicable, on these matters.</font></div><div style="margin-bottom:12pt;padding-right:2.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Data Privacy (For Jurisdictions in the European Union (&#8220;EU&#8221;) &#47; European Economic Area (&#8220;EEA&#8221;), Switzerland and the United Kingdom)</font></div><div style="margin-bottom:12pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">This section replaces Section 11 of the Agreement&#58;</font></div><div style="margin-bottom:12pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(a) Data Collection and Usage</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.  The Company collects, processes and uses personal data about the Optionee, including, but not limited to, the Optionee&#8217;s name, home address, telephone number and e-mail address, date of birth, social insurance number, passport or other identification number, salary, nationality, job title, any equity or directorships held in the Company and its Affiliates, details of all Options or any other entitlement to equity awarded, canceled, exercised, vested, unvested or outstanding in the Optionee&#8217;s favor, which the Company receives from the Optionee or the Employer.  In order to participate in the Plan, the Company will collect the Optionee&#8217;s personal data for purposes of allocating Shares and implementing, administering and managing the Plan.  The Company&#8217;s legal basis for the processing of the Optionee&#8217;s personal data is based on necessity for the performance of the Plan and pursuant to the Company&#8217;s legitimate business interests.</font></div><div style="margin-bottom:12pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(b) Stock Plan Administration Service Providers</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.  The Company transfers the Optionee&#8217;s data to E*TRADE Corporate Financial Services, Inc. (including its affiliated companies), an independent service provider based in the United States (&#8220;U.S.&#8221;), which assists the Company with the implementation, administration and management of the Plan.  In the future, </font></div></div></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72.72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exhibit 10.34</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee Stock Option Agreement</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted Under IDEXX Laboratories, Inc. 2018 Stock Incentive Plan</font></div><div><font><br></font></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:47.825%"><div style="margin-bottom:12pt;padding-right:2.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">the Company may select a different service provider and share the Optionee&#8217;s data with another company that serves in a similar manner.  The Company&#8217;s service provider(s) will open an account for the Optionee to receive and trade Shares.  The Optionee will be asked to agree on separate terms and data processing practices with the service provider(s), which is a condition to the Optionee&#8217;s ability to participate in the Plan.</font></div><div style="margin-bottom:12pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(c) International Data Transfers.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  The Optionee&#8217;s personal data will be transferred to the U.S. where the Company and its service providers are based.  The Company&#8217;s legal basis for the transfer of the Optionee&#8217;s personal data to the U.S. is its use of the standard data protection clauses.</font></div><div style="margin-bottom:12pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(d) Data Retention</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.  The Company will use the Optionee&#8217;s personal data only as long as necessary to implement, administer and manage the Optionee&#8217;s participation in the Plan or as required to comply with legal or regulatory obligations, including tax and securities laws.  When the Company no longer needs the Optionee&#8217;s personal data, which will generally be seven (7) years after the Optionee participates in the Plan, the Company will remove it from its systems.  If the Company keeps data longer, it would be to satisfy legal or regulatory obligations and the Company&#8217;s legal basis would be relevant laws or regulations.</font></div><div style="margin-bottom:12pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(e) Data Subject Rights</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.  The Optionee has a number of rights under data privacy laws in the Optionee&#8217;s country.  Depending on where the Optionee is based, his or her rights may include the right to (a) request access or copies of personal data processed by the Company, (b) rectification of incorrect data, (c) deletion of data, (d) restrictions on processing, (e) portability of data, (f) lodge complaints with competent authorities in the Optionee&#8217;s country, and&#47;or (g) receive a list with the names and addresses of any potential recipients of the Optionee&#8217;s personal data.  To receive clarification regarding the Optionee&#8217;s rights or to exercise such rights please contact the Company&#8217;s Data Privacy Officer electronically, by phone, or mail, in strict confidence. </font></div><div style="margin-bottom:12pt;padding-right:2.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Data Privacy (Non-EU Jurisdictions)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">This section supplements Section 11 of the Agreement&#58;</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">The Optionee may request a list with the names and addresses of any potential recipients of the Data by contacting his or her local human resources representative. </font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">The Optionee understands that Data will be held only as long as is necessary to implement, administer and manage the Optionee&#8217;s participation in the Plan.  The Optionee understands that he or she may, at any time, view Data, request information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing the Optionee&#8217;s local human resources representative.  </font></div><div style="margin-bottom:12pt;padding-left:5.75pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Further, the Optionee understands that he or she is providing the consents herein on a purely voluntary basis.  If the Optionee does not consent, or if the Optionee later seeks to revoke his or her consent, the Optionee&#8217;s employment status or service with the Employer will not be affected&#59; the only consequence of refusing or withdrawing consent is that the Company would not be able to grant Options or other equity awards to the Optionee or administer or maintain such awards.  Therefore, the Optionee understands that refusing or withdrawing consent may affect his or her ability to participate in the Plan.  For more information on the consequences of the Optionee&#8217;s refusal to consent or withdrawal of consent, the Optionee understands that the Optionee may contact his or her local human resources representative.</font></div><div style="margin-bottom:12pt;padding-left:1.45pt;padding-right:1.45pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">AUSTRIA</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">There are no country-specific provisions.</font></div><div style="margin-bottom:12pt;padding-left:1.45pt;padding-right:1.45pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">BRAZIL</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  The offer of the Option and the underlying Shares is not registered with the Brazilian Securities Commission (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Comiss&#227;o de Valores Mobili&#225;rios &#8211; CVM</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">).  The Shares may not be offered or sold in Brazil, except under circumstances that do not constitute a public offering or distribution of securities under Brazilian laws and regulations.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  This provision supplements the Nature of Grant section above&#58;</font></div></div><div style="display:inline-block;max-width:4.348%;min-width:3.348%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:47.827%"><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">In accepting the Option, the Optionee acknowledges that (i) the Optionee is making an investment decision and (ii) the value of the underlying Shares is not fixed and may increase or decrease without compensation to the Optionee.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Compliance with Law</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  By accepting the Option, the Optionee agrees to comply with applicable Brazilian laws and to pay any and all applicable Tax-Related Items associated with the exercise of the Option, the receipt of any dividends, and the sale of Shares acquired under the Plan.</font></div><div style="margin-bottom:12pt;padding-left:1.45pt;padding-right:1.45pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">FRANCE</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Option Not Tax-Qualified</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> The Option is not intended to qualify for specific tax and social security treatment in France.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Language Consent</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> By accepting the Option, the Optionee confirms having read and understood the Plan and Agreement, including all terms and conditions included therein, which were provided in the English language.  The Optionee accepts the terms of those documents accordingly.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Consentement &#224; la Langue Utilis&#233;e</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">En acceptant cette Option, le B&#233;n&#233;ficiaire confirme avoir lu et compris le Plan et le Contrat, incluant tous leurs termes et conditions, qui ont &#233;t&#233; transmis en langue anglaise.  Le B&#233;n&#233;ficiaire accepte les dispositions de ces documents en connaissance de cause.</font></div><div style="margin-bottom:12pt;padding-left:1.45pt;padding-right:1.45pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">GERMANY</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">There are no country-specific provisions. </font></div><div style="margin-bottom:12pt;padding-left:1.45pt;padding-right:1.45pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">NETHERLANDS</font></div><div style="margin-bottom:12pt;padding-right:2.9pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">There are no country-specific provisions.</font></div><div style="margin-bottom:12pt;padding-left:1.45pt;padding-right:1.45pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">NEW ZEALAND</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">WARNING&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> The Optionee is being offered an Option which allows the Optionee to purchase Shares in accordance with the terms of the Plan and the Agreement.  The Shares, if purchased, give the Optionee a stake in the ownership of the Company.  The Optionee may receive a return if dividends are paid. </font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">If the Company runs into financial difficulties and is wound up, the Optionee will be paid only after all creditors and holders of preferred shares have been paid.  The Optionee may lose some or all of his or her investment.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">New Zealand law normally requires people who offer financial products to give information to investors before they invest.  This information is designed to help investors to make an informed decision.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The usual rules do not apply to this offer because it is made under an employee share purchase scheme.  As a result, the Optionee may not be given all the information usually required.  The Optionee will also have fewer other legal protections for this investment.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Optionee understands that he or she should ask questions, read all documents carefully, and seek independent financial advice before exercising any Options under the Plan.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Shares are quoted and approved for trading on the NASDAQ Global Select Market in the United States of America.  This means that, if the Optionee purchases Shares under the Plan, the Optionee may be able to sell his or her investment on the NASDAQ Global Select Market if there are interested buyers.  The Optionee understands that he or she may get less than the Optionee&#8217;s investment.  The price will depend on the demand for the Shares. </font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">For information on risk factors impacting the Company&#8217;s business that may affect the value of the Shares, the Optionee should refer to the risk factors discussion in the Company&#8217;s Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, which are filed with the U.S. Securities and Exchange Commission and are available online at www.sec.gov, as </font></div></div></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72.72pt;width:100%"><div><font><br></font></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:47.825%"><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">well as on the Company&#8217;s website at https&#58;&#47;&#47;www.idexx.com&#47;corporate&#47;investors-home.html.</font></div><div style="margin-bottom:12pt;padding-left:1.45pt;padding-right:1.45pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SINGAPORE</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  The Option is being granted pursuant to the &#8220;Qualifying Person&#8221; exemption under section 273(1)(f) of the Singapore Securities and Futures Act (Chapter 289, 2006 Ed.) (&#8220;SFA&#8221;).  The Plan has not been lodged or registered as a prospectus with the Monetary Authority of Singapore.  The Optionee should note that the Option is subject to section 257 of the SFA and the Optionee will not be able to make any subsequent sale of the Shares acquired pursuant to the Option in Singapore or any offer of such subsequent sale of Shares in Singapore unless such sale or offer in Singapore is made (a) after six months after the Grant Date, or (b) pursuant to the exemptions under Part XIII Division (1) Subdivision (4) (other than section 280) of the SFA, or pursuant to, and in accordance with the conditions of, any applicable provisions of the SFA.</font></div><div style="margin-bottom:12pt;padding-left:1.45pt;padding-right:1.45pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SPAIN</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> No &#8220;offer of securities to the public,&#8221; as defined under Spanish law, has taken place or will take place in the Spanish territory in connection with the offer of the Option.  The Plan, the Agreement and any other documents evidencing the grant of the Option have not been, nor will they be, registered with the </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Comisi&#243;n Nacional del Mercado de Valores</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> (the Spanish securities regulator), and none of those documents constitutes a public offering prospectus.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  This provision supplements the Nature of Grant section above&#58;</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">In accepting the Option, the Optionee acknowledges that he or she has received a copy of the Plan, has reviewed and understands the Plan and agrees to participation in the Plan.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Optionee further understands that the Company has unilaterally, gratuitously and discretionally decided to grant Options under the Plan to employees of the Company or any Subsidiary or Affiliate throughout the world.  The decision to grant the Options is a limited decision that is entered into upon the express assumption and condition that any Option grant will not economically or otherwise bind the Company or any Subsidiary or Affiliate on an ongoing basis other than as set forth in this Agreement.  Consequently, the Optionee understands that any grant is given on the assumption and condition that it shall not become a part of any employment contract (either with the Company or any Subsidiary or Affiliate) and shall not be considered a mandatory benefit, salary for any purpose (including severance compensation) or any other right whatsoever.  Further, the Optionee understands and freely accepts that there is no guarantee that any benefit shall arise from any gratuitous and discretionary grant since the future value of the Option and the underlying Shares is unknown and unpredictable. </font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additionally, the Optionee understands that the vesting and exercisability of the Option is expressly conditioned on the Optionee&#8217;s continued and active rendering of service to the Employer such that, except as specifically provided in Section 2 of the Agreement, if the Optionee&#8217;s employment terminates for any reason whatsoever, the Optionee&#8217;s Option will cease vesting immediately effective as of the date of termination of his or her employment and any post-termination exercisability period will be measured from such date.  This will be the case, for example, even if (a) the Optionee is considered to be unfairly dismissed without good cause (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">i.e.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">, subject to a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">despido improcedente</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8221;)&#59; (b) the Optionee is dismissed for disciplinary or objective reasons or due to a collective dismissal&#59; (c) the Optionee terminates service due to a change of work location, duties or any other employment or contractual condition&#59; (d) the Optionee terminates service due to the Company&#8217;s or any Subsidiary&#8217;s or Affiliate&#8217;s unilateral breach of contract&#59; or (e) the Optionee&#8217;s employment terminates for any other reason whatsoever.  Consequently, upon termination of employment for any of the above reasons, the Optionee will automatically lose any rights to Options granted that were unvested on the date of termination of the Optionee&#8217;s employment, as described in the Agreement.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finally, the Optionee understands that this grant would not be made to him or her but for the assumptions and conditions referred to herein&#59; thus, the Optionee acknowledges and freely accepts that should any or all of the assumptions be mistaken or should any of the conditions not be met for any reason, then any grant of Options shall be null and void.</font></div><div style="margin-bottom:12pt;padding-left:1.45pt;padding-right:1.45pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SWITZERLAND</font></div></div><div style="display:inline-block;max-width:4.348%;min-width:3.348%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:47.827%"><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> Neither this document nor any other materials relating to the Option (a) constitutes a prospectus according to articles 35 et seq. of the Swiss Federal Act on Financial Services (&#8220;FinSA&#8221;), (b) may be publicly distributed or otherwise made publicly available in Switzerland to any person other than an Eligible Optionee, or (c) has been or will be filed with, approved or supervised by any Swiss reviewing body according to article 51 FinSA or any Swiss regulatory authority, including the Swiss Financial Market Supervisory Authority.</font></div><div style="margin-bottom:12pt;padding-left:1.45pt;padding-right:1.45pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">UNITED KINGDOM (&#8220;U.K.&#8221;)</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  This provision supplements Section 9 of the Agreement&#58;</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Without limitation to Section 9 of the Agreement, the Optionee hereby agrees that he or she is liable for all Tax-Related Items and hereby covenants to pay all such Tax-Related Items, as and when requested by the Company or the Employer, as applicable, or by Her Majesty&#8217;s Revenue &#38; Customs (&#8220;HMRC&#8221;) (or any other tax authority or any other relevant authority).  The Optionee also hereby agrees to indemnify and keep indemnified the Company and the Employer, as applicable, against any Tax-Related Items that they are required to pay or withhold or have paid or will pay to HMRC (or any other tax authority or any other relevant authority) on the Optionee&#8217;s behalf.</font></div><div style="padding-left:5.75pt;padding-right:2.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, if the Optionee is a director or executive officer of the Company (within the meaning of Section 13(k) of the Exchange Act), the terms of immediately foregoing provision will not apply.  In this case, the amount of the income tax not collected within 90 days of the end of the U.K. tax year in which an event giving rise to the Tax-Related Items occurs may constitute a benefit to the Optionee on which additional income tax and National Insurance contributions may be payable.  The Optionee will be responsible for reporting and paying any income tax due on this additional benefit directly to HMRC under the self-assessment regime and for reimbursing the Company or the Employer, as applicable, for the value of any National Insurance contributions due on this additional benefit, which may be recovered from the Optionee by the Company or the Employer at any time thereafter by any of the means referred to in Section 9 of the Agreement.</font></div></div></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.41
<SEQUENCE>17
<FILENAME>a1041employeersuawardagree.htm
<DESCRIPTION>EX-10.41
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i19164917620e460380d7b963363a8a6e_1"></div><div style="min-height:59.76pt;width:100%"><div style="margin-top:3.2pt;padding-left:182.95pt;padding-right:15.5pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exhibit 10.41</font></div><div style="margin-top:3.2pt;padding-left:173.57pt;padding-right:173.57pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee Restricted Stock Unit Agreement</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted Under IDEXX Laboratories, Inc. 2018 Stock Incentive Plan</font></div><div style="padding-left:173.67pt;padding-right:173.67pt;text-align:center"><font><br></font></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.687%"><div style="margin-bottom:12pt;margin-top:4pt;padding-left:17.25pt;padding-right:2.6pt;text-indent:-11.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:4.59pt;text-decoration:underline">Grant of Restricted Stock Units.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:2.6pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:6.09pt">Grant.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  IDEXX Laboratories, Inc., a Delaware corporation (the &#8220;Company&#8221;), hereby grants to the Participant a Restricted Stock Unit Award consisting of the number of Restricted Stock Units (&#8220;RSUs&#8221;) stated in this Restricted Stock Unit Agreement, including any exhibit, appendix or addendum hereto (the &#8220;Agreement&#8221;). Each RSU represents the right to receive one share of common stock, $0.10 par value, of the Company (individually a &#8220;Share&#8221; and collectively the &#8220;Shares&#8221;). The Company will record on its books the grant of the RSUs to the Participant and will issue Shares upon vesting of the RSUs as provided below. This award of RSUs is subject to the terms and conditions set forth in this Agreement, the Company&#8217;s 2018 Stock Incentive Plan (the &#8220;Plan&#8221;) and the description of the Plan set forth in the Plan Prospectus.  The Plan and the Plan Prospectus are provided to the Participant with this Agreement. Capitalized terms not otherwise defined in this Agreement shall have the meanings set forth in the Plan or the Plan Prospectus.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:5.65pt">Restrictive Covenant Agreements.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> Participant acknowledges and affirms that&#58; (i) Participant is subject to non-competition, non-solicitation and&#47;or confidentiality provisions set forth in one or more agreements with the Company or any of its Affiliates (including, as applicable, employment, consulting or advisory contracts&#59; confidentiality and nondisclosure agreements&#59; or other agreements&#59; in each case as may be amended, supplemented or replaced from time to time) (collectively, the &#8220;Restrictive Covenant Agreements&#8221;)&#59; (ii)&#160;this RSU award is granted in consideration of Participant&#8217;s agreement to be bound by the Participant&#8217;s Restrictive Covenant Agreements&#59; (iii) if the Company requests that Participant execute updated Restrictive Covenant Agreements, the vesting of this RSU award is conditioned on Participant&#8217;s execution and delivery of such updated Restrictive Covenant Agreements in a manner and by a date satisfactory to the Company in its sole discretion, and the failure of Participant to so execute and deliver any such requested updated Restrictive Covenant Agreement by such date will result in the immediate cancellation of, and automatic forfeiture of any rights Participant may have with respect to, this RSU award&#59; and (iv) Participant agrees to comply with the restrictions and obligations set forth in Participant&#8217;s Restrictive Covenant Agreements.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:17.25pt;padding-right:2.6pt;text-indent:-11.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:4.59pt;text-decoration:underline">Vesting and Forfeiture.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:2.6pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:6.09pt">Vesting. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Subject to Section 2(b), (c) and (d), the RSUs shall vest and become nonforfeitable in accordance with the vesting schedule set forth in this Agreement. </font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:5.65pt">Forfeiture</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Except as otherwise provided in this Section 2, in the event that the Participant ceases to be employed by the Company or an Affiliate or a member of the Board, as applicable (an &#8220;Eligible Grantee&#8221;) for any reason or no reason, the balance of RSUs that have not vested as of the date of such cessation will be forfeited and the Participant will have no future rights with respect to any such unvested RSUs. The Company shall determine in good faith (including in accordance with Section 409A of the Code) and in the exercise of its discretion whether the Participant has ceased to be an employee and the effective date of the Participant&#8217;s termination of such status, and such determinations shall be final, binding and conclusive.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Notwithstanding anything in this Agreement that may be to the contrary, if the Company determines that Participant has violated any provisions set forth in the Restrictive Covenant Agreements, in addition to any and all rights and remedies set forth therein or otherwise available under law or equity, Participant covenants and agrees that&#58; (i) the unvested portion of the RSUs will immediately be cancelled, and Participant shall automatically forfeit any rights Participant may have with respect to such unvested RSUs as of the date of such determination&#59; and (ii) the Company or its Affiliate may also take action at equity or in law to enforce the provisions of the Restrictive Covenant Agreements.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:1.15pt;text-indent:14.4pt"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Following application of this provision of the Agreement, Participant will continue to be bound by the obligations, promises and other agreements contained in the Restrictive Covenant Agreements and this Agreement.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:1.15pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(c)</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:6.09pt">Disability or Death</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">. In the event that the Participant&#8217;s employment or service to the Company or an Affiliate is terminated as a result of the Participant&#8217;s Disability (as defined in Section 22(e)(3) of the Code) or as a result of the Participant&#8217;s death, all RSUs that have not vested as of the date of such cessation of service shall immediately vest and become nonforfeitable as of the date of the Participant&#8217;s Disability or death&#59; provided, however, if such Disability or death occurs within one year of the grant date of this award, then this award shall continue to vest after the date of such Disability or death in accordance with the schedule described in Section 2(a) above, except that all RSUs that have not vested as of the date of such cessation of service will </font></div></div><div style="display:inline-block;max-width:2.624%;min-width:1.624%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.689%"><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:1.15pt"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">immediately vest and become nonforfeitable as of the date that is the one-year anniversary of the grant date of this award.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:1.15pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:5.65pt">Retirement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">. In the event that the Participant&#8217;s employment or service to the Company or an Affiliate is terminated as a result of the Participant&#8217;s retirement (as defined below), to the extent the date of such retirement occurs on or after the first vesting date described in the vesting schedule set forth in this Agreement, the outstanding RSUs shall continue to vest for a period that encompasses (and until) the occurrence of second vesting date following the date of such retirement (the &#8220;Extended Vesting Date&#8221;).  Notwithstanding anything in this Agreement that may be to the contrary, in the event the Participant dies or becomes disabled (as defined above) at a time after the Participant&#8217;s retirement but before the Extended Vesting Date, then this RSU shall immediately vest and become nonforfeitable as of the date of the Participant&#8217;s death or disability. &#8220;Retire&#8221; and &#8220;retirement&#8221; shall mean retirement at or after the attainment of age 60, provided that the Participant has been an employee of the Company or its Affiliate for at least 10 years as of the date of the Participant&#8217;s termination date, not including any years during which the Participant was employed by a company that was acquired by or merged with the Company, and provided further that the Participant shall be eligible to retire under the terms of this Agreement if the Participant has provided the Company written notice of such retirement in the form required by the Company at least six months prior to the Participant&#8217;s anticipated termination date due to retirement. Notwithstanding anything herein to the contrary, any of the Chief Executive Officer, the Chief Human Resources Officer or the General Counsel of the Company may waive at any time the requirement that the Participant provide at least six-months&#8217; prior written notice of retirement in a form required by the Company to be eligible to retire under the terms of this Agreement, unless the Participant is an officer (within the meaning of Rule 16b-7 under the Exchange Act) of the Company, or otherwise reports directly to the Chief Executive Officer of the Company&#59; only the Board or the Compensation Committee of the Board may grant such a waiver to the Participant if the Participant is an officer of the Company or a direct report of the Chief Executive Officer at the time of such waiver.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:2.6pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:9.19pt;text-decoration:underline">Restrictions on Transfer.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:2.6pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Participant may not sell, assign, transfer, pledge, hypothecate or otherwise dispose of by operation of law or otherwise, any RSUs, or any interest therein, except by will or the laws of descent and distribution.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:2.6pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:9.19pt;text-decoration:underline">Rights as Stockholder.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:2.6pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Neither the Participant, nor any person claiming through the Participant, will have any of the rights or privileges of a stockholder of the Company with respect to the RSUs unless and until Shares have been issued, recorded on the records of the Company or its transfer agent, and delivered to the Participant upon vesting of the RSUs. No adjustment shall be made for dividends or distributions or other rights for which the record date is prior to the date such Shares are issued. After such issuance, recordation and delivery, the Participant will have all the rights of a stockholder of the Company with respect to the Shares.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:2.6pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:9.19pt;text-decoration:underline">Delivery of Shares&#59; Compliance with Securities Laws, Etc.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:0.7pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:6.09pt">General. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Company shall, upon (and in no event more than 90 days after) vesting of RSUs hereunder, make prompt delivery of vested Shares to the Participant, or if the Participant has died or become Disabled (as defined in Section 2(c) above), to the person to whom this award is transferred by will or the laws of descent and distribution, provided that if any law or regulation requires the Company to take any action with respect to such Shares before the issuance thereof, then the date of delivery of such Shares shall be extended for the period necessary to complete such action.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:14.4pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:5.65pt">Listing, Qualification, Etc</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The RSUs shall be subject to the requirement that if, at any time, counsel to the Company shall determine that the listing, registration or qualification of Shares subject hereto upon any securities exchange or under any state, federal or foreign law, or the consent or approval of any governmental or regulatory body, or that the disclosure of non-public information or the satisfaction of any other condition is necessary as a condition of, or in connection with, the issuance of Shares hereunder, then such issuance shall be deferred until such listing, registration, qualification, consent or approval, disclosure or satisfaction of such other condition shall have been effected or obtained on terms acceptable to the Board. Nothing herein shall be deemed to require the Company to apply for, effect disclosure, or to satisfy such other condition.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:7.25pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">6.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:9.19pt;text-decoration:underline">No Special Employment Rights.</font></div></div></div><div style="height:50.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.687%"><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:7.25pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nothing contained in the Plan, the Plan Prospectus or this Agreement shall be construed or deemed to constitute an employment or service contract or confer or be deemed to confer on the Participant any right to continue in the employ or service of, or to continue any other relationship with, the Company or an Affiliate or limit in any way any right of the Company or an Affiliate, as applicable, to terminate the Participant&#8217;s employment or service or other relationship at any time, with or without cause. </font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:7.25pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">7.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:9.19pt;text-decoration:underline">Taxes.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:7.25pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(a)&#160;&#160;&#160;&#160;Responsibility for Taxes. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Participant acknowledges that, regardless of any action taken by the Company or, if different, the Participant's employer (the &#34;Employer&#8221;), the ultimate liability for all income tax (whether foreign, federal, state or local), social insurance, payroll tax, fringe benefits tax, payment on account and other tax-related items related to the Participant&#8217;s participation in the Plan and legally applicable to the Participant (the &#8220;Tax-Related Items&#8221;) is and remains the Participant&#8217;s responsibility as it may come due and may exceed the amount actually withheld by the Company or the Employer.  The Participant further acknowledges that the Company and&#47;or the Employer (i) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the RSUs, and (ii) do not commit to and are under no obligation to structure the terms of the grant or any aspect of the RSUs to reduce or eliminate the Participant&#8217;s liability for Tax-Related Items or achieve any particular tax result.  Further, if the Participant is subject to Tax-Related Items in more than one jurisdiction, the Participant acknowledges that the Company and&#47;or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.  In addition, the Participant further acknowledges that Tax-Related Items may be incurred at different times.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:7.25pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(b)&#160;&#160;&#160;&#160;Withholding. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Participant acknowledges and agrees to make arrangements satisfactory to the Company with respect to any withholding obligation the Company or the Employer (or former employer) may have for Tax-Related Items.   Without limitation to the foregoing, the Participant acknowledges and agrees that to satisfy any such withholding obligation for Tax-Related Items, the Company may (i) deduct and retain from the Shares to be distributed upon vesting of RSUs such number of Shares as is equal in value to the Tax-Related Items, (ii) withhold from the Participant's wages or other cash compensation paid to the Participant by the Company and&#47;or the Employer, (iii) withhold from proceeds of the sale of Shares acquired upon vesting and settlement of the RSUs, either through a voluntary sale or through a mandatory sale arranged by the Company (on the Participant&#8217;s behalf pursuant to this authorization), or (iv) withhold by any other method permitted under the Plan and applicable law.  </font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:7.25pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depending on the withholding method, the Company may withhold or account for Tax-Related Items by considering applicable minimum statutory withholding amounts or other applicable withholding rates, including up to the maximum applicable rate in the Participant's jurisdiction (in which case, the Participant may receive a refund of any over-withheld amount in cash and will have no entitlement to the equivalent amount in Shares).  If the obligation for Tax-Related Items is satisfied by withholding in Shares, as described in (i) above, for tax purposes, the Participant will be deemed to have been issued the full number of Shares subject to the vested portion of the RSUs.  The Company may refuse to issue or deliver the Shares or the proceeds of the sale of Shares, if the Participant fails to comply with his or her obligations in connection with the Tax-Related Items.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:7.25pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(c) &#160;&#160;&#160;&#160;Section 409A. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> The RSUs are intended to comply with Section 409A of the Code and, accordingly, to the maximum extent permitted, this Agreement shall be interpreted to be in compliance therewith. Nothing contained herein shall constitute any representation or warranty by the Company regarding compliance with Section 409A of the Code. The Company shall have no obligation to take any action to prevent the assessment of any additional income tax, interest or penalties under Section 409A of the Code on any Person and the Company and its Affiliates, and each of their respective employees and representatives, shall have no liability to the Participant with respect thereto. Notwithstanding anything to the contrary in this Agreement or the Plan, solely for purposes of amounts payable under this Agreement that are deemed to be &#8220;nonqualified deferred compensation&#8221; under Section 409A of the Code, (i) if the definition of Change in Control is required to comply with the requirements of Section 409A of the Code in order for the RSUs to comply with Section 409A of the Code, then no transaction otherwise constituting a Change in Control, as defined in the Plan, will be considered a Change in Control for such purposes unless it also qualifies as a &#8220;change in control event&#8217; within the meaning of Treasury Regulation Section 1.409A-3(i)(5)(i)&#59; and (ii) if the Participant is a &#8220;specified employee&#8221; for purposes of Section 409A of the Code at the time of his or her &#8220;separation from service&#8221; (within the meaning of Section 409A of the Code), delivery of shares in respect of any RSU that vests and becomes payable upon or in connection with the Participant&#8217;s separation from service shall be </font></div></div><div style="display:inline-block;max-width:2.624%;min-width:1.624%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.689%"><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:7.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">delayed and will be payable on the day after the first to occur of (a) the day which is six (6) months following the date of such separation from service, and (b) the date of the Participant&#8217;s death or Disability (as defined above).  </font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:7.25pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(d)&#160;&#160;&#160;&#160;Tax Consequences</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.  The Participant has reviewed with his or her own tax advisors the applicable tax consequences of this investment and the transactions contemplated by this Agreement.  With respect to such matters, the Participant relies solely on such advisors and not on any statements or representations of the Company or any of its agents, written or oral.  </font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:7.25pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">8.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:9.19pt;text-decoration:underline">Data Privacy.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Participant hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of the Participant&#8217;s personal data as described in this Agreement and any other RSU grant materials by and among, as applicable, the Employer, the Company and its Subsidiaries and Affiliates for the exclusive purpose of implementing, administering and managing the Participant&#8217;s participation in the Plan.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Participant understands that the Company and the Employer may hold certain personal information about the Participant, including, but not limited to, the Participant&#8217;s name, home address, email address and telephone number, date of birth, social insurance number, passport or other identification number, salary, nationality, job title, any shares of stock or directorships held in the Company, details of all RSUs or any other entitlement to shares of stock awarded, canceled, exercised, vested, unvested or outstanding in the Participant&#8217;s favor (&#8220;Data&#8221;), for the exclusive purpose of implementing, administering and managing the Plan. </font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Participant understands that Data will be transferred to E*TRADE or such other stock plan service provider as may be selected by the Company in the future, which is assisting the Company with the implementation, administration and management of the Plan.   The Participant understands that the recipients of the Data may be located in the United States or elsewhere, and that the recipient&#8217;s country may have different data privacy laws and protections than the Participant&#8217;s country.  </font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Participant authorizes the Company, E*TRADE and any other possible recipients which may assist the Company (presently or in the future) with implementing, administering and managing the Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the sole purposes of implementing, administering and managing the Participant&#8217;s participation in the Plan.  </font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:7.25pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">9.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:9.19pt;text-decoration:underline">Miscellaneous.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:7.8pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;padding-left:6.09pt">This Agreement and the Plan constitute the entire agreement between the parties, and supersedes all prior agreements and understandings, relating to the subject matter of this Agreement. </font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:7.25pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;padding-left:5.65pt">Except as provided herein, this Agreement may not be amended or otherwise modified unless evidenced in writing and signed by the Company and the Participant. Any provision for the benefit of the Company contained in this Agreement may be waived, either generally or in any particular instance, by the Board.  The Board may amend, alter, suspend, discontinue or terminate the Plan, or any portion thereof, at any time, subject to the requirements for certain amendments or alterations set forth in the Plan.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:18.2pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;padding-left:6.09pt">This Agreement shall be binding upon and inure to the benefit of the Company and the Participant and their respective heirs, executors, administrators, representatives, successors and assigns, subject to the restrictions on transfer set forth in Section 3 hereof.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:12.05pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;padding-left:5.65pt">The right of the Participant to receive Shares pursuant to this award is an unfunded and unsecured obligation of the Company. The Participant shall have no rights under this award other than those of an unsecured general creditor of the Company.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:12.05pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;padding-left:6.09pt">The RSUs and the provisions of this Agreement shall be governed by and construed in accordance with the laws of the State of Delaware and applicable federal law, without regard to applicable conflict of laws principles.  </font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:7.8pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;padding-left:7.87pt">The invalidity or unenforceability of any provision of this Agreement shall not affect the validity or enforceability of any other provision of this Agreement, and each other provision of this Agreement shall be severable and enforceable to the extent permitted by law.</font></div></div></div><div style="height:50.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div style="margin-top:3.2pt;padding-left:182.95pt;padding-right:15.5pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exhibit 10.41</font></div><div style="margin-top:3.2pt;padding-left:173.57pt;padding-right:173.57pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee Restricted Stock Unit Agreement</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted Under IDEXX Laboratories, Inc. 2018 Stock Incentive Plan</font></div><div style="padding-left:173.67pt;padding-right:173.67pt;text-align:center"><font><br></font></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.687%"><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:12.05pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(g)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;padding-left:5.65pt">The Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding the Participant&#8217;s participation in the Plan, or the Participant&#8217;s acquisition or sale of the underlying Shares.  </font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:8.65pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(h)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;padding-left:5.65pt">All notices under this Agreement shall be mailed or delivered by hand to the parties at their respective addresses set forth in this Agreement or at such other address as may be designated in writing by either of the parties to one another.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:8.65pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;padding-left:8.31pt">The Company may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plan by electronic means.  The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Company or a third party designated by the Company. </font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:12.05pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(j)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;padding-left:8.31pt">If the Participant works and&#47;or resides outside the United States, the RSUs and any Shares subject to the RSUs shall be subject to any special terms and conditions set forth in Exhibit A.  Moreover, if the Participant relocates outside of the United States and to one of the countries included in Exhibit A, the special terms and conditions for such country will apply to Participant to the extent the Company determines that the application of such terms and conditions is necessary or advisable for legal or administrative reasons.  Exhibit A constitutes part of this Agreement.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:8.65pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(k)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;padding-left:6.09pt">The Company reserves the right to impose other requirements on the Participant&#8217;s participation in the Plan, on the RSUs and on any Shares acquired under the Plan, to the extent the Company determines it is necessary or advisable for legal or administrative reasons, and to require the Participant to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.</font></div><div style="margin-bottom:12pt"><font><br></font></div></div><div style="display:inline-block;max-width:2.624%;min-width:1.624%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.689%"></div></div><div style="height:50.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.687%"><div style="margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit A to</font></div><div style="margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted Stock Unit Agreement</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">IDEXX Laboratories, Inc. 2018 Stock Incentive Plan</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">This Exhibit A includes special terms and conditions and notifications applicable to the Participant resides and&#47;or works outside the United States and, as applicable, in one of the countries listed below.  These terms and conditions and notifications supplement or replace (as indicated) the terms and conditions set forth in the Agreement to which it is attached.  </font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">If the Participant is a citizen or resident of a country other than the one in which he or she is currently residing and&#47;or working, or if the Participant transfers employment or residency to another country after the RSUs are granted, the Company, in its discretion, will determine the extent to which the terms and conditions set forth in this Exhibit A will apply to the Participant. </font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Capitalized terms used but not defined in this Exhibit A shall have the same meanings as in the Agreement and&#47;or the Plan, as applicable.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:1.3pt;padding-right:1.3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ALL NON-U.S. LOCATIONS</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">In accepting the RSUs, the Participant acknowledges, understands and agrees that&#58;</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(a) the Plan is established voluntarily by the Company it is discretionary in nature&#59;</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(b) the grant of the RSUs is exceptional, voluntary and occasional and does not create any contractual or other right to receive future grants of restricted stock units, or benefits in lieu of restricted stock units, even if restricted stock units have been granted in the past&#59; </font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(c) all decisions with respect to future restricted stock units or other grants, if any, will be at the sole discretion of the Company&#59;</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(d) the Participant is voluntarily participating in the Plan&#59;</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(e) the RSUs and any Shares acquired under the Plan, and the income and value of same, are not intended to replace any pension rights or compensation&#59;</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(f) the RSUs and any Shares acquired under the Plan, and the income and value of same, are not part of normal or expected compensation for any purpose, including, without limitation, calculating any severance, resignation, termination, redundancy, dismissal, end-of-service payments, holiday pay, bonuses, long-service awards, pension or retirement or welfare benefits or similar payments&#59;</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(g) unless otherwise agreed with the Company, the RSUs and any Shares acquired under the Plan, and the income and value of same, are not granted as consideration for, or in connection with, services the Participant may provide as a director of a Subsidiary or Affiliate&#59;</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(h) the future value of the Shares underlying the RSUs is unknown, indeterminable, and cannot be predicted with certainty&#59; </font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(i) for purposes of the RSUs, the Participant will be considered to have ceased employment as of the date the Participant is no longer actively providing services to the Company or an Affiliate&#59; the Company shall have the exclusive discretion to determine when the Participant is no longer actively providing services for purposes of the vesting of the RSUs.  Further, no claim or entitlement to compensation or damages shall arise from forfeiture of the RSUs resulting from the Participant ceasing to be employed by or provide services to the Company or an Affiliate for any reason whatsoever&#59; and</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(j) neither the Company, the Employer nor any Subsidiary or Affiliate shall be liable for any foreign exchange rate fluctuation between the Participant&#8217;s local currency and the United States Dollar that may affect the value of the RSUs or of any amounts due to the Participant pursuant to the vesting and settlement of the RSUs or the subsequent sale of any Shares acquired pursuant to the RSUs.</font></div></div><div style="display:inline-block;max-width:2.624%;min-width:1.624%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.689%"><div style="margin-bottom:12pt;margin-top:0.15pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Choice of Venue</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">For purposes of litigating any dispute that arises under this grant or the Agreement, the parties hereby submit to and consent to the exclusive jurisdiction of the State of Maine, agree that such litigation shall be conducted in the courts of Cumberland County, Maine, or the federal courts for the United States for the District of Maine, where this grant is made and&#47;or to be performed.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Language</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Participant acknowledges that he or she is sufficiently proficient in English to understand the terms and conditions of the Agreement.  Furthermore, if the Participant has received this Agreement or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Insider Trading Restrictions&#47;Market Abuse Laws</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Participant acknowledges that he or she may be subject to insider trading restrictions and&#47;or market abuse laws in applicable jurisdictions including, but not limited to, the United States and the Participant&#8217;s country of residence, which may affect the Participant&#8217;s ability to acquire or sell Shares or rights to Shares (e.g., RSUs) during such time as the Participant is considered to have &#8220;inside information&#8221; regarding the Company (as defined by the laws in the applicable jurisdictions).  Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable insider trading policy of the Company.  The Participant is responsible for ensuring compliance with any applicable restrictions and should consult with his or her personal legal advisor on this matter. </font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Foreign Asset&#47;Account and Exchange Control Requirements</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depending on the Participant&#8217;s country, the Participant may be subject to foreign asset&#47;account and&#47;or exchange control reporting or other requirements as a result of the vesting of the RSUs, the acquisition, holding and&#47;or transfer of Shares or cash resulting from participation in the Plan and&#47;or the opening and maintaining of a brokerage or bank account in connection with the Plan.  The Participant may be required to report such assets, accounts, account balances and values, and&#47;or related transactions to the applicable authorities in his or her country.  The Participant may also be required to repatriate sale proceeds or other funds received as a result of his or her participation in the Plan to his or her country through a designated bank or broker and&#47;or within a certain time after receipt.  The Participant acknowledges that he or she is responsible for ensuring compliance with any such requirements and that he or she should consult with the Participant&#8217;s personal tax and legal advisors, as applicable, on these matters.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Data Privacy (For Jurisdictions in the European Union (&#8220;EU&#8221;) &#47; European Economic Area (&#8220;EEA&#8221;), Switzerland and the United Kingdom)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font></div><div style="margin-bottom:12pt;margin-top:0.2pt;padding-left:6pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">This section replaces Section 8 of the Agreement&#58; </font></div><div style="margin-bottom:12pt;margin-top:0.2pt;padding-left:6pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(a) Data Collection and Usage</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.  The Company collects, processes and uses personal data about the Participant, including, but not limited to, the Participant&#8217;s name, home address, telephone number and e-mail address, date of birth, social insurance number, passport or other identification number, salary, nationality, job title, any equity or directorships held in the Company and its Affiliates, details of all RSUs or any other entitlement to equity awarded, canceled, exercised, vested, unvested or outstanding in the Participant&#8217;s favor, which the Company receives from the Participant or the Employer.  In order to participate in the Plan, the Company will collect the Participant&#8217;s personal data for purposes of allocating Shares and implementing, administering and managing the Plan.  The Company&#8217;s legal basis for the processing of the Participant&#8217;s personal data is based on necessity for the performance of the Plan and pursuant to the Company&#8217;s legitimate business interests.</font></div><div style="margin-bottom:12pt;margin-top:0.2pt;padding-left:6pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(b) Stock Plan Administration Service Providers</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.  The Company transfers the Participant&#8217;s data to E*TRADE Corporate Financial Services, Inc. (including its affiliated companies), an independent service provider based in the United States (&#8220;U.S.&#8221;), which assists the Company with the implementation, administration and management of the Plan.  In the future, the Company may select a different service provider and share the Participant&#8217;s data with another company that serves in a similar manner.  The Company&#8217;s service provider(s) will open an account for the Participant to receive and trade Shares.  The Participant will be asked to agree on separate </font></div></div></div><div style="height:50.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div style="margin-top:3.2pt;padding-left:182.95pt;padding-right:15.5pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exhibit 10.41</font></div><div style="margin-top:3.2pt;padding-left:173.57pt;padding-right:173.57pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee Restricted Stock Unit Agreement</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted Under IDEXX Laboratories, Inc. 2018 Stock Incentive Plan</font></div><div style="padding-left:173.67pt;padding-right:173.67pt;text-align:center"><font><br></font></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.687%"><div style="margin-bottom:12pt;margin-top:0.2pt;padding-left:6pt;padding-right:2.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">terms and data processing practices with the service provider(s), which is a condition to the Participant&#8217;s ability to participate in the Plan.</font></div><div style="margin-bottom:12pt;margin-top:0.2pt;padding-left:6pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(c) International Data Transfers.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  The Participant&#8217;s personal data will be transferred to the U.S. where the Company and its service providers are based.  The Company&#8217;s legal basis for the transfer of the Participant&#8217;s personal data to the U.S. is its use of the standard data protection clauses.</font></div><div style="margin-bottom:12pt;margin-top:0.2pt;padding-left:6pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(d) Data Retention</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.  The Company will use the Participant&#8217;s personal data only as long as necessary to implement, administer and manage the Participant&#8217;s participation in the Plan or as required to comply with legal or regulatory obligations, including tax and securities laws.  When the Company no longer needs the Participant&#8217;s personal data, which will generally be seven (7) years after the Participant participates in the Plan, the Company will remove it from its systems.  If the Company keeps data longer, it would be to satisfy legal or regulatory obligations and the Company&#8217;s legal basis would be relevant laws or regulations.</font></div><div style="margin-bottom:12pt;margin-top:0.2pt;padding-left:6pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(e) Data Subject Rights</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.  The Participant has a number of rights under data privacy laws in the Participant&#8217;s country.  Depending on where the Participant is based, his or her rights may include the right to (a) request access or copies of personal data processed by the Company, (b) rectification of incorrect data, (c) deletion of data, (d) restrictions on processing, (e) portability of data, (f) lodge complaints with competent authorities in the Participant&#8217;s country, and&#47;or (g) receive a list with the names and addresses of any potential recipients of the Participant&#8217;s personal data.  To receive clarification regarding the Participant&#8217;s rights or to exercise such rights please contact the Company&#8217;s Data Privacy Officer electronically, by phone, or mail, in strict confidence. </font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Data Privacy (Non-EU Jurisdictions)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">This section supplements Section 8 of the Agreement&#58;</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">The Participant may request a list with the names and addresses of any potential recipients of the Data by contacting his or her local human resources representative.  </font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">The Participant understands that Data will be held only as long as is necessary to implement, administer and manage the Participant&#8217;s participation in the Plan.  The Participant understands that he or she may, at any time, view Data, request information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing the Participant&#8217;s local human resources representative.  </font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Further, the Participant understands that he or she is providing the consents herein on a purely voluntary basis.  If the Participant does not consent, or if the Participant later seeks to revoke his or her consent, the Participant&#8217;s employment status or service with the Employer will not be affected&#59; the only consequence of refusing or withdrawing consent is that the Company would not be able to grant RSUs or other equity awards to the Participant or administer or maintain such awards.  Therefore, the Participant understands that refusing or withdrawing consent may affect his or her ability to participate in the Plan.  </font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">For more information on the consequences of the Participant&#8217;s refusal to consent or withdrawal of consent, the Participant understands that the Participant may contact his or her local human resources representative.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:1.3pt;padding-right:1.3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">AUSTRALIA</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  The offer of the RSUs is intended to comply with the provisions of the Corporations Act 2001, Australian Securities and Investments Commission (&#8220;ASIC&#8221;) Regulatory Guide 49 and ASIC Class Order 14&#47;1000.  Additional details are set forth in the Offer Document for the Offer of Restricted Stock Units to Australian Resident Employees.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Nature of Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Plan is a plan to which subdivision 83A-C of the Income Tax Assessment Act 1997 (Cth) applies (subject to conditions in the Act).</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:1.3pt;padding-right:1.3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">AUSTRIA</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">There are no country-specific provisions.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:1.3pt;padding-right:1.3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">BELGIUM</font></div></div><div style="display:inline-block;max-width:2.624%;min-width:1.624%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.689%"><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">There are no country-specific provisions.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:1.3pt;padding-right:1.3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">BRAZIL</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  The offer of the RSUs and the underlying Shares is not registered with the Brazilian Securities Commission (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Comiss&#227;o de Valores Mobili&#225;rios &#8211; CVM</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">).  The Shares may not be offered or sold in Brazil, except under circumstances that do not constitute a public offering or distribution of securities under Brazilian laws and regulations.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  This provision supplements the Nature of Grant section above&#58;</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">In accepting the RSUs, the Participant acknowledges that (i) the Participant is making an investment decision and (ii) the value of the underlying Shares is not fixed and may increase or decrease without compensation to the Participant.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Compliance with Law</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  In accepting the RSUs, the Participant agrees to comply with applicable Brazilian laws and to pay any and all applicable Tax-Related Items associated with the vesting and settlement of the RSUs, the receipt of any dividends, and the sale of Shares acquired under the Plan.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:1.3pt;padding-right:1.3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CANADA</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  The Participant is permitted to sell Shares acquired under the Plan through the designated broker appointed under the Plan, provided that the sale of such Shares takes place outside Canada through the facilities of a stock exchange on which the Shares are listed (i.e., the NASDAQ Global Select Market).</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Delivery of Shares</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> This provision supplements Section 5 of the Agreement&#58;</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">As provided herein, the Company shall, upon vesting of RSUs hereunder, make prompt delivery of vested Shares to the Participant, and the discretion to pay Awards in Shares or cash (as provided in Section 9(a) of the Plan) shall not apply to RSUs granted to Participants in Canada.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  This provision replaces subsection (i) in the Nature of Grant section above&#58;</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">For purposes of the RSUs, the Participant&#8217;s employment will terminate, and the Participant&#8217;s right (if any) to earn, seek damages in lieu of, or otherwise be paid any portion of the RSUs pursuant to this Agreement, will be measured by, the date that is the earlier of&#58;  </font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:60pt;padding-right:2.6pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;padding-left:11.34pt">the date the Participant&#8217;s employment with the Company or any of its Subsidiaries or Affiliates is terminated, whether by the Participant, by the Company or a Subsidiary or Affiliate, or by way of contractual frustration&#59; and</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:60pt;padding-right:2.6pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;padding-left:11.34pt">the date the Participant receives written notice of termination from the Company or one of its Subsidiaries or Affiliates&#59; </font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:5.75pt;padding-right:2.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">regardless of any period during which notice, pay in lieu of notice or related payments or damages are provided or required to be provided under local law.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">For greater certainty, the Participant will not earn or be entitled to any pro-rated vesting for that portion of time before the date on which the Participant&#8217;s right to vest terminates, nor will the Participant be entitled to any compensation for lost vesting. Notwithstanding the foregoing, if applicable employment standards legislation explicitly requires continued vesting during a statutory notice period, the Participant&#8217;s right to vest in the RSUs, if any, will terminate effective upon the expiry of the Participant&#8217;s minimum statutory notice period, but the Participant will not earn or be entitled to pro-rated vesting if the vesting date falls after the end of the Participant&#8217;s statutory notice period, nor will the Participant be entitled to any compensation for lost vesting. </font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Any such determination by the Company for the purposes of this Agreement shall have no effect upon any determination of the rights or obligations of the Participant or the Company (or any Subsidiary or Affiliate, as applicable) for any other purpose. </font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">The following provisions apply for Participants resident in Quebec&#58;</font></div></div></div><div style="height:50.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.687%"><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Data Privacy</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  This provision supplements the Data Privacy provision above&#58;</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Participant hereby authorizes the Company and the Company&#8217;s representatives to discuss with and obtain all relevant information from all personnel, professional or not, involved in the administration and operation of the Plan.  The Participant further authorizes the Company, the Employer and any other Subsidiary or Affiliate to disclose and discuss the Plan with their advisors.  The Participant further authorizes the Company, the Employer and any other Subsidiary or Affiliate to record and keep such information in his or her employee file.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Language Consent</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  The parties acknowledge that it is their express wish that the Agreement, as well as all documents, notices and legal proceedings entered into, given or instituted pursuant hereto or relating directly or indirectly hereto, be drawn up in English.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Consentement &#224; la Langue Utilis&#233;e</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"> Les parties reconnaissent avoir exig&#233; la r&#233;daction en anglais de la Convention, ainsi que de tous documents ex&#233;cut&#233;s, avis donn&#233;s et proc&#233;dures judiciaires intent&#233;es en vertu de, ou li&#233;s directement ou indirectement &#224;, la pr&#233;sente Convention.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:1.45pt;padding-right:1.45pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">FRANCE</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">RSUs Not Tax-Qualified</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> The RSUs are not intended to qualify for specific tax and social security treatment in France.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Language Consent</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> In accepting the RSUs, the Participant confirms having read and understood the Plan and Agreement, including all terms and conditions included therein, which were provided in the English language.  The Participant accepts the terms of those documents accordingly.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Consentement &#224; la Langue Utilis&#233;e.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">  En acceptant l&#8217;attribution, le Participant confirme avoir lu et compris le Plan et le Contrat, incluant tous leurs termes et conditions, qui ont &#233;t&#233; transmis en langue anglaise.  Le Participant accepte les dispositions de ces documents en connaissance de cause.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:1.3pt;padding-right:1.3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">FINLAND</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">There are no country-specific provisions.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:1.3pt;padding-right:1.3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">GERMANY</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">There are no country-specific provisions.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:1.3pt;padding-right:1.3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ITALY</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Plan Document Acknowledgment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  In accepting the RSUs, the Participant acknowledges that he or she has received a copy of the Plan and the Agreement and has reviewed the Plan and the Agreement, including this Exhibit A, in their entirety and fully understands and accepts all provisions of the Plan and the Agreement, including this Exhibit A.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Participant acknowledges that he or she has read and specifically and expressly approves the following paragraphs of the Agreement&#58; (i) Section 7 - Taxes, (ii) Choice of Venue provision in this Exhibit A and (iii) the Data Privacy provision (For Jurisdictions in the European Union (&#8220;EU&#8221;) &#47; European Economic Area (&#8220;EEA&#8221;), Switzerland and the United Kingdom) in this Exhibit A.</font></div><div style="margin-bottom:12pt;padding-left:1.3pt;padding-right:1.3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">JAPAN</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">There are no country-specific provisions.</font></div><div style="margin-bottom:12pt;padding-left:1.3pt;padding-right:1.3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">KOREA</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">There are no country-specific provisions.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:1.3pt;padding-right:1.3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">NETHERLANDS</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">There are no country-specific provisions.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:1.3pt;padding-right:1.3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">NEW ZEALAND</font></div></div><div style="display:inline-block;max-width:2.624%;min-width:1.624%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.689%"><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">WARNING&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> The Participant is being offered RSUs which allow the Participant to acquire Shares in accordance with the terms of the Plan and the Agreement.  The Shares, if acquired, give the Participant a stake in the ownership of the Company.  The Participant may receive a return if dividends are paid. </font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">If the Company runs into financial difficulties and is wound up, the Participant will be paid only after all creditors and holders of preferred shares have been paid.  The Participant may lose some or all of his or her investment.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">New Zealand law normally requires people who offer financial products to give information to investors before they invest.  This information is designed to help investors to make an informed decision.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The usual rules do not apply to this offer because it is made under an employee share purchase scheme.  As a result, the Participant may not be given all the information usually required.  The Participant will also have fewer other legal protections for this investment.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Participant understands that he or she should ask questions, read all documents carefully, and seek independent financial advice before deciding to participate in the Plan.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Shares are quoted and approved for trading on the NASDAQ Global Select Market in the United States of America.  This means that, if the Participant acquires Shares under the Plan, the Participant may be able to sell his or her investment on the NASDAQ Global Select Market if there are interested buyers.  The Participant understands that he or she may get less than the Participant&#8217;s investment.  The price will depend on the demand for the Shares. </font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">For information on risk factors impacting the Company&#8217;s business that may affect the value of the Shares, the Participant should refer to the risk factors discussion in the Company&#8217;s Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, which are filed with the U.S. Securities and Exchange Commission and are available online at www.sec.gov, as well as on the Company&#8217;s website at https&#58;&#47;&#47;www.idexx.com&#47;corporate&#47;investors-home.html.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:1.3pt;padding-right:1.3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">PORTUGAL</font></div><div style="margin-top:0.15pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Language Consent</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  The Participant hereby expressly declares that he or she has full knowledge of the English language and has read, understood and fully accepted and agreed with the terms and conditions established in the Plan and the Agreement.</font></div><div style="margin-top:0.15pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font><br></font></div><div style="margin-top:0.15pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Conhecimento da Lingua</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">  Participante, pelo presente instrumento, declara expressamente que tem pleno conhecimento da l&#237;ngua inglesa e que leu, compreendeu e livremente aceitou e concordou com os termos e condi&#231;&#245;es estabelecidas no Plano e no Acordo.</font></div><div style="margin-top:0.15pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font><br></font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:1.3pt;padding-right:1.3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SINGAPORE</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  The RSUs are being granted pursuant to the &#8220;Qualifying Person&#8221; exemption under section 273(1)(f) of the Singapore Securities and Futures Act (Chapter 289, 2006 Ed.) (&#8220;SFA&#8221;).  The Plan has not been lodged or registered as a prospectus with the Monetary Authority of Singapore.  The Participant should note that the RSUs are subject to section 257 of the SFA and the Participant will not be able to make any subsequent sale of the Shares acquired pursuant to the RSUs in Singapore or any offer of such subsequent sale of Shares in Singapore unless such sale or offer in Singapore is made (a) after six months after the grant date, or (b) pursuant to the exemptions under Part XIII Division (1) Subdivision (4) (other than section 280) of the SFA, or pursuant to, and in accordance with the conditions of, any applicable provisions of the SFA.</font></div><div style="margin-bottom:12pt;margin-top:0.2pt;padding-left:4.45pt;padding-right:4.45pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SOUTH AFRICA</font></div><div style="margin-bottom:12pt;margin-top:0.2pt;padding-left:6pt;padding-right:2.9pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.  Neither the RSUs nor the underlying Shares shall be publicly offered or listed on any stock exchange in South Africa.  The offer is intended to be private pursuant to Section 96(1)(g)(ii) of the Companies Act.</font></div><div style="margin-bottom:12pt;margin-top:0.2pt;padding-left:6pt;padding-right:2.9pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">This provision supplements Section 7 of the Agreement&#58;</font></div></div></div><div style="height:50.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.687%"><div style="margin-bottom:12pt;margin-top:0.2pt;padding-left:6pt;padding-right:2.9pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">By accepting the RSUs, the Participant understands and acknowledges that he or she is required to notify the Employer of the amount of any gain realized upon vesting of the RSUs. </font></div><div style="margin-bottom:12pt;margin-top:0.2pt;padding-left:6pt;padding-right:2.9pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.  The Participant is solely responsible for complying with applicable South African exchange control regulations.  Since the exchange control regulations change frequently and without notice, the Participant should consult his or her legal advisor prior to the acquisition or sale of Shares under the Plan to ensure compliance with current regulations.  As noted, it is the Participant&#8217;s responsibility to comply with South African exchange control laws, and neither the Company nor the Employer will be liable for any fines or penalties resulting from failure to comply with applicable laws.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:1.3pt;padding-right:1.3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SPAIN</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  No &#8220;offer of securities to the public,&#8221; as defined under Spanish law, has taken place or will take place in the Spanish territory in connection with the offer of the RSUs.  The Plan, the Agreement and any other documents evidencing the grant of the RSUs have not been, nor will they be, registered with the </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Comisi&#243;n Nacional del Mercado de Valores</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> (the Spanish securities regulator), and none of those documents constitutes a public offering prospectus.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  This provision supplements the Nature of Grant section above&#58;</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">In accepting the RSUs, the Participant acknowledges that he or she has received a copy of the Plan, has reviewed and understands the Plan and agrees to participation in the Plan.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Participant further understands that the Company has unilaterally, gratuitously and discretionally decided to grant RSUs under the Plan to employees of the Company or any Subsidiary or Affiliate throughout the world.  The decision to grant the RSUs is a limited decision that is entered into upon the express assumption and condition that any RSU grant will not economically or otherwise bind the Company or any Subsidiary or Affiliate on an ongoing basis other than as set forth in this Agreement.  Consequently, the Participant understands that any grant is given on the assumption and condition that it shall not become a part of any employment contract (either with the Company or any Subsidiary or Affiliate) and shall not be considered a mandatory benefit, salary for any purpose (including severance compensation) or any other right whatsoever.  Further, the Participant understands and freely accepts that there is no guarantee that any benefit shall arise from any gratuitous and discretionary grant since the future value of the RSUs and the underlying Shares is unknown and unpredictable. </font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additionally, the Participant understands that the vesting of the RSUs is conditioned on the Participant&#8217;s continued and active rendering of service to the Employer such that, except as specifically provided in Section 2 of the Agreement, if the Participant&#8217;s employment terminates for any reason whatsoever, the Participant&#8217;s RSUs will cease vesting immediately effective as of the date of termination of his or her employment.  This will be the case, for example, even if (a) the Participant is considered to be unfairly dismissed without good cause (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">i.e.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">, subject to a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">despido improcedente</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8221;)&#59; (b) the Participant is dismissed for disciplinary or objective reasons or due to a collective dismissal&#59; (c) the Participant terminates service due to a change of work location, duties or any other employment or contractual condition&#59; (d) the Participant terminates service due to the Company&#8217;s or any Subsidiary&#8217;s or Affiliate&#8217;s unilateral breach of contract&#59; or (e) the Participant&#8217;s employment terminates for any other reason whatsoever.  Consequently, upon termination of employment for any of the above reasons, the Participant will automatically lose any rights to RSUs granted that were unvested on the date of termination of the Participant&#8217;s employment, as described in the Agreement.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finally, the Participant understands that this grant would not be made to him or her but for the assumptions and conditions referred to herein&#59; thus, the Participant acknowledges and freely accepts that should any or all of the assumptions be mistaken or should any of the conditions not be met for any reason, then any grant of RSUs shall be null and void.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:4.3pt;padding-right:4.3pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SWEDEN</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Authorization to Withhold</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">This provision supplements Section 7 of the Agreement&#58;</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Without limiting the Company&#8217;s and the Employer's authority to satisfy their withholding obligations for Tax-Related Items as set forth in Section 7 of the Agreement, in accepting the RSUs, the Participant authorizes the </font></div></div><div style="display:inline-block;max-width:2.624%;min-width:1.624%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.689%"><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Company to deduct and retain from the Shares to be distributed upon vesting of RSUs or to withhold from proceeds of the sale of Shares acquired upon vesting and settlement of the RSUs, regardless of whether the Company and&#47;or the Employer have an obligation to withhold such Tax-Related Items.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:1.3pt;padding-right:1.3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SWITZERLAND</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Neither this document nor any other materials relating to the RSUs (a) constitutes a prospectus according to articles 35 et seq. of the Swiss Federal Act on Financial Services (&#8220;FinSA&#8221;), (b) may be publicly distributed or otherwise made publicly available in Switzerland to any person other than an Eligible Grantee, or (c) has been or will be filed with, approved or supervised by any Swiss reviewing body according to article 51 FinSA or any Swiss regulatory authority, including the Swiss Financial Market Supervisory Authority.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:1.3pt;padding-right:1.3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TAIWAN</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The offer of participation in the Plan is available only for Eligible Grantees of the Company and its Affiliates.  The offer of participation in the Plan is not a public offer of securities by a Taiwanese company.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:1.3pt;padding-right:1.3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">UNITED KINGDOM (&#8220;U.K.&#8221;)</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  This provision supplements Section 7 of the Agreement&#58;</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Without limitation to Section 7 of the Agreement, the Participant hereby agrees that he or she is liable for all Tax-Related Items and hereby covenants to pay all such Tax-Related Items, as and when requested by the Company or the Employer, as applicable, or by Her Majesty&#8217;s Revenue &#38; Customs (&#8220;HMRC&#8221;) (or any other tax authority or any other relevant authority).  The Participant also hereby agrees to indemnify and keep indemnified the Company and the Employer, as applicable, against any Tax-Related Items that they are required to pay or withhold or have paid or will pay to HMRC (or any other tax authority or any other relevant authority) on the Participant&#8217;s behalf.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, if the Participant is a director or executive officer of the Company (within the meaning of Section 13(k) of the Exchange Act), the terms of immediately foregoing provision will not apply.  In this case, the amount of the income tax not collected within 90 days of the end of the U.K. tax year in which an event giving rise to the Tax-Related Items occurs may constitute a benefit to the Participant on which additional income tax and National Insurance contributions may be payable.  The Participant will be responsible for reporting and paying any income tax due on this additional benefit directly to HMRC under the self-assessment regime and for reimbursing the Company or the Employer, as applicable, for the value of any National Insurance contributions due on this additional benefit, which may be recovered from the Participant by the Company or the Employer at any time thereafter by any of the means referred to in Section 7 of the Agreement.</font></div><div><font><br></font></div><div style="margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font><br></font></div><div><font><br></font></div></div></div><div style="height:50.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7</font></div><div><font><br></font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.42
<SEQUENCE>18
<FILENAME>a1042high-performerrsuagre.htm
<DESCRIPTION>EX-10.42
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i58849e8572c14047833ef7d216934f4a_1"></div><div style="min-height:92.16pt;width:100%"><div style="margin-top:3.2pt;padding-left:182.95pt;padding-right:24.5pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exhibit 10.42</font></div><div style="margin-top:3.2pt;padding-left:173.57pt;padding-right:173.57pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restricted Stock Unit Agreement</font></div><div style="padding-left:173.67pt;padding-right:173.67pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted Under IDEXX Laboratories, Inc. 2018 Stock Incentive Plan</font></div></div><div style="margin-top:0.05pt"><font><br></font></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.687%"><div style="margin-top:4.25pt;padding-left:17.25pt;padding-right:2.6pt;text-indent:-11.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:4.59pt;text-decoration:underline">Grant of Restricted Stock.</font></div><div style="margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font><br></font></div><div style="margin-top:0.4pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:117%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:117%;padding-left:2.24pt">Grant.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:117%"> IDEXX Laboratories, Inc., a Delaware corporation (the &#8220;Company&#8221;), hereby grants to the Participant a Restricted Stock Unit Award consisting of the number of Restricted Stock Units (&#8220;RSUs&#8221;) stated in this Agreement, including any exhibit, appendix or addendum hereto (the &#8220;Agreement&#8221;). Each RSU represents the right to receive one share of common stock, $.010 par value, of the Company (individually a &#8220;Share&#8221; and collectively the &#8220;Shares&#8221;). The Company will record on its books the grant of the RSUs to the Participant and will issue Shares upon vesting of the RSUs as provided below. This award of RSUs is subject to the terms and conditions set forth in this Agreement, the Company&#8217;s 2018 Stock Incentive Plan (the &#8220;Plan&#8221;) and the description of the Plan set forth in the Plan Prospectus. The Plan and the Plan Prospectus are provided to the Participant with this Agreement. Capitalized terms not otherwise defined in this Agreement shall have the meanings set forth in the Plan or the Plan Prospectus.</font></div><div style="margin-top:0.4pt;padding-left:24pt;padding-right:2.6pt"><font><br></font></div><div style="margin-top:0.4pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:117%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:117%;padding-left:1.8pt">Restrictive Covenant Agreements</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:117%">. Participant acknowledges and affirms that&#58; (i) Participant may be subject to non-competition, non-solicitation and&#47;or confidentiality provisions set forth in one or more agreements with the Company or any of its Affiliates (including, as applicable, employment, consulting or advisory contracts&#59; confidentiality and nondisclosure agreements&#59; or other agreements&#59; in each case as may be amended,  supplemented or replaced from time to time) (collectively, the &#8220;Restrictive Covenant Agreements&#8221;)&#59; (ii) this RSU award is granted in consideration of Participant&#8217;s agreement to be bound by the Participant&#8217;s Restrictive Covenant Agreements&#59; (iii) if the Company requests that Participant execute updated Restrictive Covenant Agreements, the vesting of this RSU award is conditioned on Participant&#8217;s execution and delivery of such updated Restrictive Covenant Agreements in a manner and by a date satisfactory to the Company in its sole discretion, and the failure of Participant to so execute and deliver any such requested updated Restrictive Covenant Agreement by such date will result in the immediate cancellation of, and automatic forfeiture of any rights Participant may have with respect to, this RSU award&#59; and (iv) Participant agrees to comply with the restrictions and obligations set forth in Participant&#8217;s Restrictive Covenant Agreements, if any.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:17.25pt;padding-right:2.6pt;text-indent:-11.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:4.59pt;text-decoration:underline">Vesting and Forfeiture.</font></div><div style="padding-left:17.25pt;padding-right:2.6pt"><font><br></font></div><div style="margin-top:0.4pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:117%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:117%;padding-left:2.24pt">Vesting. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:117%">Subject to Section 2(b) and (c), the RSUs shall vest and become nonforfeitable in accordance with the vesting schedule set forth in this Agreement.</font></div><div style="margin-top:0.4pt;padding-left:24pt;padding-right:2.6pt"><font><br></font></div><div style="margin-top:0.2pt;padding-left:6pt;padding-right:1.15pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:117%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:117%;padding-left:1.8pt">Forfeiture</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:117%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:117%">Except as otherwise provided in this Section 2, in the event that the Participant ceases to be employed by the Company or an Affiliate or a member of the Board, as applicable (an &#8220;Eligible Grantee&#8221;) for any reason or no reason, the balance of RSUs that have not vested as of the date of such cessation will be forfeited and the Participant will have no future rights with respect to any such unvested RSUs. The Company shall determine in good faith (including in accordance with Section 409A of the Code) and in the exercise of its discretion whether the Participant has ceased to be an employee and the effective date of the Participant&#8217;s termination of such status, and such determinations shall be final, binding and conclusive.</font></div><div style="margin-top:0.2pt;padding-left:6pt;padding-right:1.15pt"><font><br></font></div><div style="margin-top:0.2pt;padding-left:6pt;padding-right:1.15pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:117%">Notwithstanding anything in this Agreement that may be to the contrary, if the Company determines that Participant has violated any provisions set forth in the Restrictive Covenant Agreements, if any, in addition to any and all rights and remedies set forth therein or otherwise available under law or equity, Participant covenants and agrees that&#58; (i) the unvested portion of the RSUs will immediately be cancelled, and Participant shall automatically forfeit any rights Participant may have with respect to such unvested RSUs as of the date of such determination&#59; and (ii) the Company or its Affiliate may also take action at equity or in law to enforce the provisions of the Restrictive Covenant Agreements.</font></div><div style="margin-top:0.2pt;padding-left:6pt;padding-right:1.15pt;text-indent:18pt"><font><br></font></div><div style="margin-top:0.2pt;padding-left:6pt;padding-right:1.15pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:117%">Following application of this provision of the Agreement, Participant will continue to be bound by the obligations, promises and other agreements contained in the Restrictive Covenant Agreements, if any, and this Agreement.</font></div><div style="margin-top:0.2pt;padding-left:24pt;padding-right:1.15pt"><font><br></font></div></div><div style="display:inline-block;max-width:2.624%;min-width:1.624%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.689%"><div style="margin-top:0.2pt;padding-left:6pt;padding-right:1.15pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:117%">(c)</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:117%;padding-left:2.24pt">Disability or Death</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:117%">.&#160; In the event that the Participant&#8217;s employment or service to the Company or an Affiliate is terminated as a result of the Participant&#8217;s Disability (as defined in Section 22(e)(3) of the Code) or as a result of the Participant&#8217;s death, all RSUs that have not vested as of the date of such cessation of service shall immediately vest and become nonforfeitable as of the date of the Participant&#8217;s Disability or death&#59; provided, however, if such Disability or death occurs within one year of the grant date of this award, then this award shall continue to vest after the date of such Disability or death in accordance with the schedule described in Section 2(a) above, except that all RSUs that have not vested as of the date of such cessation of service will immediately vest and become nonforfeitable as of the date that is the one-year anniversary of the grant date of this award.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:15pt;padding-right:2.6pt;text-indent:-9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:2.34pt;text-decoration:underline">Restrictions on Transfer.</font></div><div style="padding-left:15pt;padding-right:2.6pt"><font><br></font></div><div style="margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Participant may not sell, assign, transfer, pledge, hypothecate or otherwise dispose of by operation of law or otherwise, any RSUs, or any interest therein, except by will or the laws of descent and distribution.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:17.25pt;padding-right:2.6pt;text-indent:-11.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:4.59pt;text-decoration:underline">Rights as Stockholder.</font></div><div style="padding-left:17.25pt;padding-right:2.6pt"><font><br></font></div><div style="margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Neither the Participant, nor any person claiming through the Participant, will have any of the rights or privileges of a stockholder of the Company with respect to the RSUs unless and until Shares have been issued, recorded on the records of the Company or its transfer agent, and delivered to the Participant upon vesting of the RSUs. No adjustment shall be made for dividends or distributions or other rights for which the record date is prior to the date such Shares are issued. After such issuance, recordation and delivery, the Participant will have all the rights of a stockholder of the Company with respect to the Shares.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:17.25pt;padding-right:2.6pt;text-indent:-11.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:4.59pt;text-decoration:underline">Delivery of Shares&#59; Compliance with Securities Laws, Etc.</font></div><div style="padding-left:17.25pt;padding-right:2.6pt"><font><br></font></div><div style="margin-top:0.4pt;padding-left:6pt;padding-right:1pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:117%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:117%;padding-left:2.24pt">General. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:117%">The Company shall, upon vesting of RSUs hereunder, make prompt delivery of vested Shares to the Participant, or if the Participant has died or become Disabled (as defined in Section 2(c) above), to the person to whom this award is transferred by will or the laws of descent and distribution, provided that if any law or regulation requires the Company to take any action with respect to such Shares before the issuance thereof, then the date of delivery of such Shares shall be extended for the period necessary to complete such action.</font></div><div style="margin-top:0.4pt;padding-left:24pt;padding-right:1pt"><font><br></font></div><div style="margin-top:0.4pt;padding-left:6pt;padding-right:1pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:117%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:117%;padding-left:1.8pt">Listing, Qualification, Etc</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:117%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:117%">The RSUs shall be subject to the requirement that if, at any time, counsel to the Company shall determine that the listing, registration or qualification of Shares subject hereto upon any securities exchange or under any state or federal law, or the consent or approval of any governmental or regulatory body, or that the disclosure of non-public information or the satisfaction of any other condition is necessary as a condition of, or in connection with,  the  issuance of Shares hereunder, then such issuance shall be deferred until such listing, registration, qualification, consent or approval, disclosure or satisfaction of such other condition shall have been effected or obtained on terms acceptable to the Board. Nothing herein shall be deemed to require the Company to apply for, effect disclosure, or to satisfy such other condition.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:17.25pt;padding-right:7.25pt;text-indent:-11.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">6.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:4.59pt;text-decoration:underline">No Special Employment Rights.</font></div><div style="padding-left:17.25pt;padding-right:7.25pt"><font><br></font></div><div style="margin-top:0.15pt;padding-left:6pt;padding-right:7.25pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nothing contained in the Plan, the Plan Prospectus or this Agreement shall be construed or deemed to constitute an employment or service contract or confer or be deemed to confer on the Participant any right to continue in the employ or service of, or to continue any other relationship with, the Company or an Affiliate or limit in any way any right of the Company or an Affiliate, as applicable, to terminate the Participant&#8217;s employment or service or other relationship at any time, with or without cause.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:17.25pt;padding-right:7.25pt;text-indent:-11.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">7.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:4.59pt;text-decoration:underline">Taxes.</font></div><div style="padding-left:17.25pt;padding-right:7.25pt"><font><br></font></div><div style="margin-top:0.2pt;padding-left:6pt;padding-right:14.45pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:118%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:118%;padding-left:2.24pt">Responsibility for Taxes. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:118%">The Participant acknowledges that, regardless of any action taken by the Company or, if different, the Participant's employer (the &#34;Employer&#8221;), the ultimate liability for all income tax (whether foreign, federal, state or local), social insurance, payroll tax, fringe benefits tax, payment on account and other tax-related items related to the Participant&#8217;s participation in the Plan and legally applicable to the </font></div></div></div><div style="height:47.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:92.16pt;width:100%"><div><font><br></font></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.687%"><div style="margin-top:0.2pt;padding-left:6pt;padding-right:14.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:118%">Participant (the &#8220;Tax-Related Items&#8221;) is and remains the Participant&#8217;s responsibility as it may come due and may exceed the amount actually withheld by the Company or the Employer.  The Participant further acknowledges that the Company and&#47;or the Employer (i) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the RSUs, and (ii) do not commit to and are under no obligation to structure the terms of the grant or any aspect of the RSUs to reduce or eliminate the Participant&#8217;s liability for Tax-Related Items or achieve any particular tax result.  Further, if the Participant is subject to Tax-Related Items in more than one jurisdiction, the Participant acknowledges that the Company and&#47;or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.  In addition, the Participant further acknowledges that Tax-Related Items may be incurred at different times. The Participant acknowledges that no election under Section 83(b) of the Internal Revenue Code of 1986 may be filed with respect to this award.</font></div><div style="margin-top:0.2pt;padding-left:24pt;padding-right:14.45pt"><font><br></font></div><div style="margin-top:0.2pt;padding-left:6pt;padding-right:14.45pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:118%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:118%;padding-left:1.8pt">Withholding.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:118%"> The Participant acknowledges and agrees to make arrangements satisfactory to the Company with respect to any withholding obligation the Company or the Employer (or former employer) may have for Tax-Related Items. Without limitation to the foregoing, the Participant acknowledges and agrees that to satisfy any such withholding obligation for Tax-Related Items, the Company may (i) deduct and retain from the Shares to be distributed upon vesting of RSUs such number of Shares as is equal in value to the Tax-Related Items, (ii) withhold from the Participant's wages or other cash compensation paid to the Participant by the Company and&#47;or the Employer, (iii) withhold from proceeds of the sale of Shares acquired upon vesting and settlement of the RSUs, either through a voluntary sale or through a mandatory sale arranged by the Company (on the Participant&#8217;s behalf pursuant to this authorization), or (iv) withhold by any other method permitted under the Plan and applicable law.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%">  </font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:7.25pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depending on the withholding method, the Company may withhold or account for Tax-Related Items by considering applicable minimum statutory withholding amounts or other applicable withholding rates, including up to the maximum applicable rate in the Participant's jurisdiction (in which case, the Participant may receive a refund of any over-withheld amount in cash and will have no entitlement to the equivalent amount in Shares).  If the obligation for Tax-Related Items is satisfied by withholding in Shares, as described in (i) above, for tax purposes, the Participant will be deemed to have been issued the full number of Shares subject to the vested portion of the RSUs.  The Company may refuse to issue or deliver the Shares or the proceeds of the sale of Shares, if the Participant fails to comply with his or her obligations in connection with the Tax-Related Items.</font></div><div style="margin-top:0.2pt;padding-left:6pt;padding-right:14.45pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:118%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:118%;padding-left:2.24pt">Tax Consequences</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:118%">.  The Participant has reviewed with his or her own tax advisors the applicable tax consequences of this investment and the transactions contemplated by this Agreement.  With respect to such matters, the Participant relies solely on such advisors and not on any statements or representations of the Company or any of its agents, written or oral.  </font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:17.25pt;padding-right:7.25pt;text-indent:-11.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">8.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:4.59pt;text-decoration:underline">Data Privacy.</font></div><div style="padding-left:17.25pt;padding-right:7.25pt"><font><br></font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Participant hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of the Participant&#8217;s personal data as described in this Agreement and any other RSU grant materials by and among, as applicable, the Employer, the Company and its Subsidiaries and Affiliates for the exclusive purpose of implementing, administering and managing the Participant&#8217;s participation in the Plan.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:7.25pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Participant understands that the Company and the Employer may hold certain personal information about the Participant, including, but not limited to, the Participant&#8217;s name, home address, email address and telephone number, date of birth, social insurance number, passport or other identification number, salary, nationality, job title, any shares of stock or directorships held in the Company, details of all RSUs or any other entitlement to shares of stock awarded, canceled, exercised, vested, unvested or outstanding in the Participant&#8217;s favor (&#8220;Data&#8221;), for the exclusive purpose of implementing, administering and managing the Plan. </font></div></div><div style="display:inline-block;max-width:2.624%;min-width:1.624%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.689%"><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Participant understands that Data will be transferred to E*TRADE or such other stock plan service provider as may be selected by the Company in the future, which is assisting the Company with the implementation, administration and management of the Plan. The Participant understands that the recipients of the Data may be located in the United States or elsewhere, and that the recipient&#8217;s country may have different data privacy laws and protections than the Participant&#8217;s country.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Participant authorizes the Company, E*TRADE and any other possible recipients which may assist the Company (presently or in the future) with implementing, administering and managing the Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the sole purposes of implementing, administering and managing the Participant&#8217;s participation in the Plan.  </font></div><div style="padding-left:17.25pt;padding-right:7.25pt;text-indent:-11.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">9.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:4.59pt;text-decoration:underline">Miscellaneous.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:7.8pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;padding-left:6.09pt">This Agreement and the Plan constitute the entire agreement between the parties, and supersedes all prior agreements and understandings, relating to the subject matter of this Agreement. </font></div><div style="margin-top:0.4pt;padding-left:6pt;padding-right:7.25pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:117%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:117%;padding-left:1.8pt">Except as provided herein, this Agreement may not be amended or otherwise modified unless evidenced in writing and signed by the Company and the Participant. Any provision for the benefit of the Company contained in this Agreement may be waived, either generally or in any particular instance, by the Board. The Board may amend, alter, suspend, discontinue or terminate the Plan, or any portion thereof, at any time, subject to the requirements for certain amendments or alterations set forth in the Plan.</font></div><div style="margin-top:0.4pt;padding-left:24pt;padding-right:7.25pt"><font><br></font></div><div style="margin-top:0.2pt;padding-left:6pt;padding-right:18.2pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:117%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:117%;padding-left:2.24pt">This Agreement shall be binding upon and inure to the benefit of the Company and the Participant and their respective heirs, executors, administrators, representatives, successors and assigns, subject to the restrictions on transfer set forth in Section 3 hereof.</font></div><div style="margin-top:0.2pt;padding-right:18.2pt"><font><br></font></div><div style="margin-top:0.2pt;padding-left:6pt;padding-right:12.05pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:117%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:117%;padding-left:1.8pt">The right of the Participant to receive Shares pursuant to this award is an unfunded and unsecured obligation of the Company. The Participant shall have no rights under this award other than those of an unsecured general creditor of the Company.</font></div><div style="margin-top:0.2pt;padding-right:12.05pt"><font><br></font></div><div style="margin-top:0.2pt;padding-left:6pt;padding-right:11.8pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:117%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:117%;padding-left:2.24pt">The RSUs and the provisions of this Agreement shall be governed by and construed in accordance with the laws of the State of Delaware and applicable federal law, without regard to applicable conflict of laws principles.</font></div><div><font><br></font></div><div style="margin-top:0.2pt;padding-left:6pt;padding-right:11.8pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:117%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:117%;padding-left:4.02pt">The invalidity or unenforceability of any provision of this Agreement shall not affect the validity or enforceability of any other provision of this Agreement, and each other provision of this Agreement shall be severable and enforceable to the extent permitted by law.</font></div><div><font><br></font></div><div style="margin-top:0.2pt;padding-left:6pt;padding-right:11.8pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:117%">(g)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:117%;padding-left:1.8pt">The Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding the Participant&#8217;s participation in the Plan, or the Participant&#8217;s acquisition or sale of the underlying Shares.  </font></div><div><font><br></font></div><div style="margin-top:0.2pt;padding-left:6pt;padding-right:11.8pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:117%">(h)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:117%;padding-left:1.8pt">All notices under this Agreement shall be mailed or delivered by hand to the parties at their respective addresses set forth in this Agreement or at such other address as may be designated in writing by either of the parties to one another.</font></div><div><font><br></font></div><div style="margin-top:0.2pt;padding-left:6pt;padding-right:11.8pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:117%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:117%;padding-left:4.46pt">The Company may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plan by electronic means.  The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Company or a third party designated by the Company. </font></div><div><font><br></font></div><div style="margin-top:0.2pt;padding-left:6pt;padding-right:11.8pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:117%">(j)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:117%;padding-left:4.46pt">The Company reserves the right to impose other requirements on the Participant&#8217;s participation in the Plan, on the RSUs and on any Shares acquired under the Plan, to the extent the Company determines it is necessary or advisable for legal or administrative reasons, and to require the Participant to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.</font></div></div></div><div style="height:47.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.43
<SEQUENCE>19
<FILENAME>a1043jmazelskyrsuawardagre.htm
<DESCRIPTION>EX-10.43
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i35fd82fea4c346f4a0c4adf084b955fc_1"></div><div style="min-height:59.76pt;width:100%"><div style="margin-top:3.2pt;padding-left:182.95pt;padding-right:33.5pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exhibit 10.43</font></div><div style="margin-top:3.2pt;padding-left:173.57pt;padding-right:173.57pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CEO Restricted Stock Unit Agreement</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted Under IDEXX Laboratories, Inc. 2018 Stock Incentive Plan</font></div><div style="padding-left:173.67pt;padding-right:173.67pt;text-align:center"><font><br></font></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.687%"><div style="margin-bottom:12pt;margin-top:4pt;padding-left:17.25pt;padding-right:2.6pt;text-indent:-11.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:4.59pt;text-decoration:underline">Grant of Restricted Stock Units.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:2.6pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:6.09pt">Grant.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  IDEXX Laboratories, Inc., a Delaware corporation (the &#8220;Company&#8221;), hereby grants to the Participant a Restricted Stock Unit Award consisting of the number of Restricted Stock Units (&#8220;RSUs&#8221;) stated in this Restricted Stock Unit Agreement, including any exhibit, appendix or addendum hereto (the &#8220;Agreement&#8221;). Each RSU represents the right to receive one share of common stock, $0.10 par value, of the Company (individually a &#8220;Share&#8221; and collectively the &#8220;Shares&#8221;). The Company will record on its books the grant of the RSUs to the Participant and will issue Shares upon vesting of the RSUs as provided below. This award of RSUs is subject to the terms and conditions set forth in this Agreement, the Company&#8217;s 2018 Stock Incentive Plan (the &#8220;Plan&#8221;) and the description of the Plan set forth in the Plan Prospectus.  The Plan and the Plan Prospectus are provided to the Participant with this Agreement. Capitalized terms not otherwise defined in this Agreement shall have the meanings set forth in the Plan or the Plan Prospectus.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:5.65pt">Restrictive Covenant Agreements.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> Participant acknowledges and affirms that&#58; (i) Participant is subject to non-competition, non-solicitation and&#47;or confidentiality provisions set forth in one or more agreements with the Company or any of its Affiliates (including, as applicable, employment, consulting or advisory contracts&#59; confidentiality and nondisclosure agreements&#59; or other agreements&#59; in each case as may be amended, supplemented or replaced from time to time) (collectively, the &#8220;Restrictive Covenant Agreements&#8221;)&#59; (ii)&#160;this RSU award is granted in consideration of Participant&#8217;s agreement to be bound by the Participant&#8217;s Restrictive Covenant Agreements&#59; (iii) if the Company requests that Participant execute updated Restrictive Covenant Agreements, the vesting of this RSU award is conditioned on Participant&#8217;s execution and delivery of such updated Restrictive Covenant Agreements in a manner and by a date satisfactory to the Company in its sole discretion, and the failure of Participant to so execute and deliver any such requested updated Restrictive Covenant Agreement by such date will result in the immediate cancellation of, and automatic forfeiture of any rights Participant may have with respect to, this RSU award&#59; and (iv) Participant agrees to comply with the restrictions and obligations set forth in Participant&#8217;s Restrictive Covenant Agreements.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:17.25pt;padding-right:2.6pt;text-indent:-11.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:4.59pt;text-decoration:underline">Vesting and Forfeiture.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:2.6pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:6.09pt">Vesting. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Subject to Section 2(b), (c) and (d), the RSUs shall vest and become nonforfeitable in accordance with the vesting schedule set forth in this Agreement. </font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:5.65pt">Forfeiture</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Except as otherwise provided in this Section 2, in the event that the Participant ceases to be employed by the Company or an Affiliate and is neither a consultant of the Company or an Affiliate nor a member of the Board,  (an &#8220;Eligible Grantee&#8221;) for any reason or no reason, the balance of RSUs that have not vested as of the date of such cessation will be forfeited and the Participant will have no future rights with respect to any such unvested RSUs. The Company shall determine in good faith (including in accordance with Section 409A of the Code) and in the exercise of its discretion whether the Participant has ceased to be an Eligible Grantee and the effective date of the Participant&#8217;s termination of such status, and such determinations shall be final, binding and conclusive. For the avoidance of doubt, a Participant shall remain an &#8220;Eligible Grantee&#8221; if such Participant is, and has been at all times since the Grant Date indicated on the opposite side of this Agreement, an employee of the Company or an Affiliate, a consultant of the Company or an Affiliate or a member of the Board.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Notwithstanding anything in this Agreement that may be to the contrary, if the Company determines that Participant has violated any provisions set forth in the Restrictive Covenant Agreements, in addition to any and all rights and remedies set forth therein or otherwise available under law or equity, Participant covenants and agrees that&#58; (i) the unvested portion of the RSUs will immediately be cancelled, and Participant shall automatically forfeit any rights Participant may have with respect to such unvested RSUs as of the date of such determination&#59; and (ii) the Company or its Affiliate may also take action at equity or in law to enforce the provisions of the Restrictive Covenant Agreements.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:1.15pt;text-indent:14.4pt"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Following application of this provision of the Agreement, Participant will continue to be bound by the obligations, promises and other agreements contained in the Restrictive Covenant Agreements and this Agreement.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:1.15pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(c)</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:6.09pt">Disability or Death</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">. In the event that the Participant&#8217;s employment or service to the Company or an Affiliate is terminated as a result of the Participant&#8217;s Disability (as defined in Section 22(e)(3) of the Code) or as a result of the Participant&#8217;s death, all RSUs that have not vested as of the date of such cessation of service shall immediately vest and become nonforfeitable as of the date of the Participant&#8217;s Disability or death&#59; provided, however, if such Disability or death occurs within one year of the grant date of this award, then this award shall continue to vest after the date of such Disability or death in </font></div></div><div style="display:inline-block;max-width:2.624%;min-width:1.624%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.689%"><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:1.15pt"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">accordance with the schedule described in Section 2(a) above, except that all RSUs that have not vested as of the date of such cessation of service will immediately vest and become nonforfeitable as of the date that is the one-year anniversary of the grant date of this award.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:1.15pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:5.65pt">Retirement.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> In the event that the Participant&#8217;s employment or service to the Company or an Affiliate is terminated as a result of the Participant&#8217;s retirement (as defined below), to the extent the date of such retirement occurs on or after the first vesting date described in the vesting schedule set forth in this Agreement, the outstanding RSUs shall continue to vest for a period that encompasses (and until) the occurrence of second vesting date following the date of such retirement (the &#8220;Extended Vesting Date&#8221;).  Notwithstanding anything in this Agreement that may be to the contrary, in the event the Participant dies or becomes disabled (as defined above) at a time after the Participant&#8217;s retirement but before the Extended Vesting Date, then this RSU shall immediately vest and become nonforfeitable as of the date of the Participant&#8217;s death or disability. &#8220;Retire&#8221; and &#8220;retirement&#8221; shall mean retirement at or after the attainment of age 60, provided that the Participant has been an employee of the Company or its Affiliate for at least 10 years as of the date of the Participant&#8217;s termination date, not including any years during which the Participant was employed by a company that was acquired by or merged with the Company, and provided further that the Participant shall be eligible to retire under the terms of this Agreement if the Participant has provided the Company written notice of such retirement in the form required by the Company at least six months prior to the Participant&#8217;s anticipated termination date due to retirement. Notwithstanding anything herein to the contrary, the Board or the Compensation Committee of the Board may waive at any time the requirement that the Participant provide at least six-months&#8217; prior written notice of retirement in a form required by the Company to be eligible to retire under the terms of this Agreement.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:2.6pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:9.19pt;text-decoration:underline">Restrictions on Transfer.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:2.6pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Participant may not sell, assign, transfer, pledge, hypothecate or otherwise dispose of by operation of law or otherwise, any RSUs, or any interest therein, except by will or the laws of descent and distribution.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:2.6pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:9.19pt;text-decoration:underline">Rights as Stockholder.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:2.6pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Neither the Participant, nor any person claiming through the Participant, will have any of the rights or privileges of a stockholder of the Company with respect to the RSUs unless and until Shares have been issued, recorded on the records of the Company or its transfer agent, and delivered to the Participant upon vesting of the RSUs. No adjustment shall be made for dividends or distributions or other rights for which the record date is prior to the date such Shares are issued. After such issuance, recordation and delivery, the Participant will have all the rights of a stockholder of the Company with respect to the Shares.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:2.6pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:9.19pt;text-decoration:underline">Delivery of Shares&#59; Compliance with Securities Laws, Etc.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:0.7pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:6.09pt">General. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Company shall, upon (and in no event more than 90 days after) vesting of RSUs hereunder, make prompt delivery of vested Shares to the Participant, or if the Participant has died or become Disabled (as defined in Section 2(c) above), to the person to whom this award is transferred by will or the laws of descent and distribution, provided that if any law or regulation requires the Company to take any action with respect to such Shares before the issuance thereof, then the date of delivery of such Shares shall be extended for the period necessary to complete such action.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:14.4pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:5.65pt">Listing, Qualification, Etc</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The RSUs shall be subject to the requirement that if, at any time, counsel to the Company shall determine that the listing, registration or qualification of Shares subject hereto upon any securities exchange or under any state, federal or foreign law, or the consent or approval of any governmental or regulatory body, or that the disclosure of non-public information or the satisfaction of any other condition is necessary as a condition of, or in connection with, the issuance of Shares hereunder, then such issuance shall be deferred until such listing, registration, qualification, consent or approval, disclosure or satisfaction of such other condition shall have been effected or obtained on terms acceptable to the Board. Nothing herein shall be deemed to require the Company to apply for, effect disclosure, or to satisfy such other condition.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:7.25pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">6.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:9.19pt;text-decoration:underline">No Special Employment Rights.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:7.25pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nothing contained in the Plan, the Plan Prospectus or this Agreement shall be construed or deemed to constitute an employment or service contract or confer or be deemed to confer on the Participant any right to continue in the employ or service of, or to continue any other relationship with, the Company or an Affiliate or limit in any way any right of the Company </font></div></div></div><div style="height:32.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.687%"><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:7.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">or an Affiliate, as applicable, to terminate the Participant&#8217;s employment or service or other relationship at any time, with or without cause. </font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:7.25pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">7.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:9.19pt;text-decoration:underline">Taxes.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:7.25pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(a)&#160;&#160;&#160;&#160;Responsibility for Taxes. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Participant acknowledges that, regardless of any action taken by the Company or, if different, the Participant's employer (the &#8220;Employer&#8221;), the ultimate liability for all income tax (whether foreign, federal, state or local), social insurance, payroll tax, fringe benefits tax, payment on account and other tax-related items related to the Participant&#8217;s participation in the Plan and legally applicable to the Participant (the &#8220;Tax-Related Items&#8221;) is and remains the Participant&#8217;s responsibility as it may come due and may exceed the amount actually withheld by the Company or the Employer.  The Participant further acknowledges that the Company and&#47;or the Employer (i) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the RSUs, and (ii) do not commit to and are under no obligation to structure the terms of the grant or any aspect of the RSUs to reduce or eliminate the Participant&#8217;s liability for Tax-Related Items or achieve any particular tax result.  Further, if the Participant is subject to Tax-Related Items in more than one jurisdiction, the Participant acknowledges that the Company and&#47;or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.  In addition, the Participant further acknowledges that Tax-Related Items may be incurred at different times.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:7.25pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(b)&#160;&#160;&#160;&#160;Withholding. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Participant acknowledges and agrees to make arrangements satisfactory to the Company with respect to any withholding obligation the Company or the Employer (or former employer) may have for Tax-Related Items.  Without limitation to the foregoing, the Participant acknowledges and agrees that to satisfy any such withholding obligation for Tax-Related Items, the Company may (i) deduct and retain from the Shares to be distributed upon vesting of RSUs such number of Shares as is equal in value to the Tax-Related Items, (ii) withhold from the Participant's wages or other cash compensation paid to the Participant by the Company and&#47;or the Employer, (iii) withhold from proceeds of the sale of Shares acquired upon vesting and settlement of the RSUs, either through a voluntary sale or through a mandatory sale arranged by the Company (on the Participant&#8217;s behalf pursuant to this authorization), or (iv) withhold by any other method permitted under the Plan and applicable law.  </font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:7.25pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depending on the withholding method, the Company may withhold or account for Tax-Related Items by considering applicable minimum statutory withholding amounts or other applicable withholding rates, including up to the maximum applicable rate in the Participant's jurisdiction (in which case, the Participant may receive a refund of any over-withheld amount in cash and will have no entitlement to the equivalent amount in Shares).  If the obligation for Tax-Related Items is satisfied by withholding in Shares, as described in (i) above, for tax purposes, the Participant will be deemed to have been issued the full number of Shares subject to the vested portion of the RSUs.  The Company may refuse to issue or deliver the Shares or the proceeds of the sale of Shares, if the Participant fails to comply with his or her obligations in connection with the Tax-Related Items.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:7.25pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(c) &#160;&#160;&#160;&#160;Section 409A. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> The RSUs are intended to comply with Section 409A of the Code and, accordingly, to the maximum extent permitted, this Agreement shall be interpreted to be in compliance therewith. Nothing contained herein shall constitute any representation or warranty by the Company regarding compliance with Section 409A of the Code. The Company shall have no obligation to take any action to prevent the assessment of any additional income tax, interest or penalties under Section 409A of the Code on any Person and the Company and its Affiliates, and each of their respective employees and representatives, shall have no liability to the Participant with respect thereto. Notwithstanding anything to the contrary in this Agreement or the Plan, solely for purposes of amounts payable under this Agreement that are deemed to be &#8220;nonqualified deferred compensation&#8221; under Section 409A of the Code, (i) if the definition of Change in Control is required to comply with the requirements of Section 409A of the Code in order for the RSUs to comply with Section 409A of the Code, then no transaction otherwise constituting a Change in Control, as defined in the Plan, will be considered a Change in Control for such purposes unless it also qualifies as a &#8220;change in control event&#8217; within the meaning of Treasury Regulation Section 1.409A-3(i)(5)(i)&#59; and (ii) if the Participant is a &#8220;specified employee&#8221; for purposes of Section 409A of the Code at the time of his or her &#8220;separation from service&#8221; (within the meaning of Section 409A of the Code), delivery of shares in respect of any RSU that vests and becomes payable upon or in connection with the Participant&#8217;s separation from service shall be delayed and will be payable on the day after the first to occur of (a) the day which is six (6) months following the date of such separation from service, and (b) the date of the Participant&#8217;s death or Disability (as defined above).  </font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:7.25pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(d) Tax Consequences</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.  The Participant has reviewed with his or her own tax advisors the applicable tax consequences of this investment and the transactions contemplated by this Agreement.  With respect to such matters, </font></div></div><div style="display:inline-block;max-width:2.624%;min-width:1.624%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.689%"><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:7.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">the Participant relies solely on such advisors and not on any statements or representations of the Company or any of its agents, written or oral.  </font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:7.25pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">8.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:9.19pt;text-decoration:underline">Data Privacy.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Participant hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of the Participant&#8217;s personal data as described in this Agreement and any other RSU grant materials by and among, as applicable, the Employer, the Company and its Subsidiaries and Affiliates for the exclusive purpose of implementing, administering and managing the Participant&#8217;s participation in the Plan.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Participant understands that the Company and the Employer may hold certain personal information about the Participant, including, but not limited to, the Participant&#8217;s name, home address, email address and telephone number, date of birth, social insurance number, passport or other identification number, salary, nationality, job title, any shares of stock or directorships held in the Company, details of all RSUs or any other entitlement to shares of stock awarded, canceled, exercised, vested, unvested or outstanding in the Participant&#8217;s favor (&#8220;Data&#8221;), for the exclusive purpose of implementing, administering and managing the Plan. </font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Participant understands that Data will be transferred to E*TRADE or such other stock plan service provider as may be selected by the Company in the future, which is assisting the Company with the implementation, administration and management of the Plan.   The Participant understands that the recipients of the Data may be located in the United States or elsewhere, and that the recipient&#8217;s country may have different data privacy laws and protections than the Participant&#8217;s country.  </font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Participant authorizes the Company, E*TRADE and any other possible recipients which may assist the Company (presently or in the future) with implementing, administering and managing the Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the sole purposes of implementing, administering and managing the Participant&#8217;s participation in the Plan.  </font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:7.25pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">9.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:9.19pt;text-decoration:underline">Miscellaneous.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:7.8pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;padding-left:6.09pt">This Agreement and the Plan constitute the entire agreement between the parties, and supersedes all prior agreements and understandings, relating to the subject matter of this Agreement. </font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:7.25pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;padding-left:5.65pt">Except as provided herein, this Agreement may not be amended or otherwise modified unless evidenced in writing and signed by the Company and the Participant. Any provision for the benefit of the Company contained in this Agreement may be waived, either generally or in any particular instance, by the Board.  The Board may amend, alter, suspend, discontinue or terminate the Plan, or any portion thereof, at any time, subject to the requirements for certain amendments or alterations set forth in the Plan.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:18.2pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;padding-left:6.09pt">This Agreement shall be binding upon and inure to the benefit of the Company and the Participant and their respective heirs, executors, administrators, representatives, successors and assigns, subject to the restrictions on transfer set forth in Section 3 hereof.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:12.05pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;padding-left:5.65pt">The right of the Participant to receive Shares pursuant to this award is an unfunded and unsecured obligation of the Company. The Participant shall have no rights under this award other than those of an unsecured general creditor of the Company.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:12.05pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;padding-left:6.09pt">The RSUs and the provisions of this Agreement shall be governed by and construed in accordance with the laws of the State of Delaware and applicable federal law, without regard to applicable conflict of laws principles.  </font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:7.8pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;padding-left:7.87pt">The invalidity or unenforceability of any provision of this Agreement shall not affect the validity or enforceability of any other provision of this Agreement, and each other provision of this Agreement shall be severable and enforceable to the extent permitted by law.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:12.05pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(g)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;padding-left:5.65pt">The Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding the Participant&#8217;s participation in the Plan, or the Participant&#8217;s acquisition or sale of the underlying Shares.  </font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:8.65pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(h)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;padding-left:5.65pt">All notices under this Agreement shall be mailed or delivered by hand to the parties at their respective addresses set forth in this Agreement or at such other address as may be designated in writing by either of the parties to one another.</font></div></div></div><div style="height:32.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div style="margin-top:3.2pt;padding-left:182.95pt;padding-right:33.5pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exhibit 10.43</font></div><div style="margin-top:3.2pt;padding-left:173.57pt;padding-right:173.57pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CEO Restricted Stock Unit Agreement</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted Under IDEXX Laboratories, Inc. 2018 Stock Incentive Plan</font></div><div style="padding-left:173.67pt;padding-right:173.67pt;text-align:center"><font><br></font></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.687%"><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:8.65pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;padding-left:8.31pt">The Company may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plan by electronic means.  The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Company or a third party designated by the Company. </font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:12.05pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(j)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;padding-left:8.31pt">If the Participant works and&#47;or resides outside the United States, the RSUs and any Shares subject to the RSUs shall be subject to any special terms and conditions set forth in Exhibit A.  Moreover, if the Participant relocates outside of the United States and to one of the countries included in Exhibit A, the special terms and conditions for such country will apply to Participant to the extent the Company determines that the application of such terms and conditions is necessary or advisable for legal or administrative reasons.  Exhibit A constitutes part of this Agreement.</font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:5.75pt;padding-right:8.65pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(k)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;padding-left:6.09pt">The Company reserves the right to impose other requirements on the Participant&#8217;s participation in the Plan, on the RSUs and on any Shares acquired under the Plan, to the extent the Company determines it is necessary or advisable for legal or administrative reasons, and to require the Participant to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.</font></div><div style="margin-bottom:12pt"><font><br></font></div></div><div style="display:inline-block;max-width:2.624%;min-width:1.624%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.689%"></div></div><div style="height:32.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.687%"><div style="margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit A to</font></div><div style="margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted Stock Unit Agreement</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">IDEXX Laboratories, Inc. 2018 Stock Incentive Plan</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">This Exhibit A includes special terms and conditions and notifications applicable to the Participant resides and&#47;or works outside the United States and, as applicable, in one of the countries listed below.  These terms and conditions and notifications supplement or replace (as indicated) the terms and conditions set forth in the Agreement to which it is attached.  </font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">If the Participant is a citizen or resident of a country other than the one in which he or she is currently residing and&#47;or working, or if the Participant transfers employment or residency to another country after the RSUs are granted, the Company, in its discretion, will determine the extent to which the terms and conditions set forth in this Exhibit A will apply to the Participant. </font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Capitalized terms used but not defined in this Exhibit A shall have the same meanings as in the Agreement and&#47;or the Plan, as applicable.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:1.3pt;padding-right:1.3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ALL NON-U.S. LOCATIONS</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">In accepting the RSUs, the Participant acknowledges, understands and agrees that&#58;</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(a) the Plan is established voluntarily by the Company it is discretionary in nature&#59;</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(b) the grant of the RSUs is exceptional, voluntary and occasional and does not create any contractual or other right to receive future grants of restricted stock units, or benefits in lieu of restricted stock units, even if restricted stock units have been granted in the past&#59; </font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(c) all decisions with respect to future restricted stock units or other grants, if any, will be at the sole discretion of the Company&#59;</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(d) the Participant is voluntarily participating in the Plan&#59;</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(e) the RSUs and any Shares acquired under the Plan, and the income and value of same, are not intended to replace any pension rights or compensation&#59;</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(f) the RSUs and any Shares acquired under the Plan, and the income and value of same, are not part of normal or expected compensation for any purpose, including, without limitation, calculating any severance, resignation, termination, redundancy, dismissal, end-of-service payments, holiday pay, bonuses, long-service awards, pension or retirement or welfare benefits or similar payments&#59;</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(g) unless otherwise agreed with the Company, the RSUs and any Shares acquired under the Plan, and the income and value of same, are not granted as consideration for, or in connection with, services the Participant may provide as a director of a Subsidiary or Affiliate&#59;</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(h) the future value of the Shares underlying the RSUs is unknown, indeterminable, and cannot be predicted with certainty&#59; </font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(i) for purposes of the RSUs, the Participant will be considered to have ceased employment as of the date the Participant is no longer actively providing services to the Company or an Affiliate&#59; the Company shall have the exclusive discretion to determine when the Participant is no longer actively providing services for purposes of the vesting of the RSUs.  Further, no claim or entitlement to compensation or damages shall arise from forfeiture of the RSUs resulting from the Participant ceasing to be employed by or provide services to the Company or an Affiliate for any reason whatsoever&#59; and</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(j) neither the Company, the Employer nor any Subsidiary or Affiliate shall be liable for any foreign exchange rate fluctuation between the Participant&#8217;s local currency and the United States Dollar that may affect the value of the RSUs or of any amounts due to the Participant pursuant to the vesting and settlement of the RSUs or the subsequent sale of any Shares acquired pursuant to the RSUs.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Choice of Venue</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">For purposes of litigating any dispute that arises under this grant or the Agreement, the parties hereby submit to and consent to the exclusive </font></div></div><div style="display:inline-block;max-width:2.624%;min-width:1.624%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.689%"><div style="margin-bottom:12pt;margin-top:0.15pt;padding-right:2.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">jurisdiction of the State of Maine, agree that such litigation shall be conducted in the courts of Cumberland County, Maine, or the federal courts for the United States for the District of Maine, where this grant is made and&#47;or to be performed.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Language</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Participant acknowledges that he or she is sufficiently proficient in English to understand the terms and conditions of the Agreement.  Furthermore, if the Participant has received this Agreement or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Insider Trading Restrictions&#47;Market Abuse Laws</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Participant acknowledges that he or she may be subject to insider trading restrictions and&#47;or market abuse laws in applicable jurisdictions including, but not limited to, the United States and the Participant&#8217;s country of residence, which may affect the Participant&#8217;s ability to acquire or sell Shares or rights to Shares (e.g., RSUs) during such time as the Participant is considered to have &#8220;inside information&#8221; regarding the Company (as defined by the laws in the applicable jurisdictions).  Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable insider trading policy of the Company.  The Participant is responsible for ensuring compliance with any applicable restrictions and should consult with his or her personal legal advisor on this matter. </font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Foreign Asset&#47;Account and Exchange Control Requirements</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depending on the Participant&#8217;s country, the Participant may be subject to foreign asset&#47;account and&#47;or exchange control reporting or other requirements as a result of the vesting of the RSUs, the acquisition, holding and&#47;or transfer of Shares or cash resulting from participation in the Plan and&#47;or the opening and maintaining of a brokerage or bank account in connection with the Plan.  The Participant may be required to report such assets, accounts, account balances and values, and&#47;or related transactions to the applicable authorities in his or her country.  The Participant may also be required to repatriate sale proceeds or other funds received as a result of his or her participation in the Plan to his or her country through a designated bank or broker and&#47;or within a certain time after receipt.  The Participant acknowledges that he or she is responsible for ensuring compliance with any such requirements and that he or she should consult with the Participant&#8217;s personal tax and legal advisors, as applicable, on these matters.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Data Privacy (For Jurisdictions in the European Union (&#8220;EU&#8221;) &#47; European Economic Area (&#8220;EEA&#8221;), Switzerland and the United Kingdom)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font></div><div style="margin-bottom:12pt;margin-top:0.2pt;padding-left:6pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">This section replaces Section 8 of the Agreement&#58; </font></div><div style="margin-bottom:12pt;margin-top:0.2pt;padding-left:6pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(a) Data Collection and Usage</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.  The Company collects, processes and uses personal data about the Participant, including, but not limited to, the Participant&#8217;s name, home address, telephone number and e-mail address, date of birth, social insurance number, passport or other identification number, salary, nationality, job title, any equity or directorships held in the Company and its Affiliates, details of all RSUs or any other entitlement to equity awarded, canceled, exercised, vested, unvested or outstanding in the Participant&#8217;s favor, which the Company receives from the Participant or the Employer.  In order to participate in the Plan, the Company will collect the Participant&#8217;s personal data for purposes of allocating Shares and implementing, administering and managing the Plan.  The Company&#8217;s legal basis for the processing of the Participant&#8217;s personal data is based on necessity for the performance of the Plan and pursuant to the Company&#8217;s legitimate business interests.</font></div><div style="margin-bottom:12pt;margin-top:0.2pt;padding-left:6pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(b) Stock Plan Administration Service Providers</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.  The Company transfers the Participant&#8217;s data to E*TRADE Corporate Financial Services, Inc. (including its affiliated companies), an independent service provider based in the United States (&#8220;U.S.&#8221;), which assists the Company with the implementation, administration and management of the Plan.  In the future, the Company may select a different service provider and share the Participant&#8217;s data with another company that serves in a similar manner.  The Company&#8217;s service provider(s) will open an account for the Participant to receive and trade Shares.  The Participant will be asked to agree on separate terms and data processing practices with the service provider(s), which is a condition to the Participant&#8217;s ability to participate in the Plan.</font></div><div style="margin-bottom:12pt;margin-top:0.2pt;padding-left:6pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(c) International Data Transfers.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  The Participant&#8217;s personal data will be transferred to the U.S. where the Company and its service providers are based.  The Company&#8217;s legal basis for the transfer of the Participant&#8217;s personal data to the U.S. is its use of the standard data protection clauses.</font></div></div></div><div style="height:32.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div style="margin-top:3.2pt;padding-left:182.95pt;padding-right:33.5pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exhibit 10.43</font></div><div style="margin-top:3.2pt;padding-left:173.57pt;padding-right:173.57pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CEO Restricted Stock Unit Agreement</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted Under IDEXX Laboratories, Inc. 2018 Stock Incentive Plan</font></div><div style="padding-left:173.67pt;padding-right:173.67pt;text-align:center"><font><br></font></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.687%"><div style="margin-bottom:12pt;margin-top:0.2pt;padding-left:6pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(d) Data Retention</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.  The Company will use the Participant&#8217;s personal data only as long as necessary to implement, administer and manage the Participant&#8217;s participation in the Plan or as required to comply with legal or regulatory obligations, including tax and securities laws.  When the Company no longer needs the Participant&#8217;s personal data, which will generally be seven (7) years after the Participant participates in the Plan, the Company will remove it from its systems.  If the Company keeps data longer, it would be to satisfy legal or regulatory obligations and the Company&#8217;s legal basis would be relevant laws or regulations.</font></div><div style="margin-bottom:12pt;margin-top:0.2pt;padding-left:6pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(e) Data Subject Rights</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.  The Participant has a number of rights under data privacy laws in the Participant&#8217;s country.  Depending on where the Participant is based, his or her rights may include the right to (a) request access or copies of personal data processed by the Company, (b) rectification of incorrect data, (c) deletion of data, (d) restrictions on processing, (e) portability of data, (f) lodge complaints with competent authorities in the Participant&#8217;s country, and&#47;or (g) receive a list with the names and addresses of any potential recipients of the Participant&#8217;s personal data.  To receive clarification regarding the Participant&#8217;s rights or to exercise such rights please contact the Company&#8217;s Data Privacy Officer electronically, by phone, or mail, in strict confidence. </font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Data Privacy (Non-EU Jurisdictions)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">This section supplements Section 8 of the Agreement&#58;</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">The Participant may request a list with the names and addresses of any potential recipients of the Data by contacting his or her local human resources representative.  </font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">The Participant understands that Data will be held only as long as is necessary to implement, administer and manage the Participant&#8217;s participation in the Plan.  The Participant understands that he or she may, at any time, view Data, request information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing the Participant&#8217;s local human resources representative.  </font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Further, the Participant understands that he or she is providing the consents herein on a purely voluntary basis.  If the Participant does not consent, or if the Participant later seeks to revoke his or her consent, the Participant&#8217;s employment status or service with the Employer will not be affected&#59; the only consequence of refusing or withdrawing consent is that the Company would not be able to grant RSUs or other equity awards to the Participant or administer or maintain such awards.  Therefore, the Participant understands that refusing or withdrawing consent may affect his or her ability to participate in the Plan.  </font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">For more information on the consequences of the Participant&#8217;s refusal to consent or withdrawal of consent, the Participant understands that the Participant may contact his or her local human resources representative.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:1.3pt;padding-right:1.3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">AUSTRALIA</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  The offer of the RSUs is intended to comply with the provisions of the Corporations Act 2001, Australian Securities and Investments Commission (&#8220;ASIC&#8221;) Regulatory Guide 49 and ASIC Class Order 14&#47;1000.  Additional details are set forth in the Offer Document for the Offer of Restricted Stock Units to Australian Resident Employees.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Nature of Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Plan is a plan to which subdivision 83A-C of the Income Tax Assessment Act 1997 (Cth) applies (subject to conditions in the Act).</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:1.3pt;padding-right:1.3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">AUSTRIA</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">There are no country-specific provisions.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:1.3pt;padding-right:1.3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">BELGIUM</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">There are no country-specific provisions.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:1.3pt;padding-right:1.3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">BRAZIL</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  The offer of the RSUs and the underlying Shares is not registered with the Brazilian Securities Commission (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Comiss&#227;o de Valores Mobili&#225;rios &#8211; CVM</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">).  The Shares may not be offered or sold in Brazil, except under circumstances that do not constitute a public offering or distribution of securities under Brazilian laws and regulations.</font></div></div><div style="display:inline-block;max-width:2.624%;min-width:1.624%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.689%"><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  This provision supplements the Nature of Grant section above&#58;</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">In accepting the RSUs, the Participant acknowledges that (i) the Participant is making an investment decision and (ii) the value of the underlying Shares is not fixed and may increase or decrease without compensation to the Participant.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Compliance with Law</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  In accepting the RSUs, the Participant agrees to comply with applicable Brazilian laws and to pay any and all applicable Tax-Related Items associated with the vesting and settlement of the RSUs, the receipt of any dividends, and the sale of Shares acquired under the Plan.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:1.3pt;padding-right:1.3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CANADA</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  The Participant is permitted to sell Shares acquired under the Plan through the designated broker appointed under the Plan, provided that the sale of such Shares takes place outside Canada through the facilities of a stock exchange on which the Shares are listed (i.e., the NASDAQ Global Select Market).</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Delivery of Shares</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> This provision supplements Section 5 of the Agreement&#58;</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">As provided herein, the Company shall, upon vesting of RSUs hereunder, make prompt delivery of vested Shares to the Participant, and the discretion to pay Awards in Shares or cash (as provided in Section 9(a) of the Plan) shall not apply to RSUs granted to Participants in Canada.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  This provision replaces subsection (i) in the Nature of Grant section above&#58;</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">For purposes of the RSUs, the Participant&#8217;s employment will terminate, and the Participant&#8217;s right (if any) to earn, seek damages in lieu of, or otherwise be paid any portion of the RSUs pursuant to this Agreement, will be measured by, the date that is the earlier of&#58;  </font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:60pt;padding-right:2.6pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;padding-left:11.34pt">the date the Participant&#8217;s employment with the Company or any of its Subsidiaries or Affiliates is terminated, whether by the Participant, by the Company or a Subsidiary or Affiliate, or by way of contractual frustration&#59; and</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:60pt;padding-right:2.6pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;padding-left:11.34pt">the date the Participant receives written notice of termination from the Company or one of its Subsidiaries or Affiliates&#59; </font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:5.75pt;padding-right:2.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">regardless of any period during which notice, pay in lieu of notice or related payments or damages are provided or required to be provided under local law.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">For greater certainty, the Participant will not earn or be entitled to any pro-rated vesting for that portion of time before the date on which the Participant&#8217;s right to vest terminates, nor will the Participant be entitled to any compensation for lost vesting. Notwithstanding the foregoing, if applicable employment standards legislation explicitly requires continued vesting during a statutory notice period, the Participant&#8217;s right to vest in the RSUs, if any, will terminate effective upon the expiry of the Participant&#8217;s minimum statutory notice period, but the Participant will not earn or be entitled to pro-rated vesting if the vesting date falls after the end of the Participant&#8217;s statutory notice period, nor will the Participant be entitled to any compensation for lost vesting. </font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Any such determination by the Company for the purposes of this Agreement shall have no effect upon any determination of the rights or obligations of the Participant or the Company (or any Subsidiary or Affiliate, as applicable) for any other purpose. </font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">The following provisions apply for Participants resident in Quebec&#58;</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Data Privacy</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  This provision supplements the Data Privacy provision above&#58;</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Participant hereby authorizes the Company and the Company&#8217;s representatives to discuss with and obtain all relevant information from all personnel, professional or not, involved in the administration and operation of the Plan.  The Participant further authorizes the Company, the Employer and any other Subsidiary or Affiliate to disclose and discuss the Plan with their advisors.  The Participant further authorizes the Company, the Employer and any other Subsidiary or Affiliate to record and keep such information in his or her employee file.</font></div></div></div><div style="height:32.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.687%"><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Language Consent</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  The parties acknowledge that it is their express wish that the Agreement, as well as all documents, notices and legal proceedings entered into, given or instituted pursuant hereto or relating directly or indirectly hereto, be drawn up in English.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Consentement &#224; la Langue Utilis&#233;e</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"> Les parties reconnaissent avoir exig&#233; la r&#233;daction en anglais de la Convention, ainsi que de tous documents ex&#233;cut&#233;s, avis donn&#233;s et proc&#233;dures judiciaires intent&#233;es en vertu de, ou li&#233;s directement ou indirectement &#224;, la pr&#233;sente Convention.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:1.45pt;padding-right:1.45pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">FRANCE</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">RSUs Not Tax-Qualified</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> The RSUs are not intended to qualify for specific tax and social security treatment in France.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Language Consent</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> In accepting the RSUs, the Participant confirms having read and understood the Plan and Agreement, including all terms and conditions included therein, which were provided in the English language.  The Participant accepts the terms of those documents accordingly.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Consentement &#224; la Langue Utilis&#233;e.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">  En acceptant l&#8217;attribution, le Participant confirme avoir lu et compris le Plan et le Contrat, incluant tous leurs termes et conditions, qui ont &#233;t&#233; transmis en langue anglaise.  Le Participant accepte les dispositions de ces documents en connaissance de cause.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:1.3pt;padding-right:1.3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">FINLAND</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">There are no country-specific provisions.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:1.3pt;padding-right:1.3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">GERMANY</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">There are no country-specific provisions.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:1.3pt;padding-right:1.3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ITALY</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Plan Document Acknowledgment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  In accepting the RSUs, the Participant acknowledges that he or she has received a copy of the Plan and the Agreement and has reviewed the Plan and the Agreement, including this Exhibit A, in their entirety and fully understands and accepts all provisions of the Plan and the Agreement, including this Exhibit A.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Participant acknowledges that he or she has read and specifically and expressly approves the following paragraphs of the Agreement&#58; (i) Section 7 - Taxes, (ii) Choice of Venue provision in this Exhibit A and (iii) the Data Privacy provision (For Jurisdictions in the European Union (&#8220;EU&#8221;) &#47; European Economic Area (&#8220;EEA&#8221;), Switzerland and the United Kingdom) in this Exhibit A.</font></div><div style="margin-bottom:12pt;padding-left:1.3pt;padding-right:1.3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">JAPAN</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">There are no country-specific provisions.</font></div><div style="margin-bottom:12pt;padding-left:1.3pt;padding-right:1.3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">KOREA</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">There are no country-specific provisions.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:1.3pt;padding-right:1.3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">NETHERLANDS</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">There are no country-specific provisions.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:1.3pt;padding-right:1.3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">NEW ZEALAND</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">WARNING&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> The Participant is being offered RSUs which allow the Participant to acquire Shares in accordance with the terms of the Plan and the Agreement.  The Shares, if acquired, give the Participant a stake in the ownership of the Company.  The Participant may receive a return if dividends are paid. </font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">If the Company runs into financial difficulties and is wound up, the Participant will be paid only after all creditors and holders of preferred shares have been paid.  The Participant may lose some or all of his or her investment.</font></div></div><div style="display:inline-block;max-width:2.624%;min-width:1.624%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.689%"><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">New Zealand law normally requires people who offer financial products to give information to investors before they invest.  This information is designed to help investors to make an informed decision.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The usual rules do not apply to this offer because it is made under an employee share purchase scheme.  As a result, the Participant may not be given all the information usually required.  The Participant will also have fewer other legal protections for this investment.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Participant understands that he or she should ask questions, read all documents carefully, and seek independent financial advice before deciding to participate in the Plan.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Shares are quoted and approved for trading on the NASDAQ Global Select Market in the United States of America.  This means that, if the Participant acquires Shares under the Plan, the Participant may be able to sell his or her investment on the NASDAQ Global Select Market if there are interested buyers.  The Participant understands that he or she may get less than the Participant&#8217;s investment.  The price will depend on the demand for the Shares. </font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">For information on risk factors impacting the Company&#8217;s business that may affect the value of the Shares, the Participant should refer to the risk factors discussion in the Company&#8217;s Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, which are filed with the U.S. Securities and Exchange Commission and are available online at www.sec.gov, as well as on the Company&#8217;s website at https&#58;&#47;&#47;www.idexx.com&#47;corporate&#47;investors-home.html.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:1.3pt;padding-right:1.3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">PORTUGAL</font></div><div style="margin-top:0.15pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Language Consent</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  The Participant hereby expressly declares that he or she has full knowledge of the English language and has read, understood and fully accepted and agreed with the terms and conditions established in the Plan and the Agreement.</font></div><div style="margin-top:0.15pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font><br></font></div><div style="margin-top:0.15pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Conhecimento da Lingua</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">  Participante, pelo presente instrumento, declara expressamente que tem pleno conhecimento da l&#237;ngua inglesa e que leu, compreendeu e livremente aceitou e concordou com os termos e condi&#231;&#245;es estabelecidas no Plano e no Acordo.</font></div><div style="margin-top:0.15pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font><br></font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:1.3pt;padding-right:1.3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SINGAPORE</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  The RSUs are being granted pursuant to the &#8220;Qualifying Person&#8221; exemption under section 273(1)(f) of the Singapore Securities and Futures Act (Chapter 289, 2006 Ed.) (&#8220;SFA&#8221;).  The Plan has not been lodged or registered as a prospectus with the Monetary Authority of Singapore.  The Participant should note that the RSUs are subject to section 257 of the SFA and the Participant will not be able to make any subsequent sale of the Shares acquired pursuant to the RSUs in Singapore or any offer of such subsequent sale of Shares in Singapore unless such sale or offer in Singapore is made (a) after six months after the grant date, or (b) pursuant to the exemptions under Part XIII Division (1) Subdivision (4) (other than section 280) of the SFA, or pursuant to, and in accordance with the conditions of, any applicable provisions of the SFA.</font></div><div style="margin-bottom:12pt;margin-top:0.2pt;padding-left:4.45pt;padding-right:4.45pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SOUTH AFRICA</font></div><div style="margin-bottom:12pt;margin-top:0.2pt;padding-left:6pt;padding-right:2.9pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.  Neither the RSUs nor the underlying Shares shall be publicly offered or listed on any stock exchange in South Africa.  The offer is intended to be private pursuant to Section 96(1)(g)(ii) of the Companies Act.</font></div><div style="margin-bottom:12pt;margin-top:0.2pt;padding-left:6pt;padding-right:2.9pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">This provision supplements Section 7 of the Agreement&#58;</font></div><div style="margin-bottom:12pt;margin-top:0.2pt;padding-left:6pt;padding-right:2.9pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">By accepting the RSUs, the Participant understands and acknowledges that he or she is required to notify the Employer of the amount of any gain realized upon vesting of the RSUs. </font></div><div style="margin-bottom:12pt;margin-top:0.2pt;padding-left:6pt;padding-right:2.9pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.  The Participant is solely responsible for complying with applicable South African exchange control regulations.  Since the exchange control regulations change frequently and without notice, the Participant should consult his or her legal advisor prior to the acquisition or sale of Shares under the Plan to ensure compliance with current regulations.  As noted, it is the Participant&#8217;s responsibility to comply with South African exchange control laws, and neither the Company nor the Employer will be liable for any fines or penalties resulting from failure to comply with applicable laws.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:1.3pt;padding-right:1.3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SPAIN</font></div></div></div><div style="height:32.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.687%"><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  No &#8220;offer of securities to the public,&#8221; as defined under Spanish law, has taken place or will take place in the Spanish territory in connection with the offer of the RSUs.  The Plan, the Agreement and any other documents evidencing the grant of the RSUs have not been, nor will they be, registered with the </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Comisi&#243;n Nacional del Mercado de Valores</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> (the Spanish securities regulator), and none of those documents constitutes a public offering prospectus.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  This provision supplements the Nature of Grant section above&#58;</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">In accepting the RSUs, the Participant acknowledges that he or she has received a copy of the Plan, has reviewed and understands the Plan and agrees to participation in the Plan.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Participant further understands that the Company has unilaterally, gratuitously and discretionally decided to grant RSUs under the Plan to employees of the Company or any Subsidiary or Affiliate throughout the world.  The decision to grant the RSUs is a limited decision that is entered into upon the express assumption and condition that any RSU grant will not economically or otherwise bind the Company or any Subsidiary or Affiliate on an ongoing basis other than as set forth in this Agreement.  Consequently, the Participant understands that any grant is given on the assumption and condition that it shall not become a part of any employment contract (either with the Company or any Subsidiary or Affiliate) and shall not be considered a mandatory benefit, salary for any purpose (including severance compensation) or any other right whatsoever.  Further, the Participant understands and freely accepts that there is no guarantee that any benefit shall arise from any gratuitous and discretionary grant since the future value of the RSUs and the underlying Shares is unknown and unpredictable. </font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additionally, the Participant understands that the vesting of the RSUs is conditioned on the Participant&#8217;s continued and active rendering of service to the Employer such that, except as specifically provided in Section 2 of the Agreement, if the Participant&#8217;s employment terminates for any reason whatsoever, the Participant&#8217;s RSUs will cease vesting immediately effective as of the date of termination of his or her employment.  This will be the case, for example, even if (a) the Participant is considered to be unfairly dismissed without good cause (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">i.e.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">, subject to a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">despido improcedente</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8221;)&#59; (b) the Participant is dismissed for disciplinary or objective reasons or due to a collective dismissal&#59; (c) the Participant terminates service due to a change of work location, duties or any other employment or contractual condition&#59; (d) the Participant terminates service due to the Company&#8217;s or any Subsidiary&#8217;s or Affiliate&#8217;s unilateral breach of contract&#59; or (e) the Participant&#8217;s employment terminates for any other reason whatsoever.  Consequently, upon termination of employment for any of the above reasons, the Participant will automatically lose any rights to RSUs granted that were unvested on the date of termination of the Participant&#8217;s employment, as described in the Agreement.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finally, the Participant understands that this grant would not be made to him or her but for the assumptions and conditions referred to herein&#59; thus, the Participant acknowledges and freely accepts that should any or all of the assumptions be mistaken or should any of the conditions not be met for any reason, then any grant of RSUs shall be null and void.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:4.3pt;padding-right:4.3pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SWEDEN</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Authorization to Withhold</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">This provision supplements Section 7 of the Agreement&#58;</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Without limiting the Company&#8217;s and the Employer's authority to satisfy their withholding obligations for Tax-Related Items as set forth in Section 7 of the Agreement, in accepting the RSUs, the Participant authorizes the Company to deduct and retain from the Shares to be distributed upon vesting of RSUs or to withhold from proceeds of the sale of Shares acquired upon vesting and settlement of the RSUs, regardless of whether the Company and&#47;or the Employer have an obligation to withhold such Tax-Related Items.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:1.3pt;padding-right:1.3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SWITZERLAND</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Neither this document nor any other materials relating to the RSUs (a) constitutes a prospectus according to articles 35 et seq. of the Swiss Federal Act on Financial Services (&#8220;FinSA&#8221;), (b) may be publicly distributed or otherwise made publicly available in Switzerland to any person other than an Eligible Grantee, or (c) has been or will be filed with, approved or supervised by any Swiss reviewing body according to article 51 FinSA or any Swiss regulatory authority, including the Swiss Financial Market Supervisory Authority.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:1.3pt;padding-right:1.3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TAIWAN</font></div></div><div style="display:inline-block;max-width:2.624%;min-width:1.624%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.689%"><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The offer of participation in the Plan is available only for Eligible Grantees of the Company and its Affiliates.  The offer of participation in the Plan is not a public offer of securities by a Taiwanese company.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:1.3pt;padding-right:1.3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">UNITED KINGDOM (&#8220;U.K.&#8221;)</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  This provision supplements Section 7 of the Agreement&#58;</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Without limitation to Section 7 of the Agreement, the Participant hereby agrees that he or she is liable for all Tax-Related Items and hereby covenants to pay all such Tax-Related Items, as and when requested by the Company or the Employer, as applicable, or by Her Majesty&#8217;s Revenue &#38; Customs (&#8220;HMRC&#8221;) (or any other tax authority or any other relevant authority).  The Participant also hereby agrees to indemnify and keep indemnified the Company and the Employer, as applicable, against any Tax-Related Items that they are required to pay or withhold or have paid or will pay to HMRC (or any other tax authority or any other relevant authority) on the Participant&#8217;s behalf.</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, if the Participant is a director or executive officer of the Company (within the meaning of Section 13(k) of the Exchange Act), the terms of immediately foregoing provision will not apply.  In this case, the amount of the income tax not collected within 90 days of the end of the U.K. tax year in which an event giving rise to the Tax-Related Items occurs may constitute a benefit to the Participant on which additional income tax and National Insurance contributions may be payable.  The Participant will be responsible for reporting and paying any income tax due on this additional benefit directly to HMRC under the self-assessment regime and for reimbursing the Company or the Employer, as applicable, for the value of any National Insurance contributions due on this additional benefit, which may be recovered from the Participant by the Company or the Employer at any time thereafter by any of the means referred to in Section 7 of the Agreement.</font></div><div><font><br></font></div><div style="margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font><br></font></div><div><font><br></font></div><div style="margin-top:0.15pt;padding-left:6pt;padding-right:2.6pt;text-indent:18pt"><font><br></font></div></div></div><div style="height:32.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.44
<SEQUENCE>20
<FILENAME>a1044jmazelskystockoptiona.htm
<DESCRIPTION>EX-10.44
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i51ee02215ebb4d7ca07047af82f2c654_1"></div><div style="min-height:72.72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exhibit 10.44</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CEO Stock Option Agreement</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted Under IDEXX Laboratories, Inc. 2018 Stock Incentive Plan</font></div><div><font><br></font></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:47.825%"><div style="margin-bottom:12pt;padding-right:-9.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">1.  Grant of Option.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:6.09pt">Grant.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  IDEXX Laboratories, Inc., a Delaware corporation (the &#8220;Company&#8221;), pursuant to the Company&#8217;s 2018 Stock Incentive Plan (the &#8220;Plan&#8221;) and this Employee Stock Option Agreement, including any exhibit, appendix or addendum hereto (the &#8220;Agreement&#8221;), hereby grants to the employee named on the opposite side of this Agreement (the &#8220;Optionee&#8221;) an option to purchase, in whole or in part, the number of shares of common stock, par value $0.10 per share, of the Company (&#8220;Shares&#8221;) at a price per Share as noted on the opposite side of this Agreement, subject to the terms and conditions of this Agreement, the Plan and the description of the Plan set forth in the Plan Prospectus.  The Plan and the Plan Prospectus are provided to the Optionee with this Agreement.  Capitalized terms not otherwise defined in this Agreement shall have the meanings set forth in the Plan or the Plan Prospectus.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:5.65pt">Restrictive Covenant Agreements.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  Optionee acknowledges and affirms that&#58; (i) Optionee is subject to non-competition, non-solicitation and&#47;or confidentiality provisions set forth in one or more agreements with the Company or any of its Affiliates (including, as applicable, employment, consulting or advisory contracts&#59; confidentiality and nondisclosure agreements&#59; or other agreements&#59; in each case as may be amended, supplemented or replaced from time to time) (collectively, the &#8220;Restrictive Covenant Agreements&#8221;)&#59; (ii) this Option is granted in consideration of Optionee&#8217;s agreement to be bound by the Optionee&#8217;s Restrictive Covenant Agreements&#59; (iii) if the Company requests that Optionee execute updated Restrictive Covenant Agreements, the vesting of this Option is conditioned on Optionee&#8217;s execution and delivery of such updated Restrictive Covenant Agreements in a manner and by a date satisfactory to the Company in its sole discretion, and the failure of Optionee to so execute and deliver any such requested updated Restrictive Covenant Agreement by such date will result in the immediate cancellation of, and automatic forfeiture of any rights Optionee may have with respect to, this Option&#59; and (iv) Optionee agrees to comply with the restrictions and obligations set forth in Optionee&#8217;s Restrictive Covenant Agreements.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">2.  Type of Stock Option.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">If the opposite side of this Agreement indicates that this Option is an &#8220;Incentive Stock Option&#8221;, this Option is intended to qualify as an incentive stock option within the meaning of Section 422 of the Internal Revenue Code of 1986, as amended from time to time (the &#8220;Code&#8221;).  If the opposite side of this Agreement indicates that this Option is a &#8220;Non-Qualified Stock Option&#8221;, this Option shall not be considered an incentive stock option as defined by Section 422 of the Code.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">3.  Exercise of Option and Provisions for Termination.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:6.93pt">Vesting Schedule and Expiration.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  Except as otherwise provided in this Agreement, this Option shall expire at 4&#58;00 p.m., Eastern time, on the Expiration Date indicated on the opposite side of this Agreement.  This Option will become exercisable (&#8220;vest&#8221;) in installments as to the number of Shares and during the respective installment periods set forth on the opposite side of this Agreement.  The right of exercise shall be cumulative so that if the Option is not exercised to the maximum extent permissible during an exercise period, it shall continue to be exercisable, in whole or in part, with respect to all Shares not so purchased at any time prior to the Expiration Date or the earlier termination of this Option.  This Option may not be exercised at any time after the Expiration Date.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:6.58pt">Exercise Procedure.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  Subject to the conditions set forth in this Agreement, this Option shall be exercised by the Optionee&#8217;s delivery of written notice of exercise through the online service designated by the Company (currently E*TRADE OptionsLink), specifying the number of Shares to be purchased and the purchase price to be paid therefor and accompanied by payment in full in accordance with Section 4.  Such exercise shall be effective upon receipt by such online service of such written notice together with the required payment.  The Optionee may purchase less than the number of Shares covered hereby, provided that no partial exercise of this Option may be for any fractional share.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:7.53pt">Continuous Relationship with the Company Required.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  Except as otherwise provided in this Section 3, this Option may not be exercised unless the Optionee, at the time he or she exercises this Option, is, and has been at all times since the Grant Date indicated on the opposite side of this Agreement, an employee of the Company or an Affiliate, a consultant of the Company or an Affiliate or a member of the Board (an &#8220;Eligible Optionee&#8221;). </font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Company shall determine in good faith (including in accordance with Section 409A of the Code) and in the exercise of its discretion whether the Optionee has ceased to be an employee, consultant or Board member, as </font></div></div><div style="display:inline-block;max-width:4.348%;min-width:3.348%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:47.827%"><div style="margin-bottom:12pt;padding-left:5.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">applicable, and the effective date of the Optionee&#8217;s termination of such status, and such determinations shall be final, binding and conclusive.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:6.58pt">Exercise Period Upon Termination of Relationship with the Company.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  If the Optionee ceases to be an Eligible Optionee for any reason, then, except as provided in paragraphs (e), (f) and (g) below, the right to exercise this Option shall terminate 3 months after such cessation (but in no event after the Expiration Date), provided that this Option shall be exercisable only to the extent that the Optionee was entitled to exercise this Option on the date of such cessation. Notwithstanding any provision in this Agreement that may be to the contrary, if, following the Optionee&#8217;s cessation of being an Eligible Optionee for any reason, except as provided in paragraphs (e), (f) and (g) below, all or a portion of the three-month exercise period applicable to the Option as described above occurs during a time when the Optionee is prohibited from trading in securities of the Company without violating applicable federal or state securities laws or the rules related to a blackout period or quiet period declared by the Company pursuant to its insider trading or similar policy, the three-month exercise period applicable to the Option will be tolled for the number of days that such prohibitions or restrictions apply, such that the three-month exercise period will be extended by the same number of days as were subject to the prohibitions or restrictions&#59;&#160;provided,&#160;however, that such three-month exercise period may not be extended due to such tolling past the Expiration Date of the Option.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:6.85pt">Exercise Period Upon Death or Disability&#59; Immediate Vesting upon Death or Disability.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  If the Optionee dies or becomes disabled (within the meaning of Section 22(e)(3) of the Code) prior to the Expiration Date while he or she is an Eligible Optionee, or if the Optionee dies within 3 months after the Optionee ceases to be an Eligible Optionee, and the Company or its Affiliate has not terminated such relationship for &#8220;cause&#8221; as specified in paragraph (g) below, this Option shall be exercisable until the 1 year anniversary date following the date of death or disability of the Optionee by the Optionee or by the person to whom this Option is transferred by will or the laws of descent and distribution, provided that this Option shall be exercisable only to the extent that this Option was exercisable by the Optionee on the date he or she ceased to be an Eligible Optionee.  Notwithstanding anything in this Agreement that may be to the contrary, in the event the Optionee dies or becomes disabled (as defined above) at a time when the Optionee is an Eligible Optionee, then this Option shall immediately vest and become exercisable with respect to all Shares underlying this Option as of the date of the Optionee&#8217;s death or disability&#59; provided, however, if such death or disability occurs within one year of the Grant Date, then this Option shall continue to vest after the date of such death or disability in accordance with the schedule described in Section 3(a) above, except that it will immediately vest and become exercisable with respect to all Shares underlying this Option as of the date that is the one-year anniversary of the Grant Date of this Option.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:8.34pt">Exercise Period Upon Retirement.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">If the Optionee retires (as defined below) prior to the Expiration Date while he or she is an Eligible Optionee, and the Company or its Affiliate has not terminated such relationship for &#8220;cause&#8221; as specified in paragraph (g) below, this Option shall (i) to the extent the date of such retirement occurs on or after the first vesting date set forth on the opposite side of this Agreement, continue to vest after the date of such retirement in accordance with the schedule described in Section 3(a) above for a period that encompass (and until) the occurrence of the second vesting date following the date of such retirement (the &#8220;Extended Vesting Date&#8221;) and (ii) to the extent vested, remain exercisable until the 3 year anniversary date following the date of retirement of the Optionee (but in no event after the Expiration Date). Notwithstanding anything in this Agreement that may be to the contrary, in the event the Optionee dies or becomes disabled (as defined above) at a time after the Optionee&#8217;s retirement but before the Extended Vesting Date, then this Option shall immediately vest and become exercisable with respect to all Shares underlying this Option as of the date of the Optionee&#8217;s death or disability. &#8220;Retire&#8221; and &#8220;retirement&#8221; shall mean retirement at or after the attainment of age 60, provided that the Optionee has been an employee of the Company or its Affiliate for at least 10 years as of the date of the Optionee&#8217;s termination date, not including any years during which the Optionee was employed by a company that was acquired by or merged with the Company, and provided further that the Optionee shall be eligible to retire under the terms of this Agreement if the Optionee has provided the Company written notice of such retirement in the form required by the Company at least six months prior to the Optionee&#8217;s anticipated termination date due to retirement. Notwithstanding anything herein to the contrary, the Board or the Compensation Committee of the Board may waive at any time the requirement that the Optionee provide at least six-months&#8217; prior written notice of retirement in a form required by the Company to be eligible to retire under the terms of this Agreement.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(g)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:7.08pt">Discharge for Cause.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  If the Optionee, prior to the Expiration Date, ceases his or her employment, consulting or Board relationship with the </font></div></div></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72.72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exhibit 10.44</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CEO Stock Option Agreement</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted Under IDEXX Laboratories, Inc. 2018 Stock Incentive Plan</font></div><div><font><br></font></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:47.825%"><div style="margin-bottom:12pt;padding-left:5.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Company or its Affiliate because he or she is discharged for &#8220;cause&#8221; (as defined below), the right to exercise this Option shall terminate immediately upon such relationship cessation.  &#8220;Cause&#8221; shall mean willful misconduct in connection with the Optionee&#8217;s employment, consulting or Board service or willful failure to perform his or her employment, consulting or Board responsibilities in the best interests of the Company (including, without limitation, breach by the Optionee of any provision of the Restrictive Covenant Agreements), as determined by the Company, which determination shall be final, binding and conclusive. The Optionee shall be considered to have been discharged for &#8220;cause&#8221; if the Company determines, within 30 days of the Optionee&#8217;s resignation, that discharge for cause was warranted.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(h)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:5.65pt">Restrictive Covenant Agreements</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">. Notwithstanding anything in the Agreement that may be to the contrary, if the Company determines that Optionee has violated any provisions set forth in the Restrictive Covenant Agreements, in addition to any and all rights and remedies set forth therein or otherwise available under law or equity, Optionee covenants and agrees that&#58; (i) the unvested portion of this Option will immediately be cancelled, and Optionee shall automatically forfeit any rights Optionee may have with respect to such unvested Option Shares as of the date of such determination&#59; (ii)&#160;the right to exercise this Option shall automatically terminate as of the date of such determination&#59; and (iii) the Company or its Affiliate may also take action at equity or in law to enforce the provisions of the Restrictive Covenant Agreements.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Following application of this provision of the Agreement, Optionee will continue to be bound by the obligations, promises and other agreements contained in the Restrictive Covenant Agreements and this Agreement.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">4.  Payment of Purchase Price.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:6.93pt">Method of Payment.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> Payment of the purchase price for Shares purchased upon exercise of this Option shall be made (i) by delivery to the Company, or to the online service designated by the Company, of an amount equal to the purchase price of such Shares, (ii)&#160;by delivery to the Company of Shares (either actually or by attestation) then owned by the Optionee for at least 6 months (or any shorter period sufficient to avoid a charge to the Company&#8217;s earnings for financial reporting purposes) or delivery of other consideration having a fair market value equal in amount to the purchase price of such Shares, (iii) to the extent permitted by the Board, in its sole discretion, by delivery of an irrevocable and unconditional undertaking by a creditworthy broker to deliver promptly to the Company sufficient funds to pay the purchase price and any required Tax-Related Items (as defined below), or delivery by the Optionee to the Company of a copy of irrevocable and unconditional instructions to a creditworthy broker to deliver promptly to the Company cash or a check sufficient to pay the purchase price and any required Tax-Related Items&#59; or (iv) by any combination of cash, Shares, and other consideration as the Board may specify.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:6.58pt">Valuation of Shares or Other Non-Cash Consideration Tendered in Payment of Purchase Price.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  For the purposes hereof, the fair market value of any Shares or other non-cash consideration which may be delivered to the Company in exercise of this Option shall be determined as provided in the Plan.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:7.53pt">Delivery of Shares Tendered in Payment of Purchase Price.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  If the Optionee exercises Options by delivery of Shares, any certificate or certificates representing the Shares to be delivered shall be duly executed in blank by the Optionee or shall be accompanied by a stock power duly executed in blank suitable for purposes of transferring such Shares, and any electronic delivery of Shares shall be in a manner sufficient for purposes of transferring such Shares to the Company.  Fractional Shares will not be accepted in payment of the purchase price of Shares acquired upon exercise of this Option.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">5.  Delivery of Shares&#59; Compliance with Securities Laws, Etc.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:6.09pt">General.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  The Company shall, upon payment of the Option price for the number of Shares purchased and paid for, make prompt delivery of such Shares to the Optionee, provided that if any law or regulation requires the Company to take any action with respect to such Shares before the issuance thereof, then the date of delivery of such Shares shall be extended for the period necessary to complete such action.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:5.65pt">Listing, Qualification, Etc.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  This Option shall be subject to the requirement that if, at any time, counsel to the Company shall determine that the listing, registration or qualification of Shares subject hereto upon any securities exchange or under any state, federal or foreign law, or the </font></div></div><div style="display:inline-block;max-width:4.348%;min-width:3.348%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:47.827%"><div style="margin-bottom:12pt;padding-left:5.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">consent or approval of any governmental or regulatory body, or that the disclosure of non-public information or the satisfaction of any other condition is necessary as a condition of, or in connection with, the issuance or purchase of Shares hereunder, this Option may not be exercised, in whole or part, unless such listing, registration, qualification, consent or approval, disclosure or satisfaction of such other condition shall have been effected or obtained on terms acceptable to the Board.  Nothing herein shall be deemed to require the Company to apply for, effect disclosure, or to satisfy such other condition.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">6.  Nontransferability of Option.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Except as provided in paragraph (e) of Section 3, this Option is personal and no rights granted hereunder may be sold, assigned, transferred, pledged or otherwise encumbered by the Optionee (whether by operation of law or otherwise).  During the lifetime of the Optionee, this Option shall be exercised only by the Optionee.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">7.  No Special Employment Rights.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nothing contained in the Plan, the Plan Prospectus or this Agreement shall be construed or deemed to constitute an employment or service contract or confer or be deemed to confer on the Optionee any right to continue in the employ or service of, or to continue any other relationship with, the Company or an Affiliate or limit in any way any right of the Company or an Affiliate, as applicable, to terminate the Optionee's employment or service or other relationship at any time, with or without cause.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">8.  Rights as a Shareholder.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Optionee shall have no rights as a shareholder with respect to any Shares which may be purchased by exercise of this Option (including, without limitation, any rights to receive dividends or non-cash distributions with respect to such Shares) unless and until a certificate representing such Shares, or electronic equivalent, is duly issued and delivered to the Optionee.  No adjustment shall be made for dividends or other rights for which the record date is prior to the date such stock certificate or electronic equivalent is issued.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">9.  Taxes.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:6.09pt">Responsibility for Taxes. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Optionee acknowledges that, regardless of any action taken by the Company or, if different, the Optionee's employer (the &#8220;Employer&#8221;), the ultimate liability for all income tax (whether foreign, federal, state or local), social insurance, payroll tax, fringe benefits tax, payment on account and other tax-related items related to the Optionee&#8217;s participation in the Plan and legally applicable to the Optionee (the &#8220;Tax-Related Items&#8221;) is and remains the Optionee&#8217;s responsibility as it may come due and may exceed the amount actually withheld by the Company or the Employer.  The Optionee further acknowledges that the Company and&#47;or the Employer (i) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Option, and (ii) do not commit to and are under no obligation to structure the terms of the grant or any aspect of the Option to reduce or eliminate the Optionee&#8217;s liability for Tax-Related Items or achieve any particular tax result.  Further, if the Optionee is subject to Tax-Related Items in more than one jurisdiction, the Optionee acknowledges that the Company and&#47;or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction. In addition, the Optionee further acknowledges that Tax-Related Items may be incurred at different times.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:5.65pt">Withholding.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> The Optionee acknowledges and agrees to make arrangements satisfactory to the Company with respect to any withholding obligation the Company or the Employer (or former employer) may have for Tax-Related Items.  Without limitation to the foregoing, the Optionee acknowledges and agrees that to satisfy any such withholding obligation for Tax-Related Items, the Company may (i) withhold from the Optionee's wages or other cash compensation paid to the Optionee by the Company and&#47;or the Employer, (ii) withhold from proceeds of the sale of Shares acquired upon exercise of the Option, either through a voluntary sale or through a mandatory sale arranged by the Company (on the Optionee&#8217;s behalf pursuant to this authorization), or (iii) withhold by any other method permitted under the Plan and applicable law.  Depending on the withholding method, the Company may withhold or account for Tax-Related Items by considering applicable minimum statutory withholding amounts or other applicable withholding rates, including up to the maximum applicable rate in the Optionee's jurisdiction (in which case, the Optionee may receive a refund of any over-withheld amount in cash and will have no entitlement to </font></div></div></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72.72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exhibit 10.44</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CEO Stock Option Agreement</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted Under IDEXX Laboratories, Inc. 2018 Stock Incentive Plan</font></div><div><font><br></font></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:47.825%"><div style="margin-bottom:12pt;padding-left:5.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">the equivalent amount in Shares). The Company may refuse to deliver the Shares or the proceeds of the sale of Shares, if the Optionee fails to comply with his or her obligations in connection with the Tax-Related Items.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;padding-left:6.09pt">Tax Consequences</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.  The Optionee has reviewed with his or her own tax advisors the applicable tax consequences of this investment and the transactions contemplated by this Agreement.  With respect to such matters, the Optionee relies solely on such advisors and not on any statements or representations of the Company or any of its agents, written or oral.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:5.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">10.  Limitations on Disposition of Incentive Stock Option Shares.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:9pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">If, as indicated on the opposite side of this Agreement, this Option is an &#8220;incentive stock option&#8221;, the Optionee understands that in order to obtain the benefits of an incentive stock option under Section 422 of the Code, no sale or other disposition may be made of any Shares acquired upon exercise of the Option within 1 year after such Shares were acquired pursuant to such exercise, nor within 2 years after the Grant Date.  If the Optionee intends to dispose, or does dispose (whether by sale, exchange, gift, transfer or otherwise), of any such Shares within said periods, he or she will notify the Company in writing within 10 days after such disposition, and provide any other information regarding such disposition that the Company may require.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">11.  Data Privacy.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Optionee hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of the Optionee&#8217;s personal data as described in this Agreement and any other Option grant materials by and among, as applicable, the Employer, the Company and its Subsidiaries and Affiliates for the exclusive purpose of implementing, administering and managing the Optionee&#8217;s participation in the Plan.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Optionee understands that the Company and the Employer may hold certain personal information about the Optionee, including, but not limited to, the Optionee&#8217;s name, home address, email address and telephone number, date of birth, social insurance number, passport or other identification number, salary, nationality, job title, any shares of stock or directorships held in the Company, details of all Options or any other entitlement to shares of stock awarded, canceled, exercised, vested, unvested or outstanding in the Optionee&#8217;s favor (&#8220;Data&#8221;), for the exclusive purpose of implementing, administering and managing the Plan. </font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Optionee understands that Data will be transferred to E*TRADE, or such other stock plan service provider as may be selected by the Company in the future, which is assisting the Company with the implementation, administration and management of the Plan.  The Optionee understands that the recipients of the Data may be located in the United States or elsewhere, and that the recipient&#8217;s country may have different data privacy laws and protections than the Optionee&#8217;s country.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Optionee authorizes the Company, E*TRADE and any other possible recipients which may assist the Company (presently or in the future) with implementing, administering and managing the Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the sole purposes of implementing, administering and managing the Optionee&#8217;s participation in the Plan.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">12.  Miscellaneous.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:7.25pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;padding-left:6.09pt">This Agreement and the Plan constitute the entire agreement between the parties, and supersedes all prior agreements and understandings, relating to the subject matter of this Agreement.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:7.25pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;padding-left:6.58pt">Except as provided herein, this Agreement may not be amended or otherwise modified unless evidenced in writing and signed by the Company and the Optionee. Any provision for the benefit of the Company contained in this Agreement may be waived, either generally or in any particular instance, by the Board.  The Board may amend, alter, suspend, discontinue or terminate the Plan, or any portion thereof, at any time, subject to the requirements for certain amendments or alterations set forth in the Plan.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:18.2pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;padding-left:6.09pt">This Agreement shall be binding upon and inure to the benefit of the Company and the Optionee and their respective heirs, </font></div></div><div style="display:inline-block;max-width:4.348%;min-width:3.348%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:47.827%"><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:18.2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">executors, administrators, representatives, successors and assigns, subject to the restrictions on transfer set forth in Section 6 hereof.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:12.05pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;padding-left:5.65pt">The Option and the provisions of this Agreement shall be governed by and construed in accordance with the laws of the State of Delaware and applicable federal law, without regard to applicable conflict of laws principles.  </font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:7.8pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;padding-left:6.09pt">The invalidity or unenforceability of any provision of this Agreement shall not affect the validity or enforceability of any other provision of this Agreement, and each other provision of this Agreement shall be severable and enforceable to the extent permitted by law.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:12.05pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;padding-left:7.87pt">The Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding the Optionee&#8217;s participation in the Plan, or the Optionee&#8217;s acquisition or sale of the underlying Shares.  </font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:8.65pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(g)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;padding-left:7.08pt">All notices under this Agreement shall be mailed or delivered by hand to the parties at their respective addresses set forth in this Agreement or at such other address as may be designated in writing by either of the parties to one another.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:8.65pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(h)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;padding-left:5.65pt">The Company may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plan by electronic means.  The Optionee hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Company or a third party designated by the Company. </font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:12.05pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;padding-left:8.31pt">If the Optionee works and&#47;or resides outside the United States, the Option and any Shares subject to the Option shall be subject to any special terms and conditions set forth in Exhibit A.  Moreover, if the Optionee relocates outside of the United States and to one of the countries included in Exhibit A, the special terms and conditions for such country will apply to the Optionee to the extent the Company determines that the application of such terms and conditions is necessary or advisable for legal or administrative reasons.  Exhibit A constitutes part of this Agreement.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:8.65pt;text-indent:14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(j)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;padding-left:8.31pt">The Company reserves the right to impose other requirements on the Optionee&#8217;s participation in the Plan, on the Option and on any Shares acquired under the Plan, to the extent the Company determines it is necessary or advisable for legal or administrative reasons, and to require the Optionee to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.</font></div><div style="padding-left:5.75pt;padding-right:2.9pt"><font><br></font></div></div></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72.72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exhibit 10.44</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CEO Stock Option Agreement</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted Under IDEXX Laboratories, Inc. 2018 Stock Incentive Plan</font></div><div><font><br></font></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:47.825%"><div style="padding-left:5.75pt;padding-right:2.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit A to</font></div><div style="padding-left:5.75pt;padding-right:2.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee Stock Option Agreement</font></div><div style="padding-left:5.75pt;padding-right:2.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">IDEXX Laboratories, Inc. 2018 Stock Incentive Plan  </font></div><div style="padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">This Exhibit A includes special terms and conditions and notifications applicable to the Optionee resides and&#47;or works outside the United States and, as applicable, in one of the countries listed below.  These terms and conditions and notifications supplement or replace (as indicated) the terms and conditions set forth in the Agreement to which it is attached.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">If the Optionee is a citizen or resident of a country other than the one in which he or she is currently residing and&#47;or working, or if the Optionee transfers employment or residency to another country after the Option is granted, the Company, in its discretion, will determine the extent to which the terms and conditions set forth in this Exhibit A will apply to the Optionee. </font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Capitalized terms used but not defined in this Exhibit A shall have the same meanings as in the Agreement and&#47;or the Plan, as applicable.</font></div><div style="margin-bottom:12pt;padding-left:1.45pt;padding-right:1.45pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ALL NON-U.S. LOCATIONS</font></div><div style="margin-bottom:12pt;padding-right:2.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">In accepting the Option, the Optionee acknowledges, understands and agrees that&#58;</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(a) the Plan is established voluntarily by the Company it is discretionary in nature&#59;</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(b) the grant of the Option is exceptional, voluntary and occasional and does not create any contractual or other right to receive future grants of options, or benefits in lieu of options, even if options have been granted in the past&#59; </font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(c) all decisions with respect to future option or other grants, if any, will be at the sole discretion of the Company&#59;</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(d) the Optionee is voluntarily participating in the Plan&#59;</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(e) the Option and any Shares acquired under the Plan, and the income and value of same, are not intended to replace any pension rights or compensation&#59;</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(f) the Option and any Shares acquired under the Plan, and the income and value of same, are not part of normal or expected compensation for any purpose, including, without limitation, calculating any severance, resignation, termination, redundancy, dismissal, end-of-service payments, holiday pay, bonuses, long-service awards, pension or retirement or welfare benefits or similar payments&#59;</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(g) unless otherwise agreed with the Company, the Option and any Shares acquired under the Plan, and the income and value of same, are not granted as consideration for, or in connection with, services the Optionee may provide as a director of a Subsidiary or Affiliate&#59;</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(h) the future value of the Shares underlying the Option is unknown, indeterminable, and cannot be predicted with certainty&#59; if the underlying Shares do not increase in value, the Option will have no value&#59; if the Optionee exercises the Option and acquires Shares, the value of such Shares may increase or decrease in value, even below the purchase price&#59; </font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:30.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(i) for purposes of the Option, the Optionee will be considered to have ceased employment as of the date the Optionee is no longer actively providing services to the Company or an Affiliate&#59; the Company shall have the exclusive discretion to determine when the Optionee is no longer actively providing services for purposes of the vesting of the Option and the exercise of the Option following termination of employment. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Further, no claim or entitlement to compensation or damages shall arise from forfeiture of the Option resulting from the Optionee ceasing to be employed by or provide services to the Company or an Affiliate for any reason whatsoever&#59; and</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:5.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(j) neither the Company, the Employer nor any Subsidiary or Affiliate shall be liable for any foreign exchange rate fluctuation between the Optionee&#8217;s local currency and the United States Dollar that may affect the value of the </font></div></div><div style="display:inline-block;max-width:4.348%;min-width:3.348%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:47.827%"><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Option or of any amounts due to the Optionee pursuant to the exercise of the Option or the subsequent sale of any Shares acquired upon exercise.</font></div><div style="margin-bottom:12pt;padding-right:2.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Choice of Venue</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:5.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">For purposes of litigating any dispute that arises under this grant or the Agreement, the parties hereby submit to and consent to the exclusive jurisdiction of the State of Maine, agree that such litigation shall be conducted in the courts of Cumberland County, Maine, or the federal courts for the United States for the District of Maine, where this grant is made and&#47;or to be performed.</font></div><div style="margin-bottom:12pt;padding-right:2.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Language</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Optionee acknowledges that he or she is sufficiently proficient in English to understand the terms and conditions of the Agreement.  Furthermore, if the Optionee has received this Agreement or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.</font></div><div style="margin-bottom:12pt;padding-right:2.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Insider Trading Restrictions&#47;Market Abuse Laws</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Optionee acknowledges that he or she may be subject to insider trading restrictions and&#47;or market abuse laws in applicable jurisdictions including, but not limited to, the United States and the Optionee&#8217;s country of residence, which may affect the Optionee&#8217;s ability to acquire or sell Shares or rights to Shares (e.g., Options) during such time as the Optionee is considered to have &#8220;inside information&#8221; regarding the Company (as defined by the laws in the applicable jurisdictions).  Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable insider trading policy of the Company.  The Optionee is responsible for ensuring compliance with any applicable restrictions and should consult with his or her personal legal advisor on this matter. </font></div><div style="margin-bottom:12pt;padding-right:2.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Foreign Asset&#47;Account and Exchange Control Requirements</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depending on the Optionee&#8217;s country, the Optionee may be subject to foreign asset&#47;account and&#47;or exchange control reporting or other requirements as a result of the exercise of the Option, the acquisition, holding and&#47;or transfer of Shares or cash resulting from participation in the Plan and&#47;or the opening and maintaining of a brokerage or bank account in connection with the Plan.  The Optionee may be required to report such assets, accounts, account balances and values, and&#47;or related transactions to the applicable authorities in his or her country.  The Optionee may also be required to repatriate sale proceeds or other funds received as a result of his or her participation in the Plan to his or her country through a designated bank or broker and&#47;or within a certain time after receipt.  The Optionee acknowledges that he or she is responsible for ensuring compliance with any such requirements and that he or she should consult with the Optionee&#8217;s own personal tax and legal advisors, as applicable, on these matters.</font></div><div style="margin-bottom:12pt;padding-right:2.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Data Privacy (For Jurisdictions in the European Union (&#8220;EU&#8221;) &#47; European Economic Area (&#8220;EEA&#8221;), Switzerland and the United Kingdom)</font></div><div style="margin-bottom:12pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">This section replaces Section 11 of the Agreement&#58;</font></div><div style="margin-bottom:12pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(a) Data Collection and Usage</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.  The Company collects, processes and uses personal data about the Optionee, including, but not limited to, the Optionee&#8217;s name, home address, telephone number and e-mail address, date of birth, social insurance number, passport or other identification number, salary, nationality, job title, any equity or directorships held in the Company and its Affiliates, details of all Options or any other entitlement to equity awarded, canceled, exercised, vested, unvested or outstanding in the Optionee&#8217;s favor, which the Company receives from the Optionee or the Employer.  In order to participate in the Plan, the Company will collect the Optionee&#8217;s personal data for purposes of allocating Shares and implementing, administering and managing the Plan.  The Company&#8217;s legal basis for the processing of the Optionee&#8217;s personal data is based on necessity for the performance of the Plan and pursuant to the Company&#8217;s legitimate business interests.</font></div><div style="margin-bottom:12pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(b) Stock Plan Administration Service Providers</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.  The Company transfers the Optionee&#8217;s data to E*TRADE Corporate Financial Services, Inc. (including its affiliated companies), an independent service provider based in the United States (&#8220;U.S.&#8221;), which assists the Company with the implementation, administration and management of the Plan.  In the future, </font></div></div></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72.72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exhibit 10.44</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CEO Stock Option Agreement</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted Under IDEXX Laboratories, Inc. 2018 Stock Incentive Plan</font></div><div><font><br></font></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:47.825%"><div style="margin-bottom:12pt;padding-right:2.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">the Company may select a different service provider and share the Optionee&#8217;s data with another company that serves in a similar manner.  The Company&#8217;s service provider(s) will open an account for the Optionee to receive and trade Shares.  The Optionee will be asked to agree on separate terms and data processing practices with the service provider(s), which is a condition to the Optionee&#8217;s ability to participate in the Plan.</font></div><div style="margin-bottom:12pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(c) International Data Transfers.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  The Optionee&#8217;s personal data will be transferred to the U.S. where the Company and its service providers are based.  The Company&#8217;s legal basis for the transfer of the Optionee&#8217;s personal data to the U.S. is its use of the standard data protection clauses.</font></div><div style="margin-bottom:12pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(d) Data Retention</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.  The Company will use the Optionee&#8217;s personal data only as long as necessary to implement, administer and manage the Optionee&#8217;s participation in the Plan or as required to comply with legal or regulatory obligations, including tax and securities laws.  When the Company no longer needs the Optionee&#8217;s personal data, which will generally be seven (7) years after the Optionee participates in the Plan, the Company will remove it from its systems.  If the Company keeps data longer, it would be to satisfy legal or regulatory obligations and the Company&#8217;s legal basis would be relevant laws or regulations.</font></div><div style="margin-bottom:12pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(e) Data Subject Rights</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">.  The Optionee has a number of rights under data privacy laws in the Optionee&#8217;s country.  Depending on where the Optionee is based, his or her rights may include the right to (a) request access or copies of personal data processed by the Company, (b) rectification of incorrect data, (c) deletion of data, (d) restrictions on processing, (e) portability of data, (f) lodge complaints with competent authorities in the Optionee&#8217;s country, and&#47;or (g) receive a list with the names and addresses of any potential recipients of the Optionee&#8217;s personal data.  To receive clarification regarding the Optionee&#8217;s rights or to exercise such rights please contact the Company&#8217;s Data Privacy Officer electronically, by phone, or mail, in strict confidence. </font></div><div style="margin-bottom:12pt;padding-right:2.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Data Privacy (Non-EU Jurisdictions)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">This section supplements Section 11 of the Agreement&#58;</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">The Optionee may request a list with the names and addresses of any potential recipients of the Data by contacting his or her local human resources representative. </font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">The Optionee understands that Data will be held only as long as is necessary to implement, administer and manage the Optionee&#8217;s participation in the Plan.  The Optionee understands that he or she may, at any time, view Data, request information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing the Optionee&#8217;s local human resources representative.  </font></div><div style="margin-bottom:12pt;padding-left:5.75pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Further, the Optionee understands that he or she is providing the consents herein on a purely voluntary basis.  If the Optionee does not consent, or if the Optionee later seeks to revoke his or her consent, the Optionee&#8217;s employment status or service with the Employer will not be affected&#59; the only consequence of refusing or withdrawing consent is that the Company would not be able to grant Options or other equity awards to the Optionee or administer or maintain such awards.  Therefore, the Optionee understands that refusing or withdrawing consent may affect his or her ability to participate in the Plan.  For more information on the consequences of the Optionee&#8217;s refusal to consent or withdrawal of consent, the Optionee understands that the Optionee may contact his or her local human resources representative.</font></div><div style="margin-bottom:12pt;padding-left:1.45pt;padding-right:1.45pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">AUSTRIA</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">There are no country-specific provisions.</font></div><div style="margin-bottom:12pt;padding-left:1.45pt;padding-right:1.45pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">BRAZIL</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  The offer of the Option and the underlying Shares is not registered with the Brazilian Securities Commission (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Comiss&#227;o de Valores Mobili&#225;rios &#8211; CVM</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">).  The Shares may not be offered or sold in Brazil, except under circumstances that do not constitute a public offering or distribution of securities under Brazilian laws and regulations.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  This provision supplements the Nature of Grant section above&#58;</font></div></div><div style="display:inline-block;max-width:4.348%;min-width:3.348%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:47.827%"><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">In accepting the Option, the Optionee acknowledges that (i) the Optionee is making an investment decision and (ii) the value of the underlying Shares is not fixed and may increase or decrease without compensation to the Optionee.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Compliance with Law</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  By accepting the Option, the Optionee agrees to comply with applicable Brazilian laws and to pay any and all applicable Tax-Related Items associated with the exercise of the Option, the receipt of any dividends, and the sale of Shares acquired under the Plan.</font></div><div style="margin-bottom:12pt;padding-left:1.45pt;padding-right:1.45pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">FRANCE</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Option Not Tax-Qualified</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> The Option is not intended to qualify for specific tax and social security treatment in France.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Language Consent</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> By accepting the Option, the Optionee confirms having read and understood the Plan and Agreement, including all terms and conditions included therein, which were provided in the English language.  The Optionee accepts the terms of those documents accordingly.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Consentement &#224; la Langue Utilis&#233;e</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">En acceptant cette Option, le B&#233;n&#233;ficiaire confirme avoir lu et compris le Plan et le Contrat, incluant tous leurs termes et conditions, qui ont &#233;t&#233; transmis en langue anglaise.  Le B&#233;n&#233;ficiaire accepte les dispositions de ces documents en connaissance de cause.</font></div><div style="margin-bottom:12pt;padding-left:1.45pt;padding-right:1.45pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">GERMANY</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">There are no country-specific provisions. </font></div><div style="margin-bottom:12pt;padding-left:1.45pt;padding-right:1.45pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">NETHERLANDS</font></div><div style="margin-bottom:12pt;padding-right:2.9pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">There are no country-specific provisions.</font></div><div style="margin-bottom:12pt;padding-left:1.45pt;padding-right:1.45pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">NEW ZEALAND</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">WARNING&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> The Optionee is being offered an Option which allows the Optionee to purchase Shares in accordance with the terms of the Plan and the Agreement.  The Shares, if purchased, give the Optionee a stake in the ownership of the Company.  The Optionee may receive a return if dividends are paid. </font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">If the Company runs into financial difficulties and is wound up, the Optionee will be paid only after all creditors and holders of preferred shares have been paid.  The Optionee may lose some or all of his or her investment.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">New Zealand law normally requires people who offer financial products to give information to investors before they invest.  This information is designed to help investors to make an informed decision.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The usual rules do not apply to this offer because it is made under an employee share purchase scheme.  As a result, the Optionee may not be given all the information usually required.  The Optionee will also have fewer other legal protections for this investment.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Optionee understands that he or she should ask questions, read all documents carefully, and seek independent financial advice before exercising any Options under the Plan.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Shares are quoted and approved for trading on the NASDAQ Global Select Market in the United States of America.  This means that, if the Optionee purchases Shares under the Plan, the Optionee may be able to sell his or her investment on the NASDAQ Global Select Market if there are interested buyers.  The Optionee understands that he or she may get less than the Optionee&#8217;s investment.  The price will depend on the demand for the Shares. </font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">For information on risk factors impacting the Company&#8217;s business that may affect the value of the Shares, the Optionee should refer to the risk factors discussion in the Company&#8217;s Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, which are filed with the U.S. Securities and Exchange Commission and are available online at www.sec.gov, as </font></div></div></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72.72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exhibit 10.44</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CEO Stock Option Agreement</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted Under IDEXX Laboratories, Inc. 2018 Stock Incentive Plan</font></div><div><font><br></font></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:47.825%"><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">well as on the Company&#8217;s website at https&#58;&#47;&#47;www.idexx.com&#47;corporate&#47;investors-home.html.</font></div><div style="margin-bottom:12pt;padding-left:1.45pt;padding-right:1.45pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SINGAPORE</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  The Option is being granted pursuant to the &#8220;Qualifying Person&#8221; exemption under section 273(1)(f) of the Singapore Securities and Futures Act (Chapter 289, 2006 Ed.) (&#8220;SFA&#8221;).  The Plan has not been lodged or registered as a prospectus with the Monetary Authority of Singapore.  The Optionee should note that the Option is subject to section 257 of the SFA and the Optionee will not be able to make any subsequent sale of the Shares acquired pursuant to the Option in Singapore or any offer of such subsequent sale of Shares in Singapore unless such sale or offer in Singapore is made (a) after six months after the Grant Date, or (b) pursuant to the exemptions under Part XIII Division (1) Subdivision (4) (other than section 280) of the SFA, or pursuant to, and in accordance with the conditions of, any applicable provisions of the SFA.</font></div><div style="margin-bottom:12pt;padding-left:1.45pt;padding-right:1.45pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SPAIN</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> No &#8220;offer of securities to the public,&#8221; as defined under Spanish law, has taken place or will take place in the Spanish territory in connection with the offer of the Option.  The Plan, the Agreement and any other documents evidencing the grant of the Option have not been, nor will they be, registered with the </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Comisi&#243;n Nacional del Mercado de Valores</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> (the Spanish securities regulator), and none of those documents constitutes a public offering prospectus.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  This provision supplements the Nature of Grant section above&#58;</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">In accepting the Option, the Optionee acknowledges that he or she has received a copy of the Plan, has reviewed and understands the Plan and agrees to participation in the Plan.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Optionee further understands that the Company has unilaterally, gratuitously and discretionally decided to grant Options under the Plan to employees of the Company or any Subsidiary or Affiliate throughout the world.  The decision to grant the Options is a limited decision that is entered into upon the express assumption and condition that any Option grant will not economically or otherwise bind the Company or any Subsidiary or Affiliate on an ongoing basis other than as set forth in this Agreement.  Consequently, the Optionee understands that any grant is given on the assumption and condition that it shall not become a part of any employment contract (either with the Company or any Subsidiary or Affiliate) and shall not be considered a mandatory benefit, salary for any purpose (including severance compensation) or any other right whatsoever.  Further, the Optionee understands and freely accepts that there is no guarantee that any benefit shall arise from any gratuitous and discretionary grant since the future value of the Option and the underlying Shares is unknown and unpredictable. </font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additionally, the Optionee understands that the vesting and exercisability of the Option is expressly conditioned on the Optionee&#8217;s continued and active rendering of service to the Employer such that, except as specifically provided in Section 2 of the Agreement, if the Optionee&#8217;s employment terminates for any reason whatsoever, the Optionee&#8217;s Option will cease vesting immediately effective as of the date of termination of his or her employment and any post-termination exercisability period will be measured from such date.  This will be the case, for example, even if (a) the Optionee is considered to be unfairly dismissed without good cause (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">i.e.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">, subject to a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">despido improcedente</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8221;)&#59; (b) the Optionee is dismissed for disciplinary or objective reasons or due to a collective dismissal&#59; (c) the Optionee terminates service due to a change of work location, duties or any other employment or contractual condition&#59; (d) the Optionee terminates service due to the Company&#8217;s or any Subsidiary&#8217;s or Affiliate&#8217;s unilateral breach of contract&#59; or (e) the Optionee&#8217;s employment terminates for any other reason whatsoever.  Consequently, upon termination of employment for any of the above reasons, the Optionee will automatically lose any rights to Options granted that were unvested on the date of termination of the Optionee&#8217;s employment, as described in the Agreement.</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finally, the Optionee understands that this grant would not be made to him or her but for the assumptions and conditions referred to herein&#59; thus, the Optionee acknowledges and freely accepts that should any or all of the assumptions be mistaken or should any of the conditions not be met for any reason, then any grant of Options shall be null and void.</font></div><div style="margin-bottom:12pt;padding-left:1.45pt;padding-right:1.45pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SWITZERLAND</font></div></div><div style="display:inline-block;max-width:4.348%;min-width:3.348%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:47.827%"><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> Neither this document nor any other materials relating to the Option (a) constitutes a prospectus according to articles 35 et seq. of the Swiss Federal Act on Financial Services (&#8220;FinSA&#8221;), (b) may be publicly distributed or otherwise made publicly available in Switzerland to any person other than an Eligible Optionee, or (c) has been or will be filed with, approved or supervised by any Swiss reviewing body according to article 51 FinSA or any Swiss regulatory authority, including the Swiss Financial Market Supervisory Authority.</font></div><div style="margin-bottom:12pt;padding-left:1.45pt;padding-right:1.45pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">UNITED KINGDOM (&#8220;U.K.&#8221;)</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  This provision supplements Section 9 of the Agreement&#58;</font></div><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:2.9pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Without limitation to Section 9 of the Agreement, the Optionee hereby agrees that he or she is liable for all Tax-Related Items and hereby covenants to pay all such Tax-Related Items, as and when requested by the Company or the Employer, as applicable, or by Her Majesty&#8217;s Revenue &#38; Customs (&#8220;HMRC&#8221;) (or any other tax authority or any other relevant authority).  The Optionee also hereby agrees to indemnify and keep indemnified the Company and the Employer, as applicable, against any Tax-Related Items that they are required to pay or withhold or have paid or will pay to HMRC (or any other tax authority or any other relevant authority) on the Optionee&#8217;s behalf.</font></div><div style="padding-left:5.75pt;padding-right:2.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, if the Optionee is a director or executive officer of the Company (within the meaning of Section 13(k) of the Exchange Act), the terms of immediately foregoing provision will not apply.  In this case, the amount of the income tax not collected within 90 days of the end of the U.K. tax year in which an event giving rise to the Tax-Related Items occurs may constitute a benefit to the Optionee on which additional income tax and National Insurance contributions may be payable.  The Optionee will be responsible for reporting and paying any income tax due on this additional benefit directly to HMRC under the self-assessment regime and for reimbursing the Company or the Employer, as applicable, for the value of any National Insurance contributions due on this additional benefit, which may be recovered from the Optionee by the Company or the Employer at any time thereafter by any of the means referred to in Section 9 of the Agreement.</font></div><div style="padding-left:5.75pt;padding-right:2.9pt"><font><br></font></div></div></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21
<SEQUENCE>21
<FILENAME>exhibit21-subsidiariesofth.htm
<DESCRIPTION>EX-21
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i9587460f6ba9428b92213e62a8a0fc5a_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:149%">Exhibit 21 </font></div><div style="margin-bottom:0.1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.985%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.811%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.904%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">IDEXX LABORATORIES, INC.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">SUBSIDIARIES OF THE REGISTRANT</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%;text-decoration:underline">Legal Entity Name</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%;text-decoration:underline">Jurisdiction of Incorporation or Formation</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:133%">342 Saco Street, LLC</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:133%">Maine</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Beijing IDEXX Laboratories Co. Limited</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">China</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">ezyVet US, Inc.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Delaware</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IDEXX Animana B.V.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Netherlands</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IDEXX Brasil Laborat&#243;rios Ltda.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Brazil</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IDEXX Brasil Participa&#231;&#245;es Ltda.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Brazil</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IDEXX Diagnostic Limited</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Ireland</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IDEXX Diavet AG</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Schwyz</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IDEXX Distribution, Inc.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Massachusetts</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IDEXX GmbH</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Germany</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IDEXX B.V.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Netherlands</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IDEXX Holding GmbH</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Germany</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IDEXX Holdings GmbH</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Zug</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IDEXX Holdings II GmbH</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Zug</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IDEXX Holdings, Inc.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Delaware</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IDEXX Laboratories II (NZ) ULC</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">New Zealand</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IDEXX Laboratories (Proprietary) Limited</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">South Africa</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IDEXX Laboratories (Shanghai) Company Limited</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">China</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IDEXX Laboratories B.V.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Netherlands</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IDEXX Laboratories Canada 1, ULC</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Nova Scotia</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IDEXX Laboratories Canada 2, ULC</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Nova Scotia</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IDEXX Laboratories Canada Corporation</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Canada</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IDEXX Laboratories Canada LP</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Ontario</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IDEXX Laboratories Co., Ltd.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Thailand</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IDEXX Laboratories Danmark ApS</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Denmark</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IDEXX Laboratories DMCC</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">UAE</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IDEXX Laboratories GmbH</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Zug</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IDEXX Laboratories Inc.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Taiwan Province of China</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IDEXX Laboratories Italia S.r.l.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Italy</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IDEXX Laboratories, KK</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Japan</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IDEXX Laboratories LLC</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Russia</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IDEXX Laboratories Limited</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">England &#38; Wales</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IDEXX Laboratories Ltd.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Korea, Republic of</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IDEXX Laboratories Norge AS</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Norway</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IDEXX Laboratories Oy</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Finland</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div><div style="margin-bottom:0.1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.985%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.811%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.904%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IDEXX Laboratories Private Limited</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">India</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IDEXX Laboratories Pty Limited</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">New South Wales</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IDEXX Laboratories Singapore Pte. Ltd.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Singapore</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IDEXX Laboratories Sp. z o.o.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Poland</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IDEXX Laboratories SRL</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Belgium</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IDEXX Laboratories Sverige AB</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Sweden</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IDEXX Laboratories, S.de R.L. de C.V.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Mexico</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IDEXX Laboratories s.r.o.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Czech Republic</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IDEXX Laboratories Slovakia s.r.o.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Slovak Republic</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IDEXX Laboratorios, S.L.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Spain</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IDEXX Montpellier SAS</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">France</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IDEXX Operations, Inc.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Delaware</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IDEXX Pharmaceuticals, LLC</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Delaware</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IDEXX Real Estate Holdings GmbH</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Germany</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IDEXX Real Estate Holdings, LLC</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Maine</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IDEXX Reference Laboratories Ltd.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Canada</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IDEXX SARL</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">France</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IDEXX Switzerland GmbH</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Bern&#47;Berne</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IDEXX Technologies GmbH</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Bern&#47;Berne</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IDEXX Technologies Limited</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">England &#38; Wales</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IDEXX UK Acquisition Limited</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">England &#38; Wales</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IDEXX Vet Med Labor GmbH</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Austria</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Laboratoire IDEXX SARL</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">France</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">labor-zentral.ch AG f&#252;r veterin&#228;rmedizinische Diagnostik</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Switzerland</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Movet Oy</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Finland</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">OPTI Medical Systems, Inc.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Delaware</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Vet Med Lab (UK) Limited</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">England &#38; Wales</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Vet Med Labor GmbH</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Germany</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:10pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23
<SEQUENCE>22
<FILENAME>idexxfy21consent.htm
<DESCRIPTION>EX-23
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i96333908e4bf4b4494b84b83bb3130e3_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:center"><font><br></font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:700;line-height:133%">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;line-height:133%">We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-36007 and 333-70846) and Form S-8 (Nos. 333-11201, 333-11199, 333-36009, 333-56685, 333-78765, 333-78769, 333-43172, 333-43170, 333-27733, 333-105426, 333-108905, 333-108906, 333-146479, 333-160083, 333-160085, 333-193136 and 333-204418) of IDEXX Laboratories, Inc. of our report dated February 16, 2022 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.</font></div><div><font><br></font></div><div style="margin-bottom:0.1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.460%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.340%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;line-height:133%">&#47;s&#47;PricewaterhouseCoopers LLP</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;line-height:133%">Boston, Massachusetts</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;line-height:133%">February 16, 2022</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>23
<FILENAME>exhibit31111.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ia3dd5bc0df534719a9268ec6ce547702_1"></div><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit 31.1</font></div><div><font><br></font></div><div style="text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-indent:18pt"><font><br></font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Jonathan J. Mazelsky, certify that&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">I have reviewed this report on Form 10-K for the year ended December 31, 2021 of IDEXX Laboratories, Inc.&#59;</font></div><div style="text-align:justify;text-indent:20.25pt"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="text-align:justify;text-indent:20.25pt"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="text-align:justify;text-indent:20.25pt"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report, based on such evaluation&#59; and</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="text-align:justify;text-indent:20.25pt"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; February 16, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Jonathan J. Mazelsky</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jonathan J. Mazelsky</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)<br></font></td></tr></table></div><div><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>24
<FILENAME>exhibit31211.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i5d650459169842419f96e4bef16091ab_1"></div><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit 31.2</font></div><div><font><br></font></div><div style="text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-indent:18pt"><font><br></font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Brian P. McKeon, certify that&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">I have reviewed this report on Form 10-K for the year ended December 31, 2021 of IDEXX Laboratories, Inc.&#59;</font></div><div style="text-align:justify;text-indent:20.25pt"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="text-align:justify;text-indent:20.25pt"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="text-align:justify;text-indent:20.25pt"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report, based on such evaluation&#59; and</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="text-align:justify;text-indent:20.25pt"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting. </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; February 16, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Brian P. McKeon</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brian P. McKeon</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">and Treasurer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)<br></font></td></tr></table></div><div><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>25
<FILENAME>exhibit32111.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ie500f7119a3b4431b8db1b04adcbf57f_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit 32.1</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED BY</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">         </font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the report on Form 10-K of IDEXX Laboratories, Inc. (the &#8220;Company&#8221;) for the year ended December 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), the undersigned certifies, pursuant to 18 U.S.C. Section 1350, as adopted by Section 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font><br></font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.661%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.139%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Jonathan J. Mazelsky</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 16, 2022</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jonathan J. Mazelsky<br>President and Chief Executive Officer</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section 906, has been provided to IDEXX Laboratories, Inc. and will be retained by IDEXX Laboratories, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>26
<FILENAME>exhibit32211.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i915b18f9525847168dc999da060d866e_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit 32.2</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED BY</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">         </font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the report on Form 10-K of IDEXX Laboratories, Inc. (the &#8220;Company&#8221;) for the year ended December 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), the undersigned certifies, pursuant to 18 U.S.C. Section 1350, as adopted by Section 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font><br></font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.661%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.139%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Brian P. McKeon</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 16, 2022</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brian P. McKeon<br>Executive Vice President, Chief Financial Officer<br>and Treasurer </font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section 906, has been provided to IDEXX Laboratories, Inc. and will be retained by IDEXX Laboratories, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>27
<FILENAME>idxx-20211231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:f52bcaef-ba11-42ce-aefc-0c16e0e0e054,g:8ec733b7-1a7e-4401-9212-15a98e503c1c-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:idxx="http://www.idexx.com/20211231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.idexx.com/20211231">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="idxx-20211231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="idxx-20211231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="idxx-20211231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="idxx-20211231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.idexx.com/role/CoverPage">
        <link:definition>000010001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://www.idexx.com/role/AuditInformation">
        <link:definition>000020002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETS" roleURI="http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS">
        <link:definition>100010003 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>100020004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFINCOME" roleURI="http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFINCOME">
        <link:definition>100030005 - Statement - CONSOLIDATED STATEMENTS OF INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" roleURI="http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME">
        <link:definition>100040006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical" roleURI="http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical">
        <link:definition>100050007 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" roleURI="http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT">
        <link:definition>100060008 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY (DEFICIT)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical" roleURI="http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical">
        <link:definition>100070009 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY (DEFICIT) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>100080010 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NatureofBusinessBasisofPresentationandPrinciplesofConsolidation" roleURI="http://www.idexx.com/role/NatureofBusinessBasisofPresentationandPrinciplesofConsolidation">
        <link:definition>210011001 - Disclosure - Nature of Business, Basis of Presentation and Principles of Consolidation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://www.idexx.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>210021002 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.idexx.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>220032001 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.idexx.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>240044001 - Disclosure - Summary of Significant Accounting Policies (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognition" roleURI="http://www.idexx.com/role/RevenueRecognition">
        <link:definition>210051003 - Disclosure - Revenue Recognition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionTables" roleURI="http://www.idexx.com/role/RevenueRecognitionTables">
        <link:definition>230063001 - Disclosure - Revenue Recognition (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionDetails" roleURI="http://www.idexx.com/role/RevenueRecognitionDetails">
        <link:definition>240074002 - Disclosure - Revenue Recognition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionLeaseRevenueDetails" roleURI="http://www.idexx.com/role/RevenueRecognitionLeaseRevenueDetails">
        <link:definition>240084003 - Disclosure - Revenue Recognition (Lease Revenue) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionExtendedWarrantiesandPostContractSupportDetails" roleURI="http://www.idexx.com/role/RevenueRecognitionExtendedWarrantiesandPostContractSupportDetails">
        <link:definition>240094004 - Disclosure - Revenue Recognition (Extended Warranties and Post-Contract Support) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionRemainingPerformanceObligationDetails" roleURI="http://www.idexx.com/role/RevenueRecognitionRemainingPerformanceObligationDetails">
        <link:definition>240104005 - Disclosure - Revenue Recognition (Remaining Performance Obligation) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionRemainingPerformanceObligationDetails_1" roleURI="http://www.idexx.com/role/RevenueRecognitionRemainingPerformanceObligationDetails_1">
        <link:definition>240104005 - Disclosure - Revenue Recognition (Remaining Performance Obligation) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionSaaSSubscriptionsDetails" roleURI="http://www.idexx.com/role/RevenueRecognitionSaaSSubscriptionsDetails">
        <link:definition>240114006 - Disclosure - Revenue Recognition (SaaS Subscriptions) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionUpFrontCustomerLoyaltyProgramsDetails" roleURI="http://www.idexx.com/role/RevenueRecognitionUpFrontCustomerLoyaltyProgramsDetails">
        <link:definition>240124007 - Disclosure - Revenue Recognition (Up-Front Customer Loyalty Programs) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionVolumeCommitmentProgramsDetails" roleURI="http://www.idexx.com/role/RevenueRecognitionVolumeCommitmentProgramsDetails">
        <link:definition>240134008 - Disclosure - Revenue Recognition (Volume Commitment Programs) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionInstrumentRebateProgramsDetails" roleURI="http://www.idexx.com/role/RevenueRecognitionInstrumentRebateProgramsDetails">
        <link:definition>240144009 - Disclosure - Revenue Recognition (Instrument Rebate Programs) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionReagentRentalProgramsDetails" roleURI="http://www.idexx.com/role/RevenueRecognitionReagentRentalProgramsDetails">
        <link:definition>240154010 - Disclosure - Revenue Recognition (Reagent Rental Programs) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionDisaggregationofRevenuebyMajorProductandServiceCategoriesDetails" roleURI="http://www.idexx.com/role/RevenueRecognitionDisaggregationofRevenuebyMajorProductandServiceCategoriesDetails">
        <link:definition>240164011 - Disclosure - Revenue Recognition (Disaggregation of Revenue by Major Product and Service Categories) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionDisaggregationofRevenuebyPrincipalGeographicAreaBasedonCustomersDomicilesDetails" roleURI="http://www.idexx.com/role/RevenueRecognitionDisaggregationofRevenuebyPrincipalGeographicAreaBasedonCustomersDomicilesDetails">
        <link:definition>240174012 - Disclosure - Revenue Recognition (Disaggregation of Revenue by Principal Geographic Area, Based on Customers' Domiciles) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionCoststoObtainaContractDetails" roleURI="http://www.idexx.com/role/RevenueRecognitionCoststoObtainaContractDetails">
        <link:definition>240184013 - Disclosure - Revenue Recognition (Costs to Obtain a Contract) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandInvestments" roleURI="http://www.idexx.com/role/AcquisitionsandInvestments">
        <link:definition>210191004 - Disclosure - Acquisitions and Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandInvestmentsDetails" roleURI="http://www.idexx.com/role/AcquisitionsandInvestmentsDetails">
        <link:definition>240204014 - Disclosure - Acquisitions and Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensation" roleURI="http://www.idexx.com/role/ShareBasedCompensation">
        <link:definition>210211005 - Disclosure - Share-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationTables" roleURI="http://www.idexx.com/role/ShareBasedCompensationTables">
        <link:definition>230223002 - Disclosure - Share-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationNarrativeDetails" roleURI="http://www.idexx.com/role/ShareBasedCompensationNarrativeDetails">
        <link:definition>240234015 - Disclosure - Share-Based Compensation (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleofSelectedFinancialImpactofShareBasedCompensationDetails" roleURI="http://www.idexx.com/role/ShareBasedCompensationScheduleofSelectedFinancialImpactofShareBasedCompensationDetails">
        <link:definition>240244016 - Disclosure - Share-Based Compensation (Schedule of Selected Financial Impact of Share-Based Compensation) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleofWeightedAveragesoftheAssumptionsUsedInEstimatingtheFairValueofStockOptionAwardsDetails" roleURI="http://www.idexx.com/role/ShareBasedCompensationScheduleofWeightedAveragesoftheAssumptionsUsedInEstimatingtheFairValueofStockOptionAwardsDetails">
        <link:definition>240254017 - Disclosure - Share-Based Compensation (Schedule of Weighted Averages of the Assumptions Used In Estimating the Fair Value of Stock Option Awards) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleofStockOptionActivityDetails" roleURI="http://www.idexx.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails">
        <link:definition>240264018 - Disclosure - Share-Based Compensation (Schedule of Stock Option Activity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleOfRestrictedStockUnitActivityDetails" roleURI="http://www.idexx.com/role/ShareBasedCompensationScheduleOfRestrictedStockUnitActivityDetails">
        <link:definition>240274019 - Disclosure - Share-Based Compensation (Schedule Of Restricted Stock Unit Activity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CreditLosses" roleURI="http://www.idexx.com/role/CreditLosses">
        <link:definition>210281006 - Disclosure - Credit Losses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CreditLossesDetails" roleURI="http://www.idexx.com/role/CreditLossesDetails">
        <link:definition>240294020 - Disclosure - Credit Losses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Inventories" roleURI="http://www.idexx.com/role/Inventories">
        <link:definition>210301007 - Disclosure - Inventories</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesTables" roleURI="http://www.idexx.com/role/InventoriesTables">
        <link:definition>230313003 - Disclosure - Inventories (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesNarrativeDetails" roleURI="http://www.idexx.com/role/InventoriesNarrativeDetails">
        <link:definition>240324021 - Disclosure - Inventories (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesScheduleofComponentsofInventoriesDetails" roleURI="http://www.idexx.com/role/InventoriesScheduleofComponentsofInventoriesDetails">
        <link:definition>240334022 - Disclosure - Inventories (Schedule of Components of Inventories) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.idexx.com/role/Leases">
        <link:definition>210341008 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.idexx.com/role/LeasesTables">
        <link:definition>230353004 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://www.idexx.com/role/LeasesNarrativeDetails">
        <link:definition>240364023 - Disclosure - Leases (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" roleURI="http://www.idexx.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails">
        <link:definition>240374024 - Disclosure - Leases (Maturities of Operating Lease Liabilities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1" roleURI="http://www.idexx.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1">
        <link:definition>240374024 - Disclosure - Leases (Maturities of Operating Lease Liabilities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSupplementalCashFlowInformationDetails" roleURI="http://www.idexx.com/role/LeasesSupplementalCashFlowInformationDetails">
        <link:definition>240384025 - Disclosure - Leases (Supplemental Cash Flow Information) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentNet" roleURI="http://www.idexx.com/role/PropertyandEquipmentNet">
        <link:definition>210391009 - Disclosure - Property and Equipment, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentNetTables" roleURI="http://www.idexx.com/role/PropertyandEquipmentNetTables">
        <link:definition>230403005 - Disclosure - Property and Equipment, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentNetScheduleofEstimatedUsefulLivesDetails" roleURI="http://www.idexx.com/role/PropertyandEquipmentNetScheduleofEstimatedUsefulLivesDetails">
        <link:definition>240414026 - Disclosure - Property and Equipment, Net (Schedule of Estimated Useful Lives) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails" roleURI="http://www.idexx.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails">
        <link:definition>240424027 - Disclosure - Property and Equipment, Net (Schedule of Property and Equipment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentNetSummaryOfDepreciationAndAmortizationCapitalizedComputerSoftwareForInternalUseAndUnpaidPropertyEquipmentReflectedInAccountPayableAndAccruedExpensesDetails" roleURI="http://www.idexx.com/role/PropertyandEquipmentNetSummaryOfDepreciationAndAmortizationCapitalizedComputerSoftwareForInternalUseAndUnpaidPropertyEquipmentReflectedInAccountPayableAndAccruedExpensesDetails">
        <link:definition>240434028 - Disclosure - Property and Equipment, Net (Summary Of Depreciation And Amortization, Capitalized Computer Software For Internal Use And Unpaid Property Equipment Reflected In Account Payable And Accrued Expenses) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentNetNarrativeDetails" roleURI="http://www.idexx.com/role/PropertyandEquipmentNetNarrativeDetails">
        <link:definition>240444029 - Disclosure - Property and Equipment, Net (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherCurrentandLongTermAssets" roleURI="http://www.idexx.com/role/OtherCurrentandLongTermAssets">
        <link:definition>210451010 - Disclosure - Other Current and Long-Term Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherCurrentandLongTermAssetsTables" roleURI="http://www.idexx.com/role/OtherCurrentandLongTermAssetsTables">
        <link:definition>230463006 - Disclosure - Other Current and Long-Term Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherCurrentandLongTermAssetsScheduleofOtherCurrentAssetsDetails" roleURI="http://www.idexx.com/role/OtherCurrentandLongTermAssetsScheduleofOtherCurrentAssetsDetails">
        <link:definition>240474030 - Disclosure - Other Current and Long-Term Assets (Schedule of Other Current Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherCurrentandLongTermAssetsScheduleofOtherNoncurrentAssetsDetails" roleURI="http://www.idexx.com/role/OtherCurrentandLongTermAssetsScheduleofOtherNoncurrentAssetsDetails">
        <link:definition>240484031 - Disclosure - Other Current and Long-Term Assets (Schedule of Other Noncurrent Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNet" roleURI="http://www.idexx.com/role/GoodwillandIntangibleAssetsNet">
        <link:definition>210491011 - Disclosure - Goodwill and Intangible Assets, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNetTables" roleURI="http://www.idexx.com/role/GoodwillandIntangibleAssetsNetTables">
        <link:definition>230503007 - Disclosure - Goodwill and Intangible Assets, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNetNarrativeDetails" roleURI="http://www.idexx.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails">
        <link:definition>240514032 - Disclosure - Goodwill and Intangible Assets, Net (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails" roleURI="http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails">
        <link:definition>240524033 - Disclosure - Goodwill and Intangible Assets, Net (Schedule of Goodwill) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNetScheduleofEstimatedUsefulLivesForIntangibleAssetsDetails" roleURI="http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofEstimatedUsefulLivesForIntangibleAssetsDetails">
        <link:definition>240534034 - Disclosure - Goodwill and Intangible Assets, Net (Schedule of Estimated Useful Lives For Intangible Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNetScheduleofIntangibleAssetsOtherThanGoodwillDetails" roleURI="http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofIntangibleAssetsOtherThanGoodwillDetails">
        <link:definition>240544035 - Disclosure - Goodwill and Intangible Assets, Net (Schedule of Intangible Assets Other Than Goodwill) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNetScheduleofExpectedAmortizationExpenseDetails" roleURI="http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofExpectedAmortizationExpenseDetails">
        <link:definition>240554036 - Disclosure - Goodwill and Intangible Assets, Net (Schedule of Expected Amortization Expense) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedLiabilitiesandOtherLongTermLiabilities" roleURI="http://www.idexx.com/role/AccruedLiabilitiesandOtherLongTermLiabilities">
        <link:definition>210561012 - Disclosure - Accrued Liabilities and Other Long Term Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedLiabilitiesandOtherLongTermLiabilitiesTables" roleURI="http://www.idexx.com/role/AccruedLiabilitiesandOtherLongTermLiabilitiesTables">
        <link:definition>230573008 - Disclosure - Accrued Liabilities and Other Long Term Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedLiabilitiesandOtherLongTermLiabilitiesScheduleofAccruedLiabilitiesDetails" roleURI="http://www.idexx.com/role/AccruedLiabilitiesandOtherLongTermLiabilitiesScheduleofAccruedLiabilitiesDetails">
        <link:definition>240584037 - Disclosure - Accrued Liabilities and Other Long Term Liabilities (Schedule of Accrued Liabilities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedLiabilitiesandOtherLongTermLiabilitiesScheduleofLongTermAccruedLiabilitiesDetails" roleURI="http://www.idexx.com/role/AccruedLiabilitiesandOtherLongTermLiabilitiesScheduleofLongTermAccruedLiabilitiesDetails">
        <link:definition>240594038 - Disclosure - Accrued Liabilities and Other Long Term Liabilities (Schedule of Long Term Accrued Liabilities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debt" roleURI="http://www.idexx.com/role/Debt">
        <link:definition>210601013 - Disclosure - Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtTables" roleURI="http://www.idexx.com/role/DebtTables">
        <link:definition>230613009 - Disclosure - Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtNarrativeDetails" roleURI="http://www.idexx.com/role/DebtNarrativeDetails">
        <link:definition>240624039 - Disclosure - Debt (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtScheduleofSeniorNoteBorrowingsDetails" roleURI="http://www.idexx.com/role/DebtScheduleofSeniorNoteBorrowingsDetails">
        <link:definition>240634040 - Disclosure - Debt (Schedule of Senior Note Borrowings) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtScheduleofAnnualPrincipalPaymentsonLongTermDebtDetails" roleURI="http://www.idexx.com/role/DebtScheduleofAnnualPrincipalPaymentsonLongTermDebtDetails">
        <link:definition>240644041 - Disclosure - Debt (Schedule of Annual Principal Payments on Long-Term Debt) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.idexx.com/role/IncomeTaxes">
        <link:definition>210651014 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.idexx.com/role/IncomeTaxesTables">
        <link:definition>230663010 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofEarningsBeforeIncomeTaxesDetails" roleURI="http://www.idexx.com/role/IncomeTaxesScheduleofEarningsBeforeIncomeTaxesDetails">
        <link:definition>240674042 - Disclosure - Income Taxes (Schedule of Earnings Before Income Taxes) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofComponentsofProvisionBenefitforIncomeTaxesDetails" roleURI="http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofProvisionBenefitforIncomeTaxesDetails">
        <link:definition>240684043 - Disclosure - Income Taxes (Schedule of Components of Provision (Benefit) for Income Taxes) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails" roleURI="http://www.idexx.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails">
        <link:definition>240694044 - Disclosure - Income Taxes (Schedule of Effective Income Tax Rate Reconciliation) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://www.idexx.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>240704045 - Disclosure - Income Taxes (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofComponentsofNetDeferredTaxAssetsandLiabilitiesDetails" roleURI="http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofNetDeferredTaxAssetsandLiabilitiesDetails">
        <link:definition>240714046 - Disclosure - Income Taxes (Schedule of Components of Net Deferred Tax Assets and Liabilities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofValuationAllowanceForDeferredTaxAssetsDetails" roleURI="http://www.idexx.com/role/IncomeTaxesScheduleofValuationAllowanceForDeferredTaxAssetsDetails">
        <link:definition>240724047 - Disclosure - Income Taxes (Schedule of Valuation Allowance For Deferred Tax Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofChangesinUnrecognizedTaxBenefitsDetails" roleURI="http://www.idexx.com/role/IncomeTaxesScheduleofChangesinUnrecognizedTaxBenefitsDetails">
        <link:definition>240734048 - Disclosure - Income Taxes (Schedule of Changes in Unrecognized Tax Benefits) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShare" roleURI="http://www.idexx.com/role/EarningsPerShare">
        <link:definition>210741015 - Disclosure - Earnings Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareTables" roleURI="http://www.idexx.com/role/EarningsPerShareTables">
        <link:definition>230753011 - Disclosure - Earnings Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareReconciliationofSharesOutstandingDetails" roleURI="http://www.idexx.com/role/EarningsPerShareReconciliationofSharesOutstandingDetails">
        <link:definition>240764049 - Disclosure - Earnings Per Share (Reconciliation of Shares Outstanding) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareScheduleofNumberofAntiDilutiveStockOptionsDetails" roleURI="http://www.idexx.com/role/EarningsPerShareScheduleofNumberofAntiDilutiveStockOptionsDetails">
        <link:definition>240774050 - Disclosure - Earnings Per Share (Schedule of Number of Anti-Dilutive Stock Options) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsContingenciesandGuarantees" roleURI="http://www.idexx.com/role/CommitmentsContingenciesandGuarantees">
        <link:definition>210781016 - Disclosure - Commitments, Contingencies and Guarantees</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsContingenciesandGuaranteesNarrativeDetails" roleURI="http://www.idexx.com/role/CommitmentsContingenciesandGuaranteesNarrativeDetails">
        <link:definition>240794051 - Disclosure - Commitments, Contingencies and Guarantees (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReporting" roleURI="http://www.idexx.com/role/SegmentReporting">
        <link:definition>210801017 - Disclosure - Segment Reporting</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingTables" roleURI="http://www.idexx.com/role/SegmentReportingTables">
        <link:definition>230813012 - Disclosure - Segment Reporting (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingNarrativeDetails" roleURI="http://www.idexx.com/role/SegmentReportingNarrativeDetails">
        <link:definition>240824052 - Disclosure - Segment Reporting (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingSummaryofSegmentPerformanceDetails" roleURI="http://www.idexx.com/role/SegmentReportingSummaryofSegmentPerformanceDetails">
        <link:definition>240834053 - Disclosure - Segment Reporting (Summary of Segment Performance) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingScheduleofNetLongLivedAssetsbyPrincipalGeographicAreasDetails" roleURI="http://www.idexx.com/role/SegmentReportingScheduleofNetLongLivedAssetsbyPrincipalGeographicAreasDetails">
        <link:definition>240844054 - Disclosure - Segment Reporting (Schedule of Net Long-Lived Assets by Principal Geographic Areas) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.idexx.com/role/FairValueMeasurements">
        <link:definition>210851018 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.idexx.com/role/FairValueMeasurementsTables">
        <link:definition>230863013 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsNarrativeDetails" roleURI="http://www.idexx.com/role/FairValueMeasurementsNarrativeDetails">
        <link:definition>240874055 - Disclosure - Fair Value Measurements (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsScheduleofFairValueofAssetsandLiabilitiesMeasuredonRecurringBasisDetails" roleURI="http://www.idexx.com/role/FairValueMeasurementsScheduleofFairValueofAssetsandLiabilitiesMeasuredonRecurringBasisDetails">
        <link:definition>240884056 - Disclosure - Fair Value Measurements (Schedule of Fair Value of Assets and Liabilities Measured on Recurring Basis) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsScheduleofContingentConsiderationLiabilityDetails" roleURI="http://www.idexx.com/role/FairValueMeasurementsScheduleofContingentConsiderationLiabilityDetails">
        <link:definition>240894057 - Disclosure - Fair Value Measurements (Schedule of Contingent Consideration Liability) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingInstruments" roleURI="http://www.idexx.com/role/HedgingInstruments">
        <link:definition>210901019 - Disclosure - Hedging Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingInstrumentsTables" roleURI="http://www.idexx.com/role/HedgingInstrumentsTables">
        <link:definition>230913014 - Disclosure - Hedging Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingInstrumentsNarrativeDetails" roleURI="http://www.idexx.com/role/HedgingInstrumentsNarrativeDetails">
        <link:definition>240924058 - Disclosure - Hedging Instruments (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingInstrumentsDerivativesDesignatedinCashFlowHedgingRelationshipsDetails" roleURI="http://www.idexx.com/role/HedgingInstrumentsDerivativesDesignatedinCashFlowHedgingRelationshipsDetails">
        <link:definition>240934059 - Disclosure - Hedging Instruments (Derivatives Designated in Cash Flow Hedging Relationships) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingInstrumentsScheduleofFairValuesandBalanceSheetClassificationsofDerivativesandNonderivativesDesignatedasHedgingInstrumentsDetails" roleURI="http://www.idexx.com/role/HedgingInstrumentsScheduleofFairValuesandBalanceSheetClassificationsofDerivativesandNonderivativesDesignatedasHedgingInstrumentsDetails">
        <link:definition>240944060 - Disclosure - Hedging Instruments (Schedule of Fair Values and Balance Sheet Classifications of Derivatives and Non-derivatives Designated as Hedging Instruments) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RepurchasesofCommonStock" roleURI="http://www.idexx.com/role/RepurchasesofCommonStock">
        <link:definition>210951020 - Disclosure - Repurchases of Common Stock</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RepurchasesofCommonStockTables" roleURI="http://www.idexx.com/role/RepurchasesofCommonStockTables">
        <link:definition>230963015 - Disclosure - Repurchases of Common Stock (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RepurchasesofCommonStockDetails" roleURI="http://www.idexx.com/role/RepurchasesofCommonStockDetails">
        <link:definition>240974061 - Disclosure - Repurchases of Common Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncome" roleURI="http://www.idexx.com/role/AccumulatedOtherComprehensiveIncome">
        <link:definition>210981021 - Disclosure - Accumulated Other Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncomeTables" roleURI="http://www.idexx.com/role/AccumulatedOtherComprehensiveIncomeTables">
        <link:definition>230993016 - Disclosure - Accumulated Other Comprehensive Income (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncomeScheduleofAccumulatedOtherComprehensiveIncomeDetails" roleURI="http://www.idexx.com/role/AccumulatedOtherComprehensiveIncomeScheduleofAccumulatedOtherComprehensiveIncomeDetails">
        <link:definition>241004062 - Disclosure - Accumulated Other Comprehensive Income (Schedule of Accumulated Other Comprehensive Income) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncomeScheduleofReclassificationsoutofAccumulatedOtherComprehensiveIncomeDetails" roleURI="http://www.idexx.com/role/AccumulatedOtherComprehensiveIncomeScheduleofReclassificationsoutofAccumulatedOtherComprehensiveIncomeDetails">
        <link:definition>241014063 - Disclosure - Accumulated Other Comprehensive Income (Schedule of Reclassifications out of Accumulated Other Comprehensive Income) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PreferredStock" roleURI="http://www.idexx.com/role/PreferredStock">
        <link:definition>211021022 - Disclosure - Preferred Stock</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PreferredStockDetails" roleURI="http://www.idexx.com/role/PreferredStockDetails">
        <link:definition>241034064 - Disclosure - Preferred Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IDEXXRetirementandIncentiveSavingsPlan" roleURI="http://www.idexx.com/role/IDEXXRetirementandIncentiveSavingsPlan">
        <link:definition>211041023 - Disclosure - IDEXX Retirement and Incentive Savings Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IDEXXRetirementandIncentiveSavingsPlanDetails" roleURI="http://www.idexx.com/role/IDEXXRetirementandIncentiveSavingsPlanDetails">
        <link:definition>241054065 - Disclosure - IDEXX Retirement and Incentive Savings Plan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="idxx_PaymentsToAcquireIntangibleAssetsAndEquityMethodInvestments" abstract="false" name="PaymentsToAcquireIntangibleAssetsAndEquityMethodInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="idxx_TreasuryStockValueAcquiredCostMethodNetOfTaxWithholdings" abstract="false" name="TreasuryStockValueAcquiredCostMethodNetOfTaxWithholdings" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="idxx_DeferredCompensationMember" abstract="false" name="DeferredCompensationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_A2022SeriesANotesMember" abstract="true" name="A2022SeriesANotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleIncludingPortionAttributableToNoncontrollingInterestMember" abstract="true" name="AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleIncludingPortionAttributableToNoncontrollingInterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_RestrictedStockUnitsExpectedToVestReducedForEstimatedForfeituresMember" abstract="false" name="RestrictedStockUnitsExpectedToVestReducedForEstimatedForfeituresMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_ExtendedWarrantiesAndPostContractSupportMember" abstract="false" name="ExtendedWarrantiesAndPostContractSupportMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_PostContractSupportContractTerm" abstract="false" name="PostContractSupportContractTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="idxx_SummaryOfSignificantAccountingPoliciesLineItems" abstract="true" name="SummaryOfSignificantAccountingPoliciesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="idxx_UpFrontCustomerLoyaltyProgramsAndVolumeCommitmentProgramsMember" abstract="false" name="UpFrontCustomerLoyaltyProgramsAndVolumeCommitmentProgramsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_OperatingLeaseLeaseNotyetCommencedExpense" abstract="false" name="OperatingLeaseLeaseNotyetCommencedExpense" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="idxx_SummaryOfDepreciationAndAmortizationCapitalizedComputerSoftwareForInternalUseAndUnpaidPropertyEquipmentReflectedInAccountPayableAndAccruedExpensesTableTextBlock" abstract="false" name="SummaryOfDepreciationAndAmortizationCapitalizedComputerSoftwareForInternalUseAndUnpaidPropertyEquipmentReflectedInAccountPayableAndAccruedExpensesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="idxx_WeightedAverageSharesOutstandingAbstract" abstract="true" name="WeightedAverageSharesOutstandingAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="idxx_ConsolidatedLeverageRatioUnderCreditFacilityNotePayable" abstract="false" name="ConsolidatedLeverageRatioUnderCreditFacilityNotePayable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="idxx_A2022SeriesANotesand2027SeriesBNotesMember" abstract="true" name="A2022SeriesANotesand2027SeriesBNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_NineteenNinetySevenEmployeeStockPurchasePlanMember" abstract="false" name="NineteenNinetySevenEmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_TreasuryStockSharesAcquiredNetOfTaxWithholdings" abstract="false" name="TreasuryStockSharesAcquiredNetOfTaxWithholdings" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="idxx_ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock" abstract="false" name="ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="idxx_LineofCreditFacilityAccordionFeatureIncreaseLimit" abstract="false" name="LineofCreditFacilityAccordionFeatureIncreaseLimit" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="idxx_A2023SeriesANotesMember" abstract="true" name="A2023SeriesANotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_OperatingExpensesMember" abstract="false" name="OperatingExpensesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_A2027SeriesBNotesMember" abstract="true" name="A2027SeriesBNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_TaxesRemittedToGovernmentalAuthoritiesOnBehalfOfCustomerPolicyTextBlock" abstract="false" name="TaxesRemittedToGovernmentalAuthoritiesOnBehalfOfCustomerPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="idxx_AccountsReceivablePercentPastDue" abstract="false" name="AccountsReceivablePercentPastDue" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="idxx_VetLabConsumablesMember" abstract="false" name="VetLabConsumablesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossAfterReclassificationAndTax" abstract="false" name="OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossAfterReclassificationAndTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="idxx_SalesTypeLeaseLeaseReceivableReclassifiedToReceivable" abstract="false" name="SalesTypeLeaseLeaseReceivableReclassifiedToReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="idxx_ContractwithCustomerAssetAndSalesTypeLeaseNetInvestmentInLeaseAllowanceforCreditLoss" abstract="false" name="ContractwithCustomerAssetAndSalesTypeLeaseNetInvestmentInLeaseAllowanceforCreditLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="idxx_PaymentRequiredUponTerminationOfEmploymentDomain" abstract="false" name="PaymentRequiredUponTerminationOfEmploymentDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_ConcentrationRiskPolicyTextBlock" abstract="false" name="ConcentrationRiskPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="idxx_PaymentRequiredToCeoUponTerminationOfEmploymentWithoutCauseOtherThanFollowingChangeInControlMember" abstract="false" name="PaymentRequiredToCeoUponTerminationOfEmploymentWithoutCauseOtherThanFollowingChangeInControlMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_CrossCurrencyInterestRateContract1Member" abstract="true" name="CrossCurrencyInterestRateContract1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_SoftwareDevelopedForInternalUseMember" abstract="false" name="SoftwareDevelopedForInternalUseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_IssuanceVestingAndSettlementOfDeferredStockUnits" abstract="false" name="IssuanceVestingAndSettlementOfDeferredStockUnits" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="idxx_SegmentsOfGoodwillLineItems" abstract="true" name="SegmentsOfGoodwillLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="idxx_RetirementAndIncentiveSavingsPlanAxis" abstract="true" name="RetirementAndIncentiveSavingsPlanAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="idxx_TwoThousandEighteenStockIncentivePlanMember" abstract="true" name="TwoThousandEighteenStockIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_DeferredTaxAssetsValuationAllowanceChargesToCostsAndExpense" abstract="false" name="DeferredTaxAssetsValuationAllowanceChargesToCostsAndExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="idxx_A2023SeriesANotesAnd2025SeriesBNotesMember" abstract="true" name="A2023SeriesANotesAnd2025SeriesBNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_RestrictedStockUnitsGrantedToEmployeesWithRatableVestingMember" abstract="false" name="RestrictedStockUnitsGrantedToEmployeesWithRatableVestingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_PaymentRequiredUponTerminationOfEmploymentLineItems" abstract="true" name="PaymentRequiredUponTerminationOfEmploymentLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="idxx_AllocatedShareBasedCompensationExpenseNetOfTaxExcludingTaxBenefitFromSettlementOfShareBasedAwards" abstract="false" name="AllocatedShareBasedCompensationExpenseNetOfTaxExcludingTaxBenefitFromSettlementOfShareBasedAwards" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="idxx_ReferenceLaboratoryinMidWestUnitedStatesMember" abstract="true" name="ReferenceLaboratoryinMidWestUnitedStatesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_StockOptionsAndStockAppreciationRightsMember" abstract="false" name="StockOptionsAndStockAppreciationRightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_DeferredTaxAssetsIntangibleAssetsBasisDifference" abstract="false" name="DeferredTaxAssetsIntangibleAssetsBasisDifference" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="idxx_RatioSharesIssuedUnderShareBasedAwardsToSharesAuthorizedUnderStockPlans" abstract="false" name="RatioSharesIssuedUnderShareBasedAwardsToSharesAuthorizedUnderStockPlans" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="idxx_CashFlowHedgeHedgePercentageOfEstimatedExposureFromIntercompanyProductsPurchasesAndSales" abstract="false" name="CashFlowHedgeHedgePercentageOfEstimatedExposureFromIntercompanyProductsPurchasesAndSales" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="idxx_PaymentRequiredUponTerminationOfEmploymentTable" abstract="true" name="PaymentRequiredUponTerminationOfEmploymentTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="idxx_CAGDiagnosticCapitalVetlabInstrumentsMember" abstract="false" name="CAGDiagnosticCapitalVetlabInstrumentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_RetirementAndIncentiveSavingsPlanLineItems" abstract="true" name="RetirementAndIncentiveSavingsPlanLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="idxx_OtherAsiaPacificMember" abstract="false" name="OtherAsiaPacificMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_DeferredStockUnitsMember" abstract="false" name="DeferredStockUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_RevenuePerformanceObligationPaymentTerm" abstract="false" name="RevenuePerformanceObligationPaymentTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="idxx_ExtendedProductWarrantyTerm" abstract="false" name="ExtendedProductWarrantyTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="idxx_AccountsReceivablePercentNotPastDue" abstract="false" name="AccountsReceivablePercentNotPastDue" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="idxx_DeferredTaxAssetsValuationAllowanceRollForward" abstract="true" name="DeferredTaxAssetsValuationAllowanceRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="idxx_BusinessCombinationsTangibleLiabilities" abstract="false" name="BusinessCombinationsTangibleLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax" abstract="false" name="OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="idxx_A2029SeriesCNotesMember" abstract="true" name="A2029SeriesCNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_RetirementAndIncentiveSavingsPlanDomain" abstract="false" name="RetirementAndIncentiveSavingsPlanDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_WaterSegmentMember" abstract="false" name="WaterSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_ResearchAndDevelopmentCostsCapitalized" abstract="false" name="ResearchAndDevelopmentCostsCapitalized" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="idxx_CompanionAnimalGroupSegmentMember" abstract="false" name="CompanionAnimalGroupSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax" abstract="false" name="OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="idxx_ShareBasedCompensationTable" abstract="true" name="ShareBasedCompensationTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="idxx_AccumulatedNetGainLossFromCashFlowHedgesForeignCurrencyExchangeContractsIncludingPortionAttributableToNoncontrollingInterestMember" abstract="true" name="AccumulatedNetGainLossFromCashFlowHedgesForeignCurrencyExchangeContractsIncludingPortionAttributableToNoncontrollingInterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_MetLife2030SeriesDNotesMember" abstract="true" name="MetLife2030SeriesDNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_TreasuryStockAcquiredAverageCostPerShareOpenMarketRepurchase" abstract="false" name="TreasuryStockAcquiredAverageCostPerShareOpenMarketRepurchase" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="idxx_Prudential2030SeriesDNotesMember" abstract="true" name="Prudential2030SeriesDNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_ReagentRentalProgramsMember" abstract="false" name="ReagentRentalProgramsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_CAGDiagnosticsRecurringRevenueMember" abstract="false" name="CAGDiagnosticsRecurringRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_AsiaPacificRegionOtherMember" abstract="true" name="AsiaPacificRegionOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_TreasuryStockAcquiredAverageCostPerShareEmployeeSurrenders" abstract="false" name="TreasuryStockAcquiredAverageCostPerShareEmployeeSurrenders" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="idxx_SeriesCSeniorNoteMember" abstract="false" name="SeriesCSeniorNoteMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_RetainedClaimLiabilityPerIncident" abstract="false" name="RetainedClaimLiabilityPerIncident" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="idxx_ReferenceLaboratoryDiagnosticAndConsultingServicesMember" abstract="false" name="ReferenceLaboratoryDiagnosticAndConsultingServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_LesseeOperatingLeaseTerminationPeriod" abstract="false" name="LesseeOperatingLeaseTerminationPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="idxx_EuropetheMiddleEastandAfricaOtherMember" abstract="true" name="EuropetheMiddleEastandAfricaOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_BusinessCombinationContingentConsiderationHoldback" abstract="false" name="BusinessCombinationContingentConsiderationHoldback" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="idxx_StockOptionsGrantedToEmployeesWithRatableVestingMember" abstract="false" name="StockOptionsGrantedToEmployeesWithRatableVestingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_DeferredTaxAssetsValuationAllowanceWriteOffCashPayments" abstract="false" name="DeferredTaxAssetsValuationAllowanceWriteOffCashPayments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="idxx_LatinAmericaAndCaribbeanMember" abstract="true" name="LatinAmericaAndCaribbeanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_ProductRightsMember" abstract="false" name="ProductRightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_ReferenceLaboratoryMember" abstract="true" name="ReferenceLaboratoryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_ComputerHardwareAndSoftwareMember" abstract="false" name="ComputerHardwareAndSoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_ForeignCurrencyBorrowingsDesignatedAsNetInvestmentHedgeOnBalanceSheetMember" abstract="false" name="ForeignCurrencyBorrowingsDesignatedAsNetInvestmentHedgeOnBalanceSheetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_SummaryOfSignificantAccountingPoliciesTable" abstract="true" name="SummaryOfSignificantAccountingPoliciesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="idxx_A2025SeriesBNotesMember" abstract="true" name="A2025SeriesBNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_ContingentPaymentMember" abstract="true" name="ContingentPaymentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_EffectiveIncomeTaxRateReconciliationSwitzerlandTaxReformEffectPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationSwitzerlandTaxReformEffectPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="idxx_PaymentRequiredUponTerminationOfEmploymentAxis" abstract="true" name="PaymentRequiredUponTerminationOfEmploymentAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="idxx_PaymentRequiredToOfficersUponTerminationOfEmploymentFollowingChangeOfControlMember" abstract="false" name="PaymentRequiredToOfficersUponTerminationOfEmploymentFollowingChangeOfControlMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_RapidAssayProductsMember" abstract="false" name="RapidAssayProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_DeferredTaxAssetsValuationAllowanceForeignCurrencyTranslation" abstract="false" name="DeferredTaxAssetsValuationAllowanceForeignCurrencyTranslation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="idxx_LineofCreditFacilityAccordionFeatureHigherBorrowingCapacityOption" abstract="false" name="LineofCreditFacilityAccordionFeatureHigherBorrowingCapacityOption" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="idxx_EzyVetMember" abstract="true" name="EzyVetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_CAGDiagnosticsServiceAndAccessoriesMember" abstract="false" name="CAGDiagnosticsServiceAndAccessoriesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_AccumulatedNetGainLossFromNetInvestmentHedgesCrossCurrencySwapsIncludingPortionAttributableToNoncontrollingInterestMember" abstract="true" name="AccumulatedNetGainLossFromNetInvestmentHedgesCrossCurrencySwapsIncludingPortionAttributableToNoncontrollingInterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_A2024SeriesBNotesMember" abstract="true" name="A2024SeriesBNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_UpFrontCustomerLoyaltyProgramsMember" abstract="false" name="UpFrontCustomerLoyaltyProgramsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_AwardsOtherThanStockOptionsAndStockAppreciationRightsMember" abstract="false" name="AwardsOtherThanStockOptionsAndStockAppreciationRightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_ScheduleOfEstimatedUsefulLivesForIntangibleAssetsTableTextBlock" abstract="false" name="ScheduleOfEstimatedUsefulLivesForIntangibleAssetsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="idxx_FinancialAssetGreaterThan60DaysPastDueMember" abstract="true" name="FinancialAssetGreaterThan60DaysPastDueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_VolumeCommitmentProgramsMember" abstract="false" name="VolumeCommitmentProgramsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_A2026SeniorNotesMember" abstract="true" name="A2026SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_VeterinarySoftwareServicesAndDiagnosticImagingSystemsMember" abstract="false" name="VeterinarySoftwareServicesAndDiagnosticImagingSystemsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationTax" abstract="false" name="OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="idxx_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome" abstract="false" name="EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="idxx_SaasSubscriptionTermOfContract" abstract="false" name="SaasSubscriptionTermOfContract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="idxx_RevolvingCreditFacilityIndividualBorrowingsMember" abstract="true" name="RevolvingCreditFacilityIndividualBorrowingsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_AuditInformationAbstract" abstract="true" name="AuditInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="idxx_NoncontrollingInterestOwnershipPercentageAcquiredFromNoncontrollingOwners" abstract="false" name="NoncontrollingInterestOwnershipPercentageAcquiredFromNoncontrollingOwners" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="idxx_FourZeroOneKPlanMember" abstract="false" name="FourZeroOneKPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_OtherSegmentMember" abstract="false" name="OtherSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_TeleradiologyBusinessMember" abstract="true" name="TeleradiologyBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_LivestockAndPoultryDiagnosticsSegmentMember" abstract="false" name="LivestockAndPoultryDiagnosticsSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_EquityMutualFundsMember" abstract="false" name="EquityMutualFundsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_A2025SeriesCNotesMember" abstract="true" name="A2025SeriesCNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_A2021SeriesANotesMember" abstract="true" name="A2021SeriesANotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationTax" abstract="false" name="OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="idxx_A2021SeriesANotesAnd2024SeriesBNotesMember" abstract="true" name="A2021SeriesANotesAnd2024SeriesBNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_BusinessCombinationContingentConsiderationLiabilityAndHoldback" abstract="false" name="BusinessCombinationContingentConsiderationLiabilityAndHoldback" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="idxx_SegmentsOfGoodwillTable" abstract="true" name="SegmentsOfGoodwillTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="idxx_RatioOfDeferredStockUnitsToSharesOfCommonStock" abstract="false" name="RatioOfDeferredStockUnitsToSharesOfCommonStock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="idxx_BusinessCombinationContingencyFairValue" abstract="false" name="BusinessCombinationContingencyFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="idxx_InstrumentRebateProgramsMember" abstract="false" name="InstrumentRebateProgramsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_AccumulatedNetGainLossFromNetInvestmentHedgesEuroDenominatedNotesIncludingPortionAttributableToNoncontrollingInterestMember" abstract="true" name="AccumulatedNetGainLossFromNetInvestmentHedgesEuroDenominatedNotesIncludingPortionAttributableToNoncontrollingInterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="idxx_RetirementAndIncentiveSavingsPlanTable" abstract="true" name="RetirementAndIncentiveSavingsPlanTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="idxx_EmployeeHealthCareInsurancePolicyMember" abstract="false" name="EmployeeHealthCareInsurancePolicyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>28
<FILENAME>idxx-20211231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:f52bcaef-ba11-42ce-aefc-0c16e0e0e054,g:8ec733b7-1a7e-4401-9212-15a98e503c1c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="idxx-20211231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_3fd4d57e-6996-43ac-a2d4-685b73a4975e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_efa8e52e-5edb-41d4-89a7-7c6b4a65aab3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_3fd4d57e-6996-43ac-a2d4-685b73a4975e" xlink:to="loc_us-gaap_CommonStockValue_efa8e52e-5edb-41d4-89a7-7c6b4a65aab3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_69b15035-f6fd-4824-b5ef-f90b545daa61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_3fd4d57e-6996-43ac-a2d4-685b73a4975e" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_69b15035-f6fd-4824-b5ef-f90b545daa61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockOtherValueOutstanding_ba1e01df-5ec4-44d2-b91b-0977e9b8c333" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockOtherValueOutstanding"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_3fd4d57e-6996-43ac-a2d4-685b73a4975e" xlink:to="loc_us-gaap_CommonStockOtherValueOutstanding_ba1e01df-5ec4-44d2-b91b-0977e9b8c333" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_44998351-3b54-4a1b-9182-197b9345838c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_3fd4d57e-6996-43ac-a2d4-685b73a4975e" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_44998351-3b54-4a1b-9182-197b9345838c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_af905eff-62ba-4161-8ac6-6e8a12283864" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_3fd4d57e-6996-43ac-a2d4-685b73a4975e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_af905eff-62ba-4161-8ac6-6e8a12283864" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_f984ccd1-9307-4341-8607-4b031799a431" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_3fd4d57e-6996-43ac-a2d4-685b73a4975e" xlink:to="loc_us-gaap_TreasuryStockValue_f984ccd1-9307-4341-8607-4b031799a431" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_cde9010f-97db-455d-8427-da028392b090" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_c0025c3b-0202-45de-98ca-5f19edee7497" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_cde9010f-97db-455d-8427-da028392b090" xlink:to="loc_us-gaap_LiabilitiesCurrent_c0025c3b-0202-45de-98ca-5f19edee7497" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_817842c3-b106-4e43-9a4f-d1e7a4776bfb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_cde9010f-97db-455d-8427-da028392b090" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_817842c3-b106-4e43-9a4f-d1e7a4776bfb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_edf25d52-0f99-47a6-877f-86ec6780b481" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_bcb0f2e8-c79f-4671-9751-02c9fdd1dd32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_edf25d52-0f99-47a6-877f-86ec6780b481" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_bcb0f2e8-c79f-4671-9751-02c9fdd1dd32" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_daa3eedc-f6d7-40ff-8bf2-ac87373013f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_edf25d52-0f99-47a6-877f-86ec6780b481" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_daa3eedc-f6d7-40ff-8bf2-ac87373013f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_26fc0717-7da7-4595-a165-c28e36e67388" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_edf25d52-0f99-47a6-877f-86ec6780b481" xlink:to="loc_us-gaap_InventoryNet_26fc0717-7da7-4595-a165-c28e36e67388" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_964cafb8-ce72-453b-8b35-32eeb1ed10c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_edf25d52-0f99-47a6-877f-86ec6780b481" xlink:to="loc_us-gaap_OtherAssetsCurrent_964cafb8-ce72-453b-8b35-32eeb1ed10c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_7a20c49a-4ee3-4a9c-9dba-497ee2fa0cbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_bb024645-4ecb-42fe-ab8b-2c8a295598f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_7a20c49a-4ee3-4a9c-9dba-497ee2fa0cbd" xlink:to="loc_us-gaap_AssetsCurrent_bb024645-4ecb-42fe-ab8b-2c8a295598f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_e28302b3-8d1c-4d1e-b90e-54a18bc99911" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_7a20c49a-4ee3-4a9c-9dba-497ee2fa0cbd" xlink:to="loc_us-gaap_AssetsNoncurrent_e28302b3-8d1c-4d1e-b90e-54a18bc99911" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_fb99348d-d656-43d0-b67c-9765a366c43d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_d3de1a15-f676-465e-805b-ff8f880bd76e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_fb99348d-d656-43d0-b67c-9765a366c43d" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_d3de1a15-f676-465e-805b-ff8f880bd76e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_e9e0c910-3f33-4506-adf8-1a55f607cbaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_fb99348d-d656-43d0-b67c-9765a366c43d" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_e9e0c910-3f33-4506-adf8-1a55f607cbaa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_9ce3ea3b-5c8b-4955-b4bf-e051f14ffcb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_fb99348d-d656-43d0-b67c-9765a366c43d" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_9ce3ea3b-5c8b-4955-b4bf-e051f14ffcb1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_19b0a423-0ac2-4aac-8d68-c068cc89610a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_fb99348d-d656-43d0-b67c-9765a366c43d" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_19b0a423-0ac2-4aac-8d68-c068cc89610a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_dd7a6174-ec76-48fc-b7a1-bab0dff706e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_fb99348d-d656-43d0-b67c-9765a366c43d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_dd7a6174-ec76-48fc-b7a1-bab0dff706e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_3840f924-767c-47e0-9579-c6e2c51ff31f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_3bc9a085-41c3-4fb8-8fdc-fa64bf00a2dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_3840f924-767c-47e0-9579-c6e2c51ff31f" xlink:to="loc_us-gaap_AccountsPayableCurrent_3bc9a085-41c3-4fb8-8fdc-fa64bf00a2dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_6a6a006e-033c-4d81-9252-0c09ea35d06c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_3840f924-767c-47e0-9579-c6e2c51ff31f" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_6a6a006e-033c-4d81-9252-0c09ea35d06c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditCurrent_3367d873-5d21-4994-8282-354e81b3a3df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LinesOfCreditCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_3840f924-767c-47e0-9579-c6e2c51ff31f" xlink:to="loc_us-gaap_LinesOfCreditCurrent_3367d873-5d21-4994-8282-354e81b3a3df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_5faea8fa-9d8b-4238-865c-c0244ca32794" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_3840f924-767c-47e0-9579-c6e2c51ff31f" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_5faea8fa-9d8b-4238-865c-c0244ca32794" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_3a0f3481-a792-4a38-b8a3-919d6fa5b07f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_3840f924-767c-47e0-9579-c6e2c51ff31f" xlink:to="loc_us-gaap_LongTermDebtCurrent_3a0f3481-a792-4a38-b8a3-919d6fa5b07f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e510da56-b110-43f6-ae82-68d139ef2e9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d1a74a10-65c0-497b-bc77-9bd3451eafb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e510da56-b110-43f6-ae82-68d139ef2e9b" xlink:to="loc_us-gaap_StockholdersEquity_d1a74a10-65c0-497b-bc77-9bd3451eafb5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_808652ca-f132-481f-b9ec-4c284568d8f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e510da56-b110-43f6-ae82-68d139ef2e9b" xlink:to="loc_us-gaap_MinorityInterest_808652ca-f132-481f-b9ec-4c284568d8f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_df8604e5-caec-4a39-a566-e4c447968582" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_2fc3f853-4da1-4c13-84a4-82f25ec9eff6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_df8604e5-caec-4a39-a566-e4c447968582" xlink:to="loc_us-gaap_Liabilities_2fc3f853-4da1-4c13-84a4-82f25ec9eff6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_9993110f-0b6a-45f1-8b9b-261de49127f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_df8604e5-caec-4a39-a566-e4c447968582" xlink:to="loc_us-gaap_CommitmentsAndContingencies_9993110f-0b6a-45f1-8b9b-261de49127f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e826585d-e08b-453a-9088-1aa432ce7d2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_df8604e5-caec-4a39-a566-e4c447968582" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e826585d-e08b-453a-9088-1aa432ce7d2a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_b2a14895-a2da-487d-a9f5-c8f260cab111" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_37dee4ff-f2a7-44e0-82ea-7cf0e918798d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_b2a14895-a2da-487d-a9f5-c8f260cab111" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_37dee4ff-f2a7-44e0-82ea-7cf0e918798d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_ea5f50ed-e0e4-4739-9976-6a277bd397a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_b2a14895-a2da-487d-a9f5-c8f260cab111" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_ea5f50ed-e0e4-4739-9976-6a277bd397a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b4eafdd7-2bf8-489d-bf49-8ab2edbb47b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_b2a14895-a2da-487d-a9f5-c8f260cab111" xlink:to="loc_us-gaap_Goodwill_b4eafdd7-2bf8-489d-bf49-8ab2edbb47b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b1046564-2b55-47c5-ba40-1e8c707b4c37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_b2a14895-a2da-487d-a9f5-c8f260cab111" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b1046564-2b55-47c5-ba40-1e8c707b4c37" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_a70291de-4a90-4cc7-8089-ad66c74d86af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_b2a14895-a2da-487d-a9f5-c8f260cab111" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_a70291de-4a90-4cc7-8089-ad66c74d86af" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="simple" xlink:href="idxx-20211231.xsd#CONSOLIDATEDSTATEMENTSOFINCOME"/>
  <link:calculationLink xlink:role="http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d133b72d-c134-4447-987b-bdbbe58ad32e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_5c1d697f-6b76-4c66-a2be-bca04acd8af1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d133b72d-c134-4447-987b-bdbbe58ad32e" xlink:to="loc_us-gaap_OperatingIncomeLoss_5c1d697f-6b76-4c66-a2be-bca04acd8af1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_d37b0a94-edc1-4eea-84cd-cedae2848e67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d133b72d-c134-4447-987b-bdbbe58ad32e" xlink:to="loc_us-gaap_InterestExpense_d37b0a94-edc1-4eea-84cd-cedae2848e67" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndOtherIncome_ee2c2af9-a2d2-4a71-810b-035cc12421ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestAndOtherIncome"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d133b72d-c134-4447-987b-bdbbe58ad32e" xlink:to="loc_us-gaap_InterestAndOtherIncome_ee2c2af9-a2d2-4a71-810b-035cc12421ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_23fa2276-4f27-486d-9d2e-73e411bcb0b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_77e94e1f-703a-4577-a23b-4fd19ef1861e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_23fa2276-4f27-486d-9d2e-73e411bcb0b9" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_77e94e1f-703a-4577-a23b-4fd19ef1861e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_08f5164a-4b3f-41dd-b316-6f6c9ece518c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_23fa2276-4f27-486d-9d2e-73e411bcb0b9" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_08f5164a-4b3f-41dd-b316-6f6c9ece518c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6c5773b0-5ca7-4611-83a3-ce650a37cdfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_6dd1afa3-2d9e-4d5a-93b8-78aacf7fc39f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_6c5773b0-5ca7-4611-83a3-ce650a37cdfe" xlink:to="loc_us-gaap_ProfitLoss_6dd1afa3-2d9e-4d5a-93b8-78aacf7fc39f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_f8c22b5a-f9e5-4746-b29f-44d25260f949" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_6c5773b0-5ca7-4611-83a3-ce650a37cdfe" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_f8c22b5a-f9e5-4746-b29f-44d25260f949" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_6e40efc1-96b4-4151-a651-442fedb47b33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_539e315e-ccd4-41dc-a740-371d93a5421f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_6e40efc1-96b4-4151-a651-442fedb47b33" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_539e315e-ccd4-41dc-a740-371d93a5421f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_8224edf4-6c49-454b-8e2b-957e5b870a7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_6e40efc1-96b4-4151-a651-442fedb47b33" xlink:to="loc_us-gaap_CostOfRevenue_8224edf4-6c49-454b-8e2b-957e5b870a7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_1df2ce0a-aef1-4deb-9526-6087e11968e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_52f12dea-77f4-4f65-a788-bbb80420d933" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_1df2ce0a-aef1-4deb-9526-6087e11968e5" xlink:to="loc_us-gaap_GrossProfit_52f12dea-77f4-4f65-a788-bbb80420d933" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_cb5fe8a3-b64b-472f-a68d-46a2b0738ae2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_1df2ce0a-aef1-4deb-9526-6087e11968e5" xlink:to="loc_us-gaap_SellingAndMarketingExpense_cb5fe8a3-b64b-472f-a68d-46a2b0738ae2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_775f5802-9ce1-49e4-a0dc-6f825fea8778" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_1df2ce0a-aef1-4deb-9526-6087e11968e5" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_775f5802-9ce1-49e4-a0dc-6f825fea8778" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_51c89854-2d0c-42af-8269-db96c287f916" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_1df2ce0a-aef1-4deb-9526-6087e11968e5" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_51c89854-2d0c-42af-8269-db96c287f916" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="idxx-20211231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:calculationLink xlink:role="http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_d7ad93da-45c0-4938-93cb-9b54aa900b63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_42188d94-2a26-4083-b770-51970de98036" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_d7ad93da-45c0-4938-93cb-9b54aa900b63" xlink:to="loc_us-gaap_ProfitLoss_42188d94-2a26-4083-b770-51970de98036" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b507c40a-6855-45bf-9f2e-f24edc1e5ad3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_d7ad93da-45c0-4938-93cb-9b54aa900b63" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b507c40a-6855-45bf-9f2e-f24edc1e5ad3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossAfterReclassificationAndTax_82f2b8c5-9324-4184-a2d3-21b52b96b18d" xlink:href="idxx-20211231.xsd#idxx_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossAfterReclassificationAndTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_3e56a3ca-f7bc-4a37-92b8-58cd2bc6b8d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_idxx_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossAfterReclassificationAndTax_82f2b8c5-9324-4184-a2d3-21b52b96b18d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_3e56a3ca-f7bc-4a37-92b8-58cd2bc6b8d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax_41e9c654-e2c0-45ce-b490-8214b08c9c9a" xlink:href="idxx-20211231.xsd#idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_idxx_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossAfterReclassificationAndTax_82f2b8c5-9324-4184-a2d3-21b52b96b18d" xlink:to="loc_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax_41e9c654-e2c0-45ce-b490-8214b08c9c9a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_4c1814b8-41e5-4217-9e97-15608879e132" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_idxx_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossAfterReclassificationAndTax_82f2b8c5-9324-4184-a2d3-21b52b96b18d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_4c1814b8-41e5-4217-9e97-15608879e132" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_f9019228-6b2f-4193-8879-14a0da8ffd2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_0fd537f8-c8b2-4f8e-8bb4-6a65f57d2614" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_f9019228-6b2f-4193-8879-14a0da8ffd2b" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_0fd537f8-c8b2-4f8e-8bb4-6a65f57d2614" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_fcb0ffc0-58d0-4fff-b69d-0e47e1816a62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_f9019228-6b2f-4193-8879-14a0da8ffd2b" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_fcb0ffc0-58d0-4fff-b69d-0e47e1816a62" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7238d660-16b0-4675-9f2c-44f37a038757" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_c9fe5973-abba-4993-9b6b-735cef36b43e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7238d660-16b0-4675-9f2c-44f37a038757" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_c9fe5973-abba-4993-9b6b-735cef36b43e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax_cf189b19-6730-4847-b67f-1ed9a73591e1" xlink:href="idxx-20211231.xsd#idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7238d660-16b0-4675-9f2c-44f37a038757" xlink:to="loc_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax_cf189b19-6730-4847-b67f-1ed9a73591e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_e66a3e5f-98ce-470a-aa9e-4de6e35b34de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7238d660-16b0-4675-9f2c-44f37a038757" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_e66a3e5f-98ce-470a-aa9e-4de6e35b34de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossAfterReclassificationAndTax_54b4fbb3-084c-45f8-9061-0b3c2f8196d2" xlink:href="idxx-20211231.xsd#idxx_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7238d660-16b0-4675-9f2c-44f37a038757" xlink:to="loc_idxx_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossAfterReclassificationAndTax_54b4fbb3-084c-45f8-9061-0b3c2f8196d2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="idxx-20211231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_dc50833a-258b-4d05-838f-7a0fc88b55da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f664edf9-49c8-4a6b-b372-b94183637ad4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_dc50833a-258b-4d05-838f-7a0fc88b55da" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f664edf9-49c8-4a6b-b372-b94183637ad4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_265a0726-3854-48ac-9d00-20889833f40e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_dc50833a-258b-4d05-838f-7a0fc88b55da" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_265a0726-3854-48ac-9d00-20889833f40e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6394748b-ed83-4b7d-9243-1a3ab0c45995" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_dc50833a-258b-4d05-838f-7a0fc88b55da" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6394748b-ed83-4b7d-9243-1a3ab0c45995" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ac838ced-69d6-42cf-a9a1-3f226325e0af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_dc50833a-258b-4d05-838f-7a0fc88b55da" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ac838ced-69d6-42cf-a9a1-3f226325e0af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f8918400-e061-4d14-ae09-c434832cbdc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_PaymentsToAcquireIntangibleAssetsAndEquityMethodInvestments_554f2311-d698-47a2-b18c-22d531ad4e03" xlink:href="idxx-20211231.xsd#idxx_PaymentsToAcquireIntangibleAssetsAndEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f8918400-e061-4d14-ae09-c434832cbdc1" xlink:to="loc_idxx_PaymentsToAcquireIntangibleAssetsAndEquityMethodInvestments_554f2311-d698-47a2-b18c-22d531ad4e03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ba9a2d3d-aa8c-4b9c-af70-1cd1f347792f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f8918400-e061-4d14-ae09-c434832cbdc1" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ba9a2d3d-aa8c-4b9c-af70-1cd1f347792f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_699e2b53-86d2-477d-b899-5855b4d2d113" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f8918400-e061-4d14-ae09-c434832cbdc1" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_699e2b53-86d2-477d-b899-5855b4d2d113" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f2a83b05-5a09-4caa-8e8d-fce71bb36373" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_83921aef-1145-42b7-91ad-5616bd0ff91a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f2a83b05-5a09-4caa-8e8d-fce71bb36373" xlink:to="loc_us-gaap_ProfitLoss_83921aef-1145-42b7-91ad-5616bd0ff91a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_c52a726e-0d34-4e7c-b3ae-6cd25da1c128" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f2a83b05-5a09-4caa-8e8d-fce71bb36373" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_c52a726e-0d34-4e7c-b3ae-6cd25da1c128" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_e5b8c6bc-ef92-4ae1-9e1e-b083440aa463" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f2a83b05-5a09-4caa-8e8d-fce71bb36373" xlink:to="loc_us-gaap_AssetImpairmentCharges_e5b8c6bc-ef92-4ae1-9e1e-b083440aa463" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForLoanLeaseAndOtherLosses_0f5d335b-d352-4197-855b-248bff81c559" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForLoanLeaseAndOtherLosses"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f2a83b05-5a09-4caa-8e8d-fce71bb36373" xlink:to="loc_us-gaap_ProvisionForLoanLeaseAndOtherLosses_0f5d335b-d352-4197-855b-248bff81c559" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_b7f87f5a-763d-43c0-a4d4-5747c5d8dd25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f2a83b05-5a09-4caa-8e8d-fce71bb36373" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_b7f87f5a-763d-43c0-a4d4-5747c5d8dd25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_e611ae08-e4c3-4c28-9a0f-a693379d32d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f2a83b05-5a09-4caa-8e8d-fce71bb36373" xlink:to="loc_us-gaap_ShareBasedCompensation_e611ae08-e4c3-4c28-9a0f-a693379d32d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_275347be-51dd-4b7a-839f-b485461672ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f2a83b05-5a09-4caa-8e8d-fce71bb36373" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_275347be-51dd-4b7a-839f-b485461672ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_6791e908-e056-4d61-8ca8-c4b31ef2323f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f2a83b05-5a09-4caa-8e8d-fce71bb36373" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_6791e908-e056-4d61-8ca8-c4b31ef2323f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_dd747e1b-c0dc-4c47-a227-fa2681315c91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f2a83b05-5a09-4caa-8e8d-fce71bb36373" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_dd747e1b-c0dc-4c47-a227-fa2681315c91" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_3c23f404-fa87-41c8-a371-770df423d12e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f2a83b05-5a09-4caa-8e8d-fce71bb36373" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_3c23f404-fa87-41c8-a371-770df423d12e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_cc649ee4-ec82-4c8e-ac05-aa71d3c14406" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f2a83b05-5a09-4caa-8e8d-fce71bb36373" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_cc649ee4-ec82-4c8e-ac05-aa71d3c14406" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_553a1e3d-ef67-4772-91f1-3b2f40d2c9c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f2a83b05-5a09-4caa-8e8d-fce71bb36373" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_553a1e3d-ef67-4772-91f1-3b2f40d2c9c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4d0ad421-2b7f-4b1a-9d51-18551ff8eb0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_5a161110-a0e9-4b86-9c8c-51f1d8ba6609" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4d0ad421-2b7f-4b1a-9d51-18551ff8eb0f" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_5a161110-a0e9-4b86-9c8c-51f1d8ba6609" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_1eedb7cc-ec7d-48d9-bd5b-f627d033b652" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4d0ad421-2b7f-4b1a-9d51-18551ff8eb0f" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_1eedb7cc-ec7d-48d9-bd5b-f627d033b652" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_86669a45-cf98-45df-bd8c-ad895ffd8d93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4d0ad421-2b7f-4b1a-9d51-18551ff8eb0f" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_86669a45-cf98-45df-bd8c-ad895ffd8d93" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_3c1f2bfa-a049-405e-b195-2976faca3c5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4d0ad421-2b7f-4b1a-9d51-18551ff8eb0f" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_3c1f2bfa-a049-405e-b195-2976faca3c5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt_477498ab-4fa5-4f93-a63b-04db3b934d71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4d0ad421-2b7f-4b1a-9d51-18551ff8eb0f" xlink:to="loc_us-gaap_RepaymentsOfSeniorDebt_477498ab-4fa5-4f93-a63b-04db3b934d71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit_3ece74a3-0c40-4070-9fa8-4f86944da1e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfLinesOfCredit"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4d0ad421-2b7f-4b1a-9d51-18551ff8eb0f" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit_3ece74a3-0c40-4070-9fa8-4f86944da1e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_6570efc6-e255-4357-a871-b1519b763f66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4d0ad421-2b7f-4b1a-9d51-18551ff8eb0f" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_6570efc6-e255-4357-a871-b1519b763f66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_987152fd-f181-4735-abb4-b5ce0da4be26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4d0ad421-2b7f-4b1a-9d51-18551ff8eb0f" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_987152fd-f181-4735-abb4-b5ce0da4be26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_9894904c-fd59-4150-b832-cf635fb73311" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4d0ad421-2b7f-4b1a-9d51-18551ff8eb0f" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_9894904c-fd59-4150-b832-cf635fb73311" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/ShareBasedCompensationScheduleofSelectedFinancialImpactofShareBasedCompensationDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#ShareBasedCompensationScheduleofSelectedFinancialImpactofShareBasedCompensationDetails"/>
  <link:calculationLink xlink:role="http://www.idexx.com/role/ShareBasedCompensationScheduleofSelectedFinancialImpactofShareBasedCompensationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_idxx_AllocatedShareBasedCompensationExpenseNetOfTaxExcludingTaxBenefitFromSettlementOfShareBasedAwards_42ff2d01-c2c4-4c38-b243-494031331d57" xlink:href="idxx-20211231.xsd#idxx_AllocatedShareBasedCompensationExpenseNetOfTaxExcludingTaxBenefitFromSettlementOfShareBasedAwards"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_dc461e9c-3bf4-4ca2-ac12-f0d03dfae421" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_idxx_AllocatedShareBasedCompensationExpenseNetOfTaxExcludingTaxBenefitFromSettlementOfShareBasedAwards_42ff2d01-c2c4-4c38-b243-494031331d57" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_dc461e9c-3bf4-4ca2-ac12-f0d03dfae421" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_74fa1be2-efa6-422a-b26a-ac71e26623fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_idxx_AllocatedShareBasedCompensationExpenseNetOfTaxExcludingTaxBenefitFromSettlementOfShareBasedAwards_42ff2d01-c2c4-4c38-b243-494031331d57" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_74fa1be2-efa6-422a-b26a-ac71e26623fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_ce30096b-2f3f-4e1a-afc3-c07ab2e5c2a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_AllocatedShareBasedCompensationExpenseNetOfTaxExcludingTaxBenefitFromSettlementOfShareBasedAwards_46f9c44e-a6e1-4578-8293-a6785135b243" xlink:href="idxx-20211231.xsd#idxx_AllocatedShareBasedCompensationExpenseNetOfTaxExcludingTaxBenefitFromSettlementOfShareBasedAwards"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_ce30096b-2f3f-4e1a-afc3-c07ab2e5c2a4" xlink:to="loc_idxx_AllocatedShareBasedCompensationExpenseNetOfTaxExcludingTaxBenefitFromSettlementOfShareBasedAwards_46f9c44e-a6e1-4578-8293-a6785135b243" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_e6479225-031b-4799-b74c-6183bf71be99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_ce30096b-2f3f-4e1a-afc3-c07ab2e5c2a4" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_e6479225-031b-4799-b74c-6183bf71be99" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/InventoriesScheduleofComponentsofInventoriesDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#InventoriesScheduleofComponentsofInventoriesDetails"/>
  <link:calculationLink xlink:role="http://www.idexx.com/role/InventoriesScheduleofComponentsofInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_7c42efb5-3fa8-40cb-a4e3-aca23521f68a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_549f1f6e-fd5c-4822-98de-c8fa37c352eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_7c42efb5-3fa8-40cb-a4e3-aca23521f68a" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_549f1f6e-fd5c-4822-98de-c8fa37c352eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_f1fb8f45-8088-41b1-82fb-3495e7a90d53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_7c42efb5-3fa8-40cb-a4e3-aca23521f68a" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_f1fb8f45-8088-41b1-82fb-3495e7a90d53" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_a6aaa49b-c163-4771-bedd-9d156b33b62b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_7c42efb5-3fa8-40cb-a4e3-aca23521f68a" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_a6aaa49b-c163-4771-bedd-9d156b33b62b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.idexx.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6dfe2a79-b87f-4aac-831b-73daacf93fee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_4121399f-db08-49fa-9e1f-6c4d547748a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6dfe2a79-b87f-4aac-831b-73daacf93fee" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_4121399f-db08-49fa-9e1f-6c4d547748a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_41c1d3df-5d42-47e0-90d7-804a02ba2033" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6dfe2a79-b87f-4aac-831b-73daacf93fee" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_41c1d3df-5d42-47e0-90d7-804a02ba2033" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_d7cf13fd-fa7c-43cd-9fa3-7cb77a75c73c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6dfe2a79-b87f-4aac-831b-73daacf93fee" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_d7cf13fd-fa7c-43cd-9fa3-7cb77a75c73c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0f3eeccf-5b18-49a7-b7a3-4990aa5546ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6dfe2a79-b87f-4aac-831b-73daacf93fee" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0f3eeccf-5b18-49a7-b7a3-4990aa5546ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_f30ad0a2-4b09-4b89-8010-bf35ebcf7439" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6dfe2a79-b87f-4aac-831b-73daacf93fee" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_f30ad0a2-4b09-4b89-8010-bf35ebcf7439" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_de8cdf65-2e01-453c-9fb6-52e48883ca97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6dfe2a79-b87f-4aac-831b-73daacf93fee" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_de8cdf65-2e01-453c-9fb6-52e48883ca97" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="idxx-20211231.xsd#LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.idexx.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_07b8ac86-aefe-4522-b893-dcb4ad9cb665" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0bf7e4b1-19af-42ae-b4ff-a2ebe17a4652" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_07b8ac86-aefe-4522-b893-dcb4ad9cb665" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0bf7e4b1-19af-42ae-b4ff-a2ebe17a4652" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_831563ee-79ef-45f0-9f74-50b2ed61bea1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_07b8ac86-aefe-4522-b893-dcb4ad9cb665" xlink:to="loc_us-gaap_OperatingLeaseLiability_831563ee-79ef-45f0-9f74-50b2ed61bea1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://www.idexx.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_17ddd8ce-a6e5-4708-90c0-431acb3320e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_8231e46e-9535-4c0b-ac18-ab08f5f0dd82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_17ddd8ce-a6e5-4708-90c0-431acb3320e5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_8231e46e-9535-4c0b-ac18-ab08f5f0dd82" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_6ad952d3-a68a-4ea5-9fcb-248a8c6ff23b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_17ddd8ce-a6e5-4708-90c0-431acb3320e5" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_6ad952d3-a68a-4ea5-9fcb-248a8c6ff23b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/OtherCurrentandLongTermAssetsScheduleofOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#OtherCurrentandLongTermAssetsScheduleofOtherCurrentAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.idexx.com/role/OtherCurrentandLongTermAssetsScheduleofOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_5cf9ad20-4472-476b-9048-13acd0589746" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCurrent_6bc22017-0216-4645-9dfc-7b5177a345f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCostsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_5cf9ad20-4472-476b-9048-13acd0589746" xlink:to="loc_us-gaap_DeferredCostsCurrent_6bc22017-0216-4645-9dfc-7b5177a345f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_b24c9224-2bcd-4ce7-8376-e45c40ccb3ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_5cf9ad20-4472-476b-9048-13acd0589746" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_b24c9224-2bcd-4ce7-8376-e45c40ccb3ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_f5f7ed9d-fd51-4194-96ca-6c7d7c747e4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_5cf9ad20-4472-476b-9048-13acd0589746" xlink:to="loc_us-gaap_IncomeTaxesReceivable_f5f7ed9d-fd51-4194-96ca-6c7d7c747e4c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_5dfc1b0f-abe7-4a67-9fb1-fd5171ceb1f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_5cf9ad20-4472-476b-9048-13acd0589746" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_5dfc1b0f-abe7-4a67-9fb1-fd5171ceb1f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNetCurrent_82154d2f-3625-41aa-80ed-284b1ee88687" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostNetCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_5cf9ad20-4472-476b-9048-13acd0589746" xlink:to="loc_us-gaap_CapitalizedContractCostNetCurrent_82154d2f-3625-41aa-80ed-284b1ee88687" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousCurrent_cc73a3e4-8249-4e56-ad92-5953a928e9ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMiscellaneousCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_5cf9ad20-4472-476b-9048-13acd0589746" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousCurrent_cc73a3e4-8249-4e56-ad92-5953a928e9ce" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/OtherCurrentandLongTermAssetsScheduleofOtherNoncurrentAssetsDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#OtherCurrentandLongTermAssetsScheduleofOtherNoncurrentAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.idexx.com/role/OtherCurrentandLongTermAssetsScheduleofOtherNoncurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_f300116f-9fe6-4d35-84e0-a82feeb9b64d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCosts_9396ce87-6406-4115-857a-6d719fec75ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCosts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_f300116f-9fe6-4d35-84e0-a82feeb9b64d" xlink:to="loc_us-gaap_DeferredCosts_9396ce87-6406-4115-857a-6d719fec75ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetNoncurrent_ac88effa-2aca-4ce6-9a1b-03078dc9fcf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNetNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_f300116f-9fe6-4d35-84e0-a82feeb9b64d" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetNoncurrent_ac88effa-2aca-4ce6-9a1b-03078dc9fcf0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivableNoncurrent_cad6c612-3edb-453a-b573-895c6d55ba83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesReceivableNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_f300116f-9fe6-4d35-84e0-a82feeb9b64d" xlink:to="loc_us-gaap_IncomeTaxesReceivableNoncurrent_cad6c612-3edb-453a-b573-895c6d55ba83" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseOtherNoncurrent_40545c0c-151b-4f24-95ec-004b3100777f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseOtherNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_f300116f-9fe6-4d35-84e0-a82feeb9b64d" xlink:to="loc_us-gaap_PrepaidExpenseOtherNoncurrent_40545c0c-151b-4f24-95ec-004b3100777f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNetNoncurrent_4ecb270a-c208-429d-aad4-12719a4d592c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostNetNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_f300116f-9fe6-4d35-84e0-a82feeb9b64d" xlink:to="loc_us-gaap_CapitalizedContractCostNetNoncurrent_4ecb270a-c208-429d-aad4-12719a4d592c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_be1fc815-dac2-4b19-a205-bbf3d001473b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_f300116f-9fe6-4d35-84e0-a82feeb9b64d" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_be1fc815-dac2-4b19-a205-bbf3d001473b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_b9b4c965-7c14-4b4d-8ec8-f89919c91830" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_f300116f-9fe6-4d35-84e0-a82feeb9b64d" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_b9b4c965-7c14-4b4d-8ec8-f89919c91830" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofIntangibleAssetsOtherThanGoodwillDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#GoodwillandIntangibleAssetsNetScheduleofIntangibleAssetsOtherThanGoodwillDetails"/>
  <link:calculationLink xlink:role="http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofIntangibleAssetsOtherThanGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d54fb1a9-c90e-4204-82a9-3797d8afd2dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_e5deba21-db1f-48e3-bc65-897611b67819" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d54fb1a9-c90e-4204-82a9-3797d8afd2dc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_e5deba21-db1f-48e3-bc65-897611b67819" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_2b9c5e3f-ebf1-4acc-bf4d-b4e9f71d0d0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d54fb1a9-c90e-4204-82a9-3797d8afd2dc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_2b9c5e3f-ebf1-4acc-bf4d-b4e9f71d0d0f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofExpectedAmortizationExpenseDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#GoodwillandIntangibleAssetsNetScheduleofExpectedAmortizationExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofExpectedAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2818cdfe-48b9-4c73-a9b0-77d3c04a7e82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_4fd98ed7-f2d1-446c-8bb3-951aeb123d43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2818cdfe-48b9-4c73-a9b0-77d3c04a7e82" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_4fd98ed7-f2d1-446c-8bb3-951aeb123d43" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_ce8b8aab-13d2-4831-a17a-55c123a395f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2818cdfe-48b9-4c73-a9b0-77d3c04a7e82" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_ce8b8aab-13d2-4831-a17a-55c123a395f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_e1b2d23f-afbd-40a6-a0c5-0b854aaf24e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2818cdfe-48b9-4c73-a9b0-77d3c04a7e82" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_e1b2d23f-afbd-40a6-a0c5-0b854aaf24e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_b446f344-33e0-4911-b480-93b66e2ae6ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2818cdfe-48b9-4c73-a9b0-77d3c04a7e82" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_b446f344-33e0-4911-b480-93b66e2ae6ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_47a3dc45-fadb-4375-bf0f-ba0e0f8ff0c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2818cdfe-48b9-4c73-a9b0-77d3c04a7e82" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_47a3dc45-fadb-4375-bf0f-ba0e0f8ff0c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_efbe4f3b-8d56-4c39-bd27-5c10765d866e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2818cdfe-48b9-4c73-a9b0-77d3c04a7e82" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_efbe4f3b-8d56-4c39-bd27-5c10765d866e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/AccruedLiabilitiesandOtherLongTermLiabilitiesScheduleofAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#AccruedLiabilitiesandOtherLongTermLiabilitiesScheduleofAccruedLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.idexx.com/role/AccruedLiabilitiesandOtherLongTermLiabilitiesScheduleofAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_ec25786d-b4ba-4f48-aa74-ac2f874f7991" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_b547359b-0bc9-4e15-9c8b-2efb4b6cbee6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_ec25786d-b4ba-4f48-aa74-ac2f874f7991" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_b547359b-0bc9-4e15-9c8b-2efb4b6cbee6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_b6dce886-d853-4ce5-a1b0-6f3785a670fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_ec25786d-b4ba-4f48-aa74-ac2f874f7991" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_b6dce886-d853-4ce5-a1b0-6f3785a670fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedMarketingCostsCurrent_e38b1d4c-6f03-48b1-8b16-0f383d4eca1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedMarketingCostsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_ec25786d-b4ba-4f48-aa74-ac2f874f7991" xlink:to="loc_us-gaap_AccruedMarketingCostsCurrent_e38b1d4c-6f03-48b1-8b16-0f383d4eca1e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_fa311421-73f2-49b6-b39a-12cfffc05b41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_ec25786d-b4ba-4f48-aa74-ac2f874f7991" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_fa311421-73f2-49b6-b39a-12cfffc05b41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_981f64b8-46ad-4e49-bab2-ca31c1ef4236" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_ec25786d-b4ba-4f48-aa74-ac2f874f7991" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_981f64b8-46ad-4e49-bab2-ca31c1ef4236" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/AccruedLiabilitiesandOtherLongTermLiabilitiesScheduleofLongTermAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#AccruedLiabilitiesandOtherLongTermLiabilitiesScheduleofLongTermAccruedLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.idexx.com/role/AccruedLiabilitiesandOtherLongTermLiabilitiesScheduleofLongTermAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_1f2b1f76-4d29-4acc-b98a-b4be4343bf2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_792f5229-54dc-4147-9f54-3a9d98c5e8bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_1f2b1f76-4d29-4acc-b98a-b4be4343bf2f" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_792f5229-54dc-4147-9f54-3a9d98c5e8bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_6b5e5bd7-0682-41d0-a0be-0f018c91c396" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_1f2b1f76-4d29-4acc-b98a-b4be4343bf2f" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_6b5e5bd7-0682-41d0-a0be-0f018c91c396" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/DebtScheduleofAnnualPrincipalPaymentsonLongTermDebtDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#DebtScheduleofAnnualPrincipalPaymentsonLongTermDebtDetails"/>
  <link:calculationLink xlink:role="http://www.idexx.com/role/DebtScheduleofAnnualPrincipalPaymentsonLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_6b0a451e-205b-4683-81e0-98928aa998d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_39eebef7-42c4-49ec-bded-c5ae7187155d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_6b0a451e-205b-4683-81e0-98928aa998d3" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_39eebef7-42c4-49ec-bded-c5ae7187155d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_35994bb8-b427-4df4-9cc3-9cd9ebf5baaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_6b0a451e-205b-4683-81e0-98928aa998d3" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_35994bb8-b427-4df4-9cc3-9cd9ebf5baaa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_0c82eb26-801c-46eb-b2c1-e6465c2b628b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_6b0a451e-205b-4683-81e0-98928aa998d3" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_0c82eb26-801c-46eb-b2c1-e6465c2b628b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_90816e26-ef23-4d10-adbb-52004962772b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_6b0a451e-205b-4683-81e0-98928aa998d3" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_90816e26-ef23-4d10-adbb-52004962772b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_689ce2a2-4cba-43b4-9530-c52c8244cdd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_6b0a451e-205b-4683-81e0-98928aa998d3" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_689ce2a2-4cba-43b4-9530-c52c8244cdd7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_3a209f92-c87a-4c58-a580-94c979d6ef95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_6b0a451e-205b-4683-81e0-98928aa998d3" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_3a209f92-c87a-4c58-a580-94c979d6ef95" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/IncomeTaxesScheduleofEarningsBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#IncomeTaxesScheduleofEarningsBeforeIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.idexx.com/role/IncomeTaxesScheduleofEarningsBeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d73f5447-245f-4602-b59a-2774185386ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_3e7326aa-7e2f-4e60-beaa-b378274ecd7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d73f5447-245f-4602-b59a-2774185386ce" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_3e7326aa-7e2f-4e60-beaa-b378274ecd7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_f363933e-4c97-4adf-af61-ec9349163442" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d73f5447-245f-4602-b59a-2774185386ce" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_f363933e-4c97-4adf-af61-ec9349163442" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofProvisionBenefitforIncomeTaxesDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#IncomeTaxesScheduleofComponentsofProvisionBenefitforIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofProvisionBenefitforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_4cae4719-90c8-43cb-92ae-403eb8e561c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_60ef094b-c401-4098-972f-ec9d71c6c61d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_4cae4719-90c8-43cb-92ae-403eb8e561c4" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_60ef094b-c401-4098-972f-ec9d71c6c61d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_1c89ce48-e0f5-4135-af79-6b2e9127dbeb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_4cae4719-90c8-43cb-92ae-403eb8e561c4" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_1c89ce48-e0f5-4135-af79-6b2e9127dbeb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_dae51c9f-babe-4a67-8d2f-9c008a0c1d76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_4cae4719-90c8-43cb-92ae-403eb8e561c4" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_dae51c9f-babe-4a67-8d2f-9c008a0c1d76" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_1b7c20d1-f042-489a-94ce-9938046d7233" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_25e58153-3862-473a-b031-3696030943db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_1b7c20d1-f042-489a-94ce-9938046d7233" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_25e58153-3862-473a-b031-3696030943db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_8b52a3d5-05b9-4e2e-8a6a-a757c67a2e9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_1b7c20d1-f042-489a-94ce-9938046d7233" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_8b52a3d5-05b9-4e2e-8a6a-a757c67a2e9d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_a54ad1e9-76ba-4a96-8922-a8a46c2786a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_1b7c20d1-f042-489a-94ce-9938046d7233" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_a54ad1e9-76ba-4a96-8922-a8a46c2786a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_767c69ca-a2e9-442c-89e3-89afe3ab8b21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_d53185fa-cea1-474f-8429-14d69b0e9d61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_767c69ca-a2e9-442c-89e3-89afe3ab8b21" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_d53185fa-cea1-474f-8429-14d69b0e9d61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_7b7b91d6-f769-4c6e-b21a-8c1865c2497d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_767c69ca-a2e9-442c-89e3-89afe3ab8b21" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_7b7b91d6-f769-4c6e-b21a-8c1865c2497d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"/>
  <link:calculationLink xlink:role="http://www.idexx.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ee186c50-fecb-44c1-a6d9-fb335751c6eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1430f0ae-881a-4865-bd84-8546d4e32554" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ee186c50-fecb-44c1-a6d9-fb335751c6eb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1430f0ae-881a-4865-bd84-8546d4e32554" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_e5b2a0f4-b2b0-421a-885e-75be6f6e5fc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ee186c50-fecb-44c1-a6d9-fb335751c6eb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_e5b2a0f4-b2b0-421a-885e-75be6f6e5fc8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_7b8ef913-d847-4fa3-ac15-f8e39f443de8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ee186c50-fecb-44c1-a6d9-fb335751c6eb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_7b8ef913-d847-4fa3-ac15-f8e39f443de8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome_07886773-4f66-425c-9edf-54f503d0f1e7" xlink:href="idxx-20211231.xsd#idxx_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ee186c50-fecb-44c1-a6d9-fb335751c6eb" xlink:to="loc_idxx_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome_07886773-4f66-425c-9edf-54f503d0f1e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_0d826854-bfb7-44be-888b-b38fea71960a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ee186c50-fecb-44c1-a6d9-fb335751c6eb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_0d826854-bfb7-44be-888b-b38fea71960a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_8a47e694-3310-400b-a3ca-0621c25d73d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ee186c50-fecb-44c1-a6d9-fb335751c6eb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_8a47e694-3310-400b-a3ca-0621c25d73d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_833a485f-4bb2-4cf5-842e-7590104abc5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ee186c50-fecb-44c1-a6d9-fb335751c6eb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_833a485f-4bb2-4cf5-842e-7590104abc5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_EffectiveIncomeTaxRateReconciliationSwitzerlandTaxReformEffectPercent_ee4de884-3653-43b5-82a3-1e626e98b78c" xlink:href="idxx-20211231.xsd#idxx_EffectiveIncomeTaxRateReconciliationSwitzerlandTaxReformEffectPercent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ee186c50-fecb-44c1-a6d9-fb335751c6eb" xlink:to="loc_idxx_EffectiveIncomeTaxRateReconciliationSwitzerlandTaxReformEffectPercent_ee4de884-3653-43b5-82a3-1e626e98b78c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofNetDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#IncomeTaxesScheduleofComponentsofNetDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofNetDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_a5fc6511-ae00-4de1-afd7-d10e6eae820c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_1301193a-a0c1-4993-8a77-cb51383d44ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_a5fc6511-ae00-4de1-afd7-d10e6eae820c" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_1301193a-a0c1-4993-8a77-cb51383d44ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_ba3bcbba-2c00-4bda-b8fe-a8663318278d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_a5fc6511-ae00-4de1-afd7-d10e6eae820c" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_ba3bcbba-2c00-4bda-b8fe-a8663318278d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_2221493b-4728-4ed9-a1f7-6ad84af8e945" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_fcd18732-f7f2-4991-8a91-8adfcc8429b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_2221493b-4728-4ed9-a1f7-6ad84af8e945" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_fcd18732-f7f2-4991-8a91-8adfcc8429b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_c400bc50-cd8a-4ee1-b820-1c4e911e2bc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_2221493b-4728-4ed9-a1f7-6ad84af8e945" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_c400bc50-cd8a-4ee1-b820-1c4e911e2bc1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_99d46151-f46c-49ab-a304-0f072060114e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost_a19cda01-22cd-4150-8cc6-8a1ca45bc5e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_99d46151-f46c-49ab-a304-0f072060114e" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost_a19cda01-22cd-4150-8cc6-8a1ca45bc5e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_cd8d5a53-5466-4a3b-9775-9f5be39ab126" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_99d46151-f46c-49ab-a304-0f072060114e" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_cd8d5a53-5466-4a3b-9775-9f5be39ab126" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_c0b632f7-da8f-4430-b616-888dd741b8b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_99d46151-f46c-49ab-a304-0f072060114e" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_c0b632f7-da8f-4430-b616-888dd741b8b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_4cde67da-90ee-4ca0-b4a0-208391983969" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_99d46151-f46c-49ab-a304-0f072060114e" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_4cde67da-90ee-4ca0-b4a0-208391983969" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains_5419ff4a-c6d9-4797-b5a9-37753e6b0c98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_99d46151-f46c-49ab-a304-0f072060114e" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains_5419ff4a-c6d9-4797-b5a9-37753e6b0c98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_32e9e641-9b23-4150-bfd9-c3e01c685337" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_3db0604f-ab78-4c5d-8b3a-321ded8f9a85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_32e9e641-9b23-4150-bfd9-c3e01c685337" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_3db0604f-ab78-4c5d-8b3a-321ded8f9a85" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_c99d3b83-6d54-4cfc-ad1e-f9de72ada493" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_32e9e641-9b23-4150-bfd9-c3e01c685337" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_c99d3b83-6d54-4cfc-ad1e-f9de72ada493" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsDeferredIncome_a8b9490f-2fbc-470a-b863-b2a4a8a40ee6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_32e9e641-9b23-4150-bfd9-c3e01c685337" xlink:to="loc_us-gaap_DeferredTaxAssetsDeferredIncome_a8b9490f-2fbc-470a-b863-b2a4a8a40ee6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_dc1dd592-9a5e-435e-b964-315f7cfec769" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_32e9e641-9b23-4150-bfd9-c3e01c685337" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_dc1dd592-9a5e-435e-b964-315f7cfec769" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_80292a61-fa16-433c-8699-4764623d6ff2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_32e9e641-9b23-4150-bfd9-c3e01c685337" xlink:to="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_80292a61-fa16-433c-8699-4764623d6ff2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_2f888ff3-0a84-4986-b42e-216ff9a51bca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_32e9e641-9b23-4150-bfd9-c3e01c685337" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_2f888ff3-0a84-4986-b42e-216ff9a51bca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_4c6ebb91-69bd-45e7-a3b1-fa0f1d73c3e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_32e9e641-9b23-4150-bfd9-c3e01c685337" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_4c6ebb91-69bd-45e7-a3b1-fa0f1d73c3e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_22205681-d1d7-4b7b-800a-a28d94c025f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_32e9e641-9b23-4150-bfd9-c3e01c685337" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_22205681-d1d7-4b7b-800a-a28d94c025f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_7a00d0d5-c5e0-4099-a87d-9bbdac970be4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_32e9e641-9b23-4150-bfd9-c3e01c685337" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_7a00d0d5-c5e0-4099-a87d-9bbdac970be4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOtherComprehensiveLoss_3ec4faa7-df11-43db-b310-42fd0a2f6994" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOtherComprehensiveLoss"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_32e9e641-9b23-4150-bfd9-c3e01c685337" xlink:to="loc_us-gaap_DeferredTaxAssetsOtherComprehensiveLoss_3ec4faa7-df11-43db-b310-42fd0a2f6994" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_DeferredTaxAssetsIntangibleAssetsBasisDifference_834767ec-d47f-4eea-8d68-97a5fc786185" xlink:href="idxx-20211231.xsd#idxx_DeferredTaxAssetsIntangibleAssetsBasisDifference"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_32e9e641-9b23-4150-bfd9-c3e01c685337" xlink:to="loc_idxx_DeferredTaxAssetsIntangibleAssetsBasisDifference_834767ec-d47f-4eea-8d68-97a5fc786185" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/EarningsPerShareReconciliationofSharesOutstandingDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#EarningsPerShareReconciliationofSharesOutstandingDetails"/>
  <link:calculationLink xlink:role="http://www.idexx.com/role/EarningsPerShareReconciliationofSharesOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d4c22877-4339-44e2-a52a-db1fedd5f99a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_cc89a72b-feeb-46c8-a7ee-a6a6f7e9bfed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d4c22877-4339-44e2-a52a-db1fedd5f99a" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_cc89a72b-feeb-46c8-a7ee-a6a6f7e9bfed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_8b917a9e-4b90-4805-ad39-32fcff5902e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d4c22877-4339-44e2-a52a-db1fedd5f99a" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_8b917a9e-4b90-4805-ad39-32fcff5902e3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/HedgingInstrumentsScheduleofFairValuesandBalanceSheetClassificationsofDerivativesandNonderivativesDesignatedasHedgingInstrumentsDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#HedgingInstrumentsScheduleofFairValuesandBalanceSheetClassificationsofDerivativesandNonderivativesDesignatedasHedgingInstrumentsDetails"/>
  <link:calculationLink xlink:role="http://www.idexx.com/role/HedgingInstrumentsScheduleofFairValuesandBalanceSheetClassificationsofDerivativesandNonderivativesDesignatedasHedgingInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection_9730652e-9ab5-4015-80e2-9944bb9698ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_483980ab-53cc-495f-a1df-ebcc744da98c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection_9730652e-9ab5-4015-80e2-9944bb9698ab" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_483980ab-53cc-495f-a1df-ebcc744da98c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction_ed266793-c8ad-4e09-9bbd-f1b5b7c767db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection_9730652e-9ab5-4015-80e2-9944bb9698ab" xlink:to="loc_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction_ed266793-c8ad-4e09-9bbd-f1b5b7c767db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection_cb75ed1c-df6c-4c45-adef-3d7d78dea0ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_ad6bbeaf-c943-42d2-9a0f-207335b9c53d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection_cb75ed1c-df6c-4c45-adef-3d7d78dea0ac" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_ad6bbeaf-c943-42d2-9a0f-207335b9c53d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction_4e085d4b-0494-48a0-86b9-318eb8ce5c88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection_cb75ed1c-df6c-4c45-adef-3d7d78dea0ac" xlink:to="loc_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction_4e085d4b-0494-48a0-86b9-318eb8ce5c88" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/RepurchasesofCommonStockDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#RepurchasesofCommonStockDetails"/>
  <link:calculationLink xlink:role="http://www.idexx.com/role/RepurchasesofCommonStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_61ee7557-5404-4ebb-8cab-a3a3eb7f4481" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_2bf22e27-9a10-4bf0-9ee8-d33cb9488921" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_61ee7557-5404-4ebb-8cab-a3a3eb7f4481" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_2bf22e27-9a10-4bf0-9ee8-d33cb9488921" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_TreasuryStockValueAcquiredCostMethodNetOfTaxWithholdings_582ef6ce-79c0-4feb-b8c7-dda90253d376" xlink:href="idxx-20211231.xsd#idxx_TreasuryStockValueAcquiredCostMethodNetOfTaxWithholdings"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_61ee7557-5404-4ebb-8cab-a3a3eb7f4481" xlink:to="loc_idxx_TreasuryStockValueAcquiredCostMethodNetOfTaxWithholdings_582ef6ce-79c0-4feb-b8c7-dda90253d376" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_4953adcf-3ec2-4adb-97fe-2a4946de6085" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_07d5c65f-84c8-4f00-8498-5e7120b06b92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired_4953adcf-3ec2-4adb-97fe-2a4946de6085" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_07d5c65f-84c8-4f00-8498-5e7120b06b92" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_TreasuryStockSharesAcquiredNetOfTaxWithholdings_d4bd15f7-48c1-4e4b-863f-af1d921ec45b" xlink:href="idxx-20211231.xsd#idxx_TreasuryStockSharesAcquiredNetOfTaxWithholdings"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired_4953adcf-3ec2-4adb-97fe-2a4946de6085" xlink:to="loc_idxx_TreasuryStockSharesAcquiredNetOfTaxWithholdings_d4bd15f7-48c1-4e4b-863f-af1d921ec45b" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>29
<FILENAME>idxx-20211231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:f52bcaef-ba11-42ce-aefc-0c16e0e0e054,g:8ec733b7-1a7e-4401-9212-15a98e503c1c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="simple" xlink:href="idxx-20211231.xsd#CONSOLIDATEDSTATEMENTSOFINCOME"/>
  <link:definitionLink xlink:role="http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="extended" id="if1438f1afdbc4faa9bfb1b58d0e0e831_CONSOLIDATEDSTATEMENTSOFINCOME">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_23f0563e-437f-423a-b6f5-c40f2999849f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_bb7e8d20-ad10-4932-b786-6ac83764c9e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_23f0563e-437f-423a-b6f5-c40f2999849f" xlink:to="loc_us-gaap_RevenuesAbstract_bb7e8d20-ad10-4932-b786-6ac83764c9e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c3fac287-6fa0-4e18-bedb-1aca13b2c5fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_bb7e8d20-ad10-4932-b786-6ac83764c9e9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c3fac287-6fa0-4e18-bedb-1aca13b2c5fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract_ca10bdba-60c1-4c6c-a167-368198f7ad8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_23f0563e-437f-423a-b6f5-c40f2999849f" xlink:to="loc_us-gaap_CostOfRevenueAbstract_ca10bdba-60c1-4c6c-a167-368198f7ad8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_ab9c8ef7-9c15-40cb-b45c-1ccf4128eb30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostOfRevenueAbstract_ca10bdba-60c1-4c6c-a167-368198f7ad8c" xlink:to="loc_us-gaap_CostOfRevenue_ab9c8ef7-9c15-40cb-b45c-1ccf4128eb30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_5e4f7449-171b-4d7b-86e5-bff1c38e881e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_23f0563e-437f-423a-b6f5-c40f2999849f" xlink:to="loc_us-gaap_GrossProfit_5e4f7449-171b-4d7b-86e5-bff1c38e881e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_d81d4cc4-8990-4b34-90d3-cb7b23654ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_23f0563e-437f-423a-b6f5-c40f2999849f" xlink:to="loc_us-gaap_OperatingExpensesAbstract_d81d4cc4-8990-4b34-90d3-cb7b23654ef0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_648f31fa-be70-4fa1-baf1-d5cceaa11aed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_d81d4cc4-8990-4b34-90d3-cb7b23654ef0" xlink:to="loc_us-gaap_SellingAndMarketingExpense_648f31fa-be70-4fa1-baf1-d5cceaa11aed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_4d31ce8f-0532-4b80-bc85-4d3f73493c4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_d81d4cc4-8990-4b34-90d3-cb7b23654ef0" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_4d31ce8f-0532-4b80-bc85-4d3f73493c4f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_bde0107e-7650-4c2f-a335-f7ac15c57c8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_d81d4cc4-8990-4b34-90d3-cb7b23654ef0" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_bde0107e-7650-4c2f-a335-f7ac15c57c8e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_6f767b2c-54fb-4446-ae75-f58a80133d7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_23f0563e-437f-423a-b6f5-c40f2999849f" xlink:to="loc_us-gaap_OperatingIncomeLoss_6f767b2c-54fb-4446-ae75-f58a80133d7b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_646c44d3-de6c-4f10-91bf-5e90586c4061" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_23f0563e-437f-423a-b6f5-c40f2999849f" xlink:to="loc_us-gaap_InterestExpense_646c44d3-de6c-4f10-91bf-5e90586c4061" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndOtherIncome_693716bf-a3c3-4c32-9005-c817cf584bb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestAndOtherIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_23f0563e-437f-423a-b6f5-c40f2999849f" xlink:to="loc_us-gaap_InterestAndOtherIncome_693716bf-a3c3-4c32-9005-c817cf584bb7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_19d914a5-d68f-4b99-a355-87d818ee04d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_23f0563e-437f-423a-b6f5-c40f2999849f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_19d914a5-d68f-4b99-a355-87d818ee04d6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_74d5001c-4554-49fa-b510-b3464a8c6f09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_23f0563e-437f-423a-b6f5-c40f2999849f" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_74d5001c-4554-49fa-b510-b3464a8c6f09" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_90927cb3-ac35-4d54-b25a-e3574525683d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_23f0563e-437f-423a-b6f5-c40f2999849f" xlink:to="loc_us-gaap_ProfitLoss_90927cb3-ac35-4d54-b25a-e3574525683d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_3ffc0631-d590-4f6f-b853-8e0a0b35d06d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_23f0563e-437f-423a-b6f5-c40f2999849f" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_3ffc0631-d590-4f6f-b853-8e0a0b35d06d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5ca29ad7-6a94-4e4f-8d90-dd5454dc7952" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_23f0563e-437f-423a-b6f5-c40f2999849f" xlink:to="loc_us-gaap_NetIncomeLoss_5ca29ad7-6a94-4e4f-8d90-dd5454dc7952" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_98340ecb-ea97-4394-8136-852abc032c35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_23f0563e-437f-423a-b6f5-c40f2999849f" xlink:to="loc_us-gaap_EarningsPerShareAbstract_98340ecb-ea97-4394-8136-852abc032c35" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_c429260f-9fb3-4938-920d-381c5611c0f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_98340ecb-ea97-4394-8136-852abc032c35" xlink:to="loc_us-gaap_EarningsPerShareBasic_c429260f-9fb3-4938-920d-381c5611c0f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_b10af7f1-4c2d-4047-ad59-d69c53f84166" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_98340ecb-ea97-4394-8136-852abc032c35" xlink:to="loc_us-gaap_EarningsPerShareDiluted_b10af7f1-4c2d-4047-ad59-d69c53f84166" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_WeightedAverageSharesOutstandingAbstract_7ba862cb-9615-46bb-b3bf-81bdf729674c" xlink:href="idxx-20211231.xsd#idxx_WeightedAverageSharesOutstandingAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_23f0563e-437f-423a-b6f5-c40f2999849f" xlink:to="loc_idxx_WeightedAverageSharesOutstandingAbstract_7ba862cb-9615-46bb-b3bf-81bdf729674c" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_44243f66-0a12-464e-9ce0-4ba18f39c6b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_idxx_WeightedAverageSharesOutstandingAbstract_7ba862cb-9615-46bb-b3bf-81bdf729674c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_44243f66-0a12-464e-9ce0-4ba18f39c6b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2186e759-04dc-4178-a19d-fa78d9b524ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_idxx_WeightedAverageSharesOutstandingAbstract_7ba862cb-9615-46bb-b3bf-81bdf729674c" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2186e759-04dc-4178-a19d-fa78d9b524ab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_3fc86cee-6397-436f-9afd-e11a597b018e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_23f0563e-437f-423a-b6f5-c40f2999849f" xlink:to="loc_us-gaap_StatementTable_3fc86cee-6397-436f-9afd-e11a597b018e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_f30acb1a-5e37-4472-8d27-0ba7139ed1cf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_3fc86cee-6397-436f-9afd-e11a597b018e" xlink:to="loc_srt_ProductOrServiceAxis_f30acb1a-5e37-4472-8d27-0ba7139ed1cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_f30acb1a-5e37-4472-8d27-0ba7139ed1cf_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_f30acb1a-5e37-4472-8d27-0ba7139ed1cf" xlink:to="loc_srt_ProductsAndServicesDomain_f30acb1a-5e37-4472-8d27-0ba7139ed1cf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_04f6e5b3-bac6-4874-b10a-d5b8a8b7e03e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_f30acb1a-5e37-4472-8d27-0ba7139ed1cf" xlink:to="loc_srt_ProductsAndServicesDomain_04f6e5b3-bac6-4874-b10a-d5b8a8b7e03e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_382e8f20-158d-4432-8fa0-233be1e6bfa0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_04f6e5b3-bac6-4874-b10a-d5b8a8b7e03e" xlink:to="loc_us-gaap_ProductMember_382e8f20-158d-4432-8fa0-233be1e6bfa0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_eee08880-c641-456e-ba6b-45b725b971b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_04f6e5b3-bac6-4874-b10a-d5b8a8b7e03e" xlink:to="loc_us-gaap_ServiceMember_eee08880-c641-456e-ba6b-45b725b971b6" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" xlink:type="simple" xlink:href="idxx-20211231.xsd#CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"/>
  <link:definitionLink xlink:role="http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" xlink:type="extended" id="ia55da00892fc4b60a5ce216b497af2cd_CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e36318ae-d2c4-4764-b678-af17e1e0c150" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_536e1795-2859-4492-993c-f899f5986db9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e36318ae-d2c4-4764-b678-af17e1e0c150" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_536e1795-2859-4492-993c-f899f5986db9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_256c6067-4415-49e9-8156-8bf554152e1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_536e1795-2859-4492-993c-f899f5986db9" xlink:to="loc_us-gaap_CommonStockSharesIssued_256c6067-4415-49e9-8156-8bf554152e1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_01e3f3de-8830-4777-89c8-58515be46965" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_536e1795-2859-4492-993c-f899f5986db9" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_01e3f3de-8830-4777-89c8-58515be46965" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_2f734d6b-75a7-456c-8559-82813a46586a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_536e1795-2859-4492-993c-f899f5986db9" xlink:to="loc_us-gaap_ProfitLoss_2f734d6b-75a7-456c-8559-82813a46586a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_81a5e9fa-c2c2-4577-a4dd-cdcddb628901" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_536e1795-2859-4492-993c-f899f5986db9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_81a5e9fa-c2c2-4577-a4dd-cdcddb628901" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_abb72c04-da50-417d-9fac-c33c12b31019" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_536e1795-2859-4492-993c-f899f5986db9" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_abb72c04-da50-417d-9fac-c33c12b31019" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_9fd97cce-1fef-4523-80ce-ca8ddba4acb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredParValueMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_536e1795-2859-4492-993c-f899f5986db9" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_9fd97cce-1fef-4523-80ce-ca8ddba4acb4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_a73a7d17-7044-4dc0-9374-0d5b9fe3f275" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_536e1795-2859-4492-993c-f899f5986db9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_a73a7d17-7044-4dc0-9374-0d5b9fe3f275" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_effc3791-d5e2-4b08-b52c-6e0509528581" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_536e1795-2859-4492-993c-f899f5986db9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_effc3791-d5e2-4b08-b52c-6e0509528581" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_IssuanceVestingAndSettlementOfDeferredStockUnits_c7544847-6a07-45f8-b989-e58e1e3a2091" xlink:href="idxx-20211231.xsd#idxx_IssuanceVestingAndSettlementOfDeferredStockUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_536e1795-2859-4492-993c-f899f5986db9" xlink:to="loc_idxx_IssuanceVestingAndSettlementOfDeferredStockUnits_c7544847-6a07-45f8-b989-e58e1e3a2091" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_276af914-0ab3-4df4-b66a-a7002b1935c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_536e1795-2859-4492-993c-f899f5986db9" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_276af914-0ab3-4df4-b66a-a7002b1935c4" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_b9ef83b6-ece6-4ed5-9feb-c99364447d39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f46395d8-98cb-4aa3-b66d-b31b62032415" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_442cbce8-dc27-46f2-9681-f83000e85449" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_e36318ae-d2c4-4764-b678-af17e1e0c150" xlink:to="loc_us-gaap_StatementTable_442cbce8-dc27-46f2-9681-f83000e85449" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_5cfbd37c-d277-4e6c-a7e6-16519ea84921" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_442cbce8-dc27-46f2-9681-f83000e85449" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_5cfbd37c-d277-4e6c-a7e6-16519ea84921" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5cfbd37c-d277-4e6c-a7e6-16519ea84921_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5cfbd37c-d277-4e6c-a7e6-16519ea84921" xlink:to="loc_us-gaap_EquityComponentDomain_5cfbd37c-d277-4e6c-a7e6-16519ea84921_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_be6d100c-fa8d-4f15-bd42-781261cfbb08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5cfbd37c-d277-4e6c-a7e6-16519ea84921" xlink:to="loc_us-gaap_EquityComponentDomain_be6d100c-fa8d-4f15-bd42-781261cfbb08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_3be301ae-af53-4e38-affd-fa027042bfb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_be6d100c-fa8d-4f15-bd42-781261cfbb08" xlink:to="loc_us-gaap_CommonStockMember_3be301ae-af53-4e38-affd-fa027042bfb9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_baddb1ac-adff-4edd-94eb-4e660c64403a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_be6d100c-fa8d-4f15-bd42-781261cfbb08" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_baddb1ac-adff-4edd-94eb-4e660c64403a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_DeferredStockUnitsMember_5f7214ef-0c2b-4607-a3c3-53769c3ff5d5" xlink:href="idxx-20211231.xsd#idxx_DeferredStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_be6d100c-fa8d-4f15-bd42-781261cfbb08" xlink:to="loc_idxx_DeferredStockUnitsMember_5f7214ef-0c2b-4607-a3c3-53769c3ff5d5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_66b2d901-2641-4c3a-a1be-14e8839325ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_be6d100c-fa8d-4f15-bd42-781261cfbb08" xlink:to="loc_us-gaap_RetainedEarningsMember_66b2d901-2641-4c3a-a1be-14e8839325ed" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_fd1b6635-5cd9-48cf-80fd-096d118757ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_be6d100c-fa8d-4f15-bd42-781261cfbb08" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_fd1b6635-5cd9-48cf-80fd-096d118757ec" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_b615819c-3008-4bf4-9cab-191350f68f9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_be6d100c-fa8d-4f15-bd42-781261cfbb08" xlink:to="loc_us-gaap_TreasuryStockMember_b615819c-3008-4bf4-9cab-191350f68f9f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_160f1712-2965-4ca9-a5e2-570ef2fd8c31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_be6d100c-fa8d-4f15-bd42-781261cfbb08" xlink:to="loc_us-gaap_NoncontrollingInterestMember_160f1712-2965-4ca9-a5e2-570ef2fd8c31" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_39ce2f60-6005-4e7b-b37f-544aa8dfe8db" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_442cbce8-dc27-46f2-9681-f83000e85449" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_39ce2f60-6005-4e7b-b37f-544aa8dfe8db" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_39ce2f60-6005-4e7b-b37f-544aa8dfe8db_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_39ce2f60-6005-4e7b-b37f-544aa8dfe8db" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_39ce2f60-6005-4e7b-b37f-544aa8dfe8db_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_8a0ca3ee-2909-4395-8aba-7a1ec0c304a7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_39ce2f60-6005-4e7b-b37f-544aa8dfe8db" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_8a0ca3ee-2909-4395-8aba-7a1ec0c304a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_e1a3c805-828a-4975-bd71-edda2fe49df3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_8a0ca3ee-2909-4395-8aba-7a1ec0c304a7" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_e1a3c805-828a-4975-bd71-edda2fe49df3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.idexx.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.idexx.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" id="i982e10b3bceb40a8a6ea6b63896ccc74_SummaryofSignificantAccountingPoliciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_idxx_SummaryOfSignificantAccountingPoliciesLineItems_4ebf49ca-588d-4850-b8c5-cc0c55cbfda9" xlink:href="idxx-20211231.xsd#idxx_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_ffbfd794-6abc-422b-b9e6-7f8b46a300a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_idxx_SummaryOfSignificantAccountingPoliciesLineItems_4ebf49ca-588d-4850-b8c5-cc0c55cbfda9" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_ffbfd794-6abc-422b-b9e6-7f8b46a300a1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ResearchAndDevelopmentCostsCapitalized_23df2002-dfa4-46cb-8d92-a8b11b514295" xlink:href="idxx-20211231.xsd#idxx_ResearchAndDevelopmentCostsCapitalized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_idxx_SummaryOfSignificantAccountingPoliciesLineItems_4ebf49ca-588d-4850-b8c5-cc0c55cbfda9" xlink:to="loc_idxx_ResearchAndDevelopmentCostsCapitalized_23df2002-dfa4-46cb-8d92-a8b11b514295" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_77b659aa-cf20-49a1-a0d0-2f4d5817813a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_idxx_SummaryOfSignificantAccountingPoliciesLineItems_4ebf49ca-588d-4850-b8c5-cc0c55cbfda9" xlink:to="loc_us-gaap_AdvertisingExpense_77b659aa-cf20-49a1-a0d0-2f4d5817813a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_b95809e3-bfa6-4a00-95e0-01d799442226" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_idxx_SummaryOfSignificantAccountingPoliciesLineItems_4ebf49ca-588d-4850-b8c5-cc0c55cbfda9" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_b95809e3-bfa6-4a00-95e0-01d799442226" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_edeeca1c-18f4-4f2b-b2b0-5e8547adae9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_idxx_SummaryOfSignificantAccountingPoliciesLineItems_4ebf49ca-588d-4850-b8c5-cc0c55cbfda9" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_edeeca1c-18f4-4f2b-b2b0-5e8547adae9d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityCumulativeEffectOfChangeInAccountingPrinciple_22b156f4-32ad-42bc-9914-ecacd8681180" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityCumulativeEffectOfChangeInAccountingPrinciple"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_idxx_SummaryOfSignificantAccountingPoliciesLineItems_4ebf49ca-588d-4850-b8c5-cc0c55cbfda9" xlink:to="loc_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityCumulativeEffectOfChangeInAccountingPrinciple_22b156f4-32ad-42bc-9914-ecacd8681180" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ContractwithCustomerAssetAndSalesTypeLeaseNetInvestmentInLeaseAllowanceforCreditLoss_177d4a59-93b5-490d-9423-fa6908b53fa9" xlink:href="idxx-20211231.xsd#idxx_ContractwithCustomerAssetAndSalesTypeLeaseNetInvestmentInLeaseAllowanceforCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_idxx_SummaryOfSignificantAccountingPoliciesLineItems_4ebf49ca-588d-4850-b8c5-cc0c55cbfda9" xlink:to="loc_idxx_ContractwithCustomerAssetAndSalesTypeLeaseNetInvestmentInLeaseAllowanceforCreditLoss_177d4a59-93b5-490d-9423-fa6908b53fa9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_ae9bdb89-ede0-44b2-9404-5b4d6cb5bb0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_idxx_SummaryOfSignificantAccountingPoliciesLineItems_4ebf49ca-588d-4850-b8c5-cc0c55cbfda9" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_ae9bdb89-ede0-44b2-9404-5b4d6cb5bb0a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_SummaryOfSignificantAccountingPoliciesTable_2c60145f-2237-49fc-8d6e-640749f2fede" xlink:href="idxx-20211231.xsd#idxx_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_idxx_SummaryOfSignificantAccountingPoliciesLineItems_4ebf49ca-588d-4850-b8c5-cc0c55cbfda9" xlink:to="loc_idxx_SummaryOfSignificantAccountingPoliciesTable_2c60145f-2237-49fc-8d6e-640749f2fede" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_c6333926-485a-4f75-95d7-7cd9b179d7aa" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_idxx_SummaryOfSignificantAccountingPoliciesTable_2c60145f-2237-49fc-8d6e-640749f2fede" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_c6333926-485a-4f75-95d7-7cd9b179d7aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_c6333926-485a-4f75-95d7-7cd9b179d7aa_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_c6333926-485a-4f75-95d7-7cd9b179d7aa" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_c6333926-485a-4f75-95d7-7cd9b179d7aa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_3de38c7b-eda0-4598-bdbf-ea6271dd9984" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_c6333926-485a-4f75-95d7-7cd9b179d7aa" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_3de38c7b-eda0-4598-bdbf-ea6271dd9984" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_ac8f953d-b434-4518-9455-863121e5a2bd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_3de38c7b-eda0-4598-bdbf-ea6271dd9984" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_ac8f953d-b434-4518-9455-863121e5a2bd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_72231795-2871-46f8-85b7-854cba126312" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_idxx_SummaryOfSignificantAccountingPoliciesTable_2c60145f-2237-49fc-8d6e-640749f2fede" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_72231795-2871-46f8-85b7-854cba126312" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_72231795-2871-46f8-85b7-854cba126312_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_72231795-2871-46f8-85b7-854cba126312" xlink:to="loc_us-gaap_TypeOfAdoptionMember_72231795-2871-46f8-85b7-854cba126312_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_6ae1e298-69f3-48d5-b9e6-58fe3ecec0a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_72231795-2871-46f8-85b7-854cba126312" xlink:to="loc_us-gaap_TypeOfAdoptionMember_6ae1e298-69f3-48d5-b9e6-58fe3ecec0a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member_8594d7d1-ac09-4583-80d5-3de5e59387ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_6ae1e298-69f3-48d5-b9e6-58fe3ecec0a6" xlink:to="loc_us-gaap_AccountingStandardsUpdate201613Member_8594d7d1-ac09-4583-80d5-3de5e59387ce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_0c06d606-6cd2-450d-9a08-8abd67264e0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_idxx_SummaryOfSignificantAccountingPoliciesTable_2c60145f-2237-49fc-8d6e-640749f2fede" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_0c06d606-6cd2-450d-9a08-8abd67264e0b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0c06d606-6cd2-450d-9a08-8abd67264e0b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0c06d606-6cd2-450d-9a08-8abd67264e0b" xlink:to="loc_us-gaap_EquityComponentDomain_0c06d606-6cd2-450d-9a08-8abd67264e0b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_66698ae9-4493-41af-9a0d-078215f0bd9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0c06d606-6cd2-450d-9a08-8abd67264e0b" xlink:to="loc_us-gaap_EquityComponentDomain_66698ae9-4493-41af-9a0d-078215f0bd9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_bfc2a843-4d4a-4f99-b045-8c98321a605c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_66698ae9-4493-41af-9a0d-078215f0bd9b" xlink:to="loc_us-gaap_RetainedEarningsMember_bfc2a843-4d4a-4f99-b045-8c98321a605c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.idexx.com/role/RevenueRecognitionDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#RevenueRecognitionDetails"/>
  <link:definitionLink xlink:role="http://www.idexx.com/role/RevenueRecognitionDetails" xlink:type="extended" id="i184399c6f96c437582736f0ce7792ed8_RevenueRecognitionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_edd4dce5-cccd-4fde-b3ee-db9b89f2fb69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_RevenuePerformanceObligationPaymentTerm_32b82605-fe9d-46ba-a9d0-bff65538c816" xlink:href="idxx-20211231.xsd#idxx_RevenuePerformanceObligationPaymentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_edd4dce5-cccd-4fde-b3ee-db9b89f2fb69" xlink:to="loc_idxx_RevenuePerformanceObligationPaymentTerm_32b82605-fe9d-46ba-a9d0-bff65538c816" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_443c16f5-7257-42c3-bb99-7476fa648e50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_edd4dce5-cccd-4fde-b3ee-db9b89f2fb69" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_443c16f5-7257-42c3-bb99-7476fa648e50" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7ca4c4bc-b158-4dc9-8fff-a21cce968f2b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_443c16f5-7257-42c3-bb99-7476fa648e50" xlink:to="loc_srt_RangeAxis_7ca4c4bc-b158-4dc9-8fff-a21cce968f2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7ca4c4bc-b158-4dc9-8fff-a21cce968f2b_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_7ca4c4bc-b158-4dc9-8fff-a21cce968f2b" xlink:to="loc_srt_RangeMember_7ca4c4bc-b158-4dc9-8fff-a21cce968f2b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6b9b2020-9e88-4d72-9e87-4a70bb8868e5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_7ca4c4bc-b158-4dc9-8fff-a21cce968f2b" xlink:to="loc_srt_RangeMember_6b9b2020-9e88-4d72-9e87-4a70bb8868e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_568d6c06-1ae0-4d3c-9fd3-b15b728846a7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_6b9b2020-9e88-4d72-9e87-4a70bb8868e5" xlink:to="loc_srt_MinimumMember_568d6c06-1ae0-4d3c-9fd3-b15b728846a7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6b70a51b-5b77-4b2b-8857-2c99a1c30ca4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_6b9b2020-9e88-4d72-9e87-4a70bb8868e5" xlink:to="loc_srt_MaximumMember_6b70a51b-5b77-4b2b-8857-2c99a1c30ca4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.idexx.com/role/RevenueRecognitionExtendedWarrantiesandPostContractSupportDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#RevenueRecognitionExtendedWarrantiesandPostContractSupportDetails"/>
  <link:definitionLink xlink:role="http://www.idexx.com/role/RevenueRecognitionExtendedWarrantiesandPostContractSupportDetails" xlink:type="extended" id="ic2d4830504dd4dffac8e2688a96e2ba0_RevenueRecognitionExtendedWarrantiesandPostContractSupportDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_90f1d2f2-f909-49b8-bbf9-99015461b6d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ExtendedProductWarrantyTerm_99f1fe89-2fbe-4b45-9a57-7ddf8e053bb7" xlink:href="idxx-20211231.xsd#idxx_ExtendedProductWarrantyTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_90f1d2f2-f909-49b8-bbf9-99015461b6d6" xlink:to="loc_idxx_ExtendedProductWarrantyTerm_99f1fe89-2fbe-4b45-9a57-7ddf8e053bb7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_PostContractSupportContractTerm_a2c676ac-44e6-4869-92ae-ecab7e02c8fe" xlink:href="idxx-20211231.xsd#idxx_PostContractSupportContractTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_90f1d2f2-f909-49b8-bbf9-99015461b6d6" xlink:to="loc_idxx_PostContractSupportContractTerm_a2c676ac-44e6-4869-92ae-ecab7e02c8fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_65dc872d-fa85-4e9f-80a5-2b10bd53f8d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_90f1d2f2-f909-49b8-bbf9-99015461b6d6" xlink:to="loc_us-gaap_ContractWithCustomerLiability_65dc872d-fa85-4e9f-80a5-2b10bd53f8d4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_3ac02d18-721f-4a01-b063-942b55a23acd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_90f1d2f2-f909-49b8-bbf9-99015461b6d6" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_3ac02d18-721f-4a01-b063-942b55a23acd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_f6d6c654-1da2-4df1-b707-e9c1eb534ff2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_90f1d2f2-f909-49b8-bbf9-99015461b6d6" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_f6d6c654-1da2-4df1-b707-e9c1eb534ff2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_7ecc3736-9292-4a3c-8502-0a8d7fb61fc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_90f1d2f2-f909-49b8-bbf9-99015461b6d6" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_7ecc3736-9292-4a3c-8502-0a8d7fb61fc7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_35671539-460e-4ff1-aada-58f56c9d7e60" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_7ecc3736-9292-4a3c-8502-0a8d7fb61fc7" xlink:to="loc_srt_ProductOrServiceAxis_35671539-460e-4ff1-aada-58f56c9d7e60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_35671539-460e-4ff1-aada-58f56c9d7e60_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_35671539-460e-4ff1-aada-58f56c9d7e60" xlink:to="loc_srt_ProductsAndServicesDomain_35671539-460e-4ff1-aada-58f56c9d7e60_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_45a97a9b-4368-4380-82dd-e45e48f8d39f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_35671539-460e-4ff1-aada-58f56c9d7e60" xlink:to="loc_srt_ProductsAndServicesDomain_45a97a9b-4368-4380-82dd-e45e48f8d39f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ExtendedWarrantiesAndPostContractSupportMember_8f46d451-8539-4e39-bf3e-66416d361b7e" xlink:href="idxx-20211231.xsd#idxx_ExtendedWarrantiesAndPostContractSupportMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_45a97a9b-4368-4380-82dd-e45e48f8d39f" xlink:to="loc_idxx_ExtendedWarrantiesAndPostContractSupportMember_8f46d451-8539-4e39-bf3e-66416d361b7e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a0e2199f-af68-407a-96ec-24a08f2b46f5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_7ecc3736-9292-4a3c-8502-0a8d7fb61fc7" xlink:to="loc_srt_RangeAxis_a0e2199f-af68-407a-96ec-24a08f2b46f5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a0e2199f-af68-407a-96ec-24a08f2b46f5_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_a0e2199f-af68-407a-96ec-24a08f2b46f5" xlink:to="loc_srt_RangeMember_a0e2199f-af68-407a-96ec-24a08f2b46f5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_27b5194b-94bb-4a01-9230-acd456456dc7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_a0e2199f-af68-407a-96ec-24a08f2b46f5" xlink:to="loc_srt_RangeMember_27b5194b-94bb-4a01-9230-acd456456dc7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_07ecba2f-74f4-43b8-afe4-2f41d4ed1711" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_27b5194b-94bb-4a01-9230-acd456456dc7" xlink:to="loc_srt_MinimumMember_07ecba2f-74f4-43b8-afe4-2f41d4ed1711" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6a2b379b-0b59-4054-8676-7473f4319d61" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_27b5194b-94bb-4a01-9230-acd456456dc7" xlink:to="loc_srt_MaximumMember_6a2b379b-0b59-4054-8676-7473f4319d61" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.idexx.com/role/RevenueRecognitionRemainingPerformanceObligationDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#RevenueRecognitionRemainingPerformanceObligationDetails"/>
  <link:definitionLink xlink:role="http://www.idexx.com/role/RevenueRecognitionRemainingPerformanceObligationDetails" xlink:type="extended" id="ic9980c303d8c45fc84b8c2b2eec50efd_RevenueRecognitionRemainingPerformanceObligationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_32ab717b-c240-4c76-b0bf-0328691bcff2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_1ab92d26-00a5-40e8-969c-0b5027ac1e45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_32ab717b-c240-4c76-b0bf-0328691bcff2" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_1ab92d26-00a5-40e8-969c-0b5027ac1e45" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_289cf5f8-7d70-4d8a-8674-3e8724f61223" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_32ab717b-c240-4c76-b0bf-0328691bcff2" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_289cf5f8-7d70-4d8a-8674-3e8724f61223" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_9fe624b6-bb26-4296-905d-c9442f84b165" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_32ab717b-c240-4c76-b0bf-0328691bcff2" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_9fe624b6-bb26-4296-905d-c9442f84b165" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_96e8a069-e5bf-4adc-8f00-3af20397e7ed" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_9fe624b6-bb26-4296-905d-c9442f84b165" xlink:to="loc_srt_ProductOrServiceAxis_96e8a069-e5bf-4adc-8f00-3af20397e7ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_96e8a069-e5bf-4adc-8f00-3af20397e7ed_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_96e8a069-e5bf-4adc-8f00-3af20397e7ed" xlink:to="loc_srt_ProductsAndServicesDomain_96e8a069-e5bf-4adc-8f00-3af20397e7ed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a7bb78ec-a885-4f4e-b8c7-8fd6395d5116" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_96e8a069-e5bf-4adc-8f00-3af20397e7ed" xlink:to="loc_srt_ProductsAndServicesDomain_a7bb78ec-a885-4f4e-b8c7-8fd6395d5116" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ExtendedWarrantiesAndPostContractSupportMember_ceb908c5-98c4-4667-9ccb-4ac48d9c9cc7" xlink:href="idxx-20211231.xsd#idxx_ExtendedWarrantiesAndPostContractSupportMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_a7bb78ec-a885-4f4e-b8c7-8fd6395d5116" xlink:to="loc_idxx_ExtendedWarrantiesAndPostContractSupportMember_ceb908c5-98c4-4667-9ccb-4ac48d9c9cc7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_UpFrontCustomerLoyaltyProgramsAndVolumeCommitmentProgramsMember_18c3cbf0-fe57-44e3-88dc-d9c3d58935d5" xlink:href="idxx-20211231.xsd#idxx_UpFrontCustomerLoyaltyProgramsAndVolumeCommitmentProgramsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_a7bb78ec-a885-4f4e-b8c7-8fd6395d5116" xlink:to="loc_idxx_UpFrontCustomerLoyaltyProgramsAndVolumeCommitmentProgramsMember_18c3cbf0-fe57-44e3-88dc-d9c3d58935d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_InstrumentRebateProgramsMember_fcc3c23b-0a0b-43bc-9a91-71db3f92f98f" xlink:href="idxx-20211231.xsd#idxx_InstrumentRebateProgramsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_a7bb78ec-a885-4f4e-b8c7-8fd6395d5116" xlink:to="loc_idxx_InstrumentRebateProgramsMember_fcc3c23b-0a0b-43bc-9a91-71db3f92f98f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ReagentRentalProgramsMember_a1ad4691-b968-4ab1-bb8a-1221d09d1f1e" xlink:href="idxx-20211231.xsd#idxx_ReagentRentalProgramsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_a7bb78ec-a885-4f4e-b8c7-8fd6395d5116" xlink:to="loc_idxx_ReagentRentalProgramsMember_a1ad4691-b968-4ab1-bb8a-1221d09d1f1e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_72f6d167-8a6e-4be4-9aed-51b488b5f0d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_9fe624b6-bb26-4296-905d-c9442f84b165" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_72f6d167-8a6e-4be4-9aed-51b488b5f0d6" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.idexx.com/role/RevenueRecognitionRemainingPerformanceObligationDetails_1" xlink:type="simple" xlink:href="idxx-20211231.xsd#RevenueRecognitionRemainingPerformanceObligationDetails_1"/>
  <link:definitionLink xlink:role="http://www.idexx.com/role/RevenueRecognitionRemainingPerformanceObligationDetails_1" xlink:type="extended" id="i9b0eace4a83d45938d841386ec0a8b62_RevenueRecognitionRemainingPerformanceObligationDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_32ab717b-c240-4c76-b0bf-0328691bcff2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_1ab92d26-00a5-40e8-969c-0b5027ac1e45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_32ab717b-c240-4c76-b0bf-0328691bcff2" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_1ab92d26-00a5-40e8-969c-0b5027ac1e45" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_289cf5f8-7d70-4d8a-8674-3e8724f61223" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_32ab717b-c240-4c76-b0bf-0328691bcff2" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_289cf5f8-7d70-4d8a-8674-3e8724f61223" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_9fe624b6-bb26-4296-905d-c9442f84b165" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_32ab717b-c240-4c76-b0bf-0328691bcff2" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_9fe624b6-bb26-4296-905d-c9442f84b165" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_96e8a069-e5bf-4adc-8f00-3af20397e7ed" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_9fe624b6-bb26-4296-905d-c9442f84b165" xlink:to="loc_srt_ProductOrServiceAxis_96e8a069-e5bf-4adc-8f00-3af20397e7ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_96e8a069-e5bf-4adc-8f00-3af20397e7ed_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_96e8a069-e5bf-4adc-8f00-3af20397e7ed" xlink:to="loc_srt_ProductsAndServicesDomain_96e8a069-e5bf-4adc-8f00-3af20397e7ed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a7bb78ec-a885-4f4e-b8c7-8fd6395d5116" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_96e8a069-e5bf-4adc-8f00-3af20397e7ed" xlink:to="loc_srt_ProductsAndServicesDomain_a7bb78ec-a885-4f4e-b8c7-8fd6395d5116" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ExtendedWarrantiesAndPostContractSupportMember_ceb908c5-98c4-4667-9ccb-4ac48d9c9cc7" xlink:href="idxx-20211231.xsd#idxx_ExtendedWarrantiesAndPostContractSupportMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_a7bb78ec-a885-4f4e-b8c7-8fd6395d5116" xlink:to="loc_idxx_ExtendedWarrantiesAndPostContractSupportMember_ceb908c5-98c4-4667-9ccb-4ac48d9c9cc7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_UpFrontCustomerLoyaltyProgramsAndVolumeCommitmentProgramsMember_18c3cbf0-fe57-44e3-88dc-d9c3d58935d5" xlink:href="idxx-20211231.xsd#idxx_UpFrontCustomerLoyaltyProgramsAndVolumeCommitmentProgramsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_a7bb78ec-a885-4f4e-b8c7-8fd6395d5116" xlink:to="loc_idxx_UpFrontCustomerLoyaltyProgramsAndVolumeCommitmentProgramsMember_18c3cbf0-fe57-44e3-88dc-d9c3d58935d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_InstrumentRebateProgramsMember_fcc3c23b-0a0b-43bc-9a91-71db3f92f98f" xlink:href="idxx-20211231.xsd#idxx_InstrumentRebateProgramsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_a7bb78ec-a885-4f4e-b8c7-8fd6395d5116" xlink:to="loc_idxx_InstrumentRebateProgramsMember_fcc3c23b-0a0b-43bc-9a91-71db3f92f98f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ReagentRentalProgramsMember_a1ad4691-b968-4ab1-bb8a-1221d09d1f1e" xlink:href="idxx-20211231.xsd#idxx_ReagentRentalProgramsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_a7bb78ec-a885-4f4e-b8c7-8fd6395d5116" xlink:to="loc_idxx_ReagentRentalProgramsMember_a1ad4691-b968-4ab1-bb8a-1221d09d1f1e" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.idexx.com/role/RevenueRecognitionSaaSSubscriptionsDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#RevenueRecognitionSaaSSubscriptionsDetails"/>
  <link:definitionLink xlink:role="http://www.idexx.com/role/RevenueRecognitionSaaSSubscriptionsDetails" xlink:type="extended" id="iafd2ecd7466d4240938197ce2bfe1c62_RevenueRecognitionSaaSSubscriptionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_99fef48d-1d8c-490d-bf06-a243c44c8371" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_SaasSubscriptionTermOfContract_918c04d1-5741-451e-84f1-5c2548e1b9cd" xlink:href="idxx-20211231.xsd#idxx_SaasSubscriptionTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_99fef48d-1d8c-490d-bf06-a243c44c8371" xlink:to="loc_idxx_SaasSubscriptionTermOfContract_918c04d1-5741-451e-84f1-5c2548e1b9cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_773bccda-5d4b-4b7e-9f22-a2bee7f29c11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_99fef48d-1d8c-490d-bf06-a243c44c8371" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_773bccda-5d4b-4b7e-9f22-a2bee7f29c11" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_b589be01-aec1-40af-b3b4-bceb8793666a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_773bccda-5d4b-4b7e-9f22-a2bee7f29c11" xlink:to="loc_srt_RangeAxis_b589be01-aec1-40af-b3b4-bceb8793666a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b589be01-aec1-40af-b3b4-bceb8793666a_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_b589be01-aec1-40af-b3b4-bceb8793666a" xlink:to="loc_srt_RangeMember_b589be01-aec1-40af-b3b4-bceb8793666a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8e8061c1-0c16-4d3d-8ccf-ad80b594a033" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_b589be01-aec1-40af-b3b4-bceb8793666a" xlink:to="loc_srt_RangeMember_8e8061c1-0c16-4d3d-8ccf-ad80b594a033" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4730eb08-e612-478d-840d-e08698f6bd5c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8e8061c1-0c16-4d3d-8ccf-ad80b594a033" xlink:to="loc_srt_MaximumMember_4730eb08-e612-478d-840d-e08698f6bd5c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.idexx.com/role/RevenueRecognitionUpFrontCustomerLoyaltyProgramsDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#RevenueRecognitionUpFrontCustomerLoyaltyProgramsDetails"/>
  <link:definitionLink xlink:role="http://www.idexx.com/role/RevenueRecognitionUpFrontCustomerLoyaltyProgramsDetails" xlink:type="extended" id="i402bd3ab2398414d9deac11f87d6588b_RevenueRecognitionUpFrontCustomerLoyaltyProgramsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_9f1ab001-f334-4cd9-a0cf-93d2a5e1cb13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostGross_bac22cee-4c7e-4de3-8ef5-574ea8ace171" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_9f1ab001-f334-4cd9-a0cf-93d2a5e1cb13" xlink:to="loc_us-gaap_CapitalizedContractCostGross_bac22cee-4c7e-4de3-8ef5-574ea8ace171" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortization_1784f561-a25c-4df5-88f3-46a67e54f5f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_9f1ab001-f334-4cd9-a0cf-93d2a5e1cb13" xlink:to="loc_us-gaap_CapitalizedContractCostAmortization_1784f561-a25c-4df5-88f3-46a67e54f5f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_ed4ad73b-bc75-471b-9c18-32c3c2ed9ae1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_9f1ab001-f334-4cd9-a0cf-93d2a5e1cb13" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_ed4ad73b-bc75-471b-9c18-32c3c2ed9ae1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_f838d36d-4bab-495b-a69d-4aa8b7e34189" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_ed4ad73b-bc75-471b-9c18-32c3c2ed9ae1" xlink:to="loc_srt_ProductOrServiceAxis_f838d36d-4bab-495b-a69d-4aa8b7e34189" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_f838d36d-4bab-495b-a69d-4aa8b7e34189_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_f838d36d-4bab-495b-a69d-4aa8b7e34189" xlink:to="loc_srt_ProductsAndServicesDomain_f838d36d-4bab-495b-a69d-4aa8b7e34189_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_da0e84dd-5e30-4c1b-a508-bced0aa6c4cf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_f838d36d-4bab-495b-a69d-4aa8b7e34189" xlink:to="loc_srt_ProductsAndServicesDomain_da0e84dd-5e30-4c1b-a508-bced0aa6c4cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_UpFrontCustomerLoyaltyProgramsMember_da77a0f0-a7b0-41fe-9e99-128c62533de1" xlink:href="idxx-20211231.xsd#idxx_UpFrontCustomerLoyaltyProgramsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_da0e84dd-5e30-4c1b-a508-bced0aa6c4cf" xlink:to="loc_idxx_UpFrontCustomerLoyaltyProgramsMember_da77a0f0-a7b0-41fe-9e99-128c62533de1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.idexx.com/role/RevenueRecognitionVolumeCommitmentProgramsDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#RevenueRecognitionVolumeCommitmentProgramsDetails"/>
  <link:definitionLink xlink:role="http://www.idexx.com/role/RevenueRecognitionVolumeCommitmentProgramsDetails" xlink:type="extended" id="i83d298f6258e40edafdbe927fc5019f8_RevenueRecognitionVolumeCommitmentProgramsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_7ff2c331-ab2c-4644-8058-d51c5e5a0720" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_90ea9021-61c1-45f9-b33e-776f1d203f2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_7ff2c331-ab2c-4644-8058-d51c5e5a0720" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_90ea9021-61c1-45f9-b33e-776f1d203f2b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable_9f1768f1-2f44-48fc-918e-d1e0c86e68a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetReclassifiedToReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_7ff2c331-ab2c-4644-8058-d51c5e5a0720" xlink:to="loc_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable_9f1768f1-2f44-48fc-918e-d1e0c86e68a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_99f65fe6-c1b4-4b36-8523-16f059231166" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_7ff2c331-ab2c-4644-8058-d51c5e5a0720" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_99f65fe6-c1b4-4b36-8523-16f059231166" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_4e2a0da4-9122-468c-8acc-b16bacec53ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_7ff2c331-ab2c-4644-8058-d51c5e5a0720" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_4e2a0da4-9122-468c-8acc-b16bacec53ff" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c31c2c15-3076-49ac-9fef-4390093538a2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_4e2a0da4-9122-468c-8acc-b16bacec53ff" xlink:to="loc_srt_ProductOrServiceAxis_c31c2c15-3076-49ac-9fef-4390093538a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c31c2c15-3076-49ac-9fef-4390093538a2_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_c31c2c15-3076-49ac-9fef-4390093538a2" xlink:to="loc_srt_ProductsAndServicesDomain_c31c2c15-3076-49ac-9fef-4390093538a2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_74e238cd-64db-4d64-8287-d7364490f6ad" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_c31c2c15-3076-49ac-9fef-4390093538a2" xlink:to="loc_srt_ProductsAndServicesDomain_74e238cd-64db-4d64-8287-d7364490f6ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_VolumeCommitmentProgramsMember_ded74986-830b-49c2-83da-53f0d5632c05" xlink:href="idxx-20211231.xsd#idxx_VolumeCommitmentProgramsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_74e238cd-64db-4d64-8287-d7364490f6ad" xlink:to="loc_idxx_VolumeCommitmentProgramsMember_ded74986-830b-49c2-83da-53f0d5632c05" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_UpFrontCustomerLoyaltyProgramsAndVolumeCommitmentProgramsMember_7bd28d5d-6aa2-4126-abd3-4f78afa7c875" xlink:href="idxx-20211231.xsd#idxx_UpFrontCustomerLoyaltyProgramsAndVolumeCommitmentProgramsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_74e238cd-64db-4d64-8287-d7364490f6ad" xlink:to="loc_idxx_UpFrontCustomerLoyaltyProgramsAndVolumeCommitmentProgramsMember_7bd28d5d-6aa2-4126-abd3-4f78afa7c875" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.idexx.com/role/RevenueRecognitionInstrumentRebateProgramsDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#RevenueRecognitionInstrumentRebateProgramsDetails"/>
  <link:definitionLink xlink:role="http://www.idexx.com/role/RevenueRecognitionInstrumentRebateProgramsDetails" xlink:type="extended" id="i8001fb79d6484e4cbbe23e968d3f2f19_RevenueRecognitionInstrumentRebateProgramsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_d15f442a-e420-4278-9460-d694d8c74c2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_eb3542d3-274d-4186-89c9-9be2066bdb90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_d15f442a-e420-4278-9460-d694d8c74c2d" xlink:to="loc_us-gaap_ContractWithCustomerLiability_eb3542d3-274d-4186-89c9-9be2066bdb90" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_dc223f63-ac22-48e3-9ef5-9e5e262d3f28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_d15f442a-e420-4278-9460-d694d8c74c2d" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_dc223f63-ac22-48e3-9ef5-9e5e262d3f28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_6f56e925-4ef8-4ed4-8f1f-e10dfba82bb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_d15f442a-e420-4278-9460-d694d8c74c2d" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_6f56e925-4ef8-4ed4-8f1f-e10dfba82bb0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_8885d75f-86a3-46d1-932f-02c62a341aec" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_6f56e925-4ef8-4ed4-8f1f-e10dfba82bb0" xlink:to="loc_srt_ProductOrServiceAxis_8885d75f-86a3-46d1-932f-02c62a341aec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_8885d75f-86a3-46d1-932f-02c62a341aec_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_8885d75f-86a3-46d1-932f-02c62a341aec" xlink:to="loc_srt_ProductsAndServicesDomain_8885d75f-86a3-46d1-932f-02c62a341aec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_647d7335-7316-4763-85a6-edbf8092192f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_8885d75f-86a3-46d1-932f-02c62a341aec" xlink:to="loc_srt_ProductsAndServicesDomain_647d7335-7316-4763-85a6-edbf8092192f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_InstrumentRebateProgramsMember_973aa45a-41f6-4ba3-a337-2b3cfc961e2d" xlink:href="idxx-20211231.xsd#idxx_InstrumentRebateProgramsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_647d7335-7316-4763-85a6-edbf8092192f" xlink:to="loc_idxx_InstrumentRebateProgramsMember_973aa45a-41f6-4ba3-a337-2b3cfc961e2d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.idexx.com/role/RevenueRecognitionReagentRentalProgramsDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#RevenueRecognitionReagentRentalProgramsDetails"/>
  <link:definitionLink xlink:role="http://www.idexx.com/role/RevenueRecognitionReagentRentalProgramsDetails" xlink:type="extended" id="i646af61fb26f441ca31c7e2185267503_RevenueRecognitionReagentRentalProgramsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_ad77cdfb-ca99-4fe6-bbf9-644d8591d1ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseLeaseReceivable_9b827c35-b441-438e-85de-9989f482dbc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseLeaseReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_ad77cdfb-ca99-4fe6-bbf9-644d8591d1ea" xlink:to="loc_us-gaap_SalesTypeLeaseLeaseReceivable_9b827c35-b441-438e-85de-9989f482dbc3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_SalesTypeLeaseLeaseReceivableReclassifiedToReceivable_5a7f3917-c951-4dab-9f99-cda96a0d1332" xlink:href="idxx-20211231.xsd#idxx_SalesTypeLeaseLeaseReceivableReclassifiedToReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_ad77cdfb-ca99-4fe6-bbf9-644d8591d1ea" xlink:to="loc_idxx_SalesTypeLeaseLeaseReceivableReclassifiedToReceivable_5a7f3917-c951-4dab-9f99-cda96a0d1332" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_2cf9c92e-c686-4dfd-8791-1117a6bf73d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_ad77cdfb-ca99-4fe6-bbf9-644d8591d1ea" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_2cf9c92e-c686-4dfd-8791-1117a6bf73d2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_ec6c9a79-8d47-48fe-9c13-9a19efcec5cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_ad77cdfb-ca99-4fe6-bbf9-644d8591d1ea" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_ec6c9a79-8d47-48fe-9c13-9a19efcec5cb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_22a72cd6-aaa9-4634-bf6a-368f2a3b14da" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_ec6c9a79-8d47-48fe-9c13-9a19efcec5cb" xlink:to="loc_srt_ProductOrServiceAxis_22a72cd6-aaa9-4634-bf6a-368f2a3b14da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_22a72cd6-aaa9-4634-bf6a-368f2a3b14da_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_22a72cd6-aaa9-4634-bf6a-368f2a3b14da" xlink:to="loc_srt_ProductsAndServicesDomain_22a72cd6-aaa9-4634-bf6a-368f2a3b14da_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_76236ca2-eec2-42e0-9e43-71bfa7afc406" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_22a72cd6-aaa9-4634-bf6a-368f2a3b14da" xlink:to="loc_srt_ProductsAndServicesDomain_76236ca2-eec2-42e0-9e43-71bfa7afc406" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ReagentRentalProgramsMember_57cb61d4-a9ea-44c9-83b6-0ec61df33097" xlink:href="idxx-20211231.xsd#idxx_ReagentRentalProgramsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_76236ca2-eec2-42e0-9e43-71bfa7afc406" xlink:to="loc_idxx_ReagentRentalProgramsMember_57cb61d4-a9ea-44c9-83b6-0ec61df33097" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.idexx.com/role/RevenueRecognitionDisaggregationofRevenuebyMajorProductandServiceCategoriesDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#RevenueRecognitionDisaggregationofRevenuebyMajorProductandServiceCategoriesDetails"/>
  <link:definitionLink xlink:role="http://www.idexx.com/role/RevenueRecognitionDisaggregationofRevenuebyMajorProductandServiceCategoriesDetails" xlink:type="extended" id="idffc1e85eb18480d8f83c30c2186385a_RevenueRecognitionDisaggregationofRevenuebyMajorProductandServiceCategoriesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_274a93fe-4baa-4f04-a821-eaf512d1be46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_62d2770c-6819-4127-a386-a529a49e4f58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_274a93fe-4baa-4f04-a821-eaf512d1be46" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_62d2770c-6819-4127-a386-a529a49e4f58" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_0d7bbee3-1199-4b04-aebd-1bf7a0e90e25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_274a93fe-4baa-4f04-a821-eaf512d1be46" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_0d7bbee3-1199-4b04-aebd-1bf7a0e90e25" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d59ed5f4-1c3d-410b-80f7-46177acf9076" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_0d7bbee3-1199-4b04-aebd-1bf7a0e90e25" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d59ed5f4-1c3d-410b-80f7-46177acf9076" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d59ed5f4-1c3d-410b-80f7-46177acf9076_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d59ed5f4-1c3d-410b-80f7-46177acf9076" xlink:to="loc_us-gaap_SegmentDomain_d59ed5f4-1c3d-410b-80f7-46177acf9076_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_74b672f4-ab35-47b2-ab75-6c5b53c071b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d59ed5f4-1c3d-410b-80f7-46177acf9076" xlink:to="loc_us-gaap_SegmentDomain_74b672f4-ab35-47b2-ab75-6c5b53c071b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_CompanionAnimalGroupSegmentMember_8a4be11f-64e1-49b7-8543-03cd4c40ea39" xlink:href="idxx-20211231.xsd#idxx_CompanionAnimalGroupSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_74b672f4-ab35-47b2-ab75-6c5b53c071b4" xlink:to="loc_idxx_CompanionAnimalGroupSegmentMember_8a4be11f-64e1-49b7-8543-03cd4c40ea39" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_WaterSegmentMember_a6e65226-94be-49f5-89f2-d0d46f9e6edf" xlink:href="idxx-20211231.xsd#idxx_WaterSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_74b672f4-ab35-47b2-ab75-6c5b53c071b4" xlink:to="loc_idxx_WaterSegmentMember_a6e65226-94be-49f5-89f2-d0d46f9e6edf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_LivestockAndPoultryDiagnosticsSegmentMember_11c1eb8b-ee84-4512-b90a-086a375c58ca" xlink:href="idxx-20211231.xsd#idxx_LivestockAndPoultryDiagnosticsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_74b672f4-ab35-47b2-ab75-6c5b53c071b4" xlink:to="loc_idxx_LivestockAndPoultryDiagnosticsSegmentMember_11c1eb8b-ee84-4512-b90a-086a375c58ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_OtherSegmentMember_f158d622-72e6-425b-a245-285cb5d7975d" xlink:href="idxx-20211231.xsd#idxx_OtherSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_74b672f4-ab35-47b2-ab75-6c5b53c071b4" xlink:to="loc_idxx_OtherSegmentMember_f158d622-72e6-425b-a245-285cb5d7975d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_f80a1070-5d49-497c-917d-d2c82fec836f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_0d7bbee3-1199-4b04-aebd-1bf7a0e90e25" xlink:to="loc_srt_ProductOrServiceAxis_f80a1070-5d49-497c-917d-d2c82fec836f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_f80a1070-5d49-497c-917d-d2c82fec836f_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_f80a1070-5d49-497c-917d-d2c82fec836f" xlink:to="loc_srt_ProductsAndServicesDomain_f80a1070-5d49-497c-917d-d2c82fec836f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_8736ff5d-7b39-457d-b27f-1646d30b786c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_f80a1070-5d49-497c-917d-d2c82fec836f" xlink:to="loc_srt_ProductsAndServicesDomain_8736ff5d-7b39-457d-b27f-1646d30b786c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_CAGDiagnosticsRecurringRevenueMember_6689cf78-494b-4d88-8421-f6adca943df8" xlink:href="idxx-20211231.xsd#idxx_CAGDiagnosticsRecurringRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_8736ff5d-7b39-457d-b27f-1646d30b786c" xlink:to="loc_idxx_CAGDiagnosticsRecurringRevenueMember_6689cf78-494b-4d88-8421-f6adca943df8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_VetLabConsumablesMember_e83dca70-9cbf-4eee-9260-03e28b923e2d" xlink:href="idxx-20211231.xsd#idxx_VetLabConsumablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_idxx_CAGDiagnosticsRecurringRevenueMember_6689cf78-494b-4d88-8421-f6adca943df8" xlink:to="loc_idxx_VetLabConsumablesMember_e83dca70-9cbf-4eee-9260-03e28b923e2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_RapidAssayProductsMember_6389bb9b-fd96-41ba-9b3c-becc636478bf" xlink:href="idxx-20211231.xsd#idxx_RapidAssayProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_idxx_CAGDiagnosticsRecurringRevenueMember_6689cf78-494b-4d88-8421-f6adca943df8" xlink:to="loc_idxx_RapidAssayProductsMember_6389bb9b-fd96-41ba-9b3c-becc636478bf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ReferenceLaboratoryDiagnosticAndConsultingServicesMember_8fa3dd12-1d71-4954-8055-849b39df7720" xlink:href="idxx-20211231.xsd#idxx_ReferenceLaboratoryDiagnosticAndConsultingServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_idxx_CAGDiagnosticsRecurringRevenueMember_6689cf78-494b-4d88-8421-f6adca943df8" xlink:to="loc_idxx_ReferenceLaboratoryDiagnosticAndConsultingServicesMember_8fa3dd12-1d71-4954-8055-849b39df7720" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_CAGDiagnosticsServiceAndAccessoriesMember_7a518c57-eec9-40ab-ae41-e7354718ca5c" xlink:href="idxx-20211231.xsd#idxx_CAGDiagnosticsServiceAndAccessoriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_idxx_CAGDiagnosticsRecurringRevenueMember_6689cf78-494b-4d88-8421-f6adca943df8" xlink:to="loc_idxx_CAGDiagnosticsServiceAndAccessoriesMember_7a518c57-eec9-40ab-ae41-e7354718ca5c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_CAGDiagnosticCapitalVetlabInstrumentsMember_f5207d5e-383f-4f9c-ba02-067841742985" xlink:href="idxx-20211231.xsd#idxx_CAGDiagnosticCapitalVetlabInstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_8736ff5d-7b39-457d-b27f-1646d30b786c" xlink:to="loc_idxx_CAGDiagnosticCapitalVetlabInstrumentsMember_f5207d5e-383f-4f9c-ba02-067841742985" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_VeterinarySoftwareServicesAndDiagnosticImagingSystemsMember_cc6341bc-530c-43c6-b102-22b1870c9ff7" xlink:href="idxx-20211231.xsd#idxx_VeterinarySoftwareServicesAndDiagnosticImagingSystemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_8736ff5d-7b39-457d-b27f-1646d30b786c" xlink:to="loc_idxx_VeterinarySoftwareServicesAndDiagnosticImagingSystemsMember_cc6341bc-530c-43c6-b102-22b1870c9ff7" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.idexx.com/role/RevenueRecognitionDisaggregationofRevenuebyPrincipalGeographicAreaBasedonCustomersDomicilesDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#RevenueRecognitionDisaggregationofRevenuebyPrincipalGeographicAreaBasedonCustomersDomicilesDetails"/>
  <link:definitionLink xlink:role="http://www.idexx.com/role/RevenueRecognitionDisaggregationofRevenuebyPrincipalGeographicAreaBasedonCustomersDomicilesDetails" xlink:type="extended" id="i475d2852675e414cb0b1c298c7a6d918_RevenueRecognitionDisaggregationofRevenuebyPrincipalGeographicAreaBasedonCustomersDomicilesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_be1d12c0-d2f9-4b6e-98ec-cd24bdb86cf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9ed8ab1c-6c81-4d36-915a-173edc099626" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_be1d12c0-d2f9-4b6e-98ec-cd24bdb86cf3" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9ed8ab1c-6c81-4d36-915a-173edc099626" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_ab1bbf38-aa02-47cd-98c1-c8c68862e054" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_be1d12c0-d2f9-4b6e-98ec-cd24bdb86cf3" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_ab1bbf38-aa02-47cd-98c1-c8c68862e054" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_e6daeecb-fbff-4e72-b853-4952bb3fe373" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ab1bbf38-aa02-47cd-98c1-c8c68862e054" xlink:to="loc_srt_StatementGeographicalAxis_e6daeecb-fbff-4e72-b853-4952bb3fe373" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e6daeecb-fbff-4e72-b853-4952bb3fe373_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_e6daeecb-fbff-4e72-b853-4952bb3fe373" xlink:to="loc_srt_SegmentGeographicalDomain_e6daeecb-fbff-4e72-b853-4952bb3fe373_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_a1784ded-1d57-46c3-83e5-3f5a4729a13b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_e6daeecb-fbff-4e72-b853-4952bb3fe373" xlink:to="loc_srt_SegmentGeographicalDomain_a1784ded-1d57-46c3-83e5-3f5a4729a13b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember_9468091e-97c7-4852-a1df-89af758c5fc1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AmericasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a1784ded-1d57-46c3-83e5-3f5a4729a13b" xlink:to="loc_srt_AmericasMember_9468091e-97c7-4852-a1df-89af758c5fc1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_fb4a3a9f-03b1-44d1-a3ba-1c1d35faa3de" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_AmericasMember_9468091e-97c7-4852-a1df-89af758c5fc1" xlink:to="loc_country_US_fb4a3a9f-03b1-44d1-a3ba-1c1d35faa3de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_03721d30-2acf-4750-9e55-1522559804f4" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_AmericasMember_9468091e-97c7-4852-a1df-89af758c5fc1" xlink:to="loc_country_CA_03721d30-2acf-4750-9e55-1522559804f4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_LatinAmericaAndCaribbeanMember_8554de5d-00d4-4ec1-a60b-81449a0bfa1a" xlink:href="idxx-20211231.xsd#idxx_LatinAmericaAndCaribbeanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_AmericasMember_9468091e-97c7-4852-a1df-89af758c5fc1" xlink:to="loc_idxx_LatinAmericaAndCaribbeanMember_8554de5d-00d4-4ec1-a60b-81449a0bfa1a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_6e17b5dd-d69f-4b74-a213-77dd8c6b61a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EMEAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a1784ded-1d57-46c3-83e5-3f5a4729a13b" xlink:to="loc_us-gaap_EMEAMember_6e17b5dd-d69f-4b74-a213-77dd8c6b61a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE_7413c4ee-7f25-410e-9a3c-34028c4cc753" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_DE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EMEAMember_6e17b5dd-d69f-4b74-a213-77dd8c6b61a2" xlink:to="loc_country_DE_7413c4ee-7f25-410e-9a3c-34028c4cc753" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_585ed44c-bc64-4846-99d2-6485e183e9d6" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EMEAMember_6e17b5dd-d69f-4b74-a213-77dd8c6b61a2" xlink:to="loc_country_GB_585ed44c-bc64-4846-99d2-6485e183e9d6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR_044690ee-ca13-4e3a-9e51-f321b334e3d3" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_FR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EMEAMember_6e17b5dd-d69f-4b74-a213-77dd8c6b61a2" xlink:to="loc_country_FR_044690ee-ca13-4e3a-9e51-f321b334e3d3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IT_32227929-05dd-49c4-abda-bf4e5f385d42" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IT"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EMEAMember_6e17b5dd-d69f-4b74-a213-77dd8c6b61a2" xlink:to="loc_country_IT_32227929-05dd-49c4-abda-bf4e5f385d42" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_ES_2817c32c-5daf-40f7-969f-e9418f06ce89" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_ES"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EMEAMember_6e17b5dd-d69f-4b74-a213-77dd8c6b61a2" xlink:to="loc_country_ES_2817c32c-5daf-40f7-969f-e9418f06ce89" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_e110d2a0-0e66-4b2d-84b5-7c727a750522" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CH"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EMEAMember_6e17b5dd-d69f-4b74-a213-77dd8c6b61a2" xlink:to="loc_country_CH_e110d2a0-0e66-4b2d-84b5-7c727a750522" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_NL_e0e6a1fc-c184-47f7-b715-51b9509f5a58" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_NL"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EMEAMember_6e17b5dd-d69f-4b74-a213-77dd8c6b61a2" xlink:to="loc_country_NL_e0e6a1fc-c184-47f7-b715-51b9509f5a58" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_EuropetheMiddleEastandAfricaOtherMember_2165a161-8b71-40ac-9b73-fefa79b0df75" xlink:href="idxx-20211231.xsd#idxx_EuropetheMiddleEastandAfricaOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EMEAMember_6e17b5dd-d69f-4b74-a213-77dd8c6b61a2" xlink:to="loc_idxx_EuropetheMiddleEastandAfricaOtherMember_2165a161-8b71-40ac-9b73-fefa79b0df75" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_9bf721db-237b-4bd3-b9c5-cb574608fb89" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AsiaPacificMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a1784ded-1d57-46c3-83e5-3f5a4729a13b" xlink:to="loc_srt_AsiaPacificMember_9bf721db-237b-4bd3-b9c5-cb574608fb89" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_AU_1c548af4-fb92-4b0b-832c-77479b666d3e" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_AU"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_AsiaPacificMember_9bf721db-237b-4bd3-b9c5-cb574608fb89" xlink:to="loc_country_AU_1c548af4-fb92-4b0b-832c-77479b666d3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_JP_a0a95aba-4855-4103-8f24-34544f53eac3" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_JP"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_AsiaPacificMember_9bf721db-237b-4bd3-b9c5-cb574608fb89" xlink:to="loc_country_JP_a0a95aba-4855-4103-8f24-34544f53eac3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN_255baec0-e314-46a3-b96a-bd22bd586034" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CN"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_AsiaPacificMember_9bf721db-237b-4bd3-b9c5-cb574608fb89" xlink:to="loc_country_CN_255baec0-e314-46a3-b96a-bd22bd586034" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_AsiaPacificRegionOtherMember_2a397628-001a-4a6d-bf9a-8a15106e38ad" xlink:href="idxx-20211231.xsd#idxx_AsiaPacificRegionOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_AsiaPacificMember_9bf721db-237b-4bd3-b9c5-cb574608fb89" xlink:to="loc_idxx_AsiaPacificRegionOtherMember_2a397628-001a-4a6d-bf9a-8a15106e38ad" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.idexx.com/role/RevenueRecognitionCoststoObtainaContractDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#RevenueRecognitionCoststoObtainaContractDetails"/>
  <link:definitionLink xlink:role="http://www.idexx.com/role/RevenueRecognitionCoststoObtainaContractDetails" xlink:type="extended" id="ib908254e7ae5437aac258cf1792d42c9_RevenueRecognitionCoststoObtainaContractDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_81c32ace-8eff-4082-a730-d58b47e504c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortizationPeriod_f4879f76-862d-48ef-99a6-0448eed5afac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostAmortizationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_81c32ace-8eff-4082-a730-d58b47e504c5" xlink:to="loc_us-gaap_CapitalizedContractCostAmortizationPeriod_f4879f76-862d-48ef-99a6-0448eed5afac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNet_5dcfa237-f559-40da-bf36-fcaea554b0d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_81c32ace-8eff-4082-a730-d58b47e504c5" xlink:to="loc_us-gaap_CapitalizedContractCostNet_5dcfa237-f559-40da-bf36-fcaea554b0d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesCommissionsAndFees_d0a8e603-5cb5-4c17-b4b8-4f51ada23c61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesCommissionsAndFees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_81c32ace-8eff-4082-a730-d58b47e504c5" xlink:to="loc_us-gaap_SalesCommissionsAndFees_d0a8e603-5cb5-4c17-b4b8-4f51ada23c61" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_604cf6e2-864a-4ebe-bd21-27867db345bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_81c32ace-8eff-4082-a730-d58b47e504c5" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_604cf6e2-864a-4ebe-bd21-27867db345bb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_70a8ca27-d04d-4423-9837-c545f71e1211" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_604cf6e2-864a-4ebe-bd21-27867db345bb" xlink:to="loc_srt_RangeAxis_70a8ca27-d04d-4423-9837-c545f71e1211" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_70a8ca27-d04d-4423-9837-c545f71e1211_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_70a8ca27-d04d-4423-9837-c545f71e1211" xlink:to="loc_srt_RangeMember_70a8ca27-d04d-4423-9837-c545f71e1211_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5a0e4808-96b5-4ba7-ba3a-ee26b59244e7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_70a8ca27-d04d-4423-9837-c545f71e1211" xlink:to="loc_srt_RangeMember_5a0e4808-96b5-4ba7-ba3a-ee26b59244e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_26466879-e0a6-4970-85de-a6cb5da3f5fd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5a0e4808-96b5-4ba7-ba3a-ee26b59244e7" xlink:to="loc_srt_MinimumMember_26466879-e0a6-4970-85de-a6cb5da3f5fd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_0c84a124-d465-4a64-ad98-fa828dbbf021" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5a0e4808-96b5-4ba7-ba3a-ee26b59244e7" xlink:to="loc_srt_MaximumMember_0c84a124-d465-4a64-ad98-fa828dbbf021" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.idexx.com/role/AcquisitionsandInvestmentsDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#AcquisitionsandInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.idexx.com/role/AcquisitionsandInvestmentsDetails" xlink:type="extended" id="ida08885615f0467a9680a70de98dcb83_AcquisitionsandInvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_aff352f1-8c27-4bde-916e-6b8ec6230167" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_242622df-8a36-41c6-a29d-3042c1a86938" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aff352f1-8c27-4bde-916e-6b8ec6230167" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_242622df-8a36-41c6-a29d-3042c1a86938" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_BusinessCombinationContingentConsiderationHoldback_f0b75b35-3259-4167-9e4f-475f265b0627" xlink:href="idxx-20211231.xsd#idxx_BusinessCombinationContingentConsiderationHoldback"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aff352f1-8c27-4bde-916e-6b8ec6230167" xlink:to="loc_idxx_BusinessCombinationContingentConsiderationHoldback_f0b75b35-3259-4167-9e4f-475f265b0627" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_0baf5dd0-e297-493f-82e6-963c01c6783d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aff352f1-8c27-4bde-916e-6b8ec6230167" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_0baf5dd0-e297-493f-82e6-963c01c6783d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_446ec811-b0e5-4be3-9d24-b54970898f63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aff352f1-8c27-4bde-916e-6b8ec6230167" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_446ec811-b0e5-4be3-9d24-b54970898f63" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c9bf20c5-dc1b-48ee-905c-ea6b92b710b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aff352f1-8c27-4bde-916e-6b8ec6230167" xlink:to="loc_us-gaap_Goodwill_c9bf20c5-dc1b-48ee-905c-ea6b92b710b2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_BusinessCombinationsTangibleLiabilities_9b896596-3125-43b3-9f2e-34bcb2e01b6f" xlink:href="idxx-20211231.xsd#idxx_BusinessCombinationsTangibleLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aff352f1-8c27-4bde-916e-6b8ec6230167" xlink:to="loc_idxx_BusinessCombinationsTangibleLiabilities_9b896596-3125-43b3-9f2e-34bcb2e01b6f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_0e3f9508-8ef6-4fb4-b82e-63bec5f6837d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aff352f1-8c27-4bde-916e-6b8ec6230167" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_0e3f9508-8ef6-4fb4-b82e-63bec5f6837d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_43fc868d-58c4-4f74-a84c-9919804ed3cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aff352f1-8c27-4bde-916e-6b8ec6230167" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_43fc868d-58c4-4f74-a84c-9919804ed3cd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_7f21f0d5-2bc5-4654-ab0a-9ee0e2225863" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aff352f1-8c27-4bde-916e-6b8ec6230167" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_7f21f0d5-2bc5-4654-ab0a-9ee0e2225863" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_baa70a8d-4fb7-4a69-8eb3-f490d0b1b705" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aff352f1-8c27-4bde-916e-6b8ec6230167" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_baa70a8d-4fb7-4a69-8eb3-f490d0b1b705" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_BusinessCombinationContingentConsiderationLiabilityAndHoldback_14b1447e-6f73-412d-8e29-ea744dcc7b82" xlink:href="idxx-20211231.xsd#idxx_BusinessCombinationContingentConsiderationLiabilityAndHoldback"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aff352f1-8c27-4bde-916e-6b8ec6230167" xlink:to="loc_idxx_BusinessCombinationContingentConsiderationLiabilityAndHoldback_14b1447e-6f73-412d-8e29-ea744dcc7b82" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_b9593824-304a-448d-88bd-7f924aeb0c0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aff352f1-8c27-4bde-916e-6b8ec6230167" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_b9593824-304a-448d-88bd-7f924aeb0c0e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_NoncontrollingInterestOwnershipPercentageAcquiredFromNoncontrollingOwners_48a3731c-6d93-4d4f-8f56-859164293cfd" xlink:href="idxx-20211231.xsd#idxx_NoncontrollingInterestOwnershipPercentageAcquiredFromNoncontrollingOwners"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aff352f1-8c27-4bde-916e-6b8ec6230167" xlink:to="loc_idxx_NoncontrollingInterestOwnershipPercentageAcquiredFromNoncontrollingOwners_48a3731c-6d93-4d4f-8f56-859164293cfd" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_a59c1bc3-613c-4c33-9afa-db669ffa7760" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aff352f1-8c27-4bde-916e-6b8ec6230167" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_a59c1bc3-613c-4c33-9afa-db669ffa7760" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8d19838d-8caa-4e3d-ba02-28c6252d3ed9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aff352f1-8c27-4bde-916e-6b8ec6230167" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8d19838d-8caa-4e3d-ba02-28c6252d3ed9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_2fe0aed8-c987-4a1b-b701-4d300a6e62fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8d19838d-8caa-4e3d-ba02-28c6252d3ed9" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_2fe0aed8-c987-4a1b-b701-4d300a6e62fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2fe0aed8-c987-4a1b-b701-4d300a6e62fb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2fe0aed8-c987-4a1b-b701-4d300a6e62fb" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2fe0aed8-c987-4a1b-b701-4d300a6e62fb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e58f6ccf-e903-4b99-9d9a-eb3f0b4f1b35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2fe0aed8-c987-4a1b-b701-4d300a6e62fb" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e58f6ccf-e903-4b99-9d9a-eb3f0b4f1b35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ReferenceLaboratoryMember_e8047660-9645-4099-9dea-124a11dbe4d8" xlink:href="idxx-20211231.xsd#idxx_ReferenceLaboratoryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e58f6ccf-e903-4b99-9d9a-eb3f0b4f1b35" xlink:to="loc_idxx_ReferenceLaboratoryMember_e8047660-9645-4099-9dea-124a11dbe4d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_TeleradiologyBusinessMember_bbaf772d-54e4-4a84-952b-1831b36d92ea" xlink:href="idxx-20211231.xsd#idxx_TeleradiologyBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e58f6ccf-e903-4b99-9d9a-eb3f0b4f1b35" xlink:to="loc_idxx_TeleradiologyBusinessMember_bbaf772d-54e4-4a84-952b-1831b36d92ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_EzyVetMember_c2e72bf5-70ba-4ce6-a688-9363feeac571" xlink:href="idxx-20211231.xsd#idxx_EzyVetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e58f6ccf-e903-4b99-9d9a-eb3f0b4f1b35" xlink:to="loc_idxx_EzyVetMember_c2e72bf5-70ba-4ce6-a688-9363feeac571" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ReferenceLaboratoryinMidWestUnitedStatesMember_553db230-2cf0-4e10-bb6b-029220c2c7ac" xlink:href="idxx-20211231.xsd#idxx_ReferenceLaboratoryinMidWestUnitedStatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e58f6ccf-e903-4b99-9d9a-eb3f0b4f1b35" xlink:to="loc_idxx_ReferenceLaboratoryinMidWestUnitedStatesMember_553db230-2cf0-4e10-bb6b-029220c2c7ac" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_648c1da5-bee9-4216-97de-5d2f235ae202" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8d19838d-8caa-4e3d-ba02-28c6252d3ed9" xlink:to="loc_srt_StatementGeographicalAxis_648c1da5-bee9-4216-97de-5d2f235ae202" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_648c1da5-bee9-4216-97de-5d2f235ae202_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_648c1da5-bee9-4216-97de-5d2f235ae202" xlink:to="loc_srt_SegmentGeographicalDomain_648c1da5-bee9-4216-97de-5d2f235ae202_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_d1920d06-8524-4420-82a9-794e222a3ed3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_648c1da5-bee9-4216-97de-5d2f235ae202" xlink:to="loc_srt_SegmentGeographicalDomain_d1920d06-8524-4420-82a9-794e222a3ed3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FI_76d2b38f-15b5-47d8-a022-3ef3325fa8bb" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_FI"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_d1920d06-8524-4420-82a9-794e222a3ed3" xlink:to="loc_country_FI_76d2b38f-15b5-47d8-a022-3ef3325fa8bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_7ed73a53-24c1-4aed-a27e-a89ea980fe2e" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CH"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_d1920d06-8524-4420-82a9-794e222a3ed3" xlink:to="loc_country_CH_7ed73a53-24c1-4aed-a27e-a89ea980fe2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f27c9f98-8195-4762-99d4-a21e0d388027" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8d19838d-8caa-4e3d-ba02-28c6252d3ed9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f27c9f98-8195-4762-99d4-a21e0d388027" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f27c9f98-8195-4762-99d4-a21e0d388027_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f27c9f98-8195-4762-99d4-a21e0d388027" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f27c9f98-8195-4762-99d4-a21e0d388027_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ab27f5a3-475e-44fb-aef5-8994b704a661" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f27c9f98-8195-4762-99d4-a21e0d388027" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ab27f5a3-475e-44fb-aef5-8994b704a661" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_38f7dc3d-1d08-4d11-99f3-d9c07fd8d4a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ab27f5a3-475e-44fb-aef5-8994b704a661" xlink:to="loc_us-gaap_CustomerRelationshipsMember_38f7dc3d-1d08-4d11-99f3-d9c07fd8d4a7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_d2cf207b-4da4-4fb6-b509-f1acfaa42fbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ab27f5a3-475e-44fb-aef5-8994b704a661" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_d2cf207b-4da4-4fb6-b509-f1acfaa42fbe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_e3c9e82a-585b-4a2f-94fd-60788ccf2551" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ab27f5a3-475e-44fb-aef5-8994b704a661" xlink:to="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_e3c9e82a-585b-4a2f-94fd-60788ccf2551" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_807bc871-60dc-4f4a-bd24-5bce8e13b065" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ab27f5a3-475e-44fb-aef5-8994b704a661" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_807bc871-60dc-4f4a-bd24-5bce8e13b065" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_e2bd5248-a351-4bd9-896d-36ec925a7bf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ab27f5a3-475e-44fb-aef5-8994b704a661" xlink:to="loc_us-gaap_TradeNamesMember_e2bd5248-a351-4bd9-896d-36ec925a7bf9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_b3c6adba-b5fe-4a7b-af5a-aebd486a087e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8d19838d-8caa-4e3d-ba02-28c6252d3ed9" xlink:to="loc_srt_ProductOrServiceAxis_b3c6adba-b5fe-4a7b-af5a-aebd486a087e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b3c6adba-b5fe-4a7b-af5a-aebd486a087e_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_b3c6adba-b5fe-4a7b-af5a-aebd486a087e" xlink:to="loc_srt_ProductsAndServicesDomain_b3c6adba-b5fe-4a7b-af5a-aebd486a087e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b3380ec0-bd26-4c58-88e3-de5e114b32e1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_b3c6adba-b5fe-4a7b-af5a-aebd486a087e" xlink:to="loc_srt_ProductsAndServicesDomain_b3380ec0-bd26-4c58-88e3-de5e114b32e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_VetLabConsumablesMember_9ca1b529-aab7-4dd0-ab42-4b30f95cef36" xlink:href="idxx-20211231.xsd#idxx_VetLabConsumablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b3380ec0-bd26-4c58-88e3-de5e114b32e1" xlink:to="loc_idxx_VetLabConsumablesMember_9ca1b529-aab7-4dd0-ab42-4b30f95cef36" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ReferenceLaboratoryDiagnosticAndConsultingServicesMember_9354f786-2349-473a-ae3f-570eb64feeea" xlink:href="idxx-20211231.xsd#idxx_ReferenceLaboratoryDiagnosticAndConsultingServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b3380ec0-bd26-4c58-88e3-de5e114b32e1" xlink:to="loc_idxx_ReferenceLaboratoryDiagnosticAndConsultingServicesMember_9354f786-2349-473a-ae3f-570eb64feeea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_RapidAssayProductsMember_df1e9603-fb09-4568-a835-d87e7f29f24b" xlink:href="idxx-20211231.xsd#idxx_RapidAssayProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b3380ec0-bd26-4c58-88e3-de5e114b32e1" xlink:to="loc_idxx_RapidAssayProductsMember_df1e9603-fb09-4568-a835-d87e7f29f24b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_VeterinarySoftwareServicesAndDiagnosticImagingSystemsMember_30d9f874-cb20-4cbf-8b4b-66602ea0834b" xlink:href="idxx-20211231.xsd#idxx_VeterinarySoftwareServicesAndDiagnosticImagingSystemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b3380ec0-bd26-4c58-88e3-de5e114b32e1" xlink:to="loc_idxx_VeterinarySoftwareServicesAndDiagnosticImagingSystemsMember_30d9f874-cb20-4cbf-8b4b-66602ea0834b" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.idexx.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#ShareBasedCompensationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.idexx.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="extended" id="if87ba3d10c09479098d1c26e901af1c2_ShareBasedCompensationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b9833ec1-8dcc-4b3e-8849-30ff8243cfc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_cc2271ff-5d59-42ac-ae0a-0ff289ca4936" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b9833ec1-8dcc-4b3e-8849-30ff8243cfc6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_cc2271ff-5d59-42ac-ae0a-0ff289ca4936" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_RatioSharesIssuedUnderShareBasedAwardsToSharesAuthorizedUnderStockPlans_1d93e421-ab95-46ff-acde-ff6e00d857d9" xlink:href="idxx-20211231.xsd#idxx_RatioSharesIssuedUnderShareBasedAwardsToSharesAuthorizedUnderStockPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b9833ec1-8dcc-4b3e-8849-30ff8243cfc6" xlink:to="loc_idxx_RatioSharesIssuedUnderShareBasedAwardsToSharesAuthorizedUnderStockPlans_1d93e421-ab95-46ff-acde-ff6e00d857d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_ee2a85c4-86c6-4d25-aca0-28596e3a2e4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b9833ec1-8dcc-4b3e-8849-30ff8243cfc6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_ee2a85c4-86c6-4d25-aca0-28596e3a2e4f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_a5b3e52b-4804-49fa-b3bb-67b128ff60af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b9833ec1-8dcc-4b3e-8849-30ff8243cfc6" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_a5b3e52b-4804-49fa-b3bb-67b128ff60af" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_c6c0cc18-03f2-4663-b341-9886c72fbb09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b9833ec1-8dcc-4b3e-8849-30ff8243cfc6" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_c6c0cc18-03f2-4663-b341-9886c72fbb09" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_667888d1-818a-4fed-b92d-221afd4348e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b9833ec1-8dcc-4b3e-8849-30ff8243cfc6" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_667888d1-818a-4fed-b92d-221afd4348e7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_df023f67-6c43-41e4-b2c8-85300c0776bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b9833ec1-8dcc-4b3e-8849-30ff8243cfc6" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_df023f67-6c43-41e4-b2c8-85300c0776bd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_b3236133-0497-4a0d-8307-d0a80151d5c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b9833ec1-8dcc-4b3e-8849-30ff8243cfc6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_b3236133-0497-4a0d-8307-d0a80151d5c8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_d483ea37-73ef-48bb-8ad4-fc785f215842" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b9833ec1-8dcc-4b3e-8849-30ff8243cfc6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_d483ea37-73ef-48bb-8ad4-fc785f215842" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_4538cabb-f92e-42ea-8b9f-76c8ee74f7c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b9833ec1-8dcc-4b3e-8849-30ff8243cfc6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_4538cabb-f92e-42ea-8b9f-76c8ee74f7c6" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_343e1721-bdef-452c-91ab-80889b12cf91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b9833ec1-8dcc-4b3e-8849-30ff8243cfc6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_343e1721-bdef-452c-91ab-80889b12cf91" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_782c5f6b-f799-4fac-adc3-0882346261fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b9833ec1-8dcc-4b3e-8849-30ff8243cfc6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_782c5f6b-f799-4fac-adc3-0882346261fc" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_c622c5b9-ea81-48de-8262-920dc51ae59d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b9833ec1-8dcc-4b3e-8849-30ff8243cfc6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_c622c5b9-ea81-48de-8262-920dc51ae59d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_c2b8c86e-1514-4693-a0b4-8db9089ec9aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b9833ec1-8dcc-4b3e-8849-30ff8243cfc6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_c2b8c86e-1514-4693-a0b4-8db9089ec9aa" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_RatioOfDeferredStockUnitsToSharesOfCommonStock_18e30660-5cff-4600-9064-80110b9ae355" xlink:href="idxx-20211231.xsd#idxx_RatioOfDeferredStockUnitsToSharesOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b9833ec1-8dcc-4b3e-8849-30ff8243cfc6" xlink:to="loc_idxx_RatioOfDeferredStockUnitsToSharesOfCommonStock_18e30660-5cff-4600-9064-80110b9ae355" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockOtherSharesOutstanding_318eeba1-8294-4071-ac60-7056cc6e7a43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockOtherSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b9833ec1-8dcc-4b3e-8849-30ff8243cfc6" xlink:to="loc_us-gaap_CommonStockOtherSharesOutstanding_318eeba1-8294-4071-ac60-7056cc6e7a43" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_b4a5cd81-fab1-4ef7-9f05-6878c1a8495c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b9833ec1-8dcc-4b3e-8849-30ff8243cfc6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_b4a5cd81-fab1-4ef7-9f05-6878c1a8495c" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_e38f1428-b237-41ed-8951-262b7c6ae234" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b9833ec1-8dcc-4b3e-8849-30ff8243cfc6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_e38f1428-b237-41ed-8951-262b7c6ae234" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_d19a0a5a-542d-4adb-8c43-68a56f6cd1b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b9833ec1-8dcc-4b3e-8849-30ff8243cfc6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_d19a0a5a-542d-4adb-8c43-68a56f6cd1b7" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ShareBasedCompensationTable_fcea940b-8f67-4a8c-87fe-77e0b0cec27a" xlink:href="idxx-20211231.xsd#idxx_ShareBasedCompensationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b9833ec1-8dcc-4b3e-8849-30ff8243cfc6" xlink:to="loc_idxx_ShareBasedCompensationTable_fcea940b-8f67-4a8c-87fe-77e0b0cec27a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_f1ddc675-333c-4dda-a55e-4de41399bd31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_idxx_ShareBasedCompensationTable_fcea940b-8f67-4a8c-87fe-77e0b0cec27a" xlink:to="loc_us-gaap_VestingAxis_f1ddc675-333c-4dda-a55e-4de41399bd31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_f1ddc675-333c-4dda-a55e-4de41399bd31_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VestingAxis_f1ddc675-333c-4dda-a55e-4de41399bd31" xlink:to="loc_us-gaap_VestingDomain_f1ddc675-333c-4dda-a55e-4de41399bd31_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_d5651e29-b1b2-402a-8967-6867be3c243b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VestingAxis_f1ddc675-333c-4dda-a55e-4de41399bd31" xlink:to="loc_us-gaap_VestingDomain_d5651e29-b1b2-402a-8967-6867be3c243b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_78b0f5a0-7c87-4c6b-b3c2-27b648b55701" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_d5651e29-b1b2-402a-8967-6867be3c243b" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_78b0f5a0-7c87-4c6b-b3c2-27b648b55701" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_ae84ca97-1828-43c2-8ea1-601b459981a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_d5651e29-b1b2-402a-8967-6867be3c243b" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_ae84ca97-1828-43c2-8ea1-601b459981a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_470ac7ba-d426-4567-a138-5d8faf82f893" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_idxx_ShareBasedCompensationTable_fcea940b-8f67-4a8c-87fe-77e0b0cec27a" xlink:to="loc_us-gaap_AwardTypeAxis_470ac7ba-d426-4567-a138-5d8faf82f893" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_470ac7ba-d426-4567-a138-5d8faf82f893_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_470ac7ba-d426-4567-a138-5d8faf82f893" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_470ac7ba-d426-4567-a138-5d8faf82f893_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bbaf8f0f-1be1-41b3-9f0d-515d119ce100" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_470ac7ba-d426-4567-a138-5d8faf82f893" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bbaf8f0f-1be1-41b3-9f0d-515d119ce100" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_TwoThousandEighteenStockIncentivePlanMember_bf322f9b-c80e-471a-84b9-296e2520a2cd" xlink:href="idxx-20211231.xsd#idxx_TwoThousandEighteenStockIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bbaf8f0f-1be1-41b3-9f0d-515d119ce100" xlink:to="loc_idxx_TwoThousandEighteenStockIncentivePlanMember_bf322f9b-c80e-471a-84b9-296e2520a2cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_StockOptionsAndStockAppreciationRightsMember_2b369337-eded-408e-a519-f2d392158c21" xlink:href="idxx-20211231.xsd#idxx_StockOptionsAndStockAppreciationRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bbaf8f0f-1be1-41b3-9f0d-515d119ce100" xlink:to="loc_idxx_StockOptionsAndStockAppreciationRightsMember_2b369337-eded-408e-a519-f2d392158c21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_AwardsOtherThanStockOptionsAndStockAppreciationRightsMember_e62d0d6d-7396-4ce8-b0e4-8d5648b32fd8" xlink:href="idxx-20211231.xsd#idxx_AwardsOtherThanStockOptionsAndStockAppreciationRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bbaf8f0f-1be1-41b3-9f0d-515d119ce100" xlink:to="loc_idxx_AwardsOtherThanStockOptionsAndStockAppreciationRightsMember_e62d0d6d-7396-4ce8-b0e4-8d5648b32fd8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_StockOptionsGrantedToEmployeesWithRatableVestingMember_1de53a71-bfb0-4323-a02a-4bdd0e8f83eb" xlink:href="idxx-20211231.xsd#idxx_StockOptionsGrantedToEmployeesWithRatableVestingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bbaf8f0f-1be1-41b3-9f0d-515d119ce100" xlink:to="loc_idxx_StockOptionsGrantedToEmployeesWithRatableVestingMember_1de53a71-bfb0-4323-a02a-4bdd0e8f83eb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_640c7911-fe7e-42e9-bb43-5c186dbbb1fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bbaf8f0f-1be1-41b3-9f0d-515d119ce100" xlink:to="loc_us-gaap_EmployeeStockOptionMember_640c7911-fe7e-42e9-bb43-5c186dbbb1fe" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_RestrictedStockUnitsGrantedToEmployeesWithRatableVestingMember_369697f3-32e2-4996-a1a7-d39c34ca3b20" xlink:href="idxx-20211231.xsd#idxx_RestrictedStockUnitsGrantedToEmployeesWithRatableVestingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bbaf8f0f-1be1-41b3-9f0d-515d119ce100" xlink:to="loc_idxx_RestrictedStockUnitsGrantedToEmployeesWithRatableVestingMember_369697f3-32e2-4996-a1a7-d39c34ca3b20" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_fb398a51-5d1e-4f89-a660-68bd4d1b1a86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bbaf8f0f-1be1-41b3-9f0d-515d119ce100" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_fb398a51-5d1e-4f89-a660-68bd4d1b1a86" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_DeferredStockUnitsMember_01ebfe6a-e744-4bd4-9ba5-6fd010e89aa5" xlink:href="idxx-20211231.xsd#idxx_DeferredStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bbaf8f0f-1be1-41b3-9f0d-515d119ce100" xlink:to="loc_idxx_DeferredStockUnitsMember_01ebfe6a-e744-4bd4-9ba5-6fd010e89aa5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_NineteenNinetySevenEmployeeStockPurchasePlanMember_d0ca5d3d-159a-4138-8ccb-1d4f7ed62857" xlink:href="idxx-20211231.xsd#idxx_NineteenNinetySevenEmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bbaf8f0f-1be1-41b3-9f0d-515d119ce100" xlink:to="loc_idxx_NineteenNinetySevenEmployeeStockPurchasePlanMember_d0ca5d3d-159a-4138-8ccb-1d4f7ed62857" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.idexx.com/role/ShareBasedCompensationScheduleofSelectedFinancialImpactofShareBasedCompensationDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#ShareBasedCompensationScheduleofSelectedFinancialImpactofShareBasedCompensationDetails"/>
  <link:definitionLink xlink:role="http://www.idexx.com/role/ShareBasedCompensationScheduleofSelectedFinancialImpactofShareBasedCompensationDetails" xlink:type="extended" id="i000ea96f2b494b75856446083290b0ea_ShareBasedCompensationScheduleofSelectedFinancialImpactofShareBasedCompensationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dc9a8ddc-b1cc-47d0-95e3-989ce11ae809" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_fea2acca-dce8-4de3-bf28-f8968f7d5b78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dc9a8ddc-b1cc-47d0-95e3-989ce11ae809" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_fea2acca-dce8-4de3-bf28-f8968f7d5b78" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_9e6f8319-75c2-49f5-9e51-c9066ec2f734" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dc9a8ddc-b1cc-47d0-95e3-989ce11ae809" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_9e6f8319-75c2-49f5-9e51-c9066ec2f734" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_AllocatedShareBasedCompensationExpenseNetOfTaxExcludingTaxBenefitFromSettlementOfShareBasedAwards_f8c80d2b-b260-4343-bc93-19e6656aa375" xlink:href="idxx-20211231.xsd#idxx_AllocatedShareBasedCompensationExpenseNetOfTaxExcludingTaxBenefitFromSettlementOfShareBasedAwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dc9a8ddc-b1cc-47d0-95e3-989ce11ae809" xlink:to="loc_idxx_AllocatedShareBasedCompensationExpenseNetOfTaxExcludingTaxBenefitFromSettlementOfShareBasedAwards_f8c80d2b-b260-4343-bc93-19e6656aa375" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_49f29ed2-2989-4c3d-a427-895b137d7831" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dc9a8ddc-b1cc-47d0-95e3-989ce11ae809" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_49f29ed2-2989-4c3d-a427-895b137d7831" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_01bcb1be-2ff9-43b3-acd3-c3cff68c9151" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dc9a8ddc-b1cc-47d0-95e3-989ce11ae809" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_01bcb1be-2ff9-43b3-acd3-c3cff68c9151" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_bc3fa9ef-7d44-46e5-9847-e212e1e301fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dc9a8ddc-b1cc-47d0-95e3-989ce11ae809" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_bc3fa9ef-7d44-46e5-9847-e212e1e301fa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_8d450264-513a-468c-96ac-c8af8ff78d5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_bc3fa9ef-7d44-46e5-9847-e212e1e301fa" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_8d450264-513a-468c-96ac-c8af8ff78d5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8d450264-513a-468c-96ac-c8af8ff78d5e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_8d450264-513a-468c-96ac-c8af8ff78d5e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8d450264-513a-468c-96ac-c8af8ff78d5e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1198db56-79f7-42f2-84cb-fd685a28c812" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_8d450264-513a-468c-96ac-c8af8ff78d5e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1198db56-79f7-42f2-84cb-fd685a28c812" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_aa9591ee-73b2-4d0a-b82b-0a39e8093d26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1198db56-79f7-42f2-84cb-fd685a28c812" xlink:to="loc_us-gaap_CostOfSalesMember_aa9591ee-73b2-4d0a-b82b-0a39e8093d26" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_OperatingExpensesMember_ffc96495-57f3-42a5-9d7d-2b941f0faa86" xlink:href="idxx-20211231.xsd#idxx_OperatingExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1198db56-79f7-42f2-84cb-fd685a28c812" xlink:to="loc_idxx_OperatingExpensesMember_ffc96495-57f3-42a5-9d7d-2b941f0faa86" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.idexx.com/role/ShareBasedCompensationScheduleOfRestrictedStockUnitActivityDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#ShareBasedCompensationScheduleOfRestrictedStockUnitActivityDetails"/>
  <link:definitionLink xlink:role="http://www.idexx.com/role/ShareBasedCompensationScheduleOfRestrictedStockUnitActivityDetails" xlink:type="extended" id="i301312db5fae4e64b2e7c428636e4468_ShareBasedCompensationScheduleOfRestrictedStockUnitActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28792e72-7e68-477c-aa9f-64935b8ae1f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4119423e-448d-47f8-897a-0d50b71268a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28792e72-7e68-477c-aa9f-64935b8ae1f2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4119423e-448d-47f8-897a-0d50b71268a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_c13ca2ef-5dfa-41b1-9d5c-2f529fda35f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4119423e-448d-47f8-897a-0d50b71268a0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_c13ca2ef-5dfa-41b1-9d5c-2f529fda35f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_771de933-0970-4cca-83cf-9b68b30e8837" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4119423e-448d-47f8-897a-0d50b71268a0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_771de933-0970-4cca-83cf-9b68b30e8837" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2df914ed-0283-469c-a389-c1c2774d5e03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4119423e-448d-47f8-897a-0d50b71268a0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2df914ed-0283-469c-a389-c1c2774d5e03" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_5431833c-af02-49ee-a784-6e483dfe8302" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4119423e-448d-47f8-897a-0d50b71268a0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_5431833c-af02-49ee-a784-6e483dfe8302" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_04d399a0-89da-4930-b704-bcdc311e5d38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_f448b7c5-fcbc-4237-9f63-710d2699011d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28792e72-7e68-477c-aa9f-64935b8ae1f2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_f448b7c5-fcbc-4237-9f63-710d2699011d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2b410aec-24e9-489d-acc9-8f1f7ac3a522" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_f448b7c5-fcbc-4237-9f63-710d2699011d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2b410aec-24e9-489d-acc9-8f1f7ac3a522" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_256ee186-2d9a-404f-a1aa-9be5b7c90584" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_f448b7c5-fcbc-4237-9f63-710d2699011d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_256ee186-2d9a-404f-a1aa-9be5b7c90584" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_15d3d80f-9fc1-41de-93b1-945468e59411" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_f448b7c5-fcbc-4237-9f63-710d2699011d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_15d3d80f-9fc1-41de-93b1-945468e59411" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_9d48a1bf-87ca-43f5-a592-fc345150a7c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_f448b7c5-fcbc-4237-9f63-710d2699011d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_9d48a1bf-87ca-43f5-a592-fc345150a7c5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3b87d83c-427d-4c52-9208-51d8d505845a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7612243d-29aa-48e2-a54e-fa281aab80d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28792e72-7e68-477c-aa9f-64935b8ae1f2" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7612243d-29aa-48e2-a54e-fa281aab80d9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_75ae3640-a2bf-4ed3-846f-17d90f35c8a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7612243d-29aa-48e2-a54e-fa281aab80d9" xlink:to="loc_us-gaap_AwardTypeAxis_75ae3640-a2bf-4ed3-846f-17d90f35c8a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_75ae3640-a2bf-4ed3-846f-17d90f35c8a9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_75ae3640-a2bf-4ed3-846f-17d90f35c8a9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_75ae3640-a2bf-4ed3-846f-17d90f35c8a9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_42c8421e-27da-40d1-af2d-23e493a63de3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_75ae3640-a2bf-4ed3-846f-17d90f35c8a9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_42c8421e-27da-40d1-af2d-23e493a63de3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_d4a45318-0df4-4f58-8c24-6a7502a8cdca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_42c8421e-27da-40d1-af2d-23e493a63de3" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_d4a45318-0df4-4f58-8c24-6a7502a8cdca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_RestrictedStockUnitsExpectedToVestReducedForEstimatedForfeituresMember_07ae177b-23e2-4828-a17f-92ad9d45a99f" xlink:href="idxx-20211231.xsd#idxx_RestrictedStockUnitsExpectedToVestReducedForEstimatedForfeituresMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_42c8421e-27da-40d1-af2d-23e493a63de3" xlink:to="loc_idxx_RestrictedStockUnitsExpectedToVestReducedForEstimatedForfeituresMember_07ae177b-23e2-4828-a17f-92ad9d45a99f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.idexx.com/role/CreditLossesDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#CreditLossesDetails"/>
  <link:definitionLink xlink:role="http://www.idexx.com/role/CreditLossesDetails" xlink:type="extended" id="i5da101f2bc2143879061a823007765c4_CreditLossesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_27b9827a-914d-4ca9-b35a-ae713dc29ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_cada6282-e1f2-4499-aa28-2ff9fbdd3420" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_27b9827a-914d-4ca9-b35a-ae713dc29ed7" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_cada6282-e1f2-4499-aa28-2ff9fbdd3420" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_AccountsReceivablePercentNotPastDue_28cb4e26-70bb-4e36-9a6b-ecb9567840a2" xlink:href="idxx-20211231.xsd#idxx_AccountsReceivablePercentNotPastDue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_27b9827a-914d-4ca9-b35a-ae713dc29ed7" xlink:to="loc_idxx_AccountsReceivablePercentNotPastDue_28cb4e26-70bb-4e36-9a6b-ecb9567840a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_AccountsReceivablePercentPastDue_35311ff9-5d10-4a07-b05f-e4cb9eee5ea1" xlink:href="idxx-20211231.xsd#idxx_AccountsReceivablePercentPastDue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_27b9827a-914d-4ca9-b35a-ae713dc29ed7" xlink:to="loc_idxx_AccountsReceivablePercentPastDue_35311ff9-5d10-4a07-b05f-e4cb9eee5ea1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDue_b7605b8d-3e72-4895-addf-834ec0ae15b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_27b9827a-914d-4ca9-b35a-ae713dc29ed7" xlink:to="loc_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDue_b7605b8d-3e72-4895-addf-834ec0ae15b6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ContractwithCustomerAssetAndSalesTypeLeaseNetInvestmentInLeaseAllowanceforCreditLoss_2266b2fd-36c3-41c2-a817-8789df123405" xlink:href="idxx-20211231.xsd#idxx_ContractwithCustomerAssetAndSalesTypeLeaseNetInvestmentInLeaseAllowanceforCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_27b9827a-914d-4ca9-b35a-ae713dc29ed7" xlink:to="loc_idxx_ContractwithCustomerAssetAndSalesTypeLeaseNetInvestmentInLeaseAllowanceforCreditLoss_2266b2fd-36c3-41c2-a817-8789df123405" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable_20182390-36ab-4611-8727-85196c32974c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_27b9827a-914d-4ca9-b35a-ae713dc29ed7" xlink:to="loc_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable_20182390-36ab-4611-8727-85196c32974c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivablesPeriodPastDueAxis_3d283840-fb7c-43ac-9e58-57e53d4bb4f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivablesPeriodPastDueAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable_20182390-36ab-4611-8727-85196c32974c" xlink:to="loc_us-gaap_FinancingReceivablesPeriodPastDueAxis_3d283840-fb7c-43ac-9e58-57e53d4bb4f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivablesPeriodPastDueDomain_3d283840-fb7c-43ac-9e58-57e53d4bb4f3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivablesPeriodPastDueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancingReceivablesPeriodPastDueAxis_3d283840-fb7c-43ac-9e58-57e53d4bb4f3" xlink:to="loc_us-gaap_FinancingReceivablesPeriodPastDueDomain_3d283840-fb7c-43ac-9e58-57e53d4bb4f3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivablesPeriodPastDueDomain_d7584960-4cf1-4a06-9f2f-8d324b738175" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivablesPeriodPastDueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancingReceivablesPeriodPastDueAxis_3d283840-fb7c-43ac-9e58-57e53d4bb4f3" xlink:to="loc_us-gaap_FinancingReceivablesPeriodPastDueDomain_d7584960-4cf1-4a06-9f2f-8d324b738175" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_FinancialAssetGreaterThan60DaysPastDueMember_08099879-1a96-48a9-85a7-e7523bd4f1e8" xlink:href="idxx-20211231.xsd#idxx_FinancialAssetGreaterThan60DaysPastDueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivablesPeriodPastDueDomain_d7584960-4cf1-4a06-9f2f-8d324b738175" xlink:to="loc_idxx_FinancialAssetGreaterThan60DaysPastDueMember_08099879-1a96-48a9-85a7-e7523bd4f1e8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.idexx.com/role/InventoriesNarrativeDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#InventoriesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.idexx.com/role/InventoriesNarrativeDetails" xlink:type="extended" id="i45d8873614144b70985d6cc2276ba0bc_InventoriesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLineItems_db98e237-9442-41b9-aaaa-0e1243d59867" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_6c518ab5-cbff-48c2-894d-0228f9498409" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InventoryLineItems_db98e237-9442-41b9-aaaa-0e1243d59867" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_6c518ab5-cbff-48c2-894d-0228f9498409" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryCurrentTable_9a28beec-2d85-49da-9f18-4daf55108e98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryCurrentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_InventoryLineItems_db98e237-9442-41b9-aaaa-0e1243d59867" xlink:to="loc_us-gaap_InventoryCurrentTable_9a28beec-2d85-49da-9f18-4daf55108e98" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_232a954c-283f-44f0-8fb9-433bb04f1aac" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_InventoryCurrentTable_9a28beec-2d85-49da-9f18-4daf55108e98" xlink:to="loc_srt_ProductOrServiceAxis_232a954c-283f-44f0-8fb9-433bb04f1aac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_232a954c-283f-44f0-8fb9-433bb04f1aac_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_232a954c-283f-44f0-8fb9-433bb04f1aac" xlink:to="loc_srt_ProductsAndServicesDomain_232a954c-283f-44f0-8fb9-433bb04f1aac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_f20ee089-f089-4697-9b37-bea22ba2e331" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_232a954c-283f-44f0-8fb9-433bb04f1aac" xlink:to="loc_srt_ProductsAndServicesDomain_f20ee089-f089-4697-9b37-bea22ba2e331" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ReagentRentalProgramsMember_40db1c9d-6569-49ec-ae78-22ac617c348b" xlink:href="idxx-20211231.xsd#idxx_ReagentRentalProgramsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f20ee089-f089-4697-9b37-bea22ba2e331" xlink:to="loc_idxx_ReagentRentalProgramsMember_40db1c9d-6569-49ec-ae78-22ac617c348b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.idexx.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#LeasesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.idexx.com/role/LeasesNarrativeDetails" xlink:type="extended" id="i4cca3e35740045a4b7048673f500c71b_LeasesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_340a0915-84f7-4cf5-bc01-5e31dc18412b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_LesseeOperatingLeaseTerminationPeriod_25d20da2-b24d-47cb-9cdc-837d362378ae" xlink:href="idxx-20211231.xsd#idxx_LesseeOperatingLeaseTerminationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_340a0915-84f7-4cf5-bc01-5e31dc18412b" xlink:to="loc_idxx_LesseeOperatingLeaseTerminationPeriod_25d20da2-b24d-47cb-9cdc-837d362378ae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_49a721e7-9210-494e-a949-53966949db80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_340a0915-84f7-4cf5-bc01-5e31dc18412b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_49a721e7-9210-494e-a949-53966949db80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_OperatingLeaseLeaseNotyetCommencedExpense_d643ce36-71b3-48d0-bcfa-86ff53ba239b" xlink:href="idxx-20211231.xsd#idxx_OperatingLeaseLeaseNotyetCommencedExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_340a0915-84f7-4cf5-bc01-5e31dc18412b" xlink:to="loc_idxx_OperatingLeaseLeaseNotyetCommencedExpense_d643ce36-71b3-48d0-bcfa-86ff53ba239b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_725e5b6c-a367-4d18-9b89-53c5f2c97bab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_340a0915-84f7-4cf5-bc01-5e31dc18412b" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_725e5b6c-a367-4d18-9b89-53c5f2c97bab" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a3eb3d58-e41a-499a-8f1b-bc61d0a9311e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_725e5b6c-a367-4d18-9b89-53c5f2c97bab" xlink:to="loc_srt_RangeAxis_a3eb3d58-e41a-499a-8f1b-bc61d0a9311e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a3eb3d58-e41a-499a-8f1b-bc61d0a9311e_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_a3eb3d58-e41a-499a-8f1b-bc61d0a9311e" xlink:to="loc_srt_RangeMember_a3eb3d58-e41a-499a-8f1b-bc61d0a9311e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9b39b9e9-0503-46f5-86e3-27116d07ed3a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_a3eb3d58-e41a-499a-8f1b-bc61d0a9311e" xlink:to="loc_srt_RangeMember_9b39b9e9-0503-46f5-86e3-27116d07ed3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_1688854e-6b46-49c8-87ba-51d16f9485f5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_9b39b9e9-0503-46f5-86e3-27116d07ed3a" xlink:to="loc_srt_MinimumMember_1688854e-6b46-49c8-87ba-51d16f9485f5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_1d834e54-2ed9-4b77-97dc-09b0d34bb2b5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_9b39b9e9-0503-46f5-86e3-27116d07ed3a" xlink:to="loc_srt_MaximumMember_1d834e54-2ed9-4b77-97dc-09b0d34bb2b5" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.idexx.com/role/PropertyandEquipmentNetScheduleofEstimatedUsefulLivesDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#PropertyandEquipmentNetScheduleofEstimatedUsefulLivesDetails"/>
  <link:definitionLink xlink:role="http://www.idexx.com/role/PropertyandEquipmentNetScheduleofEstimatedUsefulLivesDetails" xlink:type="extended" id="i6ca84aa96b8f43e18492eb08c76db818_PropertyandEquipmentNetScheduleofEstimatedUsefulLivesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b5e27175-16b9-445e-9686-7772ca54dadc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_3d1e4703-9e6e-4492-bdc2-e4f2b32d4656" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b5e27175-16b9-445e-9686-7772ca54dadc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_3d1e4703-9e6e-4492-bdc2-e4f2b32d4656" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_47e60f8e-dd87-46be-a48e-5daa9b4c5635" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b5e27175-16b9-445e-9686-7772ca54dadc" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_47e60f8e-dd87-46be-a48e-5daa9b4c5635" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b8583ed8-cf64-4142-890b-a39f493cdbf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_47e60f8e-dd87-46be-a48e-5daa9b4c5635" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b8583ed8-cf64-4142-890b-a39f493cdbf7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b8583ed8-cf64-4142-890b-a39f493cdbf7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b8583ed8-cf64-4142-890b-a39f493cdbf7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b8583ed8-cf64-4142-890b-a39f493cdbf7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_31806b44-b444-41a9-869b-f0c39ccb04a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b8583ed8-cf64-4142-890b-a39f493cdbf7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_31806b44-b444-41a9-869b-f0c39ccb04a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandImprovementsMember_2b2416ff-59d4-4249-954c-9aceeb8e8dce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_31806b44-b444-41a9-869b-f0c39ccb04a9" xlink:to="loc_us-gaap_LandImprovementsMember_2b2416ff-59d4-4249-954c-9aceeb8e8dce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_3154c2e9-2f38-4083-9255-0f4c8c1b3201" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_31806b44-b444-41a9-869b-f0c39ccb04a9" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_3154c2e9-2f38-4083-9255-0f4c8c1b3201" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_0ff73169-ee5d-40bf-aaf4-06dfcea17a4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_31806b44-b444-41a9-869b-f0c39ccb04a9" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_0ff73169-ee5d-40bf-aaf4-06dfcea17a4a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember_757a1947-05eb-425f-bd5f-745792fbac2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_31806b44-b444-41a9-869b-f0c39ccb04a9" xlink:to="loc_us-gaap_OfficeEquipmentMember_757a1947-05eb-425f-bd5f-745792fbac2d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ComputerHardwareAndSoftwareMember_561e6826-48cd-4594-aa8e-dd8cfcb9564f" xlink:href="idxx-20211231.xsd#idxx_ComputerHardwareAndSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_31806b44-b444-41a9-869b-f0c39ccb04a9" xlink:to="loc_idxx_ComputerHardwareAndSoftwareMember_561e6826-48cd-4594-aa8e-dd8cfcb9564f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_0c38940e-88eb-4142-aa27-4cee7fd031f3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_47e60f8e-dd87-46be-a48e-5daa9b4c5635" xlink:to="loc_srt_RangeAxis_0c38940e-88eb-4142-aa27-4cee7fd031f3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0c38940e-88eb-4142-aa27-4cee7fd031f3_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_0c38940e-88eb-4142-aa27-4cee7fd031f3" xlink:to="loc_srt_RangeMember_0c38940e-88eb-4142-aa27-4cee7fd031f3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a9f5d4a6-fd45-4ae0-9afc-339e6e746dff" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_0c38940e-88eb-4142-aa27-4cee7fd031f3" xlink:to="loc_srt_RangeMember_a9f5d4a6-fd45-4ae0-9afc-339e6e746dff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_2fda028c-d968-40d9-8e8e-07514aaf1950" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a9f5d4a6-fd45-4ae0-9afc-339e6e746dff" xlink:to="loc_srt_MinimumMember_2fda028c-d968-40d9-8e8e-07514aaf1950" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_66d71472-abbe-4e48-bd2f-04a7c24368f0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a9f5d4a6-fd45-4ae0-9afc-339e6e746dff" xlink:to="loc_srt_MaximumMember_66d71472-abbe-4e48-bd2f-04a7c24368f0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.idexx.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://www.idexx.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails" xlink:type="extended" id="i192b517b18544497969fca5785e0db25_PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8e3b0521-e2e2-4e21-bb96-8c0f249a0066" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_ee4b2d7e-ae74-49e3-9544-e7fcdaf64796" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8e3b0521-e2e2-4e21-bb96-8c0f249a0066" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_ee4b2d7e-ae74-49e3-9544-e7fcdaf64796" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_18014f97-c85d-4d07-84ec-656ac5fe1d9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8e3b0521-e2e2-4e21-bb96-8c0f249a0066" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_18014f97-c85d-4d07-84ec-656ac5fe1d9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_23a15bf3-eb10-4122-bf27-cccf2980204c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8e3b0521-e2e2-4e21-bb96-8c0f249a0066" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_23a15bf3-eb10-4122-bf27-cccf2980204c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_511a16d1-ee3e-487d-a96c-b5bfe4602bc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8e3b0521-e2e2-4e21-bb96-8c0f249a0066" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_511a16d1-ee3e-487d-a96c-b5bfe4602bc4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b091e8d1-6a83-49d4-aa73-c5f52660401a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_511a16d1-ee3e-487d-a96c-b5bfe4602bc4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b091e8d1-6a83-49d4-aa73-c5f52660401a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b091e8d1-6a83-49d4-aa73-c5f52660401a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b091e8d1-6a83-49d4-aa73-c5f52660401a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b091e8d1-6a83-49d4-aa73-c5f52660401a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c7f165cd-787d-4439-b703-1cb733223227" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b091e8d1-6a83-49d4-aa73-c5f52660401a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c7f165cd-787d-4439-b703-1cb733223227" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandAndLandImprovementsMember_1a73ff3f-1695-4dea-9b3f-dac4bbfee560" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandAndLandImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c7f165cd-787d-4439-b703-1cb733223227" xlink:to="loc_us-gaap_LandAndLandImprovementsMember_1a73ff3f-1695-4dea-9b3f-dac4bbfee560" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_2668a671-3b89-47ca-9880-60cc28b681ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c7f165cd-787d-4439-b703-1cb733223227" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_2668a671-3b89-47ca-9880-60cc28b681ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_82453ee7-5d48-46d3-b4b4-a0085f462227" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c7f165cd-787d-4439-b703-1cb733223227" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_82453ee7-5d48-46d3-b4b4-a0085f462227" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_1028856a-3228-4e18-9826-8f9d4ad77403" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c7f165cd-787d-4439-b703-1cb733223227" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_1028856a-3228-4e18-9826-8f9d4ad77403" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember_f8ffbfd2-415b-422c-8a15-172b555a84c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c7f165cd-787d-4439-b703-1cb733223227" xlink:to="loc_us-gaap_OfficeEquipmentMember_f8ffbfd2-415b-422c-8a15-172b555a84c9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ComputerHardwareAndSoftwareMember_be351e72-f1d2-4a93-a5b0-4361162cc907" xlink:href="idxx-20211231.xsd#idxx_ComputerHardwareAndSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c7f165cd-787d-4439-b703-1cb733223227" xlink:to="loc_idxx_ComputerHardwareAndSoftwareMember_be351e72-f1d2-4a93-a5b0-4361162cc907" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_15189962-a010-406f-9610-33ac87afb10c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c7f165cd-787d-4439-b703-1cb733223227" xlink:to="loc_us-gaap_ConstructionInProgressMember_15189962-a010-406f-9610-33ac87afb10c" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.idexx.com/role/PropertyandEquipmentNetSummaryOfDepreciationAndAmortizationCapitalizedComputerSoftwareForInternalUseAndUnpaidPropertyEquipmentReflectedInAccountPayableAndAccruedExpensesDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#PropertyandEquipmentNetSummaryOfDepreciationAndAmortizationCapitalizedComputerSoftwareForInternalUseAndUnpaidPropertyEquipmentReflectedInAccountPayableAndAccruedExpensesDetails"/>
  <link:definitionLink xlink:role="http://www.idexx.com/role/PropertyandEquipmentNetSummaryOfDepreciationAndAmortizationCapitalizedComputerSoftwareForInternalUseAndUnpaidPropertyEquipmentReflectedInAccountPayableAndAccruedExpensesDetails" xlink:type="extended" id="iff4981aba11f4f96bfec3c64d0e3ee38_PropertyandEquipmentNetSummaryOfDepreciationAndAmortizationCapitalizedComputerSoftwareForInternalUseAndUnpaidPropertyEquipmentReflectedInAccountPayableAndAccruedExpensesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_307135e6-9bfb-455a-b798-c6a059cda6b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDepreciationAndAmortization_0caffe17-2f1e-4b61-811a-325ed76a5b93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_307135e6-9bfb-455a-b798-c6a059cda6b9" xlink:to="loc_us-gaap_OtherDepreciationAndAmortization_0caffe17-2f1e-4b61-811a-325ed76a5b93" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAdditions_97eb68a2-2993-41aa-8743-e782d69debb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAdditions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_307135e6-9bfb-455a-b798-c6a059cda6b9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAdditions_97eb68a2-2993-41aa-8743-e782d69debb5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_a48c431e-cf91-4c2a-9397-7ac2f13b381f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_307135e6-9bfb-455a-b798-c6a059cda6b9" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_a48c431e-cf91-4c2a-9397-7ac2f13b381f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_09dd3d8c-0b88-4c31-80c9-dbaf23275b65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_307135e6-9bfb-455a-b798-c6a059cda6b9" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_09dd3d8c-0b88-4c31-80c9-dbaf23275b65" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e2884c92-94e6-43e8-b67a-8cd0a15fe21c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_307135e6-9bfb-455a-b798-c6a059cda6b9" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e2884c92-94e6-43e8-b67a-8cd0a15fe21c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_98dbb24d-9c14-4e4c-86ae-65ca1dae4bd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e2884c92-94e6-43e8-b67a-8cd0a15fe21c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_98dbb24d-9c14-4e4c-86ae-65ca1dae4bd4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_98dbb24d-9c14-4e4c-86ae-65ca1dae4bd4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_98dbb24d-9c14-4e4c-86ae-65ca1dae4bd4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_98dbb24d-9c14-4e4c-86ae-65ca1dae4bd4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_58e43d58-b1d9-494f-86ce-44892a256914" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_98dbb24d-9c14-4e4c-86ae-65ca1dae4bd4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_58e43d58-b1d9-494f-86ce-44892a256914" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_SoftwareDevelopedForInternalUseMember_c6ef2c86-06ed-41a6-803b-c2d7a8dae3de" xlink:href="idxx-20211231.xsd#idxx_SoftwareDevelopedForInternalUseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_58e43d58-b1d9-494f-86ce-44892a256914" xlink:to="loc_idxx_SoftwareDevelopedForInternalUseMember_c6ef2c86-06ed-41a6-803b-c2d7a8dae3de" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_aba20985-f459-4cbb-a575-789156f30bf5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e2884c92-94e6-43e8-b67a-8cd0a15fe21c" xlink:to="loc_srt_ProductOrServiceAxis_aba20985-f459-4cbb-a575-789156f30bf5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_aba20985-f459-4cbb-a575-789156f30bf5_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_aba20985-f459-4cbb-a575-789156f30bf5" xlink:to="loc_srt_ProductsAndServicesDomain_aba20985-f459-4cbb-a575-789156f30bf5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_163de35f-28dd-4a0a-93a0-3ae35f1e6188" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_aba20985-f459-4cbb-a575-789156f30bf5" xlink:to="loc_srt_ProductsAndServicesDomain_163de35f-28dd-4a0a-93a0-3ae35f1e6188" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ReagentRentalProgramsMember_e601f11a-0aab-42c7-98bf-81ec14b380c9" xlink:href="idxx-20211231.xsd#idxx_ReagentRentalProgramsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_163de35f-28dd-4a0a-93a0-3ae35f1e6188" xlink:to="loc_idxx_ReagentRentalProgramsMember_e601f11a-0aab-42c7-98bf-81ec14b380c9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.idexx.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#GoodwillandIntangibleAssetsNetNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.idexx.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails" xlink:type="extended" id="i8fa39792a8ab427992f1ed8ec567703b_GoodwillandIntangibleAssetsNetNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_c4741b5d-a49a-4c33-86d6-75fb286fa5a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_b5fb6afb-5479-4e39-b453-2e5ddf161c5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c4741b5d-a49a-4c33-86d6-75fb286fa5a6" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_b5fb6afb-5479-4e39-b453-2e5ddf161c5e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_67c5210b-289a-4d4c-853a-2e641bf7d15d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c4741b5d-a49a-4c33-86d6-75fb286fa5a6" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_67c5210b-289a-4d4c-853a-2e641bf7d15d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_92780cb8-291d-469d-a27e-747d08ebffeb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_67c5210b-289a-4d4c-853a-2e641bf7d15d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_92780cb8-291d-469d-a27e-747d08ebffeb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_92780cb8-291d-469d-a27e-747d08ebffeb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_92780cb8-291d-469d-a27e-747d08ebffeb" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_92780cb8-291d-469d-a27e-747d08ebffeb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6a7dbf75-bc44-455f-9005-5bb4d1990a41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_92780cb8-291d-469d-a27e-747d08ebffeb" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6a7dbf75-bc44-455f-9005-5bb4d1990a41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_EzyVetMember_3d55757a-6e45-4675-bc55-c7fd64dfc643" xlink:href="idxx-20211231.xsd#idxx_EzyVetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6a7dbf75-bc44-455f-9005-5bb4d1990a41" xlink:to="loc_idxx_EzyVetMember_3d55757a-6e45-4675-bc55-c7fd64dfc643" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails" xlink:type="extended" id="i53066d2ec4544fb2b48f0425ae7d70b6_GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_idxx_SegmentsOfGoodwillLineItems_413ca73f-796d-4458-bbca-ea419343f6e9" xlink:href="idxx-20211231.xsd#idxx_SegmentsOfGoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_dd6f4acf-bf80-4051-b4c4-e3caf9832636" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_idxx_SegmentsOfGoodwillLineItems_413ca73f-796d-4458-bbca-ea419343f6e9" xlink:to="loc_us-gaap_GoodwillRollForward_dd6f4acf-bf80-4051-b4c4-e3caf9832636" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f8fc95a8-c27b-490d-a6dd-102f38ef3fc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_dd6f4acf-bf80-4051-b4c4-e3caf9832636" xlink:to="loc_us-gaap_Goodwill_f8fc95a8-c27b-490d-a6dd-102f38ef3fc1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_d50ecaba-3780-4452-be2a-ee9f99cfecce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_dd6f4acf-bf80-4051-b4c4-e3caf9832636" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_d50ecaba-3780-4452-be2a-ee9f99cfecce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_f633dfbe-f6bf-4040-90e9-9eeb761319ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_dd6f4acf-bf80-4051-b4c4-e3caf9832636" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_f633dfbe-f6bf-4040-90e9-9eeb761319ad" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_a6f54437-ddea-4569-9e9d-698e09d464a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_dd6f4acf-bf80-4051-b4c4-e3caf9832636" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_a6f54437-ddea-4569-9e9d-698e09d464a2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_a3462491-9e2c-4c59-bf5d-f51c829624f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_SegmentsOfGoodwillTable_5f57e48e-80a7-42f7-b6ab-6aa6cbe4825c" xlink:href="idxx-20211231.xsd#idxx_SegmentsOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_idxx_SegmentsOfGoodwillLineItems_413ca73f-796d-4458-bbca-ea419343f6e9" xlink:to="loc_idxx_SegmentsOfGoodwillTable_5f57e48e-80a7-42f7-b6ab-6aa6cbe4825c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d7c00441-bb93-4d55-ad4a-f3f89bea8e1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_idxx_SegmentsOfGoodwillTable_5f57e48e-80a7-42f7-b6ab-6aa6cbe4825c" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d7c00441-bb93-4d55-ad4a-f3f89bea8e1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d7c00441-bb93-4d55-ad4a-f3f89bea8e1e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d7c00441-bb93-4d55-ad4a-f3f89bea8e1e" xlink:to="loc_us-gaap_SegmentDomain_d7c00441-bb93-4d55-ad4a-f3f89bea8e1e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6d5ce355-cba0-40b3-bde7-17cde40e3c1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d7c00441-bb93-4d55-ad4a-f3f89bea8e1e" xlink:to="loc_us-gaap_SegmentDomain_6d5ce355-cba0-40b3-bde7-17cde40e3c1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_CompanionAnimalGroupSegmentMember_f192fae9-7e36-4ac2-a9df-629c44a5c25f" xlink:href="idxx-20211231.xsd#idxx_CompanionAnimalGroupSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6d5ce355-cba0-40b3-bde7-17cde40e3c1a" xlink:to="loc_idxx_CompanionAnimalGroupSegmentMember_f192fae9-7e36-4ac2-a9df-629c44a5c25f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_WaterSegmentMember_c6ba363d-5890-4d04-a8c1-ea37662d02e4" xlink:href="idxx-20211231.xsd#idxx_WaterSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6d5ce355-cba0-40b3-bde7-17cde40e3c1a" xlink:to="loc_idxx_WaterSegmentMember_c6ba363d-5890-4d04-a8c1-ea37662d02e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_LivestockAndPoultryDiagnosticsSegmentMember_f9ade8db-2c51-4fb0-b10c-2e748b3e9ddc" xlink:href="idxx-20211231.xsd#idxx_LivestockAndPoultryDiagnosticsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6d5ce355-cba0-40b3-bde7-17cde40e3c1a" xlink:to="loc_idxx_LivestockAndPoultryDiagnosticsSegmentMember_f9ade8db-2c51-4fb0-b10c-2e748b3e9ddc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_OtherSegmentMember_cb680ebf-82a2-4aff-9752-3719f6330763" xlink:href="idxx-20211231.xsd#idxx_OtherSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6d5ce355-cba0-40b3-bde7-17cde40e3c1a" xlink:to="loc_idxx_OtherSegmentMember_cb680ebf-82a2-4aff-9752-3719f6330763" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofEstimatedUsefulLivesForIntangibleAssetsDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#GoodwillandIntangibleAssetsNetScheduleofEstimatedUsefulLivesForIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofEstimatedUsefulLivesForIntangibleAssetsDetails" xlink:type="extended" id="if7d0f71ada4f49b696a87a38beb8f1b7_GoodwillandIntangibleAssetsNetScheduleofEstimatedUsefulLivesForIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b2f0a517-f066-479d-aeec-a2719dacb288" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_2c06a0de-d00b-4c29-aea2-6296b403fb7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b2f0a517-f066-479d-aeec-a2719dacb288" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_2c06a0de-d00b-4c29-aea2-6296b403fb7c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_bfbfb71f-d322-488b-af30-06774dce7532" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b2f0a517-f066-479d-aeec-a2719dacb288" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_bfbfb71f-d322-488b-af30-06774dce7532" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0ffb4f4e-4c2e-44c8-b8a6-3366f1962c92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_bfbfb71f-d322-488b-af30-06774dce7532" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0ffb4f4e-4c2e-44c8-b8a6-3366f1962c92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0ffb4f4e-4c2e-44c8-b8a6-3366f1962c92_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0ffb4f4e-4c2e-44c8-b8a6-3366f1962c92" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0ffb4f4e-4c2e-44c8-b8a6-3366f1962c92_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e5ddc68a-49da-4ba2-9fc0-69716e297cd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0ffb4f4e-4c2e-44c8-b8a6-3366f1962c92" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e5ddc68a-49da-4ba2-9fc0-69716e297cd5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_87ede236-eb4a-4b39-99fb-e79e37bce4e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e5ddc68a-49da-4ba2-9fc0-69716e297cd5" xlink:to="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_87ede236-eb4a-4b39-99fb-e79e37bce4e1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ProductRightsMember_63015726-f11f-4bbe-81e6-88a8f5a03faf" xlink:href="idxx-20211231.xsd#idxx_ProductRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e5ddc68a-49da-4ba2-9fc0-69716e297cd5" xlink:to="loc_idxx_ProductRightsMember_63015726-f11f-4bbe-81e6-88a8f5a03faf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_4ae0205d-4428-4204-86cc-7a9cf22221e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e5ddc68a-49da-4ba2-9fc0-69716e297cd5" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_4ae0205d-4428-4204-86cc-7a9cf22221e0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f80ca13b-6811-4318-bb36-f916a4e39091" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_bfbfb71f-d322-488b-af30-06774dce7532" xlink:to="loc_srt_RangeAxis_f80ca13b-6811-4318-bb36-f916a4e39091" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f80ca13b-6811-4318-bb36-f916a4e39091_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_f80ca13b-6811-4318-bb36-f916a4e39091" xlink:to="loc_srt_RangeMember_f80ca13b-6811-4318-bb36-f916a4e39091_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_82e509ea-ada1-40cd-a41e-829da82ac32b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_f80ca13b-6811-4318-bb36-f916a4e39091" xlink:to="loc_srt_RangeMember_82e509ea-ada1-40cd-a41e-829da82ac32b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_48535e68-1071-4edf-928d-f320b44a3c03" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_82e509ea-ada1-40cd-a41e-829da82ac32b" xlink:to="loc_srt_MinimumMember_48535e68-1071-4edf-928d-f320b44a3c03" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6b55ccda-18a2-4b25-a95e-ec75e1a8833c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_82e509ea-ada1-40cd-a41e-829da82ac32b" xlink:to="loc_srt_MaximumMember_6b55ccda-18a2-4b25-a95e-ec75e1a8833c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofIntangibleAssetsOtherThanGoodwillDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#GoodwillandIntangibleAssetsNetScheduleofIntangibleAssetsOtherThanGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofIntangibleAssetsOtherThanGoodwillDetails" xlink:type="extended" id="ie549e517a92a44b187dbf05146e8a2d7_GoodwillandIntangibleAssetsNetScheduleofIntangibleAssetsOtherThanGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_76ffddf2-610e-467b-8e2a-d11bb0262209" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_04e27fd7-c891-48a7-8374-689b13ce1911" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_76ffddf2-610e-467b-8e2a-d11bb0262209" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_04e27fd7-c891-48a7-8374-689b13ce1911" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_382da85e-5cdf-46d7-bde2-c9548f0f7106" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_76ffddf2-610e-467b-8e2a-d11bb0262209" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_382da85e-5cdf-46d7-bde2-c9548f0f7106" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_a010e61b-4d4f-4cb0-b987-14c4a15c0d0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_76ffddf2-610e-467b-8e2a-d11bb0262209" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_a010e61b-4d4f-4cb0-b987-14c4a15c0d0b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a60d816c-897d-4058-859b-b1abc70147ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_76ffddf2-610e-467b-8e2a-d11bb0262209" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a60d816c-897d-4058-859b-b1abc70147ed" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_034af0c8-bbd6-442a-bf8a-f501735d5dfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a60d816c-897d-4058-859b-b1abc70147ed" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_034af0c8-bbd6-442a-bf8a-f501735d5dfa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_034af0c8-bbd6-442a-bf8a-f501735d5dfa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_034af0c8-bbd6-442a-bf8a-f501735d5dfa" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_034af0c8-bbd6-442a-bf8a-f501735d5dfa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1b0f8eca-e19d-408a-9ffc-04a5ec84ed71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_034af0c8-bbd6-442a-bf8a-f501735d5dfa" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1b0f8eca-e19d-408a-9ffc-04a5ec84ed71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_8621939c-f3f7-42a2-ac38-07d008e07522" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1b0f8eca-e19d-408a-9ffc-04a5ec84ed71" xlink:to="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_8621939c-f3f7-42a2-ac38-07d008e07522" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ProductRightsMember_3f10f1ab-f888-4405-ad58-d11f063cb618" xlink:href="idxx-20211231.xsd#idxx_ProductRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1b0f8eca-e19d-408a-9ffc-04a5ec84ed71" xlink:to="loc_idxx_ProductRightsMember_3f10f1ab-f888-4405-ad58-d11f063cb618" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_10b9d9ab-6b2c-4175-aec7-4875c91fa784" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1b0f8eca-e19d-408a-9ffc-04a5ec84ed71" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_10b9d9ab-6b2c-4175-aec7-4875c91fa784" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.idexx.com/role/DebtNarrativeDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#DebtNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.idexx.com/role/DebtNarrativeDetails" xlink:type="extended" id="ie951560b88044358b8d776637074f5fe_DebtNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_6577fe67-b0e5-4f84-a89f-bd537d399cc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_e5fc3077-09ba-491b-abb5-369b6442a0dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_6577fe67-b0e5-4f84-a89f-bd537d399cc8" xlink:to="loc_us-gaap_DebtInstrumentTerm_e5fc3077-09ba-491b-abb5-369b6442a0dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_0752394d-2284-41d9-aa42-2d9ea9436dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_6577fe67-b0e5-4f84-a89f-bd537d399cc8" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_0752394d-2284-41d9-aa42-2d9ea9436dcf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_LineofCreditFacilityAccordionFeatureIncreaseLimit_9c6332f2-11b5-4309-8de5-691ca803ba25" xlink:href="idxx-20211231.xsd#idxx_LineofCreditFacilityAccordionFeatureIncreaseLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_6577fe67-b0e5-4f84-a89f-bd537d399cc8" xlink:to="loc_idxx_LineofCreditFacilityAccordionFeatureIncreaseLimit_9c6332f2-11b5-4309-8de5-691ca803ba25" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_LineofCreditFacilityAccordionFeatureHigherBorrowingCapacityOption_7a804d62-889c-4043-8223-386d43cda6bd" xlink:href="idxx-20211231.xsd#idxx_LineofCreditFacilityAccordionFeatureHigherBorrowingCapacityOption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_6577fe67-b0e5-4f84-a89f-bd537d399cc8" xlink:to="loc_idxx_LineofCreditFacilityAccordionFeatureHigherBorrowingCapacityOption_7a804d62-889c-4043-8223-386d43cda6bd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_5908235f-7889-45aa-a7a7-4f01686216f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_6577fe67-b0e5-4f84-a89f-bd537d399cc8" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_5908235f-7889-45aa-a7a7-4f01686216f2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_bbcb154f-8677-42f8-97f3-2ff8a24616c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_6577fe67-b0e5-4f84-a89f-bd537d399cc8" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_bbcb154f-8677-42f8-97f3-2ff8a24616c6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_b331672e-ca2c-4547-9ff1-594dd8b9134d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_6577fe67-b0e5-4f84-a89f-bd537d399cc8" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_b331672e-ca2c-4547-9ff1-594dd8b9134d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditCurrent_bd2c61a7-f78e-4396-a402-ecede721b13b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LinesOfCreditCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_6577fe67-b0e5-4f84-a89f-bd537d399cc8" xlink:to="loc_us-gaap_LinesOfCreditCurrent_bd2c61a7-f78e-4396-a402-ecede721b13b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate_da97d9f0-b931-4f38-bdf5-ef9ffa1e7332" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_6577fe67-b0e5-4f84-a89f-bd537d399cc8" xlink:to="loc_us-gaap_DebtWeightedAverageInterestRate_da97d9f0-b931-4f38-bdf5-ef9ffa1e7332" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases_06589200-82ac-4968-b0f3-bc730f5d4750" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_6577fe67-b0e5-4f84-a89f-bd537d399cc8" xlink:to="loc_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases_06589200-82ac-4968-b0f3-bc730f5d4750" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ConsolidatedLeverageRatioUnderCreditFacilityNotePayable_5c262807-f32b-4f11-805b-b0959f41dc7c" xlink:href="idxx-20211231.xsd#idxx_ConsolidatedLeverageRatioUnderCreditFacilityNotePayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_6577fe67-b0e5-4f84-a89f-bd537d399cc8" xlink:to="loc_idxx_ConsolidatedLeverageRatioUnderCreditFacilityNotePayable_5c262807-f32b-4f11-805b-b0959f41dc7c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_b9801610-f091-4da5-bc13-7ddc23306db0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_6577fe67-b0e5-4f84-a89f-bd537d399cc8" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_b9801610-f091-4da5-bc13-7ddc23306db0" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt_cb761a51-58d4-4512-969d-138077d79dac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_6577fe67-b0e5-4f84-a89f-bd537d399cc8" xlink:to="loc_us-gaap_RepaymentsOfSeniorDebt_cb761a51-58d4-4512-969d-138077d79dac" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_33fa1338-9f86-4825-a4c1-979831cdb83d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_6577fe67-b0e5-4f84-a89f-bd537d399cc8" xlink:to="loc_us-gaap_InterestPaidNet_33fa1338-9f86-4825-a4c1-979831cdb83d" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_9c7a86cc-d1a5-4f85-a11a-ba8e313f79db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_6577fe67-b0e5-4f84-a89f-bd537d399cc8" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_9c7a86cc-d1a5-4f85-a11a-ba8e313f79db" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_91c9b913-a912-4fde-87bd-5cff06186d38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_9c7a86cc-d1a5-4f85-a11a-ba8e313f79db" xlink:to="loc_us-gaap_CreditFacilityAxis_91c9b913-a912-4fde-87bd-5cff06186d38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_91c9b913-a912-4fde-87bd-5cff06186d38_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_91c9b913-a912-4fde-87bd-5cff06186d38" xlink:to="loc_us-gaap_CreditFacilityDomain_91c9b913-a912-4fde-87bd-5cff06186d38_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_1f4b5b9b-2381-4ca1-902f-088cdf970b64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_91c9b913-a912-4fde-87bd-5cff06186d38" xlink:to="loc_us-gaap_CreditFacilityDomain_1f4b5b9b-2381-4ca1-902f-088cdf970b64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_29ff4023-ad05-42c6-b8ac-349230398bf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_1f4b5b9b-2381-4ca1-902f-088cdf970b64" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_29ff4023-ad05-42c6-b8ac-349230398bf1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_RevolvingCreditFacilityIndividualBorrowingsMember_eb4e1e4c-b01a-44ce-b3e9-4181f1bb1aea" xlink:href="idxx-20211231.xsd#idxx_RevolvingCreditFacilityIndividualBorrowingsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember_29ff4023-ad05-42c6-b8ac-349230398bf1" xlink:to="loc_idxx_RevolvingCreditFacilityIndividualBorrowingsMember_eb4e1e4c-b01a-44ce-b3e9-4181f1bb1aea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_487316d9-6a22-44e3-9372-8d2452e9b6fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_9c7a86cc-d1a5-4f85-a11a-ba8e313f79db" xlink:to="loc_us-gaap_VariableRateAxis_487316d9-6a22-44e3-9372-8d2452e9b6fe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_487316d9-6a22-44e3-9372-8d2452e9b6fe_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_487316d9-6a22-44e3-9372-8d2452e9b6fe" xlink:to="loc_us-gaap_VariableRateDomain_487316d9-6a22-44e3-9372-8d2452e9b6fe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_7f86e721-6be1-4171-b433-dd7f9deb6974" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_487316d9-6a22-44e3-9372-8d2452e9b6fe" xlink:to="loc_us-gaap_VariableRateDomain_7f86e721-6be1-4171-b433-dd7f9deb6974" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_862fc4c5-cd36-4721-aa58-19c0c8790efe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_7f86e721-6be1-4171-b433-dd7f9deb6974" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_862fc4c5-cd36-4721-aa58-19c0c8790efe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrimeRateMember_7fc2ccfd-5241-4386-a6a7-2fc8b247723c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrimeRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_7f86e721-6be1-4171-b433-dd7f9deb6974" xlink:to="loc_us-gaap_PrimeRateMember_7fc2ccfd-5241-4386-a6a7-2fc8b247723c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ef46387c-741c-4bf8-9d58-24fa208630ee" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_9c7a86cc-d1a5-4f85-a11a-ba8e313f79db" xlink:to="loc_srt_RangeAxis_ef46387c-741c-4bf8-9d58-24fa208630ee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ef46387c-741c-4bf8-9d58-24fa208630ee_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_ef46387c-741c-4bf8-9d58-24fa208630ee" xlink:to="loc_srt_RangeMember_ef46387c-741c-4bf8-9d58-24fa208630ee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a2e60617-4a0e-496c-bb83-9416b58f5cd8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_ef46387c-741c-4bf8-9d58-24fa208630ee" xlink:to="loc_srt_RangeMember_a2e60617-4a0e-496c-bb83-9416b58f5cd8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_8bd61c9a-08cb-4843-893f-b98376d1f2d7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a2e60617-4a0e-496c-bb83-9416b58f5cd8" xlink:to="loc_srt_MinimumMember_8bd61c9a-08cb-4843-893f-b98376d1f2d7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_92f0ad85-6bcf-4a34-8718-068696797c0d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a2e60617-4a0e-496c-bb83-9416b58f5cd8" xlink:to="loc_srt_MaximumMember_92f0ad85-6bcf-4a34-8718-068696797c0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_d3a60011-ad7c-425f-8be6-10ff8c5810dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_9c7a86cc-d1a5-4f85-a11a-ba8e313f79db" xlink:to="loc_us-gaap_DebtInstrumentAxis_d3a60011-ad7c-425f-8be6-10ff8c5810dc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d3a60011-ad7c-425f-8be6-10ff8c5810dc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_d3a60011-ad7c-425f-8be6-10ff8c5810dc" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d3a60011-ad7c-425f-8be6-10ff8c5810dc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_32dfea17-69a5-444e-9db6-e19020de4464" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_d3a60011-ad7c-425f-8be6-10ff8c5810dc" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_32dfea17-69a5-444e-9db6-e19020de4464" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_A2023SeriesANotesAnd2025SeriesBNotesMember_f7cf982d-8161-4f18-9026-16869dd73591" xlink:href="idxx-20211231.xsd#idxx_A2023SeriesANotesAnd2025SeriesBNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_32dfea17-69a5-444e-9db6-e19020de4464" xlink:to="loc_idxx_A2023SeriesANotesAnd2025SeriesBNotesMember_f7cf982d-8161-4f18-9026-16869dd73591" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_A2023SeriesANotesMember_c13db8bc-743c-4f92-aa49-91477af59420" xlink:href="idxx-20211231.xsd#idxx_A2023SeriesANotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_idxx_A2023SeriesANotesAnd2025SeriesBNotesMember_f7cf982d-8161-4f18-9026-16869dd73591" xlink:to="loc_idxx_A2023SeriesANotesMember_c13db8bc-743c-4f92-aa49-91477af59420" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_A2025SeriesBNotesMember_ba6ca2c9-2cff-4610-a88a-efdf354e9426" xlink:href="idxx-20211231.xsd#idxx_A2025SeriesBNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_idxx_A2023SeriesANotesAnd2025SeriesBNotesMember_f7cf982d-8161-4f18-9026-16869dd73591" xlink:to="loc_idxx_A2025SeriesBNotesMember_ba6ca2c9-2cff-4610-a88a-efdf354e9426" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_A2026SeniorNotesMember_79a53c62-59b3-47d3-9cf7-0f63df0d4c93" xlink:href="idxx-20211231.xsd#idxx_A2026SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_32dfea17-69a5-444e-9db6-e19020de4464" xlink:to="loc_idxx_A2026SeniorNotesMember_79a53c62-59b3-47d3-9cf7-0f63df0d4c93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_A2021SeriesANotesAnd2024SeriesBNotesMember_f1b57a16-4c93-43aa-81fb-bac85bc6beda" xlink:href="idxx-20211231.xsd#idxx_A2021SeriesANotesAnd2024SeriesBNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_32dfea17-69a5-444e-9db6-e19020de4464" xlink:to="loc_idxx_A2021SeriesANotesAnd2024SeriesBNotesMember_f1b57a16-4c93-43aa-81fb-bac85bc6beda" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_A2021SeriesANotesMember_fc464351-55dd-4173-bdc1-3afdb5fd80d4" xlink:href="idxx-20211231.xsd#idxx_A2021SeriesANotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_idxx_A2021SeriesANotesAnd2024SeriesBNotesMember_f1b57a16-4c93-43aa-81fb-bac85bc6beda" xlink:to="loc_idxx_A2021SeriesANotesMember_fc464351-55dd-4173-bdc1-3afdb5fd80d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_A2024SeriesBNotesMember_33158d6e-d9d6-4836-a82f-ab92ff7d1461" xlink:href="idxx-20211231.xsd#idxx_A2024SeriesBNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_idxx_A2021SeriesANotesAnd2024SeriesBNotesMember_f1b57a16-4c93-43aa-81fb-bac85bc6beda" xlink:to="loc_idxx_A2024SeriesBNotesMember_33158d6e-d9d6-4836-a82f-ab92ff7d1461" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_A2025SeriesCNotesMember_4c240dc2-ef6c-4286-98ff-c68ddb905971" xlink:href="idxx-20211231.xsd#idxx_A2025SeriesCNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_32dfea17-69a5-444e-9db6-e19020de4464" xlink:to="loc_idxx_A2025SeriesCNotesMember_4c240dc2-ef6c-4286-98ff-c68ddb905971" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_Prudential2030SeriesDNotesMember_0d861041-dea8-49cd-85b1-11dc84f0f6ac" xlink:href="idxx-20211231.xsd#idxx_Prudential2030SeriesDNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_32dfea17-69a5-444e-9db6-e19020de4464" xlink:to="loc_idxx_Prudential2030SeriesDNotesMember_0d861041-dea8-49cd-85b1-11dc84f0f6ac" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_A2022SeriesANotesand2027SeriesBNotesMember_4284bb32-2e93-4fcf-ab07-d142353aa4d2" xlink:href="idxx-20211231.xsd#idxx_A2022SeriesANotesand2027SeriesBNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_32dfea17-69a5-444e-9db6-e19020de4464" xlink:to="loc_idxx_A2022SeriesANotesand2027SeriesBNotesMember_4284bb32-2e93-4fcf-ab07-d142353aa4d2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_A2022SeriesANotesMember_e9401635-8203-4fb1-b468-65f7682d3319" xlink:href="idxx-20211231.xsd#idxx_A2022SeriesANotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_idxx_A2022SeriesANotesand2027SeriesBNotesMember_4284bb32-2e93-4fcf-ab07-d142353aa4d2" xlink:to="loc_idxx_A2022SeriesANotesMember_e9401635-8203-4fb1-b468-65f7682d3319" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_A2027SeriesBNotesMember_37afa698-8964-4c7c-982e-f5bd832bccc3" xlink:href="idxx-20211231.xsd#idxx_A2027SeriesBNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_idxx_A2022SeriesANotesand2027SeriesBNotesMember_4284bb32-2e93-4fcf-ab07-d142353aa4d2" xlink:to="loc_idxx_A2027SeriesBNotesMember_37afa698-8964-4c7c-982e-f5bd832bccc3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_A2029SeriesCNotesMember_fd262ab6-1973-43d1-a7cb-29a98ff7e43a" xlink:href="idxx-20211231.xsd#idxx_A2029SeriesCNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_32dfea17-69a5-444e-9db6-e19020de4464" xlink:to="loc_idxx_A2029SeriesCNotesMember_fd262ab6-1973-43d1-a7cb-29a98ff7e43a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_MetLife2030SeriesDNotesMember_3a5b77a1-7f93-4dbb-a451-f8bb719e2e3a" xlink:href="idxx-20211231.xsd#idxx_MetLife2030SeriesDNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_32dfea17-69a5-444e-9db6-e19020de4464" xlink:to="loc_idxx_MetLife2030SeriesDNotesMember_3a5b77a1-7f93-4dbb-a451-f8bb719e2e3a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_15fb9554-9f80-44a2-9b38-8fa6035ec50f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_9c7a86cc-d1a5-4f85-a11a-ba8e313f79db" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_15fb9554-9f80-44a2-9b38-8fa6035ec50f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_15fb9554-9f80-44a2-9b38-8fa6035ec50f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_15fb9554-9f80-44a2-9b38-8fa6035ec50f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_15fb9554-9f80-44a2-9b38-8fa6035ec50f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b49ed68e-b45d-4761-892d-31262b6f37bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_15fb9554-9f80-44a2-9b38-8fa6035ec50f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b49ed68e-b45d-4761-892d-31262b6f37bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_41c45206-1e7a-4b72-9160-bee1660a4a46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b49ed68e-b45d-4761-892d-31262b6f37bd" xlink:to="loc_us-gaap_SeniorNotesMember_41c45206-1e7a-4b72-9160-bee1660a4a46" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.idexx.com/role/DebtScheduleofSeniorNoteBorrowingsDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#DebtScheduleofSeniorNoteBorrowingsDetails"/>
  <link:definitionLink xlink:role="http://www.idexx.com/role/DebtScheduleofSeniorNoteBorrowingsDetails" xlink:type="extended" id="ic1307c84fb594aa79171fc1b1c36bd40_DebtScheduleofSeniorNoteBorrowingsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_636c40bc-fa1d-48b4-9ff6-f43b9f6f0561" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_8d640f0e-3293-4703-bd9d-2521c6d42beb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_636c40bc-fa1d-48b4-9ff6-f43b9f6f0561" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_8d640f0e-3293-4703-bd9d-2521c6d42beb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_9d57eb16-2be6-4954-baa1-4bf80b83776f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_636c40bc-fa1d-48b4-9ff6-f43b9f6f0561" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_9d57eb16-2be6-4954-baa1-4bf80b83776f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_081d75b0-fc9c-43a4-8981-481222fc4e92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_636c40bc-fa1d-48b4-9ff6-f43b9f6f0561" xlink:to="loc_us-gaap_DebtInstrumentTable_081d75b0-fc9c-43a4-8981-481222fc4e92" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_35733aaf-4285-4c6b-8418-17044654ccc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_081d75b0-fc9c-43a4-8981-481222fc4e92" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_35733aaf-4285-4c6b-8418-17044654ccc8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_35733aaf-4285-4c6b-8418-17044654ccc8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_35733aaf-4285-4c6b-8418-17044654ccc8" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_35733aaf-4285-4c6b-8418-17044654ccc8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_df821d46-af7e-497c-8fa8-91ef74314566" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_35733aaf-4285-4c6b-8418-17044654ccc8" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_df821d46-af7e-497c-8fa8-91ef74314566" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_c7136748-a1a9-4c67-80a9-abba39b58916" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_df821d46-af7e-497c-8fa8-91ef74314566" xlink:to="loc_us-gaap_SeniorNotesMember_c7136748-a1a9-4c67-80a9-abba39b58916" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_496d817e-40c7-41b7-b2e9-f0b88f905716" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_081d75b0-fc9c-43a4-8981-481222fc4e92" xlink:to="loc_us-gaap_DebtInstrumentAxis_496d817e-40c7-41b7-b2e9-f0b88f905716" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_496d817e-40c7-41b7-b2e9-f0b88f905716_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_496d817e-40c7-41b7-b2e9-f0b88f905716" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_496d817e-40c7-41b7-b2e9-f0b88f905716_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3614cfde-dddd-449a-b93b-6f77a888a099" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_496d817e-40c7-41b7-b2e9-f0b88f905716" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3614cfde-dddd-449a-b93b-6f77a888a099" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_A2023SeriesANotesMember_90c39981-d2bb-4659-acac-497a2d98f474" xlink:href="idxx-20211231.xsd#idxx_A2023SeriesANotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3614cfde-dddd-449a-b93b-6f77a888a099" xlink:to="loc_idxx_A2023SeriesANotesMember_90c39981-d2bb-4659-acac-497a2d98f474" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_A2025SeriesBNotesMember_5994d9b5-5130-4fd3-b4f3-a3a4530c5d23" xlink:href="idxx-20211231.xsd#idxx_A2025SeriesBNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3614cfde-dddd-449a-b93b-6f77a888a099" xlink:to="loc_idxx_A2025SeriesBNotesMember_5994d9b5-5130-4fd3-b4f3-a3a4530c5d23" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_A2026SeniorNotesMember_d80f7c87-958e-4434-b5b3-c4161cbbea3e" xlink:href="idxx-20211231.xsd#idxx_A2026SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3614cfde-dddd-449a-b93b-6f77a888a099" xlink:to="loc_idxx_A2026SeniorNotesMember_d80f7c87-958e-4434-b5b3-c4161cbbea3e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_A2024SeriesBNotesMember_74e1d5d8-957e-4e90-b7a1-8bbcbff57b20" xlink:href="idxx-20211231.xsd#idxx_A2024SeriesBNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3614cfde-dddd-449a-b93b-6f77a888a099" xlink:to="loc_idxx_A2024SeriesBNotesMember_74e1d5d8-957e-4e90-b7a1-8bbcbff57b20" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_A2025SeriesCNotesMember_743ec356-e025-4461-8522-bbfd44f46f6c" xlink:href="idxx-20211231.xsd#idxx_A2025SeriesCNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3614cfde-dddd-449a-b93b-6f77a888a099" xlink:to="loc_idxx_A2025SeriesCNotesMember_743ec356-e025-4461-8522-bbfd44f46f6c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_A2022SeriesANotesMember_ce18d119-b85f-444d-b08d-7c71a8bd5cb6" xlink:href="idxx-20211231.xsd#idxx_A2022SeriesANotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3614cfde-dddd-449a-b93b-6f77a888a099" xlink:to="loc_idxx_A2022SeriesANotesMember_ce18d119-b85f-444d-b08d-7c71a8bd5cb6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_A2027SeriesBNotesMember_542b3be5-c13e-47d7-a59d-967569e4a3bc" xlink:href="idxx-20211231.xsd#idxx_A2027SeriesBNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3614cfde-dddd-449a-b93b-6f77a888a099" xlink:to="loc_idxx_A2027SeriesBNotesMember_542b3be5-c13e-47d7-a59d-967569e4a3bc" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_A2029SeriesCNotesMember_53da1ecc-719f-4a51-a5ae-f8f16efbe6e0" xlink:href="idxx-20211231.xsd#idxx_A2029SeriesCNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3614cfde-dddd-449a-b93b-6f77a888a099" xlink:to="loc_idxx_A2029SeriesCNotesMember_53da1ecc-719f-4a51-a5ae-f8f16efbe6e0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_MetLife2030SeriesDNotesMember_b2fc1730-d2ca-4ed7-a76b-d03a5be38cb4" xlink:href="idxx-20211231.xsd#idxx_MetLife2030SeriesDNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3614cfde-dddd-449a-b93b-6f77a888a099" xlink:to="loc_idxx_MetLife2030SeriesDNotesMember_b2fc1730-d2ca-4ed7-a76b-d03a5be38cb4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_Prudential2030SeriesDNotesMember_2c2730c0-1dc4-429f-a263-077a163a694c" xlink:href="idxx-20211231.xsd#idxx_Prudential2030SeriesDNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3614cfde-dddd-449a-b93b-6f77a888a099" xlink:to="loc_idxx_Prudential2030SeriesDNotesMember_2c2730c0-1dc4-429f-a263-077a163a694c" xlink:type="arc" order="9"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.idexx.com/role/CommitmentsContingenciesandGuaranteesNarrativeDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#CommitmentsContingenciesandGuaranteesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.idexx.com/role/CommitmentsContingenciesandGuaranteesNarrativeDetails" xlink:type="extended" id="ic4339ae877f3417ab0a10ea5bd6dafa2_CommitmentsContingenciesandGuaranteesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_idxx_PaymentRequiredUponTerminationOfEmploymentLineItems_831e2788-c288-40ae-a4e5-8a971ec2a2bd" xlink:href="idxx-20211231.xsd#idxx_PaymentRequiredUponTerminationOfEmploymentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligation_1ed80117-e10f-4434-8abd-a9bfaaf5f561" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_idxx_PaymentRequiredUponTerminationOfEmploymentLineItems_831e2788-c288-40ae-a4e5-8a971ec2a2bd" xlink:to="loc_us-gaap_PurchaseObligation_1ed80117-e10f-4434-8abd-a9bfaaf5f561" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_1fc5f3c1-5d93-41d8-98ff-13a6b871cb60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_idxx_PaymentRequiredUponTerminationOfEmploymentLineItems_831e2788-c288-40ae-a4e5-8a971ec2a2bd" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_1fc5f3c1-5d93-41d8-98ff-13a6b871cb60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_5e9a60b3-3cb3-4ba7-b42f-2af360061848" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_idxx_PaymentRequiredUponTerminationOfEmploymentLineItems_831e2788-c288-40ae-a4e5-8a971ec2a2bd" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_5e9a60b3-3cb3-4ba7-b42f-2af360061848" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_RetainedClaimLiabilityPerIncident_6dd875d5-4d40-4b93-a95b-9fbf1c4c97a5" xlink:href="idxx-20211231.xsd#idxx_RetainedClaimLiabilityPerIncident"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_idxx_PaymentRequiredUponTerminationOfEmploymentLineItems_831e2788-c288-40ae-a4e5-8a971ec2a2bd" xlink:to="loc_idxx_RetainedClaimLiabilityPerIncident_6dd875d5-4d40-4b93-a95b-9fbf1c4c97a5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralInsuranceExpense_b7830688-3473-4c69-8f61-b70f2e30c6eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralInsuranceExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_idxx_PaymentRequiredUponTerminationOfEmploymentLineItems_831e2788-c288-40ae-a4e5-8a971ec2a2bd" xlink:to="loc_us-gaap_GeneralInsuranceExpense_b7830688-3473-4c69-8f61-b70f2e30c6eb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserve_1318ca46-012d-4fa6-bc6d-ae14d5440564" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SelfInsuranceReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_idxx_PaymentRequiredUponTerminationOfEmploymentLineItems_831e2788-c288-40ae-a4e5-8a971ec2a2bd" xlink:to="loc_us-gaap_SelfInsuranceReserve_1318ca46-012d-4fa6-bc6d-ae14d5440564" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_609726f1-d24b-41ff-80e5-b41043dbd026" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_idxx_PaymentRequiredUponTerminationOfEmploymentLineItems_831e2788-c288-40ae-a4e5-8a971ec2a2bd" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_609726f1-d24b-41ff-80e5-b41043dbd026" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits_e1d236a6-2639-45ee-a633-d16f77f8d1e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_idxx_PaymentRequiredUponTerminationOfEmploymentLineItems_831e2788-c288-40ae-a4e5-8a971ec2a2bd" xlink:to="loc_us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits_e1d236a6-2639-45ee-a633-d16f77f8d1e1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms_f04fa9bf-5b0e-4049-929b-cd2f17a754c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_idxx_PaymentRequiredUponTerminationOfEmploymentLineItems_831e2788-c288-40ae-a4e5-8a971ec2a2bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms_f04fa9bf-5b0e-4049-929b-cd2f17a754c9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_eb295bb7-716a-475a-b278-e77e79babbc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_idxx_PaymentRequiredUponTerminationOfEmploymentLineItems_831e2788-c288-40ae-a4e5-8a971ec2a2bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_eb295bb7-716a-475a-b278-e77e79babbc4" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue_84c48d77-e1d4-4465-b336-c02780484568" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuaranteeObligationsCurrentCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_idxx_PaymentRequiredUponTerminationOfEmploymentLineItems_831e2788-c288-40ae-a4e5-8a971ec2a2bd" xlink:to="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue_84c48d77-e1d4-4465-b336-c02780484568" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_PaymentRequiredUponTerminationOfEmploymentTable_b0f5ba31-4502-43de-8675-0227204d0c15" xlink:href="idxx-20211231.xsd#idxx_PaymentRequiredUponTerminationOfEmploymentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_idxx_PaymentRequiredUponTerminationOfEmploymentLineItems_831e2788-c288-40ae-a4e5-8a971ec2a2bd" xlink:to="loc_idxx_PaymentRequiredUponTerminationOfEmploymentTable_b0f5ba31-4502-43de-8675-0227204d0c15" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1adc82d7-ebf3-41b1-8958-596daad6f56e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_idxx_PaymentRequiredUponTerminationOfEmploymentTable_b0f5ba31-4502-43de-8675-0227204d0c15" xlink:to="loc_srt_RangeAxis_1adc82d7-ebf3-41b1-8958-596daad6f56e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1adc82d7-ebf3-41b1-8958-596daad6f56e_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_1adc82d7-ebf3-41b1-8958-596daad6f56e" xlink:to="loc_srt_RangeMember_1adc82d7-ebf3-41b1-8958-596daad6f56e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cd928ab3-81ac-4f78-bc5c-ad3a887326d0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_1adc82d7-ebf3-41b1-8958-596daad6f56e" xlink:to="loc_srt_RangeMember_cd928ab3-81ac-4f78-bc5c-ad3a887326d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c825760f-aa4c-4086-834c-e157b2ab0321" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_cd928ab3-81ac-4f78-bc5c-ad3a887326d0" xlink:to="loc_srt_MaximumMember_c825760f-aa4c-4086-834c-e157b2ab0321" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_b93e4df8-bf29-4e48-b79b-a8dace28f14a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_idxx_PaymentRequiredUponTerminationOfEmploymentTable_b0f5ba31-4502-43de-8675-0227204d0c15" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_b93e4df8-bf29-4e48-b79b-a8dace28f14a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_b93e4df8-bf29-4e48-b79b-a8dace28f14a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_b93e4df8-bf29-4e48-b79b-a8dace28f14a" xlink:to="loc_us-gaap_LossContingencyNatureDomain_b93e4df8-bf29-4e48-b79b-a8dace28f14a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_89afb745-4856-47d3-bf8e-0800cf142863" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_b93e4df8-bf29-4e48-b79b-a8dace28f14a" xlink:to="loc_us-gaap_LossContingencyNatureDomain_89afb745-4856-47d3-bf8e-0800cf142863" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_EmployeeHealthCareInsurancePolicyMember_4af4c117-5a26-44f0-915c-0d9bdd363bde" xlink:href="idxx-20211231.xsd#idxx_EmployeeHealthCareInsurancePolicyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_89afb745-4856-47d3-bf8e-0800cf142863" xlink:to="loc_idxx_EmployeeHealthCareInsurancePolicyMember_4af4c117-5a26-44f0-915c-0d9bdd363bde" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_PaymentRequiredUponTerminationOfEmploymentAxis_69af77a3-e3f3-4db5-8d7f-b5a4c2e61797" xlink:href="idxx-20211231.xsd#idxx_PaymentRequiredUponTerminationOfEmploymentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_idxx_PaymentRequiredUponTerminationOfEmploymentTable_b0f5ba31-4502-43de-8675-0227204d0c15" xlink:to="loc_idxx_PaymentRequiredUponTerminationOfEmploymentAxis_69af77a3-e3f3-4db5-8d7f-b5a4c2e61797" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_PaymentRequiredUponTerminationOfEmploymentDomain_69af77a3-e3f3-4db5-8d7f-b5a4c2e61797_default" xlink:href="idxx-20211231.xsd#idxx_PaymentRequiredUponTerminationOfEmploymentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_idxx_PaymentRequiredUponTerminationOfEmploymentAxis_69af77a3-e3f3-4db5-8d7f-b5a4c2e61797" xlink:to="loc_idxx_PaymentRequiredUponTerminationOfEmploymentDomain_69af77a3-e3f3-4db5-8d7f-b5a4c2e61797_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_PaymentRequiredUponTerminationOfEmploymentDomain_0f29174b-72ea-4359-8564-d88fecc33736" xlink:href="idxx-20211231.xsd#idxx_PaymentRequiredUponTerminationOfEmploymentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_idxx_PaymentRequiredUponTerminationOfEmploymentAxis_69af77a3-e3f3-4db5-8d7f-b5a4c2e61797" xlink:to="loc_idxx_PaymentRequiredUponTerminationOfEmploymentDomain_0f29174b-72ea-4359-8564-d88fecc33736" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_PaymentRequiredToCeoUponTerminationOfEmploymentWithoutCauseOtherThanFollowingChangeInControlMember_a187d512-17c8-44d6-ac1c-370d6fd2be61" xlink:href="idxx-20211231.xsd#idxx_PaymentRequiredToCeoUponTerminationOfEmploymentWithoutCauseOtherThanFollowingChangeInControlMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_idxx_PaymentRequiredUponTerminationOfEmploymentDomain_0f29174b-72ea-4359-8564-d88fecc33736" xlink:to="loc_idxx_PaymentRequiredToCeoUponTerminationOfEmploymentWithoutCauseOtherThanFollowingChangeInControlMember_a187d512-17c8-44d6-ac1c-370d6fd2be61" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_PaymentRequiredToOfficersUponTerminationOfEmploymentFollowingChangeOfControlMember_18b3c911-026a-46fb-8a8d-97644e813ec9" xlink:href="idxx-20211231.xsd#idxx_PaymentRequiredToOfficersUponTerminationOfEmploymentFollowingChangeOfControlMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_idxx_PaymentRequiredUponTerminationOfEmploymentDomain_0f29174b-72ea-4359-8564-d88fecc33736" xlink:to="loc_idxx_PaymentRequiredToOfficersUponTerminationOfEmploymentFollowingChangeOfControlMember_18b3c911-026a-46fb-8a8d-97644e813ec9" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.idexx.com/role/SegmentReportingSummaryofSegmentPerformanceDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#SegmentReportingSummaryofSegmentPerformanceDetails"/>
  <link:definitionLink xlink:role="http://www.idexx.com/role/SegmentReportingSummaryofSegmentPerformanceDetails" xlink:type="extended" id="if54c2fde0f7c432dbc469e57a9716259_SegmentReportingSummaryofSegmentPerformanceDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_eaabb2fb-5942-4ca3-aaa9-08bb68aad7a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1b8db549-b50c-489a-b588-a498e440bdbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_eaabb2fb-5942-4ca3-aaa9-08bb68aad7a7" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1b8db549-b50c-489a-b588-a498e440bdbc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_04488ba3-22b2-4190-999f-e7a174a8231f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_eaabb2fb-5942-4ca3-aaa9-08bb68aad7a7" xlink:to="loc_us-gaap_OperatingIncomeLoss_04488ba3-22b2-4190-999f-e7a174a8231f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_affb29e0-b4dd-45ce-9340-d309922e5041" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_eaabb2fb-5942-4ca3-aaa9-08bb68aad7a7" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_affb29e0-b4dd-45ce-9340-d309922e5041" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d12ab9dd-19d3-4bd3-9d2d-006238aa86b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_eaabb2fb-5942-4ca3-aaa9-08bb68aad7a7" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d12ab9dd-19d3-4bd3-9d2d-006238aa86b0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_86587af5-bf78-4b5e-a5f0-27bb97e483c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_eaabb2fb-5942-4ca3-aaa9-08bb68aad7a7" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_86587af5-bf78-4b5e-a5f0-27bb97e483c4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_c99b22ae-c336-4956-b7ed-8801e46cab62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_eaabb2fb-5942-4ca3-aaa9-08bb68aad7a7" xlink:to="loc_us-gaap_ProfitLoss_c99b22ae-c336-4956-b7ed-8801e46cab62" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_ec4a7465-c4c8-4dc8-84b9-8db05414ef6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_eaabb2fb-5942-4ca3-aaa9-08bb68aad7a7" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_ec4a7465-c4c8-4dc8-84b9-8db05414ef6f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_530aba1a-2d2e-4109-8088-f50fe4154f71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_eaabb2fb-5942-4ca3-aaa9-08bb68aad7a7" xlink:to="loc_us-gaap_NetIncomeLoss_530aba1a-2d2e-4109-8088-f50fe4154f71" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_15d37dc9-093f-4149-ba46-d404c854ee4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_eaabb2fb-5942-4ca3-aaa9-08bb68aad7a7" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_15d37dc9-093f-4149-ba46-d404c854ee4c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5cdd2ea5-0491-492c-ab22-5bd7f978055b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_eaabb2fb-5942-4ca3-aaa9-08bb68aad7a7" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5cdd2ea5-0491-492c-ab22-5bd7f978055b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_76e8382c-534a-43d0-b63c-ec346942f833" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5cdd2ea5-0491-492c-ab22-5bd7f978055b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_76e8382c-534a-43d0-b63c-ec346942f833" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_76e8382c-534a-43d0-b63c-ec346942f833_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_76e8382c-534a-43d0-b63c-ec346942f833" xlink:to="loc_us-gaap_SegmentDomain_76e8382c-534a-43d0-b63c-ec346942f833_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_73ae71f2-64c5-457b-a9a5-a0082754b0a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_76e8382c-534a-43d0-b63c-ec346942f833" xlink:to="loc_us-gaap_SegmentDomain_73ae71f2-64c5-457b-a9a5-a0082754b0a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_CompanionAnimalGroupSegmentMember_04f472d5-cddc-4a69-9e4b-bde2313dd7e4" xlink:href="idxx-20211231.xsd#idxx_CompanionAnimalGroupSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_73ae71f2-64c5-457b-a9a5-a0082754b0a4" xlink:to="loc_idxx_CompanionAnimalGroupSegmentMember_04f472d5-cddc-4a69-9e4b-bde2313dd7e4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_WaterSegmentMember_ea40c4c7-7aa0-417b-9c8f-804da253d99c" xlink:href="idxx-20211231.xsd#idxx_WaterSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_73ae71f2-64c5-457b-a9a5-a0082754b0a4" xlink:to="loc_idxx_WaterSegmentMember_ea40c4c7-7aa0-417b-9c8f-804da253d99c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_LivestockAndPoultryDiagnosticsSegmentMember_be729337-64ad-4c61-83b1-38a1ee4fc0e8" xlink:href="idxx-20211231.xsd#idxx_LivestockAndPoultryDiagnosticsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_73ae71f2-64c5-457b-a9a5-a0082754b0a4" xlink:to="loc_idxx_LivestockAndPoultryDiagnosticsSegmentMember_be729337-64ad-4c61-83b1-38a1ee4fc0e8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_OtherSegmentMember_abee6287-8267-4d46-b7ad-de6bb5e26d30" xlink:href="idxx-20211231.xsd#idxx_OtherSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_73ae71f2-64c5-457b-a9a5-a0082754b0a4" xlink:to="loc_idxx_OtherSegmentMember_abee6287-8267-4d46-b7ad-de6bb5e26d30" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.idexx.com/role/SegmentReportingScheduleofNetLongLivedAssetsbyPrincipalGeographicAreasDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#SegmentReportingScheduleofNetLongLivedAssetsbyPrincipalGeographicAreasDetails"/>
  <link:definitionLink xlink:role="http://www.idexx.com/role/SegmentReportingScheduleofNetLongLivedAssetsbyPrincipalGeographicAreasDetails" xlink:type="extended" id="ida3a4e27a97c42c0bf4fd6d36cb925a5_SegmentReportingScheduleofNetLongLivedAssetsbyPrincipalGeographicAreasDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_08e1b257-154b-4597-8877-abdc3eb9d04f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_c9658f61-f189-4435-bdee-380613bd1a99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_08e1b257-154b-4597-8877-abdc3eb9d04f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_c9658f61-f189-4435-bdee-380613bd1a99" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_6b4c5fe7-9c52-40d7-87df-5f90015a1fa7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_08e1b257-154b-4597-8877-abdc3eb9d04f" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_6b4c5fe7-9c52-40d7-87df-5f90015a1fa7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_98710934-7193-4347-a1a8-28c5d7b4159b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_6b4c5fe7-9c52-40d7-87df-5f90015a1fa7" xlink:to="loc_srt_StatementGeographicalAxis_98710934-7193-4347-a1a8-28c5d7b4159b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_98710934-7193-4347-a1a8-28c5d7b4159b_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_98710934-7193-4347-a1a8-28c5d7b4159b" xlink:to="loc_srt_SegmentGeographicalDomain_98710934-7193-4347-a1a8-28c5d7b4159b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e5de5e34-0255-40be-93ff-6d433dab6156" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_98710934-7193-4347-a1a8-28c5d7b4159b" xlink:to="loc_srt_SegmentGeographicalDomain_e5de5e34-0255-40be-93ff-6d433dab6156" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember_bbec3238-4b2b-42c6-9abc-079138f8f1e5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AmericasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_e5de5e34-0255-40be-93ff-6d433dab6156" xlink:to="loc_srt_AmericasMember_bbec3238-4b2b-42c6-9abc-079138f8f1e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_9ce45984-8b7e-4293-98a8-4bc38edca6b1" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_AmericasMember_bbec3238-4b2b-42c6-9abc-079138f8f1e5" xlink:to="loc_country_US_9ce45984-8b7e-4293-98a8-4bc38edca6b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_BR_f27f0db2-f605-4c3d-bed1-3b4aa80bf821" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_BR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_AmericasMember_bbec3238-4b2b-42c6-9abc-079138f8f1e5" xlink:to="loc_country_BR_f27f0db2-f605-4c3d-bed1-3b4aa80bf821" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_3fe12a10-3a68-489b-8a5a-8f35f8733c89" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_AmericasMember_bbec3238-4b2b-42c6-9abc-079138f8f1e5" xlink:to="loc_country_CA_3fe12a10-3a68-489b-8a5a-8f35f8733c89" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_6e426dc9-b653-4418-abc2-f2dec7f033ab" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_e5de5e34-0255-40be-93ff-6d433dab6156" xlink:to="loc_srt_EuropeMember_6e426dc9-b653-4418-abc2-f2dec7f033ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE_5af5853b-4565-4418-92fc-5bcfd43ede9e" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_DE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EuropeMember_6e426dc9-b653-4418-abc2-f2dec7f033ab" xlink:to="loc_country_DE_5af5853b-4565-4418-92fc-5bcfd43ede9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_caf111d6-50af-4be0-aa6e-b1eb48d5f9de" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EuropeMember_6e426dc9-b653-4418-abc2-f2dec7f033ab" xlink:to="loc_country_GB_caf111d6-50af-4be0-aa6e-b1eb48d5f9de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_NL_675a41f6-b7ff-4819-8535-448595cf4e38" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_NL"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EuropeMember_6e426dc9-b653-4418-abc2-f2dec7f033ab" xlink:to="loc_country_NL_675a41f6-b7ff-4819-8535-448595cf4e38" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR_70478f65-f61d-418c-a537-601b96e26bd8" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_FR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EuropeMember_6e426dc9-b653-4418-abc2-f2dec7f033ab" xlink:to="loc_country_FR_70478f65-f61d-418c-a537-601b96e26bd8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_45f14577-3245-4790-ab69-69756c23963c" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CH"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EuropeMember_6e426dc9-b653-4418-abc2-f2dec7f033ab" xlink:to="loc_country_CH_45f14577-3245-4790-ab69-69756c23963c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_EuropetheMiddleEastandAfricaOtherMember_a0727ef3-bcf8-4839-8762-4de61d01b56f" xlink:href="idxx-20211231.xsd#idxx_EuropetheMiddleEastandAfricaOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EuropeMember_6e426dc9-b653-4418-abc2-f2dec7f033ab" xlink:to="loc_idxx_EuropetheMiddleEastandAfricaOtherMember_a0727ef3-bcf8-4839-8762-4de61d01b56f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_27f73ec9-b3b5-4004-9a0f-dfba414abcec" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AsiaPacificMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_e5de5e34-0255-40be-93ff-6d433dab6156" xlink:to="loc_srt_AsiaPacificMember_27f73ec9-b3b5-4004-9a0f-dfba414abcec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_JP_e9f4a830-6a37-4971-8a8d-3d4c544faf5f" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_JP"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_AsiaPacificMember_27f73ec9-b3b5-4004-9a0f-dfba414abcec" xlink:to="loc_country_JP_e9f4a830-6a37-4971-8a8d-3d4c544faf5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_AU_f9289801-ef40-4f8a-b43c-846a031c443a" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_AU"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_AsiaPacificMember_27f73ec9-b3b5-4004-9a0f-dfba414abcec" xlink:to="loc_country_AU_f9289801-ef40-4f8a-b43c-846a031c443a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_OtherAsiaPacificMember_c89f811e-2254-4cf8-ba75-206b3d0db3ce" xlink:href="idxx-20211231.xsd#idxx_OtherAsiaPacificMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_AsiaPacificMember_27f73ec9-b3b5-4004-9a0f-dfba414abcec" xlink:to="loc_idxx_OtherAsiaPacificMember_c89f811e-2254-4cf8-ba75-206b3d0db3ce" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.idexx.com/role/FairValueMeasurementsScheduleofFairValueofAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#FairValueMeasurementsScheduleofFairValueofAssetsandLiabilitiesMeasuredonRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.idexx.com/role/FairValueMeasurementsScheduleofFairValueofAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="extended" id="ifcea1934798a441c82f9858c8d85a075_FairValueMeasurementsScheduleofFairValueofAssetsandLiabilitiesMeasuredonRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a928183b-48db-455c-b7c1-213e4426053a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_b40611fb-57c3-4efb-86d6-418a5a4f20ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a928183b-48db-455c-b7c1-213e4426053a" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_b40611fb-57c3-4efb-86d6-418a5a4f20ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsFairValueDisclosure_6d1c58ee-dad7-481c-ae0f-b0a80c64fe7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a928183b-48db-455c-b7c1-213e4426053a" xlink:to="loc_us-gaap_OtherAssetsFairValueDisclosure_6d1c58ee-dad7-481c-ae0f-b0a80c64fe7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_b38c9f78-01d8-4773-86df-f5f65d9b03f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a928183b-48db-455c-b7c1-213e4426053a" xlink:to="loc_us-gaap_DerivativeAssets_b38c9f78-01d8-4773-86df-f5f65d9b03f6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_35547f8e-89a8-477f-84d7-cafb3e5f5fc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a928183b-48db-455c-b7c1-213e4426053a" xlink:to="loc_us-gaap_DerivativeLiabilities_35547f8e-89a8-477f-84d7-cafb3e5f5fc1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesFairValueDisclosure_1b845d59-ece4-4483-ba22-b55052307e4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a928183b-48db-455c-b7c1-213e4426053a" xlink:to="loc_us-gaap_OtherLiabilitiesFairValueDisclosure_1b845d59-ece4-4483-ba22-b55052307e4e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_BusinessCombinationContingencyFairValue_a908f691-4c2e-41e7-bcce-0b5e4f47138e" xlink:href="idxx-20211231.xsd#idxx_BusinessCombinationContingencyFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a928183b-48db-455c-b7c1-213e4426053a" xlink:to="loc_idxx_BusinessCombinationContingencyFairValue_a908f691-4c2e-41e7-bcce-0b5e4f47138e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_53f6e5b9-c3f6-4875-a0f0-cf526a14d20d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a928183b-48db-455c-b7c1-213e4426053a" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_53f6e5b9-c3f6-4875-a0f0-cf526a14d20d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_1ab03d08-04fe-467a-b358-794a5c2e8ac9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_53f6e5b9-c3f6-4875-a0f0-cf526a14d20d" xlink:to="loc_us-gaap_FinancialInstrumentAxis_1ab03d08-04fe-467a-b358-794a5c2e8ac9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1ab03d08-04fe-467a-b358-794a5c2e8ac9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1ab03d08-04fe-467a-b358-794a5c2e8ac9" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1ab03d08-04fe-467a-b358-794a5c2e8ac9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_756600db-b413-4214-9a4e-4149548f5367" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1ab03d08-04fe-467a-b358-794a5c2e8ac9" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_756600db-b413-4214-9a4e-4149548f5367" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_c121ca27-7c9e-42d7-a966-ce8a3d5a75db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_756600db-b413-4214-9a4e-4149548f5367" xlink:to="loc_us-gaap_MoneyMarketFundsMember_c121ca27-7c9e-42d7-a966-ce8a3d5a75db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_EquityMutualFundsMember_d6cb7f20-9264-42af-875f-c5cf4327feae" xlink:href="idxx-20211231.xsd#idxx_EquityMutualFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_756600db-b413-4214-9a4e-4149548f5367" xlink:to="loc_idxx_EquityMutualFundsMember_d6cb7f20-9264-42af-875f-c5cf4327feae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_7ac8e051-0d48-4e8a-9e8f-bb3436e8d65b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_756600db-b413-4214-9a4e-4149548f5367" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_7ac8e051-0d48-4e8a-9e8f-bb3436e8d65b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_f84acc4c-71a6-4843-b58b-ee9dcdc20eee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_756600db-b413-4214-9a4e-4149548f5367" xlink:to="loc_us-gaap_ForeignExchangeContractMember_f84acc4c-71a6-4843-b58b-ee9dcdc20eee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_DeferredCompensationMember_3eb00a7d-a5cb-48f8-b785-519339afe532" xlink:href="idxx-20211231.xsd#idxx_DeferredCompensationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_756600db-b413-4214-9a4e-4149548f5367" xlink:to="loc_idxx_DeferredCompensationMember_3eb00a7d-a5cb-48f8-b785-519339afe532" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ContingentPaymentMember_ba0bf878-516c-4061-a023-7999b9a7c768" xlink:href="idxx-20211231.xsd#idxx_ContingentPaymentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_756600db-b413-4214-9a4e-4149548f5367" xlink:to="loc_idxx_ContingentPaymentMember_ba0bf878-516c-4061-a023-7999b9a7c768" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fa283ffd-b0cb-45d1-8a53-e2784318b323" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_53f6e5b9-c3f6-4875-a0f0-cf526a14d20d" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fa283ffd-b0cb-45d1-8a53-e2784318b323" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fa283ffd-b0cb-45d1-8a53-e2784318b323_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fa283ffd-b0cb-45d1-8a53-e2784318b323" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fa283ffd-b0cb-45d1-8a53-e2784318b323_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_907a496f-9674-4b2f-a03a-80e55a9523ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fa283ffd-b0cb-45d1-8a53-e2784318b323" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_907a496f-9674-4b2f-a03a-80e55a9523ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_a367b5b2-1f98-4b16-8e15-779c21af07f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_907a496f-9674-4b2f-a03a-80e55a9523ca" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_a367b5b2-1f98-4b16-8e15-779c21af07f1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_13abd4ea-7c3f-40a0-8fb6-8030b1d7f594" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_907a496f-9674-4b2f-a03a-80e55a9523ca" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_13abd4ea-7c3f-40a0-8fb6-8030b1d7f594" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_c31d7fac-9dbd-4d16-a68c-3b0f76c80f81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_907a496f-9674-4b2f-a03a-80e55a9523ca" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_c31d7fac-9dbd-4d16-a68c-3b0f76c80f81" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.idexx.com/role/HedgingInstrumentsNarrativeDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#HedgingInstrumentsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.idexx.com/role/HedgingInstrumentsNarrativeDetails" xlink:type="extended" id="i5a1a2c1087ba481ba7faf6ae8a21834b_HedgingInstrumentsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_5278226e-d6df-4d90-94b6-8b97956d6106" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_21e7213f-e346-401a-9178-552b9403ac57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_5278226e-d6df-4d90-94b6-8b97956d6106" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_21e7213f-e346-401a-9178-552b9403ac57" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_CashFlowHedgeHedgePercentageOfEstimatedExposureFromIntercompanyProductsPurchasesAndSales_dce32c9d-a198-4b86-a4fe-568221e954ef" xlink:href="idxx-20211231.xsd#idxx_CashFlowHedgeHedgePercentageOfEstimatedExposureFromIntercompanyProductsPurchasesAndSales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_5278226e-d6df-4d90-94b6-8b97956d6106" xlink:to="loc_idxx_CashFlowHedgeHedgePercentageOfEstimatedExposureFromIntercompanyProductsPurchasesAndSales_dce32c9d-a198-4b86-a4fe-568221e954ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge_1f529ad7-61fc-4eb6-8706-296763a1c9e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_5278226e-d6df-4d90-94b6-8b97956d6106" xlink:to="loc_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge_1f529ad7-61fc-4eb6-8706-296763a1c9e1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_a928a1c2-317b-49ff-91a8-00af7b488a2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_5278226e-d6df-4d90-94b6-8b97956d6106" xlink:to="loc_us-gaap_DerivativeNotionalAmount_a928a1c2-317b-49ff-91a8-00af7b488a2a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_63b98fae-36d0-4d73-be8b-e6a7e862ea3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_5278226e-d6df-4d90-94b6-8b97956d6106" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_63b98fae-36d0-4d73-be8b-e6a7e862ea3f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_db7b79f3-ce2f-460e-b4ad-42a6bdcd2809" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_5278226e-d6df-4d90-94b6-8b97956d6106" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_db7b79f3-ce2f-460e-b4ad-42a6bdcd2809" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax_8eca8d40-7724-4ca1-a80b-97bd1f9d71f1" xlink:href="idxx-20211231.xsd#idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_5278226e-d6df-4d90-94b6-8b97956d6106" xlink:to="loc_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax_8eca8d40-7724-4ca1-a80b-97bd1f9d71f1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeInvestingActivities_e73e1b40-7684-45bd-b0f4-ee895029e05c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromHedgeInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_5278226e-d6df-4d90-94b6-8b97956d6106" xlink:to="loc_us-gaap_ProceedsFromHedgeInvestingActivities_e73e1b40-7684-45bd-b0f4-ee895029e05c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax_3f3ee87f-f114-470e-b27d-24cfd2aadbbd" xlink:href="idxx-20211231.xsd#idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_5278226e-d6df-4d90-94b6-8b97956d6106" xlink:to="loc_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax_3f3ee87f-f114-470e-b27d-24cfd2aadbbd" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness_4a90c583-d57a-4e66-86f0-6313441d8c0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_5278226e-d6df-4d90-94b6-8b97956d6106" xlink:to="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness_4a90c583-d57a-4e66-86f0-6313441d8c0d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_f42a3033-1fe6-4cfe-8b22-9a4b542d9bfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_5278226e-d6df-4d90-94b6-8b97956d6106" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_f42a3033-1fe6-4cfe-8b22-9a4b542d9bfe" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_7fbab0f5-8273-4206-b149-80a9a92a00b5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_f42a3033-1fe6-4cfe-8b22-9a4b542d9bfe" xlink:to="loc_srt_StatementScenarioAxis_7fbab0f5-8273-4206-b149-80a9a92a00b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_7fbab0f5-8273-4206-b149-80a9a92a00b5_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_7fbab0f5-8273-4206-b149-80a9a92a00b5" xlink:to="loc_srt_ScenarioUnspecifiedDomain_7fbab0f5-8273-4206-b149-80a9a92a00b5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_cc37761e-fcd1-474b-b798-a030072a8624" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_7fbab0f5-8273-4206-b149-80a9a92a00b5" xlink:to="loc_srt_ScenarioUnspecifiedDomain_cc37761e-fcd1-474b-b798-a030072a8624" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_0a7214b4-d690-48fe-ba13-fa780cf12687" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_cc37761e-fcd1-474b-b798-a030072a8624" xlink:to="loc_srt_ScenarioForecastMember_0a7214b4-d690-48fe-ba13-fa780cf12687" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_bbc4363d-b6d0-48b0-a1e4-b8d1c1700e68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_f42a3033-1fe6-4cfe-8b22-9a4b542d9bfe" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_bbc4363d-b6d0-48b0-a1e4-b8d1c1700e68" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_bbc4363d-b6d0-48b0-a1e4-b8d1c1700e68_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_bbc4363d-b6d0-48b0-a1e4-b8d1c1700e68" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_bbc4363d-b6d0-48b0-a1e4-b8d1c1700e68_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3dd01fe2-9cc9-49c5-aa3e-4156b9cf4347" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_bbc4363d-b6d0-48b0-a1e4-b8d1c1700e68" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3dd01fe2-9cc9-49c5-aa3e-4156b9cf4347" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_bd29358f-c6bc-4727-a47b-fd829dbd6621" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3dd01fe2-9cc9-49c5-aa3e-4156b9cf4347" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_bd29358f-c6bc-4727-a47b-fd829dbd6621" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_CrossCurrencyInterestRateContract1Member_be6035b4-b2fe-4271-accb-61dc6b115c3d" xlink:href="idxx-20211231.xsd#idxx_CrossCurrencyInterestRateContract1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3dd01fe2-9cc9-49c5-aa3e-4156b9cf4347" xlink:to="loc_idxx_CrossCurrencyInterestRateContract1Member_be6035b4-b2fe-4271-accb-61dc6b115c3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_80a2ba20-5e3d-4d17-98e3-7eea818c5045" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_f42a3033-1fe6-4cfe-8b22-9a4b542d9bfe" xlink:to="loc_us-gaap_HedgingDesignationAxis_80a2ba20-5e3d-4d17-98e3-7eea818c5045" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_80a2ba20-5e3d-4d17-98e3-7eea818c5045_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_80a2ba20-5e3d-4d17-98e3-7eea818c5045" xlink:to="loc_us-gaap_HedgingDesignationDomain_80a2ba20-5e3d-4d17-98e3-7eea818c5045_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_eb900d5e-663d-4a4c-94e1-8c6eb1eb61a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_80a2ba20-5e3d-4d17-98e3-7eea818c5045" xlink:to="loc_us-gaap_HedgingDesignationDomain_eb900d5e-663d-4a4c-94e1-8c6eb1eb61a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_5df06298-7764-4ffe-bfa3-253d37b19ba5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_eb900d5e-663d-4a4c-94e1-8c6eb1eb61a8" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_5df06298-7764-4ffe-bfa3-253d37b19ba5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_90712d8b-9c02-4db3-916f-e56ddc70ff1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_f42a3033-1fe6-4cfe-8b22-9a4b542d9bfe" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_90712d8b-9c02-4db3-916f-e56ddc70ff1b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_90712d8b-9c02-4db3-916f-e56ddc70ff1b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_90712d8b-9c02-4db3-916f-e56ddc70ff1b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_90712d8b-9c02-4db3-916f-e56ddc70ff1b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c166c92e-2586-4a6f-b5d0-f023c004bc7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_90712d8b-9c02-4db3-916f-e56ddc70ff1b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c166c92e-2586-4a6f-b5d0-f023c004bc7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_SeriesCSeniorNoteMember_91672faf-4401-4bd6-8fad-5656f665a925" xlink:href="idxx-20211231.xsd#idxx_SeriesCSeniorNoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c166c92e-2586-4a6f-b5d0-f023c004bc7c" xlink:to="loc_idxx_SeriesCSeniorNoteMember_91672faf-4401-4bd6-8fad-5656f665a925" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_869901cf-370c-4164-a614-d50a0488bcf0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_f42a3033-1fe6-4cfe-8b22-9a4b542d9bfe" xlink:to="loc_srt_RangeAxis_869901cf-370c-4164-a614-d50a0488bcf0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_869901cf-370c-4164-a614-d50a0488bcf0_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_869901cf-370c-4164-a614-d50a0488bcf0" xlink:to="loc_srt_RangeMember_869901cf-370c-4164-a614-d50a0488bcf0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4aea607d-8356-4aff-99b4-bbf1410cdadf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_869901cf-370c-4164-a614-d50a0488bcf0" xlink:to="loc_srt_RangeMember_4aea607d-8356-4aff-99b4-bbf1410cdadf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_08940355-4370-477b-898b-4bd2a39d76c3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4aea607d-8356-4aff-99b4-bbf1410cdadf" xlink:to="loc_srt_MinimumMember_08940355-4370-477b-898b-4bd2a39d76c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c2aa47aa-339e-4c4e-87e8-aea3767acf62" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4aea607d-8356-4aff-99b4-bbf1410cdadf" xlink:to="loc_srt_MaximumMember_c2aa47aa-339e-4c4e-87e8-aea3767acf62" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.idexx.com/role/HedgingInstrumentsDerivativesDesignatedinCashFlowHedgingRelationshipsDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#HedgingInstrumentsDerivativesDesignatedinCashFlowHedgingRelationshipsDetails"/>
  <link:definitionLink xlink:role="http://www.idexx.com/role/HedgingInstrumentsDerivativesDesignatedinCashFlowHedgingRelationshipsDetails" xlink:type="extended" id="id55f1f55297e4fc381536746892aa46d_HedgingInstrumentsDerivativesDesignatedinCashFlowHedgingRelationshipsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_3f4a176e-0341-4ddf-8b4c-493e2692c28e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_097b2a2b-d13d-4334-8b94-86e9e88af443" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_3f4a176e-0341-4ddf-8b4c-493e2692c28e" xlink:to="loc_us-gaap_CostOfRevenue_097b2a2b-d13d-4334-8b94-86e9e88af443" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_31d9f9e1-ddb0-43b1-a6e1-b6cfa915e20b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_3f4a176e-0341-4ddf-8b4c-493e2692c28e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_31d9f9e1-ddb0-43b1-a6e1-b6cfa915e20b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_c3efd646-8465-4f98-b235-c0da326ed87e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_3f4a176e-0341-4ddf-8b4c-493e2692c28e" xlink:to="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_c3efd646-8465-4f98-b235-c0da326ed87e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_33ab2b12-a255-461f-8689-86f39569430d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_c3efd646-8465-4f98-b235-c0da326ed87e" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_33ab2b12-a255-461f-8689-86f39569430d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_33ab2b12-a255-461f-8689-86f39569430d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_33ab2b12-a255-461f-8689-86f39569430d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_33ab2b12-a255-461f-8689-86f39569430d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_a1041a5c-c648-400c-a838-e192fe7c6af9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_33ab2b12-a255-461f-8689-86f39569430d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_a1041a5c-c648-400c-a838-e192fe7c6af9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_db845641-4864-4d16-ad69-f275da457c61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a1041a5c-c648-400c-a838-e192fe7c6af9" xlink:to="loc_us-gaap_ForeignExchangeContractMember_db845641-4864-4d16-ad69-f275da457c61" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_42e63797-c69c-43d8-af65-9f0c16c30642" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_c3efd646-8465-4f98-b235-c0da326ed87e" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_42e63797-c69c-43d8-af65-9f0c16c30642" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_42e63797-c69c-43d8-af65-9f0c16c30642_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_42e63797-c69c-43d8-af65-9f0c16c30642" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_42e63797-c69c-43d8-af65-9f0c16c30642_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_49b56437-cee9-4e0f-81ad-2f10fa2155e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_42e63797-c69c-43d8-af65-9f0c16c30642" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_49b56437-cee9-4e0f-81ad-2f10fa2155e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_d19cf73f-27d5-4598-aa78-8a3c547c856c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_49b56437-cee9-4e0f-81ad-2f10fa2155e5" xlink:to="loc_us-gaap_CostOfSalesMember_d19cf73f-27d5-4598-aa78-8a3c547c856c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.idexx.com/role/HedgingInstrumentsScheduleofFairValuesandBalanceSheetClassificationsofDerivativesandNonderivativesDesignatedasHedgingInstrumentsDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#HedgingInstrumentsScheduleofFairValuesandBalanceSheetClassificationsofDerivativesandNonderivativesDesignatedasHedgingInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.idexx.com/role/HedgingInstrumentsScheduleofFairValuesandBalanceSheetClassificationsofDerivativesandNonderivativesDesignatedasHedgingInstrumentsDetails" xlink:type="extended" id="if755a07942fe4a969211f14a98dbbf7a_HedgingInstrumentsScheduleofFairValuesandBalanceSheetClassificationsofDerivativesandNonderivativesDesignatedasHedgingInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_4cbdd354-d3f4-40e7-b4e7-ef9fe5b14801" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_7e7047c8-8fc8-4a25-a209-5c5816680421" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_4cbdd354-d3f4-40e7-b4e7-ef9fe5b14801" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_7e7047c8-8fc8-4a25-a209-5c5816680421" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction_63facf03-8781-479d-b8e0-437a794b2ded" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_4cbdd354-d3f4-40e7-b4e7-ef9fe5b14801" xlink:to="loc_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction_63facf03-8781-479d-b8e0-437a794b2ded" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection_29d03972-46fb-4635-8404-8bdaca483f95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_4cbdd354-d3f4-40e7-b4e7-ef9fe5b14801" xlink:to="loc_us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection_29d03972-46fb-4635-8404-8bdaca483f95" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_3e0eff0d-0d80-42ce-894a-fa4846421f69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_4cbdd354-d3f4-40e7-b4e7-ef9fe5b14801" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_3e0eff0d-0d80-42ce-894a-fa4846421f69" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction_bde40461-dc44-45e6-9b74-6d7f47d1116c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_4cbdd354-d3f4-40e7-b4e7-ef9fe5b14801" xlink:to="loc_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction_bde40461-dc44-45e6-9b74-6d7f47d1116c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection_76528ab7-2710-4cf8-9bab-599bae879759" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_4cbdd354-d3f4-40e7-b4e7-ef9fe5b14801" xlink:to="loc_us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection_76528ab7-2710-4cf8-9bab-599bae879759" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_3e4421f4-c129-4817-81c3-578fc97d1f0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_4cbdd354-d3f4-40e7-b4e7-ef9fe5b14801" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_3e4421f4-c129-4817-81c3-578fc97d1f0e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_290bbb9f-78c4-4b4d-b1d0-551a8512251d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_3e4421f4-c129-4817-81c3-578fc97d1f0e" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_290bbb9f-78c4-4b4d-b1d0-551a8512251d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_290bbb9f-78c4-4b4d-b1d0-551a8512251d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_290bbb9f-78c4-4b4d-b1d0-551a8512251d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_290bbb9f-78c4-4b4d-b1d0-551a8512251d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_2fb66159-d599-448a-8ecb-740f63e09372" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_290bbb9f-78c4-4b4d-b1d0-551a8512251d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_2fb66159-d599-448a-8ecb-740f63e09372" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_be558eb8-039d-4c18-a4ef-23f3db31705b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2fb66159-d599-448a-8ecb-740f63e09372" xlink:to="loc_us-gaap_ForeignExchangeContractMember_be558eb8-039d-4c18-a4ef-23f3db31705b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_dd83f7a0-7b6c-458a-8ba0-040de2c402bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2fb66159-d599-448a-8ecb-740f63e09372" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_dd83f7a0-7b6c-458a-8ba0-040de2c402bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ForeignCurrencyBorrowingsDesignatedAsNetInvestmentHedgeOnBalanceSheetMember_71197473-4ed5-4af5-82b1-2b1f131de5ca" xlink:href="idxx-20211231.xsd#idxx_ForeignCurrencyBorrowingsDesignatedAsNetInvestmentHedgeOnBalanceSheetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2fb66159-d599-448a-8ecb-740f63e09372" xlink:to="loc_idxx_ForeignCurrencyBorrowingsDesignatedAsNetInvestmentHedgeOnBalanceSheetMember_71197473-4ed5-4af5-82b1-2b1f131de5ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_2086259f-d9a0-4eba-81e4-5cc79399e714" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_3e4421f4-c129-4817-81c3-578fc97d1f0e" xlink:to="loc_us-gaap_HedgingDesignationAxis_2086259f-d9a0-4eba-81e4-5cc79399e714" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_2086259f-d9a0-4eba-81e4-5cc79399e714_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_2086259f-d9a0-4eba-81e4-5cc79399e714" xlink:to="loc_us-gaap_HedgingDesignationDomain_2086259f-d9a0-4eba-81e4-5cc79399e714_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_164d4041-3411-40be-98f8-a452f7cf2cf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_2086259f-d9a0-4eba-81e4-5cc79399e714" xlink:to="loc_us-gaap_HedgingDesignationDomain_164d4041-3411-40be-98f8-a452f7cf2cf0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_7dbf45f1-565a-459c-8ec7-9349b5eda809" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_164d4041-3411-40be-98f8-a452f7cf2cf0" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_7dbf45f1-565a-459c-8ec7-9349b5eda809" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_5a031c02-cd80-4aac-8e80-b7c1e565cd24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_3e4421f4-c129-4817-81c3-578fc97d1f0e" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_5a031c02-cd80-4aac-8e80-b7c1e565cd24" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_5a031c02-cd80-4aac-8e80-b7c1e565cd24_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_5a031c02-cd80-4aac-8e80-b7c1e565cd24" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_5a031c02-cd80-4aac-8e80-b7c1e565cd24_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6df57811-1ebe-43bf-b893-b577193cca48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_5a031c02-cd80-4aac-8e80-b7c1e565cd24" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_6df57811-1ebe-43bf-b893-b577193cca48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember_1383173e-0cc8-4ba5-96bf-dc20dd4328bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6df57811-1ebe-43bf-b893-b577193cca48" xlink:to="loc_us-gaap_OtherCurrentAssetsMember_1383173e-0cc8-4ba5-96bf-dc20dd4328bd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_5fa62468-98e5-438e-a31a-02c6da8fd8f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6df57811-1ebe-43bf-b893-b577193cca48" xlink:to="loc_us-gaap_OtherAssetsMember_5fa62468-98e5-438e-a31a-02c6da8fd8f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_14b91553-e7fa-4e82-b576-8f5b52695350" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6df57811-1ebe-43bf-b893-b577193cca48" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_14b91553-e7fa-4e82-b576-8f5b52695350" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_dfe09ea4-80f9-4922-a990-fefe594ba59d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6df57811-1ebe-43bf-b893-b577193cca48" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_dfe09ea4-80f9-4922-a990-fefe594ba59d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_8182cc25-4c6f-4930-bdf1-cd0fe27ed5d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6df57811-1ebe-43bf-b893-b577193cca48" xlink:to="loc_us-gaap_LongTermDebtMember_8182cc25-4c6f-4930-bdf1-cd0fe27ed5d2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_fa0ebbf0-5a82-4767-b72b-7d0078a7c652" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_3e4421f4-c129-4817-81c3-578fc97d1f0e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_fa0ebbf0-5a82-4767-b72b-7d0078a7c652" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_fa0ebbf0-5a82-4767-b72b-7d0078a7c652_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_fa0ebbf0-5a82-4767-b72b-7d0078a7c652" xlink:to="loc_us-gaap_HedgingRelationshipDomain_fa0ebbf0-5a82-4767-b72b-7d0078a7c652_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_1f403e08-3cdd-4c29-902d-f59ef31bfd82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_fa0ebbf0-5a82-4767-b72b-7d0078a7c652" xlink:to="loc_us-gaap_HedgingRelationshipDomain_1f403e08-3cdd-4c29-902d-f59ef31bfd82" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_8f7d854a-d833-4cbb-8919-3ce886d4f572" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_1f403e08-3cdd-4c29-902d-f59ef31bfd82" xlink:to="loc_us-gaap_CashFlowHedgingMember_8f7d854a-d833-4cbb-8919-3ce886d4f572" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.idexx.com/role/AccumulatedOtherComprehensiveIncomeScheduleofAccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#AccumulatedOtherComprehensiveIncomeScheduleofAccumulatedOtherComprehensiveIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.idexx.com/role/AccumulatedOtherComprehensiveIncomeScheduleofAccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended" id="ib0c1384f2af14e818ff6d73d046b0173_AccumulatedOtherComprehensiveIncomeScheduleofAccumulatedOtherComprehensiveIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_038a75c5-5f95-4ebb-8bf4-e626a3d0c27d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_57964177-3924-40dc-93bd-6b56d65d25b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_038a75c5-5f95-4ebb-8bf4-e626a3d0c27d" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_57964177-3924-40dc-93bd-6b56d65d25b1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4c9819af-14b4-4c35-b8c9-0fc8477f8c11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_57964177-3924-40dc-93bd-6b56d65d25b1" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4c9819af-14b4-4c35-b8c9-0fc8477f8c11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_18e12972-8307-4bcb-b944-86d8c1d2256b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_57964177-3924-40dc-93bd-6b56d65d25b1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_18e12972-8307-4bcb-b944-86d8c1d2256b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_94c872ce-0f4d-4882-9763-ff21769a27ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_57964177-3924-40dc-93bd-6b56d65d25b1" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_94c872ce-0f4d-4882-9763-ff21769a27ff" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9c63a48d-6cca-4915-aca9-613f794586b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_5382bce6-395c-4eb9-953b-a129d7e9297d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_038a75c5-5f95-4ebb-8bf4-e626a3d0c27d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_5382bce6-395c-4eb9-953b-a129d7e9297d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d05f505a-c461-4b62-a83a-51a4729c9a82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_5382bce6-395c-4eb9-953b-a129d7e9297d" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d05f505a-c461-4b62-a83a-51a4729c9a82" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d05f505a-c461-4b62-a83a-51a4729c9a82_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d05f505a-c461-4b62-a83a-51a4729c9a82" xlink:to="loc_us-gaap_EquityComponentDomain_d05f505a-c461-4b62-a83a-51a4729c9a82_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9f58f240-5158-4260-8089-e2c8cca705e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d05f505a-c461-4b62-a83a-51a4729c9a82" xlink:to="loc_us-gaap_EquityComponentDomain_9f58f240-5158-4260-8089-e2c8cca705e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_731e8bc6-ffc6-46a7-af1b-3654c229428e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9f58f240-5158-4260-8089-e2c8cca705e2" xlink:to="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_731e8bc6-ffc6-46a7-af1b-3654c229428e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleIncludingPortionAttributableToNoncontrollingInterestMember_47585bc2-60ce-4c2e-b7c0-aecffcf4e42c" xlink:href="idxx-20211231.xsd#idxx_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_731e8bc6-ffc6-46a7-af1b-3654c229428e" xlink:to="loc_idxx_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleIncludingPortionAttributableToNoncontrollingInterestMember_47585bc2-60ce-4c2e-b7c0-aecffcf4e42c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_AccumulatedNetGainLossFromCashFlowHedgesForeignCurrencyExchangeContractsIncludingPortionAttributableToNoncontrollingInterestMember_5298c0f8-1b31-4dde-9ee7-35a47a9bc64f" xlink:href="idxx-20211231.xsd#idxx_AccumulatedNetGainLossFromCashFlowHedgesForeignCurrencyExchangeContractsIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_731e8bc6-ffc6-46a7-af1b-3654c229428e" xlink:to="loc_idxx_AccumulatedNetGainLossFromCashFlowHedgesForeignCurrencyExchangeContractsIncludingPortionAttributableToNoncontrollingInterestMember_5298c0f8-1b31-4dde-9ee7-35a47a9bc64f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_AccumulatedNetGainLossFromNetInvestmentHedgesEuroDenominatedNotesIncludingPortionAttributableToNoncontrollingInterestMember_eb7d2b80-12f4-46e6-830d-e07b90dc39f1" xlink:href="idxx-20211231.xsd#idxx_AccumulatedNetGainLossFromNetInvestmentHedgesEuroDenominatedNotesIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_731e8bc6-ffc6-46a7-af1b-3654c229428e" xlink:to="loc_idxx_AccumulatedNetGainLossFromNetInvestmentHedgesEuroDenominatedNotesIncludingPortionAttributableToNoncontrollingInterestMember_eb7d2b80-12f4-46e6-830d-e07b90dc39f1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_AccumulatedNetGainLossFromNetInvestmentHedgesCrossCurrencySwapsIncludingPortionAttributableToNoncontrollingInterestMember_5ff8ff0d-e48e-4128-90d8-027718d5f27a" xlink:href="idxx-20211231.xsd#idxx_AccumulatedNetGainLossFromNetInvestmentHedgesCrossCurrencySwapsIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_731e8bc6-ffc6-46a7-af1b-3654c229428e" xlink:to="loc_idxx_AccumulatedNetGainLossFromNetInvestmentHedgesCrossCurrencySwapsIncludingPortionAttributableToNoncontrollingInterestMember_5ff8ff0d-e48e-4128-90d8-027718d5f27a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_c2c47ecf-735f-4ac9-a721-e6d91689ffea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_731e8bc6-ffc6-46a7-af1b-3654c229428e" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_c2c47ecf-735f-4ac9-a721-e6d91689ffea" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.idexx.com/role/AccumulatedOtherComprehensiveIncomeScheduleofReclassificationsoutofAccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#AccumulatedOtherComprehensiveIncomeScheduleofReclassificationsoutofAccumulatedOtherComprehensiveIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.idexx.com/role/AccumulatedOtherComprehensiveIncomeScheduleofReclassificationsoutofAccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended" id="i2e1c2afdbc4f447e85528aa136cd3328_AccumulatedOtherComprehensiveIncomeScheduleofReclassificationsoutofAccumulatedOtherComprehensiveIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_09d333f4-541c-458a-a1ef-ba3c12ea9b71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_1ea58b17-645c-466a-91c3-ec924fc0e3fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_09d333f4-541c-458a-a1ef-ba3c12ea9b71" xlink:to="loc_us-gaap_CostOfRevenue_1ea58b17-645c-466a-91c3-ec924fc0e3fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_6b24c6bc-6ff5-4a7d-a8cd-6a2ff1f82ce1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_09d333f4-541c-458a-a1ef-ba3c12ea9b71" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_6b24c6bc-6ff5-4a7d-a8cd-6a2ff1f82ce1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_d8108654-d2d7-4681-8285-21dd3c2e734b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_09d333f4-541c-458a-a1ef-ba3c12ea9b71" xlink:to="loc_us-gaap_ProfitLoss_d8108654-d2d7-4681-8285-21dd3c2e734b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_8702f1e6-4685-4058-a1fe-16c5eda40477" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_09d333f4-541c-458a-a1ef-ba3c12ea9b71" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_8702f1e6-4685-4058-a1fe-16c5eda40477" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_93b66862-f8db-423b-a57e-22fad0b2405b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_8702f1e6-4685-4058-a1fe-16c5eda40477" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_93b66862-f8db-423b-a57e-22fad0b2405b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_93b66862-f8db-423b-a57e-22fad0b2405b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_93b66862-f8db-423b-a57e-22fad0b2405b" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_93b66862-f8db-423b-a57e-22fad0b2405b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_e3844203-92a1-467d-ad5a-26eacbdbde90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_93b66862-f8db-423b-a57e-22fad0b2405b" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_e3844203-92a1-467d-ad5a-26eacbdbde90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_4b32f3b2-7644-4b67-9478-3cce595d7845" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_e3844203-92a1-467d-ad5a-26eacbdbde90" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_4b32f3b2-7644-4b67-9478-3cce595d7845" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_de3825e4-1616-4099-954d-e4ff441240aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_8702f1e6-4685-4058-a1fe-16c5eda40477" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_de3825e4-1616-4099-954d-e4ff441240aa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_de3825e4-1616-4099-954d-e4ff441240aa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_de3825e4-1616-4099-954d-e4ff441240aa" xlink:to="loc_us-gaap_EquityComponentDomain_de3825e4-1616-4099-954d-e4ff441240aa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d52634ae-6f31-4863-b684-c5508e08eba6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_de3825e4-1616-4099-954d-e4ff441240aa" xlink:to="loc_us-gaap_EquityComponentDomain_d52634ae-6f31-4863-b684-c5508e08eba6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_AccumulatedNetGainLossFromCashFlowHedgesForeignCurrencyExchangeContractsIncludingPortionAttributableToNoncontrollingInterestMember_51db6569-ffb6-4c1b-898e-e83b4ffb3839" xlink:href="idxx-20211231.xsd#idxx_AccumulatedNetGainLossFromCashFlowHedgesForeignCurrencyExchangeContractsIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d52634ae-6f31-4863-b684-c5508e08eba6" xlink:to="loc_idxx_AccumulatedNetGainLossFromCashFlowHedgesForeignCurrencyExchangeContractsIncludingPortionAttributableToNoncontrollingInterestMember_51db6569-ffb6-4c1b-898e-e83b4ffb3839" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.idexx.com/role/IDEXXRetirementandIncentiveSavingsPlanDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#IDEXXRetirementandIncentiveSavingsPlanDetails"/>
  <link:definitionLink xlink:role="http://www.idexx.com/role/IDEXXRetirementandIncentiveSavingsPlanDetails" xlink:type="extended" id="ife93f14aab684ba494c355e98165c1ad_IDEXXRetirementandIncentiveSavingsPlanDetails">
    <link:loc xlink:type="locator" xlink:label="loc_idxx_RetirementAndIncentiveSavingsPlanLineItems_36283234-a35b-4d17-8bcf-7fe623dff2a0" xlink:href="idxx-20211231.xsd#idxx_RetirementAndIncentiveSavingsPlanLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_5be42029-10d7-4d5f-97bc-22cb6120bf59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_idxx_RetirementAndIncentiveSavingsPlanLineItems_36283234-a35b-4d17-8bcf-7fe623dff2a0" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_5be42029-10d7-4d5f-97bc-22cb6120bf59" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_2eae5380-3bfd-4c65-8bee-f8a9098a4fe7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_idxx_RetirementAndIncentiveSavingsPlanLineItems_36283234-a35b-4d17-8bcf-7fe623dff2a0" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_2eae5380-3bfd-4c65-8bee-f8a9098a4fe7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_567f6d48-fbc5-4593-8c05-1a32c0280436" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_idxx_RetirementAndIncentiveSavingsPlanLineItems_36283234-a35b-4d17-8bcf-7fe623dff2a0" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_567f6d48-fbc5-4593-8c05-1a32c0280436" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_RetirementAndIncentiveSavingsPlanTable_3041af61-507a-4193-9470-d72cce47df07" xlink:href="idxx-20211231.xsd#idxx_RetirementAndIncentiveSavingsPlanTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_idxx_RetirementAndIncentiveSavingsPlanLineItems_36283234-a35b-4d17-8bcf-7fe623dff2a0" xlink:to="loc_idxx_RetirementAndIncentiveSavingsPlanTable_3041af61-507a-4193-9470-d72cce47df07" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_RetirementAndIncentiveSavingsPlanAxis_b8c4a5de-8c8b-412b-b2be-c2984b7f53ac" xlink:href="idxx-20211231.xsd#idxx_RetirementAndIncentiveSavingsPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_idxx_RetirementAndIncentiveSavingsPlanTable_3041af61-507a-4193-9470-d72cce47df07" xlink:to="loc_idxx_RetirementAndIncentiveSavingsPlanAxis_b8c4a5de-8c8b-412b-b2be-c2984b7f53ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_RetirementAndIncentiveSavingsPlanDomain_b8c4a5de-8c8b-412b-b2be-c2984b7f53ac_default" xlink:href="idxx-20211231.xsd#idxx_RetirementAndIncentiveSavingsPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_idxx_RetirementAndIncentiveSavingsPlanAxis_b8c4a5de-8c8b-412b-b2be-c2984b7f53ac" xlink:to="loc_idxx_RetirementAndIncentiveSavingsPlanDomain_b8c4a5de-8c8b-412b-b2be-c2984b7f53ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_RetirementAndIncentiveSavingsPlanDomain_24d27aef-807c-4ddc-8a0a-d9fd76869a71" xlink:href="idxx-20211231.xsd#idxx_RetirementAndIncentiveSavingsPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_idxx_RetirementAndIncentiveSavingsPlanAxis_b8c4a5de-8c8b-412b-b2be-c2984b7f53ac" xlink:to="loc_idxx_RetirementAndIncentiveSavingsPlanDomain_24d27aef-807c-4ddc-8a0a-d9fd76869a71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_FourZeroOneKPlanMember_2c601841-6b2a-4a50-8a91-6f6b5c38e729" xlink:href="idxx-20211231.xsd#idxx_FourZeroOneKPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_idxx_RetirementAndIncentiveSavingsPlanDomain_24d27aef-807c-4ddc-8a0a-d9fd76869a71" xlink:to="loc_idxx_FourZeroOneKPlanMember_2c601841-6b2a-4a50-8a91-6f6b5c38e729" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>30
<FILENAME>idxx-20211231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:f52bcaef-ba11-42ce-aefc-0c16e0e0e054,g:8ec733b7-1a7e-4401-9212-15a98e503c1c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_fe46d404-7060-46a2-bd0e-44b74909d256_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_26799f87-cfe6-48aa-86c7-510075cd7364_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1176a47a-01ed-4996-95c6-72512220df04_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_c98f38bd-7e99-40db-9527-c2b6e1517985_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_AccumulatedNetGainLossFromCashFlowHedgesForeignCurrencyExchangeContractsIncludingPortionAttributableToNoncontrollingInterestMember_6b57f8b0-dc90-4c95-bef0-405f842d5e32_verboseLabel_en-US" xlink:label="lab_idxx_AccumulatedNetGainLossFromCashFlowHedgesForeignCurrencyExchangeContractsIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized (Loss) Gain on Cash Flow Hedges, Net of Tax, Foreign Currency Exchange Contracts</link:label>
    <link:label id="lab_idxx_AccumulatedNetGainLossFromCashFlowHedgesForeignCurrencyExchangeContractsIncludingPortionAttributableToNoncontrollingInterestMember_fa440af5-510e-4355-9aef-27b08d2e239a_terseLabel_en-US" xlink:label="lab_idxx_AccumulatedNetGainLossFromCashFlowHedgesForeignCurrencyExchangeContractsIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Exchange Contracts</link:label>
    <link:label id="lab_idxx_AccumulatedNetGainLossFromCashFlowHedgesForeignCurrencyExchangeContractsIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_idxx_AccumulatedNetGainLossFromCashFlowHedgesForeignCurrencyExchangeContractsIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Net Gain (Loss) from Cash Flow Hedges, Foreign Currency Exchange Contracts, Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:label id="lab_idxx_AccumulatedNetGainLossFromCashFlowHedgesForeignCurrencyExchangeContractsIncludingPortionAttributableToNoncontrollingInterestMember_documentation_en-US" xlink:label="lab_idxx_AccumulatedNetGainLossFromCashFlowHedgesForeignCurrencyExchangeContractsIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Net Gain (Loss) from Cash Flow Hedges, Foreign Currency Exchange Contracts, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_AccumulatedNetGainLossFromCashFlowHedgesForeignCurrencyExchangeContractsIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="idxx-20211231.xsd#idxx_AccumulatedNetGainLossFromCashFlowHedgesForeignCurrencyExchangeContractsIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_AccumulatedNetGainLossFromCashFlowHedgesForeignCurrencyExchangeContractsIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_idxx_AccumulatedNetGainLossFromCashFlowHedgesForeignCurrencyExchangeContractsIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_ReagentRentalProgramsMember_2b29fc5f-a59d-4881-bfcd-211158f2e75a_terseLabel_en-US" xlink:label="lab_idxx_ReagentRentalProgramsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reagent rental programs</link:label>
    <link:label id="lab_idxx_ReagentRentalProgramsMember_label_en-US" xlink:label="lab_idxx_ReagentRentalProgramsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reagent Rental Programs [Member]</link:label>
    <link:label id="lab_idxx_ReagentRentalProgramsMember_documentation_en-US" xlink:label="lab_idxx_ReagentRentalProgramsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reagent Rental Programs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ReagentRentalProgramsMember" xlink:href="idxx-20211231.xsd#idxx_ReagentRentalProgramsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_ReagentRentalProgramsMember" xlink:to="lab_idxx_ReagentRentalProgramsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_9b0a303d-361a-4f1b-a76b-7b3fa328164f_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_BusinessCombinationContingencyFairValue_f10aeed6-313f-4e35-b720-212cb9211dc9_terseLabel_en-US" xlink:label="lab_idxx_BusinessCombinationContingencyFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent payments - acquisitions</link:label>
    <link:label id="lab_idxx_BusinessCombinationContingencyFairValue_label_en-US" xlink:label="lab_idxx_BusinessCombinationContingencyFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingency, Fair Value</link:label>
    <link:label id="lab_idxx_BusinessCombinationContingencyFairValue_documentation_en-US" xlink:label="lab_idxx_BusinessCombinationContingencyFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingency, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_BusinessCombinationContingencyFairValue" xlink:href="idxx-20211231.xsd#idxx_BusinessCombinationContingencyFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_BusinessCombinationContingencyFairValue" xlink:to="lab_idxx_BusinessCombinationContingencyFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_ConsolidatedLeverageRatioUnderCreditFacilityNotePayable_36e50adb-716c-46d0-9577-4fdb8f9f616e_terseLabel_en-US" xlink:label="lab_idxx_ConsolidatedLeverageRatioUnderCreditFacilityNotePayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated leverage ratio under credit facility &amp; note payable, maximum</link:label>
    <link:label id="lab_idxx_ConsolidatedLeverageRatioUnderCreditFacilityNotePayable_label_en-US" xlink:label="lab_idxx_ConsolidatedLeverageRatioUnderCreditFacilityNotePayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Leverage Ratio Under Credit Facility Note Payable</link:label>
    <link:label id="lab_idxx_ConsolidatedLeverageRatioUnderCreditFacilityNotePayable_documentation_en-US" xlink:label="lab_idxx_ConsolidatedLeverageRatioUnderCreditFacilityNotePayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum consolidated leverage ratio permitted under debt agreements.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ConsolidatedLeverageRatioUnderCreditFacilityNotePayable" xlink:href="idxx-20211231.xsd#idxx_ConsolidatedLeverageRatioUnderCreditFacilityNotePayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_ConsolidatedLeverageRatioUnderCreditFacilityNotePayable" xlink:to="lab_idxx_ConsolidatedLeverageRatioUnderCreditFacilityNotePayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_d85086f3-7a94-4a26-9e57-aba13504f21e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition expenses</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_c5ad64af-8d7f-4523-83b5-a3367de87efd_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_2f96d2f1-387e-449b-b599-58bbe196a2b7_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases_c151f2a4-0aac-4475-b3ed-765723571b39_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction of credit facility availability</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Capacity Available for Specific Purpose Other than for Trade Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases" xlink:to="lab_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EMEAMember_6e788ca3-5446-478d-9af5-8b4097117b87_terseLabel_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe, the Middle East and Africa</link:label>
    <link:label id="lab_us-gaap_EMEAMember_label_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMEA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EMEAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EMEAMember" xlink:to="lab_us-gaap_EMEAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_980a4e3f-b508-4573-8da1-faca9c1bf776_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant date fair value, forfeited (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_32444167-2dfa-42aa-be16-2a3805ffb19b_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of acquisition-related contingent consideration and holdbacks</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration Liability, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_138032a1-9bed-46f7-8e57-bbad9204d3c1_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_a062d0f2-f9c5-48c2-980d-605a0031d447_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term - operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_246f5aa6-b49a-4ca1-9f9d-9cbc5dbdd2f6_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock_bb5f98bd-06d6-4535-b45f-4e718c7f56f0_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments, Contingencies and Guarantees</link:label>
    <link:label id="lab_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments Contingencies and Guarantees [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock" xlink:to="lab_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromHedgeInvestingActivities_75775cee-22cb-4a69-ad9e-df8e012eed0d_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromHedgeInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from net investment hedge</link:label>
    <link:label id="lab_us-gaap_ProceedsFromHedgeInvestingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromHedgeInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Hedge, Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromHedgeInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromHedgeInvestingActivities" xlink:to="lab_us-gaap_ProceedsFromHedgeInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_ScheduleOfEstimatedUsefulLivesForIntangibleAssetsTableTextBlock_85e91df1-a44f-4c64-9020-e43de8f57da4_terseLabel_en-US" xlink:label="lab_idxx_ScheduleOfEstimatedUsefulLivesForIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of estimated useful lives for intangible assets</link:label>
    <link:label id="lab_idxx_ScheduleOfEstimatedUsefulLivesForIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_idxx_ScheduleOfEstimatedUsefulLivesForIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Estimated Useful Lives For Intangible Assets [Table Text Block]</link:label>
    <link:label id="lab_idxx_ScheduleOfEstimatedUsefulLivesForIntangibleAssetsTableTextBlock_documentation_en-US" xlink:label="lab_idxx_ScheduleOfEstimatedUsefulLivesForIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Estimated Useful Lives For Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ScheduleOfEstimatedUsefulLivesForIntangibleAssetsTableTextBlock" xlink:href="idxx-20211231.xsd#idxx_ScheduleOfEstimatedUsefulLivesForIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_ScheduleOfEstimatedUsefulLivesForIntangibleAssetsTableTextBlock" xlink:to="lab_idxx_ScheduleOfEstimatedUsefulLivesForIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_86c6c67b-4f36-48e2-9ade-e4d13b8473d4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_3289154f-e743-4dd6-a6c4-bef0a20516f9_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock_a8e4ade7-9937-4bf3-977d-d2e437c94b78_terseLabel_en-US" xlink:label="lab_idxx_ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of estimated useful lives for property and equipment</link:label>
    <link:label id="lab_idxx_ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock_label_en-US" xlink:label="lab_idxx_ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Estimated Useful Lives For Property And Equipment [Table Text Block]</link:label>
    <link:label id="lab_idxx_ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock_documentation_en-US" xlink:label="lab_idxx_ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Estimated Useful Lives For Property And Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock" xlink:href="idxx-20211231.xsd#idxx_ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock" xlink:to="lab_idxx_ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_711d8a7a-f034-4afe-99a0-a92b937bcf76_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available for grant under share-based incentive plans (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7fc6251b-4f78-49bf-b7e2-bca10dddbd2a_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (decrease) increase in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_2a565637-2558-4ecb-8e77-4bfa241d439b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_d0151bb3-072f-4d19-b3c3-46a1b3dca374_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_e52b2163-3d8f-4702-b5f8-82dd22ad2c6a_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset basis differences</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_bedbe6f4-f001-481e-80ce-8f5364d12ce1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in estimated fair value</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_5226c3a4-5a2b-4019-91f7-782f37b45741_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intrinsic value of stock options exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_6d17ef48-8fc8-4df7-8459-b2f0c8307f73_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition adjustment</link:label>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_3f1fee6a-972a-4c77-8e9d-8b3a441d93a7_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of reclassifications out of accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_A2023SeriesANotesMember_06f2dc4f-6b27-464b-8d41-2637fcec56ba_terseLabel_en-US" xlink:label="lab_idxx_A2023SeriesANotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 Series A Notes</link:label>
    <link:label id="lab_idxx_A2023SeriesANotesMember_label_en-US" xlink:label="lab_idxx_A2023SeriesANotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 Series A Notes [Member]</link:label>
    <link:label id="lab_idxx_A2023SeriesANotesMember_documentation_en-US" xlink:label="lab_idxx_A2023SeriesANotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 Series A Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_A2023SeriesANotesMember" xlink:href="idxx-20211231.xsd#idxx_A2023SeriesANotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_A2023SeriesANotesMember" xlink:to="lab_idxx_A2023SeriesANotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_4bb4d6f4-2860-42bb-9006-88d38dd2ca4c_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Translation Adjustment</link:label>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_de0de557-078d-4ac9-a56a-a27f80f36329_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_04d4968d-cb08-42ac-b047-077891359fb0_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_9d4ac58c-2d75-4c91-9cee-33351a7b3d22_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets useful life</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_2c5e2d97-ba02-4584-8b98-e34a1b03865c_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross increases (decreases) in unrecognized tax positions as a result of tax positions taken during a prior period</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_ce26d4aa-6276-4996-a7c3-ef5e4d04d32f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of senior notes</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Senior Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_7288c2dc-d143-4c27-96fd-65ef7d586c45_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_899edd15-5840-45dc-a723-41123c12c3c2_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of shares underlying anti-dilutive options (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_fb7e6b12-8089-49aa-aa83-c2a22babec10_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate - operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_7d091017-7759-4a8b-85fb-6f239e2b4ede_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of components of inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_fd402e4f-ca55-41ae-ad8c-d8f21d1e3e90_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue recognized</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_9562abdb-f255-4335-bdf8-e05b7bd15457_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets, net of valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_ec2da430-64f2-473e-bc09-623894ed0a40_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_143d93a0-f582-4836-810d-03cca66a1647_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedges</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f4719fe3-c745-4eb0-a9aa-55a69c5c5328_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_3156464f-59e4-47d0-bc3a-ac429877ad3d_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteeObligationsCurrentCarryingValue_ea74edb8-4491-4535-9580-bcaba78bdd12_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities for indemnification obligations</link:label>
    <link:label id="lab_us-gaap_GuaranteeObligationsCurrentCarryingValue_label_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Current Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuaranteeObligationsCurrentCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:to="lab_us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_0a49d40e-16f1-4b20-a5e5-960da18e330d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_5147e4bd-ef84-418b-a9ab-2492a56bc366_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fully vested, at end of year (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_FinancialAssetGreaterThan60DaysPastDueMember_d9b88a3b-3528-4897-a1d2-4db809106e2c_terseLabel_en-US" xlink:label="lab_idxx_FinancialAssetGreaterThan60DaysPastDueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater than 60 Days Past Due</link:label>
    <link:label id="lab_idxx_FinancialAssetGreaterThan60DaysPastDueMember_label_en-US" xlink:label="lab_idxx_FinancialAssetGreaterThan60DaysPastDueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Asset, Greater Than 60 Days Past Due [Member]</link:label>
    <link:label id="lab_idxx_FinancialAssetGreaterThan60DaysPastDueMember_documentation_en-US" xlink:label="lab_idxx_FinancialAssetGreaterThan60DaysPastDueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Asset, Greater Than 60 Days Past Due [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_FinancialAssetGreaterThan60DaysPastDueMember" xlink:href="idxx-20211231.xsd#idxx_FinancialAssetGreaterThan60DaysPastDueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_FinancialAssetGreaterThan60DaysPastDueMember" xlink:to="lab_idxx_FinancialAssetGreaterThan60DaysPastDueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_bcc75514-56b3-4b51-a2e3-c50da5e4fbc2_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_A2021SeriesANotesMember_554e093e-890c-4736-90e4-06874682d39c_terseLabel_en-US" xlink:label="lab_idxx_A2021SeriesANotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Series A Notes</link:label>
    <link:label id="lab_idxx_A2021SeriesANotesMember_label_en-US" xlink:label="lab_idxx_A2021SeriesANotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Series A Notes [Member]</link:label>
    <link:label id="lab_idxx_A2021SeriesANotesMember_documentation_en-US" xlink:label="lab_idxx_A2021SeriesANotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Series A Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_A2021SeriesANotesMember" xlink:href="idxx-20211231.xsd#idxx_A2021SeriesANotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_A2021SeriesANotesMember" xlink:to="lab_idxx_A2021SeriesANotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_TwoThousandEighteenStockIncentivePlanMember_50ca63cd-232e-4e41-95cd-10bb54bb6819_terseLabel_en-US" xlink:label="lab_idxx_TwoThousandEighteenStockIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Stock Plan</link:label>
    <link:label id="lab_idxx_TwoThousandEighteenStockIncentivePlanMember_label_en-US" xlink:label="lab_idxx_TwoThousandEighteenStockIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Eighteen Stock Incentive Plan [Member]</link:label>
    <link:label id="lab_idxx_TwoThousandEighteenStockIncentivePlanMember_documentation_en-US" xlink:label="lab_idxx_TwoThousandEighteenStockIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Eighteen Stock Incentive Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_TwoThousandEighteenStockIncentivePlanMember" xlink:href="idxx-20211231.xsd#idxx_TwoThousandEighteenStockIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_TwoThousandEighteenStockIncentivePlanMember" xlink:to="lab_idxx_TwoThousandEighteenStockIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_463748ea-cfde-4dfd-b9cb-327794a7e52c_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_AccumulatedNetGainLossFromNetInvestmentHedgesEuroDenominatedNotesIncludingPortionAttributableToNoncontrollingInterestMember_0e6268a5-a5de-4b62-9b18-1b8e62cabe5e_terseLabel_en-US" xlink:label="lab_idxx_AccumulatedNetGainLossFromNetInvestmentHedgesEuroDenominatedNotesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized (Loss) Gain on Net Investment Hedges, Net of Tax, Euro-Denominated Notes</link:label>
    <link:label id="lab_idxx_AccumulatedNetGainLossFromNetInvestmentHedgesEuroDenominatedNotesIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_idxx_AccumulatedNetGainLossFromNetInvestmentHedgesEuroDenominatedNotesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Net Gain (Loss) From Net Investment Hedges, Euro Denominated Notes, Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:label id="lab_idxx_AccumulatedNetGainLossFromNetInvestmentHedgesEuroDenominatedNotesIncludingPortionAttributableToNoncontrollingInterestMember_documentation_en-US" xlink:label="lab_idxx_AccumulatedNetGainLossFromNetInvestmentHedgesEuroDenominatedNotesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Net Gain (Loss) From Net Investment Hedges, Euro Denominated Notes, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_AccumulatedNetGainLossFromNetInvestmentHedgesEuroDenominatedNotesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="idxx-20211231.xsd#idxx_AccumulatedNetGainLossFromNetInvestmentHedgesEuroDenominatedNotesIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_AccumulatedNetGainLossFromNetInvestmentHedgesEuroDenominatedNotesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_idxx_AccumulatedNetGainLossFromNetInvestmentHedgesEuroDenominatedNotesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_country_CN_6d8d381e-7787-403c-b0af-e25c5d001076_terseLabel_en-US" xlink:label="lab_country_CN" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">China</link:label>
    <link:label id="lab_country_CN_label_en-US" xlink:label="lab_country_CN" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CHINA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CN"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CN" xlink:to="lab_country_CN" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_5fd53501-7f7d-40ae-a047-d34b13d5954a_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_34373c97-34be-4e1b-8fad-5b3840678a29_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unpaid property and equipment, reflected in accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_RetainedClaimLiabilityPerIncident_e4a23a44-6686-4336-9b22-65f6d23c4e34_terseLabel_en-US" xlink:label="lab_idxx_RetainedClaimLiabilityPerIncident" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained claim liability per incident</link:label>
    <link:label id="lab_idxx_RetainedClaimLiabilityPerIncident_label_en-US" xlink:label="lab_idxx_RetainedClaimLiabilityPerIncident" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Claim Liability Per Incident</link:label>
    <link:label id="lab_idxx_RetainedClaimLiabilityPerIncident_documentation_en-US" xlink:label="lab_idxx_RetainedClaimLiabilityPerIncident" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained claim liability per incident.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_RetainedClaimLiabilityPerIncident" xlink:href="idxx-20211231.xsd#idxx_RetainedClaimLiabilityPerIncident"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_RetainedClaimLiabilityPerIncident" xlink:to="lab_idxx_RetainedClaimLiabilityPerIncident" xlink:type="arc" order="1"/>
    <link:label id="lab_country_DE_05730e5a-e96f-498d-b4f1-8c940e5250f6_terseLabel_en-US" xlink:label="lab_country_DE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Germany</link:label>
    <link:label id="lab_country_DE_label_en-US" xlink:label="lab_country_DE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GERMANY</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_DE"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_DE" xlink:to="lab_country_DE" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2be1e759-e966-46a2-8864-bc64c74c214a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_95af1e4b-c95a-43f1-b382-ca850e626670_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining shares available for repurchase under authorization (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_1dc0f46c-706c-40c2-968c-d41e33973ef1_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_fa13b9b3-b005-4ae4-8258-2b9d223052ad_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_1d953127-92af-4734-b4cb-cb4cf6aaa6c7_terseLabel_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares acquired through employee surrender for statutory tax withholding (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtWeightedAverageInterestRate_addd4cee-f8f1-416d-9b6a-18ce03613f9b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit facility weighted average interest rates on outstanding balance</link:label>
    <link:label id="lab_us-gaap_DebtWeightedAverageInterestRate_label_en-US" xlink:label="lab_us-gaap_DebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Weighted Average Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtWeightedAverageInterestRate" xlink:to="lab_us-gaap_DebtWeightedAverageInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_965cb797-79a6-4702-9941-f8c71a8df685_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_country_BR_3955c370-547e-4f5b-9bb4-8e9493b4cb27_terseLabel_en-US" xlink:label="lab_country_BR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Brazil</link:label>
    <link:label id="lab_country_BR_label_en-US" xlink:label="lab_country_BR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BRAZIL</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_BR" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_BR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_BR" xlink:to="lab_country_BR" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_95f55127-bd27-4b64-afca-4bd747f9fb98_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsDisclosureTextBlock_a0bed2f5-f727-4e2c-a007-97d20c8e1029_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current and Long-Term Assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_OtherAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_eeb5567b-b2a4-4e2f-bb84-ec9c068c053f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rent expense, excluding variable and short-term expenses</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_DeferredCompensationMember_caa9c456-63bb-401f-a04c-67fbb49c58d2_terseLabel_en-US" xlink:label="lab_idxx_DeferredCompensationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation</link:label>
    <link:label id="lab_idxx_DeferredCompensationMember_label_en-US" xlink:label="lab_idxx_DeferredCompensationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation [Member]</link:label>
    <link:label id="lab_idxx_DeferredCompensationMember_documentation_en-US" xlink:label="lab_idxx_DeferredCompensationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_DeferredCompensationMember" xlink:href="idxx-20211231.xsd#idxx_DeferredCompensationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_DeferredCompensationMember" xlink:to="lab_idxx_DeferredCompensationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_2311c1cb-5f36-4e17-b60a-7e350e3db358_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_65e293ad-0e9a-427b-927c-c73901d6fdca_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_a0912afd-c115-44c8-8292-b86a05682c32_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_70aa639e-aea3-484d-b324-e6e308cc3a67_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested, at beginning of year (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_57ecb1d3-5c48-4b04-b920-5a8c2383bc58_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested, at end of year (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_7df96a76-77fc-4b92-ae65-8a589a4d802f_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_country_CA_33ee31b9-577b-44e9-bf43-a680d9916c50_terseLabel_en-US" xlink:label="lab_country_CA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canada</link:label>
    <link:label id="lab_country_CA_label_en-US" xlink:label="lab_country_CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CANADA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CA" xlink:to="lab_country_CA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock_1571b5c4-0032-44e4-801e-da243f1b77cf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of net long-lived assets by principal geographic areas</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock" xlink:to="lab_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_country_CH_2ff2594d-a570-42f6-9592-3d9628593f62_terseLabel_en-US" xlink:label="lab_country_CH" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Switzerland</link:label>
    <link:label id="lab_country_CH_label_en-US" xlink:label="lab_country_CH" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SWITZERLAND</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CH"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CH" xlink:to="lab_country_CH" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostNet_0843db2a-7ea5-4332-8206-e03738c3acc8_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred commission costs</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostNet_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostNet" xlink:to="lab_us-gaap_CapitalizedContractCostNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_994c05cc-3c30-4e55-a086-57303b644508_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_e596a40e-c739-41c3-bc9f-06cd313f2c1d_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and equipment</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentMember" xlink:to="lab_us-gaap_MachineryAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_LivestockAndPoultryDiagnosticsSegmentMember_c54359e8-e979-4c20-afb9-0a1871b668a7_verboseLabel_en-US" xlink:label="lab_idxx_LivestockAndPoultryDiagnosticsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LPD segment revenue</link:label>
    <link:label id="lab_idxx_LivestockAndPoultryDiagnosticsSegmentMember_ae755740-b46e-4f65-bd62-cf0629c0205c_terseLabel_en-US" xlink:label="lab_idxx_LivestockAndPoultryDiagnosticsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LPD</link:label>
    <link:label id="lab_idxx_LivestockAndPoultryDiagnosticsSegmentMember_label_en-US" xlink:label="lab_idxx_LivestockAndPoultryDiagnosticsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Livestock And Poultry Diagnostics Segment [Member]</link:label>
    <link:label id="lab_idxx_LivestockAndPoultryDiagnosticsSegmentMember_documentation_en-US" xlink:label="lab_idxx_LivestockAndPoultryDiagnosticsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Livestock And Poultry Diagnostics Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_LivestockAndPoultryDiagnosticsSegmentMember" xlink:href="idxx-20211231.xsd#idxx_LivestockAndPoultryDiagnosticsSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_LivestockAndPoultryDiagnosticsSegmentMember" xlink:to="lab_idxx_LivestockAndPoultryDiagnosticsSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_8b9e7c9b-7f57-4eb2-b5ed-d42fa87c245b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging assets, total derivative instruments presented as cash flow hedges on the balance sheet</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Fair Value, Gross Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostNetNoncurrent_0dd2e7d6-cdb6-4d40-a3fd-df3dcaf275c2_verboseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostNetNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred sales commissions</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostNetNoncurrent_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostNetNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost, Net, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNetNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostNetNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostNetNoncurrent" xlink:to="lab_us-gaap_CapitalizedContractCostNetNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_country_AU_398e8291-2632-4321-8613-c4114da8379b_terseLabel_en-US" xlink:label="lab_country_AU" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Australia</link:label>
    <link:label id="lab_country_AU_label_en-US" xlink:label="lab_country_AU" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AUSTRALIA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_AU" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_AU"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_AU" xlink:to="lab_country_AU" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_20f60746-c339-4ff9-a030-d621d7b7edce_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property-based differences</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_27302d70-0b9a-47fe-8f0b-6004fb356311_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherDepreciationAndAmortization_5c16400c-4518-4df6-af45-161a14df8be4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization expense</link:label>
    <link:label id="lab_us-gaap_OtherDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_OtherDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherDepreciationAndAmortization" xlink:to="lab_us-gaap_OtherDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_98402f8b-21af-4e37-8ff8-879f6e6d2456_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_af04eb4b-816f-4432-9d6d-e808fd4be4c0_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of options vested during period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_b0a6184c-a24a-4f2f-bd38-44d273b7e490_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_6e812208-b42e-40b7-90f9-8d7513044165_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated carrying value of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_04085fc4-d3de-41dc-9072-da32876d155e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted Prices in Active Markets for Identical Assets (Level 1)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_c49d7c4c-948c-4bd5-a999-a9e6379395e6_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flows from Investing Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_0d13d648-86cd-4aa6-a36a-0ba74c3bb6ab_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairments</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_243df0a9-c446-42c6-9fee-c7a7e2a1be13_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_7a58dba2-8e7b-42ad-b978-85298e862219_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_ae990b6a-19bb-45cd-bbe8-662e211860e9_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross increases in unrecognized tax positions as a result of tax positions taken in the current period</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_60f8f7cf-35c6-4d13-85d7-64ff948fa8e1_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_2be0690e-1172-48ee-b849-c22c1ba782c6_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_f65438b5-b10c-44b0-915c-2bfaf176246a_terseLabel_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompete agreements</link:label>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_label_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncompeteAgreementsMember" xlink:to="lab_us-gaap_NoncompeteAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_33bae0ca-5a04-4865-b032-8fa8f899ab93_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_cd2e5452-2e8f-4fce-8598-e9d54ad33338_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits that would impact effective tax rate if recognized</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_65c1642e-c931-4cd9-a992-2fd48581b7d0_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_c1b5509a-86ed-4c49-ae5b-de9291241341_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_fe023615-78d9-49fc-a618-85ea9fe5d846_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_d67d04f8-d4f2-4e52-aa23-ec7979c7f8da_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_1e45561c-c9e9-4414-8641-5fa23f472f08_negatedLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development credit</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_f6a4a3ce-33cf-49b1-847e-69b8870c0140_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decreases in unrecognized tax positions related to settlements with taxing authorities</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_608c797f-df0d-4972-a219-fd2aeb6e3dfe_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes receivable</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesReceivable" xlink:to="lab_us-gaap_IncomeTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_27954745-ffbc-44a4-a929-7082fe80cc6b_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature Of Business, Basis Of Presentation And Principles Of Consolidation</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_6bb87ebe-7fbf-4574-96b3-61c0deca206f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in amount of contingent payable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_7cc9af6b-f246-45b0-afd3-36a7cb51f8df_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_566a2a8c-24f8-48d2-b751-c581f29bd022_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_d33ed661-0d70-4b28-97d8-a856dc7ae183_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: comprehensive income attributable to noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_RatioOfDeferredStockUnitsToSharesOfCommonStock_51e27dbc-2d59-4a5a-8641-ede3245485b5_terseLabel_en-US" xlink:label="lab_idxx_RatioOfDeferredStockUnitsToSharesOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of unissued shares of common stock each DSU represents right to receive (in shares)</link:label>
    <link:label id="lab_idxx_RatioOfDeferredStockUnitsToSharesOfCommonStock_label_en-US" xlink:label="lab_idxx_RatioOfDeferredStockUnitsToSharesOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ratio Of Deferred Stock Units To Shares Of Common Stock</link:label>
    <link:label id="lab_idxx_RatioOfDeferredStockUnitsToSharesOfCommonStock_documentation_en-US" xlink:label="lab_idxx_RatioOfDeferredStockUnitsToSharesOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The number of unissued shares of common stock that each DSU represents the right to receive.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_RatioOfDeferredStockUnitsToSharesOfCommonStock" xlink:href="idxx-20211231.xsd#idxx_RatioOfDeferredStockUnitsToSharesOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_RatioOfDeferredStockUnitsToSharesOfCommonStock" xlink:to="lab_idxx_RatioOfDeferredStockUnitsToSharesOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_765959a2-1c98-4595-9247-2ee387be77a0_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total amounts of unrecognized tax benefits, beginning of period</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_8bd3c38d-32e0-46d4-9048-b0727fc7f172_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total amounts of unrecognized tax benefits, end of period</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_SummaryOfSignificantAccountingPoliciesLineItems_2861e710-361f-4f5b-8797-818c14cb3cf8_terseLabel_en-US" xlink:label="lab_idxx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_idxx_SummaryOfSignificantAccountingPoliciesLineItems_label_en-US" xlink:label="lab_idxx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_idxx_SummaryOfSignificantAccountingPoliciesLineItems_documentation_en-US" xlink:label="lab_idxx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:href="idxx-20211231.xsd#idxx_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="lab_idxx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_DeferredTaxAssetsValuationAllowanceChargesToCostsAndExpense_b52ab69c-d5a3-49aa-ac92-7cfa749c43f9_terseLabel_en-US" xlink:label="lab_idxx_DeferredTaxAssetsValuationAllowanceChargesToCostsAndExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charges to costs and expense</link:label>
    <link:label id="lab_idxx_DeferredTaxAssetsValuationAllowanceChargesToCostsAndExpense_label_en-US" xlink:label="lab_idxx_DeferredTaxAssetsValuationAllowanceChargesToCostsAndExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance, Charges To Costs and Expense</link:label>
    <link:label id="lab_idxx_DeferredTaxAssetsValuationAllowanceChargesToCostsAndExpense_documentation_en-US" xlink:label="lab_idxx_DeferredTaxAssetsValuationAllowanceChargesToCostsAndExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance, Charges To Costs and Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_DeferredTaxAssetsValuationAllowanceChargesToCostsAndExpense" xlink:href="idxx-20211231.xsd#idxx_DeferredTaxAssetsValuationAllowanceChargesToCostsAndExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_DeferredTaxAssetsValuationAllowanceChargesToCostsAndExpense" xlink:to="lab_idxx_DeferredTaxAssetsValuationAllowanceChargesToCostsAndExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_f514d553-b6b7-4ffd-8f75-507ad1abdfd7_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_SegmentsOfGoodwillLineItems_5691c70d-e6b9-4206-84a8-d2cfc95d629f_terseLabel_en-US" xlink:label="lab_idxx_SegmentsOfGoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments Of Goodwill [Line Items]</link:label>
    <link:label id="lab_idxx_SegmentsOfGoodwillLineItems_label_en-US" xlink:label="lab_idxx_SegmentsOfGoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments Of Goodwill [Line Items]</link:label>
    <link:label id="lab_idxx_SegmentsOfGoodwillLineItems_documentation_en-US" xlink:label="lab_idxx_SegmentsOfGoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments Of Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_SegmentsOfGoodwillLineItems" xlink:href="idxx-20211231.xsd#idxx_SegmentsOfGoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_SegmentsOfGoodwillLineItems" xlink:to="lab_idxx_SegmentsOfGoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_country_FR_bcd2cc92-89ed-49bb-9da4-cac483fef3d2_terseLabel_en-US" xlink:label="lab_country_FR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">France</link:label>
    <link:label id="lab_country_FR_label_en-US" xlink:label="lab_country_FR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FRANCE</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_FR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_FR" xlink:to="lab_country_FR" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_646c0308-2850-4f82-9e99-94ff652282fd_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding (in shares)</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_ConcentrationRiskPolicyTextBlock_8214430c-d1ba-4f17-84a5-144e3fb7cdd7_terseLabel_en-US" xlink:label="lab_idxx_ConcentrationRiskPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentrations of Risk</link:label>
    <link:label id="lab_idxx_ConcentrationRiskPolicyTextBlock_label_en-US" xlink:label="lab_idxx_ConcentrationRiskPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Policy Text Block]</link:label>
    <link:label id="lab_idxx_ConcentrationRiskPolicyTextBlock_documentation_en-US" xlink:label="lab_idxx_ConcentrationRiskPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ConcentrationRiskPolicyTextBlock" xlink:href="idxx-20211231.xsd#idxx_ConcentrationRiskPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_ConcentrationRiskPolicyTextBlock" xlink:to="lab_idxx_ConcentrationRiskPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_335403fc-a811-4fb9-9bf6-718cad38e538_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_ReferenceLaboratoryinMidWestUnitedStatesMember_2feda774-966a-4808-9ff7-b7dc3eaf4e42_terseLabel_en-US" xlink:label="lab_idxx_ReferenceLaboratoryinMidWestUnitedStatesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reference laboratory in Mid-West, U.S.</link:label>
    <link:label id="lab_idxx_ReferenceLaboratoryinMidWestUnitedStatesMember_label_en-US" xlink:label="lab_idxx_ReferenceLaboratoryinMidWestUnitedStatesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reference Laboratory in Mid-West, United States [Member]</link:label>
    <link:label id="lab_idxx_ReferenceLaboratoryinMidWestUnitedStatesMember_documentation_en-US" xlink:label="lab_idxx_ReferenceLaboratoryinMidWestUnitedStatesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reference Laboratory in Mid-West, United States [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ReferenceLaboratoryinMidWestUnitedStatesMember" xlink:href="idxx-20211231.xsd#idxx_ReferenceLaboratoryinMidWestUnitedStatesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_ReferenceLaboratoryinMidWestUnitedStatesMember" xlink:to="lab_idxx_ReferenceLaboratoryinMidWestUnitedStatesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesSoughtValue_5f9c21dc-eb34-4453-ac36-4822f92bfa9c_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Damages sought</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesSoughtValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Sought, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesSoughtValue" xlink:to="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedMarketingCostsCurrent_b8986086-dd7e-47af-bd3c-272839a5801f_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedMarketingCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued customer incentives and refund obligations</link:label>
    <link:label id="lab_us-gaap_AccruedMarketingCostsCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedMarketingCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Marketing Costs, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedMarketingCostsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedMarketingCostsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedMarketingCostsCurrent" xlink:to="lab_us-gaap_AccruedMarketingCostsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains_7328b6b9-8106-4dcc-970e-c819622b0ce2_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gains on foreign currency exchange contracts and investments</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Unrealized Currency Transaction Gains</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_SummaryOfDepreciationAndAmortizationCapitalizedComputerSoftwareForInternalUseAndUnpaidPropertyEquipmentReflectedInAccountPayableAndAccruedExpensesTableTextBlock_32b9042b-75c2-46d4-af9a-71b2be9a16bd_terseLabel_en-US" xlink:label="lab_idxx_SummaryOfDepreciationAndAmortizationCapitalizedComputerSoftwareForInternalUseAndUnpaidPropertyEquipmentReflectedInAccountPayableAndAccruedExpensesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of depreciation and amortization, capitalized computer software for internal use and unpaid property equipment reflected in accounts payable and accrued expenses</link:label>
    <link:label id="lab_idxx_SummaryOfDepreciationAndAmortizationCapitalizedComputerSoftwareForInternalUseAndUnpaidPropertyEquipmentReflectedInAccountPayableAndAccruedExpensesTableTextBlock_label_en-US" xlink:label="lab_idxx_SummaryOfDepreciationAndAmortizationCapitalizedComputerSoftwareForInternalUseAndUnpaidPropertyEquipmentReflectedInAccountPayableAndAccruedExpensesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Depreciation And Amortization, Capitalized Computer Software For Internal Use And Unpaid Property Equipment Reflected In Account Payable And Accrued Expenses [Table Text Block]</link:label>
    <link:label id="lab_idxx_SummaryOfDepreciationAndAmortizationCapitalizedComputerSoftwareForInternalUseAndUnpaidPropertyEquipmentReflectedInAccountPayableAndAccruedExpensesTableTextBlock_documentation_en-US" xlink:label="lab_idxx_SummaryOfDepreciationAndAmortizationCapitalizedComputerSoftwareForInternalUseAndUnpaidPropertyEquipmentReflectedInAccountPayableAndAccruedExpensesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Depreciation And Amortization, Capitalized Computer Software For Internal Use And Unpaid Property Equipment Reflected In Account Payable And Accrued Expenses [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_SummaryOfDepreciationAndAmortizationCapitalizedComputerSoftwareForInternalUseAndUnpaidPropertyEquipmentReflectedInAccountPayableAndAccruedExpensesTableTextBlock" xlink:href="idxx-20211231.xsd#idxx_SummaryOfDepreciationAndAmortizationCapitalizedComputerSoftwareForInternalUseAndUnpaidPropertyEquipmentReflectedInAccountPayableAndAccruedExpensesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_SummaryOfDepreciationAndAmortizationCapitalizedComputerSoftwareForInternalUseAndUnpaidPropertyEquipmentReflectedInAccountPayableAndAccruedExpensesTableTextBlock" xlink:to="lab_idxx_SummaryOfDepreciationAndAmortizationCapitalizedComputerSoftwareForInternalUseAndUnpaidPropertyEquipmentReflectedInAccountPayableAndAccruedExpensesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_13ab0c56-1f0e-4069-b5f6-715d2a02cdff_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_country_GB_f615a5e9-5eae-46da-9b88-164509cb1636_terseLabel_en-US" xlink:label="lab_country_GB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United Kingdom</link:label>
    <link:label id="lab_country_GB_label_en-US" xlink:label="lab_country_GB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED KINGDOM</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_GB"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_GB" xlink:to="lab_country_GB" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_0cf21053-4f2b-4139-9d86-f3b26d60e860_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_71f74824-ce2c-45c9-8392-f14f19e7f895_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_20519fa1-3fc4-4a7a-ab66-1a544fe78c70_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price of options fully vested (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_8c69b0ad-b357-42c0-863d-3893ed069c49_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_9398e090-f8ba-482a-a7ad-5a0c5b0ae914_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense and penalties accrued</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_55797e9e-cf31-41b7-aee0-7a08aa96f828_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_4ea5415b-2139-45a1-90c5-2a8939d252f7_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_46915f2d-80b2-449b-8e2e-fe918c03b811_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining contractual term of ending balance of options outstanding</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_country_ES_9265be25-47f5-42b9-852d-87870598adf1_terseLabel_en-US" xlink:label="lab_country_ES" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Spain</link:label>
    <link:label id="lab_country_ES_label_en-US" xlink:label="lab_country_ES" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SPAIN</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_ES" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_ES"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_ES" xlink:to="lab_country_ES" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_EquityMutualFundsMember_9a2c3aca-1c22-4cf4-9284-588ae44f6a89_terseLabel_en-US" xlink:label="lab_idxx_EquityMutualFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity mutual funds</link:label>
    <link:label id="lab_idxx_EquityMutualFundsMember_label_en-US" xlink:label="lab_idxx_EquityMutualFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Mutual Funds [Member]</link:label>
    <link:label id="lab_idxx_EquityMutualFundsMember_documentation_en-US" xlink:label="lab_idxx_EquityMutualFundsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Mutual Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_EquityMutualFundsMember" xlink:href="idxx-20211231.xsd#idxx_EquityMutualFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_EquityMutualFundsMember" xlink:to="lab_idxx_EquityMutualFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostAmortizationPeriod_b1031b9b-1fce-4f3a-90e7-0f6f83e7877b_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized contract, amortization period</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostAmortizationPeriod_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost, Amortization Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostAmortizationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:to="lab_us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_cc5ddd93-ffee-4b6c-b59e-bc6cf663c2a5_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_a2412f36-3907-408b-b04e-0e8285c9c67b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease liability (current and long-term)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_d5d32137-e1aa-4313-94a4-3ac43d7356ec_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_6b7730e4-5272-4e8f-89a4-539da19a38e9_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.10 par value: Authorized: 120,000 shares; Issued: 106,878 shares in 2021 and 106,457 shares in 2020; Outstanding: 84,562 shares in 2021 and 85,449 shares in 2020</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_CAGDiagnosticsServiceAndAccessoriesMember_c619b549-0980-40df-940e-c5053ab37286_terseLabel_en-US" xlink:label="lab_idxx_CAGDiagnosticsServiceAndAccessoriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CAG Diagnostics services and accessories</link:label>
    <link:label id="lab_idxx_CAGDiagnosticsServiceAndAccessoriesMember_label_en-US" xlink:label="lab_idxx_CAGDiagnosticsServiceAndAccessoriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CAG Diagnostics Service And Accessories [Member]</link:label>
    <link:label id="lab_idxx_CAGDiagnosticsServiceAndAccessoriesMember_documentation_en-US" xlink:label="lab_idxx_CAGDiagnosticsServiceAndAccessoriesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CAG Diagnostics Service And Accessories [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_CAGDiagnosticsServiceAndAccessoriesMember" xlink:href="idxx-20211231.xsd#idxx_CAGDiagnosticsServiceAndAccessoriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_CAGDiagnosticsServiceAndAccessoriesMember" xlink:to="lab_idxx_CAGDiagnosticsServiceAndAccessoriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_bd8ec618-d14c-40bb-8291-fa4ee39cd7f4_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average recognition period for unrecognized compensation expense, in years</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e9bd322b-8c11-4967-9ee2-6ffb75cd8cbd_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant date fair value, beginning of year (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_0f77a736-dd58-4480-94c9-bf8fffb0de9b_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant date fair value, end of year (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_country_FI_895ba32a-891c-4040-acc8-2520fdd8feee_terseLabel_en-US" xlink:label="lab_country_FI" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finland</link:label>
    <link:label id="lab_country_FI_label_en-US" xlink:label="lab_country_FI" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINLAND</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_FI" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_FI"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_FI" xlink:to="lab_country_FI" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_001ab49f-cd7d-4c5b-9dfb-948180dedd5e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_RetirementAndIncentiveSavingsPlanLineItems_256e8f99-8876-4f23-bf9d-a34774d90e21_terseLabel_en-US" xlink:label="lab_idxx_RetirementAndIncentiveSavingsPlanLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement And Incentive Savings Plan [Line Items]</link:label>
    <link:label id="lab_idxx_RetirementAndIncentiveSavingsPlanLineItems_label_en-US" xlink:label="lab_idxx_RetirementAndIncentiveSavingsPlanLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement And Incentive Savings Plan [Line Items]</link:label>
    <link:label id="lab_idxx_RetirementAndIncentiveSavingsPlanLineItems_documentation_en-US" xlink:label="lab_idxx_RetirementAndIncentiveSavingsPlanLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement And Incentive Savings Plan [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_RetirementAndIncentiveSavingsPlanLineItems" xlink:href="idxx-20211231.xsd#idxx_RetirementAndIncentiveSavingsPlanLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_RetirementAndIncentiveSavingsPlanLineItems" xlink:to="lab_idxx_RetirementAndIncentiveSavingsPlanLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_StockOptionsAndStockAppreciationRightsMember_292c36cc-0121-4c5b-af58-85bd26d3c77c_terseLabel_en-US" xlink:label="lab_idxx_StockOptionsAndStockAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options and stock appreciation rights</link:label>
    <link:label id="lab_idxx_StockOptionsAndStockAppreciationRightsMember_label_en-US" xlink:label="lab_idxx_StockOptionsAndStockAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options And Stock Appreciation Rights [Member]</link:label>
    <link:label id="lab_idxx_StockOptionsAndStockAppreciationRightsMember_documentation_en-US" xlink:label="lab_idxx_StockOptionsAndStockAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options And Stock Appreciation Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_StockOptionsAndStockAppreciationRightsMember" xlink:href="idxx-20211231.xsd#idxx_StockOptionsAndStockAppreciationRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_StockOptionsAndStockAppreciationRightsMember" xlink:to="lab_idxx_StockOptionsAndStockAppreciationRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_6697d7f9-e2f5-4963-bfaa-194a17961577_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions and Investments</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDue_216ac662-853c-4b05-8786-937ca011ece3_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, noncurrent, threshold period past due</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDue_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Noncurrent, Threshold Period Past Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDue" xlink:to="lab_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_50916e44-4e0d-4611-893f-7c72f112abd2_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Axis]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_b85f93e8-1dc1-4fac-8a53-a6d1a8239e08_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_9430098b-0475-44e0-8d9e-f4aa394caa58_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of weighted averages of the assumptions used in estimating the fair value of stock option awards</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_7e9a6cf8-d7f3-4d82-97c3-9d55c2305e8c_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of other noncurrent assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets, Noncurrent [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_38574af8-afa5-42cd-a3ff-c549375e0be4_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleIncludingPortionAttributableToNoncontrollingInterestMember_80ff1a2e-f77c-48af-89d1-7e518a4d9ba4_terseLabel_en-US" xlink:label="lab_idxx_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized (Loss) Gain on Investments, Net of Tax</link:label>
    <link:label id="lab_idxx_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_idxx_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:label id="lab_idxx_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleIncludingPortionAttributableToNoncontrollingInterestMember_documentation_en-US" xlink:label="lab_idxx_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="idxx-20211231.xsd#idxx_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_idxx_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_4fe8708c-135d-422b-a61f-5c1b9da8fb0b_verboseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive effect of share-based payment awards (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_86526f41-fa06-404d-91bb-ec959e03e38a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_d6c51096-8192-4464-8726-cfbb8c74272a_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of changes in unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Income Tax Contingencies [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:to="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_LineofCreditFacilityAccordionFeatureIncreaseLimit_f64009d9-2df6-4bf7-841d-58140d468ff4_terseLabel_en-US" xlink:label="lab_idxx_LineofCreditFacilityAccordionFeatureIncreaseLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accordion feature, increase limit</link:label>
    <link:label id="lab_idxx_LineofCreditFacilityAccordionFeatureIncreaseLimit_label_en-US" xlink:label="lab_idxx_LineofCreditFacilityAccordionFeatureIncreaseLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Accordion Feature, Increase Limit</link:label>
    <link:label id="lab_idxx_LineofCreditFacilityAccordionFeatureIncreaseLimit_documentation_en-US" xlink:label="lab_idxx_LineofCreditFacilityAccordionFeatureIncreaseLimit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Accordion Feature, Increase Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_LineofCreditFacilityAccordionFeatureIncreaseLimit" xlink:href="idxx-20211231.xsd#idxx_LineofCreditFacilityAccordionFeatureIncreaseLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_LineofCreditFacilityAccordionFeatureIncreaseLimit" xlink:to="lab_idxx_LineofCreditFacilityAccordionFeatureIncreaseLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_0bafe1b4-c885-4db8-a949-ae88a552e3d1_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work-in-process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_767aca89-b143-4bf3-b679-f7e065216ced_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_dbe883c8-7fa0-42af-acc9-73a8cd307092_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_00ab55e8-c612-4a59-bd71-d55009685fe2_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4f9868ba-c15b-436f-80c8-d0787486f117_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_e58c930a-fcfb-47ba-85ab-4ab0319e3f54_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_CAGDiagnosticsRecurringRevenueMember_68a88aea-20b5-4b29-bc25-aee8b29653c8_terseLabel_en-US" xlink:label="lab_idxx_CAGDiagnosticsRecurringRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CAG Diagnostics recurring revenue:</link:label>
    <link:label id="lab_idxx_CAGDiagnosticsRecurringRevenueMember_label_en-US" xlink:label="lab_idxx_CAGDiagnosticsRecurringRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CAG Diagnostics Recurring Revenue [Member]</link:label>
    <link:label id="lab_idxx_CAGDiagnosticsRecurringRevenueMember_documentation_en-US" xlink:label="lab_idxx_CAGDiagnosticsRecurringRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CAG Diagnostics Recurring Revenue [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_CAGDiagnosticsRecurringRevenueMember" xlink:href="idxx-20211231.xsd#idxx_CAGDiagnosticsRecurringRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_CAGDiagnosticsRecurringRevenueMember" xlink:to="lab_idxx_CAGDiagnosticsRecurringRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_9f03b8d8-dc6c-4483-a3c2-870701e49653_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_WeightedAverageSharesOutstandingAbstract_433a0359-b655-4e59-9a4a-7d1b0f1a5deb_terseLabel_en-US" xlink:label="lab_idxx_WeightedAverageSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Shares Outstanding:</link:label>
    <link:label id="lab_idxx_WeightedAverageSharesOutstandingAbstract_label_en-US" xlink:label="lab_idxx_WeightedAverageSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Shares Outstanding [Abstract]</link:label>
    <link:label id="lab_idxx_WeightedAverageSharesOutstandingAbstract_documentation_en-US" xlink:label="lab_idxx_WeightedAverageSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Shares Outstanding [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_WeightedAverageSharesOutstandingAbstract" xlink:href="idxx-20211231.xsd#idxx_WeightedAverageSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_WeightedAverageSharesOutstandingAbstract" xlink:to="lab_idxx_WeightedAverageSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_FourZeroOneKPlanMember_a036463c-d2fb-45b4-ac02-4cc445e70877_terseLabel_en-US" xlink:label="lab_idxx_FourZeroOneKPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">401(k) Plan</link:label>
    <link:label id="lab_idxx_FourZeroOneKPlanMember_label_en-US" xlink:label="lab_idxx_FourZeroOneKPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Zero One K Plan [Member]</link:label>
    <link:label id="lab_idxx_FourZeroOneKPlanMember_documentation_en-US" xlink:label="lab_idxx_FourZeroOneKPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">401(k) Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_FourZeroOneKPlanMember" xlink:href="idxx-20211231.xsd#idxx_FourZeroOneKPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_FourZeroOneKPlanMember" xlink:to="lab_idxx_FourZeroOneKPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_225fe83a-ae34-4411-8698-e17dd3c8e3c6_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_5cb87c2c-ae78-4aa1-9f45-63b8b9781f3e_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_ffa10e6d-303b-421f-b350-f1cc99f8f74a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_0c156edd-ac0d-4e31-8a6b-a507981a9b95_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_977ee205-4503-42f6-a9f6-33629fdb81ba_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property-based differences</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_EzyVetMember_a1958f0e-7f25-4bcf-998f-1718499d0270_terseLabel_en-US" xlink:label="lab_idxx_EzyVetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ezyVet</link:label>
    <link:label id="lab_idxx_EzyVetMember_label_en-US" xlink:label="lab_idxx_EzyVetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ezyVet [Member]</link:label>
    <link:label id="lab_idxx_EzyVetMember_documentation_en-US" xlink:label="lab_idxx_EzyVetMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ezyVet</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_EzyVetMember" xlink:href="idxx-20211231.xsd#idxx_EzyVetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_EzyVetMember" xlink:to="lab_idxx_EzyVetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandardProductWarrantyPolicy_c83a91d0-a2c8-49b9-95e7-9d2598a81fea_verboseLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyPolicy" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warranty Reserves</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyPolicy_label_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StandardProductWarrantyPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyPolicy" xlink:to="lab_us-gaap_StandardProductWarrantyPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_PaymentRequiredUponTerminationOfEmploymentDomain_1e743c5d-5ace-46ca-b16e-49e31e035d09_terseLabel_en-US" xlink:label="lab_idxx_PaymentRequiredUponTerminationOfEmploymentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment Required Upon Termination Of Employment [Domain]</link:label>
    <link:label id="lab_idxx_PaymentRequiredUponTerminationOfEmploymentDomain_label_en-US" xlink:label="lab_idxx_PaymentRequiredUponTerminationOfEmploymentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment Required Upon Termination Of Employment [Domain]</link:label>
    <link:label id="lab_idxx_PaymentRequiredUponTerminationOfEmploymentDomain_documentation_en-US" xlink:label="lab_idxx_PaymentRequiredUponTerminationOfEmploymentDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment Required Upon Termination Of Employment [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_PaymentRequiredUponTerminationOfEmploymentDomain" xlink:href="idxx-20211231.xsd#idxx_PaymentRequiredUponTerminationOfEmploymentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_PaymentRequiredUponTerminationOfEmploymentDomain" xlink:to="lab_idxx_PaymentRequiredUponTerminationOfEmploymentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_a3addb09-fcea-421a-b8dd-aa5bc47d6885_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_08218ba9-4d6b-4b3e-8418-ed9069f5c6b1_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_4845dee1-7fe8-4356-9bb0-422c5b0942f5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition of noncontrolling interest (Note 4)</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_79e9ac8a-11ca-4ad0-be8b-1a83d89ce279_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest, purchase of Interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_60ccdabf-6c14-45f3-823a-06f23ef0cdc4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_TaxesRemittedToGovernmentalAuthoritiesOnBehalfOfCustomerPolicyTextBlock_0329a2f2-c70a-46f7-90a9-4ede92d85941_terseLabel_en-US" xlink:label="lab_idxx_TaxesRemittedToGovernmentalAuthoritiesOnBehalfOfCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes Remitted To Governmental Authorities By IDEXX On Behalf Of Customer</link:label>
    <link:label id="lab_idxx_TaxesRemittedToGovernmentalAuthoritiesOnBehalfOfCustomerPolicyTextBlock_label_en-US" xlink:label="lab_idxx_TaxesRemittedToGovernmentalAuthoritiesOnBehalfOfCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes Remitted to Governmental Authorities on Behalf of Customer [Policy Text Block]</link:label>
    <link:label id="lab_idxx_TaxesRemittedToGovernmentalAuthoritiesOnBehalfOfCustomerPolicyTextBlock_documentation_en-US" xlink:label="lab_idxx_TaxesRemittedToGovernmentalAuthoritiesOnBehalfOfCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes Remitted to Governmental Authorities on Behalf of Customer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_TaxesRemittedToGovernmentalAuthoritiesOnBehalfOfCustomerPolicyTextBlock" xlink:href="idxx-20211231.xsd#idxx_TaxesRemittedToGovernmentalAuthoritiesOnBehalfOfCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_TaxesRemittedToGovernmentalAuthoritiesOnBehalfOfCustomerPolicyTextBlock" xlink:to="lab_idxx_TaxesRemittedToGovernmentalAuthoritiesOnBehalfOfCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_TreasuryStockAcquiredAverageCostPerShareOpenMarketRepurchase_b3af9a85-7469-4fc2-82b5-404846728e1f_terseLabel_en-US" xlink:label="lab_idxx_TreasuryStockAcquiredAverageCostPerShareOpenMarketRepurchase" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average cost per share - open market repurchases (in USD per share)</link:label>
    <link:label id="lab_idxx_TreasuryStockAcquiredAverageCostPerShareOpenMarketRepurchase_label_en-US" xlink:label="lab_idxx_TreasuryStockAcquiredAverageCostPerShareOpenMarketRepurchase" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired Average Cost Per Share, Open Market Repurchase</link:label>
    <link:label id="lab_idxx_TreasuryStockAcquiredAverageCostPerShareOpenMarketRepurchase_documentation_en-US" xlink:label="lab_idxx_TreasuryStockAcquiredAverageCostPerShareOpenMarketRepurchase" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired Average Cost Per Share, Open Market Repurchase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_TreasuryStockAcquiredAverageCostPerShareOpenMarketRepurchase" xlink:href="idxx-20211231.xsd#idxx_TreasuryStockAcquiredAverageCostPerShareOpenMarketRepurchase"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_TreasuryStockAcquiredAverageCostPerShareOpenMarketRepurchase" xlink:to="lab_idxx_TreasuryStockAcquiredAverageCostPerShareOpenMarketRepurchase" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_ExtendedProductWarrantyTerm_bc88cd64-bcca-493c-9d36-8983db78f389_terseLabel_en-US" xlink:label="lab_idxx_ExtendedProductWarrantyTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended product warranty, term</link:label>
    <link:label id="lab_idxx_ExtendedProductWarrantyTerm_label_en-US" xlink:label="lab_idxx_ExtendedProductWarrantyTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended Product Warranty, Term</link:label>
    <link:label id="lab_idxx_ExtendedProductWarrantyTerm_documentation_en-US" xlink:label="lab_idxx_ExtendedProductWarrantyTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended Product Warranty, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ExtendedProductWarrantyTerm" xlink:href="idxx-20211231.xsd#idxx_ExtendedProductWarrantyTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_ExtendedProductWarrantyTerm" xlink:to="lab_idxx_ExtendedProductWarrantyTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f7b78f30-16ba-44d1-a914-ed8d9822a37d_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_4c5dcbf0-5a17-413d-85ab-75fc9ddb5691_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_4278e609-b76e-4977-9f2f-2f6e3d17876e_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_96b616da-9e2c-4a95-b262-eb4fe83c7e10_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_0d96282c-4e85-47f4-b543-997b39a63c47_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_879a7266-9f97-45c1-81ca-558704096a34_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_country_IT_3d7e4d36-7268-461c-832a-45f46f344c67_terseLabel_en-US" xlink:label="lab_country_IT" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Italy</link:label>
    <link:label id="lab_country_IT_label_en-US" xlink:label="lab_country_IT" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ITALY</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_IT" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IT"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_IT" xlink:to="lab_country_IT" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_977d8906-2859-4c53-9125-136a9bdbfc34_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Fair Value Hedge Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Fair Value Hedge Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems" xlink:to="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMember_06c52cc4-7e11-49e7-b691-a2018d451abb_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMember" xlink:to="lab_us-gaap_OtherAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_c3fb415a-a7c2-4c7b-8dfb-eb56f2caad64_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated fair value of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_label_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtFairValue" xlink:to="lab_us-gaap_LongTermDebtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_SoftwareDevelopedForInternalUseMember_48c355bb-45b3-4e9d-b8e0-36ece94e7c26_terseLabel_en-US" xlink:label="lab_idxx_SoftwareDevelopedForInternalUseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized computer software developed for internal use</link:label>
    <link:label id="lab_idxx_SoftwareDevelopedForInternalUseMember_label_en-US" xlink:label="lab_idxx_SoftwareDevelopedForInternalUseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software Developed For Internal Use [Member]</link:label>
    <link:label id="lab_idxx_SoftwareDevelopedForInternalUseMember_documentation_en-US" xlink:label="lab_idxx_SoftwareDevelopedForInternalUseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software Developed For Internal Use [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_SoftwareDevelopedForInternalUseMember" xlink:href="idxx-20211231.xsd#idxx_SoftwareDevelopedForInternalUseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_SoftwareDevelopedForInternalUseMember" xlink:to="lab_idxx_SoftwareDevelopedForInternalUseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsDeferredIncome_a9670b71-35d2-4946-ac15-1494e32b014d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsDeferredIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsDeferredIncome_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsDeferredIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Deferred Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsDeferredIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsDeferredIncome" xlink:to="lab_us-gaap_DeferredTaxAssetsDeferredIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock_7816b8f8-b1ce-458c-9f77-2a4b052c8e34_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities and Other Long Term Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_b0e6bc61-4a1f-4e24-bb06-5cfcb5db91b9_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_82b15ed7-1fea-4985-9eaf-be79c4ff981f_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_378927e6-a30c-47e8-81ee-581dc28b282d_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_label_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNatureDomain" xlink:to="lab_us-gaap_LossContingencyNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_02730554-76ef-45db-aa3e-7558dfda3afd_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_7118f4b6-8b71-428f-859c-a0e3c70d3a06_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of accrued liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_LesseeOperatingLeaseTerminationPeriod_4d5a4f92-394e-45c8-9978-1737b7d41c9a_terseLabel_en-US" xlink:label="lab_idxx_LesseeOperatingLeaseTerminationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, termination period</link:label>
    <link:label id="lab_idxx_LesseeOperatingLeaseTerminationPeriod_label_en-US" xlink:label="lab_idxx_LesseeOperatingLeaseTerminationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Termination Period</link:label>
    <link:label id="lab_idxx_LesseeOperatingLeaseTerminationPeriod_documentation_en-US" xlink:label="lab_idxx_LesseeOperatingLeaseTerminationPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Termination Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_LesseeOperatingLeaseTerminationPeriod" xlink:href="idxx-20211231.xsd#idxx_LesseeOperatingLeaseTerminationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_LesseeOperatingLeaseTerminationPeriod" xlink:to="lab_idxx_LesseeOperatingLeaseTerminationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_country_JP_9a1ac44f-4fd5-4863-af2e-7489ff590db1_terseLabel_en-US" xlink:label="lab_country_JP" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Japan</link:label>
    <link:label id="lab_country_JP_label_en-US" xlink:label="lab_country_JP" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">JAPAN</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_JP" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_JP"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_JP" xlink:to="lab_country_JP" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_7220212f-b033-4420-8d7c-7fe47108afc0_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesReceivableNoncurrent_bd932d33-9cb7-4039-bfbc-b469b2ea9870_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivableNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes receivable</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesReceivableNoncurrent_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivableNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Receivable, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivableNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesReceivableNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesReceivableNoncurrent" xlink:to="lab_us-gaap_IncomeTaxesReceivableNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e1558f94-8bbe-4765-81df-7245613a0781_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flows from Financing Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_98149228-8bfd-40be-ac4d-ce49c9b93e45_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_45368f82-8143-402f-88a2-766e0d79bfda_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total IDEXX Laboratories, Inc. stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_dea75535-f539-456f-9863-44f4b96953fd_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable_a0ae71f1-7488-457f-924b-9284aef8c4aa_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable" xlink:to="lab_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_df423b3f-c7d4-4b74-90fa-d494a0a47680_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0da0a9ec-6e08-4d67-8d05-9a6218e5a908_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value of options fully vested</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_fdd17627-8361-494b-aa0a-5be31f56b369_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7b9fd14a-e998-4cf6-89a2-7c921e96b814_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfSeniorDebt_ec3b3d38-d384-435b-bd35-bfef2be1420a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of senior notes</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfSeniorDebt_40e45e25-9d9f-4009-9250-8e667d741905_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of senior debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfSeniorDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Senior Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfSeniorDebt" xlink:to="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent_b6ed75db-3100-4a5a-b8ce-7edcc371ef15_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Miscellaneous, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:to="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_A2027SeriesBNotesMember_60577c8a-21fb-42ab-9562-07109aa62a6b_terseLabel_en-US" xlink:label="lab_idxx_A2027SeriesBNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027 Series B Notes</link:label>
    <link:label id="lab_idxx_A2027SeriesBNotesMember_label_en-US" xlink:label="lab_idxx_A2027SeriesBNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027 Series B Notes [Member]</link:label>
    <link:label id="lab_idxx_A2027SeriesBNotesMember_documentation_en-US" xlink:label="lab_idxx_A2027SeriesBNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027 Series B Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_A2027SeriesBNotesMember" xlink:href="idxx-20211231.xsd#idxx_A2027SeriesBNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_A2027SeriesBNotesMember" xlink:to="lab_idxx_A2027SeriesBNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_2803ff43-fb39-4e52-8d09-fe374914e0b2_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchases of common stock, net</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_SegmentsOfGoodwillTable_3fbb9004-17b4-4b8b-9ce5-ba6c60d5418d_terseLabel_en-US" xlink:label="lab_idxx_SegmentsOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments Of Goodwill [Table]</link:label>
    <link:label id="lab_idxx_SegmentsOfGoodwillTable_label_en-US" xlink:label="lab_idxx_SegmentsOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments Of Goodwill [Table]</link:label>
    <link:label id="lab_idxx_SegmentsOfGoodwillTable_documentation_en-US" xlink:label="lab_idxx_SegmentsOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments Of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_SegmentsOfGoodwillTable" xlink:href="idxx-20211231.xsd#idxx_SegmentsOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_SegmentsOfGoodwillTable" xlink:to="lab_idxx_SegmentsOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_e321c020-1227-42d6-ab95-be25bfcb0925_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated useful life</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_91c701bc-f074-46d3-ab6e-ef6c8a1d80e2_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_ccef9018-7a1b-40cc-9bea-741f3f23fa6f_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_08364809-4cd8-4f26-be56-58938db8bc65_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for current income taxes</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_4d957c13-ff7e-44bb-963b-71ca3c947f9a_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal Amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_cd29cc97-2ff5-432f-9692-9e6d1048b05b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate principal amount of net investment hedge</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsNoncurrentAbstract_5b64f65f-7461-46d9-846e-cfb7f1b3dd76_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract" xlink:to="lab_us-gaap_AssetsNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_9d21e036-b119-4c25-ab33-e1db7ebfa670_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit resulting from share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_93b7e766-28e6-4841-b9e8-638c5f461d48_negatedLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit resulting from share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_RetirementAndIncentiveSavingsPlanDomain_3051d44b-3e29-4041-90bb-e149e502ad98_terseLabel_en-US" xlink:label="lab_idxx_RetirementAndIncentiveSavingsPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement And Incentive Savings Plan [Domain]</link:label>
    <link:label id="lab_idxx_RetirementAndIncentiveSavingsPlanDomain_label_en-US" xlink:label="lab_idxx_RetirementAndIncentiveSavingsPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement And Incentive Savings Plan [Domain]</link:label>
    <link:label id="lab_idxx_RetirementAndIncentiveSavingsPlanDomain_documentation_en-US" xlink:label="lab_idxx_RetirementAndIncentiveSavingsPlanDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement And Incentive Savings Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_RetirementAndIncentiveSavingsPlanDomain" xlink:href="idxx-20211231.xsd#idxx_RetirementAndIncentiveSavingsPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_RetirementAndIncentiveSavingsPlanDomain" xlink:to="lab_idxx_RetirementAndIncentiveSavingsPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharePrice_92a48cca-eb0e-449d-a49e-8246ac8bf9c2_terseLabel_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share price at grant (in USD per share)</link:label>
    <link:label id="lab_us-gaap_SharePrice_label_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharePrice" xlink:to="lab_us-gaap_SharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_MetLife2030SeriesDNotesMember_9803b1be-b23b-49e4-b851-d9891b7856b7_terseLabel_en-US" xlink:label="lab_idxx_MetLife2030SeriesDNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MetLife 2030 Series D Notes</link:label>
    <link:label id="lab_idxx_MetLife2030SeriesDNotesMember_label_en-US" xlink:label="lab_idxx_MetLife2030SeriesDNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MetLife 2030 Series D Notes [Member]</link:label>
    <link:label id="lab_idxx_MetLife2030SeriesDNotesMember_documentation_en-US" xlink:label="lab_idxx_MetLife2030SeriesDNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MetLife 2030 Series D Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_MetLife2030SeriesDNotesMember" xlink:href="idxx-20211231.xsd#idxx_MetLife2030SeriesDNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_MetLife2030SeriesDNotesMember" xlink:to="lab_idxx_MetLife2030SeriesDNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_VolumeCommitmentProgramsMember_bd9a1693-64f2-412d-974a-796c23d90b32_terseLabel_en-US" xlink:label="lab_idxx_VolumeCommitmentProgramsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Volume commitment programs</link:label>
    <link:label id="lab_idxx_VolumeCommitmentProgramsMember_label_en-US" xlink:label="lab_idxx_VolumeCommitmentProgramsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Volume Commitment Programs [Member]</link:label>
    <link:label id="lab_idxx_VolumeCommitmentProgramsMember_documentation_en-US" xlink:label="lab_idxx_VolumeCommitmentProgramsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Volume Commitment Programs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_VolumeCommitmentProgramsMember" xlink:href="idxx-20211231.xsd#idxx_VolumeCommitmentProgramsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_VolumeCommitmentProgramsMember" xlink:to="lab_idxx_VolumeCommitmentProgramsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_cd33d76c-8602-4fce-b4fe-a03aef95ae6b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesFairValueLineItems" xlink:to="lab_us-gaap_DerivativesFairValueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_ef9ed3a3-8ffd-41cc-8efc-6e19428bd3db_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment fees</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Unused Capacity, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_1da75175-2948-4ccf-8fae-6965e4ac0f07_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units (RSU's)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOtherComprehensiveLoss_a2d89640-b6b2-420d-82b8-e229538ff6c9_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOtherComprehensiveLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized losses on foreign currency exchange contracts and investments</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOtherComprehensiveLoss_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOtherComprehensiveLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Other Comprehensive Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOtherComprehensiveLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOtherComprehensiveLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOtherComprehensiveLoss" xlink:to="lab_us-gaap_DeferredTaxAssetsOtherComprehensiveLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_c6a42bd5-c4a6-4120-8c00-cf07563c9df0_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_def6b0cc-73fe-4092-b64a-9d59012fd24c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_8b2972a7-7b3a-4af7-8104-d18460927829_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Award, Tranche Two</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_UpFrontCustomerLoyaltyProgramsMember_d01bfbf5-bcc9-4b32-88f1-2a3c08f3a8dd_terseLabel_en-US" xlink:label="lab_idxx_UpFrontCustomerLoyaltyProgramsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Up front customer loyalty programs</link:label>
    <link:label id="lab_idxx_UpFrontCustomerLoyaltyProgramsMember_label_en-US" xlink:label="lab_idxx_UpFrontCustomerLoyaltyProgramsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Up Front Customer Loyalty Programs [Member]</link:label>
    <link:label id="lab_idxx_UpFrontCustomerLoyaltyProgramsMember_documentation_en-US" xlink:label="lab_idxx_UpFrontCustomerLoyaltyProgramsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Up-Front Customer Loyalty Programs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_UpFrontCustomerLoyaltyProgramsMember" xlink:href="idxx-20211231.xsd#idxx_UpFrontCustomerLoyaltyProgramsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_UpFrontCustomerLoyaltyProgramsMember" xlink:to="lab_idxx_UpFrontCustomerLoyaltyProgramsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_ec0a6c8d-3d29-41e2-bdb0-eaf7e32affc6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestAndOtherIncome_63fdf54d-fa52-4207-b9b0-55ebdcf2da87_terseLabel_en-US" xlink:label="lab_us-gaap_InterestAndOtherIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InterestAndOtherIncome_label_en-US" xlink:label="lab_us-gaap_InterestAndOtherIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and Other Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndOtherIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestAndOtherIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestAndOtherIncome" xlink:to="lab_us-gaap_InterestAndOtherIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_e465b872-25f5-49c2-aeab-953bcdce1789_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_PaymentRequiredUponTerminationOfEmploymentTable_50bc2cba-b45a-4609-876b-67e3d29cb5ae_terseLabel_en-US" xlink:label="lab_idxx_PaymentRequiredUponTerminationOfEmploymentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment Required Upon Termination Of Employment [Table]</link:label>
    <link:label id="lab_idxx_PaymentRequiredUponTerminationOfEmploymentTable_label_en-US" xlink:label="lab_idxx_PaymentRequiredUponTerminationOfEmploymentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment Required Upon Termination Of Employment [Table]</link:label>
    <link:label id="lab_idxx_PaymentRequiredUponTerminationOfEmploymentTable_documentation_en-US" xlink:label="lab_idxx_PaymentRequiredUponTerminationOfEmploymentTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment Required Upon Termination Of Employment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_PaymentRequiredUponTerminationOfEmploymentTable" xlink:href="idxx-20211231.xsd#idxx_PaymentRequiredUponTerminationOfEmploymentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_PaymentRequiredUponTerminationOfEmploymentTable" xlink:to="lab_idxx_PaymentRequiredUponTerminationOfEmploymentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_RetirementAndIncentiveSavingsPlanAxis_07bb30ed-89d2-48f5-99bc-67b7f33a4f8f_terseLabel_en-US" xlink:label="lab_idxx_RetirementAndIncentiveSavingsPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement And Incentive Savings Plan [Axis]</link:label>
    <link:label id="lab_idxx_RetirementAndIncentiveSavingsPlanAxis_label_en-US" xlink:label="lab_idxx_RetirementAndIncentiveSavingsPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement And Incentive Savings Plan [Axis]</link:label>
    <link:label id="lab_idxx_RetirementAndIncentiveSavingsPlanAxis_documentation_en-US" xlink:label="lab_idxx_RetirementAndIncentiveSavingsPlanAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement And Incentive Savings Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_RetirementAndIncentiveSavingsPlanAxis" xlink:href="idxx-20211231.xsd#idxx_RetirementAndIncentiveSavingsPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_RetirementAndIncentiveSavingsPlanAxis" xlink:to="lab_idxx_RetirementAndIncentiveSavingsPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_e3c38edf-5013-436b-a060-eb5177e4dfc4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price of options forfeited (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_3121be9e-79a1-4095-8052-b3476d2d4747_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_ba7c7e00-a0c3-4941-914f-b810f3ba1d98_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_1b428ccd-3055-45f6-aed5-0638056c9463_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax (benefit) expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_cab0fca7-7a78-4d91-8ade-0f335355fd0c_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net of allowance of $5,668 in 2021 and $6,784 in 2020</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInventory_322f11ee-8dab-4088-8245-776751887be8_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory basis differences</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInventory_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsInventory" xlink:to="lab_us-gaap_DeferredTaxAssetsInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AsiaPacificMember_00926c05-f3e7-4cb3-b060-89a4c1b9378a_terseLabel_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific Region</link:label>
    <link:label id="lab_srt_AsiaPacificMember_label_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AsiaPacificMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AsiaPacificMember" xlink:to="lab_srt_AsiaPacificMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_90786cd0-3460-4de7-8708-6f36d3f98eac_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_b8a19599-5ba5-4120-8972-b01c55480462_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_DeferredTaxAssetsValuationAllowanceForeignCurrencyTranslation_1aef1aaa-3b94-4cb3-bd9a-aaabebe8d326_terseLabel_en-US" xlink:label="lab_idxx_DeferredTaxAssetsValuationAllowanceForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_idxx_DeferredTaxAssetsValuationAllowanceForeignCurrencyTranslation_label_en-US" xlink:label="lab_idxx_DeferredTaxAssetsValuationAllowanceForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance, Foreign Currency Translation</link:label>
    <link:label id="lab_idxx_DeferredTaxAssetsValuationAllowanceForeignCurrencyTranslation_documentation_en-US" xlink:label="lab_idxx_DeferredTaxAssetsValuationAllowanceForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance, Foreign Currency Translation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_DeferredTaxAssetsValuationAllowanceForeignCurrencyTranslation" xlink:href="idxx-20211231.xsd#idxx_DeferredTaxAssetsValuationAllowanceForeignCurrencyTranslation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_DeferredTaxAssetsValuationAllowanceForeignCurrencyTranslation" xlink:to="lab_idxx_DeferredTaxAssetsValuationAllowanceForeignCurrencyTranslation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_c622e973-008d-419b-9f4e-b989b6deb4bf_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_294f118d-6093-402c-9432-3f7fc102bd4b_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_b2d1c011-d0e6-4817-a86c-1594fb1dc5d0_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_8a290426-312b-4fa7-85a6-f3eeb64fa0a0_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_fd8c3a64-c2e8-4aac-bba1-92f47450b77b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification adjustment for (gain) loss included in net income, net of tax (expense) benefit of $1,347 in 2021, $(158) in 2020 and $(2,467) in 2019</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsFairValueDisclosure_6971e41a-b000-4ed1-9928-43b710691597_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_OtherAssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsFairValueDisclosure" xlink:to="lab_us-gaap_OtherAssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_e81517da-4aa0-4097-852e-413e74909276_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_96938a90-084d-456f-a5e9-298c7e587cdd_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_d810978b-e0da-4bf9-9534-57758ba9a20b_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested, intrinsic value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_4ddfc2cb-0853-49ae-80c4-7214e7430dc9_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_691a217f-7ac2-4930-b05c-66af14570b86_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_303dac0d-5cce-4765-b33f-035b40e8e088_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of reconciliation of shares outstanding for basic and diluted earnings per share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Weighted Average Number of Shares [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_country_NL_46d205d2-f9fe-4d12-8586-e5ca136dfa63_terseLabel_en-US" xlink:label="lab_country_NL" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Netherlands</link:label>
    <link:label id="lab_country_NL_label_en-US" xlink:label="lab_country_NL" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NETHERLANDS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_NL" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_NL"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_NL" xlink:to="lab_country_NL" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_PaymentRequiredUponTerminationOfEmploymentLineItems_885796dd-7734-42a5-93e9-2dbf901c5728_terseLabel_en-US" xlink:label="lab_idxx_PaymentRequiredUponTerminationOfEmploymentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment Required Upon Termination Of Employment [Line Items]</link:label>
    <link:label id="lab_idxx_PaymentRequiredUponTerminationOfEmploymentLineItems_label_en-US" xlink:label="lab_idxx_PaymentRequiredUponTerminationOfEmploymentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment Required Upon Termination Of Employment [Line Items]</link:label>
    <link:label id="lab_idxx_PaymentRequiredUponTerminationOfEmploymentLineItems_documentation_en-US" xlink:label="lab_idxx_PaymentRequiredUponTerminationOfEmploymentLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment Required Upon Termination Of Employment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_PaymentRequiredUponTerminationOfEmploymentLineItems" xlink:href="idxx-20211231.xsd#idxx_PaymentRequiredUponTerminationOfEmploymentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_PaymentRequiredUponTerminationOfEmploymentLineItems" xlink:to="lab_idxx_PaymentRequiredUponTerminationOfEmploymentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_11f02f1b-3706-470d-9919-8023f46f0afc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation from settlements</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0b10a2c8-776c-4a3e-930d-e1c08f508237_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average fair value of options granted (in USD per shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_13a89b37-a831-4be4-a803-cf547df66c1a_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_A2021SeriesANotesAnd2024SeriesBNotesMember_b890b228-63d1-4ea5-b958-32c0619bcba0_terseLabel_en-US" xlink:label="lab_idxx_A2021SeriesANotesAnd2024SeriesBNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Series A Notes and 2024 Series B Notes</link:label>
    <link:label id="lab_idxx_A2021SeriesANotesAnd2024SeriesBNotesMember_label_en-US" xlink:label="lab_idxx_A2021SeriesANotesAnd2024SeriesBNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Series A Notes And 2024 Series B Notes [Member]</link:label>
    <link:label id="lab_idxx_A2021SeriesANotesAnd2024SeriesBNotesMember_documentation_en-US" xlink:label="lab_idxx_A2021SeriesANotesAnd2024SeriesBNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Series A Notes And 2024 Series B Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_A2021SeriesANotesAnd2024SeriesBNotesMember" xlink:href="idxx-20211231.xsd#idxx_A2021SeriesANotesAnd2024SeriesBNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_A2021SeriesANotesAnd2024SeriesBNotesMember" xlink:to="lab_idxx_A2021SeriesANotesAnd2024SeriesBNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_abf03fc2-93ff-405c-9880-9a68eb897c93_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss [Line Items]</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems" xlink:to="lab_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_AllocatedShareBasedCompensationExpenseNetOfTaxExcludingTaxBenefitFromSettlementOfShareBasedAwards_022dc005-220c-43cc-a924-6db0bc89ab01_totalLabel_en-US" xlink:label="lab_idxx_AllocatedShareBasedCompensationExpenseNetOfTaxExcludingTaxBenefitFromSettlementOfShareBasedAwards" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net share-based compensation expense included in consolidated statements of income, excluding tax benefit from settlement of share-based awards</link:label>
    <link:label id="lab_idxx_AllocatedShareBasedCompensationExpenseNetOfTaxExcludingTaxBenefitFromSettlementOfShareBasedAwards_label_en-US" xlink:label="lab_idxx_AllocatedShareBasedCompensationExpenseNetOfTaxExcludingTaxBenefitFromSettlementOfShareBasedAwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allocated Share-based Compensation Expense, Net of Tax, Excluding Tax Benefit From Settlement Of Share-based Awards</link:label>
    <link:label id="lab_idxx_AllocatedShareBasedCompensationExpenseNetOfTaxExcludingTaxBenefitFromSettlementOfShareBasedAwards_documentation_en-US" xlink:label="lab_idxx_AllocatedShareBasedCompensationExpenseNetOfTaxExcludingTaxBenefitFromSettlementOfShareBasedAwards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allocated Share-based Compensation Expense, Net of Tax, Excluding Tax Benefit From Settlement Of Share-based Awards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_AllocatedShareBasedCompensationExpenseNetOfTaxExcludingTaxBenefitFromSettlementOfShareBasedAwards" xlink:href="idxx-20211231.xsd#idxx_AllocatedShareBasedCompensationExpenseNetOfTaxExcludingTaxBenefitFromSettlementOfShareBasedAwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_AllocatedShareBasedCompensationExpenseNetOfTaxExcludingTaxBenefitFromSettlementOfShareBasedAwards" xlink:to="lab_idxx_AllocatedShareBasedCompensationExpenseNetOfTaxExcludingTaxBenefitFromSettlementOfShareBasedAwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_b5291885-a06e-46ce-9b84-21642f47af81_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued under stock plans, net</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_ea49185d-ec2d-4fe5-86b0-775bd629c84a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_EuropetheMiddleEastandAfricaOtherMember_fbd2bc23-7cd1-4e76-8bab-23fd5158d67e_terseLabel_en-US" xlink:label="lab_idxx_EuropetheMiddleEastandAfricaOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_idxx_EuropetheMiddleEastandAfricaOtherMember_label_en-US" xlink:label="lab_idxx_EuropetheMiddleEastandAfricaOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe, the Middle East, and Africa, Other [Member]</link:label>
    <link:label id="lab_idxx_EuropetheMiddleEastandAfricaOtherMember_documentation_en-US" xlink:label="lab_idxx_EuropetheMiddleEastandAfricaOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe, the Middle East, and Africa, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_EuropetheMiddleEastandAfricaOtherMember" xlink:href="idxx-20211231.xsd#idxx_EuropetheMiddleEastandAfricaOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_EuropetheMiddleEastandAfricaOtherMember" xlink:to="lab_idxx_EuropetheMiddleEastandAfricaOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_SaasSubscriptionTermOfContract_3e8d64d6-823c-4e13-b534-b6ce27e11e35_terseLabel_en-US" xlink:label="lab_idxx_SaasSubscriptionTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SaaS subscription, term</link:label>
    <link:label id="lab_idxx_SaasSubscriptionTermOfContract_label_en-US" xlink:label="lab_idxx_SaasSubscriptionTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SaaS Subscription, Term of Contract</link:label>
    <link:label id="lab_idxx_SaasSubscriptionTermOfContract_documentation_en-US" xlink:label="lab_idxx_SaasSubscriptionTermOfContract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SaaS Subscription, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_SaasSubscriptionTermOfContract" xlink:href="idxx-20211231.xsd#idxx_SaasSubscriptionTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_SaasSubscriptionTermOfContract" xlink:to="lab_idxx_SaasSubscriptionTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_80e57379-3c3c-4530-9f0b-4c8365ea7c50_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on foreign currency exchange contracts, net of tax expense (benefit) of $2,133 in 2021, $(2,013) in 2020 and $362 in 2019</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_b670914f-d3c3-4dae-b430-6593b5230d3d_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimation of future revenues</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_0740846d-d9df-419e-a2c9-2cce0642b97a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration recorded from acquisitions</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_2256ce66-6dd6-40bf-b81a-a3f7e966ace8_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_5f94f65a-7f0f-4375-ab9b-9b3598c09b24_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_ContractwithCustomerAssetAndSalesTypeLeaseNetInvestmentInLeaseAllowanceforCreditLoss_80dac4f2-b674-49c5-82e7-00f2bd7cc6a6_terseLabel_en-US" xlink:label="lab_idxx_ContractwithCustomerAssetAndSalesTypeLeaseNetInvestmentInLeaseAllowanceforCreditLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserve for contract assets and sales-type leases</link:label>
    <link:label id="lab_idxx_ContractwithCustomerAssetAndSalesTypeLeaseNetInvestmentInLeaseAllowanceforCreditLoss_label_en-US" xlink:label="lab_idxx_ContractwithCustomerAssetAndSalesTypeLeaseNetInvestmentInLeaseAllowanceforCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, And Sales-Type Lease, Net Investment In Lease, Allowance for Credit Loss</link:label>
    <link:label id="lab_idxx_ContractwithCustomerAssetAndSalesTypeLeaseNetInvestmentInLeaseAllowanceforCreditLoss_documentation_en-US" xlink:label="lab_idxx_ContractwithCustomerAssetAndSalesTypeLeaseNetInvestmentInLeaseAllowanceforCreditLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, And Sales-Type Lease, Net Investment In Lease, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ContractwithCustomerAssetAndSalesTypeLeaseNetInvestmentInLeaseAllowanceforCreditLoss" xlink:href="idxx-20211231.xsd#idxx_ContractwithCustomerAssetAndSalesTypeLeaseNetInvestmentInLeaseAllowanceforCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_ContractwithCustomerAssetAndSalesTypeLeaseNetInvestmentInLeaseAllowanceforCreditLoss" xlink:to="lab_idxx_ContractwithCustomerAssetAndSalesTypeLeaseNetInvestmentInLeaseAllowanceforCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_715ee7d6-abc8-4993-80fb-4ede203290c0_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_cc0a7413-9be0-4c25-a411-ad43a8335724_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Other Observable Inputs (Level 2)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_8901a61e-badb-48eb-9fe0-fa852e5731e4_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_1fca267f-6fbc-46ba-9dc7-d7912cb1b000_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term deferred revenue, net of current portion</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_49ddefc3-ea6f-45ae-a2d3-241f061ccfd0_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_0d9e92c8-b66a-4c63-81e5-825f8ce5266a_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_0ca64d81-03e0-4172-96ea-5f7a8b88f3c0_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, estimated useful life</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_86d73741-7923-4632-b822-0676f87b095c_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_ComputerHardwareAndSoftwareMember_3ff53275-6962-45e1-9118-e586d73e4a0b_terseLabel_en-US" xlink:label="lab_idxx_ComputerHardwareAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer hardware and software</link:label>
    <link:label id="lab_idxx_ComputerHardwareAndSoftwareMember_label_en-US" xlink:label="lab_idxx_ComputerHardwareAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Hardware And Software [Member]</link:label>
    <link:label id="lab_idxx_ComputerHardwareAndSoftwareMember_documentation_en-US" xlink:label="lab_idxx_ComputerHardwareAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Hardware And Software [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ComputerHardwareAndSoftwareMember" xlink:href="idxx-20211231.xsd#idxx_ComputerHardwareAndSoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_ComputerHardwareAndSoftwareMember" xlink:to="lab_idxx_ComputerHardwareAndSoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_51388d2b-cb06-4bac-9448-cd5e202e5bc5_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_Prudential2030SeriesDNotesMember_7f4c0894-53e6-4869-90f0-7ff86cf66036_terseLabel_en-US" xlink:label="lab_idxx_Prudential2030SeriesDNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prudential 2030 Series D Notes</link:label>
    <link:label id="lab_idxx_Prudential2030SeriesDNotesMember_label_en-US" xlink:label="lab_idxx_Prudential2030SeriesDNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prudential 2030 Series D Notes [Member]</link:label>
    <link:label id="lab_idxx_Prudential2030SeriesDNotesMember_documentation_en-US" xlink:label="lab_idxx_Prudential2030SeriesDNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prudential 2030 Series D Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_Prudential2030SeriesDNotesMember" xlink:href="idxx-20211231.xsd#idxx_Prudential2030SeriesDNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_Prudential2030SeriesDNotesMember" xlink:to="lab_idxx_Prudential2030SeriesDNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_19227f43-3d8b-4d19-9a30-ba694bf8a36e_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Tax Credits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:to="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_1ab3fd52-ba08-4318-a036-7f8c49f1f41d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of minority interest</link:label>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_label_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToMinorityShareholders" xlink:to="lab_us-gaap_PaymentsToMinorityShareholders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_853d8406-04a4-4809-ac6e-7d5f6914c4b2_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_367e1237-7703-4eb3-a7cb-f35c20541962_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_c1f3a94f-1408-4a08-972f-86d94ca18df1_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_fa62e047-14c0-4e8f-9edc-a1303a2ce09e_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stated interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_0159bc9b-79a9-43fb-b21b-00bcfa70d875_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coupon Rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection_0bd3a0bb-d21a-4f83-b0a6-2e2649be4f01_totalLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging assets, net amount</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Fair Value, Offset Against Collateral, Net of Not Subject to Master Netting Arrangement, Policy Election</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection" xlink:to="lab_us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_01b7e2ec-85e8-4922-a7a6-d646e790222a_netLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Net (loss) income attributable to noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_169fb2ec-e6b0-4501-be44-3c21fd82c229_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent payment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8fbd5b91-7791-4565-8977-b4611c5fa81a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_5b8e91c4-f5ae-4d59-a587-9c9fbaf1e5e8_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_ReferenceLaboratoryMember_6d7d53d9-b909-4105-953a-e54a26476cb9_terseLabel_en-US" xlink:label="lab_idxx_ReferenceLaboratoryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reference Laboratory</link:label>
    <link:label id="lab_idxx_ReferenceLaboratoryMember_label_en-US" xlink:label="lab_idxx_ReferenceLaboratoryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reference Laboratory [Member]</link:label>
    <link:label id="lab_idxx_ReferenceLaboratoryMember_documentation_en-US" xlink:label="lab_idxx_ReferenceLaboratoryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reference Laboratory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ReferenceLaboratoryMember" xlink:href="idxx-20211231.xsd#idxx_ReferenceLaboratoryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_ReferenceLaboratoryMember" xlink:to="lab_idxx_ReferenceLaboratoryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxHolidayAggregateDollarAmount_15762926-9d1c-4930-9697-2818bbefb856_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxHolidayAggregateDollarAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax ruling exemption</link:label>
    <link:label id="lab_us-gaap_IncomeTaxHolidayAggregateDollarAmount_label_en-US" xlink:label="lab_us-gaap_IncomeTaxHolidayAggregateDollarAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Holiday, Aggregate Dollar Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxHolidayAggregateDollarAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxHolidayAggregateDollarAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxHolidayAggregateDollarAmount" xlink:to="lab_us-gaap_IncomeTaxHolidayAggregateDollarAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_0150263c-c83c-4279-81cd-7d468d400958_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental cash flow information</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_b79371fb-84cc-4f43-ab5a-037e168894e3_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d68a2bde-0c09-4ea6-af96-97b7535cad49_terseLabel_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_label_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingDomain_12bb7e7a-44ad-4ef9-bcdb-5199120bcf61_terseLabel_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:label id="lab_us-gaap_VestingDomain_label_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingDomain" xlink:to="lab_us-gaap_VestingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductMember_93b08d5c-729f-48b3-a2a7-136c4f2af35c_terseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product revenue</link:label>
    <link:label id="lab_us-gaap_ProductMember_label_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductMember" xlink:to="lab_us-gaap_ProductMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_20677157-6f97-47de-b3f1-f4a8481b7bb9_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostGross_30f19755-20bd-447f-87f5-685e8cace7ec_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized customer acquisition costs</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostGross_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostGross" xlink:to="lab_us-gaap_CapitalizedContractCostGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenue_b394e556-e938-49b0-9184-99bb2f723162_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cost of revenue</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_d665756f-8849-4717-b13c-bd18f7e92f80_verboseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of revenue</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_label_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="lab_us-gaap_CostOfRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_28b41eae-d862-4bff-a3eb-0d039965c205_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_5e53a81d-a70b-4814-982b-c190e3ecfd17_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost: 22,317 shares in 2021 and 21,008 shares in 2020</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_976b6a8b-1ab3-4b20-8646-a677f4a4ebf9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_cd90d4aa-1a97-4d6e-ad84-f3d70924c09c_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense and penalties related to unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_56c2c9c9-afa7-4167-9e2b-5e515e911907_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_e7303f1c-e9da-42a9-80c6-20fe797e62f9_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeLeaseLeaseReceivable_1fefeeaf-937f-4297-a1d7-284ec97055ed_terseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseLeaseReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease receivable asset</link:label>
    <link:label id="lab_us-gaap_SalesTypeLeaseLeaseReceivable_label_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseLeaseReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type Lease, Lease Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseLeaseReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseLeaseReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeLeaseLeaseReceivable" xlink:to="lab_us-gaap_SalesTypeLeaseLeaseReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_464d9ed8-7439-4706-8150-1859842fd0cf_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationTax_8f45851e-5802-458a-91df-9fd30adb7ea3_terseLabel_en-US" xlink:label="lab_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on Euro-denominated notes, tax expense (benefit)</link:label>
    <link:label id="lab_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationTax_label_en-US" xlink:label="lab_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Euro-Denominated Notes, Gain (Loss), After Reclassification, Tax</link:label>
    <link:label id="lab_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationTax_documentation_en-US" xlink:label="lab_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Euro-Denominated Notes, Gain (Loss), After Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationTax" xlink:href="idxx-20211231.xsd#idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationTax" xlink:to="lab_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_da95f038-9b1c-40a5-89d5-eeaeeeeed654_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_4430e672-52b7-4ebb-b70f-6ee05ba011d7_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares of common stock repurchases authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Number of Shares Authorized to be Repurchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:to="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7e48d2db-3d6c-4015-a9f6-32a2cdfdea29_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Options</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_c9a3cea6-1e67-485e-8da0-8c780c5643f3_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State income tax, net of federal tax benefit</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_0464d880-0656-4174-822a-dadaeb3fd132_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TangibleAssetImpairmentCharges_17ef9839-9f21-46a0-b173-36f6b19cbaaf_terseLabel_en-US" xlink:label="lab_us-gaap_TangibleAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-down of rental assets</link:label>
    <link:label id="lab_us-gaap_TangibleAssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_TangibleAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TangibleAssetImpairmentCharges" xlink:to="lab_us-gaap_TangibleAssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_SeriesCSeniorNoteMember_0465b48c-6933-4412-8a25-e4cf91061b7b_terseLabel_en-US" xlink:label="lab_idxx_SeriesCSeniorNoteMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series C Senior Note</link:label>
    <link:label id="lab_idxx_SeriesCSeniorNoteMember_label_en-US" xlink:label="lab_idxx_SeriesCSeniorNoteMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series C Senior Note [Member]</link:label>
    <link:label id="lab_idxx_SeriesCSeniorNoteMember_documentation_en-US" xlink:label="lab_idxx_SeriesCSeniorNoteMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series C Senior Note [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_SeriesCSeniorNoteMember" xlink:href="idxx-20211231.xsd#idxx_SeriesCSeniorNoteMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_SeriesCSeniorNoteMember" xlink:to="lab_idxx_SeriesCSeniorNoteMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_bdbdc3d1-2f45-4b33-8211-c10bf7050464_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of property and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_217306c3-71f5-4df5-89f5-08f2518b0fdc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_a6e8f104-9c2b-4221-adb6-b9af22ef029c_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement and Other Comprehensive Income Location</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_5e61d367-33db-4ec7-9c67-c011cdb573b5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_c23d2832-fb03-4e8f-9d70-260e0ef8e62d_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Fair Value Hedge Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Fair Value Hedge Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable" xlink:to="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_cbed7080-b839-4eb6-aed6-7fd0db879dac_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_29e74825-4db1-4bcb-852a-3c5cc31f060b_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_ff8d9cf3-6b32-4d44-9bbe-52e079526fed_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_a530a128-21a8-4f19-ba3c-0cae3b98ee4c_terseLabel_en-US" xlink:label="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandAndLandImprovementsMember_df0e1d91-db53-4d3c-a9b9-33a11c9fc4fb_terseLabel_en-US" xlink:label="lab_us-gaap_LandAndLandImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land and improvements</link:label>
    <link:label id="lab_us-gaap_LandAndLandImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LandAndLandImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land and Land Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandAndLandImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandAndLandImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandAndLandImprovementsMember" xlink:to="lab_us-gaap_LandAndLandImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_5c0416f4-6d8c-43a0-93ff-283498551d67_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of expected amortization expense</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_dc2f6aba-0bc4-41ec-95a1-b85cd88b9f47_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per Share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityCumulativeEffectOfChangeInAccountingPrinciple_4561fade-c60c-4a25-b7a8-b6af88167ce3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityCumulativeEffectOfChangeInAccountingPrinciple" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash cumulative effect adjustment to retained earnings, tax</link:label>
    <link:label id="lab_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityCumulativeEffectOfChangeInAccountingPrinciple_label_en-US" xlink:label="lab_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityCumulativeEffectOfChangeInAccountingPrinciple" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Effects Allocated Directly to Equity, Cumulative Effect of Change in Accounting Principle</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityCumulativeEffectOfChangeInAccountingPrinciple" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityCumulativeEffectOfChangeInAccountingPrinciple"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityCumulativeEffectOfChangeInAccountingPrinciple" xlink:to="lab_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityCumulativeEffectOfChangeInAccountingPrinciple" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_ef62d05a-211e-4af5-8f9e-9af1ef34a308_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross amount</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_6f0b54ff-be3b-42f7-a4e8-5e9ec88b8a19_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable allowance for credit losses</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage_c5eb62d9-c120-401c-8a53-d144f192b61e_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue percentage expected to be recognized</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_57ba5c74-cfb0-42bd-8211-184556db63ad_negatedLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified from accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesFairValueDisclosure_518ba45f-671e-4ddc-a45b-0a788a49a7ce_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_e7be7906-4a69-457f-8f6d-9e23f040ea78_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency exchange contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_bab9ab3b-a404-45f3-b162-71aac959187e_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency accrual</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_15846763-245a-46fc-ad8d-2e0970a6f9ec_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price of beginning balance of options outstanding (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_e7247def-0546-45fa-931f-28f909ae2109_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price of ending balance of options outstanding (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_40a7c287-d118-4453-ba5e-47432de48f4f_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on foreign currency exchange contracts, tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EuropeMember_6074524e-2dd1-44e8-8dc2-0feb499ebde7_terseLabel_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe, the Middle East and Africa</link:label>
    <link:label id="lab_srt_EuropeMember_label_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_79ea4a42-0f76-4088-94c2-aa169232a34a_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_775f6ffe-f94e-4c7f-8ad9-50fb68680bba_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Grant-Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LegalCostsPolicyTextBlock_89249115-e2cb-4b7d-ba00-0ea4d858fadb_terseLabel_en-US" xlink:label="lab_us-gaap_LegalCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Costs</link:label>
    <link:label id="lab_us-gaap_LegalCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LegalCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Costs, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalCostsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LegalCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LegalCostsPolicyTextBlock" xlink:to="lab_us-gaap_LegalCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_85fd4e28-6052-4c5a-90a5-743407b35bf3_totalLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5699f508-ba4a-4e87-b89f-474bca3e8c0f_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms_20cf4cd3-cd05-482e-8c99-664ad5456b29_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period for continued vesting of outstanding equity awards upon termination of CEO without cause other than following a change in control, years</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Plan Modification, Description and Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseOtherNoncurrent_556c2fd8-1c5d-4433-8ab8-09a989522337_verboseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseOtherNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in long-term product supply arrangements</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseOtherNoncurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseOtherNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense Other, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseOtherNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseOtherNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseOtherNoncurrent" xlink:to="lab_us-gaap_PrepaidExpenseOtherNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_260395e3-1176-401e-9e1f-2a513b6719a5_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract assets, net</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:to="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_581eef05-c6ae-4fa3-944b-c7cf1f7e8265_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_0b78c384-1604-41aa-a0bd-ef0ffbbd38cc_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Nonoperating, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_ccc4a1a5-3c0f-4aa0-a451-6a308c106ca3_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_0ef1f184-aed5-4455-9d73-d4910d712141_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on derivative instruments:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_950a2ad5-191a-4699-924d-09cc22eb5c45_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_a5e475b0-13fc-48f2-9d9b-53684c3a828c_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAdditions_ce40c2cb-fa36-4978-a5e6-dbf9a95f841f_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAdditions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized computer software developed for internal use</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAdditions_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAdditions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Additions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAdditions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAdditions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAdditions" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAdditions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_30b156b3-38bd-4a8e-99bc-9c9e85d22429_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_e00f17b1-8af3-4a41-8b50-7329f9e70bf7_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7e8bf522-41bf-4692-8a5c-220fc7564003_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6c1924d7-ab34-418f-9b7a-9f8b9cfa8307_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares outstanding for diluted earnings per share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_4c6bfa91-bb03-4cc8-9907-b7fd9c8296ec_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_537746f0-a9e0-45a2-b243-06983e013faa_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_ba0a7032-4bbf-4a1d-a7af-1e8d96ed78e4_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_6a769649-5976-44ad-ada1-0da1314beabd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of stock option activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_721f915b-1ebd-4a2f-93e6-bbf23fbc187f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit spread during period</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_c6c1fe24-2d44-411d-b5c4-fb3b87a567d2_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligation_206982ae-ee9d-45fe-b2b4-75523107868f_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum purchase commitments</link:label>
    <link:label id="lab_us-gaap_PurchaseObligation_label_en-US" xlink:label="lab_us-gaap_PurchaseObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligation" xlink:to="lab_us-gaap_PurchaseObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_f5877e41-10fc-4014-baed-6ae3dd929fb0_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6f3de11c-7807-4100-a9ab-ef555aac5970_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_bd08e221-3392-4c6b-8c46-01df07906a3a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_446aecff-ee60-4bfa-a845-b33aec95dd66_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_cfb49822-fff0-4b80-b835-45f7f10cfafe_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flows from Operating Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_b39f21c7-9974-4dbc-a25a-983b321f9218_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_36698f90-9c85-4422-b3e8-a73761bf6fed_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected term, in years</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_fb02ad04-7c03-41ab-b047-1d0aff9fecd8_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_ad42fdb2-7019-47e4-b955-ea0781c6f9c2_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares withheld for statutory tax withholding payments on restricted stock</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_9daf053e-c885-4293-8dbf-363c6ed1823b_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_4c3056d9-7af9-467d-b73d-b9d74646d39d_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unpaid inventory</link:label>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Trade, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableTradeCurrent" xlink:to="lab_us-gaap_AccountsPayableTradeCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_0a23d62f-6501-4124-b690-57fa527d791f_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_5fc5379c-bf38-4d4c-9b00-c5a06c194cb2_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution match, maximum percent of participants' eligible compensation</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_44bddab2-a985-4c2d-8206-1cd67702e6fb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value of options expected to vest</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_ca0e6921-66fc-45b0-b278-b51dc204ac50_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable_6af28ef8-365d-46a1-808b-dc6858cd3c03_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Volume commitment contract assets reclassified to accounts receivable</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, Reclassified to Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetReclassifiedToReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable" xlink:to="lab_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_49975630-8966-4428-9983-4b62e206bb15_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_27d1eddf-6553-411f-823b-b9f9d2adea38_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements Adopted and New Accounting Pronouncements Not Yet Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_79429bfc-0702-4d20-9cce-e93b54286f02_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation expense, net of estimated forfeitures, for unvested share-based compensation awards outstanding</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_59475039-8089-47b5-938d-40e6fac3e6a9_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_A2022SeriesANotesMember_97e9cddf-4a62-4327-bc28-7753cbb294bd_terseLabel_en-US" xlink:label="lab_idxx_A2022SeriesANotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Series A Notes</link:label>
    <link:label id="lab_idxx_A2022SeriesANotesMember_label_en-US" xlink:label="lab_idxx_A2022SeriesANotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Series A Notes [Member]</link:label>
    <link:label id="lab_idxx_A2022SeriesANotesMember_documentation_en-US" xlink:label="lab_idxx_A2022SeriesANotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Series A Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_A2022SeriesANotesMember" xlink:href="idxx-20211231.xsd#idxx_A2022SeriesANotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_A2022SeriesANotesMember" xlink:to="lab_idxx_A2022SeriesANotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_DeferredTaxAssetsValuationAllowanceRollForward_c3470211-258b-4e4e-af32-faa155428d71_terseLabel_en-US" xlink:label="lab_idxx_DeferredTaxAssetsValuationAllowanceRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance [Roll Forward]</link:label>
    <link:label id="lab_idxx_DeferredTaxAssetsValuationAllowanceRollForward_label_en-US" xlink:label="lab_idxx_DeferredTaxAssetsValuationAllowanceRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance [Roll Forward]</link:label>
    <link:label id="lab_idxx_DeferredTaxAssetsValuationAllowanceRollForward_documentation_en-US" xlink:label="lab_idxx_DeferredTaxAssetsValuationAllowanceRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_DeferredTaxAssetsValuationAllowanceRollForward" xlink:href="idxx-20211231.xsd#idxx_DeferredTaxAssetsValuationAllowanceRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_DeferredTaxAssetsValuationAllowanceRollForward" xlink:to="lab_idxx_DeferredTaxAssetsValuationAllowanceRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_d7f8c892-6c2a-4fe3-95df-e314db7284bd_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_541a3c99-f5ac-46c2-be76-a1d3069733a5_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_f49472bf-850f-4a89-a410-e3e6e03e118d_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_d799ec7a-b915-4a0a-9517-2a8860183908_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_d9503f0f-b301-4b53-a381-04d7b1e923a1_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_b3e44568-358d-468e-aff2-3266fc4a4a55_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxation on international earnings</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_787c4087-2991-473f-9244-eec04e1d005c_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_f0f0f4e4-288b-4e81-b566-4962e4395772_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_666edbea-9868-4f49-b7d5-7f2dfa5cf610_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_RatioSharesIssuedUnderShareBasedAwardsToSharesAuthorizedUnderStockPlans_5605786b-3e94-4b14-bae2-555981f26831_terseLabel_en-US" xlink:label="lab_idxx_RatioSharesIssuedUnderShareBasedAwardsToSharesAuthorizedUnderStockPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ratio of shares issued under share-based awards to shares authorized under stock plans</link:label>
    <link:label id="lab_idxx_RatioSharesIssuedUnderShareBasedAwardsToSharesAuthorizedUnderStockPlans_label_en-US" xlink:label="lab_idxx_RatioSharesIssuedUnderShareBasedAwardsToSharesAuthorizedUnderStockPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ratio Shares Issued Under Share Based Awards To Shares Authorized Under Stock Plans</link:label>
    <link:label id="lab_idxx_RatioSharesIssuedUnderShareBasedAwardsToSharesAuthorizedUnderStockPlans_documentation_en-US" xlink:label="lab_idxx_RatioSharesIssuedUnderShareBasedAwardsToSharesAuthorizedUnderStockPlans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The ratio of the number of shares issued under share-based awards to the number of shares authorized under stock plans.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_RatioSharesIssuedUnderShareBasedAwardsToSharesAuthorizedUnderStockPlans" xlink:href="idxx-20211231.xsd#idxx_RatioSharesIssuedUnderShareBasedAwardsToSharesAuthorizedUnderStockPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_RatioSharesIssuedUnderShareBasedAwardsToSharesAuthorizedUnderStockPlans" xlink:to="lab_idxx_RatioSharesIssuedUnderShareBasedAwardsToSharesAuthorizedUnderStockPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_93b00d8d-afb3-445c-8376-b47540711361_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Details of net investment hedges and Income Statement impact of hedging instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostNetCurrent_d7c0a3fe-efb6-4f3c-ad61-5aedc5f810de_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred sales commissions</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostNetCurrent_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostNetCurrent" xlink:to="lab_us-gaap_CapitalizedContractCostNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryLineItems_aa79d6a4-ff7b-404b-909a-ce3eef4be13f_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory [Line Items]</link:label>
    <link:label id="lab_us-gaap_InventoryLineItems_label_en-US" xlink:label="lab_us-gaap_InventoryLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryLineItems" xlink:to="lab_us-gaap_InventoryLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_ffa6b71c-fc6a-45cb-91c5-c8becefdee73_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision (benefit) for deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_712d4f48-4306-49ce-b2d5-a92734957772_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining contractual term of options fully vested and expected to vest</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_StockOptionsGrantedToEmployeesWithRatableVestingMember_caa53e83-966b-42ec-b7ed-7120ad3f0b53_terseLabel_en-US" xlink:label="lab_idxx_StockOptionsGrantedToEmployeesWithRatableVestingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options granted to employees with ratable vesting</link:label>
    <link:label id="lab_idxx_StockOptionsGrantedToEmployeesWithRatableVestingMember_label_en-US" xlink:label="lab_idxx_StockOptionsGrantedToEmployeesWithRatableVestingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options Granted To Employees With Ratable Vesting [Member]</link:label>
    <link:label id="lab_idxx_StockOptionsGrantedToEmployeesWithRatableVestingMember_documentation_en-US" xlink:label="lab_idxx_StockOptionsGrantedToEmployeesWithRatableVestingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options Granted To Employees With Ratable Vesting [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_StockOptionsGrantedToEmployeesWithRatableVestingMember" xlink:href="idxx-20211231.xsd#idxx_StockOptionsGrantedToEmployeesWithRatableVestingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_StockOptionsGrantedToEmployeesWithRatableVestingMember" xlink:to="lab_idxx_StockOptionsGrantedToEmployeesWithRatableVestingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_RestrictedStockUnitsExpectedToVestReducedForEstimatedForfeituresMember_036bf0d6-b45e-405f-8a9f-feabd76c53d4_terseLabel_en-US" xlink:label="lab_idxx_RestrictedStockUnitsExpectedToVestReducedForEstimatedForfeituresMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units expected to vest reduced for estimated forfeitures</link:label>
    <link:label id="lab_idxx_RestrictedStockUnitsExpectedToVestReducedForEstimatedForfeituresMember_label_en-US" xlink:label="lab_idxx_RestrictedStockUnitsExpectedToVestReducedForEstimatedForfeituresMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units Expected To Vest Reduced For Estimated Forfeitures [Member]</link:label>
    <link:label id="lab_idxx_RestrictedStockUnitsExpectedToVestReducedForEstimatedForfeituresMember_documentation_en-US" xlink:label="lab_idxx_RestrictedStockUnitsExpectedToVestReducedForEstimatedForfeituresMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units Expected To Vest, Reduced For Estimated Forfeitures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_RestrictedStockUnitsExpectedToVestReducedForEstimatedForfeituresMember" xlink:href="idxx-20211231.xsd#idxx_RestrictedStockUnitsExpectedToVestReducedForEstimatedForfeituresMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_RestrictedStockUnitsExpectedToVestReducedForEstimatedForfeituresMember" xlink:to="lab_idxx_RestrictedStockUnitsExpectedToVestReducedForEstimatedForfeituresMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_b7bf794a-e36f-4fe8-8e9e-dbe6ef3c640f_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_fad82a8f-3ac1-4c79-98d0-054e1a7558c3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of common stock repurchases</link:label>
    <link:label id="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_a5a0f6af-8283-457b-9a21-048fe05ac33a_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. federal statutory rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_960f5c7a-1da5-4b01-9bd6-648ad0abe577_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6550a15b-69ce-4cb1-b27f-73418fb84c18_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Disclosure Items [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_40e5dd1c-c860-4d2d-a675-a9402f42d294_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to IDEXX Laboratories, Inc. stockholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_a6165c4e-c95f-4295-8a17-fbec6a99d0c9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_edeadef6-5f95-40ac-9d3e-220f3cd90715_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_2d994492-1b34-487f-82b0-25c7606d812d_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued employee compensation and related expenses</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_b3e53791-9c8d-41b0-a180-090d346d6a8a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_b5c7fb55-7020-45de-b5b6-8f083c798dca_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_335efd7b-7de9-4248-9c19-5d8dc4e40c49_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_CrossCurrencyInterestRateContract1Member_aa81bce0-7289-4ff6-a4eb-64ad89e15395_terseLabel_en-US" xlink:label="lab_idxx_CrossCurrencyInterestRateContract1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross currency swaps</link:label>
    <link:label id="lab_idxx_CrossCurrencyInterestRateContract1Member_label_en-US" xlink:label="lab_idxx_CrossCurrencyInterestRateContract1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract, 1 [Member]</link:label>
    <link:label id="lab_idxx_CrossCurrencyInterestRateContract1Member_documentation_en-US" xlink:label="lab_idxx_CrossCurrencyInterestRateContract1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract, 1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_CrossCurrencyInterestRateContract1Member" xlink:href="idxx-20211231.xsd#idxx_CrossCurrencyInterestRateContract1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_CrossCurrencyInterestRateContract1Member" xlink:to="lab_idxx_CrossCurrencyInterestRateContract1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_d4dd11be-7712-4ee8-8757-c59f71653205_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of annual principal payments on long-term debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_PaymentsToAcquireIntangibleAssetsAndEquityMethodInvestments_bb57c867-df40-4f5f-8fec-f6f67e4bd0c1_negatedLabel_en-US" xlink:label="lab_idxx_PaymentsToAcquireIntangibleAssetsAndEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions of intangible assets and equity investments</link:label>
    <link:label id="lab_idxx_PaymentsToAcquireIntangibleAssetsAndEquityMethodInvestments_label_en-US" xlink:label="lab_idxx_PaymentsToAcquireIntangibleAssetsAndEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Intangible Assets and Equity Method Investments</link:label>
    <link:label id="lab_idxx_PaymentsToAcquireIntangibleAssetsAndEquityMethodInvestments_documentation_en-US" xlink:label="lab_idxx_PaymentsToAcquireIntangibleAssetsAndEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Intangible Assets and Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_PaymentsToAcquireIntangibleAssetsAndEquityMethodInvestments" xlink:href="idxx-20211231.xsd#idxx_PaymentsToAcquireIntangibleAssetsAndEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_PaymentsToAcquireIntangibleAssetsAndEquityMethodInvestments" xlink:to="lab_idxx_PaymentsToAcquireIntangibleAssetsAndEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_89f7ea9b-c726-4290-a5e5-f89a2d11339a_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_00571757-3bde-41ac-a2e7-03e5674ea912_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_809611fa-c2fd-4d12-bdd5-e3338250609e_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued under stock plans, net (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, before Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_49af7d20-af84-4e39-a872-57683626a07b_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_edf592e2-a182-45a6-9dbf-03c3224e0fe9_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets impairments</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_PaymentRequiredToCeoUponTerminationOfEmploymentWithoutCauseOtherThanFollowingChangeInControlMember_20aa1137-b427-49e1-93f6-cfbb50482ed5_terseLabel_en-US" xlink:label="lab_idxx_PaymentRequiredToCeoUponTerminationOfEmploymentWithoutCauseOtherThanFollowingChangeInControlMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment required to CEO upon termination of employment without cause other than following change in control</link:label>
    <link:label id="lab_idxx_PaymentRequiredToCeoUponTerminationOfEmploymentWithoutCauseOtherThanFollowingChangeInControlMember_label_en-US" xlink:label="lab_idxx_PaymentRequiredToCeoUponTerminationOfEmploymentWithoutCauseOtherThanFollowingChangeInControlMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment Required To Ceo Upon Termination Of Employment Without Cause Other Than Following Change In Control [Member]</link:label>
    <link:label id="lab_idxx_PaymentRequiredToCeoUponTerminationOfEmploymentWithoutCauseOtherThanFollowingChangeInControlMember_documentation_en-US" xlink:label="lab_idxx_PaymentRequiredToCeoUponTerminationOfEmploymentWithoutCauseOtherThanFollowingChangeInControlMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment Required To CEO Upon Termination Of Employment Without Cause Other Than Following Change In Control [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_PaymentRequiredToCeoUponTerminationOfEmploymentWithoutCauseOtherThanFollowingChangeInControlMember" xlink:href="idxx-20211231.xsd#idxx_PaymentRequiredToCeoUponTerminationOfEmploymentWithoutCauseOtherThanFollowingChangeInControlMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_PaymentRequiredToCeoUponTerminationOfEmploymentWithoutCauseOtherThanFollowingChangeInControlMember" xlink:to="lab_idxx_PaymentRequiredToCeoUponTerminationOfEmploymentWithoutCauseOtherThanFollowingChangeInControlMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_89eec41a-cc61-4ffa-b5b2-196d554b5055_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_af3c8d1b-7cc6-4b8d-b0b2-da416a1b8654_totalLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_RevolvingCreditFacilityIndividualBorrowingsMember_df0bde4b-e5f4-4f23-8bff-8be6d423e1e0_terseLabel_en-US" xlink:label="lab_idxx_RevolvingCreditFacilityIndividualBorrowingsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility, Individual Borrowings</link:label>
    <link:label id="lab_idxx_RevolvingCreditFacilityIndividualBorrowingsMember_label_en-US" xlink:label="lab_idxx_RevolvingCreditFacilityIndividualBorrowingsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility, Individual Borrowings [Member]</link:label>
    <link:label id="lab_idxx_RevolvingCreditFacilityIndividualBorrowingsMember_documentation_en-US" xlink:label="lab_idxx_RevolvingCreditFacilityIndividualBorrowingsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility, Individual Borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_RevolvingCreditFacilityIndividualBorrowingsMember" xlink:href="idxx-20211231.xsd#idxx_RevolvingCreditFacilityIndividualBorrowingsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_RevolvingCreditFacilityIndividualBorrowingsMember" xlink:to="lab_idxx_RevolvingCreditFacilityIndividualBorrowingsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_a2717c89-d056-454b-a90e-569a90cefb18_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCosts_64e1eb39-4a97-4689-82b3-427c491c7fd5_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredCosts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer acquisition costs</link:label>
    <link:label id="lab_us-gaap_DeferredCosts_label_en-US" xlink:label="lab_us-gaap_DeferredCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Costs, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCosts" xlink:to="lab_us-gaap_DeferredCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_dea35658-7c77-431b-ad42-81b678e447b1_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax_80be3e37-2f87-48d0-8b9c-e1fbaa94621f_terseLabel_en-US" xlink:label="lab_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on Euro-denominated notes, net of tax expense (benefit) of $2,011 in 2021, $(2,325) in 2020 and $564 in 2019</link:label>
    <link:label id="lab_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax_055a4a58-1902-43bb-87fc-db0cd2fe828a_verboseLabel_en-US" xlink:label="lab_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on Euro-denominated notes, net of tax</link:label>
    <link:label id="lab_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Euro-Denominated Notes, Gain (Loss), After Reclassification And Tax</link:label>
    <link:label id="lab_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax_documentation_en-US" xlink:label="lab_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Euro-Denominated Notes, Gain (Loss), After Reclassification And Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax" xlink:href="idxx-20211231.xsd#idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax" xlink:to="lab_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_84cf164b-a045-4cb1-9efe-1d76412a3ce0_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation cost</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_A2025SeriesCNotesMember_e68ac2fe-7e56-467b-b82c-19f59d99bb5f_terseLabel_en-US" xlink:label="lab_idxx_A2025SeriesCNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025 Series C Notes</link:label>
    <link:label id="lab_idxx_A2025SeriesCNotesMember_label_en-US" xlink:label="lab_idxx_A2025SeriesCNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025 Series C Notes [Member]</link:label>
    <link:label id="lab_idxx_A2025SeriesCNotesMember_documentation_en-US" xlink:label="lab_idxx_A2025SeriesCNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025 Series C Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_A2025SeriesCNotesMember" xlink:href="idxx-20211231.xsd#idxx_A2025SeriesCNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_A2025SeriesCNotesMember" xlink:to="lab_idxx_A2025SeriesCNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_WaterSegmentMember_b8680079-f308-4414-9714-24d31a3d3f08_terseLabel_en-US" xlink:label="lab_idxx_WaterSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Water segment revenue</link:label>
    <link:label id="lab_idxx_WaterSegmentMember_b8ce52c9-eef4-4bbb-9677-10f5a236096f_verboseLabel_en-US" xlink:label="lab_idxx_WaterSegmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Water</link:label>
    <link:label id="lab_idxx_WaterSegmentMember_label_en-US" xlink:label="lab_idxx_WaterSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Water Segment [Member]</link:label>
    <link:label id="lab_idxx_WaterSegmentMember_documentation_en-US" xlink:label="lab_idxx_WaterSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Water Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_WaterSegmentMember" xlink:href="idxx-20211231.xsd#idxx_WaterSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_WaterSegmentMember" xlink:to="lab_idxx_WaterSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_A2022SeriesANotesand2027SeriesBNotesMember_38b2bcb9-daca-4980-985f-93f639a29dbb_terseLabel_en-US" xlink:label="lab_idxx_A2022SeriesANotesand2027SeriesBNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Series A Notes and 2027 Series B Notes</link:label>
    <link:label id="lab_idxx_A2022SeriesANotesand2027SeriesBNotesMember_label_en-US" xlink:label="lab_idxx_A2022SeriesANotesand2027SeriesBNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Series A Notes and 2027 Series B Notes [Member]</link:label>
    <link:label id="lab_idxx_A2022SeriesANotesand2027SeriesBNotesMember_documentation_en-US" xlink:label="lab_idxx_A2022SeriesANotesand2027SeriesBNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Series A Notes and 2027 Series B Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_A2022SeriesANotesand2027SeriesBNotesMember" xlink:href="idxx-20211231.xsd#idxx_A2022SeriesANotesand2027SeriesBNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_A2022SeriesANotesand2027SeriesBNotesMember" xlink:to="lab_idxx_A2022SeriesANotesand2027SeriesBNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_05516151-5bb5-4f02-9bd0-bcd4b9bd78e9_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_80f0ffde-7ad2-4d12-a2b2-c21a74eb3034_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_SummaryOfSignificantAccountingPoliciesTable_9e1ceef3-7f22-48f9-98c2-df4fbefaaa66_terseLabel_en-US" xlink:label="lab_idxx_SummaryOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_idxx_SummaryOfSignificantAccountingPoliciesTable_label_en-US" xlink:label="lab_idxx_SummaryOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_idxx_SummaryOfSignificantAccountingPoliciesTable_documentation_en-US" xlink:label="lab_idxx_SummaryOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Significant Accounting Policies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_SummaryOfSignificantAccountingPoliciesTable" xlink:href="idxx-20211231.xsd#idxx_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_SummaryOfSignificantAccountingPoliciesTable" xlink:to="lab_idxx_SummaryOfSignificantAccountingPoliciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentAssetsMember_2b76adab-3153-4137-88b1-454f7d8ad75f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentAssetsMember" xlink:to="lab_us-gaap_OtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_LineofCreditFacilityAccordionFeatureHigherBorrowingCapacityOption_291c3a24-2d17-4217-b0f9-a3436687a2a2_terseLabel_en-US" xlink:label="lab_idxx_LineofCreditFacilityAccordionFeatureHigherBorrowingCapacityOption" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accordion feature, higher borrowing capacity option</link:label>
    <link:label id="lab_idxx_LineofCreditFacilityAccordionFeatureHigherBorrowingCapacityOption_label_en-US" xlink:label="lab_idxx_LineofCreditFacilityAccordionFeatureHigherBorrowingCapacityOption" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Accordion Feature, Higher Borrowing Capacity Option</link:label>
    <link:label id="lab_idxx_LineofCreditFacilityAccordionFeatureHigherBorrowingCapacityOption_documentation_en-US" xlink:label="lab_idxx_LineofCreditFacilityAccordionFeatureHigherBorrowingCapacityOption" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Accordion Feature, Higher Borrowing Capacity Option</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_LineofCreditFacilityAccordionFeatureHigherBorrowingCapacityOption" xlink:href="idxx-20211231.xsd#idxx_LineofCreditFacilityAccordionFeatureHigherBorrowingCapacityOption"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_LineofCreditFacilityAccordionFeatureHigherBorrowingCapacityOption" xlink:to="lab_idxx_LineofCreditFacilityAccordionFeatureHigherBorrowingCapacityOption" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_ExtendedWarrantiesAndPostContractSupportMember_1cd86848-82e6-4734-8ad3-f98e4f957190_terseLabel_en-US" xlink:label="lab_idxx_ExtendedWarrantiesAndPostContractSupportMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended warranties and post contract support</link:label>
    <link:label id="lab_idxx_ExtendedWarrantiesAndPostContractSupportMember_label_en-US" xlink:label="lab_idxx_ExtendedWarrantiesAndPostContractSupportMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended Warranties And Post Contract Support [Member]</link:label>
    <link:label id="lab_idxx_ExtendedWarrantiesAndPostContractSupportMember_documentation_en-US" xlink:label="lab_idxx_ExtendedWarrantiesAndPostContractSupportMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended Warranties and Post-Contract Support [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ExtendedWarrantiesAndPostContractSupportMember" xlink:href="idxx-20211231.xsd#idxx_ExtendedWarrantiesAndPostContractSupportMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_ExtendedWarrantiesAndPostContractSupportMember" xlink:to="lab_idxx_ExtendedWarrantiesAndPostContractSupportMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_47b69b67-4235-4f2f-a491-36b4fd26d5e4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant date fair value, granted (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_73dda613-06ba-4673-be39-1ec0ec1f2d02_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of awards vested during period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentsAbstract_8af4cf80-e432-48b8-b012-a911aadb335f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instruments [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentsAbstract_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instruments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentsAbstract" xlink:to="lab_us-gaap_DebtInstrumentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_EffectiveIncomeTaxRateReconciliationSwitzerlandTaxReformEffectPercent_825eb8cc-21f3-4f4d-967b-70091c5d5baa_terseLabel_en-US" xlink:label="lab_idxx_EffectiveIncomeTaxRateReconciliationSwitzerlandTaxReformEffectPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of Switzerland tax reform</link:label>
    <link:label id="lab_idxx_EffectiveIncomeTaxRateReconciliationSwitzerlandTaxReformEffectPercent_label_en-US" xlink:label="lab_idxx_EffectiveIncomeTaxRateReconciliationSwitzerlandTaxReformEffectPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Switzerland Tax Reform Effect, Percent</link:label>
    <link:label id="lab_idxx_EffectiveIncomeTaxRateReconciliationSwitzerlandTaxReformEffectPercent_documentation_en-US" xlink:label="lab_idxx_EffectiveIncomeTaxRateReconciliationSwitzerlandTaxReformEffectPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Switzerland Tax Reform Effect, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_EffectiveIncomeTaxRateReconciliationSwitzerlandTaxReformEffectPercent" xlink:href="idxx-20211231.xsd#idxx_EffectiveIncomeTaxRateReconciliationSwitzerlandTaxReformEffectPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_EffectiveIncomeTaxRateReconciliationSwitzerlandTaxReformEffectPercent" xlink:to="lab_idxx_EffectiveIncomeTaxRateReconciliationSwitzerlandTaxReformEffectPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_4603679d-f60b-4962-8e77-6391c3a8504c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on investments, net of tax expense (benefit) of $46 in 2021, $(120) in 2020 and $84 in 2019</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_21bae9fa-f2bf-438f-a471-46442dc375ca_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on investments, tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_d46d86e0-8c79-43a4-b1cb-f4d7e13ab966_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_98d12b52-a583-44e7-9c35-78b07527c2b8_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_fc9106d6-b10e-499d-bafc-7d92b0cd94fe_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_ContingentPaymentMember_5ab34ea3-1750-4952-b7c8-0159b0514c2b_terseLabel_en-US" xlink:label="lab_idxx_ContingentPaymentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent payment</link:label>
    <link:label id="lab_idxx_ContingentPaymentMember_label_en-US" xlink:label="lab_idxx_ContingentPaymentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Payment [Member]</link:label>
    <link:label id="lab_idxx_ContingentPaymentMember_documentation_en-US" xlink:label="lab_idxx_ContingentPaymentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ContingentPaymentMember" xlink:href="idxx-20211231.xsd#idxx_ContingentPaymentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_ContingentPaymentMember" xlink:to="lab_idxx_ContingentPaymentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_0c2106a4-dbef-4d07-94cb-cfc5c1d5de02_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_4c5f9472-6f60-4c79-9abc-12ff42b74d75_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price of options fully vested and expected to vest (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_4ca28edb-ca71-4743-b3cb-20a495686a7d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_9911782f-fedf-41cc-b83a-df807dc04840_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_02458a30-37d6-4745-b4c5-157d365055fd_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Net</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_266e562c-1e55-491f-980a-5e395c28de81_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_0bef0828-1116-49e0-97b5-9192b434d99d_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercises of stock options and employee stock purchase plans</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_00f04231-6de0-4832-861a-8e8ece5d0ca6_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, at beginning of year (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_f2cf97e3-3a66-4669-8670-a6a966755985_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, at end of year (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_fee4ae63-5906-426f-8a92-6234ba500120_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_358b22ff-3725-4cf1-b004-cd2b5fdf9996_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost_4670397f-ad9d-4b72-aa34-35c308a79858_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer acquisition costs</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Deferred Expense, Deferred Policy Acquisition Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_67e4232e-ba19-4b7d-a6f1-61cabc03ac76_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases, not yet commenced, lease term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not yet Commenced, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:to="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_81c54f09-7fa2-48b0-91ce-9fcf94e4a3bf_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Costs</link:label>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Cost [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivablesPeriodPastDueDomain_f1f64edf-4fdc-4d4b-8f68-3bdc5b53cf58_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivablesPeriodPastDueDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Asset, Period Past Due [Domain]</link:label>
    <link:label id="lab_us-gaap_FinancingReceivablesPeriodPastDueDomain_label_en-US" xlink:label="lab_us-gaap_FinancingReceivablesPeriodPastDueDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Asset, Aging [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivablesPeriodPastDueDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivablesPeriodPastDueDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivablesPeriodPastDueDomain" xlink:to="lab_us-gaap_FinancingReceivablesPeriodPastDueDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_3b770189-a1c7-4af7-bae4-900e26c2d167_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction_3956f75a-a334-489c-9f60-8a590f5b4850_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging liabilities, gross amounts subject to master netting arrangements not offset on the balance sheet</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Not Offset, Policy Election Deduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction" xlink:to="lab_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_AccountsReceivablePercentPastDue_74a84b40-fc3a-41f3-9fd1-ed15caa6c520_terseLabel_en-US" xlink:label="lab_idxx_AccountsReceivablePercentPastDue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of accounts receivable past due</link:label>
    <link:label id="lab_idxx_AccountsReceivablePercentPastDue_label_en-US" xlink:label="lab_idxx_AccountsReceivablePercentPastDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Percent Past Due</link:label>
    <link:label id="lab_idxx_AccountsReceivablePercentPastDue_documentation_en-US" xlink:label="lab_idxx_AccountsReceivablePercentPastDue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Percent Past Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_AccountsReceivablePercentPastDue" xlink:href="idxx-20211231.xsd#idxx_AccountsReceivablePercentPastDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_AccountsReceivablePercentPastDue" xlink:to="lab_idxx_AccountsReceivablePercentPastDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryCurrentTable_202b34cf-e999-4151-820c-53a640d17e70_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryCurrentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Current [Table]</link:label>
    <link:label id="lab_us-gaap_InventoryCurrentTable_label_en-US" xlink:label="lab_us-gaap_InventoryCurrentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Current [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryCurrentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryCurrentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryCurrentTable" xlink:to="lab_us-gaap_InventoryCurrentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_8102e7a5-c5fd-4403-bd2b-f4bb0df34826_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets obtained in exchange for operating lease obligations, net of early lease&#160;terminations</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_689c321d-0dd5-4d57-a4f3-3afd7bad7cf1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of components of net deferred tax assets and liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_7d33aee9-7e39-4b58-8d68-79b07c8c2678_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award vesting rights, percentage</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_28553b16-0392-4f15-86e2-dc61ce369aca_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_RevenuePerformanceObligationPaymentTerm_ee04cd95-9510-4a0e-8c51-2ddae48f9be4_terseLabel_en-US" xlink:label="lab_idxx_RevenuePerformanceObligationPaymentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General payment terms</link:label>
    <link:label id="lab_idxx_RevenuePerformanceObligationPaymentTerm_label_en-US" xlink:label="lab_idxx_RevenuePerformanceObligationPaymentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Performance Obligation, Payment Term</link:label>
    <link:label id="lab_idxx_RevenuePerformanceObligationPaymentTerm_documentation_en-US" xlink:label="lab_idxx_RevenuePerformanceObligationPaymentTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Performance Obligation, Payment Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_RevenuePerformanceObligationPaymentTerm" xlink:href="idxx-20211231.xsd#idxx_RevenuePerformanceObligationPaymentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_RevenuePerformanceObligationPaymentTerm" xlink:to="lab_idxx_RevenuePerformanceObligationPaymentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9940c820-018b-4ddc-a598-6f1fb739950c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_237413a1-4148-4323-ad91-60734afdbd46_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrimeRateMember_f8241de3-9f6b-4441-9965-c78aeb121737_terseLabel_en-US" xlink:label="lab_us-gaap_PrimeRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prime Rate</link:label>
    <link:label id="lab_us-gaap_PrimeRateMember_label_en-US" xlink:label="lab_us-gaap_PrimeRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prime Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrimeRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrimeRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrimeRateMember" xlink:to="lab_us-gaap_PrimeRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_CAGDiagnosticCapitalVetlabInstrumentsMember_70e81408-05cd-4999-859b-01a50349d1df_terseLabel_en-US" xlink:label="lab_idxx_CAGDiagnosticCapitalVetlabInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CAG Diagnostics capital - instruments</link:label>
    <link:label id="lab_idxx_CAGDiagnosticCapitalVetlabInstrumentsMember_label_en-US" xlink:label="lab_idxx_CAGDiagnosticCapitalVetlabInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CAG Diagnostic Capital Vetlab Instruments [Member]</link:label>
    <link:label id="lab_idxx_CAGDiagnosticCapitalVetlabInstrumentsMember_documentation_en-US" xlink:label="lab_idxx_CAGDiagnosticCapitalVetlabInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CAG Diagnostic Capital - VetLab Instruments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_CAGDiagnosticCapitalVetlabInstrumentsMember" xlink:href="idxx-20211231.xsd#idxx_CAGDiagnosticCapitalVetlabInstrumentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_CAGDiagnosticCapitalVetlabInstrumentsMember" xlink:to="lab_idxx_CAGDiagnosticCapitalVetlabInstrumentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_e0f8bd5f-4a7c-4866-81ea-95491c621ecf_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditLossFinancialInstrumentPolicyTextBlock_67887e2f-b309-41d8-927d-0c073e11f590_terseLabel_en-US" xlink:label="lab_us-gaap_CreditLossFinancialInstrumentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Losses</link:label>
    <link:label id="lab_us-gaap_CreditLossFinancialInstrumentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CreditLossFinancialInstrumentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Loss, Financial Instrument [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditLossFinancialInstrumentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditLossFinancialInstrumentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditLossFinancialInstrumentPolicyTextBlock" xlink:to="lab_us-gaap_CreditLossFinancialInstrumentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_ae8fb6b0-ed69-4ccb-8194-01f043e1eb20_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_a891247f-f931-45d3-a575-7a5033f0b74e_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Self-Insurance Accruals</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_e3a881f7-810a-4d85-bbb3-6ef5dcd76e68_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseCurrent" xlink:to="lab_us-gaap_PrepaidExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_1aef3fc4-b0e5-4140-9475-f60266a35051_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregated revenues</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_f6317fa1-4b70-4120-810d-aad0619b7d6f_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_40d09d9f-3d80-4a40-a620-91d95a417fcd_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer contributions</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:to="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_99409b91-abfe-46b1-bc78-a3464c79d47c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Units</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_bf999f6d-e2ad-44ad-bb33-719091791f01_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockOtherSharesOutstanding_54989a45-ceff-4743-b3ff-b7e08a7b8135_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockOtherSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred stock units, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockOtherSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockOtherSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Other Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockOtherSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockOtherSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockOtherSharesOutstanding" xlink:to="lab_us-gaap_CommonStockOtherSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_2518d6ad-7451-4991-82b2-0e6a1bf4bcfd_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax credit carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_bea5f411-f448-43bf-9e81-f8f8c806f960_netLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of shares for employee surrenders</link:label>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Decrease for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_2f982600-2a69-422c-9ce3-adffc7bb57dd_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for amounts included in the measurement of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_90cdd910-87af-44cd-9eb9-90853ffa2aa9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares authorized for grant under share-based incentive plans (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_AsiaPacificRegionOtherMember_eabc2ae6-b836-4fa3-9a6e-a5af39f069c9_terseLabel_en-US" xlink:label="lab_idxx_AsiaPacificRegionOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_idxx_AsiaPacificRegionOtherMember_label_en-US" xlink:label="lab_idxx_AsiaPacificRegionOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific Region, Other [Member]</link:label>
    <link:label id="lab_idxx_AsiaPacificRegionOtherMember_documentation_en-US" xlink:label="lab_idxx_AsiaPacificRegionOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific Region, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_AsiaPacificRegionOtherMember" xlink:href="idxx-20211231.xsd#idxx_AsiaPacificRegionOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_AsiaPacificRegionOtherMember" xlink:to="lab_idxx_AsiaPacificRegionOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_2f16b1b6-8f6c-47dd-8b57-e01d67310e21_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Costs</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_a96228c1-e32b-44b7-a1ed-3482c16d1f34_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price of acquired assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax_87b800b4-0bfb-4311-bbe0-613e9b296cc6_terseLabel_en-US" xlink:label="lab_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on cross currency swaps, net of tax expense of $1,699 in 2021, $(1,774) in 2020 and $664 in 2019</link:label>
    <link:label id="lab_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax_949471d6-d04e-47f7-9b1d-f1cd49009af8_verboseLabel_en-US" xlink:label="lab_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on cross currency swaps, net of tax</link:label>
    <link:label id="lab_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax_label_en-US" xlink:label="lab_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Cross Currency Swaps, Gain (Loss), Before Reclassification, After Tax</link:label>
    <link:label id="lab_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax_documentation_en-US" xlink:label="lab_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Cross Currency Swaps, Gain (Loss), Before Reclassification, After Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax" xlink:href="idxx-20211231.xsd#idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax" xlink:to="lab_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_7a3f1b93-613b-4d5a-be93-729aed49f0fc_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_793c5238-14c8-4d2d-a412-3b0a29824352_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_0963f43b-5001-43ba-843c-3791695bcab9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_label_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Activities, Cash Flow Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:to="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockTextBlock_f37e3db4-31ab-4f87-8121-18f46a984a80_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchases of Common Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockTextBlock_label_en-US" xlink:label="lab_us-gaap_TreasuryStockTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockTextBlock" xlink:to="lab_us-gaap_TreasuryStockTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_TreasuryStockSharesAcquiredNetOfTaxWithholdings_f9275eb0-8122-49d4-938e-222398ff4433_terseLabel_en-US" xlink:label="lab_idxx_TreasuryStockSharesAcquiredNetOfTaxWithholdings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchased during the period (in shares)</link:label>
    <link:label id="lab_idxx_TreasuryStockSharesAcquiredNetOfTaxWithholdings_label_en-US" xlink:label="lab_idxx_TreasuryStockSharesAcquiredNetOfTaxWithholdings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired, Net Of Tax Withholdings</link:label>
    <link:label id="lab_idxx_TreasuryStockSharesAcquiredNetOfTaxWithholdings_documentation_en-US" xlink:label="lab_idxx_TreasuryStockSharesAcquiredNetOfTaxWithholdings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Open market common stock repurchases.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_TreasuryStockSharesAcquiredNetOfTaxWithholdings" xlink:href="idxx-20211231.xsd#idxx_TreasuryStockSharesAcquiredNetOfTaxWithholdings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_TreasuryStockSharesAcquiredNetOfTaxWithholdings" xlink:to="lab_idxx_TreasuryStockSharesAcquiredNetOfTaxWithholdings" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_DeferredStockUnitsMember_16b3574d-bb5b-4b85-87a5-30b567ce2eb1_terseLabel_en-US" xlink:label="lab_idxx_DeferredStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Stock Units</link:label>
    <link:label id="lab_idxx_DeferredStockUnitsMember_label_en-US" xlink:label="lab_idxx_DeferredStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Stock Units [Member]</link:label>
    <link:label id="lab_idxx_DeferredStockUnitsMember_documentation_en-US" xlink:label="lab_idxx_DeferredStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Stock Units [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_DeferredStockUnitsMember" xlink:href="idxx-20211231.xsd#idxx_DeferredStockUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_DeferredStockUnitsMember" xlink:to="lab_idxx_DeferredStockUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_f67aa22d-7132-452c-9d46-4092014f8eb3_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_15c39c07-a8b7-44d7-a56d-857a1392975c_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_8ae6f9c9-6c00-414f-9b25-705ad09d2aac_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AmericasMember_ab6fecd7-cf66-4343-aec9-5ac8bbc3cde1_terseLabel_en-US" xlink:label="lab_srt_AmericasMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Americas</link:label>
    <link:label id="lab_srt_AmericasMember_label_en-US" xlink:label="lab_srt_AmericasMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Americas [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AmericasMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AmericasMember" xlink:to="lab_srt_AmericasMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_7581ef07-d3d6-4766-9e93-b6d8fece3db0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Award, Tranche One</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_ece2c55e-3c61-40f6-8e2c-fde4e551f7cb_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_84799821-1735-440c-9313-2080b558c4cf_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_e3d65377-ed0d-4ca0-8aac-8757840cbea3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price of options exercised (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceMember_b4e57f9e-a8a9-41ef-a8be-5387fec2e6a6_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service revenue</link:label>
    <link:label id="lab_us-gaap_ServiceMember_label_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceMember" xlink:to="lab_us-gaap_ServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection_090acdc2-6f69-41f2-87d8-345ee6a6a62a_totalLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging liabilities, net amount</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Fair Value, Offset Against Collateral, Net of Not Subject to Master Netting Arrangement, Policy Election</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection" xlink:to="lab_us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_8ccc2ab7-8125-4bf1-ada4-150629522d3e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_021a8598-ebd1-433c-b1f1-e71a46bfdc9c_negatedLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit resulting from settlement of share-based awards</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Exercise of Option, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_ReferenceLaboratoryDiagnosticAndConsultingServicesMember_9ded4a7e-208f-4a06-b116-39dc00ade7b0_terseLabel_en-US" xlink:label="lab_idxx_ReferenceLaboratoryDiagnosticAndConsultingServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reference laboratory diagnostic and consulting services</link:label>
    <link:label id="lab_idxx_ReferenceLaboratoryDiagnosticAndConsultingServicesMember_label_en-US" xlink:label="lab_idxx_ReferenceLaboratoryDiagnosticAndConsultingServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reference Laboratory Diagnostic And Consulting Services [Member]</link:label>
    <link:label id="lab_idxx_ReferenceLaboratoryDiagnosticAndConsultingServicesMember_documentation_en-US" xlink:label="lab_idxx_ReferenceLaboratoryDiagnosticAndConsultingServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reference Laboratory Diagnostic And Consulting Services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ReferenceLaboratoryDiagnosticAndConsultingServicesMember" xlink:href="idxx-20211231.xsd#idxx_ReferenceLaboratoryDiagnosticAndConsultingServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_ReferenceLaboratoryDiagnosticAndConsultingServicesMember" xlink:to="lab_idxx_ReferenceLaboratoryDiagnosticAndConsultingServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_f25b8551-adac-4a23-90ab-132d28bb1e95_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_fc9d06c4-266f-408d-a723-7f583633c6fe_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of other current assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Current Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_d01e153e-2562-40e3-95bf-d1b79f6a4ea4_totalLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cost of shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_939126f4-681e-4cc1-b433-d376de461a8f_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_9713c58d-274b-4d38-a302-6622da5b7c8e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_3230f66a-d3fd-434a-a640-473be1edc8a8_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average cost per share - total (in USD per share)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_label_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired, Average Cost Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:to="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_4139ef0b-1b3b-4c3d-a660-1f1a2ba372d3_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_53ddad3d-5e43-46cb-95cd-cf72a41f89c4_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets and liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_07c9c33f-5f3b-4322-ba1e-4c9651d2bbab_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_eafcd38c-894e-4cfc-9a77-373533ca1763_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_31581724-80c4-4374-b5dc-438aa6e797c9_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net effect of changes in exchange rates on cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_4b8491ba-f6ec-4899-9d41-6313c8465e09_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_66cc702c-a8e0-413f-9a91-23626aa6363c_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_171beac0-f75c-46c9-a3f3-60f99f2fcfea_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_7db0d371-3b96-4010-adb0-1a04b1adf5f5_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares of preferred stock authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_bee6259a-53b9-4588-b28e-5325aa1f2ffd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected stock price volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_dc7a12f7-c598-4036-bddd-d46c6b697f3c_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrentAbstract_50b21456-7ce4-424b-9ec0-606f0f23b9e8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract" xlink:to="lab_us-gaap_OtherAssetsNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_52acb8dd-4a98-44aa-9936-5b6110ee9872_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_adf01d52-8065-4308-ba79-3bc49fe5fcb2_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_965dfacd-c8ec-4f01-97a5-f7083b1d4373_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation accelerated expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Accelerated Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_4a29b3b6-f69d-4775-81da-440a2fe747db_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions of businesses, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_dda08189-2707-458d-ac01-f2323d00ab97_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_ff0f5dd3-d06c-46ad-8d71-30b2f7621a4d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of components of provision (benefit) for income taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_87ecdf43-2e0c-4276-92eb-d928502a528f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount from market value for employee stock purchase rights</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Offering Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_27a9ebb3-d195-4afa-9f56-5359ef95308c_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_2f2c721b-2154-4261-b0da-35ee4bbb7926_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_a8e54a61-a385-41c2-9eb8-f321f6f37032_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Unobservable Inputs (Level 3)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditLossFinancialInstrumentTextBlock_8c85e55b-16f2-4d24-8e66-dc8129662499_terseLabel_en-US" xlink:label="lab_us-gaap_CreditLossFinancialInstrumentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Losses</link:label>
    <link:label id="lab_us-gaap_CreditLossFinancialInstrumentTextBlock_label_en-US" xlink:label="lab_us-gaap_CreditLossFinancialInstrumentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Loss, Financial Instrument [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditLossFinancialInstrumentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditLossFinancialInstrumentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditLossFinancialInstrumentTextBlock" xlink:to="lab_us-gaap_CreditLossFinancialInstrumentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_c7939440-f937-4940-83e1-e1e7827e57ea_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of business segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationTax_457634d1-94b3-4a09-b665-0480a8373b98_terseLabel_en-US" xlink:label="lab_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on cross currency swaps, tax expense (benefit)</link:label>
    <link:label id="lab_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationTax_label_en-US" xlink:label="lab_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Cross Currency Swaps, Gain (Loss), Before Reclassification, Tax</link:label>
    <link:label id="lab_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationTax_documentation_en-US" xlink:label="lab_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Cross Currency Swaps, Gain (Loss), Before Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationTax" xlink:href="idxx-20211231.xsd#idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationTax" xlink:to="lab_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_96dd3384-b05a-40db-9817-33190ee65140_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue:</link:label>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_label_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenueAbstract" xlink:to="lab_us-gaap_CostOfRevenueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_abc5df53-5278-40b0-8116-f2c94e5e04e0_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding letters of credit to insurance company as security for workers' compensation claims</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_6cfec307-06ee-4835-831e-38f42585cbee_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency gains (losses)</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_690ccf44-6ea6-4992-ac10-ae621827c6cf_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNetAbstract_7085bb20-4017-43d4-b5e8-dd10580fa1bd_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryNetAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNetAbstract" xlink:to="lab_us-gaap_InventoryNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_bf3c1bce-60cd-4e81-8beb-95bbe0e8dd9b_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combinations</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_6c458850-bc06-4ae0-a953-bc7706879f2c_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies (Note 16)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod_ddbff49f-26b8-45aa-90f0-6a2719b8b495_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchases of common stock, net</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Par Value Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredParValueMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsNoncurrent_6c07da34-68ed-4d5b-84d2-d76d4ccb0e13_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term assets</link:label>
    <link:label id="lab_us-gaap_AssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_AssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrent" xlink:to="lab_us-gaap_AssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b1512c56-12d2-417e-9626-09bc2c172a43_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_eb3840e8-f09e-4761-b006-1345dcbdee9c_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_6a370569-463b-4c46-b979-0d66dc5c9826_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, allowance</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_09c1aa06-c8cc-44bf-a009-7b8c6879fc04_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued taxes</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_6ef29e16-da48-4b01-87dd-cf7aa2763375_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201613Member_2c6f147b-3c53-4801-94e0-2540b2244dc9_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-13</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201613Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-13 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201613Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_db7963d1-b204-4a2d-ad75-596e8d73b6a1_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_3b5b61b6-c9bc-4b76-a38c-e56c9a2224a7_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_5bb5fa00-3551-403a-b7e5-dcf2c769a83f_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_51b8e478-2f02-48cd-b714-d9f45b8850cb_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_70e1e2e9-cb5e-474d-a261-a2eed309289a_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_0bff45b7-4a62-4fa5-a383-db22e9b00deb_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, shares (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_fb35e59d-4fa8-4fb6-8631-9d7794b2c421_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_086fa583-9279-47b0-8181-edb9b1cafc0a_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_CompanionAnimalGroupSegmentMember_bb868ee2-0216-4db4-9c5a-0899d23c222d_verboseLabel_en-US" xlink:label="lab_idxx_CompanionAnimalGroupSegmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CAG segment revenue</link:label>
    <link:label id="lab_idxx_CompanionAnimalGroupSegmentMember_c8a5f4ea-60a1-47c4-bcf4-cf2a20d81c72_terseLabel_en-US" xlink:label="lab_idxx_CompanionAnimalGroupSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CAG</link:label>
    <link:label id="lab_idxx_CompanionAnimalGroupSegmentMember_label_en-US" xlink:label="lab_idxx_CompanionAnimalGroupSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Companion Animal Group Segment [Member]</link:label>
    <link:label id="lab_idxx_CompanionAnimalGroupSegmentMember_documentation_en-US" xlink:label="lab_idxx_CompanionAnimalGroupSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Companion Animal Group Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_CompanionAnimalGroupSegmentMember" xlink:href="idxx-20211231.xsd#idxx_CompanionAnimalGroupSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_CompanionAnimalGroupSegmentMember" xlink:to="lab_idxx_CompanionAnimalGroupSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_NineteenNinetySevenEmployeeStockPurchasePlanMember_3b63863c-65f9-4ff2-b5be-99c1928fb1d2_terseLabel_en-US" xlink:label="lab_idxx_NineteenNinetySevenEmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1997 Employee Stock Purchase Plan</link:label>
    <link:label id="lab_idxx_NineteenNinetySevenEmployeeStockPurchasePlanMember_label_en-US" xlink:label="lab_idxx_NineteenNinetySevenEmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nineteen Ninety Seven Employee Stock Purchase Plan [Member]</link:label>
    <link:label id="lab_idxx_NineteenNinetySevenEmployeeStockPurchasePlanMember_documentation_en-US" xlink:label="lab_idxx_NineteenNinetySevenEmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nineteen Ninety Seven Employee Stock Purchase Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_NineteenNinetySevenEmployeeStockPurchasePlanMember" xlink:href="idxx-20211231.xsd#idxx_NineteenNinetySevenEmployeeStockPurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_NineteenNinetySevenEmployeeStockPurchasePlanMember" xlink:to="lab_idxx_NineteenNinetySevenEmployeeStockPurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OfficeEquipmentMember_4eccd4f9-3aec-496d-bce4-162979543395_terseLabel_en-US" xlink:label="lab_us-gaap_OfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office furniture and equipment</link:label>
    <link:label id="lab_us-gaap_OfficeEquipmentMember_label_en-US" xlink:label="lab_us-gaap_OfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OfficeEquipmentMember" xlink:to="lab_us-gaap_OfficeEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_8e4b6cd8-9e21-426e-812f-8c4a4e39034f_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_86cdadb1-1d1d-4feb-a0bc-ad2c1218d92d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_b28205c4-f42e-4554-abd3-252d3c477f54_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_5092cc7d-8865-4e11-84a3-c8157b11bc61_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_d7b1d62d-02d9-417d-a789-2014722456a0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_12d4e80c-1966-4ac5-9950-5705a53e0725_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discretionary contributions</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Discretionary Contribution Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_628d8d57-ea60-4d3b-a39d-3b1807f5edb7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivablesPeriodPastDueAxis_c2bc36a2-ca3a-4452-9f24-9166ae3dc327_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivablesPeriodPastDueAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Asset, Period Past Due [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancingReceivablesPeriodPastDueAxis_label_en-US" xlink:label="lab_us-gaap_FinancingReceivablesPeriodPastDueAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Asset, Aging [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivablesPeriodPastDueAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivablesPeriodPastDueAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivablesPeriodPastDueAxis" xlink:to="lab_us-gaap_FinancingReceivablesPeriodPastDueAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_68d835c5-ee1b-48d3-b7b5-2bb7da68056b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockOtherValueOutstanding_d3724bd9-6000-4ed5-bd60-08916cccbeb5_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockOtherValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred stock units: Outstanding: 90 units in 2021 and 87 units in 2020</link:label>
    <link:label id="lab_us-gaap_CommonStockOtherValueOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockOtherValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Other Value, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockOtherValueOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockOtherValueOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockOtherValueOutstanding" xlink:to="lab_us-gaap_CommonStockOtherValueOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_36d32565-5066-4c9f-8b70-37a4cc40399b_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_03a867a4-72cb-4562-95bc-efc8ad06f52a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMember_0e4b1016-5644-4155-b0af-9ca355a34104_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMember_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMember" xlink:to="lab_us-gaap_LongTermDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_09b8b600-99bf-47a9-aff7-b2f6edac2553_terseLabel_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_label_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:to="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_025ecef5-8989-4a98-8f5f-17d7b96403a3_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_378ce32e-86cf-41d2-b85b-57a429a6c481_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-based intangible assets</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_85a337cd-7a82-4286-8a00-607b035f7a68_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_ed8de09f-3427-4d2f-aa47-a7de6c3e403d_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_c7497217-7e27-4147-848b-2f7b45356589_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of restricted stock unit activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_8d3073d6-844a-4cc4-a5a3-794f794dd82f_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charge</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_f357753b-69d4-4268-b5e1-02054aa2e321_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_9e486ddd-2f1c-46c7-89c7-4aac6f23687a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness_3b831dcc-fb99-4fed-9870-c1b6ea9082d8_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on excluded component as a reduction of interest expense</link:label>
    <link:label id="lab_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness_label_en-US" xlink:label="lab_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Components Excluded from Assessment of Interest Rate Cash Flow Hedge Effectiveness</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness" xlink:to="lab_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditLossAbstract_label_en-US" xlink:label="lab_us-gaap_CreditLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Loss [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditLossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditLossAbstract" xlink:to="lab_us-gaap_CreditLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2fa45cb8-5b0b-45db-9c05-a7cbc381793d_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_a633a2ac-3505-435f-9568-fada63ad7add_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_3f16fda8-6650-426d-af13-d15feb00e601_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_79dfd455-5e81-4cf4-bbd2-bc124781f61a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price of options granted (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_b3373b7e-1f98-47dd-919e-a3431f2d424d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_A2029SeriesCNotesMember_5efda4c1-4a29-4800-90d8-41aa2d2b1661_terseLabel_en-US" xlink:label="lab_idxx_A2029SeriesCNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2029 Series C Notes</link:label>
    <link:label id="lab_idxx_A2029SeriesCNotesMember_label_en-US" xlink:label="lab_idxx_A2029SeriesCNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2029 Series C Notes [Member]</link:label>
    <link:label id="lab_idxx_A2029SeriesCNotesMember_documentation_en-US" xlink:label="lab_idxx_A2029SeriesCNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2029 Series C Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_A2029SeriesCNotesMember" xlink:href="idxx-20211231.xsd#idxx_A2029SeriesCNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_A2029SeriesCNotesMember" xlink:to="lab_idxx_A2029SeriesCNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_da2f0306-3bc9-47c2-bc59-88dbf6474273_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards in certain state and international jurisdictions</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_ea53f217-c475-4235-b9c9-a1dca4f2b3c2_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_692070bd-7ec9-4537-8bf1-138f6a09dcdd_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_186ba38e-f8a8-4638-bf40-53b321493972_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_d7c868c6-9c45-4333-9246-cbe4a0123a02_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="lab_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_BusinessCombinationContingentConsiderationHoldback_cfb2f99d-1f3a-4a2f-bd4c-e1987ea21321_terseLabel_en-US" xlink:label="lab_idxx_BusinessCombinationContingentConsiderationHoldback" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Holdback</link:label>
    <link:label id="lab_idxx_BusinessCombinationContingentConsiderationHoldback_label_en-US" xlink:label="lab_idxx_BusinessCombinationContingentConsiderationHoldback" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Holdback</link:label>
    <link:label id="lab_idxx_BusinessCombinationContingentConsiderationHoldback_documentation_en-US" xlink:label="lab_idxx_BusinessCombinationContingentConsiderationHoldback" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Holdback</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_BusinessCombinationContingentConsiderationHoldback" xlink:href="idxx-20211231.xsd#idxx_BusinessCombinationContingentConsiderationHoldback"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_BusinessCombinationContingentConsiderationHoldback" xlink:to="lab_idxx_BusinessCombinationContingentConsiderationHoldback" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_f69c078a-d8c3-476d-90b7-c35745557621_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_BusinessCombinationContingentConsiderationLiabilityAndHoldback_3107eee7-28db-459e-b523-fea64bbebf0e_terseLabel_en-US" xlink:label="lab_idxx_BusinessCombinationContingentConsiderationLiabilityAndHoldback" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent payment and holdback</link:label>
    <link:label id="lab_idxx_BusinessCombinationContingentConsiderationLiabilityAndHoldback_label_en-US" xlink:label="lab_idxx_BusinessCombinationContingentConsiderationLiabilityAndHoldback" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability and Holdback</link:label>
    <link:label id="lab_idxx_BusinessCombinationContingentConsiderationLiabilityAndHoldback_documentation_en-US" xlink:label="lab_idxx_BusinessCombinationContingentConsiderationLiabilityAndHoldback" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability and Holdback</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_BusinessCombinationContingentConsiderationLiabilityAndHoldback" xlink:href="idxx-20211231.xsd#idxx_BusinessCombinationContingentConsiderationLiabilityAndHoldback"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_BusinessCombinationContingentConsiderationLiabilityAndHoldback" xlink:to="lab_idxx_BusinessCombinationContingentConsiderationLiabilityAndHoldback" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseIncome_bca2967a-9dbd-41fe-8f64-5b06c424b5e7_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease revenue</link:label>
    <link:label id="lab_us-gaap_LeaseIncome_label_en-US" xlink:label="lab_us-gaap_LeaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseIncome" xlink:to="lab_us-gaap_LeaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit_0a744ce9-28e5-4f83-a8f2-6e17f058ea5d_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings (repayments) on revolving credit facilities, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_24a50676-17f1-4919-855c-8081dfdd8a7e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralInsuranceExpense_c8c3e8e4-3e5c-4fcb-9294-6e4c6b33ccc3_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralInsuranceExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General insurance expense</link:label>
    <link:label id="lab_us-gaap_GeneralInsuranceExpense_label_en-US" xlink:label="lab_us-gaap_GeneralInsuranceExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General Insurance Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralInsuranceExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralInsuranceExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralInsuranceExpense" xlink:to="lab_us-gaap_GeneralInsuranceExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_2c0f1ce1-567e-4552-a638-c949cf56e4d2_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_319e205a-c4b6-4b57-8b1b-5b99f4b351f0_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_OperatingLeaseLeaseNotyetCommencedExpense_5e9c1b67-1ec6-4fc3-afd7-8cff6a2ca74c_terseLabel_en-US" xlink:label="lab_idxx_OperatingLeaseLeaseNotyetCommencedExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total minimum future lease payments, leases not yet commenced</link:label>
    <link:label id="lab_idxx_OperatingLeaseLeaseNotyetCommencedExpense_label_en-US" xlink:label="lab_idxx_OperatingLeaseLeaseNotyetCommencedExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Lease Not yet Commenced, Expense</link:label>
    <link:label id="lab_idxx_OperatingLeaseLeaseNotyetCommencedExpense_documentation_en-US" xlink:label="lab_idxx_OperatingLeaseLeaseNotyetCommencedExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Lease Not yet Commenced, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_OperatingLeaseLeaseNotyetCommencedExpense" xlink:href="idxx-20211231.xsd#idxx_OperatingLeaseLeaseNotyetCommencedExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_OperatingLeaseLeaseNotyetCommencedExpense" xlink:to="lab_idxx_OperatingLeaseLeaseNotyetCommencedExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_f15b1696-f5c2-4e22-9a9e-9270e82ff796_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesMember" xlink:to="lab_us-gaap_AccruedLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_6eeb7e44-9cf8-453e-a110-36691e721945_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_5ab73e19-84de-490f-b7a2-3182d6efc810_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_aac97701-2100-4313-87f8-3642fdb184a8_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_label_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostAmortization_63b898bf-7356-43ef-bca0-cd0298b11aba_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized customer acquisition costs recognized as a reduction of revenue</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostAmortization_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostAmortization" xlink:to="lab_us-gaap_CapitalizedContractCostAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_VeterinarySoftwareServicesAndDiagnosticImagingSystemsMember_1b66366b-3143-426d-a138-6e68df9e1414_terseLabel_en-US" xlink:label="lab_idxx_VeterinarySoftwareServicesAndDiagnosticImagingSystemsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Veterinary software, services and diagnostic imaging systems</link:label>
    <link:label id="lab_idxx_VeterinarySoftwareServicesAndDiagnosticImagingSystemsMember_label_en-US" xlink:label="lab_idxx_VeterinarySoftwareServicesAndDiagnosticImagingSystemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Veterinary Software Services And Diagnostic Imaging Systems [Member]</link:label>
    <link:label id="lab_idxx_VeterinarySoftwareServicesAndDiagnosticImagingSystemsMember_documentation_en-US" xlink:label="lab_idxx_VeterinarySoftwareServicesAndDiagnosticImagingSystemsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Veterinary Software, Services and Diagnostic Imaging Systems [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_VeterinarySoftwareServicesAndDiagnosticImagingSystemsMember" xlink:href="idxx-20211231.xsd#idxx_VeterinarySoftwareServicesAndDiagnosticImagingSystemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_VeterinarySoftwareServicesAndDiagnosticImagingSystemsMember" xlink:to="lab_idxx_VeterinarySoftwareServicesAndDiagnosticImagingSystemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_ac34570a-cf27-467c-b39b-dd06a5bfe533_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_bbc24338-c7a6-49e2-82ca-ddc6eb014337_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_003effea-2589-48e5-9937-59463c2ad10d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_7d347667-0644-4bb5-a6ee-e0e46120972c_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued in connection with the Employee Stock Purchase Plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_d04f3613-aad3-4581-a498-8f7782e0be48_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CrossCurrencyInterestRateContractMember_791d4133-2365-4a93-91ac-1dd455a34270_terseLabel_en-US" xlink:label="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross currency swaps</link:label>
    <link:label id="lab_us-gaap_CrossCurrencyInterestRateContractMember_label_en-US" xlink:label="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CrossCurrencyInterestRateContractMember" xlink:to="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_afda8df1-6387-4f5b-8758-12406d3b22fe_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_2f14ea57-af97-4f04-bc03-ec1092529ebb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of contingent consideration liability</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_CashFlowHedgeHedgePercentageOfEstimatedExposureFromIntercompanyProductsPurchasesAndSales_a6b53002-a1ef-4cbf-8c2b-2041160a8a49_terseLabel_en-US" xlink:label="lab_idxx_CashFlowHedgeHedgePercentageOfEstimatedExposureFromIntercompanyProductsPurchasesAndSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flow hedge, hedge percentage of estimated exposure from intercompany products purchases and sales</link:label>
    <link:label id="lab_idxx_CashFlowHedgeHedgePercentageOfEstimatedExposureFromIntercompanyProductsPurchasesAndSales_label_en-US" xlink:label="lab_idxx_CashFlowHedgeHedgePercentageOfEstimatedExposureFromIntercompanyProductsPurchasesAndSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedge, Hedge Percentage Of Estimated Exposure From Intercompany Products Purchases And Sales</link:label>
    <link:label id="lab_idxx_CashFlowHedgeHedgePercentageOfEstimatedExposureFromIntercompanyProductsPurchasesAndSales_documentation_en-US" xlink:label="lab_idxx_CashFlowHedgeHedgePercentageOfEstimatedExposureFromIntercompanyProductsPurchasesAndSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated portion of hedged foreign currency exposure related to intercompany product purchases and sales.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_CashFlowHedgeHedgePercentageOfEstimatedExposureFromIntercompanyProductsPurchasesAndSales" xlink:href="idxx-20211231.xsd#idxx_CashFlowHedgeHedgePercentageOfEstimatedExposureFromIntercompanyProductsPurchasesAndSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_CashFlowHedgeHedgePercentageOfEstimatedExposureFromIntercompanyProductsPurchasesAndSales" xlink:to="lab_idxx_CashFlowHedgeHedgePercentageOfEstimatedExposureFromIntercompanyProductsPurchasesAndSales" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_A2025SeriesBNotesMember_5f2f7f67-eff8-4c04-af11-4f95e41999b4_terseLabel_en-US" xlink:label="lab_idxx_A2025SeriesBNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025 Series B Notes</link:label>
    <link:label id="lab_idxx_A2025SeriesBNotesMember_label_en-US" xlink:label="lab_idxx_A2025SeriesBNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025 Series B Notes [Member]</link:label>
    <link:label id="lab_idxx_A2025SeriesBNotesMember_documentation_en-US" xlink:label="lab_idxx_A2025SeriesBNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025 Series B Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_A2025SeriesBNotesMember" xlink:href="idxx-20211231.xsd#idxx_A2025SeriesBNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_A2025SeriesBNotesMember" xlink:to="lab_idxx_A2025SeriesBNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_AccountsReceivablePercentNotPastDue_1417b89a-fca0-4939-9004-9de3afd2d250_terseLabel_en-US" xlink:label="lab_idxx_AccountsReceivablePercentNotPastDue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of accounts receivable not past due</link:label>
    <link:label id="lab_idxx_AccountsReceivablePercentNotPastDue_label_en-US" xlink:label="lab_idxx_AccountsReceivablePercentNotPastDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Percent Not Past Due</link:label>
    <link:label id="lab_idxx_AccountsReceivablePercentNotPastDue_documentation_en-US" xlink:label="lab_idxx_AccountsReceivablePercentNotPastDue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Percent Not Past Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_AccountsReceivablePercentNotPastDue" xlink:href="idxx-20211231.xsd#idxx_AccountsReceivablePercentNotPastDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_AccountsReceivablePercentNotPastDue" xlink:to="lab_idxx_AccountsReceivablePercentNotPastDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_28b0a805-c5d3-4bcf-906f-17cb4a66c313_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ec843ac6-92f5-4507-8bc2-0b68d917ce9d_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_73242dfd-49bc-465b-af5c-a195fc1c6629_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance beginning of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5e6e8978-84d4-45aa-a294-8cc469c1b653_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance end of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e75b8a77-d053-4fc1-8f86-3682b1c1c0a3_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash cumulative effect adjustment to retained earnings, net of tax</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_RetirementAndIncentiveSavingsPlanTable_6c1d43b4-5e0c-476d-aaa1-d947631c923b_terseLabel_en-US" xlink:label="lab_idxx_RetirementAndIncentiveSavingsPlanTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement And Incentive Savings Plan [Table]</link:label>
    <link:label id="lab_idxx_RetirementAndIncentiveSavingsPlanTable_label_en-US" xlink:label="lab_idxx_RetirementAndIncentiveSavingsPlanTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement And Incentive Savings Plan [Table]</link:label>
    <link:label id="lab_idxx_RetirementAndIncentiveSavingsPlanTable_documentation_en-US" xlink:label="lab_idxx_RetirementAndIncentiveSavingsPlanTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement And Incentive Savings Plan [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_RetirementAndIncentiveSavingsPlanTable" xlink:href="idxx-20211231.xsd#idxx_RetirementAndIncentiveSavingsPlanTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_RetirementAndIncentiveSavingsPlanTable" xlink:to="lab_idxx_RetirementAndIncentiveSavingsPlanTable" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_VetLabConsumablesMember_496c1366-dd55-4864-84df-de1ff0819b95_terseLabel_en-US" xlink:label="lab_idxx_VetLabConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IDEXX VetLab consumables</link:label>
    <link:label id="lab_idxx_VetLabConsumablesMember_label_en-US" xlink:label="lab_idxx_VetLabConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">VetLab Consumables [Member]</link:label>
    <link:label id="lab_idxx_VetLabConsumablesMember_documentation_en-US" xlink:label="lab_idxx_VetLabConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vetlab Consumables [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_VetLabConsumablesMember" xlink:href="idxx-20211231.xsd#idxx_VetLabConsumablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_VetLabConsumablesMember" xlink:to="lab_idxx_VetLabConsumablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_81d0b9d4-a712-46bc-bbf3-acb74c89ea2b_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_15d3799f-76cf-48e7-8371-b0e0851a138a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_2706b5c2-2e77-4622-b416-922556da4399_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_A2024SeriesBNotesMember_d6b78030-89b9-4db8-8d28-a05a9a0bf393_terseLabel_en-US" xlink:label="lab_idxx_A2024SeriesBNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024 Series B Notes</link:label>
    <link:label id="lab_idxx_A2024SeriesBNotesMember_label_en-US" xlink:label="lab_idxx_A2024SeriesBNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024 Series B Notes [Member]</link:label>
    <link:label id="lab_idxx_A2024SeriesBNotesMember_documentation_en-US" xlink:label="lab_idxx_A2024SeriesBNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024 Series B Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_A2024SeriesBNotesMember" xlink:href="idxx-20211231.xsd#idxx_A2024SeriesBNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_A2024SeriesBNotesMember" xlink:to="lab_idxx_A2024SeriesBNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetNoncurrent_eb9c3e24-8726-48dc-96ae-035cd5aa9641_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract assets, net</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetNoncurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNetNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNetNoncurrent" xlink:to="lab_us-gaap_ContractWithCustomerAssetNetNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_ac9188e9-fec8-4aaf-bb71-ba8a73db278b_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_259ed8ca-5b5f-45d7-88f3-831372b8e34b_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_2416b40a-40d5-410d-9adf-844b85797bd4_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_f3dc6e7f-57dc-45de-9484-e3b65798ceab_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of segment performance</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7fd4ec07-664e-4a2e-9537-64add27c7c64_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_3ae0a1e3-11e7-44c5-9338-eda9a1b91465_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_649f8119-7bd1-4f2c-bdc8-769f4ef1f3c9_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_ShareBasedCompensationTable_450709c1-feba-4a68-b2ec-71d60cad68b7_terseLabel_en-US" xlink:label="lab_idxx_ShareBasedCompensationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation [Table]</link:label>
    <link:label id="lab_idxx_ShareBasedCompensationTable_label_en-US" xlink:label="lab_idxx_ShareBasedCompensationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation [Table]</link:label>
    <link:label id="lab_idxx_ShareBasedCompensationTable_documentation_en-US" xlink:label="lab_idxx_ShareBasedCompensationTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ShareBasedCompensationTable" xlink:href="idxx-20211231.xsd#idxx_ShareBasedCompensationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_ShareBasedCompensationTable" xlink:to="lab_idxx_ShareBasedCompensationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_b559b832-7db6-4f29-8f07-d653493b2acb_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_116a71ba-ecbe-4493-a329-06834f8ed622_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Par value per share (in USD per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_AwardsOtherThanStockOptionsAndStockAppreciationRightsMember_9e8742a7-fc2e-41ed-8d79-ea8446195695_terseLabel_en-US" xlink:label="lab_idxx_AwardsOtherThanStockOptionsAndStockAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards other than stock options and stock appreciation rights</link:label>
    <link:label id="lab_idxx_AwardsOtherThanStockOptionsAndStockAppreciationRightsMember_label_en-US" xlink:label="lab_idxx_AwardsOtherThanStockOptionsAndStockAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Other Than Stock Options And Stock Appreciation Rights [Member]</link:label>
    <link:label id="lab_idxx_AwardsOtherThanStockOptionsAndStockAppreciationRightsMember_documentation_en-US" xlink:label="lab_idxx_AwardsOtherThanStockOptionsAndStockAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Other Than Stock Options And Stock Appreciation Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_AwardsOtherThanStockOptionsAndStockAppreciationRightsMember" xlink:href="idxx-20211231.xsd#idxx_AwardsOtherThanStockOptionsAndStockAppreciationRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_AwardsOtherThanStockOptionsAndStockAppreciationRightsMember" xlink:to="lab_idxx_AwardsOtherThanStockOptionsAndStockAppreciationRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_13240c94-cdd3-4a86-b0b5-815870798771_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_79c4e03f-7bcd-4ac9-aff8-e04d54915897_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_DeferredTaxAssetsValuationAllowanceWriteOffCashPayments_205c2bc0-850f-4462-b034-d1c991f55e39_negatedTerseLabel_en-US" xlink:label="lab_idxx_DeferredTaxAssetsValuationAllowanceWriteOffCashPayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-off/cash payments</link:label>
    <link:label id="lab_idxx_DeferredTaxAssetsValuationAllowanceWriteOffCashPayments_label_en-US" xlink:label="lab_idxx_DeferredTaxAssetsValuationAllowanceWriteOffCashPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance, Write-off/Cash Payments</link:label>
    <link:label id="lab_idxx_DeferredTaxAssetsValuationAllowanceWriteOffCashPayments_documentation_en-US" xlink:label="lab_idxx_DeferredTaxAssetsValuationAllowanceWriteOffCashPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance, Write-off/Cash Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_DeferredTaxAssetsValuationAllowanceWriteOffCashPayments" xlink:href="idxx-20211231.xsd#idxx_DeferredTaxAssetsValuationAllowanceWriteOffCashPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_DeferredTaxAssetsValuationAllowanceWriteOffCashPayments" xlink:to="lab_idxx_DeferredTaxAssetsValuationAllowanceWriteOffCashPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_a6de6e27-1119-4fe0-94e7-65a59f44b7a9_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and Marketing Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpense" xlink:to="lab_us-gaap_SellingAndMarketingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_44da0eff-1a3e-412e-b668-af2fbab45cb3_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_293325bc-91fb-4136-b463-b3b7646c8b82_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_AccumulatedNetGainLossFromNetInvestmentHedgesCrossCurrencySwapsIncludingPortionAttributableToNoncontrollingInterestMember_6559f78d-262e-4013-b6c6-62dc49a1a9ab_terseLabel_en-US" xlink:label="lab_idxx_AccumulatedNetGainLossFromNetInvestmentHedgesCrossCurrencySwapsIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized (Loss) Gain on Net Investment Hedges, Net of Tax, Cross Currency Swaps</link:label>
    <link:label id="lab_idxx_AccumulatedNetGainLossFromNetInvestmentHedgesCrossCurrencySwapsIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_idxx_AccumulatedNetGainLossFromNetInvestmentHedgesCrossCurrencySwapsIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Net Gain (Loss) From Net Investment Hedges, Cross Currency Swaps, Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:label id="lab_idxx_AccumulatedNetGainLossFromNetInvestmentHedgesCrossCurrencySwapsIncludingPortionAttributableToNoncontrollingInterestMember_documentation_en-US" xlink:label="lab_idxx_AccumulatedNetGainLossFromNetInvestmentHedgesCrossCurrencySwapsIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Net Gain (Loss) From Net Investment Hedges, Cross Currency Swaps, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_AccumulatedNetGainLossFromNetInvestmentHedgesCrossCurrencySwapsIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="idxx-20211231.xsd#idxx_AccumulatedNetGainLossFromNetInvestmentHedgesCrossCurrencySwapsIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_AccumulatedNetGainLossFromNetInvestmentHedgesCrossCurrencySwapsIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_idxx_AccumulatedNetGainLossFromNetInvestmentHedgesCrossCurrencySwapsIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_76328327-5f9b-4dde-85c2-1e239483ceef_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossAfterReclassificationAndTax_8c7529e1-bb43-4aef-b7fb-1b6c8d64dc97_totalLabel_en-US" xlink:label="lab_idxx_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on derivative instruments</link:label>
    <link:label id="lab_idxx_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_idxx_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge And Net Investment Hedge, Gain (Loss), After Reclassification And Tax</link:label>
    <link:label id="lab_idxx_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossAfterReclassificationAndTax_documentation_en-US" xlink:label="lab_idxx_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge And Net Investment Hedge, Gain (Loss), After Reclassification And Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossAfterReclassificationAndTax" xlink:href="idxx-20211231.xsd#idxx_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_idxx_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_ed95438c-6bbe-44d4-a931-c3a6a31a4331_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_be71f9c7-9c62-43f7-b30e-33fe31289611_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of hedging instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits_efee4b28-8884-441f-b78e-ab8bf6aed8f7_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee agreement contingencies</link:label>
    <link:label id="lab_us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits_label_en-US" xlink:label="lab_us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Unemployment Benefits, Severance Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits" xlink:to="lab_us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_12705fd8-11dc-4957-9de6-363f77738aed_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_TeleradiologyBusinessMember_36eaa5a5-6062-4945-b5e4-a1ab519def0a_terseLabel_en-US" xlink:label="lab_idxx_TeleradiologyBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Teleradiology Business</link:label>
    <link:label id="lab_idxx_TeleradiologyBusinessMember_label_en-US" xlink:label="lab_idxx_TeleradiologyBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Teleradiology Business [Member]</link:label>
    <link:label id="lab_idxx_TeleradiologyBusinessMember_documentation_en-US" xlink:label="lab_idxx_TeleradiologyBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Teleradiology Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_TeleradiologyBusinessMember" xlink:href="idxx-20211231.xsd#idxx_TeleradiologyBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_TeleradiologyBusinessMember" xlink:to="lab_idxx_TeleradiologyBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAbstract_fe8c1556-4478-4952-9550-2ccbdfdc84c3_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7efd46dc-b3f6-4e0c-97ad-ea5926bfd26c_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_26858a3d-fb67-425d-891e-6542d6fc0958_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_8db2c849-82ea-4f23-a0bc-6b6cd0ce1019_periodStartLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of year</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_74a617f5-bffc-4225-ab45-3174a3c809d9_periodEndLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at the end of the year</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_NoncontrollingInterestOwnershipPercentageAcquiredFromNoncontrollingOwners_1c54048d-b095-42e7-861a-0e3140171b6d_terseLabel_en-US" xlink:label="lab_idxx_NoncontrollingInterestOwnershipPercentageAcquiredFromNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest, remaining percentage purchased from noncontrolling owners</link:label>
    <link:label id="lab_idxx_NoncontrollingInterestOwnershipPercentageAcquiredFromNoncontrollingOwners_label_en-US" xlink:label="lab_idxx_NoncontrollingInterestOwnershipPercentageAcquiredFromNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage Acquired From Noncontrolling Owners</link:label>
    <link:label id="lab_idxx_NoncontrollingInterestOwnershipPercentageAcquiredFromNoncontrollingOwners_documentation_en-US" xlink:label="lab_idxx_NoncontrollingInterestOwnershipPercentageAcquiredFromNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage Acquired From Noncontrolling Owners</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_NoncontrollingInterestOwnershipPercentageAcquiredFromNoncontrollingOwners" xlink:href="idxx-20211231.xsd#idxx_NoncontrollingInterestOwnershipPercentageAcquiredFromNoncontrollingOwners"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_NoncontrollingInterestOwnershipPercentageAcquiredFromNoncontrollingOwners" xlink:to="lab_idxx_NoncontrollingInterestOwnershipPercentageAcquiredFromNoncontrollingOwners" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LinesOfCreditCurrent_4922e67d-191d-43a0-a62d-8b47779551a8_terseLabel_en-US" xlink:label="lab_us-gaap_LinesOfCreditCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit</link:label>
    <link:label id="lab_us-gaap_LinesOfCreditCurrent_74796606-b47d-4594-8358-9b720ebf06f0_verboseLabel_en-US" xlink:label="lab_us-gaap_LinesOfCreditCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding credit facility balance</link:label>
    <link:label id="lab_us-gaap_LinesOfCreditCurrent_label_en-US" xlink:label="lab_us-gaap_LinesOfCreditCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LinesOfCreditCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LinesOfCreditCurrent" xlink:to="lab_us-gaap_LinesOfCreditCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_5a01a828-34b1-446b-a177-132e77ec3713_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IDEXX Retirement and Incentive Savings Plan</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade_141049f0-50ad-4f6f-a040-00c5b7e3545c_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable, Trade</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_a0f49d1a-8013-4bc4-a0e3-5d3041513abe_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_057461ac-e882-41d7-bd93-d6c500a4710f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_9d5a7116-84dd-441f-8a17-ca0d015ba193_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_3bad8e7f-ae85-493c-b6c3-48d8832c4fff_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_2bbe0e17-a7b0-4273-8eb5-e46b531bb552_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of selected financial impact of share-based compensation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingAxis_8ff5c1d8-358b-4243-92cb-7c833a09317d_terseLabel_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:label id="lab_us-gaap_VestingAxis_label_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingAxis" xlink:to="lab_us-gaap_VestingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_95061a6b-7e0c-457c-bcf9-4f07e987675b_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated net amount of gains expected to be reclassified out of accumulated other comprehensive income and into earnings within next 12 months</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:to="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_87dbe0f1-85e1-4d50-8584-cf4f5c7737d5_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL ASSETS</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent_bd18ede7-be77-4ff2-b636-4e1acdce3001_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued long-term expenses</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_21420ef0-9cb8-4bad-9dac-4335d1c8624a_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_4c8f199f-9982-4eda-8cf1-7abe86ba0a69_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_AuditInformationAbstract_label_en-US" xlink:label="lab_idxx_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:label id="lab_idxx_AuditInformationAbstract_documentation_en-US" xlink:label="lab_idxx_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_AuditInformationAbstract" xlink:href="idxx-20211231.xsd#idxx_AuditInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_AuditInformationAbstract" xlink:to="lab_idxx_AuditInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_eee3f781-0c6a-4555-896e-a67216067ccf_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_aca1aeb2-a2a9-4d06-9693-1938e9336a36_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_e90dbf1b-bd28-4eeb-a840-c509c6183892_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_f5505635-de08-43a9-81ce-225b72320f75_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrent" xlink:to="lab_us-gaap_LiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_7e0e11e2-de90-46dc-8870-b9a8be3e92e8_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_EmployeeHealthCareInsurancePolicyMember_ff07842d-c15b-48d3-9417-72aa7b261e98_terseLabel_en-US" xlink:label="lab_idxx_EmployeeHealthCareInsurancePolicyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee healthcare insurance policy</link:label>
    <link:label id="lab_idxx_EmployeeHealthCareInsurancePolicyMember_label_en-US" xlink:label="lab_idxx_EmployeeHealthCareInsurancePolicyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Health Care Insurance Policy [Member]</link:label>
    <link:label id="lab_idxx_EmployeeHealthCareInsurancePolicyMember_documentation_en-US" xlink:label="lab_idxx_EmployeeHealthCareInsurancePolicyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Health Care Insurance Policy [Member].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_EmployeeHealthCareInsurancePolicyMember" xlink:href="idxx-20211231.xsd#idxx_EmployeeHealthCareInsurancePolicyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_EmployeeHealthCareInsurancePolicyMember" xlink:to="lab_idxx_EmployeeHealthCareInsurancePolicyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_82d780c8-b2bb-45c2-a78b-9f339dd3a25e_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognition period (in years)</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_aa9ddbfc-7877-4071-a76e-1f2519532422_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_125eba3b-b166-43f0-8898-0936875b3135_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8fe7b896-7b69-4346-a741-1f300851ae04_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_RestrictedStockUnitsGrantedToEmployeesWithRatableVestingMember_95c83b0a-95c6-4f42-be22-10274c6722b8_terseLabel_en-US" xlink:label="lab_idxx_RestrictedStockUnitsGrantedToEmployeesWithRatableVestingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units granted to employees with ratable vesting</link:label>
    <link:label id="lab_idxx_RestrictedStockUnitsGrantedToEmployeesWithRatableVestingMember_label_en-US" xlink:label="lab_idxx_RestrictedStockUnitsGrantedToEmployeesWithRatableVestingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units Granted To Employees With Ratable Vesting [Member]</link:label>
    <link:label id="lab_idxx_RestrictedStockUnitsGrantedToEmployeesWithRatableVestingMember_documentation_en-US" xlink:label="lab_idxx_RestrictedStockUnitsGrantedToEmployeesWithRatableVestingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units Granted To Employees With Ratable Vesting [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_RestrictedStockUnitsGrantedToEmployeesWithRatableVestingMember" xlink:href="idxx-20211231.xsd#idxx_RestrictedStockUnitsGrantedToEmployeesWithRatableVestingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_RestrictedStockUnitsGrantedToEmployeesWithRatableVestingMember" xlink:to="lab_idxx_RestrictedStockUnitsGrantedToEmployeesWithRatableVestingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_0d57206a-04c6-47b6-b1f9-9aa16e2d4bc9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneousCurrent_8d9cf7d9-4638-4c9b-84e1-9b05886e787d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneousCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Miscellaneous, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMiscellaneousCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:to="lab_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7a7888a9-4e52-450f-a76e-d7f0afe9d37e_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ad0f83f9-d8af-429c-9240-be361f2a84ff_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares outstanding for basic earnings per share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_e6302388-6f08-40c3-be6f-bff6e03f9930_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_852d6c13-ed75-486d-814d-078ff63bfb54_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_PostContractSupportContractTerm_ea1ad2f9-e072-4f40-ad2a-837ce3738173_terseLabel_en-US" xlink:label="lab_idxx_PostContractSupportContractTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Post-contract support contract, term</link:label>
    <link:label id="lab_idxx_PostContractSupportContractTerm_label_en-US" xlink:label="lab_idxx_PostContractSupportContractTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Post-contract Support Contract, Term</link:label>
    <link:label id="lab_idxx_PostContractSupportContractTerm_documentation_en-US" xlink:label="lab_idxx_PostContractSupportContractTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Post-contract Support Contract, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_PostContractSupportContractTerm" xlink:href="idxx-20211231.xsd#idxx_PostContractSupportContractTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_PostContractSupportContractTerm" xlink:to="lab_idxx_PostContractSupportContractTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_7f528eea-c8f1-440a-8353-47f53fa129c5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes paid</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_OtherSegmentMember_51326332-3fd8-429b-ac3f-7563d8a2c618_terseLabel_en-US" xlink:label="lab_idxx_OtherSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other segment revenue</link:label>
    <link:label id="lab_idxx_OtherSegmentMember_0a6e37e5-0c2e-4f1a-b537-ed5a67fd13a4_verboseLabel_en-US" xlink:label="lab_idxx_OtherSegmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_idxx_OtherSegmentMember_label_en-US" xlink:label="lab_idxx_OtherSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Segment [Member]</link:label>
    <link:label id="lab_idxx_OtherSegmentMember_documentation_en-US" xlink:label="lab_idxx_OtherSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_OtherSegmentMember" xlink:href="idxx-20211231.xsd#idxx_OtherSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_OtherSegmentMember" xlink:to="lab_idxx_OtherSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_ResearchAndDevelopmentCostsCapitalized_578b11bd-d736-45ea-8fe8-843d0a957057_terseLabel_en-US" xlink:label="lab_idxx_ResearchAndDevelopmentCostsCapitalized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized costs</link:label>
    <link:label id="lab_idxx_ResearchAndDevelopmentCostsCapitalized_label_en-US" xlink:label="lab_idxx_ResearchAndDevelopmentCostsCapitalized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Costs, Capitalized</link:label>
    <link:label id="lab_idxx_ResearchAndDevelopmentCostsCapitalized_documentation_en-US" xlink:label="lab_idxx_ResearchAndDevelopmentCostsCapitalized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Costs, Capitalized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ResearchAndDevelopmentCostsCapitalized" xlink:href="idxx-20211231.xsd#idxx_ResearchAndDevelopmentCostsCapitalized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_ResearchAndDevelopmentCostsCapitalized" xlink:to="lab_idxx_ResearchAndDevelopmentCostsCapitalized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_a5af8238-2468-433e-ba52-ab1eef21961d_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income attributable to IDEXX Laboratories, Inc.</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_738bcf48-0314-416b-8d2b-73c664769f32_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_945c2ff5-021d-442d-8cf1-1fb865fa44d1_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_3dd8dd19-efce-45b3-902e-fcf1cbe9ae6b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_PaymentRequiredToOfficersUponTerminationOfEmploymentFollowingChangeOfControlMember_116f0dff-2f19-473a-b1b7-416394db1576_terseLabel_en-US" xlink:label="lab_idxx_PaymentRequiredToOfficersUponTerminationOfEmploymentFollowingChangeOfControlMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment required to officers upon termination of employment following change of control</link:label>
    <link:label id="lab_idxx_PaymentRequiredToOfficersUponTerminationOfEmploymentFollowingChangeOfControlMember_label_en-US" xlink:label="lab_idxx_PaymentRequiredToOfficersUponTerminationOfEmploymentFollowingChangeOfControlMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment Required To Officers Upon Termination Of Employment Following Change Of Control [Member]</link:label>
    <link:label id="lab_idxx_PaymentRequiredToOfficersUponTerminationOfEmploymentFollowingChangeOfControlMember_documentation_en-US" xlink:label="lab_idxx_PaymentRequiredToOfficersUponTerminationOfEmploymentFollowingChangeOfControlMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment Required To Officers Upon Termination Of Employment Following Change Of Control [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_PaymentRequiredToOfficersUponTerminationOfEmploymentFollowingChangeOfControlMember" xlink:href="idxx-20211231.xsd#idxx_PaymentRequiredToOfficersUponTerminationOfEmploymentFollowingChangeOfControlMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_PaymentRequiredToOfficersUponTerminationOfEmploymentFollowingChangeOfControlMember" xlink:to="lab_idxx_PaymentRequiredToOfficersUponTerminationOfEmploymentFollowingChangeOfControlMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_64f2dc15-0702-4cfc-ab17-6e416ce1c0b8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_fc3ee1a1-cc86-4e95-bff1-af8ae6861fac_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_f98bb869-61c1-43a4-9be9-e604d49b3c6d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of effective income tax rate reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_5efd3c74-9847-4df2-988d-66891eeaddfd_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction_bfb0acf7-b4c5-49d3-8413-c495a7a5db86_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging assets, gross amounts subject to master netting arrangements not offset on the balance sheet</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Not Offset, Policy Election Deduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction" xlink:to="lab_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_84b89ca9-e21c-4d3e-8149-c4d4c279f48e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable reserves</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_11a03766-4f28-4809-b346-b84ecb3cd9cd_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_68beb24d-8674-4ac1-91ac-14231194b0a0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of fair value of assets and liabilities measured on recurring basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_68f31755-6fde-4f12-8bbb-af75c5187037_totalLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net expense (benefit) related to share-based compensation arrangements included in consolidated statements of income</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a012376d-fd4c-4594-90d7-d583f1e88cf0_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_565e7e5c-cdb7-42d2-ba97-2d57bba24b75_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome_063acab7-c586-461d-ac81-034cc64f6c81_negatedTerseLabel_en-US" xlink:label="lab_idxx_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign derived intangible income</link:label>
    <link:label id="lab_idxx_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome_label_en-US" xlink:label="lab_idxx_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Derived Intangible Income</link:label>
    <link:label id="lab_idxx_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome_documentation_en-US" xlink:label="lab_idxx_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Derived Intangible Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome" xlink:href="idxx-20211231.xsd#idxx_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome" xlink:to="lab_idxx_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_285c36e3-694a-4d0d-8f88-78f5608fa355_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Volume commitment contract assets</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNet" xlink:to="lab_us-gaap_ContractWithCustomerAssetNet" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_PaymentRequiredUponTerminationOfEmploymentAxis_62fb7fb7-c174-4f87-a133-092b2504dc29_terseLabel_en-US" xlink:label="lab_idxx_PaymentRequiredUponTerminationOfEmploymentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment Required Upon Termination Of Employment [Axis]</link:label>
    <link:label id="lab_idxx_PaymentRequiredUponTerminationOfEmploymentAxis_label_en-US" xlink:label="lab_idxx_PaymentRequiredUponTerminationOfEmploymentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment Required Upon Termination Of Employment [Axis]</link:label>
    <link:label id="lab_idxx_PaymentRequiredUponTerminationOfEmploymentAxis_documentation_en-US" xlink:label="lab_idxx_PaymentRequiredUponTerminationOfEmploymentAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment Required Upon Termination Of Employment [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_PaymentRequiredUponTerminationOfEmploymentAxis" xlink:href="idxx-20211231.xsd#idxx_PaymentRequiredUponTerminationOfEmploymentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_PaymentRequiredUponTerminationOfEmploymentAxis" xlink:to="lab_idxx_PaymentRequiredUponTerminationOfEmploymentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_ca6af1f7-d145-4c1d-ab01-be55d16e43ac_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3d2f6fdc-5dc9-46b9-98b0-5a302afc1580_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_2ceaa42a-0c9b-48b5-be72-3c53a64b9e41_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rental and operating-type reagent rental program instruments transferred from inventory to property and equipment</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_OperatingExpensesMember_00522783-396d-4b53-9d7a-4bbe9ea7f8b4_terseLabel_en-US" xlink:label="lab_idxx_OperatingExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses</link:label>
    <link:label id="lab_idxx_OperatingExpensesMember_label_en-US" xlink:label="lab_idxx_OperatingExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Member]</link:label>
    <link:label id="lab_idxx_OperatingExpensesMember_documentation_en-US" xlink:label="lab_idxx_OperatingExpensesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The allocation (or location) of expense to (in) operating expenses.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_OperatingExpensesMember" xlink:href="idxx-20211231.xsd#idxx_OperatingExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_OperatingExpensesMember" xlink:to="lab_idxx_OperatingExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForLoanLeaseAndOtherLosses_6a4bc53f-cfac-428c-a135-1a205891c015_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForLoanLeaseAndOtherLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for uncollectible accounts</link:label>
    <link:label id="lab_us-gaap_ProvisionForLoanLeaseAndOtherLosses_label_en-US" xlink:label="lab_us-gaap_ProvisionForLoanLeaseAndOtherLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for Loan, Lease, and Other Losses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForLoanLeaseAndOtherLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForLoanLeaseAndOtherLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForLoanLeaseAndOtherLosses" xlink:to="lab_us-gaap_ProvisionForLoanLeaseAndOtherLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_c001c99b-93af-4acd-b617-0381bf058e0a_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_952b0943-86cf-426b-a590-d0462e28a5e2_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total rent expense including variable rent and short-term expenses</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_727cf409-1a15-4c9c-8c68-710cbbf6d89c_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; Equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_c9cc5e9b-cc80-40bc-af1d-501b5c8d4340_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross increases (decreases) in unrecognized tax positions as a result of tax positions taken during a prior period</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_ca002ca2-9194-4e88-8f78-cfe92adfa660_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_LatinAmericaAndCaribbeanMember_151a6c57-6c87-41f5-a642-22ad0525364d_terseLabel_en-US" xlink:label="lab_idxx_LatinAmericaAndCaribbeanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Latin America &amp; Caribbean</link:label>
    <link:label id="lab_idxx_LatinAmericaAndCaribbeanMember_label_en-US" xlink:label="lab_idxx_LatinAmericaAndCaribbeanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Latin America and Caribbean [Member]</link:label>
    <link:label id="lab_idxx_LatinAmericaAndCaribbeanMember_documentation_en-US" xlink:label="lab_idxx_LatinAmericaAndCaribbeanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Latin America and Caribbean</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_LatinAmericaAndCaribbeanMember" xlink:href="idxx-20211231.xsd#idxx_LatinAmericaAndCaribbeanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_LatinAmericaAndCaribbeanMember" xlink:to="lab_idxx_LatinAmericaAndCaribbeanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_BusinessCombinationsTangibleLiabilities_c360b015-ed49-4585-8e08-ccd829d104e5_terseLabel_en-US" xlink:label="lab_idxx_BusinessCombinationsTangibleLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net tangible liabilities</link:label>
    <link:label id="lab_idxx_BusinessCombinationsTangibleLiabilities_label_en-US" xlink:label="lab_idxx_BusinessCombinationsTangibleLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations, Tangible Liabilities</link:label>
    <link:label id="lab_idxx_BusinessCombinationsTangibleLiabilities_documentation_en-US" xlink:label="lab_idxx_BusinessCombinationsTangibleLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations, Tangible Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_BusinessCombinationsTangibleLiabilities" xlink:href="idxx-20211231.xsd#idxx_BusinessCombinationsTangibleLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_BusinessCombinationsTangibleLiabilities" xlink:to="lab_idxx_BusinessCombinationsTangibleLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCostsCurrent_501b900c-82db-423e-9892-557d8f6cebd6_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer acquisition costs</link:label>
    <link:label id="lab_us-gaap_DeferredCostsCurrent_label_en-US" xlink:label="lab_us-gaap_DeferredCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Costs, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCostsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCostsCurrent" xlink:to="lab_us-gaap_DeferredCostsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_SalesTypeLeaseLeaseReceivableReclassifiedToReceivable_f0e172ec-5072-47d1-b93f-0a44b13336af_terseLabel_en-US" xlink:label="lab_idxx_SalesTypeLeaseLeaseReceivableReclassifiedToReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease receivable, reclassified to receivable</link:label>
    <link:label id="lab_idxx_SalesTypeLeaseLeaseReceivableReclassifiedToReceivable_label_en-US" xlink:label="lab_idxx_SalesTypeLeaseLeaseReceivableReclassifiedToReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-Type Lease, Lease Receivable, Reclassified To Receivable</link:label>
    <link:label id="lab_idxx_SalesTypeLeaseLeaseReceivableReclassifiedToReceivable_documentation_en-US" xlink:label="lab_idxx_SalesTypeLeaseLeaseReceivableReclassifiedToReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-Type Lease, Lease Receivable, Reclassified To Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_SalesTypeLeaseLeaseReceivableReclassifiedToReceivable" xlink:href="idxx-20211231.xsd#idxx_SalesTypeLeaseLeaseReceivableReclassifiedToReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_SalesTypeLeaseLeaseReceivableReclassifiedToReceivable" xlink:to="lab_idxx_SalesTypeLeaseLeaseReceivableReclassifiedToReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_86e3050f-e5a9-4ec1-b4b8-cd41541ebd76_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_6bcc6ec3-260c-433f-9134-aeedd4c962b4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_2bb1942f-65a5-40c5-88cd-f1df470238c0_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge_62956975-2133-4e04-a631-5b00286275c0_terseLabel_en-US" xlink:label="lab_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General duration of foreign currency exchange contracts</link:label>
    <link:label id="lab_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge_label_en-US" xlink:label="lab_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Length of Time, Foreign Currency Cash Flow Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge" xlink:to="lab_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_A2026SeniorNotesMember_2099a679-d3ce-4211-a627-0a680849f71d_terseLabel_en-US" xlink:label="lab_idxx_A2026SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026 Senior Notes</link:label>
    <link:label id="lab_idxx_A2026SeniorNotesMember_label_en-US" xlink:label="lab_idxx_A2026SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026 Senior Notes [Member]</link:label>
    <link:label id="lab_idxx_A2026SeniorNotesMember_documentation_en-US" xlink:label="lab_idxx_A2026SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026 Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_A2026SeniorNotesMember" xlink:href="idxx-20211231.xsd#idxx_A2026SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_A2026SeniorNotesMember" xlink:to="lab_idxx_A2026SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_1f0bf8b4-9edf-4dd4-bb82-8269bdf20f55_totalLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shares repurchased (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_12ebfd49-7b37-4e2b-a643-d36ed801051e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of long-term debt instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_4c90006d-a1ec-49fb-8113-15f4a1e202ae_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_953a41e7-bfcb-40f3-ba2b-460ea9ee7406_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_be14a2c5-df94-4bff-9abd-b5d31c491c00_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelatedIntangibleAssetsMember_25e22c5a-8045-41a9-a386-1e1eb614bac7_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer-related intangible assets</link:label>
    <link:label id="lab_us-gaap_CustomerRelatedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer-Related Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:to="lab_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_89b4a6e9-2337-4270-b605-3ae3872d036f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative asset</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_IssuanceVestingAndSettlementOfDeferredStockUnits_f7b05376-d3e8-4e1b-ba35-ecb079621dfd_terseLabel_en-US" xlink:label="lab_idxx_IssuanceVestingAndSettlementOfDeferredStockUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred stock units activity</link:label>
    <link:label id="lab_idxx_IssuanceVestingAndSettlementOfDeferredStockUnits_label_en-US" xlink:label="lab_idxx_IssuanceVestingAndSettlementOfDeferredStockUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance Vesting and Settlement Of Deferred Stock Units</link:label>
    <link:label id="lab_idxx_IssuanceVestingAndSettlementOfDeferredStockUnits_documentation_en-US" xlink:label="lab_idxx_IssuanceVestingAndSettlementOfDeferredStockUnits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred stock units which were issued, vested and settled during the period. Deferred stock units issued to employees will generally settle and convert to common stock not earlier than one year following their termination of employment or resignation. With respect to non-employee directors, deferred stock units issued prior to January 1, 2011 will generally settle and convert to common stock not earlier than one year from the date the recipients retire from the board. Deferred stock units issued to non-employee directors on or after January 1, 2011 will generally settle and convert to common stock: (i) not earlier than one year from the date the recipients retire from the board; or (ii) in a lump sum on another single non-discriminatory and objectively determinable date or in four equal annual installments commencing on that date. The shares of common stock associated with these deferred stock units are issuable for no cash consideration, the number of shares of common stock to be issued is fixed and issuance is not contingent.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_IssuanceVestingAndSettlementOfDeferredStockUnits" xlink:href="idxx-20211231.xsd#idxx_IssuanceVestingAndSettlementOfDeferredStockUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_IssuanceVestingAndSettlementOfDeferredStockUnits" xlink:to="lab_idxx_IssuanceVestingAndSettlementOfDeferredStockUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_34b337d5-c9ad-43b2-b0c5-e421918d0e11_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_a771125b-ae5f-412e-8855-be808df97b94_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fully vested and expected to vest, at end of year (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_OtherAsiaPacificMember_c623edc4-6800-44b6-a886-d70985176801_terseLabel_en-US" xlink:label="lab_idxx_OtherAsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_idxx_OtherAsiaPacificMember_label_en-US" xlink:label="lab_idxx_OtherAsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Asia Pacific [Member]</link:label>
    <link:label id="lab_idxx_OtherAsiaPacificMember_documentation_en-US" xlink:label="lab_idxx_OtherAsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Asia Pacific [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_OtherAsiaPacificMember" xlink:href="idxx-20211231.xsd#idxx_OtherAsiaPacificMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_OtherAsiaPacificMember" xlink:to="lab_idxx_OtherAsiaPacificMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_e1739715-5524-4b58-9416-7d96efa1fa2b_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_ProductRightsMember_8c41cef2-41d6-4603-bf53-868bdcc7dd23_terseLabel_en-US" xlink:label="lab_idxx_ProductRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product rights</link:label>
    <link:label id="lab_idxx_ProductRightsMember_label_en-US" xlink:label="lab_idxx_ProductRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Rights [Member]</link:label>
    <link:label id="lab_idxx_ProductRightsMember_documentation_en-US" xlink:label="lab_idxx_ProductRightsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ProductRightsMember" xlink:href="idxx-20211231.xsd#idxx_ProductRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_ProductRightsMember" xlink:to="lab_idxx_ProductRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_A2023SeriesANotesAnd2025SeriesBNotesMember_16f1705b-88e6-4e54-b72b-537287899874_terseLabel_en-US" xlink:label="lab_idxx_A2023SeriesANotesAnd2025SeriesBNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 Series A Notes and 2025 Series B Notes</link:label>
    <link:label id="lab_idxx_A2023SeriesANotesAnd2025SeriesBNotesMember_label_en-US" xlink:label="lab_idxx_A2023SeriesANotesAnd2025SeriesBNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 Series A Notes And 2025 Series B Notes [Member]</link:label>
    <link:label id="lab_idxx_A2023SeriesANotesAnd2025SeriesBNotesMember_documentation_en-US" xlink:label="lab_idxx_A2023SeriesANotesAnd2025SeriesBNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 Series A Notes And 2025 Series B Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_A2023SeriesANotesAnd2025SeriesBNotesMember" xlink:href="idxx-20211231.xsd#idxx_A2023SeriesANotesAnd2025SeriesBNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_A2023SeriesANotesAnd2025SeriesBNotesMember" xlink:to="lab_idxx_A2023SeriesANotesAnd2025SeriesBNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_RapidAssayProductsMember_a3119333-4133-48f3-86ce-d76f046405a0_terseLabel_en-US" xlink:label="lab_idxx_RapidAssayProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rapid assay products</link:label>
    <link:label id="lab_idxx_RapidAssayProductsMember_label_en-US" xlink:label="lab_idxx_RapidAssayProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rapid Assay Products [Member]</link:label>
    <link:label id="lab_idxx_RapidAssayProductsMember_documentation_en-US" xlink:label="lab_idxx_RapidAssayProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rapid Assay Products [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_RapidAssayProductsMember" xlink:href="idxx-20211231.xsd#idxx_RapidAssayProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_RapidAssayProductsMember" xlink:to="lab_idxx_RapidAssayProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorLeasesPolicyTextBlock_45f8656d-43e0-42c7-a91b-67514ee26b28_terseLabel_en-US" xlink:label="lab_us-gaap_LessorLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LessorLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LessorLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LessorLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LessorLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_8bd7f76d-184a-4913-b816-be3b0fa496c5_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, net of current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_68d8f53e-e275-4763-bb93-5556c257884b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share exercise price (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_d94ab4a4-202c-478e-b512-e5dd99cbd1d4_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_3202f5b1-eb01-4e52-b96a-0836be472c13_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining contractual term of options fully vested</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_8e14bff1-3d07-462d-8ef5-dbf494bcae99_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Domain]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_2544824d-cfd3-487d-826c-5e3b9b3a1b17_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_e95d923d-1090-4f11-9f43-3e42c4a37031_netLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_0b103ea8-2140-4aa8-8f11-e3a77c90b594_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_ff0d9c63-38e1-4ee8-8a64-934aa1b9fc41_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Losses) gains, net of tax</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_17c7bf21-acea-470b-91d9-b6d797db7423_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of earnings before income taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_f2aaf36f-cba0-42a1-97f0-7017baa717b2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_488657f0-38a1-41f1-aaca-0d2a56433060_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_25b37e93-47f2-4ff4-a4d7-78a2abb1b945_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c001e920-52c0-40a1-a0ca-979b7b406890_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_ForeignCurrencyBorrowingsDesignatedAsNetInvestmentHedgeOnBalanceSheetMember_9aee796a-27d0-4095-b22b-fbab446f1c23_terseLabel_en-US" xlink:label="lab_idxx_ForeignCurrencyBorrowingsDesignatedAsNetInvestmentHedgeOnBalanceSheetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency denominated debt</link:label>
    <link:label id="lab_idxx_ForeignCurrencyBorrowingsDesignatedAsNetInvestmentHedgeOnBalanceSheetMember_label_en-US" xlink:label="lab_idxx_ForeignCurrencyBorrowingsDesignatedAsNetInvestmentHedgeOnBalanceSheetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Borrowings Designated As Net Investment Hedge On Balance Sheet [Member]</link:label>
    <link:label id="lab_idxx_ForeignCurrencyBorrowingsDesignatedAsNetInvestmentHedgeOnBalanceSheetMember_documentation_en-US" xlink:label="lab_idxx_ForeignCurrencyBorrowingsDesignatedAsNetInvestmentHedgeOnBalanceSheetMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Borrowings Designated As Net Investment Hedge On The Balance Sheet [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ForeignCurrencyBorrowingsDesignatedAsNetInvestmentHedgeOnBalanceSheetMember" xlink:href="idxx-20211231.xsd#idxx_ForeignCurrencyBorrowingsDesignatedAsNetInvestmentHedgeOnBalanceSheetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_ForeignCurrencyBorrowingsDesignatedAsNetInvestmentHedgeOnBalanceSheetMember" xlink:to="lab_idxx_ForeignCurrencyBorrowingsDesignatedAsNetInvestmentHedgeOnBalanceSheetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_72f56ed3-e632-445c-a0f5-dc8fafeb80e5_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandImprovementsMember_b488787d-9741-48ec-8639-3a7461d6188d_terseLabel_en-US" xlink:label="lab_us-gaap_LandImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land improvements</link:label>
    <link:label id="lab_us-gaap_LandImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LandImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandImprovementsMember" xlink:to="lab_us-gaap_LandImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_9821f70a-6aa1-42f1-b1c6-d9ae44fb0331_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_66bddc84-0c10-4906-84b9-d905063de1d9_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_DeferredTaxAssetsIntangibleAssetsBasisDifference_86c37c35-eb4e-4938-ba2c-9e3c3464daad_terseLabel_en-US" xlink:label="lab_idxx_DeferredTaxAssetsIntangibleAssetsBasisDifference" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset basis differences</link:label>
    <link:label id="lab_idxx_DeferredTaxAssetsIntangibleAssetsBasisDifference_label_en-US" xlink:label="lab_idxx_DeferredTaxAssetsIntangibleAssetsBasisDifference" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Intangible Assets Basis Difference</link:label>
    <link:label id="lab_idxx_DeferredTaxAssetsIntangibleAssetsBasisDifference_documentation_en-US" xlink:label="lab_idxx_DeferredTaxAssetsIntangibleAssetsBasisDifference" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Intangible Assets Basis Difference</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_DeferredTaxAssetsIntangibleAssetsBasisDifference" xlink:href="idxx-20211231.xsd#idxx_DeferredTaxAssetsIntangibleAssetsBasisDifference"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_DeferredTaxAssetsIntangibleAssetsBasisDifference" xlink:to="lab_idxx_DeferredTaxAssetsIntangibleAssetsBasisDifference" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_cee119df-5d47-4441-b9a0-6f94d88d1100_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_ceef09ef-daa5-40c0-af0e-dea3aeb34cd2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of intangible assets other than goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_872e32ad-e875-49ad-a9e1-55ea2e7a2b57_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_19aa9302-b4af-4819-b1ea-53021aa85611_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c2681202-23f8-468d-805b-525c175ae428_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive gain (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3aad0b45-cf52-47a9-aee6-f2b47c7386c9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive gain (loss), net</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesCommissionsAndFees_c99aba3a-c0d7-413b-93e1-bc4bd6fdd81f_terseLabel_en-US" xlink:label="lab_us-gaap_SalesCommissionsAndFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commissions expense recognized</link:label>
    <link:label id="lab_us-gaap_SalesCommissionsAndFees_label_en-US" xlink:label="lab_us-gaap_SalesCommissionsAndFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Commissions and Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesCommissionsAndFees" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesCommissionsAndFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesCommissionsAndFees" xlink:to="lab_us-gaap_SalesCommissionsAndFees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_fd5ebf22-e309-49e4-b4cc-ce43818b985c_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decreases in unrecognized tax positions as a result of a lapse of the applicable statutes of limitations</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_3b89c43e-b564-48b7-b697-8230a774a882_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of number of anti-dilutive stock options</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_42ff902b-d09a-425b-8207-a7079ec60d77_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_TreasuryStockAcquiredAverageCostPerShareEmployeeSurrenders_cec06b8d-8d97-45fd-b25a-af36f9d645e3_terseLabel_en-US" xlink:label="lab_idxx_TreasuryStockAcquiredAverageCostPerShareEmployeeSurrenders" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average cost per share - employee surrenders (in USD per share)</link:label>
    <link:label id="lab_idxx_TreasuryStockAcquiredAverageCostPerShareEmployeeSurrenders_label_en-US" xlink:label="lab_idxx_TreasuryStockAcquiredAverageCostPerShareEmployeeSurrenders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired Average Cost Per Share, Employee Surrenders</link:label>
    <link:label id="lab_idxx_TreasuryStockAcquiredAverageCostPerShareEmployeeSurrenders_documentation_en-US" xlink:label="lab_idxx_TreasuryStockAcquiredAverageCostPerShareEmployeeSurrenders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired Average Cost Per Share, Employee Surrenders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_TreasuryStockAcquiredAverageCostPerShareEmployeeSurrenders" xlink:href="idxx-20211231.xsd#idxx_TreasuryStockAcquiredAverageCostPerShareEmployeeSurrenders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_TreasuryStockAcquiredAverageCostPerShareEmployeeSurrenders" xlink:to="lab_idxx_TreasuryStockAcquiredAverageCostPerShareEmployeeSurrenders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_b41b53f5-4937-46f7-8760-ee786538c032_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_6148ca0b-e07b-48fc-9c37-96506ee5e0e8_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_f7880fa0-3612-4de3-b223-fa3d309dbfdb_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used by investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_4fe07f5b-7e43-4023-a3b3-b932b36a081a_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and improvements</link:label>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_label_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and Building Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:to="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f73636d4-229c-4476-8262-2d44107255c5_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_UpFrontCustomerLoyaltyProgramsAndVolumeCommitmentProgramsMember_b5d98610-d152-49ca-a5fb-b2ba433506e7_terseLabel_en-US" xlink:label="lab_idxx_UpFrontCustomerLoyaltyProgramsAndVolumeCommitmentProgramsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Up front customer loyalty programs and volume commitment programs</link:label>
    <link:label id="lab_idxx_UpFrontCustomerLoyaltyProgramsAndVolumeCommitmentProgramsMember_label_en-US" xlink:label="lab_idxx_UpFrontCustomerLoyaltyProgramsAndVolumeCommitmentProgramsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Up Front Customer Loyalty Programs And Volume Commitment Programs [Member]</link:label>
    <link:label id="lab_idxx_UpFrontCustomerLoyaltyProgramsAndVolumeCommitmentProgramsMember_documentation_en-US" xlink:label="lab_idxx_UpFrontCustomerLoyaltyProgramsAndVolumeCommitmentProgramsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Up-Front Customer Loyalty Programs And Volume Commitment Programs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_UpFrontCustomerLoyaltyProgramsAndVolumeCommitmentProgramsMember" xlink:href="idxx-20211231.xsd#idxx_UpFrontCustomerLoyaltyProgramsAndVolumeCommitmentProgramsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_UpFrontCustomerLoyaltyProgramsAndVolumeCommitmentProgramsMember" xlink:to="lab_idxx_UpFrontCustomerLoyaltyProgramsAndVolumeCommitmentProgramsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_22dfa298-beee-46d6-9475-83270e1b88a2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant date fair value, vested (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_InstrumentRebateProgramsMember_1a8eec45-12ae-4a7e-8e54-e8bf15ecea20_terseLabel_en-US" xlink:label="lab_idxx_InstrumentRebateProgramsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instrument rebate programs</link:label>
    <link:label id="lab_idxx_InstrumentRebateProgramsMember_label_en-US" xlink:label="lab_idxx_InstrumentRebateProgramsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instrument Rebate Programs [Member]</link:label>
    <link:label id="lab_idxx_InstrumentRebateProgramsMember_documentation_en-US" xlink:label="lab_idxx_InstrumentRebateProgramsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instrument Rebate Programs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_InstrumentRebateProgramsMember" xlink:href="idxx-20211231.xsd#idxx_InstrumentRebateProgramsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_InstrumentRebateProgramsMember" xlink:to="lab_idxx_InstrumentRebateProgramsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_ff5638be-7a13-46a7-9263-35ac46829595_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquire business</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_a0b239c4-a188-4301-9940-eeb50ec6e9fb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification adjustment for (gain) loss included in net income, tax (expense) benefit</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfValuationAllowanceTextBlock_d8023543-6327-4286-8ac1-de20d609c3f8_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of valuation allowance</link:label>
    <link:label id="lab_us-gaap_SummaryOfValuationAllowanceTextBlock_label_en-US" xlink:label="lab_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Valuation Allowance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:to="lab_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_d60b10a3-b700-4aa1-8b51-5f0527d7c222_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_03f5bc84-1eeb-4cd3-b54d-3ceaa8d06271_negatedLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of changes in foreign currency exchange rates</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_d4ba1eb5-fc37-41ab-bf67-f36a468fc1b6_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_f8488274-98ec-4f39-bbba-309de02a75ab_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_94edcc1f-f467-45cc-91e2-a4d12c39146a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_a1321aec-1621-4d79-b1f0-de8567ea14b1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_756f07ea-98bb-4326-afbc-0cb9851b04b3_totalLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_idxx_TreasuryStockValueAcquiredCostMethodNetOfTaxWithholdings_1159ee95-07b8-4200-b586-320478915634_terseLabel_en-US" xlink:label="lab_idxx_TreasuryStockValueAcquiredCostMethodNetOfTaxWithholdings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of shares repurchased in the open market</link:label>
    <link:label id="lab_idxx_TreasuryStockValueAcquiredCostMethodNetOfTaxWithholdings_label_en-US" xlink:label="lab_idxx_TreasuryStockValueAcquiredCostMethodNetOfTaxWithholdings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Value Acquired Cost Method, Net Of Tax Withholdings</link:label>
    <link:label id="lab_idxx_TreasuryStockValueAcquiredCostMethodNetOfTaxWithholdings_documentation_en-US" xlink:label="lab_idxx_TreasuryStockValueAcquiredCostMethodNetOfTaxWithholdings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of open market common stock repurchases.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_TreasuryStockValueAcquiredCostMethodNetOfTaxWithholdings" xlink:href="idxx-20211231.xsd#idxx_TreasuryStockValueAcquiredCostMethodNetOfTaxWithholdings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_idxx_TreasuryStockValueAcquiredCostMethodNetOfTaxWithholdings" xlink:to="lab_idxx_TreasuryStockValueAcquiredCostMethodNetOfTaxWithholdings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingExpense_6e9b1659-b0dd-4b7e-8f01-2d0aa86d2ae9_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising costs</link:label>
    <link:label id="lab_us-gaap_AdvertisingExpense_label_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingExpense" xlink:to="lab_us-gaap_AdvertisingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockTextBlock_7bd48e1e-5e4e-4b29-92fe-d4d1b4c1c3b3_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock</link:label>
    <link:label id="lab_us-gaap_PreferredStockTextBlock_label_en-US" xlink:label="lab_us-gaap_PreferredStockTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockTextBlock" xlink:to="lab_us-gaap_PreferredStockTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_030e30d4-d3c1-4562-8f8d-a5298ec2e10d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging liabilities, total hedging instruments presented on the balance sheet</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Fair Value, Gross Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_8907cb4a-87f3-4b85-afcd-f53b721199dc_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of (loss) gain reclassified from accumulated other comprehensive income into income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_a45866c6-c6ea-450c-b7ef-cc53869e8615_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of revenue</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_20ef52a4-f1ed-488c-a7e6-1aa06e39f540_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued taxes</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_6f54f741-0f4b-4cc5-9861-87a1f5b36f36_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_bcf261d4-27dd-4a63-bda7-a670b816e7a7_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SelfInsuranceReserve_d4b80c72-754a-4b56-baa5-d4acfd24c171_terseLabel_en-US" xlink:label="lab_us-gaap_SelfInsuranceReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated liability for healthcare claims</link:label>
    <link:label id="lab_us-gaap_SelfInsuranceReserve_label_en-US" xlink:label="lab_us-gaap_SelfInsuranceReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Self Insurance Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SelfInsuranceReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SelfInsuranceReserve" xlink:to="lab_us-gaap_SelfInsuranceReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_fdb2ca9b-455d-4c9e-8ca6-c64300255b41_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>31
<FILENAME>idxx-20211231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:f52bcaef-ba11-42ce-aefc-0c16e0e0e054,g:8ec733b7-1a7e-4401-9212-15a98e503c1c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.idexx.com/role/CoverPage" xlink:type="simple" xlink:href="idxx-20211231.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_164c2fe3-d455-468d-9d8d-1e45e6230889" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_ab929d5c-4cb9-4365-bf5d-f10d25394802" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_164c2fe3-d455-468d-9d8d-1e45e6230889" xlink:to="loc_dei_DocumentType_ab929d5c-4cb9-4365-bf5d-f10d25394802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_abdc7155-ef46-44b3-ab30-5c6844651543" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_164c2fe3-d455-468d-9d8d-1e45e6230889" xlink:to="loc_dei_DocumentAnnualReport_abdc7155-ef46-44b3-ab30-5c6844651543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_b5d76814-aecf-4494-8f76-2a6aed45d0b8" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_164c2fe3-d455-468d-9d8d-1e45e6230889" xlink:to="loc_dei_DocumentPeriodEndDate_b5d76814-aecf-4494-8f76-2a6aed45d0b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_5593e714-cdfa-4a07-9a7b-28c8f46cae51" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_164c2fe3-d455-468d-9d8d-1e45e6230889" xlink:to="loc_dei_CurrentFiscalYearEndDate_5593e714-cdfa-4a07-9a7b-28c8f46cae51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_330b8fbc-682c-47c5-a001-01dc713f1351" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_164c2fe3-d455-468d-9d8d-1e45e6230889" xlink:to="loc_dei_DocumentTransitionReport_330b8fbc-682c-47c5-a001-01dc713f1351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_d371bca5-ae87-4285-b0e9-f97932ebb06a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_164c2fe3-d455-468d-9d8d-1e45e6230889" xlink:to="loc_dei_EntityFileNumber_d371bca5-ae87-4285-b0e9-f97932ebb06a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_2163f0bc-71be-4e3a-a46f-580134cddd64" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_164c2fe3-d455-468d-9d8d-1e45e6230889" xlink:to="loc_dei_EntityRegistrantName_2163f0bc-71be-4e3a-a46f-580134cddd64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_45d0a593-15c5-4350-bd0a-5de977f08b62" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_164c2fe3-d455-468d-9d8d-1e45e6230889" xlink:to="loc_dei_EntityIncorporationStateCountryCode_45d0a593-15c5-4350-bd0a-5de977f08b62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_c7ccfaef-653e-41f7-9c14-b8ef3ae862dc" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_164c2fe3-d455-468d-9d8d-1e45e6230889" xlink:to="loc_dei_EntityTaxIdentificationNumber_c7ccfaef-653e-41f7-9c14-b8ef3ae862dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_d46f1902-cbeb-4597-8087-ccbf3a56d2ee" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_164c2fe3-d455-468d-9d8d-1e45e6230889" xlink:to="loc_dei_EntityAddressAddressLine1_d46f1902-cbeb-4597-8087-ccbf3a56d2ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_22ebd14d-5ec6-4adc-b48e-e535e024dddd" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_164c2fe3-d455-468d-9d8d-1e45e6230889" xlink:to="loc_dei_EntityAddressCityOrTown_22ebd14d-5ec6-4adc-b48e-e535e024dddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_08587e3a-1de7-4d3a-bc0b-3e5b62db0786" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_164c2fe3-d455-468d-9d8d-1e45e6230889" xlink:to="loc_dei_EntityAddressStateOrProvince_08587e3a-1de7-4d3a-bc0b-3e5b62db0786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_c3167cf0-38b3-4c60-9052-06612b942218" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_164c2fe3-d455-468d-9d8d-1e45e6230889" xlink:to="loc_dei_EntityAddressPostalZipCode_c3167cf0-38b3-4c60-9052-06612b942218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_ac8d824c-b7ea-4f50-b841-e0ece1a06e9e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_164c2fe3-d455-468d-9d8d-1e45e6230889" xlink:to="loc_dei_CityAreaCode_ac8d824c-b7ea-4f50-b841-e0ece1a06e9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_e909affa-ee73-484a-8adb-12ce4fd87afe" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_164c2fe3-d455-468d-9d8d-1e45e6230889" xlink:to="loc_dei_LocalPhoneNumber_e909affa-ee73-484a-8adb-12ce4fd87afe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_f558f496-8ac9-49da-b2d7-028e1a8f9772" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_164c2fe3-d455-468d-9d8d-1e45e6230889" xlink:to="loc_dei_Security12bTitle_f558f496-8ac9-49da-b2d7-028e1a8f9772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_d51ea1bd-2df5-41f7-a1ba-b38b3eb735e8" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_164c2fe3-d455-468d-9d8d-1e45e6230889" xlink:to="loc_dei_TradingSymbol_d51ea1bd-2df5-41f7-a1ba-b38b3eb735e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_144055b3-0dbf-4b2b-9fb2-4d2fb2cd080b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_164c2fe3-d455-468d-9d8d-1e45e6230889" xlink:to="loc_dei_SecurityExchangeName_144055b3-0dbf-4b2b-9fb2-4d2fb2cd080b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_bdc3a48c-c7ba-4c06-b20a-a331e77c2ea9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_164c2fe3-d455-468d-9d8d-1e45e6230889" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_bdc3a48c-c7ba-4c06-b20a-a331e77c2ea9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_618b6e74-b37b-4e61-b7bd-2bc008ba023b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_164c2fe3-d455-468d-9d8d-1e45e6230889" xlink:to="loc_dei_EntityVoluntaryFilers_618b6e74-b37b-4e61-b7bd-2bc008ba023b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_7815b433-7a24-4ef3-a808-c45baa397d35" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_164c2fe3-d455-468d-9d8d-1e45e6230889" xlink:to="loc_dei_EntityCurrentReportingStatus_7815b433-7a24-4ef3-a808-c45baa397d35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_5071469a-097b-46fc-868d-fa4506e12e7b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_164c2fe3-d455-468d-9d8d-1e45e6230889" xlink:to="loc_dei_EntityInteractiveDataCurrent_5071469a-097b-46fc-868d-fa4506e12e7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_30fe8fbf-0bbd-47e7-80cb-686bc0b7b15d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_164c2fe3-d455-468d-9d8d-1e45e6230889" xlink:to="loc_dei_EntityFilerCategory_30fe8fbf-0bbd-47e7-80cb-686bc0b7b15d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_5c1d071d-671c-4200-b757-d29986de9c10" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_164c2fe3-d455-468d-9d8d-1e45e6230889" xlink:to="loc_dei_EntitySmallBusiness_5c1d071d-671c-4200-b757-d29986de9c10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_49c7758e-9a4b-40f5-83dd-3f4210e63a80" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_164c2fe3-d455-468d-9d8d-1e45e6230889" xlink:to="loc_dei_EntityEmergingGrowthCompany_49c7758e-9a4b-40f5-83dd-3f4210e63a80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_bd1786f9-d7bb-478e-b03e-f02b2ae12d6c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_164c2fe3-d455-468d-9d8d-1e45e6230889" xlink:to="loc_dei_IcfrAuditorAttestationFlag_bd1786f9-d7bb-478e-b03e-f02b2ae12d6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_207365fd-2d5b-4a56-af12-c00d0ee900dd" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_164c2fe3-d455-468d-9d8d-1e45e6230889" xlink:to="loc_dei_EntityShellCompany_207365fd-2d5b-4a56-af12-c00d0ee900dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_92bd78c9-a83a-4bbe-aba1-822b97ee531d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_164c2fe3-d455-468d-9d8d-1e45e6230889" xlink:to="loc_dei_EntityPublicFloat_92bd78c9-a83a-4bbe-aba1-822b97ee531d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_ab5855a2-d53d-4c7d-9965-ffc2707097a3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_164c2fe3-d455-468d-9d8d-1e45e6230889" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_ab5855a2-d53d-4c7d-9965-ffc2707097a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_46b084d8-3784-4057-b8a0-b6ae3521681f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_164c2fe3-d455-468d-9d8d-1e45e6230889" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_46b084d8-3784-4057-b8a0-b6ae3521681f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_7b7ec6a7-eb04-4bb2-bf99-40e097db823c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_164c2fe3-d455-468d-9d8d-1e45e6230889" xlink:to="loc_dei_AmendmentFlag_7b7ec6a7-eb04-4bb2-bf99-40e097db823c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_4a1ae12d-7624-4acd-99e8-46036973d273" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_164c2fe3-d455-468d-9d8d-1e45e6230889" xlink:to="loc_dei_DocumentFiscalYearFocus_4a1ae12d-7624-4acd-99e8-46036973d273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_54633ea7-3ae1-4433-b96f-6c48000f2033" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_164c2fe3-d455-468d-9d8d-1e45e6230889" xlink:to="loc_dei_DocumentFiscalPeriodFocus_54633ea7-3ae1-4433-b96f-6c48000f2033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_ab3d7b7f-c9b5-4aee-ad09-69de01776226" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_164c2fe3-d455-468d-9d8d-1e45e6230889" xlink:to="loc_dei_EntityCentralIndexKey_ab3d7b7f-c9b5-4aee-ad09-69de01776226" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/AuditInformation" xlink:type="simple" xlink:href="idxx-20211231.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_idxx_AuditInformationAbstract_fdd98b93-d7da-4084-82d7-9148cc51bb13" xlink:href="idxx-20211231.xsd#idxx_AuditInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_237de54e-fc7d-4386-86ee-bcb4fe62bfc6" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_AuditInformationAbstract_fdd98b93-d7da-4084-82d7-9148cc51bb13" xlink:to="loc_dei_AuditorName_237de54e-fc7d-4386-86ee-bcb4fe62bfc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_a8c5544b-3704-4702-ad13-89368543f4a8" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_AuditInformationAbstract_fdd98b93-d7da-4084-82d7-9148cc51bb13" xlink:to="loc_dei_AuditorFirmId_a8c5544b-3704-4702-ad13-89368543f4a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_7f0a5bf0-1669-4db9-84b3-714a877a5f31" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_AuditInformationAbstract_fdd98b93-d7da-4084-82d7-9148cc51bb13" xlink:to="loc_dei_AuditorLocation_7f0a5bf0-1669-4db9-84b3-714a877a5f31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="idxx-20211231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_c9078b83-81ec-473a-bbfa-adf605a0fe3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_b5cdfd2d-abeb-44ec-a466-92c58759b0c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c9078b83-81ec-473a-bbfa-adf605a0fe3a" xlink:to="loc_us-gaap_AssetsAbstract_b5cdfd2d-abeb-44ec-a466-92c58759b0c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_955153d3-2c40-4e27-9970-e15968296eaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b5cdfd2d-abeb-44ec-a466-92c58759b0c8" xlink:to="loc_us-gaap_AssetsCurrentAbstract_955153d3-2c40-4e27-9970-e15968296eaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_13f406e3-9ee4-43f8-b2c9-d17c3e5beb15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_955153d3-2c40-4e27-9970-e15968296eaa" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_13f406e3-9ee4-43f8-b2c9-d17c3e5beb15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_dd7ebae5-cdd6-44fa-8f42-00f28511df4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_955153d3-2c40-4e27-9970-e15968296eaa" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_dd7ebae5-cdd6-44fa-8f42-00f28511df4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_3aa42b43-258a-4cc7-bd2b-cc5634f4e421" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_955153d3-2c40-4e27-9970-e15968296eaa" xlink:to="loc_us-gaap_InventoryNet_3aa42b43-258a-4cc7-bd2b-cc5634f4e421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_fcbd7935-8b3e-4a6a-8608-a4237808e1eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_955153d3-2c40-4e27-9970-e15968296eaa" xlink:to="loc_us-gaap_OtherAssetsCurrent_fcbd7935-8b3e-4a6a-8608-a4237808e1eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_6d7146ae-94ff-4e6e-8736-a8905f404ab7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_955153d3-2c40-4e27-9970-e15968296eaa" xlink:to="loc_us-gaap_AssetsCurrent_6d7146ae-94ff-4e6e-8736-a8905f404ab7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract_c0245a4c-417b-4be8-aefb-6d634979723b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b5cdfd2d-abeb-44ec-a466-92c58759b0c8" xlink:to="loc_us-gaap_AssetsNoncurrentAbstract_c0245a4c-417b-4be8-aefb-6d634979723b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_9610a040-fea0-4967-a557-28b3989a337f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_c0245a4c-417b-4be8-aefb-6d634979723b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_9610a040-fea0-4967-a557-28b3989a337f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_ce0dec87-39e1-447a-b09f-ce3bc5491d4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_c0245a4c-417b-4be8-aefb-6d634979723b" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_ce0dec87-39e1-447a-b09f-ce3bc5491d4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_27a9cfd5-4911-4981-b49f-0764b0a7dce5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_c0245a4c-417b-4be8-aefb-6d634979723b" xlink:to="loc_us-gaap_Goodwill_27a9cfd5-4911-4981-b49f-0764b0a7dce5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_67c6e5bd-fa32-4035-86c4-34edb7f41466" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_c0245a4c-417b-4be8-aefb-6d634979723b" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_67c6e5bd-fa32-4035-86c4-34edb7f41466" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_f2c1d437-df6c-452b-b31f-5dfac0fb4933" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_c0245a4c-417b-4be8-aefb-6d634979723b" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_f2c1d437-df6c-452b-b31f-5dfac0fb4933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_ef5d28ca-32b7-46d3-b8c4-a257288c55e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_c0245a4c-417b-4be8-aefb-6d634979723b" xlink:to="loc_us-gaap_AssetsNoncurrent_ef5d28ca-32b7-46d3-b8c4-a257288c55e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_e0175c9b-3184-4567-b485-ed2de3b3e053" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b5cdfd2d-abeb-44ec-a466-92c58759b0c8" xlink:to="loc_us-gaap_Assets_e0175c9b-3184-4567-b485-ed2de3b3e053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_165fd6d7-10c7-403a-9f86-d0b929a3aeec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c9078b83-81ec-473a-bbfa-adf605a0fe3a" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_165fd6d7-10c7-403a-9f86-d0b929a3aeec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_bb03cbf8-ba00-4b19-9132-503379ac5cac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_165fd6d7-10c7-403a-9f86-d0b929a3aeec" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_bb03cbf8-ba00-4b19-9132-503379ac5cac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_8d6ac78e-6787-4c1b-b81a-a541398b2c20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_bb03cbf8-ba00-4b19-9132-503379ac5cac" xlink:to="loc_us-gaap_AccountsPayableCurrent_8d6ac78e-6787-4c1b-b81a-a541398b2c20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_e81aecf3-ef01-4b3d-a84e-3787f16cd359" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_bb03cbf8-ba00-4b19-9132-503379ac5cac" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_e81aecf3-ef01-4b3d-a84e-3787f16cd359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditCurrent_91dafa76-f21a-4459-aa6a-c42e9e80302d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LinesOfCreditCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_bb03cbf8-ba00-4b19-9132-503379ac5cac" xlink:to="loc_us-gaap_LinesOfCreditCurrent_91dafa76-f21a-4459-aa6a-c42e9e80302d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_be2fbb0c-1a83-46a5-867f-edb207fbd7ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_bb03cbf8-ba00-4b19-9132-503379ac5cac" xlink:to="loc_us-gaap_LongTermDebtCurrent_be2fbb0c-1a83-46a5-867f-edb207fbd7ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_ba7b5151-0b88-4c96-a890-a01ea4037c05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_bb03cbf8-ba00-4b19-9132-503379ac5cac" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_ba7b5151-0b88-4c96-a890-a01ea4037c05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_9530a404-8bea-4340-98ea-71870fce61bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_bb03cbf8-ba00-4b19-9132-503379ac5cac" xlink:to="loc_us-gaap_LiabilitiesCurrent_9530a404-8bea-4340-98ea-71870fce61bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_046a481e-2c0e-43f7-933d-24317d4dfb77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_165fd6d7-10c7-403a-9f86-d0b929a3aeec" xlink:to="loc_us-gaap_LiabilitiesNoncurrentAbstract_046a481e-2c0e-43f7-933d-24317d4dfb77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_e6d42e85-4c75-4761-8c76-86165b94e941" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_046a481e-2c0e-43f7-933d-24317d4dfb77" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_e6d42e85-4c75-4761-8c76-86165b94e941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_cdc2440d-3073-4fe7-a7f9-ecd6e1505e4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_046a481e-2c0e-43f7-933d-24317d4dfb77" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_cdc2440d-3073-4fe7-a7f9-ecd6e1505e4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_c3c0ca80-2554-48a9-9eb1-d119fe57df02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_046a481e-2c0e-43f7-933d-24317d4dfb77" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_c3c0ca80-2554-48a9-9eb1-d119fe57df02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_3212e2ba-92f2-4c51-b674-7caa55fda4e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_046a481e-2c0e-43f7-933d-24317d4dfb77" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_3212e2ba-92f2-4c51-b674-7caa55fda4e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_7d1ea480-2289-4b57-b52a-af03b1de8308" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_046a481e-2c0e-43f7-933d-24317d4dfb77" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_7d1ea480-2289-4b57-b52a-af03b1de8308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_fb638567-af9d-40bd-8a1f-8f031212c2d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_046a481e-2c0e-43f7-933d-24317d4dfb77" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_fb638567-af9d-40bd-8a1f-8f031212c2d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_bf03f0f4-aeef-495f-bb88-9aa424cd05be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_165fd6d7-10c7-403a-9f86-d0b929a3aeec" xlink:to="loc_us-gaap_Liabilities_bf03f0f4-aeef-495f-bb88-9aa424cd05be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_2d4c9cbd-aa3b-4d2e-8b4b-4029da4d86ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_165fd6d7-10c7-403a-9f86-d0b929a3aeec" xlink:to="loc_us-gaap_CommitmentsAndContingencies_2d4c9cbd-aa3b-4d2e-8b4b-4029da4d86ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_5f26eaa5-4070-46c0-aaa8-c1deefba1d10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_165fd6d7-10c7-403a-9f86-d0b929a3aeec" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_5f26eaa5-4070-46c0-aaa8-c1deefba1d10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_12a9e69e-d3cd-4257-b469-0ea8c76a2d93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_5f26eaa5-4070-46c0-aaa8-c1deefba1d10" xlink:to="loc_us-gaap_CommonStockValue_12a9e69e-d3cd-4257-b469-0ea8c76a2d93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_c4c4e5cc-54a1-4465-b1ad-ef1d5afd5c74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_5f26eaa5-4070-46c0-aaa8-c1deefba1d10" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_c4c4e5cc-54a1-4465-b1ad-ef1d5afd5c74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockOtherValueOutstanding_381999a2-aa87-40ab-ba19-e96b16256e69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockOtherValueOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_5f26eaa5-4070-46c0-aaa8-c1deefba1d10" xlink:to="loc_us-gaap_CommonStockOtherValueOutstanding_381999a2-aa87-40ab-ba19-e96b16256e69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1d9105c1-050d-45c1-a956-2c355a63289a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_5f26eaa5-4070-46c0-aaa8-c1deefba1d10" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1d9105c1-050d-45c1-a956-2c355a63289a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6a8d1bc8-debf-4707-b80b-d4a2c568fe63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_5f26eaa5-4070-46c0-aaa8-c1deefba1d10" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6a8d1bc8-debf-4707-b80b-d4a2c568fe63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_de4229ac-9976-4457-9dbb-85f548dcbf4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_5f26eaa5-4070-46c0-aaa8-c1deefba1d10" xlink:to="loc_us-gaap_TreasuryStockValue_de4229ac-9976-4457-9dbb-85f548dcbf4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_fa3bbfb0-0742-4f44-ac85-773fe1ce6960" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_5f26eaa5-4070-46c0-aaa8-c1deefba1d10" xlink:to="loc_us-gaap_StockholdersEquity_fa3bbfb0-0742-4f44-ac85-773fe1ce6960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_604aa7c3-6193-420d-97f7-5d06998880e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_5f26eaa5-4070-46c0-aaa8-c1deefba1d10" xlink:to="loc_us-gaap_MinorityInterest_604aa7c3-6193-420d-97f7-5d06998880e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_841630d9-c86a-4707-81ad-58e3372d75fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_5f26eaa5-4070-46c0-aaa8-c1deefba1d10" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_841630d9-c86a-4707-81ad-58e3372d75fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_ace12460-ddfc-4036-93a9-fb8f8744b3a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_165fd6d7-10c7-403a-9f86-d0b929a3aeec" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_ace12460-ddfc-4036-93a9-fb8f8744b3a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="idxx-20211231.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_d61e09f1-1f3b-4d2d-8ed4-ad7e365dcff1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_8f6b53e7-95dd-4f64-8817-cef6cd71296e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d61e09f1-1f3b-4d2d-8ed4-ad7e365dcff1" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_8f6b53e7-95dd-4f64-8817-cef6cd71296e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_80ef8857-870c-4f90-b77f-067967c63504" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d61e09f1-1f3b-4d2d-8ed4-ad7e365dcff1" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_80ef8857-870c-4f90-b77f-067967c63504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_08f36af1-b430-4c28-9cc0-70b4c126cbcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d61e09f1-1f3b-4d2d-8ed4-ad7e365dcff1" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_08f36af1-b430-4c28-9cc0-70b4c126cbcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_f43a8bd7-7534-4597-8f8b-c11dc2a3a726" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d61e09f1-1f3b-4d2d-8ed4-ad7e365dcff1" xlink:to="loc_us-gaap_CommonStockSharesIssued_f43a8bd7-7534-4597-8f8b-c11dc2a3a726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_6013ff3b-323b-4e6b-890d-006a256c8038" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d61e09f1-1f3b-4d2d-8ed4-ad7e365dcff1" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_6013ff3b-323b-4e6b-890d-006a256c8038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockOtherSharesOutstanding_3e3b2058-aba6-4aea-a3a9-c68008123a65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockOtherSharesOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d61e09f1-1f3b-4d2d-8ed4-ad7e365dcff1" xlink:to="loc_us-gaap_CommonStockOtherSharesOutstanding_3e3b2058-aba6-4aea-a3a9-c68008123a65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_4f23f6f1-3af0-4987-ae16-db16f0244c7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d61e09f1-1f3b-4d2d-8ed4-ad7e365dcff1" xlink:to="loc_us-gaap_TreasuryStockShares_4f23f6f1-3af0-4987-ae16-db16f0244c7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="simple" xlink:href="idxx-20211231.xsd#CONSOLIDATEDSTATEMENTSOFINCOME"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_b8cb237f-2335-4361-98a5-c56fd62427bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_3fc86cee-6397-436f-9afd-e11a597b018e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b8cb237f-2335-4361-98a5-c56fd62427bd" xlink:to="loc_us-gaap_StatementTable_3fc86cee-6397-436f-9afd-e11a597b018e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_f30acb1a-5e37-4472-8d27-0ba7139ed1cf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_3fc86cee-6397-436f-9afd-e11a597b018e" xlink:to="loc_srt_ProductOrServiceAxis_f30acb1a-5e37-4472-8d27-0ba7139ed1cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_04f6e5b3-bac6-4874-b10a-d5b8a8b7e03e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_f30acb1a-5e37-4472-8d27-0ba7139ed1cf" xlink:to="loc_srt_ProductsAndServicesDomain_04f6e5b3-bac6-4874-b10a-d5b8a8b7e03e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_382e8f20-158d-4432-8fa0-233be1e6bfa0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_04f6e5b3-bac6-4874-b10a-d5b8a8b7e03e" xlink:to="loc_us-gaap_ProductMember_382e8f20-158d-4432-8fa0-233be1e6bfa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_eee08880-c641-456e-ba6b-45b725b971b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_04f6e5b3-bac6-4874-b10a-d5b8a8b7e03e" xlink:to="loc_us-gaap_ServiceMember_eee08880-c641-456e-ba6b-45b725b971b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_23f0563e-437f-423a-b6f5-c40f2999849f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_3fc86cee-6397-436f-9afd-e11a597b018e" xlink:to="loc_us-gaap_StatementLineItems_23f0563e-437f-423a-b6f5-c40f2999849f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_bb7e8d20-ad10-4932-b786-6ac83764c9e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_23f0563e-437f-423a-b6f5-c40f2999849f" xlink:to="loc_us-gaap_RevenuesAbstract_bb7e8d20-ad10-4932-b786-6ac83764c9e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c3fac287-6fa0-4e18-bedb-1aca13b2c5fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_bb7e8d20-ad10-4932-b786-6ac83764c9e9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c3fac287-6fa0-4e18-bedb-1aca13b2c5fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract_ca10bdba-60c1-4c6c-a167-368198f7ad8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_23f0563e-437f-423a-b6f5-c40f2999849f" xlink:to="loc_us-gaap_CostOfRevenueAbstract_ca10bdba-60c1-4c6c-a167-368198f7ad8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_ab9c8ef7-9c15-40cb-b45c-1ccf4128eb30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_ca10bdba-60c1-4c6c-a167-368198f7ad8c" xlink:to="loc_us-gaap_CostOfRevenue_ab9c8ef7-9c15-40cb-b45c-1ccf4128eb30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_5e4f7449-171b-4d7b-86e5-bff1c38e881e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_23f0563e-437f-423a-b6f5-c40f2999849f" xlink:to="loc_us-gaap_GrossProfit_5e4f7449-171b-4d7b-86e5-bff1c38e881e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_d81d4cc4-8990-4b34-90d3-cb7b23654ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_23f0563e-437f-423a-b6f5-c40f2999849f" xlink:to="loc_us-gaap_OperatingExpensesAbstract_d81d4cc4-8990-4b34-90d3-cb7b23654ef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_648f31fa-be70-4fa1-baf1-d5cceaa11aed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_d81d4cc4-8990-4b34-90d3-cb7b23654ef0" xlink:to="loc_us-gaap_SellingAndMarketingExpense_648f31fa-be70-4fa1-baf1-d5cceaa11aed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_4d31ce8f-0532-4b80-bc85-4d3f73493c4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_d81d4cc4-8990-4b34-90d3-cb7b23654ef0" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_4d31ce8f-0532-4b80-bc85-4d3f73493c4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_bde0107e-7650-4c2f-a335-f7ac15c57c8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_d81d4cc4-8990-4b34-90d3-cb7b23654ef0" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_bde0107e-7650-4c2f-a335-f7ac15c57c8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_6f767b2c-54fb-4446-ae75-f58a80133d7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_23f0563e-437f-423a-b6f5-c40f2999849f" xlink:to="loc_us-gaap_OperatingIncomeLoss_6f767b2c-54fb-4446-ae75-f58a80133d7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_646c44d3-de6c-4f10-91bf-5e90586c4061" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_23f0563e-437f-423a-b6f5-c40f2999849f" xlink:to="loc_us-gaap_InterestExpense_646c44d3-de6c-4f10-91bf-5e90586c4061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndOtherIncome_693716bf-a3c3-4c32-9005-c817cf584bb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestAndOtherIncome"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_23f0563e-437f-423a-b6f5-c40f2999849f" xlink:to="loc_us-gaap_InterestAndOtherIncome_693716bf-a3c3-4c32-9005-c817cf584bb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_19d914a5-d68f-4b99-a355-87d818ee04d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_23f0563e-437f-423a-b6f5-c40f2999849f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_19d914a5-d68f-4b99-a355-87d818ee04d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_74d5001c-4554-49fa-b510-b3464a8c6f09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_23f0563e-437f-423a-b6f5-c40f2999849f" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_74d5001c-4554-49fa-b510-b3464a8c6f09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_90927cb3-ac35-4d54-b25a-e3574525683d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_23f0563e-437f-423a-b6f5-c40f2999849f" xlink:to="loc_us-gaap_ProfitLoss_90927cb3-ac35-4d54-b25a-e3574525683d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_3ffc0631-d590-4f6f-b853-8e0a0b35d06d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_23f0563e-437f-423a-b6f5-c40f2999849f" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_3ffc0631-d590-4f6f-b853-8e0a0b35d06d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5ca29ad7-6a94-4e4f-8d90-dd5454dc7952" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_23f0563e-437f-423a-b6f5-c40f2999849f" xlink:to="loc_us-gaap_NetIncomeLoss_5ca29ad7-6a94-4e4f-8d90-dd5454dc7952" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_98340ecb-ea97-4394-8136-852abc032c35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_23f0563e-437f-423a-b6f5-c40f2999849f" xlink:to="loc_us-gaap_EarningsPerShareAbstract_98340ecb-ea97-4394-8136-852abc032c35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_c429260f-9fb3-4938-920d-381c5611c0f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_98340ecb-ea97-4394-8136-852abc032c35" xlink:to="loc_us-gaap_EarningsPerShareBasic_c429260f-9fb3-4938-920d-381c5611c0f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_b10af7f1-4c2d-4047-ad59-d69c53f84166" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_98340ecb-ea97-4394-8136-852abc032c35" xlink:to="loc_us-gaap_EarningsPerShareDiluted_b10af7f1-4c2d-4047-ad59-d69c53f84166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_WeightedAverageSharesOutstandingAbstract_7ba862cb-9615-46bb-b3bf-81bdf729674c" xlink:href="idxx-20211231.xsd#idxx_WeightedAverageSharesOutstandingAbstract"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_23f0563e-437f-423a-b6f5-c40f2999849f" xlink:to="loc_idxx_WeightedAverageSharesOutstandingAbstract_7ba862cb-9615-46bb-b3bf-81bdf729674c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_44243f66-0a12-464e-9ce0-4ba18f39c6b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_WeightedAverageSharesOutstandingAbstract_7ba862cb-9615-46bb-b3bf-81bdf729674c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_44243f66-0a12-464e-9ce0-4ba18f39c6b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2186e759-04dc-4178-a19d-fa78d9b524ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_WeightedAverageSharesOutstandingAbstract_7ba862cb-9615-46bb-b3bf-81bdf729674c" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2186e759-04dc-4178-a19d-fa78d9b524ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="idxx-20211231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c52ea91d-7114-4f5a-8fc8-4199a0b553e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_f08a3ea7-9df9-46bd-abb4-c3430219d8e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c52ea91d-7114-4f5a-8fc8-4199a0b553e0" xlink:to="loc_us-gaap_ProfitLoss_f08a3ea7-9df9-46bd-abb4-c3430219d8e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_d251bd82-8a82-432d-948c-ddd02bf778ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c52ea91d-7114-4f5a-8fc8-4199a0b553e0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_d251bd82-8a82-432d-948c-ddd02bf778ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_7f56fd0a-c211-40be-8306-e0374866ba83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_d251bd82-8a82-432d-948c-ddd02bf778ce" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_7f56fd0a-c211-40be-8306-e0374866ba83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax_9f782d46-cedb-477b-8bb3-9b206882eadd" xlink:href="idxx-20211231.xsd#idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_d251bd82-8a82-432d-948c-ddd02bf778ce" xlink:to="loc_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax_9f782d46-cedb-477b-8bb3-9b206882eadd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_37e7c4a6-31b5-4d7d-9e32-4ca986af259c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_d251bd82-8a82-432d-948c-ddd02bf778ce" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_37e7c4a6-31b5-4d7d-9e32-4ca986af259c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_d6e705b6-c5b7-491f-8f7e-a27eeceae231" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c52ea91d-7114-4f5a-8fc8-4199a0b553e0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_d6e705b6-c5b7-491f-8f7e-a27eeceae231" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_782135b1-7e0b-49d2-bdb7-fcc33b1c3524" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_d6e705b6-c5b7-491f-8f7e-a27eeceae231" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_782135b1-7e0b-49d2-bdb7-fcc33b1c3524" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax_9162af6b-8bd5-482a-b724-ee7ac96a2f6e" xlink:href="idxx-20211231.xsd#idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_d6e705b6-c5b7-491f-8f7e-a27eeceae231" xlink:to="loc_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax_9162af6b-8bd5-482a-b724-ee7ac96a2f6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_e60c988d-b8c9-4542-ba2e-490591b3267c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_d6e705b6-c5b7-491f-8f7e-a27eeceae231" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_e60c988d-b8c9-4542-ba2e-490591b3267c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossAfterReclassificationAndTax_0da18bb7-2930-4d25-9f11-6524b018142e" xlink:href="idxx-20211231.xsd#idxx_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_d6e705b6-c5b7-491f-8f7e-a27eeceae231" xlink:to="loc_idxx_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossAfterReclassificationAndTax_0da18bb7-2930-4d25-9f11-6524b018142e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_65caf206-9425-4bef-81a8-31036f2c8739" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_d6e705b6-c5b7-491f-8f7e-a27eeceae231" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_65caf206-9425-4bef-81a8-31036f2c8739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_68b8c760-a901-4708-9f9d-28e8b96483d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_d6e705b6-c5b7-491f-8f7e-a27eeceae231" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_68b8c760-a901-4708-9f9d-28e8b96483d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_398f0ae2-9ee5-47a0-bdad-aaca88661df2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_d6e705b6-c5b7-491f-8f7e-a27eeceae231" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_398f0ae2-9ee5-47a0-bdad-aaca88661df2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_e6e8d2c0-d1d5-4a7d-9d86-4710d0460511" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_d6e705b6-c5b7-491f-8f7e-a27eeceae231" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_e6e8d2c0-d1d5-4a7d-9d86-4710d0460511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical" xlink:type="simple" xlink:href="idxx-20211231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_11c05f27-0efe-4c72-a7f5-7370f337e5f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationTax_a53d038e-150b-49da-a0c4-6cc7eab71653" xlink:href="idxx-20211231.xsd#idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_11c05f27-0efe-4c72-a7f5-7370f337e5f9" xlink:to="loc_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationTax_a53d038e-150b-49da-a0c4-6cc7eab71653" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_2fa45d73-f590-4269-b166-dfa66c6a4b19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_11c05f27-0efe-4c72-a7f5-7370f337e5f9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_2fa45d73-f590-4269-b166-dfa66c6a4b19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_cff42989-e480-4a2d-8250-956a0afdc0b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_11c05f27-0efe-4c72-a7f5-7370f337e5f9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_cff42989-e480-4a2d-8250-956a0afdc0b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationTax_d1b59609-4f6d-474f-87ee-8cb5d22588f3" xlink:href="idxx-20211231.xsd#idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_11c05f27-0efe-4c72-a7f5-7370f337e5f9" xlink:to="loc_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationTax_d1b59609-4f6d-474f-87ee-8cb5d22588f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_3dceaf03-28b5-41da-8e72-aba53f1a75cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_11c05f27-0efe-4c72-a7f5-7370f337e5f9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_3dceaf03-28b5-41da-8e72-aba53f1a75cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" xlink:type="simple" xlink:href="idxx-20211231.xsd#CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_a56adc6a-6b35-4b3e-8a03-d5c195ff248c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_442cbce8-dc27-46f2-9681-f83000e85449" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_a56adc6a-6b35-4b3e-8a03-d5c195ff248c" xlink:to="loc_us-gaap_StatementTable_442cbce8-dc27-46f2-9681-f83000e85449" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_5cfbd37c-d277-4e6c-a7e6-16519ea84921" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_442cbce8-dc27-46f2-9681-f83000e85449" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_5cfbd37c-d277-4e6c-a7e6-16519ea84921" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_be6d100c-fa8d-4f15-bd42-781261cfbb08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5cfbd37c-d277-4e6c-a7e6-16519ea84921" xlink:to="loc_us-gaap_EquityComponentDomain_be6d100c-fa8d-4f15-bd42-781261cfbb08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_3be301ae-af53-4e38-affd-fa027042bfb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_be6d100c-fa8d-4f15-bd42-781261cfbb08" xlink:to="loc_us-gaap_CommonStockMember_3be301ae-af53-4e38-affd-fa027042bfb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_baddb1ac-adff-4edd-94eb-4e660c64403a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_be6d100c-fa8d-4f15-bd42-781261cfbb08" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_baddb1ac-adff-4edd-94eb-4e660c64403a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_DeferredStockUnitsMember_5f7214ef-0c2b-4607-a3c3-53769c3ff5d5" xlink:href="idxx-20211231.xsd#idxx_DeferredStockUnitsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_be6d100c-fa8d-4f15-bd42-781261cfbb08" xlink:to="loc_idxx_DeferredStockUnitsMember_5f7214ef-0c2b-4607-a3c3-53769c3ff5d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_66b2d901-2641-4c3a-a1be-14e8839325ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_be6d100c-fa8d-4f15-bd42-781261cfbb08" xlink:to="loc_us-gaap_RetainedEarningsMember_66b2d901-2641-4c3a-a1be-14e8839325ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_fd1b6635-5cd9-48cf-80fd-096d118757ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_be6d100c-fa8d-4f15-bd42-781261cfbb08" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_fd1b6635-5cd9-48cf-80fd-096d118757ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_b615819c-3008-4bf4-9cab-191350f68f9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_be6d100c-fa8d-4f15-bd42-781261cfbb08" xlink:to="loc_us-gaap_TreasuryStockMember_b615819c-3008-4bf4-9cab-191350f68f9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_160f1712-2965-4ca9-a5e2-570ef2fd8c31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_be6d100c-fa8d-4f15-bd42-781261cfbb08" xlink:to="loc_us-gaap_NoncontrollingInterestMember_160f1712-2965-4ca9-a5e2-570ef2fd8c31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_39ce2f60-6005-4e7b-b37f-544aa8dfe8db" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_442cbce8-dc27-46f2-9681-f83000e85449" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_39ce2f60-6005-4e7b-b37f-544aa8dfe8db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_8a0ca3ee-2909-4395-8aba-7a1ec0c304a7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_39ce2f60-6005-4e7b-b37f-544aa8dfe8db" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_8a0ca3ee-2909-4395-8aba-7a1ec0c304a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_e1a3c805-828a-4975-bd71-edda2fe49df3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_8a0ca3ee-2909-4395-8aba-7a1ec0c304a7" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_e1a3c805-828a-4975-bd71-edda2fe49df3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e36318ae-d2c4-4764-b678-af17e1e0c150" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_442cbce8-dc27-46f2-9681-f83000e85449" xlink:to="loc_us-gaap_StatementLineItems_e36318ae-d2c4-4764-b678-af17e1e0c150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_536e1795-2859-4492-993c-f899f5986db9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e36318ae-d2c4-4764-b678-af17e1e0c150" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_536e1795-2859-4492-993c-f899f5986db9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_256c6067-4415-49e9-8156-8bf554152e1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_536e1795-2859-4492-993c-f899f5986db9" xlink:to="loc_us-gaap_CommonStockSharesIssued_256c6067-4415-49e9-8156-8bf554152e1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_01e3f3de-8830-4777-89c8-58515be46965" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_536e1795-2859-4492-993c-f899f5986db9" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_01e3f3de-8830-4777-89c8-58515be46965" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_2f734d6b-75a7-456c-8559-82813a46586a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_536e1795-2859-4492-993c-f899f5986db9" xlink:to="loc_us-gaap_ProfitLoss_2f734d6b-75a7-456c-8559-82813a46586a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_81a5e9fa-c2c2-4577-a4dd-cdcddb628901" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_536e1795-2859-4492-993c-f899f5986db9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_81a5e9fa-c2c2-4577-a4dd-cdcddb628901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_abb72c04-da50-417d-9fac-c33c12b31019" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_536e1795-2859-4492-993c-f899f5986db9" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_abb72c04-da50-417d-9fac-c33c12b31019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_9fd97cce-1fef-4523-80ce-ca8ddba4acb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredParValueMethod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_536e1795-2859-4492-993c-f899f5986db9" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_9fd97cce-1fef-4523-80ce-ca8ddba4acb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_a73a7d17-7044-4dc0-9374-0d5b9fe3f275" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_536e1795-2859-4492-993c-f899f5986db9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_a73a7d17-7044-4dc0-9374-0d5b9fe3f275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_effc3791-d5e2-4b08-b52c-6e0509528581" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_536e1795-2859-4492-993c-f899f5986db9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_effc3791-d5e2-4b08-b52c-6e0509528581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_IssuanceVestingAndSettlementOfDeferredStockUnits_c7544847-6a07-45f8-b989-e58e1e3a2091" xlink:href="idxx-20211231.xsd#idxx_IssuanceVestingAndSettlementOfDeferredStockUnits"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_536e1795-2859-4492-993c-f899f5986db9" xlink:to="loc_idxx_IssuanceVestingAndSettlementOfDeferredStockUnits_c7544847-6a07-45f8-b989-e58e1e3a2091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_276af914-0ab3-4df4-b66a-a7002b1935c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_536e1795-2859-4492-993c-f899f5986db9" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_276af914-0ab3-4df4-b66a-a7002b1935c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_b9ef83b6-ece6-4ed5-9feb-c99364447d39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_536e1795-2859-4492-993c-f899f5986db9" xlink:to="loc_us-gaap_CommonStockSharesIssued_b9ef83b6-ece6-4ed5-9feb-c99364447d39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f46395d8-98cb-4aa3-b66d-b31b62032415" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_536e1795-2859-4492-993c-f899f5986db9" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f46395d8-98cb-4aa3-b66d-b31b62032415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical" xlink:type="simple" xlink:href="idxx-20211231.xsd#CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_895a8e60-1af3-4b27-bbb0-37da5f9b5bb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_a93a1e35-6adf-43ec-834e-25dca87b5d61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_895a8e60-1af3-4b27-bbb0-37da5f9b5bb1" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_a93a1e35-6adf-43ec-834e-25dca87b5d61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="idxx-20211231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_dee188ce-a216-457c-a41c-656b636c2b98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bb9591d2-2263-4c93-b150-8a2fed69974d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_dee188ce-a216-457c-a41c-656b636c2b98" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bb9591d2-2263-4c93-b150-8a2fed69974d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_831a3e6d-338b-4529-b335-7ad4b94df9f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bb9591d2-2263-4c93-b150-8a2fed69974d" xlink:to="loc_us-gaap_ProfitLoss_831a3e6d-338b-4529-b335-7ad4b94df9f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2abbaa59-2e45-412b-bd93-56d8c2e425eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bb9591d2-2263-4c93-b150-8a2fed69974d" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2abbaa59-2e45-412b-bd93-56d8c2e425eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_4653ace4-860d-4397-992e-6b55feb1bfc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2abbaa59-2e45-412b-bd93-56d8c2e425eb" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_4653ace4-860d-4397-992e-6b55feb1bfc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_50c4717d-7d3f-4dae-a108-da22d3d809b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2abbaa59-2e45-412b-bd93-56d8c2e425eb" xlink:to="loc_us-gaap_AssetImpairmentCharges_50c4717d-7d3f-4dae-a108-da22d3d809b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForLoanLeaseAndOtherLosses_fa8c195f-f588-43a0-82be-3cff140a9e49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForLoanLeaseAndOtherLosses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2abbaa59-2e45-412b-bd93-56d8c2e425eb" xlink:to="loc_us-gaap_ProvisionForLoanLeaseAndOtherLosses_fa8c195f-f588-43a0-82be-3cff140a9e49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_8354f08b-87db-474c-8e9c-223b244f3475" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2abbaa59-2e45-412b-bd93-56d8c2e425eb" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_8354f08b-87db-474c-8e9c-223b244f3475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_9cc2a9fe-e2cd-46dd-b659-b83d94297f62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2abbaa59-2e45-412b-bd93-56d8c2e425eb" xlink:to="loc_us-gaap_ShareBasedCompensation_9cc2a9fe-e2cd-46dd-b659-b83d94297f62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_0c357521-2dac-464a-bfe3-c5abd6ef96e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2abbaa59-2e45-412b-bd93-56d8c2e425eb" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_0c357521-2dac-464a-bfe3-c5abd6ef96e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d1e3be00-1b66-4ed6-a181-81769b17104f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bb9591d2-2263-4c93-b150-8a2fed69974d" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d1e3be00-1b66-4ed6-a181-81769b17104f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_6e48631e-2686-40a4-832a-378d07195f3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d1e3be00-1b66-4ed6-a181-81769b17104f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_6e48631e-2686-40a4-832a-378d07195f3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_1c1766a0-3c7f-4715-97bf-4afbc839be02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d1e3be00-1b66-4ed6-a181-81769b17104f" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_1c1766a0-3c7f-4715-97bf-4afbc839be02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_4867b362-9117-4778-81fa-7d3041505eba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d1e3be00-1b66-4ed6-a181-81769b17104f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_4867b362-9117-4778-81fa-7d3041505eba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_f1708f3c-7a1e-417c-a9c9-14a44cbb0aba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d1e3be00-1b66-4ed6-a181-81769b17104f" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_f1708f3c-7a1e-417c-a9c9-14a44cbb0aba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_b1336382-40f1-4996-b6e1-8c67c4ade9d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d1e3be00-1b66-4ed6-a181-81769b17104f" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_b1336382-40f1-4996-b6e1-8c67c4ade9d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_13282b6a-6ef3-4e7b-a763-2038a094de43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bb9591d2-2263-4c93-b150-8a2fed69974d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_13282b6a-6ef3-4e7b-a763-2038a094de43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f7ed5ff3-45a1-4dec-8f15-3d7425fa4c76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_dee188ce-a216-457c-a41c-656b636c2b98" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f7ed5ff3-45a1-4dec-8f15-3d7425fa4c76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_abaa65ef-6866-4f06-9eef-4ed4cf184003" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f7ed5ff3-45a1-4dec-8f15-3d7425fa4c76" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_abaa65ef-6866-4f06-9eef-4ed4cf184003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_PaymentsToAcquireIntangibleAssetsAndEquityMethodInvestments_df03d011-e115-4ef1-b2fa-7b9caa2d78f3" xlink:href="idxx-20211231.xsd#idxx_PaymentsToAcquireIntangibleAssetsAndEquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f7ed5ff3-45a1-4dec-8f15-3d7425fa4c76" xlink:to="loc_idxx_PaymentsToAcquireIntangibleAssetsAndEquityMethodInvestments_df03d011-e115-4ef1-b2fa-7b9caa2d78f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_b93ad253-e87a-4e06-b5f5-87c8ac6afaa9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f7ed5ff3-45a1-4dec-8f15-3d7425fa4c76" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_b93ad253-e87a-4e06-b5f5-87c8ac6afaa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a8fee06d-baca-4298-b4d5-30ba040f7840" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f7ed5ff3-45a1-4dec-8f15-3d7425fa4c76" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a8fee06d-baca-4298-b4d5-30ba040f7840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5fb0c0fd-3ec4-4336-a130-c19c8f620f3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_dee188ce-a216-457c-a41c-656b636c2b98" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5fb0c0fd-3ec4-4336-a130-c19c8f620f3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit_f0deb07f-fbdd-4cc9-9c60-5c14d5abc55e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfLinesOfCredit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5fb0c0fd-3ec4-4336-a130-c19c8f620f3b" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit_f0deb07f-fbdd-4cc9-9c60-5c14d5abc55e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_d5b755de-db7e-4301-a975-98ef9554a24e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5fb0c0fd-3ec4-4336-a130-c19c8f620f3b" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_d5b755de-db7e-4301-a975-98ef9554a24e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt_d7a520fa-35e4-42c6-a834-2caf0b2caa3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5fb0c0fd-3ec4-4336-a130-c19c8f620f3b" xlink:to="loc_us-gaap_RepaymentsOfSeniorDebt_d7a520fa-35e4-42c6-a834-2caf0b2caa3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_d57fc07d-f95e-41a9-98e5-9a41cd92ae58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5fb0c0fd-3ec4-4336-a130-c19c8f620f3b" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_d57fc07d-f95e-41a9-98e5-9a41cd92ae58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_9d9c752a-ec3e-448e-b4c5-f31634f1af13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5fb0c0fd-3ec4-4336-a130-c19c8f620f3b" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_9d9c752a-ec3e-448e-b4c5-f31634f1af13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_a69d0a7f-6700-48cc-89da-fac8370957fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5fb0c0fd-3ec4-4336-a130-c19c8f620f3b" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_a69d0a7f-6700-48cc-89da-fac8370957fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_ec725b5a-395c-40ef-9faa-e9e3765520a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5fb0c0fd-3ec4-4336-a130-c19c8f620f3b" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_ec725b5a-395c-40ef-9faa-e9e3765520a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_35178a6d-de87-4f5c-a8e9-00520ad422ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5fb0c0fd-3ec4-4336-a130-c19c8f620f3b" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_35178a6d-de87-4f5c-a8e9-00520ad422ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_8804cab6-0a86-456f-845c-3c4373f569a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5fb0c0fd-3ec4-4336-a130-c19c8f620f3b" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_8804cab6-0a86-456f-845c-3c4373f569a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d45d600f-97d0-4d28-a28c-531e849768c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5fb0c0fd-3ec4-4336-a130-c19c8f620f3b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d45d600f-97d0-4d28-a28c-531e849768c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_440f9232-a72b-4f72-8d6b-9d5b90c7aaf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_dee188ce-a216-457c-a41c-656b636c2b98" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_440f9232-a72b-4f72-8d6b-9d5b90c7aaf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2944e623-3172-4898-93b3-3882f326603a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_dee188ce-a216-457c-a41c-656b636c2b98" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2944e623-3172-4898-93b3-3882f326603a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f3395fdb-dfad-45f4-ab5b-fae187a8db6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_dee188ce-a216-457c-a41c-656b636c2b98" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f3395fdb-dfad-45f4-ab5b-fae187a8db6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_73d09541-4923-4be6-b1b6-8faf2576841a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_dee188ce-a216-457c-a41c-656b636c2b98" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_73d09541-4923-4be6-b1b6-8faf2576841a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/NatureofBusinessBasisofPresentationandPrinciplesofConsolidation" xlink:type="simple" xlink:href="idxx-20211231.xsd#NatureofBusinessBasisofPresentationandPrinciplesofConsolidation"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/NatureofBusinessBasisofPresentationandPrinciplesofConsolidation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e88267cc-38f4-4ab1-86db-8e329f132614" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_b89935df-3dad-4f29-9a77-0cd269379e96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e88267cc-38f4-4ab1-86db-8e329f132614" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_b89935df-3dad-4f29-9a77-0cd269379e96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="idxx-20211231.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_3d1da5d2-c96a-45dd-8f81-a1845920436c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_347f477c-98f3-4ab7-a0a5-9b3c643b31d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3d1da5d2-c96a-45dd-8f81-a1845920436c" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_347f477c-98f3-4ab7-a0a5-9b3c643b31d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="idxx-20211231.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_600948d0-5915-49e7-b2a4-3dee941adae7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_1be6c83d-971c-4872-a78f-62e2b1720014" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_600948d0-5915-49e7-b2a4-3dee941adae7" xlink:to="loc_us-gaap_UseOfEstimates_1be6c83d-971c-4872-a78f-62e2b1720014" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_c83d9966-763e-420d-aedc-862b8a282cc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_600948d0-5915-49e7-b2a4-3dee941adae7" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_c83d9966-763e-420d-aedc-862b8a282cc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyPolicy_7617c57f-99fe-420a-b9ca-de02320fdfb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StandardProductWarrantyPolicy"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_600948d0-5915-49e7-b2a4-3dee941adae7" xlink:to="loc_us-gaap_StandardProductWarrantyPolicy_7617c57f-99fe-420a-b9ca-de02320fdfb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_TaxesRemittedToGovernmentalAuthoritiesOnBehalfOfCustomerPolicyTextBlock_8c8d3a27-b9ca-4896-af42-d749bdadcbb1" xlink:href="idxx-20211231.xsd#idxx_TaxesRemittedToGovernmentalAuthoritiesOnBehalfOfCustomerPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_600948d0-5915-49e7-b2a4-3dee941adae7" xlink:to="loc_idxx_TaxesRemittedToGovernmentalAuthoritiesOnBehalfOfCustomerPolicyTextBlock_8c8d3a27-b9ca-4896-af42-d749bdadcbb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_7cfca470-03c9-494a-b895-a5b1232e96cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_600948d0-5915-49e7-b2a4-3dee941adae7" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_7cfca470-03c9-494a-b895-a5b1232e96cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock_3c1f93b8-7990-45e6-b794-fd651067b2a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_600948d0-5915-49e7-b2a4-3dee941adae7" xlink:to="loc_us-gaap_AdvertisingCostsPolicyTextBlock_3c1f93b8-7990-45e6-b794-fd651067b2a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalCostsPolicyTextBlock_f674f236-3de4-45be-b257-f5618b39ef59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LegalCostsPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_600948d0-5915-49e7-b2a4-3dee941adae7" xlink:to="loc_us-gaap_LegalCostsPolicyTextBlock_f674f236-3de4-45be-b257-f5618b39ef59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_5a40a7c5-255c-4337-91ed-06889b91a6d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_600948d0-5915-49e7-b2a4-3dee941adae7" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_5a40a7c5-255c-4337-91ed-06889b91a6d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_630ae0ab-d466-40a2-a7f6-39585cf7e325" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_600948d0-5915-49e7-b2a4-3dee941adae7" xlink:to="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_630ae0ab-d466-40a2-a7f6-39585cf7e325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ConcentrationRiskPolicyTextBlock_d83fb987-39d8-4ef6-8914-5cde1b649fd4" xlink:href="idxx-20211231.xsd#idxx_ConcentrationRiskPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_600948d0-5915-49e7-b2a4-3dee941adae7" xlink:to="loc_idxx_ConcentrationRiskPolicyTextBlock_d83fb987-39d8-4ef6-8914-5cde1b649fd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_09a825a5-9962-419c-aed5-4551c6e4aae6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_600948d0-5915-49e7-b2a4-3dee941adae7" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_09a825a5-9962-419c-aed5-4551c6e4aae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_948bdf9b-67f3-46f3-b041-c28a1aa901f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_600948d0-5915-49e7-b2a4-3dee941adae7" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_948bdf9b-67f3-46f3-b041-c28a1aa901f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_e345a7f4-921c-4ff1-9a0f-e9d2f8bbe879" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_600948d0-5915-49e7-b2a4-3dee941adae7" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_e345a7f4-921c-4ff1-9a0f-e9d2f8bbe879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditLossFinancialInstrumentPolicyTextBlock_3a0429bb-e961-458d-b2dd-37d4c9009fc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditLossFinancialInstrumentPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_600948d0-5915-49e7-b2a4-3dee941adae7" xlink:to="loc_us-gaap_CreditLossFinancialInstrumentPolicyTextBlock_3a0429bb-e961-458d-b2dd-37d4c9009fc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_5073430c-a53a-4326-b362-79df2a5b21c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_600948d0-5915-49e7-b2a4-3dee941adae7" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_5073430c-a53a-4326-b362-79df2a5b21c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorLeasesPolicyTextBlock_cdf60639-dafb-4201-92fa-74e601a58fcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LessorLeasesPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_600948d0-5915-49e7-b2a4-3dee941adae7" xlink:to="loc_us-gaap_LessorLeasesPolicyTextBlock_cdf60639-dafb-4201-92fa-74e601a58fcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_798f1a1a-736f-40ed-83b7-72b4a8a38c54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_600948d0-5915-49e7-b2a4-3dee941adae7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_798f1a1a-736f-40ed-83b7-72b4a8a38c54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_ad97b086-3e7c-451b-a8bf-8f7b41818c8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_600948d0-5915-49e7-b2a4-3dee941adae7" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_ad97b086-3e7c-451b-a8bf-8f7b41818c8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_ec0c4c15-d1cd-48c5-9cff-0d35891bbc83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_600948d0-5915-49e7-b2a4-3dee941adae7" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_ec0c4c15-d1cd-48c5-9cff-0d35891bbc83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_74ee5775-6615-400b-a2a4-eff69472e9bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_600948d0-5915-49e7-b2a4-3dee941adae7" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_74ee5775-6615-400b-a2a4-eff69472e9bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_cdb633e1-0aff-4d01-a435-b3b0b13fefc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_600948d0-5915-49e7-b2a4-3dee941adae7" xlink:to="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_cdb633e1-0aff-4d01-a435-b3b0b13fefc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_e811ea99-3c32-4dc3-9286-696938df7d3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_600948d0-5915-49e7-b2a4-3dee941adae7" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_e811ea99-3c32-4dc3-9286-696938df7d3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_1539a186-0c77-4600-aa6f-113906785d86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_600948d0-5915-49e7-b2a4-3dee941adae7" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_1539a186-0c77-4600-aa6f-113906785d86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_b6afcb74-136f-43f6-977d-b8b3dac3ec08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_SummaryOfSignificantAccountingPoliciesTable_2c60145f-2237-49fc-8d6e-640749f2fede" xlink:href="idxx-20211231.xsd#idxx_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b6afcb74-136f-43f6-977d-b8b3dac3ec08" xlink:to="loc_idxx_SummaryOfSignificantAccountingPoliciesTable_2c60145f-2237-49fc-8d6e-640749f2fede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_c6333926-485a-4f75-95d7-7cd9b179d7aa" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_SummaryOfSignificantAccountingPoliciesTable_2c60145f-2237-49fc-8d6e-640749f2fede" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_c6333926-485a-4f75-95d7-7cd9b179d7aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_3de38c7b-eda0-4598-bdbf-ea6271dd9984" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_c6333926-485a-4f75-95d7-7cd9b179d7aa" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_3de38c7b-eda0-4598-bdbf-ea6271dd9984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_ac8f953d-b434-4518-9455-863121e5a2bd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_3de38c7b-eda0-4598-bdbf-ea6271dd9984" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_ac8f953d-b434-4518-9455-863121e5a2bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_72231795-2871-46f8-85b7-854cba126312" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_SummaryOfSignificantAccountingPoliciesTable_2c60145f-2237-49fc-8d6e-640749f2fede" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_72231795-2871-46f8-85b7-854cba126312" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_6ae1e298-69f3-48d5-b9e6-58fe3ecec0a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_72231795-2871-46f8-85b7-854cba126312" xlink:to="loc_us-gaap_TypeOfAdoptionMember_6ae1e298-69f3-48d5-b9e6-58fe3ecec0a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member_8594d7d1-ac09-4583-80d5-3de5e59387ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_6ae1e298-69f3-48d5-b9e6-58fe3ecec0a6" xlink:to="loc_us-gaap_AccountingStandardsUpdate201613Member_8594d7d1-ac09-4583-80d5-3de5e59387ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_0c06d606-6cd2-450d-9a08-8abd67264e0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_SummaryOfSignificantAccountingPoliciesTable_2c60145f-2237-49fc-8d6e-640749f2fede" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_0c06d606-6cd2-450d-9a08-8abd67264e0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_66698ae9-4493-41af-9a0d-078215f0bd9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0c06d606-6cd2-450d-9a08-8abd67264e0b" xlink:to="loc_us-gaap_EquityComponentDomain_66698ae9-4493-41af-9a0d-078215f0bd9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_bfc2a843-4d4a-4f99-b045-8c98321a605c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_66698ae9-4493-41af-9a0d-078215f0bd9b" xlink:to="loc_us-gaap_RetainedEarningsMember_bfc2a843-4d4a-4f99-b045-8c98321a605c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_SummaryOfSignificantAccountingPoliciesLineItems_4ebf49ca-588d-4850-b8c5-cc0c55cbfda9" xlink:href="idxx-20211231.xsd#idxx_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_SummaryOfSignificantAccountingPoliciesTable_2c60145f-2237-49fc-8d6e-640749f2fede" xlink:to="loc_idxx_SummaryOfSignificantAccountingPoliciesLineItems_4ebf49ca-588d-4850-b8c5-cc0c55cbfda9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_ffbfd794-6abc-422b-b9e6-7f8b46a300a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_SummaryOfSignificantAccountingPoliciesLineItems_4ebf49ca-588d-4850-b8c5-cc0c55cbfda9" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_ffbfd794-6abc-422b-b9e6-7f8b46a300a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ResearchAndDevelopmentCostsCapitalized_23df2002-dfa4-46cb-8d92-a8b11b514295" xlink:href="idxx-20211231.xsd#idxx_ResearchAndDevelopmentCostsCapitalized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_SummaryOfSignificantAccountingPoliciesLineItems_4ebf49ca-588d-4850-b8c5-cc0c55cbfda9" xlink:to="loc_idxx_ResearchAndDevelopmentCostsCapitalized_23df2002-dfa4-46cb-8d92-a8b11b514295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_77b659aa-cf20-49a1-a0d0-2f4d5817813a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_SummaryOfSignificantAccountingPoliciesLineItems_4ebf49ca-588d-4850-b8c5-cc0c55cbfda9" xlink:to="loc_us-gaap_AdvertisingExpense_77b659aa-cf20-49a1-a0d0-2f4d5817813a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_b95809e3-bfa6-4a00-95e0-01d799442226" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_SummaryOfSignificantAccountingPoliciesLineItems_4ebf49ca-588d-4850-b8c5-cc0c55cbfda9" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_b95809e3-bfa6-4a00-95e0-01d799442226" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_edeeca1c-18f4-4f2b-b2b0-5e8547adae9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_SummaryOfSignificantAccountingPoliciesLineItems_4ebf49ca-588d-4850-b8c5-cc0c55cbfda9" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_edeeca1c-18f4-4f2b-b2b0-5e8547adae9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityCumulativeEffectOfChangeInAccountingPrinciple_22b156f4-32ad-42bc-9914-ecacd8681180" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityCumulativeEffectOfChangeInAccountingPrinciple"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_SummaryOfSignificantAccountingPoliciesLineItems_4ebf49ca-588d-4850-b8c5-cc0c55cbfda9" xlink:to="loc_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityCumulativeEffectOfChangeInAccountingPrinciple_22b156f4-32ad-42bc-9914-ecacd8681180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ContractwithCustomerAssetAndSalesTypeLeaseNetInvestmentInLeaseAllowanceforCreditLoss_177d4a59-93b5-490d-9423-fa6908b53fa9" xlink:href="idxx-20211231.xsd#idxx_ContractwithCustomerAssetAndSalesTypeLeaseNetInvestmentInLeaseAllowanceforCreditLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_SummaryOfSignificantAccountingPoliciesLineItems_4ebf49ca-588d-4850-b8c5-cc0c55cbfda9" xlink:to="loc_idxx_ContractwithCustomerAssetAndSalesTypeLeaseNetInvestmentInLeaseAllowanceforCreditLoss_177d4a59-93b5-490d-9423-fa6908b53fa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_ae9bdb89-ede0-44b2-9404-5b4d6cb5bb0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_SummaryOfSignificantAccountingPoliciesLineItems_4ebf49ca-588d-4850-b8c5-cc0c55cbfda9" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_ae9bdb89-ede0-44b2-9404-5b4d6cb5bb0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/RevenueRecognition" xlink:type="simple" xlink:href="idxx-20211231.xsd#RevenueRecognition"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/RevenueRecognition" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_0aca0241-7206-45d4-9d42-a5574d81f255" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_c86b6e5b-3c4e-4eb8-97ea-db7eb78d7571" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_0aca0241-7206-45d4-9d42-a5574d81f255" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_c86b6e5b-3c4e-4eb8-97ea-db7eb78d7571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/RevenueRecognitionTables" xlink:type="simple" xlink:href="idxx-20211231.xsd#RevenueRecognitionTables"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/RevenueRecognitionTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_63d72259-6898-4bfc-b4e0-f5a299e259a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_3b345ff0-2c5b-4f77-a951-888770d630e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_63d72259-6898-4bfc-b4e0-f5a299e259a2" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_3b345ff0-2c5b-4f77-a951-888770d630e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/RevenueRecognitionDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#RevenueRecognitionDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/RevenueRecognitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_63729144-3ba4-42d9-90f6-24622310f3b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_443c16f5-7257-42c3-bb99-7476fa648e50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_63729144-3ba4-42d9-90f6-24622310f3b0" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_443c16f5-7257-42c3-bb99-7476fa648e50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7ca4c4bc-b158-4dc9-8fff-a21cce968f2b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_443c16f5-7257-42c3-bb99-7476fa648e50" xlink:to="loc_srt_RangeAxis_7ca4c4bc-b158-4dc9-8fff-a21cce968f2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6b9b2020-9e88-4d72-9e87-4a70bb8868e5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_7ca4c4bc-b158-4dc9-8fff-a21cce968f2b" xlink:to="loc_srt_RangeMember_6b9b2020-9e88-4d72-9e87-4a70bb8868e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_568d6c06-1ae0-4d3c-9fd3-b15b728846a7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6b9b2020-9e88-4d72-9e87-4a70bb8868e5" xlink:to="loc_srt_MinimumMember_568d6c06-1ae0-4d3c-9fd3-b15b728846a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6b70a51b-5b77-4b2b-8857-2c99a1c30ca4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6b9b2020-9e88-4d72-9e87-4a70bb8868e5" xlink:to="loc_srt_MaximumMember_6b70a51b-5b77-4b2b-8857-2c99a1c30ca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_edd4dce5-cccd-4fde-b3ee-db9b89f2fb69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_443c16f5-7257-42c3-bb99-7476fa648e50" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_edd4dce5-cccd-4fde-b3ee-db9b89f2fb69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_RevenuePerformanceObligationPaymentTerm_32b82605-fe9d-46ba-a9d0-bff65538c816" xlink:href="idxx-20211231.xsd#idxx_RevenuePerformanceObligationPaymentTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_edd4dce5-cccd-4fde-b3ee-db9b89f2fb69" xlink:to="loc_idxx_RevenuePerformanceObligationPaymentTerm_32b82605-fe9d-46ba-a9d0-bff65538c816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/RevenueRecognitionLeaseRevenueDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#RevenueRecognitionLeaseRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/RevenueRecognitionLeaseRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b80eb1d8-2c2b-4dc6-9602-0a4d9d7ff018" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseIncome_bfe612fb-f69e-4618-895a-a9be9c422cc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseIncome"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b80eb1d8-2c2b-4dc6-9602-0a4d9d7ff018" xlink:to="loc_us-gaap_LeaseIncome_bfe612fb-f69e-4618-895a-a9be9c422cc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/RevenueRecognitionExtendedWarrantiesandPostContractSupportDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#RevenueRecognitionExtendedWarrantiesandPostContractSupportDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/RevenueRecognitionExtendedWarrantiesandPostContractSupportDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_845f6b6a-d069-4e50-8100-8c7bab10a3ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_7ecc3736-9292-4a3c-8502-0a8d7fb61fc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_845f6b6a-d069-4e50-8100-8c7bab10a3ca" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_7ecc3736-9292-4a3c-8502-0a8d7fb61fc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_35671539-460e-4ff1-aada-58f56c9d7e60" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_7ecc3736-9292-4a3c-8502-0a8d7fb61fc7" xlink:to="loc_srt_ProductOrServiceAxis_35671539-460e-4ff1-aada-58f56c9d7e60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_45a97a9b-4368-4380-82dd-e45e48f8d39f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_35671539-460e-4ff1-aada-58f56c9d7e60" xlink:to="loc_srt_ProductsAndServicesDomain_45a97a9b-4368-4380-82dd-e45e48f8d39f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ExtendedWarrantiesAndPostContractSupportMember_8f46d451-8539-4e39-bf3e-66416d361b7e" xlink:href="idxx-20211231.xsd#idxx_ExtendedWarrantiesAndPostContractSupportMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_45a97a9b-4368-4380-82dd-e45e48f8d39f" xlink:to="loc_idxx_ExtendedWarrantiesAndPostContractSupportMember_8f46d451-8539-4e39-bf3e-66416d361b7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a0e2199f-af68-407a-96ec-24a08f2b46f5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_7ecc3736-9292-4a3c-8502-0a8d7fb61fc7" xlink:to="loc_srt_RangeAxis_a0e2199f-af68-407a-96ec-24a08f2b46f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_27b5194b-94bb-4a01-9230-acd456456dc7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_a0e2199f-af68-407a-96ec-24a08f2b46f5" xlink:to="loc_srt_RangeMember_27b5194b-94bb-4a01-9230-acd456456dc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_07ecba2f-74f4-43b8-afe4-2f41d4ed1711" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_27b5194b-94bb-4a01-9230-acd456456dc7" xlink:to="loc_srt_MinimumMember_07ecba2f-74f4-43b8-afe4-2f41d4ed1711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6a2b379b-0b59-4054-8676-7473f4319d61" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_27b5194b-94bb-4a01-9230-acd456456dc7" xlink:to="loc_srt_MaximumMember_6a2b379b-0b59-4054-8676-7473f4319d61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_90f1d2f2-f909-49b8-bbf9-99015461b6d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_7ecc3736-9292-4a3c-8502-0a8d7fb61fc7" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_90f1d2f2-f909-49b8-bbf9-99015461b6d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ExtendedProductWarrantyTerm_99f1fe89-2fbe-4b45-9a57-7ddf8e053bb7" xlink:href="idxx-20211231.xsd#idxx_ExtendedProductWarrantyTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_90f1d2f2-f909-49b8-bbf9-99015461b6d6" xlink:to="loc_idxx_ExtendedProductWarrantyTerm_99f1fe89-2fbe-4b45-9a57-7ddf8e053bb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_PostContractSupportContractTerm_a2c676ac-44e6-4869-92ae-ecab7e02c8fe" xlink:href="idxx-20211231.xsd#idxx_PostContractSupportContractTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_90f1d2f2-f909-49b8-bbf9-99015461b6d6" xlink:to="loc_idxx_PostContractSupportContractTerm_a2c676ac-44e6-4869-92ae-ecab7e02c8fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_65dc872d-fa85-4e9f-80a5-2b10bd53f8d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_90f1d2f2-f909-49b8-bbf9-99015461b6d6" xlink:to="loc_us-gaap_ContractWithCustomerLiability_65dc872d-fa85-4e9f-80a5-2b10bd53f8d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_3ac02d18-721f-4a01-b063-942b55a23acd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_90f1d2f2-f909-49b8-bbf9-99015461b6d6" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_3ac02d18-721f-4a01-b063-942b55a23acd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_f6d6c654-1da2-4df1-b707-e9c1eb534ff2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_90f1d2f2-f909-49b8-bbf9-99015461b6d6" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_f6d6c654-1da2-4df1-b707-e9c1eb534ff2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/RevenueRecognitionRemainingPerformanceObligationDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#RevenueRecognitionRemainingPerformanceObligationDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/RevenueRecognitionRemainingPerformanceObligationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_8a0de380-12da-4ba2-b68d-08a188b5f93f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_9fe624b6-bb26-4296-905d-c9442f84b165" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_8a0de380-12da-4ba2-b68d-08a188b5f93f" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_9fe624b6-bb26-4296-905d-c9442f84b165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_96e8a069-e5bf-4adc-8f00-3af20397e7ed" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_9fe624b6-bb26-4296-905d-c9442f84b165" xlink:to="loc_srt_ProductOrServiceAxis_96e8a069-e5bf-4adc-8f00-3af20397e7ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a7bb78ec-a885-4f4e-b8c7-8fd6395d5116" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_96e8a069-e5bf-4adc-8f00-3af20397e7ed" xlink:to="loc_srt_ProductsAndServicesDomain_a7bb78ec-a885-4f4e-b8c7-8fd6395d5116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ExtendedWarrantiesAndPostContractSupportMember_ceb908c5-98c4-4667-9ccb-4ac48d9c9cc7" xlink:href="idxx-20211231.xsd#idxx_ExtendedWarrantiesAndPostContractSupportMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_a7bb78ec-a885-4f4e-b8c7-8fd6395d5116" xlink:to="loc_idxx_ExtendedWarrantiesAndPostContractSupportMember_ceb908c5-98c4-4667-9ccb-4ac48d9c9cc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_UpFrontCustomerLoyaltyProgramsAndVolumeCommitmentProgramsMember_18c3cbf0-fe57-44e3-88dc-d9c3d58935d5" xlink:href="idxx-20211231.xsd#idxx_UpFrontCustomerLoyaltyProgramsAndVolumeCommitmentProgramsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_a7bb78ec-a885-4f4e-b8c7-8fd6395d5116" xlink:to="loc_idxx_UpFrontCustomerLoyaltyProgramsAndVolumeCommitmentProgramsMember_18c3cbf0-fe57-44e3-88dc-d9c3d58935d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_InstrumentRebateProgramsMember_fcc3c23b-0a0b-43bc-9a91-71db3f92f98f" xlink:href="idxx-20211231.xsd#idxx_InstrumentRebateProgramsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_a7bb78ec-a885-4f4e-b8c7-8fd6395d5116" xlink:to="loc_idxx_InstrumentRebateProgramsMember_fcc3c23b-0a0b-43bc-9a91-71db3f92f98f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ReagentRentalProgramsMember_a1ad4691-b968-4ab1-bb8a-1221d09d1f1e" xlink:href="idxx-20211231.xsd#idxx_ReagentRentalProgramsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_a7bb78ec-a885-4f4e-b8c7-8fd6395d5116" xlink:to="loc_idxx_ReagentRentalProgramsMember_a1ad4691-b968-4ab1-bb8a-1221d09d1f1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_72f6d167-8a6e-4be4-9aed-51b488b5f0d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_9fe624b6-bb26-4296-905d-c9442f84b165" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_72f6d167-8a6e-4be4-9aed-51b488b5f0d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_32ab717b-c240-4c76-b0bf-0328691bcff2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_9fe624b6-bb26-4296-905d-c9442f84b165" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_32ab717b-c240-4c76-b0bf-0328691bcff2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_1ab92d26-00a5-40e8-969c-0b5027ac1e45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_32ab717b-c240-4c76-b0bf-0328691bcff2" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_1ab92d26-00a5-40e8-969c-0b5027ac1e45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_289cf5f8-7d70-4d8a-8674-3e8724f61223" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_32ab717b-c240-4c76-b0bf-0328691bcff2" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_289cf5f8-7d70-4d8a-8674-3e8724f61223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/RevenueRecognitionRemainingPerformanceObligationDetails_1" xlink:type="simple" xlink:href="idxx-20211231.xsd#RevenueRecognitionRemainingPerformanceObligationDetails_1"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/RevenueRecognitionRemainingPerformanceObligationDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.idexx.com/role/RevenueRecognitionSaaSSubscriptionsDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#RevenueRecognitionSaaSSubscriptionsDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/RevenueRecognitionSaaSSubscriptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_5c5d99ef-a63a-4dc5-b6f5-c50c16004adf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_773bccda-5d4b-4b7e-9f22-a2bee7f29c11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_5c5d99ef-a63a-4dc5-b6f5-c50c16004adf" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_773bccda-5d4b-4b7e-9f22-a2bee7f29c11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_b589be01-aec1-40af-b3b4-bceb8793666a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_773bccda-5d4b-4b7e-9f22-a2bee7f29c11" xlink:to="loc_srt_RangeAxis_b589be01-aec1-40af-b3b4-bceb8793666a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8e8061c1-0c16-4d3d-8ccf-ad80b594a033" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_b589be01-aec1-40af-b3b4-bceb8793666a" xlink:to="loc_srt_RangeMember_8e8061c1-0c16-4d3d-8ccf-ad80b594a033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4730eb08-e612-478d-840d-e08698f6bd5c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8e8061c1-0c16-4d3d-8ccf-ad80b594a033" xlink:to="loc_srt_MaximumMember_4730eb08-e612-478d-840d-e08698f6bd5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_99fef48d-1d8c-490d-bf06-a243c44c8371" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_773bccda-5d4b-4b7e-9f22-a2bee7f29c11" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_99fef48d-1d8c-490d-bf06-a243c44c8371" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_SaasSubscriptionTermOfContract_918c04d1-5741-451e-84f1-5c2548e1b9cd" xlink:href="idxx-20211231.xsd#idxx_SaasSubscriptionTermOfContract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_99fef48d-1d8c-490d-bf06-a243c44c8371" xlink:to="loc_idxx_SaasSubscriptionTermOfContract_918c04d1-5741-451e-84f1-5c2548e1b9cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/RevenueRecognitionUpFrontCustomerLoyaltyProgramsDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#RevenueRecognitionUpFrontCustomerLoyaltyProgramsDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/RevenueRecognitionUpFrontCustomerLoyaltyProgramsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_606d373c-d0de-4d2e-925f-b73c8148c385" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_ed4ad73b-bc75-471b-9c18-32c3c2ed9ae1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_606d373c-d0de-4d2e-925f-b73c8148c385" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_ed4ad73b-bc75-471b-9c18-32c3c2ed9ae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_f838d36d-4bab-495b-a69d-4aa8b7e34189" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_ed4ad73b-bc75-471b-9c18-32c3c2ed9ae1" xlink:to="loc_srt_ProductOrServiceAxis_f838d36d-4bab-495b-a69d-4aa8b7e34189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_da0e84dd-5e30-4c1b-a508-bced0aa6c4cf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_f838d36d-4bab-495b-a69d-4aa8b7e34189" xlink:to="loc_srt_ProductsAndServicesDomain_da0e84dd-5e30-4c1b-a508-bced0aa6c4cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_UpFrontCustomerLoyaltyProgramsMember_da77a0f0-a7b0-41fe-9e99-128c62533de1" xlink:href="idxx-20211231.xsd#idxx_UpFrontCustomerLoyaltyProgramsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_da0e84dd-5e30-4c1b-a508-bced0aa6c4cf" xlink:to="loc_idxx_UpFrontCustomerLoyaltyProgramsMember_da77a0f0-a7b0-41fe-9e99-128c62533de1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_9f1ab001-f334-4cd9-a0cf-93d2a5e1cb13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_ed4ad73b-bc75-471b-9c18-32c3c2ed9ae1" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_9f1ab001-f334-4cd9-a0cf-93d2a5e1cb13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostGross_bac22cee-4c7e-4de3-8ef5-574ea8ace171" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_9f1ab001-f334-4cd9-a0cf-93d2a5e1cb13" xlink:to="loc_us-gaap_CapitalizedContractCostGross_bac22cee-4c7e-4de3-8ef5-574ea8ace171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortization_1784f561-a25c-4df5-88f3-46a67e54f5f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_9f1ab001-f334-4cd9-a0cf-93d2a5e1cb13" xlink:to="loc_us-gaap_CapitalizedContractCostAmortization_1784f561-a25c-4df5-88f3-46a67e54f5f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/RevenueRecognitionVolumeCommitmentProgramsDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#RevenueRecognitionVolumeCommitmentProgramsDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/RevenueRecognitionVolumeCommitmentProgramsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a6cc5ddf-67a5-4e46-b5f0-fe0a5a7b6b0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_4e2a0da4-9122-468c-8acc-b16bacec53ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a6cc5ddf-67a5-4e46-b5f0-fe0a5a7b6b0d" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_4e2a0da4-9122-468c-8acc-b16bacec53ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c31c2c15-3076-49ac-9fef-4390093538a2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_4e2a0da4-9122-468c-8acc-b16bacec53ff" xlink:to="loc_srt_ProductOrServiceAxis_c31c2c15-3076-49ac-9fef-4390093538a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_74e238cd-64db-4d64-8287-d7364490f6ad" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_c31c2c15-3076-49ac-9fef-4390093538a2" xlink:to="loc_srt_ProductsAndServicesDomain_74e238cd-64db-4d64-8287-d7364490f6ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_VolumeCommitmentProgramsMember_ded74986-830b-49c2-83da-53f0d5632c05" xlink:href="idxx-20211231.xsd#idxx_VolumeCommitmentProgramsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_74e238cd-64db-4d64-8287-d7364490f6ad" xlink:to="loc_idxx_VolumeCommitmentProgramsMember_ded74986-830b-49c2-83da-53f0d5632c05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_UpFrontCustomerLoyaltyProgramsAndVolumeCommitmentProgramsMember_7bd28d5d-6aa2-4126-abd3-4f78afa7c875" xlink:href="idxx-20211231.xsd#idxx_UpFrontCustomerLoyaltyProgramsAndVolumeCommitmentProgramsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_74e238cd-64db-4d64-8287-d7364490f6ad" xlink:to="loc_idxx_UpFrontCustomerLoyaltyProgramsAndVolumeCommitmentProgramsMember_7bd28d5d-6aa2-4126-abd3-4f78afa7c875" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_7ff2c331-ab2c-4644-8058-d51c5e5a0720" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_4e2a0da4-9122-468c-8acc-b16bacec53ff" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_7ff2c331-ab2c-4644-8058-d51c5e5a0720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_90ea9021-61c1-45f9-b33e-776f1d203f2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_7ff2c331-ab2c-4644-8058-d51c5e5a0720" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_90ea9021-61c1-45f9-b33e-776f1d203f2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable_9f1768f1-2f44-48fc-918e-d1e0c86e68a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetReclassifiedToReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_7ff2c331-ab2c-4644-8058-d51c5e5a0720" xlink:to="loc_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable_9f1768f1-2f44-48fc-918e-d1e0c86e68a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_99f65fe6-c1b4-4b36-8523-16f059231166" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_7ff2c331-ab2c-4644-8058-d51c5e5a0720" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_99f65fe6-c1b4-4b36-8523-16f059231166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/RevenueRecognitionInstrumentRebateProgramsDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#RevenueRecognitionInstrumentRebateProgramsDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/RevenueRecognitionInstrumentRebateProgramsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_d5185e74-f6ef-43cd-9261-dd46b0d4b1d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_6f56e925-4ef8-4ed4-8f1f-e10dfba82bb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_d5185e74-f6ef-43cd-9261-dd46b0d4b1d2" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_6f56e925-4ef8-4ed4-8f1f-e10dfba82bb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_8885d75f-86a3-46d1-932f-02c62a341aec" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_6f56e925-4ef8-4ed4-8f1f-e10dfba82bb0" xlink:to="loc_srt_ProductOrServiceAxis_8885d75f-86a3-46d1-932f-02c62a341aec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_647d7335-7316-4763-85a6-edbf8092192f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_8885d75f-86a3-46d1-932f-02c62a341aec" xlink:to="loc_srt_ProductsAndServicesDomain_647d7335-7316-4763-85a6-edbf8092192f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_InstrumentRebateProgramsMember_973aa45a-41f6-4ba3-a337-2b3cfc961e2d" xlink:href="idxx-20211231.xsd#idxx_InstrumentRebateProgramsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_647d7335-7316-4763-85a6-edbf8092192f" xlink:to="loc_idxx_InstrumentRebateProgramsMember_973aa45a-41f6-4ba3-a337-2b3cfc961e2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_d15f442a-e420-4278-9460-d694d8c74c2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_6f56e925-4ef8-4ed4-8f1f-e10dfba82bb0" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_d15f442a-e420-4278-9460-d694d8c74c2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_eb3542d3-274d-4186-89c9-9be2066bdb90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_d15f442a-e420-4278-9460-d694d8c74c2d" xlink:to="loc_us-gaap_ContractWithCustomerLiability_eb3542d3-274d-4186-89c9-9be2066bdb90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_dc223f63-ac22-48e3-9ef5-9e5e262d3f28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_d15f442a-e420-4278-9460-d694d8c74c2d" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_dc223f63-ac22-48e3-9ef5-9e5e262d3f28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/RevenueRecognitionReagentRentalProgramsDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#RevenueRecognitionReagentRentalProgramsDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/RevenueRecognitionReagentRentalProgramsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c18f9af0-2e1e-4ef1-a3e0-d709c40c9b6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_ec6c9a79-8d47-48fe-9c13-9a19efcec5cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c18f9af0-2e1e-4ef1-a3e0-d709c40c9b6f" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_ec6c9a79-8d47-48fe-9c13-9a19efcec5cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_22a72cd6-aaa9-4634-bf6a-368f2a3b14da" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_ec6c9a79-8d47-48fe-9c13-9a19efcec5cb" xlink:to="loc_srt_ProductOrServiceAxis_22a72cd6-aaa9-4634-bf6a-368f2a3b14da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_76236ca2-eec2-42e0-9e43-71bfa7afc406" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_22a72cd6-aaa9-4634-bf6a-368f2a3b14da" xlink:to="loc_srt_ProductsAndServicesDomain_76236ca2-eec2-42e0-9e43-71bfa7afc406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ReagentRentalProgramsMember_57cb61d4-a9ea-44c9-83b6-0ec61df33097" xlink:href="idxx-20211231.xsd#idxx_ReagentRentalProgramsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_76236ca2-eec2-42e0-9e43-71bfa7afc406" xlink:to="loc_idxx_ReagentRentalProgramsMember_57cb61d4-a9ea-44c9-83b6-0ec61df33097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_ad77cdfb-ca99-4fe6-bbf9-644d8591d1ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_ec6c9a79-8d47-48fe-9c13-9a19efcec5cb" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_ad77cdfb-ca99-4fe6-bbf9-644d8591d1ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseLeaseReceivable_9b827c35-b441-438e-85de-9989f482dbc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseLeaseReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_ad77cdfb-ca99-4fe6-bbf9-644d8591d1ea" xlink:to="loc_us-gaap_SalesTypeLeaseLeaseReceivable_9b827c35-b441-438e-85de-9989f482dbc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_SalesTypeLeaseLeaseReceivableReclassifiedToReceivable_5a7f3917-c951-4dab-9f99-cda96a0d1332" xlink:href="idxx-20211231.xsd#idxx_SalesTypeLeaseLeaseReceivableReclassifiedToReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_ad77cdfb-ca99-4fe6-bbf9-644d8591d1ea" xlink:to="loc_idxx_SalesTypeLeaseLeaseReceivableReclassifiedToReceivable_5a7f3917-c951-4dab-9f99-cda96a0d1332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_2cf9c92e-c686-4dfd-8791-1117a6bf73d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_ad77cdfb-ca99-4fe6-bbf9-644d8591d1ea" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_2cf9c92e-c686-4dfd-8791-1117a6bf73d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/RevenueRecognitionDisaggregationofRevenuebyMajorProductandServiceCategoriesDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#RevenueRecognitionDisaggregationofRevenuebyMajorProductandServiceCategoriesDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/RevenueRecognitionDisaggregationofRevenuebyMajorProductandServiceCategoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1433d282-d7a1-4f50-8e34-f4db2cc68246" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_0d7bbee3-1199-4b04-aebd-1bf7a0e90e25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1433d282-d7a1-4f50-8e34-f4db2cc68246" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_0d7bbee3-1199-4b04-aebd-1bf7a0e90e25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d59ed5f4-1c3d-410b-80f7-46177acf9076" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_0d7bbee3-1199-4b04-aebd-1bf7a0e90e25" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d59ed5f4-1c3d-410b-80f7-46177acf9076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_74b672f4-ab35-47b2-ab75-6c5b53c071b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d59ed5f4-1c3d-410b-80f7-46177acf9076" xlink:to="loc_us-gaap_SegmentDomain_74b672f4-ab35-47b2-ab75-6c5b53c071b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_CompanionAnimalGroupSegmentMember_8a4be11f-64e1-49b7-8543-03cd4c40ea39" xlink:href="idxx-20211231.xsd#idxx_CompanionAnimalGroupSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_74b672f4-ab35-47b2-ab75-6c5b53c071b4" xlink:to="loc_idxx_CompanionAnimalGroupSegmentMember_8a4be11f-64e1-49b7-8543-03cd4c40ea39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_WaterSegmentMember_a6e65226-94be-49f5-89f2-d0d46f9e6edf" xlink:href="idxx-20211231.xsd#idxx_WaterSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_74b672f4-ab35-47b2-ab75-6c5b53c071b4" xlink:to="loc_idxx_WaterSegmentMember_a6e65226-94be-49f5-89f2-d0d46f9e6edf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_LivestockAndPoultryDiagnosticsSegmentMember_11c1eb8b-ee84-4512-b90a-086a375c58ca" xlink:href="idxx-20211231.xsd#idxx_LivestockAndPoultryDiagnosticsSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_74b672f4-ab35-47b2-ab75-6c5b53c071b4" xlink:to="loc_idxx_LivestockAndPoultryDiagnosticsSegmentMember_11c1eb8b-ee84-4512-b90a-086a375c58ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_OtherSegmentMember_f158d622-72e6-425b-a245-285cb5d7975d" xlink:href="idxx-20211231.xsd#idxx_OtherSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_74b672f4-ab35-47b2-ab75-6c5b53c071b4" xlink:to="loc_idxx_OtherSegmentMember_f158d622-72e6-425b-a245-285cb5d7975d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_f80a1070-5d49-497c-917d-d2c82fec836f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_0d7bbee3-1199-4b04-aebd-1bf7a0e90e25" xlink:to="loc_srt_ProductOrServiceAxis_f80a1070-5d49-497c-917d-d2c82fec836f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_8736ff5d-7b39-457d-b27f-1646d30b786c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_f80a1070-5d49-497c-917d-d2c82fec836f" xlink:to="loc_srt_ProductsAndServicesDomain_8736ff5d-7b39-457d-b27f-1646d30b786c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_CAGDiagnosticsRecurringRevenueMember_6689cf78-494b-4d88-8421-f6adca943df8" xlink:href="idxx-20211231.xsd#idxx_CAGDiagnosticsRecurringRevenueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8736ff5d-7b39-457d-b27f-1646d30b786c" xlink:to="loc_idxx_CAGDiagnosticsRecurringRevenueMember_6689cf78-494b-4d88-8421-f6adca943df8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_VetLabConsumablesMember_e83dca70-9cbf-4eee-9260-03e28b923e2d" xlink:href="idxx-20211231.xsd#idxx_VetLabConsumablesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_CAGDiagnosticsRecurringRevenueMember_6689cf78-494b-4d88-8421-f6adca943df8" xlink:to="loc_idxx_VetLabConsumablesMember_e83dca70-9cbf-4eee-9260-03e28b923e2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_RapidAssayProductsMember_6389bb9b-fd96-41ba-9b3c-becc636478bf" xlink:href="idxx-20211231.xsd#idxx_RapidAssayProductsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_CAGDiagnosticsRecurringRevenueMember_6689cf78-494b-4d88-8421-f6adca943df8" xlink:to="loc_idxx_RapidAssayProductsMember_6389bb9b-fd96-41ba-9b3c-becc636478bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ReferenceLaboratoryDiagnosticAndConsultingServicesMember_8fa3dd12-1d71-4954-8055-849b39df7720" xlink:href="idxx-20211231.xsd#idxx_ReferenceLaboratoryDiagnosticAndConsultingServicesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_CAGDiagnosticsRecurringRevenueMember_6689cf78-494b-4d88-8421-f6adca943df8" xlink:to="loc_idxx_ReferenceLaboratoryDiagnosticAndConsultingServicesMember_8fa3dd12-1d71-4954-8055-849b39df7720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_CAGDiagnosticsServiceAndAccessoriesMember_7a518c57-eec9-40ab-ae41-e7354718ca5c" xlink:href="idxx-20211231.xsd#idxx_CAGDiagnosticsServiceAndAccessoriesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_CAGDiagnosticsRecurringRevenueMember_6689cf78-494b-4d88-8421-f6adca943df8" xlink:to="loc_idxx_CAGDiagnosticsServiceAndAccessoriesMember_7a518c57-eec9-40ab-ae41-e7354718ca5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_CAGDiagnosticCapitalVetlabInstrumentsMember_f5207d5e-383f-4f9c-ba02-067841742985" xlink:href="idxx-20211231.xsd#idxx_CAGDiagnosticCapitalVetlabInstrumentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8736ff5d-7b39-457d-b27f-1646d30b786c" xlink:to="loc_idxx_CAGDiagnosticCapitalVetlabInstrumentsMember_f5207d5e-383f-4f9c-ba02-067841742985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_VeterinarySoftwareServicesAndDiagnosticImagingSystemsMember_cc6341bc-530c-43c6-b102-22b1870c9ff7" xlink:href="idxx-20211231.xsd#idxx_VeterinarySoftwareServicesAndDiagnosticImagingSystemsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8736ff5d-7b39-457d-b27f-1646d30b786c" xlink:to="loc_idxx_VeterinarySoftwareServicesAndDiagnosticImagingSystemsMember_cc6341bc-530c-43c6-b102-22b1870c9ff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_274a93fe-4baa-4f04-a821-eaf512d1be46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_0d7bbee3-1199-4b04-aebd-1bf7a0e90e25" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_274a93fe-4baa-4f04-a821-eaf512d1be46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_62d2770c-6819-4127-a386-a529a49e4f58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_274a93fe-4baa-4f04-a821-eaf512d1be46" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_62d2770c-6819-4127-a386-a529a49e4f58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/RevenueRecognitionDisaggregationofRevenuebyPrincipalGeographicAreaBasedonCustomersDomicilesDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#RevenueRecognitionDisaggregationofRevenuebyPrincipalGeographicAreaBasedonCustomersDomicilesDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/RevenueRecognitionDisaggregationofRevenuebyPrincipalGeographicAreaBasedonCustomersDomicilesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_6aa4f507-e1df-412a-9810-f894bb7c43c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_ab1bbf38-aa02-47cd-98c1-c8c68862e054" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_6aa4f507-e1df-412a-9810-f894bb7c43c4" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_ab1bbf38-aa02-47cd-98c1-c8c68862e054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_e6daeecb-fbff-4e72-b853-4952bb3fe373" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ab1bbf38-aa02-47cd-98c1-c8c68862e054" xlink:to="loc_srt_StatementGeographicalAxis_e6daeecb-fbff-4e72-b853-4952bb3fe373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_a1784ded-1d57-46c3-83e5-3f5a4729a13b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_e6daeecb-fbff-4e72-b853-4952bb3fe373" xlink:to="loc_srt_SegmentGeographicalDomain_a1784ded-1d57-46c3-83e5-3f5a4729a13b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember_9468091e-97c7-4852-a1df-89af758c5fc1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AmericasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a1784ded-1d57-46c3-83e5-3f5a4729a13b" xlink:to="loc_srt_AmericasMember_9468091e-97c7-4852-a1df-89af758c5fc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_fb4a3a9f-03b1-44d1-a3ba-1c1d35faa3de" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_AmericasMember_9468091e-97c7-4852-a1df-89af758c5fc1" xlink:to="loc_country_US_fb4a3a9f-03b1-44d1-a3ba-1c1d35faa3de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_03721d30-2acf-4750-9e55-1522559804f4" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CA"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_AmericasMember_9468091e-97c7-4852-a1df-89af758c5fc1" xlink:to="loc_country_CA_03721d30-2acf-4750-9e55-1522559804f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_LatinAmericaAndCaribbeanMember_8554de5d-00d4-4ec1-a60b-81449a0bfa1a" xlink:href="idxx-20211231.xsd#idxx_LatinAmericaAndCaribbeanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_AmericasMember_9468091e-97c7-4852-a1df-89af758c5fc1" xlink:to="loc_idxx_LatinAmericaAndCaribbeanMember_8554de5d-00d4-4ec1-a60b-81449a0bfa1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_6e17b5dd-d69f-4b74-a213-77dd8c6b61a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EMEAMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a1784ded-1d57-46c3-83e5-3f5a4729a13b" xlink:to="loc_us-gaap_EMEAMember_6e17b5dd-d69f-4b74-a213-77dd8c6b61a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE_7413c4ee-7f25-410e-9a3c-34028c4cc753" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_DE"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EMEAMember_6e17b5dd-d69f-4b74-a213-77dd8c6b61a2" xlink:to="loc_country_DE_7413c4ee-7f25-410e-9a3c-34028c4cc753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_585ed44c-bc64-4846-99d2-6485e183e9d6" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_GB"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EMEAMember_6e17b5dd-d69f-4b74-a213-77dd8c6b61a2" xlink:to="loc_country_GB_585ed44c-bc64-4846-99d2-6485e183e9d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR_044690ee-ca13-4e3a-9e51-f321b334e3d3" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_FR"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EMEAMember_6e17b5dd-d69f-4b74-a213-77dd8c6b61a2" xlink:to="loc_country_FR_044690ee-ca13-4e3a-9e51-f321b334e3d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IT_32227929-05dd-49c4-abda-bf4e5f385d42" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IT"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EMEAMember_6e17b5dd-d69f-4b74-a213-77dd8c6b61a2" xlink:to="loc_country_IT_32227929-05dd-49c4-abda-bf4e5f385d42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_ES_2817c32c-5daf-40f7-969f-e9418f06ce89" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_ES"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EMEAMember_6e17b5dd-d69f-4b74-a213-77dd8c6b61a2" xlink:to="loc_country_ES_2817c32c-5daf-40f7-969f-e9418f06ce89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_e110d2a0-0e66-4b2d-84b5-7c727a750522" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CH"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EMEAMember_6e17b5dd-d69f-4b74-a213-77dd8c6b61a2" xlink:to="loc_country_CH_e110d2a0-0e66-4b2d-84b5-7c727a750522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_NL_e0e6a1fc-c184-47f7-b715-51b9509f5a58" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_NL"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EMEAMember_6e17b5dd-d69f-4b74-a213-77dd8c6b61a2" xlink:to="loc_country_NL_e0e6a1fc-c184-47f7-b715-51b9509f5a58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_EuropetheMiddleEastandAfricaOtherMember_2165a161-8b71-40ac-9b73-fefa79b0df75" xlink:href="idxx-20211231.xsd#idxx_EuropetheMiddleEastandAfricaOtherMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EMEAMember_6e17b5dd-d69f-4b74-a213-77dd8c6b61a2" xlink:to="loc_idxx_EuropetheMiddleEastandAfricaOtherMember_2165a161-8b71-40ac-9b73-fefa79b0df75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_9bf721db-237b-4bd3-b9c5-cb574608fb89" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AsiaPacificMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a1784ded-1d57-46c3-83e5-3f5a4729a13b" xlink:to="loc_srt_AsiaPacificMember_9bf721db-237b-4bd3-b9c5-cb574608fb89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_AU_1c548af4-fb92-4b0b-832c-77479b666d3e" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_AU"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_AsiaPacificMember_9bf721db-237b-4bd3-b9c5-cb574608fb89" xlink:to="loc_country_AU_1c548af4-fb92-4b0b-832c-77479b666d3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_JP_a0a95aba-4855-4103-8f24-34544f53eac3" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_JP"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_AsiaPacificMember_9bf721db-237b-4bd3-b9c5-cb574608fb89" xlink:to="loc_country_JP_a0a95aba-4855-4103-8f24-34544f53eac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN_255baec0-e314-46a3-b96a-bd22bd586034" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CN"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_AsiaPacificMember_9bf721db-237b-4bd3-b9c5-cb574608fb89" xlink:to="loc_country_CN_255baec0-e314-46a3-b96a-bd22bd586034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_AsiaPacificRegionOtherMember_2a397628-001a-4a6d-bf9a-8a15106e38ad" xlink:href="idxx-20211231.xsd#idxx_AsiaPacificRegionOtherMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_AsiaPacificMember_9bf721db-237b-4bd3-b9c5-cb574608fb89" xlink:to="loc_idxx_AsiaPacificRegionOtherMember_2a397628-001a-4a6d-bf9a-8a15106e38ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_be1d12c0-d2f9-4b6e-98ec-cd24bdb86cf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ab1bbf38-aa02-47cd-98c1-c8c68862e054" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_be1d12c0-d2f9-4b6e-98ec-cd24bdb86cf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9ed8ab1c-6c81-4d36-915a-173edc099626" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_be1d12c0-d2f9-4b6e-98ec-cd24bdb86cf3" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9ed8ab1c-6c81-4d36-915a-173edc099626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/RevenueRecognitionCoststoObtainaContractDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#RevenueRecognitionCoststoObtainaContractDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/RevenueRecognitionCoststoObtainaContractDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_95194c4b-4397-4d2c-a2c0-5925f50ba35d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_604cf6e2-864a-4ebe-bd21-27867db345bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_95194c4b-4397-4d2c-a2c0-5925f50ba35d" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_604cf6e2-864a-4ebe-bd21-27867db345bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_70a8ca27-d04d-4423-9837-c545f71e1211" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_604cf6e2-864a-4ebe-bd21-27867db345bb" xlink:to="loc_srt_RangeAxis_70a8ca27-d04d-4423-9837-c545f71e1211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5a0e4808-96b5-4ba7-ba3a-ee26b59244e7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_70a8ca27-d04d-4423-9837-c545f71e1211" xlink:to="loc_srt_RangeMember_5a0e4808-96b5-4ba7-ba3a-ee26b59244e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_26466879-e0a6-4970-85de-a6cb5da3f5fd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5a0e4808-96b5-4ba7-ba3a-ee26b59244e7" xlink:to="loc_srt_MinimumMember_26466879-e0a6-4970-85de-a6cb5da3f5fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_0c84a124-d465-4a64-ad98-fa828dbbf021" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5a0e4808-96b5-4ba7-ba3a-ee26b59244e7" xlink:to="loc_srt_MaximumMember_0c84a124-d465-4a64-ad98-fa828dbbf021" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_81c32ace-8eff-4082-a730-d58b47e504c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_604cf6e2-864a-4ebe-bd21-27867db345bb" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_81c32ace-8eff-4082-a730-d58b47e504c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortizationPeriod_f4879f76-862d-48ef-99a6-0448eed5afac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostAmortizationPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_81c32ace-8eff-4082-a730-d58b47e504c5" xlink:to="loc_us-gaap_CapitalizedContractCostAmortizationPeriod_f4879f76-862d-48ef-99a6-0448eed5afac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNet_5dcfa237-f559-40da-bf36-fcaea554b0d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_81c32ace-8eff-4082-a730-d58b47e504c5" xlink:to="loc_us-gaap_CapitalizedContractCostNet_5dcfa237-f559-40da-bf36-fcaea554b0d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesCommissionsAndFees_d0a8e603-5cb5-4c17-b4b8-4f51ada23c61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesCommissionsAndFees"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_81c32ace-8eff-4082-a730-d58b47e504c5" xlink:to="loc_us-gaap_SalesCommissionsAndFees_d0a8e603-5cb5-4c17-b4b8-4f51ada23c61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/AcquisitionsandInvestments" xlink:type="simple" xlink:href="idxx-20211231.xsd#AcquisitionsandInvestments"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/AcquisitionsandInvestments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_5362a278-9597-4e7d-8f0f-0c40a110fe49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_b97a4b05-5175-4585-88c1-f880fb885753" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_5362a278-9597-4e7d-8f0f-0c40a110fe49" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_b97a4b05-5175-4585-88c1-f880fb885753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/AcquisitionsandInvestmentsDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#AcquisitionsandInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/AcquisitionsandInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_51d19dfd-a4c8-41e0-864a-db611ab5b766" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8d19838d-8caa-4e3d-ba02-28c6252d3ed9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_51d19dfd-a4c8-41e0-864a-db611ab5b766" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8d19838d-8caa-4e3d-ba02-28c6252d3ed9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_2fe0aed8-c987-4a1b-b701-4d300a6e62fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8d19838d-8caa-4e3d-ba02-28c6252d3ed9" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_2fe0aed8-c987-4a1b-b701-4d300a6e62fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e58f6ccf-e903-4b99-9d9a-eb3f0b4f1b35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2fe0aed8-c987-4a1b-b701-4d300a6e62fb" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e58f6ccf-e903-4b99-9d9a-eb3f0b4f1b35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ReferenceLaboratoryMember_e8047660-9645-4099-9dea-124a11dbe4d8" xlink:href="idxx-20211231.xsd#idxx_ReferenceLaboratoryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e58f6ccf-e903-4b99-9d9a-eb3f0b4f1b35" xlink:to="loc_idxx_ReferenceLaboratoryMember_e8047660-9645-4099-9dea-124a11dbe4d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_TeleradiologyBusinessMember_bbaf772d-54e4-4a84-952b-1831b36d92ea" xlink:href="idxx-20211231.xsd#idxx_TeleradiologyBusinessMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e58f6ccf-e903-4b99-9d9a-eb3f0b4f1b35" xlink:to="loc_idxx_TeleradiologyBusinessMember_bbaf772d-54e4-4a84-952b-1831b36d92ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_EzyVetMember_c2e72bf5-70ba-4ce6-a688-9363feeac571" xlink:href="idxx-20211231.xsd#idxx_EzyVetMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e58f6ccf-e903-4b99-9d9a-eb3f0b4f1b35" xlink:to="loc_idxx_EzyVetMember_c2e72bf5-70ba-4ce6-a688-9363feeac571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ReferenceLaboratoryinMidWestUnitedStatesMember_553db230-2cf0-4e10-bb6b-029220c2c7ac" xlink:href="idxx-20211231.xsd#idxx_ReferenceLaboratoryinMidWestUnitedStatesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e58f6ccf-e903-4b99-9d9a-eb3f0b4f1b35" xlink:to="loc_idxx_ReferenceLaboratoryinMidWestUnitedStatesMember_553db230-2cf0-4e10-bb6b-029220c2c7ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_648c1da5-bee9-4216-97de-5d2f235ae202" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8d19838d-8caa-4e3d-ba02-28c6252d3ed9" xlink:to="loc_srt_StatementGeographicalAxis_648c1da5-bee9-4216-97de-5d2f235ae202" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_d1920d06-8524-4420-82a9-794e222a3ed3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_648c1da5-bee9-4216-97de-5d2f235ae202" xlink:to="loc_srt_SegmentGeographicalDomain_d1920d06-8524-4420-82a9-794e222a3ed3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FI_76d2b38f-15b5-47d8-a022-3ef3325fa8bb" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_FI"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_d1920d06-8524-4420-82a9-794e222a3ed3" xlink:to="loc_country_FI_76d2b38f-15b5-47d8-a022-3ef3325fa8bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_7ed73a53-24c1-4aed-a27e-a89ea980fe2e" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CH"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_d1920d06-8524-4420-82a9-794e222a3ed3" xlink:to="loc_country_CH_7ed73a53-24c1-4aed-a27e-a89ea980fe2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f27c9f98-8195-4762-99d4-a21e0d388027" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8d19838d-8caa-4e3d-ba02-28c6252d3ed9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f27c9f98-8195-4762-99d4-a21e0d388027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ab27f5a3-475e-44fb-aef5-8994b704a661" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f27c9f98-8195-4762-99d4-a21e0d388027" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ab27f5a3-475e-44fb-aef5-8994b704a661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_38f7dc3d-1d08-4d11-99f3-d9c07fd8d4a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ab27f5a3-475e-44fb-aef5-8994b704a661" xlink:to="loc_us-gaap_CustomerRelationshipsMember_38f7dc3d-1d08-4d11-99f3-d9c07fd8d4a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_d2cf207b-4da4-4fb6-b509-f1acfaa42fbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ab27f5a3-475e-44fb-aef5-8994b704a661" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_d2cf207b-4da4-4fb6-b509-f1acfaa42fbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_e3c9e82a-585b-4a2f-94fd-60788ccf2551" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ab27f5a3-475e-44fb-aef5-8994b704a661" xlink:to="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_e3c9e82a-585b-4a2f-94fd-60788ccf2551" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_807bc871-60dc-4f4a-bd24-5bce8e13b065" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ab27f5a3-475e-44fb-aef5-8994b704a661" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_807bc871-60dc-4f4a-bd24-5bce8e13b065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_e2bd5248-a351-4bd9-896d-36ec925a7bf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ab27f5a3-475e-44fb-aef5-8994b704a661" xlink:to="loc_us-gaap_TradeNamesMember_e2bd5248-a351-4bd9-896d-36ec925a7bf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_b3c6adba-b5fe-4a7b-af5a-aebd486a087e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8d19838d-8caa-4e3d-ba02-28c6252d3ed9" xlink:to="loc_srt_ProductOrServiceAxis_b3c6adba-b5fe-4a7b-af5a-aebd486a087e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b3380ec0-bd26-4c58-88e3-de5e114b32e1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_b3c6adba-b5fe-4a7b-af5a-aebd486a087e" xlink:to="loc_srt_ProductsAndServicesDomain_b3380ec0-bd26-4c58-88e3-de5e114b32e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_VetLabConsumablesMember_9ca1b529-aab7-4dd0-ab42-4b30f95cef36" xlink:href="idxx-20211231.xsd#idxx_VetLabConsumablesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b3380ec0-bd26-4c58-88e3-de5e114b32e1" xlink:to="loc_idxx_VetLabConsumablesMember_9ca1b529-aab7-4dd0-ab42-4b30f95cef36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ReferenceLaboratoryDiagnosticAndConsultingServicesMember_9354f786-2349-473a-ae3f-570eb64feeea" xlink:href="idxx-20211231.xsd#idxx_ReferenceLaboratoryDiagnosticAndConsultingServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b3380ec0-bd26-4c58-88e3-de5e114b32e1" xlink:to="loc_idxx_ReferenceLaboratoryDiagnosticAndConsultingServicesMember_9354f786-2349-473a-ae3f-570eb64feeea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_RapidAssayProductsMember_df1e9603-fb09-4568-a835-d87e7f29f24b" xlink:href="idxx-20211231.xsd#idxx_RapidAssayProductsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b3380ec0-bd26-4c58-88e3-de5e114b32e1" xlink:to="loc_idxx_RapidAssayProductsMember_df1e9603-fb09-4568-a835-d87e7f29f24b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_VeterinarySoftwareServicesAndDiagnosticImagingSystemsMember_30d9f874-cb20-4cbf-8b4b-66602ea0834b" xlink:href="idxx-20211231.xsd#idxx_VeterinarySoftwareServicesAndDiagnosticImagingSystemsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b3380ec0-bd26-4c58-88e3-de5e114b32e1" xlink:to="loc_idxx_VeterinarySoftwareServicesAndDiagnosticImagingSystemsMember_30d9f874-cb20-4cbf-8b4b-66602ea0834b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_aff352f1-8c27-4bde-916e-6b8ec6230167" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8d19838d-8caa-4e3d-ba02-28c6252d3ed9" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_aff352f1-8c27-4bde-916e-6b8ec6230167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_242622df-8a36-41c6-a29d-3042c1a86938" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aff352f1-8c27-4bde-916e-6b8ec6230167" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_242622df-8a36-41c6-a29d-3042c1a86938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_BusinessCombinationContingentConsiderationHoldback_f0b75b35-3259-4167-9e4f-475f265b0627" xlink:href="idxx-20211231.xsd#idxx_BusinessCombinationContingentConsiderationHoldback"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aff352f1-8c27-4bde-916e-6b8ec6230167" xlink:to="loc_idxx_BusinessCombinationContingentConsiderationHoldback_f0b75b35-3259-4167-9e4f-475f265b0627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_0baf5dd0-e297-493f-82e6-963c01c6783d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aff352f1-8c27-4bde-916e-6b8ec6230167" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_0baf5dd0-e297-493f-82e6-963c01c6783d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_446ec811-b0e5-4be3-9d24-b54970898f63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aff352f1-8c27-4bde-916e-6b8ec6230167" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_446ec811-b0e5-4be3-9d24-b54970898f63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c9bf20c5-dc1b-48ee-905c-ea6b92b710b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aff352f1-8c27-4bde-916e-6b8ec6230167" xlink:to="loc_us-gaap_Goodwill_c9bf20c5-dc1b-48ee-905c-ea6b92b710b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_BusinessCombinationsTangibleLiabilities_9b896596-3125-43b3-9f2e-34bcb2e01b6f" xlink:href="idxx-20211231.xsd#idxx_BusinessCombinationsTangibleLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aff352f1-8c27-4bde-916e-6b8ec6230167" xlink:to="loc_idxx_BusinessCombinationsTangibleLiabilities_9b896596-3125-43b3-9f2e-34bcb2e01b6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_0e3f9508-8ef6-4fb4-b82e-63bec5f6837d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aff352f1-8c27-4bde-916e-6b8ec6230167" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_0e3f9508-8ef6-4fb4-b82e-63bec5f6837d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_43fc868d-58c4-4f74-a84c-9919804ed3cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aff352f1-8c27-4bde-916e-6b8ec6230167" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_43fc868d-58c4-4f74-a84c-9919804ed3cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_7f21f0d5-2bc5-4654-ab0a-9ee0e2225863" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aff352f1-8c27-4bde-916e-6b8ec6230167" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_7f21f0d5-2bc5-4654-ab0a-9ee0e2225863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_baa70a8d-4fb7-4a69-8eb3-f490d0b1b705" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aff352f1-8c27-4bde-916e-6b8ec6230167" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_baa70a8d-4fb7-4a69-8eb3-f490d0b1b705" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_BusinessCombinationContingentConsiderationLiabilityAndHoldback_14b1447e-6f73-412d-8e29-ea744dcc7b82" xlink:href="idxx-20211231.xsd#idxx_BusinessCombinationContingentConsiderationLiabilityAndHoldback"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aff352f1-8c27-4bde-916e-6b8ec6230167" xlink:to="loc_idxx_BusinessCombinationContingentConsiderationLiabilityAndHoldback_14b1447e-6f73-412d-8e29-ea744dcc7b82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_b9593824-304a-448d-88bd-7f924aeb0c0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aff352f1-8c27-4bde-916e-6b8ec6230167" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_b9593824-304a-448d-88bd-7f924aeb0c0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_NoncontrollingInterestOwnershipPercentageAcquiredFromNoncontrollingOwners_48a3731c-6d93-4d4f-8f56-859164293cfd" xlink:href="idxx-20211231.xsd#idxx_NoncontrollingInterestOwnershipPercentageAcquiredFromNoncontrollingOwners"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aff352f1-8c27-4bde-916e-6b8ec6230167" xlink:to="loc_idxx_NoncontrollingInterestOwnershipPercentageAcquiredFromNoncontrollingOwners_48a3731c-6d93-4d4f-8f56-859164293cfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_a59c1bc3-613c-4c33-9afa-db669ffa7760" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aff352f1-8c27-4bde-916e-6b8ec6230167" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_a59c1bc3-613c-4c33-9afa-db669ffa7760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/ShareBasedCompensation" xlink:type="simple" xlink:href="idxx-20211231.xsd#ShareBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/ShareBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5e20f9f6-aa66-40ba-a8a6-3127af341cff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_7b8fef46-d65b-4c08-9c40-26f1e2738288" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5e20f9f6-aa66-40ba-a8a6-3127af341cff" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_7b8fef46-d65b-4c08-9c40-26f1e2738288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/ShareBasedCompensationTables" xlink:type="simple" xlink:href="idxx-20211231.xsd#ShareBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/ShareBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b96ea7d2-4308-4890-8d30-728d8c60fd50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_81f2cc74-3b53-4984-bae9-cc8c6082d6d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b96ea7d2-4308-4890-8d30-728d8c60fd50" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_81f2cc74-3b53-4984-bae9-cc8c6082d6d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_4c596e0f-25b3-4b5c-acd4-720b8caf3ea4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b96ea7d2-4308-4890-8d30-728d8c60fd50" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_4c596e0f-25b3-4b5c-acd4-720b8caf3ea4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_71c68c65-f784-424f-83b2-3cabc61afa8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b96ea7d2-4308-4890-8d30-728d8c60fd50" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_71c68c65-f784-424f-83b2-3cabc61afa8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_75e8c76b-79ef-4b72-97bb-05dabf4d2862" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b96ea7d2-4308-4890-8d30-728d8c60fd50" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_75e8c76b-79ef-4b72-97bb-05dabf4d2862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#ShareBasedCompensationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d7a7f83f-fa48-475d-b941-a020b6982b88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ShareBasedCompensationTable_fcea940b-8f67-4a8c-87fe-77e0b0cec27a" xlink:href="idxx-20211231.xsd#idxx_ShareBasedCompensationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d7a7f83f-fa48-475d-b941-a020b6982b88" xlink:to="loc_idxx_ShareBasedCompensationTable_fcea940b-8f67-4a8c-87fe-77e0b0cec27a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_f1ddc675-333c-4dda-a55e-4de41399bd31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_ShareBasedCompensationTable_fcea940b-8f67-4a8c-87fe-77e0b0cec27a" xlink:to="loc_us-gaap_VestingAxis_f1ddc675-333c-4dda-a55e-4de41399bd31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_d5651e29-b1b2-402a-8967-6867be3c243b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_f1ddc675-333c-4dda-a55e-4de41399bd31" xlink:to="loc_us-gaap_VestingDomain_d5651e29-b1b2-402a-8967-6867be3c243b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_78b0f5a0-7c87-4c6b-b3c2-27b648b55701" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_d5651e29-b1b2-402a-8967-6867be3c243b" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_78b0f5a0-7c87-4c6b-b3c2-27b648b55701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_ae84ca97-1828-43c2-8ea1-601b459981a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_d5651e29-b1b2-402a-8967-6867be3c243b" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_ae84ca97-1828-43c2-8ea1-601b459981a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_470ac7ba-d426-4567-a138-5d8faf82f893" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_ShareBasedCompensationTable_fcea940b-8f67-4a8c-87fe-77e0b0cec27a" xlink:to="loc_us-gaap_AwardTypeAxis_470ac7ba-d426-4567-a138-5d8faf82f893" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bbaf8f0f-1be1-41b3-9f0d-515d119ce100" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_470ac7ba-d426-4567-a138-5d8faf82f893" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bbaf8f0f-1be1-41b3-9f0d-515d119ce100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_TwoThousandEighteenStockIncentivePlanMember_bf322f9b-c80e-471a-84b9-296e2520a2cd" xlink:href="idxx-20211231.xsd#idxx_TwoThousandEighteenStockIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bbaf8f0f-1be1-41b3-9f0d-515d119ce100" xlink:to="loc_idxx_TwoThousandEighteenStockIncentivePlanMember_bf322f9b-c80e-471a-84b9-296e2520a2cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_StockOptionsAndStockAppreciationRightsMember_2b369337-eded-408e-a519-f2d392158c21" xlink:href="idxx-20211231.xsd#idxx_StockOptionsAndStockAppreciationRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bbaf8f0f-1be1-41b3-9f0d-515d119ce100" xlink:to="loc_idxx_StockOptionsAndStockAppreciationRightsMember_2b369337-eded-408e-a519-f2d392158c21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_AwardsOtherThanStockOptionsAndStockAppreciationRightsMember_e62d0d6d-7396-4ce8-b0e4-8d5648b32fd8" xlink:href="idxx-20211231.xsd#idxx_AwardsOtherThanStockOptionsAndStockAppreciationRightsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bbaf8f0f-1be1-41b3-9f0d-515d119ce100" xlink:to="loc_idxx_AwardsOtherThanStockOptionsAndStockAppreciationRightsMember_e62d0d6d-7396-4ce8-b0e4-8d5648b32fd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_StockOptionsGrantedToEmployeesWithRatableVestingMember_1de53a71-bfb0-4323-a02a-4bdd0e8f83eb" xlink:href="idxx-20211231.xsd#idxx_StockOptionsGrantedToEmployeesWithRatableVestingMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bbaf8f0f-1be1-41b3-9f0d-515d119ce100" xlink:to="loc_idxx_StockOptionsGrantedToEmployeesWithRatableVestingMember_1de53a71-bfb0-4323-a02a-4bdd0e8f83eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_640c7911-fe7e-42e9-bb43-5c186dbbb1fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bbaf8f0f-1be1-41b3-9f0d-515d119ce100" xlink:to="loc_us-gaap_EmployeeStockOptionMember_640c7911-fe7e-42e9-bb43-5c186dbbb1fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_RestrictedStockUnitsGrantedToEmployeesWithRatableVestingMember_369697f3-32e2-4996-a1a7-d39c34ca3b20" xlink:href="idxx-20211231.xsd#idxx_RestrictedStockUnitsGrantedToEmployeesWithRatableVestingMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bbaf8f0f-1be1-41b3-9f0d-515d119ce100" xlink:to="loc_idxx_RestrictedStockUnitsGrantedToEmployeesWithRatableVestingMember_369697f3-32e2-4996-a1a7-d39c34ca3b20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_fb398a51-5d1e-4f89-a660-68bd4d1b1a86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bbaf8f0f-1be1-41b3-9f0d-515d119ce100" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_fb398a51-5d1e-4f89-a660-68bd4d1b1a86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_DeferredStockUnitsMember_01ebfe6a-e744-4bd4-9ba5-6fd010e89aa5" xlink:href="idxx-20211231.xsd#idxx_DeferredStockUnitsMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bbaf8f0f-1be1-41b3-9f0d-515d119ce100" xlink:to="loc_idxx_DeferredStockUnitsMember_01ebfe6a-e744-4bd4-9ba5-6fd010e89aa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_NineteenNinetySevenEmployeeStockPurchasePlanMember_d0ca5d3d-159a-4138-8ccb-1d4f7ed62857" xlink:href="idxx-20211231.xsd#idxx_NineteenNinetySevenEmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bbaf8f0f-1be1-41b3-9f0d-515d119ce100" xlink:to="loc_idxx_NineteenNinetySevenEmployeeStockPurchasePlanMember_d0ca5d3d-159a-4138-8ccb-1d4f7ed62857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b9833ec1-8dcc-4b3e-8849-30ff8243cfc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_ShareBasedCompensationTable_fcea940b-8f67-4a8c-87fe-77e0b0cec27a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b9833ec1-8dcc-4b3e-8849-30ff8243cfc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_cc2271ff-5d59-42ac-ae0a-0ff289ca4936" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b9833ec1-8dcc-4b3e-8849-30ff8243cfc6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_cc2271ff-5d59-42ac-ae0a-0ff289ca4936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_RatioSharesIssuedUnderShareBasedAwardsToSharesAuthorizedUnderStockPlans_1d93e421-ab95-46ff-acde-ff6e00d857d9" xlink:href="idxx-20211231.xsd#idxx_RatioSharesIssuedUnderShareBasedAwardsToSharesAuthorizedUnderStockPlans"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b9833ec1-8dcc-4b3e-8849-30ff8243cfc6" xlink:to="loc_idxx_RatioSharesIssuedUnderShareBasedAwardsToSharesAuthorizedUnderStockPlans_1d93e421-ab95-46ff-acde-ff6e00d857d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_ee2a85c4-86c6-4d25-aca0-28596e3a2e4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b9833ec1-8dcc-4b3e-8849-30ff8243cfc6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_ee2a85c4-86c6-4d25-aca0-28596e3a2e4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_a5b3e52b-4804-49fa-b3bb-67b128ff60af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b9833ec1-8dcc-4b3e-8849-30ff8243cfc6" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_a5b3e52b-4804-49fa-b3bb-67b128ff60af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_c6c0cc18-03f2-4663-b341-9886c72fbb09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b9833ec1-8dcc-4b3e-8849-30ff8243cfc6" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_c6c0cc18-03f2-4663-b341-9886c72fbb09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_667888d1-818a-4fed-b92d-221afd4348e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b9833ec1-8dcc-4b3e-8849-30ff8243cfc6" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_667888d1-818a-4fed-b92d-221afd4348e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_df023f67-6c43-41e4-b2c8-85300c0776bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b9833ec1-8dcc-4b3e-8849-30ff8243cfc6" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_df023f67-6c43-41e4-b2c8-85300c0776bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_b3236133-0497-4a0d-8307-d0a80151d5c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b9833ec1-8dcc-4b3e-8849-30ff8243cfc6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_b3236133-0497-4a0d-8307-d0a80151d5c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_d483ea37-73ef-48bb-8ad4-fc785f215842" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b9833ec1-8dcc-4b3e-8849-30ff8243cfc6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_d483ea37-73ef-48bb-8ad4-fc785f215842" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_4538cabb-f92e-42ea-8b9f-76c8ee74f7c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b9833ec1-8dcc-4b3e-8849-30ff8243cfc6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_4538cabb-f92e-42ea-8b9f-76c8ee74f7c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_343e1721-bdef-452c-91ab-80889b12cf91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b9833ec1-8dcc-4b3e-8849-30ff8243cfc6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_343e1721-bdef-452c-91ab-80889b12cf91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_782c5f6b-f799-4fac-adc3-0882346261fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b9833ec1-8dcc-4b3e-8849-30ff8243cfc6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_782c5f6b-f799-4fac-adc3-0882346261fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_c622c5b9-ea81-48de-8262-920dc51ae59d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b9833ec1-8dcc-4b3e-8849-30ff8243cfc6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_c622c5b9-ea81-48de-8262-920dc51ae59d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_c2b8c86e-1514-4693-a0b4-8db9089ec9aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b9833ec1-8dcc-4b3e-8849-30ff8243cfc6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_c2b8c86e-1514-4693-a0b4-8db9089ec9aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_RatioOfDeferredStockUnitsToSharesOfCommonStock_18e30660-5cff-4600-9064-80110b9ae355" xlink:href="idxx-20211231.xsd#idxx_RatioOfDeferredStockUnitsToSharesOfCommonStock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b9833ec1-8dcc-4b3e-8849-30ff8243cfc6" xlink:to="loc_idxx_RatioOfDeferredStockUnitsToSharesOfCommonStock_18e30660-5cff-4600-9064-80110b9ae355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockOtherSharesOutstanding_318eeba1-8294-4071-ac60-7056cc6e7a43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockOtherSharesOutstanding"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b9833ec1-8dcc-4b3e-8849-30ff8243cfc6" xlink:to="loc_us-gaap_CommonStockOtherSharesOutstanding_318eeba1-8294-4071-ac60-7056cc6e7a43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_b4a5cd81-fab1-4ef7-9f05-6878c1a8495c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b9833ec1-8dcc-4b3e-8849-30ff8243cfc6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_b4a5cd81-fab1-4ef7-9f05-6878c1a8495c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_e38f1428-b237-41ed-8951-262b7c6ae234" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b9833ec1-8dcc-4b3e-8849-30ff8243cfc6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_e38f1428-b237-41ed-8951-262b7c6ae234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_d19a0a5a-542d-4adb-8c43-68a56f6cd1b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b9833ec1-8dcc-4b3e-8849-30ff8243cfc6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_d19a0a5a-542d-4adb-8c43-68a56f6cd1b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/ShareBasedCompensationScheduleofSelectedFinancialImpactofShareBasedCompensationDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#ShareBasedCompensationScheduleofSelectedFinancialImpactofShareBasedCompensationDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/ShareBasedCompensationScheduleofSelectedFinancialImpactofShareBasedCompensationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ab478d40-ac47-4689-98e0-2266ce6421fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_bc3fa9ef-7d44-46e5-9847-e212e1e301fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ab478d40-ac47-4689-98e0-2266ce6421fc" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_bc3fa9ef-7d44-46e5-9847-e212e1e301fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_8d450264-513a-468c-96ac-c8af8ff78d5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_bc3fa9ef-7d44-46e5-9847-e212e1e301fa" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_8d450264-513a-468c-96ac-c8af8ff78d5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1198db56-79f7-42f2-84cb-fd685a28c812" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_8d450264-513a-468c-96ac-c8af8ff78d5e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1198db56-79f7-42f2-84cb-fd685a28c812" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_aa9591ee-73b2-4d0a-b82b-0a39e8093d26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1198db56-79f7-42f2-84cb-fd685a28c812" xlink:to="loc_us-gaap_CostOfSalesMember_aa9591ee-73b2-4d0a-b82b-0a39e8093d26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_OperatingExpensesMember_ffc96495-57f3-42a5-9d7d-2b941f0faa86" xlink:href="idxx-20211231.xsd#idxx_OperatingExpensesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1198db56-79f7-42f2-84cb-fd685a28c812" xlink:to="loc_idxx_OperatingExpensesMember_ffc96495-57f3-42a5-9d7d-2b941f0faa86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dc9a8ddc-b1cc-47d0-95e3-989ce11ae809" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_bc3fa9ef-7d44-46e5-9847-e212e1e301fa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dc9a8ddc-b1cc-47d0-95e3-989ce11ae809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_fea2acca-dce8-4de3-bf28-f8968f7d5b78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dc9a8ddc-b1cc-47d0-95e3-989ce11ae809" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_fea2acca-dce8-4de3-bf28-f8968f7d5b78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_9e6f8319-75c2-49f5-9e51-c9066ec2f734" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dc9a8ddc-b1cc-47d0-95e3-989ce11ae809" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_9e6f8319-75c2-49f5-9e51-c9066ec2f734" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_AllocatedShareBasedCompensationExpenseNetOfTaxExcludingTaxBenefitFromSettlementOfShareBasedAwards_f8c80d2b-b260-4343-bc93-19e6656aa375" xlink:href="idxx-20211231.xsd#idxx_AllocatedShareBasedCompensationExpenseNetOfTaxExcludingTaxBenefitFromSettlementOfShareBasedAwards"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dc9a8ddc-b1cc-47d0-95e3-989ce11ae809" xlink:to="loc_idxx_AllocatedShareBasedCompensationExpenseNetOfTaxExcludingTaxBenefitFromSettlementOfShareBasedAwards_f8c80d2b-b260-4343-bc93-19e6656aa375" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_49f29ed2-2989-4c3d-a427-895b137d7831" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dc9a8ddc-b1cc-47d0-95e3-989ce11ae809" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_49f29ed2-2989-4c3d-a427-895b137d7831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_01bcb1be-2ff9-43b3-acd3-c3cff68c9151" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dc9a8ddc-b1cc-47d0-95e3-989ce11ae809" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_01bcb1be-2ff9-43b3-acd3-c3cff68c9151" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/ShareBasedCompensationScheduleofWeightedAveragesoftheAssumptionsUsedInEstimatingtheFairValueofStockOptionAwardsDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#ShareBasedCompensationScheduleofWeightedAveragesoftheAssumptionsUsedInEstimatingtheFairValueofStockOptionAwardsDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/ShareBasedCompensationScheduleofWeightedAveragesoftheAssumptionsUsedInEstimatingtheFairValueofStockOptionAwardsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2b98ae94-f3fb-4a2b-b7c0-a4dfe189abc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_6da15fbe-f82c-409d-b7a5-df741265f727" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2b98ae94-f3fb-4a2b-b7c0-a4dfe189abc3" xlink:to="loc_us-gaap_SharePrice_6da15fbe-f82c-409d-b7a5-df741265f727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_8322d533-13c4-45df-83f1-f6b776339826" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2b98ae94-f3fb-4a2b-b7c0-a4dfe189abc3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_8322d533-13c4-45df-83f1-f6b776339826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_e3ccfb76-8aa6-41ef-98b2-8e29978439a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2b98ae94-f3fb-4a2b-b7c0-a4dfe189abc3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_e3ccfb76-8aa6-41ef-98b2-8e29978439a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_81271538-48e4-4cdc-87a2-58181bc2104e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2b98ae94-f3fb-4a2b-b7c0-a4dfe189abc3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_81271538-48e4-4cdc-87a2-58181bc2104e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_ea243bb2-77de-4c8d-9130-a4288baa72be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2b98ae94-f3fb-4a2b-b7c0-a4dfe189abc3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_ea243bb2-77de-4c8d-9130-a4288baa72be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b18509c2-dd79-4bfd-be53-3880b33274f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2b98ae94-f3fb-4a2b-b7c0-a4dfe189abc3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b18509c2-dd79-4bfd-be53-3880b33274f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#ShareBasedCompensationScheduleofStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_895fc0d5-d83c-468e-8721-7892a349e831" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_5485ce4b-cf86-4df1-9ff6-82965e4cddbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_895fc0d5-d83c-468e-8721-7892a349e831" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_5485ce4b-cf86-4df1-9ff6-82965e4cddbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d52658da-6e11-4d50-bea9-3fb43ad661c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_5485ce4b-cf86-4df1-9ff6-82965e4cddbf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d52658da-6e11-4d50-bea9-3fb43ad661c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_ea6de2b8-3767-45e8-8217-1c5498bc722c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_5485ce4b-cf86-4df1-9ff6-82965e4cddbf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_ea6de2b8-3767-45e8-8217-1c5498bc722c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_a7d43314-4471-4fb7-9aa5-ba5a9706f24d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_5485ce4b-cf86-4df1-9ff6-82965e4cddbf" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_a7d43314-4471-4fb7-9aa5-ba5a9706f24d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_32c9b87c-3f63-4981-8389-c1db5cc1b3b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_5485ce4b-cf86-4df1-9ff6-82965e4cddbf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_32c9b87c-3f63-4981-8389-c1db5cc1b3b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_fd8f5798-c182-42c9-a60f-70ab05d8b54d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_5485ce4b-cf86-4df1-9ff6-82965e4cddbf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_fd8f5798-c182-42c9-a60f-70ab05d8b54d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_64023965-b6cd-43ab-a3c0-08dff9b188a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_895fc0d5-d83c-468e-8721-7892a349e831" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_64023965-b6cd-43ab-a3c0-08dff9b188a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_172371ee-1d77-4380-b907-380564b86d3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_895fc0d5-d83c-468e-8721-7892a349e831" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_172371ee-1d77-4380-b907-380564b86d3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_91fd6519-02c5-42c1-b2dd-cee979ead25d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_895fc0d5-d83c-468e-8721-7892a349e831" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_91fd6519-02c5-42c1-b2dd-cee979ead25d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_186bb14c-fcf9-4103-a156-31c9d7d58c72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_91fd6519-02c5-42c1-b2dd-cee979ead25d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_186bb14c-fcf9-4103-a156-31c9d7d58c72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_cd9bc728-da55-45be-9e1d-fc84a6ba866c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_91fd6519-02c5-42c1-b2dd-cee979ead25d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_cd9bc728-da55-45be-9e1d-fc84a6ba866c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_5b8c6543-2415-4d96-9359-52474c2adb50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_91fd6519-02c5-42c1-b2dd-cee979ead25d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_5b8c6543-2415-4d96-9359-52474c2adb50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_a10a1713-eca0-43ec-a665-09c30afdb8ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_91fd6519-02c5-42c1-b2dd-cee979ead25d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_a10a1713-eca0-43ec-a665-09c30afdb8ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_88ce1fbd-d145-4eb4-b469-cced0af4bc49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_91fd6519-02c5-42c1-b2dd-cee979ead25d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_88ce1fbd-d145-4eb4-b469-cced0af4bc49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_f58436e1-70b7-41ff-a450-7de6d3ae60ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_895fc0d5-d83c-468e-8721-7892a349e831" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_f58436e1-70b7-41ff-a450-7de6d3ae60ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_49a27853-49d6-4840-b180-f90345d800c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_895fc0d5-d83c-468e-8721-7892a349e831" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_49a27853-49d6-4840-b180-f90345d800c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_b6344020-51ba-4d0e-b8f0-fe99670b6d46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_895fc0d5-d83c-468e-8721-7892a349e831" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_b6344020-51ba-4d0e-b8f0-fe99670b6d46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_52007261-7ba5-48eb-bcc7-d34aa775f9f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_b6344020-51ba-4d0e-b8f0-fe99670b6d46" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_52007261-7ba5-48eb-bcc7-d34aa775f9f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_92c60cc6-713f-45c7-b0d0-ab279b1fc66a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_b6344020-51ba-4d0e-b8f0-fe99670b6d46" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_92c60cc6-713f-45c7-b0d0-ab279b1fc66a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_16fadeab-7d67-4477-a19c-312cf35cecf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_b6344020-51ba-4d0e-b8f0-fe99670b6d46" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_16fadeab-7d67-4477-a19c-312cf35cecf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2d039302-f99e-4b79-a211-7b0c917a1fa1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_b6344020-51ba-4d0e-b8f0-fe99670b6d46" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2d039302-f99e-4b79-a211-7b0c917a1fa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_04c920ca-728a-4876-ac5a-d49f371953ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_b6344020-51ba-4d0e-b8f0-fe99670b6d46" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_04c920ca-728a-4876-ac5a-d49f371953ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_59d6aac3-b90e-4c5d-a009-cbe36c3a52df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_b6344020-51ba-4d0e-b8f0-fe99670b6d46" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_59d6aac3-b90e-4c5d-a009-cbe36c3a52df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/ShareBasedCompensationScheduleOfRestrictedStockUnitActivityDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#ShareBasedCompensationScheduleOfRestrictedStockUnitActivityDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/ShareBasedCompensationScheduleOfRestrictedStockUnitActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9f636dc8-2e10-470c-8022-74dd776db73c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7612243d-29aa-48e2-a54e-fa281aab80d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9f636dc8-2e10-470c-8022-74dd776db73c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7612243d-29aa-48e2-a54e-fa281aab80d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_75ae3640-a2bf-4ed3-846f-17d90f35c8a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7612243d-29aa-48e2-a54e-fa281aab80d9" xlink:to="loc_us-gaap_AwardTypeAxis_75ae3640-a2bf-4ed3-846f-17d90f35c8a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_42c8421e-27da-40d1-af2d-23e493a63de3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_75ae3640-a2bf-4ed3-846f-17d90f35c8a9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_42c8421e-27da-40d1-af2d-23e493a63de3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_d4a45318-0df4-4f58-8c24-6a7502a8cdca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_42c8421e-27da-40d1-af2d-23e493a63de3" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_d4a45318-0df4-4f58-8c24-6a7502a8cdca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_RestrictedStockUnitsExpectedToVestReducedForEstimatedForfeituresMember_07ae177b-23e2-4828-a17f-92ad9d45a99f" xlink:href="idxx-20211231.xsd#idxx_RestrictedStockUnitsExpectedToVestReducedForEstimatedForfeituresMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_42c8421e-27da-40d1-af2d-23e493a63de3" xlink:to="loc_idxx_RestrictedStockUnitsExpectedToVestReducedForEstimatedForfeituresMember_07ae177b-23e2-4828-a17f-92ad9d45a99f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28792e72-7e68-477c-aa9f-64935b8ae1f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7612243d-29aa-48e2-a54e-fa281aab80d9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28792e72-7e68-477c-aa9f-64935b8ae1f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4119423e-448d-47f8-897a-0d50b71268a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28792e72-7e68-477c-aa9f-64935b8ae1f2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4119423e-448d-47f8-897a-0d50b71268a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_c13ca2ef-5dfa-41b1-9d5c-2f529fda35f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4119423e-448d-47f8-897a-0d50b71268a0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_c13ca2ef-5dfa-41b1-9d5c-2f529fda35f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_771de933-0970-4cca-83cf-9b68b30e8837" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4119423e-448d-47f8-897a-0d50b71268a0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_771de933-0970-4cca-83cf-9b68b30e8837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2df914ed-0283-469c-a389-c1c2774d5e03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4119423e-448d-47f8-897a-0d50b71268a0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2df914ed-0283-469c-a389-c1c2774d5e03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_5431833c-af02-49ee-a784-6e483dfe8302" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4119423e-448d-47f8-897a-0d50b71268a0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_5431833c-af02-49ee-a784-6e483dfe8302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_04d399a0-89da-4930-b704-bcdc311e5d38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4119423e-448d-47f8-897a-0d50b71268a0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_04d399a0-89da-4930-b704-bcdc311e5d38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_f448b7c5-fcbc-4237-9f63-710d2699011d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28792e72-7e68-477c-aa9f-64935b8ae1f2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_f448b7c5-fcbc-4237-9f63-710d2699011d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2b410aec-24e9-489d-acc9-8f1f7ac3a522" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_f448b7c5-fcbc-4237-9f63-710d2699011d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2b410aec-24e9-489d-acc9-8f1f7ac3a522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_256ee186-2d9a-404f-a1aa-9be5b7c90584" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_f448b7c5-fcbc-4237-9f63-710d2699011d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_256ee186-2d9a-404f-a1aa-9be5b7c90584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_15d3d80f-9fc1-41de-93b1-945468e59411" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_f448b7c5-fcbc-4237-9f63-710d2699011d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_15d3d80f-9fc1-41de-93b1-945468e59411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_9d48a1bf-87ca-43f5-a592-fc345150a7c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_f448b7c5-fcbc-4237-9f63-710d2699011d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_9d48a1bf-87ca-43f5-a592-fc345150a7c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3b87d83c-427d-4c52-9208-51d8d505845a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_f448b7c5-fcbc-4237-9f63-710d2699011d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3b87d83c-427d-4c52-9208-51d8d505845a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/CreditLosses" xlink:type="simple" xlink:href="idxx-20211231.xsd#CreditLosses"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/CreditLosses" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditLossAbstract_dec09562-3bbc-4d48-b815-b3b402ff2d6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditLossAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditLossFinancialInstrumentTextBlock_147c56c4-b3cb-4146-9aa5-420973218dad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditLossFinancialInstrumentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditLossAbstract_dec09562-3bbc-4d48-b815-b3b402ff2d6e" xlink:to="loc_us-gaap_CreditLossFinancialInstrumentTextBlock_147c56c4-b3cb-4146-9aa5-420973218dad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/CreditLossesDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#CreditLossesDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/CreditLossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditLossAbstract_c548f5e4-2445-4c90-9a6e-f9d1c67f4388" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditLossAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable_20182390-36ab-4611-8727-85196c32974c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditLossAbstract_c548f5e4-2445-4c90-9a6e-f9d1c67f4388" xlink:to="loc_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable_20182390-36ab-4611-8727-85196c32974c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivablesPeriodPastDueAxis_3d283840-fb7c-43ac-9e58-57e53d4bb4f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivablesPeriodPastDueAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable_20182390-36ab-4611-8727-85196c32974c" xlink:to="loc_us-gaap_FinancingReceivablesPeriodPastDueAxis_3d283840-fb7c-43ac-9e58-57e53d4bb4f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivablesPeriodPastDueDomain_d7584960-4cf1-4a06-9f2f-8d324b738175" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivablesPeriodPastDueDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivablesPeriodPastDueAxis_3d283840-fb7c-43ac-9e58-57e53d4bb4f3" xlink:to="loc_us-gaap_FinancingReceivablesPeriodPastDueDomain_d7584960-4cf1-4a06-9f2f-8d324b738175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_FinancialAssetGreaterThan60DaysPastDueMember_08099879-1a96-48a9-85a7-e7523bd4f1e8" xlink:href="idxx-20211231.xsd#idxx_FinancialAssetGreaterThan60DaysPastDueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivablesPeriodPastDueDomain_d7584960-4cf1-4a06-9f2f-8d324b738175" xlink:to="loc_idxx_FinancialAssetGreaterThan60DaysPastDueMember_08099879-1a96-48a9-85a7-e7523bd4f1e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_27b9827a-914d-4ca9-b35a-ae713dc29ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable_20182390-36ab-4611-8727-85196c32974c" xlink:to="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_27b9827a-914d-4ca9-b35a-ae713dc29ed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_cada6282-e1f2-4499-aa28-2ff9fbdd3420" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_27b9827a-914d-4ca9-b35a-ae713dc29ed7" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_cada6282-e1f2-4499-aa28-2ff9fbdd3420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_AccountsReceivablePercentNotPastDue_28cb4e26-70bb-4e36-9a6b-ecb9567840a2" xlink:href="idxx-20211231.xsd#idxx_AccountsReceivablePercentNotPastDue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_27b9827a-914d-4ca9-b35a-ae713dc29ed7" xlink:to="loc_idxx_AccountsReceivablePercentNotPastDue_28cb4e26-70bb-4e36-9a6b-ecb9567840a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_AccountsReceivablePercentPastDue_35311ff9-5d10-4a07-b05f-e4cb9eee5ea1" xlink:href="idxx-20211231.xsd#idxx_AccountsReceivablePercentPastDue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_27b9827a-914d-4ca9-b35a-ae713dc29ed7" xlink:to="loc_idxx_AccountsReceivablePercentPastDue_35311ff9-5d10-4a07-b05f-e4cb9eee5ea1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDue_b7605b8d-3e72-4895-addf-834ec0ae15b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_27b9827a-914d-4ca9-b35a-ae713dc29ed7" xlink:to="loc_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDue_b7605b8d-3e72-4895-addf-834ec0ae15b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ContractwithCustomerAssetAndSalesTypeLeaseNetInvestmentInLeaseAllowanceforCreditLoss_2266b2fd-36c3-41c2-a817-8789df123405" xlink:href="idxx-20211231.xsd#idxx_ContractwithCustomerAssetAndSalesTypeLeaseNetInvestmentInLeaseAllowanceforCreditLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_27b9827a-914d-4ca9-b35a-ae713dc29ed7" xlink:to="loc_idxx_ContractwithCustomerAssetAndSalesTypeLeaseNetInvestmentInLeaseAllowanceforCreditLoss_2266b2fd-36c3-41c2-a817-8789df123405" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/Inventories" xlink:type="simple" xlink:href="idxx-20211231.xsd#Inventories"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/Inventories" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract_fd40baa9-035f-495f-a6ff-ce932c5f34b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNetAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_0fe9ed9d-49c5-48a4-a09e-5735208400f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_fd40baa9-035f-495f-a6ff-ce932c5f34b6" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_0fe9ed9d-49c5-48a4-a09e-5735208400f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/InventoriesTables" xlink:type="simple" xlink:href="idxx-20211231.xsd#InventoriesTables"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/InventoriesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract_76d46724-4e61-4d7c-81e0-035ba324e28d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNetAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_328578c3-c6b7-482d-ad5d-e9c3de1169b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_76d46724-4e61-4d7c-81e0-035ba324e28d" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_328578c3-c6b7-482d-ad5d-e9c3de1169b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/InventoriesNarrativeDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#InventoriesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/InventoriesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract_5e1fed0e-24de-42df-8a0b-7cf751b929e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNetAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_c3b1e0f1-c2a5-4ab7-bc26-f85e65e70266" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_5e1fed0e-24de-42df-8a0b-7cf751b929e8" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_c3b1e0f1-c2a5-4ab7-bc26-f85e65e70266" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryCurrentTable_9a28beec-2d85-49da-9f18-4daf55108e98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryCurrentTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_5e1fed0e-24de-42df-8a0b-7cf751b929e8" xlink:to="loc_us-gaap_InventoryCurrentTable_9a28beec-2d85-49da-9f18-4daf55108e98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_232a954c-283f-44f0-8fb9-433bb04f1aac" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryCurrentTable_9a28beec-2d85-49da-9f18-4daf55108e98" xlink:to="loc_srt_ProductOrServiceAxis_232a954c-283f-44f0-8fb9-433bb04f1aac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_f20ee089-f089-4697-9b37-bea22ba2e331" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_232a954c-283f-44f0-8fb9-433bb04f1aac" xlink:to="loc_srt_ProductsAndServicesDomain_f20ee089-f089-4697-9b37-bea22ba2e331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ReagentRentalProgramsMember_40db1c9d-6569-49ec-ae78-22ac617c348b" xlink:href="idxx-20211231.xsd#idxx_ReagentRentalProgramsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f20ee089-f089-4697-9b37-bea22ba2e331" xlink:to="loc_idxx_ReagentRentalProgramsMember_40db1c9d-6569-49ec-ae78-22ac617c348b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLineItems_db98e237-9442-41b9-aaaa-0e1243d59867" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryCurrentTable_9a28beec-2d85-49da-9f18-4daf55108e98" xlink:to="loc_us-gaap_InventoryLineItems_db98e237-9442-41b9-aaaa-0e1243d59867" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_6c518ab5-cbff-48c2-894d-0228f9498409" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryLineItems_db98e237-9442-41b9-aaaa-0e1243d59867" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_6c518ab5-cbff-48c2-894d-0228f9498409" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/InventoriesScheduleofComponentsofInventoriesDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#InventoriesScheduleofComponentsofInventoriesDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/InventoriesScheduleofComponentsofInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract_a612e444-6eec-4715-b8bc-fc9738e2902b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNetAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_7e3f3aa5-4832-45ea-934f-dca793bfed88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_a612e444-6eec-4715-b8bc-fc9738e2902b" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_7e3f3aa5-4832-45ea-934f-dca793bfed88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_70160fce-a0c3-41f1-9e40-114c7f1adce0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_a612e444-6eec-4715-b8bc-fc9738e2902b" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_70160fce-a0c3-41f1-9e40-114c7f1adce0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_fef3633f-bb24-4eb1-ac31-1cddf3cebbf8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_a612e444-6eec-4715-b8bc-fc9738e2902b" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_fef3633f-bb24-4eb1-ac31-1cddf3cebbf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_7eb5b16b-4bb1-4a1e-bbea-d372c12ba641" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_a612e444-6eec-4715-b8bc-fc9738e2902b" xlink:to="loc_us-gaap_InventoryNet_7eb5b16b-4bb1-4a1e-bbea-d372c12ba641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/Leases" xlink:type="simple" xlink:href="idxx-20211231.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_c3848105-31cb-46f3-a0f9-b1555084c240" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_91eaaf8b-b466-45dc-9f74-edd1a31a5b26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c3848105-31cb-46f3-a0f9-b1555084c240" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_91eaaf8b-b466-45dc-9f74-edd1a31a5b26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/LeasesTables" xlink:type="simple" xlink:href="idxx-20211231.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_29fccc27-7301-4566-b0a3-0128fdd35495" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_bb94265c-3b80-4bd6-b734-e24283e456fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_29fccc27-7301-4566-b0a3-0128fdd35495" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_bb94265c-3b80-4bd6-b734-e24283e456fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_df2fac1e-6540-4d1d-8f84-9fedaa6fcb39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_29fccc27-7301-4566-b0a3-0128fdd35495" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_df2fac1e-6540-4d1d-8f84-9fedaa6fcb39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_bd518f2c-bbd2-4d10-9b48-9ae58e9cd76b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_725e5b6c-a367-4d18-9b89-53c5f2c97bab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_bd518f2c-bbd2-4d10-9b48-9ae58e9cd76b" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_725e5b6c-a367-4d18-9b89-53c5f2c97bab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a3eb3d58-e41a-499a-8f1b-bc61d0a9311e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_725e5b6c-a367-4d18-9b89-53c5f2c97bab" xlink:to="loc_srt_RangeAxis_a3eb3d58-e41a-499a-8f1b-bc61d0a9311e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9b39b9e9-0503-46f5-86e3-27116d07ed3a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_a3eb3d58-e41a-499a-8f1b-bc61d0a9311e" xlink:to="loc_srt_RangeMember_9b39b9e9-0503-46f5-86e3-27116d07ed3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_1688854e-6b46-49c8-87ba-51d16f9485f5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_9b39b9e9-0503-46f5-86e3-27116d07ed3a" xlink:to="loc_srt_MinimumMember_1688854e-6b46-49c8-87ba-51d16f9485f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_1d834e54-2ed9-4b77-97dc-09b0d34bb2b5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_9b39b9e9-0503-46f5-86e3-27116d07ed3a" xlink:to="loc_srt_MaximumMember_1d834e54-2ed9-4b77-97dc-09b0d34bb2b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_340a0915-84f7-4cf5-bc01-5e31dc18412b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_725e5b6c-a367-4d18-9b89-53c5f2c97bab" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_340a0915-84f7-4cf5-bc01-5e31dc18412b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_LesseeOperatingLeaseTerminationPeriod_25d20da2-b24d-47cb-9cdc-837d362378ae" xlink:href="idxx-20211231.xsd#idxx_LesseeOperatingLeaseTerminationPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_340a0915-84f7-4cf5-bc01-5e31dc18412b" xlink:to="loc_idxx_LesseeOperatingLeaseTerminationPeriod_25d20da2-b24d-47cb-9cdc-837d362378ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_49a721e7-9210-494e-a949-53966949db80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_340a0915-84f7-4cf5-bc01-5e31dc18412b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_49a721e7-9210-494e-a949-53966949db80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_OperatingLeaseLeaseNotyetCommencedExpense_d643ce36-71b3-48d0-bcfa-86ff53ba239b" xlink:href="idxx-20211231.xsd#idxx_OperatingLeaseLeaseNotyetCommencedExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_340a0915-84f7-4cf5-bc01-5e31dc18412b" xlink:to="loc_idxx_OperatingLeaseLeaseNotyetCommencedExpense_d643ce36-71b3-48d0-bcfa-86ff53ba239b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_b9cec790-9e65-49e6-912a-213015ad48c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_bd518f2c-bbd2-4d10-9b48-9ae58e9cd76b" xlink:to="loc_us-gaap_OperatingLeaseExpense_b9cec790-9e65-49e6-912a-213015ad48c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_89c9cc08-dc3f-4b2a-856f-47987b17dcb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_bd518f2c-bbd2-4d10-9b48-9ae58e9cd76b" xlink:to="loc_us-gaap_LeaseCost_89c9cc08-dc3f-4b2a-856f-47987b17dcb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_14de3ebf-0db4-4bd4-9e47-bbcad5fdaa1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_b77d5cb4-5b13-4248-836a-3f760f44178e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_14de3ebf-0db4-4bd4-9e47-bbcad5fdaa1d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_b77d5cb4-5b13-4248-836a-3f760f44178e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_392bcf58-f15b-433f-94f4-b26ec87a9e7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_14de3ebf-0db4-4bd4-9e47-bbcad5fdaa1d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_392bcf58-f15b-433f-94f4-b26ec87a9e7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_7a68106e-28a9-49a6-b42d-c706821aeda3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_14de3ebf-0db4-4bd4-9e47-bbcad5fdaa1d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_7a68106e-28a9-49a6-b42d-c706821aeda3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_556a690b-1edd-47cd-99d3-324e1f588e5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_14de3ebf-0db4-4bd4-9e47-bbcad5fdaa1d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_556a690b-1edd-47cd-99d3-324e1f588e5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_9b20f997-762d-44f5-b0a0-9eb6522dbe20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_14de3ebf-0db4-4bd4-9e47-bbcad5fdaa1d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_9b20f997-762d-44f5-b0a0-9eb6522dbe20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_b3def37b-82f9-4e31-92a9-83882863b079" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_14de3ebf-0db4-4bd4-9e47-bbcad5fdaa1d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_b3def37b-82f9-4e31-92a9-83882863b079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a2ed1afe-741b-446a-bac7-e03ba82ba61d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_14de3ebf-0db4-4bd4-9e47-bbcad5fdaa1d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a2ed1afe-741b-446a-bac7-e03ba82ba61d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_e3235880-4e07-4216-ab97-6b4ca811c233" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_14de3ebf-0db4-4bd4-9e47-bbcad5fdaa1d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_e3235880-4e07-4216-ab97-6b4ca811c233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_6d86ace5-ac60-4cfc-bbef-e01f5ef3e5bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_14de3ebf-0db4-4bd4-9e47-bbcad5fdaa1d" xlink:to="loc_us-gaap_OperatingLeaseLiability_6d86ace5-ac60-4cfc-bbef-e01f5ef3e5bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_ca4439e5-b155-4baa-9967-9ca91504fd48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_14de3ebf-0db4-4bd4-9e47-bbcad5fdaa1d" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_ca4439e5-b155-4baa-9967-9ca91504fd48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_cfbc6418-7c2c-4f32-95c5-39c97976a17c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_14de3ebf-0db4-4bd4-9e47-bbcad5fdaa1d" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_cfbc6418-7c2c-4f32-95c5-39c97976a17c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="idxx-20211231.xsd#LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.idexx.com/role/LeasesSupplementalCashFlowInformationDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#LeasesSupplementalCashFlowInformationDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/LeasesSupplementalCashFlowInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_c4e640b4-8d9c-4e05-93cf-408e503f1fd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_c12a15ea-d70f-4e47-86e9-cb74f91bf9e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c4e640b4-8d9c-4e05-93cf-408e503f1fd2" xlink:to="loc_us-gaap_OperatingLeasePayments_c12a15ea-d70f-4e47-86e9-cb74f91bf9e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_f5f11bd2-1146-4959-bf0e-e53bd2b594e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c4e640b4-8d9c-4e05-93cf-408e503f1fd2" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_f5f11bd2-1146-4959-bf0e-e53bd2b594e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/PropertyandEquipmentNet" xlink:type="simple" xlink:href="idxx-20211231.xsd#PropertyandEquipmentNet"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/PropertyandEquipmentNet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_72ffa056-2b0e-4bab-b099-48c6356c604f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_144608b3-daa3-4cf6-8bfa-7aef4a690557" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_72ffa056-2b0e-4bab-b099-48c6356c604f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_144608b3-daa3-4cf6-8bfa-7aef4a690557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/PropertyandEquipmentNetTables" xlink:type="simple" xlink:href="idxx-20211231.xsd#PropertyandEquipmentNetTables"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/PropertyandEquipmentNetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_8a7917c5-2622-4336-8362-ad0ce8e6b57b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock_95a58c60-4eed-4b9b-86aa-479501940a58" xlink:href="idxx-20211231.xsd#idxx_ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_8a7917c5-2622-4336-8362-ad0ce8e6b57b" xlink:to="loc_idxx_ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock_95a58c60-4eed-4b9b-86aa-479501940a58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_860c56b3-767e-4b48-b797-838a9609f1f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_8a7917c5-2622-4336-8362-ad0ce8e6b57b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_860c56b3-767e-4b48-b797-838a9609f1f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_SummaryOfDepreciationAndAmortizationCapitalizedComputerSoftwareForInternalUseAndUnpaidPropertyEquipmentReflectedInAccountPayableAndAccruedExpensesTableTextBlock_d2d56d30-f484-4123-932b-b4ee2b2d369a" xlink:href="idxx-20211231.xsd#idxx_SummaryOfDepreciationAndAmortizationCapitalizedComputerSoftwareForInternalUseAndUnpaidPropertyEquipmentReflectedInAccountPayableAndAccruedExpensesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_8a7917c5-2622-4336-8362-ad0ce8e6b57b" xlink:to="loc_idxx_SummaryOfDepreciationAndAmortizationCapitalizedComputerSoftwareForInternalUseAndUnpaidPropertyEquipmentReflectedInAccountPayableAndAccruedExpensesTableTextBlock_d2d56d30-f484-4123-932b-b4ee2b2d369a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/PropertyandEquipmentNetScheduleofEstimatedUsefulLivesDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#PropertyandEquipmentNetScheduleofEstimatedUsefulLivesDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/PropertyandEquipmentNetScheduleofEstimatedUsefulLivesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_6ca6bae9-31c0-4852-aa72-175ff1c057e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_47e60f8e-dd87-46be-a48e-5daa9b4c5635" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_6ca6bae9-31c0-4852-aa72-175ff1c057e3" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_47e60f8e-dd87-46be-a48e-5daa9b4c5635" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b8583ed8-cf64-4142-890b-a39f493cdbf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_47e60f8e-dd87-46be-a48e-5daa9b4c5635" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b8583ed8-cf64-4142-890b-a39f493cdbf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_31806b44-b444-41a9-869b-f0c39ccb04a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b8583ed8-cf64-4142-890b-a39f493cdbf7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_31806b44-b444-41a9-869b-f0c39ccb04a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandImprovementsMember_2b2416ff-59d4-4249-954c-9aceeb8e8dce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandImprovementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_31806b44-b444-41a9-869b-f0c39ccb04a9" xlink:to="loc_us-gaap_LandImprovementsMember_2b2416ff-59d4-4249-954c-9aceeb8e8dce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_3154c2e9-2f38-4083-9255-0f4c8c1b3201" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_31806b44-b444-41a9-869b-f0c39ccb04a9" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_3154c2e9-2f38-4083-9255-0f4c8c1b3201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_0ff73169-ee5d-40bf-aaf4-06dfcea17a4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_31806b44-b444-41a9-869b-f0c39ccb04a9" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_0ff73169-ee5d-40bf-aaf4-06dfcea17a4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember_757a1947-05eb-425f-bd5f-745792fbac2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_31806b44-b444-41a9-869b-f0c39ccb04a9" xlink:to="loc_us-gaap_OfficeEquipmentMember_757a1947-05eb-425f-bd5f-745792fbac2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ComputerHardwareAndSoftwareMember_561e6826-48cd-4594-aa8e-dd8cfcb9564f" xlink:href="idxx-20211231.xsd#idxx_ComputerHardwareAndSoftwareMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_31806b44-b444-41a9-869b-f0c39ccb04a9" xlink:to="loc_idxx_ComputerHardwareAndSoftwareMember_561e6826-48cd-4594-aa8e-dd8cfcb9564f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_0c38940e-88eb-4142-aa27-4cee7fd031f3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_47e60f8e-dd87-46be-a48e-5daa9b4c5635" xlink:to="loc_srt_RangeAxis_0c38940e-88eb-4142-aa27-4cee7fd031f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a9f5d4a6-fd45-4ae0-9afc-339e6e746dff" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_0c38940e-88eb-4142-aa27-4cee7fd031f3" xlink:to="loc_srt_RangeMember_a9f5d4a6-fd45-4ae0-9afc-339e6e746dff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_2fda028c-d968-40d9-8e8e-07514aaf1950" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a9f5d4a6-fd45-4ae0-9afc-339e6e746dff" xlink:to="loc_srt_MinimumMember_2fda028c-d968-40d9-8e8e-07514aaf1950" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_66d71472-abbe-4e48-bd2f-04a7c24368f0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a9f5d4a6-fd45-4ae0-9afc-339e6e746dff" xlink:to="loc_srt_MaximumMember_66d71472-abbe-4e48-bd2f-04a7c24368f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b5e27175-16b9-445e-9686-7772ca54dadc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_47e60f8e-dd87-46be-a48e-5daa9b4c5635" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b5e27175-16b9-445e-9686-7772ca54dadc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_3d1e4703-9e6e-4492-bdc2-e4f2b32d4656" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b5e27175-16b9-445e-9686-7772ca54dadc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_3d1e4703-9e6e-4492-bdc2-e4f2b32d4656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_32daa1a4-e6bb-4411-9218-89c0144ebe3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_511a16d1-ee3e-487d-a96c-b5bfe4602bc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_32daa1a4-e6bb-4411-9218-89c0144ebe3e" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_511a16d1-ee3e-487d-a96c-b5bfe4602bc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b091e8d1-6a83-49d4-aa73-c5f52660401a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_511a16d1-ee3e-487d-a96c-b5bfe4602bc4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b091e8d1-6a83-49d4-aa73-c5f52660401a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c7f165cd-787d-4439-b703-1cb733223227" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b091e8d1-6a83-49d4-aa73-c5f52660401a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c7f165cd-787d-4439-b703-1cb733223227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandAndLandImprovementsMember_1a73ff3f-1695-4dea-9b3f-dac4bbfee560" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandAndLandImprovementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c7f165cd-787d-4439-b703-1cb733223227" xlink:to="loc_us-gaap_LandAndLandImprovementsMember_1a73ff3f-1695-4dea-9b3f-dac4bbfee560" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_2668a671-3b89-47ca-9880-60cc28b681ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c7f165cd-787d-4439-b703-1cb733223227" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_2668a671-3b89-47ca-9880-60cc28b681ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_82453ee7-5d48-46d3-b4b4-a0085f462227" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c7f165cd-787d-4439-b703-1cb733223227" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_82453ee7-5d48-46d3-b4b4-a0085f462227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_1028856a-3228-4e18-9826-8f9d4ad77403" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c7f165cd-787d-4439-b703-1cb733223227" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_1028856a-3228-4e18-9826-8f9d4ad77403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember_f8ffbfd2-415b-422c-8a15-172b555a84c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c7f165cd-787d-4439-b703-1cb733223227" xlink:to="loc_us-gaap_OfficeEquipmentMember_f8ffbfd2-415b-422c-8a15-172b555a84c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ComputerHardwareAndSoftwareMember_be351e72-f1d2-4a93-a5b0-4361162cc907" xlink:href="idxx-20211231.xsd#idxx_ComputerHardwareAndSoftwareMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c7f165cd-787d-4439-b703-1cb733223227" xlink:to="loc_idxx_ComputerHardwareAndSoftwareMember_be351e72-f1d2-4a93-a5b0-4361162cc907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_15189962-a010-406f-9610-33ac87afb10c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c7f165cd-787d-4439-b703-1cb733223227" xlink:to="loc_us-gaap_ConstructionInProgressMember_15189962-a010-406f-9610-33ac87afb10c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8e3b0521-e2e2-4e21-bb96-8c0f249a0066" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_511a16d1-ee3e-487d-a96c-b5bfe4602bc4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8e3b0521-e2e2-4e21-bb96-8c0f249a0066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_ee4b2d7e-ae74-49e3-9544-e7fcdaf64796" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8e3b0521-e2e2-4e21-bb96-8c0f249a0066" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_ee4b2d7e-ae74-49e3-9544-e7fcdaf64796" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_18014f97-c85d-4d07-84ec-656ac5fe1d9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8e3b0521-e2e2-4e21-bb96-8c0f249a0066" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_18014f97-c85d-4d07-84ec-656ac5fe1d9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_23a15bf3-eb10-4122-bf27-cccf2980204c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8e3b0521-e2e2-4e21-bb96-8c0f249a0066" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_23a15bf3-eb10-4122-bf27-cccf2980204c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/PropertyandEquipmentNetSummaryOfDepreciationAndAmortizationCapitalizedComputerSoftwareForInternalUseAndUnpaidPropertyEquipmentReflectedInAccountPayableAndAccruedExpensesDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#PropertyandEquipmentNetSummaryOfDepreciationAndAmortizationCapitalizedComputerSoftwareForInternalUseAndUnpaidPropertyEquipmentReflectedInAccountPayableAndAccruedExpensesDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/PropertyandEquipmentNetSummaryOfDepreciationAndAmortizationCapitalizedComputerSoftwareForInternalUseAndUnpaidPropertyEquipmentReflectedInAccountPayableAndAccruedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0ec32628-17b1-46e1-922b-d479ca0f294a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e2884c92-94e6-43e8-b67a-8cd0a15fe21c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0ec32628-17b1-46e1-922b-d479ca0f294a" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e2884c92-94e6-43e8-b67a-8cd0a15fe21c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_98dbb24d-9c14-4e4c-86ae-65ca1dae4bd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e2884c92-94e6-43e8-b67a-8cd0a15fe21c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_98dbb24d-9c14-4e4c-86ae-65ca1dae4bd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_58e43d58-b1d9-494f-86ce-44892a256914" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_98dbb24d-9c14-4e4c-86ae-65ca1dae4bd4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_58e43d58-b1d9-494f-86ce-44892a256914" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_SoftwareDevelopedForInternalUseMember_c6ef2c86-06ed-41a6-803b-c2d7a8dae3de" xlink:href="idxx-20211231.xsd#idxx_SoftwareDevelopedForInternalUseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_58e43d58-b1d9-494f-86ce-44892a256914" xlink:to="loc_idxx_SoftwareDevelopedForInternalUseMember_c6ef2c86-06ed-41a6-803b-c2d7a8dae3de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_aba20985-f459-4cbb-a575-789156f30bf5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e2884c92-94e6-43e8-b67a-8cd0a15fe21c" xlink:to="loc_srt_ProductOrServiceAxis_aba20985-f459-4cbb-a575-789156f30bf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_163de35f-28dd-4a0a-93a0-3ae35f1e6188" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_aba20985-f459-4cbb-a575-789156f30bf5" xlink:to="loc_srt_ProductsAndServicesDomain_163de35f-28dd-4a0a-93a0-3ae35f1e6188" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ReagentRentalProgramsMember_e601f11a-0aab-42c7-98bf-81ec14b380c9" xlink:href="idxx-20211231.xsd#idxx_ReagentRentalProgramsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_163de35f-28dd-4a0a-93a0-3ae35f1e6188" xlink:to="loc_idxx_ReagentRentalProgramsMember_e601f11a-0aab-42c7-98bf-81ec14b380c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_307135e6-9bfb-455a-b798-c6a059cda6b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e2884c92-94e6-43e8-b67a-8cd0a15fe21c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_307135e6-9bfb-455a-b798-c6a059cda6b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDepreciationAndAmortization_0caffe17-2f1e-4b61-811a-325ed76a5b93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherDepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_307135e6-9bfb-455a-b798-c6a059cda6b9" xlink:to="loc_us-gaap_OtherDepreciationAndAmortization_0caffe17-2f1e-4b61-811a-325ed76a5b93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAdditions_97eb68a2-2993-41aa-8743-e782d69debb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAdditions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_307135e6-9bfb-455a-b798-c6a059cda6b9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAdditions_97eb68a2-2993-41aa-8743-e782d69debb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_a48c431e-cf91-4c2a-9397-7ac2f13b381f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_307135e6-9bfb-455a-b798-c6a059cda6b9" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_a48c431e-cf91-4c2a-9397-7ac2f13b381f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_09dd3d8c-0b88-4c31-80c9-dbaf23275b65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_307135e6-9bfb-455a-b798-c6a059cda6b9" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_09dd3d8c-0b88-4c31-80c9-dbaf23275b65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/PropertyandEquipmentNetNarrativeDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#PropertyandEquipmentNetNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/PropertyandEquipmentNetNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_2d19b80a-b78b-4c15-a956-749fbc900540" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges_8169cf52-b0a3-4194-9569-ebe75f46a30f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_2d19b80a-b78b-4c15-a956-749fbc900540" xlink:to="loc_us-gaap_TangibleAssetImpairmentCharges_8169cf52-b0a3-4194-9569-ebe75f46a30f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/OtherCurrentandLongTermAssets" xlink:type="simple" xlink:href="idxx-20211231.xsd#OtherCurrentandLongTermAssets"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/OtherCurrentandLongTermAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrentAbstract_198dd4e3-6d20-4615-9e53-c0587d13068c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsDisclosureTextBlock_23ceb126-06c1-44bf-9f46-acf3e9026a0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_198dd4e3-6d20-4615-9e53-c0587d13068c" xlink:to="loc_us-gaap_OtherAssetsDisclosureTextBlock_23ceb126-06c1-44bf-9f46-acf3e9026a0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/OtherCurrentandLongTermAssetsTables" xlink:type="simple" xlink:href="idxx-20211231.xsd#OtherCurrentandLongTermAssetsTables"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/OtherCurrentandLongTermAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrentAbstract_03590ead-7345-425e-bc82-d104230b4751" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_75138d56-2b43-4340-a9fc-0a72e3347eb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_03590ead-7345-425e-bc82-d104230b4751" xlink:to="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_75138d56-2b43-4340-a9fc-0a72e3347eb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_fd3f4488-6e97-4e45-8bd3-4d7f7611aef4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_03590ead-7345-425e-bc82-d104230b4751" xlink:to="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_fd3f4488-6e97-4e45-8bd3-4d7f7611aef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/OtherCurrentandLongTermAssetsScheduleofOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#OtherCurrentandLongTermAssetsScheduleofOtherCurrentAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/OtherCurrentandLongTermAssetsScheduleofOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrentAbstract_0e6e1eed-bda9-4099-b524-99e5b74df8c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCurrent_cb84efeb-1e02-4f74-8374-582f51611e74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCostsCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_0e6e1eed-bda9-4099-b524-99e5b74df8c5" xlink:to="loc_us-gaap_DeferredCostsCurrent_cb84efeb-1e02-4f74-8374-582f51611e74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_ab6213ed-6acd-4784-a36a-355bcbd945a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_0e6e1eed-bda9-4099-b524-99e5b74df8c5" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_ab6213ed-6acd-4784-a36a-355bcbd945a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_cd874024-1f28-4302-a8bb-7d6cc663d64a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_0e6e1eed-bda9-4099-b524-99e5b74df8c5" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_cd874024-1f28-4302-a8bb-7d6cc663d64a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_f70adee4-1c66-45dd-95b1-e96f7da16f7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_0e6e1eed-bda9-4099-b524-99e5b74df8c5" xlink:to="loc_us-gaap_IncomeTaxesReceivable_f70adee4-1c66-45dd-95b1-e96f7da16f7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNetCurrent_e362a9af-c2b3-425e-94b1-9647f37435fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostNetCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_0e6e1eed-bda9-4099-b524-99e5b74df8c5" xlink:to="loc_us-gaap_CapitalizedContractCostNetCurrent_e362a9af-c2b3-425e-94b1-9647f37435fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousCurrent_e889034d-0a85-4dd2-9c64-2b63b93304be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMiscellaneousCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_0e6e1eed-bda9-4099-b524-99e5b74df8c5" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousCurrent_e889034d-0a85-4dd2-9c64-2b63b93304be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_b0e70cf8-b37c-4722-8179-f26f6eae1c32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_0e6e1eed-bda9-4099-b524-99e5b74df8c5" xlink:to="loc_us-gaap_OtherAssetsCurrent_b0e70cf8-b37c-4722-8179-f26f6eae1c32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/OtherCurrentandLongTermAssetsScheduleofOtherNoncurrentAssetsDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#OtherCurrentandLongTermAssetsScheduleofOtherNoncurrentAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/OtherCurrentandLongTermAssetsScheduleofOtherNoncurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrentAbstract_8b4bb56e-ab1c-4ba1-9eac-5c3227ccf9b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetNoncurrent_bb87b007-b896-4265-a002-a8186e55df23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNetNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_8b4bb56e-ab1c-4ba1-9eac-5c3227ccf9b8" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetNoncurrent_bb87b007-b896-4265-a002-a8186e55df23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCosts_5f47b49d-becb-4593-ae96-cf33fd6d205b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_8b4bb56e-ab1c-4ba1-9eac-5c3227ccf9b8" xlink:to="loc_us-gaap_DeferredCosts_5f47b49d-becb-4593-ae96-cf33fd6d205b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_b1628ae6-cfac-4ba0-89cd-58ebf49c76a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_8b4bb56e-ab1c-4ba1-9eac-5c3227ccf9b8" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_b1628ae6-cfac-4ba0-89cd-58ebf49c76a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseOtherNoncurrent_563b638b-cb20-4023-9329-5f5960f4cfac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseOtherNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_8b4bb56e-ab1c-4ba1-9eac-5c3227ccf9b8" xlink:to="loc_us-gaap_PrepaidExpenseOtherNoncurrent_563b638b-cb20-4023-9329-5f5960f4cfac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNetNoncurrent_100f931d-52e7-4ef8-9ce5-ad1984bc1d88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostNetNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_8b4bb56e-ab1c-4ba1-9eac-5c3227ccf9b8" xlink:to="loc_us-gaap_CapitalizedContractCostNetNoncurrent_100f931d-52e7-4ef8-9ce5-ad1984bc1d88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivableNoncurrent_f3119dc0-e737-429e-9529-fc41cb954cd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesReceivableNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_8b4bb56e-ab1c-4ba1-9eac-5c3227ccf9b8" xlink:to="loc_us-gaap_IncomeTaxesReceivableNoncurrent_f3119dc0-e737-429e-9529-fc41cb954cd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_fff0d189-14ed-42c6-a6e7-903d21d79ed4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_8b4bb56e-ab1c-4ba1-9eac-5c3227ccf9b8" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_fff0d189-14ed-42c6-a6e7-903d21d79ed4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_c23c6ffb-eddb-47dc-a601-6fadb8d63f30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_8b4bb56e-ab1c-4ba1-9eac-5c3227ccf9b8" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_c23c6ffb-eddb-47dc-a601-6fadb8d63f30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/GoodwillandIntangibleAssetsNet" xlink:type="simple" xlink:href="idxx-20211231.xsd#GoodwillandIntangibleAssetsNet"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/GoodwillandIntangibleAssetsNet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_824a684d-8bdf-4a15-8764-f9d85f0f7aa3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_8d9f6d87-96d7-42fe-87b1-8ed27ec19fb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_824a684d-8bdf-4a15-8764-f9d85f0f7aa3" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_8d9f6d87-96d7-42fe-87b1-8ed27ec19fb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/GoodwillandIntangibleAssetsNetTables" xlink:type="simple" xlink:href="idxx-20211231.xsd#GoodwillandIntangibleAssetsNetTables"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/GoodwillandIntangibleAssetsNetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1f480e89-dc23-49cf-8a25-4d37149ee9b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_b3ff2449-4842-436e-b937-4e62c7ded519" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1f480e89-dc23-49cf-8a25-4d37149ee9b6" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_b3ff2449-4842-436e-b937-4e62c7ded519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ScheduleOfEstimatedUsefulLivesForIntangibleAssetsTableTextBlock_bb700963-5d96-4f75-a37a-eeb9602b4e9c" xlink:href="idxx-20211231.xsd#idxx_ScheduleOfEstimatedUsefulLivesForIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1f480e89-dc23-49cf-8a25-4d37149ee9b6" xlink:to="loc_idxx_ScheduleOfEstimatedUsefulLivesForIntangibleAssetsTableTextBlock_bb700963-5d96-4f75-a37a-eeb9602b4e9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_b5ab9663-288c-4629-a9c4-42b67a44df80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1f480e89-dc23-49cf-8a25-4d37149ee9b6" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_b5ab9663-288c-4629-a9c4-42b67a44df80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_184241da-f990-42cc-b4fa-4f215898fe6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1f480e89-dc23-49cf-8a25-4d37149ee9b6" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_184241da-f990-42cc-b4fa-4f215898fe6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#GoodwillandIntangibleAssetsNetNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ffdab7d7-c7a3-4978-94c5-5a4179bc4038" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_67c5210b-289a-4d4c-853a-2e641bf7d15d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ffdab7d7-c7a3-4978-94c5-5a4179bc4038" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_67c5210b-289a-4d4c-853a-2e641bf7d15d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_92780cb8-291d-469d-a27e-747d08ebffeb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_67c5210b-289a-4d4c-853a-2e641bf7d15d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_92780cb8-291d-469d-a27e-747d08ebffeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6a7dbf75-bc44-455f-9005-5bb4d1990a41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_92780cb8-291d-469d-a27e-747d08ebffeb" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6a7dbf75-bc44-455f-9005-5bb4d1990a41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_EzyVetMember_3d55757a-6e45-4675-bc55-c7fd64dfc643" xlink:href="idxx-20211231.xsd#idxx_EzyVetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6a7dbf75-bc44-455f-9005-5bb4d1990a41" xlink:to="loc_idxx_EzyVetMember_3d55757a-6e45-4675-bc55-c7fd64dfc643" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_c4741b5d-a49a-4c33-86d6-75fb286fa5a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_67c5210b-289a-4d4c-853a-2e641bf7d15d" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_c4741b5d-a49a-4c33-86d6-75fb286fa5a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_b5fb6afb-5479-4e39-b453-2e5ddf161c5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c4741b5d-a49a-4c33-86d6-75fb286fa5a6" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_b5fb6afb-5479-4e39-b453-2e5ddf161c5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_174e8c2c-2130-4311-9d5b-b941f1a7b6a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ffdab7d7-c7a3-4978-94c5-5a4179bc4038" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_174e8c2c-2130-4311-9d5b-b941f1a7b6a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_6ef25174-6e30-456a-87ea-e033ba594a21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ffdab7d7-c7a3-4978-94c5-5a4179bc4038" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_6ef25174-6e30-456a-87ea-e033ba594a21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_7b3668d6-64d0-40ea-a805-6e55b2661369" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ffdab7d7-c7a3-4978-94c5-5a4179bc4038" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_7b3668d6-64d0-40ea-a805-6e55b2661369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e4b49cdb-6528-4fe8-a1dd-64ce74542ee3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_SegmentsOfGoodwillTable_5f57e48e-80a7-42f7-b6ab-6aa6cbe4825c" xlink:href="idxx-20211231.xsd#idxx_SegmentsOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e4b49cdb-6528-4fe8-a1dd-64ce74542ee3" xlink:to="loc_idxx_SegmentsOfGoodwillTable_5f57e48e-80a7-42f7-b6ab-6aa6cbe4825c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d7c00441-bb93-4d55-ad4a-f3f89bea8e1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_SegmentsOfGoodwillTable_5f57e48e-80a7-42f7-b6ab-6aa6cbe4825c" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d7c00441-bb93-4d55-ad4a-f3f89bea8e1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6d5ce355-cba0-40b3-bde7-17cde40e3c1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d7c00441-bb93-4d55-ad4a-f3f89bea8e1e" xlink:to="loc_us-gaap_SegmentDomain_6d5ce355-cba0-40b3-bde7-17cde40e3c1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_CompanionAnimalGroupSegmentMember_f192fae9-7e36-4ac2-a9df-629c44a5c25f" xlink:href="idxx-20211231.xsd#idxx_CompanionAnimalGroupSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6d5ce355-cba0-40b3-bde7-17cde40e3c1a" xlink:to="loc_idxx_CompanionAnimalGroupSegmentMember_f192fae9-7e36-4ac2-a9df-629c44a5c25f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_WaterSegmentMember_c6ba363d-5890-4d04-a8c1-ea37662d02e4" xlink:href="idxx-20211231.xsd#idxx_WaterSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6d5ce355-cba0-40b3-bde7-17cde40e3c1a" xlink:to="loc_idxx_WaterSegmentMember_c6ba363d-5890-4d04-a8c1-ea37662d02e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_LivestockAndPoultryDiagnosticsSegmentMember_f9ade8db-2c51-4fb0-b10c-2e748b3e9ddc" xlink:href="idxx-20211231.xsd#idxx_LivestockAndPoultryDiagnosticsSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6d5ce355-cba0-40b3-bde7-17cde40e3c1a" xlink:to="loc_idxx_LivestockAndPoultryDiagnosticsSegmentMember_f9ade8db-2c51-4fb0-b10c-2e748b3e9ddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_OtherSegmentMember_cb680ebf-82a2-4aff-9752-3719f6330763" xlink:href="idxx-20211231.xsd#idxx_OtherSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6d5ce355-cba0-40b3-bde7-17cde40e3c1a" xlink:to="loc_idxx_OtherSegmentMember_cb680ebf-82a2-4aff-9752-3719f6330763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_SegmentsOfGoodwillLineItems_413ca73f-796d-4458-bbca-ea419343f6e9" xlink:href="idxx-20211231.xsd#idxx_SegmentsOfGoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_SegmentsOfGoodwillTable_5f57e48e-80a7-42f7-b6ab-6aa6cbe4825c" xlink:to="loc_idxx_SegmentsOfGoodwillLineItems_413ca73f-796d-4458-bbca-ea419343f6e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_dd6f4acf-bf80-4051-b4c4-e3caf9832636" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_SegmentsOfGoodwillLineItems_413ca73f-796d-4458-bbca-ea419343f6e9" xlink:to="loc_us-gaap_GoodwillRollForward_dd6f4acf-bf80-4051-b4c4-e3caf9832636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f8fc95a8-c27b-490d-a6dd-102f38ef3fc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_dd6f4acf-bf80-4051-b4c4-e3caf9832636" xlink:to="loc_us-gaap_Goodwill_f8fc95a8-c27b-490d-a6dd-102f38ef3fc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_d50ecaba-3780-4452-be2a-ee9f99cfecce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_dd6f4acf-bf80-4051-b4c4-e3caf9832636" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_d50ecaba-3780-4452-be2a-ee9f99cfecce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_f633dfbe-f6bf-4040-90e9-9eeb761319ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_dd6f4acf-bf80-4051-b4c4-e3caf9832636" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_f633dfbe-f6bf-4040-90e9-9eeb761319ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_a6f54437-ddea-4569-9e9d-698e09d464a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_dd6f4acf-bf80-4051-b4c4-e3caf9832636" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_a6f54437-ddea-4569-9e9d-698e09d464a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_a3462491-9e2c-4c59-bf5d-f51c829624f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_dd6f4acf-bf80-4051-b4c4-e3caf9832636" xlink:to="loc_us-gaap_Goodwill_a3462491-9e2c-4c59-bf5d-f51c829624f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofEstimatedUsefulLivesForIntangibleAssetsDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#GoodwillandIntangibleAssetsNetScheduleofEstimatedUsefulLivesForIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofEstimatedUsefulLivesForIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a9287105-dd95-4fe1-90b3-8f9a308738c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_bfbfb71f-d322-488b-af30-06774dce7532" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a9287105-dd95-4fe1-90b3-8f9a308738c9" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_bfbfb71f-d322-488b-af30-06774dce7532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0ffb4f4e-4c2e-44c8-b8a6-3366f1962c92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_bfbfb71f-d322-488b-af30-06774dce7532" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0ffb4f4e-4c2e-44c8-b8a6-3366f1962c92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e5ddc68a-49da-4ba2-9fc0-69716e297cd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0ffb4f4e-4c2e-44c8-b8a6-3366f1962c92" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e5ddc68a-49da-4ba2-9fc0-69716e297cd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_87ede236-eb4a-4b39-99fb-e79e37bce4e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e5ddc68a-49da-4ba2-9fc0-69716e297cd5" xlink:to="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_87ede236-eb4a-4b39-99fb-e79e37bce4e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ProductRightsMember_63015726-f11f-4bbe-81e6-88a8f5a03faf" xlink:href="idxx-20211231.xsd#idxx_ProductRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e5ddc68a-49da-4ba2-9fc0-69716e297cd5" xlink:to="loc_idxx_ProductRightsMember_63015726-f11f-4bbe-81e6-88a8f5a03faf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_4ae0205d-4428-4204-86cc-7a9cf22221e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e5ddc68a-49da-4ba2-9fc0-69716e297cd5" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_4ae0205d-4428-4204-86cc-7a9cf22221e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f80ca13b-6811-4318-bb36-f916a4e39091" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_bfbfb71f-d322-488b-af30-06774dce7532" xlink:to="loc_srt_RangeAxis_f80ca13b-6811-4318-bb36-f916a4e39091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_82e509ea-ada1-40cd-a41e-829da82ac32b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_f80ca13b-6811-4318-bb36-f916a4e39091" xlink:to="loc_srt_RangeMember_82e509ea-ada1-40cd-a41e-829da82ac32b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_48535e68-1071-4edf-928d-f320b44a3c03" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_82e509ea-ada1-40cd-a41e-829da82ac32b" xlink:to="loc_srt_MinimumMember_48535e68-1071-4edf-928d-f320b44a3c03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6b55ccda-18a2-4b25-a95e-ec75e1a8833c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_82e509ea-ada1-40cd-a41e-829da82ac32b" xlink:to="loc_srt_MaximumMember_6b55ccda-18a2-4b25-a95e-ec75e1a8833c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b2f0a517-f066-479d-aeec-a2719dacb288" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_bfbfb71f-d322-488b-af30-06774dce7532" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b2f0a517-f066-479d-aeec-a2719dacb288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_2c06a0de-d00b-4c29-aea2-6296b403fb7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b2f0a517-f066-479d-aeec-a2719dacb288" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_2c06a0de-d00b-4c29-aea2-6296b403fb7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofIntangibleAssetsOtherThanGoodwillDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#GoodwillandIntangibleAssetsNetScheduleofIntangibleAssetsOtherThanGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofIntangibleAssetsOtherThanGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_31d14bb2-c278-4452-bcd4-2386abd2b20d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a60d816c-897d-4058-859b-b1abc70147ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_31d14bb2-c278-4452-bcd4-2386abd2b20d" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a60d816c-897d-4058-859b-b1abc70147ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_034af0c8-bbd6-442a-bf8a-f501735d5dfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a60d816c-897d-4058-859b-b1abc70147ed" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_034af0c8-bbd6-442a-bf8a-f501735d5dfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1b0f8eca-e19d-408a-9ffc-04a5ec84ed71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_034af0c8-bbd6-442a-bf8a-f501735d5dfa" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1b0f8eca-e19d-408a-9ffc-04a5ec84ed71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_8621939c-f3f7-42a2-ac38-07d008e07522" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1b0f8eca-e19d-408a-9ffc-04a5ec84ed71" xlink:to="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_8621939c-f3f7-42a2-ac38-07d008e07522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ProductRightsMember_3f10f1ab-f888-4405-ad58-d11f063cb618" xlink:href="idxx-20211231.xsd#idxx_ProductRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1b0f8eca-e19d-408a-9ffc-04a5ec84ed71" xlink:to="loc_idxx_ProductRightsMember_3f10f1ab-f888-4405-ad58-d11f063cb618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_10b9d9ab-6b2c-4175-aec7-4875c91fa784" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1b0f8eca-e19d-408a-9ffc-04a5ec84ed71" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_10b9d9ab-6b2c-4175-aec7-4875c91fa784" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_76ffddf2-610e-467b-8e2a-d11bb0262209" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a60d816c-897d-4058-859b-b1abc70147ed" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_76ffddf2-610e-467b-8e2a-d11bb0262209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_04e27fd7-c891-48a7-8374-689b13ce1911" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_76ffddf2-610e-467b-8e2a-d11bb0262209" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_04e27fd7-c891-48a7-8374-689b13ce1911" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_382da85e-5cdf-46d7-bde2-c9548f0f7106" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_76ffddf2-610e-467b-8e2a-d11bb0262209" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_382da85e-5cdf-46d7-bde2-c9548f0f7106" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_a010e61b-4d4f-4cb0-b987-14c4a15c0d0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_76ffddf2-610e-467b-8e2a-d11bb0262209" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_a010e61b-4d4f-4cb0-b987-14c4a15c0d0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofExpectedAmortizationExpenseDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#GoodwillandIntangibleAssetsNetScheduleofExpectedAmortizationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofExpectedAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ce3b0165-0713-44f8-8a45-b9a717fa2081" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_49bb69d9-914b-4dd5-918c-2ed546127112" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ce3b0165-0713-44f8-8a45-b9a717fa2081" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_49bb69d9-914b-4dd5-918c-2ed546127112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_89a7015b-375e-4369-87ec-28a39b45bdd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ce3b0165-0713-44f8-8a45-b9a717fa2081" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_89a7015b-375e-4369-87ec-28a39b45bdd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_95062b27-3650-4c83-a29d-71b25e90fb81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ce3b0165-0713-44f8-8a45-b9a717fa2081" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_95062b27-3650-4c83-a29d-71b25e90fb81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_7c7cee9e-d93f-4277-9d1c-7f4a7cd91a13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ce3b0165-0713-44f8-8a45-b9a717fa2081" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_7c7cee9e-d93f-4277-9d1c-7f4a7cd91a13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_72351755-4b7e-4b8a-954a-0675454aae3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ce3b0165-0713-44f8-8a45-b9a717fa2081" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_72351755-4b7e-4b8a-954a-0675454aae3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_e02be2df-0c3b-49b0-a6a9-6ba39bdd5bc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ce3b0165-0713-44f8-8a45-b9a717fa2081" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_e02be2df-0c3b-49b0-a6a9-6ba39bdd5bc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_16f9cf0b-6d8f-4d59-a810-7bd1fc16247c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ce3b0165-0713-44f8-8a45-b9a717fa2081" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_16f9cf0b-6d8f-4d59-a810-7bd1fc16247c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/AccruedLiabilitiesandOtherLongTermLiabilities" xlink:type="simple" xlink:href="idxx-20211231.xsd#AccruedLiabilitiesandOtherLongTermLiabilities"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/AccruedLiabilitiesandOtherLongTermLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_2ef92323-e34e-4f49-bb79-ba3ac897ea3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock_c6411764-3035-4d9f-aba1-d0b3027cc7cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_2ef92323-e34e-4f49-bb79-ba3ac897ea3e" xlink:to="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock_c6411764-3035-4d9f-aba1-d0b3027cc7cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/AccruedLiabilitiesandOtherLongTermLiabilitiesTables" xlink:type="simple" xlink:href="idxx-20211231.xsd#AccruedLiabilitiesandOtherLongTermLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/AccruedLiabilitiesandOtherLongTermLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_72f6d040-53b1-4b42-930c-6f547e69c4bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_6aa464ac-b49b-43f3-981f-bf45d2b43315" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_72f6d040-53b1-4b42-930c-6f547e69c4bf" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_6aa464ac-b49b-43f3-981f-bf45d2b43315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_b6bf49c3-3e54-4492-9ead-69746903f309" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_72f6d040-53b1-4b42-930c-6f547e69c4bf" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_b6bf49c3-3e54-4492-9ead-69746903f309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/AccruedLiabilitiesandOtherLongTermLiabilitiesScheduleofAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#AccruedLiabilitiesandOtherLongTermLiabilitiesScheduleofAccruedLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/AccruedLiabilitiesandOtherLongTermLiabilitiesScheduleofAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_41e38b0f-3de4-4ab0-a68a-2550c5600171" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_3dd7d56a-99c3-486b-9d6a-dc49a784bf5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_41e38b0f-3de4-4ab0-a68a-2550c5600171" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_3dd7d56a-99c3-486b-9d6a-dc49a784bf5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_ba1b0f6c-1363-45e0-831e-5e06592679e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_41e38b0f-3de4-4ab0-a68a-2550c5600171" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_ba1b0f6c-1363-45e0-831e-5e06592679e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedMarketingCostsCurrent_cef32257-560c-4138-a7d7-03ef23ec66bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedMarketingCostsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_41e38b0f-3de4-4ab0-a68a-2550c5600171" xlink:to="loc_us-gaap_AccruedMarketingCostsCurrent_cef32257-560c-4138-a7d7-03ef23ec66bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_fa7526d6-6934-40c3-a4f9-798841c68713" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_41e38b0f-3de4-4ab0-a68a-2550c5600171" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_fa7526d6-6934-40c3-a4f9-798841c68713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_0d6fb431-4278-4d91-96ed-d5e4b7441e82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_41e38b0f-3de4-4ab0-a68a-2550c5600171" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_0d6fb431-4278-4d91-96ed-d5e4b7441e82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_9b5568de-58a9-47a4-b5f8-b8d28543b0a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent_0d6fb431-4278-4d91-96ed-d5e4b7441e82" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_9b5568de-58a9-47a4-b5f8-b8d28543b0a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_9efdd1ba-aa45-49f6-984e-ee2ac6bf6e38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_41e38b0f-3de4-4ab0-a68a-2550c5600171" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_9efdd1ba-aa45-49f6-984e-ee2ac6bf6e38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/AccruedLiabilitiesandOtherLongTermLiabilitiesScheduleofLongTermAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#AccruedLiabilitiesandOtherLongTermLiabilitiesScheduleofLongTermAccruedLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/AccruedLiabilitiesandOtherLongTermLiabilitiesScheduleofLongTermAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_4e8ffc72-bfca-4da0-a9ed-85f4a197cf48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_0652f4b8-eeea-4ced-9b47-935dbbbdd2e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_4e8ffc72-bfca-4da0-a9ed-85f4a197cf48" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_0652f4b8-eeea-4ced-9b47-935dbbbdd2e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_59170315-4ccd-4e98-9082-bdf74844f29b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_4e8ffc72-bfca-4da0-a9ed-85f4a197cf48" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_59170315-4ccd-4e98-9082-bdf74844f29b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_428d2fc0-f28d-44c6-b909-82203755e4f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_4e8ffc72-bfca-4da0-a9ed-85f4a197cf48" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_428d2fc0-f28d-44c6-b909-82203755e4f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/Debt" xlink:type="simple" xlink:href="idxx-20211231.xsd#Debt"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/Debt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentsAbstract_b41ea0be-4f58-40c0-8ffa-f0730ca50b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_b7dd6c51-3e7e-4ef2-be43-119ab86774ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_b41ea0be-4f58-40c0-8ffa-f0730ca50b9b" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_b7dd6c51-3e7e-4ef2-be43-119ab86774ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/DebtTables" xlink:type="simple" xlink:href="idxx-20211231.xsd#DebtTables"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/DebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentsAbstract_e97622ae-35a4-49d0-8e9b-cbabebf14e65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_e5c11d57-9086-4d60-aa58-59eb5c69ffb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_e97622ae-35a4-49d0-8e9b-cbabebf14e65" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_e5c11d57-9086-4d60-aa58-59eb5c69ffb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_b8dde7c3-69fc-43f4-8d00-8d67aba8e56a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_e97622ae-35a4-49d0-8e9b-cbabebf14e65" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_b8dde7c3-69fc-43f4-8d00-8d67aba8e56a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/DebtNarrativeDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#DebtNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/DebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_5c5dda9b-99aa-4763-98f0-bb3d7799a494" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_9c7a86cc-d1a5-4f85-a11a-ba8e313f79db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_5c5dda9b-99aa-4763-98f0-bb3d7799a494" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_9c7a86cc-d1a5-4f85-a11a-ba8e313f79db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_91c9b913-a912-4fde-87bd-5cff06186d38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_9c7a86cc-d1a5-4f85-a11a-ba8e313f79db" xlink:to="loc_us-gaap_CreditFacilityAxis_91c9b913-a912-4fde-87bd-5cff06186d38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_1f4b5b9b-2381-4ca1-902f-088cdf970b64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_91c9b913-a912-4fde-87bd-5cff06186d38" xlink:to="loc_us-gaap_CreditFacilityDomain_1f4b5b9b-2381-4ca1-902f-088cdf970b64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_29ff4023-ad05-42c6-b8ac-349230398bf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_1f4b5b9b-2381-4ca1-902f-088cdf970b64" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_29ff4023-ad05-42c6-b8ac-349230398bf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_RevolvingCreditFacilityIndividualBorrowingsMember_eb4e1e4c-b01a-44ce-b3e9-4181f1bb1aea" xlink:href="idxx-20211231.xsd#idxx_RevolvingCreditFacilityIndividualBorrowingsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember_29ff4023-ad05-42c6-b8ac-349230398bf1" xlink:to="loc_idxx_RevolvingCreditFacilityIndividualBorrowingsMember_eb4e1e4c-b01a-44ce-b3e9-4181f1bb1aea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_487316d9-6a22-44e3-9372-8d2452e9b6fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_9c7a86cc-d1a5-4f85-a11a-ba8e313f79db" xlink:to="loc_us-gaap_VariableRateAxis_487316d9-6a22-44e3-9372-8d2452e9b6fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_7f86e721-6be1-4171-b433-dd7f9deb6974" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_487316d9-6a22-44e3-9372-8d2452e9b6fe" xlink:to="loc_us-gaap_VariableRateDomain_7f86e721-6be1-4171-b433-dd7f9deb6974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_862fc4c5-cd36-4721-aa58-19c0c8790efe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_7f86e721-6be1-4171-b433-dd7f9deb6974" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_862fc4c5-cd36-4721-aa58-19c0c8790efe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrimeRateMember_7fc2ccfd-5241-4386-a6a7-2fc8b247723c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrimeRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_7f86e721-6be1-4171-b433-dd7f9deb6974" xlink:to="loc_us-gaap_PrimeRateMember_7fc2ccfd-5241-4386-a6a7-2fc8b247723c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ef46387c-741c-4bf8-9d58-24fa208630ee" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_9c7a86cc-d1a5-4f85-a11a-ba8e313f79db" xlink:to="loc_srt_RangeAxis_ef46387c-741c-4bf8-9d58-24fa208630ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a2e60617-4a0e-496c-bb83-9416b58f5cd8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_ef46387c-741c-4bf8-9d58-24fa208630ee" xlink:to="loc_srt_RangeMember_a2e60617-4a0e-496c-bb83-9416b58f5cd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_8bd61c9a-08cb-4843-893f-b98376d1f2d7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a2e60617-4a0e-496c-bb83-9416b58f5cd8" xlink:to="loc_srt_MinimumMember_8bd61c9a-08cb-4843-893f-b98376d1f2d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_92f0ad85-6bcf-4a34-8718-068696797c0d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a2e60617-4a0e-496c-bb83-9416b58f5cd8" xlink:to="loc_srt_MaximumMember_92f0ad85-6bcf-4a34-8718-068696797c0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_d3a60011-ad7c-425f-8be6-10ff8c5810dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_9c7a86cc-d1a5-4f85-a11a-ba8e313f79db" xlink:to="loc_us-gaap_DebtInstrumentAxis_d3a60011-ad7c-425f-8be6-10ff8c5810dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_32dfea17-69a5-444e-9db6-e19020de4464" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_d3a60011-ad7c-425f-8be6-10ff8c5810dc" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_32dfea17-69a5-444e-9db6-e19020de4464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_A2023SeriesANotesAnd2025SeriesBNotesMember_f7cf982d-8161-4f18-9026-16869dd73591" xlink:href="idxx-20211231.xsd#idxx_A2023SeriesANotesAnd2025SeriesBNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_32dfea17-69a5-444e-9db6-e19020de4464" xlink:to="loc_idxx_A2023SeriesANotesAnd2025SeriesBNotesMember_f7cf982d-8161-4f18-9026-16869dd73591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_A2023SeriesANotesMember_c13db8bc-743c-4f92-aa49-91477af59420" xlink:href="idxx-20211231.xsd#idxx_A2023SeriesANotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_A2023SeriesANotesAnd2025SeriesBNotesMember_f7cf982d-8161-4f18-9026-16869dd73591" xlink:to="loc_idxx_A2023SeriesANotesMember_c13db8bc-743c-4f92-aa49-91477af59420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_A2025SeriesBNotesMember_ba6ca2c9-2cff-4610-a88a-efdf354e9426" xlink:href="idxx-20211231.xsd#idxx_A2025SeriesBNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_A2023SeriesANotesAnd2025SeriesBNotesMember_f7cf982d-8161-4f18-9026-16869dd73591" xlink:to="loc_idxx_A2025SeriesBNotesMember_ba6ca2c9-2cff-4610-a88a-efdf354e9426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_A2026SeniorNotesMember_79a53c62-59b3-47d3-9cf7-0f63df0d4c93" xlink:href="idxx-20211231.xsd#idxx_A2026SeniorNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_32dfea17-69a5-444e-9db6-e19020de4464" xlink:to="loc_idxx_A2026SeniorNotesMember_79a53c62-59b3-47d3-9cf7-0f63df0d4c93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_A2021SeriesANotesAnd2024SeriesBNotesMember_f1b57a16-4c93-43aa-81fb-bac85bc6beda" xlink:href="idxx-20211231.xsd#idxx_A2021SeriesANotesAnd2024SeriesBNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_32dfea17-69a5-444e-9db6-e19020de4464" xlink:to="loc_idxx_A2021SeriesANotesAnd2024SeriesBNotesMember_f1b57a16-4c93-43aa-81fb-bac85bc6beda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_A2021SeriesANotesMember_fc464351-55dd-4173-bdc1-3afdb5fd80d4" xlink:href="idxx-20211231.xsd#idxx_A2021SeriesANotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_A2021SeriesANotesAnd2024SeriesBNotesMember_f1b57a16-4c93-43aa-81fb-bac85bc6beda" xlink:to="loc_idxx_A2021SeriesANotesMember_fc464351-55dd-4173-bdc1-3afdb5fd80d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_A2024SeriesBNotesMember_33158d6e-d9d6-4836-a82f-ab92ff7d1461" xlink:href="idxx-20211231.xsd#idxx_A2024SeriesBNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_A2021SeriesANotesAnd2024SeriesBNotesMember_f1b57a16-4c93-43aa-81fb-bac85bc6beda" xlink:to="loc_idxx_A2024SeriesBNotesMember_33158d6e-d9d6-4836-a82f-ab92ff7d1461" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_A2025SeriesCNotesMember_4c240dc2-ef6c-4286-98ff-c68ddb905971" xlink:href="idxx-20211231.xsd#idxx_A2025SeriesCNotesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_32dfea17-69a5-444e-9db6-e19020de4464" xlink:to="loc_idxx_A2025SeriesCNotesMember_4c240dc2-ef6c-4286-98ff-c68ddb905971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_Prudential2030SeriesDNotesMember_0d861041-dea8-49cd-85b1-11dc84f0f6ac" xlink:href="idxx-20211231.xsd#idxx_Prudential2030SeriesDNotesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_32dfea17-69a5-444e-9db6-e19020de4464" xlink:to="loc_idxx_Prudential2030SeriesDNotesMember_0d861041-dea8-49cd-85b1-11dc84f0f6ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_A2022SeriesANotesand2027SeriesBNotesMember_4284bb32-2e93-4fcf-ab07-d142353aa4d2" xlink:href="idxx-20211231.xsd#idxx_A2022SeriesANotesand2027SeriesBNotesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_32dfea17-69a5-444e-9db6-e19020de4464" xlink:to="loc_idxx_A2022SeriesANotesand2027SeriesBNotesMember_4284bb32-2e93-4fcf-ab07-d142353aa4d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_A2022SeriesANotesMember_e9401635-8203-4fb1-b468-65f7682d3319" xlink:href="idxx-20211231.xsd#idxx_A2022SeriesANotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_A2022SeriesANotesand2027SeriesBNotesMember_4284bb32-2e93-4fcf-ab07-d142353aa4d2" xlink:to="loc_idxx_A2022SeriesANotesMember_e9401635-8203-4fb1-b468-65f7682d3319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_A2027SeriesBNotesMember_37afa698-8964-4c7c-982e-f5bd832bccc3" xlink:href="idxx-20211231.xsd#idxx_A2027SeriesBNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_A2022SeriesANotesand2027SeriesBNotesMember_4284bb32-2e93-4fcf-ab07-d142353aa4d2" xlink:to="loc_idxx_A2027SeriesBNotesMember_37afa698-8964-4c7c-982e-f5bd832bccc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_A2029SeriesCNotesMember_fd262ab6-1973-43d1-a7cb-29a98ff7e43a" xlink:href="idxx-20211231.xsd#idxx_A2029SeriesCNotesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_32dfea17-69a5-444e-9db6-e19020de4464" xlink:to="loc_idxx_A2029SeriesCNotesMember_fd262ab6-1973-43d1-a7cb-29a98ff7e43a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_MetLife2030SeriesDNotesMember_3a5b77a1-7f93-4dbb-a451-f8bb719e2e3a" xlink:href="idxx-20211231.xsd#idxx_MetLife2030SeriesDNotesMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_32dfea17-69a5-444e-9db6-e19020de4464" xlink:to="loc_idxx_MetLife2030SeriesDNotesMember_3a5b77a1-7f93-4dbb-a451-f8bb719e2e3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_15fb9554-9f80-44a2-9b38-8fa6035ec50f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_9c7a86cc-d1a5-4f85-a11a-ba8e313f79db" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_15fb9554-9f80-44a2-9b38-8fa6035ec50f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b49ed68e-b45d-4761-892d-31262b6f37bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_15fb9554-9f80-44a2-9b38-8fa6035ec50f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b49ed68e-b45d-4761-892d-31262b6f37bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_41c45206-1e7a-4b72-9160-bee1660a4a46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b49ed68e-b45d-4761-892d-31262b6f37bd" xlink:to="loc_us-gaap_SeniorNotesMember_41c45206-1e7a-4b72-9160-bee1660a4a46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_6577fe67-b0e5-4f84-a89f-bd537d399cc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_9c7a86cc-d1a5-4f85-a11a-ba8e313f79db" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_6577fe67-b0e5-4f84-a89f-bd537d399cc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_e5fc3077-09ba-491b-abb5-369b6442a0dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_6577fe67-b0e5-4f84-a89f-bd537d399cc8" xlink:to="loc_us-gaap_DebtInstrumentTerm_e5fc3077-09ba-491b-abb5-369b6442a0dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_0752394d-2284-41d9-aa42-2d9ea9436dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_6577fe67-b0e5-4f84-a89f-bd537d399cc8" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_0752394d-2284-41d9-aa42-2d9ea9436dcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_LineofCreditFacilityAccordionFeatureIncreaseLimit_9c6332f2-11b5-4309-8de5-691ca803ba25" xlink:href="idxx-20211231.xsd#idxx_LineofCreditFacilityAccordionFeatureIncreaseLimit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_6577fe67-b0e5-4f84-a89f-bd537d399cc8" xlink:to="loc_idxx_LineofCreditFacilityAccordionFeatureIncreaseLimit_9c6332f2-11b5-4309-8de5-691ca803ba25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_LineofCreditFacilityAccordionFeatureHigherBorrowingCapacityOption_7a804d62-889c-4043-8223-386d43cda6bd" xlink:href="idxx-20211231.xsd#idxx_LineofCreditFacilityAccordionFeatureHigherBorrowingCapacityOption"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_6577fe67-b0e5-4f84-a89f-bd537d399cc8" xlink:to="loc_idxx_LineofCreditFacilityAccordionFeatureHigherBorrowingCapacityOption_7a804d62-889c-4043-8223-386d43cda6bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_5908235f-7889-45aa-a7a7-4f01686216f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_6577fe67-b0e5-4f84-a89f-bd537d399cc8" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_5908235f-7889-45aa-a7a7-4f01686216f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_bbcb154f-8677-42f8-97f3-2ff8a24616c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_6577fe67-b0e5-4f84-a89f-bd537d399cc8" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_bbcb154f-8677-42f8-97f3-2ff8a24616c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_b331672e-ca2c-4547-9ff1-594dd8b9134d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_6577fe67-b0e5-4f84-a89f-bd537d399cc8" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_b331672e-ca2c-4547-9ff1-594dd8b9134d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditCurrent_bd2c61a7-f78e-4396-a402-ecede721b13b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LinesOfCreditCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_6577fe67-b0e5-4f84-a89f-bd537d399cc8" xlink:to="loc_us-gaap_LinesOfCreditCurrent_bd2c61a7-f78e-4396-a402-ecede721b13b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate_da97d9f0-b931-4f38-bdf5-ef9ffa1e7332" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_6577fe67-b0e5-4f84-a89f-bd537d399cc8" xlink:to="loc_us-gaap_DebtWeightedAverageInterestRate_da97d9f0-b931-4f38-bdf5-ef9ffa1e7332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases_06589200-82ac-4968-b0f3-bc730f5d4750" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_6577fe67-b0e5-4f84-a89f-bd537d399cc8" xlink:to="loc_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases_06589200-82ac-4968-b0f3-bc730f5d4750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ConsolidatedLeverageRatioUnderCreditFacilityNotePayable_5c262807-f32b-4f11-805b-b0959f41dc7c" xlink:href="idxx-20211231.xsd#idxx_ConsolidatedLeverageRatioUnderCreditFacilityNotePayable"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_6577fe67-b0e5-4f84-a89f-bd537d399cc8" xlink:to="loc_idxx_ConsolidatedLeverageRatioUnderCreditFacilityNotePayable_5c262807-f32b-4f11-805b-b0959f41dc7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_b9801610-f091-4da5-bc13-7ddc23306db0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_6577fe67-b0e5-4f84-a89f-bd537d399cc8" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_b9801610-f091-4da5-bc13-7ddc23306db0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt_cb761a51-58d4-4512-969d-138077d79dac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_6577fe67-b0e5-4f84-a89f-bd537d399cc8" xlink:to="loc_us-gaap_RepaymentsOfSeniorDebt_cb761a51-58d4-4512-969d-138077d79dac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_33fa1338-9f86-4825-a4c1-979831cdb83d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_6577fe67-b0e5-4f84-a89f-bd537d399cc8" xlink:to="loc_us-gaap_InterestPaidNet_33fa1338-9f86-4825-a4c1-979831cdb83d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/DebtScheduleofSeniorNoteBorrowingsDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#DebtScheduleofSeniorNoteBorrowingsDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/DebtScheduleofSeniorNoteBorrowingsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_a97e5a9d-4775-4d78-8c55-d6a2cafeb2b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_081d75b0-fc9c-43a4-8981-481222fc4e92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a97e5a9d-4775-4d78-8c55-d6a2cafeb2b8" xlink:to="loc_us-gaap_DebtInstrumentTable_081d75b0-fc9c-43a4-8981-481222fc4e92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_35733aaf-4285-4c6b-8418-17044654ccc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_081d75b0-fc9c-43a4-8981-481222fc4e92" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_35733aaf-4285-4c6b-8418-17044654ccc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_df821d46-af7e-497c-8fa8-91ef74314566" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_35733aaf-4285-4c6b-8418-17044654ccc8" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_df821d46-af7e-497c-8fa8-91ef74314566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_c7136748-a1a9-4c67-80a9-abba39b58916" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_df821d46-af7e-497c-8fa8-91ef74314566" xlink:to="loc_us-gaap_SeniorNotesMember_c7136748-a1a9-4c67-80a9-abba39b58916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_496d817e-40c7-41b7-b2e9-f0b88f905716" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_081d75b0-fc9c-43a4-8981-481222fc4e92" xlink:to="loc_us-gaap_DebtInstrumentAxis_496d817e-40c7-41b7-b2e9-f0b88f905716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3614cfde-dddd-449a-b93b-6f77a888a099" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_496d817e-40c7-41b7-b2e9-f0b88f905716" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3614cfde-dddd-449a-b93b-6f77a888a099" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_A2023SeriesANotesMember_90c39981-d2bb-4659-acac-497a2d98f474" xlink:href="idxx-20211231.xsd#idxx_A2023SeriesANotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3614cfde-dddd-449a-b93b-6f77a888a099" xlink:to="loc_idxx_A2023SeriesANotesMember_90c39981-d2bb-4659-acac-497a2d98f474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_A2025SeriesBNotesMember_5994d9b5-5130-4fd3-b4f3-a3a4530c5d23" xlink:href="idxx-20211231.xsd#idxx_A2025SeriesBNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3614cfde-dddd-449a-b93b-6f77a888a099" xlink:to="loc_idxx_A2025SeriesBNotesMember_5994d9b5-5130-4fd3-b4f3-a3a4530c5d23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_A2026SeniorNotesMember_d80f7c87-958e-4434-b5b3-c4161cbbea3e" xlink:href="idxx-20211231.xsd#idxx_A2026SeniorNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3614cfde-dddd-449a-b93b-6f77a888a099" xlink:to="loc_idxx_A2026SeniorNotesMember_d80f7c87-958e-4434-b5b3-c4161cbbea3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_A2024SeriesBNotesMember_74e1d5d8-957e-4e90-b7a1-8bbcbff57b20" xlink:href="idxx-20211231.xsd#idxx_A2024SeriesBNotesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3614cfde-dddd-449a-b93b-6f77a888a099" xlink:to="loc_idxx_A2024SeriesBNotesMember_74e1d5d8-957e-4e90-b7a1-8bbcbff57b20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_A2025SeriesCNotesMember_743ec356-e025-4461-8522-bbfd44f46f6c" xlink:href="idxx-20211231.xsd#idxx_A2025SeriesCNotesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3614cfde-dddd-449a-b93b-6f77a888a099" xlink:to="loc_idxx_A2025SeriesCNotesMember_743ec356-e025-4461-8522-bbfd44f46f6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_A2022SeriesANotesMember_ce18d119-b85f-444d-b08d-7c71a8bd5cb6" xlink:href="idxx-20211231.xsd#idxx_A2022SeriesANotesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3614cfde-dddd-449a-b93b-6f77a888a099" xlink:to="loc_idxx_A2022SeriesANotesMember_ce18d119-b85f-444d-b08d-7c71a8bd5cb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_A2027SeriesBNotesMember_542b3be5-c13e-47d7-a59d-967569e4a3bc" xlink:href="idxx-20211231.xsd#idxx_A2027SeriesBNotesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3614cfde-dddd-449a-b93b-6f77a888a099" xlink:to="loc_idxx_A2027SeriesBNotesMember_542b3be5-c13e-47d7-a59d-967569e4a3bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_A2029SeriesCNotesMember_53da1ecc-719f-4a51-a5ae-f8f16efbe6e0" xlink:href="idxx-20211231.xsd#idxx_A2029SeriesCNotesMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3614cfde-dddd-449a-b93b-6f77a888a099" xlink:to="loc_idxx_A2029SeriesCNotesMember_53da1ecc-719f-4a51-a5ae-f8f16efbe6e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_MetLife2030SeriesDNotesMember_b2fc1730-d2ca-4ed7-a76b-d03a5be38cb4" xlink:href="idxx-20211231.xsd#idxx_MetLife2030SeriesDNotesMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3614cfde-dddd-449a-b93b-6f77a888a099" xlink:to="loc_idxx_MetLife2030SeriesDNotesMember_b2fc1730-d2ca-4ed7-a76b-d03a5be38cb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_Prudential2030SeriesDNotesMember_2c2730c0-1dc4-429f-a263-077a163a694c" xlink:href="idxx-20211231.xsd#idxx_Prudential2030SeriesDNotesMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3614cfde-dddd-449a-b93b-6f77a888a099" xlink:to="loc_idxx_Prudential2030SeriesDNotesMember_2c2730c0-1dc4-429f-a263-077a163a694c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_636c40bc-fa1d-48b4-9ff6-f43b9f6f0561" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_081d75b0-fc9c-43a4-8981-481222fc4e92" xlink:to="loc_us-gaap_DebtInstrumentLineItems_636c40bc-fa1d-48b4-9ff6-f43b9f6f0561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_8d640f0e-3293-4703-bd9d-2521c6d42beb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_636c40bc-fa1d-48b4-9ff6-f43b9f6f0561" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_8d640f0e-3293-4703-bd9d-2521c6d42beb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_9d57eb16-2be6-4954-baa1-4bf80b83776f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_636c40bc-fa1d-48b4-9ff6-f43b9f6f0561" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_9d57eb16-2be6-4954-baa1-4bf80b83776f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/DebtScheduleofAnnualPrincipalPaymentsonLongTermDebtDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#DebtScheduleofAnnualPrincipalPaymentsonLongTermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/DebtScheduleofAnnualPrincipalPaymentsonLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentsAbstract_a5fc1d3e-084a-4659-89e0-fb9717e092af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_079facda-1073-4efe-ab77-48850347fbea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_a5fc1d3e-084a-4659-89e0-fb9717e092af" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_079facda-1073-4efe-ab77-48850347fbea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_3d7acaa5-76e9-4c20-b9c3-00c2714ada6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_a5fc1d3e-084a-4659-89e0-fb9717e092af" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_3d7acaa5-76e9-4c20-b9c3-00c2714ada6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_3d50a94d-5bd3-4ddf-9eef-7e50c07b7669" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_a5fc1d3e-084a-4659-89e0-fb9717e092af" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_3d50a94d-5bd3-4ddf-9eef-7e50c07b7669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_eaa88cac-d5ce-4b23-ae91-3eef835b5284" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_a5fc1d3e-084a-4659-89e0-fb9717e092af" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_eaa88cac-d5ce-4b23-ae91-3eef835b5284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_a6837fc7-03fa-4f06-8404-67e2c66bd56e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_a5fc1d3e-084a-4659-89e0-fb9717e092af" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_a6837fc7-03fa-4f06-8404-67e2c66bd56e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_f2fdf231-74d6-4aeb-9d9e-27dd88845359" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_a5fc1d3e-084a-4659-89e0-fb9717e092af" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_f2fdf231-74d6-4aeb-9d9e-27dd88845359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_943c08d2-b299-4596-9f0a-226fc973537c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_a5fc1d3e-084a-4659-89e0-fb9717e092af" xlink:to="loc_us-gaap_LongTermDebt_943c08d2-b299-4596-9f0a-226fc973537c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/IncomeTaxes" xlink:type="simple" xlink:href="idxx-20211231.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_31f9e6dc-6d51-4180-b483-7d386f0a0f2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_f0f880a2-b31c-4f09-b2ac-46f74c0da119" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_31f9e6dc-6d51-4180-b483-7d386f0a0f2e" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_f0f880a2-b31c-4f09-b2ac-46f74c0da119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="idxx-20211231.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_582a627a-3395-44c1-aa0e-edba0fba5ae0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_c92c235f-adcc-4762-ba87-d2b7bf197aca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_582a627a-3395-44c1-aa0e-edba0fba5ae0" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_c92c235f-adcc-4762-ba87-d2b7bf197aca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_d9f0fb29-0590-4e4b-b9f6-c262556bb503" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_582a627a-3395-44c1-aa0e-edba0fba5ae0" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_d9f0fb29-0590-4e4b-b9f6-c262556bb503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_824f8316-a244-43d9-8e3e-7e7f874ab787" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_582a627a-3395-44c1-aa0e-edba0fba5ae0" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_824f8316-a244-43d9-8e3e-7e7f874ab787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_8a3fa1df-c0cf-47d0-8471-c6d119e9cfae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_582a627a-3395-44c1-aa0e-edba0fba5ae0" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_8a3fa1df-c0cf-47d0-8471-c6d119e9cfae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfValuationAllowanceTextBlock_0a5bfc49-6db4-441b-8685-59dc09501f4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_582a627a-3395-44c1-aa0e-edba0fba5ae0" xlink:to="loc_us-gaap_SummaryOfValuationAllowanceTextBlock_0a5bfc49-6db4-441b-8685-59dc09501f4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_b2af882a-de9b-41aa-836b-cc405785422f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_582a627a-3395-44c1-aa0e-edba0fba5ae0" xlink:to="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_b2af882a-de9b-41aa-836b-cc405785422f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/IncomeTaxesScheduleofEarningsBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#IncomeTaxesScheduleofEarningsBeforeIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/IncomeTaxesScheduleofEarningsBeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_b7f5aa87-ad0c-43d4-89d3-4d7b30ecec5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_b5a6b72d-300d-4da4-b0d5-421d3f603887" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b7f5aa87-ad0c-43d4-89d3-4d7b30ecec5a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_b5a6b72d-300d-4da4-b0d5-421d3f603887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_31da7008-7e67-49ff-b107-79437c4512a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b7f5aa87-ad0c-43d4-89d3-4d7b30ecec5a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_31da7008-7e67-49ff-b107-79437c4512a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_7f5a79c7-b50e-4fb1-9215-865ab19fd80b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b7f5aa87-ad0c-43d4-89d3-4d7b30ecec5a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_7f5a79c7-b50e-4fb1-9215-865ab19fd80b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofProvisionBenefitforIncomeTaxesDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#IncomeTaxesScheduleofComponentsofProvisionBenefitforIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofProvisionBenefitforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_1b2413dc-2c87-4ab0-9d50-74fdb56a3276" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_2e2ce4ed-1955-46c2-9075-1ef5f8b51831" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1b2413dc-2c87-4ab0-9d50-74fdb56a3276" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_2e2ce4ed-1955-46c2-9075-1ef5f8b51831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_4ec52a29-9e80-4db5-94b0-a38a1c14ed19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_2e2ce4ed-1955-46c2-9075-1ef5f8b51831" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_4ec52a29-9e80-4db5-94b0-a38a1c14ed19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_6da39b75-7211-4ec0-b1b2-dac4d8159685" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_2e2ce4ed-1955-46c2-9075-1ef5f8b51831" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_6da39b75-7211-4ec0-b1b2-dac4d8159685" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_597459aa-ab84-4890-9c6c-a29881a76822" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_2e2ce4ed-1955-46c2-9075-1ef5f8b51831" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_597459aa-ab84-4890-9c6c-a29881a76822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_e0f6f861-ac48-40de-8416-53ced334047f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_2e2ce4ed-1955-46c2-9075-1ef5f8b51831" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_e0f6f861-ac48-40de-8416-53ced334047f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_76a89c85-d26f-4a5c-b35c-a95801a0927e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1b2413dc-2c87-4ab0-9d50-74fdb56a3276" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_76a89c85-d26f-4a5c-b35c-a95801a0927e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_1137d244-bc4c-4100-9762-26d9bc5eed15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_76a89c85-d26f-4a5c-b35c-a95801a0927e" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_1137d244-bc4c-4100-9762-26d9bc5eed15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_5849d266-3c1a-4d83-becd-25721693299a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_76a89c85-d26f-4a5c-b35c-a95801a0927e" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_5849d266-3c1a-4d83-becd-25721693299a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_07b67886-2376-43e6-9c50-f4ac29d3f92b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_76a89c85-d26f-4a5c-b35c-a95801a0927e" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_07b67886-2376-43e6-9c50-f4ac29d3f92b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_c7ecf3b4-40f9-4d25-8529-9a6faef39b48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_76a89c85-d26f-4a5c-b35c-a95801a0927e" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_c7ecf3b4-40f9-4d25-8529-9a6faef39b48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_7a45aa4f-9815-49ac-8cb3-3e2c6f0ecb14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1b2413dc-2c87-4ab0-9d50-74fdb56a3276" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_7a45aa4f-9815-49ac-8cb3-3e2c6f0ecb14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_89b48559-b50c-4ef7-8d44-2bc2756e03ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_171d44df-2b36-4101-a291-ccabf6c60a1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_89b48559-b50c-4ef7-8d44-2bc2756e03ce" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_171d44df-2b36-4101-a291-ccabf6c60a1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_827c4462-7293-4d59-8183-5db58cd4a290" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_89b48559-b50c-4ef7-8d44-2bc2756e03ce" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_827c4462-7293-4d59-8183-5db58cd4a290" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_17fb40f4-5b75-47a8-b88b-11de232361f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_89b48559-b50c-4ef7-8d44-2bc2756e03ce" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_17fb40f4-5b75-47a8-b88b-11de232361f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome_10a17b8a-5299-43b7-a7d6-2270b2c6a989" xlink:href="idxx-20211231.xsd#idxx_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_89b48559-b50c-4ef7-8d44-2bc2756e03ce" xlink:to="loc_idxx_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome_10a17b8a-5299-43b7-a7d6-2270b2c6a989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_5136ac47-c8b7-431c-ba93-34902a14960b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_89b48559-b50c-4ef7-8d44-2bc2756e03ce" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_5136ac47-c8b7-431c-ba93-34902a14960b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_dd8928e7-60ea-4c13-81c3-c572ad4e2298" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_89b48559-b50c-4ef7-8d44-2bc2756e03ce" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_dd8928e7-60ea-4c13-81c3-c572ad4e2298" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_EffectiveIncomeTaxRateReconciliationSwitzerlandTaxReformEffectPercent_383de297-5b85-48c0-abd4-8ff28d32c972" xlink:href="idxx-20211231.xsd#idxx_EffectiveIncomeTaxRateReconciliationSwitzerlandTaxReformEffectPercent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_89b48559-b50c-4ef7-8d44-2bc2756e03ce" xlink:to="loc_idxx_EffectiveIncomeTaxRateReconciliationSwitzerlandTaxReformEffectPercent_383de297-5b85-48c0-abd4-8ff28d32c972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_0f60c743-b615-493e-93e5-6e642f6e75e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_89b48559-b50c-4ef7-8d44-2bc2756e03ce" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_0f60c743-b615-493e-93e5-6e642f6e75e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5f725b4e-129e-4f72-82ba-e624a090c859" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_89b48559-b50c-4ef7-8d44-2bc2756e03ce" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5f725b4e-129e-4f72-82ba-e624a090c859" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_160273ac-ec9d-4b70-8401-d4e14108bb5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_8ac9e638-08d1-44a0-9d50-2a4195ddbdbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_160273ac-ec9d-4b70-8401-d4e14108bb5c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_8ac9e638-08d1-44a0-9d50-2a4195ddbdbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_08acd3ce-f0d5-4e2a-96c0-ae2facf9d1ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_160273ac-ec9d-4b70-8401-d4e14108bb5c" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_08acd3ce-f0d5-4e2a-96c0-ae2facf9d1ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxHolidayAggregateDollarAmount_c6238a29-ad09-40fb-a7de-2e18acfd698a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxHolidayAggregateDollarAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_160273ac-ec9d-4b70-8401-d4e14108bb5c" xlink:to="loc_us-gaap_IncomeTaxHolidayAggregateDollarAmount_c6238a29-ad09-40fb-a7de-2e18acfd698a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_b9274298-c377-40e4-aca2-0e4bde9d59c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_160273ac-ec9d-4b70-8401-d4e14108bb5c" xlink:to="loc_us-gaap_OperatingLossCarryforwards_b9274298-c377-40e4-aca2-0e4bde9d59c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_fb7a9e76-ca8e-4551-853f-7f4a9fcc699a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_160273ac-ec9d-4b70-8401-d4e14108bb5c" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_fb7a9e76-ca8e-4551-853f-7f4a9fcc699a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_6f275a08-79fe-4fb7-ba91-52926965fcfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_160273ac-ec9d-4b70-8401-d4e14108bb5c" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_6f275a08-79fe-4fb7-ba91-52926965fcfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_a902c2d2-595a-4a34-b68c-6496b7e55786" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_160273ac-ec9d-4b70-8401-d4e14108bb5c" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_a902c2d2-595a-4a34-b68c-6496b7e55786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofNetDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#IncomeTaxesScheduleofComponentsofNetDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofNetDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_cf525ca7-fd3c-4a5a-b4ef-5d1d48ea9182" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_1de95dc2-6736-4f3c-bbb8-3c34610cfacd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_cf525ca7-fd3c-4a5a-b4ef-5d1d48ea9182" xlink:to="loc_us-gaap_AssetsAbstract_1de95dc2-6736-4f3c-bbb8-3c34610cfacd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_bd56bb2d-5f15-4709-92f4-f31cfa289dca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1de95dc2-6736-4f3c-bbb8-3c34610cfacd" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_bd56bb2d-5f15-4709-92f4-f31cfa289dca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_369ac518-0af0-4585-98e1-48fa72d98a31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1de95dc2-6736-4f3c-bbb8-3c34610cfacd" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_369ac518-0af0-4585-98e1-48fa72d98a31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsDeferredIncome_84faa331-d57e-455b-a10e-51e8821f2fe0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1de95dc2-6736-4f3c-bbb8-3c34610cfacd" xlink:to="loc_us-gaap_DeferredTaxAssetsDeferredIncome_84faa331-d57e-455b-a10e-51e8821f2fe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_bbc03333-7d6a-4eb4-a49a-18971132cac5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1de95dc2-6736-4f3c-bbb8-3c34610cfacd" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_bbc03333-7d6a-4eb4-a49a-18971132cac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_2d908c55-18b5-475b-b15f-a0c51e028a43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1de95dc2-6736-4f3c-bbb8-3c34610cfacd" xlink:to="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_2d908c55-18b5-475b-b15f-a0c51e028a43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_DeferredTaxAssetsIntangibleAssetsBasisDifference_3f4c3816-9241-4448-af54-a874839e4084" xlink:href="idxx-20211231.xsd#idxx_DeferredTaxAssetsIntangibleAssetsBasisDifference"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1de95dc2-6736-4f3c-bbb8-3c34610cfacd" xlink:to="loc_idxx_DeferredTaxAssetsIntangibleAssetsBasisDifference_3f4c3816-9241-4448-af54-a874839e4084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_456a3e09-be56-48c2-9f7c-5fd98ea4bd73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1de95dc2-6736-4f3c-bbb8-3c34610cfacd" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_456a3e09-be56-48c2-9f7c-5fd98ea4bd73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_c58920c1-8591-437b-adae-429b6b0259c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1de95dc2-6736-4f3c-bbb8-3c34610cfacd" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_c58920c1-8591-437b-adae-429b6b0259c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_3be11438-2d70-4409-91bc-86d1f06feeea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1de95dc2-6736-4f3c-bbb8-3c34610cfacd" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_3be11438-2d70-4409-91bc-86d1f06feeea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_16d72d2a-74df-477f-aa93-8e09441b5596" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1de95dc2-6736-4f3c-bbb8-3c34610cfacd" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_16d72d2a-74df-477f-aa93-8e09441b5596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOtherComprehensiveLoss_419d973a-d813-4860-9438-595c2bf564ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOtherComprehensiveLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1de95dc2-6736-4f3c-bbb8-3c34610cfacd" xlink:to="loc_us-gaap_DeferredTaxAssetsOtherComprehensiveLoss_419d973a-d813-4860-9438-595c2bf564ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_321e464c-b9e0-4c02-ab99-dbf3d9ff4fdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1de95dc2-6736-4f3c-bbb8-3c34610cfacd" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_321e464c-b9e0-4c02-ab99-dbf3d9ff4fdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_68223b61-5e72-4ab1-8278-0bac623411c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1de95dc2-6736-4f3c-bbb8-3c34610cfacd" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_68223b61-5e72-4ab1-8278-0bac623411c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_1c705001-f495-409b-86f5-ebdb6c518f11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1de95dc2-6736-4f3c-bbb8-3c34610cfacd" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_1c705001-f495-409b-86f5-ebdb6c518f11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_d6a96686-da5a-4783-bbf4-b3b48d34bd7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_cf525ca7-fd3c-4a5a-b4ef-5d1d48ea9182" xlink:to="loc_us-gaap_LiabilitiesAbstract_d6a96686-da5a-4783-bbf4-b3b48d34bd7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost_ef394a3a-d806-44d2-9d22-4b0eb07b0470" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_d6a96686-da5a-4783-bbf4-b3b48d34bd7d" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost_ef394a3a-d806-44d2-9d22-4b0eb07b0470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_1881eadb-11b4-44a4-a8a9-837d99a749f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_d6a96686-da5a-4783-bbf4-b3b48d34bd7d" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_1881eadb-11b4-44a4-a8a9-837d99a749f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_011affbc-0884-475b-a225-8bdbadd8fad5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_d6a96686-da5a-4783-bbf4-b3b48d34bd7d" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_011affbc-0884-475b-a225-8bdbadd8fad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_27435686-a662-446d-b6f4-2d031017bf00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_d6a96686-da5a-4783-bbf4-b3b48d34bd7d" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_27435686-a662-446d-b6f4-2d031017bf00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains_97dec78a-fa6c-404f-8c5e-1a493c1d243e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_d6a96686-da5a-4783-bbf4-b3b48d34bd7d" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains_97dec78a-fa6c-404f-8c5e-1a493c1d243e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_51ac8b3e-4800-47bb-ab23-e64d3e7595f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_d6a96686-da5a-4783-bbf4-b3b48d34bd7d" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_51ac8b3e-4800-47bb-ab23-e64d3e7595f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_d1cf2378-684d-4eb1-91dd-30d7d3ac9a44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_cf525ca7-fd3c-4a5a-b4ef-5d1d48ea9182" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_d1cf2378-684d-4eb1-91dd-30d7d3ac9a44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/IncomeTaxesScheduleofValuationAllowanceForDeferredTaxAssetsDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#IncomeTaxesScheduleofValuationAllowanceForDeferredTaxAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/IncomeTaxesScheduleofValuationAllowanceForDeferredTaxAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_1b100ffb-df40-4d9b-8cfd-b7eb5b334120" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_DeferredTaxAssetsValuationAllowanceRollForward_a62c810b-d20e-46c3-a6b2-ad79cec64a9a" xlink:href="idxx-20211231.xsd#idxx_DeferredTaxAssetsValuationAllowanceRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1b100ffb-df40-4d9b-8cfd-b7eb5b334120" xlink:to="loc_idxx_DeferredTaxAssetsValuationAllowanceRollForward_a62c810b-d20e-46c3-a6b2-ad79cec64a9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_899a24be-294d-47ca-a076-5c192a77d0be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_DeferredTaxAssetsValuationAllowanceRollForward_a62c810b-d20e-46c3-a6b2-ad79cec64a9a" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_899a24be-294d-47ca-a076-5c192a77d0be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_DeferredTaxAssetsValuationAllowanceChargesToCostsAndExpense_0ab21c03-26f8-4912-ae66-d7a977a42e36" xlink:href="idxx-20211231.xsd#idxx_DeferredTaxAssetsValuationAllowanceChargesToCostsAndExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_DeferredTaxAssetsValuationAllowanceRollForward_a62c810b-d20e-46c3-a6b2-ad79cec64a9a" xlink:to="loc_idxx_DeferredTaxAssetsValuationAllowanceChargesToCostsAndExpense_0ab21c03-26f8-4912-ae66-d7a977a42e36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_DeferredTaxAssetsValuationAllowanceWriteOffCashPayments_0da20968-b67f-4923-8db8-e0d5ccb1d1d9" xlink:href="idxx-20211231.xsd#idxx_DeferredTaxAssetsValuationAllowanceWriteOffCashPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_DeferredTaxAssetsValuationAllowanceRollForward_a62c810b-d20e-46c3-a6b2-ad79cec64a9a" xlink:to="loc_idxx_DeferredTaxAssetsValuationAllowanceWriteOffCashPayments_0da20968-b67f-4923-8db8-e0d5ccb1d1d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_DeferredTaxAssetsValuationAllowanceForeignCurrencyTranslation_6d52ed2d-9f4f-423f-bab5-81e2e9b059a9" xlink:href="idxx-20211231.xsd#idxx_DeferredTaxAssetsValuationAllowanceForeignCurrencyTranslation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_DeferredTaxAssetsValuationAllowanceRollForward_a62c810b-d20e-46c3-a6b2-ad79cec64a9a" xlink:to="loc_idxx_DeferredTaxAssetsValuationAllowanceForeignCurrencyTranslation_6d52ed2d-9f4f-423f-bab5-81e2e9b059a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_7b91ff7b-4bc4-47b2-8a5e-be79d2d01fd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_DeferredTaxAssetsValuationAllowanceRollForward_a62c810b-d20e-46c3-a6b2-ad79cec64a9a" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_7b91ff7b-4bc4-47b2-8a5e-be79d2d01fd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/IncomeTaxesScheduleofChangesinUnrecognizedTaxBenefitsDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#IncomeTaxesScheduleofChangesinUnrecognizedTaxBenefitsDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/IncomeTaxesScheduleofChangesinUnrecognizedTaxBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_3e3e4688-d3e3-441a-adbc-2a0edd0fb20c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_89ef33ba-32b8-4bf9-be54-b34e0c3d3963" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3e3e4688-d3e3-441a-adbc-2a0edd0fb20c" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_89ef33ba-32b8-4bf9-be54-b34e0c3d3963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_de956041-1eaf-40ee-959c-9c493a2df612" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_89ef33ba-32b8-4bf9-be54-b34e0c3d3963" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_de956041-1eaf-40ee-959c-9c493a2df612" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_449c1c70-cbf4-4f18-b867-0edba382b846" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_89ef33ba-32b8-4bf9-be54-b34e0c3d3963" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_449c1c70-cbf4-4f18-b867-0edba382b846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_39e78932-046a-4d78-a695-ee30ab1fdbea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_89ef33ba-32b8-4bf9-be54-b34e0c3d3963" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_39e78932-046a-4d78-a695-ee30ab1fdbea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_6aeb02fe-b289-4512-a4a1-10f0f58d1e0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_89ef33ba-32b8-4bf9-be54-b34e0c3d3963" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_6aeb02fe-b289-4512-a4a1-10f0f58d1e0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_61005985-2a7f-4450-a22e-1d513b1ea195" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_89ef33ba-32b8-4bf9-be54-b34e0c3d3963" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_61005985-2a7f-4450-a22e-1d513b1ea195" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_c96c453c-7f84-4b55-8b8d-8db7842a0d51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_89ef33ba-32b8-4bf9-be54-b34e0c3d3963" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_c96c453c-7f84-4b55-8b8d-8db7842a0d51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_9814d135-9a8b-47c9-a7c8-55b2fcf5df45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_89ef33ba-32b8-4bf9-be54-b34e0c3d3963" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_9814d135-9a8b-47c9-a7c8-55b2fcf5df45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/EarningsPerShare" xlink:type="simple" xlink:href="idxx-20211231.xsd#EarningsPerShare"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/EarningsPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_8099f40d-8d1d-4fbf-8d85-3d5d66d0212d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_00cc416d-2cd0-4289-88e6-6c95379ef819" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8099f40d-8d1d-4fbf-8d85-3d5d66d0212d" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_00cc416d-2cd0-4289-88e6-6c95379ef819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="idxx-20211231.xsd#EarningsPerShareTables"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/EarningsPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_ae40535f-2e3f-4514-8df2-95a77f959766" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_52478898-946b-4805-8642-4780b81269b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ae40535f-2e3f-4514-8df2-95a77f959766" xlink:to="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_52478898-946b-4805-8642-4780b81269b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_81e59dcf-08e3-46f0-a329-1bb67b2e20b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ae40535f-2e3f-4514-8df2-95a77f959766" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_81e59dcf-08e3-46f0-a329-1bb67b2e20b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/EarningsPerShareReconciliationofSharesOutstandingDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#EarningsPerShareReconciliationofSharesOutstandingDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/EarningsPerShareReconciliationofSharesOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_b13ce805-e601-4cac-889a-2227145b4586" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_20da52f4-b628-42fc-82c9-edf28ba6afb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b13ce805-e601-4cac-889a-2227145b4586" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_20da52f4-b628-42fc-82c9-edf28ba6afb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_0cb6b43a-0471-47d6-ac9e-cd18a6921be6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b13ce805-e601-4cac-889a-2227145b4586" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_0cb6b43a-0471-47d6-ac9e-cd18a6921be6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_67e9d386-61c4-4e40-a99d-860ae19742bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b13ce805-e601-4cac-889a-2227145b4586" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_67e9d386-61c4-4e40-a99d-860ae19742bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/EarningsPerShareScheduleofNumberofAntiDilutiveStockOptionsDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#EarningsPerShareScheduleofNumberofAntiDilutiveStockOptionsDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/EarningsPerShareScheduleofNumberofAntiDilutiveStockOptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_df43783e-00b7-4288-bf20-c1b9f15f5b94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2789da1b-2fe8-48ee-b012-68b931463294" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_df43783e-00b7-4288-bf20-c1b9f15f5b94" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2789da1b-2fe8-48ee-b012-68b931463294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/CommitmentsContingenciesandGuarantees" xlink:type="simple" xlink:href="idxx-20211231.xsd#CommitmentsContingenciesandGuarantees"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/CommitmentsContingenciesandGuarantees" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_300e1abb-93f2-4290-858b-d359d5e60d33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock_0cf44daf-1a13-4145-ae99-4149001bc11a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_300e1abb-93f2-4290-858b-d359d5e60d33" xlink:to="loc_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock_0cf44daf-1a13-4145-ae99-4149001bc11a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/CommitmentsContingenciesandGuaranteesNarrativeDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#CommitmentsContingenciesandGuaranteesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/CommitmentsContingenciesandGuaranteesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_59bdeae0-435b-406c-a3ff-eae25923ade9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_PaymentRequiredUponTerminationOfEmploymentTable_b0f5ba31-4502-43de-8675-0227204d0c15" xlink:href="idxx-20211231.xsd#idxx_PaymentRequiredUponTerminationOfEmploymentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_59bdeae0-435b-406c-a3ff-eae25923ade9" xlink:to="loc_idxx_PaymentRequiredUponTerminationOfEmploymentTable_b0f5ba31-4502-43de-8675-0227204d0c15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1adc82d7-ebf3-41b1-8958-596daad6f56e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_PaymentRequiredUponTerminationOfEmploymentTable_b0f5ba31-4502-43de-8675-0227204d0c15" xlink:to="loc_srt_RangeAxis_1adc82d7-ebf3-41b1-8958-596daad6f56e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cd928ab3-81ac-4f78-bc5c-ad3a887326d0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_1adc82d7-ebf3-41b1-8958-596daad6f56e" xlink:to="loc_srt_RangeMember_cd928ab3-81ac-4f78-bc5c-ad3a887326d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c825760f-aa4c-4086-834c-e157b2ab0321" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_cd928ab3-81ac-4f78-bc5c-ad3a887326d0" xlink:to="loc_srt_MaximumMember_c825760f-aa4c-4086-834c-e157b2ab0321" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_b93e4df8-bf29-4e48-b79b-a8dace28f14a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_PaymentRequiredUponTerminationOfEmploymentTable_b0f5ba31-4502-43de-8675-0227204d0c15" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_b93e4df8-bf29-4e48-b79b-a8dace28f14a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_89afb745-4856-47d3-bf8e-0800cf142863" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_b93e4df8-bf29-4e48-b79b-a8dace28f14a" xlink:to="loc_us-gaap_LossContingencyNatureDomain_89afb745-4856-47d3-bf8e-0800cf142863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_EmployeeHealthCareInsurancePolicyMember_4af4c117-5a26-44f0-915c-0d9bdd363bde" xlink:href="idxx-20211231.xsd#idxx_EmployeeHealthCareInsurancePolicyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_89afb745-4856-47d3-bf8e-0800cf142863" xlink:to="loc_idxx_EmployeeHealthCareInsurancePolicyMember_4af4c117-5a26-44f0-915c-0d9bdd363bde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_PaymentRequiredUponTerminationOfEmploymentAxis_69af77a3-e3f3-4db5-8d7f-b5a4c2e61797" xlink:href="idxx-20211231.xsd#idxx_PaymentRequiredUponTerminationOfEmploymentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_PaymentRequiredUponTerminationOfEmploymentTable_b0f5ba31-4502-43de-8675-0227204d0c15" xlink:to="loc_idxx_PaymentRequiredUponTerminationOfEmploymentAxis_69af77a3-e3f3-4db5-8d7f-b5a4c2e61797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_PaymentRequiredUponTerminationOfEmploymentDomain_0f29174b-72ea-4359-8564-d88fecc33736" xlink:href="idxx-20211231.xsd#idxx_PaymentRequiredUponTerminationOfEmploymentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_PaymentRequiredUponTerminationOfEmploymentAxis_69af77a3-e3f3-4db5-8d7f-b5a4c2e61797" xlink:to="loc_idxx_PaymentRequiredUponTerminationOfEmploymentDomain_0f29174b-72ea-4359-8564-d88fecc33736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_PaymentRequiredToCeoUponTerminationOfEmploymentWithoutCauseOtherThanFollowingChangeInControlMember_a187d512-17c8-44d6-ac1c-370d6fd2be61" xlink:href="idxx-20211231.xsd#idxx_PaymentRequiredToCeoUponTerminationOfEmploymentWithoutCauseOtherThanFollowingChangeInControlMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_PaymentRequiredUponTerminationOfEmploymentDomain_0f29174b-72ea-4359-8564-d88fecc33736" xlink:to="loc_idxx_PaymentRequiredToCeoUponTerminationOfEmploymentWithoutCauseOtherThanFollowingChangeInControlMember_a187d512-17c8-44d6-ac1c-370d6fd2be61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_PaymentRequiredToOfficersUponTerminationOfEmploymentFollowingChangeOfControlMember_18b3c911-026a-46fb-8a8d-97644e813ec9" xlink:href="idxx-20211231.xsd#idxx_PaymentRequiredToOfficersUponTerminationOfEmploymentFollowingChangeOfControlMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_PaymentRequiredUponTerminationOfEmploymentDomain_0f29174b-72ea-4359-8564-d88fecc33736" xlink:to="loc_idxx_PaymentRequiredToOfficersUponTerminationOfEmploymentFollowingChangeOfControlMember_18b3c911-026a-46fb-8a8d-97644e813ec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_PaymentRequiredUponTerminationOfEmploymentLineItems_831e2788-c288-40ae-a4e5-8a971ec2a2bd" xlink:href="idxx-20211231.xsd#idxx_PaymentRequiredUponTerminationOfEmploymentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_PaymentRequiredUponTerminationOfEmploymentTable_b0f5ba31-4502-43de-8675-0227204d0c15" xlink:to="loc_idxx_PaymentRequiredUponTerminationOfEmploymentLineItems_831e2788-c288-40ae-a4e5-8a971ec2a2bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligation_1ed80117-e10f-4434-8abd-a9bfaaf5f561" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_PaymentRequiredUponTerminationOfEmploymentLineItems_831e2788-c288-40ae-a4e5-8a971ec2a2bd" xlink:to="loc_us-gaap_PurchaseObligation_1ed80117-e10f-4434-8abd-a9bfaaf5f561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_1fc5f3c1-5d93-41d8-98ff-13a6b871cb60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_PaymentRequiredUponTerminationOfEmploymentLineItems_831e2788-c288-40ae-a4e5-8a971ec2a2bd" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_1fc5f3c1-5d93-41d8-98ff-13a6b871cb60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_5e9a60b3-3cb3-4ba7-b42f-2af360061848" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_PaymentRequiredUponTerminationOfEmploymentLineItems_831e2788-c288-40ae-a4e5-8a971ec2a2bd" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_5e9a60b3-3cb3-4ba7-b42f-2af360061848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_RetainedClaimLiabilityPerIncident_6dd875d5-4d40-4b93-a95b-9fbf1c4c97a5" xlink:href="idxx-20211231.xsd#idxx_RetainedClaimLiabilityPerIncident"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_PaymentRequiredUponTerminationOfEmploymentLineItems_831e2788-c288-40ae-a4e5-8a971ec2a2bd" xlink:to="loc_idxx_RetainedClaimLiabilityPerIncident_6dd875d5-4d40-4b93-a95b-9fbf1c4c97a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralInsuranceExpense_b7830688-3473-4c69-8f61-b70f2e30c6eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralInsuranceExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_PaymentRequiredUponTerminationOfEmploymentLineItems_831e2788-c288-40ae-a4e5-8a971ec2a2bd" xlink:to="loc_us-gaap_GeneralInsuranceExpense_b7830688-3473-4c69-8f61-b70f2e30c6eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserve_1318ca46-012d-4fa6-bc6d-ae14d5440564" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SelfInsuranceReserve"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_PaymentRequiredUponTerminationOfEmploymentLineItems_831e2788-c288-40ae-a4e5-8a971ec2a2bd" xlink:to="loc_us-gaap_SelfInsuranceReserve_1318ca46-012d-4fa6-bc6d-ae14d5440564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_609726f1-d24b-41ff-80e5-b41043dbd026" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_PaymentRequiredUponTerminationOfEmploymentLineItems_831e2788-c288-40ae-a4e5-8a971ec2a2bd" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_609726f1-d24b-41ff-80e5-b41043dbd026" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits_e1d236a6-2639-45ee-a633-d16f77f8d1e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_PaymentRequiredUponTerminationOfEmploymentLineItems_831e2788-c288-40ae-a4e5-8a971ec2a2bd" xlink:to="loc_us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits_e1d236a6-2639-45ee-a633-d16f77f8d1e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms_f04fa9bf-5b0e-4049-929b-cd2f17a754c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_PaymentRequiredUponTerminationOfEmploymentLineItems_831e2788-c288-40ae-a4e5-8a971ec2a2bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms_f04fa9bf-5b0e-4049-929b-cd2f17a754c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_eb295bb7-716a-475a-b278-e77e79babbc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_PaymentRequiredUponTerminationOfEmploymentLineItems_831e2788-c288-40ae-a4e5-8a971ec2a2bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_eb295bb7-716a-475a-b278-e77e79babbc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue_84c48d77-e1d4-4465-b336-c02780484568" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuaranteeObligationsCurrentCarryingValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_PaymentRequiredUponTerminationOfEmploymentLineItems_831e2788-c288-40ae-a4e5-8a971ec2a2bd" xlink:to="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue_84c48d77-e1d4-4465-b336-c02780484568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/SegmentReporting" xlink:type="simple" xlink:href="idxx-20211231.xsd#SegmentReporting"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/SegmentReporting" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_d0a2dc51-7fa2-439a-82a0-7b81ecceb16d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_9538cdbb-4d58-4ea4-8a81-02c801b7b422" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_d0a2dc51-7fa2-439a-82a0-7b81ecceb16d" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_9538cdbb-4d58-4ea4-8a81-02c801b7b422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/SegmentReportingTables" xlink:type="simple" xlink:href="idxx-20211231.xsd#SegmentReportingTables"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/SegmentReportingTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_cdee3f5b-7580-40eb-8307-eb3c212f6b89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_b8749850-8800-4ec8-95f6-59afa23953de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_cdee3f5b-7580-40eb-8307-eb3c212f6b89" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_b8749850-8800-4ec8-95f6-59afa23953de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock_17f8d991-7533-40fe-8ab8-3ba3d05766b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_cdee3f5b-7580-40eb-8307-eb3c212f6b89" xlink:to="loc_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock_17f8d991-7533-40fe-8ab8-3ba3d05766b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/SegmentReportingNarrativeDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#SegmentReportingNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/SegmentReportingNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_3d65796c-202a-4761-af10-9e68cd71177d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_c87e1153-35af-47bd-b173-69798e43be9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_3d65796c-202a-4761-af10-9e68cd71177d" xlink:to="loc_us-gaap_NumberOfReportableSegments_c87e1153-35af-47bd-b173-69798e43be9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/SegmentReportingSummaryofSegmentPerformanceDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#SegmentReportingSummaryofSegmentPerformanceDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/SegmentReportingSummaryofSegmentPerformanceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_4cb1518a-fae1-4674-a571-36a231a29f41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5cdd2ea5-0491-492c-ab22-5bd7f978055b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_4cb1518a-fae1-4674-a571-36a231a29f41" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5cdd2ea5-0491-492c-ab22-5bd7f978055b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_76e8382c-534a-43d0-b63c-ec346942f833" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5cdd2ea5-0491-492c-ab22-5bd7f978055b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_76e8382c-534a-43d0-b63c-ec346942f833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_73ae71f2-64c5-457b-a9a5-a0082754b0a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_76e8382c-534a-43d0-b63c-ec346942f833" xlink:to="loc_us-gaap_SegmentDomain_73ae71f2-64c5-457b-a9a5-a0082754b0a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_CompanionAnimalGroupSegmentMember_04f472d5-cddc-4a69-9e4b-bde2313dd7e4" xlink:href="idxx-20211231.xsd#idxx_CompanionAnimalGroupSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_73ae71f2-64c5-457b-a9a5-a0082754b0a4" xlink:to="loc_idxx_CompanionAnimalGroupSegmentMember_04f472d5-cddc-4a69-9e4b-bde2313dd7e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_WaterSegmentMember_ea40c4c7-7aa0-417b-9c8f-804da253d99c" xlink:href="idxx-20211231.xsd#idxx_WaterSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_73ae71f2-64c5-457b-a9a5-a0082754b0a4" xlink:to="loc_idxx_WaterSegmentMember_ea40c4c7-7aa0-417b-9c8f-804da253d99c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_LivestockAndPoultryDiagnosticsSegmentMember_be729337-64ad-4c61-83b1-38a1ee4fc0e8" xlink:href="idxx-20211231.xsd#idxx_LivestockAndPoultryDiagnosticsSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_73ae71f2-64c5-457b-a9a5-a0082754b0a4" xlink:to="loc_idxx_LivestockAndPoultryDiagnosticsSegmentMember_be729337-64ad-4c61-83b1-38a1ee4fc0e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_OtherSegmentMember_abee6287-8267-4d46-b7ad-de6bb5e26d30" xlink:href="idxx-20211231.xsd#idxx_OtherSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_73ae71f2-64c5-457b-a9a5-a0082754b0a4" xlink:to="loc_idxx_OtherSegmentMember_abee6287-8267-4d46-b7ad-de6bb5e26d30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_eaabb2fb-5942-4ca3-aaa9-08bb68aad7a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5cdd2ea5-0491-492c-ab22-5bd7f978055b" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_eaabb2fb-5942-4ca3-aaa9-08bb68aad7a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1b8db549-b50c-489a-b588-a498e440bdbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_eaabb2fb-5942-4ca3-aaa9-08bb68aad7a7" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1b8db549-b50c-489a-b588-a498e440bdbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_04488ba3-22b2-4190-999f-e7a174a8231f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_eaabb2fb-5942-4ca3-aaa9-08bb68aad7a7" xlink:to="loc_us-gaap_OperatingIncomeLoss_04488ba3-22b2-4190-999f-e7a174a8231f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_affb29e0-b4dd-45ce-9340-d309922e5041" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_eaabb2fb-5942-4ca3-aaa9-08bb68aad7a7" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_affb29e0-b4dd-45ce-9340-d309922e5041" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d12ab9dd-19d3-4bd3-9d2d-006238aa86b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_eaabb2fb-5942-4ca3-aaa9-08bb68aad7a7" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d12ab9dd-19d3-4bd3-9d2d-006238aa86b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_86587af5-bf78-4b5e-a5f0-27bb97e483c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_eaabb2fb-5942-4ca3-aaa9-08bb68aad7a7" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_86587af5-bf78-4b5e-a5f0-27bb97e483c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_c99b22ae-c336-4956-b7ed-8801e46cab62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_eaabb2fb-5942-4ca3-aaa9-08bb68aad7a7" xlink:to="loc_us-gaap_ProfitLoss_c99b22ae-c336-4956-b7ed-8801e46cab62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_ec4a7465-c4c8-4dc8-84b9-8db05414ef6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_eaabb2fb-5942-4ca3-aaa9-08bb68aad7a7" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_ec4a7465-c4c8-4dc8-84b9-8db05414ef6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_530aba1a-2d2e-4109-8088-f50fe4154f71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_eaabb2fb-5942-4ca3-aaa9-08bb68aad7a7" xlink:to="loc_us-gaap_NetIncomeLoss_530aba1a-2d2e-4109-8088-f50fe4154f71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_15d37dc9-093f-4149-ba46-d404c854ee4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_eaabb2fb-5942-4ca3-aaa9-08bb68aad7a7" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_15d37dc9-093f-4149-ba46-d404c854ee4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/SegmentReportingScheduleofNetLongLivedAssetsbyPrincipalGeographicAreasDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#SegmentReportingScheduleofNetLongLivedAssetsbyPrincipalGeographicAreasDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/SegmentReportingScheduleofNetLongLivedAssetsbyPrincipalGeographicAreasDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_fd9934fe-7b33-4046-ba36-283de0d6953b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_6b4c5fe7-9c52-40d7-87df-5f90015a1fa7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_fd9934fe-7b33-4046-ba36-283de0d6953b" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_6b4c5fe7-9c52-40d7-87df-5f90015a1fa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_98710934-7193-4347-a1a8-28c5d7b4159b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_6b4c5fe7-9c52-40d7-87df-5f90015a1fa7" xlink:to="loc_srt_StatementGeographicalAxis_98710934-7193-4347-a1a8-28c5d7b4159b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e5de5e34-0255-40be-93ff-6d433dab6156" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_98710934-7193-4347-a1a8-28c5d7b4159b" xlink:to="loc_srt_SegmentGeographicalDomain_e5de5e34-0255-40be-93ff-6d433dab6156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember_bbec3238-4b2b-42c6-9abc-079138f8f1e5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AmericasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_e5de5e34-0255-40be-93ff-6d433dab6156" xlink:to="loc_srt_AmericasMember_bbec3238-4b2b-42c6-9abc-079138f8f1e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_9ce45984-8b7e-4293-98a8-4bc38edca6b1" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_AmericasMember_bbec3238-4b2b-42c6-9abc-079138f8f1e5" xlink:to="loc_country_US_9ce45984-8b7e-4293-98a8-4bc38edca6b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_BR_f27f0db2-f605-4c3d-bed1-3b4aa80bf821" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_BR"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_AmericasMember_bbec3238-4b2b-42c6-9abc-079138f8f1e5" xlink:to="loc_country_BR_f27f0db2-f605-4c3d-bed1-3b4aa80bf821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_3fe12a10-3a68-489b-8a5a-8f35f8733c89" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CA"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_AmericasMember_bbec3238-4b2b-42c6-9abc-079138f8f1e5" xlink:to="loc_country_CA_3fe12a10-3a68-489b-8a5a-8f35f8733c89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_6e426dc9-b653-4418-abc2-f2dec7f033ab" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_e5de5e34-0255-40be-93ff-6d433dab6156" xlink:to="loc_srt_EuropeMember_6e426dc9-b653-4418-abc2-f2dec7f033ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE_5af5853b-4565-4418-92fc-5bcfd43ede9e" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_DE"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EuropeMember_6e426dc9-b653-4418-abc2-f2dec7f033ab" xlink:to="loc_country_DE_5af5853b-4565-4418-92fc-5bcfd43ede9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_caf111d6-50af-4be0-aa6e-b1eb48d5f9de" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_GB"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EuropeMember_6e426dc9-b653-4418-abc2-f2dec7f033ab" xlink:to="loc_country_GB_caf111d6-50af-4be0-aa6e-b1eb48d5f9de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_NL_675a41f6-b7ff-4819-8535-448595cf4e38" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_NL"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EuropeMember_6e426dc9-b653-4418-abc2-f2dec7f033ab" xlink:to="loc_country_NL_675a41f6-b7ff-4819-8535-448595cf4e38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR_70478f65-f61d-418c-a537-601b96e26bd8" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_FR"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EuropeMember_6e426dc9-b653-4418-abc2-f2dec7f033ab" xlink:to="loc_country_FR_70478f65-f61d-418c-a537-601b96e26bd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_45f14577-3245-4790-ab69-69756c23963c" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CH"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EuropeMember_6e426dc9-b653-4418-abc2-f2dec7f033ab" xlink:to="loc_country_CH_45f14577-3245-4790-ab69-69756c23963c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_EuropetheMiddleEastandAfricaOtherMember_a0727ef3-bcf8-4839-8762-4de61d01b56f" xlink:href="idxx-20211231.xsd#idxx_EuropetheMiddleEastandAfricaOtherMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EuropeMember_6e426dc9-b653-4418-abc2-f2dec7f033ab" xlink:to="loc_idxx_EuropetheMiddleEastandAfricaOtherMember_a0727ef3-bcf8-4839-8762-4de61d01b56f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_27f73ec9-b3b5-4004-9a0f-dfba414abcec" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AsiaPacificMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_e5de5e34-0255-40be-93ff-6d433dab6156" xlink:to="loc_srt_AsiaPacificMember_27f73ec9-b3b5-4004-9a0f-dfba414abcec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_JP_e9f4a830-6a37-4971-8a8d-3d4c544faf5f" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_JP"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_AsiaPacificMember_27f73ec9-b3b5-4004-9a0f-dfba414abcec" xlink:to="loc_country_JP_e9f4a830-6a37-4971-8a8d-3d4c544faf5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_AU_f9289801-ef40-4f8a-b43c-846a031c443a" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_AU"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_AsiaPacificMember_27f73ec9-b3b5-4004-9a0f-dfba414abcec" xlink:to="loc_country_AU_f9289801-ef40-4f8a-b43c-846a031c443a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_OtherAsiaPacificMember_c89f811e-2254-4cf8-ba75-206b3d0db3ce" xlink:href="idxx-20211231.xsd#idxx_OtherAsiaPacificMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_AsiaPacificMember_27f73ec9-b3b5-4004-9a0f-dfba414abcec" xlink:to="loc_idxx_OtherAsiaPacificMember_c89f811e-2254-4cf8-ba75-206b3d0db3ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_08e1b257-154b-4597-8877-abdc3eb9d04f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_6b4c5fe7-9c52-40d7-87df-5f90015a1fa7" xlink:to="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_08e1b257-154b-4597-8877-abdc3eb9d04f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_c9658f61-f189-4435-bdee-380613bd1a99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_08e1b257-154b-4597-8877-abdc3eb9d04f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_c9658f61-f189-4435-bdee-380613bd1a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="idxx-20211231.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_5eb70942-0423-411c-9050-2baa1b7e9be1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_d04ea255-9995-4a69-9b20-ac879b118dc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_5eb70942-0423-411c-9050-2baa1b7e9be1" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_d04ea255-9995-4a69-9b20-ac879b118dc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="idxx-20211231.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_9b9309a5-da83-49a0-9235-e27548cc28a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_e267c51e-b3de-4a7e-9d9c-8c5524a312f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9b9309a5-da83-49a0-9235-e27548cc28a2" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_e267c51e-b3de-4a7e-9d9c-8c5524a312f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_c5d848a9-0412-476b-b32c-d40943740dbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9b9309a5-da83-49a0-9235-e27548cc28a2" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_c5d848a9-0412-476b-b32c-d40943740dbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_2905f375-bbea-4e39-a5d3-d2f388af8b5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_00fb3d68-3b96-4805-a790-942c80ae553f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_2905f375-bbea-4e39-a5d3-d2f388af8b5b" xlink:to="loc_us-gaap_LongTermDebtFairValue_00fb3d68-3b96-4805-a790-942c80ae553f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_216da581-d627-490b-b865-59deb7501981" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_2905f375-bbea-4e39-a5d3-d2f388af8b5b" xlink:to="loc_us-gaap_LongTermDebt_216da581-d627-490b-b865-59deb7501981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_51f6231e-321b-486a-af06-ce1bae82bf6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_2905f375-bbea-4e39-a5d3-d2f388af8b5b" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_51f6231e-321b-486a-af06-ce1bae82bf6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_f552868d-bf69-4cbc-8783-4782e4e5e5a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_2905f375-bbea-4e39-a5d3-d2f388af8b5b" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_f552868d-bf69-4cbc-8783-4782e4e5e5a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/FairValueMeasurementsScheduleofFairValueofAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#FairValueMeasurementsScheduleofFairValueofAssetsandLiabilitiesMeasuredonRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/FairValueMeasurementsScheduleofFairValueofAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_1c3f172b-90bc-4457-a390-a3f9f0e5f264" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_53f6e5b9-c3f6-4875-a0f0-cf526a14d20d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1c3f172b-90bc-4457-a390-a3f9f0e5f264" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_53f6e5b9-c3f6-4875-a0f0-cf526a14d20d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_1ab03d08-04fe-467a-b358-794a5c2e8ac9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_53f6e5b9-c3f6-4875-a0f0-cf526a14d20d" xlink:to="loc_us-gaap_FinancialInstrumentAxis_1ab03d08-04fe-467a-b358-794a5c2e8ac9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_756600db-b413-4214-9a4e-4149548f5367" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1ab03d08-04fe-467a-b358-794a5c2e8ac9" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_756600db-b413-4214-9a4e-4149548f5367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_c121ca27-7c9e-42d7-a966-ce8a3d5a75db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_756600db-b413-4214-9a4e-4149548f5367" xlink:to="loc_us-gaap_MoneyMarketFundsMember_c121ca27-7c9e-42d7-a966-ce8a3d5a75db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_EquityMutualFundsMember_d6cb7f20-9264-42af-875f-c5cf4327feae" xlink:href="idxx-20211231.xsd#idxx_EquityMutualFundsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_756600db-b413-4214-9a4e-4149548f5367" xlink:to="loc_idxx_EquityMutualFundsMember_d6cb7f20-9264-42af-875f-c5cf4327feae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_7ac8e051-0d48-4e8a-9e8f-bb3436e8d65b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_756600db-b413-4214-9a4e-4149548f5367" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_7ac8e051-0d48-4e8a-9e8f-bb3436e8d65b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_f84acc4c-71a6-4843-b58b-ee9dcdc20eee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_756600db-b413-4214-9a4e-4149548f5367" xlink:to="loc_us-gaap_ForeignExchangeContractMember_f84acc4c-71a6-4843-b58b-ee9dcdc20eee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_DeferredCompensationMember_3eb00a7d-a5cb-48f8-b785-519339afe532" xlink:href="idxx-20211231.xsd#idxx_DeferredCompensationMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_756600db-b413-4214-9a4e-4149548f5367" xlink:to="loc_idxx_DeferredCompensationMember_3eb00a7d-a5cb-48f8-b785-519339afe532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ContingentPaymentMember_ba0bf878-516c-4061-a023-7999b9a7c768" xlink:href="idxx-20211231.xsd#idxx_ContingentPaymentMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_756600db-b413-4214-9a4e-4149548f5367" xlink:to="loc_idxx_ContingentPaymentMember_ba0bf878-516c-4061-a023-7999b9a7c768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fa283ffd-b0cb-45d1-8a53-e2784318b323" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_53f6e5b9-c3f6-4875-a0f0-cf526a14d20d" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fa283ffd-b0cb-45d1-8a53-e2784318b323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_907a496f-9674-4b2f-a03a-80e55a9523ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fa283ffd-b0cb-45d1-8a53-e2784318b323" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_907a496f-9674-4b2f-a03a-80e55a9523ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_a367b5b2-1f98-4b16-8e15-779c21af07f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_907a496f-9674-4b2f-a03a-80e55a9523ca" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_a367b5b2-1f98-4b16-8e15-779c21af07f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_13abd4ea-7c3f-40a0-8fb6-8030b1d7f594" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_907a496f-9674-4b2f-a03a-80e55a9523ca" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_13abd4ea-7c3f-40a0-8fb6-8030b1d7f594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_c31d7fac-9dbd-4d16-a68c-3b0f76c80f81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_907a496f-9674-4b2f-a03a-80e55a9523ca" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_c31d7fac-9dbd-4d16-a68c-3b0f76c80f81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a928183b-48db-455c-b7c1-213e4426053a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_53f6e5b9-c3f6-4875-a0f0-cf526a14d20d" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a928183b-48db-455c-b7c1-213e4426053a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_b40611fb-57c3-4efb-86d6-418a5a4f20ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a928183b-48db-455c-b7c1-213e4426053a" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_b40611fb-57c3-4efb-86d6-418a5a4f20ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsFairValueDisclosure_6d1c58ee-dad7-481c-ae0f-b0a80c64fe7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a928183b-48db-455c-b7c1-213e4426053a" xlink:to="loc_us-gaap_OtherAssetsFairValueDisclosure_6d1c58ee-dad7-481c-ae0f-b0a80c64fe7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_b38c9f78-01d8-4773-86df-f5f65d9b03f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a928183b-48db-455c-b7c1-213e4426053a" xlink:to="loc_us-gaap_DerivativeAssets_b38c9f78-01d8-4773-86df-f5f65d9b03f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_35547f8e-89a8-477f-84d7-cafb3e5f5fc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a928183b-48db-455c-b7c1-213e4426053a" xlink:to="loc_us-gaap_DerivativeLiabilities_35547f8e-89a8-477f-84d7-cafb3e5f5fc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesFairValueDisclosure_1b845d59-ece4-4483-ba22-b55052307e4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a928183b-48db-455c-b7c1-213e4426053a" xlink:to="loc_us-gaap_OtherLiabilitiesFairValueDisclosure_1b845d59-ece4-4483-ba22-b55052307e4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_BusinessCombinationContingencyFairValue_a908f691-4c2e-41e7-bcce-0b5e4f47138e" xlink:href="idxx-20211231.xsd#idxx_BusinessCombinationContingencyFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a928183b-48db-455c-b7c1-213e4426053a" xlink:to="loc_idxx_BusinessCombinationContingencyFairValue_a908f691-4c2e-41e7-bcce-0b5e4f47138e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/FairValueMeasurementsScheduleofContingentConsiderationLiabilityDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#FairValueMeasurementsScheduleofContingentConsiderationLiabilityDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/FairValueMeasurementsScheduleofContingentConsiderationLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_c7f75360-370a-4a99-94a6-f06fcc7b5ace" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_909396f2-45a7-4ef1-8f28-5ef90f4dc5bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_c7f75360-370a-4a99-94a6-f06fcc7b5ace" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_909396f2-45a7-4ef1-8f28-5ef90f4dc5bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_fb98314b-5208-4fc3-843f-727e74d1825c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_909396f2-45a7-4ef1-8f28-5ef90f4dc5bc" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_fb98314b-5208-4fc3-843f-727e74d1825c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_b563d28f-a642-40eb-a1cc-5fa549f88ffd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_909396f2-45a7-4ef1-8f28-5ef90f4dc5bc" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_b563d28f-a642-40eb-a1cc-5fa549f88ffd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_a1e85445-388f-4a7b-a053-972688ab135b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_909396f2-45a7-4ef1-8f28-5ef90f4dc5bc" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_a1e85445-388f-4a7b-a053-972688ab135b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3f133621-d708-46a2-a2cc-2c8df4024fbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_909396f2-45a7-4ef1-8f28-5ef90f4dc5bc" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3f133621-d708-46a2-a2cc-2c8df4024fbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/HedgingInstruments" xlink:type="simple" xlink:href="idxx-20211231.xsd#HedgingInstruments"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/HedgingInstruments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_db200057-d4d1-492a-be58-081593464c4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_37c0dacc-ba31-4663-bf91-40bbb147aead" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_db200057-d4d1-492a-be58-081593464c4c" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_37c0dacc-ba31-4663-bf91-40bbb147aead" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/HedgingInstrumentsTables" xlink:type="simple" xlink:href="idxx-20211231.xsd#HedgingInstrumentsTables"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/HedgingInstrumentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_af590b48-d60e-4845-a35b-9d142d255851" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_ac4899a8-40c1-4b61-9813-f2b71f14b2b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_af590b48-d60e-4845-a35b-9d142d255851" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_ac4899a8-40c1-4b61-9813-f2b71f14b2b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_5111257f-857f-45f3-bb5e-8308200ba758" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_af590b48-d60e-4845-a35b-9d142d255851" xlink:to="loc_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_5111257f-857f-45f3-bb5e-8308200ba758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/HedgingInstrumentsNarrativeDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#HedgingInstrumentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/HedgingInstrumentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_fc92975c-ca69-477f-b95b-ab38e50b2686" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_f42a3033-1fe6-4cfe-8b22-9a4b542d9bfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_fc92975c-ca69-477f-b95b-ab38e50b2686" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_f42a3033-1fe6-4cfe-8b22-9a4b542d9bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_7fbab0f5-8273-4206-b149-80a9a92a00b5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_f42a3033-1fe6-4cfe-8b22-9a4b542d9bfe" xlink:to="loc_srt_StatementScenarioAxis_7fbab0f5-8273-4206-b149-80a9a92a00b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_cc37761e-fcd1-474b-b798-a030072a8624" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_7fbab0f5-8273-4206-b149-80a9a92a00b5" xlink:to="loc_srt_ScenarioUnspecifiedDomain_cc37761e-fcd1-474b-b798-a030072a8624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_0a7214b4-d690-48fe-ba13-fa780cf12687" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_cc37761e-fcd1-474b-b798-a030072a8624" xlink:to="loc_srt_ScenarioForecastMember_0a7214b4-d690-48fe-ba13-fa780cf12687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_bbc4363d-b6d0-48b0-a1e4-b8d1c1700e68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_f42a3033-1fe6-4cfe-8b22-9a4b542d9bfe" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_bbc4363d-b6d0-48b0-a1e4-b8d1c1700e68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3dd01fe2-9cc9-49c5-aa3e-4156b9cf4347" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_bbc4363d-b6d0-48b0-a1e4-b8d1c1700e68" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3dd01fe2-9cc9-49c5-aa3e-4156b9cf4347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_bd29358f-c6bc-4727-a47b-fd829dbd6621" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3dd01fe2-9cc9-49c5-aa3e-4156b9cf4347" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_bd29358f-c6bc-4727-a47b-fd829dbd6621" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_CrossCurrencyInterestRateContract1Member_be6035b4-b2fe-4271-accb-61dc6b115c3d" xlink:href="idxx-20211231.xsd#idxx_CrossCurrencyInterestRateContract1Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3dd01fe2-9cc9-49c5-aa3e-4156b9cf4347" xlink:to="loc_idxx_CrossCurrencyInterestRateContract1Member_be6035b4-b2fe-4271-accb-61dc6b115c3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_80a2ba20-5e3d-4d17-98e3-7eea818c5045" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_f42a3033-1fe6-4cfe-8b22-9a4b542d9bfe" xlink:to="loc_us-gaap_HedgingDesignationAxis_80a2ba20-5e3d-4d17-98e3-7eea818c5045" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_eb900d5e-663d-4a4c-94e1-8c6eb1eb61a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_80a2ba20-5e3d-4d17-98e3-7eea818c5045" xlink:to="loc_us-gaap_HedgingDesignationDomain_eb900d5e-663d-4a4c-94e1-8c6eb1eb61a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_5df06298-7764-4ffe-bfa3-253d37b19ba5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_eb900d5e-663d-4a4c-94e1-8c6eb1eb61a8" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_5df06298-7764-4ffe-bfa3-253d37b19ba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_90712d8b-9c02-4db3-916f-e56ddc70ff1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_f42a3033-1fe6-4cfe-8b22-9a4b542d9bfe" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_90712d8b-9c02-4db3-916f-e56ddc70ff1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c166c92e-2586-4a6f-b5d0-f023c004bc7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_90712d8b-9c02-4db3-916f-e56ddc70ff1b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c166c92e-2586-4a6f-b5d0-f023c004bc7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_SeriesCSeniorNoteMember_91672faf-4401-4bd6-8fad-5656f665a925" xlink:href="idxx-20211231.xsd#idxx_SeriesCSeniorNoteMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c166c92e-2586-4a6f-b5d0-f023c004bc7c" xlink:to="loc_idxx_SeriesCSeniorNoteMember_91672faf-4401-4bd6-8fad-5656f665a925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_869901cf-370c-4164-a614-d50a0488bcf0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_f42a3033-1fe6-4cfe-8b22-9a4b542d9bfe" xlink:to="loc_srt_RangeAxis_869901cf-370c-4164-a614-d50a0488bcf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4aea607d-8356-4aff-99b4-bbf1410cdadf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_869901cf-370c-4164-a614-d50a0488bcf0" xlink:to="loc_srt_RangeMember_4aea607d-8356-4aff-99b4-bbf1410cdadf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_08940355-4370-477b-898b-4bd2a39d76c3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4aea607d-8356-4aff-99b4-bbf1410cdadf" xlink:to="loc_srt_MinimumMember_08940355-4370-477b-898b-4bd2a39d76c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c2aa47aa-339e-4c4e-87e8-aea3767acf62" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4aea607d-8356-4aff-99b4-bbf1410cdadf" xlink:to="loc_srt_MaximumMember_c2aa47aa-339e-4c4e-87e8-aea3767acf62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_5278226e-d6df-4d90-94b6-8b97956d6106" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_f42a3033-1fe6-4cfe-8b22-9a4b542d9bfe" xlink:to="loc_us-gaap_DerivativeLineItems_5278226e-d6df-4d90-94b6-8b97956d6106" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_21e7213f-e346-401a-9178-552b9403ac57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_5278226e-d6df-4d90-94b6-8b97956d6106" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_21e7213f-e346-401a-9178-552b9403ac57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_CashFlowHedgeHedgePercentageOfEstimatedExposureFromIntercompanyProductsPurchasesAndSales_dce32c9d-a198-4b86-a4fe-568221e954ef" xlink:href="idxx-20211231.xsd#idxx_CashFlowHedgeHedgePercentageOfEstimatedExposureFromIntercompanyProductsPurchasesAndSales"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_5278226e-d6df-4d90-94b6-8b97956d6106" xlink:to="loc_idxx_CashFlowHedgeHedgePercentageOfEstimatedExposureFromIntercompanyProductsPurchasesAndSales_dce32c9d-a198-4b86-a4fe-568221e954ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge_1f529ad7-61fc-4eb6-8706-296763a1c9e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_5278226e-d6df-4d90-94b6-8b97956d6106" xlink:to="loc_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge_1f529ad7-61fc-4eb6-8706-296763a1c9e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_a928a1c2-317b-49ff-91a8-00af7b488a2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_5278226e-d6df-4d90-94b6-8b97956d6106" xlink:to="loc_us-gaap_DerivativeNotionalAmount_a928a1c2-317b-49ff-91a8-00af7b488a2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_63b98fae-36d0-4d73-be8b-e6a7e862ea3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_5278226e-d6df-4d90-94b6-8b97956d6106" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_63b98fae-36d0-4d73-be8b-e6a7e862ea3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_db7b79f3-ce2f-460e-b4ad-42a6bdcd2809" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_5278226e-d6df-4d90-94b6-8b97956d6106" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_db7b79f3-ce2f-460e-b4ad-42a6bdcd2809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax_8eca8d40-7724-4ca1-a80b-97bd1f9d71f1" xlink:href="idxx-20211231.xsd#idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_5278226e-d6df-4d90-94b6-8b97956d6106" xlink:to="loc_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax_8eca8d40-7724-4ca1-a80b-97bd1f9d71f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeInvestingActivities_e73e1b40-7684-45bd-b0f4-ee895029e05c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromHedgeInvestingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_5278226e-d6df-4d90-94b6-8b97956d6106" xlink:to="loc_us-gaap_ProceedsFromHedgeInvestingActivities_e73e1b40-7684-45bd-b0f4-ee895029e05c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax_3f3ee87f-f114-470e-b27d-24cfd2aadbbd" xlink:href="idxx-20211231.xsd#idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_5278226e-d6df-4d90-94b6-8b97956d6106" xlink:to="loc_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax_3f3ee87f-f114-470e-b27d-24cfd2aadbbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness_4a90c583-d57a-4e66-86f0-6313441d8c0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_5278226e-d6df-4d90-94b6-8b97956d6106" xlink:to="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness_4a90c583-d57a-4e66-86f0-6313441d8c0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/HedgingInstrumentsDerivativesDesignatedinCashFlowHedgingRelationshipsDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#HedgingInstrumentsDerivativesDesignatedinCashFlowHedgingRelationshipsDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/HedgingInstrumentsDerivativesDesignatedinCashFlowHedgingRelationshipsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_666c4caf-f597-4179-91db-fbf288fd71b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_c3efd646-8465-4f98-b235-c0da326ed87e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_666c4caf-f597-4179-91db-fbf288fd71b2" xlink:to="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_c3efd646-8465-4f98-b235-c0da326ed87e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_33ab2b12-a255-461f-8689-86f39569430d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_c3efd646-8465-4f98-b235-c0da326ed87e" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_33ab2b12-a255-461f-8689-86f39569430d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_a1041a5c-c648-400c-a838-e192fe7c6af9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_33ab2b12-a255-461f-8689-86f39569430d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_a1041a5c-c648-400c-a838-e192fe7c6af9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_db845641-4864-4d16-ad69-f275da457c61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a1041a5c-c648-400c-a838-e192fe7c6af9" xlink:to="loc_us-gaap_ForeignExchangeContractMember_db845641-4864-4d16-ad69-f275da457c61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_42e63797-c69c-43d8-af65-9f0c16c30642" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_c3efd646-8465-4f98-b235-c0da326ed87e" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_42e63797-c69c-43d8-af65-9f0c16c30642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_49b56437-cee9-4e0f-81ad-2f10fa2155e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_42e63797-c69c-43d8-af65-9f0c16c30642" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_49b56437-cee9-4e0f-81ad-2f10fa2155e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_d19cf73f-27d5-4598-aa78-8a3c547c856c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_49b56437-cee9-4e0f-81ad-2f10fa2155e5" xlink:to="loc_us-gaap_CostOfSalesMember_d19cf73f-27d5-4598-aa78-8a3c547c856c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_3f4a176e-0341-4ddf-8b4c-493e2692c28e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_c3efd646-8465-4f98-b235-c0da326ed87e" xlink:to="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_3f4a176e-0341-4ddf-8b4c-493e2692c28e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_097b2a2b-d13d-4334-8b94-86e9e88af443" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_3f4a176e-0341-4ddf-8b4c-493e2692c28e" xlink:to="loc_us-gaap_CostOfRevenue_097b2a2b-d13d-4334-8b94-86e9e88af443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_31d9f9e1-ddb0-43b1-a6e1-b6cfa915e20b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_3f4a176e-0341-4ddf-8b4c-493e2692c28e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_31d9f9e1-ddb0-43b1-a6e1-b6cfa915e20b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/HedgingInstrumentsScheduleofFairValuesandBalanceSheetClassificationsofDerivativesandNonderivativesDesignatedasHedgingInstrumentsDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#HedgingInstrumentsScheduleofFairValuesandBalanceSheetClassificationsofDerivativesandNonderivativesDesignatedasHedgingInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/HedgingInstrumentsScheduleofFairValuesandBalanceSheetClassificationsofDerivativesandNonderivativesDesignatedasHedgingInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_473ef3d9-5430-455b-9170-1e2dcaca3bd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_3e4421f4-c129-4817-81c3-578fc97d1f0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_473ef3d9-5430-455b-9170-1e2dcaca3bd1" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_3e4421f4-c129-4817-81c3-578fc97d1f0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_290bbb9f-78c4-4b4d-b1d0-551a8512251d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_3e4421f4-c129-4817-81c3-578fc97d1f0e" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_290bbb9f-78c4-4b4d-b1d0-551a8512251d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_2fb66159-d599-448a-8ecb-740f63e09372" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_290bbb9f-78c4-4b4d-b1d0-551a8512251d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_2fb66159-d599-448a-8ecb-740f63e09372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_be558eb8-039d-4c18-a4ef-23f3db31705b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2fb66159-d599-448a-8ecb-740f63e09372" xlink:to="loc_us-gaap_ForeignExchangeContractMember_be558eb8-039d-4c18-a4ef-23f3db31705b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_dd83f7a0-7b6c-458a-8ba0-040de2c402bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2fb66159-d599-448a-8ecb-740f63e09372" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_dd83f7a0-7b6c-458a-8ba0-040de2c402bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_ForeignCurrencyBorrowingsDesignatedAsNetInvestmentHedgeOnBalanceSheetMember_71197473-4ed5-4af5-82b1-2b1f131de5ca" xlink:href="idxx-20211231.xsd#idxx_ForeignCurrencyBorrowingsDesignatedAsNetInvestmentHedgeOnBalanceSheetMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2fb66159-d599-448a-8ecb-740f63e09372" xlink:to="loc_idxx_ForeignCurrencyBorrowingsDesignatedAsNetInvestmentHedgeOnBalanceSheetMember_71197473-4ed5-4af5-82b1-2b1f131de5ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_2086259f-d9a0-4eba-81e4-5cc79399e714" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_3e4421f4-c129-4817-81c3-578fc97d1f0e" xlink:to="loc_us-gaap_HedgingDesignationAxis_2086259f-d9a0-4eba-81e4-5cc79399e714" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_164d4041-3411-40be-98f8-a452f7cf2cf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_2086259f-d9a0-4eba-81e4-5cc79399e714" xlink:to="loc_us-gaap_HedgingDesignationDomain_164d4041-3411-40be-98f8-a452f7cf2cf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_7dbf45f1-565a-459c-8ec7-9349b5eda809" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_164d4041-3411-40be-98f8-a452f7cf2cf0" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_7dbf45f1-565a-459c-8ec7-9349b5eda809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_5a031c02-cd80-4aac-8e80-b7c1e565cd24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_3e4421f4-c129-4817-81c3-578fc97d1f0e" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_5a031c02-cd80-4aac-8e80-b7c1e565cd24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6df57811-1ebe-43bf-b893-b577193cca48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_5a031c02-cd80-4aac-8e80-b7c1e565cd24" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_6df57811-1ebe-43bf-b893-b577193cca48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember_1383173e-0cc8-4ba5-96bf-dc20dd4328bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6df57811-1ebe-43bf-b893-b577193cca48" xlink:to="loc_us-gaap_OtherCurrentAssetsMember_1383173e-0cc8-4ba5-96bf-dc20dd4328bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_5fa62468-98e5-438e-a31a-02c6da8fd8f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6df57811-1ebe-43bf-b893-b577193cca48" xlink:to="loc_us-gaap_OtherAssetsMember_5fa62468-98e5-438e-a31a-02c6da8fd8f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_14b91553-e7fa-4e82-b576-8f5b52695350" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6df57811-1ebe-43bf-b893-b577193cca48" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_14b91553-e7fa-4e82-b576-8f5b52695350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_dfe09ea4-80f9-4922-a990-fefe594ba59d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6df57811-1ebe-43bf-b893-b577193cca48" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_dfe09ea4-80f9-4922-a990-fefe594ba59d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_8182cc25-4c6f-4930-bdf1-cd0fe27ed5d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6df57811-1ebe-43bf-b893-b577193cca48" xlink:to="loc_us-gaap_LongTermDebtMember_8182cc25-4c6f-4930-bdf1-cd0fe27ed5d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_fa0ebbf0-5a82-4767-b72b-7d0078a7c652" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_3e4421f4-c129-4817-81c3-578fc97d1f0e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_fa0ebbf0-5a82-4767-b72b-7d0078a7c652" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_1f403e08-3cdd-4c29-902d-f59ef31bfd82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_fa0ebbf0-5a82-4767-b72b-7d0078a7c652" xlink:to="loc_us-gaap_HedgingRelationshipDomain_1f403e08-3cdd-4c29-902d-f59ef31bfd82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_8f7d854a-d833-4cbb-8919-3ce886d4f572" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_1f403e08-3cdd-4c29-902d-f59ef31bfd82" xlink:to="loc_us-gaap_CashFlowHedgingMember_8f7d854a-d833-4cbb-8919-3ce886d4f572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_4cbdd354-d3f4-40e7-b4e7-ef9fe5b14801" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_3e4421f4-c129-4817-81c3-578fc97d1f0e" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_4cbdd354-d3f4-40e7-b4e7-ef9fe5b14801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_7e7047c8-8fc8-4a25-a209-5c5816680421" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_4cbdd354-d3f4-40e7-b4e7-ef9fe5b14801" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_7e7047c8-8fc8-4a25-a209-5c5816680421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction_63facf03-8781-479d-b8e0-437a794b2ded" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_4cbdd354-d3f4-40e7-b4e7-ef9fe5b14801" xlink:to="loc_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction_63facf03-8781-479d-b8e0-437a794b2ded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection_29d03972-46fb-4635-8404-8bdaca483f95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_4cbdd354-d3f4-40e7-b4e7-ef9fe5b14801" xlink:to="loc_us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection_29d03972-46fb-4635-8404-8bdaca483f95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_3e0eff0d-0d80-42ce-894a-fa4846421f69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_4cbdd354-d3f4-40e7-b4e7-ef9fe5b14801" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_3e0eff0d-0d80-42ce-894a-fa4846421f69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction_bde40461-dc44-45e6-9b74-6d7f47d1116c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_4cbdd354-d3f4-40e7-b4e7-ef9fe5b14801" xlink:to="loc_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction_bde40461-dc44-45e6-9b74-6d7f47d1116c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection_76528ab7-2710-4cf8-9bab-599bae879759" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_4cbdd354-d3f4-40e7-b4e7-ef9fe5b14801" xlink:to="loc_us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection_76528ab7-2710-4cf8-9bab-599bae879759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/RepurchasesofCommonStock" xlink:type="simple" xlink:href="idxx-20211231.xsd#RepurchasesofCommonStock"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/RepurchasesofCommonStock" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_72e61e94-e303-43ce-9d88-8fce2add4dce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockTextBlock_061a28d3-e5cd-4f39-9aa6-366f67cc5525" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_72e61e94-e303-43ce-9d88-8fce2add4dce" xlink:to="loc_us-gaap_TreasuryStockTextBlock_061a28d3-e5cd-4f39-9aa6-366f67cc5525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/RepurchasesofCommonStockTables" xlink:type="simple" xlink:href="idxx-20211231.xsd#RepurchasesofCommonStockTables"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/RepurchasesofCommonStockTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_2959536e-b945-49c4-af2c-e71cddd54488" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_f40bc7b7-7808-4540-afc4-1a96a05d3658" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_2959536e-b945-49c4-af2c-e71cddd54488" xlink:to="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_f40bc7b7-7808-4540-afc4-1a96a05d3658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/RepurchasesofCommonStockDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#RepurchasesofCommonStockDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/RepurchasesofCommonStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_5901da7a-32a9-43dd-91e8-b26d73816b59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_a235bf6d-a510-465c-9771-4b956117006e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5901da7a-32a9-43dd-91e8-b26d73816b59" xlink:to="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_a235bf6d-a510-465c-9771-4b956117006e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_be798a72-dfde-4a7a-b771-9b6d16e951ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5901da7a-32a9-43dd-91e8-b26d73816b59" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_be798a72-dfde-4a7a-b771-9b6d16e951ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_TreasuryStockSharesAcquiredNetOfTaxWithholdings_8ee2562e-b208-4ce8-834c-70c218dea127" xlink:href="idxx-20211231.xsd#idxx_TreasuryStockSharesAcquiredNetOfTaxWithholdings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5901da7a-32a9-43dd-91e8-b26d73816b59" xlink:to="loc_idxx_TreasuryStockSharesAcquiredNetOfTaxWithholdings_8ee2562e-b208-4ce8-834c-70c218dea127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_b71bbda7-b706-49ed-b439-23d73149834a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5901da7a-32a9-43dd-91e8-b26d73816b59" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_b71bbda7-b706-49ed-b439-23d73149834a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_3963cbe2-1ceb-411c-84fe-9ae94a358150" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5901da7a-32a9-43dd-91e8-b26d73816b59" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_3963cbe2-1ceb-411c-84fe-9ae94a358150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_TreasuryStockValueAcquiredCostMethodNetOfTaxWithholdings_7f89abd4-96e6-4904-92b4-6dad826f744e" xlink:href="idxx-20211231.xsd#idxx_TreasuryStockValueAcquiredCostMethodNetOfTaxWithholdings"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5901da7a-32a9-43dd-91e8-b26d73816b59" xlink:to="loc_idxx_TreasuryStockValueAcquiredCostMethodNetOfTaxWithholdings_7f89abd4-96e6-4904-92b4-6dad826f744e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_a27f6d3c-7130-43f9-a783-09a1affef088" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5901da7a-32a9-43dd-91e8-b26d73816b59" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_a27f6d3c-7130-43f9-a783-09a1affef088" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_5df10f57-c3f8-4064-ae2f-b43d4752d938" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5901da7a-32a9-43dd-91e8-b26d73816b59" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_5df10f57-c3f8-4064-ae2f-b43d4752d938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_TreasuryStockAcquiredAverageCostPerShareOpenMarketRepurchase_3633632a-79fd-4879-b1b7-de53e0804d9e" xlink:href="idxx-20211231.xsd#idxx_TreasuryStockAcquiredAverageCostPerShareOpenMarketRepurchase"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5901da7a-32a9-43dd-91e8-b26d73816b59" xlink:to="loc_idxx_TreasuryStockAcquiredAverageCostPerShareOpenMarketRepurchase_3633632a-79fd-4879-b1b7-de53e0804d9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_TreasuryStockAcquiredAverageCostPerShareEmployeeSurrenders_4006f820-2184-4f58-8be3-66fb0a5485d1" xlink:href="idxx-20211231.xsd#idxx_TreasuryStockAcquiredAverageCostPerShareEmployeeSurrenders"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5901da7a-32a9-43dd-91e8-b26d73816b59" xlink:to="loc_idxx_TreasuryStockAcquiredAverageCostPerShareEmployeeSurrenders_4006f820-2184-4f58-8be3-66fb0a5485d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_825f3c31-a647-45b3-ab93-7f05ce255da5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5901da7a-32a9-43dd-91e8-b26d73816b59" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_825f3c31-a647-45b3-ab93-7f05ce255da5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/AccumulatedOtherComprehensiveIncome" xlink:type="simple" xlink:href="idxx-20211231.xsd#AccumulatedOtherComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/AccumulatedOtherComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_1af52281-c069-4181-af96-fbd35d2097d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_c10161b0-1150-4060-8c3a-bf96cb915fb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_1af52281-c069-4181-af96-fbd35d2097d9" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_c10161b0-1150-4060-8c3a-bf96cb915fb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/AccumulatedOtherComprehensiveIncomeTables" xlink:type="simple" xlink:href="idxx-20211231.xsd#AccumulatedOtherComprehensiveIncomeTables"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/AccumulatedOtherComprehensiveIncomeTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_97a68165-5b74-43a2-91cd-8e6ef4b0b963" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_e8215e57-6610-406c-8628-4ec47c322508" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_97a68165-5b74-43a2-91cd-8e6ef4b0b963" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_e8215e57-6610-406c-8628-4ec47c322508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_a68c2be4-00db-4477-87c4-aa5467560166" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_97a68165-5b74-43a2-91cd-8e6ef4b0b963" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_a68c2be4-00db-4477-87c4-aa5467560166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/AccumulatedOtherComprehensiveIncomeScheduleofAccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#AccumulatedOtherComprehensiveIncomeScheduleofAccumulatedOtherComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/AccumulatedOtherComprehensiveIncomeScheduleofAccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_5bef97c1-4040-4e88-b8cd-f56a50f562ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_5382bce6-395c-4eb9-953b-a129d7e9297d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_5bef97c1-4040-4e88-b8cd-f56a50f562ce" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_5382bce6-395c-4eb9-953b-a129d7e9297d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d05f505a-c461-4b62-a83a-51a4729c9a82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_5382bce6-395c-4eb9-953b-a129d7e9297d" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d05f505a-c461-4b62-a83a-51a4729c9a82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9f58f240-5158-4260-8089-e2c8cca705e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d05f505a-c461-4b62-a83a-51a4729c9a82" xlink:to="loc_us-gaap_EquityComponentDomain_9f58f240-5158-4260-8089-e2c8cca705e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_731e8bc6-ffc6-46a7-af1b-3654c229428e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9f58f240-5158-4260-8089-e2c8cca705e2" xlink:to="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_731e8bc6-ffc6-46a7-af1b-3654c229428e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleIncludingPortionAttributableToNoncontrollingInterestMember_47585bc2-60ce-4c2e-b7c0-aecffcf4e42c" xlink:href="idxx-20211231.xsd#idxx_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_731e8bc6-ffc6-46a7-af1b-3654c229428e" xlink:to="loc_idxx_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleIncludingPortionAttributableToNoncontrollingInterestMember_47585bc2-60ce-4c2e-b7c0-aecffcf4e42c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_AccumulatedNetGainLossFromCashFlowHedgesForeignCurrencyExchangeContractsIncludingPortionAttributableToNoncontrollingInterestMember_5298c0f8-1b31-4dde-9ee7-35a47a9bc64f" xlink:href="idxx-20211231.xsd#idxx_AccumulatedNetGainLossFromCashFlowHedgesForeignCurrencyExchangeContractsIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_731e8bc6-ffc6-46a7-af1b-3654c229428e" xlink:to="loc_idxx_AccumulatedNetGainLossFromCashFlowHedgesForeignCurrencyExchangeContractsIncludingPortionAttributableToNoncontrollingInterestMember_5298c0f8-1b31-4dde-9ee7-35a47a9bc64f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_AccumulatedNetGainLossFromNetInvestmentHedgesEuroDenominatedNotesIncludingPortionAttributableToNoncontrollingInterestMember_eb7d2b80-12f4-46e6-830d-e07b90dc39f1" xlink:href="idxx-20211231.xsd#idxx_AccumulatedNetGainLossFromNetInvestmentHedgesEuroDenominatedNotesIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_731e8bc6-ffc6-46a7-af1b-3654c229428e" xlink:to="loc_idxx_AccumulatedNetGainLossFromNetInvestmentHedgesEuroDenominatedNotesIncludingPortionAttributableToNoncontrollingInterestMember_eb7d2b80-12f4-46e6-830d-e07b90dc39f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_AccumulatedNetGainLossFromNetInvestmentHedgesCrossCurrencySwapsIncludingPortionAttributableToNoncontrollingInterestMember_5ff8ff0d-e48e-4128-90d8-027718d5f27a" xlink:href="idxx-20211231.xsd#idxx_AccumulatedNetGainLossFromNetInvestmentHedgesCrossCurrencySwapsIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_731e8bc6-ffc6-46a7-af1b-3654c229428e" xlink:to="loc_idxx_AccumulatedNetGainLossFromNetInvestmentHedgesCrossCurrencySwapsIncludingPortionAttributableToNoncontrollingInterestMember_5ff8ff0d-e48e-4128-90d8-027718d5f27a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_c2c47ecf-735f-4ac9-a721-e6d91689ffea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_731e8bc6-ffc6-46a7-af1b-3654c229428e" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_c2c47ecf-735f-4ac9-a721-e6d91689ffea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_038a75c5-5f95-4ebb-8bf4-e626a3d0c27d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_5382bce6-395c-4eb9-953b-a129d7e9297d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_038a75c5-5f95-4ebb-8bf4-e626a3d0c27d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_57964177-3924-40dc-93bd-6b56d65d25b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_038a75c5-5f95-4ebb-8bf4-e626a3d0c27d" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_57964177-3924-40dc-93bd-6b56d65d25b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4c9819af-14b4-4c35-b8c9-0fc8477f8c11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_57964177-3924-40dc-93bd-6b56d65d25b1" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4c9819af-14b4-4c35-b8c9-0fc8477f8c11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_18e12972-8307-4bcb-b944-86d8c1d2256b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_57964177-3924-40dc-93bd-6b56d65d25b1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_18e12972-8307-4bcb-b944-86d8c1d2256b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_94c872ce-0f4d-4882-9763-ff21769a27ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_57964177-3924-40dc-93bd-6b56d65d25b1" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_94c872ce-0f4d-4882-9763-ff21769a27ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9c63a48d-6cca-4915-aca9-613f794586b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_57964177-3924-40dc-93bd-6b56d65d25b1" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9c63a48d-6cca-4915-aca9-613f794586b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/AccumulatedOtherComprehensiveIncomeScheduleofReclassificationsoutofAccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#AccumulatedOtherComprehensiveIncomeScheduleofReclassificationsoutofAccumulatedOtherComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/AccumulatedOtherComprehensiveIncomeScheduleofReclassificationsoutofAccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_02c8b523-cea2-42cf-9412-ce00b06b9c89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_8702f1e6-4685-4058-a1fe-16c5eda40477" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_02c8b523-cea2-42cf-9412-ce00b06b9c89" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_8702f1e6-4685-4058-a1fe-16c5eda40477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_93b66862-f8db-423b-a57e-22fad0b2405b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_8702f1e6-4685-4058-a1fe-16c5eda40477" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_93b66862-f8db-423b-a57e-22fad0b2405b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_e3844203-92a1-467d-ad5a-26eacbdbde90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_93b66862-f8db-423b-a57e-22fad0b2405b" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_e3844203-92a1-467d-ad5a-26eacbdbde90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_4b32f3b2-7644-4b67-9478-3cce595d7845" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_e3844203-92a1-467d-ad5a-26eacbdbde90" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_4b32f3b2-7644-4b67-9478-3cce595d7845" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_de3825e4-1616-4099-954d-e4ff441240aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_8702f1e6-4685-4058-a1fe-16c5eda40477" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_de3825e4-1616-4099-954d-e4ff441240aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d52634ae-6f31-4863-b684-c5508e08eba6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_de3825e4-1616-4099-954d-e4ff441240aa" xlink:to="loc_us-gaap_EquityComponentDomain_d52634ae-6f31-4863-b684-c5508e08eba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_AccumulatedNetGainLossFromCashFlowHedgesForeignCurrencyExchangeContractsIncludingPortionAttributableToNoncontrollingInterestMember_51db6569-ffb6-4c1b-898e-e83b4ffb3839" xlink:href="idxx-20211231.xsd#idxx_AccumulatedNetGainLossFromCashFlowHedgesForeignCurrencyExchangeContractsIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d52634ae-6f31-4863-b684-c5508e08eba6" xlink:to="loc_idxx_AccumulatedNetGainLossFromCashFlowHedgesForeignCurrencyExchangeContractsIncludingPortionAttributableToNoncontrollingInterestMember_51db6569-ffb6-4c1b-898e-e83b4ffb3839" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_09d333f4-541c-458a-a1ef-ba3c12ea9b71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_8702f1e6-4685-4058-a1fe-16c5eda40477" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_09d333f4-541c-458a-a1ef-ba3c12ea9b71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_1ea58b17-645c-466a-91c3-ec924fc0e3fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_09d333f4-541c-458a-a1ef-ba3c12ea9b71" xlink:to="loc_us-gaap_CostOfRevenue_1ea58b17-645c-466a-91c3-ec924fc0e3fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_6b24c6bc-6ff5-4a7d-a8cd-6a2ff1f82ce1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_09d333f4-541c-458a-a1ef-ba3c12ea9b71" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_6b24c6bc-6ff5-4a7d-a8cd-6a2ff1f82ce1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_d8108654-d2d7-4681-8285-21dd3c2e734b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_09d333f4-541c-458a-a1ef-ba3c12ea9b71" xlink:to="loc_us-gaap_ProfitLoss_d8108654-d2d7-4681-8285-21dd3c2e734b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/PreferredStock" xlink:type="simple" xlink:href="idxx-20211231.xsd#PreferredStock"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/PreferredStock" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_6e4485cc-92cf-482c-b9f8-867c6fbade2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockTextBlock_4e7b9a11-6615-4cd8-929c-d90880cd2023" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_6e4485cc-92cf-482c-b9f8-867c6fbade2c" xlink:to="loc_us-gaap_PreferredStockTextBlock_4e7b9a11-6615-4cd8-929c-d90880cd2023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/PreferredStockDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#PreferredStockDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/PreferredStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_5404a15e-c01e-4c7b-b256-ec81ca8dab65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_ab0751e1-43db-40ea-9ecb-c94071eb073f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_5404a15e-c01e-4c7b-b256-ec81ca8dab65" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_ab0751e1-43db-40ea-9ecb-c94071eb073f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_695f7d42-00a8-4241-b2a6-439e31cdb680" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_5404a15e-c01e-4c7b-b256-ec81ca8dab65" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_695f7d42-00a8-4241-b2a6-439e31cdb680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_ad83bad4-cb9b-41e5-be80-54950dc799dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_5404a15e-c01e-4c7b-b256-ec81ca8dab65" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_ad83bad4-cb9b-41e5-be80-54950dc799dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/IDEXXRetirementandIncentiveSavingsPlan" xlink:type="simple" xlink:href="idxx-20211231.xsd#IDEXXRetirementandIncentiveSavingsPlan"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/IDEXXRetirementandIncentiveSavingsPlan" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a30c9014-dbab-4910-a56f-847359a7ada8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_f478d5dc-7ac3-428e-9411-f9b4c09d688a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a30c9014-dbab-4910-a56f-847359a7ada8" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_f478d5dc-7ac3-428e-9411-f9b4c09d688a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.idexx.com/role/IDEXXRetirementandIncentiveSavingsPlanDetails" xlink:type="simple" xlink:href="idxx-20211231.xsd#IDEXXRetirementandIncentiveSavingsPlanDetails"/>
  <link:presentationLink xlink:role="http://www.idexx.com/role/IDEXXRetirementandIncentiveSavingsPlanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_871a88f2-4fe5-433b-9272-aecfadb5f5c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_RetirementAndIncentiveSavingsPlanTable_3041af61-507a-4193-9470-d72cce47df07" xlink:href="idxx-20211231.xsd#idxx_RetirementAndIncentiveSavingsPlanTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_871a88f2-4fe5-433b-9272-aecfadb5f5c7" xlink:to="loc_idxx_RetirementAndIncentiveSavingsPlanTable_3041af61-507a-4193-9470-d72cce47df07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_RetirementAndIncentiveSavingsPlanAxis_b8c4a5de-8c8b-412b-b2be-c2984b7f53ac" xlink:href="idxx-20211231.xsd#idxx_RetirementAndIncentiveSavingsPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_RetirementAndIncentiveSavingsPlanTable_3041af61-507a-4193-9470-d72cce47df07" xlink:to="loc_idxx_RetirementAndIncentiveSavingsPlanAxis_b8c4a5de-8c8b-412b-b2be-c2984b7f53ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_RetirementAndIncentiveSavingsPlanDomain_24d27aef-807c-4ddc-8a0a-d9fd76869a71" xlink:href="idxx-20211231.xsd#idxx_RetirementAndIncentiveSavingsPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_RetirementAndIncentiveSavingsPlanAxis_b8c4a5de-8c8b-412b-b2be-c2984b7f53ac" xlink:to="loc_idxx_RetirementAndIncentiveSavingsPlanDomain_24d27aef-807c-4ddc-8a0a-d9fd76869a71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_FourZeroOneKPlanMember_2c601841-6b2a-4a50-8a91-6f6b5c38e729" xlink:href="idxx-20211231.xsd#idxx_FourZeroOneKPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_RetirementAndIncentiveSavingsPlanDomain_24d27aef-807c-4ddc-8a0a-d9fd76869a71" xlink:to="loc_idxx_FourZeroOneKPlanMember_2c601841-6b2a-4a50-8a91-6f6b5c38e729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_idxx_RetirementAndIncentiveSavingsPlanLineItems_36283234-a35b-4d17-8bcf-7fe623dff2a0" xlink:href="idxx-20211231.xsd#idxx_RetirementAndIncentiveSavingsPlanLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_RetirementAndIncentiveSavingsPlanTable_3041af61-507a-4193-9470-d72cce47df07" xlink:to="loc_idxx_RetirementAndIncentiveSavingsPlanLineItems_36283234-a35b-4d17-8bcf-7fe623dff2a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_5be42029-10d7-4d5f-97bc-22cb6120bf59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_RetirementAndIncentiveSavingsPlanLineItems_36283234-a35b-4d17-8bcf-7fe623dff2a0" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_5be42029-10d7-4d5f-97bc-22cb6120bf59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_2eae5380-3bfd-4c65-8bee-f8a9098a4fe7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_RetirementAndIncentiveSavingsPlanLineItems_36283234-a35b-4d17-8bcf-7fe623dff2a0" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_2eae5380-3bfd-4c65-8bee-f8a9098a4fe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_567f6d48-fbc5-4593-8c05-1a32c0280436" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_idxx_RetirementAndIncentiveSavingsPlanLineItems_36283234-a35b-4d17-8bcf-7fe623dff2a0" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_567f6d48-fbc5-4593-8c05-1a32c0280436" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>idxx-20211231_g1.jpg
<TEXT>
begin 644 idxx-20211231_g1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  K .,# 2(  A$! Q$!_\0
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MR_Z&[7?_  9S_P#Q='_"SO&7_0W:[_X,Y_\ XNOK'_AEOP'_ ,^MU_X$4?\
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M^C7KI_V:?^2R:%_VU_\ 2=ZYCXH?\E,\6_\ 88O/_1KUT_[-/_)9-"_[:_\
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MF?/LZU\ >97UK^R%&L_@/6HY55E-_M96_P!Q:)1]TJG)1FKGSD_Q\^((9O\
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5.U$R6\*!$5IY'('IEF)/XFBH+/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>idxx-20211231_g2.jpg
<TEXT>
begin 644 idxx-20211231_g2.jpg
M_]C_X  02D9)1@ ! @$ \ #P  #__@ 23$5!1%1/3TQ3('8R,"XP /_; (0
M!04%" 4(# <'# P)"0D,#0P,# P-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-
M#0T-#0T-#0T-#0T-#0T-#0T-#0$%" @*!PH,!P<,#0P*# T-#0T-#0T-#0T-
M#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-_\0!H@
M 04! 0$! 0$           $" P0%!@<("0H+ 0 # 0$! 0$! 0$!
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M\O/T]?;W^/GZ_\  $0@!\@-' P$1  (1 0,1 ?_:  P# 0 "$0,1 #\ ^RZ
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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MIL)A&SQ*R1R))&LL3JC/(R'8X5T,CX920V#M4 Z&@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M 'RO^% !]DA_YYI_WRO^% !]DA_YYI_WRO\ A0 ?9(?^>:?]\K_A0 ?9(?\
MGFG_ 'RO^% !]DA_YYI_WRO^% !]DA_YYI_WRO\ A0 ?9(?^>:?]\K_A0 ?9
M(?\ GFG_ 'RO^% !]DA_YYI_WRO^% !]DA_YYI_WRO\ A0 ?9(?^>:?]\K_A
M0 ?9(?\ GFG_ 'RO^% !]DA_YYI_WRO^% !]DA_YYI_WRO\ A0 ?9(?^>:?]
M\K_A0 ?9(?\ GFG_ 'RO^% !]DA_YYI_WRO^% !]DA_YYI_WRO\ A0 ?9(?^
M>:?]\K_A0 ?9(?\ GFG_ 'RO^% !]DA_YYI_WRO^% !]DA_YYI_WRO\ A0 ?
M9(?^>:?]\K_A0 ?9(?\ GFG_ 'RO^% !]DA_YYI_WRO^% !]DA_YYI_WRO\
MA0 ?9(?^>:?]\K_A0 ?9(?\ GFG_ 'RO^% !]DA_YYI_WRO^% !]DA_YYI_W
MRO\ A0 ?9(?^>:?]\K_A0 ?9(?\ GFG_ 'RO^% !]DA_YYI_WRO^% !]DA_Y
MYI_WRO\ A0 ?9(?^>:?]\K_A0 ?9(?\ GFG_ 'RO^% !]DA_YYI_WRO^% !]
MDA_YYI_WRO\ A0 ?9(?^>:?]\K_A0 ?9(?\ GFG_ 'RO^% !]DA_YYI_WRO^
M% !]DA_YYI_WRO\ A0 ?9(?^>:?]\K_A0 ?9(?\ GFG_ 'RO^% !]DA_YYI_
MWRO^% !]DA_YYI_WRO\ A0 ?9(?^>:?]\K_A0 ?9(?\ GFG_ 'RO^% !]DA_
MYYI_WRO^% !]DA_YYI_WRO\ A0 ?9(?^>:?]\K_A0 ?9(?\ GFG_ 'RO^% !
M]DA_YYI_WRO^% !]DA_YYI_WRO\ A0 ?9(?^>:?]\K_A0 ?9(?\ GFG_ 'RO
M^% !]DA_YYI_WRO^% !]DA_YYI_WRO\ A0 ](4BY157/H /Y4 24 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MQP=KJIVE6 VLI(!?H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M$2X (T@ODAM[R5+J:UL]6DEB2199;I;)XI(4=HVW7,A261F575KA8"-P&T@
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MT?\ */\ ^(H /)?_ )Z/^4?_ ,10 >2__/1_RC_^(H /)?\ YZ/^4?\ \10
M>2__ #T?\H__ (B@ \E_^>C_ )1__$4 'DO_ ,]'_*/_ .(H /)?_GH_Y1__
M !% !Y+_ //1_P H_P#XB@ \E_\ GH_Y1_\ Q% !Y+_\]'_*/_XB@ \E_P#G
MH_Y1_P#Q% !Y+_\ /1_RC_\ B* #R7_YZ/\ E'_\10 >2_\ ST?\H_\ XB@
M\E_^>C_E'_\ $4 'DO\ \]'_ "C_ /B* #R7_P">C_E'_P#$4 'DO_ST?\H_
M_B* #R7_ .>C_E'_ /$4 'DO_P ]'_*/_P"(H /)?_GH_P"4?_Q% !Y+_P#/
M1_RC_P#B* #R7_YZ/^4?_P 10 >2_P#ST?\ */\ ^(H /)?_ )Z/^4?_ ,10
M >2__/1_RC_^(H /)?\ YZ/^4?\ \10 >2__ #T?\H__ (B@ \E_^>C_ )1_
M_$4 'DO_ ,]'_*/_ .(H /)?_GH_Y1__ !% !Y+_ //1_P H_P#XB@ \E_\
MGH_Y1_\ Q% !Y+_\]'_*/_XB@ \E_P#GH_Y1_P#Q% !Y+_\ /1_RC_\ B* #
MR7_YZ/\ E'_\10 >2_\ ST?\H_\ XB@ \E_^>C_E'_\ $4 'DO\ \]'_ "C_
M /B* #R7_P">C_E'_P#$4 'DO_ST?\H__B* #R7_ .>C_E'_ /$4 'DO_P ]
M'_*/_P"(H /)?_GH_P"4?_Q% !Y+_P#/1_RC_P#B* #R7_YZ/^4?_P 10 >2
M_P#ST?\ */\ ^(H /)?_ )Z/^4?_ ,10 >2__/1_RC_^(H /)?\ YZ/^4?\
M\10 >2__ #T?\H__ (B@ \E_^>C_ )1__$4 'DO_ ,]'_*/_ .(H /)?_GH_
MY1__ !% !Y+_ //1_P H_P#XB@ \E_\ GH_Y1_\ Q% !Y+_\]'_*/_XB@ \E
M_P#GH_Y1_P#Q% !Y+_\ /1_RC_\ B* #R7_YZ/\ E'_\10 >2_\ ST?\H_\
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M1$ 554 *J@8  '  '  X X% #Z "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * .9U/7S'*;'34%U>=&
M&?W4&?XIV'0XY$2_O&XSL4[P /TK0!:R&\O'-U>2?>E?'RCKLC7I'&.RKQW8
MLV6(!T= !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 V218E+N0B*"69B  !R22>  .23TH XQ]1N_$A\K2RUM9 X>[(Q)*.XMP?N
MJ?\ GLPR>L2])* .DTS2;;2(A#:H$7DD]V)Y+,3R23R2223R230!HT % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!7M+N*]3S8&WH'DCS@CYHI&B<<
M@9 =& (X;&Y25() +% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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MNF_NI_WVW_QN@ W3?W4_[[;_ .-T &Z;^ZG_ 'VW_P ;H -TW]U/^^V_^-T
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M+(C0>@Y)Y=F;YJ .EW3?W$_[[;_XW0 ;IO[J?]]M_P#&Z #=-_=3_OMO_C=
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 -=UC4NY"JH)))P !R22>  .IH
M XV35+KQ$WDZ03#9])+PCYG'<6P(Z?\ 3=AC_GDK<. #H=*TBWT>+R;9<<DL
MQR69CR69CDLS'DL223R2: -.@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H S]2U2WTF+SKEMH)PB@;GD8]$C0?,['L .G)P 2 #F
MH["[\2LL^I V]F.4LP0=_<-<L.'/<1#,2GKYA 8 '911+"H2,!5'0#B@!] !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!SNJZ^MI
M+]ALT^TWS#(B!PD8/1YW&?+7N%YD?^%2,L "+3- *RB_U)_M5\1C<1A(U/5(
M4R0B<<\EFZNS'F@#IZ "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H Q]?DO8K"9],7?=A1Y8PI/+ ,5#D(75-S1A_E+A0P()! .7T
M75+31K*YD%S<7*PR;S;W, ANXYKEC+Y93RH"[7,TA,1,>TLS!9&5?E ,VVOO
M$%W#=1!V>ZM]0A5UMUM T5N\$4TT4)N (G,9D*H\I+M@$GD@ %W^W)YH;>SM
M9[E+F?4&LYY+F.U^T6_E1O-(@6&/[*S,B+Y;A)4V2[R6(  !O>'KVY>>]T^[
MD^T/83HJS$(KR1S1).@D6-4CWIO*$HB!E"G;G+, =/0!"US$AVLZ CJ"P!_G
M0 GVN'_GHG_?2_XT 'VN'_GHG_?2_P"- !]KA_YZ)_WTO^- !]KA_P">B?\
M?2_XT 'VN'_GHG_?2_XT 'VN'_GHG_?2_P"- !]KA_YZ)_WTO^- !]KA_P">
MB?\ ?2_XT 'VN'_GHG_?2_XT 'VN'_GHG_?2_P"- !]KA_YZ)_WTO^- !]KA
M_P">B?\ ?2_XT 'VN'_GHG_?2_XT 'VN'_GHG_?2_P"- !]KA_YZ)_WTO^-
M!]KA_P">B?\ ?2_XT 'VN'_GHG_?2_XT 'VN'_GHG_?2_P"- !]KA_YZ)_WT
MO^- !]KA_P">B?\ ?2_XT 'VN'_GHG_?2_XT 'VN'_GHG_?2_P"- !]KA_YZ
M)_WTO^- !]KA_P">B?\ ?2_XT 'VN'_GHG_?2_XT 'VN'_GHG_?2_P"- !]K
MA_YZ)_WTO^- !]KA_P">B?\ ?2_XT 'VN'_GHG_?2_XT 'VN'_GHG_?2_P"-
M !]KA_YZ)_WTO^- !]KA_P">B?\ ?2_XT 'VN'_GHG_?2_XT 'VN'_GHG_?2
M_P"- !]KA_YZ)_WTO^- !]KA_P">B?\ ?2_XT 'VN'_GHG_?2_XT 'VN'_GH
MG_?2_P"- !]KA_YZ)_WTO^- !]KA_P">B?\ ?2_XT 'VN'_GHG_?2_XT 'VN
M'_GHG_?2_P"- !]KA_YZ)_WTO^- !]KA_P">B?\ ?2_XT 'VN'_GHG_?2_XT
M 'VN'_GHG_?2_P"- !]KA_YZ)_WTO^- !]KA_P">B?\ ?2_XT 'VN'_GHG_?
M2_XT 'VN'_GHG_?2_P"- !]KA_YZ)_WTO^- !]KA_P">B?\ ?2_XT 'VN'_G
MHG_?2_XT 'VN'_GHG_?2_P"- !]KA_YZ)_WTO^- !]KA_P">B?\ ?2_XT 'V
MN'_GHG_?2_XT 'VN'_GHG_?2_P"- !]KA_YZ)_WTO^- !]KA_P">B?\ ?2_X
MT 'VN'_GHG_?2_XT 'VN'_GHG_?2_P"- !]KA_YZ)_WTO^- !]KA_P">B?\
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MH[.R?NPYW$NS'& ".W\&66GO++IS/I\LTHE+VRVZ%0(_+\E5:!T,!_UAC='
ME/FJ0P4@ G/A2V^SB$23B87/VS[2&3S_ +2<@R\QF'E"8O+\GRA&=@C  P :
M>E:3'I*.$9YI)Y&EFFE*F25R ,ML5$ 5%5%5$1550 N<D@&I0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 4-1U.WTF$W%TVQ!P  2SL>B(HRS
MN>RJ"3] : .96RN_$Y$E^#;6'5;3/S2>C7+ X/KY*DQC^,R'& #L884MT$<8
M"JHP . * )* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@#G]6UY;%_L=JGVJ^==RP*<!0<@/,^"(X\@XX+O@A%;!P 5].T!C,-0U
M-_M%X1@<8BA!ZI"F2$'J22[]79N  #J.E !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 86M:R=/V6ULHFO;C(AB/08^]+)CD11
MY!8]6.$7YF& !=$T5=*1G<F:YF;?-,WWG<]3[  !54<*H"C@4 ;E !0 4 %
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M"T:,#N4KP&8 VZ "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * *]W=Q6,+W%PPCBC!9F/0 ?J
M3V &23@ $F@#E=.LIM;NAJU^I2.//V2W;_EFIX,L@Z><XZ]?+4[!R7+ '94
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * .'G9_%MQY$9QI4#?O&'_+W(I^XI[P(1\Q'$KC'^K7YP#MD01@*HP!P!
M0 Z@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * ,;Q#%;36$L=['+-;ML#K"KM(!YBXD41_O/W1Q*=F7
M 0E58@*0#F-&U2Z:WNI-][=Z>%@%I=&V O&\U0LKI"8(_/CA#),LAMF,@\P*
MMR5"T 9=M;0N;I]0AO[JTENK>2.Z,%U%>-,D+$N\5NL,ZQ0E4BB:&VB4,_*M
MAY: %2"^2&WO)4NIK6SU:26))%EENELGBDA1VC;=<R%)9&95=6N%@(W ;2
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M?_'* #;-_>3_ +X;_P".4 &V;^\G_?#?_'* #;-_>3_OAO\ XY0 ;9O[R?\
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 <UKNL2V[)I^G@/?W RN1E88\X,\@]!R(T_P"6C\?=#E0#
M0TC28](A\M,N[$M)(W+R.W+.Y[LQY/Y#    -6@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@".*9)QNB974,RDJ00&1BCKD9^9'5E8=58%3@@B@"2@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@#"UW6O[*18X5\Z\N"5@A_O-W=R/NQ1Y!=OHJY9E! %T72/[.
M5IIV\Z[G.^>4CEFQT _A11\J(.%4 =<D@&Y0 4 % !0 4 % !0 4 % !0 4
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M_P"<?_Q= !YS_P#/-_SC_P#BZ #SG_YYO^<?_P 70 ><_P#SS?\ ./\ ^+H
M/.?_ )YO^<?_ ,70 ><__/-_SC_^+H /.?\ YYO^<?\ \70 ><__ #S?\X__
M (N@ \Y_^>;_ )Q__%T 'G/_ ,\W_./_ .+H /.?_GF_YQ__ != !YS_ //-
M_P X_P#XN@ \Y_\ GF_YQ_\ Q= !YS_\\W_./_XN@ \Y_P#GF_YQ_P#Q= !Y
MS_\ /-_SC_\ BZ #SG_YYO\ G'_\70 ><_\ SS?\X_\ XN@ \Y_^>;_G'_\
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M?_GF_P"<?_Q= !YS_P#/-_SC_P#BZ #SG_YYO^<?_P 70 ><_P#SS?\ ./\
M^+H /.?_ )YO^<?_ ,70 ><__/-_SC_^+H /.?\ YYO^<?\ \70 ><__ #S?
M\X__ (N@ \Y_^>;_ )Q__%T 'G/_ ,\W_./_ .+H RM7UQ-'A\V6*1G=@D4:
ME"\LC?=10')]V.,(H+-A0: *&C6$\;MJ-_&TE[.!N(*;8D'*PQ9?(1<]>KL2
M[<G  .D\Y_\ GF_YQ_\ Q= !YS_\\W_./_XN@ \Y_P#GF_YQ_P#Q= !YS_\
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M #S?\X__ (N@ \Y_^>;_ )Q__%T 'G/_ ,\W_./_ .+H /.?_GF_YQ__ !=
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % $%S<Q643W$[".*)2
MSNQP%4<DDT <I8VTGB*=-3O%*6T1)M(&&",\>?*/^>K#[JG_ %2''WV<T =E
MTH * "@ H * "@ H * "@ H * "@ H * "@ H * ,V?5[6W.TN';IM3YSGT.
MW('XD4 3V]P;J(R(K1DYP' S[$X)X/7K0!F_V9<W/_'U.V#_  1_(OTXP2/J
M30!K6]LEK&(8QA%S@?4Y/ZT 3@ <#B@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * $9@@+,0JJ,DG@ #J2>P% '
M$HI\7S+,V1I<#AHE/'VJ13Q*P_YXJ>85/WC^]/\ RSP =LJA1@< =* %H *
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M_GHG_?2_XT 'VN'_ )Z)_P!]+_C0 ?:X?^>B?]]+_C0 ?:X?^>B?]]+_ (T
M'VN'_GHG_?2_XT 'VN'_ )Z)_P!]+_C0 ?:X?^>B?]]+_C0 ?:X?^>B?]]+_
M (T 'VN'_GHG_?2_XT 'VN'_ )Z)_P!]+_C0 ?:X?^>B?]]+_C0 ?:X?^>B?
M]]+_ (T 'VN'_GHG_?2_XT 'VN'_ )Z)_P!]+_C0 ?:X?^>B?]]+_C0 ?:X?
M^>B?]]+_ (T 'VN'_GHG_?2_XT 'VN'_ )Z)_P!]+_C0 ?:X?^>B?]]+_C0
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M7_&@ ^UP_P#/1/\ OI?\: #[7#_ST3_OI?\ &@ ^UP_\]$_[Z7_&@ ^UP_\
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M(58XT1"\A1(XT50&D=B=S%OFP #:H * "@ H * "@ H * "@ H * "@ H *
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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MII.KQ:LLFQ7AEMY#%-#*%$D3@ @-L9T(9"KHR.Z,K##9#  &K0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 8VH>(;#3&\N>5?.
M[0Q@R2G_ +91AGQ[D!?4B@#).L:IJ7&GVHMHS_RVNSEOJ((FY'<;ID/3*<G
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MC_\ B* #R7_YZ/\ E'_\10 >2_\ ST?\H_\ XB@ \E_^>C_E'_\ $4 'DO\
M\]'_ "C_ /B* #R7_P">C_E'_P#$4 'DO_ST?\H__B* #R7_ .>C_E'_ /$4
M 'DO_P ]'_*/_P"(H /)?_GH_P"4?_Q% !Y+_P#/1_RC_P#B* #R7_YZ/^4?
M_P 10 >2_P#ST?\ */\ ^(H /)?_ )Z/^4?_ ,10 >2__/1_RC_^(H /)?\
MYZ/^4?\ \10 >2__ #T?\H__ (B@ \E_^>C_ )1__$4 'DO_ ,]'_*/_ .(H
M /)?_GH_Y1__ !% !Y+_ //1_P H_P#XB@ \E_\ GH_Y1_\ Q% !Y+_\]'_*
M/_XB@ \E_P#GH_Y1_P#Q% !Y+_\ /1_RC_\ B* #R7_YZ/\ E'_\10 >2_\
MST?\H_\ XB@ \E_^>C_E'_\ $4 'DO\ \]'_ "C_ /B* #R7_P">C_E'_P#$
M4 'DO_ST?\H__B* #R7_ .>C_E'_ /$4 'DO_P ]'_*/_P"(H SK_4+;2@&N
M[KR<_=#&/<WLB!"[GV4$^U &"==O+[Y=*@G<'I-<A((_J$\IIF^CI%G^]UP
M._X1_4=2'_$SOI=IZQ6P$"?0E<R,.Q#2%2/X>30!KZ?X=M-+79:CRQUX6(9/
MJ?W?)/<GDT :ODL/^6C_ )1__$4 +Y+_ //1_P H_P#XB@ \E_\ GH_Y1_\
MQ% !Y+_\]'_*/_XB@ \E_P#GH_Y1_P#Q% !Y+_\ /1_RC_\ B* #R7_YZ/\
ME'_\10 AB91DRN .Y\O_ .(H K03)=%A#.S[,9("8YST;R\'IV)QWZB@"@UA
M?79*S3M%%DX$84,1VRP7/U[>U %^TTX64?E12.%Z](^IZG[E %KR7_YZ/^4?
M_P 10 >2_P#ST?\ */\ ^(H /)?_ )Z/^4?_ ,10 >2__/1_RC_^(H /)?\
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M_P 10 >2_P#ST?\ */\ ^(H /)?_ )Z/^4?_ ,10 >2__/1_RC_^(H /)?\
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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MKS[ D ]<<4 6@ .E "T % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 ,EE2!&EE94C12S,Q"JJJ,EF)P   223@#DT 9
MFC:Y9Z]"T]C(LJ)))&=K(Q!C=DR=C-A9 OF1YP6C9&(&<  >VM:>EL+YKFW%
MJYPLYFC$1.2N!)NV$[E(P#U!'4&@!4UFPDMS>I<V[6J'#3B6,Q*<@8,@;8#D
M@<GJ0.] %JTNX+Z);BUD2>%\[9(V5T;!*G#*2IPP(.#P00>10!8H * "@ H
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MNF_NI_WVW_QN@ W3?W4_[[;_ .-T &Z;^ZG_ 'VW_P ;H -TW]U/^^V_^-T
M&Z;^ZG_?;?\ QN@ W3?W4_[[;_XW0 ;IO[J?]]M_\;H -TW]U/\ OMO_ (W0
M ;IO[J?]]M_\;H -TW]U/^^V_P#C= !NF_NI_P!]M_\ &Z #=-_=3_OMO_C=
M !NF_NI_WVW_ ,;H -TW]U/^^V_^-T ,>:2(;G$:J.I,A _,QT 8L_BFPMSM
M>YLPW]T7(9_^^%0M^E %)O&=L>(4EG/I'#<X_!WMTC/_ 'U0 U?$]]-Q!ILY
M]Y)8HP?^^3(WYJ/I0 \WWB"?_56MK;_]=)I9?S"Q0_EG\: (_LGB.?\ UES;
M0?\ 7"+&/^_PG_SVH 3_ (1R_F_X^;VYD]=EP8/_ $GAAQ^&*  >"[-_^/B$
M7)]9YI)3_P"1$>@#6MM#MK08AMH$QZ''\HA0!I)"T?W8HA]&/_QN@";=-_<3
M_OMO_C= !NF_NI_WVW_QN@ W3?W4_P"^V_\ C= !NF_NI_WVW_QN@ W3?W4_
M[[;_ .-T ->66,;F$:@=S(0/S,= %>ZO7M(_-=%([!69B<^F(_UZ4 9W]KW4
MHS';A 2!NEDP,DX' 7N2 .<DG'6@"S>R2SQXC=8\;F)C=F8B,[74!8BQ*L<$
M+\V[Y>O% &=%IR+)N>-IY%8@L[OPP4/D%XQN!X 9=R[OE)!!P :ZW%U)C]PB
MCY<[Y>0"N3@+&X+*V%(R >2&( R 13W=S;1^;.;:!?W>2\C!0=W[P;F"#YEX
M3@;&^9MX^0 %.74&WI 9-S7"N4,6XJ5D;,;^8L#*OEJ-JDN P)9U8E2 !HGN
M;EI5%LP*%MOFS$)(2-A 50_R$#(5E R=VT.2: $-IJ$L2&-;>VDW9<C+' &U
M=I9" P3Y<D-QP !0!=%E<_:/M&_Y<8$0D8(.,9P(^3WYS@]* (HM%CBC:$QH
MZ2,&8/(S9(Z'+1D\4 :"6Y0*!%$ @POSG@>W[N@"<&4=$C_[[/\ \;H 7=-_
M=3_OMO\ XW0 ;IO[J?\ ?;?_ !N@ W3?W4_[[;_XW0 ;IO[J?]]M_P#&Z #=
M-_=3_OMO_C= !NF_NI_WVW_QN@ W3?W4_P"^V_\ C= !NF_NI_WVW_QN@ W3
M?W4_[[;_ .-T &Z;^ZG_ 'VW_P ;H -TW]U/^^V_^-T &Z;^ZG_?;?\ QN@
MW3?W4_[[;_XW0 ;IO[J?]]M_\;H -TW]U/\ OMO_ (W0 ;IO[J?]]M_\;H -
MTW]U/^^V_P#C= !NF_NI_P!]M_\ &Z #=-_=3_OMO_C= !NF_NI_WVW_ ,;H
M -TW]U/^^V_^-T &Z;^ZG_?;?_&Z #=-_=3_ +[;_P"-T &Z;^ZG_?;?_&Z
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MP\L]5^7;DNO7)PL@V[F *"^'59M\\LDI#$C<03@IMVDL&. QW@C!R "2H(8
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M\YW$MC&XDY)..,]: -$1(N, # P..@H ?0 4 % !0 4 % !0 4 % !0 4 %
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M/1;9(1 ZF5%;>/,)<[L8SELG.* -(0HI! &0, XYQ0!)0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M-*Y9Y/+=R%+LSA2%+8"@ '6T 0M.J'!#\>B.1^84C\J $^TIZ/\ ]^Y/_B:
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M/1_^_<G_ ,30 ?:4]'_[]R?_ !- !]I3T?\ []R?_$T 'VE/1_\ OW)_\30
M?:4]'_[]R?\ Q- !]I3T?_OW)_\ $T 'VE/1_P#OW)_\30 ?:4]'_P"_<G_Q
M- !]I3T?_OW)_P#$T 'VE/1_^_<G_P 30 ?:4]'_ ._<G_Q- !]I3T?_ +]R
M?_$T 'VE/1_^_<G_ ,30 ?:4]'_[]R?_ !- !]I3T?\ []R?_$T 'VE/1_\
MOW)_\30 ?:4]'_[]R?\ Q- !]I3T?_OW)_\ $T 'VE/1_P#OW)_\30 ?:4]'
M_P"_<G_Q- !]I3T?_OW)_P#$T 'VE/1_^_<G_P 30 ?:4]'_ ._<G_Q- !]I
M3T?_ +]R?_$T 'VE/1_^_<G_ ,30 ?:4]'_[]R?_ !- !]I3T?\ []R?_$T
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M* !8UC&% 4>@ '\J '4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M_GFG_?*_X4 'V2'_ )YI_P!\K_A0 ?9(?^>:?]\K_A0 ?9(?^>:?]\K_ (4
M'V2'_GFG_?*_X4 'V2'_ )YI_P!\K_A0 ?9(?^>:?]\K_A0 ?9(?^>:?]\K_
M (4 'V2'_GFG_?*_X4 'V2'_ )YI_P!\K_A0 ?9(?^>:?]\K_A0 ?9(?^>:?
M]\K_ (4 'V2'_GFG_?*_X4 'V2'_ )YI_P!\K_A0 ?9(?^>:?]\K_A0 ?9(?
M^>:?]\K_ (4 'V2'_GFG_?*_X4 'V2'_ )YI_P!\K_A0 ?9(?^>:?]\K_A0
M?9(?^>:?]\K_ (4 'V2'_GFG_?*_X4 'V2'_ )YI_P!\K_A0 ?9(?^>:?]\K
M_A0 ?9(?^>:?]\K_ (4 'V2'_GFG_?*_X4 'V2'_ )YI_P!\K_A0 ?9(?^>:
M?]\K_A0 ?9(?^>:?]\K_ (4 'V2'_GFG_?*_X4 'V2'_ )YI_P!\K_A0 ?9(
M?^>:?]\K_A0 ?9(?^>:?]\K_ (4 'V2'_GFG_?*_X4 'V2'_ )YI_P!\K_A0
M ?9(?^>:?]\K_A0 ?9(?^>:?]\K_ (4 'V2'_GFG_?*_X4 'V2'_ )YI_P!\
MK_A0 ?9(?^>:?]\K_A0 ?9(?^>:?]\K_ (4 'V2'_GFG_?*_X4 'V2'_ )YI
M_P!\K_A0 ?9(?^>:?]\K_A0 ?9(?^>:?]\K_ (4 'V2'_GFG_?*_X4 'V2'_
M )YI_P!\K_A0 ?9(?^>:?]\K_A0 ?9(?^>:?]\K_ (4 'V2'_GFG_?*_X4 '
MV2'_ )YI_P!\K_A0 ?9(?^>:?]\K_A0 ?9(?^>:?]\K_ (4 'V2'_GFG_?*_
MX4 'V2'_ )YI_P!\K_A0 ?9(?^>:?]\K_A0 ?9(?^>:?]\K_ (4 'V2'_GFG
M_?*_X4 'V2'_ )YI_P!\K_A0 ](8XCE%53[ #^5 $E !0 4 % !0 4 % !0
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MNTY&#G!R* $LK^VU&/SK.6.XBR1OB=9%R.HW(2,CN,\4 6J "@ H * "@ H
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M;;O\[S%\K;_>\S.S;[YQ[T 68Y%E421D.C@,K*0001D$$<$$<@C@B@!U !0
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M1MJ@&%JLL M=6TURHU2ZU -!$>)Y 6@^S21C&]TC"DAU!6,(V2N#0![-0 4
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M>)?-4\!H\L-X.1@KD'- #[K6;*R<PRSPK-C(B:6))&.TL %=UY8 D9(&.20
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M1@PW*2K+E21E6!5AU!!!Y% $U !0 4 % &"VOI]M>QA@N)S T23RQK&8X6F
M*!PTJRM\K*[M%%(B(P+,-K[0#%O_ !BUE>R6J6ZR1P7%M;.3,5G>2Y4,I@M_
M)82JJDL294)$<I4%4R0#8U+Q -/N191VUS=S&!K@B 0<1JP0_P"MGB+-N( 5
M S'/ H DN?$-K;Z9_;*[IK4Q)*OE@;V5]NW =D ;YAD,RX.0<$8H ;+KPL[2
M6]OK>XM$AV@+)Y#O(7(5%C%O/,"SNRHH8KEF';) !0?QA;PLT$T%S%>+)%&M
MHPA,TIG#&-HV29X"A"2EF,RB/RG\S;\NX V-)U>+5EDV*\,MO(8IH90HDB<
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MWM\FYGM-N<^2MNV_.,;O/@GQMP<;-OWCNW<8 ,_^QKO_ *"5[_WQI_\ \@T
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M< 3V^CZAI^C16\$ %RM[)-*$%LTP1KF5_-@,Y-MY_EF/:TI.U"PX<*  4XM
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MK2""$LI0^48\@, 3Z]HNJ7$.J6RVBW<FJQ6[)*DD2Q(\4"1M&PF=91LDC:6
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MBA?]->X<.#/YC!2Q?"L-F ">QT:_TZWTF0P-+)837)FAC>'>%G2X564O*D3
M%T+ 2;L-P"010 Z3P]=B"X\N%1/)K45XAS%DPI<0MYFXMVC5_E8[\97;\V"
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 136\5P )D60(RNH90P#H0R.,@X96 96'*D @@T 2T % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
*% !0 4 % '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>image_01.jpg
<TEXT>
begin 644 image_01.jpg
MB5!.1PT*&@H    -24A$4@  !B@    !" (   #+BK&'    '$E$051X7NW!
H(0$    "(/^?UA4V( 4   " @P'.:6:7NK=RS@    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>image_02.jpg
<TEXT>
begin 644 image_02.jpg
MB5!.1PT*&@H    -24A$4@  #+(    _" (   #!W)?^   #!DE$051X7NW:
M,0T , S L/(GW?YCL,@^@R&S            A,P;            ^)DM#
M        (,46!@          D&(+ P          2+&% 0          I-C"
M            4FQA            *;8P          " %%L8          !
MBBT,           @Q18&          "08@L#          !(L84!
M  "DV,(           !2;&$            IMC           ( 46Q@
M     $"*+0P          "#%%@8          )!B"P,          $BQA0$
M         *38P@           %)L80           "FV,           @!1;
M&           0(HM#           (,46!@          D&(+ P
M2+&% 0          I-C"            4FQA            *;8P
M  " %%L8          ! BBT,           @Q18&          "08@L#
M      !(L84!          "DV,(           !2;&$            IMC
M         ( 46Q@          $"*+0P          "#%%@8          )!B
M"P,          $BQA0$          *38P@           %)L80
M "FV,           @!1;&           0(HM#           (,46!@
M    D&(+ P          2+&% 0          I-C"            4FQA
M        *;8P          " %%L8          ! BBT,           @Q18&
M          "08@L#          !(L84!          "DV,(           !2
5#B?"EJ%0!V L     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>36
<FILENAME>image_04.jpg
<TEXT>
begin 644 image_04.jpg
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M!P!EF^T!@(S-]@! QF9[ "!CLST D.'& X"RS?8 0,9F>P @8[,] )"QV1X
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M#P!D;+8' #(VVP, &9OM 8 ,-QX E&VV!P R-ML# !F;[0& C,WV $"&&P\
MRC;; P 9F^T!@(S-]@! QF9[ "##C0< 99OM 8",S?8 0,9F>P @8[,] )#A
MQ@. LLWV $#&9GL (&.S/0"0L=D> ,APXP% V69[ "!CLST D+'9'@#(V&P/
8 &3\ 1#S:,@O:18E     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>37
<FILENAME>image_1.jpg
<TEXT>
begin 644 image_1.jpg
MB5!.1PT*&@H    -24A$4@  !.(    !" (   #\>Y8N    &TE$051X7NW!
G(0$    "(/^?UAL&( 4  ( ; R96F"WJ_ LZ     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>38
<FILENAME>image_10.jpg
<TEXT>
begin 644 image_10.jpg
MB5!.1PT*&@H    -24A$4@   [<    '" (   !<)"V\    4DE$051X7NW6
MH1' ,  #L>R_=,--'>*>-,#C/]\[!P  _B%7MY!I   8E:M;R#0  (S*U2UD
M&@  1N7J%C(-  "C<G4+F08 @%&YNH5, P# I@M$< L2_-^4"     !)14Y$
$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>39
<FILENAME>image_1011.jpg
<TEXT>
begin 644 image_1011.jpg
MB5!.1PT*&@H    -24A$4@  !#<    !" (   !%0](C    &DE$051X7NW!
F(0$    "(/^?UAL&( 4  '@R/SN9$!(T$B<     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>40
<FILENAME>image_102.jpg
<TEXT>
begin 644 image_102.jpg
MB5!.1PT*&@H    -24A$4@  !KD    !" (   #EXU)0    &TE$051X7NW!
G 0$   ""H/Z?MB/  @    "H SQP& *##RD!     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>41
<FILENAME>image_1021.jpg
<TEXT>
begin 644 image_1021.jpg
MB5!.1PT*&@H    -24A$4@  !#(    !" (   "C:AEG    &DE$051X7NW!
F(0$    "(/^?UAD6( 4  +@:KUN*'[1G1(4     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>42
<FILENAME>image_103.jpg
<TEXT>
begin 644 image_103.jpg
MB5!.1PT*&@H    -24A$4@   4     !" (    @@>"     $4E$051X7F/X
=/PI&P2@8L@  0PZ\;C&K22P     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>43
<FILENAME>image_1041.jpg
<TEXT>
begin 644 image_1041.jpg
MB5!.1PT*&@H    -24A$4@   7D    !" (   "T9TER    $DE$051X7F/X
>/PI&P2@8!;0' &//9M+52TXL     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>44
<FILENAME>image_108.jpg
<TEXT>
begin 644 image_108.jpg
MB5!.1PT*&@H    -24A$4@   6,    !" (   "$ZUA3    $DE$051X7F/X
>/PI&P2@8!80  #D\)13:3(+*     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>45
<FILENAME>image_11.jpg
<TEXT>
begin 644 image_11.jpg
MB5!.1PT*&@H    -24A$4@   A<    '" (    T\OBM    0$E$051X7NW5
MH0T ,0#$L.Z_])='.NEY;1Z<\_UV "#ZBJTE /056TL Z"NVE@#05VPM :"O
?V%H"0%^QM03@>1?_/B3J[LDI"P    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>46
<FILENAME>image_1111.jpg
<TEXT>
begin 644 image_1111.jpg
MB5!.1PT*&@H    -24A$4@   5T    !" (   #RT>K8    $DE$051X7F/X
>/PI&P2@8!:@  #8=$R;R=BU6     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>47
<FILENAME>image_112.jpg
<TEXT>
begin 644 image_112.jpg
MB5!.1PT*&@H    -24A$4@   J8    !" (   "#G_NW    %TE$051X7F/X
C/PI&P2@8!:-@%(R"$0  IH+J>$>B3N\     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>48
<FILENAME>image_1121.jpg
<TEXT>
begin 644 image_1121.jpg
MB5!.1PT*&@H    -24A$4@   ?0    !" (   "GG,O#    %$E$051X7F/X
@/PI&P2@8!:-@V $ 3QK6<(BW[@<     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>49
<FILENAME>image_114.jpg
<TEXT>
begin 644 image_114.jpg
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MAVA,R3N/4_=*B;AB @^Z9'^S=BE\$7%$#D@,G% N^&[HQGTE:;Z&0X$(Y3A
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MNU[:P+FA\8]M7G$[D:=-Q)&J*[FO,#ZS N^0Z Z;8P)#D52_N$!FD=XZ<.!
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M=\:P52).3L3A9++)7W08HA'SDI74N[/)#&P$TDDE<Z0>M6T?D:I+C6ATZD9
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MC9 WVVRS3:HD0M.A1%ST4"*N^$0<.@RIIJ>>>JI9FZW90M(1AXB3[#?(NKS
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MD;$(X-U*TFHP@I-XVK( Q"+&IJT+$LH*Q7&E4"+.#^J!B'OQQ1>MYX-O[TH
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MH.W?0/HG 7(0,A4CV"4R,(^!/$(W0_:GT>VR[$0<@("!3$CZ7;@O7(WV6F>
M[*.T(K4@T/;<<\_4B&;6%][W<4B1I@.RCXCTM$#63]QYH7^$:T,'J!84A"X=
MIP1!UD0<X+W"QR3]]LAVWDE2^<[[Y*S%_=[8<]A;."72V,L,[G+61J2\I+F$
M;5#_$?N[$DY$'$")Q7AP\1#87CR+(Q*'P49/*Q2<YY#NXJNS6XA&(>( WAM)
MI\RX0XDX-Q 5B@<GSGF#7./R;]NVK?%\0!2AN.+=YN*%P(ASUCBC*+=9A6S[
M!L)[YLR9B<FXR@&9'<HTABO164N>4:\G;:>"$G%^4.]$'" :AA#Z(AB@1,(A
MZ].(+L*8CQL)D,: B*>D0V6J#0Y(6P0BCE 7HU>)N&P']S1U/C'V?'9FJP:?
M1!S[E$B/-.ZQ.(.[#_*<,@Z5]5DE]9YP2"8%Q!_9/!#G<2+HLQXX;TF13%JC
M6XFXKX <)34O[ZA(""2BR](@64.@_T)\D.*<EEV?UH"$HPYRFK8&$>PN*9*N
MHYZ(.-XK-O\^^^R3^][F][%+B:9+HH\@J_G&V+Q%VL]A7>-J$=K.1!Q Z.*9
M3=-P37L@L(@^R:*;8R,1<0#/O*_OHD2<.U \*<R;-#(E#4&",HQWO-& ,H)G
MD LI;]E5;>!E),S;AW&G1)P?- (1!U!L((E<.JVE/2#-, K3 N<=LB1)9&J<
M 4&/Q_?AAQ]>;TZ<+UMI -=R $K$93.0SZ1)$O6<5P=QGT0<0 ]!IB6-Z'$=
MW#UGG'&&*>?0%!3SMOU[:DLE05A8GGT(N9/W7I,.C%":2R5Q7"@1]PU(2:,\
M4QY.*8AH(AU)B?,%2CVPQR&_\MZ[K!?BTT>':>Q* G1\S;V>B+@0Z-[4J<Y:
MMH<#O8@R!6EUJ@?<PP2QN-0\]S60&011T.BO&F(1<0!/.2FE1;R8"(\DE-RU
MFTQ<-!H11PHR[:I]?!LEXN(!96K&C!GB8L8^!B0<Z:QI>N.*!CPI1 X6J4 S
MQCGD>-).5;6@1)P?- H1!S#"B8)%.<YZ_T, HJ0F[6S5%)!QR-2L(EPX W1M
MI=MX-4#.V>:"D>2BY"L1YW]0OXAZAR^^^&*N[\DW$0?0#6D\X5KC*>X@HI_O
M7TN7Y_S:GM&]>_=$:T;GH7%6TFA [E!2IL(AK<>;9$"B$1D7%TK$?1N4!*%)
M2!HIERZ#\C%9- [ Z4:],PC'/$D92E<U3=]+$Z3V)BV346O4(Q$'T+\)L,K:
MQN0[T/R#=Y:V'L)^1F^%1_#UO6T#N4\F0S5'4HC81!S@I5&,F2ZF%(_,8Y&5
M@XN- YQEIQ/0:$0<X,*A6URM//BX0XFX^&!/<X$@C+,DBE"Z*<B*H5%D@RTM
M0'A1#!H"(,_09@0XI""AS&D57ZX&)>+\H)&(N! 8XD3G4C/#MPSB[AD\>+ 7
M!2T$,I6F.&D8VE'KZ-V[=[!V[=K(<\PZ(1ZBGL5]YU)\7HFX= =&"AYV[F#.
M 9TUB20IPOO+@H@#[&&Z/-)DQ4<]8>Y<RJ.0T<*=$*7+0Y+9GD>SN#@D/H3Y
M66>=):Y138D=B'(B'\:.'1O,GS_?./9H.$=J+X.]$@[F%/YW= Y^C[^_;-DR
M0S#2L9-O2J0E<B$N,8)M1MVD.'M4B;CUP?[':4*M7Y^$'&>+*#BZ<"=-,79%
M2,AQ;_&>L]"#.3]T3H:0"FM ^@)G#M(IS>[8X:A7(@ZPMR&ND&&^,[#8W]1+
M8]UQ&F^Y "Z!L@8TU/*9EEPYX*-PTI%:;=O/B8BX$/P(1AI-$?*(V,$@(*P2
M<B1MK[D$C4C$ ;XK]0C..^\\D>%G^T8< (QR*92(JPX(L3///#,3CRH*()V
M4";+!"XDE&*Z6J51H--UM&G3QG3E\7GIAE BS@\:D8@+ 7E%=)</I0;C!@.
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M% J%0J%0*!0*1>GQQS_^,9@\>7*PPPX[Y$ZNN0RZH_[F-[])O5:=0J%0*/Q
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GH5 H% J%0J%0*!0*A4*AR #_#V9OGJ0;@7[_     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>50
<FILENAME>image_121.jpg
<TEXT>
begin 644 image_121.jpg
MB5!.1PT*&@H    -24A$4@   A<    '" (    T\OBM    0$E$051X7NW5
MH0T ,0#$L.Z_])='.NEY;1Z<\_UV "#ZBJTE /056TL Z"NVE@#05VPM :"O
?V%H"0%^QM03@>1?_/B3J[LDI"P    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>51
<FILENAME>image_13.jpg
<TEXT>
begin 644 image_13.jpg
MB5!.1PT*&@H    -24A$4@  !JD    '" (    4%#"E    4DE$051X7NW8
MP0T $   ,?LO38*G!5S:,3KF-@    " _YWNN^GG_@     @P_T!    0)/[
M P   ( F]P<     38_[ P    !BW!\     -"T3J"H) R@JIP    !)14Y$
$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>52
<FILENAME>image_133.jpg
<TEXT>
begin 644 image_133.jpg
MB5!.1PT*&@H    -24A$4@  !KL    !" (   #A%H)M    '$E$051X7NW!
H(0$    "(/^?UN0+( 4     N 'A9QW\##[570    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>53
<FILENAME>image_141.jpg
<TEXT>
begin 644 image_141.jpg
MB5!.1PT*&@H    -24A$4@   [<    '" (   !<)"V\    4DE$051X7NW6
MH1' ,  #L>R_=,--'>*>-,#C/]\[!P  _B%7MY!I   8E:M;R#0  (S*U2UD
M&@  1N7J%C(-  "C<G4+F08 @%&YNH5, P# I@M$< L2_-^4"     !)14Y$
$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>54
<FILENAME>image_142.jpg
<TEXT>
begin 644 image_142.jpg
MB5!.1PT*&@H    -24A$4@   JT    !" (   ![?P!     %TE$051X7F/X
C/PI&P2@8!:-@%(R"D0H R9__8Z1$?_4     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>55
<FILENAME>image_152.jpg
<TEXT>
begin 644 image_152.jpg
MB5!.1PT*&@H    -24A$4@   D4    !" (   !?2DW%    %DE$051X7F/X
B/PI&P2@8!:-@% Q]  !(3<B,0SS2%0    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>56
<FILENAME>image_162.jpg
<TEXT>
begin 644 image_162.jpg
MB5!.1PT*&@H    -24A$4@  !-,    !" (   ![2G\H    &TE$051X7NW!
G(0$    "(/^?UA4V( 4  ("G 3\V:UJ'S30T     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>57
<FILENAME>image_172.jpg
<TEXT>
begin 644 image_172.jpg
MB5!.1PT*&@H    -24A$4@   A4    !" (   #F7LN-    %4E$051X7F/X
A/PI&P2@8!:-@%) . (4..1R;\G&A     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>58
<FILENAME>image_18.jpg
<TEXT>
begin 644 image_18.jpg
MB5!.1PT*&@H    -24A$4@   @0    !" (    N,B%;    %$E$051X7F/X
@/PI&P2@8!:-@Q , &B4&3X&[#*D     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>59
<FILENAME>image_21.jpg
<TEXT>
begin 644 image_21.jpg
MB5!.1PT*&@H    -24A$4@  !.(    !" (   #\>Y8N    &TE$051X7NW!
G(0$    "(/^?UAL&( 4  ( ; R96F"WJ_ LZ     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>60
<FILENAME>image_211.jpg
<TEXT>
begin 644 image_211.jpg
MB5!.1PT*&@H    -24A$4@   ?\    !" (   !??# T    %$E$051X7F/X
@/PI&P2@8!:-@Y $ )!OW3S!H \H     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>61
<FILENAME>image_22.jpg
<TEXT>
begin 644 image_22.jpg
MB5!.1PT*&@H    -24A$4@  !3<    !" (   "$S0WC    &TE$051X7NW!
G(0$    "(/^?UAL&( 4    ^#,OSECW/2=D8     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>62
<FILENAME>image_25.jpg
<TEXT>
begin 644 image_25.jpg
MB5!.1PT*&@H    -24A$4@   ?T    !" (   !;B> )    %$E$051X7F/X
@/PI&P2@8!:-@) $ 9MCQ5?6Y>A(     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>63
<FILENAME>image_32.jpg
<TEXT>
begin 644 image_32.jpg
MB5!.1PT*&@H    -24A$4@   =H    !" (   #V"/B@    %$E$051X7F/X
@/PI&P2@8!:-@$   I16(OE9CE4(     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>64
<FILENAME>image_34.jpg
<TEXT>
begin 644 image_34.jpg
MB5!.1PT*&@H    -24A$4@   AP    !" (    :2^!'    %DE$051X7F/X
B/PI&P2@8!:-@%% )   :S4X'SA!Y:     !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>65
<FILENAME>image_35.jpg
<TEXT>
begin 644 image_35.jpg
MB5!.1PT*&@H    -24A$4@  !7L    !" (     2^K-    &TE$051X7NW!
G(0$    "(/^?UA-&( 4   !X&^RH88 =R?'[     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>66
<FILENAME>image_38.jpg
<TEXT>
begin 644 image_38.jpg
MB5!.1PT*&@H    -24A$4@   <P    !" (   #<N D/    %$E$051X7F/X
@/PI&P2@8!:. 9@  CF]>Z"$T!M,     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>67
<FILENAME>image_391.jpg
<TEXT>
begin 644 image_391.jpg
MB5!.1PT*&@H    -24A$4@  #+(    !" (   #_K/$C    ($E$051X7NW!
L 0D    "H/Z?KA^AI@           !P9(SWR%F)X[3P     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>68
<FILENAME>image_40.jpg
<TEXT>
begin 644 image_40.jpg
MB5!.1PT*&@H    -24A$4@  !"D    !" (   !\)&-X    &DE$051X7NW!
F(0$    "(/^?UA4V( 4  /@;>O1O.JYJ)1<     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>69
<FILENAME>image_411.jpg
<TEXT>
begin 644 image_411.jpg
MB5!.1PT*&@H    -24A$4@  !",    !" (   !K!O.Q    &DE$051X7NW!
F(0$    "(/^?UA-&( 4  '@;0-Y=3%^?G5<     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>70
<FILENAME>image_42.jpg
<TEXT>
begin 644 image_42.jpg
MB5!.1PT*&@H    -24A$4@   7     !" (   !(<F*X    $DE$051X7F/X
>/PI&P2@8!50" .BT2^UREKC1     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>71
<FILENAME>image_43.jpg
<TEXT>
begin 644 image_43.jpg
MB5!.1PT*&@H    -24A$4@   6L    !" (   "7/!BG    $DE$051X7F/X
>/PI&P2@8!>0" -XL//Q^;7:'     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>72
<FILENAME>image_441.jpg
<TEXT>
begin 644 image_441.jpg
MB5!.1PT*&@H    -24A$4@   V8    !" (    ZKBK6    &4E$051X7NW!
E 0$    !(/]/\\""*@4 @&L0.RAEK'NMEP    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>73
<FILENAME>image_45.jpg
<TEXT>
begin 644 image_45.jpg
MB5!.1PT*&@H    -24A$4@   5D    !" (   #[.DJB    $TE$051X7F/X
?/PI&P2@8!?__ P"2! <RW<.U_0    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>74
<FILENAME>image_451.jpg
<TEXT>
begin 644 image_451.jpg
MB5!.1PT*&@H    -24A$4@   U8    !" (   !27:CN    &$E$051X7NW!
D 0$    !(/]/,T25 @!P9N"G^(:Q-;?L     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>75
<FILENAME>image_47.jpg
<TEXT>
begin 644 image_47.jpg
MB5!.1PT*&@H    -24A$4@   5\    !" (   #V)#KE    $DE$051X7F/X
>/PI&P2@8!=@  +WL&2"#S)@?     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>76
<FILENAME>image_471.jpg
<TEXT>
begin 644 image_471.jpg
MB5!.1PT*&@H    -24A$4@  !)<    !" (   #L&]CR    &DE$051X7NW!
F 0D    "H/Z?KAV!F@(  /!C<CVW_U<KF?L     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>77
<FILENAME>image_481.jpg
<TEXT>
begin 644 image_481.jpg
MB5!.1PT*&@H    -24A$4@   MP    !" (   !B].[F    &4E$051X7F/X
E/PI&P2@8!:-@%(R"43 (  !QEXOEI6!_N@    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>78
<FILENAME>image_491.jpg
<TEXT>
begin 644 image_491.jpg
MB5!.1PT*&@H    -24A$4@   Q,    !" (    JSF0*    &4E$051X7NW!
E 0$    !(/]/<\& *@4 X#/N$C!/ =4+K@    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>79
<FILENAME>image_501.jpg
<TEXT>
begin 644 image_501.jpg
MB5!.1PT*&@H    -24A$4@  !,X    !" (   "I&G5P    &TE$051X7NW!
G(0$    "(/^?UA-&( 4  ("K 5TM7&G:*QA=     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>80
<FILENAME>image_511.jpg
<TEXT>
begin 644 image_511.jpg
MB5!.1PT*&@H    -24A$4@   ?0    !" (   "GG,O#    %$E$051X7F/X
@/PI&P2@8!:-@V $ 3QK6<(BW[@<     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>81
<FILENAME>image_512.jpg
<TEXT>
begin 644 image_512.jpg
MB5!.1PT*&@H    -24A$4@   J4    !" (   !HJ$"T    %TE$051X7F/X
C/PI&P2@8!:-@%(R"X0X Z>KG>[#"Z$(     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>82
<FILENAME>image_52.jpg
<TEXT>
begin 644 image_52.jpg
MB5!.1PT*&@H    -24A$4@   HP    !" (   #;X&BN    %TE$051X7F/X
C/PI&P2@8!:-@%(R"00D X;.<QC6N64@     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>83
<FILENAME>image_521.jpg
<TEXT>
begin 644 image_521.jpg
MB5!.1PT*&@H    -24A$4@   M$    !" (   "7"F56    &4E$051X7F/X
E/PI&P2@8!:-@%(R"44![  !V$FL&R>2%8     !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>84
<FILENAME>image_55.jpg
<TEXT>
begin 644 image_55.jpg
MB5!.1PT*&@H    -24A$4@   C$    !" (   "@Z&@G    %DE$051X7F/X
B/PI&P2@8!:-@% P.   H.XS($$+TR@    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>85
<FILENAME>image_56.jpg
<TEXT>
begin 644 image_56.jpg
MB5!.1PT*&@H    -24A$4@  ! H    !" (   #83MNK    &DE$051X7NW!
F 0D    "H/Z?+FB'F@(  -P ML02E]["V%,     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>86
<FILENAME>image_57.jpg
<TEXT>
begin 644 image_57.jpg
MB5!.1PT*&@H    -24A$4@   V(    !" (    S18JL    &4E$051X7NW!
E 0$    !(/]/,\"%*@4 @#-M'QQQ$8%; P    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>87
<FILENAME>image_58.jpg
<TEXT>
begin 644 image_58.jpg
MB5!.1PT*&@H    -24A$4@   DP    !" (   "C7V8/    %DE$051X7F/X
B/PI&P2@8!:-@% Q3  "BX=UWJ,18#     !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>88
<FILENAME>image_59.jpg
<TEXT>
begin 644 image_59.jpg
MB5!.1PT*&@H    -24A$4@   C8    !" (   !"-'->    %DE$051X7F/X
B/PI&P2@8!:-@% Q*  #?\YNY!HJ)>@    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>89
<FILENAME>image_60.jpg
<TEXT>
begin 644 image_60.jpg
MB5!.1PT*&@H    -24A$4@  !(8    !" (    D=S(D    &DE$051X7NW!
F(0$    "(/^?UAD6( 4  .!DOI6%,J.+6[L     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>90
<FILENAME>image_611.jpg
<TEXT>
begin 644 image_611.jpg
MB5!.1PT*&@H    -24A$4@  !)L    !" (   #V)SA\    &DE$051X7NW!
F 0D    "H/Z?KAV!F@(  /!I8&K#\\R=UJ(     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>91
<FILENAME>image_62.jpg
<TEXT>
begin 644 image_62.jpg
MB5!.1PT*&@H    -24A$4@   O$    !" (   #85V:&    &4E$051X7F/X
E/PI&P2@8!:-@%(R"43#T 0"YB,JF;]:P>     !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>92
<FILENAME>image_631.jpg
<TEXT>
begin 644 image_631.jpg
MB5!.1PT*&@H    -24A$4@  !GT    !" (   "4M_R+    '$E$051X7NW!
H(0$    "(/^?UA-&( 4     W@8,S&2G9;^#'P    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>93
<FILENAME>image_64.jpg
<TEXT>
begin 644 image_64.jpg
MB5!.1PT*&@H    -24A$4@   O,    !" (   #<HK:[    &4E$051X7F/X
E/PI&P2@8!:-@%(R"43!<  ".HM"@T::B%     !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>94
<FILENAME>image_65.jpg
<TEXT>
begin 644 image_65.jpg
MB5!.1PT*&@H    -24A$4@   KL    !" (   !1S_'O    &4E$051X7F/X
E/PI&P2@8!:-@%(R"44 (   V""E(S>IP70    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>95
<FILENAME>image_66.jpg
<TEXT>
begin 644 image_66.jpg
MB5!.1PT*&@H    -24A$4@  !P0    !" (   !?98T9    &TE$051X7NW!
G 0$    !(/]/,T25 @     <&$KI^"$5="76     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>96
<FILENAME>image_67.jpg
<TEXT>
begin 644 image_67.jpg
MB5!.1PT*&@H    -24A$4@   M@    !" (   !K'TZ<    &4E$051X7F/X
E/PI&P2@8!:-@%(R"43!    D/W_QDS9'*     !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>97
<FILENAME>image_68.jpg
<TEXT>
begin 644 image_68.jpg
MB5!.1PT*&@H    -24A$4@   J\    !" (   !_BM!]    %TE$051X7F/X
C/PI&P2@8!:-@%(R"D0T VS8%;.L4HA      245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>98
<FILENAME>image_710.jpg
<TEXT>
begin 644 image_710.jpg
MB5!.1PT*&@H    -24A$4@  !2\    '" (   !F[2_B    2DE$051X7NW7
ML0T ( ##,/Y_&B9 8B>3/57J!1D#    2,SM/0   (!/U#@   #4;HV?!0
I #34.    -34.    -34.    -06JB$45#=,<G$     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>99
<FILENAME>image_711.jpg
<TEXT>
begin 644 image_711.jpg
MB5!.1PT*&@H    -24A$4@   J8    !" (   "#G_NW    %TE$051X7F/X
C/PI&P2@8!:-@%(R"$0  IH+J>$>B3N\     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>100
<FILENAME>image_79.jpg
<TEXT>
begin 644 image_79.jpg
MB5!.1PT*&@H    -24A$4@   ?\    !" (   !??# T    %$E$051X7F/X
@/PI&P2@8!:-@Y $ )!OW3S!H \H     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>101
<FILENAME>image_8.jpg
<TEXT>
begin 644 image_8.jpg
MB5!.1PT*&@H    -24A$4@  !5\    !" (   !&_4EG    &DE$051X7NW!
F 0$    !(/]/,T25 @   -\&??P-U*V[$1L     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>102
<FILENAME>image_81.jpg
<TEXT>
begin 644 image_81.jpg
MB5!.1PT*&@H    -24A$4@  !5\    !" (   !&_4EG    &DE$051X7NW!
F 0$    !(/]/,T25 @   -\&??P-U*V[$1L     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>103
<FILENAME>image_810.jpg
<TEXT>
begin 644 image_810.jpg
MB5!.1PT*&@H    -24A$4@  !3(    '" (   "TO26Z    2TE$051X7NW7
ML0T ( P#L/[_-$C R)PL]A>>=0P    0<2?^/J[E    D*3E    4*/E
J4*/E    4/-I.0   )"GY0   %"S 9&N:$R!36N$     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>104
<FILENAME>image_821.jpg
<TEXT>
begin 644 image_821.jpg
MB5!.1PT*&@H    -24A$4@   =H    !" (   #V"/B@    %$E$051X7F/X
@/PI&P2@8!:-@$   I16(OE9CE4(     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>105
<FILENAME>image_92.jpg
<TEXT>
begin 644 image_92.jpg
MB5!.1PT*&@H    -24A$4@   E,    !" (   !U^KQJ    %DE$051X7F/X
B/PI&P2@8!:-@%(PD  "TVO)B\+WMQP    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>106
<FILENAME>image_921.jpg
<TEXT>
begin 644 image_921.jpg
MB5!.1PT*&@H    -24A$4@   ?T    !" (   !;B> )    %$E$051X7F/X
@/PI&P2@8!:-@) $ 9MCQ5?6Y>A(     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>107
<FILENAME>image_931.jpg
<TEXT>
begin 644 image_931.jpg
MB5!.1PT*&@H    -24A$4@   AP    !" (    :2^!'    %DE$051X7F/X
B/PI&P2@8!:-@%% )   :S4X'SA!Y:     !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>108
<FILENAME>image_97.jpg
<TEXT>
begin 644 image_97.jpg
MB5!.1PT*&@H    -24A$4@   <P    !" (   #<N D/    %$E$051X7F/X
@/PI&P2@8!:. 9@  CF]>Z"$T!M,     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101991665912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Feb. 02, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">0-19271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">IDEXX LABORATORIES INC /DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">01-0393723<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">One IDEXX Drive<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Westbrook,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">ME<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">04092<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">207<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">556-0300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.10 par value per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">IDXX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 53,417,914,936<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84,249,085<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text"><div style="margin-top:5pt;text-align:center;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Part III&#8212;Specifically identified portions of the Company&#8217;s definitive Proxy Statement to be filed in connection with the Company&#8217;s 2022 annual meeting of stockholders (the &#8220;2022 Annual Meeting&#8221;), to be held on May 11, 2022, are incorporated herein by referenc</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">e.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000874716<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140102080379288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_AuditInformationAbstract', window );"><strong>Audit Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">PricewaterhouseCoopers LLP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">238<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Boston, Massachusetts<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_AuditInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Audit Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_AuditInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>idxx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101988008984">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 144,454<span></span>
</td>
<td class="nump">$ 383,928<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowance of $5,668 in 2021 and $6,784 in 2020</a></td>
<td class="nump">368,348<span></span>
</td>
<td class="nump">331,429<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">269,030<span></span>
</td>
<td class="nump">209,873<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">173,823<span></span>
</td>
<td class="nump">137,508<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">955,655<span></span>
</td>
<td class="nump">1,062,738<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>Long-Term Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">587,667<span></span>
</td>
<td class="nump">555,167<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">105,101<span></span>
</td>
<td class="nump">91,171<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">359,345<span></span>
</td>
<td class="nump">243,347<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">99,035<span></span>
</td>
<td class="nump">52,543<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets</a></td>
<td class="nump">330,400<span></span>
</td>
<td class="nump">289,595<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total long-term assets</a></td>
<td class="nump">1,481,548<span></span>
</td>
<td class="nump">1,231,823<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">2,437,203<span></span>
</td>
<td class="nump">2,294,561<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">116,140<span></span>
</td>
<td class="nump">74,558<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">458,909<span></span>
</td>
<td class="nump">415,648<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LinesOfCreditCurrent', window );">Line of credit</a></td>
<td class="nump">73,500<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">74,996<span></span>
</td>
<td class="nump">49,988<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Current portion of deferred revenue</a></td>
<td class="nump">40,034<span></span>
</td>
<td class="nump">42,567<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">763,579<span></span>
</td>
<td class="nump">582,761<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Long-Term Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income tax liabilities</a></td>
<td class="nump">8,935<span></span>
</td>
<td class="nump">11,707<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, net of current portion</a></td>
<td class="nump">775,205<span></span>
</td>
<td class="nump">858,492<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Long-term deferred revenue, net of current portion</a></td>
<td class="nump">41,174<span></span>
</td>
<td class="nump">46,163<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">87,377<span></span>
</td>
<td class="nump">77,039<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">70,941<span></span>
</td>
<td class="nump">85,604<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total long-term liabilities</a></td>
<td class="nump">983,632<span></span>
</td>
<td class="nump">1,079,005<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">1,747,211<span></span>
</td>
<td class="nump">1,661,766<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies (Note 16)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Stockholders&#8217; Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.10 par value: Authorized: 120,000 shares; Issued: 106,878 shares in 2021 and 106,457 shares in 2020; Outstanding: 84,562 shares in 2021 and 85,449 shares in 2020</a></td>
<td class="nump">10,688<span></span>
</td>
<td class="nump">10,646<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">1,377,320<span></span>
</td>
<td class="nump">1,294,849<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockOtherValueOutstanding', window );">Deferred stock units: Outstanding: 90 units in 2021 and 87 units in 2020</a></td>
<td class="nump">5,719<span></span>
</td>
<td class="nump">4,503<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">2,920,440<span></span>
</td>
<td class="nump">2,175,595<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(53,484)<span></span>
</td>
<td class="num">(53,615)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost: 22,317 shares in 2021 and 21,008 shares in 2020</a></td>
<td class="num">(3,570,691)<span></span>
</td>
<td class="num">(2,799,890)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total IDEXX Laboratories, Inc. stockholders&#8217; equity</a></td>
<td class="nump">689,992<span></span>
</td>
<td class="nump">632,088<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">707<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">689,992<span></span>
</td>
<td class="nump">632,795<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</a></td>
<td class="nump">$ 2,437,203<span></span>
</td>
<td class="nump">$ 2,294,561<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockOtherValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of shares of other common stock instruments held by shareholders, such as exchangeable shares. May be all or portion of the number of common shares authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockOtherValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LinesOfCreditCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LinesOfCreditCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101991643800">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Accounts receivable, allowance</a></td>
<td class="nump">$ 5,668<span></span>
</td>
<td class="nump">$ 6,784<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in USD per share)</a></td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">120,000,000<span></span>
</td>
<td class="nump">120,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">106,878,000<span></span>
</td>
<td class="nump">106,457,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">84,562,000<span></span>
</td>
<td class="nump">85,449,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockOtherSharesOutstanding', window );">Deferred stock units, outstanding (in shares)</a></td>
<td class="nump">90,000<span></span>
</td>
<td class="nump">87,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, shares (in shares)</a></td>
<td class="nump">22,317,000<span></span>
</td>
<td class="nump">21,008,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockOtherSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of shares of other common stock instruments held by shareholders, such as exchangeable shares. May be all or portion of the number of common shares authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockOtherSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101991686568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF INCOME - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 3,215,360<span></span>
</td>
<td class="nump">$ 2,706,655<span></span>
</td>
<td class="nump">$ 2,406,908<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Cost of Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Total cost of revenue</a></td>
<td class="nump">1,325,928<span></span>
</td>
<td class="nump">1,135,615<span></span>
</td>
<td class="nump">1,041,359<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">1,889,432<span></span>
</td>
<td class="nump">1,571,040<span></span>
</td>
<td class="nump">1,365,549<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="nump">486,735<span></span>
</td>
<td class="nump">434,435<span></span>
</td>
<td class="nump">418,193<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">309,660<span></span>
</td>
<td class="nump">300,832<span></span>
</td>
<td class="nump">261,317<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">161,009<span></span>
</td>
<td class="nump">141,249<span></span>
</td>
<td class="nump">133,193<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">932,028<span></span>
</td>
<td class="nump">694,524<span></span>
</td>
<td class="nump">552,846<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(29,808)<span></span>
</td>
<td class="num">(33,125)<span></span>
</td>
<td class="num">(31,055)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestAndOtherIncome', window );">Interest income</a></td>
<td class="nump">434<span></span>
</td>
<td class="nump">586<span></span>
</td>
<td class="nump">427<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before provision for income taxes</a></td>
<td class="nump">902,654<span></span>
</td>
<td class="nump">661,985<span></span>
</td>
<td class="nump">522,218<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">157,810<span></span>
</td>
<td class="nump">79,854<span></span>
</td>
<td class="nump">94,426<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">744,844<span></span>
</td>
<td class="nump">582,131<span></span>
</td>
<td class="nump">427,792<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net (loss) income attributable to noncontrolling interest</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">355<span></span>
</td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to IDEXX Laboratories, Inc. stockholders</a></td>
<td class="nump">$ 744,845<span></span>
</td>
<td class="nump">$ 581,776<span></span>
</td>
<td class="nump">$ 427,720<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings per Share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in USD per share)</a></td>
<td class="nump">$ 8.74<span></span>
</td>
<td class="nump">$ 6.82<span></span>
</td>
<td class="nump">$ 4.97<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in USD per share)</a></td>
<td class="nump">$ 8.60<span></span>
</td>
<td class="nump">$ 6.71<span></span>
</td>
<td class="nump">$ 4.89<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_WeightedAverageSharesOutstandingAbstract', window );"><strong>Weighted Average Shares Outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">85,200<span></span>
</td>
<td class="nump">85,342<span></span>
</td>
<td class="nump">86,115<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">86,572<span></span>
</td>
<td class="nump">86,722<span></span>
</td>
<td class="nump">87,542<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 1,875,308<span></span>
</td>
<td class="nump">$ 1,586,809<span></span>
</td>
<td class="nump">$ 1,423,144<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Cost of Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Total cost of revenue</a></td>
<td class="nump">656,823<span></span>
</td>
<td class="nump">557,795<span></span>
</td>
<td class="nump">506,202<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">1,340,052<span></span>
</td>
<td class="nump">1,119,846<span></span>
</td>
<td class="nump">983,764<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Cost of Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Total cost of revenue</a></td>
<td class="nump">$ 669,105<span></span>
</td>
<td class="nump">$ 577,820<span></span>
</td>
<td class="nump">$ 535,157<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_WeightedAverageSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Shares Outstanding [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_WeightedAverageSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>idxx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndOtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndOtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101988525128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 744,844<span></span>
</td>
<td class="nump">$ 582,131<span></span>
</td>
<td class="nump">$ 427,792<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Other comprehensive income (loss), net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="num">(26,731)<span></span>
</td>
<td class="nump">15,151<span></span>
</td>
<td class="num">(1,590)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax', window );">Unrealized gain (loss) on Euro-denominated notes, net of tax expense (benefit) of $2,011 in 2021, $(2,325) in 2020 and $564 in 2019</a></td>
<td class="nump">6,404<span></span>
</td>
<td class="num">(7,378)<span></span>
</td>
<td class="nump">1,790<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized gain (loss) on investments, net of tax expense (benefit) of $46 in 2021, $(120) in 2020 and $84 in 2019</a></td>
<td class="nump">146<span></span>
</td>
<td class="num">(382)<span></span>
</td>
<td class="nump">267<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Unrealized gain (loss) on derivative instruments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Unrealized gain (loss) on foreign currency exchange contracts, net of tax expense (benefit) of $2,133 in 2021, $(2,013) in 2020 and $362 in 2019</a></td>
<td class="nump">9,139<span></span>
</td>
<td class="num">(8,527)<span></span>
</td>
<td class="nump">1,196<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax', window );">Unrealized gain (loss) on cross currency swaps, net of tax expense of $1,699 in 2021, $(1,774) in 2020 and $664 in 2019</a></td>
<td class="nump">5,399<span></span>
</td>
<td class="num">(5,626)<span></span>
</td>
<td class="nump">2,107<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Reclassification adjustment for (gain) loss included in net income, net of tax (expense) benefit of $1,347 in 2021, $(158) in 2020 and $(2,467) in 2019</a></td>
<td class="nump">5,774<span></span>
</td>
<td class="num">(671)<span></span>
</td>
<td class="num">(8,161)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossAfterReclassificationAndTax', window );">Unrealized gain (loss) on derivative instruments</a></td>
<td class="nump">20,312<span></span>
</td>
<td class="num">(14,824)<span></span>
</td>
<td class="num">(4,858)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive gain (loss), net of tax</a></td>
<td class="nump">131<span></span>
</td>
<td class="num">(7,433)<span></span>
</td>
<td class="num">(4,391)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income</a></td>
<td class="nump">744,975<span></span>
</td>
<td class="nump">574,698<span></span>
</td>
<td class="nump">423,401<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Less: comprehensive income attributable to noncontrolling interest</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">355<span></span>
</td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income attributable to IDEXX Laboratories, Inc.</a></td>
<td class="nump">$ 744,976<span></span>
</td>
<td class="nump">$ 574,343<span></span>
</td>
<td class="nump">$ 423,329<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss), Cash Flow Hedge And Net Investment Hedge, Gain (Loss), After Reclassification And Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>idxx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss), Net Investment Hedge, Cross Currency Swaps, Gain (Loss), Before Reclassification, After Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>idxx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss), Net Investment Hedge, Euro-Denominated Notes, Gain (Loss), After Reclassification And Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>idxx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101990046792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationTax', window );">Unrealized gain (loss) on Euro-denominated notes, tax expense (benefit)</a></td>
<td class="nump">$ 2,011<span></span>
</td>
<td class="num">$ (2,325)<span></span>
</td>
<td class="nump">$ 564<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax', window );">Unrealized gain (loss) on investments, tax expense (benefit)</a></td>
<td class="nump">46<span></span>
</td>
<td class="num">(120)<span></span>
</td>
<td class="nump">84<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax', window );">Unrealized gain (loss) on foreign currency exchange contracts, tax expense (benefit)</a></td>
<td class="nump">2,133<span></span>
</td>
<td class="num">(2,013)<span></span>
</td>
<td class="nump">362<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationTax', window );">Unrealized gain (loss) on cross currency swaps, tax expense (benefit)</a></td>
<td class="nump">1,699<span></span>
</td>
<td class="num">(1,774)<span></span>
</td>
<td class="nump">664<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax', window );">Reclassification adjustment for (gain) loss included in net income, tax (expense) benefit</a></td>
<td class="nump">$ 1,347<span></span>
</td>
<td class="num">$ (158)<span></span>
</td>
<td class="num">$ (2,467)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss), Net Investment Hedge, Cross Currency Swaps, Gain (Loss), Before Reclassification, Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>idxx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss), Net Investment Hedge, Euro-Denominated Notes, Gain (Loss), After Reclassification, Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>idxx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after adjustment, of tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) for reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101983238968">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY (DEFICIT) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Cumulative Effect, Period of Adoption, Adjustment</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Deferred Stock Units</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th">
<div>Retained Earnings </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Treasury Stock</div></th>
<th class="th"><div>Noncontrolling Interest</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance beginning of period (in shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105,087<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance beginning of period at Dec. 31, 2018</a></td>
<td class="num">$ (9,233)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,509<span></span>
</td>
<td class="nump">$ 1,138,216<span></span>
</td>
<td class="nump">$ 4,524<span></span>
</td>
<td class="nump">$ 1,167,928<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (41,791)<span></span>
</td>
<td class="num">$ (2,288,899)<span></span>
</td>
<td class="nump">$ 280<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">427,792<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">427,720<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive gain (loss), net</a></td>
<td class="num">(4,391)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,391)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredParValueMethod', window );">Repurchases of common stock, net</a></td>
<td class="num">(311,644)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(311,644)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross', window );">Common stock issued under stock plans, net (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">624<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross', window );">Common stock issued under stock plans, net</a></td>
<td class="nump">36,023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 62<span></span>
</td>
<td class="nump">36,551<span></span>
</td>
<td class="num">(590)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_IssuanceVestingAndSettlementOfDeferredStockUnits', window );">Deferred stock units activity</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(324)<span></span>
</td>
<td class="nump">324<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation cost</a></td>
<td class="nump">39,278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,074<span></span>
</td>
<td class="nump">204<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance end of period (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105,711<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance end of period at Dec. 31, 2019</a></td>
<td class="nump">177,825<span></span>
</td>
<td class="num">$ (1,829)<span></span>
</td>
<td class="nump">$ 10,571<span></span>
</td>
<td class="nump">1,213,517<span></span>
</td>
<td class="nump">4,462<span></span>
</td>
<td class="nump">1,595,648<span></span>
</td>
<td class="num">$ (1,829)<span></span>
</td>
<td class="num">(46,182)<span></span>
</td>
<td class="num">(2,600,543)<span></span>
</td>
<td class="nump">352<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">582,131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">581,776<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">355<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive gain (loss), net</a></td>
<td class="num">(7,433)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,433)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredParValueMethod', window );">Repurchases of common stock, net</a></td>
<td class="num">(199,347)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(199,347)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross', window );">Common stock issued under stock plans, net (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">746<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross', window );">Common stock issued under stock plans, net</a></td>
<td class="nump">50,497<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75<span></span>
</td>
<td class="nump">51,368<span></span>
</td>
<td class="num">(946)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_IssuanceVestingAndSettlementOfDeferredStockUnits', window );">Deferred stock units activity</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(894)<span></span>
</td>
<td class="nump">894<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation cost</a></td>
<td class="nump">$ 30,951<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,858<span></span>
</td>
<td class="nump">93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance end of period (in shares) at Dec. 31, 2020</a></td>
<td class="nump">106,457<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106,457<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance end of period at Dec. 31, 2020</a></td>
<td class="nump">$ 632,795<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,646<span></span>
</td>
<td class="nump">1,294,849<span></span>
</td>
<td class="nump">4,503<span></span>
</td>
<td class="nump">2,175,595<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(53,615)<span></span>
</td>
<td class="num">(2,799,890)<span></span>
</td>
<td class="nump">707<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">744,844<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">744,845<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive gain (loss), net</a></td>
<td class="nump">131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Acquisition of noncontrolling interest (Note 4)</a></td>
<td class="num">(990)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(284)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(706)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredParValueMethod', window );">Repurchases of common stock, net</a></td>
<td class="num">(770,801)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(770,801)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross', window );">Common stock issued under stock plans, net (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">421<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross', window );">Common stock issued under stock plans, net</a></td>
<td class="nump">46,258<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42<span></span>
</td>
<td class="nump">46,228<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_IssuanceVestingAndSettlementOfDeferredStockUnits', window );">Deferred stock units activity</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,035)<span></span>
</td>
<td class="nump">1,035<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation cost</a></td>
<td class="nump">$ 37,755<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,562<span></span>
</td>
<td class="nump">193<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance end of period (in shares) at Dec. 31, 2021</a></td>
<td class="nump">106,878<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106,878<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance end of period at Dec. 31, 2021</a></td>
<td class="nump">$ 689,992<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,688<span></span>
</td>
<td class="nump">$ 1,377,320<span></span>
</td>
<td class="nump">$ 5,719<span></span>
</td>
<td class="nump">$ 2,920,440<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (53,484)<span></span>
</td>
<td class="num">$ (3,570,691)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_IssuanceVestingAndSettlementOfDeferredStockUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net deferred stock units which were issued, vested and settled during the period. Deferred stock units issued to employees will generally settle and convert to common stock not earlier than one year following their termination of employment or resignation. With respect to non-employee directors, deferred stock units issued prior to January 1, 2011 will generally settle and convert to common stock not earlier than one year from the date the recipients retire from the board. Deferred stock units issued to non-employee directors on or after January 1, 2011 will generally settle and convert to common stock: (i) not earlier than one year from the date the recipients retire from the board; or (ii) in a lump sum on another single non-discriminatory and objectively determinable date or in four equal annual installments commencing on that date. The shares of common stock associated with these deferred stock units are issuable for no cash consideration, the number of shares of common stock to be issued is fixed and issuance is not contingent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_IssuanceVestingAndSettlementOfDeferredStockUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>idxx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromRedemptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569655-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4616395-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromRedemptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredParValueMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the par value method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredParValueMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101989768776">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY (DEFICIT) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in USD per share)</a></td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101988410232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash Flows from Operating Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 744,844<span></span>
</td>
<td class="nump">$ 582,131<span></span>
</td>
<td class="nump">$ 427,792<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">104,596<span></span>
</td>
<td class="nump">95,998<span></span>
</td>
<td class="nump">88,011<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="nump">5,148<span></span>
</td>
<td class="nump">2,501<span></span>
</td>
<td class="nump">968<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForLoanLeaseAndOtherLosses', window );">Provision for uncollectible accounts</a></td>
<td class="nump">1,484<span></span>
</td>
<td class="nump">4,946<span></span>
</td>
<td class="nump">662<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndTaxCredits', window );">Deferred income taxes</a></td>
<td class="num">(3,377)<span></span>
</td>
<td class="num">(38,082)<span></span>
</td>
<td class="nump">6,162<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation expense</a></td>
<td class="nump">37,755<span></span>
</td>
<td class="nump">30,951<span></span>
</td>
<td class="nump">39,278<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Other</a></td>
<td class="nump">2,619<span></span>
</td>
<td class="nump">1,379<span></span>
</td>
<td class="nump">1,254<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(33,141)<span></span>
</td>
<td class="num">(60,722)<span></span>
</td>
<td class="num">(22,472)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(52,919)<span></span>
</td>
<td class="num">(18,885)<span></span>
</td>
<td class="num">(37,306)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade', window );">Accounts payable</a></td>
<td class="nump">11,233<span></span>
</td>
<td class="nump">981<span></span>
</td>
<td class="nump">1,957<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="num">(7,551)<span></span>
</td>
<td class="num">(13,373)<span></span>
</td>
<td class="num">(12,360)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other assets and liabilities</a></td>
<td class="num">(55,145)<span></span>
</td>
<td class="nump">60,238<span></span>
</td>
<td class="num">(34,788)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">755,546<span></span>
</td>
<td class="nump">648,063<span></span>
</td>
<td class="nump">459,158<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash Flows from Investing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(119,549)<span></span>
</td>
<td class="num">(106,958)<span></span>
</td>
<td class="num">(154,969)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_PaymentsToAcquireIntangibleAssetsAndEquityMethodInvestments', window );">Acquisitions of intangible assets and equity investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(918)<span></span>
</td>
<td class="num">(255)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisitions of businesses, net of cash acquired</a></td>
<td class="num">(173,418)<span></span>
</td>
<td class="num">(1,500)<span></span>
</td>
<td class="num">(50,304)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used by investing activities</a></td>
<td class="num">(292,967)<span></span>
</td>
<td class="num">(109,376)<span></span>
</td>
<td class="num">(205,528)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash Flows from Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit', window );">Borrowings (repayments) on revolving credit facilities, net</a></td>
<td class="nump">73,500<span></span>
</td>
<td class="num">(289,625)<span></span>
</td>
<td class="num">(110,275)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt', window );">Issuance of senior notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfSeniorDebt', window );">Payments of senior notes</a></td>
<td class="num">(50,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Debt issuance costs</a></td>
<td class="num">(2,650)<span></span>
</td>
<td class="num">(5,025)<span></span>
</td>
<td class="num">(154)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Purchase of minority interest</a></td>
<td class="num">(990)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchases of common stock, net</a></td>
<td class="num">(746,777)<span></span>
</td>
<td class="num">(182,815)<span></span>
</td>
<td class="num">(301,658)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Proceeds from exercises of stock options and employee stock purchase plans</a></td>
<td class="nump">46,565<span></span>
</td>
<td class="nump">51,328<span></span>
</td>
<td class="nump">36,106<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities', window );">Payment of acquisition-related contingent consideration and holdbacks</a></td>
<td class="num">(1,500)<span></span>
</td>
<td class="num">(1,676)<span></span>
</td>
<td class="num">(2,375)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares withheld for statutory tax withholding payments on restricted stock</a></td>
<td class="num">(15,562)<span></span>
</td>
<td class="num">(20,603)<span></span>
</td>
<td class="num">(8,053)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used by financing activities</a></td>
<td class="num">(697,414)<span></span>
</td>
<td class="num">(248,416)<span></span>
</td>
<td class="num">(286,409)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Net effect of changes in exchange rates on cash</a></td>
<td class="num">(4,639)<span></span>
</td>
<td class="nump">3,331<span></span>
</td>
<td class="num">(689)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net (decrease) increase in cash and cash equivalents</a></td>
<td class="num">(239,474)<span></span>
</td>
<td class="nump">293,602<span></span>
</td>
<td class="num">(33,468)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">383,928<span></span>
</td>
<td class="nump">90,326<span></span>
</td>
<td class="nump">123,794<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">$ 144,454<span></span>
</td>
<td class="nump">$ 383,928<span></span>
</td>
<td class="nump">$ 90,326<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_PaymentsToAcquireIntangibleAssetsAndEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments to Acquire Intangible Assets and Equity Method Investments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_PaymentsToAcquireIntangibleAssetsAndEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>idxx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) and income tax credits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableTrade</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123371682&amp;loc=d3e55415-109406<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing with the highest claim on the assets of the entity in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or cash outflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with either short term or long term maturity that is collateralized (backed by pledge, mortgage or other lien in the entity's assets).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForLoanLeaseAndOtherLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related loan transactions, lease transactions, credit loss from transactions other than loan and lease transactions, and other loss based on assessment of uncollectability from the counterparty to reduce the account to their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953423-111524<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.11)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForLoanLeaseAndOtherLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfSeniorDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfSeniorDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101989867000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Business, Basis of Presentation and Principles of Consolidation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Nature Of Business, Basis Of Presentation And Principles Of Consolidation</a></td>
<td class="text">NATURE OF BUSINESS, BASIS OF PRESENTATION AND PRINCIPLES OF CONSOLIDATION<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements of IDEXX Laboratories, Inc. and its subsidiaries have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") and with the requirements of Regulation S-X.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These statements include the accounts of IDEXX Laboratories, Inc., and our wholly-owned and majority-owned subsidiaries (&#8220;IDEXX,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; or &#8220;our&#8221;). We do not have any variable interest entities for which we are the primary beneficiary. All intercompany transactions and balances have been eliminated in&#160;consolidation.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have included certain terms and abbreviations used throughout this Annual Report on Form 10-K in the &#8220;Glossary of Terms and Selected Abbreviations.&#8221;&#160;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We develop, manufacture, and distribute products and provide services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing industries. We also sell human medical point-of-care products and laboratory diagnostics. Our principal line of business, which we refer to as our Companion Animal Group (&#8220;CAG&#8221;) operating segment, provides diagnostic capabilities and information management solutions for the companion animal veterinary industry, as well as the biomedical research community. Our principal regions for these products and services are the United States (&#8220;U.S.&#8221;), Europe, Japan, China, and Australia, but we also sell to customers and distributors in many other countries around the world. Our Water operating segment provides innovative testing solutions for the quality and safety of water principally in the U.S. and Europe, but we also sell to customers in many other countries around the world. Our Livestock, Poultry and Dairy (&#8220;LPD&#8221;) operating segment provides diagnostic tests and related instrumentation and performs services that are used to manage the health status of livestock and poultry, to improve producer efficiency, and to ensure the quality and safety of milk. Our principal regions for these products and services are Europe, China, and Australia, but we also sell to customers in many other countries around the world. We also operate a smaller operating segment that is comprised of our human medical diagnostic products and services business (&#8220;OPTI Medical&#8221;). Financial information about our OPTI Medical operating segment is combined and presented with our out-licensing arrangements remaining from our pharmaceutical business in an &#8220;Other&#8221; category because they do not meet the quantitative or qualitative thresholds for reportable segments. Refer to "Note 3. Revenue Recognition" for additional information regarding disaggregated revenue by segment, major product and service categories, and geographical areas. Refer to "Note 17. Segment Reporting" for additional information regarding our reportable operating segments.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101989577848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary Of Significant Accounting Policies</a></td>
<td class="text">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)&#160;&#160;&#160;&#160;Estimates</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of these consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures. On an ongoing basis, we evaluate these estimates, including those related to reserves for accounts receivable; goodwill and other intangible assets; income taxes; inventory valuation; revenue recognition, product returns, customer programs, and multiple element arrangements; share-based compensation; warranty reserves; self-insurance reserves; fair value measurements and loss contingencies. We accrue contingent liabilities when it is probable that future expenditures will be made and such expenditures can be reasonably estimated. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ materially from these estimates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">b</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider all highly liquid investments with original maturities of ninety days or less to be cash equivalents. Cash and cash equivalents consist primarily of demand deposits, money market funds, and short-duration agency bonds and commercial paper as described above. There is no restricted cash on our consolidated balance sheets for the years ended December 31, 2021 and 2020.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(c)&#160;&#160;&#160;&#160;Inventories &#8211; Refer to Note 7 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(d)&#160;&#160;&#160;&#160;Property and Equipment &#8211; Refer to Note 9 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(e)&#160;&#160;&#160;&#160;Goodwill and Other Intangible Assets &#8211; Refer to Note 11 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(f)&#160;&#160;&#160;&#160;Warranty Reserves</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide a standard twelve-month warranty on all instruments sold. We recognize the cost of instrument warranties in cost of product revenue at the time revenue is recognized based on the estimated cost to repair the instrument over its warranty period. Cost of product revenue reflects not only estimated warranty expense for instruments sold in the current period, but also any changes in estimated warranty expense for the portion of the aggregate installed base that is under warranty. Estimated warranty expense is based on a variety of inputs, including historical instrument performance in the customers&#8217; environments, historical and estimated costs incurred in servicing instruments and projected instrument reliability. Should actual service rates or costs differ from our estimates, revisions to the estimated warranty liability would be required. The liability for warranties is included in accrued liabilities in the accompanying consolidated balance sheets. The amount of warranty reserve during the years ended December 31, 2021 and 2020, was not material.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(g)&#160;&#160;&#160;&#160;Income Taxes &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Refer to Note 14 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(h)&#160;&#160;&#160;&#160;Taxes Remitted to Governmental Authorities by IDEXX on Behalf of Customer</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We calculate, collect from our customers, and remit to governmental authorities, sales, value-added, and excise taxes assessed by governmental authorities in connection with revenue-producing transactions with our customers. We report these taxes on a net basis and do not include these tax amounts in revenue or cost of product or service revenue.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(i)&#160;&#160;&#160;&#160;Revenue Recognition &#8211; Refer to Note 3 </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(j)&#160;&#160;&#160;&#160;Research and Development Costs</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development costs, which consist of employee compensation and benefits, materials and external consulting, and product development costs, are expensed as incurred. We evaluate our research and development costs for capitalization after the technological feasibility has been established for software and products containing software to be sold; however, no costs were capitalized during the years ended December 31, 2021, 2020, and 2019. Software developed to deliver hosted services to our customers has been designated as internal use, and we capitalize certain costs incurred in connection with developing or obtaining software designated for internal use based on three distinct stages of development. Refer to "Note 9. Property and Equipment, Net" for further information on internal use software. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(k)&#160;&#160;&#160;&#160;Advertising Costs</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advertising costs, which are recognized as sales and marketing expense in the period in which they are incurred, were $3.3 million, $1.4 million, and $1.5 million for the years ended December 31, 2021, 2020, and 2019, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(l)&#160;&#160;&#160;&#160;Legal Costs</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legal costs are considered period costs and, accordingly, are expensed in the year services are provided.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(m)&#160;&#160;&#160;&#160;Share-Based Compensation &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Refer to Note 5 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(n)&#160;&#160;&#160;&#160;Self-Insurance Accruals &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Refer to Note 16 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(o)&#160;&#160;&#160;&#160;Leases &#8211; Refer to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 8 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(p)&#160;&#160;&#160;&#160;Earnings per Share &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Refer to Note 15 </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(q)&#160;&#160;&#160;&#160;Foreign Currency</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The functional currency of all except eight of our subsidiaries is their local currency, however, the assets and liabilities of the majority of our foreign subsidiaries are translated to the U.S. dollar using the exchange rate in effect at the balance sheet date. Revenue and expense accounts are translated to the U.S. dollar using the exchange rate at the date which those elements are recognized, and where it is impractical to do so, an average exchange rate in effect during the period is used to translate those elements. Cumulative translation gains and losses are shown in the accompanying consolidated balance sheets as a separate component of accumulated other comprehensive income (&#8220;AOCI&#8221;). &#160;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues and expenses denominated in a currency other than the respective subsidiary&#8217;s functional currency are recorded at the current exchange rate when the transaction is recognized. Monetary assets and liabilities denominated in a currency other than the respective subsidiary&#8217;s functional currency are remeasured at each balance sheet date using the exchange rate in effect at each balance sheet date. These foreign currency gains and losses are included in general and administrative expenses within our Other segment. We recognized aggregate foreign currency losses of $2.1 million, gains of $0.6 million, and losses of $1.1 million for the years ended December 31, 2021, 2020, and 2019, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(r)&#160;&#160;&#160;&#160;Hedging Instruments &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Refer to Note 19 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(s)&#160;&#160;&#160;&#160;Fair Value Measurements &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Refer to Note 18 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(t)&#160;&#160;&#160;&#160;Comprehensive Income</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We report all changes in equity, including net income and transactions or other events and circumstances from non-owner sources during the period in which they are recognized. We have chosen to present comprehensive income, which encompasses net income, foreign currency translation adjustments, gains and losses on our net investment hedges and the difference between the cost and the fair market value of investments in debt and equity securities, and forward currency exchange contracts, in the consolidated statements of comprehensive income. Refer to "Note 21. Accumulated Other Comprehensive Income" for information about the effects on net income of significant amounts reclassified out of each component of AOCI for the years ended December 31, 2021, 2020, and 2019.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(u)&#160;&#160;&#160;&#160;Concentrations of Risk</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Financial instruments that potentially subject us to concentrations of credit risk are principally cash, cash equivalents, accounts receivable, and derivatives. To mitigate such risk with respect to cash and cash equivalents, we place our cash with highly-rated financial institutions, in non-interest bearing accounts that are insured by the U.S. government and money market funds invested in government securities. Concentration of credit risk with respect to accounts receivable is limited to certain customers to whom we make substantial sales. To reduce risk, we routinely assess the financial strength of our most significant customers and monitor the amounts owed to us, taking appropriate action when necessary. As a result, we believe that accounts receivable credit risk exposure is limited. We maintain an allowance for doubtful accounts, but historically have not experienced any material losses related to an individual customer or group of customers in any particular industry or geographic area.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To mitigate concentration of credit risk with respect to derivatives we enter into transactions with highly-rated financial institutions, enter into master netting arrangements with counterparties to our derivative transactions and frequently monitor the creditworthiness of our counterparties. Our master netting arrangements reduce our exposure in that they permit outstanding receivables and payables with the counterparties to our derivative transactions to be offset in the event of default. We have not incurred such losses and consider the risk of counterparty default to be minimal.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Inventory</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If we are unable to obtain adequate quantities of the inventory we need to sell our products, we could face cost increases or delays or discontinuations in product shipments, which could have a material adverse effect on our results of operations. Many of the third parties that provide us with the instruments we sell, as well as certain components, raw materials and consumables used in or with our products, are sole or single-source suppliers. Some of the products that we purchase from these sources are proprietary or complex in nature, and, therefore, cannot be readily or easily replaced by alternative sources.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(v)&#160;&#160;&#160;&#160;New Accounting Pronouncements Adopted</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We adopted ASU 2016-02, "Leases (Topic 842)," as of January 1, 2019, using the optional transition method that allows for a cumulative-effect adjustment in the period of adoption and did not restate prior periods.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We adopted ASU 2018-13, "Fair Value Measurement (Topic 820)," as of January 1, 2020, which modifies the disclosure requirements on fair value measurements under ASC Topic No. 820, Fair Value Measurement, as amended (&#8220;ASC 820&#8221;). ASU 2018-13 removes (a) the prior requirement to disclose the amount and reason for transfers between Level 1 and Level 2 of the fair value hierarchy contained in ASC 820, (b) the policy for timing of transfers between levels, and (c) the valuation processes used for Level 3 fair value measurements. ASU 2018-13 also adds, among other things, a requirement to disclose the range and weighted average of significant unobservable inputs used in Level 3 fair value measurements. The adoption did not have a material impact on our consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;We adopted ASU 2016-13, &#8220;Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,&#8221; effective January 1, 2020, using the modified retrospective transition method. This ASU amends the impairment model to utilize an expected loss methodology in place of the incurred loss methodology for financial instruments, including trade receivables and leased equipment. The amendment requires entities to consider a broader range of information to estimate expected credit losses, which may result in earlier recognition of losses. We recorded a non-cash cumulative effect adjustment to retained earnings of $1.8&#160;million, net of $0.6&#160;million of income taxes, on our opening consolidated balance sheet as of January 1, 2020. This adjustment, before the impact of income taxes, was comprised of $2.3&#160;million related to our contract assets and sales-type leases, and $0.2&#160;million related to accounts receivable. Refer to "Note 6. Credit Losses" for more information on our presentation of credit losses.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective January 1, 2021, we adopted ASU 2019-12, &#8220;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes.&#8221; The new guidance is intended to simplify the accounting for income taxes by removing certain exceptions and by updating accounting requirements around goodwill recognized for tax purposes and the allocation of current and deferred tax expense among legal entities, among other minor changes. The adoption of ASU 2019-12 did not have a material impact on our consolidated financial statements.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In July 2021, the FASB issued ASU 2021-05, &#8220;Leases (Topic 842); Lessors - Certain Leases with Variable Lease Payments.&#8221; ASU 2021-05 requires a lessor to classify a lease with variable payments that do not depend on an index or rate as an operating lease if another lease classification (i.e., sales-type or direct financing) would result in recognition of a day-one loss. We have elected to adopt this standard as of the third quarter of 2021, on a prospective basis. The adoption of ASU 2021-05 did not have a material impact on our consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(w)&#160;&#160;&#160;&#160;New Accounting Pronouncements Not Yet Adopted</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued ASU 2021-08, &#8220;Business Combinations (Topic 805): Accounting for Acquired Contract Assets and Contract Liabilities.&#8221; ASU 2021-08 is intended to improve comparability for both the recognition and measurement of acquired revenue contracts with customers at the date of and after a business combination by providing consistent recognition guidance. This standard is effective for fiscal years beginning after December 15, 2022. Adoption of the ASU 2021-08 should be applied prospectively. Early adoption is permitted, including in an interim period, for any period for which financial statements have not yet been issued. We are currently evaluating the impact, if any, of ASU 2021-08 on our consolidated financial statements.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU 2020-04, "Facilitation of the Effects of Reference Rate Reform on Financial Reporting.&#8221; ASU 2020-04 is intended to provide optional expedients and exceptions to the U.S. GAAP guidance on contract modifications and hedge accounting to ease the financial reporting burdens related to the discontinuation of the London Interbank Offered Rate (&#8220;LIBOR&#8221;) or by another reference rate expected to be discontinued. The FASB also issued ASU 2021-01, "Reference Rate Reform (Topic 848): Scope," in January 2021. It clarifies that certain optional expedients and exceptions apply to derivatives that are affected by the discounting transition. The amendments in this ASU affect the guidance in ASU No. 2020-04 and are effective in the same timeframe as ASU 2020-04. The relief offered by this guidance, if adopted, is available to companies for the period March 12, 2020 through December 31, 2022. Our Credit Facility includes a provision for the determination of a benchmark replacement rate as a successor to the LIBOR rate, therefore; we do not expect the discontinuation of LIBOR to have an impact on our consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101989451352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue Recognition</a></td>
<td class="text">REVENUE RECOGNITION <div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue is recognized when, or as, performance obligations under the terms of a contract are satisfied, which occurs when control of the promised products or services is transferred to a customer. We exclude sales, use, value-added, and other taxes we collect on behalf of third parties from revenue. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring products or services to a customer. To accurately present the consideration received in exchange for promised products or services, we apply the five-step model outlined below:</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Identification of a contract or agreement with a customer</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Identification of our performance obligations in the contract or agreement</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Determination of the transaction price</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Allocation of the transaction price to the performance obligations</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Recognition of revenue when, or as, we satisfy a performance obligation</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into contracts that can include various combinations of products and services, which are generally capable of being distinct and accounted for as separate performance obligations. The timing of revenue recognition, billings, and cash collections results in accounts receivable, lease receivables, and contract assets as a result of revenue recognized in advance of billings (included within other assets), and contract liabilities or deferred revenue as a result of receiving consideration in advance of revenue recognition within our consolidated balance sheet. Our general payment terms range from&#160;30&#160;to&#160;60&#160;days, with exceptions in certain geographies. Below is a listing of our major categories of revenue for our products and services.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Diagnostic Products and Accessories</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Diagnostic products and accessories revenues, including IDEXX VetLab</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> consumables and accessories, rapid assay, LPD, Water, and OPTI testing products, are predominantly recognized and invoiced at the time of shipment, which is when the customer obtains control of the product based on legal title transfer and we have the right to payment. We also provide customers with certain consumables that are recognized upon utilization by the customer, which is when we have the right to payment and the risks and rewards of ownership transfer. Shipping costs reimbursed by the customer are included in revenue and cost of sales. As a practical expedient, we do not account for shipping activities as a separate performance obligation.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Laboratory Diagnostic and Consulting Services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Laboratory diagnostic and consulting services revenues are recognized and invoiced when the laboratory diagnostic service is performed.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Instruments, Software and Systems</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;CAG Diagnostics capital instruments, veterinary software, and diagnostic imaging systems revenues are recognized and invoiced when the customer obtains control of the products based on legal title transfer and we have the right to payment, which generally occurs at the time of installation and customer acceptance. Our instruments, software, and systems are often included in one of our significant customer programs, as further described below. For veterinary software systems that include multiple performance obligations, such as perpetual software licenses and computer hardware, we allocate revenue to each performance obligation based on estimates of the price that we would charge the customer for each promised product or service if it were sold on a standalone basis.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Lease Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Revenues from instrument rental agreements and reagent rental programs are recognized either as operating leases on a ratable basis over the term of the agreement or as sales-type leases at the time of installation and customer acceptance. Customers typically pay for the right to use instruments under rental agreements in equal monthly amounts over the term of the rental agreement. Our reagent rental programs provide our customers the right to use our instruments upon entering into agreements to purchase specified amounts of consumables, which are considered embedded leases. For some agreements, the customers are provided with the right to purchase the instrument at the end of the lease term. Lease revenues from these agreements are presented in product revenue on our consolidated income statement. Lease revenue was approximately $20.8 million for the&#160;year ended December 31, 2021, as compared to $17.5 million for the year ended December 31, 2020, including both operating leases and sales-type leases under ASC 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for leases entered into after January 1, 2019, and ASC 840, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for leases entered into prior to 2019. Refer to below for revenue recognition under our reagent rental programs. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Extended Warranties and Post-Contract Support</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. CAG Diagnostics capital instruments and diagnostic imaging systems&#160;extended warranties typically provide customers with continued coverage for a period of&#160;<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzQ4MjE_1e3581e2-aa87-4799-8610-c43eba500df3">one</span>&#160;to&#160;<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzIzNTc2_f9986b18-206a-41dd-850a-8be4c0938fc3">five&#160;years</span> beyond the first-year standard warranty. Customers can either pay in full for the extended warranty at the time of instrument or system purchase, or can be billed on a quarterly basis over the term of the contract. We recognize revenue associated with extended </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">warranties over time on a ratable basis using a time-elapsed measure of performance over the contract term, which approximates the expected timing in which applicable services are performed.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Veterinary software post-contract support provides customers with access to technical support when and as needed through access to call centers and online customer assistance. Post-contract support contracts typically have a term of&#160;12 months and customers are billed for post-contract support in equal quarterly amounts over the term. We recognize revenue for post-contract support services over time on a ratable basis using a time elapsed measure of performance over the contract term, which approximates the expected timing in which applicable services are performed.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 31, 2020, our deferred revenue related to extended warranties and post-contract support was&#160;$35.1 million, of which approximately&#160;$23.1 million&#160;was recognized during the year ended&#160;December 31, 2021. Furthermore, as a result of new agreements, our deferred revenue related to extended warranties and post-contract support was $30.0 million at&#160;December 31, 2021. We do not disclose information about remaining performance obligations that are part of contracts with an original expected duration of one year or less, and do not adjust for the effect of the financing components when the period between customer payment and revenue recognition is one year or less. Deferred revenue related to extended warranties and post-contract support with an original duration of more than&#160;one year&#160;was&#160;$16.0 million&#160;at&#160;December 31, 2021, of which approximately 49%,&#160;29%,&#160;14%, 5%,&#160;and&#160;3%&#160;are expected to be recognized during 2022, 2023, 2024, 2025, and thereafter, respectively. Additionally, we have determined these agreements do not include a significant financing component.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">SaaS Subscriptions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;We offer a variety of veterinary software and diagnostic imaging SaaS subscriptions including ezyVet, Animana, Neo, Cornerstone Cloud, Pet Health Network Pro, Petly Plans, Web PACS, rVetLink, and SmartFlow. We recognize revenue for our SaaS subscriptions over time on a ratable basis over the contract term, beginning on the date our service is made available to the customer. Our subscription contracts vary in term from monthly to&#160;two years. Customers typically pay for our subscription contracts in equal monthly amounts over the term of the agreement. Deferred revenue related to our SaaS subscriptions is not material.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Contracts with Multiple Performance Obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We enter into contracts with multiple performance obligations where customers purchase a combination of IDEXX products and services. Determining whether products and services are considered distinct performance obligations that should be accounted for separately requires significant judgment. We determine the transaction price for a contract based on the total consideration we expect to receive in exchange for the transferred goods or services. To the extent the transaction price includes variable consideration, such as volume rebates or expected price adjustments, we apply judgment in constraining the estimated variable consideration due to factors that may cause reversal of revenue recognized. We evaluate constraints based on our historical and projected experience with similar customer contracts.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We allocate revenue to each performance obligation in proportion to the relative standalone selling prices, and recognize revenue when transfer of the related goods or services has occurred for each obligation. We utilize the observable standalone selling price when available, which represents the price charged for the performance obligation when sold separately. When standalone selling prices for our products or services are not directly observable, we determine the standalone selling prices using relevant information available and apply suitable estimation methods including, but not limited to, the cost plus a margin approach. We recognize revenue as each performance obligation is satisfied, either at a point in time or over time, as described in the revenue categories above. We do not disclose information about remaining performance obligations that are part of contracts with an original expected duration of one year or less.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following customer programs represent our most significant customer contracts which contain multiple performance obligations:</span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Customer Commitment Programs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We offer customer incentives upon entering into multi-year agreements to   purchase annual minimum amounts of products and services.</span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Up-Front Customer Loyalty Programs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our up-front loyalty programs provide customers with incentives in the form of cash payments or IDEXX Points upon entering into multi-year agreements to purchase annual minimum amounts of future products or services. If a customer breaches their agreement, they are required to refund all or a portion of the up-front cash or IDEXX Points, or make other repayments, remedial actions, or both. Up-front incentives to customers in the form of cash or IDEXX Points are not made in exchange for distinct goods or services and are capitalized as customer acquisition costs within other current and long-term assets, which are subsequently recognized as a reduction to revenue over the term of the customer agreement. If these up-front incentives are subsequently utilized to purchase instruments, we </span></div><div style="padding-left:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">allocate total consideration, including future committed purchases less up-front incentives and estimates of expected price adjustments, based on relative standalone selling prices to identified performance obligations, and recognize instrument revenue and cost at the time of installation and customer acceptance. To the extent invoiced instrument revenue exceeds recognized instrument revenue, we record deferred revenue as a contract liability, which is subsequently recognized upon the purchase of products and services over the term of the contract. We have determined these agreements do not include a significant financing component. Differences between estimated and actual customer purchases may impact the timing and amount of revenue recognition.</span></div><div style="padding-left:72pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 31, 2020, our capitalized customer acquisition costs were&#160;$148.1 million, of which approximately&#160;$43.6 million&#160;was recognized as a reduction of revenue during the&#160;year ended&#160;December 31, 2021. Furthermore, as a result of new up-front customer loyalty payments, net of subsequent recognition, our capitalized customer acquisition costs were&#160;$158.3 million&#160;at&#160;December 31, 2021. We monitor customer purchases over the term of their agreement to assess the realizability of our capitalized customer acquisition costs and review estimates of variable consideration. Impairments, revenue adjustments that relate to performance obligations satisfied in prior periods, and contract modifications during the&#160;years ended&#160;December 31, 2021 and 2020, were not material.</span></div><div style="padding-left:72pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Volume Commitment Programs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our volume commitment programs, such as our IDEXX 360 program, provide customers with a free or discounted instrument or system upon entering into multi-year agreements to purchase annual minimum amounts of products and services. We allocate total consideration, including future committed purchases and expected price adjustments, based on relative standalone selling prices to identified performance obligations and recognize instrument revenue and cost at the time of installation and customer acceptance in advance of billing the customer, which is also when the customer obtains control of the instrument based on legal title transfer. Our right to future consideration related to instrument revenue is recorded as a contract asset within other current and long-term assets. The contract asset is transferred to accounts receivable when customers are billed for products and services over the term of the contract. We have determined these agreements do not include a significant financing component. Differences between estimated and actual customer purchases may impact the timing and amount of revenue recognition. </span></div><div style="padding-left:72pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 31, 2020, our volume commitment contract assets were&#160;$115.5 million, of which approximately $26.3 million&#160;was reclassified to accounts receivable when customers were billed for related products and services during the&#160;year ended&#160;December 31, 2021. Furthermore, as a result of new placements under volume commitment programs, net of subsequent amounts reclassified to accounts receivable, and allowances established for credit losses, our contract assets were&#160;$159.9 million&#160;at&#160;December 31, 2021. We monitor customer purchases over the term of their agreement to assess the realizability of our contract assets and review estimates of variable consideration. Impairments, revenue adjustments that relate to performance obligations satisfied in prior periods, and contract modifications during the&#160;years ended&#160;December 31, 2021 and 2020, were not material.</span></div><div style="padding-left:72pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For our up-front customer loyalty and volume commitment programs, we estimate future revenues related to multi-year agreements to be approximately&#160;$2.9 billion, of which approximately&#160;25%,&#160;24%,&#160;20%, 15%, and&#160;16%&#160;are expected to be recognized during 2022, 2023, 2024, 2025, and thereafter, respectively. These future revenues relate to performance obligations not yet satisfied, for which customers have committed to purchase goods and services, net of the expected revenue reductions from customer acquisition costs and expected price adjustments, and as a result, are lower than stated contractual commitments by our customers.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Instrument Rebate Programs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our instrument rebate programs require an instrument purchase and provide customers the opportunity to earn future rebates based on the volume of products and services they purchase over the term of the program. We account for the customer&#8217;s right to earn rebates on future purchases as a separate performance obligation and determine the standalone selling price based on an estimate of rebates the customer will earn over the term of the program. Total consideration allocated to identified performance obligations is limited to goods and services that the customer is presently obligated to purchase and does not include estimates of future purchases that are optional. We allocate total consideration to identified performance obligations, including the customer&#8217;s right to earn rebates on future purchases, which is deferred and recognized upon the purchase of future products and services, partly offsetting future rebates as they are earned.</span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 31, 2020, our deferred revenue related to instrument rebate programs was&#160;$39.3 million, of which approximately $14.3 million was recognized when customers purchased eligible products and services and earned rebates during the&#160;year ended&#160;December 31, 2021. Furthermore, as a result of new instrument purchases under rebate programs, net of subsequent recognition, our deferred revenue was&#160;$33.0 million&#160;at&#160;December 31, 2021, of which approximately&#160;36%,&#160;26%,&#160;17%, 11%, and&#160;10%&#160;are expected to be recognized during 2022, 2023, 2024, 2025, and thereafter, respectively.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Reagent Rental Programs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our reagent rental programs provide our customers the right to use our instruments upon entering into multi-year agreements to purchase annual minimum amounts of consumables. These types of agreements include an embedded lease for the right to use our instrument and we determine the amount of lease revenue allocated to the instrument based on relative standalone selling prices. We evaluate the terms of these embedded leases to determine classification as either a sales-type lease or an operating lease.</span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Sales-type Reagent Rental Programs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our reagent rental programs that effectively transfer control of instruments to our customers are classified as sales-type leases and we recognize instrument revenue and cost in advance of billing the customer, at the time of installation and customer acceptance. Our right to future consideration related to instrument revenue is recorded as a lease receivable within other current and long-term assets, and is transferred to accounts receivable when customers are billed for products and services over the term of the contract. On December 31, 2020, our lease receivable assets were $11.1&#160;million, of which approximately $2.2&#160;million was reclassified to accounts receivable when customers were billed for related products and services during the year ended December 31, 2021. Furthermore, as a result of new placements under sales-type reagent rental programs, net of subsequent amounts reclassified to accounts receivable, and allowances established for credit losses, our lease receivable assets were $15.3 million at December 31, 2021. The impacts of discounting and unearned income at December 31, 2021, were not material. Profit and loss recognized at the commencement date and interest income during the year ended December 31, 2021, were not material. We monitor customer purchases over the term of their agreement to assess the realizability of our lease receivable assets. Impairments during the year ended December 31, 2021, were not material.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Operating-type Reagent Rental Programs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our reagent rental programs that do not effectively transfer control of instruments to our customers are classified as operating leases and we recognize instrument revenue and costs ratably over the term of the agreement. The cost of the instrument is capitalized within property and equipment.</span></div><div style="padding-left:72pt;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate future revenue to be recognized related to our reagent rental programs of approximately&#160;$38.3 million, of which approximately&#160;32%,&#160;26%,&#160;20%, 14%, and 8%&#160;are expected to be recognized during 2022, 2023, 2024, 2025, and thereafter, respectively. These future revenues relate to performance obligations not yet satisfied for which customers have committed to future purchases, net of any expected price adjustments, and as a result, may be lower than stated contractual commitments by our customers.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other Customer Incentive Programs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Certain agreements with customers include discounts or rebates on the sale of products and services applied retrospectively, such as volume rebates achieved by purchasing a specified purchase threshold of goods and services. We account for these discounts as variable consideration and estimate the likelihood of a customer meeting the threshold in order to determine the transaction price using the most predictive approach. We typically use the most-likely-amount method for incentives that are offered to individual customers, and the expected-value method for programs that are offered to a broad group of customers. Revenue adjustments that relate to performance obligations satisfied in prior periods during the&#160;years ended&#160;December 31, 2021 and 2020, were not material. Refund obligations related to customer incentive programs are recorded in accrued liabilities for the actual issuance of incentives, incentives earned but not yet issued, and estimates of incentives to be earned in the future.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Program Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. At times, we combine elements of our significant customer programs within a single customer contract. We separate each significant program element and include the contract assets, customer acquisition costs, deferred revenues, and estimated future revenues within the most relevant program disclosures above. Each customer contract is presented as a net contract asset or net contract liability on our consolidated balance sheet.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">IDEXX Points</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. IDEXX Points may be applied to trade receivables due to us, converted to cash, or applied against the purchase price of IDEXX products and services. We consider IDEXX Points equivalent to cash. IDEXX Points that have not </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">yet been used by customers are included in accrued liabilities until utilized or expired. Breakage is not material because customers can apply IDEXX Points to trade receivables at any time.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Accounts Receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We recognize revenue when it is probable that we will collect substantially all of the consideration to which we will be entitled, based on the customer&#8217;s intent and ability to pay the promised consideration. We apply judgment in determining the customer&#8217;s ability and intention to pay, which is based on a variety of factors including the customer&#8217;s historical payment experience or, in the case of a new customer, published credit and financial information pertaining to the customer. We have&#160;no&#160;significant customers that accounted for greater than 10% of our consolidated revenues and we have&#160;no&#160;concentration of credit risk as of&#160;December 31, 2021.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Disaggregated Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We present disaggregated revenue for our CAG segment based on major product and service categories. Our Water segment is comprised of a single major product category. Although our LPD segment does not meet the quantitative requirements to be reported as a separate segment, we believe it is important to disaggregate these revenues as a major product and service category separately from our Other reportable segment given its distinct markets, and therefore we have elected to report LPD as a reportable segment.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table&#160;presents disaggregated revenue by major product and service categories:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:58.311%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.694%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.694%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.696%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CAG segment revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CAG Diagnostics recurring revenue:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,534,562&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,113,839&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,828,329&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">IDEXX VetLab consumables</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">1,006,781&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">824,376&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">693,360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Rapid assay products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">296,852&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">253,018&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">232,149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Reference laboratory diagnostic and consulting services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">1,123,656&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">946,268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">822,497&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">CAG Diagnostics services and accessories</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">107,273&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">90,177&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">80,323&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CAG Diagnostics capital - instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">149,140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108,950&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132,685&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Veterinary software, services and diagnostic imaging systems</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">206,258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">162,976&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">158,169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CAG segment revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,889,960&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,385,765&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,119,183&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Water segment revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">146,505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">128,625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LPD segment revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">135,887&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">145,845&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132,635&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other segment revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,240&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,215,360&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,706,655&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,406,908&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue by principal geographic area, based on customers&#8217; domiciles, was as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:58.311%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.694%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.694%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.696%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Americas</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,995,683&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,691,224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,495,516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">139,727&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107,398&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99,550&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Latin America &amp; Caribbean</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66,623&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,863&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56,515&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,202,033&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,850,485&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,651,581&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Europe, the Middle East and Africa</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">146,762&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">119,353&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">114,955&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90,156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90,969&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">France</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90,836&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74,814&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64,767&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Italy</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,062&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,817&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,725&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Spain</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,439&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Switzerland</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,984&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,855&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Netherlands</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,656&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,461&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,397&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">167,525&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">148,049&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">122,206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">681,949&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">562,765&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">498,439&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asia Pacific Region</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Australia</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94,414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">79,629&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71,069&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74,725&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67,246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">China</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,845&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,518&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89,523&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68,206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61,055&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">331,378&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">293,405&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">256,888&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,215,360&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,706,655&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,406,908&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Costs to Obtain a Contract</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We capitalize sales commissions and the related fringe benefits earned by our sales force when considered incremental and recoverable costs of obtaining a contract. Our contracts include performance obligations related to various goods and services, some of which are satisfied at a point in time and others over time. Commission costs related to performance obligations satisfied at a point in time are expensed at the time of sale, which is when revenue is recognized. Commission costs related to long-term service contracts and performance obligations satisfied over time, including extended warranties and SaaS subscriptions, are deferred and recognized on a systematic basis that is consistent with the transfer of the goods or services to which the asset relates. We apply judgment in estimating the amortization period, which ranges from&#160;3&#160;to&#160;7 years, by taking into consideration our customer contract terms, history of renewals, and expected length of customer relationship, as well as the useful life of the underlying technology and products. Amortization expense is included in sales and marketing expenses in the accompanying consolidated statements of income. Deferred commission costs are periodically reviewed for impairment.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 31, 2020, our deferred commission costs, included within other assets, were&#160;$17.5 million, of which approximately&#160;$5.7 million&#160;of commission expense was recognized during the&#160;year ended&#160;December 31, 2021. Furthermore, as a result of commissions related to new extended warranties and SaaS subscriptions, net of subsequent recognition, our deferred commission costs were&#160;$19.5 million&#160;at&#160;December 31, 2021. Impairments of deferred commission costs during the&#160;years ended&#160;December 31, 2021 and 2020, were not material.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101989501048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Investments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Acquisitions and Investments</a></td>
<td class="text">ACQUISITIONS AND INVESTMENTS<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our acquisitions of businesses and other assets enhance our existing businesses by either expanding our geographic range, customer base, or existing product and service lines. From time to time, we may acquire small reference laboratories or radiology practices that we account for as either asset purchases or business combinations.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2021, we acquired the shares of a reference laboratory located in Finland for approximately $13.4&#160;million in cash, including a holdback of approximately $1.4&#160;million. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This acquisition expands our international reference laboratory presence and was accounted for as a business combination. The fair values of the assets acquired consist of&#160;customer relationship intangibles of approximately $7.4&#160;million, with a life of 10 years; a non-compete agreement of approximately $0.8&#160;million, with a life of 3 years; approximately $5.3&#160;million of goodwill, representing synergies within our broader CAG portfolio; and approximately $0.1&#160;million in net tangible liabilities. The purchase price allocation is </span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">subject to revision as additional information becomes available regarding review of taxes and the settlement of the working capital adjustment. Goodwill related to this acquisition is not expected to be deductible for tax purposes. Pro forma information has not been presented for this acquisition because such information is not material to the financial statements. The results of operations have been included in our CAG segment since the acquisition date. The acquisition expenses were not material.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2021, we acquired the assets of a teleradiology business for approximately $5.4&#160;million, including a contingent payment of $0.3&#160;million. This acquisition expands our current teleradiology capability. The acquired assets primarily consist of a customer relationship intangible of approximately $1.7&#160;million, with a weighted average life of</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 10 years</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and approximately $3.7&#160;million in goodwill. Goodwill related to this acquisition is expected to be deductible for tax purposes. Pro forma information has not been presented for this acquisition because such information is not material to the financial statements. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of operations have been included in our CAG segment since the acquisition date. The acquisition expenses were not material.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2021, we acquired the assets of the ezyVet cloud-based veterinary software businesses and the shares of ezyVet US, Inc., as well as the Vet Radar business assets, for approximately $157.2&#160;million, including an estimated contingent payment of $5.0&#160;million. The acquired assets include the ezyVet cloud-native practice management system software and the Vet Radar cloud-based workflow management software. The acquisition expands our cloud-based software offerings to support our customers with technology solutions that raise the standards of care for patients and improve practice efficiency. The fair values of assets acquired were as follow: approximately </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$32.0&#160;million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in customer-related intangible with a weighted average life of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10 years;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> approximately </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$8.4&#160;million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in technology-related intangibles with a weighted average life </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6 years;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> approximately </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$2.4&#160;million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in trademarks with a weighted average life of</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 14 years;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> approximately </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1.8&#160;million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in non-compete agreements with a weighted average life of</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 5 years;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> approximately </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$109.4&#160;million </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in goodwill, r</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">epresenting synergies within our broader CAG portfolio; and approximately $3.2&#160;million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in net tangible assets. Goodwill has been allocated to multiple reporting units based upon the fair value of projected earnings as of the date of the acquisition. The goodwill was allocated as follows: approximately $23.4&#160;million to IDEXX VetLab&#174;, approximately $27.0 million to Reference Laboratories, approximately $11.1&#160;million to Rapid Assay, and approximately $47.9&#160;million to Veterinary Software Services. Goodwill related to this acquisition is expected to be deductible for tax purposes. Pro forma information has not been presented for this acquisition because such information is not material to the financial statements. The results of operations have been included in our CAG segment since the acquisition date. During the fourth quarter, we increased the contingent payable by $2.0&#160;million, for a total expected payment of $7.0&#160;million. This increase to the contingent payment is expensed as the adjustment was made after the measurement period. The acquisition expenses were approximately $2.2&#160;million. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2021, we acquired the shares of a reference laboratory located in Switzerland for approximately $5.5&#160;million in cash, including holdback and contingent payments of approximately $1.1&#160;million. This acquisition expands our international reference laboratory presence and was accounted for as a business combination. The fair values of the assets acquired consist of&#160;approximately $4.3&#160;million&#160;in intangible assets, primarily for customer relationships, which will be amortized over 9 years, approximately $1.8&#160;million for goodwill, representing synergies within our broader CAG portfolio, and approximately $0.6&#160;million&#160;of liabilities, including deferred taxes associated with the acquired intangible assets. Goodwill related to this acquisition is not deductible for tax purposes. Pro forma information has not been presented for this acquisition because such information is not material to the financial statements. The results of operations have been included in our CAG segment since the acquisition date. The acquisition expenses were not material.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2019 we acquired the assets of a multi-site reference laboratory business in the mid-west of the U.S. for $50.0 million in cash. This acquisition expands our national reference laboratory presence in the U.S., and was accounted for as a business combination. We finalized the valuation of the fair value of the assets acquired during the first quarter of 2020. The fair value of the assets acquired consists of $26.9 million in intangible assets, primarily for customer relationships, with a weighted average life of 13.8 years, $0.2 million of tangible assets, and $22.9 million of goodwill, representing synergies within our reference laboratory portfolio.&#160;The goodwill is expected to be deductible for income tax purposes. Pro forma information has not been presented for this acquisition because such information is not material to the financial statements. The results of operations have been included in our CAG segment since the acquisition date. The acquisition expenses incurred were not material. </span></div>Acquisition of noncontrolling interestDuring the fourth quarter of 2021, we acquired the remaining 5% interest of our sole foreign joint venture operation for approximately $1.0&#160;million. As a result, we no longer record any minority interest in the equity section of our consolidated balance sheet. This transaction is recorded as an equity transaction, with no gain or loss reflected in the consolidated statements of income.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101989421592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Share-Based Compensation</a></td>
<td class="text">SHARE-BASED COMPENSATION <div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide for various forms of share-based compensation awards to our employees and non-employee directors. Our share-based compensation plans allow for the issuance of a mix of stock options, restricted stock, stock appreciation rights, employee stock purchase rights, and other stock unit awards.&#160;With the exception of stock options, the fair value of our awards is equal to the closing stock price of IDEXX common stock on the date of grant. We calculate the fair value of our stock option awards using the Black-Scholes-Merton option-pricing model. For stock options, restricted stock units (&#8220;RSUs&#8221;), and deferred stock units (&#8220;DSUs&#8221;), share-based compensation expense is recognized net of estimated forfeitures, on a straight-line basis over the requisite service period of the award for stock options.&#160;For performance-based restricted stock units (&#8220;PBRSUs&#8221;), share-based compensation expense is recognized net of estimated forfeitures, on a grade-vesting methodology over the requisite service period.&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options permit a holder to buy IDEXX stock upon vesting at the stock option exercise price set on the day of grant. An RSU is an agreement to issue shares of IDEXX stock at the time of vesting. A PBRSU is an agreement to issue shares of IDEXX stock at the time of vesting upon successful completion of certain performance goals. DSUs are granted under our Executive Deferred Compensation Plan (the &#8220;Executive Plan&#8221;) and non-employee Director Deferred Compensation Plan (the &#8220;Director Plan&#8221;). DSUs may or may not have vesting conditions depending on the plan under which they are issued. We did not issue any restricted stock or stock appreciation rights during the years ended December 31, 2021, 2020, and 2019, nor were any restricted stock or stock appreciation rights outstanding as of those years ended.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We primarily issue shares of common stock to satisfy stock option exercises and employee stock purchase rights and to settle RSUs, PBRSUs, and DSUs. We issue shares of treasury stock to settle certain RSUs and upon the exercise of certain stock options, which were not material for the years ended December 31, 2021, 2020, and 2019. The number of shares of common stock and treasury stock issued are equivalent to the number of awards exercised or&#160;settled.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With the exception of employee stock purchase rights, equity awards are issued to employees and non-employee di</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rectors under the 2018 Stock Incentive Plan (the "2018 Stock Plan"). Our Board of Directors has authorized the issuance of 7.5 million shar</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">es of our common stock under the 2018 Stock Plan. Any shares that are subject to awards of stock options or stock appreciation rights will be counted against the share limit as one share for every share granted. Any shares that are issued other than stock options and stock appreciation rights will be counted against the share limit as 2.4 shares for every share granted. If any shares issued under our prior plans are forfeited, settled for cash, or expire, these shares, to the extent of such forfeiture, cash settlement, or expiration, will again be available for issuance under the 2018 Stock Plan. As of December 31, 2021, there were approximately 6.5 million remaining shares available for issuance under the 2018 Stock Plan.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation costs are classified in the consolidated financial statements consistent with the classification of cash compensation paid to the employees receiving such share-based compensation. The following is a summary of share-based compensation costs and related tax benefits recorded in our consolidated statements of income:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:58.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense included in cost of revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,044&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,681&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense included in operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,711&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,536&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total share-based compensation expense included in consolidated statements of income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,755&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,951&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,278&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax benefit resulting from share-based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,734)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,965)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,861)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net share-based compensation expense included in consolidated statements of income, excluding tax benefit from settlement of share-based awards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,021&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,986&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,417&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax benefit resulting from settlement of share-based awards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32,474)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(38,981)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19,140)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net expense (benefit) related to share-based compensation arrangements included in consolidated statements of income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">547&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,995)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,277&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2019, we entered into a mutual separation agreement with our former CEO, pursuant to which Mr. Ayers&#8217;s outstanding stock options were modified, resulting in a share-based compensation expense of approximately $10.9 million, primarily representing an acceleration of the cost of the equity awards. This expense was partially offset by a reduction to our provision for income taxes of approximately $0.8 million. Other than the modification to Mr. Ayers's stock options, as described above, there were no other material modifications to the terms of outstanding options, RSUs,&#160;PBRSUs, or DSUs during the years ended December 31, 2021, 2020, or 2019.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense is reduced for an estimate of the number of awards that are expected to be forfeited. We use historical data and other factors to estimate expected employee terminations and to evaluate whether particular groups of employees have significantly different forfeiture expectations.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total unrecognized compensation expense, net of estimated forfeitures, for unvested share-based compensation awards at December 31, 2021, was $64.1 million, which will be recognized over a weighted average period of approximately 1.3 years.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Options</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to December 4, 2019, all options granted to employees primarily vest ratably over five years on each anniversary of the date of grant. Options granted to non-employee directors vest fully on the first anniversary of the date of grant. Employee grants after December 4, 2019 vest ratably over four years. Vesting of option awards issued is conditional based on continuous service. Options granted after May 8, 2013 have a contractual term of ten years and options granted between January 1, 2006 and May 8, 2013 had contractual terms of seven years. Upon any change in control of the company, 25% of the unvested stock options then outstanding will vest and become exercisable. However, if the acquiring entity does not assume outstanding options, then all options will vest immediately prior to the change in control.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the Black-Scholes-Merton option-pricing model to determine the fair value of options granted. Option-pricing models require the input of highly subjective assumptions, particularly for the expected stock price volatility and the expected term of options. Changes in the subjective input assumptions can affect the fair value estimate. Our expected stock price volatility assumptions are based on the historical volatility of our stock over periods that are similar to the expected terms of grants and other relevant factors. We derive the expected term based on historical experience and other relevant factors concerning expected employee behavior with regard to option exercise. The risk-free interest rate is based on U.S. Treasury yields for a maturity approximating the expected term calculated at the date of grant. We have never paid any cash dividends on our common stock and we have no intention to pay a dividend at this time; therefore, we assume that no dividends will be paid over the expected terms of option awards.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine the assumptions used in the valuation of option awards as of the date of grant. Differences in the expected stock price volatility, expected term or risk-free interest rate may necessitate distinct valuation assumptions at those grant dates. As such, we may use different assumptions for options granted throughout the year. The weighted averages of the valuation assumptions used to determine the fair value of each option award on the date of grant and the weighted average estimated fair values were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:58.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share price at grant</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">546.36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">291.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">218.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share exercise price</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">550.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">291.14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">220.88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected stock price volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected term, in years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average fair value of options granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">169.15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84.92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65.53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the status of options granted under our share-based compensation plans at December 31, 2021, and changes during the year then ended, are presented in the table below:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:39.575%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.996%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.996%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.996%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.001%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Options (000)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Remaining Contractual Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value ($000)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding as of December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,953&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">149.32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">550.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(310)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102.78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">261.95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding as of December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,757&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">188.47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">825,745&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fully vested as of December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,109&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">127.30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">588,831&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fully vested and expected to vest as of December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,738&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">186.72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">819,777&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total fair value of options vested were $17.3 million, $14.6 million, and $12.2 million during the years ended December 31, 2021, 2020, and 2019, respectively</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intrinsic value of stock options exercised represents the amount by which the market price of the common stock exceeded the exercise price, before applicable income taxes. The total intrinsic values of stock options exercised were $147.9 million, $163.0 million, and $83.7 million during the years ended December 31, 2021, 2020, and 2019, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Stock Units&#160;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to December 4, 2019, the majority of RSUs, including our PBRSUs, granted to employees vest ratably over five years on each anniversary of the date of grant. Employee grants after December 4, 2019, will vest ratably over 4 years. PBRSUs granted to employees vest based on meeting performance goals set on the day of grant. RSUs granted to non-employee directors vest fully on the first anniversary of the date of grant. Vesting as it relates to RSUs and PBRSUs issued is conditional based on continuous service. Upon any change in control of the company, 25% of the unvested RSUs and PBRSUs then outstanding will vest, provided, however, that if the acquiring entity does not assume the RSUs and PBRSUs, then all such units will vest immediately prior to the change in control. At time of grant, we assume all PBRSUs will meet performance goals to vest.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the status of RSUs and PBRSUs granted under our share-based compensation plans at December 31, 2021, and changes during the period then ended, are presented in the table below:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:69.281%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.977%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Units (000)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Grant-Date Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nonvested as of December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">202.47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nonvested as of December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">306.18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected to vest as of December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">303.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total fair values of RSUs and PBRSUs vested were $46.1 million, $27.9 million, and $23.8 million during the years ended December 31, 2021, 2020, and 2019, respectively. The aggregate intrinsic value of nonvested RSUs and PBRSUs as of December 31, 2021, which is equal to the fair value of IDEXX&#8217;s common stock as of December 31, 2021, multiplied by the number of nonvested units as of December 31, 2021, was $108.8 million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Deferred Stock Units</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our Director Plan, non-employee directors may defer a portion of their cash fees in the form of vested DSUs. Prior to 2014, certain members of our management could elect to defer a portion of their cash compensation in the form of vested deferred stock units under our Executive Plan. Each DSU represents the right to receive one unissued share of our common stock. These recipients receive a number of DSUs equal to the amount of cash fees or compensation deferred divided by the closing sale price of the common stock on the date of deferral. Also, under the Director Plan, non-employee directors are awarded annual grants of either RSUs or DSUs that vest fully on the first anniversary of the date of grant. Vesting for these annual RSU and DSU grants is conditional based on continuous service. Vested DSUs are distributed as shares of common stock on the distribution date elected by the participant and pursuant to the terms of the Director or Executive Plan, as applicable.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were approximately 90,000 and 87,000 vested DSUs outstanding under our share-based compensation plans as of December 31, 2021 and 2020, respectively. During 2020, approximately 59,000 DSUs were distributed as shares of common stock to our former CEO in accordance with the terms of the Executive Plan and the deferral elections he previously made. Unvested DSUs as of December 31, 2021 and 2020, were not material.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee Stock Purchase Rights</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employee stock purchase rights are issued under the 1997 Employee Stock Purchase Plan, under which we reserved and may issue up to an aggregate of 4.7 million shares of common stock in periodic offerings. Under this plan, stock is sold to employees at a 15% discount off the closing price of the stock on the last day of each quarter. The dollar value of this discount is equal to the fair value of purchase rights recognized as share-based compensation. We issued approximately 29,500,&#160;39,000, and 47,000 shares of common stock in connection with the Employee Stock Purchase Plan during the years ended December 31, 2021, 2020, and 2019, respectively. As of December 31, 2021, there were approximately 1.1 million remaining shares available for issuance under the 1997 Employee Stock Purchase Plan.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101989863880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Credit Losses<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditLossAbstract', window );"><strong>Credit Loss [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditLossFinancialInstrumentTextBlock', window );">Credit Losses</a></td>
<td class="text">CREDIT LOSSESWe are exposed to credit losses primarily through our sales of products and services to our customers. We maintain allowances for credit losses for potentially uncollectible receivables. We base our estimates on a detailed analysis of specific customer situations and a percentage of our accounts receivable by aging category. Historical credit loss experience provides the basis for the estimation of expected credit losses. Adjustments to historical loss information are made for differences in current economic conditions. Refer to "Note 2. Accounting Policies" for more information on our adoption of ASU 2016-13 on January 1, 2020, using the modified retrospective transition method.<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional allowances may be required if either the financial condition of our customers was to deteriorate, or a strengthening U.S. dollar impacts the ability of foreign customers to make payments to us on their U.S. dollar-denominated purchases. We monitor our ongoing credit exposure through active review of counterparty balances against contract terms and due dates. Our activities include timely account reconciliations, dispute resolution, and payment confirmations. We may employ collection agencies and legal counsel to pursue recovery of defaulted receivables.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Account balances are charged off against the allowance when we believe it is probable the receivable will not be recovered. We may require collateralized asset support or a prepayment to mitigate credit risk. We do not have any off-balance sheet credit exposure related to our customers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts Receivable</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The allowance for credit losses associated with accounts receivable was $5.7&#160;million and $6.8&#160;million at December 31, 2021, and December 31, 2020, respectively. Accounts receivable reflected on the balance sheet is net of this reserve. Based on an aging analysis, at December 31, 2021, approximately 90% of our accounts receivable had not yet reached the invoice due date and approximately 10% was considered past due, of which approximately 1.8% was greater than 60 days past due. At December 31, 2020, approximately 88% of our accounts receivable had not yet reached the invoice due date and approximately 12% was considered past due, of which approximately 1.5% was greater than 60 days past due. Write-offs and recoveries related to credit losses during the years ended December 31, 2021, 2020, and 2019 were not material.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract assets and lease receivables</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The allowance for credit losses associated with the contract assets and lease receivables was $4.4&#160;million and $3.7&#160;million at December 31, 2021 and 2020, respectively. The assets reflected on the balance sheet are net of these reserves. Historically, we have experienced low credit loss rates on our customer commitment programs and lease receivables. We apply judgment in determining the customer&#8217;s ability and intention to pay, which is based on a variety of factors including the customer&#8217;s historical payment experience or, in the case of a new customer, published credit and financial information pertaining to the customer. Write-offs and recoveries related to credit losses during the years ended December 31, 2021, 2020, and 2019 were not material.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditLossFinancialInstrumentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for credit loss on financial instrument measured at amortized cost basis, net investment in lease, off-balance sheet credit exposure, and available-for-sale debt security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922895-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919272-210447<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919236-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919269-210447<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919244-210447<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919230-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditLossFinancialInstrumentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101989467960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNetAbstract', window );"><strong>Inventory, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventories</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INVENTORIES</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost (first-in, first-out) or net realizable value. Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. We write down the carrying value of inventory for estimated obsolescence by an amount equal to the difference between the cost of inventory and the estimated market value when warranted based on assumptions of future demand, market conditions, remaining shelf life, or product functionality. If actual market conditions or results of estimated functionality are less favorable than those we estimated, additional inventory write-downs may be required, which would have a negative effect on results of operations.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unpaid inventory reflected within accounts payable in our consolidated balance sheets was $64.4 million, $45.6 million, and $39.5 million at December 31, 2021, 2020, and 2019, respectively. Instrument inventory transferred to property and equipment related to rental and operating-type reagent rental programs was $11.6&#160;million, $9.6&#160;million, $14.5&#160;million during the years ended December 31, 2021, 2020, and 2019, respectively.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of inventories are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"><tr><td style="width:1.0%"/><td style="width:68.015%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.549%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.292%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.549%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.895%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,427&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,986&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,397&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,374&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">182,206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143,513&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">269,030&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">209,873&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101989409528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LEASES</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of our facilities are occupied under operating lease arrangements with various expiration dates through 2067, some of which include options to extend the life of the lease, and some of which include options to terminate the lease within 1 year. In certain instances, we are responsible for the real estate taxes and operating expenses related to these facilities.&#160;Additionally, we enter into operating leases for certain vehicles and office equipment in the normal course of business. We determine the expected term of any executed agreements using the non-cancelable lease term plus any renewal options by which the failure to renew imposes a penalty in such amount that renewal is reasonably assured. The derived expected term is then used in the determination of a financing or operating lease and in the calculation of straight-line rent expense. Rent escalations are considered in the calculation of minimum lease payments in our capital lease tests and in determining straight-line rent expense for operating leases. Minimum&#160;lease&#160;payments include the fixed&#160;lease&#160;component of the agreement, as well as fixed rate increases that are initially measured at the&#160;lease&#160;commencement date. Variable lease payments based on an index and payments associated with&#160;non-lease&#160;components and short-term rentals (leases with terms less than 12 months) are expensed as incurred. Consideration is&#160;allocated&#160;to the&#160;lease&#160;and non-lease components based on the estimated standalone prices.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine if an arrangement is a lease at its inception. Operating leases are included in operating lease right-of-use assets, accrued liabilities, and long-term operating lease liabilities in our consolidated balance sheets. Our financing leases are not material to the financial statements.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease liabilities and right-of-use assets are recognized at commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an explicit rate, we use our incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. Our lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Rent expense for lease payments is recognized on a straight-line basis over the lease term. The operating lease right-of-use assets also includes any rent prepayments, lease incentives upon receipt, and straight-line rent expense impacts, which represent the differences between our operating lease liabilities and right-of-use assets.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of operating lease liabilities are as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:85.517%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.283%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,402&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,523&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,675&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,437&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,047&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">122,206&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,898)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease liability (current and long-term)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107,308&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total minimum future lease payments of approximately $1.6 million for leases that have not commenced as of December 31, 2021, are not included in the consolidated financial statements, as we do not yet control the underlying assets. These leases are expected to commence during 2022 through 2024 with lease terms of approximately 3 to 5.25 years.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average remaining lease term - operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.4 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.3 years</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average discount rate - operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expenses incurred related to operating leases, excluding variable and short-term leases, were approximately $23.0 million and $21.7&#160;million during the year ended December 31, 2021 and 2020, respectively. Total expenses incurred related to </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">operating leases, including variable rent and short-term leases, were approximately $25.5 million and $24.5 million for the years ended December 31, 2021 and 2020, respectively.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information for leases is as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended <br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of operating lease liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,214&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,619&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for operating lease obligations, net of early lease&#160;terminations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,572&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,807&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101989886696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment, Net</a></td>
<td class="text">PROPERTY AND EQUIPMENT, NET <div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost, net of accumulated depreciation and amortization. The costs of additions and improvements are capitalized, while maintenance and repairs are charged to expense as incurred. When an item is sold or retired, the cost and related accumulated depreciation are relieved, and the resulting gain or loss, if any, is recognized in the consolidated statements of income. We evaluate our property and equipment for impairment periodically or as changes in circumstances or the occurrence of events suggest the remaining value is not recoverable from future cash flows. If the carrying value of our&#160;property and equipment is impaired, an impairment charge is recorded for the amount by which the carrying value of the property and equipment exceeds its fair value.&#160;We provide for depreciation and amortization primarily using the straight-line method by charges to the consolidated statements of income in amounts that allocate the cost of property and equipment over their estimated useful lives as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:60.246%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.731%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.723%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Asset Classification</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Land improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15 to 20 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10 to 40 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shorter of remaining lease term or useful life of improvements</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 to 8 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Office furniture and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 to 7 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Computer hardware and software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 to 7 years</span></div></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We capitalize interest on the acquisition and construction of significant assets that require a substantial period of time to be made ready for use. The capitalized interest is included in the cost of the completed asset and depreciated over the asset&#8217;s estimated useful life. The amount of interest capitalized during the years ended December 31, 2021 and 2020, was not material.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We capitalize certain costs incurred in connection with developing or obtaining software designated for internal use based on three distinct stages of development. Qualifying costs incurred during the application development stage, which consist primarily of internal payroll and direct fringe benefits and external direct project costs, including labor and travel, are capitalized and amortized on a straight-line basis over the estimated useful life of the asset. Costs incurred during the preliminary project and post-implementation and operation phases are expensed as incurred. These costs relate primarily to the determination of performance requirements, data conversion, and training. Software developed to deliver hosted services to our customers has been designated as internal use.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net, consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.377%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 7.75pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Land and improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,642&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,982&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">329,091&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">319,384&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93,248&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,459&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">382,753&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">353,301&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Office furniture and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69,090&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67,527&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Computer hardware and software</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">276,895&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">265,664&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,339&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,764&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,236,058&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,142,081&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">648,391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">586,914&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">587,667&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">555,167&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below are the amounts of depreciation and amortization of property and equipment, capitalized computer software for internal use, unpaid property and equipment reflected in accounts payable and accrued expenses, and rental and reagent rental program instruments transferred from inventory to property and equipment:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:58.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 7.75pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92,376&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86,095&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78,495&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capitalized computer software developed for internal use</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,753&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,472&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unpaid property and equipment, reflected in accounts payable and accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,343&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,688&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rental and operating-type reagent rental program instruments transferred from inventory to property and equipment (Note 3)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,628&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,645&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:72pt;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had impairments of $5.1&#160;million for the year ended December 31, 2021, associated with a write-down of rental assets in certain regions.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101989898696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Current and Long-Term Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrentAbstract', window );"><strong>Other Assets, Noncurrent [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsDisclosureTextBlock', window );">Other Current and Long-Term Assets</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OTHER CURRENT AND LONG-TERM ASSETS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current assets consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.391%"><tr><td style="width:1.0%"/><td style="width:67.399%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.542%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.542%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.613%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 7.75pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer acquisition costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,942&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,751&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,997&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,556&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract assets, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,772&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,837&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taxes receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,464&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,476&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred sales commissions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,738&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">173,823&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">137,508&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Contract assets, net, are net of allowances for credit loss. Refer to "Note 6. Credit Losses."</span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term assets consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"/><td style="width:67.196%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.862%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.162%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 7.75pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract assets, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">122,160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91,681&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer acquisition costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109,392&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104,369&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,784&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,549&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investment in long-term product supply arrangements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,065&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred sales commissions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,019&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,719&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taxes receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,806&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,329&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,891&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,883&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">330,400&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">289,595&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>(1) Contract assets, net, are net of allowances for credit loss. Refer to "Note 6. Credit Losses<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other assets. This disclosure includes other current assets and other noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101989451912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Intangible Assets, Net</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GOODWILL AND INTANGIBLE ASSETS, NET</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A significant portion of the purchase price for acquired businesses is generally assigned to intangible assets. Intangible assets other than goodwill are initially valued at fair value. If a quoted price in an active market for the identical asset is not readily available at the measurement date, the fair value of the intangible asset is estimated based on discounted cash flows using market participant assumptions, which are assumptions that are not specific to IDEXX. The selection of appropriate valuation methodologies and the estimation of discounted cash flows require significant assumptions about the timing and amounts of future cash flows, risks, appropriate discount rates, and the useful lives of intangible assets. When significant, we utilize independent valuation experts to advise and assist us in determining the fair values of the identified intangible assets acquired in connection with a business acquisition and in determining appropriate amortization methods and periods for those intangible assets. Goodwill is initially valued based on the excess of the purchase price of a business combination over the fair value of acquired net assets recognized and represents the future economic benefits arising from other assets acquired that could not be separately identified and recognized.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business combinations regularly include contingent consideration arrangements that require additional consideration to be paid based on the achievement of established objectives, most commonly related to customer retention or revenue growth of the customer base during the post-combination period. We assess contingent consideration to determine if it should be recognized at its fair value on the acquisition date. A liability resulting from contingent consideration is remeasured to fair value at each reporting date until the contingency is resolved, with changes in fair value recognized in earnings if changes in estimates are made after the measurement period. During the fourth quarter of 2021, we increased the fair value of the contingent payment to ezyVet by $2.0&#160;million. Changes in the fair value of contingent consideration and differences arising upon settlement were not material during the years ended December 31, 2020, and 2019.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We assess goodwill for impairment annually, at the reporting unit level, in the fourth quarter and whenever events or circumstances indicate impairment may exist. In evaluating goodwill for impairment, we have the option to first assess the qualitative factors to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the goodwill impairment test. The more likely than not threshold is defined as having a likelihood of more than 50%. If, after assessing the totality of events or circumstances, we determine that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, we would assess the fair value of all of our reporting units and compare the fair value of the reporting unit to its carrying value to determine if the carrying value exceeds its fair value, and if a goodwill impairment loss should be recognized. In contrast, we can opt to bypass the qualitative assessment for any reporting unit in any period and proceed directly to assessing the fair value of all of our reporting units and compare the fair value of the reporting unit to carrying value to determine if any impairment exists. Doing so does not preclude us from performing the qualitative assessment in any subsequent&#160;period.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2021, we elected to bypass the qualitative approach that allows the assessment of qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount and instead proceeded directly to assessing the fair value of all of our reporting units and comparing the fair values of each reporting unit to the carrying values to determine if any impairment exists. We estimate the fair values of applicable reporting units using an income approach based on discounted forecasted cash flows. We make significant assumptions about the extent and timing of future cash flows, growth rates and discount rates. Model assumptions are based on our projections and best estimates, using appropriate and customary market participant assumptions. In addition, we make certain assumptions in allocating shared assets and liabilities to individual reporting units in determining the carrying value of each reporting unit. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in forecasted cash flows or the discount rate would affect the estimated fair values of our reporting units and could result in a goodwill impairment loss in a future period.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No goodwill impairments were identified during the years ended December 31, 2021, 2020, or 2019, and no accumulated impairment losses are recorded.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We assess the realizability of intangible assets other than goodwill whenever events or changes in circumstances indicate that the carrying value may not be recoverable. If an impairment review is triggered, we evaluate the carrying value of intangible assets based on estimated undiscounted future cash flows over the remaining useful life of the primary asset of the asset group and compare that value to the carrying value of the asset group. The asset group is the lowest level for which identifiable cash flows associated with the intangible asset are largely independent. The cash flows that are used contain our best estimates, using appropriate and customary assumptions and projections at the time. If the net carrying value of an intangible asset exceeds the related estimated undiscounted future cash flows, an impairment loss to adjust the intangible asset to its fair value would be reported as a non-cash charge to earnings. If necessary, we would calculate the fair value of an intangible asset using the present value of the estimated future cash flows to be generated by the intangible asset, and applying a risk-adjusted discount rate. We had no impairments of our intangible assets during the years ended December 31, 2021 and 2019.&#160;The amount of impairment for the year ended December 31, 2020 was immaterial.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill for the years ended December 31, 2021, 2020, and 2019, were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:31.550%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.642%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CAG</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Water</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LPD</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">182,386&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,221&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,351&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,531&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">214,489&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Business combinations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impact of changes in foreign currency exchange rates</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">390&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(119)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">409&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">207,350&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,611&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,232&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,531&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">239,724&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Business combinations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition adjustment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,900)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,900)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impact of changes in foreign currency exchange rates</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,724&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">412&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,303&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">210,394&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,023&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,399&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,531&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">243,347&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Business combinations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">120,346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">120,346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impact of changes in foreign currency exchange rates</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,569)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(695)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,348)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">327,171&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,939&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,704&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,531&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">359,345&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to "Note 4. Acquisitions and Investments" for information regarding goodwill and other intangible assets recognized in connection with the acquisition of businesses and other assets during the years ended December 31, 2021, 2020, and 2019.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide for amortization primarily using the straight-line method by charges to income in amounts that allocate the intangible assets over their estimated useful lives as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:60.246%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.731%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.723%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Asset Classification</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer-related intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 to 17 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product rights </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 to 15 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncompete agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 to 5 years</span></div></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets other than goodwill consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:33.307%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.124%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.124%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.124%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.125%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer-related intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121,936&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,349&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">83,587&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80,810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,838&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,972&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product rights </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,332&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,018&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,609&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,541&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncompete agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">827&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,430&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,030&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143,543&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,508&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99,035&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97,210&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,667&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,543&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">     The above table excludes fully amortized intangible assets for the periods presented.</span></div><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Customer-related intangible assets are comprised of customer lists and customer relationships acquired from third parties.</span></div><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Product rights comprise certain technologies, intellectual property, licenses, and trade names acquired from third parties.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense of intangible assets other than goodwill was $12.1 million, $9.8 million, and $9.4 million for the years ended December 31, 2021, 2020, and 2019, respectively.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2021, the aggregate amortization expense associated with intangible assets is estimated to be as follows for each of the next five years and thereafter:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:81.330%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.470%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortization Expense</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,188&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,430&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,381&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,633&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,370&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,033&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99,035&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101989478280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Liabilities and Other Long Term Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAbstract', window );"><strong>Accrued Liabilities, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureTextBlock', window );">Accrued Liabilities and Other Long Term Liabilities</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ACCRUED LIABILITIES AND OTHER LONG-TERM LIABILITIES</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"><tr><td style="width:1.0%"/><td style="width:67.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.676%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.827%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued employee compensation and related expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">182,926&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">167,649&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">133,978&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">112,526&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued customer incentives and refund obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">79,469&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,064&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,605&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,676&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,931&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,733&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDgvZnJhZzo2YjI1NjU3MGQ2Y2M0ZTllYWY5MDBhYzk2ZTU2Yjg3My90YWJsZTpkMzgwNTNlNWU4ZTg0N2FhYWQ5MDI3M2UxMDAzMzM5MS90YWJsZXJhbmdlOmQzODA1M2U1ZThlODQ3YWFhZDkwMjczZTEwMDMzMzkxXzctMC0xLTEtMA_5d2faed1-a462-48ce-9b44-a109b44ef227"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDgvZnJhZzo2YjI1NjU3MGQ2Y2M0ZTllYWY5MDBhYzk2ZTU2Yjg3My90YWJsZTpkMzgwNTNlNWU4ZTg0N2FhYWQ5MDI3M2UxMDAzMzM5MS90YWJsZXJhbmdlOmQzODA1M2U1ZThlODQ3YWFhZDkwMjczZTEwMDMzMzkxXzctMC0xLTEtMA_e4f554de-7131-4a19-8325-4f920319c89c">Accrued liabilities</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">458,909&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">415,648&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term liabilities consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"/><td style="width:67.501%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.780%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.931%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56,466&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,313&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued long-term expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,475&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,941&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85,604&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101989478840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Debt Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt</a></td>
<td class="text">DEBT <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Credit Facility</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December&#160;9, 2021, we, along with IDEXX Distribution, Inc., IDEXX Operations, Inc., OPTI Medical Systems, Inc., IDEXX Laboratories Canada Corporation, IDEXX B.V., IDEXX Laboratories B.V., and IDEXX Laboratories GmbH, our wholly-owned subsidiaries (whether directly or indirectly held) (collectively, the &#8220;Borrowers&#8221;), entered into a fourth amended and restated credit agreement (the &#8220;Credit Agreement&#8221;) relating to a five year unsecured revolving credit facility in the principal amount of $1 billion, among the Borrowers, the lenders party thereto, JPMorgan Chase Bank, N.A., as administrative agent, JPMorgan Chase Bank, N.A., Toronto Branch, as Toronto agent, and the other parties thereto.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement amends and restates that certain third amended and restated credit agreement, dated as of April 14, 2020, (which provided for a $1&#160;billion three-year unsecured revolving credit facility) to extend the maturity to December 9, 2026 with aggregate commitments available for borrowing by the Borrowers of $1&#160;billion with the option to increase the aggregate commitments by $250&#160;million, for an aggregate maximum of up to $1.25&#160;billion, subject to the Borrowers obtaining commitments from existing or new lenders and satisfying other conditions specified in the Credit Agreement.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our Credit Facility prior to the December&#160;9, 2021 amendment, the applicable interest rates on borrowings are based on the prevailing LIBOR, Canadian Dollar Rate, or EURIBOR, but not less than 1.0%, plus a credit spread ranging from 1.375% to 2.00%, based on our gross leverage ratio. The Credit Facility also allowed for borrowings based on the prevailing Prime rate, but not less than 2.00%, plus a credit spread from 0.375% to 1.00%. Under the Credit Facility, we also pay quarterly commitment fees ranging from 0.2% to 0.375%, based on our leverage ratio, on any unused commitment. Under our current amended Credit Facility, the applicable interest rates on borrowings are based on the prevailing LIBOR, Canadian Dollar Rate, or EURIBOR, but not less than 0.0%, plus a credit spread ranging from 0.875% to 1.375%, depending on our gross leverage ratio. The Credit Facility also allowed for borrowings based on the prevailing Prime rate, but not less than 1.00%, plus a credit spread from 0.0% to 0.375%. Under the current Credit Facility, we also pay quarterly commitment fees ranging from 0.075% to 0.25%, based on our leverage ratio, on any unused commitment. Our Credit Facility includes a provision for the determination of one or more benchmark replacement rates (including SOFR) as a successor to the LIBOR rate. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2021, we had $73.5 million outstanding borrowings under our Credit Facility with a weighted average effective interest rate of 1.1%. Our weighted average borrowing rate for the year ended December 31, 2021, was 2.7%, which reflected borrowings under our prior Credit Facility. At December 31, 2020, we had&#160;no&#160;outstanding borrowings under our Credit Facility. The funds available under the Credit Facility reflect a further reduction due to the issuance of letters of credit, which were issued in connection with our workers&#8217; compensation&#160;policy, for $1.4 million in the year ended December 31, 2021 and 2020.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Credit Facility does not mature until December 9, 2026, all individual borrowings under the terms of the Credit Facility with an interest rate based on the prevailing LIBOR, Canadian Dollar Rate, or EURIBOR (as selected by the Borrower) have a stated term between 1 and 180 days. At the end of each term, the obligation is either repaid or rolled over into a new borrowing, or replaced by a borrowing based on a specific benchmark rate (where interest is then paid monthly). The Credit Facility contains a subjective material adverse event notification clause, which allows the debt holders to call the loans under the Credit Facility if we fail to provide prompt written notice to the syndicate of such an event. Based on the stated term and the existence of the subjective material adverse event clause, this Credit Facility is reflected in the current liabilities section of our consolidated balance sheets. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The obligations under the Credit Facility may be accelerated upon the occurrence of an event of default under the Credit Facility, which includes customary events of default including payment defaults, defaults in the performance of the affirmative, negative and financial covenants, the inaccuracy of representations or warranties, bankruptcy and insolvency </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">related defaults, defaults relating to judgments, certain events related to employee pension benefit plans under the Employee Retirement Income Security Act of 1974, the failure to pay specified indebtedness, cross-acceleration to specified indebtedness, and a change of control default. The Credit Facility contains affirmative, negative, and financial covenants customary for financings of this type. The negative covenants include restrictions on liens, indebtedness of subsidiaries of the Company, fundamental changes, investments, transactions with affiliates, and certain restrictive agreements. The sole financial covenant is a consolidated leverage ratio test that requires our ratio of debt to earnings before interest, taxes, depreciation, amortization, and share-based compensation defined as the consolidated leverage ratio under the terms of the Credit Facility, not to exceed 3.5-to-1. At December 31, 2021, we were in compliance with the covenants of the Credit Facility.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Senior Notes</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following describes all of our currently outstanding unsecured senior notes issued and sold in private placements (collectively, the "Senior Notes") as of December 31, 2021:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"/><td style="width:8.796%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.833%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.387%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.833%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.272%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.981%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.833%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.580%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.833%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.847%"/><td style="width:0.1%"/></tr><tr><td colspan="33" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Principal Amount in thousands)</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Issue Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Due Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Series</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Principal Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Coupon Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Senior Note Agreement</span></td></tr><tr style="height:8pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12/11/2013</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12/11/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023 Series A Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.94&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">NY Life 2013 Note Agreement</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12/11/2013</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12/11/2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025 Series B Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">NY Life 2013 Note Agreement</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9/4/2014</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9/4/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026 Senior Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">NY Life 2014 Note Agreement</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7/21/2014</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7/21/2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024 Series B Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prudential 2015 Amended Agreement</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6/18/2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6/18/2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025 Series C Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8364;</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,857&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.785&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prudential 2015 Amended Agreement</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/12/2015</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/12/2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022 Series A Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MetLife 2014 Note Agreement</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/12/2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/12/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027 Series B Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MetLife 2014 Note Agreement</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3/14/2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3/14/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2029 Series C Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MetLife 2014 Note Agreement</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4/2/2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4/2/2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MetLife 2030 Series D Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MetLife 2014 Note Agreement</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4/14/2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4/14/2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prudential 2030 Series D Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prudential 2015 Amended Agreement</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following narrative represents our Senior Note activity:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">NY Life 2013 and 2014 Note Agreements, Including Amendments</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2013, we issued and sold through a private placement an aggregate principal amount of $150 million of unsecured senior notes consisting of $75 million of 3.94% Series A Senior Notes due December&#160;11, 2023 (the &#8220;2023 Series A Notes&#8221;) and $75 million of 4.04% Series B Senior Notes due December&#160;11, 2025 (the &#8220;2025 Series B Notes&#8221;) under a Note Purchase Agreement among the Company, New York Life Insurance Company and the accredited institutional purchasers named therein (as amended on April 10, 2020, the &#8220;NY Life 2013 Note Agreement&#8221;).</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2014, we issued and sold through a private placement an aggregate principal amount of $75 million of unsecured 3.72% senior notes due September 4, 2026 (the &#8220;2026 Senior Notes&#8221;) under a Note Purchase Agreement dated as of July 22, 2014, among the Company, New York Life Insurance Company and the accredited institutional purchasers named therein (as amended April 10, 2020, the &#8220;NY Life 2014 Note Agreement&#8221;).</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 10, 2020, we amended the NY Life 2013 Note Agreement and the NY Life 2014 Note Agreement by entering into two Amendments to Note Purchase Agreement with New York Life Insurance Company and the other parties thereto, which modified several defined terms, schedules and covenant baskets in the NY Life 2013 Agreement and the NY Life 2014 Note Agreement to create additional operating flexibility, and in particular to align such provisions with similar modifications we made substantially concurrently in our other debt facilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Prudential 2015 Amended Agreement, Including Amendments</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2014, we issued and sold through a private placement an aggregate principal amount of $125 million of unsecured senior notes consisting of $50 million of 3.32% Series A Senior Notes due July&#160;21, 2021 (the &#8220;2021 Series A Notes&#8221;) and $75 million of 3.76% Series B Senior Notes due July&#160;21, 2024 (the &#8220;2024 Series B Notes&#8221;) under a Note Purchase and Private Shelf Agreement among the Company, Prudential Investment Management, Inc. (&#8220;Prudential&#8221;) and the accredited </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">institutional purchasers named therein (the &#8220;Prudential 2014 Note Agreement&#8221;). The $50&#160;million 3.32% Series A Senior Note was repaid in full on the July 21, 2021 due date.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2015, we entered into an Amended and Restated Multi-Currency Note Purchase and Private Shelf Agreement (the &#8220;Original Prudential 2015 Amended Agreement"), among the Company, Prudential, and the accredited institutional purchasers named therein, which amends and restates the Prudential 2014 Note Agreement. Pursuant to the Original Prudential 2015 Amended Agreement, we issued and sold through an aggregated private placement an aggregate principal amount of &#8364;88.9 million of unsecured 1.785%&#160;Series&#160;C Senior Notes due June&#160;18, 2025 (the &#8220;2025 Series C Notes&#8221;).</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 9, 2019, we entered into the Amendment to Note Purchase and Private Shelf Agreement (the "Prudential First Amendment") with Prudential and the other parties thereto, which amended certain reporting provisions in the Original Prudential 2015 Amended Agreement. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 10, 2020, we entered into the Second Amendment to the Prudential 2015 Amended Agreement (the &#8220;Prudential Second Amendment&#8221;), in order to (i) increase the facility size to $425&#160;million, (ii) extend the facility issuance period to April 10, 2023, (iii) make various implementing and administrative changes in order to facilitate a $75&#160;million notes issuance on April 14, 2020, (iv) allow the amount available to be issued under the facility to equal $425&#160;million less the amount of notes outstanding from time to time during the issuance period and (v)&#160;modify several defined terms, schedules and covenant baskets in the Original Prudential 2015 Amended Agreement, as amended by the Prudential First Amendment, to create additional operating flexibility, and in particular to align such provisions with similar modifications we made substantially concurrently in our other debt facilities. We refer to the Original Prudential 2015 Agreement, as amended by the Prudential First Amendment and the Prudential Second Amendment, as the "Prudential 2015 Amended Agreement."</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 14, 2020, we issued and sold to Prudential and other purchasers $75&#160;million of our unsecured senior notes (the &#8220;Prudential 2030 Series D Notes&#8221;) pursuant to the Prudential Second Amendment. The entire outstanding balance of the Prudential 2030 Series D Notes is due and payable on April 14, 2030, and the Prudential 2030 Series D Notes bear interest at the rate of 2.50% per annum. We used the proceeds received from the Prudential 2030 Series D Notes for general corporate purposes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">MetLife 2014 Note Agreement, Including Amendments</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We entered into a Multicurrency Note Purchase and Private Shelf Agreement, dated as of December 19, 2014 (the "Original MetLife 2014 Note Agreement"), among the Company, Metropolitan Life Insurance Company (&#8220;MetLife&#8221;) and the accredited institutional purchasers named therein pursuant to which we agreed to issue and sell an aggregate principal amount of $150 million of unsecured senior notes consisting of $75 million of our 3.25% Series A Senior Notes having a seven-year term (the "2022 Series A Notes"), and $75 million of our 3.72% Series B Senior Notes having a twelve-year term ("2027 Series B Notes"). The issuance, sale and purchase of these&#160;notes occurred in February 2015. The aggregate principal amount of our 2022 Series A Notes for $75.0&#160;million will become due and payable on February 12, 2022.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 14, 2019, we amended the Original MetLife 2014 Note Agreement. Pursuant to the Original MetLife 2014 Note Agreement, as so amended, we issued and sold through a private placement an aggregate principal amount of $100 million of unsecured senior notes at a 4.19% per annum rate, due March 14, 2029 (the "2029 Series C Notes").</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 23, 2020, we entered into the Second Amendment to the Original MetLife 2014 Note Agreement (the &#8220;MetLife Second Amendment&#8221;), in order to (i) increase the facility size from $150&#160;million to $300&#160;million, (ii) extend the facility issuance period to December 20, 2022, (iii) make various implementing and administrative changes in order to facilitate a $125&#160;million notes issuance on April 2, 2020 and (iv) allow the amount available to be issued under the facility to equal $300&#160;million, less the amounts outstanding on 2029 Series C Notes and MetLife 2030 Series D Notes.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 2, 2020, we issued and sold to MetLife and other purchasers $125&#160;million of our unsecured senior notes (the &#8220;MetLife 2030 Series D Notes&#8221;) pursuant to the MetLife Second Amendment. The entire outstanding principal balance of the MetLife 2030 Series D Notes is due and payable on April 2, 2030, and the MetLife 2030 Series D Notes bear interest at the rate of 2.50% per annum. We used the proceeds received from the MetLife 2030 Series D Notes for general corporate purposes. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We refer to the Original MetLife 2014 Agreement, as so amended, as the "MetLife 2014 Agreement," and together with the NY Life 2013 Note Agreement, NY Life 2014 Note Agreement, and Prudential 2015 Amended Note Agreement, collectively, as the "Senior Note Agreements."</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Senior Note Agreements</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Senior Note Agreements contain affirmative, negative, and financial covenants customary for agreements of this type. The negative covenants include restrictions on liens, indebtedness of our subsidiaries, priority indebtedness, fundamental changes, investments, transactions with affiliates, certain restrictive agreements, and violations of laws and regulations. The sole financial covenant is a consolidated leverage ratio test that requires our ratio of debt to earnings before interest, taxes, depreciation, amortization, and share-based compensation, as defined in the Senior Note Agreements, not to exceed 3.5-to-1. At December 31, 2021, we were in compliance with the covenants of the Senior Note Agreements.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Should we elect to prepay the Senior Notes, such aggregate prepayment will include the applicable make-whole amount(s), as defined within the applicable Senior Note Agreements. Additionally, in the event of a change in control of the Company or upon the disposition of certain assets of the Company the proceeds of which are not reinvested (as defined in the Senior Note Agreements), we may be required to prepay all or a portion of the Senior Notes. The obligations under the Senior Notes may be accelerated upon the occurrence of an event of default under the applicable Senior Note Agreement, each of which includes customary events of default including payment defaults, defaults in the performance of the affirmative, negative and financial covenants, the inaccuracy of representations or warranties, bankruptcy and insolvency related defaults, defaults relating to judgments, certain events related to employee pension benefit plans under the Employee Retirement Income Security Act of 1974, the failure to pay specified indebtedness and cross-acceleration to specified indebtedness. We used the net proceeds from the issuances and sale of the Senior Notes for general corporate purposes. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Annual principal payments on long-term debt at December 31, 2021, are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:71.773%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ending December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">175,711&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">375,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">850,711&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total interest paid on all debt (including our Credit Facility) for the years ended December 31, 2021, 2020, and 2019, was $30.5 million, $32.4 million, and $29.7 million, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101989867832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INCOME TAXES</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes is determined using the asset and liability approach of accounting for income taxes. Under this approach, deferred taxes represent the estimated future tax effects of temporary differences between book and tax treatment of assets and liabilities and carryforwards to the extent they are realizable. We record a valuation allowance to reduce our deferred tax assets to the amount that is more likely than not to be realized. In assessing the need for a valuation allowance, we consider future taxable income and ongoing prudent and feasible tax planning strategies. In the event that we determine that we would be able to realize our deferred tax assets in the future in excess of the net recorded amount, a reduction of the valuation allowance would increase income in the period such determination was made. Likewise, should we determine that we would not be able to realize all or part of our net deferred tax asset in the future, a reduction to the deferred tax asset would be charged to income in the period such determination was made.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record a liability for uncertain tax positions that do not meet the more likely than not standard as prescribed by the authoritative guidance for income tax accounting. We record tax benefits for only those positions that we believe will more likely than not be sustained.&#160;Unrecognized tax benefits are the differences between tax positions taken, or expected to be taken, in tax returns, and the benefits recognized for accounting purposes. We classify uncertain tax positions as long-term liabilities.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant judgment is required in determining our worldwide provision for income taxes and our income tax filings are regularly under audit by tax authorities. Any audit result differing from amounts recorded would increase or decrease income in the period that we determine such adjustment is likely. Interest expense and penalties associated with the underpayment of income taxes are included in income tax expense.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings before income taxes were as follows:</span><span style="font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%"/></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:58.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Domestic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">689,994&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">483,694&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">377,964&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">212,660&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">178,291&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">144,254&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 30.25pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">902,654&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">661,985&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">522,218&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision (benefit) for income taxes comprised the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:58.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">112,811&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72,921&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,147&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,967&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,288&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,301&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">161,246&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">116,568&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,400&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,019)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,126)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,826&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(503)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,863)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">269&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,086&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19,725)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">931&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,436)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36,714)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,026&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">157,810&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">79,854&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94,426&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes differs from the amounts computed by applying the statutory federal income tax rate as follows:</span><span style="font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%"/></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:58.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. federal statutory rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State income tax, net of federal tax benefit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taxation on international earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign derived intangible income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation from settlements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development credit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impact of Switzerland tax reform</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:27pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our effective income tax rate was 17.5% for the year ended December 31, 2021, and 12.1% for the year ended December 31, 2020. Our effective income tax rate for the year ended December 31, 2021, was higher primarily due to the prior year one-time positive impact related to the enactment of tax reform in Switzerland due to recording a deferred tax asset related to the transitional benefits, as well as higher tax benefits in the prior year related to share-based compensation.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective income tax rate was 12.1% for the year ended December 31, 2020, and 18.1% for the year ended December 31, 2019. Our effective income tax rate for the year ended December 31, 2020, was lower primarily due to the one-time positive impact related to the enactment of tax reform in Switzerland due to recording a deferred tax asset related to the transitional benefits, as well as higher tax benefits related to share-based compensation. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes paid, net of refunds received, for the periods ended December 31, 2021, 2020, and 2019, were $161.7 million, $110.7 million, and $88.0 million, respectively.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have received a tax ruling from the Netherlands that documents our mutual understanding of how existing tax laws apply to our circumstances. Primarily as a result of this tax ruling, our net income was higher by $21.4 million,&#160;$14.2 million, and $13.7 million for the years ended December 31, 2021, 2020,&#160;and&#160;2019, respectively. The benefits from our tax rulings are reflected within the overall benefits received from taxation on international earnings in the table above. On December 21, 2021, </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">the Netherlands adopted legislation eliminating the tax benefits related to this tax ruling for tax years beginning after December 31, 2021. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the net deferred tax assets (liabilities) included in the accompanying consolidated balance sheets are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:66.594%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.318%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.320%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,433&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,830&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable reserves</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,131&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,269&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,629&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventory basis differences</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,553&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,272&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property-based differences</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,865&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible asset basis differences</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,606&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,319&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,484&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,570&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,427&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax credit carryforwards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,483&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,385&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized losses on foreign currency exchange contracts and investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,755&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,060&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">161,835&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">162,787&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(39,280)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(40,262)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets, net of valuation allowance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">122,555&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">122,525&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7.75pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer acquisition costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(37,265)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34,449)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property-based differences</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(42,363)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(49,547)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible asset basis differences</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17,345)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16,134)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,662)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,241)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized gains on foreign currency exchange contracts and investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,071)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(312)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(106,706)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(102,683)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net deferred tax assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,849&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,842&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, we record valuation allowances against certain deferred tax assets related to temporary differences, including intangible asset basis differences and net operating loss (&#8220;NOL&#8221;) and tax credit carryforwards, as it is more likely than not that they will not be realized or utilized within the carryforward period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in valuation allowance for deferred tax assets:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:58.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,262&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,454&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,212&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Charges to costs and expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,464&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,076&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,489&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Write-off/cash payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,182)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(226)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,264)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(234)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at the end of the year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,280&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,262&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,454&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, we have NOLs in certain state and international jurisdictions of approximately $32.9 million available to offset future taxable income. Most of these NOLs will expire at various dates between 2022 and 2028 and the remainder have indefinite lives.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in unrecognized tax positions:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:58.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total amounts of unrecognized tax benefits, beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,484&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,841&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross increases (decreases) in unrecognized tax positions as a result of tax positions taken during a prior period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">443&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,755)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(276)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross increases in unrecognized tax positions as a result of tax positions taken in the current period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,083&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Decreases in unrecognized tax positions related to settlements with taxing authorities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(537)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,446)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Decreases in unrecognized tax positions as a result of a lapse of the applicable statutes of limitations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,015)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(355)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,213)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total amounts of unrecognized tax benefits, end of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,789&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,484&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,841&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Of the total unrecognized tax benefits at December 31, 2021 and 2020, $22.2 million and $21.8 million, respectively, comprise unrecognized tax positions that would, if recognized, affect our effective tax rate.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December 31, 2021, 2020, and 2019, we recorded interest expense and penalties of $1.1 million, $1.3 million, and $1.8 million, respectively, as income tax expense in our consolidated statement of income. At December 31, 2021, 2020, and 2019, we had $3.8 million, $3.6 million, and $3.6 million, respectively, of estimated interest expense and penalties accrued in our consolidated balance sheets.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of our business, our income tax filings are regularly under audit by tax authorities. While we believe we have appropriately provided for all uncertain tax positions, amounts asserted by taxing authorities could be greater or less than our accrued position. Accordingly, additional provisions on income tax matters, or reductions of previously accrued provisions, could be recorded in the future as we revise our estimates due to changing facts and circumstances or the underlying matters are settled or otherwise resolved. We are currently under tax examinations in various jurisdictions. We anticipate that these examinations will be concluded within the next two years. With few exceptions, we are no longer subject to income tax examinations in any jurisdiction in which we conduct significant taxable activities for years before 2016.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101989449672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EARNINGS PER SHARE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is computed by dividing net income attributable to our stockholders by the weighted average number of shares of common stock and vested deferred stock units outstanding during the year. The computation of diluted earnings per share is similar to the computation of basic earnings per share, except that the denominator is increased for the assumed exercise of dilutive options and assumed issuance of unvested restricted stock units and unvested deferred stock units using the treasury stock method unless the effect is anti-dilutive. The treasury stock method assumes that proceeds, including cash received from the exercise of employee stock options and the&#160;total unrecognized compensation expense for unvested share-based compensation awards, would be used to purchase our common stock at the average market price during the period.&#160;Vested deferred stock units outstanding are included in shares outstanding for basic and diluted earnings per share because the associated shares of our common stock are issuable for no cash consideration, the number of shares of our common stock to be issued is fixed and issuance is not contingent. Refer to "Note 5. Share-Based Compensation" for additional information regarding deferred stock units.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of weighted average shares outstanding for basic and diluted earnings per share:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:58.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares outstanding for basic earnings per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85,342&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86,115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares outstanding for diluted earnings per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares outstanding for basic earnings per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85,342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86,115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive effect of share-based payment awards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,372&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,380&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,427&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86,572&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86,722&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87,542&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain options to acquire shares have been excluded from the calculation of shares outstanding for diluted earnings per share because they were anti-dilutive. The following table presents information concerning those anti-dilutive options:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:58.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average number of shares underlying anti-dilutive options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101989422312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments, Contingencies and Guarantees<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock', window );">Commitments, Contingencies and Guarantees</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COMMITMENTS, CONTINGENCIES AND GUARANTEES</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commitments</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to "Note 8. Leases" for more information regarding our lease commitments.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are required to annually purchase a minimum amount of inventory from certain suppliers. Through 2026, we have a total of $2.9 million in minimum purchase commitments under these arrangements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingencies</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to claims that&#160;may&#160;arise in the ordinary course of business, including with respect to actual and threatened litigation and other matters. We accrue for loss contingencies when it is probable that future expenditures will be made, and such expenditures can be reasonably estimated. However, the results of legal actions cannot be predicted with certainty, and therefore our actual losses with respect to these contingencies could exceed our accruals. Except for the litigation matter described below, at December 31, 2021, our accruals with respect to actual and threatened litigation were not material. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;We are a defendant in an ongoing litigation matter involving an alleged breach of contract for underpayment of royalty payments made from 2004 through 2017 under an expired patent license agreement. The plaintiff has asserted a claim of approximately $50&#160;million, inclusive of interest through June 30, 2020, alleging that the incorrect royalty provision was applied to certain licensed products and services throughout the agreement term and that royalties were also due on non-licensed diagnostic services that were provided concurrently with licensed services. The trial court previously ruled in favor of the plaintiff in this matter and we are appealing the judgment and continue to vigorously defend ourselves against the plaintiff&#8217;s allegations. While we believe the claim is without merit, litigation is inherently unpredictable and there can be no assurance that we will prevail in this matter. During the third quarter of 2020, we established an accrual of $27.5&#160;million related to this ongoing matter, which represents the amount of a contingent loss that we have determined to be probable and estimable. We have not made any adjustments to this accrual since it was established. The actual cost of resolving this matter may be higher or lower than the amount we have accrued.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We self-insure costs associated with health, workers&#8217; compensation, auto, and general welfare claims incurred by our U.S. and Canadian employees up to certain limits. Insurance companies provide insurance for claims above these limits. Claim liabilities are recorded for estimates of the loss that we will ultimately incur on reported claims, as well as estimates of claims that have been incurred but not yet reported. Such liabilities are based on individual coverage, the average time from when a claim is incurred to the time it is paid and judgments about the present, and expected levels of claim frequency and severity. Estimated claim liabilities could be significantly affected if future occurrences and claims differ from these assumptions and historical trends. Estimated claim liabilities are included in accrued liabilities in the accompanying consolidated balance sheets.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our current employee healthcare insurance policy for U.S. employees, we retain claims liability risk per incident up to $1 million per year in 2021, 2020, and 2019. We recognized U.S. employee healthcare claim expense of $78.5 million, $59.5 million, and $59.3 million for the years ended December 31, 2021, 2020, and 2019, respectively, which represents actual claims paid and an estimate of our liability for the uninsured portion of employee healthcare obligations that have been incurred but not paid. Should employee health insurance claims exceed our estimated liability, we would have further obligations. Our estimated liability for healthcare claims that have been incurred but not paid as of December 31, 2021 and 2020, was approximately $7.8 million and $5.5 million, respectively.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Workers&#8217; compensation and automobile claim expenses recognized during the years ended December 31, 2021, 2020, and 2019 and our respective liability for such claims as of December 31, 2021, 2020, and 2019 were not material. For the years ended on or prior to December&#160;31, 2018, based on our retained claim liability per incident and our aggregate claim liability per year, our maximum liability in excess of the amounts deemed probable and previously recognized is not material as of </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 31, 2021. As of December 31, 2021, we had outstanding letters of credit totaling $1.4 million to the insurance companies as security for the claims in connection with these policies.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into an employment agreement with our chief executive officer whereby payment may be required if we terminate his employment without cause other than following a change in control. The amount payable is based upon the executive&#8217;s salary at the time of termination and the cost to us of continuing to provide certain benefits. Had this officer been terminated without cause at December 31, 2021, other than following a change in control, we would have had an obligation for salaries and benefits of approximately $2.0 million under such agreement. In addition, the agreement provides for continued vesting of his outstanding equity awards for a period of two years, which would accelerate approximately $8.0 million of share-based compensation expense as of December 31, 2021.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into employment agreements with each of our officers that require us to make certain payments in the event the officer&#8217;s employment is terminated under certain circumstances within a certain period following a change in control. The amount payable by us under each of these agreements is based on the officer&#8217;s salary and bonus history at the time of termination and the cost to us of continuing to provide certain benefits. Had all of our officers been terminated in qualifying terminations following a change in control at December 31, 2021, we would have had aggregate obligations of approximately $42.2 million under these agreements. These agreements also provide for the acceleration of the vesting of all stock options and restricted stock units upon any qualifying termination following a change in control. At this time, we believe the likelihood of terminations as a result of the scenarios described is remote, and therefore, we have not accrued for such loss contingencies.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we have received notices alleging that our products infringe third-party proprietary rights, although we are not aware of any pending litigation with respect to such claims. Patent litigation frequently is complex and expensive, and the outcome of patent litigation can be difficult to predict. There can be no assurance that we will prevail in any infringement proceedings that may be commenced against us. If we lose any such litigation, we may be stopped from selling certain products and/or we may be required to pay damages as a result of the litigation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Guarantees</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into agreements with third parties in the ordinary course of business under which we are obligated to indemnify such third parties for and against various risks and losses. The precise terms of such indemnities vary with the nature of the agreement. In many cases, we limit the maximum amount of our indemnification obligations, but in some cases, those obligations may be theoretically unlimited. We have not incurred material expenses in discharging any of these indemnification obligations and, based on our analysis of the nature of the risks involved, we believe that the fair value of potential indemnification under these agreements is minimal. Accordingly, we have recorded no liabilities for these obligations at December 31, 2021 and 2020.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When acquiring a business, we sometimes assume liability for certain events or occurrences that took place prior to the date of acquisition. As of December 31, 2021 and 2020, we do not have any material pre-acquisition liabilities recorded.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments, contingencies, and guarantees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -URI http://asc.fasb.org/topic&amp;trid=2155896<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>135
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101995893064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Reporting</a></td>
<td class="text">SEGMENT REPORTING <div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate primarily through three business segments: diagnostic and information management-based products and services for the companion animal veterinary industry, which we refer to as CAG; water quality products (&#8220;Water&#8221;); and diagnostic products and services for livestock and poultry health, improve producer efficiency, and to ensure the quality and safety of milk, which we refer to as LPD. Our Other operating segment combines and presents our human medical diagnostic products and services business with our out-licensing arrangements because they do not meet the quantitative or qualitative thresholds for reportable segments.&#160;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision-maker (the "CODM"), or decision-making group, in deciding how to allocate resources and in assessing performance. Our CODM is our Chief Executive Officer. Our reportable segments include: CAG, Water, LPD, and Other. Assets are not allocated to segments for internal reporting purposes.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CAG provides products and provide services for veterinarians and the biomedical research community, primarily related to diagnostics and information management. Water provides a range of innovative products used in the detection and quantification of various microbiological parameters in water. LPD provides diagnostic tests and related instrumentation and provides services that are used to manage the health status of livestock and poultry, to improve producer efficiency, and to ensure the quality and safety of milk. OPTI Medical develops, manufactures, and distributes human medical diagnostic products and provides human medical diagnostic services.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intersegment revenues, which are not included in the table below, were not material for the years ended December 31, 2021, 2020, and 2019.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of segment performance:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.797%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CAG</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Water</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LPD</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,889,960&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">146,505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">135,887&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,215,360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">824,022&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65,444&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,636&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,926&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">932,028&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(29,374)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income before provision for income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">902,654&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">157,810&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">744,844&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Net income attributable to noncontrolling interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to IDEXX Laboratories, Inc. stockholders</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">744,845&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94,202&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,709&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,908&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,777&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104,596&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,385,765&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">128,625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">145,845&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,420&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,706,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">574,887&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,867&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,008&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,762&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">694,524&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32,539)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income before provision for income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">661,985&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">79,854&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">582,131&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Net income attributable to noncontrolling interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to IDEXX Laboratories, Inc. stockholders</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">581,776&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,697&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,630&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,070&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,601&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95,998&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,119,183&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132,635&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,240&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,406,908&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">462,605&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61,923&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,735&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,583&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">552,846&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,628)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income before provision for income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">522,218&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94,426&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">427,792&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Net income attributable to noncontrolling interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to IDEXX Laboratories, Inc. stockholders</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">427,720&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77,620&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,794&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,007&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,590&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,011&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to "Note 3. Revenue Recognition" for a summary of disaggregated revenue by reportable segment and by major product and service category for the years ended December 31, 2021, 2020, and 2019.&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net long-lived assets, consisting of net property and equipment, are subject to geographic risks because they are generally difficult to move and to effectively utilize in another geographic area in a reasonable time period and because they are relatively illiquid. Net long-lived assets by principal geographic areas were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:66.594%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.318%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.320%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Americas</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">436,003&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">412,700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Brazil</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,043&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,797&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,003&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,993&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 12.25pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">460,049&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">438,490&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Europe, the Middle East and Africa</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,451&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67,354&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,828&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,191&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Netherlands</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,405&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,267&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">France</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,884&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,062&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Switzerland</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,545&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,821&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,668&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98,934&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102,285&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asia Pacific Region</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,845&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Australia</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,584&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,304&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,585&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,684&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,392&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">587,667&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">555,167&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101989448552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FAIR VALUE MEASUREMENTS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. GAAP defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. U.S. GAAP requires an entity to maximize the use of observable inputs, where available, and minimize the use of unobservable inputs when measuring fair value.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have certain financial assets and liabilities that are measured at fair value on a recurring basis, certain nonfinancial assets and liabilities that may be measured at fair value on a non-recurring basis, and certain financial assets and liabilities that are not measured at fair value in our consolidated balance sheets but for which we disclose the fair value. The fair value disclosures of these assets and liabilities are based on a three-level hierarchy, which is defined as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:498.00pt"><tr><td style="width:1.0pt"/><td style="width:85.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:409.00pt"/><td style="width:1.0pt"/></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quoted prices in active markets for identical assets or liabilities that the entity can access at the measurement date.</span></td></tr><tr style="height:33pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities measured at fair value are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability. We did not have any transfers between Level 1 and Level 2, or transfers in or out of Level 3, of the fair value hierarchy during the years ended December 31, 2021 and 2020.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cross currency swap contracts are measured at fair value on a recurring basis in our accompanying consolidated balance sheets. We measure the fair value of our cross currency swap contracts classified as derivative instruments using prevailing market conditions as of the close of business on each balance sheet date. The product of this calculation is then adjusted for counterparty risk.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our foreign currency exchange contracts are measured at fair value on a recurring basis in our accompanying consolidated balance sheets. We measure the fair value of our foreign currency exchange contracts classified as derivative </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">instruments using an income approach, based on prevailing market forward rates less the contract rate multiplied by the notional amount. The product of this calculation is then adjusted for counterparty risk.&#160;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts outstanding under our unsecured revolving credit facility ("Credit Facility" or &#8220;line of credit&#8221;) and senior notes (&#8220;long-term debt&#8221;) are measured at carrying value in our accompanying consolidated balance sheets though we disclose the fair value of these financial instruments. We determine the fair value of the amount outstanding under our Credit Facility and long-term debt using an income approach, utilizing a discounted cash flow analysis based on current market interest rates for debt issues with similar remaining years to maturity, adjusted for applicable credit risk. Our Credit Facility and long-term debt are valued using Level 2 inputs. The estimated fair value of our Credit Facility approximates its carrying value. At December 31, 2021, the estimated fair value and carrying value of our long-term debt were $916.3 million and $850.7 million, respectively. At December 31, 2020, the estimated fair value and carrying value of our long-term debt were $1.0 billion and $909.1 million, respectively.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth our assets and liabilities that were measured at fair value on a recurring basis by level within the fair value hierarchy:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:45.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.402%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Quoted Prices in Active Markets for Identical Assets <br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant Other Observable Inputs <br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant Unobservable Inputs <br/>(Level 3)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Money market funds </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity mutual funds </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross currency swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange contracts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange contracts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">601&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">601&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred compensation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">826&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">826&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent payments - acquisitions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:45.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.402%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Quoted Prices in Active Markets for Identical Assets <br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant Other Observable Inputs <br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant Unobservable Inputs <br/>(Level 3)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at December 31, 2020</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Money market funds </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity mutual funds </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange contracts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross currency swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,841&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,841&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange contracts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred compensation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Money market funds with an original maturity of less than ninety days are included within cash and cash equivalents. The remaining balance of cash and cash equivalents as of December 31, 2021, and December 31, 2020, consisted of demand deposits.</span></div><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Equity mutual funds relate to a deferred compensation plan that was assumed as part of a previous business combination. This amount is included within other long-term assets. Refer to footnote (4) below for a discussion of the related deferred compensation liability.</span></div><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Cross currency swaps and foreign currency exchange contracts are included within other current assets; other long-term assets; accrued liabilities; or other long-term liabilities depending on the gain (loss) position and anticipated settlement date.</span></div><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">A deferred compensation plan assumed as part of a previous business combination is included within accrued liabilities and other long-term liabilities. The fair value of our deferred compensation plan is indexed to the performance of the underlying equity mutual funds discussed in footnote (2) above.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair values of certain financial instruments, including cash and cash equivalents, accounts receivable, and accounts payable, approximate carrying value due to their short maturity.&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingent Consideration</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have classified our liabilities for contingent consideration related to acquisitions within Level 3 of the fair value hierarchy because the fair value is determined using significant unobservable inputs, which includes the achievements of future revenues. The contingent consideration is included within other short-term liabilities.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record changes in the estimated fair value of contingent consideration in the consolidated statements of income. Changes in contingent consideration liabilities are measured at fair value on a recurring basis using unobservable inputs (Level 3) and during the year ended December 31, 2021, are as follows:</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.794%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.276%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Contingent consideration as of December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent consideration recorded from acquisitions (Note 4)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,230&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in estimated fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Contingent consideration as of December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,230&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We originally recorded a $5.0&#160;million contingent consideration associated with our acquisition of ezyVet during the second quarter of 2021. During the fourth quarter of 2021, we increased the contingent consideration by $2.0&#160;million to reflect the most recent estimate associated with achievements of future revenue.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101989864440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Hedging Instruments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Hedging Instruments</a></td>
<td class="text">HEDGING INSTRUMENTS <div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Disclosure within this note is presented to provide transparency about how and why we use derivative and non-derivative instruments (collectively &#8220;hedging instruments&#8221;), how the instruments and related hedged items are accounted for, and how the instruments and related hedged items affect our financial position, results of operations, and cash flows.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to certain risks related to our ongoing business operations. The primary risk that we currently manage by using hedging instruments is foreign currency exchange risk. We may also enter into interest rate swaps to minimize the impact of interest rate fluctuations associated with borrowings under our variable-rate Credit Facility.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our subsidiaries enter into foreign currency exchange contracts to manage the exchange risk associated with their forecasted intercompany inventory purchases and sales for the next year. From time to time, we may also enter into other foreign currency exchange contracts, cross currency swaps, or foreign-denominated debt issuances to minimize the impact of foreign currency fluctuations associated with specific balance sheet exposures, including net investments in certain foreign subsidiaries. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary purpose of our foreign currency hedging activities is to protect against the volatility associated with foreign currency transactions, including transactions denominated in euro, British pound, Japanese yen, Canadian dollar, and Australian dollar. We also utilize natural hedges to mitigate our transaction and commitment exposures. Our corporate policy prescribes the range of allowable hedging activity. We enter into foreign currency exchange contracts with well-capitalized multinational financial institutions, and we do not hold or engage in transactions involving hedging instruments for purposes other than risk management. Our accounting policies for these contracts are based on our designation of such instruments as hedging transactions.&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize all hedging instruments on the balance sheet at fair value at the balance sheet date. Instruments that do not qualify for hedge accounting treatment must be recorded at fair value through earnings. To qualify for hedge accounting treatment, cash flow and net investment hedges must be highly effective in offsetting changes to expected future cash flows or fair value on hedged transactions. If the instrument qualifies for hedge accounting, changes in the fair value of the hedging instrument from the effective portion of the hedge are deferred in AOCI, net of tax, and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. We immediately record in earnings the extent to which a hedging instrument is not effective in achieving offsetting changes in fair value. We de-designate hedging instruments from hedge accounting when the likelihood of the hedged transaction occurring becomes less than probable. For de-designated </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">instruments, the gain or loss from the time of de-designation through maturity of the instrument is recognized in earnings. Any gain or loss in AOCI at the time of de-designation is reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. Refer to &#8220;Note 21. Accumulated Other Comprehensive Income&#8221; for further information regarding the effect of hedging instruments on the consolidated statements of income for the years ended December 31, 2021, 2020, and 2019.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into master netting arrangements with the counterparties to our derivative transactions which permit certain outstanding receivables and payables to be offset in the event of default. Our derivative contracts do not require either party to post cash collateral. We elect to present our derivative assets and liabilities in the accompanying consolidated balance sheets on a gross basis. All cash flows related to our foreign currency exchange contracts are classified as operating cash flows, which is consistent with the cash flow treatment of the underlying items being hedged.&#160;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to "Note 18. Fair Value Measurements" for additional information regarding the fair value of our derivative instruments and "Note 21. Accumulated Other Comprehensive Income" for additional information regarding the effect of derivative instruments designated as cash flow hedges on the consolidated statements of income.&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Flow Hedges</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have designated our foreign currency exchange contracts as cash flow hedges as these derivative instruments mitigate the exposure to variability in the cash flows of forecasted transactions attributable to foreign currency exchange. Unless noted otherwise, we have also designated our derivative instruments as qualifying for hedge accounting treatment.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not de-designate any instruments from hedge accounting treatment during the years ended December 31, 2021, 2020, and 2019. Gains and losses related to hedge ineffectiveness recognized in earnings during the years ended December 31, 2021, 2020, and 2019 were not material.&#160;At December 31, 2021, the estimated amount of net gains, net of tax, which are expected to be reclassified out of AOCI and into earnings within the next twelve months is $5.0 million if exchange rates do not fluctuate from the levels at December 31, 2021.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We target to hedge approximately 75% to 85% of the estimated exposure from intercompany product purchases and sales denominated in the euro, British pound, Canadian dollar, Japanese yen, and Australian dollar. We have additional unhedged foreign currency exposures related to foreign services and emerging markets where it is not practical to hedge.&#160;We primarily utilize foreign currency exchange contracts with durations of less than 24 months. Quarterly, we enter into contracts to hedge incremental portions of anticipated foreign currency transactions for the current and following year. As a result, our risk with respect to foreign currency exchange rate fluctuations and the notional value of foreign currency exchange contracts may vary throughout the year.&#160;The U.S. dollar is the currency purchased or sold in all of our foreign currency exchange contracts. The notional amount of foreign currency exchange contracts to hedge forecasted intercompany inventory purchases and sales totaled $286.7 million, and $202.7 million at December 31, 2021 and 2020, respectively.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the effect of cash flow hedge accounting on our consolidated statements of income and comprehensive income, and provides information regarding the location and amounts of pretax gains or losses of derivatives:&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:43.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.164%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.579%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Financial statement line items in which effects of cash flow hedges are recorded</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,325,928&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,135,615&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,041,359&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount of (loss) gain reclassified from accumulated other comprehensive income into income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,121)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">829&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,628&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Investment Hedges, Euro-Denominated Notes</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2015, we issued and sold through a private placement an aggregate principal amount of &#8364;88.9 million in euro-denominated 1.785% Series C Senior Notes due June 18, 2025. We have designated these euro-denominated notes as a hedge of our euro net investment in certain foreign subsidiaries to reduce the volatility in stockholders&#8217; equity caused by changes in foreign currency exchange rates in the euro relative to the U.S. dollar. As a result of this designation, gains and losses from the change in translated U.S. dollar value of these euro-denominated notes are recorded in AOCI rather than to earnings. We recorded a gain of $6.4 million, a loss of $7.4 million, and a gain of $1.8 million, net of tax, within AOCI as a result of this net </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">investment hedge for the years ended December 31, 2021, 2020, and 2019, respectively. The related cumulative unrealized gain recorded at December 31, 2021, will not be reclassified in earnings until the complete or substantially complete liquidation of the net investment in the hedged foreign operations or all or a portion of the hedge no longer qualifies for hedge accounting treatment. Refer to "Note 13. Debt" to the consolidated financial statements included in this Annual Report on Form 10-K for further information regarding the issuance of these euro-denominated notes.&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Investment Hedges, Cross Currency Swaps</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into several cross currency swap contracts as a hedge of our net investment in foreign operations to offset foreign currency translation gains and losses on the net investment. These cross currency swaps have maturity dates beginning on June 30, 2023, through June 18, 2025. At maturity of the cross currency swap contracts, we will deliver the notional amounts of&#160;&#8364;90.0 million and will receive approximately&#160;$104.5 million&#160;from the counterparties on June 30, 2023, and we will deliver the notional amount of &#8364;15.0 million and will receive approximately $17.5 million from the counterparties on June 18, 2025. The change in fair value of the cross currency swap contracts are recorded in AOCI and will be reclassified to earnings when the foreign subsidiaries are sold or substantially liquidated. We recorded a gain of $5.4 million, a loss of $5.6 million, and a gain of $2.1 million, net of tax, within AOCI as a result of these net investment hedges, during the&#160;years ended&#160;December 31, 2021, 2020, and 2019, respectively. We will receive quarterly interest payments from the counterparties based on a fixed interest rate until maturity of the cross currency swaps. This interest rate component is excluded from the assessment of hedge effectiveness and, thus, is recognized as a reduction to interest expense over the life of the hedge instrument. We recognized approximately&#160;$2.8 million&#160;and $2.7 million related to the excluded component as a reduction of interest expense for the&#160;years ended&#160;December 31, 2021 and 2020, respectively.&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Values of Hedging Instruments Designated as Hedges in Consolidated Balance Sheets</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of hedging instruments, their respective classification on the consolidated balance sheets, and amounts subject to offset under master netting arrangements consisted of the following derivative instruments, unless otherwise noted:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:47.798%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.786%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.909%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Hedging Assets</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives and non-derivatives designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross currency swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total derivative instruments presented as hedge instruments on the balance sheet</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,768&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross amounts subject to master netting arrangements not offset on the balance sheet</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(601)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(125)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net amount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,167&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:47.798%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.786%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.909%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Hedging Liabilities</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives and non-derivatives designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">601&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross currency swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,841&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total derivative instruments presented as cash flow hedges on the balance sheet</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">601&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,214&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-derivative foreign currency denominated debt designated as net investment hedge on the balance sheet </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100,711&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109,125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total hedging instruments presented on the balance sheet</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101,312&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">124,339&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross amounts subject to master netting arrangements not offset on the balance sheet</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(601)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(125)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net amount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100,711&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">124,214&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts represent reported carrying amounts of our foreign currency denominated debt. Refer to "Note 18. Fair Value Measurements" for information regarding the fair value of our long-term debt.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123477628&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>138
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101989572920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Repurchases of Common Stock<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockTextBlock', window );">Repurchases of Common Stock</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REPURCHASES OF COMMON STOCK</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, our Board of Directors has authorized the repurchase of u</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">p to 73.0 million sh</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ares of our common stock in the open market or in negotiated transactions pursuant to the Company&#8217;s share repurchase program. We believe that the repurchase of our common stock is a favorable means of returning value to our stockholders, and we also repurchase to offset the dilutive effect of our share-based compensation programs. Repurchases of our common stock may vary depending upon the level of other investing activities and the share price. As of December 31, 2021, there are approximate</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ly 5.0 million rem</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">aining shares available for repurchase under this authorization.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We primarily acquire shares by repurchases in the open market. However, we also acquire shares that are surrendered by employees in payment for the minimum required statutory withholding taxes due on the vesting of restricted stock units and the settlement of deferred stock units, otherwise referred to herein as employee surrenders. We issue shares of treasury stock upon the vesting of certain restricted stock units and upon the exercise of certain stock options. The number of shares of treasury stock issued during the years ended December 31, 2021, 2020, and 2019, was not material.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our open market common stock repurchases, reported on a trade date basis, and shares acquired through employee surrenders:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:58.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands, except per share amounts)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares repurchased in the open market</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,283&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">721&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,215&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares acquired through employee surrenders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">for statutory tax withholding</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total shares repurchased</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,312&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">779&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,254&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of shares repurchased in the open market</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">755,545&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">179,623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">303,838&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of shares for employee surrenders</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,562&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,603&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,054&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total cost of shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">771,107&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200,226&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">311,892&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average cost per share - open market repurchases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">588.58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">249.20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">249.84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average cost per share - employee surrenders</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">548.08&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">354.98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">210.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average cost per share - total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">587.70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">257.08&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">248.62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -URI http://asc.fasb.org/subtopic&amp;trid=2208821<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>139
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101989377080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Accumulated Other Comprehensive Income</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ACCUMULATED OTHER COMPREHENSIVE INCOME</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in AOCI, net of tax, consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:27.785%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.897%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.562%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.190%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.897%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.287%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31, 2021 and 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized (Loss) Gain on Cash Flow Hedges, Net of Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized (Loss) Gain on Net Investment Hedges, Net of Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized (Loss) Gain on Investments, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign Currency Exchange Contracts</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Euro-Denominated Notes</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cross Currency Swaps</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cumulative Translation Adjustment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(736)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(50,419)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(46,182)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(382)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,527)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,378)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,626)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,762)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(671)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(671)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(272)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,934)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,982)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,159)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35,268)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(53,615)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,404&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,399&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(26,731)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,643)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(126)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,979&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">422&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,240&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(61,999)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(53,484)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents components and amounts reclassified out of AOCI to net income:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"/><td style="width:34.455%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.492%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.492%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Affected Line Item in the Statements of Income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amounts Reclassified from AOCI for the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gains (losses) on derivative instruments included in net income:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,121)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">829&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,628&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax (benefit) expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,347)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Losses) gains, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,774)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">671&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,161&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI http://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>140
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101989375112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Preferred Stock<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract', window );"><strong>Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockTextBlock', window );">Preferred Stock</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PREFERRED STOCK</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span>Our Board of Directors is authorized, subject to any limitations prescribed by law, without further stockholder approval, to issue from time to time up to 500,000 shares of Preferred Stock, $1.00 par value per share (&#8220;Preferred Stock&#8221;), in one or more series. Each such series of Preferred Stock shall have such number of shares, designations, preferences, voting powers, qualifications, and special or relative rights or privileges as shall be determined by the Board of Directors, which may include, among others, dividend rights, voting rights, redemption and sinking fund provisions, liquidation preferences, conversion rights, and preemptive rights. There are no shares of Preferred Stock outstanding as of December 31, 2021 and 2020.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>141
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101989492936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>IDEXX Retirement and Incentive Savings Plan<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">IDEXX Retirement and Incentive Savings Plan</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IDEXX RETIREMENT AND INCENTIVE SAVINGS PLAN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have established the IDEXX Retirement and Incentive Savings Plan (the &#8220;401(k) Plan&#8221;). U.S. employees eligible to participate in the 401(k) Plan may contribute specified percentages of their salaries. We match a portion of these contributions, not to exceed 5% of participants&#8217; eligible compensation. We matched $25.8 million, $23.4 million, and $21.1 million for the years ended December 31, 2021, 2020, and 2019, respectively. In addition, we may make contributions to the 401(k) Plan at the discretion of the Board of Directors. There were no discretionary contributions in 2021, 2020 or 2019.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have established defined contribution plans for regional employees in Europe and in Canada. With respect to these plans, our contributions over the past three years have not been material.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>142
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101988255640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Estimates</a></td>
<td class="text">EstimatesThe preparation of these consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures. On an ongoing basis, we evaluate these estimates, including those related to reserves for accounts receivable; goodwill and other intangible assets; income taxes; inventory valuation; revenue recognition, product returns, customer programs, and multiple element arrangements; share-based compensation; warranty reserves; self-insurance reserves; fair value measurements and loss contingencies. We accrue contingent liabilities when it is probable that future expenditures will be made and such expenditures can be reasonably estimated. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ materially from these estimates.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash And Cash Equivalents</a></td>
<td class="text">Cash and Cash EquivalentsWe consider all highly liquid investments with original maturities of ninety days or less to be cash equivalents. Cash and cash equivalents consist primarily of demand deposits, money market funds, and short-duration agency bonds and commercial paper as described above.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyPolicy', window );">Warranty Reserves</a></td>
<td class="text">Warranty ReservesWe provide a standard twelve-month warranty on all instruments sold. We recognize the cost of instrument warranties in cost of product revenue at the time revenue is recognized based on the estimated cost to repair the instrument over its warranty period. Cost of product revenue reflects not only estimated warranty expense for instruments sold in the current period, but also any changes in estimated warranty expense for the portion of the aggregate installed base that is under warranty. Estimated warranty expense is based on a variety of inputs, including historical instrument performance in the customers&#8217; environments, historical and estimated costs incurred in servicing instruments and projected instrument reliability. Should actual service rates or costs differ from our estimates, revisions to the estimated warranty liability would be required. The liability for warranties is included in accrued liabilities in the accompanying consolidated balance sheets.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_TaxesRemittedToGovernmentalAuthoritiesOnBehalfOfCustomerPolicyTextBlock', window );">Taxes Remitted To Governmental Authorities By IDEXX On Behalf Of Customer</a></td>
<td class="text">Taxes Remitted to Governmental Authorities by IDEXX on Behalf of CustomerWe calculate, collect from our customers, and remit to governmental authorities, sales, value-added, and excise taxes assessed by governmental authorities in connection with revenue-producing transactions with our customers. We report these taxes on a net basis and do not include these tax amounts in revenue or cost of product or service revenue.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research And Development Costs</a></td>
<td class="text">Research and Development CostsResearch and development costs, which consist of employee compensation and benefits, materials and external consulting, and product development costs, are expensed as incurred. We evaluate our research and development costs for capitalization after the technological feasibility has been established for software and products containing software to be sold; however, no costs were capitalized during the years ended December 31, 2021, 2020, and 2019. Software developed to deliver hosted services to our customers has been designated as internal use, and we capitalize certain costs incurred in connection with developing or obtaining software designated for internal use based on three distinct stages of development. Refer to "Note 9. Property and Equipment, Net" for further information on internal use software.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising Costs</a></td>
<td class="text">Advertising CostsAdvertising costs, which are recognized as sales and marketing expense in the period in which they are incurred, were $3.3 million, $1.4 million, and $1.5 million for the years ended December 31, 2021, 2020, and 2019, respectively.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalCostsPolicyTextBlock', window );">Legal Costs</a></td>
<td class="text">Legal CostsLegal costs are considered period costs and, accordingly, are expensed in the year services are provided.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency</a></td>
<td class="text">Foreign CurrencyThe functional currency of all except eight of our subsidiaries is their local currency, however, the assets and liabilities of the majority of our foreign subsidiaries are translated to the U.S. dollar using the exchange rate in effect at the balance sheet date. Revenue and expense accounts are translated to the U.S. dollar using the exchange rate at the date which those elements are recognized, and where it is impractical to do so, an average exchange rate in effect during the period is used to translate those elements. Cumulative translation gains and losses are shown in the accompanying consolidated balance sheets as a separate component of accumulated other comprehensive income (&#8220;AOCI&#8221;). &#160;Revenues and expenses denominated in a currency other than the respective subsidiary&#8217;s functional currency are recorded at the current exchange rate when the transaction is recognized. Monetary assets and liabilities denominated in a currency other than the respective subsidiary&#8217;s functional currency are remeasured at each balance sheet date using the exchange rate in effect at each balance sheet date. These foreign currency gains and losses are included in general and administrative expenses within our Other segment.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive Income</a></td>
<td class="text">Comprehensive Income&#160;&#160;&#160;&#160;We report all changes in equity, including net income and transactions or other events and circumstances from non-owner sources during the period in which they are recognized. We have chosen to present comprehensive income, which encompasses net income, foreign currency translation adjustments, gains and losses on our net investment hedges and the difference between the cost and the fair market value of investments in debt and equity securities, and forward currency exchange contracts, in the consolidated statements of comprehensive income. Refer to<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_ConcentrationRiskPolicyTextBlock', window );">Concentrations of Risk</a></td>
<td class="text">Concentrations of Risk<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Financial instruments that potentially subject us to concentrations of credit risk are principally cash, cash equivalents, accounts receivable, and derivatives. To mitigate such risk with respect to cash and cash equivalents, we place our cash with highly-rated financial institutions, in non-interest bearing accounts that are insured by the U.S. government and money market funds invested in government securities. Concentration of credit risk with respect to accounts receivable is limited to certain customers to whom we make substantial sales. To reduce risk, we routinely assess the financial strength of our most significant customers and monitor the amounts owed to us, taking appropriate action when necessary. As a result, we believe that accounts receivable credit risk exposure is limited. We maintain an allowance for doubtful accounts, but historically have not experienced any material losses related to an individual customer or group of customers in any particular industry or geographic area.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To mitigate concentration of credit risk with respect to derivatives we enter into transactions with highly-rated financial institutions, enter into master netting arrangements with counterparties to our derivative transactions and frequently monitor the creditworthiness of our counterparties. Our master netting arrangements reduce our exposure in that they permit outstanding receivables and payables with the counterparties to our derivative transactions to be offset in the event of default. We have not incurred such losses and consider the risk of counterparty default to be minimal.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Inventory</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If we are unable to obtain adequate quantities of the inventory we need to sell our products, we could face cost increases or delays or discontinuations in product shipments, which could have a material adverse effect on our results of operations. Many of the third parties that provide us with the instruments we sell, as well as certain components, raw materials and consumables used in or with our products, are sole or single-source suppliers. Some of the products that we purchase from these sources are proprietary or complex in nature, and, therefore, cannot be readily or easily replaced by alternative sources.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Pronouncements Adopted and New Accounting Pronouncements Not Yet Adopted</a></td>
<td class="text">New Accounting Pronouncements Adopted<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We adopted ASU 2016-02, "Leases (Topic 842)," as of January 1, 2019, using the optional transition method that allows for a cumulative-effect adjustment in the period of adoption and did not restate prior periods.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We adopted ASU 2018-13, "Fair Value Measurement (Topic 820)," as of January 1, 2020, which modifies the disclosure requirements on fair value measurements under ASC Topic No. 820, Fair Value Measurement, as amended (&#8220;ASC 820&#8221;). ASU 2018-13 removes (a) the prior requirement to disclose the amount and reason for transfers between Level 1 and Level 2 of the fair value hierarchy contained in ASC 820, (b) the policy for timing of transfers between levels, and (c) the valuation processes used for Level 3 fair value measurements. ASU 2018-13 also adds, among other things, a requirement to disclose the range and weighted average of significant unobservable inputs used in Level 3 fair value measurements. The adoption did not have a material impact on our consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;We adopted ASU 2016-13, &#8220;Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,&#8221; effective January 1, 2020, using the modified retrospective transition method. This ASU amends the impairment model to utilize an expected loss methodology in place of the incurred loss methodology for financial instruments, including trade receivables and leased equipment. The amendment requires entities to consider a broader range of information to estimate expected credit losses, which may result in earlier recognition of losses. We recorded a non-cash cumulative effect adjustment to retained earnings of $1.8&#160;million, net of $0.6&#160;million of income taxes, on our opening consolidated balance sheet as of January 1, 2020. This adjustment, before the impact of income taxes, was comprised of $2.3&#160;million related to our contract assets and sales-type leases, and $0.2&#160;million related to accounts receivable. Refer to "Note 6. Credit Losses" for more information on our presentation of credit losses.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective January 1, 2021, we adopted ASU 2019-12, &#8220;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes.&#8221; The new guidance is intended to simplify the accounting for income taxes by removing certain exceptions and by updating accounting requirements around goodwill recognized for tax purposes and the allocation of current and deferred tax expense among legal entities, among other minor changes. The adoption of ASU 2019-12 did not have a material impact on our consolidated financial statements.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In July 2021, the FASB issued ASU 2021-05, &#8220;Leases (Topic 842); Lessors - Certain Leases with Variable Lease Payments.&#8221; ASU 2021-05 requires a lessor to classify a lease with variable payments that do not depend on an index or rate as an operating lease if another lease classification (i.e., sales-type or direct financing) would result in recognition of a day-one loss. We have elected to adopt this standard as of the third quarter of 2021, on a prospective basis. The adoption of ASU 2021-05 did not have a material impact on our consolidated financial statements.</span></div>New Accounting Pronouncements Not Yet Adopted<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued ASU 2021-08, &#8220;Business Combinations (Topic 805): Accounting for Acquired Contract Assets and Contract Liabilities.&#8221; ASU 2021-08 is intended to improve comparability for both the recognition and measurement of acquired revenue contracts with customers at the date of and after a business combination by providing consistent recognition guidance. This standard is effective for fiscal years beginning after December 15, 2022. Adoption of the ASU 2021-08 should be applied prospectively. Early adoption is permitted, including in an interim period, for any period for which financial statements have not yet been issued. We are currently evaluating the impact, if any, of ASU 2021-08 on our consolidated financial statements.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU 2020-04, "Facilitation of the Effects of Reference Rate Reform on Financial Reporting.&#8221; ASU 2020-04 is intended to provide optional expedients and exceptions to the U.S. GAAP guidance on contract modifications and hedge accounting to ease the financial reporting burdens related to the discontinuation of the London Interbank Offered Rate (&#8220;LIBOR&#8221;) or by another reference rate expected to be discontinued. The FASB also issued ASU 2021-01, "Reference Rate Reform (Topic 848): Scope," in January 2021. It clarifies that certain optional expedients and exceptions apply to derivatives that are affected by the discounting transition. The amendments in this ASU affect the guidance in ASU No. 2020-04 and are effective in the same timeframe as ASU 2020-04. The relief offered by this guidance, if adopted, is available to companies for the period March 12, 2020 through December 31, 2022. Our Credit Facility includes a provision for the determination of a benchmark replacement rate as a successor to the LIBOR rate, therefore; we do not expect the discontinuation of LIBOR to have an impact on our consolidated financial statements.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue is recognized when, or as, performance obligations under the terms of a contract are satisfied, which occurs when control of the promised products or services is transferred to a customer. We exclude sales, use, value-added, and other taxes we collect on behalf of third parties from revenue. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring products or services to a customer. To accurately present the consideration received in exchange for promised products or services, we apply the five-step model outlined below:</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Identification of a contract or agreement with a customer</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Identification of our performance obligations in the contract or agreement</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Determination of the transaction price</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Allocation of the transaction price to the performance obligations</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Recognition of revenue when, or as, we satisfy a performance obligation</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-Based Compensation</a></td>
<td class="text">We provide for various forms of share-based compensation awards to our employees and non-employee directors. Our share-based compensation plans allow for the issuance of a mix of stock options, restricted stock, stock appreciation rights, employee stock purchase rights, and other stock unit awards.&#160;With the exception of stock options, the fair value of our awards is equal to the closing stock price of IDEXX common stock on the date of grant. We calculate the fair value of our stock option awards using the Black-Scholes-Merton option-pricing model. For stock options, restricted stock units (&#8220;RSUs&#8221;), and deferred stock units (&#8220;DSUs&#8221;), share-based compensation expense is recognized net of estimated forfeitures, on a straight-line basis over the requisite service period of the award for stock options.&#160;For performance-based restricted stock units (&#8220;PBRSUs&#8221;), share-based compensation expense is recognized net of estimated forfeitures, on a grade-vesting methodology over the requisite service period.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditLossFinancialInstrumentPolicyTextBlock', window );">Credit Losses</a></td>
<td class="text">We are exposed to credit losses primarily through our sales of products and services to our customers. We maintain allowances for credit losses for potentially uncollectible receivables. We base our estimates on a detailed analysis of specific customer situations and a percentage of our accounts receivable by aging category. Historical credit loss experience provides the basis for the estimation of expected credit losses. Adjustments to historical loss information are made for differences in current economic conditions. Refer to "Note 2. Accounting Policies" for more information on our adoption of ASU 2016-13 on January 1, 2020, using the modified retrospective transition method.<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional allowances may be required if either the financial condition of our customers was to deteriorate, or a strengthening U.S. dollar impacts the ability of foreign customers to make payments to us on their U.S. dollar-denominated purchases. We monitor our ongoing credit exposure through active review of counterparty balances against contract terms and due dates. Our activities include timely account reconciliations, dispute resolution, and payment confirmations. We may employ collection agencies and legal counsel to pursue recovery of defaulted receivables.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Account balances are charged off against the allowance when we believe it is probable the receivable will not be recovered. We may require collateralized asset support or a prepayment to mitigate credit risk. We do not have any off-balance sheet credit exposure related to our customers.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text">Inventories are stated at the lower of cost (first-in, first-out) or net realizable value. Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. We write down the carrying value of inventory for estimated obsolescence by an amount equal to the difference between the cost of inventory and the estimated market value when warranted based on assumptions of future demand, market conditions, remaining shelf life, or product functionality. If actual market conditions or results of estimated functionality are less favorable than those we estimated, additional inventory write-downs may be required, which would have a negative effect on results of operations.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LessorLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of our facilities are occupied under operating lease arrangements with various expiration dates through 2067, some of which include options to extend the life of the lease, and some of which include options to terminate the lease within 1 year. In certain instances, we are responsible for the real estate taxes and operating expenses related to these facilities.&#160;Additionally, we enter into operating leases for certain vehicles and office equipment in the normal course of business. We determine the expected term of any executed agreements using the non-cancelable lease term plus any renewal options by which the failure to renew imposes a penalty in such amount that renewal is reasonably assured. The derived expected term is then used in the determination of a financing or operating lease and in the calculation of straight-line rent expense. Rent escalations are considered in the calculation of minimum lease payments in our capital lease tests and in determining straight-line rent expense for operating leases. Minimum&#160;lease&#160;payments include the fixed&#160;lease&#160;component of the agreement, as well as fixed rate increases that are initially measured at the&#160;lease&#160;commencement date. Variable lease payments based on an index and payments associated with&#160;non-lease&#160;components and short-term rentals (leases with terms less than 12 months) are expensed as incurred. Consideration is&#160;allocated&#160;to the&#160;lease&#160;and non-lease components based on the estimated standalone prices.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine if an arrangement is a lease at its inception. Operating leases are included in operating lease right-of-use assets, accrued liabilities, and long-term operating lease liabilities in our consolidated balance sheets. Our financing leases are not material to the financial statements.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease liabilities and right-of-use assets are recognized at commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an explicit rate, we use our incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. Our lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Rent expense for lease payments is recognized on a straight-line basis over the lease term. The operating lease right-of-use assets also includes any rent prepayments, lease incentives upon receipt, and straight-line rent expense impacts, which represent the differences between our operating lease liabilities and right-of-use assets.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost, net of accumulated depreciation and amortization. The costs of additions and improvements are capitalized, while maintenance and repairs are charged to expense as incurred. When an item is sold or retired, the cost and related accumulated depreciation are relieved, and the resulting gain or loss, if any, is recognized in the consolidated statements of income. We evaluate our property and equipment for impairment periodically or as changes in circumstances or the occurrence of events suggest the remaining value is not recoverable from future cash flows. If the carrying value of our&#160;property and equipment is impaired, an impairment charge is recorded for the amount by which the carrying value of the property and equipment exceeds its fair value.&#160;We provide for depreciation and amortization primarily using the straight-line method by charges to the consolidated statements of income in amounts that allocate the cost of property and equipment over their estimated useful lives as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:60.246%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.731%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.723%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Asset Classification</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Land improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15 to 20 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10 to 40 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shorter of remaining lease term or useful life of improvements</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 to 8 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Office furniture and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 to 7 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Computer hardware and software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 to 7 years</span></div></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We capitalize interest on the acquisition and construction of significant assets that require a substantial period of time to be made ready for use. The capitalized interest is included in the cost of the completed asset and depreciated over the asset&#8217;s estimated useful life. The amount of interest capitalized during the years ended December 31, 2021 and 2020, was not material.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We capitalize certain costs incurred in connection with developing or obtaining software designated for internal use based on three distinct stages of development. Qualifying costs incurred during the application development stage, which consist primarily of internal payroll and direct fringe benefits and external direct project costs, including labor and travel, are capitalized and amortized on a straight-line basis over the estimated useful life of the asset. Costs incurred during the preliminary project and post-implementation and operation phases are expensed as incurred. These costs relate primarily to the determination of performance requirements, data conversion, and training. Software developed to deliver hosted services to our customers has been designated as internal use.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Goodwill and Other Intangible Assets</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A significant portion of the purchase price for acquired businesses is generally assigned to intangible assets. Intangible assets other than goodwill are initially valued at fair value. If a quoted price in an active market for the identical asset is not readily available at the measurement date, the fair value of the intangible asset is estimated based on discounted cash flows using market participant assumptions, which are assumptions that are not specific to IDEXX. The selection of appropriate valuation methodologies and the estimation of discounted cash flows require significant assumptions about the timing and amounts of future cash flows, risks, appropriate discount rates, and the useful lives of intangible assets. When significant, we utilize independent valuation experts to advise and assist us in determining the fair values of the identified intangible assets acquired in connection with a business acquisition and in determining appropriate amortization methods and periods for those intangible assets. Goodwill is initially valued based on the excess of the purchase price of a business combination over the fair value of acquired net assets recognized and represents the future economic benefits arising from other assets acquired that could not be separately identified and recognized.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business combinations regularly include contingent consideration arrangements that require additional consideration to be paid based on the achievement of established objectives, most commonly related to customer retention or revenue growth of the customer base during the post-combination period. We assess contingent consideration to determine if it should be recognized at its fair value on the acquisition date. A liability resulting from contingent consideration is remeasured to fair value at each reporting date until the contingency is resolved, with changes in fair value recognized in earnings if changes in estimates are made after the measurement period. During the fourth quarter of 2021, we increased the fair value of the contingent payment to ezyVet by $2.0&#160;million. Changes in the fair value of contingent consideration and differences arising upon settlement were not material during the years ended December 31, 2020, and 2019.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We assess goodwill for impairment annually, at the reporting unit level, in the fourth quarter and whenever events or circumstances indicate impairment may exist. In evaluating goodwill for impairment, we have the option to first assess the qualitative factors to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the goodwill impairment test. The more likely than not threshold is defined as having a likelihood of more than 50%. If, after assessing the totality of events or circumstances, we determine that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, we would assess the fair value of all of our reporting units and compare the fair value of the reporting unit to its carrying value to determine if the carrying value exceeds its fair value, and if a goodwill impairment loss should be recognized. In contrast, we can opt to bypass the qualitative assessment for any reporting unit in any period and proceed directly to assessing the fair value of all of our reporting units and compare the fair value of the reporting unit to carrying value to determine if any impairment exists. Doing so does not preclude us from performing the qualitative assessment in any subsequent&#160;period.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2021, we elected to bypass the qualitative approach that allows the assessment of qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount and instead proceeded directly to assessing the fair value of all of our reporting units and comparing the fair values of each reporting unit to the carrying values to determine if any impairment exists. We estimate the fair values of applicable reporting units using an income approach based on discounted forecasted cash flows. We make significant assumptions about the extent and timing of future cash flows, growth rates and discount rates. Model assumptions are based on our projections and best estimates, using appropriate and customary market participant assumptions. In addition, we make certain assumptions in allocating shared assets and liabilities to individual reporting units in determining the carrying value of each reporting unit. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in forecasted cash flows or the discount rate would affect the estimated fair values of our reporting units and could result in a goodwill impairment loss in a future period.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No goodwill impairments were identified during the years ended December 31, 2021, 2020, or 2019, and no accumulated impairment losses are recorded.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We assess the realizability of intangible assets other than goodwill whenever events or changes in circumstances indicate that the carrying value may not be recoverable. If an impairment review is triggered, we evaluate the carrying value of intangible assets based on estimated undiscounted future cash flows over the remaining useful life of the primary asset of the asset group and compare that value to the carrying value of the asset group. The asset group is the lowest level for which identifiable cash flows associated with the intangible asset are largely independent. The cash flows that are used contain our best estimates, using appropriate and customary assumptions and projections at the time. If the net carrying value of an intangible asset exceeds the related estimated undiscounted future cash flows, an impairment loss to adjust the intangible asset to its fair value would be reported as a non-cash charge to earnings. If necessary, we would calculate the fair value of an intangible asset using the present value of the estimated future cash flows to be generated by the intangible asset, and applying a risk-adjusted discount rate. We had no impairments of our intangible assets during the years ended December 31, 2021 and 2019.&#160;The amount of impairment for the year ended December 31, 2020 was immaterial.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide for amortization primarily using the straight-line method by charges to income in amounts that allocate the intangible assets over their estimated useful lives as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:60.246%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.731%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.723%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Asset Classification</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer-related intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 to 17 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product rights </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 to 15 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncompete agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 to 5 years</span></div></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes is determined using the asset and liability approach of accounting for income taxes. Under this approach, deferred taxes represent the estimated future tax effects of temporary differences between book and tax treatment of assets and liabilities and carryforwards to the extent they are realizable. We record a valuation allowance to reduce our deferred tax assets to the amount that is more likely than not to be realized. In assessing the need for a valuation allowance, we consider future taxable income and ongoing prudent and feasible tax planning strategies. In the event that we determine that we would be able to realize our deferred tax assets in the future in excess of the net recorded amount, a reduction of the valuation allowance would increase income in the period such determination was made. Likewise, should we determine that we would not be able to realize all or part of our net deferred tax asset in the future, a reduction to the deferred tax asset would be charged to income in the period such determination was made.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record a liability for uncertain tax positions that do not meet the more likely than not standard as prescribed by the authoritative guidance for income tax accounting. We record tax benefits for only those positions that we believe will more likely than not be sustained.&#160;Unrecognized tax benefits are the differences between tax positions taken, or expected to be taken, in tax returns, and the benefits recognized for accounting purposes. We classify uncertain tax positions as long-term liabilities.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant judgment is required in determining our worldwide provision for income taxes and our income tax filings are regularly under audit by tax authorities. Any audit result differing from amounts recorded would increase or decrease income in the period that we determine such adjustment is likely. Interest expense and penalties associated with the underpayment of income taxes are included in income tax expense.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share</a></td>
<td class="text">Basic earnings per share is computed by dividing net income attributable to our stockholders by the weighted average number of shares of common stock and vested deferred stock units outstanding during the year. The computation of diluted earnings per share is similar to the computation of basic earnings per share, except that the denominator is increased for the assumed exercise of dilutive options and assumed issuance of unvested restricted stock units and unvested deferred stock units using the treasury stock method unless the effect is anti-dilutive. The treasury stock method assumes that proceeds, including cash received from the exercise of employee stock options and the&#160;total unrecognized compensation expense for unvested share-based compensation awards, would be used to purchase our common stock at the average market price during the period.&#160;Vested deferred stock units outstanding are included in shares outstanding for basic and diluted earnings per share because the associated shares of our common stock are issuable for no cash consideration, the number of shares of our common stock to be issued is fixed and issuance is not contingent. Refer to "Note 5. Share-Based Compensation" for additional information regarding deferred stock units.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">Self-Insurance Accruals</a></td>
<td class="text">We are subject to claims that&#160;may&#160;arise in the ordinary course of business, including with respect to actual and threatened litigation and other matters. We accrue for loss contingencies when it is probable that future expenditures will be made, and such expenditures can be reasonably estimated. However, the results of legal actions cannot be predicted with certainty, and therefore our actual losses with respect to these contingencies could exceed our accruals.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value Measurements</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. GAAP defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. U.S. GAAP requires an entity to maximize the use of observable inputs, where available, and minimize the use of unobservable inputs when measuring fair value.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have certain financial assets and liabilities that are measured at fair value on a recurring basis, certain nonfinancial assets and liabilities that may be measured at fair value on a non-recurring basis, and certain financial assets and liabilities that are not measured at fair value in our consolidated balance sheets but for which we disclose the fair value. The fair value disclosures of these assets and liabilities are based on a three-level hierarchy, which is defined as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:498.00pt"><tr><td style="width:1.0pt"/><td style="width:85.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:409.00pt"/><td style="width:1.0pt"/></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quoted prices in active markets for identical assets or liabilities that the entity can access at the measurement date.</span></td></tr><tr style="height:33pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities measured at fair value are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability. We did not have any transfers between Level 1 and Level 2, or transfers in or out of Level 3, of the fair value hierarchy during the years ended December 31, 2021 and 2020.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cross currency swap contracts are measured at fair value on a recurring basis in our accompanying consolidated balance sheets. We measure the fair value of our cross currency swap contracts classified as derivative instruments using prevailing market conditions as of the close of business on each balance sheet date. The product of this calculation is then adjusted for counterparty risk.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our foreign currency exchange contracts are measured at fair value on a recurring basis in our accompanying consolidated balance sheets. We measure the fair value of our foreign currency exchange contracts classified as derivative </span></div>instruments using an income approach, based on prevailing market forward rates less the contract rate multiplied by the notional amount. The product of this calculation is then adjusted for counterparty risk.&#160;The amounts outstanding under our unsecured revolving credit facility ("Credit Facility" or &#8220;line of credit&#8221;) and senior notes (&#8220;long-term debt&#8221;) are measured at carrying value in our accompanying consolidated balance sheets though we disclose the fair value of these financial instruments. We determine the fair value of the amount outstanding under our Credit Facility and long-term debt using an income approach, utilizing a discounted cash flow analysis based on current market interest rates for debt issues with similar remaining years to maturity, adjusted for applicable credit risk. Our Credit Facility and long-term debt are valued using Level 2 inputs. The estimated fair value of our Credit Facility approximates its carrying value.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Hedging Instruments</a></td>
<td class="text">We recognize all hedging instruments on the balance sheet at fair value at the balance sheet date. Instruments that do not qualify for hedge accounting treatment must be recorded at fair value through earnings. To qualify for hedge accounting treatment, cash flow and net investment hedges must be highly effective in offsetting changes to expected future cash flows or fair value on hedged transactions. If the instrument qualifies for hedge accounting, changes in the fair value of the hedging instrument from the effective portion of the hedge are deferred in AOCI, net of tax, and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. We immediately record in earnings the extent to which a hedging instrument is not effective in achieving offsetting changes in fair value. We de-designate hedging instruments from hedge accounting when the likelihood of the hedged transaction occurring becomes less than probable. For de-designated instruments, the gain or loss from the time of de-designation through maturity of the instrument is recognized in earnings. Any gain or loss in AOCI at the time of de-designation is reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. Refer to &#8220;Note 21. Accumulated Other Comprehensive Income&#8221; for further information regarding the effect of hedging instruments on the consolidated statements of income for the years ended December 31, 2021, 2020, and 2019.We enter into master netting arrangements with the counterparties to our derivative transactions which permit certain outstanding receivables and payables to be offset in the event of default. Our derivative contracts do not require either party to post cash collateral. We elect to present our derivative assets and liabilities in the accompanying consolidated balance sheets on a gross basis. All cash flows related to our foreign currency exchange contracts are classified as operating cash flows, which is consistent with the cash flow treatment of the underlying items being hedged.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_ConcentrationRiskPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Concentration Risk</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_ConcentrationRiskPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>idxx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_TaxesRemittedToGovernmentalAuthoritiesOnBehalfOfCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Taxes Remitted to Governmental Authorities on Behalf of Customer</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_TaxesRemittedToGovernmentalAuthoritiesOnBehalfOfCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>idxx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123368208&amp;loc=d3e12565-110249<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6049-115624<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditLossFinancialInstrumentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit loss on financial instrument measured at amortized cost basis, net investment in lease, off-balance sheet credit exposure, and available-for-sale debt security. Includes, but is not limited to, methodology used to estimate allowance for credit loss, how writeoff of uncollectible amount is recognized, and determination of past due status and nonaccrual status.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 35<br> -Paragraph 7A<br> -URI http://asc.fasb.org/extlink&amp;oid=125515542&amp;loc=SL120269220-210453<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3D<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL120267969-210447<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922895-210455<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 35<br> -Paragraph 13A<br> -URI http://asc.fasb.org/extlink&amp;oid=125515542&amp;loc=SL120267917-210453<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 35<br> -Paragraph 8A<br> -URI http://asc.fasb.org/extlink&amp;oid=124266218&amp;loc=SL120267834-210445<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 30<br> -Paragraph 4A<br> -URI http://asc.fasb.org/extlink&amp;oid=124256539&amp;loc=SL120269210-210444<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919260-210447<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL120267845-210446<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919253-210447<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919272-210447<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 30<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=124256539&amp;loc=SL120254536-210444<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3C<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL120267966-210447<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 30<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=124268681&amp;loc=SL120267897-210452<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919244-210447<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3D<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL120267862-210455<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.M.Q4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122651532&amp;loc=SL122037091-237805<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3C<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL120267859-210455<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL120267853-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditLossFinancialInstrumentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41675-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI http://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 330<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6471895&amp;loc=d3e55923-109411<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124437754&amp;loc=d3e543-108305<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for legal costs incurred to protect or defend the entity's assets and rights, or to obtain assets, including monetary damages, or to obtain rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=27011672&amp;loc=d3e149975-122751<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangements entered into by lessor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL117410129-209981<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919352-209981<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL117410129-209981<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL119206284-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for standard warranties including the methodology for measuring the liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123368208&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>143
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101989878856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregated revenues</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table&#160;presents disaggregated revenue by major product and service categories:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:58.311%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.694%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.694%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.696%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CAG segment revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CAG Diagnostics recurring revenue:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,534,562&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,113,839&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,828,329&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">IDEXX VetLab consumables</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">1,006,781&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">824,376&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">693,360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Rapid assay products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">296,852&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">253,018&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">232,149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Reference laboratory diagnostic and consulting services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">1,123,656&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">946,268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">822,497&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">CAG Diagnostics services and accessories</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">107,273&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">90,177&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">80,323&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CAG Diagnostics capital - instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">149,140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108,950&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132,685&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Veterinary software, services and diagnostic imaging systems</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">206,258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">162,976&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">158,169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CAG segment revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,889,960&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,385,765&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,119,183&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Water segment revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">146,505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">128,625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LPD segment revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">135,887&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">145,845&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132,635&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other segment revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,240&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,215,360&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,706,655&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,406,908&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue by principal geographic area, based on customers&#8217; domiciles, was as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:58.311%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.694%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.694%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.696%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Americas</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,995,683&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,691,224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,495,516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">139,727&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107,398&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99,550&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Latin America &amp; Caribbean</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66,623&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,863&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56,515&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,202,033&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,850,485&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,651,581&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Europe, the Middle East and Africa</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">146,762&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">119,353&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">114,955&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90,156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90,969&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">France</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90,836&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74,814&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64,767&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Italy</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,062&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,817&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,725&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Spain</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,439&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Switzerland</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,984&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,855&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Netherlands</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,656&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,461&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,397&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">167,525&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">148,049&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">122,206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">681,949&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">562,765&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">498,439&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asia Pacific Region</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Australia</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94,414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">79,629&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71,069&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74,725&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67,246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">China</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,845&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,518&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89,523&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68,206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61,055&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">331,378&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">293,405&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">256,888&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,215,360&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,706,655&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,406,908&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>144
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101988082552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of selected financial impact of share-based compensation</a></td>
<td class="text">The following is a summary of share-based compensation costs and related tax benefits recorded in our consolidated statements of income:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:58.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense included in cost of revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,044&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,681&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense included in operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,711&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,536&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total share-based compensation expense included in consolidated statements of income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,755&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,951&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,278&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax benefit resulting from share-based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,734)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,965)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,861)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net share-based compensation expense included in consolidated statements of income, excluding tax benefit from settlement of share-based awards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,021&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,986&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,417&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax benefit resulting from settlement of share-based awards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32,474)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(38,981)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19,140)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net expense (benefit) related to share-based compensation arrangements included in consolidated statements of income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">547&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,995)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,277&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of weighted averages of the assumptions used in estimating the fair value of stock option awards</a></td>
<td class="text">The weighted averages of the valuation assumptions used to determine the fair value of each option award on the date of grant and the weighted average estimated fair values were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:58.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share price at grant</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">546.36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">291.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">218.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share exercise price</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">550.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">291.14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">220.88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected stock price volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected term, in years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average fair value of options granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">169.15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84.92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65.53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of stock option activity</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the status of options granted under our share-based compensation plans at December 31, 2021, and changes during the year then ended, are presented in the table below:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:39.575%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.996%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.996%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.996%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.001%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Options (000)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Remaining Contractual Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value ($000)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding as of December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,953&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">149.32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">550.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(310)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102.78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">261.95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding as of December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,757&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">188.47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">825,745&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fully vested as of December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,109&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">127.30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">588,831&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fully vested and expected to vest as of December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,738&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">186.72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">819,777&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Schedule of restricted stock unit activity</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the status of RSUs and PBRSUs granted under our share-based compensation plans at December 31, 2021, and changes during the period then ended, are presented in the table below:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:69.281%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.977%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Units (000)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Grant-Date Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nonvested as of December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">202.47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nonvested as of December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">306.18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected to vest as of December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">303.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>145
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101989354024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNetAbstract', window );"><strong>Inventory, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of components of inventories</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of inventories are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"><tr><td style="width:1.0%"/><td style="width:68.015%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.549%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.292%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.549%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.895%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,427&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,986&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,397&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,374&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">182,206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143,513&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">269,030&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">209,873&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>146
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101992460728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Maturities of operating lease liabilities</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of operating lease liabilities are as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:85.517%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.283%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,402&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,523&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,675&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,437&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,047&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">122,206&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,898)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease liability (current and long-term)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107,308&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Supplemental cash flow information</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average remaining lease term - operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.4 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.3 years</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average discount rate - operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information for leases is as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended <br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of operating lease liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,214&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,619&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for operating lease obligations, net of early lease&#160;terminations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,572&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,807&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>147
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140102075455576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock', window );">Schedule of estimated useful lives for property and equipment</a></td>
<td class="text">We provide for depreciation and amortization primarily using the straight-line method by charges to the consolidated statements of income in amounts that allocate the cost of property and equipment over their estimated useful lives as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:60.246%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.731%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.723%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Asset Classification</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Land improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15 to 20 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10 to 40 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shorter of remaining lease term or useful life of improvements</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 to 8 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Office furniture and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 to 7 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Computer hardware and software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 to 7 years</span></div></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of property and equipment</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net, consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.377%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 7.75pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Land and improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,642&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,982&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">329,091&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">319,384&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93,248&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,459&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">382,753&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">353,301&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Office furniture and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69,090&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67,527&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Computer hardware and software</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">276,895&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">265,664&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,339&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,764&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,236,058&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,142,081&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">648,391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">586,914&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">587,667&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">555,167&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_SummaryOfDepreciationAndAmortizationCapitalizedComputerSoftwareForInternalUseAndUnpaidPropertyEquipmentReflectedInAccountPayableAndAccruedExpensesTableTextBlock', window );">Summary of depreciation and amortization, capitalized computer software for internal use and unpaid property equipment reflected in accounts payable and accrued expenses</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below are the amounts of depreciation and amortization of property and equipment, capitalized computer software for internal use, unpaid property and equipment reflected in accounts payable and accrued expenses, and rental and reagent rental program instruments transferred from inventory to property and equipment:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:58.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 7.75pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92,376&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86,095&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78,495&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capitalized computer software developed for internal use</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,753&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,472&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unpaid property and equipment, reflected in accounts payable and accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,343&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,688&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rental and operating-type reagent rental program instruments transferred from inventory to property and equipment (Note 3)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,628&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,645&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Estimated Useful Lives For Property And Equipment [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>idxx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_SummaryOfDepreciationAndAmortizationCapitalizedComputerSoftwareForInternalUseAndUnpaidPropertyEquipmentReflectedInAccountPayableAndAccruedExpensesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Summary Of Depreciation And Amortization, Capitalized Computer Software For Internal Use And Unpaid Property Equipment Reflected In Account Payable And Accrued Expenses [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_SummaryOfDepreciationAndAmortizationCapitalizedComputerSoftwareForInternalUseAndUnpaidPropertyEquipmentReflectedInAccountPayableAndAccruedExpensesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>idxx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>148
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101989521768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Current and Long-Term Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrentAbstract', window );"><strong>Other Assets, Noncurrent [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock', window );">Schedule of other current assets</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current assets consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.391%"><tr><td style="width:1.0%"/><td style="width:67.399%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.542%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.542%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.613%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 7.75pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer acquisition costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,942&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,751&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,997&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,556&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract assets, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,772&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,837&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taxes receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,464&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,476&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred sales commissions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,738&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">173,823&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">137,508&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>(1) Contract assets, net, are net of allowances for credit loss. Refer to "Note 6. Credit Losses<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock', window );">Schedule of other noncurrent assets</a></td>
<td class="text"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term assets consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"/><td style="width:67.196%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.862%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.162%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 7.75pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract assets, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">122,160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91,681&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer acquisition costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109,392&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104,369&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,784&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,549&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investment in long-term product supply arrangements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,065&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred sales commissions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,019&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,719&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taxes receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,806&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,329&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,891&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,883&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">330,400&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">289,595&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>(1) Contract assets, net, are net of allowances for credit loss. Refer to "Note 6. Credit Losses<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of other current assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>149
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101989453992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of goodwill</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill for the years ended December 31, 2021, 2020, and 2019, were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:31.550%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.642%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CAG</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Water</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LPD</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">182,386&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,221&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,351&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,531&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">214,489&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Business combinations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impact of changes in foreign currency exchange rates</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">390&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(119)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">409&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">207,350&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,611&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,232&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,531&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">239,724&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Business combinations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition adjustment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,900)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,900)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impact of changes in foreign currency exchange rates</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,724&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">412&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,303&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">210,394&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,023&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,399&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,531&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">243,347&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Business combinations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">120,346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">120,346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impact of changes in foreign currency exchange rates</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,569)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(695)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,348)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">327,171&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,939&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,704&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,531&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">359,345&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_ScheduleOfEstimatedUsefulLivesForIntangibleAssetsTableTextBlock', window );">Schedule of estimated useful lives for intangible assets</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide for amortization primarily using the straight-line method by charges to income in amounts that allocate the intangible assets over their estimated useful lives as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:60.246%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.731%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.723%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Asset Classification</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer-related intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 to 17 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product rights </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 to 15 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncompete agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 to 5 years</span></div></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of intangible assets other than goodwill</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets other than goodwill consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:33.307%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.124%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.124%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.124%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.125%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer-related intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121,936&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,349&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">83,587&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80,810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,838&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,972&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product rights </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,332&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,018&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,609&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,541&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncompete agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">827&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,430&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,030&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143,543&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,508&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99,035&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97,210&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,667&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,543&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">     The above table excludes fully amortized intangible assets for the periods presented.</span></div><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Customer-related intangible assets are comprised of customer lists and customer relationships acquired from third parties.</span></div><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Product rights comprise certain technologies, intellectual property, licenses, and trade names acquired from third parties.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of expected amortization expense</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2021, the aggregate amortization expense associated with intangible assets is estimated to be as follows for each of the next five years and thereafter:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:81.330%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.470%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortization Expense</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,188&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,430&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,381&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,633&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,370&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,033&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99,035&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_ScheduleOfEstimatedUsefulLivesForIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Estimated Useful Lives For Intangible Assets [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_ScheduleOfEstimatedUsefulLivesForIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>idxx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>150
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101994526376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Liabilities and Other Long Term Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAbstract', window );"><strong>Accrued Liabilities, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of accrued liabilities</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"><tr><td style="width:1.0%"/><td style="width:67.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.676%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.827%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued employee compensation and related expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">182,926&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">167,649&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">133,978&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">112,526&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued customer incentives and refund obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">79,469&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,064&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,605&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,676&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,931&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,733&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDgvZnJhZzo2YjI1NjU3MGQ2Y2M0ZTllYWY5MDBhYzk2ZTU2Yjg3My90YWJsZTpkMzgwNTNlNWU4ZTg0N2FhYWQ5MDI3M2UxMDAzMzM5MS90YWJsZXJhbmdlOmQzODA1M2U1ZThlODQ3YWFhZDkwMjczZTEwMDMzMzkxXzctMC0xLTEtMA_5d2faed1-a462-48ce-9b44-a109b44ef227"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDgvZnJhZzo2YjI1NjU3MGQ2Y2M0ZTllYWY5MDBhYzk2ZTU2Yjg3My90YWJsZTpkMzgwNTNlNWU4ZTg0N2FhYWQ5MDI3M2UxMDAzMzM5MS90YWJsZXJhbmdlOmQzODA1M2U1ZThlODQ3YWFhZDkwMjczZTEwMDMzMzkxXzctMC0xLTEtMA_e4f554de-7131-4a19-8325-4f920319c89c">Accrued liabilities</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">458,909&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">415,648&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock', window );">Schedule of other long-term liabilities</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term liabilities consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"/><td style="width:67.501%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.780%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.931%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56,466&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,313&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued long-term expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,475&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,941&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85,604&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other noncurrent liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>151
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101992462120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Debt Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of long-term debt instruments</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following describes all of our currently outstanding unsecured senior notes issued and sold in private placements (collectively, the "Senior Notes") as of December 31, 2021:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"/><td style="width:8.796%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.833%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.387%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.833%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.272%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.981%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.833%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.580%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.833%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.847%"/><td style="width:0.1%"/></tr><tr><td colspan="33" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Principal Amount in thousands)</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Issue Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Due Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Series</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Principal Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Coupon Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Senior Note Agreement</span></td></tr><tr style="height:8pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12/11/2013</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12/11/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023 Series A Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.94&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">NY Life 2013 Note Agreement</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12/11/2013</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12/11/2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025 Series B Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">NY Life 2013 Note Agreement</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9/4/2014</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9/4/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026 Senior Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">NY Life 2014 Note Agreement</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7/21/2014</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7/21/2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024 Series B Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prudential 2015 Amended Agreement</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6/18/2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6/18/2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025 Series C Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8364;</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,857&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.785&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prudential 2015 Amended Agreement</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/12/2015</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/12/2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022 Series A Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MetLife 2014 Note Agreement</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/12/2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/12/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027 Series B Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MetLife 2014 Note Agreement</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3/14/2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3/14/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2029 Series C Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MetLife 2014 Note Agreement</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4/2/2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4/2/2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MetLife 2030 Series D Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MetLife 2014 Note Agreement</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4/14/2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4/14/2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prudential 2030 Series D Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prudential 2015 Amended Agreement</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of annual principal payments on long-term debt</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Annual principal payments on long-term debt at December 31, 2021, are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:71.773%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ending December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">175,711&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">375,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">850,711&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>152
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101991571864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of earnings before income taxes</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings before income taxes were as follows:</span><span style="font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%"/></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:58.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Domestic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">689,994&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">483,694&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">377,964&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">212,660&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">178,291&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">144,254&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 30.25pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">902,654&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">661,985&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">522,218&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of components of provision (benefit) for income taxes</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision (benefit) for income taxes comprised the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:58.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">112,811&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72,921&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,147&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,967&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,288&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,301&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">161,246&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">116,568&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,400&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,019)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,126)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,826&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(503)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,863)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">269&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,086&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19,725)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">931&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,436)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36,714)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,026&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">157,810&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">79,854&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94,426&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of effective income tax rate reconciliation</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes differs from the amounts computed by applying the statutory federal income tax rate as follows:</span><span style="font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%"/></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:58.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. federal statutory rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State income tax, net of federal tax benefit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taxation on international earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign derived intangible income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation from settlements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development credit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impact of Switzerland tax reform</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of components of net deferred tax assets and liabilities</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the net deferred tax assets (liabilities) included in the accompanying consolidated balance sheets are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:66.594%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.318%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.320%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,433&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,830&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable reserves</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,131&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,269&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,629&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventory basis differences</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,553&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,272&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property-based differences</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,865&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible asset basis differences</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,606&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,319&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,484&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,570&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,427&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax credit carryforwards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,483&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,385&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized losses on foreign currency exchange contracts and investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,755&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,060&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">161,835&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">162,787&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(39,280)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(40,262)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets, net of valuation allowance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">122,555&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">122,525&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7.75pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer acquisition costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(37,265)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34,449)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property-based differences</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(42,363)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(49,547)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible asset basis differences</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17,345)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16,134)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,662)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,241)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized gains on foreign currency exchange contracts and investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,071)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(312)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(106,706)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(102,683)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net deferred tax assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,849&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,842&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SummaryOfValuationAllowanceTextBlock', window );">Summary of valuation allowance</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in valuation allowance for deferred tax assets:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:58.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,262&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,454&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,212&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Charges to costs and expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,464&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,076&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,489&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Write-off/cash payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,182)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(226)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,264)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(234)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at the end of the year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,280&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,262&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,454&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock', window );">Schedule of changes in unrecognized tax benefits</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in unrecognized tax positions:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:58.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total amounts of unrecognized tax benefits, beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,484&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,841&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross increases (decreases) in unrecognized tax positions as a result of tax positions taken during a prior period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">443&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,755)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(276)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross increases in unrecognized tax positions as a result of tax positions taken in the current period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,083&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Decreases in unrecognized tax positions related to settlements with taxing authorities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(537)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,446)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Decreases in unrecognized tax positions as a result of a lapse of the applicable statutes of limitations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,015)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(355)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,213)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total amounts of unrecognized tax benefits, end of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,789&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,484&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,841&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfIncomeTaxContingenciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfValuationAllowanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfValuationAllowanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>153
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101992460728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock', window );">Schedule of reconciliation of shares outstanding for basic and diluted earnings per share</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of weighted average shares outstanding for basic and diluted earnings per share:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:58.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares outstanding for basic earnings per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85,342&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86,115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares outstanding for diluted earnings per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares outstanding for basic earnings per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85,342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86,115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive effect of share-based payment awards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,372&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,380&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,427&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86,572&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86,722&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87,542&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of number of anti-dilutive stock options</a></td>
<td class="text">The following table presents information concerning those anti-dilutive options:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:58.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average number of shares underlying anti-dilutive options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>154
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101992452376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Summary of segment performance</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of segment performance:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.797%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CAG</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Water</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LPD</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,889,960&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">146,505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">135,887&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,215,360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">824,022&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65,444&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,636&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,926&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">932,028&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(29,374)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income before provision for income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">902,654&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">157,810&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">744,844&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Net income attributable to noncontrolling interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to IDEXX Laboratories, Inc. stockholders</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">744,845&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94,202&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,709&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,908&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,777&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104,596&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,385,765&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">128,625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">145,845&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,420&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,706,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">574,887&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,867&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,008&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,762&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">694,524&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32,539)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income before provision for income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">661,985&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">79,854&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">582,131&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Net income attributable to noncontrolling interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to IDEXX Laboratories, Inc. stockholders</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">581,776&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,697&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,630&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,070&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,601&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95,998&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,119,183&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132,635&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,240&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,406,908&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">462,605&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61,923&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,735&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,583&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">552,846&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,628)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income before provision for income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">522,218&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94,426&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">427,792&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Net income attributable to noncontrolling interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to IDEXX Laboratories, Inc. stockholders</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">427,720&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77,620&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,794&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,007&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,590&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,011&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock', window );">Schedule of net long-lived assets by principal geographic areas</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net long-lived assets, consisting of net property and equipment, are subject to geographic risks because they are generally difficult to move and to effectively utilize in another geographic area in a reasonable time period and because they are relatively illiquid. Net long-lived assets by principal geographic areas were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:66.594%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.318%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.320%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Americas</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">436,003&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">412,700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Brazil</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,043&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,797&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,003&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,993&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 12.25pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">460,049&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">438,490&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Europe, the Middle East and Africa</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,451&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67,354&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,828&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,191&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Netherlands</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,405&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,267&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">France</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,884&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,062&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Switzerland</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,545&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,821&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,668&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98,934&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102,285&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asia Pacific Region</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,845&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Australia</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,584&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,304&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,585&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,684&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,392&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">587,667&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">555,167&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the names of foreign countries in which material long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets are located, and amount of such long-lived assets located in that country or foreign geographic area.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>155
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101992410152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of fair value of assets and liabilities measured on recurring basis</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth our assets and liabilities that were measured at fair value on a recurring basis by level within the fair value hierarchy:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:45.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.402%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Quoted Prices in Active Markets for Identical Assets <br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant Other Observable Inputs <br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant Unobservable Inputs <br/>(Level 3)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Money market funds </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity mutual funds </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross currency swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange contracts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange contracts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">601&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">601&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred compensation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">826&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">826&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent payments - acquisitions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:45.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.402%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Quoted Prices in Active Markets for Identical Assets <br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant Other Observable Inputs <br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant Unobservable Inputs <br/>(Level 3)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at December 31, 2020</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Money market funds </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity mutual funds </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange contracts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross currency swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,841&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,841&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange contracts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred compensation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Money market funds with an original maturity of less than ninety days are included within cash and cash equivalents. The remaining balance of cash and cash equivalents as of December 31, 2021, and December 31, 2020, consisted of demand deposits.</span></div><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Equity mutual funds relate to a deferred compensation plan that was assumed as part of a previous business combination. This amount is included within other long-term assets. Refer to footnote (4) below for a discussion of the related deferred compensation liability.</span></div><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Cross currency swaps and foreign currency exchange contracts are included within other current assets; other long-term assets; accrued liabilities; or other long-term liabilities depending on the gain (loss) position and anticipated settlement date.</span></div><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">A deferred compensation plan assumed as part of a previous business combination is included within accrued liabilities and other long-term liabilities. The fair value of our deferred compensation plan is indexed to the performance of the underlying equity mutual funds discussed in footnote (2) above.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Schedule of contingent consideration liability</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record changes in the estimated fair value of contingent consideration in the consolidated statements of income. Changes in contingent consideration liabilities are measured at fair value on a recurring basis using unobservable inputs (Level 3) and during the year ended December 31, 2021, are as follows:</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.794%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.276%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Contingent consideration as of December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent consideration recorded from acquisitions (Note 4)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,230&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in estimated fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Contingent consideration as of December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,230&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>156
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101992415512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Hedging Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Details of net investment hedges and Income Statement impact of hedging instruments</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the effect of cash flow hedge accounting on our consolidated statements of income and comprehensive income, and provides information regarding the location and amounts of pretax gains or losses of derivatives:&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:43.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.164%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.579%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Financial statement line items in which effects of cash flow hedges are recorded</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,325,928&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,135,615&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,041,359&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount of (loss) gain reclassified from accumulated other comprehensive income into income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,121)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">829&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,628&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Schedule of hedging instruments</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of hedging instruments, their respective classification on the consolidated balance sheets, and amounts subject to offset under master netting arrangements consisted of the following derivative instruments, unless otherwise noted:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:47.798%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.786%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.909%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Hedging Assets</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives and non-derivatives designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross currency swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total derivative instruments presented as hedge instruments on the balance sheet</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,768&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross amounts subject to master netting arrangements not offset on the balance sheet</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(601)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(125)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net amount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,167&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:47.798%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.786%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.909%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Hedging Liabilities</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives and non-derivatives designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">601&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross currency swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,841&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total derivative instruments presented as cash flow hedges on the balance sheet</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">601&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,214&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-derivative foreign currency denominated debt designated as net investment hedge on the balance sheet </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100,711&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109,125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total hedging instruments presented on the balance sheet</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101,312&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">124,339&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross amounts subject to master netting arrangements not offset on the balance sheet</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(601)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(125)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net amount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100,711&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">124,214&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts represent reported carrying amounts of our foreign currency denominated debt. Refer to "Note 18. Fair Value Measurements" for information regarding the fair value of our long-term debt.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative instruments (including nonderivative instruments that are designated and qualify as hedging instruments) of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>157
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101989368104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Repurchases of Common Stock (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock', window );">Schedule of common stock repurchases</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our open market common stock repurchases, reported on a trade date basis, and shares acquired through employee surrenders:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:58.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands, except per share amounts)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares repurchased in the open market</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,283&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">721&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,215&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares acquired through employee surrenders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">for statutory tax withholding</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total shares repurchased</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,312&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">779&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,254&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of shares repurchased in the open market</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">755,545&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">179,623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">303,838&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of shares for employee surrenders</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,562&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,603&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,054&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total cost of shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">771,107&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200,226&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">311,892&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average cost per share - open market repurchases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">588.58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">249.20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">249.84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average cost per share - employee surrenders</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">548.08&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">354.98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">210.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average cost per share - total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">587.70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">257.08&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">248.62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23309-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfTreasuryStockByClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>158
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101992452376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of accumulated other comprehensive income</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in AOCI, net of tax, consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:27.785%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.897%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.562%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.190%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.897%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.287%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31, 2021 and 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized (Loss) Gain on Cash Flow Hedges, Net of Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized (Loss) Gain on Net Investment Hedges, Net of Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized (Loss) Gain on Investments, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign Currency Exchange Contracts</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Euro-Denominated Notes</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cross Currency Swaps</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cumulative Translation Adjustment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(736)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(50,419)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(46,182)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(382)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,527)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,378)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,626)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,762)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(671)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(671)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(272)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,934)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,982)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,159)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35,268)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(53,615)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,404&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,399&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(26,731)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,643)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(126)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,979&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">422&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,240&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(61,999)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(53,484)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock', window );">Summary of reclassifications out of accumulated other comprehensive income</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents components and amounts reclassified out of AOCI to net income:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"/><td style="width:34.455%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.492%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.492%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Affected Line Item in the Statements of Income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amounts Reclassified from AOCI for the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gains (losses) on derivative instruments included in net income:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,121)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">829&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,628&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax (benefit) expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,347)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Losses) gains, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,774)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">671&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,161&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>159
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101985291880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 01, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_ResearchAndDevelopmentCostsCapitalized', window );">Capitalized costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,300,000<span></span>
</td>
<td class="nump">1,400,000<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign currency gains (losses)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,100,000)<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="num">(1,100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Non-cash cumulative effect adjustment to retained earnings, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">689,992,000<span></span>
</td>
<td class="nump">632,795,000<span></span>
</td>
<td class="nump">177,825,000<span></span>
</td>
<td class="num">$ (9,233,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_ContractwithCustomerAssetAndSalesTypeLeaseNetInvestmentInLeaseAllowanceforCreditLoss', window );">Reserve for contract assets and sales-type leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,400,000<span></span>
</td>
<td class="nump">3,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Accounts receivable allowance for credit losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,700,000<span></span>
</td>
<td class="nump">6,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Non-cash cumulative effect adjustment to retained earnings, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,920,440,000<span></span>
</td>
<td class="nump">$ 2,175,595,000<span></span>
</td>
<td class="nump">1,595,648,000<span></span>
</td>
<td class="nump">$ 1,167,928,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201613Member', window );">Accounting Standards Update 2016-13</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_ContractwithCustomerAssetAndSalesTypeLeaseNetInvestmentInLeaseAllowanceforCreditLoss', window );">Reserve for contract assets and sales-type leases</a></td>
<td class="nump">$ 2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Accounts receivable allowance for credit losses</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201613Member', window );">Accounting Standards Update 2016-13 | Retained Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityCumulativeEffectOfChangeInAccountingPrinciple', window );">Non-cash cumulative effect adjustment to retained earnings, tax</a></td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Non-cash cumulative effect adjustment to retained earnings, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,829,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment | Retained Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Non-cash cumulative effect adjustment to retained earnings, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,829,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment | Accounting Standards Update 2016-13 | Retained Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Non-cash cumulative effect adjustment to retained earnings, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_ContractwithCustomerAssetAndSalesTypeLeaseNetInvestmentInLeaseAllowanceforCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract with Customer, Asset, And Sales-Type Lease, Net Investment In Lease, Allowance for Credit Loss</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_ContractwithCustomerAssetAndSalesTypeLeaseNetInvestmentInLeaseAllowanceforCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>idxx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_ResearchAndDevelopmentCostsCapitalized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research And Development Costs, Capitalized</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_ResearchAndDevelopmentCostsCapitalized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>idxx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_SummaryOfSignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Summary Of Significant Accounting Policies [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_SummaryOfSignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>idxx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30226-110892<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28228-110885<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityCumulativeEffectOfChangeInAccountingPrinciple">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cumulative tax effect on beginning retained earnings from change in accounting principle.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e39076-109324<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityCumulativeEffectOfChangeInAccountingPrinciple</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201613Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201613Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>160
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101985584088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_RevenuePerformanceObligationPaymentTerm', window );">General payment terms</a></td>
<td class="text">30 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_RevenuePerformanceObligationPaymentTerm', window );">General payment terms</a></td>
<td class="text">60 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_RevenuePerformanceObligationPaymentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue, Performance Obligation, Payment Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_RevenuePerformanceObligationPaymentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>idxx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>161
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101992449592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition (Lease Revenue) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseIncome', window );">Lease revenue</a></td>
<td class="nump">$ 20.8<span></span>
</td>
<td class="nump">$ 17.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease income from operating, direct financing, and sales-type leases. Includes, but is not limited to, variable lease payments, interest income, profit (loss) recognized at commencement, and lease payments paid and payable to lessor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919372-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>162
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101991751992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition (Extended Warranties and Post-Contract Support) (Details) - Extended warranties and post contract support - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_PostContractSupportContractTerm', window );">Post-contract support contract, term</a></td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="nump">$ 30.0<span></span>
</td>
<td class="nump">$ 35.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Deferred revenue recognized</a></td>
<td class="nump">23.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Estimation of future revenues</a></td>
<td class="nump">$ 16.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=idxx_ExtendedWarrantiesAndPostContractSupportMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_ExtendedProductWarrantyTerm', window );">Extended product warranty, term</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=idxx_ExtendedWarrantiesAndPostContractSupportMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_ExtendedProductWarrantyTerm', window );">Extended product warranty, term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_ExtendedProductWarrantyTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Extended Product Warranty, Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_ExtendedProductWarrantyTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>idxx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_PostContractSupportContractTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Post-contract Support Contract, Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_PostContractSupportContractTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>idxx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=idxx_ExtendedWarrantiesAndPostContractSupportMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=idxx_ExtendedWarrantiesAndPostContractSupportMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>163
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101983379752">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Revenue Recognition (Remaining Performance Obligation) (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=idxx_ExtendedWarrantiesAndPostContractSupportMember', window );">Extended warranties and post contract support | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Revenue percentage expected to be recognized</a></td>
<td class="nump">49.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue recognition period (in years)</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=idxx_ExtendedWarrantiesAndPostContractSupportMember', window );">Extended warranties and post contract support | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Revenue percentage expected to be recognized</a></td>
<td class="nump">29.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue recognition period (in years)</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=idxx_ExtendedWarrantiesAndPostContractSupportMember', window );">Extended warranties and post contract support | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Revenue percentage expected to be recognized</a></td>
<td class="nump">14.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue recognition period (in years)</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=idxx_ExtendedWarrantiesAndPostContractSupportMember', window );">Extended warranties and post contract support | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Revenue percentage expected to be recognized</a></td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue recognition period (in years)</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=idxx_ExtendedWarrantiesAndPostContractSupportMember', window );">Extended warranties and post contract support | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Revenue percentage expected to be recognized</a></td>
<td class="nump">3.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue recognition period (in years)</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=idxx_UpFrontCustomerLoyaltyProgramsAndVolumeCommitmentProgramsMember', window );">Up front customer loyalty programs and volume commitment programs | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Revenue percentage expected to be recognized</a></td>
<td class="nump">25.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue recognition period (in years)</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=idxx_UpFrontCustomerLoyaltyProgramsAndVolumeCommitmentProgramsMember', window );">Up front customer loyalty programs and volume commitment programs | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Revenue percentage expected to be recognized</a></td>
<td class="nump">24.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue recognition period (in years)</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=idxx_UpFrontCustomerLoyaltyProgramsAndVolumeCommitmentProgramsMember', window );">Up front customer loyalty programs and volume commitment programs | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Revenue percentage expected to be recognized</a></td>
<td class="nump">20.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue recognition period (in years)</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=idxx_UpFrontCustomerLoyaltyProgramsAndVolumeCommitmentProgramsMember', window );">Up front customer loyalty programs and volume commitment programs | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Revenue percentage expected to be recognized</a></td>
<td class="nump">15.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue recognition period (in years)</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=idxx_UpFrontCustomerLoyaltyProgramsAndVolumeCommitmentProgramsMember', window );">Up front customer loyalty programs and volume commitment programs | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Revenue percentage expected to be recognized</a></td>
<td class="nump">16.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue recognition period (in years)</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=idxx_InstrumentRebateProgramsMember', window );">Instrument rebate programs | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Revenue percentage expected to be recognized</a></td>
<td class="nump">36.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue recognition period (in years)</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=idxx_InstrumentRebateProgramsMember', window );">Instrument rebate programs | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Revenue percentage expected to be recognized</a></td>
<td class="nump">26.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue recognition period (in years)</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=idxx_InstrumentRebateProgramsMember', window );">Instrument rebate programs | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Revenue percentage expected to be recognized</a></td>
<td class="nump">17.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue recognition period (in years)</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=idxx_InstrumentRebateProgramsMember', window );">Instrument rebate programs | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Revenue percentage expected to be recognized</a></td>
<td class="nump">11.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue recognition period (in years)</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=idxx_InstrumentRebateProgramsMember', window );">Instrument rebate programs | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Revenue percentage expected to be recognized</a></td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue recognition period (in years)</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=idxx_ReagentRentalProgramsMember', window );">Reagent rental programs | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Revenue percentage expected to be recognized</a></td>
<td class="nump">32.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue recognition period (in years)</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=idxx_ReagentRentalProgramsMember', window );">Reagent rental programs | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Revenue percentage expected to be recognized</a></td>
<td class="nump">26.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue recognition period (in years)</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=idxx_ReagentRentalProgramsMember', window );">Reagent rental programs | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Revenue percentage expected to be recognized</a></td>
<td class="nump">20.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue recognition period (in years)</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=idxx_ReagentRentalProgramsMember', window );">Reagent rental programs | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Revenue percentage expected to be recognized</a></td>
<td class="nump">14.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue recognition period (in years)</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=idxx_ReagentRentalProgramsMember', window );">Reagent rental programs | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Revenue percentage expected to be recognized</a></td>
<td class="nump">8.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue recognition period (in years)</a></td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=idxx_ExtendedWarrantiesAndPostContractSupportMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=idxx_ExtendedWarrantiesAndPostContractSupportMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2025-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2025-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2026-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2026-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=idxx_UpFrontCustomerLoyaltyProgramsAndVolumeCommitmentProgramsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=idxx_UpFrontCustomerLoyaltyProgramsAndVolumeCommitmentProgramsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=idxx_InstrumentRebateProgramsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=idxx_InstrumentRebateProgramsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=idxx_ReagentRentalProgramsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=idxx_ReagentRentalProgramsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>164
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101992405592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition (SaaS Subscriptions) (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_SaasSubscriptionTermOfContract', window );">SaaS subscription, term</a></td>
<td class="text">2 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_SaasSubscriptionTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>SaaS Subscription, Term of Contract</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_SaasSubscriptionTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>idxx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>165
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101985566392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition (Up-Front Customer Loyalty Programs) (Details) - Up front customer loyalty programs - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostGross', window );">Capitalized customer acquisition costs</a></td>
<td class="nump">$ 158.3<span></span>
</td>
<td class="nump">$ 148.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAmortization', window );">Capitalized customer acquisition costs recognized as a reduction of revenue</a></td>
<td class="nump">$ 43.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for asset recognized from cost incurred to obtain or fulfill contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123353750&amp;loc=SL49131252-203054<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123353750&amp;loc=SL49131252-203054<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=idxx_UpFrontCustomerLoyaltyProgramsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=idxx_UpFrontCustomerLoyaltyProgramsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>166
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101991744920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition (Volume Commitment Programs) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=idxx_VolumeCommitmentProgramsMember', window );">Volume commitment programs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Volume commitment contract assets</a></td>
<td class="nump">$ 159.9<span></span>
</td>
<td class="nump">$ 115.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable', window );">Volume commitment contract assets reclassified to accounts receivable</a></td>
<td class="nump">26.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=idxx_UpFrontCustomerLoyaltyProgramsAndVolumeCommitmentProgramsMember', window );">Up front customer loyalty programs and volume commitment programs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Estimation of future revenues</a></td>
<td class="nump">$ 2,900.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130533-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time from transfer to receivable due to right to consideration becoming unconditional.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetReclassifiedToReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=idxx_VolumeCommitmentProgramsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=idxx_VolumeCommitmentProgramsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=idxx_UpFrontCustomerLoyaltyProgramsAndVolumeCommitmentProgramsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=idxx_UpFrontCustomerLoyaltyProgramsAndVolumeCommitmentProgramsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>167
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101992196040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition (Instrument Rebate Programs) (Details) - Instrument rebate programs - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="nump">$ 33.0<span></span>
</td>
<td class="nump">$ 39.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Deferred revenue recognized</a></td>
<td class="nump">$ 14.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=idxx_InstrumentRebateProgramsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=idxx_InstrumentRebateProgramsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>168
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101992365624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition (Reagent Rental Programs) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseLeaseReceivable', window );">Lease receivable asset</a></td>
<td class="nump">$ 15.3<span></span>
</td>
<td class="nump">$ 11.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_SalesTypeLeaseLeaseReceivableReclassifiedToReceivable', window );">Lease receivable, reclassified to receivable</a></td>
<td class="nump">2.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=idxx_ReagentRentalProgramsMember', window );">Reagent rental programs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Estimation of future revenues</a></td>
<td class="nump">$ 38.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_SalesTypeLeaseLeaseReceivableReclassifiedToReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sales-Type Lease, Lease Receivable, Reclassified To Receivable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_SalesTypeLeaseLeaseReceivableReclassifiedToReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>idxx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeLeaseLeaseReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lease payments not yet received by lessor and amount expected to be derived from underlying asset, following end of lease term guaranteed by lessee or other third party unrelated to lessor, from sales-type lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919379-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeLeaseLeaseReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=idxx_ReagentRentalProgramsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=idxx_ReagentRentalProgramsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>169
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101985438840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition (Disaggregation of Revenue by Major Product and Service Categories) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 3,215,360<span></span>
</td>
<td class="nump">$ 2,706,655<span></span>
</td>
<td class="nump">$ 2,406,908<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=idxx_CompanionAnimalGroupSegmentMember', window );">CAG segment revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">2,889,960<span></span>
</td>
<td class="nump">2,385,765<span></span>
</td>
<td class="nump">2,119,183<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=idxx_CompanionAnimalGroupSegmentMember', window );">CAG segment revenue | CAG Diagnostics recurring revenue:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">2,534,562<span></span>
</td>
<td class="nump">2,113,839<span></span>
</td>
<td class="nump">1,828,329<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=idxx_CompanionAnimalGroupSegmentMember', window );">CAG segment revenue | IDEXX VetLab consumables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">1,006,781<span></span>
</td>
<td class="nump">824,376<span></span>
</td>
<td class="nump">693,360<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=idxx_CompanionAnimalGroupSegmentMember', window );">CAG segment revenue | Rapid assay products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">296,852<span></span>
</td>
<td class="nump">253,018<span></span>
</td>
<td class="nump">232,149<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=idxx_CompanionAnimalGroupSegmentMember', window );">CAG segment revenue | Reference laboratory diagnostic and consulting services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">1,123,656<span></span>
</td>
<td class="nump">946,268<span></span>
</td>
<td class="nump">822,497<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=idxx_CompanionAnimalGroupSegmentMember', window );">CAG segment revenue | CAG Diagnostics services and accessories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">107,273<span></span>
</td>
<td class="nump">90,177<span></span>
</td>
<td class="nump">80,323<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=idxx_CompanionAnimalGroupSegmentMember', window );">CAG segment revenue | CAG Diagnostics capital - instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">149,140<span></span>
</td>
<td class="nump">108,950<span></span>
</td>
<td class="nump">132,685<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=idxx_CompanionAnimalGroupSegmentMember', window );">CAG segment revenue | Veterinary software, services and diagnostic imaging systems</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">206,258<span></span>
</td>
<td class="nump">162,976<span></span>
</td>
<td class="nump">158,169<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=idxx_WaterSegmentMember', window );">Water segment revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">146,505<span></span>
</td>
<td class="nump">128,625<span></span>
</td>
<td class="nump">132,850<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=idxx_LivestockAndPoultryDiagnosticsSegmentMember', window );">LPD segment revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">135,887<span></span>
</td>
<td class="nump">145,845<span></span>
</td>
<td class="nump">132,635<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=idxx_OtherSegmentMember', window );">Other segment revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 43,008<span></span>
</td>
<td class="nump">$ 46,420<span></span>
</td>
<td class="nump">$ 22,240<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=idxx_CompanionAnimalGroupSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=idxx_CompanionAnimalGroupSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=idxx_CAGDiagnosticsRecurringRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=idxx_CAGDiagnosticsRecurringRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=idxx_VetLabConsumablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=idxx_VetLabConsumablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=idxx_RapidAssayProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=idxx_RapidAssayProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=idxx_ReferenceLaboratoryDiagnosticAndConsultingServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=idxx_ReferenceLaboratoryDiagnosticAndConsultingServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=idxx_CAGDiagnosticsServiceAndAccessoriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=idxx_CAGDiagnosticsServiceAndAccessoriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=idxx_CAGDiagnosticCapitalVetlabInstrumentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=idxx_CAGDiagnosticCapitalVetlabInstrumentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=idxx_VeterinarySoftwareServicesAndDiagnosticImagingSystemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=idxx_VeterinarySoftwareServicesAndDiagnosticImagingSystemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=idxx_WaterSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=idxx_WaterSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=idxx_LivestockAndPoultryDiagnosticsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=idxx_LivestockAndPoultryDiagnosticsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=idxx_OtherSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=idxx_OtherSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>170
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101984851576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition (Disaggregation of Revenue by Principal Geographic Area, Based on Customers' Domiciles) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 3,215,360<span></span>
</td>
<td class="nump">$ 2,706,655<span></span>
</td>
<td class="nump">$ 2,406,908<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AmericasMember', window );">Americas</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">2,202,033<span></span>
</td>
<td class="nump">1,850,485<span></span>
</td>
<td class="nump">1,651,581<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">1,995,683<span></span>
</td>
<td class="nump">1,691,224<span></span>
</td>
<td class="nump">1,495,516<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CA', window );">Canada</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">139,727<span></span>
</td>
<td class="nump">107,398<span></span>
</td>
<td class="nump">99,550<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=idxx_LatinAmericaAndCaribbeanMember', window );">Latin America &amp; Caribbean</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">66,623<span></span>
</td>
<td class="nump">51,863<span></span>
</td>
<td class="nump">56,515<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember', window );">Europe, the Middle East and Africa</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">681,949<span></span>
</td>
<td class="nump">562,765<span></span>
</td>
<td class="nump">498,439<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_DE', window );">Germany</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">146,762<span></span>
</td>
<td class="nump">119,353<span></span>
</td>
<td class="nump">104,081<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_GB', window );">United Kingdom</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">114,955<span></span>
</td>
<td class="nump">90,156<span></span>
</td>
<td class="nump">90,969<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_FR', window );">France</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">90,836<span></span>
</td>
<td class="nump">74,814<span></span>
</td>
<td class="nump">64,767<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IT', window );">Italy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">52,062<span></span>
</td>
<td class="nump">42,817<span></span>
</td>
<td class="nump">39,725<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_ES', window );">Spain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">48,169<span></span>
</td>
<td class="nump">39,265<span></span>
</td>
<td class="nump">36,439<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CH', window );">Switzerland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">31,984<span></span>
</td>
<td class="nump">24,850<span></span>
</td>
<td class="nump">20,855<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_NL', window );">Netherlands</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">29,656<span></span>
</td>
<td class="nump">23,461<span></span>
</td>
<td class="nump">19,397<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=idxx_EuropetheMiddleEastandAfricaOtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">167,525<span></span>
</td>
<td class="nump">148,049<span></span>
</td>
<td class="nump">122,206<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">Asia Pacific Region</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">331,378<span></span>
</td>
<td class="nump">293,405<span></span>
</td>
<td class="nump">256,888<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_AU', window );">Australia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">94,414<span></span>
</td>
<td class="nump">79,629<span></span>
</td>
<td class="nump">71,069<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_JP', window );">Japan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">84,275<span></span>
</td>
<td class="nump">74,725<span></span>
</td>
<td class="nump">67,246<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CN', window );">China</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">63,166<span></span>
</td>
<td class="nump">70,845<span></span>
</td>
<td class="nump">57,518<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=idxx_AsiaPacificRegionOtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 89,523<span></span>
</td>
<td class="nump">$ 68,206<span></span>
</td>
<td class="nump">$ 61,055<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AmericasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AmericasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=idxx_LatinAmericaAndCaribbeanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=idxx_LatinAmericaAndCaribbeanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_EMEAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_DE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_DE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_FR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_FR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IT">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IT</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_ES">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_ES</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CH">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CH</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_NL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_NL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=idxx_EuropetheMiddleEastandAfricaOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=idxx_EuropetheMiddleEastandAfricaOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaPacificMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_AU">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_AU</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_JP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_JP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CN">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CN</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=idxx_AsiaPacificRegionOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=idxx_AsiaPacificRegionOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>171
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101985277464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition (Costs to Obtain a Contract) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostNet', window );">Deferred commission costs</a></td>
<td class="nump">$ 19.5<span></span>
</td>
<td class="nump">$ 17.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesCommissionsAndFees', window );">Commissions expense recognized</a></td>
<td class="nump">$ 5.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAmortizationPeriod', window );">Capitalized contract, amortization period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAmortizationPeriod', window );">Capitalized contract, amortization period</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAmortizationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortization period of cost capitalized in obtaining or fulfilling contract with customer, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 40<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123353750&amp;loc=SL49131251-203054<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAmortizationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123353750&amp;loc=SL49131252-203054<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesCommissionsAndFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Primarily represents commissions incurred in the period based upon the sale by commissioned employees or third parties of the entity's goods or services, and fees for sales assistance or product enhancements performed by third parties (such as a distributor or value added reseller).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesCommissionsAndFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>172
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101981372088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Investments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="6">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 359,345<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 239,724<span></span>
</td>
<td class="nump">$ 359,345<span></span>
</td>
<td class="nump">$ 243,347<span></span>
</td>
<td class="nump">$ 214,489<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_NoncontrollingInterestOwnershipPercentageAcquiredFromNoncontrollingOwners', window );">Noncontrolling interest, remaining percentage purchased from noncontrolling owners</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Noncontrolling interest, purchase of Interests</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=idxx_ReferenceLaboratoryMember', window );">Reference Laboratory | Finland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to acquire business</a></td>
<td class="nump">13,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_BusinessCombinationContingentConsiderationHoldback', window );">Holdback</a></td>
<td class="nump">1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">5,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_BusinessCombinationsTangibleLiabilities', window );">Net tangible liabilities</a></td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=idxx_ReferenceLaboratoryMember', window );">Reference Laboratory | Finland | Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets</a></td>
<td class="nump">$ 7,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=idxx_ReferenceLaboratoryMember', window );">Reference Laboratory | Finland | Noncompete agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets</a></td>
<td class="nump">$ 800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=idxx_ReferenceLaboratoryMember', window );">Reference Laboratory | Switzerland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Purchase price of acquired assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_BusinessCombinationContingentConsiderationLiabilityAndHoldback', window );">Contingent payment and holdback</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=idxx_ReferenceLaboratoryMember', window );">Reference Laboratory | Switzerland | Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=idxx_TeleradiologyBusinessMember', window );">Teleradiology Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Purchase price of acquired assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=idxx_TeleradiologyBusinessMember', window );">Teleradiology Business | Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=idxx_EzyVetMember', window );">ezyVet</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">109,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Purchase price of acquired assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">157,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent payment</a></td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in amount of contingent payable</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acquisition expenses</a></td>
<td class="nump">$ 2,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=idxx_EzyVetMember', window );">ezyVet | IDEXX VetLab consumables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=idxx_EzyVetMember', window );">ezyVet | Reference laboratory diagnostic and consulting services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=idxx_EzyVetMember', window );">ezyVet | Rapid assay products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=idxx_EzyVetMember', window );">ezyVet | Veterinary software, services and diagnostic imaging systems</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=idxx_EzyVetMember', window );">ezyVet | Noncompete agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=idxx_EzyVetMember', window );">ezyVet | Customer-related intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=idxx_EzyVetMember', window );">ezyVet | Technology-based intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=idxx_EzyVetMember', window );">ezyVet | Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">14 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=idxx_ReferenceLaboratoryinMidWestUnitedStatesMember', window );">Reference laboratory in Mid-West, U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Purchase price of acquired assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=idxx_ReferenceLaboratoryinMidWestUnitedStatesMember', window );">Reference laboratory in Mid-West, U.S. | Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">13 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_BusinessCombinationContingentConsiderationHoldback">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Holdback</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_BusinessCombinationContingentConsiderationHoldback</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>idxx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_BusinessCombinationContingentConsiderationLiabilityAndHoldback">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Liability and Holdback</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_BusinessCombinationContingentConsiderationLiabilityAndHoldback</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>idxx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_BusinessCombinationsTangibleLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combinations, Tangible Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_BusinessCombinationsTangibleLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>idxx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_NoncontrollingInterestOwnershipPercentageAcquiredFromNoncontrollingOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Ownership Percentage Acquired From Noncontrolling Owners</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_NoncontrollingInterestOwnershipPercentageAcquiredFromNoncontrollingOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>idxx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromRedemptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569655-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4616395-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromRedemptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=idxx_ReferenceLaboratoryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=idxx_ReferenceLaboratoryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_FI">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_FI</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CH">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CH</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=idxx_TeleradiologyBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=idxx_TeleradiologyBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=idxx_EzyVetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=idxx_EzyVetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=idxx_VetLabConsumablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=idxx_VetLabConsumablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=idxx_ReferenceLaboratoryDiagnosticAndConsultingServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=idxx_ReferenceLaboratoryDiagnosticAndConsultingServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=idxx_RapidAssayProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=idxx_RapidAssayProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=idxx_VeterinarySoftwareServicesAndDiagnosticImagingSystemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=idxx_VeterinarySoftwareServicesAndDiagnosticImagingSystemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=idxx_ReferenceLaboratoryinMidWestUnitedStatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=idxx_ReferenceLaboratoryinMidWestUnitedStatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>173
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101982865320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Narrative) (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37,755<span></span>
</td>
<td class="nump">$ 30,951<span></span>
</td>
<td class="nump">$ 39,278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Income tax benefit resulting from share-based compensation expense | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,734<span></span>
</td>
<td class="nump">3,965<span></span>
</td>
<td class="nump">4,861<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation expense, net of estimated forfeitures, for unvested share-based compensation awards outstanding | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 64,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted average recognition period for unrecognized compensation expense, in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Intrinsic value of stock options exercised | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 147,900<span></span>
</td>
<td class="nump">$ 163,000<span></span>
</td>
<td class="nump">$ 83,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested', window );">Nonvested, intrinsic value | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 108,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_RatioOfDeferredStockUnitsToSharesOfCommonStock', window );">Number of unissued shares of common stock each DSU represents right to receive (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockOtherSharesOutstanding', window );">Deferred stock units, outstanding (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,000<span></span>
</td>
<td class="nump">87,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=idxx_TwoThousandEighteenStockIncentivePlanMember', window );">2018 Stock Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Shares authorized for grant under share-based incentive plans (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for grant under share-based incentive plans (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=idxx_StockOptionsAndStockAppreciationRightsMember', window );">Stock options and stock appreciation rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_RatioSharesIssuedUnderShareBasedAwardsToSharesAuthorizedUnderStockPlans', window );">Ratio of shares issued under share-based awards to shares authorized under stock plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=idxx_AwardsOtherThanStockOptionsAndStockAppreciationRightsMember', window );">Awards other than stock options and stock appreciation rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_RatioSharesIssuedUnderShareBasedAwardsToSharesAuthorizedUnderStockPlans', window );">Ratio of shares issued under share-based awards to shares authorized under stock plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense | $</a></td>
<td class="nump">$ 10,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Income tax benefit resulting from share-based compensation expense | $</a></td>
<td class="num">$ (800)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Fair value of options vested during period | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,300<span></span>
</td>
<td class="nump">$ 14,600<span></span>
</td>
<td class="nump">$ 12,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units (RSU's)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Fair value of awards vested during period | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 46,100<span></span>
</td>
<td class="nump">$ 27,900<span></span>
</td>
<td class="nump">$ 23,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=idxx_DeferredStockUnitsMember', window );">Deferred Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockOtherSharesOutstanding', window );">Deferred stock units, outstanding (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,000<span></span>
</td>
<td class="nump">87,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=idxx_NineteenNinetySevenEmployeeStockPurchasePlanMember', window );">1997 Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Shares authorized for grant under share-based incentive plans (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for grant under share-based incentive plans (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate', window );">Discount from market value for employee stock purchase rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Common stock issued in connection with the Employee Stock Purchase Plan (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,500<span></span>
</td>
<td class="nump">39,000<span></span>
</td>
<td class="nump">47,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember', window );">Share-based Compensation Award, Tranche One | Stock options granted to employees with ratable vesting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember', window );">Share-based Compensation Award, Tranche One | Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Contractual term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember', window );">Share-based Compensation Award, Tranche One | Restricted stock units granted to employees with ratable vesting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember', window );">Share-based Compensation Award, Tranche Two | Stock options granted to employees with ratable vesting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember', window );">Share-based Compensation Award, Tranche Two | Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Contractual term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember', window );">Share-based Compensation Award, Tranche Two | Restricted stock units granted to employees with ratable vesting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_RatioOfDeferredStockUnitsToSharesOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of unissued shares of common stock that each DSU represents the right to receive.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_RatioOfDeferredStockUnitsToSharesOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>idxx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_RatioSharesIssuedUnderShareBasedAwardsToSharesAuthorizedUnderStockPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The ratio of the number of shares issued under share-based awards to the number of shares authorized under stock plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_RatioSharesIssuedUnderShareBasedAwardsToSharesAuthorizedUnderStockPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>idxx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockOtherSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of shares of other common stock instruments held by shareholders, such as exchangeable shares. May be all or portion of the number of common shares authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockOtherSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discount rate from fair value on offering date that participants pay for shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intrinsic value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=idxx_TwoThousandEighteenStockIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=idxx_TwoThousandEighteenStockIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=idxx_StockOptionsAndStockAppreciationRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=idxx_StockOptionsAndStockAppreciationRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=idxx_AwardsOtherThanStockOptionsAndStockAppreciationRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=idxx_AwardsOtherThanStockOptionsAndStockAppreciationRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=idxx_DeferredStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=idxx_DeferredStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=idxx_NineteenNinetySevenEmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=idxx_NineteenNinetySevenEmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=idxx_StockOptionsGrantedToEmployeesWithRatableVestingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=idxx_StockOptionsGrantedToEmployeesWithRatableVestingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=idxx_RestrictedStockUnitsGrantedToEmployeesWithRatableVestingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=idxx_RestrictedStockUnitsGrantedToEmployeesWithRatableVestingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>174
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101991610728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Schedule of Selected Financial Impact of Share-Based Compensation) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">$ 37,755<span></span>
</td>
<td class="nump">$ 30,951<span></span>
</td>
<td class="nump">$ 39,278<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Income tax benefit resulting from share-based compensation expense</a></td>
<td class="num">(4,734)<span></span>
</td>
<td class="num">(3,965)<span></span>
</td>
<td class="num">(4,861)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_AllocatedShareBasedCompensationExpenseNetOfTaxExcludingTaxBenefitFromSettlementOfShareBasedAwards', window );">Net share-based compensation expense included in consolidated statements of income, excluding tax benefit from settlement of share-based awards</a></td>
<td class="nump">33,021<span></span>
</td>
<td class="nump">26,986<span></span>
</td>
<td class="nump">34,417<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions', window );">Income tax benefit resulting from settlement of share-based awards</a></td>
<td class="num">(32,474)<span></span>
</td>
<td class="num">(38,981)<span></span>
</td>
<td class="num">(19,140)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Net expense (benefit) related to share-based compensation arrangements included in consolidated statements of income</a></td>
<td class="nump">547<span></span>
</td>
<td class="num">(11,995)<span></span>
</td>
<td class="nump">15,277<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">4,044<span></span>
</td>
<td class="nump">3,415<span></span>
</td>
<td class="nump">2,681<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=idxx_OperatingExpensesMember', window );">Operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">$ 33,711<span></span>
</td>
<td class="nump">$ 27,536<span></span>
</td>
<td class="nump">$ 36,597<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_AllocatedShareBasedCompensationExpenseNetOfTaxExcludingTaxBenefitFromSettlementOfShareBasedAwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Allocated Share-based Compensation Expense, Net of Tax, Excluding Tax Benefit From Settlement Of Share-based Awards</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_AllocatedShareBasedCompensationExpenseNetOfTaxExcludingTaxBenefitFromSettlementOfShareBasedAwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>idxx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of expense for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=idxx_OperatingExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=idxx_OperatingExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>175
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101993627768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Schedule of Weighted Averages of the Assumptions Used In Estimating the Fair Value of Stock Option Awards) (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price at grant (in USD per share)</a></td>
<td class="nump">$ 546.36<span></span>
</td>
<td class="nump">$ 291.14<span></span>
</td>
<td class="nump">$ 218.66<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Share exercise price (in USD per share)</a></td>
<td class="nump">$ 550.10<span></span>
</td>
<td class="nump">$ 291.14<span></span>
</td>
<td class="nump">$ 220.88<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Expected stock price volatility</a></td>
<td class="nump">30.00%<span></span>
</td>
<td class="nump">27.00%<span></span>
</td>
<td class="nump">26.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term, in years</a></td>
<td class="text">6 years 2 months 12 days<span></span>
</td>
<td class="text">6 years<span></span>
</td>
<td class="text">6 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">0.70%<span></span>
</td>
<td class="nump">1.40%<span></span>
</td>
<td class="nump">2.40%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average fair value of options granted (in USD per shares)</a></td>
<td class="nump">$ 169.15<span></span>
</td>
<td class="nump">$ 84.92<span></span>
</td>
<td class="nump">$ 65.53<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rate of weighted-average expected volatility for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>176
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101985256552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Schedule of Stock Option Activity) (Details)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, at beginning of year (in shares) | shares</a></td>
<td class="nump">1,953<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares) | shares</a></td>
<td class="nump">144<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares) | shares</a></td>
<td class="num">(310)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(30)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, at end of year (in shares) | shares</a></td>
<td class="nump">1,757<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Fully vested, at end of year (in shares) | shares</a></td>
<td class="nump">1,109<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Fully vested and expected to vest, at end of year (in shares) | shares</a></td>
<td class="nump">1,738<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price of beginning balance of options outstanding (in USD per share) | $ / shares</a></td>
<td class="nump">$ 149.32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price of options granted (in USD per share) | $ / shares</a></td>
<td class="nump">550.10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price of options exercised (in USD per share) | $ / shares</a></td>
<td class="nump">102.78<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price of options forfeited (in USD per share) | $ / shares</a></td>
<td class="nump">261.95<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price of ending balance of options outstanding (in USD per share) | $ / shares</a></td>
<td class="nump">188.47<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted average exercise price of options fully vested (in USD per share) | $ / shares</a></td>
<td class="nump">127.30<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price of options fully vested and expected to vest (in USD per share) | $ / shares</a></td>
<td class="nump">$ 186.72<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining contractual term of ending balance of options outstanding</a></td>
<td class="text">5 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contractual term of options fully vested</a></td>
<td class="text">4 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contractual term of options fully vested and expected to vest</a></td>
<td class="text">5 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value | $</a></td>
<td class="nump">$ 825,745<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate intrinsic value of options fully vested | $</a></td>
<td class="nump">588,831<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Aggregate intrinsic value of options expected to vest | $</a></td>
<td class="nump">$ 819,777<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>177
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101985407144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Schedule Of Restricted Stock Unit Activity) (Details)<br> shares in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units (RSU's)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Units</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested, at beginning of year (in shares) | shares</a></td>
<td class="nump">218<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="num">(85)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested, at end of year (in shares) | shares</a></td>
<td class="nump">165<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant-Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value, beginning of year (in USD per share) | $ / shares</a></td>
<td class="nump">$ 202.47<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value, granted (in USD per share) | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value, vested (in USD per share) | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value, forfeited (in USD per share) | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value, end of year (in USD per share) | $ / shares</a></td>
<td class="nump">$ 306.18<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=idxx_RestrictedStockUnitsExpectedToVestReducedForEstimatedForfeituresMember', window );">Restricted stock units expected to vest reduced for estimated forfeitures</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Units</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested, at end of year (in shares) | shares</a></td>
<td class="nump">156<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant-Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value, end of year (in USD per share) | $ / shares</a></td>
<td class="nump">$ 303.00<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=idxx_RestrictedStockUnitsExpectedToVestReducedForEstimatedForfeituresMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=idxx_RestrictedStockUnitsExpectedToVestReducedForEstimatedForfeituresMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>178
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101993627048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Credit Losses (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems', window );"><strong>Financing Receivable, Allowance for Credit Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Accounts receivable allowance for credit losses</a></td>
<td class="nump">$ 5.7<span></span>
</td>
<td class="nump">$ 6.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_AccountsReceivablePercentNotPastDue', window );">Percent of accounts receivable not past due</a></td>
<td class="nump">90.00%<span></span>
</td>
<td class="nump">88.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_AccountsReceivablePercentPastDue', window );">Percent of accounts receivable past due</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDue', window );">Accounts receivable, noncurrent, threshold period past due</a></td>
<td class="text">60 days<span></span>
</td>
<td class="text">60 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_ContractwithCustomerAssetAndSalesTypeLeaseNetInvestmentInLeaseAllowanceforCreditLoss', window );">Reserve for contract assets and sales-type leases</a></td>
<td class="nump">$ 4.4<span></span>
</td>
<td class="nump">$ 3.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivablesPeriodPastDueAxis=idxx_FinancialAssetGreaterThan60DaysPastDueMember', window );">Greater than 60 Days Past Due</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems', window );"><strong>Financing Receivable, Allowance for Credit Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_AccountsReceivablePercentPastDue', window );">Percent of accounts receivable past due</a></td>
<td class="nump">1.80%<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_AccountsReceivablePercentNotPastDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable, Percent Not Past Due</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_AccountsReceivablePercentNotPastDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>idxx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_AccountsReceivablePercentPastDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable, Percent Past Due</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_AccountsReceivablePercentPastDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>idxx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_ContractwithCustomerAssetAndSalesTypeLeaseNetInvestmentInLeaseAllowanceforCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract with Customer, Asset, And Sales-Type Lease, Net Investment In Lease, Allowance for Credit Loss</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_ContractwithCustomerAssetAndSalesTypeLeaseNetInvestmentInLeaseAllowanceforCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>idxx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold period for when accounts receivable, classified as noncurrent, is considered past due, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Excludes threshold period past due to write off as uncollectible.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919253-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivablesPeriodPastDueAxis=idxx_FinancialAssetGreaterThan60DaysPastDueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivablesPeriodPastDueAxis=idxx_FinancialAssetGreaterThan60DaysPastDueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>179
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101989737976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories (Narrative) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNetAbstract', window );"><strong>Inventory, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Unpaid inventory</a></td>
<td class="nump">$ 64,400<span></span>
</td>
<td class="nump">$ 45,600<span></span>
</td>
<td class="nump">$ 39,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=idxx_ReagentRentalProgramsMember', window );">Reagent rental programs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLineItems', window );"><strong>Inventory [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Rental and operating-type reagent rental program instruments transferred from inventory to property and equipment</a></td>
<td class="nump">$ 11,628<span></span>
</td>
<td class="nump">$ 9,645<span></span>
</td>
<td class="nump">$ 14,498<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=idxx_ReagentRentalProgramsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=idxx_ReagentRentalProgramsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>180
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101991662312">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories (Schedule of Components of Inventories) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNetAbstract', window );"><strong>Inventory, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 60,427<span></span>
</td>
<td class="nump">$ 45,986<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work-in-process</a></td>
<td class="nump">26,397<span></span>
</td>
<td class="nump">20,374<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">182,206<span></span>
</td>
<td class="nump">143,513<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">$ 269,030<span></span>
</td>
<td class="nump">$ 209,873<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>181
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101982846856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_OperatingLeaseLeaseNotyetCommencedExpense', window );">Total minimum future lease payments, leases not yet commenced</a></td>
<td class="nump">$ 1.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Rent expense, excluding variable and short-term expenses</a></td>
<td class="nump">23.0<span></span>
</td>
<td class="nump">$ 21.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total rent expense including variable rent and short-term expenses</a></td>
<td class="nump">$ 25.5<span></span>
</td>
<td class="nump">$ 24.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1', window );">Operating leases, not yet commenced, lease term</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_LesseeOperatingLeaseTerminationPeriod', window );">Operating lease, termination period</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1', window );">Operating leases, not yet commenced, lease term</a></td>
<td class="text">5 years 3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_LesseeOperatingLeaseTerminationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Termination Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_LesseeOperatingLeaseTerminationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>idxx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_OperatingLeaseLeaseNotyetCommencedExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Lease Not yet Commenced, Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_OperatingLeaseLeaseNotyetCommencedExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>idxx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease not yet commenced, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>182
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101988313272">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases (Maturities of Operating Lease Liabilities) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 22,402<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="nump">21,122<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2024</a></td>
<td class="nump">16,523<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2025</a></td>
<td class="nump">12,675<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2026</a></td>
<td class="nump">10,437<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">39,047<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">122,206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interest</a></td>
<td class="num">(14,898)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liability (current and long-term)</a></td>
<td class="nump">$ 107,308<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term - operating leases</a></td>
<td class="text">9 years 4 months 24 days<span></span>
</td>
<td class="text">10 years 3 months 18 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate - operating leases</a></td>
<td class="nump">2.50%<span></span>
</td>
<td class="nump">2.90%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>183
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101991925800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Supplemental Cash Flow Information) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Cash paid for amounts included in the measurement of operating lease liabilities</a></td>
<td class="nump">$ 24,214<span></span>
</td>
<td class="nump">$ 19,619<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for operating lease obligations, net of early lease&#160;terminations</a></td>
<td class="nump">$ 37,572<span></span>
</td>
<td class="nump">$ 26,807<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>184
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101985454744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net (Schedule of Estimated Useful Lives) (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandImprovementsMember', window );">Land improvements | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">15 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandImprovementsMember', window );">Land improvements | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">20 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Buildings and improvements | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Buildings and improvements | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">40 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">8 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember', window );">Office furniture and equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember', window );">Office furniture and equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=idxx_ComputerHardwareAndSoftwareMember', window );">Computer hardware and software | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=idxx_ComputerHardwareAndSoftwareMember', window );">Computer hardware and software | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=idxx_ComputerHardwareAndSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=idxx_ComputerHardwareAndSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>185
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101985424072">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and Equipment, Net (Schedule of Property and Equipment) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross amount</a></td>
<td class="nump">$ 1,236,058<span></span>
</td>
<td class="nump">$ 1,142,081<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation and amortization</a></td>
<td class="nump">648,391<span></span>
</td>
<td class="nump">586,914<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total property and equipment, net</a></td>
<td class="nump">587,667<span></span>
</td>
<td class="nump">555,167<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandAndLandImprovementsMember', window );">Land and improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross amount</a></td>
<td class="nump">22,642<span></span>
</td>
<td class="nump">13,982<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Buildings and improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross amount</a></td>
<td class="nump">329,091<span></span>
</td>
<td class="nump">319,384<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross amount</a></td>
<td class="nump">93,248<span></span>
</td>
<td class="nump">82,459<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross amount</a></td>
<td class="nump">382,753<span></span>
</td>
<td class="nump">353,301<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember', window );">Office furniture and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross amount</a></td>
<td class="nump">69,090<span></span>
</td>
<td class="nump">67,527<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=idxx_ComputerHardwareAndSoftwareMember', window );">Computer hardware and software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross amount</a></td>
<td class="nump">276,895<span></span>
</td>
<td class="nump">265,664<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross amount</a></td>
<td class="nump">$ 62,339<span></span>
</td>
<td class="nump">$ 39,764<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandAndLandImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandAndLandImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=idxx_ComputerHardwareAndSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=idxx_ComputerHardwareAndSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>186
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101993653592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net (Summary Of Depreciation And Amortization, Capitalized Computer Software For Internal Use And Unpaid Property Equipment Reflected In Account Payable And Accrued Expenses) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherDepreciationAndAmortization', window );">Depreciation and amortization expense</a></td>
<td class="nump">$ 92,376<span></span>
</td>
<td class="nump">$ 86,095<span></span>
</td>
<td class="nump">$ 78,495<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Unpaid property and equipment, reflected in accounts payable and accrued liabilities</a></td>
<td class="nump">19,326<span></span>
</td>
<td class="nump">13,343<span></span>
</td>
<td class="nump">24,688<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=idxx_ReagentRentalProgramsMember', window );">Reagent rental programs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Rental and operating-type reagent rental program instruments transferred from inventory to property and equipment</a></td>
<td class="nump">11,628<span></span>
</td>
<td class="nump">9,645<span></span>
</td>
<td class="nump">14,498<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=idxx_SoftwareDevelopedForInternalUseMember', window );">Capitalized computer software developed for internal use</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAdditions', window );">Capitalized computer software developed for internal use</a></td>
<td class="nump">$ 14,753<span></span>
</td>
<td class="nump">$ 18,472<span></span>
</td>
<td class="nump">$ 20,130<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of acquisition of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=idxx_ReagentRentalProgramsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=idxx_ReagentRentalProgramsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=idxx_SoftwareDevelopedForInternalUseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=idxx_SoftwareDevelopedForInternalUseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>187
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101989886696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net (Narrative) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TangibleAssetImpairmentCharges', window );">Write-down of rental assets</a></td>
<td class="nump">$ 5.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TangibleAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The charge against earnings resulting from the aggregate write down of tangible assets from their carrying value to their fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TangibleAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>188
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101985280392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Current and Long-Term Assets (Schedule of Other Current Assets) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrentAbstract', window );"><strong>Other Assets, Noncurrent [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCostsCurrent', window );">Customer acquisition costs</a></td>
<td class="nump">$ 48,942<span></span>
</td>
<td class="nump">$ 43,751<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">41,997<span></span>
</td>
<td class="nump">34,556<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Contract assets, net</a></td>
<td class="nump">37,772<span></span>
</td>
<td class="nump">23,837<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivable', window );">Taxes receivable</a></td>
<td class="nump">19,464<span></span>
</td>
<td class="nump">19,476<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostNetCurrent', window );">Deferred sales commissions</a></td>
<td class="nump">6,475<span></span>
</td>
<td class="nump">5,738<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsMiscellaneousCurrent', window );">Other</a></td>
<td class="nump">19,173<span></span>
</td>
<td class="nump">10,150<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">$ 173,823<span></span>
</td>
<td class="nump">$ 137,508<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer; classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123353750&amp;loc=SL49131252-203054<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130533-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of deferred costs capitalized at the end of the reporting period that are expected to be charged against earnings within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.5(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsMiscellaneousCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other miscellaneous assets expected to be realized or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsMiscellaneousCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6787-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123349782&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>189
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101985258792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Current and Long-Term Assets (Schedule of Other Noncurrent Assets) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrentAbstract', window );"><strong>Other Assets, Noncurrent [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetNoncurrent', window );">Contract assets, net</a></td>
<td class="nump">$ 122,160<span></span>
</td>
<td class="nump">$ 104,369<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCosts', window );">Customer acquisition costs</a></td>
<td class="nump">109,392<span></span>
</td>
<td class="nump">91,681<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred income taxes</a></td>
<td class="nump">24,784<span></span>
</td>
<td class="nump">31,549<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseOtherNoncurrent', window );">Investment in long-term product supply arrangements</a></td>
<td class="nump">13,348<span></span>
</td>
<td class="nump">12,065<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostNetNoncurrent', window );">Deferred sales commissions</a></td>
<td class="nump">13,019<span></span>
</td>
<td class="nump">11,719<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivableNoncurrent', window );">Taxes receivable</a></td>
<td class="nump">1,806<span></span>
</td>
<td class="nump">6,329<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsMiscellaneousNoncurrent', window );">Other</a></td>
<td class="nump">45,891<span></span>
</td>
<td class="nump">31,883<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets</a></td>
<td class="nump">$ 330,400<span></span>
</td>
<td class="nump">$ 289,595<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostNetNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer; classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123353750&amp;loc=SL49131252-203054<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostNetNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130533-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred cost, excluding capitalized cost related to contract with customer; classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivableNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due after one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(5)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivableNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsMiscellaneousNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other miscellaneous assets expected to be realized or consumed after one year or normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsMiscellaneousNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseOtherNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of amounts paid in advance which will be charged against earnings in periods after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseOtherNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>190
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101988415320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Intangible assets impairments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Aggregate amortization expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,100,000<span></span>
</td>
<td class="nump">$ 9,800,000<span></span>
</td>
<td class="nump">$ 9,400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=idxx_EzyVetMember', window );">ezyVet</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in amount of contingent payable</a></td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=idxx_EzyVetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=idxx_EzyVetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>191
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101985328920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net (Schedule of Goodwill) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">$ 243,347<span></span>
</td>
<td class="nump">$ 239,724<span></span>
</td>
<td class="nump">$ 214,489<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Business combinations</a></td>
<td class="nump">120,346<span></span>
</td>
<td class="nump">220<span></span>
</td>
<td class="nump">24,826<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Acquisition adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,900)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Impact of changes in foreign currency exchange rates</a></td>
<td class="num">(4,348)<span></span>
</td>
<td class="nump">5,303<span></span>
</td>
<td class="nump">409<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">359,345<span></span>
</td>
<td class="nump">243,347<span></span>
</td>
<td class="nump">239,724<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=idxx_CompanionAnimalGroupSegmentMember', window );">CAG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">210,394<span></span>
</td>
<td class="nump">207,350<span></span>
</td>
<td class="nump">182,386<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Business combinations</a></td>
<td class="nump">120,346<span></span>
</td>
<td class="nump">220<span></span>
</td>
<td class="nump">24,826<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Acquisition adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,900)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Impact of changes in foreign currency exchange rates</a></td>
<td class="num">(3,569)<span></span>
</td>
<td class="nump">4,724<span></span>
</td>
<td class="nump">138<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">327,171<span></span>
</td>
<td class="nump">210,394<span></span>
</td>
<td class="nump">207,350<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=idxx_WaterSegmentMember', window );">Water</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">12,023<span></span>
</td>
<td class="nump">11,611<span></span>
</td>
<td class="nump">11,221<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Business combinations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Acquisition adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Impact of changes in foreign currency exchange rates</a></td>
<td class="num">(84)<span></span>
</td>
<td class="nump">412<span></span>
</td>
<td class="nump">390<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">11,939<span></span>
</td>
<td class="nump">12,023<span></span>
</td>
<td class="nump">11,611<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=idxx_LivestockAndPoultryDiagnosticsSegmentMember', window );">LPD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">14,399<span></span>
</td>
<td class="nump">14,232<span></span>
</td>
<td class="nump">14,351<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Business combinations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Acquisition adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Impact of changes in foreign currency exchange rates</a></td>
<td class="num">(695)<span></span>
</td>
<td class="nump">167<span></span>
</td>
<td class="num">(119)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">13,704<span></span>
</td>
<td class="nump">14,399<span></span>
</td>
<td class="nump">14,232<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=idxx_OtherSegmentMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">6,531<span></span>
</td>
<td class="nump">6,531<span></span>
</td>
<td class="nump">6,531<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Business combinations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Acquisition adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Impact of changes in foreign currency exchange rates</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">$ 6,531<span></span>
</td>
<td class="nump">$ 6,531<span></span>
</td>
<td class="nump">$ 6,531<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=idxx_CompanionAnimalGroupSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=idxx_CompanionAnimalGroupSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=idxx_WaterSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=idxx_WaterSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=idxx_LivestockAndPoultryDiagnosticsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=idxx_LivestockAndPoultryDiagnosticsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=idxx_OtherSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=idxx_OtherSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>192
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101985320312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net (Schedule of Estimated Useful Lives For Intangible Assets) (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember', window );">Customer-related intangible assets | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets, estimated useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember', window );">Customer-related intangible assets | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets, estimated useful life</a></td>
<td class="text">17 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=idxx_ProductRightsMember', window );">Product rights | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets, estimated useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=idxx_ProductRightsMember', window );">Product rights | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets, estimated useful life</a></td>
<td class="text">15 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Noncompete agreements | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets, estimated useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Noncompete agreements | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets, estimated useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=idxx_ProductRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=idxx_ProductRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>193
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101983138040">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net (Schedule of Intangible Assets Other Than Goodwill) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">$ 143,543<span></span>
</td>
<td class="nump">$ 97,210<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">44,508<span></span>
</td>
<td class="nump">44,667<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">99,035<span></span>
</td>
<td class="nump">52,543<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember', window );">Customer-related intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">121,936<span></span>
</td>
<td class="nump">80,810<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">38,349<span></span>
</td>
<td class="nump">32,838<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">83,587<span></span>
</td>
<td class="nump">47,972<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=idxx_ProductRightsMember', window );">Product rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">17,350<span></span>
</td>
<td class="nump">15,150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">5,332<span></span>
</td>
<td class="nump">11,609<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">12,018<span></span>
</td>
<td class="nump">3,541<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Noncompete agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">4,257<span></span>
</td>
<td class="nump">1,250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">827<span></span>
</td>
<td class="nump">220<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">$ 3,430<span></span>
</td>
<td class="nump">$ 1,030<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=idxx_ProductRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=idxx_ProductRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>194
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101993649048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net (Schedule of Expected Amortization Expense) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 14,188<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2023</a></td>
<td class="nump">12,430<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2024</a></td>
<td class="nump">11,381<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2025</a></td>
<td class="nump">10,633<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2026</a></td>
<td class="nump">10,370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">40,033<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">$ 99,035<span></span>
</td>
<td class="nump">$ 52,543<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>195
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101989688808">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Liabilities and Other Long Term Liabilities (Schedule of Accrued Liabilities) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAbstract', window );"><strong>Accrued Liabilities, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued employee compensation and related expenses</a></td>
<td class="nump">$ 182,926<span></span>
</td>
<td class="nump">$ 167,649<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">133,978<span></span>
</td>
<td class="nump">112,526<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedMarketingCostsCurrent', window );">Accrued customer incentives and refund obligations</a></td>
<td class="nump">79,469<span></span>
</td>
<td class="nump">75,064<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Accrued taxes</a></td>
<td class="nump">42,605<span></span>
</td>
<td class="nump">42,676<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current lease liabilities</a></td>
<td class="nump">$ 19,931<span></span>
</td>
<td class="nump">$ 17,733<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Accrued liabilities<span></span>
</td>
<td class="text">Accrued liabilities<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">$ 458,909<span></span>
</td>
<td class="nump">$ 415,648<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedMarketingCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for the marketing, trade and selling of the entity's goods and services.   Marketing costs would include expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services; costs of public relations and corporate promotions; and obligations incurred and payable for sales discounts, rebates, price protection programs, etc. offered to customers and under government programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedMarketingCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>196
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101993652792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Liabilities and Other Long Term Liabilities (Schedule of Long Term Accrued Liabilities) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAbstract', window );"><strong>Accrued Liabilities, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesNoncurrent', window );">Accrued taxes</a></td>
<td class="nump">$ 56,466<span></span>
</td>
<td class="nump">$ 60,313<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesNoncurrent', window );">Other accrued long-term expenses</a></td>
<td class="nump">14,475<span></span>
</td>
<td class="nump">25,291<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">$ 70,941<span></span>
</td>
<td class="nump">$ 85,604<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>197
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101976672136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 09, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 21, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 14, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 19, 2014 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Apr. 10, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 02, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 23, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 22, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 14, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2015 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Sep. 30, 2014 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 31, 2014 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2013 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LinesOfCreditCurrent', window );">Outstanding credit facility balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 73,500,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfSeniorDebt', window );">Repayments of senior debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,500,000<span></span>
</td>
<td class="nump">32,400,000<span></span>
</td>
<td class="nump">$ 29,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_ConsolidatedLeverageRatioUnderCreditFacilityNotePayable', window );">Consolidated leverage ratio under credit facility &amp; note payable, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=idxx_A2023SeriesANotesAnd2025SeriesBNotesMember', window );">2023 Series A Notes and 2025 Series B Notes | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=idxx_A2023SeriesANotesMember', window );">2023 Series A Notes | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.94%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.94%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.94%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=idxx_A2025SeriesBNotesMember', window );">2025 Series B Notes | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.04%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.04%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.04%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=idxx_A2026SeniorNotesMember', window );">2026 Senior Notes | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.72%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.72%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.72%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=idxx_A2021SeriesANotesAnd2024SeriesBNotesMember', window );">2021 Series A Notes and 2024 Series B Notes | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 125,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=idxx_A2021SeriesANotesMember', window );">2021 Series A Notes | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.32%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfSeniorDebt', window );">Repayments of senior debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=idxx_A2024SeriesBNotesMember', window );">2024 Series B Notes | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.76%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.76%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.76%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=idxx_A2025SeriesCNotesMember', window );">2025 Series C Notes | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.785%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.785%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.785%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal Amount | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 88,857,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 88,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=idxx_Prudential2030SeriesDNotesMember', window );">Prudential 2030 Series D Notes | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 425,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=idxx_A2022SeriesANotesand2027SeriesBNotesMember', window );">2022 Series A Notes and 2027 Series B Notes | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=idxx_A2022SeriesANotesMember', window );">2022 Series A Notes | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal Amount</a></td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=idxx_A2027SeriesBNotesMember', window );">2027 Series B Notes | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.72%<span></span>
</td>
<td class="nump">3.72%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.72%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=idxx_A2029SeriesCNotesMember', window );">2029 Series C Notes | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.19%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.19%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.19%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=idxx_MetLife2030SeriesDNotesMember', window );">MetLife 2030 Series D Notes | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000,000<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 125,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 125,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_PrimeRateMember', window );">Prime Rate | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Credit spread during period</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument, term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Borrowing capacity</a></td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_LineofCreditFacilityAccordionFeatureIncreaseLimit', window );">Accordion feature, increase limit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_LineofCreditFacilityAccordionFeatureHigherBorrowingCapacityOption', window );">Accordion feature, higher borrowing capacity option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LinesOfCreditCurrent', window );">Outstanding credit facility balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 73,500,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtWeightedAverageInterestRate', window );">Credit facility weighted average interest rates on outstanding balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases', window );">Reduction of credit facility availability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400,000<span></span>
</td>
<td class="nump">$ 1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_ConsolidatedLeverageRatioUnderCreditFacilityNotePayable', window );">Consolidated leverage ratio under credit facility &amp; note payable, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Commitment fees</a></td>
<td class="nump">0.075%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Commitment fees</a></td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | LIBOR | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Credit spread during period</a></td>
<td class="nump">0.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | LIBOR | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Credit spread during period</a></td>
<td class="nump">1.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Prime Rate | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Prime Rate | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Credit spread during period</a></td>
<td class="nump">0.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=idxx_RevolvingCreditFacilityIndividualBorrowingsMember', window );">Revolving Credit Facility, Individual Borrowings | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 day<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=idxx_RevolvingCreditFacilityIndividualBorrowingsMember', window );">Revolving Credit Facility, Individual Borrowings | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">180 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_ConsolidatedLeverageRatioUnderCreditFacilityNotePayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum consolidated leverage ratio permitted under debt agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_ConsolidatedLeverageRatioUnderCreditFacilityNotePayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>idxx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_LineofCreditFacilityAccordionFeatureHigherBorrowingCapacityOption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Accordion Feature, Higher Borrowing Capacity Option</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_LineofCreditFacilityAccordionFeatureHigherBorrowingCapacityOption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>idxx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_LineofCreditFacilityAccordionFeatureIncreaseLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Accordion Feature, Increase Limit</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_LineofCreditFacilityAccordionFeatureIncreaseLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>idxx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of debt outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum amount of borrowing capacity under a line of credit that is available as of the balance sheet date for a specific purpose other than for financing goods acquired for inventory or imminent delivery to a customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LinesOfCreditCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LinesOfCreditCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfSeniorDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfSeniorDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=idxx_A2023SeriesANotesAnd2025SeriesBNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=idxx_A2023SeriesANotesAnd2025SeriesBNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=idxx_A2023SeriesANotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=idxx_A2023SeriesANotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=idxx_A2025SeriesBNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=idxx_A2025SeriesBNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=idxx_A2026SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=idxx_A2026SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=idxx_A2021SeriesANotesAnd2024SeriesBNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=idxx_A2021SeriesANotesAnd2024SeriesBNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=idxx_A2021SeriesANotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=idxx_A2021SeriesANotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=idxx_A2024SeriesBNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=idxx_A2024SeriesBNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=idxx_A2025SeriesCNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=idxx_A2025SeriesCNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=idxx_Prudential2030SeriesDNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=idxx_Prudential2030SeriesDNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=idxx_A2022SeriesANotesand2027SeriesBNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=idxx_A2022SeriesANotesand2027SeriesBNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=idxx_A2022SeriesANotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=idxx_A2022SeriesANotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=idxx_A2027SeriesBNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=idxx_A2027SeriesBNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=idxx_A2029SeriesCNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=idxx_A2029SeriesCNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=idxx_MetLife2030SeriesDNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=idxx_MetLife2030SeriesDNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_PrimeRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_PrimeRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=idxx_RevolvingCreditFacilityIndividualBorrowingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=idxx_RevolvingCreditFacilityIndividualBorrowingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>198
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101982261736">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt (Schedule of Senior Note Borrowings) (Details) - Senior Notes<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 09, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 14, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 02, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 14, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2015 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 19, 2014 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2014 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 31, 2014 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2013 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">2023 Series A Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal Amount</a></td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Coupon Rate</a></td>
<td class="nump">3.94%<span></span>
</td>
<td class="nump">3.94%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.94%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">2025 Series B Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal Amount</a></td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Coupon Rate</a></td>
<td class="nump">4.04%<span></span>
</td>
<td class="nump">4.04%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.04%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">2026 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal Amount</a></td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Coupon Rate</a></td>
<td class="nump">3.72%<span></span>
</td>
<td class="nump">3.72%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.72%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">2024 Series B Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal Amount</a></td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Coupon Rate</a></td>
<td class="nump">3.76%<span></span>
</td>
<td class="nump">3.76%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.76%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">2025 Series C Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal Amount | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 88,857,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 88,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Coupon Rate</a></td>
<td class="nump">1.785%<span></span>
</td>
<td class="nump">1.785%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.785%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">2022 Series A Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal Amount</a></td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Coupon Rate</a></td>
<td class="nump">3.25%<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">2027 Series B Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal Amount</a></td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Coupon Rate</a></td>
<td class="nump">3.72%<span></span>
</td>
<td class="nump">3.72%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.72%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">2029 Series C Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal Amount</a></td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Coupon Rate</a></td>
<td class="nump">4.19%<span></span>
</td>
<td class="nump">4.19%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.19%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">MetLife 2030 Series D Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal Amount</a></td>
<td class="nump">$ 125,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 125,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Coupon Rate</a></td>
<td class="nump">2.50%<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Prudential 2030 Series D Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal Amount</a></td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Coupon Rate</a></td>
<td class="nump">2.50%<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=idxx_A2023SeriesANotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=idxx_A2023SeriesANotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=idxx_A2025SeriesBNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=idxx_A2025SeriesBNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=idxx_A2026SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=idxx_A2026SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=idxx_A2024SeriesBNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=idxx_A2024SeriesBNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=idxx_A2025SeriesCNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=idxx_A2025SeriesCNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=idxx_A2022SeriesANotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=idxx_A2022SeriesANotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=idxx_A2027SeriesBNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=idxx_A2027SeriesBNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=idxx_A2029SeriesCNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=idxx_A2029SeriesCNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=idxx_MetLife2030SeriesDNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=idxx_MetLife2030SeriesDNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=idxx_Prudential2030SeriesDNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=idxx_Prudential2030SeriesDNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>199
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101985295896">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt (Schedule of Annual Principal Payments on Long-Term Debt) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Debt Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2023</a></td>
<td class="nump">75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2024</a></td>
<td class="nump">75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2025</a></td>
<td class="nump">175,711<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2026</a></td>
<td class="nump">75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">Thereafter</a></td>
<td class="nump">375,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total</a></td>
<td class="nump">$ 850,711<span></span>
</td>
<td class="nump">$ 909,100<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>200
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101990037816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Schedule of Earnings Before Income Taxes) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">Domestic</a></td>
<td class="nump">$ 689,994<span></span>
</td>
<td class="nump">$ 483,694<span></span>
</td>
<td class="nump">$ 377,964<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">International</a></td>
<td class="nump">212,660<span></span>
</td>
<td class="nump">178,291<span></span>
</td>
<td class="nump">144,254<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before provision for income taxes</a></td>
<td class="nump">$ 902,654<span></span>
</td>
<td class="nump">$ 661,985<span></span>
</td>
<td class="nump">$ 522,218<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>201
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101976645640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Schedule of Components of Provision (Benefit) for Income Taxes) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 112,811<span></span>
</td>
<td class="nump">$ 72,921<span></span>
</td>
<td class="nump">$ 52,194<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">19,147<span></span>
</td>
<td class="nump">17,346<span></span>
</td>
<td class="nump">11,967<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">International</a></td>
<td class="nump">29,288<span></span>
</td>
<td class="nump">26,301<span></span>
</td>
<td class="nump">24,239<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Provision for current income taxes</a></td>
<td class="nump">161,246<span></span>
</td>
<td class="nump">116,568<span></span>
</td>
<td class="nump">88,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="num">(7,019)<span></span>
</td>
<td class="num">(14,126)<span></span>
</td>
<td class="nump">4,826<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="num">(503)<span></span>
</td>
<td class="num">(2,863)<span></span>
</td>
<td class="nump">269<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">International</a></td>
<td class="nump">4,086<span></span>
</td>
<td class="num">(19,725)<span></span>
</td>
<td class="nump">931<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Provision (benefit) for deferred income taxes</a></td>
<td class="num">(3,436)<span></span>
</td>
<td class="num">(36,714)<span></span>
</td>
<td class="nump">6,026<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">$ 157,810<span></span>
</td>
<td class="nump">$ 79,854<span></span>
</td>
<td class="nump">$ 94,426<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>202
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101991626904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Schedule of Effective Income Tax Rate Reconciliation) (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">U.S. federal statutory rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State income tax, net of federal tax benefit</a></td>
<td class="nump">2.10%<span></span>
</td>
<td class="nump">2.40%<span></span>
</td>
<td class="nump">2.30%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Taxation on international earnings</a></td>
<td class="num">(0.80%)<span></span>
</td>
<td class="num">(1.00%)<span></span>
</td>
<td class="num">(1.10%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome', window );">Foreign derived intangible income</a></td>
<td class="num">(1.20%)<span></span>
</td>
<td class="num">(1.10%)<span></span>
</td>
<td class="num">(1.10%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Share-based compensation from settlements</a></td>
<td class="num">(3.60%)<span></span>
</td>
<td class="num">(5.90%)<span></span>
</td>
<td class="num">(3.60%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch', window );">Research and development credit</a></td>
<td class="num">(0.70%)<span></span>
</td>
<td class="num">(0.80%)<span></span>
</td>
<td class="num">(0.80%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_EffectiveIncomeTaxRateReconciliationSwitzerlandTaxReformEffectPercent', window );">Impact of Switzerland tax reform</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(3.30%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other, net</a></td>
<td class="nump">0.70%<span></span>
</td>
<td class="nump">0.80%<span></span>
</td>
<td class="nump">1.40%<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="nump">17.50%<span></span>
</td>
<td class="nump">12.10%<span></span>
</td>
<td class="nump">18.10%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Foreign Derived Intangible Income</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>idxx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_EffectiveIncomeTaxRateReconciliationSwitzerlandTaxReformEffectPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Switzerland Tax Reform Effect, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_EffectiveIncomeTaxRateReconciliationSwitzerlandTaxReformEffectPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>idxx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>203
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101982202296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">17.50%<span></span>
</td>
<td class="nump">12.10%<span></span>
</td>
<td class="nump">18.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes paid</a></td>
<td class="nump">$ 161.7<span></span>
</td>
<td class="nump">$ 110.7<span></span>
</td>
<td class="nump">$ 88.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxHolidayAggregateDollarAmount', window );">Income tax ruling exemption</a></td>
<td class="nump">21.4<span></span>
</td>
<td class="nump">14.2<span></span>
</td>
<td class="nump">13.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards in certain state and international jurisdictions</a></td>
<td class="nump">32.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits that would impact effective tax rate if recognized</a></td>
<td class="nump">22.2<span></span>
</td>
<td class="nump">21.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense', window );">Interest expense and penalties related to unrecognized tax benefits</a></td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Interest expense and penalties accrued</a></td>
<td class="nump">$ 3.8<span></span>
</td>
<td class="nump">$ 3.6<span></span>
</td>
<td class="nump">$ 3.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxHolidayAggregateDollarAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income taxes from which a reporting entity is exempt or for which it will receive a reduction in income taxes as a result of the income tax holiday granted by the taxing jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxHolidayAggregateDollarAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>204
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101976619224">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes (Schedule of Components of Net Deferred Tax Assets and Liabilities) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="nump">$ 48,433<span></span>
</td>
<td class="nump">$ 46,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts', window );">Accounts receivable reserves</a></td>
<td class="nump">2,131<span></span>
</td>
<td class="nump">2,505<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsDeferredIncome', window );">Deferred revenue</a></td>
<td class="nump">6,269<span></span>
</td>
<td class="nump">7,629<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInventory', window );">Inventory basis differences</a></td>
<td class="nump">6,553<span></span>
</td>
<td class="nump">4,272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment', window );">Property-based differences</a></td>
<td class="nump">16,132<span></span>
</td>
<td class="nump">14,865<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_DeferredTaxAssetsIntangibleAssetsBasisDifference', window );">Intangible asset basis differences</a></td>
<td class="nump">46,606<span></span>
</td>
<td class="nump">51,319<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Share-based compensation</a></td>
<td class="nump">10,740<span></span>
</td>
<td class="nump">10,011<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther', window );">Other</a></td>
<td class="nump">1,163<span></span>
</td>
<td class="nump">1,484<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">8,570<span></span>
</td>
<td class="nump">5,427<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Tax credit carryforwards</a></td>
<td class="nump">13,483<span></span>
</td>
<td class="nump">13,385<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOtherComprehensiveLoss', window );">Unrealized losses on foreign currency exchange contracts and investments</a></td>
<td class="nump">1,755<span></span>
</td>
<td class="nump">5,060<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total assets</a></td>
<td class="nump">161,835<span></span>
</td>
<td class="nump">162,787<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(39,280)<span></span>
</td>
<td class="num">(40,262)<span></span>
</td>
<td class="num">$ (9,454)<span></span>
</td>
<td class="num">$ (6,212)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Total assets, net of valuation allowance</a></td>
<td class="nump">122,555<span></span>
</td>
<td class="nump">122,525<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost', window );">Customer acquisition costs</a></td>
<td class="num">(37,265)<span></span>
</td>
<td class="num">(34,449)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Property-based differences</a></td>
<td class="num">(42,363)<span></span>
</td>
<td class="num">(49,547)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets', window );">Intangible asset basis differences</a></td>
<td class="num">(17,345)<span></span>
</td>
<td class="num">(16,134)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Other</a></td>
<td class="num">(5,662)<span></span>
</td>
<td class="num">(2,241)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains', window );">Unrealized gains on foreign currency exchange contracts and investments</a></td>
<td class="num">(4,071)<span></span>
</td>
<td class="num">(312)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total liabilities</a></td>
<td class="num">(106,706)<span></span>
</td>
<td class="num">(102,683)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax assets</a></td>
<td class="nump">$ 15,849<span></span>
</td>
<td class="nump">$ 19,842<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_DeferredTaxAssetsIntangibleAssetsBasisDifference">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Intangible Assets Basis Difference</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_DeferredTaxAssetsIntangibleAssetsBasisDifference</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>idxx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsDeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsDeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOtherComprehensiveLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from unrealized losses in other comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOtherComprehensiveLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from provisions, reserves, allowances, and accruals, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount as of the balance sheet date of the estimated future tax effects attributable to policy acquisition costs being expensed for tax purposes but capitalized in conformity with generally accepted accounting principles, which will reverse in future periods when amortization of such capitalized costs cannot be deducted for tax purposes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from unrealized gains on foreign currency transactions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>205
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101988559512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Schedule of Valuation Allowance For Deferred Tax Assets) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_DeferredTaxAssetsValuationAllowanceRollForward', window );"><strong>Deferred Tax Assets, Valuation Allowance [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Balance at beginning of year</a></td>
<td class="nump">$ 40,262<span></span>
</td>
<td class="nump">$ 9,454<span></span>
</td>
<td class="nump">$ 6,212<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_DeferredTaxAssetsValuationAllowanceChargesToCostsAndExpense', window );">Charges to costs and expense</a></td>
<td class="nump">1,464<span></span>
</td>
<td class="nump">31,076<span></span>
</td>
<td class="nump">3,489<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_DeferredTaxAssetsValuationAllowanceWriteOffCashPayments', window );">Write-off/cash payments</a></td>
<td class="num">(1,182)<span></span>
</td>
<td class="num">(34)<span></span>
</td>
<td class="num">(226)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_DeferredTaxAssetsValuationAllowanceForeignCurrencyTranslation', window );">Foreign currency translation</a></td>
<td class="num">(1,264)<span></span>
</td>
<td class="num">(234)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Balance at the end of the year</a></td>
<td class="nump">$ 39,280<span></span>
</td>
<td class="nump">$ 40,262<span></span>
</td>
<td class="nump">$ 9,454<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_DeferredTaxAssetsValuationAllowanceChargesToCostsAndExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Valuation Allowance, Charges To Costs and Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_DeferredTaxAssetsValuationAllowanceChargesToCostsAndExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>idxx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_DeferredTaxAssetsValuationAllowanceForeignCurrencyTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Valuation Allowance, Foreign Currency Translation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_DeferredTaxAssetsValuationAllowanceForeignCurrencyTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>idxx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_DeferredTaxAssetsValuationAllowanceRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Valuation Allowance</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_DeferredTaxAssetsValuationAllowanceRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>idxx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_DeferredTaxAssetsValuationAllowanceWriteOffCashPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Valuation Allowance, Write-off/Cash Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_DeferredTaxAssetsValuationAllowanceWriteOffCashPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>idxx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>206
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101981323608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Schedule of Changes in Unrecognized Tax Benefits) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Total amounts of unrecognized tax benefits, beginning of period</a></td>
<td class="nump">$ 22,484<span></span>
</td>
<td class="nump">$ 26,841<span></span>
</td>
<td class="nump">$ 24,247<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Gross increases (decreases) in unrecognized tax positions as a result of tax positions taken during a prior period</a></td>
<td class="nump">443<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Gross increases (decreases) in unrecognized tax positions as a result of tax positions taken during a prior period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,755)<span></span>
</td>
<td class="num">(276)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Gross increases in unrecognized tax positions as a result of tax positions taken in the current period</a></td>
<td class="nump">2,414<span></span>
</td>
<td class="nump">4,199<span></span>
</td>
<td class="nump">4,083<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities', window );">Decreases in unrecognized tax positions related to settlements with taxing authorities</a></td>
<td class="num">(537)<span></span>
</td>
<td class="num">(6,446)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Decreases in unrecognized tax positions as a result of a lapse of the applicable statutes of limitations</a></td>
<td class="num">(3,015)<span></span>
</td>
<td class="num">(355)<span></span>
</td>
<td class="num">(1,213)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Total amounts of unrecognized tax benefits, end of period</a></td>
<td class="nump">$ 21,789<span></span>
</td>
<td class="nump">$ 22,484<span></span>
</td>
<td class="nump">$ 26,841<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>207
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101988271592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Reconciliation of Shares Outstanding) (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Shares outstanding for basic earnings per share (in shares)</a></td>
<td class="nump">85,200<span></span>
</td>
<td class="nump">85,342<span></span>
</td>
<td class="nump">86,115<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of share-based payment awards (in shares)</a></td>
<td class="nump">1,372<span></span>
</td>
<td class="nump">1,380<span></span>
</td>
<td class="nump">1,427<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Shares outstanding for diluted earnings per share (in shares)</a></td>
<td class="nump">86,572<span></span>
</td>
<td class="nump">86,722<span></span>
</td>
<td class="nump">87,542<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>208
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101989549976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Schedule of Number of Anti-Dilutive Stock Options) (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Weighted average number of shares underlying anti-dilutive options (in shares)</a></td>
<td class="nump">121<span></span>
</td>
<td class="nump">206<span></span>
</td>
<td class="nump">200<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>209
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101982752392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments, Contingencies and Guarantees (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_PaymentRequiredUponTerminationOfEmploymentLineItems', window );"><strong>Payment Required Upon Termination Of Employment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligation', window );">Minimum purchase commitments</a></td>
<td class="nump">$ 2,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSoughtValue', window );">Damages sought</a></td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Loss contingency accrual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Outstanding letters of credit to insurance company as security for workers' compensation claims</a></td>
<td class="nump">$ 1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms', window );">Period for continued vesting of outstanding equity awards upon termination of CEO without cause other than following a change in control, years</a></td>
<td class="text">two years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost', window );">Share-based compensation accelerated expense</a></td>
<td class="nump">$ 8,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsCurrentCarryingValue', window );">Liabilities for indemnification obligations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_PaymentRequiredUponTerminationOfEmploymentAxis=idxx_PaymentRequiredToCeoUponTerminationOfEmploymentWithoutCauseOtherThanFollowingChangeInControlMember', window );">Payment required to CEO upon termination of employment without cause other than following change in control</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_PaymentRequiredUponTerminationOfEmploymentLineItems', window );"><strong>Payment Required Upon Termination Of Employment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits', window );">Employee agreement contingencies</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_PaymentRequiredUponTerminationOfEmploymentAxis=idxx_PaymentRequiredToOfficersUponTerminationOfEmploymentFollowingChangeOfControlMember', window );">Payment required to officers upon termination of employment following change of control</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_PaymentRequiredUponTerminationOfEmploymentLineItems', window );"><strong>Payment Required Upon Termination Of Employment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits', window );">Employee agreement contingencies</a></td>
<td class="nump">42,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=idxx_EmployeeHealthCareInsurancePolicyMember', window );">Employee healthcare insurance policy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_PaymentRequiredUponTerminationOfEmploymentLineItems', window );"><strong>Payment Required Upon Termination Of Employment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralInsuranceExpense', window );">General insurance expense</a></td>
<td class="nump">78,500,000<span></span>
</td>
<td class="nump">59,500,000<span></span>
</td>
<td class="nump">$ 59,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserve', window );">Estimated liability for healthcare claims</a></td>
<td class="nump">7,800,000<span></span>
</td>
<td class="nump">5,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Employee healthcare insurance policy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_PaymentRequiredUponTerminationOfEmploymentLineItems', window );"><strong>Payment Required Upon Termination Of Employment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_RetainedClaimLiabilityPerIncident', window );">Retained claim liability per incident</a></td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_PaymentRequiredUponTerminationOfEmploymentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payment Required Upon Termination Of Employment [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_PaymentRequiredUponTerminationOfEmploymentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>idxx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_RetainedClaimLiabilityPerIncident">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Retained claim liability per incident.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_RetainedClaimLiabilityPerIncident</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>idxx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralInsuranceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The expense in the period incurred with respect to protection provided by insurance entities against risks other than risks associated with production (which are allocated to cost of sales).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralInsuranceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteeObligationsCurrentCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current carrying amount of the liability for the freestanding or embedded guarantor's obligations under the guarantee or each group of similar guarantees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12069-110248<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteeObligationsCurrentCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesSoughtValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value (monetary amount) of the award the plaintiff seeks in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesSoughtValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SelfInsuranceReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions) of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SelfInsuranceReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of additional cost recognized for award under share-based payment arrangement from occurrence of event accelerating recognition of cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of modification of award under share-based payment arrangement. Includes, but is not limited to, terms for expiration date, vesting rights and exercise price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Liability for amount due employees, in addition to wages and any other money that employers owe employees, when their employment ends through a layoff or other termination. For example, a company may provide involuntarily terminated employees with a lump sum payment equal to one week's salary for every year of employment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_PaymentRequiredUponTerminationOfEmploymentAxis=idxx_PaymentRequiredToCeoUponTerminationOfEmploymentWithoutCauseOtherThanFollowingChangeInControlMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_PaymentRequiredUponTerminationOfEmploymentAxis=idxx_PaymentRequiredToCeoUponTerminationOfEmploymentWithoutCauseOtherThanFollowingChangeInControlMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_PaymentRequiredUponTerminationOfEmploymentAxis=idxx_PaymentRequiredToOfficersUponTerminationOfEmploymentFollowingChangeOfControlMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_PaymentRequiredUponTerminationOfEmploymentAxis=idxx_PaymentRequiredToOfficersUponTerminationOfEmploymentFollowingChangeOfControlMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=idxx_EmployeeHealthCareInsurancePolicyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=idxx_EmployeeHealthCareInsurancePolicyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>210
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101994493016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of business segments</a></td>
<td class="nump">3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>211
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101985520200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Summary of Segment Performance) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 3,215,360<span></span>
</td>
<td class="nump">$ 2,706,655<span></span>
</td>
<td class="nump">$ 2,406,908<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">932,028<span></span>
</td>
<td class="nump">694,524<span></span>
</td>
<td class="nump">552,846<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest expense, net</a></td>
<td class="num">(29,374)<span></span>
</td>
<td class="num">(32,539)<span></span>
</td>
<td class="num">(30,628)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before provision for income taxes</a></td>
<td class="nump">902,654<span></span>
</td>
<td class="nump">661,985<span></span>
</td>
<td class="nump">522,218<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">157,810<span></span>
</td>
<td class="nump">79,854<span></span>
</td>
<td class="nump">94,426<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">744,844<span></span>
</td>
<td class="nump">582,131<span></span>
</td>
<td class="nump">427,792<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net (loss) income attributable to noncontrolling interest</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">355<span></span>
</td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to IDEXX Laboratories, Inc. stockholders</a></td>
<td class="nump">744,845<span></span>
</td>
<td class="nump">581,776<span></span>
</td>
<td class="nump">427,720<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">104,596<span></span>
</td>
<td class="nump">95,998<span></span>
</td>
<td class="nump">88,011<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=idxx_CompanionAnimalGroupSegmentMember', window );">CAG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">2,889,960<span></span>
</td>
<td class="nump">2,385,765<span></span>
</td>
<td class="nump">2,119,183<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">824,022<span></span>
</td>
<td class="nump">574,887<span></span>
</td>
<td class="nump">462,605<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">94,202<span></span>
</td>
<td class="nump">84,697<span></span>
</td>
<td class="nump">77,620<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=idxx_WaterSegmentMember', window );">Water</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">146,505<span></span>
</td>
<td class="nump">128,625<span></span>
</td>
<td class="nump">132,850<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">65,444<span></span>
</td>
<td class="nump">58,867<span></span>
</td>
<td class="nump">61,923<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">2,709<span></span>
</td>
<td class="nump">2,630<span></span>
</td>
<td class="nump">2,794<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=idxx_LivestockAndPoultryDiagnosticsSegmentMember', window );">LPD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">135,887<span></span>
</td>
<td class="nump">145,845<span></span>
</td>
<td class="nump">132,635<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">28,636<span></span>
</td>
<td class="nump">40,008<span></span>
</td>
<td class="nump">24,735<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">3,908<span></span>
</td>
<td class="nump">4,070<span></span>
</td>
<td class="nump">4,007<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=idxx_OtherSegmentMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">43,008<span></span>
</td>
<td class="nump">46,420<span></span>
</td>
<td class="nump">22,240<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">13,926<span></span>
</td>
<td class="nump">20,762<span></span>
</td>
<td class="nump">3,583<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">$ 3,777<span></span>
</td>
<td class="nump">$ 4,601<span></span>
</td>
<td class="nump">$ 3,590<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNonoperatingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of nonoperating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNonoperatingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=idxx_CompanionAnimalGroupSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=idxx_CompanionAnimalGroupSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=idxx_WaterSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=idxx_WaterSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=idxx_LivestockAndPoultryDiagnosticsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=idxx_LivestockAndPoultryDiagnosticsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=idxx_OtherSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=idxx_OtherSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>212
<FILENAME>R104.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101976584184">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Segment Reporting (Schedule of Net Long-Lived Assets by Principal Geographic Areas) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">$ 587,667<span></span>
</td>
<td class="nump">$ 555,167<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AmericasMember', window );">Americas</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">460,049<span></span>
</td>
<td class="nump">438,490<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">436,003<span></span>
</td>
<td class="nump">412,700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_BR', window );">Brazil</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">17,043<span></span>
</td>
<td class="nump">20,797<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CA', window );">Canada</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">7,003<span></span>
</td>
<td class="nump">4,993<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe, the Middle East and Africa</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">98,934<span></span>
</td>
<td class="nump">102,285<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_DE', window );">Germany</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">60,451<span></span>
</td>
<td class="nump">67,354<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_GB', window );">United Kingdom</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">9,828<span></span>
</td>
<td class="nump">10,191<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_NL', window );">Netherlands</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">19,405<span></span>
</td>
<td class="nump">15,267<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_FR', window );">France</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">1,884<span></span>
</td>
<td class="nump">2,062<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CH', window );">Switzerland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">3,545<span></span>
</td>
<td class="nump">3,743<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=idxx_EuropetheMiddleEastandAfricaOtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">3,821<span></span>
</td>
<td class="nump">3,668<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">Asia Pacific Region</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">28,684<span></span>
</td>
<td class="nump">14,392<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_JP', window );">Japan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">5,845<span></span>
</td>
<td class="nump">4,503<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_AU', window );">Australia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">14,584<span></span>
</td>
<td class="nump">3,304<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=idxx_OtherAsiaPacificMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">$ 8,255<span></span>
</td>
<td class="nump">$ 6,585<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AmericasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AmericasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_BR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_BR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_DE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_DE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_NL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_NL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_FR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_FR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CH">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CH</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=idxx_EuropetheMiddleEastandAfricaOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=idxx_EuropetheMiddleEastandAfricaOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaPacificMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_JP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_JP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_AU">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_AU</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=idxx_OtherAsiaPacificMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=idxx_OtherAsiaPacificMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>213
<FILENAME>R105.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101991571864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Narrative) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Estimated fair value of long-term debt</a></td>
<td class="nump">$ 916,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 916,300<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Estimated carrying value of long-term debt</a></td>
<td class="nump">850,711<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">850,711<span></span>
</td>
<td class="nump">$ 909,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Contingent consideration recorded from acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="nump">5,230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in estimated fair value</a></td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>214
<FILENAME>R106.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101982143304">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements (Schedule of Fair Value of Assets and Liabilities Measured on Recurring Basis) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 76<span></span>
</td>
<td class="nump">$ 76<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds | Quoted Prices in Active Markets for Identical Assets (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">76<span></span>
</td>
<td class="nump">76<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds | Significant Other Observable Inputs (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds | Significant Unobservable Inputs (Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=idxx_EquityMutualFundsMember', window );">Equity mutual funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsFairValueDisclosure', window );">Other long-term assets</a></td>
<td class="nump">826<span></span>
</td>
<td class="nump">1,145<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=idxx_EquityMutualFundsMember', window );">Equity mutual funds | Quoted Prices in Active Markets for Identical Assets (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsFairValueDisclosure', window );">Other long-term assets</a></td>
<td class="nump">826<span></span>
</td>
<td class="nump">1,145<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=idxx_EquityMutualFundsMember', window );">Equity mutual funds | Significant Other Observable Inputs (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsFairValueDisclosure', window );">Other long-term assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=idxx_EquityMutualFundsMember', window );">Equity mutual funds | Significant Unobservable Inputs (Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsFairValueDisclosure', window );">Other long-term assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross currency swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsFairValueDisclosure', window );">Other long-term assets</a></td>
<td class="nump">4,256<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,841<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross currency swaps | Quoted Prices in Active Markets for Identical Assets (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsFairValueDisclosure', window );">Other long-term assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross currency swaps | Significant Other Observable Inputs (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsFairValueDisclosure', window );">Other long-term assets</a></td>
<td class="nump">4,256<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,841<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross currency swaps | Significant Unobservable Inputs (Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsFairValueDisclosure', window );">Other long-term assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign currency exchange contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative asset</a></td>
<td class="nump">6,512<span></span>
</td>
<td class="nump">125<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">601<span></span>
</td>
<td class="nump">12,373<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign currency exchange contracts | Quoted Prices in Active Markets for Identical Assets (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign currency exchange contracts | Significant Other Observable Inputs (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative asset</a></td>
<td class="nump">6,512<span></span>
</td>
<td class="nump">125<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">601<span></span>
</td>
<td class="nump">12,373<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign currency exchange contracts | Significant Unobservable Inputs (Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=idxx_DeferredCompensationMember', window );">Deferred compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesFairValueDisclosure', window );">Other liabilities</a></td>
<td class="nump">826<span></span>
</td>
<td class="nump">1,145<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=idxx_DeferredCompensationMember', window );">Deferred compensation | Quoted Prices in Active Markets for Identical Assets (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesFairValueDisclosure', window );">Other liabilities</a></td>
<td class="nump">826<span></span>
</td>
<td class="nump">1,145<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=idxx_DeferredCompensationMember', window );">Deferred compensation | Significant Other Observable Inputs (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesFairValueDisclosure', window );">Other liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=idxx_DeferredCompensationMember', window );">Deferred compensation | Significant Unobservable Inputs (Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesFairValueDisclosure', window );">Other liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=idxx_ContingentPaymentMember', window );">Contingent payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_BusinessCombinationContingencyFairValue', window );">Contingent payments - acquisitions</a></td>
<td class="nump">7,230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=idxx_ContingentPaymentMember', window );">Contingent payment | Quoted Prices in Active Markets for Identical Assets (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_BusinessCombinationContingencyFairValue', window );">Contingent payments - acquisitions</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=idxx_ContingentPaymentMember', window );">Contingent payment | Significant Other Observable Inputs (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_BusinessCombinationContingencyFairValue', window );">Contingent payments - acquisitions</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=idxx_ContingentPaymentMember', window );">Contingent payment | Significant Unobservable Inputs (Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_BusinessCombinationContingencyFairValue', window );">Contingent payments - acquisitions</a></td>
<td class="nump">$ 7,230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_BusinessCombinationContingencyFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingency, Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_BusinessCombinationContingencyFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>idxx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of other assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of other liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=idxx_EquityMutualFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=idxx_EquityMutualFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=idxx_DeferredCompensationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=idxx_DeferredCompensationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=idxx_ContingentPaymentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=idxx_ContingentPaymentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>215
<FILENAME>R107.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101992584792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Schedule of Contingent Consideration Liability) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Contingent consideration recorded from acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="nump">5,230<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in estimated fair value</a></td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Ending balance</a></td>
<td class="nump">$ 7,230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,230<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>216
<FILENAME>R108.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101981994280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Hedging Instruments (Narrative) (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 18, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Jun. 30, 2015 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths', window );">Estimated net amount of gains expected to be reclassified out of accumulated other comprehensive income and into earnings within next 12 months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge', window );">General duration of foreign currency exchange contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">24 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 286,700<span></span>
</td>
<td class="nump">$ 202,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax', window );">Unrealized gain (loss) on Euro-denominated notes, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,404<span></span>
</td>
<td class="num">(7,378)<span></span>
</td>
<td class="nump">$ 1,790<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax', window );">Unrealized gain (loss) on cross currency swaps, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,399<span></span>
</td>
<td class="num">(5,626)<span></span>
</td>
<td class="nump">2,107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_CashFlowHedgeHedgePercentageOfEstimatedExposureFromIntercompanyProductsPurchasesAndSales', window );">Cash flow hedge, hedge percentage of estimated exposure from intercompany products purchases and sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_CashFlowHedgeHedgePercentageOfEstimatedExposureFromIntercompanyProductsPurchasesAndSales', window );">Cash flow hedge, hedge percentage of estimated exposure from intercompany products purchases and sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=idxx_SeriesCSeniorNoteMember', window );">Series C Senior Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount of net investment hedge | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 88,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.785%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross currency swaps | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 90,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax', window );">Unrealized gain (loss) on cross currency swaps, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,400<span></span>
</td>
<td class="num">(5,600)<span></span>
</td>
<td class="nump">$ 2,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness', window );">Gain (loss) on excluded component as a reduction of interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,800<span></span>
</td>
<td class="nump">$ 2,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=idxx_CrossCurrencyInterestRateContract1Member', window );">Cross currency swaps | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast | Cross currency swaps | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromHedgeInvestingActivities', window );">Proceeds from net investment hedge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 104,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast | Cross currency swaps | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromHedgeInvestingActivities', window );">Proceeds from net investment hedge</a></td>
<td class="nump">$ 17,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_CashFlowHedgeHedgePercentageOfEstimatedExposureFromIntercompanyProductsPurchasesAndSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Estimated portion of hedged foreign currency exposure related to intercompany product purchases and sales.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_CashFlowHedgeHedgePercentageOfEstimatedExposureFromIntercompanyProductsPurchasesAndSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>idxx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss), Net Investment Hedge, Cross Currency Swaps, Gain (Loss), Before Reclassification, After Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>idxx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss), Net Investment Hedge, Euro-Denominated Notes, Gain (Loss), After Reclassification And Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>idxx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net gain (loss) included in earnings for the period relating to components of the gain (loss) on interest rate cash flow hedging instruments excluded from the assessment of fair value hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum period of time the entity is hedging its exposure to variability in future cash flows for forecasted transactions, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Excludes forecasted transactions related to payment of variable interest on existing financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromHedgeInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow for a financial contract that meets the hedge criteria as either a cash flow hedge, fair value hedge, or hedge of a net investment in a foreign operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 27<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3581-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromHedgeInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=idxx_SeriesCSeniorNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=idxx_SeriesCSeniorNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=idxx_CrossCurrencyInterestRateContract1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=idxx_CrossCurrencyInterestRateContract1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>217
<FILENAME>R109.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101991887496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Hedging Instruments (Derivatives Designated in Cash Flow Hedging Relationships) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems', window );"><strong>Foreign Currency Fair Value Hedge Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Total cost of revenue</a></td>
<td class="nump">$ 1,325,928<span></span>
</td>
<td class="nump">$ 1,135,615<span></span>
</td>
<td class="nump">$ 1,041,359<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign currency exchange contracts | Cost of revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems', window );"><strong>Foreign Currency Fair Value Hedge Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Amount of (loss) gain reclassified from accumulated other comprehensive income into income</a></td>
<td class="num">$ (7,121)<span></span>
</td>
<td class="nump">$ 829<span></span>
</td>
<td class="nump">$ 10,628<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>218
<FILENAME>R110.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101982221816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Hedging Instruments (Schedule of Fair Values and Balance Sheet Classifications of Derivatives and Non-derivatives Designated as Hedging Instruments) (Details) - Designated as Hedging Instrument - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Hedging assets, total derivative instruments presented as cash flow hedges on the balance sheet</a></td>
<td class="nump">$ 10,768<span></span>
</td>
<td class="nump">$ 125<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction', window );">Hedging assets, gross amounts subject to master netting arrangements not offset on the balance sheet</a></td>
<td class="num">(601)<span></span>
</td>
<td class="num">(125)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection', window );">Hedging assets, net amount</a></td>
<td class="nump">10,167<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Hedging liabilities, total hedging instruments presented on the balance sheet</a></td>
<td class="nump">101,312<span></span>
</td>
<td class="nump">124,339<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction', window );">Hedging liabilities, gross amounts subject to master netting arrangements not offset on the balance sheet</a></td>
<td class="num">(601)<span></span>
</td>
<td class="num">(125)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection', window );">Hedging liabilities, net amount</a></td>
<td class="nump">100,711<span></span>
</td>
<td class="nump">124,214<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Cash Flow Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Hedging liabilities, total hedging instruments presented on the balance sheet</a></td>
<td class="nump">601<span></span>
</td>
<td class="nump">15,214<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign currency exchange contracts | Other current assets | Cash Flow Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Hedging assets, total derivative instruments presented as cash flow hedges on the balance sheet</a></td>
<td class="nump">6,512<span></span>
</td>
<td class="nump">125<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign currency exchange contracts | Accrued liabilities | Cash Flow Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Hedging liabilities, total hedging instruments presented on the balance sheet</a></td>
<td class="nump">601<span></span>
</td>
<td class="nump">12,373<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross currency swaps | Other long-term assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Hedging assets, total derivative instruments presented as cash flow hedges on the balance sheet</a></td>
<td class="nump">4,256<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross currency swaps | Other long-term liabilities | Cash Flow Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Hedging liabilities, total hedging instruments presented on the balance sheet</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,841<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=idxx_ForeignCurrencyBorrowingsDesignatedAsNetInvestmentHedgeOnBalanceSheetMember', window );">Foreign currency denominated debt | Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Hedging liabilities, total hedging instruments presented on the balance sheet</a></td>
<td class="nump">$ 100,711<span></span>
</td>
<td class="nump">$ 109,125<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after effects of master netting arrangements, deduction of assets not subject to a master netting arrangement and elected not to be offset, of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, offset against an obligation to return collateral.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226016-175313<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, elected not to be offset, deducted from derivative assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226016-175313<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after effects of master netting arrangements, deduction of liabilities not subject to a master netting arrangement and elected not to be offset, of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, offset against the right to receive collateral.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226016-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, elected not to be offset, deducted from derivative liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226016-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=idxx_ForeignCurrencyBorrowingsDesignatedAsNetInvestmentHedgeOnBalanceSheetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=idxx_ForeignCurrencyBorrowingsDesignatedAsNetInvestmentHedgeOnBalanceSheetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LongTermDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_LongTermDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>219
<FILENAME>R111.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101985381240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Repurchases of Common Stock (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased', window );">Shares of common stock repurchases authorized (in shares)</a></td>
<td class="nump">73,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased', window );">Remaining shares available for repurchase under authorization (in shares)</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_TreasuryStockSharesAcquiredNetOfTaxWithholdings', window );">Share repurchased during the period (in shares)</a></td>
<td class="nump">1,283,000<span></span>
</td>
<td class="nump">721,000<span></span>
</td>
<td class="nump">1,215,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Shares acquired through employee surrender for statutory tax withholding (in shares)</a></td>
<td class="nump">29,000<span></span>
</td>
<td class="nump">58,000<span></span>
</td>
<td class="nump">39,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Total shares repurchased (in shares)</a></td>
<td class="nump">1,312,000<span></span>
</td>
<td class="nump">779,000<span></span>
</td>
<td class="nump">1,254,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_TreasuryStockValueAcquiredCostMethodNetOfTaxWithholdings', window );">Cost of shares repurchased in the open market</a></td>
<td class="nump">$ 755,545<span></span>
</td>
<td class="nump">$ 179,623<span></span>
</td>
<td class="nump">$ 303,838<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Cost of shares for employee surrenders</a></td>
<td class="nump">15,562<span></span>
</td>
<td class="nump">20,603<span></span>
</td>
<td class="nump">8,054<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Total cost of shares</a></td>
<td class="nump">$ 771,107<span></span>
</td>
<td class="nump">$ 200,226<span></span>
</td>
<td class="nump">$ 311,892<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_TreasuryStockAcquiredAverageCostPerShareOpenMarketRepurchase', window );">Average cost per share - open market repurchases (in USD per share)</a></td>
<td class="nump">$ 588.58<span></span>
</td>
<td class="nump">$ 249.20<span></span>
</td>
<td class="nump">$ 249.84<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_TreasuryStockAcquiredAverageCostPerShareEmployeeSurrenders', window );">Average cost per share - employee surrenders (in USD per share)</a></td>
<td class="nump">548.08<span></span>
</td>
<td class="nump">354.98<span></span>
</td>
<td class="nump">210.10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Average cost per share - total (in USD per share)</a></td>
<td class="nump">$ 587.70<span></span>
</td>
<td class="nump">$ 257.08<span></span>
</td>
<td class="nump">$ 248.62<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_TreasuryStockAcquiredAverageCostPerShareEmployeeSurrenders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock Acquired Average Cost Per Share, Employee Surrenders</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_TreasuryStockAcquiredAverageCostPerShareEmployeeSurrenders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>idxx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_TreasuryStockAcquiredAverageCostPerShareOpenMarketRepurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock Acquired Average Cost Per Share, Open Market Repurchase</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_TreasuryStockAcquiredAverageCostPerShareOpenMarketRepurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>idxx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_TreasuryStockSharesAcquiredNetOfTaxWithholdings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Open market common stock repurchases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_TreasuryStockSharesAcquiredNetOfTaxWithholdings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>idxx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_TreasuryStockValueAcquiredCostMethodNetOfTaxWithholdings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cost of open market common stock repurchases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_TreasuryStockValueAcquiredCostMethodNetOfTaxWithholdings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>idxx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The remaining number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>220
<FILENAME>R112.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101976586760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Schedule of Accumulated Other Comprehensive Income) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance beginning of period</a></td>
<td class="nump">$ 632,795<span></span>
</td>
<td class="nump">$ 177,825<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="num">(5,643)<span></span>
</td>
<td class="num">(6,762)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive income</a></td>
<td class="nump">5,774<span></span>
</td>
<td class="num">(671)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance end of period</a></td>
<td class="nump">689,992<span></span>
</td>
<td class="nump">632,795<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance beginning of period</a></td>
<td class="num">(53,615)<span></span>
</td>
<td class="num">(46,182)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance end of period</a></td>
<td class="num">(53,484)<span></span>
</td>
<td class="num">(53,615)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=idxx_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleIncludingPortionAttributableToNoncontrollingInterestMember', window );">Unrealized (Loss) Gain on Investments, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance beginning of period</a></td>
<td class="num">(272)<span></span>
</td>
<td class="nump">110<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">146<span></span>
</td>
<td class="num">(382)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance end of period</a></td>
<td class="num">(126)<span></span>
</td>
<td class="num">(272)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=idxx_AccumulatedNetGainLossFromCashFlowHedgesForeignCurrencyExchangeContractsIncludingPortionAttributableToNoncontrollingInterestMember', window );">Unrealized (Loss) Gain on Cash Flow Hedges, Net of Tax, Foreign Currency Exchange Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance beginning of period</a></td>
<td class="num">(9,934)<span></span>
</td>
<td class="num">(736)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">9,139<span></span>
</td>
<td class="num">(8,527)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive income</a></td>
<td class="nump">5,774<span></span>
</td>
<td class="num">(671)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance end of period</a></td>
<td class="nump">4,979<span></span>
</td>
<td class="num">(9,934)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=idxx_AccumulatedNetGainLossFromNetInvestmentHedgesEuroDenominatedNotesIncludingPortionAttributableToNoncontrollingInterestMember', window );">Unrealized (Loss) Gain on Net Investment Hedges, Net of Tax, Euro-Denominated Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance beginning of period</a></td>
<td class="num">(5,982)<span></span>
</td>
<td class="nump">1,396<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">6,404<span></span>
</td>
<td class="num">(7,378)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance end of period</a></td>
<td class="nump">422<span></span>
</td>
<td class="num">(5,982)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=idxx_AccumulatedNetGainLossFromNetInvestmentHedgesCrossCurrencySwapsIncludingPortionAttributableToNoncontrollingInterestMember', window );">Unrealized (Loss) Gain on Net Investment Hedges, Net of Tax, Cross Currency Swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance beginning of period</a></td>
<td class="num">(2,159)<span></span>
</td>
<td class="nump">3,467<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">5,399<span></span>
</td>
<td class="num">(5,626)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance end of period</a></td>
<td class="nump">3,240<span></span>
</td>
<td class="num">(2,159)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember', window );">Cumulative Translation Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance beginning of period</a></td>
<td class="num">(35,268)<span></span>
</td>
<td class="num">(50,419)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="num">(26,731)<span></span>
</td>
<td class="nump">15,151<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance end of period</a></td>
<td class="num">$ (61,999)<span></span>
</td>
<td class="num">$ (35,268)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AOCIAttributableToParentNetOfTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=idxx_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=idxx_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=idxx_AccumulatedNetGainLossFromCashFlowHedgesForeignCurrencyExchangeContractsIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=idxx_AccumulatedNetGainLossFromCashFlowHedgesForeignCurrencyExchangeContractsIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=idxx_AccumulatedNetGainLossFromNetInvestmentHedgesEuroDenominatedNotesIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=idxx_AccumulatedNetGainLossFromNetInvestmentHedgesEuroDenominatedNotesIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=idxx_AccumulatedNetGainLossFromNetInvestmentHedgesCrossCurrencySwapsIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=idxx_AccumulatedNetGainLossFromNetInvestmentHedgesCrossCurrencySwapsIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>221
<FILENAME>R113.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101981348952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Schedule of Reclassifications out of Accumulated Other Comprehensive Income) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenue</a></td>
<td class="nump">$ 1,325,928<span></span>
</td>
<td class="nump">$ 1,135,615<span></span>
</td>
<td class="nump">$ 1,041,359<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Tax (benefit) expense</a></td>
<td class="nump">157,810<span></span>
</td>
<td class="nump">79,854<span></span>
</td>
<td class="nump">94,426<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">(Losses) gains, net of tax</a></td>
<td class="nump">744,844<span></span>
</td>
<td class="nump">582,131<span></span>
</td>
<td class="nump">427,792<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Reclassification out of Accumulated Other Comprehensive Income | Foreign Currency Exchange Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenue</a></td>
<td class="num">(7,121)<span></span>
</td>
<td class="nump">829<span></span>
</td>
<td class="nump">10,628<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Tax (benefit) expense</a></td>
<td class="num">(1,347)<span></span>
</td>
<td class="nump">158<span></span>
</td>
<td class="nump">2,467<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">(Losses) gains, net of tax</a></td>
<td class="num">$ (5,774)<span></span>
</td>
<td class="nump">$ 671<span></span>
</td>
<td class="nump">$ 8,161<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=idxx_AccumulatedNetGainLossFromCashFlowHedgesForeignCurrencyExchangeContractsIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=idxx_AccumulatedNetGainLossFromCashFlowHedgesForeignCurrencyExchangeContractsIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>222
<FILENAME>R114.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101984690584">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Preferred Stock (Details) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract', window );"><strong>Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Shares of preferred stock authorized (in shares)</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Par value per share (in USD per share)</a></td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>223
<FILENAME>R115.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140101988271752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>IDEXX Retirement and Incentive Savings Plan (Details) - 401(k) Plan - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_idxx_RetirementAndIncentiveSavingsPlanLineItems', window );"><strong>Retirement And Incentive Savings Plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent', window );">Contribution match, maximum percent of participants' eligible compensation</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Employer contributions</a></td>
<td class="nump">$ 25,800,000<span></span>
</td>
<td class="nump">$ 23,400,000<span></span>
</td>
<td class="nump">$ 21,100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount', window );">Discretionary contributions</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_RetirementAndIncentiveSavingsPlanLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Retirement And Incentive Savings Plan [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_RetirementAndIncentiveSavingsPlanLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>idxx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of discretionary contributions made by an employer to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_idxx_RetirementAndIncentiveSavingsPlanAxis=idxx_FourZeroOneKPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">idxx_RetirementAndIncentiveSavingsPlanAxis=idxx_FourZeroOneKPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>224
<FILENAME>idxx-20211231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:idxx="http://www.idexx.com/20211231"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="idxx-20211231.xsd" xlink:type="simple"/>
    <context id="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i309abd36f89849cfae9056eea2c66b2e_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i36ae306a96da42d1a0ef962db0aad1ea_I20220202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
        </entity>
        <period>
            <instant>2022-02-02</instant>
        </period>
    </context>
    <context id="i257dea584c2540acb77224b3a70b171d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5bc10811c8b443b6ae93662c965b99e4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic726475fb9e14ee5a91a94f1384e1a43_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic3e97410fa904f6b9da8bf1da4160760_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icaff31c4dfc74beebd9e4f2367f76db7_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1e1d4a27d5524619b8f8d3d7ab6dc3e9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id5e9c5621d1e4b70b61639e6582ff3c2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ida0b80c182f342c3996f1a84b8b8fb9c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0c634b937c58472e84857eacf99e17df_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i28d0821cac8841b29cf960002d3bc993_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ifc55888d777a4d23bc9cfb38c781c1b0_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ia5198e31e82c4830868ddd894d8bea8e_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i47457672ea94468ab1c5cd3068086847_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:DeferredStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ia510c04f9d61478ea746fbff0dd20e7a_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i0030920649fc4bfeaec05aad85e23ea9_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i3ca52acda88f4806b415035b2e87a637_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i4eba3ab172724f5cb99036c1a25946f4_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i3eebac5bf6864fc4a7c5f697b102c9f9_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie44c061415214719bc569b35577d8629_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i52c9d97bec804143a591d49a316a5d59_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8ddfcdc960064849802514d1f2a8bbfb_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i459299d77adf46b2baa2eefe5c566758_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id1564d43c43d4ed28f279068c2cec341_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if3ee522263ee4c1ab1a5860feaa32d9b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:DeferredStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ifb04d957babc4708830136f812aa04c6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia754ac48509b4751bfa3915a39627bc6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i979a783478524796bf27df092c164acb_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:DeferredStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if0d07a5bb51144978faf2ec5745936dc_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iaf017de1fe8245b490bf3ba36d73909c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8fa2c23303164297bbef06a53a57f47d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i070ac0c233c64a6b8c2c8c44a84a6b9c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i40d60db7ecae431bbb3cc52673c3f08c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9dcdb5ab830946f987d2c255bb59ed41_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i843cb27f38cc4792b41236eefc1a5b9a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3c49c956c8bd476fbc5a218bb26fc1e7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ifefe9c40d7f444cfaa6687822f8d9fe2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6390dc8d6016472b99f4f5e8bcd76bd7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1405c98ed2d04737be98553084c09616_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7353d8a3c0814b3387f39a6d5c074615_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ieb488124070d493c8bc4c944a20bf01a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:DeferredStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib43cc74de7f9447797f368526c52d81a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iacf2e4f12bb748b29e58438c9e86121d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie21fa7b167864efaa91ab594caaa329f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:DeferredStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3e204f1ef8454b7688e083aa906679b1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i57792c148d4b4ba5b2eb677b657b7a2b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iffadbee2ebda4dbd995c7ad9756f26ae_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i592d601cd0814365b50dc596de883440_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5494ccc733ab4588a07cf0c681f7fc5b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i429f0a9281954c8991dd7a289fa848cf_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i62a7d75347e640f1a8e7e3577bb0a247_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i17c7e782291f468da00d43bcb50b822f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i80d844cab93d4373b5a710038b7a3f8a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if4e99dbc526e4e2185b83986a19641e6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ifdf9b694355c4799a0d984c56a7af188_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:DeferredStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8486d76f7282415c96b78263d0e53fed_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i65e8850835e644b0a942d37199d2fac2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9152bd3467a54594bc1a3df15df505af_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:DeferredStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i22db15f5a3f64f13a2a4241901d35b3e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia4ce9f46b7a347608b97422112175f6f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8be03ed376d64697b29c2563ea25de6d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i727ded70819a4775adf0f51b27e35673_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i21b5e95e95564226a627f64e7713aea8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201613Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="idb0fcabcbe0847e89f685ded467776c8_D20200101-20200101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201613Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-01-01</endDate>
        </period>
    </context>
    <context id="ic23d3f2012b145a986354fd6baa91f83_I20200101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201613Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-01</instant>
        </period>
    </context>
    <context id="i464c41d2cb9948979da5af09e9a6709b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2547ad5bc951453f98e34b5d0f26b8bb_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i35fada0f29454b9e9fbe5fa23ce2f2e7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:ExtendedWarrantiesAndPostContractSupportMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id896191bdc6d41d1afbef82d66327428_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:ExtendedWarrantiesAndPostContractSupportMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if381570659954770b2820ee07047c157_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:ExtendedWarrantiesAndPostContractSupportMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i242e9b6f55554b858443459f0e68afb7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:ExtendedWarrantiesAndPostContractSupportMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i685e23f0c6e840b7aecebc2994601eb2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:ExtendedWarrantiesAndPostContractSupportMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia8d9c432d3bf4b74adffb2d189372886_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:ExtendedWarrantiesAndPostContractSupportMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id18052a9bc8947e885971777f75a622b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:ExtendedWarrantiesAndPostContractSupportMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i489a306049d8454da4686e43ac9f9be5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:ExtendedWarrantiesAndPostContractSupportMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2024-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iee7069d3c7944d9d8e2527acff1fbc06_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:ExtendedWarrantiesAndPostContractSupportMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2025-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i047ec28985a54ca496f585918ccf62f6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:ExtendedWarrantiesAndPostContractSupportMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2026-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i96beb1b4304e4f20a74ee69716a60a3e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:UpFrontCustomerLoyaltyProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i437a7bd65c7c46ae8cd7c9e49b4ee334_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:UpFrontCustomerLoyaltyProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib7205413c9894bd7a9838d72705913eb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:UpFrontCustomerLoyaltyProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2f2f5cdb189f4934b1e3cebeb924b507_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:VolumeCommitmentProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i79ce71bddf09448f9ea714ce6102c47b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:VolumeCommitmentProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i09befd933773486bbae96a48cee3829b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:VolumeCommitmentProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i51f68fc78b89418293d672d19db8aff1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:UpFrontCustomerLoyaltyProgramsAndVolumeCommitmentProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3f8679f022804acba3547f27b82749ee_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:UpFrontCustomerLoyaltyProgramsAndVolumeCommitmentProgramsMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia1b14ac41fb14c2d8d6ba017fa4e925e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:UpFrontCustomerLoyaltyProgramsAndVolumeCommitmentProgramsMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icb7e410e248e43c994cb93d2f03fbf8f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:UpFrontCustomerLoyaltyProgramsAndVolumeCommitmentProgramsMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2024-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie2230e0e134c41099416ecb0514e3a3c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:UpFrontCustomerLoyaltyProgramsAndVolumeCommitmentProgramsMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2025-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3e0eda093e4c442d97a50489871ee0c6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:UpFrontCustomerLoyaltyProgramsAndVolumeCommitmentProgramsMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2026-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4c2e03def5d746e991b38bd94dccfbdb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:InstrumentRebateProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icf88e478362d4b679f69d782be7a8360_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:InstrumentRebateProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id886e662c2af48208ad13c5d0017a93e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:InstrumentRebateProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i76e3709ae6e04372b5824637c99c55ce_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:InstrumentRebateProgramsMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ide72157b20624cbba3e378503b944506_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:InstrumentRebateProgramsMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8af8821a5a8e4e06898dabdea6965ee3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:InstrumentRebateProgramsMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2024-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i865e2c5df39b4cecb1d900db1ae6ca7d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:InstrumentRebateProgramsMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2025-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if8efddd0307c4f6c9b1fab4c82f7cd7b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:InstrumentRebateProgramsMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2026-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i269b18a6e9c74892a68183dfb6d26182_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:ReagentRentalProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0e53a7345431421d90c84f0714010ab8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:ReagentRentalProgramsMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i26a9c61e7add4db7b09dd7228e5adf11_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:ReagentRentalProgramsMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i552f56ee344349d0a8fe803f1d4ac028_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:ReagentRentalProgramsMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2024-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia21b4eae913c4602899f11b240ecd020_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:ReagentRentalProgramsMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2025-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8e6515d33c104d37893035bf37f096ad_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:ReagentRentalProgramsMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2026-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i723287d015984ccaa532d58c82848761_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:CAGDiagnosticsRecurringRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:CompanionAnimalGroupSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if77b95f4c71f4d27a4b24d6a7f47cb19_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:CAGDiagnosticsRecurringRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:CompanionAnimalGroupSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3495e15513b94d078ea449cf5f428620_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:CAGDiagnosticsRecurringRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:CompanionAnimalGroupSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iaf886748aba34b2dae8f6c7817ad2a16_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:VetLabConsumablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:CompanionAnimalGroupSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i45c842be487a4adeaf405fb278d02adb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:VetLabConsumablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:CompanionAnimalGroupSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iecf199144d3940e08f79eb67130f5a22_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:VetLabConsumablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:CompanionAnimalGroupSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9a1a0bb358d847259b4ee304e5a46a33_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:RapidAssayProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:CompanionAnimalGroupSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i793b95b40c3a4a9490a98b288a146ee0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:RapidAssayProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:CompanionAnimalGroupSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i56aa1f828bc845f58439fe0a42646b60_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:RapidAssayProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:CompanionAnimalGroupSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i82504fe08ede4c6f89672ec5a625601e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:ReferenceLaboratoryDiagnosticAndConsultingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:CompanionAnimalGroupSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i32b9c9eff8ca4148be177ce0cbdddd6b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:ReferenceLaboratoryDiagnosticAndConsultingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:CompanionAnimalGroupSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1430c1be15d34b1abe49cb43d2d401ba_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:ReferenceLaboratoryDiagnosticAndConsultingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:CompanionAnimalGroupSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3a2f9d2f1d5a4674af66963a5565e7f1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:CAGDiagnosticsServiceAndAccessoriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:CompanionAnimalGroupSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib81ecabbb8614cf1b2acb2b54f2c36f9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:CAGDiagnosticsServiceAndAccessoriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:CompanionAnimalGroupSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i91c8a095edc841769c85865c8e5036f2_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:CAGDiagnosticsServiceAndAccessoriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:CompanionAnimalGroupSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib4caa366375c4cb9a3594b681a103170_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:CAGDiagnosticCapitalVetlabInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:CompanionAnimalGroupSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i726e9c456ab44126a671318ab9275f7f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:CAGDiagnosticCapitalVetlabInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:CompanionAnimalGroupSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4e5c3cd621d24cb28572507163aed2f7_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:CAGDiagnosticCapitalVetlabInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:CompanionAnimalGroupSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7fd4d20f53cd47b499e032d174f468fc_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:VeterinarySoftwareServicesAndDiagnosticImagingSystemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:CompanionAnimalGroupSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i69584183a25e434eb0dbc26d4f7a118d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:VeterinarySoftwareServicesAndDiagnosticImagingSystemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:CompanionAnimalGroupSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8301f630e8b443fe8e590fcd68eab16f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:VeterinarySoftwareServicesAndDiagnosticImagingSystemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:CompanionAnimalGroupSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6c823cc0aa3945d9874ea09ab5940878_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:CompanionAnimalGroupSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i40313073e9c743ad89084e7fbcbd7e5e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:CompanionAnimalGroupSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ief827aa39f934947a553685160a5543c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:CompanionAnimalGroupSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i81c0a80f385a4f18ab5cb5919ed28318_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:WaterSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic0b173f4625a4e1e807adc8eeb4e0592_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:WaterSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iab0b6ebdef1a4be9b052a1b82c635759_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:WaterSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i4174c33ea3f8443fbc6587f7ac9a43ab_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:LivestockAndPoultryDiagnosticsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4525be5d1c1b4d458fe78f047e981dc1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:LivestockAndPoultryDiagnosticsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i34e8ebea941e457cbadc1ce152e6a396_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:LivestockAndPoultryDiagnosticsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i94cd933d7b7b431caa324dc2936f5c55_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:OtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i100119c49d8f4098bf6afdc675782162_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:OtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia6f9b6007f00420291efefe0008f3d10_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:OtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i074301c2df824186bd2aba7d250d51cf_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i01f16b1d8f40480ea91113c41cce5e7a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4020a52f56894866abcca95a1a1497f1_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i766a0f5291584f90863a5968d8de067c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4c8215241a5640df9c12270ca8891308_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i098a241b58744ea38131468a239f7847_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9d89e0f871864b189335e7739d42fe07_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">idxx:LatinAmericaAndCaribbeanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7743a6f4bd764d2a9da6c4de5e290df5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">idxx:LatinAmericaAndCaribbeanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i875c0d290dfb4cbf8a2b59d7e2c6d1fe_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">idxx:LatinAmericaAndCaribbeanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i76f3ab4debf64563bc6a167ac410e9c3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibe22eae831934369a9a0015d3c260ab2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie4ec176e93ab43bb98dd7714f2512730_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie659b0df466445ae9609de3ee174d80c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if0c4109668754b8693ca7161318090f9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ifa67f291b9eb45a780298d9ae25ddaf3_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ia7dbddd91eb54624978a0b4ed56ec859_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iaded4b965f664c0d806bbe1ac965cd5d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3d87cb22b86c44f4b570eed70a1378eb_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i75c498c811384ef09dcd9c2fe08380c8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i66eb4e58d2ee4aaca353fee7f134054f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0dc62339001e4ad4a1835c85eedc299e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9f1ed5c7ebf34e30a0fdb012cddf7440_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IT</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib9c07a32fa054809a3705b5c0d25c972_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IT</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i024ff5694a8c4073a3e5ce8f499229f6_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IT</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0a12365e7904425790e4a07eca696916_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:ES</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib98678b4e8cf4f749ac3e5c05952d91b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:ES</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id2f16826ba294aa484551884f87d09e8_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:ES</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7896731fe12243f1875fd4ce04068904_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie109583690ce4e2eae0a0a5c373a2ee4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie037b3568c7d47d8914ff5010a0aedcd_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8207a8f256ab4cc6a3250a19887134bd_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:NL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4ec2b03ad795418a8009824d2524452f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:NL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i33cd1326584149ccbfa7ddc29ff1f6c8_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:NL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i4b82ba0179564e93a090862f65ad1917_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">idxx:EuropetheMiddleEastandAfricaOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id596dfd4731c4532a3f61ad928fd2c5c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">idxx:EuropetheMiddleEastandAfricaOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i07e74761556442abb8ddcffbbc211fcf_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">idxx:EuropetheMiddleEastandAfricaOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if20538cc41914789b22efe5b91f2f3a7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic5db3ce1c3924c83b379d8a61e0f7372_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4b9195b1ced7483697bc7828d38b1dc3_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ibf1299bd5850495db5bab930c750f59c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="icaa60874497e43898b35ee415a2bc80f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i220bf3ab1a154b9a8693e8e99867b9ac_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5f4a460cb3fc481b87a66c1143b1c6ae_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="idfb45a09b6c94d2f9c4fa39784fc4f4c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i27d98417a7ed441dbaefaf4e3c7d8e3e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ice113159eb944073881b74017325c32e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i25c97c45426b49229b105df880a272e6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i725b5e5dc5f042a7ae398d70fbeee8a5_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1c7784e6972a40e794a9b073a04021a7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">idxx:AsiaPacificRegionOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id95808181fe340cf9c9a3e0c0794af01_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">idxx:AsiaPacificRegionOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8756d035ba8e462584f1d7c8d7dddac4_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">idxx:AsiaPacificRegionOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic225702a7bba4086a0eb7207e3dcb702_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8b04ff1af6a74efbb011731141a869fb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i471d983af3ad4dbda5429f440f2683ff_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iec94ca1756b3473faecedf9258139d41_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9aa403826a744b88a310a196d527c4da_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i842723fe206441498f4f17f31a9787fc_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FI</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:ReferenceLaboratoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie8c73a699ac1449a83257aa402845ff6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FI</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:ReferenceLaboratoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic0b97d19fd5e4d9da47732f2832e48e0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FI</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:ReferenceLaboratoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iea6bbd7bf4aa409f81e8b4939eaeebb7_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FI</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:ReferenceLaboratoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5aeff8abf9cf474cb8eef1fda56b68fb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FI</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:ReferenceLaboratoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i809c93aee53e4f94943260050b20b48b_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FI</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:ReferenceLaboratoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ifd3e48c2fc1c450db3e7a70a7d818589_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:TeleradiologyBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ifce9ad75783047eca6a078e591b5a29e_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:TeleradiologyBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="id1280d77ec9a4626b628ba48e7a82fee_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:TeleradiologyBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ida01d0b9ae19406cba72ddf3076630da_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:TeleradiologyBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4cad12a2c61c492fa2913b23e32f05f6_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:EzyVetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia2728c192ba740b3bccbeb6af69b3ba8_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:EzyVetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ibfd9997d2b384ba184794f3511297632_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:EzyVetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i385bd1940c0e4f08b7a962517de3c1b1_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:EzyVetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i305a1c1723984399939954021ea102bb_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:EzyVetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if6b9086908654520873d5861115fad00_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:EzyVetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2d303cab977e469191f8b6b1552d036c_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:EzyVetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i331a2e7b2a724d3d95f8d3fa0aa4fb7f_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:EzyVetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i55647d483f84421fa97e4bd81c6d5d69_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:EzyVetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i21fecd38873f4b64b92a766a37bdf70b_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:EzyVetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i37946dde29a24a35b13eae3f304d5a27_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:VetLabConsumablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:EzyVetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ie9efbaf1e37c410ea20352d5d9dfc9b2_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:ReferenceLaboratoryDiagnosticAndConsultingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:EzyVetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i51b0af3a479b46bfa75da33ccbef5a0d_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:RapidAssayProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:EzyVetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iee0529f10fe24e86ad8b423b1dcfdfcd_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:VeterinarySoftwareServicesAndDiagnosticImagingSystemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:EzyVetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ifb7924f502ed418b8a52fa0f86e77e1b_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:EzyVetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i19e2681a08f94930a55705e928524d31_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:EzyVetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id8e658249a1b4ada9bf653d6f869d521_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:ReferenceLaboratoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i19c6a768e2a14d0bb7d30636dbb2c293_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:ReferenceLaboratoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i98a1c47a6a4347cd86ea3a19f76e6f2c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:ReferenceLaboratoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ibf189d70c3364256b7c496f71fbb573e_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:ReferenceLaboratoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iaa9a585d1027406aaf397c11d9f703e3_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:ReferenceLaboratoryinMidWestUnitedStatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1d6f007fbb65407089a89432eb6964c5_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:ReferenceLaboratoryinMidWestUnitedStatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i21fe577fc12d43d6aa8593e56fbbd4ba_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:ReferenceLaboratoryinMidWestUnitedStatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i80310c05b475409f9d808f6d23317bc9_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">idxx:ReferenceLaboratoryinMidWestUnitedStatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ifd0bd4a0a64d4c9fa9955ab39bcd5b33_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3338ed00513241bc832c9f2114b7b270_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">idxx:TwoThousandEighteenStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i97018d52b0af4870b3849b272b1355ec_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">idxx:StockOptionsAndStockAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i8c8ce4fcf0ad47d1a61060c9d791ef17_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">idxx:AwardsOtherThanStockOptionsAndStockAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i4a16b614e5514b46a709cdefac9167c9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">idxx:TwoThousandEighteenStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ida1ffc64f6764bb4be6d2faec82e9f3f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7b83a53333fa4f00b4d62d186eefc036_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie726a1d133bf4ad5a692bd283baf4341_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i154151cc952a42e2b9337039f8030f64_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">idxx:OperatingExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id0b2c60d6a4244439cacf26a55fa991c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">idxx:OperatingExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id3a4a8e504c24b93880965b1c3991089_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">idxx:OperatingExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i77a5beb76e6b48498eed44e9a602baed_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie3cf8555002d4b4cbd01dce8c9e1e1d3_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">idxx:StockOptionsGrantedToEmployeesWithRatableVestingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i45554c00d32c4d45a16d94dd9b602937_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">idxx:StockOptionsGrantedToEmployeesWithRatableVestingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="idae58301e68b412eb28334afea378d2b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9c3e894425d54b5a84d42ae55eb839ae_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i982c1764182b47d1b743c71bb7b33923_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0491e8e2530147698782b2a10a30d90b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3299da84372d432f98da6898831dd963_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1594d5a312e047069a064e029de5cf8b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">idxx:RestrictedStockUnitsGrantedToEmployeesWithRatableVestingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i84fa425282ab417da8ba5a3609c0031e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">idxx:RestrictedStockUnitsGrantedToEmployeesWithRatableVestingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ief941e5acd344fed862240efdd3a7288_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ibcdf728b3b3f46f08f1609441281d24e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0cad033f6b01464bbca11ea746ae0dd3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i694b32aa47f046748a1598cc0d558051_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibf6a2e2744a44ea98ebe5ee2a3b57059_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">idxx:RestrictedStockUnitsExpectedToVestReducedForEstimatedForfeituresMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib209d359b518453c8297929f6c24722a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9958c792661247119c39c9e01d982deb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">idxx:DeferredStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7663c8e364ea4807a7ad1cbb6bafde89_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">idxx:DeferredStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i230d8313826f436cae6610d654452ab4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">idxx:DeferredStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6e7ee8e291c54e02a81d0c39ffc5ad6b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">idxx:NineteenNinetySevenEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id26ee05f76cc40ac87ab6c4856efecfa_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">idxx:NineteenNinetySevenEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0a5d4fe659be4cccaf4e997156b223a2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">idxx:NineteenNinetySevenEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i07cab270359146efa8ad17bde260ed6c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">idxx:NineteenNinetySevenEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id4706d2219354fd4aca929cb8a8e0ce0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">idxx:NineteenNinetySevenEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if2d8a957b59b41bd9d689b2d4b69d6a4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivablesPeriodPastDueAxis">idxx:FinancialAssetGreaterThan60DaysPastDueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4fa881c75f4742dfb92d9cee4bd32188_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivablesPeriodPastDueAxis">idxx:FinancialAssetGreaterThan60DaysPastDueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if03c9c1348554db4936cf06e9bd802c2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:ReagentRentalProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6f415ad968794c3b9bf10b5e7c9d08e8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:ReagentRentalProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i69d7e5c1eec24001a74325f821a31cba_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">idxx:ReagentRentalProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i358c864968b04228b7d1de65d4356012_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iaae1104f80a84293b957aad0e5ba9d49_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie6f5e29e1d644e1380b56d80b5c8ab21_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iec5713b70bef4889b876769c7518056a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia3d9107992e245d2808adc5e2bef7264_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9a4a3d9081da4e4890098ab4828eff02_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ifcd90bb4b001420db3089207a9817b90_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iefcc27d08de64329bcdafc6e24f95d6f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1e07bfbfbbdc4286ac526097dcc2014a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">idxx:ComputerHardwareAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i283cc22fdf494c59a8affd0dcad7b35a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">idxx:ComputerHardwareAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9c5014947c2d49ac8200d45c4f5828a0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndLandImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if6e52598ae7b4d548bd924fa1808d713_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndLandImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i84c5988a324d4a31a0b062f598b122e2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i27518b77901a4762b6f2872c61ab1b01_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5325a16dfc33486bb52b0c132af02290_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8ced4bf3c1a540939075a145fafad2f1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id90597dbb49948fabb735806b012f616_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7dad70e6dd004c2695b06a59bd68945a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2a2074f7bc9b4a2cbf6ed3b610f98409_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i69684bf965814a318039fff0559aee1f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic4c3038a1c6e434f960b3b42480ee814_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">idxx:ComputerHardwareAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i24004ed53abe4277a8577a3ab12dd906_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">idxx:ComputerHardwareAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9bc87de78fd14b56ba2c24532ac28a94_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i46df05df390f4fb8b267041b3f7c430b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i17db583051954f429123c0a1d6ba693f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">idxx:SoftwareDevelopedForInternalUseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="idc48fab68f194aaa84d1e8ed6fa2892f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">idxx:SoftwareDevelopedForInternalUseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6de38908909247f4abb7093d04baaf61_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">idxx:SoftwareDevelopedForInternalUseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i4a0c9bdb38c5437ba4c6b8c7c0183c5d_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:CompanionAnimalGroupSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ibf8bbc6500694651b48a90bd7484b109_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:WaterSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ibf7bd16dde3b49debd9c67b5be3e1fb9_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:LivestockAndPoultryDiagnosticsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i553fbb83ebff498cbd25aefa9eee9276_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:OtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i9f05fb527b154dee8865a625a6eff114_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:CompanionAnimalGroupSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if93e0292c6f54be59c39937e7fd58164_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:WaterSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6e064fdd1f8949e0a40782734de7a004_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:LivestockAndPoultryDiagnosticsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia7599f68f6de408b80c30adab94958b2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:OtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ief4601e8865549a09377d9dfd17d74d4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:CompanionAnimalGroupSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i463e678af3d24f9d8074cd935b869239_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:WaterSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i929ca297bc5248beabe8f044d7430225_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:LivestockAndPoultryDiagnosticsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if8867f1bde2348b596b2427e15fb4d2e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:OtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i91597ef710044b0aaf747bf9fd3b6882_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:CompanionAnimalGroupSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7b559b62389c4dffbc62f92796f64370_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:WaterSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib956b0023d37451a873e726de05dc04d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:LivestockAndPoultryDiagnosticsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i81db4aa26c9a45f9b2ac5198a22acfe8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">idxx:OtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib25dbfb85b114a83a3384494c07c9a83_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iccd74787592547aabe3fc45e8160f1f6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6d6af357c77b4c45a43103bb36b9db75_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">idxx:ProductRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6625320757264c3d977d4eb7923c35ee_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">idxx:ProductRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i570237e99c1d4a9b8c6dca9eae26bea8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i637fcf9a068c4d6798c09d00dea42126_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic59101fdcfff4269aef991be04a88a6f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i24ed2ad1bc274728bf194148636a8d78_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia89659b032284471b33d455d42efc26b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">idxx:ProductRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i87c2ea63490848ab92d756e41e990b46_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">idxx:ProductRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0f20409febb84c2483223228e9e1771a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8bec47a954cb4a1d86389d1590f9c5e0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3d67cbfaa5224fec8d1c48c0eb22dc85_D20211209-20211209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-09</startDate>
            <endDate>2021-12-09</endDate>
        </period>
    </context>
    <context id="ie379750e8a014b58b9ca70bcde9817d8_I20211209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-09</instant>
        </period>
    </context>
    <context id="i88842c37e6494006b237d52fce7c5c33_I20200414">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-14</instant>
        </period>
    </context>
    <context id="i7027aef0a2c5405c8952b0b711093dd4_D20200414-20200414">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-14</startDate>
            <endDate>2020-04-14</endDate>
        </period>
    </context>
    <context id="i4c25f29396c647aa8d6098ef0911bfef_I20200414">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-14</instant>
        </period>
    </context>
    <context id="i5cc431806cd042369dfc78d28f3b1659_D20200414-20200414">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-14</startDate>
            <endDate>2020-04-14</endDate>
        </period>
    </context>
    <context id="if38e3d02f10c4f32b074213b34fef777_D20200414-20200414">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-14</startDate>
            <endDate>2020-04-14</endDate>
        </period>
    </context>
    <context id="i1da5c94143f545488db1a5e8851e0d7b_I20200414">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-14</instant>
        </period>
    </context>
    <context id="i2743639b7f854d2faacd705017e8a980_D20200414-20200414">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-14</startDate>
            <endDate>2020-04-14</endDate>
        </period>
    </context>
    <context id="idc1466922ecb4c6d968b86b7b8b94009_D20200414-20200414">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-14</startDate>
            <endDate>2020-04-14</endDate>
        </period>
    </context>
    <context id="icb88319a299b42b499f9dd03bbc3c710_D20200414-20200414">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-14</startDate>
            <endDate>2020-04-14</endDate>
        </period>
    </context>
    <context id="id297fa8846f44eef8316d35feb8ee7fc_D20200414-20200414">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-14</startDate>
            <endDate>2020-04-14</endDate>
        </period>
    </context>
    <context id="i77d25639b7e24f3b863f76aff1a3baf2_I20211209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-09</instant>
        </period>
    </context>
    <context id="i7c3da4e4c9c14ee59aa58eb74d6eaf8c_D20211209-20211209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-09</startDate>
            <endDate>2021-12-09</endDate>
        </period>
    </context>
    <context id="i90bd3d6a0a4241c0aea364074afe7a3d_D20211209-20211209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-09</startDate>
            <endDate>2021-12-09</endDate>
        </period>
    </context>
    <context id="i9320b95542d34067bb078b7df10a68d7_I20211209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-09</instant>
        </period>
    </context>
    <context id="ibc7eca7b08f24e31ad1cdc3bac81938f_D20211209-20211209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-09</startDate>
            <endDate>2021-12-09</endDate>
        </period>
    </context>
    <context id="ib9a066585bb047ed81604bdfa2257801_D20211209-20211209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-09</startDate>
            <endDate>2021-12-09</endDate>
        </period>
    </context>
    <context id="ib1a6a37dfa0846f0a5ce8ea8202bfac9_D20211209-20211209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-09</startDate>
            <endDate>2021-12-09</endDate>
        </period>
    </context>
    <context id="icfa56c2f5e4b4609b398b0b8b4950963_D20211209-20211209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-09</startDate>
            <endDate>2021-12-09</endDate>
        </period>
    </context>
    <context id="i82a6155f7ccc4f55b9a6fe7e36a127df_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iae060c362bae4cb5b9a839012e39422e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9c8cf4c740be48fd83d344c66d438cd7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">idxx:RevolvingCreditFacilityIndividualBorrowingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0707fa55e90849738007f16cfef51f10_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">idxx:RevolvingCreditFacilityIndividualBorrowingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i99c7fc5496044f18a226eb36d6d3f865_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i291ef135622f4a9baf284e7cfaad88c9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:A2023SeriesANotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i870fa3036a764a809f0d8c67c310cf72_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:A2025SeriesBNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3dd02565f2614274847ab1493dffefe3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:A2026SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0978c28bf335475c882b17687ef6c41d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:A2024SeriesBNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9b730ee02fe84774a4802313f2dbde61_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:A2025SeriesCNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iea3b4083103c42cb8b20a1a66e2e0b7e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:A2022SeriesANotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id7ee5545c45b452ba5b532018c57c675_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:A2027SeriesBNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i71fe397c3c014eb0902555a2b916dc0b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:A2029SeriesCNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i19e6230043be4bc494d45facd3995c64_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:MetLife2030SeriesDNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5dc25052aa62435dbe48e2738f88c2ff_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:Prudential2030SeriesDNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2d9352de44824a5bb1085c5d21e9f1f4_I20131231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:A2023SeriesANotesAnd2025SeriesBNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-12-31</instant>
        </period>
    </context>
    <context id="ib0a1cfdb16bd4fe5831d9ba3c46d91ef_I20131231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:A2023SeriesANotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-12-31</instant>
        </period>
    </context>
    <context id="i1acbae80f997433a88234dd2778c498b_I20131231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:A2025SeriesBNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-12-31</instant>
        </period>
    </context>
    <context id="i9268fbd98f1642a29877996cd39b28a8_I20140930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:A2026SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-09-30</instant>
        </period>
    </context>
    <context id="i85b9b901dae14f1f8f19b213cedc6d10_I20140731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:A2021SeriesANotesAnd2024SeriesBNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-07-31</instant>
        </period>
    </context>
    <context id="i728c0393124f4d3aa9ce9f98a65c1909_I20140731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:A2021SeriesANotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-07-31</instant>
        </period>
    </context>
    <context id="i6b9efa5452f740aca86e464a7d20a380_I20140731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:A2024SeriesBNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-07-31</instant>
        </period>
    </context>
    <context id="ie9096849c1ac4387b32b1369124e6e10_D20210721-20210721">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:A2021SeriesANotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-21</startDate>
            <endDate>2021-07-21</endDate>
        </period>
    </context>
    <context id="i6fd942875b8149d6801ca7948aa50eb9_I20150630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:A2025SeriesCNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-06-30</instant>
        </period>
    </context>
    <context id="i2c27f682ff974979b7a9c14a0852f4b1_I20200410">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:Prudential2030SeriesDNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-10</instant>
        </period>
    </context>
    <context id="ia4f21d4f936e451bb937db30e6e6c516_I20200414">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:Prudential2030SeriesDNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-14</instant>
        </period>
    </context>
    <context id="ia7f558575c4f45f3b51e71f291325f3a_I20141219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:A2022SeriesANotesand2027SeriesBNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-12-19</instant>
        </period>
    </context>
    <context id="ia1b615997c6845d992165c221d916601_I20141219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:A2022SeriesANotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-12-19</instant>
        </period>
    </context>
    <context id="i5c06758cf49c487989c8d74d5a4fe45a_D20141219-20141219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:A2022SeriesANotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-12-19</startDate>
            <endDate>2014-12-19</endDate>
        </period>
    </context>
    <context id="i693b06087db042f486f6b01601900261_I20141219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:A2027SeriesBNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-12-19</instant>
        </period>
    </context>
    <context id="iea5f10448a374b6f90d116e53e14ac51_D20141219-20141219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:A2027SeriesBNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-12-19</startDate>
            <endDate>2014-12-19</endDate>
        </period>
    </context>
    <context id="i78dd1a8fbcfa4a6d8b5587990a0d4b8b_I20211209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:A2022SeriesANotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-09</instant>
        </period>
    </context>
    <context id="i69f00534ab5c47f6bb7e698a1e5b33f2_I20190314">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:A2029SeriesCNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-14</instant>
        </period>
    </context>
    <context id="i8e2ecd2fe69f46929ab4f66300904bb0_I20200322">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:MetLife2030SeriesDNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-22</instant>
        </period>
    </context>
    <context id="i94bcd6d66d644d71ba9e5e425c3343f9_I20200323">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:MetLife2030SeriesDNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-23</instant>
        </period>
    </context>
    <context id="i82a0a4b3853c4d43b57df66540d93b3a_I20200402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">idxx:MetLife2030SeriesDNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-02</instant>
        </period>
    </context>
    <context id="ie9b830d7b3a74e4f9431f662334d4e77_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie58c704216a6458da306b8341192f2b4_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i94032e21bcdb4fd5a7a56338b7e76c84_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">idxx:EmployeeHealthCareInsurancePolicyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9a8414f50ab04a91a3892300c9d0d3d7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">idxx:EmployeeHealthCareInsurancePolicyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1c3f540bc4ee4adeaf82639617d91385_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">idxx:EmployeeHealthCareInsurancePolicyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib865674d7bab445389b9c3bbec146020_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">idxx:EmployeeHealthCareInsurancePolicyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie45306aad98e47fdbad67873c8c7d7cd_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">idxx:EmployeeHealthCareInsurancePolicyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i44fa2e5abf144441938e326da9122112_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">idxx:EmployeeHealthCareInsurancePolicyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i773e63ef7fdd42e489afb58247b219a0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">idxx:EmployeeHealthCareInsurancePolicyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if5c4c6cccd414bef949b6f0b3b152901_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">idxx:EmployeeHealthCareInsurancePolicyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8f64c178a0b14875b7618692b20160b1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="idxx:PaymentRequiredUponTerminationOfEmploymentAxis">idxx:PaymentRequiredToCeoUponTerminationOfEmploymentWithoutCauseOtherThanFollowingChangeInControlMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id4f5b7c174554a70b226143cb3f524f5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="idxx:PaymentRequiredUponTerminationOfEmploymentAxis">idxx:PaymentRequiredToOfficersUponTerminationOfEmploymentFollowingChangeOfControlMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia2df645a45b34a2399502ce17943dcf7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4b80e825cd834af08c3a61075a948afe_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia3c0173254014c148d3b60dec589c0b2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:BR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i19eca0b32b324c3498847ac936ef58f4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:BR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6f5c837a15cc413bb88e37606fc78b84_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5d6b1606b16f45a0ac3be2c84a8d6205_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0a98d26251bb48daa1b953041bbb17e4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if2b60381ab6f424a9ae0d17bcd461dc7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5d067073a4ae4d32b902fa480a4007da_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if14611aca76842bd9bd4db89f308d803_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i374199d035fc499c91845154d21c433e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie8c119688026495c80d9335fe78c12c9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4a516ef8f02d4ad4b2f748492aab4933_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:NL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0c16c76e13144f0ba4ee1ef3535feacb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:NL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id29d95bc12294baa874f679042b1e77e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic4c58acfb1f047b382030e4bc62b5020_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iccfd38ad58364c78a9294def05c76d02_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6da1a2f76bee4a21ac439aeda4137fa7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3e3d1826c3d34af3978413aa009dbae7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">idxx:EuropetheMiddleEastandAfricaOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0e3cdf5fc1964d82bdc2516cce09684d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">idxx:EuropetheMiddleEastandAfricaOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2106bb13edcc49e8b8fce61d61723790_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i64399f2ed4a0466e9bdbbf1a7f6103c6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3de7482682304e00b18c68ebffb19f78_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iceb0cdafe9d44f85a2de864face16fef_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if41bc213fa8343d59b436514629c5506_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i76762f7f0d2c450d89d3f32990898187_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i26ff5d65efbd4393a5a6f50b163b1890_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">idxx:OtherAsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia347a126d78942fbbf80ff326e0aa2a5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">idxx:OtherAsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8ffc4cfd2c574feda0ea3ae4daaa562c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4a25163d8a7f45b78b59192fe48c8632_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1bc42ef3733b4728851d7a59ec0cfb20_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i86eb4694a98b40318766c041f67be8c5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ieeaf8edb07e74b67a220042fa77426c6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i206dbd1506c344a7b46d2edcee18de52_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2258666cd26e4775980e24a9d689b0c1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">idxx:EquityMutualFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i787da85c3dea4d1b8cbac83c56d8a8c7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">idxx:EquityMutualFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib92b086f14c04b4cafa21f8ec54f598a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">idxx:EquityMutualFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia0bf1cce14634a27bdb520f17b857f93_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">idxx:EquityMutualFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i224b783ac8494c7db115e134494538a7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idaf6c4c313dd4b59950dfdc2cebfd879_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i991a2d9a94c94f4ea20968ce0eeb2d8a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5defc11409fd41638fd2fde139f135f5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i02adea61db9c4d30a6aebbf9a1e7dbef_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ief2e06ac5412417d8e6cdbbfb30aaabe_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9bbbcba12a794c06878aa6883f1b3785_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i89ead21a0e784572a2136d6d2a0a1694_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i77cb9a89ff4949bb8bc7f0848c680d19_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">idxx:DeferredCompensationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6f5042c99e1f40d89108212d50d27e54_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">idxx:DeferredCompensationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if6298f7d8f2c4ee7926bc69c8be65de3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">idxx:DeferredCompensationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i335b527a64fd4bee959d70654d76f369_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">idxx:DeferredCompensationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2631d5bf8f7b4edf839dd6d1ffca5a4d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">idxx:ContingentPaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i83f6672993344e548b6db84a0a80f0da_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">idxx:ContingentPaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7c872711fc4b45339979cdb106678fe3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">idxx:ContingentPaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i58118ac9fa5b41048fd3e947040036e9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">idxx:ContingentPaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i608997adc8b645bcbaaf1f91a45b978b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4d3f919fc9944acb95a3e26a8e3a840b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie3de38ceae5e40a3a39f1ed4d9f73eb2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iccdf369f478f4fb8b529dbbf7bf67b64_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idca6b93b00b44f62bbc514784faff67d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">idxx:EquityMutualFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ife95a3279b8f411aa329c1a3be662fd3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">idxx:EquityMutualFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id52d5e57570042d09f53a0980b212d20_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">idxx:EquityMutualFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic08687ee74ce470e94fd105bae7ecbdc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">idxx:EquityMutualFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5a44d7e6553d48599a9003be65d3c761_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0dbc7dd68361493785eff3dfc58a1b14_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i315d962b616d493fb4d154dd8f021e44_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iae303435a98a42f1bc19b02e47518558_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7ded36872dbb4598a2981b577f9f6307_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i00732657e2a24ab78c424730ef55e468_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia3c0063a469d414bb87cadabfe0a1f2b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibd016343073542aaa9022d71864f8954_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ideb425f832b5493cadaae1d434f30a46_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">idxx:DeferredCompensationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i966b54bea1fd484184ebf43c56e298a7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">idxx:DeferredCompensationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i671303cff5aa4ae2b8d910b00202004d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">idxx:DeferredCompensationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i82b77254c5584204b9d7b6c3d673b43b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">idxx:DeferredCompensationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1902b241fd2f47aaaa617a00218e386f_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia1ef4a96731942908ce11fe9891aa0bf_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id9c53b6812ef44e0a021ef872c3e03e2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i12d3943c8fa0485b86f83616b4c036c1_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie463159bdbe0401fa1699ea9bbc087e7_I20150630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">idxx:SeriesCSeniorNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-06-30</instant>
        </period>
    </context>
    <context id="i78c0899cc8ce4403916f4aed0daa467b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i500dd303994d474bb3c6133348ce968f_D20230630-20230630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-30</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="ied1674e5cf1c49dab027aef8b772a006_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">idxx:CrossCurrencyInterestRateContract1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i29716f7451ce47209ffc3a126855c5bc_D20250618-20250618">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">idxx:CrossCurrencyInterestRateContract1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-18</startDate>
            <endDate>2025-06-18</endDate>
        </period>
    </context>
    <context id="i2d594a7833ec49b39f9b6d981b10a581_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id2a5f0696ab0404987ffb0a495402d7d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2c94572bec9745c49286936d60cee01c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i545077a6c3224507841852d11c8c9273_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibfce4063123c459eb84ed75e6fc79108_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iacbb16db3cb7452eb84960f47dc683ab_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i050978c75e2a45678abaff399b9bc5f6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie4698c4affbf4e699d54f34e5350d605_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i06a7e9fd40ce477ebb37684aa46d2543_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie64c1bfe251d4ea8a0ed2f0eea68ad6d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i22e9c32bb1ff4a549672a6a6a514fca9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1e5cf4395f024a8996343fcdfd9b3ca3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i286b8b14cd394335903921c6ba48d7f5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i91aaaf38003044fe91000cefb4286f16_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie944714e2148495fabc8b885bf09a852_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i051a71adeb9449eea0629393ed4795bc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">idxx:ForeignCurrencyBorrowingsDesignatedAsNetInvestmentHedgeOnBalanceSheetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i53807fb41e524bf69fec4117ad94a99b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">idxx:ForeignCurrencyBorrowingsDesignatedAsNetInvestmentHedgeOnBalanceSheetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib94d76d2a4f64ef8baf558bb1ad20c66_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i00c84acd109f46f4b2185c4801aa483a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:AccumulatedNetGainLossFromCashFlowHedgesForeignCurrencyExchangeContractsIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i516b4d9fd6fd4bb08abfd83a2b8ece20_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:AccumulatedNetGainLossFromNetInvestmentHedgesEuroDenominatedNotesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7b7ca21c16c34b8ebd18b0be7aa71fb1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:AccumulatedNetGainLossFromNetInvestmentHedgesCrossCurrencySwapsIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6aa0f83e00f94d788fc79a84dd2ef035_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i72ee32005bc94787a60e211d2b2aaa25_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i142bd154aa264e73939304fcd4c000c4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i72130b38c837460c9d490b3337d85e4d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:AccumulatedNetGainLossFromCashFlowHedgesForeignCurrencyExchangeContractsIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6870132d22054c5ebea0784212917113_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:AccumulatedNetGainLossFromNetInvestmentHedgesEuroDenominatedNotesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib3230b72e1154329a7f1a763ed0a1187_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:AccumulatedNetGainLossFromNetInvestmentHedgesCrossCurrencySwapsIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i03c7f98144624caeae57bd38fd0dd2a5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iea843d40d1ac442bba04f284af6399c9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3a978f3211e44df89ba9cd591258b169_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:AccumulatedNetGainLossFromCashFlowHedgesForeignCurrencyExchangeContractsIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2758281c7e1d44f1bc14207e44f8c0d7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:AccumulatedNetGainLossFromNetInvestmentHedgesEuroDenominatedNotesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iee2ff9304f8843b881a4c91cf1c6c997_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:AccumulatedNetGainLossFromNetInvestmentHedgesCrossCurrencySwapsIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i66e22c6b00494e2c8ccec8824592cb57_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if3d475356743442ba6915b1578a8771f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4d04bcb41a5b4086b6a2d38ce5f3b1a9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="icd5c0e3eaafc4cd3b022efb186592847_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:AccumulatedNetGainLossFromCashFlowHedgesForeignCurrencyExchangeContractsIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic61a4aba587c4549ba286bb3f06809be_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:AccumulatedNetGainLossFromNetInvestmentHedgesEuroDenominatedNotesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4a726385a3934ca297a4094723c83a69_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:AccumulatedNetGainLossFromNetInvestmentHedgesCrossCurrencySwapsIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if975ef26add547cc8029bf3cfcc205a4_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic1cfcd32b9eb44fc909c66daaa2fdc89_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia1e09d47b7c249178ff89343c0d5d024_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:AccumulatedNetGainLossFromCashFlowHedgesForeignCurrencyExchangeContractsIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2708e84b292c4f1bafc45174e5905b07_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:AccumulatedNetGainLossFromNetInvestmentHedgesEuroDenominatedNotesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i78635773a43a47999ed10eb8f309ed8a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:AccumulatedNetGainLossFromNetInvestmentHedgesCrossCurrencySwapsIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifa324d754a4d4cb0ab3eb052f773e75e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2aefce1f274544f1b2e978eb3e0fa0dc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie311c88fa22749e2b4cf06d52ec95566_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:AccumulatedNetGainLossFromCashFlowHedgesForeignCurrencyExchangeContractsIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6de86e101cec44aa84d8d1454d201a7f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:AccumulatedNetGainLossFromCashFlowHedgesForeignCurrencyExchangeContractsIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if8ae9e76f2d44f91afd70c49049644e1_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">idxx:AccumulatedNetGainLossFromCashFlowHedgesForeignCurrencyExchangeContractsIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id7c4b2e2ed354c54b264719bdf6db254_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="idxx:RetirementAndIncentiveSavingsPlanAxis">idxx:FourZeroOneKPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1c65cec1a82840efbc15a4b904412850_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="idxx:RetirementAndIncentiveSavingsPlanAxis">idxx:FourZeroOneKPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ibbe59bdb4621433ca1dedcd48056713a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
            <segment>
                <xbrldi:explicitMember dimension="idxx:RetirementAndIncentiveSavingsPlanAxis">idxx:FourZeroOneKPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="segment">
        <measure>idxx:segment</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV80L2ZyYWc6ZWM4ZDU0ZTJmOGVjNGQ1NjgyZTQ1YmJkOTRkYWMzMzUvdGFibGU6OTdhNDg3ZjA2MzBlNDQ1Mzg4ZjRkNzU5ZjBiMTcxZGQvdGFibGVyYW5nZTo5N2E0ODdmMDYzMGU0NDUzODhmNGQ3NTlmMGIxNzFkZF8zLTEtMS0xLTA_e6301fcf-81b1-407c-bca3-37def8e7b962">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV80L2ZyYWc6ZWM4ZDU0ZTJmOGVjNGQ1NjgyZTQ1YmJkOTRkYWMzMzUvdGFibGU6OTdhNDg3ZjA2MzBlNDQ1Mzg4ZjRkNzU5ZjBiMTcxZGQvdGFibGVyYW5nZTo5N2E0ODdmMDYzMGU0NDUzODhmNGQ3NTlmMGIxNzFkZF80LTEtMS0xLTA_ca45dcb0-f67c-4c5e-81c6-c622471f7fbe">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV80L2ZyYWc6ZWM4ZDU0ZTJmOGVjNGQ1NjgyZTQ1YmJkOTRkYWMzMzUvdGFibGU6OTdhNDg3ZjA2MzBlNDQ1Mzg4ZjRkNzU5ZjBiMTcxZGQvdGFibGVyYW5nZTo5N2E0ODdmMDYzMGU0NDUzODhmNGQ3NTlmMGIxNzFkZF81LTEtMS0xLTA_edacf6ee-f0c7-4530-996c-8cc8e691a766">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityRegistrantName
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV80L2ZyYWc6ZWM4ZDU0ZTJmOGVjNGQ1NjgyZTQ1YmJkOTRkYWMzMzUvdGFibGU6OTdhNDg3ZjA2MzBlNDQ1Mzg4ZjRkNzU5ZjBiMTcxZGQvdGFibGVyYW5nZTo5N2E0ODdmMDYzMGU0NDUzODhmNGQ3NTlmMGIxNzFkZF82LTEtMS0xLTA_d344e9dd-ce2a-4298-a344-18128164bde8">IDEXX LABORATORIES INC /DE</dei:EntityRegistrantName>
    <dei:EntityCentralIndexKey
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV80L2ZyYWc6ZWM4ZDU0ZTJmOGVjNGQ1NjgyZTQ1YmJkOTRkYWMzMzUvdGFibGU6OTdhNDg3ZjA2MzBlNDQ1Mzg4ZjRkNzU5ZjBiMTcxZGQvdGFibGVyYW5nZTo5N2E0ODdmMDYzMGU0NDUzODhmNGQ3NTlmMGIxNzFkZF83LTEtMS0xLTA_0f8276a4-e799-4a56-a84b-fe7d930802f7">0000874716</dei:EntityCentralIndexKey>
    <idxx:ExtendedProductWarrantyTerm
      contextRef="i35fada0f29454b9e9fbe5fa23ce2f2e7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzQ4MjE_1e3581e2-aa87-4799-8610-c43eba500df3">P1Y</idxx:ExtendedProductWarrantyTerm>
    <idxx:ExtendedProductWarrantyTerm
      contextRef="id896191bdc6d41d1afbef82d66327428_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzIzNTc2_f9986b18-206a-41dd-850a-8be4c0938fc3">P5Y</idxx:ExtendedProductWarrantyTerm>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="ia8d9c432d3bf4b74adffb2d189372886_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODEvZnJhZzoyMTM0ZDg3OGJjZTE0MWQ2YTk5MDRiZTI3YTljMTM0Ny90YWJsZTpjNWJhYWYwMTY5YWI0ODAwYmI5ODIyZTU1MDljOWIwNS90YWJsZXJhbmdlOmM1YmFhZjAxNjlhYjQ4MDBiYjk4MjJlNTUwOWM5YjA1XzItMS0xLTEtMA_b2b1751e-51e6-4a7e-bbd6-0c8faf837743">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="id18052a9bc8947e885971777f75a622b_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODEvZnJhZzoyMTM0ZDg3OGJjZTE0MWQ2YTk5MDRiZTI3YTljMTM0Ny90YWJsZTpjNWJhYWYwMTY5YWI0ODAwYmI5ODIyZTU1MDljOWIwNS90YWJsZXJhbmdlOmM1YmFhZjAxNjlhYjQ4MDBiYjk4MjJlNTUwOWM5YjA1XzItMi0xLTEtMA_2412c471-c7b4-4763-bc4f-67f2a39a69ff">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i489a306049d8454da4686e43ac9f9be5_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODEvZnJhZzoyMTM0ZDg3OGJjZTE0MWQ2YTk5MDRiZTI3YTljMTM0Ny90YWJsZTpjNWJhYWYwMTY5YWI0ODAwYmI5ODIyZTU1MDljOWIwNS90YWJsZXJhbmdlOmM1YmFhZjAxNjlhYjQ4MDBiYjk4MjJlNTUwOWM5YjA1XzItMy0xLTEtMA_798c85ef-3b4f-46f2-bcaf-fc1d12210417">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="iee7069d3c7944d9d8e2527acff1fbc06_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODEvZnJhZzoyMTM0ZDg3OGJjZTE0MWQ2YTk5MDRiZTI3YTljMTM0Ny90YWJsZTpjNWJhYWYwMTY5YWI0ODAwYmI5ODIyZTU1MDljOWIwNS90YWJsZXJhbmdlOmM1YmFhZjAxNjlhYjQ4MDBiYjk4MjJlNTUwOWM5YjA1XzItNC0xLTEtMA_8b88f6b1-79b2-4bd3-8c56-421d4a6821c9">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i047ec28985a54ca496f585918ccf62f6_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODEvZnJhZzoyMTM0ZDg3OGJjZTE0MWQ2YTk5MDRiZTI3YTljMTM0Ny90YWJsZTpjNWJhYWYwMTY5YWI0ODAwYmI5ODIyZTU1MDljOWIwNS90YWJsZXJhbmdlOmM1YmFhZjAxNjlhYjQ4MDBiYjk4MjJlNTUwOWM5YjA1XzItNS0xLTEtMA_6ecee727-b857-43ac-a346-4c5d1a816848"
      xsi:nil="true"/>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i3f8679f022804acba3547f27b82749ee_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODEvZnJhZzoyMTM0ZDg3OGJjZTE0MWQ2YTk5MDRiZTI3YTljMTM0Ny90YWJsZTpjNWJhYWYwMTY5YWI0ODAwYmI5ODIyZTU1MDljOWIwNS90YWJsZXJhbmdlOmM1YmFhZjAxNjlhYjQ4MDBiYjk4MjJlNTUwOWM5YjA1XzMtMS0xLTEtMA_fed92f74-3318-40f5-95cc-a96959949376">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="ia1b14ac41fb14c2d8d6ba017fa4e925e_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODEvZnJhZzoyMTM0ZDg3OGJjZTE0MWQ2YTk5MDRiZTI3YTljMTM0Ny90YWJsZTpjNWJhYWYwMTY5YWI0ODAwYmI5ODIyZTU1MDljOWIwNS90YWJsZXJhbmdlOmM1YmFhZjAxNjlhYjQ4MDBiYjk4MjJlNTUwOWM5YjA1XzMtMi0xLTEtMA_b1365d85-eb03-4768-b6f0-adc21a7aaae7">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="icb7e410e248e43c994cb93d2f03fbf8f_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODEvZnJhZzoyMTM0ZDg3OGJjZTE0MWQ2YTk5MDRiZTI3YTljMTM0Ny90YWJsZTpjNWJhYWYwMTY5YWI0ODAwYmI5ODIyZTU1MDljOWIwNS90YWJsZXJhbmdlOmM1YmFhZjAxNjlhYjQ4MDBiYjk4MjJlNTUwOWM5YjA1XzMtMy0xLTEtMA_e1ea477e-b77e-4d35-9da2-cc12436f7449">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="ie2230e0e134c41099416ecb0514e3a3c_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODEvZnJhZzoyMTM0ZDg3OGJjZTE0MWQ2YTk5MDRiZTI3YTljMTM0Ny90YWJsZTpjNWJhYWYwMTY5YWI0ODAwYmI5ODIyZTU1MDljOWIwNS90YWJsZXJhbmdlOmM1YmFhZjAxNjlhYjQ4MDBiYjk4MjJlNTUwOWM5YjA1XzMtNC0xLTEtMA_929d1ebb-af21-4771-a85e-e4fb3d0d7a44">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i3e0eda093e4c442d97a50489871ee0c6_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODEvZnJhZzoyMTM0ZDg3OGJjZTE0MWQ2YTk5MDRiZTI3YTljMTM0Ny90YWJsZTpjNWJhYWYwMTY5YWI0ODAwYmI5ODIyZTU1MDljOWIwNS90YWJsZXJhbmdlOmM1YmFhZjAxNjlhYjQ4MDBiYjk4MjJlNTUwOWM5YjA1XzMtNS0xLTEtMA_a3c5585d-4222-400a-ad6e-243f1cbe82cb"
      xsi:nil="true"/>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i76e3709ae6e04372b5824637c99c55ce_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODEvZnJhZzoyMTM0ZDg3OGJjZTE0MWQ2YTk5MDRiZTI3YTljMTM0Ny90YWJsZTpjNWJhYWYwMTY5YWI0ODAwYmI5ODIyZTU1MDljOWIwNS90YWJsZXJhbmdlOmM1YmFhZjAxNjlhYjQ4MDBiYjk4MjJlNTUwOWM5YjA1XzQtMS0xLTEtMA_c38eb3af-98fe-4502-ae06-d6ce05ccb86b">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="ide72157b20624cbba3e378503b944506_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODEvZnJhZzoyMTM0ZDg3OGJjZTE0MWQ2YTk5MDRiZTI3YTljMTM0Ny90YWJsZTpjNWJhYWYwMTY5YWI0ODAwYmI5ODIyZTU1MDljOWIwNS90YWJsZXJhbmdlOmM1YmFhZjAxNjlhYjQ4MDBiYjk4MjJlNTUwOWM5YjA1XzQtMi0xLTEtMA_e2d490b2-6094-4aad-8bb6-8ff9d8d8d446">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i8af8821a5a8e4e06898dabdea6965ee3_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODEvZnJhZzoyMTM0ZDg3OGJjZTE0MWQ2YTk5MDRiZTI3YTljMTM0Ny90YWJsZTpjNWJhYWYwMTY5YWI0ODAwYmI5ODIyZTU1MDljOWIwNS90YWJsZXJhbmdlOmM1YmFhZjAxNjlhYjQ4MDBiYjk4MjJlNTUwOWM5YjA1XzQtMy0xLTEtMA_b898e5c2-3782-4948-b237-8bd7214838a6">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i865e2c5df39b4cecb1d900db1ae6ca7d_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODEvZnJhZzoyMTM0ZDg3OGJjZTE0MWQ2YTk5MDRiZTI3YTljMTM0Ny90YWJsZTpjNWJhYWYwMTY5YWI0ODAwYmI5ODIyZTU1MDljOWIwNS90YWJsZXJhbmdlOmM1YmFhZjAxNjlhYjQ4MDBiYjk4MjJlNTUwOWM5YjA1XzQtNC0xLTEtMA_6b055acb-acb9-4690-b65a-bf14993d3754">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="if8efddd0307c4f6c9b1fab4c82f7cd7b_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODEvZnJhZzoyMTM0ZDg3OGJjZTE0MWQ2YTk5MDRiZTI3YTljMTM0Ny90YWJsZTpjNWJhYWYwMTY5YWI0ODAwYmI5ODIyZTU1MDljOWIwNS90YWJsZXJhbmdlOmM1YmFhZjAxNjlhYjQ4MDBiYjk4MjJlNTUwOWM5YjA1XzQtNS0xLTEtMA_b37ba342-8004-476e-b83a-b2d11cd9a29d"
      xsi:nil="true"/>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i0e53a7345431421d90c84f0714010ab8_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODEvZnJhZzoyMTM0ZDg3OGJjZTE0MWQ2YTk5MDRiZTI3YTljMTM0Ny90YWJsZTpjNWJhYWYwMTY5YWI0ODAwYmI5ODIyZTU1MDljOWIwNS90YWJsZXJhbmdlOmM1YmFhZjAxNjlhYjQ4MDBiYjk4MjJlNTUwOWM5YjA1XzUtMS0xLTEtMA_59822875-22e5-4793-87b2-fd135bfb8f38">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i26a9c61e7add4db7b09dd7228e5adf11_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODEvZnJhZzoyMTM0ZDg3OGJjZTE0MWQ2YTk5MDRiZTI3YTljMTM0Ny90YWJsZTpjNWJhYWYwMTY5YWI0ODAwYmI5ODIyZTU1MDljOWIwNS90YWJsZXJhbmdlOmM1YmFhZjAxNjlhYjQ4MDBiYjk4MjJlNTUwOWM5YjA1XzUtMi0xLTEtMA_9fef5566-be30-4e03-b95a-43711818522d">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i552f56ee344349d0a8fe803f1d4ac028_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODEvZnJhZzoyMTM0ZDg3OGJjZTE0MWQ2YTk5MDRiZTI3YTljMTM0Ny90YWJsZTpjNWJhYWYwMTY5YWI0ODAwYmI5ODIyZTU1MDljOWIwNS90YWJsZXJhbmdlOmM1YmFhZjAxNjlhYjQ4MDBiYjk4MjJlNTUwOWM5YjA1XzUtMy0xLTEtMA_2c7339aa-6b7c-473d-9d44-1b1fbc99f9ae">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="ia21b4eae913c4602899f11b240ecd020_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODEvZnJhZzoyMTM0ZDg3OGJjZTE0MWQ2YTk5MDRiZTI3YTljMTM0Ny90YWJsZTpjNWJhYWYwMTY5YWI0ODAwYmI5ODIyZTU1MDljOWIwNS90YWJsZXJhbmdlOmM1YmFhZjAxNjlhYjQ4MDBiYjk4MjJlNTUwOWM5YjA1XzUtNC0xLTEtMA_479dd2aa-dcd6-4790-a76f-b26a13baf80d">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i8e6515d33c104d37893035bf37f096ad_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODEvZnJhZzoyMTM0ZDg3OGJjZTE0MWQ2YTk5MDRiZTI3YTljMTM0Ny90YWJsZTpjNWJhYWYwMTY5YWI0ODAwYmI5ODIyZTU1MDljOWIwNS90YWJsZXJhbmdlOmM1YmFhZjAxNjlhYjQ4MDBiYjk4MjJlNTUwOWM5YjA1XzUtNS0xLTEtMA_578439bd-f5fd-4b3e-b058-463b7d111e21"
      xsi:nil="true"/>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDgvZnJhZzo2YjI1NjU3MGQ2Y2M0ZTllYWY5MDBhYzk2ZTU2Yjg3My90YWJsZTpkMzgwNTNlNWU4ZTg0N2FhYWQ5MDI3M2UxMDAzMzM5MS90YWJsZXJhbmdlOmQzODA1M2U1ZThlODQ3YWFhZDkwMjczZTEwMDMzMzkxXzctMC0xLTEtMA_5d2faed1-a462-48ce-9b44-a109b44ef227">http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDgvZnJhZzo2YjI1NjU3MGQ2Y2M0ZTllYWY5MDBhYzk2ZTU2Yjg3My90YWJsZTpkMzgwNTNlNWU4ZTg0N2FhYWQ5MDI3M2UxMDAzMzM5MS90YWJsZXJhbmdlOmQzODA1M2U1ZThlODQ3YWFhZDkwMjczZTEwMDMzMzkxXzctMC0xLTEtMA_e4f554de-7131-4a19-8325-4f920319c89c">http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <dei:DocumentType
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGV4dHJlZ2lvbjo0ZTZiNWVlMjc2OWM0ZDgxOWNkZjVkN2FlZDlkMGQzN18zMzM3_aef457c6-3957-465f-afb2-446b9de6d1d2">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGFibGU6ZDA3OWI0MmRmMDMzNDI4Zjk3M2I4MTUyNGQ5ZDMxODMvdGFibGVyYW5nZTpkMDc5YjQyZGYwMzM0MjhmOTczYjgxNTI0ZDlkMzE4M18xLTAtMS0xLTA_1e9255eb-ae58-4009-af5e-85da8be253a4">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGV4dHJlZ2lvbjo0ZTZiNWVlMjc2OWM0ZDgxOWNkZjVkN2FlZDlkMGQzN18xMTY_531cec0c-c8bd-421c-8c13-214c1bea0ea1">2021-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGV4dHJlZ2lvbjo0ZTZiNWVlMjc2OWM0ZDgxOWNkZjVkN2FlZDlkMGQzN18xMTY_f09f3280-0a62-42f6-8083-8388d08479ca">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGFibGU6ZDlkNDc0NzZkZjA0NGNkYjhmZGU3MDIxMmM2ZDBiOTAvdGFibGVyYW5nZTpkOWQ0NzQ3NmRmMDQ0Y2RiOGZkZTcwMjEyYzZkMGI5MF8wLTAtMS0xLTA_59c797f4-5829-4b17-814c-cd85b2193c0b">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGV4dHJlZ2lvbjo0ZTZiNWVlMjc2OWM0ZDgxOWNkZjVkN2FlZDlkMGQzN18zMzQw_c1a9986d-965f-4c38-9416-e65f0769e1f1">0-19271</dei:EntityFileNumber>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGFibGU6ZjNjNzRmNGNkMjkwNGViMWJkNmU0NzlmMjFhZDhjN2MvdGFibGVyYW5nZTpmM2M3NGY0Y2QyOTA0ZWIxYmQ2ZTQ3OWYyMWFkOGM3Y18wLTAtMS0xLTA_ae206a52-606f-4aa4-85f6-d096d4508cd8">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGFibGU6ZjNjNzRmNGNkMjkwNGViMWJkNmU0NzlmMjFhZDhjN2MvdGFibGVyYW5nZTpmM2M3NGY0Y2QyOTA0ZWIxYmQ2ZTQ3OWYyMWFkOGM3Y18wLTMtMS0xLTA_c31f28ba-a2db-4d29-b489-8f8cd7915491">01-0393723</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGFibGU6ZjNjNzRmNGNkMjkwNGViMWJkNmU0NzlmMjFhZDhjN2MvdGFibGVyYW5nZTpmM2M3NGY0Y2QyOTA0ZWIxYmQ2ZTQ3OWYyMWFkOGM3Y18zLTAtMS0xLTA_a4835bec-6f16-458a-9bdb-8e0ded30b118">One IDEXX Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGFibGU6ZjNjNzRmNGNkMjkwNGViMWJkNmU0NzlmMjFhZDhjN2MvdGFibGVyYW5nZTpmM2M3NGY0Y2QyOTA0ZWIxYmQ2ZTQ3OWYyMWFkOGM3Y18zLTEtMS0xLTA_5577cbbe-014f-4775-9c89-2aed50e24580">Westbrook,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGFibGU6ZjNjNzRmNGNkMjkwNGViMWJkNmU0NzlmMjFhZDhjN2MvdGFibGVyYW5nZTpmM2M3NGY0Y2QyOTA0ZWIxYmQ2ZTQ3OWYyMWFkOGM3Y18zLTItMS0xLTA_a341fa25-07f2-4119-b50d-d7b3c4ce3402">ME</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGFibGU6ZjNjNzRmNGNkMjkwNGViMWJkNmU0NzlmMjFhZDhjN2MvdGFibGVyYW5nZTpmM2M3NGY0Y2QyOTA0ZWIxYmQ2ZTQ3OWYyMWFkOGM3Y18zLTMtMS0xLTA_2b6a0c95-922d-4413-b920-e8c109adc477">04092</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGV4dHJlZ2lvbjo0ZTZiNWVlMjc2OWM0ZDgxOWNkZjVkN2FlZDlkMGQzN18zMzQx_3ab02d48-c509-4819-b04d-1fe7b5726780">207</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGV4dHJlZ2lvbjo0ZTZiNWVlMjc2OWM0ZDgxOWNkZjVkN2FlZDlkMGQzN18zMzMy_0264ef35-8b19-4fdb-b513-44bd5e97d2b4">556-0300</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGFibGU6ZTVmYmZjNDgwYzRiNGYxYWJkY2IxMjQwMWIzMTIyMzkvdGFibGVyYW5nZTplNWZiZmM0ODBjNGI0ZjFhYmRjYjEyNDAxYjMxMjIzOV8xLTAtMS0xLTA_4ac5026c-4796-4ae8-96a1-cec1b334cd76">Common Stock, $0.10 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGFibGU6ZTVmYmZjNDgwYzRiNGYxYWJkY2IxMjQwMWIzMTIyMzkvdGFibGVyYW5nZTplNWZiZmM0ODBjNGI0ZjFhYmRjYjEyNDAxYjMxMjIzOV8xLTEtMS0xLTA_24c5a157-67cf-42ed-88b2-f346a4d774b8">IDXX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGFibGU6ZTVmYmZjNDgwYzRiNGYxYWJkY2IxMjQwMWIzMTIyMzkvdGFibGVyYW5nZTplNWZiZmM0ODBjNGI0ZjFhYmRjYjEyNDAxYjMxMjIzOV8xLTItMS0xLTA_6e8e41a6-a14d-4709-9612-aa5ef5248f55">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGV4dHJlZ2lvbjo0ZTZiNWVlMjc2OWM0ZDgxOWNkZjVkN2FlZDlkMGQzN18zMzMz_397a4b24-a718-44cf-84d9-562fc21c23c0">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGV4dHJlZ2lvbjo0ZTZiNWVlMjc2OWM0ZDgxOWNkZjVkN2FlZDlkMGQzN18zMzM0_934beb28-b076-4756-af41-eef0611d65f0">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGV4dHJlZ2lvbjo0ZTZiNWVlMjc2OWM0ZDgxOWNkZjVkN2FlZDlkMGQzN18zMzM5_cdeeb6f3-82a7-446c-b53f-ff517d04508b">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGV4dHJlZ2lvbjo0ZTZiNWVlMjc2OWM0ZDgxOWNkZjVkN2FlZDlkMGQzN18zMzM1_1c0793df-c9b0-416d-84d9-5abf646447cc">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGFibGU6NzFhOTk1Nzc2NGFmNGQ4N2I4Yjg4MWJkNTcxZTdkZGEvdGFibGVyYW5nZTo3MWE5OTU3NzY0YWY0ZDg3YjhiODgxYmQ1NzFlN2RkYV8wLTAtMS0xLTA_c9ee7fca-b86d-4fb3-ad3a-c357639dd153">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGFibGU6NzFhOTk1Nzc2NGFmNGQ4N2I4Yjg4MWJkNTcxZTdkZGEvdGFibGVyYW5nZTo3MWE5OTU3NzY0YWY0ZDg3YjhiODgxYmQ1NzFlN2RkYV8xLTMtMS0xLTA_28e5f661-bf3e-459e-80f1-e123e1a45931">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGFibGU6NzFhOTk1Nzc2NGFmNGQ4N2I4Yjg4MWJkNTcxZTdkZGEvdGFibGVyYW5nZTo3MWE5OTU3NzY0YWY0ZDg3YjhiODgxYmQ1NzFlN2RkYV8yLTMtMS0xLTA_b67048cf-1e12-463f-8c37-7dfb5beb46d8">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGV4dHJlZ2lvbjo0ZTZiNWVlMjc2OWM0ZDgxOWNkZjVkN2FlZDlkMGQzN18zMzQy_5e0b5be0-174b-4b1f-8b62-d30eb6c3e6cf">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGV4dHJlZ2lvbjo0ZTZiNWVlMjc2OWM0ZDgxOWNkZjVkN2FlZDlkMGQzN18zMzQz_25a69deb-98cd-47ed-8334-0a8374827ca4">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="i309abd36f89849cfae9056eea2c66b2e_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGV4dHJlZ2lvbjo0ZTZiNWVlMjc2OWM0ZDgxOWNkZjVkN2FlZDlkMGQzN18yODM3_110e2fd1-aa27-4082-ae3e-9dd08cc5f3e0"
      unitRef="usd">53417914936</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i36ae306a96da42d1a0ef962db0aad1ea_I20220202"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGV4dHJlZ2lvbjo0ZTZiNWVlMjc2OWM0ZDgxOWNkZjVkN2FlZDlkMGQzN18zMDIw_ff0ded5b-ef04-4386-bc34-a820464a7cbd"
      unitRef="shares">84249085</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xL2ZyYWc6NGU2YjVlZTI3NjljNGQ4MTljZGY1ZDdhZWQ5ZDBkMzcvdGV4dHJlZ2lvbjo0ZTZiNWVlMjc2OWM0ZDgxOWNkZjVkN2FlZDlkMGQzN18zMzM2_5af5e692-9d7b-4493-a63a-64a87eb06205">&lt;div style="margin-top:5pt;text-align:center;text-indent:20.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;DOCUMENTS INCORPORATED BY REFERENCE&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Part III&#x2014;Specifically identified portions of the Company&#x2019;s definitive Proxy Statement to be filed in connection with the Company&#x2019;s 2022 annual meeting of stockholders (the &#x201c;2022 Annual Meeting&#x201d;), to be held on May 11, 2022, are incorporated herein by referenc&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;e.&lt;/span&gt;&lt;/div&gt;</dei:DocumentsIncorporatedByReferenceTextBlock>
    <dei:AuditorFirmId
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNDgvZnJhZzo5Mjk5NDZhZTdlN2Y0OWU2YWYzMWE5Nzk0ZDZmZmRiZi90YWJsZTpkMzQ0ZThhNmI3MTY0YTA5YTFjZTk4OTg5ODNmNGYzZi90YWJsZXJhbmdlOmQzNDRlOGE2YjcxNjRhMDlhMWNlOTg5ODk4M2Y0ZjNmXzMtMC0xLTEtNDk2OTcvdGV4dHJlZ2lvbjo5MmJkNDRiNTRhY2Q0MzVlYmI3YWI0Yzk1NzFlNTA1ZV80OTQ3ODAyMzI1MTg4_55748079-f0e7-46fb-8eec-1592a1d929d9">238</dei:AuditorFirmId>
    <dei:AuditorName
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTEvZnJhZzo1NzYxNjUxMTUwNTA0ZThiYTUwN2EwYjBkNzVjZDdjZi90ZXh0cmVnaW9uOjU3NjE2NTExNTA1MDRlOGJhNTA3YTBiMGQ3NWNkN2NmXzY1OTcwNjk3ODU3NTY_7064828b-e8d0-4a15-9d85-7edd63a71a74">PricewaterhouseCoopers LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTEvZnJhZzo1NzYxNjUxMTUwNTA0ZThiYTUwN2EwYjBkNzVjZDdjZi90ZXh0cmVnaW9uOjU3NjE2NTExNTA1MDRlOGJhNTA3YTBiMGQ3NWNkN2NmXzY1OTcwNjk3ODU3NTg_b73ecc07-cc04-4687-bc8e-0f5ecaa93a88">Boston, Massachusetts</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzQtMS0xLTEtMA_0ab8889f-0746-4157-a6f5-b98c715f8f3f"
      unitRef="usd">144454000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzQtMy0xLTEtMA_59b8c571-c83d-4e12-9390-85e094799548"
      unitRef="usd">383928000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzUtMC0xLTEtMC90ZXh0cmVnaW9uOjMyMjNhMmY0OWJjMjQwNzNhMzVjMTlhYzgwZTIwNjA1XzQ0_17b9dc9c-acd5-4f2d-a4c3-cfc0d7560a32"
      unitRef="usd">5668000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzUtMC0xLTEtMC90ZXh0cmVnaW9uOjMyMjNhMmY0OWJjMjQwNzNhMzVjMTlhYzgwZTIwNjA1XzU5_431b0eb6-dab0-469f-8b3a-9d6860ff7044"
      unitRef="usd">6784000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzUtMS0xLTEtMA_6b71d3d7-9978-4a2c-ab7d-7b0932214ae4"
      unitRef="usd">368348000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzUtMy0xLTEtMA_aab449e9-f60a-4d72-9f22-537ab619eb34"
      unitRef="usd">331429000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzYtMS0xLTEtMA_bb414073-fe5d-4bc0-b89b-f57ce1965a5a"
      unitRef="usd">269030000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzYtMy0xLTEtMA_ac6db532-5d9d-46fb-a49b-39690a5a8780"
      unitRef="usd">209873000</us-gaap:InventoryNet>
    <us-gaap:OtherAssetsCurrent
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzctMS0xLTEtMA_d27a2d32-1d99-49a6-a000-c2a9d491feea"
      unitRef="usd">173823000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzctMy0xLTEtMA_9a1f3b39-595f-40d6-8f61-5a290bfba772"
      unitRef="usd">137508000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzgtMS0xLTEtMA_91eaf403-cc3f-4024-83a0-900f530a28cb"
      unitRef="usd">955655000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzgtMy0xLTEtMA_83a0779a-3150-4c2e-bd6b-fc040845273c"
      unitRef="usd">1062738000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzEwLTEtMS0xLTA_5490efd4-f9ca-4458-874b-64ac1271572d"
      unitRef="usd">587667000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzEwLTMtMS0xLTA_380a2b3b-ede0-4ff6-9282-6448f7898243"
      unitRef="usd">555167000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzExLTEtMS0xLTA_6947c108-4f70-4be0-b3ab-00866fff8089"
      unitRef="usd">105101000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzExLTMtMS0xLTA_6efa60a7-b0b3-4ce6-8bc7-848e9e7eab8b"
      unitRef="usd">91171000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzEyLTEtMS0xLTA_ec3c7f8d-d4f4-421d-b063-737569ab6481"
      unitRef="usd">359345000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzEyLTMtMS0xLTA_d143c37b-7281-4fea-bcb5-c0ea2e3dd859"
      unitRef="usd">243347000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzEzLTEtMS0xLTA_e3330425-5b1c-4855-bccd-ec71fb1c2af7"
      unitRef="usd">99035000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzEzLTMtMS0xLTA_34cb3589-7e6e-47dc-96bb-9547b535aa30"
      unitRef="usd">52543000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzE0LTEtMS0xLTA_d19924ae-e02c-4ae0-a8c0-1366262aacbc"
      unitRef="usd">330400000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzE0LTMtMS0xLTA_c4ee1e92-3207-460a-b3ea-c6ec9e69c70b"
      unitRef="usd">289595000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzE1LTEtMS0xLTA_61e7a4e3-5d92-4c26-8601-4bceb2309622"
      unitRef="usd">1481548000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzE1LTMtMS0xLTA_feac8879-26ce-4d7a-8ca5-0a0d079922fa"
      unitRef="usd">1231823000</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzE2LTEtMS0xLTA_a21d390f-55ed-4b33-b1ba-84d39a8732fd"
      unitRef="usd">2437203000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzE2LTMtMS0xLTA_71467f79-586b-4f14-a158-d16db6a4e763"
      unitRef="usd">2294561000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzIwLTEtMS0xLTA_6ca45926-1cad-45fd-8198-941e48bfadef"
      unitRef="usd">116140000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzIwLTMtMS0xLTA_643f7208-baa5-40cf-a67e-5519cb913f3f"
      unitRef="usd">74558000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzIxLTEtMS0xLTA_1392a55d-02e9-484f-b19a-eba75f24a614"
      unitRef="usd">458909000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzIxLTMtMS0xLTA_a7dff9ef-d398-4f09-8888-59cf6dcc1df2"
      unitRef="usd">415648000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:LinesOfCreditCurrent
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzIyLTEtMS0xLTA_946d5f47-e365-4d56-8109-61b8c048db9f"
      unitRef="usd">73500000</us-gaap:LinesOfCreditCurrent>
    <us-gaap:LinesOfCreditCurrent
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzIyLTMtMS0xLTA_e4c4c85d-dc86-4d8f-bb1f-0c6f74417d31"
      unitRef="usd">0</us-gaap:LinesOfCreditCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzIzLTEtMS0xLTA_90f3fc4a-f74a-4eeb-8db1-49db3c16126b"
      unitRef="usd">74996000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzIzLTMtMS0xLTA_94c84fb7-96fc-46f4-afba-b66832854d22"
      unitRef="usd">49988000</us-gaap:LongTermDebtCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzI0LTEtMS0xLTA_5cc61e43-f2fe-46a9-997b-11e0a350d50f"
      unitRef="usd">40034000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzI0LTMtMS0xLTA_7b715940-e1d6-4b44-b458-5aec9ee96e54"
      unitRef="usd">42567000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzI1LTEtMS0xLTA_4196313d-0d9d-426b-8704-d67117947b1b"
      unitRef="usd">763579000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzI1LTMtMS0xLTA_97a2bfa4-7dd6-4e07-867e-91fb2a2ce08e"
      unitRef="usd">582761000</us-gaap:LiabilitiesCurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzI3LTEtMS0xLTA_ab898cd7-8580-434c-b5e3-1c14b6ee8ca3"
      unitRef="usd">8935000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzI3LTMtMS0xLTA_d1844b8e-44ee-4b01-9751-42cc7d22fec3"
      unitRef="usd">11707000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzI4LTEtMS0xLTA_1a23176a-038e-4619-9dd7-a007f8de6e90"
      unitRef="usd">775205000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzI4LTMtMS0xLTA_537fba2c-0f6e-474d-b9c4-744bc15fdf72"
      unitRef="usd">858492000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzI5LTEtMS0xLTA_aaf1dd6c-fd0b-434d-9b21-fad112c09c58"
      unitRef="usd">41174000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzI5LTMtMS0xLTA_290f2700-242e-44c0-baec-9c5a4cbdb3f8"
      unitRef="usd">46163000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzMwLTEtMS0xLTA_eb82ea0d-a786-44ff-83dc-77b6fade8792"
      unitRef="usd">87377000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzMwLTMtMS0xLTA_4f99a029-2f2d-4e0a-83af-beebe5109ee7"
      unitRef="usd">77039000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzMxLTEtMS0xLTA_5238b733-9e15-442d-b4b7-f50021855573"
      unitRef="usd">70941000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzMxLTMtMS0xLTA_62216a61-9ffc-4a56-9012-5bb37dc94d19"
      unitRef="usd">85604000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzMyLTEtMS0xLTA_7d14d78b-45e0-4024-8584-4b7b65df5e2d"
      unitRef="usd">983632000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzMyLTMtMS0xLTA_965f4b2a-d071-4b9e-84f8-51643fb23c79"
      unitRef="usd">1079005000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzMzLTEtMS0xLTA_86933f8a-a046-4636-981b-552851c44964"
      unitRef="usd">1747211000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzMzLTMtMS0xLTA_f70e270f-d8e2-48e3-b25a-6aec6cf5ea3d"
      unitRef="usd">1661766000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzM1LTEtMS0xLTA_0797c32c-a822-431d-a453-c55addc21c9c"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzM1LTMtMS0xLTA_132eac87-2b4b-491f-96f0-a884e14a9575"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzM4LTAtMS0xLTAvdGV4dHJlZ2lvbjpjMGE2YTI4NmMwOGU0MWFiOTE5MjQyYzRiOTIwZjhmYV8xOA_9f0430ce-186f-44ed-9952-741a20f9f16c"
      unitRef="usdPerShare">0.10</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzM4LTAtMS0xLTAvdGV4dHJlZ2lvbjpjMGE2YTI4NmMwOGU0MWFiOTE5MjQyYzRiOTIwZjhmYV8xOA_f30eafc3-4904-43e9-b0f9-47845a19abfa"
      unitRef="usdPerShare">0.10</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzM4LTAtMS0xLTAvdGV4dHJlZ2lvbjpjMGE2YTI4NmMwOGU0MWFiOTE5MjQyYzRiOTIwZjhmYV80NA_0a0fd88a-0cac-4dd0-9089-21ae48ebfc44"
      unitRef="shares">120000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzM4LTAtMS0xLTAvdGV4dHJlZ2lvbjpjMGE2YTI4NmMwOGU0MWFiOTE5MjQyYzRiOTIwZjhmYV80NA_b4a15684-fed9-45b8-a802-558439d14dcc"
      unitRef="shares">120000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzM4LTAtMS0xLTAvdGV4dHJlZ2lvbjpjMGE2YTI4NmMwOGU0MWFiOTE5MjQyYzRiOTIwZjhmYV82Mw_0dc82297-af16-49fd-952a-0ed5cf9deea2"
      unitRef="shares">106878000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzM4LTAtMS0xLTAvdGV4dHJlZ2lvbjpjMGE2YTI4NmMwOGU0MWFiOTE5MjQyYzRiOTIwZjhmYV84NQ_bd4bc1d4-5d33-4060-867e-91fec41a8428"
      unitRef="shares">106457000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzM4LTAtMS0xLTAvdGV4dHJlZ2lvbjpjMGE2YTI4NmMwOGU0MWFiOTE5MjQyYzRiOTIwZjhmYV8xMTc_dd3d1a0c-5a07-495f-9c6e-ed84663a7f8d"
      unitRef="shares">84562000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzM4LTAtMS0xLTAvdGV4dHJlZ2lvbjpjMGE2YTI4NmMwOGU0MWFiOTE5MjQyYzRiOTIwZjhmYV8xMzk_f39f6259-dada-4ee8-9fa7-d8c50b195b79"
      unitRef="shares">85449000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzM4LTEtMS0xLTA_8ef33d2c-394e-456c-b4bc-91d4c287ddd5"
      unitRef="usd">10688000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzM4LTMtMS0xLTA_ec8cffc1-ca10-41e4-adae-caf4f6cbf3c3"
      unitRef="usd">10646000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzM5LTEtMS0xLTA_46ff2846-0555-4552-8bf6-d4bc411c20f7"
      unitRef="usd">1377320000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzM5LTMtMS0xLTA_c34462e1-9340-4806-9fcf-381020b0b184"
      unitRef="usd">1294849000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:CommonStockOtherSharesOutstanding
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzQwLTAtMS0xLTAvdGV4dHJlZ2lvbjo5ZDRlMmVlNjliODA0ODRlODI5YjQxMjgzNDI4ODUxZF8zOQ_1c1b9930-5053-4226-915a-7ad6d7bae8ea"
      unitRef="shares">90000</us-gaap:CommonStockOtherSharesOutstanding>
    <us-gaap:CommonStockOtherSharesOutstanding
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzQwLTAtMS0xLTAvdGV4dHJlZ2lvbjo5ZDRlMmVlNjliODA0ODRlODI5YjQxMjgzNDI4ODUxZF82MA_d2f04924-b8a1-41a7-b735-be1f6b5e5c46"
      unitRef="shares">87000</us-gaap:CommonStockOtherSharesOutstanding>
    <us-gaap:CommonStockOtherValueOutstanding
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzQwLTEtMS0xLTA_62fb1057-5157-4f29-913f-ed40f1dc2168"
      unitRef="usd">5719000</us-gaap:CommonStockOtherValueOutstanding>
    <us-gaap:CommonStockOtherValueOutstanding
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzQwLTMtMS0xLTA_a60fc317-62cf-4d4a-b409-5a2de8509d7b"
      unitRef="usd">4503000</us-gaap:CommonStockOtherValueOutstanding>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzQxLTEtMS0xLTA_2a93bc7f-e300-4947-9fc9-e1c374daf487"
      unitRef="usd">2920440000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzQxLTMtMS0xLTA_0a1696bf-1054-41bd-8f42-db37e90f6334"
      unitRef="usd">2175595000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzQyLTEtMS0xLTA_12d73362-d7e8-4d24-b3e8-6cbafb2756b3"
      unitRef="usd">-53484000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzQyLTMtMS0xLTA_8b3ba948-2d93-4d30-ab56-3f995941ab34"
      unitRef="usd">-53615000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockShares
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzQzLTAtMS0xLTAvdGV4dHJlZ2lvbjpkMTE5NGY3OTE0YmY0NTVmYTc0NGM0ZjYyZTgwMzczMF8yOQ_22567f3f-3889-49e2-99a5-619e1a914241"
      unitRef="shares">22317000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzQzLTAtMS0xLTAvdGV4dHJlZ2lvbjpkMTE5NGY3OTE0YmY0NTVmYTc0NGM0ZjYyZTgwMzczMF81MQ_2b327e5e-012b-4817-8cda-ccefd64f5333"
      unitRef="shares">21008000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzQzLTEtMS0xLTA_072159cf-58af-4976-b488-b6ea2099568e"
      unitRef="usd">3570691000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzQzLTMtMS0xLTA_9561cdfe-c82e-4f51-b244-2cf4a04305a2"
      unitRef="usd">2799890000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquity
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzQ0LTEtMS0xLTA_0e797a78-8358-47c1-9d43-7c0ffca26bf1"
      unitRef="usd">689992000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzQ0LTMtMS0xLTA_5a4e09d0-126d-4f50-873c-28719a49a1eb"
      unitRef="usd">632088000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzQ1LTEtMS0xLTA_34e9f8f8-ff92-4acb-beb7-f8e3b30d3573"
      unitRef="usd">0</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzQ1LTMtMS0xLTA_cf2bcf49-fb30-4611-8b32-d7f502e4697e"
      unitRef="usd">707000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzQ2LTEtMS0xLTA_aa5ba6f9-4def-4ed9-ae99-c09e4b2cdc0e"
      unitRef="usd">689992000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzQ2LTMtMS0xLTA_e8fe0f51-17fc-4ee8-bda8-fbece1ea7b6e"
      unitRef="usd">632795000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzQ3LTEtMS0xLTA_56e91076-5eb6-4cca-9678-539dec0fb9ed"
      unitRef="usd">2437203000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTQvZnJhZzo1Mzc0NzkzNzdlMzQ0NzYxODIzMThkOGQwZDZlODI4Ny90YWJsZTowNzczY2Q5NjFkZDY0ZGY2OWRlODViYmZmYWQ5MzMwZi90YWJsZXJhbmdlOjA3NzNjZDk2MWRkNjRkZjY5ZGU4NWJiZmZhZDkzMzBmXzQ3LTMtMS0xLTA_4dfbd97b-4cd9-440f-91f6-1fde2bb8f75c"
      unitRef="usd">2294561000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic726475fb9e14ee5a91a94f1384e1a43_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzQtMi0xLTEtMA_51a269ad-8708-4ae1-bc5a-2f864a7bece1"
      unitRef="usd">1875308000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic3e97410fa904f6b9da8bf1da4160760_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzQtNC0xLTEtMA_690a0296-4789-47f5-8f1c-17707870575f"
      unitRef="usd">1586809000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icaff31c4dfc74beebd9e4f2367f76db7_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzQtNi0xLTEtMA_a676fd82-3ad0-4124-ab77-1a7b7fa7f93f"
      unitRef="usd">1423144000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1e1d4a27d5524619b8f8d3d7ab6dc3e9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzUtMi0xLTEtMA_54e198ae-c2a0-4d1a-87ee-7ebcb437bb11"
      unitRef="usd">1340052000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id5e9c5621d1e4b70b61639e6582ff3c2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzUtNC0xLTEtMA_f16264a0-823e-4705-b971-3159f8f5072c"
      unitRef="usd">1119846000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ida0b80c182f342c3996f1a84b8b8fb9c_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzUtNi0xLTEtMA_361bbe5c-bacb-4540-86eb-6ebbfde8af1c"
      unitRef="usd">983764000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzYtMi0xLTEtMA_830c9b53-920a-456e-b479-86179f91216c"
      unitRef="usd">3215360000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzYtNC0xLTEtMA_61f38393-e584-4908-8691-826f3ec02d7f"
      unitRef="usd">2706655000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzYtNi0xLTEtMA_f0f0c014-cefb-4ae0-8199-dbc34f7271eb"
      unitRef="usd">2406908000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="ic726475fb9e14ee5a91a94f1384e1a43_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzgtMi0xLTEtMA_e37016f6-3cac-4c7a-aab1-1c69877a9eb6"
      unitRef="usd">656823000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="ic3e97410fa904f6b9da8bf1da4160760_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzgtNC0xLTEtMA_87273e52-bcf4-47a3-a712-8766c59c10d0"
      unitRef="usd">557795000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="icaff31c4dfc74beebd9e4f2367f76db7_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzgtNi0xLTEtMA_4eeb5b70-5607-426e-9a14-12603974ae5f"
      unitRef="usd">506202000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i1e1d4a27d5524619b8f8d3d7ab6dc3e9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzktMi0xLTEtMA_675e953a-ab67-4276-8043-fdadd0cdc026"
      unitRef="usd">669105000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="id5e9c5621d1e4b70b61639e6582ff3c2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzktNC0xLTEtMA_1a464bca-922a-4537-b406-10560b75cbee"
      unitRef="usd">577820000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="ida0b80c182f342c3996f1a84b8b8fb9c_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzktNi0xLTEtMA_3fa427b6-45d7-465c-ba58-4d0eaa32f12c"
      unitRef="usd">535157000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzEwLTItMS0xLTA_dd82f00e-d630-4f2a-9a5c-26ccd6c32236"
      unitRef="usd">1325928000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzEwLTQtMS0xLTA_b1e330f6-89fc-4a56-850e-b17265ea9b23"
      unitRef="usd">1135615000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzEwLTYtMS0xLTA_221a0350-5ba1-49dc-b424-2eb99208802f"
      unitRef="usd">1041359000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzExLTItMS0xLTA_d1cc86d3-b04a-4e3e-bcc1-a808ca73e509"
      unitRef="usd">1889432000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzExLTQtMS0xLTA_3dacfd0d-9e2e-4b13-a483-901c4b955d77"
      unitRef="usd">1571040000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzExLTYtMS0xLTA_1a8dd90c-89f5-4a4d-b601-735459c658f3"
      unitRef="usd">1365549000</us-gaap:GrossProfit>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzEzLTItMS0xLTA_20a2249b-4e0c-4510-ba52-d286be45d671"
      unitRef="usd">486735000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzEzLTQtMS0xLTA_0c7cc69d-56fd-407e-9e4e-8e65f70af159"
      unitRef="usd">434435000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzEzLTYtMS0xLTA_21f65ea2-aed9-4600-a465-3b07e2ea0883"
      unitRef="usd">418193000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzE0LTItMS0xLTA_150aad81-be01-4937-b5a6-9b462d66b9aa"
      unitRef="usd">309660000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzE0LTQtMS0xLTA_57e6b859-bf09-489b-a2bf-460fc01a6551"
      unitRef="usd">300832000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzE0LTYtMS0xLTA_f9d3f698-2075-42e6-a638-5cc5ceccda80"
      unitRef="usd">261317000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzE1LTItMS0xLTA_fab49f0a-d79c-4ebd-ad05-c86405e4a2fe"
      unitRef="usd">161009000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzE1LTQtMS0xLTA_9956d6dc-2872-480c-a24d-ff7c59cbcd3c"
      unitRef="usd">141249000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzE1LTYtMS0xLTA_aa455517-b492-41fc-bc18-9891399ee454"
      unitRef="usd">133193000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzE2LTItMS0xLTA_0b0f853a-2ed1-4a23-8170-0c65b0bfdd7a"
      unitRef="usd">932028000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzE2LTQtMS0xLTA_3e33db7e-ba13-490b-b0b9-cbd613d9af8b"
      unitRef="usd">694524000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzE2LTYtMS0xLTA_6bcdc547-d9cf-44a4-977d-5dabaf47cc82"
      unitRef="usd">552846000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzE3LTItMS0xLTA_891ba522-fc16-430b-8e6e-115336a8b389"
      unitRef="usd">29808000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzE3LTQtMS0xLTA_8832ac1e-ece0-4ac7-beeb-1a540e1c5882"
      unitRef="usd">33125000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzE3LTYtMS0xLTA_12679f55-0979-4d49-8f28-3f0dc532a5d3"
      unitRef="usd">31055000</us-gaap:InterestExpense>
    <us-gaap:InterestAndOtherIncome
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzE4LTItMS0xLTA_bed8f5d2-0126-4cb4-9f0a-dac0dd82f962"
      unitRef="usd">434000</us-gaap:InterestAndOtherIncome>
    <us-gaap:InterestAndOtherIncome
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzE4LTQtMS0xLTA_df0f8702-5b27-4424-aaed-0c549b94b4a5"
      unitRef="usd">586000</us-gaap:InterestAndOtherIncome>
    <us-gaap:InterestAndOtherIncome
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzE4LTYtMS0xLTA_887d9996-eb9a-4d6d-aa47-45e55e0cfe0a"
      unitRef="usd">427000</us-gaap:InterestAndOtherIncome>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzE5LTItMS0xLTA_db1f4b71-4ceb-452f-9b52-6086e07de634"
      unitRef="usd">902654000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzE5LTQtMS0xLTA_74d9086b-e373-4f7a-878a-3f7bb1eebf15"
      unitRef="usd">661985000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzE5LTYtMS0xLTA_43c13105-1381-493e-b484-3f3ce9f427c9"
      unitRef="usd">522218000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzIwLTItMS0xLTA_4b024c58-dd52-499d-86c2-3d044873bf6c"
      unitRef="usd">157810000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzIwLTQtMS0xLTA_c4ce0d38-4abb-4fb7-ae42-75a7ec1e9084"
      unitRef="usd">79854000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzIwLTYtMS0xLTA_3da8ffb3-16e1-45cc-a01e-24e26e29429c"
      unitRef="usd">94426000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzIxLTItMS0xLTA_9b82a0f6-e35b-4f0c-aed2-744268feaeba"
      unitRef="usd">744844000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzIxLTQtMS0xLTA_2d51578d-92c0-422d-b3e2-e238a80c2423"
      unitRef="usd">582131000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzIxLTYtMS0xLTA_43ac8608-e191-49bc-b647-affe6f7dfd33"
      unitRef="usd">427792000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzIyLTItMS0xLTA_659c30b3-a477-4bc4-a982-11e5dd1188e7"
      unitRef="usd">-1000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzIyLTQtMS0xLTA_e1cc6bd0-be46-4ddd-878c-144dc770c1cc"
      unitRef="usd">355000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzIyLTYtMS0xLTA_7cbe7e35-9daa-4c25-9154-baf0adc82fb4"
      unitRef="usd">72000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzIzLTItMS0xLTA_a25ad020-062b-4d76-bb88-085b587eb3aa"
      unitRef="usd">744845000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzIzLTQtMS0xLTA_77022c00-dbd9-402d-b475-7938770eab02"
      unitRef="usd">581776000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzIzLTYtMS0xLTA_93816e3c-0831-432c-bbdf-e9f509e5be30"
      unitRef="usd">427720000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzI2LTItMS0xLTA_b8a65a7a-acb0-469f-a982-746fa723fd39"
      unitRef="usdPerShare">8.74</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzI2LTQtMS0xLTA_145e807b-a4bf-4177-8520-7d111fb704be"
      unitRef="usdPerShare">6.82</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzI2LTYtMS0xLTA_6599b26d-78de-4ea5-b609-d74bf2262d28"
      unitRef="usdPerShare">4.97</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzI3LTItMS0xLTA_97359304-d4cd-424d-b98f-3bf60387aa28"
      unitRef="usdPerShare">8.60</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzI3LTQtMS0xLTA_60cb88cc-602f-421c-848d-f373faeeddd7"
      unitRef="usdPerShare">6.71</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzI3LTYtMS0xLTA_d9cd5f85-b98f-467a-8704-135cdab5a036"
      unitRef="usdPerShare">4.89</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzI5LTItMS0xLTA_dec4462e-e9c7-4c2d-b86a-c4d82fd902a7"
      unitRef="shares">85200000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzI5LTQtMS0xLTA_b4307fb8-1593-4c8c-a59b-ff6b024aa491"
      unitRef="shares">85342000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzI5LTYtMS0xLTA_6c2bb234-bd1e-4204-a9e6-10f730ea2eaf"
      unitRef="shares">86115000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzMwLTItMS0xLTA_7d32e950-2e03-4c99-8724-7b9d2d28ee79"
      unitRef="shares">86572000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzMwLTQtMS0xLTA_78342e3c-3e59-44ad-95af-3251c4656f5d"
      unitRef="shares">86722000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNTcvZnJhZzpjMDc1ZGJmNjM2YzI0ZmUyOTQ1YzUxOTAxZDIzNmY5Zi90YWJsZToxYjkzNDRiYjhlOGI0NjIyYmFlYzUxNzA2NjA5MDNmOC90YWJsZXJhbmdlOjFiOTM0NGJiOGU4YjQ2MjJiYWVjNTE3MDY2MDkwM2Y4XzMwLTYtMS0xLTA_c7b30374-fb8d-4ebe-8902-bc14be43b33e"
      unitRef="shares">87542000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzMtMi0xLTEtMA_ecaecda6-0f59-4a04-978c-de52bfd438e1"
      unitRef="usd">744844000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzMtNC0xLTEtMA_f22bbd8a-519a-411f-9f99-a8121eb3e508"
      unitRef="usd">582131000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzMtNi0xLTEtMA_da79eddc-6525-4111-bc5b-ca460903dc14"
      unitRef="usd">427792000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzUtMi0xLTEtMA_798bfb26-cfb3-430d-bcf2-1d97929af7d7"
      unitRef="usd">-26731000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzUtNC0xLTEtMA_0851cf7a-60cd-45f1-8e19-bb44ed6dedda"
      unitRef="usd">15151000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzUtNi0xLTEtMA_fd80ae1b-255c-45a6-9676-502b4b1672c2"
      unitRef="usd">-1590000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <idxx:OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationTax
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzYtMC0xLTEtMC90ZXh0cmVnaW9uOjFhY2ExNTYzZmExZTRmY2Q5NGRhZGI3MjA5MDBkZjg2Xzg2_cc1c3633-fea4-4eaf-b7f4-b7e1d8ce80a7"
      unitRef="usd">2011000</idxx:OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationTax>
    <idxx:OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationTax
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzYtMC0xLTEtMC90ZXh0cmVnaW9uOjFhY2ExNTYzZmExZTRmY2Q5NGRhZGI3MjA5MDBkZjg2Xzk2_912bddd8-8f70-4225-9c44-38eb1b990877"
      unitRef="usd">-2325000</idxx:OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationTax>
    <idxx:OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationTax
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzYtMC0xLTEtMC90ZXh0cmVnaW9uOjFhY2ExNTYzZmExZTRmY2Q5NGRhZGI3MjA5MDBkZjg2XzEwOQ_a2e351a7-aac7-4038-9d35-d60c9ef5e70f"
      unitRef="usd">564000</idxx:OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationTax>
    <idxx:OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzYtMi0xLTEtMA_f3e7aa16-4031-405d-9942-ca28585252f3"
      unitRef="usd">6404000</idxx:OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax>
    <idxx:OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzYtNC0xLTEtMA_d80cdb2e-1541-47f3-a5c9-09c448454903"
      unitRef="usd">-7378000</idxx:OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax>
    <idxx:OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzYtNi0xLTEtMA_40f95300-e7c8-422b-a3d8-528b518700c4"
      unitRef="usd">1790000</idxx:OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzctMC0xLTEtMC90ZXh0cmVnaW9uOjlhMmY3MThjZjJmYzRjMDViM2NlZGMzYTZjMTA4ZGE4Xzc1_4211f045-051a-411d-9928-b5a88e9af2b7"
      unitRef="usd">46000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzctMC0xLTEtMC90ZXh0cmVnaW9uOjlhMmY3MThjZjJmYzRjMDViM2NlZGMzYTZjMTA4ZGE4Xzg1_ce1f7031-875e-42a6-b3e9-c97733a4cd7b"
      unitRef="usd">-120000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzctMC0xLTEtMC90ZXh0cmVnaW9uOjlhMmY3MThjZjJmYzRjMDViM2NlZGMzYTZjMTA4ZGE4Xzk4_a4251b36-0a8a-4377-89a1-a1d835ea2b3f"
      unitRef="usd">84000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzctMi0xLTEtMA_b0444eca-0e2b-46b6-a88b-3b4a6ac922c9"
      unitRef="usd">146000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzctNC0xLTEtMA_2a7f0920-7e15-43df-bbe7-91e891fd8d7c"
      unitRef="usd">-382000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzctNi0xLTEtMA_a236d5cf-649a-49f5-968a-a8f37682036e"
      unitRef="usd">267000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzktMC0xLTEtMC90ZXh0cmVnaW9uOmY0MGM2OTM5ODliZDQ4M2E4ZGYxNjBiN2I2ODZlZDQ4Xzk5_3fc43863-4b7d-4d51-ac39-90da9dbcc537"
      unitRef="usd">2133000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzktMC0xLTEtMC90ZXh0cmVnaW9uOmY0MGM2OTM5ODliZDQ4M2E4ZGYxNjBiN2I2ODZlZDQ4XzEwOQ_bff33f10-a3b9-42ab-9fb5-79b691a178c6"
      unitRef="usd">-2013000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzktMC0xLTEtMC90ZXh0cmVnaW9uOmY0MGM2OTM5ODliZDQ4M2E4ZGYxNjBiN2I2ODZlZDQ4XzEyMg_6d1d77d2-4538-49b1-8aa7-56ad4b194572"
      unitRef="usd">362000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzktMi0xLTEtMA_fdf20d6a-d371-46cd-b1f1-00d5dd8f3427"
      unitRef="usd">9139000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzktNC0xLTEtMA_b22c9d9d-7712-44a1-9e94-5dc58c5da168"
      unitRef="usd">-8527000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzktNi0xLTEtMA_bb07c84a-d14b-4c26-ab04-4e8cc198f774"
      unitRef="usd">1196000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <idxx:OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationTax
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzEwLTAtMS0xLTAvdGV4dHJlZ2lvbjo4OGQ4NTQxN2FjNzY0ODhjODdhODA3ZjJhMDBlYTE5NF83NA_92e90e31-8d07-4043-95d7-70f040f264e8"
      unitRef="usd">1699000</idxx:OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationTax>
    <idxx:OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationTax
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzEwLTAtMS0xLTAvdGV4dHJlZ2lvbjo4OGQ4NTQxN2FjNzY0ODhjODdhODA3ZjJhMDBlYTE5NF84NA_32a804fb-2694-41d9-a2a1-7d6e1e0b994d"
      unitRef="usd">-1774000</idxx:OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationTax>
    <idxx:OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationTax
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzEwLTAtMS0xLTAvdGV4dHJlZ2lvbjo4OGQ4NTQxN2FjNzY0ODhjODdhODA3ZjJhMDBlYTE5NF85Nw_1dba11a0-deca-4539-a8ad-73b894812636"
      unitRef="usd">664000</idxx:OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationTax>
    <idxx:OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzEwLTItMS0xLTA_0aa49bc8-f768-4a15-9c0d-f065d1c02ce6"
      unitRef="usd">5399000</idxx:OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax>
    <idxx:OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzEwLTQtMS0xLTA_4d4134d7-1330-41e3-91cc-18f44ae7aace"
      unitRef="usd">-5626000</idxx:OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax>
    <idxx:OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzEwLTYtMS0xLTA_0b3af18e-dbf8-482f-aef0-ab698b532ee8"
      unitRef="usd">2107000</idxx:OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzExLTAtMS0xLTAvdGV4dHJlZ2lvbjo0MmVhZDQ3NGRkZjA0Zjg5YjgxZWZjMTc3ZmI5M2QxNl8xMTM_57792ab0-3227-4769-a0b6-2377903ca3dd"
      unitRef="usd">-1347000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzExLTAtMS0xLTAvdGV4dHJlZ2lvbjo0MmVhZDQ3NGRkZjA0Zjg5YjgxZWZjMTc3ZmI5M2QxNl8xMjM_94cbc67a-e998-4557-bc13-df263f4169d5"
      unitRef="usd">158000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzExLTAtMS0xLTAvdGV4dHJlZ2lvbjo0MmVhZDQ3NGRkZjA0Zjg5YjgxZWZjMTc3ZmI5M2QxNl8xMzY_2df48049-06df-43a8-84f8-e3d466351378"
      unitRef="usd">2467000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzExLTItMS0xLTA_6c2dec65-db44-481a-b4a4-db430cd4db6d"
      unitRef="usd">-5774000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzExLTQtMS0xLTA_a2141a38-5a99-4045-96e9-f44b4c68e353"
      unitRef="usd">671000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzExLTYtMS0xLTA_e68336fc-fec6-4fd5-8fb6-144fc035c8cf"
      unitRef="usd">8161000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <idxx:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossAfterReclassificationAndTax
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzEyLTItMS0xLTA_c801422f-5c1e-483d-a6e0-c36091d38cc9"
      unitRef="usd">20312000</idxx:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossAfterReclassificationAndTax>
    <idxx:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossAfterReclassificationAndTax
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzEyLTQtMS0xLTA_770a1d3d-543c-426f-a78f-6fd3e6662aa5"
      unitRef="usd">-14824000</idxx:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossAfterReclassificationAndTax>
    <idxx:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossAfterReclassificationAndTax
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzEyLTYtMS0xLTA_40508bd5-1157-4d69-bdb1-28845387d864"
      unitRef="usd">-4858000</idxx:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzEzLTItMS0xLTA_567aec53-fc03-4de9-91f0-c6e5e7456b49"
      unitRef="usd">131000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzEzLTQtMS0xLTA_2bbc11d1-9132-410c-9279-197a575525e1"
      unitRef="usd">-7433000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzEzLTYtMS0xLTA_f7569ad7-04b3-4cd9-aa46-89df51c7e0ba"
      unitRef="usd">-4391000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzE0LTItMS0xLTA_d5501668-69a5-4e61-91ac-ef23fad52b95"
      unitRef="usd">744975000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzE0LTQtMS0xLTA_8345c9d4-7ed2-459a-a7bf-4453ff3b649c"
      unitRef="usd">574698000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzE0LTYtMS0xLTA_f570eee6-c9d2-43db-82c5-d382df144317"
      unitRef="usd">423401000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzE1LTItMS0xLTA_5b0bc255-5011-41a8-81fd-c2cd1c406d7f"
      unitRef="usd">-1000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzE1LTQtMS0xLTA_14141bea-302a-4d96-aac4-8bfeedf5017e"
      unitRef="usd">355000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzE1LTYtMS0xLTA_2cadb6d4-df7a-4fec-b3e1-fc05065c14c0"
      unitRef="usd">72000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzE2LTItMS0xLTA_8a1f2eb3-599b-4d38-8618-e3f6bac9d7ee"
      unitRef="usd">744976000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzE2LTQtMS0xLTA_722d4784-2378-42cd-87a0-71c715970c03"
      unitRef="usd">574343000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjAvZnJhZzo3YmI1MTNmOWJkMTI0NTJkOGI5M2I2Y2Q3MjcxYTFjOC90YWJsZTo2M2Q1ZjQzMTcxMmY0MTQxYTVmMjdhMTkwNGEyMzgxOS90YWJsZXJhbmdlOjYzZDVmNDMxNzEyZjQxNDFhNWYyN2ExOTA0YTIzODE5XzE2LTYtMS0xLTA_ba18acd6-dbce-49ae-b23f-69f330e9236f"
      unitRef="usd">423329000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i0c634b937c58472e84857eacf99e17df_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzEtMy0xLTEtMC90ZXh0cmVnaW9uOmE1YzgwNmEzODhkYTQxMDM5OWQxMzMwNjk0NWVmOGY2XzQ_27fa8067-4248-4613-8c86-d7a95995b465"
      unitRef="usdPerShare">0.10</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i28d0821cac8841b29cf960002d3bc993_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzEtMy0xLTEtMC90ZXh0cmVnaW9uOmE1YzgwNmEzODhkYTQxMDM5OWQxMzMwNjk0NWVmOGY2XzQ_2e9f3f3b-51bd-4bf0-b4fd-e521d3b0bc3c"
      unitRef="usdPerShare">0.10</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzEtMy0xLTEtMC90ZXh0cmVnaW9uOmE1YzgwNmEzODhkYTQxMDM5OWQxMzMwNjk0NWVmOGY2XzQ_4af2980a-5972-4335-9289-593eb41ac66a"
      unitRef="usdPerShare">0.10</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzEtMy0xLTEtMC90ZXh0cmVnaW9uOmE1YzgwNmEzODhkYTQxMDM5OWQxMzMwNjk0NWVmOGY2XzQ_62fcfd21-2da4-4f5a-8a07-5045993adb13"
      unitRef="usdPerShare">0.10</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued
      contextRef="ifc55888d777a4d23bc9cfb38c781c1b0_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzItMS0xLTEtMA_4b9ef2aa-0b1a-4d57-a516-2539507099f1"
      unitRef="shares">105087000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifc55888d777a4d23bc9cfb38c781c1b0_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzItMy0xLTEtMA_ecfe4a9c-732e-4df6-9d52-9e2021075aa2"
      unitRef="usd">10509000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia5198e31e82c4830868ddd894d8bea8e_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzItNS0xLTEtMA_19521d79-fe09-4eb7-8384-3acd68ed5b5d"
      unitRef="usd">1138216000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i47457672ea94468ab1c5cd3068086847_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzItNy0xLTEtMA_f84779da-fa48-4e6c-8a51-a54887ec2ae1"
      unitRef="usd">4524000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia510c04f9d61478ea746fbff0dd20e7a_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzItOS0xLTEtMA_abf4fa53-381e-4fc4-bab9-ff1e7333d7bd"
      unitRef="usd">1167928000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0030920649fc4bfeaec05aad85e23ea9_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzItMTEtMS0xLTA_b4d00d0a-523b-4f27-a7db-62fd323ca7a6"
      unitRef="usd">-41791000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3ca52acda88f4806b415035b2e87a637_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzItMTMtMS0xLTA_e2ab3fca-21df-48b9-90e0-0fc7e47cd114"
      unitRef="usd">-2288899000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4eba3ab172724f5cb99036c1a25946f4_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzItMTUtMS0xLTA_c0627aa8-7bf3-4ece-a635-e0262d21b68f"
      unitRef="usd">280000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i28d0821cac8841b29cf960002d3bc993_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzItMTctMS0xLTA_056136ca-416a-4612-b8d8-9b06afa593b9"
      unitRef="usd">-9233000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i3eebac5bf6864fc4a7c5f697b102c9f9_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzQtOS0xLTEtMA_b4dba41b-a123-43c9-97c7-fc5c320aa875"
      unitRef="usd">427720000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ie44c061415214719bc569b35577d8629_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzQtMTUtMS0xLTA_9d228ae9-3ea7-40bb-9380-49a3f0cb58d6"
      unitRef="usd">72000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzQtMTctMS0xLTA_55fa0ad8-cbc4-452b-9090-de9f0c645b08"
      unitRef="usd">427792000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i52c9d97bec804143a591d49a316a5d59_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzUtMTEtMS0xLTA_2ba28d54-b8c8-4afd-ac31-22b2f3d7228e"
      unitRef="usd">-4391000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzUtMTctMS0xLTA_d2e2d144-f17c-46a7-8586-4be255b78ec4"
      unitRef="usd">-4391000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="i8ddfcdc960064849802514d1f2a8bbfb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzYtMTMtMS0xLTA_4386aeea-8bfe-4406-8fa9-e8ddb60b0de5"
      unitRef="usd">311644000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzYtMTctMS0xLTA_a0eda618-33e1-426f-9cf8-3cce5b395f0e"
      unitRef="usd">311644000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross
      contextRef="i459299d77adf46b2baa2eefe5c566758_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzctMS0xLTEtMA_45ed194e-cfd5-4a7a-8d79-c3f1ac233f5b"
      unitRef="shares">624000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross
      contextRef="i459299d77adf46b2baa2eefe5c566758_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzctMy0xLTEtMA_14036ae2-36fb-47c0-a77f-a31d5f12013b"
      unitRef="usd">62000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross
      contextRef="id1564d43c43d4ed28f279068c2cec341_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzctNS0xLTEtMA_22e734b9-31a1-454b-b3dc-30ea8516d5e2"
      unitRef="usd">36551000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross
      contextRef="if3ee522263ee4c1ab1a5860feaa32d9b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzctNy0xLTEtMA_d97781c4-990d-46b3-8176-10e731dd4846"
      unitRef="usd">-590000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzctMTctMS0xLTA_6b095257-0e61-480d-bd3c-d74df96b6b63"
      unitRef="usd">36023000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <idxx:IssuanceVestingAndSettlementOfDeferredStockUnits
      contextRef="id1564d43c43d4ed28f279068c2cec341_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzgtNS0xLTEtMA_19432e37-f4b3-4e58-9b97-cc9751eb5134"
      unitRef="usd">-324000</idxx:IssuanceVestingAndSettlementOfDeferredStockUnits>
    <idxx:IssuanceVestingAndSettlementOfDeferredStockUnits
      contextRef="if3ee522263ee4c1ab1a5860feaa32d9b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzgtNy0xLTEtMA_faf1e2ef-c0d3-4b13-adbf-f7dce407b68d"
      unitRef="usd">324000</idxx:IssuanceVestingAndSettlementOfDeferredStockUnits>
    <idxx:IssuanceVestingAndSettlementOfDeferredStockUnits
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzgtMTctMS0xLTA_b11baa09-b082-40d9-83a6-772fb5e54b54"
      unitRef="usd">0</idxx:IssuanceVestingAndSettlementOfDeferredStockUnits>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="id1564d43c43d4ed28f279068c2cec341_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzktNS0xLTEtMA_ccde1724-73e5-445e-a1f0-3942afd2e0e0"
      unitRef="usd">39074000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="if3ee522263ee4c1ab1a5860feaa32d9b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzktNy0xLTEtMA_c9135eef-907f-4344-8285-d9f3be60da74"
      unitRef="usd">204000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzktMTctMS0xLTA_acd8a7cc-a10d-4e8a-8524-127f0d76613b"
      unitRef="usd">39278000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:CommonStockSharesIssued
      contextRef="ifb04d957babc4708830136f812aa04c6_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzEwLTEtMS0xLTA_c9ba0775-f67d-42ef-a1b2-a328e16ed566"
      unitRef="shares">105711000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifb04d957babc4708830136f812aa04c6_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzEwLTMtMS0xLTA_d7a32438-b482-4471-b459-ede647ac4fb9"
      unitRef="usd">10571000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia754ac48509b4751bfa3915a39627bc6_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzEwLTUtMS0xLTA_8900e67c-94c7-4bd6-8869-52a989349a5f"
      unitRef="usd">1213517000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i979a783478524796bf27df092c164acb_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzEwLTctMS0xLTA_09822db4-24a4-45fc-8bc6-bd961e7217cf"
      unitRef="usd">4462000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if0d07a5bb51144978faf2ec5745936dc_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzEwLTktMS0xLTA_9ed9afe8-c169-46de-ad64-d909b2428c20"
      unitRef="usd">1595648000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iaf017de1fe8245b490bf3ba36d73909c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzEwLTExLTEtMS0w_24fd2fef-9dcc-4888-aaaf-2b2499c7e463"
      unitRef="usd">-46182000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8fa2c23303164297bbef06a53a57f47d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzEwLTEzLTEtMS0w_ad0f8ef3-7802-4490-a2a0-dc20faf241fe"
      unitRef="usd">-2600543000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i070ac0c233c64a6b8c2c8c44a84a6b9c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzEwLTE1LTEtMS0w_ae833369-9ddc-4b00-b3d3-adf5fd517f0e"
      unitRef="usd">352000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0c634b937c58472e84857eacf99e17df_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzEwLTE3LTEtMS0w_b14d33da-2cf1-4a19-9e08-6a2227d20899"
      unitRef="usd">177825000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i40d60db7ecae431bbb3cc52673c3f08c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzExLTktMS0xLTI4ODY5_80053aed-f3ef-4cc7-8102-641923a39179"
      unitRef="usd">-1829000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9dcdb5ab830946f987d2c255bb59ed41_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzExLTE3LTEtMS0yODg1OA_ccaeb2e3-fb84-421e-a83e-b1de962526e6"
      unitRef="usd">-1829000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i843cb27f38cc4792b41236eefc1a5b9a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzExLTktMS0xLTA_b7677535-433f-4e8f-82ee-34eacc5d20cf"
      unitRef="usd">581776000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i3c49c956c8bd476fbc5a218bb26fc1e7_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzExLTE1LTEtMS0w_3437b91d-4efc-4cd2-995d-4dfeec5209bd"
      unitRef="usd">355000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzExLTE3LTEtMS0w_6593bc2d-aca5-4c50-b911-08a0226ef64f"
      unitRef="usd">582131000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ifefe9c40d7f444cfaa6687822f8d9fe2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzEyLTExLTEtMS0w_7b78cf0c-ce99-4060-a1b6-16fc71f56618"
      unitRef="usd">-7433000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzEyLTE3LTEtMS0w_a74711b1-8fa5-42b5-b97f-a286f22ea75a"
      unitRef="usd">-7433000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="i6390dc8d6016472b99f4f5e8bcd76bd7_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzEzLTEzLTEtMS0w_601fa4ff-c4ca-4a46-aabe-9aa2e63231a6"
      unitRef="usd">199347000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzEzLTE3LTEtMS0w_17125669-4830-469f-9751-e8dc3f0d2da5"
      unitRef="usd">199347000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross
      contextRef="i1405c98ed2d04737be98553084c09616_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzE0LTEtMS0xLTA_7a3ca31f-cc34-4411-84ad-68f12f7cfd0b"
      unitRef="shares">746000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross
      contextRef="i1405c98ed2d04737be98553084c09616_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzE0LTMtMS0xLTA_7567c8e5-cb55-4be1-a020-74c93a30cd25"
      unitRef="usd">75000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross
      contextRef="i7353d8a3c0814b3387f39a6d5c074615_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzE0LTUtMS0xLTA_3636a6ab-0041-434e-b62f-4516ab8e86e4"
      unitRef="usd">51368000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross
      contextRef="ieb488124070d493c8bc4c944a20bf01a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzE0LTctMS0xLTA_bad92b73-327c-4197-9542-32275d3f097b"
      unitRef="usd">-946000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzE0LTE3LTEtMS0w_45430939-8b6e-41d1-a800-d39ea634c8cb"
      unitRef="usd">50497000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <idxx:IssuanceVestingAndSettlementOfDeferredStockUnits
      contextRef="i7353d8a3c0814b3387f39a6d5c074615_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzE1LTUtMS0xLTA_551686d6-0e82-4560-a4bf-ba91270f62ec"
      unitRef="usd">-894000</idxx:IssuanceVestingAndSettlementOfDeferredStockUnits>
    <idxx:IssuanceVestingAndSettlementOfDeferredStockUnits
      contextRef="ieb488124070d493c8bc4c944a20bf01a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzE1LTctMS0xLTA_6e55b56b-1808-41eb-aa26-b70978ca8c37"
      unitRef="usd">894000</idxx:IssuanceVestingAndSettlementOfDeferredStockUnits>
    <idxx:IssuanceVestingAndSettlementOfDeferredStockUnits
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzE1LTE3LTEtMS0w_d4219928-c36b-45ff-b097-ee5e0a6260ae"
      unitRef="usd">0</idxx:IssuanceVestingAndSettlementOfDeferredStockUnits>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i7353d8a3c0814b3387f39a6d5c074615_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzE2LTUtMS0xLTA_e59daf5c-9e38-4092-ab35-aaa3b7b807c1"
      unitRef="usd">30858000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ieb488124070d493c8bc4c944a20bf01a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzE2LTctMS0xLTA_b5ad080d-1501-4a89-b2bd-8af6500d4597"
      unitRef="usd">93000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzE2LTE3LTEtMS0w_9afa0454-87c7-457a-a4fa-f6b6506b6b7d"
      unitRef="usd">30951000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:CommonStockSharesIssued
      contextRef="ib43cc74de7f9447797f368526c52d81a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzE3LTEtMS0xLTA_42ab4769-c701-4af2-9035-87ce1296e1bc"
      unitRef="shares">106457000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib43cc74de7f9447797f368526c52d81a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzE3LTMtMS0xLTA_a0735728-8a26-4154-af3c-147c6f3c82b3"
      unitRef="usd">10646000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iacf2e4f12bb748b29e58438c9e86121d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzE3LTUtMS0xLTA_a9c4ab08-ba1b-4b4b-b48d-80040f5bebf5"
      unitRef="usd">1294849000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie21fa7b167864efaa91ab594caaa329f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzE3LTctMS0xLTA_f4af18fc-4477-41b5-af1b-c9910b7fa43b"
      unitRef="usd">4503000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3e204f1ef8454b7688e083aa906679b1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzE3LTktMS0xLTA_57b19dd5-b7ea-4e89-aabe-a5897cf5b01a"
      unitRef="usd">2175595000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i57792c148d4b4ba5b2eb677b657b7a2b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzE3LTExLTEtMS0w_963d4442-309f-4019-b73a-6c35bcbf4dc9"
      unitRef="usd">-53615000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iffadbee2ebda4dbd995c7ad9756f26ae_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzE3LTEzLTEtMS0w_02fb8be7-02a3-464f-b80e-d8677a3ae28b"
      unitRef="usd">-2799890000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i592d601cd0814365b50dc596de883440_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzE3LTE1LTEtMS0w_9e31d667-6377-429f-b4d7-82617a2a0947"
      unitRef="usd">707000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzE3LTE3LTEtMS0w_1212ce8f-c6ff-4217-8292-a967c2176550"
      unitRef="usd">632795000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i5494ccc733ab4588a07cf0c681f7fc5b_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzE5LTktMS0xLTA_23e43693-a5cc-4df3-9059-88f99648038c"
      unitRef="usd">744845000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i429f0a9281954c8991dd7a289fa848cf_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzE5LTE1LTEtMS0w_f5f7a651-bfc3-4b55-8cdd-5e1965b17578"
      unitRef="usd">-1000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzE5LTE3LTEtMS0w_74840288-293b-4e05-9482-1f3635942d84"
      unitRef="usd">744844000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i62a7d75347e640f1a8e7e3577bb0a247_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzIwLTExLTEtMS0w_59f40b9f-2d27-472e-9bcf-2c15470528a2"
      unitRef="usd">131000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzIwLTE3LTEtMS0w_8da826e7-080e-4ee0-95e2-800de322f01f"
      unitRef="usd">131000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="i17c7e782291f468da00d43bcb50b822f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzIwLTUtMS0xLTMxNTYz_d275cc01-4223-4bd0-945a-c7d65a44790a"
      unitRef="usd">284000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="i429f0a9281954c8991dd7a289fa848cf_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzIwLTE1LTEtMS0zMTU2Mw_a71eabe4-3139-4f23-9355-69469b02d1ee"
      unitRef="usd">706000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzIwLTE3LTEtMS0zMTU2Mw_ad4c1ddb-424d-4c40-a1ac-ed86de804594"
      unitRef="usd">990000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="i80d844cab93d4373b5a710038b7a3f8a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzIxLTEzLTEtMS0w_d670f73b-ce39-4f61-ab08-2ee029d7f425"
      unitRef="usd">770801000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzIxLTE3LTEtMS0w_f3149966-01aa-4f36-b579-d8782f49c41e"
      unitRef="usd">770801000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross
      contextRef="if4e99dbc526e4e2185b83986a19641e6_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzIyLTEtMS0xLTA_89e2c711-1c7f-4c72-be97-d0696ae63b50"
      unitRef="shares">421000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross
      contextRef="if4e99dbc526e4e2185b83986a19641e6_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzIyLTMtMS0xLTA_7598a588-d343-43ec-aaa8-85f63d3e1791"
      unitRef="usd">42000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross
      contextRef="i17c7e782291f468da00d43bcb50b822f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzIyLTUtMS0xLTA_3baac1cd-e2e0-4391-bae6-a10f2921521a"
      unitRef="usd">46228000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross
      contextRef="ifdf9b694355c4799a0d984c56a7af188_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzIyLTctMS0xLTA_15aa6c5b-a9dc-4c11-9f0e-de86ec1b4d1e"
      unitRef="usd">-12000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross
      contextRef="i80d844cab93d4373b5a710038b7a3f8a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzIyLTEzLTEtMS0w_0e99af05-d86f-4c19-b5fd-fe6ab28ac8b8"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzIyLTE3LTEtMS0w_2b018eaf-1f11-43f9-ba6a-a882f224cdd2"
      unitRef="usd">46258000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <idxx:IssuanceVestingAndSettlementOfDeferredStockUnits
      contextRef="i17c7e782291f468da00d43bcb50b822f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzIzLTUtMS0xLTA_de4ee581-ab02-44fb-b9da-896285ee38d6"
      unitRef="usd">-1035000</idxx:IssuanceVestingAndSettlementOfDeferredStockUnits>
    <idxx:IssuanceVestingAndSettlementOfDeferredStockUnits
      contextRef="ifdf9b694355c4799a0d984c56a7af188_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzIzLTctMS0xLTA_ffcc72ac-c8f4-4229-80c8-e703ea750bb1"
      unitRef="usd">1035000</idxx:IssuanceVestingAndSettlementOfDeferredStockUnits>
    <idxx:IssuanceVestingAndSettlementOfDeferredStockUnits
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzIzLTE3LTEtMS0w_a5f37628-e3a0-4da5-b83e-24251a93de35"
      unitRef="usd">0</idxx:IssuanceVestingAndSettlementOfDeferredStockUnits>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i17c7e782291f468da00d43bcb50b822f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzI0LTUtMS0xLTA_cc25cc18-f460-4c03-b236-90345c41c701"
      unitRef="usd">37562000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ifdf9b694355c4799a0d984c56a7af188_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzI0LTctMS0xLTA_70615075-9122-43a7-9174-df7da04cbf73"
      unitRef="usd">193000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzI0LTE3LTEtMS0w_92296602-fc32-42d6-904c-db9822269653"
      unitRef="usd">37755000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:CommonStockSharesIssued
      contextRef="i8486d76f7282415c96b78263d0e53fed_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzI1LTEtMS0xLTA_37cbb891-d853-4a85-97a2-69d598036f3c"
      unitRef="shares">106878000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8486d76f7282415c96b78263d0e53fed_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzI1LTMtMS0xLTA_404ffebe-c402-4d38-a3c3-6e90a54ab8e8"
      unitRef="usd">10688000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i65e8850835e644b0a942d37199d2fac2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzI1LTUtMS0xLTA_5730f417-37b3-4eba-84f3-1c59471e041a"
      unitRef="usd">1377320000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9152bd3467a54594bc1a3df15df505af_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzI1LTctMS0xLTA_36d9b52e-b44d-42f5-9a2c-66d03a18719a"
      unitRef="usd">5719000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i22db15f5a3f64f13a2a4241901d35b3e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzI1LTktMS0xLTA_f99741c5-def1-4035-8b88-07e94329e3e7"
      unitRef="usd">2920440000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia4ce9f46b7a347608b97422112175f6f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzI1LTExLTEtMS0w_f3c99153-6598-47d1-9965-738bee66bc8a"
      unitRef="usd">-53484000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8be03ed376d64697b29c2563ea25de6d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzI1LTEzLTEtMS0w_e57eacf4-4f9c-473b-a732-51fc56d4c172"
      unitRef="usd">-3570691000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i727ded70819a4775adf0f51b27e35673_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzI1LTE1LTEtMS0w_a9115ab3-2a1e-4be4-bb9d-a7bf6bfb3c3c"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjMvZnJhZzpkOTQ1MTAyNmRhZmM0YTRjYTQ4OTY4Mjk3ZDg1OGUyMy90YWJsZTo3ZGVlZjZjNWFmMWY0N2M1YjMzNmIzMzNhNzk5MzBkOS90YWJsZXJhbmdlOjdkZWVmNmM1YWYxZjQ3YzViMzM2YjMzM2E3OTkzMGQ5XzI1LTE3LTEtMS0w_a363c6ff-d340-42a0-9ec3-f8a6788d14f8"
      unitRef="usd">689992000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzQtMi0xLTEtMA_0efccce3-5c43-4891-a3a0-2b1944c10dcc"
      unitRef="usd">744844000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzQtNC0xLTEtMA_ffc2f92f-6fa2-4c3f-a20f-3919947f43fc"
      unitRef="usd">582131000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzQtNi0xLTEtMA_3b000992-dd1b-42a3-a99c-c67a188cc7a9"
      unitRef="usd">427792000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzYtMi0xLTEtMA_f1464019-0f4c-4fa6-b6e9-3e4052d8927d"
      unitRef="usd">104596000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzYtNC0xLTEtMA_e3abde26-ce3e-470d-bb5c-b5da65456761"
      unitRef="usd">95998000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzYtNi0xLTEtMA_44fca121-a341-45bb-aa85-9be5cc9edaa5"
      unitRef="usd">88011000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:AssetImpairmentCharges
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzctMi0xLTEtMA_da1e7504-c44e-461a-b965-787ae80d96fe"
      unitRef="usd">5148000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzctNC0xLTEtMA_0ccbcf1c-6710-4ef2-a414-57aff504f5c2"
      unitRef="usd">2501000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzctNi0xLTEtMA_aa83c43b-e800-48e7-aca1-416947831549"
      unitRef="usd">968000</us-gaap:AssetImpairmentCharges>
    <us-gaap:ProvisionForLoanLeaseAndOtherLosses
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzgtMi0xLTEtMA_92a346c5-f42c-477d-bdaf-455290c87006"
      unitRef="usd">1484000</us-gaap:ProvisionForLoanLeaseAndOtherLosses>
    <us-gaap:ProvisionForLoanLeaseAndOtherLosses
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzgtNC0xLTEtMA_79c19930-d967-4002-853f-745cdb899758"
      unitRef="usd">4946000</us-gaap:ProvisionForLoanLeaseAndOtherLosses>
    <us-gaap:ProvisionForLoanLeaseAndOtherLosses
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzgtNi0xLTEtMA_52028e1b-16ff-46db-9388-23920108395e"
      unitRef="usd">662000</us-gaap:ProvisionForLoanLeaseAndOtherLosses>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzktMi0xLTEtMA_ac90128f-ef53-4e80-918d-223804944e75"
      unitRef="usd">-3377000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzktNC0xLTEtMA_3ad2bc36-6b92-44f0-90a7-1f6d892f88b7"
      unitRef="usd">-38082000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzktNi0xLTEtMA_304cc79a-3d77-4400-bab7-00073b9bc4e4"
      unitRef="usd">6162000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:ShareBasedCompensation
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzEwLTItMS0xLTA_ee20a3f6-e359-4956-88d1-062c8419f2bd"
      unitRef="usd">37755000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzEwLTQtMS0xLTA_a39d18d0-d53a-45f3-9da2-487b366e4f72"
      unitRef="usd">30951000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzEwLTYtMS0xLTA_574d90c1-bd2c-4251-baaf-03d4684dcae6"
      unitRef="usd">39278000</us-gaap:ShareBasedCompensation>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzExLTItMS0xLTA_de82355c-6ac1-4b92-b4cf-5001c1232f3e"
      unitRef="usd">2619000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzExLTQtMS0xLTA_7fddb226-0fb9-4507-985e-c5a84fd60a26"
      unitRef="usd">1379000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzExLTYtMS0xLTA_e9800855-6942-4e7a-a31e-36db237c2632"
      unitRef="usd">1254000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzEzLTItMS0xLTA_15ae1033-5486-4244-ac62-121cf826dca3"
      unitRef="usd">33141000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzEzLTQtMS0xLTA_944b5e96-0f55-46ed-a83f-54bf0ead6fe0"
      unitRef="usd">60722000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzEzLTYtMS0xLTA_c302eb70-698f-4dbe-8cda-d549ac490fc5"
      unitRef="usd">22472000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzE0LTItMS0xLTA_2de93bca-430c-4a1f-b5ca-d8c494727d9f"
      unitRef="usd">52919000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzE0LTQtMS0xLTA_c25ead62-6c96-49fe-87f9-a902ce14de13"
      unitRef="usd">18885000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzE0LTYtMS0xLTA_5bb594f5-5134-484d-b693-98cf9983e092"
      unitRef="usd">37306000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzE1LTItMS0xLTA_2c607698-e94d-4eb7-882c-75f8756a0fe2"
      unitRef="usd">11233000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzE1LTQtMS0xLTA_b06d9d8d-f8b1-42e2-ad50-70e4516fa83e"
      unitRef="usd">981000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzE1LTYtMS0xLTA_be864fcc-614f-4293-9c0b-ea8d5bb2c286"
      unitRef="usd">1957000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzE2LTItMS0xLTA_323a4d2f-45ad-4d1c-b7b9-d26896d4e08f"
      unitRef="usd">-7551000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzE2LTQtMS0xLTA_df1c5f60-7f74-4fe2-bc72-232ad41363b9"
      unitRef="usd">-13373000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzE2LTYtMS0xLTA_e139ead5-57f9-4a6c-b63a-bf1b6660c156"
      unitRef="usd">-12360000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzE3LTItMS0xLTA_01c6fb52-baeb-4e9e-b532-575d40866756"
      unitRef="usd">55145000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzE3LTQtMS0xLTA_5897be2e-5ff4-4944-8e2b-1bd29ecd8e53"
      unitRef="usd">-60238000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzE3LTYtMS0xLTA_461f4ee8-c738-4a90-9ad9-0ff36ac12556"
      unitRef="usd">34788000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzE4LTItMS0xLTA_c13fe369-ef48-4601-8054-ab533fa5b3ad"
      unitRef="usd">755546000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzE4LTQtMS0xLTA_6f9e8f2f-5a1e-4283-823a-a8e389d93df5"
      unitRef="usd">648063000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzE4LTYtMS0xLTA_d9cee97c-1696-4a17-9c50-e0546a384b76"
      unitRef="usd">459158000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzIwLTItMS0xLTA_9db66aaf-1450-4234-9534-98b71cc487c2"
      unitRef="usd">119549000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzIwLTQtMS0xLTA_4dbe35c9-43d3-40a8-ae2f-394c1945c48e"
      unitRef="usd">106958000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzIwLTYtMS0xLTA_0ef4011a-bce6-4640-a7e6-8d6481c0c6bc"
      unitRef="usd">154969000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <idxx:PaymentsToAcquireIntangibleAssetsAndEquityMethodInvestments
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzIzLTItMS0xLTA_63a1ff8c-b2a9-4d66-8c93-2cab654851bb"
      unitRef="usd">0</idxx:PaymentsToAcquireIntangibleAssetsAndEquityMethodInvestments>
    <idxx:PaymentsToAcquireIntangibleAssetsAndEquityMethodInvestments
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzIzLTQtMS0xLTA_318eb179-e2f2-4152-85b4-757d75f04391"
      unitRef="usd">918000</idxx:PaymentsToAcquireIntangibleAssetsAndEquityMethodInvestments>
    <idxx:PaymentsToAcquireIntangibleAssetsAndEquityMethodInvestments
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzIzLTYtMS0xLTA_0e7bf4c0-29d1-4c5b-b82a-3812a58f454b"
      unitRef="usd">255000</idxx:PaymentsToAcquireIntangibleAssetsAndEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzI0LTItMS0xLTA_76efc731-aa90-4f73-9f29-03fcf0c61a53"
      unitRef="usd">173418000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzI0LTQtMS0xLTA_610ffdc7-2382-4cc3-b8d4-c2d56878e7c5"
      unitRef="usd">1500000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzI0LTYtMS0xLTA_2c416ee3-acb9-4327-bb34-352e4db50570"
      unitRef="usd">50304000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzI1LTItMS0xLTA_fc0368fd-7e9e-4418-9f6f-97fbc61fc66b"
      unitRef="usd">-292967000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzI1LTQtMS0xLTA_4b3e8135-429e-4501-9a86-d98299505e9c"
      unitRef="usd">-109376000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzI1LTYtMS0xLTA_08c17e43-b744-4059-9862-48fc347aaa3f"
      unitRef="usd">-205528000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromRepaymentsOfLinesOfCredit
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzI3LTItMS0xLTA_99981711-cbc7-4663-bbff-e2fefce888a9"
      unitRef="usd">73500000</us-gaap:ProceedsFromRepaymentsOfLinesOfCredit>
    <us-gaap:ProceedsFromRepaymentsOfLinesOfCredit
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzI3LTQtMS0xLTA_dbb270e3-2399-4f9b-b296-d42233c6be13"
      unitRef="usd">-289625000</us-gaap:ProceedsFromRepaymentsOfLinesOfCredit>
    <us-gaap:ProceedsFromRepaymentsOfLinesOfCredit
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzI3LTYtMS0xLTA_43cc4fb9-3702-4092-8400-903bfa73d848"
      unitRef="usd">-110275000</us-gaap:ProceedsFromRepaymentsOfLinesOfCredit>
    <us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzI4LTItMS0xLTA_0e29e375-1b63-4f72-890a-64cb0f16a31f"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzI4LTQtMS0xLTA_946aabd6-5b55-48fc-88b4-5b3237facac6"
      unitRef="usd">200000000</us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzI4LTYtMS0xLTA_c15cb58e-539d-4480-96f5-69fbffefa5c7"
      unitRef="usd">100000000</us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzI5LTItMS0xLTQwNTUw_457dcd2e-89bb-4115-a785-bf08187164e6"
      unitRef="usd">50000000</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzI5LTQtMS0xLTQwNTUw_d06e2c1d-5ee6-43e2-9d08-0defada41e34"
      unitRef="usd">0</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzI5LTYtMS0xLTQwNTUw_590f288a-54c0-44e9-a8cc-90c40f9ded4f"
      unitRef="usd">0</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzI5LTItMS0xLTA_4b2f03fa-d1b9-417e-a0d6-9fb185360248"
      unitRef="usd">2650000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzI5LTQtMS0xLTA_d4ce1321-280a-4ffc-ba88-1556c1dadba6"
      unitRef="usd">5025000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzI5LTYtMS0xLTA_f9b71842-8752-47c3-a9ab-c785c8d1415d"
      unitRef="usd">154000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzMwLTItMS0xLTQwNTI3_c3cf4484-77f6-4157-b01f-d8cd447bb698"
      unitRef="usd">990000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzMwLTQtMS0xLTQwNTI3_18084601-c407-405d-98d4-d15d28bf3dba"
      unitRef="usd">0</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzMwLTYtMS0xLTQwNTI3_81564388-ff1a-4acf-b679-3657cc7fc69d"
      unitRef="usd">0</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzMwLTItMS0xLTA_ab11deb9-bcb4-45d3-99d1-e1cfdc010f01"
      unitRef="usd">746777000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzMwLTQtMS0xLTA_372febf5-dc77-4640-962e-1accb8ab0f0f"
      unitRef="usd">182815000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzMwLTYtMS0xLTA_edd0d123-d57b-4bdb-a108-94f1b2311f20"
      unitRef="usd">301658000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzMxLTItMS0xLTA_f8cbbdac-2745-47b8-b7c5-2c5c48662a8c"
      unitRef="usd">46565000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzMxLTQtMS0xLTA_8b145c7d-9dd3-415c-b951-c089ed50763b"
      unitRef="usd">51328000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzMxLTYtMS0xLTA_2d60c797-12d9-4f75-9791-e3062abda59a"
      unitRef="usd">36106000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzMyLTItMS0xLTA_f1440f49-204c-48d6-8389-c25a441adfae"
      unitRef="usd">1500000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzMyLTQtMS0xLTA_b347eb25-d722-40d5-ba36-d9dcd209a109"
      unitRef="usd">1676000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzMyLTYtMS0xLTA_8b1fc936-c744-4a77-9e0b-d235c7b2a280"
      unitRef="usd">2375000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzMzLTItMS0xLTA_6ebd56f7-c1fb-4249-a837-cd86aea19e2f"
      unitRef="usd">15562000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzMzLTQtMS0xLTA_ffb0d83f-b872-42d5-999b-90c946e40ce2"
      unitRef="usd">20603000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzMzLTYtMS0xLTA_1b0f3657-1d57-4ee0-a776-3080dae3d4f3"
      unitRef="usd">8053000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzM0LTItMS0xLTA_f3b6a67a-c891-47f9-846e-fdad60afe123"
      unitRef="usd">-697414000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzM0LTQtMS0xLTA_15f3046f-4313-4cf5-b08e-72ca47cdefc1"
      unitRef="usd">-248416000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzM0LTYtMS0xLTA_5ca9a259-c95f-4ab2-b8e1-a138100cf8d1"
      unitRef="usd">-286409000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzM1LTItMS0xLTA_8538c46c-765e-4148-a051-b0b7b8d1eec8"
      unitRef="usd">-4639000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzM1LTQtMS0xLTA_038ffe51-e0dd-4449-b1d2-66f6bcec94b8"
      unitRef="usd">3331000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzM1LTYtMS0xLTA_36deb11b-5013-4836-a538-76f7cc59696d"
      unitRef="usd">-689000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzM2LTItMS0xLTA_15e9b253-4105-404b-bf33-0028b39a4cfe"
      unitRef="usd">-239474000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzM2LTQtMS0xLTA_4a4b6e63-23c2-4b89-a4bc-85d0e6ba0507"
      unitRef="usd">293602000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzM2LTYtMS0xLTA_3266e7ad-6169-4d4a-9440-b5dd14fa8b4e"
      unitRef="usd">-33468000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzM3LTItMS0xLTA_7105a6ec-cab2-4a98-b6ff-711ea789e49b"
      unitRef="usd">383928000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i0c634b937c58472e84857eacf99e17df_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzM3LTQtMS0xLTA_414e8f0f-24c0-4633-9caf-07b5ba14612d"
      unitRef="usd">90326000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i28d0821cac8841b29cf960002d3bc993_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzM3LTYtMS0xLTA_a2a74a5a-1fc5-4ee9-a740-9cf2cfda87ac"
      unitRef="usd">123794000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzM4LTItMS0xLTA_874ae737-458f-431b-8700-85910e01b8e5"
      unitRef="usd">144454000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzM4LTQtMS0xLTA_48598edc-6a1d-4826-a090-518288717d2a"
      unitRef="usd">383928000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i0c634b937c58472e84857eacf99e17df_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNjYvZnJhZzpiYzAxMGYzNGVkNDA0MmZhYjUwZmE1N2I5NTAzNmJkOS90YWJsZTpmN2JhN2FhMTAzOGI0NTEwYTIzYWUxMThmYzcxZDZiZC90YWJsZXJhbmdlOmY3YmE3YWExMDM4YjQ1MTBhMjNhZTExOGZjNzFkNmJkXzM4LTYtMS0xLTA_8ff2001c-4a93-4603-9223-902d3785f2aa"
      unitRef="usd">90326000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzIvZnJhZzoxNWNmZjJlMWNjMmY0MzA1OTAwOWMxOGIyZjQ5MDg4YS90ZXh0cmVnaW9uOjE1Y2ZmMmUxY2MyZjQzMDU5MDA5YzE4YjJmNDkwODhhXzI5Mzg_e409fe1c-95a1-4747-a060-7f30711b41cf">NATURE OF BUSINESS, BASIS OF PRESENTATION AND PRINCIPLES OF CONSOLIDATION&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying consolidated financial statements of IDEXX Laboratories, Inc. and its subsidiaries have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") and with the requirements of Regulation S-X.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These statements include the accounts of IDEXX Laboratories, Inc., and our wholly-owned and majority-owned subsidiaries (&#x201c;IDEXX,&#x201d; the &#x201c;Company,&#x201d; &#x201c;we,&#x201d; or &#x201c;our&#x201d;). We do not have any variable interest entities for which we are the primary beneficiary. All intercompany transactions and balances have been eliminated in&#160;consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have included certain terms and abbreviations used throughout this Annual Report on Form 10-K in the &#x201c;Glossary of Terms and Selected Abbreviations.&#x201d;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We develop, manufacture, and distribute products and provide services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing industries. We also sell human medical point-of-care products and laboratory diagnostics. Our principal line of business, which we refer to as our Companion Animal Group (&#x201c;CAG&#x201d;) operating segment, provides diagnostic capabilities and information management solutions for the companion animal veterinary industry, as well as the biomedical research community. Our principal regions for these products and services are the United States (&#x201c;U.S.&#x201d;), Europe, Japan, China, and Australia, but we also sell to customers and distributors in many other countries around the world. Our Water operating segment provides innovative testing solutions for the quality and safety of water principally in the U.S. and Europe, but we also sell to customers in many other countries around the world. Our Livestock, Poultry and Dairy (&#x201c;LPD&#x201d;) operating segment provides diagnostic tests and related instrumentation and performs services that are used to manage the health status of livestock and poultry, to improve producer efficiency, and to ensure the quality and safety of milk. Our principal regions for these products and services are Europe, China, and Australia, but we also sell to customers in many other countries around the world. We also operate a smaller operating segment that is comprised of our human medical diagnostic products and services business (&#x201c;OPTI Medical&#x201d;). Financial information about our OPTI Medical operating segment is combined and presented with our out-licensing arrangements remaining from our pharmaceutical business in an &#x201c;Other&#x201d; category because they do not meet the quantitative or qualitative thresholds for reportable segments. Refer to "Note 3. Revenue Recognition" for additional information regarding disaggregated revenue by segment, major product and service categories, and geographical areas. Refer to "Note 17. Segment Reporting" for additional information regarding our reportable operating segments.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzUvZnJhZzoyMGZkYjA1ZDllZjM0ODQyYmVjNzIwYzAxMzcxMTc1Yy90ZXh0cmVnaW9uOjIwZmRiMDVkOWVmMzQ4NDJiZWM3MjBjMDEzNzExNzVjXzEzNTM0_168b9816-8b10-4a97-ab8f-7b9f733a1851">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Estimates&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of these consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures. On an ongoing basis, we evaluate these estimates, including those related to reserves for accounts receivable; goodwill and other intangible assets; income taxes; inventory valuation; revenue recognition, product returns, customer programs, and multiple element arrangements; share-based compensation; warranty reserves; self-insurance reserves; fair value measurements and loss contingencies. We accrue contingent liabilities when it is probable that future expenditures will be made and such expenditures can be reasonably estimated. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ materially from these estimates.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;b&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We consider all highly liquid investments with original maturities of ninety days or less to be cash equivalents. Cash and cash equivalents consist primarily of demand deposits, money market funds, and short-duration agency bonds and commercial paper as described above. There is no restricted cash on our consolidated balance sheets for the years ended December 31, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(c)&#160;&#160;&#160;&#160;Inventories &#x2013; Refer to Note 7 &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(d)&#160;&#160;&#160;&#160;Property and Equipment &#x2013; Refer to Note 9 &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(e)&#160;&#160;&#160;&#160;Goodwill and Other Intangible Assets &#x2013; Refer to Note 11 &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(f)&#160;&#160;&#160;&#160;Warranty Reserves&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We provide a standard twelve-month warranty on all instruments sold. We recognize the cost of instrument warranties in cost of product revenue at the time revenue is recognized based on the estimated cost to repair the instrument over its warranty period. Cost of product revenue reflects not only estimated warranty expense for instruments sold in the current period, but also any changes in estimated warranty expense for the portion of the aggregate installed base that is under warranty. Estimated warranty expense is based on a variety of inputs, including historical instrument performance in the customers&#x2019; environments, historical and estimated costs incurred in servicing instruments and projected instrument reliability. Should actual service rates or costs differ from our estimates, revisions to the estimated warranty liability would be required. The liability for warranties is included in accrued liabilities in the accompanying consolidated balance sheets. The amount of warranty reserve during the years ended December 31, 2021 and 2020, was not material.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(g)&#160;&#160;&#160;&#160;Income Taxes &#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Refer to Note 14 &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(h)&#160;&#160;&#160;&#160;Taxes Remitted to Governmental Authorities by IDEXX on Behalf of Customer&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We calculate, collect from our customers, and remit to governmental authorities, sales, value-added, and excise taxes assessed by governmental authorities in connection with revenue-producing transactions with our customers. We report these taxes on a net basis and do not include these tax amounts in revenue or cost of product or service revenue.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(i)&#160;&#160;&#160;&#160;Revenue Recognition &#x2013; Refer to Note 3 &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(j)&#160;&#160;&#160;&#160;Research and Development Costs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development costs, which consist of employee compensation and benefits, materials and external consulting, and product development costs, are expensed as incurred. We evaluate our research and development costs for capitalization after the technological feasibility has been established for software and products containing software to be sold; however, no costs were capitalized during the years ended December 31, 2021, 2020, and 2019. Software developed to deliver hosted services to our customers has been designated as internal use, and we capitalize certain costs incurred in connection with developing or obtaining software designated for internal use based on three distinct stages of development. Refer to "Note 9. Property and Equipment, Net" for further information on internal use software. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(k)&#160;&#160;&#160;&#160;Advertising Costs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Advertising costs, which are recognized as sales and marketing expense in the period in which they are incurred, were $3.3 million, $1.4 million, and $1.5 million for the years ended December 31, 2021, 2020, and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(l)&#160;&#160;&#160;&#160;Legal Costs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Legal costs are considered period costs and, accordingly, are expensed in the year services are provided.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(m)&#160;&#160;&#160;&#160;Share-Based Compensation &#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Refer to Note 5 &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(n)&#160;&#160;&#160;&#160;Self-Insurance Accruals &#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Refer to Note 16 &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(o)&#160;&#160;&#160;&#160;Leases &#x2013; Refer to&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Note 8 &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(p)&#160;&#160;&#160;&#160;Earnings per Share &#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Refer to Note 15 &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(q)&#160;&#160;&#160;&#160;Foreign Currency&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The functional currency of all except eight of our subsidiaries is their local currency, however, the assets and liabilities of the majority of our foreign subsidiaries are translated to the U.S. dollar using the exchange rate in effect at the balance sheet date. Revenue and expense accounts are translated to the U.S. dollar using the exchange rate at the date which those elements are recognized, and where it is impractical to do so, an average exchange rate in effect during the period is used to translate those elements. Cumulative translation gains and losses are shown in the accompanying consolidated balance sheets as a separate component of accumulated other comprehensive income (&#x201c;AOCI&#x201d;). &#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues and expenses denominated in a currency other than the respective subsidiary&#x2019;s functional currency are recorded at the current exchange rate when the transaction is recognized. Monetary assets and liabilities denominated in a currency other than the respective subsidiary&#x2019;s functional currency are remeasured at each balance sheet date using the exchange rate in effect at each balance sheet date. These foreign currency gains and losses are included in general and administrative expenses within our Other segment. We recognized aggregate foreign currency losses of $2.1 million, gains of $0.6 million, and losses of $1.1 million for the years ended December 31, 2021, 2020, and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(r)&#160;&#160;&#160;&#160;Hedging Instruments &#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Refer to Note 19 &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(s)&#160;&#160;&#160;&#160;Fair Value Measurements &#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Refer to Note 18 &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(t)&#160;&#160;&#160;&#160;Comprehensive Income&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;We report all changes in equity, including net income and transactions or other events and circumstances from non-owner sources during the period in which they are recognized. We have chosen to present comprehensive income, which encompasses net income, foreign currency translation adjustments, gains and losses on our net investment hedges and the difference between the cost and the fair market value of investments in debt and equity securities, and forward currency exchange contracts, in the consolidated statements of comprehensive income. Refer to "Note 21. Accumulated Other Comprehensive Income" for information about the effects on net income of significant amounts reclassified out of each component of AOCI for the years ended December 31, 2021, 2020, and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(u)&#160;&#160;&#160;&#160;Concentrations of Risk&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Financial instruments that potentially subject us to concentrations of credit risk are principally cash, cash equivalents, accounts receivable, and derivatives. To mitigate such risk with respect to cash and cash equivalents, we place our cash with highly-rated financial institutions, in non-interest bearing accounts that are insured by the U.S. government and money market funds invested in government securities. Concentration of credit risk with respect to accounts receivable is limited to certain customers to whom we make substantial sales. To reduce risk, we routinely assess the financial strength of our most significant customers and monitor the amounts owed to us, taking appropriate action when necessary. As a result, we believe that accounts receivable credit risk exposure is limited. We maintain an allowance for doubtful accounts, but historically have not experienced any material losses related to an individual customer or group of customers in any particular industry or geographic area.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To mitigate concentration of credit risk with respect to derivatives we enter into transactions with highly-rated financial institutions, enter into master netting arrangements with counterparties to our derivative transactions and frequently monitor the creditworthiness of our counterparties. Our master netting arrangements reduce our exposure in that they permit outstanding receivables and payables with the counterparties to our derivative transactions to be offset in the event of default. We have not incurred such losses and consider the risk of counterparty default to be minimal.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Inventory&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. If we are unable to obtain adequate quantities of the inventory we need to sell our products, we could face cost increases or delays or discontinuations in product shipments, which could have a material adverse effect on our results of operations. Many of the third parties that provide us with the instruments we sell, as well as certain components, raw materials and consumables used in or with our products, are sole or single-source suppliers. Some of the products that we purchase from these sources are proprietary or complex in nature, and, therefore, cannot be readily or easily replaced by alternative sources.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(v)&#160;&#160;&#160;&#160;New Accounting Pronouncements Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We adopted ASU 2016-02, "Leases (Topic 842)," as of January 1, 2019, using the optional transition method that allows for a cumulative-effect adjustment in the period of adoption and did not restate prior periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We adopted ASU 2018-13, "Fair Value Measurement (Topic 820)," as of January 1, 2020, which modifies the disclosure requirements on fair value measurements under ASC Topic No. 820, Fair Value Measurement, as amended (&#x201c;ASC 820&#x201d;). ASU 2018-13 removes (a) the prior requirement to disclose the amount and reason for transfers between Level 1 and Level 2 of the fair value hierarchy contained in ASC 820, (b) the policy for timing of transfers between levels, and (c) the valuation processes used for Level 3 fair value measurements. ASU 2018-13 also adds, among other things, a requirement to disclose the range and weighted average of significant unobservable inputs used in Level 3 fair value measurements. The adoption did not have a material impact on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#160;&#160;&#160;&#160;We adopted ASU 2016-13, &#x201c;Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,&#x201d; effective January 1, 2020, using the modified retrospective transition method. This ASU amends the impairment model to utilize an expected loss methodology in place of the incurred loss methodology for financial instruments, including trade receivables and leased equipment. The amendment requires entities to consider a broader range of information to estimate expected credit losses, which may result in earlier recognition of losses. We recorded a non-cash cumulative effect adjustment to retained earnings of $1.8&#160;million, net of $0.6&#160;million of income taxes, on our opening consolidated balance sheet as of January 1, 2020. This adjustment, before the impact of income taxes, was comprised of $2.3&#160;million related to our contract assets and sales-type leases, and $0.2&#160;million related to accounts receivable. Refer to "Note 6. Credit Losses" for more information on our presentation of credit losses.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effective January 1, 2021, we adopted ASU 2019-12, &#x201c;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes.&#x201d; The new guidance is intended to simplify the accounting for income taxes by removing certain exceptions and by updating accounting requirements around goodwill recognized for tax purposes and the allocation of current and deferred tax expense among legal entities, among other minor changes. The adoption of ASU 2019-12 did not have a material impact on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In July 2021, the FASB issued ASU 2021-05, &#x201c;Leases (Topic 842); Lessors - Certain Leases with Variable Lease Payments.&#x201d; ASU 2021-05 requires a lessor to classify a lease with variable payments that do not depend on an index or rate as an operating lease if another lease classification (i.e., sales-type or direct financing) would result in recognition of a day-one loss. We have elected to adopt this standard as of the third quarter of 2021, on a prospective basis. The adoption of ASU 2021-05 did not have a material impact on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(w)&#160;&#160;&#160;&#160;New Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2021, the FASB issued ASU 2021-08, &#x201c;Business Combinations (Topic 805): Accounting for Acquired Contract Assets and Contract Liabilities.&#x201d; ASU 2021-08 is intended to improve comparability for both the recognition and measurement of acquired revenue contracts with customers at the date of and after a business combination by providing consistent recognition guidance. This standard is effective for fiscal years beginning after December 15, 2022. Adoption of the ASU 2021-08 should be applied prospectively. Early adoption is permitted, including in an interim period, for any period for which financial statements have not yet been issued. We are currently evaluating the impact, if any, of ASU 2021-08 on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued ASU 2020-04, "Facilitation of the Effects of Reference Rate Reform on Financial Reporting.&#x201d; ASU 2020-04 is intended to provide optional expedients and exceptions to the U.S. GAAP guidance on contract modifications and hedge accounting to ease the financial reporting burdens related to the discontinuation of the London Interbank Offered Rate (&#x201c;LIBOR&#x201d;) or by another reference rate expected to be discontinued. The FASB also issued ASU 2021-01, "Reference Rate Reform (Topic 848): Scope," in January 2021. It clarifies that certain optional expedients and exceptions apply to derivatives that are affected by the discounting transition. The amendments in this ASU affect the guidance in ASU No. 2020-04 and are effective in the same timeframe as ASU 2020-04. The relief offered by this guidance, if adopted, is available to companies for the period March 12, 2020 through December 31, 2022. Our Credit Facility includes a provision for the determination of a benchmark replacement rate as a successor to the LIBOR rate, therefore; we do not expect the discontinuation of LIBOR to have an impact on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzUvZnJhZzoyMGZkYjA1ZDllZjM0ODQyYmVjNzIwYzAxMzcxMTc1Yy90ZXh0cmVnaW9uOjIwZmRiMDVkOWVmMzQ4NDJiZWM3MjBjMDEzNzExNzVjXzEzNTUw_a184097d-9e43-4b38-9b83-2e27e7f552b3">EstimatesThe preparation of these consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures. On an ongoing basis, we evaluate these estimates, including those related to reserves for accounts receivable; goodwill and other intangible assets; income taxes; inventory valuation; revenue recognition, product returns, customer programs, and multiple element arrangements; share-based compensation; warranty reserves; self-insurance reserves; fair value measurements and loss contingencies. We accrue contingent liabilities when it is probable that future expenditures will be made and such expenditures can be reasonably estimated. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ materially from these estimates.</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzUvZnJhZzoyMGZkYjA1ZDllZjM0ODQyYmVjNzIwYzAxMzcxMTc1Yy90ZXh0cmVnaW9uOjIwZmRiMDVkOWVmMzQ4NDJiZWM3MjBjMDEzNzExNzVjXzEzNTI2_9540dee4-7e51-41b8-83a8-623e55e03f69">Cash and Cash EquivalentsWe consider all highly liquid investments with original maturities of ninety days or less to be cash equivalents. Cash and cash equivalents consist primarily of demand deposits, money market funds, and short-duration agency bonds and commercial paper as described above.</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzUvZnJhZzoyMGZkYjA1ZDllZjM0ODQyYmVjNzIwYzAxMzcxMTc1Yy90ZXh0cmVnaW9uOjIwZmRiMDVkOWVmMzQ4NDJiZWM3MjBjMDEzNzExNzVjXzE3Nzg_3a43f338-0acb-423b-8069-a8fd0a7a8058"
      unitRef="usd">0</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzUvZnJhZzoyMGZkYjA1ZDllZjM0ODQyYmVjNzIwYzAxMzcxMTc1Yy90ZXh0cmVnaW9uOjIwZmRiMDVkOWVmMzQ4NDJiZWM3MjBjMDEzNzExNzVjXzE3Nzg_a858cc59-c5d2-4214-99e6-23baf53a2de5"
      unitRef="usd">0</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:StandardProductWarrantyPolicy
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzUvZnJhZzoyMGZkYjA1ZDllZjM0ODQyYmVjNzIwYzAxMzcxMTc1Yy90ZXh0cmVnaW9uOjIwZmRiMDVkOWVmMzQ4NDJiZWM3MjBjMDEzNzExNzVjXzEzNTI3_b264ca6b-11ed-49da-ab9a-36372b4ce884">Warranty ReservesWe provide a standard twelve-month warranty on all instruments sold. We recognize the cost of instrument warranties in cost of product revenue at the time revenue is recognized based on the estimated cost to repair the instrument over its warranty period. Cost of product revenue reflects not only estimated warranty expense for instruments sold in the current period, but also any changes in estimated warranty expense for the portion of the aggregate installed base that is under warranty. Estimated warranty expense is based on a variety of inputs, including historical instrument performance in the customers&#x2019; environments, historical and estimated costs incurred in servicing instruments and projected instrument reliability. Should actual service rates or costs differ from our estimates, revisions to the estimated warranty liability would be required. The liability for warranties is included in accrued liabilities in the accompanying consolidated balance sheets.</us-gaap:StandardProductWarrantyPolicy>
    <idxx:TaxesRemittedToGovernmentalAuthoritiesOnBehalfOfCustomerPolicyTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzUvZnJhZzoyMGZkYjA1ZDllZjM0ODQyYmVjNzIwYzAxMzcxMTc1Yy90ZXh0cmVnaW9uOjIwZmRiMDVkOWVmMzQ4NDJiZWM3MjBjMDEzNzExNzVjXzEzNTQ2_c1594c82-b593-4556-8005-e076003f73f5">Taxes Remitted to Governmental Authorities by IDEXX on Behalf of CustomerWe calculate, collect from our customers, and remit to governmental authorities, sales, value-added, and excise taxes assessed by governmental authorities in connection with revenue-producing transactions with our customers. We report these taxes on a net basis and do not include these tax amounts in revenue or cost of product or service revenue.</idxx:TaxesRemittedToGovernmentalAuthoritiesOnBehalfOfCustomerPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzUvZnJhZzoyMGZkYjA1ZDllZjM0ODQyYmVjNzIwYzAxMzcxMTc1Yy90ZXh0cmVnaW9uOjIwZmRiMDVkOWVmMzQ4NDJiZWM3MjBjMDEzNzExNzVjXzEzNTQz_15cd0857-5173-4cde-b0ec-a83de8e45dd0">Research and Development CostsResearch and development costs, which consist of employee compensation and benefits, materials and external consulting, and product development costs, are expensed as incurred. We evaluate our research and development costs for capitalization after the technological feasibility has been established for software and products containing software to be sold; however, no costs were capitalized during the years ended December 31, 2021, 2020, and 2019. Software developed to deliver hosted services to our customers has been designated as internal use, and we capitalize certain costs incurred in connection with developing or obtaining software designated for internal use based on three distinct stages of development. Refer to "Note 9. Property and Equipment, Net" for further information on internal use software.</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <idxx:ResearchAndDevelopmentCostsCapitalized
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzUvZnJhZzoyMGZkYjA1ZDllZjM0ODQyYmVjNzIwYzAxMzcxMTc1Yy90ZXh0cmVnaW9uOjIwZmRiMDVkOWVmMzQ4NDJiZWM3MjBjMDEzNzExNzVjXzM5NzQ_4935365b-3c20-4117-974f-614a5af6b62b"
      unitRef="usd">0</idxx:ResearchAndDevelopmentCostsCapitalized>
    <idxx:ResearchAndDevelopmentCostsCapitalized
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzUvZnJhZzoyMGZkYjA1ZDllZjM0ODQyYmVjNzIwYzAxMzcxMTc1Yy90ZXh0cmVnaW9uOjIwZmRiMDVkOWVmMzQ4NDJiZWM3MjBjMDEzNzExNzVjXzM5NzQ_4aa5f4f8-62a6-46c3-9584-b991cf07a699"
      unitRef="usd">0</idxx:ResearchAndDevelopmentCostsCapitalized>
    <idxx:ResearchAndDevelopmentCostsCapitalized
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzUvZnJhZzoyMGZkYjA1ZDllZjM0ODQyYmVjNzIwYzAxMzcxMTc1Yy90ZXh0cmVnaW9uOjIwZmRiMDVkOWVmMzQ4NDJiZWM3MjBjMDEzNzExNzVjXzM5NzQ_928a15c7-b83a-4438-83a7-94079bf6d112"
      unitRef="usd">0</idxx:ResearchAndDevelopmentCostsCapitalized>
    <us-gaap:AdvertisingCostsPolicyTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzUvZnJhZzoyMGZkYjA1ZDllZjM0ODQyYmVjNzIwYzAxMzcxMTc1Yy90ZXh0cmVnaW9uOjIwZmRiMDVkOWVmMzQ4NDJiZWM3MjBjMDEzNzExNzVjXzEzNTEy_7d4afc3d-3de9-46b1-852d-6d6211e0bdcc">Advertising CostsAdvertising costs, which are recognized as sales and marketing expense in the period in which they are incurred, were $3.3 million, $1.4 million, and $1.5 million for the years ended December 31, 2021, 2020, and 2019, respectively.</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:AdvertisingExpense
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzUvZnJhZzoyMGZkYjA1ZDllZjM0ODQyYmVjNzIwYzAxMzcxMTc1Yy90ZXh0cmVnaW9uOjIwZmRiMDVkOWVmMzQ4NDJiZWM3MjBjMDEzNzExNzVjXzQ1MTc_9961c4b4-70ca-460b-a276-8421b6bb55d1"
      unitRef="usd">3300000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzUvZnJhZzoyMGZkYjA1ZDllZjM0ODQyYmVjNzIwYzAxMzcxMTc1Yy90ZXh0cmVnaW9uOjIwZmRiMDVkOWVmMzQ4NDJiZWM3MjBjMDEzNzExNzVjXzQ1MjE_e73e3f5a-6d01-47fc-8c32-e2263237176b"
      unitRef="usd">1400000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzUvZnJhZzoyMGZkYjA1ZDllZjM0ODQyYmVjNzIwYzAxMzcxMTc1Yy90ZXh0cmVnaW9uOjIwZmRiMDVkOWVmMzQ4NDJiZWM3MjBjMDEzNzExNzVjXzQ1Mjk_4c1b473a-d977-45ed-b2ea-d7e16a4518bf"
      unitRef="usd">1500000</us-gaap:AdvertisingExpense>
    <us-gaap:LegalCostsPolicyTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzUvZnJhZzoyMGZkYjA1ZDllZjM0ODQyYmVjNzIwYzAxMzcxMTc1Yy90ZXh0cmVnaW9uOjIwZmRiMDVkOWVmMzQ4NDJiZWM3MjBjMDEzNzExNzVjXzEzNTIz_0f320136-e787-4f15-ac7f-f9d008613d4f">Legal CostsLegal costs are considered period costs and, accordingly, are expensed in the year services are provided.</us-gaap:LegalCostsPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzUvZnJhZzoyMGZkYjA1ZDllZjM0ODQyYmVjNzIwYzAxMzcxMTc1Yy90ZXh0cmVnaW9uOjIwZmRiMDVkOWVmMzQ4NDJiZWM3MjBjMDEzNzExNzVjXzEzNTU3_333ca656-9185-4fe3-ae4f-64b1bb32bc20">Foreign CurrencyThe functional currency of all except eight of our subsidiaries is their local currency, however, the assets and liabilities of the majority of our foreign subsidiaries are translated to the U.S. dollar using the exchange rate in effect at the balance sheet date. Revenue and expense accounts are translated to the U.S. dollar using the exchange rate at the date which those elements are recognized, and where it is impractical to do so, an average exchange rate in effect during the period is used to translate those elements. Cumulative translation gains and losses are shown in the accompanying consolidated balance sheets as a separate component of accumulated other comprehensive income (&#x201c;AOCI&#x201d;). &#160;Revenues and expenses denominated in a currency other than the respective subsidiary&#x2019;s functional currency are recorded at the current exchange rate when the transaction is recognized. Monetary assets and liabilities denominated in a currency other than the respective subsidiary&#x2019;s functional currency are remeasured at each balance sheet date using the exchange rate in effect at each balance sheet date. These foreign currency gains and losses are included in general and administrative expenses within our Other segment.</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzUvZnJhZzoyMGZkYjA1ZDllZjM0ODQyYmVjNzIwYzAxMzcxMTc1Yy90ZXh0cmVnaW9uOjIwZmRiMDVkOWVmMzQ4NDJiZWM3MjBjMDEzNzExNzVjXzYxMzU_641335c5-b72e-4254-8c00-239398742650"
      unitRef="usd">-2100000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzUvZnJhZzoyMGZkYjA1ZDllZjM0ODQyYmVjNzIwYzAxMzcxMTc1Yy90ZXh0cmVnaW9uOjIwZmRiMDVkOWVmMzQ4NDJiZWM3MjBjMDEzNzExNzVjXzYxNTM_8687bbbf-50c7-464c-b93c-b982e5da2779"
      unitRef="usd">600000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzUvZnJhZzoyMGZkYjA1ZDllZjM0ODQyYmVjNzIwYzAxMzcxMTc1Yy90ZXh0cmVnaW9uOjIwZmRiMDVkOWVmMzQ4NDJiZWM3MjBjMDEzNzExNzVjXzYxNjA_c8b42c23-510a-49eb-83c9-eb75c8534a0f"
      unitRef="usd">-1100000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzUvZnJhZzoyMGZkYjA1ZDllZjM0ODQyYmVjNzIwYzAxMzcxMTc1Yy90ZXh0cmVnaW9uOjIwZmRiMDVkOWVmMzQ4NDJiZWM3MjBjMDEzNzExNzVjXzEzNTUz_82fa2710-070b-4fb8-bf99-6f1913e8ad0e">Comprehensive Income&#160;&#160;&#160;&#160;We report all changes in equity, including net income and transactions or other events and circumstances from non-owner sources during the period in which they are recognized. We have chosen to present comprehensive income, which encompasses net income, foreign currency translation adjustments, gains and losses on our net investment hedges and the difference between the cost and the fair market value of investments in debt and equity securities, and forward currency exchange contracts, in the consolidated statements of comprehensive income. Refer to</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <idxx:ConcentrationRiskPolicyTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzUvZnJhZzoyMGZkYjA1ZDllZjM0ODQyYmVjNzIwYzAxMzcxMTc1Yy90ZXh0cmVnaW9uOjIwZmRiMDVkOWVmMzQ4NDJiZWM3MjBjMDEzNzExNzVjXzEzNTMw_cbe1cb29-3d10-4288-9c07-043665a0b665">Concentrations of Risk&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Financial instruments that potentially subject us to concentrations of credit risk are principally cash, cash equivalents, accounts receivable, and derivatives. To mitigate such risk with respect to cash and cash equivalents, we place our cash with highly-rated financial institutions, in non-interest bearing accounts that are insured by the U.S. government and money market funds invested in government securities. Concentration of credit risk with respect to accounts receivable is limited to certain customers to whom we make substantial sales. To reduce risk, we routinely assess the financial strength of our most significant customers and monitor the amounts owed to us, taking appropriate action when necessary. As a result, we believe that accounts receivable credit risk exposure is limited. We maintain an allowance for doubtful accounts, but historically have not experienced any material losses related to an individual customer or group of customers in any particular industry or geographic area.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To mitigate concentration of credit risk with respect to derivatives we enter into transactions with highly-rated financial institutions, enter into master netting arrangements with counterparties to our derivative transactions and frequently monitor the creditworthiness of our counterparties. Our master netting arrangements reduce our exposure in that they permit outstanding receivables and payables with the counterparties to our derivative transactions to be offset in the event of default. We have not incurred such losses and consider the risk of counterparty default to be minimal.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Inventory&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. If we are unable to obtain adequate quantities of the inventory we need to sell our products, we could face cost increases or delays or discontinuations in product shipments, which could have a material adverse effect on our results of operations. Many of the third parties that provide us with the instruments we sell, as well as certain components, raw materials and consumables used in or with our products, are sole or single-source suppliers. Some of the products that we purchase from these sources are proprietary or complex in nature, and, therefore, cannot be readily or easily replaced by alternative sources.&lt;/span&gt;&lt;/div&gt;</idxx:ConcentrationRiskPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzUvZnJhZzoyMGZkYjA1ZDllZjM0ODQyYmVjNzIwYzAxMzcxMTc1Yy90ZXh0cmVnaW9uOjIwZmRiMDVkOWVmMzQ4NDJiZWM3MjBjMDEzNzExNzVjXzEzNTI1_5d2d9431-1e96-4f8f-a40d-edb7cb158794">New Accounting Pronouncements Adopted&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We adopted ASU 2016-02, "Leases (Topic 842)," as of January 1, 2019, using the optional transition method that allows for a cumulative-effect adjustment in the period of adoption and did not restate prior periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We adopted ASU 2018-13, "Fair Value Measurement (Topic 820)," as of January 1, 2020, which modifies the disclosure requirements on fair value measurements under ASC Topic No. 820, Fair Value Measurement, as amended (&#x201c;ASC 820&#x201d;). ASU 2018-13 removes (a) the prior requirement to disclose the amount and reason for transfers between Level 1 and Level 2 of the fair value hierarchy contained in ASC 820, (b) the policy for timing of transfers between levels, and (c) the valuation processes used for Level 3 fair value measurements. ASU 2018-13 also adds, among other things, a requirement to disclose the range and weighted average of significant unobservable inputs used in Level 3 fair value measurements. The adoption did not have a material impact on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#160;&#160;&#160;&#160;We adopted ASU 2016-13, &#x201c;Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,&#x201d; effective January 1, 2020, using the modified retrospective transition method. This ASU amends the impairment model to utilize an expected loss methodology in place of the incurred loss methodology for financial instruments, including trade receivables and leased equipment. The amendment requires entities to consider a broader range of information to estimate expected credit losses, which may result in earlier recognition of losses. We recorded a non-cash cumulative effect adjustment to retained earnings of $1.8&#160;million, net of $0.6&#160;million of income taxes, on our opening consolidated balance sheet as of January 1, 2020. This adjustment, before the impact of income taxes, was comprised of $2.3&#160;million related to our contract assets and sales-type leases, and $0.2&#160;million related to accounts receivable. Refer to "Note 6. Credit Losses" for more information on our presentation of credit losses.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effective January 1, 2021, we adopted ASU 2019-12, &#x201c;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes.&#x201d; The new guidance is intended to simplify the accounting for income taxes by removing certain exceptions and by updating accounting requirements around goodwill recognized for tax purposes and the allocation of current and deferred tax expense among legal entities, among other minor changes. The adoption of ASU 2019-12 did not have a material impact on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In July 2021, the FASB issued ASU 2021-05, &#x201c;Leases (Topic 842); Lessors - Certain Leases with Variable Lease Payments.&#x201d; ASU 2021-05 requires a lessor to classify a lease with variable payments that do not depend on an index or rate as an operating lease if another lease classification (i.e., sales-type or direct financing) would result in recognition of a day-one loss. We have elected to adopt this standard as of the third quarter of 2021, on a prospective basis. The adoption of ASU 2021-05 did not have a material impact on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;New Accounting Pronouncements Not Yet Adopted&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2021, the FASB issued ASU 2021-08, &#x201c;Business Combinations (Topic 805): Accounting for Acquired Contract Assets and Contract Liabilities.&#x201d; ASU 2021-08 is intended to improve comparability for both the recognition and measurement of acquired revenue contracts with customers at the date of and after a business combination by providing consistent recognition guidance. This standard is effective for fiscal years beginning after December 15, 2022. Adoption of the ASU 2021-08 should be applied prospectively. Early adoption is permitted, including in an interim period, for any period for which financial statements have not yet been issued. We are currently evaluating the impact, if any, of ASU 2021-08 on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued ASU 2020-04, "Facilitation of the Effects of Reference Rate Reform on Financial Reporting.&#x201d; ASU 2020-04 is intended to provide optional expedients and exceptions to the U.S. GAAP guidance on contract modifications and hedge accounting to ease the financial reporting burdens related to the discontinuation of the London Interbank Offered Rate (&#x201c;LIBOR&#x201d;) or by another reference rate expected to be discontinued. The FASB also issued ASU 2021-01, "Reference Rate Reform (Topic 848): Scope," in January 2021. It clarifies that certain optional expedients and exceptions apply to derivatives that are affected by the discounting transition. The amendments in this ASU affect the guidance in ASU No. 2020-04 and are effective in the same timeframe as ASU 2020-04. The relief offered by this guidance, if adopted, is available to companies for the period March 12, 2020 through December 31, 2022. Our Credit Facility includes a provision for the determination of a benchmark replacement rate as a successor to the LIBOR rate, therefore; we do not expect the discontinuation of LIBOR to have an impact on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i21b5e95e95564226a627f64e7713aea8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzUvZnJhZzoyMGZkYjA1ZDllZjM0ODQyYmVjNzIwYzAxMzcxMTc1Yy90ZXh0cmVnaW9uOjIwZmRiMDVkOWVmMzQ4NDJiZWM3MjBjMDEzNzExNzVjXzExMjUx_b4658067-17e5-4607-a14f-9523fb0cee2d"
      unitRef="usd">1800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquityCumulativeEffectOfChangeInAccountingPrinciple
      contextRef="idb0fcabcbe0847e89f685ded467776c8_D20200101-20200101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzUvZnJhZzoyMGZkYjA1ZDllZjM0ODQyYmVjNzIwYzAxMzcxMTc1Yy90ZXh0cmVnaW9uOjIwZmRiMDVkOWVmMzQ4NDJiZWM3MjBjMDEzNzExNzVjXzExMjYy_a33f5d2c-1a34-4187-8e1e-b9e557a958c5"
      unitRef="usd">-600000</us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquityCumulativeEffectOfChangeInAccountingPrinciple>
    <idxx:ContractwithCustomerAssetAndSalesTypeLeaseNetInvestmentInLeaseAllowanceforCreditLoss
      contextRef="ic23d3f2012b145a986354fd6baa91f83_I20200101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzUvZnJhZzoyMGZkYjA1ZDllZjM0ODQyYmVjNzIwYzAxMzcxMTc1Yy90ZXh0cmVnaW9uOjIwZmRiMDVkOWVmMzQ4NDJiZWM3MjBjMDEzNzExNzVjXzExNDE2_9cb1620b-c278-4c3a-9fb1-8104037c435c"
      unitRef="usd">2300000</idxx:ContractwithCustomerAssetAndSalesTypeLeaseNetInvestmentInLeaseAllowanceforCreditLoss>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="ic23d3f2012b145a986354fd6baa91f83_I20200101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzUvZnJhZzoyMGZkYjA1ZDllZjM0ODQyYmVjNzIwYzAxMzcxMTc1Yy90ZXh0cmVnaW9uOjIwZmRiMDVkOWVmMzQ4NDJiZWM3MjBjMDEzNzExNzVjXzExNDc3_d01307e9-d41b-4772-8e67-69aa96de424b"
      unitRef="usd">200000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzIzNTc0_085b6220-4db2-4c0a-bcbf-8a56720282a2">REVENUE RECOGNITION &lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our revenue is recognized when, or as, performance obligations under the terms of a contract are satisfied, which occurs when control of the promised products or services is transferred to a customer. We exclude sales, use, value-added, and other taxes we collect on behalf of third parties from revenue. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring products or services to a customer. To accurately present the consideration received in exchange for promised products or services, we apply the five-step model outlined below:&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"&gt;Identification of a contract or agreement with a customer&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"&gt;Identification of our performance obligations in the contract or agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"&gt;Determination of the transaction price&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"&gt;Allocation of the transaction price to the performance obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"&gt;Recognition of revenue when, or as, we satisfy a performance obligation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We enter into contracts that can include various combinations of products and services, which are generally capable of being distinct and accounted for as separate performance obligations. The timing of revenue recognition, billings, and cash collections results in accounts receivable, lease receivables, and contract assets as a result of revenue recognized in advance of billings (included within other assets), and contract liabilities or deferred revenue as a result of receiving consideration in advance of revenue recognition within our consolidated balance sheet. Our general payment terms range from&#160;30&#160;to&#160;60&#160;days, with exceptions in certain geographies. Below is a listing of our major categories of revenue for our products and services.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Diagnostic Products and Accessories&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Diagnostic products and accessories revenues, including IDEXX VetLab&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; consumables and accessories, rapid assay, LPD, Water, and OPTI testing products, are predominantly recognized and invoiced at the time of shipment, which is when the customer obtains control of the product based on legal title transfer and we have the right to payment. We also provide customers with certain consumables that are recognized upon utilization by the customer, which is when we have the right to payment and the risks and rewards of ownership transfer. Shipping costs reimbursed by the customer are included in revenue and cost of sales. As a practical expedient, we do not account for shipping activities as a separate performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Laboratory Diagnostic and Consulting Services&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Laboratory diagnostic and consulting services revenues are recognized and invoiced when the laboratory diagnostic service is performed.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Instruments, Software and Systems&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&#160;CAG Diagnostics capital instruments, veterinary software, and diagnostic imaging systems revenues are recognized and invoiced when the customer obtains control of the products based on legal title transfer and we have the right to payment, which generally occurs at the time of installation and customer acceptance. Our instruments, software, and systems are often included in one of our significant customer programs, as further described below. For veterinary software systems that include multiple performance obligations, such as perpetual software licenses and computer hardware, we allocate revenue to each performance obligation based on estimates of the price that we would charge the customer for each promised product or service if it were sold on a standalone basis.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Lease Revenue&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Revenues from instrument rental agreements and reagent rental programs are recognized either as operating leases on a ratable basis over the term of the agreement or as sales-type leases at the time of installation and customer acceptance. Customers typically pay for the right to use instruments under rental agreements in equal monthly amounts over the term of the rental agreement. Our reagent rental programs provide our customers the right to use our instruments upon entering into agreements to purchase specified amounts of consumables, which are considered embedded leases. For some agreements, the customers are provided with the right to purchase the instrument at the end of the lease term. Lease revenues from these agreements are presented in product revenue on our consolidated income statement. Lease revenue was approximately $20.8 million for the&#160;year ended December 31, 2021, as compared to $17.5 million for the year ended December 31, 2020, including both operating leases and sales-type leases under ASC 842, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for leases entered into after January 1, 2019, and ASC 840, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for leases entered into prior to 2019. Refer to below for revenue recognition under our reagent rental programs. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Extended Warranties and Post-Contract Support&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. CAG Diagnostics capital instruments and diagnostic imaging systems&#160;extended warranties typically provide customers with continued coverage for a period of&#160;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzQ4MjE_1e3581e2-aa87-4799-8610-c43eba500df3"&gt;one&lt;/span&gt;&#160;to&#160;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzIzNTc2_f9986b18-206a-41dd-850a-8be4c0938fc3"&gt;five&#160;years&lt;/span&gt; beyond the first-year standard warranty. Customers can either pay in full for the extended warranty at the time of instrument or system purchase, or can be billed on a quarterly basis over the term of the contract. We recognize revenue associated with extended &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;warranties over time on a ratable basis using a time-elapsed measure of performance over the contract term, which approximates the expected timing in which applicable services are performed.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Veterinary software post-contract support provides customers with access to technical support when and as needed through access to call centers and online customer assistance. Post-contract support contracts typically have a term of&#160;12 months and customers are billed for post-contract support in equal quarterly amounts over the term. We recognize revenue for post-contract support services over time on a ratable basis using a time elapsed measure of performance over the contract term, which approximates the expected timing in which applicable services are performed.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 31, 2020, our deferred revenue related to extended warranties and post-contract support was&#160;$35.1 million, of which approximately&#160;$23.1 million&#160;was recognized during the year ended&#160;December 31, 2021. Furthermore, as a result of new agreements, our deferred revenue related to extended warranties and post-contract support was $30.0 million at&#160;December 31, 2021. We do not disclose information about remaining performance obligations that are part of contracts with an original expected duration of one year or less, and do not adjust for the effect of the financing components when the period between customer payment and revenue recognition is one year or less. Deferred revenue related to extended warranties and post-contract support with an original duration of more than&#160;one year&#160;was&#160;$16.0 million&#160;at&#160;December 31, 2021, of which approximately 49%,&#160;29%,&#160;14%, 5%,&#160;and&#160;3%&#160;are expected to be recognized during 2022, 2023, 2024, 2025, and thereafter, respectively. Additionally, we have determined these agreements do not include a significant financing component.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;SaaS Subscriptions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&#160;We offer a variety of veterinary software and diagnostic imaging SaaS subscriptions including ezyVet, Animana, Neo, Cornerstone Cloud, Pet Health Network Pro, Petly Plans, Web PACS, rVetLink, and SmartFlow. We recognize revenue for our SaaS subscriptions over time on a ratable basis over the contract term, beginning on the date our service is made available to the customer. Our subscription contracts vary in term from monthly to&#160;two years. Customers typically pay for our subscription contracts in equal monthly amounts over the term of the agreement. Deferred revenue related to our SaaS subscriptions is not material.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Contracts with Multiple Performance Obligations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. We enter into contracts with multiple performance obligations where customers purchase a combination of IDEXX products and services. Determining whether products and services are considered distinct performance obligations that should be accounted for separately requires significant judgment. We determine the transaction price for a contract based on the total consideration we expect to receive in exchange for the transferred goods or services. To the extent the transaction price includes variable consideration, such as volume rebates or expected price adjustments, we apply judgment in constraining the estimated variable consideration due to factors that may cause reversal of revenue recognized. We evaluate constraints based on our historical and projected experience with similar customer contracts.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We allocate revenue to each performance obligation in proportion to the relative standalone selling prices, and recognize revenue when transfer of the related goods or services has occurred for each obligation. We utilize the observable standalone selling price when available, which represents the price charged for the performance obligation when sold separately. When standalone selling prices for our products or services are not directly observable, we determine the standalone selling prices using relevant information available and apply suitable estimation methods including, but not limited to, the cost plus a margin approach. We recognize revenue as each performance obligation is satisfied, either at a point in time or over time, as described in the revenue categories above. We do not disclose information about remaining performance obligations that are part of contracts with an original expected duration of one year or less.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following customer programs represent our most significant customer contracts which contain multiple performance obligations:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Customer Commitment Programs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. We offer customer incentives upon entering into multi-year agreements to   purchase annual minimum amounts of products and services.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Up-Front Customer Loyalty Programs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Our up-front loyalty programs provide customers with incentives in the form of cash payments or IDEXX Points upon entering into multi-year agreements to purchase annual minimum amounts of future products or services. If a customer breaches their agreement, they are required to refund all or a portion of the up-front cash or IDEXX Points, or make other repayments, remedial actions, or both. Up-front incentives to customers in the form of cash or IDEXX Points are not made in exchange for distinct goods or services and are capitalized as customer acquisition costs within other current and long-term assets, which are subsequently recognized as a reduction to revenue over the term of the customer agreement. If these up-front incentives are subsequently utilized to purchase instruments, we &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;allocate total consideration, including future committed purchases less up-front incentives and estimates of expected price adjustments, based on relative standalone selling prices to identified performance obligations, and recognize instrument revenue and cost at the time of installation and customer acceptance. To the extent invoiced instrument revenue exceeds recognized instrument revenue, we record deferred revenue as a contract liability, which is subsequently recognized upon the purchase of products and services over the term of the contract. We have determined these agreements do not include a significant financing component. Differences between estimated and actual customer purchases may impact the timing and amount of revenue recognition.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 31, 2020, our capitalized customer acquisition costs were&#160;$148.1 million, of which approximately&#160;$43.6 million&#160;was recognized as a reduction of revenue during the&#160;year ended&#160;December 31, 2021. Furthermore, as a result of new up-front customer loyalty payments, net of subsequent recognition, our capitalized customer acquisition costs were&#160;$158.3 million&#160;at&#160;December 31, 2021. We monitor customer purchases over the term of their agreement to assess the realizability of our capitalized customer acquisition costs and review estimates of variable consideration. Impairments, revenue adjustments that relate to performance obligations satisfied in prior periods, and contract modifications during the&#160;years ended&#160;December 31, 2021 and 2020, were not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Volume Commitment Programs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Our volume commitment programs, such as our IDEXX 360 program, provide customers with a free or discounted instrument or system upon entering into multi-year agreements to purchase annual minimum amounts of products and services. We allocate total consideration, including future committed purchases and expected price adjustments, based on relative standalone selling prices to identified performance obligations and recognize instrument revenue and cost at the time of installation and customer acceptance in advance of billing the customer, which is also when the customer obtains control of the instrument based on legal title transfer. Our right to future consideration related to instrument revenue is recorded as a contract asset within other current and long-term assets. The contract asset is transferred to accounts receivable when customers are billed for products and services over the term of the contract. We have determined these agreements do not include a significant financing component. Differences between estimated and actual customer purchases may impact the timing and amount of revenue recognition. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 31, 2020, our volume commitment contract assets were&#160;$115.5 million, of which approximately $26.3 million&#160;was reclassified to accounts receivable when customers were billed for related products and services during the&#160;year ended&#160;December 31, 2021. Furthermore, as a result of new placements under volume commitment programs, net of subsequent amounts reclassified to accounts receivable, and allowances established for credit losses, our contract assets were&#160;$159.9 million&#160;at&#160;December 31, 2021. We monitor customer purchases over the term of their agreement to assess the realizability of our contract assets and review estimates of variable consideration. Impairments, revenue adjustments that relate to performance obligations satisfied in prior periods, and contract modifications during the&#160;years ended&#160;December 31, 2021 and 2020, were not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For our up-front customer loyalty and volume commitment programs, we estimate future revenues related to multi-year agreements to be approximately&#160;$2.9 billion, of which approximately&#160;25%,&#160;24%,&#160;20%, 15%, and&#160;16%&#160;are expected to be recognized during 2022, 2023, 2024, 2025, and thereafter, respectively. These future revenues relate to performance obligations not yet satisfied, for which customers have committed to purchase goods and services, net of the expected revenue reductions from customer acquisition costs and expected price adjustments, and as a result, are lower than stated contractual commitments by our customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Instrument Rebate Programs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Our instrument rebate programs require an instrument purchase and provide customers the opportunity to earn future rebates based on the volume of products and services they purchase over the term of the program. We account for the customer&#x2019;s right to earn rebates on future purchases as a separate performance obligation and determine the standalone selling price based on an estimate of rebates the customer will earn over the term of the program. Total consideration allocated to identified performance obligations is limited to goods and services that the customer is presently obligated to purchase and does not include estimates of future purchases that are optional. We allocate total consideration to identified performance obligations, including the customer&#x2019;s right to earn rebates on future purchases, which is deferred and recognized upon the purchase of future products and services, partly offsetting future rebates as they are earned.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 31, 2020, our deferred revenue related to instrument rebate programs was&#160;$39.3 million, of which approximately $14.3 million was recognized when customers purchased eligible products and services and earned rebates during the&#160;year ended&#160;December 31, 2021. Furthermore, as a result of new instrument purchases under rebate programs, net of subsequent recognition, our deferred revenue was&#160;$33.0 million&#160;at&#160;December 31, 2021, of which approximately&#160;36%,&#160;26%,&#160;17%, 11%, and&#160;10%&#160;are expected to be recognized during 2022, 2023, 2024, 2025, and thereafter, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Reagent Rental Programs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Our reagent rental programs provide our customers the right to use our instruments upon entering into multi-year agreements to purchase annual minimum amounts of consumables. These types of agreements include an embedded lease for the right to use our instrument and we determine the amount of lease revenue allocated to the instrument based on relative standalone selling prices. We evaluate the terms of these embedded leases to determine classification as either a sales-type lease or an operating lease.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Sales-type Reagent Rental Programs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Our reagent rental programs that effectively transfer control of instruments to our customers are classified as sales-type leases and we recognize instrument revenue and cost in advance of billing the customer, at the time of installation and customer acceptance. Our right to future consideration related to instrument revenue is recorded as a lease receivable within other current and long-term assets, and is transferred to accounts receivable when customers are billed for products and services over the term of the contract. On December 31, 2020, our lease receivable assets were $11.1&#160;million, of which approximately $2.2&#160;million was reclassified to accounts receivable when customers were billed for related products and services during the year ended December 31, 2021. Furthermore, as a result of new placements under sales-type reagent rental programs, net of subsequent amounts reclassified to accounts receivable, and allowances established for credit losses, our lease receivable assets were $15.3 million at December 31, 2021. The impacts of discounting and unearned income at December 31, 2021, were not material. Profit and loss recognized at the commencement date and interest income during the year ended December 31, 2021, were not material. We monitor customer purchases over the term of their agreement to assess the realizability of our lease receivable assets. Impairments during the year ended December 31, 2021, were not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Operating-type Reagent Rental Programs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Our reagent rental programs that do not effectively transfer control of instruments to our customers are classified as operating leases and we recognize instrument revenue and costs ratably over the term of the agreement. The cost of the instrument is capitalized within property and equipment.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We estimate future revenue to be recognized related to our reagent rental programs of approximately&#160;$38.3 million, of which approximately&#160;32%,&#160;26%,&#160;20%, 14%, and 8%&#160;are expected to be recognized during 2022, 2023, 2024, 2025, and thereafter, respectively. These future revenues relate to performance obligations not yet satisfied for which customers have committed to future purchases, net of any expected price adjustments, and as a result, may be lower than stated contractual commitments by our customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Other Customer Incentive Programs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Certain agreements with customers include discounts or rebates on the sale of products and services applied retrospectively, such as volume rebates achieved by purchasing a specified purchase threshold of goods and services. We account for these discounts as variable consideration and estimate the likelihood of a customer meeting the threshold in order to determine the transaction price using the most predictive approach. We typically use the most-likely-amount method for incentives that are offered to individual customers, and the expected-value method for programs that are offered to a broad group of customers. Revenue adjustments that relate to performance obligations satisfied in prior periods during the&#160;years ended&#160;December 31, 2021 and 2020, were not material. Refund obligations related to customer incentive programs are recorded in accrued liabilities for the actual issuance of incentives, incentives earned but not yet issued, and estimates of incentives to be earned in the future.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Program Combinations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. At times, we combine elements of our significant customer programs within a single customer contract. We separate each significant program element and include the contract assets, customer acquisition costs, deferred revenues, and estimated future revenues within the most relevant program disclosures above. Each customer contract is presented as a net contract asset or net contract liability on our consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;IDEXX Points&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. IDEXX Points may be applied to trade receivables due to us, converted to cash, or applied against the purchase price of IDEXX products and services. We consider IDEXX Points equivalent to cash. IDEXX Points that have not &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;yet been used by customers are included in accrued liabilities until utilized or expired. Breakage is not material because customers can apply IDEXX Points to trade receivables at any time.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Accounts Receivable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. We recognize revenue when it is probable that we will collect substantially all of the consideration to which we will be entitled, based on the customer&#x2019;s intent and ability to pay the promised consideration. We apply judgment in determining the customer&#x2019;s ability and intention to pay, which is based on a variety of factors including the customer&#x2019;s historical payment experience or, in the case of a new customer, published credit and financial information pertaining to the customer. We have&#160;no&#160;significant customers that accounted for greater than 10% of our consolidated revenues and we have&#160;no&#160;concentration of credit risk as of&#160;December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Disaggregated Revenues&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. We present disaggregated revenue for our CAG segment based on major product and service categories. Our Water segment is comprised of a single major product category. Although our LPD segment does not meet the quantitative requirements to be reported as a separate segment, we believe it is important to disaggregate these revenues as a major product and service category separately from our Other reportable segment given its distinct markets, and therefore we have elected to report LPD as a reportable segment.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table&#160;presents disaggregated revenue by major product and service categories:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.311%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.696%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CAG segment revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CAG Diagnostics recurring revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,534,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,113,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,828,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;IDEXX VetLab consumables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;1,006,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;824,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;693,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Rapid assay products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;296,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;253,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;232,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Reference laboratory diagnostic and consulting services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;1,123,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;946,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;822,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;CAG Diagnostics services and accessories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;107,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;90,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;80,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CAG Diagnostics capital - instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;149,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;108,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;132,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Veterinary software, services and diagnostic imaging systems&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;206,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;162,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;158,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CAG segment revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,889,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,385,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,119,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Water segment revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;146,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;128,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;132,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;LPD segment revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;135,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;145,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;132,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other segment revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,215,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,706,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,406,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue by principal geographic area, based on customers&#x2019; domiciles, was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.311%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.696%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Americas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,995,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,691,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,495,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Canada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;139,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;107,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;99,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Latin America &amp;amp; Caribbean&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;66,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;56,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,202,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,850,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,651,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Europe, the Middle East and Africa&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;146,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;119,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;104,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;United Kingdom&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;114,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;90,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;90,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;90,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;74,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Italy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Spain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Switzerland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Netherlands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;167,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;148,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;122,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;681,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;562,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;498,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Asia Pacific Region&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Australia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;94,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;79,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;71,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Japan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;84,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;74,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;67,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;57,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;89,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;331,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;293,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;256,888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,215,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,706,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,406,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Costs to Obtain a Contract&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. We capitalize sales commissions and the related fringe benefits earned by our sales force when considered incremental and recoverable costs of obtaining a contract. Our contracts include performance obligations related to various goods and services, some of which are satisfied at a point in time and others over time. Commission costs related to performance obligations satisfied at a point in time are expensed at the time of sale, which is when revenue is recognized. Commission costs related to long-term service contracts and performance obligations satisfied over time, including extended warranties and SaaS subscriptions, are deferred and recognized on a systematic basis that is consistent with the transfer of the goods or services to which the asset relates. We apply judgment in estimating the amortization period, which ranges from&#160;3&#160;to&#160;7 years, by taking into consideration our customer contract terms, history of renewals, and expected length of customer relationship, as well as the useful life of the underlying technology and products. Amortization expense is included in sales and marketing expenses in the accompanying consolidated statements of income. Deferred commission costs are periodically reviewed for impairment.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 31, 2020, our deferred commission costs, included within other assets, were&#160;$17.5 million, of which approximately&#160;$5.7 million&#160;of commission expense was recognized during the&#160;year ended&#160;December 31, 2021. Furthermore, as a result of commissions related to new extended warranties and SaaS subscriptions, net of subsequent recognition, our deferred commission costs were&#160;$19.5 million&#160;at&#160;December 31, 2021. Impairments of deferred commission costs during the&#160;years ended&#160;December 31, 2021 and 2020, were not material.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzIzNTc1_beef8fe9-ff47-4ae1-af48-cd7a1eceb6ac">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our revenue is recognized when, or as, performance obligations under the terms of a contract are satisfied, which occurs when control of the promised products or services is transferred to a customer. We exclude sales, use, value-added, and other taxes we collect on behalf of third parties from revenue. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring products or services to a customer. To accurately present the consideration received in exchange for promised products or services, we apply the five-step model outlined below:&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"&gt;Identification of a contract or agreement with a customer&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"&gt;Identification of our performance obligations in the contract or agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"&gt;Determination of the transaction price&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"&gt;Allocation of the transaction price to the performance obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"&gt;Recognition of revenue when, or as, we satisfy a performance obligation&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <idxx:RevenuePerformanceObligationPaymentTerm
      contextRef="i464c41d2cb9948979da5af09e9a6709b_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzE1MzI_e1c55c46-1e87-4142-8010-325ec3912d57">P30D</idxx:RevenuePerformanceObligationPaymentTerm>
    <idxx:RevenuePerformanceObligationPaymentTerm
      contextRef="i2547ad5bc951453f98e34b5d0f26b8bb_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzE1Mzg_1718c9b6-02ee-4782-a728-f2cdf982131c">P60D</idxx:RevenuePerformanceObligationPaymentTerm>
    <us-gaap:LeaseIncome
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzQyOTc_914ec932-9e26-4cfd-bae9-2bedece2ad38"
      unitRef="usd">20800000</us-gaap:LeaseIncome>
    <us-gaap:LeaseIncome
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzQzMzg_829701db-eb94-432c-bf77-cc10d713fa38"
      unitRef="usd">17500000</us-gaap:LeaseIncome>
    <idxx:PostContractSupportContractTerm
      contextRef="if381570659954770b2820ee07047c157_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzIzNTc3_4a4a79ca-a423-40a2-a1a0-ab31b6e7ac3b">P12M</idxx:PostContractSupportContractTerm>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i242e9b6f55554b858443459f0e68afb7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzU5NTI_3304372b-4c4b-4d7f-b9bd-a2daf5b64309"
      unitRef="usd">35100000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="if381570659954770b2820ee07047c157_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzU5Nzk_e5a1d643-b27b-40e7-baeb-85aea3d9c74a"
      unitRef="usd">23100000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i685e23f0c6e840b7aecebc2994601eb2_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzYxNDk_9c5ca92d-0b58-4848-9cb1-4faf2688c933"
      unitRef="usd">30000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i685e23f0c6e840b7aecebc2994601eb2_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzY1Nzk_802d08f3-fbd3-49be-81b8-554a5c279a62"
      unitRef="usd">16000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="ia8d9c432d3bf4b74adffb2d189372886_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzY2MTI_5106b11e-aa25-4dfd-870d-dee83223fe11"
      unitRef="number">0.49</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="id18052a9bc8947e885971777f75a622b_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzY2MTY_0c25985f-375d-4aa9-9925-58b4e200e972"
      unitRef="number">0.29</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="i489a306049d8454da4686e43ac9f9be5_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzY2MjA_8a8a28c8-a455-4ae1-8807-aab64080e170"
      unitRef="number">0.14</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="iee7069d3c7944d9d8e2527acff1fbc06_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzY2MjQ_5a14fea0-f40f-44fe-9e57-753aa9c2d1b5"
      unitRef="number">0.05</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="i047ec28985a54ca496f585918ccf62f6_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzY2MzI_17bf9768-c097-4aa9-b0db-4588548a7433"
      unitRef="number">0.03</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <idxx:SaasSubscriptionTermOfContract
      contextRef="i2547ad5bc951453f98e34b5d0f26b8bb_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzcyNTI_9fa7dbee-1933-45b0-8376-1e621cc76216">P2Y</idxx:SaasSubscriptionTermOfContract>
    <us-gaap:CapitalizedContractCostGross
      contextRef="i96beb1b4304e4f20a74ee69716a60a3e_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzExMTgx_62aa3602-b111-4d50-a4d9-9f20953c4b9f"
      unitRef="usd">148100000</us-gaap:CapitalizedContractCostGross>
    <us-gaap:CapitalizedContractCostAmortization
      contextRef="i437a7bd65c7c46ae8cd7c9e49b4ee334_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzExMjA4_7918085c-1e0f-470c-b8a4-570301a85241"
      unitRef="usd">43600000</us-gaap:CapitalizedContractCostAmortization>
    <us-gaap:CapitalizedContractCostGross
      contextRef="ib7205413c9894bd7a9838d72705913eb_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzExNDI2_1af4cea4-25f6-49a1-8b70-040fe410e9d7"
      unitRef="usd">158300000</us-gaap:CapitalizedContractCostGross>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i2f2f5cdb189f4934b1e3cebeb924b507_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzEzMDA1_aeee6fe5-2c98-4883-a3cb-ffd5d7c433a4"
      unitRef="usd">115500000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetReclassifiedToReceivable
      contextRef="i79ce71bddf09448f9ea714ce6102c47b_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzEzMDMy_8ce65d17-3dcb-410f-970c-64404635fb8d"
      unitRef="usd">26300000</us-gaap:ContractWithCustomerAssetReclassifiedToReceivable>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i09befd933773486bbae96a48cee3829b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzEzMzc0_68c0cc5d-2874-4902-b7f7-df145ecc01ab"
      unitRef="usd">159900000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i51f68fc78b89418293d672d19db8aff1_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzEzODc0_8c76a91a-eab9-4a44-9678-d68e2edfb446"
      unitRef="usd">2900000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="i3f8679f022804acba3547f27b82749ee_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzEzOTAx_3de8bb83-dc1a-4cb2-a310-eb3f01bc61ea"
      unitRef="number">0.25</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="ia1b14ac41fb14c2d8d6ba017fa4e925e_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzEzOTA1_96e5beab-ffa7-4472-a645-949dd60e723d"
      unitRef="number">0.24</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="icb7e410e248e43c994cb93d2f03fbf8f_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzEzOTA5_ae4913a1-9724-4771-ab75-c7e89ec20197"
      unitRef="number">0.20</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="ie2230e0e134c41099416ecb0514e3a3c_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzEzOTEz_a35f27cb-4767-4e90-9972-6f7bb0cf6e31"
      unitRef="number">0.15</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="i3e0eda093e4c442d97a50489871ee0c6_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzEzOTIx_09d536b9-7ca0-4066-8642-0b601b48fa20"
      unitRef="number">0.16</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i4c2e03def5d746e991b38bd94dccfbdb_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzE1Mzgz_8251292b-8875-45ab-9c40-fb13d61a2cc9"
      unitRef="usd">39300000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="icf88e478362d4b679f69d782be7a8360_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzE1NDEw_8798b6ff-3588-442e-ae4d-c392f0160538"
      unitRef="usd">14300000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiability
      contextRef="id886e662c2af48208ad13c5d0017a93e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzE1NjYy_e997b525-808d-4015-9347-0725d0782f6e"
      unitRef="usd">33000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="i76e3709ae6e04372b5824637c99c55ce_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzE1Njk1_c6ae1e71-77c5-456d-8ffa-7ef4b507336e"
      unitRef="number">0.36</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="ide72157b20624cbba3e378503b944506_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzE1Njk5_9952d751-c734-4ed0-917f-81d35b41cb41"
      unitRef="number">0.26</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="i8af8821a5a8e4e06898dabdea6965ee3_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzE1NzAz_b0ddc4d9-b0dd-4b00-a447-1f0600330a4a"
      unitRef="number">0.17</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="i865e2c5df39b4cecb1d900db1ae6ca7d_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzE1NzA3_6e65844e-efc5-4132-abe8-5a7e2f4d35ae"
      unitRef="number">0.11</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="if8efddd0307c4f6c9b1fab4c82f7cd7b_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzE1NzE1_f6f69a34-ac1d-413b-9b61-8cb734b30231"
      unitRef="number">0.10</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:SalesTypeLeaseLeaseReceivable
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzE2OTU3_c226a4cd-e7fa-4e96-803e-c15963b31bd0"
      unitRef="usd">11100000</us-gaap:SalesTypeLeaseLeaseReceivable>
    <idxx:SalesTypeLeaseLeaseReceivableReclassifiedToReceivable
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzE2OTg0_678f82f6-bd89-4120-87df-a6e70bc833d7"
      unitRef="usd">2200000</idxx:SalesTypeLeaseLeaseReceivableReclassifiedToReceivable>
    <us-gaap:SalesTypeLeaseLeaseReceivable
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzE3MzU2_9af734fc-5f5b-4b53-b78f-e54f02a0b913"
      unitRef="usd">15300000</us-gaap:SalesTypeLeaseLeaseReceivable>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i269b18a6e9c74892a68183dfb6d26182_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzE4MTcz_b41f6098-c152-4cad-a300-2448f56103d3"
      unitRef="usd">38300000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="i0e53a7345431421d90c84f0714010ab8_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzE4MjAw_4a96aedf-dffb-4e07-8637-57d3cdeab51f"
      unitRef="number">0.32</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="i26a9c61e7add4db7b09dd7228e5adf11_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzE4MjA0_1ee506ea-203c-4861-a02a-99a00ced3023"
      unitRef="number">0.26</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="i552f56ee344349d0a8fe803f1d4ac028_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzE4MjA4_c5ac9b71-99a7-4f27-90be-3a4bb766f30d"
      unitRef="number">0.20</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="ia21b4eae913c4602899f11b240ecd020_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzE4MjEy_a67bab8b-3402-42c4-ba68-512f11378121"
      unitRef="number">0.14</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="i8e6515d33c104d37893035bf37f096ad_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzE4MjIw_6770813d-c79f-41f8-af04-dadad6b9f43c"
      unitRef="number">0.08</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzIzNTcz_f1134e75-3536-41b6-b52f-ed9606aaca08">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table&#160;presents disaggregated revenue by major product and service categories:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.311%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.696%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CAG segment revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CAG Diagnostics recurring revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,534,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,113,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,828,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;IDEXX VetLab consumables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;1,006,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;824,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;693,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Rapid assay products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;296,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;253,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;232,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Reference laboratory diagnostic and consulting services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;1,123,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;946,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;822,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;CAG Diagnostics services and accessories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;107,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;90,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;80,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CAG Diagnostics capital - instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;149,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;108,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;132,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Veterinary software, services and diagnostic imaging systems&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;206,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;162,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;158,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CAG segment revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,889,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,385,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,119,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Water segment revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;146,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;128,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;132,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;LPD segment revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;135,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;145,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;132,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other segment revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,215,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,706,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,406,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue by principal geographic area, based on customers&#x2019; domiciles, was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.311%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.696%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Americas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,995,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,691,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,495,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Canada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;139,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;107,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;99,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Latin America &amp;amp; Caribbean&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;66,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;56,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,202,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,850,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,651,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Europe, the Middle East and Africa&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;146,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;119,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;104,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;United Kingdom&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;114,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;90,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;90,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;90,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;74,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Italy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Spain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Switzerland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Netherlands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;167,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;148,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;122,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;681,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;562,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;498,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Asia Pacific Region&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Australia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;94,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;79,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;71,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Japan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;84,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;74,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;67,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;57,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;89,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;331,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;293,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;256,888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,215,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,706,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,406,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i723287d015984ccaa532d58c82848761_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzMtMi0xLTEtMA_d69b8f79-8abb-43da-84b6-1c89a42c44e4"
      unitRef="usd">2534562000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if77b95f4c71f4d27a4b24d6a7f47cb19_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzMtNC0xLTEtMA_5a0ec126-1832-496c-81ae-b983de0b3cfc"
      unitRef="usd">2113839000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3495e15513b94d078ea449cf5f428620_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzMtNi0xLTEtMA_a4fd2997-6afe-4de6-8da7-de39b3c1a28d"
      unitRef="usd">1828329000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaf886748aba34b2dae8f6c7817ad2a16_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzQtMi0xLTEtMA_4fdde402-6c59-486a-8072-61b26aa2386d"
      unitRef="usd">1006781000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i45c842be487a4adeaf405fb278d02adb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzQtNC0xLTEtMA_362c52f5-ed85-4bec-8502-e79ac8a2fe2a"
      unitRef="usd">824376000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iecf199144d3940e08f79eb67130f5a22_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzQtNi0xLTEtMA_98321059-7bed-4ee5-8720-033c74f509b1"
      unitRef="usd">693360000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9a1a0bb358d847259b4ee304e5a46a33_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzUtMi0xLTEtMA_eb2aa210-feac-4b16-a342-357072b936b3"
      unitRef="usd">296852000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i793b95b40c3a4a9490a98b288a146ee0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzUtNC0xLTEtMA_c804f623-cb61-4e13-b84d-f4d00a925809"
      unitRef="usd">253018000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i56aa1f828bc845f58439fe0a42646b60_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzUtNi0xLTEtMA_41e41d19-61c5-465a-baf7-7efec90e8a18"
      unitRef="usd">232149000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i82504fe08ede4c6f89672ec5a625601e_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzYtMi0xLTEtMA_378387a7-4c53-4318-aa44-863652e5964a"
      unitRef="usd">1123656000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i32b9c9eff8ca4148be177ce0cbdddd6b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzYtNC0xLTEtMA_312e42f8-39ba-4a85-ab79-4c503da7781a"
      unitRef="usd">946268000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1430c1be15d34b1abe49cb43d2d401ba_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzYtNi0xLTEtMA_aeff330b-4e32-432e-8c77-6a45eee5b945"
      unitRef="usd">822497000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3a2f9d2f1d5a4674af66963a5565e7f1_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzctMi0xLTEtMA_ef043ca3-8c62-486f-b3d0-4ec621c8a182"
      unitRef="usd">107273000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib81ecabbb8614cf1b2acb2b54f2c36f9_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzctNC0xLTEtMA_0abda156-3605-46ec-9fd5-e0bfbac97fda"
      unitRef="usd">90177000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i91c8a095edc841769c85865c8e5036f2_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzctNi0xLTEtMA_558ac567-a4aa-4aa1-8b2f-828e65b64948"
      unitRef="usd">80323000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib4caa366375c4cb9a3594b681a103170_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzgtMi0xLTEtMA_da4aaf74-f3c8-41b7-bd59-83bff6230a90"
      unitRef="usd">149140000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i726e9c456ab44126a671318ab9275f7f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzgtNC0xLTEtMA_1a831201-94b8-4f81-8eb6-72fb6226caf1"
      unitRef="usd">108950000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4e5c3cd621d24cb28572507163aed2f7_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzgtNi0xLTEtMA_01181bfd-a147-49cb-a2be-62ebb72e9ec8"
      unitRef="usd">132685000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7fd4d20f53cd47b499e032d174f468fc_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzktMi0xLTEtMA_a0de7785-f4de-45a8-ba8b-3888a6056118"
      unitRef="usd">206258000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i69584183a25e434eb0dbc26d4f7a118d_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzktNC0xLTEtMA_e99d5d2f-f511-43e6-ac73-17a24ecce476"
      unitRef="usd">162976000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8301f630e8b443fe8e590fcd68eab16f_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzktNi0xLTEtMA_7315fb63-ade3-4f23-ac47-92c9f3792132"
      unitRef="usd">158169000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6c823cc0aa3945d9874ea09ab5940878_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzEwLTItMS0xLTA_0d5e780a-01df-4f69-bf59-290b706bcfe0"
      unitRef="usd">2889960000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i40313073e9c743ad89084e7fbcbd7e5e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzEwLTQtMS0xLTA_5cd3dee0-6fb2-4dac-9050-7c7291eec553"
      unitRef="usd">2385765000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ief827aa39f934947a553685160a5543c_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzEwLTYtMS0xLTA_06b9ba11-2976-463c-b6e9-a550a8570864"
      unitRef="usd">2119183000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i81c0a80f385a4f18ab5cb5919ed28318_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzEyLTItMS0xLTA_374c905f-d485-45f3-903c-31322db10ccb"
      unitRef="usd">146505000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic0b173f4625a4e1e807adc8eeb4e0592_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzEyLTQtMS0xLTA_5b6ded7e-98ba-4b1a-8677-12b5d5ebee12"
      unitRef="usd">128625000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iab0b6ebdef1a4be9b052a1b82c635759_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzEyLTYtMS0xLTA_8d7422ab-12c0-447e-88b7-ce29b3a3bd7f"
      unitRef="usd">132850000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4174c33ea3f8443fbc6587f7ac9a43ab_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzEzLTItMS0xLTA_afcea5fc-2d51-407a-8daf-ff5b06b99f5b"
      unitRef="usd">135887000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4525be5d1c1b4d458fe78f047e981dc1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzEzLTQtMS0xLTA_c80331f0-45d0-4333-8883-1f1a0061a08a"
      unitRef="usd">145845000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i34e8ebea941e457cbadc1ce152e6a396_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzEzLTYtMS0xLTA_41df3fab-00e3-42fd-aede-e5a4e64f420f"
      unitRef="usd">132635000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i94cd933d7b7b431caa324dc2936f5c55_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzE0LTItMS0xLTA_c1b545ae-dc5f-42c4-ab73-0a6a43e0e34a"
      unitRef="usd">43008000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i100119c49d8f4098bf6afdc675782162_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzE0LTQtMS0xLTA_fad925b1-69cf-412b-aa35-e07ddbe858b0"
      unitRef="usd">46420000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia6f9b6007f00420291efefe0008f3d10_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzE0LTYtMS0xLTA_2d8b879a-ac10-4297-a2be-df9a5a13dd7d"
      unitRef="usd">22240000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzE2LTItMS0xLTA_403475ed-0cd7-493b-9483-10adc47f07ea"
      unitRef="usd">3215360000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzE2LTQtMS0xLTA_fbf1a4c4-0d6f-488e-be08-e6b22b1acc51"
      unitRef="usd">2706655000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo1NmMyMWIxNjkzMzc0NmU4YjliNjBkZjc2YzQ1MTJlOC90YWJsZXJhbmdlOjU2YzIxYjE2OTMzNzQ2ZThiOWI2MGRmNzZjNDUxMmU4XzE2LTYtMS0xLTA_948f0e8e-8e7a-4ac5-bb9b-96a4d5bcfa29"
      unitRef="usd">2406908000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i074301c2df824186bd2aba7d250d51cf_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzMtMi0xLTEtMA_0a7f1689-b310-460e-83c5-dafe2e33e91d"
      unitRef="usd">1995683000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i01f16b1d8f40480ea91113c41cce5e7a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzMtNC0xLTEtMA_7d36203e-fd72-4051-8b79-463e5674e298"
      unitRef="usd">1691224000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4020a52f56894866abcca95a1a1497f1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzMtNi0xLTEtMA_57178030-b766-4e22-ae78-cc23d18448c1"
      unitRef="usd">1495516000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i766a0f5291584f90863a5968d8de067c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzQtMi0xLTEtMA_fd789936-bc8e-49fc-8b3c-9a3d7ded5df8"
      unitRef="usd">139727000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4c8215241a5640df9c12270ca8891308_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzQtNC0xLTEtMA_fb9cec10-0281-49da-9737-0a523101850d"
      unitRef="usd">107398000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i098a241b58744ea38131468a239f7847_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzQtNi0xLTEtMA_3a8ff9cc-bda5-4c23-baad-7e3eefdede60"
      unitRef="usd">99550000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9d89e0f871864b189335e7739d42fe07_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzUtMi0xLTEtMA_e8aff146-147a-40d6-8a6d-a0be43335cc0"
      unitRef="usd">66623000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7743a6f4bd764d2a9da6c4de5e290df5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzUtNC0xLTEtMA_46e98154-3447-48f6-803e-207a3e177231"
      unitRef="usd">51863000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i875c0d290dfb4cbf8a2b59d7e2c6d1fe_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzUtNi0xLTEtMA_1a32a823-4736-438d-b43d-34e13e0f812b"
      unitRef="usd">56515000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i76f3ab4debf64563bc6a167ac410e9c3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzYtMi0xLTEtMA_9d73f19a-3043-45ef-9252-6eb68c2aa273"
      unitRef="usd">2202033000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibe22eae831934369a9a0015d3c260ab2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzYtNC0xLTEtMA_3d7c9e85-73e1-49e6-9fd2-4f47fb9b4ed9"
      unitRef="usd">1850485000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie4ec176e93ab43bb98dd7714f2512730_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzYtNi0xLTEtMA_0fdee1c7-476c-4879-a0e1-cfeb0c0cc085"
      unitRef="usd">1651581000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie659b0df466445ae9609de3ee174d80c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzktMi0xLTEtMA_6992afe9-ceb1-4fe5-a8cf-59ad8d191bf2"
      unitRef="usd">146762000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if0c4109668754b8693ca7161318090f9_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzktNC0xLTEtMA_5d5f5f5c-6b01-4976-98cf-598cb2ab5ae7"
      unitRef="usd">119353000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifa67f291b9eb45a780298d9ae25ddaf3_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzktNi0xLTEtMA_18fba1ee-f7ac-4dc7-b672-606565f91377"
      unitRef="usd">104081000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia7dbddd91eb54624978a0b4ed56ec859_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzEwLTItMS0xLTA_2fee71fb-b074-4693-9138-73020abd47b8"
      unitRef="usd">114955000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaded4b965f664c0d806bbe1ac965cd5d_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzEwLTQtMS0xLTA_fe076dbc-9d1b-4590-86bc-e4101bbf846b"
      unitRef="usd">90156000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3d87cb22b86c44f4b570eed70a1378eb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzEwLTYtMS0xLTA_000bd2c5-56e8-41eb-a60e-c8f854a1f987"
      unitRef="usd">90969000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i75c498c811384ef09dcd9c2fe08380c8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzExLTItMS0xLTA_3604e7e9-f9c8-4383-8525-52218f65b224"
      unitRef="usd">90836000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i66eb4e58d2ee4aaca353fee7f134054f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzExLTQtMS0xLTA_67732d51-91d0-4f4f-91d3-e13b202890ca"
      unitRef="usd">74814000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0dc62339001e4ad4a1835c85eedc299e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzExLTYtMS0xLTA_339fd872-5d8b-4d51-b41d-40041adf4648"
      unitRef="usd">64767000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9f1ed5c7ebf34e30a0fdb012cddf7440_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzEyLTItMS0xLTA_cb30c38b-63da-4bd0-8fce-fa3e9d74b01a"
      unitRef="usd">52062000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib9c07a32fa054809a3705b5c0d25c972_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzEyLTQtMS0xLTA_fc0ecc47-a83f-4d59-84da-276abe8ade53"
      unitRef="usd">42817000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i024ff5694a8c4073a3e5ce8f499229f6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzEyLTYtMS0xLTA_0d2d40e4-1f26-47d3-b948-4677e5f025c9"
      unitRef="usd">39725000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0a12365e7904425790e4a07eca696916_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzEzLTItMS0xLTA_93143bae-bda5-4183-8dd3-b918ef47463c"
      unitRef="usd">48169000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib98678b4e8cf4f749ac3e5c05952d91b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzEzLTQtMS0xLTA_db51dbad-88f0-4534-b14c-e841384f0fa6"
      unitRef="usd">39265000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id2f16826ba294aa484551884f87d09e8_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzEzLTYtMS0xLTA_5f2db307-74ac-4fc2-b2da-1c5ae8a9d2a6"
      unitRef="usd">36439000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7896731fe12243f1875fd4ce04068904_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzE0LTItMS0xLTA_fdbcca44-4bcb-447f-b09f-d5c9ef2be156"
      unitRef="usd">31984000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie109583690ce4e2eae0a0a5c373a2ee4_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzE0LTQtMS0xLTA_5f0999c8-9151-499d-bee7-53924e5621dc"
      unitRef="usd">24850000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie037b3568c7d47d8914ff5010a0aedcd_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzE0LTYtMS0xLTA_2f160ade-2355-4ff6-8ed6-9678a52b5ba2"
      unitRef="usd">20855000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8207a8f256ab4cc6a3250a19887134bd_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzE1LTItMS0xLTA_d2f275f6-ddae-46d2-9ccd-dfe80ee5aea3"
      unitRef="usd">29656000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4ec2b03ad795418a8009824d2524452f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzE1LTQtMS0xLTA_e073d6bc-5367-4cc6-b090-9f669087c6b4"
      unitRef="usd">23461000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i33cd1326584149ccbfa7ddc29ff1f6c8_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzE1LTYtMS0xLTA_1332e15a-342a-4a9d-9108-0944131ed327"
      unitRef="usd">19397000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4b82ba0179564e93a090862f65ad1917_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzE2LTItMS0xLTA_33fa03a2-d8b3-435a-8555-b253db89be57"
      unitRef="usd">167525000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id596dfd4731c4532a3f61ad928fd2c5c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzE2LTQtMS0xLTA_6c51b680-ce22-486f-9ca8-29a1b4113f67"
      unitRef="usd">148049000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i07e74761556442abb8ddcffbbc211fcf_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzE2LTYtMS0xLTA_ab0ebada-6086-4174-9768-f21ad2380aa2"
      unitRef="usd">122206000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if20538cc41914789b22efe5b91f2f3a7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzE3LTItMS0xLTA_363a8935-2209-4e33-a81b-6c45331a33fb"
      unitRef="usd">681949000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic5db3ce1c3924c83b379d8a61e0f7372_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzE3LTQtMS0xLTA_8544ebc3-e824-47f9-96c7-9f39329e9129"
      unitRef="usd">562765000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4b9195b1ced7483697bc7828d38b1dc3_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzE3LTYtMS0xLTA_d0fe0450-4a74-4db7-98c6-0cc570ed9c1d"
      unitRef="usd">498439000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibf1299bd5850495db5bab930c750f59c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzE5LTItMS0xLTA_e47a8cc9-9bc1-49df-8870-8b02a6a657d8"
      unitRef="usd">94414000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icaa60874497e43898b35ee415a2bc80f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzE5LTQtMS0xLTA_94413a82-6c86-4465-844c-b1871b373f74"
      unitRef="usd">79629000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i220bf3ab1a154b9a8693e8e99867b9ac_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzE5LTYtMS0xLTA_3e7f780b-ccd7-48c4-9a60-0c8e2131d57a"
      unitRef="usd">71069000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5f4a460cb3fc481b87a66c1143b1c6ae_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzIwLTItMS0xLTA_b9462a58-01ca-4644-a724-f27671f0a339"
      unitRef="usd">84275000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idfb45a09b6c94d2f9c4fa39784fc4f4c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzIwLTQtMS0xLTA_6e2712bb-3252-4db1-94d6-c6d691bfb65d"
      unitRef="usd">74725000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i27d98417a7ed441dbaefaf4e3c7d8e3e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzIwLTYtMS0xLTA_422022a3-a0b8-4811-9ff8-107eb9279e08"
      unitRef="usd">67246000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ice113159eb944073881b74017325c32e_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzIxLTItMS0xLTA_22f2d0e9-9cc5-4b2d-b1cb-9df51374bf53"
      unitRef="usd">63166000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i25c97c45426b49229b105df880a272e6_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzIxLTQtMS0xLTA_65e89083-eada-4d2d-8ec2-8c9809b81c56"
      unitRef="usd">70845000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i725b5e5dc5f042a7ae398d70fbeee8a5_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzIxLTYtMS0xLTA_280f2379-09d5-4e36-858e-7880f687a64d"
      unitRef="usd">57518000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1c7784e6972a40e794a9b073a04021a7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzIyLTItMS0xLTA_45bf8219-1180-4047-aa71-444713ca0350"
      unitRef="usd">89523000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id95808181fe340cf9c9a3e0c0794af01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzIyLTQtMS0xLTA_2a559437-ead2-49de-ab58-d897a7e39735"
      unitRef="usd">68206000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8756d035ba8e462584f1d7c8d7dddac4_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzIyLTYtMS0xLTA_01d851b6-cd0e-48e8-878f-f9cb4f11b8d4"
      unitRef="usd">61055000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic225702a7bba4086a0eb7207e3dcb702_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzIzLTItMS0xLTA_6b779038-d124-4b6f-844a-d103d1c3c5e7"
      unitRef="usd">331378000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8b04ff1af6a74efbb011731141a869fb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzIzLTQtMS0xLTA_d66a7af7-edc8-4011-927c-11a798c38150"
      unitRef="usd">293405000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i471d983af3ad4dbda5429f440f2683ff_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzIzLTYtMS0xLTA_4e833e79-84e1-4b1d-b7f7-f638b1292007"
      unitRef="usd">256888000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzI0LTItMS0xLTA_839a9841-a7c0-440f-9ca5-87efc43394b9"
      unitRef="usd">3215360000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzI0LTQtMS0xLTA_b4420b77-80cb-45c0-8d6a-7601ec168ef2"
      unitRef="usd">2706655000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90YWJsZTo5ZDRiYzk4YjNkZTk0MzNlYmE3ZTE4MTAzNDQzYzMzOS90YWJsZXJhbmdlOjlkNGJjOThiM2RlOTQzM2ViYTdlMTgxMDM0NDNjMzM5XzI0LTYtMS0xLTA_58d1c9bf-65af-4e1f-9dbb-5e5234b15006"
      unitRef="usd">2406908000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CapitalizedContractCostAmortizationPeriod
      contextRef="iec94ca1756b3473faecedf9258139d41_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzIyNzM5_a0c4fc7d-aeb6-4afa-af61-7b2e74003d4f">P3Y</us-gaap:CapitalizedContractCostAmortizationPeriod>
    <us-gaap:CapitalizedContractCostAmortizationPeriod
      contextRef="i9aa403826a744b88a310a196d527c4da_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzIyNzQ1_14874113-3a17-4360-9b06-25abd3f9ff61">P7Y</us-gaap:CapitalizedContractCostAmortizationPeriod>
    <us-gaap:CapitalizedContractCostNet
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzIzMjA5_afa7fd7f-9311-4732-9aa9-cd1814b81f44"
      unitRef="usd">17500000</us-gaap:CapitalizedContractCostNet>
    <us-gaap:SalesCommissionsAndFees
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzIzMjM2_db0f47cc-140b-4ff1-aed7-4f0f7b6dc49a"
      unitRef="usd">5700000</us-gaap:SalesCommissionsAndFees>
    <us-gaap:CapitalizedContractCostNet
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xNzgvZnJhZzo5ZGJjNDU0NzMxMTk0ZmNmODIwNmRmN2I5ZmUzOGM4OS90ZXh0cmVnaW9uOjlkYmM0NTQ3MzExOTRmY2Y4MjA2ZGY3YjlmZTM4Yzg5XzIzNDY4_847b3f72-ea40-4167-97f8-0719ecf623f9"
      unitRef="usd">19500000</us-gaap:CapitalizedContractCostNet>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzIxNjU_38f061a6-09e1-4183-93be-b42569794d09">ACQUISITIONS AND INVESTMENTS&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We believe that our acquisitions of businesses and other assets enhance our existing businesses by either expanding our geographic range, customer base, or existing product and service lines. From time to time, we may acquire small reference laboratories or radiology practices that we account for as either asset purchases or business combinations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2021, we acquired the shares of a reference laboratory located in Finland for approximately $13.4&#160;million in cash, including a holdback of approximately $1.4&#160;million. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;This acquisition expands our international reference laboratory presence and was accounted for as a business combination. The fair values of the assets acquired consist of&#160;customer relationship intangibles of approximately $7.4&#160;million, with a life of 10 years; a non-compete agreement of approximately $0.8&#160;million, with a life of 3 years; approximately $5.3&#160;million of goodwill, representing synergies within our broader CAG portfolio; and approximately $0.1&#160;million in net tangible liabilities. The purchase price allocation is &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;subject to revision as additional information becomes available regarding review of taxes and the settlement of the working capital adjustment. Goodwill related to this acquisition is not expected to be deductible for tax purposes. Pro forma information has not been presented for this acquisition because such information is not material to the financial statements. The results of operations have been included in our CAG segment since the acquisition date. The acquisition expenses were not material.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the third quarter of 2021, we acquired the assets of a teleradiology business for approximately $5.4&#160;million, including a contingent payment of $0.3&#160;million. This acquisition expands our current teleradiology capability. The acquired assets primarily consist of a customer relationship intangible of approximately $1.7&#160;million, with a weighted average life of&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; 10 years&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and approximately $3.7&#160;million in goodwill. Goodwill related to this acquisition is expected to be deductible for tax purposes. Pro forma information has not been presented for this acquisition because such information is not material to the financial statements. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The results of operations have been included in our CAG segment since the acquisition date. The acquisition expenses were not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the second quarter of 2021, we acquired the assets of the ezyVet cloud-based veterinary software businesses and the shares of ezyVet US, Inc., as well as the Vet Radar business assets, for approximately $157.2&#160;million, including an estimated contingent payment of $5.0&#160;million. The acquired assets include the ezyVet cloud-native practice management system software and the Vet Radar cloud-based workflow management software. The acquisition expands our cloud-based software offerings to support our customers with technology solutions that raise the standards of care for patients and improve practice efficiency. The fair values of assets acquired were as follow: approximately &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$32.0&#160;million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in customer-related intangible with a weighted average life of &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10 years;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; approximately &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$8.4&#160;million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in technology-related intangibles with a weighted average life &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;of&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6 years;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; approximately &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$2.4&#160;million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in trademarks with a weighted average life of&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; 14 years;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; approximately &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$1.8&#160;million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in non-compete agreements with a weighted average life of&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; 5 years;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; approximately &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$109.4&#160;million &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in goodwill, r&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;epresenting synergies within our broader CAG portfolio; and approximately $3.2&#160;million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in net tangible assets. Goodwill has been allocated to multiple reporting units based upon the fair value of projected earnings as of the date of the acquisition. The goodwill was allocated as follows: approximately $23.4&#160;million to IDEXX VetLab&#xae;, approximately $27.0 million to Reference Laboratories, approximately $11.1&#160;million to Rapid Assay, and approximately $47.9&#160;million to Veterinary Software Services. Goodwill related to this acquisition is expected to be deductible for tax purposes. Pro forma information has not been presented for this acquisition because such information is not material to the financial statements. The results of operations have been included in our CAG segment since the acquisition date. During the fourth quarter, we increased the contingent payable by $2.0&#160;million, for a total expected payment of $7.0&#160;million. This increase to the contingent payment is expensed as the adjustment was made after the measurement period. The acquisition expenses were approximately $2.2&#160;million. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of 2021, we acquired the shares of a reference laboratory located in Switzerland for approximately $5.5&#160;million in cash, including holdback and contingent payments of approximately $1.1&#160;million. This acquisition expands our international reference laboratory presence and was accounted for as a business combination. The fair values of the assets acquired consist of&#160;approximately $4.3&#160;million&#160;in intangible assets, primarily for customer relationships, which will be amortized over 9 years, approximately $1.8&#160;million for goodwill, representing synergies within our broader CAG portfolio, and approximately $0.6&#160;million&#160;of liabilities, including deferred taxes associated with the acquired intangible assets. Goodwill related to this acquisition is not deductible for tax purposes. Pro forma information has not been presented for this acquisition because such information is not material to the financial statements. The results of operations have been included in our CAG segment since the acquisition date. The acquisition expenses were not material.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2019 we acquired the assets of a multi-site reference laboratory business in the mid-west of the U.S. for $50.0 million in cash. This acquisition expands our national reference laboratory presence in the U.S., and was accounted for as a business combination. We finalized the valuation of the fair value of the assets acquired during the first quarter of 2020. The fair value of the assets acquired consists of $26.9 million in intangible assets, primarily for customer relationships, with a weighted average life of 13.8 years, $0.2 million of tangible assets, and $22.9 million of goodwill, representing synergies within our reference laboratory portfolio.&#160;The goodwill is expected to be deductible for income tax purposes. Pro forma information has not been presented for this acquisition because such information is not material to the financial statements. The results of operations have been included in our CAG segment since the acquisition date. The acquisition expenses incurred were not material. &lt;/span&gt;&lt;/div&gt;Acquisition of noncontrolling interestDuring the fourth quarter of 2021, we acquired the remaining 5% interest of our sole foreign joint venture operation for approximately $1.0&#160;million. As a result, we no longer record any minority interest in the equity section of our consolidated balance sheet. This transaction is recorded as an equity transaction, with no gain or loss reflected in the consolidated statements of income.</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i842723fe206441498f4f17f31a9787fc_D20211001-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzQ5NDc4MDIzNDY2NzA_38bc3e78-d6f5-480c-b4fe-a5d8a1ce5a9a"
      unitRef="usd">13400000</us-gaap:PaymentsToAcquireBusinessesGross>
    <idxx:BusinessCombinationContingentConsiderationHoldback
      contextRef="ie8c73a699ac1449a83257aa402845ff6_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzQ5NDc4MDIzNDY2ODU_90a7db38-79de-4cf6-a139-84f19594c6d3"
      unitRef="usd">1400000</idxx:BusinessCombinationContingentConsiderationHoldback>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ic0b97d19fd5e4d9da47732f2832e48e0_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzQ5NDc4MDIzNDY2OTk_f0404de9-c156-4d7f-aaaa-79102d6b4d23"
      unitRef="usd">7400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="iea6bbd7bf4aa409f81e8b4939eaeebb7_D20211001-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzQ5NDc4MDIzNDY3MTU_5ea37576-4ad7-493c-8dbc-b1342b8fde9d">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i5aeff8abf9cf474cb8eef1fda56b68fb_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzQ5NDc4MDIzNDY3Mjg_0fffefe0-5637-421b-9388-5864b38edfff"
      unitRef="usd">800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i809c93aee53e4f94943260050b20b48b_D20211001-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzQ5NDc4MDIzNDY3NDQ_a2d5a95f-99d2-4515-98fe-dc5ad88d7421">P3Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:Goodwill
      contextRef="ie8c73a699ac1449a83257aa402845ff6_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzQ5NDc4MDIzNDY3NTY_6bd6a3f3-fd14-4535-9449-d9b063823f3b"
      unitRef="usd">5300000</us-gaap:Goodwill>
    <idxx:BusinessCombinationsTangibleLiabilities
      contextRef="ie8c73a699ac1449a83257aa402845ff6_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzI3NDg3NzkwOTEzMzY_ad505da9-84e8-48e0-b00b-b9081f5ccca6"
      unitRef="usd">100000</idxx:BusinessCombinationsTangibleLiabilities>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ifd3e48c2fc1c450db3e7a70a7d818589_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzEwOTk1MTE2NDIzMTc_361160d6-36e7-487f-a00a-00e6f6ad3797"
      unitRef="usd">5400000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ifce9ad75783047eca6a078e591b5a29e_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzEwOTk1MTE2NDIzNTY_94d7e966-e7a4-4666-aa76-caab586e69ce"
      unitRef="usd">300000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="id1280d77ec9a4626b628ba48e7a82fee_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzEwOTk1MTE2NDI1MTc_f9bb5c06-7a38-4f87-8704-62b7bbb374b0"
      unitRef="usd">1700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ida01d0b9ae19406cba72ddf3076630da_D20210701-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzEwOTk1MTE2NDI1NTQ_4e079b01-81f1-4c64-9acb-f4e2c7471a75">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:Goodwill
      contextRef="ifce9ad75783047eca6a078e591b5a29e_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzEwOTk1MTE2NDI1Nzc_ee7ea99f-0f7d-489c-b683-38914afa7a72"
      unitRef="usd">3700000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i4cad12a2c61c492fa2913b23e32f05f6_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzEwOTk1MTE2NDMzMDc_5470db9e-d49a-44da-a73a-9f541e908854"
      unitRef="usd">157200000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ia2728c192ba740b3bccbeb6af69b3ba8_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzEwOTk1MTE2NDMzNTc_1df1f96d-c03d-484f-8451-289cef63931f"
      unitRef="usd">5000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ibfd9997d2b384ba184794f3511297632_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzEwOTk1MTE2NDM4MTc_9e1a8422-0585-4d27-a5bd-119a255f95e3"
      unitRef="usd">32000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i385bd1940c0e4f08b7a962517de3c1b1_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzEwOTk1MTE2NDM4ODQ_5a01c875-0683-4d26-9b23-57cded50bc7a">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i305a1c1723984399939954021ea102bb_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzEwOTk1MTE2NDM5MDM_33c602e8-f585-441e-bb81-eed6ff9ffd98"
      unitRef="usd">8400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="if6b9086908654520873d5861115fad00_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzEwOTk1MTE2NDM5NzM_c095bcb3-1cff-45a6-aa17-4e9d37bb8dac">P6Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i2d303cab977e469191f8b6b1552d036c_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzEwOTk1MTE2NDM5OTI_ec064426-8c18-4295-bf80-a27fd34e0692"
      unitRef="usd">2400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i331a2e7b2a724d3d95f8d3fa0aa4fb7f_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzEwOTk1MTE2NDQwNDI_8538fd21-30d1-4c94-bb9f-8f89ca3ef74a">P14Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i55647d483f84421fa97e4bd81c6d5d69_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzEwOTk1MTE2NDQwNjE_92a41a4b-7a74-44cf-a34f-d636f30a2868"
      unitRef="usd">1800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i21fecd38873f4b64b92a766a37bdf70b_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzEwOTk1MTE2NDQxMjM_a611f7a9-b64e-487c-b043-362f3194ea9d">P5Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:Goodwill
      contextRef="ia2728c192ba740b3bccbeb6af69b3ba8_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzEwOTk1MTE2NDQxNDI_2523057b-23ba-40c0-9996-8b449766ff53"
      unitRef="usd">109400000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ia2728c192ba740b3bccbeb6af69b3ba8_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzEwOTk1MTE2NDQyMzQ_9e0760b6-50dc-4c28-afef-43be274acf48"
      unitRef="usd">3200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:Goodwill
      contextRef="i37946dde29a24a35b13eae3f304d5a27_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzEwOTk1MTE2NDQ0MjY_151e21b4-9b1a-4706-993b-872c51d6f146"
      unitRef="usd">23400000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ie9efbaf1e37c410ea20352d5d9dfc9b2_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzEwOTk1MTE2NDQ0NjI_25a85a6d-c473-45db-b58f-cfe0099dde9e"
      unitRef="usd">27000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i51b0af3a479b46bfa75da33ccbef5a0d_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzEwOTk1MTE2NDQ1MDU_963b11c7-3d52-4755-a937-4d3d7ba9b54b"
      unitRef="usd">11100000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="iee0529f10fe24e86ad8b423b1dcfdfcd_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzEwOTk1MTE2NDQ1NDM_f401ca23-c5b0-48c2-a8b9-9377f6c06e8f"
      unitRef="usd">47900000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="ifb7924f502ed418b8a52fa0f86e77e1b_D20211001-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzQzOTgwNDY1MzM0NDE_b9385caa-da15-4d19-842b-691e4ddefdcd"
      unitRef="usd">2000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i19e2681a08f94930a55705e928524d31_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzQzOTgwNDY1MzM0Mjk_b376ce64-f92d-424f-a774-64d0a3f8ee65"
      unitRef="usd">7000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="ifb7924f502ed418b8a52fa0f86e77e1b_D20211001-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzI3NDg3NzkwOTE0MDA_1de41898-277f-48ce-ac16-eeab98c6b798"
      unitRef="usd">2200000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="id8e658249a1b4ada9bf653d6f869d521_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzEwOTk1MTE2NDUwNjc_58c0a9b9-5a96-4ca8-a957-f0c2c225fb3b"
      unitRef="usd">5500000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <idxx:BusinessCombinationContingentConsiderationLiabilityAndHoldback
      contextRef="i19c6a768e2a14d0bb7d30636dbb2c293_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzEwOTk1MTE2NDUxNDA_9cb3187d-c147-4eac-8dc3-9c00a68706ed"
      unitRef="usd">1100000</idxx:BusinessCombinationContingentConsiderationLiabilityAndHoldback>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i98a1c47a6a4347cd86ea3a19f76e6f2c_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzEwOTk1MTE2NDUzMzE_ea5fe9b3-acfc-4971-81c9-07fae65c4009"
      unitRef="usd">4300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ibf189d70c3364256b7c496f71fbb573e_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzEwOTk1MTE2NDU0MjQ_684d2ec1-3e3a-4cbc-8b5f-c38fe1909dfc">P9Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:Goodwill
      contextRef="i19c6a768e2a14d0bb7d30636dbb2c293_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzEwOTk1MTE2NDU0NDM_c919c6aa-243f-4794-9766-a827032f4d45"
      unitRef="usd">1800000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i19c6a768e2a14d0bb7d30636dbb2c293_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzEwOTk1MTE2NDU1MzY_9a694b35-98b3-4dd0-95cc-af01730991b1"
      unitRef="usd">600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="iaa9a585d1027406aaf397c11d9f703e3_D20191001-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzM1OA_7d794169-8046-4de6-88e9-e279d9d92ff9"
      unitRef="usd">50000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i1d6f007fbb65407089a89432eb6964c5_I20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzY1Mg_f153a26f-54e7-44bb-bcd3-f3532fea67cd"
      unitRef="usd">26900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i21fe577fc12d43d6aa8593e56fbbd4ba_D20200101-20200331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1Xzc0Nw_ba86227d-06b7-418c-acb1-101a1cb0e8d7">P13Y9M18D</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i80310c05b475409f9d808f6d23317bc9_I20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1Xzc1MQ_8fe6acc3-7c7e-4762-9b0a-2f3f5ba4fe1d"
      unitRef="usd">200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:Goodwill
      contextRef="i80310c05b475409f9d808f6d23317bc9_I20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1Xzc3OA_208a46d4-0158-4998-9a08-9c6ae355efae"
      unitRef="usd">22900000</us-gaap:Goodwill>
    <idxx:NoncontrollingInterestOwnershipPercentageAcquiredFromNoncontrollingOwners
      contextRef="ifd0bd4a0a64d4c9fa9955ab39bcd5b33_D20211001-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzQ5NDc4MDIzNDY3NzA_b8695fbc-1db9-4fb3-8d21-7fbeb97d5f45"
      unitRef="number">0.05</idxx:NoncontrollingInterestOwnershipPercentageAcquiredFromNoncontrollingOwners>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="ifd0bd4a0a64d4c9fa9955ab39bcd5b33_D20211001-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODQvZnJhZzpiN2FkMTRlYWQzMDQ0ZWJkYTdjMGViMzQyMDEzOTdmNS90ZXh0cmVnaW9uOmI3YWQxNGVhZDMwNDRlYmRhN2MwZWIzNDIwMTM5N2Y1XzQ5NDc4MDIzNDY3NzQ_3318ab33-b352-4d2d-bbcc-339d07cdc0ed"
      unitRef="usd">1000000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzExMjM0_cfbfa2e9-4e2e-4a2e-af98-eefc53a857f8">SHARE-BASED COMPENSATION &lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We provide for various forms of share-based compensation awards to our employees and non-employee directors. Our share-based compensation plans allow for the issuance of a mix of stock options, restricted stock, stock appreciation rights, employee stock purchase rights, and other stock unit awards.&#160;With the exception of stock options, the fair value of our awards is equal to the closing stock price of IDEXX common stock on the date of grant. We calculate the fair value of our stock option awards using the Black-Scholes-Merton option-pricing model. For stock options, restricted stock units (&#x201c;RSUs&#x201d;), and deferred stock units (&#x201c;DSUs&#x201d;), share-based compensation expense is recognized net of estimated forfeitures, on a straight-line basis over the requisite service period of the award for stock options.&#160;For performance-based restricted stock units (&#x201c;PBRSUs&#x201d;), share-based compensation expense is recognized net of estimated forfeitures, on a grade-vesting methodology over the requisite service period.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock options permit a holder to buy IDEXX stock upon vesting at the stock option exercise price set on the day of grant. An RSU is an agreement to issue shares of IDEXX stock at the time of vesting. A PBRSU is an agreement to issue shares of IDEXX stock at the time of vesting upon successful completion of certain performance goals. DSUs are granted under our Executive Deferred Compensation Plan (the &#x201c;Executive Plan&#x201d;) and non-employee Director Deferred Compensation Plan (the &#x201c;Director Plan&#x201d;). DSUs may or may not have vesting conditions depending on the plan under which they are issued. We did not issue any restricted stock or stock appreciation rights during the years ended December 31, 2021, 2020, and 2019, nor were any restricted stock or stock appreciation rights outstanding as of those years ended.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We primarily issue shares of common stock to satisfy stock option exercises and employee stock purchase rights and to settle RSUs, PBRSUs, and DSUs. We issue shares of treasury stock to settle certain RSUs and upon the exercise of certain stock options, which were not material for the years ended December 31, 2021, 2020, and 2019. The number of shares of common stock and treasury stock issued are equivalent to the number of awards exercised or&#160;settled.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;With the exception of employee stock purchase rights, equity awards are issued to employees and non-employee di&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;rectors under the 2018 Stock Incentive Plan (the "2018 Stock Plan"). Our Board of Directors has authorized the issuance of 7.5 million shar&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;es of our common stock under the 2018 Stock Plan. Any shares that are subject to awards of stock options or stock appreciation rights will be counted against the share limit as one share for every share granted. Any shares that are issued other than stock options and stock appreciation rights will be counted against the share limit as 2.4 shares for every share granted. If any shares issued under our prior plans are forfeited, settled for cash, or expire, these shares, to the extent of such forfeiture, cash settlement, or expiration, will again be available for issuance under the 2018 Stock Plan. As of December 31, 2021, there were approximately 6.5 million remaining shares available for issuance under the 2018 Stock Plan.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Share-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation costs are classified in the consolidated financial statements consistent with the classification of cash compensation paid to the employees receiving such share-based compensation. The following is a summary of share-based compensation costs and related tax benefits recorded in our consolidated statements of income:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense included in cost of revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense included in operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total share-based compensation expense included in consolidated statements of income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax benefit resulting from share-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,734)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,965)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,861)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net share-based compensation expense included in consolidated statements of income, excluding tax benefit from settlement of share-based awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax benefit resulting from settlement of share-based awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(32,474)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(38,981)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(19,140)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net expense (benefit) related to share-based compensation arrangements included in consolidated statements of income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11,995)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the fourth quarter of 2019, we entered into a mutual separation agreement with our former CEO, pursuant to which Mr. Ayers&#x2019;s outstanding stock options were modified, resulting in a share-based compensation expense of approximately $10.9 million, primarily representing an acceleration of the cost of the equity awards. This expense was partially offset by a reduction to our provision for income taxes of approximately $0.8 million. Other than the modification to Mr. Ayers's stock options, as described above, there were no other material modifications to the terms of outstanding options, RSUs,&#160;PBRSUs, or DSUs during the years ended December 31, 2021, 2020, or 2019.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense is reduced for an estimate of the number of awards that are expected to be forfeited. We use historical data and other factors to estimate expected employee terminations and to evaluate whether particular groups of employees have significantly different forfeiture expectations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total unrecognized compensation expense, net of estimated forfeitures, for unvested share-based compensation awards at December 31, 2021, was $64.1 million, which will be recognized over a weighted average period of approximately 1.3 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to December 4, 2019, all options granted to employees primarily vest ratably over five years on each anniversary of the date of grant. Options granted to non-employee directors vest fully on the first anniversary of the date of grant. Employee grants after December 4, 2019 vest ratably over four years. Vesting of option awards issued is conditional based on continuous service. Options granted after May 8, 2013 have a contractual term of ten years and options granted between January 1, 2006 and May 8, 2013 had contractual terms of seven years. Upon any change in control of the company, 25% of the unvested stock options then outstanding will vest and become exercisable. However, if the acquiring entity does not assume outstanding options, then all options will vest immediately prior to the change in control.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We use the Black-Scholes-Merton option-pricing model to determine the fair value of options granted. Option-pricing models require the input of highly subjective assumptions, particularly for the expected stock price volatility and the expected term of options. Changes in the subjective input assumptions can affect the fair value estimate. Our expected stock price volatility assumptions are based on the historical volatility of our stock over periods that are similar to the expected terms of grants and other relevant factors. We derive the expected term based on historical experience and other relevant factors concerning expected employee behavior with regard to option exercise. The risk-free interest rate is based on U.S. Treasury yields for a maturity approximating the expected term calculated at the date of grant. We have never paid any cash dividends on our common stock and we have no intention to pay a dividend at this time; therefore, we assume that no dividends will be paid over the expected terms of option awards.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determine the assumptions used in the valuation of option awards as of the date of grant. Differences in the expected stock price volatility, expected term or risk-free interest rate may necessitate distinct valuation assumptions at those grant dates. As such, we may use different assumptions for options granted throughout the year. The weighted averages of the valuation assumptions used to determine the fair value of each option award on the date of grant and the weighted average estimated fair values were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share price at grant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;546.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;291.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;218.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share exercise price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;550.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;291.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;220.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected stock price volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected term, in years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average fair value of options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;169.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;84.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the status of options granted under our share-based compensation plans at December 31, 2021, and changes during the year then ended, are presented in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.575%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.996%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.996%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.996%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.001%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number of Options (000)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average Remaining Contractual Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate Intrinsic Value ($000)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;149.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;550.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(310)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;102.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;261.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;188.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;825,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fully vested as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;127.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;588,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fully vested and expected to vest as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;186.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;819,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total fair value of options vested were $17.3 million, $14.6 million, and $12.2 million during the years ended December 31, 2021, 2020, and 2019, respectively&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intrinsic value of stock options exercised represents the amount by which the market price of the common stock exceeded the exercise price, before applicable income taxes. The total intrinsic values of stock options exercised were $147.9 million, $163.0 million, and $83.7 million during the years ended December 31, 2021, 2020, and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Restricted Stock Units&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to December 4, 2019, the majority of RSUs, including our PBRSUs, granted to employees vest ratably over five years on each anniversary of the date of grant. Employee grants after December 4, 2019, will vest ratably over 4 years. PBRSUs granted to employees vest based on meeting performance goals set on the day of grant. RSUs granted to non-employee directors vest fully on the first anniversary of the date of grant. Vesting as it relates to RSUs and PBRSUs issued is conditional based on continuous service. Upon any change in control of the company, 25% of the unvested RSUs and PBRSUs then outstanding will vest, provided, however, that if the acquiring entity does not assume the RSUs and PBRSUs, then all such units will vest immediately prior to the change in control. At time of grant, we assume all PBRSUs will meet performance goals to vest.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the status of RSUs and PBRSUs granted under our share-based compensation plans at December 31, 2021, and changes during the period then ended, are presented in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.281%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number of Units (000)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant-Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Nonvested as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;202.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Nonvested as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;306.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected to vest as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;303.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total fair values of RSUs and PBRSUs vested were $46.1 million, $27.9 million, and $23.8 million during the years ended December 31, 2021, 2020, and 2019, respectively. The aggregate intrinsic value of nonvested RSUs and PBRSUs as of December 31, 2021, which is equal to the fair value of IDEXX&#x2019;s common stock as of December 31, 2021, multiplied by the number of nonvested units as of December 31, 2021, was $108.8 million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Deferred Stock Units&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under our Director Plan, non-employee directors may defer a portion of their cash fees in the form of vested DSUs. Prior to 2014, certain members of our management could elect to defer a portion of their cash compensation in the form of vested deferred stock units under our Executive Plan. Each DSU represents the right to receive one unissued share of our common stock. These recipients receive a number of DSUs equal to the amount of cash fees or compensation deferred divided by the closing sale price of the common stock on the date of deferral. Also, under the Director Plan, non-employee directors are awarded annual grants of either RSUs or DSUs that vest fully on the first anniversary of the date of grant. Vesting for these annual RSU and DSU grants is conditional based on continuous service. Vested DSUs are distributed as shares of common stock on the distribution date elected by the participant and pursuant to the terms of the Director or Executive Plan, as applicable.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were approximately 90,000 and 87,000 vested DSUs outstanding under our share-based compensation plans as of December 31, 2021 and 2020, respectively. During 2020, approximately 59,000 DSUs were distributed as shares of common stock to our former CEO in accordance with the terms of the Executive Plan and the deferral elections he previously made. Unvested DSUs as of December 31, 2021 and 2020, were not material.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Employee Stock Purchase Rights&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Employee stock purchase rights are issued under the 1997 Employee Stock Purchase Plan, under which we reserved and may issue up to an aggregate of 4.7 million shares of common stock in periodic offerings. Under this plan, stock is sold to employees at a 15% discount off the closing price of the stock on the last day of each quarter. The dollar value of this discount is equal to the fair value of purchase rights recognized as share-based compensation. We issued approximately 29,500,&#160;39,000, and 47,000 shares of common stock in connection with the Employee Stock Purchase Plan during the years ended December 31, 2021, 2020, and 2019, respectively. As of December 31, 2021, there were approximately 1.1 million remaining shares available for issuance under the 1997 Employee Stock Purchase Plan.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzExMjQz_8fefd82e-6376-4704-a6f7-73046461e0c0">We provide for various forms of share-based compensation awards to our employees and non-employee directors. Our share-based compensation plans allow for the issuance of a mix of stock options, restricted stock, stock appreciation rights, employee stock purchase rights, and other stock unit awards.&#160;With the exception of stock options, the fair value of our awards is equal to the closing stock price of IDEXX common stock on the date of grant. We calculate the fair value of our stock option awards using the Black-Scholes-Merton option-pricing model. For stock options, restricted stock units (&#x201c;RSUs&#x201d;), and deferred stock units (&#x201c;DSUs&#x201d;), share-based compensation expense is recognized net of estimated forfeitures, on a straight-line basis over the requisite service period of the award for stock options.&#160;For performance-based restricted stock units (&#x201c;PBRSUs&#x201d;), share-based compensation expense is recognized net of estimated forfeitures, on a grade-vesting methodology over the requisite service period.</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i3338ed00513241bc832c9f2114b7b270_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzI1MDc_c5ef602a-5162-4dea-8df9-a394484c92f1"
      unitRef="shares">7500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <idxx:RatioSharesIssuedUnderShareBasedAwardsToSharesAuthorizedUnderStockPlans
      contextRef="i97018d52b0af4870b3849b272b1355ec_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzI2OTE_d28b9186-29a1-48b5-81da-55a6bcddbdb1"
      unitRef="number">1</idxx:RatioSharesIssuedUnderShareBasedAwardsToSharesAuthorizedUnderStockPlans>
    <idxx:RatioSharesIssuedUnderShareBasedAwardsToSharesAuthorizedUnderStockPlans
      contextRef="i8c8ce4fcf0ad47d1a61060c9d791ef17_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzI4NTA_7ba1dfe1-b9ba-4598-8699-98ef34e0d74c"
      unitRef="number">2.4</idxx:RatioSharesIssuedUnderShareBasedAwardsToSharesAuthorizedUnderStockPlans>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i4a16b614e5514b46a709cdefac9167c9_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzMxNTA_08508169-11be-4733-9f7b-23a9847e5951"
      unitRef="shares">6500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzExMjQ1_9a539c7e-3280-4409-9b0f-9f9bf6ec1223">The following is a summary of share-based compensation costs and related tax benefits recorded in our consolidated statements of income:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense included in cost of revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense included in operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total share-based compensation expense included in consolidated statements of income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax benefit resulting from share-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,734)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,965)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,861)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net share-based compensation expense included in consolidated statements of income, excluding tax benefit from settlement of share-based awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax benefit resulting from settlement of share-based awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(32,474)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(38,981)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(19,140)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net expense (benefit) related to share-based compensation arrangements included in consolidated statements of income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11,995)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ida1ffc64f6764bb4be6d2faec82e9f3f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo0YTZjNWMzNDg2Zjk0ZGRjOGIwMjA1ZDIxMjQxYTA3OC90YWJsZXJhbmdlOjRhNmM1YzM0ODZmOTRkZGM4YjAyMDVkMjEyNDFhMDc4XzMtMi0xLTEtMA_246f2a06-1161-41b8-903a-56428d58a26d"
      unitRef="usd">4044000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i7b83a53333fa4f00b4d62d186eefc036_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo0YTZjNWMzNDg2Zjk0ZGRjOGIwMjA1ZDIxMjQxYTA3OC90YWJsZXJhbmdlOjRhNmM1YzM0ODZmOTRkZGM4YjAyMDVkMjEyNDFhMDc4XzMtNC0xLTEtMA_45b2c289-7979-4a6e-a20f-e89998900d8e"
      unitRef="usd">3415000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie726a1d133bf4ad5a692bd283baf4341_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo0YTZjNWMzNDg2Zjk0ZGRjOGIwMjA1ZDIxMjQxYTA3OC90YWJsZXJhbmdlOjRhNmM1YzM0ODZmOTRkZGM4YjAyMDVkMjEyNDFhMDc4XzMtNi0xLTEtMA_f06f1eaa-1cc3-4c8c-a8cf-3aecf0b67b25"
      unitRef="usd">2681000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i154151cc952a42e2b9337039f8030f64_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo0YTZjNWMzNDg2Zjk0ZGRjOGIwMjA1ZDIxMjQxYTA3OC90YWJsZXJhbmdlOjRhNmM1YzM0ODZmOTRkZGM4YjAyMDVkMjEyNDFhMDc4XzQtMi0xLTEtMA_4082491c-1a2b-49c1-95ff-5fafb14bb2cb"
      unitRef="usd">33711000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="id0b2c60d6a4244439cacf26a55fa991c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo0YTZjNWMzNDg2Zjk0ZGRjOGIwMjA1ZDIxMjQxYTA3OC90YWJsZXJhbmdlOjRhNmM1YzM0ODZmOTRkZGM4YjAyMDVkMjEyNDFhMDc4XzQtNC0xLTEtMA_c1c1f284-d8e9-44a8-bd3b-9699cc6f86e5"
      unitRef="usd">27536000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="id3a4a8e504c24b93880965b1c3991089_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo0YTZjNWMzNDg2Zjk0ZGRjOGIwMjA1ZDIxMjQxYTA3OC90YWJsZXJhbmdlOjRhNmM1YzM0ODZmOTRkZGM4YjAyMDVkMjEyNDFhMDc4XzQtNi0xLTEtMA_0b5353c7-aed9-41f0-9685-42eeaa8dabe9"
      unitRef="usd">36597000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo0YTZjNWMzNDg2Zjk0ZGRjOGIwMjA1ZDIxMjQxYTA3OC90YWJsZXJhbmdlOjRhNmM1YzM0ODZmOTRkZGM4YjAyMDVkMjEyNDFhMDc4XzUtMi0xLTEtMA_e5ca5b71-088c-412c-aeb6-75efdcf1e4c3"
      unitRef="usd">37755000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo0YTZjNWMzNDg2Zjk0ZGRjOGIwMjA1ZDIxMjQxYTA3OC90YWJsZXJhbmdlOjRhNmM1YzM0ODZmOTRkZGM4YjAyMDVkMjEyNDFhMDc4XzUtNC0xLTEtMA_d16589c9-9700-4241-a0f8-590cf3079e04"
      unitRef="usd">30951000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo0YTZjNWMzNDg2Zjk0ZGRjOGIwMjA1ZDIxMjQxYTA3OC90YWJsZXJhbmdlOjRhNmM1YzM0ODZmOTRkZGM4YjAyMDVkMjEyNDFhMDc4XzUtNi0xLTEtMA_d07038a8-ac48-416c-a787-75bf06cd778d"
      unitRef="usd">39278000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo0YTZjNWMzNDg2Zjk0ZGRjOGIwMjA1ZDIxMjQxYTA3OC90YWJsZXJhbmdlOjRhNmM1YzM0ODZmOTRkZGM4YjAyMDVkMjEyNDFhMDc4XzYtMi0xLTEtMA_b874558e-beaf-422d-a5b1-aadb89117951"
      unitRef="usd">4734000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo0YTZjNWMzNDg2Zjk0ZGRjOGIwMjA1ZDIxMjQxYTA3OC90YWJsZXJhbmdlOjRhNmM1YzM0ODZmOTRkZGM4YjAyMDVkMjEyNDFhMDc4XzYtNC0xLTEtMA_3284a2e4-15a3-42b7-baf4-87d2c4df05d5"
      unitRef="usd">3965000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo0YTZjNWMzNDg2Zjk0ZGRjOGIwMjA1ZDIxMjQxYTA3OC90YWJsZXJhbmdlOjRhNmM1YzM0ODZmOTRkZGM4YjAyMDVkMjEyNDFhMDc4XzYtNi0xLTEtMA_673f3f8a-e625-4ffb-9f93-dea61e7dbe1b"
      unitRef="usd">4861000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <idxx:AllocatedShareBasedCompensationExpenseNetOfTaxExcludingTaxBenefitFromSettlementOfShareBasedAwards
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo0YTZjNWMzNDg2Zjk0ZGRjOGIwMjA1ZDIxMjQxYTA3OC90YWJsZXJhbmdlOjRhNmM1YzM0ODZmOTRkZGM4YjAyMDVkMjEyNDFhMDc4XzctMi0xLTEtMA_046835b3-d44a-4870-960f-e2d361eac0a9"
      unitRef="usd">33021000</idxx:AllocatedShareBasedCompensationExpenseNetOfTaxExcludingTaxBenefitFromSettlementOfShareBasedAwards>
    <idxx:AllocatedShareBasedCompensationExpenseNetOfTaxExcludingTaxBenefitFromSettlementOfShareBasedAwards
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo0YTZjNWMzNDg2Zjk0ZGRjOGIwMjA1ZDIxMjQxYTA3OC90YWJsZXJhbmdlOjRhNmM1YzM0ODZmOTRkZGM4YjAyMDVkMjEyNDFhMDc4XzctNC0xLTEtMA_bd6b8677-ab63-4b2d-8839-990469da1063"
      unitRef="usd">26986000</idxx:AllocatedShareBasedCompensationExpenseNetOfTaxExcludingTaxBenefitFromSettlementOfShareBasedAwards>
    <idxx:AllocatedShareBasedCompensationExpenseNetOfTaxExcludingTaxBenefitFromSettlementOfShareBasedAwards
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo0YTZjNWMzNDg2Zjk0ZGRjOGIwMjA1ZDIxMjQxYTA3OC90YWJsZXJhbmdlOjRhNmM1YzM0ODZmOTRkZGM4YjAyMDVkMjEyNDFhMDc4XzctNi0xLTEtMA_2838f635-744d-4683-b221-7436ff5b9d58"
      unitRef="usd">34417000</idxx:AllocatedShareBasedCompensationExpenseNetOfTaxExcludingTaxBenefitFromSettlementOfShareBasedAwards>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo0YTZjNWMzNDg2Zjk0ZGRjOGIwMjA1ZDIxMjQxYTA3OC90YWJsZXJhbmdlOjRhNmM1YzM0ODZmOTRkZGM4YjAyMDVkMjEyNDFhMDc4XzgtMi0xLTEtMA_bdf57399-504d-4ca8-a6b0-3ad570389b20"
      unitRef="usd">32474000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo0YTZjNWMzNDg2Zjk0ZGRjOGIwMjA1ZDIxMjQxYTA3OC90YWJsZXJhbmdlOjRhNmM1YzM0ODZmOTRkZGM4YjAyMDVkMjEyNDFhMDc4XzgtNC0xLTEtMA_d57cac91-efad-4b20-a879-cffdb38059b5"
      unitRef="usd">38981000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo0YTZjNWMzNDg2Zjk0ZGRjOGIwMjA1ZDIxMjQxYTA3OC90YWJsZXJhbmdlOjRhNmM1YzM0ODZmOTRkZGM4YjAyMDVkMjEyNDFhMDc4XzgtNi0xLTEtMA_e29a4859-cef6-444d-b2da-9b72d474888d"
      unitRef="usd">19140000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo0YTZjNWMzNDg2Zjk0ZGRjOGIwMjA1ZDIxMjQxYTA3OC90YWJsZXJhbmdlOjRhNmM1YzM0ODZmOTRkZGM4YjAyMDVkMjEyNDFhMDc4XzktMi0xLTEtMA_881b8767-afeb-49ed-9f22-d24510dcdfce"
      unitRef="usd">547000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo0YTZjNWMzNDg2Zjk0ZGRjOGIwMjA1ZDIxMjQxYTA3OC90YWJsZXJhbmdlOjRhNmM1YzM0ODZmOTRkZGM4YjAyMDVkMjEyNDFhMDc4XzktNC0xLTEtMA_acf9bdb6-97e3-4402-9d1b-59b6e38097f5"
      unitRef="usd">-11995000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo0YTZjNWMzNDg2Zjk0ZGRjOGIwMjA1ZDIxMjQxYTA3OC90YWJsZXJhbmdlOjRhNmM1YzM0ODZmOTRkZGM4YjAyMDVkMjEyNDFhMDc4XzktNi0xLTEtMA_cad656f6-ac7a-4282-9a14-67d2839383df"
      unitRef="usd">15277000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i77a5beb76e6b48498eed44e9a602baed_D20191001-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzM4MzE_82538d87-0db5-49f6-8df7-afe9f46b6b2b"
      unitRef="usd">10900000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i77a5beb76e6b48498eed44e9a602baed_D20191001-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzQwMDg_b6e2131a-c46b-4a66-b4c2-c0af91c192e1"
      unitRef="usd">-800000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzQ2Nzc_b1653f82-53ea-4394-9cd7-930d60087fc8"
      unitRef="usd">64100000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzQ3NTQ_0f0c65ca-5a5a-4585-808c-e7020df69a91">P1Y3M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ie3cf8555002d4b4cbd01dce8c9e1e1d3_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzQ4NjM_caec9f54-1dc9-4947-98d8-cc8ec7b8b49e">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i45554c00d32c4d45a16d94dd9b602937_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzUwNzE_1e1ad7ff-9b5f-4e74-a7e6-ab95704dbd48">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="idae58301e68b412eb28334afea378d2b_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzUyMTI_507a95c4-80a8-458c-a32d-ec6e48fe9c7c">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i9c3e894425d54b5a84d42ae55eb839ae_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzUzMDA_cbef7407-2093-46a6-8247-6bba21f7acda">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i982c1764182b47d1b743c71bb7b33923_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzUzNDc_c42e7db7-186f-492a-a61b-0a52ef3fc788"
      unitRef="number">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzExMjM2_d92b136e-6c4d-4764-adbf-7dcadb1a0fd9">The weighted averages of the valuation assumptions used to determine the fair value of each option award on the date of grant and the weighted average estimated fair values were as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share price at grant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;546.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;291.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;218.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share exercise price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;550.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;291.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;220.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected stock price volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected term, in years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average fair value of options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;169.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;84.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:SharePrice
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTBhNWZjNzgzMmQ0NjIxYWExOGUxMDdmYzdkMTUzZi90YWJsZXJhbmdlOmU1MGE1ZmM3ODMyZDQ2MjFhYTE4ZTEwN2ZjN2QxNTNmXzMtMi0xLTEtMA_87ad5995-f4e4-4cff-b297-66aff1f9e297"
      unitRef="usdPerShare">546.36</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTBhNWZjNzgzMmQ0NjIxYWExOGUxMDdmYzdkMTUzZi90YWJsZXJhbmdlOmU1MGE1ZmM3ODMyZDQ2MjFhYTE4ZTEwN2ZjN2QxNTNmXzMtNC0xLTEtMA_c170dc96-83bd-4ed2-b5c7-f7e5d377a327"
      unitRef="usdPerShare">291.14</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="i0c634b937c58472e84857eacf99e17df_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTBhNWZjNzgzMmQ0NjIxYWExOGUxMDdmYzdkMTUzZi90YWJsZXJhbmdlOmU1MGE1ZmM3ODMyZDQ2MjFhYTE4ZTEwN2ZjN2QxNTNmXzMtNi0xLTEtMA_a9d64541-ce3b-4a8e-a391-8cfb58128381"
      unitRef="usdPerShare">218.66</us-gaap:SharePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTBhNWZjNzgzMmQ0NjIxYWExOGUxMDdmYzdkMTUzZi90YWJsZXJhbmdlOmU1MGE1ZmM3ODMyZDQ2MjFhYTE4ZTEwN2ZjN2QxNTNmXzQtMi0xLTEtMA_92e47f8c-ba12-4f26-a37f-147b1b891e0f"
      unitRef="usdPerShare">550.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTBhNWZjNzgzMmQ0NjIxYWExOGUxMDdmYzdkMTUzZi90YWJsZXJhbmdlOmU1MGE1ZmM3ODMyZDQ2MjFhYTE4ZTEwN2ZjN2QxNTNmXzQtNC0xLTEtMA_71c99001-e44d-4bee-a256-e3920bd99abc"
      unitRef="usdPerShare">291.14</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="i0c634b937c58472e84857eacf99e17df_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTBhNWZjNzgzMmQ0NjIxYWExOGUxMDdmYzdkMTUzZi90YWJsZXJhbmdlOmU1MGE1ZmM3ODMyZDQ2MjFhYTE4ZTEwN2ZjN2QxNTNmXzQtNi0xLTEtMA_b334b07a-cc19-4229-81f3-22c2c969ec0c"
      unitRef="usdPerShare">220.88</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTBhNWZjNzgzMmQ0NjIxYWExOGUxMDdmYzdkMTUzZi90YWJsZXJhbmdlOmU1MGE1ZmM3ODMyZDQ2MjFhYTE4ZTEwN2ZjN2QxNTNmXzUtMi0xLTEtMA_80b8e04b-eb99-4489-bf70-4b3149699cb3"
      unitRef="number">0.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTBhNWZjNzgzMmQ0NjIxYWExOGUxMDdmYzdkMTUzZi90YWJsZXJhbmdlOmU1MGE1ZmM3ODMyZDQ2MjFhYTE4ZTEwN2ZjN2QxNTNmXzUtNC0xLTEtMA_49ea2a81-08e8-459f-bd2e-bb4dcd1ca63f"
      unitRef="number">0.27</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTBhNWZjNzgzMmQ0NjIxYWExOGUxMDdmYzdkMTUzZi90YWJsZXJhbmdlOmU1MGE1ZmM3ODMyZDQ2MjFhYTE4ZTEwN2ZjN2QxNTNmXzUtNi0xLTEtMA_ede791bb-8c9c-4d9e-a4b3-d42f1885a8a4"
      unitRef="number">0.26</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTBhNWZjNzgzMmQ0NjIxYWExOGUxMDdmYzdkMTUzZi90YWJsZXJhbmdlOmU1MGE1ZmM3ODMyZDQ2MjFhYTE4ZTEwN2ZjN2QxNTNmXzYtMi0xLTEtMA_f482111f-0425-4586-ac36-1ecce8a50829">P6Y2M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTBhNWZjNzgzMmQ0NjIxYWExOGUxMDdmYzdkMTUzZi90YWJsZXJhbmdlOmU1MGE1ZmM3ODMyZDQ2MjFhYTE4ZTEwN2ZjN2QxNTNmXzYtNC0xLTEtMA_ad124f19-9fff-4203-971c-e2c8d17cd3aa">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTBhNWZjNzgzMmQ0NjIxYWExOGUxMDdmYzdkMTUzZi90YWJsZXJhbmdlOmU1MGE1ZmM3ODMyZDQ2MjFhYTE4ZTEwN2ZjN2QxNTNmXzYtNi0xLTEtMA_cf9e1ac6-5684-47d8-91e9-76f6f0917508">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTBhNWZjNzgzMmQ0NjIxYWExOGUxMDdmYzdkMTUzZi90YWJsZXJhbmdlOmU1MGE1ZmM3ODMyZDQ2MjFhYTE4ZTEwN2ZjN2QxNTNmXzctMi0xLTEtMA_95016b85-f1b1-47cd-a277-8bedae7bd5bf"
      unitRef="number">0.007</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTBhNWZjNzgzMmQ0NjIxYWExOGUxMDdmYzdkMTUzZi90YWJsZXJhbmdlOmU1MGE1ZmM3ODMyZDQ2MjFhYTE4ZTEwN2ZjN2QxNTNmXzctNC0xLTEtMA_ba3a7604-ac64-480f-85a8-3270abd8d232"
      unitRef="number">0.014</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTBhNWZjNzgzMmQ0NjIxYWExOGUxMDdmYzdkMTUzZi90YWJsZXJhbmdlOmU1MGE1ZmM3ODMyZDQ2MjFhYTE4ZTEwN2ZjN2QxNTNmXzctNi0xLTEtMA_16323669-6051-4be4-8d0b-6a3a72c87a3d"
      unitRef="number">0.024</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTBhNWZjNzgzMmQ0NjIxYWExOGUxMDdmYzdkMTUzZi90YWJsZXJhbmdlOmU1MGE1ZmM3ODMyZDQ2MjFhYTE4ZTEwN2ZjN2QxNTNmXzgtMi0xLTEtMA_22d07a98-3150-4a2c-be09-48571217159c"
      unitRef="usdPerShare">169.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTBhNWZjNzgzMmQ0NjIxYWExOGUxMDdmYzdkMTUzZi90YWJsZXJhbmdlOmU1MGE1ZmM3ODMyZDQ2MjFhYTE4ZTEwN2ZjN2QxNTNmXzgtNC0xLTEtMA_24044ce8-77f2-42f6-844c-d0abb196bd56"
      unitRef="usdPerShare">84.92</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTBhNWZjNzgzMmQ0NjIxYWExOGUxMDdmYzdkMTUzZi90YWJsZXJhbmdlOmU1MGE1ZmM3ODMyZDQ2MjFhYTE4ZTEwN2ZjN2QxNTNmXzgtNi0xLTEtMA_5188b2ad-e5fc-422d-81ea-598b5a3c6b34"
      unitRef="usdPerShare">65.53</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzExMjM5_c331eae3-875b-4e69-af19-69a41ed77786">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the status of options granted under our share-based compensation plans at December 31, 2021, and changes during the year then ended, are presented in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.575%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.996%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.996%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.996%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.001%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number of Options (000)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average Remaining Contractual Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate Intrinsic Value ($000)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;149.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;550.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(310)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;102.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;261.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;188.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;825,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fully vested as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;127.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;588,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fully vested and expected to vest as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;186.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;819,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTU1NDRhM2FkM2E0YzY1YjA5MWMyZWI2NTc3NDBjYi90YWJsZXJhbmdlOmU1NTU0NGEzYWQzYTRjNjViMDkxYzJlYjY1Nzc0MGNiXzItMi0xLTEtMA_27b479d5-0c04-4f42-814c-8e8e843a9b98"
      unitRef="shares">1953000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTU1NDRhM2FkM2E0YzY1YjA5MWMyZWI2NTc3NDBjYi90YWJsZXJhbmdlOmU1NTU0NGEzYWQzYTRjNjViMDkxYzJlYjY1Nzc0MGNiXzItNC0xLTEtMA_872a9f74-a442-4278-9fde-08b818370a40"
      unitRef="usdPerShare">149.32</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTU1NDRhM2FkM2E0YzY1YjA5MWMyZWI2NTc3NDBjYi90YWJsZXJhbmdlOmU1NTU0NGEzYWQzYTRjNjViMDkxYzJlYjY1Nzc0MGNiXzMtMi0xLTEtMA_4af2ba0b-41ab-41f1-9f42-003304171d90"
      unitRef="shares">144000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTU1NDRhM2FkM2E0YzY1YjA5MWMyZWI2NTc3NDBjYi90YWJsZXJhbmdlOmU1NTU0NGEzYWQzYTRjNjViMDkxYzJlYjY1Nzc0MGNiXzMtNC0xLTEtMA_2ca61173-8832-419f-bab7-311453c78b29"
      unitRef="usdPerShare">550.10</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTU1NDRhM2FkM2E0YzY1YjA5MWMyZWI2NTc3NDBjYi90YWJsZXJhbmdlOmU1NTU0NGEzYWQzYTRjNjViMDkxYzJlYjY1Nzc0MGNiXzQtMi0xLTEtMA_f9de1bda-6b49-41de-92b1-2102b3ade15d"
      unitRef="shares">310000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTU1NDRhM2FkM2E0YzY1YjA5MWMyZWI2NTc3NDBjYi90YWJsZXJhbmdlOmU1NTU0NGEzYWQzYTRjNjViMDkxYzJlYjY1Nzc0MGNiXzQtNC0xLTEtMA_57e0a063-a60e-45bc-8884-26a059257868"
      unitRef="usdPerShare">102.78</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTU1NDRhM2FkM2E0YzY1YjA5MWMyZWI2NTc3NDBjYi90YWJsZXJhbmdlOmU1NTU0NGEzYWQzYTRjNjViMDkxYzJlYjY1Nzc0MGNiXzUtMi0xLTEtMA_fc9fb370-bc69-45f6-9081-27f38d0bc4a7"
      unitRef="shares">30000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTU1NDRhM2FkM2E0YzY1YjA5MWMyZWI2NTc3NDBjYi90YWJsZXJhbmdlOmU1NTU0NGEzYWQzYTRjNjViMDkxYzJlYjY1Nzc0MGNiXzUtNC0xLTEtMA_f5a5a1ef-96cc-4597-8198-16ab0976a252"
      unitRef="usdPerShare">261.95</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTU1NDRhM2FkM2E0YzY1YjA5MWMyZWI2NTc3NDBjYi90YWJsZXJhbmdlOmU1NTU0NGEzYWQzYTRjNjViMDkxYzJlYjY1Nzc0MGNiXzYtMi0xLTEtMA_2990f27b-b1dc-41a7-b7fc-71610c902aad"
      unitRef="shares">1757000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTU1NDRhM2FkM2E0YzY1YjA5MWMyZWI2NTc3NDBjYi90YWJsZXJhbmdlOmU1NTU0NGEzYWQzYTRjNjViMDkxYzJlYjY1Nzc0MGNiXzYtNC0xLTEtMA_d742fc98-4d50-488f-a6de-8b87f67586cc"
      unitRef="usdPerShare">188.47</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTU1NDRhM2FkM2E0YzY1YjA5MWMyZWI2NTc3NDBjYi90YWJsZXJhbmdlOmU1NTU0NGEzYWQzYTRjNjViMDkxYzJlYjY1Nzc0MGNiXzYtNi0xLTEtMA_4276888c-f5f2-4a49-b2eb-a7ada86d7b56">P5Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTU1NDRhM2FkM2E0YzY1YjA5MWMyZWI2NTc3NDBjYi90YWJsZXJhbmdlOmU1NTU0NGEzYWQzYTRjNjViMDkxYzJlYjY1Nzc0MGNiXzYtOC0xLTEtMA_779d10c5-1180-4931-9033-6df1dd896822"
      unitRef="usd">825745000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTU1NDRhM2FkM2E0YzY1YjA5MWMyZWI2NTc3NDBjYi90YWJsZXJhbmdlOmU1NTU0NGEzYWQzYTRjNjViMDkxYzJlYjY1Nzc0MGNiXzgtMi0xLTEtMA_0a8da189-0fb6-4cfd-b6c8-ad6ee617f151"
      unitRef="shares">1109000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTU1NDRhM2FkM2E0YzY1YjA5MWMyZWI2NTc3NDBjYi90YWJsZXJhbmdlOmU1NTU0NGEzYWQzYTRjNjViMDkxYzJlYjY1Nzc0MGNiXzgtNC0xLTEtMA_ee2d1bdc-18df-4620-aaa1-106059d83353"
      unitRef="usdPerShare">127.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTU1NDRhM2FkM2E0YzY1YjA5MWMyZWI2NTc3NDBjYi90YWJsZXJhbmdlOmU1NTU0NGEzYWQzYTRjNjViMDkxYzJlYjY1Nzc0MGNiXzgtNi0xLTEtMA_efe93f92-1074-46bd-8510-5d1b164a2541">P4Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTU1NDRhM2FkM2E0YzY1YjA5MWMyZWI2NTc3NDBjYi90YWJsZXJhbmdlOmU1NTU0NGEzYWQzYTRjNjViMDkxYzJlYjY1Nzc0MGNiXzgtOC0xLTEtMA_27c827be-0725-4821-9ef4-6a95d8b1fbae"
      unitRef="usd">588831000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTU1NDRhM2FkM2E0YzY1YjA5MWMyZWI2NTc3NDBjYi90YWJsZXJhbmdlOmU1NTU0NGEzYWQzYTRjNjViMDkxYzJlYjY1Nzc0MGNiXzEwLTItMS0xLTA_7f1e33ff-d49b-4842-b27a-06b3e032a4c9"
      unitRef="shares">1738000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTU1NDRhM2FkM2E0YzY1YjA5MWMyZWI2NTc3NDBjYi90YWJsZXJhbmdlOmU1NTU0NGEzYWQzYTRjNjViMDkxYzJlYjY1Nzc0MGNiXzEwLTQtMS0xLTA_082779d2-4ae5-4c22-8087-d13c62193492"
      unitRef="usdPerShare">186.72</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTU1NDRhM2FkM2E0YzY1YjA5MWMyZWI2NTc3NDBjYi90YWJsZXJhbmdlOmU1NTU0NGEzYWQzYTRjNjViMDkxYzJlYjY1Nzc0MGNiXzEwLTYtMS0xLTA_563a93b8-6483-463e-8fef-62d7d60c8c45">P5Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTplNTU1NDRhM2FkM2E0YzY1YjA5MWMyZWI2NTc3NDBjYi90YWJsZXJhbmdlOmU1NTU0NGEzYWQzYTRjNjViMDkxYzJlYjY1Nzc0MGNiXzEwLTgtMS0xLTA_39156b82-1169-4908-a1b1-e7ad3f11603e"
      unitRef="usd">819777000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="i0491e8e2530147698782b2a10a30d90b_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzczNjE_ded332d0-5914-4b00-96d6-87271b01a8e7"
      unitRef="usd">17300000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="i3299da84372d432f98da6898831dd963_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzczNjU_2da5711f-fa9b-48b6-aa77-78d63366f355"
      unitRef="usd">14600000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="i982c1764182b47d1b743c71bb7b33923_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzczNzM_82da06e1-2128-4460-991f-7739331abddd"
      unitRef="usd">12200000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzc2NTk_beb42eec-e23d-4c33-91b2-e51596161f23"
      unitRef="usd">147900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzc2NjM_296ac358-7da8-427a-a54d-c82cbe13eaf4"
      unitRef="usd">163000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzc2NzE_8f478a3e-a478-4b7a-9c6c-9c4453c99612"
      unitRef="usd">83700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i1594d5a312e047069a064e029de5cf8b_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzc4NjM_3f5ae400-6726-4910-9522-5ed7d546c58b">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i84fa425282ab417da8ba5a3609c0031e_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzc5NzE_8f6a556a-5eb0-4289-935e-048b654e684d">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="ief941e5acd344fed862240efdd3a7288_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzgzMDA_6d5d7f51-fb63-4120-bf4b-b3c0faea9dbe"
      unitRef="number">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzExMjQx_2ef7d456-48c5-4a38-b643-72f496281dba">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the status of RSUs and PBRSUs granted under our share-based compensation plans at December 31, 2021, and changes during the period then ended, are presented in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.281%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number of Units (000)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant-Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Nonvested as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;202.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Nonvested as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;306.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected to vest as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;303.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ibcdf728b3b3f46f08f1609441281d24e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo3MWY2NGQ2MjUxZjQ0M2E5OGQzZmQ1OTBiOWIyNDhiZi90YWJsZXJhbmdlOjcxZjY0ZDYyNTFmNDQzYTk4ZDNmZDU5MGI5YjI0OGJmXzItMi0xLTEtMA_34ae9642-0e0c-4981-90e8-4d39be568149"
      unitRef="shares">218000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ibcdf728b3b3f46f08f1609441281d24e_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo3MWY2NGQ2MjUxZjQ0M2E5OGQzZmQ1OTBiOWIyNDhiZi90YWJsZXJhbmdlOjcxZjY0ZDYyNTFmNDQzYTk4ZDNmZDU5MGI5YjI0OGJmXzItNC0xLTEtMA_aa2b48d6-8a1e-4635-ad1a-869abdae5e5d"
      unitRef="usdPerShare">202.47</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i0cad033f6b01464bbca11ea746ae0dd3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo3MWY2NGQ2MjUxZjQ0M2E5OGQzZmQ1OTBiOWIyNDhiZi90YWJsZXJhbmdlOjcxZjY0ZDYyNTFmNDQzYTk4ZDNmZDU5MGI5YjI0OGJmXzMtMi0xLTEtMA_2bc0120a-cb10-4be4-a577-b24e1cb10ee5"
      unitRef="shares">44000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i0cad033f6b01464bbca11ea746ae0dd3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo3MWY2NGQ2MjUxZjQ0M2E5OGQzZmQ1OTBiOWIyNDhiZi90YWJsZXJhbmdlOjcxZjY0ZDYyNTFmNDQzYTk4ZDNmZDU5MGI5YjI0OGJmXzMtNC0xLTEtMA_f74847d2-1894-4d4b-84c3-3bc4f0567535"
      unitRef="usdPerShare"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i0cad033f6b01464bbca11ea746ae0dd3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo3MWY2NGQ2MjUxZjQ0M2E5OGQzZmQ1OTBiOWIyNDhiZi90YWJsZXJhbmdlOjcxZjY0ZDYyNTFmNDQzYTk4ZDNmZDU5MGI5YjI0OGJmXzQtMi0xLTEtMA_a45f5551-5337-4d1a-ba1d-26d48e47d95d"
      unitRef="shares">85000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i0cad033f6b01464bbca11ea746ae0dd3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo3MWY2NGQ2MjUxZjQ0M2E5OGQzZmQ1OTBiOWIyNDhiZi90YWJsZXJhbmdlOjcxZjY0ZDYyNTFmNDQzYTk4ZDNmZDU5MGI5YjI0OGJmXzQtNC0xLTEtMA_54a8b2fa-ea77-41fb-aff2-cef9fa1a2414"
      unitRef="usdPerShare"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i0cad033f6b01464bbca11ea746ae0dd3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo3MWY2NGQ2MjUxZjQ0M2E5OGQzZmQ1OTBiOWIyNDhiZi90YWJsZXJhbmdlOjcxZjY0ZDYyNTFmNDQzYTk4ZDNmZDU5MGI5YjI0OGJmXzUtMi0xLTEtMA_e0a7396b-ec25-4a58-bb00-8a83c56fdc3e"
      unitRef="shares">12000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i0cad033f6b01464bbca11ea746ae0dd3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo3MWY2NGQ2MjUxZjQ0M2E5OGQzZmQ1OTBiOWIyNDhiZi90YWJsZXJhbmdlOjcxZjY0ZDYyNTFmNDQzYTk4ZDNmZDU5MGI5YjI0OGJmXzUtNC0xLTEtMA_a626de08-cd72-4eee-b26f-13e3772a9c1d"
      unitRef="usdPerShare"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i694b32aa47f046748a1598cc0d558051_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo3MWY2NGQ2MjUxZjQ0M2E5OGQzZmQ1OTBiOWIyNDhiZi90YWJsZXJhbmdlOjcxZjY0ZDYyNTFmNDQzYTk4ZDNmZDU5MGI5YjI0OGJmXzYtMi0xLTEtMA_7fd9d354-b7d9-49ad-884f-9842cc0c0293"
      unitRef="shares">165000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i694b32aa47f046748a1598cc0d558051_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo3MWY2NGQ2MjUxZjQ0M2E5OGQzZmQ1OTBiOWIyNDhiZi90YWJsZXJhbmdlOjcxZjY0ZDYyNTFmNDQzYTk4ZDNmZDU5MGI5YjI0OGJmXzYtNC0xLTEtMA_aaec2cd5-8d12-4650-b1eb-1aba39eb4a68"
      unitRef="usdPerShare">306.18</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ibf6a2e2744a44ea98ebe5ee2a3b57059_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo3MWY2NGQ2MjUxZjQ0M2E5OGQzZmQ1OTBiOWIyNDhiZi90YWJsZXJhbmdlOjcxZjY0ZDYyNTFmNDQzYTk4ZDNmZDU5MGI5YjI0OGJmXzgtMi0xLTEtMA_ccae6ac8-2fd5-4c46-87f1-b81654719c44"
      unitRef="shares">156000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ibf6a2e2744a44ea98ebe5ee2a3b57059_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90YWJsZTo3MWY2NGQ2MjUxZjQ0M2E5OGQzZmQ1OTBiOWIyNDhiZi90YWJsZXJhbmdlOjcxZjY0ZDYyNTFmNDQzYTk4ZDNmZDU5MGI5YjI0OGJmXzgtNC0xLTEtMA_4933ac3a-5c69-4273-a5df-280e3801f1a1"
      unitRef="usdPerShare">303.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i0cad033f6b01464bbca11ea746ae0dd3_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzg4MzI_4158357b-a5f2-49e5-a0db-7651d899d425"
      unitRef="usd">46100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="ib209d359b518453c8297929f6c24722a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzg4MzY_fd3ae318-d13e-4917-8577-12d79a83d0c3"
      unitRef="usd">27900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="ief941e5acd344fed862240efdd3a7288_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzg4NDQ_ecc6861a-6335-497e-9941-e8e1216b815a"
      unitRef="usd">23800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzkwOTM_108a1b0a-0282-4f90-b070-c39de84ba402"
      unitRef="usd">108800000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested>
    <idxx:RatioOfDeferredStockUnitsToSharesOfCommonStock
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzk0NTM_6e708f7b-8667-4b72-8208-61786cf9fc9c"
      unitRef="number">1</idxx:RatioOfDeferredStockUnitsToSharesOfCommonStock>
    <us-gaap:CommonStockOtherSharesOutstanding
      contextRef="i9958c792661247119c39c9e01d982deb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzEwMTEx_1aebfeef-ceff-41d7-af28-f72dcb031e04"
      unitRef="shares">90000</us-gaap:CommonStockOtherSharesOutstanding>
    <us-gaap:CommonStockOtherSharesOutstanding
      contextRef="i7663c8e364ea4807a7ad1cbb6bafde89_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzEwMTE4_9fa6461a-1f04-49d2-b6ec-4a13e8221a55"
      unitRef="shares">87000</us-gaap:CommonStockOtherSharesOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i230d8313826f436cae6610d654452ab4_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzEwMjQ0_8486a44e-1dc7-46db-834e-b7990ddf77b5"
      unitRef="shares">59000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i6e7ee8e291c54e02a81d0c39ffc5ad6b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzEwNjQz_5b17ea97-05d5-4af2-9454-1ca83297ddb1"
      unitRef="shares">4700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate
      contextRef="id26ee05f76cc40ac87ab6c4856efecfa_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzEwNzQx_c7d27e35-1354-4c37-80ec-a16d2e385a61"
      unitRef="number">0.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i0a5d4fe659be4cccaf4e997156b223a2_D20210101-20211231"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzEwOTY2_4b79be3a-3f27-4459-84ac-d3007e4de95b"
      unitRef="shares">29500</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="id26ee05f76cc40ac87ab6c4856efecfa_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzEwOTcw_e9d09de4-21e6-420a-9cf3-9aacb9108585"
      unitRef="shares">39000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i07cab270359146efa8ad17bde260ed6c_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzEwOTc4_b169ade2-9b3b-4927-aab5-0fe65795839c"
      unitRef="shares">47000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="id4706d2219354fd4aca929cb8a8e0ce0_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xODcvZnJhZzpjNmMzYzQyZWY0NDA0MTA0OGFkYmE5YmNkMjg4ZmNmMy90ZXh0cmVnaW9uOmM2YzNjNDJlZjQ0MDQxMDQ4YWRiYTliY2QyODhmY2YzXzExMTQz_d877016e-e281-4e5b-acab-f8892174b308"
      unitRef="shares">1100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:CreditLossFinancialInstrumentTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTAvZnJhZzoxNDIxNDRiOTBlNmQ0YzcyODE3MDg1Y2FhZjkxNWUwYi90ZXh0cmVnaW9uOjE0MjE0NGI5MGU2ZDRjNzI4MTcwODVjYWFmOTE1ZTBiXzMwOTY_cd4f712c-2fe6-42fc-9598-4c490ab67412">CREDIT LOSSESWe are exposed to credit losses primarily through our sales of products and services to our customers. We maintain allowances for credit losses for potentially uncollectible receivables. We base our estimates on a detailed analysis of specific customer situations and a percentage of our accounts receivable by aging category. Historical credit loss experience provides the basis for the estimation of expected credit losses. Adjustments to historical loss information are made for differences in current economic conditions. Refer to "Note 2. Accounting Policies" for more information on our adoption of ASU 2016-13 on January 1, 2020, using the modified retrospective transition method.&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additional allowances may be required if either the financial condition of our customers was to deteriorate, or a strengthening U.S. dollar impacts the ability of foreign customers to make payments to us on their U.S. dollar-denominated purchases. We monitor our ongoing credit exposure through active review of counterparty balances against contract terms and due dates. Our activities include timely account reconciliations, dispute resolution, and payment confirmations. We may employ collection agencies and legal counsel to pursue recovery of defaulted receivables.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Account balances are charged off against the allowance when we believe it is probable the receivable will not be recovered. We may require collateralized asset support or a prepayment to mitigate credit risk. We do not have any off-balance sheet credit exposure related to our customers.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounts Receivable&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The allowance for credit losses associated with accounts receivable was $5.7&#160;million and $6.8&#160;million at December 31, 2021, and December 31, 2020, respectively. Accounts receivable reflected on the balance sheet is net of this reserve. Based on an aging analysis, at December 31, 2021, approximately 90% of our accounts receivable had not yet reached the invoice due date and approximately 10% was considered past due, of which approximately 1.8% was greater than 60 days past due. At December 31, 2020, approximately 88% of our accounts receivable had not yet reached the invoice due date and approximately 12% was considered past due, of which approximately 1.5% was greater than 60 days past due. Write-offs and recoveries related to credit losses during the years ended December 31, 2021, 2020, and 2019 were not material.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Contract assets and lease receivables&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The allowance for credit losses associated with the contract assets and lease receivables was $4.4&#160;million and $3.7&#160;million at December 31, 2021 and 2020, respectively. The assets reflected on the balance sheet are net of these reserves. Historically, we have experienced low credit loss rates on our customer commitment programs and lease receivables. We apply judgment in determining the customer&#x2019;s ability and intention to pay, which is based on a variety of factors including the customer&#x2019;s historical payment experience or, in the case of a new customer, published credit and financial information pertaining to the customer. Write-offs and recoveries related to credit losses during the years ended December 31, 2021, 2020, and 2019 were not material.&lt;/span&gt;&lt;/div&gt;</us-gaap:CreditLossFinancialInstrumentTextBlock>
    <us-gaap:CreditLossFinancialInstrumentPolicyTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTAvZnJhZzoxNDIxNDRiOTBlNmQ0YzcyODE3MDg1Y2FhZjkxNWUwYi90ZXh0cmVnaW9uOjE0MjE0NGI5MGU2ZDRjNzI4MTcwODVjYWFmOTE1ZTBiXzMwOTc_6c5acba4-9b75-46a4-a8ee-b8cb0fd777b0">We are exposed to credit losses primarily through our sales of products and services to our customers. We maintain allowances for credit losses for potentially uncollectible receivables. We base our estimates on a detailed analysis of specific customer situations and a percentage of our accounts receivable by aging category. Historical credit loss experience provides the basis for the estimation of expected credit losses. Adjustments to historical loss information are made for differences in current economic conditions. Refer to "Note 2. Accounting Policies" for more information on our adoption of ASU 2016-13 on January 1, 2020, using the modified retrospective transition method.&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additional allowances may be required if either the financial condition of our customers was to deteriorate, or a strengthening U.S. dollar impacts the ability of foreign customers to make payments to us on their U.S. dollar-denominated purchases. We monitor our ongoing credit exposure through active review of counterparty balances against contract terms and due dates. Our activities include timely account reconciliations, dispute resolution, and payment confirmations. We may employ collection agencies and legal counsel to pursue recovery of defaulted receivables.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Account balances are charged off against the allowance when we believe it is probable the receivable will not be recovered. We may require collateralized asset support or a prepayment to mitigate credit risk. We do not have any off-balance sheet credit exposure related to our customers.&lt;/span&gt;&lt;/div&gt;</us-gaap:CreditLossFinancialInstrumentPolicyTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTAvZnJhZzoxNDIxNDRiOTBlNmQ0YzcyODE3MDg1Y2FhZjkxNWUwYi90ZXh0cmVnaW9uOjE0MjE0NGI5MGU2ZDRjNzI4MTcwODVjYWFmOTE1ZTBiXzU0OTc1NTgxNDI0OTI_db3428db-6aa3-416f-959c-1354889dde6b"
      unitRef="usd">5700000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTAvZnJhZzoxNDIxNDRiOTBlNmQ0YzcyODE3MDg1Y2FhZjkxNWUwYi90ZXh0cmVnaW9uOjE0MjE0NGI5MGU2ZDRjNzI4MTcwODVjYWFmOTE1ZTBiXzU0OTc1NTgxNDI0NzU_6ed40290-c107-4245-8d9a-cfe17cd1010f"
      unitRef="usd">6800000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <idxx:AccountsReceivablePercentNotPastDue
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTAvZnJhZzoxNDIxNDRiOTBlNmQ0YzcyODE3MDg1Y2FhZjkxNWUwYi90ZXh0cmVnaW9uOjE0MjE0NGI5MGU2ZDRjNzI4MTcwODVjYWFmOTE1ZTBiXzE4NzY_ed44e7c0-3590-4465-99cf-22360696a0c2"
      unitRef="number">0.90</idxx:AccountsReceivablePercentNotPastDue>
    <idxx:AccountsReceivablePercentPastDue
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTAvZnJhZzoxNDIxNDRiOTBlNmQ0YzcyODE3MDg1Y2FhZjkxNWUwYi90ZXh0cmVnaW9uOjE0MjE0NGI5MGU2ZDRjNzI4MTcwODVjYWFmOTE1ZTBiXzE5NjU_0252b9a6-4769-4ce0-8e2a-d68d6f2393a8"
      unitRef="number">0.10</idxx:AccountsReceivablePercentPastDue>
    <idxx:AccountsReceivablePercentPastDue
      contextRef="if2d8a957b59b41bd9d689b2d4b69d6a4_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTAvZnJhZzoxNDIxNDRiOTBlNmQ0YzcyODE3MDg1Y2FhZjkxNWUwYi90ZXh0cmVnaW9uOjE0MjE0NGI5MGU2ZDRjNzI4MTcwODVjYWFmOTE1ZTBiXzIwMTY_2eac47b0-6cbc-41c1-bf68-b33f78616da2"
      unitRef="number">0.018</idxx:AccountsReceivablePercentPastDue>
    <us-gaap:AccountsReceivableNoncurrentThresholdPeriodPastDue
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTAvZnJhZzoxNDIxNDRiOTBlNmQ0YzcyODE3MDg1Y2FhZjkxNWUwYi90ZXh0cmVnaW9uOjE0MjE0NGI5MGU2ZDRjNzI4MTcwODVjYWFmOTE1ZTBiXzIwMzY_3eabe38b-46a0-4942-b00e-580db70c14d5">P60D</us-gaap:AccountsReceivableNoncurrentThresholdPeriodPastDue>
    <idxx:AccountsReceivablePercentNotPastDue
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTAvZnJhZzoxNDIxNDRiOTBlNmQ0YzcyODE3MDg1Y2FhZjkxNWUwYi90ZXh0cmVnaW9uOjE0MjE0NGI5MGU2ZDRjNzI4MTcwODVjYWFmOTE1ZTBiXzU0OTc1NTgxNDI1MjE_c69b8c08-dd20-46e6-9c81-71f2d6a7677a"
      unitRef="number">0.88</idxx:AccountsReceivablePercentNotPastDue>
    <idxx:AccountsReceivablePercentPastDue
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTAvZnJhZzoxNDIxNDRiOTBlNmQ0YzcyODE3MDg1Y2FhZjkxNWUwYi90ZXh0cmVnaW9uOjE0MjE0NGI5MGU2ZDRjNzI4MTcwODVjYWFmOTE1ZTBiXzU0OTc1NTgxNDI1MzA_20c1bf69-e54d-4685-a900-e418136e06c4"
      unitRef="number">0.12</idxx:AccountsReceivablePercentPastDue>
    <idxx:AccountsReceivablePercentPastDue
      contextRef="i4fa881c75f4742dfb92d9cee4bd32188_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTAvZnJhZzoxNDIxNDRiOTBlNmQ0YzcyODE3MDg1Y2FhZjkxNWUwYi90ZXh0cmVnaW9uOjE0MjE0NGI5MGU2ZDRjNzI4MTcwODVjYWFmOTE1ZTBiXzU0OTc1NTgxNDI1MTE_1d044b17-dd0e-4976-8619-b994830eca66"
      unitRef="number">0.015</idxx:AccountsReceivablePercentPastDue>
    <us-gaap:AccountsReceivableNoncurrentThresholdPeriodPastDue
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTAvZnJhZzoxNDIxNDRiOTBlNmQ0YzcyODE3MDg1Y2FhZjkxNWUwYi90ZXh0cmVnaW9uOjE0MjE0NGI5MGU2ZDRjNzI4MTcwODVjYWFmOTE1ZTBiXzIyNDU_cb1fdae6-cccb-4772-bcda-b0fd7624da46">P60D</us-gaap:AccountsReceivableNoncurrentThresholdPeriodPastDue>
    <idxx:ContractwithCustomerAssetAndSalesTypeLeaseNetInvestmentInLeaseAllowanceforCreditLoss
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTAvZnJhZzoxNDIxNDRiOTBlNmQ0YzcyODE3MDg1Y2FhZjkxNWUwYi90ZXh0cmVnaW9uOjE0MjE0NGI5MGU2ZDRjNzI4MTcwODVjYWFmOTE1ZTBiXzQzOTgwNDY1MTQ5MTU_fb4e12f0-04c3-4a76-a001-d203216440aa"
      unitRef="usd">4400000</idxx:ContractwithCustomerAssetAndSalesTypeLeaseNetInvestmentInLeaseAllowanceforCreditLoss>
    <idxx:ContractwithCustomerAssetAndSalesTypeLeaseNetInvestmentInLeaseAllowanceforCreditLoss
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTAvZnJhZzoxNDIxNDRiOTBlNmQ0YzcyODE3MDg1Y2FhZjkxNWUwYi90ZXh0cmVnaW9uOjE0MjE0NGI5MGU2ZDRjNzI4MTcwODVjYWFmOTE1ZTBiXzI1MDI_28ee1a6d-eb83-4dd7-bce5-b3541c86c7aa"
      unitRef="usd">3700000</idxx:ContractwithCustomerAssetAndSalesTypeLeaseNetInvestmentInLeaseAllowanceforCreditLoss>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTMvZnJhZzoyNTY0Yjc1NDkzMDg0NTBhYTIxY2I0MzNlMTMzZmUyZS90ZXh0cmVnaW9uOjI1NjRiNzU0OTMwODQ1MGFhMjFjYjQzM2UxMzNmZTJlXzk4Ng_ab217dc1-62e1-46b8-bfd2-95894bcb7903">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;INVENTORIES&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories are stated at the lower of cost (first-in, first-out) or net realizable value. Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. We write down the carrying value of inventory for estimated obsolescence by an amount equal to the difference between the cost of inventory and the estimated market value when warranted based on assumptions of future demand, market conditions, remaining shelf life, or product functionality. If actual market conditions or results of estimated functionality are less favorable than those we estimated, additional inventory write-downs may be required, which would have a negative effect on results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unpaid inventory reflected within accounts payable in our consolidated balance sheets was $64.4 million, $45.6 million, and $39.5 million at December 31, 2021, 2020, and 2019, respectively. Instrument inventory transferred to property and equipment related to rental and operating-type reagent rental programs was $11.6&#160;million, $9.6&#160;million, $14.5&#160;million during the years ended December 31, 2021, 2020, and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of inventories are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.015%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.292%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.895%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;182,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;143,513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;269,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;209,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTMvZnJhZzoyNTY0Yjc1NDkzMDg0NTBhYTIxY2I0MzNlMTMzZmUyZS90ZXh0cmVnaW9uOjI1NjRiNzU0OTMwODQ1MGFhMjFjYjQzM2UxMzNmZTJlXzk4Nw_e4b03bac-2f49-4f86-87da-ab6ab6000f3c">Inventories are stated at the lower of cost (first-in, first-out) or net realizable value. Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. We write down the carrying value of inventory for estimated obsolescence by an amount equal to the difference between the cost of inventory and the estimated market value when warranted based on assumptions of future demand, market conditions, remaining shelf life, or product functionality. If actual market conditions or results of estimated functionality are less favorable than those we estimated, additional inventory write-downs may be required, which would have a negative effect on results of operations.</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTMvZnJhZzoyNTY0Yjc1NDkzMDg0NTBhYTIxY2I0MzNlMTMzZmUyZS90ZXh0cmVnaW9uOjI1NjRiNzU0OTMwODQ1MGFhMjFjYjQzM2UxMzNmZTJlXzg4OA_df35dafa-13ca-4f1c-a642-c99bcc84240b"
      unitRef="usd">64400000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTMvZnJhZzoyNTY0Yjc1NDkzMDg0NTBhYTIxY2I0MzNlMTMzZmUyZS90ZXh0cmVnaW9uOjI1NjRiNzU0OTMwODQ1MGFhMjFjYjQzM2UxMzNmZTJlXzg5Mg_e33a1207-c3fa-4bad-ac49-23069e783061"
      unitRef="usd">45600000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="i0c634b937c58472e84857eacf99e17df_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTMvZnJhZzoyNTY0Yjc1NDkzMDg0NTBhYTIxY2I0MzNlMTMzZmUyZS90ZXh0cmVnaW9uOjI1NjRiNzU0OTMwODQ1MGFhMjFjYjQzM2UxMzNmZTJlXzkwMA_02f34747-41dd-487d-ba55-487c4bed2ba1"
      unitRef="usd">39500000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="if03c9c1348554db4936cf06e9bd802c2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTMvZnJhZzoyNTY0Yjc1NDkzMDg0NTBhYTIxY2I0MzNlMTMzZmUyZS90ZXh0cmVnaW9uOjI1NjRiNzU0OTMwODQ1MGFhMjFjYjQzM2UxMzNmZTJlXzQzOTgwNDY1MTI5MTY_644b5637-20d6-4b4b-92b5-3c80dd81429e"
      unitRef="usd">11600000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i6f415ad968794c3b9bf10b5e7c9d08e8_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTMvZnJhZzoyNTY0Yjc1NDkzMDg0NTBhYTIxY2I0MzNlMTMzZmUyZS90ZXh0cmVnaW9uOjI1NjRiNzU0OTMwODQ1MGFhMjFjYjQzM2UxMzNmZTJlXzQzOTgwNDY1MTI5MjA_d782d0e2-bd2c-4f0c-b1e7-f2daeecacca4"
      unitRef="usd">9600000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i69d7e5c1eec24001a74325f821a31cba_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTMvZnJhZzoyNTY0Yjc1NDkzMDg0NTBhYTIxY2I0MzNlMTMzZmUyZS90ZXh0cmVnaW9uOjI1NjRiNzU0OTMwODQ1MGFhMjFjYjQzM2UxMzNmZTJlXzQzOTgwNDY1MTI5MjQ_393a903e-c51c-454f-829e-665a730e3d87"
      unitRef="usd">14500000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTMvZnJhZzoyNTY0Yjc1NDkzMDg0NTBhYTIxY2I0MzNlMTMzZmUyZS90ZXh0cmVnaW9uOjI1NjRiNzU0OTMwODQ1MGFhMjFjYjQzM2UxMzNmZTJlXzk5MQ_0b546b4c-f77a-4df4-b599-abc6e4404109">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of inventories are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.015%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.292%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.895%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;182,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;143,513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;269,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;209,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTMvZnJhZzoyNTY0Yjc1NDkzMDg0NTBhYTIxY2I0MzNlMTMzZmUyZS90YWJsZTo1ZWZkYzA5NWU3YmE0MjVjODE5OTUwNWU5ZDY3ODZjMC90YWJsZXJhbmdlOjVlZmRjMDk1ZTdiYTQyNWM4MTk5NTA1ZTlkNjc4NmMwXzItMi0xLTEtMA_552d329c-ab59-466d-b009-b62fa74abb60"
      unitRef="usd">60427000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTMvZnJhZzoyNTY0Yjc1NDkzMDg0NTBhYTIxY2I0MzNlMTMzZmUyZS90YWJsZTo1ZWZkYzA5NWU3YmE0MjVjODE5OTUwNWU5ZDY3ODZjMC90YWJsZXJhbmdlOjVlZmRjMDk1ZTdiYTQyNWM4MTk5NTA1ZTlkNjc4NmMwXzItNC0xLTEtMA_104efb77-7fa2-4e6d-ae23-96bed8df7d72"
      unitRef="usd">45986000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTMvZnJhZzoyNTY0Yjc1NDkzMDg0NTBhYTIxY2I0MzNlMTMzZmUyZS90YWJsZTo1ZWZkYzA5NWU3YmE0MjVjODE5OTUwNWU5ZDY3ODZjMC90YWJsZXJhbmdlOjVlZmRjMDk1ZTdiYTQyNWM4MTk5NTA1ZTlkNjc4NmMwXzMtMi0xLTEtMA_3455bcce-449a-4352-b6fe-954ca3a5b0d8"
      unitRef="usd">26397000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTMvZnJhZzoyNTY0Yjc1NDkzMDg0NTBhYTIxY2I0MzNlMTMzZmUyZS90YWJsZTo1ZWZkYzA5NWU3YmE0MjVjODE5OTUwNWU5ZDY3ODZjMC90YWJsZXJhbmdlOjVlZmRjMDk1ZTdiYTQyNWM4MTk5NTA1ZTlkNjc4NmMwXzMtNC0xLTEtMA_2197b9b7-7c46-4a3d-98e8-63752cd8d49e"
      unitRef="usd">20374000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTMvZnJhZzoyNTY0Yjc1NDkzMDg0NTBhYTIxY2I0MzNlMTMzZmUyZS90YWJsZTo1ZWZkYzA5NWU3YmE0MjVjODE5OTUwNWU5ZDY3ODZjMC90YWJsZXJhbmdlOjVlZmRjMDk1ZTdiYTQyNWM4MTk5NTA1ZTlkNjc4NmMwXzQtMi0xLTEtMA_cc09e511-fc3c-4ba0-aeae-52d2c651b5e5"
      unitRef="usd">182206000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTMvZnJhZzoyNTY0Yjc1NDkzMDg0NTBhYTIxY2I0MzNlMTMzZmUyZS90YWJsZTo1ZWZkYzA5NWU3YmE0MjVjODE5OTUwNWU5ZDY3ODZjMC90YWJsZXJhbmdlOjVlZmRjMDk1ZTdiYTQyNWM4MTk5NTA1ZTlkNjc4NmMwXzQtNC0xLTEtMA_1a2ee7d8-1810-4217-95ce-f52ffa8e5283"
      unitRef="usd">143513000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTMvZnJhZzoyNTY0Yjc1NDkzMDg0NTBhYTIxY2I0MzNlMTMzZmUyZS90YWJsZTo1ZWZkYzA5NWU3YmE0MjVjODE5OTUwNWU5ZDY3ODZjMC90YWJsZXJhbmdlOjVlZmRjMDk1ZTdiYTQyNWM4MTk5NTA1ZTlkNjc4NmMwXzUtMi0xLTEtMA_12097070-d4fd-456f-b3dc-513103353e85"
      unitRef="usd">269030000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTMvZnJhZzoyNTY0Yjc1NDkzMDg0NTBhYTIxY2I0MzNlMTMzZmUyZS90YWJsZTo1ZWZkYzA5NWU3YmE0MjVjODE5OTUwNWU5ZDY3ODZjMC90YWJsZXJhbmdlOjVlZmRjMDk1ZTdiYTQyNWM4MTk5NTA1ZTlkNjc4NmMwXzUtNC0xLTEtMA_10e3672e-f86b-42d5-ad9d-9bf2984661d2"
      unitRef="usd">209873000</us-gaap:InventoryNet>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90ZXh0cmVnaW9uOmQ4MDc4ODc3YTVmODQ0YWE4YjFmM2FhNTFkMzEyMTMxXzM2MTc_85f24314-14e5-40ef-bd4e-fc2a0432f0f4">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;LEASES&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The majority of our facilities are occupied under operating lease arrangements with various expiration dates through 2067, some of which include options to extend the life of the lease, and some of which include options to terminate the lease within 1 year. In certain instances, we are responsible for the real estate taxes and operating expenses related to these facilities.&#160;Additionally, we enter into operating leases for certain vehicles and office equipment in the normal course of business. We determine the expected term of any executed agreements using the non-cancelable lease term plus any renewal options by which the failure to renew imposes a penalty in such amount that renewal is reasonably assured. The derived expected term is then used in the determination of a financing or operating lease and in the calculation of straight-line rent expense. Rent escalations are considered in the calculation of minimum lease payments in our capital lease tests and in determining straight-line rent expense for operating leases. Minimum&#160;lease&#160;payments include the fixed&#160;lease&#160;component of the agreement, as well as fixed rate increases that are initially measured at the&#160;lease&#160;commencement date. Variable lease payments based on an index and payments associated with&#160;non-lease&#160;components and short-term rentals (leases with terms less than 12 months) are expensed as incurred. Consideration is&#160;allocated&#160;to the&#160;lease&#160;and non-lease components based on the estimated standalone prices.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determine if an arrangement is a lease at its inception. Operating leases are included in operating lease right-of-use assets, accrued liabilities, and long-term operating lease liabilities in our consolidated balance sheets. Our financing leases are not material to the financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Right-of-use assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease liabilities and right-of-use assets are recognized at commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an explicit rate, we use our incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. Our lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Rent expense for lease payments is recognized on a straight-line basis over the lease term. The operating lease right-of-use assets also includes any rent prepayments, lease incentives upon receipt, and straight-line rent expense impacts, which represent the differences between our operating lease liabilities and right-of-use assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of operating lease liabilities are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.283%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;122,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,898)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease liability (current and long-term)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;107,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total minimum future lease payments of approximately $1.6 million for leases that have not commenced as of December 31, 2021, are not included in the consolidated financial statements, as we do not yet control the underlying assets. These leases are expected to commence during 2022 through 2024 with lease terms of approximately 3 to 5.25 years.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.707%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term - operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.4 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate - operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expenses incurred related to operating leases, excluding variable and short-term leases, were approximately $23.0 million and $21.7&#160;million during the year ended December 31, 2021 and 2020, respectively. Total expenses incurred related to &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;operating leases, including variable rent and short-term leases, were approximately $25.5 million and $24.5 million for the years ended December 31, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information for leases is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.707%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;For the Years Ended &lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for operating lease obligations, net of early lease&#160;terminations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LessorLeasesPolicyTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90ZXh0cmVnaW9uOmQ4MDc4ODc3YTVmODQ0YWE4YjFmM2FhNTFkMzEyMTMxXzM2MTk_4b71a4af-146f-489a-a128-0212c94a4b3f">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The majority of our facilities are occupied under operating lease arrangements with various expiration dates through 2067, some of which include options to extend the life of the lease, and some of which include options to terminate the lease within 1 year. In certain instances, we are responsible for the real estate taxes and operating expenses related to these facilities.&#160;Additionally, we enter into operating leases for certain vehicles and office equipment in the normal course of business. We determine the expected term of any executed agreements using the non-cancelable lease term plus any renewal options by which the failure to renew imposes a penalty in such amount that renewal is reasonably assured. The derived expected term is then used in the determination of a financing or operating lease and in the calculation of straight-line rent expense. Rent escalations are considered in the calculation of minimum lease payments in our capital lease tests and in determining straight-line rent expense for operating leases. Minimum&#160;lease&#160;payments include the fixed&#160;lease&#160;component of the agreement, as well as fixed rate increases that are initially measured at the&#160;lease&#160;commencement date. Variable lease payments based on an index and payments associated with&#160;non-lease&#160;components and short-term rentals (leases with terms less than 12 months) are expensed as incurred. Consideration is&#160;allocated&#160;to the&#160;lease&#160;and non-lease components based on the estimated standalone prices.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determine if an arrangement is a lease at its inception. Operating leases are included in operating lease right-of-use assets, accrued liabilities, and long-term operating lease liabilities in our consolidated balance sheets. Our financing leases are not material to the financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Right-of-use assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease liabilities and right-of-use assets are recognized at commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an explicit rate, we use our incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. Our lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Rent expense for lease payments is recognized on a straight-line basis over the lease term. The operating lease right-of-use assets also includes any rent prepayments, lease incentives upon receipt, and straight-line rent expense impacts, which represent the differences between our operating lease liabilities and right-of-use assets.&lt;/span&gt;&lt;/div&gt;</us-gaap:LessorLeasesPolicyTextBlock>
    <idxx:LesseeOperatingLeaseTerminationPeriod
      contextRef="i2547ad5bc951453f98e34b5d0f26b8bb_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90ZXh0cmVnaW9uOmQ4MDc4ODc3YTVmODQ0YWE4YjFmM2FhNTFkMzEyMTMxXzYwNDczMTM5NTc2OTE_6988ae0b-d8f0-4846-aa07-ec42235693c5">P1Y</idxx:LesseeOperatingLeaseTerminationPeriod>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90ZXh0cmVnaW9uOmQ4MDc4ODc3YTVmODQ0YWE4YjFmM2FhNTFkMzEyMTMxXzM2MTM_9ec6a663-6334-47bc-a91f-89df04a0ccb0">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of operating lease liabilities are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.283%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;122,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,898)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease liability (current and long-term)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;107,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90YWJsZTo2YjBkNDJlYjhiODY0MTM1ODFmNzlmODJkNTM5YzliMi90YWJsZXJhbmdlOjZiMGQ0MmViOGI4NjQxMzU4MWY3OWY4MmQ1MzljOWIyXzItMS0xLTEtMA_25c7b207-d950-4e2d-a21f-0c23d5748687"
      unitRef="usd">22402000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90YWJsZTo2YjBkNDJlYjhiODY0MTM1ODFmNzlmODJkNTM5YzliMi90YWJsZXJhbmdlOjZiMGQ0MmViOGI4NjQxMzU4MWY3OWY4MmQ1MzljOWIyXzMtMS0xLTEtMA_b1a34c08-8343-4986-a699-cfe3d413c350"
      unitRef="usd">21122000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90YWJsZTo2YjBkNDJlYjhiODY0MTM1ODFmNzlmODJkNTM5YzliMi90YWJsZXJhbmdlOjZiMGQ0MmViOGI4NjQxMzU4MWY3OWY4MmQ1MzljOWIyXzQtMS0xLTEtMA_1bd11d33-34e6-4514-b5c7-13ca160eb58e"
      unitRef="usd">16523000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90YWJsZTo2YjBkNDJlYjhiODY0MTM1ODFmNzlmODJkNTM5YzliMi90YWJsZXJhbmdlOjZiMGQ0MmViOGI4NjQxMzU4MWY3OWY4MmQ1MzljOWIyXzUtMS0xLTEtMA_78e9d52a-09bc-497f-b0e3-e3f234c1524d"
      unitRef="usd">12675000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90YWJsZTo2YjBkNDJlYjhiODY0MTM1ODFmNzlmODJkNTM5YzliMi90YWJsZXJhbmdlOjZiMGQ0MmViOGI4NjQxMzU4MWY3OWY4MmQ1MzljOWIyXzYtMS0xLTEtMA_18e6bd6a-3c05-4935-a15c-1b6a11997a62"
      unitRef="usd">10437000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90YWJsZTo2YjBkNDJlYjhiODY0MTM1ODFmNzlmODJkNTM5YzliMi90YWJsZXJhbmdlOjZiMGQ0MmViOGI4NjQxMzU4MWY3OWY4MmQ1MzljOWIyXzctMS0xLTEtMA_e0a4a841-f7c0-4575-aaac-5994659b2d4c"
      unitRef="usd">39047000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90YWJsZTo2YjBkNDJlYjhiODY0MTM1ODFmNzlmODJkNTM5YzliMi90YWJsZXJhbmdlOjZiMGQ0MmViOGI4NjQxMzU4MWY3OWY4MmQ1MzljOWIyXzgtMS0xLTEtMA_e43d4af1-8437-42c5-baf8-159180107a9d"
      unitRef="usd">122206000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90YWJsZTo2YjBkNDJlYjhiODY0MTM1ODFmNzlmODJkNTM5YzliMi90YWJsZXJhbmdlOjZiMGQ0MmViOGI4NjQxMzU4MWY3OWY4MmQ1MzljOWIyXzktMS0xLTEtMA_1d53385b-c532-437e-92b8-c88f3cbcac3c"
      unitRef="usd">14898000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90YWJsZTo2YjBkNDJlYjhiODY0MTM1ODFmNzlmODJkNTM5YzliMi90YWJsZXJhbmdlOjZiMGQ0MmViOGI4NjQxMzU4MWY3OWY4MmQ1MzljOWIyXzEwLTEtMS0xLTA_000bd66a-f040-4770-987e-08f24a3c7ce2"
      unitRef="usd">107308000</us-gaap:OperatingLeaseLiability>
    <idxx:OperatingLeaseLeaseNotyetCommencedExpense
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90ZXh0cmVnaW9uOmQ4MDc4ODc3YTVmODQ0YWE4YjFmM2FhNTFkMzEyMTMxXzI5NDM_690c5df6-6842-4caa-8c62-761b071269a1"
      unitRef="usd">1600000</idxx:OperatingLeaseLeaseNotyetCommencedExpense>
    <us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1
      contextRef="iec94ca1756b3473faecedf9258139d41_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90ZXh0cmVnaW9uOmQ4MDc4ODc3YTVmODQ0YWE4YjFmM2FhNTFkMzEyMTMxXzMxODE_18530353-0774-4ea5-9b4f-8ee50d07909e">P3Y</us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1>
    <us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1
      contextRef="i9aa403826a744b88a310a196d527c4da_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90ZXh0cmVnaW9uOmQ4MDc4ODc3YTVmODQ0YWE4YjFmM2FhNTFkMzEyMTMxXzMxODc_9d58680b-3eb1-477c-b1a5-21cb4504ecf7">P5Y3M</us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90ZXh0cmVnaW9uOmQ4MDc4ODc3YTVmODQ0YWE4YjFmM2FhNTFkMzEyMTMxXzM2MjA_54e0ecfd-a868-4cd5-862c-825a4bf38a84">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.707%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term - operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.4 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate - operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information for leases is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.707%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;For the Years Ended &lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for operating lease obligations, net of early lease&#160;terminations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90YWJsZTo2YzY5NTJiNjg5YmQ0MDAwOTFiNDk3NTVmZTViNWEyNS90YWJsZXJhbmdlOjZjNjk1MmI2ODliZDQwMDA5MWI0OTc1NWZlNWI1YTI1XzItMS0xLTEtMA_ba81b78c-f03e-4f6a-8384-32581d58d10b">P9Y4M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90YWJsZTo2YzY5NTJiNjg5YmQ0MDAwOTFiNDk3NTVmZTViNWEyNS90YWJsZXJhbmdlOjZjNjk1MmI2ODliZDQwMDA5MWI0OTc1NWZlNWI1YTI1XzItMy0xLTEtMA_a7d98133-bfc7-4866-a4da-af51f204c110">P10Y3M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90YWJsZTo2YzY5NTJiNjg5YmQ0MDAwOTFiNDk3NTVmZTViNWEyNS90YWJsZXJhbmdlOjZjNjk1MmI2ODliZDQwMDA5MWI0OTc1NWZlNWI1YTI1XzQtMS0xLTEtMA_d54a9f64-c10c-448a-aad2-140799579ecf"
      unitRef="number">0.025</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90YWJsZTo2YzY5NTJiNjg5YmQ0MDAwOTFiNDk3NTVmZTViNWEyNS90YWJsZXJhbmdlOjZjNjk1MmI2ODliZDQwMDA5MWI0OTc1NWZlNWI1YTI1XzQtMy0xLTEtMA_469d5e27-1b13-44fb-b463-e2ea33976eb2"
      unitRef="number">0.029</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseExpense
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90ZXh0cmVnaW9uOmQ4MDc4ODc3YTVmODQ0YWE4YjFmM2FhNTFkMzEyMTMxXzMzMDY_b21d0694-9c26-496f-8e6c-979d20911e20"
      unitRef="usd">23000000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90ZXh0cmVnaW9uOmQ4MDc4ODc3YTVmODQ0YWE4YjFmM2FhNTFkMzEyMTMxXzMzMTM_3157e538-d78b-40b7-a609-035b2eaf4c3f"
      unitRef="usd">21700000</us-gaap:OperatingLeaseExpense>
    <us-gaap:LeaseCost
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90ZXh0cmVnaW9uOmQ4MDc4ODc3YTVmODQ0YWE4YjFmM2FhNTFkMzEyMTMxXzI3NDg3NzkwNzQzMzU_4d9c80ee-2f99-478c-adf4-69acd783180b"
      unitRef="usd">25500000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90ZXh0cmVnaW9uOmQ4MDc4ODc3YTVmODQ0YWE4YjFmM2FhNTFkMzEyMTMxXzM0ODY_bcaa6d59-1763-42f0-a77c-4db77913173d"
      unitRef="usd">24500000</us-gaap:LeaseCost>
    <us-gaap:OperatingLeasePayments
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90YWJsZToxODhhN2NkZTYwMmQ0NzBmYTA5MTZhNjRhZGM4YWU5NS90YWJsZXJhbmdlOjE4OGE3Y2RlNjAyZDQ3MGZhMDkxNmE2NGFkYzhhZTk1XzMtMS0xLTEtMA_d579c071-43e7-4f23-87c1-b013214b1cc8"
      unitRef="usd">24214000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90YWJsZToxODhhN2NkZTYwMmQ0NzBmYTA5MTZhNjRhZGM4YWU5NS90YWJsZXJhbmdlOjE4OGE3Y2RlNjAyZDQ3MGZhMDkxNmE2NGFkYzhhZTk1XzMtMy0xLTEtMA_96217bed-29a8-47df-a200-9a07d3a9ea17"
      unitRef="usd">19619000</us-gaap:OperatingLeasePayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90YWJsZToxODhhN2NkZTYwMmQ0NzBmYTA5MTZhNjRhZGM4YWU5NS90YWJsZXJhbmdlOjE4OGE3Y2RlNjAyZDQ3MGZhMDkxNmE2NGFkYzhhZTk1XzQtMS0xLTEtMA_c5305ad6-03e8-46ef-be52-3c1cad7a5a6b"
      unitRef="usd">37572000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTYvZnJhZzpkODA3ODg3N2E1Zjg0NGFhOGIxZjNhYTUxZDMxMjEzMS90YWJsZToxODhhN2NkZTYwMmQ0NzBmYTA5MTZhNjRhZGM4YWU5NS90YWJsZXJhbmdlOjE4OGE3Y2RlNjAyZDQ3MGZhMDkxNmE2NGFkYzhhZTk1XzQtMy0xLTEtMA_872ee0e3-f6d7-46fd-a635-44b641b65520"
      unitRef="usd">26807000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90ZXh0cmVnaW9uOjMxYTU2MmNlNGEzOTRlMDBhYmIyMGQwNGIxZTk0ZDY3XzI2MjA_f50acbcf-1b5d-46c1-a6dd-eca798d28d8c">PROPERTY AND EQUIPMENT, NET &lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment are stated at cost, net of accumulated depreciation and amortization. The costs of additions and improvements are capitalized, while maintenance and repairs are charged to expense as incurred. When an item is sold or retired, the cost and related accumulated depreciation are relieved, and the resulting gain or loss, if any, is recognized in the consolidated statements of income. We evaluate our property and equipment for impairment periodically or as changes in circumstances or the occurrence of events suggest the remaining value is not recoverable from future cash flows. If the carrying value of our&#160;property and equipment is impaired, an impairment charge is recorded for the amount by which the carrying value of the property and equipment exceeds its fair value.&#160;We provide for depreciation and amortization primarily using the straight-line method by charges to the consolidated statements of income in amounts that allocate the cost of property and equipment over their estimated useful lives as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.246%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:3.731%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Asset Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Land improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15 to 20 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10 to 40 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shorter of remaining lease term or useful life of improvements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3 to 8 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Office furniture and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3 to 7 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Computer hardware and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3 to 7 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We capitalize interest on the acquisition and construction of significant assets that require a substantial period of time to be made ready for use. The capitalized interest is included in the cost of the completed asset and depreciated over the asset&#x2019;s estimated useful life. The amount of interest capitalized during the years ended December 31, 2021 and 2020, was not material.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We capitalize certain costs incurred in connection with developing or obtaining software designated for internal use based on three distinct stages of development. Qualifying costs incurred during the application development stage, which consist primarily of internal payroll and direct fringe benefits and external direct project costs, including labor and travel, are capitalized and amortized on a straight-line basis over the estimated useful life of the asset. Costs incurred during the preliminary project and post-implementation and operation phases are expensed as incurred. These costs relate primarily to the determination of performance requirements, data conversion, and training. Software developed to deliver hosted services to our customers has been designated as internal use.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net, consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.377%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt 0 7.75pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Land and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;329,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;319,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;93,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;382,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;353,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Office furniture and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;67,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Computer hardware and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;276,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;265,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,236,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,142,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;648,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;586,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;587,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;555,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Below are the amounts of depreciation and amortization of property and equipment, capitalized computer software for internal use, unpaid property and equipment reflected in accounts payable and accrued expenses, and rental and reagent rental program instruments transferred from inventory to property and equipment:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt 0 7.75pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;92,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Capitalized computer software developed for internal use&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unpaid property and equipment, reflected in accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rental and operating-type reagent rental program instruments transferred from inventory to property and equipment (Note 3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We had impairments of $5.1&#160;million for the year ended December 31, 2021, associated with a write-down of rental assets in certain regions.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90ZXh0cmVnaW9uOjMxYTU2MmNlNGEzOTRlMDBhYmIyMGQwNGIxZTk0ZDY3XzI2MTA_0e156fe4-41b4-4c78-9bdd-7b45ba1bbbfd">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment are stated at cost, net of accumulated depreciation and amortization. The costs of additions and improvements are capitalized, while maintenance and repairs are charged to expense as incurred. When an item is sold or retired, the cost and related accumulated depreciation are relieved, and the resulting gain or loss, if any, is recognized in the consolidated statements of income. We evaluate our property and equipment for impairment periodically or as changes in circumstances or the occurrence of events suggest the remaining value is not recoverable from future cash flows. If the carrying value of our&#160;property and equipment is impaired, an impairment charge is recorded for the amount by which the carrying value of the property and equipment exceeds its fair value.&#160;We provide for depreciation and amortization primarily using the straight-line method by charges to the consolidated statements of income in amounts that allocate the cost of property and equipment over their estimated useful lives as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.246%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:3.731%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Asset Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Land improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15 to 20 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10 to 40 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shorter of remaining lease term or useful life of improvements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3 to 8 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Office furniture and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3 to 7 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Computer hardware and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3 to 7 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We capitalize interest on the acquisition and construction of significant assets that require a substantial period of time to be made ready for use. The capitalized interest is included in the cost of the completed asset and depreciated over the asset&#x2019;s estimated useful life. The amount of interest capitalized during the years ended December 31, 2021 and 2020, was not material.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We capitalize certain costs incurred in connection with developing or obtaining software designated for internal use based on three distinct stages of development. Qualifying costs incurred during the application development stage, which consist primarily of internal payroll and direct fringe benefits and external direct project costs, including labor and travel, are capitalized and amortized on a straight-line basis over the estimated useful life of the asset. Costs incurred during the preliminary project and post-implementation and operation phases are expensed as incurred. These costs relate primarily to the determination of performance requirements, data conversion, and training. Software developed to deliver hosted services to our customers has been designated as internal use.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <idxx:ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90ZXh0cmVnaW9uOjMxYTU2MmNlNGEzOTRlMDBhYmIyMGQwNGIxZTk0ZDY3XzI2MjI_58797505-bb23-4e19-b18e-15e01fd3fa60">We provide for depreciation and amortization primarily using the straight-line method by charges to the consolidated statements of income in amounts that allocate the cost of property and equipment over their estimated useful lives as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.246%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:3.731%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Asset Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Land improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15 to 20 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10 to 40 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shorter of remaining lease term or useful life of improvements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3 to 8 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Office furniture and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3 to 7 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Computer hardware and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3 to 7 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</idxx:ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i358c864968b04228b7d1de65d4356012_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo4NzFmNDBiZmYxYzc0ZDA4OWQ2MmU1ODljNjc5ZDhlZS90YWJsZXJhbmdlOjg3MWY0MGJmZjFjNzRkMDg5ZDYyZTU4OWM2NzlkOGVlXzItMi0xLTEtMC90ZXh0cmVnaW9uOjdlZWViMDFjZTQwNDRkYTM4NDU5NDdhNjIzM2Y1OGNmXzQ_cfcb217b-f828-4796-a36f-7c7be74d7983">P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="iaae1104f80a84293b957aad0e5ba9d49_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo4NzFmNDBiZmYxYzc0ZDA4OWQ2MmU1ODljNjc5ZDhlZS90YWJsZXJhbmdlOjg3MWY0MGJmZjFjNzRkMDg5ZDYyZTU4OWM2NzlkOGVlXzItMi0xLTEtMC90ZXh0cmVnaW9uOjdlZWViMDFjZTQwNDRkYTM4NDU5NDdhNjIzM2Y1OGNmXzEw_44f271e7-1b85-4dff-9604-7bb1705a8e34">P20Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ie6f5e29e1d644e1380b56d80b5c8ab21_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo4NzFmNDBiZmYxYzc0ZDA4OWQ2MmU1ODljNjc5ZDhlZS90YWJsZXJhbmdlOjg3MWY0MGJmZjFjNzRkMDg5ZDYyZTU4OWM2NzlkOGVlXzMtMi0xLTEtMC90ZXh0cmVnaW9uOmI2OTM1YmIxMmMxNzQ4OTU5ZDhiMmU5YjczM2Q1MWFkXzQ_44bbac0d-181c-4b1f-a09d-555ece335e92">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="iec5713b70bef4889b876769c7518056a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo4NzFmNDBiZmYxYzc0ZDA4OWQ2MmU1ODljNjc5ZDhlZS90YWJsZXJhbmdlOjg3MWY0MGJmZjFjNzRkMDg5ZDYyZTU4OWM2NzlkOGVlXzMtMi0xLTEtMC90ZXh0cmVnaW9uOmI2OTM1YmIxMmMxNzQ4OTU5ZDhiMmU5YjczM2Q1MWFkXzEw_9a225f21-3d35-4b47-b0c2-acf296b8e4f1">P40Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ia3d9107992e245d2808adc5e2bef7264_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo4NzFmNDBiZmYxYzc0ZDA4OWQ2MmU1ODljNjc5ZDhlZS90YWJsZXJhbmdlOjg3MWY0MGJmZjFjNzRkMDg5ZDYyZTU4OWM2NzlkOGVlXzUtMi0xLTEtMC90ZXh0cmVnaW9uOjhkYmNlZDAxZDAxZjQ3MGFhOGFiNGU3YmU4ODMwYjVhXzQ_57dd9166-1a01-4ede-97d4-0d4cb0119386">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i9a4a3d9081da4e4890098ab4828eff02_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo4NzFmNDBiZmYxYzc0ZDA4OWQ2MmU1ODljNjc5ZDhlZS90YWJsZXJhbmdlOjg3MWY0MGJmZjFjNzRkMDg5ZDYyZTU4OWM2NzlkOGVlXzUtMi0xLTEtMC90ZXh0cmVnaW9uOjhkYmNlZDAxZDAxZjQ3MGFhOGFiNGU3YmU4ODMwYjVhXzEw_f91f8e86-ea95-485b-9bc2-c1c75c1902ea">P8Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ifcd90bb4b001420db3089207a9817b90_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo4NzFmNDBiZmYxYzc0ZDA4OWQ2MmU1ODljNjc5ZDhlZS90YWJsZXJhbmdlOjg3MWY0MGJmZjFjNzRkMDg5ZDYyZTU4OWM2NzlkOGVlXzYtMi0xLTEtMC90ZXh0cmVnaW9uOjU4MGZmYjYyYmNhNjRhMGNiN2IyZWI2MzdiZmY3M2QwXzQ_933751f3-7012-4cf3-9f82-7c2b8352fd6d">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="iefcc27d08de64329bcdafc6e24f95d6f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo4NzFmNDBiZmYxYzc0ZDA4OWQ2MmU1ODljNjc5ZDhlZS90YWJsZXJhbmdlOjg3MWY0MGJmZjFjNzRkMDg5ZDYyZTU4OWM2NzlkOGVlXzYtMi0xLTEtMC90ZXh0cmVnaW9uOjU4MGZmYjYyYmNhNjRhMGNiN2IyZWI2MzdiZmY3M2QwXzEw_2490b725-173f-4769-b838-8b622f6d3197">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i1e07bfbfbbdc4286ac526097dcc2014a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo4NzFmNDBiZmYxYzc0ZDA4OWQ2MmU1ODljNjc5ZDhlZS90YWJsZXJhbmdlOjg3MWY0MGJmZjFjNzRkMDg5ZDYyZTU4OWM2NzlkOGVlXzctMi0xLTEtMC90ZXh0cmVnaW9uOmM0YTAzNGUyMTdlMDQ5Yjg5ZDk5YmEyYzEzM2FmNTEwXzQ_7cf2a121-5f04-4e9c-a758-9555fbffa43c">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i283cc22fdf494c59a8affd0dcad7b35a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo4NzFmNDBiZmYxYzc0ZDA4OWQ2MmU1ODljNjc5ZDhlZS90YWJsZXJhbmdlOjg3MWY0MGJmZjFjNzRkMDg5ZDYyZTU4OWM2NzlkOGVlXzctMi0xLTEtMC90ZXh0cmVnaW9uOmM0YTAzNGUyMTdlMDQ5Yjg5ZDk5YmEyYzEzM2FmNTEwXzEw_9d84e4d7-84b3-4551-b983-1a037fb2d55f">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90ZXh0cmVnaW9uOjMxYTU2MmNlNGEzOTRlMDBhYmIyMGQwNGIxZTk0ZDY3XzI2MjM_70cdf313-b59a-411e-98fb-e97e84c88857">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net, consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.377%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt 0 7.75pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Land and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;329,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;319,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;93,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;382,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;353,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Office furniture and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;67,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Computer hardware and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;276,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;265,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,236,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,142,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;648,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;586,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;587,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;555,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i9c5014947c2d49ac8200d45c4f5828a0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo5NDJiMTM5ZDRkYTM0NWQ1ODQ3ZjdkZjZjZWY3ZjAyYi90YWJsZXJhbmdlOjk0MmIxMzlkNGRhMzQ1ZDU4NDdmN2RmNmNlZjdmMDJiXzItMi0xLTEtMA_0d73f3b2-b1c1-4f66-8243-2614c8cd3b1f"
      unitRef="usd">22642000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="if6e52598ae7b4d548bd924fa1808d713_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo5NDJiMTM5ZDRkYTM0NWQ1ODQ3ZjdkZjZjZWY3ZjAyYi90YWJsZXJhbmdlOjk0MmIxMzlkNGRhMzQ1ZDU4NDdmN2RmNmNlZjdmMDJiXzItNC0xLTEtMA_8aee411a-2c88-4db0-87b9-539f015a6e5d"
      unitRef="usd">13982000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i84c5988a324d4a31a0b062f598b122e2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo5NDJiMTM5ZDRkYTM0NWQ1ODQ3ZjdkZjZjZWY3ZjAyYi90YWJsZXJhbmdlOjk0MmIxMzlkNGRhMzQ1ZDU4NDdmN2RmNmNlZjdmMDJiXzMtMi0xLTEtMA_35139ff4-eeb5-4a09-8753-15b7d171248b"
      unitRef="usd">329091000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i27518b77901a4762b6f2872c61ab1b01_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo5NDJiMTM5ZDRkYTM0NWQ1ODQ3ZjdkZjZjZWY3ZjAyYi90YWJsZXJhbmdlOjk0MmIxMzlkNGRhMzQ1ZDU4NDdmN2RmNmNlZjdmMDJiXzMtNC0xLTEtMA_80103309-a6a9-4d9e-84be-2ae37ac0fa4f"
      unitRef="usd">319384000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i5325a16dfc33486bb52b0c132af02290_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo5NDJiMTM5ZDRkYTM0NWQ1ODQ3ZjdkZjZjZWY3ZjAyYi90YWJsZXJhbmdlOjk0MmIxMzlkNGRhMzQ1ZDU4NDdmN2RmNmNlZjdmMDJiXzQtMi0xLTEtMA_a5a9774d-ebef-455a-a010-2f1d93bdb7ec"
      unitRef="usd">93248000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i8ced4bf3c1a540939075a145fafad2f1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo5NDJiMTM5ZDRkYTM0NWQ1ODQ3ZjdkZjZjZWY3ZjAyYi90YWJsZXJhbmdlOjk0MmIxMzlkNGRhMzQ1ZDU4NDdmN2RmNmNlZjdmMDJiXzQtNC0xLTEtMA_08c976e0-708f-414e-b958-46e3c88e15a9"
      unitRef="usd">82459000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="id90597dbb49948fabb735806b012f616_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo5NDJiMTM5ZDRkYTM0NWQ1ODQ3ZjdkZjZjZWY3ZjAyYi90YWJsZXJhbmdlOjk0MmIxMzlkNGRhMzQ1ZDU4NDdmN2RmNmNlZjdmMDJiXzUtMi0xLTEtMA_f7a37199-110e-42c7-b153-19b316fdee26"
      unitRef="usd">382753000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i7dad70e6dd004c2695b06a59bd68945a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo5NDJiMTM5ZDRkYTM0NWQ1ODQ3ZjdkZjZjZWY3ZjAyYi90YWJsZXJhbmdlOjk0MmIxMzlkNGRhMzQ1ZDU4NDdmN2RmNmNlZjdmMDJiXzUtNC0xLTEtMA_e716150a-df98-4bc7-9e95-6d13f3db0296"
      unitRef="usd">353301000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i2a2074f7bc9b4a2cbf6ed3b610f98409_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo5NDJiMTM5ZDRkYTM0NWQ1ODQ3ZjdkZjZjZWY3ZjAyYi90YWJsZXJhbmdlOjk0MmIxMzlkNGRhMzQ1ZDU4NDdmN2RmNmNlZjdmMDJiXzYtMi0xLTEtMA_bdf1e153-a0e7-4cfe-a02b-048205fd86bd"
      unitRef="usd">69090000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i69684bf965814a318039fff0559aee1f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo5NDJiMTM5ZDRkYTM0NWQ1ODQ3ZjdkZjZjZWY3ZjAyYi90YWJsZXJhbmdlOjk0MmIxMzlkNGRhMzQ1ZDU4NDdmN2RmNmNlZjdmMDJiXzYtNC0xLTEtMA_66d337c7-e083-426d-a985-b1eb5db7fad9"
      unitRef="usd">67527000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ic4c3038a1c6e434f960b3b42480ee814_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo5NDJiMTM5ZDRkYTM0NWQ1ODQ3ZjdkZjZjZWY3ZjAyYi90YWJsZXJhbmdlOjk0MmIxMzlkNGRhMzQ1ZDU4NDdmN2RmNmNlZjdmMDJiXzctMi0xLTEtMA_677dec54-1fcc-4c9d-9726-0d442a69a142"
      unitRef="usd">276895000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i24004ed53abe4277a8577a3ab12dd906_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo5NDJiMTM5ZDRkYTM0NWQ1ODQ3ZjdkZjZjZWY3ZjAyYi90YWJsZXJhbmdlOjk0MmIxMzlkNGRhMzQ1ZDU4NDdmN2RmNmNlZjdmMDJiXzctNC0xLTEtMA_d6851aa5-3893-446c-9276-1665f0ed5d15"
      unitRef="usd">265664000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i9bc87de78fd14b56ba2c24532ac28a94_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo5NDJiMTM5ZDRkYTM0NWQ1ODQ3ZjdkZjZjZWY3ZjAyYi90YWJsZXJhbmdlOjk0MmIxMzlkNGRhMzQ1ZDU4NDdmN2RmNmNlZjdmMDJiXzgtMi0xLTEtMA_e555d2ab-a124-4824-af04-f46e3ad7f7c4"
      unitRef="usd">62339000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i46df05df390f4fb8b267041b3f7c430b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo5NDJiMTM5ZDRkYTM0NWQ1ODQ3ZjdkZjZjZWY3ZjAyYi90YWJsZXJhbmdlOjk0MmIxMzlkNGRhMzQ1ZDU4NDdmN2RmNmNlZjdmMDJiXzgtNC0xLTEtMA_509524d0-30f9-476c-9d8c-e0e6d1a9f70d"
      unitRef="usd">39764000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo5NDJiMTM5ZDRkYTM0NWQ1ODQ3ZjdkZjZjZWY3ZjAyYi90YWJsZXJhbmdlOjk0MmIxMzlkNGRhMzQ1ZDU4NDdmN2RmNmNlZjdmMDJiXzktMi0xLTEtMA_e4909243-edd0-4e7f-ab10-5fccab4d5a6d"
      unitRef="usd">1236058000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo5NDJiMTM5ZDRkYTM0NWQ1ODQ3ZjdkZjZjZWY3ZjAyYi90YWJsZXJhbmdlOjk0MmIxMzlkNGRhMzQ1ZDU4NDdmN2RmNmNlZjdmMDJiXzktNC0xLTEtMA_b35a8c3b-e190-4709-958c-37ddf99cc36a"
      unitRef="usd">1142081000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo5NDJiMTM5ZDRkYTM0NWQ1ODQ3ZjdkZjZjZWY3ZjAyYi90YWJsZXJhbmdlOjk0MmIxMzlkNGRhMzQ1ZDU4NDdmN2RmNmNlZjdmMDJiXzEwLTItMS0xLTA_9374e6ea-81ab-4b0d-bd15-f4a7cf75c614"
      unitRef="usd">648391000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo5NDJiMTM5ZDRkYTM0NWQ1ODQ3ZjdkZjZjZWY3ZjAyYi90YWJsZXJhbmdlOjk0MmIxMzlkNGRhMzQ1ZDU4NDdmN2RmNmNlZjdmMDJiXzEwLTQtMS0xLTA_bfbabdc4-eb6e-41d6-9697-2aedac3a7840"
      unitRef="usd">586914000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo5NDJiMTM5ZDRkYTM0NWQ1ODQ3ZjdkZjZjZWY3ZjAyYi90YWJsZXJhbmdlOjk0MmIxMzlkNGRhMzQ1ZDU4NDdmN2RmNmNlZjdmMDJiXzExLTItMS0xLTA_cbb20e83-7e93-46b1-a106-6b781f567d30"
      unitRef="usd">587667000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTo5NDJiMTM5ZDRkYTM0NWQ1ODQ3ZjdkZjZjZWY3ZjAyYi90YWJsZXJhbmdlOjk0MmIxMzlkNGRhMzQ1ZDU4NDdmN2RmNmNlZjdmMDJiXzExLTQtMS0xLTA_1a1f8e85-e248-4484-b024-176f885fe6a6"
      unitRef="usd">555167000</us-gaap:PropertyPlantAndEquipmentNet>
    <idxx:SummaryOfDepreciationAndAmortizationCapitalizedComputerSoftwareForInternalUseAndUnpaidPropertyEquipmentReflectedInAccountPayableAndAccruedExpensesTableTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90ZXh0cmVnaW9uOjMxYTU2MmNlNGEzOTRlMDBhYmIyMGQwNGIxZTk0ZDY3XzI2MTg_a5548e97-6a8f-440c-a81c-3af1053ff42d">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Below are the amounts of depreciation and amortization of property and equipment, capitalized computer software for internal use, unpaid property and equipment reflected in accounts payable and accrued expenses, and rental and reagent rental program instruments transferred from inventory to property and equipment:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt 0 7.75pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;92,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Capitalized computer software developed for internal use&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unpaid property and equipment, reflected in accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rental and operating-type reagent rental program instruments transferred from inventory to property and equipment (Note 3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</idxx:SummaryOfDepreciationAndAmortizationCapitalizedComputerSoftwareForInternalUseAndUnpaidPropertyEquipmentReflectedInAccountPayableAndAccruedExpensesTableTextBlock>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTpjZTA3M2I4MWY0OWI0NmVmODcyYTc0ZjQ4YjJmOTk5OS90YWJsZXJhbmdlOmNlMDczYjgxZjQ5YjQ2ZWY4NzJhNzRmNDhiMmY5OTk5XzMtMi0xLTEtMA_a5bc9b21-44bc-4929-993a-380eeeb52d30"
      unitRef="usd">92376000</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTpjZTA3M2I4MWY0OWI0NmVmODcyYTc0ZjQ4YjJmOTk5OS90YWJsZXJhbmdlOmNlMDczYjgxZjQ5YjQ2ZWY4NzJhNzRmNDhiMmY5OTk5XzMtNC0xLTEtMA_347c890e-1ea5-4728-b6de-a7940ba85387"
      unitRef="usd">86095000</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTpjZTA3M2I4MWY0OWI0NmVmODcyYTc0ZjQ4YjJmOTk5OS90YWJsZXJhbmdlOmNlMDczYjgxZjQ5YjQ2ZWY4NzJhNzRmNDhiMmY5OTk5XzMtNi0xLTEtMA_8ac2b7d2-ab91-4917-8e24-ba0836eb1103"
      unitRef="usd">78495000</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="i17db583051954f429123c0a1d6ba693f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTpjZTA3M2I4MWY0OWI0NmVmODcyYTc0ZjQ4YjJmOTk5OS90YWJsZXJhbmdlOmNlMDczYjgxZjQ5YjQ2ZWY4NzJhNzRmNDhiMmY5OTk5XzQtMi0xLTEtMA_32a07f6d-2466-44e0-a7ff-6c4d5dbd89a3"
      unitRef="usd">14753000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="idc48fab68f194aaa84d1e8ed6fa2892f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTpjZTA3M2I4MWY0OWI0NmVmODcyYTc0ZjQ4YjJmOTk5OS90YWJsZXJhbmdlOmNlMDczYjgxZjQ5YjQ2ZWY4NzJhNzRmNDhiMmY5OTk5XzQtNC0xLTEtMA_414cd894-e42d-47de-b8df-bed8ff571306"
      unitRef="usd">18472000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="i6de38908909247f4abb7093d04baaf61_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTpjZTA3M2I4MWY0OWI0NmVmODcyYTc0ZjQ4YjJmOTk5OS90YWJsZXJhbmdlOmNlMDczYjgxZjQ5YjQ2ZWY4NzJhNzRmNDhiMmY5OTk5XzQtNi0xLTEtMA_1babf52a-21a2-498d-9419-f4e054c9dd2e"
      unitRef="usd">20130000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTpjZTA3M2I4MWY0OWI0NmVmODcyYTc0ZjQ4YjJmOTk5OS90YWJsZXJhbmdlOmNlMDczYjgxZjQ5YjQ2ZWY4NzJhNzRmNDhiMmY5OTk5XzUtMi0xLTEtMA_a9f2046c-5a48-4054-9adb-79f66340d07d"
      unitRef="usd">19326000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTpjZTA3M2I4MWY0OWI0NmVmODcyYTc0ZjQ4YjJmOTk5OS90YWJsZXJhbmdlOmNlMDczYjgxZjQ5YjQ2ZWY4NzJhNzRmNDhiMmY5OTk5XzUtNC0xLTEtMA_6c1ec6c4-9ec2-4778-a183-2c786edb13df"
      unitRef="usd">13343000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTpjZTA3M2I4MWY0OWI0NmVmODcyYTc0ZjQ4YjJmOTk5OS90YWJsZXJhbmdlOmNlMDczYjgxZjQ5YjQ2ZWY4NzJhNzRmNDhiMmY5OTk5XzUtNi0xLTEtMA_6f65f129-9aa7-4d60-8825-cf665f576202"
      unitRef="usd">24688000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="if03c9c1348554db4936cf06e9bd802c2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTpjZTA3M2I4MWY0OWI0NmVmODcyYTc0ZjQ4YjJmOTk5OS90YWJsZXJhbmdlOmNlMDczYjgxZjQ5YjQ2ZWY4NzJhNzRmNDhiMmY5OTk5XzYtMi0xLTEtMA_02ab951a-e15d-4ab7-a17b-d0d66afa990f"
      unitRef="usd">11628000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i6f415ad968794c3b9bf10b5e7c9d08e8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTpjZTA3M2I4MWY0OWI0NmVmODcyYTc0ZjQ4YjJmOTk5OS90YWJsZXJhbmdlOmNlMDczYjgxZjQ5YjQ2ZWY4NzJhNzRmNDhiMmY5OTk5XzYtNC0xLTEtMA_851b06e0-6c8b-43a6-a63b-0af3fd2fa530"
      unitRef="usd">9645000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i69d7e5c1eec24001a74325f821a31cba_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90YWJsZTpjZTA3M2I4MWY0OWI0NmVmODcyYTc0ZjQ4YjJmOTk5OS90YWJsZXJhbmdlOmNlMDczYjgxZjQ5YjQ2ZWY4NzJhNzRmNDhiMmY5OTk5XzYtNi0xLTEtMA_2e72faf5-212a-4ac0-ab29-d5c549b87106"
      unitRef="usd">14498000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:TangibleAssetImpairmentCharges
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8xOTkvZnJhZzozMWE1NjJjZTRhMzk0ZTAwYWJiMjBkMDRiMWU5NGQ2Ny90ZXh0cmVnaW9uOjMxYTU2MmNlNGEzOTRlMDBhYmIyMGQwNGIxZTk0ZDY3XzQzOTgwNDY1MTM4OTA_041a3bae-3bf6-4a11-a4cc-a5ce3ebb1248"
      unitRef="usd">5100000</us-gaap:TangibleAssetImpairmentCharges>
    <us-gaap:OtherAssetsDisclosureTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90ZXh0cmVnaW9uOjg2YzFiOWYxOTI3MjQxMmY4N2Y4ODQ3ZTBkYjEyZDk4XzEzNg_cc3a327d-bf26-41bb-980a-afe80dcb7209">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;OTHER CURRENT AND LONG-TERM ASSETS&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other current assets consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.391%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.399%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.542%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.542%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt 0 7.75pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer acquisition costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contract assets, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Taxes receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred sales commissions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;173,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;137,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) Contract assets, net, are net of allowances for credit loss. Refer to "Note 6. Credit Losses."&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other long-term assets consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.196%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.540%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.862%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.540%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.162%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt 0 7.75pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contract assets, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;122,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer acquisition costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;109,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;104,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investment in long-term product supply arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred sales commissions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Taxes receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;330,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;289,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;(1) Contract assets, net, are net of allowances for credit loss. Refer to "Note 6. Credit Losses</us-gaap:OtherAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90ZXh0cmVnaW9uOjg2YzFiOWYxOTI3MjQxMmY4N2Y4ODQ3ZTBkYjEyZDk4XzEzNw_593d5212-175c-4ec6-bd4b-6a6ebe24d5f4">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other current assets consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.391%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.399%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.542%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.542%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt 0 7.75pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer acquisition costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contract assets, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Taxes receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred sales commissions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;173,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;137,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;(1) Contract assets, net, are net of allowances for credit loss. Refer to "Note 6. Credit Losses</us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock>
    <us-gaap:DeferredCostsCurrent
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTpiZTczZDVlNGZhYjk0ZjdjYTAxYWNhOTUwNzM2OWJkYy90YWJsZXJhbmdlOmJlNzNkNWU0ZmFiOTRmN2NhMDFhY2E5NTA3MzY5YmRjXzItMi0xLTEtMA_019ba8f0-2f22-4e51-8334-ec79c4fc35d1"
      unitRef="usd">48942000</us-gaap:DeferredCostsCurrent>
    <us-gaap:DeferredCostsCurrent
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTpiZTczZDVlNGZhYjk0ZjdjYTAxYWNhOTUwNzM2OWJkYy90YWJsZXJhbmdlOmJlNzNkNWU0ZmFiOTRmN2NhMDFhY2E5NTA3MzY5YmRjXzItNC0xLTEtMA_536ffc45-d166-4a98-a1e8-14ce28979271"
      unitRef="usd">43751000</us-gaap:DeferredCostsCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTpiZTczZDVlNGZhYjk0ZjdjYTAxYWNhOTUwNzM2OWJkYy90YWJsZXJhbmdlOmJlNzNkNWU0ZmFiOTRmN2NhMDFhY2E5NTA3MzY5YmRjXzMtMi0xLTEtMA_4b3c333d-ddbc-4c22-807f-1aacaec2b1e2"
      unitRef="usd">41997000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTpiZTczZDVlNGZhYjk0ZjdjYTAxYWNhOTUwNzM2OWJkYy90YWJsZXJhbmdlOmJlNzNkNWU0ZmFiOTRmN2NhMDFhY2E5NTA3MzY5YmRjXzMtNC0xLTEtMA_f7d67c31-a687-48d1-b2c8-669ef2068632"
      unitRef="usd">34556000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTpiZTczZDVlNGZhYjk0ZjdjYTAxYWNhOTUwNzM2OWJkYy90YWJsZXJhbmdlOmJlNzNkNWU0ZmFiOTRmN2NhMDFhY2E5NTA3MzY5YmRjXzQtMi0xLTEtMA_7b2b88f9-64c9-4706-b0d3-bc746a109665"
      unitRef="usd">37772000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTpiZTczZDVlNGZhYjk0ZjdjYTAxYWNhOTUwNzM2OWJkYy90YWJsZXJhbmdlOmJlNzNkNWU0ZmFiOTRmN2NhMDFhY2E5NTA3MzY5YmRjXzQtNC0xLTEtMA_5769b9e6-d9f7-44fa-9ea6-1c2712552af8"
      unitRef="usd">23837000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:IncomeTaxesReceivable
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTpiZTczZDVlNGZhYjk0ZjdjYTAxYWNhOTUwNzM2OWJkYy90YWJsZXJhbmdlOmJlNzNkNWU0ZmFiOTRmN2NhMDFhY2E5NTA3MzY5YmRjXzUtMi0xLTEtMA_4f02b86a-cd90-4d76-ab11-ee70fcd91635"
      unitRef="usd">19464000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:IncomeTaxesReceivable
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTpiZTczZDVlNGZhYjk0ZjdjYTAxYWNhOTUwNzM2OWJkYy90YWJsZXJhbmdlOmJlNzNkNWU0ZmFiOTRmN2NhMDFhY2E5NTA3MzY5YmRjXzUtNC0xLTEtMA_46e696cb-6507-4f4b-bbb4-243c0f36de08"
      unitRef="usd">19476000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:CapitalizedContractCostNetCurrent
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTpiZTczZDVlNGZhYjk0ZjdjYTAxYWNhOTUwNzM2OWJkYy90YWJsZXJhbmdlOmJlNzNkNWU0ZmFiOTRmN2NhMDFhY2E5NTA3MzY5YmRjXzYtMi0xLTEtMA_b6298812-3dc7-432d-a34d-1c0e08095623"
      unitRef="usd">6475000</us-gaap:CapitalizedContractCostNetCurrent>
    <us-gaap:CapitalizedContractCostNetCurrent
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTpiZTczZDVlNGZhYjk0ZjdjYTAxYWNhOTUwNzM2OWJkYy90YWJsZXJhbmdlOmJlNzNkNWU0ZmFiOTRmN2NhMDFhY2E5NTA3MzY5YmRjXzYtNC0xLTEtMA_6a27e3c8-d69c-4940-a7b9-5c0c4dd5bc21"
      unitRef="usd">5738000</us-gaap:CapitalizedContractCostNetCurrent>
    <us-gaap:OtherAssetsMiscellaneousCurrent
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTpiZTczZDVlNGZhYjk0ZjdjYTAxYWNhOTUwNzM2OWJkYy90YWJsZXJhbmdlOmJlNzNkNWU0ZmFiOTRmN2NhMDFhY2E5NTA3MzY5YmRjXzctMi0xLTEtMA_30d1f688-e810-478d-8cb5-91a649671038"
      unitRef="usd">19173000</us-gaap:OtherAssetsMiscellaneousCurrent>
    <us-gaap:OtherAssetsMiscellaneousCurrent
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTpiZTczZDVlNGZhYjk0ZjdjYTAxYWNhOTUwNzM2OWJkYy90YWJsZXJhbmdlOmJlNzNkNWU0ZmFiOTRmN2NhMDFhY2E5NTA3MzY5YmRjXzctNC0xLTEtMA_d2ed089c-a7bc-433e-94e6-27d94214340b"
      unitRef="usd">10150000</us-gaap:OtherAssetsMiscellaneousCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTpiZTczZDVlNGZhYjk0ZjdjYTAxYWNhOTUwNzM2OWJkYy90YWJsZXJhbmdlOmJlNzNkNWU0ZmFiOTRmN2NhMDFhY2E5NTA3MzY5YmRjXzgtMi0xLTEtMA_e4336139-4afc-44ce-b331-832b6aad0098"
      unitRef="usd">173823000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTpiZTczZDVlNGZhYjk0ZjdjYTAxYWNhOTUwNzM2OWJkYy90YWJsZXJhbmdlOmJlNzNkNWU0ZmFiOTRmN2NhMDFhY2E5NTA3MzY5YmRjXzgtNC0xLTEtMA_aa55874a-4d66-4a84-b45f-6ed02f81845e"
      unitRef="usd">137508000</us-gaap:OtherAssetsCurrent>
    <us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90ZXh0cmVnaW9uOjg2YzFiOWYxOTI3MjQxMmY4N2Y4ODQ3ZTBkYjEyZDk4XzEzNQ_2b3f22b4-f466-450a-ac77-fe08de06ed27">&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other long-term assets consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.196%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.540%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.862%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.540%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.162%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt 0 7.75pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contract assets, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;122,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer acquisition costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;109,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;104,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investment in long-term product supply arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred sales commissions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Taxes receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;330,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;289,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;(1) Contract assets, net, are net of allowances for credit loss. Refer to "Note 6. Credit Losses</us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock>
    <us-gaap:ContractWithCustomerAssetNetNoncurrent
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTo1ZmQyYTkxYzE2MDA0MjhjODhkZjczZTVhMWJjMzYzOS90YWJsZXJhbmdlOjVmZDJhOTFjMTYwMDQyOGM4OGRmNzNlNWExYmMzNjM5XzItMi0xLTEtMA_af54e3ff-1622-4040-b959-5550a5bff692"
      unitRef="usd">122160000</us-gaap:ContractWithCustomerAssetNetNoncurrent>
    <us-gaap:DeferredCosts
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTo1ZmQyYTkxYzE2MDA0MjhjODhkZjczZTVhMWJjMzYzOS90YWJsZXJhbmdlOjVmZDJhOTFjMTYwMDQyOGM4OGRmNzNlNWExYmMzNjM5XzItNC0xLTEtMA_a6af2fef-9514-4779-9aba-b879364ab0ea"
      unitRef="usd">91681000</us-gaap:DeferredCosts>
    <us-gaap:DeferredCosts
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTo1ZmQyYTkxYzE2MDA0MjhjODhkZjczZTVhMWJjMzYzOS90YWJsZXJhbmdlOjVmZDJhOTFjMTYwMDQyOGM4OGRmNzNlNWExYmMzNjM5XzMtMi0xLTEtMA_f3cd7ae9-53b2-472c-aa2b-9658437fa0ec"
      unitRef="usd">109392000</us-gaap:DeferredCosts>
    <us-gaap:ContractWithCustomerAssetNetNoncurrent
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTo1ZmQyYTkxYzE2MDA0MjhjODhkZjczZTVhMWJjMzYzOS90YWJsZXJhbmdlOjVmZDJhOTFjMTYwMDQyOGM4OGRmNzNlNWExYmMzNjM5XzMtNC0xLTEtMA_1db2d8e8-78e0-45e3-be80-d8a27c28e324"
      unitRef="usd">104369000</us-gaap:ContractWithCustomerAssetNetNoncurrent>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTo1ZmQyYTkxYzE2MDA0MjhjODhkZjczZTVhMWJjMzYzOS90YWJsZXJhbmdlOjVmZDJhOTFjMTYwMDQyOGM4OGRmNzNlNWExYmMzNjM5XzQtMi0xLTEtMA_8b95cad5-b190-4f64-a8b4-ca50f7dd2b3f"
      unitRef="usd">24784000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTo1ZmQyYTkxYzE2MDA0MjhjODhkZjczZTVhMWJjMzYzOS90YWJsZXJhbmdlOjVmZDJhOTFjMTYwMDQyOGM4OGRmNzNlNWExYmMzNjM5XzQtNC0xLTEtMA_0bb617e1-e291-4df7-8782-3346beb2c5d3"
      unitRef="usd">31549000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:PrepaidExpenseOtherNoncurrent
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTo1ZmQyYTkxYzE2MDA0MjhjODhkZjczZTVhMWJjMzYzOS90YWJsZXJhbmdlOjVmZDJhOTFjMTYwMDQyOGM4OGRmNzNlNWExYmMzNjM5XzUtMi0xLTEtMA_11cdfde4-4f5c-4e93-a7ba-ce0bb44ef58e"
      unitRef="usd">13348000</us-gaap:PrepaidExpenseOtherNoncurrent>
    <us-gaap:PrepaidExpenseOtherNoncurrent
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTo1ZmQyYTkxYzE2MDA0MjhjODhkZjczZTVhMWJjMzYzOS90YWJsZXJhbmdlOjVmZDJhOTFjMTYwMDQyOGM4OGRmNzNlNWExYmMzNjM5XzUtNC0xLTEtMA_96d0637b-61f3-4514-8f7c-1e7642562df6"
      unitRef="usd">12065000</us-gaap:PrepaidExpenseOtherNoncurrent>
    <us-gaap:CapitalizedContractCostNetNoncurrent
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTo1ZmQyYTkxYzE2MDA0MjhjODhkZjczZTVhMWJjMzYzOS90YWJsZXJhbmdlOjVmZDJhOTFjMTYwMDQyOGM4OGRmNzNlNWExYmMzNjM5XzYtMi0xLTEtMA_769c9cfc-beb0-4b3d-b39e-97b99f534d7b"
      unitRef="usd">13019000</us-gaap:CapitalizedContractCostNetNoncurrent>
    <us-gaap:CapitalizedContractCostNetNoncurrent
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTo1ZmQyYTkxYzE2MDA0MjhjODhkZjczZTVhMWJjMzYzOS90YWJsZXJhbmdlOjVmZDJhOTFjMTYwMDQyOGM4OGRmNzNlNWExYmMzNjM5XzYtNC0xLTEtMA_b9e7efc1-e7a8-4b55-8df7-7b85ef5ea740"
      unitRef="usd">11719000</us-gaap:CapitalizedContractCostNetNoncurrent>
    <us-gaap:IncomeTaxesReceivableNoncurrent
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTo1ZmQyYTkxYzE2MDA0MjhjODhkZjczZTVhMWJjMzYzOS90YWJsZXJhbmdlOjVmZDJhOTFjMTYwMDQyOGM4OGRmNzNlNWExYmMzNjM5XzctMi0xLTEtMA_d84ce9f3-dd87-48bc-9534-822628368075"
      unitRef="usd">1806000</us-gaap:IncomeTaxesReceivableNoncurrent>
    <us-gaap:IncomeTaxesReceivableNoncurrent
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTo1ZmQyYTkxYzE2MDA0MjhjODhkZjczZTVhMWJjMzYzOS90YWJsZXJhbmdlOjVmZDJhOTFjMTYwMDQyOGM4OGRmNzNlNWExYmMzNjM5XzctNC0xLTEtMA_04b6ded9-2283-4616-8318-cbba355514c0"
      unitRef="usd">6329000</us-gaap:IncomeTaxesReceivableNoncurrent>
    <us-gaap:OtherAssetsMiscellaneousNoncurrent
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTo1ZmQyYTkxYzE2MDA0MjhjODhkZjczZTVhMWJjMzYzOS90YWJsZXJhbmdlOjVmZDJhOTFjMTYwMDQyOGM4OGRmNzNlNWExYmMzNjM5XzgtMi0xLTEtMA_0afb2c38-4998-47ef-8b10-af4717de1596"
      unitRef="usd">45891000</us-gaap:OtherAssetsMiscellaneousNoncurrent>
    <us-gaap:OtherAssetsMiscellaneousNoncurrent
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTo1ZmQyYTkxYzE2MDA0MjhjODhkZjczZTVhMWJjMzYzOS90YWJsZXJhbmdlOjVmZDJhOTFjMTYwMDQyOGM4OGRmNzNlNWExYmMzNjM5XzgtNC0xLTEtMA_1ba1460e-c80a-4e20-a8a1-edb4b47f249d"
      unitRef="usd">31883000</us-gaap:OtherAssetsMiscellaneousNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTo1ZmQyYTkxYzE2MDA0MjhjODhkZjczZTVhMWJjMzYzOS90YWJsZXJhbmdlOjVmZDJhOTFjMTYwMDQyOGM4OGRmNzNlNWExYmMzNjM5XzktMi0xLTEtMA_44139037-3ad4-4652-9809-c5673e599326"
      unitRef="usd">330400000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDIvZnJhZzo4NmMxYjlmMTkyNzI0MTJmODdmODg0N2UwZGIxMmQ5OC90YWJsZTo1ZmQyYTkxYzE2MDA0MjhjODhkZjczZTVhMWJjMzYzOS90YWJsZXJhbmdlOjVmZDJhOTFjMTYwMDQyOGM4OGRmNzNlNWExYmMzNjM5XzktNC0xLTEtMA_3e82effc-5c49-42d8-9611-0386a7a690a3"
      unitRef="usd">289595000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90ZXh0cmVnaW9uOjFiMzBlOTFiNDExNTRmNGRhYzlmYTU1ZGIwNTIxMzBkXzc2NzQ_9cea3ba8-27fb-4d49-b9db-cb17052ec907">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;GOODWILL AND INTANGIBLE ASSETS, NET&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A significant portion of the purchase price for acquired businesses is generally assigned to intangible assets. Intangible assets other than goodwill are initially valued at fair value. If a quoted price in an active market for the identical asset is not readily available at the measurement date, the fair value of the intangible asset is estimated based on discounted cash flows using market participant assumptions, which are assumptions that are not specific to IDEXX. The selection of appropriate valuation methodologies and the estimation of discounted cash flows require significant assumptions about the timing and amounts of future cash flows, risks, appropriate discount rates, and the useful lives of intangible assets. When significant, we utilize independent valuation experts to advise and assist us in determining the fair values of the identified intangible assets acquired in connection with a business acquisition and in determining appropriate amortization methods and periods for those intangible assets. Goodwill is initially valued based on the excess of the purchase price of a business combination over the fair value of acquired net assets recognized and represents the future economic benefits arising from other assets acquired that could not be separately identified and recognized.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our business combinations regularly include contingent consideration arrangements that require additional consideration to be paid based on the achievement of established objectives, most commonly related to customer retention or revenue growth of the customer base during the post-combination period. We assess contingent consideration to determine if it should be recognized at its fair value on the acquisition date. A liability resulting from contingent consideration is remeasured to fair value at each reporting date until the contingency is resolved, with changes in fair value recognized in earnings if changes in estimates are made after the measurement period. During the fourth quarter of 2021, we increased the fair value of the contingent payment to ezyVet by $2.0&#160;million. Changes in the fair value of contingent consideration and differences arising upon settlement were not material during the years ended December 31, 2020, and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We assess goodwill for impairment annually, at the reporting unit level, in the fourth quarter and whenever events or circumstances indicate impairment may exist. In evaluating goodwill for impairment, we have the option to first assess the qualitative factors to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the goodwill impairment test. The more likely than not threshold is defined as having a likelihood of more than 50%. If, after assessing the totality of events or circumstances, we determine that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, we would assess the fair value of all of our reporting units and compare the fair value of the reporting unit to its carrying value to determine if the carrying value exceeds its fair value, and if a goodwill impairment loss should be recognized. In contrast, we can opt to bypass the qualitative assessment for any reporting unit in any period and proceed directly to assessing the fair value of all of our reporting units and compare the fair value of the reporting unit to carrying value to determine if any impairment exists. Doing so does not preclude us from performing the qualitative assessment in any subsequent&#160;period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the fourth quarter of 2021, we elected to bypass the qualitative approach that allows the assessment of qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount and instead proceeded directly to assessing the fair value of all of our reporting units and comparing the fair values of each reporting unit to the carrying values to determine if any impairment exists. We estimate the fair values of applicable reporting units using an income approach based on discounted forecasted cash flows. We make significant assumptions about the extent and timing of future cash flows, growth rates and discount rates. Model assumptions are based on our projections and best estimates, using appropriate and customary market participant assumptions. In addition, we make certain assumptions in allocating shared assets and liabilities to individual reporting units in determining the carrying value of each reporting unit. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in forecasted cash flows or the discount rate would affect the estimated fair values of our reporting units and could result in a goodwill impairment loss in a future period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No goodwill impairments were identified during the years ended December 31, 2021, 2020, or 2019, and no accumulated impairment losses are recorded.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We assess the realizability of intangible assets other than goodwill whenever events or changes in circumstances indicate that the carrying value may not be recoverable. If an impairment review is triggered, we evaluate the carrying value of intangible assets based on estimated undiscounted future cash flows over the remaining useful life of the primary asset of the asset group and compare that value to the carrying value of the asset group. The asset group is the lowest level for which identifiable cash flows associated with the intangible asset are largely independent. The cash flows that are used contain our best estimates, using appropriate and customary assumptions and projections at the time. If the net carrying value of an intangible asset exceeds the related estimated undiscounted future cash flows, an impairment loss to adjust the intangible asset to its fair value would be reported as a non-cash charge to earnings. If necessary, we would calculate the fair value of an intangible asset using the present value of the estimated future cash flows to be generated by the intangible asset, and applying a risk-adjusted discount rate. We had no impairments of our intangible assets during the years ended December 31, 2021 and 2019.&#160;The amount of impairment for the year ended December 31, 2020 was immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the carrying amount of goodwill for the years ended December 31, 2021, 2020, and 2019, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.642%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;CAG&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Water&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;LPD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;182,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;214,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Business combinations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Impact of changes in foreign currency exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(119)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;207,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;239,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Business combinations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Acquisition adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,900)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,900)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Impact of changes in foreign currency exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;210,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;243,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Business combinations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;120,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;120,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Impact of changes in foreign currency exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,569)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(695)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,348)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;327,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;359,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to "Note 4. Acquisitions and Investments" for information regarding goodwill and other intangible assets recognized in connection with the acquisition of businesses and other assets during the years ended December 31, 2021, 2020, and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We provide for amortization primarily using the straight-line method by charges to income in amounts that allocate the intangible assets over their estimated useful lives as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.246%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:3.731%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Asset Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer-related intangible assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3 to 17 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Product rights &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5 to 15 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Noncompete agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3 to 5 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets other than goodwill consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.307%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.124%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.124%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.124%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.125%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer-related intangible assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;121,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;83,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;80,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Product rights &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Noncompete agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;143,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;99,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;97,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;     The above table excludes fully amortized intangible assets for the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Customer-related intangible assets are comprised of customer lists and customer relationships acquired from third parties.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Product rights comprise certain technologies, intellectual property, licenses, and trade names acquired from third parties.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense of intangible assets other than goodwill was $12.1 million, $9.8 million, and $9.4 million for the years ended December 31, 2021, 2020, and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December 31, 2021, the aggregate amortization expense associated with intangible assets is estimated to be as follows for each of the next five years and thereafter:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.330%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.470%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortization Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;99,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90ZXh0cmVnaW9uOjFiMzBlOTFiNDExNTRmNGRhYzlmYTU1ZGIwNTIxMzBkXzc2ODQ_29b0e79b-e8cb-4e16-adc4-08cf18e053d2">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A significant portion of the purchase price for acquired businesses is generally assigned to intangible assets. Intangible assets other than goodwill are initially valued at fair value. If a quoted price in an active market for the identical asset is not readily available at the measurement date, the fair value of the intangible asset is estimated based on discounted cash flows using market participant assumptions, which are assumptions that are not specific to IDEXX. The selection of appropriate valuation methodologies and the estimation of discounted cash flows require significant assumptions about the timing and amounts of future cash flows, risks, appropriate discount rates, and the useful lives of intangible assets. When significant, we utilize independent valuation experts to advise and assist us in determining the fair values of the identified intangible assets acquired in connection with a business acquisition and in determining appropriate amortization methods and periods for those intangible assets. Goodwill is initially valued based on the excess of the purchase price of a business combination over the fair value of acquired net assets recognized and represents the future economic benefits arising from other assets acquired that could not be separately identified and recognized.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our business combinations regularly include contingent consideration arrangements that require additional consideration to be paid based on the achievement of established objectives, most commonly related to customer retention or revenue growth of the customer base during the post-combination period. We assess contingent consideration to determine if it should be recognized at its fair value on the acquisition date. A liability resulting from contingent consideration is remeasured to fair value at each reporting date until the contingency is resolved, with changes in fair value recognized in earnings if changes in estimates are made after the measurement period. During the fourth quarter of 2021, we increased the fair value of the contingent payment to ezyVet by $2.0&#160;million. Changes in the fair value of contingent consideration and differences arising upon settlement were not material during the years ended December 31, 2020, and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We assess goodwill for impairment annually, at the reporting unit level, in the fourth quarter and whenever events or circumstances indicate impairment may exist. In evaluating goodwill for impairment, we have the option to first assess the qualitative factors to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the goodwill impairment test. The more likely than not threshold is defined as having a likelihood of more than 50%. If, after assessing the totality of events or circumstances, we determine that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, we would assess the fair value of all of our reporting units and compare the fair value of the reporting unit to its carrying value to determine if the carrying value exceeds its fair value, and if a goodwill impairment loss should be recognized. In contrast, we can opt to bypass the qualitative assessment for any reporting unit in any period and proceed directly to assessing the fair value of all of our reporting units and compare the fair value of the reporting unit to carrying value to determine if any impairment exists. Doing so does not preclude us from performing the qualitative assessment in any subsequent&#160;period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the fourth quarter of 2021, we elected to bypass the qualitative approach that allows the assessment of qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount and instead proceeded directly to assessing the fair value of all of our reporting units and comparing the fair values of each reporting unit to the carrying values to determine if any impairment exists. We estimate the fair values of applicable reporting units using an income approach based on discounted forecasted cash flows. We make significant assumptions about the extent and timing of future cash flows, growth rates and discount rates. Model assumptions are based on our projections and best estimates, using appropriate and customary market participant assumptions. In addition, we make certain assumptions in allocating shared assets and liabilities to individual reporting units in determining the carrying value of each reporting unit. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in forecasted cash flows or the discount rate would affect the estimated fair values of our reporting units and could result in a goodwill impairment loss in a future period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No goodwill impairments were identified during the years ended December 31, 2021, 2020, or 2019, and no accumulated impairment losses are recorded.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We assess the realizability of intangible assets other than goodwill whenever events or changes in circumstances indicate that the carrying value may not be recoverable. If an impairment review is triggered, we evaluate the carrying value of intangible assets based on estimated undiscounted future cash flows over the remaining useful life of the primary asset of the asset group and compare that value to the carrying value of the asset group. The asset group is the lowest level for which identifiable cash flows associated with the intangible asset are largely independent. The cash flows that are used contain our best estimates, using appropriate and customary assumptions and projections at the time. If the net carrying value of an intangible asset exceeds the related estimated undiscounted future cash flows, an impairment loss to adjust the intangible asset to its fair value would be reported as a non-cash charge to earnings. If necessary, we would calculate the fair value of an intangible asset using the present value of the estimated future cash flows to be generated by the intangible asset, and applying a risk-adjusted discount rate. We had no impairments of our intangible assets during the years ended December 31, 2021 and 2019.&#160;The amount of impairment for the year ended December 31, 2020 was immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We provide for amortization primarily using the straight-line method by charges to income in amounts that allocate the intangible assets over their estimated useful lives as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.246%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:3.731%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Asset Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer-related intangible assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3 to 17 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Product rights &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5 to 15 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Noncompete agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3 to 5 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="ifb7924f502ed418b8a52fa0f86e77e1b_D20211001-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90ZXh0cmVnaW9uOjFiMzBlOTFiNDExNTRmNGRhYzlmYTU1ZGIwNTIxMzBkXzQzOTgwNDY1MjAyMjI_d83a8d36-fda6-49d4-b1ca-ea0bbda85a83"
      unitRef="usd">2000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90ZXh0cmVnaW9uOjFiMzBlOTFiNDExNTRmNGRhYzlmYTU1ZGIwNTIxMzBkXzQ3OTY_313132f7-3603-4cbe-8ac0-ae46b5ec9605"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90ZXh0cmVnaW9uOjFiMzBlOTFiNDExNTRmNGRhYzlmYTU1ZGIwNTIxMzBkXzQ3OTY_d325378b-81ca-44c5-abee-bb6a4c93c6f1"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90ZXh0cmVnaW9uOjFiMzBlOTFiNDExNTRmNGRhYzlmYTU1ZGIwNTIxMzBkXzQ3OTY_d3a604d9-d95e-4c66-bdba-98933b3e12d7"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90ZXh0cmVnaW9uOjFiMzBlOTFiNDExNTRmNGRhYzlmYTU1ZGIwNTIxMzBkXzYxNTA_d6b97470-ce81-44cb-bf44-b9716374c789"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90ZXh0cmVnaW9uOjFiMzBlOTFiNDExNTRmNGRhYzlmYTU1ZGIwNTIxMzBkXzYxNTA_dcdf7ca5-df1c-4fd8-ac1d-972e3d398d8c"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90ZXh0cmVnaW9uOjFiMzBlOTFiNDExNTRmNGRhYzlmYTU1ZGIwNTIxMzBkXzc2NzA_182ce805-570b-4993-b1ef-9af3f92bbbd0">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the carrying amount of goodwill for the years ended December 31, 2021, 2020, and 2019, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.642%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;CAG&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Water&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;LPD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;182,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;214,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Business combinations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Impact of changes in foreign currency exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(119)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;207,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;239,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Business combinations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Acquisition adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,900)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,900)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Impact of changes in foreign currency exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;210,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;243,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Business combinations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;120,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;120,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Impact of changes in foreign currency exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,569)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(695)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,348)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;327,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;359,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i4a0c9bdb38c5437ba4c6b8c7c0183c5d_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzEtMi0xLTEtMA_2259adba-0738-478d-9351-d9207c149722"
      unitRef="usd">182386000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ibf8bbc6500694651b48a90bd7484b109_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzEtNC0xLTEtMA_fe916338-a1b2-4d7a-8c2c-09e763eed3c7"
      unitRef="usd">11221000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ibf7bd16dde3b49debd9c67b5be3e1fb9_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzEtNi0xLTEtMA_f2bedd7f-ec57-40f2-bf8e-c1eef62961f3"
      unitRef="usd">14351000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i553fbb83ebff498cbd25aefa9eee9276_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzEtOC0xLTEtMA_e7405303-3842-44e2-afce-aaf91c84ba55"
      unitRef="usd">6531000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i28d0821cac8841b29cf960002d3bc993_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzEtMTAtMS0xLTA_68c38ee2-e7d9-4f55-a178-0c226cf25a44"
      unitRef="usd">214489000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ief827aa39f934947a553685160a5543c_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzItMi0xLTEtMA_94a6eb78-5daf-4a84-bf42-912cd2ee3ae7"
      unitRef="usd">24826000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="iab0b6ebdef1a4be9b052a1b82c635759_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzItNC0xLTEtMA_6c269d81-f981-4b0e-8e69-d2982f0f3e23"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i34e8ebea941e457cbadc1ce152e6a396_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzItNi0xLTEtMA_cd958492-a52f-4145-acb1-c81fe0009666"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ia6f9b6007f00420291efefe0008f3d10_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzItOC0xLTEtMA_7a488d99-2946-4ec8-95a4-4d4b0302b1bc"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzItMTAtMS0xLTA_3f9d09c3-93ff-4233-a85a-b042354f4e7a"
      unitRef="usd">24826000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ief827aa39f934947a553685160a5543c_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzMtMi0xLTEtMA_04f86268-d98f-4403-b739-31c34ba00300"
      unitRef="usd">-138000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="iab0b6ebdef1a4be9b052a1b82c635759_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzMtNC0xLTEtMA_85bb2380-a310-45d4-a5c0-420ef24939c3"
      unitRef="usd">-390000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i34e8ebea941e457cbadc1ce152e6a396_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzMtNi0xLTEtMA_f504ba8d-6ee5-4133-8613-376646c97628"
      unitRef="usd">119000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ia6f9b6007f00420291efefe0008f3d10_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzMtOC0xLTEtMA_c41bc164-4ddb-4e3e-8a93-a333b8e74284"
      unitRef="usd">0</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzMtMTAtMS0xLTA_a79196e1-a389-461a-ac4e-2117fa3fcd90"
      unitRef="usd">-409000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="i9f05fb527b154dee8865a625a6eff114_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzQtMi0xLTEtMA_6ac0a0c4-3cec-404a-832b-aa0a26c3e7c7"
      unitRef="usd">207350000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="if93e0292c6f54be59c39937e7fd58164_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzQtNC0xLTEtMA_ef01b307-c070-42b2-a38b-1a30df0019a6"
      unitRef="usd">11611000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i6e064fdd1f8949e0a40782734de7a004_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzQtNi0xLTEtMA_b4388e07-558c-4bbd-abc8-7b65ae69cb9f"
      unitRef="usd">14232000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ia7599f68f6de408b80c30adab94958b2_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzQtOC0xLTEtMA_1d5ed016-c96c-4e26-a93c-877285039a8b"
      unitRef="usd">6531000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i0c634b937c58472e84857eacf99e17df_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzQtMTAtMS0xLTA_6e120d19-130b-46ae-8337-3b1da9ab32b2"
      unitRef="usd">239724000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i40313073e9c743ad89084e7fbcbd7e5e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzUtMi0xLTEtMA_20346f77-72a0-4c0a-89a1-f824e3725dca"
      unitRef="usd">220000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ic0b173f4625a4e1e807adc8eeb4e0592_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzUtNC0xLTEtMA_12eabf14-e167-4df5-87f5-687eff8ac897"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i4525be5d1c1b4d458fe78f047e981dc1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzUtNi0xLTEtMA_fb197374-ad41-461e-b0d2-2aafe1f6367c"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i100119c49d8f4098bf6afdc675782162_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzUtOC0xLTEtMA_dd811bcf-d654-4b82-a978-a52fe7abc222"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzUtMTAtMS0xLTA_6ae02961-bd5e-46b1-b8d6-4282d435f232"
      unitRef="usd">220000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i40313073e9c743ad89084e7fbcbd7e5e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzYtMi0xLTEtMA_c4231755-3573-4d85-894b-c01faf8205d3"
      unitRef="usd">-1900000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="ic0b173f4625a4e1e807adc8eeb4e0592_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzYtNC0xLTEtMA_f3eb753b-9610-403a-be0e-e41fda2c3432"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i4525be5d1c1b4d458fe78f047e981dc1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzYtNi0xLTEtMA_8e188804-75c7-4608-8873-25ca5bcd9316"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i100119c49d8f4098bf6afdc675782162_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzYtOC0xLTEtMA_8481792a-6c68-432e-9f7d-981d1688825b"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzYtMTAtMS0xLTA_17db7785-c5ae-404e-8537-a12791f66034"
      unitRef="usd">-1900000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i40313073e9c743ad89084e7fbcbd7e5e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzctMi0xLTEtMA_fd522346-3ded-43b4-be9c-3e5ccdd5c78f"
      unitRef="usd">-4724000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ic0b173f4625a4e1e807adc8eeb4e0592_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzctNC0xLTEtMA_0a6f4385-f57b-4839-b04d-d31cfbad3079"
      unitRef="usd">-412000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i4525be5d1c1b4d458fe78f047e981dc1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzctNi0xLTEtMA_afdffa45-d8ca-45aa-9141-f3f0f9e938e7"
      unitRef="usd">-167000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i100119c49d8f4098bf6afdc675782162_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzctOC0xLTEtMA_09733ec5-db8e-466e-93d0-af38103b9185"
      unitRef="usd">0</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzctMTAtMS0xLTA_d28cb60d-b2fe-4170-9163-5f5836ecbe48"
      unitRef="usd">-5303000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="ief4601e8865549a09377d9dfd17d74d4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzgtMi0xLTEtMA_09c10078-d9bd-48ed-9867-3b281a01efab"
      unitRef="usd">210394000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i463e678af3d24f9d8074cd935b869239_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzgtNC0xLTEtMA_fa541906-3163-40ad-a4ce-9976522956a2"
      unitRef="usd">12023000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i929ca297bc5248beabe8f044d7430225_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzgtNi0xLTEtMA_30bf45f5-dd8b-4de2-876a-906f61b1d76f"
      unitRef="usd">14399000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="if8867f1bde2348b596b2427e15fb4d2e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzgtOC0xLTEtMA_52e3a3df-bee9-4692-817d-05934a2ca023"
      unitRef="usd">6531000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzgtMTAtMS0xLTA_76585e2e-6073-4a16-8e7f-180ac7f6ae57"
      unitRef="usd">243347000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i6c823cc0aa3945d9874ea09ab5940878_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzktMi0xLTEtNDExMTU_a2489cd8-bb6b-4406-ba09-b0285c72dd97"
      unitRef="usd">120346000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i81c0a80f385a4f18ab5cb5919ed28318_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzktNC0xLTEtNDExMTU_e0366cbb-80bb-40b3-aacb-770450ab644d"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i4174c33ea3f8443fbc6587f7ac9a43ab_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzktNi0xLTEtNDExMTU_0fa9ae23-bed2-4763-aee3-b9d7a814778b"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i94cd933d7b7b431caa324dc2936f5c55_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzktOC0xLTEtNDExMTU_8ba27478-580d-41e5-ab92-e15c08047189"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzktMTAtMS0xLTQxMTE1_5226de27-b65f-4c4d-bcd5-95cc68ee8632"
      unitRef="usd">120346000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i6c823cc0aa3945d9874ea09ab5940878_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzEwLTItMS0xLTA_dd27579f-6075-4be9-b648-36975d6c015a"
      unitRef="usd">3569000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i81c0a80f385a4f18ab5cb5919ed28318_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzEwLTQtMS0xLTA_9a624329-0a94-43a5-9407-ef19a5a0675a"
      unitRef="usd">84000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i4174c33ea3f8443fbc6587f7ac9a43ab_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzEwLTYtMS0xLTA_ffb92cc7-8312-4418-8f58-d9503ba368d2"
      unitRef="usd">695000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i94cd933d7b7b431caa324dc2936f5c55_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzEwLTgtMS0xLTA_5bde7576-8fe2-4180-bcc9-bfdb0ee4c73a"
      unitRef="usd">0</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzEwLTEwLTEtMS0w_a0054c1c-e4a6-43aa-a8f3-b0b1f258e20a"
      unitRef="usd">4348000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="i91597ef710044b0aaf747bf9fd3b6882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzExLTItMS0xLTA_0e5c6615-22d0-4148-8b4a-151685948d21"
      unitRef="usd">327171000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i7b559b62389c4dffbc62f92796f64370_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzExLTQtMS0xLTA_a4739948-f92b-4d7c-9aa8-fdabee87a2ae"
      unitRef="usd">11939000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ib956b0023d37451a873e726de05dc04d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzExLTYtMS0xLTA_ff35a402-f330-45be-97a1-8b252fcde5fb"
      unitRef="usd">13704000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i81db4aa26c9a45f9b2ac5198a22acfe8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzExLTgtMS0xLTA_69e9bef0-1913-45c9-837b-cf0f19518293"
      unitRef="usd">6531000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo0ZGFiNDg5NWFhNGU0MWMyOTBiOWJmNjczMzMxNTNiNy90YWJsZXJhbmdlOjRkYWI0ODk1YWE0ZTQxYzI5MGI5YmY2NzMzMzE1M2I3XzExLTEwLTEtMS0w_d392c9ac-80e4-4515-a9c1-8072e823af17"
      unitRef="usd">359345000</us-gaap:Goodwill>
    <idxx:ScheduleOfEstimatedUsefulLivesForIntangibleAssetsTableTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90ZXh0cmVnaW9uOjFiMzBlOTFiNDExNTRmNGRhYzlmYTU1ZGIwNTIxMzBkXzc2NzE_da0fe9e5-28ed-434f-a76c-aacd1ccd582e">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We provide for amortization primarily using the straight-line method by charges to income in amounts that allocate the intangible assets over their estimated useful lives as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.246%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:3.731%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Asset Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer-related intangible assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3 to 17 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Product rights &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5 to 15 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Noncompete agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3 to 5 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</idxx:ScheduleOfEstimatedUsefulLivesForIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ib25dbfb85b114a83a3384494c07c9a83_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTpkNzdmNWM4OTEwYzQ0NGI1YTUzMzU4ZjIwN2I0Njg1Ny90YWJsZXJhbmdlOmQ3N2Y1Yzg5MTBjNDQ0YjVhNTMzNThmMjA3YjQ2ODU3XzItMi0xLTEtMC90ZXh0cmVnaW9uOmJlMTUwZDc4YzJhYzRjOTE5OTc0MzcyNmZlNzc5ODMzXzQ_444537be-3fb5-49a2-bdae-549bdc908ac9">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="iccd74787592547aabe3fc45e8160f1f6_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTpkNzdmNWM4OTEwYzQ0NGI1YTUzMzU4ZjIwN2I0Njg1Ny90YWJsZXJhbmdlOmQ3N2Y1Yzg5MTBjNDQ0YjVhNTMzNThmMjA3YjQ2ODU3XzItMi0xLTEtMC90ZXh0cmVnaW9uOmJlMTUwZDc4YzJhYzRjOTE5OTc0MzcyNmZlNzc5ODMzXzEw_92d7833f-21da-404f-8bf9-dd0585d86ed9">P17Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i6d6af357c77b4c45a43103bb36b9db75_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTpkNzdmNWM4OTEwYzQ0NGI1YTUzMzU4ZjIwN2I0Njg1Ny90YWJsZXJhbmdlOmQ3N2Y1Yzg5MTBjNDQ0YjVhNTMzNThmMjA3YjQ2ODU3XzMtMi0xLTEtMC90ZXh0cmVnaW9uOjc0MzIzMTc5ZmVmNTQ5ZTQ5NDRjNjRlZDI2MjYyZDU0XzQ_9de915bf-911c-4797-b3af-dd00fbfbd180">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i6625320757264c3d977d4eb7923c35ee_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTpkNzdmNWM4OTEwYzQ0NGI1YTUzMzU4ZjIwN2I0Njg1Ny90YWJsZXJhbmdlOmQ3N2Y1Yzg5MTBjNDQ0YjVhNTMzNThmMjA3YjQ2ODU3XzMtMi0xLTEtMC90ZXh0cmVnaW9uOjc0MzIzMTc5ZmVmNTQ5ZTQ5NDRjNjRlZDI2MjYyZDU0XzEw_990f9b9d-bc82-459d-9836-27c2fb37a28a">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i570237e99c1d4a9b8c6dca9eae26bea8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTpkNzdmNWM4OTEwYzQ0NGI1YTUzMzU4ZjIwN2I0Njg1Ny90YWJsZXJhbmdlOmQ3N2Y1Yzg5MTBjNDQ0YjVhNTMzNThmMjA3YjQ2ODU3XzQtMi0xLTEtMC90ZXh0cmVnaW9uOmUyNzcxNTY0ZTFkZjQxMzJhOThmYWZlMzQxNDgxOGQxXzQ_ad2c0112-f294-4e8d-9329-7f1193e18a4f">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i637fcf9a068c4d6798c09d00dea42126_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTpkNzdmNWM4OTEwYzQ0NGI1YTUzMzU4ZjIwN2I0Njg1Ny90YWJsZXJhbmdlOmQ3N2Y1Yzg5MTBjNDQ0YjVhNTMzNThmMjA3YjQ2ODU3XzQtMi0xLTEtMC90ZXh0cmVnaW9uOmUyNzcxNTY0ZTFkZjQxMzJhOThmYWZlMzQxNDgxOGQxXzEw_1684e271-2ec8-4b32-9926-9be0d921b37c">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90ZXh0cmVnaW9uOjFiMzBlOTFiNDExNTRmNGRhYzlmYTU1ZGIwNTIxMzBkXzc2NzI_002747d3-467c-4cec-86ee-5c9bf8fe84ba">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets other than goodwill consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.307%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.124%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.124%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.124%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.125%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer-related intangible assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;121,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;83,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;80,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Product rights &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Noncompete agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;143,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;99,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;97,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;     The above table excludes fully amortized intangible assets for the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Customer-related intangible assets are comprised of customer lists and customer relationships acquired from third parties.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Product rights comprise certain technologies, intellectual property, licenses, and trade names acquired from third parties.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ic59101fdcfff4269aef991be04a88a6f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTowODVlOTk3NmE3OWQ0ODAyYjgyODdiNzFhMTY0YjI2Zi90YWJsZXJhbmdlOjA4NWU5OTc2YTc5ZDQ4MDJiODI4N2I3MWExNjRiMjZmXzMtMi0xLTEtMA_9212b2ed-d608-4a7d-a1cb-9d1bda4166b6"
      unitRef="usd">121936000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic59101fdcfff4269aef991be04a88a6f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTowODVlOTk3NmE3OWQ0ODAyYjgyODdiNzFhMTY0YjI2Zi90YWJsZXJhbmdlOjA4NWU5OTc2YTc5ZDQ4MDJiODI4N2I3MWExNjRiMjZmXzMtNC0xLTEtMA_becfeefe-7ce5-4205-a52e-8ff2e2d0c20b"
      unitRef="usd">38349000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ic59101fdcfff4269aef991be04a88a6f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTowODVlOTk3NmE3OWQ0ODAyYjgyODdiNzFhMTY0YjI2Zi90YWJsZXJhbmdlOjA4NWU5OTc2YTc5ZDQ4MDJiODI4N2I3MWExNjRiMjZmXzMtNi0xLTEtMA_796bd5c3-dafb-472d-93a2-7209c1c122c4"
      unitRef="usd">83587000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i24ed2ad1bc274728bf194148636a8d78_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTowODVlOTk3NmE3OWQ0ODAyYjgyODdiNzFhMTY0YjI2Zi90YWJsZXJhbmdlOjA4NWU5OTc2YTc5ZDQ4MDJiODI4N2I3MWExNjRiMjZmXzMtOC0xLTEtMA_c65a6e0a-2632-4c57-8849-67ddb88bd9bc"
      unitRef="usd">80810000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i24ed2ad1bc274728bf194148636a8d78_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTowODVlOTk3NmE3OWQ0ODAyYjgyODdiNzFhMTY0YjI2Zi90YWJsZXJhbmdlOjA4NWU5OTc2YTc5ZDQ4MDJiODI4N2I3MWExNjRiMjZmXzMtMTAtMS0xLTA_24d93e6b-0be2-43f0-a11f-2ab88096a127"
      unitRef="usd">32838000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i24ed2ad1bc274728bf194148636a8d78_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTowODVlOTk3NmE3OWQ0ODAyYjgyODdiNzFhMTY0YjI2Zi90YWJsZXJhbmdlOjA4NWU5OTc2YTc5ZDQ4MDJiODI4N2I3MWExNjRiMjZmXzMtMTItMS0xLTA_db9c98a4-4e57-4c6b-8ab8-8128166f7d41"
      unitRef="usd">47972000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ia89659b032284471b33d455d42efc26b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTowODVlOTk3NmE3OWQ0ODAyYjgyODdiNzFhMTY0YjI2Zi90YWJsZXJhbmdlOjA4NWU5OTc2YTc5ZDQ4MDJiODI4N2I3MWExNjRiMjZmXzQtMi0xLTEtMA_6b701ed2-f3f9-4ca2-b5e9-01ed86526ecd"
      unitRef="usd">17350000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ia89659b032284471b33d455d42efc26b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTowODVlOTk3NmE3OWQ0ODAyYjgyODdiNzFhMTY0YjI2Zi90YWJsZXJhbmdlOjA4NWU5OTc2YTc5ZDQ4MDJiODI4N2I3MWExNjRiMjZmXzQtNC0xLTEtMA_033d671e-1555-4d22-936b-62ef6f83e2c4"
      unitRef="usd">5332000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ia89659b032284471b33d455d42efc26b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTowODVlOTk3NmE3OWQ0ODAyYjgyODdiNzFhMTY0YjI2Zi90YWJsZXJhbmdlOjA4NWU5OTc2YTc5ZDQ4MDJiODI4N2I3MWExNjRiMjZmXzQtNi0xLTEtMA_4642de26-affd-40f0-9edf-49c71c39fad0"
      unitRef="usd">12018000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i87c2ea63490848ab92d756e41e990b46_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTowODVlOTk3NmE3OWQ0ODAyYjgyODdiNzFhMTY0YjI2Zi90YWJsZXJhbmdlOjA4NWU5OTc2YTc5ZDQ4MDJiODI4N2I3MWExNjRiMjZmXzQtOC0xLTEtMA_64882342-7b58-484b-ba8f-5e983ec14a0a"
      unitRef="usd">15150000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i87c2ea63490848ab92d756e41e990b46_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTowODVlOTk3NmE3OWQ0ODAyYjgyODdiNzFhMTY0YjI2Zi90YWJsZXJhbmdlOjA4NWU5OTc2YTc5ZDQ4MDJiODI4N2I3MWExNjRiMjZmXzQtMTAtMS0xLTA_ec14f4d5-16ec-4db1-ab3b-72ede1c1d789"
      unitRef="usd">11609000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i87c2ea63490848ab92d756e41e990b46_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTowODVlOTk3NmE3OWQ0ODAyYjgyODdiNzFhMTY0YjI2Zi90YWJsZXJhbmdlOjA4NWU5OTc2YTc5ZDQ4MDJiODI4N2I3MWExNjRiMjZmXzQtMTItMS0xLTA_5796b8f4-03f9-4130-a6ce-8c202e3de94c"
      unitRef="usd">3541000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i0f20409febb84c2483223228e9e1771a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTowODVlOTk3NmE3OWQ0ODAyYjgyODdiNzFhMTY0YjI2Zi90YWJsZXJhbmdlOjA4NWU5OTc2YTc5ZDQ4MDJiODI4N2I3MWExNjRiMjZmXzUtMi0xLTEtMA_2da1c856-090d-42cc-b51d-58310ea78b97"
      unitRef="usd">4257000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i0f20409febb84c2483223228e9e1771a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTowODVlOTk3NmE3OWQ0ODAyYjgyODdiNzFhMTY0YjI2Zi90YWJsZXJhbmdlOjA4NWU5OTc2YTc5ZDQ4MDJiODI4N2I3MWExNjRiMjZmXzUtNC0xLTEtMA_bd256324-8514-495d-9244-9c56aadeec09"
      unitRef="usd">827000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i0f20409febb84c2483223228e9e1771a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTowODVlOTk3NmE3OWQ0ODAyYjgyODdiNzFhMTY0YjI2Zi90YWJsZXJhbmdlOjA4NWU5OTc2YTc5ZDQ4MDJiODI4N2I3MWExNjRiMjZmXzUtNi0xLTEtMA_81a95ec4-422b-4f88-aebe-fcbd62e72fee"
      unitRef="usd">3430000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i8bec47a954cb4a1d86389d1590f9c5e0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTowODVlOTk3NmE3OWQ0ODAyYjgyODdiNzFhMTY0YjI2Zi90YWJsZXJhbmdlOjA4NWU5OTc2YTc5ZDQ4MDJiODI4N2I3MWExNjRiMjZmXzUtOC0xLTEtMA_ab3d0ed7-eea3-4e8d-9857-c61ef434340c"
      unitRef="usd">1250000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i8bec47a954cb4a1d86389d1590f9c5e0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTowODVlOTk3NmE3OWQ0ODAyYjgyODdiNzFhMTY0YjI2Zi90YWJsZXJhbmdlOjA4NWU5OTc2YTc5ZDQ4MDJiODI4N2I3MWExNjRiMjZmXzUtMTAtMS0xLTA_2480176a-c354-4c65-8b27-d548dff39571"
      unitRef="usd">220000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i8bec47a954cb4a1d86389d1590f9c5e0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTowODVlOTk3NmE3OWQ0ODAyYjgyODdiNzFhMTY0YjI2Zi90YWJsZXJhbmdlOjA4NWU5OTc2YTc5ZDQ4MDJiODI4N2I3MWExNjRiMjZmXzUtMTItMS0xLTA_7277b2de-9d38-4f5e-b606-fc9d9c476248"
      unitRef="usd">1030000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTowODVlOTk3NmE3OWQ0ODAyYjgyODdiNzFhMTY0YjI2Zi90YWJsZXJhbmdlOjA4NWU5OTc2YTc5ZDQ4MDJiODI4N2I3MWExNjRiMjZmXzYtMi0xLTEtMA_45f4092b-c25c-4ccd-a636-6da796ca0b3e"
      unitRef="usd">143543000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTowODVlOTk3NmE3OWQ0ODAyYjgyODdiNzFhMTY0YjI2Zi90YWJsZXJhbmdlOjA4NWU5OTc2YTc5ZDQ4MDJiODI4N2I3MWExNjRiMjZmXzYtNC0xLTEtMA_d9c8ccfa-5340-44e7-a8bb-b69b20f49c66"
      unitRef="usd">44508000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTowODVlOTk3NmE3OWQ0ODAyYjgyODdiNzFhMTY0YjI2Zi90YWJsZXJhbmdlOjA4NWU5OTc2YTc5ZDQ4MDJiODI4N2I3MWExNjRiMjZmXzYtNi0xLTEtMA_63ec3ae6-8d1a-4615-b785-557fe108349e"
      unitRef="usd">99035000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTowODVlOTk3NmE3OWQ0ODAyYjgyODdiNzFhMTY0YjI2Zi90YWJsZXJhbmdlOjA4NWU5OTc2YTc5ZDQ4MDJiODI4N2I3MWExNjRiMjZmXzYtOC0xLTEtMA_766428be-f30a-443c-a679-6920d2f1af96"
      unitRef="usd">97210000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTowODVlOTk3NmE3OWQ0ODAyYjgyODdiNzFhMTY0YjI2Zi90YWJsZXJhbmdlOjA4NWU5OTc2YTc5ZDQ4MDJiODI4N2I3MWExNjRiMjZmXzYtMTAtMS0xLTA_17c5c49e-bfed-408f-b06f-c88d2a294981"
      unitRef="usd">44667000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTowODVlOTk3NmE3OWQ0ODAyYjgyODdiNzFhMTY0YjI2Zi90YWJsZXJhbmdlOjA4NWU5OTc2YTc5ZDQ4MDJiODI4N2I3MWExNjRiMjZmXzYtMTItMS0xLTA_9085c0ee-9e1c-4ecf-a1ce-aefdc572294d"
      unitRef="usd">52543000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90ZXh0cmVnaW9uOjFiMzBlOTFiNDExNTRmNGRhYzlmYTU1ZGIwNTIxMzBkXzc0NDM_62d158a9-712a-44f5-8b74-5d7c46657ee1"
      unitRef="usd">12100000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90ZXh0cmVnaW9uOjFiMzBlOTFiNDExNTRmNGRhYzlmYTU1ZGIwNTIxMzBkXzc0NDc_1d569401-74c3-486c-81d8-e9291538b713"
      unitRef="usd">9800000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90ZXh0cmVnaW9uOjFiMzBlOTFiNDExNTRmNGRhYzlmYTU1ZGIwNTIxMzBkXzc0NTU_6faaf4de-135a-44e9-a1a7-62b8308164fa"
      unitRef="usd">9400000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90ZXh0cmVnaW9uOjFiMzBlOTFiNDExNTRmNGRhYzlmYTU1ZGIwNTIxMzBkXzc2Nzg_ea9a9f19-d9bf-40a0-9386-9fa068b831cc">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December 31, 2021, the aggregate amortization expense associated with intangible assets is estimated to be as follows for each of the next five years and thereafter:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.330%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.470%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortization Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;99,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo1MmJiMTNhNzRhNjQ0ZDhiYTgzNjllNWI0NTRlYjU4OC90YWJsZXJhbmdlOjUyYmIxM2E3NGE2NDRkOGJhODM2OWU1YjQ1NGViNTg4XzItMS0xLTEtMA_14841a19-41b3-4b6d-b94a-18d9a04464fc"
      unitRef="usd">14188000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo1MmJiMTNhNzRhNjQ0ZDhiYTgzNjllNWI0NTRlYjU4OC90YWJsZXJhbmdlOjUyYmIxM2E3NGE2NDRkOGJhODM2OWU1YjQ1NGViNTg4XzMtMS0xLTEtMA_945eba3a-441c-4d95-ba22-9202120d914b"
      unitRef="usd">12430000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo1MmJiMTNhNzRhNjQ0ZDhiYTgzNjllNWI0NTRlYjU4OC90YWJsZXJhbmdlOjUyYmIxM2E3NGE2NDRkOGJhODM2OWU1YjQ1NGViNTg4XzQtMS0xLTEtMA_994efa0c-adb2-49c6-b9f5-7fcd388be541"
      unitRef="usd">11381000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo1MmJiMTNhNzRhNjQ0ZDhiYTgzNjllNWI0NTRlYjU4OC90YWJsZXJhbmdlOjUyYmIxM2E3NGE2NDRkOGJhODM2OWU1YjQ1NGViNTg4XzUtMS0xLTEtMA_a674bbd5-439b-42f8-82c0-9de4f91f75a2"
      unitRef="usd">10633000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo1MmJiMTNhNzRhNjQ0ZDhiYTgzNjllNWI0NTRlYjU4OC90YWJsZXJhbmdlOjUyYmIxM2E3NGE2NDRkOGJhODM2OWU1YjQ1NGViNTg4XzYtMS0xLTEtMA_76e6b99f-f51b-41fd-8e6c-69fc0aa2c691"
      unitRef="usd">10370000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo1MmJiMTNhNzRhNjQ0ZDhiYTgzNjllNWI0NTRlYjU4OC90YWJsZXJhbmdlOjUyYmIxM2E3NGE2NDRkOGJhODM2OWU1YjQ1NGViNTg4XzctMS0xLTEtMA_ef9d7109-d612-4c9e-8475-87eccf4af44f"
      unitRef="usd">40033000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDUvZnJhZzoxYjMwZTkxYjQxMTU0ZjRkYWM5ZmE1NWRiMDUyMTMwZC90YWJsZTo1MmJiMTNhNzRhNjQ0ZDhiYTgzNjllNWI0NTRlYjU4OC90YWJsZXJhbmdlOjUyYmIxM2E3NGE2NDRkOGJhODM2OWU1YjQ1NGViNTg4XzgtMS0xLTEtMA_51f56b8e-4a74-4465-9fbd-807b4d0fbd6e"
      unitRef="usd">99035000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:OtherLiabilitiesDisclosureTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDgvZnJhZzo2YjI1NjU3MGQ2Y2M0ZTllYWY5MDBhYzk2ZTU2Yjg3My90ZXh0cmVnaW9uOjZiMjU2NTcwZDZjYzRlOWVhZjkwMGFjOTZlNTZiODczXzE0MA_0f17602e-47a4-4aec-b854-72effc8d0c5d">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;ACCRUED LIABILITIES AND OTHER LONG-TERM LIABILITIES&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued liabilities consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.676%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.827%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued employee compensation and related expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;182,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;167,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;133,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;112,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued customer incentives and refund obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;79,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDgvZnJhZzo2YjI1NjU3MGQ2Y2M0ZTllYWY5MDBhYzk2ZTU2Yjg3My90YWJsZTpkMzgwNTNlNWU4ZTg0N2FhYWQ5MDI3M2UxMDAzMzM5MS90YWJsZXJhbmdlOmQzODA1M2U1ZThlODQ3YWFhZDkwMjczZTEwMDMzMzkxXzctMC0xLTEtMA_5d2faed1-a462-48ce-9b44-a109b44ef227"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDgvZnJhZzo2YjI1NjU3MGQ2Y2M0ZTllYWY5MDBhYzk2ZTU2Yjg3My90YWJsZTpkMzgwNTNlNWU4ZTg0N2FhYWQ5MDI3M2UxMDAzMzM5MS90YWJsZXJhbmdlOmQzODA1M2U1ZThlODQ3YWFhZDkwMjczZTEwMDMzMzkxXzctMC0xLTEtMA_e4f554de-7131-4a19-8325-4f920319c89c"&gt;Accrued liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;458,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;415,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other long-term liabilities consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.501%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.780%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.931%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;56,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other accrued long-term expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;85,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OtherLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDgvZnJhZzo2YjI1NjU3MGQ2Y2M0ZTllYWY5MDBhYzk2ZTU2Yjg3My90ZXh0cmVnaW9uOjZiMjU2NTcwZDZjYzRlOWVhZjkwMGFjOTZlNTZiODczXzE0Mg_d67a8dc4-5727-47a2-bacd-714fa6055f21">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued liabilities consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.676%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.827%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued employee compensation and related expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;182,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;167,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;133,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;112,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued customer incentives and refund obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;79,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDgvZnJhZzo2YjI1NjU3MGQ2Y2M0ZTllYWY5MDBhYzk2ZTU2Yjg3My90YWJsZTpkMzgwNTNlNWU4ZTg0N2FhYWQ5MDI3M2UxMDAzMzM5MS90YWJsZXJhbmdlOmQzODA1M2U1ZThlODQ3YWFhZDkwMjczZTEwMDMzMzkxXzctMC0xLTEtMA_5d2faed1-a462-48ce-9b44-a109b44ef227"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDgvZnJhZzo2YjI1NjU3MGQ2Y2M0ZTllYWY5MDBhYzk2ZTU2Yjg3My90YWJsZTpkMzgwNTNlNWU4ZTg0N2FhYWQ5MDI3M2UxMDAzMzM5MS90YWJsZXJhbmdlOmQzODA1M2U1ZThlODQ3YWFhZDkwMjczZTEwMDMzMzkxXzctMC0xLTEtMA_e4f554de-7131-4a19-8325-4f920319c89c"&gt;Accrued liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;458,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;415,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDgvZnJhZzo2YjI1NjU3MGQ2Y2M0ZTllYWY5MDBhYzk2ZTU2Yjg3My90YWJsZTpkMzgwNTNlNWU4ZTg0N2FhYWQ5MDI3M2UxMDAzMzM5MS90YWJsZXJhbmdlOmQzODA1M2U1ZThlODQ3YWFhZDkwMjczZTEwMDMzMzkxXzItMi0xLTEtMA_50fa8b91-c277-4f9a-9306-916097ace4a3"
      unitRef="usd">182926000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDgvZnJhZzo2YjI1NjU3MGQ2Y2M0ZTllYWY5MDBhYzk2ZTU2Yjg3My90YWJsZTpkMzgwNTNlNWU4ZTg0N2FhYWQ5MDI3M2UxMDAzMzM5MS90YWJsZXJhbmdlOmQzODA1M2U1ZThlODQ3YWFhZDkwMjczZTEwMDMzMzkxXzItNC0xLTEtMA_6d2cd230-3a75-4bf3-879d-f39a36262b25"
      unitRef="usd">167649000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDgvZnJhZzo2YjI1NjU3MGQ2Y2M0ZTllYWY5MDBhYzk2ZTU2Yjg3My90YWJsZTpkMzgwNTNlNWU4ZTg0N2FhYWQ5MDI3M2UxMDAzMzM5MS90YWJsZXJhbmdlOmQzODA1M2U1ZThlODQ3YWFhZDkwMjczZTEwMDMzMzkxXzMtMi0xLTEtMA_e5ce586c-fdf9-48e5-b1e6-458e057948e3"
      unitRef="usd">133978000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDgvZnJhZzo2YjI1NjU3MGQ2Y2M0ZTllYWY5MDBhYzk2ZTU2Yjg3My90YWJsZTpkMzgwNTNlNWU4ZTg0N2FhYWQ5MDI3M2UxMDAzMzM5MS90YWJsZXJhbmdlOmQzODA1M2U1ZThlODQ3YWFhZDkwMjczZTEwMDMzMzkxXzMtNC0xLTEtMA_01909c46-24a6-498f-a8b1-955a8842fdf2"
      unitRef="usd">112526000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedMarketingCostsCurrent
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDgvZnJhZzo2YjI1NjU3MGQ2Y2M0ZTllYWY5MDBhYzk2ZTU2Yjg3My90YWJsZTpkMzgwNTNlNWU4ZTg0N2FhYWQ5MDI3M2UxMDAzMzM5MS90YWJsZXJhbmdlOmQzODA1M2U1ZThlODQ3YWFhZDkwMjczZTEwMDMzMzkxXzQtMi0xLTEtMA_fa223819-e51c-4835-aa0b-75b389965a7f"
      unitRef="usd">79469000</us-gaap:AccruedMarketingCostsCurrent>
    <us-gaap:AccruedMarketingCostsCurrent
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDgvZnJhZzo2YjI1NjU3MGQ2Y2M0ZTllYWY5MDBhYzk2ZTU2Yjg3My90YWJsZTpkMzgwNTNlNWU4ZTg0N2FhYWQ5MDI3M2UxMDAzMzM5MS90YWJsZXJhbmdlOmQzODA1M2U1ZThlODQ3YWFhZDkwMjczZTEwMDMzMzkxXzQtNC0xLTEtMA_99f8a856-5d95-43c1-aab0-1a38c7689a8d"
      unitRef="usd">75064000</us-gaap:AccruedMarketingCostsCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDgvZnJhZzo2YjI1NjU3MGQ2Y2M0ZTllYWY5MDBhYzk2ZTU2Yjg3My90YWJsZTpkMzgwNTNlNWU4ZTg0N2FhYWQ5MDI3M2UxMDAzMzM5MS90YWJsZXJhbmdlOmQzODA1M2U1ZThlODQ3YWFhZDkwMjczZTEwMDMzMzkxXzUtMi0xLTEtMA_172676ba-8b13-4f05-903c-5a0494afda77"
      unitRef="usd">42605000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDgvZnJhZzo2YjI1NjU3MGQ2Y2M0ZTllYWY5MDBhYzk2ZTU2Yjg3My90YWJsZTpkMzgwNTNlNWU4ZTg0N2FhYWQ5MDI3M2UxMDAzMzM5MS90YWJsZXJhbmdlOmQzODA1M2U1ZThlODQ3YWFhZDkwMjczZTEwMDMzMzkxXzUtNC0xLTEtMA_d6d818f9-dbdb-4df6-a670-f24a89c358d0"
      unitRef="usd">42676000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDgvZnJhZzo2YjI1NjU3MGQ2Y2M0ZTllYWY5MDBhYzk2ZTU2Yjg3My90YWJsZTpkMzgwNTNlNWU4ZTg0N2FhYWQ5MDI3M2UxMDAzMzM5MS90YWJsZXJhbmdlOmQzODA1M2U1ZThlODQ3YWFhZDkwMjczZTEwMDMzMzkxXzYtMi0xLTEtMA_f0c16dab-25c4-47db-911f-98abfc9a286c"
      unitRef="usd">19931000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDgvZnJhZzo2YjI1NjU3MGQ2Y2M0ZTllYWY5MDBhYzk2ZTU2Yjg3My90YWJsZTpkMzgwNTNlNWU4ZTg0N2FhYWQ5MDI3M2UxMDAzMzM5MS90YWJsZXJhbmdlOmQzODA1M2U1ZThlODQ3YWFhZDkwMjczZTEwMDMzMzkxXzYtNC0xLTEtMA_b54293a3-6ff3-43ec-a1a7-30d0777474fe"
      unitRef="usd">17733000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDgvZnJhZzo2YjI1NjU3MGQ2Y2M0ZTllYWY5MDBhYzk2ZTU2Yjg3My90YWJsZTpkMzgwNTNlNWU4ZTg0N2FhYWQ5MDI3M2UxMDAzMzM5MS90YWJsZXJhbmdlOmQzODA1M2U1ZThlODQ3YWFhZDkwMjczZTEwMDMzMzkxXzctMi0xLTEtMA_c6e50415-59e7-4f9a-88a3-21777f9194a8"
      unitRef="usd">458909000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDgvZnJhZzo2YjI1NjU3MGQ2Y2M0ZTllYWY5MDBhYzk2ZTU2Yjg3My90YWJsZTpkMzgwNTNlNWU4ZTg0N2FhYWQ5MDI3M2UxMDAzMzM5MS90YWJsZXJhbmdlOmQzODA1M2U1ZThlODQ3YWFhZDkwMjczZTEwMDMzMzkxXzctNC0xLTEtMA_52693fa7-05d3-47b2-a624-117a52063c8e"
      unitRef="usd">415648000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OtherNoncurrentLiabilitiesTableTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDgvZnJhZzo2YjI1NjU3MGQ2Y2M0ZTllYWY5MDBhYzk2ZTU2Yjg3My90ZXh0cmVnaW9uOjZiMjU2NTcwZDZjYzRlOWVhZjkwMGFjOTZlNTZiODczXzE0NA_171a78b4-e6f1-4665-a089-19c6041b3c2c">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other long-term liabilities consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.501%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.780%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.931%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;56,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other accrued long-term expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;85,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OtherNoncurrentLiabilitiesTableTextBlock>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDgvZnJhZzo2YjI1NjU3MGQ2Y2M0ZTllYWY5MDBhYzk2ZTU2Yjg3My90YWJsZTo3Zjk5NTQzZGE4N2U0NjE4ODRlYWM3YzM5ZmI5NGZjOC90YWJsZXJhbmdlOjdmOTk1NDNkYTg3ZTQ2MTg4NGVhYzdjMzlmYjk0ZmM4XzItMi0xLTEtMA_e8c1c8e1-131f-4919-9682-475eb55da76e"
      unitRef="usd">56466000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDgvZnJhZzo2YjI1NjU3MGQ2Y2M0ZTllYWY5MDBhYzk2ZTU2Yjg3My90YWJsZTo3Zjk5NTQzZGE4N2U0NjE4ODRlYWM3YzM5ZmI5NGZjOC90YWJsZXJhbmdlOjdmOTk1NDNkYTg3ZTQ2MTg4NGVhYzdjMzlmYjk0ZmM4XzItNC0xLTEtMA_59b1b931-2358-4f0e-a8fd-ab0762e1f03f"
      unitRef="usd">60313000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDgvZnJhZzo2YjI1NjU3MGQ2Y2M0ZTllYWY5MDBhYzk2ZTU2Yjg3My90YWJsZTo3Zjk5NTQzZGE4N2U0NjE4ODRlYWM3YzM5ZmI5NGZjOC90YWJsZXJhbmdlOjdmOTk1NDNkYTg3ZTQ2MTg4NGVhYzdjMzlmYjk0ZmM4XzMtMi0xLTEtMA_51e0796e-b8a6-4599-8b24-299b419adc92"
      unitRef="usd">14475000</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDgvZnJhZzo2YjI1NjU3MGQ2Y2M0ZTllYWY5MDBhYzk2ZTU2Yjg3My90YWJsZTo3Zjk5NTQzZGE4N2U0NjE4ODRlYWM3YzM5ZmI5NGZjOC90YWJsZXJhbmdlOjdmOTk1NDNkYTg3ZTQ2MTg4NGVhYzdjMzlmYjk0ZmM4XzMtNC0xLTEtMA_8bb35a11-8322-4653-9d23-89850182f0a5"
      unitRef="usd">25291000</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDgvZnJhZzo2YjI1NjU3MGQ2Y2M0ZTllYWY5MDBhYzk2ZTU2Yjg3My90YWJsZTo3Zjk5NTQzZGE4N2U0NjE4ODRlYWM3YzM5ZmI5NGZjOC90YWJsZXJhbmdlOjdmOTk1NDNkYTg3ZTQ2MTg4NGVhYzdjMzlmYjk0ZmM4XzQtMi0xLTEtMA_255d5dfc-b224-43a2-ba52-3d70ab9de0f0"
      unitRef="usd">70941000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMDgvZnJhZzo2YjI1NjU3MGQ2Y2M0ZTllYWY5MDBhYzk2ZTU2Yjg3My90YWJsZTo3Zjk5NTQzZGE4N2U0NjE4ODRlYWM3YzM5ZmI5NGZjOC90YWJsZXJhbmdlOjdmOTk1NDNkYTg3ZTQ2MTg4NGVhYzdjMzlmYjk0ZmM4XzQtNC0xLTEtMA_22d77e30-20ff-4998-a1dd-5e3f162c894c"
      unitRef="usd">85604000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzEzNjcz_9c67180f-e36c-4440-b99d-c36e394485f8">DEBT &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Credit Facility&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December&#160;9, 2021, we, along with IDEXX Distribution, Inc., IDEXX Operations, Inc., OPTI Medical Systems, Inc., IDEXX Laboratories Canada Corporation, IDEXX B.V., IDEXX Laboratories B.V., and IDEXX Laboratories GmbH, our wholly-owned subsidiaries (whether directly or indirectly held) (collectively, the &#x201c;Borrowers&#x201d;), entered into a fourth amended and restated credit agreement (the &#x201c;Credit Agreement&#x201d;) relating to a five year unsecured revolving credit facility in the principal amount of $1 billion, among the Borrowers, the lenders party thereto, JPMorgan Chase Bank, N.A., as administrative agent, JPMorgan Chase Bank, N.A., Toronto Branch, as Toronto agent, and the other parties thereto.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Credit Agreement amends and restates that certain third amended and restated credit agreement, dated as of April 14, 2020, (which provided for a $1&#160;billion three-year unsecured revolving credit facility) to extend the maturity to December 9, 2026 with aggregate commitments available for borrowing by the Borrowers of $1&#160;billion with the option to increase the aggregate commitments by $250&#160;million, for an aggregate maximum of up to $1.25&#160;billion, subject to the Borrowers obtaining commitments from existing or new lenders and satisfying other conditions specified in the Credit Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under our Credit Facility prior to the December&#160;9, 2021 amendment, the applicable interest rates on borrowings are based on the prevailing LIBOR, Canadian Dollar Rate, or EURIBOR, but not less than 1.0%, plus a credit spread ranging from 1.375% to 2.00%, based on our gross leverage ratio. The Credit Facility also allowed for borrowings based on the prevailing Prime rate, but not less than 2.00%, plus a credit spread from 0.375% to 1.00%. Under the Credit Facility, we also pay quarterly commitment fees ranging from 0.2% to 0.375%, based on our leverage ratio, on any unused commitment. Under our current amended Credit Facility, the applicable interest rates on borrowings are based on the prevailing LIBOR, Canadian Dollar Rate, or EURIBOR, but not less than 0.0%, plus a credit spread ranging from 0.875% to 1.375%, depending on our gross leverage ratio. The Credit Facility also allowed for borrowings based on the prevailing Prime rate, but not less than 1.00%, plus a credit spread from 0.0% to 0.375%. Under the current Credit Facility, we also pay quarterly commitment fees ranging from 0.075% to 0.25%, based on our leverage ratio, on any unused commitment. Our Credit Facility includes a provision for the determination of one or more benchmark replacement rates (including SOFR) as a successor to the LIBOR rate. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December 31, 2021, we had $73.5 million outstanding borrowings under our Credit Facility with a weighted average effective interest rate of 1.1%. Our weighted average borrowing rate for the year ended December 31, 2021, was 2.7%, which reflected borrowings under our prior Credit Facility. At December 31, 2020, we had&#160;no&#160;outstanding borrowings under our Credit Facility. The funds available under the Credit Facility reflect a further reduction due to the issuance of letters of credit, which were issued in connection with our workers&#x2019; compensation&#160;policy, for $1.4 million in the year ended December 31, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although the Credit Facility does not mature until December 9, 2026, all individual borrowings under the terms of the Credit Facility with an interest rate based on the prevailing LIBOR, Canadian Dollar Rate, or EURIBOR (as selected by the Borrower) have a stated term between 1 and 180 days. At the end of each term, the obligation is either repaid or rolled over into a new borrowing, or replaced by a borrowing based on a specific benchmark rate (where interest is then paid monthly). The Credit Facility contains a subjective material adverse event notification clause, which allows the debt holders to call the loans under the Credit Facility if we fail to provide prompt written notice to the syndicate of such an event. Based on the stated term and the existence of the subjective material adverse event clause, this Credit Facility is reflected in the current liabilities section of our consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The obligations under the Credit Facility may be accelerated upon the occurrence of an event of default under the Credit Facility, which includes customary events of default including payment defaults, defaults in the performance of the affirmative, negative and financial covenants, the inaccuracy of representations or warranties, bankruptcy and insolvency &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;related defaults, defaults relating to judgments, certain events related to employee pension benefit plans under the Employee Retirement Income Security Act of 1974, the failure to pay specified indebtedness, cross-acceleration to specified indebtedness, and a change of control default. The Credit Facility contains affirmative, negative, and financial covenants customary for financings of this type. The negative covenants include restrictions on liens, indebtedness of subsidiaries of the Company, fundamental changes, investments, transactions with affiliates, and certain restrictive agreements. The sole financial covenant is a consolidated leverage ratio test that requires our ratio of debt to earnings before interest, taxes, depreciation, amortization, and share-based compensation defined as the consolidated leverage ratio under the terms of the Credit Facility, not to exceed 3.5-to-1. At December 31, 2021, we were in compliance with the covenants of the Credit Facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Senior Notes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following describes all of our currently outstanding unsecured senior notes issued and sold in private placements (collectively, the "Senior Notes") as of December 31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.796%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.833%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.387%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.833%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.272%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.981%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.833%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.580%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.833%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(Principal Amount in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Issue Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Due Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Series&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Principal Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Coupon Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Senior Note Agreement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12/11/2013&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12/11/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023 Series A Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;NY Life 2013 Note Agreement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12/11/2013&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12/11/2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025 Series B Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;NY Life 2013 Note Agreement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9/4/2014&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9/4/2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;NY Life 2014 Note Agreement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7/21/2014&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7/21/2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024 Series B Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prudential 2015 Amended Agreement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6/18/2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6/18/2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025 Series C Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x20ac;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prudential 2015 Amended Agreement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2/12/2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2/12/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022 Series A Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;MetLife 2014 Note Agreement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2/12/2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2/12/2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2027 Series B Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;MetLife 2014 Note Agreement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3/14/2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3/14/2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2029 Series C Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;MetLife 2014 Note Agreement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4/2/2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4/2/2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;MetLife 2030 Series D Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;125,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;MetLife 2014 Note Agreement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4/14/2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4/14/2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prudential 2030 Series D Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prudential 2015 Amended Agreement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following narrative represents our Senior Note activity:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;NY Life 2013 and 2014 Note Agreements, Including Amendments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2013, we issued and sold through a private placement an aggregate principal amount of $150 million of unsecured senior notes consisting of $75 million of 3.94% Series A Senior Notes due December&#160;11, 2023 (the &#x201c;2023 Series A Notes&#x201d;) and $75 million of 4.04% Series B Senior Notes due December&#160;11, 2025 (the &#x201c;2025 Series B Notes&#x201d;) under a Note Purchase Agreement among the Company, New York Life Insurance Company and the accredited institutional purchasers named therein (as amended on April 10, 2020, the &#x201c;NY Life 2013 Note Agreement&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2014, we issued and sold through a private placement an aggregate principal amount of $75 million of unsecured 3.72% senior notes due September 4, 2026 (the &#x201c;2026 Senior Notes&#x201d;) under a Note Purchase Agreement dated as of July 22, 2014, among the Company, New York Life Insurance Company and the accredited institutional purchasers named therein (as amended April 10, 2020, the &#x201c;NY Life 2014 Note Agreement&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 10, 2020, we amended the NY Life 2013 Note Agreement and the NY Life 2014 Note Agreement by entering into two Amendments to Note Purchase Agreement with New York Life Insurance Company and the other parties thereto, which modified several defined terms, schedules and covenant baskets in the NY Life 2013 Agreement and the NY Life 2014 Note Agreement to create additional operating flexibility, and in particular to align such provisions with similar modifications we made substantially concurrently in our other debt facilities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Prudential 2015 Amended Agreement, Including Amendments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2014, we issued and sold through a private placement an aggregate principal amount of $125 million of unsecured senior notes consisting of $50 million of 3.32% Series A Senior Notes due July&#160;21, 2021 (the &#x201c;2021 Series A Notes&#x201d;) and $75 million of 3.76% Series B Senior Notes due July&#160;21, 2024 (the &#x201c;2024 Series B Notes&#x201d;) under a Note Purchase and Private Shelf Agreement among the Company, Prudential Investment Management, Inc. (&#x201c;Prudential&#x201d;) and the accredited &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;institutional purchasers named therein (the &#x201c;Prudential 2014 Note Agreement&#x201d;). The $50&#160;million 3.32% Series A Senior Note was repaid in full on the July 21, 2021 due date.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2015, we entered into an Amended and Restated Multi-Currency Note Purchase and Private Shelf Agreement (the &#x201c;Original Prudential 2015 Amended Agreement"), among the Company, Prudential, and the accredited institutional purchasers named therein, which amends and restates the Prudential 2014 Note Agreement. Pursuant to the Original Prudential 2015 Amended Agreement, we issued and sold through an aggregated private placement an aggregate principal amount of &#x20ac;88.9 million of unsecured 1.785%&#160;Series&#160;C Senior Notes due June&#160;18, 2025 (the &#x201c;2025 Series C Notes&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 9, 2019, we entered into the Amendment to Note Purchase and Private Shelf Agreement (the "Prudential First Amendment") with Prudential and the other parties thereto, which amended certain reporting provisions in the Original Prudential 2015 Amended Agreement. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 10, 2020, we entered into the Second Amendment to the Prudential 2015 Amended Agreement (the &#x201c;Prudential Second Amendment&#x201d;), in order to (i) increase the facility size to $425&#160;million, (ii) extend the facility issuance period to April 10, 2023, (iii) make various implementing and administrative changes in order to facilitate a $75&#160;million notes issuance on April 14, 2020, (iv) allow the amount available to be issued under the facility to equal $425&#160;million less the amount of notes outstanding from time to time during the issuance period and (v)&#160;modify several defined terms, schedules and covenant baskets in the Original Prudential 2015 Amended Agreement, as amended by the Prudential First Amendment, to create additional operating flexibility, and in particular to align such provisions with similar modifications we made substantially concurrently in our other debt facilities. We refer to the Original Prudential 2015 Agreement, as amended by the Prudential First Amendment and the Prudential Second Amendment, as the "Prudential 2015 Amended Agreement."&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 14, 2020, we issued and sold to Prudential and other purchasers $75&#160;million of our unsecured senior notes (the &#x201c;Prudential 2030 Series D Notes&#x201d;) pursuant to the Prudential Second Amendment. The entire outstanding balance of the Prudential 2030 Series D Notes is due and payable on April 14, 2030, and the Prudential 2030 Series D Notes bear interest at the rate of 2.50% per annum. We used the proceeds received from the Prudential 2030 Series D Notes for general corporate purposes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;MetLife 2014 Note Agreement, Including Amendments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We entered into a Multicurrency Note Purchase and Private Shelf Agreement, dated as of December 19, 2014 (the "Original MetLife 2014 Note Agreement"), among the Company, Metropolitan Life Insurance Company (&#x201c;MetLife&#x201d;) and the accredited institutional purchasers named therein pursuant to which we agreed to issue and sell an aggregate principal amount of $150 million of unsecured senior notes consisting of $75 million of our 3.25% Series A Senior Notes having a seven-year term (the "2022 Series A Notes"), and $75 million of our 3.72% Series B Senior Notes having a twelve-year term ("2027 Series B Notes"). The issuance, sale and purchase of these&#160;notes occurred in February 2015. The aggregate principal amount of our 2022 Series A Notes for $75.0&#160;million will become due and payable on February 12, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 14, 2019, we amended the Original MetLife 2014 Note Agreement. Pursuant to the Original MetLife 2014 Note Agreement, as so amended, we issued and sold through a private placement an aggregate principal amount of $100 million of unsecured senior notes at a 4.19% per annum rate, due March 14, 2029 (the "2029 Series C Notes").&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 23, 2020, we entered into the Second Amendment to the Original MetLife 2014 Note Agreement (the &#x201c;MetLife Second Amendment&#x201d;), in order to (i) increase the facility size from $150&#160;million to $300&#160;million, (ii) extend the facility issuance period to December 20, 2022, (iii) make various implementing and administrative changes in order to facilitate a $125&#160;million notes issuance on April 2, 2020 and (iv) allow the amount available to be issued under the facility to equal $300&#160;million, less the amounts outstanding on 2029 Series C Notes and MetLife 2030 Series D Notes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 2, 2020, we issued and sold to MetLife and other purchasers $125&#160;million of our unsecured senior notes (the &#x201c;MetLife 2030 Series D Notes&#x201d;) pursuant to the MetLife Second Amendment. The entire outstanding principal balance of the MetLife 2030 Series D Notes is due and payable on April 2, 2030, and the MetLife 2030 Series D Notes bear interest at the rate of 2.50% per annum. We used the proceeds received from the MetLife 2030 Series D Notes for general corporate purposes. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We refer to the Original MetLife 2014 Agreement, as so amended, as the "MetLife 2014 Agreement," and together with the NY Life 2013 Note Agreement, NY Life 2014 Note Agreement, and Prudential 2015 Amended Note Agreement, collectively, as the "Senior Note Agreements."&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Senior Note Agreements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Senior Note Agreements contain affirmative, negative, and financial covenants customary for agreements of this type. The negative covenants include restrictions on liens, indebtedness of our subsidiaries, priority indebtedness, fundamental changes, investments, transactions with affiliates, certain restrictive agreements, and violations of laws and regulations. The sole financial covenant is a consolidated leverage ratio test that requires our ratio of debt to earnings before interest, taxes, depreciation, amortization, and share-based compensation, as defined in the Senior Note Agreements, not to exceed 3.5-to-1. At December 31, 2021, we were in compliance with the covenants of the Senior Note Agreements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Should we elect to prepay the Senior Notes, such aggregate prepayment will include the applicable make-whole amount(s), as defined within the applicable Senior Note Agreements. Additionally, in the event of a change in control of the Company or upon the disposition of certain assets of the Company the proceeds of which are not reinvested (as defined in the Senior Note Agreements), we may be required to prepay all or a portion of the Senior Notes. The obligations under the Senior Notes may be accelerated upon the occurrence of an event of default under the applicable Senior Note Agreement, each of which includes customary events of default including payment defaults, defaults in the performance of the affirmative, negative and financial covenants, the inaccuracy of representations or warranties, bankruptcy and insolvency related defaults, defaults relating to judgments, certain events related to employee pension benefit plans under the Employee Retirement Income Security Act of 1974, the failure to pay specified indebtedness and cross-acceleration to specified indebtedness. We used the net proceeds from the issuances and sale of the Senior Notes for general corporate purposes. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Annual principal payments on long-term debt at December 31, 2021, are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.773%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Years Ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;175,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;375,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;850,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total interest paid on all debt (including our Credit Facility) for the years ended December 31, 2021, 2020, and 2019, was $30.5 million, $32.4 million, and $29.7 million, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtInstrumentTerm
      contextRef="i3d67cbfaa5224fec8d1c48c0eb22dc85_D20211209-20211209"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzQzOTgwNDY1NTI3MjM_eeeb100a-ff79-46bc-812f-4dc56fff9da6">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ie379750e8a014b58b9ca70bcde9817d8_I20211209"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzI3NDg3NzkxMTA5ODE_4c68eefe-3789-4325-8515-29e9117ccdb9"
      unitRef="usd">1000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i88842c37e6494006b237d52fce7c5c33_I20200414"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzg1Ng_b077570f-14bb-4b6f-acbc-48246c22a46d"
      unitRef="usd">1000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="i7027aef0a2c5405c8952b0b711093dd4_D20200414-20200414"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzQzOTgwNDY1MjcxOTI_0a92cfbf-02de-44a7-b9e4-a0b18971f08c">P3Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i88842c37e6494006b237d52fce7c5c33_I20200414"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzEwMzE_8a5eb8b4-3e69-41b9-a695-a77f72cb2e63"
      unitRef="usd">1000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <idxx:LineofCreditFacilityAccordionFeatureIncreaseLimit
      contextRef="i88842c37e6494006b237d52fce7c5c33_I20200414"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzEwOTE_e15aef0d-79be-4b4c-bc32-763c477a6cf3"
      unitRef="usd">250000000</idxx:LineofCreditFacilityAccordionFeatureIncreaseLimit>
    <idxx:LineofCreditFacilityAccordionFeatureHigherBorrowingCapacityOption
      contextRef="i88842c37e6494006b237d52fce7c5c33_I20200414"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzExMjk_7597d925-ac33-4cb8-8da3-b7efbddde604"
      unitRef="usd">1250000000</idxx:LineofCreditFacilityAccordionFeatureHigherBorrowingCapacityOption>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4c25f29396c647aa8d6098ef0911bfef_I20200414"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzY1OTcwNjk4MDcxMjY_9f43d5c1-19d9-4b01-a01a-8b0949028409"
      unitRef="number">0.010</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i5cc431806cd042369dfc78d28f3b1659_D20200414-20200414"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzY1OTcwNjk4MDcxMzI_15720a9b-56f2-46c0-b3b7-97a791ff7e3a"
      unitRef="number">0.01375</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="if38e3d02f10c4f32b074213b34fef777_D20200414-20200414"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzY1OTcwNjk4MDcxNDA_e6f59e93-eb5a-48dc-bf05-7b574341b225"
      unitRef="number">0.0200</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i1da5c94143f545488db1a5e8851e0d7b_I20200414"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzY1OTcwNjk4MDcxNDc_72e325e7-7ee3-49af-bfb1-b10b03eb89ab"
      unitRef="number">0.0200</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i2743639b7f854d2faacd705017e8a980_D20200414-20200414"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzY1OTcwNjk4MDcxNTQ_43b56fce-011b-4406-b3d6-963133523728"
      unitRef="number">0.00375</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="idc1466922ecb4c6d968b86b7b8b94009_D20200414-20200414"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzY1OTcwNjk4MDcxNjM_c4dd1a78-1043-4ca0-81bf-aeb75d408c49"
      unitRef="number">0.0100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="icb88319a299b42b499f9dd03bbc3c710_D20200414-20200414"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzY1OTcwNjk4MDcxNzA_22811e59-82c0-44da-8152-f527c4f297ce"
      unitRef="number">0.002</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="id297fa8846f44eef8316d35feb8ee7fc_D20200414-20200414"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzY1OTcwNjk4MDcxNzY_8a5c9429-1c69-4a20-9f8f-0caf6ff84866"
      unitRef="number">0.00375</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i77d25639b7e24f3b863f76aff1a3baf2_I20211209"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzY1OTcwNjk4MDcxODQ_4ff3e872-f5e5-4daa-893a-acded9492168"
      unitRef="number">0.000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i7c3da4e4c9c14ee59aa58eb74d6eaf8c_D20211209-20211209"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzY1OTcwNjk4MDcxOTE_b375866b-95bc-4152-a216-f2dd3370275f"
      unitRef="number">0.00875</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i90bd3d6a0a4241c0aea364074afe7a3d_D20211209-20211209"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzY1OTcwNjk4MDcxOTk_29756013-221c-48f8-954e-52619b25f89c"
      unitRef="number">0.01375</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9320b95542d34067bb078b7df10a68d7_I20211209"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzY1OTcwNjk4MDcyMDc_38f21725-a891-487e-9808-e19b002fb45e"
      unitRef="number">0.0100</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ibc7eca7b08f24e31ad1cdc3bac81938f_D20211209-20211209"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzY1OTcwNjk4MDcyMTQ_abe2396d-3428-46ab-8534-257954f67ac9"
      unitRef="number">0.000</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ib9a066585bb047ed81604bdfa2257801_D20211209-20211209"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzY1OTcwNjk4MDcyMjE_d5dbf1f5-b177-4965-a875-f95ac8fb7e58"
      unitRef="number">0.00375</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="ib1a6a37dfa0846f0a5ce8ea8202bfac9_D20211209-20211209"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzY1OTcwNjk4MDcyMjk_0ff8da99-1a6e-4bce-bd30-c379e26a91eb"
      unitRef="number">0.00075</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="icfa56c2f5e4b4609b398b0b8b4950963_D20211209-20211209"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzY1OTcwNjk4MDcyMzc_eb47b5f4-0d2e-42f7-b67e-a8d1f572f88c"
      unitRef="number">0.0025</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <us-gaap:LinesOfCreditCurrent
      contextRef="i82a6155f7ccc4f55b9a6fe7e36a127df_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzI3NDg3NzkxMDQzOTI_897687f1-0bb4-4293-8826-183493dbf312"
      unitRef="usd">73500000</us-gaap:LinesOfCreditCurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i82a6155f7ccc4f55b9a6fe7e36a127df_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzI3NDg3NzkxMDQ0OTY_ec2f1ce9-4d1b-4c4c-accb-bc030411ffcc"
      unitRef="number">0.011</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtWeightedAverageInterestRate
      contextRef="i82a6155f7ccc4f55b9a6fe7e36a127df_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzY1OTcwNjk4MDcyNDU_f3cceb5a-3b5c-4d9d-9573-0dccc51679c2"
      unitRef="number">0.027</us-gaap:DebtWeightedAverageInterestRate>
    <us-gaap:LinesOfCreditCurrent
      contextRef="iae060c362bae4cb5b9a839012e39422e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzI3NDg3NzkxMDQ2NjA_a497e487-6ccd-458e-ac86-d86f051d674b"
      unitRef="usd">0</us-gaap:LinesOfCreditCurrent>
    <us-gaap:LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases
      contextRef="i82a6155f7ccc4f55b9a6fe7e36a127df_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzI3NDg3NzkxMDQ5MDU_6bb4e359-6705-4bf4-ae56-061d862baede"
      unitRef="usd">1400000</us-gaap:LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases>
    <us-gaap:LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases
      contextRef="iae060c362bae4cb5b9a839012e39422e_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzI3NDg3NzkxMDQ5MDU_88a8323f-9ed6-48bd-9f18-c3bcaf36b2e2"
      unitRef="usd">1400000</us-gaap:LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases>
    <us-gaap:DebtInstrumentTerm
      contextRef="i9c8cf4c740be48fd83d344c66d438cd7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzE1NDE_43ef5d0a-79d3-40d6-b63c-805fdbc5e0fd">P1D</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm
      contextRef="i0707fa55e90849738007f16cfef51f10_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzE1NDg_2a7492eb-a3fa-4d23-96cc-c7052243d277">P180D</us-gaap:DebtInstrumentTerm>
    <idxx:ConsolidatedLeverageRatioUnderCreditFacilityNotePayable
      contextRef="i99c7fc5496044f18a226eb36d6d3f865_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzQ0Mzg_f032b6a0-5306-40e5-a997-76f1b2d4a925"
      unitRef="number">0.035</idxx:ConsolidatedLeverageRatioUnderCreditFacilityNotePayable>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzEzNjc0_24d33cef-4f21-47e5-a530-ae89f2ad7b99">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following describes all of our currently outstanding unsecured senior notes issued and sold in private placements (collectively, the "Senior Notes") as of December 31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.796%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.833%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.387%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.833%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.272%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.981%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.833%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.580%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.833%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(Principal Amount in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Issue Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Due Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Series&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Principal Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Coupon Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Senior Note Agreement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12/11/2013&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12/11/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023 Series A Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;NY Life 2013 Note Agreement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12/11/2013&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12/11/2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025 Series B Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;NY Life 2013 Note Agreement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9/4/2014&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9/4/2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;NY Life 2014 Note Agreement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7/21/2014&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7/21/2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024 Series B Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prudential 2015 Amended Agreement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6/18/2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6/18/2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025 Series C Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x20ac;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prudential 2015 Amended Agreement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2/12/2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2/12/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022 Series A Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;MetLife 2014 Note Agreement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2/12/2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2/12/2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2027 Series B Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;MetLife 2014 Note Agreement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3/14/2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3/14/2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2029 Series C Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;MetLife 2014 Note Agreement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4/2/2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4/2/2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;MetLife 2030 Series D Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;125,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;MetLife 2014 Note Agreement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4/14/2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4/14/2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prudential 2030 Series D Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prudential 2015 Amended Agreement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i291ef135622f4a9baf284e7cfaad88c9_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90YWJsZTplMDI3OTM0NTBhNDY0ZjYyOWVjMmY2YzYyZjgyMTAxMS90YWJsZXJhbmdlOmUwMjc5MzQ1MGE0NjRmNjI5ZWMyZjZjNjJmODIxMDExXzQtNi0xLTEtMA_4e3b74d0-b3d7-46b4-9e50-9648ce32b07f"
      unitRef="usd">75000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i291ef135622f4a9baf284e7cfaad88c9_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90YWJsZTplMDI3OTM0NTBhNDY0ZjYyOWVjMmY2YzYyZjgyMTAxMS90YWJsZXJhbmdlOmUwMjc5MzQ1MGE0NjRmNjI5ZWMyZjZjNjJmODIxMDExXzQtOC0xLTEtMA_2055c4dd-e03c-4dd6-96b6-5fd398ba0c73"
      unitRef="number">0.0394</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i870fa3036a764a809f0d8c67c310cf72_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90YWJsZTplMDI3OTM0NTBhNDY0ZjYyOWVjMmY2YzYyZjgyMTAxMS90YWJsZXJhbmdlOmUwMjc5MzQ1MGE0NjRmNjI5ZWMyZjZjNjJmODIxMDExXzUtNi0xLTEtMA_f634cfe4-a36d-4898-952f-a822d3dd5efb"
      unitRef="usd">75000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i870fa3036a764a809f0d8c67c310cf72_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90YWJsZTplMDI3OTM0NTBhNDY0ZjYyOWVjMmY2YzYyZjgyMTAxMS90YWJsZXJhbmdlOmUwMjc5MzQ1MGE0NjRmNjI5ZWMyZjZjNjJmODIxMDExXzUtOC0xLTEtMA_a9c715df-0b9c-40e3-8237-40da30935f33"
      unitRef="number">0.0404</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i3dd02565f2614274847ab1493dffefe3_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90YWJsZTplMDI3OTM0NTBhNDY0ZjYyOWVjMmY2YzYyZjgyMTAxMS90YWJsZXJhbmdlOmUwMjc5MzQ1MGE0NjRmNjI5ZWMyZjZjNjJmODIxMDExXzYtNi0xLTEtMA_442f2248-a94b-4dc4-8b0e-37693549dcd3"
      unitRef="usd">75000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3dd02565f2614274847ab1493dffefe3_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90YWJsZTplMDI3OTM0NTBhNDY0ZjYyOWVjMmY2YzYyZjgyMTAxMS90YWJsZXJhbmdlOmUwMjc5MzQ1MGE0NjRmNjI5ZWMyZjZjNjJmODIxMDExXzYtOC0xLTEtMA_de2d09b3-4c07-4811-b9f9-b6b938d34a99"
      unitRef="number">0.0372</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i0978c28bf335475c882b17687ef6c41d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90YWJsZTplMDI3OTM0NTBhNDY0ZjYyOWVjMmY2YzYyZjgyMTAxMS90YWJsZXJhbmdlOmUwMjc5MzQ1MGE0NjRmNjI5ZWMyZjZjNjJmODIxMDExXzgtNi0xLTEtMA_5cf31689-ff09-44b7-94dd-65b3e49b2b64"
      unitRef="usd">75000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0978c28bf335475c882b17687ef6c41d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90YWJsZTplMDI3OTM0NTBhNDY0ZjYyOWVjMmY2YzYyZjgyMTAxMS90YWJsZXJhbmdlOmUwMjc5MzQ1MGE0NjRmNjI5ZWMyZjZjNjJmODIxMDExXzgtOC0xLTEtMA_c426f887-e22a-46d6-9077-58bcef027b9f"
      unitRef="number">0.0376</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i9b730ee02fe84774a4802313f2dbde61_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90YWJsZTplMDI3OTM0NTBhNDY0ZjYyOWVjMmY2YzYyZjgyMTAxMS90YWJsZXJhbmdlOmUwMjc5MzQ1MGE0NjRmNjI5ZWMyZjZjNjJmODIxMDExXzktNi0xLTEtMA_48e3abbf-f25a-4cdf-8fad-e1bd0d56a58b"
      unitRef="eur">88857000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9b730ee02fe84774a4802313f2dbde61_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90YWJsZTplMDI3OTM0NTBhNDY0ZjYyOWVjMmY2YzYyZjgyMTAxMS90YWJsZXJhbmdlOmUwMjc5MzQ1MGE0NjRmNjI5ZWMyZjZjNjJmODIxMDExXzktOC0xLTEtMA_93e6ef6b-262e-4922-a69b-4b2aa05245a1"
      unitRef="number">0.01785</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="iea3b4083103c42cb8b20a1a66e2e0b7e_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90YWJsZTplMDI3OTM0NTBhNDY0ZjYyOWVjMmY2YzYyZjgyMTAxMS90YWJsZXJhbmdlOmUwMjc5MzQ1MGE0NjRmNjI5ZWMyZjZjNjJmODIxMDExXzEwLTYtMS0xLTA_bfdd5f2d-b5ad-4d6c-9f4e-b20077ee9285"
      unitRef="usd">75000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iea3b4083103c42cb8b20a1a66e2e0b7e_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90YWJsZTplMDI3OTM0NTBhNDY0ZjYyOWVjMmY2YzYyZjgyMTAxMS90YWJsZXJhbmdlOmUwMjc5MzQ1MGE0NjRmNjI5ZWMyZjZjNjJmODIxMDExXzEwLTgtMS0xLTA_7dabc754-f1db-4e89-b371-9ca3c3c70d16"
      unitRef="number">0.0325</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="id7ee5545c45b452ba5b532018c57c675_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90YWJsZTplMDI3OTM0NTBhNDY0ZjYyOWVjMmY2YzYyZjgyMTAxMS90YWJsZXJhbmdlOmUwMjc5MzQ1MGE0NjRmNjI5ZWMyZjZjNjJmODIxMDExXzExLTYtMS0xLTA_7da5434f-7247-41df-b8b2-1bb016ca3c22"
      unitRef="usd">75000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id7ee5545c45b452ba5b532018c57c675_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90YWJsZTplMDI3OTM0NTBhNDY0ZjYyOWVjMmY2YzYyZjgyMTAxMS90YWJsZXJhbmdlOmUwMjc5MzQ1MGE0NjRmNjI5ZWMyZjZjNjJmODIxMDExXzExLTgtMS0xLTA_759e420d-3741-4776-9809-aeeae0310148"
      unitRef="number">0.0372</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i71fe397c3c014eb0902555a2b916dc0b_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90YWJsZTplMDI3OTM0NTBhNDY0ZjYyOWVjMmY2YzYyZjgyMTAxMS90YWJsZXJhbmdlOmUwMjc5MzQ1MGE0NjRmNjI5ZWMyZjZjNjJmODIxMDExXzEyLTYtMS0xLTA_3e954e36-933b-44c7-89e5-99cb675ecc5b"
      unitRef="usd">100000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i71fe397c3c014eb0902555a2b916dc0b_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90YWJsZTplMDI3OTM0NTBhNDY0ZjYyOWVjMmY2YzYyZjgyMTAxMS90YWJsZXJhbmdlOmUwMjc5MzQ1MGE0NjRmNjI5ZWMyZjZjNjJmODIxMDExXzEyLTgtMS0xLTA_15b44fe6-dadc-4845-89cd-4d091f284b2a"
      unitRef="number">0.0419</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i19e6230043be4bc494d45facd3995c64_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90YWJsZTplMDI3OTM0NTBhNDY0ZjYyOWVjMmY2YzYyZjgyMTAxMS90YWJsZXJhbmdlOmUwMjc5MzQ1MGE0NjRmNjI5ZWMyZjZjNjJmODIxMDExXzEzLTYtMS0xLTA_5b2ca874-619e-4756-ab50-bd35c516addc"
      unitRef="usd">125000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i19e6230043be4bc494d45facd3995c64_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90YWJsZTplMDI3OTM0NTBhNDY0ZjYyOWVjMmY2YzYyZjgyMTAxMS90YWJsZXJhbmdlOmUwMjc5MzQ1MGE0NjRmNjI5ZWMyZjZjNjJmODIxMDExXzEzLTgtMS0xLTA_469d0da4-c318-454d-96a2-584588005bf5"
      unitRef="number">0.0250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i5dc25052aa62435dbe48e2738f88c2ff_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90YWJsZTplMDI3OTM0NTBhNDY0ZjYyOWVjMmY2YzYyZjgyMTAxMS90YWJsZXJhbmdlOmUwMjc5MzQ1MGE0NjRmNjI5ZWMyZjZjNjJmODIxMDExXzE0LTYtMS0xLTA_f2c4e402-9dd9-453f-831e-cfbb92e1536a"
      unitRef="usd">75000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5dc25052aa62435dbe48e2738f88c2ff_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90YWJsZTplMDI3OTM0NTBhNDY0ZjYyOWVjMmY2YzYyZjgyMTAxMS90YWJsZXJhbmdlOmUwMjc5MzQ1MGE0NjRmNjI5ZWMyZjZjNjJmODIxMDExXzE0LTgtMS0xLTA_83eacedd-c8ff-4b39-91cd-9ff5f69d28ce"
      unitRef="number">0.0250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i2d9352de44824a5bb1085c5d21e9f1f4_I20131231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzQ5MTc_54714351-5290-4043-97ec-432155497723"
      unitRef="usd">150000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ib0a1cfdb16bd4fe5831d9ba3c46d91ef_I20131231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzQ5NjA_f0c3e5eb-6991-4929-a988-4d98d6e74d04"
      unitRef="usd">75000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib0a1cfdb16bd4fe5831d9ba3c46d91ef_I20131231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzQ5NjY_f60f8954-171b-47fd-b8f8-a6348c052718"
      unitRef="number">0.0394</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i1acbae80f997433a88234dd2778c498b_I20131231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzUwNDU_39dbe970-33eb-4cc9-9fbf-f9836f5010df"
      unitRef="usd">75000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i1acbae80f997433a88234dd2778c498b_I20131231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzUwNTE_653c3c0c-adcb-46f9-9694-c0e9d6db3ef1"
      unitRef="number">0.0404</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i9268fbd98f1642a29877996cd39b28a8_I20140930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzU0MzU_b2920275-7578-4d03-b420-06f81f319532"
      unitRef="usd">75000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9268fbd98f1642a29877996cd39b28a8_I20140930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzU0NTE_d4de045c-ecee-498d-a850-3d7fd5192dc3"
      unitRef="number">0.0372</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i85b9b901dae14f1f8f19b213cedc6d10_I20140731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzY0NDI_835e465a-b50b-456e-b36b-a5554b43425a"
      unitRef="usd">125000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i728c0393124f4d3aa9ce9f98a65c1909_I20140731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzY0ODU_6cbf77dc-803b-4bb8-86e1-29e246e5377a"
      unitRef="usd">50000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i728c0393124f4d3aa9ce9f98a65c1909_I20140731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzY0OTE_28c1eea4-a1ce-43e0-94bd-7e5c40ce2204"
      unitRef="number">0.0332</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i6b9efa5452f740aca86e464a7d20a380_I20140731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzY1NjY_613bcbaf-11df-48c6-b6a0-f43c7a00dc0d"
      unitRef="usd">75000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6b9efa5452f740aca86e464a7d20a380_I20140731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzY1NzI_a535c88f-a905-4546-9959-1767fd501854"
      unitRef="number">0.0376</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="ie9096849c1ac4387b32b1369124e6e10_D20210721-20210721"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzY1OTcwNjk4MDcyNTE_95744b78-6e70-4735-8ef3-997c70067e05"
      unitRef="usd">50000000</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i728c0393124f4d3aa9ce9f98a65c1909_I20140731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzY1OTcwNjk4MDcyNjQ_62070bf6-88de-4f1f-9d7e-c47d10d6d4f8"
      unitRef="number">0.0332</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i6fd942875b8149d6801ca7948aa50eb9_I20150630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzczMzM_ee328302-5d15-4b36-96a8-32c1558d557b"
      unitRef="eur">88900000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6fd942875b8149d6801ca7948aa50eb9_I20150630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzczNDk_eea7333d-c3fa-4adb-ba7e-7d9abbeb9964"
      unitRef="number">0.01785</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i2c27f682ff974979b7a9c14a0852f4b1_I20200410"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzc4NzQ_eb80b803-ccc5-46e6-88a3-f13513dbfff8"
      unitRef="usd">425000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ia4f21d4f936e451bb937db30e6e6c516_I20200414"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzgwMjI_8f5e6bd2-ae89-4728-bc7c-4bf3c3002f72"
      unitRef="usd">75000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i2c27f682ff974979b7a9c14a0852f4b1_I20200410"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzgxMzI_0f1767c2-60e3-47e1-95a8-d398ea8a18e5"
      unitRef="usd">425000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ia4f21d4f936e451bb937db30e6e6c516_I20200414"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzg4MTY_28650b2b-0d2e-4f47-8f1f-3c1b5609c61e"
      unitRef="usd">75000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia4f21d4f936e451bb937db30e6e6c516_I20200414"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzkxMDg_7bfeeca8-3c72-41de-bfdc-4d0f08b28d45"
      unitRef="number">0.0250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ia7f558575c4f45f3b51e71f291325f3a_I20141219"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzk2MzM_9a7e1b43-2542-4387-88aa-baa1d8dc07d9"
      unitRef="usd">150000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ia1b615997c6845d992165c221d916601_I20141219"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzk2NzY_d488b7f0-47c3-41fa-8892-a870abd77169"
      unitRef="usd">75000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia1b615997c6845d992165c221d916601_I20141219"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzk2ODY_b7682b89-9bab-4788-a6cc-a4700899cb22"
      unitRef="number">0.0325</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentTerm
      contextRef="i5c06758cf49c487989c8d74d5a4fe45a_D20141219-20141219"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzQzOTgwNDY1MjcxOTM_449e97ad-ab00-4107-94b2-73cec69f71e6">P7Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i693b06087db042f486f6b01601900261_I20141219"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzk3NjY_bb6331c3-163b-475a-a79d-7351a2f41beb"
      unitRef="usd">75000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i693b06087db042f486f6b01601900261_I20141219"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzk3NzY_c2c56abc-add2-45c9-a0db-7f99db4ce2bd"
      unitRef="number">0.0372</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentTerm
      contextRef="iea5f10448a374b6f90d116e53e14ac51_D20141219-20141219"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzQzOTgwNDY1MjcxOTQ_d0124635-8836-4edb-9327-a9b9d8d34eea">P12Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i78dd1a8fbcfa4a6d8b5587990a0d4b8b_I20211209"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzI3NDg3NzkwOTQ0NDc_3c8cf305-efb6-417d-be10-bb5a240445e7"
      unitRef="usd">75000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i69f00534ab5c47f6bb7e698a1e5b33f2_I20190314"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzEwMTQ1_5f1508d6-985f-4500-940a-570e994d79ae"
      unitRef="usd">100000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i69f00534ab5c47f6bb7e698a1e5b33f2_I20190314"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzEwMTc5_db808952-01bc-4f18-8bad-748f05621232"
      unitRef="number">0.0419</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i8e2ecd2fe69f46929ab4f66300904bb0_I20200322"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzEwNDMx_b3ca29ff-582c-4722-9eed-cb2bcdac13f2"
      unitRef="usd">150000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i94bcd6d66d644d71ba9e5e425c3343f9_I20200323"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzEwNDM3_bea32b16-1502-46ed-997b-0448553c498f"
      unitRef="usd">300000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i82a0a4b3853c4d43b57df66540d93b3a_I20200402"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzEwNTg4_d92876e5-0ad5-4ecf-8927-2c6f202338be"
      unitRef="usd">125000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i94bcd6d66d644d71ba9e5e425c3343f9_I20200323"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzEwNzAw_841fe419-e147-43bf-a638-6582c7d52da8"
      unitRef="usd">300000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i82a0a4b3853c4d43b57df66540d93b3a_I20200402"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzEwODYx_259c9a82-bfce-4256-adc9-3a498c449f69"
      unitRef="usd">125000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i82a0a4b3853c4d43b57df66540d93b3a_I20200402"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzExMTUw_f880a169-8555-4737-9edf-aa55ce6e9415"
      unitRef="number">0.0250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <idxx:ConsolidatedLeverageRatioUnderCreditFacilityNotePayable
      contextRef="ie9b830d7b3a74e4f9431f662334d4e77_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzEyMTc2_dfdb22d5-6100-4217-ae65-eca09101bfe0"
      unitRef="number">0.035</idxx:ConsolidatedLeverageRatioUnderCreditFacilityNotePayable>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzEzNjY5_e967ae23-128a-442f-b9df-2c244be03e78">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Annual principal payments on long-term debt at December 31, 2021, are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.773%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Years Ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;175,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;375,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;850,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90YWJsZTo2ODliY2QwYzk3Nzc0MGY2OTE3NWJkNDYyNmMwNzA0MC90YWJsZXJhbmdlOjY4OWJjZDBjOTc3NzQwZjY5MTc1YmQ0NjI2YzA3MDQwXzMtMi0xLTEtMA_ba4aaf28-e0ab-4076-bf0e-0b1aab66e81b"
      unitRef="usd">75000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90YWJsZTo2ODliY2QwYzk3Nzc0MGY2OTE3NWJkNDYyNmMwNzA0MC90YWJsZXJhbmdlOjY4OWJjZDBjOTc3NzQwZjY5MTc1YmQ0NjI2YzA3MDQwXzQtMi0xLTEtMA_750f8663-a4f9-4215-90d2-0d46f5c168b5"
      unitRef="usd">75000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90YWJsZTo2ODliY2QwYzk3Nzc0MGY2OTE3NWJkNDYyNmMwNzA0MC90YWJsZXJhbmdlOjY4OWJjZDBjOTc3NzQwZjY5MTc1YmQ0NjI2YzA3MDQwXzUtMi0xLTEtMA_3c167701-3072-47d7-b103-a838163d113e"
      unitRef="usd">75000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90YWJsZTo2ODliY2QwYzk3Nzc0MGY2OTE3NWJkNDYyNmMwNzA0MC90YWJsZXJhbmdlOjY4OWJjZDBjOTc3NzQwZjY5MTc1YmQ0NjI2YzA3MDQwXzYtMi0xLTEtMA_df7af7c8-ac50-4493-8537-0d2e01abbd43"
      unitRef="usd">175711000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90YWJsZTo2ODliY2QwYzk3Nzc0MGY2OTE3NWJkNDYyNmMwNzA0MC90YWJsZXJhbmdlOjY4OWJjZDBjOTc3NzQwZjY5MTc1YmQ0NjI2YzA3MDQwXzctMi0xLTEtMA_b3f7d765-f115-4be9-b87a-33e8cd6119b8"
      unitRef="usd">75000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90YWJsZTo2ODliY2QwYzk3Nzc0MGY2OTE3NWJkNDYyNmMwNzA0MC90YWJsZXJhbmdlOjY4OWJjZDBjOTc3NzQwZjY5MTc1YmQ0NjI2YzA3MDQwXzgtMi0xLTEtMA_f4e4150d-e10f-4afe-b06b-7b087ff13ff4"
      unitRef="usd">375000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:LongTermDebt
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90YWJsZTo2ODliY2QwYzk3Nzc0MGY2OTE3NWJkNDYyNmMwNzA0MC90YWJsZXJhbmdlOjY4OWJjZDBjOTc3NzQwZjY5MTc1YmQ0NjI2YzA3MDQwXzktMi0xLTEtMA_01ebb413-5871-46cf-aad7-a1ccc411ff36"
      unitRef="usd">850711000</us-gaap:LongTermDebt>
    <us-gaap:InterestPaidNet
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzEzNjQw_3906c4ad-dcdf-4a75-afef-8a878c96db42"
      unitRef="usd">30500000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzEzNjQ0_48457be5-319a-4915-8b29-44ae61d3000e"
      unitRef="usd">32400000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTQvZnJhZzo3ZTA1ZWJhYjE4OWQ0YTAwOTMyMTRkYmM2YWU1NTExZC90ZXh0cmVnaW9uOjdlMDVlYmFiMTg5ZDRhMDA5MzIxNGRiYzZhZTU1MTFkXzEzNjUy_b19829d9-9ab3-4caa-92ef-15e4bfd8b916"
      unitRef="usd">29700000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90ZXh0cmVnaW9uOjk2Y2VlMWJjZmEwNDRkMTc5MDEwMDVkMTk1MTExYmFjXzY1OTU_8e28ab85-41a1-4153-ab71-d0e6ac649536">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;INCOME TAXES&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision for income taxes is determined using the asset and liability approach of accounting for income taxes. Under this approach, deferred taxes represent the estimated future tax effects of temporary differences between book and tax treatment of assets and liabilities and carryforwards to the extent they are realizable. We record a valuation allowance to reduce our deferred tax assets to the amount that is more likely than not to be realized. In assessing the need for a valuation allowance, we consider future taxable income and ongoing prudent and feasible tax planning strategies. In the event that we determine that we would be able to realize our deferred tax assets in the future in excess of the net recorded amount, a reduction of the valuation allowance would increase income in the period such determination was made. Likewise, should we determine that we would not be able to realize all or part of our net deferred tax asset in the future, a reduction to the deferred tax asset would be charged to income in the period such determination was made.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record a liability for uncertain tax positions that do not meet the more likely than not standard as prescribed by the authoritative guidance for income tax accounting. We record tax benefits for only those positions that we believe will more likely than not be sustained.&#160;Unrecognized tax benefits are the differences between tax positions taken, or expected to be taken, in tax returns, and the benefits recognized for accounting purposes. We classify uncertain tax positions as long-term liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant judgment is required in determining our worldwide provision for income taxes and our income tax filings are regularly under audit by tax authorities. Any audit result differing from amounts recorded would increase or decrease income in the period that we determine such adjustment is likely. Interest expense and penalties associated with the underpayment of income taxes are included in income tax expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Earnings before income taxes were as follows:&lt;/span&gt;&lt;span style="font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%"/&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;689,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;483,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;377,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;212,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;178,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;144,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 30.25pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;902,654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;661,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;522,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision (benefit) for income taxes comprised the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;112,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;72,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;161,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;116,568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,019)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,126)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(503)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,863)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(19,725)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,436)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(36,714)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;157,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;79,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;94,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision for income taxes differs from the amounts computed by applying the statutory federal income tax rate as follows:&lt;/span&gt;&lt;span style="font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%"/&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;State income tax, net of federal tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Taxation on international earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign derived intangible income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share-based compensation from settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Research and development credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Impact of Switzerland tax reform&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Our effective income tax rate was 17.5% for the year ended December 31, 2021, and 12.1% for the year ended December 31, 2020. Our effective income tax rate for the year ended December 31, 2021, was higher primarily due to the prior year one-time positive impact related to the enactment of tax reform in Switzerland due to recording a deferred tax asset related to the transitional benefits, as well as higher tax benefits in the prior year related to share-based compensation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our effective income tax rate was 12.1% for the year ended December 31, 2020, and 18.1% for the year ended December 31, 2019. Our effective income tax rate for the year ended December 31, 2020, was lower primarily due to the one-time positive impact related to the enactment of tax reform in Switzerland due to recording a deferred tax asset related to the transitional benefits, as well as higher tax benefits related to share-based compensation. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income taxes paid, net of refunds received, for the periods ended December 31, 2021, 2020, and 2019, were $161.7 million, $110.7 million, and $88.0 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;We have received a tax ruling from the Netherlands that documents our mutual understanding of how existing tax laws apply to our circumstances. Primarily as a result of this tax ruling, our net income was higher by $21.4 million,&#160;$14.2 million, and $13.7 million for the years ended December 31, 2021, 2020,&#160;and&#160;2019, respectively. The benefits from our tax rulings are reflected within the overall benefits received from taxation on international earnings in the table above. On December 21, 2021, &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;the Netherlands adopted legislation eliminating the tax benefits related to this tax ruling for tax years beginning after December 31, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of the net deferred tax assets (liabilities) included in the accompanying consolidated balance sheets are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.318%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.320%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts receivable reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Inventory basis differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property-based differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intangible asset basis differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Tax credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unrealized losses on foreign currency exchange contracts and investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;161,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;162,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(39,280)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(40,262)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets, net of valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;122,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;122,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7.75pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer acquisition costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(37,265)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(34,449)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property-based differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(42,363)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(49,547)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intangible asset basis differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(17,345)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16,134)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,662)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,241)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unrealized gains on foreign currency exchange contracts and investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,071)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(312)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(106,706)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(102,683)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2021, we record valuation allowances against certain deferred tax assets related to temporary differences, including intangible asset basis differences and net operating loss (&#x201c;NOL&#x201d;) and tax credit carryforwards, as it is more likely than not that they will not be realized or utilized within the carryforward period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the changes in valuation allowance for deferred tax assets:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Charges to costs and expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Write-off/cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,182)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(226)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,264)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(234)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at the end of the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2021, we have NOLs in certain state and international jurisdictions of approximately $32.9 million available to offset future taxable income. Most of these NOLs will expire at various dates between 2022 and 2028 and the remainder have indefinite lives.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the changes in unrecognized tax positions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total amounts of unrecognized tax benefits, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gross increases (decreases) in unrecognized tax positions as a result of tax positions taken during a prior period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,755)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(276)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gross increases in unrecognized tax positions as a result of tax positions taken in the current period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Decreases in unrecognized tax positions related to settlements with taxing authorities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(537)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,446)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Decreases in unrecognized tax positions as a result of a lapse of the applicable statutes of limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,015)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(355)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,213)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total amounts of unrecognized tax benefits, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Of the total unrecognized tax benefits at December 31, 2021 and 2020, $22.2 million and $21.8 million, respectively, comprise unrecognized tax positions that would, if recognized, affect our effective tax rate.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended December 31, 2021, 2020, and 2019, we recorded interest expense and penalties of $1.1 million, $1.3 million, and $1.8 million, respectively, as income tax expense in our consolidated statement of income. At December 31, 2021, 2020, and 2019, we had $3.8 million, $3.6 million, and $3.6 million, respectively, of estimated interest expense and penalties accrued in our consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the ordinary course of our business, our income tax filings are regularly under audit by tax authorities. While we believe we have appropriately provided for all uncertain tax positions, amounts asserted by taxing authorities could be greater or less than our accrued position. Accordingly, additional provisions on income tax matters, or reductions of previously accrued provisions, could be recorded in the future as we revise our estimates due to changing facts and circumstances or the underlying matters are settled or otherwise resolved. We are currently under tax examinations in various jurisdictions. We anticipate that these examinations will be concluded within the next two years. With few exceptions, we are no longer subject to income tax examinations in any jurisdiction in which we conduct significant taxable activities for years before 2016.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90ZXh0cmVnaW9uOjk2Y2VlMWJjZmEwNDRkMTc5MDEwMDVkMTk1MTExYmFjXzY1OTA_ffb4f78b-2e1f-4bb4-a508-1a32a043ba48">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision for income taxes is determined using the asset and liability approach of accounting for income taxes. Under this approach, deferred taxes represent the estimated future tax effects of temporary differences between book and tax treatment of assets and liabilities and carryforwards to the extent they are realizable. We record a valuation allowance to reduce our deferred tax assets to the amount that is more likely than not to be realized. In assessing the need for a valuation allowance, we consider future taxable income and ongoing prudent and feasible tax planning strategies. In the event that we determine that we would be able to realize our deferred tax assets in the future in excess of the net recorded amount, a reduction of the valuation allowance would increase income in the period such determination was made. Likewise, should we determine that we would not be able to realize all or part of our net deferred tax asset in the future, a reduction to the deferred tax asset would be charged to income in the period such determination was made.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record a liability for uncertain tax positions that do not meet the more likely than not standard as prescribed by the authoritative guidance for income tax accounting. We record tax benefits for only those positions that we believe will more likely than not be sustained.&#160;Unrecognized tax benefits are the differences between tax positions taken, or expected to be taken, in tax returns, and the benefits recognized for accounting purposes. We classify uncertain tax positions as long-term liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant judgment is required in determining our worldwide provision for income taxes and our income tax filings are regularly under audit by tax authorities. Any audit result differing from amounts recorded would increase or decrease income in the period that we determine such adjustment is likely. Interest expense and penalties associated with the underpayment of income taxes are included in income tax expense.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90ZXh0cmVnaW9uOjk2Y2VlMWJjZmEwNDRkMTc5MDEwMDVkMTk1MTExYmFjXzY1Nzk_042658e7-23a1-4c57-ac72-7ce01dcdf69f">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Earnings before income taxes were as follows:&lt;/span&gt;&lt;span style="font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%"/&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;689,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;483,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;377,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;212,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;178,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;144,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 30.25pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;902,654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;661,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;522,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo2NmY3YTlmNjkxY2Q0Yzc5YmQ4YTUzZThhOGZmOWQ2MS90YWJsZXJhbmdlOjY2ZjdhOWY2OTFjZDRjNzliZDhhNTNlOGE4ZmY5ZDYxXzMtMi0xLTEtMA_d7589c9d-58b0-4ef6-85b6-ef8233bb838a"
      unitRef="usd">689994000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo2NmY3YTlmNjkxY2Q0Yzc5YmQ4YTUzZThhOGZmOWQ2MS90YWJsZXJhbmdlOjY2ZjdhOWY2OTFjZDRjNzliZDhhNTNlOGE4ZmY5ZDYxXzMtNC0xLTEtMA_c857d390-2462-4f28-97dd-4cadcd10e2de"
      unitRef="usd">483694000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo2NmY3YTlmNjkxY2Q0Yzc5YmQ4YTUzZThhOGZmOWQ2MS90YWJsZXJhbmdlOjY2ZjdhOWY2OTFjZDRjNzliZDhhNTNlOGE4ZmY5ZDYxXzMtNi0xLTEtMA_fcfd19d5-c689-40a0-a691-977578c41e4d"
      unitRef="usd">377964000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo2NmY3YTlmNjkxY2Q0Yzc5YmQ4YTUzZThhOGZmOWQ2MS90YWJsZXJhbmdlOjY2ZjdhOWY2OTFjZDRjNzliZDhhNTNlOGE4ZmY5ZDYxXzQtMi0xLTEtMA_27c4ffa1-c17c-43d5-be1d-3bda236b2d68"
      unitRef="usd">212660000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo2NmY3YTlmNjkxY2Q0Yzc5YmQ4YTUzZThhOGZmOWQ2MS90YWJsZXJhbmdlOjY2ZjdhOWY2OTFjZDRjNzliZDhhNTNlOGE4ZmY5ZDYxXzQtNC0xLTEtMA_797c6956-9007-4278-aa4e-f36726b6b7fc"
      unitRef="usd">178291000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo2NmY3YTlmNjkxY2Q0Yzc5YmQ4YTUzZThhOGZmOWQ2MS90YWJsZXJhbmdlOjY2ZjdhOWY2OTFjZDRjNzliZDhhNTNlOGE4ZmY5ZDYxXzQtNi0xLTEtMA_74f8677c-e4a6-4b61-b2f2-8acebcf2fd2a"
      unitRef="usd">144254000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo2NmY3YTlmNjkxY2Q0Yzc5YmQ4YTUzZThhOGZmOWQ2MS90YWJsZXJhbmdlOjY2ZjdhOWY2OTFjZDRjNzliZDhhNTNlOGE4ZmY5ZDYxXzUtMi0xLTEtMA_a32bd2d5-8585-46d3-8560-8405c6fe7fb2"
      unitRef="usd">902654000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo2NmY3YTlmNjkxY2Q0Yzc5YmQ4YTUzZThhOGZmOWQ2MS90YWJsZXJhbmdlOjY2ZjdhOWY2OTFjZDRjNzliZDhhNTNlOGE4ZmY5ZDYxXzUtNC0xLTEtMA_b260549d-27c5-40cb-93a2-f99b1ec40c68"
      unitRef="usd">661985000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo2NmY3YTlmNjkxY2Q0Yzc5YmQ4YTUzZThhOGZmOWQ2MS90YWJsZXJhbmdlOjY2ZjdhOWY2OTFjZDRjNzliZDhhNTNlOGE4ZmY5ZDYxXzUtNi0xLTEtMA_963ea20a-d8a9-4dad-b301-b99432eb0f1f"
      unitRef="usd">522218000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90ZXh0cmVnaW9uOjk2Y2VlMWJjZmEwNDRkMTc5MDEwMDVkMTk1MTExYmFjXzY1OTI_3a5b94b9-4c9f-4873-86f4-ec9bfbdf0f77">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision (benefit) for income taxes comprised the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;112,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;72,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;161,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;116,568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,019)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,126)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(503)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,863)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(19,725)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,436)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(36,714)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;157,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;79,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;94,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo5NmEzYzU2NjI0YzA0Y2JiOTBhZGMyYWNkYTBhNTkzZi90YWJsZXJhbmdlOjk2YTNjNTY2MjRjMDRjYmI5MGFkYzJhY2RhMGE1OTNmXzMtMi0xLTEtMA_c160d3ee-3cf5-42fb-8dc6-97a64a38628f"
      unitRef="usd">112811000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo5NmEzYzU2NjI0YzA0Y2JiOTBhZGMyYWNkYTBhNTkzZi90YWJsZXJhbmdlOjk2YTNjNTY2MjRjMDRjYmI5MGFkYzJhY2RhMGE1OTNmXzMtNC0xLTEtMA_082e900b-fb86-4821-a8ce-7ea4a255ce1f"
      unitRef="usd">72921000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo5NmEzYzU2NjI0YzA0Y2JiOTBhZGMyYWNkYTBhNTkzZi90YWJsZXJhbmdlOjk2YTNjNTY2MjRjMDRjYmI5MGFkYzJhY2RhMGE1OTNmXzMtNi0xLTEtMA_3c9c2c24-afea-4735-9533-d4cffa8a7cd2"
      unitRef="usd">52194000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo5NmEzYzU2NjI0YzA0Y2JiOTBhZGMyYWNkYTBhNTkzZi90YWJsZXJhbmdlOjk2YTNjNTY2MjRjMDRjYmI5MGFkYzJhY2RhMGE1OTNmXzQtMi0xLTEtMA_83951d9c-d7c1-413e-ae6e-632f20ce64fc"
      unitRef="usd">19147000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo5NmEzYzU2NjI0YzA0Y2JiOTBhZGMyYWNkYTBhNTkzZi90YWJsZXJhbmdlOjk2YTNjNTY2MjRjMDRjYmI5MGFkYzJhY2RhMGE1OTNmXzQtNC0xLTEtMA_76c00914-ec5d-427e-9e27-40737f4f2d4d"
      unitRef="usd">17346000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo5NmEzYzU2NjI0YzA0Y2JiOTBhZGMyYWNkYTBhNTkzZi90YWJsZXJhbmdlOjk2YTNjNTY2MjRjMDRjYmI5MGFkYzJhY2RhMGE1OTNmXzQtNi0xLTEtMA_0377e197-8556-48f3-9eef-9fc304653a6e"
      unitRef="usd">11967000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo5NmEzYzU2NjI0YzA0Y2JiOTBhZGMyYWNkYTBhNTkzZi90YWJsZXJhbmdlOjk2YTNjNTY2MjRjMDRjYmI5MGFkYzJhY2RhMGE1OTNmXzUtMi0xLTEtMA_8d6d1c57-4f0c-4e38-a1a6-7c2a7c43831b"
      unitRef="usd">29288000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo5NmEzYzU2NjI0YzA0Y2JiOTBhZGMyYWNkYTBhNTkzZi90YWJsZXJhbmdlOjk2YTNjNTY2MjRjMDRjYmI5MGFkYzJhY2RhMGE1OTNmXzUtNC0xLTEtMA_a34301a4-4214-4ba8-bd31-ec7822907884"
      unitRef="usd">26301000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo5NmEzYzU2NjI0YzA0Y2JiOTBhZGMyYWNkYTBhNTkzZi90YWJsZXJhbmdlOjk2YTNjNTY2MjRjMDRjYmI5MGFkYzJhY2RhMGE1OTNmXzUtNi0xLTEtMA_eb04068c-2a2f-4aca-9471-1c2204c62d04"
      unitRef="usd">24239000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo5NmEzYzU2NjI0YzA0Y2JiOTBhZGMyYWNkYTBhNTkzZi90YWJsZXJhbmdlOjk2YTNjNTY2MjRjMDRjYmI5MGFkYzJhY2RhMGE1OTNmXzYtMi0xLTEtMA_ac800317-b67a-438f-a31b-7cccbcb4517d"
      unitRef="usd">161246000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo5NmEzYzU2NjI0YzA0Y2JiOTBhZGMyYWNkYTBhNTkzZi90YWJsZXJhbmdlOjk2YTNjNTY2MjRjMDRjYmI5MGFkYzJhY2RhMGE1OTNmXzYtNC0xLTEtMA_c6b36a07-0e3b-46d0-b001-a450fc0f0483"
      unitRef="usd">116568000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo5NmEzYzU2NjI0YzA0Y2JiOTBhZGMyYWNkYTBhNTkzZi90YWJsZXJhbmdlOjk2YTNjNTY2MjRjMDRjYmI5MGFkYzJhY2RhMGE1OTNmXzYtNi0xLTEtMA_581092b6-f0e6-4ea2-a420-dbc76e57ef25"
      unitRef="usd">88400000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo5NmEzYzU2NjI0YzA0Y2JiOTBhZGMyYWNkYTBhNTkzZi90YWJsZXJhbmdlOjk2YTNjNTY2MjRjMDRjYmI5MGFkYzJhY2RhMGE1OTNmXzgtMi0xLTEtMA_bfc1e11d-7ddf-4221-a8bc-30495c085adb"
      unitRef="usd">-7019000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo5NmEzYzU2NjI0YzA0Y2JiOTBhZGMyYWNkYTBhNTkzZi90YWJsZXJhbmdlOjk2YTNjNTY2MjRjMDRjYmI5MGFkYzJhY2RhMGE1OTNmXzgtNC0xLTEtMA_b31e76c3-dde0-401b-8a91-a7750bd3bd7e"
      unitRef="usd">-14126000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo5NmEzYzU2NjI0YzA0Y2JiOTBhZGMyYWNkYTBhNTkzZi90YWJsZXJhbmdlOjk2YTNjNTY2MjRjMDRjYmI5MGFkYzJhY2RhMGE1OTNmXzgtNi0xLTEtMA_2e658a17-e52f-4d22-9636-d16fd46a569b"
      unitRef="usd">4826000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo5NmEzYzU2NjI0YzA0Y2JiOTBhZGMyYWNkYTBhNTkzZi90YWJsZXJhbmdlOjk2YTNjNTY2MjRjMDRjYmI5MGFkYzJhY2RhMGE1OTNmXzktMi0xLTEtMA_ae606d0e-77fe-404a-9d85-866ffc1631f8"
      unitRef="usd">-503000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo5NmEzYzU2NjI0YzA0Y2JiOTBhZGMyYWNkYTBhNTkzZi90YWJsZXJhbmdlOjk2YTNjNTY2MjRjMDRjYmI5MGFkYzJhY2RhMGE1OTNmXzktNC0xLTEtMA_f330f4e5-a91d-4fcc-a1a8-6bf9573b6ce0"
      unitRef="usd">-2863000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo5NmEzYzU2NjI0YzA0Y2JiOTBhZGMyYWNkYTBhNTkzZi90YWJsZXJhbmdlOjk2YTNjNTY2MjRjMDRjYmI5MGFkYzJhY2RhMGE1OTNmXzktNi0xLTEtMA_487e080c-c1c9-4090-bd8f-270ebc728fb8"
      unitRef="usd">269000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo5NmEzYzU2NjI0YzA0Y2JiOTBhZGMyYWNkYTBhNTkzZi90YWJsZXJhbmdlOjk2YTNjNTY2MjRjMDRjYmI5MGFkYzJhY2RhMGE1OTNmXzEwLTItMS0xLTA_ef8598fb-78dd-43f2-b6dc-d704c056eb33"
      unitRef="usd">4086000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo5NmEzYzU2NjI0YzA0Y2JiOTBhZGMyYWNkYTBhNTkzZi90YWJsZXJhbmdlOjk2YTNjNTY2MjRjMDRjYmI5MGFkYzJhY2RhMGE1OTNmXzEwLTQtMS0xLTA_7cfb136f-8652-4db4-8f61-23a50f90dca5"
      unitRef="usd">-19725000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo5NmEzYzU2NjI0YzA0Y2JiOTBhZGMyYWNkYTBhNTkzZi90YWJsZXJhbmdlOjk2YTNjNTY2MjRjMDRjYmI5MGFkYzJhY2RhMGE1OTNmXzEwLTYtMS0xLTA_24ca264a-c54d-4840-80f8-46f9521cff9f"
      unitRef="usd">931000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo5NmEzYzU2NjI0YzA0Y2JiOTBhZGMyYWNkYTBhNTkzZi90YWJsZXJhbmdlOjk2YTNjNTY2MjRjMDRjYmI5MGFkYzJhY2RhMGE1OTNmXzExLTItMS0xLTA_5e261b0d-3fd2-4151-a44c-32f20cdce95e"
      unitRef="usd">-3436000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo5NmEzYzU2NjI0YzA0Y2JiOTBhZGMyYWNkYTBhNTkzZi90YWJsZXJhbmdlOjk2YTNjNTY2MjRjMDRjYmI5MGFkYzJhY2RhMGE1OTNmXzExLTQtMS0xLTA_0165fdc9-fa98-40b3-97f6-0da43f70af1c"
      unitRef="usd">-36714000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo5NmEzYzU2NjI0YzA0Y2JiOTBhZGMyYWNkYTBhNTkzZi90YWJsZXJhbmdlOjk2YTNjNTY2MjRjMDRjYmI5MGFkYzJhY2RhMGE1OTNmXzExLTYtMS0xLTA_57dd3967-b0bf-439e-b701-2501f079abec"
      unitRef="usd">6026000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo5NmEzYzU2NjI0YzA0Y2JiOTBhZGMyYWNkYTBhNTkzZi90YWJsZXJhbmdlOjk2YTNjNTY2MjRjMDRjYmI5MGFkYzJhY2RhMGE1OTNmXzEyLTItMS0xLTA_b918dc7a-b8e9-49cc-ab33-44c855f57d12"
      unitRef="usd">157810000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo5NmEzYzU2NjI0YzA0Y2JiOTBhZGMyYWNkYTBhNTkzZi90YWJsZXJhbmdlOjk2YTNjNTY2MjRjMDRjYmI5MGFkYzJhY2RhMGE1OTNmXzEyLTQtMS0xLTA_904d1ff7-db89-4487-a5e9-e04ec4d36926"
      unitRef="usd">79854000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo5NmEzYzU2NjI0YzA0Y2JiOTBhZGMyYWNkYTBhNTkzZi90YWJsZXJhbmdlOjk2YTNjNTY2MjRjMDRjYmI5MGFkYzJhY2RhMGE1OTNmXzEyLTYtMS0xLTA_68b3b25e-ee2c-456f-a2f1-e5c8cc45c422"
      unitRef="usd">94426000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90ZXh0cmVnaW9uOjk2Y2VlMWJjZmEwNDRkMTc5MDEwMDVkMTk1MTExYmFjXzY1OTM_b556150a-33d4-418f-980c-8300767c4304">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision for income taxes differs from the amounts computed by applying the statutory federal income tax rate as follows:&lt;/span&gt;&lt;span style="font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%"/&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;State income tax, net of federal tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Taxation on international earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign derived intangible income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share-based compensation from settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Research and development credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Impact of Switzerland tax reform&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxMDQwMGE1N2VmMmY0YjU2OGMzNDk4NTAwOTIyN2YwNS90YWJsZXJhbmdlOjEwNDAwYTU3ZWYyZjRiNTY4YzM0OTg1MDA5MjI3ZjA1XzMtMi0xLTEtMA_aec978db-87bf-4e9d-8afe-90765209e510"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxMDQwMGE1N2VmMmY0YjU2OGMzNDk4NTAwOTIyN2YwNS90YWJsZXJhbmdlOjEwNDAwYTU3ZWYyZjRiNTY4YzM0OTg1MDA5MjI3ZjA1XzMtNC0xLTEtMA_54748e5c-e2ad-43bd-b5e5-75d25815ab02"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxMDQwMGE1N2VmMmY0YjU2OGMzNDk4NTAwOTIyN2YwNS90YWJsZXJhbmdlOjEwNDAwYTU3ZWYyZjRiNTY4YzM0OTg1MDA5MjI3ZjA1XzMtNi0xLTEtMA_3be39fbf-c64b-4aa1-9089-cf209a2da3f8"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxMDQwMGE1N2VmMmY0YjU2OGMzNDk4NTAwOTIyN2YwNS90YWJsZXJhbmdlOjEwNDAwYTU3ZWYyZjRiNTY4YzM0OTg1MDA5MjI3ZjA1XzQtMi0xLTEtMA_38204ef9-263c-4053-9c67-7c69a5ad4ecb"
      unitRef="number">0.021</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxMDQwMGE1N2VmMmY0YjU2OGMzNDk4NTAwOTIyN2YwNS90YWJsZXJhbmdlOjEwNDAwYTU3ZWYyZjRiNTY4YzM0OTg1MDA5MjI3ZjA1XzQtNC0xLTEtMA_a7d241a6-dc77-41cc-b904-dd8deb79bd65"
      unitRef="number">0.024</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxMDQwMGE1N2VmMmY0YjU2OGMzNDk4NTAwOTIyN2YwNS90YWJsZXJhbmdlOjEwNDAwYTU3ZWYyZjRiNTY4YzM0OTg1MDA5MjI3ZjA1XzQtNi0xLTEtMA_892dddea-65e7-4aae-bcd7-893afe5fe88a"
      unitRef="number">0.023</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxMDQwMGE1N2VmMmY0YjU2OGMzNDk4NTAwOTIyN2YwNS90YWJsZXJhbmdlOjEwNDAwYTU3ZWYyZjRiNTY4YzM0OTg1MDA5MjI3ZjA1XzUtMi0xLTEtMA_a00837db-a6c9-43cb-9c71-bf796feaaa99"
      unitRef="number">-0.008</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxMDQwMGE1N2VmMmY0YjU2OGMzNDk4NTAwOTIyN2YwNS90YWJsZXJhbmdlOjEwNDAwYTU3ZWYyZjRiNTY4YzM0OTg1MDA5MjI3ZjA1XzUtNC0xLTEtMA_2a5f84d8-2cc4-4332-a349-93cdd496be35"
      unitRef="number">-0.010</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxMDQwMGE1N2VmMmY0YjU2OGMzNDk4NTAwOTIyN2YwNS90YWJsZXJhbmdlOjEwNDAwYTU3ZWYyZjRiNTY4YzM0OTg1MDA5MjI3ZjA1XzUtNi0xLTEtMA_25782b06-e7ba-4322-b59d-fcee499cd413"
      unitRef="number">-0.011</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <idxx:EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxMDQwMGE1N2VmMmY0YjU2OGMzNDk4NTAwOTIyN2YwNS90YWJsZXJhbmdlOjEwNDAwYTU3ZWYyZjRiNTY4YzM0OTg1MDA5MjI3ZjA1XzYtMi0xLTEtMA_366c7c44-306f-41a1-977c-a8cd81552dba"
      unitRef="number">0.012</idxx:EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome>
    <idxx:EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxMDQwMGE1N2VmMmY0YjU2OGMzNDk4NTAwOTIyN2YwNS90YWJsZXJhbmdlOjEwNDAwYTU3ZWYyZjRiNTY4YzM0OTg1MDA5MjI3ZjA1XzYtNC0xLTEtMA_9d97ba4a-c5b1-484d-a58a-69daf1268c07"
      unitRef="number">0.011</idxx:EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome>
    <idxx:EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxMDQwMGE1N2VmMmY0YjU2OGMzNDk4NTAwOTIyN2YwNS90YWJsZXJhbmdlOjEwNDAwYTU3ZWYyZjRiNTY4YzM0OTg1MDA5MjI3ZjA1XzYtNi0xLTEtMA_731ae5ff-572d-469e-966c-8f8c03c25ecc"
      unitRef="number">0.011</idxx:EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxMDQwMGE1N2VmMmY0YjU2OGMzNDk4NTAwOTIyN2YwNS90YWJsZXJhbmdlOjEwNDAwYTU3ZWYyZjRiNTY4YzM0OTg1MDA5MjI3ZjA1XzctMi0xLTEtMA_cdb0b33a-9286-4568-a2e1-0fea98e89084"
      unitRef="number">0.036</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxMDQwMGE1N2VmMmY0YjU2OGMzNDk4NTAwOTIyN2YwNS90YWJsZXJhbmdlOjEwNDAwYTU3ZWYyZjRiNTY4YzM0OTg1MDA5MjI3ZjA1XzctNC0xLTEtMA_cbea06b7-eccd-46a4-87a5-534145e09f6e"
      unitRef="number">0.059</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxMDQwMGE1N2VmMmY0YjU2OGMzNDk4NTAwOTIyN2YwNS90YWJsZXJhbmdlOjEwNDAwYTU3ZWYyZjRiNTY4YzM0OTg1MDA5MjI3ZjA1XzctNi0xLTEtMA_fdc35f73-785a-4042-b7f0-2db2b77b8acd"
      unitRef="number">0.036</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxMDQwMGE1N2VmMmY0YjU2OGMzNDk4NTAwOTIyN2YwNS90YWJsZXJhbmdlOjEwNDAwYTU3ZWYyZjRiNTY4YzM0OTg1MDA5MjI3ZjA1XzgtMi0xLTEtMA_49b4f9a1-7e11-4eac-b748-37a13f5cd171"
      unitRef="number">0.007</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxMDQwMGE1N2VmMmY0YjU2OGMzNDk4NTAwOTIyN2YwNS90YWJsZXJhbmdlOjEwNDAwYTU3ZWYyZjRiNTY4YzM0OTg1MDA5MjI3ZjA1XzgtNC0xLTEtMA_f226998f-f4fb-47e1-8355-6ebf5c76a537"
      unitRef="number">0.008</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxMDQwMGE1N2VmMmY0YjU2OGMzNDk4NTAwOTIyN2YwNS90YWJsZXJhbmdlOjEwNDAwYTU3ZWYyZjRiNTY4YzM0OTg1MDA5MjI3ZjA1XzgtNi0xLTEtMA_41026c3f-4240-4de6-9789-b61660dfea75"
      unitRef="number">0.008</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <idxx:EffectiveIncomeTaxRateReconciliationSwitzerlandTaxReformEffectPercent
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxMDQwMGE1N2VmMmY0YjU2OGMzNDk4NTAwOTIyN2YwNS90YWJsZXJhbmdlOjEwNDAwYTU3ZWYyZjRiNTY4YzM0OTg1MDA5MjI3ZjA1XzktMi0xLTEtMA_3469ba26-90a0-4fd0-9e5a-be7ce62ed515"
      unitRef="number">0</idxx:EffectiveIncomeTaxRateReconciliationSwitzerlandTaxReformEffectPercent>
    <idxx:EffectiveIncomeTaxRateReconciliationSwitzerlandTaxReformEffectPercent
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxMDQwMGE1N2VmMmY0YjU2OGMzNDk4NTAwOTIyN2YwNS90YWJsZXJhbmdlOjEwNDAwYTU3ZWYyZjRiNTY4YzM0OTg1MDA5MjI3ZjA1XzktNC0xLTEtMA_7633077f-677a-4f0b-947f-b9f143ae34bd"
      unitRef="number">-0.033</idxx:EffectiveIncomeTaxRateReconciliationSwitzerlandTaxReformEffectPercent>
    <idxx:EffectiveIncomeTaxRateReconciliationSwitzerlandTaxReformEffectPercent
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxMDQwMGE1N2VmMmY0YjU2OGMzNDk4NTAwOTIyN2YwNS90YWJsZXJhbmdlOjEwNDAwYTU3ZWYyZjRiNTY4YzM0OTg1MDA5MjI3ZjA1XzktNi0xLTEtMA_e457b743-f47b-43fa-bbb7-5015ccb2aacd"
      unitRef="number">0</idxx:EffectiveIncomeTaxRateReconciliationSwitzerlandTaxReformEffectPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxMDQwMGE1N2VmMmY0YjU2OGMzNDk4NTAwOTIyN2YwNS90YWJsZXJhbmdlOjEwNDAwYTU3ZWYyZjRiNTY4YzM0OTg1MDA5MjI3ZjA1XzExLTItMS0xLTA_deffb944-f5e4-4a45-b7d9-df1111efafc9"
      unitRef="number">0.007</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxMDQwMGE1N2VmMmY0YjU2OGMzNDk4NTAwOTIyN2YwNS90YWJsZXJhbmdlOjEwNDAwYTU3ZWYyZjRiNTY4YzM0OTg1MDA5MjI3ZjA1XzExLTQtMS0xLTA_8a205aba-4ab4-4e2d-9b43-85ce41193377"
      unitRef="number">0.008</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxMDQwMGE1N2VmMmY0YjU2OGMzNDk4NTAwOTIyN2YwNS90YWJsZXJhbmdlOjEwNDAwYTU3ZWYyZjRiNTY4YzM0OTg1MDA5MjI3ZjA1XzExLTYtMS0xLTA_d6c98923-ebab-4a89-9be0-e18693401fcb"
      unitRef="number">0.014</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxMDQwMGE1N2VmMmY0YjU2OGMzNDk4NTAwOTIyN2YwNS90YWJsZXJhbmdlOjEwNDAwYTU3ZWYyZjRiNTY4YzM0OTg1MDA5MjI3ZjA1XzEyLTItMS0xLTA_4a63e4e3-5806-498c-a17d-40a8ea0d449d"
      unitRef="number">0.175</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxMDQwMGE1N2VmMmY0YjU2OGMzNDk4NTAwOTIyN2YwNS90YWJsZXJhbmdlOjEwNDAwYTU3ZWYyZjRiNTY4YzM0OTg1MDA5MjI3ZjA1XzEyLTQtMS0xLTA_4711924c-8612-4df1-8e50-2eb1c48e2e9e"
      unitRef="number">0.121</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxMDQwMGE1N2VmMmY0YjU2OGMzNDk4NTAwOTIyN2YwNS90YWJsZXJhbmdlOjEwNDAwYTU3ZWYyZjRiNTY4YzM0OTg1MDA5MjI3ZjA1XzEyLTYtMS0xLTA_9c836bcf-8391-49f1-81f8-4d7e2d98b9e5"
      unitRef="number">0.181</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90ZXh0cmVnaW9uOjk2Y2VlMWJjZmEwNDRkMTc5MDEwMDVkMTk1MTExYmFjXzIzMjI_27cf2dc9-6fd4-40b6-8097-89e9139d04bb"
      unitRef="number">0.175</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90ZXh0cmVnaW9uOjk2Y2VlMWJjZmEwNDRkMTc5MDEwMDVkMTk1MTExYmFjXzIzNTI_8f9edcc7-e163-4cff-b777-7181a02d8fc8"
      unitRef="number">0.121</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90ZXh0cmVnaW9uOjk2Y2VlMWJjZmEwNDRkMTc5MDEwMDVkMTk1MTExYmFjXzI3MzU_8f9edcc7-e163-4cff-b777-7181a02d8fc8"
      unitRef="number">0.121</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90ZXh0cmVnaW9uOjk2Y2VlMWJjZmEwNDRkMTc5MDEwMDVkMTk1MTExYmFjXzI3NjU_94495aaf-78b0-465c-a594-7c7e32cf3492"
      unitRef="number">0.181</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90ZXh0cmVnaW9uOjk2Y2VlMWJjZmEwNDRkMTc5MDEwMDVkMTk1MTExYmFjXzMxNDQ_25fb71fa-7198-4be0-85bc-6174b3f67a17"
      unitRef="usd">161700000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90ZXh0cmVnaW9uOjk2Y2VlMWJjZmEwNDRkMTc5MDEwMDVkMTk1MTExYmFjXzMxNDg_f45b4ef8-5afb-4118-b45c-b90ac792e232"
      unitRef="usd">110700000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90ZXh0cmVnaW9uOjk2Y2VlMWJjZmEwNDRkMTc5MDEwMDVkMTk1MTExYmFjXzMxNTY_dd7d93ed-d0c2-4866-8597-71ccad058621"
      unitRef="usd">88000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxHolidayAggregateDollarAmount
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90ZXh0cmVnaW9uOjk2Y2VlMWJjZmEwNDRkMTc5MDEwMDVkMTk1MTExYmFjXzQwMjk_cd72edd8-938e-476b-9f28-fd610c4b3123"
      unitRef="usd">21400000</us-gaap:IncomeTaxHolidayAggregateDollarAmount>
    <us-gaap:IncomeTaxHolidayAggregateDollarAmount
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90ZXh0cmVnaW9uOjk2Y2VlMWJjZmEwNDRkMTc5MDEwMDVkMTk1MTExYmFjXzQwMzM_64031fb2-9101-412a-acd4-0e9512e1e70b"
      unitRef="usd">14200000</us-gaap:IncomeTaxHolidayAggregateDollarAmount>
    <us-gaap:IncomeTaxHolidayAggregateDollarAmount
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90ZXh0cmVnaW9uOjk2Y2VlMWJjZmEwNDRkMTc5MDEwMDVkMTk1MTExYmFjXzQwNDE_5db6af6a-ba19-4c07-b075-3b3a1748577c"
      unitRef="usd">13700000</us-gaap:IncomeTaxHolidayAggregateDollarAmount>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90ZXh0cmVnaW9uOjk2Y2VlMWJjZmEwNDRkMTc5MDEwMDVkMTk1MTExYmFjXzY1OTg_157b94e3-bad6-4c4a-9e89-9a234217356b">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of the net deferred tax assets (liabilities) included in the accompanying consolidated balance sheets are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.318%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.320%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts receivable reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Inventory basis differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property-based differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intangible asset basis differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Tax credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unrealized losses on foreign currency exchange contracts and investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;161,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;162,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(39,280)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(40,262)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets, net of valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;122,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;122,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7.75pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer acquisition costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(37,265)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(34,449)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property-based differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(42,363)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(49,547)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intangible asset basis differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(17,345)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16,134)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,662)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,241)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unrealized gains on foreign currency exchange contracts and investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,071)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(312)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(106,706)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(102,683)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzMtMi0xLTEtMA_a91e0df4-380f-4bac-b52f-5d6ca566b743"
      unitRef="usd">48433000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzMtNC0xLTEtMA_f9410c94-7af9-4345-8455-9665d1f1af89"
      unitRef="usd">46830000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzQtMi0xLTEtMA_e9afac53-704f-46a3-b2e3-c8c1adbd7926"
      unitRef="usd">2131000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzQtNC0xLTEtMA_192279b1-80a8-4165-b69c-54daed39b8ad"
      unitRef="usd">2505000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsDeferredIncome
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzUtMi0xLTEtMA_39431c7c-3b23-49d1-a61b-3ccf7e42480f"
      unitRef="usd">6269000</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredTaxAssetsDeferredIncome
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzUtNC0xLTEtMA_d2114fbe-4615-4491-97c8-4d759807f26c"
      unitRef="usd">7629000</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredTaxAssetsInventory
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzYtMi0xLTEtMA_86f19db6-7ae4-4f90-a53d-683d842667dd"
      unitRef="usd">6553000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsInventory
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzYtNC0xLTEtMA_e73be908-a144-4267-a149-ae6715bf2774"
      unitRef="usd">4272000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzctMi0xLTEtMA_0829ff08-112c-499c-9d5b-f8aa517749f2"
      unitRef="usd">16132000</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzctNC0xLTEtMA_a7f6f99a-3f46-41ef-b286-f26a1ba1f2d0"
      unitRef="usd">14865000</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <idxx:DeferredTaxAssetsIntangibleAssetsBasisDifference
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzgtMi0xLTEtMA_c4e0b31e-62a4-4710-94c1-6631c5c370f3"
      unitRef="usd">46606000</idxx:DeferredTaxAssetsIntangibleAssetsBasisDifference>
    <idxx:DeferredTaxAssetsIntangibleAssetsBasisDifference
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzgtNC0xLTEtMA_222d0cf5-e34a-4f97-82f0-1aad01d6abe5"
      unitRef="usd">51319000</idxx:DeferredTaxAssetsIntangibleAssetsBasisDifference>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzktMi0xLTEtMA_a666453e-eb7d-4706-b272-3ae43a5295a4"
      unitRef="usd">10740000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzktNC0xLTEtMA_fbe58b06-74c9-4adf-9665-a7c716a4cfbb"
      unitRef="usd">10011000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzEwLTItMS0xLTA_ee9495aa-7ef0-4659-9af1-fbb48c30e338"
      unitRef="usd">1163000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzEwLTQtMS0xLTA_989b5e49-ece3-4930-a25c-e834317429fa"
      unitRef="usd">1484000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzExLTItMS0xLTA_63736df1-323f-49ae-af9c-076667ecf700"
      unitRef="usd">8570000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzExLTQtMS0xLTA_0e50c294-fb49-4730-9ed1-049da1abf537"
      unitRef="usd">5427000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzEyLTItMS0xLTA_300127bd-8f5e-4a40-b93a-1f71f438a10f"
      unitRef="usd">13483000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzEyLTQtMS0xLTA_14f37836-89eb-4051-bf1e-d2aa1177ca8a"
      unitRef="usd">13385000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsOtherComprehensiveLoss
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzEzLTItMS0xLTA_7be52536-5574-49e8-a9be-df5f101e5576"
      unitRef="usd">1755000</us-gaap:DeferredTaxAssetsOtherComprehensiveLoss>
    <us-gaap:DeferredTaxAssetsOtherComprehensiveLoss
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzEzLTQtMS0xLTA_89adb518-faa9-4bcf-bdbb-fd0577e38256"
      unitRef="usd">5060000</us-gaap:DeferredTaxAssetsOtherComprehensiveLoss>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzE0LTItMS0xLTA_60534b96-3a2b-49b1-b84e-685d237c6943"
      unitRef="usd">161835000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzE0LTQtMS0xLTA_5a0a4320-071e-4ea1-a8e9-8b83b5d655fc"
      unitRef="usd">162787000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzE1LTItMS0xLTA_14de3c47-30b3-4ca9-b4eb-c420ee96ee93"
      unitRef="usd">39280000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzE1LTQtMS0xLTA_fe97b850-a5e2-423a-95cc-a1aecfcddf73"
      unitRef="usd">40262000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzE2LTItMS0xLTA_13633e92-365d-4c0a-82d6-dc935fc45f38"
      unitRef="usd">122555000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzE2LTQtMS0xLTA_b8b22ddb-b204-4a6d-9401-a8f83ae9b141"
      unitRef="usd">122525000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzE5LTItMS0xLTA_e2119af7-a3f9-467a-a9b0-df6fe68ada4e"
      unitRef="usd">37265000</us-gaap:DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost>
    <us-gaap:DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzE5LTQtMS0xLTA_74a70c97-afa5-4676-bf2c-597856aed84c"
      unitRef="usd">34449000</us-gaap:DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzIwLTItMS0xLTA_78cd4382-a003-47c9-9223-41f49d7c1061"
      unitRef="usd">42363000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzIwLTQtMS0xLTA_ceecfcb2-8127-464b-9eba-6bd4c4ddc4cf"
      unitRef="usd">49547000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzIxLTItMS0xLTA_74cd986a-89ec-4e14-9d2a-f48ee598f4c8"
      unitRef="usd">17345000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzIxLTQtMS0xLTA_b899ecde-ba53-4aca-ad1f-0013b8555705"
      unitRef="usd">16134000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzIyLTItMS0xLTA_9eca6a45-1949-4703-9510-d27082183da9"
      unitRef="usd">5662000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzIyLTQtMS0xLTA_25be063a-9d9c-49ae-8d91-e77547644b59"
      unitRef="usd">2241000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzIzLTItMS0xLTA_9189fd69-0c6a-4e96-93d3-fe8020959b93"
      unitRef="usd">4071000</us-gaap:DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains>
    <us-gaap:DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzIzLTQtMS0xLTA_15ef3e35-ee79-4fd7-93f9-1931a5980d62"
      unitRef="usd">312000</us-gaap:DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzI0LTItMS0xLTA_a4570cd5-ec52-42db-b779-cc957beacf03"
      unitRef="usd">106706000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzI0LTQtMS0xLTA_c9177bbd-15b7-4228-bca2-653f997f83ac"
      unitRef="usd">102683000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzI1LTItMS0xLTA_5f73a5f7-d827-4aca-8b97-8ef655ccf006"
      unitRef="usd">15849000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1N2U1NGRmODkwY2U0YmNiYTdmYmIyZDAxNDM2OGRiZi90YWJsZXJhbmdlOjU3ZTU0ZGY4OTBjZTRiY2JhN2ZiYjJkMDE0MzY4ZGJmXzI1LTQtMS0xLTA_fd58df0a-c86e-442e-83b3-706864ed255d"
      unitRef="usd">19842000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:SummaryOfValuationAllowanceTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90ZXh0cmVnaW9uOjk2Y2VlMWJjZmEwNDRkMTc5MDEwMDVkMTk1MTExYmFjXzY1ODE_cee0886a-abee-4d8b-b851-8aa1a82ed929">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the changes in valuation allowance for deferred tax assets:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Charges to costs and expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Write-off/cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,182)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(226)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,264)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(234)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at the end of the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SummaryOfValuationAllowanceTextBlock>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1YTI4ODAxZmJjNjk0NTEyOTU0YzYwM2YzNTYwODhlYi90YWJsZXJhbmdlOjVhMjg4MDFmYmM2OTQ1MTI5NTRjNjAzZjM1NjA4OGViXzMtMi0xLTEtMA_e2a29535-765b-4c2d-be6c-4250b4338510"
      unitRef="usd">40262000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i0c634b937c58472e84857eacf99e17df_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1YTI4ODAxZmJjNjk0NTEyOTU0YzYwM2YzNTYwODhlYi90YWJsZXJhbmdlOjVhMjg4MDFmYmM2OTQ1MTI5NTRjNjAzZjM1NjA4OGViXzMtNC0xLTEtMA_6e023e8c-6db2-40ce-8066-b6ff04bec888"
      unitRef="usd">9454000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i28d0821cac8841b29cf960002d3bc993_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1YTI4ODAxZmJjNjk0NTEyOTU0YzYwM2YzNTYwODhlYi90YWJsZXJhbmdlOjVhMjg4MDFmYmM2OTQ1MTI5NTRjNjAzZjM1NjA4OGViXzMtNi0xLTEtMA_9c712a6b-9143-4ec2-90cd-fa8ff52c59c2"
      unitRef="usd">6212000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <idxx:DeferredTaxAssetsValuationAllowanceChargesToCostsAndExpense
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1YTI4ODAxZmJjNjk0NTEyOTU0YzYwM2YzNTYwODhlYi90YWJsZXJhbmdlOjVhMjg4MDFmYmM2OTQ1MTI5NTRjNjAzZjM1NjA4OGViXzQtMi0xLTEtMA_bd62b46d-dd4b-4af6-9da5-8a258765e99a"
      unitRef="usd">1464000</idxx:DeferredTaxAssetsValuationAllowanceChargesToCostsAndExpense>
    <idxx:DeferredTaxAssetsValuationAllowanceChargesToCostsAndExpense
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1YTI4ODAxZmJjNjk0NTEyOTU0YzYwM2YzNTYwODhlYi90YWJsZXJhbmdlOjVhMjg4MDFmYmM2OTQ1MTI5NTRjNjAzZjM1NjA4OGViXzQtNC0xLTEtMA_3c62e9b1-9113-443a-b912-404addc10814"
      unitRef="usd">31076000</idxx:DeferredTaxAssetsValuationAllowanceChargesToCostsAndExpense>
    <idxx:DeferredTaxAssetsValuationAllowanceChargesToCostsAndExpense
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1YTI4ODAxZmJjNjk0NTEyOTU0YzYwM2YzNTYwODhlYi90YWJsZXJhbmdlOjVhMjg4MDFmYmM2OTQ1MTI5NTRjNjAzZjM1NjA4OGViXzQtNi0xLTEtMA_ae3f1a15-5d7e-4450-8baf-8f9837a4fd53"
      unitRef="usd">3489000</idxx:DeferredTaxAssetsValuationAllowanceChargesToCostsAndExpense>
    <idxx:DeferredTaxAssetsValuationAllowanceWriteOffCashPayments
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1YTI4ODAxZmJjNjk0NTEyOTU0YzYwM2YzNTYwODhlYi90YWJsZXJhbmdlOjVhMjg4MDFmYmM2OTQ1MTI5NTRjNjAzZjM1NjA4OGViXzUtMi0xLTEtMA_eece8492-cfef-411a-ba62-aa020b1ef34f"
      unitRef="usd">1182000</idxx:DeferredTaxAssetsValuationAllowanceWriteOffCashPayments>
    <idxx:DeferredTaxAssetsValuationAllowanceWriteOffCashPayments
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1YTI4ODAxZmJjNjk0NTEyOTU0YzYwM2YzNTYwODhlYi90YWJsZXJhbmdlOjVhMjg4MDFmYmM2OTQ1MTI5NTRjNjAzZjM1NjA4OGViXzUtNC0xLTEtMA_6553c0fd-7845-4284-a8f0-9b1c3089d51e"
      unitRef="usd">34000</idxx:DeferredTaxAssetsValuationAllowanceWriteOffCashPayments>
    <idxx:DeferredTaxAssetsValuationAllowanceWriteOffCashPayments
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1YTI4ODAxZmJjNjk0NTEyOTU0YzYwM2YzNTYwODhlYi90YWJsZXJhbmdlOjVhMjg4MDFmYmM2OTQ1MTI5NTRjNjAzZjM1NjA4OGViXzUtNi0xLTEtMA_d9569f93-ace5-4986-9068-1b6d0aaf143d"
      unitRef="usd">226000</idxx:DeferredTaxAssetsValuationAllowanceWriteOffCashPayments>
    <idxx:DeferredTaxAssetsValuationAllowanceForeignCurrencyTranslation
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1YTI4ODAxZmJjNjk0NTEyOTU0YzYwM2YzNTYwODhlYi90YWJsZXJhbmdlOjVhMjg4MDFmYmM2OTQ1MTI5NTRjNjAzZjM1NjA4OGViXzYtMi0xLTEtMA_240f53df-1899-4483-9eb4-a2f1eb601902"
      unitRef="usd">-1264000</idxx:DeferredTaxAssetsValuationAllowanceForeignCurrencyTranslation>
    <idxx:DeferredTaxAssetsValuationAllowanceForeignCurrencyTranslation
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1YTI4ODAxZmJjNjk0NTEyOTU0YzYwM2YzNTYwODhlYi90YWJsZXJhbmdlOjVhMjg4MDFmYmM2OTQ1MTI5NTRjNjAzZjM1NjA4OGViXzYtNC0xLTEtMA_c5e72708-d201-46a2-bf32-eb0e1527306c"
      unitRef="usd">-234000</idxx:DeferredTaxAssetsValuationAllowanceForeignCurrencyTranslation>
    <idxx:DeferredTaxAssetsValuationAllowanceForeignCurrencyTranslation
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1YTI4ODAxZmJjNjk0NTEyOTU0YzYwM2YzNTYwODhlYi90YWJsZXJhbmdlOjVhMjg4MDFmYmM2OTQ1MTI5NTRjNjAzZjM1NjA4OGViXzYtNi0xLTEtMA_0445d857-d838-425f-ab0e-6fd6cf691281"
      unitRef="usd">-21000</idxx:DeferredTaxAssetsValuationAllowanceForeignCurrencyTranslation>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1YTI4ODAxZmJjNjk0NTEyOTU0YzYwM2YzNTYwODhlYi90YWJsZXJhbmdlOjVhMjg4MDFmYmM2OTQ1MTI5NTRjNjAzZjM1NjA4OGViXzctMi0xLTEtMA_4e78cf33-48a4-4c77-903d-03d50c096138"
      unitRef="usd">39280000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1YTI4ODAxZmJjNjk0NTEyOTU0YzYwM2YzNTYwODhlYi90YWJsZXJhbmdlOjVhMjg4MDFmYmM2OTQ1MTI5NTRjNjAzZjM1NjA4OGViXzctNC0xLTEtMA_25c5e502-3bf2-41fd-8130-cd09b76e193c"
      unitRef="usd">40262000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i0c634b937c58472e84857eacf99e17df_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZTo1YTI4ODAxZmJjNjk0NTEyOTU0YzYwM2YzNTYwODhlYi90YWJsZXJhbmdlOjVhMjg4MDFmYmM2OTQ1MTI5NTRjNjAzZjM1NjA4OGViXzctNi0xLTEtMA_4912c357-3456-4673-896c-45808edda1a3"
      unitRef="usd">9454000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90ZXh0cmVnaW9uOjk2Y2VlMWJjZmEwNDRkMTc5MDEwMDVkMTk1MTExYmFjXzQ4OTI_e24d4876-0df7-4826-9182-77a687488309"
      unitRef="usd">32900000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:SummaryOfIncomeTaxContingenciesTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90ZXh0cmVnaW9uOjk2Y2VlMWJjZmEwNDRkMTc5MDEwMDVkMTk1MTExYmFjXzY1ODQ_059fba6f-5407-42b0-8a85-e7bd0c06b426">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the changes in unrecognized tax positions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total amounts of unrecognized tax benefits, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gross increases (decreases) in unrecognized tax positions as a result of tax positions taken during a prior period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,755)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(276)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gross increases in unrecognized tax positions as a result of tax positions taken in the current period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Decreases in unrecognized tax positions related to settlements with taxing authorities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(537)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,446)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Decreases in unrecognized tax positions as a result of a lapse of the applicable statutes of limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,015)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(355)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,213)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total amounts of unrecognized tax benefits, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SummaryOfIncomeTaxContingenciesTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxYWZjOWIwYWZkNDg0N2I4YTRhNjY3NDQxNTU0OWUyZS90YWJsZXJhbmdlOjFhZmM5YjBhZmQ0ODQ3YjhhNGE2Njc0NDE1NTQ5ZTJlXzMtMi0xLTEtMA_37888f2e-1c44-4775-ba53-42ec9143c9bd"
      unitRef="usd">22484000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i0c634b937c58472e84857eacf99e17df_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxYWZjOWIwYWZkNDg0N2I4YTRhNjY3NDQxNTU0OWUyZS90YWJsZXJhbmdlOjFhZmM5YjBhZmQ0ODQ3YjhhNGE2Njc0NDE1NTQ5ZTJlXzMtNC0xLTEtMA_d51f6848-1fbd-4d95-8143-550386e06103"
      unitRef="usd">26841000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i28d0821cac8841b29cf960002d3bc993_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxYWZjOWIwYWZkNDg0N2I4YTRhNjY3NDQxNTU0OWUyZS90YWJsZXJhbmdlOjFhZmM5YjBhZmQ0ODQ3YjhhNGE2Njc0NDE1NTQ5ZTJlXzMtNi0xLTEtMA_47408862-956c-40c1-abb7-a590705b59c2"
      unitRef="usd">24247000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxYWZjOWIwYWZkNDg0N2I4YTRhNjY3NDQxNTU0OWUyZS90YWJsZXJhbmdlOjFhZmM5YjBhZmQ0ODQ3YjhhNGE2Njc0NDE1NTQ5ZTJlXzQtMi0xLTEtMA_cc5d6d2f-81ff-4f68-a02c-39287347b1cf"
      unitRef="usd">443000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxYWZjOWIwYWZkNDg0N2I4YTRhNjY3NDQxNTU0OWUyZS90YWJsZXJhbmdlOjFhZmM5YjBhZmQ0ODQ3YjhhNGE2Njc0NDE1NTQ5ZTJlXzQtNC0xLTEtMA_d3fe1adb-8ed1-47b8-bc4e-509f5f697718"
      unitRef="usd">1755000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxYWZjOWIwYWZkNDg0N2I4YTRhNjY3NDQxNTU0OWUyZS90YWJsZXJhbmdlOjFhZmM5YjBhZmQ0ODQ3YjhhNGE2Njc0NDE1NTQ5ZTJlXzQtNi0xLTEtMA_b973e2ed-c37c-4015-bc7c-a42f57a4d155"
      unitRef="usd">276000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxYWZjOWIwYWZkNDg0N2I4YTRhNjY3NDQxNTU0OWUyZS90YWJsZXJhbmdlOjFhZmM5YjBhZmQ0ODQ3YjhhNGE2Njc0NDE1NTQ5ZTJlXzUtMi0xLTEtMA_6c61af83-c09a-4c26-976f-dda291d4e2b0"
      unitRef="usd">2414000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxYWZjOWIwYWZkNDg0N2I4YTRhNjY3NDQxNTU0OWUyZS90YWJsZXJhbmdlOjFhZmM5YjBhZmQ0ODQ3YjhhNGE2Njc0NDE1NTQ5ZTJlXzUtNC0xLTEtMA_c07d58c2-f621-4c2e-979d-2b5fef2ad16c"
      unitRef="usd">4199000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxYWZjOWIwYWZkNDg0N2I4YTRhNjY3NDQxNTU0OWUyZS90YWJsZXJhbmdlOjFhZmM5YjBhZmQ0ODQ3YjhhNGE2Njc0NDE1NTQ5ZTJlXzUtNi0xLTEtMA_823eb087-cd6c-42da-b420-394cb13f35db"
      unitRef="usd">4083000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxYWZjOWIwYWZkNDg0N2I4YTRhNjY3NDQxNTU0OWUyZS90YWJsZXJhbmdlOjFhZmM5YjBhZmQ0ODQ3YjhhNGE2Njc0NDE1NTQ5ZTJlXzYtMi0xLTEtMA_c3abec27-fd25-46b7-9352-ef2fe71fa03b"
      unitRef="usd">537000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxYWZjOWIwYWZkNDg0N2I4YTRhNjY3NDQxNTU0OWUyZS90YWJsZXJhbmdlOjFhZmM5YjBhZmQ0ODQ3YjhhNGE2Njc0NDE1NTQ5ZTJlXzYtNC0xLTEtMA_81235a65-6541-4c76-af85-b6d3e36da23b"
      unitRef="usd">6446000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxYWZjOWIwYWZkNDg0N2I4YTRhNjY3NDQxNTU0OWUyZS90YWJsZXJhbmdlOjFhZmM5YjBhZmQ0ODQ3YjhhNGE2Njc0NDE1NTQ5ZTJlXzYtNi0xLTEtMA_df01e35e-fcad-44df-96f5-04a39b950fe6"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxYWZjOWIwYWZkNDg0N2I4YTRhNjY3NDQxNTU0OWUyZS90YWJsZXJhbmdlOjFhZmM5YjBhZmQ0ODQ3YjhhNGE2Njc0NDE1NTQ5ZTJlXzctMi0xLTEtMA_61f1b895-6898-489d-b6ad-ce92f813365f"
      unitRef="usd">3015000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxYWZjOWIwYWZkNDg0N2I4YTRhNjY3NDQxNTU0OWUyZS90YWJsZXJhbmdlOjFhZmM5YjBhZmQ0ODQ3YjhhNGE2Njc0NDE1NTQ5ZTJlXzctNC0xLTEtMA_f2f79a2a-ccaa-4aea-8dbf-740e434d5337"
      unitRef="usd">355000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxYWZjOWIwYWZkNDg0N2I4YTRhNjY3NDQxNTU0OWUyZS90YWJsZXJhbmdlOjFhZmM5YjBhZmQ0ODQ3YjhhNGE2Njc0NDE1NTQ5ZTJlXzctNi0xLTEtMA_3c29033d-54b6-4071-bbac-7b3a977e9dd2"
      unitRef="usd">1213000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxYWZjOWIwYWZkNDg0N2I4YTRhNjY3NDQxNTU0OWUyZS90YWJsZXJhbmdlOjFhZmM5YjBhZmQ0ODQ3YjhhNGE2Njc0NDE1NTQ5ZTJlXzgtMi0xLTEtMA_f5676b33-d807-4cfa-b4b2-b86d9d48e39c"
      unitRef="usd">21789000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxYWZjOWIwYWZkNDg0N2I4YTRhNjY3NDQxNTU0OWUyZS90YWJsZXJhbmdlOjFhZmM5YjBhZmQ0ODQ3YjhhNGE2Njc0NDE1NTQ5ZTJlXzgtNC0xLTEtMA_52a2ea28-57b8-470b-8dcd-9df94edf02a7"
      unitRef="usd">22484000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i0c634b937c58472e84857eacf99e17df_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90YWJsZToxYWZjOWIwYWZkNDg0N2I4YTRhNjY3NDQxNTU0OWUyZS90YWJsZXJhbmdlOjFhZmM5YjBhZmQ0ODQ3YjhhNGE2Njc0NDE1NTQ5ZTJlXzgtNi0xLTEtMA_b5deb5b1-ce00-4b85-98bc-2f1d1b08863d"
      unitRef="usd">26841000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90ZXh0cmVnaW9uOjk2Y2VlMWJjZmEwNDRkMTc5MDEwMDVkMTk1MTExYmFjXzUyNzM_95b5f719-2837-44d2-a8e1-e9d1258769aa"
      unitRef="usd">22200000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90ZXh0cmVnaW9uOjk2Y2VlMWJjZmEwNDRkMTc5MDEwMDVkMTk1MTExYmFjXzUyODA_64ca76a9-9ebb-4890-9436-ab6362abd4d4"
      unitRef="usd">21800000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90ZXh0cmVnaW9uOjk2Y2VlMWJjZmEwNDRkMTc5MDEwMDVkMTk1MTExYmFjXzU0Nzg_daad9da0-6a47-4d36-b3dd-c87f86dd6ec2"
      unitRef="usd">1100000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90ZXh0cmVnaW9uOjk2Y2VlMWJjZmEwNDRkMTc5MDEwMDVkMTk1MTExYmFjXzU0ODI_0e748207-9489-4d32-b383-09e6e2899554"
      unitRef="usd">1300000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90ZXh0cmVnaW9uOjk2Y2VlMWJjZmEwNDRkMTc5MDEwMDVkMTk1MTExYmFjXzU0OTA_999d1675-f496-4102-afbb-e1fa138db1f5"
      unitRef="usd">1800000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90ZXh0cmVnaW9uOjk2Y2VlMWJjZmEwNDRkMTc5MDEwMDVkMTk1MTExYmFjXzU1OTY_5a972493-2f05-4af9-9c2e-e33c61d6f023"
      unitRef="usd">3800000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90ZXh0cmVnaW9uOjk2Y2VlMWJjZmEwNDRkMTc5MDEwMDVkMTk1MTExYmFjXzU2MDA_05c06b2a-dce9-4263-ad89-af389a253189"
      unitRef="usd">3600000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="i0c634b937c58472e84857eacf99e17df_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMTcvZnJhZzo5NmNlZTFiY2ZhMDQ0ZDE3OTAxMDA1ZDE5NTExMWJhYy90ZXh0cmVnaW9uOjk2Y2VlMWJjZmEwNDRkMTc5MDEwMDVkMTk1MTExYmFjXzU2MDg_ac886fbb-af46-4b1f-ba6f-654970d6d7bc"
      unitRef="usd">3600000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjAvZnJhZzoxMmE3M2IwMjg3ODU0M2YxYTM2ZjAzYzJlMjhkYmQyMi90ZXh0cmVnaW9uOjEyYTczYjAyODc4NTQzZjFhMzZmMDNjMmUyOGRiZDIyXzE2Mzk_c34559b5-f0d0-432d-98e4-685d53155442">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;EARNINGS PER SHARE&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic earnings per share is computed by dividing net income attributable to our stockholders by the weighted average number of shares of common stock and vested deferred stock units outstanding during the year. The computation of diluted earnings per share is similar to the computation of basic earnings per share, except that the denominator is increased for the assumed exercise of dilutive options and assumed issuance of unvested restricted stock units and unvested deferred stock units using the treasury stock method unless the effect is anti-dilutive. The treasury stock method assumes that proceeds, including cash received from the exercise of employee stock options and the&#160;total unrecognized compensation expense for unvested share-based compensation awards, would be used to purchase our common stock at the average market price during the period.&#160;Vested deferred stock units outstanding are included in shares outstanding for basic and diluted earnings per share because the associated shares of our common stock are issuable for no cash consideration, the number of shares of our common stock to be issued is fixed and issuance is not contingent. Refer to "Note 5. Share-Based Compensation" for additional information regarding deferred stock units.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of weighted average shares outstanding for basic and diluted earnings per share:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares outstanding for basic earnings per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;85,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;85,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares outstanding for diluted earnings per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares outstanding for basic earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;85,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;85,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dilutive effect of share-based payment awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;87,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain options to acquire shares have been excluded from the calculation of shares outstanding for diluted earnings per share because they were anti-dilutive. The following table presents information concerning those anti-dilutive options:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average number of shares underlying anti-dilutive options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjAvZnJhZzoxMmE3M2IwMjg3ODU0M2YxYTM2ZjAzYzJlMjhkYmQyMi90ZXh0cmVnaW9uOjEyYTczYjAyODc4NTQzZjFhMzZmMDNjMmUyOGRiZDIyXzE2MzI_c2a99c2e-2285-483d-a21b-9db233a20910">Basic earnings per share is computed by dividing net income attributable to our stockholders by the weighted average number of shares of common stock and vested deferred stock units outstanding during the year. The computation of diluted earnings per share is similar to the computation of basic earnings per share, except that the denominator is increased for the assumed exercise of dilutive options and assumed issuance of unvested restricted stock units and unvested deferred stock units using the treasury stock method unless the effect is anti-dilutive. The treasury stock method assumes that proceeds, including cash received from the exercise of employee stock options and the&#160;total unrecognized compensation expense for unvested share-based compensation awards, would be used to purchase our common stock at the average market price during the period.&#160;Vested deferred stock units outstanding are included in shares outstanding for basic and diluted earnings per share because the associated shares of our common stock are issuable for no cash consideration, the number of shares of our common stock to be issued is fixed and issuance is not contingent. Refer to "Note 5. Share-Based Compensation" for additional information regarding deferred stock units.</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjAvZnJhZzoxMmE3M2IwMjg3ODU0M2YxYTM2ZjAzYzJlMjhkYmQyMi90ZXh0cmVnaW9uOjEyYTczYjAyODc4NTQzZjFhMzZmMDNjMmUyOGRiZDIyXzE2MzM_b3d8afea-9947-42c1-9ff6-2b4331423a17">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of weighted average shares outstanding for basic and diluted earnings per share:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares outstanding for basic earnings per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;85,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;85,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares outstanding for diluted earnings per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares outstanding for basic earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;85,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;85,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dilutive effect of share-based payment awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;87,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjAvZnJhZzoxMmE3M2IwMjg3ODU0M2YxYTM2ZjAzYzJlMjhkYmQyMi90YWJsZTo4OTBkZmNlYjQ4NTU0YmFkOGYyN2U1NjI0NGIxODM0OC90YWJsZXJhbmdlOjg5MGRmY2ViNDg1NTRiYWQ4ZjI3ZTU2MjQ0YjE4MzQ4XzMtMi0xLTEtMA_c5b28276-0ad8-4cb5-a318-161feb5e3fc1"
      unitRef="shares">85200000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjAvZnJhZzoxMmE3M2IwMjg3ODU0M2YxYTM2ZjAzYzJlMjhkYmQyMi90YWJsZTo4OTBkZmNlYjQ4NTU0YmFkOGYyN2U1NjI0NGIxODM0OC90YWJsZXJhbmdlOjg5MGRmY2ViNDg1NTRiYWQ4ZjI3ZTU2MjQ0YjE4MzQ4XzMtNC0xLTEtMA_3ec3dbea-d398-4276-8a44-6263cc2e4e05"
      unitRef="shares">85342000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjAvZnJhZzoxMmE3M2IwMjg3ODU0M2YxYTM2ZjAzYzJlMjhkYmQyMi90YWJsZTo4OTBkZmNlYjQ4NTU0YmFkOGYyN2U1NjI0NGIxODM0OC90YWJsZXJhbmdlOjg5MGRmY2ViNDg1NTRiYWQ4ZjI3ZTU2MjQ0YjE4MzQ4XzMtNi0xLTEtMA_584528d1-f3b0-40dc-8751-e81c49b94f8a"
      unitRef="shares">86115000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjAvZnJhZzoxMmE3M2IwMjg3ODU0M2YxYTM2ZjAzYzJlMjhkYmQyMi90YWJsZTo4OTBkZmNlYjQ4NTU0YmFkOGYyN2U1NjI0NGIxODM0OC90YWJsZXJhbmdlOjg5MGRmY2ViNDg1NTRiYWQ4ZjI3ZTU2MjQ0YjE4MzQ4XzYtMi0xLTEtMA_246e983e-e867-4452-b298-f0206c2c1fd1"
      unitRef="shares">85200000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjAvZnJhZzoxMmE3M2IwMjg3ODU0M2YxYTM2ZjAzYzJlMjhkYmQyMi90YWJsZTo4OTBkZmNlYjQ4NTU0YmFkOGYyN2U1NjI0NGIxODM0OC90YWJsZXJhbmdlOjg5MGRmY2ViNDg1NTRiYWQ4ZjI3ZTU2MjQ0YjE4MzQ4XzYtNC0xLTEtMA_e883def2-519c-46c2-947d-689d57e9a3a7"
      unitRef="shares">85342000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjAvZnJhZzoxMmE3M2IwMjg3ODU0M2YxYTM2ZjAzYzJlMjhkYmQyMi90YWJsZTo4OTBkZmNlYjQ4NTU0YmFkOGYyN2U1NjI0NGIxODM0OC90YWJsZXJhbmdlOjg5MGRmY2ViNDg1NTRiYWQ4ZjI3ZTU2MjQ0YjE4MzQ4XzYtNi0xLTEtMA_1f55cedb-2f50-41f9-ac82-386e9c5cb04c"
      unitRef="shares">86115000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjAvZnJhZzoxMmE3M2IwMjg3ODU0M2YxYTM2ZjAzYzJlMjhkYmQyMi90YWJsZTo4OTBkZmNlYjQ4NTU0YmFkOGYyN2U1NjI0NGIxODM0OC90YWJsZXJhbmdlOjg5MGRmY2ViNDg1NTRiYWQ4ZjI3ZTU2MjQ0YjE4MzQ4XzctMi0xLTEtMA_fa70cc86-1a89-45ed-980b-6077885bb617"
      unitRef="shares">1372000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjAvZnJhZzoxMmE3M2IwMjg3ODU0M2YxYTM2ZjAzYzJlMjhkYmQyMi90YWJsZTo4OTBkZmNlYjQ4NTU0YmFkOGYyN2U1NjI0NGIxODM0OC90YWJsZXJhbmdlOjg5MGRmY2ViNDg1NTRiYWQ4ZjI3ZTU2MjQ0YjE4MzQ4XzctNC0xLTEtMA_d7ef67a6-51a0-4cc7-b718-059ba9e93cc9"
      unitRef="shares">1380000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjAvZnJhZzoxMmE3M2IwMjg3ODU0M2YxYTM2ZjAzYzJlMjhkYmQyMi90YWJsZTo4OTBkZmNlYjQ4NTU0YmFkOGYyN2U1NjI0NGIxODM0OC90YWJsZXJhbmdlOjg5MGRmY2ViNDg1NTRiYWQ4ZjI3ZTU2MjQ0YjE4MzQ4XzctNi0xLTEtMA_0bb4fc21-617c-43f9-93dd-5411c9628187"
      unitRef="shares">1427000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjAvZnJhZzoxMmE3M2IwMjg3ODU0M2YxYTM2ZjAzYzJlMjhkYmQyMi90YWJsZTo4OTBkZmNlYjQ4NTU0YmFkOGYyN2U1NjI0NGIxODM0OC90YWJsZXJhbmdlOjg5MGRmY2ViNDg1NTRiYWQ4ZjI3ZTU2MjQ0YjE4MzQ4XzgtMi0xLTEtMA_867f52b5-6081-4ebe-b466-22bf69d48429"
      unitRef="shares">86572000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjAvZnJhZzoxMmE3M2IwMjg3ODU0M2YxYTM2ZjAzYzJlMjhkYmQyMi90YWJsZTo4OTBkZmNlYjQ4NTU0YmFkOGYyN2U1NjI0NGIxODM0OC90YWJsZXJhbmdlOjg5MGRmY2ViNDg1NTRiYWQ4ZjI3ZTU2MjQ0YjE4MzQ4XzgtNC0xLTEtMA_32ee942b-7464-473f-8762-332d943ea067"
      unitRef="shares">86722000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjAvZnJhZzoxMmE3M2IwMjg3ODU0M2YxYTM2ZjAzYzJlMjhkYmQyMi90YWJsZTo4OTBkZmNlYjQ4NTU0YmFkOGYyN2U1NjI0NGIxODM0OC90YWJsZXJhbmdlOjg5MGRmY2ViNDg1NTRiYWQ4ZjI3ZTU2MjQ0YjE4MzQ4XzgtNi0xLTEtMA_939e26cf-cd5c-49be-a53f-f72738a543aa"
      unitRef="shares">87542000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjAvZnJhZzoxMmE3M2IwMjg3ODU0M2YxYTM2ZjAzYzJlMjhkYmQyMi90ZXh0cmVnaW9uOjEyYTczYjAyODc4NTQzZjFhMzZmMDNjMmUyOGRiZDIyXzE2Mjk_53628577-87ee-4d71-883e-487c0fe79e22">The following table presents information concerning those anti-dilutive options:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average number of shares underlying anti-dilutive options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjAvZnJhZzoxMmE3M2IwMjg3ODU0M2YxYTM2ZjAzYzJlMjhkYmQyMi90YWJsZTphOTNmMTk3NTBlYTA0Y2Q5YTRlOWY3ZDQwYjZjNDIyNC90YWJsZXJhbmdlOmE5M2YxOTc1MGVhMDRjZDlhNGU5ZjdkNDBiNmM0MjI0XzMtMi0xLTEtMA_f7767806-5022-4639-a1bb-5be7195cacc5"
      unitRef="shares">121000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjAvZnJhZzoxMmE3M2IwMjg3ODU0M2YxYTM2ZjAzYzJlMjhkYmQyMi90YWJsZTphOTNmMTk3NTBlYTA0Y2Q5YTRlOWY3ZDQwYjZjNDIyNC90YWJsZXJhbmdlOmE5M2YxOTc1MGVhMDRjZDlhNGU5ZjdkNDBiNmM0MjI0XzMtNC0xLTEtMA_336e5472-3e5b-4dd2-baa4-da5a9162e458"
      unitRef="shares">206000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjAvZnJhZzoxMmE3M2IwMjg3ODU0M2YxYTM2ZjAzYzJlMjhkYmQyMi90YWJsZTphOTNmMTk3NTBlYTA0Y2Q5YTRlOWY3ZDQwYjZjNDIyNC90YWJsZXJhbmdlOmE5M2YxOTc1MGVhMDRjZDlhNGU5ZjdkNDBiNmM0MjI0XzMtNi0xLTEtMA_facf34af-7a3c-4e2a-9c0c-ebeaf77ada28"
      unitRef="shares">200000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:CommitmentsContingenciesAndGuaranteesTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjMvZnJhZzpmNzg3MGU2OWQ2ZDc0ZTVhYWEyMzVlYmI1Y2IwNGZjYy90ZXh0cmVnaW9uOmY3ODcwZTY5ZDZkNzRlNWFhYTIzNWViYjVjYjA0ZmNjXzc1MTY_47be6efd-ba99-4db9-8b9a-2d5a20731bca">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;COMMITMENTS, CONTINGENCIES AND GUARANTEES&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Commitments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to "Note 8. Leases" for more information regarding our lease commitments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are required to annually purchase a minimum amount of inventory from certain suppliers. Through 2026, we have a total of $2.9 million in minimum purchase commitments under these arrangements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are subject to claims that&#160;may&#160;arise in the ordinary course of business, including with respect to actual and threatened litigation and other matters. We accrue for loss contingencies when it is probable that future expenditures will be made, and such expenditures can be reasonably estimated. However, the results of legal actions cannot be predicted with certainty, and therefore our actual losses with respect to these contingencies could exceed our accruals. Except for the litigation matter described below, at December 31, 2021, our accruals with respect to actual and threatened litigation were not material. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#160;&#160;&#160;&#160;We are a defendant in an ongoing litigation matter involving an alleged breach of contract for underpayment of royalty payments made from 2004 through 2017 under an expired patent license agreement. The plaintiff has asserted a claim of approximately $50&#160;million, inclusive of interest through June 30, 2020, alleging that the incorrect royalty provision was applied to certain licensed products and services throughout the agreement term and that royalties were also due on non-licensed diagnostic services that were provided concurrently with licensed services. The trial court previously ruled in favor of the plaintiff in this matter and we are appealing the judgment and continue to vigorously defend ourselves against the plaintiff&#x2019;s allegations. While we believe the claim is without merit, litigation is inherently unpredictable and there can be no assurance that we will prevail in this matter. During the third quarter of 2020, we established an accrual of $27.5&#160;million related to this ongoing matter, which represents the amount of a contingent loss that we have determined to be probable and estimable. We have not made any adjustments to this accrual since it was established. The actual cost of resolving this matter may be higher or lower than the amount we have accrued.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We self-insure costs associated with health, workers&#x2019; compensation, auto, and general welfare claims incurred by our U.S. and Canadian employees up to certain limits. Insurance companies provide insurance for claims above these limits. Claim liabilities are recorded for estimates of the loss that we will ultimately incur on reported claims, as well as estimates of claims that have been incurred but not yet reported. Such liabilities are based on individual coverage, the average time from when a claim is incurred to the time it is paid and judgments about the present, and expected levels of claim frequency and severity. Estimated claim liabilities could be significantly affected if future occurrences and claims differ from these assumptions and historical trends. Estimated claim liabilities are included in accrued liabilities in the accompanying consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under our current employee healthcare insurance policy for U.S. employees, we retain claims liability risk per incident up to $1 million per year in 2021, 2020, and 2019. We recognized U.S. employee healthcare claim expense of $78.5 million, $59.5 million, and $59.3 million for the years ended December 31, 2021, 2020, and 2019, respectively, which represents actual claims paid and an estimate of our liability for the uninsured portion of employee healthcare obligations that have been incurred but not paid. Should employee health insurance claims exceed our estimated liability, we would have further obligations. Our estimated liability for healthcare claims that have been incurred but not paid as of December 31, 2021 and 2020, was approximately $7.8 million and $5.5 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Workers&#x2019; compensation and automobile claim expenses recognized during the years ended December 31, 2021, 2020, and 2019 and our respective liability for such claims as of December 31, 2021, 2020, and 2019 were not material. For the years ended on or prior to December&#160;31, 2018, based on our retained claim liability per incident and our aggregate claim liability per year, our maximum liability in excess of the amounts deemed probable and previously recognized is not material as of &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December 31, 2021. As of December 31, 2021, we had outstanding letters of credit totaling $1.4 million to the insurance companies as security for the claims in connection with these policies.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have entered into an employment agreement with our chief executive officer whereby payment may be required if we terminate his employment without cause other than following a change in control. The amount payable is based upon the executive&#x2019;s salary at the time of termination and the cost to us of continuing to provide certain benefits. Had this officer been terminated without cause at December 31, 2021, other than following a change in control, we would have had an obligation for salaries and benefits of approximately $2.0 million under such agreement. In addition, the agreement provides for continued vesting of his outstanding equity awards for a period of two years, which would accelerate approximately $8.0 million of share-based compensation expense as of December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have entered into employment agreements with each of our officers that require us to make certain payments in the event the officer&#x2019;s employment is terminated under certain circumstances within a certain period following a change in control. The amount payable by us under each of these agreements is based on the officer&#x2019;s salary and bonus history at the time of termination and the cost to us of continuing to provide certain benefits. Had all of our officers been terminated in qualifying terminations following a change in control at December 31, 2021, we would have had aggregate obligations of approximately $42.2 million under these agreements. These agreements also provide for the acceleration of the vesting of all stock options and restricted stock units upon any qualifying termination following a change in control. At this time, we believe the likelihood of terminations as a result of the scenarios described is remote, and therefore, we have not accrued for such loss contingencies.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, we have received notices alleging that our products infringe third-party proprietary rights, although we are not aware of any pending litigation with respect to such claims. Patent litigation frequently is complex and expensive, and the outcome of patent litigation can be difficult to predict. There can be no assurance that we will prevail in any infringement proceedings that may be commenced against us. If we lose any such litigation, we may be stopped from selling certain products and/or we may be required to pay damages as a result of the litigation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Guarantees&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We enter into agreements with third parties in the ordinary course of business under which we are obligated to indemnify such third parties for and against various risks and losses. The precise terms of such indemnities vary with the nature of the agreement. In many cases, we limit the maximum amount of our indemnification obligations, but in some cases, those obligations may be theoretically unlimited. We have not incurred material expenses in discharging any of these indemnification obligations and, based on our analysis of the nature of the risks involved, we believe that the fair value of potential indemnification under these agreements is minimal. Accordingly, we have recorded no liabilities for these obligations at December 31, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When acquiring a business, we sometimes assume liability for certain events or occurrences that took place prior to the date of acquisition. As of December 31, 2021 and 2020, we do not have any material pre-acquisition liabilities recorded.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsContingenciesAndGuaranteesTextBlock>
    <us-gaap:PurchaseObligation
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjMvZnJhZzpmNzg3MGU2OWQ2ZDc0ZTVhYWEyMzVlYmI1Y2IwNGZjYy90ZXh0cmVnaW9uOmY3ODcwZTY5ZDZkNzRlNWFhYTIzNWViYjVjYjA0ZmNjXzIzNw_fa1fb302-06d7-4e50-81ce-295f09561d94"
      unitRef="usd">2900000</us-gaap:PurchaseObligation>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjMvZnJhZzpmNzg3MGU2OWQ2ZDc0ZTVhYWEyMzVlYmI1Y2IwNGZjYy90ZXh0cmVnaW9uOmY3ODcwZTY5ZDZkNzRlNWFhYTIzNWViYjVjYjA0ZmNjXzc1MTg_11d74a90-0baf-4a62-9be7-b3858f2f9c9d">We are subject to claims that&#160;may&#160;arise in the ordinary course of business, including with respect to actual and threatened litigation and other matters. We accrue for loss contingencies when it is probable that future expenditures will be made, and such expenditures can be reasonably estimated. However, the results of legal actions cannot be predicted with certainty, and therefore our actual losses with respect to these contingencies could exceed our accruals.</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjMvZnJhZzpmNzg3MGU2OWQ2ZDc0ZTVhYWEyMzVlYmI1Y2IwNGZjYy90ZXh0cmVnaW9uOmY3ODcwZTY5ZDZkNzRlNWFhYTIzNWViYjVjYjA0ZmNjXzExNzQ_ac1f9db2-57ba-4162-befa-b95a2328b5c7"
      unitRef="usd">50000000</us-gaap:LossContingencyDamagesSoughtValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="ie58c704216a6458da306b8341192f2b4_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjMvZnJhZzpmNzg3MGU2OWQ2ZDc0ZTVhYWEyMzVlYmI1Y2IwNGZjYy90ZXh0cmVnaW9uOmY3ODcwZTY5ZDZkNzRlNWFhYTIzNWViYjVjYjA0ZmNjXzE4MjM_ac548613-7bb4-4e87-bb5e-5afff886c698"
      unitRef="usd">27500000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <idxx:RetainedClaimLiabilityPerIncident
      contextRef="i94032e21bcdb4fd5a7a56338b7e76c84_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjMvZnJhZzpmNzg3MGU2OWQ2ZDc0ZTVhYWEyMzVlYmI1Y2IwNGZjYy90ZXh0cmVnaW9uOmY3ODcwZTY5ZDZkNzRlNWFhYTIzNWViYjVjYjA0ZmNjXzMwNzE_4d88381d-2e02-4022-bdc9-c039b4597b38"
      unitRef="usd">1000000</idxx:RetainedClaimLiabilityPerIncident>
    <idxx:RetainedClaimLiabilityPerIncident
      contextRef="i9a8414f50ab04a91a3892300c9d0d3d7_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjMvZnJhZzpmNzg3MGU2OWQ2ZDc0ZTVhYWEyMzVlYmI1Y2IwNGZjYy90ZXh0cmVnaW9uOmY3ODcwZTY5ZDZkNzRlNWFhYTIzNWViYjVjYjA0ZmNjXzMwNzE_7100854d-2d58-49e0-adca-c7b8a5d38576"
      unitRef="usd">1000000</idxx:RetainedClaimLiabilityPerIncident>
    <idxx:RetainedClaimLiabilityPerIncident
      contextRef="i1c3f540bc4ee4adeaf82639617d91385_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjMvZnJhZzpmNzg3MGU2OWQ2ZDc0ZTVhYWEyMzVlYmI1Y2IwNGZjYy90ZXh0cmVnaW9uOmY3ODcwZTY5ZDZkNzRlNWFhYTIzNWViYjVjYjA0ZmNjXzMwNzE_905be856-31ed-4c29-98c5-311bbb29ecc6"
      unitRef="usd">1000000</idxx:RetainedClaimLiabilityPerIncident>
    <us-gaap:GeneralInsuranceExpense
      contextRef="ib865674d7bab445389b9c3bbec146020_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjMvZnJhZzpmNzg3MGU2OWQ2ZDc0ZTVhYWEyMzVlYmI1Y2IwNGZjYy90ZXh0cmVnaW9uOmY3ODcwZTY5ZDZkNzRlNWFhYTIzNWViYjVjYjA0ZmNjXzMxNTg_7136930c-eb2c-4113-9c15-af89456aa10d"
      unitRef="usd">78500000</us-gaap:GeneralInsuranceExpense>
    <us-gaap:GeneralInsuranceExpense
      contextRef="ie45306aad98e47fdbad67873c8c7d7cd_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjMvZnJhZzpmNzg3MGU2OWQ2ZDc0ZTVhYWEyMzVlYmI1Y2IwNGZjYy90ZXh0cmVnaW9uOmY3ODcwZTY5ZDZkNzRlNWFhYTIzNWViYjVjYjA0ZmNjXzMxNjI_d901164f-f09a-4693-a565-1686bdc0c62b"
      unitRef="usd">59500000</us-gaap:GeneralInsuranceExpense>
    <us-gaap:GeneralInsuranceExpense
      contextRef="i44fa2e5abf144441938e326da9122112_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjMvZnJhZzpmNzg3MGU2OWQ2ZDc0ZTVhYWEyMzVlYmI1Y2IwNGZjYy90ZXh0cmVnaW9uOmY3ODcwZTY5ZDZkNzRlNWFhYTIzNWViYjVjYjA0ZmNjXzMxNzA_45084c3b-707d-430f-9c44-573aab4e1de0"
      unitRef="usd">59300000</us-gaap:GeneralInsuranceExpense>
    <us-gaap:SelfInsuranceReserve
      contextRef="i773e63ef7fdd42e489afb58247b219a0_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjMvZnJhZzpmNzg3MGU2OWQ2ZDc0ZTVhYWEyMzVlYmI1Y2IwNGZjYy90ZXh0cmVnaW9uOmY3ODcwZTY5ZDZkNzRlNWFhYTIzNWViYjVjYjA0ZmNjXzM2MTY_7dbfc972-cdc9-4b5c-9fa9-286b3492ad5e"
      unitRef="usd">7800000</us-gaap:SelfInsuranceReserve>
    <us-gaap:SelfInsuranceReserve
      contextRef="if5c4c6cccd414bef949b6f0b3b152901_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjMvZnJhZzpmNzg3MGU2OWQ2ZDc0ZTVhYWEyMzVlYmI1Y2IwNGZjYy90ZXh0cmVnaW9uOmY3ODcwZTY5ZDZkNzRlNWFhYTIzNWViYjVjYjA0ZmNjXzM2MjM_5bc869e0-0b1e-417f-b224-9588c5fa3464"
      unitRef="usd">5500000</us-gaap:SelfInsuranceReserve>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjMvZnJhZzpmNzg3MGU2OWQ2ZDc0ZTVhYWEyMzVlYmI1Y2IwNGZjYy90ZXh0cmVnaW9uOmY3ODcwZTY5ZDZkNzRlNWFhYTIzNWViYjVjYjA0ZmNjXzQxNDc_6fb47255-d946-4fcf-9095-ae46558cea9e"
      unitRef="usd">1400000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:SupplementalUnemploymentBenefitsSeveranceBenefits
      contextRef="i8f64c178a0b14875b7618692b20160b1_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjMvZnJhZzpmNzg3MGU2OWQ2ZDc0ZTVhYWEyMzVlYmI1Y2IwNGZjYy90ZXh0cmVnaW9uOmY3ODcwZTY5ZDZkNzRlNWFhYTIzNWViYjVjYjA0ZmNjXzQ3NTQ_286e0a21-964d-4278-9a5f-26578562c06a"
      unitRef="usd">2000000</us-gaap:SupplementalUnemploymentBenefitsSeveranceBenefits>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjMvZnJhZzpmNzg3MGU2OWQ2ZDc0ZTVhYWEyMzVlYmI1Y2IwNGZjYy90ZXh0cmVnaW9uOmY3ODcwZTY5ZDZkNzRlNWFhYTIzNWViYjVjYjA0ZmNjXzQ4ODY_0acb7610-3d0d-499c-9855-7bef31278c5b">two years</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjMvZnJhZzpmNzg3MGU2OWQ2ZDc0ZTVhYWEyMzVlYmI1Y2IwNGZjYy90ZXh0cmVnaW9uOmY3ODcwZTY5ZDZkNzRlNWFhYTIzNWViYjVjYjA0ZmNjXzQ5Mjc_bd57ca49-cd8a-4594-9060-ed49e727e83e"
      unitRef="usd">8000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost>
    <us-gaap:SupplementalUnemploymentBenefitsSeveranceBenefits
      contextRef="id4f5b7c174554a70b226143cb3f524f5_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjMvZnJhZzpmNzg3MGU2OWQ2ZDc0ZTVhYWEyMzVlYmI1Y2IwNGZjYy90ZXh0cmVnaW9uOmY3ODcwZTY5ZDZkNzRlNWFhYTIzNWViYjVjYjA0ZmNjXzU1ODA_7c9415db-6a65-49ce-a99b-e1f5c17ddbf1"
      unitRef="usd">42200000</us-gaap:SupplementalUnemploymentBenefitsSeveranceBenefits>
    <us-gaap:GuaranteeObligationsCurrentCarryingValue
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjMvZnJhZzpmNzg3MGU2OWQ2ZDc0ZTVhYWEyMzVlYmI1Y2IwNGZjYy90ZXh0cmVnaW9uOmY3ODcwZTY5ZDZkNzRlNWFhYTIzNWViYjVjYjA0ZmNjXzcyMzk_7a69e850-5a5a-433b-be57-673f870b80e2"
      unitRef="usd">0</us-gaap:GuaranteeObligationsCurrentCarryingValue>
    <us-gaap:GuaranteeObligationsCurrentCarryingValue
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjMvZnJhZzpmNzg3MGU2OWQ2ZDc0ZTVhYWEyMzVlYmI1Y2IwNGZjYy90ZXh0cmVnaW9uOmY3ODcwZTY5ZDZkNzRlNWFhYTIzNWViYjVjYjA0ZmNjXzcyMzk_c5f4972a-4ce2-4ba9-906f-d4d53cccabfe"
      unitRef="usd">0</us-gaap:GuaranteeObligationsCurrentCarryingValue>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90ZXh0cmVnaW9uOmZlY2Q2OGE2MTBkNzQ0MzhiMzFhNDRiODBiZmZjZjliXzQ0MDI_2e2f7d0f-da25-42a2-b7a2-4be6cd1bd651">SEGMENT REPORTING &lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We operate primarily through three business segments: diagnostic and information management-based products and services for the companion animal veterinary industry, which we refer to as CAG; water quality products (&#x201c;Water&#x201d;); and diagnostic products and services for livestock and poultry health, improve producer efficiency, and to ensure the quality and safety of milk, which we refer to as LPD. Our Other operating segment combines and presents our human medical diagnostic products and services business with our out-licensing arrangements because they do not meet the quantitative or qualitative thresholds for reportable segments.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision-maker (the "CODM"), or decision-making group, in deciding how to allocate resources and in assessing performance. Our CODM is our Chief Executive Officer. Our reportable segments include: CAG, Water, LPD, and Other. Assets are not allocated to segments for internal reporting purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CAG provides products and provide services for veterinarians and the biomedical research community, primarily related to diagnostics and information management. Water provides a range of innovative products used in the detection and quantification of various microbiological parameters in water. LPD provides diagnostic tests and related instrumentation and provides services that are used to manage the health status of livestock and poultry, to improve producer efficiency, and to ensure the quality and safety of milk. OPTI Medical develops, manufactures, and distributes human medical diagnostic products and provides human medical diagnostic services.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intersegment revenues, which are not included in the table below, were not material for the years ended December 31, 2021, 2020, and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of segment performance:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.350%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.797%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;CAG&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Water&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;LPD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,889,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;146,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;135,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,215,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;824,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;932,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(29,374)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income before provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;902,654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;157,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;744,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Net income attributable to noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to IDEXX Laboratories, Inc. stockholders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;744,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;94,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;104,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,385,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;128,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;145,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,706,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;574,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;694,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(32,539)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income before provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;661,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;79,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;582,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Net income attributable to noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to IDEXX Laboratories, Inc. stockholders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;581,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;84,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,119,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;132,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;132,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,406,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;462,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;552,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(30,628)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income before provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;522,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;94,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;427,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Net income attributable to noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to IDEXX Laboratories, Inc. stockholders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;427,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;77,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to "Note 3. Revenue Recognition" for a summary of disaggregated revenue by reportable segment and by major product and service category for the years ended December 31, 2021, 2020, and 2019.&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net long-lived assets, consisting of net property and equipment, are subject to geographic risks because they are generally difficult to move and to effectively utilize in another geographic area in a reasonable time period and because they are relatively illiquid. Net long-lived assets by principal geographic areas were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.318%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.320%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Americas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;436,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;412,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Brazil&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Canada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 12.25pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;460,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;438,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Europe, the Middle East and Africa&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;67,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;United Kingdom&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Netherlands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Switzerland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;98,934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;102,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Asia Pacific Region&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Japan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Australia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;587,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;555,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90ZXh0cmVnaW9uOmZlY2Q2OGE2MTBkNzQ0MzhiMzFhNDRiODBiZmZjZjliXzU0_a85012c6-d016-4ff9-85f0-e541e422706f"
      unitRef="segment">3</us-gaap:NumberOfReportableSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90ZXh0cmVnaW9uOmZlY2Q2OGE2MTBkNzQ0MzhiMzFhNDRiODBiZmZjZjliXzQ0MDM_47edebee-ce88-4aa4-bc6d-c55eeb90507f">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of segment performance:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.350%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.797%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;CAG&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Water&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;LPD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,889,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;146,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;135,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,215,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;824,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;932,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(29,374)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income before provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;902,654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;157,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;744,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Net income attributable to noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to IDEXX Laboratories, Inc. stockholders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;744,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;94,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;104,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,385,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;128,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;145,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,706,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;574,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;694,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(32,539)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income before provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;661,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;79,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;582,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Net income attributable to noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to IDEXX Laboratories, Inc. stockholders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;581,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;84,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,119,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;132,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;132,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,406,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;462,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;552,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(30,628)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income before provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;522,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;94,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;427,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Net income attributable to noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to IDEXX Laboratories, Inc. stockholders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;427,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;77,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6c823cc0aa3945d9874ea09ab5940878_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzMtMi0xLTEtMA_341cb13a-087b-4e03-a6db-8203e7df4e5b"
      unitRef="usd">2889960000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i81c0a80f385a4f18ab5cb5919ed28318_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzMtNC0xLTEtMA_83e84e7e-e3d0-4979-a2d5-0b3ba51a817a"
      unitRef="usd">146505000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4174c33ea3f8443fbc6587f7ac9a43ab_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzMtNi0xLTEtMA_60d86135-511a-45bd-9be0-8b8b22d93a5f"
      unitRef="usd">135887000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i94cd933d7b7b431caa324dc2936f5c55_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzMtOC0xLTEtMA_f20e37db-8421-4e78-9d46-981a2077c7ad"
      unitRef="usd">43008000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzMtMTAtMS0xLTA_55c17136-2d70-40dd-8ffb-f9dc2e66d6b9"
      unitRef="usd">3215360000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6c823cc0aa3945d9874ea09ab5940878_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzUtMi0xLTEtMA_f1e55e99-607e-4009-8df8-33525b8871c2"
      unitRef="usd">824022000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i81c0a80f385a4f18ab5cb5919ed28318_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzUtNC0xLTEtMA_1f0222bf-44a8-4f72-9cdc-4b8f6c9c9e70"
      unitRef="usd">65444000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i4174c33ea3f8443fbc6587f7ac9a43ab_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzUtNi0xLTEtMA_8b19d128-7e57-4df7-8aca-8ecc1e41c2ba"
      unitRef="usd">28636000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i94cd933d7b7b431caa324dc2936f5c55_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzUtOC0xLTEtMA_bea61297-ef75-43ee-8e1f-50ba4feaa1a2"
      unitRef="usd">13926000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzUtMTAtMS0xLTA_246dfdb2-0389-4d61-82c7-69efefebd74b"
      unitRef="usd">932028000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzYtMTAtMS0xLTA_14b9f4ab-b2a2-4845-98ac-4ccbd9221215"
      unitRef="usd">-29374000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzctMTAtMS0xLTA_5a7d5869-45ee-4270-ad2d-599a6b80ac58"
      unitRef="usd">902654000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzgtMTAtMS0xLTA_e8a19d4f-eb71-4a76-836a-5abea12930c0"
      unitRef="usd">157810000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzktMTAtMS0xLTA_ea1f8dce-f200-4279-b5f3-d654b31e25c0"
      unitRef="usd">744844000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzEwLTEwLTEtMS0w_2460e4b3-65c6-4152-a0ce-1c033b068d39"
      unitRef="usd">-1000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzExLTEwLTEtMS0w_5cee70c9-69f6-415e-a493-4df675cd2bbd"
      unitRef="usd">744845000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i6c823cc0aa3945d9874ea09ab5940878_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzEzLTItMS0xLTA_f7e57ebc-cd88-401b-87fa-ac6dcb67452e"
      unitRef="usd">94202000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i81c0a80f385a4f18ab5cb5919ed28318_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzEzLTQtMS0xLTA_3718c504-e8f2-4f13-a1da-6d95bd58f74f"
      unitRef="usd">2709000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i4174c33ea3f8443fbc6587f7ac9a43ab_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzEzLTYtMS0xLTA_df4af3c4-c18d-4f38-a71a-4cd146db3c08"
      unitRef="usd">3908000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i94cd933d7b7b431caa324dc2936f5c55_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzEzLTgtMS0xLTA_4f4ee1f6-4d6d-4558-86d7-acd56599bfcb"
      unitRef="usd">3777000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzEzLTEwLTEtMS0w_c434f823-4f5f-48ec-b51a-a0f9c61cdec8"
      unitRef="usd">104596000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i40313073e9c743ad89084e7fbcbd7e5e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzE2LTItMS0xLTA_24ebe4e4-f90f-4eb0-84aa-ea8ee4888e32"
      unitRef="usd">2385765000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic0b173f4625a4e1e807adc8eeb4e0592_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzE2LTQtMS0xLTA_953220ce-74e8-4804-a105-ebb063c554ae"
      unitRef="usd">128625000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4525be5d1c1b4d458fe78f047e981dc1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzE2LTYtMS0xLTA_419659a6-bc25-48e3-99b9-a533c7e24a64"
      unitRef="usd">145845000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i100119c49d8f4098bf6afdc675782162_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzE2LTgtMS0xLTA_e0fb1be7-1d65-4cb7-a6e5-aad0889c7613"
      unitRef="usd">46420000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzE2LTEwLTEtMS0w_f5198a34-4f18-4da8-a09c-7550da50891c"
      unitRef="usd">2706655000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="i40313073e9c743ad89084e7fbcbd7e5e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzE4LTItMS0xLTA_103b716b-e3bf-48b2-b328-c308e62ade82"
      unitRef="usd">574887000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic0b173f4625a4e1e807adc8eeb4e0592_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzE4LTQtMS0xLTA_84550578-807c-463d-bfd3-fd1b8615664a"
      unitRef="usd">58867000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i4525be5d1c1b4d458fe78f047e981dc1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzE4LTYtMS0xLTA_3b5f6cdb-433d-4fcd-92c1-85454d5e7551"
      unitRef="usd">40008000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i100119c49d8f4098bf6afdc675782162_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzE4LTgtMS0xLTA_6f163f0d-f471-4149-8596-dccd5d3a4778"
      unitRef="usd">20762000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzE4LTEwLTEtMS0w_3e96711b-fcdd-4d87-aa38-73d7a70ff845"
      unitRef="usd">694524000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzE5LTEwLTEtMS0w_0656b1d0-fdbf-4431-a28c-eed64b06ec96"
      unitRef="usd">-32539000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzIwLTEwLTEtMS0w_5f9be17a-190b-4c9e-ab63-119c42ef4759"
      unitRef="usd">661985000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzIxLTEwLTEtMS0w_c44887fa-179d-4241-ae86-00d259489d5c"
      unitRef="usd">79854000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzIyLTEwLTEtMS0w_94d3a76a-cded-4566-ba8e-b936e6eeef6e"
      unitRef="usd">582131000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzIzLTEwLTEtMS0w_f23e0342-27d9-43a6-b2b2-e06212f20a80"
      unitRef="usd">355000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzI0LTEwLTEtMS0w_1d5ff033-f450-41af-8a82-caa3ccf94e99"
      unitRef="usd">581776000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i40313073e9c743ad89084e7fbcbd7e5e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzI2LTItMS0xLTA_24b4edb9-5ec2-4715-96ea-678154576833"
      unitRef="usd">84697000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ic0b173f4625a4e1e807adc8eeb4e0592_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzI2LTQtMS0xLTA_8ca9196d-9f74-476c-97de-93bfd2ad68f9"
      unitRef="usd">2630000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i4525be5d1c1b4d458fe78f047e981dc1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzI2LTYtMS0xLTA_aaf57688-692f-42e3-924d-64066f9b0081"
      unitRef="usd">4070000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i100119c49d8f4098bf6afdc675782162_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzI2LTgtMS0xLTA_66cd1ec0-2901-431a-9dc7-2078e27b8ed3"
      unitRef="usd">4601000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzI2LTEwLTEtMS0w_508121ce-b828-4a42-bbe6-b0cbba4c86ab"
      unitRef="usd">95998000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ief827aa39f934947a553685160a5543c_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzI5LTItMS0xLTA_bb6d7ec8-7177-405c-9dcb-c8a93fd9e3f8"
      unitRef="usd">2119183000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iab0b6ebdef1a4be9b052a1b82c635759_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzI5LTQtMS0xLTA_d0fc02b7-cc1b-4eb3-8ea7-b4761f8948a2"
      unitRef="usd">132850000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i34e8ebea941e457cbadc1ce152e6a396_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzI5LTYtMS0xLTA_b19c5753-926b-4fa1-b94b-9598a5856b1c"
      unitRef="usd">132635000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia6f9b6007f00420291efefe0008f3d10_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzI5LTgtMS0xLTA_ee51dae1-9d46-4733-a9de-8916f941e74a"
      unitRef="usd">22240000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzI5LTEwLTEtMS0w_2e3eace4-3114-437f-933e-6697ee7a40da"
      unitRef="usd">2406908000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="ief827aa39f934947a553685160a5543c_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzMxLTItMS0xLTA_935fe98c-9f1f-4546-9bb1-032f514beec9"
      unitRef="usd">462605000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iab0b6ebdef1a4be9b052a1b82c635759_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzMxLTQtMS0xLTA_43724634-931d-4c6b-a8c0-96cd79f7d29d"
      unitRef="usd">61923000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i34e8ebea941e457cbadc1ce152e6a396_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzMxLTYtMS0xLTA_2cf32d8e-e6f9-432b-ac60-5a3ae44aada4"
      unitRef="usd">24735000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia6f9b6007f00420291efefe0008f3d10_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzMxLTgtMS0xLTA_e6cd222f-5c16-40db-8b7a-bee2e54a1a1a"
      unitRef="usd">3583000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzMxLTEwLTEtMS0w_18fe7859-f6cf-45df-87ea-f820b63ebc0b"
      unitRef="usd">552846000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzMyLTEwLTEtMS0w_92cb1668-960f-419b-b149-ddb97993a334"
      unitRef="usd">-30628000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzMzLTEwLTEtMS0w_46e4e99d-c3a5-4259-b9d4-ae2b176f2e80"
      unitRef="usd">522218000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzM0LTEwLTEtMS0w_2b0c6f7a-3357-47b6-b78e-18c3c308c6bc"
      unitRef="usd">94426000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzM1LTEwLTEtMS0w_d190080a-1f8c-4291-b2cb-a072c32b16e2"
      unitRef="usd">427792000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzM2LTEwLTEtMS0w_45d7d111-ef1f-4ac0-9e18-0463b1d04a76"
      unitRef="usd">72000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzM3LTEwLTEtMS0w_f9d3f2a5-ec17-40dd-b668-f9c47a0a7a36"
      unitRef="usd">427720000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ief827aa39f934947a553685160a5543c_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzM5LTItMS0xLTA_9b9063cc-1be0-4e7a-b5cf-f0b7afb17921"
      unitRef="usd">77620000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="iab0b6ebdef1a4be9b052a1b82c635759_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzM5LTQtMS0xLTA_857bfac1-97c2-462d-8dfd-9a123878980b"
      unitRef="usd">2794000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i34e8ebea941e457cbadc1ce152e6a396_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzM5LTYtMS0xLTA_ff080e97-f92f-443e-9040-ea860beba78c"
      unitRef="usd">4007000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ia6f9b6007f00420291efefe0008f3d10_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzM5LTgtMS0xLTA_5146231f-c424-458b-ac2a-bb0d6524a573"
      unitRef="usd">3590000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTo5MjQ2NDg4NWI3YzI0ODczOWY5MDRkOWQ2MGNhYzVhMy90YWJsZXJhbmdlOjkyNDY0ODg1YjdjMjQ4NzM5ZjkwNGQ5ZDYwY2FjNWEzXzM5LTEwLTEtMS0w_af311426-8f66-4824-812e-c694de1a1239"
      unitRef="usd">88011000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90ZXh0cmVnaW9uOmZlY2Q2OGE2MTBkNzQ0MzhiMzFhNDRiODBiZmZjZjliXzQ0MDU_13e80e16-e477-471e-bc15-34e7e31aedfc">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net long-lived assets, consisting of net property and equipment, are subject to geographic risks because they are generally difficult to move and to effectively utilize in another geographic area in a reasonable time period and because they are relatively illiquid. Net long-lived assets by principal geographic areas were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.318%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.320%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Americas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;436,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;412,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Brazil&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Canada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 12.25pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;460,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;438,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Europe, the Middle East and Africa&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;67,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;United Kingdom&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Netherlands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Switzerland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;98,934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;102,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Asia Pacific Region&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Japan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Australia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;587,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;555,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ia2df645a45b34a2399502ce17943dcf7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzMtMi0xLTEtMA_0234e19f-9128-432a-9541-4e82d2790243"
      unitRef="usd">436003000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i4b80e825cd834af08c3a61075a948afe_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzMtNC0xLTEtMA_f67d9c11-107f-4961-a2f7-102b99feb92f"
      unitRef="usd">412700000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ia3c0173254014c148d3b60dec589c0b2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzQtMi0xLTEtMA_9ba34bf2-d375-4be5-bd3b-3d465ed132e2"
      unitRef="usd">17043000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i19eca0b32b324c3498847ac936ef58f4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzQtNC0xLTEtMA_12013b65-a6f7-41ba-992b-cf9afe9a2c9e"
      unitRef="usd">20797000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i6f5c837a15cc413bb88e37606fc78b84_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzUtMi0xLTEtMA_b42a9c4d-7cea-4465-a743-f0eb21fd300c"
      unitRef="usd">7003000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i5d6b1606b16f45a0ac3be2c84a8d6205_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzUtNC0xLTEtMA_60bf7a70-4a9b-45aa-a1cf-e3fdeea7c519"
      unitRef="usd">4993000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i0a98d26251bb48daa1b953041bbb17e4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzYtMi0xLTEtMA_aebbecbb-883e-4f44-bf96-1cdf73251107"
      unitRef="usd">460049000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="if2b60381ab6f424a9ae0d17bcd461dc7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzYtNC0xLTEtMA_b320825f-65f3-480c-a7fe-42c0d855702b"
      unitRef="usd">438490000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i5d067073a4ae4d32b902fa480a4007da_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzgtMi0xLTEtMA_fb5954e5-2957-4539-b685-bb8f9dc65749"
      unitRef="usd">60451000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="if14611aca76842bd9bd4db89f308d803_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzgtNC0xLTEtMA_7257d80b-1b58-4712-819f-74baf6813803"
      unitRef="usd">67354000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i374199d035fc499c91845154d21c433e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzktMi0xLTEtMA_bdb6d38b-d1cf-4aaf-81c7-60da053f6b12"
      unitRef="usd">9828000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ie8c119688026495c80d9335fe78c12c9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzktNC0xLTEtMA_bd39909b-e891-4da9-b444-ff2e1faa2291"
      unitRef="usd">10191000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i4a516ef8f02d4ad4b2f748492aab4933_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzEwLTItMS0xLTA_c3d1a9bf-9903-464a-998d-f80ec1cb4db0"
      unitRef="usd">19405000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i0c16c76e13144f0ba4ee1ef3535feacb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzEwLTQtMS0xLTA_0db102f5-b973-4262-bb7f-da9d641bd053"
      unitRef="usd">15267000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="id29d95bc12294baa874f679042b1e77e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzExLTItMS0xLTA_4a04a70a-01e4-4ab6-bcce-3742c7797e3f"
      unitRef="usd">1884000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ic4c58acfb1f047b382030e4bc62b5020_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzExLTQtMS0xLTA_7503c189-2da7-4d38-8337-43ed252434d9"
      unitRef="usd">2062000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="iccfd38ad58364c78a9294def05c76d02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzEyLTItMS0xLTA_bc881ad8-435f-4691-af78-2fc5342e484d"
      unitRef="usd">3545000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i6da1a2f76bee4a21ac439aeda4137fa7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzEyLTQtMS0xLTA_539802d1-69a1-479f-a711-67b475e0a825"
      unitRef="usd">3743000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i3e3d1826c3d34af3978413aa009dbae7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzEzLTItMS0xLTA_13be48d3-8c33-4247-ad96-9e2184731e9c"
      unitRef="usd">3821000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i0e3cdf5fc1964d82bdc2516cce09684d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzEzLTQtMS0xLTA_f2ae0d83-b3e4-4dbb-8cf3-5674e6a23cad"
      unitRef="usd">3668000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i2106bb13edcc49e8b8fce61d61723790_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzE0LTItMS0xLTA_ebe83fb2-cf7b-40b7-8059-ea912d2a71e8"
      unitRef="usd">98934000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i64399f2ed4a0466e9bdbbf1a7f6103c6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzE0LTQtMS0xLTA_f3585062-67d7-40eb-845e-04d5e9ce99e4"
      unitRef="usd">102285000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i3de7482682304e00b18c68ebffb19f78_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzE2LTItMS0xLTA_3a9ea9e4-897f-4d4b-8011-20baa8c0843a"
      unitRef="usd">5845000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="iceb0cdafe9d44f85a2de864face16fef_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzE2LTQtMS0xLTA_fe979967-3fbc-4bbb-8e91-8fb99493b158"
      unitRef="usd">4503000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="if41bc213fa8343d59b436514629c5506_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzE3LTItMS0xLTA_0bafe0f9-3758-42f4-b522-edd14cdba1a1"
      unitRef="usd">14584000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i76762f7f0d2c450d89d3f32990898187_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzE3LTQtMS0xLTA_53dcad28-c67f-44d6-b6a3-3adecd142824"
      unitRef="usd">3304000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i26ff5d65efbd4393a5a6f50b163b1890_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzE4LTItMS0xLTA_1bac0985-2c3f-4483-b446-279b486d328c"
      unitRef="usd">8255000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ia347a126d78942fbbf80ff326e0aa2a5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzE4LTQtMS0xLTA_96261911-e756-4507-ac64-94eb946906f6"
      unitRef="usd">6585000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i8ffc4cfd2c574feda0ea3ae4daaa562c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzE5LTItMS0xLTA_755f7ea0-fe11-47e1-bf23-2ec92f073c9c"
      unitRef="usd">28684000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i4a25163d8a7f45b78b59192fe48c8632_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzE5LTQtMS0xLTA_522fbe71-f5fb-44c4-8460-9ac272afb916"
      unitRef="usd">14392000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzIwLTItMS0xLTA_aa42ca29-d330-4021-bb39-ba26a9c9ce72"
      unitRef="usd">587667000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjYvZnJhZzpmZWNkNjhhNjEwZDc0NDM4YjMxYTQ0YjgwYmZmY2Y5Yi90YWJsZTpkNDBkYTU5YmM4MzM0YWU5YWNhYTU4YTc5YjdkY2VmMi90YWJsZXJhbmdlOmQ0MGRhNTliYzgzMzRhZTlhY2FhNThhNzliN2RjZWYyXzIwLTQtMS0xLTA_45640a15-fc66-4588-bfa5-e93685856ab8"
      unitRef="usd">555167000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90ZXh0cmVnaW9uOmVlODVkZTI1NGU5NzRiMmE4YjkxNGU1NTgwZTIxNjlmXzQ1NjM_424453ed-c11f-4f56-9835-c87b3d024e49">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;FAIR VALUE MEASUREMENTS&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. GAAP defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. U.S. GAAP requires an entity to maximize the use of observable inputs, where available, and minimize the use of unobservable inputs when measuring fair value.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have certain financial assets and liabilities that are measured at fair value on a recurring basis, certain nonfinancial assets and liabilities that may be measured at fair value on a non-recurring basis, and certain financial assets and liabilities that are not measured at fair value in our consolidated balance sheets but for which we disclose the fair value. The fair value disclosures of these assets and liabilities are based on a three-level hierarchy, which is defined as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:498.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:85.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:409.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Quoted prices in active markets for identical assets or liabilities that the entity can access at the measurement date.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:33pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities measured at fair value are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability. We did not have any transfers between Level 1 and Level 2, or transfers in or out of Level 3, of the fair value hierarchy during the years ended December 31, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our cross currency swap contracts are measured at fair value on a recurring basis in our accompanying consolidated balance sheets. We measure the fair value of our cross currency swap contracts classified as derivative instruments using prevailing market conditions as of the close of business on each balance sheet date. The product of this calculation is then adjusted for counterparty risk.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our foreign currency exchange contracts are measured at fair value on a recurring basis in our accompanying consolidated balance sheets. We measure the fair value of our foreign currency exchange contracts classified as derivative &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;instruments using an income approach, based on prevailing market forward rates less the contract rate multiplied by the notional amount. The product of this calculation is then adjusted for counterparty risk.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amounts outstanding under our unsecured revolving credit facility ("Credit Facility" or &#x201c;line of credit&#x201d;) and senior notes (&#x201c;long-term debt&#x201d;) are measured at carrying value in our accompanying consolidated balance sheets though we disclose the fair value of these financial instruments. We determine the fair value of the amount outstanding under our Credit Facility and long-term debt using an income approach, utilizing a discounted cash flow analysis based on current market interest rates for debt issues with similar remaining years to maturity, adjusted for applicable credit risk. Our Credit Facility and long-term debt are valued using Level 2 inputs. The estimated fair value of our Credit Facility approximates its carrying value. At December 31, 2021, the estimated fair value and carrying value of our long-term debt were $916.3 million and $850.7 million, respectively. At December 31, 2020, the estimated fair value and carrying value of our long-term debt were $1.0 billion and $909.1 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables set forth our assets and liabilities that were measured at fair value on a recurring basis by level within the fair value hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Quoted Prices in Active Markets for Identical Assets &lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Significant Other Observable Inputs &lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Significant Unobservable Inputs &lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Money market funds &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Equity mutual funds &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross currency swaps &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange contracts &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange contracts &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred compensation &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contingent payments - acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Quoted Prices in Active Markets for Identical Assets &lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Significant Other Observable Inputs &lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Significant Unobservable Inputs &lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Money market funds &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Equity mutual funds &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange contracts &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross currency swaps &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange contracts &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred compensation &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Money market funds with an original maturity of less than ninety days are included within cash and cash equivalents. The remaining balance of cash and cash equivalents as of December 31, 2021, and December 31, 2020, consisted of demand deposits.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Equity mutual funds relate to a deferred compensation plan that was assumed as part of a previous business combination. This amount is included within other long-term assets. Refer to footnote (4) below for a discussion of the related deferred compensation liability.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Cross currency swaps and foreign currency exchange contracts are included within other current assets; other long-term assets; accrued liabilities; or other long-term liabilities depending on the gain (loss) position and anticipated settlement date.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;A deferred compensation plan assumed as part of a previous business combination is included within accrued liabilities and other long-term liabilities. The fair value of our deferred compensation plan is indexed to the performance of the underlying equity mutual funds discussed in footnote (2) above.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair values of certain financial instruments, including cash and cash equivalents, accounts receivable, and accounts payable, approximate carrying value due to their short maturity.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Contingent Consideration&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have classified our liabilities for contingent consideration related to acquisitions within Level 3 of the fair value hierarchy because the fair value is determined using significant unobservable inputs, which includes the achievements of future revenues. The contingent consideration is included within other short-term liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record changes in the estimated fair value of contingent consideration in the consolidated statements of income. Changes in contingent consideration liabilities are measured at fair value on a recurring basis using unobservable inputs (Level 3) and during the year ended December 31, 2021, are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.794%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.276%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Contingent consideration as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contingent consideration recorded from acquisitions (Note 4)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in estimated fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Contingent consideration as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We originally recorded a $5.0&#160;million contingent consideration associated with our acquisition of ezyVet during the second quarter of 2021. During the fourth quarter of 2021, we increased the contingent consideration by $2.0&#160;million to reflect the most recent estimate associated with achievements of future revenue.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90ZXh0cmVnaW9uOmVlODVkZTI1NGU5NzRiMmE4YjkxNGU1NTgwZTIxNjlmXzQ1NTk_494a22f5-7c01-4e61-b2af-af071e4f98a3">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. GAAP defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. U.S. GAAP requires an entity to maximize the use of observable inputs, where available, and minimize the use of unobservable inputs when measuring fair value.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have certain financial assets and liabilities that are measured at fair value on a recurring basis, certain nonfinancial assets and liabilities that may be measured at fair value on a non-recurring basis, and certain financial assets and liabilities that are not measured at fair value in our consolidated balance sheets but for which we disclose the fair value. The fair value disclosures of these assets and liabilities are based on a three-level hierarchy, which is defined as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:498.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:85.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:409.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Quoted prices in active markets for identical assets or liabilities that the entity can access at the measurement date.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:33pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities measured at fair value are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability. We did not have any transfers between Level 1 and Level 2, or transfers in or out of Level 3, of the fair value hierarchy during the years ended December 31, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our cross currency swap contracts are measured at fair value on a recurring basis in our accompanying consolidated balance sheets. We measure the fair value of our cross currency swap contracts classified as derivative instruments using prevailing market conditions as of the close of business on each balance sheet date. The product of this calculation is then adjusted for counterparty risk.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our foreign currency exchange contracts are measured at fair value on a recurring basis in our accompanying consolidated balance sheets. We measure the fair value of our foreign currency exchange contracts classified as derivative &lt;/span&gt;&lt;/div&gt;instruments using an income approach, based on prevailing market forward rates less the contract rate multiplied by the notional amount. The product of this calculation is then adjusted for counterparty risk.&#160;The amounts outstanding under our unsecured revolving credit facility ("Credit Facility" or &#x201c;line of credit&#x201d;) and senior notes (&#x201c;long-term debt&#x201d;) are measured at carrying value in our accompanying consolidated balance sheets though we disclose the fair value of these financial instruments. We determine the fair value of the amount outstanding under our Credit Facility and long-term debt using an income approach, utilizing a discounted cash flow analysis based on current market interest rates for debt issues with similar remaining years to maturity, adjusted for applicable credit risk. Our Credit Facility and long-term debt are valued using Level 2 inputs. The estimated fair value of our Credit Facility approximates its carrying value.</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:LongTermDebtFairValue
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90ZXh0cmVnaW9uOmVlODVkZTI1NGU5NzRiMmE4YjkxNGU1NTgwZTIxNjlmXzMwMzg_f5e555e8-5e8f-4a47-91f0-d93d7b1f6e1f"
      unitRef="usd">916300000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebt
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90ZXh0cmVnaW9uOmVlODVkZTI1NGU5NzRiMmE4YjkxNGU1NTgwZTIxNjlmXzMwNDU_caf95622-112b-49ef-95ce-8be7668f40a1"
      unitRef="usd">850700000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtFairValue
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90ZXh0cmVnaW9uOmVlODVkZTI1NGU5NzRiMmE4YjkxNGU1NTgwZTIxNjlmXzMxNDE_d3fe7dae-f677-4927-8026-93e607836087"
      unitRef="usd">1000000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebt
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90ZXh0cmVnaW9uOmVlODVkZTI1NGU5NzRiMmE4YjkxNGU1NTgwZTIxNjlmXzMxNDg_468d62f6-cd6e-4e5b-b08c-4ea93c3ce05a"
      unitRef="usd">909100000</us-gaap:LongTermDebt>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90ZXh0cmVnaW9uOmVlODVkZTI1NGU5NzRiMmE4YjkxNGU1NTgwZTIxNjlmXzQ1NjQ_44cc6beb-2d9b-4d18-9a13-dc5606b10bca">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables set forth our assets and liabilities that were measured at fair value on a recurring basis by level within the fair value hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Quoted Prices in Active Markets for Identical Assets &lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Significant Other Observable Inputs &lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Significant Unobservable Inputs &lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Money market funds &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Equity mutual funds &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross currency swaps &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange contracts &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange contracts &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred compensation &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contingent payments - acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Quoted Prices in Active Markets for Identical Assets &lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Significant Other Observable Inputs &lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Significant Unobservable Inputs &lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Money market funds &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Equity mutual funds &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange contracts &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross currency swaps &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange contracts &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred compensation &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Money market funds with an original maturity of less than ninety days are included within cash and cash equivalents. The remaining balance of cash and cash equivalents as of December 31, 2021, and December 31, 2020, consisted of demand deposits.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Equity mutual funds relate to a deferred compensation plan that was assumed as part of a previous business combination. This amount is included within other long-term assets. Refer to footnote (4) below for a discussion of the related deferred compensation liability.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Cross currency swaps and foreign currency exchange contracts are included within other current assets; other long-term assets; accrued liabilities; or other long-term liabilities depending on the gain (loss) position and anticipated settlement date.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;A deferred compensation plan assumed as part of a previous business combination is included within accrued liabilities and other long-term liabilities. The fair value of our deferred compensation plan is indexed to the performance of the underlying equity mutual funds discussed in footnote (2) above.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i1bc42ef3733b4728851d7a59ec0cfb20_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpmMDE1MzE2YmUyOTY0Y2VlOGRiMjdhYzE1Y2MyZmI3Yy90YWJsZXJhbmdlOmYwMTUzMTZiZTI5NjRjZWU4ZGIyN2FjMTVjYzJmYjdjXzQtMi0xLTEtMA_cee75b01-063e-4748-a73b-002a5f64933e"
      unitRef="usd">76000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i86eb4694a98b40318766c041f67be8c5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpmMDE1MzE2YmUyOTY0Y2VlOGRiMjdhYzE1Y2MyZmI3Yy90YWJsZXJhbmdlOmYwMTUzMTZiZTI5NjRjZWU4ZGIyN2FjMTVjYzJmYjdjXzQtNC0xLTEtMA_3d0fd62e-80e0-43ef-a498-b2165930b0a3"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ieeaf8edb07e74b67a220042fa77426c6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpmMDE1MzE2YmUyOTY0Y2VlOGRiMjdhYzE1Y2MyZmI3Yy90YWJsZXJhbmdlOmYwMTUzMTZiZTI5NjRjZWU4ZGIyN2FjMTVjYzJmYjdjXzQtNi0xLTEtMA_cfdba241-4441-4333-aff9-255c223e67f1"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i206dbd1506c344a7b46d2edcee18de52_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpmMDE1MzE2YmUyOTY0Y2VlOGRiMjdhYzE1Y2MyZmI3Yy90YWJsZXJhbmdlOmYwMTUzMTZiZTI5NjRjZWU4ZGIyN2FjMTVjYzJmYjdjXzQtOC0xLTEtMA_f76c78a8-2b3a-4b40-9d5d-f3a41e0ed1a3"
      unitRef="usd">76000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:OtherAssetsFairValueDisclosure
      contextRef="i2258666cd26e4775980e24a9d689b0c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpmMDE1MzE2YmUyOTY0Y2VlOGRiMjdhYzE1Y2MyZmI3Yy90YWJsZXJhbmdlOmYwMTUzMTZiZTI5NjRjZWU4ZGIyN2FjMTVjYzJmYjdjXzUtMi0xLTEtMA_0e129190-bfda-4532-ac99-72d82c92b613"
      unitRef="usd">826000</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:OtherAssetsFairValueDisclosure
      contextRef="i787da85c3dea4d1b8cbac83c56d8a8c7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpmMDE1MzE2YmUyOTY0Y2VlOGRiMjdhYzE1Y2MyZmI3Yy90YWJsZXJhbmdlOmYwMTUzMTZiZTI5NjRjZWU4ZGIyN2FjMTVjYzJmYjdjXzUtNC0xLTEtMA_ab438e3e-a62e-4366-b34a-5f0b2e719066"
      unitRef="usd">0</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:OtherAssetsFairValueDisclosure
      contextRef="ib92b086f14c04b4cafa21f8ec54f598a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpmMDE1MzE2YmUyOTY0Y2VlOGRiMjdhYzE1Y2MyZmI3Yy90YWJsZXJhbmdlOmYwMTUzMTZiZTI5NjRjZWU4ZGIyN2FjMTVjYzJmYjdjXzUtNi0xLTEtMA_e3926022-9951-47c5-9ff3-1219e4142f07"
      unitRef="usd">0</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:OtherAssetsFairValueDisclosure
      contextRef="ia0bf1cce14634a27bdb520f17b857f93_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpmMDE1MzE2YmUyOTY0Y2VlOGRiMjdhYzE1Y2MyZmI3Yy90YWJsZXJhbmdlOmYwMTUzMTZiZTI5NjRjZWU4ZGIyN2FjMTVjYzJmYjdjXzUtOC0xLTEtMA_1c9d97d0-4008-4e86-9bc2-c84b2caf4845"
      unitRef="usd">826000</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:OtherAssetsFairValueDisclosure
      contextRef="i224b783ac8494c7db115e134494538a7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpmMDE1MzE2YmUyOTY0Y2VlOGRiMjdhYzE1Y2MyZmI3Yy90YWJsZXJhbmdlOmYwMTUzMTZiZTI5NjRjZWU4ZGIyN2FjMTVjYzJmYjdjXzYtMi0xLTEtMzc2MzM_dbfc85cd-1736-4fc8-bb3a-179204d76e70"
      unitRef="usd">0</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:OtherAssetsFairValueDisclosure
      contextRef="idaf6c4c313dd4b59950dfdc2cebfd879_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpmMDE1MzE2YmUyOTY0Y2VlOGRiMjdhYzE1Y2MyZmI3Yy90YWJsZXJhbmdlOmYwMTUzMTZiZTI5NjRjZWU4ZGIyN2FjMTVjYzJmYjdjXzYtNC0xLTEtMzc2MzM_1d9fbf08-8622-4ecb-a6fe-cf01054b9af5"
      unitRef="usd">4256000</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:OtherAssetsFairValueDisclosure
      contextRef="i991a2d9a94c94f4ea20968ce0eeb2d8a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpmMDE1MzE2YmUyOTY0Y2VlOGRiMjdhYzE1Y2MyZmI3Yy90YWJsZXJhbmdlOmYwMTUzMTZiZTI5NjRjZWU4ZGIyN2FjMTVjYzJmYjdjXzYtNi0xLTEtMzc2MzM_2522b74f-b960-4b56-aaca-e3da30dd462b"
      unitRef="usd">0</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:OtherAssetsFairValueDisclosure
      contextRef="i5defc11409fd41638fd2fde139f135f5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpmMDE1MzE2YmUyOTY0Y2VlOGRiMjdhYzE1Y2MyZmI3Yy90YWJsZXJhbmdlOmYwMTUzMTZiZTI5NjRjZWU4ZGIyN2FjMTVjYzJmYjdjXzYtOC0xLTEtMzc2MzM_32de49ee-7dda-49c5-bc81-1e11faaeffa3"
      unitRef="usd">4256000</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:DerivativeAssets
      contextRef="i02adea61db9c4d30a6aebbf9a1e7dbef_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpmMDE1MzE2YmUyOTY0Y2VlOGRiMjdhYzE1Y2MyZmI3Yy90YWJsZXJhbmdlOmYwMTUzMTZiZTI5NjRjZWU4ZGIyN2FjMTVjYzJmYjdjXzYtMi0xLTEtMA_f847ecd2-5577-434f-a0a1-a823e627a927"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ief2e06ac5412417d8e6cdbbfb30aaabe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpmMDE1MzE2YmUyOTY0Y2VlOGRiMjdhYzE1Y2MyZmI3Yy90YWJsZXJhbmdlOmYwMTUzMTZiZTI5NjRjZWU4ZGIyN2FjMTVjYzJmYjdjXzYtNC0xLTEtMA_517430dc-eaba-437b-81f9-9cecf7f8f3ca"
      unitRef="usd">6512000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i9bbbcba12a794c06878aa6883f1b3785_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpmMDE1MzE2YmUyOTY0Y2VlOGRiMjdhYzE1Y2MyZmI3Yy90YWJsZXJhbmdlOmYwMTUzMTZiZTI5NjRjZWU4ZGIyN2FjMTVjYzJmYjdjXzYtNi0xLTEtMA_2b13ec29-83b5-4a3c-8a3f-9c6198b4d1bf"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i89ead21a0e784572a2136d6d2a0a1694_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpmMDE1MzE2YmUyOTY0Y2VlOGRiMjdhYzE1Y2MyZmI3Yy90YWJsZXJhbmdlOmYwMTUzMTZiZTI5NjRjZWU4ZGIyN2FjMTVjYzJmYjdjXzYtOC0xLTEtMA_f967414e-8ced-44b4-b639-f8211d9344a5"
      unitRef="usd">6512000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeLiabilities
      contextRef="i02adea61db9c4d30a6aebbf9a1e7dbef_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpmMDE1MzE2YmUyOTY0Y2VlOGRiMjdhYzE1Y2MyZmI3Yy90YWJsZXJhbmdlOmYwMTUzMTZiZTI5NjRjZWU4ZGIyN2FjMTVjYzJmYjdjXzktMi0xLTEtMA_2c01ccba-b0b4-4a22-b980-b8840d3498ae"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="ief2e06ac5412417d8e6cdbbfb30aaabe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpmMDE1MzE2YmUyOTY0Y2VlOGRiMjdhYzE1Y2MyZmI3Yy90YWJsZXJhbmdlOmYwMTUzMTZiZTI5NjRjZWU4ZGIyN2FjMTVjYzJmYjdjXzktNC0xLTEtMA_9d47f895-37ed-4f1a-90e2-07711201bb8a"
      unitRef="usd">601000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i9bbbcba12a794c06878aa6883f1b3785_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpmMDE1MzE2YmUyOTY0Y2VlOGRiMjdhYzE1Y2MyZmI3Yy90YWJsZXJhbmdlOmYwMTUzMTZiZTI5NjRjZWU4ZGIyN2FjMTVjYzJmYjdjXzktNi0xLTEtMA_0ea85be3-b0bc-427c-8b25-b2b20a924091"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i89ead21a0e784572a2136d6d2a0a1694_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpmMDE1MzE2YmUyOTY0Y2VlOGRiMjdhYzE1Y2MyZmI3Yy90YWJsZXJhbmdlOmYwMTUzMTZiZTI5NjRjZWU4ZGIyN2FjMTVjYzJmYjdjXzktOC0xLTEtMA_b9e8d4b7-83a9-4062-be02-0f8e0b544961"
      unitRef="usd">601000</us-gaap:DerivativeLiabilities>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="i77cb9a89ff4949bb8bc7f0848c680d19_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpmMDE1MzE2YmUyOTY0Y2VlOGRiMjdhYzE1Y2MyZmI3Yy90YWJsZXJhbmdlOmYwMTUzMTZiZTI5NjRjZWU4ZGIyN2FjMTVjYzJmYjdjXzEwLTItMS0xLTA_a97b75b6-e5a5-4167-827f-42b7720a9a18"
      unitRef="usd">826000</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="i6f5042c99e1f40d89108212d50d27e54_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpmMDE1MzE2YmUyOTY0Y2VlOGRiMjdhYzE1Y2MyZmI3Yy90YWJsZXJhbmdlOmYwMTUzMTZiZTI5NjRjZWU4ZGIyN2FjMTVjYzJmYjdjXzEwLTQtMS0xLTA_d9e7684a-caec-4b4c-b592-4efd6663ea92"
      unitRef="usd">0</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="if6298f7d8f2c4ee7926bc69c8be65de3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpmMDE1MzE2YmUyOTY0Y2VlOGRiMjdhYzE1Y2MyZmI3Yy90YWJsZXJhbmdlOmYwMTUzMTZiZTI5NjRjZWU4ZGIyN2FjMTVjYzJmYjdjXzEwLTYtMS0xLTA_bd375bac-8a44-425c-b1f1-909dc6870669"
      unitRef="usd">0</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="i335b527a64fd4bee959d70654d76f369_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpmMDE1MzE2YmUyOTY0Y2VlOGRiMjdhYzE1Y2MyZmI3Yy90YWJsZXJhbmdlOmYwMTUzMTZiZTI5NjRjZWU4ZGIyN2FjMTVjYzJmYjdjXzEwLTgtMS0xLTA_e7690c50-7f84-488f-b7bf-134f9debfdf2"
      unitRef="usd">826000</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <idxx:BusinessCombinationContingencyFairValue
      contextRef="i2631d5bf8f7b4edf839dd6d1ffca5a4d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpmMDE1MzE2YmUyOTY0Y2VlOGRiMjdhYzE1Y2MyZmI3Yy90YWJsZXJhbmdlOmYwMTUzMTZiZTI5NjRjZWU4ZGIyN2FjMTVjYzJmYjdjXzExLTItMS0xLTI5MDk2_7206acf6-e461-4922-be4f-51ea7f962af3"
      unitRef="usd">0</idxx:BusinessCombinationContingencyFairValue>
    <idxx:BusinessCombinationContingencyFairValue
      contextRef="i83f6672993344e548b6db84a0a80f0da_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpmMDE1MzE2YmUyOTY0Y2VlOGRiMjdhYzE1Y2MyZmI3Yy90YWJsZXJhbmdlOmYwMTUzMTZiZTI5NjRjZWU4ZGIyN2FjMTVjYzJmYjdjXzExLTQtMS0xLTI5MDk2_4e4d1200-5f89-433a-a647-6d7045514433"
      unitRef="usd">0</idxx:BusinessCombinationContingencyFairValue>
    <idxx:BusinessCombinationContingencyFairValue
      contextRef="i7c872711fc4b45339979cdb106678fe3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpmMDE1MzE2YmUyOTY0Y2VlOGRiMjdhYzE1Y2MyZmI3Yy90YWJsZXJhbmdlOmYwMTUzMTZiZTI5NjRjZWU4ZGIyN2FjMTVjYzJmYjdjXzExLTYtMS0xLTI5MDk2_f3f38f0c-fc8f-4c69-8896-8b1c0d4ee58e"
      unitRef="usd">7230000</idxx:BusinessCombinationContingencyFairValue>
    <idxx:BusinessCombinationContingencyFairValue
      contextRef="i58118ac9fa5b41048fd3e947040036e9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpmMDE1MzE2YmUyOTY0Y2VlOGRiMjdhYzE1Y2MyZmI3Yy90YWJsZXJhbmdlOmYwMTUzMTZiZTI5NjRjZWU4ZGIyN2FjMTVjYzJmYjdjXzExLTgtMS0xLTI5MDk2_ab359078-42e8-40bc-9102-a5d722a10ab3"
      unitRef="usd">7230000</idxx:BusinessCombinationContingencyFairValue>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i608997adc8b645bcbaaf1f91a45b978b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpjYmJiZTNhYjBiYmM0ZTVkYjNmNDFlZjA0NjBhOTZhYy90YWJsZXJhbmdlOmNiYmJlM2FiMGJiYzRlNWRiM2Y0MWVmMDQ2MGE5NmFjXzQtMi0xLTEtMA_8a9c6800-3eb4-4933-a489-6500de24ffcb"
      unitRef="usd">76000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i4d3f919fc9944acb95a3e26a8e3a840b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpjYmJiZTNhYjBiYmM0ZTVkYjNmNDFlZjA0NjBhOTZhYy90YWJsZXJhbmdlOmNiYmJlM2FiMGJiYzRlNWRiM2Y0MWVmMDQ2MGE5NmFjXzQtNC0xLTEtMA_94b33d70-2f20-42f1-81e4-86b5b751fdfd"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ie3de38ceae5e40a3a39f1ed4d9f73eb2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpjYmJiZTNhYjBiYmM0ZTVkYjNmNDFlZjA0NjBhOTZhYy90YWJsZXJhbmdlOmNiYmJlM2FiMGJiYzRlNWRiM2Y0MWVmMDQ2MGE5NmFjXzQtNi0xLTEtMA_12af8bba-76c6-467a-838d-6beef253188e"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="iccdf369f478f4fb8b529dbbf7bf67b64_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpjYmJiZTNhYjBiYmM0ZTVkYjNmNDFlZjA0NjBhOTZhYy90YWJsZXJhbmdlOmNiYmJlM2FiMGJiYzRlNWRiM2Y0MWVmMDQ2MGE5NmFjXzQtOC0xLTEtMA_5c7aa461-7705-4bca-bbe7-dc1a61f8d178"
      unitRef="usd">76000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:OtherAssetsFairValueDisclosure
      contextRef="idca6b93b00b44f62bbc514784faff67d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpjYmJiZTNhYjBiYmM0ZTVkYjNmNDFlZjA0NjBhOTZhYy90YWJsZXJhbmdlOmNiYmJlM2FiMGJiYzRlNWRiM2Y0MWVmMDQ2MGE5NmFjXzUtMi0xLTEtMA_e3f4cbf7-6881-4639-b248-72891a7c1d06"
      unitRef="usd">1145000</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:OtherAssetsFairValueDisclosure
      contextRef="ife95a3279b8f411aa329c1a3be662fd3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpjYmJiZTNhYjBiYmM0ZTVkYjNmNDFlZjA0NjBhOTZhYy90YWJsZXJhbmdlOmNiYmJlM2FiMGJiYzRlNWRiM2Y0MWVmMDQ2MGE5NmFjXzUtNC0xLTEtMA_cdad74c9-dd69-4d86-a1d7-c190e86a21ec"
      unitRef="usd">0</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:OtherAssetsFairValueDisclosure
      contextRef="id52d5e57570042d09f53a0980b212d20_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpjYmJiZTNhYjBiYmM0ZTVkYjNmNDFlZjA0NjBhOTZhYy90YWJsZXJhbmdlOmNiYmJlM2FiMGJiYzRlNWRiM2Y0MWVmMDQ2MGE5NmFjXzUtNi0xLTEtMA_ce22a51c-039e-4921-9c7d-055bed408499"
      unitRef="usd">0</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:OtherAssetsFairValueDisclosure
      contextRef="ic08687ee74ce470e94fd105bae7ecbdc_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpjYmJiZTNhYjBiYmM0ZTVkYjNmNDFlZjA0NjBhOTZhYy90YWJsZXJhbmdlOmNiYmJlM2FiMGJiYzRlNWRiM2Y0MWVmMDQ2MGE5NmFjXzUtOC0xLTEtMA_2cf5ce1e-19ac-437a-8bac-d7fbdcae63c6"
      unitRef="usd">1145000</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:DerivativeAssets
      contextRef="i5a44d7e6553d48599a9003be65d3c761_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpjYmJiZTNhYjBiYmM0ZTVkYjNmNDFlZjA0NjBhOTZhYy90YWJsZXJhbmdlOmNiYmJlM2FiMGJiYzRlNWRiM2Y0MWVmMDQ2MGE5NmFjXzctMi0xLTEtMA_53648e0b-7953-4b09-a361-2518906ba189"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i0dbc7dd68361493785eff3dfc58a1b14_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpjYmJiZTNhYjBiYmM0ZTVkYjNmNDFlZjA0NjBhOTZhYy90YWJsZXJhbmdlOmNiYmJlM2FiMGJiYzRlNWRiM2Y0MWVmMDQ2MGE5NmFjXzctNC0xLTEtMA_c0ee2966-6515-4710-9851-c834e2bc870b"
      unitRef="usd">125000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i315d962b616d493fb4d154dd8f021e44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpjYmJiZTNhYjBiYmM0ZTVkYjNmNDFlZjA0NjBhOTZhYy90YWJsZXJhbmdlOmNiYmJlM2FiMGJiYzRlNWRiM2Y0MWVmMDQ2MGE5NmFjXzctNi0xLTEtMA_9a61ad4b-96ce-4390-b985-916f4da0198d"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="iae303435a98a42f1bc19b02e47518558_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpjYmJiZTNhYjBiYmM0ZTVkYjNmNDFlZjA0NjBhOTZhYy90YWJsZXJhbmdlOmNiYmJlM2FiMGJiYzRlNWRiM2Y0MWVmMDQ2MGE5NmFjXzctOC0xLTEtMA_c17f26bc-7029-4f98-b5b3-1b8dcd78051f"
      unitRef="usd">125000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeLiabilities
      contextRef="i7ded36872dbb4598a2981b577f9f6307_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpjYmJiZTNhYjBiYmM0ZTVkYjNmNDFlZjA0NjBhOTZhYy90YWJsZXJhbmdlOmNiYmJlM2FiMGJiYzRlNWRiM2Y0MWVmMDQ2MGE5NmFjXzktMi0xLTEtMjUz_b0acf1b0-6c64-4e4b-9637-73f1383ec26b"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i00732657e2a24ab78c424730ef55e468_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpjYmJiZTNhYjBiYmM0ZTVkYjNmNDFlZjA0NjBhOTZhYy90YWJsZXJhbmdlOmNiYmJlM2FiMGJiYzRlNWRiM2Y0MWVmMDQ2MGE5NmFjXzktNC0xLTEtMjUz_0d7620c4-4f0a-4484-9ab2-3342f75ee66a"
      unitRef="usd">2841000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="ia3c0063a469d414bb87cadabfe0a1f2b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpjYmJiZTNhYjBiYmM0ZTVkYjNmNDFlZjA0NjBhOTZhYy90YWJsZXJhbmdlOmNiYmJlM2FiMGJiYzRlNWRiM2Y0MWVmMDQ2MGE5NmFjXzktNi0xLTEtMjUz_70c183e9-acf6-4a77-8fa9-bcdbe0eefba2"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="ibd016343073542aaa9022d71864f8954_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpjYmJiZTNhYjBiYmM0ZTVkYjNmNDFlZjA0NjBhOTZhYy90YWJsZXJhbmdlOmNiYmJlM2FiMGJiYzRlNWRiM2Y0MWVmMDQ2MGE5NmFjXzktOC0xLTEtMjUz_66466b67-ed9b-4f60-84b4-a5b8542319d1"
      unitRef="usd">2841000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i5a44d7e6553d48599a9003be65d3c761_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpjYmJiZTNhYjBiYmM0ZTVkYjNmNDFlZjA0NjBhOTZhYy90YWJsZXJhbmdlOmNiYmJlM2FiMGJiYzRlNWRiM2Y0MWVmMDQ2MGE5NmFjXzktMi0xLTEtMA_fc9319f8-156e-45bd-9a53-6700794e0470"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i0dbc7dd68361493785eff3dfc58a1b14_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpjYmJiZTNhYjBiYmM0ZTVkYjNmNDFlZjA0NjBhOTZhYy90YWJsZXJhbmdlOmNiYmJlM2FiMGJiYzRlNWRiM2Y0MWVmMDQ2MGE5NmFjXzktNC0xLTEtMA_c7e006e0-a45b-4c3d-ba20-c485a74eb61d"
      unitRef="usd">12373000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i315d962b616d493fb4d154dd8f021e44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpjYmJiZTNhYjBiYmM0ZTVkYjNmNDFlZjA0NjBhOTZhYy90YWJsZXJhbmdlOmNiYmJlM2FiMGJiYzRlNWRiM2Y0MWVmMDQ2MGE5NmFjXzktNi0xLTEtMA_1fe57a8e-d1ab-4ee9-ac06-5a8088b67421"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="iae303435a98a42f1bc19b02e47518558_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpjYmJiZTNhYjBiYmM0ZTVkYjNmNDFlZjA0NjBhOTZhYy90YWJsZXJhbmdlOmNiYmJlM2FiMGJiYzRlNWRiM2Y0MWVmMDQ2MGE5NmFjXzktOC0xLTEtMA_3aee6bc9-e01f-4b70-a551-fee8d5c4ed51"
      unitRef="usd">12373000</us-gaap:DerivativeLiabilities>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="ideb425f832b5493cadaae1d434f30a46_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpjYmJiZTNhYjBiYmM0ZTVkYjNmNDFlZjA0NjBhOTZhYy90YWJsZXJhbmdlOmNiYmJlM2FiMGJiYzRlNWRiM2Y0MWVmMDQ2MGE5NmFjXzEwLTItMS0xLTA_adf4f4a4-9516-4052-8129-ca410d6b0c13"
      unitRef="usd">1145000</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="i966b54bea1fd484184ebf43c56e298a7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpjYmJiZTNhYjBiYmM0ZTVkYjNmNDFlZjA0NjBhOTZhYy90YWJsZXJhbmdlOmNiYmJlM2FiMGJiYzRlNWRiM2Y0MWVmMDQ2MGE5NmFjXzEwLTQtMS0xLTA_f07a8749-abec-4c80-bef8-0ae1b4e11156"
      unitRef="usd">0</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="i671303cff5aa4ae2b8d910b00202004d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpjYmJiZTNhYjBiYmM0ZTVkYjNmNDFlZjA0NjBhOTZhYy90YWJsZXJhbmdlOmNiYmJlM2FiMGJiYzRlNWRiM2Y0MWVmMDQ2MGE5NmFjXzEwLTYtMS0xLTA_b139fc43-85e6-4df0-9027-48b37e1b4649"
      unitRef="usd">0</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="i82b77254c5584204b9d7b6c3d673b43b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTpjYmJiZTNhYjBiYmM0ZTVkYjNmNDFlZjA0NjBhOTZhYy90YWJsZXJhbmdlOmNiYmJlM2FiMGJiYzRlNWRiM2Y0MWVmMDQ2MGE5NmFjXzEwLTgtMS0xLTA_3a3dd76d-d075-4acc-8a6b-bba3fc4af738"
      unitRef="usd">1145000</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90ZXh0cmVnaW9uOmVlODVkZTI1NGU5NzRiMmE4YjkxNGU1NTgwZTIxNjlmXzQzOTgwNDY1MTYzNzc_fd61f205-b9dc-4320-b55c-1047a6cd64a2">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record changes in the estimated fair value of contingent consideration in the consolidated statements of income. Changes in contingent consideration liabilities are measured at fair value on a recurring basis using unobservable inputs (Level 3) and during the year ended December 31, 2021, are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.794%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.276%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Contingent consideration as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contingent consideration recorded from acquisitions (Note 4)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in estimated fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Contingent consideration as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTo4MmMzZGExZjJkMGY0N2MzYThmYWQ4MTY3ZDcxMGU5Mi90YWJsZXJhbmdlOjgyYzNkYTFmMmQwZjQ3YzNhOGZhZDgxNjdkNzEwZTkyXzItMi0xLTEtMjg3Mzk_ab83e4b4-43dc-4376-89ac-f3ae6d902d0d"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTo4MmMzZGExZjJkMGY0N2MzYThmYWQ4MTY3ZDcxMGU5Mi90YWJsZXJhbmdlOjgyYzNkYTFmMmQwZjQ3YzNhOGZhZDgxNjdkNzEwZTkyXzMtMi0xLTEtMjg3Mzk_a9b6cf68-f517-4564-b674-d29350c2ed51"
      unitRef="usd">5230000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTo4MmMzZGExZjJkMGY0N2MzYThmYWQ4MTY3ZDcxMGU5Mi90YWJsZXJhbmdlOjgyYzNkYTFmMmQwZjQ3YzNhOGZhZDgxNjdkNzEwZTkyXzQtMi0xLTEtMjg3Mzk_1349f35f-44ca-40d4-a490-eecbaa56b8e3"
      unitRef="usd">2000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90YWJsZTo4MmMzZGExZjJkMGY0N2MzYThmYWQ4MTY3ZDcxMGU5Mi90YWJsZXJhbmdlOjgyYzNkYTFmMmQwZjQ3YzNhOGZhZDgxNjdkNzEwZTkyXzUtMi0xLTEtMjg3Mzk_7c777a4b-8092-4106-9d98-48801b10f6ed"
      unitRef="usd">7230000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="i1902b241fd2f47aaaa617a00218e386f_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90ZXh0cmVnaW9uOmVlODVkZTI1NGU5NzRiMmE4YjkxNGU1NTgwZTIxNjlmXzQ5NDc4MDIzMzEyODk_e4894180-cca2-43a3-97a8-9008bd09de8c"
      unitRef="usd">5000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="ifd0bd4a0a64d4c9fa9955ab39bcd5b33_D20211001-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMjkvZnJhZzplZTg1ZGUyNTRlOTc0YjJhOGI5MTRlNTU4MGUyMTY5Zi90ZXh0cmVnaW9uOmVlODVkZTI1NGU5NzRiMmE4YjkxNGU1NTgwZTIxNjlmXzQ5NDc4MDIzMzEzMDE_a563fe74-0cfc-4535-9f39-77d56361e354"
      unitRef="usd">2000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90ZXh0cmVnaW9uOjQ3YTdmNzg2NDkyZjQwZmRiNDY3NDE3ODk2OWU4NTc0Xzk2Nzk_d61167ae-6eed-4925-a81a-d79648996d4d">HEDGING INSTRUMENTS &lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Disclosure within this note is presented to provide transparency about how and why we use derivative and non-derivative instruments (collectively &#x201c;hedging instruments&#x201d;), how the instruments and related hedged items are accounted for, and how the instruments and related hedged items affect our financial position, results of operations, and cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are exposed to certain risks related to our ongoing business operations. The primary risk that we currently manage by using hedging instruments is foreign currency exchange risk. We may also enter into interest rate swaps to minimize the impact of interest rate fluctuations associated with borrowings under our variable-rate Credit Facility.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our subsidiaries enter into foreign currency exchange contracts to manage the exchange risk associated with their forecasted intercompany inventory purchases and sales for the next year. From time to time, we may also enter into other foreign currency exchange contracts, cross currency swaps, or foreign-denominated debt issuances to minimize the impact of foreign currency fluctuations associated with specific balance sheet exposures, including net investments in certain foreign subsidiaries. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The primary purpose of our foreign currency hedging activities is to protect against the volatility associated with foreign currency transactions, including transactions denominated in euro, British pound, Japanese yen, Canadian dollar, and Australian dollar. We also utilize natural hedges to mitigate our transaction and commitment exposures. Our corporate policy prescribes the range of allowable hedging activity. We enter into foreign currency exchange contracts with well-capitalized multinational financial institutions, and we do not hold or engage in transactions involving hedging instruments for purposes other than risk management. Our accounting policies for these contracts are based on our designation of such instruments as hedging transactions.&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize all hedging instruments on the balance sheet at fair value at the balance sheet date. Instruments that do not qualify for hedge accounting treatment must be recorded at fair value through earnings. To qualify for hedge accounting treatment, cash flow and net investment hedges must be highly effective in offsetting changes to expected future cash flows or fair value on hedged transactions. If the instrument qualifies for hedge accounting, changes in the fair value of the hedging instrument from the effective portion of the hedge are deferred in AOCI, net of tax, and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. We immediately record in earnings the extent to which a hedging instrument is not effective in achieving offsetting changes in fair value. We de-designate hedging instruments from hedge accounting when the likelihood of the hedged transaction occurring becomes less than probable. For de-designated &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;instruments, the gain or loss from the time of de-designation through maturity of the instrument is recognized in earnings. Any gain or loss in AOCI at the time of de-designation is reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. Refer to &#x201c;Note 21. Accumulated Other Comprehensive Income&#x201d; for further information regarding the effect of hedging instruments on the consolidated statements of income for the years ended December 31, 2021, 2020, and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We enter into master netting arrangements with the counterparties to our derivative transactions which permit certain outstanding receivables and payables to be offset in the event of default. Our derivative contracts do not require either party to post cash collateral. We elect to present our derivative assets and liabilities in the accompanying consolidated balance sheets on a gross basis. All cash flows related to our foreign currency exchange contracts are classified as operating cash flows, which is consistent with the cash flow treatment of the underlying items being hedged.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to "Note 18. Fair Value Measurements" for additional information regarding the fair value of our derivative instruments and "Note 21. Accumulated Other Comprehensive Income" for additional information regarding the effect of derivative instruments designated as cash flow hedges on the consolidated statements of income.&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have designated our foreign currency exchange contracts as cash flow hedges as these derivative instruments mitigate the exposure to variability in the cash flows of forecasted transactions attributable to foreign currency exchange. Unless noted otherwise, we have also designated our derivative instruments as qualifying for hedge accounting treatment.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We did not de-designate any instruments from hedge accounting treatment during the years ended December 31, 2021, 2020, and 2019. Gains and losses related to hedge ineffectiveness recognized in earnings during the years ended December 31, 2021, 2020, and 2019 were not material.&#160;At December 31, 2021, the estimated amount of net gains, net of tax, which are expected to be reclassified out of AOCI and into earnings within the next twelve months is $5.0 million if exchange rates do not fluctuate from the levels at December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We target to hedge approximately 75% to 85% of the estimated exposure from intercompany product purchases and sales denominated in the euro, British pound, Canadian dollar, Japanese yen, and Australian dollar. We have additional unhedged foreign currency exposures related to foreign services and emerging markets where it is not practical to hedge.&#160;We primarily utilize foreign currency exchange contracts with durations of less than 24 months. Quarterly, we enter into contracts to hedge incremental portions of anticipated foreign currency transactions for the current and following year. As a result, our risk with respect to foreign currency exchange rate fluctuations and the notional value of foreign currency exchange contracts may vary throughout the year.&#160;The U.S. dollar is the currency purchased or sold in all of our foreign currency exchange contracts. The notional amount of foreign currency exchange contracts to hedge forecasted intercompany inventory purchases and sales totaled $286.7 million, and $202.7 million at December 31, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the effect of cash flow hedge accounting on our consolidated statements of income and comprehensive income, and provides information regarding the location and amounts of pretax gains or losses of derivatives:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.579%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Financial statement line items in which effects of cash flow hedges are recorded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,325,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,135,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,041,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amount of (loss) gain reclassified from accumulated other comprehensive income into income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,121)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Net Investment Hedges, Euro-Denominated Notes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2015, we issued and sold through a private placement an aggregate principal amount of &#x20ac;88.9 million in euro-denominated 1.785% Series C Senior Notes due June 18, 2025. We have designated these euro-denominated notes as a hedge of our euro net investment in certain foreign subsidiaries to reduce the volatility in stockholders&#x2019; equity caused by changes in foreign currency exchange rates in the euro relative to the U.S. dollar. As a result of this designation, gains and losses from the change in translated U.S. dollar value of these euro-denominated notes are recorded in AOCI rather than to earnings. We recorded a gain of $6.4 million, a loss of $7.4 million, and a gain of $1.8 million, net of tax, within AOCI as a result of this net &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;investment hedge for the years ended December 31, 2021, 2020, and 2019, respectively. The related cumulative unrealized gain recorded at December 31, 2021, will not be reclassified in earnings until the complete or substantially complete liquidation of the net investment in the hedged foreign operations or all or a portion of the hedge no longer qualifies for hedge accounting treatment. Refer to "Note 13. Debt" to the consolidated financial statements included in this Annual Report on Form 10-K for further information regarding the issuance of these euro-denominated notes.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Net Investment Hedges, Cross Currency Swaps&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have entered into several cross currency swap contracts as a hedge of our net investment in foreign operations to offset foreign currency translation gains and losses on the net investment. These cross currency swaps have maturity dates beginning on June 30, 2023, through June 18, 2025. At maturity of the cross currency swap contracts, we will deliver the notional amounts of&#160;&#x20ac;90.0 million and will receive approximately&#160;$104.5 million&#160;from the counterparties on June 30, 2023, and we will deliver the notional amount of &#x20ac;15.0 million and will receive approximately $17.5 million from the counterparties on June 18, 2025. The change in fair value of the cross currency swap contracts are recorded in AOCI and will be reclassified to earnings when the foreign subsidiaries are sold or substantially liquidated. We recorded a gain of $5.4 million, a loss of $5.6 million, and a gain of $2.1 million, net of tax, within AOCI as a result of these net investment hedges, during the&#160;years ended&#160;December 31, 2021, 2020, and 2019, respectively. We will receive quarterly interest payments from the counterparties based on a fixed interest rate until maturity of the cross currency swaps. This interest rate component is excluded from the assessment of hedge effectiveness and, thus, is recognized as a reduction to interest expense over the life of the hedge instrument. We recognized approximately&#160;$2.8 million&#160;and $2.7 million related to the excluded component as a reduction of interest expense for the&#160;years ended&#160;December 31, 2021 and 2020, respectively.&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair Values of Hedging Instruments Designated as Hedges in Consolidated Balance Sheets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair values of hedging instruments, their respective classification on the consolidated balance sheets, and amounts subject to offset under master netting arrangements consisted of the following derivative instruments, unless otherwise noted:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.798%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.786%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.909%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Hedging Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivatives and non-derivatives designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total derivative instruments presented as hedge instruments on the balance sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gross amounts subject to master netting arrangements not offset on the balance sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(601)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.798%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.786%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.909%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Hedging Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivatives and non-derivatives designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total derivative instruments presented as cash flow hedges on the balance sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-derivative foreign currency denominated debt designated as net investment hedge on the balance sheet &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;109,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total hedging instruments presented on the balance sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;101,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;124,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gross amounts subject to master netting arrangements not offset on the balance sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(601)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;124,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Amounts represent reported carrying amounts of our foreign currency denominated debt. Refer to "Note 18. Fair Value Measurements" for information regarding the fair value of our long-term debt.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90ZXh0cmVnaW9uOjQ3YTdmNzg2NDkyZjQwZmRiNDY3NDE3ODk2OWU4NTc0Xzk2ODA_e1fa8bfc-e0fb-4c51-bd38-71f290a0728e">We recognize all hedging instruments on the balance sheet at fair value at the balance sheet date. Instruments that do not qualify for hedge accounting treatment must be recorded at fair value through earnings. To qualify for hedge accounting treatment, cash flow and net investment hedges must be highly effective in offsetting changes to expected future cash flows or fair value on hedged transactions. If the instrument qualifies for hedge accounting, changes in the fair value of the hedging instrument from the effective portion of the hedge are deferred in AOCI, net of tax, and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. We immediately record in earnings the extent to which a hedging instrument is not effective in achieving offsetting changes in fair value. We de-designate hedging instruments from hedge accounting when the likelihood of the hedged transaction occurring becomes less than probable. For de-designated instruments, the gain or loss from the time of de-designation through maturity of the instrument is recognized in earnings. Any gain or loss in AOCI at the time of de-designation is reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. Refer to &#x201c;Note 21. Accumulated Other Comprehensive Income&#x201d; for further information regarding the effect of hedging instruments on the consolidated statements of income for the years ended December 31, 2021, 2020, and 2019.We enter into master netting arrangements with the counterparties to our derivative transactions which permit certain outstanding receivables and payables to be offset in the event of default. Our derivative contracts do not require either party to post cash collateral. We elect to present our derivative assets and liabilities in the accompanying consolidated balance sheets on a gross basis. All cash flows related to our foreign currency exchange contracts are classified as operating cash flows, which is consistent with the cash flow treatment of the underlying items being hedged.</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90ZXh0cmVnaW9uOjQ3YTdmNzg2NDkyZjQwZmRiNDY3NDE3ODk2OWU4NTc0XzUwNzQ_71e2d97f-1037-4486-9dec-afd768c82d9b"
      unitRef="usd">5000000</us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths>
    <idxx:CashFlowHedgeHedgePercentageOfEstimatedExposureFromIntercompanyProductsPurchasesAndSales
      contextRef="i464c41d2cb9948979da5af09e9a6709b_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90ZXh0cmVnaW9uOjQ3YTdmNzg2NDkyZjQwZmRiNDY3NDE3ODk2OWU4NTc0XzI3NDg3NzkwNzk0OTg_9afae603-32c6-49f1-94e5-fe57181c860e"
      unitRef="number">0.75</idxx:CashFlowHedgeHedgePercentageOfEstimatedExposureFromIntercompanyProductsPurchasesAndSales>
    <idxx:CashFlowHedgeHedgePercentageOfEstimatedExposureFromIntercompanyProductsPurchasesAndSales
      contextRef="i2547ad5bc951453f98e34b5d0f26b8bb_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90ZXh0cmVnaW9uOjQ3YTdmNzg2NDkyZjQwZmRiNDY3NDE3ODk2OWU4NTc0XzUxNzA_16e160e6-c9c6-4925-881a-798df3928f07"
      unitRef="number">0.85</idxx:CashFlowHedgeHedgePercentageOfEstimatedExposureFromIntercompanyProductsPurchasesAndSales>
    <us-gaap:MaximumLengthOfTimeForeignCurrencyCashFlowHedge
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90ZXh0cmVnaW9uOjQ3YTdmNzg2NDkyZjQwZmRiNDY3NDE3ODk2OWU4NTc0XzU1NjQ_36b21f9a-9092-4946-86f8-95af4719f268">P24M</us-gaap:MaximumLengthOfTimeForeignCurrencyCashFlowHedge>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90ZXh0cmVnaW9uOjQ3YTdmNzg2NDkyZjQwZmRiNDY3NDE3ODk2OWU4NTc0XzYxMTk_86eaaa49-452b-4e29-ad3f-79538dfb33d6"
      unitRef="usd">286700000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90ZXh0cmVnaW9uOjQ3YTdmNzg2NDkyZjQwZmRiNDY3NDE3ODk2OWU4NTc0XzYxMjc_b66cb1f5-20ff-4e70-bc53-236d3f2ea076"
      unitRef="usd">202700000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90ZXh0cmVnaW9uOjQ3YTdmNzg2NDkyZjQwZmRiNDY3NDE3ODk2OWU4NTc0Xzk2ODE_3e336ef9-de29-40a6-a6d6-05a350a3fae6">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the effect of cash flow hedge accounting on our consolidated statements of income and comprehensive income, and provides information regarding the location and amounts of pretax gains or losses of derivatives:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.579%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Financial statement line items in which effects of cash flow hedges are recorded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,325,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,135,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,041,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amount of (loss) gain reclassified from accumulated other comprehensive income into income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,121)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:CostOfRevenue
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTo2OWI5YWRjNWU4YTg0YWU4ODMxOTQ5Y2QzMWZmYTE0OS90YWJsZXJhbmdlOjY5YjlhZGM1ZThhODRhZTg4MzE5NDljZDMxZmZhMTQ5XzMtNC0xLTEtMA_5e6e1013-88e6-4f58-b8e9-1d99859cb168"
      unitRef="usd">1325928000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTo2OWI5YWRjNWU4YTg0YWU4ODMxOTQ5Y2QzMWZmYTE0OS90YWJsZXJhbmdlOjY5YjlhZGM1ZThhODRhZTg4MzE5NDljZDMxZmZhMTQ5XzMtNi0xLTEtMA_a393cad8-0900-4aa9-82a0-16f2d924bf7e"
      unitRef="usd">1135615000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTo2OWI5YWRjNWU4YTg0YWU4ODMxOTQ5Y2QzMWZmYTE0OS90YWJsZXJhbmdlOjY5YjlhZGM1ZThhODRhZTg4MzE5NDljZDMxZmZhMTQ5XzMtOC0xLTEtMA_2e7ee554-bb18-42b5-ae63-21ba55260d1b"
      unitRef="usd">1041359000</us-gaap:CostOfRevenue>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="ia1ef4a96731942908ce11fe9891aa0bf_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTo2OWI5YWRjNWU4YTg0YWU4ODMxOTQ5Y2QzMWZmYTE0OS90YWJsZXJhbmdlOjY5YjlhZGM1ZThhODRhZTg4MzE5NDljZDMxZmZhMTQ5XzUtNC0xLTEtMA_9e2e73f5-5240-45d5-9107-951cff0362c5"
      unitRef="usd">-7121000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="id9c53b6812ef44e0a021ef872c3e03e2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTo2OWI5YWRjNWU4YTg0YWU4ODMxOTQ5Y2QzMWZmYTE0OS90YWJsZXJhbmdlOjY5YjlhZGM1ZThhODRhZTg4MzE5NDljZDMxZmZhMTQ5XzUtNi0xLTEtMA_c366acea-b1ec-464b-bc5b-5fe9362ae34f"
      unitRef="usd">829000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i12d3943c8fa0485b86f83616b4c036c1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTo2OWI5YWRjNWU4YTg0YWU4ODMxOTQ5Y2QzMWZmYTE0OS90YWJsZXJhbmdlOjY5YjlhZGM1ZThhODRhZTg4MzE5NDljZDMxZmZhMTQ5XzUtOC0xLTEtMA_96fe87c8-b44d-4a1c-9c86-281bf3ffc281"
      unitRef="usd">10628000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ie463159bdbe0401fa1699ea9bbc087e7_I20150630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90ZXh0cmVnaW9uOjQ3YTdmNzg2NDkyZjQwZmRiNDY3NDE3ODk2OWU4NTc0XzY1NDY_4f3937b8-7c27-438e-afb3-7772d4dd7c52"
      unitRef="eur">88900000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ie463159bdbe0401fa1699ea9bbc087e7_I20150630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90ZXh0cmVnaW9uOjQ3YTdmNzg2NDkyZjQwZmRiNDY3NDE3ODk2OWU4NTc0XzY1Njk_2a157f92-e783-449b-a4c5-ac95e95fd536"
      unitRef="number">0.01785</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <idxx:OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90ZXh0cmVnaW9uOjQ3YTdmNzg2NDkyZjQwZmRiNDY3NDE3ODk2OWU4NTc0XzcwNzI_ea8c6c5d-434a-4064-b72b-e5fcfa7a2d43"
      unitRef="usd">6400000</idxx:OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax>
    <idxx:OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90ZXh0cmVnaW9uOjQ3YTdmNzg2NDkyZjQwZmRiNDY3NDE3ODk2OWU4NTc0XzcwODg_3b6efe8a-f33b-4503-b0ff-184dd6ce8021"
      unitRef="usd">-7400000</idxx:OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax>
    <idxx:OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90ZXh0cmVnaW9uOjQ3YTdmNzg2NDkyZjQwZmRiNDY3NDE3ODk2OWU4NTc0XzcwOTU_7063a241-3163-401e-87f9-342e33568887"
      unitRef="usd">1800000</idxx:OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i78c0899cc8ce4403916f4aed0daa467b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90ZXh0cmVnaW9uOjQ3YTdmNzg2NDkyZjQwZmRiNDY3NDE3ODk2OWU4NTc0XzgxMTY_e74fc6c6-53bf-4d15-b28d-270c53796cdb"
      unitRef="eur">90000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:ProceedsFromHedgeInvestingActivities
      contextRef="i500dd303994d474bb3c6133348ce968f_D20230630-20230630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90ZXh0cmVnaW9uOjQ3YTdmNzg2NDkyZjQwZmRiNDY3NDE3ODk2OWU4NTc0XzgxNTA_5bc1dcdc-04b0-4751-967b-e310ef050b07"
      unitRef="usd">104500000</us-gaap:ProceedsFromHedgeInvestingActivities>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ied1674e5cf1c49dab027aef8b772a006_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90ZXh0cmVnaW9uOjQ3YTdmNzg2NDkyZjQwZmRiNDY3NDE3ODk2OWU4NTc0XzgyMzg_9eb844c2-c487-454b-aaab-756db61559de"
      unitRef="eur">15000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:ProceedsFromHedgeInvestingActivities
      contextRef="i29716f7451ce47209ffc3a126855c5bc_D20250618-20250618"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90ZXh0cmVnaW9uOjQ3YTdmNzg2NDkyZjQwZmRiNDY3NDE3ODk2OWU4NTc0XzgyNzI_8ed2eb99-9cbe-431c-b203-d6f091e6253f"
      unitRef="usd">17500000</us-gaap:ProceedsFromHedgeInvestingActivities>
    <idxx:OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax
      contextRef="i2d594a7833ec49b39f9b6d981b10a581_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90ZXh0cmVnaW9uOjQ3YTdmNzg2NDkyZjQwZmRiNDY3NDE3ODk2OWU4NTc0Xzg1Mjc_86ed7eaa-32e9-4d85-8901-52b3cbba12b1"
      unitRef="usd">5400000</idxx:OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax>
    <idxx:OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax
      contextRef="id2a5f0696ab0404987ffb0a495402d7d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90ZXh0cmVnaW9uOjQ3YTdmNzg2NDkyZjQwZmRiNDY3NDE3ODk2OWU4NTc0Xzg1NDE_aeb1af32-1a28-4330-966b-a833659ed971"
      unitRef="usd">-5600000</idxx:OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax>
    <idxx:OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax
      contextRef="i2c94572bec9745c49286936d60cee01c_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90ZXh0cmVnaW9uOjQ3YTdmNzg2NDkyZjQwZmRiNDY3NDE3ODk2OWU4NTc0XzEwOTk1MTE2Mzc1ODY_08ca0047-be9a-404e-a6fd-94a89f7e5d4d"
      unitRef="usd">2100000</idxx:OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness
      contextRef="i2d594a7833ec49b39f9b6d981b10a581_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90ZXh0cmVnaW9uOjQ3YTdmNzg2NDkyZjQwZmRiNDY3NDE3ODk2OWU4NTc0XzkwMzk_1bc30d5b-587d-4d6c-835e-5002b0bfbf70"
      unitRef="usd">2800000</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness
      contextRef="id2a5f0696ab0404987ffb0a495402d7d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90ZXh0cmVnaW9uOjQ3YTdmNzg2NDkyZjQwZmRiNDY3NDE3ODk2OWU4NTc0XzkwNDY_839b50e8-08b2-4259-8737-23a763e9941d"
      unitRef="usd">2700000</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness>
    <us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90ZXh0cmVnaW9uOjQ3YTdmNzg2NDkyZjQwZmRiNDY3NDE3ODk2OWU4NTc0Xzk2ODQ_111f5e4c-66fc-4499-9448-94371cd4e969">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair values of hedging instruments, their respective classification on the consolidated balance sheets, and amounts subject to offset under master netting arrangements consisted of the following derivative instruments, unless otherwise noted:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.798%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.786%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.909%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Hedging Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivatives and non-derivatives designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total derivative instruments presented as hedge instruments on the balance sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gross amounts subject to master netting arrangements not offset on the balance sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(601)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.798%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.786%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.909%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Hedging Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivatives and non-derivatives designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total derivative instruments presented as cash flow hedges on the balance sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-derivative foreign currency denominated debt designated as net investment hedge on the balance sheet &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;109,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total hedging instruments presented on the balance sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;101,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;124,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gross amounts subject to master netting arrangements not offset on the balance sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(601)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;124,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Amounts represent reported carrying amounts of our foreign currency denominated debt. Refer to "Note 18. Fair Value Measurements" for information regarding the fair value of our long-term debt.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i545077a6c3224507841852d11c8c9273_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTpjOTUxZDgwMjNhMGY0YmQ0YmNhNDZjOWUzYWQ2NjZmNC90YWJsZXJhbmdlOmM5NTFkODAyM2EwZjRiZDRiY2E0NmM5ZTNhZDY2NmY0XzQtNC0xLTEtMA_5faeb018-3c8d-4cf2-b46f-6fce5e64b11d"
      unitRef="usd">6512000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ibfce4063123c459eb84ed75e6fc79108_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTpjOTUxZDgwMjNhMGY0YmQ0YmNhNDZjOWUzYWQ2NjZmNC90YWJsZXJhbmdlOmM5NTFkODAyM2EwZjRiZDRiY2E0NmM5ZTNhZDY2NmY0XzQtNi0xLTEtMA_40c4a849-8d00-4aa9-939b-0b876caf477e"
      unitRef="usd">125000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="iacbb16db3cb7452eb84960f47dc683ab_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTpjOTUxZDgwMjNhMGY0YmQ0YmNhNDZjOWUzYWQ2NjZmNC90YWJsZXJhbmdlOmM5NTFkODAyM2EwZjRiZDRiY2E0NmM5ZTNhZDY2NmY0XzUtNC0xLTEtMA_945511e4-8d83-479e-b045-e5bee7ea9447"
      unitRef="usd">4256000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i050978c75e2a45678abaff399b9bc5f6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTpjOTUxZDgwMjNhMGY0YmQ0YmNhNDZjOWUzYWQ2NjZmNC90YWJsZXJhbmdlOmM5NTFkODAyM2EwZjRiZDRiY2E0NmM5ZTNhZDY2NmY0XzUtNi0xLTEtMA_6f090a6a-7527-4299-9042-d52744413b6e"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ie4698c4affbf4e699d54f34e5350d605_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTpjOTUxZDgwMjNhMGY0YmQ0YmNhNDZjOWUzYWQ2NjZmNC90YWJsZXJhbmdlOmM5NTFkODAyM2EwZjRiZDRiY2E0NmM5ZTNhZDY2NmY0XzctNC0xLTEtMA_99a68cbf-16af-430a-85f7-4ad30ac64b12"
      unitRef="usd">10768000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i06a7e9fd40ce477ebb37684aa46d2543_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTpjOTUxZDgwMjNhMGY0YmQ0YmNhNDZjOWUzYWQ2NjZmNC90YWJsZXJhbmdlOmM5NTFkODAyM2EwZjRiZDRiY2E0NmM5ZTNhZDY2NmY0XzctNi0xLTEtMA_32ec2fd2-5695-4927-bb71-fc397cad1b03"
      unitRef="usd">125000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction
      contextRef="ie4698c4affbf4e699d54f34e5350d605_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTpjOTUxZDgwMjNhMGY0YmQ0YmNhNDZjOWUzYWQ2NjZmNC90YWJsZXJhbmdlOmM5NTFkODAyM2EwZjRiZDRiY2E0NmM5ZTNhZDY2NmY0XzgtNC0xLTEtMA_7ed81def-e3ba-4ca1-89ed-557f774fa7e3"
      unitRef="usd">601000</us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction>
    <us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction
      contextRef="i06a7e9fd40ce477ebb37684aa46d2543_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTpjOTUxZDgwMjNhMGY0YmQ0YmNhNDZjOWUzYWQ2NjZmNC90YWJsZXJhbmdlOmM5NTFkODAyM2EwZjRiZDRiY2E0NmM5ZTNhZDY2NmY0XzgtNi0xLTEtMA_a08dfdec-7edd-4e7f-ba61-cb3d080dd740"
      unitRef="usd">125000</us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction>
    <us-gaap:DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
      contextRef="ie4698c4affbf4e699d54f34e5350d605_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTpjOTUxZDgwMjNhMGY0YmQ0YmNhNDZjOWUzYWQ2NjZmNC90YWJsZXJhbmdlOmM5NTFkODAyM2EwZjRiZDRiY2E0NmM5ZTNhZDY2NmY0XzktNC0xLTEtMA_9a620fcd-f79b-46e1-beda-3d9a895d83e9"
      unitRef="usd">10167000</us-gaap:DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection>
    <us-gaap:DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
      contextRef="i06a7e9fd40ce477ebb37684aa46d2543_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTpjOTUxZDgwMjNhMGY0YmQ0YmNhNDZjOWUzYWQ2NjZmNC90YWJsZXJhbmdlOmM5NTFkODAyM2EwZjRiZDRiY2E0NmM5ZTNhZDY2NmY0XzktNi0xLTEtMA_80a8f4a4-4762-4210-bf42-9c7cdca26a46"
      unitRef="usd">0</us-gaap:DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ie64c1bfe251d4ea8a0ed2f0eea68ad6d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTpjZDhkNzc4YzI1YjA0YjU1OTk4YWFjNTNmOWM3MjRkMC90YWJsZXJhbmdlOmNkOGQ3NzhjMjViMDRiNTU5OThhYWM1M2Y5YzcyNGQwXzQtNC0xLTEtMA_0fb65aeb-0fdb-4bb5-a49c-5549944ae41e"
      unitRef="usd">601000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i22e9c32bb1ff4a549672a6a6a514fca9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTpjZDhkNzc4YzI1YjA0YjU1OTk4YWFjNTNmOWM3MjRkMC90YWJsZXJhbmdlOmNkOGQ3NzhjMjViMDRiNTU5OThhYWM1M2Y5YzcyNGQwXzQtNi0xLTEtMA_2b8e1d67-1d99-4833-85fe-80ef63287b85"
      unitRef="usd">12373000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i1e5cf4395f024a8996343fcdfd9b3ca3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTpjZDhkNzc4YzI1YjA0YjU1OTk4YWFjNTNmOWM3MjRkMC90YWJsZXJhbmdlOmNkOGQ3NzhjMjViMDRiNTU5OThhYWM1M2Y5YzcyNGQwXzYtNC0xLTEtMA_6ea8f02e-0acc-4ae0-8869-79e6a860a657"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i286b8b14cd394335903921c6ba48d7f5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTpjZDhkNzc4YzI1YjA0YjU1OTk4YWFjNTNmOWM3MjRkMC90YWJsZXJhbmdlOmNkOGQ3NzhjMjViMDRiNTU5OThhYWM1M2Y5YzcyNGQwXzYtNi0xLTEtMA_3e87daea-8155-4a9a-94f8-b6c25c0de55f"
      unitRef="usd">2841000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i91aaaf38003044fe91000cefb4286f16_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTpjZDhkNzc4YzI1YjA0YjU1OTk4YWFjNTNmOWM3MjRkMC90YWJsZXJhbmdlOmNkOGQ3NzhjMjViMDRiNTU5OThhYWM1M2Y5YzcyNGQwXzctNC0xLTEtMA_ee2db50f-ecfd-4e5c-9705-0d0f47fbbf74"
      unitRef="usd">601000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ie944714e2148495fabc8b885bf09a852_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTpjZDhkNzc4YzI1YjA0YjU1OTk4YWFjNTNmOWM3MjRkMC90YWJsZXJhbmdlOmNkOGQ3NzhjMjViMDRiNTU5OThhYWM1M2Y5YzcyNGQwXzctNi0xLTEtMA_fd764ab6-6914-4719-92f8-c2e92e7dca77"
      unitRef="usd">15214000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i051a71adeb9449eea0629393ed4795bc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTpjZDhkNzc4YzI1YjA0YjU1OTk4YWFjNTNmOWM3MjRkMC90YWJsZXJhbmdlOmNkOGQ3NzhjMjViMDRiNTU5OThhYWM1M2Y5YzcyNGQwXzgtNC0xLTEtMA_4199c02c-5a57-4e5a-93d6-dda6603f7595"
      unitRef="usd">100711000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i53807fb41e524bf69fec4117ad94a99b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTpjZDhkNzc4YzI1YjA0YjU1OTk4YWFjNTNmOWM3MjRkMC90YWJsZXJhbmdlOmNkOGQ3NzhjMjViMDRiNTU5OThhYWM1M2Y5YzcyNGQwXzgtNi0xLTEtMA_499452f6-c182-4f82-8603-ce9dc0c87805"
      unitRef="usd">109125000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ie4698c4affbf4e699d54f34e5350d605_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTpjZDhkNzc4YzI1YjA0YjU1OTk4YWFjNTNmOWM3MjRkMC90YWJsZXJhbmdlOmNkOGQ3NzhjMjViMDRiNTU5OThhYWM1M2Y5YzcyNGQwXzktNC0xLTEtMA_692b6834-50c7-4832-9e5f-d358b7a7499e"
      unitRef="usd">101312000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i06a7e9fd40ce477ebb37684aa46d2543_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTpjZDhkNzc4YzI1YjA0YjU1OTk4YWFjNTNmOWM3MjRkMC90YWJsZXJhbmdlOmNkOGQ3NzhjMjViMDRiNTU5OThhYWM1M2Y5YzcyNGQwXzktNi0xLTEtMA_c320d88f-3dd0-4631-b290-de9cddcc1d4f"
      unitRef="usd">124339000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction
      contextRef="ie4698c4affbf4e699d54f34e5350d605_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTpjZDhkNzc4YzI1YjA0YjU1OTk4YWFjNTNmOWM3MjRkMC90YWJsZXJhbmdlOmNkOGQ3NzhjMjViMDRiNTU5OThhYWM1M2Y5YzcyNGQwXzEwLTQtMS0xLTA_e52e0bec-5a12-4e16-a4ee-167fb6e7050d"
      unitRef="usd">601000</us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction>
    <us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction
      contextRef="i06a7e9fd40ce477ebb37684aa46d2543_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTpjZDhkNzc4YzI1YjA0YjU1OTk4YWFjNTNmOWM3MjRkMC90YWJsZXJhbmdlOmNkOGQ3NzhjMjViMDRiNTU5OThhYWM1M2Y5YzcyNGQwXzEwLTYtMS0xLTA_0e39b81c-c911-4c8b-a424-7a8f26b029c5"
      unitRef="usd">125000</us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction>
    <us-gaap:DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
      contextRef="ie4698c4affbf4e699d54f34e5350d605_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTpjZDhkNzc4YzI1YjA0YjU1OTk4YWFjNTNmOWM3MjRkMC90YWJsZXJhbmdlOmNkOGQ3NzhjMjViMDRiNTU5OThhYWM1M2Y5YzcyNGQwXzExLTQtMS0xLTA_67a3b278-0b23-49ad-82b6-00debbefc458"
      unitRef="usd">100711000</us-gaap:DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection>
    <us-gaap:DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
      contextRef="i06a7e9fd40ce477ebb37684aa46d2543_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzIvZnJhZzo0N2E3Zjc4NjQ5MmY0MGZkYjQ2NzQxNzg5NjllODU3NC90YWJsZTpjZDhkNzc4YzI1YjA0YjU1OTk4YWFjNTNmOWM3MjRkMC90YWJsZXJhbmdlOmNkOGQ3NzhjMjViMDRiNTU5OThhYWM1M2Y5YzcyNGQwXzExLTYtMS0xLTA_d8991ad3-cd4e-4779-9d14-4c1bc2e6fb22"
      unitRef="usd">124214000</us-gaap:DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection>
    <us-gaap:TreasuryStockTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90ZXh0cmVnaW9uOmE5MDExODRjYTg3YTQ3ZjhiMmRmZTcwMzhhOTg5NGJmXzE0MDM_eac71fd5-f79e-4166-8c00-07bcb701bbb6">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;REPURCHASES OF COMMON STOCK&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2021, our Board of Directors has authorized the repurchase of u&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;p to 73.0 million sh&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ares of our common stock in the open market or in negotiated transactions pursuant to the Company&#x2019;s share repurchase program. We believe that the repurchase of our common stock is a favorable means of returning value to our stockholders, and we also repurchase to offset the dilutive effect of our share-based compensation programs. Repurchases of our common stock may vary depending upon the level of other investing activities and the share price. As of December 31, 2021, there are approximate&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ly 5.0 million rem&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;aining shares available for repurchase under this authorization.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We primarily acquire shares by repurchases in the open market. However, we also acquire shares that are surrendered by employees in payment for the minimum required statutory withholding taxes due on the vesting of restricted stock units and the settlement of deferred stock units, otherwise referred to herein as employee surrenders. We issue shares of treasury stock upon the vesting of certain restricted stock units and upon the exercise of certain stock options. The number of shares of treasury stock issued during the years ended December 31, 2021, 2020, and 2019, was not material.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of our open market common stock repurchases, reported on a trade date basis, and shares acquired through employee surrenders:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares repurchased in the open market&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares acquired through employee surrenders&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;for statutory tax withholding&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total shares repurchased&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of shares repurchased in the open market&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;755,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;179,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;303,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of shares for employee surrenders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total cost of shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;771,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;200,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;311,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Average cost per share - open market repurchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;588.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;249.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;249.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Average cost per share - employee surrenders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;548.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;354.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;210.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Average cost per share - total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;587.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;257.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;248.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:TreasuryStockTextBlock>
    <us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90ZXh0cmVnaW9uOmE5MDExODRjYTg3YTQ3ZjhiMmRmZTcwMzhhOTg5NGJmXzExMg_50271533-ff34-4576-85a3-0c99b4263f9d"
      unitRef="shares">73000000</us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90ZXh0cmVnaW9uOmE5MDExODRjYTg3YTQ3ZjhiMmRmZTcwMzhhOTg5NGJmXzYwMQ_5cfae2fa-447e-42ac-aa0b-24f0d2b1f088"
      unitRef="shares">5000000</us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:ScheduleOfTreasuryStockByClassTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90ZXh0cmVnaW9uOmE5MDExODRjYTg3YTQ3ZjhiMmRmZTcwMzhhOTg5NGJmXzE0MDQ_265d4c45-a315-409f-a56f-db11e47b2960">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of our open market common stock repurchases, reported on a trade date basis, and shares acquired through employee surrenders:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares repurchased in the open market&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares acquired through employee surrenders&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;for statutory tax withholding&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total shares repurchased&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of shares repurchased in the open market&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;755,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;179,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;303,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of shares for employee surrenders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total cost of shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;771,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;200,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;311,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Average cost per share - open market repurchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;588.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;249.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;249.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Average cost per share - employee surrenders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;548.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;354.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;210.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Average cost per share - total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;587.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;257.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;248.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfTreasuryStockByClassTextBlock>
    <idxx:TreasuryStockSharesAcquiredNetOfTaxWithholdings
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90YWJsZTo3MWNiNTA4OGFiNGE0ZWNjYjc5MDRjMDIzNTA3ZjNjOC90YWJsZXJhbmdlOjcxY2I1MDg4YWI0YTRlY2NiNzkwNGMwMjM1MDdmM2M4XzMtMi0xLTEtMA_1ccf71e7-1408-4e66-944a-32034a2165a5"
      unitRef="shares">1283000</idxx:TreasuryStockSharesAcquiredNetOfTaxWithholdings>
    <idxx:TreasuryStockSharesAcquiredNetOfTaxWithholdings
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90YWJsZTo3MWNiNTA4OGFiNGE0ZWNjYjc5MDRjMDIzNTA3ZjNjOC90YWJsZXJhbmdlOjcxY2I1MDg4YWI0YTRlY2NiNzkwNGMwMjM1MDdmM2M4XzMtNC0xLTEtMA_e71c9a59-957b-4112-b1a3-6b28ee37cd62"
      unitRef="shares">721000</idxx:TreasuryStockSharesAcquiredNetOfTaxWithholdings>
    <idxx:TreasuryStockSharesAcquiredNetOfTaxWithholdings
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90YWJsZTo3MWNiNTA4OGFiNGE0ZWNjYjc5MDRjMDIzNTA3ZjNjOC90YWJsZXJhbmdlOjcxY2I1MDg4YWI0YTRlY2NiNzkwNGMwMjM1MDdmM2M4XzMtNi0xLTEtMA_5ebb0529-b87d-4ec6-9fec-9b25e699795d"
      unitRef="shares">1215000</idxx:TreasuryStockSharesAcquiredNetOfTaxWithholdings>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90YWJsZTo3MWNiNTA4OGFiNGE0ZWNjYjc5MDRjMDIzNTA3ZjNjOC90YWJsZXJhbmdlOjcxY2I1MDg4YWI0YTRlY2NiNzkwNGMwMjM1MDdmM2M4XzQtMi0xLTEtMA_86c51f0d-7ee6-4db4-b10d-8569eddc04a3"
      unitRef="shares">29000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90YWJsZTo3MWNiNTA4OGFiNGE0ZWNjYjc5MDRjMDIzNTA3ZjNjOC90YWJsZXJhbmdlOjcxY2I1MDg4YWI0YTRlY2NiNzkwNGMwMjM1MDdmM2M4XzQtNC0xLTEtMA_74c348a9-1406-42c0-9e3b-2161c4e3bde6"
      unitRef="shares">58000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90YWJsZTo3MWNiNTA4OGFiNGE0ZWNjYjc5MDRjMDIzNTA3ZjNjOC90YWJsZXJhbmdlOjcxY2I1MDg4YWI0YTRlY2NiNzkwNGMwMjM1MDdmM2M4XzQtNi0xLTEtMA_6756142d-db7a-462a-9860-7600224b326c"
      unitRef="shares">39000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90YWJsZTo3MWNiNTA4OGFiNGE0ZWNjYjc5MDRjMDIzNTA3ZjNjOC90YWJsZXJhbmdlOjcxY2I1MDg4YWI0YTRlY2NiNzkwNGMwMjM1MDdmM2M4XzUtMi0xLTEtMA_1dc6a3da-de1a-4ad6-ba05-343f69597a18"
      unitRef="shares">1312000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90YWJsZTo3MWNiNTA4OGFiNGE0ZWNjYjc5MDRjMDIzNTA3ZjNjOC90YWJsZXJhbmdlOjcxY2I1MDg4YWI0YTRlY2NiNzkwNGMwMjM1MDdmM2M4XzUtNC0xLTEtMA_2508de74-c954-4e3d-bcc9-dc8908af35a6"
      unitRef="shares">779000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90YWJsZTo3MWNiNTA4OGFiNGE0ZWNjYjc5MDRjMDIzNTA3ZjNjOC90YWJsZXJhbmdlOjcxY2I1MDg4YWI0YTRlY2NiNzkwNGMwMjM1MDdmM2M4XzUtNi0xLTEtMA_1ff21611-120f-468d-8278-7adbb65c0941"
      unitRef="shares">1254000</us-gaap:TreasuryStockSharesAcquired>
    <idxx:TreasuryStockValueAcquiredCostMethodNetOfTaxWithholdings
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90YWJsZTo3MWNiNTA4OGFiNGE0ZWNjYjc5MDRjMDIzNTA3ZjNjOC90YWJsZXJhbmdlOjcxY2I1MDg4YWI0YTRlY2NiNzkwNGMwMjM1MDdmM2M4XzctMi0xLTEtMA_4657cdba-4deb-4e9b-a946-6195ba0b624e"
      unitRef="usd">755545000</idxx:TreasuryStockValueAcquiredCostMethodNetOfTaxWithholdings>
    <idxx:TreasuryStockValueAcquiredCostMethodNetOfTaxWithholdings
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90YWJsZTo3MWNiNTA4OGFiNGE0ZWNjYjc5MDRjMDIzNTA3ZjNjOC90YWJsZXJhbmdlOjcxY2I1MDg4YWI0YTRlY2NiNzkwNGMwMjM1MDdmM2M4XzctNC0xLTEtMA_e0e51326-7153-4b9f-886a-e6da43a380cc"
      unitRef="usd">179623000</idxx:TreasuryStockValueAcquiredCostMethodNetOfTaxWithholdings>
    <idxx:TreasuryStockValueAcquiredCostMethodNetOfTaxWithholdings
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90YWJsZTo3MWNiNTA4OGFiNGE0ZWNjYjc5MDRjMDIzNTA3ZjNjOC90YWJsZXJhbmdlOjcxY2I1MDg4YWI0YTRlY2NiNzkwNGMwMjM1MDdmM2M4XzctNi0xLTEtMA_535e762e-08a0-4b52-bb39-c516eb2be303"
      unitRef="usd">303838000</idxx:TreasuryStockValueAcquiredCostMethodNetOfTaxWithholdings>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90YWJsZTo3MWNiNTA4OGFiNGE0ZWNjYjc5MDRjMDIzNTA3ZjNjOC90YWJsZXJhbmdlOjcxY2I1MDg4YWI0YTRlY2NiNzkwNGMwMjM1MDdmM2M4XzgtMi0xLTEtMA_105ee9a1-37b5-4cda-b520-ae1565edb668"
      unitRef="usd">15562000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90YWJsZTo3MWNiNTA4OGFiNGE0ZWNjYjc5MDRjMDIzNTA3ZjNjOC90YWJsZXJhbmdlOjcxY2I1MDg4YWI0YTRlY2NiNzkwNGMwMjM1MDdmM2M4XzgtNC0xLTEtMA_00b84eae-5af4-4df6-a9b8-dfa01b58f1fc"
      unitRef="usd">20603000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90YWJsZTo3MWNiNTA4OGFiNGE0ZWNjYjc5MDRjMDIzNTA3ZjNjOC90YWJsZXJhbmdlOjcxY2I1MDg4YWI0YTRlY2NiNzkwNGMwMjM1MDdmM2M4XzgtNi0xLTEtMA_d2f68903-d7b2-4880-8622-37d94b67e271"
      unitRef="usd">8054000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90YWJsZTo3MWNiNTA4OGFiNGE0ZWNjYjc5MDRjMDIzNTA3ZjNjOC90YWJsZXJhbmdlOjcxY2I1MDg4YWI0YTRlY2NiNzkwNGMwMjM1MDdmM2M4XzktMi0xLTEtMA_fc8be775-42a0-43ed-a134-4d9e5c5ffdfc"
      unitRef="usd">771107000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90YWJsZTo3MWNiNTA4OGFiNGE0ZWNjYjc5MDRjMDIzNTA3ZjNjOC90YWJsZXJhbmdlOjcxY2I1MDg4YWI0YTRlY2NiNzkwNGMwMjM1MDdmM2M4XzktNC0xLTEtMA_9cb34eef-a052-4cdc-89e5-5c24487ab0ab"
      unitRef="usd">200226000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90YWJsZTo3MWNiNTA4OGFiNGE0ZWNjYjc5MDRjMDIzNTA3ZjNjOC90YWJsZXJhbmdlOjcxY2I1MDg4YWI0YTRlY2NiNzkwNGMwMjM1MDdmM2M4XzktNi0xLTEtMA_a3cfe86c-2ef9-46f9-bdf2-8105de875d76"
      unitRef="usd">311892000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <idxx:TreasuryStockAcquiredAverageCostPerShareOpenMarketRepurchase
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90YWJsZTo3MWNiNTA4OGFiNGE0ZWNjYjc5MDRjMDIzNTA3ZjNjOC90YWJsZXJhbmdlOjcxY2I1MDg4YWI0YTRlY2NiNzkwNGMwMjM1MDdmM2M4XzExLTItMS0xLTA_f1833ebb-7ea5-4917-9566-b9e02be28d2d"
      unitRef="usdPerShare">588.58</idxx:TreasuryStockAcquiredAverageCostPerShareOpenMarketRepurchase>
    <idxx:TreasuryStockAcquiredAverageCostPerShareOpenMarketRepurchase
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90YWJsZTo3MWNiNTA4OGFiNGE0ZWNjYjc5MDRjMDIzNTA3ZjNjOC90YWJsZXJhbmdlOjcxY2I1MDg4YWI0YTRlY2NiNzkwNGMwMjM1MDdmM2M4XzExLTQtMS0xLTA_6103534d-fe9b-4ef2-bade-bb7a386e45bb"
      unitRef="usdPerShare">249.20</idxx:TreasuryStockAcquiredAverageCostPerShareOpenMarketRepurchase>
    <idxx:TreasuryStockAcquiredAverageCostPerShareOpenMarketRepurchase
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90YWJsZTo3MWNiNTA4OGFiNGE0ZWNjYjc5MDRjMDIzNTA3ZjNjOC90YWJsZXJhbmdlOjcxY2I1MDg4YWI0YTRlY2NiNzkwNGMwMjM1MDdmM2M4XzExLTYtMS0xLTA_1463264d-1e90-486a-a9b2-0c7ef8817a19"
      unitRef="usdPerShare">249.84</idxx:TreasuryStockAcquiredAverageCostPerShareOpenMarketRepurchase>
    <idxx:TreasuryStockAcquiredAverageCostPerShareEmployeeSurrenders
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90YWJsZTo3MWNiNTA4OGFiNGE0ZWNjYjc5MDRjMDIzNTA3ZjNjOC90YWJsZXJhbmdlOjcxY2I1MDg4YWI0YTRlY2NiNzkwNGMwMjM1MDdmM2M4XzEyLTItMS0xLTA_7719d257-204f-4314-8f74-0aa6c81c446f"
      unitRef="usdPerShare">548.08</idxx:TreasuryStockAcquiredAverageCostPerShareEmployeeSurrenders>
    <idxx:TreasuryStockAcquiredAverageCostPerShareEmployeeSurrenders
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90YWJsZTo3MWNiNTA4OGFiNGE0ZWNjYjc5MDRjMDIzNTA3ZjNjOC90YWJsZXJhbmdlOjcxY2I1MDg4YWI0YTRlY2NiNzkwNGMwMjM1MDdmM2M4XzEyLTQtMS0xLTA_e5b531e4-7b89-4621-8db2-7c34ef97e703"
      unitRef="usdPerShare">354.98</idxx:TreasuryStockAcquiredAverageCostPerShareEmployeeSurrenders>
    <idxx:TreasuryStockAcquiredAverageCostPerShareEmployeeSurrenders
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90YWJsZTo3MWNiNTA4OGFiNGE0ZWNjYjc5MDRjMDIzNTA3ZjNjOC90YWJsZXJhbmdlOjcxY2I1MDg4YWI0YTRlY2NiNzkwNGMwMjM1MDdmM2M4XzEyLTYtMS0xLTA_f85092fe-4840-4438-8d6a-a9dbeffd0630"
      unitRef="usdPerShare">210.10</idxx:TreasuryStockAcquiredAverageCostPerShareEmployeeSurrenders>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90YWJsZTo3MWNiNTA4OGFiNGE0ZWNjYjc5MDRjMDIzNTA3ZjNjOC90YWJsZXJhbmdlOjcxY2I1MDg4YWI0YTRlY2NiNzkwNGMwMjM1MDdmM2M4XzEzLTItMS0xLTA_c87a211e-235a-429b-bd0d-1d765fdcdde0"
      unitRef="usdPerShare">587.70</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90YWJsZTo3MWNiNTA4OGFiNGE0ZWNjYjc5MDRjMDIzNTA3ZjNjOC90YWJsZXJhbmdlOjcxY2I1MDg4YWI0YTRlY2NiNzkwNGMwMjM1MDdmM2M4XzEzLTQtMS0xLTA_d7a2fd49-63fe-4ddd-baaf-f013aeec42d8"
      unitRef="usdPerShare">257.08</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i4176a2a2b0514d25a5512b7071c96d68_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzUvZnJhZzphOTAxMTg0Y2E4N2E0N2Y4YjJkZmU3MDM4YTk4OTRiZi90YWJsZTo3MWNiNTA4OGFiNGE0ZWNjYjc5MDRjMDIzNTA3ZjNjOC90YWJsZXJhbmdlOjcxY2I1MDg4YWI0YTRlY2NiNzkwNGMwMjM1MDdmM2M4XzEzLTYtMS0xLTA_c71fdab6-5a26-42f1-ac32-489de5753ab2"
      unitRef="usdPerShare">248.62</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90ZXh0cmVnaW9uOjQ4ZTIzYjYxMmE1YzQwZWVhYmRhYzNmYzE5ZjVjYjA3XzE5Mw_05dc0d18-e30c-4d18-bd81-3deec9dfa695">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;ACCUMULATED OTHER COMPREHENSIVE INCOME&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in AOCI, net of tax, consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.785%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.897%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.190%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.897%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.287%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31, 2021 and 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized (Loss) Gain on Cash Flow Hedges, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized (Loss) Gain on Net Investment Hedges, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized (Loss) Gain on Investments, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign Currency Exchange Contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Euro-Denominated Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cross Currency Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cumulative Translation Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(736)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(50,419)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(46,182)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(382)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,527)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,378)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,626)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,762)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(671)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(671)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(272)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,934)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,982)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,159)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(35,268)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(53,615)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(26,731)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,643)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(126)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(61,999)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(53,484)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents components and amounts reclassified out of AOCI to net income:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.455%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.540%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.540%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.492%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.540%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.492%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.540%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Affected Line Item in the Statements of Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amounts Reclassified from AOCI for the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gains (losses) on derivative instruments included in net income:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,121)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Tax (benefit) expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,347)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(Losses) gains, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,774)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90ZXh0cmVnaW9uOjQ4ZTIzYjYxMmE1YzQwZWVhYmRhYzNmYzE5ZjVjYjA3XzE4OQ_61b81bab-4722-497b-bdbf-262786251152">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in AOCI, net of tax, consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.785%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.897%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.190%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.897%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.287%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31, 2021 and 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized (Loss) Gain on Cash Flow Hedges, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized (Loss) Gain on Net Investment Hedges, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized (Loss) Gain on Investments, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign Currency Exchange Contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Euro-Denominated Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cross Currency Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cumulative Translation Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(736)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(50,419)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(46,182)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(382)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,527)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,378)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,626)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,762)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(671)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(671)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(272)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,934)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,982)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,159)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(35,268)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(53,615)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(26,731)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,643)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(126)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(61,999)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(53,484)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib94d76d2a4f64ef8baf558bb1ad20c66_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzQtMi0xLTEtMA_a525912c-5896-4859-8e28-eaf6a5df33a6"
      unitRef="usd">110000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i00c84acd109f46f4b2185c4801aa483a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzQtNC0xLTEtMA_b480b5f7-a2f8-4a7b-8dc2-bb9d826e159f"
      unitRef="usd">-736000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i516b4d9fd6fd4bb08abfd83a2b8ece20_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzQtNi0xLTEtMA_5e7017d4-3b33-4625-ae17-009ebeedaae5"
      unitRef="usd">1396000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7b7ca21c16c34b8ebd18b0be7aa71fb1_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzQtOC0xLTEtMA_3305d7c6-6840-42f1-a881-fc5e55f87478"
      unitRef="usd">3467000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6aa0f83e00f94d788fc79a84dd2ef035_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzQtMTAtMS0xLTA_209630b4-4987-4f15-9a4e-0e83c9628c78"
      unitRef="usd">-50419000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i72ee32005bc94787a60e211d2b2aaa25_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzQtMTItMS0xLTA_191444ca-f18b-4cc0-b5e7-81f0ccf61224"
      unitRef="usd">-46182000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i142bd154aa264e73939304fcd4c000c4_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzUtMi0xLTEtMA_75f294b6-bf87-470b-8bcd-8d548585c920"
      unitRef="usd">-382000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i72130b38c837460c9d490b3337d85e4d_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzUtNC0xLTEtMA_82fc8fb4-4e5f-49df-9ea7-5d25862b67bc"
      unitRef="usd">-8527000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i6870132d22054c5ebea0784212917113_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzUtNi0xLTEtMA_4605d2f2-5502-4105-8eb4-98055add5675"
      unitRef="usd">-7378000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ib3230b72e1154329a7f1a763ed0a1187_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzUtOC0xLTEtMA_27cb8ecd-00c5-4a11-a0b7-ea8eccf3eec8"
      unitRef="usd">-5626000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i03c7f98144624caeae57bd38fd0dd2a5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzUtMTAtMS0xLTA_bcb19a7a-ae61-4c40-a281-44fd72f14ffd"
      unitRef="usd">15151000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzUtMTItMS0xLTA_b734ea10-3e01-4307-ae6e-0cb2923c303b"
      unitRef="usd">-6762000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i142bd154aa264e73939304fcd4c000c4_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzYtMi0xLTEtMA_6950000d-ddee-4c47-b26d-5578b955cf47"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i72130b38c837460c9d490b3337d85e4d_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzYtNC0xLTEtMA_4d2f9f88-fab4-47d8-a4d1-b61e92285cc6"
      unitRef="usd">671000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i6870132d22054c5ebea0784212917113_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzYtNi0xLTEtMA_6bf0fba5-d9c5-46bc-a038-fe9a531c9550"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ib3230b72e1154329a7f1a763ed0a1187_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzYtOC0xLTEtMA_b7dda998-3980-421f-8a09-6608857a8a34"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i03c7f98144624caeae57bd38fd0dd2a5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzYtMTAtMS0xLTA_363c8215-958a-4229-81d7-2d0fdb8cca84"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i9db1b80103494a38bf58a2d6cc42a785_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzYtMTItMS0xLTA_b31ee764-a008-4f0c-9501-e9b480ac5997"
      unitRef="usd">671000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iea843d40d1ac442bba04f284af6399c9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzctMi0xLTEtMA_e04d9cde-722e-4fe4-b618-e78cffc32a06"
      unitRef="usd">-272000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3a978f3211e44df89ba9cd591258b169_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzctNC0xLTEtMA_53991151-f210-425b-ad1d-8619e941d557"
      unitRef="usd">-9934000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2758281c7e1d44f1bc14207e44f8c0d7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzctNi0xLTEtMA_62da6c3b-292a-499a-967c-49067bfa1bb8"
      unitRef="usd">-5982000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iee2ff9304f8843b881a4c91cf1c6c997_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzctOC0xLTEtMA_e5d51a7b-a4fe-4c33-a814-11c4bedbd8b5"
      unitRef="usd">-2159000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i66e22c6b00494e2c8ccec8824592cb57_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzctMTAtMS0xLTA_c0febb6e-fa0e-4083-ba40-ea6627920f21"
      unitRef="usd">-35268000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if3d475356743442ba6915b1578a8771f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzctMTItMS0xLTA_e769cede-98e8-44e3-8aa6-6689f284549a"
      unitRef="usd">-53615000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i4d04bcb41a5b4086b6a2d38ce5f3b1a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzgtMi0xLTEtMA_4e360617-f4a1-4ae3-b5b3-15a23e7f1d83"
      unitRef="usd">146000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="icd5c0e3eaafc4cd3b022efb186592847_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzgtNC0xLTEtMA_17c59af5-048a-44df-bc6f-bcf6339d59ab"
      unitRef="usd">9139000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ic61a4aba587c4549ba286bb3f06809be_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzgtNi0xLTEtMA_cb8bff12-eade-497b-ad22-bdff0c9d5ae5"
      unitRef="usd">6404000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i4a726385a3934ca297a4094723c83a69_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzgtOC0xLTEtMA_4fe4f29f-f431-4721-948c-559fd3e3e6d0"
      unitRef="usd">5399000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="if975ef26add547cc8029bf3cfcc205a4_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzgtMTAtMS0xLTA_f01d5002-b560-44a8-8ea5-31a85b3ff56e"
      unitRef="usd">-26731000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzgtMTItMS0xLTA_df21352e-6d05-4883-9fc6-a80d7d295db5"
      unitRef="usd">-5643000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i4d04bcb41a5b4086b6a2d38ce5f3b1a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzktMi0xLTEtMA_89ef95fc-8f42-4553-bb74-13f3b61cf6c0"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="icd5c0e3eaafc4cd3b022efb186592847_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzktNC0xLTEtMA_883602a7-3524-4f2f-aa87-4fa451ed2b45"
      unitRef="usd">-5774000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ic61a4aba587c4549ba286bb3f06809be_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzktNi0xLTEtMA_96989505-0ef7-4e94-af6b-a8385d79412b"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i4a726385a3934ca297a4094723c83a69_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzktOC0xLTEtMA_9fe6cc43-1340-46d5-b855-6a2b866d2173"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="if975ef26add547cc8029bf3cfcc205a4_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzktMTAtMS0xLTA_7024916d-670c-465d-8e8f-dc5fa0c3c3be"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzktMTItMS0xLTA_da23849d-7480-457b-a7e5-4851ffa5a0c1"
      unitRef="usd">-5774000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic1cfcd32b9eb44fc909c66daaa2fdc89_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzEwLTItMS0xLTA_5c5b2946-4701-4890-b90f-92b7d3a25acc"
      unitRef="usd">-126000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia1e09d47b7c249178ff89343c0d5d024_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzEwLTQtMS0xLTA_5e88ac99-14ec-428d-b062-792be53478fd"
      unitRef="usd">4979000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2708e84b292c4f1bafc45174e5905b07_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzEwLTYtMS0xLTA_c80e8677-f8b5-466c-ae4e-d81fe3c7f8ec"
      unitRef="usd">422000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i78635773a43a47999ed10eb8f309ed8a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzEwLTgtMS0xLTA_2029448a-70ed-493f-842f-4d4a032bc1f4"
      unitRef="usd">3240000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifa324d754a4d4cb0ab3eb052f773e75e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzEwLTEwLTEtMS0w_9bfc91a3-c4fa-41f4-83fc-f2af093eb493"
      unitRef="usd">-61999000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2aefce1f274544f1b2e978eb3e0fa0dc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZToxM2M4YWFmNTY0NmY0ZTkxODBkOWNlMjYwMmZhYzhmZi90YWJsZXJhbmdlOjEzYzhhYWY1NjQ2ZjRlOTE4MGQ5Y2UyNjAyZmFjOGZmXzEwLTEyLTEtMS0w_6bc5788d-c4db-428e-9615-c89dcb50e787"
      unitRef="usd">-53484000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90ZXh0cmVnaW9uOjQ4ZTIzYjYxMmE1YzQwZWVhYmRhYzNmYzE5ZjVjYjA3XzE4NQ_186861fe-9b3d-4603-8ca3-b748b860a990">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents components and amounts reclassified out of AOCI to net income:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.455%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.540%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.540%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.492%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.540%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.492%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.540%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Affected Line Item in the Statements of Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amounts Reclassified from AOCI for the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gains (losses) on derivative instruments included in net income:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,121)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Tax (benefit) expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,347)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(Losses) gains, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,774)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock>
    <us-gaap:CostOfRevenue
      contextRef="ie311c88fa22749e2b4cf06d52ec95566_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZTo1YjYyYTk5ODVlMTU0ZDgwOGNlMjdmMTllMTYwN2Y0MC90YWJsZXJhbmdlOjViNjJhOTk4NWUxNTRkODA4Y2UyN2YxOWUxNjA3ZjQwXzQtNC0xLTEtMA_2666b5a6-f21a-4b46-a81e-f42ee4832838"
      unitRef="usd">-7121000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i6de86e101cec44aa84d8d1454d201a7f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZTo1YjYyYTk5ODVlMTU0ZDgwOGNlMjdmMTllMTYwN2Y0MC90YWJsZXJhbmdlOjViNjJhOTk4NWUxNTRkODA4Y2UyN2YxOWUxNjA3ZjQwXzQtNi0xLTEtMA_28741445-da35-4f25-bd69-0ead801aa446"
      unitRef="usd">829000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="if8ae9e76f2d44f91afd70c49049644e1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZTo1YjYyYTk5ODVlMTU0ZDgwOGNlMjdmMTllMTYwN2Y0MC90YWJsZXJhbmdlOjViNjJhOTk4NWUxNTRkODA4Y2UyN2YxOWUxNjA3ZjQwXzQtOC0xLTEtMA_394da584-0389-43db-87bb-ce0166684e5a"
      unitRef="usd">10628000</us-gaap:CostOfRevenue>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ie311c88fa22749e2b4cf06d52ec95566_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZTo1YjYyYTk5ODVlMTU0ZDgwOGNlMjdmMTllMTYwN2Y0MC90YWJsZXJhbmdlOjViNjJhOTk4NWUxNTRkODA4Y2UyN2YxOWUxNjA3ZjQwXzUtNC0xLTEtMA_90a1f90b-1a6c-4c2d-ad7c-264f84582ad8"
      unitRef="usd">-1347000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i6de86e101cec44aa84d8d1454d201a7f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZTo1YjYyYTk5ODVlMTU0ZDgwOGNlMjdmMTllMTYwN2Y0MC90YWJsZXJhbmdlOjViNjJhOTk4NWUxNTRkODA4Y2UyN2YxOWUxNjA3ZjQwXzUtNi0xLTEtMA_5cb9cf94-b90f-402c-8279-973c24c6ab1e"
      unitRef="usd">158000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if8ae9e76f2d44f91afd70c49049644e1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZTo1YjYyYTk5ODVlMTU0ZDgwOGNlMjdmMTllMTYwN2Y0MC90YWJsZXJhbmdlOjViNjJhOTk4NWUxNTRkODA4Y2UyN2YxOWUxNjA3ZjQwXzUtOC0xLTEtMA_869dd994-11ac-4aa5-93bd-268f5abfe9d2"
      unitRef="usd">2467000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="ie311c88fa22749e2b4cf06d52ec95566_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZTo1YjYyYTk5ODVlMTU0ZDgwOGNlMjdmMTllMTYwN2Y0MC90YWJsZXJhbmdlOjViNjJhOTk4NWUxNTRkODA4Y2UyN2YxOWUxNjA3ZjQwXzYtNC0xLTEtMA_fd803e02-26ea-4596-9baf-09b7d8dbc8cf"
      unitRef="usd">-5774000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i6de86e101cec44aa84d8d1454d201a7f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZTo1YjYyYTk5ODVlMTU0ZDgwOGNlMjdmMTllMTYwN2Y0MC90YWJsZXJhbmdlOjViNjJhOTk4NWUxNTRkODA4Y2UyN2YxOWUxNjA3ZjQwXzYtNi0xLTEtMA_843bb1c4-5ab7-4d50-a83c-d3f01ae289c5"
      unitRef="usd">671000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if8ae9e76f2d44f91afd70c49049644e1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yMzgvZnJhZzo0OGUyM2I2MTJhNWM0MGVlYWJkYWMzZmMxOWY1Y2IwNy90YWJsZTo1YjYyYTk5ODVlMTU0ZDgwOGNlMjdmMTllMTYwN2Y0MC90YWJsZXJhbmdlOjViNjJhOTk4NWUxNTRkODA4Y2UyN2YxOWUxNjA3ZjQwXzYtOC0xLTEtMA_468c03a3-96bc-4745-9a52-d0dd70f3188a"
      unitRef="usd">8161000</us-gaap:ProfitLoss>
    <us-gaap:PreferredStockTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yNDEvZnJhZzpkNDE2MjFiZjRiOWU0MGNlODY3OTZhYzZkZWNlYmQ5YS90ZXh0cmVnaW9uOmQ0MTYyMWJmNGI5ZTQwY2U4Njc5NmFjNmRlY2ViZDlhXzczOA_d07a2ed5-6fac-4d9d-b49b-eb96100e3351">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;PREFERRED STOCK&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;Our Board of Directors is authorized, subject to any limitations prescribed by law, without further stockholder approval, to issue from time to time up to 500,000 shares of Preferred Stock, $1.00 par value per share (&#x201c;Preferred Stock&#x201d;), in one or more series. Each such series of Preferred Stock shall have such number of shares, designations, preferences, voting powers, qualifications, and special or relative rights or privileges as shall be determined by the Board of Directors, which may include, among others, dividend rights, voting rights, redemption and sinking fund provisions, liquidation preferences, conversion rights, and preemptive rights. There are no shares of Preferred Stock outstanding as of December 31, 2021 and 2020.</us-gaap:PreferredStockTextBlock>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yNDEvZnJhZzpkNDE2MjFiZjRiOWU0MGNlODY3OTZhYzZkZWNlYmQ5YS90ZXh0cmVnaW9uOmQ0MTYyMWJmNGI5ZTQwY2U4Njc5NmFjNmRlY2ViZDlhXzE4MA_68292f61-893e-4ae2-bbbc-030944d99300"
      unitRef="shares">500000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yNDEvZnJhZzpkNDE2MjFiZjRiOWU0MGNlODY3OTZhYzZkZWNlYmQ5YS90ZXh0cmVnaW9uOmQ0MTYyMWJmNGI5ZTQwY2U4Njc5NmFjNmRlY2ViZDlhXzIxMA_4bcb2674-db4c-4e71-b5b8-4cd6a5f6ce29"
      unitRef="usdPerShare">1.00</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i5bc10811c8b443b6ae93662c965b99e4_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yNDEvZnJhZzpkNDE2MjFiZjRiOWU0MGNlODY3OTZhYzZkZWNlYmQ5YS90ZXh0cmVnaW9uOmQ0MTYyMWJmNGI5ZTQwY2U4Njc5NmFjNmRlY2ViZDlhXzY4MA_c10932dd-fdc4-49b5-9815-76779e7a242c"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i257dea584c2540acb77224b3a70b171d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yNDEvZnJhZzpkNDE2MjFiZjRiOWU0MGNlODY3OTZhYzZkZWNlYmQ5YS90ZXh0cmVnaW9uOmQ0MTYyMWJmNGI5ZTQwY2U4Njc5NmFjNmRlY2ViZDlhXzY4MA_c3514494-1f51-421f-ba53-17cbdb654194"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yNDQvZnJhZzphNGE1ZGNlN2VjODc0NjY1YjczNGFlM2MwZTIzMDJkNi90ZXh0cmVnaW9uOmE0YTVkY2U3ZWM4NzQ2NjViNzM0YWUzYzBlMjMwMmQ2Xzc2NQ_562a8f79-9b7f-4470-ad6c-7c7dc9f4d5f1">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;IDEXX RETIREMENT AND INCENTIVE SAVINGS PLAN&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have established the IDEXX Retirement and Incentive Savings Plan (the &#x201c;401(k) Plan&#x201d;). U.S. employees eligible to participate in the 401(k) Plan may contribute specified percentages of their salaries. We match a portion of these contributions, not to exceed 5% of participants&#x2019; eligible compensation. We matched $25.8 million, $23.4 million, and $21.1 million for the years ended December 31, 2021, 2020, and 2019, respectively. In addition, we may make contributions to the 401(k) Plan at the discretion of the Board of Directors. There were no discretionary contributions in 2021, 2020 or 2019.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also have established defined contribution plans for regional employees in Europe and in Canada. With respect to these plans, our contributions over the past three years have not been material.&lt;/span&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent
      contextRef="id7c4b2e2ed354c54b264719bdf6db254_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yNDQvZnJhZzphNGE1ZGNlN2VjODc0NjY1YjczNGFlM2MwZTIzMDJkNi90ZXh0cmVnaW9uOmE0YTVkY2U3ZWM4NzQ2NjViNzM0YWUzYzBlMjMwMmQ2XzI4Ng_30e5f8df-d2ee-43a3-a246-135b06444e45"
      unitRef="number">0.05</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent
      contextRef="i1c65cec1a82840efbc15a4b904412850_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yNDQvZnJhZzphNGE1ZGNlN2VjODc0NjY1YjczNGFlM2MwZTIzMDJkNi90ZXh0cmVnaW9uOmE0YTVkY2U3ZWM4NzQ2NjViNzM0YWUzYzBlMjMwMmQ2XzI4Ng_6205be4c-0132-427f-99fc-0139ab1f5d5a"
      unitRef="number">0.05</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent
      contextRef="ibbe59bdb4621433ca1dedcd48056713a_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yNDQvZnJhZzphNGE1ZGNlN2VjODc0NjY1YjczNGFlM2MwZTIzMDJkNi90ZXh0cmVnaW9uOmE0YTVkY2U3ZWM4NzQ2NjViNzM0YWUzYzBlMjMwMmQ2XzI4Ng_a4e2834d-d797-45c7-8ed7-09ab26d84a63"
      unitRef="number">0.05</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="id7c4b2e2ed354c54b264719bdf6db254_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yNDQvZnJhZzphNGE1ZGNlN2VjODc0NjY1YjczNGFlM2MwZTIzMDJkNi90ZXh0cmVnaW9uOmE0YTVkY2U3ZWM4NzQ2NjViNzM0YWUzYzBlMjMwMmQ2XzM0MA_f8759b76-8fc9-452e-82a0-063ca5e39d54"
      unitRef="usd">25800000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="ibbe59bdb4621433ca1dedcd48056713a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yNDQvZnJhZzphNGE1ZGNlN2VjODc0NjY1YjczNGFlM2MwZTIzMDJkNi90ZXh0cmVnaW9uOmE0YTVkY2U3ZWM4NzQ2NjViNzM0YWUzYzBlMjMwMmQ2XzM0NA_8dc984ee-d3c9-4704-956e-0a51c158739b"
      unitRef="usd">23400000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i1c65cec1a82840efbc15a4b904412850_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yNDQvZnJhZzphNGE1ZGNlN2VjODc0NjY1YjczNGFlM2MwZTIzMDJkNi90ZXh0cmVnaW9uOmE0YTVkY2U3ZWM4NzQ2NjViNzM0YWUzYzBlMjMwMmQ2XzM1Mg_fa939012-f40f-46e9-ad4e-72ec10589844"
      unitRef="usd">21100000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="ibbe59bdb4621433ca1dedcd48056713a_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yNDQvZnJhZzphNGE1ZGNlN2VjODc0NjY1YjczNGFlM2MwZTIzMDJkNi90ZXh0cmVnaW9uOmE0YTVkY2U3ZWM4NzQ2NjViNzM0YWUzYzBlMjMwMmQ2XzUxOA_7ad81184-23f6-462a-bb6f-e043bae58fab"
      unitRef="usd">0</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="i1c65cec1a82840efbc15a4b904412850_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yNDQvZnJhZzphNGE1ZGNlN2VjODc0NjY1YjczNGFlM2MwZTIzMDJkNi90ZXh0cmVnaW9uOmE0YTVkY2U3ZWM4NzQ2NjViNzM0YWUzYzBlMjMwMmQ2XzUxOA_8254bb86-82db-4f17-9adf-d7f3c8779698"
      unitRef="usd">0</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="id7c4b2e2ed354c54b264719bdf6db254_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVkNzk1YTY4NTFkNzQ2Y2E5MTRhMmRkYWU3NjFjMzI5L3NlYzo1ZDc5NWE2ODUxZDc0NmNhOTE0YTJkZGFlNzYxYzMyOV8yNDQvZnJhZzphNGE1ZGNlN2VjODc0NjY1YjczNGFlM2MwZTIzMDJkNi90ZXh0cmVnaW9uOmE0YTVkY2U3ZWM4NzQ2NjViNzM0YWUzYzBlMjMwMmQ2XzUxOA_d4f6212c-aac0-4db1-b73b-53098ef488c5"
      unitRef="usd">0</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>225
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( !IW4%0'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    "  :=U!45K _I.X    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+/
M2L0P$(=?17)OITVQ8.CFLN))07!!\1:2V=U@\X=DI-VWMZV[740?P&-F?OGF
M&YA.1Z%#PN<4(B:RF&]&U_LL=-RP(U$4 %D?T:E<3@D_-?<A.473,QT@*OVA
M#@B\JEIP2,HH4C #B[@2F>R,%CJAHI#.>*-7?/Q,_0(S&K!'AYXRU&4-3,X3
MXVGL.[@"9AAA<OF[@&8E+M4_L4L'V#DY9KNFAF$HAV;)33O4\/;T^+*L6UB?
M27F-TZ]L!9TB;MAE\FNSO=\],,DKSHN*%W6[J^_$;2L:_CZ[_O"["KM@[-[^
M8^.+H.S@UUW(+U!+ P04    "  :=U!4F5R<(Q &  "<)P  $P   'AL+W1H
M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03<VEVV[29A.U.
M'X416(UL>621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X
M8-DOV]:[MR_>X%<R)!%!,!FGK_# "J5,7K5::0##.'W)$Q+#W(*+"$MX%,O6
M7.!;&B\CUNJTV]U6A&ELH1A'9&!]7BQH0-!445IO7R"TY1\S^!7+5(UEHP$3
M5T$FN8BT\OELQ?S:WCYES^DZ'3*!;C ;6"!_SF^GY$Y:B.%4PL3 :F<_5FO'
MT=)(@(+)?90%NDGVH],5"#(-.SJ=6,YV?/;$[9^,RMIT-&T:X./Q>#BVR]*+
M<!P$X%&[GL*=]&R_I$$)M*-IT&38]MJND::JC5-/T_=]W^N;:)P*C5M/TVMW
MW=..B<:MT'@-OO%/A\.NB<:KT'3K:28G_:YKI.D6:$)&X^MZ$A6UY4#3( !8
M<';6S-(#EEXI^G64&MD=N]U!7/!8[CF)$?[&Q036:=(9EC1&<IV0!0X -\31
M3%!\KT&VBN#"DM)<D-;/*;50&@B:R('U1X(AQ=RO_?67N\FD,WJ=?3K.:Y1_
M::L!I^V[F\^3_'/HY)^GD]=-0LYPO"P)\?LC6V&')VX[$W(Z'&="?,_V]I&E
M)3+/[_D*ZTX\9Q]6EK!=S\_DGHQR([O=]EA]]D]';B/7J<"S(M>41B1%G\@M
MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7
MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V<
M/!T3$LV4"P9!AI<D)A*I.7Y-2!/^*Z7:_IS30/"4+R3Z2I&/:;,CIW0FS>@S
M&L%&KQMUAVC2/'K^!?F<-0H<D1L= F<;LT8AA&F[\!ZO)(Z:K<(1*T(^8ADV
M&G*U%H&V<:F$8%H2QM%X3M*T$?Q9K#63/F#([,V1=<[6D0X1DEXW0CYBSHN0
M$;\>ACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0'
MHYI9";V$5FJ?JH<T/J@>,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y
M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RS<C'5*^3*=@Y
MG\#L_6@^GO'M^MDDA*^:62TC%I!+@;-!)+C\B\KP*L0)Z&1;)0G+5--E-XH2
MGD(;;NE3]4J5U^6ON2BX/%ODZ:^A=#XLS_D\7^>TS0LS0[=R2^JVE+ZU)CA*
M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D*
MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-#
MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B
M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P
MOFH]M!5.S_Y9K<B?#!%.%@L22&.4%Z9*HO,94[[G*TG$53B_13.V$I<8O./F
MQW%.4[@2=K8/ C*YNSFI>F4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W
MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2
MD 83 <V4R43P H)DIAR F/H+O?(,N2D5SJT^.7]%+(.&3E[2)1(4BK ,!2$7
M<N/O[Y-J=XS7^BR!;814,F35%\I#B<$],W)#V%0E\Z[:)@N%V^)4S;L:OB9@
M2\-Z;ITM)__;7M0]M!<]1O.CF> >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F
M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+
M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5
M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0    (
M !IW4%168\/BGP8   X:   8    >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
MI5G;;N,V$'UNOX)P%T46B&.)\G5S 1Q?6G=S<>WL;K9%'VB)MH5(I$M2<?SW
M'5*RY0UD2D#S$.O".3J:(<\,1U=;+E[DFE*%WN*(R>O:6JG-IT9#^FL:$WG!
M-Y3!G247,5%P*E8-N1&4!,8HCAK8<=J-F(2L=G-EKDW%S15/5!0R.A5()G%,
MQ.Z61GQ[77-K^PNS<+56^D+CYFI#5G1.U9?-5,!9XX 2A#%E,N0,";J\KO7=
M3T.OHPW,B*\AW<JC8Z1?9<'YBSZ9!-<U1S.B$?65AB#P\TH'-(HT$O#X-P.M
M'9ZI#8^/]^AC\_+P,@LBZ8!'W\) K:]KW1H*Z)(DD9KQ[>\T>Z&6QO-Y),U_
MM$W'MG -^8E4/,Z,@4$<LO27O&6..#+H.B<,<&: WQFXS1,&7F;@O3=HGS!H
M9@9-XYGT58P?AD21FRO!MTCHT8"F#XPSC36\?LATW.=*P-T0[-3-@+]2@:80
M8E1'7^9#=/;AXU5# ;*^W_ SE-L4!9] <3&ZYTRM)1JQ@ 8_ C2 TH$7WO.Z
MQ5;$(?4OD.>>(^Q@MX#0P&X^IHL+Y&!CC@O,AW;S/Q(&3W>*GO[#VW@'+WL&
MS[-Z^>_^0BH!,_T?"V3S -DTD,U3#N)^ NM/H:?=AA9%S&[N.O7/%A:M XM6
M-19]QA(2H1G=<*&*Z-AQE$BHA4[[0*==C<Z4BI '>C8B6!:%_BE!RN;?SS_]
M5#('.@=N'2OB(!%"4QN'T@=/?:=$6/G9T>IU%]<]&Z_N@5>WXD02!.3<J/'I
M,-JQEB22MCCV#IQZ5IP14Z':@:LBBAZ2>$%%$1<[AE-W>[AC\Y#KY"+I5.$S
MHZM0KV!PU@.)"Z-6 C09CIZ?T5W_]G'6?WJ<349S-'D8H,9P9.-Y).9N%9X3
MYG,!$20ZF.=HKF"*(2[0@"=,B1W\!L7D[>AVDC@GB:N0?")O:!+ Q N7H6^8
M6D)= NFX=<?K>1WLV1CF:NUZ51CV@T!0*<_W!^@.QJ%'5NP[.R18H33X0P&%
MCHUFG@%<NX:_ISG09Q#F)[YEA13M<-^H5 L!%=JYC5V>&5R[I+]G=YB%4\%?
M0^87>]&.>6^=@7F6<.WB_I[:E$L%DOQ7N#F]-.R(3M/I81NW/$NX)6G",(,2
M_C05.P!V.C8B>5IP[5I^QW6:FJXYLVEP"4BKU8:5Z3@V1GE2<.V*_A0JR =\
MB5Q\MOB(YM1/!'BKD)8=:<#C&/1FKKC_<HX^.!>N@S:0CU])E%"T@5I-KHFP
MK5*<YPYLEWQ(JT'(5FB^BQ<\*B); C 9/C_;F.39 =OU>^\P-'KSUX1!R7\J
MBY4 /?3GP_Z?-DYY,L"5DL$WV/C57Q@(%X252)AS 9I(F11/NA+,[U3:N.5I
M %=* U]Y!&D3-L6F'A&RD)$=Z8';".6"CRL)_KZ23*LT,[= 6Y-B8G;$$E?E
M8H\KB?V$*2K2K;RN:\F>:B$S.V()LUSK<26M-Z%# TA!*RX*):,$YXX(6#!]
MWZ< !#!!"FGCF&L^MDMVQG$>DRA"MXF$V[(XFG:<LO(;Y^*/[;J=,1K%5*ST
M!/L-$-0:4E*\(:S8??]O9X#S+(#MVCT9C&>HGP2A@EJBKQ14+6GU.([(JI"9
M':]DZ^GE0N]5VB3,UZ!E-D^5P)1YRLOUWJNT&Y@FBRCTP3V<%"W$88;2,BBZ
M3_AZT_*:;J?G-GM>^ZKQ6D0B%WBODL#_F''G.KM*])@H"!XSZ?$L9&G2E47]
MIT'VE/81R6X3-WM.MW6"X5%OQB[.^PVP/-HWP?)>Z/W>DH)\%9>J9:B/@R_W
MHX<GL\%[G$WUAF\T1+??T6PT'LU&#X,1FA*AT&0R^?67+G;QY7Q#?;,9BJ(=
M"K.M$3 Q*L^9U*6/6M/]W#)6G4NIVYPA"XWH0FW]MDM+;;.G5QPM*%J"4@4(
M'.QSQK*&ZS:$]5R$ICMFB*3MG)A2DU_@P5)';LVC #(@.M.&V@([EV9\UOZY
M3\>;.^[EQ_/L^; B @3/O"<[Y*8]/7R.(-; Z<CC:W VD 3'B\SQB%[85D*>
M.#U[FNN#,P+CD%,B40)0NBCS3.E5[)@=]X'&<+%0\$O RMJ3>9;T*C;.,E99
M_^PT+SO<^+N-59X7O4IY<0#$!)":L("^H<^T6%7M4 [\=3O-CMLN8M8X:J#K
ME&<^1$A8+E#XI;WTP]7#QXZ^:?$W\N'IEY)[HC.F1!%=@JEST8$(BO3C0WJB
M^,:TXQ=<*1Z;PS4EL*ST +B_Y%SM3_0##I^ ;OX#4$L#!!0    ( !IW4%0G
M&<OC(0(  '8%   8    >&PO=V]R:W-H965T<R]S:&5E=#(N>&ULC93?;]HP
M$,?_%2O/%8'PHUT5(D%9-2284*MN#],>3'(0J[&=V9>E^^]W=D+&)(AXB7WV
MW<??N_@<U]J\VQP V8<LE)T'.6+Y&(8VS4%R.] E*-HY:",YDFF.H2T-\,P'
MR2*,AL-9*+E001+[M9U)8EUA(13L#+.5E-S\64*AZWDP"DX++^*8HUL(D[CD
M1W@%?"MWAJRPHV1"@K)"*V;@, \6H\?ES/E[AV\":GLV9RZ3O=;OSEAG\V#H
M!$$!*3H"I^$W/$%1.!#)^-4R@^Y(%W@^/]&??>Z4RYY;>-+%=Y%A/@\> I;!
M@5<%ONCZ"[3Y3!TOU87U7U8WOM&G@*6512W;8%(@A6I&_M'6X3S@_DI U 9$
M7G=SD%>YXLB3V.B:&>=--#?QJ?IH$B>4^RFO:&A74!PFBRH3R-:J^;U4ISA$
MPKK-,&T1RP8174&,(K;5"G/+/JL,LO\!(>GI1$4G4<NHE[B"=,#&HSL6#:-1
M#V_<)3GVO/&M2;(?B[U%0U?B9P]^TN$G'C_IPVO#OG()E\K7'[TS(H6:(YA<
M5^YZ4<,9RS:;78^T:2=M>I.T9V$D6Z\NJ>L'1..''AFS3L;L)AD;G5Z]9/V$
MI:964'=LRZWE:4Z%0K27E(5GO2#!''W'6Y;J2F'3%MUJ]Z@LFE[ZY]Z\2%MN
MCD)95L"!0H>#>RJ5:;J\,5"7OK/V&JE/_32GAQ&,<Z#]@]9X,MP!W5.;_ 50
M2P,$%     @ &G=05.,&SK+ !P  &A\  !@   !X;"]W;W)K<VAE971S+W-H
M965T,RYX;6RM66UOX[@1_BN$&Q1W@!/S52_>)( WSG6-NLEV[6VO'QF9B865
M19]$)9O^^HYD1[)%2O8!_9)8U$/R&9(SSPQU_::S'_E:*8-^;I(TOQFLC=F.
M1Z,\6JN-S*_T5J7PYEEG&VG@,7L9Y=M,R575:9.,*,;>:"/C='![7;5]S6ZO
M=6&2.%5?,Y07FXW,WC^K1+_=#,C@H^%;_+(V9</H]GHK7]1"F>_;KQD\C>I1
M5O%&I7FL4Y2IYYO!A(SO."T[5(A_Q>HM/_B-2E.>M/Y1/LQ6-P-<,E*)BDPY
MA(1_K^I.)4DY$O#X8S_HH)ZS['CX^V/TWRKCP9@GF:L[G?P[7IGUS2 8H)5Z
MED5BONFW+VIOD"C'BW225W_1VQZ+!R@J<J,W^\[ 8!.GN__RYWXA#CH0WM&!
M[CO0<SNP?0=6&;IC5IDUE4;>7F?Z#64E&D8K?U1K4_4&:^*TW,:%R>!M#/W,
M[=WCP^)Q/IM.EO=3]'DRGSS<W:/%E_O[Y0)=HN^+*?KEXE=T@>(4+=>ZR&6Z
MRJ]'!F8N^X^B_2R?=[/0CEFF*KI"C P1Q90XNM^=WQT?=Q^!O;71M#::5N.Q
M+J.++%.I09,\5R8?]XS(ZA%9-2+O&E'F:P1K@Z+RA_JCB%]E E,XUVHWE*B&
M*MWL]99PS@6_'KT>KHD-8P$+:5##CICRFBGO93J)(ET ,?#!2 '+IT0-40KQ
M0C\CF8!7RS12Y<.%&'I>4&Y\N6F5<1?>T _XO@F[3-O-[1UR]@+&@Y9I#A@C
MG(9NTT1MFN@U;9:^PI+K+%;.91?6I-0+,<,M;@X8#@.?N;EY-3>OE]NC6:L,
M''IW\&1U\%PD/6MVXK. LA9)!XSY G><#;\FZ?>27&HCDS-(^M;LH1">$"V2
M-HQ@CX(Y;I9!S3+H]=ZY3E\NERK;G.&_83UFV&OYUPR$,3/OU3$OW7<+4F4J
MQW M0&A9)@+?\_S6 CA@0I #V!%7@IN8C?L/$W"5)DY?4*) PE!6:M6E?KXL
MX*%[V_:C'F^(()BT:#MP(2$^Z:!](#6DE_;?M%Z]Q4GBY$;LD"!"QMMGRH&C
MG#'>M::-)!!Z(G@8F;[$$ [W*]BY^?N!CI8'XHC%U(8)*GA''"&-TI!^J=E%
MDJ1T E,Z0<]^,T>8Q1RW(YX#1X-0A**#:B,UI%]K=O'D+*JV(A >$&$IAPM(
M&3F,D,=D&_$@_>JQ?%Q.YFBR6$#JXZ3H$ ;.?(K;L=D%I"$77I<#-1I"O+/R
MEGDLG^(D-B!T?<&/-'&?] ?^.BG8RO<R(W#:[PCGQ"/<.DTVSN="= 1]TD1]
M$ISBF!5JA9+&>"?-P)J>BR#$89NF T>$Q[MX-DI"^J5D#L]E_A1E:A6[ XBM
M"SX3MEO:,.PF1QOEH/W*\7&"MCJKJBC@V;CG2CTY^5);#WP>AEZ+KP,&J*!C
M06DC&[1?-AR<H4Y3T+B")!92OL)Y7JFM%!#Z6#O+=L&HZ-)H>E!B].O)<2YU
MXM!26RM\CPF_?6@=.!%0ORNRT$94*#LSISHSMM!&!&B_"$P_]BI.([U1R,B?
M)Y?##O)!: FL P59"N[:N48(:+\0S(\<HBZ.HN-CZ.1M1W[?%Q1;S&U<( (>
MT@[JC4#0_BKCD/JQA_PI,^SJ@L/*6I[C@'G$ZQ!BVH@1[1>CQ@C=RG-/'1M;
M>:!N\]M9N0/F^YAU%)^T$2C:+U#MQ.P46UN ?!SR=C+N@ 7"P[R#;2-3M%^F
MVKG9*;:V&(4!\QAMT[5Q!/LAQAW))&NDB_5+UYYP/TWF*'%\[E/27E87T/,(
M%'$=/!NY8B?D2F\VL2G+Q[RJ)N]T6AYAE4; &?WRH(U"Q/O5R;YWY/)&=YQO
M9:1N!MM,Y2I[58-;Y+I.^S\,=&Q](WNL_VIM873T8ZV3E<KRO_XEH,3_A.ZA
MGC;OO==L!_=L)R[:8'4A!\C+:8;H E\1#$EKAEYE4J@QFA1FK;/XOVHU1H3B
M(<88Y6L)1GY"LSPOJG;L#0,_V+<?77"5K[CPCU_A3^BQ,#F4ARO8QS$*^%!X
MU-4]$$/.PU9OYT;;%1=,';2+'3>,=QW11I+9B3O %62F$/S!G[8R7ET"TTAN
M8_ O)UF'SD)49;2=L+J 4/B L'40;B29]4MRG4-4^XZ*-#;Y^'A70KQK/MX0
M_ZC1O1>V& N?M#,O!XH+W*%UK!%LUB_8WY21T+1"2F8IV.$.:K;0TI!B;I5>
M+B#Q16<ESQI-9B<+Q&)3)-( 5;V[RM0;B!WK\H/.*RBSSMW4;:V]% R.1)NY
M$^>1+N*-*+-^45YFD#D4V?M'Q) &F.=FC"@=,N*[O)@2"!O!.5YL2_,E).W8
M"RVU<2"I#\51V%'1L4;'V3DZ/IO>__X[FLLG#0E3=0,^1+,TNMJ9W8K'JHK'
M3HML]?:", S;*N_"03SHJO5X(_*\7^0?-!0)J<ETDI1I7YQ";J)R9U7*;05O
M^X,#TED?\$;@>;_ [U;\SRTLMZM,Y\*Z< Q.2H<?\$:7^8ERM+K=FL\FGV?S
MV7)VOT"3ARE:+!_O_O[E<3Z]_[:HU?J?WV?+_SB-H-87*?<-F OHO $;'7RX
M++\:_T-F+W&:0[K_##WQE0]#9+L/L;L'H[?5M\PG;8S>5#_72L(>E !X_ZPA
MO=H_E)]'Z\_AM_\#4$L#!!0    ( !IW4%1$9 RF"P,  /((   8    >&PO
M=V]R:W-H965T<R]S:&5E=#0N>&ULE99=4^(P%(;_2J:S%SKCV@]*6QQ@!D%'
M9UQE1'<O=O8BE /-V"9LDH+NK]^3%#MH 94+FJ3GXWE/3YIVUT(^J0Q D^<B
MYZKG9%HOSUQ7I1D45)V*)7"\,Q>RH!JG<N&JI00ZLTY%[@:>%[D%9=SI=^W:
M6/:[HM0YXS"61)5%0>7+.>1BW7-\YW7AGBTR;1;<?G=)%S !_;@<2YRY=909
M*X K)CB1,.\Y _]LV#'VUN G@[7:&A.C9"K$DYE<SWJ.9X @AU2;"!0O*QA"
MGIM B/%W$].I4QK'[?%K]$NK';5,J8*AR'^QF<YZ3N*0&<QIF>M[L;Z"C9ZV
MB9>*7-E_LJYLHXY#TE)I46R<D:!@O+K2YTT=MAS\<(]#L'$(/NO0VCBTK-"*
MS,H:44W[72G61!IKC&8&MC;6&]4P;I[B1$N\R]!/]X=WMY.[F^O1X.%B1,X'
M-X/;X0697%U</$S(T9A*X#H#S5*:'Y/OY'$R(D??CLDWPCAYR$2I*)^IKJN1
MQ,1STTW6\RIKL"?K"-)3TO)/2. %_@[WX>?=O;?N+NJOBQ#410ALO-:>>!--
M-6!K:B+FY))QRE-&<S(6BME>^SV8*BVQX_X<2-:JD[5LLG!/LD&:BI)KA7L@
M!;:BTQQ.",UQ.V%:V%7+*E[;QC.[<M5O1U'2=5?;%6L:17$2UD9O4,,:-3R(
M.A1%@?*Q"=.G$[*DDJQH7@(YPJ=O6F$)^#[(L$F.=V%7L>,M(N_4?T=]V.8-
M=+N&;G\!VN(I0DN="<G^P<S"5ZL[J:O@T1:1CV]$^WO'_AG+-PJB6D'T=05,
MJ?)C^JC)Y$5)G#3I=UJ&[7@O?5S3QU^GQ_-#:7Q7,+[X2$+< $O"=A0T%>PP
M;(=A9Z^ I!:0'!0P@CE(B;6V$DC)F58G7U&0-, Z.]JG:97L+WZG9N\<9'_
MDUR5\N5=^3\ [C10@J#EQTWF'8:^YR5-;'?K1#)? S^H7#"N2 YS=/5.8]P\
MLCIAJXD62WM(387&(\\.,_PH 6D,\/Y<"/TZ,>=>_9G3_P]02P,$%     @
M&G=05/JT/F97!@  11H  !@   !X;"]W;W)K<VAE971S+W-H965T-2YX;6RM
M6=MNVS@0_17"Z$,+M+9X$24%28 D2G<#-!?$Z;:OBDW;0F312]%)^O<[DAW)
M)BG&B_;%MN0S(Y[A<,Z0.GZ1ZJE:"*'1Z[(HJY/!0NO5T6A4319BF55#N1(E
M_#.3:IEIN%3S4;52(ILV1LMB1(* CY997@Y.CYM[=^KT6*YUD9?B3J%JO5QF
MZM>Y*.3+R0 /WF[<Y_.%KF^,3H]7V5R,A?Z^NE-P-6J]3/.E**M<EDB)V<G@
M#!^E-*P-&L0_N7BI=GZCFLJCE$_UQ=7T9!#4(Q*%F.C:109?S^)"%$7M"<;Q
M[];IH'UF;;C[^\W[UX8\D'G,*G$ABQ_Y5"].!O$ 3<4L6Q?Z7K[\+;:$F@%.
M9%$UG^AEBPT&:+*NM%QNC6$$R[S<?&>OVT#L&&#>8T"V!L0T8#T&=&M #S5@
M6P/61&9#I8E#FNGL]%C)%Z1J-'BK?S3!;*R!?E[6\S[6"O[-P4Z?7MS>C&^_
M7:5G#Y<I&C_ U_7ES<,8W7Y%5S<7M]>7Z OZ/D[1QP^?4+7(E*A07J*'A5Q7
M63FM/J,/>]?'(PV#JEV/)ML!G&\&0'H&@ FZEJ5>5.BRG(KIOH,1L&DID3=*
MY\3K,163(:+X,R(!P8X!71QN'CC,TX/-<>)A0]L)HHT_VN/O7CR+<BV./*Y8
MZXHUKEB/JP>ILP(6:^/0-5,;\[ QKPO&\RDE.*0<PO"\&T ;1Z* \S#<QZ4.
M' MX$L0M;H]'V/((O2&YD)5&<H8." UO7?(#0C/9.O:$:..&[U#"E(0)B8T0
M.7"8AAR;(7+@ @;(Q!VBJ.43>?G\I615H962LUR[:$3V8^,X8908-!RX,((1
M&AF1.G 4\H'UT(A;&K%WIB]?0=\J4?FF.&E])=Z0C+,"BA<4*2B?ZDGHO)R[
M(I-83%C,(VK,VX4#1ADS8:D#AF.<4'=8<-!5[< _OZ(4"C*VII--01?R2JNL
MEE!G!0ZL8= @X=:Z=N*"V,R*U($C'%,<]=#:$2/LI74O*I&IR:+A-8556,@5
M-!G.%-ZZVLLYCH,@,4DY< P3EIBD'#A*^^>*=*2(E]15.9%+@69*+A'T:_4T
MR=*ME,0:0D)!ALSBXL#QA(6$F91L7!B2F/$>2ITF8?H.)2V@%=!(;!:HDPRU
M'OZ%)'%@D7'@(.[$7$I.' YV1&>?3*>*V"^++9F\F2@G%^9:[B81&Q3&W&3A
M\$3ZUDTGB#@\),4>!6P$1%WVG_.F,8?++2NDLU?A3KK03KJ \-"B9^,XQTEL
MS9.-"PDAN$?T<2?1V*_1=_^/ED-9PRC&5LVS<1&0LI:2#4L8(WTKJ=-I[!?J
M&^'-.UM7(\9B9LV-C0MC A799&'C(/NBA/30Z'0:QUX:WT15':&:S,<".H]/
M;].3::WRQ[7.'@N8*XE*"?=+K60!'N: VBP])_?87N_8Y&UCJ-6%.D!1'^&N
MF<#^;J*;-XOC57KY\R?ZECU**/52Y0)V2;! AP@V<Y.GA2RF0KE3-K'ZY6:V
MS=[#@0MC'$56K;%Q]6R3P$V>=-T'"?QM6:9*F#YH,(5"XWI7Z&O02"?_Q"__
MYUF53]!'V%#66\[:>;/E_.0*UM95M$,N'D;FPG"@^# V^QD'B@V3GJI,.N$G
M?N%/\V*MQ?100L1!B)M\;! ?1N8R=Z#8,.[IQ4FG^L2_%?W1'*( H;-GZ&+F
M8C/U%;I=ZTI#QP8IX<V#3I&)7Y&[/-@<.;CC92MI')+ K.].&&56"CA@'..>
MYH)TRDS\RKR; SXRMFC&/(S,[9@3%A&+C ,6A:RGZ)%.@<F["CQ=3[1[?[SO
MLQ- $OWN^0;I9(CX9>C=$XZM_6Y)Q! ::G6E+B!T<[&YO4A=0$8HWM'H?3*=
MQ)#D3QUST*YT4__&\>"##FKO\7C(8T*-0#EP80@MA:G"+ES 87/C#A/M1(/Z
M16,LU',^$0<D)>TJ-R6_FY1TYP#/OUEZ-RFIO;/!E 5!:"Y_%Q!#"\Y,Y7<
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MF(B,;GELKM\>8<Y#D2'\N%HI+>DF_7PEG%^%\_-P_IEPCYRJ2)K\AQ%LJ'I
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MB&Z8W"1<08IK<MF]Z%-.LF@RBHD6V_S970E-CW@^C*DO0VD ]/]:4-DL)R9
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MPU/!0=AO ?1[RHA,KN1"Z43;F'5,ZHKX$IB))H8/"S"L3G1Y!=8M= RKAQW
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M\8:W;"8P: 9\0?>OBXO? %!+ P04    "  :=U!4*"%^KUD6  "[/0  &0
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ML1+0%^7/GTH$F8Q5N,F5UI2'S2+>I;22<^>ILK*/]@IH9#.H:M&$*E++=ON
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M;Y@-O1LY5Y1(GW?M)"OA#G-,P8:7U 8L5\E/K'U$%1/'5;O$P80*4&.7^H+
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MC@W!4\[Q:3T"=94EP&JRD-=V>R\X=%N!D.#XQYWJK*/2AA>$9$])5:8I11Y
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M-@UM:U$IU@!P*'9%5N64 =4">?,EJN*?J?)]PZ-M_IZ>03R>5CP^BE^8*QA
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MB;LA5]:'K.W5L9WWU#\,5]UY=!&'HRT-AIV$VSLA[-U TG/5S/%=%3P:US>
MPQ=&DN.3Z OYAA"^6E.S0&E*Q=SE?>U3\,<'%EWB1\4FJC8P071/BF9/;9OL
M229XHO,/E\U$F;NZGVZ2-M.#$]QHP>6V@&[;E>_<N$0S%?5KTLU;3^!-SLT.
M/%T&69>,;;'&ELICE>[PEKVZCFAF$V"3?913*_->089KKN&'W'U;Q2*.MLJ=
M2L5V9GP@%/%2LRS.=@<[&4BA&60-/MY&+"FB]TH,K//X'H?5+ LY7U]J<DA,
MWQ(PC =[V;?+TMS%AK9BEZ%:N?M/-FTY-M=S 0-,R9=GD4UB&+E^VUD#5NW5
M@QJQCMO. ]M.79PS+#\;+%S/E09>W%:6CE_B^B[?='LJCYG[A^CGAPQ1';'(
M4&GE72'9W73VNZ/8=.Y=\;.4LKO^XL@3[Z^Z@ [MZ&_7H)&ITI+_P(O[5-@_
MCW/)?Q6F?IS_MLY/=$L#GN'=PJO#P6+VB$=+["]EEM/?B%EG)2@L_;A7$G00
M'X#OMUE6VE]P _='@Y[_-U!+ P04    "  :=U!4VVE^TI$(  "Z'@  &0
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ML$Y75#GJ,ICV[%)A=&0&A&JM2VS2,<L<F>&"9G<8%>/B=-B/DR8 ;4]GP6[
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M+\EX'/='; !-/!B^.XA&_0'[G1"^!9#[*22="5+HCF)PY#Y1&(S'T;B7;%#
M0[V@G35P<S]CO3$Q-HQ'76 ,N1Q#8S0:C8+.<;<SVPTI,9PFP%?3TYTF_7C8
MO$6>3I,N1):;L__Z 2NXXLK@+Y Y#MS!\]<&X<WIFY_O:%.^EGBN@D,9?XX,
MB5W]@!;8WYFQ@+^IS7A8)S+A,&.8FR*(!RR^"!T*P#X8(>$T)VS%\S;7.TZN
M&K:M?ONC<&IUF@Q[D*#:&A[WP'ZOJ^$8@M*?89NN^BM=.CG04QM%_D,J"TO-
M ,B,*ZE-@93EQD([>^Y7ZK1_K@N.@N:HM6??]82&UP.L>F"Y%(+@XM9UC?UW
M4S9)O_HLP+7QD )HC(V8E:95_@#>RO<+;?T_V2UO<K"_7X[<?4(H2 O7(A.R
M_=D^&1=M[!?TR73696Y3_5JK?%7YFSVD]Q"!XP960B*.7K+#16RNC@]A@$V-
M_6NQ@!VT_2H:,(EB#Q:@XGMQ@[[Z.U874\P_R_)@(>P@.,3:"S49"JFKX%#
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M<OE+>A;GB>T\X/SSGZW]M)/2G>I)ZM!I5<-#6J3)/#O'Q_PL65XLZ MN?XS
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M#<$6_)@K"<BB#?B>61NZ%Q+0WY?>_0M02P,$%     @ &G=05&\SRKD6"
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MK+\5  F^/[1'_K=)\&GB:WN%2GP?-S6 *K26.E'K"\/N#'VA=;HV=[QDX5P
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MA&/P&L?XBPB9V\)9T38=&EYU&W3DCU-RWMCG_P&')#HZRJ$U*AQM<=3#I1Y
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M\:M$/3^[XU9+O7;L 2Q[S+F%2<\C+GWMB1IC'C'2(QB#E'TVVN>.W>D,LI<
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M\+DA;07.!0%8K7#0411<>WG6.!F3>U@[^NQB.DIK!$#F.I0%585"">YR=%X
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M;-R'XX,W9=A!E\;C1AMN<_P+ 98$1C0><(+4#V2@_5,R^Q=02P,$%     @
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M*IMMPA(9,FJJ_%JI'.%HOX'02EJO$[V24%B -XFRK(T@4NG5H*& 5=\+31X
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M-GIRN8M!L/'P\=;"H_[D^&G+G3?W:)AW:3WM'X\G+7?>-:+D#]$=C7>N7RL
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M "F/+A0A&X\>VV8+)S-U8PW-;R ^DC@DV<P83U"6W3RE-R\!$C% *QR_48G
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M#K)8_0K,WD=3@5 5<R^F!:O;V+A:65,O5P+H5Q+*(YG-/9=.NG+J244/-IK
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MG_VC",J5O%+Q#O>.B %)I L4<H<B+;/W1=/3=W*K;Y1] Q/"/68SB[AQ[6&
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MVQ/6_Q^#_Z,R:_[?@;FI*E/PQY62B%6Z84;JP0+A#]J@_6>2%_\!4$L#!!0
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M)^/Y'0'534!G&%G[KCM*8WO8;TO[:*!R"39>2&DNACM@>(:25U!+ P04
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M_D<.5 !'0OY!] I&*]+OQ18EID)I2]G.=5M?B+Q$62?Y4]DJ."@NU=@,AL#
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MEDHY182Q2/AZNL27@Y6C]#?]XONQHDCV*BI)HO=ICY*:/5?#J.-IXK):O<"
M2O&HD%@)HFIQ]>P+T,TE]9*!IR+&1U<^=@(0A$0$4;.!II5^0G<-H4X-%]_4
MRJUK"B11Z$,=V-3^I0ZNG(9KV] UA/BBRAORE$SR^J19!9JY 2RA1"P-#F :
M:0"LU6JPQ#=-+A^ 6+1F6>2M@\UJ6@XP?V1;(2U'&5B-2EHUPKY8A(BSQXGE
MK<$$AW$:"B7!EV[5$R=6+Y$U<3F7!B#%?FV&*[V^K_J6!@!VXPZP!#T,X$ZA
MF M-ZJKGI@?T'.I5G)D "CF A#S:G+ M_(QB!#IFF?!?Y#ZA00S%%5PQV!1S
M_3KDM)WQBH<@.%6Q#?&\CJV(Q#\0O!76")9R3,(!U*_Q+XQ;JMF1EGZ/CTBI
MYOU.9@XZI-0;2EN% ':I&N?R,-X4.T#.+8OP:8AD\^S'<[.&?B< H4^NT.P"
M6T]+"I2B2I+6S:](U:;FKILJHE+L/EL.&HF5.H))5K!4=89DC,$ZHSC2= FC
M>E)'&8_^*_33(Y="'!YLI#5-R@AO&NHYTV:/*I,,P@HS]T]#$7*]R*B_5_O9
M1!^25XF#N6PU]R;&#B.6C:[L3+LNCI97F(Y!&LR0P"DR;'DTS:V3==3+"U;)
MKC?0^X><9U@:.Z0*\O1=^O4E]KW0CI@CW9=F4C%9;QBRPW$&C9I.@D*#WDQD
MH$1R-8M%W3CD@0AHQV/>;T^7CM$PB0I0[0/U(B#+C8)6)  K4LU8?U>18!A@
M2)9,MI2.&_W7P4X<X#*@.#%;+3S@WT_.)YF#\J-']C1LZM&=$E6*7;K4H'X.
M%A<<77';5(:V$WT2MR@G(L9*Z(Q'CC=T*G022SPX BZ^0MQ!NCPM?0,Z$"6Y
MG2PO\7N$V*K6PY]L;< 5[[%!QJZX.5;XSBLHB 1C>D;L%VJDE8IQK3$AZQ&D
M;</-K_!;+\3X=LBRAXPY\5W>[8^UQ_6>BB'NI&7)(0C191;LG;%5R2"B[#.J
MJZ. ?K_7(-J^$T7MO"P2EXHJT9%24LLE9MQ+4NU#Z6!*T5[$=C"+Z88NX_V!
MQA3OAPP4];?4!D8++60;VY85A3/1&/)D[C SY8\\)D@$4U3-&5$2.%LLM@0Q
M7:7H#"IQW+HZU\ZRW LR]9X0^DM>:-)P"[$>)3#P6<10:N%(-EK'ME*P/&U/
MY/-[:R3AXE:CT:R"2V<PJL:G=J8>37/-@THIX^YR=RUP'W8+VX\?$N7PQG1]
M]NY+[2O%+FW[A+3Y@0@,BNBS18Y&*[=*:/O-QK7:<%HMY."WX'HB\B\1QR/9
M(+8V);:OL7:)C.5Q+\+$CKC]2\XG).D9LCL^< 4I)=.KV!/=/%'M3Z>5-(6Q
M:3'HYS"&AZW70IB-SL&&42>QW00LHH&2\ANI\%H>93,A4>Q.E*#\OIVM?!>U
M+7&@G-F=,M[2NFR (6'U=$6,$M5C3R5G7W(F:/8J3=F-G49_X?=^0$/XAQ-"
MOGZ*6UI<27+DR[ZL"BI=.'WR"I_\7)\DQ\&6VJS:I]ZA#LRNMXB)1LOQ3=P(
M6^;)ZS_F*RPU;H80>8)S/Y>IW[#MNNZ;FB)L8\]^(<]B6+['!<'Y%:&A7F@)
MESS[(6D\%SH9>&T>Q,$Y125$@:[I5\&8,V51(@/%]F0_;IZT"S !3>RT*X7"
M7$"3%^RNZULG'-GT[PO+&C0NM6@E^@SZ$8/'6/HL,SF@U%?A3C^'KCLC^+9V
MFCBG*3=A#?]*8T%IND:%AWF;J-WSP1'\[^S]]Y]]KC4?@X49$%!RL-"B[19)
M8P[;728]L</20$]JO'3<UV1['-^%#IAIVTMY1AKR:G^^F'$,ZBYE%Y,G&58T
M&TIQRR'OI1>.(DLPZA&ON+WS.(CV*)YW["[719/A[=%7C]B["^4\QE&&C'L;
MK+9QH_F]7/_0=NI,L]%I/^[&L8E"MD)FAN8 Y5=AF7L(32%@$,?^)QIC3JJ@
ML37?8KJOWC_L'0[<>^IUO,.!"PI&%=+I86\2UC=HD1TR>SA,PO=+2.1578N<
M;RB]L]@O!P-*C<+PDHFY7;/P6=-7+-Y3D?B(2#T@S=AJ"Q@=R'[O/<5/-8R3
MZZ4XH?^,)D%1WAQURR:.&C0KN6Q@:%':6HE"\U\'24%LEJ;[H<2D0%F!.6E.
MLRN,TB::BZR4VYJ4>Q%!&EJQ33I/KG90UT=(>0"@4\H3,_UX4Q :!*:I3"Q5
MCJDL:D2=9BJ,+UY%XT!TA@7&BR"DD%H8E%ZD<J+#SBC:B3XCLU*=FUN.1UL@
M4:B8\0Y1C6P2LSIV.TAM+;H*L=!*'0(Q/ZCAL'U>W);BF4.4;JDGU(A7(:)$
M[/,A.9HL\ ?H'@AH1!":<IJAPC*8.>D09-5B/D_INL*-!X0&?'N*K0"EP%=(
M)1F07.I^_+22-C(CO('SR\>*@8+ 28DGP*%V7?3#17\5&Z#L%)"N2W+ABB:T
M1$%JW6;A$I0$V%RQ0)$ZB=EK@TC8K#DOGC:VFT.7T-BN<*T;;$%411>1N4 F
M32Q.8F6I6AECCNDKK%*"-38X ]2PW6THX;*-ISUU+D-ZF+%/CK,>J<5(B$B%
ME"@PS''3OF8KG?-P-R"5N)<5*:'Z+&5?6=F/,MX>L=X&\<%IEZRSL-#,&W53
MEYTIRDK]E:EY.*;)<V3@QMP/$%T$A QGET%V;8@]P*+,1-I;,M;]<%-*&*H*
MZ=1\A="1!P)KDAP57#87G0!FT-0Q$6K, 0(CEUBT,;,K]B&W$DD!_FT\E+7'
M%M6G!9:'&( ISL@P R63BN+^./[JR,S_VV)^I57@H!/&]9X.=YX&ZB)QZRG-
MDM,0:+63.Z&H9W3BS;^G:9)T.X^(&%2*@?<FK^N>@["YO>N+EH3IRM3@(_1,
M' !7>NC6V']8W3@8JTU\/MC7C'P&ML4#YCU] F%" 6A3UG=FF71\E%I [J.]
MDA EPMB.=)CW0;5YMQ1OQDSQE-1@N<08V3--27U5^=%1OF=>$\2UH]<(A@R
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M,\6P\W20=B&9D WTJ^""\J:?_-CS<I&.,?,>>H^.;Z2G("?J)('+P;I<3+W
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M?W1^CT/BO7*=W]''K<-K7?&!I^BX!BJ6/W""@V\^TO*^^6]02P,$%     @
M&G=05.OJ%A>)!0  %PL  !D   !X;"]W;W)K<VAE971S+W-H965T,S4N>&UL
MI59I;]PV$/TK@VT0I ";E2A1HAS;@*^D:9/6L',513]P):Y6C21N26XV[J_O
M(_>( SMN@7Z1> S?7&^&/%P;^]$MM/;T>>A'=S19>+\\F$Y=O="#<D_-4H_8
MF1L[*(^I;:=N:;5JXJ&AG_(D*::#ZL;)\6%<N[3'AV;E^V[4EY;<:AB4O3G5
MO5D?3=+);N&J:Q<^+$R/#Y>JU=?:OUU>6LRF>Y2F&_3H.C.2U?.CR4EZ<)H'
M^2CPKM-K=VM,P9.9,1_#Y&5S-$F"0;K7M0\("K]/^DSW?0""&7]M,2=[E>'@
M[?$._7GT';[,E--GIG_?-7YQ-)$3:O1<K7I_9=8_ZJT_(N#5IG?Q2^N-;%Y.
MJ%XY;X;M85@P=./FKSYOXW#K@$R^<8!O#_!H]T91M/)<>75\:,V:;) &6AA$
M5^-I&->-(2G7WF*WPSE_?*4_Z7&EZ4K7IAV[&*DG;]2LU^[[PZF'AB WK;=H
MIQLT_@VTE--K,_J%HXNQT<W7 %.8MK>/[^P[Y0\BGNOZ*64I(Y[P] &\;.]O
M%O&R?_%W;LU 9[#5@A>(N5_068RVMO3[R<S%]3\>4)CO%>918?XM!SJGVM;J
M5GG=@,91O;LOM _BA.(\<$M5ZZ,)JL]I^TE/CM\LX(GI45G=V)(/::.X.WI'
MS7V::78#^OQI+.1,LX+O:FPHP'6UIAJBK;&==@?TI!O)+\S*0<!]3Z@!3#7]
MII7=II>0'#W,$+%=@L(GP2>MZ.SD!6!;U*_?Z3Z(B^>=:D?C?%<[;-0K:X/M
M>Y%'Q)G(<B8*'L=IFC&951BG3'+),E[1R_.+#Q_HG?:OU(QJ,Z*C1,9"!+V(
ME3(ER7.6E0455<:R(J$KM>P:4LZIFYWGCGA5,"DX<9&Q))7$,^C+*Q3#7%L]
M(B"]FAFKO+$W".?.[ABRJ+;WP?9M](+ZE&>L$ 55><%X(6$&9WE5WG%\?R1
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M/8L7U]0DHG8*M+Y4=.V:B7/0MIWC_P%02P,$%     @ &G=05,\,W2,A"
M^Q4  !D   !X;"]W;W)K<VAE971S+W-H965T-#0N>&ULK5AK;^,V%OTKA'=V
M80.L+5+OV21 ,H_N -MV,)EIL5CL!UJB8V%DR26I9-)?WW,I67$RMIMV%D@L
MR2;O\]QS+W5VUYK/=JVU8U\V=6//)VOGMB\7"UNL]4;9>;O5#7Y9M6:C'![-
MS<)NC5:EW[2I%S((DL5&5<WDXLQ_]]Y<G+6=JZM&OS?,=IN-,O=7NF[OSB=B
MLOOB0W6S=O3%XN)LJV[TM7:?MN\-GA:CE++:Z,96;<.,7IU/+L7+JYS6^P4_
M5_K.[MTS\F39MI_IX5UY/@G((%WKPI$$A<NM?J7KF@3!C%\'F9-1)6W<O]])
M?^M]AR]+9?6KMOZE*MWZ?))-6*E7JJO=A_;N7WKP)R9Y15M;_\GN^K5),F%%
M9UV[&3;#@DW5]%?U98C#WH8L.+)!#ANDM[M7Y*U\K9RZ.#/M'3.T&M+HQKOJ
M=\.XJJ&D7#N#7ROL<Q?OFJ+=:/91?=&633^J9:WM[&SA()H6+(I!S%4O1AX1
M(R3[H6W<VK(W3:G+QP(6L&DT3.X,NY(G);[6Q9R%@C,92'%"7C@Z&GIYX1\Z
MREY7MJA;VQG-_GNYM,X &O\[H2(:541>171$Q34JINQJS=H5T\HT57-CV5*C
M<C2K>O6.XGPHO"<E4V6^M%M5Z/,)2L]J<ZLG%V].J&!W&M\HRU9MC;JS+]FT
M:IA;MYU536EG#)#&HV;_@:%#TAA"KC=+;<:PTT> #Y&SUQ!M756P%RS)<I[G
M$>ZB+.2)OPO3E.=)Q-XU3IM&4<&IFDDA>9($3*09E[E@(HJXC&E]'N 7?Y<D
M@N=9C+M82BY%QDYD(AXS$3\[$PC*MFUTXRP];4U[6WE&F2YUHU>5FR%&Y@_S
M<U+?X?Q\1'B?H\Y;:"J+#%!&^HPAL=^<LU>=,?";O=6E-DC'"R:0D$P(W*62
MYU+XJ'.!%%X[Y303.1=1BGSQ,$JP&CE-G^8TYS++F$QX&$ 9$AKF3"")TN](
M>)QD+,MX% 0P;J5A0CE:,$TY#)NQJ8BXD,F,13R3R:!\&@<A?H*%":XRR9]H
MCGB0)=B:\U3&,Y:'@DU#'H40,PT3GHIHQA(>0!X<C5,X&I"C.<]ZR$4\PF\G
MT)6,Z$J>7^>KE?:-92^ES) [1A=M4U1UY>T_A*G36A[#YRO0E!4T P8KTVX\
M*M2F[0CDA*;.(>C+>Z:VV_H>4/(++*+<N=;<L]60CJ<F[_/%GP7;I_GU?!3\
MH,K+E6(>L+\_N?1)?S"!LP8S"$*Z$T)F#47#Y!RZYA'^0Z)P'U*&O^H10D;2
MG0;SC% V#_RG\+6#!MV@81LDJZ2-JKFIT.YV)F"=W*WN/Z_7RNCOJ.>7/JH8
M17K%/N96.U?KC2>6:3@G%,9SPK:__P 64*98,Y0NE-YB^MG26E:@'N 0+$QG
M.SO]Y[L-",0'X/JN<K]I4]-6GQOB]PW[Q]\R$.H_20'J8_?T$Y)D^MA!)/XS
M)A"H-R,NQ^R*=!XC[H)BB4M&EQ/5D([5D/Y%KB6;RAT%D!G*(FC6AP1EL41M
MN.HPW9Y4>9QN'^LG^!ZS8;IGP(P@4'>EAT5?2P5)4HVO'92Q;>NJ5+ZH%-)2
MH)AHXH(KI[OLUP7S])N 7?8&71:%Z:! ?R&<H<"IO8+=0KI)>!8&M*0O<5"+
MKFYI5F.#^Y:!QD&(DL=!_,"[!L!K.@U:)#I->2*)5/&=KTT@N]H1B893%NOB
M. 31RE2R]P:3OW'W0P'L+P/+BU"BG8.J8V+I72GYX!Z0"P>2(&&QX"&HXFA=
MB8"G44"7 $W*(YL)+I(0GU$6L1^)(& 45B,O&.' =LJ8>Y3'G3*E91F/TX#%
M(/K43WI#L3U>)- TLI N(>:.3PW.,G7U&VPA@3"V9UO/%H7OH,4]LE*LX20A
MK/'S8H_B"K&TKN< P=,XANX  \_'UH&.!JA1<\S"&%?)TRQE/ZNZZ_U5A!H/
MIVE(;978*@J0*Q#1OHB1&F\/;!48FV)H]E<9LW\_ !L3 !T@$$55_-JAD?BM
M16L]9:50%!-?H3%&(*X3"9]&DH?4E:=1SN,(S/6,I$_]&$$:/%[0G?N,3F,,
MA=)W>AF!9O<R<(-3Y%].P!0#0DKD'8HQ?GM5#C,"3 D!$;6@\3.#/S\>H0>:
M('@6Y72# 2*2I^:&;&3*[#13]@??(XD\1(,GY1VGP7&$A$N4H?[$C0A;SVY]
M)"V1W2% T:AQ(";?/(Y>#=2I !9]4S74JBD6]]A/).>!3X,:C_J3 4X#DKT"
M69"QKAV 2VD?2))H 8<.Z K2A%%9Y^P74SG]7;M:+0IEUVRK[@=T@$@RZ>%.
MT*/A\^U3D %8C:W[>&"]3/S2?@. M>< ^:UAR-!E!A?Z(O[:EQ/8R4?LY,_O
ML@_YZQH:,V\:7SU[ ]/!IGI2P_\#35]9LVU[SOEV\ QT.,RX",)1S_EC=('2
MJK9$*D"/U$->T-$EB^CH0X<7G':^-]1(, * AHC_IZ4>;F>GG:+.KZ@#=[5G
MY\<_.O598][L#!FB,,I7<'FP)HI" A@:!D$K!1:?&O'-BH=)IAC.@(-BQ$!$
M:/ BS_UY*J2@/TNET;4?@%"'^Y,O1M4UK?1.=DBP&<@V#FF^3=!:DH=A];G*
MGOBG6*VV5N^JC4XU5=%CT1\TM$=$76TJIWH!.!@&PC<W'V+4L@AG?PI$0W4_
MP ?IRO(#.#I4W(N]%W)HOS?^M2,=S:"X?S<W?CN^V;SL7^@]+.]?B_X ^J.F
M6.L5MF+$CR?,]*\:^P?7;OWKO67KT.O][5HKG'-H 7Y?M:W;/9""\7WOQ>]0
M2P,$%     @ &G=05%!DQ#<' P  !P@  !D   !X;"]W;W)K<VAE971S+W-H
M965T-#4N>&ULI57;;MLP#/T5PD\MD-:7)$T6) %Z&[:' 4'3K1B&/2@V'0N5
M)4^2F_;O1\F.VQ5)D*$ONI*'1](A-=TH_6@*1 O/I9!F%A365I,P-&F!)3/G
MJD)).[G2);,TU>O05!I9YIU*$291=!&6C,M@/O5K"SV?JMH*+G&AP=1ER?3+
M%0JUF05QL%VXX^O"NH5P/JW8&I=HOU<+3;.P0\EXB=)P)4%C/@LNX\G5T-E[
M@Q\<-^;-&-Q)5DH]NLG7;!9$CA *3*U#8-0]X34*X8"(QI\6,^A".L>WXRWZ
M9W]V.LN*&;Q6XH%GMI@%XP RS%DM[)W:?,'V/)Y@JH3Q+6Q:VRB M#96E:TS
M,2BY;'KVW-[#,0Y)ZY!XWDT@S_*&63:?:K4![:P)S0W\4;TWD>/2/<K2:MKE
MY&?GMTQ++M<&%JAA63"-<'+/5@+-Z32T%,"9A6D+=M6 )7O X@2^*6D+ [<R
MP^Q?@)"8=?22+;VKY"#B#:;GT(][D$1)? "OWQVW[_'ZQQ_WU^7*6$WJ^'T
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M%O13HW8&M)\K9;<3%Z#[^^=_ 5!+ P04    "  :=U!40/N!9! &  !L#@
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M^C' &(JMM8L?M#N+=R)>R.J )(R2.(K9#KQD?=LDX"7_^[9_G4ZL,_"-OW?
M\S4\#_!\&WSOV41/B1U.6D@3(J>KY%,&W8GG _+0+D0ECT>(."O-C1R=O)U+
M,M4-HLGKKRP1#Q&UY=Q#LJ<ZXN9Z:457VWT"=\:G)']*80:N""PMVXDTP=KG
MI\_)>^'P]?+J@OP.64/.=6=UHVI,U^2M=J()I,"4-[);2O(3B6E1E+3,(HP9
MSV@:I7Z4I)C/,>()C:("@X3&+*4)!%]TE6YQ':-;@CQCA(]4"Y$BYC2*8XRR
ME'+./7Q!LR0+B+2,_:!,8@@50(&JTCHB;Y&KK*2D0S;;BTN:Y'S_X9")A$$D
M61A]HT)*P2=1_9H3M]*2,HIIEG)RM5V$I3DM6$1>XX!A(>><%M#PI;3V<'-!
M.&?49.E\.!&G2:<QWSD#[@)S#UKOL?U=VUY<7'[X0%Z*B89YM%'24G^E X+<
M4'V<ZZ:6QINLUR,%D_"52HD^Z74U$:WW]?M^ E;C%,0%OO*H#'24 RUY[GEB
M$:=IF7EZHT?T)D5*\RR0ZLF(PXBGX530FU$>1P-N!D.FV^E-<SXX15K0(@O>
M$0W>$4<X)# /3=.8;Z,7Y*=)^0WT9AFC99'NHC<O:0$'V& C+6+*$O;][":P
MPP]@-RT8Z,F^RF[!:5;F@84L\6P@CO+^/XN8IS^E95G RJQ\1"YC)65%$N(+
MD9Q&PRA+/+EQ3&/>D\M!KG>8K>3R#+M"['N#QQX2T9P'G(2FX8PTQ1D\V\IM
M!/<JOH';U"O(BEW<PILXTL8&%SS.:5[&W\]M'O\(:H,:B)RO49OG,,H08"7O
MJ8WRWJBEGR\*&C%&=A2R=%W(TMV%#+U?O<0U4%$\(8WN9C\W:)^@E+7263*Y
M QVXN%J@$,RDGAFQF*N*"'2&]JE*M_/ IRO=ZZ=.I@146&5#]1[4@V/  =U=
ML)K\M%0+7P.I5P:U<?(/.D!/R(::1MF/N(2LQ-)*7PSO@O!,=G#DIKDCM9I.
M5876SF]L]8T,V!C+Z52&3A)"2Z<:=2_A %C5H4Q^9HJP1+Q-=-?[!3I:7YR5
MK@/B%RH8V8@!7L'=<)GZ@#QIB=T<D!5\%))#KV"_Z (>5?Q0RC^?B<AI"TTK
M@+SKE*_[UP[E/_ALDL'Y?"1SYO-]1,Z,N%<-83F->!*2.-+0N>A$+4@>9#D2
M#WXS)'I> J&@'&Y[N?3DT="0O%)U#1M="L26-\[IU)].GDO?R-P1[.0I(UE.
M$R3I0:7?X <U4A R-UH!%E%6,F\OD-'XBQ+D-8YLA(XC1J%Y9GQ+1!C*#T<@
M1:@TUROE[GMI'THH9JB$N$/?]R3 9?C-LH*4!2T3CD.0;%!(3JT2Y$I4"IZ"
M7#KS8?JK6(B.]#41Y0O7/EWZ!K.!*,,$3DUH$O$!O: QZ@-Z)<#YFHIE2"5(
M2GV+Y1,_PCY4R#1-*</HJ?@>;[P P-DLO',L0F79N?XQL)Y=/Z5.^Q?$?^+]
M.^R5,#.%1-[(*;9&!SDBU_1OF_[#Z45X3TRTP^LD#.=X#DKC!; ^U=H]?/@#
MU@_,DW\!4$L#!!0    ( !IW4%2"(C*KL@4  "81   9    >&PO=V]R:W-H
M965T<R]S:&5E=#0W+GAM;,U86V_;-A3^*X0W# [@VK)L)T&:&,BEPPJT:];T
M\C#L@9:.+:(2J9)4'/_[?8=2'+N6W;3 @+U8$LES_\Z%/E\:^\5E1%X\%+EV
M%YW,^_)L,'!)1H5T?5.2QL[<V$)Z?-K%P)669!J(BGP01]'QH)!*=Z;G8>W6
M3L]-Y7.EZ=8*5Q6%M*LKRLWRHC/L/"Z\5XO,\\)@>E[*!=V1_UC>6GP-UEQ2
M59!VRFAA:7[1N1R>74WX?#CP2='2;;P+MF1FS!?^>)U>=")6B')*/'.0>-S3
M->4Y,X(:7QN>G;5()MQ\?^3^>[ =MLRDHVN3?U:ISRXZIQV1TEQ6N7]OEG]0
M8T]0,#&Y"[]B69\].>F(I'+>% TQ-"B4KI_RH?'#!L%IM(<@;@CBH'<M*&AY
M([V<GENS%)9/@QN_!%,#-913FH-RYRUV%>C\]'>IK/@D\XK$6Y*NL@2/>R>Z
M'^0L)W=T/O"0PF<'2</QJN88[^$XC,5;HWWFQ"N=4KK-8 #UUCK&CSI>Q0<Y
MWE#2%Z-A3\11/#S ;[2V>13XC;YO\XUR26[8;"?^OIPY;P&3?P[(&*]EC(.,
M\1X9=\B>M,I)F+F8L[S[( ]?TCF"@Z5.1:[D3.7**T@O:N^G(H ]J:Q5>L&
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ME22^S:U9\?.)RCCP^EI*V@],@L.#O/@+4$L#!!0    ( !IW4%28?.;+L 0
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M@EID5/8 [>>2'HEN8@T<FN[Y?U!+ P04    "  :=U!4,]#9Z*@$   !%@
M&0   'AL+W=O<FMS:&5E=',O<VAE970U,2YX;6S%6%MSXC84_BL:I@_)3(@M
M&=]V"#,)D.EVVFTF3-J'3A\46X"ZMD4E$9).?WPEV[$A%H)T=]D\!%_.=^[Z
MCJSAAO'/8DF(!,]Y5HBKWE+*U0?'$<F2Y%A<LA4IU)LYXSF6ZI8O'+'B!*<E
M*,\<Y+J!DV-:]$;#\MD='PW96F:T('<<B'6>8_YR0S*VN>K!WNN#>[I82OW
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M;EB:G@_2.ICU7 A],>P&_5\D^0E02P,$%     @ &G=05#2=]80_ @  (@4
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M6Y;F$4-I'<SY3@A]WM@ [;.8_0)02P,$%     @ &G=05,[M8)4M P  - H
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M[>(]J#F8IH';OM#:/J\T\P]WTT<G_P!02P,$%     @ &G=05"7W$&@T @
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M$,X0R7BI;0:-2T?<76^MW_G8*98%,SA6XCM/[7(8] -(,6,K86=J\QGK>+S
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ME4;C#6B_T-H]3;R#[MV?_0102P,$%     @ &G=05"$:;Z&  @  X04  !D
M  !X;"]W;W)K<VAE971S+W-H965T-3DN>&ULE51=;]HP%/TK5M0'*G4$$NBZ
M*B"UT&F55@W!NCU,>S#)3;#JC\QVH-NOW[43TO0#M+W$7^<<G^N;>Y.=T@]F
M V#)H^#23(*-M>5E&)IT X*:OBI!XDFNM* 6E[H(3:F!9IXD>!@-!N>AH$P&
MT\3O+?0T497E3,)"$U,)0?7O:^!J-PF&P7YCR8J-=1OA-"EI 2NP]^5"XRIL
M53(F0!JF)-&03X*KX>5L[/ >\(W!SG3FQ$6R5NK!+6ZS23!PAH!#:IT"Q6$+
M,^#<":&-7XUFT%[IB-WY7OVCCQUC65,#,\6_L\QN)L%%0#+(:<7M4NT^01./
M-Y@J;OR7[!KL("!I9:P2#1D="";KD3XV[] A#,\/$**&$+TDC X0XH80^T!K
M9SZL.;5TFFBU(]JA4<U-_-MX-D;#I,OBRFH\9<BSTR5L059 EI"J0C+_M+U;
M::RN,%<6]]?4 EEH56@JS"GIS<%2QG'VCG1PNL:5#0X/[U=STCLY)2>$27+'
M.$=IDX063;NKP[0Q>%T;C X8'$;D3DF[,>1&9I ]%P@QVC;D:!_R=714<0YI
MG\3#,Q(-HN$;AF;_3A\<L1.W&8B]7GP\ V?XU*[JF"S( K2O3YD"^;+FK* N
M+V?DYK'$OQ\R\I4)AU,Y6>&1R6E=$S\^HS:YM2#,SR/.1JVSD7<V.AAI#EKC
M=;JV^%;R:H6Q5W =8SN-XR3<=I^SAEQT(1_Z3Z!GUL:MM?%_6</1_[]_7OXA
MM<OQ*PO#T2L+8:>*!.C"-Q=#4E5)6Q=4N]OVKRM?MN$3O&Y^=U073!K"(4?J
MH/\>#>BZH=0+JTI?DVMEL<+]=(,]&+0#X'FNE-TOW 5M5Y_^!5!+ P04
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M5/47;&JM-P+Q6FF1U\%F!'E:;#_9SWHB]@(@Z0E =0!J!_@] ;@.P,\-\.L
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M4Z7G5(]LFK3COSZ,'_6,'R+PL<C5I@)O\J58GB>8:C*.C*!'1JZ1-^-")*\
MAB\!"A!T#&C^_>&!(WSQW>$P]LP&'_7%33[<EZ]7RK\_:"AXKT16_>.Y$3G>
MB#0W(CTW^E0H_4B4A^0N'0_AM FOW>AAAA&DF&F2'D[I[>)0&#!&Z3ENX<"1
M@,5!=,2=S8,>YT&]\[C2CZU,>.6AA!U3L7&Y#X\W"H=Q?PAGIUS5CR?&%O==
M'(QH0"*;>P>.44@CZ.8^.LXC\L[CLS8@;2!WBBOA$R ^YHO'%0 &QD:#81*T
M\6><Q3%ED:V!"\ABB!"Q1' !24PI9&X5X,F: +V3F?.<+[F/%V12H9$E,$X'
M\4 )<)<P'(<HM!5PX((0QY$M0!>G%:5!#_W&2:'?2C]HKG+0&A'X@6?;G\&<
ME_+^7O#<1Y7Q.$A'5L5X(&0#56$=%AECJ/.UZ,(HC!BV-7' :FOJT<0X+/1;
M[)M=J6OMET!M!/@HE\M4@#>\4D!7+>!J50OE8\L8((Q&%L9X(XP'"A-WA8E@
M3&);F2Z.,A0R>]%PX$@<$1R[M4'&>Y'?>]\)W0#DWWRUG[$^!,<5 !EK1&B8
M &W\N<&SD"%+ !<.QIC:WPT7+B!!WZJ-C/,BO_.VZ_9O,E\OB\Q'CO% 1$;6
MP9@A\E=\3^M '?S6*ZVM0Q<7!Y R6P87+&9]7P/CM,COM&]+GB?"1XEQ.Q2.
MS+YQ/.2O^9YF/W+0%6%FD]^%A22"=M'D@#$2LK"'?..FR.^F[_4L? Z$C9OA
M8%SNL3$[[*_SGN2^C3^S=A1T#,@!(RB"5EVU<,#J\JMG;<;&2+'?2.^V7/KJ
M(GS2+(_<+6-C<'A@O]S&GY$:06:OO@X8CE%G\77!6._:BXUY8K]YWNVE^D^4
MJ:Z#?+08$\,C]\S8F!P>V#7C;IN+H:Y8; 4<W;5NF0-; 0<LB&C?TV\,%/L-
M]'>A:])& %_+C(V3X9&;9F*LC@QLFDFWQ44QLU?4N0N&"8.6 @Z8+I/B'N\G
MQD:)WT;_J 7P$6*<C(S<+1-C=61@MTP<73 +*;*K'A>.1('=)BQ<.(3T:M)#
M_\F+1[^37E62@QN>R)5,-%]KS9R/(6-M9.0FF1C7(P.;9-)M:S&&.(QL,;HX
M%&,2=%Z>.G"415'/RU-B3)7X3?5J5ZF2I]+7#A/C;63D=I@8VR,#VV'2;5]C
M0NP"<^Z A3%#G6^# P:#OB: &DNE?DO]E6^][XBH<34Z<B=,C>W1@9TP[7:N
M$4&A;44.6$A"V[$6#A@+$>DQ(FHLE?HM=;Z1N>^YI\;2Z,C=+SW9[AC8_=)N
MN\HP9/8:[("%040ZW'=A-*2P;]/&."CU.^A3:S U#D9'[GVIL3<ZL/=MXT\W
MN:*8=MZ-.F L.EU96^X=,!AT*M#IR6YR)LIULRM?@:38Y>JPC7J\>MSYOVKV
MNZWKU_#UXK!_;](<?D[PD9=KF5<@%2N=,G@5ZC&5AQWZPXDJMLV>]7VA5)$U
MAQO!EZ*L ?KS55&HQY/Z!L??2<S^!U!+ P04    "  :=U!49Y*Z;>D"  #I
M"   &0   'AL+W=O<FMS:&5E=',O<VAE970V,RYX;6S-5EUOVC 4_2M6M(=6
M8N2#\M$*D%KHM$I#0[!N#],>3'(3K,9V9IN/]M?OVH&4=I#N95)?(+;O.3GW
M7-LW_8U4#WH)8,B6YT(/O*4QQ97OZW@)G.JF+$#@2BH5IP:'*O-UH8 F#L1S
M/PJ"CL\I$]ZP[^:F:MB7*Y,S 5-%](ISJAYO()>;@1=Z^XD9RY;&3OC#?D$S
MF(.Y+Z8*1W[%DC .0C,IB()TX%V'5Z/0 5S$=P8;??!,;"H+*1_LX"X9>(%5
M!#G$QE)0_%O#"/+<,J&.WSM2KWJG!1X^[]D_N>0QF075,)+Y#Y:8Y<#K>22!
ME*YR,Y.;S[!+J&WY8IEK]TLVN]C (_%*&\EW8%3 F2C_Z79GQ $@[)P 1#M
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MR!K(WQ><IX<O60?'F_[7_P-02P,$%     @ &G=05-=/F:/!!P  H2H  !D
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M68F6SZB/>R#/9OIN3WB!_OI-N43W$FKQ]X6 PBZ@T 04OB*@O!\0/.EGL)5
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M<EX<XQ0-R;;FZ&3)I&2IN=P C8#K!]3]%6/RU- )RL.TZ=]02P,$%     @
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M;("6<6'.X0*>'@=P]N$</@"7\,"%H*R;CF])U$']>"UPLQ*(C@@,,*Y"+:Q
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M7VVT*&S;&PM-3=0N$YJ+*(T!W4^%T*N-<=!,VL%_4$L#!!0    ( !IW4%1
MQJP?<P(  %0&   9    >&PO=V]R:W-H965T<R]S:&5E=#<R+GAM;(U534_C
M,!#]*U;$ 20@WVF+TDC0"BV'72&Z+(?5'MQDVE@X=M9V&_CW:SLA"B5TN30>
M^[WG-V-[FC9</,L20*&7BC(Y=TJEZBO7E7D)%9:7O :F5S9<5%CI4&Q=60O
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M+B=:0;0]K T4KVT;6'.EFXH=EKKM@S  O;[A7+T%IK/T?R39/U!+ P04
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M[ 987TMI'B?V#M#?^>;_ 5!+ P04    "  :=U!4!0+5+[@"  !0!@  &0
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M3(!^GW*N'AOF#MC=^5?_ 5!+ P04    "  :=U!4*3/BF\$#  !$"P  &0
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M"_M_0.T2[/E.*3H%3J#[XZ1_ %!+ P04    "  :=U!4;6$<&>L"  !E"
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M>'+#O?FV 6D%YOU6"/T\L;?G^+6T_!=02P,$%     @ &G=05%<\1&;M @
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M"TCC@/>70NC-Q@2H/H-&?P!02P,$%     @ &G=05*HH*44Z!0  1QH  !D
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M!(CK:TKY\: <H'UWM/P74$L#!!0    ( !IW4%2< F;H!@,  (T,   9
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M5UUOFS 4_2L6VD,KK<4?D$"51.I2;:O4;=6ZCX=I#RXXB37 F6V:;;]^-J%
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MYAWS;<L<?, \@WR,0O\,!5[@'Y!/CY=[[^6NKEY?PJ O86#]A<>7\ Q-:R&
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MMG-OXI$,UK3DYHO<_0&UH*'E2R77[I?L:MO0(VFIC<QK,$:0,U']TWV]$2U
M-#H!B&M W 4,3@"2&I"\%S"H 0.W,Y44MP]+:NABIN2.*&N-;';@-M.A43X3
M-N]/1N%7ACBSN!>IS('\2?>@R=5GJA2UB;@F5TLPE'%]37XCST]+<O7AFGP@
M3) 'QCEF3,\"@_XM2Y#6OFXK7_$)7U%,'J0P6TT^B0RRMP0!!MY$'Q^BOXW/
M,BXA]4D2_4KB,(YZ KI[/SSL@2_?#8^F9]0D32X2QY=<S 59,IURJ4L%Y*^;
ME38*[\??9UP,&A<#YV)PPL6G]1K<3<-,.F<&G6'*H2^;YZFBL3\,?^G;] NX
MV(]Z<<L+N,DQ[LT>#)L]&)XENF^4XY$O*,OZM%<4$T=A:^?+(AI%_G@6O+25
M]EA%8==J65D-6U:326/R1L*HD3!ZIP2B2ORX(;"'O+"5M$],139M!1!'_J"C
MY=@H&OAQ1TJ/4=+2^T;,N!$S/BOF,[YN^([9PH-"\-1KDF(=^H&/VHZJ3-NB
MDX+":B2(-GA6"149+AI0@EK)E)-_2L5TQMQ;TEN9QD>!)[$_[0]\T@0^.1OX
MLU"0RHU@/R%SN5B!@#4SFI@M-?C@E1SCS N\NP2:BW>X<82MR2N^+^;)<=KB
M;D;N>HPB_\3QFC;"IA>.%^XM:(QZC_V%KC8<1Y0;AG=& <?X4;(DY:DMZ-,S
M/3X\?M21TV>3= YAG\T)Q5'X^@Z&_T<S35-5]J>I)FY7@:053Z6KUVC4$7;!
MJ%(6M![['-3&-4UX960I3/5R-JM-8W;CVI'.^JUMV%P3\4I3=7L/5&V8T(3#
M&BFQH&'M4E4#54V,+%Q+L9(&&Q0WW&+3"<H:X/>UE.8PL0Z:-G;Q'U!+ P04
M    "  :=U!46]5,9@H%  "?$P  &0   'AL+W=O<FMS:&5E=',O<VAE970Y
M-BYX;6RM6-MNVS@0_17"Z$,*U)%(75TX!MHXBPVPEZ!)NL^,3-M$)=$E:3O9
MK]^AK$B*2"G>Q;[8HG1F=#@<SAEJ?A3RA]HRIM%SD9?J:K+5>O?9\U2V9055
MEV+'2GBR%K*@&H9RXZF=9'15&16Y1WP_]@K*R\EB7MV[DXNYV.N<E^Q.(K4O
M"BI?OK)<'*\F>/)ZXQO?;+6YX2WF.[IA]TP_[NXDC+S&RXH7K%1<E$BR]=7D
M"_Y\0T)C4"&^<W94G6MDIO(DQ \SN%U=37S#B.4LT\8%A;\#NV9Y;CP!CY^U
MTTGS3F/8O7[U_DLU>9C,$U7L6N1_\97>7DW2"5JQ-=WG^ILX_LKJ"47&7R9R
M5?VB8XWU)RC;*RV*VA@8%+P\_=/G.A = QP.&)#:@)QK$-0&P;D&86T0GFL0
MU0;5U+W3W*O +:FFB[D41R0-&KR9BRKZE37$BY<F4>ZUA*<<[/3BMLQ$P= #
M?68*7=Q#'J[V.4-BC:Y%L1,E*[4RHS\@9Y=LS:1D*X-&7Y1B\(B6*_0;IT\\
MYYHS]1%=+)FF/(>K*7J\7Z*+#Q_1!\1+]+ 5>P5P-?<T$#>O][*:Y-<323)
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M:]!IH,6N^MSQ)#34M^IRR^B*20. YVLA].O ?$%IOLDM_@%02P,$%     @
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M-P:Q4Z:FXG1844/G4R7W1%DT>K,-)Z:S1OI,V+S?&X6S#.W,_+-(90'D@;Z
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MUZB= YVOE+*[A;N@^P,8_P502P,$%     @ &G=05'CS#B?6!   [A$  !H
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MN%YX_^#PE</1GJV)KZ30^M4;GZME%'M!(*!$3V#N<X G$,*#G(R?(S.:4OK
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M+C2>O;^+B!G&>#!0=V%T"HUN$,.R=2\?C'=PY[76>#)\@NF_)/\-4$L#!!0
M   ( !IW4%3^N3NDG@4  !\9   :    >&PO=V]R:W-H965T<R]S:&5E=#$P
M,RYX;6R]66UOVS80_BN$T0\IT-;D\452D!AH[&X+D&Y!LJX%AGV0;=H6*HF>
M1"?I?OTHR9$<DE+=(NV71"_/'?GP>/><Z+-[57PN-U)J])"E>7D^VFB]/1V/
MR\5&9G'Y1FUE;MZL5)'%VMP6ZW&Y+62\K(VR= P8BW$6)_EH<E8_NRXF9VJG
MTR27UP4J=UD6%U\N9*KNST=D]/C@)EEO=/5@/#G;QFMY*_6'[75A[L:MEV62
MR;Q,5(X*N3H?O26G,PJ508WX*Y'WY<$UJJC,E?I<W5PNST>XFI%,Y4)7+F+S
M[TY.99I6GLP\_MT[';5C5H:'UX_>?ZG)&S+SN)13E7Y,EGIS/@I':"E7\2[5
M-^K^-[DGQ"M_"Y66]5]TO\?B$5KL2JVRO;&909;DS?_X8;\0!P9$]!C W@!L
M ]9C0/<&]%@#MC=@]<HT5.IUF,4ZGIP5ZAX5%=IXJR[JQ:RM#?TDK^)^JPOS
M-C%V>G(KUR:*&MW(K2ITDJ_1R6VS!9!:H<>WU[*HMUB^D"_1R4SJ.$G+E^@U
M^G [0R<O7J(7*,G1GQNU*^-\69Z-M9E:-<!XL9_&13,-Z)D& ?1>Y7I3HG?Y
M4BZ?.A@;3BTQ>"1V 8,>9W+Q!E'R"@$&XIG0]'AS[#&?'6U.H@$VM T3K?W1
MH\-TF3=)7R7/WU<&CBZUS,I_!@9C[6"L'HSU#'8C[V2^D[XH-H:\-JQ*RMV$
M N%4F"6Z.UQ<%P<!%H+SI[B9!\>PB'#8XIXPX"T#/LC@,E^H3*)5H3)D2F11
M+Y-W6S9^Q,$$(FI"'EI\7)B(& =FT7%AG$/(A)^-:-F(K[#1LI"E1O+!E/M2
MOD*YU#XRPAG^-40TL&8Y]< H<!I99'PP+* G-$%+)C@F-'-IMJ]$VT+=);6&
MF%M30^IW.GZ0WF %;K P"&[S<V%"D"BT]YX+XP! >OB%+;]PD-_U-S$*G3D0
M'H3$3B<7%A@^]NYS41%CT+/YHI9/-,CG=]-[-"Q\\X_<B3$6,CLB+HR'0"BQ
M"+@P!D$0@9\!P9W&X4$.5[(L3U'%Y"15I1&N?5ABK8MDOM/Q/#4Q4BA7YGFN
M"Y6F58E-]GGGE3/L9H=%9^K!4*<">D!!'^$#42='!LWA>#E[]^D3NHKGRE1%
M522R?&6TQ*B5:346GS<J7<K"+^#$'VMNLW9Q/"1!(&SB+JZ*-N >\M"1AT'R
M,VDZX$722*-I1U"<59KY7_W RPS<+,2,1\)FYN(B'D6A3<R%A2$FI(=7UP(0
M.LAK^O;7 7$GG;H3]N-["=)),1G6XH%N@KAZ"6$814X[X0/2D ?"R28/D)"(
MA+1G]3L-)E\3X6-;"N(*9VBZ&@";E(OC 0O#P.;DXI@ @7D/I4Z)R; 4?WNB
M> 28F6[))N;"3 \4.;Q<F*D2O?G?"3 95N"/L2G;0UNWDSX2_?A,@4ZF8%BF
M!C(%7)4@3'!L%U\?#D(!=I[X<!1"WK/XT"D/#"O/\6D";OTWK9S3.GA@/ R%
MO9E\WD@$/6D/G9C ,XL)N-7??/I$-BL/2E!LD_+YBE@/ITY(8%A(KJYG0_NU
M$Q+X"4("G9# =PL)N&6?4.Z4TJD/Q[C3P\R\_DR >DHN="H"SZ4BX%9]D\C4
M[DD\,(8QMGL2GS<6]/+I) 2>64+ +?HTLJ<[]: 8#IST\*%PT,.ITP\8UH\_
M]&90/Z#3#_@)^D$[_:#?K1_4K?>,.MMDZH,)!O;">V#FRYGUB ?MQ(,^EWA0
MM]P3&H&='1X88--CV'Q<F*D>/=I!.^V@SZP=>W]/CM>"P"YB'A03V/Z6]OGB
MD1VB\<')<2:+=7T"7Z*%VN6Z.6MMG[:G_&_KLVWK^04YG35G]9V;YJ>#]W&Q
M3O(2I7)E7.(W@9E2T9S&-S=:;>OSZ;G26F7UY4;&YC.T ICW*Z7TXTTU0/N;
MR.1_4$L#!!0    ( !IW4%38,3/(^00  )$;   :    >&PO=V]R:W-H965T
M<R]S:&5E=#$P-"YX;6S%F5UOVS84AO\*8?0B!=)8_-!7X1APG+3KEFY&O&P7
MPRX8B;:)2J)+T7'27S]*5D3%DK@&,*";1++/.3Y\7^L1CS79"_DMWS"FP%.:
M9/GE:*/4]N-XG$<;EM+\0FQ9IM]9"9E2I4_E>IQO):-QF90F8^0XWCBE/!M-
M)^5K"SF=B)U*>,86$N2[-*7R^8HE8G\Y@J.7%^[X>J.*%\;3R9:NV9*I^^U"
MZK-Q727F*<MR+C(@V>IR-(,?YR0H$LJ(OSC;YXUC4"SE08AOQ<F7^'+D%!VQ
MA$6J*$'UOT<V9TE25-)]?*^*CNK/+!*;QR_5/Y6+UXMYH#F;B^1O'JO-Y2@8
M@9BMZ"Y1=V+_"ZL6Y!;U(I'DY5^PKV*=$8AVN1)IE:P[2'EV^$^?*B$:"9#T
M)* J ?UL JX2<+G00V?ELJZIHM.)%'L@BVA=K3@HM2FS]6IX5MBX5%*_RW6>
MFB[96INBP!W;"JEXM@9G2_U5B7<) V(%?M=?I%N1K3_<:K%C,,MSIG+P\ P6
MDF<1W]($?&9B+>EVPR,PTU^D_#TXNV:*\D0??0#WRVMP]NX]> =X!O[<B%U.
MLSB?C)7NO>A@'%5]7AWZ1#U]7K/H F!X#I"#8$?Z_.?3G=?I8ZU8+1NJ94-E
M/=Q3[XX]LFS'<K"2(@4W3XK)3&LQ+PUC,@=ZE1W"_7.KZX OBJ7YOY8N<-T%
M+KL@/5TLI+Z<I7HN/XU]W_%MX>4YR)CJ4OA0S"V+%9?WX]0-?,_S)^/'II(=
M8:X+&V&O>B5UK\3:ZTS+PB.:6Y;MUJ7< <7WZBZ\4XI_*.8U5"6>XY#P2/R.
M,!R0T.D6WZ][]:V]WF=<:2&6BBIF<R"HZP4#.A#6782G="#LD%9;@(\<Z B#
MR'=Z'(". :UC[?9*TA\\L2P;-I@-!Y0?&@A"=$H#JFI-::'OD&,#.L*0XX<]
M_($&EM!.RSG-:$QM"S<L@V1( PP(H7M2 ]R6LG[[ NB((F&(>^0WN(1V7M[L
MBF;/@=HP\)7'L=Y@W-!<E:W/5L6]P2:)(1WTA[3&$!(&)[4F:(D>!B$FQ]ZT
MPZ"#4.#VN&-0"NTL_<STGCA[MFV-#.F0,Z %R& 2P5-:4%5K:NLYQ(5'%G2%
M^=@EW0Z@QH[2#M/J'OV;WH/'(K4)8(B'\)!&&%PB^][OK4:0CFL!!<<^M*.@
M T/8XX-A*K(S58\\&R:3]ICRNI[A'O*&-,& $=GW@&\UP6_+&Q+'/7:A(\Q%
M?<,",OA$=GQ^DC2+F&WA!FTH'')6,UC$]@W@6Z<UIZUL$!S?$#JBD..A;OFQ
M02>VHW.YY^K'X2JPK=W #0\Z+S<&YM-.S+BEKB;]\370%>63G@T3-M3$=FK^
M47#(MFJ#-#SDP(P-"O%)1V;<'H9Q@([OQUU1GA?TJ&]PB>VXG.6<@@6-^(I'
MX(ZMN<AL&ABPX2%'9VRHB$\Z/./V6(P"KXVC=A@D..SA$3'L)'9V_DJWU*8_
M,60C0\[.Q!"1G'1V)NVAV U:).J((J[30R)BJ$GLU)QI<21-N&U"(XT? H<<
MGHFA(CGI\$S:8S$D;NL*Z C#V.F9#HA!)[&C\_]N!L2 C0PY(!,#0G+2 ;FJ
MUOQ9.D!NZP)H1WEN:SH>-YZ7% ^KOE*YYED.$K;2:<Z%K_/EX?G/X42);?D(
MY4$H+5)YN&$T9K((T.^OA% O)\53F?HIW/0_4$L#!!0    ( !IW4%1?!U0-
M]P(  ,@(   :    >&PO=V]R:W-H965T<R]S:&5E=#$P-2YX;6RE5FU/VS 0
M_BM6Q >0!GEK4D!M)?J"MDE," ;[,.V#FUP;B\0NMM/"O]_92;.N+Z'3^J&Q
MG7N>N^=\]J6W$O)%90":O!4Y5WTGTWIQ[;HJR:"@ZD(L@..;F9 %U3B5<U<M
M)-#4@HK<#3PO=@O*N#/HV;5[.>B)4N>,P[TDJBP**M^'D(M5W_&=]<(#FV?:
M++B#WH+.X1'TT^)>XLQM6%)6 %=,<")AUG=N_.M)U]A;@V<&*[4Q)D;)5(@7
M,_F2]AW/! 0Y)-HP4'PL801Y;H@PC->:TVE<&N#F>,U^:[6CEBE5,!+Y#Y;J
MK.]<.B2%&2US_2!6GZ'6$QF^1.3*_I-59=M%CTFIM"AJ,,X+QJLG?:OSL %
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M]--E7'\<JVK/74R:1 !>NRU'4"K)O&2A<P'3[B"?5+I ;]>\O7.FBIT?2;J
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M(I 6"7';A]4^F&226#AVUW9:D/;C=^RDH86VXFE?$MN9<V;.C#,S6DKUHDL
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M(V5P,L285#-PFHV1<]>"GZ7!ANZ6)<YH4-8 O^=2FM7&.NBF_N0?4$L#!!0
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M: &\WW"NCC=Z@/88NOP74$L#!!0    ( !MW4%3=)UP_P 4  'T=   :
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MG)]/3%(;!R M;\@],0=H/4)V/?I5#C!L'MQ@WE\%&,P4NL8X0"L.LBO.D3G
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M,U;5J<ZM*0KE!0UI9<#LE?H\YJ5+A'TD))$!LT5NE7P6(&2+ ;,N7,%Q<.7
MS^:JG[M6<*@_\%8L5$D1D2L&S+)8ECN7TL\J:]W[&LY;DV_?W2F[%]."1C)
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M!ZH2J"X?J$F@MGP@<RJC T3JL 9H;<JU ;PV!=L 8IN2;0"S3=$V@-JF;!O
M;5.X#2"W*=T&L-L4;P/H[55O#]#;J]X>H+?O?FP#]/:JMP?H[55O#]#;J]X>
MH+=7O3U ;Z]Z>X#>7O7V +V]ZNT!>@?5.P#T#JIW .@=5.\ T#MTFR4 O8/J
M'0!Z!]4[ /0.JG< Z!U4[P#0.ZC> :!W4+T#0.^H>D> WE'UC@"]H^H= 7I'
MU3L"]([=9C= [ZAZ1X#>4?6. +VCZAT!>D?5.P+TCJIW!.B=5.\$T#NIW@F@
M=U*]$T#OI'HG@-Y)]4X O5/W9R5 [Z1Z)X#>2?5. +V3ZIT >B?5.P'TSJIW
M!NB=5>\,T#NKWAF@=U:],T#OK'IG@-Y9]<X O7-WV 2@=U:],T#OK'IG@-Y9
M]<X O8OJ70!Z%]6[ /0NJG<!Z%U4[P+0NZC>!:!W4;T+0.^B>A> WJ4[+ C0
MNZC>!:!W4;T+0.^J>E> WE7UK@"]J^I= 7I7U;L"]*ZJ=P7H757O"M"[JMX5
MH'=5O2M []H=]@;H757O"M"[J=X-H'=3O1M [Z9Z-X#>3?5N +V;ZMT >C?5
MNP'T;JIW ^C=5.\&T+NIW@V@=^O*.@"]S?5U'8#?YKK"C@,(;JZK[#B X>:Z
MTHX#*&ZNJ^TX@./FNN*. TANKJON.(#EYKKRC@-H;JZK[SB Y^:Z H\CB-X7
M,!D-S+Z"21"]+V$B6IA]#1/1P^R+F(@F9E_%_-8NYC2_;<?I,]''N@OPG7K/
MY^^.G\]_7W[<[%^M=ZZ'KS&FF[]02P,$%     @ &W=05$4/!/Z) @  V4
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M;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ &G=05%:P/Z3N    *P(  !$
M             ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @
M&G=05)E<G",0!@  G"<  !,              ( !S $  'AL+W1H96UE+W1H
M96UE,2YX;6Q02P$"% ,4    "  :=U!45F/#XI\&   .&@  &
M    @($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @
M&G=05"<9R^,A @  =@4  !@              ("!X@X  'AL+W=O<FMS:&5E
M=',O<VAE970R+GAM;%!+ 0(4 Q0    ( !IW4%3C!LZRP <  !H?   8
M          " @3D1  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4
M    "  :=U!41&0,I@L#  #R"   &               @($O&0  >&PO=V]R
M:W-H965T<R]S:&5E=#0N>&UL4$L! A0#%     @ &G=05/JT/F97!@  11H
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M965T.2YX;6Q02P$"% ,4    "  :=U!4YO/DMCL(  !U(0  &0
M    @(%^-@  >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    (
M !IW4%2#&^ 2WP8  ,80   9              " @? ^  !X;"]W;W)K<VAE
M971S+W-H965T,3$N>&UL4$L! A0#%     @ &G=05"@A?J]9%@  NST  !D
M             ("!!D8  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"
M% ,4    "  :=U!4VX9![XT<  ! :   &0              @(&67   >&PO
M=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( !IW4%3;:7[2D0@
M +H>   9              " @5IY  !X;"]W;W)K<VAE971S+W-H965T,30N
M>&UL4$L! A0#%     @ &G=05%P*/9C7$0  [3D  !D              ("!
M(H(  'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4    "  :=U!4
M5(A9TJ\&  #!$   &0              @($PE   >&PO=V]R:W-H965T<R]S
M:&5E=#$V+GAM;%!+ 0(4 Q0    ( !IW4%2D("ICIP0  . )   9
M      " @1:;  !X;"]W;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%
M  @ &G=05!NXQU\E"   .Q4  !D              ("!])\  'AL+W=O<FMS
M:&5E=',O<VAE970Q."YX;6Q02P$"% ,4    "  :=U!4;S/*N18(   I%
M&0              @(%0J   >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+
M 0(4 Q0    ( !IW4%1NEA7FH@,   8(   9              " @9VP  !X
M;"]W;W)K<VAE971S+W-H965T,C N>&UL4$L! A0#%     @ &G=05$V7:KBQ
M#0  52@  !D              ("!=K0  'AL+W=O<FMS:&5E=',O<VAE970R
M,2YX;6Q02P$"% ,4    "  :=U!4B0S[AR$#   X!P  &0
M@(%>P@  >&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( !IW
M4%3]V=DGEQ(  ,U$   9              " @;;%  !X;"]W;W)K<VAE971S
M+W-H965T,C,N>&UL4$L! A0#%     @ &G=05$ $2*J0#@  "RD  !D
M         ("!A-@  'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4
M    "  :=U!4%@B9..$$  "@#   &0              @(%+YP  >&PO=V]R
M:W-H965T<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    ( !IW4%1"C=W;8@T  .4C
M   9              " @6/L  !X;"]W;W)K<VAE971S+W-H965T,C8N>&UL
M4$L! A0#%     @ &G=05)%R<D(O"0  V14  !D              ("!_/D
M 'AL+W=O<FMS:&5E=',O<VAE970R-RYX;6Q02P$"% ,4    "  :=U!4"%V:
M_,8*  "H(@  &0              @(%B P$ >&PO=V]R:W-H965T<R]S:&5E
M=#(X+GAM;%!+ 0(4 Q0    ( !IW4%11H/S;O0\  %@R   9
M  " @5\. 0!X;"]W;W)K<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @
M&G=05*TRO;AL!0  IPP  !D              ("!4QX! 'AL+W=O<FMS:&5E
M=',O<VAE970S,"YX;6Q02P$"% ,4    "  :=U!4!14^6JP$  #4"@  &0
M            @('V(P$ >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4
M Q0    ( !IW4%0$ #;$%@(  )($   9              " @=DH 0!X;"]W
M;W)K<VAE971S+W-H965T,S(N>&UL4$L! A0#%     @ &G=05$QZK5^+ P
MSP<  !D              ("!)BL! 'AL+W=O<FMS:&5E=',O<VAE970S,RYX
M;6Q02P$"% ,4    "  :=U!4HS=BMI0P  "*I0  &0              @('H
M+@$ >&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( !IW4%3K
MZA87B04  !<+   9              " @;-? 0!X;"]W;W)K<VAE971S+W-H
M965T,S4N>&UL4$L! A0#%     @ &G=05.'UH903!@  $A$  !D
M     ("!<V4! 'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( !IW4%3>^>9S( 8  / /   9              "
M@4=[ 0!X;"]W;W)K<VAE971S+W-H965T-#$N>&UL4$L! A0#%     @ &G=0
M5' V+SDA P  J@<  !D              ("!GH$! 'AL+W=O<FMS:&5E=',O
M<VAE970T,BYX;6Q02P$"% ,4    "  :=U!4CXUQ6?8#  """@  &0
M        @('VA $ >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0
M   ( !IW4%3/#-TC(0@  /L5   9              " @2.) 0!X;"]W;W)K
M<VAE971S+W-H965T-#0N>&UL4$L! A0#%     @ &G=05%!DQ#<' P  !P@
M !D              ("!>Y$! 'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q0
M2P$"% ,4    "  :=U!40/N!9! &  !L#@  &0              @(&YE $
M>&PO=V]R:W-H965T<R]S:&5E=#0V+GAM;%!+ 0(4 Q0    ( !IW4%2"(C*K
ML@4  "81   9              " @0"; 0!X;"]W;W)K<VAE971S+W-H965T
M-#<N>&UL4$L! A0#%     @ &G=05(U^21%$!0  + X  !D
M ("!Z: ! 'AL+W=O<FMS:&5E=',O<VAE970T."YX;6Q02P$"% ,4    "  :
M=U!49:#?]V@#  "<!P  &0              @(%DI@$ >&PO=V]R:W-H965T
M<R]S:&5E=#0Y+GAM;%!+ 0(4 Q0    ( !IW4%28?.;+L 0  ( +   9
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M970U-"YX;6Q02P$"% ,4    "  :=U!4CRH@R+D%  !*.@  &0
M    @($GO $ >&PO=V]R:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4 Q0    (
M !IW4%0E]Q!H- (  /,$   9              " @1?" 0!X;"]W;W)K<VAE
M971S+W-H965T-38N>&UL4$L! A0#%     @ &G=05(53;2*G @  .P8  !D
M             ("!@L0! 'AL+W=O<FMS:&5E=',O<VAE970U-RYX;6Q02P$"
M% ,4    "  :=U!4VQ;@CNH"   #"   &0              @(%@QP$ >&PO
M=V]R:W-H965T<R]S:&5E=#4X+GAM;%!+ 0(4 Q0    ( !IW4%0A&F^A@ (
M .$%   9              " @8'* 0!X;"]W;W)K<VAE971S+W-H965T-3DN
M>&UL4$L! A0#%     @ &G=05/PG+I+! @  4@<  !D              ("!
M.,T! 'AL+W=O<FMS:&5E=',O<VAE970V,"YX;6Q02P$"% ,4    "  :=U!4
M(,1'L#8%   :&   &0              @($PT $ >&PO=V]R:W-H965T<R]S
M:&5E=#8Q+GAM;%!+ 0(4 Q0    ( !IW4%18'?!;1@8  #,A   9
M      " @9W5 0!X;"]W;W)K<VAE971S+W-H965T-C(N>&UL4$L! A0#%
M  @ &G=05&>2NFWI @  Z0@  !D              ("!&MP! 'AL+W=O<FMS
M:&5E=',O<VAE970V,RYX;6Q02P$"% ,4    "  :=U!4,-0RZSX(  #U+P
M&0              @($ZWP$ >&PO=V]R:W-H965T<R]S:&5E=#8T+GAM;%!+
M 0(4 Q0    ( !IW4%373YFCP0<  *$J   9              " @:_G 0!X
M;"]W;W)K<VAE971S+W-H965T-C4N>&UL4$L! A0#%     @ &G=05&Z^JR+E
M P  !0X  !D              ("!I^\! 'AL+W=O<FMS:&5E=',O<VAE970V
M-BYX;6Q02P$"% ,4    "  :=U!40_Z*]9$#   >"P  &0
M@('#\P$ >&PO=V]R:W-H965T<R]S:&5E=#8W+GAM;%!+ 0(4 Q0    ( !IW
M4%3"ORP"O00  %@3   9              " @8OW 0!X;"]W;W)K<VAE971S
M+W-H965T-C@N>&UL4$L! A0#%     @ &G=05/7-[_+# P  50X  !D
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M=#<S+GAM;%!+ 0(4 Q0    ( !IW4%0-/5M[+@,  /\)   9
M  " @;<, @!X;"]W;W)K<VAE971S+W-H965T-S0N>&UL4$L! A0#%     @
M&G=05 4"U2^X @  4 8  !D              ("!'! " 'AL+W=O<FMS:&5E
M=',O<VAE970W-2YX;6Q02P$"% ,4    "  :=U!4K-38N7<#  "Y$0  &0
M            @($+$P( >&PO=V]R:W-H965T<R]S:&5E=#<V+GAM;%!+ 0(4
M Q0    ( !IW4%2H92ARY0,  /\/   9              " @;D6 @!X;"]W
M;W)K<VAE971S+W-H965T-S<N>&UL4$L! A0#%     @ &G=05"DSXIO! P
M1 L  !D              ("!U1H" 'AL+W=O<FMS:&5E=',O<VAE970W."YX
M;6Q02P$"% ,4    "  :=U!4G%9(\2@"  !]!   &0              @('-
M'@( >&PO=V]R:W-H965T<R]S:&5E=#<Y+GAM;%!+ 0(4 Q0    ( !IW4%1M
M81P9ZP(  &4(   9              " @2PA @!X;"]W;W)K<VAE971S+W-H
M965T.# N>&UL4$L! A0#%     @ &G=05->;>^8L P  .0D  !D
M     ("!3B0" 'AL+W=O<FMS:&5E=',O<VAE970X,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( !IW4%2KU _1E0(  #P'   9              "
M@48W @!X;"]W;W)K<VAE971S+W-H965T.#8N>&UL4$L! A0#%     @ &G=0
M5%)W1SL@ P  1@D  !D              ("!$CH" 'AL+W=O<FMS:&5E=',O
M<VAE970X-RYX;6Q02P$"% ,4    "  :=U!4C0U1<F8"   .!@  &0
M        @(%I/0( >&PO=V]R:W-H965T<R]S:&5E=#@X+GAM;%!+ 0(4 Q0
M   ( !IW4%3?9#.H  H  %-'   9              " @09  @!X;"]W;W)K
M<VAE971S+W-H965T.#DN>&UL4$L! A0#%     @ &G=05,@PF";V!   =Q\
M !D              ("!/4H" 'AL+W=O<FMS:&5E=',O<VAE970Y,"YX;6Q0
M2P$"% ,4    "  :=U!4#VTYLG<"   8!P  &0              @(%J3P(
M>&PO=V]R:W-H965T<R]S:&5E=#DQ+GAM;%!+ 0(4 Q0    ( !IW4%0;CZUC
MP@(  &0'   9              " @1A2 @!X;"]W;W)K<VAE971S+W-H965T
M.3(N>&UL4$L! A0#%     @ &G=05-N/21F* P  4PP  !D
M ("!$54" 'AL+W=O<FMS:&5E=',O<VAE970Y,RYX;6Q02P$"% ,4    "  :
M=U!4K=*5R,$#  !8#@  &0              @('26 ( >&PO=V]R:W-H965T
M<R]S:&5E=#DT+GAM;%!+ 0(4 Q0    ( !IW4%0-,$K4B ,  -(*   9
M          " @<I< @!X;"]W;W)K<VAE971S+W-H965T.34N>&UL4$L! A0#
M%     @ &G=05%O53&8*!0  GQ,  !D              ("!B6 " 'AL+W=O
M<FMS:&5E=',O<VAE970Y-BYX;6Q02P$"% ,4    "  :=U!4+/ PBRX#   L
M"0  &0              @('*90( >&PO=V]R:W-H965T<R]S:&5E=#DW+GAM
M;%!+ 0(4 Q0    ( !IW4%1MTCH_U0,  %(,   9              " @2]I
M @!X;"]W;W)K<VAE971S+W-H965T.3@N>&UL4$L! A0#%     @ &G=05!L7
MS+C$ @  SP<  !D              ("!.VT" 'AL+W=O<FMS:&5E=',O<VAE
M970Y.2YX;6Q02P$"% ,4    "  :=U!4WQMRR7D"   ,!@  &@
M    @($V< ( >&PO=V]R:W-H965T<R]S:&5E=#$P,"YX;6Q02P$"% ,4
M"  :=U!4>/,.)]8$  #N$0  &@              @('G<@( >&PO=V]R:W-H
M965T<R]S:&5E=#$P,2YX;6Q02P$"% ,4    "  :=U!4\J:"7 4"  !7!
M&@              @('U=P( >&PO=V]R:W-H965T<R]S:&5E=#$P,BYX;6Q0
M2P$"% ,4    "  :=U!4_KD[I)X%   ?&0  &@              @($R>@(
M>&PO=V]R:W-H965T<R]S:&5E=#$P,RYX;6Q02P$"% ,4    "  :=U!4V#$S
MR/D$  "1&P  &@              @($(@ ( >&PO=V]R:W-H965T<R]S:&5E
M=#$P-"YX;6Q02P$"% ,4    "  :=U!47P=4#?<"  #("   &@
M    @($YA0( >&PO=V]R:W-H965T<R]S:&5E=#$P-2YX;6Q02P$"% ,4
M"  :=U!4[1>/,*(&  "Y,0  &@              @(%HB ( >&PO=V]R:W-H
M965T<R]S:&5E=#$P-BYX;6Q02P$"% ,4    "  :=U!4F[2-*P<#   >"
M&@              @(%"CP( >&PO=V]R:W-H965T<R]S:&5E=#$P-RYX;6Q0
M2P$"% ,4    "  :=U!4$[,9,VX%  #(%@  &@              @(&!D@(
M>&PO=V]R:W-H965T<R]S:&5E=#$P."YX;6Q02P$"% ,4    "  :=U!4"KH0
ML P#   !"   &@              @($GF ( >&PO=V]R:W-H965T<R]S:&5E
M=#$P.2YX;6Q02P$"% ,4    "  :=U!4*V,)X6@$   I%   &@
M    @(%KFP( >&PO=V]R:W-H965T<R]S:&5E=#$Q,"YX;6Q02P$"% ,4
M"  ;=U!4(XS32C0$  "2#@  &@              @($+H ( >&PO=V]R:W-H
M965T<R]S:&5E=#$Q,2YX;6Q02P$"% ,4    "  ;=U!4W2=</\ %  !]'0
M&@              @(%WI ( >&PO=V]R:W-H965T<R]S:&5E=#$Q,BYX;6Q0
M2P$"% ,4    "  ;=U!44U<] W4#  !!"P  &@              @(%OJ@(
M>&PO=V]R:W-H965T<R]S:&5E=#$Q,RYX;6Q02P$"% ,4    "  ;=U!4OIES
MQE("  "V!0  &@              @($<K@( >&PO=V]R:W-H965T<R]S:&5E
M=#$Q-"YX;6Q02P$"% ,4    "  ;=U!4(<I0!,,"  #.!P  &@
M    @(&FL ( >&PO=V]R:W-H965T<R]S:&5E=#$Q-2YX;6Q02P$"% ,4
M"  ;=U!4QJ6!,S4#   ($P  #0              @ &ALP( >&PO<W1Y;&5S
M+GAM;%!+ 0(4 Q0    ( !MW4%27BKL<P    !,"   +              "
M 0&W @!?<F5L<R\N<F5L<U!+ 0(4 Q0    ( !MW4%0VKEB<Z@<  %M+   /
M              "  >JW @!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    "  ;
M=U!4,)0:5S,#  ""0P  &@              @ $!P ( >&PO7W)E;',O=V]R
M:V)O;VLN>&UL+G)E;'-02P$"% ,4    "  ;=U!410\$_HD"  #90   $P
M            @ %LPP( 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     >P![
+ .0A   FQ@(    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>226
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>227
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>228
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>527</ContextCount>
  <ElementCount>609</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>139</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>6</UnitCount>
  <MyReports>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000010001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>000020002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>100010003 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>100020004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>100030005 - Statement - CONSOLIDATED STATEMENTS OF INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFINCOME</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>100040006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>100050007 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>100060008 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY (DEFICIT)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY (DEFICIT)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>100070009 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY (DEFICIT) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY (DEFICIT) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>100080010 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>210011001 - Disclosure - Nature of Business, Basis of Presentation and Principles of Consolidation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/NatureofBusinessBasisofPresentationandPrinciplesofConsolidation</Role>
      <ShortName>Nature of Business, Basis of Presentation and Principles of Consolidation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>210021002 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>210051003 - Disclosure - Revenue Recognition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/RevenueRecognition</Role>
      <ShortName>Revenue Recognition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>210191004 - Disclosure - Acquisitions and Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/AcquisitionsandInvestments</Role>
      <ShortName>Acquisitions and Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>210211005 - Disclosure - Share-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/ShareBasedCompensation</Role>
      <ShortName>Share-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>210281006 - Disclosure - Credit Losses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/CreditLosses</Role>
      <ShortName>Credit Losses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>210301007 - Disclosure - Inventories</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/Inventories</Role>
      <ShortName>Inventories</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>210341008 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>210391009 - Disclosure - Property and Equipment, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/PropertyandEquipmentNet</Role>
      <ShortName>Property and Equipment, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>210451010 - Disclosure - Other Current and Long-Term Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/OtherCurrentandLongTermAssets</Role>
      <ShortName>Other Current and Long-Term Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>210491011 - Disclosure - Goodwill and Intangible Assets, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/GoodwillandIntangibleAssetsNet</Role>
      <ShortName>Goodwill and Intangible Assets, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>210561012 - Disclosure - Accrued Liabilities and Other Long Term Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/AccruedLiabilitiesandOtherLongTermLiabilities</Role>
      <ShortName>Accrued Liabilities and Other Long Term Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>210601013 - Disclosure - Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/Debt</Role>
      <ShortName>Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>210651014 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>210741015 - Disclosure - Earnings Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/EarningsPerShare</Role>
      <ShortName>Earnings Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>210781016 - Disclosure - Commitments, Contingencies and Guarantees</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/CommitmentsContingenciesandGuarantees</Role>
      <ShortName>Commitments, Contingencies and Guarantees</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>210801017 - Disclosure - Segment Reporting</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/SegmentReporting</Role>
      <ShortName>Segment Reporting</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>210851018 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>210901019 - Disclosure - Hedging Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/HedgingInstruments</Role>
      <ShortName>Hedging Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>210951020 - Disclosure - Repurchases of Common Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/RepurchasesofCommonStock</Role>
      <ShortName>Repurchases of Common Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>210981021 - Disclosure - Accumulated Other Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/AccumulatedOtherComprehensiveIncome</Role>
      <ShortName>Accumulated Other Comprehensive Income</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>211021022 - Disclosure - Preferred Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/PreferredStock</Role>
      <ShortName>Preferred Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>211041023 - Disclosure - IDEXX Retirement and Incentive Savings Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/IDEXXRetirementandIncentiveSavingsPlan</Role>
      <ShortName>IDEXX Retirement and Incentive Savings Plan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>220032001 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.idexx.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>230063001 - Disclosure - Revenue Recognition (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/RevenueRecognitionTables</Role>
      <ShortName>Revenue Recognition (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.idexx.com/role/RevenueRecognition</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>230223002 - Disclosure - Share-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/ShareBasedCompensationTables</Role>
      <ShortName>Share-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.idexx.com/role/ShareBasedCompensation</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>230313003 - Disclosure - Inventories (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/InventoriesTables</Role>
      <ShortName>Inventories (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.idexx.com/role/Inventories</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>230353004 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.idexx.com/role/Leases</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>230403005 - Disclosure - Property and Equipment, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/PropertyandEquipmentNetTables</Role>
      <ShortName>Property and Equipment, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.idexx.com/role/PropertyandEquipmentNet</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>230463006 - Disclosure - Other Current and Long-Term Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/OtherCurrentandLongTermAssetsTables</Role>
      <ShortName>Other Current and Long-Term Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.idexx.com/role/OtherCurrentandLongTermAssets</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>230503007 - Disclosure - Goodwill and Intangible Assets, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/GoodwillandIntangibleAssetsNetTables</Role>
      <ShortName>Goodwill and Intangible Assets, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.idexx.com/role/GoodwillandIntangibleAssetsNet</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>230573008 - Disclosure - Accrued Liabilities and Other Long Term Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/AccruedLiabilitiesandOtherLongTermLiabilitiesTables</Role>
      <ShortName>Accrued Liabilities and Other Long Term Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.idexx.com/role/AccruedLiabilitiesandOtherLongTermLiabilities</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>230613009 - Disclosure - Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/DebtTables</Role>
      <ShortName>Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.idexx.com/role/Debt</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>230663010 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.idexx.com/role/IncomeTaxes</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>230753011 - Disclosure - Earnings Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/EarningsPerShareTables</Role>
      <ShortName>Earnings Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.idexx.com/role/EarningsPerShare</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>230813012 - Disclosure - Segment Reporting (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/SegmentReportingTables</Role>
      <ShortName>Segment Reporting (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.idexx.com/role/SegmentReporting</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>230863013 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.idexx.com/role/FairValueMeasurements</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>230913014 - Disclosure - Hedging Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/HedgingInstrumentsTables</Role>
      <ShortName>Hedging Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.idexx.com/role/HedgingInstruments</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>230963015 - Disclosure - Repurchases of Common Stock (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/RepurchasesofCommonStockTables</Role>
      <ShortName>Repurchases of Common Stock (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.idexx.com/role/RepurchasesofCommonStock</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>230993016 - Disclosure - Accumulated Other Comprehensive Income (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/AccumulatedOtherComprehensiveIncomeTables</Role>
      <ShortName>Accumulated Other Comprehensive Income (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.idexx.com/role/AccumulatedOtherComprehensiveIncome</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>240044001 - Disclosure - Summary of Significant Accounting Policies (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Summary of Significant Accounting Policies (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/SummaryofSignificantAccountingPoliciesPolicies</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>240074002 - Disclosure - Revenue Recognition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/RevenueRecognitionDetails</Role>
      <ShortName>Revenue Recognition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/RevenueRecognitionTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>240084003 - Disclosure - Revenue Recognition (Lease Revenue) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/RevenueRecognitionLeaseRevenueDetails</Role>
      <ShortName>Revenue Recognition (Lease Revenue) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/RevenueRecognitionTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>240094004 - Disclosure - Revenue Recognition (Extended Warranties and Post-Contract Support) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/RevenueRecognitionExtendedWarrantiesandPostContractSupportDetails</Role>
      <ShortName>Revenue Recognition (Extended Warranties and Post-Contract Support) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/RevenueRecognitionTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>240104005 - Disclosure - Revenue Recognition (Remaining Performance Obligation) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/RevenueRecognitionRemainingPerformanceObligationDetails</Role>
      <ShortName>Revenue Recognition (Remaining Performance Obligation) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/RevenueRecognitionTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>240114006 - Disclosure - Revenue Recognition (SaaS Subscriptions) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/RevenueRecognitionSaaSSubscriptionsDetails</Role>
      <ShortName>Revenue Recognition (SaaS Subscriptions) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/RevenueRecognitionTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>240124007 - Disclosure - Revenue Recognition (Up-Front Customer Loyalty Programs) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/RevenueRecognitionUpFrontCustomerLoyaltyProgramsDetails</Role>
      <ShortName>Revenue Recognition (Up-Front Customer Loyalty Programs) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/RevenueRecognitionTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>240134008 - Disclosure - Revenue Recognition (Volume Commitment Programs) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/RevenueRecognitionVolumeCommitmentProgramsDetails</Role>
      <ShortName>Revenue Recognition (Volume Commitment Programs) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/RevenueRecognitionTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>240144009 - Disclosure - Revenue Recognition (Instrument Rebate Programs) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/RevenueRecognitionInstrumentRebateProgramsDetails</Role>
      <ShortName>Revenue Recognition (Instrument Rebate Programs) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/RevenueRecognitionTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>240154010 - Disclosure - Revenue Recognition (Reagent Rental Programs) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/RevenueRecognitionReagentRentalProgramsDetails</Role>
      <ShortName>Revenue Recognition (Reagent Rental Programs) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/RevenueRecognitionTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>240164011 - Disclosure - Revenue Recognition (Disaggregation of Revenue by Major Product and Service Categories) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/RevenueRecognitionDisaggregationofRevenuebyMajorProductandServiceCategoriesDetails</Role>
      <ShortName>Revenue Recognition (Disaggregation of Revenue by Major Product and Service Categories) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/RevenueRecognitionTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>240174012 - Disclosure - Revenue Recognition (Disaggregation of Revenue by Principal Geographic Area, Based on Customers' Domiciles) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/RevenueRecognitionDisaggregationofRevenuebyPrincipalGeographicAreaBasedonCustomersDomicilesDetails</Role>
      <ShortName>Revenue Recognition (Disaggregation of Revenue by Principal Geographic Area, Based on Customers' Domiciles) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/RevenueRecognitionTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>240184013 - Disclosure - Revenue Recognition (Costs to Obtain a Contract) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/RevenueRecognitionCoststoObtainaContractDetails</Role>
      <ShortName>Revenue Recognition (Costs to Obtain a Contract) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/RevenueRecognitionTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>240204014 - Disclosure - Acquisitions and Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/AcquisitionsandInvestmentsDetails</Role>
      <ShortName>Acquisitions and Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/AcquisitionsandInvestments</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>240234015 - Disclosure - Share-Based Compensation (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/ShareBasedCompensationNarrativeDetails</Role>
      <ShortName>Share-Based Compensation (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>240244016 - Disclosure - Share-Based Compensation (Schedule of Selected Financial Impact of Share-Based Compensation) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/ShareBasedCompensationScheduleofSelectedFinancialImpactofShareBasedCompensationDetails</Role>
      <ShortName>Share-Based Compensation (Schedule of Selected Financial Impact of Share-Based Compensation) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>240254017 - Disclosure - Share-Based Compensation (Schedule of Weighted Averages of the Assumptions Used In Estimating the Fair Value of Stock Option Awards) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/ShareBasedCompensationScheduleofWeightedAveragesoftheAssumptionsUsedInEstimatingtheFairValueofStockOptionAwardsDetails</Role>
      <ShortName>Share-Based Compensation (Schedule of Weighted Averages of the Assumptions Used In Estimating the Fair Value of Stock Option Awards) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>240264018 - Disclosure - Share-Based Compensation (Schedule of Stock Option Activity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails</Role>
      <ShortName>Share-Based Compensation (Schedule of Stock Option Activity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>240274019 - Disclosure - Share-Based Compensation (Schedule Of Restricted Stock Unit Activity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/ShareBasedCompensationScheduleOfRestrictedStockUnitActivityDetails</Role>
      <ShortName>Share-Based Compensation (Schedule Of Restricted Stock Unit Activity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>240294020 - Disclosure - Credit Losses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/CreditLossesDetails</Role>
      <ShortName>Credit Losses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/CreditLosses</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>240324021 - Disclosure - Inventories (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/InventoriesNarrativeDetails</Role>
      <ShortName>Inventories (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/InventoriesTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>240334022 - Disclosure - Inventories (Schedule of Components of Inventories) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/InventoriesScheduleofComponentsofInventoriesDetails</Role>
      <ShortName>Inventories (Schedule of Components of Inventories) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/InventoriesTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>240364023 - Disclosure - Leases (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/LeasesTables</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>240374024 - Disclosure - Leases (Maturities of Operating Lease Liabilities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails</Role>
      <ShortName>Leases (Maturities of Operating Lease Liabilities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/LeasesTables</ParentRole>
      <Position>74</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>240384025 - Disclosure - Leases (Supplemental Cash Flow Information) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/LeasesSupplementalCashFlowInformationDetails</Role>
      <ShortName>Leases (Supplemental Cash Flow Information) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/LeasesTables</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>240414026 - Disclosure - Property and Equipment, Net (Schedule of Estimated Useful Lives) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/PropertyandEquipmentNetScheduleofEstimatedUsefulLivesDetails</Role>
      <ShortName>Property and Equipment, Net (Schedule of Estimated Useful Lives) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/PropertyandEquipmentNetTables</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>240424027 - Disclosure - Property and Equipment, Net (Schedule of Property and Equipment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails</Role>
      <ShortName>Property and Equipment, Net (Schedule of Property and Equipment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/PropertyandEquipmentNetTables</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>240434028 - Disclosure - Property and Equipment, Net (Summary Of Depreciation And Amortization, Capitalized Computer Software For Internal Use And Unpaid Property Equipment Reflected In Account Payable And Accrued Expenses) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/PropertyandEquipmentNetSummaryOfDepreciationAndAmortizationCapitalizedComputerSoftwareForInternalUseAndUnpaidPropertyEquipmentReflectedInAccountPayableAndAccruedExpensesDetails</Role>
      <ShortName>Property and Equipment, Net (Summary Of Depreciation And Amortization, Capitalized Computer Software For Internal Use And Unpaid Property Equipment Reflected In Account Payable And Accrued Expenses) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/PropertyandEquipmentNetTables</ParentRole>
      <Position>78</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>240444029 - Disclosure - Property and Equipment, Net (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/PropertyandEquipmentNetNarrativeDetails</Role>
      <ShortName>Property and Equipment, Net (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/PropertyandEquipmentNetTables</ParentRole>
      <Position>79</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>240474030 - Disclosure - Other Current and Long-Term Assets (Schedule of Other Current Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/OtherCurrentandLongTermAssetsScheduleofOtherCurrentAssetsDetails</Role>
      <ShortName>Other Current and Long-Term Assets (Schedule of Other Current Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/OtherCurrentandLongTermAssetsTables</ParentRole>
      <Position>80</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>240484031 - Disclosure - Other Current and Long-Term Assets (Schedule of Other Noncurrent Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/OtherCurrentandLongTermAssetsScheduleofOtherNoncurrentAssetsDetails</Role>
      <ShortName>Other Current and Long-Term Assets (Schedule of Other Noncurrent Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/OtherCurrentandLongTermAssetsTables</ParentRole>
      <Position>81</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>240514032 - Disclosure - Goodwill and Intangible Assets, Net (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails</Role>
      <ShortName>Goodwill and Intangible Assets, Net (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/GoodwillandIntangibleAssetsNetTables</ParentRole>
      <Position>82</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>240524033 - Disclosure - Goodwill and Intangible Assets, Net (Schedule of Goodwill) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails</Role>
      <ShortName>Goodwill and Intangible Assets, Net (Schedule of Goodwill) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/GoodwillandIntangibleAssetsNetTables</ParentRole>
      <Position>83</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>240534034 - Disclosure - Goodwill and Intangible Assets, Net (Schedule of Estimated Useful Lives For Intangible Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofEstimatedUsefulLivesForIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Intangible Assets, Net (Schedule of Estimated Useful Lives For Intangible Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/GoodwillandIntangibleAssetsNetTables</ParentRole>
      <Position>84</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>240544035 - Disclosure - Goodwill and Intangible Assets, Net (Schedule of Intangible Assets Other Than Goodwill) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofIntangibleAssetsOtherThanGoodwillDetails</Role>
      <ShortName>Goodwill and Intangible Assets, Net (Schedule of Intangible Assets Other Than Goodwill) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/GoodwillandIntangibleAssetsNetTables</ParentRole>
      <Position>85</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>240554036 - Disclosure - Goodwill and Intangible Assets, Net (Schedule of Expected Amortization Expense) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofExpectedAmortizationExpenseDetails</Role>
      <ShortName>Goodwill and Intangible Assets, Net (Schedule of Expected Amortization Expense) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/GoodwillandIntangibleAssetsNetTables</ParentRole>
      <Position>86</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>240584037 - Disclosure - Accrued Liabilities and Other Long Term Liabilities (Schedule of Accrued Liabilities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/AccruedLiabilitiesandOtherLongTermLiabilitiesScheduleofAccruedLiabilitiesDetails</Role>
      <ShortName>Accrued Liabilities and Other Long Term Liabilities (Schedule of Accrued Liabilities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/AccruedLiabilitiesandOtherLongTermLiabilitiesTables</ParentRole>
      <Position>87</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>240594038 - Disclosure - Accrued Liabilities and Other Long Term Liabilities (Schedule of Long Term Accrued Liabilities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/AccruedLiabilitiesandOtherLongTermLiabilitiesScheduleofLongTermAccruedLiabilitiesDetails</Role>
      <ShortName>Accrued Liabilities and Other Long Term Liabilities (Schedule of Long Term Accrued Liabilities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/AccruedLiabilitiesandOtherLongTermLiabilitiesTables</ParentRole>
      <Position>88</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>240624039 - Disclosure - Debt (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/DebtNarrativeDetails</Role>
      <ShortName>Debt (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/DebtTables</ParentRole>
      <Position>89</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>240634040 - Disclosure - Debt (Schedule of Senior Note Borrowings) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/DebtScheduleofSeniorNoteBorrowingsDetails</Role>
      <ShortName>Debt (Schedule of Senior Note Borrowings) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/DebtTables</ParentRole>
      <Position>90</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>240644041 - Disclosure - Debt (Schedule of Annual Principal Payments on Long-Term Debt) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/DebtScheduleofAnnualPrincipalPaymentsonLongTermDebtDetails</Role>
      <ShortName>Debt (Schedule of Annual Principal Payments on Long-Term Debt) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/DebtTables</ParentRole>
      <Position>91</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>240674042 - Disclosure - Income Taxes (Schedule of Earnings Before Income Taxes) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/IncomeTaxesScheduleofEarningsBeforeIncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Schedule of Earnings Before Income Taxes) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/IncomeTaxesTables</ParentRole>
      <Position>92</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>240684043 - Disclosure - Income Taxes (Schedule of Components of Provision (Benefit) for Income Taxes) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofProvisionBenefitforIncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Schedule of Components of Provision (Benefit) for Income Taxes) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/IncomeTaxesTables</ParentRole>
      <Position>93</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>240694044 - Disclosure - Income Taxes (Schedule of Effective Income Tax Rate Reconciliation) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails</Role>
      <ShortName>Income Taxes (Schedule of Effective Income Tax Rate Reconciliation) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/IncomeTaxesTables</ParentRole>
      <Position>94</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>240704045 - Disclosure - Income Taxes (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/IncomeTaxesTables</ParentRole>
      <Position>95</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>240714046 - Disclosure - Income Taxes (Schedule of Components of Net Deferred Tax Assets and Liabilities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofNetDeferredTaxAssetsandLiabilitiesDetails</Role>
      <ShortName>Income Taxes (Schedule of Components of Net Deferred Tax Assets and Liabilities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/IncomeTaxesTables</ParentRole>
      <Position>96</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>240724047 - Disclosure - Income Taxes (Schedule of Valuation Allowance For Deferred Tax Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/IncomeTaxesScheduleofValuationAllowanceForDeferredTaxAssetsDetails</Role>
      <ShortName>Income Taxes (Schedule of Valuation Allowance For Deferred Tax Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/IncomeTaxesTables</ParentRole>
      <Position>97</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>240734048 - Disclosure - Income Taxes (Schedule of Changes in Unrecognized Tax Benefits) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/IncomeTaxesScheduleofChangesinUnrecognizedTaxBenefitsDetails</Role>
      <ShortName>Income Taxes (Schedule of Changes in Unrecognized Tax Benefits) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/IncomeTaxesTables</ParentRole>
      <Position>98</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>240764049 - Disclosure - Earnings Per Share (Reconciliation of Shares Outstanding) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/EarningsPerShareReconciliationofSharesOutstandingDetails</Role>
      <ShortName>Earnings Per Share (Reconciliation of Shares Outstanding) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/EarningsPerShareTables</ParentRole>
      <Position>99</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>240774050 - Disclosure - Earnings Per Share (Schedule of Number of Anti-Dilutive Stock Options) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/EarningsPerShareScheduleofNumberofAntiDilutiveStockOptionsDetails</Role>
      <ShortName>Earnings Per Share (Schedule of Number of Anti-Dilutive Stock Options) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/EarningsPerShareTables</ParentRole>
      <Position>100</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>240794051 - Disclosure - Commitments, Contingencies and Guarantees (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/CommitmentsContingenciesandGuaranteesNarrativeDetails</Role>
      <ShortName>Commitments, Contingencies and Guarantees (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/CommitmentsContingenciesandGuarantees</ParentRole>
      <Position>101</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>240824052 - Disclosure - Segment Reporting (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/SegmentReportingNarrativeDetails</Role>
      <ShortName>Segment Reporting (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/SegmentReportingTables</ParentRole>
      <Position>102</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>240834053 - Disclosure - Segment Reporting (Summary of Segment Performance) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/SegmentReportingSummaryofSegmentPerformanceDetails</Role>
      <ShortName>Segment Reporting (Summary of Segment Performance) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/SegmentReportingTables</ParentRole>
      <Position>103</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R104.htm</HtmlFileName>
      <LongName>240844054 - Disclosure - Segment Reporting (Schedule of Net Long-Lived Assets by Principal Geographic Areas) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/SegmentReportingScheduleofNetLongLivedAssetsbyPrincipalGeographicAreasDetails</Role>
      <ShortName>Segment Reporting (Schedule of Net Long-Lived Assets by Principal Geographic Areas) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/SegmentReportingTables</ParentRole>
      <Position>104</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R105.htm</HtmlFileName>
      <LongName>240874055 - Disclosure - Fair Value Measurements (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/FairValueMeasurementsNarrativeDetails</Role>
      <ShortName>Fair Value Measurements (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>105</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R106.htm</HtmlFileName>
      <LongName>240884056 - Disclosure - Fair Value Measurements (Schedule of Fair Value of Assets and Liabilities Measured on Recurring Basis) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/FairValueMeasurementsScheduleofFairValueofAssetsandLiabilitiesMeasuredonRecurringBasisDetails</Role>
      <ShortName>Fair Value Measurements (Schedule of Fair Value of Assets and Liabilities Measured on Recurring Basis) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>106</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R107.htm</HtmlFileName>
      <LongName>240894057 - Disclosure - Fair Value Measurements (Schedule of Contingent Consideration Liability) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/FairValueMeasurementsScheduleofContingentConsiderationLiabilityDetails</Role>
      <ShortName>Fair Value Measurements (Schedule of Contingent Consideration Liability) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>107</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R108.htm</HtmlFileName>
      <LongName>240924058 - Disclosure - Hedging Instruments (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/HedgingInstrumentsNarrativeDetails</Role>
      <ShortName>Hedging Instruments (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/HedgingInstrumentsTables</ParentRole>
      <Position>108</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R109.htm</HtmlFileName>
      <LongName>240934059 - Disclosure - Hedging Instruments (Derivatives Designated in Cash Flow Hedging Relationships) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/HedgingInstrumentsDerivativesDesignatedinCashFlowHedgingRelationshipsDetails</Role>
      <ShortName>Hedging Instruments (Derivatives Designated in Cash Flow Hedging Relationships) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/HedgingInstrumentsTables</ParentRole>
      <Position>109</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R110.htm</HtmlFileName>
      <LongName>240944060 - Disclosure - Hedging Instruments (Schedule of Fair Values and Balance Sheet Classifications of Derivatives and Non-derivatives Designated as Hedging Instruments) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/HedgingInstrumentsScheduleofFairValuesandBalanceSheetClassificationsofDerivativesandNonderivativesDesignatedasHedgingInstrumentsDetails</Role>
      <ShortName>Hedging Instruments (Schedule of Fair Values and Balance Sheet Classifications of Derivatives and Non-derivatives Designated as Hedging Instruments) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/HedgingInstrumentsTables</ParentRole>
      <Position>110</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R111.htm</HtmlFileName>
      <LongName>240974061 - Disclosure - Repurchases of Common Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/RepurchasesofCommonStockDetails</Role>
      <ShortName>Repurchases of Common Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/RepurchasesofCommonStockTables</ParentRole>
      <Position>111</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R112.htm</HtmlFileName>
      <LongName>241004062 - Disclosure - Accumulated Other Comprehensive Income (Schedule of Accumulated Other Comprehensive Income) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/AccumulatedOtherComprehensiveIncomeScheduleofAccumulatedOtherComprehensiveIncomeDetails</Role>
      <ShortName>Accumulated Other Comprehensive Income (Schedule of Accumulated Other Comprehensive Income) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/AccumulatedOtherComprehensiveIncomeTables</ParentRole>
      <Position>112</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R113.htm</HtmlFileName>
      <LongName>241014063 - Disclosure - Accumulated Other Comprehensive Income (Schedule of Reclassifications out of Accumulated Other Comprehensive Income) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/AccumulatedOtherComprehensiveIncomeScheduleofReclassificationsoutofAccumulatedOtherComprehensiveIncomeDetails</Role>
      <ShortName>Accumulated Other Comprehensive Income (Schedule of Reclassifications out of Accumulated Other Comprehensive Income) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/AccumulatedOtherComprehensiveIncomeTables</ParentRole>
      <Position>113</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R114.htm</HtmlFileName>
      <LongName>241034064 - Disclosure - Preferred Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/PreferredStockDetails</Role>
      <ShortName>Preferred Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/PreferredStock</ParentRole>
      <Position>114</Position>
    </Report>
    <Report instance="idxx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R115.htm</HtmlFileName>
      <LongName>241054065 - Disclosure - IDEXX Retirement and Incentive Savings Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.idexx.com/role/IDEXXRetirementandIncentiveSavingsPlanDetails</Role>
      <ShortName>IDEXX Retirement and Incentive Savings Plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.idexx.com/role/IDEXXRetirementandIncentiveSavingsPlan</ParentRole>
      <Position>115</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="idxx-20211231.htm">idxx-20211231.htm</File>
    <File>a1019idexxortholetterdated.htm</File>
    <File>a1034employeestockoptionaw.htm</File>
    <File>a1041employeersuawardagree.htm</File>
    <File>a1042high-performerrsuagre.htm</File>
    <File>a1043jmazelskyrsuawardagre.htm</File>
    <File>a1044jmazelskystockoptiona.htm</File>
    <File>ex1028idexx-directoroption.htm</File>
    <File>ex1029idexx-directorrsuagr.htm</File>
    <File>exhibit101-orthoagreement.htm</File>
    <File>exhibit1010-orthorowagreem.htm</File>
    <File>exhibit1011-orthorowagreem.htm</File>
    <File>exhibit1013-orthorowagreem.htm</File>
    <File>exhibit1014-orthorowagreem.htm</File>
    <File>exhibit1016-orthorowagreem.htm</File>
    <File>exhibit102-orthousagreemen.htm</File>
    <File>exhibit105-orthousagreemen.htm</File>
    <File>exhibit106-orthousagreemen.htm</File>
    <File>exhibit109-orthousagreemen.htm</File>
    <File>exhibit21-subsidiariesofth.htm</File>
    <File>exhibit31111.htm</File>
    <File>exhibit31211.htm</File>
    <File>exhibit32111.htm</File>
    <File>exhibit32211.htm</File>
    <File>idexx-10_22amendeddirector.htm</File>
    <File>idexxfy21consent.htm</File>
    <File>idxx-20211231.xsd</File>
    <File>idxx-20211231_cal.xml</File>
    <File>idxx-20211231_def.xml</File>
    <File>idxx-20211231_lab.xml</File>
    <File>idxx-20211231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>idxx-20211231_g1.jpg</File>
    <File>idxx-20211231_g2.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1536">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="37">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>231
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "idxx-20211231.htm": {
   "axisCustom": 2,
   "axisStandard": 28,
   "contextCount": 527,
   "dts": {
    "calculationLink": {
     "local": [
      "idxx-20211231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "idxx-20211231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "idxx-20211231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "idxx-20211231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "idxx-20211231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "idxx-20211231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 828,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 22,
    "http://www.idexx.com/20211231": 2,
    "http://xbrl.sec.gov/dei/2021q4": 5,
    "total": 29
   },
   "keyCustom": 46,
   "keyStandard": 563,
   "memberCustom": 67,
   "memberStandard": 69,
   "nsprefix": "idxx",
   "nsuri": "http://www.idexx.com/20211231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000010001 - Document - Cover Page",
     "role": "http://www.idexx.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100080010 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AssetImpairmentCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R100": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240774050 - Disclosure - Earnings Per Share (Schedule of Number of Anti-Dilutive Stock Options) (Details)",
     "role": "http://www.idexx.com/role/EarningsPerShareScheduleofNumberofAntiDilutiveStockOptionsDetails",
     "shortName": "Earnings Per Share (Schedule of Number of Anti-Dilutive Stock Options) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R101": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i257dea584c2540acb77224b3a70b171d_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PurchaseObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240794051 - Disclosure - Commitments, Contingencies and Guarantees (Narrative) (Details)",
     "role": "http://www.idexx.com/role/CommitmentsContingenciesandGuaranteesNarrativeDetails",
     "shortName": "Commitments, Contingencies and Guarantees (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i257dea584c2540acb77224b3a70b171d_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PurchaseObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R102": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240824052 - Disclosure - Segment Reporting (Narrative) (Details)",
     "role": "http://www.idexx.com/role/SegmentReportingNarrativeDetails",
     "shortName": "Segment Reporting (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R103": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240834053 - Disclosure - Segment Reporting (Summary of Segment Performance) (Details)",
     "role": "http://www.idexx.com/role/SegmentReportingSummaryofSegmentPerformanceDetails",
     "shortName": "Segment Reporting (Summary of Segment Performance) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:InterestIncomeExpenseNonoperatingNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R104": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i257dea584c2540acb77224b3a70b171d_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240844054 - Disclosure - Segment Reporting (Schedule of Net Long-Lived Assets by Principal Geographic Areas) (Details)",
     "role": "http://www.idexx.com/role/SegmentReportingScheduleofNetLongLivedAssetsbyPrincipalGeographicAreasDetails",
     "shortName": "Segment Reporting (Schedule of Net Long-Lived Assets by Principal Geographic Areas) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i0a98d26251bb48daa1b953041bbb17e4_I20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R105": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i257dea584c2540acb77224b3a70b171d_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtFairValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240874055 - Disclosure - Fair Value Measurements (Narrative) (Details)",
     "role": "http://www.idexx.com/role/FairValueMeasurementsNarrativeDetails",
     "shortName": "Fair Value Measurements (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i5bc10811c8b443b6ae93662c965b99e4_I20201231",
      "decimals": "-8",
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R106": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i206dbd1506c344a7b46d2edcee18de52_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240884056 - Disclosure - Fair Value Measurements (Schedule of Fair Value of Assets and Liabilities Measured on Recurring Basis) (Details)",
     "role": "http://www.idexx.com/role/FairValueMeasurementsScheduleofFairValueofAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
     "shortName": "Fair Value Measurements (Schedule of Fair Value of Assets and Liabilities Measured on Recurring Basis) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i206dbd1506c344a7b46d2edcee18de52_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R107": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i5bc10811c8b443b6ae93662c965b99e4_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240894057 - Disclosure - Fair Value Measurements (Schedule of Contingent Consideration Liability) (Details)",
     "role": "http://www.idexx.com/role/FairValueMeasurementsScheduleofContingentConsiderationLiabilityDetails",
     "shortName": "Fair Value Measurements (Schedule of Contingent Consideration Liability) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i5bc10811c8b443b6ae93662c965b99e4_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R108": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240924058 - Disclosure - Hedging Instruments (Narrative) (Details)",
     "role": "http://www.idexx.com/role/HedgingInstrumentsNarrativeDetails",
     "shortName": "Hedging Instruments (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R109": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CostOfRevenue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240934059 - Disclosure - Hedging Instruments (Derivatives Designated in Cash Flow Hedging Relationships) (Details)",
     "role": "http://www.idexx.com/role/HedgingInstrumentsDerivativesDesignatedinCashFlowHedgingRelationshipsDetails",
     "shortName": "Hedging Instruments (Derivatives Designated in Cash Flow Hedging Relationships) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "ia1ef4a96731942908ce11fe9891aa0bf_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210011001 - Disclosure - Nature of Business, Basis of Presentation and Principles of Consolidation",
     "role": "http://www.idexx.com/role/NatureofBusinessBasisofPresentationandPrinciplesofConsolidation",
     "shortName": "Nature of Business, Basis of Presentation and Principles of Consolidation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R110": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "ie4698c4affbf4e699d54f34e5350d605_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240944060 - Disclosure - Hedging Instruments (Schedule of Fair Values and Balance Sheet Classifications of Derivatives and Non-derivatives Designated as Hedging Instruments) (Details)",
     "role": "http://www.idexx.com/role/HedgingInstrumentsScheduleofFairValuesandBalanceSheetClassificationsofDerivativesandNonderivativesDesignatedasHedgingInstrumentsDetails",
     "shortName": "Hedging Instruments (Schedule of Fair Values and Balance Sheet Classifications of Derivatives and Non-derivatives Designated as Hedging Instruments) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "ie4698c4affbf4e699d54f34e5350d605_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R111": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i257dea584c2540acb77224b3a70b171d_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240974061 - Disclosure - Repurchases of Common Stock (Details)",
     "role": "http://www.idexx.com/role/RepurchasesofCommonStockDetails",
     "shortName": "Repurchases of Common Stock (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i257dea584c2540acb77224b3a70b171d_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R112": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i5bc10811c8b443b6ae93662c965b99e4_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241004062 - Disclosure - Accumulated Other Comprehensive Income (Schedule of Accumulated Other Comprehensive Income) (Details)",
     "role": "http://www.idexx.com/role/AccumulatedOtherComprehensiveIncomeScheduleofAccumulatedOtherComprehensiveIncomeDetails",
     "shortName": "Accumulated Other Comprehensive Income (Schedule of Accumulated Other Comprehensive Income) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R113": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CostOfRevenue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241014063 - Disclosure - Accumulated Other Comprehensive Income (Schedule of Reclassifications out of Accumulated Other Comprehensive Income) (Details)",
     "role": "http://www.idexx.com/role/AccumulatedOtherComprehensiveIncomeScheduleofReclassificationsoutofAccumulatedOtherComprehensiveIncomeDetails",
     "shortName": "Accumulated Other Comprehensive Income (Schedule of Reclassifications out of Accumulated Other Comprehensive Income) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "ie311c88fa22749e2b4cf06d52ec95566_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostOfRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R114": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i257dea584c2540acb77224b3a70b171d_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241034064 - Disclosure - Preferred Stock (Details)",
     "role": "http://www.idexx.com/role/PreferredStockDetails",
     "shortName": "Preferred Stock (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i257dea584c2540acb77224b3a70b171d_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R115": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "id7c4b2e2ed354c54b264719bdf6db254_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241054065 - Disclosure - IDEXX Retirement and Incentive Savings Plan (Details)",
     "role": "http://www.idexx.com/role/IDEXXRetirementandIncentiveSavingsPlanDetails",
     "shortName": "IDEXX Retirement and Incentive Savings Plan (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "id7c4b2e2ed354c54b264719bdf6db254_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210021002 - Disclosure - Summary of Significant Accounting Policies",
     "role": "http://www.idexx.com/role/SummaryofSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210051003 - Disclosure - Revenue Recognition",
     "role": "http://www.idexx.com/role/RevenueRecognition",
     "shortName": "Revenue Recognition",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210191004 - Disclosure - Acquisitions and Investments",
     "role": "http://www.idexx.com/role/AcquisitionsandInvestments",
     "shortName": "Acquisitions and Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210211005 - Disclosure - Share-Based Compensation",
     "role": "http://www.idexx.com/role/ShareBasedCompensation",
     "shortName": "Share-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CreditLossFinancialInstrumentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210281006 - Disclosure - Credit Losses",
     "role": "http://www.idexx.com/role/CreditLosses",
     "shortName": "Credit Losses",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CreditLossFinancialInstrumentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210301007 - Disclosure - Inventories",
     "role": "http://www.idexx.com/role/Inventories",
     "shortName": "Inventories",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210341008 - Disclosure - Leases",
     "role": "http://www.idexx.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210391009 - Disclosure - Property and Equipment, Net",
     "role": "http://www.idexx.com/role/PropertyandEquipmentNet",
     "shortName": "Property and Equipment, Net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "false",
     "longName": "000020002 - Document - Audit Information",
     "role": "http://www.idexx.com/role/AuditInformation",
     "shortName": "Audit Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210451010 - Disclosure - Other Current and Long-Term Assets",
     "role": "http://www.idexx.com/role/OtherCurrentandLongTermAssets",
     "shortName": "Other Current and Long-Term Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210491011 - Disclosure - Goodwill and Intangible Assets, Net",
     "role": "http://www.idexx.com/role/GoodwillandIntangibleAssetsNet",
     "shortName": "Goodwill and Intangible Assets, Net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210561012 - Disclosure - Accrued Liabilities and Other Long Term Liabilities",
     "role": "http://www.idexx.com/role/AccruedLiabilitiesandOtherLongTermLiabilities",
     "shortName": "Accrued Liabilities and Other Long Term Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210601013 - Disclosure - Debt",
     "role": "http://www.idexx.com/role/Debt",
     "shortName": "Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210651014 - Disclosure - Income Taxes",
     "role": "http://www.idexx.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210741015 - Disclosure - Earnings Per Share",
     "role": "http://www.idexx.com/role/EarningsPerShare",
     "shortName": "Earnings Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsContingenciesAndGuaranteesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210781016 - Disclosure - Commitments, Contingencies and Guarantees",
     "role": "http://www.idexx.com/role/CommitmentsContingenciesandGuarantees",
     "shortName": "Commitments, Contingencies and Guarantees",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsContingenciesAndGuaranteesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210801017 - Disclosure - Segment Reporting",
     "role": "http://www.idexx.com/role/SegmentReporting",
     "shortName": "Segment Reporting",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210851018 - Disclosure - Fair Value Measurements",
     "role": "http://www.idexx.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210901019 - Disclosure - Hedging Instruments",
     "role": "http://www.idexx.com/role/HedgingInstruments",
     "shortName": "Hedging Instruments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i257dea584c2540acb77224b3a70b171d_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100010003 - Statement - CONSOLIDATED BALANCE SHEETS",
     "role": "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i257dea584c2540acb77224b3a70b171d_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210951020 - Disclosure - Repurchases of Common Stock",
     "role": "http://www.idexx.com/role/RepurchasesofCommonStock",
     "shortName": "Repurchases of Common Stock",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210981021 - Disclosure - Accumulated Other Comprehensive Income",
     "role": "http://www.idexx.com/role/AccumulatedOtherComprehensiveIncome",
     "shortName": "Accumulated Other Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "211021022 - Disclosure - Preferred Stock",
     "role": "http://www.idexx.com/role/PreferredStock",
     "shortName": "Preferred Stock",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "211041023 - Disclosure - IDEXX Retirement and Incentive Savings Plan",
     "role": "http://www.idexx.com/role/IDEXXRetirementandIncentiveSavingsPlan",
     "shortName": "IDEXX Retirement and Incentive Savings Plan",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UseOfEstimates",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "220032001 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "role": "http://www.idexx.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UseOfEstimates",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230063001 - Disclosure - Revenue Recognition (Tables)",
     "role": "http://www.idexx.com/role/RevenueRecognitionTables",
     "shortName": "Revenue Recognition (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230223002 - Disclosure - Share-Based Compensation (Tables)",
     "role": "http://www.idexx.com/role/ShareBasedCompensationTables",
     "shortName": "Share-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230313003 - Disclosure - Inventories (Tables)",
     "role": "http://www.idexx.com/role/InventoriesTables",
     "shortName": "Inventories (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230353004 - Disclosure - Leases (Tables)",
     "role": "http://www.idexx.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "idxx:ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230403005 - Disclosure - Property and Equipment, Net (Tables)",
     "role": "http://www.idexx.com/role/PropertyandEquipmentNetTables",
     "shortName": "Property and Equipment, Net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "idxx:ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i257dea584c2540acb77224b3a70b171d_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100020004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i257dea584c2540acb77224b3a70b171d_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230463006 - Disclosure - Other Current and Long-Term Assets (Tables)",
     "role": "http://www.idexx.com/role/OtherCurrentandLongTermAssetsTables",
     "shortName": "Other Current and Long-Term Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230503007 - Disclosure - Goodwill and Intangible Assets, Net (Tables)",
     "role": "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetTables",
     "shortName": "Goodwill and Intangible Assets, Net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230573008 - Disclosure - Accrued Liabilities and Other Long Term Liabilities (Tables)",
     "role": "http://www.idexx.com/role/AccruedLiabilitiesandOtherLongTermLiabilitiesTables",
     "shortName": "Accrued Liabilities and Other Long Term Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230613009 - Disclosure - Debt (Tables)",
     "role": "http://www.idexx.com/role/DebtTables",
     "shortName": "Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230663010 - Disclosure - Income Taxes (Tables)",
     "role": "http://www.idexx.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230753011 - Disclosure - Earnings Per Share (Tables)",
     "role": "http://www.idexx.com/role/EarningsPerShareTables",
     "shortName": "Earnings Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230813012 - Disclosure - Segment Reporting (Tables)",
     "role": "http://www.idexx.com/role/SegmentReportingTables",
     "shortName": "Segment Reporting (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230863013 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://www.idexx.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230913014 - Disclosure - Hedging Instruments (Tables)",
     "role": "http://www.idexx.com/role/HedgingInstrumentsTables",
     "shortName": "Hedging Instruments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230963015 - Disclosure - Repurchases of Common Stock (Tables)",
     "role": "http://www.idexx.com/role/RepurchasesofCommonStockTables",
     "shortName": "Repurchases of Common Stock (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100030005 - Statement - CONSOLIDATED STATEMENTS OF INCOME",
     "role": "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
     "shortName": "CONSOLIDATED STATEMENTS OF INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:GrossProfit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230993016 - Disclosure - Accumulated Other Comprehensive Income (Tables)",
     "role": "http://www.idexx.com/role/AccumulatedOtherComprehensiveIncomeTables",
     "shortName": "Accumulated Other Comprehensive Income (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i257dea584c2540acb77224b3a70b171d_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240044001 - Disclosure - Summary of Significant Accounting Policies (Narrative) (Details)",
     "role": "http://www.idexx.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Summary of Significant Accounting Policies (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i257dea584c2540acb77224b3a70b171d_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i464c41d2cb9948979da5af09e9a6709b_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "idxx:RevenuePerformanceObligationPaymentTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240074002 - Disclosure - Revenue Recognition (Details)",
     "role": "http://www.idexx.com/role/RevenueRecognitionDetails",
     "shortName": "Revenue Recognition (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i464c41d2cb9948979da5af09e9a6709b_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "idxx:RevenuePerformanceObligationPaymentTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240084003 - Disclosure - Revenue Recognition (Lease Revenue) (Details)",
     "role": "http://www.idexx.com/role/RevenueRecognitionLeaseRevenueDetails",
     "shortName": "Revenue Recognition (Lease Revenue) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "if381570659954770b2820ee07047c157_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "idxx:PostContractSupportContractTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240094004 - Disclosure - Revenue Recognition (Extended Warranties and Post-Contract Support) (Details)",
     "role": "http://www.idexx.com/role/RevenueRecognitionExtendedWarrantiesandPostContractSupportDetails",
     "shortName": "Revenue Recognition (Extended Warranties and Post-Contract Support) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "if381570659954770b2820ee07047c157_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "idxx:PostContractSupportContractTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "ia8d9c432d3bf4b74adffb2d189372886_I20211231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligationPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240104005 - Disclosure - Revenue Recognition (Remaining Performance Obligation) (Details)",
     "role": "http://www.idexx.com/role/RevenueRecognitionRemainingPerformanceObligationDetails",
     "shortName": "Revenue Recognition (Remaining Performance Obligation) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "ia8d9c432d3bf4b74adffb2d189372886_I20211231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligationPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i2547ad5bc951453f98e34b5d0f26b8bb_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "idxx:SaasSubscriptionTermOfContract",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240114006 - Disclosure - Revenue Recognition (SaaS Subscriptions) (Details)",
     "role": "http://www.idexx.com/role/RevenueRecognitionSaaSSubscriptionsDetails",
     "shortName": "Revenue Recognition (SaaS Subscriptions) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i2547ad5bc951453f98e34b5d0f26b8bb_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "idxx:SaasSubscriptionTermOfContract",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "ib7205413c9894bd7a9838d72705913eb_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CapitalizedContractCostGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240124007 - Disclosure - Revenue Recognition (Up-Front Customer Loyalty Programs) (Details)",
     "role": "http://www.idexx.com/role/RevenueRecognitionUpFrontCustomerLoyaltyProgramsDetails",
     "shortName": "Revenue Recognition (Up-Front Customer Loyalty Programs) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "ib7205413c9894bd7a9838d72705913eb_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CapitalizedContractCostGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i09befd933773486bbae96a48cee3829b_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240134008 - Disclosure - Revenue Recognition (Volume Commitment Programs) (Details)",
     "role": "http://www.idexx.com/role/RevenueRecognitionVolumeCommitmentProgramsDetails",
     "shortName": "Revenue Recognition (Volume Commitment Programs) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i09befd933773486bbae96a48cee3829b_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "id886e662c2af48208ad13c5d0017a93e_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240144009 - Disclosure - Revenue Recognition (Instrument Rebate Programs) (Details)",
     "role": "http://www.idexx.com/role/RevenueRecognitionInstrumentRebateProgramsDetails",
     "shortName": "Revenue Recognition (Instrument Rebate Programs) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "id886e662c2af48208ad13c5d0017a93e_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100040006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "role": "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i257dea584c2540acb77224b3a70b171d_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SalesTypeLeaseLeaseReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240154010 - Disclosure - Revenue Recognition (Reagent Rental Programs) (Details)",
     "role": "http://www.idexx.com/role/RevenueRecognitionReagentRentalProgramsDetails",
     "shortName": "Revenue Recognition (Reagent Rental Programs) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i257dea584c2540acb77224b3a70b171d_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SalesTypeLeaseLeaseReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240164011 - Disclosure - Revenue Recognition (Disaggregation of Revenue by Major Product and Service Categories) (Details)",
     "role": "http://www.idexx.com/role/RevenueRecognitionDisaggregationofRevenuebyMajorProductandServiceCategoriesDetails",
     "shortName": "Revenue Recognition (Disaggregation of Revenue by Major Product and Service Categories) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i723287d015984ccaa532d58c82848761_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240174012 - Disclosure - Revenue Recognition (Disaggregation of Revenue by Principal Geographic Area, Based on Customers' Domiciles) (Details)",
     "role": "http://www.idexx.com/role/RevenueRecognitionDisaggregationofRevenuebyPrincipalGeographicAreaBasedonCustomersDomicilesDetails",
     "shortName": "Revenue Recognition (Disaggregation of Revenue by Principal Geographic Area, Based on Customers' Domiciles) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i76f3ab4debf64563bc6a167ac410e9c3_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i257dea584c2540acb77224b3a70b171d_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CapitalizedContractCostNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240184013 - Disclosure - Revenue Recognition (Costs to Obtain a Contract) (Details)",
     "role": "http://www.idexx.com/role/RevenueRecognitionCoststoObtainaContractDetails",
     "shortName": "Revenue Recognition (Costs to Obtain a Contract) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i257dea584c2540acb77224b3a70b171d_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CapitalizedContractCostNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i257dea584c2540acb77224b3a70b171d_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240204014 - Disclosure - Acquisitions and Investments (Details)",
     "role": "http://www.idexx.com/role/AcquisitionsandInvestmentsDetails",
     "shortName": "Acquisitions and Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "ifd0bd4a0a64d4c9fa9955ab39bcd5b33_D20211001-20211231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "idxx:NoncontrollingInterestOwnershipPercentageAcquiredFromNoncontrollingOwners",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240234015 - Disclosure - Share-Based Compensation (Narrative) (Details)",
     "role": "http://www.idexx.com/role/ShareBasedCompensationNarrativeDetails",
     "shortName": "Share-Based Compensation (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i257dea584c2540acb77224b3a70b171d_I20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240244016 - Disclosure - Share-Based Compensation (Schedule of Selected Financial Impact of Share-Based Compensation) (Details)",
     "role": "http://www.idexx.com/role/ShareBasedCompensationScheduleofSelectedFinancialImpactofShareBasedCompensationDetails",
     "shortName": "Share-Based Compensation (Schedule of Selected Financial Impact of Share-Based Compensation) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "idxx:AllocatedShareBasedCompensationExpenseNetOfTaxExcludingTaxBenefitFromSettlementOfShareBasedAwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i257dea584c2540acb77224b3a70b171d_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240254017 - Disclosure - Share-Based Compensation (Schedule of Weighted Averages of the Assumptions Used In Estimating the Fair Value of Stock Option Awards) (Details)",
     "role": "http://www.idexx.com/role/ShareBasedCompensationScheduleofWeightedAveragesoftheAssumptionsUsedInEstimatingtheFairValueofStockOptionAwardsDetails",
     "shortName": "Share-Based Compensation (Schedule of Weighted Averages of the Assumptions Used In Estimating the Fair Value of Stock Option Awards) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i257dea584c2540acb77224b3a70b171d_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i5bc10811c8b443b6ae93662c965b99e4_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240264018 - Disclosure - Share-Based Compensation (Schedule of Stock Option Activity) (Details)",
     "role": "http://www.idexx.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails",
     "shortName": "Share-Based Compensation (Schedule of Stock Option Activity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i5bc10811c8b443b6ae93662c965b99e4_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "ibcdf728b3b3f46f08f1609441281d24e_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240274019 - Disclosure - Share-Based Compensation (Schedule Of Restricted Stock Unit Activity) (Details)",
     "role": "http://www.idexx.com/role/ShareBasedCompensationScheduleOfRestrictedStockUnitActivityDetails",
     "shortName": "Share-Based Compensation (Schedule Of Restricted Stock Unit Activity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "ibcdf728b3b3f46f08f1609441281d24e_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "idxx:OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100050007 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical)",
     "role": "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "idxx:OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i257dea584c2540acb77224b3a70b171d_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240294020 - Disclosure - Credit Losses (Details)",
     "role": "http://www.idexx.com/role/CreditLossesDetails",
     "shortName": "Credit Losses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i257dea584c2540acb77224b3a70b171d_I20211231",
      "decimals": "2",
      "lang": "en-US",
      "name": "idxx:AccountsReceivablePercentNotPastDue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i257dea584c2540acb77224b3a70b171d_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableTradeCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240324021 - Disclosure - Inventories (Narrative) (Details)",
     "role": "http://www.idexx.com/role/InventoriesNarrativeDetails",
     "shortName": "Inventories (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i257dea584c2540acb77224b3a70b171d_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableTradeCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i257dea584c2540acb77224b3a70b171d_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240334022 - Disclosure - Inventories (Schedule of Components of Inventories) (Details)",
     "role": "http://www.idexx.com/role/InventoriesScheduleofComponentsofInventoriesDetails",
     "shortName": "Inventories (Schedule of Components of Inventories) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i257dea584c2540acb77224b3a70b171d_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i257dea584c2540acb77224b3a70b171d_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "idxx:OperatingLeaseLeaseNotyetCommencedExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240364023 - Disclosure - Leases (Narrative) (Details)",
     "role": "http://www.idexx.com/role/LeasesNarrativeDetails",
     "shortName": "Leases (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i257dea584c2540acb77224b3a70b171d_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "idxx:OperatingLeaseLeaseNotyetCommencedExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i257dea584c2540acb77224b3a70b171d_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240374024 - Disclosure - Leases (Maturities of Operating Lease Liabilities) (Details)",
     "role": "http://www.idexx.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails",
     "shortName": "Leases (Maturities of Operating Lease Liabilities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i257dea584c2540acb77224b3a70b171d_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240384025 - Disclosure - Leases (Supplemental Cash Flow Information) (Details)",
     "role": "http://www.idexx.com/role/LeasesSupplementalCashFlowInformationDetails",
     "shortName": "Leases (Supplemental Cash Flow Information) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i358c864968b04228b7d1de65d4356012_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240414026 - Disclosure - Property and Equipment, Net (Schedule of Estimated Useful Lives) (Details)",
     "role": "http://www.idexx.com/role/PropertyandEquipmentNetScheduleofEstimatedUsefulLivesDetails",
     "shortName": "Property and Equipment, Net (Schedule of Estimated Useful Lives) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i358c864968b04228b7d1de65d4356012_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i257dea584c2540acb77224b3a70b171d_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240424027 - Disclosure - Property and Equipment, Net (Schedule of Property and Equipment) (Details)",
     "role": "http://www.idexx.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails",
     "shortName": "Property and Equipment, Net (Schedule of Property and Equipment) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i257dea584c2540acb77224b3a70b171d_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "idxx:SummaryOfDepreciationAndAmortizationCapitalizedComputerSoftwareForInternalUseAndUnpaidPropertyEquipmentReflectedInAccountPayableAndAccruedExpensesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240434028 - Disclosure - Property and Equipment, Net (Summary Of Depreciation And Amortization, Capitalized Computer Software For Internal Use And Unpaid Property Equipment Reflected In Account Payable And Accrued Expenses) (Details)",
     "role": "http://www.idexx.com/role/PropertyandEquipmentNetSummaryOfDepreciationAndAmortizationCapitalizedComputerSoftwareForInternalUseAndUnpaidPropertyEquipmentReflectedInAccountPayableAndAccruedExpensesDetails",
     "shortName": "Property and Equipment, Net (Summary Of Depreciation And Amortization, Capitalized Computer Software For Internal Use And Unpaid Property Equipment Reflected In Account Payable And Accrued Expenses) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "idxx:SummaryOfDepreciationAndAmortizationCapitalizedComputerSoftwareForInternalUseAndUnpaidPropertyEquipmentReflectedInAccountPayableAndAccruedExpensesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TangibleAssetImpairmentCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240444029 - Disclosure - Property and Equipment, Net (Narrative) (Details)",
     "role": "http://www.idexx.com/role/PropertyandEquipmentNetNarrativeDetails",
     "shortName": "Property and Equipment, Net (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TangibleAssetImpairmentCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "ifc55888d777a4d23bc9cfb38c781c1b0_I20181231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100060008 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS\u2019 EQUITY (DEFICIT)",
     "role": "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
     "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS\u2019 EQUITY (DEFICIT)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "ifc55888d777a4d23bc9cfb38c781c1b0_I20181231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i257dea584c2540acb77224b3a70b171d_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredCostsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240474030 - Disclosure - Other Current and Long-Term Assets (Schedule of Other Current Assets) (Details)",
     "role": "http://www.idexx.com/role/OtherCurrentandLongTermAssetsScheduleofOtherCurrentAssetsDetails",
     "shortName": "Other Current and Long-Term Assets (Schedule of Other Current Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i257dea584c2540acb77224b3a70b171d_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredCostsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i257dea584c2540acb77224b3a70b171d_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNetNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240484031 - Disclosure - Other Current and Long-Term Assets (Schedule of Other Noncurrent Assets) (Details)",
     "role": "http://www.idexx.com/role/OtherCurrentandLongTermAssetsScheduleofOtherNoncurrentAssetsDetails",
     "shortName": "Other Current and Long-Term Assets (Schedule of Other Noncurrent Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i257dea584c2540acb77224b3a70b171d_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNetNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240514032 - Disclosure - Goodwill and Intangible Assets, Net (Narrative) (Details)",
     "role": "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails",
     "shortName": "Goodwill and Intangible Assets, Net (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i5bc10811c8b443b6ae93662c965b99e4_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240524033 - Disclosure - Goodwill and Intangible Assets, Net (Schedule of Goodwill) (Details)",
     "role": "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails",
     "shortName": "Goodwill and Intangible Assets, Net (Schedule of Goodwill) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "idxx:ScheduleOfEstimatedUsefulLivesForIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "ib25dbfb85b114a83a3384494c07c9a83_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240534034 - Disclosure - Goodwill and Intangible Assets, Net (Schedule of Estimated Useful Lives For Intangible Assets) (Details)",
     "role": "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofEstimatedUsefulLivesForIntangibleAssetsDetails",
     "shortName": "Goodwill and Intangible Assets, Net (Schedule of Estimated Useful Lives For Intangible Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "idxx:ScheduleOfEstimatedUsefulLivesForIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "ib25dbfb85b114a83a3384494c07c9a83_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i257dea584c2540acb77224b3a70b171d_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240544035 - Disclosure - Goodwill and Intangible Assets, Net (Schedule of Intangible Assets Other Than Goodwill) (Details)",
     "role": "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofIntangibleAssetsOtherThanGoodwillDetails",
     "shortName": "Goodwill and Intangible Assets, Net (Schedule of Intangible Assets Other Than Goodwill) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i257dea584c2540acb77224b3a70b171d_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i257dea584c2540acb77224b3a70b171d_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240554036 - Disclosure - Goodwill and Intangible Assets, Net (Schedule of Expected Amortization Expense) (Details)",
     "role": "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofExpectedAmortizationExpenseDetails",
     "shortName": "Goodwill and Intangible Assets, Net (Schedule of Expected Amortization Expense) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i257dea584c2540acb77224b3a70b171d_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i257dea584c2540acb77224b3a70b171d_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240584037 - Disclosure - Accrued Liabilities and Other Long Term Liabilities (Schedule of Accrued Liabilities) (Details)",
     "role": "http://www.idexx.com/role/AccruedLiabilitiesandOtherLongTermLiabilitiesScheduleofAccruedLiabilitiesDetails",
     "shortName": "Accrued Liabilities and Other Long Term Liabilities (Schedule of Accrued Liabilities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i257dea584c2540acb77224b3a70b171d_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i257dea584c2540acb77224b3a70b171d_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedIncomeTaxesNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240594038 - Disclosure - Accrued Liabilities and Other Long Term Liabilities (Schedule of Long Term Accrued Liabilities) (Details)",
     "role": "http://www.idexx.com/role/AccruedLiabilitiesandOtherLongTermLiabilitiesScheduleofLongTermAccruedLiabilitiesDetails",
     "shortName": "Accrued Liabilities and Other Long Term Liabilities (Schedule of Long Term Accrued Liabilities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i257dea584c2540acb77224b3a70b171d_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedIncomeTaxesNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i257dea584c2540acb77224b3a70b171d_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LinesOfCreditCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240624039 - Disclosure - Debt (Narrative) (Details)",
     "role": "http://www.idexx.com/role/DebtNarrativeDetails",
     "shortName": "Debt (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:InterestPaidNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i257dea584c2540acb77224b3a70b171d_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100070009 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS\u2019 EQUITY (DEFICIT) (Parenthetical)",
     "role": "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical",
     "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS\u2019 EQUITY (DEFICIT) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i0c634b937c58472e84857eacf99e17df_I20191231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i291ef135622f4a9baf284e7cfaad88c9_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240634040 - Disclosure - Debt (Schedule of Senior Note Borrowings) (Details)",
     "role": "http://www.idexx.com/role/DebtScheduleofSeniorNoteBorrowingsDetails",
     "shortName": "Debt (Schedule of Senior Note Borrowings) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i257dea584c2540acb77224b3a70b171d_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240644041 - Disclosure - Debt (Schedule of Annual Principal Payments on Long-Term Debt) (Details)",
     "role": "http://www.idexx.com/role/DebtScheduleofAnnualPrincipalPaymentsonLongTermDebtDetails",
     "shortName": "Debt (Schedule of Annual Principal Payments on Long-Term Debt) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i257dea584c2540acb77224b3a70b171d_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240674042 - Disclosure - Income Taxes (Schedule of Earnings Before Income Taxes) (Details)",
     "role": "http://www.idexx.com/role/IncomeTaxesScheduleofEarningsBeforeIncomeTaxesDetails",
     "shortName": "Income Taxes (Schedule of Earnings Before Income Taxes) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240684043 - Disclosure - Income Taxes (Schedule of Components of Provision (Benefit) for Income Taxes) (Details)",
     "role": "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofProvisionBenefitforIncomeTaxesDetails",
     "shortName": "Income Taxes (Schedule of Components of Provision (Benefit) for Income Taxes) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R94": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240694044 - Disclosure - Income Taxes (Schedule of Effective Income Tax Rate Reconciliation) (Details)",
     "role": "http://www.idexx.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails",
     "shortName": "Income Taxes (Schedule of Effective Income Tax Rate Reconciliation) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R95": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240704045 - Disclosure - Income Taxes (Narrative) (Details)",
     "role": "http://www.idexx.com/role/IncomeTaxesNarrativeDetails",
     "shortName": "Income Taxes (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxesPaidNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R96": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i257dea584c2540acb77224b3a70b171d_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240714046 - Disclosure - Income Taxes (Schedule of Components of Net Deferred Tax Assets and Liabilities) (Details)",
     "role": "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofNetDeferredTaxAssetsandLiabilitiesDetails",
     "shortName": "Income Taxes (Schedule of Components of Net Deferred Tax Assets and Liabilities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i257dea584c2540acb77224b3a70b171d_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R97": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfValuationAllowanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i5bc10811c8b443b6ae93662c965b99e4_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsValuationAllowance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240724047 - Disclosure - Income Taxes (Schedule of Valuation Allowance For Deferred Tax Assets) (Details)",
     "role": "http://www.idexx.com/role/IncomeTaxesScheduleofValuationAllowanceForDeferredTaxAssetsDetails",
     "shortName": "Income Taxes (Schedule of Valuation Allowance For Deferred Tax Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfValuationAllowanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "idxx:DeferredTaxAssetsValuationAllowanceChargesToCostsAndExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R98": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i5bc10811c8b443b6ae93662c965b99e4_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240734048 - Disclosure - Income Taxes (Schedule of Changes in Unrecognized Tax Benefits) (Details)",
     "role": "http://www.idexx.com/role/IncomeTaxesScheduleofChangesinUnrecognizedTaxBenefitsDetails",
     "shortName": "Income Taxes (Schedule of Changes in Unrecognized Tax Benefits) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i28d0821cac8841b29cf960002d3bc993_I20181231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R99": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240764049 - Disclosure - Earnings Per Share (Reconciliation of Shares Outstanding) (Details)",
     "role": "http://www.idexx.com/role/EarningsPerShareReconciliationofSharesOutstandingDetails",
     "shortName": "Earnings Per Share (Reconciliation of Shares Outstanding) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "idxx-20211231.htm",
      "contextRef": "i17a3b2c59ff047cbb3680ffbbdddfafa_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 139,
   "tag": {
    "country_AU": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "AUSTRALIA",
        "terseLabel": "Australia"
       }
      }
     },
     "localname": "AU",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.idexx.com/role/RevenueRecognitionDisaggregationofRevenuebyPrincipalGeographicAreaBasedonCustomersDomicilesDetails",
      "http://www.idexx.com/role/SegmentReportingScheduleofNetLongLivedAssetsbyPrincipalGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_BR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "BRAZIL",
        "terseLabel": "Brazil"
       }
      }
     },
     "localname": "BR",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.idexx.com/role/SegmentReportingScheduleofNetLongLivedAssetsbyPrincipalGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_CA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CANADA",
        "terseLabel": "Canada"
       }
      }
     },
     "localname": "CA",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.idexx.com/role/RevenueRecognitionDisaggregationofRevenuebyPrincipalGeographicAreaBasedonCustomersDomicilesDetails",
      "http://www.idexx.com/role/SegmentReportingScheduleofNetLongLivedAssetsbyPrincipalGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_CH": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SWITZERLAND",
        "terseLabel": "Switzerland"
       }
      }
     },
     "localname": "CH",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.idexx.com/role/AcquisitionsandInvestmentsDetails",
      "http://www.idexx.com/role/RevenueRecognitionDisaggregationofRevenuebyPrincipalGeographicAreaBasedonCustomersDomicilesDetails",
      "http://www.idexx.com/role/SegmentReportingScheduleofNetLongLivedAssetsbyPrincipalGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_CN": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CHINA",
        "terseLabel": "China"
       }
      }
     },
     "localname": "CN",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.idexx.com/role/RevenueRecognitionDisaggregationofRevenuebyPrincipalGeographicAreaBasedonCustomersDomicilesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_DE": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "GERMANY",
        "terseLabel": "Germany"
       }
      }
     },
     "localname": "DE",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.idexx.com/role/RevenueRecognitionDisaggregationofRevenuebyPrincipalGeographicAreaBasedonCustomersDomicilesDetails",
      "http://www.idexx.com/role/SegmentReportingScheduleofNetLongLivedAssetsbyPrincipalGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_ES": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SPAIN",
        "terseLabel": "Spain"
       }
      }
     },
     "localname": "ES",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.idexx.com/role/RevenueRecognitionDisaggregationofRevenuebyPrincipalGeographicAreaBasedonCustomersDomicilesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_FI": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "FINLAND",
        "terseLabel": "Finland"
       }
      }
     },
     "localname": "FI",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.idexx.com/role/AcquisitionsandInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_FR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "FRANCE",
        "terseLabel": "France"
       }
      }
     },
     "localname": "FR",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.idexx.com/role/RevenueRecognitionDisaggregationofRevenuebyPrincipalGeographicAreaBasedonCustomersDomicilesDetails",
      "http://www.idexx.com/role/SegmentReportingScheduleofNetLongLivedAssetsbyPrincipalGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_GB": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED KINGDOM",
        "terseLabel": "United Kingdom"
       }
      }
     },
     "localname": "GB",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.idexx.com/role/RevenueRecognitionDisaggregationofRevenuebyPrincipalGeographicAreaBasedonCustomersDomicilesDetails",
      "http://www.idexx.com/role/SegmentReportingScheduleofNetLongLivedAssetsbyPrincipalGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_IT": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ITALY",
        "terseLabel": "Italy"
       }
      }
     },
     "localname": "IT",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.idexx.com/role/RevenueRecognitionDisaggregationofRevenuebyPrincipalGeographicAreaBasedonCustomersDomicilesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_JP": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "JAPAN",
        "terseLabel": "Japan"
       }
      }
     },
     "localname": "JP",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.idexx.com/role/RevenueRecognitionDisaggregationofRevenuebyPrincipalGeographicAreaBasedonCustomersDomicilesDetails",
      "http://www.idexx.com/role/SegmentReportingScheduleofNetLongLivedAssetsbyPrincipalGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_NL": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NETHERLANDS",
        "terseLabel": "Netherlands"
       }
      }
     },
     "localname": "NL",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.idexx.com/role/RevenueRecognitionDisaggregationofRevenuebyPrincipalGeographicAreaBasedonCustomersDomicilesDetails",
      "http://www.idexx.com/role/SegmentReportingScheduleofNetLongLivedAssetsbyPrincipalGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.idexx.com/role/RevenueRecognitionDisaggregationofRevenuebyPrincipalGeographicAreaBasedonCustomersDomicilesDetails",
      "http://www.idexx.com/role/SegmentReportingScheduleofNetLongLivedAssetsbyPrincipalGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.idexx.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r840",
      "r841",
      "r842"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.idexx.com/role/AuditInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r840",
      "r841",
      "r842"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.idexx.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r840",
      "r841",
      "r842"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.idexx.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.idexx.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.idexx.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r840",
      "r841",
      "r842"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.idexx.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.idexx.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.idexx.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.idexx.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r843"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.idexx.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.idexx.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r838"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.idexx.com/role/CoverPage"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.idexx.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.idexx.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.idexx.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.idexx.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r837"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.idexx.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding (in shares)"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.idexx.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.idexx.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r837"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.idexx.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.idexx.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r837"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.idexx.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.idexx.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r852"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.idexx.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.idexx.com/role/CoverPage"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r837"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.idexx.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r837"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.idexx.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r837"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.idexx.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r837"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.idexx.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.idexx.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r853"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.idexx.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r840",
      "r841",
      "r842"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.idexx.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.idexx.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r836"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.idexx.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r839"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.idexx.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.idexx.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "idxx_A2021SeriesANotesAnd2024SeriesBNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2021 Series A Notes And 2024 Series B Notes [Member]",
        "label": "2021 Series A Notes And 2024 Series B Notes [Member]",
        "terseLabel": "2021 Series A Notes and 2024 Series B Notes"
       }
      }
     },
     "localname": "A2021SeriesANotesAnd2024SeriesBNotesMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_A2021SeriesANotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2021 Series A Notes [Member]",
        "label": "2021 Series A Notes [Member]",
        "terseLabel": "2021 Series A Notes"
       }
      }
     },
     "localname": "A2021SeriesANotesMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_A2022SeriesANotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2022 Series A Notes [Member]",
        "label": "2022 Series A Notes [Member]",
        "terseLabel": "2022 Series A Notes"
       }
      }
     },
     "localname": "A2022SeriesANotesMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/DebtNarrativeDetails",
      "http://www.idexx.com/role/DebtScheduleofSeniorNoteBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_A2022SeriesANotesand2027SeriesBNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2022 Series A Notes and 2027 Series B Notes [Member]",
        "label": "2022 Series A Notes and 2027 Series B Notes [Member]",
        "terseLabel": "2022 Series A Notes and 2027 Series B Notes"
       }
      }
     },
     "localname": "A2022SeriesANotesand2027SeriesBNotesMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_A2023SeriesANotesAnd2025SeriesBNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2023 Series A Notes And 2025 Series B Notes [Member]",
        "label": "2023 Series A Notes And 2025 Series B Notes [Member]",
        "terseLabel": "2023 Series A Notes and 2025 Series B Notes"
       }
      }
     },
     "localname": "A2023SeriesANotesAnd2025SeriesBNotesMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_A2023SeriesANotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2023 Series A Notes [Member]",
        "label": "2023 Series A Notes [Member]",
        "terseLabel": "2023 Series A Notes"
       }
      }
     },
     "localname": "A2023SeriesANotesMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/DebtNarrativeDetails",
      "http://www.idexx.com/role/DebtScheduleofSeniorNoteBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_A2024SeriesBNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2024 Series B Notes [Member]",
        "label": "2024 Series B Notes [Member]",
        "terseLabel": "2024 Series B Notes"
       }
      }
     },
     "localname": "A2024SeriesBNotesMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/DebtNarrativeDetails",
      "http://www.idexx.com/role/DebtScheduleofSeniorNoteBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_A2025SeriesBNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2025 Series B Notes [Member]",
        "label": "2025 Series B Notes [Member]",
        "terseLabel": "2025 Series B Notes"
       }
      }
     },
     "localname": "A2025SeriesBNotesMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/DebtNarrativeDetails",
      "http://www.idexx.com/role/DebtScheduleofSeniorNoteBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_A2025SeriesCNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2025 Series C Notes [Member]",
        "label": "2025 Series C Notes [Member]",
        "terseLabel": "2025 Series C Notes"
       }
      }
     },
     "localname": "A2025SeriesCNotesMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/DebtNarrativeDetails",
      "http://www.idexx.com/role/DebtScheduleofSeniorNoteBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_A2026SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2026 Senior Notes [Member]",
        "label": "2026 Senior Notes [Member]",
        "terseLabel": "2026 Senior Notes"
       }
      }
     },
     "localname": "A2026SeniorNotesMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/DebtNarrativeDetails",
      "http://www.idexx.com/role/DebtScheduleofSeniorNoteBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_A2027SeriesBNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2027 Series B Notes [Member]",
        "label": "2027 Series B Notes [Member]",
        "terseLabel": "2027 Series B Notes"
       }
      }
     },
     "localname": "A2027SeriesBNotesMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/DebtNarrativeDetails",
      "http://www.idexx.com/role/DebtScheduleofSeniorNoteBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_A2029SeriesCNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2029 Series C Notes [Member]",
        "label": "2029 Series C Notes [Member]",
        "terseLabel": "2029 Series C Notes"
       }
      }
     },
     "localname": "A2029SeriesCNotesMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/DebtNarrativeDetails",
      "http://www.idexx.com/role/DebtScheduleofSeniorNoteBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Including Portion Attributable to Noncontrolling Interest",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Unrealized (Loss) Gain on Investments, Net of Tax"
       }
      }
     },
     "localname": "AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/AccumulatedOtherComprehensiveIncomeScheduleofAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_AccountsReceivablePercentNotPastDue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Receivable, Percent Not Past Due",
        "label": "Accounts Receivable, Percent Not Past Due",
        "terseLabel": "Percent of accounts receivable not past due"
       }
      }
     },
     "localname": "AccountsReceivablePercentNotPastDue",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/CreditLossesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "idxx_AccountsReceivablePercentPastDue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Receivable, Percent Past Due",
        "label": "Accounts Receivable, Percent Past Due",
        "terseLabel": "Percent of accounts receivable past due"
       }
      }
     },
     "localname": "AccountsReceivablePercentPastDue",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/CreditLossesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "idxx_AccumulatedNetGainLossFromCashFlowHedgesForeignCurrencyExchangeContractsIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated Net Gain (Loss) from Cash Flow Hedges, Foreign Currency Exchange Contracts, Including Portion Attributable to Noncontrolling Interest",
        "label": "Accumulated Net Gain (Loss) from Cash Flow Hedges, Foreign Currency Exchange Contracts, Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Foreign Currency Exchange Contracts",
        "verboseLabel": "Unrealized (Loss) Gain on Cash Flow Hedges, Net of Tax, Foreign Currency Exchange Contracts"
       }
      }
     },
     "localname": "AccumulatedNetGainLossFromCashFlowHedgesForeignCurrencyExchangeContractsIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/AccumulatedOtherComprehensiveIncomeScheduleofAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.idexx.com/role/AccumulatedOtherComprehensiveIncomeScheduleofReclassificationsoutofAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_AccumulatedNetGainLossFromNetInvestmentHedgesCrossCurrencySwapsIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated Net Gain (Loss) From Net Investment Hedges, Cross Currency Swaps, Including Portion Attributable to Noncontrolling Interest",
        "label": "Accumulated Net Gain (Loss) From Net Investment Hedges, Cross Currency Swaps, Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Unrealized (Loss) Gain on Net Investment Hedges, Net of Tax, Cross Currency Swaps"
       }
      }
     },
     "localname": "AccumulatedNetGainLossFromNetInvestmentHedgesCrossCurrencySwapsIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/AccumulatedOtherComprehensiveIncomeScheduleofAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_AccumulatedNetGainLossFromNetInvestmentHedgesEuroDenominatedNotesIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated Net Gain (Loss) From Net Investment Hedges, Euro Denominated Notes, Including Portion Attributable to Noncontrolling Interest",
        "label": "Accumulated Net Gain (Loss) From Net Investment Hedges, Euro Denominated Notes, Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Unrealized (Loss) Gain on Net Investment Hedges, Net of Tax, Euro-Denominated Notes"
       }
      }
     },
     "localname": "AccumulatedNetGainLossFromNetInvestmentHedgesEuroDenominatedNotesIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/AccumulatedOtherComprehensiveIncomeScheduleofAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_AllocatedShareBasedCompensationExpenseNetOfTaxExcludingTaxBenefitFromSettlementOfShareBasedAwards": {
     "auth_ref": [],
     "calculation": {
      "http://www.idexx.com/role/ShareBasedCompensationScheduleofSelectedFinancialImpactofShareBasedCompensationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allocated Share-based Compensation Expense, Net of Tax, Excluding Tax Benefit From Settlement Of Share-based Awards",
        "label": "Allocated Share-based Compensation Expense, Net of Tax, Excluding Tax Benefit From Settlement Of Share-based Awards",
        "totalLabel": "Net share-based compensation expense included in consolidated statements of income, excluding tax benefit from settlement of share-based awards"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpenseNetOfTaxExcludingTaxBenefitFromSettlementOfShareBasedAwards",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationScheduleofSelectedFinancialImpactofShareBasedCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "idxx_AsiaPacificRegionOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asia Pacific Region, Other [Member]",
        "label": "Asia Pacific Region, Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "AsiaPacificRegionOtherMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/RevenueRecognitionDisaggregationofRevenuebyPrincipalGeographicAreaBasedonCustomersDomicilesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_AuditInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Audit Information [Abstract]",
        "label": "Audit Information [Abstract]"
       }
      }
     },
     "localname": "AuditInformationAbstract",
     "nsuri": "http://www.idexx.com/20211231",
     "xbrltype": "stringItemType"
    },
    "idxx_AwardsOtherThanStockOptionsAndStockAppreciationRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Awards Other Than Stock Options And Stock Appreciation Rights [Member]",
        "label": "Awards Other Than Stock Options And Stock Appreciation Rights [Member]",
        "terseLabel": "Awards other than stock options and stock appreciation rights"
       }
      }
     },
     "localname": "AwardsOtherThanStockOptionsAndStockAppreciationRightsMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_BusinessCombinationContingencyFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingency, Fair Value",
        "label": "Business Combination, Contingency, Fair Value",
        "terseLabel": "Contingent payments - acquisitions"
       }
      }
     },
     "localname": "BusinessCombinationContingencyFairValue",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/FairValueMeasurementsScheduleofFairValueofAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "idxx_BusinessCombinationContingentConsiderationHoldback": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Holdback",
        "label": "Business Combination, Contingent Consideration, Holdback",
        "terseLabel": "Holdback"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationHoldback",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/AcquisitionsandInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "idxx_BusinessCombinationContingentConsiderationLiabilityAndHoldback": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Liability and Holdback",
        "label": "Business Combination, Contingent Consideration, Liability and Holdback",
        "terseLabel": "Contingent payment and holdback"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityAndHoldback",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/AcquisitionsandInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "idxx_BusinessCombinationsTangibleLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combinations, Tangible Liabilities",
        "label": "Business Combinations, Tangible Liabilities",
        "terseLabel": "Net tangible liabilities"
       }
      }
     },
     "localname": "BusinessCombinationsTangibleLiabilities",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/AcquisitionsandInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "idxx_CAGDiagnosticCapitalVetlabInstrumentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CAG Diagnostic Capital - VetLab Instruments [Member]",
        "label": "CAG Diagnostic Capital Vetlab Instruments [Member]",
        "terseLabel": "CAG Diagnostics capital - instruments"
       }
      }
     },
     "localname": "CAGDiagnosticCapitalVetlabInstrumentsMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/RevenueRecognitionDisaggregationofRevenuebyMajorProductandServiceCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_CAGDiagnosticsRecurringRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CAG Diagnostics Recurring Revenue [Member]",
        "label": "CAG Diagnostics Recurring Revenue [Member]",
        "terseLabel": "CAG Diagnostics recurring revenue:"
       }
      }
     },
     "localname": "CAGDiagnosticsRecurringRevenueMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/RevenueRecognitionDisaggregationofRevenuebyMajorProductandServiceCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_CAGDiagnosticsServiceAndAccessoriesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CAG Diagnostics Service And Accessories [Member]",
        "label": "CAG Diagnostics Service And Accessories [Member]",
        "terseLabel": "CAG Diagnostics services and accessories"
       }
      }
     },
     "localname": "CAGDiagnosticsServiceAndAccessoriesMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/RevenueRecognitionDisaggregationofRevenuebyMajorProductandServiceCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_CashFlowHedgeHedgePercentageOfEstimatedExposureFromIntercompanyProductsPurchasesAndSales": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated portion of hedged foreign currency exposure related to intercompany product purchases and sales.",
        "label": "Cash Flow Hedge, Hedge Percentage Of Estimated Exposure From Intercompany Products Purchases And Sales",
        "terseLabel": "Cash flow hedge, hedge percentage of estimated exposure from intercompany products purchases and sales"
       }
      }
     },
     "localname": "CashFlowHedgeHedgePercentageOfEstimatedExposureFromIntercompanyProductsPurchasesAndSales",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/HedgingInstrumentsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "idxx_CompanionAnimalGroupSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Companion Animal Group Segment [Member]",
        "label": "Companion Animal Group Segment [Member]",
        "terseLabel": "CAG",
        "verboseLabel": "CAG segment revenue"
       }
      }
     },
     "localname": "CompanionAnimalGroupSegmentMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails",
      "http://www.idexx.com/role/RevenueRecognitionDisaggregationofRevenuebyMajorProductandServiceCategoriesDetails",
      "http://www.idexx.com/role/SegmentReportingSummaryofSegmentPerformanceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_ComputerHardwareAndSoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Computer Hardware And Software [Member]",
        "label": "Computer Hardware And Software [Member]",
        "terseLabel": "Computer hardware and software"
       }
      }
     },
     "localname": "ComputerHardwareAndSoftwareMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/PropertyandEquipmentNetScheduleofEstimatedUsefulLivesDetails",
      "http://www.idexx.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_ConcentrationRiskPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Concentration Risk",
        "label": "Concentration Risk [Policy Text Block]",
        "terseLabel": "Concentrations of Risk"
       }
      }
     },
     "localname": "ConcentrationRiskPolicyTextBlock",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "idxx_ConsolidatedLeverageRatioUnderCreditFacilityNotePayable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum consolidated leverage ratio permitted under debt agreements.",
        "label": "Consolidated Leverage Ratio Under Credit Facility Note Payable",
        "terseLabel": "Consolidated leverage ratio under credit facility &amp; note payable, maximum"
       }
      }
     },
     "localname": "ConsolidatedLeverageRatioUnderCreditFacilityNotePayable",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "idxx_ContingentPaymentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Payment",
        "label": "Contingent Payment [Member]",
        "terseLabel": "Contingent payment"
       }
      }
     },
     "localname": "ContingentPaymentMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/FairValueMeasurementsScheduleofFairValueofAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_ContractwithCustomerAssetAndSalesTypeLeaseNetInvestmentInLeaseAllowanceforCreditLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with Customer, Asset, And Sales-Type Lease, Net Investment In Lease, Allowance for Credit Loss",
        "label": "Contract with Customer, Asset, And Sales-Type Lease, Net Investment In Lease, Allowance for Credit Loss",
        "terseLabel": "Reserve for contract assets and sales-type leases"
       }
      }
     },
     "localname": "ContractwithCustomerAssetAndSalesTypeLeaseNetInvestmentInLeaseAllowanceforCreditLoss",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/CreditLossesDetails",
      "http://www.idexx.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "idxx_CrossCurrencyInterestRateContract1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cross Currency Interest Rate Contract, 1",
        "label": "Cross Currency Interest Rate Contract, 1 [Member]",
        "terseLabel": "Cross currency swaps"
       }
      }
     },
     "localname": "CrossCurrencyInterestRateContract1Member",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/HedgingInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_DeferredCompensationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Compensation [Member]",
        "label": "Deferred Compensation [Member]",
        "terseLabel": "Deferred compensation"
       }
      }
     },
     "localname": "DeferredCompensationMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/FairValueMeasurementsScheduleofFairValueofAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_DeferredStockUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Stock Units [Member]",
        "label": "Deferred Stock Units [Member]",
        "terseLabel": "Deferred Stock Units"
       }
      }
     },
     "localname": "DeferredStockUnitsMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://www.idexx.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_DeferredTaxAssetsIntangibleAssetsBasisDifference": {
     "auth_ref": [],
     "calculation": {
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofNetDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Intangible Assets Basis Difference",
        "label": "Deferred Tax Assets, Intangible Assets Basis Difference",
        "terseLabel": "Intangible asset basis differences"
       }
      }
     },
     "localname": "DeferredTaxAssetsIntangibleAssetsBasisDifference",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofNetDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "idxx_DeferredTaxAssetsValuationAllowanceChargesToCostsAndExpense": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Valuation Allowance, Charges To Costs and Expense",
        "label": "Deferred Tax Assets, Valuation Allowance, Charges To Costs and Expense",
        "terseLabel": "Charges to costs and expense"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowanceChargesToCostsAndExpense",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesScheduleofValuationAllowanceForDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "idxx_DeferredTaxAssetsValuationAllowanceForeignCurrencyTranslation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Valuation Allowance, Foreign Currency Translation",
        "label": "Deferred Tax Assets, Valuation Allowance, Foreign Currency Translation",
        "terseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowanceForeignCurrencyTranslation",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesScheduleofValuationAllowanceForDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "idxx_DeferredTaxAssetsValuationAllowanceRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Valuation Allowance",
        "label": "Deferred Tax Assets, Valuation Allowance [Roll Forward]",
        "terseLabel": "Deferred Tax Assets, Valuation Allowance [Roll Forward]"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowanceRollForward",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesScheduleofValuationAllowanceForDeferredTaxAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "idxx_DeferredTaxAssetsValuationAllowanceWriteOffCashPayments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Valuation Allowance, Write-off/Cash Payments",
        "label": "Deferred Tax Assets, Valuation Allowance, Write-off/Cash Payments",
        "negatedTerseLabel": "Write-off/cash payments"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowanceWriteOffCashPayments",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesScheduleofValuationAllowanceForDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "idxx_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome": {
     "auth_ref": [],
     "calculation": {
      "http://www.idexx.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Foreign Derived Intangible Income",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Derived Intangible Income",
        "negatedTerseLabel": "Foreign derived intangible income"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncome",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "idxx_EffectiveIncomeTaxRateReconciliationSwitzerlandTaxReformEffectPercent": {
     "auth_ref": [],
     "calculation": {
      "http://www.idexx.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Switzerland Tax Reform Effect, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Switzerland Tax Reform Effect, Percent",
        "terseLabel": "Impact of Switzerland tax reform"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationSwitzerlandTaxReformEffectPercent",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "idxx_EmployeeHealthCareInsurancePolicyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Health Care Insurance Policy [Member].",
        "label": "Employee Health Care Insurance Policy [Member]",
        "terseLabel": "Employee healthcare insurance policy"
       }
      }
     },
     "localname": "EmployeeHealthCareInsurancePolicyMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/CommitmentsContingenciesandGuaranteesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_EquityMutualFundsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Mutual Funds [Member]",
        "label": "Equity Mutual Funds [Member]",
        "terseLabel": "Equity mutual funds"
       }
      }
     },
     "localname": "EquityMutualFundsMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/FairValueMeasurementsScheduleofFairValueofAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_EuropetheMiddleEastandAfricaOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Europe, the Middle East, and Africa, Other [Member]",
        "label": "Europe, the Middle East, and Africa, Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "EuropetheMiddleEastandAfricaOtherMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/RevenueRecognitionDisaggregationofRevenuebyPrincipalGeographicAreaBasedonCustomersDomicilesDetails",
      "http://www.idexx.com/role/SegmentReportingScheduleofNetLongLivedAssetsbyPrincipalGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_ExtendedProductWarrantyTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extended Product Warranty, Term",
        "label": "Extended Product Warranty, Term",
        "terseLabel": "Extended product warranty, term"
       }
      }
     },
     "localname": "ExtendedProductWarrantyTerm",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/RevenueRecognitionExtendedWarrantiesandPostContractSupportDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "idxx_ExtendedWarrantiesAndPostContractSupportMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extended Warranties and Post-Contract Support [Member]",
        "label": "Extended Warranties And Post Contract Support [Member]",
        "terseLabel": "Extended warranties and post contract support"
       }
      }
     },
     "localname": "ExtendedWarrantiesAndPostContractSupportMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/RevenueRecognitionExtendedWarrantiesandPostContractSupportDetails",
      "http://www.idexx.com/role/RevenueRecognitionRemainingPerformanceObligationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_EzyVetMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ezyVet",
        "label": "ezyVet [Member]",
        "terseLabel": "ezyVet"
       }
      }
     },
     "localname": "EzyVetMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/AcquisitionsandInvestmentsDetails",
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_FinancialAssetGreaterThan60DaysPastDueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial Asset, Greater Than 60 Days Past Due [Member]",
        "label": "Financial Asset, Greater Than 60 Days Past Due [Member]",
        "terseLabel": "Greater than 60 Days Past Due"
       }
      }
     },
     "localname": "FinancialAssetGreaterThan60DaysPastDueMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/CreditLossesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_ForeignCurrencyBorrowingsDesignatedAsNetInvestmentHedgeOnBalanceSheetMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign Currency Borrowings Designated As Net Investment Hedge On The Balance Sheet [Member]",
        "label": "Foreign Currency Borrowings Designated As Net Investment Hedge On Balance Sheet [Member]",
        "terseLabel": "Foreign currency denominated debt"
       }
      }
     },
     "localname": "ForeignCurrencyBorrowingsDesignatedAsNetInvestmentHedgeOnBalanceSheetMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/HedgingInstrumentsScheduleofFairValuesandBalanceSheetClassificationsofDerivativesandNonderivativesDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_FourZeroOneKPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "401(k) Plan [Member]",
        "label": "Four Zero One K Plan [Member]",
        "terseLabel": "401(k) Plan"
       }
      }
     },
     "localname": "FourZeroOneKPlanMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/IDEXXRetirementandIncentiveSavingsPlanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_InstrumentRebateProgramsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument Rebate Programs [Member]",
        "label": "Instrument Rebate Programs [Member]",
        "terseLabel": "Instrument rebate programs"
       }
      }
     },
     "localname": "InstrumentRebateProgramsMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/RevenueRecognitionInstrumentRebateProgramsDetails",
      "http://www.idexx.com/role/RevenueRecognitionRemainingPerformanceObligationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_IssuanceVestingAndSettlementOfDeferredStockUnits": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net deferred stock units which were issued, vested and settled during the period. Deferred stock units issued to employees will generally settle and convert to common stock not earlier than one year following their termination of employment or resignation. With respect to non-employee directors, deferred stock units issued prior to January 1, 2011 will generally settle and convert to common stock not earlier than one year from the date the recipients retire from the board. Deferred stock units issued to non-employee directors on or after January 1, 2011 will generally settle and convert to common stock: (i) not earlier than one year from the date the recipients retire from the board; or (ii) in a lump sum on another single non-discriminatory and objectively determinable date or in four equal annual installments commencing on that date. The shares of common stock associated with these deferred stock units are issuable for no cash consideration, the number of shares of common stock to be issued is fixed and issuance is not contingent.",
        "label": "Issuance Vesting and Settlement Of Deferred Stock Units",
        "terseLabel": "Deferred stock units activity"
       }
      }
     },
     "localname": "IssuanceVestingAndSettlementOfDeferredStockUnits",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "idxx_LatinAmericaAndCaribbeanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Latin America and Caribbean",
        "label": "Latin America and Caribbean [Member]",
        "terseLabel": "Latin America &amp; Caribbean"
       }
      }
     },
     "localname": "LatinAmericaAndCaribbeanMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/RevenueRecognitionDisaggregationofRevenuebyPrincipalGeographicAreaBasedonCustomersDomicilesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_LesseeOperatingLeaseTerminationPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Termination Period",
        "label": "Lessee, Operating Lease, Termination Period",
        "terseLabel": "Operating lease, termination period"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTerminationPeriod",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "idxx_LineofCreditFacilityAccordionFeatureHigherBorrowingCapacityOption": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line of Credit Facility, Accordion Feature, Higher Borrowing Capacity Option",
        "label": "Line of Credit Facility, Accordion Feature, Higher Borrowing Capacity Option",
        "terseLabel": "Accordion feature, higher borrowing capacity option"
       }
      }
     },
     "localname": "LineofCreditFacilityAccordionFeatureHigherBorrowingCapacityOption",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "idxx_LineofCreditFacilityAccordionFeatureIncreaseLimit": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line of Credit Facility, Accordion Feature, Increase Limit",
        "label": "Line of Credit Facility, Accordion Feature, Increase Limit",
        "terseLabel": "Accordion feature, increase limit"
       }
      }
     },
     "localname": "LineofCreditFacilityAccordionFeatureIncreaseLimit",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "idxx_LivestockAndPoultryDiagnosticsSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Livestock And Poultry Diagnostics Segment [Member]",
        "label": "Livestock And Poultry Diagnostics Segment [Member]",
        "terseLabel": "LPD",
        "verboseLabel": "LPD segment revenue"
       }
      }
     },
     "localname": "LivestockAndPoultryDiagnosticsSegmentMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails",
      "http://www.idexx.com/role/RevenueRecognitionDisaggregationofRevenuebyMajorProductandServiceCategoriesDetails",
      "http://www.idexx.com/role/SegmentReportingSummaryofSegmentPerformanceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_MetLife2030SeriesDNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "MetLife 2030 Series D Notes",
        "label": "MetLife 2030 Series D Notes [Member]",
        "terseLabel": "MetLife 2030 Series D Notes"
       }
      }
     },
     "localname": "MetLife2030SeriesDNotesMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/DebtNarrativeDetails",
      "http://www.idexx.com/role/DebtScheduleofSeniorNoteBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_NineteenNinetySevenEmployeeStockPurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nineteen Ninety Seven Employee Stock Purchase Plan [Member]",
        "label": "Nineteen Ninety Seven Employee Stock Purchase Plan [Member]",
        "terseLabel": "1997 Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "NineteenNinetySevenEmployeeStockPurchasePlanMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_NoncontrollingInterestOwnershipPercentageAcquiredFromNoncontrollingOwners": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interest, Ownership Percentage Acquired From Noncontrolling Owners",
        "label": "Noncontrolling Interest, Ownership Percentage Acquired From Noncontrolling Owners",
        "terseLabel": "Noncontrolling interest, remaining percentage purchased from noncontrolling owners"
       }
      }
     },
     "localname": "NoncontrollingInterestOwnershipPercentageAcquiredFromNoncontrollingOwners",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/AcquisitionsandInvestmentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "idxx_OperatingExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The allocation (or location) of expense to (in) operating expenses.",
        "label": "Operating Expenses [Member]",
        "terseLabel": "Operating expenses"
       }
      }
     },
     "localname": "OperatingExpensesMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationScheduleofSelectedFinancialImpactofShareBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_OperatingLeaseLeaseNotyetCommencedExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Lease Not yet Commenced, Expense",
        "label": "Operating Lease, Lease Not yet Commenced, Expense",
        "terseLabel": "Total minimum future lease payments, leases not yet commenced"
       }
      }
     },
     "localname": "OperatingLeaseLeaseNotyetCommencedExpense",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "idxx_OtherAsiaPacificMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Asia Pacific [Member]",
        "label": "Other Asia Pacific [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAsiaPacificMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/SegmentReportingScheduleofNetLongLivedAssetsbyPrincipalGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss), Cash Flow Hedge And Net Investment Hedge, Gain (Loss), After Reclassification And Tax",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge And Net Investment Hedge, Gain (Loss), After Reclassification And Tax",
        "totalLabel": "Unrealized gain (loss) on derivative instruments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "idxx_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossAfterReclassificationAndTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss), Net Investment Hedge, Cross Currency Swaps, Gain (Loss), Before Reclassification, After Tax",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Cross Currency Swaps, Gain (Loss), Before Reclassification, After Tax",
        "terseLabel": "Unrealized gain (loss) on cross currency swaps, net of tax expense of $1,699 in 2021, $(1,774) in 2020 and $664 in 2019",
        "verboseLabel": "Unrealized gain (loss) on cross currency swaps, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.idexx.com/role/HedgingInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss), Net Investment Hedge, Cross Currency Swaps, Gain (Loss), Before Reclassification, Tax",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Cross Currency Swaps, Gain (Loss), Before Reclassification, Tax",
        "terseLabel": "Unrealized gain (loss) on cross currency swaps, tax expense (benefit)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationTax",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss), Net Investment Hedge, Euro-Denominated Notes, Gain (Loss), After Reclassification And Tax",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Euro-Denominated Notes, Gain (Loss), After Reclassification And Tax",
        "terseLabel": "Unrealized gain (loss) on Euro-denominated notes, net of tax expense (benefit) of $2,011 in 2021, $(2,325) in 2020 and $564 in 2019",
        "verboseLabel": "Unrealized gain (loss) on Euro-denominated notes, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.idexx.com/role/HedgingInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "idxx_OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss), Net Investment Hedge, Euro-Denominated Notes, Gain (Loss), After Reclassification, Tax",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Euro-Denominated Notes, Gain (Loss), After Reclassification, Tax",
        "terseLabel": "Unrealized gain (loss) on Euro-denominated notes, tax expense (benefit)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationTax",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "idxx_OtherSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Segment [Member]",
        "label": "Other Segment [Member]",
        "terseLabel": "Other segment revenue",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "OtherSegmentMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails",
      "http://www.idexx.com/role/RevenueRecognitionDisaggregationofRevenuebyMajorProductandServiceCategoriesDetails",
      "http://www.idexx.com/role/SegmentReportingSummaryofSegmentPerformanceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_PaymentRequiredToCeoUponTerminationOfEmploymentWithoutCauseOtherThanFollowingChangeInControlMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment Required To CEO Upon Termination Of Employment Without Cause Other Than Following Change In Control [Member]",
        "label": "Payment Required To Ceo Upon Termination Of Employment Without Cause Other Than Following Change In Control [Member]",
        "terseLabel": "Payment required to CEO upon termination of employment without cause other than following change in control"
       }
      }
     },
     "localname": "PaymentRequiredToCeoUponTerminationOfEmploymentWithoutCauseOtherThanFollowingChangeInControlMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/CommitmentsContingenciesandGuaranteesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_PaymentRequiredToOfficersUponTerminationOfEmploymentFollowingChangeOfControlMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment Required To Officers Upon Termination Of Employment Following Change Of Control [Member]",
        "label": "Payment Required To Officers Upon Termination Of Employment Following Change Of Control [Member]",
        "terseLabel": "Payment required to officers upon termination of employment following change of control"
       }
      }
     },
     "localname": "PaymentRequiredToOfficersUponTerminationOfEmploymentFollowingChangeOfControlMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/CommitmentsContingenciesandGuaranteesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_PaymentRequiredUponTerminationOfEmploymentAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment Required Upon Termination Of Employment [Axis]",
        "label": "Payment Required Upon Termination Of Employment [Axis]",
        "terseLabel": "Payment Required Upon Termination Of Employment [Axis]"
       }
      }
     },
     "localname": "PaymentRequiredUponTerminationOfEmploymentAxis",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/CommitmentsContingenciesandGuaranteesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "idxx_PaymentRequiredUponTerminationOfEmploymentDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment Required Upon Termination Of Employment [Domain]",
        "label": "Payment Required Upon Termination Of Employment [Domain]",
        "terseLabel": "Payment Required Upon Termination Of Employment [Domain]"
       }
      }
     },
     "localname": "PaymentRequiredUponTerminationOfEmploymentDomain",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/CommitmentsContingenciesandGuaranteesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_PaymentRequiredUponTerminationOfEmploymentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment Required Upon Termination Of Employment [Line Items]",
        "label": "Payment Required Upon Termination Of Employment [Line Items]",
        "terseLabel": "Payment Required Upon Termination Of Employment [Line Items]"
       }
      }
     },
     "localname": "PaymentRequiredUponTerminationOfEmploymentLineItems",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/CommitmentsContingenciesandGuaranteesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "idxx_PaymentRequiredUponTerminationOfEmploymentTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment Required Upon Termination Of Employment [Table]",
        "label": "Payment Required Upon Termination Of Employment [Table]",
        "terseLabel": "Payment Required Upon Termination Of Employment [Table]"
       }
      }
     },
     "localname": "PaymentRequiredUponTerminationOfEmploymentTable",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/CommitmentsContingenciesandGuaranteesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "idxx_PaymentsToAcquireIntangibleAssetsAndEquityMethodInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments to Acquire Intangible Assets and Equity Method Investments",
        "label": "Payments to Acquire Intangible Assets and Equity Method Investments",
        "negatedLabel": "Acquisitions of intangible assets and equity investments"
       }
      }
     },
     "localname": "PaymentsToAcquireIntangibleAssetsAndEquityMethodInvestments",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "idxx_PostContractSupportContractTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Post-contract Support Contract, Term",
        "label": "Post-contract Support Contract, Term",
        "terseLabel": "Post-contract support contract, term"
       }
      }
     },
     "localname": "PostContractSupportContractTerm",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/RevenueRecognitionExtendedWarrantiesandPostContractSupportDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "idxx_ProductRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product Rights [Member]",
        "label": "Product Rights [Member]",
        "terseLabel": "Product rights"
       }
      }
     },
     "localname": "ProductRightsMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofEstimatedUsefulLivesForIntangibleAssetsDetails",
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofIntangibleAssetsOtherThanGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_Prudential2030SeriesDNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prudential 2030 Series D Notes",
        "label": "Prudential 2030 Series D Notes [Member]",
        "terseLabel": "Prudential 2030 Series D Notes"
       }
      }
     },
     "localname": "Prudential2030SeriesDNotesMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/DebtNarrativeDetails",
      "http://www.idexx.com/role/DebtScheduleofSeniorNoteBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_RapidAssayProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rapid Assay Products [Member]",
        "label": "Rapid Assay Products [Member]",
        "terseLabel": "Rapid assay products"
       }
      }
     },
     "localname": "RapidAssayProductsMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/AcquisitionsandInvestmentsDetails",
      "http://www.idexx.com/role/RevenueRecognitionDisaggregationofRevenuebyMajorProductandServiceCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_RatioOfDeferredStockUnitsToSharesOfCommonStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of unissued shares of common stock that each DSU represents the right to receive.",
        "label": "Ratio Of Deferred Stock Units To Shares Of Common Stock",
        "terseLabel": "Number of unissued shares of common stock each DSU represents right to receive (in shares)"
       }
      }
     },
     "localname": "RatioOfDeferredStockUnitsToSharesOfCommonStock",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "idxx_RatioSharesIssuedUnderShareBasedAwardsToSharesAuthorizedUnderStockPlans": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The ratio of the number of shares issued under share-based awards to the number of shares authorized under stock plans.",
        "label": "Ratio Shares Issued Under Share Based Awards To Shares Authorized Under Stock Plans",
        "terseLabel": "Ratio of shares issued under share-based awards to shares authorized under stock plans"
       }
      }
     },
     "localname": "RatioSharesIssuedUnderShareBasedAwardsToSharesAuthorizedUnderStockPlans",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "idxx_ReagentRentalProgramsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reagent Rental Programs [Member]",
        "label": "Reagent Rental Programs [Member]",
        "terseLabel": "Reagent rental programs"
       }
      }
     },
     "localname": "ReagentRentalProgramsMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/InventoriesNarrativeDetails",
      "http://www.idexx.com/role/PropertyandEquipmentNetSummaryOfDepreciationAndAmortizationCapitalizedComputerSoftwareForInternalUseAndUnpaidPropertyEquipmentReflectedInAccountPayableAndAccruedExpensesDetails",
      "http://www.idexx.com/role/RevenueRecognitionReagentRentalProgramsDetails",
      "http://www.idexx.com/role/RevenueRecognitionRemainingPerformanceObligationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_ReferenceLaboratoryDiagnosticAndConsultingServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reference Laboratory Diagnostic And Consulting Services [Member]",
        "label": "Reference Laboratory Diagnostic And Consulting Services [Member]",
        "terseLabel": "Reference laboratory diagnostic and consulting services"
       }
      }
     },
     "localname": "ReferenceLaboratoryDiagnosticAndConsultingServicesMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/AcquisitionsandInvestmentsDetails",
      "http://www.idexx.com/role/RevenueRecognitionDisaggregationofRevenuebyMajorProductandServiceCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_ReferenceLaboratoryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reference Laboratory",
        "label": "Reference Laboratory [Member]",
        "terseLabel": "Reference Laboratory"
       }
      }
     },
     "localname": "ReferenceLaboratoryMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/AcquisitionsandInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_ReferenceLaboratoryinMidWestUnitedStatesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reference Laboratory in Mid-West, United States [Member]",
        "label": "Reference Laboratory in Mid-West, United States [Member]",
        "terseLabel": "Reference laboratory in Mid-West, U.S."
       }
      }
     },
     "localname": "ReferenceLaboratoryinMidWestUnitedStatesMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/AcquisitionsandInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_ResearchAndDevelopmentCostsCapitalized": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research And Development Costs, Capitalized",
        "label": "Research And Development Costs, Capitalized",
        "terseLabel": "Capitalized costs"
       }
      }
     },
     "localname": "ResearchAndDevelopmentCostsCapitalized",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "idxx_RestrictedStockUnitsExpectedToVestReducedForEstimatedForfeituresMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Stock Units Expected To Vest, Reduced For Estimated Forfeitures [Member]",
        "label": "Restricted Stock Units Expected To Vest Reduced For Estimated Forfeitures [Member]",
        "terseLabel": "Restricted stock units expected to vest reduced for estimated forfeitures"
       }
      }
     },
     "localname": "RestrictedStockUnitsExpectedToVestReducedForEstimatedForfeituresMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationScheduleOfRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_RestrictedStockUnitsGrantedToEmployeesWithRatableVestingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Stock Units Granted To Employees With Ratable Vesting [Member]",
        "label": "Restricted Stock Units Granted To Employees With Ratable Vesting [Member]",
        "terseLabel": "Restricted stock units granted to employees with ratable vesting"
       }
      }
     },
     "localname": "RestrictedStockUnitsGrantedToEmployeesWithRatableVestingMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_RetainedClaimLiabilityPerIncident": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Retained claim liability per incident.",
        "label": "Retained Claim Liability Per Incident",
        "terseLabel": "Retained claim liability per incident"
       }
      }
     },
     "localname": "RetainedClaimLiabilityPerIncident",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/CommitmentsContingenciesandGuaranteesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "idxx_RetirementAndIncentiveSavingsPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Retirement And Incentive Savings Plan [Axis]",
        "label": "Retirement And Incentive Savings Plan [Axis]",
        "terseLabel": "Retirement And Incentive Savings Plan [Axis]"
       }
      }
     },
     "localname": "RetirementAndIncentiveSavingsPlanAxis",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/IDEXXRetirementandIncentiveSavingsPlanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "idxx_RetirementAndIncentiveSavingsPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Retirement And Incentive Savings Plan [Domain]",
        "label": "Retirement And Incentive Savings Plan [Domain]",
        "terseLabel": "Retirement And Incentive Savings Plan [Domain]"
       }
      }
     },
     "localname": "RetirementAndIncentiveSavingsPlanDomain",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/IDEXXRetirementandIncentiveSavingsPlanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_RetirementAndIncentiveSavingsPlanLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Retirement And Incentive Savings Plan [Line Items]",
        "label": "Retirement And Incentive Savings Plan [Line Items]",
        "terseLabel": "Retirement And Incentive Savings Plan [Line Items]"
       }
      }
     },
     "localname": "RetirementAndIncentiveSavingsPlanLineItems",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/IDEXXRetirementandIncentiveSavingsPlanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "idxx_RetirementAndIncentiveSavingsPlanTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Retirement And Incentive Savings Plan [Table]",
        "label": "Retirement And Incentive Savings Plan [Table]",
        "terseLabel": "Retirement And Incentive Savings Plan [Table]"
       }
      }
     },
     "localname": "RetirementAndIncentiveSavingsPlanTable",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/IDEXXRetirementandIncentiveSavingsPlanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "idxx_RevenuePerformanceObligationPaymentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue, Performance Obligation, Payment Term",
        "label": "Revenue, Performance Obligation, Payment Term",
        "terseLabel": "General payment terms"
       }
      }
     },
     "localname": "RevenuePerformanceObligationPaymentTerm",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/RevenueRecognitionDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "idxx_RevolvingCreditFacilityIndividualBorrowingsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revolving Credit Facility, Individual Borrowings",
        "label": "Revolving Credit Facility, Individual Borrowings [Member]",
        "terseLabel": "Revolving Credit Facility, Individual Borrowings"
       }
      }
     },
     "localname": "RevolvingCreditFacilityIndividualBorrowingsMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_SaasSubscriptionTermOfContract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SaaS Subscription, Term of Contract",
        "label": "SaaS Subscription, Term of Contract",
        "terseLabel": "SaaS subscription, term"
       }
      }
     },
     "localname": "SaasSubscriptionTermOfContract",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/RevenueRecognitionSaaSSubscriptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "idxx_SalesTypeLeaseLeaseReceivableReclassifiedToReceivable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales-Type Lease, Lease Receivable, Reclassified To Receivable",
        "label": "Sales-Type Lease, Lease Receivable, Reclassified To Receivable",
        "terseLabel": "Lease receivable, reclassified to receivable"
       }
      }
     },
     "localname": "SalesTypeLeaseLeaseReceivableReclassifiedToReceivable",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/RevenueRecognitionReagentRentalProgramsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "idxx_ScheduleOfEstimatedUsefulLivesForIntangibleAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Estimated Useful Lives For Intangible Assets [Table Text Block]",
        "label": "Schedule Of Estimated Useful Lives For Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of estimated useful lives for intangible assets"
       }
      }
     },
     "localname": "ScheduleOfEstimatedUsefulLivesForIntangibleAssetsTableTextBlock",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "idxx_ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Estimated Useful Lives For Property And Equipment [Table Text Block]",
        "label": "Schedule Of Estimated Useful Lives For Property And Equipment [Table Text Block]",
        "terseLabel": "Schedule of estimated useful lives for property and equipment"
       }
      }
     },
     "localname": "ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/PropertyandEquipmentNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "idxx_SegmentsOfGoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Segments Of Goodwill [Line Items]",
        "label": "Segments Of Goodwill [Line Items]",
        "terseLabel": "Segments Of Goodwill [Line Items]"
       }
      }
     },
     "localname": "SegmentsOfGoodwillLineItems",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "idxx_SegmentsOfGoodwillTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Segments Of Goodwill [Table]",
        "label": "Segments Of Goodwill [Table]",
        "terseLabel": "Segments Of Goodwill [Table]"
       }
      }
     },
     "localname": "SegmentsOfGoodwillTable",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "idxx_SeriesCSeniorNoteMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series C Senior Note [Member]",
        "label": "Series C Senior Note [Member]",
        "terseLabel": "Series C Senior Note"
       }
      }
     },
     "localname": "SeriesCSeniorNoteMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/HedgingInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_ShareBasedCompensationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Based Compensation [Table]",
        "label": "Share Based Compensation [Table]",
        "terseLabel": "Share Based Compensation [Table]"
       }
      }
     },
     "localname": "ShareBasedCompensationTable",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "idxx_SoftwareDevelopedForInternalUseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Software Developed For Internal Use [Member]",
        "label": "Software Developed For Internal Use [Member]",
        "terseLabel": "Capitalized computer software developed for internal use"
       }
      }
     },
     "localname": "SoftwareDevelopedForInternalUseMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/PropertyandEquipmentNetSummaryOfDepreciationAndAmortizationCapitalizedComputerSoftwareForInternalUseAndUnpaidPropertyEquipmentReflectedInAccountPayableAndAccruedExpensesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_StockOptionsAndStockAppreciationRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Options And Stock Appreciation Rights [Member]",
        "label": "Stock Options And Stock Appreciation Rights [Member]",
        "terseLabel": "Stock options and stock appreciation rights"
       }
      }
     },
     "localname": "StockOptionsAndStockAppreciationRightsMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_StockOptionsGrantedToEmployeesWithRatableVestingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Options Granted To Employees With Ratable Vesting [Member]",
        "label": "Stock Options Granted To Employees With Ratable Vesting [Member]",
        "terseLabel": "Stock options granted to employees with ratable vesting"
       }
      }
     },
     "localname": "StockOptionsGrantedToEmployeesWithRatableVestingMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_SummaryOfDepreciationAndAmortizationCapitalizedComputerSoftwareForInternalUseAndUnpaidPropertyEquipmentReflectedInAccountPayableAndAccruedExpensesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary Of Depreciation And Amortization, Capitalized Computer Software For Internal Use And Unpaid Property Equipment Reflected In Account Payable And Accrued Expenses [Table Text Block]",
        "label": "Summary Of Depreciation And Amortization, Capitalized Computer Software For Internal Use And Unpaid Property Equipment Reflected In Account Payable And Accrued Expenses [Table Text Block]",
        "terseLabel": "Summary of depreciation and amortization, capitalized computer software for internal use and unpaid property equipment reflected in accounts payable and accrued expenses"
       }
      }
     },
     "localname": "SummaryOfDepreciationAndAmortizationCapitalizedComputerSoftwareForInternalUseAndUnpaidPropertyEquipmentReflectedInAccountPayableAndAccruedExpensesTableTextBlock",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/PropertyandEquipmentNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "idxx_SummaryOfSignificantAccountingPoliciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary Of Significant Accounting Policies [Line Items]",
        "label": "Summary Of Significant Accounting Policies [Line Items]",
        "terseLabel": "Summary Of Significant Accounting Policies [Line Items]"
       }
      }
     },
     "localname": "SummaryOfSignificantAccountingPoliciesLineItems",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "idxx_SummaryOfSignificantAccountingPoliciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary Of Significant Accounting Policies [Table]",
        "label": "Summary Of Significant Accounting Policies [Table]",
        "terseLabel": "Summary Of Significant Accounting Policies [Table]"
       }
      }
     },
     "localname": "SummaryOfSignificantAccountingPoliciesTable",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "idxx_TaxesRemittedToGovernmentalAuthoritiesOnBehalfOfCustomerPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Taxes Remitted to Governmental Authorities on Behalf of Customer",
        "label": "Taxes Remitted to Governmental Authorities on Behalf of Customer [Policy Text Block]",
        "terseLabel": "Taxes Remitted To Governmental Authorities By IDEXX On Behalf Of Customer"
       }
      }
     },
     "localname": "TaxesRemittedToGovernmentalAuthoritiesOnBehalfOfCustomerPolicyTextBlock",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "idxx_TeleradiologyBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Teleradiology Business",
        "label": "Teleradiology Business [Member]",
        "terseLabel": "Teleradiology Business"
       }
      }
     },
     "localname": "TeleradiologyBusinessMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/AcquisitionsandInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_TreasuryStockAcquiredAverageCostPerShareEmployeeSurrenders": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Treasury Stock Acquired Average Cost Per Share, Employee Surrenders",
        "label": "Treasury Stock Acquired Average Cost Per Share, Employee Surrenders",
        "terseLabel": "Average cost per share - employee surrenders (in USD per share)"
       }
      }
     },
     "localname": "TreasuryStockAcquiredAverageCostPerShareEmployeeSurrenders",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/RepurchasesofCommonStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "idxx_TreasuryStockAcquiredAverageCostPerShareOpenMarketRepurchase": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Treasury Stock Acquired Average Cost Per Share, Open Market Repurchase",
        "label": "Treasury Stock Acquired Average Cost Per Share, Open Market Repurchase",
        "terseLabel": "Average cost per share - open market repurchases (in USD per share)"
       }
      }
     },
     "localname": "TreasuryStockAcquiredAverageCostPerShareOpenMarketRepurchase",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/RepurchasesofCommonStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "idxx_TreasuryStockSharesAcquiredNetOfTaxWithholdings": {
     "auth_ref": [],
     "calculation": {
      "http://www.idexx.com/role/RepurchasesofCommonStockDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_TreasuryStockSharesAcquired",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Open market common stock repurchases.",
        "label": "Treasury Stock, Shares, Acquired, Net Of Tax Withholdings",
        "terseLabel": "Share repurchased during the period (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquiredNetOfTaxWithholdings",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/RepurchasesofCommonStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "idxx_TreasuryStockValueAcquiredCostMethodNetOfTaxWithholdings": {
     "auth_ref": [],
     "calculation": {
      "http://www.idexx.com/role/RepurchasesofCommonStockDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_TreasuryStockValueAcquiredCostMethod",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost of open market common stock repurchases.",
        "label": "Treasury Stock Value Acquired Cost Method, Net Of Tax Withholdings",
        "terseLabel": "Cost of shares repurchased in the open market"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethodNetOfTaxWithholdings",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/RepurchasesofCommonStockDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "idxx_TwoThousandEighteenStockIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Thousand Eighteen Stock Incentive Plan [Member]",
        "label": "Two Thousand Eighteen Stock Incentive Plan [Member]",
        "terseLabel": "2018 Stock Plan"
       }
      }
     },
     "localname": "TwoThousandEighteenStockIncentivePlanMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_UpFrontCustomerLoyaltyProgramsAndVolumeCommitmentProgramsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Up-Front Customer Loyalty Programs And Volume Commitment Programs [Member]",
        "label": "Up Front Customer Loyalty Programs And Volume Commitment Programs [Member]",
        "terseLabel": "Up front customer loyalty programs and volume commitment programs"
       }
      }
     },
     "localname": "UpFrontCustomerLoyaltyProgramsAndVolumeCommitmentProgramsMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/RevenueRecognitionRemainingPerformanceObligationDetails",
      "http://www.idexx.com/role/RevenueRecognitionVolumeCommitmentProgramsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_UpFrontCustomerLoyaltyProgramsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Up-Front Customer Loyalty Programs [Member]",
        "label": "Up Front Customer Loyalty Programs [Member]",
        "terseLabel": "Up front customer loyalty programs"
       }
      }
     },
     "localname": "UpFrontCustomerLoyaltyProgramsMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/RevenueRecognitionUpFrontCustomerLoyaltyProgramsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_VetLabConsumablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vetlab Consumables [Member]",
        "label": "VetLab Consumables [Member]",
        "terseLabel": "IDEXX VetLab consumables"
       }
      }
     },
     "localname": "VetLabConsumablesMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/AcquisitionsandInvestmentsDetails",
      "http://www.idexx.com/role/RevenueRecognitionDisaggregationofRevenuebyMajorProductandServiceCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_VeterinarySoftwareServicesAndDiagnosticImagingSystemsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Veterinary Software, Services and Diagnostic Imaging Systems [Member]",
        "label": "Veterinary Software Services And Diagnostic Imaging Systems [Member]",
        "terseLabel": "Veterinary software, services and diagnostic imaging systems"
       }
      }
     },
     "localname": "VeterinarySoftwareServicesAndDiagnosticImagingSystemsMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/AcquisitionsandInvestmentsDetails",
      "http://www.idexx.com/role/RevenueRecognitionDisaggregationofRevenuebyMajorProductandServiceCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_VolumeCommitmentProgramsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Volume Commitment Programs [Member]",
        "label": "Volume Commitment Programs [Member]",
        "terseLabel": "Volume commitment programs"
       }
      }
     },
     "localname": "VolumeCommitmentProgramsMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/RevenueRecognitionVolumeCommitmentProgramsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_WaterSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Water Segment [Member]",
        "label": "Water Segment [Member]",
        "terseLabel": "Water segment revenue",
        "verboseLabel": "Water"
       }
      }
     },
     "localname": "WaterSegmentMember",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails",
      "http://www.idexx.com/role/RevenueRecognitionDisaggregationofRevenuebyMajorProductandServiceCategoriesDetails",
      "http://www.idexx.com/role/SegmentReportingSummaryofSegmentPerformanceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "idxx_WeightedAverageSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Shares Outstanding [Abstract]",
        "label": "Weighted Average Shares Outstanding [Abstract]",
        "terseLabel": "Weighted Average Shares Outstanding:"
       }
      }
     },
     "localname": "WeightedAverageSharesOutstandingAbstract",
     "nsuri": "http://www.idexx.com/20211231",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_AmericasMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Americas [Member]",
        "terseLabel": "Americas"
       }
      }
     },
     "localname": "AmericasMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/RevenueRecognitionDisaggregationofRevenuebyPrincipalGeographicAreaBasedonCustomersDomicilesDetails",
      "http://www.idexx.com/role/SegmentReportingScheduleofNetLongLivedAssetsbyPrincipalGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_AsiaPacificMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asia Pacific [Member]",
        "terseLabel": "Asia Pacific Region"
       }
      }
     },
     "localname": "AsiaPacificMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/RevenueRecognitionDisaggregationofRevenuebyPrincipalGeographicAreaBasedonCustomersDomicilesDetails",
      "http://www.idexx.com/role/SegmentReportingScheduleofNetLongLivedAssetsbyPrincipalGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r2",
      "r169",
      "r176",
      "r182",
      "r264",
      "r514",
      "r515",
      "r516",
      "r559",
      "r560",
      "r641",
      "r644",
      "r646",
      "r647",
      "r856"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://www.idexx.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r2",
      "r169",
      "r176",
      "r182",
      "r264",
      "r514",
      "r515",
      "r516",
      "r559",
      "r560",
      "r641",
      "r644",
      "r646",
      "r647",
      "r856"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://www.idexx.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r2",
      "r169",
      "r176",
      "r182",
      "r264",
      "r514",
      "r515",
      "r516",
      "r559",
      "r560",
      "r641",
      "r644",
      "r646",
      "r647",
      "r856"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://www.idexx.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Europe [Member]",
        "terseLabel": "Europe, the Middle East and Africa"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/SegmentReportingScheduleofNetLongLivedAssetsbyPrincipalGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r376",
      "r408",
      "r469",
      "r472",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r746",
      "r803",
      "r806",
      "r833",
      "r834"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CommitmentsContingenciesandGuaranteesNarrativeDetails",
      "http://www.idexx.com/role/DebtNarrativeDetails",
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofEstimatedUsefulLivesForIntangibleAssetsDetails",
      "http://www.idexx.com/role/HedgingInstrumentsNarrativeDetails",
      "http://www.idexx.com/role/LeasesNarrativeDetails",
      "http://www.idexx.com/role/PropertyandEquipmentNetScheduleofEstimatedUsefulLivesDetails",
      "http://www.idexx.com/role/RevenueRecognitionCoststoObtainaContractDetails",
      "http://www.idexx.com/role/RevenueRecognitionDetails",
      "http://www.idexx.com/role/RevenueRecognitionExtendedWarrantiesandPostContractSupportDetails",
      "http://www.idexx.com/role/RevenueRecognitionSaaSSubscriptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r376",
      "r408",
      "r469",
      "r472",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r746",
      "r803",
      "r806",
      "r833",
      "r834"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/DebtNarrativeDetails",
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofEstimatedUsefulLivesForIntangibleAssetsDetails",
      "http://www.idexx.com/role/HedgingInstrumentsNarrativeDetails",
      "http://www.idexx.com/role/LeasesNarrativeDetails",
      "http://www.idexx.com/role/PropertyandEquipmentNetScheduleofEstimatedUsefulLivesDetails",
      "http://www.idexx.com/role/RevenueRecognitionCoststoObtainaContractDetails",
      "http://www.idexx.com/role/RevenueRecognitionDetails",
      "http://www.idexx.com/role/RevenueRecognitionExtendedWarrantiesandPostContractSupportDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r240",
      "r437",
      "r441",
      "r750",
      "r802",
      "r804"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AcquisitionsandInvestmentsDetails",
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.idexx.com/role/InventoriesNarrativeDetails",
      "http://www.idexx.com/role/PropertyandEquipmentNetSummaryOfDepreciationAndAmortizationCapitalizedComputerSoftwareForInternalUseAndUnpaidPropertyEquipmentReflectedInAccountPayableAndAccruedExpensesDetails",
      "http://www.idexx.com/role/RevenueRecognitionDisaggregationofRevenuebyMajorProductandServiceCategoriesDetails",
      "http://www.idexx.com/role/RevenueRecognitionExtendedWarrantiesandPostContractSupportDetails",
      "http://www.idexx.com/role/RevenueRecognitionInstrumentRebateProgramsDetails",
      "http://www.idexx.com/role/RevenueRecognitionReagentRentalProgramsDetails",
      "http://www.idexx.com/role/RevenueRecognitionRemainingPerformanceObligationDetails",
      "http://www.idexx.com/role/RevenueRecognitionUpFrontCustomerLoyaltyProgramsDetails",
      "http://www.idexx.com/role/RevenueRecognitionVolumeCommitmentProgramsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r240",
      "r437",
      "r441",
      "r750",
      "r802",
      "r804"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AcquisitionsandInvestmentsDetails",
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.idexx.com/role/InventoriesNarrativeDetails",
      "http://www.idexx.com/role/PropertyandEquipmentNetSummaryOfDepreciationAndAmortizationCapitalizedComputerSoftwareForInternalUseAndUnpaidPropertyEquipmentReflectedInAccountPayableAndAccruedExpensesDetails",
      "http://www.idexx.com/role/RevenueRecognitionDisaggregationofRevenuebyMajorProductandServiceCategoriesDetails",
      "http://www.idexx.com/role/RevenueRecognitionExtendedWarrantiesandPostContractSupportDetails",
      "http://www.idexx.com/role/RevenueRecognitionInstrumentRebateProgramsDetails",
      "http://www.idexx.com/role/RevenueRecognitionReagentRentalProgramsDetails",
      "http://www.idexx.com/role/RevenueRecognitionRemainingPerformanceObligationDetails",
      "http://www.idexx.com/role/RevenueRecognitionUpFrontCustomerLoyaltyProgramsDetails",
      "http://www.idexx.com/role/RevenueRecognitionVolumeCommitmentProgramsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r376",
      "r408",
      "r449",
      "r469",
      "r472",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r746",
      "r803",
      "r806",
      "r833",
      "r834"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CommitmentsContingenciesandGuaranteesNarrativeDetails",
      "http://www.idexx.com/role/DebtNarrativeDetails",
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofEstimatedUsefulLivesForIntangibleAssetsDetails",
      "http://www.idexx.com/role/HedgingInstrumentsNarrativeDetails",
      "http://www.idexx.com/role/LeasesNarrativeDetails",
      "http://www.idexx.com/role/PropertyandEquipmentNetScheduleofEstimatedUsefulLivesDetails",
      "http://www.idexx.com/role/RevenueRecognitionCoststoObtainaContractDetails",
      "http://www.idexx.com/role/RevenueRecognitionDetails",
      "http://www.idexx.com/role/RevenueRecognitionExtendedWarrantiesandPostContractSupportDetails",
      "http://www.idexx.com/role/RevenueRecognitionSaaSSubscriptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r376",
      "r408",
      "r449",
      "r469",
      "r472",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r746",
      "r803",
      "r806",
      "r833",
      "r834"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CommitmentsContingenciesandGuaranteesNarrativeDetails",
      "http://www.idexx.com/role/DebtNarrativeDetails",
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofEstimatedUsefulLivesForIntangibleAssetsDetails",
      "http://www.idexx.com/role/HedgingInstrumentsNarrativeDetails",
      "http://www.idexx.com/role/LeasesNarrativeDetails",
      "http://www.idexx.com/role/PropertyandEquipmentNetScheduleofEstimatedUsefulLivesDetails",
      "http://www.idexx.com/role/RevenueRecognitionCoststoObtainaContractDetails",
      "http://www.idexx.com/role/RevenueRecognitionDetails",
      "http://www.idexx.com/role/RevenueRecognitionExtendedWarrantiesandPostContractSupportDetails",
      "http://www.idexx.com/role/RevenueRecognitionSaaSSubscriptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r177",
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]",
        "terseLabel": "Forecast"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/HedgingInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r177",
      "r182",
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/HedgingInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r241",
      "r242",
      "r437",
      "r442",
      "r805",
      "r824",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829",
      "r830",
      "r831",
      "r832"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AcquisitionsandInvestmentsDetails",
      "http://www.idexx.com/role/RevenueRecognitionDisaggregationofRevenuebyPrincipalGeographicAreaBasedonCustomersDomicilesDetails",
      "http://www.idexx.com/role/SegmentReportingScheduleofNetLongLivedAssetsbyPrincipalGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r241",
      "r242",
      "r437",
      "r442",
      "r805",
      "r819",
      "r824",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829",
      "r830",
      "r831",
      "r832"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AcquisitionsandInvestmentsDetails",
      "http://www.idexx.com/role/RevenueRecognitionDisaggregationofRevenuebyPrincipalGeographicAreaBasedonCustomersDomicilesDetails",
      "http://www.idexx.com/role/SegmentReportingScheduleofNetLongLivedAssetsbyPrincipalGeographicAreasDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r177",
      "r182",
      "r344",
      "r470",
      "r714"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/HedgingInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
        "terseLabel": "AOCI Attributable to Parent, Net of Tax [Roll Forward]"
       }
      }
     },
     "localname": "AOCIAttributableToParentNetOfTaxRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AccumulatedOtherComprehensiveIncomeScheduleofAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate201613Member": {
     "auth_ref": [
      "r260"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2016-13 Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.",
        "label": "Accounting Standards Update 2016-13 [Member]",
        "terseLabel": "Accounting Standards Update 2016-13"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201613Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r62",
      "r713"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableTradeCurrent": {
     "auth_ref": [
      "r19",
      "r62"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Trade, Current",
        "terseLabel": "Unpaid inventory"
       }
      }
     },
     "localname": "AccountsPayableTradeCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/InventoriesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r11",
      "r43",
      "r246",
      "r247"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net of allowance of $5,668 in 2021 and $6,784 in 2020"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDue": {
     "auth_ref": [
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold period for when accounts receivable, classified as noncurrent, is considered past due, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Excludes threshold period past due to write off as uncollectible.",
        "label": "Accounts Receivable, Noncurrent, Threshold Period Past Due",
        "terseLabel": "Accounts receivable, noncurrent, threshold period past due"
       }
      }
     },
     "localname": "AccountsReceivableNoncurrentThresholdPeriodPastDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CreditLossesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r35",
      "r761",
      "r785"
     ],
     "calculation": {
      "http://www.idexx.com/role/AccruedLiabilitiesandOtherLongTermLiabilitiesScheduleofAccruedLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes, Current",
        "terseLabel": "Accrued taxes"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AccruedLiabilitiesandOtherLongTermLiabilitiesScheduleofAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesNoncurrent": {
     "auth_ref": [
      "r38",
      "r761",
      "r785"
     ],
     "calculation": {
      "http://www.idexx.com/role/AccruedLiabilitiesandOtherLongTermLiabilitiesScheduleofLongTermAccruedLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.",
        "label": "Accrued Income Taxes, Noncurrent",
        "terseLabel": "Accrued taxes"
       }
      }
     },
     "localname": "AccruedIncomeTaxesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AccruedLiabilitiesandOtherLongTermLiabilitiesScheduleofLongTermAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://www.idexx.com/role/AccruedLiabilitiesandOtherLongTermLiabilitiesScheduleofAccruedLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued liabilities",
        "totalLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AccruedLiabilitiesandOtherLongTermLiabilitiesScheduleofAccruedLiabilitiesDetails",
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Liabilities, Current [Abstract]",
        "terseLabel": "Accrued Liabilities, Current [Abstract]"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccruedLiabilitiesMember": {
     "auth_ref": [
      "r66"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered.",
        "label": "Accrued Liabilities [Member]",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/HedgingInstrumentsScheduleofFairValuesandBalanceSheetClassificationsofDerivativesandNonderivativesDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccruedMarketingCostsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.idexx.com/role/AccruedLiabilitiesandOtherLongTermLiabilitiesScheduleofAccruedLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for the marketing, trade and selling of the entity's goods and services.   Marketing costs would include expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services; costs of public relations and corporate promotions; and obligations incurred and payable for sales discounts, rebates, price protection programs, etc. offered to customers and under government programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Marketing Costs, Current",
        "terseLabel": "Accrued customer incentives and refund obligations"
       }
      }
     },
     "localname": "AccruedMarketingCostsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AccruedLiabilitiesandOtherLongTermLiabilitiesScheduleofAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r60",
      "r333"
     ],
     "calculation": {
      "http://www.idexx.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "terseLabel": "Less accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r90",
      "r98",
      "r107",
      "r108",
      "r109",
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Cumulative Translation Adjustment"
       }
      }
     },
     "localname": "AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AccumulatedOtherComprehensiveIncomeScheduleofAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AccumulatedOtherComprehensiveIncomeScheduleofAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.idexx.com/role/AccumulatedOtherComprehensiveIncomeScheduleofReclassificationsoutofAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r46",
      "r95",
      "r97",
      "r98",
      "r787",
      "r814",
      "r818"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "verboseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r107",
      "r108",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AccumulatedOtherComprehensiveIncomeScheduleofAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.idexx.com/role/AccumulatedOtherComprehensiveIncomeScheduleofReclassificationsoutofAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r94",
      "r98",
      "r107",
      "r108",
      "r109",
      "r166",
      "r167",
      "r168",
      "r605",
      "r809",
      "r810",
      "r858"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Intangible assets useful life"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AcquisitionsandInvestmentsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r166",
      "r167",
      "r168",
      "r514",
      "r515",
      "r516",
      "r646"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r170",
      "r171",
      "r172",
      "r173",
      "r182",
      "r252",
      "r253",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r361",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r557",
      "r558",
      "r559",
      "r560",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r710",
      "r752",
      "r753",
      "r754",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817",
      "r818",
      "r854",
      "r855",
      "r856",
      "r857",
      "r858"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "calculation": {
      "http://www.idexx.com/role/RepurchasesofCommonStockDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_TreasuryStockValueAcquiredCostMethod",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Decrease for Tax Withholding Obligation",
        "netLabel": "Cost of shares for employee surrenders"
       }
      }
     },
     "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/RepurchasesofCommonStockDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r474",
      "r476",
      "r520",
      "r521"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Share-based compensation cost"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "auth_ref": [
      "r523"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for advertising cost.",
        "label": "Advertising Cost [Policy Text Block]",
        "terseLabel": "Advertising Costs"
       }
      }
     },
     "localname": "AdvertisingCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AdvertisingExpense": {
     "auth_ref": [
      "r524"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.",
        "label": "Advertising Expense",
        "terseLabel": "Advertising costs"
       }
      }
     },
     "localname": "AdvertisingExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r476",
      "r505",
      "r519"
     ],
     "calculation": {
      "http://www.idexx.com/role/ShareBasedCompensationScheduleofSelectedFinancialImpactofShareBasedCompensationDetails": {
       "order": 1.0,
       "parentTag": "idxx_AllocatedShareBasedCompensationExpenseNetOfTaxExcludingTaxBenefitFromSettlementOfShareBasedAwards",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.idexx.com/role/ShareBasedCompensationScheduleofSelectedFinancialImpactofShareBasedCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.idexx.com/role/ShareBasedCompensationScheduleofSelectedFinancialImpactofShareBasedCompensationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of expense for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expense, after Tax",
        "totalLabel": "Net expense (benefit) related to share-based compensation arrangements included in consolidated statements of income"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpenseNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationScheduleofSelectedFinancialImpactofShareBasedCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r249",
      "r270",
      "r273",
      "r274"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "terseLabel": "Accounts receivable allowance for credit losses"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CreditLossesDetails",
      "http://www.idexx.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r50",
      "r249",
      "r270"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, allowance"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r143",
      "r317",
      "r325"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Aggregate amortization expense"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r193"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Weighted average number of shares underlying anti-dilutive options (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/EarningsPerShareScheduleofNumberofAntiDilutiveStockOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r94",
      "r98",
      "r107",
      "r108",
      "r109",
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, including the portion attributable to the noncontrolling interest. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "AociIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AccumulatedOtherComprehensiveIncomeScheduleofAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r143",
      "r330"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "terseLabel": "Impairment charge"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r158",
      "r222",
      "r229",
      "r236",
      "r259",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r600",
      "r606",
      "r661",
      "r711",
      "r713",
      "r759",
      "r784"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "TOTAL ASSETS"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS",
        "verboseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofNetDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r13",
      "r15",
      "r80",
      "r158",
      "r259",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r600",
      "r606",
      "r661",
      "r711",
      "r713"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current Assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsNoncurrent": {
     "auth_ref": [
      "r26",
      "r27",
      "r28",
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r158",
      "r259",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r600",
      "r606",
      "r661",
      "r711"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.",
        "label": "Assets, Noncurrent",
        "totalLabel": "Total long-term assets"
       }
      }
     },
     "localname": "AssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Noncurrent [Abstract]",
        "terseLabel": "Long-Term Assets:"
       }
      }
     },
     "localname": "AssetsNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r477",
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.idexx.com/role/ShareBasedCompensationScheduleOfRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/HedgingInstrumentsScheduleofFairValuesandBalanceSheetClassificationsofDerivativesandNonderivativesDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r619",
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/HedgingInstrumentsScheduleofFairValuesandBalanceSheetClassificationsofDerivativesandNonderivativesDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingAndBuildingImprovementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Building and Building Improvements [Member]",
        "terseLabel": "Buildings and improvements"
       }
      }
     },
     "localname": "BuildingAndBuildingImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/PropertyandEquipmentNetScheduleofEstimatedUsefulLivesDetails",
      "http://www.idexx.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r468",
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AcquisitionsandInvestmentsDetails",
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r468",
      "r471",
      "r576",
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AcquisitionsandInvestmentsDetails",
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AcquisitionsandInvestmentsDetails",
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionRelatedCosts": {
     "auth_ref": [
      "r575"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.",
        "label": "Business Combination, Acquisition Related Costs",
        "terseLabel": "Acquisition expenses"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AcquisitionsandInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r585",
      "r586",
      "r588"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Purchase price of acquired assets"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AcquisitionsandInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r142",
      "r591"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "terseLabel": "Change in amount of contingent payable"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AcquisitionsandInvestmentsDetails",
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r584",
      "r587",
      "r590"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "terseLabel": "Contingent payment"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AcquisitionsandInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r592"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Acquisitions and Investments"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AcquisitionsandInvestments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r578",
      "r579"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AcquisitionsandInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r579"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AcquisitionsandInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r148",
      "r149",
      "r150"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Unpaid property and equipment, reflected in accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/PropertyandEquipmentNetSummaryOfDepreciationAndAmortizationCapitalizedComputerSoftwareForInternalUseAndUnpaidPropertyEquipmentReflectedInAccountPayableAndAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedContractCostAmortization": {
     "auth_ref": [
      "r305"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for asset recognized from cost incurred to obtain or fulfill contract with customer.",
        "label": "Capitalized Contract Cost, Amortization",
        "terseLabel": "Capitalized customer acquisition costs recognized as a reduction of revenue"
       }
      }
     },
     "localname": "CapitalizedContractCostAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/RevenueRecognitionUpFrontCustomerLoyaltyProgramsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedContractCostAmortizationPeriod": {
     "auth_ref": [
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization period of cost capitalized in obtaining or fulfilling contract with customer, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Capitalized Contract Cost, Amortization Period",
        "terseLabel": "Capitalized contract, amortization period"
       }
      }
     },
     "localname": "CapitalizedContractCostAmortizationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/RevenueRecognitionCoststoObtainaContractDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_CapitalizedContractCostGross": {
     "auth_ref": [
      "r304"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer.",
        "label": "Capitalized Contract Cost, Gross",
        "terseLabel": "Capitalized customer acquisition costs"
       }
      }
     },
     "localname": "CapitalizedContractCostGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/RevenueRecognitionUpFrontCustomerLoyaltyProgramsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedContractCostNet": {
     "auth_ref": [
      "r304"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer.",
        "label": "Capitalized Contract Cost, Net",
        "terseLabel": "Deferred commission costs"
       }
      }
     },
     "localname": "CapitalizedContractCostNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/RevenueRecognitionCoststoObtainaContractDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedContractCostNetCurrent": {
     "auth_ref": [
      "r304"
     ],
     "calculation": {
      "http://www.idexx.com/role/OtherCurrentandLongTermAssetsScheduleofOtherCurrentAssetsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer; classified as current.",
        "label": "Capitalized Contract Cost, Net, Current",
        "terseLabel": "Deferred sales commissions"
       }
      }
     },
     "localname": "CapitalizedContractCostNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/OtherCurrentandLongTermAssetsScheduleofOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedContractCostNetNoncurrent": {
     "auth_ref": [
      "r304"
     ],
     "calculation": {
      "http://www.idexx.com/role/OtherCurrentandLongTermAssetsScheduleofOtherNoncurrentAssetsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer; classified as noncurrent.",
        "label": "Capitalized Contract Cost, Net, Noncurrent",
        "verboseLabel": "Deferred sales commissions"
       }
      }
     },
     "localname": "CapitalizedContractCostNetNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/OtherCurrentandLongTermAssetsScheduleofOtherNoncurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r9",
      "r57",
      "r145"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/FairValueMeasurementsScheduleofFairValueofAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r25",
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash And Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r138",
      "r145",
      "r151"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents at end of period",
        "periodStartLabel": "Cash and cash equivalents at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r138",
      "r674"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net (decrease) increase in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths": {
     "auth_ref": [
      "r635"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.",
        "label": "Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months",
        "terseLabel": "Estimated net amount of gains expected to be reclassified out of accumulated other comprehensive income and into earnings within next 12 months"
       }
      }
     },
     "localname": "CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/HedgingInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedges"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/HedgingInstrumentsScheduleofFairValuesandBalanceSheetClassificationsofDerivativesandNonderivativesDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r72",
      "r343",
      "r767",
      "r792"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "verboseLabel": "Commitments and Contingencies (Note 16)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "auth_ref": [
      "r357",
      "r820"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.",
        "label": "Commitments and Contingencies, Policy [Policy Text Block]",
        "terseLabel": "Self-Insurance Accruals"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock": {
     "auth_ref": [
      "r342",
      "r353",
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments, contingencies, and guarantees.",
        "label": "Commitments Contingencies and Guarantees [Text Block]",
        "terseLabel": "Commitments, Contingencies and Guarantees"
       }
      }
     },
     "localname": "CommitmentsContingenciesAndGuaranteesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CommitmentsContingenciesandGuarantees"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r166",
      "r167",
      "r646"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockOtherSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of shares of other common stock instruments held by shareholders, such as exchangeable shares. May be all or portion of the number of common shares authorized.",
        "label": "Common Stock, Other Shares, Outstanding",
        "verboseLabel": "Deferred stock units, outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockOtherSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.idexx.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockOtherValueOutstanding": {
     "auth_ref": [],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of shares of other common stock instruments held by shareholders, such as exchangeable shares. May be all or portion of the number of common shares authorized.",
        "label": "Common Stock, Other Value, Outstanding",
        "terseLabel": "Deferred stock units: Outstanding: 90 units in 2021 and 87 units in 2020"
       }
      }
     },
     "localname": "CommonStockOtherValueOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in USD per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "periodEndLabel": "Balance end of period (in shares)",
        "periodStartLabel": "Balance beginning of period (in shares)",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r42",
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r42",
      "r713"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "verboseLabel": "Common stock, $0.10 par value: Authorized: 120,000 shares; Issued: 106,878 shares in 2021 and 106,457 shares in 2020; Outstanding: 84,562 shares in 2021 and 85,449 shares in 2020"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r102",
      "r104",
      "r105",
      "r118",
      "r773",
      "r798"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income attributable to IDEXX Laboratories, Inc."
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r102",
      "r104",
      "r117",
      "r596",
      "r597",
      "r610",
      "r772",
      "r797"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "terseLabel": "Less: comprehensive income attributable to noncontrolling interest"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r102",
      "r104",
      "r116",
      "r595",
      "r610",
      "r771",
      "r796"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r115",
      "r125",
      "r770",
      "r795"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AccumulatedOtherComprehensiveIncome"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for comprehensive income.",
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "terseLabel": "Comprehensive Income"
       }
      }
     },
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress [Member]",
        "terseLabel": "Construction in progress"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerAssetNet": {
     "auth_ref": [
      "r422",
      "r424",
      "r438"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss",
        "terseLabel": "Volume commitment contract assets"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/RevenueRecognitionVolumeCommitmentProgramsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerAssetNetCurrent": {
     "auth_ref": [
      "r422",
      "r424",
      "r438"
     ],
     "calculation": {
      "http://www.idexx.com/role/OtherCurrentandLongTermAssetsScheduleofOtherCurrentAssetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss, Current",
        "terseLabel": "Contract assets, net"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/OtherCurrentandLongTermAssetsScheduleofOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerAssetNetNoncurrent": {
     "auth_ref": [
      "r422",
      "r424",
      "r438"
     ],
     "calculation": {
      "http://www.idexx.com/role/OtherCurrentandLongTermAssetsScheduleofOtherNoncurrentAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as noncurrent.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss, Noncurrent",
        "terseLabel": "Contract assets, net"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNetNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/OtherCurrentandLongTermAssetsScheduleofOtherNoncurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerAssetReclassifiedToReceivable": {
     "auth_ref": [
      "r425"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time from transfer to receivable due to right to consideration becoming unconditional.",
        "label": "Contract with Customer, Asset, Reclassified to Receivable",
        "terseLabel": "Volume commitment contract assets reclassified to accounts receivable"
       }
      }
     },
     "localname": "ContractWithCustomerAssetReclassifiedToReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/RevenueRecognitionVolumeCommitmentProgramsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r422",
      "r423",
      "r438"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/RevenueRecognitionExtendedWarrantiesandPostContractSupportDetails",
      "http://www.idexx.com/role/RevenueRecognitionInstrumentRebateProgramsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r422",
      "r423",
      "r438"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Current portion of deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "auth_ref": [
      "r422",
      "r423",
      "r438"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Contract with Customer, Liability, Noncurrent",
        "terseLabel": "Long-term deferred revenue, net of current portion"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r439"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Deferred revenue recognized"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/RevenueRecognitionExtendedWarrantiesandPostContractSupportDetails",
      "http://www.idexx.com/role/RevenueRecognitionInstrumentRebateProgramsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r121",
      "r750"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Rental and operating-type reagent rental program instruments transferred from inventory to property and equipment"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/InventoriesNarrativeDetails",
      "http://www.idexx.com/role/PropertyandEquipmentNetSummaryOfDepreciationAndAmortizationCapitalizedComputerSoftwareForInternalUseAndUnpaidPropertyEquipmentReflectedInAccountPayableAndAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r122",
      "r158",
      "r259",
      "r362",
      "r363",
      "r364",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r661"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost of Revenue",
        "terseLabel": "Total cost of revenue",
        "verboseLabel": "Cost of revenue"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AccumulatedOtherComprehensiveIncomeScheduleofReclassificationsoutofAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.idexx.com/role/HedgingInstrumentsDerivativesDesignatedinCashFlowHedgingRelationshipsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of Revenue [Abstract]",
        "terseLabel": "Cost of Revenue:"
       }
      }
     },
     "localname": "CostOfRevenueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of revenue"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/HedgingInstrumentsDerivativesDesignatedinCashFlowHedgingRelationshipsDetails",
      "http://www.idexx.com/role/ShareBasedCompensationScheduleofSelectedFinancialImpactofShareBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Credit Loss [Abstract]"
       }
      }
     },
     "localname": "CreditLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditLossFinancialInstrumentPolicyTextBlock": {
     "auth_ref": [
      "r267",
      "r268",
      "r269",
      "r271",
      "r272",
      "r276",
      "r278",
      "r280",
      "r281",
      "r282",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit loss on financial instrument measured at amortized cost basis, net investment in lease, off-balance sheet credit exposure, and available-for-sale debt security. Includes, but is not limited to, methodology used to estimate allowance for credit loss, how writeoff of uncollectible amount is recognized, and determination of past due status and nonaccrual status.",
        "label": "Credit Loss, Financial Instrument [Policy Text Block]",
        "terseLabel": "Credit Losses"
       }
      }
     },
     "localname": "CreditLossFinancialInstrumentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CreditLossFinancialInstrumentTextBlock": {
     "auth_ref": [
      "r272",
      "r279",
      "r280",
      "r283",
      "r284",
      "r293",
      "r294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for credit loss on financial instrument measured at amortized cost basis, net investment in lease, off-balance sheet credit exposure, and available-for-sale debt security.",
        "label": "Credit Loss, Financial Instrument [Text Block]",
        "terseLabel": "Credit Losses"
       }
      }
     },
     "localname": "CreditLossFinancialInstrumentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CreditLosses"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CrossCurrencyInterestRateContractMember": {
     "auth_ref": [
      "r450",
      "r630"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to interest rates and foreign exchange rates.",
        "label": "Cross Currency Interest Rate Contract [Member]",
        "terseLabel": "Cross currency swaps"
       }
      }
     },
     "localname": "CrossCurrencyInterestRateContractMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/FairValueMeasurementsScheduleofFairValueofAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://www.idexx.com/role/HedgingInstrumentsNarrativeDetails",
      "http://www.idexx.com/role/HedgingInstrumentsScheduleofFairValuesandBalanceSheetClassificationsofDerivativesandNonderivativesDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r159",
      "r554",
      "r563"
     ],
     "calculation": {
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofProvisionBenefitforIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofProvisionBenefitforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r159",
      "r554"
     ],
     "calculation": {
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofProvisionBenefitforIncomeTaxesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "International"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofProvisionBenefitforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r159",
      "r554",
      "r563",
      "r565"
     ],
     "calculation": {
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofProvisionBenefitforIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Provision for current income taxes"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofProvisionBenefitforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofProvisionBenefitforIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r159",
      "r554",
      "r563"
     ],
     "calculation": {
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofProvisionBenefitforIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofProvisionBenefitforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerRelatedIntangibleAssetsMember": {
     "auth_ref": [
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer-related asset, including, but not limited to, customer lists, and noncontractual customer relationships.",
        "label": "Customer-Related Intangible Assets [Member]",
        "terseLabel": "Customer-related intangible assets"
       }
      }
     },
     "localname": "CustomerRelatedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AcquisitionsandInvestmentsDetails",
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofEstimatedUsefulLivesForIntangibleAssetsDetails",
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofIntangibleAssetsOtherThanGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AcquisitionsandInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r156",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r390",
      "r397",
      "r398",
      "r400",
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/Debt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r34",
      "r35",
      "r36",
      "r157",
      "r164",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r380",
      "r386",
      "r387",
      "r388",
      "r389",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r402",
      "r403",
      "r404",
      "r405",
      "r687",
      "r760",
      "r763",
      "r781"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/DebtNarrativeDetails",
      "http://www.idexx.com/role/DebtScheduleofSeniorNoteBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Credit spread during period"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r373",
      "r402",
      "r403",
      "r685",
      "r687",
      "r688"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Aggregate principal amount of net investment hedge",
        "verboseLabel": "Principal Amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/DebtNarrativeDetails",
      "http://www.idexx.com/role/DebtScheduleofSeniorNoteBorrowingsDetails",
      "http://www.idexx.com/role/HedgingInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r69",
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Coupon Rate",
        "verboseLabel": "Stated interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/DebtNarrativeDetails",
      "http://www.idexx.com/role/DebtScheduleofSeniorNoteBorrowingsDetails",
      "http://www.idexx.com/role/HedgingInstrumentsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/DebtScheduleofSeniorNoteBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r70",
      "r157",
      "r164",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r380",
      "r386",
      "r387",
      "r388",
      "r389",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r402",
      "r403",
      "r404",
      "r405",
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/DebtNarrativeDetails",
      "http://www.idexx.com/role/DebtScheduleofSeniorNoteBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r70",
      "r157",
      "r164",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r380",
      "r386",
      "r387",
      "r388",
      "r389",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r399",
      "r402",
      "r403",
      "r404",
      "r405",
      "r411",
      "r412",
      "r413",
      "r414",
      "r684",
      "r685",
      "r687",
      "r688",
      "r779"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/DebtScheduleofSeniorNoteBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Debt instrument, term"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtInstrumentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instruments [Abstract]",
        "terseLabel": "Debt Instruments [Abstract]"
       }
      }
     },
     "localname": "DebtInstrumentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtWeightedAverageInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average interest rate of debt outstanding.",
        "label": "Debt, Weighted Average Interest Rate",
        "terseLabel": "Credit facility weighted average interest rates on outstanding balance"
       }
      }
     },
     "localname": "DebtWeightedAverageInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DeferredCosts": {
     "auth_ref": [
      "r33",
      "r758",
      "r783"
     ],
     "calculation": {
      "http://www.idexx.com/role/OtherCurrentandLongTermAssetsScheduleofOtherNoncurrentAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred cost, excluding capitalized cost related to contract with customer; classified as noncurrent.",
        "label": "Deferred Costs, Noncurrent",
        "verboseLabel": "Customer acquisition costs"
       }
      }
     },
     "localname": "DeferredCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/OtherCurrentandLongTermAssetsScheduleofOtherNoncurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCostsCurrent": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://www.idexx.com/role/OtherCurrentandLongTermAssetsScheduleofOtherCurrentAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of deferred costs capitalized at the end of the reporting period that are expected to be charged against earnings within one year or the normal operating cycle, if longer.",
        "label": "Deferred Costs, Current",
        "terseLabel": "Customer acquisition costs"
       }
      }
     },
     "localname": "DeferredCostsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/OtherCurrentandLongTermAssetsScheduleofOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r159",
      "r555",
      "r563"
     ],
     "calculation": {
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofProvisionBenefitforIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofProvisionBenefitforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r159",
      "r555",
      "r563"
     ],
     "calculation": {
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofProvisionBenefitforIncomeTaxesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "terseLabel": "International"
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofProvisionBenefitforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r529",
      "r530"
     ],
     "calculation": {
      "http://www.idexx.com/role/OtherCurrentandLongTermAssetsScheduleofOtherNoncurrentAssetsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/OtherCurrentandLongTermAssetsScheduleofOtherNoncurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r143",
      "r159",
      "r555",
      "r563",
      "r564",
      "r565"
     ],
     "calculation": {
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofProvisionBenefitforIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "totalLabel": "Provision (benefit) for deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofProvisionBenefitforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Deferred"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofProvisionBenefitforIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r39",
      "r40",
      "r545",
      "r762",
      "r780"
     ],
     "calculation": {
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofNetDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Total liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofNetDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r529",
      "r530"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxesAndTaxCredits": {
     "auth_ref": [
      "r144"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) and income tax credits.",
        "label": "Deferred Income Taxes and Tax Credits",
        "verboseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxesAndTaxCredits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r159",
      "r555",
      "r563"
     ],
     "calculation": {
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofProvisionBenefitforIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofProvisionBenefitforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsDeferredIncome": {
     "auth_ref": [
      "r552",
      "r553"
     ],
     "calculation": {
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofNetDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.",
        "label": "Deferred Tax Assets, Deferred Income",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "DeferredTaxAssetsDeferredIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofNetDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r546"
     ],
     "calculation": {
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofNetDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofNetDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsInventory": {
     "auth_ref": [
      "r552",
      "r553"
     ],
     "calculation": {
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofNetDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.",
        "label": "Deferred Tax Assets, Inventory",
        "terseLabel": "Inventory basis differences"
       }
      }
     },
     "localname": "DeferredTaxAssetsInventory",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofNetDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r548"
     ],
     "calculation": {
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofNetDeferredTaxAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "totalLabel": "Net deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofNetDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r548"
     ],
     "calculation": {
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofNetDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Total assets, net of valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofNetDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r552",
      "r553"
     ],
     "calculation": {
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofNetDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofNetDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOtherComprehensiveLoss": {
     "auth_ref": [
      "r552",
      "r553"
     ],
     "calculation": {
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofNetDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from unrealized losses in other comprehensive income.",
        "label": "Deferred Tax Assets, Other Comprehensive Loss",
        "terseLabel": "Unrealized losses on foreign currency exchange contracts and investments"
       }
      }
     },
     "localname": "DeferredTaxAssetsOtherComprehensiveLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofNetDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment": {
     "auth_ref": [],
     "calculation": {
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofNetDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Assets, Property, Plant and Equipment",
        "terseLabel": "Property-based differences"
       }
      }
     },
     "localname": "DeferredTaxAssetsPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofNetDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": {
     "auth_ref": [
      "r551",
      "r552",
      "r553"
     ],
     "calculation": {
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofNetDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards",
        "terseLabel": "Tax credit carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofNetDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r552",
      "r553"
     ],
     "calculation": {
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofNetDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofNetDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther": {
     "auth_ref": [
      "r552",
      "r553"
     ],
     "calculation": {
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofNetDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from provisions, reserves, allowances, and accruals, classified as other.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofNetDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": {
     "auth_ref": [
      "r552",
      "r553"
     ],
     "calculation": {
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofNetDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofNetDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts": {
     "auth_ref": [
      "r552",
      "r553"
     ],
     "calculation": {
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofNetDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.",
        "label": "Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Accounts Receivable, Allowance for Credit Loss",
        "terseLabel": "Accounts receivable reserves"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofNetDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r547"
     ],
     "calculation": {
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofNetDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Valuation allowance",
        "periodEndLabel": "Balance at the end of the year",
        "periodStartLabel": "Balance at beginning of year"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofNetDeferredTaxAssetsandLiabilitiesDetails",
      "http://www.idexx.com/role/IncomeTaxesScheduleofValuationAllowanceForDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost": {
     "auth_ref": [
      "r552",
      "r553"
     ],
     "calculation": {
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofNetDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount as of the balance sheet date of the estimated future tax effects attributable to policy acquisition costs being expensed for tax purposes but capitalized in conformity with generally accepted accounting principles, which will reverse in future periods when amortization of such capitalized costs cannot be deducted for tax purposes.",
        "label": "Deferred Tax Liabilities, Deferred Expense, Deferred Policy Acquisition Cost",
        "negatedLabel": "Customer acquisition costs"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofNetDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets": {
     "auth_ref": [
      "r552",
      "r553"
     ],
     "calculation": {
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofNetDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.",
        "label": "Deferred Tax Liabilities, Intangible Assets",
        "negatedLabel": "Intangible asset basis differences"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofNetDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesOther": {
     "auth_ref": [
      "r552",
      "r553"
     ],
     "calculation": {
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofNetDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.",
        "label": "Deferred Tax Liabilities, Other",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofNetDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r552",
      "r553"
     ],
     "calculation": {
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofNetDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "negatedLabel": "Property-based differences"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofNetDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains": {
     "auth_ref": [
      "r552",
      "r553"
     ],
     "calculation": {
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofNetDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from unrealized gains on foreign currency transactions.",
        "label": "Deferred Tax Liabilities, Unrealized Currency Transaction Gains",
        "negatedLabel": "Unrealized gains on foreign currency exchange contracts and investments"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofNetDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "auth_ref": [
      "r467"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for defined contribution plan.",
        "label": "Defined Contribution Plan, Cost",
        "terseLabel": "Employer contributions"
       }
      }
     },
     "localname": "DefinedContributionPlanCostRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IDEXXRetirementandIncentiveSavingsPlanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of discretionary contributions made by an employer to a defined contribution plan.",
        "label": "Defined Contribution Plan, Employer Discretionary Contribution Amount",
        "terseLabel": "Discretionary contributions"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IDEXXRetirementandIncentiveSavingsPlanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay",
        "verboseLabel": "Contribution match, maximum percent of participants' eligible compensation"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IDEXXRetirementandIncentiveSavingsPlanDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r143",
      "r217"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.idexx.com/role/SegmentReportingSummaryofSegmentPerformanceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection": {
     "auth_ref": [
      "r84",
      "r86"
     ],
     "calculation": {
      "http://www.idexx.com/role/HedgingInstrumentsScheduleofFairValuesandBalanceSheetClassificationsofDerivativesandNonderivativesDesignatedasHedgingInstrumentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after effects of master netting arrangements, deduction of assets not subject to a master netting arrangement and elected not to be offset, of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, offset against an obligation to return collateral.",
        "label": "Derivative Asset, Fair Value, Offset Against Collateral, Net of Not Subject to Master Netting Arrangement, Policy Election",
        "totalLabel": "Hedging assets, net amount"
       }
      }
     },
     "localname": "DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/HedgingInstrumentsScheduleofFairValuesandBalanceSheetClassificationsofDerivativesandNonderivativesDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction": {
     "auth_ref": [
      "r83",
      "r86"
     ],
     "calculation": {
      "http://www.idexx.com/role/HedgingInstrumentsScheduleofFairValuesandBalanceSheetClassificationsofDerivativesandNonderivativesDesignatedasHedgingInstrumentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, elected not to be offset, deducted from derivative assets.",
        "label": "Derivative Asset, Not Offset, Policy Election Deduction",
        "negatedTerseLabel": "Hedging assets, gross amounts subject to master netting arrangements not offset on the balance sheet"
       }
      }
     },
     "localname": "DerivativeAssetNotOffsetPolicyElectionDeduction",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/HedgingInstrumentsScheduleofFairValuesandBalanceSheetClassificationsofDerivativesandNonderivativesDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssets": {
     "auth_ref": [
      "r82",
      "r85",
      "r87",
      "r660"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset",
        "terseLabel": "Derivative asset"
       }
      }
     },
     "localname": "DerivativeAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/FairValueMeasurementsScheduleofFairValueofAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/HedgingInstrumentsDerivativesDesignatedinCashFlowHedgingRelationshipsDetails",
      "http://www.idexx.com/role/HedgingInstrumentsNarrativeDetails",
      "http://www.idexx.com/role/HedgingInstrumentsScheduleofFairValuesandBalanceSheetClassificationsofDerivativesandNonderivativesDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r81",
      "r87",
      "r88",
      "r622",
      "r728"
     ],
     "calculation": {
      "http://www.idexx.com/role/HedgingInstrumentsScheduleofFairValuesandBalanceSheetClassificationsofDerivativesandNonderivativesDesignatedasHedgingInstrumentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Fair Value, Gross Asset",
        "terseLabel": "Hedging assets, total derivative instruments presented as cash flow hedges on the balance sheet"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/HedgingInstrumentsScheduleofFairValuesandBalanceSheetClassificationsofDerivativesandNonderivativesDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "auth_ref": [
      "r81",
      "r87",
      "r88",
      "r622",
      "r728"
     ],
     "calculation": {
      "http://www.idexx.com/role/HedgingInstrumentsScheduleofFairValuesandBalanceSheetClassificationsofDerivativesandNonderivativesDesignatedasHedgingInstrumentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Fair Value, Gross Liability",
        "terseLabel": "Hedging liabilities, total hedging instruments presented on the balance sheet"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/HedgingInstrumentsScheduleofFairValuesandBalanceSheetClassificationsofDerivativesandNonderivativesDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r87",
      "r620",
      "r623",
      "r628",
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/HedgingInstrumentsDerivativesDesignatedinCashFlowHedgingRelationshipsDetails",
      "http://www.idexx.com/role/HedgingInstrumentsNarrativeDetails",
      "http://www.idexx.com/role/HedgingInstrumentsScheduleofFairValuesandBalanceSheetClassificationsofDerivativesandNonderivativesDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r637",
      "r649"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Hedging Instruments"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/HedgingInstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r617",
      "r620",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/HedgingInstrumentsScheduleofFairValuesandBalanceSheetClassificationsofDerivativesandNonderivativesDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLiabilities": {
     "auth_ref": [
      "r82",
      "r85",
      "r87",
      "r660"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability",
        "terseLabel": "Derivative liabilities"
       }
      }
     },
     "localname": "DerivativeLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/FairValueMeasurementsScheduleofFairValueofAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection": {
     "auth_ref": [
      "r84",
      "r86"
     ],
     "calculation": {
      "http://www.idexx.com/role/HedgingInstrumentsScheduleofFairValuesandBalanceSheetClassificationsofDerivativesandNonderivativesDesignatedasHedgingInstrumentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after effects of master netting arrangements, deduction of liabilities not subject to a master netting arrangement and elected not to be offset, of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, offset against the right to receive collateral.",
        "label": "Derivative Liability, Fair Value, Offset Against Collateral, Net of Not Subject to Master Netting Arrangement, Policy Election",
        "totalLabel": "Hedging liabilities, net amount"
       }
      }
     },
     "localname": "DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/HedgingInstrumentsScheduleofFairValuesandBalanceSheetClassificationsofDerivativesandNonderivativesDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction": {
     "auth_ref": [
      "r83",
      "r86"
     ],
     "calculation": {
      "http://www.idexx.com/role/HedgingInstrumentsScheduleofFairValuesandBalanceSheetClassificationsofDerivativesandNonderivativesDesignatedasHedgingInstrumentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, elected not to be offset, deducted from derivative liabilities.",
        "label": "Derivative Liability, Not Offset, Policy Election Deduction",
        "negatedTerseLabel": "Hedging liabilities, gross amounts subject to master netting arrangements not offset on the balance sheet"
       }
      }
     },
     "localname": "DerivativeLiabilityNotOffsetPolicyElectionDeduction",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/HedgingInstrumentsScheduleofFairValuesandBalanceSheetClassificationsofDerivativesandNonderivativesDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/HedgingInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r613",
      "r615"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Notional amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/HedgingInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativesFairValueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivatives, Fair Value [Line Items]",
        "terseLabel": "Derivatives, Fair Value [Line Items]"
       }
      }
     },
     "localname": "DerivativesFairValueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/HedgingInstrumentsScheduleofFairValuesandBalanceSheetClassificationsofDerivativesandNonderivativesDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r163",
      "r612",
      "r614",
      "r617",
      "r618",
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Hedging Instruments"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r617"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Designated as Hedging Instrument"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/HedgingInstrumentsNarrativeDetails",
      "http://www.idexx.com/role/HedgingInstrumentsScheduleofFairValuesandBalanceSheetClassificationsofDerivativesandNonderivativesDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/RevenueRecognitionDisaggregationofRevenuebyMajorProductandServiceCategoriesDetails",
      "http://www.idexx.com/role/RevenueRecognitionDisaggregationofRevenuebyPrincipalGeographicAreaBasedonCustomersDomicilesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r437",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/RevenueRecognitionDisaggregationofRevenuebyMajorProductandServiceCategoriesDetails",
      "http://www.idexx.com/role/RevenueRecognitionDisaggregationofRevenuebyPrincipalGeographicAreaBasedonCustomersDomicilesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregated revenues"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/RevenueRecognitionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Share-Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EMEAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regions of Europe, Middle East and Africa.",
        "label": "EMEA [Member]",
        "terseLabel": "Europe, the Middle East and Africa"
       }
      }
     },
     "localname": "EMEAMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/RevenueRecognitionDisaggregationofRevenuebyPrincipalGeographicAreaBasedonCustomersDomicilesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings per Share:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r119",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r183",
      "r185",
      "r190",
      "r191",
      "r192",
      "r197",
      "r198",
      "r647",
      "r648",
      "r774",
      "r799"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic (in USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r119",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r185",
      "r190",
      "r191",
      "r192",
      "r197",
      "r198",
      "r647",
      "r648",
      "r774",
      "r799"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r193",
      "r195"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r193",
      "r195",
      "r196",
      "r199"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/EarningsPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r674"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Net effect of changes in exchange rates on cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r532"
     ],
     "calculation": {
      "http://www.idexx.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective income tax rate",
        "totalLabel": "Effective tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesNarrativeDetails",
      "http://www.idexx.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r161",
      "r532",
      "r567"
     ],
     "calculation": {
      "http://www.idexx.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "U.S. federal statutory rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r532",
      "r567"
     ],
     "calculation": {
      "http://www.idexx.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent",
        "terseLabel": "Taxation on international earnings"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "auth_ref": [
      "r532",
      "r567"
     ],
     "calculation": {
      "http://www.idexx.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent",
        "negatedTerseLabel": "Share-based compensation from settlements"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "auth_ref": [
      "r532",
      "r567"
     ],
     "calculation": {
      "http://www.idexx.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "terseLabel": "Other, net"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r532",
      "r567"
     ],
     "calculation": {
      "http://www.idexx.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "State income tax, net of federal tax benefit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch": {
     "auth_ref": [
      "r532",
      "r567"
     ],
     "calculation": {
      "http://www.idexx.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent",
        "negatedLabel": "Research and development credit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsResearch",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://www.idexx.com/role/AccruedLiabilitiesandOtherLongTermLiabilitiesScheduleofAccruedLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued employee compensation and related expenses"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AccruedLiabilitiesandOtherLongTermLiabilitiesScheduleofAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r507"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation expense, net of estimated forfeitures, for unvested share-based compensation awards outstanding"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Weighted average recognition period for unrecognized compensation expense, in years"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "auth_ref": [
      "r505"
     ],
     "calculation": {
      "http://www.idexx.com/role/ShareBasedCompensationScheduleofSelectedFinancialImpactofShareBasedCompensationDetails": {
       "order": 2.0,
       "parentTag": "idxx_AllocatedShareBasedCompensationExpenseNetOfTaxExcludingTaxBenefitFromSettlementOfShareBasedAwards",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expense, Tax Benefit",
        "negatedLabel": "Income tax benefit resulting from share-based compensation expense",
        "terseLabel": "Income tax benefit resulting from share-based compensation expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.idexx.com/role/ShareBasedCompensationScheduleofSelectedFinancialImpactofShareBasedCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions": {
     "auth_ref": [
      "r509"
     ],
     "calculation": {
      "http://www.idexx.com/role/ShareBasedCompensationScheduleofSelectedFinancialImpactofShareBasedCompensationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit from exercise of option under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Exercise of Option, Tax Benefit",
        "negatedLabel": "Income tax benefit resulting from settlement of share-based awards"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationScheduleofSelectedFinancialImpactofShareBasedCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r2",
      "r107",
      "r108",
      "r109",
      "r166",
      "r167",
      "r168",
      "r171",
      "r179",
      "r181",
      "r201",
      "r264",
      "r410",
      "r415",
      "r514",
      "r515",
      "r516",
      "r559",
      "r560",
      "r646",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r681",
      "r809",
      "r810",
      "r811",
      "r858"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AccumulatedOtherComprehensiveIncomeScheduleofAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.idexx.com/role/AccumulatedOtherComprehensiveIncomeScheduleofReclassificationsoutofAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://www.idexx.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/FairValueMeasurementsScheduleofFairValueofAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r650",
      "r651",
      "r652",
      "r657"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/FairValueMeasurementsScheduleofFairValueofAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r388",
      "r402",
      "r403",
      "r450",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r464",
      "r651",
      "r718",
      "r719",
      "r720"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/FairValueMeasurementsScheduleofFairValueofAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r388",
      "r450",
      "r452",
      "r457",
      "r464",
      "r651",
      "r718"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Quoted Prices in Active Markets for Identical Assets (Level 1)"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/FairValueMeasurementsScheduleofFairValueofAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r388",
      "r402",
      "r403",
      "r450",
      "r452",
      "r457",
      "r464",
      "r651",
      "r719"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Significant Other Observable Inputs (Level 2)"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/FairValueMeasurementsScheduleofFairValueofAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r388",
      "r402",
      "r403",
      "r450",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r464",
      "r651",
      "r720"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Significant Unobservable Inputs (Level 3)"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/FairValueMeasurementsScheduleofFairValueofAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/FairValueMeasurementsScheduleofContingentConsiderationLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r653",
      "r657"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of contingent consideration liability"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "auth_ref": [
      "r654"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "terseLabel": "Change in estimated fair value"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.idexx.com/role/FairValueMeasurementsScheduleofContingentConsiderationLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues": {
     "auth_ref": [
      "r655"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances",
        "terseLabel": "Contingent consideration recorded from acquisitions"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.idexx.com/role/FairValueMeasurementsScheduleofContingentConsiderationLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r653"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/FairValueMeasurementsScheduleofContingentConsiderationLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r388",
      "r402",
      "r403",
      "r450",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r464",
      "r718",
      "r719",
      "r720"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Disclosure Items [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/FairValueMeasurementsScheduleofFairValueofAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r658",
      "r659"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "auth_ref": [
      "r619",
      "r625",
      "r634"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]"
       }
      }
     },
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/HedgingInstrumentsScheduleofFairValuesandBalanceSheetClassificationsofDerivativesandNonderivativesDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r272",
      "r275",
      "r276",
      "r277",
      "r283",
      "r293",
      "r294",
      "r295",
      "r296",
      "r399",
      "r409",
      "r637",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r844",
      "r845",
      "r846",
      "r847",
      "r848",
      "r849",
      "r850"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/FairValueMeasurementsScheduleofFairValueofAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Financing Receivable, Allowance for Credit Loss [Line Items]",
        "terseLabel": "Financing Receivable, Allowance for Credit Loss [Line Items]"
       }
      }
     },
     "localname": "FinancingReceivableAllowanceForCreditLossesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CreditLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancingReceivablesPeriodPastDueAxis": {
     "auth_ref": [
      "r250",
      "r276",
      "r285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by period in which financial asset is past due or not past due.",
        "label": "Financial Asset, Aging [Axis]",
        "terseLabel": "Financial Asset, Period Past Due [Axis]"
       }
      }
     },
     "localname": "FinancingReceivablesPeriodPastDueAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CreditLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancingReceivablesPeriodPastDueDomain": {
     "auth_ref": [
      "r250",
      "r276",
      "r285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period in which financial asset is past due or not past due. For past due, element name and standard label in Financial Asset, [numeric lower end] to [numeric higher end] [date measure] Past Due [Member] or Financial Asset, Greater than [low end numeric value] [date measure] Past Due [Member] or Financial Asset, Less than [high end numeric value] [date measure] Past Due [Member] formats.",
        "label": "Financial Asset, Aging [Domain]",
        "terseLabel": "Financial Asset, Period Past Due [Domain]"
       }
      }
     },
     "localname": "FinancingReceivablesPeriodPastDueDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CreditLossesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "verboseLabel": "Intangible assets, estimated useful life"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofEstimatedUsefulLivesForIntangibleAssetsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r324"
     ],
     "calculation": {
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofIntangibleAssetsOtherThanGoodwillDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "terseLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofIntangibleAssetsOtherThanGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofExpectedAmortizationExpenseDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofExpectedAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r326"
     ],
     "calculation": {
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofExpectedAmortizationExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofExpectedAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r326"
     ],
     "calculation": {
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofExpectedAmortizationExpenseDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofExpectedAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r326"
     ],
     "calculation": {
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofExpectedAmortizationExpenseDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofExpectedAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r326"
     ],
     "calculation": {
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofExpectedAmortizationExpenseDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofExpectedAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r326"
     ],
     "calculation": {
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofExpectedAmortizationExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofExpectedAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r318",
      "r320",
      "r324",
      "r327",
      "r751",
      "r755"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AcquisitionsandInvestmentsDetails",
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofEstimatedUsefulLivesForIntangibleAssetsDetails",
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofIntangibleAssetsOtherThanGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r324",
      "r755"
     ],
     "calculation": {
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofIntangibleAssetsOtherThanGoodwillDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Cost"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofIntangibleAssetsOtherThanGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofIntangibleAssetsOtherThanGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r318",
      "r323"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AcquisitionsandInvestmentsDetails",
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofEstimatedUsefulLivesForIntangibleAssetsDetails",
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofIntangibleAssetsOtherThanGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r324",
      "r751"
     ],
     "calculation": {
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofExpectedAmortizationExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofIntangibleAssetsOtherThanGoodwillDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofExpectedAmortizationExpenseDetails",
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofIntangibleAssetsOtherThanGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Foreign Currency Fair Value Hedge Derivative [Line Items]",
        "terseLabel": "Foreign Currency Fair Value Hedge Derivative [Line Items]"
       }
      }
     },
     "localname": "ForeignCurrencyFairValueHedgeDerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/HedgingInstrumentsDerivativesDesignatedinCashFlowHedgingRelationshipsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about derivative instruments designated as foreign currency fair value hedging instruments.",
        "label": "Foreign Currency Fair Value Hedge Derivative [Table]",
        "terseLabel": "Foreign Currency Fair Value Hedge Derivative [Table]"
       }
      }
     },
     "localname": "ForeignCurrencyFairValueHedgeDerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/HedgingInstrumentsDerivativesDesignatedinCashFlowHedgingRelationshipsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "auth_ref": [
      "r670",
      "r671",
      "r672",
      "r673"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), before Tax",
        "terseLabel": "Foreign currency gains (losses)"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r682"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign Currency"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r87",
      "r450",
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "terseLabel": "Foreign currency exchange contracts"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/FairValueMeasurementsScheduleofFairValueofAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://www.idexx.com/role/HedgingInstrumentsDerivativesDesignatedinCashFlowHedgingRelationshipsDetails",
      "http://www.idexx.com/role/HedgingInstrumentsScheduleofFairValuesandBalanceSheetClassificationsofDerivativesandNonderivativesDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness": {
     "auth_ref": [
      "r627"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net gain (loss) included in earnings for the period relating to components of the gain (loss) on interest rate cash flow hedging instruments excluded from the assessment of fair value hedge effectiveness.",
        "label": "Gain (Loss) on Components Excluded from Assessment of Interest Rate Cash Flow Hedge Effectiveness",
        "terseLabel": "Gain (loss) on excluded component as a reduction of interest expense"
       }
      }
     },
     "localname": "GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/HedgingInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r124"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralInsuranceExpense": {
     "auth_ref": [
      "r124"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The expense in the period incurred with respect to protection provided by insurance entities against risks other than risks associated with production (which are allocated to cost of sales).",
        "label": "General Insurance Expense",
        "terseLabel": "General insurance expense"
       }
      }
     },
     "localname": "GeneralInsuranceExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CommitmentsContingenciesandGuaranteesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r306",
      "r308",
      "r713",
      "r757"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AcquisitionsandInvestmentsDetails",
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r309"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Business combinations"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "verboseLabel": "Goodwill and Intangible Assets, Net"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "auth_ref": [
      "r313",
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Goodwill and Other Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r311"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "negatedLabel": "Impact of changes in foreign currency exchange rates"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r143",
      "r307",
      "r310",
      "r314"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "terseLabel": "Goodwill impairments"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r312",
      "r574"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Purchase Accounting Adjustments",
        "verboseLabel": "Acquisition adjustment"
       }
      }
     },
     "localname": "GoodwillPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r120",
      "r158",
      "r222",
      "r228",
      "r232",
      "r235",
      "r238",
      "r259",
      "r362",
      "r363",
      "r364",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r661"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GuaranteeObligationsCurrentCarryingValue": {
     "auth_ref": [
      "r356"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current carrying amount of the liability for the freestanding or embedded guarantor's obligations under the guarantee or each group of similar guarantees.",
        "label": "Guarantor Obligations, Current Carrying Value",
        "terseLabel": "Liabilities for indemnification obligations"
       }
      }
     },
     "localname": "GuaranteeObligationsCurrentCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CommitmentsContingenciesandGuaranteesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r617",
      "r632"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/HedgingInstrumentsNarrativeDetails",
      "http://www.idexx.com/role/HedgingInstrumentsScheduleofFairValuesandBalanceSheetClassificationsofDerivativesandNonderivativesDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r617"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/HedgingInstrumentsNarrativeDetails",
      "http://www.idexx.com/role/HedgingInstrumentsScheduleofFairValuesandBalanceSheetClassificationsofDerivativesandNonderivativesDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r617"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/HedgingInstrumentsScheduleofFairValuesandBalanceSheetClassificationsofDerivativesandNonderivativesDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r143",
      "r328"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.",
        "label": "Impairment of Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Intangible assets impairments"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r160",
      "r566"
     ],
     "calculation": {
      "http://www.idexx.com/role/IncomeTaxesScheduleofEarningsBeforeIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "Domestic"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesScheduleofEarningsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r113",
      "r222",
      "r228",
      "r232",
      "r235",
      "r238",
      "r756",
      "r768",
      "r777",
      "r800"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      },
      "http://www.idexx.com/role/IncomeTaxesScheduleofEarningsBeforeIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before provision for income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.idexx.com/role/IncomeTaxesScheduleofEarningsBeforeIncomeTaxesDetails",
      "http://www.idexx.com/role/SegmentReportingSummaryofSegmentPerformanceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r160",
      "r566"
     ],
     "calculation": {
      "http://www.idexx.com/role/IncomeTaxesScheduleofEarningsBeforeIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "International"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesScheduleofEarningsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r336",
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/HedgingInstrumentsDerivativesDesignatedinCashFlowHedgingRelationshipsDetails",
      "http://www.idexx.com/role/ShareBasedCompensationScheduleofSelectedFinancialImpactofShareBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location",
        "verboseLabel": "Income Statement and Other Comprehensive Income Location"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/HedgingInstrumentsDerivativesDesignatedinCashFlowHedgingRelationshipsDetails",
      "http://www.idexx.com/role/ShareBasedCompensationScheduleofSelectedFinancialImpactofShareBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r161",
      "r533",
      "r543",
      "r550",
      "r561",
      "r568",
      "r571",
      "r572",
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityCumulativeEffectOfChangeInAccountingPrinciple": {
     "auth_ref": [
      "r562",
      "r569"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cumulative tax effect on beginning retained earnings from change in accounting principle.",
        "label": "Income Tax Effects Allocated Directly to Equity, Cumulative Effect of Change in Accounting Principle",
        "negatedTerseLabel": "Non-cash cumulative effect adjustment to retained earnings, tax"
       }
      }
     },
     "localname": "IncomeTaxEffectsAllocatedDirectlyToEquityCumulativeEffectOfChangeInAccountingPrinciple",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r162",
      "r180",
      "r181",
      "r220",
      "r531",
      "r562",
      "r570",
      "r801"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      },
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofProvisionBenefitforIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Provision for income taxes",
        "totalLabel": "Provision for income taxes",
        "verboseLabel": "Tax (benefit) expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AccumulatedOtherComprehensiveIncomeScheduleofReclassificationsoutofAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofProvisionBenefitforIncomeTaxesDetails",
      "http://www.idexx.com/role/SegmentReportingSummaryofSegmentPerformanceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxHolidayAggregateDollarAmount": {
     "auth_ref": [
      "r568"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income taxes from which a reporting entity is exempt or for which it will receive a reduction in income taxes as a result of the income tax holiday granted by the taxing jurisdiction.",
        "label": "Income Tax Holiday, Aggregate Dollar Amount",
        "terseLabel": "Income tax ruling exemption"
       }
      }
     },
     "localname": "IncomeTaxHolidayAggregateDollarAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r106",
      "r527",
      "r528",
      "r543",
      "r544",
      "r549",
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r147"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Income taxes paid"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesReceivable": {
     "auth_ref": [
      "r75",
      "r766",
      "r793"
     ],
     "calculation": {
      "http://www.idexx.com/role/OtherCurrentandLongTermAssetsScheduleofOtherCurrentAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.",
        "label": "Income Taxes Receivable, Current",
        "terseLabel": "Taxes receivable"
       }
      }
     },
     "localname": "IncomeTaxesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/OtherCurrentandLongTermAssetsScheduleofOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesReceivableNoncurrent": {
     "auth_ref": [
      "r33",
      "r782"
     ],
     "calculation": {
      "http://www.idexx.com/role/OtherCurrentandLongTermAssetsScheduleofOtherNoncurrentAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount due after one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.",
        "label": "Income Taxes Receivable, Noncurrent",
        "terseLabel": "Taxes receivable"
       }
      }
     },
     "localname": "IncomeTaxesReceivableNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/OtherCurrentandLongTermAssetsScheduleofOtherNoncurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableTrade": {
     "auth_ref": [
      "r142"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Payable, Trade",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableTrade",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r142"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "auth_ref": [
      "r142",
      "r747"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r142"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r142"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedLabel": "Other assets and liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r186",
      "r187",
      "r188",
      "r192"
     ],
     "calculation": {
      "http://www.idexx.com/role/EarningsPerShareReconciliationofSharesOutstandingDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "verboseLabel": "Dilutive effect of share-based payment awards (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/EarningsPerShareReconciliationofSharesOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r316",
      "r322"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestAndOtherIncome": {
     "auth_ref": [],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).",
        "label": "Interest and Other Income",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InterestAndOtherIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r111",
      "r216",
      "r683",
      "r686",
      "r776"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeExpenseNonoperatingNet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of nonoperating interest income (expense).",
        "label": "Interest Income (Expense), Nonoperating, Net",
        "terseLabel": "Interest expense, net"
       }
      }
     },
     "localname": "InterestIncomeExpenseNonoperatingNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/SegmentReportingSummaryofSegmentPerformanceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r136",
      "r139",
      "r147"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryCurrentTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about inventory expected to be sold or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Current [Table]",
        "terseLabel": "Inventory, Current [Table]"
       }
      }
     },
     "localname": "InventoryCurrentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/InventoriesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/Inventories"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r51",
      "r299"
     ],
     "calculation": {
      "http://www.idexx.com/role/InventoriesScheduleofComponentsofInventoriesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/InventoriesScheduleofComponentsofInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Inventory [Line Items]",
        "terseLabel": "Inventory [Line Items]"
       }
      }
     },
     "localname": "InventoryLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/InventoriesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r10",
      "r77",
      "r713"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.idexx.com/role/InventoriesScheduleofComponentsofInventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories",
        "totalLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.idexx.com/role/InventoriesScheduleofComponentsofInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory, Net [Abstract]",
        "terseLabel": "Inventory, Net [Abstract]"
       }
      }
     },
     "localname": "InventoryNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r21",
      "r78",
      "r153",
      "r200",
      "r297",
      "r298",
      "r300",
      "r748"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r53",
      "r299"
     ],
     "calculation": {
      "http://www.idexx.com/role/InventoriesScheduleofComponentsofInventoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/InventoriesScheduleofComponentsofInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r52",
      "r299"
     ],
     "calculation": {
      "http://www.idexx.com/role/InventoriesScheduleofComponentsofInventoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work-in-process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/InventoriesScheduleofComponentsofInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LandAndLandImprovementsMember": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Real estate held and assets that are an addition or improvement to real estate held.",
        "label": "Land and Land Improvements [Member]",
        "terseLabel": "Land and improvements"
       }
      }
     },
     "localname": "LandAndLandImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LandImprovementsMember": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to real estate held.",
        "label": "Land Improvements [Member]",
        "terseLabel": "Land improvements"
       }
      }
     },
     "localname": "LandImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/PropertyandEquipmentNetScheduleofEstimatedUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r700",
      "r702"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "terseLabel": "Total rent expense including variable rent and short-term expenses"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r700"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Supplemental cash flow information"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseIncome": {
     "auth_ref": [
      "r708"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease income from operating, direct financing, and sales-type leases. Includes, but is not limited to, variable lease payments, interest income, profit (loss) recognized at commencement, and lease payments paid and payable to lessor.",
        "label": "Lease Income",
        "terseLabel": "Lease revenue"
       }
      }
     },
     "localname": "LeaseIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/RevenueRecognitionLeaseRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LegalCostsPolicyTextBlock": {
     "auth_ref": [
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for legal costs incurred to protect or defend the entity's assets and rights, or to obtain assets, including monetary damages, or to obtain rights.",
        "label": "Legal Costs, Policy [Policy Text Block]",
        "terseLabel": "Legal Costs"
       }
      }
     },
     "localname": "LegalCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r695"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1": {
     "auth_ref": [
      "r694"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease not yet commenced, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Lease Not yet Commenced, Term of Contract",
        "terseLabel": "Operating leases, not yet commenced, lease term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r701"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Maturities of operating lease liabilities"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r701"
     ],
     "calculation": {
      "http://www.idexx.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.idexx.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r701"
     ],
     "calculation": {
      "http://www.idexx.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r701"
     ],
     "calculation": {
      "http://www.idexx.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r701"
     ],
     "calculation": {
      "http://www.idexx.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r701"
     ],
     "calculation": {
      "http://www.idexx.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r701"
     ],
     "calculation": {
      "http://www.idexx.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r701"
     ],
     "calculation": {
      "http://www.idexx.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r701"
     ],
     "calculation": {
      "http://www.idexx.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r703"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LessorLeasesPolicyTextBlock": {
     "auth_ref": [
      "r704",
      "r705",
      "r706",
      "r707"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangements entered into by lessor.",
        "label": "Lessor, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LessorLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Outstanding letters of credit to insurance company as security for workers' compensation claims"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CommitmentsContingenciesandGuaranteesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r65",
      "r158",
      "r230",
      "r259",
      "r362",
      "r363",
      "r364",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r601",
      "r606",
      "r607",
      "r661",
      "r711",
      "r712"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [Abstract]",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesScheduleofComponentsofNetDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r49",
      "r158",
      "r259",
      "r661",
      "r713",
      "r765",
      "r790"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "verboseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r68",
      "r158",
      "r259",
      "r362",
      "r363",
      "r364",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r601",
      "r606",
      "r607",
      "r661",
      "r711",
      "r712",
      "r713"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "auth_ref": [
      "r22",
      "r23",
      "r24",
      "r36",
      "r37",
      "r158",
      "r259",
      "r362",
      "r363",
      "r364",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r601",
      "r606",
      "r607",
      "r661",
      "r711",
      "r712"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.",
        "label": "Liabilities, Noncurrent",
        "totalLabel": "Total long-term liabilities"
       }
      }
     },
     "localname": "LiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Noncurrent [Abstract]",
        "terseLabel": "Long-Term Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum amount of borrowing capacity under a line of credit that is available as of the balance sheet date for a specific purpose other than for financing goods acquired for inventory or imminent delivery to a customer.",
        "label": "Line of Credit Facility, Capacity Available for Specific Purpose Other than for Trade Purchases",
        "terseLabel": "Reduction of credit facility availability"
       }
      }
     },
     "localname": "LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]",
        "terseLabel": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r63"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r63",
      "r157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]",
        "terseLabel": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/DebtNarrativeDetails",
      "http://www.idexx.com/role/HedgingInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.",
        "label": "Line of Credit Facility, Unused Capacity, Commitment Fee Percentage",
        "terseLabel": "Commitment fees"
       }
      }
     },
     "localname": "LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LinesOfCreditCurrent": {
     "auth_ref": [
      "r34",
      "r760"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Line of Credit, Current",
        "terseLabel": "Line of credit",
        "verboseLabel": "Outstanding credit facility balance"
       }
      }
     },
     "localname": "LinesOfCreditCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.idexx.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "LIBOR"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r36",
      "r387",
      "r401",
      "r402",
      "r403",
      "r763",
      "r786"
     ],
     "calculation": {
      "http://www.idexx.com/role/DebtScheduleofAnnualPrincipalPaymentsonLongTermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "terseLabel": "Estimated carrying value of long-term debt",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/DebtScheduleofAnnualPrincipalPaymentsonLongTermDebtDetails",
      "http://www.idexx.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Current Maturities",
        "terseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.",
        "label": "Long-term Debt, Fair Value",
        "terseLabel": "Estimated fair value of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": {
     "auth_ref": [
      "r164",
      "r359",
      "r392"
     ],
     "calculation": {
      "http://www.idexx.com/role/DebtScheduleofAnnualPrincipalPaymentsonLongTermDebtDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/DebtScheduleofAnnualPrincipalPaymentsonLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r164",
      "r359",
      "r392"
     ],
     "calculation": {
      "http://www.idexx.com/role/DebtScheduleofAnnualPrincipalPaymentsonLongTermDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/DebtScheduleofAnnualPrincipalPaymentsonLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "auth_ref": [
      "r164",
      "r359",
      "r392"
     ],
     "calculation": {
      "http://www.idexx.com/role/DebtScheduleofAnnualPrincipalPaymentsonLongTermDebtDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/DebtScheduleofAnnualPrincipalPaymentsonLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r164",
      "r359",
      "r392"
     ],
     "calculation": {
      "http://www.idexx.com/role/DebtScheduleofAnnualPrincipalPaymentsonLongTermDebtDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/DebtScheduleofAnnualPrincipalPaymentsonLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r164",
      "r359",
      "r392"
     ],
     "calculation": {
      "http://www.idexx.com/role/DebtScheduleofAnnualPrincipalPaymentsonLongTermDebtDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/DebtScheduleofAnnualPrincipalPaymentsonLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r164",
      "r359",
      "r392"
     ],
     "calculation": {
      "http://www.idexx.com/role/DebtScheduleofAnnualPrincipalPaymentsonLongTermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/DebtScheduleofAnnualPrincipalPaymentsonLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt arrangement having an initial term longer than one year or beyond the normal operating cycle, if longer.",
        "label": "Long-term Debt [Member]",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/HedgingInstrumentsScheduleofFairValuesandBalanceSheetClassificationsofDerivativesandNonderivativesDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "verboseLabel": "Long-term debt, net of current portion"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/DebtNarrativeDetails",
      "http://www.idexx.com/role/DebtScheduleofSeniorNoteBorrowingsDetails",
      "http://www.idexx.com/role/HedgingInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r70",
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/DebtNarrativeDetails",
      "http://www.idexx.com/role/DebtScheduleofSeniorNoteBorrowingsDetails",
      "http://www.idexx.com/role/HedgingInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "auth_ref": [
      "r343",
      "r344",
      "r345",
      "r347",
      "r348",
      "r349",
      "r351",
      "r354",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.",
        "label": "Loss Contingency Nature [Axis]",
        "terseLabel": "Loss Contingency Nature [Axis]"
       }
      }
     },
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CommitmentsContingenciesandGuaranteesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "auth_ref": [
      "r343"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability.",
        "label": "Loss Contingency Accrual",
        "terseLabel": "Loss contingency accrual"
       }
      }
     },
     "localname": "LossContingencyAccrualAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CommitmentsContingenciesandGuaranteesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyDamagesSoughtValue": {
     "auth_ref": [
      "r343",
      "r346",
      "r350"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value (monetary amount) of the award the plaintiff seeks in the legal matter.",
        "label": "Loss Contingency, Damages Sought, Value",
        "terseLabel": "Damages sought"
       }
      }
     },
     "localname": "LossContingencyDamagesSoughtValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CommitmentsContingenciesandGuaranteesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyNatureDomain": {
     "auth_ref": [
      "r343",
      "r344",
      "r345",
      "r347",
      "r348",
      "r349",
      "r351",
      "r354",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.",
        "label": "Loss Contingency, Nature [Domain]",
        "terseLabel": "Loss Contingency, Nature [Domain]"
       }
      }
     },
     "localname": "LossContingencyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CommitmentsContingenciesandGuaranteesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment [Member]",
        "terseLabel": "Machinery and equipment"
       }
      }
     },
     "localname": "MachineryAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/PropertyandEquipmentNetScheduleofEstimatedUsefulLivesDetails",
      "http://www.idexx.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge": {
     "auth_ref": [
      "r636"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum period of time the entity is hedging its exposure to variability in future cash flows for forecasted transactions, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Excludes forecasted transactions related to payment of variable interest on existing financial instruments.",
        "label": "Maximum Length of Time, Foreign Currency Cash Flow Hedge",
        "terseLabel": "General duration of foreign currency exchange contracts"
       }
      }
     },
     "localname": "MaximumLengthOfTimeForeignCurrencyCashFlowHedge",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/HedgingInstrumentsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r76",
      "r158",
      "r259",
      "r362",
      "r366",
      "r367",
      "r368",
      "r371",
      "r372",
      "r661",
      "r764",
      "r789"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interest"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromRedemptions": {
     "auth_ref": [
      "r415",
      "r598",
      "r599"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).",
        "label": "Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests",
        "negatedTerseLabel": "Acquisition of noncontrolling interest (Note 4)",
        "terseLabel": "Noncontrolling interest, purchase of Interests"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromRedemptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AcquisitionsandInvestmentsDetails",
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money market funds"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/FairValueMeasurementsScheduleofFairValueofAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r138"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash Flows from Financing Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r138"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used by investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash Flows from Investing Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r138",
      "r140",
      "r144"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash Flows from Operating Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r7",
      "r100",
      "r103",
      "r109",
      "r114",
      "r144",
      "r158",
      "r170",
      "r174",
      "r175",
      "r176",
      "r177",
      "r180",
      "r181",
      "r189",
      "r222",
      "r228",
      "r232",
      "r235",
      "r238",
      "r259",
      "r362",
      "r363",
      "r364",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r648",
      "r661",
      "r769",
      "r794"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net income attributable to IDEXX Laboratories, Inc. stockholders"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.idexx.com/role/SegmentReportingSummaryofSegmentPerformanceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r100",
      "r103",
      "r109",
      "r180",
      "r181",
      "r603",
      "r609"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "netLabel": "Less: Net (loss) income attributable to noncontrolling interest"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.idexx.com/role/SegmentReportingSummaryofSegmentPerformanceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "New Accounting Pronouncements Adopted and New Accounting Pronouncements Not Yet Adopted"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncompeteAgreementsMember": {
     "auth_ref": [
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.",
        "label": "Noncompete Agreements [Member]",
        "terseLabel": "Noncompete agreements"
       }
      }
     },
     "localname": "NoncompeteAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AcquisitionsandInvestmentsDetails",
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofEstimatedUsefulLivesForIntangibleAssetsDetails",
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofIntangibleAssetsOtherThanGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r166",
      "r167",
      "r168",
      "r415",
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling Interest"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of business segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OfficeEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine.",
        "label": "Office Equipment [Member]",
        "terseLabel": "Office furniture and equipment"
       }
      }
     },
     "localname": "OfficeEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/PropertyandEquipmentNetScheduleofEstimatedUsefulLivesDetails",
      "http://www.idexx.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r222",
      "r228",
      "r232",
      "r235",
      "r238"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Income from operations",
        "totalLabel": "Income from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.idexx.com/role/SegmentReportingSummaryofSegmentPerformanceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r692"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense",
        "terseLabel": "Rent expense, excluding variable and short-term expenses"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r690"
     ],
     "calculation": {
      "http://www.idexx.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Total lease liability (current and long-term)"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r690"
     ],
     "calculation": {
      "http://www.idexx.com/role/AccruedLiabilitiesandOtherLongTermLiabilitiesScheduleofAccruedLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AccruedLiabilitiesandOtherLongTermLiabilitiesScheduleofAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes current operating lease liability.",
        "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AccruedLiabilitiesandOtherLongTermLiabilitiesScheduleofAccruedLiabilitiesDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r690"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "verboseLabel": "Long-term operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r693",
      "r696"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Cash paid for amounts included in the measurement of operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r689"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r699",
      "r702"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate - operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r698",
      "r702"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term - operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r551"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards in certain state and international jurisdictions"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r8",
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Nature Of Business, Basis Of Presentation And Principles Of Consolidation"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/NatureofBusinessBasisofPresentationandPrinciplesofConsolidation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r18",
      "r19",
      "r20",
      "r66"
     ],
     "calculation": {
      "http://www.idexx.com/role/AccruedLiabilitiesandOtherLongTermLiabilitiesScheduleofAccruedLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "verboseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AccruedLiabilitiesandOtherLongTermLiabilitiesScheduleofAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesNoncurrent": {
     "auth_ref": [
      "r71"
     ],
     "calculation": {
      "http://www.idexx.com/role/AccruedLiabilitiesandOtherLongTermLiabilitiesScheduleofLongTermAccruedLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Noncurrent",
        "terseLabel": "Other accrued long-term expenses"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AccruedLiabilitiesandOtherLongTermLiabilitiesScheduleofLongTermAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r79",
      "r713"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.idexx.com/role/OtherCurrentandLongTermAssetsScheduleofOtherCurrentAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets",
        "totalLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.idexx.com/role/OtherCurrentandLongTermAssetsScheduleofOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for other assets. This disclosure includes other current assets and other noncurrent assets.",
        "label": "Other Assets Disclosure [Text Block]",
        "terseLabel": "Other Current and Long-Term Assets"
       }
      }
     },
     "localname": "OtherAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/OtherCurrentandLongTermAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAssetsFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of other assets.",
        "label": "Other Assets, Fair Value Disclosure",
        "terseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "OtherAssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/FairValueMeasurementsScheduleofFairValueofAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsMember": {
     "auth_ref": [
      "r619",
      "r634"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other assets.",
        "label": "Other Assets [Member]",
        "terseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "OtherAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/HedgingInstrumentsScheduleofFairValuesandBalanceSheetClassificationsofDerivativesandNonderivativesDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsMiscellaneousCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.idexx.com/role/OtherCurrentandLongTermAssetsScheduleofOtherCurrentAssetsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other miscellaneous assets expected to be realized or consumed within one year or operating cycle, if longer.",
        "label": "Other Assets, Miscellaneous, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAssetsMiscellaneousCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/OtherCurrentandLongTermAssetsScheduleofOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsMiscellaneousNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.idexx.com/role/OtherCurrentandLongTermAssetsScheduleofOtherNoncurrentAssetsDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other miscellaneous assets expected to be realized or consumed after one year or normal operating cycle, if longer.",
        "label": "Other Assets, Miscellaneous, Noncurrent",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "OtherAssetsMiscellaneousNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/OtherCurrentandLongTermAssetsScheduleofOtherNoncurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      },
      "http://www.idexx.com/role/OtherCurrentandLongTermAssetsScheduleofOtherNoncurrentAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other long-term assets",
        "totalLabel": "Other long-term assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.idexx.com/role/OtherCurrentandLongTermAssetsScheduleofOtherNoncurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Assets, Noncurrent [Abstract]",
        "terseLabel": "Other Assets, Noncurrent [Abstract]"
       }
      }
     },
     "localname": "OtherAssetsNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax [Abstract]",
        "terseLabel": "Unrealized gain (loss) on derivative instruments:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax": {
     "auth_ref": [
      "r92",
      "r93",
      "r96"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after adjustment, of tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax",
        "terseLabel": "Unrealized gain (loss) on investments, tax expense (benefit)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r98",
      "r107",
      "r108",
      "r110",
      "r675",
      "r677",
      "r681"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "terseLabel": "Other comprehensive income (loss) before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AccumulatedOtherComprehensiveIncomeScheduleofAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax": {
     "auth_ref": [
      "r91",
      "r95"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "idxx_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossAfterReclassificationAndTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax",
        "verboseLabel": "Unrealized gain (loss) on foreign currency exchange contracts, net of tax expense (benefit) of $2,133 in 2021, $(2,013) in 2020 and $362 in 2019"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax": {
     "auth_ref": [
      "r96"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax",
        "verboseLabel": "Unrealized gain (loss) on foreign currency exchange contracts, tax expense (benefit)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": {
     "auth_ref": [
      "r95",
      "r99"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 3.0,
       "parentTag": "idxx_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossAfterReclassificationAndTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax",
        "negatedTerseLabel": "Reclassification adjustment for (gain) loss included in net income, net of tax (expense) benefit of $1,347 in 2021, $(158) in 2020 and $(2,467) in 2019"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": {
     "auth_ref": [
      "r95",
      "r99",
      "r626"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax",
        "terseLabel": "Amount of (loss) gain reclassified from accumulated other comprehensive income into income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/HedgingInstrumentsDerivativesDesignatedinCashFlowHedgingRelationshipsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax": {
     "auth_ref": [
      "r96"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) for reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax",
        "negatedTerseLabel": "Reclassification adjustment for (gain) loss included in net income, tax (expense) benefit"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "verboseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r101",
      "r104",
      "r107",
      "r108",
      "r110",
      "r115",
      "r410",
      "r675",
      "r680",
      "r681",
      "r770",
      "r795"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive gain (loss), net",
        "totalLabel": "Other comprehensive gain (loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]",
        "terseLabel": "Other comprehensive income (loss), net of tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r92",
      "r95"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax",
        "terseLabel": "Unrealized gain (loss) on investments, net of tax expense (benefit) of $46 in 2021, $(120) in 2020 and $84 in 2019"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentAssetsMember": {
     "auth_ref": [
      "r619",
      "r634"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current assets.",
        "label": "Other Current Assets [Member]",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/HedgingInstrumentsScheduleofFairValuesandBalanceSheetClassificationsofDerivativesandNonderivativesDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherDepreciationAndAmortization": {
     "auth_ref": [
      "r123",
      "r143",
      "r331"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.",
        "label": "Other Depreciation and Amortization",
        "terseLabel": "Depreciation and amortization expense"
       }
      }
     },
     "localname": "OtherDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/PropertyandEquipmentNetSummaryOfDepreciationAndAmortizationCapitalizedComputerSoftwareForInternalUseAndUnpaidPropertyEquipmentReflectedInAccountPayableAndAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r67"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for other liabilities.",
        "label": "Other Liabilities Disclosure [Text Block]",
        "terseLabel": "Accrued Liabilities and Other Long Term Liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AccruedLiabilitiesandOtherLongTermLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherLiabilitiesFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of other liabilities.",
        "label": "Other Liabilities, Fair Value Disclosure",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/FairValueMeasurementsScheduleofFairValueofAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r71"
     ],
     "calculation": {
      "http://www.idexx.com/role/AccruedLiabilitiesandOtherLongTermLiabilitiesScheduleofLongTermAccruedLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities",
        "totalLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AccruedLiabilitiesandOtherLongTermLiabilitiesScheduleofLongTermAccruedLiabilitiesDetails",
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/HedgingInstrumentsScheduleofFairValuesandBalanceSheetClassificationsofDerivativesandNonderivativesDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Table Text Block]",
        "terseLabel": "Schedule of other long-term liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AccruedLiabilitiesandOtherLongTermLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherOperatingActivitiesCashFlowStatement": {
     "auth_ref": [],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).",
        "label": "Other Operating Activities, Cash Flow Statement",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherOperatingActivitiesCashFlowStatement",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": {
     "auth_ref": [
      "r134"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.",
        "label": "Payment for Contingent Consideration Liability, Financing Activities",
        "negatedLabel": "Payment of acquisition-related contingent consideration and holdbacks"
       }
      }
     },
     "localname": "PaymentForContingentConsiderationLiabilityFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r131"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Repurchases of common stock, net"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r133"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "negatedLabel": "Debt issuance costs"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r131"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "negatedLabel": "Shares withheld for statutory tax withholding payments on restricted stock"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r127",
      "r589"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Payments to acquire business"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AcquisitionsandInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r127"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Acquisitions of businesses, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r128"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToMinorityShareholders": {
     "auth_ref": [
      "r135"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.",
        "label": "Payments to Noncontrolling Interests",
        "negatedTerseLabel": "Purchase of minority interest"
       }
      }
     },
     "localname": "PaymentsToMinorityShareholders",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r449",
      "r451",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "IDEXX Retirement and Incentive Savings Plan"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IDEXXRetirementandIncentiveSavingsPlan"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]",
        "terseLabel": "Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]"
       }
      }
     },
     "localname": "PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r41",
      "r407"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Par value per share (in USD per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/PreferredStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r41"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Shares of preferred stock authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/PreferredStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r41"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred Stock outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/PreferredStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockTextBlock": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock.",
        "label": "Preferred Stock [Text Block]",
        "terseLabel": "Preferred Stock"
       }
      }
     },
     "localname": "PreferredStockTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/PreferredStock"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "auth_ref": [
      "r12",
      "r14",
      "r301",
      "r302"
     ],
     "calculation": {
      "http://www.idexx.com/role/OtherCurrentandLongTermAssetsScheduleofOtherCurrentAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense, Current",
        "terseLabel": "Prepaid expenses"
       }
      }
     },
     "localname": "PrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/OtherCurrentandLongTermAssetsScheduleofOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseOtherNoncurrent": {
     "auth_ref": [
      "r17",
      "r61"
     ],
     "calculation": {
      "http://www.idexx.com/role/OtherCurrentandLongTermAssetsScheduleofOtherNoncurrentAssetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of amounts paid in advance which will be charged against earnings in periods after one year or beyond the operating cycle, if longer.",
        "label": "Prepaid Expense Other, Noncurrent",
        "verboseLabel": "Investment in long-term product supply arrangements"
       }
      }
     },
     "localname": "PrepaidExpenseOtherNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/OtherCurrentandLongTermAssetsScheduleofOtherNoncurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrimeRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate charged by financial institutions to their most creditworthy borrowers.",
        "label": "Prime Rate [Member]",
        "terseLabel": "Prime Rate"
       }
      }
     },
     "localname": "PrimeRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromHedgeInvestingActivities": {
     "auth_ref": [
      "r126",
      "r141"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow for a financial contract that meets the hedge criteria as either a cash flow hedge, fair value hedge, or hedge of a net investment in a foreign operation.",
        "label": "Proceeds from Hedge, Investing Activities",
        "terseLabel": "Proceeds from net investment hedge"
       }
      }
     },
     "localname": "ProceedsFromHedgeInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/HedgingInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt": {
     "auth_ref": [
      "r130"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a borrowing with the highest claim on the assets of the entity in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle, if longer).",
        "label": "Proceeds from Issuance of Senior Long-term Debt",
        "terseLabel": "Issuance of senior notes"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSeniorLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r129",
      "r509"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised",
        "terseLabel": "Proceeds from exercises of stock options and employee stock purchase plans"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfLinesOfCredit": {
     "auth_ref": [],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash inflow or cash outflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with either short term or long term maturity that is collateralized (backed by pledge, mortgage or other lien in the entity's assets).",
        "label": "Proceeds from (Repayments of) Lines of Credit",
        "verboseLabel": "Borrowings (repayments) on revolving credit facilities, net"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductMember": {
     "auth_ref": [
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery.",
        "label": "Product [Member]",
        "terseLabel": "Product revenue"
       }
      }
     },
     "localname": "ProductMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r7",
      "r100",
      "r103",
      "r109",
      "r137",
      "r158",
      "r170",
      "r180",
      "r181",
      "r222",
      "r228",
      "r232",
      "r235",
      "r238",
      "r259",
      "r362",
      "r363",
      "r364",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r595",
      "r602",
      "r604",
      "r609",
      "r610",
      "r648",
      "r661",
      "r777"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "netLabel": "Net income",
        "terseLabel": "Net income",
        "totalLabel": "Net income",
        "verboseLabel": "(Losses) gains, net of tax"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AccumulatedOtherComprehensiveIncomeScheduleofReclassificationsoutofAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://www.idexx.com/role/SegmentReportingSummaryofSegmentPerformanceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAdditions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of acquisition of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Additions",
        "terseLabel": "Capitalized computer software developed for internal use"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAdditions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/PropertyandEquipmentNetSummaryOfDepreciationAndAmortizationCapitalizedComputerSoftwareForInternalUseAndUnpaidPropertyEquipmentReflectedInAccountPayableAndAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r60",
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/PropertyandEquipmentNetScheduleofEstimatedUsefulLivesDetails",
      "http://www.idexx.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails",
      "http://www.idexx.com/role/PropertyandEquipmentNetSummaryOfDepreciationAndAmortizationCapitalizedComputerSoftwareForInternalUseAndUnpaidPropertyEquipmentReflectedInAccountPayableAndAccruedExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r338",
      "r821",
      "r822",
      "r823"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "Property and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/PropertyandEquipmentNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r59",
      "r332"
     ],
     "calculation": {
      "http://www.idexx.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Gross amount"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofEstimatedUsefulLivesForIntangibleAssetsDetails",
      "http://www.idexx.com/role/PropertyandEquipmentNetScheduleofEstimatedUsefulLivesDetails",
      "http://www.idexx.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails",
      "http://www.idexx.com/role/PropertyandEquipmentNetSummaryOfDepreciationAndAmortizationCapitalizedComputerSoftwareForInternalUseAndUnpaidPropertyEquipmentReflectedInAccountPayableAndAccruedExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r29",
      "r30",
      "r334",
      "r713",
      "r778",
      "r791"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      },
      "http://www.idexx.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Total property and equipment, net",
        "verboseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.idexx.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails",
      "http://www.idexx.com/role/SegmentReportingScheduleofNetLongLivedAssetsbyPrincipalGeographicAreasDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r58",
      "r334",
      "r821",
      "r822"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r29",
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of property and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/PropertyandEquipmentNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r29",
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/PropertyandEquipmentNetScheduleofEstimatedUsefulLivesDetails",
      "http://www.idexx.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails",
      "http://www.idexx.com/role/PropertyandEquipmentNetSummaryOfDepreciationAndAmortizationCapitalizedComputerSoftwareForInternalUseAndUnpaidPropertyEquipmentReflectedInAccountPayableAndAccruedExpensesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Estimated useful life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/PropertyandEquipmentNetScheduleofEstimatedUsefulLivesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ProvisionForLoanLeaseAndOtherLosses": {
     "auth_ref": [
      "r142",
      "r248",
      "r775"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense related loan transactions, lease transactions, credit loss from transactions other than loan and lease transactions, and other loss based on assessment of uncollectability from the counterparty to reduce the account to their net realizable value.",
        "label": "Provision for Loan, Lease, and Other Losses",
        "terseLabel": "Provision for uncollectible accounts"
       }
      }
     },
     "localname": "ProvisionForLoanLeaseAndOtherLosses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.",
        "label": "Purchase Obligation",
        "terseLabel": "Minimum purchase commitments"
       }
      }
     },
     "localname": "PurchaseObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CommitmentsContingenciesandGuaranteesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r98",
      "r107",
      "r108",
      "r110",
      "r675",
      "r679",
      "r681"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "negatedLabel": "Amounts reclassified from accumulated other comprehensive income"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AccumulatedOtherComprehensiveIncomeScheduleofAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis": {
     "auth_ref": [
      "r109"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Axis]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Axis]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AccumulatedOtherComprehensiveIncomeScheduleofReclassificationsoutofAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain": {
     "auth_ref": [
      "r109"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Domain]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Domain]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AccumulatedOtherComprehensiveIncomeScheduleofReclassificationsoutofAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r109"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Member]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AccumulatedOtherComprehensiveIncomeScheduleofReclassificationsoutofAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]",
        "terseLabel": "Summary of reclassifications out of accumulated other comprehensive income"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AccumulatedOtherComprehensiveIncomeTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesScheduleofChangesinUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfSeniorDebt": {
     "auth_ref": [
      "r132"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period.",
        "label": "Repayments of Senior Debt",
        "negatedTerseLabel": "Payments of senior notes",
        "terseLabel": "Repayments of senior debt"
       }
      }
     },
     "localname": "RepaymentsOfSeniorDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.idexx.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r525",
      "r749",
      "r835"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research And Development Costs"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r9",
      "r25",
      "r145",
      "r151"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash and Cash Equivalents, Current",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted stock units (RSU's)"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.idexx.com/role/ShareBasedCompensationScheduleOfRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r45",
      "r415",
      "r517",
      "r713",
      "r788",
      "r813",
      "r818"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r2",
      "r166",
      "r167",
      "r168",
      "r171",
      "r179",
      "r181",
      "r264",
      "r514",
      "r515",
      "r516",
      "r559",
      "r560",
      "r646",
      "r809",
      "r811"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://www.idexx.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r213",
      "r214",
      "r227",
      "r233",
      "r234",
      "r240",
      "r241",
      "r244",
      "r436",
      "r437",
      "r750"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Total revenue",
        "verboseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.idexx.com/role/RevenueRecognitionDisaggregationofRevenuebyMajorProductandServiceCategoriesDetails",
      "http://www.idexx.com/role/RevenueRecognitionDisaggregationofRevenuebyPrincipalGeographicAreaBasedonCustomersDomicilesDetails",
      "http://www.idexx.com/role/SegmentReportingSummaryofSegmentPerformanceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r434",
      "r435",
      "r440",
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/RevenueRecognition"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r154",
      "r155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r432"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "terseLabel": "Estimation of future revenues"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/RevenueRecognitionExtendedWarrantiesandPostContractSupportDetails",
      "http://www.idexx.com/role/RevenueRecognitionReagentRentalProgramsDetails",
      "http://www.idexx.com/role/RevenueRecognitionVolumeCommitmentProgramsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/RevenueRecognitionCoststoObtainaContractDetails",
      "http://www.idexx.com/role/RevenueRecognitionDetails",
      "http://www.idexx.com/role/RevenueRecognitionExtendedWarrantiesandPostContractSupportDetails",
      "http://www.idexx.com/role/RevenueRecognitionInstrumentRebateProgramsDetails",
      "http://www.idexx.com/role/RevenueRecognitionReagentRentalProgramsDetails",
      "http://www.idexx.com/role/RevenueRecognitionRemainingPerformanceObligationDetails",
      "http://www.idexx.com/role/RevenueRecognitionSaaSSubscriptionsDetails",
      "http://www.idexx.com/role/RevenueRecognitionUpFrontCustomerLoyaltyProgramsDetails",
      "http://www.idexx.com/role/RevenueRecognitionVolumeCommitmentProgramsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": {
     "auth_ref": [
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period",
        "terseLabel": "Revenue recognition period (in years)"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/RevenueRecognitionRemainingPerformanceObligationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": {
     "auth_ref": [
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/RevenueRecognitionRemainingPerformanceObligationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/RevenueRecognitionCoststoObtainaContractDetails",
      "http://www.idexx.com/role/RevenueRecognitionDetails",
      "http://www.idexx.com/role/RevenueRecognitionExtendedWarrantiesandPostContractSupportDetails",
      "http://www.idexx.com/role/RevenueRecognitionInstrumentRebateProgramsDetails",
      "http://www.idexx.com/role/RevenueRecognitionReagentRentalProgramsDetails",
      "http://www.idexx.com/role/RevenueRecognitionRemainingPerformanceObligationDetails",
      "http://www.idexx.com/role/RevenueRecognitionSaaSSubscriptionsDetails",
      "http://www.idexx.com/role/RevenueRecognitionUpFrontCustomerLoyaltyProgramsDetails",
      "http://www.idexx.com/role/RevenueRecognitionVolumeCommitmentProgramsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationPercentage": {
     "auth_ref": [
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Percentage",
        "terseLabel": "Revenue percentage expected to be recognized"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/RevenueRecognitionRemainingPerformanceObligationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenue:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenues from External Customers and Long-Lived Assets [Line Items]",
        "terseLabel": "Revenues from External Customers and Long-Lived Assets [Line Items]"
       }
      }
     },
     "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/SegmentReportingScheduleofNetLongLivedAssetsbyPrincipalGeographicAreasDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r697",
      "r702"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-use assets obtained in exchange for operating lease obligations, net of early lease\u00a0terminations"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesCommissionsAndFees": {
     "auth_ref": [
      "r124"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primarily represents commissions incurred in the period based upon the sale by commissioned employees or third parties of the entity's goods or services, and fees for sales assistance or product enhancements performed by third parties (such as a distributor or value added reseller).",
        "label": "Sales Commissions and Fees",
        "terseLabel": "Commissions expense recognized"
       }
      }
     },
     "localname": "SalesCommissionsAndFees",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/RevenueRecognitionCoststoObtainaContractDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesTypeLeaseLeaseReceivable": {
     "auth_ref": [
      "r709"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lease payments not yet received by lessor and amount expected to be derived from underlying asset, following end of lease term guaranteed by lessee or other third party unrelated to lessor, from sales-type lease.",
        "label": "Sales-type Lease, Lease Receivable",
        "terseLabel": "Lease receivable asset"
       }
      }
     },
     "localname": "SalesTypeLeaseLeaseReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/RevenueRecognitionReagentRentalProgramsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of accrued liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AccruedLiabilitiesandOtherLongTermLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r98",
      "r680",
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of accumulated other comprehensive income"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AccumulatedOtherComprehensiveIncomeTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r193"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "verboseLabel": "Schedule of number of anti-dilutive stock options"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/EarningsPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r576",
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AcquisitionsandInvestmentsDetails",
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of components of provision (benefit) for income taxes"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r70",
      "r164",
      "r402",
      "r404",
      "r411",
      "r412",
      "r413",
      "r414",
      "r684",
      "r685",
      "r688",
      "r779"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of long-term debt instruments"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of components of net deferred tax assets and liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "auth_ref": [
      "r625"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "terseLabel": "Details of net investment hedges and Income Statement impact of hedging instruments"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/HedgingInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "auth_ref": [
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of derivative instruments (including nonderivative instruments that are designated and qualify as hedging instruments) of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.",
        "label": "Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location [Table Text Block]",
        "terseLabel": "Schedule of hedging instruments"
       }
      }
     },
     "localname": "ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/HedgingInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of effective income tax rate reconciliation"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r476",
      "r504",
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationScheduleofSelectedFinancialImpactofShareBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r476",
      "r504",
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Schedule of selected financial impact of share-based compensation"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock": {
     "auth_ref": [
      "r242"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the names of foreign countries in which material long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets are located, and amount of such long-lived assets located in that country or foreign geographic area.",
        "label": "Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country [Table Text Block]",
        "terseLabel": "Schedule of net long-lived assets by principal geographic areas"
       }
      }
     },
     "localname": "ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r650",
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of fair value of assets and liabilities measured on recurring basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable": {
     "auth_ref": [
      "r275",
      "r851"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about allowance for credit loss on financing receivable.",
        "label": "Financing Receivable, Allowance for Credit Loss [Table]",
        "terseLabel": "Financing Receivable, Allowance for Credit Loss [Table]"
       }
      }
     },
     "localname": "ScheduleOfFinancingReceivableAllowanceForCreditLossesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CreditLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r318",
      "r323",
      "r751"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofIntangibleAssetsOtherThanGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r318",
      "r323"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of intangible assets other than goodwill"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r313",
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Schedule of earnings before income taxes"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r21",
      "r54",
      "r55",
      "r56"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "verboseLabel": "Schedule of components of inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/InventoriesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-term Debt [Table Text Block]",
        "terseLabel": "Schedule of annual principal payments on long-term debt"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of noncurrent assets.",
        "label": "Schedule of Other Assets, Noncurrent [Table Text Block]",
        "verboseLabel": "Schedule of other noncurrent assets"
       }
      }
     },
     "localname": "ScheduleOfOtherAssetsNoncurrentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/OtherCurrentandLongTermAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amounts of other current assets.",
        "label": "Schedule of Other Current Assets [Table Text Block]",
        "terseLabel": "Schedule of other current assets"
       }
      }
     },
     "localname": "ScheduleOfOtherCurrentAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/OtherCurrentandLongTermAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r60",
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofEstimatedUsefulLivesForIntangibleAssetsDetails",
      "http://www.idexx.com/role/PropertyandEquipmentNetScheduleofEstimatedUsefulLivesDetails",
      "http://www.idexx.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails",
      "http://www.idexx.com/role/PropertyandEquipmentNetSummaryOfDepreciationAndAmortizationCapitalizedComputerSoftwareForInternalUseAndUnpaidPropertyEquipmentReflectedInAccountPayableAndAccruedExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": {
     "auth_ref": [
      "r112",
      "r243"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]",
        "terseLabel": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/SegmentReportingScheduleofNetLongLivedAssetsbyPrincipalGeographicAreasDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r222",
      "r225",
      "r231",
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/SegmentReportingSummaryofSegmentPerformanceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r222",
      "r225",
      "r231",
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "verboseLabel": "Summary of segment performance"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r477",
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationScheduleOfRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
     "auth_ref": [
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Schedule of restricted stock unit activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r484",
      "r494",
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Schedule of stock option activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "verboseLabel": "Schedule of weighted averages of the assumptions used in estimating the fair value of stock option awards"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfTreasuryStockByClassTextBlock": {
     "auth_ref": [
      "r416",
      "r417",
      "r418",
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table Text Block]",
        "terseLabel": "Schedule of common stock repurchases"
       }
      }
     },
     "localname": "ScheduleOfTreasuryStockByClassTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/RepurchasesofCommonStockTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock": {
     "auth_ref": [
      "r194"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).",
        "label": "Schedule of Weighted Average Number of Shares [Table Text Block]",
        "terseLabel": "Schedule of reconciliation of shares outstanding for basic and diluted earnings per share"
       }
      }
     },
     "localname": "ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/EarningsPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r323"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Schedule of expected amortization expense"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r209",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r227",
      "r228",
      "r229",
      "r230",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r238",
      "r244",
      "r340",
      "r341",
      "r802"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails",
      "http://www.idexx.com/role/RevenueRecognitionDisaggregationofRevenuebyMajorProductandServiceCategoriesDetails",
      "http://www.idexx.com/role/SegmentReportingSummaryofSegmentPerformanceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r209",
      "r211",
      "r212",
      "r222",
      "r226",
      "r232",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r243",
      "r244",
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment Reporting"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/SegmentReporting"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/SegmentReportingSummaryofSegmentPerformanceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SelfInsuranceReserve": {
     "auth_ref": [
      "r71"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions) of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property.",
        "label": "Self Insurance Reserve",
        "terseLabel": "Estimated liability for healthcare claims"
       }
      }
     },
     "localname": "SelfInsuranceReserve",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CommitmentsContingenciesandGuaranteesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingAndMarketingExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.",
        "label": "Selling and Marketing Expense",
        "terseLabel": "Sales and marketing"
       }
      }
     },
     "localname": "SellingAndMarketingExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/DebtNarrativeDetails",
      "http://www.idexx.com/role/DebtScheduleofSeniorNoteBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ServiceMember": {
     "auth_ref": [
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.",
        "label": "Service [Member]",
        "terseLabel": "Service revenue"
       }
      }
     },
     "localname": "ServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r142"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of additional cost recognized for award under share-based payment arrangement from occurrence of event accelerating recognition of cost.",
        "label": "Share-based Payment Arrangement, Accelerated Cost",
        "terseLabel": "Share-based compensation accelerated expense"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CommitmentsContingenciesandGuaranteesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate": {
     "auth_ref": [
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discount rate from fair value on offering date that participants pay for shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Offering Date",
        "terseLabel": "Discount from market value for employee stock purchase rights"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationScheduleOfRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average grant date fair value, forfeited (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationScheduleOfRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationScheduleOfRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average grant date fair value, granted (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationScheduleOfRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Nonvested, at end of year (in shares)",
        "periodStartLabel": "Nonvested, at beginning of year (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationScheduleOfRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Number of Units"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationScheduleOfRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Weighted average grant date fair value, end of year (in USD per share)",
        "periodStartLabel": "Weighted average grant date fair value, beginning of year (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationScheduleOfRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted Average Grant-Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationScheduleOfRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Vested (in shares)",
        "terseLabel": "Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.idexx.com/role/ShareBasedCompensationScheduleOfRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r496"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "terseLabel": "Fair value of awards vested during period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average grant date fair value, vested (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationScheduleOfRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price",
        "terseLabel": "Share exercise price (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationScheduleofWeightedAveragesoftheAssumptionsUsedInEstimatingtheFairValueofStockOptionAwardsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationScheduleofWeightedAveragesoftheAssumptionsUsedInEstimatingtheFairValueofStockOptionAwardsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate": {
     "auth_ref": [
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rate of weighted-average expected volatility for award under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate",
        "terseLabel": "Expected stock price volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationScheduleofWeightedAveragesoftheAssumptionsUsedInEstimatingtheFairValueofStockOptionAwardsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.idexx.com/role/ShareBasedCompensationScheduleOfRestrictedStockUnitActivityDetails",
      "http://www.idexx.com/role/ShareBasedCompensationScheduleofSelectedFinancialImpactofShareBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "terseLabel": "Shares authorized for grant under share-based incentive plans (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Shares available for grant under share-based incentive plans (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Fully vested, at end of year (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price of options fully vested (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r496"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Intrinsic value of stock options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average fair value of options granted (in USD per shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationScheduleofWeightedAveragesoftheAssumptionsUsedInEstimatingtheFairValueofStockOptionAwardsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r508"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r486",
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Outstanding, at end of year (in shares)",
        "periodStartLabel": "Outstanding, at beginning of year (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Number of Options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Weighted average exercise price of ending balance of options outstanding (in USD per share)",
        "periodStartLabel": "Weighted average exercise price of beginning balance of options outstanding (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [
      "r497"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value of options expected to vest"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "terseLabel": "Fully vested and expected to vest, at end of year (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price of options fully vested and expected to vest (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms": {
     "auth_ref": [
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of modification of award under share-based payment arrangement. Includes, but is not limited to, terms for expiration date, vesting rights and exercise price.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Plan Modification, Description and Terms",
        "terseLabel": "Period for continued vesting of outstanding equity awards upon termination of CEO without cause other than following a change in control, years"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CommitmentsContingenciesandGuaranteesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r475",
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.idexx.com/role/ShareBasedCompensationScheduleOfRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price of options exercised (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price of options forfeited (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price of options granted (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share-based Payment Arrangement, Tranche One [Member]",
        "terseLabel": "Share-based Compensation Award, Tranche One"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheOneMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share-based Payment Arrangement, Tranche Two [Member]",
        "terseLabel": "Share-based Compensation Award, Tranche Two"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheTwoMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r477",
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Share-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share Price",
        "terseLabel": "Share price at grant (in USD per share)"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationScheduleofWeightedAveragesoftheAssumptionsUsedInEstimatingtheFairValueofStockOptionAwardsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "auth_ref": [
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of vesting of award under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage",
        "terseLabel": "Award vesting rights, percentage"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intrinsic value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested",
        "terseLabel": "Nonvested, intrinsic value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period",
        "terseLabel": "Contractual term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r500",
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected term, in years"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationScheduleofWeightedAveragesoftheAssumptionsUsedInEstimatingtheFairValueofStockOptionAwardsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r508"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value of options fully vested"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted average remaining contractual term of options fully vested"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted average remaining contractual term of ending balance of options outstanding"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted average remaining contractual term of options fully vested and expected to vest"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": {
     "auth_ref": [
      "r483"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value",
        "terseLabel": "Fair value of options vested during period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "calculation": {
      "http://www.idexx.com/role/RepurchasesofCommonStockDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_TreasuryStockSharesAcquired",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation",
        "terseLabel": "Shares acquired through employee surrender for statutory tax withholding (in shares)"
       }
      }
     },
     "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/RepurchasesofCommonStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r152",
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary Of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StandardProductWarrantyPolicy": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for standard warranties including the methodology for measuring the liability.",
        "label": "Standard Product Warranty, Policy [Policy Text Block]",
        "verboseLabel": "Warranty Reserves"
       }
      }
     },
     "localname": "StandardProductWarrantyPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r6",
      "r209",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r227",
      "r228",
      "r229",
      "r230",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r238",
      "r244",
      "r313",
      "r337",
      "r340",
      "r341",
      "r802"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails",
      "http://www.idexx.com/role/RevenueRecognitionDisaggregationofRevenuebyMajorProductandServiceCategoriesDetails",
      "http://www.idexx.com/role/SegmentReportingSummaryofSegmentPerformanceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r2",
      "r74",
      "r107",
      "r108",
      "r109",
      "r166",
      "r167",
      "r168",
      "r171",
      "r179",
      "r181",
      "r201",
      "r264",
      "r410",
      "r415",
      "r514",
      "r515",
      "r516",
      "r559",
      "r560",
      "r646",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r681",
      "r809",
      "r810",
      "r811",
      "r858"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AccumulatedOtherComprehensiveIncomeScheduleofAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.idexx.com/role/AccumulatedOtherComprehensiveIncomeScheduleofReclassificationsoutofAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://www.idexx.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r166",
      "r167",
      "r168",
      "r201",
      "r750"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r41",
      "r42",
      "r410",
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Common stock issued in connection with the Employee Stock Purchase Plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, before Forfeiture",
        "terseLabel": "Common stock issued under stock plans, net (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r41",
      "r42",
      "r410",
      "r415",
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Exercised (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture",
        "terseLabel": "Common stock issued under stock plans, net"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensationGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.",
        "label": "Stock Repurchase Program, Number of Shares Authorized to be Repurchased",
        "terseLabel": "Shares of common stock repurchases authorized (in shares)"
       }
      }
     },
     "localname": "StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/RepurchasesofCommonStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The remaining number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.",
        "label": "Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased",
        "terseLabel": "Remaining shares available for repurchase under authorization (in shares)"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/RepurchasesofCommonStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r42",
      "r47",
      "r48",
      "r158",
      "r251",
      "r259",
      "r661",
      "r713"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total IDEXX Laboratories, Inc. stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r2",
      "r3",
      "r108",
      "r158",
      "r166",
      "r167",
      "r168",
      "r171",
      "r179",
      "r259",
      "r264",
      "r415",
      "r514",
      "r515",
      "r516",
      "r559",
      "r560",
      "r593",
      "r594",
      "r608",
      "r646",
      "r661",
      "r675",
      "r676",
      "r681",
      "r810",
      "r811",
      "r858"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Balance end of period",
        "periodStartLabel": "Balance beginning of period",
        "terseLabel": "Non-cash cumulative effect adjustment to retained earnings, net of tax",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AccumulatedOtherComprehensiveIncomeScheduleofAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://www.idexx.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "verboseLabel": "Stockholders\u2019 Equity:"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SummaryOfIncomeTaxContingenciesTextBlock": {
     "auth_ref": [
      "r535",
      "r542",
      "r544"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Summary of Income Tax Contingencies [Table Text Block]",
        "terseLabel": "Schedule of changes in unrecognized tax benefits"
       }
      }
     },
     "localname": "SummaryOfIncomeTaxContingenciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SummaryOfValuationAllowanceTextBlock": {
     "auth_ref": [
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance.",
        "label": "Summary of Valuation Allowance [Table Text Block]",
        "terseLabel": "Summary of valuation allowance"
       }
      }
     },
     "localname": "SummaryOfValuationAllowanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability for amount due employees, in addition to wages and any other money that employers owe employees, when their employment ends through a layoff or other termination. For example, a company may provide involuntarily terminated employees with a lump sum payment equal to one week's salary for every year of employment.",
        "label": "Supplemental Unemployment Benefits, Severance Benefits",
        "terseLabel": "Employee agreement contingencies"
       }
      }
     },
     "localname": "SupplementalUnemploymentBenefitsSeveranceBenefits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CommitmentsContingenciesandGuaranteesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TangibleAssetImpairmentCharges": {
     "auth_ref": [
      "r5",
      "r335"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The charge against earnings resulting from the aggregate write down of tangible assets from their carrying value to their fair value.",
        "label": "Tangible Asset Impairment Charges",
        "terseLabel": "Write-down of rental assets"
       }
      }
     },
     "localname": "TangibleAssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/PropertyandEquipmentNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
        "label": "Technology-Based Intangible Assets [Member]",
        "terseLabel": "Technology-based intangible assets"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AcquisitionsandInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "terseLabel": "Trademarks"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/AcquisitionsandInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r399",
      "r409",
      "r637",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r844",
      "r845",
      "r846",
      "r847",
      "r848",
      "r849",
      "r850"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/FairValueMeasurementsScheduleofFairValueofAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockAcquiredAverageCostPerShare": {
     "auth_ref": [
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.",
        "label": "Treasury Stock Acquired, Average Cost Per Share",
        "terseLabel": "Average cost per share - total (in USD per share)"
       }
      }
     },
     "localname": "TreasuryStockAcquiredAverageCostPerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/RepurchasesofCommonStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r73",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r73",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury stock, shares (in shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r42",
      "r410",
      "r415"
     ],
     "calculation": {
      "http://www.idexx.com/role/RepurchasesofCommonStockDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "totalLabel": "Total shares repurchased (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/RepurchasesofCommonStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockTextBlock": {
     "auth_ref": [
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Treasury Stock [Text Block]",
        "terseLabel": "Repurchases of Common Stock"
       }
      }
     },
     "localname": "TreasuryStockTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/RepurchasesofCommonStock"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r73",
      "r416",
      "r419"
     ],
     "calculation": {
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Treasury stock, at cost: 22,317 shares in 2021 and 21,008 shares in 2020"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r410",
      "r415",
      "r416"
     ],
     "calculation": {
      "http://www.idexx.com/role/RepurchasesofCommonStockDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "totalLabel": "Total cost of shares"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/RepurchasesofCommonStockDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredParValueMethod": {
     "auth_ref": [
      "r410",
      "r415",
      "r416"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the par value method.",
        "label": "Treasury Stock, Value, Acquired, Par Value Method",
        "negatedTerseLabel": "Repurchases of common stock, net"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredParValueMethod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r170",
      "r171",
      "r172",
      "r173",
      "r182",
      "r252",
      "r253",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r361",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r557",
      "r558",
      "r559",
      "r560",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r710",
      "r752",
      "r753",
      "r754",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817",
      "r818",
      "r854",
      "r855",
      "r856",
      "r857",
      "r858"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Type of Adoption [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r526",
      "r536"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Total amounts of unrecognized tax benefits, end of period",
        "periodStartLabel": "Total amounts of unrecognized tax benefits, beginning of period"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesScheduleofChangesinUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r537"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "negatedLabel": "Gross increases (decreases) in unrecognized tax positions as a result of tax positions taken during a prior period"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesScheduleofChangesinUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": {
     "auth_ref": [
      "r539"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities",
        "negatedLabel": "Decreases in unrecognized tax positions related to settlements with taxing authorities"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesScheduleofChangesinUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r534"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "terseLabel": "Interest expense and penalties accrued"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": {
     "auth_ref": [
      "r534"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense",
        "terseLabel": "Interest expense and penalties related to unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r538"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Gross increases in unrecognized tax positions as a result of tax positions taken in the current period"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesScheduleofChangesinUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r537"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Gross increases (decreases) in unrecognized tax positions as a result of tax positions taken during a prior period"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesScheduleofChangesinUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r540"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "negatedLabel": "Decreases in unrecognized tax positions as a result of a lapse of the applicable statutes of limitations"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesScheduleofChangesinUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r541"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "terseLabel": "Unrecognized tax benefits that would impact effective tax rate if recognized"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VestingAxis": {
     "auth_ref": [
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Axis]",
        "terseLabel": "Vesting [Axis]"
       }
      }
     },
     "localname": "VestingAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VestingDomain": {
     "auth_ref": [
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Domain]",
        "terseLabel": "Vesting [Domain]"
       }
      }
     },
     "localname": "VestingDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r184",
      "r192"
     ],
     "calculation": {
      "http://www.idexx.com/role/EarningsPerShareReconciliationofSharesOutstandingDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Shares outstanding for diluted earnings per share (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.idexx.com/role/EarningsPerShareReconciliationofSharesOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r183",
      "r192"
     ],
     "calculation": {
      "http://www.idexx.com/role/EarningsPerShareReconciliationofSharesOutstandingDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Shares outstanding for basic earnings per share (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.idexx.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.idexx.com/role/EarningsPerShareReconciliationofSharesOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 6
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "http://asc.fasb.org/topic&trid=2134417"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "27",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3581-108585"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1707-109256"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1757-109256"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1500-109256"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e543-108305"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(25))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(26))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=SL6953401-111524"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(10))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL82887624-210437"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124256539&loc=SL120269210-210444"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124256539&loc=SL120254536-210444"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8A",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124266218&loc=SL120267834-210445"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(11))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL120267845-210446"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919260-210447"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919269-210447"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919272-210447"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL120267966-210447"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL120267969-210447"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919236-210447"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "80",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124267575&loc=SL82922355-210448"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 6.M.Q4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122651532&loc=SL122037091-237805"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124268681&loc=SL120267897-210452"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13A",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=125515542&loc=SL120267917-210453"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=125515542&loc=SL120269220-210453"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL120267853-210455"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL120267859-210455"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL120267862-210455"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=123353750&loc=SL49131251-203054"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=123353750&loc=SL49131252-203054"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=123353750&loc=SL49131252-203054"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2420-110228"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=27011672&loc=d3e149975-122751"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "460",
   "URI": "http://asc.fasb.org/topic&trid=2155896"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S65",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359872&loc=SL124427846-239511"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(23))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/subtopic&trid=2208821"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130533-203044"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(a)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(b)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e39076-109324"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5227-128473"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4613674-111683"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569655-111683"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4616395-111683"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(6)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123421605&loc=SL5629052-113961"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "http://asc.fasb.org/topic&trid=2229140"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20,24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28228-110885"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123602790&loc=d3e30226-110892"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "http://asc.fasb.org/topic&trid=2175825"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL77919352-209981"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL119206284-209981"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL117410129-209981"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL117410129-209981"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL77919372-209981"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL77919379-209981"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=123371682&loc=d3e55415-109406"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.10)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.11)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(5)(c))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.5(c))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r802": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r803": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r804": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r805": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r806": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r807": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r808": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r809": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r810": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r811": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r812": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r813": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r814": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r815": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r816": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r817": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r818": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r819": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r820": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "450",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624"
  },
  "r821": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r822": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r823": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916"
  },
  "r824": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r825": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r826": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r827": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r828": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r829": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(1)(i)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r830": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r831": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r832": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r833": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r834": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r835": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r836": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r837": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r838": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r839": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r840": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r841": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r842": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r843": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r844": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r845": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)"
  },
  "r846": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)"
  },
  "r847": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)"
  },
  "r848": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)"
  },
  "r849": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313"
  },
  "r850": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)"
  },
  "r851": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1405"
  },
  "r852": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r853": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r854": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848"
  },
  "r855": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848"
  },
  "r856": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848"
  },
  "r857": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848"
  },
  "r858": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226016-175313"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e640-108580"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e689-108580"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>232
<FILENAME>0000874716-22-000007-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000874716-22-000007-xbrl.zip
M4$L#!!0    ( !MW4%1(7O54T L  +],   >    83$P,3EI9&5X>&]R=&AO
M;&5T=&5R9&%T960N:'1M[5QM<QHY$OY^OZ+7N<LZ6[P;.[;QNHH N;"QP8=)
MLOF4$C,"M)D9S4H:,/?KKUL:WF(@3BJQQ[DX5788:32M?GGZ44O#V2_-;J/_
M_JH%8Q,&</7FQ46[ 7OY8O'=0:-8;/:;\*I_>0'50JD,?<4B+8R0$0N*Q59G
M#_;&QL2GQ>)T.BU,#PI2C8K]7I&&JA8#*34O^,;?.S^C*_B;,__\'V>_Y//0
ME%X2\LB IS@SW(=$BV@$[WRN/T(^G_9JR'BFQ&ALH%*J5."=5!_%A+EV(TS
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M6V[#/7UR<(QNR7W[J3X<,J&TVS4^JLW'@;K6B;)HX?K/KR^'S(A/;-]DS(B
MFW<X,R+<K7W6RE'F-K&WI_P'WP3^UD:KW.WU7H\6L?1V"F9,2PS\S><U[Q/!
M[R;ZYI?JOO$7)]SWI%[,K/I7<NC]2[&+CZS2D5LOA#^$PG;RD$SQDKO-IT]?
MTK,6@MER -3B-8\$+NW>4MWY"M=D=H,@ZSZ0$?.2IS69X=F.\B;WW+>2E)^O
M?RU)5JW[5:']Y6V/@[X4W5=[V2\9._\?4$L#!!0    ( !MW4%2TG;MK24$
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M&W']RF4JHU\K/2G9-%9)0B/)>&@SM1 U+9JTL#YH2<,558J6)C,#JRN-<!_
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M#\QFR)*^P C%9TTJEM*IM_'BNJ'X4EBS<A4[SN""&$1QUP?%1/ZP[8%]DF^
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MYY!.V%>C+6[:$2,Y9[M;>2U28'>E\3*I.%YZME1$HA?:I.&)YE ACS69NR0
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M%BNS@76&D\%1,<1ZZ-2_2L%V6R!'+H2?SC!I(FG0R+Q_L90#:?K'O&[U&:$
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M:AYS2[=YWQ:5SR$:IZ"G:5G5-CY*7PY4[F6CIQSS*9K:NK]>\+9S4%#P*%K
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M!#&<,<21=RLI"5B=I&"REA;NYCWB+Q9^4QJ<V=.=-\+36#H2,/P3$J+,47.
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M:LVU&9SH^DQ+J3;M.VT;A*#MJQ/T7>#$9GH0%3+1N\,-4:HC*7EP:2"3*>?
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M,&=_<($KRX/0JEA_*@"):%IJRVTUXVX8,^I;)T&8;,DW$NRA+UD$0^]OYV0
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M&6;_T5:&?TR+1_*OF4+2-4.1AC0@%U5$MI+T>AQ%)RE2DV&-N8&H>JSGJ+5
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M^%O(@JJ3%=<&[10PHFVZ1^V.Q%1-N8%FJ6M.:TP;[('@$^U15%V,5<I+=/C
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M+!,(P?F*_G5X>!CMFRZ$(&%8"Y_8WW= 5#CP2&$'NP(O-]>]):!G>L_C$-I
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M^D;9[51J55'W*;,OAALN<0$EZLE88XF.;5TTGX-TP5UAO*[%DK+G W>X"GO
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MD)R7RG,X?;8*M@=->G^,(K:^ JW>"'O=+=?56MJF(2TKW#8UJ3\_T>Q9,L]
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M9:/!=,P)SV![&C[%S9-)OT1SV*,S?%V*+M\.=,^C77+^JA*T7CA9,"=!GSF
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MWF-#XNS-ZJ$KNU?;^39RQR]>)#9WW!<Q<AP%EOVJ91A;=BY?>+-)OC4O$HZ
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MLRM6.U21BTF3V_*IIU8\#YL4ML$!-R/[</\7O#-35/W(!:PXO\LGHHJ*&U9
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M[0&NS*G.*:>N6+>#JW]  F,CE3L;I)F#I\TT_>+*?Q/TI23@ THK+7_[*$]
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MJCX$ZT'FFRB=Q*.D*I>R!JI"[V+6HC!E-2HN&  I4T/7XB*&KS*IJJKL(F9
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MI!7=.:NJA2&+DIS[]!]\&E@V7[Z,XV).W\12%4;3)Z?Y;,U G1[/JGGV 'Q
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M&5+X5&;C[+)$+24F0&1M%IBS;LI6O W>LASQA?8HK1J6>3L=O\2M1*5FG3$
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M)I>^<Y4YSB1^Q7&06\4L;HI%VU[&OY?F:5*%5HK9KBV#E?^=1KY>[;_?OG<
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MZN33<2S=#Y>;+'9.F[!CF/1C88;U,VXL.AB)K8C 2JX= F8/"[:K957K681
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M<=MGO<UFR\C!?]ID)O.Q1",<F[;78NPSGHLMGS"U6<%3_:H)+CXQ?FTR+-P
MVZ0U+^"792M0VJYI3+TFBV*Q:@0P3:DQ-Q9E.-B)UOO:I L47S09:W=-5G<Z
M#E@,5RX[$11_KH$A'0F!O&Z6J;9V'/B-6/P'5:5K.M,'7F?.(^,'.&2I PS:
MU1%]8\778<6=QEM#'*VG!57(F8V31MDM\YJI&K9L/3BB+V!H&)&X\/UE7U$8
M!7S8=6=.XE"S-.(W#MR 0HKM1%8'+S_U>"KUQFKY!U=V<?43&@M80 <BR27$
MHFNI:%(6YV -G1(GGZC\W#8J&V@NTP?+VM/9DI=-VGG@@F.Q&3_9_04OS!3U
M'K&!.JY)<^6RHF/Z_4=$X?08E6"+UEQCZK,D Z[:,V"5547/J!6P/'+UH>_%
M->^Q()X-9KE93;FU^SXS'-P>%&B=$4:N39Y?NXT;@AM#NQ0D/'-G &61WEB2
M4M8RC6Y>MR=]B>UQ+2E!^QJ> P.>ZQ[:)RYZ3S"VJK'"@WK6F#[$MA5,IP:
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M]I&9D6]2XR?R&5-&*;J*"01(\D2QOP9GU3R03(<P)'52Y#M'OX11J=M$=GV
M&0U!),K!CMU.,.J>(9[H,2\)R"F^;MZ=Z4-/3/G+,!^BY<G2L #D)9Z4X#*<
MLP9T063%15.B91HV;]I(H*T_L@NKFPY3-*JM<J>WJW5?VA0X2,]L-<Z[2/5"
MVK0:VNKO.%Z!HHECDT:^7DC&W4W=,%$EM[/U^NW!Q&FI2,F<-ES>BP2<E&HA
M-0O29\!T5I1N@S%**8-S$!=5/6K1K-?8HG?IKD;(?YB2UXMJ;9%F?47B2"NO
M>+9G/PBJ&V-D6&;K (G(HG &C7V30R7BQ_1B$6(Z$V;,ZG/I+G%1G.LP'4AN
M[MU8KXH9YE0W#" A_A'+'&TY(YU2TYN3\GIUXDJ3Z=C2^[#:C,.#1*F2[&9H
ME7. N* G];#SK>U'QI5YC<!^<F6,%W66B+,78J[:'CP?J!RMA=*FJTD>&=W%
MQQ\&2G4,JS?[LNEX"<_>'ES!@1A%F)N#I10!^RAR1TB\J,-Z+XT-\YT*.QQO
ME&CR3ONIH;\+>B VC8I[7>'V '$.?_GXZ</QP08*[<M$-,H>PC(QEML.X?2"
MR>)U)'R ._K7#P?_.GZ[N1MZ7?OKHW,)O@7%X=BQF_LSN^XXM%!,.XY[Z_;K
M0KQ(T[M2GY(<\:&%_EJJWS'/@9JFFE4%.8;@3Y1(>1L3O*8> \.!T?SY3_O[
MSU\A($CT3P7OAW&^*U NX0_/7I5I45%%S-[>J^CPG^_N?&.V10OW8&Q$ Z#-
MXKRPJN!<-5[VD4 \BO,O3LNXF7$S;9%C L[CM9U'_6L"Z\9/%4F>4$WNI#$.
M-,]ISH]VVTQ.1225/^KGW4S>L390N'?*,(QB7[4=+,@"6DMB'3%@^5WH'C?+
M5P2@L6' P\PS$">J'0"P[4JQXRZ8^&0P&;Q28@=;J=P60*<,RI)I^MGVX!O
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M=N,'=/LTF)?VY,6KZ+"I8%.=O/G;NP^'MHW\5B @">?(Y7B%-J$T5K*_;W>
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MBK_#5^B?T;P%+2!Z4G4>>O@[# ):I=P3_"J=QO.,HG'MRJX0;$^QBS"[:A[
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MX/.&'M7!19D\34H8%C3)N(]L? 9Z9C/LLX[<#)A:S#FTF]'A_M Z;W/C%'^
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M W;HQ!$8!!AQKM;"="358Q9M@;>EOLXD&BUD-SWLD; OD_K=ROF<'*.+$JU
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M:F<10]FM_3!RFCJX58%L(<B%XJI2\,RBO,X@:N[BK/S"6#+8*ANL-K%[ -H
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M_WAU=O$N>/W^W=N+-^?OKB[.?@HNWKU]__'GLZN+]_0%7G#^!CX-KO[KXC*
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M11A<I%$O#$3P1B;B1N0R@%=SIM_.X&8">C.8Y2J-U$PDP2P1D<3;#U%'RJ+
M\8@R> %C#<Y%40:7$YD,Y\&;'(8&VUQ.9Q,%3[F2*5XN97#X\N#H( Q^Z5WV
MSGK!WE__]'(PZ+\RB_3H$[Y*0='D;<Q(G_U <W?P:C\0:1R\S\M)]OPU7*4B
M6*DW2HS3K"A5Y*PQ:KY_@>%JKK&"79.-1BJ2M):XE!=IK,99\#J7\K-9RX]9
M-)%%B7O*W&<[E_']ZS<;,\YZ$>^O@3=#3_WZ7^<?S\_ BL'T!A-02D/4-R(H
MJMDL43)'K2' 69O_6^9%,,KR8%*!#0X$?AVQ-J*-'.?SH$@4>%\A_<TJ:ZT[
MBE1-8>^[M_SKGXY/7^W2U-93\I,8XN[.<B7U.[Y=[R%+\0%L#OK,&S+@^H4,
MR:;.:'B@,*<SD9)EI6&' ;DZ<%A0:9F933D/Q!A4)ATFV@;Z'R*M1#[_ZY\.
M7O1?@0$\.#T]#?;P$=NT9A]R!>_9+^"1&$$W9MB./223ELMB!BL0P/+@+.L%
M@I7X=''U\?VEUC&P?O3U+ZG"H]]E"2= UD-GA1*D52IP@3*^ZM,Y^.675\&9
M5CO!'BQN+$<PE!C44Y+=[)/"P1OLIM(YK_)L)H,?>Y^V4MO\^&EC!NOLUP?1
M)7?<]'HA;]W@VZFAM'2;K*78NX$EE_ ?7/<I_@,_@T5$-40+TBU.4$RRO,0]
M,H*=0Q?&^(L);",\#&9P2/P,1SF9EP+6>IK%:F2=K!*O*K-=5%1AX#H5CMKZ
M\5/S)2LG<-(QTU,?AYT9WDW[W27JQ@R\?C?\WC1[\PRU JX2',!E(@6H:OSE
MI2S+A#=JO65CBE[S=KV4LU).AS+7&W9 D:#!]NW8+DDW9N".#4=#.JOR659(
M7 #0[M,L'0<9:EM84I6.\3R+JXG)A5JUN[YTN$KEX[+CUYW:2IN-++G&NYO-
M$ZMB5J$_:\)_^D13PHEQ%U\QYZ4"+T?E$BVA_#+34Z=RF*.$YVZB9N@%97F,
MRY/IW(^.D:UP[Y?%&<+@9J*B"7AA2>(\,BA$0OL!AX=[Y>#D5>&$..H1VR]M
M2(,=!&/+6:Q9GL555!9@TBE4.YW)4J&5VN$X1SF!H8PG^!*Y6[Y>89B&(=S,
M;GL.A]-JDS>,1KSX# M36)<K2>#S"B/:^);EY=S,M4JOP?L*"C5.R67"L[^8
MJ1(NK7<)+FQCG_#KEY#^A:6723#)$MQ9.,AQ:C8'C!^V!CQ9TK/@V=>P"6#3
MP?N)?IQ>78S&P@RBFH!'5@6L&6R'KUOA34W3L'GJ2.FIZ3@02?F?S^!5&\O_
M=WAZT/MM-GX6%'FT^!F+8&X\^_)J<3JN894Q,J[G@*:#O]:YU!>#H]F7SM3K
MAKT\W>G(I1/)'W3E35OS1GEEL%^45?^>->6U7,@T6SEY/OKU3\00#!#8F[LF
MI_E_)[FY\PP6]_D07K7/S^E\\[U(;L2\>/:-$N*;MKZW*,>6&F2#DQ95;FP$
MAL5!)Z:E2BM4(G40X W8G4NV.ZF,9%' @88,F@*+HG\!J@EM5B.X'H):C)+*
M>BZN[OMC?3%ZP/>HCE6TQJ3M5%*EMHAI=N,Z.*C-^>B0PL*(/!?IF#8'9T6<
M0!#E5^0U>#(SVCRPR+%-%+HNB;/T^'-XP)2_@%T2*_8^X<=LUC!K'&OP"VP?
M#"^H]$$<DG7P'H^T-._>_XK(BH_G;]]_/ ]=SYHF8*CC=W@<&V4)N(YHP%]V
M*>A2#.%]LUH5/5*4)!&S0GYO_O$*??E$S+]7*8V%?G0?,P>C[_592Y8PMV5L
MGJR_[M%7WY5QUW>G1T=+O^WW#N[UW:!W/+C?75>-]?2P=W X6.NVW]$\\%S
M=!?@P/WGL\-GM36*4?%]/YA]"0Z:CE0B1XLSGLW61U3=$Y#4O2,/:FVG1=YF
M:5K^S-9+M"K&\>;\[<6["P2-738$IIWY';WJ6VO"+M*VQX*JDE4B^A-P(()C
M6D$6I9@(<&8FXIJ/6%,)!VUT8"18JAFYF?3%=-&L;Y$6'1SV7KY8_O5]%1XJ
MYX>_ZTF_=]I?[[8/JT9YMA_\35T'H_KM=(\7Z@\0:E?,N0[26[U9Z%#SUJS@
MT[3SSWZX:IH[$PEN!_1[.[IKMTK+/-4]^@3TIHE@>+6Y'>MVU04_,LK31!S_
M/9>Y5YQ^EV[2,NW.#B3%^3J;@GL2L?/R1I32*]#M6#]=\J4!/R^X],LK2[\C
M-VF9=F<'DK*T&56O)+=CW<Z":"*G5"*)Z"D-70CICUQ1X;\($C%'."9^2I >
MQ&N-5#(- \03$2XH22AS/JT8](/X;?99&2 68-$_)DN+4I450?LX5^H\%.%
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M3!^718$ Q_M@5 DFD<J1*CG4S?P4=?P;EF28@>5U&WS9,+A%:C:;( =G5&<
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M<CJS(%B?2F$99K@2=2^!)JOL(DJ1?D^H>9DD!;I;^@A$9$+LBGM@N$\K;F3
MP$NT^1(]6E#GE[14S0:ZVH4G]QBI.EC5CK0:7]U2%W\Y1D)QKK'^<Z,Q+[KB
MC0^XJ8M+E:V1V0TVUQBIK1ELC<<T. -4:;E.9U[G+@8:;O.C&D)BJ]=KDFUX
M/(6MP$;!\1"I_W5JE1CMXB8M25SE5(8D%OK"#.58,:2<;%9S@M6H.1$(.^R>
M6S1:SA0Q)-W,, %G_KQ=4TJ[BXTN<:)4T\ZM1H[&ZKWFROW7/QV?OF+G@L(I
M7!20V2JZ#KYTQC,UET$SZ9MJOF:)0EW<H%%3+>["KQ7)J>QKK*E+)W#KN8MD
M;"QWR/[;-987(A9JH<?UNCO1^% DVW:%:S? JU9K-1.O]YBF+!)<J6,J3]R-
M2=V=="UC4[WX$\^#GWBN">[>>"V]N^_=_4UT);U$FR_1X^$(%X#@PG'4=";6
MP__N:#ZH]<$01@L.& ;#4N-XL[]>I8U\+#I8HZK$ILX4/M*'"%R7*W#-'!A\
MD37![3J9"^YFHJ@]8PYN@J9_B+GMM28U:-9W15D&OJC.^M9)%S@]N%TDX!2
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M>0/<3CWZLJ#-3SWNB7V6[&IBDRP^I77/W6%0J%,!SB'\/SD:85IWM$!U6T[
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M@1%1#QC(@NG QTD#+2H]QXJG12.+R8Y E(@*OK#"5&F"K+,4RG&>BQD10XM
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M B.Z\43'QY/79^S=R<=?+Y4?6W]^?_+N[!+B!9[L$@NMLJUR)8;AR2XV(G/
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M14C2 B3D\E$)7:HG5Z9PFSK#?;!6F$0*S*0D2:;E06[1D>?*B*E"_;9&C@F
M^FWW4K]M;6ZJ5J,-Y>M0O@ZF.DSU\J@L0%1\1-*\GANU4MG,22]TQ_L<ZVC>
M7 2A[ZG^KE*7<;5K._#EUYF*;N2_EM:UJ@%$L4!/JZCZ2()23S.'$K86/LOO
MGZ([RZ9J*MV45WDN;9K%G@GM@,@F _G7WO(7SP^R?;22#Z$8!L+4E_;G"U6/
M:+5';B9RFE:O,R7GAOY,#F:X,B)=/D^!I0)Z TY=Y:EQKKRF^Z>;KC8CJCF7
MM*-?YJ%Z"T4&+WV,=I"HC8M(,'4&<CLWW7+U?!I7Q^:TKDPIO![P>D#V*:_'
M49D E?3X](EQYIH-0)<>U5Z.I+9_[C&Y9R073;O(8IZ=/C<%\X1XS&/3I@'F
M\]5=+CGZL- N(WUT<'W>Y7PKFLB-S9K9'B^(@RX(6B%F7>[[UX'>R--\K'@N
M)U?5Z%4^MVN*D)A=72L-4C$SASGC'+)0J5\^G[N+&ON).RYU8- '/"D:HV\A
M*@^%(3D=(HV<*(X$X^R:TY&0)&EA<])2G6I9[C%;LS'MY\"<L5;=?,]=Y)3J
M/=CR?&*JI)N'O%&[(T<Z5#20B*[R[])(IORK6):35&IM&,8S8<HB>U'@N^HZ
M'8OQPK2.KU'%(I7U0<JB<7VJOB#;GJ=>%OJN2)]LGI8\7"(1WT0P=$**7&7@
MRA6_=< Z;N50)64YQ0=L('5KRCJ1E\QK#C0)D[?<,.J<>1KYDH=5%HL&LFTR
M-L9+3*5^.%J=L>]P23JDJ]7'73LFFT:W5=%J]XQ6@&,:_NHW).DQ^E@RI<C0
M:I%<I+@V<WIJ<PQ;>25Y]\'*T_.?1V-]IM=:\H-TZ ,A=YY <&D@\8&[4$^C
MTM?2P/@.*D>; >80MW[\M1^[AJFXISM.RGO$F,YO)8?1EH,ZD*]67OUGWXPI
MHF='LHGBCDRWFLU!Y,P)'W[Q_&M7C":ZI4XBDQ1KI>M;,R@9)FP<NWHI\9D?
M+Z=MZWNY89S,O,KU,8X#SPFG<H$K6U$:87% (B4SJZ%\<TB%LWUMD3J94M\Y
M0(9R\FAX\@8U5-U"2(WQ@#U;F,FZ>8YTO(.JJ6N8@7 %UPLD:[F9$,H:*F70
M_;G3>XQ(UD%KSZ?W.$+9T8'\^6AA3#X)5PIUWQ.). PWEI.6)IE9&_IDHY,0
M41.[C>K>2+.S[A+T5>X6RDMJQ'7>'52L@/1#3Y<B&%,Y@!4E;$,<+H=96_/P
M_O5(43'B0HUN39-[V[]YFL:CC/7&4CYGIQ_/3O\#USE<Y[![']<UT46=4AM<
M$V>J3L!8>XF31 RY3YHN>,I5S"<J?3Q384=NCV.YZWN1HSSMRQU4"M"AZX>Z
M2(!4<Y092#T&=>U[4E0=SYYB<,W'M:^U>S[B-"9EED;^[OI'Y4/):!'P$'*^
MAQ8!!49T8Q/VLX_G'UZS#S^QDS<?S\[>G;V_0CL J-DE%E9E6]U*_$+-MD#-
MOERMRZ(U8N/1-W59,LVA2-4CQWGR4PM"4U=RF(4(1AF/W3*(FM;&4?YW^71_
MM.R@>)K->GE-OL98&C74 5%^-Q"!9L=6XX UZXW>G@&J)[YP(LFQPQT@W[\K
MLK!)Z\T<50-)ZV@ZCJSM8NC$,+4?0M?KP]0N,*(;M:.SC^_.WZ/C'DSLL@NI
MLJUJ)79A8A<;T=5JVBSE>0VTY>QXJFKJ8,&$HQ)1=$*H25XRMN*R2JHZNH *
MJ2N@4+8(%5)1(;7R,A854@N.R"1,^]EM+F23V'$CM=-- E\7(J+SD*;ADNX3
M0:7\QAF_M/J0W5&3ODOISW6]HTCG>#K+EA!IHJLZ[[<Y(.6M89X<N_SPK%\W
M*:8CO@B3?/Y,XJY\Z,AGH5]C)\F!0]/80OMT*?^$4I3I+8[G^>2R-"^B\23;
M__JIFL$BYUT:X,J9@D&2NDRM)TRV+N6.2USY")9ZA$I)IU<GZ;;ZP3BVB&.+
MD%0H(5MT1#E;B3K*I<Y5A+[[-7,.@.(8N@2L.F@Q#.2&$/F!VFDFOKI#"F/7
M^2-V1CI'\%GF2,#8')B?Q\'<#_5&-/3EWRKO/Q!^,.&>\Z>Z\3G]TLN3]F3P
MW47<9PXP.3/:R>AV+?,AJB&J(0E>/AM"5!<:T;E1,+4@%*Z@GJ=TT%*=]J):
M(4()O-?!@EU2Z0PFI=S$\T,Y_+1)ZH&6K$Z4>Z3S("-")U(7]D@95@5+'#I&
MJE3Z7[@7\V!A*OH=L*<_]!O'?_^[_)_6\<&-VCAEB&=_S1:"!Z$Y?+EV7A):
M-%QSB% A0H4]8"-"A1:MA49T*HT=<RQ=N9&D-41>N6M/!*I=NC*F\LT>91.M
M1*^6?3P&@NE,,GW^.MED4^_;JA//5!531\^=,9OY5%6#K+#L_OMCZK>+HS#B
MGJJ9.^1S2DN4L^8/OZ3'Q6C4*P?&'%7#@6J$!<D):E='W[BR%:4J$NDJYA].
M7ZMVL\IT<SQE.M+9L4#H,_H9;<&<,0^3J3#%@T/-))+UVRJ1ME&GOS90+PV[
MI"C)JC)!NHG"H"I.T(A,1]EPI<H(/3<SN9EJ/:NUC&DE&FU*S\R=\:7P6G<#
MA=8KL&$A>Y/M$5UO"XUH+8%#;W!+(<ECJ>YS-=1$X"G[<WV[$^PLIL*>RT=!
M!$($8GTI$8B>0X5&=+6A"*[I?",AATBA"PJU*,></D&6+5VGG7'?,0,R_8=,
M[3#7F4GU7OU^5;MN2;8Y8/+?COKW2/W;/6#4LZ,A/S7DWTTZ'"65WF9+_K_\
M=5->:\IKS;X:7JM^8.1Y& =?'>-8%-_F3L"3LL W#C@M?.=XL=)L*2Y/)2>&
M(EOHR=3E\\10A*'IX\J'4T>8-[K^1-6%5HT1/?E;ZNJ4#3MI-VI*@9R= VXP
MG/MX!,G0K./<1X$1W73NXZ</'T_/V+N37\X^?3R#0(%?O<1BJFSK6@E>G/RP
MH+C"^QSON%0274?)RZ2;YMC4D98?1\+5;MFY"*AVF2I1K<^#D*/6M!0A736K
M7.>6:-^L"JT5R<VWA6RD]5=5 YM3FXN!6/BF3W=:]W19>_09+W;)AY](!6?O
M^&=!0,\H*:P(%2!T85G/]PXSU,VRQB0Q0K+Y;;IP^;H?/3$+I'&BVZV:?C+T
M6&5)Z"<2+57_E&"H2WYGJ"G&5--#Y61(OHIG8G5C+W/5AE:.#H.J#:C:@*H-
M]WF^K%GK[T$MKM?Z>U#A&SL;[[?R"=1KW8KY!,JG; -1\1$9S8=[4C7B(0M]
M"L2%V9K]\X .?PU)#*J$"DX-"$CO<75'.):C-*JL"X?T:[KM0&I3*N7D9GU*
M)97.A-"=0\*8>L6L:.M)7D>FG8NR!)(28)0,(Y07/+J6@U@<COTXH!8%T314
M+?2<),LE V\DM*N:JB&K+)K55AIC^4LGL3D(5325&L-$]RXP?>UVUA/U@3H#
M;+S64E"Y[BF9*&?L*OMDQ22Z\7S$#KDD:\HR7.-PC1=#(#4;<(T7&-%-WH,W
M'WX[^_C^_/T;]O;D]Z<_=/K'[)=/'\\O7Y^?HDP2G.4E%UQE6^E*%,-97FQ$
M5Z9%7!3$*LGC@'V50QHYIHM65KO?S,)(W>H37P*B)&\JHJ0Z=BEO>4AIWBK1
M@E^G]20N(U,$@1#\QP^^'+!/ER>ZGH,K)I2.H=--F/9+Z:(/:V^>Q:'2K@=*
MEXZ2'/JAU'FU43&G;MZ!.KS[.0Z<<.3H A3FASF#V#C^*ZT!5]H=7U>?<)"V
M?%,M#87N#2EQJ@Z3JQV]7:XSXU=&H-J)RRF79HY#4.3\QC/MH)X'@GJ5+9W3
MIB:5ZT1)I[K<@,.R-H6N?C'2(0758G.41#"&?D@FTC+3)V-H<+EM2?HMTC-V
M8VKN0D!-H\.PQE17&#TLW79$(PYUJ()82M&)&ERFC;[#,!;$ ]1V_88GK'0
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M  J@  J@  J@  J@  J@ ,K._B"(J@ 40 '4 X%J-BQ-XOMTJ0X@R@%7BV
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MB'0@>.1X\GL$I*L$JGCRJ-?HL5:[VP6QJ@&J>!P(%W^U.+"4H(K'A5A6U>+
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MR0M/)O)5-+P:._$6+!!_Q$X@;^:CSY)0J^.>\9%@/%+WR9&E8_;C()IN#/>
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M,YJ[NTWY^+D?.I'C>R\"X?+(^2K,3.E'9^\R\UQ?WL('H>_&T>8M>AY>_G-
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M'&@T:[V^/5.P'T'0;'>L8=AB"8(R,6R[N].=>RK,=+_V3+.,QTT!"J  "J
M"J  "J  "J  "J  "J  "J  "J  ZB_D,13<JZD.:I6.9O>$:J<2O4/A12)X
M+%SY208FR>)?4> N:A4C&E !%5 !%5 !E0VHK%4R3KD[C%T>B1$H9@?%LK4P
M?KP%O"3IO<3TA:UF.2IK%^5OOELU$\U:6EV80PHA"&8'P<[&8S&D@T'LHQA(
M505TLX-NFEKLC ^G()D=)/O9=T=TI@KTLH->9HE=<&<$3;A,J*SER&=9^_0Y
MJ&8)U?X&LEE(MA_9RG)C9(:">)80[U]14(.TM)%RH%K)J 9UV7)4V\,=>35^
M>LW&1I&?Y7?Z.<6L\E,B(O1SB- '$1Z8"*T<(K1 A <E0K>_08/T*Y  PJ@J
M1'B$=8!NQT]>-L*(DHS1[AAHT2X() ;:XC$T.GV!F8'64H:N&-SJK=_M6=@E
M UHQ7L:N"V8&6BL9&DL7S RT5C(TEF[%F'E/R1=%=+4WO=&M7.V64Q:@2B%X
MJD:P4H(J'A?NLM%;!0C+JGJ@BLB%Y415VK6UB_O8)CSE9$#L5M7BP%*"*AX7
M8EE5BP-+":IX7(AE934'(BWYR<M6<#M?:5G=XT"+> ](#+0%9&B$:L',0&LI
M0U<,;O76+]*2R\G+V'7!S$!K)4-CZ8*9@=9*AL;2K1@S5R@MN1U-D99<-5#6
M"YZJ$:R4H(K'A0B=5XL#2PFJB%Q83E2E75M(2[:! ;%;58L#2PFJ>%R(954M
M#BPEJ.)Q(9:5U1R(M.2-:4%6,M BW ,25Q9M\1@:D5HP,] "+= ";2G1%F\C
MPI8+9@9:*QD:2Q?,#+16,C26;L68N4(IR;=TLUM.6( "*( "*( "*%M ;?9V
MMD*5O IB<1C/G_[0Z56,8):FV"!GJ%H<"%  !5  9:%DQU9E-0<BO17IK4 +
MM$ +M$ +M$#[R([%<@2OK_R(N[OZ&ZM X+)E)R / \P,M$ +M$!;2K3%VXBP
MY5:,F>\W]7'FC$:N*(<+]J[0"P -H  *H  *H  *H  *H "JY*#J!$D;'B__
MZ<PFC+O1_SUQ9GPB_M?OUC[/)_*68+CQE7Y*\N[YM^,9#R:.=ZCMM!?26EF?
M%S5M^O+QM3.*IB^.FNWYMR<P*0 *H  *H*H("OO/ _DJ_Q'Q@2L2L!D_X^;$
MF6\B?ZX^9M .A1>)8 W9IHMWK/X[_A[DO]@DJKOJDLSCH%:_L<%"R^_NGX=N
M,:T//8G=G7V[ZA_]Q8 89^W:VKQUF_)%<S]T(L?W7@3"Y9'S59C9T2_)WF7F
MH[Z\A0]"WXVCS5NV#B+[[S18+M*).!P$@G\YY&/)I2^X>\T7X>KK9Y( V8'?
M\IVWI^_-<V@#D^CU/Q)#/^"*8/+U(J!?/7EY,HQB[C(^F01BPB/!ODI2S@2;
MQ\%PRD,Q8H,%.W]]]N]_,^Z-S%^O?F-.R%S_6@0LFG(OO2GP/XMA)&_BD;P@
MV$#(J?"DX&7^6'VQ$#QM"O?H\_+D96TK7<V&<4B[PXMZK=%7I%02>+D0 CF-
M-%Z7ST/Q(OGC>.2$<Y<O7CB>>J.ZZ2Z228ZQ5M>,;>)4YLWZLAP574IVO95K
MS5J[V]QZ]:8[;[[6;O;N=&>C5M]ZK5WK'&V_>M>G-FO-^MU0[F>LCS&O]=[]
M/W4_\]JI]1IW&^O#SVNGUJFWK)G7NXYU/_-Z\[5^_?[E0*-9Z_7MF8+]"()F
MNV,-PQ9+$)2)8=O=G>[<4TVP^S6EFV4\Z0Q0  50  50  50  50  50  50
M  50  50  50?R&%IN!>375&L'0TNR=4.U6'UNE-CX4K/\G I%C\*PK<1:UB
M1 ,JH (JH (JH+(!E;5*QBEWA['+(S$"Q>R@6+8,RX^W@)><MR@Q?6&K68[*
MVD7YF^]6S42SEE87YHA""(+90;"S\5@,Z6P1^R@&4E4!W>R@FZ86.^/#*4AF
M!\E^]MT1G:D"O>R@EUEB%]P901,N$RIK.?)9UCY]#JI90K6_@6P6DNU'MK+<
M&)FA()XEQ/M7%-08Q*6-I /52D8UZ,N6H]H>[\BK#M1K;E8'6GZGGU/,"E,E
M(D(_APA]$.&!B=#*(4(+1'A0(G3[&S1(OP()((RJ0H1'6 ?HM/WD92.,*,L8
MK;:!%JVJ0&*@+1Y#H\L<F!EH+67HBL&MWOK=GH9=,J 5XV7LNF!FH+62H;%T
MP<Q :R5#8^E6C)GWE'Q11%=[TQO=RM5N.64!JA2"IVH$*R6HXG'A+AN]58"P
MK*H'JHA<6$Y4I5U;N[B/;<)33@;$;E4M#BPEJ.)Q(995M3BPE*"*QX585E9S
M(-*2G[QL!;?SE9;5/0ZTB/> Q$!;0(9&J!;,#+26,G3%X%9O_2(MN9R\C%T7
MS RT5C(TEBZ8&6BM9&@LW8HQ<X72DMO1%&G)50-EO>"I&L%*":IX7(C0>;4X
ML)2@BLB%Y415VK6%M&0;&!"[5;4XL)2@BL>%6%;5XL!2@BH>%V)96<V!2$O>
MF!9D)0,MPCT@<671%H^A$:D%,P,MT (MT)82;?$V(FRY8&:@M9*AL73!S$!K
M)4-CZ5:,F2N4DGQ+-[OEA 4H@ (H@ (H@+(%U&9O9RM4R:L@%H?Q_.D/G5[%
M"&9IB@URAJK%@0 %4  %4!9*=FQ55G,@TEN1W@JT0 NT0 NT0 NTC^Q8+$?P
M^LJ/N+NKO[$*!"Y;=@+R,,#,0 NT0 NTI41;O(T(6V[%F/E^4Q]GSFCDBG*X
M8.\*O0#0  J@  J@  J@  J@  J@2@ZJ3I"TX?'RG\YLPK@;_=\39\8GXG_]
M;NWS?")O"88;7^FG).^>?SN>\6#B>(?:3GLAK97U>5'3IB\?7SNC:/KBJ-F>
M?WL"DP*@  J@ *J*H+#_/)"O\A\1'[@B 9OQ,VY.G/DF\N<O-KV.FP[=L?KO
M^'L =X75S8&E9WPDAG[ (\?W7LC7BX!^]>3E*7>'L:N^9OZ8G;\^^_>_G_[0
M:S:ZQR&["/RY'] U'@EV.>6!H!\%8D"?G_$PC&>2LNQD&,7<97PR"<2$+GWU
MW7@FV#P.AE,>BA$;+/2C&?=&YJ]7OS'QA[PM3'\=^)_%,)*_YA&+IH(-A)Q(
MCUX@7TI?+ 0/GB?$>?1I)6[)IH$4G37R./XFUC@A\L[IV_!1YGS;"LV;<RE[
M:(&F8_,#"8/&Y?)Y*%XD?QR/G'#N\L4+QU-/5C?=1?C)L=3J:CQ)&,.\65^N
MUQIT*1&*:]?ZS?H-5[??V:AMOZ]1Z[?O_ZG]=JV[XV/O-Z0CE\BC[0"]9O-H
M#YK%8T+:CZ[T>(C>Q[.!"&A;"%UG))^[9:=QHI!=3^7B7QSZUYZ\&L:#T!DY
M/'#D3;[<4P*YL7 OW9*4=&'9**UYPT.$+ZW@C43EO.U/(1\*#*EL\D$EZ3)O
MFY2XA9" 0(! @$"P'I$6",9PE5:D7.9Z9?]M:T:677;_;8V[C-U?>./.ICE_
M\G+5A9*PG/)T;-U,Y'?M;OZ5OZ^RZ 'S@]5O:G>>K^QR'0HO$D$Q9K#=R['O
MU[R;K7YCP[VY_.[^_9L%9L-MOJG-O$/UC_YB0,)M"]^8YW2;\D5S/W24[ @$
M28NO8ND ^7$UX]+,1WUY"Q^$OAM'F[=L'43VWVFPW&4FXG 0"/[ED(\EE[[@
M[C5?A*NOGTD"9 =^RW?>GKXWSV'QUUX^VUP.IV(4NT*S3X\I0=8X9F=RI YY
MV&A#/IV*F1-&P8)=KNK"15\JMTC*MH^@6X1I'\(4PA3"]/&%:9\=LK-O?#9W
M513MU \C=C+Z'(?13(Z9933RNPO4HL[$,Q5,DNKLQ<6YW%..&JO*[H_/MR(V
M)N8AV9,OZK6CIN*90D5[;HJ@]&KM9NM.<9F;K[4;[7N/]K1JS?I=Q[/]6K/6
MJ.]CK$=']S_6?<UKO=VU9E[W,5;,*^85\]JLM5OWOQ= OH)?,:^8U[W-Z]%C
M) #MZ<1Z\U'C7P %4  %4  %4  %4  %4  %4  %4  %4  %4  %4  %4  %
M4  %4(]247D_Z%09YM+1#*B "JB "JB JDJH=H*ESR \%K!MIS*$QP/'9PV0
MS#:2-:'T A50 150 150 =6C:U WE6!NU!N;!^LS7^HG%;,,<[GHT,RC0W//
M=(!Z:CFJOJWVTH]48.##Z6N6U*$"X>P@W'\$#RKGE["66C^RTRGW)@+TLH->
M:G4U02T[J/4WK"ZKZ 5I:!>]( UMHE:N-+R[A5E$B%01#9:*)<3Z%'*(>EN(
M12L+M+*#5N<> [GL(1=H90^M'"PMD OD@B2L/*WREM:.QF0FT)I<RBLZO1&"
M;>5$8%L(A-\W ]X<!V_GQ<';R$=X6#(T\M)"&D@+ 1E !I#AL?:&7L[6T ,1
ML!9 !I"A0F3XCAVTV4%'J/^.[TJHFPPI_1#'&\E/+PX5%>Z]YL!?;9)V ^_>
M^UP]#O(=4U_O@C:@%P'N8\+=TO^WQ!S]8U6 5HR7_U89I%5<M7MEYFJA+2)#
M5PQN]=8O=MUR\C)V73 ST%K)T%BZ8&:@M92A*P:W>NL7"G,Y>1F[+I@9:*UD
M:"S=BC'SGFH8E3CF;3G!;PVJB$NWG*AN)9!L8L-=%'V;\)23 7?9^ZT"5.(5
M95>YODHOJ[*B*NW:PFYE P-BMZH6!Y825/&X\!#KJEHL6$I01>3"<J(J[=J"
M%F@# V*WJA8'EA)4\;@0R\IJ#L0)5YQPK7 20^7@5B^3 :F#Y>1EY!^!F8'6
M4H:N&-SJK5_LNN7D9>RZ8&:@M9*AL73!S$!K*4-7#&[UUB\4YG+R,G9=,#/0
M6LG06+H58V:<<,4)5_O25<J)JK1).,@6M8$!D=96+0XL):@B<F$Y495V;6&W
MLH$!L5M5BP-+":IX7(AE52T.+"6H(G)A.5&5=FU!";2! ;%;58L#2PFJ>%R(
M964U!^* *PZX(F,#:($6:"W:I)%[!&8&6J#%\JT:B:N%MG@,C9T7S RT5C(T
MEBZ8&6B!%LNW:B2N%MKB,31V7C ST%K)T%BZ%6/FBI]R79F/"IUO[=N9K7+E
M1]PM?YI*"?**D"A5+0XL):@B<F$Y495V;2%;W@8&Q&Y5+0XL):CB<2&65;4X
ML)2@BLB%Y415VK4%)= &!L1N52T.+"6HXG$AEI75'(@CD_<0.2IK]# _I%2.
M +&*-;%GW[++_7F%(\5E3@9 V@.8&6@M9>B*P:W>^D4WG'+R,G9=,#/06LG0
M6+I@9J"UE*$K!K=ZZQ<*<SEY&;LNF!EHK61H+-V*,;.*F_XCX@-7) '"3&AS
MQH.)XQWJ0;_HR)>8;R)__F(SK+DY26/UW_'W .X*JYL+ZW(H/!XX/FNP4]\;
MNG'H^-[3'SJ]8Y:E\JD?1NQD]#D.HYF0@_XH_HB=0(S8LP_15 2,KH?LW!L&
M@H?RZ\%"WB[G:^4A/S)?4I1=7)P_7PVK9F;-L,0AT5\.L5-KJ9E2DYQ.E1^,
M1$#3Y/)Y*%XD?QR/G'#N\L4+QU- U4W'FW188RO%=?KR\;4SBJ8O.IW:4;WW
MXY,T*FY>K*\V:C1Q*<.O7&O6^JWVUJOU6F/KM9N>VCVJ-5JM>W_L?@:[GZ=V
M:IUF;R]C[>[TU#T=HKU?2=8L8V(50 $40!4$5*X8/'JX5+''3PS30Q^)H1_P
M2.I*+R18$="OGKS,*$BGW!W&KOI%,H&/I[5FE3"EVR&K#6B!MA1HOR.1RR-X
MI7@=1C%W6:[WH4*%72S-J<<A :LY$)K?DY=O11AJW]C%Q3D[G7)O(MBS-1?7
MF/TM/Y\<NE;Y/.'P^5>,F:WP Q;D@&411;@^\K,TU*% 6B.!H$!:S8&EBI8V
M;XR6FG#H4LJ$:<#T%H'/YN-$/IN]K9'/F\-LG5;_W@-T1^U:OW=TI\?>?*W?
MN=M@;P;2VT>,\JC6;>YE"HZ:"'T"%$ !%$#! 8;09S4\&.5V4@%NE7BY0L'/
M2SX3C(>,#_RO EXK:]8HO%96<R"TOAVUOK$?%$W;RQ*S6/.F_(./.UU0A8$6
M:,N"MD**L,D"5"?2= H.M&%KE$=HPU9S(+3A;!+@TQ]ZS6;]F'(!+]PX7#WK
MJBXVCK=D"?X=.8*5\=(A1[!BS&Q%P!PY@MLU3&0'VJ>(0;.TF@,?N@=%06 _
M$-HB2MD[9V*#%^S3#*$#5XR9[]<A.7-&(U<45)#=LE'07:$7 %I%0=4)DF:^
ME_]T9A/&W>C_GC@S/A'_:S2:C=KG^43>% QSOM1/2MX__W:7I/RC9GO^[4GY
M6<NN$R+YL/[.#O..@JQ]N>+].V!^L/K-TQ_:W>/0=4:"JNBUUPZ7J OAJKRY
MQ3QEN4+W7"O&S'7J&Y#TN%[^<T!\<4>XQ3@XE+='6$6S;>>AIF(4NT+#:]25
M2[S1.&9GWX9N/!(CR?ZQ%P7.#?QJ'MBEQ.RY'SHJ5R(0E$#\51@)J-^6O<M,
M57UY"Q^$OAM'F[=LY:+LO]-@*40GXG 0"/[ED(_E3+_@[C5?A*NOGTG:9 =^
MRW=N._=5K]4?X]27''>MKL=^VX*7G4:MV^W<^Z&G=JW>N.LAK!N>6J_U&[O5
MIK3"AXL#&J4'=;]\*+>3Q_*INP/N.=P:@CVN??1X='KKB.$T$EX8"<<K)R=Z
M(S\(P(E%I]-;)YK&&S*C-%P8S 3D8?'I](X/Q<@O+1?^*8(!=SYS#XQ8<%*]
MXVY43B9\Q:<!=\"!1:?3.]_C0[^<+"A<'L0A6+#@='KO!]=\44X6]$.I93#N
MC=C/(OA33/ROC@?]L.AD^S#CY3237\7NA >P4 I/J O^Q0FCDG+A:>#S"$Q8
M>#I=^*[<N<K)@HLY5,/BD^E?/.)!.1GP3S&<LH]B'@]<9PA&+#BYU"-*ZB\\
M"Z,-7RAXL'AT^AB'84E9\"<>^/)IYR$I'-B6BTZN2^ZQ=]*.],KI.'PC_& "
M@5AX.EWR>.2PDX /2BH6?XZ]"0\68,2"T^G2];_R+R5EPO.AV' #@ F+1R=B
MPHWLD](P88!LAL(3Z?+:B?X406F=AI()_P 3%IQ(EXOU^%9IV"\,N'#!@ 4G
MTQ7_[)0X>/>+'XRP%Q>>3%=Q\$64,ZGF5_XG_S+=6&#@PN*1BKB04N)+*PU_
MC:^Y$X$/"TZF3U\H&5F4DP47P63Q)\2A!:3ZY#F1&"F/-3N;.0&/1%A*GGS+
MHZ\(H!2>3)_^'(@OHK2;\ULQX)X/L5AT.OU'2!WQ'HL&/7YAE2W%<!K5*X:S
M"\"*%XO9D;Y_C4D>?TWL5&RHD18;.G]]]N]_LS,ODK3]"X6QBK'R-9BW?$!M
MHWRJG,1.N<='G)WZP=STDF+/]'?/B= Y=UQ$BQI[&XUJ[-E)'$:!).;6WSY[
M_]_G>DKU#22I_RLXA6:VW'+ ?OV5/?N%RTUDZT.ON',M+[-S;UA+/UG,DEO$
M=!-B&F(:8OH&,=U,Q?2'T]=E$=(?@FCJ'Y[*"Z05L]<.GWA^*%5D*1LYDW"<
MD*2T/V:_R+>$PCM4=QAIF)'=MWB0/_5"^>?3'UJ]X_33.S%2-VJ![\R4TV!-
MYF]_!_NU]FLM*\G_ZG#2$9Q[H^^^?;='7D0BV<HNI8G"Y18H[KZ1W,O*NR\>
MO-^2T[HX*)T?7JD62E*"^9(L1)=H*L<YF?IQ)/]T0B:^39V!HYIW2K/0&SM4
M3=F19(JDK%15V6OL:BI8($9\2 ]P//G3F=9!ICQD R$\^113['$@ACP.!9-/
ME ^7\S=ESYSGS/,C)N^1X.23:8#/'/GMM1^[=(M\\6PN2"Q\%>Y"/C68C6.7
M.6.F#[S([T9..'3]4(QJCTOXQQ>Y6]20EL6[]#\&_F@A_V<:S=R7_Q]02P,$
M%     @ &W=05.^9<0D<K   Z ,- !X   !E>&AI8FET,3 Q,"UO<G1H;W)O
M=V%G<F5E;2YH=&WL?>MWVS:V[_?[5_"V9WKMLQ35DM_-G%G+C94>SZ1VKNVT
MIY_N@DA(0D.1*A]V-'_]W0^ !"E*41P[IF3,FK:V)0+8 +C?^[?__K_/K][<
M_O%^X$VR:>B]__#SNXLWWG>O?OSQ]_TW/_YX?GON_??MK^^\@^Y>S[M-1)2J
M3,61"'_\<7#YG??=),MF/_WXX_W]??=^OQLGXQ]OKW_$H0Y^#.,XE=T@"[[[
MQ]_Q+_!O*8)__*^__^]7K[SSV,^G,LH\/Y$BDX&7IRH:>[\',OWHO7JEO_4F
MGLT3-9YD7G^OW_=^CY./ZD[PYYG*0OD/,\[??^3?__XC3?+W81S,__'W0-UY
M*OBO[U2P-]H[/CCM!WXP.NA+,3PY/.H%_2 8]H_E4;#__WJPR!_AZ_Q,FLU#
M^5_?357T:B)Q_I^.^[/L];T*LLE/O;V]OWU'W_O'WT=QE,%D"3S,/_(8BR.)
M9 R##>,LBZ<_'<)8^B]9/*-?,_DI>R5"-8Y^(H*_X['-\T/A?QPG<1X%K_PX
MC).?OA_1_U[KW_;H?Z_QD5<C,57A_*?_<ZNF,OT_G13.[%4J$S7BCU/U;PDT
MP)STZ[VF#YX.520-O4@D+RJ0?IP(//2?8'J9X+>^^\?@TT0-5?;#][VCO=>]
MO6YOK[H#Q>X8"CZW4.]2WGO7\51$7[/D[_[Q9G!]>W9QZ;VYNGQ[<3ZXO+TX
M>^==7+Z]NO[U[/;BBC[ +PS.X:_>[7]?W'CP!GSX%;[9\7X]N_X7?/#S'][9
MS>W@^N+F7S<=[[_/;KR?!X-+[^K7B]M;_'CPYNS#S<"[N/7@Z<NK6W@.OPT3
MG5V>>[]??7AW[KV[^-?@W1\>?_/-U:_O![<7MQ>_#6"XZU^]VRN8>N!=#WZY
MN+F]/KN$D=[JEP\>.K^X>?/NZF9PWEW8U(=<*!_>#YE\ZQMUT'@\9[]<#P:X
MV0^FK!UTT,4IB/%4ZDU%(#TY&DD_4W?2$ZD7C[QL(KW>L:'U*==]U#U<8^&O
M9S$S\)\2&0I<Z&O<UE?[]/2=3#+EBU#?FZ%();_MV>1;D+#FUC//"<0<-_C*
MS^*A3#H@(/;V.]Y09O=21AZ\^?_S/]X@3^*9]'[N_M;M>,(#/C;3K,P#224B
MF!0$#S(U.JA0W..0M_#CI80_)*&(@M2[GX <\V:)BGPU$Z$W"X4O\8M#E%DR
M3?'T1>;]*X[#27PGHU"("-;3\7J]WJEW.?!>>3?^1,TF<?CJ6OWYL;,PQ<X/
MWY_T^WNO6[/+JU@_[6UK5HKW ?:N]WK7@ZWTKI)L$K]Z ]_"B^R=*S&.XA1N
M==KQ+B*?[@%*FC] E:A<B'N53>!01\J7=)HP-CP0J''LO4FD_.B=)_"V=$!$
M^1.99GCES#@=[T/WIGO6W:QCO'ISWIIUEH?8H5,4H-+!:X$_)K#9H""F](:F
M^6P6SCTQAA,A[;'.;_\IHEPD<ZV6P!MX>GI:8PIT2]Z<>SLXX"8=V/M$Q8GA
M:6=F"UJS]/(,'ZZUM$.V__[?@^O!&6A^>$TF<+&&>'L$WSX%P@(NF@ 3:/YO
MF:3>" YEDH/>Z@G\V*=SX[L;)',O#178-'RM^0*N-2((IRGP+WO('[X_/'V-
MXVS3]I;;<C63?.<UI]XL;LHT?+AIS6(MN3@1P!_)!@!U1T59[.%E+7BHBHBW
M?H@4VN$WS&TWCCM^N&DU3_1@UW?$+@LF/YX.X9N>#_JV@.UG0T$E*.QF6IZE
M'U48,AN!(Y-A"'_/4?M$]I]D<_H$!E71'4A(+P6%78'R(M"E(F8J@Z_"I^Q=
MT3K/F>8PL)#4"^0(EA  )PKC^UTM:D-RQ<Q$)$,/M%54C(%YP=#+>%('M&/E
M3U #EI]PZ9(6!8N\ [;''$Z2W#+L#74L^$LTIN7E*7 JX'D=?)PH0BDO0DG2
M'!E$R4,M7E'P2N:K4_%1ZD]@YB#W,S#'X@0V.)[.9*9808 O[@SU"<@HS1/S
M#%P=- ZB3$4Y+DQK&;" <YC\AB>/)"B&*>@6M!4*9M!/ ,6XX H+[\"Q^&$>
M$)FDZY>[OW5LO)%_\+VE#VYEDJ@LAIVS[QW8/E)%NUZ@\#X@'P(B/\H,MS50
M6H:"\04W'_^;R'$.MQ-',4^@HCY+Y)U088<.A:\BW/@4'ZY*%[S&<.!PYX@1
M:C;HI7(F$GI#"G:((UFZ9O46:))8"0,NJM=L;FZ,)AVNE99?I[\X>21(L4;K
M@XW-M@?MH<7$ZO*QI""1(^0&>@LUZYCFQ!Z8'>#S? ;RDS\1T9BNY\<HOG\U
MB>]Q8;#+$7(:8_DLI=@Z YZH<2<CN. B27 FGGMQ%X/"%+/?YZK6HY7;];:S
M0[_"$J8\E'5Q8#J^# )6&F@7<7'IZ!R^]NUK\/I:@]A>XT672]V/7+S)/.=>
M^8@8IG&89XN/?,;US/^>)&;DF1C+5T-X-3Z^$B/8LI]$>"_FZ7?/Y.YN!P>[
MO/H=O;#7@[=7UP.^3< -,@57$R_*4!N:>/5'<0AB$E7PDX??G$:?;":&(#R*
M"Y" S,5-",4LE3^9'UX'*IV%8OZ3BH@,>NCUXGPU!Q[-QQ_KPSP][1[V3O$\
M,SC$+# 3\Z=[W1Y^]&,6+'[6[_9[ATL_7?7DZE$/]X\?]&2ON[?TL]/][O'!
MR5K#_DC[P'L!NYV"$O)?W^U_5[XW 0KQG_JS3UZO>H*A'"UN>#S[[JG#'LUW
MN5<:W9KD3::&E;3MH6B5X7(^>'MQ>8&AJ9L*P70S?Z0W?6,Y[ 6*;-!T"J6&
MF"PS4]2-0>D'DR<EF9U.!*@99*OBEZ:@7I$R#NI5/".!2!],%[U+WYJ) FW=
M/9:*35QT%6?:/^R>'"W_^*$,[Z"[UW_\40^/NB=K#ONX;)1W^]'?U/ZS\AY'
MU#<@:EO$N?:\%7PSU7ZDC3G!ERGGO_O';57<&4O6-NR[6WIC-XK#O-3[^0)X
MIO$H.9:Y&>>&R3"_#6YO!S>W98C",$[C.?_W7":.<;I;VJ9CVIX;2(SS33R=
M8E2%%)=SD4G'0#?C_'0.I$YZ.N9<2,<LW8ULTS%MSPTD9EE$2!V3W(QS._/\
MB9Q24C!FA>@ :X=^2105'PDO%'-,DL*_4B8,)I^,5#CM>)B70_DU84@9(-.<
M<V4HF8IT5DZ1\;#P"$/1:::RG,+X'(FV)L78OP)9&R@8 H:;S(.$!L.(8S3'
MC'2%0=\ !U,X7YBKP,XIP9!]G&=>J*8JX_QEX?UV<7M]=</!]:[W%E=S%ZM
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M1JK&2XLKM)THV5%0M^,P?$0=0_T\Q/ITW2]V3F8H6-B12B>VG\#J44M&9?&
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MSR'+.LJ<?EZU ':M]WK7R4 G UO)7QU%[:?HV63@AQF8$I429"-[5C)<,A*
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M$TD$=Q0"T'$R0GOGD$04)U.07\,\!:)!2DQBL$,Z]3: PSC^:'K*8E FK<4
MBJGF7B31VXY.;5X7+=$>JV8^55)M5TD,#F\E<A8G&6)W<,96&1);OD%\/#H?
MV&#1)]-B16@*A3EA05A6$9)'T1:5S>O[4:5AM76FG?*T[-)&TZOI6(T</F_
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M$(^;N,ESD_YN!J74N2](WJS59-=0+)#:21P&K/?K>8W#9V<&8I0I\OTDITG
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MWT?*]X+8SZ=%7 DS I*%9@SLKF,,#UUKV)!FT,&]"KE.(IQW%CJ -#0=$(L
MRM2GH6CUIW,5IG&:4:8 NA:_&-"Q0DI9@;+T@^K?J;3#ECJ<2<B&3)G'=A][
M]U)^3$VYHY6_AK($KPREI86P%3#55->XFA)B%%16N3+NLB2:S7D0/;6&*+$>
MRQR&]ENRT1(G),!P\ H]"D\9CS^K RMWN$*U?B*+NU2*PDZA#+!'DUV$(&M!
MT+.B@,7E2MM3AM@ -C(ET0JO"96V%L;S2Z@O.:X&%%U]B:LOV;+ZDL^ (>X?
M/@488N]A]25/L]:5G?]ZW>->W]67.(H<14]*$6*R*/0E:,ALTJG2JCNW:VES
MK*%4])U%Z!H[:%OY*D-.6+!TI&@;7:O^[3S*E,86-''7:K?K!2]&@]MA03?:
M(!FQBGOVN_M'CP^8V^\>]A\VZDINOM\]>F'<_*2[35QBV_C>JK3*B\O?KB[>
M#&Z\L\MS[_W9'[\.+F]?#EMQI<VNM'GC7V]DOWN];:)G^TZHS 51T5V,>1\%
M*IKE>^,.:,@NE_5<RF=Q9,!TT%UH,@Q'.IY&9<PEV#&-U?4&Y;A%-&ZHPI!!
M9G  CK#%D2S6!RNC0C%@UDEJ8.<HQE;%MQY: &_6 ]$Z+>!&\.7XOH*-A\Y2
M7L&+TFZ/3C9(N^V?OBSM]M1IMRVF:&5/P/]Y\^[#S<5O%[=_O!QN\C2*XL/;
MP#R+4GN\YF*WA4=MVUN-7-<IM1M0EUIHCQFA"*/>A\E1$E1$&Z0;]%%,G-*)
M5['G$R(/@4V/1BI4E(2UQL-S[[Q,+=NIA;:M.#35$HU4I%*L<,5NR1J!$IM(
M(^.F1#3X.RV#<Q'.(A'._XW=.3&C%_'UX6=,-QZI9&K&*$/;I-@6[N J*=QK
MM*BN2IO+J_"*F_3M/+E3&N*XEA17339H<XTN _(_+]*0:=)3%$0;$Z,P6[(D
MES]\?WCRN@2$FB4J3HJD/GO_^7QW] '/\),,\QE$FL++)V7*Z?*UBVQA\A-,
M=<#8Y<E'!DNO676=2DM<!*J 7>3IR[Q#&FPH)5Q5@I;'V(5&31>^90MVZAV+
M:CT"Z#U0!I4>UUTBK*?:#JPE52[='5<([;(?6RD-GTE?Z6\3/5NJKS!#7]18
MF#NOI9^47[6TD:*)NU\DP,-?HTR-%&%/MUEN5[$U#I]3@%.VOIARWPXN%,!@
M.-8Q4^]O2_6R%,%XF D8BMR9IC%'BATL%!9?A?,"2ZIC*J)A,XIN/NPZ3:D7
MDCD]I55(J^N*'@)4A]/7U9XO'3K\69[,8L061Y%,=5ZH=JCH#B:*8:VAO)-A
MJKL!DM,SAGLHX(KX:D9)DCZ0->;V0XD<<W(HE^5UK+KS D/<JKS_<%/W%%M]
MBN##8H,6=F1M3;6OM0@C_V4U/0$S:VW@+80.0P6%-(ASZM%7RWZH+;CN\3;:
M.+^2*^?B+G\^SIA0D4HJP@+F$2^F&<OT>KF52:+P4#H+J\*O\ZWJ>F=\-^@&
MXFB67KCS8&K@@W*.IN*4W8Y=NFA40#F.,ZHH-#8/MU$$^X8[CT>Z8%$D"5ZB
MLO5+G&=%XY?%,WTZ,A@3@18FC#J>UM=7].JQ>]24X*NBT$$I79>A&F(#KJ]W
M:*D6NLD.OE7NK7[WH/_X"9/][M[!X[OB3O>[O?V7%2[H[;EX08LI6J4(_7IV
M_:_![<7E+][9]?79Y2\#3(>Y>4FA@\.C]5[6+^$!A]W>X?)/'QXZ>(JUGIQV
M>WV7#[/9% $'=K&#=E/$ELF]8O4/%5!,S2ZZ6\*?V<HFN#);930::>FL-Z7<
M5=6U:UE,8C:+5<1]3T$1M8%+L.<C[,</WQ_ ;SGP6I]L+K ?<.04$4K &!SF
M8"R0:82+&W_10CQXF G5#2+)W\HNX2#VTGB=1!=S/!M;XG;B2MQ<B=M6E[A]
M>UWEH'NX]Q1YQD^D5QT?K;=8IU>UE2+4JUR,H]44K=:KR/.=(@=4Z80!<T9:
MVT&7.<$08%#93Q0P?R4*9<QH1"I"#!]4RM96HG8,?"QZTUD1JS2W7-2QUM&J
M=AWFCHLZN_>=6/+^-A&T?4=DL>2/4LZHWH)A6F3 H&<$BI+FH:X0IOKCM(PT
M/]@&;C8]&8^%P;N'<A[K1QFA91%2#1O_Q%'$D2.-%80AUN:U.;;LV+)[YXDM
M.RRT5E.$[ \[WX F.@;^Q1C_S*LY000TW90Z[>!#Y*TS>JJD-!(_3[-XREHQ
M/7*'<)8J0M!DDR)D\BD->ZW$N1=#\G1M.MYO%[?75S=%)C,P:/T7468H8WI'
MDD=>&H<RG%<?T3D=.H% A*D!*,:,DU1:8!<=*VLBM #')$)6P#II4\K< P%:
M/2954P>B8CM0+I21^EKEW[GT)>*',8'[O8[7W]O;[WH/[DFA]XB$Y++,6Q!8
M()ER(IBR7@GJTYPCYI=WRDP8$J9)G(\G%4NDL[CIUDF8+)N8S"-.-[*Z6/AY
MDN!FZ&_+*'@%&Y]8=T84ILY"IDR1A,99'; ^RE8JQ;2!2D4R$^%GJ266RQGB
MI&-NAU$8=(H2U8>"=9862;W%4QUK*'LWG%QW<MT)#4?1!E!TNY \!XP,&%RJ
M9;!)U&4.&,^P4T(.,FV^5(Y7 :(ZA/-/J6ZOAO-7E/)&S6VZU89$EO.M@VUU
M4%(A/P9N/I,18J!2UB@EDJ($O"<["I:!W#_.LU?QZ%7Q-]B+.VYW'5 U%*S9
M5"F5')_ /HN<4!1S(&?J8JPA?Y79O2B2)%-NK^0C]"K[ZH2'4%8@A+AU12'L
MAS*[E[H3$]N@,)I94+?2IP'U@FD<8(N&V A".%4B02\1%A7D?L;E7DIW)B05
MJL,-(::( $LNR4SR(9I'0C'$Y%KZUBOZQ?X8Q-I,^!_%&/<Y+E%)L0-M JH/
M7XK/KL(^8+V!IA\52DW,M/0G(AE+6XJ"A :-B3*!Z799=C.>I<Y4K<[-JD:C
MK8V;+/U)1#Y6K$)*=3L11&C0*[<!945JX&0)<Q<O(;X.B>1.&@4B&ACX6'64
M$+8YCULVY< >&S$/9ZU9?T(+;KI5MHNXV(6RVJA\4T(U5=HI47Q/3F=A/)><
M3JW5<OVQUA/YC^7WS-)2':%W*HM369PX=!1M $6VG 0+6Q*$-B:[!W(:Z:9&
MIC<A?#0&)HAM__#;8@K<#N0;V+]#,(*YVY$?IUJ&:%T#PW!%Z,ZR\D4&QETD
MYZEFU-[(<%(:8A>,63#%D6WG66%UAD)-4;O)0Q))M*X=H<M-\1N1'&.*$V9<
M^=23 R1]RA8]2VWT28_RT(,_(QPXRBP;1ZCN;R;/=DU %M*Y@F"TQ%V \^X,
MK16"T,PT=GN]D7)2*F)5@".]=@WGKK/ ZO43HJY%D"147#N&]CJ7X6A=@!05
MK9.P@H+%Z'"),CY_?JRL@Z?.4G<ET3 ,EDKH$79\BT),XD'4)RT\RTY=\'Q$
M[BZ]AAD"T].] *49-#LQ8PC4EY"5=NJRTEQ6VE9GI3G@=0>\ON7*DZ.H_12M
M4&U9N6J7<EL PZ!;2$5_YE0/3DU2!3?\-!$?4@K55+#OB1>,G]-WTRS)_0+&
M1T1C2L3#YJ 2T3!KTZ,REJ>-WJ 4>YFOUG ++"2B@%5$W@L<L-0&C7+;*;1T
M7W8*;15/2*OL-%BJX#*(1,,A%%@S'=V'".%^2J2=9$H**76*)26;(DNTH;K1
M["ZIJ4KMZDA9@^OO\Y2J:)0HJI,7'M;-HQ+OQ[,YQ?<ZZ"+"FOGD(P7V\!<O
ME>COXM[CB$0:D']XWN2SHDEAS4BNA<JSV/ZOO"S+C]%V4+)9\V<>679-<;X,
M7E4Q:#B&JU^3C,8!-3U/9"V(K#?(ZQUU]XZT"5DL<LD6.L^8\XPYH>0HV@"*
MU@$G8;%@L[XX"N=%(SX88:"3>9"1%M@?7>]MGJ"4F\:)[)AHQI*9/)Z$,H60
MV>O@@S4NSU_ZP7*PT01M(O+B C1%33%;'GZ"OQ*:=P/BWR),!V&Z&0?6@AQ"
MA2G).3>4=A-7B%1Q"DY_;\^;H?\AI3":?DAGL)# -4"(&)1!H6T-B#E,).9Q
M"=RCQD8GH>P:^4GZ.05P)DO3@M#WA;$:H;/_%S=WRP"_5R-XG.ZM5V3> @2/
M?O?H<+T%;8NHZ_4<@D>+*5H)97;V;G#CW7QX__[J^D4ULG' '0ZX8^,I L;K
M@#O:3='G@3O*3"+.QC'I:FLC=SCOA/-.N!<->:$KMF\U17:"(V7V6LF-U<Y>
ME#)I&&&1]ZB3@N/[R(0RK.1+NT%8'-X1A#T,IT;*1S\%<-QI6L_"(3^\4&&>
M<!BA!@D;HQ5.?GJL^]"#,?+[BS*^CP\VR/@^Z;TPX[OOC.\64[3*^$9F<W'Y
MRW:Q$H?KY'"=MOJ-)I;KS.X-Z%U15A]A"4\8L[ZH%450)/_*89F86)*F>4)5
M05;60)YRWO%(85L!>2?"W&HQM0 =@K;Y*,=")XST^#EU=<5HF<3$AAJT?/DT
M]\+XOWHA9\5"WI<+0044]GQS&F+TGF^1YBJ;7(X"EL4N1<-T(@PM4NANY1U
M<'UJ/T$?8(#4G<):I^ Z73G/5"MET7.I"\XSU7YUX0.FEW#S/M-0)8HSK"(O
M.P=U+#E"R2V>R+-)G, T0:4TZLZNQ 4A@BDA))5$1BJ"!M8V.8VH6(R$KY-V
M=5*HKO5*U]5!&F!+)*;VDB\,A5U]@0B9%D>8W<.]<#"CDAU<IF*J-M$:ZDJI
MZ#A9N9ZL]&X(3H#O2.'LI-M5EJX5BBLJFD6?JBBV\I:R>[RKNCEK=B_#._D*
MCC>C]EXJ#KK>[Y_O7J3[N]8[074JV 2PO+*U9^42X;5+,\Q"KU6\*WJW8GX/
M#.Q/'JF_"'5H[99$YG VM82NO^=*Z%P)G2NA<R5TS@'H*'HI%#V;2K]$0:YJ
M-HSZ^\"^CFF3[F8!]-@Q[P4UOM3XN]X9/&H#$14M2+'!JPY<&YU*Y 'Z+U?E
MB&O%ME\V(L6VD?GP3TW@0OK^YFCK_59ZMC8Y9N=R[S>6<??V7?B_Q12MXFH_
MGUU[;Z[.J7WFY;GW_NS-O\Y^<?D +A]@NSG6MKWBQ(-=/D"[*;I=]):7KLQ$
MV9Y6AA'%;$]0UH<(YA 34H;E'2U2\EWNO8MPNK>+&*"+<+::(@N)60,G+DEB
MRM1LN;^C $&<S%-"5(9U10@MK?.EBN<6.G+0L 08 S,#8>C*L#"F1^Q(6;*>
MKG?!\\H[W81/(')T1/"/E<FH8%_-K*$YE#I!+TKDJ>F,(#:CAND6'K5CO1@(
M'ED]^*1(0DP: N&!$#\^:=S:.Y/(4-YA:-A.!3,4\K*=W'!RPS$EDANN&U^K
M*1I\\N4L(R=TF>@"FG+5S7P !A"HTF%\WRF!>MD_'3$V+Z:\W,?)1TRTC'U%
M+FO2M!M8OI%09;L!"[#.= X@'SN[RA>_;SOZ;[@!JM56@0?C5@H%_%FJH="\
M2$RE1GZAWX-$H[81RIB=!C'*DTBENN? "I)U\T!J@X&R#R0'-<#HZ/84JY\N
MUPVV"HN/P--H<"1)@QSQW8C>6^QV9':(7?R8SE3"RIBD#(:C>4%5;/O=PX/C
MS7%C[_76 Y+8%MG6.W!N[!93M+**[?KL?.#]>G;]KQOR8_/OEV>_#FZVB[U\
M>^_P4;=__-"4F&_NR3Z!O5LO7V9;F-:VO>7$AITGN]T4H28I/V$>=XH>"*.4
MIV73)W12LY,FP5YKF'[2WP-^&.4CX6>Y;E%VE<"3K][ !.3(.5=B',4IT AJ
MZ47D=TF'YC%W^#]GY^?7@YN;71JP]]I;JGG75/I'4-ZQ_ZF&6,Y3:;1QNUM6
MDQ)?U^$QY;AJQ=2*Q)Q7QGEE'(=!(>"\^:VFJ-(H4BIBC,+_*U>(S!O%B8%:
MC^:>@7E764@N;HQU C>D2N02W;:)H5(;18N),D\%KGFGDBR7!>3O6>E=*%M#
MBX V*ZTW;JPBFM7"#%I@&#A][.'THEP4)T<;XZ+H=8].7YB+XM"Y*%I,T2H7
MQ?NSV\'EK7=Q>3[X]?+B]L)Y)K[>,W&P_[!1G\$S<=P].3AX4;QJVUYNXK[.
M,]%NBLILB;);%:I^$VR9P!KK1"13ZHY@P&_#. 6;G?M <:LJNU.5=S\161K+
M.ZRT*;T(H1R+D+I3=71'HZ)W55EK4_:NRI-,-\&BPF->R51@'P@_3U#;'(+4
MF$IJFV6 >:M%-Z@BFU9.::Y(T]4J=@BK4=2NG-LLF3 ;-3/BQ4UDJ+O"6]V4
MBCY(!1(E^FU@Q3]\?W#\&L:W->9%!9GR:70=#UP(G,9J36\MM5.NE=NX,ZQ-
MX6_Q[L7<#%3!N%R2S*/G[GH7HZ9=^C,/QL862&4&1@?]IJBI:R"Y<X?I'B7T
MPLP*TQ?01+7?:] FEFL:ZY+[K8ES%>!T*JX"O"7JJ N4M5@SV#Y=QU'4?HKJ
M_2N-.J;20EG30:"'Z%ZH^X"&)%.A @N41R'(.#EB&1E'?)1:%9QSPS'M<*UH
M@I8:I2$C.Y::&H]&KQ!5"?5E4N^*L8KFK]0XDY"=;"I&.4;[*E,/)346-2EI
M.!GY25SHRX6^',L@+X,+?;6:(COTU>!G(*[6 B\#KJ-E/H:BUR9*-2L=I,.]
M+!_J<5CQ[4"-1C(I/1R-GH1.V:ESG84562$DY=Z+2(;>N4SA4I*G8\=?<RS<
M.Q.(=-+/23_'6DGZN7*<5E.$*%'L*B414O:[)RU>YV/@6@MHT\.E\$^4&8*5
M+D47)EU^4P5SA7DR;'%<*_DYZNX=<<G/BTK1Z*_9-+,%*1K][O[^"P-#.G(I
M&BVF:%6*QN]GU]=GE[=_=+QW%V<_7[R[N/V#JDETSL;;BS=GMQ=7E]O%:IZC
M1?'!\<:T*#[IGJP)/;<M#&S;WGABR2YOH]T4&4?P<.[=BP1AY]F'\</WAR>O
MMXOA/@ULW'/ 9^X?K9?1]D4,]ZA[W'?8U)M-T8[8W29RMA28NL%I&LA0P2(Y
M;ECKM@'6MQ]/9Z%RC<B^;)\)8L,U(W,^WC9RGV<1#T,G'EI-416HCVOG)@A+
MQWV4THJGMZB\TRF]!,;GQU&J4@K0$<*27=B7I[D(#6@=1C89'L]R$8]&RE<4
MW(MQSHP<QF4?IY2C>1Q+-=!#$78M"&F=,U/P-X%_8>>Q3?,.GYYV#WNG#_38
M/# )<;59<G3Z^%6!3[/6$]B[HY?E<MX^!H0>&Y<#TVJ*%M%0,5$=^'@<%?!N
MIL$D_&<A<-?SQ#"^DYV*:,#,%$5]'9OZV#"P*7!8OP(DMR3Q8X25!SK?,) C
MG!^G*Y-K"E'!*3,8RTQDEB?4VK)X8B'G$@;59A*5K-L+JI6GN(P.I^T[1H$O
MN\OH:#5%S2Q8I+ . DEM2KQ8WM)K!.IP?,^,-0JH(BK=1#_^:BW\,V[\_8<Y
MW%>[\8_V'I:B\1DW_O'CK_7DJ'MZX@J,-ILBY\9O.445"";N#J#[N4]G63@W
M*<91'%F>>P1X3D1"!=>+6CF<.>JOVK?RF>\.=YV.ZW1<]R(ZCW;;*=)-4\!V
MQZ:UP-.B="036;3@0FA[$6:2RF2F<8"LM-FW4&D8L\+]8&!&-?K]#!O=BM!@
M^+\$D(E^@P:_7+M?E]QO39P#F:!3<2 3+G?6Y<Z^/,&)BO[!-A&T?4=4MD="
M'0.4D(!;Y*FT;K,QL@-AD$<&RURGVRH,Q&M,=X+H17M1!G:\I/PFQ4I&*HN*
M F<J C:=YDR9*^@Z4YE@NZ!,^Q2=N>C,1??&$E,]W":"MN^(;LJ81I6)'G:\
MS\ _%- /Z(NC3"7JI6;AY%#U;*<&"0$,TX!!6-TJ&N$>=CFI"GCU3*^1&+!I
MB*JB/W/VV<UDDL81-7E34^QK@09L$L.?+6 &M%*!55,I+WK\(J:7YR!:K=2M
MI?@%S3CJW%ZNH!D?:@*0*)IG>#N2I9D=DHKOH_(;NQV[GX;Y)95^(C7.9#R;
M4UEQM5&>Y1]%'Z<&C?#C*:S#KRR& 3"(3H3 & KL*HN-\^ S[I^J@>V#$C5"
MU;,AHCD=0U2,Q=*6#!8\@HD:@AFG6^;Q?FJYN;BME2UU(M2)4,>?280>;1-!
M6UID<J8M RT &$&(1:;!^&U,)MY!OJC;1K6SPN1"XUY(^9S%);H1UFY5RID$
MO#GK'YQ@7=]WV&\Z$Y!N&[/;HSG>H/=(6BMV'>3^?<*"O(BZYC/87(+:(@7N
M'LUM+=59<P#%3*>\YPW'@HA=8C8+YUWOK5 AHB=R&CR:]OP(GK(O]9%CJGVF
MLCP#PQYL=$Q,-*&)Q4TK=*H2M<6&7BFP&#TU8M4MCL)Y ^)69\GX>*D,JC<\
MR+IMP'Z'(5!TV_P44S(1=[)$A2&U-DWSJ=3H9E&6Q"%]CLF945K <6E]+*/8
M#BJ+6H\F?/!EX]%D:1S*8F0]FAD<*)&?9.*K%-T@%KGPQB]=,#M!% *BP19W
MO"'HUAA;@H_T-!T^0C/+BE4W[%,0PQVF6!43LFPS%M:+EXJ^&%1W[#.WI%C2
M;76X>Z5C9@ROSFKW%-\ I1O_\0R+;:#Q;8%;1+?6RN%=7,/2NV+F[E1&;QX/
MU[K#[YKY0K'TH03)DT@!!I(8AG,:#1'LP,#X#%6*;0%=ZL+#W\=YJ"^5B+CS
M%#PC1YA%;%*BRT5U8&HR$7<^:0."=P>N"=T."[5^<1$->R+\CU%\'\I@S-#Z
MAB?1U2K>;[Z@:)AXHSSD5TE,X[S<MJ7S"GUQK'V%]T,W'S=MU,$(RQ-D*=:N
MIC!SBOAW,5NDRD+L:R#$A\W#Y<$#M%1N)4!K['@[<[U9J_=(MU9'9$,B,Y&A
M%/R"V.:;ML=K5)%5]^^UYM$LF3V@48SS*$EV= )?#^;:Y -R@:G'8,-K=I@N
MO$[,3:Q=\V.TT9&)T,8N._4HX.O,"+]W("TH.J;9==,36-*%^F'$!5LC+)JJ
M*&$+[+!<9K<6V=N,+,ZO0&-X*MR$)T+:.CI\665/O6.'M-5BBE96YP_>7 _>
M_+%A">$MS 8XVM^@;("C Y<-L-D4 <MU2%KMIFA -9@CCGV86!5H?[HO P5
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MLU4IAK4_(#F\LZ=GFLFP\:G3<=Q.>T.C=TT[\I%&[_&F0]##1F^C5:F!Q.O
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M'%:,\3_#VP"TEDQ;I)70;K;7B8&$>(&VW&2&MZ%B9*ZZMX$SF@:1N YG0Y5
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MQZMWC&F"W1"VU=C^IO/=$+9L'<%>"-L\WFPW_S>:H+G>F]AW#U  !5  !5
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M.FN]^;CE>:+^7YLY]NO) Q$\&[?5 A1  11  11  11  11  11  11  11
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MQSE*_^S&O8GXWS =A:_^#U!+ P04    "  ;=U!40V: _3X8  " 1P( '@
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ME.@SF8F)O9]JI[(>"-B&CP,S-)L@.42R(96^MNOC)(J"">E/4J8 @7TY(7'
MP=PG R&G++IFP"(>PG! H.>.>:S@&P5G8_('D_'[=]7ZH6:H(0()V+ED1$NC
M'KW3$>Q.&D$.8Z8T<4#9@9RF-LA\F,]=ISSO?-76_F4+G)!6(<4:4:DXU "C
M)P/!H!JZACT002!N-+O=P[S!M*<CR_(G:=*(*S#?M<D"8CZ.P>5-U=$#UA;
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M1] ,C3D;OA'.UD4QS6#;]F1%&L0T8[,4CE9F*3P]:;#5NQ,_ETUKW49IT_?
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M?[D[Y<&<Z31!A1:T\J"Q[4&BO6*-G<*K0R]^>X$H+:;$48RJEP>X%&B6,+V
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M::$%C.AC2D$6U9,S)[Z90EBAVMN:#O9S%R#K)!^&OWB!CZYLO)WWR#WK7%.
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MJ[ <1#DB#X&]$9M;#MOT]!A,= F6>;KI9(1;AMG[CH(8E\<;"Y"4R:V&[+S
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MD$@^(J)^%W6*LOGN)?H6J-/_ U!+ P04    "  ;=U!4RJ15C&\9  #L2 (
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M\_6Q==/U,(_O6<46H-H*/EDUL+;/$+8 XA9RS:I!-WC5/[T8O+:.AT^(L%H
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MA: 0%()"4/;9@0.>HA&(H-;W$HV#!MJ -H+"1)&%H)"II03U]4=8WHO@'NC
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M$(F,A=42IPOVAB*<PM=$Q=';_P)02P,$%     @ &W=05%@2>WTT%P  9ZX
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M?-N4GDUB] 8HX;D)R+8XF'_P'.BY'A(:$,>15C5R09@**BOA@PH,92S17.I
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M /  :9 EJ.088F9SG:W+WDWFE25 *_)CZJ,ME/U% !2$'C+CVTIJ_5/?NZ6
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M \<VX3NLA>)X0<$CY8]/$*\;;SN]\78X\*PY_!F'$^?L_P%02P,$%     @
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MAYP^JA"#C'K$1<5ST("J?HYZQ'\@Q$8@*;]]0\TQ"8?FG:.:;:3/$89W+/R
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MH?'ML:4OZ*M'!S9FHLQC+_.>S^T_'GRVPQDT M?E6@5LRY_49(/>C2P156
M+=<9.XRLTQGPADY@F6P 8,N.J!_1Y,$%Z]4>L X1RA@EZA+08AH>AL'UJ3M:
M>YZ-S^&OL/F?,",9^KY5LBZF(4'7N-%\"3R+V0K'UL2D2! K\U=PSW.LP-_^
MRC/R(<KP6L^E!R.9]T7=E+<4_ARZ\^#Q@*1Z+L$_4K@/?;S$U@.>>.]..'MK
M7=$>2:TN"0T 3)_:,+G_"3$_ _'4$]L7F65G- KLF?2>.GP+  6) Z@/Y2#[
MP@VQB0L-WG')XYY'+WPAOH5[$407VF2O,>QN;["!PPQ(5#(,)X )KH!(-'QG
MVC1SFK@(G E6XX?M/%C$'!#^O7"AA"_,<BGGDY&W(.@7IN4O$%X4K.!V*'>Y
MJICJ#H^M;D:BD8F.%;TVBV7,NA^MT<VF##YO.TS"N0,RNQI)[[!/LU>7'ITI
M/SP>A_=8C_\.0'E2/EZF=N &4VDPG+G6Q OFS%1?S]3(.6+]93P<S>Y"@ZPA
MWJ%(_X1MV\"O,V4]5X;N(+H?CE<08S4;.V.U^LL@8Y\1=02F1I^&'+9LA)VO
M.'K PIC:/#(9+L]S=ELRVR@'=2^,WOAN$)J^#$IK(2)FDC&%/PMYLC<CY#"C
MS>E'6#E?O,I-UTTWZ%3,<) NW.A-%F]P&R/4W!Z%N<;N0@=F#VSJ4S@WT][O
MW"8SCV#6YL)A/I\AR/NN,PH%"].%_!&6W@$2PF=  $,)]QR6&,3;7'>_%P+U
MX7!WQHP65\QPC9H[%F;@Z]L<O"5>CX06^46,(!+^7*,0E_&[=Q[Q11\]#"F3
M\.OAZ1ZWQ1VP6YB6#9D GIF]XCL#$K+5QG<=F\R,;0]X8&9_TM$ &O+_^8Z.
M0&G^2]'2_QX/WB'/-=8N+=FGP!&_KI:9A,6D?A+0A* 6(C.+,TAX.[+*<EIF
M_.M(;$*YG.$"91^^/Z*AS#7";^S?QF2)71(I3L:?T*0_$8_=(+MQ=:V!OM:Z
MC6JG@WBF5?,/+J H<([-$\Y"P66101C; '%IKF<CP4,\$]+ @<=#.$MB-VS"
M#.#]1=%K!F.+F<\D<L\I4\+,J@X3L@-_"'*6^3$N&<,-:(F#Q8NR*$.U&T:L
M)P0T.+C]GL]=?NA[J((?3XF*#1&:[>YM,U6NUQJU<JF.*K723:/9Z=;*'7!Q
M&N7TA_=J3KG:_6>4K-ZJMOF.GJB5^,_#]803#/TKGI'7#^\S^2N/_P0K&K[D
MH2:S*M7\58-0ZYCQV'^M_-N78V8SGX"I_],9VO8$M9P'XGKQF?3XPZL!%F>\
MR1PW6*'GH2H!$QX;,*U,=0+@U&4;H.--WB\M9H:Y8&6Q[8$Z]+1Z5SWJPN'!
M6%J:[;C.=Y6;M\Q\_4(-@EI@ME+SR+M($H.G"K@"<2>PJG$;1%7#_XZ:5+YJ
M\^V/J:49C_6$%V,YWWM%@HX3;"O-U\+,Z?JX%^9[^\XY\AR+L%0-#PT"[&+;
M=UPT#ER/K07QM*5HT4M7UE8#-OO6QQGE-@8_>"U*RV6B$/)QHC+<@:^7KIO@
MP3?;M>K^+GRLQC-W+V,J9I;]2QO[0VRCTB2I#F:LB)\(+R@N)$="D'S96(\G
MT<M#3%UH_WQNIG,%6:XVCXSYI%(]009\/.W)QVB_;5U/+CORONC+4R"7'3<N
M.[Y]\:W-G5[?E1W;KK986GAH&;9<IT\M$OY1KM=:W@NA]3A.TQ?B=UGR^S0E
MU"6ID@T7AL2G!N+CGN9,G84."<\*>U\LI#0UKQ92]U%5#@/#U8*B9E6E^/&<
M>YC4\_DB;=\)7)87-5NQ#6M5\$HF]!?Z4NUVJYUN5,#D,8\R3A-W?=_8-])R
M#T('-:CO.@-BQV08I7H7G75N6MV/VWI=LK#-]B7 UVW'9\5(^\3%'HG) &[J
M]_O2X<8*#"<V ^BV]HZ".SZK)N<Z/J%QX:-RNUK:=QQE5H66,N:*R2!*]<][
M$Z-D_<"L)30>.MYXB/WMT(B3^%J1^]-\_5N"+7^((B4W2]A=$_U*MJBD%&5!
M],-<Y-5\]N-27:\ZSUTOV70$;2\W>C9[$^4*,-:\^A'-TB*CUZM_!VQF-W9J
MO4\915.7U1$TK!:SN8]13F>DD[@6>G!F&DG55E30D^64XD?.;?3;CY?W_;F)
MO+M6$U/2*O=1?58J8.YSN."DI6#6+#SVR.7TERN3>F,+3RZIS<?.7SHDY;68
M!]\XQXQX'VCGF],/1_9]FMOW%[ZYX5XF7<QEM]Z&X6Q_]9%FM4(ZF]=>O-EB
M.J\67[Q5-9M6M9=O5LNE576WJ;W@9 M)!\SAC;']SW?Z+"$Z"H1<:N-?"-@+
ML?_U=#Z_G#G,PB1KK.*,CY0)7:I?SR 3#5^4D5F]8+1@H3P].@6%0D&TB3@I
M$@N)T<\M82GXB/UZPH@]78(+B=]IE$-8HCX1I#E=)'<XZ9OBDMYC+C#;0?,H
M\45$]=WWNJA$'4VLUX;O;J/?5CU:"PN?3:_QU:_HXI'FK(Q?92$WGU:S.^T]
M7EM9A0F\3.GIPH;(1 ^(&ZY%:_^WLEPG%B.7L6708/0,42395++I4=CT),VE
M\F=!->K*P 0TA\JW35'-H?+0L?CA2HXE(7ISTQ64S#=X-,)H97@B(K4]WW\G
M& DWK.F?+E#K]X)2>36#1E"<GA8!3Q*CK=MF1U :UVS''6";&K-(O_" /6%J
MGB1ZZY5;0<F].C(!P=J]KHGJKX89NCUJ43?HR0R8=Y_N;@2E]!T>V,1[7H0[
M$0/MBIH/L3F;_F21*CB=6QOH+"!:K^\;@I)Q\R:JDX7K*1*:X_6"[P&(]::,
MC=M7#BH<'8>M$YE,.J^JAVR=T#-I17OYK1,YQL%RVX!PP)<YY8D?VBFF&,L\
M4YG<)9.[XLBYS\]!3,8P9>I64D<H4WH2/\Z32A40D(!R*3'!0Q0\:+UI<4)
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M/[ 0[8/N[5G4@&LF]0S+ ?6<EEKR42VI;]>2%SW'G,!_0W]D??I_4$L#!!0
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MX8(LIA!KR5SPT.-S&I!Y0#V&4XPPKC(I40:JR"$$+\*H5&0X9<%H23H"Q $
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MY!MA-%$4@J+MP0:J7D0"BHX!+"2$Z'52/_OY9_BG>88;H*G\DE'( @TTFTT
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MAQ98(HLI!TO)!#!8MU^ =$$[9LO2S@2=$[%?$BPL7@$0C*UA^Y&FSBHU;I,
MKYDU4+@'_FM( .[0YLW9"!KK>X4Q#O8Z[\YKR+&5&&0/K^>1.;H_%0SB+J24
M6X^S+0^OK;K0D7:_[5V>? )N/J=B16$FK#P2C-Z6-5T^I<&"+N7.LY_'?U]<
M:FXP!?;()&2;/'V;FR$ 21)$B'WRH?4:5(4$#MB&@2RY.4SYD78/=N\A:N4>
M9<,ND&<P.M/?QBJL.ND<D8; WC2;R\.VGEV"H+FP3)/C,2-</LP^=!2,<=EX
M8P.DSN36(3LK,)+*\3)33,X&*;LF&YQRE #E@[WVZ AIG@U;AB8(-@X8LDTP
MS>GG196KZEU>)=OO-WR=^?Z3T@QWW4Z1PBFN ,9@:P$=(#5&;$ZH@;'N_)Y
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MU@=D,2O0-56^;J8#]V+$<4<XGDN(6;"JLU\<..5253(1D[;R  %=:^=(F+,
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MHKA@5+9AED<V;.M-K[?V?=\=C'E6D+PR3]Y@!Q(NC,Z*$@$4/8YA0B.:A51
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MBWN[A81XK$JUN>5?;E/6W_7%CKEB.OP'4$L#!!0    ( !MW4%07Q9%$)04
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MB@M&91-F>63#GE[TZF7/]]W!F&<%R3?FR1OL0\*%V7-#B0"*'L<PH1'-EE1
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M*1 T)9JC.[<L-R?4]"GW9@E9XC$MU>Z2?[B8V7Y7=T3FMNKP;U!+ P04
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MBO.WPJ12+A>/04W@<EGD>0,V8@.F6-#JN8V"_M8=O -?=B!.S@=7P_.S$JE
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M%3;%.FQD'Y(_")+C7FV+4@F1Q/+/',,BQ>G;P;B##YH\\$H!E6J+;'K8A#1
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M!NU"P<WV6D-1ET33D^8]Y@57I87H!?*;PC@@]<-U>DL(P9FWFCTUYJ]I=UH
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M2C7.[/FQ[?QXQRE5BU*K4W[44F.W+V;"*39U/R);GS4^-9?5#Y08;*C>%VM
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M/;YWZT?_^&=EQ:U??CUX5EXK"W\]N-7/!_SR\E^OR^K@K3:$ZAI+M1.&Z":
M12:DZ$W8FOZW-.?2E]_\^<GA_WVC%)W>]0*[J2S/T;N4VQI2%0X(Q04P&D,G
M]5F5FIQ,MLG^P5K(GD%#,4A G5.H,DG6VPFPI0EZIW%,(V>\I8)4-LR@K]X_
MA[N0)GI=D>7O'!_N9Z6_7JY/=BO'OE@?2/]Z]>JY<F<Y/7E^W,\<KY][NCA;
MSG_GI/#?7B[7<?G[]SC[_+<?>OX=EO/3Q?K1^K#SU^>\/J/37SF;='$C61],
MNG@TK?UQF\KBB_47DM\]EG[SSO][_YS-AV_^YN*I]^_^?&U,+QXM5[Q8W=*9
M\\T%2L9>O._M:V^^9GU[J743;]]^Q-DK%X\O/N2K]P;J=\?-&^)<?6Q("%14
MJ<CTL(5=B3&[\[TW$[W9@N$Z.\2^.A^L./'FS8W.7_FX$3B=3<]^_=,U^\Z>
M/%%9.UW(-^<5$KY^].#6Q=LO7KIXW-__^Z.I%MF;R!0K@ZN6C32*KF;#7*WP
M>C2[B7;;-9JN%Q,P[A-'<_F4=9+^9D#/Z;Q^\=(C>@E[M54C^L$,O=R(OC<"
ME_#YMFH$S*>,P+LS5../!YT\;WZ].GVA7^O=2]=VBU?SQ5^<S+]Y?W_RELSF
M&@W]WFT_EM+OW>*K][_]GS&_)!<AA99)+(@$)LL$S7H$L0Q^ (MV_FO+47?T
MSAY6_;"7SX^G9;HZD).L'U&G)]W;ZQ6"EHO5U^?'#.\M'LCBQ;3(C9=3E8@+
MI_+\U;.W_OVKW[WCFZ%Z\\&CL*S%"R6PIC$9:#%39<S-JF&PT:1HUOB9"_RN
M90*/%3_S\?B9S>''K7E;H+:2((ODJF+;G(^II5CS^CBTI7/\+.WQ^X_X:;SR
ML?CII9O"STI?:G>IAN @6LK8L/J:.,?:Y^9.Z.?YD[NHGS4(E1"=5<<9LKI[
MT49/$@,ZG9C%[81^7@]^@^AG99/1%*MP>7#%$\5F>[$*U)F8J>R$?EX+?L/H
M)]5L%4!K/!"P5]\E(+L:2P''"<, \V\4O >;(CMVZT,/U04.P3K5KV0U9*L1
M!^#]*/AF2O20R:>BT7YR@H A"9>F0:Y-=7VT:&N&ZVV<^^$(?$*D[[":?M*7
M"R+8[$A_]ZC?M)<0*43K/-9>UVG;1@ W-@*M'RU K"DEUKG3?^W2LL>2T!:;
MS?6-P&5-Q1N#<+$/<OM_3OONR/SD^7RF#Y?OVPU]_F0^>[":EU\V;SNN!!H.
MEE"\[><[ +W!B+56)*B8A5%V!IH;M:YWK?CX!Y[6.[.;_'RZXN.1P 0)0HHJ
MGTP $3G;$DKU)F)'#-+H85K7L+K5MX864M<3Z-%LNEJ.!!Z=1:88:%2CA83"
M"6++K9E:G9'$HX?G;=;)BJ<SJ;=YT9-.QH*/,=Z0,Q&H%<A-6(H)S!6#.*]S
M:F?PN5'*Z<GI<:_3?F_U5!;]NH4\[7=[(7=F97YR!4'-E4#F"P?'I3)B S0Q
M@PT]4TH]R,31CU_Q+BY[N%CO,+P:D]< DMFK$4HN.6BA9"+C8['L JGRP<Z
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M3A%1#'I%R<28*-O1PS/$QN(&\0EJ<URQ@!4R9.['8'),*<>0<N+SKO*[@,_
M&XL;A*PUKEE$@:H,-5>B4!)72B$V%UEV!K)KVUC<Y'PBUY=(2NTAF(\A!U-+
MH%@%T0.8G0'G^C<6-XD2J(-0>I%^SA 0V:323(EH6VHEY!'4>MHZ\S1\!2A0
M=\\P.;04H""1K55M&%)C!"QM]U =9)]A$&RCXU13\) D@NF%H22)5^\E9\,.
MTNYA._P^PR! VU22] TDL@TB5C:F@L]%#6GNVTH["/0@:YB#@(NF(FAHWGO
M@T\^!T[6&(\::_B&0U1='[</.SRD#82HYIZ6)2#.8LCH"2-;BF E[AZDU[>)
M- R@M5&.!#Z$GH-#;"HAE! Y<;.(NP/H,/L,PP@O8*PIMN30@0V%8E8;&WWM
M;2N;7&-9_#%/SBNIUQ^#( :#/JAG"^K-$KCJDU55=8V+VQEHAMAGV!Q,9(/+
MU4-,'" 0Y&+9UV9#;<$$;J.':8A]ALW!XUS--K2@;F3L30_8,:C2D;'5A^QE
M]/ ,LL^P.7P8BE O7Z"./J1H,%,"UQ&Q*;0X_NFS+?L,FX,,LQ@O:HIBC="K
M.SDJ+D0O[$*5N#L^P_7M,VP.G.12E9H,6F)(J?>0-BW8[/JJ6$Q^9\ 98)]A
M@U;)YB#4_PM1U2YR=$GMDZ2D%DH8M_<@RN=Y@.FCA^7M'9??S1>'\JO*_OQT
MUMM=_K"8S_3'LAZUWQJ'\ZMT7&>5%W7YZ'G5$58:1.M'<DJG9M,*YZ+V 2$)
M4HNH%J&J;YQ2+/A!)F+_84_O4=/HKR=*OG?IIW17<K[ZUG?.LX7 A-$':#7F
MGO#5\,S>;375QH+U>QON[\'W*2=Y(Q2PU?6"KH"4J++&S(:$."9#8]AP[X;F
M/L^.Y*W=.9C.IB>G)[NX8.@")*XA%PHZWWSKM?PAAVJ:BQGS6 'CE[L*F ^-
M*RL\U!,M=6*U+/J4\T5<<S*&#?*_/,,^ZLZ_WYAIO>IUNS<<5P?F9UXL5."F
MLKPQJS_,EZN;/?+@LGIP^OSY?+&3B145*6H(DFN)517:LO*FH:LQ>I? C6&[
MYR]/]#UO/J7.(=J03 Q$:BJ2R0Z=$3&IMU/75T;"FSVZOV_^P0GEV(+^ QD#
M G@(U(Q$5(5(VYO&NK6@7DDB:UPW&NFIJX)@<F(IDHM3)SL:*WF+-P_'@-,&
MMS^P4@'?.[,UR FXMI9=M4@^.<3XN>-T_O3JU7.I_SF$OB\O9'8J]^6$IWT=
MY@=9M/GBA#5ROI>/IT?<%_MNOWPN927UX?1$+[G7'NBSRZ;?9-KS L[%\^PW
M^/O5W/AO==[OTQGD+L3[:C_IS;B^,X"#DK]WJ5\S?W;:O\L;4E\TO3^_A_YX
M<8.+5RX>_\<^]SII3'!,N2#UU4<,E&Q*J:7 T9V?6!IP*NT<A_V0'-X2?=H6
M.P)([$TT0+4?J*P,$:. Y]YV1P/^/?DW3'[8DW]KR"^B\2957Q(!5)T!XH)+
M7%JS+1<SN!.U<^0/>_)O#?F-^CK%(6'@ (6!-#A7U\=B*2VZMB?_ILD?]^3?
M&O)3S))M!F] H#G#"42B^OV1HV&_Q4?>_P2G1\^_6^@O>O-TN9J?R.+N_!4?
MKU[I&XX6?#*6&A+@$Z=<8RBI0&3!4E,A <J*DO<P_J7@ZX9I^ 7@G)P)8'TA
MC;)S34SHL2:7C-H<+X-'V:.!\FKR"IMKH=1LD1J0AVS%%U&-) <YF/$NS_\T
M/SX]D7Z(9[I.E1F9$B8JDFRNO;,- #823A:*Q-X8%])8LB:V J#A-=!0EE;)
M^Y0\8,R9A2(#%K5JZ&B\&CC(+-N<^@7;(K:2,*MMLHJ$KS&Y:JEFY-;L:''Y
M8]ND'OS(@?,-8Z)FG$/3FWZQ#Y":2QE= I(M/J0U$'"[&EM_KMMB[^\)VVQ[
MZT+;]._B*O9L9F-38Q!R8?#9L'.L&_5&UJ[;AI*3@#7B  4T["0HO4J,:\:W
MW'"+#XCN;</N[+AMRVP0Y[P1(];W<Q-&9X.-4K()%L2S+_O9\)G,AD&WX+9E
M-GB="94->='9 *Y2XF  "9,5,66_][7?^_J,/"6-%<3X*BW4!%&(;/:8*T$M
MI>6ZQ26[_P2X.SHFB]-^K_N2E2HC6_PM#=5U3>BCJY#[0D>DFM!E2:Q/FO$O
M_EX?0,,O_E;$*#&ZXK@!.H-<K2^A&HW0F;:YH-#6@'@UA4^B^&2()8H!GUP.
MZ"#ZI!%C":%\=KCLJ@NR7R+L(B3)V9"R,]%!R9F]DA^#\9D PO 9CWNR[\#*
MY+:0'5D=*&<YL+I18J+&=Y5S%8X4@\@6E[3:DWV_P'=9LBNEG;J3S5.&(B7;
M2L;4;-6Q*9RVN+C>GNS[];M+DKVAM%JK\285:+%0MHV5]NA:*C4-GDBS<ZP;
M]?K=R -4%Y7>R%&H)$!R'-&BKRW'ZJ+%\1[)OR]\M 9EMN+CD8'2R]QS\A#
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MMM56,K4*U9D6E&:0,A")\:[:! UZ8?WQ6TEEDP['C!>O'LS;ZE=>R,7BA/I
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MPH[I]KW5TYUVDJU*KZ4"5+&!(<PM<JLEII#0V;AK3O(UPCF,DQP;Y6A,:L:
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MCH9SV-RZZFPI44.[H/XF(2;K(=?=4<O#N[NEEB#%9>.Y)@I@D=$80@<:ASN
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MH?+I/6DV!/P0QP<N44+ ^$W-WQ(Y113'%JK).56O%CG6G%UQY,]M])XIVW0
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MD.-#.OQ!R/'AI9\2<I#/)BJ.-1M0!Q-CB]E8U0TRQL6]>FQK,M0&U4,X-&M
MPTR?(,=&IEH;)7C1N$/=S+UZ;"<9AE>/A+5:QI9+8^!8,:N'FH@,FPH9\_97
MI]HNPEQS.NU&"DA%:L8$#YPU,$EJ/7*22,A60O;^K.2H&A._CU&W+)52Y=SX
MS82F*$Y*=4V!;Q#)$6=H,7ICR$#.YQTD>XO=;>7 YYU*:3H3G-L $PARJ;%&
M_0^@)IN9) BXWB</?*,W3/![)FPO$_PF-,'U"JO98_ %*O@<4E5-"&"JQAQG
MRU5][=+L-6%;F0 3LPE-$,KH>Z<?SPD$&H&WR@2GBE!!TACJPVP!-,/79I"
M)1EP-G*$@)6]B8HL6$NNN0SG,_H:4M\NS>0-97X1J.429]7&J8-3 R<.T7M4
MES?%@K#]5:CNSI?+F_HK36=',BL].'UUR*O3A=QK;Y]^M\+,[9/GQ_-7(O\M
M?+QZ>I,7HI)XNOC_[+T)<]M(LB[Z5Q ^YY[KCA#56 J;/:<C:"T>S5A+2[(]
M]HL7';5!A T"; "43/_ZFUD%@*!$V;0L602%GHEND00*A<JLS"_7HBF7)QD\
MK%,]YAZF_14-B$4BUZ3,)#2TJ!.$6%?$0V$*1[=HML*>*=:?*< BNK=4<8ZG
MW9F,$RD)%7@*@NTYH6?Y(K0 $W6AI*AGBGLN+6*!YWH^F$4,[&/B@IQ@(7<8
MDWA(&8BD3@&A7\P=W41,0&33HU2$@21^)!@5GA_X#@<@)7PNJJ.;*H+WP.$^
M"6ZN3G#SW@A.2$1MZ5(6603^P0[ZTK$] ;# Q@VM0BEA1? >%-QK!"1<F>#7
M]?Q/';CE2,^1$6QN06Q)@I!&S ULXC/;"JG9Z_FUU<:1RPGW..<"X#N344A"
MYD4F<YCEVJ%I]<;<VII<0>01;OD!-9E%,%_:]ZS "VUF8^H"6^.V4#H5D<[P
M\E/Y]S3.I7@[R=)SF8_CE)9PT7&DR70]?W'QIO-L1V;?N/-]7(ZR:;E#IX4\
M+D<R/Q_1=#]+$M4-=F>$./H@13;)LZ0C.U: E<U\(#QQ74)]D]G8'=#A#&PM
M&WY[$F0_CJ*8R[SXQNW7R*REP5J3N6GX53W\9M,O7(OJQWJ,E;M^45N P' I
M<9E#J(W]74R;2\L/B2-XY*\OWZ"->U8"-L'K7\OL(J>34<QIHCF$9U,@[.S%
MV[-U).HB,F:!*0/;Y2( &D1FP!WJ6:;O4JQOB=:X@?]CT^#^U";%=E>^8[O$
MM$!_DD XS#.%Y&X0<I"FG=\'KT[7?A]8H>0 6QP;_D^X0\( 6]MRK/"(W"!:
MXQ#"8]/@_O:!!] _<'QJN9P3RV$L "O=]TPOXG[ @C7N_+4B#7:&:[\/7.$Q
MP.KXKPA4LTFYPZ3- T(#X=FFV_E]\& TN+]]8-(P$+9G8V49* -*+1:ZCDG@
M([-\V=U]@#\/Q[ 0G':E[5AD@RIV HLRV \VH2&5IK!\Q@7Q+,']SNZ'7T:+
M^]L7KC ]W_0=2J@D E1U:-H1MIZFQ#1]03N[+VK9M+NW_OO! KZW**>^%Q";
MB9 )(E@01HX9B,!T.KL?'IP&][</')]882A,QXTX"4,>6@%Q+9<(V^+$<=:X
M6_:*-'C]:NWW@0RX985>$)BV1T+ K9@^"021/OQ@5P?B='D?/!@-[F\?$.I:
M8)X%D6D+0@5AV-TG(*%-*2- C<[O@Z,W:[\/3&YYW/>DY5B$1":C1$I+1HZ+
M>X%RUOE]\& TN+]](.Q0A"X#N6.'A%$*:Q1Y?FB"?K:DO\ZG)ZQ(@_WU]Q]Q
MPMV \HA9D4E\Y@28A8[]RSV;N9A#U/5]\& TN+]]P'DDG( *-W \POV AK ?
MA(Q,%R24,+OO1]WYY]KO T]0BX(>]A@F6-JJUQK8S((2R_$CVEU[^<%I<(_V
M@72$%=@>QP-_:>2$?@"K3ZEIAH)1V=VXFDZ6F.;91)8C>1@+D<@]BNLDAA%Z
M,E1$O2.>)5,Z7$1@PH$9040 MC2W <]R+E6?0M'9G;(&5+J_O61;IL>8Y4C!
MP=:6 0LB+CU+>)9O.X"Q.KN7\&=-I([L%P\421C9$DP]DWB>#)E@++*H'WEX
M;)C7V?WRBRAQC_I%2+"S;2^P'9-(TV16P+U L@C0;QCY06?W1*WC_W6R]KN!
M2V9R02,9"K"[ Y?:0@8>B2B7EA?I<R\ZN1L>G ;WMP\B8C%N6TY$ X<XP@T9
M<3S7(IX=<M<UO<[O@^';M=\'ON=[8&Y$IK Y<4T1A,*)'#L,S2 ,K*#[]L:#
MT> >,9(71:[P7!DQ 4K:H2[U(A?4@N> :N@P1E)(5J'581'3$\KA,;PC<(DZ
MQ*>6[0D_"(D= 50*S AVAB=-2FW:W42.7T^4^TR0CSCA$<@JUR>1%-24U,%@
M-J74]6S>V9VBL@DZMT<(18O;$0$8$<1E?L#<$)LF2!+PP'/LSNZ17TF.^]L=
M@*:(+2/'=QQ&?#L(7$OXU TE-WG$[#76(W7ESSZ-\W<TF<I7L^;/?\*(-.>C
MV1MY*9/%SB3-10?I9%H6Z@KKOOK5[,<I37E,D^O-<NH+#K-4S@YI_EF6^]-4
M="4E*_ D(UY(:!@P8CH \CR/F\2*/)_)@*]QN<E#4>:7\J?=$3:1V-Q!"F;Z
M$MNG^M3&ME9V1'V?V!Y?8^ML(]C$Z0B;V*8GF,#C6[A#"/5!M A;"BZE%0CI
MKG'0<-/EO&V[@0>B78#-0GS?#0-38@:N\(*0F7R-JTF_2QD=(OE["I,]G)93
MFJS=]OT>"ED7)O$#7]# Y8Z0E B+!9Q1'CC<]0#5!WR-8YT;P"1=@0(LM)D9
M>)%% "<RPFE$;0O  7=)!&)EC1/'-X!)N@($J,DBBW-I$0^KD7TFF&N;D>6S
MP/6C<(VS21^&2=:%+K9-F!\X(-5)2+@OF&6YT@*L%F*K+MIE"5]?L)-CQY!I
MGF-?D -X]UP6Y2DMI6H00'FY3ONY*\A T,CCA#N6(P1A+C87$)'@-I<L$H$?
M]GS3@X5E?!.&%K5%2$'8A"0BDMJ8C\6E*26S1:?!0B?YIBOXP14RXI9%S# 2
MQ/*<(!)V)$!3A9'EN.O<!>>7\<VZD,JTL?6K9PD6<B(<DWI4,A:%U)* +ZKD
MF6Z3:C_+97R1[GWAJM?0.F[LK@ )&=G2]"@8BY9-+%\$TN.8>LB <2AE:UQ>
MLTG<TAGXP!CCC%HVGA#.32_P TJ](' BBSE^%SI,;P*W= 4T!*&DPK:H*?V
MN+Y-;<OQA"?PD!;+"]>XU<<#<\NZ$,CW.0MI$$81P4:D+&#<C\R 8,:S*:PN
M6Y'**[0K(PEX3NQDXPG<J7H6KM-&[@I(P(1'8O,PE%9$, W5,@/;LH5K"MN7
M;I<W<B?XI"OP(/+L,(@ 1$8VGD'AA[;'N!?R@$D/+,C.>YG7G4^Z @P<QV6N
M[5./1((P*4,W%+[IN43X7N1X3U'OK MI;,^QA,LBV,:,2!$%3B@ LEE1Q*E+
MJ\+-#I.FZ5%>5DV.UVG_=@4/@+WG>;X=AHY#".C_@'F"!01@?6!&YCKW*ML
M)ND*&/!YX-N^946<,.(Z3ACZ(1?,,H%U@JC[8&"MF:0K2, -+"N@/(RHRXAE
MDB 2C@R);Q+3=#S9>23PHTRR+G3QS #V*Q4 W3WBHL^/1E846MC./O2#->Y\
MU5<K?)=-[K%)G7" *<*(AR$AE+/0I8ZT/1I(AP;$[ *;=#D-_6&AP/VQB73
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M85'(\MY\N&N[Q8K7-$[?P*9Z-:N>>RH3-<%B%$^N;3Y:C/:3[*JZL"-F%8O
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MVOLV]>!_KD4B3L/UEW'][NEWSV/I'@O3.X@3NI%I$QJ$(9:A1EQ$(@1[F7;
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M_,]_A8 Y7]XJD3NV69?S\?#HZ.WPC7&Z=W)\>FZ<O#T]>SL\.C?.CPU 8^<
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M_&*,3FT^ $X^'^'X7S^"0!N:1Z^//G\ (/OQ]5OG</?@R^'XT(9[XN/SX0T
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M@?[WR]!/&#N<9,"SR<=XHATM/;]^EU_GMJ/-/&KR$&2O;8L!(98S8*%M#F3
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M>S*0Q*+>@%I$@# V0Y##ECV@U)61:Y,@<EU $L.SW>&?QNLD8S0!\R@! \G
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M \[=R)'FLS]<9XM8_E9HD:W0\6HM4I/SCVVC.A4)S'^PR"<96%5;UQD!J%R
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MC,U.R]E$-XY[FC[8MY/!?IZAW57'VI-L1A,PW?J<A3OE+$PG@T@MZ/5U7))
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M" Z,OSW3N86ELGO4-_!%4G_&AR695FQ#!:\.P;1 MP',^]D*/3&!UNGL6R0
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M)73_5G&76<LV1;*_F2O+$ZTLU=>[J"NU*^)8>?ZK +&R:]3SD)D9SJ!RNZA
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MP2>8!9/J#F" >4K$5IV7KT@^+9KI=)O9;^1O-!U!6A1M,5&E(RI''\9+E*2
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MR1ND]4U.#E^^>[5_YPO@VMP2'_F$WAW]1KSPO!9J-T/MRA")TN&Y"IR3X,;
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M)6RMMI4[EW:RC^OLXS:$UV/67!.]ZKD2B6IA'J/RP+,<LH-2 HD$:CGLL<F
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M8!W+5F;VR;PJMZI-TRLI/ ZYMG-NUT>B ](3X0'&OFC'C;4DLILQ5P!L)<+
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MFG^3,T)=F@+\0(%0?>19UK"IG4BZ<UY-N/-GH8LMTM0(W*@/8U6,4 92B?"
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M,H#/C[(FYYZ(C!)61"?)RRKPMB(S#5P1D_>!I#%NI?7U-'D./_SV_G=[O;U
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M&LQ?-F/2XZEK[&CFM3^MZLXU[?&/?_6Q)QMW-/.5'\.)L2&J<Z/#3S?G.X=
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M!<%,J>^R8P=^:^N\F2@\G[8I:W@SO2=F'S';#/]EIZZ:+ET9+8+X+5UYSLT
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MN6MQ]8M95L]A-%I.Z/G'CA+VH?T&CLA%OL0/(F.9O)RV(JQ1JN)^+9@[QTH
MC#C1*_$+@K,,5KS@A('_4TC&OS_8![]@O&VD*L"[15>6G2O8B:\S=&B.0J\0
MH3*X3L!/6-7<7;?F9;:3@R "A6X8%QHZBT0K7@%WC0:;UVP^77GB ;_&>9O
MB40M8)<A#>3/6Y-IL1ND+_PZT4;#3>4XOTL>VA8,5D@^??YZGQ'7^,GW;GG
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MEW</A1-T"T,#7B.SZ#7)_)J3':0/W/$]_3;QS:WD^,DR,<#$"J/;G'M,P3;
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M%F%RD7CFI$,!.K\DV,)\823HB;H#WDX]7LK3AT2FGO%6IA<K$QHT=U3>^5!
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MTCX<+;:P70[A&/:_<E&2095I<L7/O$;U*4$^<O%0XV%\C((;0<B10G.3%.$
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MR@^SOGD"3GS:<6CH$J0&QO7J,::9$7*2);1>B0=PK"CW#V(ZKA@_R/>[K.)
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MLK\HZQL"_OZ6EM4HBU6O*Z>)T^VU/]8!)[ $EEA/C*GRR'49\1#%:6D(G=-
M.81.T=#YLTCCZ'W@]ZGS'_CDZ22<;OA0E#=;U^4-Z^ <W\!\ZEC-/!7^)S^A
M@*YIKH%/T\7(<9(II;:1UR&[*W[KSW1Z.8TYZN=:OGE6[09J1=Q#"1ZS%G)H
M&*95K!?:I_3GN@0,.G& 6(*K<?\T=B:XI/YA&?SMQY%=D\7_?4QWN737B^7I
M+AQNEOSGDVP_>7ZX'Q^\V-])GC\[&,2'.\_BW22)T^<'.X.]W</_?7;XY,'D
MR+Z5,WET<7IU>M1['?6.CL[>O;TZ??M;=')Y=?JF=W5R&?7>'D>]R\MW;T"B
MG;V]W&BA3L&3K 8#K5:S+5::.S$)AQ@/&0ABA>.>HOA=AQ-'8D)V(_LZ9#-*
M P_'\VH>1E0DWI@>7',6K,\X]Y0+(S!7/\ &+12R),?L7?>R&_W6ZYVS=<%?
MC8V=@[U[6MZBV@+5CJL?0+4_)O@[SNBO63)2D"X*9&:V8-]'L#2F;)5#6IU(
M_:^,VXX:KDL4M$6=-MQ57.Z<$8DLIM'RH#@\Q\CPN^:9#'DACDIQ*OV@:2?@
M?T<EQ2FISP"5KG"BH/%54U[24 'PH68L81"S\83W4L-&+HQ$A21HTY<$])3F
M8[3)6368C6MB%Q,& W,^>'\I+N@9EE"QP2;@R/W",WVC- VIYJXCB5GQY@+Y
ME :"79 D A$<H">1+&T:L-_ DI!9VF,%KR/$P#K[[L[(K<W9Z#+_%D[_R7D,
M=LCI:2<ZQ4+H%]WHE3MJE_ZH$2<O&HV.JND8%'LG>HM]I';!3Y^-J8X#YG1I
M[/4>$R?CI,_AQB!JY(EB36^]1<J F#B_KL<5UQ<I!UH+I*<>1SO;6W\(8"9)
M?=&.&"/6?8C]<"8R'$?(VGKM;AWC9AO #5*588E%IF0,"L&B7;%0LMA;94AT
M\ N5=2(*+VF6B5W/L-.D5!1<5+"':/;E='GTCC'Y%+?2)5>2@7C>R1HC4UM%
M608N6*PI-2?5%_;A@VN$0]S9&U_/[MC??7+O=H"0V\,5&I2C@O9@HT_P%Y5C
M>]VH97WN(+ T1KN:+?_.8LUW6[-%YZQ8F*J,!UWY0;-\D]X"<)GQ4M+#Y#O_
M-I6U&R_#R"41H*:0V6CUG_9:MI*E[(,GH[3IU.'50(4=N4? T6I*;%OK2([1
MG94NIO#(Y24GS:8+"84+$>BR9("<2;TN9WE"-:]!)X*:55::S[TMJ%)1"AQX
M7"S?866*.AX(?@!#[ZPU==%,&R+\=CEE44UCE:H:CU7VF-$,*U)8<KH;0*^2
M%NJCLDP"@B#*/U+H XM%IDO&)M>D)D..C+-@++X65[B#JK2O5( \1JK1H 1#
M@@U7U#)G\._<JP]NO5AK@Q@>F2B[9,G;E74<XR>E-JA'/3B(9S5G%JHZSFTE
MC=Z\- D-8 N("!K<&>M6<L]_\:R,K<M@-XDQN:"TNP4;?[61]H) =[J*&(]"
M%L?V^\*&7*EA8A'<&A(13$&.V"!MZ4TG1..^LD'N93=(6.DP@$/_L+933;E
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M7A#A&C58,;QSGF1*,\>^J%Z_U[8-/!:78;KS_8E>PW;?9-ACM/XF8B20%%%
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M1F&C:  3>'.$ ^%5#?04_ZH33++B]P@J"#-C E) K;O>'<"[_Q^[^P;W%=-
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M20(<%RG?'G&L7P"-23DY*I=9$!$^'R<'K@?U"XV\I3(7R$H58.""!)QT<Z1
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M]_\J_Z#9;V2,-Z/2?(Y9T4>I][63#'7YGGA+W&)3E:$Z<L[3LUA2;G_*.>9
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M.*E]K6XHQH?-FV0,)[MM@I59_I2.+7VHILGXK;2:_'":-)LS*!H9<P@$?+#
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M#_$CB"M%GR#-0[%QK?%YPY:)4H>NR(\ U1NPB:'9KS=-F0(G O !WJ%=Q&G
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MML]S85W29R=KWE*MD24)U%4"V:ICME7RTJ!O@^'/3^2&2N.^??S&5HU!B_"
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MYG.A/Y&GP)SP.P ]#_AM74#>-"%S=KLXS1>+.,%[Q6F6Y/QQ2(!:.("FW(%
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M#&JKZGG/I=72^26G56(FZN$%";8T2%BY3='UA[_*M@U6K@^0)K:)\AZA![S
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MR;50/,7?[=;^N]WFX?HS_-M![1KAVA2,O"*ZWC![ZA0>2K_T2:#CX%'.BF6
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M<T+X$UH-X_%.]@RS8"&_=X*CI3RX/C ^N._D;<!^\7S_>\#(07_\]3@0U>^
M_?WQ\-=O/70W?F9B=TQ?*;-I<L]YINY>]X/8%&OJ+PQ_#D$XP*PX@Q<.<YJ9
MNS"K81I16%;E:6,A!J7IRGK3>L?IZ?ATXA#UAE_.<(NI\D^:S%0Y/A>()=S
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MA<1:6B,-4L8*Q%-JD>*&(9,:;&,18<7HQI:H1]%5;/!Y;)-J@'<1P$5M+)4
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M\%U\ Q-7IA$5$EEE0RO%!,E4Q<@F1@#X2*'C[.P!YU</-5["P(G;U7:^5T>
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M]<7GG8/N_NG';O.DVVGM-'!KQS]_3QR=O#_?/_EZT80QA[EXG5RTWG\AA@!
M,XP$%@QQ2D'IB5 H5C:RL58N<6IC2U[=NS,!6RUO;25>JR1>=+_QQ=(4<TDY
MTHDB8+ZJ&.F8":0=22,MG# \\C4C;Q:ORA_[X/[8H$K!MU,%/Y:F9KNEPDFI
M)EC$2!#X@Z=4 @RS%#G+<4K\@98HV=@2]9BL4D'&RCV[FE94I<</J\=3&TI%
M.#6,Q A6+47<<H4TQQ()1:U+!); J3:V>%W@>U=RK[RUOZN1!VZDX)>VYM2@
M!^.ORJDNFU@4,[Z;3WC#F/'IN.N/"(#9VC&=JM[1(B%IIJPJ59)I$P.78!@C
M+GGLW3H2.6)8S*U*>1)O;-&ZI+C.>>6D?;K:O"AZ46GS0VOSE&!@12(9Z12!
MM<#!H-86)2FGR&H6.XG3B#'NM9G$HB[D*K6W?F;M8DI*4>N'2NZF?WHV<,>N
M-^Q\=[5N?_C,NL6\>!#B,837A)^N!):FRQ%,HNWR8F2=O=_"BC3=J)6VU7D%
M8 L$L)FZJX3:F+$($"MV"5A(WC?(X*?(:)5J&HM(LXTMP>H\N5HB^DH1F,K+
ML8;*_?L\I%+N553N*3M)---*\@11*QDH-\-(:1$AEDHI)"=*>W8"RAV1J]3D
M493[H<N+K&3HN#UP:C@>_"Q*4:@1S,5P]%@!XV(XI1,8E<HN4&4O;CAV\6V_
MO2N:;XY8>,?3(]QL?SP]:L.[O-G'<,^?G]M??\"[7>R_3GZVWG^A5$1QRGR6
M2"(1EXXB*95 $9&.*$DXY03L$5IGY%<GSQXSB%R)W'J('-D'D=.,QDXX!.NJ
M$4](C!)C%8)=(;413P5CP" IJ6/\JT.V]PDLKZW'Z&'LL!OTJSHRL 3U*M=&
MI$1(DR*1J!0@.8Z0YDF"=.04Q4#$HL1M;+&ZB'$]DE?+1-^>AU6^WM75W*7L
MC)7F+D%S2ZTI1$2,31TRB6\$G@J"-.4<49-RY2N "5\_@M9C*>O)G)R\1]'<
MY]<\:V]G]Y]_:F^5[@_4J#_HN&&]MM<SFYGY=*F0HPN%'*O66H\9?BX7V,P*
M:U88MD ,PS/LP\4R5G&"$B82Q&-#D+2<H=C@-#6*1CH%@S!*9%W*JJ]6I?7+
M8RZ5UB];ZZ?,12CNL+08$1I9SUPP2F)F$$UB(A67BC@-6L]H'2^LP,"ZM-1:
M94+C&\[!AP;]+ES[6NN &@[<<%0EQ"V9D>QW>D <1S_W\@F?1::T<^XLNG"#
M?@5*=P.EF281C#N9)FF"TE12Q&&UD':^H7CBF&;8LM!0/!!U^N<*9<I4OI#5
M)!17E;92SCLJ9^FT<4JU2;E$*:@BXA$A*-',IX4 >:".1S)V&ULQOAHU>B(I
M;&OAZJ@\&JO)'Z[:-GL]TQW[B7O7'_A1-$:C04>/1TIW7;L_R_/FLX[*'KH7
MNM$R]5!*:!7Y OO6I8C[HM2PZTAD,.PWFAIKL*N\(!52/(87I$**QT>*4H&W
M)'781WI(G)JL;*FV"FP6[8PC3L4Z<IGG)+Y_.O^:>4["LQE>H5S_>#Y7:K4;
M;VMO]QJO]M[NM?=V#VN-YD[ML-W:_M^_6F]W=@\.)VV]WG_8:Q\MK2/K7!1<
M-6;YK^6]_E,!_R6T96_T;.407RJLLS(!%)&3!,<1$DY'B!NCD(SB! DF87IQ
MJJ6S/I3/65RG]S\,?E=->6375 5X%> MNRU]!7@/ 'A3'LMMJJV,-6"=[\#$
M<>K;CT2(I-91K9,T%L8#GJ\>***K68<K"GB+:-5[6S_]+>Y1>E\&;V3[8S#:
MKKSP8W=\_8U1SK48R!TC%X^_#X0;OO0E2SOF-D[68U=3QA\,5KV?/@#;ZX_@
M<6H O^Z%:.S70:@I/1C5^FEM=.R&S@-GD/-PM#CM]%3/=(*K%GX1VGMOSFA1
MF-E_!^N^R',O'4+*A\.]A776'X;BJR\'KJM&G>_NSQ\=.SHNT+STK6P67^+I
M5Y2&,8U'UW^EM"[&>:_"HM> X%]M2M2/Z37BEY+^2W_Z\0;D%Q:L;14E@MB8
M1\8?9%'46N7BB!A&Y1<BXHWB6\<3>#A37QW2 Z>^(97".[Y4W1_JYW#CWS-3
M<=KIH?*\7YZR;&*V_EL/X'MSQOJHLWK% @ZSFJ=$-EZU#AKMU@&8P/7:7G-[
M,S.$/[PZW-O9:_A?S[[/+=YDWC2LX 1LMYJ'K;=[.XWVKK?\X:_]W6;[L-9Z
M[>>AM;^[0F\P7S%>%"-<TL-O#XUA.)T>P%U_##>UPWK-G1L'.\F9&V0'>&KJ
M%/:"T7#)8[YQA']<NZ2G:O 5=-SO?]F9SH"^4_ ,NR,,LZO.ANYE\<.?MC,\
MZZJ?+SN]\+#PI3_S>^6(Z^'BTHX6Y">[G".)E)N)8!Y,\@TU?W".,YL!9RXQ
MK.R:2#:YO/XRWB2_>4TP^EO?O&FPA&Q&+*X&NYS!\MN)P2\\O7=@D[_\*!%7
M/CN']&48NDK>X=?]@6=NM2.G!L/:;L\";=MQQIUJ0#-&ZE?9VL/,9XG(W\&*
M6NVY]F[1:S,3[OC"SVWB<#5QOS5QOB3ONFKPROD,Y[N!JLFI)N<W)N>A^X(\
M2BW;[ZXW=B]O@]V_G:ASORE;!TFI9JR:L95#HYNJ;*]X]O"[0=^.S:@VR.#I
MMR3GGC'DIQ\F?I*18!/3B,?")T@0[IQ0DBC)4\(2[HCB[,N.M_$P_!?=MO9X
M$,'7@_[IMD]LA"%\ZHR.M\=#F XWV#W/LR$;PZ&#_]DU*A!H\BCQV<G^CB&?
MW_Q]VCS9IT<7>_CSZ8>?K?9[<G3QX;S5;L"]]BZ:IT=B$O%M]\^/3KY=-'<.
M.D<GQ]W6FSW</-G[>73ZNNN_T[QHT.9)0^SO-$];VY>CQ+X1^SYNOOF[TWKS
M@1^=O*?[)W]WCCY]/&FV=]G^SA'=W_GV T;"_[EX/]KOX*P@>>.+((I&4EF4
MQ#A!7#F"M!$*T32)N(I#RJ-O,9?$HL[F5&]:^S-9%6@]3=!B3L:<X%1)S--(
M2ZL2G1*K.,AK'.$ 6K@ K5N56*] ZU%!J[D] :U(8H6IC!"/?8G#.!4H28E!
M)(YQ#$ F8+?RH"62J)[@5>J+68%6!5HW@)9*4T8,MZF)N79.6^EX2ED4IW%D
M=>Q!B\@<M(BL0&OU06O*M%041ZE-*&+*8L0)Y4CI.$8$6%:<JCB5+( 6IZQ.
M^-5*Z]4AVX?0UD,W^-XQ[EYF\K,N.W\'N"..6*YH;(6@/")2)VEBF8V5CJSG
M;Y5AN5YP]V'&L.2.R$0Y9*@"N+-$@8GI'(J=-IJS6&L2#$O&<1V+19VX7=-#
MM4]:S:UPTHB($DL<US'6$8F8=)%(*- =0RM3;-W4O&2*I22B$0<-3RAS8(IA
M@;2,"6)$^$H_ L?4>#4G1-83'E5J_G357&&=8$- JQFGADD9I40E7">PKVMI
M*N-E[=1\NINSB&CMA$':U^SB@H/"1TXC^+].K4M42D#-9<+J<71OTV7UFLF$
M9U.Q&:_,L?>;2@0M,<1W*[1;R)'1=89"$BNFJ8$=,,4\-EJS*,%IJK6U-E6I
MJ@R;]8+"H[)ADS!LI!8,28H50&'DD.:Q!#PDL4QA7R.1\<T<*!%U%BVJ>^^Z
MG".O .(V "&M)D"6"&9<<L42G8I$41L9PZF*$U&91.L&$.7H%$E9PB1#3B0<
M<8D3P 9)P$**4N8,IC9.0\\('-4CL:B&P!5 /"6 X"2.%%548T&XI4()0:B.
M<4R,C&R45,;4V@'$E$&D.,4&$XZ,2[7/N0%CBDB)K#:,IS&-0VEV6N< $')A
M.3>K5V)L_7*[M_O#<.Q_U7*\JWO<<(_GE.5;".C9\K-][[*1/^F]>N'YL7X1
M6VF.,=4NO+A=^&O9CG<LQB1*(\2,,HB;6"&E-$'$1#*)8R6=CC:V(A'5$[JH
M:G!KRL.?MOHN.E.T4M^EJ6_)RDZ )S,G*/(]"Q"/%4,J)A0E<109(0W!%F]L
M"1$OHDIOI;ZKJ[Z+SIFLU'=YZCO=?8$H::%CC 2 +.(T<D@J,(D)C3 #/%;.
MIW +L( !=%=(?9]3+F1A3 RKG,CUS8FLX&Q)</:M;$Q$L7!2,# A=.3A+(Y0
M@CE#J05AQ;ZY"/7&1"3K!"^J9T"5!+5ZZKOP7,=*?9>FOB5C@B@><>TKPE/J
M8_HL1IKC"(&R1EC'P@"Q!#82Q_6$WCNB7ZGOZJKOHG,8*_5=GOJ6LA-3!5NN
M[^H@+.R^4<A3]+W.+79*,9H2GX0LF*@3<>_NA55VXOVR$TUN5:Q(:.+YYA@L
M/$NQ KLE@=WNC[?MO4E?!VMA>\+8(1OY/JTI,!:I /)H9(R-#*.41>%D%15U
M2=<F?:#2_75.0*QT?XFZ_WZB^YHXQG :H43ZWH1*P$\"H$"3F$;"*:DI"\>M
M@.M$I,HMK'3_ 7(+*]U?HNX?372?4J(P$Q@)K0CBTH*5PRE'U&DI*4X23$,!
M"<QA[Q>+JGJS+FF#J]>9=+ZBOAGTAT.?GY5V1H\=27F^&+APVR<LZ[NPJA4"
M+A !SV<L'V),$EF&-.8*<<> ^!A#D$IP8I1/!\$R%"M,9)VSJHM[I?D/8/E4
MFK\TS9_:/<PJDUILD734(:X)0XHG# %--5Q+(6P<AXI_L><_BPK15)K_E#1_
MX79/I?E+T_RIU4-48JW$QGL\!.**6Z0C6**8"2ZDB422!H\'BT1=\'M;/0^E
M^0L*_:RRI;-[?N9Z0S?\O5-2MW7U5/=8S#V>4V+C(:#QL*9ZMG:J!M_<",;_
MV*;XD]YY%VYM'[INUQ]6[MG]8@%SM*DVX@5NQ!=EXYMB12F7&NQNV(VY(-@G
M65!D:1)IQX6-8K*QQ9.H#EOS"B595,J\X@9TI<P/I<Q3>QJ;V)A(6B2BU"*.
M8P>6-7<H<9%(8ZQ2(B0H,^-U7BGS$U;FA=O$E3(_E#*7 H,D];%_BI2S$O$(
M8Z1X)!#3H-?4*9PD8")SDM2)O/=)YA5-?UQUD^.-Z[F!Z@:C0]G33J\S' W4
MJ//]T1,@GS2^+3[.EZTCX%MC9A4KD%L\R.&R^4$$5LHF!&F'??:#/Z(A5(2D
MYA&PSTA+I3:V&);U:&%%%]<TM>E):_3BXW>51C^D1D]M$!&[2"="(IUBH"V)
MU B(:.H)3&HP41%P4:_1N)[</Y9?:?3*:O3BXW*51C^D1D\-D51:ED8R@76*
M!>+414A%+$'"&&&<,58E>&.+1J3.R+W/855%'7ZS/?W0J8$Y#I:(==]=MW]V
MZGJ/GHOXI"%N"07ALU4$C-N9KF$%<(L'.%(V0E*EN4RQ0C:6!G&G+5(6"V22
MB&/AN**IV]@B '#X_FU'*[?IRNKS$NJW5_K\8/H\-4&D%, PK4$TB2F8(-B
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M4N?N]]*IJD*3JVDU%%'4UX/^Z38\J],;P_2U)KESKX(T9)]K^]7?/1\-%*Q
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M>!1J9A>H7%,+A/^+LO6E8,.VP*P1CJ@&!A='2.LD03@16B2QTTQ- E'/[<Q
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MN'3^6>*Y_^J4>&X9([1W&#$64=8_&W][+IK[SY-P[K\Z)U6Q]Q#7G5<"N(;
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M-(Y(N8TZ 9=+RUK3KJ$W.5)<D5T9N-JI=8' RL#WQ,"3JM$D&%BK%*',N<S
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M4.[@8#!J3M$^'>*>&_<^XV]?>G&\>ZI)IW[K>!V?TLFO.)^OZ7#\XU^9LDS
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M9405]\P"!$9C"$O+&J!KX.(9K(4?.U>9Z$$RD8V>>9.91H %)XQ/TC@>50C
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M>70Z2UAI)Z@]I["(V2#=+^E"L"F:G)9V/IV-0][?GXG)ULC346<TF4P_I'!
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M/RP%Y5QZ63C%8B&8%(7VA!2,&VZT$JR4Y-%CMD<OR1EFMKTA;]QZMGC'$K?
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M6WGQS[9BL9W?TL?_M6YZAE%AG-";:ENWM(BVE9_8?EXGKOM(=HC0.1L=C1I
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M%,):4Q@#!)?:B<@(B4:!'F"W16:AC>6D),($+:0(5I2ZC();;RK007)'YJ]
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MMMUE,<,_<J[YW@6.,598Y\%]M[8.PKG)E2.OY[ 46##-[X?;@HEV4($,#7*
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MY(IIM3BWLSA<SNWTBN% )HY2%=S%?!%/=JF>KVH!54$$1BH)&E(H)XR)A+-
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MI;U?5D5_W\[[OSZS[/DVSN=;,1*HLMPQ+TV%20OO'"\UJ2J'4X<J6]F=N__
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M\K@U*M)4\7.0,10P7X)RR60>=6(E=T;,RO'XN1QG7G!OP7211F@BA4TD2)&
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MM]Z_[4U.PB2.!\?52/WJ+5,N>8R$,2.&>NZ]$3+'Y&PRS2!N!K$7_ 1>;GH
MBS&8U 0%O\&2G8+(JM<''C>!P7"-\'.]VZ/Q?+/QK>MEPY\]B+1ILR"3B@/\
M\?'A6>_]27J'](E[D2?P>O!X>*_JEJ,1(-GG:B%P?0:C--L(>/8[I'F0I0T2
MU_B\<P*2%*9_09+GZ&3TS"@=A#2B^!QS*HXKRX1+DNV_/'=07139/\^9-,V
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M-,:]S)93F6#V2V@X_(E>T\-!_IAK9Q8*0A__?3*8#&K_&H!::*B^$:]M,P$
M[*!VR<%]^1.8H0ARK1O ILV#Z@90%^!N_!FO?9='[\;^&)3,VE?5/[=+@Y_
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ME;TPRF"<$[V.3D1B4\"67T*"F52 4A*@.%T<&/L1" "^)!@1RE, J7?C7$6
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M7'DHO+L_ 4Z?G&#F=&N09C:S6&\]8Y@#(/DPXA?G.7 U:-39$G6J^G'C:YS
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M&L/T6K*Z8\.1N5*R.4Q=\Y$[4-FG'0![%X-@U@!F,HEIP1[+UD=!7*34:VO
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MH..R0?MEO6!VLFZ66NO19SZ9GA_"[QT.*EUZ<L= HS,P_:0XUF:3UE!L&^J
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MV8"^D(IVWH'VQ-;%C-(:,MBH]8VK0N4&'%\V#>-*6]Y:PZB4O":G:*5UI=^
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M5OZQC@/">^0J):0!MVKW89CS9\Y<M-6<*DI93 T7+)1+2'8UL>:VV-8@C%0
M0<>C267J_%"=' *B^O%TD*8'LPRVUEU-0A$]O\6'R>CP9'K]+:VTH5BEQSP1
MBOY"L-+8A<5K_7DPGLWG&!0)$H J/Y#*E/O!'Y[ZL\G:WR^\%< J:2_AY;>_
M?@_J/R_M6ZVM1"%S!,&=#<T@NX7-5BCO;>;,,L'4VLP S6D35><8!*?&>6M
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M^5FU_'=<_NWSQN[> 04-YLIA)+WS8-AX@ER2&CG&DM*2R&!SK?B"C:Q<_T.
M@$$1F("]X[;#@_MH\XSM,K>(3?#,RX#F[A%L8D?==BC34B;+.EM/&X:]8"_>
MXAK#/L"B=9%IEP\38!\PG"*'<41"X^ 4]H0' <8*GHVRYHS*_D2MP>*8-P7N
M7IJS4,<?9MY6IL!#;5<"WSOPTCCML48A4! '&24R7A.D"$"NM$JJ'"S5BS1^
M%<R")Y692F!F!>9RXX "1,"F8% 4/(# :(&LP1A%3C1A,F+I^<+F1D]M(O!D
MM29>B<05IR$Y0X/Q,7(7&"5:+Q:%RD1XH"CL;AV0@#F'_1JP V<&,241& D&
M@>9QS7#T5LIL+BS*Z[^7N7 ?+:_,A669"Q?-S:\'WI$4+.P*WGNP&<!.0\X'
MBXKL TEYL%S>Q5SXUFL-(NJF5!YUC$+P^>1C*O!]/:3ZT'345UKY^'Y\3E6<
M.HQ/A&S_6LK#FXJAER0H=YB59X^L%YO%>,'R6-^/CFLV\B@W3L.7G!VS>W$6
M_\QC;<;!=E&]F\^-MD^+UR9!6)B'JT2H*NBZ&(P^7>[L'IXW-_=@X_D$S_'U
M(#D>"4T8X=SJG8.EBBS&!($9"]N]Y+"L-A<U\A4+PE>B\]S[&&EL;A]0'2.Q
M,J#H-(A+" KVL2B08X+#6DJOLKBPGY_9+(B W\A:40!>B5L_"<;G(^])-+[D
MH"K"\?WIO++V1:[J+P^5K]+*  ^[Y]=2SGKC++CI@^2B/*15B%$^)#_LV<X-
M:%H<8&>ZHHO:\3 <%M]HG9;9(YTRZ[Y YM&%)R27XS21?-'6:9&_EY^UFY,B
MID@S)WQ.MO;=PB.,$DML24Q5)F#<>(^IE+?Q,?Q4@EVW5Q_SRODB+3!EXB[8
MO,;7J=?.AJ[=ZA]=Y=;ET5XET4QGLYV5['?%6+K7AK-:YLS]4P+N7,? YNL8
M7J140;ULJ<)+5BF4\#/_<R4FY&GSP_/&=PKJ?I&K[-M%FLSJY(,WQMO817-W
M#^\=@VN\>7()6Q=N[OY^M+>[_6./;N/&9;/=V&U<[G>^7NQ_F=W&MDGS^'.K
M6;C6#=BZ/I'&QP]'#1C7WO&GRP;]^@.^W]G?_:/]S^4);QX>6 <P&#Q!DD:"
MN'0:N10H,D(;[L",-9C-E4U8GX0CC$1PU[RGVAD%_U!M#9;!DMET\!>1\NWF
MWUO-W9W/V[E28P4$>R[%^.?^UN*:C)]-_BKZ:<^EUJM6XO$"*GU^$+G#S-E<
M"<4-XDGG9E3!(@NNA9.PT(GY614=SV!KE"S9'Q0FARU3),$<+(E*?;<_J/VK
MH.@$J:J79)VH.QS\=\YE/"UC\^W691&R+T@NUD&$YE_-5MM4D4*F4(U@#4](
M.$8F5[<'=EM.[O=@=Y;6E\OI_;'?KX.5F0U3,#6[IW#ABYQ'&5J^Z/52C'-<
MP7S6CF4V;<ZP[?9MNS2$BBJ G(5YQ:AQGDVP6NB>CPV^7N\BCVG"UM$:RUD1
M:K@:?#?GY\.$%B9C+N0X'1.X7J/^N"J:J+DX.(]Q=)\\J=>N/N;QNKI#IV""
M&8VDS%.UN:JXH!:=F+_]_K!3,KT5!O P=X@'*QO4-]3'E[BJS*A?*WJ-[51K
MMU*9QSVJP(%+G/HR?QS,\/7:=LJ9S?F)YBZ6OP4>QK ](GR=C/S:)0K9*A8N
MV>_=WBBMUN9YZ/9S'??5%V&5KI+7KZ:F6".4UV@NCWWL$9P7#-)EHBS(Y&%1
M;5&+,/?P1$6I[V287;#(1QG5OU0YW]?3,]L*4]-VY2SF ,&(6JXX8P.GIUB&
MULBY@[G(O9QM*5E3'N7SQ\1F0^Y_E4/=[=D0WY<1]]<2HGCNC>"0[VP<A,1$
M@!T4$>8M; 3$(RLY1=X8Y[WFE&.W]DXNBF@]K,O/TM))JP6_]X*+QN%!9,P"
M "CD&:PZ=S8@Z\$&H Q+$Y6&?S(MFUB?[T/Y\ 8\V$O&G6'*@Z8K&C770D6P
M4F'%P;5(>='OTG>G6O3[FWOGC8T#3!/CBJM,M1P0!U,/.2M$_LUS%P-U16L^
ML^#0M'9[GO#MG"Q7A=53^TQA58UHZ7.<KI=WV%$$+V_39\7GIR):>7ES=1J\
M/]J,3P_1X.(L;^NYE&DP_L0DPGC?72AAYHTG#,12\. X0))/6$;C@L;4_Y3D
M;$Y0WX.]MI,^=KNAGX/KH_KD+]WV:V&-?'8YG3YKV18Y+U!F.@')%$QYD(!4
MW"%#G4#,:QR")IP:\$H(68!4UZ+G]]N?9.)$V&"D5H9[YHQ+!#L1E3<!ZZCO
MW86N$H5'BL(Q6"E*TX C12Y0#U8*]LB1J%"BP<;HP5"UF2]^R9)@@HK"$[@!
M6$&86,49%4E38AGQSMZ[:UPE"8^5A$\'.1G<8!:1%V"J<L$3TH #2$IA%<.1
M!:T %/B"G>SZD=J2:,?NX0(^;7SK2TYW'+;C3II$ND:6T6YA*KW=>)=H?#H
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M_N:@[KI6CX<ZX;V=&5QN3##SV.NUC3X@4DEDFQ]Q)$VA6PC36:_['9 HSR%
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M26<;R,39VZ__G'D*?=@S/L) 6XVH2@[Q *;=F>"0!W\6"QJ]P==J.X/9<!9
MWN#@.-@(PS57PF*+G>(P7]=J.S^'X'_8VEK[LO'''ZW5SEIKH[.]VOFP\?:/
M]=;J7W^M;__5;G76MQ="!ZZQB1];D=E6_H>3<GD2B3/@%W/%< SP2W#:^4@"
M5SCJP*)Z])KKMZCGGT#C_.EK5LVMM8][U#@<E7$H:@^J&8E$-GB.L/:)Z(@%
M"_3JK,H0A&"1$D<M%U[ I#A+E?'6\B")N*WL>DF,BUX )^HYJZZOMH9 PXL$
ME+PW:AWW!Z6,3TJM'X\'_L .X1<0R5@2P[*&4]X'X,9#>%CF?ZUBV-J/O3@
M#GF:"28\$+X ?+$XE[0)[UQN;5S]J-4O0]2C ^C[_D1(2V):@$M;E(_\9KLP
MXBT[:B5;#*H_X4E 6EO_-^[GTO!5^XI>"QZ27:!OL75D!U^!VN8VYZX4>:"S
MWU&]-K>YUQ^U!M&&(K?ZFRVZ99%X>$O^_E&TV6"5NS.#'<5V57O^_/W3(;K:
MQ?S@.!R!^YO;E<NCAA8,:  3"!Y7_LS;X4$K =L>MO(0[D];>FRS8U0<V^J<
MO/'1<9X*H.HG!X4_*(>D]G$>L%%%X*$;PV/PN&$.\Z!OK*W_\\]R:QL:-XS=
MZ*<3:H^/!WT8*&A8V84*S8[BZ* ?0-CV"YA)VPMEKR8]F-PYN_&#6$K")?FI
M-]"Z_K@:2WA6[F=^N#W*#QKFIZ;Q" :X]L1V:U ,O\(_]99.W]T:P%_YVJ2%
MXV%,XVZK"U-=/FV&J'TYB+UZZV DX;Y1D3.G6UGSCF.I?K71B-^/P3T=YF&T
MX5L!DE\V>IA/((!79@D+,2^D@'!"CRZ+Q/!<)DI92T598^2JN)\K4)&+H/5Z
MDPDZ*48PQ^=:=:E66F[#E3?7APC&%"3GK#Z?U4Q"7XK\>Z4#_>%U:851FAJ&
M++C75.Y<?DNA^.YSRV9C0Q:PB];[_I$K>A,!^A8',Y3G?!RR SH9FT'T?9BN
MLZSLT/Y!/![$8=[W7-U?"0Q\I]<_ EEW@#FIR$,*<I,')0WZ1Q,XN3K8I;:
M('5#J2\NZP8H' P?=+8V7]5KIZU8OL&?O,'97#!HWQH/9LY('N?]<=<.<M=[
MOCL.<6+7]K,VE =N!$#S2O9JN\^K49SJ?0[WY*\ I%Z^!90'QC?OGKPL/]8?
M%/%;!:D@ ( Q +C%\"!_PQW&$K9!PX_ZPU&YOZS?@P:61:@K:^*G=00'H B]
M2K;R']\B&.36_J!_ BHTD<[S[^86M,)X,%778W@ZJHMGI22 %I5*E$-UPUA
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MVLVIDD*#:0VFO61,PUXR[L#?]$)S1:/F6JAH?3(F$A52@VG/&E.K5U*(A.)
M#"(L'Z,B;42:,868(\$:ZQ@XI$LKE)FVHOREP-KKRJ&>7R6%9CGXCLO!F(&Z
M*!:-5YS9H W6/*KDO LJBOB#LX;ONT.D@;=[P-OG2\67,>,R*844M1AQCRW2
MQA*4-.61*2J"SWM :)-)^>LJJ\>.*)9X7M+CD42-E0U>Q^AXQ,+0.2MKDX0U
M%R6N1<@)C=8EPE$D4B$>D@"7"WY(K4!XM?7:J"8)Z]=79"ZH<%$$XHGC@0N=
MHM+Y1,5H- F>-(J\D(I<RXUVQ"BF.+*!DYR$%9'#@2)J;8HD22;5_#98-XJ\
ML(H,-Q!B/#=!)XZ-=DG:%+Q40L'4R\8B+Z0BUR*A(6A"G$\H2,$1=YHB:Y0N
M*Z!$99VG^4R31I%_=44VP1&G05'S5N&<M9"$MC1([SFU2HO&#WY6/[@>YK,Y
M&T@2Y(*(8'H=_*:#1)QJ&C@3B3*Z:([PZZJ'6HK\L"A5SH;#\7"4#SEO"J(^
MYA[+.<3Q?K"MX\_QP!_885SU/I_E#4.Y>CZWPV958WYPMU,/^X'Y840)@9A0
M#/&@!=*&.^0Q239IBD7(!WFT#;Z.=W??AMF4<%I88O)H,;][Z'/C:ORT*M</
M&F/1*<$< O*"$0"V12[BB"(G*5CJ&6?S<S4:C5Y8C7ZTX%^CT4^BT1?&64>B
MM<8<*>$5N")8(ZW!3%/AK7 ^&$::>JFO0*,?+0K8:/13:'0M'*BY)LI0BZ27
M&H%!CL@D%5!&9B)!V0&Z&XU^H1I]'W]Z#O' QI]>% 6OAP^)"D[!!"(O;,Q;
M;R/2@BED"56&)"EAQA?*H7Y=&8!-%=4%XS:/'UB\;SVH!@T?@H:^'EU,05#*
MN$0L 'GDS''D8*(1B\+[$,"KT6EIA<\C8;I9^UQ8%9]#B+$I"?746EP++&(K
M$V= :9)0#G'-3*X,'U!@Q"=G \"W 2TF#]Z?VNCPPNKP'(**C0X_N0Y?6&*;
M0DJ6"Q2TMX@+:Y$AG*#$$DXF&J;S68A$JD:'?UD=?K0P8E-Q]<E4NA9+Q$8Q
M%CVHM-,Y44E&9%C R":F"6;.$"V:U,)?7ZT?/Y38>-!/[$'7XHF!:N\D#LC1
M!%I.% ;#+1D2,,M,1N\BUTLKHLTP6R =?^T%67-V:%.0M2D>\>A'4'&)25F'
M57!CL6%*!1-2("HH<--R\8C[$+D&QN<'X_N7SIHR'B97Y;.F7$!<Q[SD*W/M
M"*J)A2E,UBVM4(+;S+R8VA$-JC6H]BBQ)LFB5!K\F$!Y F\5*YZ3G833TE!F
M&E1[3E2K9YQ:P8G!$K',2#FV 5GNP0TU2@I*C9"6+JT0VL;TP>2T ;4&U%XR
MJ!EJO*5&.2\HURY:%W/\G -/8YA2T8#:LX+:!55CV"4.WC4*03O$0Z1(*VD1
MX%R2Q)&@9%60E9D''X'2@%H#:B\9U!)XGBH1!TK" -2$D8YRJB(1R?% 8P-J
MSPEJM;4"02.S+"3D8LR'.AD -:("PL(P;JFWP-":@JP-IC685@CG"=:$>.TX
M9T[::)B4U!LIG#&QB:D];TRMMC0"3J86D48D<=Z[;(E$.JJ$B,;6JP0S)_(I
M1YRU&7]P7L-3P=I<T[$7&XR::JQ/?BJ(UY1YCZUEAHM@M.+18F.!N7&L57DX
M)R73I6(RSW)2#? ]!/B^GB\F=-;6<]OV+.7:^*"1<Q+<5(XE<C"5R&&JA5<T
MA%SJD5 ,X"<7:&7XE:LTP?/6:4U GS5.3 O+$]&@S![TF9@8J&;D,76ZR>/Z
M:76>1M&GZAPQD$SO'-(8?G#L&++6.Z04Y@);)SD/33+7*U!G3A3WC$7+D@;_
M(SD/+%<E9;VQG%G7J/-"JO,5ZXR3-392AAR@,.)*@CK'"'^:H*PF7"D]OWW>
MC3HOKCJ;<N6:!>64XXQX8-Z4!T\-DTEX(1IU7D1UWKIBG;6S5'&ED= X($ZB
M0-89BB(1'FO,%=&F4>>%4^?Y[Z!0ECGJA4EYZQ/0-2:!>2?G0@C))MOXSPNK
MTA>!P]RV=;(G*)4A4H6<% EQSP-R/@ADA/=2QZ@EHXOH0+^N6J]/5J^AJ5SS
MW#'$9I?)4R+B^LD?VQL7NTP"54*9E)=2!.(N&H!%KA&31HD@/2;"+JVPMI#7
M<UZ:,K"_@EH_6ABQV=?]")K[\5QSC964,VH0MH8CSBPP&(X5BHD8*RR6*FNN
MOKZIH%';7T%M'RU<V*CM(ZCMSKG:@M-HJ/<* ;92Q#G12">1]P<)S)P%OS*
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M@,E1A"VMF.7K*^T7DY]1\SX"P'.*.3CR#@O" Q56"$*=PHJ 3Q&DS@) S$0
MB&D$X-$$8/OSGDS6)AXB(DQD]8\&O .KD*1.,W#[)$\V"P"_40#.">IIM(-A
M*X(Q"ZVUZ..1 TO!2+N50;S\B2MAR;/:!J8T/ 9;#/Y@]_1F,G2#@9QE5B^9
MX#E8G,M"]I<_B&'<C?UTBR/[?CP:#V)='M<K8[J=6?\VM.=MM^^_OCY9HYVS
M_;UHC36)&!2,2XACBY%A6B*3+)8:Y(UXO]2*H)''>>8'XWASS??G)$NC6>*=
M-<#N[P_BOLU%5V81*J!0?5^47L9),3J8P:X*T)_A"( I?V?4;[E\!12LV^V?
M5)Y@M/X@,[/\NAZ,1RN!'$Y4KZ2O0,^B3:,X>'.C3AW9P7[1*[WOJFY^Y9-.
MO?K*-X?1[-KC87PS_>7W4 R/N_;T3=$KQZ2\Z??)LR:N_HPZ\^6D59=_/RG"
MZ."- 7,B6 Y"31+^)R^NKI+E,CYU)=107=-DF;&;+^-E<N.UVQY+Y#)7=WOL
M#_8IW/-@ YB!1PO_E0]\4XS@3?X. <%_96_IH#^&AX;A;W>H%'1+5WT.3PR>
M)]RI9O;NDG\S@>1+?;SCO-YEF\D]0EL+'2*>$?J;4PVM15XQ #"G#]D ]8LM
MB\SJX4)+[6)E-LY@@AUX__9)['Z+F]"8@]>1J4,VC_Y3;&YW#CIGGPXZAQ_Q
M[MI!L;.]?]8Y['8[7S; %?G4W3G\S+?>75WX^'RZ<P0TDJZSSH=UVEG[]'7K
MPW\.MM8VZ=:7SP3:0#H?_BXZV_O\G[/IHD>9J4.XYL227*'0@6OK9$#.<(N(
M#L9BSL&SR94(>)OH>1TNMP@[(5\ _(!:L1L9QFNOCOH\J+0##L3V2;\!H_F!
MT68=C P7T5F6(RQY$388@9S-YXSDR:0X&,)=>3K!',H;+5[1U 4'(_Y38/0:
MBD$\(Q@=#&)LX&A^</3Q$AP9'I/%'MG@:#XB10(W2@*IY /3VD61#Z,DI,WT
M@VLX-]SHGG D&FZT<'#TOC\>-&@T/S3Z7$<C*Q5W+@C$F7&(TZ21IAXC$R)/
MAB0E+ 4TPFW)YI6AUI"CNZ*1;,C1XJ$1?+=!H_FAT4X=C92,TAF34!($T(BD
M@'24'DF3/+:6>FE(B49,_4H5M%X &FV?KVTV#&FA,&DUSTD#3/,')E\'IIA,
M4 0;%"0!I\V;B#17 FD5O4_<)L[3T@K';?Q+T:0[;W&:W-=L<7JR\6E0L]GB
M]#S N%\'1D&2D$Y'Q*WBB',ID$D.:!M6C@<,O\JYU3B9NQ+-<8?3U4T(^>\L
MYT5O7%KK.VQ+*$5/!&6$E5J0H+CTUA!N:0@V*DD\HV:/8KWT>-NJKJ7A7<OI
M*=/P.B#!C[(=Y8YI@*VG>?GLSA.Z_&K[7FGL]9\+,2"/FX2\E=,[_RBL*[I%
MWH6T5@Q]MS\<#Q8HMWA_:C[HSN$&Z1Q^9IL?\CLV\>YVM[OS94=LKKT]V#G[
M2G>W/\-W]MGFZ=7<XMUB\_ S[6S[D]VUW<.=LT_=K2]_'^P>?CW9_/#^<&M[
MM]O9WBVVUOS9/V?K&$P 3D1)3,$$* LFP$:/G!8\'RV;DM<!>S$Q^@"&,:QF
M(YP/G>62<A&XXB(&(-!:$6F<A4>I&:G(SR'LJ^_>??J\OM;Z8V/U[<8?&]L;
MZW^U5CMKK:WM_UW_U/ICJ_,!;:]_VJQ?7P@]N&:++AN+&_+WZ]:JDN,?3]+E
M216!2$>U /V*/'%C*/98$ZQ=='!K6'JJ?0);:=5[D)M04]<%VP7P#)JZOQ>D
MLCIXCH2B*JLK1<"R E*$)RNQ$(F2E[ )H)K<5O=B=K,H#8OAJ-HDG!/TJ\3]
MS/06-A=?+9N?R\67:EEA\5.Y^+=?$US./\.?+4OU<X]]EL9JJIYA.\(C>^M/
MM2/A#DGZ+VKSPK7-1LU8G(\%?J1=',V&CV9PFMTPYRPG'AUW^Z>QJH,2>\.*
MH.?]AM.R*9,]CH]RQGRS_Z:)NM\2=5^?".>G2A1K_M:[\6  )NRE!-Y_SA^K
M N_'7S?/]D\ZVYUNY\MGOKN]CSOT_<'.EX]PSP;;I)^_;ZZMGFV>;8K-OZX$
MWH\^GFVMK1+X#MG=/NANK7UD.U_>'^RN@0]WZ,]VM]=/-M?@SK.OW\LM-A?%
MQ05.5CM#D*<*?+ED+#(,2V0 *XVR/G++EE:(IFV3\X@6)E>BP:4&EQZ_X&&#
M2T^*2[4C9&2@/E"&$=@2@;A+#&EE DK,6":II(X*P"6IVI*;!<*E5Y##=<XH
M'\(7?U $M\D&FS/#*I>=KH>S&QB;.XQMUNE5%#Z*7)(KA600UU$@1Z)$7.B(
MA3+P2:97C+6-FM=16 M4R[I1XSD3DD:-GTZ-:VPD%[,SGDM$N07E-3KE ^T(
M,D)8K3D%[<[;6PAMBX=[20N4N/F"V,AY^=ZBEV/>Q;<XG$2W$O2OU7?0TJJL
M[V/$MYH=-7/F*Y-IW;2#KW$$H_6N/QPU,#=_F/M89RO)4LHT,2B*7.) ,X&L
MQ0XIX9@V8*NL2DLKRK2Y7"2?J]'AQ20KC0X_E0[7J(HQ25LM)!*Y0@EGGH .
M.XR(9=HKJ8W-&51*M+&\7A"VB9L\ 5,9V>]-T.0ED9"-G@=FN9VGK4&ON:/7
MYSH#(8I*)9U%X%TQQ!,6R&#FD; XEYI/P2JUM,)I6^)YG77;A$L63X'GS$ :
M!7Y<!:[1CR"#)CH9%%QPB(<D\^&J&"7*K3:>"1UPI<"J"90\J?I-)+_5C788
MZTG/33SD!5"1K>,XL-F)^B-/WS3T>]K V=SA;.=21 1[(H-UB K/$5> :8:0
MA(RV+GECJ9:Y JUI&[9(5=8:+5Y,/M)H\=-I<8V4.,&I898AF1)X%2SZZH0<
MA@-62G'%4P0M5FWU\+(;34SD7CI8?R<\PZ/B.SHH0HB]-XV$WRKA?K1Y(>$B
MT&1C(,AR21'7/B(#4 5BCO._,5&JFM&>UVA'GH3()VXIP@CBN4*]9E3D]%F*
M&3$>/)V9^PO/4>3R/\WIX<^?#MN<'OY$T=0F;>61<>K">_$R"LR)0,+$27*_
MUD"#* '6DPPQW.JE%2YTV^ '+^@NS,'A#9(V2+J82#KGL':#I(^+I#4/4E!I
M6 *7$8L 'J1R%%E).2)$64&Q9%Z#!PE0VY9\7GF\SX^DCU.@;-+OB1+Q7.3B
MN#\L\MUORKVHQ;<XJ6TQT;#:79/1P!>W6 <='X]NON7:;OAGJC?R'C%\>33J
M/P\&%WNS]R-R@VB_HNH44-L]L:?#I7]?KCI2]%!]"*_V_N8YN*54S[.7WBGS
MFSO]GJ_PK"F\<U%XIY-7QXE58#M0E G\3BD%LE@;!!ZGQ/F,-$]?PNF[Y22W
MNOW>/@+Q/GKQ!7CT,N7B)POP"/RS=6MNKVG#'Z.FC=(_=W+OLS36L+LUJ"G
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M.ERKT_%\WQ_\5>TD\'^.!\?]82QK8FT?V!Y<VA[8$.%SGW=;#QO.=P=-$9N
MN!*H7F3"(*FP )<=G#8;A418$E"6C& AWJO@V<^!7R,3"R036L.449:0B4$B
MKAU8X40T\LQYFYAT-.82X<O7JY[=[!=,MO[<1M+*C419.*[O!_HUO.5N/EMP
M_V"F20A]>%%>62NW(&?C,2JZU_8@Y\)#W;(.S[<BC&WWNG7*S\YAC>'T0-#9
M_E;OBE?UP.R4UK^ 7@_CE'A=WO7\&Y"H7!>C-2G84-9$=G%T$N/MN^Z-USYQ
MKSAV8,Q3T"PPSKV4@3/M@[ICE;0[[+H/]O35Z?TZZ>1B*BPF$;!%RN23NC$H
MO)/,(XU%"LZ+B%.]=L+YYOJLJ[?-'598)2M$-%@#&6,:P]]$^@2O(VF27MG,
MW0/F;G^/6L4-C0Y9EBQX2Y0A X07>3#EE'(6J%(P=QI?FST8LV'I]&0]S<4/
M "RB!3:9=;/*;>N[;K$_J5,W;,5B0E./;1&RX@]RY2_X#3S::46OO"?T'(]*
M=)B$3DM$L/6R"%.TL=/-H;X><,V E N0#6JQGZ(L?]-KE>\_ DD[Z)[^-CO'
M(<NA+7I53+;<YIJC2" VT/=<$RI FX?0[6\YH@N0FU]?==1W[7@8I\RZ3),8
M3D+%;M0ZZ'?+_:[069]AN"P8U >#< O3+U)V(A.@:;YM4G4F_WMT/&J=# H@
M];VR#?Z<]0]/>[DR7!7J&HY]B=9E8Y=;;^LP78?3:<&@<H]NG/@,Y9=^. +3
M3H\.8(ROM7]8<Z@G-GRZ\%<_AWHX\3ER%'U<[OXM2Y.6#72V6WHQPX,81\,9
ML?"79,2W+ZG&;5-_9$]!J/-!16 7!^5(C(\G4]?WU2!6\S2=W_Q[B,F.NZ.;
MGSN5SO.E#3\>CJ!?@]/J(</Z4RX6*H[M:;F",;DR;)__=EXU+0Y*=*T)CTVI
MR'@+TM,&]=Z?%+@"64M%#[Z8A<D#!,#OHTD%+?@\]\WZT_P0  #0WAP6K48+
M,.'$#@;P=1":O-+3^SH8'X_@R_FA118:>!K\>5D,9E:<G<[\9'IX/GP</(!R
MT_F;JA;@MS@Y<WQ2MKEVUZ3$+KZXQ3IX^WAT\RW73BE^)A%\CQBY,CZUGP>#
MBS-S]R-R@VB_(IN@N6]L]P1P?^G?ET^#+WJH/H17>W^S<MY2U/2'14JO%#65
M"DA!(B:0J+B+/I>IQ]@3;G-11D>>IJCI[.$N10F4=X;FU"M.'H[#?EDLH7U>
MM&RBC],'Y%)#1\?=_FG,RM8KUR+!ZL4$V@UV\A*8K$^_^"F.BD&U^%@= -CZ
M*Q<UR@"SZDO$($;Q2O>RF<F^PZC*O:C77<@&+(9>'.;FY6Q!=(Y+D_(S-WT[
M*Z9M@0O=VR]Q(4\<&/_I(/S(!,]"D/9-$%+#LAR*FGPC.S<E(&4.<'H<JU>>
MP]'%W1-(+$O# <V90$X/#%7,Q5?K_:IL:ZW@Z=1; L-L>SD4!G.1<_]'N7UE
MY\LG?(-'3V9Y!# VM).W5%X5=!:,XBA.AFTJ!^?M*:L#3HI>#*MN .;$&4.1
M#:^];$8OKX2#V1^.JAIY@_A_8Y"186EYJXNE"7!E>0]PN'M5>F=,_1JC:E<G
M+)?9I .8^DEA67O4'XR*L^E?N;3'@1T CMC)>OMYZ#!+0-&K"NV5M."6QM[-
M-VV7#G!9D<O'&.Z;6FJ\2EYP(S'GB6A &QD=DT$&EK04,SV.FTO9O*MUYX])
M;S[ESI094)?C4IW^*/YI3W-$ZC6OYWS$FV?[>PDSZJ3%2# LP:., EEC%%(R
M$4<#MR;O19^UB(Q&?41FKL546055J+M72B'H628JYW6T+E!@MFR]^)C2[(K;
M?\5>7L_* CB\7R7R1RQ-_Y<_B&'<C5OIL@L_?.55ZO$>Y8$Q'Q/BB1+$5=8-
M4!-DHS:)VJ"<,5>KSB^H$Y3ZV3W.Y ><$#\H7,ZR J]XZ@%63F(N'%Y;3+LH
MR3BL!+>7!7>Z?%5:&W"RLXX?#XIOV0<^S[T:SJHVOE27_Z7?)C5?KZ''FQO5
M&+C&/A#@?)Z&N'P8SSG%+\_"N' ;RO,W<DOL\3"^F?[R>RB&T-33-T6O'*[R
MIM\G3Y_X&OD%5\[>*-]779X0;Z.7C9*9>T_.R)N\>$++ETM:?N4XD>J:7E9&
MWG@5+Y.?O*89^ZD[;VNK669:O9"V4K9,%7V$QAK]<W?>+@04BQ<RL')9Z)NO
M+E9;&5G6_&X2._N RXM3R1;K(,OR@6\*<',*?X>3K_[UYWEM_=6JMGX9/>J/
MX2UA^-NE\XXF W$E3E-9K=D'MOWPU-[FJXO^U1\<[WJ+\%<&]WF.>;M&KDMA
MW\BTI+4&-.0.Q[;^Q,"]B$%8:X;@KSBXV]&]O^H 7 7]5SP4[_KE(LZGUZX1
MYV[711G?.QA_?8OQO]/1AO.U8,TK7_,K7\%)](3^FY!_4TS88QP\_XL/&FT&
M[>Z#EH>K51&EUNJ5>/03GM#]ZY^Q_4N>DDT-B8DP(2E-W)I<CDSSJ'RR-FCM
MS>R-!#^L"?'>^E@QUA=R2/9/KDM4AV0?=S?7-AA\!W>VWQYTUG;P[N'.Z=:7
MOP\WCW;HSMG.Z>[A/MR_^GWSKRN'9!]]/MD\]&+S["/9_+"..X>?CCJ'&^+_
ML?>F36T>7;?P7U%QGOM44J4F/0_.4U0YQLGKNP+$"4Z"OU ]@D!(' W&^->_
MNZ]+ @$"(Y! @KX'&R-=0P][]=J[]U[]^9\MN.;ST?;1?T]V-C]\W=I\_[4Z
M)+MU<4@VCRS+AF69\:#RL8X<F2@P,I)K'RM%\+2VH4033]&4>=@AV?,XYGK>
M8$YG _.IT+0Z!CQ=B7DQ-ORR*VV?VG)W)HZWQT)D^5X4,<NUEI58LY-(I)!U
M-"SVBN5]>C.OP^T?:;?/8 #_*03PWGVUO=?XO95B(SL;]P@,W+\K4O6?5>J*
M1WI=UQK\H/FSNIV6-6%*I]W?ZQ)CK^N71WA=W^F]67KLA7E=TUJXU&O6+.7;
M"B?+,)-626XU-@D'[:7RC&"?%"U>UQ)QMT^37E>2C/N4#\-E,B"N31:0I0E9
M36E@(8B8W+R\KNFHN%"OZ[Y@?I?7=5]H6AT#GJY2LQ@;+E[7/"UWPNNRQBLB
M0D+8&9^SHQG2E*E<>0O#:)A(#+PNOHX?[77-QVY7QNMZG01P85[7ZCF@YB>>
M?2Y>?/89NXS*TF6S>%RR,;7JHNQRE5VNN_TM(.;@KTN1J"2<*JZYLHYD:<V4
M8HJL^%M+Q-KVKNQR<9HHY1I9PQWBP?-\S')$3$F@;-P$'UC9Y7H-NUP+LN'B
M;\W3<B?\K1!IR,KPB'L,7I8F!#F3#'+2&:8#X]:8O,NE;AXG6':Y"OV[P]_B
MKWR72_U$R<,=KM?IKH_ZC)8^F\GCXF6/J^QQ/<SGPD9I3[5+#'BZ$EYKZD@^
MYB FZ3D)Q>=:(N9V,.ES"9\8D=J@E+!!G#N%3$Y7DL*QR(VC3O*RQ_4:]K@6
M9,/%YYJGY4[X7)Y3F;16*%)J$9<YLQ KA81V/B9,%7A@E<\EE\-N5\;G>IT$
M\(_>, O>9'DT<#=$X^WH2/97N],E?R(Z>UX/RY1[G8[[J,\>F%WX.OML,KOP
M7=GMNG>__=__HYGDCXH<+O?J=2M]B\,;JHQ.,1PCIBEJKA2W7&,@:BS1X$*4
MI/A?2\3BCJ_L>>G(K',))2J Q?F0D$XVH$A<P$%("W1N;4/KIA8WC^,J>UZK
M:<#3E5478\/%_YJGY4[X7X9%":ZQ0U3FXW<-I<A*XQ!WU%HL*!>6Y/-[E+ZI
MP5HVO0H/?&(';/4\4OH3H0]WP%ZG%S_J,TI+G\WB@-%YB&J4K:_7N/45+7,<
M:T8P\YQZIQW%EE@I(XW8J5A<KR4B<._/?M_=&VS]E4G<VWV70A! KY$3X''Q
M(#TRB4<$(XB5BM%0+<K>UVO8^UJ0$1??:[ZF>W!ANBI8YY7@*)$ +E?4!CFF
M"#+>,L^\PH'(O/E%'^U[E<VO5T !M^)@,0F'J^>&/L[K>IVN^]CK4J7/9O&Z
MU#P2#E_;ME<I\LJ$+0 ]%X(+SX7C@CHKG&" 6MH+Y:42Q>M:)NKV==+K NHF
M..,)*<H5XB0DE/DV(LYA(C-_H[14>;V&':\%&7'QNN9KNA->ES"14QP04SP?
MK*8D,AH;9&.T$8/W3+@N95Z% CZWU[5Z#BC[B52Z&J8X[;/V&2U]-I/79>:1
M;%CVNE[C7I<B*3*C//. V-%A@ZD0PE)GB P>N^)U+1-U.Y_TNE@T@D<&A(TQ
MASCW"FD3!3+&.Z#:T7OAUC9@1I3-KI?N=BW(BHO;-5_;O72["+C'/$6)@@T>
M<<T%V*[/.];8D*S_[ZC-:H:9/2Z#X:Z,V_4Z.6#9[+KH"O ?L@>!B],^8Y>Q
MTF4/,3B&Q\[79MGR*EM>,SE?Q$1)&<:<N<B=YX8'+I+U@1DCO.3%^5HF O=M
MTOD2CGJK%4<2!A%Q)22R3F#D A->$ G3U>>S.<J>UXMWOA9DQ<7YFJ_M7CI?
M7)J @^7(,Z(1%SP@(RU% MPPK3$6+HFU#;HNEL1P5\;Y>NU<\-7O>?'1_LW#
M7(G7Z;N/^NR![M?K[+,KA97S\<#*]M=KW/X2P5.!!;564LY$  :G(U5,)ZT]
M3:EX8,O$XO"D!Y:HYY%CBDP(!E@<2T@S$I%/SAD:B6#2EE*OU[#[M2 C+@[8
M?$WWT@'3+ ) !IBG.B7$'3/($ ]>6$HB@7-&M8_S<<#*[M=K8X/WD]GX:6!=
M.\+?H?5E8SS)ML'L>RV_\;_5+^M+7.^GC8O+J]_#'^/V57W2ZN2'OV&RZNJY
M-I_@[[6?YO;O'D9@&>UV]PP&#""MU[.#UI?8Z,53P"]XN7ZC.^Q-'K[4R-;T
MI34X?W.C;7<V?&'MJ^[XIC6 R>3OT>(KI[?93ICF>_>;C0\=WQ[F65Q/B>JW
MLS5XR4;Z0Z>Q&7W,:V#5]F;C+#9:_?X09GONAGZW'1J#0[#G@\.&;9SV6E]@
MW6J<M@%N<^OA2PU[ #UT4/VZU^KXUBF8C:VX:J.;&O\S WFFP3!!0^1<4VZ%
M<P1KX46@))I$4A7X)&SAY%FNZ K\^=]#[$_^[MA_S'#G*,!*_'=[[^37UM;N
M@?B\">^V^196UP]?MW_[L[7W[?/AY]U/9 O>_]]O'^'=_;[@B@#=(4A0@Q''
MG"&CHD><42($-TI1MK9!IBRB#9B:[3RX,.##3C_Z80\F4+_&ATYVH?- ]UO]
M0;:=&6>%PY;X%!R1+O 4!9#R8)QEGLM@2$QE5BQL5FP?@5N$/8LB.B2-(5G#
MS"!KM$8\&!UD5#S@2OW]SDDQ&_]>T(B_;/[]N''>VT\2)VT$1T01A[A* 3EP
M>)"5C&L/WI B5>&.N7D>[G\NI9$F#V1LA&&\6%YJGDU($]89RAH_#(!C_-__
MHRG%/U>_N"JN5'U"?OZQ6H1F 0MBO;-1XV2,XHQ9K2GC(5"EM.=&NP(6"YI$
MG\ZV-S_M,P/.LE$8,0:(P;T'1RQEY5*CF4P"$QS2G,%B02->P.+6<=Y]OR]%
MEE#!'MG@89QE@G&6AB./HPDR.!83N>7P[/]<5O3?#RS$=; 0US0!+L "G$[@
ML;;F[7\,>_[0]B<(?&:E0#_RS=YU3X!MGS<K'KW7[1W7]!^&?]BS'7_QA0I_
M\@76>Z T+9@&C1;,D=9@F!L#3/=T])A>OYI.U;=[L=5I_&#[\,#:<81)_!;(
M<;M!<-4D^'.B27<<'3UNVOJJ>QE_Q=/!A9O!G]?-,%3JY("^)"(YM=1HI8R1
M.;_"46UUA1@<&X;+&C%?[,!;WS[M.VJRL(= 2JA,(S%#CE.,L$R:)$:,8/2[
M:\2EES&C@O)BQKZL%K>->%XM @\1<^$1P'N60=8!62V ) 1@F8(8&CR[I2;\
M/U>]R+Q(7$()K\!47E\?KAX+?N_5(>1A:P!JP_3Z[[!]WJ"T.4*K9ULX[K=J
M7(]4O8Q58^?FH@FKQKAG<D_<L7!>]/\=W=1PYXV8#3<')5J=0;<Q..M.1/8:
M\)O;)LM9:W!X[SG0S4/;.+6]068MU3@/NM":PY8_;)QT0RNUJG#)E]B#B1%B
M@KZ *V/OI-\$\#B,8=B&"_/M?/=+[-C\[K9_'.$=8<+<Z(K9>@%:"5,T+ZPY
M0C^:G=W3F(.^T#&I';^V7*O=&L"LS_>#)U9-\<.V[>6KJX!]HS^$QISVNE]:
M?;A%O^ZA?@LF!GRK;J2W@_JCV#BQ(<(EKC^P5: =S UP&A"]!Z\$_X"'Y!!S
MW7,!L+:1K,\O 3TXX[1>EACS=W<57F9\N8;29R=]6CCC#";!1L(324  8,4G
MS,?@92!XM/"K$AB8,P78P]N;'_8U$Y%+89$3&!Q&(2-R3#IDA1#<<<:IL%5Z
M^]/&EA75'C/#".6)!V:M\=$DHZT4GAALRJQ8V*R ]]J7WB6E@D<:YXISYS32
M,A)$3:1<1L&4@EGQG0V'&2N;%S/BQ0&X=9S! 8 ^)S%:CBSQX "PB)'A+B 5
MA>?81^"S/#L ;)H#<'ML.2\M=:B(UJ$B<MT5(/.**TMG8K*""YH4Q]9;F*=<
M<JL"Q9;ILGPL; *1O#DA"7/>V81(U@+DVDODI,4H<>:5Q3AX'.8<5U[0B!>@
MN'6<OWW8MX+E4X43L@:+7$DCD3'"(*)D#A5@H@6_Y<#:N^+*-X""7P>*ZP?;
M?R=JD.'CCQ%A_>LPMM/=4>8)ZO^A\P5&O_KBENW H%\P__7&#Z/WN?SZ%;RZ
M%DZXROUS=^3YV^H,*R_KBC<PXN1< &D_[?8K)^]-+[:KM)Z?SUIA<#A.E)RX
MJD[!>H,O+[$.2/MP</LE$TE=OG*MG\GO^!4Q>JU_)OX\[(W?YQ0& #GP?H^1
M3?"Z;VS[S)[WUWZZTJJ35@=-=N'UUM_ND=5_7AN:VK2E$B2!$Q)(5-Q%;T*$
M/O&$6X^C<Z2&([@FAK>#RH%A*HBDK)6>1VH=8\$ZRTRRSC$OUQ;K[-[9W?>-
M;$W8W%5O^-8(5B/GHLVR4$?@<%)SXXGUG&GE&'6$20-\+P*UQ/N;F19@18%E
MCGZ8Q&\DK\/WG_'4GE>>^$ZJ@24#>EFN;X/QG5U_MGUTS+<V_7D._AJA.'=*
M(QD51EPQ@71,#'!=>86Q5!&+J1R_!NSQ^EU8_NJ,^M''?4FQPBY)I'4 QI](
M0B:HB#Q7@> @ T]Z)L;?.+/]G(!J6U4$,@W;[;RMFA&ECC"-/8"\WN=0_FH'
MOZO 6:<*V(HJ<%:MIM4F0HZX=BZBAYD8_ E3LMJ\V!JV!RWTKHJB^O,9.,LD
M,N_T6@>MC./?#5BN_3AU:^3RNN;#MT'&X?$JWE_'OGMU,ZL(>N/N]6,]-[L_
MM'5X.W___JVZ.TXY$9,,#XE9CH^DOO_!S3(%PZE6PFG"39 :$V^5X=I: 4RA
MQC*!9=FNGC.J^6];W[;V8V14,TR1"$3DVA*9B_LU$$Q/A-!!"%6=OKQ^4UEM
M'AO6"QK]LI+=-N;;F\<PYE8QX-?(LV01M\$A9V'U4L$ V89>-Y+?=F[O?VK>
M4J]A]<_OIGFDG3C*<M+?R7)Z=]4C7>UU;:<#;N]YPU0[Z^;FRI;[X&+OZ^8&
M['?7L+4)>/^UU>L/+N^V]F.])SGQC7MMT(YWG'WL#2Q0#R AW5ZUV3"QVSG:
MAKW_*K/>6/5QG+(Y?V,H_XH 9N'JB-Y<O:=TSVV^XO4;CJVB6>T8]W*L!A[Q
M0^M'^'?>U88YDV\TVCP^;^0VYF_,5);BJ4I2TY2,XD89I\"= #\=:T$3=_6I
MZQAS\CT(_AVZ<2>]JXC0KZ,WVK)?6R?#DU^ZO5Y5;O7.GL(G@_.R*-\"T!S:
ML!^=QO _AKSWL"C+F!T-RU B3! 67$K9O>"W'NTW6IB;,%-@JL!(QQ$27$R4
M3 "K9(Y3,)!NR'/FRH1GU;5P\8D]CHTO%KXT!!@X.6U7\S?#0T87&TY:G1:L
MNG4%':!8YR#VKTS6T2.K!(R9YJ7EB1)PI R3D0OBG&$J.(8C=$>6#+N8E[P0
MP[G.P8.SK:,/^SJ)*%V@R.:C);FB&CFO/%#$Q#S#F"8U/8_Q:F"CWL*^F&Z7
MJ<)\#*P_M+[\V+"Y'+-VI6I?PGZQK78N.LUSR%UX+'6\^LI4AL_C_QL">!;0
M6]4)]Q5^OX]3W@;Q%$D<&4RX2) 1X(D$9G2TVA(=Q3U K]&._?[D3 +OI)Z$
MW>$@YV-5"4BIUSUI#( R5$MV_CL,JT2Y?.%U<,Q(]\.7'T>/R;E>YX]+9YO%
M6Y](EW3GU]G%-0[87,%LM\8_N?(ZU8O%W9WSL$ZYH,%W\*SJCM<)]BW,=NV%
M,%L^P6QOQ(.ZU_V(D0]Q&<XJ2_DJ("O?VMW;IUH*[*A#.- <K>8*Z1RR9IXX
M(;'QDL1[+.4 I-F,;\E2NW7WZX;>V,6N[^FU(.8=!EKOE.4/>_$*D#O;KHE%
MNNEYW7@RS/,J/)$G]*D]K^C%-4;"<',:8$R[F8L AJU1I*EA!]4UO8R],V=C
M+,A 2AALNED<?]W:/-A7+L7H<ZS3*YJ/X8S(I7R\1, ):T=UX+?IFOXG4P.8
M)S"8U0(V[(]R]F'-]#&&O)?C([A$8<0TOC^; , :![%3D0K?[9UVJYD$)G+:
M[:]L4O@=6I\O,!W\G^O[6/6.E9]YPZIYI5KG0L*$U''%47;/V@51NJ.7;]G#
M@BMZW=-N]LL[MY5WC--U1G>_*U?GG@D2DWA?!Q]SQ4M^U8IQ5"2DYB"QW9YO
M?KQ520@ME/"P_(G$G"!1D40-813^:>L=<T*)*0QDOE!+\RZ3L>#..<X0%1R@
MEFF5 UH6.6M)T,%C%<PS:*]8XB01.55#:BZ",91(X6&:!T.DQ*3,BH7-"GC^
M?N!:.Y5RVHP'CY\D"[/"4&2UPM8%I8@TWTU[S91T1K*UF%$O9.NVL=[9W-MW
M2FKJM$'&V:R_HK/TBO?(<H6QSF?PY3//V?J4\,YM.?*']DL5AQX/_TB/[IK8
MI<=2">T3-YYK9;3Q.B@>!%!NH-HV)\S5@XTN1_VN8=Z-O9,K9@ULP;\)P]Y9
MMQ< EU[=^'[\MK-[<+:]N4>VCOQ7N/\^YR8:90.R#H-Q$ZQR/01%BOGHI4F*
M1+FVD2-H'70.3M1U0<$JF#8B.>#WT&M5#A6GF;7 P3"')=;@56%.$]<R28?!
MNR4&8RH+TB_,^EDN<'!.,D8 Y(G,E5!*6&25"3 C!+$P',1%MP"D7]"H%Z2_
M=:QA5??4"VE=%L\)P/6$-\CBX)!*Q@3'?:0NW"J',+W(X5Y('ZU(!'.N+5/<
MR61P("17V<6<="Y(0?IY(_W'_8 )Y3+G/&LF$8\PS(91A:QQ!G@]XS':M8W!
M66Q_B7=!?89Y=:U&96V4'C_>C6DV^F!8=>QN[$/74;_^*-=HM,WC*X>[VMOX
M-;K>T/:J"FU1W^YNGS)CS)0EIXK.S%1YJT,@5B?GD^56!NW _53&8# %[O3%
M";.XK#?SG:,?V/;F >#0,=S[(][>]/O, _MC6*"8',Q1H@)RD6#DG+"4 V"(
MJ/+:L_Z]'/TS^+OAHN]6NX4WHL@7<XU4PBJ4OH!4-C"S45Q\E,TVJ4]RG_C3
M'9G*=\8&;;_1[XZ?]KS2"D!8,1:,6R<\5T @G(K2:$NB<(PE6I$(@UG9O)JS
M*;\_@V>2?5C5!=9!(J-% CZ!<W4UMD@H'(WA01D;JW/;'Q([LH-+5G%O4KF0
M^5!(Y>VSP(O]X#361E"$"5!+GHA&VH&+J;A.6$A*:)95FWH"^,1F3;4]UZS0
M>Q+<J+GT-LVUQ.2UEY"2G)N:<_IF3V6]#UQ?V?L=?V\NJ:S5YME,.CB11A]H
M HM,7!IJK.-)2H:QP=PY/-I(9926O*XG,-WMS:VO^XYY2TU*2&CJ<R8A12;&
M@+RCS@?K"8#F].#_5?XU8UZSX7!W&23\C\,J09PU441.A6>,LV0NI@(K4^%I
MI@+;=]'F@F6)8+1I3FP.N5#6H>RV"\&RHG%:VV"WGD#UH,3FB2,@:F+^_+G-
MFEILN6,ZMSEPYH0* %."XV"8J[<C<[X'_AY,%4XY\SS</>#[P5"M9!0(VR 0
MCSXA;:A"U,N4L]^9=G&Z7M?]LIMK#Q#7F://D=]<P&^Y)MVWMV?[FI,4.3$H
M$JX0&'W*IP]H)/.ZJ(*@P>I[@=^U#.>KF<TP+Z:PV&HF7E*X&^E'*\]QK]C=
M;3FMXPYX=$)KP>]G,Z6=S;VO^U08;ZRFR*6LN$:%S%+]!C$+#,)S;E+.'/@^
M?M\_I?4.V[DUG_4V5^C69-;+4-6UM-8[GGYG3BN]GM)ZUXWFF,^Z(/LH,9);
MK.+KUNZGL_VD-;9$&@1<6F0M&@6.5H!5Q@KAHXR&DWDFM-XUE[Z3S7JS.O@[
M*\IJK$.WEK)<"9[<'N8>%Z'<\O6UVHR[![%:NZJBG.\(A3?OTL9NCG)0IU>\
M7/\N=&([YG,08_O\\E4G-6PNSQ*\7B0S5;[M7B/[&K7=V))KNRV'5IN:VGW3
MY^-*L]O=*CP[K5G5HIM%&VQ*K4P7P2::C4[>]ZI^RN:= (" 5%0X7%<CPF7#
M/IA'WJO,.&TO[U?1#2 4@_/36+.4\<TFKFY5>?NQ$BSJM7Q=!I@++UNQT\_A
MW5SB%T,G>RDC@I6+ UNA9?,:T<PTI]NK@C437VTV$CB_&0H'^5WK:$N^VUA0
M$OXQZ$$WVM$3*_C+#6^WLFQ2<T+!8O1>7^)$V^K>^-+JMD>%B_!J;7LVUEXZ
M&(Y^7S<;P").Z;I,MFR5<-QMM^H<_795"'I0,:46P'[F3H-#8$\]\-J!X-6'
MR=8?PB.K\L?LTMM>!RA?9ETP!O&"=T$C[=?<FI!/HX6'#RJ7#SR]WJ#U;?RO
M[-,<VAX @,T+M>^>G$+?CS_M7U2ECNI-I\^>9J:YU;M\S4O\C!0O&J<9#@K8
MG.*1)\,9 8I'&0/"%Y4:*1'"?]&TX\39F.FUPM>O;]Y-].COHP[],S?G4XZ'
M7(T^Y%;\41/=5\WYX'Z>[H<4'*5!($ERKB4E"MDH!8K>8@.=[U+$.=OJIB>$
M!EU$UAMO!Y<!4C92F:O\Y[-83<MJ<H&)96_D@G%<@L'(0;F%!JPT[OYUV!VV
M0[5;EHE/MI33+-%W?KW%N>X[%TQ/YAR,937KK)$Q9%9!FU/H3E_Y:3D C<X.
M,];4H9P?^C]>L=_<X2,;GKCLELYNO+TH^<X,;71=SK*M<A[L"%3K,>T,>MWV
M>/3&)3]PT^'I2'8PM/IC\I2_-@97V^_'RV$?7WC%4X#/1M)",($RQ.3BGXSB
MT* ?[@M./S;KRO+S'!P=06F8& *;!1*S<G&E5E2_X_5AJ:&\ZX#4C3#_,KQZ
M);]P]!CK/8QTKX+UBWX8I9.-G'&8A1<="NVPP_9@XJ;?&Z,FP#[TRT4'C:;%
MY()<W;T_>?O619G<>$J-/JD6B?JG<5^"$U?%C29"!U.IP6W,H#Z""7Z?&VW]
M>;[)Q;'HXW43/(]\9GIG4"WFSG:.>\/3@3\?"0H D'^IRMTJE@Y=.>5U:P*?
MJ]*ZC:-A.!BM1^-)-NJ$\0WR$@48U#V/N86=+$D P]6!:33(23]7QO7]^(M_
MQAQ>J?KK0Z?*V?HKQW@R[7CKJ_$C1O'F*-;>:@][52@^SZW^*2Q3U:%%5[A,
MI>C0Z_;[Z&*BC+8EIU]PU9'NQ,&EB5SXT..M@_KN58+CE(D\NSM].\[>D4%+
ME&6.>F%2PEQYX/)2XY2<"R$DF^S4)?UJO.:OD?[%3MJR@]S;,$=VTN_=SD'.
MILW1G-UL'KOPS%_:77_\^I;M;]M'>V(_&JELI P1JBWBG";D3$B(>LJYBYA%
MI=<:$>C-:5X0>\,XQ5M]_B7R;:>3=Z8NXY9C,>G*'X!11U5^;T5Z[52BD=<(
MFR=XWB#KO[F5$P X'H O.^B>OA%5<P<5S%[X^WE+%N40A3WMQS?C'W[.JUC;
MGK]I=:J7KR[Z>72O49 @N\7 . < W.U1 *#JW?KCD<=LS+K"*CO-@Q[\/XP?
M//*GURM_^J=!N/F9(NM*L5L_QNODUL_NNJU>Y^SV3Q]Z5R+7N5'WNNU/54?4
MG0'=G8>M8O47X8F0UZPW]/1K@T /3X17VC'=[/'NZ;RGL)F]9KT*B_Q0K:7=
M(=PT]'^\F)"C_KBCJ3@W=&WVKZY.3]X6>:GZ;0]<VG[C?;V3,6GIB^G"*=U1
MQ^V6ID/JG;PKK?_.4(]@+(,<-*U1N<2-\7L^=IH]XI%3^KJ7&_H,73W=9NM=
MO9FZVOKC@QX,4$"C=TS5?^YJ\S.9V_0FYT2F>UC6=]MY?8[,TC^XL>R]]#_7
MNVBFYBWOA)]%ZE"H$*W0W%.13WIR2E'*<]@..Z)(&)<B78W/(78C$VB"Q%^2
M^\GS0_X8T\ /G6UX_&Y5]K4%[W+8OU\^ UM1=V#OG__V/^]VX1GMUA[]>+97
ME4)ZO/7;'H5GL>U__GN\O;EWOGVRE5.!\-;XFG__>^A.0GOG: ^>\=^CSYN_
M'.WL>KCVX]EG<!.V=CW9._F(MX\^T+UO;]G6YL>S?[]M#;9:^.OON^\'6V_W
MG>76)JI1Q+FN'BN)7,(1P=A:ZZ2,FE25M4U\:U[18TPDKQFSF,K#H!G<[;A:
MT,P>!,W7VGGK\DUGZZNI,%WP;!8\R^1V]ZQ;8&Q^,/9Q$L:4P$E+R9#ER>1M
M#($,#A3AP&42GDCMQ+Q@;#J:/ &,K1[#Y(M@F/>"L?NRS0)C,\/882_& F3S
M [)/DT#& *N4P@0QG$4E55#($0RXIIDFD@5"6"Q\[,F!3!0^]N* [-=N/DRL
MX-B\<&QO$L="4C8IKY'U B/.#4,Y[:^2D,;$.A<X6]L@ &2*D,+(G@S(9&%D
M+P_(6E\*(9LCD/DK 3*6@(1)@1*I#CB,!CFM+&(L:A\D(<;I0LB>UBAWLR!T
ME;5>:-D+0K.W>40+H,T?T XF 2WQR(G  46"$^(V1>2P=$@YK%5*A*7$US;8
MRXJ5W6<G>]X[G:.M\5&:$(-FA^XP)QV-S?S>>^<O<)]TCIU3X/86N"T0.C\(
M/9Z$4$RB<YPP)+0BB$N?:V2#0I9X[SDA*3&YMJ$%GH=S.W>#>3@ _U3E/TX6
M94Y(L;Z8*MS=;JX@NRAD/[70CV"\N6*@2D3]X3*C/I=FU=5%C7%YT8]5LG7.
MP#ZO$MKJ8M@IF:NUT$1.VQZI8]K9-"0>E&T] 1WB.G2,J^/_@ 9OQR(A<4<&
M]L>S?6:P]-P&%'S(-$H)!%0J(6VUTM[(X'@^D !/J9QJ7"BQS"3)$QQQ&L:3
M<<,MTRX);6F0@#C4*BVJ\<;C\<9EO.<YWGB?:RZ4BP(Q8BSBA@BD'36(<QLE
M"0PP*<)XTW5^QWC/>NP )TI::JG#@O! A16"4*>P(GF&25UIDIO1F!-3QGR.
M8_[I?-\1HZD)!AGK&.+>6F0HV#@1D;L4M#,$UGEJUM4=8P[=?3K6/5A_M*Q!
M-1 B*".LU(($!>S#&L(!"8*-2A+/J-FG1*T]Q7%N=Y;2;\-X-@B_:/-SK.6-
MIWGX] ZHB=[-/Y>B0Q9;QU67S.W:KYNMOF]W^\/>$M5L^3&:"/A>^_/NK^ _
M? 8T^(@_;[YG.[MOOP(RP#W?BXPD6QEMSJ^CR3&\T]_MK>P_G&1QRC^/L\SP
MUN;[,T 9^/D8D.3]5T";HW^_[9&=W4_[.E)MG1:($PM. Q$,60?N0\!16B^Y
M$> T-$9P$,/;#,I,:1VX!H:!*4\$ZR" 8X1\" "+U)L;)5[/,<T_;+_;V7K?
MV'W[[_N_EF)J7W=,[E?5>%.GY/N]?W6T(C4DX*"TE(9K:_/)8$2D9*V2<!^Y
M]F16]P<X?_[\=5O<VWWH/)Z4=HA& A0=7'9D!=:(6$8MYLQ9O@I%DKMU<7Q]
MEGKE7;;J@N1*Z:/2;XNY3+(JBA_VQZ?05Y7V%>-LMVQ]9GLN,.]U1R7DUOM<
M7U0=ZW[MGNN-3Z."Z*Q7,KJF*K^.U<DH]8,O"KMKG8#^ $AC+K=.PT%5#&V_
M-F)*0'WJ<O]XDLN.>^>-T(+?5A7Q6;UD<!9CI^&ZW>-:G0JN&N03Z$_&L@.U
M8,!D.UJC<F=O>[US>/<SVPO]L696)>I;O=)Y51P*]VJWON6XQ>BH>-_MA89M
M?+'MD:U7VJI5R3O< IHWS,7OP]Z5YHY?8_20D0AKI=,"7722%5C:K6-@>/EW
MG;$PBAL_/H;UQH=:_*!_,4"=+)I2">A,>YE*OZ ZFC*/Q&6?5F6KH\&J="@[
M!]U:^Z^2X:HK\Z/MMRIM6'CS7.&>I6(:E11Q/&CE\?TP*>Y0-0.>=C&-+GYS
M5BE89&F#D=+LJ#FW]L](1V#TNKD4_ZL?Z?B,B]CK$<C*FE4G@E-4=_JD"L.T
MP:G?Y4+L?=0%E\(%6:VYDM$8-Z.^00ZKG-@ H_\[#-!9JY\/ KI0YKBMR7D
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M^E_K%X[1I:O4*P<HSS-JV!EFLC;?O>T/V[]>CYK<)U;R=GQH_%_CP;[RY8M
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M^.SH\TF&CC^/X;YB:_/]V=;FW_#S,=F":_=.?CWZ]]N';P =^U3Y1(,W2*;
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M3?6H9['C5QR9:38Z.?\W-;[,B;,4WVV9HS;;L=1CSA/XZ!4"PR1CT5#$I A
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M]FKD" 9HL@^NE3[=[&U?EN0!#OOC8*>S.Q44J?S1X&S43?.:Q'2G=)C\W(W
M3)%;.TE5H&XG7F;+O_'KLXJ*SQKQ=Q)\3&7R,#EJ)CG>D$%\BC[S]9=R$DJ3
M[]*4Y[UR?^G[+@FO6'SM^MWZ5M.;F[Q&#VRQN^/@)[VP'R_;[CL7"/7K>?OA
MSVW%[[YG,OA@0T N*(58:J)GG?#(<1Z"U16O9+QJ SMOM-7&$LFT4#H5-I;6
M2P'&L#;Q2F.:RS;[S^T99-6*7U3[IH_C$CUH8K 4UKC*4*8C5:Q*U6QT$)QX
M%>C:C>_Y!AVMHHA(<>V+'*:DN7=&D]/39-ZF '<K.^9TY!<W"KW3'!/.';UY
M7D^K&B_T^X9U]<S9*+R8_O +B.^SGCE_4??S[/)#O[1CM8R12.%2S[J\?<W'
M%U2R7C64TK;>;M_<?KR>/[K42:_YC,IURF_^N%K'W_D9I]\WZM<FB^%#RI[)
M9/6Z$F6NRY^K6E?L>^?SZ 1+UJ66MQHV]YYLN?>:[K*7VEO.-[;LA7@5(P9G
M#];V-0_XHDZW@MTM&L'^*RO78-V!1CSZG\MM/;^RU)O[Y<K;;$NC&SQ-2]PK
MT;"\$]/R!X?9?MB^8C\L[,TMZ>'&3;K75Y_%=K[<?+4,:GJFJ\_.F)]X_;__
ML?43KSY[4W_B];^<KX)]D"I4W 4\KS:1COE_EYM(?TO*/N4.)*?)+0C@FTN]
M!67<.$9KV"2S)[7<SB?2F:[\*WNY<LWJKV\Y7K:S;&?9S@?9SH>T3WZVO5PQ
MTKRS[$W]MU=5]EZ_ZM=-/.F[J.C2:B]3T5UVJ>H\@[WZ/Y=WZ4XK7&GBO\,%
M"N$4H<Y5QE#-N-=*LF J;2S7K%)2?:N@!KT<&VM),%W_3'W.TA3>UN/CEY,1
M;$<8;G]N>\1NYF2/X _,Y]O=W:;/-'QV^/8_HW<' [Y[\B?9VSIB>V]WZ.&7
MG6I_RWW9?WO(=[=>?T@7-'9?[1T??OG[>/>\?>:?_QS;4]_;/_EPOK=U"-\_
MPH<G_@3&87M?=OF[DP^?]E[]R=]M'7XZ)+^=P#J^_/-E=[Q;5Y]_/]@>[VZ^
MIPP[BZE!<)(6L5!19(2W2)&*!NDC"ZE^"^DJI;M:W-3T\3Y\DH3('?FE@%8!
MK6\5*<, 6*J*5''#(E: 5@X "^O@B:*X@-:S ZV]ES/04C0H%F1 @?H*,2TU
M,L1SE&I?&XZ-PM*L;6 FNKRZJ<-C@:S5X>L"6;DC!Y;,41H,C8HQ&JT37,DH
MC=.&46,+9#T[R+K0LT3E4T-:CCC&J:29]4C;4"%EE27$:VIX!,BB'#0M62"K
M0-:S@"S-') N]=)*RRAV8"(2YAW15$3N."^0]=P@:_]"RXJD"E0F6Y 1#*9A
M*BCKF4!:84,J*9TT?FV#T6Y57>UJ4A"K(-8J(M9]J\,6Q%HUQ-H]V!SO_I50
M:_,]3Z4*,16(> F&8>4]4G"X*&H02D$(+ZQ>VZ!=@GF7KI0WJXT\7$I(QZ3)
MR'W\*,^2(T44ML4/)BFQ^'*HJ,RRS'+E9_D3! 9W^KD89:[;V%[J'?1')4Y8
M5*NGBA/.;KXWI/G[8'3+&LY%=;J-ZO1F/@X8<> \:(U$)0-H3I5&RD>%*.6$
M6Z4D=F1M0Q'6K<C5"M#%VBN0M(J0M/0H8(&D!X:DN2@?C@ UQ$;$F%&(14F0
M=MXA9E443CL=9+6V(7B7L:M-X HB%41:141:>I"O(-)#(]*%DJ0LUAX3A62J
M2,Q\E$@99Y *SN' 0$6RJ<6:Z@HJ"B(51'H6B+3T&%Y!I =&I+D8G0U&8*(E
M"E%RQ&@( $8X(EY94'B#,=B0E%;0U:0@4D&DYX%(2X_1%41Z:$?27 R.,.&C
MMP155&E0D@1&BCB)A X1_K->,KNVH2GI5F25\@9^J'NW-[GX4T_(T7C:%Z;;
MZ8?Q"MTG^[%B1F66JSM+<C>^OE9Y6#D1^Z_'E;$C6"_\=%G83D&FD;7;#=+L
M#?JS0L%[X9;MCXOTO8WT/5R0OIA9'9FQR*96"$PQCK0R#C'GK->$8(+YV@;1
M72JO.DVO5#BZH^Q['+G[;$/K-C?Y;,K8CIHNI*E6=/YL;#Z'!PFVES'*&+<:
MXVLBL1WCUE?_GX>\?$J3],(2G6:.-GW!]V>9-[]FM&B^=Y#08?OS>&BF/35W
MQN%T!%*U;5G<R\9M(WB+<%V><'6+Z:5&>JX$6+4\!,2(K)#QQ".NM1%65<9Q
M!:9M1;J"+RLD>9=R&\7NO9[1_UBNQ%VQ--LRQC,=XX<T0I]>J(*P;*W.7T,_
MQ+H(Q"4*Q*,%@1B4P=JSB(*5&#$C!5)4&,2-#08332M7K6U@+KL*W_NV1;$Y
M[\*'>V'<2KIB598QBE7Y4PA 4'1!WI7XYG)EWH=%F6=P5-X%%$E5)2-0(\LC
M11YL/DMQ(#S)/,E85RTM+[48@??GR]_#:/2B<R$6.V;<]!]K^AVFOI/SWI2F
MB5\8/7E\M(SQ$X_Q0YJ(JQ&G!"2X<,)NSF'!P> FOVJ1FG>0FMN??C_(_Y\D
MYZ>4%E0%$)!(<"<0PYP@4X$4Q:ZBU%9">:K!5"PQR4>W#Z\(PIVM[7_^Z?QN
M0.LPX\&P3LTG@576.[EY:&JX'(8E5EG&>/0Q'M:27#4.O7,R\.V7O]+JP5,:
MT M*0;&AEZ@-?%[0!CA0K*R<1D+'K T$9)BFZ4Z5D-QY D<X-:*75<'UL8SH
MZ41:HM;/N81/&:.,L>14WI] M]X*9T.0$DV3X=1,W9RFWM]?\B]*19UR$>JI
M*NK,$R;\W OIA\V^WYRCSZ+U+%'K^?+[P<XL<A#3M?%@'7(^=;FOL$5*1H.,
M$]Y9(1DG86U#LRX<Y@I=C"H853#J$4OL%(QZ?(SZ<X915&+E>,504)$@.%"*
M#/8&":^Y]5Q%R6+J!R0K72"J0-2S@*BEU]PI$/7X$'4X@R@?F8G4,>2P\@!1
M5"$C4U,-YS$3WE)7J53D69>R] 6BG@E$+;T(3X&HQX>HHQE$L<A"P,FS[05
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MQ$,5+;9!(NP%8):S$AD1.#+&5TII)P6F:QM,=!E9I4)A!;(*9'TE:\<#32N
M),HT,Q0@BRM#O'".$2,5+Y#U_"!K+D(>.=;*4);2H,$V]$8A4VF').>5-[Q2
M&KLF%UIT!5\E36LI,?(5B[,\8->0,LLRR\><Y4\0'6Q;7D209)W!K*9]"186
MW>JI@H6E">##ZDYL/A@(*K&56%@4:&K@KBQ!EA*%'*U4$,3XH,C:!I>LJ]2]
M4Z"+O5<PZ7F& @LF/3@F783Z% .[C4N%X-@<8H)Z9*.G*'HPX@7F0C #F*2Z
M2A1(*I#T/"!IZ9&^ DD/#DD7D3QJ>13.6\0H35=9G4>:.(P49YQY'B3G>&V#
M5=WJ_G=9"R052'J>@;P"20\.21>!.A&QH+'R*++4T@<S#6BD!?+.>>ZI85*J
M=#&C*\6]BQ052"J0]#P#=062'AR2Y@)Q-&@A,;8(%"10D[R2R, I(DF]-+**
M$4R[M0VA69>3>[=<67X8[L>XH7>3G[]ICM )3<N];J<?OJ]E2@D<E5D^YUG>
MHM/9-[6'E9.Q=VG5L@0A>T.KEBG(-,*V;>ZY-^@/IE)X+Y0FG\L4OWQ!_%:"
M"XM]A:)/P1Q&,3)$.12"%\Q6(C@MUC8HZ7)ZM2C@[?NW++]&Q$\08+>Y2WSG
MK'2X+F.LWABW:%_V\W;_7+I1>F&+3A-(Z_X$MF]_EG_S:T:+69OL,-K^/!X:
M.(&Z;X;G.^-P.KJI]UF1KLN2KCN+C=%XU#9@:1#6E47,Z8",%11E'RH)D4FN
MP;@5N*O5LG),5Z^?Z/.S?/]8KLA=L6S;,L8S'>.'-$.?7JJ"M&SMSE]#/\2Z
M2,1E2L3/ERH3,I4;8V"I/6*$@;T9E$!5Y0G73&G/W=J&U%W%E]5@NQB==VP:
M6LS*,D8Q*W\* 0B*+LB[$N)<LLP[7Y!YFGEJI##(^9 JA@N!K%$!64U%$ &$
ME @I.95T,;W:)+M8@4_%F+^'T>A%YRO-M/L+_A3X5N-0*39B&:/8B#^*B%QH
M&[TYAP '@YO\J458WD58+I:NCX0&.#N"B/0:,9I*(1%+4*@$P222U)!N;8/>
M_TI^L0Z_SSJ\(@5WMK;_^:?SNP&5PXP'PSJ,NAW@F'68X<!].![T0!$IH<HR
MQJ./\;!VY*IQZ)VS@6^__*(;W$8W*!;T$I6":D$IP)['6%&*(N,58MA$I(PB
M*/52<RYJ%K1.%C3N2GGO?C:/;$%/)](2M7[.=7S*&&6,):?R_@2Z]7RSM([I
M^XZ9ZY)6RNJ4FU!/55:G=/%[9*WG4M,-RX*W&O'@"&(2<Z1%,$A(A3GC4BA*
MUS84ZPI=:EH4C'H>&+7T,CL%HQX?H^;J[CBCL18>Z2@98)1P2$L?D*8V>F*\
M4%&G,JJ"ELK/!:*>!T0MO>Q.@:C'AZB+.CS&Q*0K*20TB8B1U%&#,(\$JX2(
MVE:52G5XNI4L$%4@ZGE U-++\!2(>GR(FJO+(YS'P56(:#@Q1K%!VCL)9R=5
M(-*JX%,#C:ZHEI4>5B"J0-0SB[45B'I\B)J_R@AJ$L$N(*N(0LPP@JP- MG*
M66N84\+8M0W-NUJO4CG#'[%;1AFCC''G,7ZH.)J\5CJ!%-$ESZR,\>S&^ GN
M4K3=SQ[B:L2]T]U7;:]N;T!<M\(?Q8 (41%I#-51)Q-"&LZI4!P42?B)49<,
M"*Q; P+KTH!OU>T)/A_<ME9X&9Q"$DN)6,5=<GE8Y)31-'H=:$REB+L8ZRY6
M=(62_0MJ%=2Z&;6,K:P(UH>(#;-!VXH3@\%F=H)RR75!K>>'6A?A;E]%5Q$K
MD7/8(A8L12H8B2R3 D>EF3)D;0-3TE7\WM&D@ED%LQX%LR@+*MA@-,.!<>FL
M\0Z[@#D) O0O43#K^6'61?S;8NU \J2HMP#,B@8CJYE%FFMEN$KE7UV#62"A
M"F85S'H6F&52ZH:H*AFKBI&*:!PB_ ?34Y%Z7!7,>GZ8=1$0#X%C;P(&FY )
MQ"2ER&@?D-(8SAW$E$SM_ CI$E;4K )9SP.R&);"$$/ ),3,$VXXQV!+5!([
M+;Q0!;*>'V3-!<A)H,&XP!#%F"%&942:TH"$T#($:5CE$V9U626Z^OXM_Y9?
MON)^,?(5B[,\8-.0,LLRR\><Y4\0'6P;7D209)W!K*)]"186W>JI@H6E">"#
MZDZ[G^>#@9KR&+1R2$<<$>-@\VEK,:HHB: KVQ"<7MM@@G1%55Q4!9.>!R8M
M/118,.G!,>DBU <&'&&",C#BL$?,"8N,<A72PGFIH_1$^[6-U+F%E.R$ DG/
M Y*6'NDKD/3@D'01R2,N4N)50$'$5!J5 "0Y42%NJ F,&>,-6]L@K"M+(*]
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M>A&> E&/#U$757DX!LV)XH@<(PPQKE*A, +FGJV\X(09+FFNRJ.+H5<@ZGE
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M=O\KI8_%_C]!);CM2>*6;KZPM%M[WPN=;3-J;C9MQI1$5^HH?V6,GRP0]RH
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MN_#9[L$A?P=P^.Z?X\J=_MTW;_5D__3OWO[6WQ_>'>S@O5=O^-Z7U_7NZ3;
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M9I+-V:N<@W4D )5((LA@$\"D55A*4Z%2A4IKL+5;H!)CP@FJK.0I<!>C$28
M*XO<O"HQ67EI3XH^1V/T 8O(8"\P4DD#^FB=D%,N(<)X,B$W9DITW;RTQ\[0
M>XKFE? -6&IL]VNG]KR5YS#54,WZ_PX:9:#M;CFMU2'+2SQDH9*1(%P"*]'Q
M&))F)@092$K>"LO#35C<"#]^O/Y]T(,U]'IO.RW7:!<AYS&3^O,Q+%<FXFI
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MWPY.X(G;[YI?3[;P[LGO\.ROQ_-'CKOP_?\TZ_1=H_['?QH'%_",+Q\;=7J
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ME18ID5N_TIQHB#E% ?[).2>Y+5L.8&I*Z&]K),<WV'6C##A8;+Q>]%_&-U]
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M_(06O)#6H 4/+^Z5@W&V/P ;\;QVUN@?9[0O8B/V1Q[T,!@7*8\0M= 6O3[
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M^6+:A_5:67@7$5$F+.+4..0"#H@$)44*/H2(\T&MVE35<4@%1,\"B%;EPU9
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MF'1@C'&=2)U*5M9-8XCH4)!8AC*FFC =J01;8%+^: 7(\^G2\NG<S1<O:9^
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M;=D7A2?R2K$@7QOYS^!]EMK@H-[J )#KH6LG7>!0T>%OUKZ&BP=>!/?]K/?
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M:$$5J<NJ6-Y:95X$'NAOSX,3Z"3<Q;UQ:%@G:F$7LE<;OJ[QT;*DA&P2PE7
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MG,,=.2$4YJ+ ).7)E%41'(I8+SV@CLZR8/N$#:[!&-3VV8H1NT]T^P.X*_J
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M.Q!E&@BF9='KS^,%3<VSV?S%+$Q7G5$NJG'7K9" L:*SE#I"EEK4Q%@+U2H
MH5PLQ?&D=;=JV ^!&U+DZ7!JJJG(&NJO@O-Y'?)E/>FSQ(/'].*8W.5HB[-%
M!["&/!HE$X.@L@)M:S>F[#+MAIUTU_W(AM3QZ&!ZJZ&PVA4XH[T0?R$^YYH(
M@]/%F?Y$P\D:8Z[V4)6K=N3@ ZMEM;R4UF<I<I\D]/5X-J&+^6/1I8%@VB:
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M+XI[G74=_*YVKK[M['=[J-B]G[FWFFT[ZD:J=O6TL\></W.D4_$A"V*FLO4
MRD0BJG+ 94B9:>>MZG/?^S:65HTY5C=<+\9G8A*"<0N$PH RBM9 +@ELU-S:
M(,GH['-2OP[-D%3HGERXJ]'&SI/?L.@*?@KC?)XP?@$E"I6\$ I$3)DT-UIP
MTAI I9-BB?;D3KDL:^$,R0-L3(3]I[]E1=Z+IB]7RN.3G68Q^UPS:'EM&J3
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MN8 F8R;%VC!<,O!1B&B$EJ%;!*#;>O=0.%I1NT$H^$G^A+/%>'YA+J9ST9H
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MC-.BCI5'YG6A;Y,TVJ.(X7*GQPUWVLWKW&F/<A\1^NXN')#VQQCO6+7*</1
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MTG_T>@XD!+=Y/?LP8V\>KRZ@'IS7LQ>G.KF^MB'S_G(_K50V@62(23(MD;.
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M<=OII;]AR7LE'6T(?54<]'#BL)KW1\\9_=JW@M8USF(D=]D@4U[1<U8"W7;
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MEYLT]G[,>OKDSC*K)ZF&CO6])(UPLMI.C2G!;!PCPF0=2C*&K@Z3&>=9T]-
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M(+Z?P>DZ4TWS'$4*F5EC0^T=EJJ[VC,I(5GADM(^=LP_W+C(_O2[ 7DP;4#
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MJN98KBXV+.TJX"4=V2?1,QD$640VD BE0^:TR]QC+ 7;-$=Y -#A0P$M2/#
MGM='&0VBRIM@U6^G>!W^[@"PZ>7$DQ /<S4QB$([D*2_-@Y"&PNN#K^H,Z=K
MJV)##EC@W# 3H\XB! ZZU1B @]#EB8N(P[!E&R4,'7]X\]\__P-7-3PJ&U-;
MBS.+M66C74 RAB57LM6Y)*O54R[HO4\]"HNXC\0G0XCKX.&%F]Z)J[_7+,[P
M\*/:!APZ+G$M\F 4MS9+3-IH339IU+YP+0V@RXY'^T3DX>&']KD0O#(M9Q^N
M/_3&H-9"I5KKSURPM5"G7H;%! R)LT%I52QVBPH^\I"^!\_J S]-SL_?3J9_
MPC2?Y6R+AE18++[6 1E!;E[2#&DY)7@EK6H3-MD 9G][TJ#J7#]:^HJY@3>]
M@E3K05,PX%F2+C(=.!V9-F<F>)UM@T65U,:R6"'8_[G36QT/J'<K638P(U<X
MEH=H?GTY'8V_?L3I:$(+-!P31&#*U05J(UE$2?S%4$)(!5.C*6./H3H=W?>6
M>8.<[Q6VCY?3] UFN"P#JWU&\G]>SN:+O>ZL6*5R(1^_V%AH]9J3C86!!<3H
MK% B0)LP62=XI\.0X;30( M\!9(6C*.OXU>U@&&<?GZ9PGAVO@@$_X-D]ZXV
M-09;R !3CN7:NT@;6T&2HV6#1QZRMAID4[X\C?%T2#.P/@9LZ'#O\ .EK=1!
MT--E8CJ90 LWF14CDI>!?E?:VHW]4OONF7[+EI7%.*S3@3P'Q[0LCD4+D5D
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MS^;3RT5F$$XOSM"4I+ASC(=8$\)$9!"C8<J&:*MIQM<KQP=:Z'TL^]];AN/
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M!M2L2Z'/5O/"D2E9#6;'ZQU2R$P:*9+-6D9LTYCJ>+H4#L&!SOT)MY%W@Z+
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M,DF"EC@3.6FF)7$0I%6,UVH!J\ &?7KUK;OJ>5!IWE=U&#JW\M7DXF(T7\P
M?34AW..O.$ZC1:G8/RYA"N,YXNP]3*<P'_W 'GF6NSVH;\[E ,M;S[_42@5
M[UQ16CB(' 1'>DNSS5! GNWVR#XO\-4,UT_X7Y>C*>8_OD_&7W!Z,1K7$=#C
M#^4-J6?R\VZZC5<"I?.>)4E?-*?3!#19#!Z"HZ-&@ES/GW_HG=[^X;V[\R^G
MGG^(YZ.OB\><"<R>"^$8"EZN(@8>8F808@$HIK3*.;V/9<\UGJV5?Z^#?S_A
M-[@P?3>9W7K1?KZ&"_B*L\^3RZ_?YO\!YY=X)DHR127!3*Z)HZ)&(FKW"$&[
M;?1.D'O39ISXD]!.G"S#JJ9)@LT=@"]2FE["^8OY*]J>?](/KT :#&!Y5$RE
MVA0L@F-1R\(D%&5Y'9>H6Z7@=8#W:W%H !4-'3+^5(_P,>97YS"Z>#>"N*C0
M_(C3W^C<K\;@F<W9.Y,-TUES0A?JW$T362BQB*13<& ZG;9//NI$R=! S@,&
MFE=4_0>.<0KGY%!<DIF7\,U?WW$\P[/HO.*6%JMTK9U/-C!?K&#1\2*1G ';
MJ%#D 4 G2I(AU="@&?MG/"_7F#[A#*<_Z/Q3PB?0EI0GR<\L8%E,EFPG%#H;
MK;EIU'%[$YH3YT5O!;2H>,?Y'*>S57G_A\OY;$Z.(IUKRZ(GRX.3MM1$!1W)
M0"+;R'-:<-2":Y5CYNN->H>R/9Y =N)D&50Q P;9K\E\^?W[5?D)G/\QQNO5
MOZ3-KXSFL\_X Q=$7_W@#$66RA*_I56!:8,D#5OGMHD:U"H^"VSC(V\-]<2I
MU59U#5JS?/X&4WQ)3G]^-;FH9RE<:6-:I^4LD/^\^2M+:;[X$Z;YXSF,?Y_D
M41FEQ3]YC;,T'7U?_.MQKD*>G15.FVZ(A9E8Q^SPVAA=ALA2ED4X<(;,MC:T
M;+BJ4V?PL1!BP+N0WFLCSQ3/Z<6=W_V7KR:S^1E&27Y(=,P)"TP[ RR2\!DZ
MARY$B#$U,O,:K.9O<K<EP(.W/CT\T]7%PTW8=O;J<CHEZ'?C*%XG[;.KL=RL
M:VH/&31*698XH>7::V/;A+JZ(CQQ\C51U(; :;\,YNY2N:K4B;R8"$J0Z<)E
M;1Z(S%MG&)?22:XS3Z);_&O+![<N:M]_#*REY ]=!G]W!*J G+S,1/!8ZLU
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M9"=#C4%5T,#'J#,$OBQG"*P:BPLO4Y*T=25;:E<T,HDR>=4I\X+283:Y39K
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M@VXU/+<?[OT[+P,H?]W:V9_F!HP]+HJN%Y[<S?F\NE&M*4"?,5U.%UE@+W[
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M24E)2D9EE[+B+GE%)<5OBPB)8'-$Q23$Q"04I26E%?_/AKX#<MN!%I@0$=(
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M]^WN=^XY]_UN&&,.QO[VG'/--=>:WUI[484;Q<T"2FT-E : 0"'@R^D/P)T
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MGM\3NO<\<^'E=>'+39W>C:PIOS];^4?%&,(T^9?]NU0;3\""0<T"6<17++D
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M6K2WCI>1Z% DX)+$@=3X]BER0YBJUJ#M(.?.D,BZ#HK;>T?>NW>E7FSQ1!4
M<-[I7XPW5.89JNU3NJ6J.":/DI$AMT3CKIVOO?6P*9T,1_1_^T8>J;#_U9,N
M]3BZW9<B1*:<)[O^_MR;K6S*?C\$EM*5@>49K9->XT=^NR4K\BO)<69E_11S
MZNP"''.&D(\(M/N_O"5VX:U'H*^UI)Q/9(DE4D/HRO>(;^00OMZ,%#L87P^+
M%=H)EC9@7;US3O+3&;V*+"A*.->BL.>-E3B-B^>0-MJB)M'LI/^IW61[A\\;
MM.SWDDWUCWLZ.OYNK&VYT$KQ/D2:Z,2KO KXH6D@X1EQI!;E9,< ]N9T24\!
MQ'IST[;>C517MO)D.)I*.H,WD_.V5(-+<&7J[MN1V)"C/AFUB];;L5C6ZQ%/
M4^6S5'6=V0)<2ZBL RWS$H1*-274!FL=D[K].74J9 QHJZ!HR$@_7%B0OS&V
M5S[TX;$%^R":IC?X8!D',H./+ &;#P[T21\MG*Y;/H'=G)/ MROL.' &29")
M [OO<4 &![[7 845',CV.&C'@=9^R(K2T6YPK]*)")I"%@=6,DZ\<&#[)@CL
MPP&%F=UX''B A?VT\-/";VP!)FCRD4;S_OM4?L:I4'6FY'-"L?OZ2.^@T05"
M;(6U,I:8Z7S8=OT-Z>W*M(J0FM ,&^6N9OKKG&<4;]53;W0V@M7_.4W];2PH
M7\"FYDK &#9JGS#^<+@<3 SL/@X*77,5;:AMTJ_%]]FJ6=C!$E.^?W%Q;5"#
M,X8EQ3*FY19UWP_T,[34G=^@912:PL-F%^J#]XPE__(%7FF\0;6+LS?=7H)1
M%J,E@YQ<N;A<N5SA"V,#0@8NM+A0@["SFY.;PXP7XAV-8G.W=(Y0P@8_[R-[
MYUR^3VP\*!!5;CN.0D!UOZM7;O'/B]4'8A#%W)?D=9?50Y@?I"9,\L>0GAW3
M&!8J1/<0PG.^Q*XN3ZS?-=LYFE'RSSB7M>(^M1*4&SRN,+F]'%B_=Y11=:<2
M<EMWR.UK38Q4@9&.1)E#(.M4K]DB1L,9X3/D4\$":AL!N/;?5"ES7]P0=9;:
M\/6>L-6];!8E8VC$4E%!69"+T8*B12NS+K@<1+Q\(3(6R46HRS4MT:M(^K(I
MY3!3X"B:#U;X=Y7;E0OQV=VE4^8-#6!K1AP32$)B? -YYP<)@O=R%J^7R/)^
M\NO'CXK6B932FK:(P5]@Y"9X,X317/G>CZ<EJ>-$/E\_4R^-Z,?/AV@0 #UH
M_^_-K_Y=4%I,MMK33%Y^)_/$H'?=DTX3D81D>1I;F<V5=5Z^E=^-ZNP@/@.W
M0N!._,%:\R\'M0WOLP=E]A/8#_[->$DX#F^X]0[.33S[<- ;1#X9\CT123,Q
MR9P?$UG,*-OH*;%^F6CVVV<DX]NQ-&FE[6_R5C@ #^8ZEFGB7KL$7,PG>(IL
M&-JH?$*^R2H5@\N A?P/L5WXYW5"*+1'I2 &$P#(\[(;]0BHH^]<%^\98[(@
M9^)1""I05]!N/@EXL4RG%'#R%0>Z%8!?U^/3?K^)Q?O/M>+7%]GZ)&!]$;,4
M+?UP4<M6WR02 I(/+[F_*%+,7@(."N-AZ\9\@WCPV!Y_:D7D*>H\<+JJC. S
M]A>O8,%XRNV=LMX?Q,#4%5N- \;12L3@U7\M"VP_[^^N^M%8CK<Y/N+!T\-W
M+Z(M,SP8LX5W=-4X& D0(B@A45B+:Y.F/2/5J;>2&!FQ-=<E;-(MNE;%B>RY
M.ZEM^%+5+YAJQ:?$?H5D24>^<L+,(TR?IP[N,?MEDYA'Y>XLQEXS/I2\HO!,
M2QJL54@C8)69>G@5\ZCI\2DW^^K:NH8&J9#W#5\0/'33UZ7&43'OM ;/LIGK
MT$B(LZ?(<C ST;_P"N09SOJD6SEZD=LQRHP[$1%K'S7,N&@GSR+X./%+EY8K
M:P&D_Y39^5"S%GTB7",!P5F ]P]V).,G_B<>>)E\]/I>8&M+&UUW4_A!E#1D
M+Y7@H=[*0T,<*';'L$_%)UR8)6_C+\8JLW@P%<0 1D]PY 35?=6, XHT)S^N
M;V-A&YZGC$$-!]ZD'3F!0PNEW0&EK:<XP 0N?*0X^JI[N!K<AJ;XS1\0=_?]
MSNE#B^Q9B",.[[MFFO,!GQ:BF'+875M"*O:2V5!&2-';Y]X$@_YI]?,O+7^D
M*C1(A)*%Y,'/E?]2/J%HR2>8$4B55*QFQ6FXX&__8/WT?PL/&[1+"K-WO449
MG )0?YYR#3X8S.OXT;MS9;K9.2AS88H8<CGMNCH@L:6?&L4$UAI%P5+15S+E
MN=H&S)RPKZ4V']TTGW+T3)>%FVE/WW)'?=X5"6WE V*!@@TKDJMWH_)74PM=
MW'Q<V%/GTMPRGUI0\6:L>+P)1#CZF]UI396>OA^8:)F*YL"!,%0JQV=/O"]O
MY.[G+)YL]=KOI"N$<'@@&N]@L^^>T/44-2["'#4&R3-6+DF&WB[LO#.61[3T
M@M-89H"R(9Q:9L 0/W$TJ\=\N1&,_^85%A8_7/)T9-F-JRF::SO0\SDSY#/<
M56FI$+9;^@L'@:U85\*>E9<_T T7WOB \,HWTA,%,%K(C?^@J<##BOI!T&Q7
M<)BW!GY@F]_VD)_$Q"-0&)"6=*&#T>8!RQOQ@Z^,LQ3-%^;1K+;/>!+%[?-2
M(AA',;IWGS\"@XU_ ([VUP2D^_.MY"'4<<HS%DLM2*J>N/ 3CP7%AH^,.PF'
M'<TWT(U,X\9IY/'N5?VD M]X4QT4*L1.?SL1&!0BVPFF_1>A@CL0$MD %DP
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M5H:$.;1KU$ <LAC!08I65YQZ7WG7=7D<[WA:IZ-)>>JPJ3:4(CW@,G[;04;
M <"3]<6?3F"4/O^N5I5^_JF=:]N)36/7FZNQ!3KHQE1?&T,T?M2F^U4C^AYB
M^HGE'A4MK5&D$<4.I3A=,FG6A"K&"4+V[+&0EJWY;6=I^XYN%L@KOU05&/S
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MT4])*BPWW[5B4(O9<V$^O&+-]+_:^ZZ@IKMVWW^H4J43BDH)2!="%]10#(F
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M?Y W<_+,U_GVM.5+UZ@$QE>D0-W7<'Z5DTP4S;2<CI>0%I<M65^?L,(*.8!
M!H>WL3T_/'Y>)^-6G;ON>.ZT(^/U'$+4$]J/_F'J)3QFF!]D,?(B6"4=QE;7
M%5=U<P%EKO4X3.:"YLX4@H(RW%7 @WAWU* NML-R#WTW6=HNVL2<'\D_X4==
M06.\:5:F#?W-\4_$I89K+T6%:2JAN_%).</,YTE+@%[8Y]&IEW</PWKZ]<]2
M6IH:S@GP'*83KO2Y^:BN^A:6:C0-RO&O*Y, T-%?\+*J._CO,3<ZO$9WWYN;
M$9;'27(HO&:BTPV@>Y%9G/JQU?W>O+F"U*EK23M8V;PO5FTFV*,O-;60,JW
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MDORKV<@_/7MJSLM.1UR2(Q/7?N,G4@C+ZZ&&6W,H+=43P*B+$QZX9GJ$>#^
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M9LCU:S7 LM4#E%(1L)*: *)4 ;S5!?P/?/_P;R 7*LG50>IT!N[Q]^Q^=6_
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M>]=:V<D,EE)H((2X!Q 4G9[-GPVM=.-ITB/[,<$?F<G7H@,EW@O.H[7\S3>
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M^JQ30CIQ5SU%02T6RX=.>%GI (-2*2J/;[8_K/'O+)<WD(4/VOS*04$.EAX
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M_=#Q#,R^^AX8H;T?TL]0_7>Z*DU%XZ]T+>VQ&TVI$"PB4'%)S:&G_FA@<\Q
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M3&.5Y2S-G<H\>8PYM>_#3F1 *] (#792^Y:SO RZ&Z\'AG)@@KZ$X@#=##P
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M&V#EM0>@6XEO0"TS^-B%I[_MY8Y06./+8=QQK2]W(([,+X];>_K73Z? [[F
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MF$=Q#$4D<XAP7$"*<P[C3*]Q%@N>B<AG*;L./,U5/C?B@H=&3,\V6JZ0NQ'
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M;.L7/CM/W88Q-P-3"X^/M3KXF^6RC9C2^S+P=V.K*SCKLMZ>LWZJ*UEJ/6_
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MHGGX&ERQ=7 @#8#8T-$M5F+-6C\EJ(4&1NH;>\1?"W[3%(;K<0;M"JV',V8
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M'CA#%+K/P>6!Q^YKX S%B3X&[O?VHR;]H,^J23N5U0SGHD@+%,.")"E$>9I
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M.6PA*8NPR#@L$J(@PJ9J24(+&*<Y1RJAIGJ)SV(]>/K4%FM;"Z!I;>I9'>T
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M+E?FC+HIQ*[MGHPAS&%.TA0B%"<0TR2#$G%%XB@WU:Z=(]C.##(U\JC%!&]
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M6$$BB@@F>20CJ;#,$Z^*$CZ#3XUE&ME!*SS8*U1EY=]O[]RO<;?/U+CQT5"
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M-0%JN0)\)46Y!J;=2$?-@VMFPO&\.3B^0Y\KM]#NI+L!MP?8OJFQ_1B4D?R
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M_'=['D;<\7L]#PK[R4[/PX[8,_FP(%2?.RN3LVT$*FD0$1X@F#%=T2$D%-(
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M34.KN>""<"%3F$C%+2@@#&(>"QA%@8P9QT$6.G5F<1A[:G2C5])=+5VU,:H
MZ\K;+Q_69A+LF&<@: ?FH9,]ACODI&%^8P5S[YQ9!\ &R9^U&?]5<FD=@#F7
M5^ORB)[>YB9P^8M8Z!BJCP6AQ<*4H6W+UD0<8X1P!$,:(XCR3!\"T@!&"<O2
M(.5Y&'$G?_.U$:?&7'>,E;IJ9)O H@,8=JF$VOU0UJJ8..&E<R3#]2FP]$G[
M!'9HKW0C*VRAZT@[0-T@:VC\NJ.OCCJN0]H6A".7M/6-?>L&Z=W>MC#:1SV=
M^ICM>U'IWG9)G.$08J9[VX6*>$B8!S#  8]1RE.2.P4>7!AK:KQS5&RR%1;\
MH<5UKBET'F0[?O$$W<#,TANU'O6&KN+AN?#0^?%&KD!T5?'C4D37;^EYHG6^
M^;I:N#=/&\-9=T^K<EW\JTZRH,IRD31)8!9$ 40)%Y F-(6Y#/*893CGS(E3
MW$68&M5TQ 1=.1V/JMRGPO*\:E" ASZT,L)#(SW8B;_=K3EC[WZ.U1L^OX=9
M[F*,>Z+5&Z:C8ZW^3W)O1/E%%UIHDLGB.!&29Q1F7&"((I0KNRG$,.&*TY!
M 4-6#NV#YTZ-KO0Z4E3K@I$%Z)P<]N@]V07O,A?= ,G !-,;#:=VDR=TO[G!
M9/>9H[64/*%(MXGDJ5_WR-E^4VI'C=D>L6VS<!T=V%8M"9NWCI \I$P$,(MR
M]<E*F4*"!(4I(CS'(DQB;.4B=AIU:A^TD1NP1G!0_4F>75*HK<&^_(D/!N'
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M(H-!+)(T0XJ%0J>V$Y;C3HUR&K&!GMU=HSE31KH5'?S1"N\8%V,[%7;^@@$
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MYIRD80R#E!*=91Q#JAM9AX(%@H4RXH&56_=UU9B:J?!^:PYH;Q;1^E7@Q2@
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MY2Q*,Z>0F$&DG!HW&UE-&QAM5Y5&VIGN!-/(VR/WW_O$6A+S:T_7T+1]>PV
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MM+]IMJ.[<:=N(O%36Z>KFK!:_%FWXJ#'Y!#?Z/K-&/$FW;AI)+Y!/<HM\3Y
MC[('7W0,DE" *();E?H]^_&V((_+5;4NV-V2ZP8T-0TU8K91TI@+CD@F=)B$
MA(@$J:+W,(4QYBP("!>97:3J35),S<[<Z@$66T4 WVIBDEO95A?%Z;4R#B4#
M>L_799X>;18&YN3=!.QT #LE3,_$G1J@U:-/\8;>,^%0W&&,&1FI^,-@,^-6
M'^)61"_6C^C]\/'J2]RJ_U[]B9L?=KO;?RD^K,53-9=10O,D,2X-II:C*(8X
M(!2&<<2CG-)0X,3%N7%BC*DM-AVOZQ]:2&"D=/1DG,+2W=/= Z'Q7-)6X-SD
M*SY0?S"G;CO.JWE?#Q2]Y"8]O+3G:3S[)OAFH0S>NA5,'2%\9]J'&G='I[PK
MPSQ(&8)1FBJ#-,@Y))FB@4PF>9S&,4NEDWO3?NBI$4,KN8DE,PG K$D^Z--W
MU6$*+$_]!P%VZ,U^!].F8U:#:2UXXP\=IE&T.V)^0PKLAQ\WWL 9EJ-@!/<G
M>"A);8Z-VCJ&NFO[;V+];<7G/ A%F,1J2YVDD6(PH6R8A$K(0YIAF1(D"'*)
M,; 9=&K1 0]Z#+5'KG9N3D>^LH+:CJE\ S@P1QT6DVW.WG>U9+74H!9[H*+6
M5T :KL3UN8%?K^#U%2@NEK^^=F_/LQU2ZNX@NE&(<3;N%FX<XS!*)8)I'@J(
M& LA17$,>9RE7* T)+E3"M39D:9F*K6"ZLCI.MS:\1SE+*26YR(^@!J85HXQ
M&J@\_E4P_!Y+G!UMW&.&:TH?'1M<O:%GW:DV?>E=4U?ICE8F5W..LS!FB=I/
M11G2S2SC')(XB&":1A$G"<U8[K2S.CO2Y-BAD>]_.I:8.HND'2EXP6=@4M@E
M-K9"@C]:,3U2PE4H_):3.CO:N)6DKBE]5$3JZ@T>=BVM.=+D7&BKI*6@>1S%
M@4Q3H@P&R75U*0))B@*(LIB*4'"6D[QW:YT+ T^-,-IT*[-_V2;K 0C,UNGF
M-#[K^>BQO?&$\JA;G,[6ID7>;'&N&W.W[7(LL!INIW-I\-?;[5A <G''8W._
M>Q&\WXIE\;1Y:@Y>41AC(0,*0ZJ;<K.8*Y9* QC*D$24Q%G$K1*9CYX\-1IJ
MA+.O@+>/TV7VN$G[@>FAD<MS^;N3VMY<_6[_J:,5OSNI3+?VW>D+^AD0'Y:L
MK(-4Z_]_6.[W 'Q#GHNUB96?)S'GA*M/,A$HABAE%.*$<<AD%A$4RAPSY!8N
M:C^XU1L\:CQH?<10']>8J*%.MI2;S> P!796@V=8QR&&5FCP4ROVSSI?_JC!
MZ [PO5JYGRZ457<V)=P!]&I,. P_JCGA#LNA0='C"?UH[==R556?RY4LUO,@
M8YC%L82)U$9%'$60$N-$Q6D2\HA2=:/#H4WGV5,[FS&B@6<CFQL)=0&S8YF>
M, Q,(S4"GR\CX$P()W3U^L5WGS_J)WU"L<-O]M0EP]=]>_AS-1=$,A[G#.88
MZ<]5,HA)EL$XBY,X9B3,4J>R1H[C3VW/H-Z=>+BJ;QIPNP]_0!@')H=>-=^4
M"J]3\JV#W:M5?-,R3+;@6P>@6^J]=1]S2X^D>_GN._NFDXMT!Y+[I6Z:KO_3
M;9A>R$*/^$54Z[)@:G>B?W&WY/L_Z%PYC\,D#[,(P3Q@2%DM&8(TX4S]+2<D
M%1E65HU["R6O,DZ-('6= F'4U)$IM9JFZ)9H= ;J;=!-UI> *4WZM&'R.\>6
M)]"O.W-#GUUO)ZS5KV[AI"9)"STS?X*.[#.P4ZO^I=X,'OZL<X/O%D^#S,0
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ML7=UA-'#"TB",[^<EZK.<[++&9E9,W.B?RAP=7)&EMRB["S/TQ\ )"7*DBB
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M=1MVQ42?JWJ[D&E6%%E*85YRI L_8T@SH9!/H@P1DH@T<?*"^!)L;@QC40C
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MI6Y*)S@L<1%!%M-<D#+""7?R6OL7<6X4I#4$ORQ-56>3^-0H9]*AC+Z U("
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MYYZK\ W4J6><3&_4F><J ,]WXKGNL2.K*8N5VD8N/ZWJIXT.V&MK8"P89JG
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MHHPYBM,4)FF>043*%)8Q83#F'&4925%2N*7ZVXT[M\_<B U8*S>H?Y)'1[^
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M$F*$*,Z*LJ <N>0TC$9L@LP$/XC94>98' )3Y$XL984-&+W.?'A*7:_\=S#
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MI*LH*B115B*(TPS#DA9))*B,<AFYE=R]%L9I"N;VT@%:,($DS)0  +3987E
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M\*I-LZS!+[S3QZ3!/O64-KU:'CM5 %'_I^O:*J7U >SA'[?DO\4*\"=31XJ
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M:JJM93>$<;,P3!3!L0W,(IWHH)6];7[72:^[M^^0-PH HT%(P!W"ED("/U%
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M.(4\"W*<A)GZ.+3>/CT^QMSF' =WN0\YBRW/R_$8F9'K6A-:0M"(."2S\@1
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M3AQ-56E%=\PG<C6,'<N,"/?(].,%:?<PN6%X^0V+<Y1AVC"X80 =A+T-O,W
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M</OITL8NQ^!5 IF'VPUT]=MH0Q-$35:L(,M;4T?=U'3YNEX6[&5!44B36.I
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M;6SLO6EW6T>2)OR]?X7'\W6RG/M2I[OGT)3DTFG9U(AR>>;]@A.Y4>@" 34
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MC1I"Z>2@31G8%1AZ=9;A/E22"6<]#_RYCBK[7['?I:<92.VE[2=NV/<0?1L
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M+B6-1%"#CF).AH#)CJ00=6**JE3I#<?C]#1CM'H&4P_2;R(#_JQ'>)LQ$6@
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M.+Z='L/G,7H&MQ@;!1ED4B$0):&\3M2*> :1I,RB@AQ5,+(*[+Y-V] US<T
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M+?PAA0DL%N,\#G E+92)R\;R*#4)Y96P-.4!E_>".,^IMA9-7(S?\GH/1^[
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M(ITH4VYS82(2:BQG*E./L56=Z_/'R!G65O6H[OO7YGO+O@$ ?2C9[&F*5S4
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M0RJE@61(C^&\R9D'(3#<]AS#;10SL519$A4+*BF@AG<:,OG/Q/3A/;.!X=#
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MF[<1Z4N)2+O%4Y$I#,(YD"0Y)9(;2YS4E$3M9+3!R' ?3*VX7W^L_/8N!^/
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M8D4H3YZ@.7(%<[>J^?@->$V2J/LIJ&?(_;Z8+Y<31!5%M@@!K:K;?65]RZ,
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MSEYK![ A]=$7O*XXB PM2\5!E#:1QR@$.&X]%&&*P8 \2=$:4;N J-F(M:.
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M1UI6IV606R6TX-$D<KIRFYMRIY5'GP<^1ZI[W[KH0V3?15WT =?M?=(V!VY
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M/ C%98H@:H<TA8&!3YJ!524%;5 *VZ;1;4-_>#LA<L>IQ%-+]T8<(HN854[
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MG4J4# AA62!''KWSOW)J!Z*EWWNZQX!R# 4=CD>_P>,L?ZF#&#Z?U<2^F]?
MX8H^1MQN@\M/7TE9KW"94ZV&I9^L/_EZOEQ--)<&H[(0'<E U2Y, 6F[D<HS
M@5QYTZCZ?7A>^KT2W-K\-M3YRP)_O;Q*!$Y7RX^D?:+ZZR0EYX7+%@S+""IR
M25Y4E!"U%9A4%L*WR:$>1V^_=XQ;@_A$W9T*U//X#9_^/5W]3UY<XJPVEOA8
MKZM\V_S==ES/1#I)+I&WY"DY\I1<9("AWI(I1;@D1?16#.8Z_)*<<3N8CN8]
M#*NF%Q*<O5]]S8N+]%]7R]6Z8>R$%<.B51*"6>>B90;ZGP:3C1+%9*OS>*;S
M(;7CCL,=TW">I+=NL?G4,=Y$%RMT4!FX\/66GA7@1$#(1BADGD77J)OX_C2.
M.W[WO#@\64>]GV"]PT5EZT<>YG#JT>,&/7=ZGMAS7&0T3%B)$7+T"52PM0D6
MK27RU+CBS(6@V_1</_N1TI/ =QA]-M(!<XF#(K!OCH,%*NYU2B&%<X;21QNG
M<2XJ'H"=$XS3(3KJ8&N\L[H_X#2]RZL)(Q8266HHZ^XB62!X4[W/+ K&XA//
MC1?9#2W]GMF<@J839=X3:OX^OYPF_'GQY<MB'>3^-K^\Q,5V('$T0KIZ3Q(3
M\[5F*=04: :1.;%;DO&N<1NFY\CK]RQE$&P-IID.X+8UK[,OM3/':W)"?E*X
M_&]<I.4D>&&5\ ZBK',T65: $070-R%ELKP^MKDNN)NF?L]#3@'60#KH $W_
MF"THNOTRF_[/NO?JMBYN^?DKKOXYO[I,?WS[3L*ZV?*O"SQ*L.BS-1#14=2A
M-0>G90%;%/H2HVEUI^ X>OL]JS@%A6?07;\(O1'JASS#R]HC^&*6KOL+;0]E
M)J90J(VU[Y8OZS9#MAZ]\'H,*8PWNL32INKN!*+[/9)H@-7!M?A" 7L1X^(J
MIPEZ)J)( K37" JE@F!<!*.\"39K;5V;YD0G$-WOH<6Y 7N,%E].Z][7=UI[
M49CVJ&,[WNO8WK+#V?YO/T.7LR-%<88$82Q:Z(@6"D73]?8-0E"Y@$X\*9?)
MA+J6G4.;) BWPP%N5CBYU#I% <;60N-"?(80',@HE>$L%HRI"8OWZ>@WT7<(
M!AZ:P!-D?;15^Y$783[P?;^;95E%M/W9UK>HM0^+'VLCOC;>>+G<&O$[ZW=2
MQP.'(!+H4D_X+//@15%0)">NA?.IT1BQH3@8%Y^GX&C'I<"SJK0#G_)(OJ^G
M6?P^7_PVOPJK<G5)OZM9K^5$&H]1<P<,"Z,PT&GP+G-0KJ 5R3MLU/AQ>%[&
MS8R/#^^AU-PCT.]? YXX51"E)!]>VW7R(@!RED'S[)S@191&4RY_0=BX"?26
M$#Q! 3WBZ8_9#Q+H?/%S$D)DDOX/;#(4I>6@ )5'X,Y;SJ6(M&[. Z4;FL;-
MEK=$T7%B[Q% 'Q;S[WFQ^OGA$F<KLL)O_OMJ^KU6@DW(FC(7M2960O4I:&D$
M7L>5,C+ F0F'JLW0SOUI'#<1WA)@PZAE[,M03ZR;ZZLTFW^_PN5T>7W7*^:)
M+"I*QPUYKZI66"@'6#0M*6>5DSXKYAZTC]A1OWSHF\=-4P^ I/;R[M%Z/78H
M[]Y7H75SG>A\YD*+JLTV<IT=G[6IQ=@"?+&10BER)S.JD.R9[-P W(R;O3YO
M[-!6U2\#[NOR[4G4S@L6Z\FGIV4L+7FQ"<F?%3Z8P(3V\4QAQ X*QZVO/R\L
M#U=)CU![IB9$ALRYD@Y$LA2#JYILXB&",XD79DK.^4SYPQ,+=9H5TK<$W$"*
MZ1%S-Y?X[K/%3;(B"01;>[ H:\G9K3=.'5GR.L!6:]_F%'E/ O=+1[.7"+8!
M--(CT-8FNGH'B_R53/;TQWHNV$1QG[R5",EQ2>Z!8>#K<M)>1Q&*-NI<!R-/
M$[@?T%[DP<< &ND1:'];5"ZDX%D1J1!\)KL<F0 ,WD,*129?BBJIS;'NT_3L
M!Z,7><!PN+P[Z*7YB(O'\]LG==J&#(:#SE;4;I'D6 KK@ 6L!=^*\W-Y^(^)
MVP]/+_*TX$1-C-I68"=3]5(*CY9I1NHNJLY\9SZ0EU@TY)""J0=LA9_IN'3?
MJT#\11X4'"KK#LS1G;J"&YDD@]X89R#5DAME:[/V4!0$&91+LB9.VNQ@3Q#3
M[\6Q4ZJ33I5Z7][/O7+!>]F1ZW]^F%].X\^+^-]7T^7T)D%7&UTK7/M[C-:>
M2@)\$F1F \N!V<"4;;[-'4G[N$5))\-GMR$[ARY[VRCO\+S[)(X[QS.FVH>P
M]FU76,]-T(.3-GF/5OG2_.!@'T+'-9CG0>8P6NH8AG^;S]._IY>7F_K\>X=Z
M#_\]89QC*2$"<W5T7STB1E$'"I##@2FY@JEY*<AQI(];=W0>J+;29,?@W1R)
M"*NDKJ)$8V@;4"9!,"1*D9CDC-M0V#DW]_T/III%'N<!W.'2[QA*]2(37M9K
M3)LQDO'GYP7.EB0YTMG?<#I;3KQ-.5J'4-"0&\Y4 1=U!H[*R\B34++M5,5#
M*1ZWC.D\(!Q8;UTA]"8FO%N2KSE&%V0&Y1@C$08RW4%(R$8EF:WVNIQI_-*A
M-R>:E3FU0MK)\C^Y3VV[7/ =EFHN*?%8A+0.C%.IEIMR\#PED(SD)#%Z5&WF
M*_V"L'X[KIR2E!E2&[UWJ[N]#OHXZ5UO8CPNI!_V1NQA;VUT$_8$UL_1(B]P
MQB@<@%04F;14$\FQD!]G<]!!2L5%&P>ZP0W8I^M5'\O_X_SR\O=-W<$$C8B.
M,^)?L%R'CDMR9H, 3-;''(W"AVU:]JT.?O:]_5Z'/000SQ<*#R?XOA+1.X_Q
MG/<H5,@@?#7=-B(@LP9TY%Z@M8F%YD'":0>J0P.N.3"..&P]1$M' ^][7DSG
M=6CQ8M7@RL-CKEY_Q<67O/P\KVGR>O/QNC,,(P>51R9!F.) >4Z"S(9<8XO>
M6E0B2S.4?=M%Q#C)XG-A[ZPJZN[VS6,^_[F8KO+[4E[C\NL'_+GM )Y0,&\<
M!&,+\4A!DTO!069)QQ@X.<[[S1\ZDH!Q8HG>('BR:L8?OK(OJ]MQ2_<20Y?K
MCTQ,TB(GD< 710P+62!@T.!X%MD'ICT.AL7=9(R3)>X-D0.IZ84XB#9X7HH-
MH$*L1R\D1(<Z0\C6$Z>,EW2F:V%'.HB#)XQ[=! /T=*)#N*;63IG%H9<D!FY
M(-/9CM9M@W<DV_-]K7J0'</N&7(N,LNLC'.0Z#M0BE,$DD($@2RGQ$H0[,6-
M)7@P :;L$/F;O^+E59K.OFPZ2R\_Y 7I8$8_^#Q_\Q=^F\[R9L#1ZFHQ6]Y=
M]<[G(F5 D(*<$Q7*^L9E3>JKS*),TILVMK,U9_VF@@[!Z4-#VQ4>.G /=O _
MJ87!ABD./&.IS; S>.TC^*B\1)&*N;TU<8YVIN.BL2_4[-?O]" 5CIY0^@4S
M9 X6&9=Y^3$OKR[KE=#?24D?Z-V+#VL*Z+,?YIN*S.5$*1]K)3K$>KRJ"J]#
ME(T%,@\!I2,1JW/WXMV?^G%+&%\BTMN!HU\#_5L^A&?ILW5>"F"J=FY*UE%H
MXC7D+!D&"AQ"HVOL0U _[GG[2UP0[<#112W2069@D\)9/<&WP1R8*!1 "^=!
MZ9K?5DC;)2NL:)=X9N<>,7 (_>.6<[[$9=$2("]MI_B45ZO+O,ZT_W.Z^DJ?
MKTJZ6GV=+S8U988SIKW3%%75]+O2K)9C9^!)<QG(I>2^36']H&R,6V[Z$A?)
M&>#2\R;R,:>K=9WN??[?XO=E?E\NOG^_G$8,EYDBGM55/;1Z._TV76V')D9O
MHM(R@BWU"D/0]?:"2_7<RCHED)$PSKEF3F%FW/+9E[ARS@:=GM?/Q#NN$I<:
M/+I0RU@\H(T.M ZBQ*)346?=-\;M$O@2<7R0"KL]:'J#BRJ_*LIUE\1C#H\>
M/>/T Z'GR1KHD.?A2VXGFS/OBV+5K/!4YW$5^HXV;9ET,B81[Z)-;X-=%)T\
M=?K!<S^3!%_1!_XU82Q&Q4T"$1,#53UXY[(!$[V6EE:-X_XLK-Z0-&X*>Q!,
M/!HH/8CXNQRD]8BUNG4?=02]XTG#VY*G2&QM43 KIJ4N(+(L-496A)XBP&NT
MMGCMK6F3:F]E4:Z/Z=^7?^;IEZ_D+EW\R O\DM]=?0MY\;ZLW[9<R_H6[EHH
MZYQWX)4)]1H6N6]&B7K)BP7'A?&AS5VEH\CMU!(=@J6'EJB]VCK(\-PR>3%;
M3=/T\JI.A_V4X]4F"M^XD3FMTUKS;]^O5ENW<[>==CQKGV(!YNI9NBD4MTOA
M@8=@;!!9L-!FFQR>EW$/SAJC>A2%#S@+KN76?#_(FF^7^ONKU7*%LQI5G5 _
M=O2[AM_>CV.SM0,0N(RY&LYL:)&KB)$</8\@A+!<Z:!TH[FWK1R 9_>/.]*N
M\R7B1+"$NHZ?"T90_$WQ,3A! 7.F)>X"&BRA3<KO(#([W? /P<Y#T]A.35U,
MP%R?5=5\.UZ28?\VGVT8NUBM%M- 9KZZ,?/;\0_;6Q,7BT4M+=U>H(C!!"41
MF+(D79L,8/098N(.C1<\Y#8K\W3:.]W*3\'KF17:!8AWK-'?JA^3TZ.E.C$V
M^R2= <-KA3LY3H#>)_+)&6;NK1*A30'R@82.6Y%R3G,ZB*JZ; ?Q4(JWY?D;
MWN=KE_NW:Y=[1;[S^^_KLYH!O<G#7SJ\6WDBXZW]RU24M$YF8"S8FDAT$(I@
M$'GPA>NB@V^366GE7YX8R6U.B";".I^0!Q EDT/C<H; N #C@I=<&0KIVHAE
M$/([]4</P=JCD>MG5VN7:?/JVTQ7:W_E]7Q6S\ SQ:QY2=O&WZZ0G)E5/BZ+
MOM^#3S>/1S PD F\\^:+6;KW\J<NP3"6.88 7A911VTQ<-H%2%+[I,D#2++-
MO:.#R#S56.[2QL5=;=PY=8I%J80%.-89*N3T &;OZW>>,1XBYVWJG ^C<USS
MUPYG#VUB0^V]7./W#A=UJ-F/?((?>=R+SF0<GV=P%&.I?4@9ZX <J0,H9B*@
M+ 7H9T)[(3'E-J<<9S&6Z\OJVX3!Q_S?5U-:"__X/I]]SHMOT]FUPT&XFJ\_
MLCX#FP1&[@Q*BA,UHW4M4Z;8S6I@%"P*IA*+7/\*AL>\^"79OD-@<Z_#1$ME
MC'@.N5RL)A]K/NKBK^ERPC%%)Y*%'$HUUW4ZD-=U8)E)B,D4;?:Z/T%/O;.@
MZ%\/%].]UX[8,*RI5N>GBK@'7/R9:P9A$I,7#H,$QS&"*I;BJ*AI\22)SEDI
M3-JK>>/^R-B\>!QLG*"RATH_0GXCJ_U/_&OZ[>K;->%.:&M8'9&I:EMK9\!)
M^BYS;8/ P*38ZS1L+\7?>_7(JC]&<?,AI-A!5<IZ.._=G?35SW>XHGWT?;G]
M\<_UX@A>9I7*.JWB:]:8OK,^ +J$,0M7N&H3G^U/XXA- <^QOS166G=PW'+U
MV_P;3F<3Y[$$2W&E<MK4$S1)3+D,S#$*/KD2KE&SEF>(&GF85B,</ NWXY4R
M=I_)S1+,^>\9+U=?7Y.(_YA1R%#[<VTF@VU-N,*B(N<6-(HZ$*PP\)PV I8H
MI$C22 HL]HJN]GQA3R Z0;OSQJ(>&S[[6_CUBC,D.VM10I;5ETRURV"R!8(F
MQT!DPZVW>Z'HL/>.V)3T'%M@:TV\')!MER@C>\ZM"F!%QIKK\$!K54%RKN08
MI;1[]F(^],TO(I8_7/_'X>P(972&M,_SUWG^#(?UYOC\:O4:KY9Y/:CK\U><
M_3ZO#2YIY]AT1?QC5C<2(G)KW9$[FVKG!5YO("JUKGGB$:1E%$LG$4CVQV"S
M :TO LW'H.P9/(^M\NY6P/M2II&>_8Q,'K"_<;1OV><NR.@Y11&BMN,Q)8 C
M%QN\-4IEQV6.^[6!'IZV%Q$;#X[P\ZJT,T0_P_3;Z2S_L<K?EA,G>1;6.8BU
M9$8QS( JTQ:)WO(<!8J0!G8@;EX^8K_R#IW5XW320=;FP]4B?D7:),+E],NF
MT3K/R;$:V&7.:DL9J8CXD !]*(A%%_UPZQ\H6?.8EA>QM1^I^_F@BN@ 2@^R
M$;_A-_R2EY_F5U^^KFI;]3SA)>HB(P>=?#VC20Z\*P6X1!.<Y3&8-L/%?DG:
MB]AAAP':L&KJ#W<7,2ZN\/*"G-_%XB?]<,.4SAX-"Q)DI"\JH(6@1 &!11K&
M#'>JS:S4O<A[$:F?)O@;0%UCNVX?:[W5+*?7ESC]=CV^\^>'O/AC%J>)!#<Q
M*3FKDP:5ZA"]0,L*O0[@2R@\JN@M[E?T\\M7O0BW[#0@-9!Y!U;L;WF6%WAY
MDVN_G@86K).L-MV7RM)"B(;BJ6(X!$N15I8LFAR:V*T=!(TX%^;<EFH(E72
MK$_YLMSP\)'TM?A!>[SD+J(RI'A1NP^A@1 -^9:9JZ258A2S-X'54]2,T_-P
M%$R=K(P. /4VK^K#WI?7].[IZL[UQ.UM&L.\%:9P2$(%<B#)=W2,!!049Q1^
MA\1$FQO0OZ)LG*:$X[A90RJI ]!]NOK^_7)[D?L?LWPCK>ONB9]RO4%+B^JF
MG6+F24A#:TD86=M(9Y*>D1(2-\7:4OM(M\EC'$SJ7K!T_Q&P;*O&'G!ZTTJ@
MWCLD?V&KQYM^ J]^/NXV4%N*?KC$V9_S-"W3N/Z3W_(R+J;K&\ 7LSHIDR1?
M&&T./A30H8ZZ8\J#%SY 3*)PBU:KAV<40T&Z(5=[H=__9Z"_%W"\Y(5R$6.^
M)".QNO^7=8SR) =!,5ZP8'D]\;$:(9"R(%N;K0\80FSDUC;@9K_L-_O?O3*&
M0D,'*^+F*M_M&<!R.R7C?G+,J:A<LO5@("E0RI#7)J6!R(@[IIS2IDTN<U\*
M]T/N?\;!31.M=7G-]E/^LI'L]_FBIF_O$[O?#=I'SSC]<NSS9 UT[_7A2VY[
M5S 4*6H.MF ]7/8(3B #&QPA)^; 39O6WKLH.CU==/^YM_<S;V^,>RU=3('"
MQJ1IO62L)Y.NUEE$QWBP08DV4RKW(&[<DNQ!</(X:32L2EZ$=3F^\?>.)PUO
M:1HV_MZ)HYARED4'L-JQ.ETT@).L7GN447!13'"-0L!6]N:FU^[#-_PQ*_/%
MM[62R/O;_/(6\,%9Y9UFX!PC0>3HP.MB0'ND%29I/3R\ZC%X!^6#".[4+AV"
MI]UMDMNIKHN&BK>,OIFMIJN?_R3#<&N$W\_^EN=?%OC]ZS1>U"%>;^>S+V^G
M/W*Z6"YSG7_WQRQ-?TS3%=;Y,7GZA<*3J]EJL;[VM?GVYZUT>$UJ>4\[A9:2
M-%)R+?MQ( /*Q+0U)K3)GI^3RW$[C39>#9V!Y$5L]T.TY_GE,X=W <[2=&<G
M7&4RVGH3JQAJ@L-PP,(9^&S(&;2<6_NR@H_K_J>;!Z^GMFW>M)Q$9S/G6H+4
M=:RZ#0D"MQ*,M]YE)4/V;>ZP[Z:ITRW]$%0\-&(#*>!%F)Q/5]^^X>+G_-I[
M^9 7:Z]E%H<T0GN\97BS="AKK0V5BH%K[A *9@[*6 6H+2TU0_X>1^&+:G06
MVT?4LKZ'H&-*(J,&IFCC5EY$P" $Z)!L\=8QK=N4<AU!;*>F[1 <G1BM'*RR
M#DX0ZHC3S6G)U7(ZR\OEM?%>7Z:U)COIB 4M5;V:E1@$(R/D*)7Q2A37J'7I
MLV2-C+36H'@(PL$TU /<-K1O;_Y9B=GR(L"HJ$%I&P ]20D9<\)J%1BV*BF\
M0\;(<!I.O4_G@(^0]=CE\?58%F?K2H7I-[S\VV)^]7W+S?:>)E-%69$TT,**
MH-!X\E55@) R6769DLWJ5V[7?J_J8EL[1H?S9@(=&Q[_I!6SN$]^1L6BBA8L
M(@/%23(^NEJ?J!(*+9/W<2\\/'YV%WFG4P%PHLA&3:FN&:AYKV6=<'$Q2Q_F
M5Y>KQ<_?IOAE-E^NIG%YG[.0K?!26I(2IEIMS\')0)N 0YZS*I%EMQ<8#GCI
MN(-F!D))*R&/;3#6_2SNDT^?R$8X"TX86R_\& B6&$G9A*"S,$FRO3#R^-GC
M7*@:& HGBJR/,YC=_OG;FT*>C!B"* &TK^-D(TI 1 _,A6 <8K)H6_J@SU(W
M\MYS[DAG:'UU$/!\S#_R["IOILK,UBF)VFGG]179V6]YL9DZ4_,5RR7Y_CE]
MQK\F/+@4M/(0-"-?K X&"]HY0%6SIHJ%U&BXVA'$=N$>#XB8^7G5UX6=?/^]
M5L.NQ1>)JWK=FN(!Y5P@40D12&C<,_#>%\@6N57H: \L33#X!#%=>.#M,':J
M^#NP<G_,Z%GD.FXXV-YZ?3>?S:]9>Y=7$RPE")\9!)7(8]0Q@Y>* ;D-W@N1
M-6N4T=^'NB[\]W88&UQ!78#N>KE<F^?I[(I8V:ZG^6SY*I,8\^9S9)GKD#<R
MX:3,Z0P7/]=2)1G$30>PR[7<-V*:)"XP>)("]ZDVDZ O/HD$C!E!$0XZ$]KT
MG6G(5!=Q24N(]P&'P6:HGKHRB,7M0M_>C)PXHYW%HB'4>0>*@C9 71@(&X*W
M63G9Z*[3#H+&Z0QQ9D2>IH8.[.R'Q9RH7KLET7L*YC!#K-=0E-<U!9!3K<KD
M69F(P;2IXK^E89S.#V?#S)'"[L#HD =Q:X+O#TO?855S5&CKI::H:OO81%^<
M"AXH?&):<96+:1-C'$SJ.%T@S@:ZMJH[')M^@\U97@V/S(F6# -R!)%$IM"*
M$=6,PO.B6<F*:U5LFS#D'AGC-' 8!U$'B;P#2_9;IC?'Z?;:_/?+O+TT?_&M
M2NM_MJTV=9(V11*'EV4]^!1";<B3%*,EH57.JDV2;A_JQFF0<#9T#:Z@EU%\
MNDW'SPNMK@=W <+/#XOI+$Z_X^6#2P-#UJ6>1$"#DM7A!-*ZFK4D[Z4J&6Q8
M7[ZH9V=(7IUP,F66C->R42%G\VK6;8I\'7530)T7,[R\SH_7T:T/%+,Y)C)!
M15VR!1\UK7Z6+#B;"NA2YT=KY*75J=M)=/=UVG$4NG;7N#97Y,@#,&\J[6X-
M EZNJ^R\L^232 66U_;%4ED@;\61_*).-I"'XO=:G7L-P]Q)1B]EK>UQ,!]:
M*6,C:[,P[[*PK;_(.F6=B0DFM":QA)I2+P5,4E(FBN"YWNMFYG[(VD7&>"-7
M!U+O?&A9CPR8"UI*1/GRNI8JY"B%K+E $4"):,!CB,"LY](55WC6@Z'D_KM'
MA,8PBIP/(M41\1 W%W4G__@T\3$K[9T"%RS%R8(6AG=8&8C2Y131A.=2$\L<
M_Y\O\Q__[_:)&RAL_[%&PAH#M^\;3_>G:&I^DM@Z4/2KCY,B;&$I""B&$<*C
M3!!RHF4:%*)CH;AGIV\?INA7'\<IH!A8T0>*K0-%O[Z8R)*Y0,Y HG&U%JC.
MD]((KDA=G)4R/MM[Y3!%O[X8IXIA8$4?*+:1M_(W5XOY]^NI\B8K86K.*1A-
M3HWB#HAKPJM(.1)VI<3A HF[;QYOA0^_C1\MT0Z6_&]O)AJ+=A1P@])&;RCV
MHD30(1;B/*?LG^LR=-B2_^W->)OX\7J:GR2T#M3\MU>3B(5SG@QH5GL;A,P
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M#R6Z#FXR'%C9\/:F6)&YS(/0%KBND^^TM^ <><084I0Y^,14FTKU8RGNI7'
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MY0GS-@@4 1*O/2*D5#7[3E],]MDY+$KM=1_M2(NV)>-%I"".U/B3!NX8\7>
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MQI$91T;!=:88W1C>[[<(: 1%ZSDJ&Z40FK7.FSN*\/-4G4/0^>/$N_:27D#
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M/ZF]_Z)^!'^;__F/_P)02P$"% ,4    "  ;=U!42%[U5- +  "_3   '@
M            @ $     83$P,3EI9&5X>&]R=&AO;&5T=&5R9&%T960N:'1M
M4$L! A0#%     @ &W=05+2=NVM)00  .G$! !X              ( !# P
M &$Q,#,T96UP;&]Y965S=&]C:V]P=&EO;F%W+FAT;5!+ 0(4 Q0    ( !MW
M4%2,15%J0$<  (F_ 0 >              "  9%-  !A,3 T,65M<&QO>65E
M<G-U87=A<F1A9W)E92YH=&U02P$"% ,4    "  ;=U!4S;\XP",;  ".B@
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M;VXN:'1M4$L! A0#%     @ &W=05&QA-OK=%P  L'D  !X
M ( ! E8! &5X,3 R.6ED97AX+61I<F5C=&]R<G-U86=R+FAT;5!+ 0(4 Q0
M   ( !MW4%3@0W*H3]<  /NX$  =              "  1MN 0!E>&AI8FET
M,3 Q+6]R=&AO86=R965M96YT+FAT;5!+ 0(4 Q0    ( !MW4%3OF7$)'*P
M .@##0 >              "  :5% @!E>&AI8FET,3 Q,"UO<G1H;W)O=V%G
M<F5E;2YH=&U02P$"% ,4    "  ;=U!40V: _3X8  " 1P( '@
M    @ ']\0( 97AH:6)I=#$P,3$M;W)T:&]R;W=A9W)E96TN:'1M4$L! A0#
M%     @ &W=05'42-%4,%0  $)L  !X              ( !=PH# &5X:&EB
M:70Q,#$S+6]R=&AO<F]W86=R965M+FAT;5!+ 0(4 Q0    ( !MW4%2PIPL-
M]R,  ".H @ >              "  ;\? P!E>&AI8FET,3 Q-"UO<G1H;W)O
M=V%G<F5E;2YH=&U02P$"% ,4    "  ;=U!4$XOR]28.  !@2@  '@
M        @ 'R0P, 97AH:6)I=#$P,38M;W)T:&]R;W=A9W)E96TN:'1M4$L!
M A0#%     @ &W=05,JD58QO&0  [$@" !X              ( !5%(# &5X
M:&EB:70Q,#(M;W)T:&]U<V%G<F5E;65N+FAT;5!+ 0(4 Q0    ( !MW4%18
M$GM]-!<  &>N   >              "  ?]K P!E>&AI8FET,3 U+6]R=&AO
M=7-A9W)E96UE;BYH=&U02P$"% ,4    "  ;=U!4R69XPRLD  #QI0( '@
M            @ %O@P, 97AH:6)I=#$P-BUO<G1H;W5S86=R965M96XN:'1M
M4$L! A0#%     @ &W=05#H%+[([#@  E$H  !X              ( !UJ<#
M &5X:&EB:70Q,#DM;W)T:&]U<V%G<F5E;65N+FAT;5!+ 0(4 Q0    ( !MW
M4%1Z:R>2! @  &2S   >              "  4VV P!E>&AI8FET,C$M<W5B
M<VED:6%R:65S;V9T:"YH=&U02P$"% ,4    "  ;=U!4ZEPUJI\(  !L+0
M$               @ &-O@, 97AH:6)I=#,Q,3$Q+FAT;5!+ 0(4 Q0    (
M !MW4%1]L22CK@@  %HN   0              "  5K' P!E>&AI8FET,S$R
M,3$N:'1M4$L! A0#%     @ &W=05%,ZP/@7!0  O1(  !
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M,#(Q,3(S,5]C86PN>&UL4$L! A0#%     @ &W=05-?)")SJD0  )&8& !4
M             ( !H%D) &ED>'@M,C R,3$R,S%?9&5F+GAM;%!+ 0(4 Q0
M   ( !MW4%1A8@$$EPX  .</   4              "  ;WK"0!I9'AX+3(P
M,C$Q,C,Q7V<Q+FIP9U!+ 0(4 Q0    ( !MW4%14/T2E=5P  />H   4
M          "  8;Z"0!I9'AX+3(P,C$Q,C,Q7V<R+FIP9U!+ 0(4 Q0    (
M !MW4%3D(WE>9)@! !FB$  5              "  2U7"@!I9'AX+3(P,C$Q
M,C,Q7VQA8BYX;6Q02P$"% ,4    "  ;=U!4X!M75<?X  !6<@L %0
M        @ '$[PL :61X>"TR,#(Q,3(S,5]P<F4N>&UL4$L%!@     A "$
*-PD  +[H#     $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
